data_2ha1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ha1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.19 -0.67 . . . . 3.83 109.19 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.39 150.7 18.54 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.991 -0.844 . . . . 1.39 110.991 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -35.56 142.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 124.015 3.143 . . . . 0.86 113.76 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.563 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -80.06 173.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.268 -1.333 . . . . 1.43 108.802 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -105.62 125.86 51.47 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.394 -0.522 . . . . 1.94 111.407 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.49 144.02 33.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.662 -0.699 . . . . 1.19 110.629 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.03 168.3 25.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.891 0.377 . . . . 3.92 111.145 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.586 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.98 131.08 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.01 -0.541 . . . . 3.88 110.074 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.16 162.31 35.78 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.861 0.362 . . . . 3.92 111.217 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 9' ' ' THR . 79.8 mm-40 36.07 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.611 -0.514 . . . . 6.08 109.611 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.586 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.6 32.57 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.973 -0.558 . . . . 4.01 111.6 -178.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.636 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.32 -29.1 72.43 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.487 2.125 . . . . 4.51 111.819 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.636 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.64 125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 3.51 110.443 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 17' ' ' SER . 2.8 mp0 -123.91 158.29 60.56 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 4.3 110.435 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.646 ' HG2' ' NE ' ' A' ' 143' ' ' ARG . 97.7 Cg_endo -82.02 -64.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.94 2.427 . . . . 1.96 113.428 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.725 HD21 ' N ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -108.35 -19.53 13.44 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.067 0.395 . . . . 3.33 112.067 -178.495 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.725 ' N ' HD21 ' A' ' 16' ' ' ASN . 9.8 p -107.31 152.04 24.67 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.484 -0.486 . . . . 1.53 111.338 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.26 102.9 2.23 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.769 -0.65 . . . . 2.29 110.675 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.68 145.61 13.01 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.853 2.369 . . . . 0.88 112.664 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.413 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.74 167.92 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.899 -0.591 . . . . 2.12 109.919 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.12 147.95 29.09 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.829 -0.434 . . . . 2.67 109.829 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.499 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.6 p90 -142.29 157.29 44.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.972 0.415 . . . . 0.32 111.194 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.466 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.05 155.34 44.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.797 -0.638 . . . . 2.77 110.092 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.65 173.05 6.34 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.118 0.485 . . . . 1.25 110.743 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.68 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.873 2.382 . . . . 1.12 111.515 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.11 -51.0 0.69 Allowed Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.674 -0.411 . . . . 4.05 110.098 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.655 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.84 152.32 82.58 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.791 2.327 . . . . 2.12 111.426 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.67 42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.413 0.625 . . . . 2.85 110.606 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.822 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.63 -41.67 98.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.976 -1.011 . . . . 3.11 110.632 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.443 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.7 mt -109.83 137.81 40.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.821 -0.627 . . . . 1.86 111.343 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.9 -72.94 0.7 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.109 -0.496 . . . . 1.61 111.938 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.12 148.4 24.46 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.623 0.601 . . . . 1.67 112.623 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.81 124.82 45.07 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.424 -0.584 . . . . 1.07 109.424 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.07 134.73 60.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.626 -0.43 . . . . 1.55 110.625 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.488 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -120.0 128.66 53.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.054 0.454 . . . . 1.33 111.241 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 138.96 49.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.779 -0.646 . . . . 2.36 110.141 178.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.418 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.01 163.18 35.01 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.125 0.488 . . . . 0.38 112.119 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.489 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.47 139.59 7.87 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 115.484 -0.78 . . . . 2.31 110.506 178.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.684 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.8 Cg_endo -63.55 115.46 3.06 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.33 2.02 . . . . 0.86 111.784 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.674 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.96 81.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.891 -0.411 . . . . 3.44 109.891 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.23 -20.67 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.998 -0.546 . . . . 2.72 111.906 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -157.66 157.82 34.3 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.78 -0.368 . . . . 2.78 110.465 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.42 27.85 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 2.3 110.151 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -75.88 1.31 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.122 -0.561 . . . . 1.8 111.812 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.93 152.34 35.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.984 0.421 . . . . 5.48 110.995 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.12 2.53 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.992 -0.549 . . . . 1.84 111.886 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.17 149.63 29.81 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.457 0.646 . . . . 2.27 112.565 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.97 156.46 46.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.781 -1.099 . . . . 1.92 110.285 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.21 158.43 41.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.967 -0.56 . . . . 1.09 111.776 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.6 m -115.24 135.6 53.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.422 -0.808 . . . . 1.16 109.79 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.445 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.45 121.98 23.71 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.418 -0.355 . . . . 1.39 111.568 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.51 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.5 Cg_exo -46.27 151.75 1.58 Allowed 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.624 2.216 . . . . 0.72 112.121 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.96 -22.98 63.11 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 116.029 -0.532 . . . . 0.74 112.81 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.51 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.8 -16.9 45.99 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 120.244 -0.582 . . . . 1.26 111.804 -178.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.49 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.57 138.39 31.61 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.707 -0.397 . . . . 1.59 110.329 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -121.46 13.96 11.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.391 -0.368 . . . . 2.07 111.569 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.475 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.0 143.48 25.21 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.648 -0.421 . . . . 0.96 111.064 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.716 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.9 t80 -114.84 -169.3 1.52 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.864 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.716 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.76 125.95 9.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.422 -0.808 . . . . 1.19 109.818 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.477 HG23 HD11 ' A' ' 60' ' ' ILE . 66.9 mt -114.96 123.27 70.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.346 -0.542 . . . . 1.47 111.166 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -126.47 163.4 23.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.807 -0.633 . . . . 3.0 110.498 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.18 18.94 59.88 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.714 -0.954 . . . . 0.5 110.714 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.434 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.9 mt -79.06 157.27 28.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.065 0.46 . . . . 1.21 111.326 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.664 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -99.55 134.01 21.45 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.608 -0.723 . . . . 3.2 110.399 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.98 143.54 60.71 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.519 2.146 . . . . 1.09 111.944 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.0 25.57 75.43 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.997 -0.841 . . . . 0.72 110.997 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.643 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.19 158.8 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.72 0.295 . . . . 1.47 110.43 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.15 139.9 42.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.884 0.373 . . . . 1.23 110.583 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.664 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.6 m-85 -122.54 136.49 54.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.923 -0.581 . . . . 1.1 110.69 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.489 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.3 pt-20 -98.89 131.04 45.28 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.545 -0.909 . . . . 1.87 108.545 177.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.46 153.9 16.64 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.326 -0.94 . . . . 0.39 111.969 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.0 140.93 46.05 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.675 -0.491 . . . . 1.8 109.675 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.466 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.0 tp -115.76 118.87 34.24 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.474 -0.49 . . . . 1.11 110.468 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.43 129.08 68.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.388 . . . . 1.51 110.68 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.79 120.79 43.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.27 -0.423 . . . . 1.47 110.732 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.667 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.5 146.42 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.115 0.483 . . . . 1.33 111.082 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.822 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.02 153.85 21.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.496 -0.775 . . . . 2.49 109.89 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.1 88.55 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.88 0.372 . . . . 4.2 110.43 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.622 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.25 32.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.829 -0.623 . . . . 6.4 110.614 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.1 -117.37 3.29 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.447 -0.661 . . . . 1.74 111.447 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.449 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.37 177.43 8.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.222 0.534 . . . . 3.64 111.601 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.18 149.49 32.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.405 -0.816 . . . . 1.7 110.41 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.13 144.68 38.76 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.467 -0.333 . . . . 2.7 110.6 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -128.0 136.01 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.05 0.453 . . . . 1.16 111.555 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.09 141.33 52.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.681 -0.691 . . . . 1.14 110.279 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.449 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.63 138.86 51.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.126 0.489 . . . . 4.33 111.501 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.25 164.19 37.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.564 -0.744 . . . . 0.91 109.471 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.571 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.31 151.49 38.4 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.422 -0.511 . . . . 1.47 111.042 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.574 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.7 p90 -146.18 172.7 13.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.788 -0.642 . . . . 0.51 111.017 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.449 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.69 160.65 21.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.455 -0.793 . . . . 1.92 109.897 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.449 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.42 121.8 22.8 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.653 -0.419 . . . . 1.63 110.816 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.1 p -128.33 146.42 50.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.048 -0.524 . . . . 2.37 111.858 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.798 -0.637 . . . . 3.63 109.974 176.792 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 4.6 p . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 111.988 0.366 . . . . 1.25 111.988 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.468 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.9 167.6 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.097 0.475 . . . . 1.16 110.932 179.474 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.62 145.56 50.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.704 -0.68 . . . . 0.78 110.123 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.26 101.66 9.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.063 -0.717 . . . . 1.08 109.063 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.462 HG11 ' N ' ' A' ' 131' ' ' SER . 71.7 t -112.93 139.69 36.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.026 -0.534 . . . . 1.1 111.109 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.462 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.2 p -128.66 152.47 48.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.7 -0.682 . . . . 0.87 109.929 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.647 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.6 p90 -144.8 -165.01 2.05 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.692 -0.403 . . . . 0.37 110.569 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -123.95 127.17 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 1.14 110.809 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.176 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.97 58.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.126 -0.488 . . . . 1.91 110.31 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.21 24.57 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.892 -0.595 . . . . 1.56 111.52 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.176 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.11 128.76 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.638 -0.425 . . . . 1.56 110.919 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.5 -9.51 56.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.883 -0.599 . . . . 1.88 110.289 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.16 0.25 55.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.14 -0.482 . . . . 1.63 110.289 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.958 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.21 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 1.11 109.899 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 185' ' ' ILE . 94.2 p -96.28 -15.47 21.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.259 0.552 . . . . 1.01 110.056 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.54 175.6 45.76 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.887 -1.285 . . . . 0.14 109.887 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -123.48 151.57 42.61 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.69 -0.404 . . . . 0.21 110.509 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.646 ' NE ' ' HG2' ' A' ' 15' ' ' PRO . 73.0 ttt-85 -132.34 121.22 23.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.136 -0.484 . . . . 1.54 109.881 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.494 HG23 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.15 136.51 38.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.664 -0.698 . . . . 1.08 110.707 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 79.5 tt0 -129.29 129.95 45.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.038 -0.528 . . . . 1.32 110.057 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.9 p90 -138.79 135.31 34.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.985 -0.552 . . . . 1.05 110.567 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.415 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.28 39.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.762 -0.654 . . . . 1.16 109.733 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.939 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -70.99 124.87 25.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.978 0.418 . . . . 1.23 110.713 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.499 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.76 -7.7 49.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.687 -0.688 . . . . 0.86 110.891 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.85 -69.69 0.85 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 1.66 111.343 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.451 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.7 -35.35 76.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.017 -0.538 . . . . 1.66 111.492 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.093 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.19 7.25 88.58 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.806 -0.918 . . . . 1.62 110.806 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.318 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.99 -171.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.779 0.323 . . . . 1.86 110.275 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.318 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.32 139.09 44.95 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.947 0.403 . . . . 1.98 110.187 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.415 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.1 Cg_endo -70.81 145.75 51.91 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 122.725 2.284 . . . . 0.62 112.31 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.85 145.71 42.62 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.195 -0.669 . . . . 1.14 109.195 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.531 ' HH ' ' CE ' ' A' ' 64' ' ' LYS . 6.2 p90 -123.21 141.36 52.06 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.378 -0.529 . . . . 1.44 111.573 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.7 mt -128.1 127.67 43.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.338 -0.846 . . . . 1.08 108.952 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 52.4 t0 -101.63 131.22 47.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.172 0.511 . . . . 1.09 111.763 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.506 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -127.97 157.57 73.44 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.317 -0.856 . . . . 1.04 109.566 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.75 158.04 58.34 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.439 2.093 . . . . 0.21 112.262 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.3 -12.18 5.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.842 -0.617 . . . . 0.88 110.725 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.4 p -92.81 -8.74 42.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 1.06 110.711 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.42 34.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.378 -0.374 . . . . 1.05 110.391 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.19 16.66 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.354 -0.385 . . . . 1.07 110.491 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.0 p -167.53 147.18 5.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.644 -0.502 . . . . 0.92 109.644 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.506 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.19 150.39 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.538 -0.465 . . . . 1.09 111.576 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.497 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.28 124.94 50.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.624 -0.716 . . . . 1.31 109.809 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.515 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.37 104.88 29.57 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.924 0.392 . . . . 1.09 111.105 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.5 Cg_endo -90.94 -179.54 1.52 Allowed 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 123.197 2.598 . . . . 0.48 112.243 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.72 32.63 18.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.394 -0.821 . . . . 1.26 111.417 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.515 HD21 HG21 ' A' ' 169' ' ' ILE . 24.4 mt -86.33 148.51 25.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.496 -0.32 . . . . 1.12 110.521 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.767 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.24 114.82 61.1 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.912 0.387 . . . . 1.3 110.696 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.0 140.53 95.76 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.858 2.372 . . . . 0.92 112.014 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.16 21.2 74.1 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.009 -0.837 . . . . 0.44 111.009 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.451 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.81 150.12 49.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.732 0.301 . . . . 3.05 110.688 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.499 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.14 131.59 46.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 1.48 109.833 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.939 ' CE2' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.48 148.28 44.03 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.143 -0.48 . . . . 0.89 111.038 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.3 mt -105.33 125.29 60.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.27 -1.011 . . . . 1.12 108.27 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.5 132.47 63.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.183 0.516 . . . . 1.1 111.274 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.9 m-20 -136.46 122.59 20.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.532 -0.758 . . . . 0.43 109.636 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.596 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.03 125.39 54.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.187 -0.46 . . . . 1.07 110.665 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.671 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.9 m-85 -117.25 137.97 52.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.007 -0.542 . . . . 0.92 109.835 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.76 135.07 42.78 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.786 -0.82 . . . . 0.49 108.786 178.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 140' ' ' SER . 85.3 mt -99.09 122.92 51.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.07 0.462 . . . . 1.08 110.96 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.449 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.5 p -83.79 169.7 14.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.534 -0.757 . . . . 0.89 110.484 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.83 -14.51 15.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.04 -0.527 . . . . 1.6 110.934 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.505 ' C ' ' OG1' ' A' ' 59' ' ' THR . 79.2 m-20 -96.1 -4.29 43.12 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.833 -0.347 . . . . 1.18 110.825 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.516 ' N ' ' HG1' ' A' ' 59' ' ' THR . . . 87.78 13.89 64.02 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.379 -0.689 . . . . 0.34 111.379 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -84.62 139.05 32.34 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.058 -0.257 . . . . 1.22 110.518 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -106.76 141.11 38.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.903 0.382 . . . . 1.44 110.513 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.6 m -136.72 126.97 26.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 1.39 110.36 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.671 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.5 tp -68.06 117.25 9.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.329 -0.396 . . . . 1.08 110.528 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.647 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.1 pt -109.03 -21.84 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 1.08 110.712 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.87 125.79 5.9 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.514 -0.475 . . . . 1.1 111.485 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.487 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.75 120.24 21.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.79 -0.641 . . . . 0.94 109.578 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.71 29.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.955 0.407 . . . . 1.07 110.927 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.47 158.66 18.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.052 -0.522 . . . . 0.89 110.413 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.09 157.96 43.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.03 -0.532 . . . . 0.67 110.659 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 104.26 9.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.721 -0.672 . . . . 1.17 110.047 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.477 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 66.6 p . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.876 -1.059 . . . . 1.26 110.665 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.197 -0.668 . . . . 3.83 109.197 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.72 18.54 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.049 -0.821 . . . . 1.39 111.049 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.73 142.41 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.09 0 C-N-CA 123.94 3.093 . . . . 0.86 113.748 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.572 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.0 t -79.93 173.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.205 -1.361 . . . . 1.43 108.83 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.64 125.89 51.51 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.482 -0.487 . . . . 1.94 111.409 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 p -136.52 143.99 33.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.573 -0.74 . . . . 1.19 110.622 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.06 168.25 25.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.936 0.398 . . . . 3.92 111.072 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.587 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.4 mt -108.87 131.1 60.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.019 -0.537 . . . . 3.88 110.155 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.21 162.32 35.77 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.931 0.396 . . . . 3.92 111.149 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.1 mt-10 36.06 31.68 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.559 -0.534 . . . . 6.08 109.559 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.587 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.53 69.63 33.56 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.939 -0.573 . . . . 4.01 111.533 -178.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.28 -29.09 72.75 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.501 2.134 . . . . 4.51 111.881 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.64 125.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 3.51 110.477 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.701 HE22 ' CD ' ' A' ' 191' ' ' GLN . 18.7 mm-40 -123.9 158.33 60.37 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 4.3 110.462 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.54 ' CG ' ' NE ' ' A' ' 143' ' ' ARG . 98.8 Cg_endo -82.08 -64.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.901 2.401 . . . . 1.96 113.494 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.673 ' OD1' ' O ' ' A' ' 63' ' ' LEU . 51.6 t30 -108.43 -19.56 13.41 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.119 0.415 . . . . 3.33 112.119 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 1.3 p -107.27 152.03 24.66 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.499 -0.48 . . . . 1.53 111.346 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.28 102.88 2.23 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.737 -0.665 . . . . 2.29 110.689 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.57 145.63 13.19 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.914 2.409 . . . . 0.88 112.639 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.411 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.8 167.98 24.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.808 -0.633 . . . . 2.12 109.924 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.16 147.93 29.03 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.74 -0.467 . . . . 2.67 109.74 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.499 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.4 p90 -142.3 157.3 44.97 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.624 -0.43 . . . . 0.32 111.212 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.462 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.9 m-20 -128.04 155.22 44.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.831 -0.622 . . . . 2.77 110.187 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.62 172.99 6.42 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.097 0.475 . . . . 1.25 110.743 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.54 173.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.885 2.39 . . . . 1.12 111.513 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.01 -51.15 0.69 Allowed Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.746 -0.381 . . . . 4.05 110.093 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.651 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.8 Cg_exo -64.89 152.4 82.38 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.743 2.295 . . . . 2.12 111.423 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.68 42.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.423 0.63 . . . . 2.85 110.587 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.815 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.59 -41.65 98.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.011 -0.995 . . . . 3.11 110.671 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.438 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.2 mt -109.92 137.87 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.783 -0.644 . . . . 1.86 111.251 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.95 -72.92 0.7 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.025 -0.534 . . . . 1.61 111.856 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.15 148.4 24.44 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.557 0.577 . . . . 1.67 112.557 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.8 124.87 45.19 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.41 -0.589 . . . . 1.07 109.41 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.8 mt -118.15 134.8 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.618 -0.433 . . . . 1.55 110.553 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.487 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -120.09 128.66 53.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.071 0.462 . . . . 1.33 111.149 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.547 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.14 139.01 49.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.656 -0.702 . . . . 2.36 110.097 178.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.416 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -145.09 163.19 35.06 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.076 0.465 . . . . 0.38 112.108 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.488 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.49 139.58 7.85 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 115.453 -0.794 . . . . 2.31 110.437 178.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.57 115.46 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.316 2.011 . . . . 0.86 111.784 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.672 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.9 81.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.94 -0.392 . . . . 3.44 109.94 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.14 -20.64 0.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.998 -0.547 . . . . 2.72 111.946 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.56 157.77 34.37 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.815 -0.354 . . . . 2.78 110.559 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.39 27.88 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.23 -0.441 . . . . 2.3 110.17 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.87 -75.9 1.31 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.825 -0.51 . . . . 1.8 111.825 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.89 152.26 35.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.871 0.367 . . . . 5.48 111.051 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.676 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.21 -169.16 2.54 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.077 -0.511 . . . . 1.84 111.925 179.417 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.412 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.11 149.69 29.68 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.409 0.623 . . . . 2.27 112.557 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.08 156.47 45.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.82 -1.082 . . . . 1.92 110.262 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.26 158.33 41.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.938 -0.574 . . . . 1.09 111.791 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 m -115.13 135.67 53.94 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.368 -0.833 . . . . 1.16 109.86 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.443 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.44 121.9 23.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.444 -0.344 . . . . 1.39 111.555 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.2 Cg_exo -46.3 151.74 1.61 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.634 2.223 . . . . 0.72 112.2 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.02 -22.95 63.2 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 116.157 -0.474 . . . . 0.74 112.808 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.515 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.77 -16.88 46.2 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.21 -0.596 . . . . 1.26 111.787 -178.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.488 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.5 mt -91.54 138.46 31.56 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.83 -0.348 . . . . 1.59 110.271 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -121.58 13.93 10.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.362 -0.381 . . . . 2.07 111.548 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.93 143.49 25.28 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.626 -0.43 . . . . 0.96 111.08 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.713 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.85 -169.35 1.53 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.212 0.53 . . . . 1.0 110.829 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.713 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 84.9 m -151.75 125.95 9.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.334 -0.848 . . . . 1.19 109.832 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.432 HD11 HG23 ' A' ' 60' ' ' ILE . 66.6 mt -114.82 123.19 70.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.428 -0.509 . . . . 1.47 111.28 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.576 ' CE ' HG13 ' A' ' 185' ' ' ILE . 8.6 mmtt -126.44 163.31 23.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.906 -0.588 . . . . 3.0 110.482 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.581 ' HA2' HD22 ' A' ' 16' ' ' ASN . . . 85.14 19.06 59.71 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.678 -0.969 . . . . 0.5 110.678 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.673 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 73.9 mt -79.09 157.25 28.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.053 0.454 . . . . 1.21 111.339 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.742 ' HZ3' ' HH ' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -99.45 133.9 21.59 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.568 -0.742 . . . . 3.2 110.491 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.82 143.55 61.68 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.54 2.16 . . . . 1.09 112.029 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.77 25.66 75.3 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.033 -0.827 . . . . 0.72 111.033 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.638 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.13 158.86 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.684 0.278 . . . . 1.47 110.466 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.21 139.96 42.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.967 0.413 . . . . 1.23 110.495 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.638 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.58 136.46 54.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.863 -0.608 . . . . 1.1 110.74 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.95 131.09 45.28 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.541 -0.911 . . . . 1.87 108.541 177.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.487 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.57 153.91 16.67 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.201 -0.999 . . . . 0.39 111.947 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -134.97 140.89 46.05 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.681 -0.489 . . . . 1.8 109.681 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.465 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.0 tp -115.73 118.97 34.53 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.418 -0.513 . . . . 1.11 110.503 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.2 mt -112.45 129.12 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.287 -0.415 . . . . 1.51 110.592 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.9 120.88 43.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.253 -0.43 . . . . 1.47 110.715 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.671 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.69 146.57 11.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.292 0.568 . . . . 1.33 110.921 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.815 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.12 153.88 21.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.513 -0.767 . . . . 2.49 109.941 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.21 88.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.963 0.411 . . . . 4.2 110.371 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.62 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.38 32.45 0.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.784 -0.644 . . . . 6.4 110.577 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.01 -117.39 3.3 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.452 -0.659 . . . . 1.74 111.452 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.448 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.41 177.47 8.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.252 0.548 . . . . 3.64 111.58 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.22 149.47 31.98 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.373 -0.83 . . . . 1.7 110.312 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.15 144.7 38.73 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.463 -0.335 . . . . 2.7 110.528 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -128.03 136.0 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 121.041 0.448 . . . . 1.16 111.538 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.05 141.37 52.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.687 -0.688 . . . . 1.14 110.292 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.449 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.67 138.81 51.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.128 0.49 . . . . 4.33 111.479 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.487 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.19 164.25 37.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.527 -0.761 . . . . 0.91 109.494 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.574 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.33 151.49 38.4 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.442 -0.503 . . . . 1.47 111.075 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.8 p90 -146.15 172.72 13.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.724 -0.671 . . . . 0.51 111.04 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.45 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.67 160.69 21.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.431 -0.804 . . . . 1.92 109.843 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.45 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.4 121.85 22.89 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.573 -0.451 . . . . 1.63 110.752 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.5 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.6 p -126.6 161.34 28.25 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 114.003 1.112 . . . . 2.37 114.003 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.8 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 113.272 -1.786 . . . . 3.63 108.886 178.831 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.536 0.405 0 CA-C-O 121.19 0.519 . . . . 1.25 111.418 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.477 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.85 167.57 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.525 -0.761 . . . . 1.16 110.984 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.489 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.9 m-30 -133.64 145.5 50.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.733 -0.667 . . . . 0.78 110.081 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.23 101.67 9.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.124 -0.695 . . . . 1.08 109.124 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.465 HG11 ' N ' ' A' ' 131' ' ' SER . 71.4 t -112.95 139.7 36.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.974 -0.557 . . . . 1.1 111.069 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.465 ' N ' HG11 ' A' ' 130' ' ' VAL . 69.0 p -128.8 152.48 48.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.612 -0.722 . . . . 0.87 109.776 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.641 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.7 p90 -144.71 -164.9 2.02 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.668 -0.413 . . . . 0.37 110.632 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.732 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.4 t -123.97 127.1 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.218 -0.446 . . . . 1.14 110.788 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.157 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.216 -0.447 . . . . 1.91 110.374 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.14 24.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.928 -0.578 . . . . 1.56 111.469 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.157 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.16 128.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.54 -0.464 . . . . 1.56 110.952 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.39 -9.59 56.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.975 -0.557 . . . . 1.88 110.249 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.18 0.17 55.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.218 -0.446 . . . . 1.63 110.299 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.966 HG11 ' O ' ' A' ' 136' ' ' SER . 2.6 p -65.19 137.17 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.954 -0.566 . . . . 1.11 110.027 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 185' ' ' ILE . 92.5 p -96.14 -15.56 22.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.263 0.554 . . . . 1.01 110.101 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.62 175.58 45.81 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 109.772 -1.331 . . . . 0.14 109.772 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.4 151.59 42.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.971 0.415 . . . . 0.21 110.516 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.558 ' NH2' ' HB3' ' A' ' 157' ' ' TYR . 78.1 ttt-85 -132.42 121.17 23.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.103 -0.499 . . . . 1.54 109.964 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.48 HG23 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.14 136.56 38.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.708 -0.678 . . . . 1.08 110.684 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 84.1 tt0 -129.34 129.8 45.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.961 -0.563 . . . . 1.32 110.085 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.59 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.64 135.24 34.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.033 -0.53 . . . . 1.05 110.703 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.401 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.25 161.3 39.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.865 -0.607 . . . . 1.16 109.763 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.931 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -71.0 124.89 25.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.006 0.432 . . . . 1.23 110.763 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.87 -7.66 49.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.816 -0.629 . . . . 0.86 110.84 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -109.79 -69.67 0.85 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.01 0.433 . . . . 1.66 111.514 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.44 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.3 mt-10 -60.76 -35.22 75.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.033 -0.53 . . . . 1.66 111.51 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.094 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.07 7.27 88.56 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.804 -0.919 . . . . 1.62 110.804 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.323 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.9 t0 -27.95 -171.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.761 0.315 . . . . 1.86 110.314 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.323 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.2 pm0 -82.27 139.11 45.11 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.044 0.449 . . . . 1.98 110.226 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.401 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.94 145.87 51.46 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.726 2.284 . . . . 0.62 112.32 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.81 145.7 42.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.217 -0.66 . . . . 1.14 109.217 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.742 ' HH ' ' HZ3' ' A' ' 64' ' ' LYS . 4.0 p90 -123.31 141.32 52.11 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.349 -0.54 . . . . 1.44 111.537 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.429 ' HA ' HD22 ' A' ' 158' ' ' LEU . 71.4 mt -128.05 127.66 43.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.239 -0.892 . . . . 1.08 108.932 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.671 ' OD2' ' ND2' ' A' ' 16' ' ' ASN . 63.3 t0 -101.49 131.12 47.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.135 0.493 . . . . 1.09 111.879 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.516 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -127.93 157.57 73.34 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.358 -0.837 . . . . 1.04 109.566 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.83 157.98 58.41 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.492 2.128 . . . . 0.21 112.311 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.22 -12.16 4.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.855 -0.611 . . . . 0.88 110.822 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.5 p -92.77 -8.69 42.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.058 -0.519 . . . . 1.06 110.734 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.2 135.39 34.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.413 . . . . 1.05 110.357 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.16 16.68 4.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.439 -0.346 . . . . 1.07 110.504 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.1 p -167.59 147.13 5.04 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.63 -0.507 . . . . 0.92 109.63 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.516 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.1 p -152.21 150.61 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 1.09 111.525 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.37 124.9 50.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.559 -0.746 . . . . 1.31 109.789 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.526 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.28 104.87 29.22 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.424 -0.353 . . . . 1.09 111.088 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.0 Cg_endo -91.0 -179.5 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 123.235 2.624 . . . . 0.48 112.251 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.71 32.58 18.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.413 -0.812 . . . . 1.26 111.438 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.526 HD21 HG21 ' A' ' 169' ' ' ILE . 24.0 mt -86.35 148.5 25.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.772 0.32 . . . . 1.12 110.486 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.763 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.3 114.83 61.22 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.075 0.464 . . . . 1.3 110.704 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.01 140.57 95.94 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.821 2.348 . . . . 0.92 112.04 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.17 74.42 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.101 -0.8 . . . . 0.44 111.101 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.44 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.84 150.23 49.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.896 0.379 . . . . 3.05 110.598 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.491 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.1 tttt -100.14 131.75 45.91 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.997 -0.547 . . . . 1.48 109.799 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.931 ' CE2' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.62 148.26 44.13 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.114 -0.494 . . . . 0.89 110.992 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.2 mt -105.32 125.37 60.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.298 -1.001 . . . . 1.12 108.298 177.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.5 132.57 63.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.154 0.502 . . . . 1.1 111.305 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.57 122.58 20.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.494 -0.775 . . . . 0.43 109.537 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.583 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.0 125.33 54.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.227 -0.442 . . . . 1.07 110.739 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.662 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.3 m-85 -117.21 137.76 52.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.064 -0.516 . . . . 0.92 109.926 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.565 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.66 134.96 42.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.805 -0.813 . . . . 0.49 108.805 178.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.576 HG13 ' CE ' ' A' ' 61' ' ' LYS . 7.7 mm -99.11 122.91 51.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.177 0.513 . . . . 1.08 110.922 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.452 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.6 p -83.76 169.74 14.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.533 -0.758 . . . . 0.89 110.494 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.706 ' O ' ' OG1' ' A' ' 59' ' ' THR . 97.5 mt-10 -59.74 -14.59 15.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.011 -0.541 . . . . 1.6 111.028 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.452 ' H ' ' HG ' ' A' ' 186' ' ' SER . 96.1 m-20 -96.12 -4.22 43.16 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.804 -0.358 . . . . 1.18 110.792 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.79 13.85 64.07 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.388 -0.685 . . . . 0.34 111.388 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -84.58 139.01 32.4 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.107 -0.237 . . . . 1.22 110.506 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.701 ' CD ' HE22 ' A' ' 14' ' ' GLN . 11.8 mt-30 -106.68 141.09 38.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.815 0.34 . . . . 1.44 110.584 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.1 m -136.71 126.93 26.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 1.39 110.359 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.662 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.6 tp -68.07 117.3 9.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.278 -0.419 . . . . 1.08 110.551 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.641 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -109.05 -21.7 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 1.08 110.764 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.91 125.69 5.84 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.542 -0.463 . . . . 1.1 111.459 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.497 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.8 120.28 21.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.726 -0.67 . . . . 0.94 109.517 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.63 151.62 29.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.917 0.389 . . . . 1.07 110.984 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.43 158.5 18.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.049 -0.523 . . . . 0.89 110.464 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -145.97 157.93 43.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.235 -0.439 . . . . 0.67 110.768 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 104.54 9.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.784 -0.644 . . . . 1.17 109.972 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.489 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 68.1 p . . . . . 0 C--O 1.219 -0.534 0 CA-C-O 117.882 -1.056 . . . . 1.26 110.617 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.6 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.199 -0.667 . . . . 3.83 109.199 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.38 150.7 18.54 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.024 -0.83 . . . . 1.39 111.024 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -35.66 142.4 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.101 0 C-N-CA 124.025 3.15 . . . . 0.86 113.742 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.562 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -79.97 173.32 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.29 -1.323 . . . . 1.43 108.769 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.55 125.93 51.55 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.411 -0.516 . . . . 1.94 111.44 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.55 143.95 34.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.618 -0.719 . . . . 1.19 110.622 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.05 168.31 25.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.931 0.396 . . . . 3.92 111.12 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.577 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -108.98 131.06 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.957 -0.565 . . . . 3.88 110.076 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.2 162.31 35.79 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.954 0.407 . . . . 3.92 111.194 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 10' ' ' GLU . 73.1 tt0 36.14 31.53 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.637 -0.505 . . . . 6.08 109.637 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.577 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.42 69.58 32.41 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.958 -0.564 . . . . 4.01 111.621 -178.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.29 -29.09 72.62 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.529 2.153 . . . . 4.51 111.802 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.52 125.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 3.51 110.548 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.529 ' CB ' ' O ' ' A' ' 17' ' ' SER . 11.7 mt-30 -123.89 158.34 60.33 Favored Pre-proline 0 C--O 1.234 0.26 0 CA-C-N 116.241 -0.436 . . . . 4.3 110.537 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.486 ' CG ' ' NH1' ' A' ' 143' ' ' ARG . 98.3 Cg_endo -82.12 -64.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.931 2.42 . . . . 1.96 113.457 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.627 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 61.9 t30 -108.4 -19.5 13.44 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.114 0.413 . . . . 3.33 112.114 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.554 ' HG ' ' N ' ' A' ' 18' ' ' HIS . 29.7 t -107.31 152.1 24.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.148 0.499 . . . . 1.53 111.339 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.578 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.24 102.92 2.23 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.687 -0.688 . . . . 2.29 110.61 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.72 145.64 12.95 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.888 2.392 . . . . 0.88 112.568 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.411 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.81 167.98 24.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.896 -0.593 . . . . 2.12 109.961 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.23 147.89 28.94 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.776 -0.453 . . . . 2.67 109.776 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.506 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.4 p90 -142.24 157.29 45.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.017 0.437 . . . . 0.32 111.196 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.465 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.04 155.26 44.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.715 -0.675 . . . . 2.77 110.064 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.6 173.05 6.34 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 121.111 0.481 . . . . 1.25 110.728 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.69 173.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.779 2.319 . . . . 1.12 111.533 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.484 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.1 -51.03 0.69 Allowed Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 120.694 -0.402 . . . . 4.05 110.111 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.654 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.81 152.32 82.52 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.737 2.291 . . . . 2.12 111.483 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.64 42.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.332 0.587 . . . . 2.85 110.564 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.814 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.65 -41.55 98.21 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.953 -1.021 . . . . 3.11 110.722 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.451 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.1 mt -109.87 137.89 40.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.842 -0.617 . . . . 1.86 111.276 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.93 -72.95 0.7 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.063 -0.517 . . . . 1.61 111.911 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.09 148.28 24.54 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.593 0.59 . . . . 1.67 112.593 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.81 124.94 45.36 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.324 -0.621 . . . . 1.07 109.324 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.03 134.75 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.619 -0.433 . . . . 1.55 110.705 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.488 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -119.99 128.59 53.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.998 0.428 . . . . 1.33 111.281 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.541 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.06 138.95 49.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.741 -0.663 . . . . 2.36 110.14 179.008 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.418 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.2 p90 -145.08 163.14 35.2 Favored 'General case' 0 C--N 1.335 -0.065 0 CA-C-O 121.197 0.523 . . . . 0.38 112.036 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.488 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.48 139.63 7.89 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.38 -0.827 . . . . 2.31 110.482 178.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.63 115.47 3.07 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.392 2.061 . . . . 0.86 111.767 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.684 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.0 81.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.927 -0.397 . . . . 3.44 109.927 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.931 -0.577 . . . . 2.72 111.943 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.2 p -157.59 157.8 34.37 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.865 -0.334 . . . . 2.78 110.577 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.401 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.4 m -120.38 27.8 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 2.3 110.213 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.7 -75.9 1.31 Allowed Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.11 -0.566 . . . . 1.8 111.878 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.88 152.29 35.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.411 . . . . 5.48 110.949 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.665 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.18 -169.07 2.52 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.032 -0.531 . . . . 1.84 111.96 179.343 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.411 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.77 29.59 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 121.48 0.657 . . . . 2.27 112.539 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.15 156.47 45.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.784 -1.098 . . . . 1.92 110.242 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.2 158.35 41.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.931 -0.577 . . . . 1.09 111.841 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.14 135.67 53.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.539 -0.755 . . . . 1.16 109.832 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.45 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.44 121.91 23.71 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.474 -0.33 . . . . 1.39 111.55 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.514 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.4 Cg_exo -46.26 151.7 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.65 2.234 . . . . 0.72 112.124 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.97 -22.97 63.12 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 116.026 -0.533 . . . . 0.74 112.843 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.514 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.82 -16.79 46.39 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.213 -0.595 . . . . 1.26 111.837 -178.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.491 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.3 mt -91.64 138.39 31.6 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.798 -0.361 . . . . 1.59 110.323 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.54 14.01 11.0 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.426 -0.352 . . . . 2.07 111.527 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.07 143.46 25.14 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.671 -0.411 . . . . 0.96 111.075 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.716 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.78 -169.39 1.54 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.888 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.716 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 m -151.69 125.89 9.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.4 -0.818 . . . . 1.19 109.882 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.437 HG23 HD11 ' A' ' 60' ' ' ILE . 66.9 mt -114.88 123.23 70.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.409 -0.516 . . . . 1.47 111.117 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.563 ' HG2' ' N ' ' A' ' 62' ' ' GLY . 37.8 ttpt -126.42 163.38 23.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.824 -0.625 . . . . 3.0 110.49 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.563 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.07 19.04 59.86 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.795 -0.922 . . . . 0.5 110.795 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.627 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.8 mt -79.06 157.17 28.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.043 0.449 . . . . 1.21 111.345 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.594 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 1.5 tttp -99.44 133.93 21.58 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.569 -0.741 . . . . 3.2 110.451 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.46 ' HD3' ' CD1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.84 143.61 61.76 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.505 2.137 . . . . 1.09 112.01 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.75 25.67 75.28 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.071 -0.812 . . . . 0.72 111.071 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.651 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.3 p -128.07 158.74 39.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.715 0.293 . . . . 1.47 110.484 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.11 139.92 42.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.88 0.371 . . . . 1.23 110.581 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.651 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.9 m-85 -122.6 136.51 54.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 1.1 110.764 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.91 131.05 45.28 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.485 -0.932 . . . . 1.87 108.485 177.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.52 153.93 16.65 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.251 -0.976 . . . . 0.39 111.927 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.05 140.89 45.93 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.68 -0.489 . . . . 1.8 109.68 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.471 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.1 tp -115.78 118.88 34.25 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.508 -0.477 . . . . 1.11 110.468 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.9 mt -112.43 129.05 68.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 1.51 110.578 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.84 120.86 43.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.213 -0.449 . . . . 1.47 110.75 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.663 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.63 146.46 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.175 0.512 . . . . 1.33 111.032 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.814 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.0 mt-30 -105.97 153.85 21.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.565 -0.743 . . . . 2.49 110.001 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.2 mt-30 -39.21 88.58 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.92 0.391 . . . . 4.2 110.442 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.23 32.72 0.21 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.77 -0.65 . . . . 6.4 110.558 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.34 3.29 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.499 -0.64 . . . . 1.74 111.499 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.453 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.4 177.4 9.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.244 0.545 . . . . 3.64 111.596 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.15 149.55 32.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.407 -0.815 . . . . 1.7 110.495 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.14 144.65 38.72 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.489 -0.323 . . . . 2.7 110.596 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -128.0 135.94 61.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 121.052 0.453 . . . . 1.16 111.573 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -123.99 141.35 52.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.688 -0.687 . . . . 1.14 110.306 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.466 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.6 138.81 51.69 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.113 0.482 . . . . 4.33 111.528 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.19 164.18 37.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.568 -0.742 . . . . 0.91 109.514 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.561 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.1 p30 -145.29 151.54 38.51 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.351 -0.54 . . . . 1.47 111.008 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.578 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.0 p90 -146.16 172.71 13.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.747 -0.66 . . . . 0.51 111.015 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.444 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.68 160.73 21.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.414 -0.812 . . . . 1.92 109.915 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.444 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.44 121.86 22.86 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.548 -0.461 . . . . 1.63 110.8 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.4 p -128.55 165.39 20.83 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.458 0.91 . . . . 2.37 113.458 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 76.2 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 113.894 -1.503 . . . . 3.63 107.552 177.146 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.481 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 121.976 0.893 . . . . 1.25 110.399 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.471 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.9 167.54 0.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.875 -1.057 . . . . 1.16 110.868 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.488 ' CZ ' HG22 ' A' ' 201' ' ' THR . 8.0 m-30 -133.5 145.52 50.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.664 -0.698 . . . . 0.78 110.16 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.23 101.64 9.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.104 -0.702 . . . . 1.08 109.104 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.469 HG11 ' N ' ' A' ' 131' ' ' SER . 71.0 t -113.02 139.68 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.078 -0.51 . . . . 1.1 111.033 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.469 ' N ' HG11 ' A' ' 130' ' ' VAL . 66.6 p -128.7 152.49 48.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.6 -0.727 . . . . 0.87 109.827 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.649 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.5 p90 -144.72 -164.92 2.02 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.759 -0.376 . . . . 0.37 110.668 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.3 t -123.94 127.21 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 1.14 110.812 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.174 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -58.03 58.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 1.91 110.313 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.743 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.1 24.48 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.881 -0.6 . . . . 1.56 111.52 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.174 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.23 128.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.633 -0.427 . . . . 1.56 110.994 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.46 -9.58 55.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.009 -0.542 . . . . 1.88 110.38 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.4 p -87.16 0.4 55.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.043 -0.526 . . . . 1.63 110.307 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.948 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.31 137.22 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 116.018 -0.537 . . . . 1.11 109.939 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 185' ' ' ILE . 60.9 m -96.33 -15.45 21.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.276 0.56 . . . . 1.01 110.003 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.454 ' HA3' ' HZ1' ' A' ' 61' ' ' LYS . . . 178.57 175.57 45.76 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 109.876 -1.289 . . . . 0.14 109.876 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.39 151.63 42.38 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.716 -0.394 . . . . 0.21 110.541 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.695 ' NH1' ' OE1' ' A' ' 191' ' ' GLN . 20.6 ttm180 -132.43 121.12 22.91 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.18 -0.464 . . . . 1.54 109.955 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.502 HG23 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.11 136.56 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.652 -0.704 . . . . 1.08 110.635 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 84.7 tt0 -129.37 129.97 45.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.951 -0.568 . . . . 1.32 109.992 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.601 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.79 135.21 34.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.983 -0.553 . . . . 1.05 110.616 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.407 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.32 39.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.775 -0.648 . . . . 1.16 109.668 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.936 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.4 mt -70.98 124.84 25.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.077 0.465 . . . . 1.23 110.738 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.0 p -71.6 -7.88 50.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.735 -0.666 . . . . 0.86 110.879 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.79 -69.59 0.85 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.316 -0.402 . . . . 1.66 111.473 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.478 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.61 -35.45 76.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.16 -0.473 . . . . 1.66 111.477 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.085 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.21 88.61 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.783 -0.927 . . . . 1.62 110.783 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.328 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.9 t0 -27.9 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.675 0.274 . . . . 1.86 110.351 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.328 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.2 pm0 -82.2 139.02 45.31 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.925 0.393 . . . . 1.98 110.25 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.407 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.9 Cg_endo -70.9 145.8 51.47 Favored 'Trans proline' 0 C--N 1.302 -1.91 0 C-N-CA 122.671 2.247 . . . . 0.62 112.392 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.77 145.82 42.47 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.237 -0.653 . . . . 1.14 109.237 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.485 ' CD2' ' HB2' ' A' ' 16' ' ' ASN . 6.1 p90 -123.39 141.32 52.11 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.385 -0.526 . . . . 1.44 111.486 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.42 ' HA ' HD22 ' A' ' 158' ' ' LEU . 71.0 mt -128.17 127.69 43.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.247 -0.888 . . . . 1.08 108.922 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 68.3 t0 -101.7 131.21 48.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.184 0.516 . . . . 1.09 111.683 -178.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.519 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -127.93 157.48 73.66 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.276 -0.875 . . . . 1.04 109.614 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -69.74 158.03 58.4 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.37 2.047 . . . . 0.21 112.304 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.28 -12.2 5.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.825 -0.625 . . . . 0.88 110.677 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.3 p -92.73 -8.83 42.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 1.06 110.749 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.47 34.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 1.05 110.407 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.8 p -133.15 16.52 4.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.38 . . . . 1.07 110.579 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.5 p -167.53 147.17 5.1 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.626 -0.509 . . . . 0.92 109.626 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.519 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.2 150.44 12.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.518 -0.473 . . . . 1.09 111.54 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.496 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.31 125.01 50.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.634 -0.712 . . . . 1.31 109.789 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.524 HG21 HD21 ' A' ' 172' ' ' LEU . 1.8 mt -99.51 104.88 30.09 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.911 0.386 . . . . 1.09 111.054 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.4 Cg_endo -90.93 -179.53 1.52 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 123.2 2.6 . . . . 0.48 112.24 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.74 32.58 18.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.415 -0.812 . . . . 1.26 111.394 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.524 HD21 HG21 ' A' ' 169' ' ' ILE . 24.2 mt -86.27 148.56 25.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.528 -0.305 . . . . 1.12 110.586 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.763 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.33 114.8 61.1 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.007 0.432 . . . . 1.3 110.707 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.0 140.62 96.17 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.878 2.385 . . . . 0.92 112.009 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.03 21.27 74.31 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.021 -0.831 . . . . 0.44 111.021 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.478 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.86 150.13 49.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.759 0.314 . . . . 3.05 110.685 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.495 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.17 131.61 46.02 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.052 -0.522 . . . . 1.48 109.825 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.936 ' CE2' HD21 ' A' ' 148' ' ' LEU . 75.1 m-85 -120.48 148.27 44.04 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.161 -0.472 . . . . 0.89 111.018 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.28 125.37 60.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.279 -1.008 . . . . 1.12 108.279 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.52 132.5 63.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.138 0.494 . . . . 1.1 111.202 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.5 122.54 20.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.585 -0.734 . . . . 0.43 109.673 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.591 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -100.95 125.46 54.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.296 -0.411 . . . . 1.07 110.609 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.674 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.0 m-85 -117.31 137.93 52.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.043 -0.526 . . . . 0.92 109.823 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.562 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.73 135.0 42.86 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.774 -0.824 . . . . 0.49 108.774 178.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' A' ' 140' ' ' SER . 89.1 mt -99.04 122.96 51.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.102 0.477 . . . . 1.08 110.988 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.451 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.0 p -83.85 169.65 14.91 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.538 -0.756 . . . . 0.89 110.444 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -59.72 -14.6 14.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.012 -0.54 . . . . 1.6 110.937 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.477 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.0 m-20 -95.97 -4.37 43.4 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.83 -0.348 . . . . 1.18 110.834 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.85 13.95 63.79 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.347 -0.701 . . . . 0.34 111.347 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -84.71 138.97 32.33 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.999 -0.281 . . . . 1.22 110.481 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.695 ' OE1' ' NH1' ' A' ' 143' ' ' ARG . 14.9 pt20 -106.6 141.08 38.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 1.44 110.553 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.0 m -136.64 127.1 26.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 1.39 110.409 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.674 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.5 tp -68.29 117.36 9.99 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.683 -0.407 . . . . 1.08 110.481 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.649 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.1 pt -109.03 -21.84 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 1.08 110.677 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.89 125.75 5.88 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.565 -0.454 . . . . 1.1 111.452 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.494 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.74 120.26 21.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.683 -0.69 . . . . 0.94 109.505 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.61 151.73 29.17 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.653 -0.419 . . . . 1.07 110.938 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.46 158.67 18.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.055 -0.521 . . . . 0.89 110.404 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.14 157.89 43.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.174 -0.466 . . . . 0.67 110.67 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.25 104.41 9.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.734 -0.666 . . . . 1.17 110.1 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.488 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.9 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.853 -1.07 . . . . 1.26 110.667 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.2 m . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.191 -0.67 . . . . 3.83 109.191 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.34 150.65 18.55 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.057 -0.817 . . . . 1.39 111.057 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -35.67 142.41 0.1 Allowed 'Trans proline' 0 C--N 1.297 -2.166 0 C-N-CA 124.115 3.21 . . . . 0.86 113.718 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.573 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.4 t -80.07 173.53 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.205 -1.361 . . . . 1.43 108.742 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -105.68 125.81 51.42 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.41 -0.516 . . . . 1.94 111.522 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.44 143.97 34.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.684 -0.689 . . . . 1.19 110.699 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.98 168.25 25.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.971 0.415 . . . . 3.92 111.097 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.588 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.0 mt -108.94 131.05 60.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.935 -0.575 . . . . 3.88 110.118 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.21 162.34 35.72 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.468 -0.333 . . . . 3.92 111.257 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 10' ' ' GLU . 72.7 tt0 36.14 31.47 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 109.653 -0.499 . . . . 6.08 109.653 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.588 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.35 69.54 31.59 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.935 -0.575 . . . . 4.01 111.582 -178.753 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.632 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.22 -29.2 73.35 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.592 2.195 . . . . 4.51 111.814 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.668 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 3.2 m 149.63 125.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 3.51 110.413 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.668 ' NE2' ' O ' ' A' ' 13' ' ' SER . 1.8 mp0 -123.95 158.35 60.46 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.265 -0.425 . . . . 4.3 110.481 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.646 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 98.3 Cg_endo -82.14 -64.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.83 2.353 . . . . 1.96 113.498 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.642 ' OD1' ' N ' ' A' ' 17' ' ' SER . 23.5 p-10 -108.44 -19.61 13.4 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.027 0.38 . . . . 3.33 112.027 -178.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.642 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 93.6 p -107.4 151.93 24.86 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.469 -0.492 . . . . 1.53 111.297 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.576 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.11 102.98 2.26 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.684 -0.689 . . . . 2.29 110.671 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.7 Cg_endo -82.72 145.72 12.99 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.872 2.381 . . . . 0.88 112.556 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.413 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.84 167.97 24.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.849 -0.614 . . . . 2.12 109.879 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.15 147.94 29.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.795 -0.446 . . . . 2.67 109.795 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.499 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.7 p90 -142.26 157.31 44.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.038 0.447 . . . . 0.32 111.248 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.464 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.04 155.33 44.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.813 -0.631 . . . . 2.77 110.09 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.4 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . . . -132.6 173.19 6.18 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.085 -0.507 . . . . 1.25 110.779 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.72 173.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.844 2.363 . . . . 1.12 111.51 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.479 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -51.03 0.69 Allowed Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.723 -0.391 . . . . 4.05 110.141 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.654 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.8 152.31 82.57 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.765 2.31 . . . . 2.12 111.449 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.68 42.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.428 0.632 . . . . 2.85 110.631 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.821 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.56 -41.63 98.4 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.931 -1.031 . . . . 3.11 110.676 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.435 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.2 mt -109.86 137.91 39.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.763 -0.653 . . . . 1.86 111.234 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.01 -72.9 0.7 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.987 -0.551 . . . . 1.61 111.843 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.21 148.4 24.39 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.547 0.573 . . . . 1.67 112.547 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.76 124.82 45.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.458 -0.571 . . . . 1.07 109.458 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.7 mt -118.07 134.72 60.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.665 -0.414 . . . . 1.55 110.632 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.487 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -119.99 128.64 53.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.062 0.458 . . . . 1.33 111.277 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.12 138.98 49.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.73 -0.668 . . . . 2.36 110.145 178.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.418 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.05 163.14 35.16 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.178 0.513 . . . . 0.38 112.055 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.45 139.53 7.86 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.377 -0.829 . . . . 2.31 110.451 178.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.49 115.45 3.04 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.285 1.99 . . . . 0.86 111.796 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.667 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.91 81.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.933 -0.395 . . . . 3.44 109.933 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.688 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.24 -20.58 0.06 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.059 -0.519 . . . . 2.72 111.971 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.9 p -157.67 157.79 34.22 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.836 -0.345 . . . . 2.78 110.604 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.402 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.41 27.77 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 2.3 110.195 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.86 -75.84 1.31 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.022 -0.609 . . . . 1.8 111.805 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.86 152.4 35.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.946 0.403 . . . . 5.48 110.954 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.28 -169.18 2.54 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.0 -0.546 . . . . 1.84 111.972 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.74 29.63 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.379 0.609 . . . . 2.27 112.611 -177.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.03 156.46 46.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.768 -1.105 . . . . 1.92 110.291 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.18 158.36 41.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.004 -0.544 . . . . 1.09 111.83 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 m -115.16 135.59 54.02 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.433 -0.803 . . . . 1.16 109.893 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.446 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.3 121.94 23.89 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.509 -0.314 . . . . 1.39 111.545 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.519 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.7 Cg_exo -46.28 151.74 1.59 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.744 2.296 . . . . 0.72 112.084 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.0 -23.03 63.27 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 116.045 -0.525 . . . . 0.74 112.779 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.519 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.75 -16.88 46.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.384 0.592 . . . . 1.26 111.81 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.485 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.6 mt -91.6 138.43 31.57 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.768 -0.373 . . . . 1.59 110.254 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.54 14.0 11.0 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.302 -0.408 . . . . 2.07 111.458 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.476 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.0 p -149.99 143.46 25.21 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.684 -0.406 . . . . 0.96 111.081 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.722 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.82 -169.39 1.54 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.22 0.533 . . . . 1.0 110.83 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.722 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.8 m -151.75 125.94 9.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.406 -0.815 . . . . 1.19 109.832 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.425 HG23 HD11 ' A' ' 60' ' ' ILE . 67.0 mt -114.93 123.34 70.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.36 -0.536 . . . . 1.47 111.134 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.747 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 16.6 ptpt -126.55 163.4 23.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.742 -0.663 . . . . 3.0 110.388 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.02 19.22 59.64 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.721 -0.951 . . . . 0.5 110.721 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.435 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 74.2 mt -79.16 157.23 27.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.127 0.489 . . . . 1.21 111.306 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.625 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -99.47 133.98 21.52 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.588 -0.733 . . . . 3.2 110.486 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.429 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.88 143.62 61.6 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.554 2.169 . . . . 1.09 111.915 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.82 25.55 75.43 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.084 -0.806 . . . . 0.72 111.084 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.639 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.3 p -128.09 158.75 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.691 0.281 . . . . 1.47 110.51 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.06 139.99 41.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.908 0.385 . . . . 1.23 110.591 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.639 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.62 136.43 54.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.948 -0.569 . . . . 1.1 110.801 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.91 131.07 45.27 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.479 -0.934 . . . . 1.87 108.479 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.488 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.57 153.89 16.67 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.281 -0.961 . . . . 0.39 111.974 -178.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.01 140.9 46.02 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.628 -0.508 . . . . 1.8 109.628 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.46 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.1 tp -115.74 118.92 34.39 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.447 -0.501 . . . . 1.11 110.551 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.42 129.1 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.378 -0.373 . . . . 1.51 110.635 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.84 120.9 43.93 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.326 -0.397 . . . . 1.47 110.683 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.67 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.64 146.45 11.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.143 0.497 . . . . 1.33 111.099 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.821 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.5 mt-30 -106.0 153.92 21.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.58 -0.736 . . . . 2.49 109.91 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.24 88.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.93 0.395 . . . . 4.2 110.441 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.33 32.58 0.22 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.8 -0.636 . . . . 6.4 110.543 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.03 -117.4 3.3 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.436 -0.666 . . . . 1.74 111.436 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.445 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.32 177.36 9.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.134 0.492 . . . . 3.64 111.697 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.19 149.49 32.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.44 -0.8 . . . . 1.7 110.422 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.11 144.65 38.78 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.438 -0.346 . . . . 2.7 110.624 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.97 136.02 61.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.135 0.493 . . . . 1.16 111.527 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.09 141.37 52.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.681 -0.691 . . . . 1.14 110.299 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.62 138.89 51.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.074 0.464 . . . . 4.33 111.446 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.33 164.1 38.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.575 -0.739 . . . . 0.91 109.485 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.577 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.28 151.51 38.47 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.393 -0.523 . . . . 1.47 111.048 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.576 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.2 p90 -146.21 172.79 12.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 0.51 110.972 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.455 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.82 160.72 21.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.345 -0.843 . . . . 1.92 109.804 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.455 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.4 121.94 23.01 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.582 -0.447 . . . . 1.63 110.745 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.547 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -126.63 158.61 35.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.385 0.612 . . . . 2.37 112.279 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.29 -0.868 . . . . 3.63 111.185 179.698 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.634 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 4.5 p . . . . . 0 N--CA 1.466 0.333 0 CA-C-O 121.473 0.654 . . . . 1.25 110.167 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.479 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.9 167.55 0.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.297 -0.865 . . . . 1.16 110.932 -179.636 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.54 145.56 50.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.707 -0.679 . . . . 0.78 110.112 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.24 101.69 9.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.08 -0.711 . . . . 1.08 109.08 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.471 HG11 ' N ' ' A' ' 131' ' ' SER . 71.3 t -113.0 139.62 37.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.108 -0.497 . . . . 1.1 111.063 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.471 ' N ' HG11 ' A' ' 130' ' ' VAL . 65.9 p -128.7 152.59 48.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.651 -0.704 . . . . 0.87 109.877 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.647 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.6 p90 -144.84 -164.96 2.04 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.63 -0.428 . . . . 0.37 110.621 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.9 t -123.97 127.23 73.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 1.14 110.819 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.172 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.92 58.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.49 . . . . 1.91 110.37 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.17 24.62 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.925 -0.58 . . . . 1.56 111.538 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.172 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.1 128.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.61 -0.436 . . . . 1.56 110.932 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -86.38 -9.68 55.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.895 -0.593 . . . . 1.88 110.332 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.07 0.21 55.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.115 -0.493 . . . . 1.63 110.304 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.963 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.26 137.16 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 1.11 109.952 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.747 ' O ' ' NZ ' ' A' ' 61' ' ' LYS . 69.3 m -96.19 -15.56 21.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.242 0.544 . . . . 1.01 110.019 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.61 175.56 45.78 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 109.915 -1.274 . . . . 0.14 109.915 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.44 151.66 42.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.027 0.442 . . . . 0.21 110.465 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.764 ' NH2' ' OE2' ' A' ' 145' ' ' GLU . 31.6 ttt85 -132.43 121.23 23.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.058 -0.519 . . . . 1.54 109.887 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.489 HG23 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.11 136.47 38.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.697 -0.683 . . . . 1.08 110.655 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.764 ' OE2' ' NH2' ' A' ' 143' ' ' ARG . 97.6 mt-10 -129.37 129.86 45.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.097 -0.501 . . . . 1.32 109.991 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.592 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.7 135.4 34.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.954 -0.566 . . . . 1.05 110.614 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.403 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.44 161.27 40.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.78 -0.646 . . . . 1.16 109.702 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.936 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.4 mt -71.0 124.81 25.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.029 0.442 . . . . 1.23 110.736 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.66 -7.82 50.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.726 -0.67 . . . . 0.86 110.872 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -109.75 -69.6 0.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 1.66 111.484 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.431 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.64 -35.39 76.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.053 -0.521 . . . . 1.66 111.557 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.086 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.26 88.57 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.807 -0.917 . . . . 1.62 110.807 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.337 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.89 -171.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 1.86 110.278 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.337 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.09 45.2 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.021 0.439 . . . . 1.98 110.236 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.403 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.3 Cg_endo -70.96 145.86 51.26 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 C-N-CA 122.7 2.267 . . . . 0.62 112.35 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.83 145.78 42.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.202 -0.666 . . . . 1.14 109.202 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.521 ' CB ' ' NH1' ' A' ' 143' ' ' ARG . 35.9 p90 -123.33 141.31 52.11 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.303 -0.559 . . . . 1.44 111.484 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.418 ' HA ' HD22 ' A' ' 158' ' ' LEU . 71.0 mt -128.1 127.7 43.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.317 -0.856 . . . . 1.08 108.94 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.527 ' OD1' ' O ' ' A' ' 159' ' ' ASP . 54.7 p-10 -101.65 131.2 48.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.206 0.526 . . . . 1.09 111.794 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.512 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -127.96 157.55 73.48 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.286 -0.87 . . . . 1.04 109.533 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.91 157.95 58.4 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 122.369 2.046 . . . . 0.21 112.261 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.2 p -59.24 -12.04 4.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.832 -0.622 . . . . 0.88 110.761 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.8 p -92.92 -8.74 42.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.451 . . . . 1.06 110.642 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.25 135.47 34.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.349 -0.387 . . . . 1.05 110.353 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.8 p -133.21 16.79 4.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 1.07 110.52 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.0 p -167.6 147.11 5.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.633 -0.506 . . . . 0.92 109.633 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.512 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.12 150.46 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.516 -0.473 . . . . 1.09 111.521 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.497 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 124.88 50.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.659 -0.7 . . . . 1.31 109.849 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.525 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.31 104.91 29.58 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.377 -0.374 . . . . 1.09 111.143 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.2 Cg_endo -91.0 -179.49 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.926 0 C-N-CA 123.135 2.557 . . . . 0.48 112.218 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.69 32.59 18.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.31 -0.859 . . . . 1.26 111.465 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.634 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.1 mt -86.33 148.56 25.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.812 0.339 . . . . 1.12 110.404 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.771 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.32 114.82 61.21 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.093 0.473 . . . . 1.3 110.665 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.96 140.61 96.07 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.916 2.41 . . . . 0.92 111.935 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.11 21.06 74.57 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.132 -0.787 . . . . 0.44 111.132 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.431 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.76 150.16 49.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.746 0.308 . . . . 3.05 110.668 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.495 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.21 131.61 46.06 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.105 -0.498 . . . . 1.48 109.767 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.936 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.48 148.26 44.06 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.039 -0.528 . . . . 0.89 110.948 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.6 mt -105.33 125.43 60.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.308 -0.997 . . . . 1.12 108.308 177.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.64 132.5 63.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.199 0.523 . . . . 1.1 111.174 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.64 20.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.549 -0.75 . . . . 0.43 109.617 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.59 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.16 125.44 55.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.175 -0.466 . . . . 1.07 110.65 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.669 ' CE1' HD11 ' A' ' 193' ' ' LEU . 47.9 m-85 -117.17 137.86 52.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.99 -0.55 . . . . 0.92 109.883 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.68 135.05 42.74 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.76 -0.83 . . . . 0.49 108.76 178.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 140' ' ' SER . 79.6 mt -99.06 123.0 51.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.151 0.501 . . . . 1.08 110.964 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.45 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.2 p -83.91 169.66 14.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.531 -0.759 . . . . 0.89 110.443 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.523 ' O ' ' OG1' ' A' ' 59' ' ' THR . 97.0 mt-10 -59.67 -14.53 14.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.031 -0.531 . . . . 1.6 111.069 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.45 ' H ' ' HG ' ' A' ' 186' ' ' SER . 95.3 m-20 -96.15 -4.26 42.99 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.855 -0.338 . . . . 1.18 110.825 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.44 ' N ' ' HG1' ' A' ' 59' ' ' THR . . . 87.81 13.93 63.9 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.301 -0.72 . . . . 0.34 111.301 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -84.65 139.12 32.27 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.994 -0.282 . . . . 1.22 110.476 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -106.71 141.06 38.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.897 0.38 . . . . 1.44 110.527 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.72 126.97 26.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 1.39 110.408 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.669 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.6 tp -68.1 117.31 9.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.247 -0.433 . . . . 1.08 110.532 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.647 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -109.0 -21.9 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 1.08 110.699 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.85 125.86 5.95 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.52 -0.472 . . . . 1.1 111.51 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.497 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.93 120.22 21.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.741 -0.663 . . . . 0.94 109.501 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.59 151.66 29.1 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.621 -0.432 . . . . 1.07 110.941 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.41 158.5 18.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.518 . . . . 0.89 110.45 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.03 157.95 43.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.135 -0.484 . . . . 0.67 110.671 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 104.3 9.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.711 -0.677 . . . . 1.17 110.056 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.485 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 66.6 p . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.981 -1.009 . . . . 1.26 110.637 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.157 -0.683 . . . . 3.83 109.157 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.455 ' H ' ' HB3' ' A' ' 1' ' ' SER . . . -116.31 150.62 18.56 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.078 -0.809 . . . . 1.39 111.078 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -35.61 142.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 123.944 3.096 . . . . 0.86 113.835 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.566 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.1 t -79.89 173.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.275 -1.329 . . . . 1.43 108.898 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.402 ' H ' ' CG1' ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.59 125.9 51.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.164 0.507 . . . . 1.94 111.464 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 p -136.55 144.06 33.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.625 -0.716 . . . . 1.19 110.602 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.07 168.27 25.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.908 0.385 . . . . 3.92 111.112 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.585 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -108.99 131.2 60.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.947 -0.569 . . . . 3.88 110.04 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 69.3 p -141.25 162.31 35.79 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.368 -0.378 . . . . 3.92 111.162 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 9' ' ' THR . 29.9 tt0 36.12 31.56 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.659 -0.497 . . . . 6.08 109.659 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.585 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.48 69.56 32.91 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.881 -0.599 . . . . 4.01 111.489 -178.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.2 -29.2 73.56 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.618 2.212 . . . . 4.51 111.808 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.6 125.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.14 -0.482 . . . . 3.51 110.528 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.53 HE22 ' H ' ' A' ' 13' ' ' SER . 2.0 mp0 -124.0 158.31 60.74 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.348 -0.387 . . . . 4.3 110.408 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.502 ' HG2' ' CD ' ' A' ' 143' ' ' ARG . 97.3 Cg_endo -81.98 -64.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.812 2.342 . . . . 1.96 113.58 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.472 ' H ' ' HG2' ' A' ' 15' ' ' PRO . 99.4 m-20 -108.51 -19.51 13.42 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.072 0.397 . . . . 3.33 112.072 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 2.6 m -107.38 152.0 24.75 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.13 0.491 . . . . 1.53 111.265 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.4 t-80 -155.25 102.98 2.23 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.691 -0.686 . . . . 2.29 110.677 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -82.69 145.61 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.936 2.424 . . . . 0.88 112.601 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.406 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.8 167.91 24.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.932 -0.576 . . . . 2.12 109.883 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.09 147.97 29.12 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.795 -0.446 . . . . 2.67 109.795 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.497 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.4 p90 -142.32 157.31 44.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.047 0.451 . . . . 0.32 111.112 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.469 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.1 m-20 -128.07 155.31 44.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.789 -0.641 . . . . 2.77 110.127 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.59 172.93 6.51 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.17 -0.468 . . . . 1.25 110.815 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.52 173.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 122.869 2.379 . . . . 1.12 111.573 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.12 -51.03 0.68 Allowed Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 120.68 -0.408 . . . . 4.05 110.126 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.646 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.79 152.39 82.27 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.744 2.296 . . . . 2.12 111.49 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.67 42.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.379 0.609 . . . . 2.85 110.552 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.816 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.56 -41.58 98.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.011 -0.995 . . . . 3.11 110.707 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.437 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.4 mt -109.93 137.79 40.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.765 -0.652 . . . . 1.86 111.255 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.92 -72.9 0.7 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.096 -0.502 . . . . 1.61 111.902 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.24 148.44 24.35 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.597 0.592 . . . . 1.67 112.597 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.84 124.93 45.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.328 -0.619 . . . . 1.07 109.328 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.7 mt -118.16 134.74 60.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.635 -0.426 . . . . 1.55 110.623 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.485 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -120.03 128.57 53.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.057 0.456 . . . . 1.33 111.216 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.548 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.12 139.04 49.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.708 -0.678 . . . . 2.36 110.069 178.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.415 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.2 p90 -145.14 163.14 35.25 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-O 121.215 0.531 . . . . 0.38 112.017 -178.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.42 139.59 7.92 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 115.421 -0.809 . . . . 2.31 110.431 178.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.55 115.51 3.09 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.256 1.971 . . . . 0.86 111.825 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.67 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.08 81.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.885 -0.413 . . . . 3.44 109.885 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.21 -20.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.985 -0.552 . . . . 2.72 111.886 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 p -157.65 157.78 34.23 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.789 -0.364 . . . . 2.78 110.548 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 m -120.39 27.84 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.239 -0.437 . . . . 2.3 110.224 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.89 -75.83 1.31 Allowed Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.141 -0.552 . . . . 1.8 111.832 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.91 152.39 35.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.398 . . . . 5.48 111.015 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.63 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.23 -169.15 2.54 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.166 -0.47 . . . . 1.84 111.943 179.452 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.411 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.11 149.71 29.65 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.485 0.66 . . . . 2.27 112.532 -177.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.12 156.5 45.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.756 -1.111 . . . . 1.92 110.281 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.25 158.33 41.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.981 -0.554 . . . . 1.09 111.783 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 m -115.23 135.68 53.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.545 -0.752 . . . . 1.16 109.757 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.442 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.45 121.96 23.71 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 1.39 111.512 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.516 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.5 Cg_exo -46.41 151.77 1.68 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.699 2.266 . . . . 0.72 112.135 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.01 -23.02 63.27 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 116.106 -0.497 . . . . 0.74 112.735 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.516 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.1 p-80 -82.68 -16.97 46.16 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 117.379 0.59 . . . . 1.26 111.811 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.494 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.2 mt -91.56 138.44 31.56 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.728 -0.389 . . . . 1.59 110.278 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.57 13.98 10.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.39 -0.368 . . . . 2.07 111.572 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.4 p -150.0 143.49 25.22 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.593 -0.443 . . . . 0.96 111.071 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.84 -169.4 1.54 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.261 0.553 . . . . 1.0 110.818 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.781 ' HG1' ' NZ ' ' A' ' 61' ' ' LYS . 1.7 t -151.75 125.87 9.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.361 -0.836 . . . . 1.19 109.792 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.44 HD11 HG23 ' A' ' 60' ' ' ILE . 66.6 mt -114.81 123.25 70.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.401 -0.52 . . . . 1.47 111.248 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.781 ' NZ ' ' HG1' ' A' ' 59' ' ' THR . 59.6 mttp -126.47 163.33 23.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.838 -0.619 . . . . 3.0 110.426 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.19 18.97 59.79 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.712 -0.955 . . . . 0.5 110.712 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.427 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 74.2 mt -79.05 157.29 28.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.116 0.484 . . . . 1.21 111.319 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.63 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -99.48 134.04 21.47 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.604 -0.725 . . . . 3.2 110.384 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.99 143.62 60.99 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.551 2.167 . . . . 1.09 111.902 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.65 75.31 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.081 -0.808 . . . . 0.72 111.081 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.639 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.21 158.79 40.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.743 0.306 . . . . 1.47 110.44 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.16 139.96 41.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.974 0.416 . . . . 1.23 110.547 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.639 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.55 136.51 54.9 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.855 -0.611 . . . . 1.1 110.75 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.98 131.09 45.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.538 -0.912 . . . . 1.87 108.538 177.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.485 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.53 153.84 16.66 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.322 -0.942 . . . . 0.39 112.006 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.87 140.94 46.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.702 -0.481 . . . . 1.8 109.702 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.468 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.0 tp -115.83 118.88 34.23 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.496 -0.482 . . . . 1.11 110.468 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.8 mt -112.36 129.04 68.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.293 -0.412 . . . . 1.51 110.749 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.81 120.93 44.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.356 -0.383 . . . . 1.47 110.655 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.67 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.62 146.42 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.115 0.483 . . . . 1.33 111.03 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.816 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.5 mt-30 -106.07 153.91 21.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.494 -0.776 . . . . 2.49 109.843 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.14 88.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.958 0.409 . . . . 4.2 110.479 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.32 32.52 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.847 -0.615 . . . . 6.4 110.653 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.27 3.28 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.95 -0.643 . . . . 1.74 111.533 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.452 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.42 177.38 9.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.143 0.497 . . . . 3.64 111.635 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.13 149.54 32.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.382 -0.827 . . . . 1.7 110.331 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.15 144.7 38.74 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.354 -0.385 . . . . 2.7 110.6 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -128.0 136.0 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-O 121.047 0.451 . . . . 1.16 111.587 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.07 141.39 52.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.66 -0.7 . . . . 1.14 110.245 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.456 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.61 138.81 51.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.094 0.473 . . . . 4.33 111.485 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.485 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.21 164.19 37.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.597 -0.729 . . . . 0.91 109.51 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.574 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 46.9 p30 -145.21 151.56 38.59 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.441 -0.504 . . . . 1.47 111.071 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.8 p90 -146.28 172.68 13.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.729 -0.669 . . . . 0.51 110.994 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.448 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.73 160.68 21.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.443 -0.799 . . . . 1.92 109.864 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.448 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.42 121.9 22.94 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.547 -0.461 . . . . 1.63 110.771 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.528 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.2 p -127.16 164.9 20.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 122.5 1.143 . . . . 2.37 114.033 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.569 ' OG ' ' CE2' ' A' ' 157' ' ' TYR . 22.4 t . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 113.198 -1.819 . . . . 3.63 109.128 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 67.5 p . . . . . 0 CA--C 1.517 -0.309 0 N-CA-C 108.557 -0.905 . . . . 1.25 108.557 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.473 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.76 167.61 0.24 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.878 -1.056 . . . . 1.16 110.897 -179.184 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.65 145.52 50.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.688 -0.687 . . . . 0.78 110.117 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.28 101.63 9.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.076 -0.713 . . . . 1.08 109.076 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.465 HG11 ' N ' ' A' ' 131' ' ' SER . 71.4 t -112.87 139.73 36.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.056 -0.52 . . . . 1.1 111.097 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.465 ' N ' HG11 ' A' ' 130' ' ' VAL . 68.0 p -128.75 152.56 48.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.599 -0.728 . . . . 0.87 109.816 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.646 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.8 p90 -144.8 -164.93 2.03 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.742 -0.383 . . . . 0.37 110.67 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.731 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.7 t -123.98 127.17 73.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.18 -0.463 . . . . 1.14 110.718 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.162 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.98 58.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.135 -0.484 . . . . 1.91 110.297 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.731 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.05 24.42 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.991 -0.55 . . . . 1.56 111.533 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.162 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.23 128.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.549 -0.46 . . . . 1.56 110.954 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.44 -9.61 55.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.979 -0.555 . . . . 1.88 110.288 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.8 p -87.09 0.27 55.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 1.63 110.282 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.958 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.29 137.26 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.064 -0.517 . . . . 1.11 109.913 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.668 ' OG ' ' NZ ' ' A' ' 61' ' ' LYS . 10.9 p -96.26 -15.49 21.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.287 0.565 . . . . 1.01 110.076 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.57 175.57 45.76 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.91 -1.276 . . . . 0.14 109.91 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.48 151.63 42.54 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.578 -0.449 . . . . 0.21 110.458 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.723 ' NH2' ' OE1' ' A' ' 191' ' ' GLN . 52.3 ttp85 -132.38 121.17 23.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.108 -0.496 . . . . 1.54 109.997 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.479 HG23 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.08 136.59 38.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.686 -0.688 . . . . 1.08 110.694 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 73.8 tt0 -129.34 129.87 45.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.981 -0.554 . . . . 1.32 110.109 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.72 135.27 34.57 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.027 -0.533 . . . . 1.05 110.602 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.406 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.32 39.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.83 -0.623 . . . . 1.16 109.739 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.945 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -71.0 124.89 25.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.995 0.426 . . . . 1.23 110.694 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.494 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.9 -7.63 49.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.757 -0.656 . . . . 0.86 110.856 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.81 -69.6 0.85 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.924 0.393 . . . . 1.66 111.468 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.44 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.7 -35.27 75.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.02 -0.537 . . . . 1.66 111.498 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.099 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.01 7.29 88.54 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.838 -0.905 . . . . 1.62 110.838 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.324 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.97 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.817 0.342 . . . . 1.86 110.261 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.324 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.17 139.04 45.43 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.407 . . . . 1.98 110.199 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.406 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.9 Cg_endo -70.86 145.8 51.75 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.753 2.302 . . . . 0.62 112.376 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.79 145.63 42.65 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.276 -0.639 . . . . 1.14 109.276 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.633 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 88.1 m-85 -123.31 141.46 51.96 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.311 -0.556 . . . . 1.44 111.516 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.439 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.7 mt -128.17 127.63 43.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.306 -0.861 . . . . 1.08 108.951 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -101.61 131.21 47.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.075 0.464 . . . . 1.09 111.687 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.517 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -127.96 157.59 73.37 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.347 -0.842 . . . . 1.04 109.553 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.85 158.02 58.23 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 122.413 2.075 . . . . 0.21 112.247 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.31 -12.15 5.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.742 -0.663 . . . . 0.88 110.684 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.9 p -92.8 -8.76 42.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.148 -0.478 . . . . 1.06 110.783 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.46 34.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 1.05 110.435 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.25 16.78 4.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 1.07 110.52 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.5 p -167.58 147.1 5.04 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.596 -0.52 . . . . 0.92 109.596 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.517 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.21 150.49 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.458 -0.497 . . . . 1.09 111.55 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.499 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.25 125.03 50.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.606 -0.725 . . . . 1.31 109.822 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.517 HG21 HD21 ' A' ' 172' ' ' LEU . 1.8 mt -99.49 104.88 30.05 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.378 -0.374 . . . . 1.09 111.011 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.8 Cg_endo -90.97 -179.5 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 123.195 2.597 . . . . 0.48 112.24 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.67 32.64 18.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.381 -0.827 . . . . 1.26 111.435 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 169' ' ' ILE . 24.0 mt -86.29 148.59 25.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.467 -0.333 . . . . 1.12 110.563 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.771 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.37 114.86 61.37 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.016 0.436 . . . . 1.3 110.624 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.07 140.61 95.97 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.83 2.353 . . . . 0.92 111.93 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.1 21.21 74.25 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.006 -0.838 . . . . 0.44 111.006 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.44 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.87 150.13 49.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.752 0.311 . . . . 3.05 110.756 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.494 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.15 131.7 45.94 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.091 -0.504 . . . . 1.48 109.728 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.945 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.7 m-85 -120.49 148.31 44.0 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.091 -0.504 . . . . 0.89 111.02 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.7 mt -105.25 125.25 60.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.347 -0.983 . . . . 1.12 108.347 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.51 132.45 63.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.198 0.523 . . . . 1.1 111.303 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.44 122.6 20.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.542 -0.754 . . . . 0.43 109.655 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.591 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.12 125.38 55.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.257 -0.429 . . . . 1.07 110.627 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.669 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.7 m-85 -117.15 137.86 52.04 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.534 . . . . 0.92 109.882 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.564 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.68 135.11 42.64 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.846 -0.798 . . . . 0.49 108.846 178.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.547 ' O ' ' N ' ' A' ' 140' ' ' SER . 26.6 mt -99.09 123.01 51.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.074 0.464 . . . . 1.08 110.918 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.592 ' OG ' ' OD1' ' A' ' 188' ' ' ASP . 87.4 p -83.91 169.73 14.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.515 -0.766 . . . . 0.89 110.529 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.77 -14.55 15.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.096 -0.502 . . . . 1.6 110.953 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.671 ' OD1' ' N ' ' A' ' 190' ' ' GLU . 37.1 p30 -96.18 -4.16 43.08 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.785 -0.366 . . . . 1.18 110.773 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.74 13.86 64.17 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.339 -0.705 . . . . 0.34 111.339 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.671 ' N ' ' OD1' ' A' ' 188' ' ' ASP . 84.4 tt0 -84.59 139.03 32.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.705 0.288 . . . . 1.22 110.456 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.723 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 87.4 mt-30 -106.74 141.03 38.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 1.44 110.557 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.0 m -136.72 127.15 26.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 1.39 110.326 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.669 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.7 tp -68.21 117.38 9.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 1.08 110.454 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.646 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.4 pt -109.08 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 1.08 110.71 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.5 tp -156.91 125.74 5.86 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.511 -0.476 . . . . 1.1 111.448 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.495 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.77 120.28 21.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.775 -0.648 . . . . 0.94 109.504 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.67 151.68 29.06 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.628 -0.429 . . . . 1.07 110.901 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.43 158.58 18.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.986 -0.552 . . . . 0.89 110.492 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -146.05 158.04 43.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.67 110.633 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.35 104.31 9.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.717 -0.674 . . . . 1.17 109.981 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.483 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 66.9 p . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.94 -1.028 . . . . 1.26 110.701 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.0 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.223 -0.658 . . . . 3.83 109.223 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.46 150.67 18.53 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.971 -0.852 . . . . 1.39 110.971 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -35.58 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.056 0 C-N-CA 124.009 3.139 . . . . 0.86 113.811 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.567 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -79.94 173.47 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.219 -1.355 . . . . 1.43 108.882 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.64 125.92 51.54 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.376 -0.529 . . . . 1.94 111.444 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.51 143.96 34.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.671 -0.695 . . . . 1.19 110.691 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.01 168.3 25.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.923 0.392 . . . . 3.92 111.093 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.589 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.7 mt -109.06 131.08 60.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.975 -0.557 . . . . 3.88 110.098 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.16 162.26 35.92 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.466 -0.334 . . . . 3.92 111.255 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 73.7 mm-40 36.15 31.63 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.558 -0.534 . . . . 6.08 109.558 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.589 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.53 69.6 33.5 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.006 -0.543 . . . . 4.01 111.521 -178.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.639 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.37 -28.99 71.87 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.433 2.089 . . . . 4.51 111.906 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.681 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 3.2 m 149.58 125.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 3.51 110.481 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.681 ' NE2' ' O ' ' A' ' 13' ' ' SER . 3.4 mp0 -123.96 158.39 60.39 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.314 -0.403 . . . . 4.3 110.409 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.619 ' CG ' ' NH1' ' A' ' 143' ' ' ARG . 97.2 Cg_endo -82.03 -64.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.902 2.402 . . . . 1.96 113.488 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.62 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 64.6 t30 -108.46 -19.59 13.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.305 -0.407 . . . . 3.33 112.012 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 5.3 p -107.3 152.11 24.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.187 0.518 . . . . 1.53 111.242 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.573 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.34 102.89 2.22 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.7 -0.682 . . . . 2.29 110.685 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.527 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.67 145.57 13.01 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.923 2.415 . . . . 0.88 112.605 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.415 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.75 167.95 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.881 -0.6 . . . . 2.12 109.895 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.21 147.94 29.01 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.674 -0.491 . . . . 2.67 109.674 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.494 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.5 p90 -142.27 157.33 44.95 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.605 -0.438 . . . . 0.32 111.195 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.47 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.2 m-20 -128.04 155.29 44.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.781 -0.645 . . . . 2.77 110.017 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.63 172.99 6.41 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.128 -0.487 . . . . 1.25 110.737 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.68 173.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.851 2.367 . . . . 1.12 111.598 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.483 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.98 -51.15 0.69 Allowed Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 120.725 -0.39 . . . . 4.05 110.051 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.656 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.4 Cg_exo -64.75 152.36 82.31 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.783 2.322 . . . . 2.12 111.477 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.75 42.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.35 0.595 . . . . 2.85 110.46 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.824 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.6 -41.64 98.3 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.059 -0.973 . . . . 3.11 110.625 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.436 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.4 mt -109.82 137.76 40.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.811 -0.631 . . . . 1.86 111.276 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.88 -72.91 0.7 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.053 -0.522 . . . . 1.61 111.965 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.18 148.4 24.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.617 0.599 . . . . 1.67 112.617 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -121.78 124.89 45.27 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.315 -0.624 . . . . 1.07 109.315 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.02 134.68 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.623 -0.431 . . . . 1.55 110.67 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.483 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -119.93 128.6 53.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.978 0.418 . . . . 1.33 111.283 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.541 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.92 49.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.724 -0.671 . . . . 2.36 110.217 178.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.421 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.0 163.21 34.89 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.169 0.509 . . . . 0.38 112.054 -178.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.56 139.56 7.78 Favored Pre-proline 0 C--N 1.333 -0.12 0 CA-C-N 115.346 -0.843 . . . . 2.31 110.428 178.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.46 115.42 3.01 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.318 2.012 . . . . 0.86 111.802 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.97 81.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.92 -0.4 . . . . 3.44 109.92 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.23 -20.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 2.72 111.936 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.2 p -157.68 157.76 34.13 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.737 -0.385 . . . . 2.78 110.51 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.402 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.4 m -120.29 27.82 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.182 -0.463 . . . . 2.3 110.186 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.83 -75.87 1.31 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.178 -0.534 . . . . 1.8 111.829 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.89 152.2 35.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.898 0.38 . . . . 5.48 111.055 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.11 -169.14 2.55 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.113 -0.494 . . . . 1.84 111.954 179.394 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.12 149.68 29.71 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.456 0.646 . . . . 2.27 112.672 -177.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.07 156.5 45.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.858 -1.065 . . . . 1.92 110.285 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.24 158.34 41.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.903 -0.589 . . . . 1.09 111.873 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 m -115.19 135.58 54.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.472 -0.785 . . . . 1.16 109.865 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.448 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.35 121.93 23.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.467 -0.333 . . . . 1.39 111.538 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.7 Cg_exo -46.41 151.77 1.68 Allowed 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.666 2.244 . . . . 0.72 112.059 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.04 -22.85 63.14 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-N 115.957 -0.565 . . . . 0.74 112.81 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.515 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.84 -16.89 45.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.371 0.586 . . . . 1.26 111.825 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.485 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.53 138.42 31.59 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.725 -0.39 . . . . 1.59 110.375 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.55 13.95 10.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.387 -0.369 . . . . 2.07 111.551 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.99 143.4 25.17 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.681 -0.408 . . . . 0.96 111.098 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.75 -169.25 1.51 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.037 -0.528 . . . . 1.0 110.906 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.76 ' OG1' ' N ' ' A' ' 189' ' ' GLY . 1.3 m -151.82 125.86 9.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.432 -0.804 . . . . 1.19 109.805 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.428 HG23 HD11 ' A' ' 60' ' ' ILE . 66.5 mt -114.8 123.25 70.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.429 -0.508 . . . . 1.47 111.21 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -126.48 163.41 23.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.842 -0.617 . . . . 3.0 110.436 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.457 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.17 18.99 59.79 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.631 -0.988 . . . . 0.5 110.631 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.62 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 74.1 mt -79.07 157.26 28.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.149 0.5 . . . . 1.21 111.309 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.65 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 10.9 mttp -99.44 133.95 21.56 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.588 -0.733 . . . . 3.2 110.494 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.84 143.6 61.72 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.637 2.225 . . . . 1.09 111.916 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.79 25.5 75.48 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.105 -0.798 . . . . 0.72 111.105 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.639 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.09 158.79 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.321 . . . . 1.47 110.449 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.19 139.91 42.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.94 0.4 . . . . 1.23 110.534 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.65 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.7 m-85 -122.53 136.45 54.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.944 -0.571 . . . . 1.1 110.776 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.84 131.02 45.27 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.483 -0.932 . . . . 1.87 108.483 177.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.49 153.9 16.65 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.301 -0.952 . . . . 0.39 111.943 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.96 140.93 46.09 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.71 -0.478 . . . . 1.8 109.71 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.463 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.9 tp -115.67 118.93 34.44 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.476 -0.489 . . . . 1.11 110.488 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.51 129.19 68.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.342 -0.39 . . . . 1.51 110.647 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.92 120.7 43.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.242 -0.436 . . . . 1.47 110.774 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.667 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.52 146.5 11.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.217 0.532 . . . . 1.33 111.02 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.824 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.01 153.85 21.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.536 -0.756 . . . . 2.49 109.982 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.13 88.47 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.898 0.38 . . . . 4.2 110.521 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.36 32.6 0.22 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.78 -0.645 . . . . 6.4 110.589 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.33 3.29 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.504 -0.638 . . . . 1.74 111.504 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.443 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.36 177.38 9.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.135 0.493 . . . . 3.64 111.687 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.17 149.5 32.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.401 -0.818 . . . . 1.7 110.401 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.13 144.68 38.75 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.459 -0.337 . . . . 2.7 110.613 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -128.04 135.95 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.049 0.452 . . . . 1.16 111.473 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.02 141.34 52.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.599 -0.728 . . . . 1.14 110.236 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.446 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.64 138.85 51.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.117 0.484 . . . . 4.33 111.541 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.491 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.25 164.18 37.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.506 -0.77 . . . . 0.91 109.493 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.572 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.1 p30 -145.25 151.51 38.49 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.41 -0.516 . . . . 1.47 111.084 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.573 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.5 p90 -146.19 172.65 13.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.762 -0.654 . . . . 0.51 111.104 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.454 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.61 160.67 21.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.467 -0.788 . . . . 1.92 109.861 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.454 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.37 121.98 23.12 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 120.63 -0.428 . . . . 1.63 110.747 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.564 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.8 p -127.83 164.23 22.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.647 0.737 . . . . 2.37 112.689 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.5 t . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 114.63 -1.168 . . . . 3.63 109.682 178.593 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.5 p . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 121.295 0.569 . . . . 1.25 110.312 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.479 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.85 167.57 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.483 -0.78 . . . . 1.16 111.003 -179.283 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.58 145.57 50.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.746 -0.661 . . . . 0.78 110.141 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.28 101.7 9.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.073 -0.714 . . . . 1.08 109.073 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.47 HG11 ' N ' ' A' ' 131' ' ' SER . 71.5 t -112.93 139.63 37.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 1.1 111.069 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.47 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.7 p -128.7 152.58 48.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.621 -0.718 . . . . 0.87 109.834 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.648 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.9 p90 -144.78 -165.01 2.05 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.687 -0.405 . . . . 0.37 110.675 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -123.95 127.16 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.198 -0.455 . . . . 1.14 110.861 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.175 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.88 58.32 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.086 -0.506 . . . . 1.91 110.402 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.12 24.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.934 -0.576 . . . . 1.56 111.435 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.175 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.12 128.69 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.594 -0.443 . . . . 1.56 110.98 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.4 -9.55 56.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.58 . . . . 1.88 110.278 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.0 p -87.09 0.2 55.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.08 0.467 . . . . 1.63 110.358 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.963 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.22 137.07 25.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.951 -0.568 . . . . 1.11 109.961 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 185' ' ' ILE . 89.4 p -96.12 -15.54 22.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.262 0.553 . . . . 1.01 110.057 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.56 175.6 45.78 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 109.861 -1.296 . . . . 0.14 109.861 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -123.45 151.65 42.47 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.65 -0.42 . . . . 0.21 110.529 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.619 ' NH1' ' CG ' ' A' ' 15' ' ' PRO . 36.7 ttp85 -132.33 121.16 23.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.131 -0.486 . . . . 1.54 109.919 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.49 HG23 HG11 ' A' ' 167' ' ' VAL . 46.5 t -105.09 136.48 38.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.705 -0.679 . . . . 1.08 110.661 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 85.2 tt0 -129.33 129.88 45.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.029 -0.532 . . . . 1.32 110.013 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.75 135.25 34.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.005 -0.543 . . . . 1.05 110.638 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.405 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.26 161.3 39.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.659 -0.7 . . . . 1.16 109.704 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.939 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.1 mt -70.98 124.87 25.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.068 0.461 . . . . 1.23 110.729 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.497 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.73 -7.77 50.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.766 -0.652 . . . . 0.86 110.874 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.79 -69.67 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.35 -0.386 . . . . 1.66 111.416 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.44 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.74 -35.33 76.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.076 -0.511 . . . . 1.66 111.42 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.088 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.22 88.6 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.785 -0.926 . . . . 1.62 110.785 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.336 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.89 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.778 0.323 . . . . 1.86 110.25 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.336 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.33 138.99 44.87 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.941 0.401 . . . . 1.98 110.145 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.405 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.2 Cg_endo -70.79 145.76 52.05 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.635 2.223 . . . . 0.62 112.406 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.79 145.66 42.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.264 -0.643 . . . . 1.14 109.264 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.581 ' CE1' ' CG ' ' A' ' 16' ' ' ASN . 6.3 p90 -123.27 141.23 52.19 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.453 -0.499 . . . . 1.44 111.567 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.418 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.6 mt -128.03 127.66 43.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.35 -0.841 . . . . 1.08 108.964 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.571 ' HB2' HD22 ' A' ' 16' ' ' ASN . 30.1 t0 -101.65 131.16 48.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.185 0.517 . . . . 1.09 111.767 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.508 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -127.99 157.57 73.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.31 -0.859 . . . . 1.04 109.508 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -69.8 157.96 58.52 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.437 2.091 . . . . 0.21 112.197 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.4 p -59.11 -12.27 4.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.737 -0.665 . . . . 0.88 110.813 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.4 p -92.83 -8.71 42.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.128 -0.487 . . . . 1.06 110.633 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.31 34.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.454 -0.339 . . . . 1.05 110.364 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.1 p -133.05 16.65 4.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.454 -0.339 . . . . 1.07 110.624 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.6 p -167.55 147.11 5.07 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.61 -0.515 . . . . 0.92 109.61 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.508 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.1 p -152.21 150.42 12.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.548 -0.461 . . . . 1.09 111.598 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.499 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 124.95 50.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.628 -0.715 . . . . 1.31 109.811 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.523 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.4 104.87 29.68 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.428 -0.351 . . . . 1.09 111.038 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.8 Cg_endo -91.04 -179.58 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 123.224 2.616 . . . . 0.48 112.179 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.78 32.59 18.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.324 -0.853 . . . . 1.26 111.427 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.523 HD21 HG21 ' A' ' 169' ' ' ILE . 24.1 mt -86.36 148.51 25.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.476 -0.329 . . . . 1.12 110.532 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.772 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.22 114.77 60.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.982 0.42 . . . . 1.3 110.688 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -58.97 140.57 95.91 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.891 2.394 . . . . 0.92 112.017 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.06 21.25 74.25 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.047 -0.821 . . . . 0.44 111.047 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.44 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.97 150.23 49.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 3.05 110.62 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.497 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.2 131.64 46.02 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.077 -0.511 . . . . 1.48 109.809 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.939 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.54 148.33 43.99 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.136 -0.484 . . . . 0.89 110.992 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.1 mt -105.35 125.41 60.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.281 -1.007 . . . . 1.12 108.281 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.58 132.57 63.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.126 0.489 . . . . 1.1 111.247 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.58 122.52 20.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.57 -0.741 . . . . 0.43 109.69 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.593 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -100.94 125.36 54.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.242 -0.436 . . . . 1.07 110.62 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.671 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.2 m-85 -117.17 137.86 52.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.023 -0.535 . . . . 0.92 109.956 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.573 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.67 134.95 42.88 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.838 -0.801 . . . . 0.49 108.838 178.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.564 ' O ' ' N ' ' A' ' 140' ' ' SER . 84.3 mt -99.1 122.94 51.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.09 0.471 . . . . 1.08 110.962 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.449 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.9 p -83.88 169.68 14.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.518 -0.764 . . . . 0.89 110.461 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.667 ' C ' ' HG1' ' A' ' 59' ' ' THR . 43.3 tt0 -59.67 -14.63 14.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.077 -0.511 . . . . 1.6 110.936 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.732 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.6 m-20 -96.07 -4.27 43.26 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.866 -0.333 . . . . 1.18 110.818 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.76 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.79 13.87 64.04 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.312 -0.715 . . . . 0.34 111.312 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -84.62 139.13 32.29 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.015 -0.274 . . . . 1.22 110.449 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.489 ' NE2' ' HG3' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -106.73 141.11 38.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.797 0.332 . . . . 1.44 110.601 179.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.75 126.97 26.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 1.39 110.402 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.671 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.4 tp -68.12 117.22 9.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.386 -0.37 . . . . 1.08 110.543 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.648 HD12 ' CD1' ' A' ' 132' ' ' TRP . 43.8 pt -108.97 -21.8 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.457 . . . . 1.08 110.838 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.93 125.74 5.85 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.467 -0.493 . . . . 1.1 111.49 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.496 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.7 120.17 21.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.702 -0.681 . . . . 0.94 109.576 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.58 151.76 29.23 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.594 -0.443 . . . . 1.07 110.929 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.48 158.56 18.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.007 -0.542 . . . . 0.89 110.38 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.08 157.9 43.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 0.67 110.646 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.14 104.34 9.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.748 -0.66 . . . . 1.17 110.043 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.484 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 66.5 p . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.01 -0.995 . . . . 1.26 110.653 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.553 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.6 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.226 -0.657 . . . . 3.83 109.226 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.64 18.54 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.071 -0.811 . . . . 1.39 111.071 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -35.62 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.297 -2.147 0 C-N-CA 124.039 3.159 . . . . 0.86 113.773 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.575 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.0 t -79.83 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.296 -1.32 . . . . 1.43 108.912 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.66 125.9 51.53 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.489 -0.484 . . . . 1.94 111.424 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.57 143.91 34.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.677 -0.692 . . . . 1.19 110.57 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.97 168.33 25.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.966 0.412 . . . . 3.92 111.142 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.587 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.0 130.99 60.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.976 -0.557 . . . . 3.88 110.101 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.8 p -141.14 162.26 35.9 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.902 0.382 . . . . 3.92 111.164 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 21.3 pt-20 36.12 31.61 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.695 -0.483 . . . . 6.08 109.695 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.587 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.59 32.61 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.867 -0.606 . . . . 4.01 111.578 -178.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.633 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.28 -29.1 72.79 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.465 2.11 . . . . 4.51 111.884 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.633 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.61 125.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 3.51 110.511 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.577 ' O ' ' O ' ' A' ' 92' ' ' THR . 1.5 mp0 -123.91 158.36 60.31 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.304 -0.407 . . . . 4.3 110.378 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.6 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 96.3 Cg_endo -82.11 -64.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.874 2.382 . . . . 1.96 113.542 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.66 ' ND2' ' N ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -108.48 -19.66 13.37 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.081 0.4 . . . . 3.33 112.081 -178.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.66 ' N ' ' ND2' ' A' ' 16' ' ' ASN . 95.8 p -107.2 152.02 24.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.164 0.507 . . . . 1.53 111.333 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.25 102.98 2.23 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.79 -0.641 . . . . 2.29 110.669 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.6 145.58 13.11 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.932 2.422 . . . . 0.88 112.59 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.416 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.82 167.91 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.911 -0.586 . . . . 2.12 109.899 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.14 147.85 28.96 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.855 -0.424 . . . . 2.67 109.855 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.499 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.5 p90 -142.18 157.34 44.97 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.663 -0.415 . . . . 0.32 111.223 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.466 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.2 m-20 -128.12 155.3 44.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.81 -0.632 . . . . 2.77 110.024 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.58 173.02 6.38 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.065 -0.516 . . . . 1.25 110.723 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.6 173.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.876 2.384 . . . . 1.12 111.543 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.04 -50.99 0.69 Allowed Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.68 -0.408 . . . . 4.05 110.166 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.658 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.84 152.38 82.38 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.797 2.331 . . . . 2.12 111.438 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.8 42.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.415 0.626 . . . . 2.85 110.538 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.819 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.54 -41.62 98.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.01 -0.996 . . . . 3.11 110.697 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.441 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.4 mt -109.86 137.82 40.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.815 -0.63 . . . . 1.86 111.274 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.9 -72.96 0.7 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.057 -0.52 . . . . 1.61 111.913 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.09 148.33 24.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.638 0.606 . . . . 1.67 112.638 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.84 124.88 45.2 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.318 -0.623 . . . . 1.07 109.318 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.0 134.79 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.647 -0.421 . . . . 1.55 110.649 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.484 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -120.03 128.66 53.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.297 -0.41 . . . . 1.33 111.191 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.54 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.17 138.97 49.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.807 -0.633 . . . . 2.36 110.023 179.003 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.415 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.03 163.11 35.23 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.119 0.485 . . . . 0.38 112.074 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.43 139.51 7.87 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.413 -0.812 . . . . 2.31 110.42 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.52 115.45 3.04 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.336 2.024 . . . . 0.86 111.77 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.679 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.94 81.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.868 -0.419 . . . . 3.44 109.868 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.21 -20.74 0.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.983 -0.553 . . . . 2.72 111.919 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -157.55 157.81 34.44 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.806 -0.358 . . . . 2.78 110.592 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.404 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.34 27.68 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 2.3 110.22 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.79 -75.86 1.31 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.08 -0.581 . . . . 1.8 111.884 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.82 152.28 35.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.845 0.355 . . . . 5.48 111.045 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.18 -169.16 2.55 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.071 -0.513 . . . . 1.84 111.955 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.415 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.73 29.65 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.431 0.634 . . . . 2.27 112.589 -177.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.13 156.53 45.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.87 -1.059 . . . . 1.92 110.16 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.25 158.33 41.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.898 -0.592 . . . . 1.09 111.826 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.0 m -115.23 135.71 53.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.386 -0.824 . . . . 1.16 109.758 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.451 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.39 121.91 23.77 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.371 -0.377 . . . . 1.39 111.546 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.513 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.7 Cg_exo -46.41 151.76 1.68 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.653 2.235 . . . . 0.72 112.08 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.91 -23.04 63.06 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 116.028 -0.533 . . . . 0.74 112.854 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.513 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.69 -17.03 45.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.343 0.572 . . . . 1.26 111.803 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.487 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.49 138.46 31.56 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.699 -0.4 . . . . 1.59 110.32 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.59 14.02 10.96 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.398 -0.365 . . . . 2.07 111.551 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.474 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.1 143.42 25.08 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.675 -0.41 . . . . 0.96 111.048 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.716 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.74 -169.42 1.54 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.938 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.716 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.5 t -151.72 125.91 9.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.438 -0.801 . . . . 1.19 109.828 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.467 HG23 HD11 ' A' ' 60' ' ' ILE . 66.5 mt -114.77 123.29 70.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.373 -0.531 . . . . 1.47 111.207 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.646 ' NZ ' ' N ' ' A' ' 142' ' ' PHE . 88.9 tttt -126.52 163.34 23.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.898 -0.592 . . . . 3.0 110.417 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.513 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.17 18.96 59.84 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.793 -0.923 . . . . 0.5 110.793 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.44 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.8 mt -79.15 157.28 27.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.108 0.48 . . . . 1.21 111.299 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.616 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 4.5 mttp -99.47 133.92 21.57 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.531 -0.759 . . . . 3.2 110.536 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.535 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.87 143.56 61.38 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.584 2.189 . . . . 1.09 111.95 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.77 25.71 75.24 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.088 -0.805 . . . . 0.72 111.088 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.64 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.25 158.73 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.717 0.294 . . . . 1.47 110.371 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.11 139.93 41.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.946 0.403 . . . . 1.23 110.516 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.64 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.63 136.42 54.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.905 -0.589 . . . . 1.1 110.782 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.87 131.04 45.27 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.442 -0.947 . . . . 1.87 108.442 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.49 153.97 16.64 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.313 -0.946 . . . . 0.39 111.935 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.05 140.85 45.91 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.726 -0.472 . . . . 1.8 109.726 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.462 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.8 tp -115.72 118.95 34.47 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.411 -0.516 . . . . 1.11 110.53 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.9 mt -112.44 129.03 68.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.332 -0.395 . . . . 1.51 110.582 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.85 120.78 43.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.294 -0.412 . . . . 1.47 110.764 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.668 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.45 146.47 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.173 0.511 . . . . 1.33 111.069 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.819 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.08 153.85 21.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.525 -0.761 . . . . 2.49 109.947 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.425 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.15 88.62 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.938 0.399 . . . . 4.2 110.408 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.613 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.61 0.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.85 -0.614 . . . . 6.4 110.592 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.17 -117.35 3.28 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.424 -0.67 . . . . 1.74 111.424 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.445 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.1 m170 -81.43 177.36 9.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.194 0.521 . . . . 3.64 111.637 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.08 149.61 32.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.398 -0.819 . . . . 1.7 110.353 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.553 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.21 144.71 38.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.449 -0.341 . . . . 2.7 110.528 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -128.03 135.97 61.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.002 0.43 . . . . 1.16 111.534 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.07 141.36 52.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.677 -0.692 . . . . 1.14 110.211 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.442 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.62 138.86 51.67 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.083 0.468 . . . . 4.33 111.577 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.491 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.27 164.09 38.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.623 -0.717 . . . . 0.91 109.468 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.57 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.18 151.62 38.72 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.473 -0.491 . . . . 1.47 111.046 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.574 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.7 p90 -146.35 172.71 13.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.734 -0.666 . . . . 0.51 111.033 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.449 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.5 t -118.78 160.65 21.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.479 -0.782 . . . . 1.92 109.828 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.449 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.34 121.82 22.92 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.627 -0.429 . . . . 1.63 110.83 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.577 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.0 p -128.18 162.99 25.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.082 -0.508 . . . . 2.37 111.667 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.6 m . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 3.63 110.028 178.388 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 121.888 0.851 . . . . 1.25 109.317 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.477 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.82 167.54 0.25 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.959 -1.018 . . . . 1.16 110.944 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.481 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.9 m-30 -133.66 145.48 49.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.757 -0.656 . . . . 0.78 110.178 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.23 101.76 9.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.075 -0.713 . . . . 1.08 109.075 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.468 HG11 ' N ' ' A' ' 131' ' ' SER . 72.0 t -112.96 139.68 36.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.982 -0.554 . . . . 1.1 111.077 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.468 ' N ' HG11 ' A' ' 130' ' ' VAL . 68.1 p -128.79 152.6 48.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.625 -0.716 . . . . 0.87 109.812 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.65 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.6 p90 -144.76 -164.97 2.04 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.731 -0.388 . . . . 0.37 110.666 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.5 t -123.87 127.12 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 1.14 110.853 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.18 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -58.03 58.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 1.91 110.383 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.11 24.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.831 -0.622 . . . . 1.56 111.482 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.18 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.18 128.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.59 -0.444 . . . . 1.56 110.904 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.42 -9.59 55.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.926 -0.579 . . . . 1.88 110.332 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.419 ' HB ' ' OE2' ' A' ' 187' ' ' GLU . 28.5 p -87.09 0.2 55.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.094 -0.503 . . . . 1.63 110.348 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.965 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.28 137.21 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.987 -0.551 . . . . 1.11 109.905 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 185' ' ' ILE . 81.8 p -96.19 -15.59 21.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.301 0.572 . . . . 1.01 110.04 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.613 ' C ' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.61 175.57 45.79 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 109.929 -1.269 . . . . 0.14 109.929 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.646 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . 76.2 m-85 -123.45 151.63 42.48 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.605 -0.438 . . . . 0.21 110.521 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.6 ' CZ ' ' CG ' ' A' ' 15' ' ' PRO . 73.8 ttt-85 -132.38 121.18 23.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.14 -0.482 . . . . 1.54 109.938 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.5 HG23 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.09 136.49 38.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.646 -0.707 . . . . 1.08 110.705 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 81.4 tt0 -129.3 129.82 45.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.966 -0.561 . . . . 1.32 110.132 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.606 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 36.1 p90 -138.65 135.3 34.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.06 -0.518 . . . . 1.05 110.659 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.407 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.31 161.35 39.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.723 -0.672 . . . . 1.16 109.699 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.949 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.3 mt -71.01 124.84 25.31 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.666 -0.414 . . . . 1.23 110.814 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.82 -7.66 49.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.764 -0.653 . . . . 0.86 110.76 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -109.78 -69.69 0.85 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.003 0.43 . . . . 1.66 111.477 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.473 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.58 -35.4 75.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.995 -0.548 . . . . 1.66 111.561 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.076 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.14 88.66 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.905 -0.878 . . . . 1.62 110.905 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.332 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.92 -171.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.742 0.306 . . . . 1.86 110.24 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.332 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.3 139.04 44.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 1.98 110.198 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.407 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 48.1 Cg_endo -70.83 145.79 51.88 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 122.755 2.304 . . . . 0.62 112.299 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.83 145.83 42.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.263 -0.643 . . . . 1.14 109.263 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.535 ' CE1' ' CD ' ' A' ' 65' ' ' PRO . 14.5 p90 -123.37 141.24 52.19 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.356 -0.538 . . . . 1.44 111.54 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.408 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.5 mt -128.03 127.68 43.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.356 -0.838 . . . . 1.08 108.95 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.482 ' OD2' ' HA2' ' A' ' 62' ' ' GLY . 95.2 m-20 -101.69 131.1 48.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.127 0.489 . . . . 1.09 111.76 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.495 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -127.91 157.59 73.26 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.323 -0.853 . . . . 1.04 109.557 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -69.76 158.0 58.46 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.467 2.111 . . . . 0.21 112.239 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.28 -12.14 5.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.754 -0.657 . . . . 0.88 110.79 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.7 p -92.85 -8.75 42.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 1.06 110.662 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.15 135.36 34.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.394 -0.366 . . . . 1.05 110.361 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.17 16.72 4.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.358 -0.383 . . . . 1.07 110.502 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.0 p -167.55 147.04 5.05 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.694 -0.484 . . . . 0.92 109.694 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.5 HG11 HG23 ' A' ' 144' ' ' VAL . 6.1 p -152.11 150.53 12.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.514 -0.474 . . . . 1.09 111.509 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.499 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.34 124.89 50.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.541 -0.754 . . . . 1.31 109.825 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.522 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.43 104.86 29.69 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.404 -0.362 . . . . 1.09 111.117 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 84.3 Cg_endo -90.99 -179.42 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 123.046 2.497 . . . . 0.48 112.163 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.61 32.68 18.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.393 -0.821 . . . . 1.26 111.501 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.522 HD21 HG21 ' A' ' 169' ' ' ILE . 24.4 mt -86.4 148.64 25.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 1.12 110.467 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.78 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.42 114.85 61.39 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.976 0.417 . . . . 1.3 110.585 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.0 140.62 96.16 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.866 2.377 . . . . 0.92 111.962 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.27 74.19 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.042 -0.823 . . . . 0.44 111.042 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.473 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.99 150.1 49.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.333 . . . . 3.05 110.62 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.5 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.08 131.62 45.92 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.026 -0.533 . . . . 1.48 109.745 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.949 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.5 148.47 43.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.16 -0.473 . . . . 0.89 111.036 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.5 mt -105.42 125.32 60.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.271 -1.011 . . . . 1.12 108.271 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.58 132.51 63.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.164 0.507 . . . . 1.1 111.192 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.47 122.57 20.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.565 -0.743 . . . . 0.43 109.628 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.596 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.02 125.42 54.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.286 -0.415 . . . . 1.07 110.713 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.674 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.5 m-85 -117.26 137.81 52.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.07 -0.514 . . . . 0.92 109.837 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.574 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.61 135.03 42.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.828 -0.805 . . . . 0.49 108.828 178.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.594 ' O ' ' N ' ' A' ' 140' ' ' SER . 50.0 mm -99.11 122.91 51.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.148 0.499 . . . . 1.08 111.015 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.445 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.1 p -83.84 169.62 14.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.547 -0.752 . . . . 0.89 110.49 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.597 ' O ' ' CG2' ' A' ' 59' ' ' THR . 0.0 OUTLIER -59.67 -14.59 14.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.06 -0.518 . . . . 1.6 110.954 -179.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.445 ' H ' ' HG ' ' A' ' 186' ' ' SER . 87.2 m-20 -96.03 -4.35 43.24 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.784 -0.366 . . . . 1.18 110.793 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.78 14.0 63.82 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.356 -0.697 . . . . 0.34 111.356 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -84.66 139.07 32.3 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.093 -0.243 . . . . 1.22 110.439 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.492 ' NE2' ' HG3' ' A' ' 14' ' ' GLN . 4.1 mt-30 -106.78 141.05 38.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.868 0.366 . . . . 1.44 110.537 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.4 m -136.67 127.05 26.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 1.39 110.367 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.674 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.6 tp -68.18 117.25 9.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.319 -0.4 . . . . 1.08 110.486 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.65 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.1 pt -109.01 -21.69 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 1.08 110.725 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.96 125.78 5.85 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.55 -0.46 . . . . 1.1 111.466 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.488 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.82 120.19 21.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.739 -0.664 . . . . 0.94 109.591 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.62 151.66 29.08 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.608 -0.437 . . . . 1.07 110.895 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.8 p -110.38 158.61 18.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.99 -0.55 . . . . 0.89 110.451 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.13 157.95 43.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.068 -0.514 . . . . 0.67 110.639 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.36 9.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.689 -0.687 . . . . 1.17 109.99 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.481 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.5 p . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.966 -1.016 . . . . 1.26 110.556 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.9 m . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.18 -0.674 . . . . 3.83 109.18 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.36 150.72 18.54 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.956 -0.858 . . . . 1.39 110.956 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -35.52 142.39 0.1 OUTLIER 'Trans proline' 0 C--N 1.3 -2.024 0 C-N-CA 123.965 3.11 . . . . 0.86 113.845 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.563 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.1 t -79.96 173.47 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.25 -1.341 . . . . 1.43 108.904 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.401 ' H ' ' CG1' ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.59 125.91 51.53 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.416 -0.513 . . . . 1.94 111.423 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.62 144.01 33.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.688 -0.687 . . . . 1.19 110.693 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.04 168.29 25.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.852 0.358 . . . . 3.92 111.093 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.587 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.92 131.03 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.019 -0.537 . . . . 3.88 110.109 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.21 162.22 36.0 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.917 0.389 . . . . 3.92 111.213 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 32.6 tp10 36.23 31.47 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.651 -0.5 . . . . 6.08 109.651 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.587 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.65 32.74 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.914 -0.585 . . . . 4.01 111.575 -178.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.632 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.29 -29.16 72.68 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.494 2.129 . . . . 4.51 111.81 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.632 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.7 125.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 3.51 110.377 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.646 ' O ' ' O ' ' A' ' 92' ' ' THR . 11.7 mp0 -123.97 158.41 60.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.321 -0.399 . . . . 4.3 110.49 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.551 ' HB2' HH21 ' A' ' 143' ' ' ARG . 96.9 Cg_endo -82.11 -64.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.852 2.368 . . . . 1.96 113.47 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.577 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 63.5 t30 -108.35 -19.67 13.39 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.081 0.4 . . . . 3.33 112.081 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 66.1 p -107.31 152.13 24.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.206 0.527 . . . . 1.53 111.246 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.573 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.33 102.96 2.22 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.702 -0.681 . . . . 2.29 110.63 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.75 145.58 12.88 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.912 2.408 . . . . 0.88 112.611 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.41 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.73 167.96 24.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.938 -0.573 . . . . 2.12 109.879 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -149.14 147.99 29.11 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.609 -0.515 . . . . 2.67 109.609 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.496 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.8 p90 -142.28 157.26 45.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.019 0.437 . . . . 0.32 111.229 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.464 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.9 m-20 -128.05 155.24 44.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.853 -0.612 . . . . 2.77 110.098 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.57 172.99 6.41 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.137 0.494 . . . . 1.25 110.801 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.61 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.913 2.409 . . . . 1.12 111.534 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.479 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.14 -51.06 0.68 Allowed Pre-proline 0 C--N 1.328 -0.344 0 C-N-CA 120.709 -0.397 . . . . 4.05 110.052 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.652 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.79 152.32 82.53 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.808 2.339 . . . . 2.12 111.442 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.66 42.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.373 0.606 . . . . 2.85 110.571 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.82 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.73 -41.56 98.04 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.037 -0.983 . . . . 3.11 110.653 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.438 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.2 mt -109.91 137.85 40.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.767 -0.651 . . . . 1.86 111.211 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.91 -72.94 0.7 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.004 -0.544 . . . . 1.61 111.936 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.15 148.37 24.45 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.651 0.611 . . . . 1.67 112.651 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.82 124.82 45.06 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.35 -0.611 . . . . 1.07 109.35 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.9 mt -118.08 134.73 60.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.646 -0.422 . . . . 1.55 110.566 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.488 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -119.99 128.63 53.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.434 . . . . 1.33 111.288 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.547 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.14 139.01 49.73 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.746 -0.661 . . . . 2.36 110.115 178.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.418 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.0 p90 -145.14 163.13 35.3 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.176 0.512 . . . . 0.38 112.018 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.489 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.48 139.49 7.81 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 115.399 -0.818 . . . . 2.31 110.484 178.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.53 115.5 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.309 2.006 . . . . 0.86 111.839 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.667 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.03 81.21 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.81 -0.441 . . . . 3.44 109.81 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.15 -20.75 0.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.027 -0.533 . . . . 2.72 111.843 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.4 p -157.52 157.75 34.4 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.937 -0.305 . . . . 2.78 110.65 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.43 27.9 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.27 -0.423 . . . . 2.3 110.241 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.89 -75.83 1.31 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.066 -0.587 . . . . 1.8 111.834 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.91 152.27 35.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.964 0.411 . . . . 5.48 110.927 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.676 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.24 -169.14 2.53 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.068 -0.514 . . . . 1.84 111.938 179.298 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.11 149.69 29.68 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.463 0.649 . . . . 2.27 112.569 -177.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -140.98 156.53 46.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.745 -1.116 . . . . 1.92 110.257 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.3 158.47 41.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.967 -0.56 . . . . 1.09 111.706 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.7 m -115.24 135.69 53.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.385 -0.825 . . . . 1.16 109.799 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.443 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.43 122.05 23.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.403 -0.362 . . . . 1.39 111.48 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.514 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.1 Cg_exo -46.45 151.75 1.71 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.675 2.25 . . . . 0.72 112.115 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.98 -22.87 63.03 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 116.092 -0.504 . . . . 0.74 112.798 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.514 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.9 -16.9 45.66 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.259 -0.576 . . . . 1.26 111.763 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.491 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.5 mt -91.52 138.37 31.63 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.848 -0.341 . . . . 1.59 110.366 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.56 13.92 10.97 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.409 -0.359 . . . . 2.07 111.561 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.475 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -150.01 143.49 25.21 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.658 -0.417 . . . . 0.96 111.061 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.72 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.82 -169.38 1.54 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.961 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.72 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.3 m -151.69 125.92 9.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.483 -0.78 . . . . 1.19 109.867 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 60' ' ' ILE . 66.9 mt -114.94 123.29 70.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.404 -0.518 . . . . 1.47 111.186 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -126.48 163.48 23.25 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.824 -0.625 . . . . 3.0 110.37 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.436 ' HA2' HD22 ' A' ' 16' ' ' ASN . . . 85.09 18.9 60.09 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.735 -0.946 . . . . 0.5 110.735 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.577 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.4 mt -78.9 157.22 28.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.065 0.459 . . . . 1.21 111.438 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.617 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -99.52 133.94 21.52 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.684 -0.689 . . . . 3.2 110.396 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.433 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.95 143.62 61.18 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.519 2.146 . . . . 1.09 111.97 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.73 25.79 75.15 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.041 -0.823 . . . . 0.72 111.041 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.637 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.16 158.85 39.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.705 0.288 . . . . 1.47 110.456 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.23 139.95 42.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.946 0.403 . . . . 1.23 110.562 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.637 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.6 m-85 -122.59 136.42 54.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.949 -0.568 . . . . 1.1 110.729 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.489 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.9 131.01 45.31 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.488 -0.93 . . . . 1.87 108.488 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.488 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.46 153.85 16.64 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.261 -0.971 . . . . 0.39 111.917 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.93 140.9 46.1 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.73 -0.47 . . . . 1.8 109.73 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.467 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.9 tp -115.7 118.9 34.35 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.493 -0.483 . . . . 1.11 110.553 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.2 mt -112.43 129.08 68.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.303 -0.408 . . . . 1.51 110.669 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.78 120.84 43.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.289 -0.414 . . . . 1.47 110.715 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.67 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.52 146.43 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.241 0.543 . . . . 1.33 111.01 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.82 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.02 153.9 21.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.524 -0.762 . . . . 2.49 109.956 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.26 88.65 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.932 0.396 . . . . 4.2 110.42 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.622 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.21 32.73 0.21 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.793 -0.639 . . . . 6.4 110.609 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.12 -117.38 3.29 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.437 -0.665 . . . . 1.74 111.437 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.449 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.5 177.37 8.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.158 0.504 . . . . 3.64 111.661 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.1 149.51 32.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.481 -0.781 . . . . 1.7 110.359 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.16 144.72 38.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.417 -0.356 . . . . 2.7 110.558 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -128.01 136.01 61.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 121.048 0.451 . . . . 1.16 111.506 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.04 141.37 52.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.624 -0.716 . . . . 1.14 110.279 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.45 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.68 138.93 51.66 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.441 -0.503 . . . . 4.33 111.466 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 53.0 p90 -152.32 164.23 37.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.521 -0.763 . . . . 0.91 109.467 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.575 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.1 p30 -145.24 151.52 38.51 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.503 -0.479 . . . . 1.47 111.084 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.573 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.1 p90 -146.22 172.7 13.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.782 -0.645 . . . . 0.51 111.068 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.453 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.5 t -118.8 160.61 21.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.496 -0.774 . . . . 1.92 109.821 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.453 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.36 121.83 22.92 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 120.587 -0.445 . . . . 1.63 110.781 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.646 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -128.08 163.55 24.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.156 -0.475 . . . . 2.37 110.309 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.464 0.272 0 C-N-CA 120.312 -0.555 . . . . 3.63 110.628 178.847 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.3 p . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.657 0.265 . . . . 1.25 110.818 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.471 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.86 167.55 0.26 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 1.16 110.959 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.54 145.6 50.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.692 -0.685 . . . . 0.78 110.186 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.29 101.65 9.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.086 -0.709 . . . . 1.08 109.086 177.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.459 HG11 ' N ' ' A' ' 131' ' ' SER . 71.1 t -113.0 139.78 36.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.985 -0.552 . . . . 1.1 111.063 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.459 ' N ' HG11 ' A' ' 130' ' ' VAL . 66.7 p -128.71 152.49 48.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.67 -0.696 . . . . 0.87 109.832 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.649 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.9 p90 -144.7 -164.89 2.02 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.722 -0.391 . . . . 0.37 110.691 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.734 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -124.06 127.24 73.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.198 -0.456 . . . . 1.14 110.73 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.172 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.099 -0.501 . . . . 1.91 110.342 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -37.96 24.45 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.946 -0.57 . . . . 1.56 111.566 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.172 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.13 128.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.724 -0.391 . . . . 1.56 111.002 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -86.45 -9.51 56.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.942 -0.572 . . . . 1.88 110.281 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.14 0.16 55.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 1.63 110.315 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.962 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.06 137.15 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 116.008 -0.542 . . . . 1.11 109.985 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 185' ' ' ILE . 87.3 p -96.26 -15.48 21.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.242 0.544 . . . . 1.01 110.066 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.64 175.61 45.86 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 109.881 -1.288 . . . . 0.14 109.881 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.51 151.6 42.63 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.673 -0.411 . . . . 0.21 110.434 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.551 HH21 ' HB2' ' A' ' 15' ' ' PRO . 69.4 ttt-85 -132.36 121.16 23.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.122 -0.49 . . . . 1.54 109.926 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.491 HG23 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.04 136.6 38.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.681 -0.691 . . . . 1.08 110.69 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 83.7 tt0 -129.43 129.84 45.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.067 -0.515 . . . . 1.32 110.01 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.6 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.7 135.32 34.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.965 -0.561 . . . . 1.05 110.656 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.414 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.38 39.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.77 -0.65 . . . . 1.16 109.641 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.938 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.3 mt -71.13 124.85 25.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.039 0.447 . . . . 1.23 110.673 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.73 -7.72 49.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.684 -0.689 . . . . 0.86 110.883 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.77 -69.74 0.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.315 -0.402 . . . . 1.66 111.432 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.442 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.68 -35.21 75.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.027 -0.533 . . . . 1.66 111.563 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.093 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.07 7.29 88.54 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.814 -0.914 . . . . 1.62 110.814 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.322 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.93 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.773 0.321 . . . . 1.86 110.256 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.322 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.33 139.05 44.89 Favored Pre-proline 0 N--CA 1.454 -0.261 0 CA-C-N 116.302 -0.408 . . . . 1.98 110.157 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.414 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.2 Cg_endo -70.85 145.89 52.06 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 C-N-CA 122.656 2.237 . . . . 0.62 112.398 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.6 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.82 145.68 42.63 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.232 -0.655 . . . . 1.14 109.232 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.57 ' CE2' ' CG ' ' A' ' 16' ' ' ASN . 37.3 p90 -123.24 141.37 52.05 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.345 -0.542 . . . . 1.44 111.463 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.7 mt -128.12 127.74 43.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.313 -0.858 . . . . 1.08 108.966 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -101.68 131.17 48.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.097 0.475 . . . . 1.09 111.779 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.505 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -127.89 157.56 73.33 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.373 -0.831 . . . . 1.04 109.61 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -69.84 158.0 58.32 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.382 2.054 . . . . 0.21 112.27 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.1 p -59.24 -12.17 5.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.792 -0.64 . . . . 0.88 110.714 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.3 p -92.79 -8.74 42.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 1.06 110.714 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.41 34.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.363 -0.38 . . . . 1.05 110.434 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.4 p -133.14 16.58 4.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.348 -0.387 . . . . 1.07 110.475 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.6 p -167.48 147.23 5.15 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.642 -0.503 . . . . 0.92 109.642 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.505 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.18 150.35 13.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.617 -0.433 . . . . 1.09 111.606 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.5 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.25 124.95 50.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.67 -0.695 . . . . 1.31 109.803 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.519 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.42 104.9 29.84 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.426 -0.352 . . . . 1.09 111.117 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.3 Cg_endo -90.91 -179.46 1.51 Allowed 'Trans proline' 0 C--N 1.3 -1.988 0 C-N-CA 123.231 2.621 . . . . 0.48 112.282 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 61.56 32.65 18.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.475 -0.784 . . . . 1.26 111.499 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.519 HD21 HG21 ' A' ' 169' ' ' ILE . 23.6 mt -86.4 148.58 25.51 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.887 -0.325 . . . . 1.12 110.433 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.766 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.27 114.87 61.36 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.051 0.453 . . . . 1.3 110.69 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.95 140.52 95.66 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.951 2.434 . . . . 0.92 111.955 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.27 74.16 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.023 -0.831 . . . . 0.44 111.023 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.442 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.89 150.13 49.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 3.05 110.643 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.501 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.11 131.58 45.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.094 -0.503 . . . . 1.48 109.814 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.938 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.49 148.3 44.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.022 -0.536 . . . . 0.89 111.043 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.1 mt -105.27 125.29 60.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.286 -1.005 . . . . 1.12 108.286 177.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.46 132.47 63.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.193 0.52 . . . . 1.1 111.315 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.6 20.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.501 -0.772 . . . . 0.43 109.638 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.594 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -101.03 125.39 54.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.217 -0.447 . . . . 1.07 110.73 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.674 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.9 m-85 -117.25 137.9 52.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.954 -0.566 . . . . 0.92 109.823 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.569 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.71 135.02 42.81 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.797 -0.816 . . . . 0.49 108.797 178.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 140' ' ' SER . 44.5 mm -99.08 123.0 51.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.136 0.493 . . . . 1.08 110.937 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.449 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.0 p -83.94 169.73 14.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.568 -0.742 . . . . 0.89 110.466 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -59.82 -14.44 14.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.057 -0.519 . . . . 1.6 110.888 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.507 ' C ' ' OG1' ' A' ' 59' ' ' THR . 96.4 m-20 -96.19 -4.34 42.71 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.834 -0.347 . . . . 1.18 110.708 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.62 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.85 13.93 63.83 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.3 -0.72 . . . . 0.34 111.3 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -84.64 139.03 32.34 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.099 -0.24 . . . . 1.22 110.49 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.43 ' NE2' ' OG ' ' A' ' 17' ' ' SER . 1.6 mt-30 -106.64 141.05 38.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.436 -0.347 . . . . 1.44 110.542 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.5 m -136.7 127.07 26.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 1.39 110.374 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.674 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.8 tp -68.11 117.3 9.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.329 -0.396 . . . . 1.08 110.502 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.649 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.3 pt -109.09 -21.81 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 1.08 110.625 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.91 125.72 5.85 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.523 -0.471 . . . . 1.1 111.48 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.484 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.76 120.22 21.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.799 -0.637 . . . . 0.94 109.541 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.62 151.68 29.11 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.663 -0.415 . . . . 1.07 110.938 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.42 158.61 18.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.062 -0.517 . . . . 0.89 110.408 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.1 157.96 43.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.107 -0.497 . . . . 0.67 110.667 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 104.29 9.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.714 -0.676 . . . . 1.17 110.032 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.478 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 68.2 p . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.858 -1.068 . . . . 1.26 110.664 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.55 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.3 m . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.141 -0.688 . . . . 3.83 109.141 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.32 150.72 18.54 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.048 -0.821 . . . . 1.39 111.048 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -35.59 142.42 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.121 0 C-N-CA 124.009 3.139 . . . . 0.86 113.824 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.571 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.3 t -80.02 173.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.199 -1.364 . . . . 1.43 108.775 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 23' ' ' ASN . 96.1 mt-10 -105.62 125.92 51.55 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.385 -0.526 . . . . 1.94 111.371 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.48 143.99 34.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.629 -0.714 . . . . 1.19 110.689 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.4 25.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.833 0.349 . . . . 3.92 111.145 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.589 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.07 131.0 61.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 3.88 109.989 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.16 162.44 35.48 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.882 0.372 . . . . 3.92 111.169 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 9' ' ' THR . 71.0 tt0 36.02 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.088 -0.505 . . . . 6.08 109.689 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.589 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.59 33.07 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.924 -0.58 . . . . 4.01 111.62 -178.777 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.636 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.33 -29.04 72.25 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.438 2.092 . . . . 4.51 111.868 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.636 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.57 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 3.51 110.518 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.675 HE21 HE21 ' A' ' 191' ' ' GLN . 23.2 mt-30 -123.96 158.22 60.92 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.36 -0.382 . . . . 4.3 110.468 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.469 ' HG2' ' CZ ' ' A' ' 143' ' ' ARG . 96.4 Cg_endo -81.94 -64.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.903 2.402 . . . . 1.96 113.568 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.64 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 56.6 t30 -108.49 -19.55 13.41 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.027 0.38 . . . . 3.33 112.027 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.535 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 43.3 t -107.36 152.1 24.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.091 0.472 . . . . 1.53 111.29 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.3 102.87 2.22 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.675 -0.693 . . . . 2.29 110.666 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.68 145.59 13.0 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.882 2.388 . . . . 0.88 112.59 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.413 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.81 167.88 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 2.12 109.863 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.08 148.0 29.17 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.804 -0.443 . . . . 2.67 109.804 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.496 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.8 p90 -142.31 157.29 44.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.065 0.46 . . . . 0.32 111.168 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.469 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.02 155.24 44.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.751 -0.659 . . . . 2.77 110.122 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.53 173.13 6.25 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 121.168 0.509 . . . . 1.25 110.665 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -50.65 173.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.816 2.344 . . . . 1.12 111.551 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.481 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.09 -51.13 0.68 Allowed Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.775 -0.37 . . . . 4.05 110.062 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.659 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.72 152.22 82.81 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.856 2.371 . . . . 2.12 111.481 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.63 42.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.479 0.657 . . . . 2.85 110.624 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.824 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.68 -41.62 98.13 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.89 -1.05 . . . . 3.11 110.569 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.438 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.8 mt -109.79 137.79 40.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.846 -0.616 . . . . 1.86 111.262 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.87 -72.96 0.7 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.043 -0.526 . . . . 1.61 111.939 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.12 148.35 24.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.593 0.59 . . . . 1.67 112.593 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.84 124.82 45.05 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.304 -0.628 . . . . 1.07 109.304 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.6 mt -117.99 134.69 60.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.683 -0.407 . . . . 1.55 110.658 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.484 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -120.0 128.58 53.68 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.053 0.454 . . . . 1.33 111.277 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.1 139.05 49.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.778 -0.646 . . . . 2.36 110.133 178.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.42 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.1 163.16 35.17 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.145 0.498 . . . . 0.38 112.067 -178.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.494 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.4 139.69 7.99 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.452 -0.795 . . . . 2.31 110.479 178.793 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.58 115.49 3.08 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.273 1.982 . . . . 0.86 111.879 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.666 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.04 81.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.865 -0.42 . . . . 3.44 109.865 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.693 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.925 -0.58 . . . . 2.72 111.939 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.8 p -157.56 157.81 34.43 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.877 -0.329 . . . . 2.78 110.617 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.403 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.8 m -120.38 27.8 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 2.3 110.16 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -75.83 1.31 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.143 -0.551 . . . . 1.8 111.846 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.85 152.25 35.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.91 0.386 . . . . 5.48 111.084 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.673 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.16 -169.01 2.5 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.103 -0.498 . . . . 1.84 111.919 179.352 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.17 149.72 29.68 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.434 0.635 . . . . 2.27 112.582 -177.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.08 156.48 45.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.856 -1.065 . . . . 1.92 110.316 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.21 158.39 41.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.027 -0.533 . . . . 1.09 111.75 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.8 m -115.22 135.61 53.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.445 -0.798 . . . . 1.16 109.751 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.448 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.41 121.98 23.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.394 -0.367 . . . . 1.39 111.513 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.519 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.9 Cg_exo -46.33 151.66 1.66 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.656 2.237 . . . . 0.72 112.097 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.83 -23.11 62.98 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 116.0 -0.545 . . . . 0.74 112.771 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.519 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.71 -16.87 46.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.371 0.586 . . . . 1.26 111.882 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.483 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.55 138.29 31.69 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.804 -0.359 . . . . 1.59 110.368 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.39 13.8 11.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.391 -0.368 . . . . 2.07 111.578 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.83 143.52 25.39 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.662 -0.415 . . . . 0.96 111.084 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.725 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.85 -169.39 1.54 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.222 0.534 . . . . 1.0 110.883 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.725 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.7 t -151.74 125.88 9.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.418 -0.81 . . . . 1.19 109.806 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.42 HG23 HD11 ' A' ' 60' ' ' ILE . 66.9 mt -114.89 123.29 70.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.369 -0.532 . . . . 1.47 111.24 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.482 ' CD ' ' CD1' ' A' ' 185' ' ' ILE . 1.2 mtmt -126.49 163.44 23.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.773 -0.649 . . . . 3.0 110.405 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.439 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.07 19.0 59.94 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.776 -0.93 . . . . 0.5 110.776 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.64 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.6 mt -79.07 157.23 28.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.124 0.488 . . . . 1.21 111.411 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.646 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -99.49 133.9 21.57 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.677 -0.692 . . . . 3.2 110.439 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.479 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.74 143.55 62.12 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.61 2.207 . . . . 1.09 111.948 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.86 25.63 75.34 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.98 -0.848 . . . . 0.72 110.98 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.642 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.16 158.76 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.747 0.308 . . . . 1.47 110.406 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.18 139.94 42.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.941 0.4 . . . . 1.23 110.566 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.646 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.55 136.5 54.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.944 -0.571 . . . . 1.1 110.763 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.494 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.96 131.03 45.32 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.522 -0.918 . . . . 1.87 108.522 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.44 153.9 16.63 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.354 -0.927 . . . . 0.39 111.945 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.15 140.91 45.78 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.632 -0.507 . . . . 1.8 109.632 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.46 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.1 tp -115.69 118.93 34.45 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.422 -0.511 . . . . 1.11 110.469 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.2 mt -112.45 129.11 68.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.322 -0.399 . . . . 1.51 110.614 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.87 120.86 43.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.305 -0.407 . . . . 1.47 110.636 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.669 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.61 146.47 11.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.305 0.574 . . . . 1.33 110.969 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.824 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -105.96 153.84 21.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.459 -0.791 . . . . 2.49 109.943 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.2 mt-30 -39.24 88.61 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.955 0.407 . . . . 4.2 110.439 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.624 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.757 -0.656 . . . . 6.4 110.57 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.11 -117.35 3.29 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.433 -0.667 . . . . 1.74 111.433 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.442 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.45 177.43 8.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.132 0.491 . . . . 3.64 111.688 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.2 149.48 32.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.448 -0.797 . . . . 1.7 110.391 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.55 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.1 144.62 38.8 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.444 -0.344 . . . . 2.7 110.588 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -127.99 135.93 61.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.075 0.464 . . . . 1.16 111.589 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.571 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.01 141.4 52.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.661 . . . . 1.14 110.237 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.445 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.69 138.82 51.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.214 0.531 . . . . 4.33 111.501 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.21 164.27 37.71 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.532 -0.758 . . . . 0.91 109.468 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.573 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 46.9 p30 -145.29 151.53 38.49 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.335 -0.546 . . . . 1.47 111.042 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.2 p90 -146.3 172.67 13.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.842 -0.617 . . . . 0.51 110.959 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.455 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.5 t -118.77 160.66 21.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.43 -0.805 . . . . 1.92 109.856 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.455 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.38 121.94 23.05 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.585 -0.446 . . . . 1.63 110.742 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.2 p -130.6 162.37 29.49 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 112.963 0.727 . . . . 2.37 112.963 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.6 t . . . . . 0 C--N 1.316 -0.868 0 CA-C-N 114.39 -1.277 . . . . 3.63 111.522 175.837 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.537 0.447 0 N-CA-C 113.086 0.773 . . . . 1.25 113.086 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.482 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.91 167.53 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.997 0.427 . . . . 1.16 110.94 179.169 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.486 ' CZ ' HG22 ' A' ' 201' ' ' THR . 8.0 m-30 -133.51 145.51 50.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.677 -0.692 . . . . 0.78 110.178 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.3 t -124.31 101.77 9.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.049 -0.723 . . . . 1.08 109.049 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.471 HG11 ' N ' ' A' ' 131' ' ' SER . 72.0 t -112.99 139.62 37.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.985 -0.552 . . . . 1.1 111.09 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.471 ' N ' HG11 ' A' ' 130' ' ' VAL . 66.6 p -128.68 152.62 48.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.669 -0.696 . . . . 0.87 109.822 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.648 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.7 p90 -144.86 -165.0 2.05 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.737 -0.385 . . . . 0.37 110.653 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -123.95 127.21 73.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.189 -0.459 . . . . 1.14 110.793 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.173 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.98 58.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.149 -0.478 . . . . 1.91 110.367 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.19 24.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.867 -0.606 . . . . 1.56 111.451 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.173 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.22 128.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.998 0.428 . . . . 1.56 110.933 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.53 -9.5 56.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.94 -0.573 . . . . 1.88 110.319 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.22 0.33 55.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.052 -0.522 . . . . 1.63 110.288 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.963 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.38 137.3 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 115.988 -0.551 . . . . 1.11 109.908 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 185' ' ' ILE . 1.9 m -96.24 -15.51 21.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.282 0.563 . . . . 1.01 110.076 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.586 ' N ' HG12 ' A' ' 185' ' ' ILE . . . 178.65 175.55 45.81 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 109.844 -1.303 . . . . 0.14 109.844 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.45 151.6 42.52 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.668 -0.413 . . . . 0.21 110.449 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.536 ' NH2' ' HB3' ' A' ' 157' ' ' TYR . 74.4 ttt-85 -132.31 121.17 23.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.116 -0.493 . . . . 1.54 109.948 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.492 HG23 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.14 136.61 38.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.718 -0.674 . . . . 1.08 110.62 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 80.7 tt0 -129.33 129.87 45.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.902 -0.59 . . . . 1.32 110.072 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.76 135.29 34.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.163 0.506 . . . . 1.05 110.595 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.402 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.25 161.42 39.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.754 -0.657 . . . . 1.16 109.695 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.939 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -71.14 124.89 25.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.039 0.447 . . . . 1.23 110.684 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.77 -7.7 49.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.745 -0.662 . . . . 0.86 110.885 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -109.85 -69.64 0.85 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 1.66 111.331 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.441 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.7 -35.33 76.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.079 -0.51 . . . . 1.66 111.445 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.082 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.2 7.13 88.66 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.828 -0.909 . . . . 1.62 110.828 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.339 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.96 -171.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 1.86 110.272 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.339 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.22 139.07 45.28 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.941 0.401 . . . . 1.98 110.196 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.402 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.4 Cg_endo -70.89 145.79 51.55 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 122.789 2.326 . . . . 0.62 112.295 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.8 145.77 42.54 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.264 -0.643 . . . . 1.14 109.264 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.536 ' HB3' ' NH2' ' A' ' 143' ' ' ARG . 34.5 p90 -123.33 141.31 52.12 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.364 -0.534 . . . . 1.44 111.449 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.412 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.8 mt -128.1 127.79 43.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.226 -0.897 . . . . 1.08 108.915 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.487 ' HB2' ' ND2' ' A' ' 16' ' ' ASN . 67.8 t0 -101.69 131.21 48.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.16 0.505 . . . . 1.09 111.732 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.508 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -128.03 157.62 73.41 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.334 -0.848 . . . . 1.04 109.541 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -69.83 158.08 58.08 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.385 2.057 . . . . 0.21 112.248 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.31 -12.19 5.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.839 -0.618 . . . . 0.88 110.673 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.9 p -92.83 -8.74 42.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 1.06 110.661 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.23 135.45 34.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.405 -0.362 . . . . 1.05 110.346 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.0 p -133.13 16.6 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.396 . . . . 1.07 110.524 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.8 p -167.54 147.05 5.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.707 -0.479 . . . . 0.92 109.707 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.508 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.12 150.56 12.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.533 -0.467 . . . . 1.09 111.568 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.495 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.43 124.98 50.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.567 -0.742 . . . . 1.31 109.768 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.527 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.31 104.9 29.5 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.344 -0.389 . . . . 1.09 111.034 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.9 Cg_endo -91.03 -179.56 1.49 Allowed 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 123.215 2.61 . . . . 0.48 112.212 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.77 32.61 18.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.427 -0.806 . . . . 1.26 111.458 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.527 HD21 HG21 ' A' ' 169' ' ' ILE . 24.0 mt -86.42 148.5 25.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.442 -0.345 . . . . 1.12 110.391 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.773 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.4 mt -88.24 114.92 61.56 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.987 0.422 . . . . 1.3 110.69 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.12 140.55 95.55 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.879 2.386 . . . . 0.92 111.978 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.21 74.33 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.102 -0.799 . . . . 0.44 111.102 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.441 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.81 150.26 49.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.781 0.324 . . . . 3.05 110.661 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.31 131.61 46.15 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.105 -0.498 . . . . 1.48 109.769 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.939 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.47 148.4 43.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.012 -0.54 . . . . 0.89 110.962 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.36 125.37 60.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.262 -1.014 . . . . 1.12 108.262 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.56 132.5 63.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.158 0.504 . . . . 1.1 111.249 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.9 m-20 -136.48 122.63 20.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.48 -0.782 . . . . 0.43 109.693 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.592 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.07 125.39 55.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.241 -0.436 . . . . 1.07 110.63 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.67 ' CE1' HD11 ' A' ' 193' ' ' LEU . 47.9 m-85 -117.2 137.88 52.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.974 -0.557 . . . . 0.92 109.912 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.571 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.7 135.09 42.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.734 -0.839 . . . . 0.49 108.734 178.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.586 HG12 ' N ' ' A' ' 141' ' ' GLY . 0.8 OUTLIER -99.24 123.01 51.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.216 0.531 . . . . 1.08 110.866 -178.722 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.447 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.4 p -83.84 169.81 14.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.512 -0.767 . . . . 0.89 110.399 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.507 ' OE1' ' OG ' ' A' ' 140' ' ' SER . 48.0 tp10 -59.89 -14.52 15.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.948 -0.569 . . . . 1.6 110.962 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.447 ' H ' ' HG ' ' A' ' 186' ' ' SER . 95.5 m-20 -96.09 -4.25 43.2 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.818 -0.353 . . . . 1.18 110.825 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.89 13.82 63.93 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.297 -0.721 . . . . 0.34 111.297 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -84.53 139.04 32.41 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.116 -0.233 . . . . 1.22 110.519 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.675 HE21 HE21 ' A' ' 14' ' ' GLN . 74.3 mt-30 -106.77 141.06 38.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.852 0.358 . . . . 1.44 110.596 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.0 m -136.69 126.97 26.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 1.39 110.345 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.67 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.4 tp -68.0 117.22 9.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.254 -0.43 . . . . 1.08 110.502 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.648 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.1 pt -109.09 -21.69 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.241 -0.436 . . . . 1.08 110.728 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.92 125.71 5.84 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.527 -0.469 . . . . 1.1 111.5 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.496 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.76 120.31 21.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.764 -0.653 . . . . 0.94 109.539 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.72 151.6 28.93 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.587 -0.445 . . . . 1.07 110.89 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.41 158.58 18.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.052 -0.522 . . . . 0.89 110.461 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -145.99 158.06 43.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.67 110.651 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.37 104.38 9.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.775 -0.648 . . . . 1.17 110.012 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.486 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.2 p . . . . . 0 C--O 1.222 -0.39 0 CA-C-O 117.887 -1.054 . . . . 1.26 110.659 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.553 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.148 -0.686 . . . . 3.83 109.148 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.41 150.63 18.55 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.992 -0.843 . . . . 1.39 110.992 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -35.51 142.32 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.085 0 C-N-CA 124.083 3.189 . . . . 0.86 113.799 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.573 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.3 t -79.98 173.38 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.281 -1.327 . . . . 1.43 108.779 178.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.57 125.88 51.5 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.378 -0.529 . . . . 1.94 111.439 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.5 144.02 33.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.653 -0.703 . . . . 1.19 110.633 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -151.98 168.39 25.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.908 0.385 . . . . 3.92 111.162 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.588 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.12 131.06 60.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.053 -0.521 . . . . 3.88 110.055 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.1 p -141.16 162.22 36.02 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.88 0.371 . . . . 3.92 111.26 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 98.1 mt-10 36.17 31.59 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.587 -0.523 . . . . 6.08 109.587 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.588 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.4 69.53 32.08 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.97 -0.559 . . . . 4.01 111.547 -178.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.27 -29.08 72.81 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.494 2.129 . . . . 4.51 111.858 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.61 125.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.118 -0.492 . . . . 3.51 110.48 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.677 ' NE2' ' OE1' ' A' ' 191' ' ' GLN . 0.6 OUTLIER -123.98 158.4 60.37 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.313 -0.403 . . . . 4.3 110.453 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.549 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 99.0 Cg_endo -82.12 -64.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.942 2.428 . . . . 1.96 113.437 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.489 ' ND2' ' H ' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -108.49 -19.57 13.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.019 0.377 . . . . 3.33 112.019 -178.439 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.577 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 7.7 p -107.26 152.09 24.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.21 0.529 . . . . 1.53 111.252 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.37 102.94 2.21 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.67 -0.696 . . . . 2.29 110.647 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.63 145.61 13.09 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.884 2.389 . . . . 0.88 112.598 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.417 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.84 167.91 24.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.897 -0.592 . . . . 2.12 109.939 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.14 148.0 29.13 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.751 -0.463 . . . . 2.67 109.751 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.496 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.7 p90 -142.19 157.25 45.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.017 0.437 . . . . 0.32 111.242 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.467 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.9 m-20 -128.06 155.32 44.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.856 -0.611 . . . . 2.77 110.137 178.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.61 173.03 6.36 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 121.105 0.479 . . . . 1.25 110.741 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.69 173.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.932 2.422 . . . . 1.12 111.498 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -51.05 0.69 Allowed Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 120.714 -0.395 . . . . 4.05 110.155 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.659 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.84 152.39 82.33 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.756 2.304 . . . . 2.12 111.452 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.73 42.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.309 0.576 . . . . 2.85 110.496 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.82 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.66 -41.67 98.18 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.974 -1.012 . . . . 3.11 110.645 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.44 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.4 mt -109.82 137.9 39.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.795 -0.639 . . . . 1.86 111.242 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.06 -72.87 0.71 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.009 -0.541 . . . . 1.61 111.863 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.12 148.52 24.4 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.58 0.585 . . . . 1.67 112.58 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.96 124.9 45.12 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.301 -0.629 . . . . 1.07 109.301 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.07 134.7 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.645 -0.422 . . . . 1.55 110.594 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.484 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -120.02 128.67 53.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.04 0.448 . . . . 1.33 111.237 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.54 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.11 138.94 49.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.735 -0.666 . . . . 2.36 110.088 179.031 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.415 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.04 163.16 35.09 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.181 0.515 . . . . 0.38 112.061 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.491 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.42 139.6 7.92 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.45 -0.795 . . . . 2.31 110.462 178.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.54 115.45 3.04 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.307 2.004 . . . . 0.86 111.837 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.676 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.97 81.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.834 -0.432 . . . . 3.44 109.834 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.693 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.979 -0.555 . . . . 2.72 111.886 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 p -157.59 157.84 34.44 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.79 -0.364 . . . . 2.78 110.569 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.44 27.87 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.256 -0.429 . . . . 2.3 110.189 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.91 -75.89 1.31 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.115 -0.564 . . . . 1.8 111.766 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.94 152.33 35.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.011 0.434 . . . . 5.48 110.91 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.2 -169.19 2.56 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.98 -0.555 . . . . 1.84 111.946 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.415 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.6 mttp -110.08 149.56 29.84 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.471 0.653 . . . . 2.27 112.633 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.01 156.51 46.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.836 -1.074 . . . . 1.92 110.242 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.22 158.42 41.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.931 -0.577 . . . . 1.09 111.718 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.1 m -115.26 135.62 53.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.4 -0.818 . . . . 1.16 109.814 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.448 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.43 121.9 23.73 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.407 -0.36 . . . . 1.39 111.591 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.3 Cg_exo -46.23 151.69 1.57 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.626 2.217 . . . . 0.72 112.135 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.79 -23.15 62.93 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 116.071 -0.513 . . . . 0.74 112.826 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.515 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.81 -16.83 46.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.371 0.586 . . . . 1.26 111.831 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.485 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.3 mt -91.57 138.43 31.58 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.767 -0.373 . . . . 1.59 110.307 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -121.54 13.92 10.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.418 -0.356 . . . . 2.07 111.548 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.477 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.0 p -150.02 143.36 25.12 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.721 -0.392 . . . . 0.96 111.06 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.721 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.77 -169.35 1.53 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.918 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.721 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 t -151.75 125.83 9.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.431 -0.804 . . . . 1.19 109.87 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.471 HG23 HD11 ' A' ' 60' ' ' ILE . 66.7 mt -114.84 123.26 70.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.42 -0.512 . . . . 1.47 111.18 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -126.57 163.34 23.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.732 -0.667 . . . . 3.0 110.412 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.489 ' H ' ' ND2' ' A' ' 16' ' ' ASN . . . 85.18 18.95 59.84 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.742 -0.943 . . . . 0.5 110.742 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.44 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 74.1 mt -79.1 157.23 28.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.052 0.453 . . . . 1.21 111.357 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.614 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -99.48 133.96 21.53 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.584 -0.735 . . . . 3.2 110.433 179.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.92 143.59 61.23 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.614 2.209 . . . . 1.09 111.89 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.78 25.69 75.26 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.068 -0.813 . . . . 0.72 111.068 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.641 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.23 158.78 40.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.679 0.276 . . . . 1.47 110.423 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.27 139.95 42.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.034 0.445 . . . . 1.23 110.57 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.641 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.7 m-85 -122.54 136.4 54.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.967 -0.56 . . . . 1.1 110.745 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.491 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.91 131.05 45.29 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.474 -0.936 . . . . 1.87 108.474 177.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.52 153.84 16.66 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.283 -0.96 . . . . 0.39 112.011 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.93 140.88 46.09 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.671 -0.492 . . . . 1.8 109.671 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.462 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.3 tp -115.77 118.9 34.33 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.458 -0.497 . . . . 1.11 110.476 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.45 129.12 68.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.26 -0.427 . . . . 1.51 110.619 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.9 120.77 43.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.273 -0.421 . . . . 1.47 110.713 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.668 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.52 146.46 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.107 0.48 . . . . 1.33 111.044 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.82 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.02 153.9 21.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.54 -0.755 . . . . 2.49 109.929 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.15 88.67 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.912 0.387 . . . . 4.2 110.401 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.616 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.16 32.64 0.2 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.835 -0.621 . . . . 6.4 110.659 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.02 -117.36 3.3 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.495 -0.642 . . . . 1.74 111.495 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.443 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.45 177.49 8.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.17 0.509 . . . . 3.64 111.642 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.2 149.47 31.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.427 -0.806 . . . . 1.7 110.377 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.553 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.09 144.63 38.81 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.506 -0.315 . . . . 2.7 110.616 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -127.93 136.0 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.026 0.441 . . . . 1.16 111.601 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.06 141.31 52.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.676 -0.693 . . . . 1.14 110.3 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.441 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.65 138.74 51.77 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.095 0.474 . . . . 4.33 111.54 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.17 164.14 37.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.562 -0.744 . . . . 0.91 109.498 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.571 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.18 151.57 38.64 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.428 -0.509 . . . . 1.47 111.062 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.575 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.0 p90 -146.18 172.76 12.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.748 -0.66 . . . . 0.51 111.028 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.45 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.83 160.63 21.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.432 -0.804 . . . . 1.92 109.804 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.45 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.31 121.9 23.07 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.593 -0.443 . . . . 1.63 110.798 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.632 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.7 p -127.37 168.16 15.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.256 0.55 . . . . 2.37 112.351 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.0 p . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.514 -0.766 . . . . 3.63 110.931 179.745 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.526 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 3.6 p . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 108.939 -0.763 . . . . 1.25 108.939 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.478 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.77 167.5 0.25 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.288 -0.869 . . . . 1.16 111.004 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.57 145.6 50.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.785 -0.643 . . . . 0.78 110.118 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.3 101.55 9.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.126 -0.694 . . . . 1.08 109.126 177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.472 HG11 ' N ' ' A' ' 131' ' ' SER . 70.8 t -112.93 139.8 36.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.006 -0.543 . . . . 1.1 110.988 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.472 ' N ' HG11 ' A' ' 130' ' ' VAL . 68.1 p -128.74 152.63 48.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.575 -0.739 . . . . 0.87 109.778 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.655 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.7 p90 -144.89 -164.96 2.04 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.717 -0.393 . . . . 0.37 110.622 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.734 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -123.92 127.22 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 1.14 110.815 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.179 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -58.05 58.34 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.168 -0.469 . . . . 1.91 110.326 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.09 24.42 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.905 -0.589 . . . . 1.56 111.447 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.179 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.28 128.7 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.638 -0.425 . . . . 1.56 110.913 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -86.37 -9.58 56.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.971 -0.559 . . . . 1.88 110.381 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.7 p -87.13 0.28 55.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 1.63 110.279 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.961 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.33 137.27 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.988 -0.551 . . . . 1.11 109.888 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.581 ' N ' ' O ' ' A' ' 185' ' ' ILE . 88.8 p -96.25 -15.53 21.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.25 0.548 . . . . 1.01 109.999 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.6 175.56 45.78 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 109.832 -1.307 . . . . 0.14 109.832 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.43 151.54 42.56 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.719 -0.392 . . . . 0.21 110.538 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.843 ' NE ' HE22 ' A' ' 191' ' ' GLN . 8.5 tmm_? -132.22 121.19 23.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.153 -0.476 . . . . 1.54 109.899 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.498 HG23 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.13 136.61 38.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.739 -0.664 . . . . 1.08 110.653 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 77.6 tt0 -129.36 129.86 45.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 1.32 110.03 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.605 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.8 135.23 34.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.066 -0.516 . . . . 1.05 110.638 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.406 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.27 161.38 39.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.723 -0.672 . . . . 1.16 109.665 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.944 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.4 mt -71.02 124.88 25.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.991 0.424 . . . . 1.23 110.755 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.1 p -71.74 -7.67 49.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.725 -0.671 . . . . 0.86 110.866 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -109.83 -69.57 0.86 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 1.66 111.481 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.462 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.69 -35.41 76.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.11 -0.496 . . . . 1.66 111.451 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.077 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.2 7.18 88.63 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.76 -0.936 . . . . 1.62 110.76 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.331 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.86 -171.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.779 0.323 . . . . 1.86 110.324 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.331 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.16 139.11 45.48 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.96 0.409 . . . . 1.98 110.216 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.406 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.5 Cg_endo -70.98 145.84 51.14 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 C-N-CA 122.746 2.297 . . . . 0.62 112.288 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.83 145.77 42.56 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.224 -0.658 . . . . 1.14 109.224 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.474 ' CZ ' ' HB3' ' A' ' 15' ' ' PRO . 7.8 m-85 -123.28 141.37 52.05 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.344 -0.543 . . . . 1.44 111.526 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.7 mt -128.16 127.69 43.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.286 -0.87 . . . . 1.08 108.932 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.533 ' OD1' ' O ' ' A' ' 159' ' ' ASP . 55.4 p-10 -101.62 131.19 47.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.125 0.488 . . . . 1.09 111.818 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.503 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -128.04 157.58 73.53 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.393 -0.821 . . . . 1.04 109.514 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -69.88 158.09 57.96 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.335 2.023 . . . . 0.21 112.24 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.36 -12.08 5.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.842 -0.617 . . . . 0.88 110.734 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.3 p -92.79 -8.8 42.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.101 -0.5 . . . . 1.06 110.762 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.36 34.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.304 -0.407 . . . . 1.05 110.434 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.9 p -133.11 16.58 4.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.447 -0.342 . . . . 1.07 110.515 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.8 p -167.47 147.21 5.16 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.607 -0.516 . . . . 0.92 109.607 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.503 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.24 150.51 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.551 -0.459 . . . . 1.09 111.57 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.36 124.89 50.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.604 -0.725 . . . . 1.31 109.786 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.523 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.34 104.84 29.26 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.358 -0.383 . . . . 1.09 111.028 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.9 Cg_endo -91.04 -179.43 1.47 Allowed 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 123.103 2.535 . . . . 0.48 112.237 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.72 32.62 18.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.381 -0.827 . . . . 1.26 111.381 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.526 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.1 mt -86.34 148.51 25.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.788 0.328 . . . . 1.12 110.476 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.78 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.26 114.83 61.18 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.969 0.414 . . . . 1.3 110.725 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.05 140.57 95.82 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.882 2.388 . . . . 0.92 111.977 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.17 21.12 74.25 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.078 -0.809 . . . . 0.44 111.078 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.462 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.83 150.2 49.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.833 0.349 . . . . 3.05 110.623 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.493 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.12 131.65 45.95 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.983 -0.553 . . . . 1.48 109.818 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.944 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.5 148.34 43.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.138 -0.483 . . . . 0.89 111.01 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.38 125.38 60.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.258 -1.015 . . . . 1.12 108.258 177.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.5 132.55 63.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.092 0.473 . . . . 1.1 111.283 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.55 122.55 20.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.624 -0.717 . . . . 0.43 109.659 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.595 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -100.95 125.33 54.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.219 -0.446 . . . . 1.07 110.709 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.67 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.4 m-85 -117.21 137.98 52.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.997 -0.547 . . . . 0.92 109.887 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.575 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.76 135.0 42.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.779 -0.823 . . . . 0.49 108.779 178.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.581 ' O ' ' N ' ' A' ' 140' ' ' SER . 74.6 mt -99.17 122.98 51.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.161 0.505 . . . . 1.08 110.893 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.444 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.7 p -83.94 169.7 14.76 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.539 -0.755 . . . . 0.89 110.383 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -59.74 -14.53 14.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.05 -0.523 . . . . 1.6 110.964 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.444 ' H ' ' HG ' ' A' ' 186' ' ' SER . 95.5 m-20 -96.07 -4.4 43.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.795 0.331 . . . . 1.18 110.829 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.426 ' N ' ' HB ' ' A' ' 59' ' ' THR . . . 87.85 13.84 63.97 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.364 -0.694 . . . . 0.34 111.364 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -84.58 139.09 32.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.059 -0.256 . . . . 1.22 110.482 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.843 HE22 ' NE ' ' A' ' 143' ' ' ARG . 88.5 mt-30 -106.81 141.08 38.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.91 0.386 . . . . 1.44 110.526 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.4 m -136.71 126.94 26.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 1.39 110.349 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.67 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.4 tp -68.11 117.26 9.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.317 -0.401 . . . . 1.08 110.564 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.655 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -109.01 -21.81 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 1.08 110.77 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.85 125.71 5.89 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.547 -0.461 . . . . 1.1 111.501 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.492 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.74 120.27 21.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.821 -0.627 . . . . 0.94 109.542 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.69 151.65 28.99 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.752 -0.379 . . . . 1.07 110.922 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.43 158.49 18.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.967 -0.56 . . . . 0.89 110.447 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.01 157.95 43.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.127 -0.488 . . . . 0.67 110.669 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.26 104.37 9.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.774 -0.648 . . . . 1.17 109.964 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.479 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 66.6 p . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.948 -1.025 . . . . 1.26 110.638 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.1 m . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.285 -0.635 . . . . 3.83 109.285 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.45 150.76 18.52 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.012 -0.835 . . . . 1.39 111.012 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -35.7 142.39 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.067 0 C-N-CA 123.999 3.133 . . . . 0.86 113.759 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.575 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -79.9 173.36 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.222 -1.354 . . . . 1.43 108.822 178.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' A' ' 23' ' ' ASN . 96.2 mt-10 -105.62 125.88 51.5 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.435 -0.506 . . . . 1.94 111.438 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 143.93 34.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.655 -0.702 . . . . 1.19 110.73 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.28 25.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 3.92 111.129 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.589 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.99 131.07 60.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.008 -0.542 . . . . 3.88 110.082 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.8 p -141.19 162.3 35.82 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.759 0.314 . . . . 3.92 111.249 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 10' ' ' GLU . 70.6 tt0 36.02 31.6 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.69 -0.485 . . . . 6.08 109.69 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.589 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.56 32.42 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.896 -0.593 . . . . 4.01 111.568 -178.744 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.3 -29.08 72.53 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.449 2.1 . . . . 4.51 111.818 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.64 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 3.51 110.513 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.582 ' HG3' ' NE2' ' A' ' 191' ' ' GLN . 7.0 mp0 -124.01 158.35 60.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.392 -0.367 . . . . 4.3 110.426 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.681 ' HD2' HH12 ' A' ' 143' ' ' ARG . 96.5 Cg_endo -82.0 -64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.835 2.356 . . . . 1.96 113.57 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.838 ' ND2' ' H ' ' A' ' 62' ' ' GLY . 9.9 t30 -108.46 -19.55 13.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.265 -0.425 . . . . 3.33 112.074 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 18.0 p -107.31 152.09 24.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.163 0.506 . . . . 1.53 111.387 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.578 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.19 102.9 2.24 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.726 -0.67 . . . . 2.29 110.691 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.406 ' HB3' ' HA3' ' A' ' 189' ' ' GLY . 73.6 Cg_endo -82.63 145.63 13.1 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.915 2.41 . . . . 0.88 112.607 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.414 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.87 167.92 24.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.906 -0.588 . . . . 2.12 109.904 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.1 148.02 29.18 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.783 -0.451 . . . . 2.67 109.783 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.502 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.4 p90 -142.29 157.27 45.01 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.621 -0.432 . . . . 0.32 111.137 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.463 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.9 m-20 -128.02 155.31 44.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.732 -0.667 . . . . 2.77 110.051 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.4 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . . . -132.63 173.12 6.26 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.214 0.531 . . . . 1.25 110.68 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.69 173.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.819 2.346 . . . . 1.12 111.497 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -50.97 0.69 Allowed Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.666 -0.414 . . . . 4.05 110.191 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.655 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.82 152.3 82.63 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.821 2.347 . . . . 2.12 111.466 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.64 42.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.331 0.586 . . . . 2.85 110.543 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.821 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.54 -41.66 98.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.047 -0.978 . . . . 3.11 110.683 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.434 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.8 mt -109.8 137.87 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.813 -0.63 . . . . 1.86 111.296 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.02 -72.88 0.7 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.095 -0.502 . . . . 1.61 111.84 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.19 148.35 24.43 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.558 0.577 . . . . 1.67 112.558 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.77 124.86 45.19 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.348 -0.612 . . . . 1.07 109.348 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.3 mt -117.99 134.73 60.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.724 -0.391 . . . . 1.55 110.61 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.486 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -119.99 128.62 53.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.067 0.46 . . . . 1.33 111.252 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.14 138.96 49.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.799 -0.637 . . . . 2.36 110.073 179.05 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.416 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.0 p90 -145.11 163.24 34.92 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.14 0.495 . . . . 0.38 112.059 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.5 139.55 7.83 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.423 -0.808 . . . . 2.31 110.428 178.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.62 115.47 3.07 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.347 2.032 . . . . 0.86 111.823 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.668 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.97 81.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.887 -0.412 . . . . 3.44 109.887 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.25 -20.59 0.06 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.05 -0.523 . . . . 2.72 111.969 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 p -157.61 157.81 34.35 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.822 -0.351 . . . . 2.78 110.535 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.403 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.48 27.88 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 2.3 110.123 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.82 -75.94 1.31 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.17 -0.538 . . . . 1.8 111.839 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.87 152.36 35.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.946 0.403 . . . . 5.48 111.058 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.09 2.52 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.101 -0.499 . . . . 1.84 111.998 179.43 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.416 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.18 149.64 29.8 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.464 0.649 . . . . 2.27 112.565 -177.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.03 156.47 46.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.893 -1.048 . . . . 1.92 110.302 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.18 158.44 41.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.931 -0.577 . . . . 1.09 111.796 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.27 135.53 54.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.438 -0.801 . . . . 1.16 109.848 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.448 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.31 121.98 23.89 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.506 -0.315 . . . . 1.39 111.529 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.521 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.6 Cg_exo -46.39 151.76 1.67 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.716 2.277 . . . . 0.72 112.098 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.94 -23.01 63.11 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 116.076 -0.511 . . . . 0.74 112.792 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.521 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.78 -16.94 45.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.425 0.613 . . . . 1.26 111.821 -178.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.482 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.3 mt -91.49 138.44 31.57 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.737 -0.385 . . . . 1.59 110.352 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -121.48 13.93 11.03 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.442 -0.345 . . . . 2.07 111.638 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.473 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.02 143.49 25.2 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.607 -0.437 . . . . 0.96 111.022 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.72 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.79 -169.38 1.53 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.212 0.529 . . . . 1.0 110.886 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.864 ' HG1' ' N ' ' A' ' 189' ' ' GLY . 1.2 m -151.74 125.86 9.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.437 -0.801 . . . . 1.19 109.893 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.431 HD11 HG23 ' A' ' 60' ' ' ILE . 66.4 mt -114.84 123.34 70.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.366 -0.533 . . . . 1.47 111.234 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.87 ' HZ3' ' CA ' ' A' ' 141' ' ' GLY . 15.9 mtpt -126.59 163.42 23.46 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.753 -0.658 . . . . 3.0 110.394 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.838 ' H ' ' ND2' ' A' ' 16' ' ' ASN . . . 85.11 19.07 59.76 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.682 -0.967 . . . . 0.5 110.682 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.435 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 74.0 mt -79.11 157.19 28.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.996 0.427 . . . . 1.21 111.36 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.63 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 4.3 mttp -99.48 133.87 21.6 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.71 -0.677 . . . . 3.2 110.464 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.89 143.63 61.6 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.497 2.131 . . . . 1.09 111.906 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.79 25.67 75.28 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.073 -0.811 . . . . 0.72 111.073 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.642 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.3 p -128.14 158.73 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.683 0.278 . . . . 1.47 110.461 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.03 140.03 41.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.909 0.385 . . . . 1.23 110.648 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.642 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.68 136.52 54.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.948 -0.569 . . . . 1.1 110.71 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.96 131.1 45.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.436 -0.95 . . . . 1.87 108.436 177.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.48 153.87 16.65 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.355 -0.926 . . . . 0.39 111.918 -178.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.03 141.01 46.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.624 -0.51 . . . . 1.8 109.624 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.458 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.9 tp -115.71 119.02 34.69 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.422 -0.511 . . . . 1.11 110.545 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.53 129.1 68.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.359 -0.382 . . . . 1.51 110.601 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.88 120.76 43.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.332 -0.395 . . . . 1.47 110.724 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.672 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.5 146.38 11.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.192 0.52 . . . . 1.33 111.032 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.821 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -105.98 153.81 21.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.512 -0.767 . . . . 2.49 109.986 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.07 88.49 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.9 0.381 . . . . 4.2 110.525 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.3 32.61 0.21 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.864 -0.607 . . . . 6.4 110.661 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.05 -117.37 3.29 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.437 -0.665 . . . . 1.74 111.437 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.444 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.39 177.38 9.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.153 0.501 . . . . 3.64 111.597 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.18 149.55 32.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.39 -0.823 . . . . 1.7 110.4 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.16 144.71 38.7 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.455 -0.339 . . . . 2.7 110.591 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -128.08 135.94 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 121.088 0.47 . . . . 1.16 111.5 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.01 141.35 52.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.668 -0.696 . . . . 1.14 110.373 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.445 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.6 138.8 51.7 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.553 -0.459 . . . . 4.33 111.575 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.489 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.21 164.14 37.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.572 -0.74 . . . . 0.91 109.618 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.576 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.2 151.57 38.63 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.411 -0.516 . . . . 1.47 111.027 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.578 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.9 p90 -146.26 172.64 13.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.767 -0.651 . . . . 0.51 111.023 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.454 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.7 t -118.61 160.7 21.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.479 -0.782 . . . . 1.92 109.922 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.454 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.45 121.87 22.87 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.623 -0.431 . . . . 1.63 110.774 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.6 p -126.92 155.57 42.84 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 114.62 1.341 . . . . 2.37 114.62 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 82.2 p . . . . . 0 N--CA 1.456 -0.142 0 CA-C-N 112.996 -1.911 . . . . 3.63 109.102 177.317 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 2.0 p . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 121.151 0.5 . . . . 1.25 110.417 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.482 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.91 167.58 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.613 -0.721 . . . . 1.16 110.92 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.485 ' CZ ' HG22 ' A' ' 201' ' ' THR . 8.0 m-30 -133.56 145.55 50.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.675 -0.693 . . . . 0.78 110.146 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.33 101.72 9.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.021 -0.733 . . . . 1.08 109.021 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.472 HG11 ' N ' ' A' ' 131' ' ' SER . 72.0 t -112.94 139.74 36.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.0 -0.545 . . . . 1.1 111.078 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.472 ' N ' HG11 ' A' ' 130' ' ' VAL . 68.1 p -128.82 152.45 48.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.681 -0.69 . . . . 0.87 109.868 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.649 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.7 p90 -144.71 -164.88 2.02 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.667 -0.413 . . . . 0.37 110.711 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -124.0 127.11 73.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 1.14 110.833 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.176 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 1.91 110.315 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.15 24.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.916 -0.584 . . . . 1.56 111.471 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.176 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.16 128.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.599 -0.441 . . . . 1.56 110.929 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.4 -9.65 55.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.975 -0.557 . . . . 1.88 110.306 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.1 0.27 55.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 1.63 110.376 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.961 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.31 137.18 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.976 -0.556 . . . . 1.11 109.945 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.701 ' C ' ' HZ1' ' A' ' 61' ' ' LYS . 75.7 m -96.16 -15.52 22.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.337 0.589 . . . . 1.01 110.077 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.87 ' CA ' ' HZ3' ' A' ' 61' ' ' LYS . . . 178.54 175.51 45.68 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 109.793 -1.323 . . . . 0.14 109.793 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.4 151.61 42.43 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.574 -0.45 . . . . 0.21 110.466 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.681 HH12 ' HD2' ' A' ' 15' ' ' PRO . 60.0 ttp180 -132.28 121.25 23.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.11 -0.495 . . . . 1.54 109.954 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.494 HG23 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.19 136.58 38.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.634 -0.712 . . . . 1.08 110.665 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.522 ' CD ' ' CE2' ' A' ' 157' ' ' TYR . 80.8 tt0 -129.35 129.82 45.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.858 -0.61 . . . . 1.32 110.065 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.71 135.31 34.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.98 -0.554 . . . . 1.05 110.619 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.404 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.32 161.37 39.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.781 -0.645 . . . . 1.16 109.634 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.941 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.3 mt -71.07 124.77 25.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.019 0.438 . . . . 1.23 110.783 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.62 -7.77 49.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.74 -0.664 . . . . 0.86 110.9 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -109.77 -69.74 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 1.66 111.421 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.444 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.66 -35.34 75.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.065 -0.516 . . . . 1.66 111.497 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.083 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.14 7.29 88.55 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.772 -0.931 . . . . 1.62 110.772 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.34 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.97 -171.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 1.86 110.207 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.34 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.39 139.01 44.66 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 1.98 110.17 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.404 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.3 Cg_endo -70.84 145.8 51.88 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 C-N-CA 122.752 2.301 . . . . 0.62 112.343 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.84 145.68 42.64 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.222 -0.659 . . . . 1.14 109.222 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.522 ' CE2' ' CD ' ' A' ' 145' ' ' GLU . 83.1 m-85 -123.3 141.39 52.04 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.289 -0.564 . . . . 1.44 111.526 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.409 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.6 mt -128.07 127.66 43.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.288 -0.869 . . . . 1.08 108.917 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.712 ' OD1' ' ND2' ' A' ' 16' ' ' ASN . 13.6 m-20 -101.57 131.1 47.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.099 0.476 . . . . 1.09 111.751 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.506 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -127.95 157.57 73.39 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.396 -0.82 . . . . 1.04 109.602 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.78 158.03 58.31 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.453 2.102 . . . . 0.21 112.268 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.0 p -59.33 -12.12 5.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.782 -0.645 . . . . 0.88 110.75 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.0 p -92.81 -8.79 42.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.068 -0.514 . . . . 1.06 110.753 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.1 135.4 34.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 1.05 110.408 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.17 16.57 4.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.435 -0.348 . . . . 1.07 110.459 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.5 p -167.5 147.16 5.12 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.612 -0.514 . . . . 0.92 109.612 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.506 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.21 150.48 12.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.6 -0.44 . . . . 1.09 111.629 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 4.0 t-20 -106.36 124.96 50.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.625 -0.716 . . . . 1.31 109.758 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.527 HG21 HD21 ' A' ' 172' ' ' LEU . 1.8 mt -99.43 104.99 30.5 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 1.09 111.088 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.9 Cg_endo -91.17 -179.5 1.45 Allowed 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 123.099 2.532 . . . . 0.48 112.138 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.67 32.75 18.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.414 -0.812 . . . . 1.26 111.391 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.527 HD21 HG21 ' A' ' 169' ' ' ILE . 23.7 mt -86.46 148.54 25.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.474 -0.33 . . . . 1.12 110.436 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.774 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.3 114.91 61.57 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.059 0.457 . . . . 1.3 110.699 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.01 140.54 95.81 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.873 2.382 . . . . 0.92 112.041 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.18 21.06 74.35 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.061 -0.815 . . . . 0.44 111.061 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.444 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.79 150.22 49.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.786 0.327 . . . . 3.05 110.681 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.1 131.58 45.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.068 -0.514 . . . . 1.48 109.811 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.941 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.3 m-85 -120.45 148.3 43.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.153 -0.476 . . . . 0.89 111.055 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.3 125.36 60.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.261 -1.014 . . . . 1.12 108.261 177.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.49 132.39 63.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.155 0.502 . . . . 1.1 111.26 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.39 122.61 20.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.637 -0.71 . . . . 0.43 109.645 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.593 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.05 125.43 54.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.214 -0.448 . . . . 1.07 110.631 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.67 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.7 m-85 -117.27 137.92 52.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.027 -0.533 . . . . 0.92 109.842 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.572 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.78 135.07 42.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.773 -0.825 . . . . 0.49 108.773 178.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.567 ' O ' ' N ' ' A' ' 140' ' ' SER . 50.6 mm -99.12 122.96 51.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.137 0.494 . . . . 1.08 110.864 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.448 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.3 p -83.83 169.71 14.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.565 -0.743 . . . . 0.89 110.503 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -59.78 -14.53 15.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.006 -0.543 . . . . 1.6 110.963 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.448 ' H ' ' HG ' ' A' ' 186' ' ' SER . 94.9 m-20 -96.03 -4.29 43.34 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.872 -0.331 . . . . 1.18 110.795 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.864 ' N ' ' HG1' ' A' ' 59' ' ' THR . . . 87.76 13.93 64.01 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.403 -0.679 . . . . 0.34 111.403 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -84.76 139.14 32.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.736 0.303 . . . . 1.22 110.349 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.582 ' NE2' ' HG3' ' A' ' 14' ' ' GLN . 7.7 pt20 -106.83 141.05 38.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.968 0.413 . . . . 1.44 110.465 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.73 126.99 26.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 1.39 110.402 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.67 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.5 tp -68.08 117.27 9.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.371 -0.377 . . . . 1.08 110.502 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.649 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.3 pt -109.06 -21.82 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.471 . . . . 1.08 110.741 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.84 125.84 5.94 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.558 -0.457 . . . . 1.1 111.495 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.495 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.84 120.21 21.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.708 -0.678 . . . . 0.94 109.497 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.59 151.69 29.14 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.712 -0.395 . . . . 1.07 110.987 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.48 158.57 18.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.081 -0.509 . . . . 0.89 110.382 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.07 157.97 43.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.084 -0.507 . . . . 0.67 110.624 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.37 9.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.662 -0.699 . . . . 1.17 109.972 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.485 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.4 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.894 -1.051 . . . . 1.26 110.719 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.145 -0.687 . . . . 3.83 109.145 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.426 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.77 18.53 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.061 -0.815 . . . . 1.39 111.061 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -35.66 142.44 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.057 0 C-N-CA 123.959 3.106 . . . . 0.86 113.808 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.57 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -79.98 173.4 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 114.286 -1.325 . . . . 1.43 108.853 178.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.4 ' H ' ' CG1' ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.67 125.9 51.52 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.429 -0.508 . . . . 1.94 111.384 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.45 143.95 34.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.586 -0.734 . . . . 1.19 110.705 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.02 168.31 25.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.88 0.371 . . . . 3.92 111.13 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.575 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.5 mt -108.97 131.02 60.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.993 -0.549 . . . . 3.88 110.154 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.15 162.35 35.69 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.954 0.407 . . . . 3.92 111.202 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 10' ' ' GLU . 76.1 tt0 36.04 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.659 -0.497 . . . . 6.08 109.659 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.575 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.5 32.32 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.921 -0.581 . . . . 4.01 111.606 -178.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.641 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.1 Cg_endo -63.17 -29.12 73.77 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.445 2.097 . . . . 4.51 111.906 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.641 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.65 125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 3.51 110.494 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.553 ' O ' ' O ' ' A' ' 92' ' ' THR . 2.4 mm-40 -123.9 158.39 60.19 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.32 -0.4 . . . . 4.3 110.409 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.521 ' HG3' ' CZ ' ' A' ' 143' ' ' ARG . 97.0 Cg_endo -82.0 -64.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.976 2.451 . . . . 1.96 113.556 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.619 ' ND2' ' CD2' ' A' ' 157' ' ' TYR . 11.1 m120 -108.42 -19.71 13.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.277 -0.419 . . . . 3.33 112.074 -178.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 7.1 p -107.26 152.08 24.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.143 0.497 . . . . 1.53 111.354 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.569 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.3 102.9 2.22 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.708 -0.678 . . . . 2.29 110.632 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.6 145.61 13.13 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.927 2.418 . . . . 0.88 112.589 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.402 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.84 168.01 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.919 -0.582 . . . . 2.12 109.889 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.15 147.85 28.94 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.763 -0.458 . . . . 2.67 109.763 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.504 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.6 p90 -142.23 157.38 44.91 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.593 -0.443 . . . . 0.32 111.241 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.467 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.8 m-20 -127.98 155.31 44.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.863 -0.608 . . . . 2.77 110.128 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.63 173.01 6.39 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 121.125 0.488 . . . . 1.25 110.749 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.68 174.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.822 2.348 . . . . 1.12 111.557 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.15 -51.06 0.68 Allowed Pre-proline 0 C--N 1.328 -0.342 0 C-N-CA 120.719 -0.392 . . . . 4.05 110.068 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.649 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.82 152.38 82.35 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.711 2.274 . . . . 2.12 111.451 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.64 42.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.322 0.582 . . . . 2.85 110.575 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.813 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.69 -41.58 98.11 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.027 -0.988 . . . . 3.11 110.63 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.446 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.4 mt -109.89 137.91 39.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.771 -0.65 . . . . 1.86 111.207 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.98 -72.88 0.7 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.965 -0.561 . . . . 1.61 111.927 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.27 148.34 24.38 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.594 0.591 . . . . 1.67 112.594 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -121.8 124.86 45.17 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.396 -0.594 . . . . 1.07 109.396 177.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.08 134.78 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.614 -0.434 . . . . 1.55 110.644 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.486 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -120.01 128.52 53.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.03 0.443 . . . . 1.33 111.267 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.04 139.07 49.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.81 -0.632 . . . . 2.36 110.064 178.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.414 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.2 p90 -145.09 163.15 35.18 Favored 'General case' 0 N--CA 1.458 -0.056 0 C-N-CA 120.559 -0.456 . . . . 0.38 112.134 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.4 139.69 7.99 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.478 -0.783 . . . . 2.31 110.449 178.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.65 115.44 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.366 2.044 . . . . 0.86 111.799 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.686 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.03 81.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.901 -0.407 . . . . 3.44 109.901 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.697 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.21 -20.61 0.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.97 -0.559 . . . . 2.72 111.933 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.6 p -157.68 157.77 34.16 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.801 -0.36 . . . . 2.78 110.596 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.4 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.26 27.79 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.247 -0.433 . . . . 2.3 110.159 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.81 -75.95 1.31 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.175 -0.536 . . . . 1.8 111.826 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.87 152.27 35.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.942 0.401 . . . . 5.48 110.944 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.648 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.16 -169.15 2.55 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.031 -0.532 . . . . 1.84 111.927 179.386 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.412 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.18 149.67 29.76 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.483 0.659 . . . . 2.27 112.463 -177.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.03 156.59 46.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.702 -1.135 . . . . 1.92 110.216 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.28 158.27 41.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.98 -0.554 . . . . 1.09 111.842 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.09 135.66 53.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.493 -0.776 . . . . 1.16 109.82 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.448 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.46 122.02 23.72 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.427 -0.351 . . . . 1.39 111.534 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.52 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.2 Cg_exo -46.39 151.75 1.67 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.717 2.278 . . . . 0.72 112.053 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.92 -23.05 63.11 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 115.958 -0.564 . . . . 0.74 112.79 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.52 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.87 -16.7 46.57 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.213 -0.595 . . . . 1.26 111.809 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.491 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.5 mt -91.66 138.42 31.57 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.83 -0.348 . . . . 1.59 110.248 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -121.57 13.92 10.96 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.375 -0.375 . . . . 2.07 111.462 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.482 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 86.8 p -149.93 143.46 25.26 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.651 -0.42 . . . . 0.96 111.088 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.82 -169.4 1.54 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.203 0.525 . . . . 1.0 110.897 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.723 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 20.2 m -151.68 125.89 9.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.444 -0.798 . . . . 1.19 109.863 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.447 HD11 HG23 ' A' ' 60' ' ' ILE . 66.6 mt -114.87 123.29 70.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.304 -0.558 . . . . 1.47 111.217 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.568 ' HG2' ' N ' ' A' ' 62' ' ' GLY . 87.5 tttt -126.55 163.4 23.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.863 -0.608 . . . . 3.0 110.396 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.568 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.07 19.07 59.81 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.771 -0.932 . . . . 0.5 110.771 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.435 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.7 mt -79.12 157.17 28.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.147 0.498 . . . . 1.21 111.304 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.606 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -99.42 133.9 21.62 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.544 -0.753 . . . . 3.2 110.56 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.666 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.85 143.49 61.27 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.615 2.21 . . . . 1.09 111.937 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.84 25.64 75.32 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.087 -0.805 . . . . 0.72 111.087 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.65 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.2 158.84 40.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.754 0.311 . . . . 1.47 110.377 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.479 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.18 139.86 42.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.364 -0.38 . . . . 1.23 110.554 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.65 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.55 136.42 54.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.985 -0.552 . . . . 1.1 110.779 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.9 131.02 45.3 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.493 -0.928 . . . . 1.87 108.493 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.38 153.92 16.62 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.315 -0.945 . . . . 0.39 111.985 -178.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.98 140.95 46.09 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.693 -0.484 . . . . 1.8 109.693 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.473 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.1 tp -115.71 118.82 34.12 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.558 -0.457 . . . . 1.11 110.482 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.45 129.11 68.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.371 -0.377 . . . . 1.51 110.675 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.85 120.87 43.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.272 -0.422 . . . . 1.47 110.687 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.671 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.56 146.45 11.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.068 0.461 . . . . 1.33 111.035 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.813 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.0 153.88 21.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.514 -0.766 . . . . 2.49 109.934 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.27 88.6 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.996 0.426 . . . . 4.2 110.469 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.28 32.63 0.21 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.823 -0.626 . . . . 6.4 110.6 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.35 3.29 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.483 -0.647 . . . . 1.74 111.483 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.452 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.48 177.4 8.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 3.64 111.577 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.13 149.41 31.96 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.423 -0.808 . . . . 1.7 110.369 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.06 144.71 38.9 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.43 -0.35 . . . . 2.7 110.6 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.98 136.0 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 121.07 0.462 . . . . 1.16 111.603 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.57 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.6 m -124.13 141.23 52.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.668 -0.697 . . . . 1.14 110.302 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.487 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.64 138.88 51.67 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.493 -0.483 . . . . 4.33 111.485 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.23 164.22 37.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.501 -0.772 . . . . 0.91 109.48 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.565 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 46.9 p30 -145.25 151.55 38.55 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.429 -0.509 . . . . 1.47 111.037 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.569 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.0 p90 -146.25 172.77 12.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.739 -0.664 . . . . 0.51 111.007 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.448 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.84 160.58 21.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.529 -0.76 . . . . 1.92 109.826 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.448 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.3 121.79 22.92 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.567 -0.453 . . . . 1.63 110.803 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.553 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.0 p -127.37 161.11 29.42 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.226 0.454 . . . . 2.37 112.226 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.464 0.263 0 CA-C-N 115.766 -0.652 . . . . 3.63 110.361 178.489 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.9 p . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.843 0.354 . . . . 1.25 110.676 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.478 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.9 167.55 0.26 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 1.16 110.914 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.61 145.53 50.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.677 -0.692 . . . . 0.78 110.099 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.28 101.69 9.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.096 -0.705 . . . . 1.08 109.096 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.472 HG11 ' N ' ' A' ' 131' ' ' SER . 71.0 t -112.96 139.64 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.059 -0.519 . . . . 1.1 111.078 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.472 ' N ' HG11 ' A' ' 130' ' ' VAL . 69.5 p -128.73 152.61 48.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.721 -0.672 . . . . 0.87 109.776 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.657 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.4 p90 -144.8 -164.95 2.04 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.682 -0.407 . . . . 0.37 110.549 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.733 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.9 t -123.91 127.19 73.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.103 -0.499 . . . . 1.14 110.817 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.157 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.97 58.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 1.91 110.376 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.12 24.47 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.856 -0.611 . . . . 1.56 111.524 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.157 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.13 128.76 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.542 -0.463 . . . . 1.56 110.868 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.43 -9.71 55.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.849 -0.614 . . . . 1.88 110.31 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.0 0.22 55.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 1.63 110.414 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.964 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.25 137.21 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.951 -0.568 . . . . 1.11 109.955 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.559 ' N ' ' O ' ' A' ' 185' ' ' ILE . 5.6 m -96.32 -15.41 21.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.219 0.533 . . . . 1.01 110.016 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.452 ' HA3' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.51 175.56 45.7 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 109.839 -1.304 . . . . 0.14 109.839 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -123.53 151.61 42.65 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.64 -0.424 . . . . 0.21 110.485 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.728 ' NH2' ' CD2' ' A' ' 183' ' ' TYR . 69.8 ttp85 -132.33 121.15 23.07 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.081 -0.509 . . . . 1.54 109.931 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.494 HG23 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.08 136.53 38.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.689 -0.687 . . . . 1.08 110.65 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.486 ' HB2' HH12 ' A' ' 143' ' ' ARG . 81.1 tt0 -129.36 129.91 45.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.993 -0.548 . . . . 1.32 110.07 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.603 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.7 p90 -138.75 135.4 34.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.023 -0.535 . . . . 1.05 110.558 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.405 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.38 161.36 39.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.723 -0.671 . . . . 1.16 109.717 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.929 HD21 ' CE2' ' A' ' 178' ' ' TYR . 85.9 mt -71.09 124.86 25.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.018 0.437 . . . . 1.23 110.725 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.76 -7.56 48.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.813 -0.631 . . . . 0.86 110.887 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -109.89 -69.77 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 1.66 111.428 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.448 ' CD ' HH21 ' A' ' 176' ' ' ARG . 53.8 mt-10 -60.56 -35.46 76.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.028 -0.533 . . . . 1.66 111.535 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.074 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.26 88.58 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.8 -0.92 . . . . 1.62 110.8 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.327 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.96 -171.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 1.86 110.243 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.327 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.27 139.13 45.12 Favored Pre-proline 0 N--CA 1.454 -0.262 0 CA-C-O 120.997 0.427 . . . . 1.98 110.243 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.405 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.3 Cg_endo -70.93 145.77 51.22 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 C-N-CA 122.782 2.321 . . . . 0.62 112.302 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.78 145.71 42.58 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.238 -0.653 . . . . 1.14 109.238 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.666 ' CE1' ' CD ' ' A' ' 65' ' ' PRO . 35.6 p90 -123.28 141.31 52.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.234 0.54 . . . . 1.44 111.577 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.402 ' HA ' HD22 ' A' ' 158' ' ' LEU . 71.2 mt -128.09 127.72 43.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.274 -0.875 . . . . 1.08 108.944 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 5.0 t0 -101.63 131.17 48.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.102 0.477 . . . . 1.09 111.722 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.518 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.1 mt -127.94 157.66 73.1 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.277 -0.874 . . . . 1.04 109.601 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -69.92 158.03 58.12 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 122.439 2.093 . . . . 0.21 112.226 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.1 p -59.32 -12.13 5.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.773 -0.649 . . . . 0.88 110.7 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.0 p -92.84 -8.76 42.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.094 -0.503 . . . . 1.06 110.675 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.15 135.43 34.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.326 -0.397 . . . . 1.05 110.391 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.7 p -133.18 16.65 4.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.443 -0.344 . . . . 1.07 110.462 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.5 p -167.6 147.11 5.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.607 -0.516 . . . . 0.92 109.607 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.517 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.21 150.43 12.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.5 -0.48 . . . . 1.09 111.594 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.493 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.28 125.0 50.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.619 -0.719 . . . . 1.31 109.792 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.522 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.46 104.97 30.44 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.391 -0.368 . . . . 1.09 110.99 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.4 Cg_endo -90.99 -179.48 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 123.117 2.545 . . . . 0.48 112.162 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.61 32.64 18.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.341 -0.845 . . . . 1.26 111.493 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.522 HD21 HG21 ' A' ' 169' ' ' ILE . 23.7 mt -86.39 148.49 25.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.339 . . . . 1.12 110.494 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.776 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.23 114.83 61.18 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.311 -0.404 . . . . 1.3 110.658 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.98 140.5 95.63 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.837 2.358 . . . . 0.92 112.08 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.16 21.21 74.04 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.036 -0.825 . . . . 0.44 111.036 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.448 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.87 150.18 49.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 3.05 110.686 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.21 131.73 45.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.088 -0.506 . . . . 1.48 109.747 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.929 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.55 148.19 44.19 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.129 -0.487 . . . . 0.89 111.08 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.26 125.3 60.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.303 -0.999 . . . . 1.12 108.303 177.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.52 132.46 63.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.162 0.506 . . . . 1.1 111.197 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.45 122.5 20.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.555 -0.748 . . . . 0.43 109.636 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.588 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.96 125.49 54.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.255 -0.43 . . . . 1.07 110.647 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.728 ' CD2' ' NH2' ' A' ' 143' ' ' ARG . 48.5 m-85 -117.34 137.84 52.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.985 -0.552 . . . . 0.92 109.891 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.569 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.73 135.02 42.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.729 -0.841 . . . . 0.49 108.729 179.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.559 ' O ' ' N ' ' A' ' 140' ' ' SER . 83.3 mt -99.05 122.86 51.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.11 0.481 . . . . 1.08 110.961 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.445 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.5 p -83.81 169.73 14.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.542 -0.754 . . . . 0.89 110.525 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.82 -14.54 15.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.119 -0.491 . . . . 1.6 110.956 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.505 ' C ' ' HG1' ' A' ' 59' ' ' THR . 97.0 m-20 -96.03 -4.25 43.42 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.852 -0.339 . . . . 1.18 110.879 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.452 ' N ' HG21 ' A' ' 59' ' ' THR . . . 87.81 13.83 64.08 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.336 -0.706 . . . . 0.34 111.336 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -84.6 139.17 32.28 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.027 -0.269 . . . . 1.22 110.458 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.507 HE22 ' HG2' ' A' ' 15' ' ' PRO . 86.2 mt-30 -106.77 141.04 38.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 1.44 110.535 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.1 m -136.65 127.06 26.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 1.39 110.388 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.669 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.7 tp -68.24 117.29 9.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.92 0.39 . . . . 1.08 110.448 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.657 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.1 pt -109.07 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 1.08 110.714 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.1 tp -156.88 125.68 5.85 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.554 -0.459 . . . . 1.1 111.486 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.497 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.75 120.27 21.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.77 -0.65 . . . . 0.94 109.536 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.66 29.06 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.602 -0.439 . . . . 1.07 110.903 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.45 158.65 18.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.092 -0.504 . . . . 0.89 110.442 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.15 157.99 43.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.171 -0.468 . . . . 0.67 110.654 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 104.33 9.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.699 -0.682 . . . . 1.17 110.025 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.48 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 66.5 p . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.888 -1.053 . . . . 1.26 110.672 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.55 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.201 -0.666 . . . . 3.83 109.201 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.459 ' H ' ' HB3' ' A' ' 1' ' ' SER . . . -116.37 150.64 18.55 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.983 -0.847 . . . . 1.39 110.983 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -35.58 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.092 0 C-N-CA 124.03 3.153 . . . . 0.86 113.754 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.569 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.1 t -80.04 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.208 -1.36 . . . . 1.43 108.857 178.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.4 ' H ' ' CG1' ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.64 125.8 51.4 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.426 -0.51 . . . . 1.94 111.434 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.5 143.96 34.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.625 -0.716 . . . . 1.19 110.583 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.93 168.37 25.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.386 -0.37 . . . . 3.92 111.09 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.586 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.02 131.09 60.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.008 -0.542 . . . . 3.88 110.047 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.1 p -141.18 162.27 35.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.84 0.352 . . . . 3.92 111.27 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.8 mt-10 36.09 31.62 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.601 -0.518 . . . . 6.08 109.601 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.586 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.41 69.52 32.19 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.932 -0.576 . . . . 4.01 111.558 -178.752 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.24 -29.2 73.23 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.57 2.18 . . . . 4.51 111.837 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.71 125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 3.51 110.449 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.72 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -123.93 158.34 60.44 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.329 -0.396 . . . . 4.3 110.444 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.474 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 96.9 Cg_endo -81.94 -64.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.965 2.443 . . . . 1.96 113.574 -179.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.474 ' H ' ' HG2' ' A' ' 15' ' ' PRO . 10.2 m120 -108.47 -19.62 13.39 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.088 0.403 . . . . 3.33 112.088 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.72 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 89.1 p -107.32 152.05 24.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.101 0.477 . . . . 1.53 111.346 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.578 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.26 102.92 2.23 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.711 -0.677 . . . . 2.29 110.583 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.75 145.68 12.93 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.781 2.321 . . . . 0.88 112.554 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.407 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.78 167.96 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.845 -0.616 . . . . 2.12 109.903 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.16 147.95 29.05 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.742 -0.466 . . . . 2.67 109.742 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.499 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.3 p90 -142.23 157.3 45.0 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.567 -0.453 . . . . 0.32 111.169 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.467 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.8 m-20 -127.97 155.26 44.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.773 -0.649 . . . . 2.77 110.199 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.64 173.05 6.34 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.113 0.482 . . . . 1.25 110.702 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -50.74 173.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.834 2.356 . . . . 1.12 111.505 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.92 -51.08 0.7 Allowed Pre-proline 0 C--N 1.33 -0.265 0 C-N-CA 120.717 -0.393 . . . . 4.05 110.212 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.648 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.8 152.41 82.22 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.683 2.255 . . . . 2.12 111.501 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.68 42.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.343 0.592 . . . . 2.85 110.601 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.815 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.64 -41.66 98.22 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.004 -0.998 . . . . 3.11 110.655 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.437 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.5 mt -109.73 137.84 40.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.784 -0.643 . . . . 1.86 111.308 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.02 -72.89 0.7 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.075 -0.512 . . . . 1.61 111.906 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.22 148.43 24.37 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.581 0.586 . . . . 1.67 112.581 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -121.76 124.82 45.12 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.448 -0.575 . . . . 1.07 109.448 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.7 mt -118.08 134.75 60.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.55 -0.46 . . . . 1.55 110.569 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.486 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -120.02 128.72 53.79 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.057 0.456 . . . . 1.33 111.268 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.547 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.97 49.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.707 -0.678 . . . . 2.36 110.159 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.417 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.2 p90 -144.98 163.19 34.93 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.092 0.473 . . . . 0.38 112.172 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.55 139.49 7.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.512 -0.767 . . . . 2.31 110.502 178.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.694 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.44 115.45 3.03 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.296 1.997 . . . . 0.86 111.846 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.96 81.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.9 -0.407 . . . . 3.44 109.9 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.694 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.14 -20.6 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.993 -0.549 . . . . 2.72 111.887 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.7 p -157.69 157.76 34.12 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.884 -0.326 . . . . 2.78 110.596 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.36 27.8 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.466 . . . . 2.3 110.205 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.73 -75.88 1.31 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.116 -0.564 . . . . 1.8 111.926 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.89 152.25 35.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.966 0.412 . . . . 5.48 110.959 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.633 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.23 -169.18 2.55 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.06 -0.518 . . . . 1.84 111.97 179.367 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.411 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.08 149.74 29.59 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.392 0.615 . . . . 2.27 112.564 -177.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.08 156.45 45.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.81 -1.086 . . . . 1.92 110.287 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.22 158.28 41.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.925 -0.579 . . . . 1.09 111.8 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.04 135.69 53.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.476 -0.783 . . . . 1.16 109.801 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.442 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.42 121.94 23.75 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.481 -0.327 . . . . 1.39 111.526 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.514 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.0 Cg_exo -46.37 151.66 1.68 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.688 2.259 . . . . 0.72 112.151 178.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.87 -23.03 62.99 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 116.043 -0.526 . . . . 0.74 112.784 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.514 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.6 p-80 -82.81 -16.86 46.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.391 0.596 . . . . 1.26 111.804 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.491 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.63 138.4 31.6 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.751 -0.379 . . . . 1.59 110.323 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.47 13.87 11.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.383 -0.371 . . . . 2.07 111.542 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.48 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.0 p -149.95 143.45 25.24 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.617 -0.433 . . . . 0.96 111.04 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.87 -169.25 1.51 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.913 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.714 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 97.4 m -151.83 125.95 9.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.417 -0.811 . . . . 1.19 109.8 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.444 HD11 HG23 ' A' ' 60' ' ' ILE . 66.6 mt -114.88 123.25 70.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.376 -0.53 . . . . 1.47 111.2 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.809 ' NZ ' ' N ' ' A' ' 141' ' ' GLY . 96.7 mttt -126.53 163.37 23.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.879 -0.601 . . . . 3.0 110.41 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.17 18.94 59.89 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.697 -0.961 . . . . 0.5 110.697 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.427 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.8 mt -79.04 157.27 28.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.13 0.491 . . . . 1.21 111.363 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.632 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -99.45 134.01 21.51 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.598 -0.728 . . . . 3.2 110.451 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.91 143.58 61.26 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.555 2.17 . . . . 1.09 111.867 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.72 75.23 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.998 -0.841 . . . . 0.72 110.998 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.637 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.15 158.76 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.567 0.223 . . . . 1.47 110.46 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.15 139.95 41.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.944 0.402 . . . . 1.23 110.627 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.637 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.57 136.43 54.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.041 -0.527 . . . . 1.1 110.77 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.92 130.99 45.33 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.53 -0.915 . . . . 1.87 108.53 177.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.485 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.45 153.92 16.63 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.349 -0.929 . . . . 0.39 111.913 -178.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.04 140.94 46.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.642 -0.503 . . . . 1.8 109.642 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.466 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.0 tp -115.78 118.86 34.21 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.505 -0.478 . . . . 1.11 110.46 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.8 mt -112.43 128.94 68.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.223 -0.444 . . . . 1.51 110.65 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.73 120.9 43.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.324 -0.398 . . . . 1.47 110.707 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.671 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.57 146.51 11.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.137 0.494 . . . . 1.33 111.015 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.815 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.11 153.86 21.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.585 -0.734 . . . . 2.49 109.955 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.14 88.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.004 0.43 . . . . 4.2 110.503 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.22 32.7 0.21 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.808 -0.633 . . . . 6.4 110.511 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.09 -117.37 3.29 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.443 -0.663 . . . . 1.74 111.443 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.451 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.37 177.35 9.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.177 0.513 . . . . 3.64 111.69 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.1 149.59 32.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.476 -0.783 . . . . 1.7 110.371 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.55 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.2 144.78 38.67 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.407 -0.361 . . . . 2.7 110.501 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -128.07 136.03 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 121.071 0.463 . . . . 1.16 111.487 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.11 141.39 52.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.697 -0.683 . . . . 1.14 110.212 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.4 ttp180 -117.69 138.93 51.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.185 0.517 . . . . 4.33 111.406 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.485 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.34 164.15 38.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.539 -0.755 . . . . 0.91 109.531 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.574 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.29 151.49 38.42 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.391 -0.523 . . . . 1.47 111.072 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.578 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.3 p90 -146.11 172.79 12.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.713 -0.676 . . . . 0.51 111.044 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.45 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.8 160.63 21.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.46 -0.791 . . . . 1.92 109.809 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.45 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.35 121.91 23.04 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.535 -0.466 . . . . 1.63 110.776 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.549 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -128.2 164.31 22.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.668 0.747 . . . . 2.37 112.682 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.552 ' OG ' ' CE2' ' A' ' 157' ' ' TYR . 30.3 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 114.712 -1.131 . . . . 3.63 109.001 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 122.137 0.97 . . . . 1.25 110.926 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.474 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.91 167.53 0.26 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.626 -1.17 . . . . 1.16 110.946 -179.193 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.484 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.8 m-30 -133.65 145.54 50.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.678 -0.692 . . . . 0.78 110.102 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.28 101.68 9.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.075 -0.713 . . . . 1.08 109.075 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.464 HG11 ' N ' ' A' ' 131' ' ' SER . 71.8 t -112.86 139.7 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.987 -0.551 . . . . 1.1 111.133 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.464 ' N ' HG11 ' A' ' 130' ' ' VAL . 68.2 p -128.73 152.5 48.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.624 -0.716 . . . . 0.87 109.786 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.642 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.7 p90 -144.79 -165.04 2.05 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.705 -0.398 . . . . 0.37 110.629 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.729 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -123.81 127.19 73.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 1.14 110.836 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.162 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.99 58.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.222 -0.444 . . . . 1.91 110.38 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.729 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.19 24.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.855 -0.612 . . . . 1.56 111.518 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.162 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.15 128.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.628 -0.429 . . . . 1.56 110.897 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -86.56 -9.6 55.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.938 -0.573 . . . . 1.88 110.215 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.2 p -87.09 0.22 55.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.153 -0.476 . . . . 1.63 110.344 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.962 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.38 137.33 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.969 -0.56 . . . . 1.11 109.9 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.73 ' C ' ' HZ2' ' A' ' 61' ' ' LYS . 3.5 p -96.29 -15.53 21.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.262 0.553 . . . . 1.01 110.045 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.809 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.59 175.52 45.74 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.786 -1.325 . . . . 0.14 109.786 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -123.34 151.59 42.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.954 0.407 . . . . 0.21 110.551 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.728 ' NH2' ' OE1' ' A' ' 191' ' ' GLN . 64.1 ttp85 -132.34 121.18 23.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.153 -0.476 . . . . 1.54 109.989 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.48 HG23 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.07 136.49 38.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.706 -0.679 . . . . 1.08 110.747 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 81.3 tt0 -129.33 129.92 45.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.994 -0.548 . . . . 1.32 110.105 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.3 p90 -138.73 135.27 34.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.957 -0.565 . . . . 1.05 110.57 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.404 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.31 161.43 39.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.737 -0.665 . . . . 1.16 109.662 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.939 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.3 mt -70.99 124.85 25.32 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.672 -0.411 . . . . 1.23 110.775 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.84 -7.6 49.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.779 -0.646 . . . . 0.86 110.814 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -109.91 -69.63 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.845 0.355 . . . . 1.66 111.399 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.439 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.3 mt-10 -60.75 -35.29 76.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 1.66 111.471 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.095 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.15 7.18 88.62 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.789 -0.924 . . . . 1.62 110.789 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.324 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.95 -171.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.765 0.316 . . . . 1.86 110.301 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.324 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.2 139.02 45.33 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 1.98 110.221 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.404 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 45.8 Cg_endo -70.9 145.79 51.45 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.675 2.25 . . . . 0.62 112.32 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.83 145.74 42.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.196 -0.668 . . . . 1.14 109.196 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.673 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 86.7 m-85 -123.29 141.31 52.11 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.366 -0.534 . . . . 1.44 111.513 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.434 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.8 mt -128.05 127.66 43.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.286 -0.87 . . . . 1.08 108.925 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -101.58 131.05 47.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.127 0.489 . . . . 1.09 111.751 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.516 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -127.86 157.56 73.25 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.388 -0.824 . . . . 1.04 109.6 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.72 158.06 58.32 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.479 2.12 . . . . 0.21 112.225 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.38 -12.17 5.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.744 -0.662 . . . . 0.88 110.675 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.7 p -92.78 -8.75 42.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 1.06 110.778 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.34 34.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 1.05 110.329 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.5 p -133.05 16.55 4.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.396 -0.366 . . . . 1.07 110.531 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.52 147.05 5.08 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.642 -0.503 . . . . 0.92 109.642 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.516 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.18 150.44 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.46 -0.496 . . . . 1.09 111.564 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.35 124.93 50.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.6 -0.727 . . . . 1.31 109.837 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.521 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.36 104.91 29.72 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.879 0.371 . . . . 1.09 111.065 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -91.0 -179.49 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.922 0 C-N-CA 123.241 2.628 . . . . 0.48 112.191 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.61 32.65 18.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.328 -0.851 . . . . 1.26 111.467 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.521 HD21 HG21 ' A' ' 169' ' ' ILE . 23.8 mt -86.41 148.54 25.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.782 0.325 . . . . 1.12 110.4 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.767 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.26 114.86 61.3 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.919 0.39 . . . . 1.3 110.642 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.02 140.57 95.94 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.915 2.41 . . . . 0.92 111.922 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.05 21.2 74.4 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.087 -0.805 . . . . 0.44 111.087 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.439 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.9 150.2 49.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.913 0.387 . . . . 3.05 110.529 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.493 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.16 131.63 45.99 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.974 -0.557 . . . . 1.48 109.813 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.939 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.51 148.35 43.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.127 -0.488 . . . . 0.89 111.063 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.32 125.29 60.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.323 -0.991 . . . . 1.12 108.323 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.46 132.45 63.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.174 0.511 . . . . 1.1 111.346 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.44 122.49 20.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.541 -0.754 . . . . 0.43 109.684 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.589 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -100.95 125.38 54.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.281 -0.418 . . . . 1.07 110.723 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.668 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.7 m-85 -117.22 137.86 52.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.045 -0.525 . . . . 0.92 109.854 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.565 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.71 134.97 42.89 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.809 -0.811 . . . . 0.49 108.809 178.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.545 ' O ' ' N ' ' A' ' 140' ' ' SER . 11.6 mt -99.05 122.94 51.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.123 0.487 . . . . 1.08 110.926 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.451 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.3 p -83.8 169.7 14.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.582 -0.735 . . . . 0.89 110.481 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -59.82 -14.48 15.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.016 -0.538 . . . . 1.6 110.979 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.451 ' H ' ' HG ' ' A' ' 186' ' ' SER . 95.3 m-20 -96.03 -4.35 43.26 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.877 -0.329 . . . . 1.18 110.796 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.79 13.91 63.97 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.36 -0.696 . . . . 0.34 111.36 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -84.73 139.14 32.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.632 0.253 . . . . 1.22 110.437 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.728 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 86.0 mt-30 -106.73 141.07 38.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.406 -0.361 . . . . 1.44 110.527 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.76 127.02 26.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.125 -0.488 . . . . 1.39 110.363 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.668 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.6 tp -68.15 117.37 9.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.293 -0.412 . . . . 1.08 110.486 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.642 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -109.11 -21.65 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.119 -0.491 . . . . 1.08 110.724 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.89 125.6 5.82 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.601 -0.44 . . . . 1.1 111.482 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.497 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.75 120.2 21.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.774 -0.648 . . . . 0.94 109.562 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.65 151.74 29.14 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.642 -0.423 . . . . 1.07 110.89 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.54 158.55 18.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.043 -0.526 . . . . 0.89 110.439 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.05 157.91 43.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.67 110.723 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 104.34 9.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.855 -0.611 . . . . 1.17 110.04 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.484 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.1 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.89 -1.052 . . . . 1.26 110.608 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.553 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.9 m . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.242 -0.651 . . . . 3.83 109.242 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.27 150.59 18.57 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.041 -0.823 . . . . 1.39 111.041 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.64 142.45 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 123.967 3.111 . . . . 0.86 113.748 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.573 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -80.0 173.41 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.176 -1.374 . . . . 1.43 108.758 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.59 125.91 51.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.157 0.503 . . . . 1.94 111.431 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 143.96 34.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.593 -0.73 . . . . 1.19 110.607 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.07 168.25 25.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.916 0.389 . . . . 3.92 111.123 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.589 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.83 131.07 60.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.986 -0.552 . . . . 3.88 110.103 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.24 162.35 35.69 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.777 0.322 . . . . 3.92 111.255 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 67.7 tt0 36.04 31.67 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.58 -0.526 . . . . 6.08 109.58 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.589 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.56 32.58 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.917 -0.583 . . . . 4.01 111.585 -178.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.636 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.33 -29.14 72.33 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.499 2.133 . . . . 4.51 111.796 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.673 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 3.2 m 149.66 125.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.143 -0.48 . . . . 3.51 110.495 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.673 ' NE2' ' O ' ' A' ' 13' ' ' SER . 5.8 mp0 -124.02 158.36 60.61 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 4.3 110.47 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.468 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 97.5 Cg_endo -82.08 -64.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.865 2.377 . . . . 1.96 113.51 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.653 ' OD1' ' N ' ' A' ' 17' ' ' SER . 1.1 p-10 -108.44 -19.54 13.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.36 -0.382 . . . . 3.33 112.029 -178.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.653 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 95.9 p -107.36 152.04 24.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.174 0.512 . . . . 1.53 111.29 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.5 t-80 -155.32 102.95 2.22 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.662 -0.699 . . . . 2.29 110.565 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.501 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.7 Cg_endo -82.63 145.61 13.09 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.85 2.367 . . . . 0.88 112.667 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.417 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.78 167.86 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.924 -0.58 . . . . 2.12 109.899 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.06 148.06 29.26 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.74 -0.467 . . . . 2.67 109.74 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.498 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.5 p90 -142.36 157.28 44.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.005 0.431 . . . . 0.32 111.169 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.467 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.1 m-20 -128.09 155.31 44.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.745 -0.661 . . . . 2.77 110.112 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.6 173.0 6.4 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.175 -0.466 . . . . 1.25 110.756 -179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.63 173.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.877 2.384 . . . . 1.12 111.605 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.01 -51.16 0.69 Allowed Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 120.74 -0.384 . . . . 4.05 110.083 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.658 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.75 152.33 82.44 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.798 2.332 . . . . 2.12 111.437 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.69 42.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.456 0.646 . . . . 2.85 110.554 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.819 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.63 -41.54 98.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.993 -1.003 . . . . 3.11 110.718 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.44 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.8 mt -109.87 137.77 40.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.791 -0.641 . . . . 1.86 111.255 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.96 -72.99 0.7 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.028 -0.533 . . . . 1.61 111.837 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.13 148.5 24.41 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.556 0.576 . . . . 1.67 112.556 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.95 124.87 45.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.263 -0.643 . . . . 1.07 109.263 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.4 mt -118.05 134.72 60.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.715 -0.394 . . . . 1.55 110.698 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.485 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -120.02 128.55 53.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.047 0.451 . . . . 1.33 111.271 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.541 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.08 139.1 49.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.722 -0.672 . . . . 2.36 110.126 178.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.415 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.09 163.11 35.31 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.134 0.492 . . . . 0.38 112.05 -178.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.489 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.53 139.73 7.9 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.453 -0.794 . . . . 2.31 110.421 178.727 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.65 115.47 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.322 2.015 . . . . 0.86 111.769 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.679 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.9 81.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.925 -0.398 . . . . 3.44 109.925 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.049 -0.523 . . . . 2.72 111.893 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.7 p -157.56 157.81 34.44 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.804 -0.358 . . . . 2.78 110.538 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.403 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.32 27.69 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.215 -0.448 . . . . 2.3 110.204 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.77 -75.81 1.31 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 121.157 -0.544 . . . . 1.8 111.875 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -117.95 152.34 35.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.959 0.409 . . . . 5.48 110.983 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.29 -169.1 2.51 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.052 -0.522 . . . . 1.84 111.925 179.424 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.415 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.22 149.67 29.79 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.497 0.665 . . . . 2.27 112.511 -177.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.08 156.44 45.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.773 -1.103 . . . . 1.92 110.225 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.1 158.35 41.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.826 -0.624 . . . . 1.09 111.785 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.0 m -115.21 135.71 53.89 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.458 -0.792 . . . . 1.16 109.847 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.451 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.42 121.93 23.74 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.418 -0.355 . . . . 1.39 111.576 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.513 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.5 Cg_exo -46.36 151.76 1.64 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.683 2.255 . . . . 0.72 112.107 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.9 -23.12 63.14 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 116.057 -0.519 . . . . 0.74 112.765 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.513 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.5 p-80 -82.75 -16.9 46.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.37 0.585 . . . . 1.26 111.802 -178.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.488 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.3 mt -91.58 138.41 31.59 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.802 -0.359 . . . . 1.59 110.334 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.52 13.83 10.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.37 -0.377 . . . . 2.07 111.56 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.475 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.9 143.46 25.29 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.643 -0.423 . . . . 0.96 111.09 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.717 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.77 -169.39 1.54 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.888 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.719 ' HG1' ' C ' ' A' ' 188' ' ' ASP . 2.5 m -151.79 125.92 9.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.386 -0.824 . . . . 1.19 109.739 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.463 HG23 HD11 ' A' ' 60' ' ' ILE . 66.5 mt -114.81 123.29 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.416 -0.514 . . . . 1.47 111.161 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.624 ' CG ' ' N ' ' A' ' 62' ' ' GLY . 18.1 ttpt -126.49 163.45 23.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.874 -0.603 . . . . 3.0 110.432 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.624 ' N ' ' CG ' ' A' ' 61' ' ' LYS . . . 85.09 18.99 59.91 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.731 -0.948 . . . . 0.5 110.731 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.44 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.6 mt -79.1 157.19 28.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.074 0.464 . . . . 1.21 111.412 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.615 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 1.2 mttp -99.37 133.92 21.63 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.702 -0.681 . . . . 3.2 110.504 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.88 143.54 61.24 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.541 2.161 . . . . 1.09 112.059 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.91 25.58 75.41 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.063 -0.815 . . . . 0.72 111.063 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.64 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.15 158.78 39.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.687 0.279 . . . . 1.47 110.381 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.14 139.91 42.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.89 0.376 . . . . 1.23 110.569 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.64 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.2 m-85 -122.49 136.42 54.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.007 -0.542 . . . . 1.1 110.842 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.489 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.95 131.02 45.33 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.464 -0.939 . . . . 1.87 108.464 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.49 153.89 16.65 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.281 -0.961 . . . . 0.39 111.915 -178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.99 140.92 46.06 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.677 -0.49 . . . . 1.8 109.677 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.461 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.9 tp -115.76 118.89 34.29 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.42 -0.512 . . . . 1.11 110.539 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.6 mt -112.32 129.03 68.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.369 -0.378 . . . . 1.51 110.699 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.84 120.92 43.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.319 -0.4 . . . . 1.47 110.743 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.667 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.6 146.45 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.109 0.48 . . . . 1.33 111.066 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.819 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.08 153.88 21.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.546 -0.752 . . . . 2.49 110.018 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.2 mt-30 -39.15 88.51 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.868 0.366 . . . . 4.2 110.409 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.31 32.61 0.21 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.853 -0.612 . . . . 6.4 110.582 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.1 -117.37 3.29 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.419 -0.672 . . . . 1.74 111.419 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.446 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.44 177.44 8.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.249 0.547 . . . . 3.64 111.613 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.17 149.47 32.04 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.37 -0.832 . . . . 1.7 110.363 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.553 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.15 144.7 38.73 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.441 -0.345 . . . . 2.7 110.578 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -127.98 135.98 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 120.616 -0.434 . . . . 1.16 111.597 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -123.99 141.26 52.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.701 -0.681 . . . . 1.14 110.342 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.441 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.51 138.96 51.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.142 0.496 . . . . 4.33 111.503 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.36 164.13 38.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.53 -0.759 . . . . 0.91 109.428 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.57 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.2 151.62 38.7 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.314 -0.554 . . . . 1.47 110.972 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.574 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.8 p90 -146.29 172.69 13.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.69 -0.686 . . . . 0.51 111.008 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.448 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.76 160.74 21.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.446 -0.797 . . . . 1.92 109.866 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.448 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.41 121.84 22.87 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.563 -0.455 . . . . 1.63 110.771 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.2 p -126.92 154.6 44.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.646 0.736 . . . . 2.37 112.759 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.444 ' OG ' ' OH ' ' A' ' 157' ' ' TYR . 22.8 t . . . . . 0 N--CA 1.455 -0.199 0 CA-C-N 114.616 -1.175 . . . . 3.63 111.91 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.61 ' HG ' ' CG2' ' A' ' 201' ' ' THR . 92.6 p . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 122.617 1.199 . . . . 1.25 113.195 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.479 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.91 167.5 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.243 -1.344 . . . . 1.16 110.938 179.797 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.56 145.64 50.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.736 -0.665 . . . . 0.78 110.156 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.26 101.47 9.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.157 -0.683 . . . . 1.08 109.157 177.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.472 HG11 ' N ' ' A' ' 131' ' ' SER . 71.7 t -112.91 139.65 36.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.099 -0.5 . . . . 1.1 111.101 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.472 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.3 p -128.61 152.55 48.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.605 -0.725 . . . . 0.87 109.83 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.654 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.4 p90 -144.75 -164.87 2.01 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.634 -0.426 . . . . 0.37 110.606 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.735 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -124.06 127.19 73.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.246 -0.434 . . . . 1.14 110.784 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.179 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.99 58.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.028 -0.533 . . . . 1.91 110.358 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.735 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.15 24.61 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.872 -0.604 . . . . 1.56 111.527 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.179 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.08 128.73 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.614 -0.434 . . . . 1.56 110.942 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.31 -9.77 55.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.862 -0.608 . . . . 1.88 110.309 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.12 0.31 55.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 1.63 110.366 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.962 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.16 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.891 -0.595 . . . . 1.11 109.99 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.579 ' N ' ' O ' ' A' ' 185' ' ' ILE . 32.2 t -96.21 -15.51 22.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.311 0.576 . . . . 1.01 110.062 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.408 ' HA3' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.58 175.62 45.81 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 109.795 -1.322 . . . . 0.14 109.795 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.53 151.59 42.68 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.661 -0.416 . . . . 0.21 110.435 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.691 ' NH2' ' OE1' ' A' ' 191' ' ' GLN . 60.3 ttp85 -132.35 121.22 23.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.129 -0.487 . . . . 1.54 109.872 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.497 HG23 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.15 136.52 38.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.702 -0.681 . . . . 1.08 110.68 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 75.8 tt0 -129.33 129.84 45.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.01 -0.541 . . . . 1.32 110.121 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.605 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.4 p90 -138.73 135.37 34.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.049 -0.523 . . . . 1.05 110.596 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.405 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.38 161.38 39.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.702 -0.681 . . . . 1.16 109.697 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.945 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.0 mt -71.07 124.92 25.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.004 0.43 . . . . 1.23 110.766 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.75 -7.81 50.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.756 -0.656 . . . . 0.86 110.9 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.73 -69.65 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 1.66 111.453 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.461 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.68 -35.25 75.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 1.66 111.519 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.079 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 78.98 7.33 88.5 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.862 -0.895 . . . . 1.62 110.862 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.334 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -28.01 -171.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.784 0.326 . . . . 1.86 110.275 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.334 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.14 45.23 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.909 0.385 . . . . 1.98 110.186 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.405 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 45.9 Cg_endo -71.01 145.84 50.97 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 122.688 2.259 . . . . 0.62 112.383 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.78 145.74 42.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.249 -0.648 . . . . 1.14 109.249 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.57 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 93.5 m-85 -123.35 141.36 52.07 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.292 -0.563 . . . . 1.44 111.511 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.413 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.9 mt -128.12 127.72 43.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.334 -0.848 . . . . 1.08 108.934 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.62 ' HB2' HD21 ' A' ' 16' ' ' ASN . 4.0 t0 -101.65 131.07 48.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.183 0.516 . . . . 1.09 111.72 -178.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.542 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.1 mt -127.88 157.6 73.16 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.262 -0.881 . . . . 1.04 109.567 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -69.89 158.16 57.73 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.332 2.021 . . . . 0.21 112.203 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.4 -12.1 5.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.778 -0.646 . . . . 0.88 110.76 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.0 p -92.91 -8.64 42.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.072 -0.513 . . . . 1.06 110.677 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.2 135.33 34.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.318 -0.401 . . . . 1.05 110.406 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.4 p -133.13 16.72 4.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.426 -0.352 . . . . 1.07 110.493 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.55 147.18 5.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.663 -0.495 . . . . 0.92 109.663 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.503 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.26 150.42 12.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.498 -0.481 . . . . 1.09 111.521 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.497 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.32 124.96 50.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.57 -0.741 . . . . 1.31 109.754 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.522 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.32 104.88 29.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.343 -0.39 . . . . 1.09 111.119 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 84.7 Cg_endo -91.01 -179.47 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.909 0 C-N-CA 123.152 2.568 . . . . 0.48 112.153 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.61 32.71 18.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.314 -0.857 . . . . 1.26 111.398 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.522 HD21 HG21 ' A' ' 169' ' ' ILE . 23.9 mt -86.44 148.59 25.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.781 0.324 . . . . 1.12 110.43 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.779 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.4 mt -88.36 114.85 61.33 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.055 0.455 . . . . 1.3 110.664 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.03 140.63 96.15 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.928 2.418 . . . . 0.92 111.936 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.02 21.24 74.4 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.081 -0.808 . . . . 0.44 111.081 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.461 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.88 150.19 49.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 3.05 110.626 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.493 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.2 131.63 46.03 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.021 -0.536 . . . . 1.48 109.805 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.945 ' CE2' HD21 ' A' ' 148' ' ' LEU . 75.2 m-85 -120.47 148.28 44.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.06 -0.518 . . . . 0.89 111.048 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.2 mt -105.31 125.37 60.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.274 -1.01 . . . . 1.12 108.274 177.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.62 132.48 63.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.19 0.519 . . . . 1.1 111.223 -178.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.51 122.59 20.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.509 -0.768 . . . . 0.43 109.585 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.595 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.0 125.33 54.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 1.07 110.67 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.671 ' CE1' HD11 ' A' ' 193' ' ' LEU . 49.0 m-85 -117.2 137.93 52.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.031 -0.531 . . . . 0.92 109.77 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.575 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.68 135.06 42.71 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.798 -0.816 . . . . 0.49 108.798 178.786 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 140' ' ' SER . 72.5 mt -99.14 122.92 51.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.08 0.467 . . . . 1.08 110.903 -178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.444 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.4 p -83.84 169.77 14.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.559 -0.746 . . . . 0.89 110.522 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.555 ' O ' ' OG1' ' A' ' 59' ' ' THR . 17.1 pt-20 -59.75 -14.59 15.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.096 -0.502 . . . . 1.6 110.966 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.719 ' C ' ' HG1' ' A' ' 59' ' ' THR . 95.3 m-20 -96.02 -4.3 43.36 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.843 -0.343 . . . . 1.18 110.841 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.623 ' N ' ' HG1' ' A' ' 59' ' ' THR . . . 87.83 13.78 64.11 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.409 -0.677 . . . . 0.34 111.409 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -84.66 139.05 32.32 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.803 -0.233 . . . . 1.22 110.461 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.691 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 87.4 mt-30 -106.75 141.09 38.56 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.835 -0.346 . . . . 1.44 110.558 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.4 m -136.68 126.94 26.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 1.39 110.42 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.671 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.5 tp -68.09 117.26 9.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.915 0.388 . . . . 1.08 110.528 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.654 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.4 pt -109.07 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 1.08 110.653 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.9 125.61 5.81 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.524 -0.471 . . . . 1.1 111.6 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.495 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.71 120.23 21.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.841 -0.618 . . . . 0.94 109.604 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.59 151.68 29.12 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.697 -0.401 . . . . 1.07 110.893 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.41 158.66 18.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.005 -0.543 . . . . 0.89 110.439 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.12 157.91 43.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.089 -0.505 . . . . 0.67 110.649 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.43 9.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.711 -0.677 . . . . 1.17 109.992 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.61 ' CG2' ' HG ' ' A' ' 126' ' ' SER . 68.3 p . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.986 -1.006 . . . . 1.26 110.598 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.196 -0.668 . . . . 3.83 109.196 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.44 150.69 18.53 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.982 -0.847 . . . . 1.39 110.982 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.55 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 124.035 3.157 . . . . 0.86 113.772 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.569 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -79.93 173.43 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.264 -1.334 . . . . 1.43 108.853 178.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -105.64 125.84 51.45 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.437 -0.505 . . . . 1.94 111.49 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.51 143.93 34.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.661 -0.7 . . . . 1.19 110.712 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.31 25.62 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.874 0.369 . . . . 3.92 111.081 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.59 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.0 mt -108.96 131.08 60.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.926 -0.579 . . . . 3.88 110.044 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.15 162.28 35.87 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.838 0.352 . . . . 3.92 111.252 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.4 mt-10 36.13 31.57 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.592 -0.521 . . . . 6.08 109.592 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.59 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.45 69.56 32.61 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.94 -0.573 . . . . 4.01 111.627 -178.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.37 -29.0 71.88 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.431 2.087 . . . . 4.51 111.854 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.61 125.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 3.51 110.498 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.616 HE21 ' C ' ' A' ' 17' ' ' SER . 14.0 mt-30 -124.04 158.38 60.63 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.348 -0.387 . . . . 4.3 110.414 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.465 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 98.4 Cg_endo -82.14 -64.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.905 2.403 . . . . 1.96 113.428 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.764 ' ND2' ' CD2' ' A' ' 157' ' ' TYR . 1.3 m120 -108.42 -19.62 13.39 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.08 0.4 . . . . 3.33 112.08 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.616 ' C ' HE21 ' A' ' 14' ' ' GLN . 57.7 m -107.33 152.14 24.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.164 0.507 . . . . 1.53 111.302 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.34 103.0 2.22 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.681 -0.69 . . . . 2.29 110.569 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.652 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.7 145.67 13.01 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.823 2.348 . . . . 0.88 112.6 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.417 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.82 167.96 24.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.898 -0.592 . . . . 2.12 109.928 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.13 147.9 29.02 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.777 -0.453 . . . . 2.67 109.777 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.498 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.5 p90 -142.22 157.33 44.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.0 0.428 . . . . 0.32 111.225 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.468 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.04 155.27 44.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.779 -0.646 . . . . 2.77 110.106 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.56 173.1 6.27 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 121.118 0.485 . . . . 1.25 110.743 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.72 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.864 2.376 . . . . 1.12 111.507 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.48 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -51.05 0.69 Allowed Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.76 -0.376 . . . . 4.05 110.142 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.658 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.87 152.31 82.66 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.837 2.358 . . . . 2.12 111.369 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.71 42.25 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.426 0.631 . . . . 2.85 110.588 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.821 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.58 -41.59 98.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.019 -0.991 . . . . 3.11 110.644 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.441 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.8 mt -109.85 137.87 40.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.748 -0.66 . . . . 1.86 111.329 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.99 -72.93 0.7 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.099 -0.501 . . . . 1.61 111.886 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.22 148.41 24.38 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.607 0.595 . . . . 1.67 112.607 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -121.88 124.81 44.99 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.397 -0.594 . . . . 1.07 109.397 177.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.05 134.71 60.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.66 -0.416 . . . . 1.55 110.647 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.485 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -119.96 128.63 53.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.036 0.446 . . . . 1.33 111.249 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.541 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.03 139.01 49.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.738 -0.665 . . . . 2.36 110.143 178.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.417 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.03 163.11 35.24 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 120.55 -0.46 . . . . 0.38 112.135 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.46 139.62 7.9 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.498 -0.774 . . . . 2.31 110.485 178.763 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.62 115.46 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.302 2.001 . . . . 0.86 111.827 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.677 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.92 81.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.84 -0.43 . . . . 3.44 109.84 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.52 0.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.016 -0.538 . . . . 2.72 111.898 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.4 p -157.67 157.81 34.24 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.862 -0.335 . . . . 2.78 110.554 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.402 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.36 27.77 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.181 -0.463 . . . . 2.3 110.222 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -75.8 1.31 Allowed Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.103 -0.57 . . . . 1.8 111.892 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.89 152.36 35.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.927 0.394 . . . . 5.48 110.965 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.673 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.27 -169.14 2.53 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.059 -0.519 . . . . 1.84 111.965 179.373 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.09 149.57 29.84 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.468 0.651 . . . . 2.27 112.606 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.99 156.47 46.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.807 -1.088 . . . . 1.92 110.234 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.2 158.36 41.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.951 -0.568 . . . . 1.09 111.792 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.0 m -115.16 135.68 53.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.446 -0.797 . . . . 1.16 109.817 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.449 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.45 121.92 23.7 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.422 -0.353 . . . . 1.39 111.567 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.512 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.1 Cg_exo -46.41 151.71 1.7 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.753 2.302 . . . . 0.72 112.029 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.89 -23.02 63.01 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 115.989 -0.551 . . . . 0.74 112.742 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.81 -16.88 46.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.436 0.618 . . . . 1.26 111.758 -178.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.487 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.6 138.36 31.63 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.799 -0.36 . . . . 1.59 110.368 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.47 13.85 11.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.399 -0.364 . . . . 2.07 111.447 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.477 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.95 143.52 25.28 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.657 -0.417 . . . . 0.96 111.101 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.719 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.4 t80 -114.74 -169.36 1.53 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.981 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.719 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.85 125.9 9.19 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.449 -0.796 . . . . 1.19 109.826 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.469 HG23 HD11 ' A' ' 60' ' ' ILE . 66.8 mt -114.87 123.33 70.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.364 -0.534 . . . . 1.47 111.153 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.43 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 63.9 pttt -126.54 163.36 23.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.843 -0.617 . . . . 3.0 110.425 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.16 18.87 60.05 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.749 -0.941 . . . . 0.5 110.749 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.438 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.7 mt -79.03 157.23 28.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.091 0.472 . . . . 1.21 111.376 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.661 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 1.8 mtmm -99.48 133.89 21.58 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.593 -0.73 . . . . 3.2 110.454 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.64 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.9 Cg_endo -67.87 143.66 61.83 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.451 2.101 . . . . 1.09 111.942 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.87 25.49 75.5 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.063 -0.815 . . . . 0.72 111.063 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.641 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.08 158.86 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.744 0.307 . . . . 1.47 110.403 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.2 139.92 42.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.945 0.402 . . . . 1.23 110.508 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.661 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.4 m-85 -122.54 136.41 54.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.922 -0.581 . . . . 1.1 110.726 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.93 131.09 45.26 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.51 -0.922 . . . . 1.87 108.51 177.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.5 153.93 16.65 Favored Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.338 -0.934 . . . . 0.39 111.943 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.04 140.96 46.01 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.702 -0.481 . . . . 1.8 109.702 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.464 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.6 tp -115.67 118.99 34.61 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.478 -0.489 . . . . 1.11 110.503 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.9 mt -112.52 129.15 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.301 -0.409 . . . . 1.51 110.594 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.9 120.92 43.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.29 -0.413 . . . . 1.47 110.696 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.667 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.58 146.47 11.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.133 0.492 . . . . 1.33 111.019 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.821 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.12 153.97 21.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.566 -0.743 . . . . 2.49 109.852 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.24 88.61 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.966 0.413 . . . . 4.2 110.347 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.616 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.28 32.62 0.21 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.828 -0.624 . . . . 6.4 110.558 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.35 3.29 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.482 -0.647 . . . . 1.74 111.482 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.447 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.41 177.41 8.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.028 0.442 . . . . 3.64 111.699 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.23 149.48 31.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.512 -0.767 . . . . 1.7 110.378 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.18 144.65 38.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.436 -0.347 . . . . 2.7 110.526 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -128.02 136.05 61.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-O 121.155 0.502 . . . . 1.16 111.538 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.04 141.29 52.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.573 -0.74 . . . . 1.14 110.318 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.445 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.62 138.87 51.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.082 0.468 . . . . 4.33 111.486 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.491 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.32 164.1 38.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.536 -0.756 . . . . 0.91 109.523 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.571 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.22 151.64 38.71 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.354 -0.538 . . . . 1.47 111.027 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.575 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.0 p90 -146.24 172.77 12.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.644 -0.707 . . . . 0.51 110.995 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.451 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.81 160.66 21.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.391 -0.822 . . . . 1.92 109.854 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.451 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.38 121.89 22.97 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.536 -0.466 . . . . 1.63 110.74 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.576 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.4 p -131.76 -136.55 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 122.284 1.04 . . . . 2.37 111.303 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 92' ' ' THR . 30.4 t . . . . . 0 N--CA 1.449 -0.478 0 CA-C-N 112.712 -2.04 . . . . 3.63 106.222 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.607 ' HB2' ' HB ' ' A' ' 201' ' ' THR . 70.4 p . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 123.697 1.713 . . . . 1.25 108.726 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.479 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.8 167.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 113.047 -1.888 . . . . 1.16 110.988 -178.372 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.58 145.6 50.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.729 -0.668 . . . . 0.78 110.127 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.3 101.61 9.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.121 -0.696 . . . . 1.08 109.121 177.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.469 HG11 ' N ' ' A' ' 131' ' ' SER . 71.1 t -112.94 139.64 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.027 -0.533 . . . . 1.1 111.068 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.469 ' N ' HG11 ' A' ' 130' ' ' VAL . 68.7 p -128.67 152.65 48.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.667 -0.697 . . . . 0.87 109.793 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.651 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.7 p90 -144.76 -164.92 2.03 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.672 -0.411 . . . . 0.37 110.636 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.738 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -124.03 127.13 73.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 1.14 110.905 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.177 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.87 58.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 1.91 110.306 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.738 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.1 24.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.004 -0.544 . . . . 1.56 111.426 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.177 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.24 128.73 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.657 -0.417 . . . . 1.56 110.954 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -86.35 -9.53 56.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.933 -0.576 . . . . 1.88 110.393 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.0 p -87.18 0.21 55.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.47 . . . . 1.63 110.264 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.96 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.26 137.16 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.001 -0.545 . . . . 1.11 109.988 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.577 ' N ' ' O ' ' A' ' 185' ' ' ILE . 0.9 OUTLIER -96.19 -15.47 22.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.294 0.569 . . . . 1.01 110.1 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.622 ' N ' HG12 ' A' ' 185' ' ' ILE . . . 178.52 175.57 45.72 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 109.814 -1.315 . . . . 0.14 109.814 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.5 151.66 42.54 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.595 -0.442 . . . . 0.21 110.465 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.673 ' NH2' ' OE1' ' A' ' 191' ' ' GLN . 58.6 ttp85 -132.42 121.2 23.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.139 -0.482 . . . . 1.54 109.943 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.497 HG23 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.15 136.57 38.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.68 -0.691 . . . . 1.08 110.648 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 81.3 tt0 -129.38 129.85 45.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.957 -0.565 . . . . 1.32 110.016 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 36.2 p90 -138.62 135.29 34.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.972 -0.558 . . . . 1.05 110.731 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.408 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.29 161.35 39.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.839 -0.619 . . . . 1.16 109.632 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.943 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.1 mt -71.09 124.84 25.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.072 0.463 . . . . 1.23 110.73 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.71 -7.79 50.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.723 -0.671 . . . . 0.86 110.881 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -109.77 -69.58 0.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 1.66 111.519 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.454 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.69 -35.46 76.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.115 -0.493 . . . . 1.66 111.435 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.085 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.21 88.62 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.797 -0.921 . . . . 1.62 110.797 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.336 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.91 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 1.86 110.224 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.336 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.31 139.07 44.97 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.247 -0.433 . . . . 1.98 110.164 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.408 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.3 Cg_endo -70.92 145.81 51.38 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 122.756 2.304 . . . . 0.62 112.363 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.91 145.74 42.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.186 -0.672 . . . . 1.14 109.186 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.764 ' CD2' ' ND2' ' A' ' 16' ' ' ASN . 35.4 p90 -123.21 141.29 52.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.164 0.507 . . . . 1.44 111.599 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.7 mt -128.03 127.72 43.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.282 -0.872 . . . . 1.08 108.987 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.493 ' OD1' ' O ' ' A' ' 159' ' ' ASP . 53.8 p-10 -101.62 131.09 48.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.207 0.527 . . . . 1.09 111.821 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.503 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -127.92 157.53 73.45 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.363 -0.835 . . . . 1.04 109.604 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.77 158.06 58.24 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.366 2.044 . . . . 0.21 112.268 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.32 -12.13 5.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.787 -0.642 . . . . 0.88 110.685 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.86 -8.71 42.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.154 -0.475 . . . . 1.06 110.679 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.39 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.354 -0.384 . . . . 1.05 110.404 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.7 p -133.15 16.7 4.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.429 -0.35 . . . . 1.07 110.52 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.56 147.12 5.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.664 -0.495 . . . . 0.92 109.664 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.503 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.18 150.41 12.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.541 -0.464 . . . . 1.09 111.572 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.34 125.0 50.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.624 -0.716 . . . . 1.31 109.794 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.524 HG21 HD21 ' A' ' 172' ' ' LEU . 1.8 mt -99.44 104.86 29.7 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 1.09 111.064 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.8 Cg_endo -90.92 -179.58 1.53 Allowed 'Trans proline' 0 C--N 1.302 -1.895 0 C-N-CA 123.184 2.59 . . . . 0.48 112.219 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 61.77 32.65 18.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.382 -0.826 . . . . 1.26 111.37 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.524 HD21 HG21 ' A' ' 169' ' ' ILE . 24.0 mt -86.38 148.49 25.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.784 0.326 . . . . 1.12 110.498 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.776 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.33 114.84 61.29 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.989 0.423 . . . . 1.3 110.6 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.01 140.57 95.96 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.835 2.356 . . . . 0.92 111.994 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.31 74.08 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.0 -0.84 . . . . 0.44 111.0 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.454 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.8 mmm-85 -126.94 150.24 49.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 3.05 110.604 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.18 131.7 45.97 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.052 -0.522 . . . . 1.48 109.81 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.943 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.7 m-85 -120.57 148.34 44.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.052 -0.522 . . . . 0.89 111.013 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.35 125.33 60.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.262 -1.014 . . . . 1.12 108.262 177.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.6 132.59 63.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.139 0.495 . . . . 1.1 111.206 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.5 122.47 20.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.483 -0.78 . . . . 0.43 109.666 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.595 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.04 125.39 54.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.382 -0.372 . . . . 1.07 110.586 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.672 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.8 m-85 -117.24 137.86 52.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.973 -0.558 . . . . 0.92 109.918 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.573 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.63 135.02 42.73 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.829 -0.804 . . . . 0.49 108.829 178.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.622 HG12 ' N ' ' A' ' 141' ' ' GLY . 0.8 OUTLIER -99.03 123.0 51.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.156 0.503 . . . . 1.08 110.934 -178.828 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.444 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.9 p -83.98 169.71 14.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.566 -0.743 . . . . 0.89 110.411 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.637 ' C ' ' HG1' ' A' ' 59' ' ' THR . 82.2 tt0 -59.62 -14.67 14.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.036 -0.529 . . . . 1.6 110.964 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.652 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 87.8 m-20 -96.0 -4.38 43.28 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.862 -0.335 . . . . 1.18 110.83 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.85 13.79 64.07 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.376 -0.69 . . . . 0.34 111.376 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -84.53 139.05 32.41 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.096 -0.241 . . . . 1.22 110.569 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.673 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 88.9 mt-30 -106.73 140.97 38.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.48 -0.327 . . . . 1.44 110.623 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.67 127.03 26.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.171 -0.468 . . . . 1.39 110.407 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.672 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.5 tp -68.23 117.33 9.89 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.717 -0.393 . . . . 1.08 110.508 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.651 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.0 pt -108.94 -21.9 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 1.08 110.752 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.87 125.75 5.88 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.509 -0.476 . . . . 1.1 111.486 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.493 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.78 120.2 21.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.701 -0.681 . . . . 0.94 109.586 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.64 151.66 29.06 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.621 -0.432 . . . . 1.07 110.904 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.41 158.57 18.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.02 -0.536 . . . . 0.89 110.417 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -146.08 157.88 43.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.089 -0.505 . . . . 0.67 110.725 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.25 104.49 9.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.772 -0.649 . . . . 1.17 110.022 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.607 ' HB ' ' HB2' ' A' ' 126' ' ' SER . 68.0 p . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.842 -1.075 . . . . 1.26 110.588 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.55 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.142 -0.688 . . . . 3.83 109.142 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.426 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.37 150.75 18.53 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.925 -0.87 . . . . 1.39 110.925 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -35.74 142.42 0.1 Allowed 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 123.902 3.068 . . . . 0.86 113.857 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.566 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.3 t -79.96 173.34 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.254 -1.339 . . . . 1.43 108.825 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -105.57 125.89 51.5 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.412 -0.515 . . . . 1.94 111.422 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.52 144.08 33.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.618 -0.719 . . . . 1.19 110.599 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.08 168.19 26.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.875 0.369 . . . . 3.92 111.127 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.591 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.93 131.19 60.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.964 -0.562 . . . . 3.88 110.124 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.21 162.36 35.67 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.806 0.336 . . . . 3.92 111.208 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.7 mt-10 35.94 31.76 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.592 -0.521 . . . . 6.08 109.592 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.591 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.54 69.58 33.63 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.959 -0.564 . . . . 4.01 111.587 -178.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.29 -29.13 72.68 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.532 2.154 . . . . 4.51 111.865 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 3.51 110.532 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.717 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -124.0 158.38 60.51 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.352 -0.385 . . . . 4.3 110.347 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.563 ' CG ' ' NH2' ' A' ' 143' ' ' ARG . 97.0 Cg_endo -82.02 -64.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.877 2.385 . . . . 1.96 113.547 -179.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.69 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 63.2 t30 -108.4 -19.62 13.4 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.11 0.411 . . . . 3.33 112.11 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.717 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 27.6 t -107.37 152.07 24.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.184 0.516 . . . . 1.53 111.285 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.22 102.97 2.24 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.722 -0.672 . . . . 2.29 110.606 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.7 Cg_endo -82.81 145.69 12.83 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.888 2.392 . . . . 0.88 112.557 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.415 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.82 167.84 25.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.876 -0.602 . . . . 2.12 109.858 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.06 147.91 29.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.796 -0.446 . . . . 2.67 109.796 178.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.496 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.6 p90 -142.21 157.25 45.07 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.686 -0.406 . . . . 0.32 111.177 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.468 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.1 155.3 44.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.873 -0.603 . . . . 2.77 110.102 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.63 173.01 6.39 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.156 0.503 . . . . 1.25 110.696 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.62 173.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.892 2.394 . . . . 1.12 111.481 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.48 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.1 -51.07 0.68 Allowed Pre-proline 0 C--N 1.33 -0.265 0 C-N-CA 120.686 -0.406 . . . . 4.05 110.085 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.657 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.81 152.39 82.28 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.729 2.286 . . . . 2.12 111.44 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.77 42.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.399 0.618 . . . . 2.85 110.522 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.823 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.55 -41.74 98.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.002 -0.999 . . . . 3.11 110.651 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.435 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.1 mt -109.77 137.88 39.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.814 -0.63 . . . . 1.86 111.293 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.97 -72.87 0.7 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.008 -0.542 . . . . 1.61 111.97 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.19 148.47 24.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.532 0.567 . . . . 1.67 112.532 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -121.87 124.81 44.99 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.397 -0.594 . . . . 1.07 109.397 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.4 mt -117.97 134.8 60.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.616 -0.434 . . . . 1.55 110.604 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.484 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -120.05 128.6 53.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.983 0.42 . . . . 1.33 111.207 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.18 139.02 49.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.772 -0.649 . . . . 2.36 110.102 178.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.42 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.05 163.19 35.01 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 121.133 0.492 . . . . 0.38 112.066 -178.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.49 139.53 7.82 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.434 -0.803 . . . . 2.31 110.416 178.85 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 41' ' ' ASN . 18.0 Cg_endo -63.43 115.41 3.0 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.351 2.034 . . . . 0.86 111.847 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.668 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.99 81.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.866 -0.42 . . . . 3.44 109.866 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.688 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.24 -20.66 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.968 -0.56 . . . . 2.72 111.923 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.65 157.79 34.26 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.835 -0.346 . . . . 2.78 110.559 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.38 27.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 2.3 110.163 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.84 -75.88 1.31 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.118 -0.563 . . . . 1.8 111.867 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.87 152.29 35.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.973 0.416 . . . . 5.48 111.0 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.15 -169.02 2.51 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.061 -0.518 . . . . 1.84 111.981 179.335 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.19 149.71 29.72 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.482 0.658 . . . . 2.27 112.533 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.07 156.51 45.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.791 -1.095 . . . . 1.92 110.213 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.21 158.4 41.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.976 -0.557 . . . . 1.09 111.802 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.3 m -115.15 135.63 53.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.435 -0.802 . . . . 1.16 109.906 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.445 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.4 122.06 23.79 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.512 -0.313 . . . . 1.39 111.523 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.516 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.0 Cg_exo -46.46 151.74 1.73 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.689 2.259 . . . . 0.72 112.077 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.87 -23.09 63.03 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 116.065 -0.516 . . . . 0.74 112.805 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.516 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.75 -16.83 46.44 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.225 -0.59 . . . . 1.26 111.821 -178.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.484 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.6 mt -91.67 138.43 31.57 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.807 -0.357 . . . . 1.59 110.232 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.48 13.81 11.02 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.277 -0.42 . . . . 2.07 111.482 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.4 p -149.92 143.48 25.29 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.631 -0.428 . . . . 0.96 111.058 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.81 -169.29 1.52 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.209 0.528 . . . . 1.0 110.851 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.723 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 0.6 OUTLIER -151.84 125.91 9.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.433 -0.803 . . . . 1.19 109.765 179.281 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.419 HG23 HD11 ' A' ' 60' ' ' ILE . 66.3 mt -114.81 123.25 70.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.435 -0.506 . . . . 1.47 111.219 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.496 ' HB3' ' CD1' ' A' ' 185' ' ' ILE . 25.7 pttm -126.48 163.43 23.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.888 -0.596 . . . . 3.0 110.497 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.479 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.02 19.08 59.87 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.781 -0.928 . . . . 0.5 110.781 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.69 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.8 mt -79.1 157.3 28.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.09 0.472 . . . . 1.21 111.311 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.654 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 4.0 mttt -99.58 133.96 21.48 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.616 -0.72 . . . . 3.2 110.434 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.425 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.94 143.6 61.15 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.539 2.16 . . . . 1.09 111.936 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.84 25.58 75.39 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.091 -0.803 . . . . 0.72 111.091 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.637 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.17 158.84 39.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.715 0.293 . . . . 1.47 110.415 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.23 139.96 42.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.913 0.387 . . . . 1.23 110.56 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.654 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.9 m-85 -122.59 136.46 54.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.967 -0.56 . . . . 1.1 110.778 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.82 131.05 45.23 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.491 -0.929 . . . . 1.87 108.491 177.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.58 153.92 16.67 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.214 -0.993 . . . . 0.39 111.933 -178.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.03 140.9 45.99 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.698 -0.482 . . . . 1.8 109.698 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.462 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.1 tp -115.75 118.91 34.36 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.426 -0.51 . . . . 1.11 110.462 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.2 mt -112.41 129.15 68.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 1.51 110.608 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.82 120.86 43.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.242 -0.435 . . . . 1.47 110.747 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.669 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.58 146.46 11.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.169 0.509 . . . . 1.33 111.022 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.823 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.01 153.92 21.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.519 -0.764 . . . . 2.49 109.888 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.19 88.52 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.937 0.399 . . . . 4.2 110.428 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.41 32.53 0.22 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.841 -0.618 . . . . 6.4 110.53 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.04 -117.34 3.29 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.472 -0.651 . . . . 1.74 111.472 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.445 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.4 177.37 9.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.218 0.532 . . . . 3.64 111.643 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.2 149.5 32.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.435 -0.802 . . . . 1.7 110.385 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.55 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.21 144.7 38.61 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.432 -0.349 . . . . 2.7 110.511 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -127.98 135.93 61.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-O 121.087 0.47 . . . . 1.16 111.508 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.03 141.52 51.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.59 -0.732 . . . . 1.14 110.192 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.448 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.66 138.93 51.65 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.482 -0.487 . . . . 4.33 111.481 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.489 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.29 164.23 37.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.582 -0.736 . . . . 0.91 109.399 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.574 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 46.9 p30 -145.29 151.51 38.45 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.434 -0.506 . . . . 1.47 111.064 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.572 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.2 p90 -146.2 172.72 13.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.768 -0.651 . . . . 0.51 111.005 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.454 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.78 160.76 21.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.442 -0.799 . . . . 1.92 109.807 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.454 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.5 121.86 22.79 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.565 -0.454 . . . . 1.63 110.722 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.587 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.0 p -127.02 161.87 27.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.222 0.534 . . . . 2.37 111.864 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 115.516 -0.766 . . . . 3.63 110.531 179.368 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.461 0.121 0 CA-C-O 120.925 0.393 . . . . 1.25 110.311 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.478 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.68 167.5 0.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.883 -0.599 . . . . 1.16 110.949 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.56 145.53 50.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.685 -0.688 . . . . 0.78 110.197 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.23 101.62 9.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.106 -0.702 . . . . 1.08 109.106 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.467 HG11 ' N ' ' A' ' 131' ' ' SER . 72.1 t -112.94 139.67 36.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.071 -0.513 . . . . 1.1 111.103 -178.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.467 ' N ' HG11 ' A' ' 130' ' ' VAL . 68.0 p -128.76 152.59 48.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.677 -0.692 . . . . 0.87 109.846 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.645 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.7 p90 -144.81 -164.91 2.03 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.688 -0.405 . . . . 0.37 110.675 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -123.97 127.19 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 1.14 110.784 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.174 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -58.0 58.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.188 -0.46 . . . . 1.91 110.349 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.21 24.62 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.857 -0.611 . . . . 1.56 111.485 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.174 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.11 128.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.626 -0.43 . . . . 1.56 110.923 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.47 -9.62 55.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.837 -0.62 . . . . 1.88 110.329 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 29.0 p -86.96 0.13 55.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.061 -0.518 . . . . 1.63 110.391 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.963 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.23 137.3 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.96 -0.564 . . . . 1.11 109.989 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.575 ' N ' ' O ' ' A' ' 185' ' ' ILE . 7.1 p -96.33 -15.56 21.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.37 0.605 . . . . 1.01 110.029 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.589 ' H ' HG21 ' A' ' 185' ' ' ILE . . . 178.58 175.53 45.74 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 109.809 -1.316 . . . . 0.14 109.809 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -123.42 151.52 42.55 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.63 -0.428 . . . . 0.21 110.492 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.847 ' NH2' HE22 ' A' ' 191' ' ' GLN . 8.7 tmm_? -132.29 121.16 23.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.126 -0.488 . . . . 1.54 109.956 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.493 HG23 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.05 136.62 38.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.632 -0.713 . . . . 1.08 110.621 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 75.9 tt0 -129.39 129.89 45.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.95 -0.568 . . . . 1.32 110.043 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.7 p90 -138.75 135.27 34.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.034 -0.53 . . . . 1.05 110.673 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.408 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.36 39.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.694 -0.685 . . . . 1.16 109.697 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.94 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.4 mt -70.97 124.79 25.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.992 0.425 . . . . 1.23 110.718 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.76 -7.64 49.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.768 -0.651 . . . . 0.86 110.989 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.8 -69.72 0.85 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.264 -0.426 . . . . 1.66 111.387 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.445 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.3 mt-10 -60.8 -35.25 75.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 1.66 111.459 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.09 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.26 7.12 88.68 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.829 -0.908 . . . . 1.62 110.829 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.336 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.3 t0 -27.98 -171.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.801 0.334 . . . . 1.86 110.322 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.336 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.25 139.11 45.19 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-O 120.979 0.419 . . . . 1.98 110.238 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.408 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.0 Cg_endo -70.85 145.76 51.69 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 122.77 2.313 . . . . 0.62 112.325 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.82 145.69 42.62 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.25 -0.648 . . . . 1.14 109.25 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.646 ' CE2' ' CG ' ' A' ' 16' ' ' ASN . 25.0 p90 -123.24 141.38 52.04 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.348 -0.541 . . . . 1.44 111.532 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.413 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.9 mt -128.18 127.69 43.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.275 -0.875 . . . . 1.08 108.953 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.53 ' HB2' HD22 ' A' ' 16' ' ' ASN . 33.2 t0 -101.61 131.2 47.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.19 0.519 . . . . 1.09 111.779 -178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.504 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -128.0 157.52 73.65 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.348 -0.842 . . . . 1.04 109.585 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -69.87 157.95 58.45 Favored 'Trans proline' 0 C--N 1.302 -1.904 0 C-N-CA 122.49 2.126 . . . . 0.21 112.23 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.4 p -59.14 -12.19 4.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.743 -0.662 . . . . 0.88 110.817 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.1 p -92.79 -8.76 42.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 1.06 110.73 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.09 135.37 34.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.325 -0.398 . . . . 1.05 110.481 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.19 16.69 4.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.452 -0.34 . . . . 1.07 110.514 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.4 p -167.51 147.16 5.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.609 -0.515 . . . . 0.92 109.609 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.504 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.21 150.5 12.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.489 -0.484 . . . . 1.09 111.503 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.5 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 4.0 t-20 -106.35 124.98 50.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.585 -0.734 . . . . 1.31 109.81 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.524 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.36 104.92 29.83 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 1.09 111.081 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.1 Cg_endo -90.97 -179.51 1.5 Allowed 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 123.231 2.621 . . . . 0.48 112.204 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.69 32.63 18.35 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.385 -0.825 . . . . 1.26 111.411 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.524 HD21 HG21 ' A' ' 169' ' ' ILE . 23.9 mt -86.39 148.51 25.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.448 -0.342 . . . . 1.12 110.489 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.771 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.5 mt -88.23 114.91 61.52 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.029 0.442 . . . . 1.3 110.686 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.01 140.53 95.77 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.897 2.398 . . . . 0.92 111.992 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.16 21.14 74.23 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.032 -0.827 . . . . 0.44 111.032 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.445 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.83 150.14 49.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.768 0.318 . . . . 3.05 110.73 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.5 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.27 131.78 46.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.139 -0.482 . . . . 1.48 109.757 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.94 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.57 148.28 44.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.031 -0.532 . . . . 0.89 110.99 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.2 mt -105.32 125.4 60.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.222 -1.029 . . . . 1.12 108.222 177.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.58 132.56 63.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.205 0.526 . . . . 1.1 111.216 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.64 20.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.575 -0.739 . . . . 0.43 109.617 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.593 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.05 125.32 55.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.269 -0.423 . . . . 1.07 110.657 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.673 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.9 m-85 -117.21 137.94 52.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.031 -0.531 . . . . 0.92 109.835 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.74 135.07 42.76 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.785 -0.82 . . . . 0.49 108.785 178.863 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.589 HG21 ' H ' ' A' ' 141' ' ' GLY . 11.7 tt -99.15 123.01 51.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.167 0.508 . . . . 1.08 110.873 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.585 ' OG ' ' OD1' ' A' ' 188' ' ' ASP . 88.6 p -83.98 169.77 14.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.516 -0.766 . . . . 0.89 110.485 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -59.8 -14.5 15.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.095 -0.502 . . . . 1.6 110.897 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.671 ' OD1' ' N ' ' A' ' 190' ' ' GLU . 37.0 p30 -96.17 -4.2 43.01 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.782 -0.367 . . . . 1.18 110.731 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.463 ' N ' ' HB ' ' A' ' 59' ' ' THR . . . 87.82 13.85 64.03 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.377 -0.689 . . . . 0.34 111.377 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.671 ' N ' ' OD1' ' A' ' 188' ' ' ASP . 82.2 tt0 -84.67 139.0 32.34 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.04 -0.264 . . . . 1.22 110.472 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.847 HE22 ' NH2' ' A' ' 143' ' ' ARG . 90.3 mt-30 -106.72 141.11 38.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.873 0.368 . . . . 1.44 110.523 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 61.8 m -136.72 127.07 26.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.078 -0.51 . . . . 1.39 110.276 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.673 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.4 tp -68.14 117.21 9.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.284 -0.416 . . . . 1.08 110.554 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.645 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.0 pt -108.99 -21.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 1.08 110.795 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.84 125.68 5.88 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.519 -0.472 . . . . 1.1 111.465 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.492 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.71 120.3 21.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.799 -0.637 . . . . 0.94 109.585 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.66 151.74 29.13 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.667 -0.413 . . . . 1.07 110.916 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.47 158.57 18.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.015 -0.538 . . . . 0.89 110.41 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.1 157.86 43.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.123 -0.49 . . . . 0.67 110.696 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.26 104.28 9.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.78 -0.646 . . . . 1.17 110.096 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.482 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.0 p . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 117.845 -1.074 . . . . 1.26 110.655 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.224 -0.658 . . . . 3.83 109.224 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.39 150.62 18.55 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.012 -0.835 . . . . 1.39 111.012 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -35.62 142.35 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.05 0 C-N-CA 124.022 3.148 . . . . 0.86 113.828 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.568 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.0 t -79.91 173.3 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.283 -1.326 . . . . 1.43 108.891 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -105.49 125.86 51.47 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.479 -0.488 . . . . 1.94 111.482 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 143.99 33.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.665 -0.698 . . . . 1.19 110.689 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.94 168.23 25.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.922 0.391 . . . . 3.92 111.101 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.59 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.94 131.06 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.004 -0.544 . . . . 3.88 110.079 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.17 162.27 35.88 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.836 0.35 . . . . 3.92 111.239 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.6 mt-10 36.18 31.5 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.648 -0.501 . . . . 6.08 109.648 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.59 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.63 32.6 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.97 -0.559 . . . . 4.01 111.574 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.2 Cg_endo -63.16 -29.18 73.92 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.484 2.123 . . . . 4.51 111.888 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 3.51 110.518 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.619 ' NE2' ' O ' ' A' ' 13' ' ' SER . 6.0 mp0 -123.98 158.29 60.74 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 4.3 110.368 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.524 ' HA ' ' HG ' ' A' ' 93' ' ' SER . 97.5 Cg_endo -81.98 -64.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.958 2.439 . . . . 1.96 113.431 -179.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.933 HD22 ' HB2' ' A' ' 157' ' ' TYR . 5.7 m-20 -108.48 -19.53 13.42 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.07 0.396 . . . . 3.33 112.07 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 60.3 m -107.36 152.0 24.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.159 0.504 . . . . 1.53 111.258 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.4 t-80 -155.26 102.97 2.23 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.623 -0.717 . . . . 2.29 110.618 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.597 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.5 Cg_endo -82.7 145.63 12.99 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.885 2.39 . . . . 0.88 112.601 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.416 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.8 167.96 24.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.815 -0.63 . . . . 2.12 109.909 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.16 147.98 29.09 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.712 -0.477 . . . . 2.67 109.712 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.494 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.6 p90 -142.28 157.23 45.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.026 0.441 . . . . 0.32 111.165 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.47 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.06 155.23 44.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.752 -0.658 . . . . 2.77 110.116 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.55 173.05 6.34 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 121.091 0.472 . . . . 1.25 110.748 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.65 173.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.851 2.367 . . . . 1.12 111.502 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.484 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.06 -51.12 0.69 Allowed Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.643 -0.423 . . . . 4.05 110.08 179.819 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.658 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.76 152.31 82.49 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.796 2.33 . . . . 2.12 111.416 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.66 42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.35 0.595 . . . . 2.85 110.607 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.822 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.52 -41.63 98.5 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.017 -0.992 . . . . 3.11 110.68 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.439 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.2 mt -109.86 137.79 40.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.818 -0.628 . . . . 1.86 111.287 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.88 -72.83 0.71 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.013 -0.539 . . . . 1.61 111.986 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.21 148.43 24.38 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.517 0.562 . . . . 1.67 112.517 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.86 124.86 45.12 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.312 -0.625 . . . . 1.07 109.312 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.04 134.78 60.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.614 -0.434 . . . . 1.55 110.689 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.482 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -120.02 128.63 53.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 1.33 111.246 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.541 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.96 49.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.751 -0.659 . . . . 2.36 110.178 178.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.42 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.07 163.17 35.09 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.16 0.505 . . . . 0.38 112.128 -178.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.47 139.54 7.84 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.468 -0.787 . . . . 2.31 110.468 178.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.695 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.57 115.52 3.09 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.313 2.009 . . . . 0.86 111.791 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.674 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.01 81.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.885 -0.413 . . . . 3.44 109.885 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.695 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.51 0.06 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.987 -0.551 . . . . 2.72 111.889 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.8 p -157.72 157.69 33.96 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.82 0.343 . . . . 2.78 110.552 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.34 27.89 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 2.3 110.194 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.81 -75.96 1.31 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.2 -0.524 . . . . 1.8 111.81 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.79 152.29 35.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.824 0.345 . . . . 5.48 111.042 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.24 -169.11 2.52 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.107 -0.497 . . . . 1.84 111.884 179.334 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.67 29.73 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.524 0.678 . . . . 2.27 112.514 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.05 156.46 46.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.689 -1.141 . . . . 1.92 110.263 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.16 158.34 41.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.91 -0.586 . . . . 1.09 111.818 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.1 m -115.08 135.61 54.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.505 -0.77 . . . . 1.16 109.86 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.449 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.36 121.95 23.82 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.439 -0.346 . . . . 1.39 111.55 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.511 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.0 Cg_exo -46.37 151.79 1.64 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.653 2.235 . . . . 0.72 112.116 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.98 -23.01 63.19 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 116.052 -0.522 . . . . 0.74 112.763 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.511 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.1 p-80 -82.8 -16.84 46.26 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.216 -0.594 . . . . 1.26 111.861 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.485 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.66 138.51 31.5 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.657 -0.417 . . . . 1.59 110.281 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.55 13.94 10.98 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.314 -0.403 . . . . 2.07 111.568 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.01 143.35 25.12 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.611 -0.436 . . . . 0.96 111.068 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.722 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.63 -169.29 1.51 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.188 0.518 . . . . 1.0 110.941 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.722 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.3 t -151.8 125.97 9.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.416 -0.811 . . . . 1.19 109.808 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.472 HG23 HD11 ' A' ' 60' ' ' ILE . 66.6 mt -114.93 123.2 70.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.404 -0.518 . . . . 1.47 111.217 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -126.47 163.39 23.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.829 -0.623 . . . . 3.0 110.426 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.19 18.97 59.79 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.705 -0.958 . . . . 0.5 110.705 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.439 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.9 mt -79.1 157.14 28.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.093 0.473 . . . . 1.21 111.324 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.653 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 3.0 mtpp -99.39 133.97 21.57 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 3.2 110.463 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.89 143.58 61.36 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.586 2.191 . . . . 1.09 111.963 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.87 25.58 75.4 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.023 -0.831 . . . . 0.72 111.023 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.639 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.15 158.74 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.706 0.288 . . . . 1.47 110.466 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.13 139.93 42.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.883 0.373 . . . . 1.23 110.602 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.653 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.3 m-85 -122.49 136.48 54.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.55 . . . . 1.1 110.775 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.98 130.98 45.36 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.539 -0.911 . . . . 1.87 108.539 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.43 153.91 16.63 Favored Glycine 0 C--O 1.227 -0.344 0 C-N-CA 120.299 -0.953 . . . . 0.39 111.962 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.97 140.91 46.07 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.73 -0.47 . . . . 1.8 109.73 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.465 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.7 tp -115.73 118.95 34.48 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.456 -0.498 . . . . 1.11 110.533 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.9 mt -112.42 129.05 68.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.323 -0.399 . . . . 1.51 110.628 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.9 120.8 43.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.287 -0.415 . . . . 1.47 110.713 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.665 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.53 146.46 11.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.231 0.538 . . . . 1.33 111.058 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.822 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.03 153.94 21.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.495 -0.775 . . . . 2.49 109.949 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.2 mt-30 -39.21 88.6 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.895 0.379 . . . . 4.2 110.446 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.24 32.62 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.822 -0.626 . . . . 6.4 110.598 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.08 -117.33 3.29 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.457 -0.657 . . . . 1.74 111.457 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.442 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.51 177.42 8.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.197 0.522 . . . . 3.64 111.6 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.16 149.44 31.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.451 -0.795 . . . . 1.7 110.451 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.14 144.65 38.73 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.479 -0.328 . . . . 2.7 110.533 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.5 p -128.01 135.99 61.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-O 121.036 0.446 . . . . 1.16 111.555 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.05 141.32 52.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.662 -0.699 . . . . 1.14 110.304 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.443 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.63 138.82 51.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.053 0.454 . . . . 4.33 111.577 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.491 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.25 164.21 37.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.548 -0.751 . . . . 0.91 109.435 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.57 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.28 151.47 38.4 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.399 -0.52 . . . . 1.47 111.058 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.575 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.2 p90 -146.18 172.66 13.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.802 -0.636 . . . . 0.51 111.039 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.451 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.6 160.71 21.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.456 -0.793 . . . . 1.92 109.897 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.451 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.43 121.81 22.8 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.591 -0.444 . . . . 1.63 110.778 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.494 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -127.64 163.88 23.28 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 114.03 1.122 . . . . 2.37 114.03 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.524 ' HG ' ' HA ' ' A' ' 15' ' ' PRO . 55.2 m . . . . . 0 C--O 1.232 0.183 0 CA-C-N 113.55 -1.659 . . . . 3.63 108.815 177.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.5 p . . . . . 0 CA--C 1.521 -0.138 0 CA-C-O 121.139 0.495 . . . . 1.25 110.365 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.48 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.86 167.59 0.25 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.602 -0.726 . . . . 1.16 110.955 -179.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.62 145.48 50.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.731 -0.668 . . . . 0.78 110.156 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.16 101.64 9.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.095 -0.706 . . . . 1.08 109.095 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.471 HG11 ' N ' ' A' ' 131' ' ' SER . 71.1 t -112.92 139.78 36.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.056 -0.52 . . . . 1.1 110.95 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.471 ' N ' HG11 ' A' ' 130' ' ' VAL . 66.9 p -128.74 152.57 48.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.598 -0.728 . . . . 0.87 109.792 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.652 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.7 p90 -144.8 -164.87 2.02 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.741 -0.384 . . . . 0.37 110.667 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.5 t -123.98 127.12 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 1.14 110.823 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.176 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.87 58.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.126 -0.488 . . . . 1.91 110.368 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -37.95 24.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.934 -0.575 . . . . 1.56 111.579 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.176 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.23 128.68 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.659 -0.417 . . . . 1.56 110.96 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.42 -9.53 56.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.0 -0.545 . . . . 1.88 110.32 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.8 p -87.16 0.25 55.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 1.63 110.29 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.961 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.26 137.26 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.994 -0.548 . . . . 1.11 109.956 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.571 ' N ' ' O ' ' A' ' 185' ' ' ILE . 90.3 p -96.29 -15.5 21.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.27 0.557 . . . . 1.01 110.048 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.58 175.57 45.77 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 109.88 -1.288 . . . . 0.14 109.88 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.47 151.62 42.54 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.569 -0.452 . . . . 0.21 110.496 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.787 HH22 ' NE2' ' A' ' 191' ' ' GLN . 41.8 ttp180 -132.26 121.14 23.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.15 -0.477 . . . . 1.54 109.924 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.494 HG23 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.14 136.63 38.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.734 -0.666 . . . . 1.08 110.649 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 99.2 mt-10 -129.45 129.86 45.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.942 -0.572 . . . . 1.32 110.044 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.601 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.7 p90 -138.68 135.35 34.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.046 -0.525 . . . . 1.05 110.611 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.404 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.41 161.36 39.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.793 -0.64 . . . . 1.16 109.621 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.943 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -71.05 124.99 25.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.036 0.446 . . . . 1.23 110.694 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.497 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.7 p -71.94 -7.7 50.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.766 -0.652 . . . . 0.86 110.797 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -109.72 -69.67 0.85 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.967 0.413 . . . . 1.66 111.455 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.451 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.71 -35.28 75.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.998 -0.546 . . . . 1.66 111.522 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.081 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.11 7.23 88.59 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.825 -0.91 . . . . 1.62 110.825 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.34 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.83 -171.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.324 . . . . 1.86 110.256 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.34 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.26 139.02 45.14 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-O 120.945 0.402 . . . . 1.98 110.205 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.404 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.9 Cg_endo -70.75 145.73 52.2 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 122.808 2.339 . . . . 0.62 112.361 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.86 145.69 42.65 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.312 -0.625 . . . . 1.14 109.312 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.933 ' HB2' HD22 ' A' ' 16' ' ' ASN . 0.2 OUTLIER -123.26 141.32 52.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.31 0.576 . . . . 1.44 111.421 -178.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.408 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.9 mt -128.14 127.61 43.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.271 -0.877 . . . . 1.08 108.921 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 159' ' ' ASP . 51.4 p-10 -101.61 131.21 47.94 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.194 0.521 . . . . 1.09 111.731 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.505 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -128.02 157.58 73.5 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.237 -0.892 . . . . 1.04 109.493 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.81 158.02 58.33 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.435 2.09 . . . . 0.21 112.267 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.36 -12.11 5.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.792 -0.64 . . . . 0.88 110.708 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.7 p -92.82 -8.67 42.9 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.129 -0.487 . . . . 1.06 110.715 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.38 34.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.319 -0.4 . . . . 1.05 110.394 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.12 16.53 4.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.398 -0.365 . . . . 1.07 110.558 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.4 p -167.45 147.23 5.18 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.661 -0.496 . . . . 0.92 109.661 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.505 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.32 150.42 12.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.565 -0.454 . . . . 1.09 111.602 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.496 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.26 124.94 50.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.559 -0.746 . . . . 1.31 109.843 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.525 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.45 104.86 29.72 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.918 0.389 . . . . 1.09 111.098 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 84.4 Cg_endo -91.05 -179.42 1.47 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 123.132 2.555 . . . . 0.48 112.163 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.56 32.73 18.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.366 -0.834 . . . . 1.26 111.419 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.525 HD21 HG21 ' A' ' 169' ' ' ILE . 24.1 mt -86.37 148.52 25.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.454 -0.339 . . . . 1.12 110.454 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.776 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.31 114.88 61.44 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.018 0.437 . . . . 1.3 110.64 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -58.98 140.62 96.14 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.815 2.343 . . . . 0.92 112.051 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.16 74.4 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.088 -0.805 . . . . 0.44 111.088 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.451 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.86 150.21 49.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.313 . . . . 3.05 110.634 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.497 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.13 131.63 45.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.519 . . . . 1.48 109.789 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.943 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.55 148.38 43.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.066 -0.515 . . . . 0.89 110.995 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.4 125.28 60.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.363 -0.977 . . . . 1.12 108.363 177.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.47 132.51 63.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.149 0.5 . . . . 1.1 111.217 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.49 122.66 20.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.54 -0.755 . . . . 0.43 109.729 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.594 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.09 125.37 55.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.284 -0.417 . . . . 1.07 110.664 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.672 ' CE1' HD11 ' A' ' 193' ' ' LEU . 49.1 m-85 -117.18 138.04 51.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.978 -0.555 . . . . 0.92 109.875 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.571 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.81 134.97 43.0 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.77 -0.826 . . . . 0.49 108.77 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.571 ' O ' ' N ' ' A' ' 140' ' ' SER . 85.4 mt -99.09 122.93 51.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.145 0.498 . . . . 1.08 110.961 -178.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.447 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.2 p -83.89 169.65 14.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.526 -0.761 . . . . 0.89 110.447 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.63 ' O ' ' CG2' ' A' ' 59' ' ' THR . 51.5 tp10 -59.79 -14.39 14.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.034 -0.53 . . . . 1.6 110.982 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.597 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.1 m-20 -96.18 -4.24 42.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.857 0.361 . . . . 1.18 110.817 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.8 13.88 64.0 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.384 -0.687 . . . . 0.34 111.384 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.5 tp10 -84.7 139.09 32.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.712 0.292 . . . . 1.22 110.422 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.787 ' NE2' HH22 ' A' ' 143' ' ' ARG . 6.9 pt20 -106.71 141.03 38.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.405 -0.362 . . . . 1.44 110.602 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.4 m -136.72 127.06 26.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 1.39 110.301 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.672 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.5 tp -68.19 117.27 9.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.244 -0.434 . . . . 1.08 110.577 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.652 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.1 pt -108.97 -21.86 5.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 1.08 110.711 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.83 125.72 5.9 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.551 -0.46 . . . . 1.1 111.535 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.495 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.79 120.12 21.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.854 -0.612 . . . . 0.94 109.603 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.58 151.66 29.11 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.676 -0.409 . . . . 1.07 110.97 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.49 158.66 18.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.89 110.411 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.14 157.87 43.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.043 -0.526 . . . . 0.67 110.627 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.2 104.31 9.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.722 -0.672 . . . . 1.17 110.119 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.483 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 66.7 p . . . . . 0 C--O 1.221 -0.414 0 CA-C-O 117.902 -1.047 . . . . 1.26 110.666 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.4 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.267 -0.642 . . . . 3.83 109.267 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.425 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.39 150.72 18.53 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.006 -0.838 . . . . 1.39 111.006 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -35.61 142.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 124.007 3.138 . . . . 0.86 113.789 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.567 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.3 t -80.04 173.39 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.288 -1.324 . . . . 1.43 108.745 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.66 125.86 51.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.398 -0.521 . . . . 1.94 111.444 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.48 144.06 33.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.564 -0.744 . . . . 1.19 110.631 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.09 168.33 25.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.944 0.402 . . . . 3.92 111.127 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.59 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -108.99 131.06 60.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.972 -0.558 . . . . 3.88 110.116 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.2 p -141.14 162.25 35.93 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.875 0.369 . . . . 3.92 111.24 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 75.0 mm-40 36.1 31.61 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.633 -0.506 . . . . 6.08 109.633 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.59 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.55 69.69 33.96 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.952 -0.567 . . . . 4.01 111.618 -178.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.34 -29.07 72.2 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.498 2.132 . . . . 4.51 111.851 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.64 125.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.098 -0.501 . . . . 3.51 110.477 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.82 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -123.99 158.31 60.71 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 4.3 110.437 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 97.1 Cg_endo -81.95 -64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.858 2.372 . . . . 1.96 113.553 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.7 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 52.1 t30 -108.48 -19.55 13.41 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.119 0.414 . . . . 3.33 112.119 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.82 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 47.1 m -107.31 152.05 24.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.136 0.493 . . . . 1.53 111.281 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.569 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.5 t-80 -155.32 102.86 2.22 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.72 -0.673 . . . . 2.29 110.682 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.6 145.72 13.17 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.875 2.383 . . . . 0.88 112.627 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.415 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.88 167.98 24.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.896 -0.593 . . . . 2.12 109.879 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.15 148.03 29.15 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.786 -0.45 . . . . 2.67 109.786 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.495 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.8 p90 -142.32 157.3 44.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.936 0.398 . . . . 0.32 111.303 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.467 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.07 155.34 44.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.841 -0.618 . . . . 2.77 110.092 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.67 173.08 6.31 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 121.122 0.487 . . . . 1.25 110.76 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.74 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.841 2.361 . . . . 1.12 111.512 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.48 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.14 -50.97 0.69 Allowed Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.62 -0.432 . . . . 4.05 110.133 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.656 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.85 152.4 82.32 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.678 2.252 . . . . 2.12 111.559 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.75 42.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.401 0.62 . . . . 2.85 110.528 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.822 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.63 -41.63 98.24 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.008 -0.996 . . . . 3.11 110.616 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.438 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.9 mt -109.79 137.86 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.84 -0.618 . . . . 1.86 111.227 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.0 -72.84 0.71 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.042 -0.526 . . . . 1.61 111.937 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.29 148.38 24.34 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.549 0.574 . . . . 1.67 112.549 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.82 124.89 45.23 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.345 -0.613 . . . . 1.07 109.345 177.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.4 mt -118.06 134.75 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.608 -0.437 . . . . 1.55 110.616 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.486 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -119.98 128.66 53.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.996 0.427 . . . . 1.33 111.245 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.93 49.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.79 -0.641 . . . . 2.36 110.213 178.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.418 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -144.98 163.17 35.01 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.118 0.485 . . . . 0.38 112.043 -178.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.52 139.57 7.82 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.417 -0.811 . . . . 2.31 110.503 178.746 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.3 Cg_endo -63.54 115.47 3.06 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.347 2.032 . . . . 0.86 111.818 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.3 tttp -46.85 81.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.883 -0.414 . . . . 3.44 109.883 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.7 0.06 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.109 -0.496 . . . . 2.72 111.914 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 p -157.55 157.81 34.46 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.857 -0.337 . . . . 2.78 110.592 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.33 27.77 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.213 -0.449 . . . . 2.3 110.183 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.77 -75.97 1.31 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.198 -0.525 . . . . 1.8 111.811 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.86 152.25 35.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.947 0.403 . . . . 5.48 111.019 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.676 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.17 -169.14 2.54 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.996 -0.547 . . . . 1.84 112.048 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.16 149.67 29.74 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 121.476 0.655 . . . . 2.27 112.561 -177.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.99 156.42 46.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.763 -1.108 . . . . 1.92 110.347 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.13 158.39 41.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.209 0.528 . . . . 1.09 111.828 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.1 m -115.22 135.57 54.03 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.57 -0.741 . . . . 1.16 109.794 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.446 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.36 121.96 23.82 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.33 -0.396 . . . . 1.39 111.495 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.516 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.9 Cg_exo -46.3 151.65 1.64 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.733 2.289 . . . . 0.72 112.081 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.84 -23.06 62.94 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-N 116.037 -0.529 . . . . 0.74 112.814 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.516 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.87 -16.74 46.38 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.236 -0.585 . . . . 1.26 111.779 -178.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.486 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.6 mt -91.69 138.41 31.59 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.807 -0.357 . . . . 1.59 110.308 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.54 13.98 10.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.315 -0.402 . . . . 2.07 111.482 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 86.8 p -149.97 143.5 25.25 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.696 -0.402 . . . . 0.96 111.03 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.721 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.87 -169.43 1.55 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.286 0.565 . . . . 1.0 110.808 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.721 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.4 t -151.77 125.89 9.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.375 -0.83 . . . . 1.19 109.908 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.42 HG23 HD11 ' A' ' 60' ' ' ILE . 66.4 mt -114.74 123.27 70.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.424 -0.51 . . . . 1.47 111.257 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.75 ' HZ3' ' HG ' ' A' ' 140' ' ' SER . 21.5 mtmt -126.48 163.33 23.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.88 -0.6 . . . . 3.0 110.464 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.473 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.14 18.99 59.84 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.77 -0.932 . . . . 0.5 110.77 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.7 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.6 mt -79.05 157.35 28.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.043 0.449 . . . . 1.21 111.408 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.654 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 6.6 mttp -99.54 133.95 21.51 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.666 -0.697 . . . . 3.2 110.412 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.54 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.92 143.66 61.53 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.495 2.13 . . . . 1.09 111.945 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.78 25.47 75.52 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.161 -0.776 . . . . 0.72 111.161 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.639 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.04 158.84 39.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.655 0.264 . . . . 1.47 110.51 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.23 139.89 42.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.916 0.388 . . . . 1.23 110.516 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.654 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.6 136.41 54.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.959 -0.564 . . . . 1.1 110.799 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.88 130.91 45.3 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.51 -0.922 . . . . 1.87 108.51 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.36 153.79 16.63 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.298 -0.953 . . . . 0.39 112.07 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.91 140.97 46.18 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.696 -0.483 . . . . 1.8 109.696 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.462 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.0 tp -115.78 118.96 34.49 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.456 -0.498 . . . . 1.11 110.483 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.9 mt -112.5 129.02 68.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.334 -0.394 . . . . 1.51 110.645 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.82 120.84 43.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.326 -0.397 . . . . 1.47 110.766 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.668 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.6 146.47 11.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.144 0.497 . . . . 1.33 110.985 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.822 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.0 153.88 21.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.575 -0.738 . . . . 2.49 109.902 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.18 88.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.901 0.382 . . . . 4.2 110.427 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.62 0.21 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.8 -0.636 . . . . 6.4 110.56 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.34 3.29 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.406 -0.678 . . . . 1.74 111.406 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.446 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.38 177.39 9.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.132 0.492 . . . . 3.64 111.652 -179.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.12 149.5 32.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.504 -0.771 . . . . 1.7 110.421 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.17 144.65 38.67 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.402 -0.363 . . . . 2.7 110.623 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -128.0 135.96 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.997 0.427 . . . . 1.16 111.568 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.0 141.35 52.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.667 -0.697 . . . . 1.14 110.289 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.447 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.65 138.8 51.73 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.089 0.471 . . . . 4.33 111.529 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.491 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.17 164.22 37.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.553 -0.749 . . . . 0.91 109.556 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.573 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.3 151.48 38.4 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.432 -0.507 . . . . 1.47 111.004 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.569 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.0 p90 -146.15 172.75 12.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.714 -0.676 . . . . 0.51 111.024 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.453 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.69 160.71 21.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.454 -0.794 . . . . 1.92 109.849 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.605 ' CG2' HE22 ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.43 121.89 22.91 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.575 -0.45 . . . . 1.63 110.778 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.634 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.8 p -127.62 165.52 19.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 2.37 111.415 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 N--CA 1.462 0.141 0 N-CA-C 109.617 -0.512 . . . . 3.63 109.617 179.018 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.9 p . . . . . 0 CA--C 1.522 -0.097 0 CA-C-O 120.866 0.365 . . . . 1.25 110.546 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.478 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.91 167.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.873 -0.603 . . . . 1.16 110.916 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.484 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.9 m-30 -133.61 145.56 50.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.674 -0.693 . . . . 0.78 110.138 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.21 101.63 9.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.086 -0.709 . . . . 1.08 109.086 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.468 HG11 ' N ' ' A' ' 131' ' ' SER . 71.7 t -112.93 139.64 36.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.033 -0.531 . . . . 1.1 111.076 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.468 ' N ' HG11 ' A' ' 130' ' ' VAL . 68.8 p -128.71 152.54 48.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.669 -0.696 . . . . 0.87 109.869 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.644 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.8 p90 -144.71 -164.93 2.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.688 -0.405 . . . . 0.37 110.716 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -124.01 127.19 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 1.14 110.83 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.175 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.94 58.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.059 -0.519 . . . . 1.91 110.388 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.16 24.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.876 -0.602 . . . . 1.56 111.507 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.175 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.18 128.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.618 -0.433 . . . . 1.56 110.921 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -86.53 -9.51 56.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.942 -0.572 . . . . 1.88 110.339 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.18 0.34 55.47 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.045 -0.525 . . . . 1.63 110.444 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.962 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.23 137.23 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.847 -0.615 . . . . 1.11 109.93 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.75 ' HG ' ' HZ3' ' A' ' 61' ' ' LYS . 87.2 p -96.34 -15.4 21.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.324 0.583 . . . . 1.01 110.068 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.56 175.54 45.73 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 109.836 -1.306 . . . . 0.14 109.836 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.44 151.61 42.5 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.637 -0.425 . . . . 0.21 110.488 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.614 ' NH1' ' OE1' ' A' ' 191' ' ' GLN . 55.9 ttp180 -132.36 121.2 23.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.141 -0.481 . . . . 1.54 109.92 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.493 HG23 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.16 136.62 38.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.753 -0.658 . . . . 1.08 110.652 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 22.4 tp10 -129.35 129.93 45.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.981 -0.554 . . . . 1.32 109.974 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.6 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.75 135.35 34.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.993 -0.549 . . . . 1.05 110.507 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.409 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.38 161.37 39.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.721 -0.672 . . . . 1.16 109.666 179.778 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.94 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -71.06 124.88 25.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.946 0.403 . . . . 1.23 110.772 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.499 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.7 p -71.75 -7.78 50.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.75 -0.659 . . . . 0.86 110.853 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -109.8 -69.76 0.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.318 -0.401 . . . . 1.66 111.394 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.444 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.5 mt-10 -60.65 -35.32 75.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.033 -0.531 . . . . 1.66 111.441 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.091 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.16 7.32 88.53 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.785 -0.926 . . . . 1.62 110.785 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.334 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.4 t0 -28.15 -171.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.807 0.337 . . . . 1.86 110.266 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.334 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.15 45.23 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-O 120.918 0.389 . . . . 1.98 110.139 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.409 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.1 Cg_endo -70.98 145.81 51.07 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 C-N-CA 122.717 2.278 . . . . 0.62 112.318 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.6 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.83 145.83 42.51 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.243 -0.651 . . . . 1.14 109.243 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.572 ' CE2' ' CG ' ' A' ' 16' ' ' ASN . 27.5 p90 -123.37 141.32 52.11 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.372 -0.531 . . . . 1.44 111.514 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.418 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.7 mt -128.11 127.62 43.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.318 -0.855 . . . . 1.08 108.994 178.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.547 ' HB3' ' ND2' ' A' ' 16' ' ' ASN . 37.6 p-10 -101.55 131.14 47.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.08 0.467 . . . . 1.09 111.771 -178.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.506 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -127.94 157.51 73.57 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.376 -0.829 . . . . 1.04 109.58 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.74 157.94 58.69 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 122.429 2.086 . . . . 0.21 112.269 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.1 p -59.26 -12.14 5.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.776 -0.647 . . . . 0.88 110.682 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.0 p -92.87 -8.7 42.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 1.06 110.711 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.11 135.31 34.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.284 -0.416 . . . . 1.05 110.394 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.1 p -133.12 16.7 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 1.07 110.502 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.8 p -167.52 147.11 5.09 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.602 -0.518 . . . . 0.92 109.602 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.506 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.1 p -152.18 150.38 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.476 -0.489 . . . . 1.09 111.589 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.22 124.94 50.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.63 -0.714 . . . . 1.31 109.792 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.523 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.44 104.91 30.02 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.917 0.389 . . . . 1.09 111.112 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -90.97 -179.47 1.5 Allowed 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 123.18 2.586 . . . . 0.48 112.23 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.64 32.67 18.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.395 -0.821 . . . . 1.26 111.387 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.523 HD21 HG21 ' A' ' 169' ' ' ILE . 23.9 mt -86.39 148.56 25.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.79 0.328 . . . . 1.12 110.489 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.771 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.4 114.77 61.01 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.978 0.418 . . . . 1.3 110.595 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -58.92 140.52 95.62 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.823 2.348 . . . . 0.92 112.06 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.15 21.18 74.15 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.061 -0.815 . . . . 0.44 111.061 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.444 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.88 150.15 49.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.808 0.337 . . . . 3.05 110.691 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.499 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.15 131.65 45.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.117 -0.492 . . . . 1.48 109.772 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.94 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.5 m-85 -120.45 148.27 44.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.172 -0.467 . . . . 0.89 111.09 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.2 mt -105.35 125.28 60.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.342 -0.985 . . . . 1.12 108.342 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.43 132.51 63.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.096 0.474 . . . . 1.1 111.353 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.47 122.44 20.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.523 -0.762 . . . . 0.43 109.651 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.593 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.98 125.39 54.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.333 -0.394 . . . . 1.07 110.651 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.672 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.5 m-85 -117.19 137.9 52.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.017 -0.538 . . . . 0.92 109.888 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.571 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.65 134.98 42.81 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.758 -0.83 . . . . 0.49 108.758 178.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.574 ' O ' ' N ' ' A' ' 140' ' ' SER . 65.3 mt -99.08 123.08 51.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.214 0.53 . . . . 1.08 110.927 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.446 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.7 p -83.99 169.73 14.69 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.498 -0.773 . . . . 0.89 110.362 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -59.82 -14.47 15.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.978 -0.555 . . . . 1.6 110.966 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.446 ' H ' ' HG ' ' A' ' 186' ' ' SER . 95.2 m-20 -96.05 -4.32 43.22 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.837 -0.345 . . . . 1.18 110.856 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.487 ' HA2' ' HG1' ' A' ' 59' ' ' THR . . . 87.79 13.95 63.9 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.359 -0.696 . . . . 0.34 111.359 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -84.78 139.06 32.22 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.01 -0.276 . . . . 1.22 110.437 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.614 ' OE1' ' NH1' ' A' ' 143' ' ' ARG . 6.9 pt20 -106.7 141.06 38.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.893 0.378 . . . . 1.44 110.532 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.2 m -136.78 127.05 26.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.113 -0.494 . . . . 1.39 110.39 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.672 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.2 tp -68.15 117.28 9.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.294 -0.412 . . . . 1.08 110.527 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.644 HD12 ' CD1' ' A' ' 132' ' ' TRP . 43.9 pt -108.97 -21.87 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 1.08 110.724 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.87 125.81 5.91 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.457 -0.497 . . . . 1.1 111.468 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.492 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.71 120.21 21.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.75 -0.659 . . . . 0.94 109.56 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.7 29.11 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.6 -0.44 . . . . 1.07 110.892 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.45 158.54 18.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.89 110.472 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.07 157.88 43.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.133 -0.485 . . . . 0.67 110.649 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.21 104.35 9.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.703 -0.681 . . . . 1.17 110.05 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.484 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.2 p . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.866 -1.064 . . . . 1.26 110.669 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.5 m . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.179 -0.675 . . . . 3.83 109.179 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.32 150.7 18.54 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.05 -0.82 . . . . 1.39 111.05 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -35.57 142.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.076 0 C-N-CA 124.004 3.136 . . . . 0.86 113.815 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.563 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -80.02 173.52 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.256 -1.338 . . . . 1.43 108.846 178.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.6 125.88 51.49 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.453 -0.499 . . . . 1.94 111.352 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 144.02 33.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.678 -0.692 . . . . 1.19 110.726 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.0 168.32 25.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.895 0.379 . . . . 3.92 111.149 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.581 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.6 mt -109.06 131.12 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.993 -0.549 . . . . 3.88 110.076 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.2 162.33 35.74 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.862 0.363 . . . . 3.92 111.159 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 9' ' ' THR . 71.7 tt0 36.0 31.68 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 109.652 -0.499 . . . . 6.08 109.652 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.581 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.53 69.61 33.55 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.916 -0.584 . . . . 4.01 111.493 -178.735 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.38 -29.03 71.83 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.474 2.116 . . . . 4.51 111.832 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.6 125.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 3.51 110.433 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.697 ' O ' ' O ' ' A' ' 92' ' ' THR . 14.2 mm-40 -123.89 158.4 60.11 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.256 -0.429 . . . . 4.3 110.434 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HG3' HE22 ' A' ' 191' ' ' GLN . 96.3 Cg_endo -81.99 -64.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.895 2.396 . . . . 1.96 113.534 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.562 HD21 ' CG ' ' A' ' 159' ' ' ASP . 43.2 p-10 -108.38 -19.56 13.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.3 -0.409 . . . . 3.33 112.048 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 3.5 m -107.44 152.13 24.61 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.428 -0.509 . . . . 1.53 111.314 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.58 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.0 t-80 -155.32 102.92 2.22 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.608 -0.724 . . . . 2.29 110.674 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.68 145.67 13.02 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.823 2.349 . . . . 0.88 112.627 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.414 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.78 168.0 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.867 -0.606 . . . . 2.12 109.874 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.23 148.02 29.1 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.688 -0.486 . . . . 2.67 109.688 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.505 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.6 p90 -142.34 157.34 44.9 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.615 -0.434 . . . . 0.32 111.187 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.469 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.9 m-20 -128.09 155.31 44.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.789 -0.641 . . . . 2.77 110.163 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.62 173.02 6.38 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 121.112 0.482 . . . . 1.25 110.741 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.68 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.913 2.408 . . . . 1.12 111.502 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.485 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.07 -51.01 0.69 Allowed Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.719 -0.392 . . . . 4.05 110.165 179.841 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.656 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.85 152.38 82.39 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.757 2.305 . . . . 2.12 111.404 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.77 42.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.363 0.601 . . . . 2.85 110.517 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.82 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.62 -41.72 98.25 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.006 -0.997 . . . . 3.11 110.634 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.451 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.5 mt -109.8 137.85 40.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.741 -0.663 . . . . 1.86 111.287 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.93 -72.92 0.7 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.061 -0.518 . . . . 1.61 111.897 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.37 24.44 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.618 0.599 . . . . 1.67 112.618 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.87 124.92 45.25 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.331 -0.618 . . . . 1.07 109.331 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.11 134.77 60.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.624 -0.43 . . . . 1.55 110.551 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.485 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -120.09 128.57 53.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.064 0.459 . . . . 1.33 111.244 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.539 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.04 138.96 49.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.75 -0.659 . . . . 2.36 110.175 179.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.416 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.0 p90 -145.11 163.23 34.93 Favored 'General case' 0 CA--C 1.523 -0.067 0 CA-C-O 121.194 0.521 . . . . 0.38 112.052 -178.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.487 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.52 139.54 7.81 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 115.389 -0.823 . . . . 2.31 110.494 178.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.47 115.49 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.286 1.991 . . . . 0.86 111.856 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.681 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.04 81.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.803 -0.443 . . . . 3.44 109.803 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.65 0.06 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.971 -0.559 . . . . 2.72 111.942 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 p -157.66 157.72 34.11 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.744 -0.383 . . . . 2.78 110.538 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.403 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.26 27.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.224 -0.444 . . . . 2.3 110.181 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.91 -75.9 1.31 Allowed Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.133 -0.556 . . . . 1.8 111.8 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.79 152.24 35.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.895 0.378 . . . . 5.48 110.995 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.667 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.21 -169.14 2.54 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.132 -0.486 . . . . 1.84 111.882 179.337 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.416 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.58 29.86 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.462 0.649 . . . . 2.27 112.594 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.99 156.37 46.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.794 -1.094 . . . . 1.92 110.316 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.09 158.44 41.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.988 -0.551 . . . . 1.09 111.87 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.7 m -115.21 135.66 53.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.511 -0.768 . . . . 1.16 109.832 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.453 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.31 121.91 23.87 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.403 -0.362 . . . . 1.39 111.554 -179.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.511 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.2 Cg_exo -46.39 151.74 1.67 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.636 2.224 . . . . 0.72 112.156 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.85 -23.11 63.03 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 116.029 -0.532 . . . . 0.74 112.794 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.511 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.76 -16.89 46.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.375 0.587 . . . . 1.26 111.84 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.491 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.53 138.39 31.61 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.803 -0.359 . . . . 1.59 110.323 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.5 13.86 11.01 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.406 -0.361 . . . . 2.07 111.554 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.476 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.96 143.46 25.24 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.659 -0.416 . . . . 0.96 111.057 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.713 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.8 -169.37 1.53 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.895 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.713 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.0 t -151.77 125.8 9.19 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.366 -0.834 . . . . 1.19 109.853 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.439 HG23 HD11 ' A' ' 60' ' ' ILE . 66.8 mt -114.8 123.4 70.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.28 -0.568 . . . . 1.47 111.156 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -126.53 163.4 23.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.831 -0.622 . . . . 3.0 110.423 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.14 18.92 59.98 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.757 -0.937 . . . . 0.5 110.757 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.437 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 74.0 mt -79.03 157.18 28.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.039 0.447 . . . . 1.21 111.314 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.666 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 3.1 mttm -99.38 133.9 21.63 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.627 -0.715 . . . . 3.2 110.51 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.95 143.58 61.01 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.5 2.133 . . . . 1.09 111.95 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.86 25.7 75.25 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.049 -0.821 . . . . 0.72 111.049 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.649 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.2 158.78 40.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.649 0.262 . . . . 1.47 110.468 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.476 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.2 139.95 42.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.915 0.388 . . . . 1.23 110.579 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.666 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.3 m-85 -122.56 136.42 54.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.936 -0.575 . . . . 1.1 110.81 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.487 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.93 131.03 45.32 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.516 -0.92 . . . . 1.87 108.516 177.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.46 153.93 16.64 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.2 -1.0 . . . . 0.39 111.97 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.98 140.99 46.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.708 -0.478 . . . . 1.8 109.708 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.468 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.8 tp -115.83 118.87 34.22 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.47 -0.492 . . . . 1.11 110.523 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.4 mt -112.44 129.14 68.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.289 -0.414 . . . . 1.51 110.578 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.85 120.89 43.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.256 -0.429 . . . . 1.47 110.685 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.663 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.59 146.53 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.169 0.509 . . . . 1.33 111.018 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.82 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.08 153.87 21.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.519 -0.764 . . . . 2.49 109.935 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.11 88.53 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.909 0.385 . . . . 4.2 110.386 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.622 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.67 0.21 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.822 -0.626 . . . . 6.4 110.532 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.12 -117.33 3.28 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.394 -0.682 . . . . 1.74 111.394 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.45 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.38 177.41 8.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.165 0.507 . . . . 3.64 111.646 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.24 149.55 32.1 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.446 -0.797 . . . . 1.7 110.413 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.14 144.63 38.71 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.444 -0.344 . . . . 2.7 110.599 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -127.97 135.91 61.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 120.69 -0.404 . . . . 1.16 111.607 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.0 141.36 52.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.755 -0.657 . . . . 1.14 110.325 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.73 138.91 51.71 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.181 0.515 . . . . 4.33 111.478 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.29 164.1 38.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.47 -0.787 . . . . 0.91 109.539 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.563 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.23 151.64 38.72 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.412 -0.515 . . . . 1.47 111.005 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.58 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.3 p90 -146.23 172.74 13.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.688 -0.687 . . . . 0.51 111.092 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.44 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.77 160.68 21.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.492 -0.777 . . . . 1.92 109.887 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.44 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.36 121.96 23.1 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.559 -0.456 . . . . 1.63 110.761 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.697 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -130.99 -145.26 0.27 Allowed 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 121.941 0.877 . . . . 2.37 111.478 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.9 p . . . . . 0 CA--C 1.537 0.465 0 CA-C-N 114.191 -1.368 . . . . 3.63 107.897 177.8 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 122.746 1.26 . . . . 1.25 107.853 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.471 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.78 167.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.005 -1.452 . . . . 1.16 111.022 -178.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.6 145.54 50.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.765 -0.652 . . . . 0.78 110.14 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.22 101.59 9.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.099 -0.704 . . . . 1.08 109.099 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.469 HG11 ' N ' ' A' ' 131' ' ' SER . 71.6 t -112.94 139.7 36.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.071 -0.513 . . . . 1.1 111.052 -178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.469 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.3 p -128.62 152.58 48.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.642 -0.708 . . . . 0.87 109.842 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.641 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.4 p90 -144.78 -164.89 2.02 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.736 -0.386 . . . . 0.37 110.708 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.741 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -123.99 127.2 73.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.256 -0.429 . . . . 1.14 110.833 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.161 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.99 58.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.075 -0.512 . . . . 1.91 110.332 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.741 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.12 24.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.88 -0.6 . . . . 1.56 111.481 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.161 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.2 128.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.619 -0.433 . . . . 1.56 110.891 179.782 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.38 -9.7 55.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.896 -0.593 . . . . 1.88 110.325 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.07 0.31 55.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.058 -0.519 . . . . 1.63 110.39 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.962 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.34 137.17 25.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.919 -0.582 . . . . 1.11 109.955 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 185' ' ' ILE . 1.8 m -96.15 -15.51 22.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.313 0.578 . . . . 1.01 110.044 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.616 ' N ' HG12 ' A' ' 185' ' ' ILE . . . 178.62 175.63 45.85 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.846 -1.301 . . . . 0.14 109.846 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -123.4 151.57 42.47 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.705 -0.398 . . . . 0.21 110.504 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.878 HH21 ' N ' ' A' ' 159' ' ' ASP . 1.5 tpm_? -132.39 121.25 23.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.111 -0.495 . . . . 1.54 109.878 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.479 HG23 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.06 136.56 38.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.654 -0.703 . . . . 1.08 110.649 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 85.3 tt0 -129.37 129.9 45.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.016 -0.538 . . . . 1.32 110.0 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.592 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.66 135.31 34.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.928 -0.578 . . . . 1.05 110.632 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.401 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.29 161.37 39.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.758 -0.655 . . . . 1.16 109.688 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.933 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -71.06 124.87 25.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.981 0.419 . . . . 1.23 110.72 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.489 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.84 -7.67 49.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.759 -0.655 . . . . 0.86 110.886 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.79 -69.74 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 1.66 111.429 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.421 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.59 -35.39 75.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.083 -0.508 . . . . 1.66 111.441 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.092 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.15 7.24 88.59 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.776 -0.929 . . . . 1.62 110.776 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.308 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.4 t0 -27.94 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.759 0.314 . . . . 1.86 110.246 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.308 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.32 139.03 44.92 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.947 0.403 . . . . 1.98 110.14 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.401 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.7 Cg_endo -70.78 145.86 52.37 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 C-N-CA 122.751 2.301 . . . . 0.62 112.327 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.88 145.69 42.66 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.223 -0.658 . . . . 1.14 109.223 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.487 ' HB3' ' CZ ' ' A' ' 143' ' ' ARG . 83.5 m-85 -123.28 141.34 52.09 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.354 -0.539 . . . . 1.44 111.54 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.651 ' C ' HH21 ' A' ' 143' ' ' ARG . 70.8 mt -128.09 127.7 43.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.298 -0.865 . . . . 1.08 108.935 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.878 ' N ' HH21 ' A' ' 143' ' ' ARG . 55.9 t0 -101.68 131.16 48.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.258 0.551 . . . . 1.09 111.661 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.519 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -127.94 157.55 73.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.333 -0.849 . . . . 1.04 109.636 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -69.81 158.02 58.29 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.394 2.063 . . . . 0.21 112.238 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.28 -12.12 5.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.806 -0.634 . . . . 0.88 110.76 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.8 p -92.8 -8.82 42.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.124 -0.489 . . . . 1.06 110.687 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.21 135.31 34.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.383 . . . . 1.05 110.338 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.5 p -133.09 16.75 4.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 1.07 110.502 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.9 p -167.64 147.06 4.97 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.627 -0.508 . . . . 0.92 109.627 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.519 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.1 p -152.19 150.45 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.398 -0.521 . . . . 1.09 111.51 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.28 124.96 50.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.626 -0.716 . . . . 1.31 109.81 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.517 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.41 104.89 29.78 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.403 -0.362 . . . . 1.09 111.094 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.4 Cg_endo -90.98 -179.49 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 123.158 2.572 . . . . 0.48 112.198 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.75 32.61 18.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.435 -0.802 . . . . 1.26 111.359 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 169' ' ' ILE . 24.1 mt -86.31 148.5 25.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.54 -0.3 . . . . 1.12 110.487 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.766 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.5 mt -88.29 114.8 61.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.986 0.422 . . . . 1.3 110.636 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.95 140.51 95.61 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.98 2.453 . . . . 0.92 111.93 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.03 21.32 74.18 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.025 -0.83 . . . . 0.44 111.025 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.421 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.86 150.21 49.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.864 0.364 . . . . 3.05 110.589 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.489 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.2 131.65 46.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.993 -0.549 . . . . 1.48 109.801 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.933 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.5 m-85 -120.5 148.37 43.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.069 -0.514 . . . . 0.89 110.999 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.39 125.27 60.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.243 -1.021 . . . . 1.12 108.243 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.49 132.59 63.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.211 0.529 . . . . 1.1 111.227 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.59 20.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.526 -0.761 . . . . 0.43 109.622 179.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.588 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -101.07 125.38 55.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.293 -0.412 . . . . 1.07 110.711 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.674 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.8 m-85 -117.21 137.92 52.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.967 -0.56 . . . . 0.92 109.866 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.78 135.07 42.8 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.763 -0.829 . . . . 0.49 108.763 178.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.616 HG12 ' N ' ' A' ' 141' ' ' GLY . 0.8 OUTLIER -99.08 122.89 51.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.175 0.512 . . . . 1.08 110.938 -178.718 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.452 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.6 p -83.84 169.66 14.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.586 -0.734 . . . . 0.89 110.408 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.461 ' HA ' ' HG ' ' A' ' 140' ' ' SER . 97.0 mt-10 -59.72 -14.52 14.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.959 -0.564 . . . . 1.6 111.023 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.452 ' H ' ' HG ' ' A' ' 186' ' ' SER . 95.6 m-20 -96.12 -4.27 43.07 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.779 -0.368 . . . . 1.18 110.793 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.84 13.92 63.86 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.346 -0.702 . . . . 0.34 111.346 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -84.59 139.09 32.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.574 0.225 . . . . 1.22 110.433 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.514 HE22 ' HG3' ' A' ' 15' ' ' PRO . 83.8 mt-30 -106.82 141.08 38.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.373 . . . . 1.44 110.545 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.8 m -136.74 127.03 26.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.093 -0.503 . . . . 1.39 110.374 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.674 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.5 tp -68.07 117.3 9.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 1.08 110.53 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.641 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -109.07 -21.75 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 1.08 110.7 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.92 125.7 5.84 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.489 -0.484 . . . . 1.1 111.514 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.497 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.68 120.2 21.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.685 -0.689 . . . . 0.94 109.563 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.6 151.68 29.13 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.692 -0.403 . . . . 1.07 110.943 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.43 158.59 18.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 0.89 110.409 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.1 157.91 43.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.099 -0.501 . . . . 0.67 110.66 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.37 9.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.732 -0.667 . . . . 1.17 109.995 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.48 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.5 p . . . . . 0 C--O 1.218 -0.555 0 CA-C-O 117.949 -1.024 . . . . 1.26 110.531 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.8 m . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.253 -0.647 . . . . 3.83 109.253 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.36 150.69 18.54 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.986 -0.846 . . . . 1.39 110.986 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -35.67 142.39 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 123.953 3.102 . . . . 0.86 113.789 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.574 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.1 t -80.0 173.38 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.282 -1.326 . . . . 1.43 108.9 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.59 125.88 51.49 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.395 -0.522 . . . . 1.94 111.413 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.46 144.03 33.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.63 -0.714 . . . . 1.19 110.686 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.02 168.36 25.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.947 0.403 . . . . 3.92 111.117 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.589 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.08 130.94 61.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.983 -0.553 . . . . 3.88 110.013 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.5 p -141.03 162.3 35.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.85 0.357 . . . . 3.92 111.226 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 9' ' ' THR . 70.6 tt0 36.13 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.624 -0.509 . . . . 6.08 109.624 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.589 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.57 33.07 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.968 -0.56 . . . . 4.01 111.637 -178.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.22 -29.12 73.32 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.453 2.102 . . . . 4.51 111.872 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 3.51 110.422 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 17' ' ' SER . 3.3 mp0 -123.86 158.4 60.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 4.3 110.438 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.586 ' N ' ' OG ' ' A' ' 93' ' ' SER . 98.1 Cg_endo -82.13 -64.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.81 2.34 . . . . 1.96 113.592 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.496 ' ND2' ' HB2' ' A' ' 157' ' ' TYR . 72.8 m-20 -108.47 -19.47 13.44 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.107 0.41 . . . . 3.33 112.107 -178.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 4.9 p -107.47 152.05 24.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.18 0.514 . . . . 1.53 111.277 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.26 102.89 2.23 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.622 -0.717 . . . . 2.29 110.637 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.502 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.7 Cg_endo -82.71 145.66 12.97 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.851 2.368 . . . . 0.88 112.595 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.416 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.83 167.99 24.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.833 -0.621 . . . . 2.12 109.864 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -149.17 147.88 28.98 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.781 -0.451 . . . . 2.67 109.781 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.495 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.5 p90 -142.27 157.32 44.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.078 0.466 . . . . 0.32 111.177 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.471 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.09 155.23 44.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.766 -0.652 . . . . 2.77 110.033 179.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.58 173.1 6.28 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.037 -0.529 . . . . 1.25 110.747 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.66 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.858 2.372 . . . . 1.12 111.548 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.05 -51.11 0.69 Allowed Pre-proline 0 C--N 1.33 -0.271 0 C-N-CA 120.687 -0.405 . . . . 4.05 110.01 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.66 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.4 Cg_exo -64.77 152.35 82.36 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.751 2.301 . . . . 2.12 111.484 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.77 42.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.363 0.602 . . . . 2.85 110.581 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.82 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.69 -41.69 98.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.969 -1.014 . . . . 3.11 110.55 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.434 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.3 mt -109.82 137.91 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.846 -0.615 . . . . 1.86 111.258 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.06 -72.96 0.7 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.978 -0.555 . . . . 1.61 111.828 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.19 148.31 24.45 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.583 0.586 . . . . 1.67 112.583 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.82 124.92 45.31 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.302 -0.629 . . . . 1.07 109.302 177.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.0 mt -118.09 134.83 60.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.616 -0.434 . . . . 1.55 110.604 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.483 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -120.08 128.56 53.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 1.33 111.243 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.11 139.07 49.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.757 -0.656 . . . . 2.36 110.064 179.006 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.418 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.18 163.1 35.41 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 121.176 0.512 . . . . 0.38 112.014 -178.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.42 139.62 7.93 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.448 -0.796 . . . . 2.31 110.449 178.852 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.696 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.55 115.5 3.08 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.251 1.968 . . . . 0.86 111.85 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.673 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.95 81.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.908 -0.405 . . . . 3.44 109.908 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.696 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.2 -20.73 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.034 -0.53 . . . . 2.72 112.03 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.6 p -157.6 157.74 34.24 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.879 -0.328 . . . . 2.78 110.599 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.407 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.8 m -120.37 27.83 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 2.3 110.207 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.83 -75.9 1.31 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.121 -0.562 . . . . 1.8 111.886 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.83 152.29 35.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.073 0.463 . . . . 5.48 110.919 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.2 -169.14 2.54 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.991 -0.55 . . . . 1.84 111.997 179.292 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.09 149.61 29.78 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-O 121.431 0.634 . . . . 2.27 112.684 -177.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.96 156.52 46.05 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 114.809 -1.087 . . . . 1.92 110.302 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.2 158.43 41.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.872 -0.604 . . . . 1.09 111.785 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.7 m -115.25 135.55 54.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.517 -0.765 . . . . 1.16 109.755 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.453 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.4 121.97 23.78 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.433 -0.348 . . . . 1.39 111.584 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.514 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.4 Cg_exo -46.28 151.72 1.6 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.73 2.287 . . . . 0.72 112.12 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.93 -23.02 63.09 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 116.055 -0.521 . . . . 0.74 112.785 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.514 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.77 -16.89 46.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.407 0.604 . . . . 1.26 111.803 -178.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.48 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.2 mt -91.57 138.41 31.59 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.841 -0.344 . . . . 1.59 110.348 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.58 13.91 10.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.364 -0.38 . . . . 2.07 111.544 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -149.98 143.46 25.22 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.714 -0.394 . . . . 0.96 111.003 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.724 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.8 -169.37 1.53 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.942 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.724 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 t -151.81 125.86 9.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.443 -0.799 . . . . 1.19 109.816 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.423 HG23 HD11 ' A' ' 60' ' ' ILE . 66.5 mt -114.86 123.4 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.312 -0.555 . . . . 1.47 111.195 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.694 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 63.1 pttt -126.63 163.37 23.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.782 -0.644 . . . . 3.0 110.402 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.12 19.03 59.8 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.733 -0.947 . . . . 0.5 110.733 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.44 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.3 mt -78.97 157.18 28.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.045 0.45 . . . . 1.21 111.378 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.647 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -99.48 133.87 21.6 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.62 -0.718 . . . . 3.2 110.486 179.737 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.8 143.5 61.54 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.594 2.196 . . . . 1.09 111.988 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.93 25.59 75.4 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.034 -0.826 . . . . 0.72 111.034 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.645 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.18 158.74 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.73 0.3 . . . . 1.47 110.409 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.12 139.97 41.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.926 0.394 . . . . 1.23 110.522 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.647 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.8 m-85 -122.59 136.43 54.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.986 -0.552 . . . . 1.1 110.757 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.91 131.01 45.31 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.463 -0.94 . . . . 1.87 108.463 177.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.43 153.9 16.63 Favored Glycine 0 C--O 1.228 -0.269 0 C-N-CA 120.357 -0.925 . . . . 0.39 111.968 -178.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.08 140.85 45.85 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.723 -0.473 . . . . 1.8 109.723 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.461 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.2 tp -115.7 118.93 34.43 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.483 -0.487 . . . . 1.11 110.573 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.2 mt -112.55 129.09 68.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.409 . . . . 1.51 110.603 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.78 120.74 43.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.259 -0.428 . . . . 1.47 110.739 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.667 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.58 146.5 11.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.098 0.475 . . . . 1.33 111.058 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.82 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.11 153.91 21.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.505 -0.771 . . . . 2.49 109.835 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.18 88.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.928 0.395 . . . . 4.2 110.381 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.622 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.859 -0.609 . . . . 6.4 110.549 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.09 -117.36 3.29 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.43 -0.668 . . . . 1.74 111.43 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.439 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.29 177.41 9.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.182 0.515 . . . . 3.64 111.638 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.27 149.5 31.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.466 -0.788 . . . . 1.7 110.425 179.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.21 144.67 38.61 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.482 -0.326 . . . . 2.7 110.576 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -128.02 136.0 61.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 121.139 0.495 . . . . 1.16 111.499 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.574 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.09 141.45 52.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.622 -0.717 . . . . 1.14 110.248 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.75 138.91 51.72 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 120.492 -0.483 . . . . 4.33 111.438 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.28 164.18 37.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.545 -0.752 . . . . 0.91 109.521 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.57 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.1 p30 -145.27 151.54 38.52 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.327 -0.549 . . . . 1.47 111.009 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.574 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.9 p90 -146.2 172.75 12.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.743 -0.662 . . . . 0.51 111.033 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.452 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.5 t -118.77 160.7 21.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.459 -0.791 . . . . 1.92 109.806 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.452 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.34 121.91 23.05 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.54 -0.464 . . . . 1.63 110.749 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.512 ' OG1' ' N ' ' A' ' 93' ' ' SER . 70.3 p -128.92 -114.48 0.26 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.392 0.886 . . . . 2.37 113.392 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.586 ' OG ' ' N ' ' A' ' 15' ' ' PRO . 48.0 p . . . . . 0 C--N 1.343 0.317 0 CA-C-N 114.956 -1.02 . . . . 3.63 110.789 -178.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.3 p . . . . . 0 CA--C 1.521 -0.145 0 CA-C-O 121.422 0.629 . . . . 1.25 109.672 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.482 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.77 167.57 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.427 -0.806 . . . . 1.16 110.983 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.486 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.9 m-30 -133.65 145.47 50.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.809 -0.632 . . . . 0.78 110.133 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.19 101.44 9.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.165 -0.68 . . . . 1.08 109.165 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.471 HG11 ' N ' ' A' ' 131' ' ' SER . 71.5 t -112.87 139.71 36.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.094 -0.503 . . . . 1.1 111.09 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.471 ' N ' HG11 ' A' ' 130' ' ' VAL . 68.8 p -128.69 152.59 48.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.59 -0.732 . . . . 0.87 109.75 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.648 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.7 p90 -144.84 -164.88 2.02 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.641 -0.423 . . . . 0.37 110.675 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -123.98 127.22 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.436 . . . . 1.14 110.82 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.169 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -58.06 58.4 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.123 -0.49 . . . . 1.91 110.368 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.17 24.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.809 -0.632 . . . . 1.56 111.437 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.169 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.14 128.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.646 -0.422 . . . . 1.56 111.036 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.41 -9.59 56.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.935 -0.575 . . . . 1.88 110.295 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.22 0.38 55.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 1.63 110.286 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.968 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.22 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.029 -0.532 . . . . 1.11 109.938 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.694 ' O ' ' NZ ' ' A' ' 61' ' ' LYS . 70.5 m -96.24 -15.58 21.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.256 0.55 . . . . 1.01 110.022 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.576 ' HA3' ' HZ2' ' A' ' 61' ' ' LYS . . . 178.62 175.61 45.83 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 109.858 -1.297 . . . . 0.14 109.858 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.49 151.61 42.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.961 0.41 . . . . 0.21 110.426 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.733 HH12 ' NE2' ' A' ' 191' ' ' GLN . 50.8 ttp180 -132.31 121.16 23.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.119 -0.491 . . . . 1.54 109.918 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.489 HG23 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.05 136.49 38.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.761 -0.654 . . . . 1.08 110.693 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.52 ' HG2' ' CD2' ' A' ' 157' ' ' TYR . 94.4 mt-10 -129.36 129.86 45.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.06 -0.518 . . . . 1.32 110.056 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.591 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.67 135.27 34.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.987 -0.552 . . . . 1.05 110.622 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.28 161.34 39.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.751 -0.659 . . . . 1.16 109.665 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.934 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.5 mt -70.92 124.76 25.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.975 0.417 . . . . 1.23 110.735 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.7 p -71.71 -7.79 50.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.768 -0.651 . . . . 0.86 110.833 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -109.81 -69.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.295 -0.411 . . . . 1.66 111.332 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.428 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.64 -35.39 76.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.106 -0.497 . . . . 1.66 111.469 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.074 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.1 7.23 88.59 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.853 -0.899 . . . . 1.62 110.853 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.331 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.89 -171.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.753 0.311 . . . . 1.86 110.365 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.331 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.23 139.11 45.24 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.965 0.412 . . . . 1.98 110.23 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.403 ' HG2' ' OH ' ' A' ' 157' ' ' TYR . 46.4 Cg_endo -70.94 145.76 51.17 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.762 2.308 . . . . 0.62 112.332 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.77 145.76 42.52 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.24 -0.652 . . . . 1.14 109.24 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.702 ' CD1' ' N ' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -123.37 141.3 52.13 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.312 -0.555 . . . . 1.44 111.5 -179.048 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.3 mt -128.04 127.67 43.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.333 -0.848 . . . . 1.08 109.016 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -101.73 131.21 48.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.15 0.5 . . . . 1.09 111.708 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.509 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -127.94 157.64 73.15 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.273 -0.876 . . . . 1.04 109.54 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.9 157.99 58.27 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.376 2.051 . . . . 0.21 112.282 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.3 -12.1 5.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 0.88 110.743 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.1 p -92.83 -8.75 42.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 1.06 110.722 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.15 135.33 34.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.406 . . . . 1.05 110.428 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 p -133.17 16.75 4.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.478 -0.328 . . . . 1.07 110.506 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.9 p -167.57 147.09 5.05 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.598 -0.519 . . . . 0.92 109.598 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.509 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.14 150.48 12.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.508 -0.477 . . . . 1.09 111.589 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.49 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 124.97 50.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.596 -0.729 . . . . 1.31 109.78 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.529 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.46 104.86 29.79 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.872 0.368 . . . . 1.09 111.025 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.2 Cg_endo -90.96 -179.53 1.51 Allowed 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 123.216 2.611 . . . . 0.48 112.203 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 61.7 32.66 18.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.374 -0.83 . . . . 1.26 111.403 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.529 HD21 HG21 ' A' ' 169' ' ' ILE . 24.1 mt -86.42 148.52 25.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.444 -0.343 . . . . 1.12 110.471 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.778 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.8 mt -88.28 114.96 61.75 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.06 0.457 . . . . 1.3 110.677 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.14 140.6 95.71 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.824 2.349 . . . . 0.92 112.026 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.23 74.23 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.046 -0.822 . . . . 0.44 111.046 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.428 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.91 150.22 49.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.803 0.335 . . . . 3.05 110.641 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.488 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.2 131.63 46.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.008 -0.542 . . . . 1.48 109.756 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.934 ' CE2' HD21 ' A' ' 148' ' ' LEU . 75.2 m-85 -120.5 148.27 44.05 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.105 -0.498 . . . . 0.89 111.062 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.7 mt -105.36 125.38 60.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.194 -1.039 . . . . 1.12 108.194 177.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.54 132.52 63.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.172 0.511 . . . . 1.1 111.3 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.47 122.62 20.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.549 -0.751 . . . . 0.43 109.613 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.587 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.1 125.35 55.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.268 -0.424 . . . . 1.07 110.622 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.665 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.5 m-85 -117.28 137.91 52.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.946 -0.57 . . . . 0.92 109.84 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.571 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.63 135.07 42.65 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.745 -0.835 . . . . 0.49 108.745 178.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.546 ' O ' ' N ' ' A' ' 140' ' ' SER . 47.2 mm -99.1 122.93 51.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.155 0.502 . . . . 1.08 110.969 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.451 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.5 p -83.91 169.59 14.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.591 -0.731 . . . . 0.89 110.496 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -59.62 -14.56 14.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.046 -0.524 . . . . 1.6 110.966 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.502 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.6 m-20 -96.13 -4.29 43.01 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.905 -0.318 . . . . 1.18 110.749 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.86 13.78 64.06 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.389 -0.684 . . . . 0.34 111.389 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -84.59 139.01 32.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.625 0.25 . . . . 1.22 110.415 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.733 ' NE2' HH12 ' A' ' 143' ' ' ARG . 3.3 mt-30 -106.68 141.15 38.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.339 . . . . 1.44 110.565 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 61.9 m -136.72 127.04 26.49 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.216 -0.447 . . . . 1.39 110.383 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.665 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.6 tp -68.14 117.43 9.96 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.699 -0.401 . . . . 1.08 110.519 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.648 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -109.1 -21.73 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 1.08 110.767 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.98 125.72 5.81 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.422 -0.511 . . . . 1.1 111.448 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.497 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.69 120.2 21.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.787 -0.642 . . . . 0.94 109.601 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.62 151.68 29.1 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.757 -0.377 . . . . 1.07 110.916 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.5 158.56 18.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.002 -0.545 . . . . 0.89 110.438 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.02 157.89 43.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.119 -0.491 . . . . 0.67 110.609 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.29 104.39 9.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.779 -0.646 . . . . 1.17 110.069 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.486 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 68.7 p . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.99 -1.005 . . . . 1.26 110.56 -179.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.208 -0.664 . . . . 3.83 109.208 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.69 18.54 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.032 -0.827 . . . . 1.39 111.032 179.729 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -35.66 142.4 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.042 0 C-N-CA 123.97 3.113 . . . . 0.86 113.826 -179.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.569 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.0 t -79.98 173.33 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.308 -1.315 . . . . 1.43 108.846 178.431 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 23' ' ' ASN . 96.1 mt-10 -105.55 125.87 51.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.435 -0.506 . . . . 1.94 111.393 -179.538 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 144.01 33.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.628 -0.715 . . . . 1.19 110.564 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.98 168.4 25.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.319 -0.401 . . . . 3.92 111.131 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.581 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -109.06 131.1 60.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.98 -0.554 . . . . 3.88 110.048 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.14 162.25 35.94 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.442 -0.345 . . . . 3.92 111.284 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.4 mt-10 36.21 31.51 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.607 -0.516 . . . . 6.08 109.607 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.581 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.58 32.55 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.019 -0.537 . . . . 4.01 111.558 -178.737 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.637 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.29 -29.14 72.69 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.494 2.129 . . . . 4.51 111.854 179.395 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.637 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.65 125.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.016 -0.538 . . . . 3.51 110.502 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.613 ' N ' ' NE2' ' A' ' 14' ' ' GLN . 0.8 OUTLIER -123.91 158.33 60.43 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.368 -0.378 . . . . 4.3 110.486 179.995 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.469 ' HG2' HE22 ' A' ' 191' ' ' GLN . 97.6 Cg_endo -82.11 -64.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.808 2.339 . . . . 1.96 113.446 -178.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.736 ' ND2' ' HZ2' ' A' ' 61' ' ' LYS . 52.9 t30 -108.42 -19.54 13.42 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.087 0.403 . . . . 3.33 112.087 -178.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 27.2 m -107.33 152.07 24.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.214 0.531 . . . . 1.53 111.256 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.0 t-80 -155.22 102.91 2.24 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.705 -0.68 . . . . 2.29 110.66 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.476 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.4 Cg_endo -82.6 145.59 13.12 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.882 2.388 . . . . 0.88 112.676 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.412 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.77 167.99 24.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 2.12 109.982 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.14 147.95 29.07 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.75 -0.463 . . . . 2.67 109.75 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.504 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.6 p90 -142.27 157.28 45.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.017 0.437 . . . . 0.32 111.242 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.464 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.8 m-20 -127.96 155.3 44.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.786 -0.643 . . . . 2.77 110.132 178.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.66 173.06 6.33 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 121.14 0.495 . . . . 1.25 110.666 -179.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.66 173.88 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.882 2.388 . . . . 1.12 111.506 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.06 -50.93 0.69 Allowed Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 120.717 -0.393 . . . . 4.05 110.134 179.902 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.654 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.8 Cg_exo -64.96 152.43 82.35 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.697 2.264 . . . . 2.12 111.451 179.187 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.77 42.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.385 0.612 . . . . 2.85 110.518 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.813 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.67 -41.68 98.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.02 -0.991 . . . . 3.11 110.722 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.447 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.5 mt -109.78 137.86 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.723 -0.672 . . . . 1.86 111.311 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.98 -72.82 0.71 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.013 -0.54 . . . . 1.61 111.92 -178.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.23 148.4 24.37 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.593 0.59 . . . . 1.67 112.593 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.85 124.74 44.84 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.413 -0.588 . . . . 1.07 109.413 177.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.4 mt -117.88 134.72 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.666 -0.414 . . . . 1.55 110.701 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.489 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -120.02 128.55 53.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 1.33 111.228 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.15 138.99 49.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.708 -0.678 . . . . 2.36 110.11 178.974 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.414 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -144.99 163.23 34.83 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.152 0.501 . . . . 0.38 112.066 -178.081 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.488 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.59 139.65 7.81 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.435 -0.802 . . . . 2.31 110.397 178.808 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.66 115.54 3.12 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.284 1.989 . . . . 0.86 111.793 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.683 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.03 81.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.899 -0.408 . . . . 3.44 109.899 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.688 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.22 -20.54 0.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.969 -0.56 . . . . 2.72 111.9 -179.526 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 p -157.65 157.69 34.05 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 120.855 -0.338 . . . . 2.78 110.569 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.3 27.79 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.249 -0.432 . . . . 2.3 110.223 179.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.79 -75.91 1.31 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.184 -0.531 . . . . 1.8 111.831 -179.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.93 152.31 35.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.981 0.419 . . . . 5.48 110.939 -179.285 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.669 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.2 -169.14 2.54 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.001 -0.545 . . . . 1.84 111.873 179.415 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.413 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.6 mttp -110.13 149.66 29.74 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.48 0.657 . . . . 2.27 112.568 -177.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.01 156.42 46.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.757 -1.111 . . . . 1.92 110.325 178.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.21 158.27 41.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.978 -0.555 . . . . 1.09 111.788 -179.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.8 m -115.07 135.58 54.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.502 -0.772 . . . . 1.16 109.889 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.452 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.33 121.96 23.86 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.422 -0.353 . . . . 1.39 111.588 -179.171 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.514 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.3 Cg_exo -46.29 151.7 1.62 Allowed 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.706 2.271 . . . . 0.72 112.181 178.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.01 -23.02 63.28 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 116.133 -0.485 . . . . 0.74 112.708 -179.107 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.514 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.78 -16.79 46.49 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.223 -0.591 . . . . 1.26 111.854 -178.341 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.492 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.5 mt -91.6 138.45 31.56 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.779 -0.368 . . . . 1.59 110.321 179.338 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.54 13.79 10.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.433 -0.349 . . . . 2.07 111.475 -179.285 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.477 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.91 143.56 25.35 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.591 -0.444 . . . . 0.96 111.003 179.633 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.4 t80 -114.88 -169.41 1.54 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.127 0.489 . . . . 1.0 110.904 -179.455 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.714 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.74 125.85 9.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.408 -0.815 . . . . 1.19 109.805 179.288 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.449 HD11 HG23 ' A' ' 60' ' ' ILE . 66.7 mt -114.77 123.21 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.415 -0.514 . . . . 1.47 111.268 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.749 ' HZ1' ' CD1' ' A' ' 185' ' ' ILE . 50.4 tttp -126.5 163.4 23.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.884 -0.598 . . . . 3.0 110.431 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.598 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.15 19.02 59.78 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.737 -0.945 . . . . 0.5 110.737 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.437 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.5 mt -79.09 157.18 28.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.077 0.465 . . . . 1.21 111.327 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.609 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -99.41 134.05 21.5 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.525 -0.762 . . . . 3.2 110.49 179.722 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.587 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -68.03 143.66 60.89 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.463 2.109 . . . . 1.09 111.908 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.79 25.64 75.32 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.031 -0.828 . . . . 0.72 111.031 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.648 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.15 158.8 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.735 0.302 . . . . 1.47 110.369 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.09 139.94 41.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.333 -0.394 . . . . 1.23 110.565 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.648 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.58 136.46 54.89 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.954 -0.566 . . . . 1.1 110.82 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.98 131.06 45.32 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.481 -0.933 . . . . 1.87 108.481 177.67 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.5 153.87 16.65 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.221 -0.99 . . . . 0.39 111.935 -178.566 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.93 140.94 46.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.648 -0.501 . . . . 1.8 109.648 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.471 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.2 tp -115.79 118.86 34.21 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.488 -0.485 . . . . 1.11 110.524 179.64 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.8 mt -112.4 129.08 68.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 1.51 110.66 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.82 120.89 43.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.261 -0.427 . . . . 1.47 110.701 -179.649 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.668 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.55 146.44 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.184 0.516 . . . . 1.33 111.001 -179.284 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.813 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.06 153.82 21.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.499 -0.773 . . . . 2.49 109.974 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.23 88.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.959 0.409 . . . . 4.2 110.433 -179.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.43 32.56 0.23 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.74 -0.664 . . . . 6.4 110.604 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.16 -117.33 3.28 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.443 -0.663 . . . . 1.74 111.443 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.451 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.48 177.42 8.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.157 0.503 . . . . 3.64 111.655 -179.131 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.17 149.59 32.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.468 -0.787 . . . . 1.7 110.35 179.181 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.2 144.62 38.59 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.386 -0.37 . . . . 2.7 110.527 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -127.94 136.01 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 121.032 0.444 . . . . 1.16 111.617 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.1 141.35 52.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.634 -0.712 . . . . 1.14 110.285 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.463 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.62 138.87 51.67 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.085 0.469 . . . . 4.33 111.535 -179.354 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.491 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.28 164.15 38.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.524 -0.762 . . . . 0.91 109.53 179.371 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.565 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.1 p30 -145.22 151.52 38.53 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.411 -0.516 . . . . 1.47 111.049 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.575 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.2 p90 -146.19 172.73 13.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.781 -0.645 . . . . 0.51 111.053 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.44 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.73 160.67 21.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.414 -0.812 . . . . 1.92 109.841 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.44 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.47 121.9 22.88 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.563 -0.455 . . . . 1.63 110.768 179.927 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.413 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -128.28 151.03 49.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.051 -0.522 . . . . 2.37 111.421 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--N 1.332 -0.18 0 CA-C-O 121.357 0.599 . . . . 3.63 110.337 177.66 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 112.286 0.476 . . . . 1.25 112.286 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.48 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.9 167.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.064 -0.516 . . . . 1.16 110.931 179.124 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.479 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.9 m-30 -133.66 145.52 50.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.772 -0.649 . . . . 0.78 110.111 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.29 101.62 9.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.087 -0.708 . . . . 1.08 109.087 177.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.459 HG11 ' N ' ' A' ' 131' ' ' SER . 72.4 t -112.85 139.67 36.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.015 -0.538 . . . . 1.1 111.129 -178.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.459 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.4 p -128.72 152.49 48.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.692 -0.685 . . . . 0.87 109.852 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.647 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.7 p90 -144.72 -164.84 2.01 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.705 -0.398 . . . . 0.37 110.678 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.734 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.3 t -124.01 127.17 73.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 1.14 110.799 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.172 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.95 58.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.138 -0.483 . . . . 1.91 110.283 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.07 24.4 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.003 -0.544 . . . . 1.56 111.442 -179.721 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.172 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.2 128.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.688 -0.405 . . . . 1.56 111.002 179.823 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -86.41 -9.6 55.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.885 -0.598 . . . . 1.88 110.294 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.15 0.25 55.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.471 . . . . 1.63 110.351 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.959 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.22 137.3 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.943 -0.571 . . . . 1.11 109.955 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 185' ' ' ILE . 69.3 m -96.38 -15.51 21.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.336 0.588 . . . . 1.01 110.011 -179.65 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.55 175.56 45.74 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 109.847 -1.301 . . . . 0.14 109.847 179.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.43 151.65 42.44 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.601 -0.439 . . . . 0.21 110.488 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.495 ' NH2' ' CD2' ' A' ' 183' ' ' TYR . 68.8 ttp85 -132.37 121.13 23.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.175 -0.466 . . . . 1.54 109.87 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.502 HG23 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.03 136.61 38.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.678 -0.692 . . . . 1.08 110.687 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 83.3 tt0 -129.37 129.95 45.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.942 -0.572 . . . . 1.32 110.031 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.9 p90 -138.77 135.26 34.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.998 -0.547 . . . . 1.05 110.582 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.408 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.32 161.4 39.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.769 -0.65 . . . . 1.16 109.638 179.804 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.944 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -71.05 124.79 25.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.99 0.424 . . . . 1.23 110.666 -179.585 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.74 -7.65 49.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.756 -0.656 . . . . 0.86 110.909 -179.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.9 -69.71 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.301 -0.409 . . . . 1.66 111.357 -179.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.472 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.65 -35.35 76.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.083 -0.508 . . . . 1.66 111.471 -179.09 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.076 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.12 88.67 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.771 -0.932 . . . . 1.62 110.771 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.324 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.9 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.74 0.305 . . . . 1.86 110.334 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.324 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.35 139.11 44.85 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.01 0.433 . . . . 1.98 110.165 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.408 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.5 Cg_endo -70.97 145.89 51.34 Favored 'Trans proline' 0 C--N 1.301 -1.936 0 C-N-CA 122.601 2.201 . . . . 0.62 112.365 -179.472 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.89 145.67 42.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.147 -0.686 . . . . 1.14 109.147 179.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.587 ' CE1' ' CD ' ' A' ' 65' ' ' PRO . 11.5 p90 -123.2 141.41 52.0 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.363 -0.535 . . . . 1.44 111.6 -179.2 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.407 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.7 mt -128.14 127.61 43.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.326 -0.852 . . . . 1.08 108.911 179.016 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.593 ' OD2' ' ND2' ' A' ' 16' ' ' ASN . 66.9 m-20 -101.59 131.23 47.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.143 0.497 . . . . 1.09 111.781 -178.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.506 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -128.03 157.52 73.71 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.324 -0.853 . . . . 1.04 109.477 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -69.78 158.05 58.25 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.433 2.089 . . . . 0.21 112.218 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.1 p -59.33 -12.14 5.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.824 -0.626 . . . . 0.88 110.698 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.1 p -92.8 -8.8 42.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 1.06 110.742 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.39 34.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 1.05 110.433 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.7 p -133.14 16.68 4.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.413 -0.358 . . . . 1.07 110.483 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.58 147.09 5.04 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.658 -0.497 . . . . 0.92 109.658 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.506 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.14 150.49 12.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.515 -0.474 . . . . 1.09 111.588 -179.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 125.0 50.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.667 -0.697 . . . . 1.31 109.761 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.512 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.6 105.01 31.17 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.985 0.422 . . . . 1.09 110.999 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.0 Cg_endo -91.03 -179.51 1.48 Allowed 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 123.158 2.572 . . . . 0.48 112.174 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.69 32.64 18.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.428 -0.805 . . . . 1.26 111.443 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.512 HD21 HG21 ' A' ' 169' ' ' ILE . 24.0 mt -86.34 148.47 25.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.47 -0.332 . . . . 1.12 110.487 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.777 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.14 114.91 61.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.982 0.42 . . . . 1.3 110.666 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.1 140.61 95.89 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.901 2.401 . . . . 0.92 111.971 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.1 21.12 74.47 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.072 -0.811 . . . . 0.44 111.072 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.472 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.79 150.24 49.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.849 0.357 . . . . 3.05 110.641 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.501 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.3 131.69 46.09 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.062 -0.517 . . . . 1.48 109.755 179.335 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.944 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.61 148.36 44.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.07 -0.514 . . . . 0.89 110.94 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.39 125.41 60.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.255 -1.017 . . . . 1.12 108.255 177.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.53 132.53 63.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.084 0.469 . . . . 1.1 111.251 -178.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.9 m-20 -136.47 122.54 20.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.604 -0.725 . . . . 0.43 109.669 179.297 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.595 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.02 125.41 54.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.281 -0.418 . . . . 1.07 110.682 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.672 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.2 m-85 -117.23 137.8 52.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.999 -0.546 . . . . 0.92 109.9 179.538 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.573 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.64 135.01 42.74 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.853 -0.795 . . . . 0.49 108.853 178.816 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.749 ' CD1' ' HZ1' ' A' ' 61' ' ' LYS . 81.3 mt -99.12 122.94 51.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.212 0.53 . . . . 1.08 110.909 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.45 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.7 p -83.87 169.72 14.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.512 -0.767 . . . . 0.89 110.501 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 187' ' ' GLU . 49.5 tp10 -59.74 -14.59 15.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.01 -0.541 . . . . 1.6 110.902 -179.563 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.55 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.8 m-20 -96.06 -4.27 43.3 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.836 -0.346 . . . . 1.18 110.809 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.82 13.89 63.94 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.346 -0.701 . . . . 0.34 111.346 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -84.73 139.1 32.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.67 0.271 . . . . 1.22 110.437 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.469 HE22 ' HG2' ' A' ' 15' ' ' PRO . 87.1 mt-30 -106.75 141.08 38.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.361 . . . . 1.44 110.551 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.0 m -136.72 127.05 26.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 1.39 110.35 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.672 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.6 tp -68.17 117.29 9.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.266 -0.424 . . . . 1.08 110.566 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.647 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.0 pt -108.96 -21.89 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 1.08 110.706 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.86 125.76 5.89 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.412 -0.515 . . . . 1.1 111.449 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.491 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.72 120.21 21.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.793 -0.64 . . . . 0.94 109.643 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.63 151.7 29.11 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.642 -0.423 . . . . 1.07 110.954 -179.272 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.54 158.58 18.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.04 -0.527 . . . . 0.89 110.38 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.04 157.95 43.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.67 110.645 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.29 104.34 9.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.732 -0.667 . . . . 1.17 110.061 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.479 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 68.2 p . . . . . 0 C--O 1.221 -0.407 0 CA-C-O 117.837 -1.078 . . . . 1.26 110.593 -179.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.9 m . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.244 -0.65 . . . . 3.83 109.244 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.434 ' H ' ' HB3' ' A' ' 1' ' ' SER . . . -116.33 150.73 18.54 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.03 -0.828 . . . . 1.39 111.03 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -35.67 142.41 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.054 0 C-N-CA 123.934 3.089 . . . . 0.86 113.813 -179.23 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.559 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.1 t -79.94 173.43 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.257 -1.338 . . . . 1.43 108.804 178.42 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.403 ' H ' ' CG1' ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.64 125.85 51.47 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.424 -0.51 . . . . 1.94 111.392 -179.553 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.58 144.06 33.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.655 -0.702 . . . . 1.19 110.597 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.04 168.36 25.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.857 0.361 . . . . 3.92 111.105 -179.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.579 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.4 mt -109.0 131.08 60.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.002 -0.545 . . . . 3.88 110.063 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.5 p -141.17 162.3 35.82 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.829 0.347 . . . . 3.92 111.202 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 69.3 mm-40 36.1 31.57 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.563 -0.532 . . . . 6.08 109.563 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.579 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.41 69.59 32.3 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.968 -0.56 . . . . 4.01 111.625 -178.833 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.639 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.21 -29.23 73.47 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.496 2.131 . . . . 4.51 111.864 179.339 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.639 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.72 125.58 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.142 -0.481 . . . . 3.51 110.512 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.534 ' CB ' ' O ' ' A' ' 17' ' ' SER . 28.2 mt-30 -124.02 158.34 60.69 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.406 -0.361 . . . . 4.3 110.466 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.539 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 98.1 Cg_endo -82.01 -64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.843 2.362 . . . . 1.96 113.503 -178.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.811 ' ND2' ' CE2' ' A' ' 157' ' ' TYR . 5.1 t-20 -108.38 -19.65 13.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.326 -0.397 . . . . 3.33 112.064 -178.553 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 31.1 m -107.3 152.05 24.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.145 0.498 . . . . 1.53 111.266 -179.358 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.569 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.31 102.96 2.22 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.677 -0.692 . . . . 2.29 110.637 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.69 145.55 12.97 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.915 2.41 . . . . 0.88 112.646 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 pt -130.74 167.98 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.881 -0.6 . . . . 2.12 109.922 179.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.15 147.96 29.07 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.738 -0.467 . . . . 2.67 109.738 178.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.501 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.6 p90 -142.29 157.25 45.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.017 0.437 . . . . 0.32 111.204 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.473 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.9 m-20 -127.99 155.31 44.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.817 -0.629 . . . . 2.77 110.087 178.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.62 173.05 6.33 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.187 -0.461 . . . . 1.25 110.741 -179.199 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -50.72 173.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.885 0 C-N-CA 122.867 2.378 . . . . 1.12 111.497 179.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.95 -50.97 0.7 Allowed Pre-proline 0 C--N 1.33 -0.255 0 C-N-CA 120.672 -0.411 . . . . 4.05 110.134 179.847 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.648 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.97 152.4 82.48 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.652 2.235 . . . . 2.12 111.419 179.219 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.68 42.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.427 0.632 . . . . 2.85 110.615 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.82 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.65 -41.56 98.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.97 -1.014 . . . . 3.11 110.691 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.442 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.6 mt -109.95 137.92 40.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.728 -0.669 . . . . 1.86 111.259 -179.462 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.03 -72.87 0.7 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.039 -0.528 . . . . 1.61 111.894 -178.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.35 24.45 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.581 0.586 . . . . 1.67 112.581 -179.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -121.84 124.9 45.22 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.338 -0.616 . . . . 1.07 109.338 177.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.9 mt -118.04 134.7 60.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.651 -0.42 . . . . 1.55 110.61 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.48 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -119.99 128.6 53.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.978 0.418 . . . . 1.33 111.334 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.549 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.07 138.99 49.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.715 -0.675 . . . . 2.36 110.215 178.972 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.418 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.06 163.12 35.23 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.109 0.48 . . . . 0.38 112.093 -178.065 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.4 139.58 7.93 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.466 -0.788 . . . . 2.31 110.538 178.777 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.694 ' O ' ' N ' ' A' ' 41' ' ' ASN . 18.2 Cg_endo -63.46 115.4 3.01 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.322 2.014 . . . . 0.86 111.94 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.674 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.98 81.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.837 -0.431 . . . . 3.44 109.837 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.694 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.31 -20.65 0.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.015 -0.538 . . . . 2.72 111.927 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.2 p -157.56 157.83 34.48 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.809 -0.356 . . . . 2.78 110.56 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.42 27.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 2.3 110.125 179.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.87 -75.84 1.31 Allowed Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.178 -0.534 . . . . 1.8 111.89 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.91 152.31 35.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.961 0.41 . . . . 5.48 111.056 -179.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.645 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.13 2.53 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.126 -0.488 . . . . 1.84 111.985 179.364 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.08 149.67 29.69 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.464 0.649 . . . . 2.27 112.563 -177.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.04 156.52 46.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.762 -1.108 . . . . 1.92 110.259 178.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.22 158.34 41.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.916 -0.584 . . . . 1.09 111.82 -179.306 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.6 m -115.23 135.7 53.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.479 -0.782 . . . . 1.16 109.75 179.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.441 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.31 121.96 23.88 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.353 -0.385 . . . . 1.39 111.546 -179.153 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.519 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.4 Cg_exo -46.41 151.71 1.7 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.731 2.287 . . . . 0.72 112.083 179.029 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.99 -22.92 63.11 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.076 -0.511 . . . . 0.74 112.747 -179.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.519 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.85 -16.83 46.1 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 117.382 0.591 . . . . 1.26 111.786 -178.34 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.497 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.5 mt -91.58 138.42 31.58 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.766 -0.373 . . . . 1.59 110.385 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.55 13.88 10.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.442 -0.344 . . . . 2.07 111.587 -179.318 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.48 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.4 p -150.03 143.37 25.12 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.595 -0.442 . . . . 0.96 111.03 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.72 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.67 -169.36 1.53 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.969 -179.452 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.72 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.81 125.86 9.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.411 -0.813 . . . . 1.19 109.841 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.442 HD11 HG23 ' A' ' 60' ' ' ILE . 66.4 mt -114.78 123.25 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.429 -0.508 . . . . 1.47 111.208 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -126.5 163.38 23.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.77 -0.65 . . . . 3.0 110.469 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.681 ' C ' HD22 ' A' ' 16' ' ' ASN . . . 85.11 19.14 59.63 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.662 -0.975 . . . . 0.5 110.662 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.687 ' N ' ' ND2' ' A' ' 16' ' ' ASN . 73.6 mt -79.13 157.17 27.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.975 0.417 . . . . 1.21 111.331 -179.658 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.621 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 2.7 mttm -99.46 133.87 21.61 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.571 -0.74 . . . . 3.2 110.43 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.84 143.62 61.8 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.548 2.165 . . . . 1.09 111.908 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.81 25.61 75.35 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.071 -0.812 . . . . 0.72 111.071 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.644 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.3 p -128.15 158.67 40.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.651 0.262 . . . . 1.47 110.475 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.12 139.85 42.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.988 0.423 . . . . 1.23 110.571 -179.73 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.644 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.3 m-85 -122.46 136.52 54.91 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.902 -0.59 . . . . 1.1 110.766 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -99.02 131.07 45.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.468 -0.938 . . . . 1.87 108.468 177.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.483 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.54 153.82 16.67 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.341 -0.933 . . . . 0.39 112.0 -178.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.94 140.96 46.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.689 -0.486 . . . . 1.8 109.689 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.471 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.4 tp -115.75 118.88 34.27 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.454 -0.498 . . . . 1.11 110.48 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.9 mt -112.46 129.14 68.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.347 -0.388 . . . . 1.51 110.63 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.9 120.74 43.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.287 -0.415 . . . . 1.47 110.69 -179.568 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.675 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.47 146.36 11.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.139 0.495 . . . . 1.33 111.076 -179.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.82 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -105.95 153.86 21.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.559 -0.746 . . . . 2.49 109.925 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.16 88.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.865 0.364 . . . . 4.2 110.42 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.633 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.39 32.55 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.826 -0.624 . . . . 6.4 110.558 -179.942 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.04 -117.44 3.3 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.418 -0.673 . . . . 1.74 111.418 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.453 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.38 177.31 9.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.209 0.528 . . . . 3.64 111.665 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.11 149.43 32.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.442 -0.799 . . . . 1.7 110.403 179.221 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.08 144.65 38.85 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.458 -0.337 . . . . 2.7 110.594 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.94 135.97 61.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 121.118 0.485 . . . . 1.16 111.582 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.559 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -123.95 141.37 52.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.657 -0.701 . . . . 1.14 110.359 179.531 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.482 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.6 138.89 51.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.08 0.467 . . . . 4.33 111.527 -179.365 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.483 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.31 164.15 38.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.577 -0.738 . . . . 0.91 109.526 179.353 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.574 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 46.8 p30 -145.21 151.59 38.64 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.392 -0.523 . . . . 1.47 111.069 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.569 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.9 p90 -146.2 172.72 13.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.767 -0.652 . . . . 0.51 111.045 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.445 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.71 160.69 21.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.47 -0.786 . . . . 1.92 109.815 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.445 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.35 121.84 22.93 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.582 -0.447 . . . . 1.63 110.759 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -127.45 154.65 44.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 2.37 112.109 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.2 p . . . . . 0 CA--C 1.528 0.128 0 CA-C-N 115.662 -0.699 . . . . 3.63 111.459 178.856 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 84.6 p . . . . . 0 N--CA 1.462 0.134 0 CA-C-O 120.81 0.338 . . . . 1.25 111.259 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.469 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.84 167.57 0.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.977 -0.556 . . . . 1.16 110.855 179.743 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.483 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.9 m-30 -133.61 145.61 50.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.665 -0.698 . . . . 0.78 110.154 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.32 101.65 9.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.108 -0.701 . . . . 1.08 109.108 177.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.468 HG11 ' N ' ' A' ' 131' ' ' SER . 71.6 t -112.91 139.75 36.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.997 -0.547 . . . . 1.1 111.132 -178.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.468 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.7 p -128.74 152.56 48.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.686 -0.688 . . . . 0.87 109.883 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.644 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.5 p90 -144.82 -164.98 2.04 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.738 -0.385 . . . . 0.37 110.612 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.74 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.4 t -123.93 127.13 73.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 1.14 110.801 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.149 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 1.91 110.378 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.74 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.06 24.41 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.932 -0.576 . . . . 1.56 111.4 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.149 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.21 128.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.652 -0.419 . . . . 1.56 110.937 179.819 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -86.36 -9.62 56.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.869 -0.605 . . . . 1.88 110.376 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.12 0.26 55.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 1.63 110.307 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.964 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.34 137.28 25.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.993 -0.549 . . . . 1.11 109.894 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 185' ' ' ILE . 72.0 m -96.25 -15.5 21.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.305 0.574 . . . . 1.01 110.053 -179.698 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.54 175.57 45.73 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 109.822 -1.311 . . . . 0.14 109.822 179.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -123.48 151.62 42.56 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.65 -0.42 . . . . 0.21 110.545 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.64 ' NH2' ' CD2' ' A' ' 183' ' ' TYR . 69.2 ttp85 -132.26 121.11 23.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.12 -0.491 . . . . 1.54 109.979 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.487 HG23 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.01 136.49 38.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.744 -0.662 . . . . 1.08 110.658 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 80.0 tt0 -129.34 129.88 45.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.987 -0.551 . . . . 1.32 110.096 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.72 135.34 34.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.998 -0.546 . . . . 1.05 110.605 -179.708 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.41 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.31 161.36 39.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.679 -0.692 . . . . 1.16 109.627 179.844 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.943 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.3 mt -71.02 124.9 25.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.054 0.454 . . . . 1.23 110.708 -179.676 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.503 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.78 -7.6 49.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.713 -0.676 . . . . 0.86 110.952 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -109.86 -69.7 0.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.405 . . . . 1.66 111.417 -179.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.426 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.66 -35.34 76.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.108 -0.496 . . . . 1.66 111.486 -179.142 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.094 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.19 7.21 88.61 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.806 -0.918 . . . . 1.62 110.806 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.312 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.91 -171.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.739 0.304 . . . . 1.86 110.23 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.312 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.37 139.07 44.75 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.973 0.416 . . . . 1.98 110.205 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.41 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.8 Cg_endo -70.89 145.87 51.72 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.662 2.241 . . . . 0.62 112.391 -179.526 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.9 145.75 42.62 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.217 -0.66 . . . . 1.14 109.217 179.276 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.811 ' CE2' ' ND2' ' A' ' 16' ' ' ASN . 49.2 p90 -123.26 141.22 52.21 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.418 -0.513 . . . . 1.44 111.536 -179.013 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.9 mt -128.05 127.67 43.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.329 -0.85 . . . . 1.08 109.068 178.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -101.74 131.2 48.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.236 0.541 . . . . 1.09 111.726 -178.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.515 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -127.97 157.55 73.51 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.226 -0.897 . . . . 1.04 109.558 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.78 157.96 58.56 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 122.521 2.148 . . . . 0.21 112.178 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.1 p -59.28 -12.11 5.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.77 -0.65 . . . . 0.88 110.74 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.79 -8.83 42.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.085 -0.507 . . . . 1.06 110.703 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.13 135.39 34.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 1.05 110.364 179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.1 p -133.21 16.71 4.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.339 -0.392 . . . . 1.07 110.521 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.7 p -167.56 147.14 5.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.65 -0.5 . . . . 0.92 109.65 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.515 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.22 150.5 12.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.561 -0.456 . . . . 1.09 111.545 -179.619 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.487 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.39 124.93 50.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.644 -0.707 . . . . 1.31 109.827 179.466 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.515 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.32 104.82 29.08 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.428 -0.351 . . . . 1.09 111.158 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.7 Cg_endo -91.02 -179.47 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 123.188 2.592 . . . . 0.48 112.188 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.53 32.8 18.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.444 -0.798 . . . . 1.26 111.467 179.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.515 HD21 HG21 ' A' ' 169' ' ' ILE . 24.1 mt -86.43 148.49 25.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.468 -0.333 . . . . 1.12 110.409 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.769 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.29 114.83 61.2 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.091 0.472 . . . . 1.3 110.722 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.01 140.63 96.19 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.878 2.385 . . . . 0.92 111.952 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.03 21.25 74.35 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.087 -0.805 . . . . 0.44 111.087 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.426 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.97 150.25 49.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.928 0.394 . . . . 3.05 110.541 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.503 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.18 131.66 45.99 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.983 -0.553 . . . . 1.48 109.792 179.316 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.943 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.56 148.22 44.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.07 -0.513 . . . . 0.89 111.101 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.24 125.4 60.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.263 -1.014 . . . . 1.12 108.263 177.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.6 132.43 63.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.202 0.525 . . . . 1.1 111.338 -178.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.46 122.62 20.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.477 -0.783 . . . . 0.43 109.63 179.342 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.585 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.07 125.39 55.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.176 -0.465 . . . . 1.07 110.654 -179.493 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.67 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.7 m-85 -117.3 137.93 52.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.001 -0.545 . . . . 0.92 109.839 179.533 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.563 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.63 135.06 42.66 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.79 -0.819 . . . . 0.49 108.79 178.916 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.546 ' O ' ' N ' ' A' ' 140' ' ' SER . 81.3 mt -99.14 122.83 51.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.101 0.477 . . . . 1.08 111.022 -178.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.448 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.5 p -83.73 169.74 14.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.568 -0.742 . . . . 0.89 110.499 -179.694 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.81 -14.5 15.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.028 -0.533 . . . . 1.6 110.975 -179.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.448 ' H ' ' HG ' ' A' ' 186' ' ' SER . 95.3 m-20 -96.09 -4.26 43.21 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.854 -0.339 . . . . 1.18 110.86 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.7 14.03 63.94 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.365 -0.694 . . . . 0.34 111.365 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -84.73 139.08 32.24 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.03 -0.268 . . . . 1.22 110.484 179.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -106.72 141.03 38.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.871 0.367 . . . . 1.44 110.517 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.0 m -136.74 126.99 26.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 1.39 110.337 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.67 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.5 tp -68.05 117.35 9.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.308 -0.406 . . . . 1.08 110.534 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.644 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -109.09 -21.82 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 1.08 110.68 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.8 125.72 5.92 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.489 -0.484 . . . . 1.1 111.487 -179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.496 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.78 120.26 21.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.835 -0.62 . . . . 0.94 109.554 179.123 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.66 29.05 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.71 -0.396 . . . . 1.07 110.942 -179.28 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.8 p -110.4 158.64 18.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.521 . . . . 0.89 110.382 179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.11 157.83 43.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.057 -0.519 . . . . 0.67 110.691 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.22 104.31 9.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.762 -0.654 . . . . 1.17 110.058 179.513 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.483 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.2 p . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.991 -1.005 . . . . 1.26 110.577 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.0 m . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.196 -0.668 . . . . 3.83 109.196 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.425 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.36 150.7 18.54 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.981 -0.848 . . . . 1.39 110.981 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -35.68 142.38 0.1 Allowed 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 123.982 3.122 . . . . 0.86 113.835 -179.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.568 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -79.92 173.41 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.306 -1.316 . . . . 1.43 108.81 178.413 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.402 ' H ' ' CG1' ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.55 125.84 51.45 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.484 -0.486 . . . . 1.94 111.46 -179.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.5 144.01 33.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.638 -0.71 . . . . 1.19 110.689 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.36 25.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.946 0.403 . . . . 3.92 111.089 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.576 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -109.01 131.15 60.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.99 -0.55 . . . . 3.88 110.05 179.833 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.25 162.33 35.74 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.823 0.344 . . . . 3.92 111.236 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.3 mt-10 35.99 31.69 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.626 -0.509 . . . . 6.08 109.626 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.576 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.55 32.99 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.944 -0.571 . . . . 4.01 111.541 -178.816 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.643 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.21 -29.09 73.38 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.478 2.119 . . . . 4.51 111.883 179.333 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.643 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.55 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 3.51 110.487 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.62 ' NE2' ' O ' ' A' ' 13' ' ' SER . 1.7 mp0 -124.0 158.3 60.77 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.32 -0.4 . . . . 4.3 110.456 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.542 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 97.0 Cg_endo -82.0 -64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.939 2.426 . . . . 1.96 113.511 -178.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.558 HD21 ' CD ' ' A' ' 143' ' ' ARG . 78.2 m-20 -108.52 -19.48 13.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.311 -0.404 . . . . 3.33 112.082 -178.531 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 27.5 m -107.29 152.01 24.7 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.44 -0.504 . . . . 1.53 111.329 -179.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.571 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.0 t-80 -155.17 102.87 2.25 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.796 -0.638 . . . . 2.29 110.742 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.61 145.71 13.16 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.862 2.375 . . . . 0.88 112.55 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.4 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.85 167.94 24.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.795 -0.639 . . . . 2.12 109.847 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.17 147.88 28.97 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.754 -0.462 . . . . 2.67 109.754 178.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.504 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.6 p90 -142.23 157.34 44.96 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.673 -0.411 . . . . 0.32 111.252 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.47 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.1 m-20 -128.06 155.31 44.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.866 -0.607 . . . . 2.77 110.085 179.029 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.67 172.98 6.44 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.128 -0.487 . . . . 1.25 110.798 -179.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.6 174.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 122.859 2.373 . . . . 1.12 111.552 179.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.07 -51.15 0.68 Allowed Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 120.664 -0.414 . . . . 4.05 110.112 179.795 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.65 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.83 152.33 82.52 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.757 2.304 . . . . 2.12 111.44 179.225 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.68 42.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.426 0.632 . . . . 2.85 110.628 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.813 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.66 -41.58 98.17 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.966 -1.015 . . . . 3.11 110.651 179.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.448 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.9 mt -109.82 137.85 40.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.851 -0.613 . . . . 1.86 111.311 -179.511 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.06 -72.9 0.7 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.054 -0.521 . . . . 1.61 111.853 -178.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.16 148.41 24.43 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.59 0.589 . . . . 1.67 112.59 -179.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.79 124.86 45.18 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.327 -0.62 . . . . 1.07 109.327 177.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.05 134.76 60.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.678 -0.409 . . . . 1.55 110.636 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.484 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -119.99 128.49 53.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.437 . . . . 1.33 111.237 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -130.99 139.07 49.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.756 -0.657 . . . . 2.36 110.151 178.899 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.414 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.2 p90 -145.12 163.18 35.11 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.165 0.507 . . . . 0.38 112.094 -178.162 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.51 139.59 7.84 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.431 -0.804 . . . . 2.31 110.479 178.829 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.698 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.9 Cg_endo -63.51 115.43 3.03 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.436 2.091 . . . . 0.86 111.787 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.685 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.08 81.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.984 0.421 . . . . 3.44 109.874 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.698 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.94 -0.573 . . . . 2.72 111.946 -179.532 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.8 p -157.52 157.79 34.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.759 0.314 . . . . 2.78 110.601 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.402 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 16.0 m -120.43 27.92 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 2.3 110.092 179.586 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.92 -75.89 1.31 Allowed Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.083 -0.58 . . . . 1.8 111.764 -179.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.84 152.3 35.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 5.48 110.973 -179.295 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.649 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.24 -169.17 2.54 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.084 -0.507 . . . . 1.84 111.936 179.337 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.414 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.09 149.65 29.73 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.495 0.664 . . . . 2.27 112.556 -177.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.05 156.49 46.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.789 -1.096 . . . . 1.92 110.274 178.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.15 158.39 41.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.981 -0.554 . . . . 1.09 111.837 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.1 m -115.19 135.64 53.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.476 -0.784 . . . . 1.16 109.784 179.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.45 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.38 121.94 23.79 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.432 -0.349 . . . . 1.39 111.548 -179.158 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.52 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.4 Cg_exo -46.32 151.74 1.62 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.658 2.239 . . . . 0.72 112.101 179.023 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.91 -23.01 63.04 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 116.015 -0.539 . . . . 0.74 112.799 -179.289 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.52 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.87 -16.87 45.9 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.208 -0.597 . . . . 1.26 111.755 -178.306 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.49 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.2 mt -91.47 138.44 31.58 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.809 -0.356 . . . . 1.59 110.321 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.62 13.95 10.93 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.36 -0.382 . . . . 2.07 111.464 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.482 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.5 p -150.05 143.48 25.16 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.648 -0.421 . . . . 0.96 111.005 179.602 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.722 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.78 -169.31 1.52 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.857 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.722 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.79 125.83 9.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.333 -0.849 . . . . 1.19 109.841 179.275 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.445 HG23 HD11 ' A' ' 60' ' ' ILE . 66.6 mt -114.74 123.19 70.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.417 -0.513 . . . . 1.47 111.23 -179.733 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.753 ' NZ ' ' OG ' ' A' ' 140' ' ' SER . 66.4 mttt -126.47 163.44 23.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.928 -0.578 . . . . 3.0 110.441 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.01 19.14 59.78 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.759 -0.937 . . . . 0.5 110.759 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.435 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 74.1 mt -79.12 157.31 27.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.078 0.466 . . . . 1.21 111.291 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.602 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 1.2 mttm -99.55 134.0 21.46 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.659 -0.7 . . . . 3.2 110.393 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.654 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.92 143.53 61.0 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.579 2.186 . . . . 1.09 111.925 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.92 25.57 75.41 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.035 -0.826 . . . . 0.72 111.035 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.651 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.19 158.74 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.64 0.257 . . . . 1.47 110.421 -179.521 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.17 139.86 42.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.925 0.393 . . . . 1.23 110.582 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.651 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.46 136.41 54.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.969 -0.56 . . . . 1.1 110.878 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.86 131.01 45.29 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.545 -0.909 . . . . 1.87 108.545 177.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.52 153.87 16.66 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.237 -0.982 . . . . 0.39 111.867 -178.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.97 140.99 46.13 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.684 -0.487 . . . . 1.8 109.684 179.561 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.472 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.0 tp -115.79 118.92 34.36 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.459 -0.496 . . . . 1.11 110.507 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.9 mt -112.49 129.1 68.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.349 -0.387 . . . . 1.51 110.564 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.8 120.89 43.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.251 -0.432 . . . . 1.47 110.669 -179.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.671 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.64 146.5 11.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.246 0.546 . . . . 1.33 111.005 -179.332 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.813 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.09 153.94 21.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.499 -0.773 . . . . 2.49 109.924 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.13 88.57 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.85 0.357 . . . . 4.2 110.427 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.24 32.59 0.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.869 -0.605 . . . . 6.4 110.616 -179.887 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.06 -117.33 3.29 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.471 -0.652 . . . . 1.74 111.471 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.453 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.36 177.35 9.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.198 0.523 . . . . 3.64 111.692 -179.256 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.12 149.61 32.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.464 -0.789 . . . . 1.7 110.478 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.15 144.68 38.72 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.501 -0.318 . . . . 2.7 110.529 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.5 p -128.0 136.01 61.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 120.615 -0.434 . . . . 1.16 111.549 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.03 141.37 52.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.677 -0.692 . . . . 1.14 110.27 179.656 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.489 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.61 138.91 51.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.128 0.489 . . . . 4.33 111.506 -179.379 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 53.0 p90 -152.39 164.19 38.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.554 -0.748 . . . . 0.91 109.4 179.365 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.564 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.1 p30 -145.24 151.54 38.54 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.327 -0.549 . . . . 1.47 111.051 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.571 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.2 p90 -146.2 172.72 13.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.719 -0.673 . . . . 0.51 110.997 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.448 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.5 t -118.72 160.76 21.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.426 -0.807 . . . . 1.92 109.82 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.448 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.46 121.9 22.9 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 120.514 -0.475 . . . . 1.63 110.735 179.942 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.5 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -128.23 163.84 23.84 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.495 0.924 . . . . 2.37 113.495 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.2 t . . . . . 0 C--N 1.331 -0.205 0 N-CA-C 107.16 -1.422 . . . . 3.63 107.16 176.64 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 121.343 0.592 . . . . 1.25 110.081 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.479 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.86 167.56 0.25 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.351 -0.84 . . . . 1.16 110.906 -179.696 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.479 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.9 m-30 -133.64 145.59 50.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.671 -0.695 . . . . 0.78 110.112 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.23 101.66 9.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.124 -0.695 . . . . 1.08 109.124 177.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.472 HG11 ' N ' ' A' ' 131' ' ' SER . 72.0 t -112.94 139.6 37.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.031 -0.531 . . . . 1.1 111.075 -178.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.472 ' N ' HG11 ' A' ' 130' ' ' VAL . 68.1 p -128.63 152.5 48.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.638 -0.71 . . . . 0.87 109.87 179.606 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.655 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.5 p90 -144.8 -164.88 2.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.67 -0.412 . . . . 0.37 110.631 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.732 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -124.0 127.21 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.298 -0.41 . . . . 1.14 110.83 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.154 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -58.11 58.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 1.91 110.239 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.23 24.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.882 -0.599 . . . . 1.56 111.435 -179.661 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.154 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.14 128.75 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.586 -0.446 . . . . 1.56 110.894 179.872 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.32 -9.75 55.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.886 -0.597 . . . . 1.88 110.339 179.78 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.59 ' O ' ' CD ' ' A' ' 187' ' ' GLU . 27.8 p -87.12 0.3 55.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.004 -0.543 . . . . 1.63 110.314 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.964 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.37 137.23 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.915 -0.584 . . . . 1.11 109.959 179.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.753 ' OG ' ' NZ ' ' A' ' 61' ' ' LYS . 89.3 p -96.27 -15.49 21.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.304 0.573 . . . . 1.01 110.017 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.58 175.56 45.76 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.788 -1.325 . . . . 0.14 109.788 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.52 151.65 42.59 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.614 -0.435 . . . . 0.21 110.455 179.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.58 ' NH1' HD12 ' A' ' 185' ' ' ILE . 38.3 ttp-105 -132.37 121.18 23.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.038 -0.528 . . . . 1.54 109.884 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.494 HG23 HG11 ' A' ' 167' ' ' VAL . 46.1 t -104.97 136.57 38.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.752 -0.658 . . . . 1.08 110.669 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 97.5 mt-10 -129.43 129.82 45.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.998 -0.547 . . . . 1.32 110.091 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.6 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.63 135.34 34.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.079 -0.51 . . . . 1.05 110.587 -179.646 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.403 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.36 161.38 39.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.783 -0.644 . . . . 1.16 109.647 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.931 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.3 mt -71.1 124.88 25.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.063 0.459 . . . . 1.23 110.709 -179.623 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.91 -7.57 49.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.745 -0.661 . . . . 0.86 110.869 -179.74 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.81 -69.63 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 1.66 111.439 -179.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.447 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.71 -35.35 76.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.006 -0.543 . . . . 1.66 111.47 -179.094 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.078 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.17 88.64 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.763 -0.935 . . . . 1.62 110.763 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.326 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.4 t0 -27.88 -171.7 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.792 0.33 . . . . 1.86 110.275 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.326 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.27 139.12 45.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.408 . . . . 1.98 110.152 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.403 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 48.1 Cg_endo -70.86 145.85 51.86 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 122.695 2.264 . . . . 0.62 112.299 -179.591 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.6 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.92 145.75 42.65 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.173 -0.677 . . . . 1.14 109.173 179.157 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.654 ' CE1' ' CD ' ' A' ' 65' ' ' PRO . 48.4 p90 -123.34 141.33 52.1 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.336 -0.546 . . . . 1.44 111.564 -179.117 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.4 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.8 mt -128.04 127.6 43.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.349 -0.841 . . . . 1.08 109.001 179.008 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -101.65 131.1 48.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.207 0.527 . . . . 1.09 111.783 -178.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.515 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -127.87 157.62 73.09 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.308 -0.86 . . . . 1.04 109.586 179.647 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -69.75 157.98 58.56 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 C-N-CA 122.431 2.087 . . . . 0.21 112.29 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.1 p -59.23 -12.22 5.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.871 -0.604 . . . . 0.88 110.725 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.9 p -92.83 -8.73 42.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.107 -0.497 . . . . 1.06 110.753 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.15 135.35 34.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.451 . . . . 1.05 110.436 179.672 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 p -133.11 16.71 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.437 -0.347 . . . . 1.07 110.536 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.9 p -167.52 147.04 5.07 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.639 -0.504 . . . . 0.92 109.639 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.515 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.21 150.42 12.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.567 -0.453 . . . . 1.09 111.63 -179.658 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.496 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.32 124.96 50.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.595 -0.729 . . . . 1.31 109.832 179.519 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.519 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.38 104.92 29.88 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.882 0.372 . . . . 1.09 111.03 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.1 Cg_endo -91.0 -179.44 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 123.175 2.583 . . . . 0.48 112.137 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.54 32.69 18.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.362 -0.835 . . . . 1.26 111.49 179.325 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.519 HD21 HG21 ' A' ' 169' ' ' ILE . 24.1 mt -86.33 148.54 25.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.427 -0.351 . . . . 1.12 110.435 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.775 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.35 114.82 61.19 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.026 0.441 . . . . 1.3 110.705 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.96 140.55 95.82 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.904 2.403 . . . . 0.92 111.969 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.1 21.24 74.17 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.064 -0.814 . . . . 0.44 111.064 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.447 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.87 150.18 49.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.808 0.337 . . . . 3.05 110.631 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.26 131.61 46.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 1.48 109.737 179.381 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.931 ' CE2' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.45 148.2 44.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.107 -0.497 . . . . 0.89 111.119 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.31 125.4 60.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.275 -1.009 . . . . 1.12 108.275 177.728 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.5 132.54 63.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.156 0.503 . . . . 1.1 111.249 -178.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.55 122.63 20.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.485 -0.78 . . . . 0.43 109.553 179.288 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.585 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.0 125.4 54.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.224 -0.443 . . . . 1.07 110.658 -179.526 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.669 ' CE1' HD11 ' A' ' 193' ' ' LEU . 47.9 m-85 -117.23 137.79 52.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.101 -0.5 . . . . 0.92 109.921 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.569 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.74 135.01 42.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.743 -0.836 . . . . 0.49 108.743 178.922 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.58 HD12 ' NH1' ' A' ' 143' ' ' ARG . 42.1 mm -99.1 122.91 51.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.107 0.479 . . . . 1.08 110.949 -178.757 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.447 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.6 p -83.86 169.67 14.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.483 -0.78 . . . . 0.89 110.447 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.59 ' CD ' ' O ' ' A' ' 138' ' ' THR . 41.0 mp0 -59.64 -14.6 14.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.975 -0.557 . . . . 1.6 111.036 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.447 ' H ' ' HG ' ' A' ' 186' ' ' SER . 95.8 m-20 -96.16 -4.21 43.06 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.853 -0.339 . . . . 1.18 110.765 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.736 ' O ' ' NE2' ' A' ' 191' ' ' GLN . . . 87.69 13.94 64.13 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.366 -0.693 . . . . 0.34 111.366 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -84.61 139.1 32.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.63 0.252 . . . . 1.22 110.484 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.736 ' NE2' ' O ' ' A' ' 189' ' ' GLY . 0.0 OUTLIER -106.69 141.06 38.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 1.44 110.564 179.733 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.67 127.0 26.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 1.39 110.392 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.669 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.4 tp -68.11 117.35 9.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.323 -0.399 . . . . 1.08 110.531 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.655 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -109.04 -21.91 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 1.08 110.659 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.9 125.78 5.88 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.527 -0.469 . . . . 1.1 111.507 -179.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.498 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.77 120.2 21.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.77 -0.65 . . . . 0.94 109.539 179.249 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.6 151.66 29.09 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.724 -0.39 . . . . 1.07 110.938 -179.271 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.42 158.61 18.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 0.89 110.404 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -146.16 157.91 43.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.502 . . . . 0.67 110.666 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.27 104.3 9.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.801 -0.636 . . . . 1.17 110.007 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.479 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.5 p . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 117.948 -1.025 . . . . 1.26 110.641 -179.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.203 -0.666 . . . . 3.83 109.203 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.452 ' H ' ' HB3' ' A' ' 1' ' ' SER . . . -116.34 150.67 18.55 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.037 -0.825 . . . . 1.39 111.037 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -35.67 142.38 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 124.039 3.159 . . . . 0.86 113.792 -179.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.563 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.1 t -79.98 173.41 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.281 -1.327 . . . . 1.43 108.881 178.428 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.402 ' H ' ' CG1' ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.6 125.86 51.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.214 0.531 . . . . 1.94 111.354 -179.526 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 143.98 33.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.564 -0.744 . . . . 1.19 110.596 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -151.99 168.35 25.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.943 0.401 . . . . 3.92 111.076 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.583 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.97 131.02 60.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.974 -0.557 . . . . 3.88 110.076 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.19 162.33 35.74 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.834 0.349 . . . . 3.92 111.197 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 79.9 mm-40 36.13 31.59 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 109.547 -0.538 . . . . 6.08 109.547 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.583 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.48 69.56 32.95 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.964 -0.562 . . . . 4.01 111.624 -178.831 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.22 -29.11 73.27 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.414 2.076 . . . . 4.51 111.856 179.351 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.124 -0.489 . . . . 3.51 110.49 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.534 ' OE1' ' O ' ' A' ' 13' ' ' SER . 2.0 mp0 -123.93 158.4 60.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.304 -0.407 . . . . 4.3 110.379 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.516 ' HD2' HE22 ' A' ' 191' ' ' GLN . 98.3 Cg_endo -82.09 -64.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.922 2.415 . . . . 1.96 113.431 -178.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.627 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 60.7 t30 -108.46 -19.53 13.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.312 -0.404 . . . . 3.33 112.065 -178.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 4.2 p -107.26 152.02 24.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.149 0.499 . . . . 1.53 111.313 -179.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.25 102.94 2.23 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.723 -0.671 . . . . 2.29 110.68 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.65 145.61 13.05 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.847 2.365 . . . . 0.88 112.651 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.405 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.84 167.84 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.949 -0.569 . . . . 2.12 109.843 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.05 148.02 29.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.826 -0.435 . . . . 2.67 109.826 178.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.499 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.5 p90 -142.25 157.2 45.1 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.66 -0.416 . . . . 0.32 111.203 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.468 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -127.98 155.29 44.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.783 -0.644 . . . . 2.77 110.129 178.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.57 173.05 6.34 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.172 -0.467 . . . . 1.25 110.807 -179.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -50.74 173.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 122.839 2.359 . . . . 1.12 111.449 179.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.48 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.03 -51.04 0.69 Allowed Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.688 -0.405 . . . . 4.05 110.062 179.868 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.647 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.8 Cg_exo -64.87 152.32 82.62 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.789 2.326 . . . . 2.12 111.441 179.258 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.75 42.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.465 0.65 . . . . 2.85 110.547 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.817 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.66 -41.73 98.16 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.962 -1.017 . . . . 3.11 110.65 179.722 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.441 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.5 mt -109.73 137.91 39.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.711 -0.677 . . . . 1.86 111.343 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.93 -73.01 0.7 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.084 -0.507 . . . . 1.61 111.874 -178.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.19 148.41 24.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.575 0.583 . . . . 1.67 112.575 -179.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -121.86 124.81 45.0 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.341 -0.615 . . . . 1.07 109.341 177.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.09 134.68 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.721 -0.391 . . . . 1.55 110.614 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.486 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -119.98 128.59 53.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.055 0.455 . . . . 1.33 111.326 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.04 138.95 49.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.738 -0.664 . . . . 2.36 110.153 179.014 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.417 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -145.04 163.17 35.07 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 121.133 0.492 . . . . 0.38 112.098 -178.166 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.491 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.48 139.57 7.86 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.42 -0.809 . . . . 2.31 110.482 178.85 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.8 Cg_endo -63.64 115.53 3.11 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.25 1.966 . . . . 0.86 111.852 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.67 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.93 81.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.871 -0.418 . . . . 3.44 109.871 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.16 -20.62 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.015 -0.538 . . . . 2.72 111.899 -179.546 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 p -157.7 157.76 34.12 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.812 -0.355 . . . . 2.78 110.56 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.36 27.87 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.173 -0.467 . . . . 2.3 110.178 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.83 -75.94 1.31 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.129 -0.557 . . . . 1.8 111.808 -179.243 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.88 152.29 35.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.918 0.389 . . . . 5.48 111.021 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.12 2.53 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.093 -0.503 . . . . 1.84 111.902 179.44 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.411 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.18 149.77 29.62 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 121.433 0.635 . . . . 2.27 112.543 -177.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.12 156.45 45.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.834 -1.076 . . . . 1.92 110.154 178.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.22 158.4 41.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.848 -0.614 . . . . 1.09 111.773 -179.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.9 m -115.17 135.64 53.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.476 -0.783 . . . . 1.16 109.839 179.308 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.44 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.44 121.91 23.71 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.483 -0.326 . . . . 1.39 111.528 -179.09 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.5 Cg_exo -46.26 151.67 1.6 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.663 2.242 . . . . 0.72 112.212 178.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.97 -22.96 63.1 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 116.097 -0.502 . . . . 0.74 112.755 -179.162 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.515 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.1 p-80 -82.75 -16.95 46.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.432 0.616 . . . . 1.26 111.815 -178.372 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.493 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.3 mt -91.58 138.31 31.67 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.773 -0.371 . . . . 1.59 110.354 179.354 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -121.48 13.95 11.04 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.353 -0.385 . . . . 2.07 111.564 -179.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.0 p -149.96 143.51 25.27 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.654 -0.418 . . . . 0.96 111.034 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.84 -169.38 1.54 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.894 -179.463 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.711 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 t -151.77 125.89 9.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.427 -0.806 . . . . 1.19 109.795 179.273 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.435 HD11 HG23 ' A' ' 60' ' ' ILE . 66.7 mt -114.91 123.22 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.396 -0.522 . . . . 1.47 111.196 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.405 ' HZ3' ' CB ' ' A' ' 140' ' ' SER . 53.1 mtmt -126.4 163.31 23.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.809 -0.632 . . . . 3.0 110.514 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.477 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.2 18.83 60.07 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.823 -0.911 . . . . 0.5 110.823 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.627 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.7 mt -78.93 157.3 28.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.002 0.43 . . . . 1.21 111.446 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.626 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 2.9 mptp? -99.53 133.98 21.49 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.638 -0.71 . . . . 3.2 110.422 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.937 ' HB3' ' O ' ' A' ' 93' ' ' SER . 36.6 Cg_endo -67.82 143.51 61.47 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.613 2.209 . . . . 1.09 111.901 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.96 25.55 75.45 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.987 -0.845 . . . . 0.72 110.987 179.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.64 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.1 158.71 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.654 0.264 . . . . 1.47 110.408 -179.532 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.09 139.98 41.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.85 0.357 . . . . 1.23 110.593 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.64 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.53 136.45 54.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.035 -0.53 . . . . 1.1 110.687 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.491 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.89 131.08 45.25 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.522 -0.918 . . . . 1.87 108.522 177.482 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.485 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.58 153.9 16.67 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.273 -0.965 . . . . 0.39 111.924 -178.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.98 140.91 46.06 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.699 -0.482 . . . . 1.8 109.699 179.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.469 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.1 tp -115.71 118.86 34.22 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.398 -0.521 . . . . 1.11 110.494 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.8 mt -112.45 129.11 68.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.372 -0.377 . . . . 1.51 110.66 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.83 120.84 43.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.289 -0.414 . . . . 1.47 110.726 -179.657 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.673 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.52 146.41 11.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.099 0.476 . . . . 1.33 111.042 -179.238 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.817 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.03 153.89 21.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.586 -0.733 . . . . 2.49 109.963 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.18 88.55 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.856 0.36 . . . . 4.2 110.425 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.34 32.58 0.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.814 -0.63 . . . . 6.4 110.605 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.15 -117.32 3.28 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.471 -0.652 . . . . 1.74 111.471 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.453 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.42 177.4 8.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.293 0.568 . . . . 3.64 111.593 -179.188 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.19 149.57 32.18 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.397 -0.82 . . . . 1.7 110.365 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.22 144.59 38.55 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.396 -0.365 . . . . 2.7 110.59 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -127.91 136.02 61.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 121.13 0.49 . . . . 1.16 111.462 -179.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.09 141.27 52.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.593 -0.73 . . . . 1.14 110.34 179.55 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.457 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.4 ttp180 -117.56 138.88 51.62 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.573 -0.451 . . . . 4.33 111.598 -179.4 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.485 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.23 164.15 37.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.59 -0.732 . . . . 0.91 109.513 179.452 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.572 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 46.9 p30 -145.27 151.56 38.55 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.374 -0.53 . . . . 1.47 111.059 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.572 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.0 p90 -146.28 172.76 13.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.74 -0.664 . . . . 0.51 111.012 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.447 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.71 160.61 21.54 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.483 -0.781 . . . . 1.92 109.937 179.636 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.447 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.38 121.88 22.96 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.548 -0.461 . . . . 1.63 110.742 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.541 ' O ' ' CB ' ' A' ' 93' ' ' SER . 70.1 p -124.86 154.63 40.75 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 113.092 0.775 . . . . 2.37 113.092 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.937 ' O ' ' HB3' ' A' ' 65' ' ' PRO . 27.6 t . . . . . 0 C--O 1.216 -0.674 0 CA-C-N 113.607 -1.633 . . . . 3.63 108.04 -178.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.593 ' CB ' ' HB ' ' A' ' 201' ' ' THR . 33.5 p . . . . . 0 CA--C 1.52 -0.174 0 CA-C-O 122.571 1.177 . . . . 1.25 109.69 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.471 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.93 167.58 0.26 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.208 -1.36 . . . . 1.16 110.979 -178.914 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.52 145.57 50.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.727 -0.669 . . . . 0.78 110.169 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.28 101.67 9.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.075 -0.713 . . . . 1.08 109.075 177.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.454 HG11 ' N ' ' A' ' 131' ' ' SER . 72.1 t -112.94 139.6 37.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.018 -0.537 . . . . 1.1 111.117 -178.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.454 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.9 p -128.58 152.55 48.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.692 -0.686 . . . . 0.87 109.839 179.62 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.649 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.6 p90 -144.82 -164.97 2.04 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.661 -0.416 . . . . 0.37 110.655 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.734 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.9 t -123.88 127.23 73.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 1.14 110.891 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.168 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.98 58.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 1.91 110.322 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.07 24.5 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 1.56 111.574 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.168 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.2 128.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.622 -0.431 . . . . 1.56 110.919 179.905 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.55 -9.51 55.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.92 -0.582 . . . . 1.88 110.354 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.18 0.18 55.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.086 -0.506 . . . . 1.63 110.275 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.95 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.16 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.976 -0.556 . . . . 1.11 109.881 179.757 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 185' ' ' ILE . 89.3 p -96.2 -15.53 21.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.313 0.578 . . . . 1.01 110.101 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.64 175.64 45.87 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 109.891 -1.284 . . . . 0.14 109.891 179.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.51 151.54 42.69 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.605 -0.438 . . . . 0.21 110.55 179.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.501 ' CZ ' ' CG ' ' A' ' 15' ' ' PRO . 64.1 ttp85 -132.2 121.14 23.21 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.148 -0.478 . . . . 1.54 109.936 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.49 HG23 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.11 136.48 38.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.782 -0.644 . . . . 1.08 110.713 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 80.2 tt0 -129.28 129.85 45.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.879 -0.6 . . . . 1.32 110.121 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.3 p90 -138.66 135.34 34.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.998 -0.546 . . . . 1.05 110.614 -179.686 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.412 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.41 161.4 39.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.792 -0.64 . . . . 1.16 109.617 179.84 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.935 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -71.15 124.95 25.61 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.606 -0.438 . . . . 1.23 110.749 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.504 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.84 -7.57 49.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.753 -0.658 . . . . 0.86 110.916 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -109.87 -69.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.01 0.433 . . . . 1.66 111.354 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.442 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.65 -35.36 76.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.066 -0.515 . . . . 1.66 111.466 -179.093 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.091 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.13 7.23 88.59 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.763 -0.935 . . . . 1.62 110.763 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.314 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.96 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.777 0.322 . . . . 1.86 110.32 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.314 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.33 139.08 44.92 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.036 0.446 . . . . 1.98 110.192 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.412 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.89 145.81 51.61 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.778 2.318 . . . . 0.62 112.309 -179.48 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.85 145.73 42.61 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.184 -0.673 . . . . 1.14 109.184 179.237 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.624 ' CE1' ' CG ' ' A' ' 16' ' ' ASN . 7.6 p90 -123.35 141.36 52.06 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.249 -0.58 . . . . 1.44 111.449 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.424 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.4 mt -128.11 127.64 43.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.228 -0.896 . . . . 1.08 109.039 178.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -101.66 131.18 48.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.199 0.523 . . . . 1.09 111.72 -178.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.5 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -127.98 157.53 73.58 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.315 -0.857 . . . . 1.04 109.521 179.737 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -69.81 158.02 58.3 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 122.307 2.005 . . . . 0.21 112.291 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.2 p -59.13 -12.25 4.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.831 -0.622 . . . . 0.88 110.759 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.86 -8.82 42.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.103 -0.499 . . . . 1.06 110.676 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.06 135.27 34.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.35 -0.386 . . . . 1.05 110.473 179.675 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.9 p -133.06 16.66 4.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.489 -0.323 . . . . 1.07 110.573 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.1 p -167.53 147.12 5.09 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.624 -0.51 . . . . 0.92 109.624 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.5 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.18 150.5 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.564 -0.455 . . . . 1.09 111.526 -179.663 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.24 124.91 50.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.566 -0.743 . . . . 1.31 109.832 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.511 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.39 104.84 29.43 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.83 0.348 . . . . 1.09 111.08 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.0 Cg_endo -90.92 -179.47 1.51 Allowed 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 123.186 2.591 . . . . 0.48 112.172 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 61.59 32.61 18.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.331 -0.85 . . . . 1.26 111.476 179.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.511 HD21 HG21 ' A' ' 169' ' ' ILE . 23.8 mt -86.27 148.53 25.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.469 -0.332 . . . . 1.12 110.522 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.766 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.4 mt -88.28 114.89 61.45 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.959 0.409 . . . . 1.3 110.721 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.12 140.61 95.81 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.826 2.351 . . . . 0.92 112.01 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.11 21.17 74.32 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.028 -0.829 . . . . 0.44 111.028 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.442 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.8 mmm-85 -126.83 150.31 49.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 3.05 110.625 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.504 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.28 131.65 46.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.978 -0.555 . . . . 1.48 109.814 179.316 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.935 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.55 148.36 43.96 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.113 -0.494 . . . . 0.89 110.974 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.5 mt -105.35 125.38 60.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.296 -1.002 . . . . 1.12 108.296 177.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.52 132.44 63.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.177 0.513 . . . . 1.1 111.222 -178.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.62 20.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.64 -0.709 . . . . 0.43 109.633 179.216 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.593 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.97 125.46 54.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 1.07 110.71 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.671 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.5 m-85 -117.26 137.87 52.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.048 -0.524 . . . . 0.92 109.891 179.51 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.566 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.73 135.06 42.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.765 -0.828 . . . . 0.49 108.765 178.887 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 140' ' ' SER . 63.1 mt -99.03 122.91 51.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.106 0.479 . . . . 1.08 110.956 -178.75 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.451 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.4 p -83.88 169.66 14.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.563 -0.744 . . . . 0.89 110.54 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -59.76 -14.49 14.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.085 -0.507 . . . . 1.6 110.914 -179.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.451 ' H ' ' HG ' ' A' ' 186' ' ' SER . 94.7 m-20 -96.13 -4.31 42.97 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.79 -0.364 . . . . 1.18 110.769 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.82 13.96 63.83 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.316 -0.713 . . . . 0.34 111.316 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -84.64 139.13 32.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.642 0.258 . . . . 1.22 110.443 179.658 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.516 HE22 ' HD2' ' A' ' 15' ' ' PRO . 41.0 mt-30 -106.79 141.06 38.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.97 0.414 . . . . 1.44 110.552 179.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.1 m -136.62 127.11 26.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.487 . . . . 1.39 110.408 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.671 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.6 tp -68.2 117.31 9.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.39 -0.368 . . . . 1.08 110.438 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.649 HD12 ' CD1' ' A' ' 132' ' ' TRP . 43.9 pt -109.09 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 1.08 110.744 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.92 125.68 5.83 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.477 -0.489 . . . . 1.1 111.475 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.491 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.71 120.21 21.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.731 -0.668 . . . . 0.94 109.58 179.191 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.58 151.69 29.15 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.71 -0.396 . . . . 1.07 110.881 -179.242 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.54 158.58 18.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.89 110.339 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -146.03 157.94 43.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.031 -0.531 . . . . 0.67 110.714 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.39 9.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.753 -0.658 . . . . 1.17 110.05 179.568 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.593 ' HB ' ' CB ' ' A' ' 126' ' ' SER . 67.9 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 117.829 -1.081 . . . . 1.26 110.619 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.5 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.196 -0.668 . . . . 3.83 109.196 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.452 ' H ' ' HB3' ' A' ' 1' ' ' SER . . . -116.35 150.64 18.55 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.999 -0.84 . . . . 1.39 110.999 179.753 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -35.5 142.39 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 124.002 3.135 . . . . 0.86 113.794 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.559 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.3 t -80.06 173.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.246 -1.343 . . . . 1.43 108.825 178.451 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -105.55 125.98 51.6 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.45 -0.5 . . . . 1.94 111.412 -179.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.62 143.91 34.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.658 -0.701 . . . . 1.19 110.667 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.4 25.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.925 0.393 . . . . 3.92 111.042 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.583 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -109.06 131.05 60.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.926 -0.579 . . . . 3.88 110.091 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.8 p -141.17 162.37 35.64 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.438 -0.347 . . . . 3.92 111.249 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 9' ' ' THR . 96.3 mt-10 35.98 31.65 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.616 -0.513 . . . . 6.08 109.616 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.583 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.51 69.64 33.42 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.007 -0.542 . . . . 4.01 111.609 -178.833 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.23 -29.18 73.3 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.5 2.133 . . . . 4.51 111.868 179.32 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.63 125.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.493 . . . . 3.51 110.514 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.717 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -123.89 158.39 60.17 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.306 -0.407 . . . . 4.3 110.45 -179.988 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.53 ' HG3' ' CZ ' ' A' ' 143' ' ' ARG . 98.2 Cg_endo -82.1 -64.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.916 2.411 . . . . 1.96 113.44 -178.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.461 ' H ' ' HG2' ' A' ' 15' ' ' PRO . 6.5 m120 -108.4 -19.52 13.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.065 0.394 . . . . 3.33 112.065 -178.48 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.717 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 7.0 p -107.48 152.0 24.81 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.436 -0.506 . . . . 1.53 111.28 -179.361 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.57 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.18 102.94 2.25 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.709 -0.678 . . . . 2.29 110.654 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -82.74 145.64 12.93 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.879 2.386 . . . . 0.88 112.577 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.409 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.85 167.96 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.871 -0.604 . . . . 2.12 109.892 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -149.12 147.97 29.12 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.708 -0.478 . . . . 2.67 109.708 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.502 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.5 p90 -142.3 157.23 45.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.04 0.448 . . . . 0.32 111.188 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.464 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.1 m-20 -128.03 155.19 44.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.705 -0.679 . . . . 2.77 110.101 179.055 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.58 173.01 6.39 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.155 0.503 . . . . 1.25 110.688 -179.153 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.62 173.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 122.831 2.354 . . . . 1.12 111.555 179.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.484 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.04 -51.13 0.69 Allowed Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.76 -0.376 . . . . 4.05 110.074 179.831 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.65 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.81 152.35 82.45 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.813 2.342 . . . . 2.12 111.426 179.259 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.76 42.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.418 0.628 . . . . 2.85 110.526 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.818 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.54 -41.71 98.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.964 -1.016 . . . . 3.11 110.642 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.445 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.7 mt -109.8 137.79 40.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.857 -0.611 . . . . 1.86 111.305 -179.416 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.95 -72.92 0.7 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.105 -0.498 . . . . 1.61 111.891 -178.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.16 148.43 24.42 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.571 0.582 . . . . 1.67 112.571 -179.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.79 124.83 45.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.36 -0.607 . . . . 1.07 109.36 177.493 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.6 mt -117.97 134.72 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.685 -0.406 . . . . 1.55 110.676 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.489 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -120.01 128.65 53.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.421 . . . . 1.33 111.233 179.742 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 138.89 49.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.766 -0.652 . . . . 2.36 110.156 178.998 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.421 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -144.99 163.25 34.76 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.118 0.485 . . . . 0.38 112.113 -178.114 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.488 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.53 139.55 7.81 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.493 -0.776 . . . . 2.31 110.485 178.887 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.59 115.44 3.05 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.279 1.986 . . . . 0.86 111.865 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.673 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.95 81.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.925 -0.398 . . . . 3.44 109.925 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.921 -0.582 . . . . 2.72 111.95 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -157.68 157.76 34.15 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.813 -0.355 . . . . 2.78 110.523 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.37 27.9 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 2.3 110.147 179.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.83 -75.91 1.31 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.154 -0.546 . . . . 1.8 111.832 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.4 mtp180 -117.82 152.33 35.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.943 0.401 . . . . 5.48 110.959 -179.32 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.35 -169.11 2.51 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.976 -0.556 . . . . 1.84 111.954 179.271 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.414 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.05 149.61 29.76 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.483 0.659 . . . . 2.27 112.532 -177.772 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.02 156.5 46.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.788 -1.096 . . . . 1.92 110.199 178.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.24 158.42 41.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.932 -0.576 . . . . 1.09 111.777 -179.407 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.3 m -115.13 135.62 54.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.479 -0.782 . . . . 1.16 109.838 179.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.443 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.4 122.04 23.79 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.444 -0.344 . . . . 1.39 111.497 -179.164 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.516 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.4 Cg_exo -46.43 151.78 1.69 Allowed 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.692 2.261 . . . . 0.72 112.128 179.046 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.0 -22.99 63.21 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 116.044 -0.526 . . . . 0.74 112.728 -179.116 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.516 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.83 -16.8 46.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.383 0.592 . . . . 1.26 111.818 -178.352 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.493 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.3 mt -91.68 138.37 31.62 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.716 -0.393 . . . . 1.59 110.25 179.387 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.5 14.06 11.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.342 -0.39 . . . . 2.07 111.601 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.472 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -150.0 143.39 25.16 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.682 -0.407 . . . . 0.96 111.07 179.607 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.709 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.84 -169.33 1.53 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.222 0.534 . . . . 1.0 110.844 -179.439 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.709 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.75 125.87 9.23 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.439 -0.8 . . . . 1.19 109.887 179.283 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.476 HG23 HD11 ' A' ' 60' ' ' ILE . 66.7 mt -114.85 123.3 70.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.372 -0.531 . . . . 1.47 111.143 -179.673 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.43 ' HD3' ' CD1' ' A' ' 185' ' ' ILE . 56.1 mtmt -126.59 163.4 23.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.827 -0.624 . . . . 3.0 110.381 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.11 18.93 60.01 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.817 -0.913 . . . . 0.5 110.817 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.431 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 74.3 mt -79.04 157.32 28.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.106 0.479 . . . . 1.21 111.369 -179.65 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.604 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -99.53 134.0 21.48 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.601 -0.727 . . . . 3.2 110.404 179.811 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.94 143.59 61.1 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.533 2.155 . . . . 1.09 111.925 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.88 25.51 75.48 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 111.056 -0.818 . . . . 0.72 111.056 179.685 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.645 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.07 158.91 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.667 0.27 . . . . 1.47 110.421 -179.639 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.23 139.96 42.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.393 -0.367 . . . . 1.23 110.588 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.645 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 94.0 m-85 -122.65 136.52 54.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.906 -0.588 . . . . 1.1 110.713 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.94 131.03 45.32 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.527 -0.916 . . . . 1.87 108.527 177.661 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.48 153.89 16.65 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.331 -0.937 . . . . 0.39 111.931 -178.558 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.02 140.88 45.99 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.69 -0.485 . . . . 1.8 109.69 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.469 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.0 tp -115.71 118.8 34.08 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.513 -0.475 . . . . 1.11 110.509 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.7 mt -112.32 129.0 68.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.357 -0.383 . . . . 1.51 110.707 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.79 120.76 43.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.374 -0.375 . . . . 1.47 110.785 -179.694 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.668 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.55 146.57 11.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.219 0.533 . . . . 1.33 111.017 -179.255 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.818 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.11 153.81 21.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.523 -0.762 . . . . 2.49 109.948 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.25 88.66 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.012 0.434 . . . . 4.2 110.448 -179.68 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.22 32.74 0.21 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.786 -0.643 . . . . 6.4 110.56 -179.871 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.22 -117.41 3.27 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.443 -0.663 . . . . 1.74 111.443 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.452 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.31 177.3 9.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.168 0.509 . . . . 3.64 111.635 -179.229 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.09 149.57 32.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.428 -0.805 . . . . 1.7 110.34 179.186 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.14 144.64 38.72 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.429 -0.35 . . . . 2.7 110.509 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -128.06 136.09 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 121.056 0.455 . . . . 1.16 111.525 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.559 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.05 141.26 52.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.653 -0.703 . . . . 1.14 110.277 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.451 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.61 138.86 51.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.127 0.489 . . . . 4.33 111.481 -179.374 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.489 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.3 164.2 37.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.534 -0.757 . . . . 0.91 109.518 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.57 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.23 151.61 38.66 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.43 -0.508 . . . . 1.47 111.131 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.57 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.9 p90 -146.32 172.69 13.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.82 -0.627 . . . . 0.51 110.998 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.447 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.76 160.75 21.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.455 -0.793 . . . . 1.92 109.897 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.447 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.39 121.91 22.98 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.584 -0.446 . . . . 1.63 110.67 -179.943 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.592 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.6 p -127.44 165.36 19.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.469 0.652 . . . . 2.37 112.562 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.211 -0.904 . . . . 3.63 109.978 178.727 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.464 0.267 0 CA-C-O 120.708 0.29 . . . . 1.25 111.652 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.468 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.96 167.56 0.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.075 -0.511 . . . . 1.16 110.946 -179.033 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.57 145.52 50.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.79 -0.641 . . . . 0.78 110.078 -179.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.26 101.78 9.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.055 -0.72 . . . . 1.08 109.055 177.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.462 HG11 ' N ' ' A' ' 131' ' ' SER . 71.2 t -113.05 139.72 36.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 1.1 110.942 -178.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.462 ' N ' HG11 ' A' ' 130' ' ' VAL . 69.2 p -128.74 152.63 48.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.588 -0.733 . . . . 0.87 109.781 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.645 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.8 p90 -144.83 -165.06 2.06 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.793 -0.363 . . . . 0.37 110.638 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -123.89 127.15 73.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.466 . . . . 1.14 110.896 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.173 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.84 58.26 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.123 -0.489 . . . . 1.91 110.365 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.743 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.08 24.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.936 -0.575 . . . . 1.56 111.44 -179.705 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.173 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.14 128.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.619 -0.432 . . . . 1.56 110.881 179.853 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -86.49 -9.56 55.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.915 -0.584 . . . . 1.88 110.311 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.5 p -87.17 0.27 55.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.141 -0.481 . . . . 1.63 110.286 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.943 HG11 ' O ' ' A' ' 136' ' ' SER . 2.6 p -65.18 137.16 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.011 -0.54 . . . . 1.11 110.037 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.575 ' N ' ' O ' ' A' ' 185' ' ' ILE . 69.4 m -96.19 -15.54 22.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.356 0.598 . . . . 1.01 110.065 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.582 ' H ' HG23 ' A' ' 185' ' ' ILE . . . 178.6 175.55 45.77 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 109.881 -1.288 . . . . 0.14 109.881 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -123.36 151.64 42.32 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.698 -0.401 . . . . 0.21 110.484 179.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.835 ' NH2' ' CE1' ' A' ' 157' ' ' TYR . 70.3 ttt-85 -132.42 121.26 23.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.059 0.457 . . . . 1.54 109.803 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.486 HG23 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.16 136.47 38.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.635 -0.711 . . . . 1.08 110.66 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.58 ' C ' ' CD ' ' A' ' 145' ' ' GLU . 0.3 OUTLIER -129.31 129.89 45.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.014 -0.539 . . . . 1.32 110.037 -179.937 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.603 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.67 135.21 34.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.07 -0.513 . . . . 1.05 110.673 -179.7 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.415 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.28 161.38 39.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.875 -0.602 . . . . 1.16 109.728 179.823 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.942 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.0 mt -71.14 124.91 25.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.038 0.447 . . . . 1.23 110.649 -179.459 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.75 -7.76 50.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.787 -0.642 . . . . 0.86 110.874 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -109.78 -69.68 0.85 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.913 0.387 . . . . 1.66 111.347 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.438 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.67 -35.29 75.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.118 -0.492 . . . . 1.66 111.505 -179.101 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.102 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.1 7.12 88.66 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.864 -0.894 . . . . 1.62 110.864 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.327 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.89 -171.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.811 0.339 . . . . 1.86 110.264 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.327 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.32 139.09 44.94 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-O 120.98 0.419 . . . . 1.98 110.211 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.415 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.89 145.86 51.7 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 C-N-CA 122.741 2.294 . . . . 0.62 112.321 -179.516 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.95 145.73 42.69 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.211 -0.663 . . . . 1.14 109.211 179.216 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.835 ' CE1' ' NH2' ' A' ' 143' ' ' ARG . 8.3 m-85 -123.22 141.37 52.05 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.358 -0.537 . . . . 1.44 111.54 -179.089 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.446 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.2 mt -128.07 127.65 43.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.269 -0.878 . . . . 1.08 108.986 178.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -101.62 131.19 47.97 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.162 0.506 . . . . 1.09 111.791 -178.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.515 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -127.97 157.55 73.5 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.257 -0.883 . . . . 1.04 109.552 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.73 157.98 58.57 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.473 2.115 . . . . 0.21 112.207 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.35 -12.08 5.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.764 -0.653 . . . . 0.88 110.721 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.3 p -92.88 -8.68 42.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.185 -0.461 . . . . 1.06 110.713 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.21 135.4 34.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 1.05 110.383 179.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.9 p -133.09 16.61 4.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.386 -0.37 . . . . 1.07 110.548 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.5 p -167.54 147.11 5.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.58 -0.526 . . . . 0.92 109.58 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.515 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.1 p -152.23 150.43 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.519 -0.472 . . . . 1.09 111.542 -179.634 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.499 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.23 124.98 50.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.66 -0.7 . . . . 1.31 109.845 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.504 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.45 104.92 30.11 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.43 -0.35 . . . . 1.09 110.986 -179.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.5 Cg_endo -91.02 -179.49 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 123.116 2.544 . . . . 0.48 112.201 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.67 32.68 18.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.401 -0.818 . . . . 1.26 111.463 179.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.504 HD21 HG21 ' A' ' 169' ' ' ILE . 24.2 mt -86.39 148.51 25.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.455 -0.339 . . . . 1.12 110.496 179.554 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.773 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.25 114.86 61.32 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.029 0.442 . . . . 1.3 110.662 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.98 140.51 95.67 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.921 2.414 . . . . 0.92 112.026 179.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.18 21.14 74.19 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.052 -0.819 . . . . 0.44 111.052 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.438 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.86 150.21 49.36 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.966 -0.293 . . . . 3.05 110.671 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.495 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.23 131.67 46.03 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.094 -0.503 . . . . 1.48 109.782 179.32 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.942 ' CE2' HD21 ' A' ' 148' ' ' LEU . 75.1 m-85 -120.46 148.33 43.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.09 -0.504 . . . . 0.89 111.056 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.4 125.3 60.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.284 -1.006 . . . . 1.12 108.284 177.696 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.49 132.47 63.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.154 0.502 . . . . 1.1 111.236 -178.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.43 122.56 20.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.509 -0.769 . . . . 0.43 109.644 179.268 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.595 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.99 125.41 54.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.318 -0.401 . . . . 1.07 110.672 -179.512 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.667 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.8 m-85 -117.31 137.95 52.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.987 -0.551 . . . . 0.92 109.793 179.585 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.562 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.75 134.99 42.9 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.778 -0.823 . . . . 0.49 108.778 178.917 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.582 HG23 ' H ' ' A' ' 141' ' ' GLY . 5.3 tt -99.18 122.99 51.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.204 0.526 . . . . 1.08 110.891 -178.692 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.448 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.7 p -83.78 169.7 14.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.524 -0.762 . . . . 0.89 110.46 -179.662 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.81 -14.49 15.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.09 -0.505 . . . . 1.6 110.933 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.448 ' H ' ' HG ' ' A' ' 186' ' ' SER . 96.8 m-20 -96.14 -4.23 43.07 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.827 -0.349 . . . . 1.18 110.807 -179.792 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.83 13.8 64.08 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.349 -0.701 . . . . 0.34 111.349 179.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -84.63 139.11 32.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.675 0.274 . . . . 1.22 110.453 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.49 HE22 ' HD2' ' A' ' 15' ' ' PRO . 77.3 mt-30 -106.71 141.02 38.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.36 . . . . 1.44 110.588 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.2 m -136.71 127.01 26.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 1.39 110.43 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.667 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.4 tp -68.09 117.28 9.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.254 -0.43 . . . . 1.08 110.507 -179.869 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.645 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -109.03 -21.75 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 1.08 110.693 -179.746 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.1 tp -156.88 125.64 5.84 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.542 -0.463 . . . . 1.1 111.477 -179.707 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.487 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.74 120.16 21.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.843 -0.617 . . . . 0.94 109.554 179.188 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.6 151.74 29.18 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.642 -0.423 . . . . 1.07 110.91 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.44 158.53 18.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.015 -0.539 . . . . 0.89 110.406 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -146.03 157.93 43.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 0.67 110.719 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.18 104.32 9.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.826 -0.624 . . . . 1.17 110.083 179.526 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.477 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.7 p . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.914 -1.041 . . . . 1.26 110.637 -179.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.3 m . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.231 -0.655 . . . . 3.83 109.231 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.72 18.53 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.952 -0.859 . . . . 1.39 110.952 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -35.54 142.4 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.106 0 C-N-CA 123.99 3.127 . . . . 0.86 113.733 -179.293 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.568 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -80.06 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 114.189 -1.369 . . . . 1.43 108.837 178.372 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.401 ' H ' ' CG1' ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.62 125.82 51.43 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.407 -0.517 . . . . 1.94 111.496 -179.568 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.46 144.02 33.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.685 -0.689 . . . . 1.19 110.636 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.03 168.35 25.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.985 0.421 . . . . 3.92 111.054 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.583 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.99 131.07 60.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.905 -0.589 . . . . 3.88 110.087 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 69.0 p -141.22 162.36 35.67 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.853 0.359 . . . . 3.92 111.178 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 9' ' ' THR . 53.2 mp0 35.94 31.69 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.638 -0.505 . . . . 6.08 109.638 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.583 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.55 32.47 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.932 -0.577 . . . . 4.01 111.563 -178.817 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.24 -29.22 73.25 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.466 2.11 . . . . 4.51 111.815 179.348 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.72 125.49 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.123 -0.489 . . . . 3.51 110.574 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.658 ' O ' ' O ' ' A' ' 92' ' ' THR . 39.6 mt-30 -123.86 158.28 60.44 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.862 0.363 . . . . 4.3 110.474 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.469 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 98.1 Cg_endo -82.05 -64.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.875 2.383 . . . . 1.96 113.474 -178.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.702 ' CG ' ' CD2' ' A' ' 157' ' ' TYR . 64.4 t30 -108.41 -19.68 13.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.287 -0.415 . . . . 3.33 112.063 -178.468 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 43.0 t -107.26 152.07 24.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.14 0.495 . . . . 1.53 111.38 -179.438 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.573 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.3 102.92 2.22 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.725 -0.67 . . . . 2.29 110.688 179.868 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.62 145.61 13.1 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.935 2.423 . . . . 0.88 112.574 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.407 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.83 167.92 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.95 -0.568 . . . . 2.12 109.926 179.506 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.16 147.95 29.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.73 -0.47 . . . . 2.67 109.73 178.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.501 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.5 p90 -142.27 157.28 45.01 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.597 -0.441 . . . . 0.32 111.215 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.466 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.02 155.29 44.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.754 -0.657 . . . . 2.77 110.12 178.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.55 173.1 6.28 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.172 -0.467 . . . . 1.25 110.785 -179.229 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.61 173.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.902 2.401 . . . . 1.12 111.555 179.32 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.48 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.05 -51.06 0.69 Allowed Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.757 -0.377 . . . . 4.05 110.13 179.777 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.65 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.9 152.34 82.6 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.72 2.28 . . . . 2.12 111.419 179.202 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.64 42.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.411 0.624 . . . . 2.85 110.614 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.814 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.66 -41.68 98.18 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.001 -0.999 . . . . 3.11 110.626 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.44 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.7 mt -109.77 137.87 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.793 -0.64 . . . . 1.86 111.315 -179.516 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.99 -72.93 0.7 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.996 -0.547 . . . . 1.61 111.84 -178.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -88.12 148.37 24.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.582 0.586 . . . . 1.67 112.582 -179.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.78 124.91 45.31 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.328 -0.619 . . . . 1.07 109.328 177.43 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.11 134.78 60.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.658 -0.417 . . . . 1.55 110.617 179.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.488 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -120.01 128.61 53.7 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.222 -0.445 . . . . 1.33 111.236 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.07 138.97 49.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.814 -0.63 . . . . 2.36 110.18 178.956 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.415 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.2 p90 -145.07 163.14 35.17 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.1 0.476 . . . . 0.38 112.094 -178.115 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.46 139.58 7.88 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.438 -0.801 . . . . 2.31 110.493 178.836 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.687 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.3 Cg_endo -63.65 115.52 3.11 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.265 1.977 . . . . 0.86 111.807 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.676 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.94 81.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.908 -0.404 . . . . 3.44 109.908 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.687 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.992 -0.549 . . . . 2.72 111.901 -179.517 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.9 p -157.64 157.71 34.11 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.882 -0.327 . . . . 2.78 110.575 179.766 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.27 27.76 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.169 -0.469 . . . . 2.3 110.19 179.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.77 -75.95 1.31 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.785 -0.526 . . . . 1.8 111.785 -179.217 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.86 152.3 35.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 5.48 111.0 -179.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.676 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.14 -169.11 2.54 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.028 -0.533 . . . . 1.84 111.926 179.382 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.17 149.66 29.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.416 0.627 . . . . 2.27 112.598 -177.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.05 156.41 46.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.843 -1.072 . . . . 1.92 110.262 178.667 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.23 158.29 41.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.933 -0.576 . . . . 1.09 111.773 -179.31 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.04 135.67 53.96 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.483 -0.781 . . . . 1.16 109.859 179.303 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.443 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.47 121.99 23.69 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.533 -0.303 . . . . 1.39 111.585 -179.186 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.0 Cg_exo -46.31 151.71 1.63 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.727 2.285 . . . . 0.72 112.029 179.119 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.81 -23.19 63.04 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 116.049 -0.523 . . . . 0.74 112.782 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.515 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.79 -16.74 46.64 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.213 -0.595 . . . . 1.26 111.761 -178.259 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.493 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.6 mt -91.7 138.44 31.56 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.709 -0.396 . . . . 1.59 110.298 179.381 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.46 13.85 11.04 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.392 -0.367 . . . . 2.07 111.518 -179.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.475 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.7 p -150.01 143.45 25.18 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.65 -0.42 . . . . 0.96 110.973 179.7 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.9 t80 -114.84 -169.48 1.56 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.869 -179.404 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.711 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 t -151.67 125.91 9.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.412 -0.813 . . . . 1.19 109.797 179.292 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 60' ' ' ILE . 66.9 mt -114.85 123.32 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.356 -0.538 . . . . 1.47 111.189 -179.808 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -126.56 163.3 23.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.894 -0.594 . . . . 3.0 110.448 179.746 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.476 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.14 19.03 59.77 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.75 -0.94 . . . . 0.5 110.75 -179.897 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.676 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.9 mt -79.05 157.3 28.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.124 0.488 . . . . 1.21 111.301 -179.642 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.62 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -99.52 133.85 21.59 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.575 -0.739 . . . . 3.2 110.489 179.741 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.408 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.8 Cg_endo -67.81 143.74 62.47 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.454 2.103 . . . . 1.09 112.001 179.773 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.7 25.59 75.37 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.125 -0.79 . . . . 0.72 111.125 179.774 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.643 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.21 158.66 40.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.648 0.261 . . . . 1.47 110.439 -179.533 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.09 139.98 41.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.0 0.429 . . . . 1.23 110.535 -179.737 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.643 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.59 136.49 54.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.89 -0.595 . . . . 1.1 110.689 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.92 130.96 45.32 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.523 -0.917 . . . . 1.87 108.523 177.566 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.488 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.43 153.93 16.63 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.318 -0.944 . . . . 0.39 111.999 -178.658 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.03 140.85 45.95 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.779 -0.452 . . . . 1.8 109.779 179.585 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.468 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.5 tp -115.71 119.0 34.62 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.422 -0.511 . . . . 1.11 110.48 179.757 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.9 mt -112.51 129.02 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.332 -0.395 . . . . 1.51 110.578 -179.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.7 120.86 43.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.283 -0.417 . . . . 1.47 110.749 -179.754 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.671 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.53 146.47 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.116 0.484 . . . . 1.33 111.104 -179.375 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.814 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.06 153.82 21.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.581 -0.736 . . . . 2.49 109.965 179.776 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.12 88.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.913 0.387 . . . . 4.2 110.467 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.41 32.56 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.809 -0.632 . . . . 6.4 110.51 179.998 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.02 -117.37 3.3 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.479 -0.648 . . . . 1.74 111.479 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.452 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.41 177.37 9.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.268 0.556 . . . . 3.64 111.634 -179.244 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.17 149.48 32.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.485 -0.78 . . . . 1.7 110.415 179.179 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.1 144.69 38.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.489 -0.323 . . . . 2.7 110.598 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -128.02 136.05 61.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-O 121.063 0.459 . . . . 1.16 111.544 -179.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.11 141.31 52.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.624 -0.717 . . . . 1.14 110.214 179.695 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.457 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.55 138.88 51.62 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.111 0.481 . . . . 4.33 111.538 -179.391 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.34 164.19 37.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.569 -0.741 . . . . 0.91 109.405 179.37 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.572 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.1 p30 -145.28 151.6 38.6 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.369 -0.533 . . . . 1.47 111.062 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.573 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.8 p90 -146.23 172.7 13.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.778 -0.646 . . . . 0.51 111.033 179.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.446 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.72 160.69 21.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.483 -0.781 . . . . 1.92 109.939 179.515 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.446 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.38 121.93 23.04 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.547 -0.461 . . . . 1.63 110.671 -179.932 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.658 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.7 p -128.45 165.74 20.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.099 -0.501 . . . . 2.37 110.497 179.636 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.4 t . . . . . 0 N--CA 1.464 0.242 0 C-N-CA 120.468 -0.493 . . . . 3.63 109.914 178.812 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 121.264 0.554 . . . . 1.25 110.79 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.477 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.8 167.52 0.25 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.503 -0.771 . . . . 1.16 110.942 179.419 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.6 145.51 50.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.704 -0.68 . . . . 0.78 110.128 -179.879 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.27 101.65 9.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.087 -0.708 . . . . 1.08 109.087 177.693 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.465 HG11 ' N ' ' A' ' 131' ' ' SER . 71.2 t -112.94 139.74 36.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.055 -0.52 . . . . 1.1 111.033 -178.862 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.465 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.7 p -128.7 152.54 48.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.549 -0.75 . . . . 0.87 109.81 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.647 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.8 p90 -144.79 -164.93 2.03 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.769 -0.373 . . . . 0.37 110.64 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -123.99 127.15 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.183 -0.462 . . . . 1.14 110.814 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.164 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.92 58.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 1.91 110.339 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.06 24.48 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.923 -0.581 . . . . 1.56 111.465 -179.698 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.164 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.13 128.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.601 -0.44 . . . . 1.56 110.918 179.801 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.46 -9.54 56.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.855 -0.611 . . . . 1.88 110.309 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.8 p -87.1 0.25 55.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.073 -0.512 . . . . 1.63 110.343 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.956 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.29 137.26 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.016 -0.538 . . . . 1.11 109.982 179.69 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 185' ' ' ILE . 71.1 m -96.24 -15.55 21.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.239 0.542 . . . . 1.01 110.0 -179.629 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.59 175.54 45.76 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 109.845 -1.302 . . . . 0.14 109.845 179.707 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.48 151.58 42.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.989 0.423 . . . . 0.21 110.43 179.78 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.806 ' NH2' ' CD2' ' A' ' 183' ' ' TYR . 62.5 ttp85 -132.38 121.18 23.07 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.145 -0.479 . . . . 1.54 109.977 179.744 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.493 HG23 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.01 136.62 37.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.615 -0.721 . . . . 1.08 110.655 -179.755 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.501 ' CD ' ' O ' ' A' ' 156' ' ' GLN . 24.8 tp10 -129.41 129.9 45.28 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.933 -0.576 . . . . 1.32 110.067 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.594 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.2 p90 -138.72 135.3 34.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.962 -0.563 . . . . 1.05 110.627 -179.717 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.403 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.33 161.35 39.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.815 -0.629 . . . . 1.16 109.682 179.79 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.939 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -71.02 124.83 25.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.049 0.452 . . . . 1.23 110.747 -179.596 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.502 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.74 -7.69 49.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.704 -0.68 . . . . 0.86 110.779 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -109.86 -69.76 0.85 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.937 0.399 . . . . 1.66 111.336 -179.231 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.452 ' CD ' HH21 ' A' ' 176' ' ' ARG . 53.9 mt-10 -60.61 -35.39 76.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.111 -0.495 . . . . 1.66 111.493 -179.083 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.089 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.18 7.23 88.6 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.808 -0.917 . . . . 1.62 110.808 -179.854 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.32 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.91 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.835 0.35 . . . . 1.86 110.262 179.861 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.32 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.29 139.1 45.05 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.974 0.416 . . . . 1.98 110.126 179.619 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.403 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.5 Cg_endo -70.92 145.81 51.38 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 122.71 2.273 . . . . 0.62 112.275 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.85 145.75 42.59 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.243 -0.651 . . . . 1.14 109.243 179.16 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.702 ' CD2' ' CG ' ' A' ' 16' ' ' ASN . 27.3 p90 -123.26 141.34 52.08 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.296 -0.561 . . . . 1.44 111.57 -179.115 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.7 mt -128.09 127.76 43.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.313 -0.858 . . . . 1.08 108.978 178.923 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -101.68 131.1 48.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.171 0.51 . . . . 1.09 111.747 -178.733 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.506 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -127.88 157.51 73.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.248 -0.887 . . . . 1.04 109.624 179.686 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.76 158.02 58.4 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.464 2.109 . . . . 0.21 112.297 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.3 p -59.21 -12.25 5.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.879 -0.6 . . . . 0.88 110.696 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.2 p -92.81 -8.73 42.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 1.06 110.724 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.23 135.33 34.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.348 -0.387 . . . . 1.05 110.374 179.713 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.1 p -133.12 16.68 4.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 1.07 110.499 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.7 p -167.54 147.12 5.08 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.617 -0.512 . . . . 0.92 109.617 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.506 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.12 150.49 12.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.495 -0.482 . . . . 1.09 111.538 -179.636 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.32 124.8 50.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 1.31 109.833 179.452 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.513 HG21 HD21 ' A' ' 172' ' ' LEU . 1.8 mt -99.31 104.93 29.7 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.915 0.388 . . . . 1.09 111.077 -179.909 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.2 Cg_endo -91.02 -179.47 1.48 Allowed 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 123.177 2.585 . . . . 0.48 112.18 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.69 32.59 18.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.382 -0.826 . . . . 1.26 111.422 179.276 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.513 HD21 HG21 ' A' ' 169' ' ' ILE . 24.1 mt -86.31 148.53 25.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.52 -0.309 . . . . 1.12 110.501 179.562 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.771 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.34 114.84 61.28 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.041 0.448 . . . . 1.3 110.631 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.0 140.6 96.09 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.871 2.381 . . . . 0.92 111.94 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.03 21.2 74.47 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.032 -0.827 . . . . 0.44 111.032 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.452 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.81 150.31 49.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.784 0.326 . . . . 3.05 110.677 179.882 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.502 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.28 131.58 46.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.097 -0.501 . . . . 1.48 109.773 179.377 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.939 ' CE2' HD21 ' A' ' 148' ' ' LEU . 75.2 m-85 -120.45 148.31 43.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.111 -0.495 . . . . 0.89 111.022 -179.806 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.32 125.36 60.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.271 -1.011 . . . . 1.12 108.271 177.726 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.55 132.45 63.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.139 0.495 . . . . 1.1 111.218 -178.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.46 20.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.594 -0.73 . . . . 0.43 109.682 179.286 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.591 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.7 t -100.84 125.32 54.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.291 -0.413 . . . . 1.07 110.798 -179.585 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.806 ' CD2' ' NH2' ' A' ' 143' ' ' ARG . 48.5 m-85 -117.18 137.84 52.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.103 -0.499 . . . . 0.92 109.875 179.535 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.62 135.03 42.69 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.853 -0.795 . . . . 0.49 108.853 178.814 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' A' ' 140' ' ' SER . 84.8 mt -99.09 122.93 51.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.1 0.476 . . . . 1.08 110.923 -178.724 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.451 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.1 p -83.91 169.75 14.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.566 -0.743 . . . . 0.89 110.481 -179.702 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -59.82 -14.47 15.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.096 -0.502 . . . . 1.6 110.938 -179.539 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.451 ' H ' ' HG ' ' A' ' 186' ' ' SER . 88.4 m-20 -96.11 -4.25 43.15 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.863 -0.335 . . . . 1.18 110.758 -179.804 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.44 ' N ' ' HB ' ' A' ' 59' ' ' THR . . . 87.75 13.84 64.18 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.431 -0.668 . . . . 0.34 111.431 179.884 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -84.62 139.0 32.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.622 0.248 . . . . 1.22 110.443 179.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.804 ' NE2' ' HE ' ' A' ' 143' ' ' ARG . 86.6 mt-30 -106.62 141.02 38.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.871 0.367 . . . . 1.44 110.639 179.682 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.6 m -136.68 127.04 26.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 1.39 110.431 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.672 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.4 tp -68.17 117.35 9.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.348 -0.387 . . . . 1.08 110.507 -179.885 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.647 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.1 pt -109.1 -21.81 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.125 -0.489 . . . . 1.08 110.652 -179.674 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.9 125.68 5.84 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.489 -0.484 . . . . 1.1 111.479 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.495 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.73 120.33 21.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.756 -0.656 . . . . 0.94 109.504 179.165 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.67 151.67 29.04 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.659 -0.416 . . . . 1.07 110.952 -179.314 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.45 158.58 18.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.523 . . . . 0.89 110.467 179.707 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.08 157.93 43.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.046 -0.525 . . . . 0.67 110.527 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.21 104.41 9.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.728 -0.669 . . . . 1.17 110.088 179.44 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.474 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.4 p . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 117.839 -1.077 . . . . 1.26 110.659 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.219 -0.66 . . . . 3.83 109.219 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.36 150.81 18.52 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.012 -0.835 . . . . 1.39 111.012 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -35.81 142.43 0.11 Allowed 'Trans proline' 0 C--N 1.297 -2.141 0 C-N-CA 123.975 3.117 . . . . 0.86 113.761 -179.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.572 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.1 t -79.9 173.4 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.196 -1.365 . . . . 1.43 108.839 178.425 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.62 125.9 51.52 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.412 -0.515 . . . . 1.94 111.421 -179.662 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.47 144.01 33.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.613 -0.721 . . . . 1.19 110.649 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.01 168.33 25.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.837 0.351 . . . . 3.92 111.215 -179.762 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.584 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 65.9 mt -108.95 131.16 60.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.053 -0.521 . . . . 3.88 110.074 179.864 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.8 p -141.26 162.25 35.93 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.835 0.35 . . . . 3.92 111.223 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 9' ' ' THR . 98.0 mt-10 36.21 31.51 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.636 -0.505 . . . . 6.08 109.636 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.584 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.66 32.71 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.939 -0.573 . . . . 4.01 111.587 -178.787 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.641 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.24 -29.28 73.21 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.529 2.153 . . . . 4.51 111.82 179.391 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.641 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.71 125.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 3.51 110.43 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.631 ' CG ' HE22 ' A' ' 191' ' ' GLN . 10.2 mp0 -124.05 158.28 60.97 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.405 . . . . 4.3 110.432 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.555 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 96.4 Cg_endo -81.94 -64.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.935 2.423 . . . . 1.96 113.547 -179.037 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.813 ' ND2' ' CD1' ' A' ' 157' ' ' TYR . 7.3 m-20 -108.39 -19.55 13.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.262 -0.426 . . . . 3.33 112.084 -178.551 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 37.5 t -107.3 152.08 24.61 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.488 -0.485 . . . . 1.53 111.322 -179.435 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.573 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.29 102.92 2.23 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.716 -0.675 . . . . 2.29 110.705 179.803 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.63 145.68 13.12 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.928 2.419 . . . . 0.88 112.522 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.408 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.9 168.02 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.86 -0.609 . . . . 2.12 109.919 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.17 147.94 29.04 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.736 -0.468 . . . . 2.67 109.736 178.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.501 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.6 p90 -142.26 157.27 45.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.994 0.426 . . . . 0.32 111.229 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.467 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.8 m-20 -128.02 155.27 44.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.86 -0.609 . . . . 2.77 110.163 178.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.6 172.95 6.48 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.082 0.467 . . . . 1.25 110.777 -179.197 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.59 173.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.836 2.357 . . . . 1.12 111.597 179.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.06 -51.01 0.69 Allowed Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.729 -0.388 . . . . 4.05 110.051 179.89 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.65 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.83 152.37 82.39 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.797 2.331 . . . . 2.12 111.449 179.22 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.78 42.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.433 0.635 . . . . 2.85 110.554 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.813 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.65 -41.65 98.21 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.019 -0.991 . . . . 3.11 110.702 179.727 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.44 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.4 mt -109.84 137.86 40.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.659 -0.701 . . . . 1.86 111.24 -179.437 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.96 -72.89 0.7 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.017 -0.538 . . . . 1.61 111.933 -179.018 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.12 148.28 24.51 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.594 0.59 . . . . 1.67 112.594 -179.661 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.74 124.83 45.16 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.43 -0.582 . . . . 1.07 109.43 177.432 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.02 134.75 60.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.612 -0.435 . . . . 1.55 110.611 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.487 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -119.97 128.65 53.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.042 0.448 . . . . 1.33 111.309 179.674 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.548 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.19 139.02 49.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.679 -0.692 . . . . 2.36 110.114 178.967 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.418 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.2 p90 -145.0 163.15 35.07 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.119 0.485 . . . . 0.38 112.099 -178.094 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.49 139.6 7.86 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.406 -0.816 . . . . 2.31 110.533 178.728 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.686 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.8 Cg_endo -63.43 115.39 2.99 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.313 2.008 . . . . 0.86 111.893 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.676 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.89 81.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.92 -0.4 . . . . 3.44 109.92 -179.856 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.686 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.023 -0.535 . . . . 2.72 111.875 -179.41 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.2 p -157.63 157.87 34.44 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.787 -0.365 . . . . 2.78 110.506 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.45 27.83 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.478 . . . . 2.3 110.164 179.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.8 -75.87 1.31 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.157 -0.544 . . . . 1.8 111.859 -179.255 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.89 152.29 35.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 5.48 111.037 -179.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.637 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.23 -169.17 2.55 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.041 -0.527 . . . . 1.84 111.928 179.422 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.412 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.13 149.69 29.69 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.397 0.617 . . . . 2.27 112.615 -177.854 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.01 156.46 46.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.891 -1.05 . . . . 1.92 110.326 178.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.19 158.37 41.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.038 -0.528 . . . . 1.09 111.85 -179.317 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.8 m -115.17 135.67 53.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.5 -0.773 . . . . 1.16 109.815 179.296 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.445 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.43 122.01 23.75 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.515 -0.311 . . . . 1.39 111.511 -179.141 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.4 Cg_exo -46.48 151.81 1.71 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.668 2.245 . . . . 0.72 112.083 179.04 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.91 -23.08 63.13 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 116.033 -0.53 . . . . 0.74 112.821 -179.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.515 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.5 p-80 -82.79 -16.77 46.56 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.167 -0.613 . . . . 1.26 111.762 -178.293 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.49 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.69 138.47 31.54 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.766 -0.374 . . . . 1.59 110.266 179.399 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.61 13.93 10.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.409 -0.36 . . . . 2.07 111.476 -179.341 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -150.0 143.47 25.2 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.65 -0.42 . . . . 0.96 111.093 179.522 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.9 t80 -114.77 -169.32 1.52 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.263 0.554 . . . . 1.0 110.853 -179.386 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.714 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 5.4 p -151.83 125.95 9.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.403 -0.817 . . . . 1.19 109.737 179.284 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.428 HD11 HG23 ' A' ' 60' ' ' ILE . 66.7 mt -114.97 123.32 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.278 -0.569 . . . . 1.47 111.146 -179.797 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.628 ' HZ2' ' HA3' ' A' ' 141' ' ' GLY . 55.9 mtpt -126.57 163.41 23.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.835 -0.621 . . . . 3.0 110.371 179.776 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.04 19.04 59.9 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.743 -0.943 . . . . 0.5 110.743 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.433 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.4 mt -79.08 157.27 28.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.125 0.488 . . . . 1.21 111.361 -179.694 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.623 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -99.49 133.9 21.57 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.562 -0.744 . . . . 3.2 110.406 179.838 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.421 ' HD3' ' CE2' ' A' ' 157' ' ' TYR . 36.9 Cg_endo -67.84 143.56 61.6 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.563 2.175 . . . . 1.09 111.893 179.799 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.88 25.58 75.39 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.999 -0.841 . . . . 0.72 110.999 179.649 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.643 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.16 158.82 39.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.689 0.28 . . . . 1.47 110.426 -179.641 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.12 139.98 41.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.344 -0.389 . . . . 1.23 110.637 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.643 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.6 m-85 -122.63 136.39 54.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 1.1 110.753 -179.878 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.3 pt-20 -98.83 130.95 45.27 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.51 -0.922 . . . . 1.87 108.51 177.615 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.488 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.42 153.86 16.63 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.365 -0.922 . . . . 0.39 112.082 -178.711 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.98 140.86 46.02 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.709 -0.478 . . . . 1.8 109.709 179.647 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.469 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.3 tp -115.69 118.91 34.38 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.493 -0.483 . . . . 1.11 110.526 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.9 mt -112.48 129.08 68.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.298 -0.41 . . . . 1.51 110.648 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.82 120.8 43.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.325 -0.398 . . . . 1.47 110.669 -179.558 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.671 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.56 146.4 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.089 0.471 . . . . 1.33 111.098 -179.299 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.813 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.1 mt-30 -106.01 153.86 21.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.601 -0.727 . . . . 2.49 109.989 179.798 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.11 88.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.899 0.38 . . . . 4.2 110.439 -179.756 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.3 32.66 0.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.791 -0.64 . . . . 6.4 110.539 -179.915 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.16 -117.29 3.27 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.464 -0.654 . . . . 1.74 111.464 -179.765 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.451 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.1 m170 -81.5 177.45 8.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.234 0.54 . . . . 3.64 111.571 -179.173 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.1 149.59 32.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.392 -0.822 . . . . 1.7 110.406 179.18 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.19 144.58 38.6 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.453 -0.34 . . . . 2.7 110.629 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.96 136.02 61.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 120.582 -0.447 . . . . 1.16 111.536 -179.76 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.06 141.3 52.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.671 -0.695 . . . . 1.14 110.347 179.595 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.461 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.55 138.88 51.62 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 120.588 -0.445 . . . . 4.33 111.546 -179.329 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.35 164.17 38.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.604 -0.725 . . . . 0.91 109.474 179.336 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.571 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.24 151.62 38.67 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.4 -0.52 . . . . 1.47 111.065 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.573 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.3 p90 -146.28 172.63 13.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.727 -0.67 . . . . 0.51 111.047 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.444 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.5 t -118.68 160.72 21.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.485 -0.78 . . . . 1.92 109.846 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.444 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.39 121.89 22.97 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.558 -0.457 . . . . 1.63 110.784 179.913 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.601 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.8 p -128.0 162.8 25.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.14 -0.482 . . . . 2.37 111.126 179.706 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 109.914 -0.402 . . . . 3.63 109.914 178.427 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 CA--C 1.522 -0.117 0 CA-C-O 120.904 0.383 . . . . 1.25 110.278 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.47 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.88 167.54 0.26 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.917 -0.583 . . . . 1.16 110.916 179.932 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.53 145.51 50.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.707 -0.679 . . . . 0.78 110.196 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.21 101.74 9.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.064 -0.717 . . . . 1.08 109.064 177.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.461 HG11 ' N ' ' A' ' 131' ' ' SER . 71.2 t -112.99 139.75 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.03 -0.532 . . . . 1.1 111.008 -178.902 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.461 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.4 p -128.76 152.54 48.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.574 -0.739 . . . . 0.87 109.746 179.615 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.645 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.6 p90 -144.8 -164.96 2.04 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.657 -0.417 . . . . 0.37 110.578 -179.781 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -124.0 127.22 73.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.122 -0.49 . . . . 1.14 110.793 -179.794 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.175 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -58.1 58.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.141 -0.481 . . . . 1.91 110.299 179.918 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.18 24.52 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.863 -0.608 . . . . 1.56 111.476 -179.674 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.175 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.14 128.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.654 -0.418 . . . . 1.56 111.0 179.842 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.39 -9.56 56.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.931 -0.577 . . . . 1.88 110.352 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.6 p -87.1 0.17 55.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.073 -0.512 . . . . 1.63 110.297 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.96 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.22 137.22 25.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.977 -0.556 . . . . 1.11 109.972 179.69 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.589 ' N ' ' O ' ' A' ' 185' ' ' ILE . 72.3 m -96.22 -15.66 21.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.296 0.569 . . . . 1.01 110.055 -179.674 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.628 ' HA3' ' HZ2' ' A' ' 61' ' ' LYS . . . 178.67 175.63 45.9 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 109.888 -1.285 . . . . 0.14 109.888 179.57 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.4 151.69 42.34 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.605 -0.438 . . . . 0.21 110.501 179.719 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.847 HH12 ' NE2' ' A' ' 191' ' ' GLN . 52.9 ttp180 -132.37 121.27 23.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.128 -0.487 . . . . 1.54 109.883 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.496 HG23 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.1 136.49 38.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.698 -0.683 . . . . 1.08 110.693 -179.826 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 82.7 tt0 -129.34 129.89 45.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.973 -0.558 . . . . 1.32 110.047 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.71 135.28 34.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.053 -0.521 . . . . 1.05 110.623 -179.706 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.414 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.33 161.27 40.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.773 -0.649 . . . . 1.16 109.705 179.84 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.94 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.0 mt -71.0 124.91 25.45 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.641 -0.424 . . . . 1.23 110.751 -179.568 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.76 -7.72 49.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.763 -0.653 . . . . 0.86 110.913 -179.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -109.77 -69.69 0.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 1.66 111.393 -179.28 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.455 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.4 mt-10 -60.64 -35.39 76.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.003 -0.544 . . . . 1.66 111.45 -179.077 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.089 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.15 88.64 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.785 -0.926 . . . . 1.62 110.785 -179.793 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.315 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.3 t0 -27.94 -171.71 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.725 0.297 . . . . 1.86 110.283 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.315 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.14 45.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.043 0.449 . . . . 1.98 110.224 179.595 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.414 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 45.4 Cg_endo -70.96 145.88 51.34 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.729 2.286 . . . . 0.62 112.248 -179.467 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.83 145.75 42.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.228 -0.656 . . . . 1.14 109.228 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.813 ' CD1' ' ND2' ' A' ' 16' ' ' ASN . 21.3 p90 -123.31 141.33 52.1 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.377 -0.529 . . . . 1.44 111.491 -179.115 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.422 ' HA ' HD22 ' A' ' 158' ' ' LEU . 71.6 mt -128.16 127.71 43.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.269 -0.878 . . . . 1.08 108.872 178.926 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.499 ' OD1' ' O ' ' A' ' 159' ' ' ASP . 54.2 p-10 -101.62 131.1 48.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.195 0.522 . . . . 1.09 111.751 -178.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.502 HD13 ' HB ' ' A' ' 167' ' ' VAL . 5.9 mt -127.87 157.55 73.29 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.318 -0.855 . . . . 1.04 109.617 179.653 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -69.89 158.07 58.01 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.297 1.998 . . . . 0.21 112.251 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.2 p -59.25 -12.16 5.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.785 -0.643 . . . . 0.88 110.684 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.78 -8.8 42.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 1.06 110.7 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.24 135.39 34.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 1.05 110.351 179.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.7 p -133.09 16.65 4.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.388 -0.369 . . . . 1.07 110.573 179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.3 p -167.56 147.17 5.07 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.59 -0.522 . . . . 0.92 109.59 179.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.502 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.21 150.55 12.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.532 -0.467 . . . . 1.09 111.535 -179.658 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.497 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.38 124.9 50.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.572 -0.74 . . . . 1.31 109.851 179.463 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.516 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.33 104.85 29.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.385 -0.37 . . . . 1.09 111.062 -179.818 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -90.96 -179.58 1.52 Allowed 'Trans proline' 0 C--N 1.301 -1.951 0 C-N-CA 123.28 2.653 . . . . 0.48 112.211 179.909 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.73 32.64 18.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.407 -0.815 . . . . 1.26 111.449 179.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.516 HD21 HG21 ' A' ' 169' ' ' ILE . 24.2 mt -86.33 148.44 25.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.551 -0.295 . . . . 1.12 110.509 179.592 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.771 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.4 mt -88.17 114.89 61.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.349 -0.387 . . . . 1.3 110.702 -179.75 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.12 140.63 95.91 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.744 2.296 . . . . 0.92 111.99 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.14 21.15 74.26 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.012 -0.835 . . . . 0.44 111.012 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.455 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.86 150.24 49.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.847 0.356 . . . . 3.05 110.682 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.501 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.26 131.65 46.08 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.044 -0.525 . . . . 1.48 109.733 179.426 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.94 ' CE2' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.55 148.3 44.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.064 -0.516 . . . . 0.89 111.048 -179.84 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.3 mt -105.31 125.41 60.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.218 -1.03 . . . . 1.12 108.218 177.787 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.61 132.43 63.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.13 0.491 . . . . 1.1 111.285 -178.632 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.41 122.46 20.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.519 -0.764 . . . . 0.43 109.655 179.369 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.594 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.95 125.44 54.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.3 -0.409 . . . . 1.07 110.632 -179.516 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.673 ' CE1' HD11 ' A' ' 193' ' ' LEU . 49.4 m-85 -117.31 137.89 52.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.981 -0.554 . . . . 0.92 109.802 179.53 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.68 135.08 42.69 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.776 -0.824 . . . . 0.49 108.776 178.837 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 140' ' ' SER . 78.1 mt -99.13 122.93 51.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.126 0.489 . . . . 1.08 111.003 -178.805 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.449 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.9 p -83.9 169.71 14.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.546 -0.752 . . . . 0.89 110.489 -179.646 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.612 ' O ' ' CG2' ' A' ' 59' ' ' THR . 97.8 mt-10 -59.74 -14.52 14.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.08 -0.509 . . . . 1.6 111.01 -179.564 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.449 ' H ' ' HG ' ' A' ' 186' ' ' SER . 91.4 m-20 -96.02 -4.32 43.34 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.837 -0.345 . . . . 1.18 110.868 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.8 13.9 63.97 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.329 -0.708 . . . . 0.34 111.329 179.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -84.72 139.0 32.31 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.01 -0.276 . . . . 1.22 110.462 179.652 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.847 ' NE2' HH12 ' A' ' 143' ' ' ARG . 2.3 mt-30 -106.61 141.11 38.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.877 0.37 . . . . 1.44 110.536 179.789 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.0 m -136.8 127.0 26.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 1.39 110.386 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.673 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.3 tp -68.17 117.2 9.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.318 -0.401 . . . . 1.08 110.549 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.645 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.1 pt -108.94 -21.84 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 1.08 110.7 -179.694 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.86 125.76 5.9 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.559 -0.456 . . . . 1.1 111.513 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.484 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.69 120.2 21.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.756 -0.656 . . . . 0.94 109.585 179.189 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.65 29.05 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.718 -0.393 . . . . 1.07 110.87 -179.264 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.36 158.57 18.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.89 110.48 179.664 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -146.09 158.01 43.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.095 -0.502 . . . . 0.67 110.648 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.35 9.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.772 -0.649 . . . . 1.17 110.013 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.477 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 66.7 p . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.94 -1.028 . . . . 1.26 110.66 -179.686 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.2 m . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.206 -0.664 . . . . 3.83 109.206 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.438 ' H ' ' HB3' ' A' ' 1' ' ' SER . . . -116.33 150.73 18.54 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.999 -0.841 . . . . 1.39 110.999 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.62 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.061 0 C-N-CA 123.98 3.12 . . . . 0.86 113.788 -179.236 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.561 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.1 t -80.02 173.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.329 -1.305 . . . . 1.43 108.772 178.412 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.404 ' H ' ' CG1' ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.63 125.89 51.51 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.41 -0.516 . . . . 1.94 111.438 -179.558 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.55 143.93 34.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.656 -0.702 . . . . 1.19 110.662 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.95 168.37 25.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.934 0.397 . . . . 3.92 110.996 -179.625 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.579 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.98 131.08 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.893 -0.594 . . . . 3.88 110.057 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.18 162.37 35.66 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.828 0.347 . . . . 3.92 111.253 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.2 mt-10 35.93 31.74 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.159 0.504 . . . . 6.08 109.696 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.579 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.57 69.58 33.92 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.814 -0.63 . . . . 4.01 111.492 -178.728 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.615 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.23 -29.16 73.24 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.444 2.096 . . . . 4.51 111.794 179.318 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.615 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.68 125.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.228 -0.442 . . . . 3.51 110.447 -179.926 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 17' ' ' SER . 3.1 mp0 -123.91 158.31 60.48 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 4.3 110.494 179.852 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.469 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 97.6 Cg_endo -81.93 -64.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.0 2.467 . . . . 1.96 113.532 -179.005 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.716 ' CG ' ' CD1' ' A' ' 157' ' ' TYR . 66.5 t30 -108.37 -19.64 13.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.268 -0.424 . . . . 3.33 112.08 -178.559 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 29.1 t -107.3 152.08 24.61 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.46 -0.496 . . . . 1.53 111.339 -179.398 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.33 102.98 2.22 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.734 -0.666 . . . . 2.29 110.583 179.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.69 145.6 12.99 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.93 2.42 . . . . 0.88 112.569 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 pt -130.8 167.9 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.916 -0.584 . . . . 2.12 109.835 179.563 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.15 147.97 29.08 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.756 -0.461 . . . . 2.67 109.756 178.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.496 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.6 p90 -142.24 157.28 45.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.026 0.441 . . . . 0.32 111.235 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.473 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.0 155.35 44.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.83 -0.623 . . . . 2.77 110.176 178.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.62 173.05 6.34 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.145 0.498 . . . . 1.25 110.682 -179.129 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.71 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.851 2.368 . . . . 1.12 111.501 179.367 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.48 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.98 -51.06 0.69 Allowed Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 120.767 -0.373 . . . . 4.05 110.139 179.856 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.65 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.9 152.31 82.7 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.782 2.322 . . . . 2.12 111.428 179.232 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.73 42.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.388 0.613 . . . . 2.85 110.526 -179.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.82 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.58 -41.64 98.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.988 -1.005 . . . . 3.11 110.685 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.443 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.6 mt -109.93 137.84 40.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.771 -0.649 . . . . 1.86 111.31 -179.488 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.0 -72.83 0.71 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.022 -0.536 . . . . 1.61 111.851 -178.948 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.24 148.33 24.4 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.604 0.594 . . . . 1.67 112.604 -179.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.84 124.93 45.31 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.307 -0.627 . . . . 1.07 109.307 177.572 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.8 mt -118.09 134.77 60.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.589 -0.444 . . . . 1.55 110.685 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.481 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -120.06 128.61 53.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.036 0.446 . . . . 1.33 111.216 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.549 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.08 138.98 49.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.809 -0.632 . . . . 2.36 110.104 178.981 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.417 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.03 163.22 34.89 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 121.168 0.509 . . . . 0.38 112.126 -178.222 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.494 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.47 139.62 7.89 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.444 -0.798 . . . . 2.31 110.449 178.861 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.68 115.62 3.17 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.261 1.974 . . . . 0.86 111.781 179.998 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.02 81.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.879 -0.415 . . . . 3.44 109.879 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.23 -20.49 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.053 -0.522 . . . . 2.72 111.898 -179.546 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 p -157.7 157.79 34.17 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.803 -0.359 . . . . 2.78 110.527 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.4 m -120.34 27.76 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 2.3 110.179 179.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.69 -76.05 1.32 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.793 -0.523 . . . . 1.8 111.793 -179.211 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.88 152.33 35.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.922 0.391 . . . . 5.48 111.023 -179.323 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.642 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.06 2.51 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.081 -0.509 . . . . 1.84 111.948 179.372 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.17 149.66 29.77 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 112.59 0.589 . . . . 2.27 112.59 -177.812 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.01 156.45 46.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.826 -1.079 . . . . 1.92 110.268 178.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.21 158.34 41.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.961 -0.563 . . . . 1.09 111.778 -179.37 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 m -115.2 135.63 53.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.44 -0.8 . . . . 1.16 109.759 179.291 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.442 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.31 121.98 23.89 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.341 -0.39 . . . . 1.39 111.576 -179.157 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.518 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.5 Cg_exo -46.42 151.69 1.71 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.731 2.287 . . . . 0.72 112.068 179.052 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.8 -23.15 62.96 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 116.053 -0.521 . . . . 0.74 112.783 -179.258 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.518 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.1 p-80 -82.66 -17.02 46.08 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.264 -0.574 . . . . 1.26 111.798 -178.294 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.497 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.54 138.4 31.6 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.745 -0.382 . . . . 1.59 110.29 179.506 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.51 13.93 11.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.487 -0.324 . . . . 2.07 111.558 -179.385 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -150.04 143.54 25.21 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.633 -0.427 . . . . 0.96 111.016 179.598 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.718 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.9 t80 -114.87 -169.35 1.53 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.209 0.528 . . . . 1.0 110.836 -179.336 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.718 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.78 125.9 9.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.389 -0.823 . . . . 1.19 109.806 179.278 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.454 HD11 HG23 ' A' ' 60' ' ' ILE . 66.8 mt -114.9 123.33 70.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.328 -0.549 . . . . 1.47 111.111 -179.759 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.513 ' HZ1' ' CG1' ' A' ' 185' ' ' ILE . 51.6 mtpt -126.57 163.31 23.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.788 -0.642 . . . . 3.0 110.491 179.667 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.44 ' HA2' HD22 ' A' ' 16' ' ' ASN . . . 85.25 18.91 59.83 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.749 -0.941 . . . . 0.5 110.749 -179.876 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.581 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 74.1 mt -79.12 157.34 27.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.099 0.476 . . . . 1.21 111.381 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.631 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 8.7 mttm -99.55 133.94 21.51 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.642 -0.708 . . . . 3.2 110.416 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.85 143.66 61.91 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.538 2.159 . . . . 1.09 111.931 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.82 25.44 75.56 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.098 -0.801 . . . . 0.72 111.098 179.716 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.64 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.0 158.82 39.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.755 0.312 . . . . 1.47 110.419 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.12 139.94 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.307 -0.406 . . . . 1.23 110.642 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.64 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.58 136.54 54.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.534 . . . . 1.1 110.704 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.494 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -99.0 131.17 45.25 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.422 -0.955 . . . . 1.87 108.422 177.647 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.488 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.66 153.84 16.69 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.246 -0.978 . . . . 0.39 111.907 -178.595 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.94 140.9 46.1 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.734 -0.469 . . . . 1.8 109.734 179.584 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.469 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.1 tp -115.75 118.89 34.31 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.462 -0.495 . . . . 1.11 110.522 179.679 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.2 mt -112.4 129.18 68.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.282 -0.417 . . . . 1.51 110.6 -179.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.9 120.83 43.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.227 -0.442 . . . . 1.47 110.698 -179.677 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.675 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.58 146.42 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.22 0.533 . . . . 1.33 111.018 -179.269 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.82 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.02 153.9 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.472 -0.786 . . . . 2.49 109.864 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.434 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.05 88.47 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.875 0.369 . . . . 4.2 110.499 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.631 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.26 32.63 0.21 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.868 -0.605 . . . . 6.4 110.625 -179.867 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.14 -117.28 3.28 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.447 -0.661 . . . . 1.74 111.447 -179.746 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.454 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.39 177.35 9.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.126 0.489 . . . . 3.64 111.681 -179.218 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.14 149.56 32.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.454 -0.794 . . . . 1.7 110.367 179.162 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.19 144.68 38.64 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.484 -0.325 . . . . 2.7 110.593 179.865 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -128.04 135.93 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.065 0.46 . . . . 1.16 111.53 -179.706 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -123.98 141.3 52.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.625 -0.716 . . . . 1.14 110.247 179.692 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.473 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.61 138.87 51.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.091 0.472 . . . . 4.33 111.527 -179.421 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.31 164.22 37.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.55 -0.75 . . . . 0.91 109.455 179.393 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.576 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.28 151.56 38.54 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.384 -0.526 . . . . 1.47 110.985 -179.962 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.574 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.9 p90 -146.24 172.72 13.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.75 -0.659 . . . . 0.51 111.013 179.84 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.446 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.73 160.71 21.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.431 -0.804 . . . . 1.92 109.889 179.572 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.446 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.34 121.82 22.92 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.612 -0.435 . . . . 1.63 110.757 -179.995 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.457 ' OG1' ' N ' ' A' ' 93' ' ' SER . 70.3 p -129.54 -122.56 0.22 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.252 0.549 . . . . 2.37 112.0 179.609 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.457 ' N ' ' OG1' ' A' ' 92' ' ' THR . 8.1 t . . . . . 0 C--N 1.347 0.457 0 CA-C-N 114.8 -1.091 . . . . 3.63 111.057 -179.707 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 122.124 0.964 . . . . 1.25 110.191 . . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.475 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.79 167.54 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.676 -1.147 . . . . 1.16 110.955 -179.956 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.486 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.9 m-30 -133.55 145.65 50.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.626 -0.715 . . . . 0.78 110.087 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.38 101.65 9.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.027 -0.731 . . . . 1.08 109.027 177.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.466 HG11 ' N ' ' A' ' 131' ' ' SER . 71.4 t -112.9 139.66 36.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.018 -0.537 . . . . 1.1 111.049 -178.837 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.466 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.0 p -128.7 152.5 48.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.598 -0.728 . . . . 0.87 109.83 179.588 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.647 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.9 p90 -144.74 -164.86 2.01 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.738 -0.385 . . . . 0.37 110.727 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -124.01 127.18 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.259 -0.428 . . . . 1.14 110.838 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.144 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.97 58.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 1.91 110.292 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.2 24.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.993 -0.549 . . . . 1.56 111.514 -179.66 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.144 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.14 128.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.639 -0.425 . . . . 1.56 110.961 179.828 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.47 -9.57 55.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.918 -0.583 . . . . 1.88 110.357 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.2 p -87.06 0.17 55.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 1.63 110.332 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.965 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.29 137.19 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.951 -0.568 . . . . 1.11 110.009 179.776 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 185' ' ' ILE . 84.8 p -96.16 -15.58 22.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.355 0.597 . . . . 1.01 110.062 -179.602 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.61 175.59 45.81 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 109.882 -1.287 . . . . 0.14 109.882 179.651 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.42 151.49 42.57 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.701 -0.4 . . . . 0.21 110.558 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.841 ' NH2' ' CD2' ' A' ' 183' ' ' TYR . 66.7 ttp85 -132.27 121.27 23.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.19 -0.459 . . . . 1.54 109.94 179.751 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.485 HG23 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.1 136.62 38.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.738 -0.664 . . . . 1.08 110.695 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 21.7 tp10 -129.46 129.85 45.13 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.004 -0.543 . . . . 1.32 110.013 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.593 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.4 p90 -138.74 135.26 34.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.983 -0.553 . . . . 1.05 110.537 -179.678 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.406 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.28 161.34 39.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.729 -0.669 . . . . 1.16 109.679 179.766 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.939 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.3 mt -70.96 124.77 25.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.04 0.448 . . . . 1.23 110.772 -179.624 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.504 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.76 -7.62 49.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.737 -0.665 . . . . 0.86 110.908 -179.781 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -109.83 -69.69 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.304 -0.407 . . . . 1.66 111.433 -179.314 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.433 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.72 -35.26 75.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.056 -0.52 . . . . 1.66 111.529 -179.119 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.096 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.19 88.62 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.828 -0.909 . . . . 1.62 110.828 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.318 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -28.06 -171.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 1.86 110.317 179.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.318 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.16 139.05 45.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 1.98 110.237 179.61 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.406 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.91 145.82 51.49 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 122.702 2.268 . . . . 0.62 112.366 -179.554 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.593 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.8 145.7 42.6 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.287 -0.635 . . . . 1.14 109.287 179.235 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.716 ' CD1' ' CG ' ' A' ' 16' ' ' ASN . 49.3 p90 -123.29 141.43 51.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.209 0.528 . . . . 1.44 111.489 -179.069 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.6 mt -128.17 127.61 43.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.25 -0.886 . . . . 1.08 108.988 178.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 40.7 t0 -101.67 131.22 48.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.202 0.525 . . . . 1.09 111.679 -178.698 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.578 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -127.88 157.59 73.19 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.23 -0.896 . . . . 1.04 109.679 179.614 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.78 157.91 58.72 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 C-N-CA 122.51 2.14 . . . . 0.21 112.241 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.3 p -59.2 -12.18 4.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.781 -0.645 . . . . 0.88 110.768 -179.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.6 p -92.85 -8.69 42.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.068 -0.515 . . . . 1.06 110.717 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.29 135.46 34.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.349 -0.387 . . . . 1.05 110.349 179.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.4 p -133.19 16.64 4.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.402 -0.363 . . . . 1.07 110.531 -179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.7 p -167.55 147.09 5.06 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.651 -0.5 . . . . 0.92 109.651 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.509 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.18 150.51 12.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.462 -0.495 . . . . 1.09 111.588 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.492 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.38 125.02 50.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.626 -0.715 . . . . 1.31 109.772 179.483 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.508 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.42 104.88 29.77 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.334 -0.394 . . . . 1.09 111.036 -179.891 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -90.94 -179.49 1.51 Allowed 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 123.146 2.564 . . . . 0.48 112.277 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 61.64 32.7 18.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.373 -0.831 . . . . 1.26 111.479 179.315 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.508 HD21 HG21 ' A' ' 169' ' ' ILE . 24.2 mt -86.51 148.59 25.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.778 0.323 . . . . 1.12 110.388 179.632 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.765 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.35 114.86 61.36 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.093 0.473 . . . . 1.3 110.58 -179.648 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.05 140.59 95.93 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.974 2.449 . . . . 0.92 111.858 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.02 21.3 74.26 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.049 -0.821 . . . . 0.44 111.049 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.433 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.9 150.16 49.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.758 0.314 . . . . 3.05 110.584 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.504 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.22 131.64 46.05 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.018 -0.537 . . . . 1.48 109.767 179.327 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.939 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.55 148.26 44.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.091 -0.504 . . . . 0.89 111.049 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.1 mt -105.3 125.3 60.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.288 -1.004 . . . . 1.12 108.288 177.812 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.52 132.51 63.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.169 0.509 . . . . 1.1 111.261 -178.591 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.53 122.64 20.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.527 -0.76 . . . . 0.43 109.552 179.321 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.582 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.14 125.35 55.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.157 -0.474 . . . . 1.07 110.666 -179.545 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.841 ' CD2' ' NH2' ' A' ' 143' ' ' ARG . 48.3 m-85 -117.2 137.95 52.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.912 -0.586 . . . . 0.92 109.869 179.556 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.562 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.73 134.92 42.98 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.817 -0.808 . . . . 0.49 108.817 178.895 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' A' ' 140' ' ' SER . 51.6 mm -99.05 123.01 51.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.107 0.479 . . . . 1.08 110.962 -178.769 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.45 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.0 p -83.97 169.73 14.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.557 -0.747 . . . . 0.89 110.492 -179.698 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.84 -14.4 14.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.956 -0.566 . . . . 1.6 110.916 -179.448 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.45 ' H ' ' HG ' ' A' ' 186' ' ' SER . 94.2 m-20 -96.13 -4.28 43.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.839 0.352 . . . . 1.18 110.875 -179.853 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.85 13.91 63.86 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.285 -0.726 . . . . 0.34 111.285 179.792 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -84.66 139.14 32.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.728 0.299 . . . . 1.22 110.432 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -106.81 141.05 38.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.424 -0.353 . . . . 1.44 110.545 179.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.2 m -136.64 126.99 26.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 1.39 110.375 179.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.665 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.6 tp -68.18 117.31 9.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.32 -0.4 . . . . 1.08 110.467 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.647 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.3 pt -108.99 -21.84 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 1.08 110.676 -179.742 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.89 125.68 5.85 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.526 -0.47 . . . . 1.1 111.555 -179.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.497 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.77 120.24 21.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.814 -0.63 . . . . 0.94 109.538 179.259 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.65 151.69 29.08 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.619 -0.432 . . . . 1.07 110.85 -179.259 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.4 158.65 18.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.042 -0.526 . . . . 0.89 110.382 179.714 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -146.08 157.89 43.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.097 -0.501 . . . . 0.67 110.643 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.24 104.31 9.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.819 -0.628 . . . . 1.17 110.068 179.523 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.486 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.2 p . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.909 -1.043 . . . . 1.26 110.635 -179.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.2 m . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.189 -0.671 . . . . 3.83 109.189 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.73 18.54 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.045 -0.822 . . . . 1.39 111.045 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -35.68 142.37 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.086 0 C-N-CA 123.97 3.113 . . . . 0.86 113.832 -179.271 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.574 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -79.96 173.5 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 114.192 -1.367 . . . . 1.43 108.817 178.451 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 23' ' ' ASN . 96.2 mt-10 -105.62 125.88 51.5 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.406 -0.518 . . . . 1.94 111.41 -179.571 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 143.97 34.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.615 -0.721 . . . . 1.19 110.71 179.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.27 25.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.893 0.378 . . . . 3.92 111.133 -179.641 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.59 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.89 131.09 60.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.989 -0.551 . . . . 3.88 110.085 179.883 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.19 162.39 35.6 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.479 -0.328 . . . . 3.92 111.257 -179.995 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 95.0 mt-10 36.06 31.56 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.642 -0.503 . . . . 6.08 109.642 179.901 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.59 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.35 69.52 31.59 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.881 -0.599 . . . . 4.01 111.564 -178.721 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.23 -29.16 73.21 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.522 2.148 . . . . 4.51 111.821 179.39 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.65 125.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 3.51 110.367 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.534 ' OE1' ' O ' ' A' ' 13' ' ' SER . 3.1 mp0 -123.97 158.31 60.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.394 . . . . 4.3 110.479 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.47 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 97.0 Cg_endo -81.99 -64.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.935 2.424 . . . . 1.96 113.551 -179.035 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.836 HD22 ' CB ' ' A' ' 157' ' ' TYR . 28.1 m-80 -108.41 -19.64 13.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.051 0.389 . . . . 3.33 112.051 -178.546 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 79.3 p -107.35 152.08 24.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.159 0.504 . . . . 1.53 111.302 -179.369 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.29 102.9 2.23 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.671 -0.695 . . . . 2.29 110.656 179.918 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.7 145.59 12.97 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.872 2.381 . . . . 0.88 112.614 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.414 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.73 167.97 24.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.858 -0.61 . . . . 2.12 109.834 179.642 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.2 148.01 29.11 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.67 -0.493 . . . . 2.67 109.67 178.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.5 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.7 p90 -142.27 157.2 45.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.979 0.419 . . . . 0.32 111.223 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.463 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.1 m-20 -127.99 155.37 44.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.851 -0.613 . . . . 2.77 110.094 178.88 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.401 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . . . -132.64 173.13 6.24 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.07 -0.514 . . . . 1.25 110.716 -179.22 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.401 ' CD ' ' CB ' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.65 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.849 2.366 . . . . 1.12 111.515 179.393 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -51.08 0.69 Allowed Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.741 -0.383 . . . . 4.05 110.072 179.838 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.654 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.88 152.34 82.57 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.754 2.303 . . . . 2.12 111.456 179.245 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.66 42.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.446 0.641 . . . . 2.85 110.647 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.821 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.59 -41.64 98.33 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.004 -0.998 . . . . 3.11 110.669 179.742 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.433 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.8 mt -109.82 137.8 40.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.814 -0.63 . . . . 1.86 111.349 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.01 -72.89 0.7 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.125 -0.489 . . . . 1.61 111.833 -178.906 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -88.19 148.41 24.4 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.546 0.573 . . . . 1.67 112.546 -179.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.76 124.82 45.12 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.34 -0.615 . . . . 1.07 109.34 177.542 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.01 134.66 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.731 -0.388 . . . . 1.55 110.74 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.487 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -120.01 128.71 53.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.008 0.432 . . . . 1.33 111.213 179.78 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 139.02 49.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.693 -0.685 . . . . 2.36 110.112 179.004 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.416 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.12 163.21 35.01 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.162 0.506 . . . . 0.38 112.077 -178.135 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.491 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.46 139.52 7.84 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.473 -0.785 . . . . 2.31 110.487 178.927 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.55 115.55 3.1 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.279 1.986 . . . . 0.86 111.82 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.667 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.98 81.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.894 -0.409 . . . . 3.44 109.894 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.688 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.3 -20.68 0.06 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.025 -0.534 . . . . 2.72 111.932 -179.48 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.62 157.81 34.33 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.819 -0.352 . . . . 2.78 110.598 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.402 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.33 27.78 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 2.3 110.203 179.611 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.89 -75.78 1.31 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.088 -0.577 . . . . 1.8 111.836 -179.242 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.95 152.29 35.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.991 0.424 . . . . 5.48 110.946 -179.35 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.18 -169.07 2.52 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.009 -0.542 . . . . 1.84 111.911 179.373 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.416 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.19 149.61 29.85 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.473 0.654 . . . . 2.27 112.543 -177.822 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.03 156.47 46.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.8 -1.091 . . . . 1.92 110.25 178.633 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.23 158.38 41.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.964 -0.562 . . . . 1.09 111.866 -179.368 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.3 m -115.19 135.57 54.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.519 -0.764 . . . . 1.16 109.862 179.33 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.446 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.36 121.97 23.82 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.415 -0.357 . . . . 1.39 111.493 -179.073 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.518 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.4 Cg_exo -46.33 151.74 1.63 Allowed 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.593 2.195 . . . . 0.72 112.177 178.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.89 -23.01 62.99 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 116.128 -0.487 . . . . 0.74 112.77 -179.252 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.518 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.86 -16.91 45.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.456 0.628 . . . . 1.26 111.734 -178.264 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.484 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.56 138.37 31.62 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.873 -0.331 . . . . 1.59 110.314 179.361 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.58 14.05 10.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.32 -0.4 . . . . 2.07 111.479 -179.402 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.474 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.4 p -150.04 143.4 25.13 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.599 -0.441 . . . . 0.96 110.961 179.644 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.721 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.78 -169.37 1.53 Allowed 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.242 0.544 . . . . 1.0 110.874 -179.505 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.739 ' OG1' ' C ' ' A' ' 188' ' ' ASP . 2.6 m -151.78 125.92 9.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.371 -0.832 . . . . 1.19 109.814 179.276 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.427 HG23 HD11 ' A' ' 60' ' ' ILE . 66.8 mt -114.88 123.25 70.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.448 -0.501 . . . . 1.47 111.199 -179.699 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -126.49 163.35 23.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.842 -0.617 . . . . 3.0 110.394 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.614 ' H ' HH22 ' A' ' 143' ' ' ARG . . . 85.04 19.07 59.86 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.728 -0.949 . . . . 0.5 110.728 -179.954 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.436 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.5 mt -79.11 157.22 28.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.06 0.457 . . . . 1.21 111.362 -179.679 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.628 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 3.7 mtpp -99.46 134.02 21.5 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.561 -0.745 . . . . 3.2 110.473 179.779 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.91 143.58 61.24 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.573 2.182 . . . . 1.09 111.899 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.81 25.63 75.33 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.034 -0.826 . . . . 0.72 111.034 179.686 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.641 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.14 158.81 39.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.694 0.283 . . . . 1.47 110.398 -179.592 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.16 140.02 41.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.843 0.354 . . . . 1.23 110.565 -179.813 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.641 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.7 m-85 -122.63 136.38 54.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.901 -0.59 . . . . 1.1 110.792 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.491 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.76 131.03 45.21 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.593 -0.892 . . . . 1.87 108.593 177.574 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.488 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.55 153.83 16.67 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.244 -0.979 . . . . 0.39 111.981 -178.635 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.89 140.98 46.2 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.782 -0.451 . . . . 1.8 109.782 179.534 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.46 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.4 tp -115.78 118.92 34.38 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.39 -0.524 . . . . 1.11 110.525 179.72 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.9 mt -112.42 129.05 68.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.372 -0.376 . . . . 1.51 110.632 -179.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.75 120.82 43.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.333 -0.394 . . . . 1.47 110.756 -179.7 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.671 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.55 146.52 11.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.182 0.515 . . . . 1.33 111.04 -179.302 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.821 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.03 153.9 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.515 -0.766 . . . . 2.49 109.973 179.816 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.2 88.6 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.965 0.412 . . . . 4.2 110.392 -179.768 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.618 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.27 32.69 0.21 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.786 -0.643 . . . . 6.4 110.582 -179.94 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.12 -117.43 3.29 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.405 -0.678 . . . . 1.74 111.405 -179.684 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.445 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.5 177.37 8.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.168 0.509 . . . . 3.64 111.652 -179.181 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -148.12 149.54 32.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.38 -0.827 . . . . 1.7 110.375 179.223 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.18 144.63 38.64 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.485 -0.325 . . . . 2.7 110.513 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -127.97 136.02 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 120.619 -0.432 . . . . 1.16 111.519 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.574 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.15 141.32 52.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.645 -0.707 . . . . 1.14 110.284 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.447 ' N ' HG21 ' A' ' 85' ' ' THR . 42.4 ttp180 -117.66 138.9 51.67 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.502 -0.479 . . . . 4.33 111.531 -179.32 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.25 164.21 37.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.524 -0.762 . . . . 0.91 109.502 179.467 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.575 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.31 151.53 38.48 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.37 -0.532 . . . . 1.47 110.974 179.977 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.9 p90 -146.19 172.81 12.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.754 -0.657 . . . . 0.51 111.027 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.454 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.77 160.63 21.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.523 -0.762 . . . . 1.92 109.892 179.621 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.454 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.33 121.89 23.03 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.568 -0.453 . . . . 1.63 110.777 179.972 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.2 p -127.56 147.96 50.34 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.119 -0.491 . . . . 2.37 112.292 179.728 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 CA--C 1.532 0.279 0 CA-C-N 115.417 -0.811 . . . . 3.63 113.008 178.691 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.5 p . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 121.259 0.552 . . . . 1.25 109.881 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.481 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.85 167.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.536 -0.756 . . . . 1.16 110.96 179.939 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.484 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.9 m-30 -133.59 145.57 50.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.664 -0.698 . . . . 0.78 110.125 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.25 101.68 9.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.051 -0.722 . . . . 1.08 109.051 177.725 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.467 HG11 ' N ' ' A' ' 131' ' ' SER . 71.3 t -112.95 139.7 36.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.992 -0.549 . . . . 1.1 111.107 -178.911 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.467 ' N ' HG11 ' A' ' 130' ' ' VAL . 68.0 p -128.76 152.55 48.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.705 -0.679 . . . . 0.87 109.795 179.609 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.645 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.6 p90 -144.75 -164.85 2.01 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.62 -0.432 . . . . 0.37 110.651 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.6 t -123.97 127.17 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 1.14 110.804 -179.835 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.174 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.1 p -57.89 58.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.111 -0.495 . . . . 1.91 110.44 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.743 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.13 24.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.971 -0.559 . . . . 1.56 111.478 -179.591 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.174 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.1 128.62 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.674 -0.41 . . . . 1.56 110.999 179.833 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.35 -9.52 56.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.883 -0.599 . . . . 1.88 110.381 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.8 p -87.16 0.32 55.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.52 . . . . 1.63 110.27 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.967 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.33 137.19 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.023 -0.535 . . . . 1.11 109.977 179.717 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.583 ' N ' ' O ' ' A' ' 185' ' ' ILE . 93.8 p -96.2 -15.56 21.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.248 0.547 . . . . 1.01 110.046 -179.673 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.61 175.67 45.88 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 109.859 -1.297 . . . . 0.14 109.859 179.595 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.46 151.6 42.54 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.683 -0.407 . . . . 0.21 110.525 179.778 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.622 ' NH1' ' HB2' ' A' ' 159' ' ' ASP . 10.3 tpp180 -132.35 121.18 23.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.172 -0.467 . . . . 1.54 109.911 179.809 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.496 HG23 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.08 136.63 38.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.74 -0.664 . . . . 1.08 110.632 -179.777 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 79.3 tt0 -129.41 129.89 45.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.996 -0.547 . . . . 1.32 110.044 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.601 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.4 p90 -138.71 135.24 34.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.055 -0.52 . . . . 1.05 110.611 -179.669 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.408 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.27 161.32 39.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.841 -0.618 . . . . 1.16 109.734 179.834 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.945 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.4 mt -71.02 124.78 25.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.011 0.434 . . . . 1.23 110.767 -179.644 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.67 -7.7 49.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.777 -0.647 . . . . 0.86 110.915 -179.814 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.88 -69.58 0.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.303 -0.408 . . . . 1.66 111.449 -179.283 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.454 ' CD ' HH21 ' A' ' 176' ' ' ARG . 53.9 mt-10 -60.74 -35.33 76.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 1.66 111.506 -179.184 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.08 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.15 7.26 88.57 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.857 -0.897 . . . . 1.62 110.857 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.341 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.4 t0 -27.9 -171.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 1.86 110.229 179.798 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.341 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.4 139.1 44.67 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.036 0.446 . . . . 1.98 110.185 179.614 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.408 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 45.8 Cg_endo -70.91 145.79 51.39 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 122.675 2.25 . . . . 0.62 112.302 -179.466 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.75 145.72 42.54 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.318 -0.623 . . . . 1.14 109.318 179.157 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.836 ' CB ' HD22 ' A' ' 16' ' ' ASN . 22.3 p90 -123.27 141.34 52.09 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.384 -0.526 . . . . 1.44 111.536 -179.067 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.402 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.9 mt -128.14 127.66 43.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.314 -0.857 . . . . 1.08 108.936 178.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.622 ' HB2' ' NH1' ' A' ' 143' ' ' ARG . 29.5 t0 -101.6 131.09 47.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.171 0.51 . . . . 1.09 111.738 -178.77 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.497 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -127.91 157.52 73.49 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.2 -0.909 . . . . 1.04 109.583 179.643 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -69.8 158.14 57.94 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.351 2.034 . . . . 0.21 112.3 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.2 p -59.36 -12.19 5.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.733 -0.667 . . . . 0.88 110.744 -179.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.9 p -92.77 -8.71 42.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.086 -0.506 . . . . 1.06 110.718 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.14 135.38 34.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 1.05 110.378 179.67 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.5 p -133.18 16.72 4.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 1.07 110.552 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.1 p -167.59 147.12 5.04 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.619 -0.512 . . . . 0.92 109.619 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.497 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.2 150.46 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.548 -0.461 . . . . 1.09 111.59 -179.653 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.499 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.31 124.98 50.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.637 -0.71 . . . . 1.31 109.812 179.493 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.526 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.37 104.9 29.71 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.412 -0.358 . . . . 1.09 111.107 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.7 Cg_endo -91.06 -179.49 1.47 Allowed 'Trans proline' 0 C--N 1.301 -1.964 0 C-N-CA 123.178 2.585 . . . . 0.48 112.213 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 61.63 32.71 18.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.463 -0.79 . . . . 1.26 111.439 179.302 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.526 HD21 HG21 ' A' ' 169' ' ' ILE . 24.1 mt -86.35 148.51 25.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.436 -0.347 . . . . 1.12 110.469 179.547 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.776 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.29 114.83 61.2 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.076 0.465 . . . . 1.3 110.645 -179.75 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.98 140.58 95.96 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.908 2.405 . . . . 0.92 111.959 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.15 74.45 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.006 -0.837 . . . . 0.44 111.006 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.454 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.8 mmm-85 -126.87 150.27 49.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.38 . . . . 3.05 110.6 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.5 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.23 131.63 46.06 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.011 -0.54 . . . . 1.48 109.737 179.392 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.945 ' CE2' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.44 148.36 43.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.099 -0.501 . . . . 0.89 111.037 -179.868 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.34 125.34 60.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.258 -1.016 . . . . 1.12 108.258 177.745 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.54 132.53 63.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.085 0.469 . . . . 1.1 111.221 -178.595 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.54 122.56 20.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.591 -0.732 . . . . 0.43 109.626 179.258 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.593 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.03 125.37 54.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.181 -0.463 . . . . 1.07 110.729 -179.556 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.674 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.5 m-85 -117.14 137.83 52.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.014 -0.539 . . . . 0.92 109.903 179.565 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.574 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.63 134.98 42.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.815 -0.809 . . . . 0.49 108.815 178.832 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.583 ' O ' ' N ' ' A' ' 140' ' ' SER . 46.0 mm -99.05 122.94 51.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.131 0.491 . . . . 1.08 111.024 -178.826 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.443 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.6 p -83.76 169.66 14.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.571 -0.74 . . . . 0.89 110.511 -179.688 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.87 -14.43 15.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.034 -0.53 . . . . 1.6 110.979 -179.593 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.739 ' C ' ' OG1' ' A' ' 59' ' ' THR . 96.3 m-20 -96.03 -4.3 43.31 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.894 -0.323 . . . . 1.18 110.861 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.508 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.79 13.9 63.99 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.354 -0.699 . . . . 0.34 111.354 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -84.72 139.06 32.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.696 0.284 . . . . 1.22 110.389 179.731 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -106.61 141.02 38.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.423 -0.353 . . . . 1.44 110.674 179.646 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.0 m -136.73 127.09 26.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 1.39 110.338 179.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.674 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.5 tp -68.19 117.38 9.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.959 0.409 . . . . 1.08 110.451 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.645 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.1 pt -109.06 -21.86 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 1.08 110.71 -179.699 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.86 125.73 5.88 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 120.442 -0.503 . . . . 1.1 111.508 -179.757 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.488 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.81 120.21 21.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.792 -0.64 . . . . 0.94 109.581 179.195 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.63 151.7 29.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.96 0.41 . . . . 1.07 110.883 -179.239 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.45 158.6 18.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.009 -0.542 . . . . 0.89 110.409 179.725 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -146.11 157.92 43.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 0.67 110.678 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 104.34 9.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.811 -0.631 . . . . 1.17 110.053 179.582 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.484 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.3 p . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.964 -1.017 . . . . 1.26 110.61 -179.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.548 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.209 -0.663 . . . . 3.83 109.209 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.455 ' H ' ' HB3' ' A' ' 1' ' ' SER . . . -116.4 150.66 18.54 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.023 -0.831 . . . . 1.39 111.023 179.814 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -35.65 142.37 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.114 0 C-N-CA 123.956 3.104 . . . . 0.86 113.881 -179.23 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.567 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -79.96 173.35 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.261 -1.336 . . . . 1.43 108.841 178.507 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.402 ' H ' ' CG1' ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.49 125.89 51.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.127 0.489 . . . . 1.94 111.454 -179.639 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.56 144.01 33.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.575 -0.739 . . . . 1.19 110.621 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.08 168.24 25.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.914 0.388 . . . . 3.92 111.118 -179.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.583 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.5 mt -108.91 131.07 60.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.042 -0.526 . . . . 3.88 110.06 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.5 p -141.24 162.27 35.88 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.853 0.358 . . . . 3.92 111.203 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 48.1 mt-10 36.1 31.61 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.625 -0.509 . . . . 6.08 109.625 179.847 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.583 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.6 33.11 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.951 -0.568 . . . . 4.01 111.609 -178.844 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.639 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.24 -29.13 73.12 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.486 2.124 . . . . 4.51 111.838 179.325 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.639 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.58 125.62 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 3.51 110.527 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.707 ' O ' ' O ' ' A' ' 92' ' ' THR . 1.8 mp0 -123.99 158.3 60.75 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 4.3 110.411 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.552 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 98.3 Cg_endo -82.05 -64.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.874 2.383 . . . . 1.96 113.491 -178.983 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.727 ' ND2' ' CD1' ' A' ' 157' ' ' TYR . 1.2 m120 -108.44 -19.6 13.4 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.12 0.415 . . . . 3.33 112.12 -178.562 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.797 ' HG ' ' HZ3' ' A' ' 61' ' ' LYS . 55.8 m -107.3 152.03 24.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.171 0.51 . . . . 1.53 111.298 -179.411 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.571 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.21 102.88 2.24 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.681 -0.69 . . . . 2.29 110.618 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.66 145.64 13.04 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.925 2.417 . . . . 0.88 112.643 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.407 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.8 167.9 24.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.89 -0.595 . . . . 2.12 109.885 179.561 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -149.12 147.97 29.1 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.677 -0.49 . . . . 2.67 109.677 178.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.501 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.3 p90 -142.21 157.35 44.96 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.623 -0.431 . . . . 0.32 111.167 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.467 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.05 155.24 44.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.822 -0.626 . . . . 2.77 110.119 178.962 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.58 173.09 6.29 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.081 -0.508 . . . . 1.25 110.765 -179.217 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.68 174.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.909 2.406 . . . . 1.12 111.518 179.362 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.11 -51.16 0.68 Allowed Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.727 -0.389 . . . . 4.05 110.054 179.899 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.647 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.74 152.32 82.44 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.769 2.312 . . . . 2.12 111.442 179.189 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.69 42.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.351 0.596 . . . . 2.85 110.531 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.815 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.58 -41.72 98.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.05 -0.977 . . . . 3.11 110.609 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.44 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.2 mt -109.86 137.83 40.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.782 -0.644 . . . . 1.86 111.23 -179.363 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.94 -72.88 0.7 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.031 -0.531 . . . . 1.61 111.937 -178.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.15 148.36 24.46 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.559 0.577 . . . . 1.67 112.559 -179.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.87 124.84 45.06 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.302 -0.629 . . . . 1.07 109.302 177.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.4 mt -117.97 134.68 60.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.787 -0.365 . . . . 1.55 110.642 179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.487 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.8 mt -120.01 128.63 53.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 1.33 111.292 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.549 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.14 138.97 49.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.727 -0.67 . . . . 2.36 110.145 179.014 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.416 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -145.07 163.26 34.81 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 121.265 0.555 . . . . 0.38 112.037 -178.117 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.491 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.55 139.51 7.76 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 115.431 -0.804 . . . . 2.31 110.506 178.873 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.3 Cg_endo -63.5 115.46 3.05 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.344 2.03 . . . . 0.86 111.81 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.674 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.02 81.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.882 -0.414 . . . . 3.44 109.882 -179.81 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.72 0.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.943 -0.571 . . . . 2.72 111.916 -179.467 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.4 p -157.55 157.82 34.48 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.848 -0.341 . . . . 2.78 110.613 179.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.8 m -120.42 27.85 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.438 . . . . 2.3 110.144 179.558 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.78 -75.9 1.31 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.107 -0.568 . . . . 1.8 111.886 -179.284 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.88 152.34 35.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.944 0.402 . . . . 5.48 110.994 -179.42 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.676 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.21 -169.1 2.53 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.033 -0.53 . . . . 1.84 111.989 179.367 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.19 149.68 29.75 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.412 0.625 . . . . 2.27 112.583 -177.848 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.06 156.52 45.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.837 -1.074 . . . . 1.92 110.241 178.688 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.2 158.46 41.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.968 -0.56 . . . . 1.09 111.822 -179.349 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.6 m -115.31 135.72 53.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.479 -0.782 . . . . 1.16 109.747 179.291 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.441 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.46 121.93 23.69 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.385 -0.371 . . . . 1.39 111.579 -179.182 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.517 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.0 Cg_exo -46.24 151.67 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.729 2.286 . . . . 0.72 112.129 179.042 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.84 -23.11 63.01 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 116.083 -0.508 . . . . 0.74 112.77 -179.227 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.517 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.81 -16.83 46.24 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.224 -0.59 . . . . 1.26 111.819 -178.319 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.494 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.67 138.49 31.52 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.709 -0.397 . . . . 1.59 110.246 179.398 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.54 13.9 10.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.345 -0.389 . . . . 2.07 111.542 -179.363 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.476 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.97 143.41 25.19 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.63 -0.428 . . . . 0.96 111.059 179.676 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.4 t80 -114.76 -169.37 1.53 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.167 0.508 . . . . 1.0 110.899 -179.432 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.714 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.81 125.78 9.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.454 -0.794 . . . . 1.19 109.858 179.278 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.427 HD11 HG23 ' A' ' 60' ' ' ILE . 66.7 mt -114.81 123.16 70.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.382 -0.527 . . . . 1.47 111.282 -179.798 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.797 ' HZ3' ' HG ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -126.41 163.4 23.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.882 -0.599 . . . . 3.0 110.426 179.749 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.635 ' H ' ' HD3' ' A' ' 61' ' ' LYS . . . 85.11 19.0 59.86 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.759 -0.936 . . . . 0.5 110.759 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.431 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.9 mt -78.98 157.25 28.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.111 0.482 . . . . 1.21 111.3 -179.631 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.621 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -99.51 133.9 21.56 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.627 -0.715 . . . . 3.2 110.415 179.743 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.76 143.61 62.21 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.571 2.181 . . . . 1.09 112.022 179.731 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.76 25.6 75.37 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.061 -0.816 . . . . 0.72 111.061 179.715 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.644 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.14 158.77 39.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.751 0.31 . . . . 1.47 110.444 -179.673 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.13 140.08 41.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.932 0.396 . . . . 1.23 110.516 -179.765 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.644 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.65 136.46 54.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.886 -0.597 . . . . 1.1 110.75 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.491 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.86 131.02 45.28 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.506 -0.924 . . . . 1.87 108.506 177.637 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.487 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.46 153.92 16.64 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 120.321 -0.942 . . . . 0.39 111.985 -178.685 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.98 140.87 46.03 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.71 -0.478 . . . . 1.8 109.71 179.61 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.469 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.8 tp -115.71 118.9 34.34 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.526 -0.47 . . . . 1.11 110.534 179.691 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.5 129.09 68.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 1.51 110.647 -179.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.86 120.76 43.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.327 -0.397 . . . . 1.47 110.691 -179.577 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.673 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.54 146.47 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.197 0.523 . . . . 1.33 111.0 -179.266 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.815 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.09 153.9 21.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.501 -0.772 . . . . 2.49 109.924 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.21 88.51 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.938 0.399 . . . . 4.2 110.426 -179.653 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.628 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.42 32.61 0.23 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.807 -0.633 . . . . 6.4 110.581 -179.906 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.14 -117.28 3.28 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.492 -0.643 . . . . 1.74 111.492 -179.722 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.452 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.1 m170 -81.55 177.41 8.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.18 0.514 . . . . 3.64 111.516 -179.106 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.2 149.58 32.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.444 -0.798 . . . . 1.7 110.415 179.107 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.548 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.22 144.58 38.54 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.454 -0.339 . . . . 2.7 110.592 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -127.91 135.97 61.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.597 -0.441 . . . . 1.16 111.586 -179.761 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -123.99 141.32 52.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.733 -0.667 . . . . 1.14 110.259 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.46 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.65 138.96 51.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.134 0.492 . . . . 4.33 111.463 -179.414 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.487 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.37 164.15 38.07 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.514 -0.766 . . . . 0.91 109.442 179.352 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.569 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.15 151.59 38.69 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.366 -0.534 . . . . 1.47 110.985 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.571 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.9 p90 -146.3 172.75 13.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.689 -0.687 . . . . 0.51 111.018 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.446 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.5 t -118.74 160.67 21.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.443 -0.799 . . . . 1.92 109.846 179.66 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.446 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.38 121.8 22.84 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.624 -0.43 . . . . 1.63 110.833 179.962 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.707 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.2 p -127.85 170.0 13.28 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 116.09 -0.504 . . . . 2.37 110.677 179.683 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.466 0.329 0 CA-C-O 121.11 0.481 . . . . 3.63 110.119 179.415 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.44 0 CA-C-O 120.92 0.39 . . . . 1.25 111.511 . . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.478 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.83 167.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.917 -0.583 . . . . 1.16 110.99 179.868 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.478 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.9 m-30 -133.59 145.59 50.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.748 -0.66 . . . . 0.78 110.11 -179.881 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.35 101.65 9.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.08 -0.711 . . . . 1.08 109.08 177.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.469 HG11 ' N ' ' A' ' 131' ' ' SER . 71.5 t -112.96 139.74 36.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.978 -0.555 . . . . 1.1 111.071 -178.836 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.469 ' N ' HG11 ' A' ' 130' ' ' VAL . 69.1 p -128.78 152.5 48.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.613 -0.721 . . . . 0.87 109.741 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.647 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.8 p90 -144.8 -165.0 2.05 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.675 -0.41 . . . . 0.37 110.618 -179.775 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.738 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -123.86 127.15 73.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.218 -0.446 . . . . 1.14 110.894 -179.881 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.158 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.8 58.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 1.91 110.36 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.738 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.19 24.56 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.99 -0.55 . . . . 1.56 111.541 -179.583 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.158 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.16 128.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.615 -0.434 . . . . 1.56 110.95 179.831 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -86.45 -9.66 55.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.973 -0.558 . . . . 1.88 110.295 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.09 0.2 55.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 1.63 110.313 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.961 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.25 137.16 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.957 -0.565 . . . . 1.11 109.997 179.711 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.562 ' N ' ' O ' ' A' ' 185' ' ' ILE . 0.2 OUTLIER -96.2 -15.55 21.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.32 0.581 . . . . 1.01 110.021 -179.613 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.6 175.52 45.74 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 109.863 -1.295 . . . . 0.14 109.863 179.685 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -123.39 151.63 42.38 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.655 -0.418 . . . . 0.21 110.523 179.711 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.632 ' NH1' ' CB ' ' A' ' 157' ' ' TYR . 10.4 ttt85 -132.34 121.22 23.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.078 -0.51 . . . . 1.54 109.954 179.754 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.492 HG23 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.09 136.53 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.666 -0.697 . . . . 1.08 110.678 -179.752 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 84.2 tt0 -129.37 129.88 45.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.017 -0.538 . . . . 1.32 110.128 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.593 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.73 135.29 34.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.001 -0.545 . . . . 1.05 110.653 -179.684 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.401 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.26 161.34 39.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.721 -0.672 . . . . 1.16 109.682 179.883 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.935 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -71.06 124.83 25.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.971 0.415 . . . . 1.23 110.764 -179.662 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.503 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.74 -7.63 49.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.709 -0.678 . . . . 0.86 110.872 -179.775 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -109.87 -69.67 0.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.979 0.418 . . . . 1.66 111.386 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.443 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.74 -35.28 75.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.03 -0.532 . . . . 1.66 111.44 -179.095 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.09 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.08 7.26 88.56 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.858 -0.897 . . . . 1.62 110.858 -179.787 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.315 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.98 -171.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.331 . . . . 1.86 110.218 179.86 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.315 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.19 139.03 45.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.962 0.41 . . . . 1.98 110.233 179.627 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.401 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.1 Cg_endo -70.88 145.87 51.79 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 C-N-CA 122.751 2.301 . . . . 0.62 112.286 -179.469 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.593 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.91 145.7 42.68 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.199 -0.667 . . . . 1.14 109.199 179.237 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.727 ' CD1' ' ND2' ' A' ' 16' ' ' ASN . 43.2 p90 -123.31 141.33 52.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.269 0.557 . . . . 1.44 111.506 -179.102 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.3 mt -128.08 127.62 43.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.297 -0.865 . . . . 1.08 109.021 178.949 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -101.58 131.11 47.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.178 0.513 . . . . 1.09 111.812 -178.736 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.506 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -127.93 157.51 73.56 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.315 -0.857 . . . . 1.04 109.658 179.653 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.83 158.08 58.08 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 C-N-CA 122.389 2.059 . . . . 0.21 112.215 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.2 p -59.28 -12.2 5.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.754 -0.657 . . . . 0.88 110.736 -179.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.7 p -92.8 -8.68 42.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.132 -0.486 . . . . 1.06 110.79 -179.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.39 34.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.247 -0.433 . . . . 1.05 110.354 179.701 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.8 p -133.16 16.73 4.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.394 -0.367 . . . . 1.07 110.492 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.4 p -167.54 147.13 5.08 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.569 -0.53 . . . . 0.92 109.569 179.841 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.506 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.14 150.52 12.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.467 -0.493 . . . . 1.09 111.592 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.496 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.34 124.9 50.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.674 -0.694 . . . . 1.31 109.803 179.504 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.514 HD13 HG22 ' A' ' 169' ' ' ILE . 1.7 mt -99.33 104.82 29.06 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.382 -0.372 . . . . 1.09 111.131 -179.933 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.5 Cg_endo -90.92 -179.48 1.51 Allowed 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 123.192 2.595 . . . . 0.48 112.296 179.883 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.7 32.59 18.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.46 -0.791 . . . . 1.26 111.462 179.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.511 HD21 HG21 ' A' ' 169' ' ' ILE . 24.1 mt -86.32 148.51 25.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.457 -0.338 . . . . 1.12 110.44 179.615 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.77 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.28 114.83 61.19 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.008 0.432 . . . . 1.3 110.7 -179.767 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -58.98 140.59 96.03 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.851 2.367 . . . . 0.92 112.039 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.06 21.24 74.27 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.028 -0.829 . . . . 0.44 111.028 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.443 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.9 150.17 49.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.857 0.36 . . . . 3.05 110.578 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.503 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.19 131.62 46.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.039 -0.528 . . . . 1.48 109.795 179.335 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.935 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.48 148.25 44.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.117 -0.492 . . . . 0.89 111.089 -179.863 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.21 125.28 60.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.342 -0.984 . . . . 1.12 108.342 177.742 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.53 132.58 63.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.129 0.49 . . . . 1.1 111.238 -178.593 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.55 122.52 20.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.461 -0.791 . . . . 0.43 109.574 179.362 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.589 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.99 125.39 54.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.337 -0.392 . . . . 1.07 110.706 -179.563 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.67 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.5 m-85 -117.24 137.92 52.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.086 -0.506 . . . . 0.92 109.833 179.573 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.83 134.96 43.02 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.802 -0.814 . . . . 0.49 108.802 178.865 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.562 ' O ' ' N ' ' A' ' 140' ' ' SER . 3.7 mt -99.01 122.92 51.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.09 0.472 . . . . 1.08 111.001 -178.736 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.45 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.8 p -83.84 169.82 14.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.562 -0.744 . . . . 0.89 110.469 -179.685 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.84 -14.51 15.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.058 -0.519 . . . . 1.6 110.928 -179.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.45 ' H ' ' HG ' ' A' ' 186' ' ' SER . 95.4 m-20 -96.07 -4.42 42.97 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.878 -0.329 . . . . 1.18 110.83 -179.815 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.9 13.85 63.86 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.368 -0.693 . . . . 0.34 111.368 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -84.62 139.04 32.35 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.775 -0.25 . . . . 1.22 110.446 179.694 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.415 HE22 ' HG2' ' A' ' 14' ' ' GLN . 4.0 mp0 -106.71 141.07 38.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.485 -0.325 . . . . 1.44 110.63 179.708 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.4 m -136.7 127.02 26.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 1.39 110.329 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.67 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.6 tp -68.11 117.29 9.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.327 -0.397 . . . . 1.08 110.477 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.647 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.1 pt -109.03 -21.85 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 1.08 110.716 -179.785 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.1 tp -156.87 125.8 5.91 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.566 -0.454 . . . . 1.1 111.564 -179.829 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.498 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.7 120.16 21.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.731 -0.668 . . . . 0.94 109.579 179.289 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.65 151.75 29.16 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.714 -0.394 . . . . 1.07 110.884 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.55 158.6 18.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.054 -0.521 . . . . 0.89 110.469 179.675 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.09 157.87 43.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.191 -0.459 . . . . 0.67 110.725 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.27 104.41 9.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.771 -0.649 . . . . 1.17 110.024 179.559 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.478 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.1 p . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 117.88 -1.057 . . . . 1.26 110.638 -179.691 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.9 m . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.248 -0.649 . . . . 3.83 109.248 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.42 150.73 18.53 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.037 -0.825 . . . . 1.39 111.037 179.692 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -35.65 142.43 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 123.988 3.125 . . . . 0.86 113.795 -179.197 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.571 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.3 t -80.04 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 114.295 -1.321 . . . . 1.43 108.808 178.447 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.405 ' H ' ' CG1' ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.68 125.87 51.49 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.415 -0.514 . . . . 1.94 111.395 -179.533 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 144.03 33.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.555 -0.748 . . . . 1.19 110.646 179.921 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.05 168.33 25.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.894 0.378 . . . . 3.92 111.096 -179.614 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.574 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.4 mt -109.03 131.14 60.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.006 -0.543 . . . . 3.88 110.074 179.861 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.505 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.3 p -141.21 162.3 35.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.859 0.361 . . . . 3.92 111.217 -179.903 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 10' ' ' GLU . 80.1 tt0 36.13 31.57 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.629 -0.508 . . . . 6.08 109.629 179.811 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.574 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.55 69.58 33.73 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.945 -0.57 . . . . 4.01 111.58 -178.753 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.17 -29.14 73.74 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.525 2.15 . . . . 4.51 111.868 179.304 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.63 125.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 3.51 110.41 -179.973 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.669 HE21 ' C ' ' A' ' 17' ' ' SER . 14.3 mt-30 -123.96 158.38 60.41 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 4.3 110.405 179.942 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.573 ' HD2' HH12 ' A' ' 143' ' ' ARG . 97.4 Cg_endo -82.03 -64.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.942 2.428 . . . . 1.96 113.558 -179.086 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.552 ' ND2' ' OD1' ' A' ' 159' ' ' ASP . 98.7 m-20 -108.48 -19.51 13.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.075 0.398 . . . . 3.33 112.075 -178.54 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.669 ' C ' HE21 ' A' ' 14' ' ' GLN . 29.1 t -107.35 151.99 24.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.083 0.468 . . . . 1.53 111.296 -179.405 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.2 102.92 2.24 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.656 -0.702 . . . . 2.29 110.722 179.786 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.72 145.59 12.93 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.962 2.441 . . . . 0.88 112.636 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.407 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.75 167.92 24.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.894 -0.594 . . . . 2.12 109.853 179.672 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -149.12 148.02 29.17 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.768 -0.456 . . . . 2.67 109.768 178.816 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.505 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.5 p90 -142.34 157.29 44.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.031 0.443 . . . . 0.32 111.212 179.954 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.461 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.9 m-20 -128.02 155.29 44.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.777 -0.647 . . . . 2.77 110.111 179.072 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.69 172.95 6.49 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.155 0.502 . . . . 1.25 110.701 -179.171 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.6 173.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.844 0 C-N-CA 122.876 2.384 . . . . 1.12 111.475 179.421 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.479 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.1 -51.07 0.68 Allowed Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 120.68 -0.408 . . . . 4.05 110.111 179.881 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.654 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.81 152.33 82.49 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.716 2.277 . . . . 2.12 111.497 179.139 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.66 42.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.417 0.627 . . . . 2.85 110.58 -179.881 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.814 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.69 -41.54 98.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.959 -1.019 . . . . 3.11 110.7 179.775 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.449 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.8 mt -109.9 137.82 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.738 -0.665 . . . . 1.86 111.29 -179.479 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.89 -72.96 0.7 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.056 -0.52 . . . . 1.61 111.982 -179.006 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.43 24.41 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.62 0.6 . . . . 1.67 112.62 -179.689 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.78 124.88 45.24 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.365 -0.606 . . . . 1.07 109.365 177.524 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.06 134.82 60.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.724 -0.391 . . . . 1.55 110.63 179.913 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.489 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -120.15 128.68 53.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.078 0.466 . . . . 1.33 111.138 179.792 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.541 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.99 49.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.716 -0.674 . . . . 2.36 110.162 178.92 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.416 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -145.0 163.22 34.87 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.153 0.502 . . . . 0.38 112.097 -178.127 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.488 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.56 139.53 7.76 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.483 -0.781 . . . . 2.31 110.443 178.805 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.43 115.5 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.283 1.989 . . . . 0.86 111.855 179.946 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.686 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.06 81.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.914 0.388 . . . . 3.44 109.964 -179.853 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.14 -20.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.962 -0.563 . . . . 2.72 111.901 -179.466 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -157.62 157.75 34.22 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.885 -0.326 . . . . 2.78 110.586 179.819 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.402 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.34 27.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.173 -0.467 . . . . 2.3 110.232 179.567 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.84 -75.86 1.31 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.144 -0.55 . . . . 1.8 111.796 -179.204 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.86 152.3 35.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.959 0.409 . . . . 5.48 110.951 -179.268 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.66 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.26 -169.16 2.54 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.033 -0.53 . . . . 1.84 111.938 179.352 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.416 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.08 149.58 29.83 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.436 0.636 . . . . 2.27 112.634 -177.903 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.0 156.48 46.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.83 -1.077 . . . . 1.92 110.318 178.562 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.16 158.45 41.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.926 -0.579 . . . . 1.09 111.82 -179.373 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 m -115.22 135.62 53.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.483 -0.781 . . . . 1.16 109.8 179.322 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.452 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.48 121.95 23.67 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.459 -0.337 . . . . 1.39 111.489 -179.14 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.2 Cg_exo -46.25 151.68 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.67 2.246 . . . . 0.72 112.141 178.993 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.88 -22.98 62.95 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.998 -0.547 . . . . 0.74 112.882 -179.268 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.515 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.83 -16.81 46.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.346 0.573 . . . . 1.26 111.839 -178.38 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.494 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.5 mt -91.73 138.36 31.62 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.749 -0.38 . . . . 1.59 110.335 179.371 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.45 13.93 11.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.353 -0.385 . . . . 2.07 111.546 -179.3 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.8 p -149.98 143.54 25.27 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.612 -0.435 . . . . 0.96 111.028 179.594 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.721 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.85 -169.32 1.53 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.174 0.511 . . . . 1.0 110.855 -179.423 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.721 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 50.1 m -151.8 125.93 9.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.332 -0.849 . . . . 1.19 109.783 179.247 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.431 HG23 HD11 ' A' ' 60' ' ' ILE . 66.6 mt -114.91 123.28 70.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.336 -0.546 . . . . 1.47 111.162 -179.793 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.561 ' HG2' ' N ' ' A' ' 62' ' ' GLY . 88.2 tttt -126.48 163.4 23.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.788 -0.642 . . . . 3.0 110.431 179.709 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.561 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.1 18.99 59.89 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.833 -0.907 . . . . 0.5 110.833 -179.906 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.44 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.9 mt -79.03 157.23 28.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.054 0.454 . . . . 1.21 111.33 -179.589 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.601 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 3.6 mttp -99.55 134.05 21.43 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.571 -0.741 . . . . 3.2 110.413 179.77 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.94 143.62 61.22 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.501 2.134 . . . . 1.09 111.948 179.82 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.64 75.32 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.054 -0.818 . . . . 0.72 111.054 179.721 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.649 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.17 158.79 40.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.743 0.306 . . . . 1.47 110.428 -179.662 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.14 139.93 42.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.971 0.415 . . . . 1.23 110.582 -179.778 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.649 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.3 m-85 -122.5 136.43 54.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.0 -0.546 . . . . 1.1 110.803 -179.886 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.95 130.95 45.34 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.548 -0.908 . . . . 1.87 108.548 177.639 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.47 153.86 16.65 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.332 -0.937 . . . . 0.39 111.89 -178.517 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.01 140.89 46.01 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.717 -0.475 . . . . 1.8 109.717 179.529 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.472 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.8 tp -115.72 119.01 34.67 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.498 -0.481 . . . . 1.11 110.477 179.683 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.53 129.15 68.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 1.51 110.579 -179.904 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.83 120.74 43.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.322 -0.399 . . . . 1.47 110.715 -179.67 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.67 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.53 146.52 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.184 0.516 . . . . 1.33 111.025 -179.349 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.814 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.01 153.86 21.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.482 -0.781 . . . . 2.49 109.986 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.16 88.57 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.953 0.406 . . . . 4.2 110.375 -179.758 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.624 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.33 32.51 0.21 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.843 -0.617 . . . . 6.4 110.602 -179.966 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.99 -117.35 3.3 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.502 -0.639 . . . . 1.74 111.502 -179.758 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.451 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.44 177.36 9.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.254 0.55 . . . . 3.64 111.604 -179.239 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.06 149.47 32.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.428 -0.806 . . . . 1.7 110.502 179.185 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.13 144.73 38.77 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.479 -0.328 . . . . 2.7 110.544 179.854 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.5 p -128.01 135.91 61.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-O 120.936 0.398 . . . . 1.16 111.597 -179.775 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.571 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -123.94 141.34 52.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.678 -0.692 . . . . 1.14 110.301 179.634 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.482 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.68 138.86 51.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.136 0.493 . . . . 4.33 111.451 -179.382 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.25 164.14 37.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.567 -0.742 . . . . 0.91 109.464 179.403 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.561 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.23 151.56 38.58 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.391 -0.524 . . . . 1.47 111.015 179.983 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.0 p90 -146.19 172.74 13.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.81 -0.632 . . . . 0.51 111.058 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.451 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.75 160.78 21.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.46 -0.791 . . . . 1.92 109.89 179.529 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.451 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.42 121.92 22.98 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.556 -0.458 . . . . 1.63 110.722 179.955 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.521 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.3 p -130.01 166.07 20.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.673 0.749 . . . . 2.37 112.861 179.669 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.529 ' HB2' ' CE1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 114.692 -1.14 . . . . 3.63 110.563 177.226 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.9 p . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 121.005 0.431 . . . . 1.25 110.753 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.467 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.92 167.57 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.74 -0.664 . . . . 1.16 110.985 -179.359 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.493 ' CZ ' HG22 ' A' ' 201' ' ' THR . 8.0 m-30 -133.57 145.49 50.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.808 -0.633 . . . . 0.78 110.182 -179.92 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.27 101.67 9.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.083 -0.71 . . . . 1.08 109.083 177.714 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.468 HG11 ' N ' ' A' ' 131' ' ' SER . 71.1 t -112.96 139.77 36.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.943 -0.572 . . . . 1.1 111.004 -178.834 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.468 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.4 p -128.79 152.53 48.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.642 -0.708 . . . . 0.87 109.799 179.619 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.652 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.8 p90 -144.82 -165.02 2.05 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.776 -0.37 . . . . 0.37 110.674 -179.737 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.745 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -123.97 127.2 73.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.198 -0.455 . . . . 1.14 110.815 -179.856 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.175 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.89 58.37 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.076 -0.511 . . . . 1.91 110.363 179.821 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.745 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.21 24.6 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 1.56 111.509 -179.705 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.175 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.18 128.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.627 -0.429 . . . . 1.56 110.95 179.822 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.45 -9.55 56.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.977 -0.556 . . . . 1.88 110.379 179.703 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.0 p -87.09 0.19 55.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.119 -0.491 . . . . 1.63 110.278 179.924 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.941 HG11 ' O ' ' A' ' 136' ' ' SER . 2.6 p -65.27 137.15 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.02 -0.537 . . . . 1.11 109.994 179.711 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 185' ' ' ILE . 91.1 p -96.23 -15.53 21.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.236 0.541 . . . . 1.01 109.992 -179.608 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.439 ' HA3' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.62 175.55 45.79 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 109.88 -1.288 . . . . 0.14 109.88 179.662 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.4 151.56 42.47 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.957 0.408 . . . . 0.21 110.487 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.81 HH22 ' NE2' ' A' ' 191' ' ' GLN . 77.1 mtm180 -132.29 121.1 23.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.112 -0.495 . . . . 1.54 109.966 179.758 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.507 HG23 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.05 136.62 38.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.781 -0.645 . . . . 1.08 110.661 -179.779 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.552 ' CD ' ' HH ' ' A' ' 157' ' ' TYR . 85.5 tt0 -129.42 129.84 45.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.914 -0.584 . . . . 1.32 110.041 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.605 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 36.0 p90 -138.7 135.36 34.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.024 -0.535 . . . . 1.05 110.66 -179.742 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.408 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.36 161.33 39.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.778 -0.646 . . . . 1.16 109.6 179.897 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.938 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.3 mt -71.11 124.88 25.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.104 0.478 . . . . 1.23 110.768 -179.674 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.499 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.79 -7.61 49.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.664 -0.698 . . . . 0.86 110.861 -179.724 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -109.85 -69.71 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.354 -0.384 . . . . 1.66 111.395 -179.305 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.491 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.61 -35.36 75.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.04 -0.527 . . . . 1.66 111.582 -179.165 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.08 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.12 7.2 88.61 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.895 -0.882 . . . . 1.62 110.895 -179.798 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.335 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.92 -171.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.849 0.357 . . . . 1.86 110.257 179.897 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.335 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.21 138.98 45.29 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.948 0.404 . . . . 1.98 110.229 179.599 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.408 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 48.3 Cg_endo -70.73 145.74 52.33 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 C-N-CA 122.729 2.286 . . . . 0.62 112.377 -179.586 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.79 145.75 42.54 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.251 -0.648 . . . . 1.14 109.251 179.155 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.552 ' HH ' ' CD ' ' A' ' 145' ' ' GLU . 96.4 m-85 -123.31 141.33 52.1 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.346 -0.542 . . . . 1.44 111.553 -179.124 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.419 ' HA ' HD22 ' A' ' 158' ' ' LEU . 71.5 mt -128.08 127.68 43.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.372 -0.831 . . . . 1.08 108.959 178.987 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.552 ' OD1' ' ND2' ' A' ' 16' ' ' ASN . 67.3 m-20 -101.63 131.15 48.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.154 0.502 . . . . 1.09 111.725 -178.726 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.521 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -127.99 157.49 73.73 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.316 -0.857 . . . . 1.04 109.581 179.667 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.67 157.99 58.64 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.414 2.076 . . . . 0.21 112.261 179.936 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.32 -12.09 5.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.823 -0.626 . . . . 0.88 110.689 -179.855 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.9 -8.7 42.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 1.06 110.67 -179.933 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.24 135.41 34.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.368 -0.378 . . . . 1.05 110.425 179.662 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.17 16.71 4.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.348 -0.387 . . . . 1.07 110.476 179.983 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.4 p -167.59 147.1 5.03 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.629 -0.508 . . . . 0.92 109.629 179.797 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.521 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.14 150.49 12.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.567 -0.453 . . . . 1.09 111.592 -179.573 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.494 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.32 124.91 50.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.657 -0.701 . . . . 1.31 109.812 179.499 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.526 HG21 HD21 ' A' ' 172' ' ' LEU . 1.8 mt -99.42 104.93 30.04 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.912 0.387 . . . . 1.09 111.058 -179.884 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.3 Cg_endo -91.0 -179.53 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 123.256 2.638 . . . . 0.48 112.243 179.86 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.69 32.61 18.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.36 -0.836 . . . . 1.26 111.461 179.308 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.526 HD21 HG21 ' A' ' 169' ' ' ILE . 24.5 mt -86.36 148.54 25.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.51 -0.314 . . . . 1.12 110.464 179.619 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.761 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.32 114.93 61.66 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.986 0.422 . . . . 1.3 110.643 -179.701 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -58.95 140.54 95.78 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.949 2.433 . . . . 0.92 111.922 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.1 21.16 74.36 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.018 -0.833 . . . . 0.44 111.018 179.785 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.491 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.81 150.17 49.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 3.05 110.669 179.996 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.499 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.15 131.66 45.97 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.074 -0.512 . . . . 1.48 109.783 179.371 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.938 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.5 m-85 -120.61 148.26 44.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.159 -0.473 . . . . 0.89 111.039 -179.822 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.3 mt -105.35 125.36 60.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.244 -1.021 . . . . 1.12 108.244 177.804 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.53 132.54 63.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.143 0.496 . . . . 1.1 111.228 -178.586 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.51 122.51 20.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.502 -0.772 . . . . 0.43 109.689 179.276 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.591 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.95 125.32 54.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.199 -0.455 . . . . 1.07 110.716 -179.55 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.67 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.7 m-85 -117.15 137.99 51.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.955 -0.566 . . . . 0.92 109.889 179.443 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.555 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.74 134.98 42.9 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.806 -0.813 . . . . 0.49 108.806 178.882 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.784 ' CD1' ' NE ' ' A' ' 143' ' ' ARG . 13.2 mt -99.04 122.9 51.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.116 0.484 . . . . 1.08 110.959 -178.738 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.449 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.7 p -83.83 169.72 14.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.609 -0.723 . . . . 0.89 110.479 -179.693 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -59.86 -14.46 15.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.053 -0.521 . . . . 1.6 110.92 -179.555 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.449 ' H ' ' HG ' ' A' ' 186' ' ' SER . 94.5 m-20 -96.15 -4.24 43.03 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.825 -0.35 . . . . 1.18 110.809 -179.825 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.81 13.89 63.97 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.342 -0.703 . . . . 0.34 111.342 179.835 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -84.63 139.01 32.37 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.076 -0.25 . . . . 1.22 110.424 179.686 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.81 ' NE2' HH22 ' A' ' 143' ' ' ARG . 0.0 OUTLIER -106.69 141.12 38.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.87 0.367 . . . . 1.44 110.558 179.718 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.3 m -136.7 127.03 26.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 1.39 110.327 179.952 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.67 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.5 tp -68.16 117.38 9.91 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.675 -0.41 . . . . 1.08 110.533 -179.95 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.652 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.1 pt -109.01 -21.82 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 1.08 110.773 -179.778 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.5 tp -156.95 125.75 5.84 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.523 -0.471 . . . . 1.1 111.475 -179.77 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.494 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.8 120.23 21.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.787 -0.642 . . . . 0.94 109.519 179.253 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.68 29.08 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.591 -0.444 . . . . 1.07 110.868 -179.265 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.43 158.57 18.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.014 -0.539 . . . . 0.89 110.44 179.702 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.02 157.89 43.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.088 -0.505 . . . . 0.67 110.698 179.995 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.19 104.32 9.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.761 -0.654 . . . . 1.17 110.101 179.493 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.493 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 66.8 p . . . . . 0 C--O 1.221 -0.414 0 CA-C-O 117.953 -1.022 . . . . 1.26 110.631 -179.628 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.553 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.1 m . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.161 -0.681 . . . . 3.83 109.161 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.69 18.54 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.011 -0.835 . . . . 1.39 111.011 179.809 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -35.67 142.4 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.084 0 C-N-CA 123.933 3.089 . . . . 0.86 113.76 -179.222 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.566 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.1 t -79.93 173.43 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.173 -1.376 . . . . 1.43 108.785 178.416 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.66 125.78 51.38 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.425 -0.51 . . . . 1.94 111.44 -179.559 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.38 144.01 34.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.692 -0.685 . . . . 1.19 110.652 179.959 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.1 168.24 25.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.97 0.414 . . . . 3.92 111.111 -179.67 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.582 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.96 131.04 60.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.002 -0.544 . . . . 3.88 110.123 179.868 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.12 162.34 35.71 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.822 0.344 . . . . 3.92 111.274 -179.924 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 98.9 mt-10 36.14 31.51 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.592 -0.521 . . . . 6.08 109.592 179.819 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.582 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.59 32.58 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.001 -0.545 . . . . 4.01 111.512 -178.721 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.3 -28.98 72.54 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.424 2.083 . . . . 4.51 111.92 179.301 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.64 125.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.101 -0.499 . . . . 3.51 110.442 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.618 ' O ' ' O ' ' A' ' 92' ' ' THR . 4.7 mt-30 -123.87 158.33 60.32 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 4.3 110.491 179.914 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 143' ' ' ARG . 97.5 Cg_endo -82.07 -64.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.927 2.418 . . . . 1.96 113.515 -179.047 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.662 ' OD1' ' NH1' ' A' ' 143' ' ' ARG . 9.7 m120 -108.49 -19.59 13.4 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.076 0.399 . . . . 3.33 112.076 -178.509 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 8.3 p -107.32 152.06 24.64 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.479 -0.488 . . . . 1.53 111.338 -179.442 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.28 102.94 2.23 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.653 -0.703 . . . . 2.29 110.634 179.894 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.551 ' CD ' HE22 ' A' ' 14' ' ' GLN . 73.8 Cg_endo -82.72 145.53 12.91 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.974 2.45 . . . . 0.88 112.575 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.41 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.76 167.92 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.884 -0.598 . . . . 2.12 109.892 179.579 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.15 147.91 29.02 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.682 -0.488 . . . . 2.67 109.682 178.913 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.503 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.9 p90 -142.2 157.37 44.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.979 0.419 . . . . 0.32 111.242 179.907 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.463 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.12 155.26 44.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.819 -0.628 . . . . 2.77 110.095 179.0 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.59 173.03 6.36 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.105 0.478 . . . . 1.25 110.774 -179.243 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -50.58 173.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.818 2.346 . . . . 1.12 111.588 179.29 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -50.95 0.7 Allowed Pre-proline 0 C--N 1.33 -0.245 0 C-N-CA 120.713 -0.395 . . . . 4.05 110.159 179.81 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.653 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.99 152.36 82.65 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.752 2.301 . . . . 2.12 111.404 179.197 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.5 p -63.76 42.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.355 0.598 . . . . 2.85 110.495 -179.769 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.815 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.7 -41.6 98.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.997 -1.001 . . . . 3.11 110.579 179.8 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.445 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.6 mt -109.79 137.89 39.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.823 -0.626 . . . . 1.86 111.262 -179.421 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.04 -72.9 0.7 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.023 -0.535 . . . . 1.61 111.887 -179.029 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.47 24.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.521 0.564 . . . . 1.67 112.521 -179.609 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.89 124.92 45.24 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.311 -0.626 . . . . 1.07 109.311 177.483 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.2 mt -118.02 134.76 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.703 -0.399 . . . . 1.55 110.666 179.917 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.487 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -120.07 128.64 53.67 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.985 0.422 . . . . 1.33 111.22 179.748 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.547 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.11 139.02 49.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.753 -0.658 . . . . 2.36 110.057 179.001 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.417 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.2 p90 -145.06 163.14 35.18 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.162 0.506 . . . . 0.38 112.086 -178.166 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.488 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.43 139.69 7.97 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 115.472 -0.785 . . . . 2.31 110.441 178.743 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.687 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.3 Cg_endo -63.58 115.45 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.364 2.043 . . . . 0.86 111.836 179.995 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.68 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.05 81.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.973 0.416 . . . . 3.44 109.884 -179.786 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.687 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.26 -20.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.003 -0.544 . . . . 2.72 111.942 -179.442 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.64 157.78 34.24 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 120.887 -0.325 . . . . 2.78 110.561 179.78 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.4 27.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.166 -0.47 . . . . 2.3 110.235 179.517 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.86 -75.89 1.31 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.029 -0.605 . . . . 1.8 111.796 -179.224 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.81 152.34 35.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.92 0.39 . . . . 5.48 110.957 -179.286 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.23 -169.06 2.51 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.043 -0.526 . . . . 1.84 111.938 179.332 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.413 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.18 149.64 29.8 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.449 0.643 . . . . 2.27 112.581 -177.858 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.02 156.49 46.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.853 -1.067 . . . . 1.92 110.236 178.718 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.33 158.35 41.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.966 -0.561 . . . . 1.09 111.722 -179.327 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 m -115.18 135.56 54.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.441 -0.799 . . . . 1.16 109.829 179.314 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.447 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.37 122.04 23.83 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.391 -0.368 . . . . 1.39 111.529 -179.17 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.7 Cg_exo -46.31 151.75 1.62 Allowed 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.734 2.289 . . . . 0.72 112.081 178.987 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.92 -23.0 63.06 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 115.957 -0.565 . . . . 0.74 112.809 -179.312 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.515 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.85 -16.85 46.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.369 0.584 . . . . 1.26 111.756 -178.268 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.492 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.3 mt -91.63 138.47 31.54 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.76 -0.376 . . . . 1.59 110.323 179.362 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.54 13.86 10.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.295 -0.411 . . . . 2.07 111.512 -179.297 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.473 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.98 143.41 25.19 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.664 -0.415 . . . . 0.96 110.998 179.7 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.74 -169.43 1.54 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.932 -179.512 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.711 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 7.7 m -151.66 125.93 9.33 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.429 -0.805 . . . . 1.19 109.946 179.118 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.467 HG23 HD11 ' A' ' 60' ' ' ILE . 66.5 mt -114.85 123.2 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.412 -0.515 . . . . 1.47 111.17 -179.712 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.507 ' HG2' ' N ' ' A' ' 62' ' ' GLY . 86.3 tttt -126.43 163.4 23.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.812 -0.631 . . . . 3.0 110.5 179.645 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.507 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.11 18.97 59.92 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.775 -0.93 . . . . 0.5 110.775 -179.922 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.434 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.4 mt -78.95 157.22 28.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.135 0.493 . . . . 1.21 111.385 -179.696 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.61 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 2.9 mttp -99.52 133.95 21.52 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.593 -0.73 . . . . 3.2 110.442 179.758 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.528 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.81 143.57 61.82 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.553 2.169 . . . . 1.09 111.975 179.794 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.87 25.55 75.43 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.016 -0.834 . . . . 0.72 111.016 179.716 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.645 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.1 158.82 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.709 0.29 . . . . 1.47 110.448 -179.591 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.15 139.79 42.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.924 0.392 . . . . 1.23 110.575 -179.74 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.645 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.51 136.52 54.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.001 -0.545 . . . . 1.1 110.78 -179.984 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.89 131.06 45.27 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.492 -0.929 . . . . 1.87 108.492 177.622 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.49 153.85 16.65 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.3 -0.952 . . . . 0.39 111.965 -178.664 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.92 141.02 46.19 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.687 -0.486 . . . . 1.8 109.687 179.504 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.47 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.8 tp -115.83 118.89 34.26 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.499 -0.48 . . . . 1.11 110.534 179.651 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.1 mt -112.42 129.11 68.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.239 -0.437 . . . . 1.51 110.585 -179.874 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.81 120.86 43.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.326 -0.397 . . . . 1.47 110.707 -179.726 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.668 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.6 146.43 11.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.491 . . . . 1.33 110.978 -179.271 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.815 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.1 mt-30 -106.03 153.87 21.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.508 -0.769 . . . . 2.49 109.938 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.16 88.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.917 0.389 . . . . 4.2 110.45 -179.729 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.624 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.25 32.72 0.21 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.819 -0.628 . . . . 6.4 110.573 -179.923 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.23 -117.39 3.27 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.407 -0.677 . . . . 1.74 111.407 -179.727 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.45 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.25 177.41 9.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.238 0.542 . . . . 3.64 111.604 -179.218 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.21 149.47 31.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.401 -0.818 . . . . 1.7 110.418 179.108 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.553 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.15 144.62 38.69 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.487 -0.324 . . . . 2.7 110.562 179.905 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -127.89 135.99 61.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 120.649 -0.421 . . . . 1.16 111.552 -179.761 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.03 141.41 52.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.714 -0.675 . . . . 1.14 110.318 179.544 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.456 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.78 138.92 51.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.184 0.516 . . . . 4.33 111.428 -179.324 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.29 164.23 37.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.513 -0.767 . . . . 0.91 109.42 179.438 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.57 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.32 151.52 38.45 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.384 -0.526 . . . . 1.47 110.996 -179.994 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.572 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.9 p90 -146.17 172.76 12.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.754 -0.657 . . . . 0.51 111.0 179.844 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.445 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.74 160.74 21.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.42 -0.809 . . . . 1.92 109.863 179.561 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.445 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.43 121.85 22.85 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.645 -0.422 . . . . 1.63 110.766 179.974 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.618 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.8 p -126.42 163.75 22.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.346 0.593 . . . . 2.37 112.08 179.72 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.413 -0.812 . . . . 3.63 110.665 -179.686 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 95.7 p . . . . . 0 N--CA 1.461 0.085 0 N-CA-C 109.715 -0.476 . . . . 1.25 109.715 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.479 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.7 167.48 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.019 0.438 . . . . 1.16 111.005 179.481 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.56 145.6 50.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.718 -0.674 . . . . 0.78 110.101 -179.949 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.3 101.72 9.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.986 -0.746 . . . . 1.08 108.986 177.755 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.465 HG11 ' N ' ' A' ' 131' ' ' SER . 70.9 t -112.99 139.7 36.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.089 -0.505 . . . . 1.1 111.054 -178.904 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.465 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.7 p -128.74 152.5 48.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.603 -0.726 . . . . 0.87 109.849 179.603 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.645 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.7 p90 -144.72 -164.98 2.04 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.732 -0.387 . . . . 0.37 110.688 -179.736 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -123.93 127.17 73.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 1.14 110.843 -179.885 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.164 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.95 58.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.178 -0.464 . . . . 1.91 110.329 179.862 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.07 24.41 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.916 -0.584 . . . . 1.56 111.499 -179.673 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.164 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.22 128.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.568 -0.453 . . . . 1.56 110.899 179.829 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.31 -9.76 55.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.879 -0.601 . . . . 1.88 110.323 179.76 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.4 p -87.04 0.26 55.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 1.63 110.4 179.994 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.955 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.29 137.25 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.877 -0.601 . . . . 1.11 109.969 179.74 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 185' ' ' ILE . 88.8 p -96.27 -15.54 21.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.279 0.562 . . . . 1.01 110.035 -179.643 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.441 ' HA3' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.58 175.56 45.77 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.83 -1.308 . . . . 0.14 109.83 179.679 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -123.49 151.59 42.6 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.621 -0.431 . . . . 0.21 110.468 179.723 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.662 ' NH1' ' OD1' ' A' ' 16' ' ' ASN . 12.7 ttt85 -132.29 121.1 23.04 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.086 -0.506 . . . . 1.54 110.005 179.805 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.496 HG23 HG11 ' A' ' 167' ' ' VAL . 46.0 t -105.03 136.49 38.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.777 -0.647 . . . . 1.08 110.724 -179.759 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 78.8 tt0 -129.27 129.91 45.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.061 -0.518 . . . . 1.32 110.151 179.98 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.71 135.34 34.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.994 -0.548 . . . . 1.05 110.623 -179.709 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.403 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.34 161.38 39.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.703 -0.68 . . . . 1.16 109.716 179.846 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.94 HD21 ' CE2' ' A' ' 178' ' ' TYR . 85.8 mt -71.12 124.91 25.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.986 0.422 . . . . 1.23 110.689 -179.534 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.502 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.8 -7.68 49.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.739 -0.664 . . . . 0.86 110.862 -179.81 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -109.84 -69.58 0.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.365 -0.38 . . . . 1.66 111.519 -179.381 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.455 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.69 -35.32 76.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.095 -0.502 . . . . 1.66 111.569 -179.192 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.086 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.2 7.2 88.62 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.75 -0.94 . . . . 1.62 110.75 -179.936 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.325 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.85 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 1.86 110.291 179.801 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.325 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.25 139.08 45.17 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 1.98 110.165 179.64 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.403 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.3 Cg_endo -70.94 145.84 51.38 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 C-N-CA 122.712 2.275 . . . . 0.62 112.31 -179.546 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.87 145.81 42.56 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.182 -0.673 . . . . 1.14 109.182 179.267 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.657 ' CD2' ' OD1' ' A' ' 16' ' ' ASN . 51.0 p90 -123.38 141.27 52.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.185 0.517 . . . . 1.44 111.536 -179.093 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.406 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.5 mt -128.05 127.65 43.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.242 -0.89 . . . . 1.08 108.92 179.007 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 19.1 t0 -101.58 131.05 47.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.15 0.5 . . . . 1.09 111.824 -178.85 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.517 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.1 mt -127.83 157.61 73.04 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.303 -0.862 . . . . 1.04 109.624 179.624 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.84 158.04 58.21 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.395 2.063 . . . . 0.21 112.239 179.938 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.2 p -59.24 -12.22 5.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.739 -0.664 . . . . 0.88 110.746 -179.824 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.4 p -92.81 -8.68 42.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.09 -0.505 . . . . 1.06 110.689 -179.883 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.3 135.35 34.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.332 -0.395 . . . . 1.05 110.318 179.734 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.4 p -133.08 16.69 4.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.322 -0.399 . . . . 1.07 110.508 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.0 p -167.54 147.05 5.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.579 -0.526 . . . . 0.92 109.579 179.851 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.506 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.11 150.48 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.095 0.474 . . . . 1.09 111.585 -179.695 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.3 125.01 50.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.571 -0.741 . . . . 1.31 109.828 179.456 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.515 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.4 104.93 30.03 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.358 -0.383 . . . . 1.09 111.066 -179.895 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.5 Cg_endo -90.98 -179.5 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 123.22 2.613 . . . . 0.48 112.15 179.916 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.74 32.53 18.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.371 -0.831 . . . . 1.26 111.418 179.175 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.515 HD21 HG21 ' A' ' 169' ' ' ILE . 24.2 mt -86.33 148.53 25.56 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.911 -0.315 . . . . 1.12 110.505 179.587 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.776 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.32 114.88 61.43 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 121.069 0.461 . . . . 1.3 110.688 -179.732 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.97 140.5 95.62 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.877 2.384 . . . . 0.92 112.1 179.815 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.18 21.13 74.2 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.029 -0.828 . . . . 0.44 111.029 179.907 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.455 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.77 150.25 49.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.75 0.31 . . . . 3.05 110.747 179.881 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.502 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.22 131.65 46.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.063 -0.517 . . . . 1.48 109.799 179.333 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.94 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.47 148.33 43.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.079 -0.51 . . . . 0.89 111.077 -179.892 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.34 125.4 60.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.281 -1.007 . . . . 1.12 108.281 177.701 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.63 132.55 63.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.308 0.575 . . . . 1.1 111.17 -178.595 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.5 122.59 20.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.433 -0.803 . . . . 0.43 109.642 179.285 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.591 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.3 t -101.05 125.39 55.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.2 -0.454 . . . . 1.07 110.598 -179.436 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.67 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.3 m-85 -117.25 137.88 52.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.017 -0.538 . . . . 0.92 109.899 179.456 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.573 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.68 135.02 42.79 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.811 -0.811 . . . . 0.49 108.811 178.872 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 140' ' ' SER . 5.2 mp -99.04 122.94 51.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.16 0.505 . . . . 1.08 110.926 -178.747 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.451 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.3 p -83.86 169.79 14.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.517 -0.765 . . . . 0.89 110.453 -179.71 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.89 -14.53 15.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.048 -0.523 . . . . 1.6 110.823 -179.504 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.548 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.3 m-20 -96.11 -4.22 43.21 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.817 -0.353 . . . . 1.18 110.847 -179.811 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.466 ' N ' HG22 ' A' ' 59' ' ' THR . . . 87.74 13.9 64.09 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.376 -0.69 . . . . 0.34 111.376 179.858 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.62 139.03 32.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.652 0.263 . . . . 1.22 110.438 179.652 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.448 ' NE2' ' HD3' ' A' ' 143' ' ' ARG . 97.1 mt-30 -106.69 141.04 38.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.809 0.337 . . . . 1.44 110.617 179.675 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 61.8 m -136.65 127.12 26.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 1.39 110.316 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.67 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.4 tp -68.1 117.36 9.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.287 -0.415 . . . . 1.08 110.584 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.645 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.0 pt -109.18 -21.67 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 1.08 110.732 -179.69 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.97 125.73 5.82 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.542 -0.463 . . . . 1.1 111.521 -179.879 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.496 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.79 120.13 21.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.777 -0.647 . . . . 0.94 109.58 179.248 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.55 151.71 29.19 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.639 -0.424 . . . . 1.07 110.882 -179.276 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.8 p -110.36 158.56 18.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.019 -0.537 . . . . 0.89 110.442 179.709 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -146.05 157.86 43.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.67 110.663 -179.969 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.31 104.36 9.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.801 -0.636 . . . . 1.17 110.043 179.49 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.474 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 66.9 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.843 -1.075 . . . . 1.26 110.621 -179.655 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.2 m . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.189 -0.671 . . . . 3.83 109.189 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.66 18.54 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.988 -0.845 . . . . 1.39 110.988 179.72 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -35.47 142.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.058 0 C-N-CA 123.934 3.089 . . . . 0.86 113.832 -179.283 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.569 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -79.99 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.274 -1.33 . . . . 1.43 108.83 178.368 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -105.62 125.94 51.57 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.376 -0.529 . . . . 1.94 111.461 -179.601 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.47 144.01 33.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.63 -0.713 . . . . 1.19 110.72 179.869 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.03 168.34 25.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.925 0.393 . . . . 3.92 111.137 -179.674 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.585 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.5 mt -109.06 131.02 60.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.957 -0.565 . . . . 3.88 110.024 179.928 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.15 162.36 35.67 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.865 0.364 . . . . 3.92 111.219 -179.961 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 16.9 pt-20 36.16 31.45 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.682 -0.488 . . . . 6.08 109.682 179.847 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.585 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.4 69.61 32.3 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.934 -0.575 . . . . 4.01 111.593 -178.747 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.28 -29.08 72.73 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.497 2.132 . . . . 4.51 111.822 179.354 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.58 125.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 3.51 110.481 -179.947 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 17' ' ' SER . 13.2 mp0 -123.8 158.41 59.85 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.294 -0.412 . . . . 4.3 110.456 179.959 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.468 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 97.2 Cg_endo -82.1 -64.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.861 2.374 . . . . 1.96 113.456 -179.039 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.674 ' OD1' ' N ' ' A' ' 17' ' ' SER . 1.4 p-10 -108.39 -19.61 13.4 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.106 0.41 . . . . 3.33 112.106 -178.498 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.674 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 33.4 m -107.34 152.1 24.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.116 0.484 . . . . 1.53 111.328 -179.421 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.37 102.96 2.21 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.693 -0.685 . . . . 2.29 110.652 179.804 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.6 145.57 13.12 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.921 2.414 . . . . 0.88 112.61 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.414 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.78 167.9 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.955 -0.566 . . . . 2.12 109.842 179.567 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.17 147.9 28.99 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.812 -0.44 . . . . 2.67 109.812 178.822 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.503 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.5 p90 -142.21 157.32 44.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.005 0.431 . . . . 0.32 111.11 -179.951 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.463 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.09 155.19 44.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.699 -0.682 . . . . 2.77 110.086 178.978 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.55 173.04 6.35 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.185 -0.462 . . . . 1.25 110.732 -179.193 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.58 173.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.974 2.449 . . . . 1.12 111.492 179.333 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.479 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.09 -51.03 0.69 Allowed Pre-proline 0 C--N 1.328 -0.349 0 C-N-CA 120.666 -0.414 . . . . 4.05 110.078 179.853 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.654 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.84 152.32 82.57 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.798 2.332 . . . . 2.12 111.483 179.219 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.67 42.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.38 0.61 . . . . 2.85 110.534 -179.869 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.817 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.67 -41.58 98.17 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.032 -0.985 . . . . 3.11 110.68 179.709 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.444 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.6 mt -109.93 137.82 40.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.773 -0.648 . . . . 1.86 111.271 -179.439 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.92 -72.98 0.7 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.999 -0.546 . . . . 1.61 111.865 -178.963 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.16 148.42 24.42 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.587 0.588 . . . . 1.67 112.587 -179.625 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.85 124.87 45.14 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.319 -0.623 . . . . 1.07 109.319 177.572 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.02 134.67 60.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.718 -0.393 . . . . 1.55 110.72 179.939 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.489 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -119.96 128.67 53.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.055 0.455 . . . . 1.33 111.275 179.788 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 138.88 49.64 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.758 -0.655 . . . . 2.36 110.08 179.087 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.414 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -145.0 163.23 34.84 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.158 0.504 . . . . 0.38 112.086 -178.198 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.486 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.51 139.57 7.83 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.482 -0.781 . . . . 2.31 110.451 178.846 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.684 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.9 Cg_endo -63.54 115.44 3.04 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.279 1.986 . . . . 0.86 111.891 179.938 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.679 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.3 tttp -46.99 81.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.871 -0.418 . . . . 3.44 109.871 -179.827 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.58 0.06 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.92 -0.582 . . . . 2.72 111.874 -179.584 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 p -157.7 157.81 34.21 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 120.747 -0.381 . . . . 2.78 110.561 179.764 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.42 27.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 2.3 110.161 179.659 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.81 -75.89 1.31 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.19 -0.528 . . . . 1.8 111.861 -179.243 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.96 152.32 35.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.968 0.413 . . . . 5.48 110.988 -179.383 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.18 -169.14 2.54 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.993 -0.549 . . . . 1.84 111.922 179.425 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.414 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.6 mttp -110.14 149.62 29.81 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.477 0.656 . . . . 2.27 112.599 -177.922 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.0 156.58 46.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.768 -1.105 . . . . 1.92 110.306 178.6 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.3 158.39 41.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.901 -0.59 . . . . 1.09 111.785 -179.311 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.8 m -115.25 135.67 53.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.459 -0.791 . . . . 1.16 109.784 179.317 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.449 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.43 121.95 23.73 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.419 -0.355 . . . . 1.39 111.505 -179.105 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.513 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.0 Cg_exo -46.34 151.73 1.64 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.639 2.226 . . . . 0.72 112.189 179.019 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.89 -23.07 63.07 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-N 116.063 -0.517 . . . . 0.74 112.81 -179.189 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.513 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.79 -16.9 46.07 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.237 -0.585 . . . . 1.26 111.761 -178.274 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.489 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.54 138.48 31.54 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.689 -0.404 . . . . 1.59 110.309 179.372 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.6 13.98 10.95 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.404 -0.362 . . . . 2.07 111.567 -179.416 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.472 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.98 143.44 25.21 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.607 -0.437 . . . . 0.96 111.052 179.586 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.708 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.82 -169.36 1.53 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.203 0.525 . . . . 1.0 110.916 -179.523 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.708 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 t -151.69 125.89 9.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.448 -0.796 . . . . 1.19 109.84 179.262 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.466 HG23 HD11 ' A' ' 60' ' ' ILE . 66.7 mt -114.83 123.27 70.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.33 -0.548 . . . . 1.47 111.205 -179.785 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -126.43 163.41 23.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.872 -0.603 . . . . 3.0 110.379 179.788 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.16 18.83 60.11 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.783 -0.927 . . . . 0.5 110.783 -179.953 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.437 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 74.2 mt -79.05 157.31 28.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.156 0.503 . . . . 1.21 111.28 -179.521 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.613 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 4.8 mptp? -99.59 134.0 21.44 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.554 -0.748 . . . . 3.2 110.414 179.8 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.401 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.9 Cg_endo -67.8 143.64 62.09 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.591 2.194 . . . . 1.09 111.971 179.784 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.75 25.62 75.34 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.101 -0.8 . . . . 0.72 111.101 179.705 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.645 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.15 158.78 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.692 0.282 . . . . 1.47 110.397 -179.574 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.17 139.96 41.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.882 0.372 . . . . 1.23 110.621 -179.825 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.645 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.2 m-85 -122.56 136.33 54.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.994 -0.548 . . . . 1.1 110.818 -179.901 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.486 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.79 131.05 45.22 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.546 -0.909 . . . . 1.87 108.546 177.593 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.48 153.79 16.66 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.308 -0.949 . . . . 0.39 111.986 -178.579 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.92 140.92 46.13 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.658 -0.497 . . . . 1.8 109.658 179.584 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.467 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.1 tp -115.75 118.84 34.15 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.452 -0.499 . . . . 1.11 110.536 179.672 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.42 129.05 68.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.339 -0.391 . . . . 1.51 110.658 -179.862 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.74 120.88 43.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.27 -0.423 . . . . 1.47 110.73 -179.634 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.667 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.62 146.5 11.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.17 0.51 . . . . 1.33 110.944 -179.223 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.817 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.06 153.93 21.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.46 -0.791 . . . . 2.49 109.891 179.826 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.18 88.52 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.896 0.379 . . . . 4.2 110.424 -179.809 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.36 32.52 0.22 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.873 -0.603 . . . . 6.4 110.628 -179.953 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.02 -117.38 3.3 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.431 -0.667 . . . . 1.74 111.431 -179.693 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.451 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.43 177.42 8.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.135 0.493 . . . . 3.64 111.658 -179.189 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.1 149.54 32.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.503 -0.771 . . . . 1.7 110.391 179.167 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.18 144.66 38.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.471 -0.331 . . . . 2.7 110.515 179.863 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -127.94 136.09 61.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 121.035 0.445 . . . . 1.16 111.57 -179.806 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.7 m -124.15 141.29 52.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.753 -0.658 . . . . 1.14 110.316 179.635 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.451 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.58 138.91 51.62 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.125 0.488 . . . . 4.33 111.524 -179.339 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.3 164.14 38.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.575 -0.739 . . . . 0.91 109.474 179.386 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.57 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.1 p30 -145.29 151.57 38.56 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.293 -0.563 . . . . 1.47 111.011 179.937 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.572 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.0 p90 -146.21 172.72 13.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.792 -0.64 . . . . 0.51 111.079 179.895 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.446 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.77 160.7 21.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.57 -0.741 . . . . 1.92 109.847 179.644 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.446 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.46 121.89 22.88 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.524 -0.47 . . . . 1.63 110.712 -179.965 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.6 p -125.41 151.83 45.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.909 0.862 . . . . 2.37 112.908 179.695 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.462 0.161 0 CA-C-N 114.053 -1.43 . . . . 3.63 113.876 -179.402 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 122.668 1.223 . . . . 1.25 108.137 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.478 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.82 167.6 0.25 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.121 -1.399 . . . . 1.16 110.904 -178.85 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.69 145.56 50.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.692 -0.686 . . . . 0.78 110.084 -179.934 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.26 101.7 9.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.07 -0.715 . . . . 1.08 109.07 177.678 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.458 HG11 ' N ' ' A' ' 131' ' ' SER . 71.2 t -112.88 139.69 36.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.989 -0.551 . . . . 1.1 111.073 -178.914 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.458 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.9 p -128.68 152.55 48.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.637 -0.71 . . . . 0.87 109.84 179.568 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.645 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.8 p90 -144.81 -164.98 2.04 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.693 -0.403 . . . . 0.37 110.64 -179.764 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.733 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.6 t -123.95 127.16 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 1.14 110.844 -179.88 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.174 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.94 58.36 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.103 -0.499 . . . . 1.91 110.415 179.808 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.29 24.59 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.931 -0.577 . . . . 1.56 111.479 -179.541 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.174 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.2 128.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.686 -0.405 . . . . 1.56 111.004 179.8 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -86.45 -9.62 55.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.886 -0.597 . . . . 1.88 110.337 179.775 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.12 0.35 55.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.094 -0.503 . . . . 1.63 110.289 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.959 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.34 137.19 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 1.11 109.977 179.663 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 185' ' ' ILE . 76.6 p -96.28 -15.4 21.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.304 0.574 . . . . 1.01 110.044 -179.649 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.52 175.58 45.72 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.856 -1.297 . . . . 0.14 109.856 179.59 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.45 151.63 42.49 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.62 -0.432 . . . . 0.21 110.484 179.745 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.443 ' NH1' ' HG2' ' A' ' 15' ' ' PRO . 45.2 ttp180 -132.33 121.22 23.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.143 -0.48 . . . . 1.54 109.899 179.814 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.5 HG23 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.13 136.54 38.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.732 -0.667 . . . . 1.08 110.634 -179.711 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 80.7 tt0 -129.5 129.86 45.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.975 -0.557 . . . . 1.32 110.006 -179.91 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.69 135.32 34.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.937 -0.574 . . . . 1.05 110.633 -179.676 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.409 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.32 161.4 39.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.753 -0.658 . . . . 1.16 109.619 179.875 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.942 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.1 mt -71.04 124.8 25.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.973 0.416 . . . . 1.23 110.772 -179.642 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.79 -7.64 49.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.832 -0.622 . . . . 0.86 110.875 -179.738 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -109.82 -69.72 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.963 0.411 . . . . 1.66 111.407 -179.267 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.47 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.69 -35.31 75.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.014 -0.539 . . . . 1.66 111.563 -179.155 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.076 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.07 7.29 88.55 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.829 -0.908 . . . . 1.62 110.829 -179.83 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.319 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.95 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.734 0.302 . . . . 1.86 110.322 179.818 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.319 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.13 45.22 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.976 0.417 . . . . 1.98 110.193 179.624 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.409 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.8 Cg_endo -70.85 145.9 52.06 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 C-N-CA 122.621 2.214 . . . . 0.62 112.368 -179.568 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.87 145.73 42.63 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.21 -0.663 . . . . 1.14 109.21 179.21 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.455 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 6.0 p90 -123.24 141.31 52.11 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.399 -0.52 . . . . 1.44 111.57 -179.108 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.409 ' HA ' HD22 ' A' ' 158' ' ' LEU . 71.3 mt -128.18 127.73 43.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.337 -0.847 . . . . 1.08 108.844 178.956 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.548 ' OD1' ' O ' ' A' ' 159' ' ' ASP . 54.4 p-10 -101.65 131.15 48.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.174 0.511 . . . . 1.09 111.751 -178.76 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.504 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -127.92 157.49 73.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.362 -0.836 . . . . 1.04 109.559 179.768 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -69.76 158.0 58.47 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.485 2.123 . . . . 0.21 112.203 179.903 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.2 p -59.27 -12.16 5.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.755 -0.657 . . . . 0.88 110.75 -179.842 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.81 -8.84 42.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.113 -0.494 . . . . 1.06 110.678 -179.823 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.11 135.32 34.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.325 -0.398 . . . . 1.05 110.463 179.68 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 32.1 p -133.07 16.6 4.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.465 -0.334 . . . . 1.07 110.582 179.953 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.1 p -167.53 147.09 5.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.61 -0.515 . . . . 0.92 109.61 179.897 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.504 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.2 p -152.2 150.52 12.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.518 -0.473 . . . . 1.09 111.528 -179.632 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.39 124.98 50.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.608 -0.724 . . . . 1.31 109.763 179.517 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.515 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.39 104.93 29.96 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.909 0.385 . . . . 1.09 111.02 -179.879 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.0 Cg_endo -91.03 -179.56 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 123.12 2.547 . . . . 0.48 112.179 179.89 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 61.81 32.54 18.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.372 -0.831 . . . . 1.26 111.435 179.246 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.515 HD21 HG21 ' A' ' 169' ' ' ILE . 24.0 mt -86.46 148.5 25.52 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.918 -0.313 . . . . 1.12 110.474 179.592 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.777 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.27 114.85 61.27 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 121.06 0.457 . . . . 1.3 110.674 -179.64 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -58.95 140.63 96.15 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.9 2.4 . . . . 0.92 111.99 179.853 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 76.99 21.26 74.44 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.082 -0.807 . . . . 0.44 111.082 179.864 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.47 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.84 150.15 49.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.783 0.325 . . . . 3.05 110.669 179.944 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.5 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.17 131.66 45.99 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.047 -0.524 . . . . 1.48 109.784 179.28 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.942 ' CE2' HD21 ' A' ' 148' ' ' LEU . 75.2 m-85 -120.5 148.32 43.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.096 -0.502 . . . . 0.89 110.951 -179.813 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.35 125.39 60.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.295 -1.002 . . . . 1.12 108.295 177.657 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.59 132.45 63.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.206 0.527 . . . . 1.1 111.274 -178.61 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.45 122.6 20.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.46 -0.791 . . . . 0.43 109.64 179.278 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.595 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -101.02 125.41 54.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.234 -0.439 . . . . 1.07 110.72 -179.566 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.673 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.3 m-85 -117.22 137.91 52.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.992 -0.549 . . . . 0.92 109.884 179.535 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.571 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.75 135.04 42.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.801 -0.815 . . . . 0.49 108.801 178.872 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 140' ' ' SER . 80.6 mt -98.98 122.93 51.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.134 0.492 . . . . 1.08 110.981 -178.774 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.45 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.8 p -83.89 169.67 14.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.593 -0.73 . . . . 0.89 110.447 -179.709 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.82 -14.49 15.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.996 -0.547 . . . . 1.6 110.928 -179.552 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.45 ' H ' ' HG ' ' A' ' 186' ' ' SER . 95.2 m-20 -96.05 -4.3 43.24 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.857 -0.337 . . . . 1.18 110.808 -179.832 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.445 ' CA ' ' HG1' ' A' ' 59' ' ' THR . . . 87.83 13.84 64.01 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.351 -0.699 . . . . 0.34 111.351 179.848 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -84.64 139.1 32.3 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.774 -0.251 . . . . 1.22 110.43 179.737 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.4 ' OE1' ' NH1' ' A' ' 143' ' ' ARG . 15.2 pt20 -106.72 141.07 38.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.423 -0.353 . . . . 1.44 110.53 179.773 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.75 127.06 26.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 1.39 110.332 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.673 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.8 tp -68.13 117.21 9.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.247 -0.433 . . . . 1.08 110.42 -179.876 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.645 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.1 pt -108.98 -21.83 5.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 1.08 110.688 -179.787 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.82 125.82 5.95 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.512 -0.475 . . . . 1.1 111.476 -179.803 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.489 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.82 120.15 21.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.764 -0.653 . . . . 0.94 109.564 179.174 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.63 151.63 29.03 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.691 -0.404 . . . . 1.07 110.932 -179.284 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.31 158.64 18.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.041 -0.527 . . . . 0.89 110.431 179.723 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -146.12 157.86 43.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.078 -0.51 . . . . 0.67 110.652 -179.997 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.22 104.29 9.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.827 -0.624 . . . . 1.17 110.086 179.522 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.478 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.0 p . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.851 -1.071 . . . . 1.26 110.727 -179.727 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.4 m . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.269 -0.641 . . . . 3.83 109.269 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.74 18.53 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.032 -0.827 . . . . 1.39 111.032 179.683 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -35.7 142.38 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.113 0 C-N-CA 124.004 3.136 . . . . 0.86 113.806 -179.247 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.57 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.0 t -79.93 173.4 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.14 -1.391 . . . . 1.43 108.888 178.41 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.53 125.86 51.46 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.448 -0.501 . . . . 1.94 111.496 -179.618 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.51 143.99 33.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.687 -0.688 . . . . 1.19 110.585 179.967 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.07 168.27 25.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.934 0.397 . . . . 3.92 111.074 -179.671 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.59 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 65.9 mt -108.93 131.01 60.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.946 -0.57 . . . . 3.88 110.139 179.877 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.14 162.27 35.88 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.869 0.366 . . . . 3.92 111.247 -179.88 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.7 mt-10 36.21 31.5 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.601 -0.518 . . . . 6.08 109.601 179.781 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.59 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.63 33.17 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.962 -0.563 . . . . 4.01 111.555 -178.764 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.642 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.24 -29.22 73.2 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.531 2.154 . . . . 4.51 111.849 179.304 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.642 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.71 125.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 3.51 110.474 179.971 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.561 ' O ' ' O ' ' A' ' 92' ' ' THR . 2.3 mp0 -123.98 158.34 60.59 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.362 -0.381 . . . . 4.3 110.436 179.965 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.471 ' HG3' ' NH1' ' A' ' 143' ' ' ARG . 96.7 Cg_endo -82.12 -64.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.837 2.358 . . . . 1.96 113.485 -179.023 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.54 ' OD1' ' O ' ' A' ' 63' ' ' LEU . 2.5 t-20 -108.5 -19.51 13.42 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.06 0.393 . . . . 3.33 112.06 -178.501 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 9.1 p -107.36 152.02 24.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.103 0.477 . . . . 1.53 111.299 -179.456 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.576 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.25 102.89 2.23 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.694 -0.684 . . . . 2.29 110.649 179.844 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.4 Cg_endo -82.62 145.66 13.12 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.885 2.39 . . . . 0.88 112.621 179.896 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.417 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.84 167.93 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.901 -0.59 . . . . 2.12 109.856 179.595 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -149.17 147.85 28.94 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.819 -0.437 . . . . 2.67 109.819 178.872 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.492 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.6 p90 -142.19 157.34 44.97 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.685 -0.406 . . . . 0.32 111.228 179.946 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.472 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.1 m-20 -128.03 155.23 44.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.737 -0.665 . . . . 2.77 110.117 179.023 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.6 173.04 6.35 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.024 0.44 . . . . 1.25 110.79 -179.266 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.71 173.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.914 2.41 . . . . 1.12 111.528 179.402 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.94 -51.01 0.7 Allowed Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.616 -0.434 . . . . 4.05 110.17 179.867 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.66 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.9 152.35 82.57 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.681 2.254 . . . . 2.12 111.48 179.183 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.71 42.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.406 0.622 . . . . 2.85 110.562 -179.82 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.818 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.7 -41.51 98.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.943 -1.026 . . . . 3.11 110.657 179.784 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.438 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.3 mt -110.0 137.87 40.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.72 -0.673 . . . . 1.86 111.181 -179.409 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.99 -72.97 0.7 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.939 -0.573 . . . . 1.61 111.819 -178.944 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.19 148.44 24.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.591 0.589 . . . . 1.67 112.591 -179.592 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.79 124.75 44.93 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.363 -0.606 . . . . 1.07 109.363 177.556 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.6 mt -117.99 134.71 60.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.696 -0.402 . . . . 1.55 110.67 179.89 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.481 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -119.98 128.58 53.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.043 0.449 . . . . 1.33 111.225 179.767 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.07 138.98 49.83 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.768 -0.651 . . . . 2.36 110.138 178.954 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.42 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.0 163.25 34.77 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 121.165 0.507 . . . . 0.38 112.061 -178.151 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.56 139.63 7.82 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.415 -0.811 . . . . 2.31 110.399 178.825 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.71 115.52 3.12 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.308 2.005 . . . . 0.86 111.822 179.985 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.675 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.96 81.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.897 -0.408 . . . . 3.44 109.897 -179.801 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.697 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.012 -0.54 . . . . 2.72 111.936 -179.496 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.2 p -157.65 157.79 34.25 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.839 -0.345 . . . . 2.78 110.568 179.77 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.407 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.38 27.79 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 2.3 110.165 179.574 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.75 -75.79 1.31 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.183 -0.532 . . . . 1.8 111.888 -179.245 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -118.03 152.29 35.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.931 0.396 . . . . 5.48 110.968 -179.317 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.673 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.15 2.54 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.106 -0.497 . . . . 1.84 112.007 179.39 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.04 149.67 29.66 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.457 0.646 . . . . 2.27 112.543 -177.836 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.15 156.44 45.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.789 -1.096 . . . . 1.92 110.161 178.635 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.21 158.35 41.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.905 -0.589 . . . . 1.09 111.745 -179.351 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.3 m -115.11 135.59 54.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.454 -0.794 . . . . 1.16 109.831 179.287 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.451 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.34 121.86 23.82 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.411 -0.359 . . . . 1.39 111.596 -179.156 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.0 Cg_exo -46.23 151.67 1.58 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.695 2.263 . . . . 0.72 112.173 178.992 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.83 -23.16 63.05 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 116.096 -0.502 . . . . 0.74 112.796 -179.205 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.515 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.7 -16.95 46.17 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.245 -0.582 . . . . 1.26 111.824 -178.316 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.481 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.5 mt -91.51 138.39 31.61 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.782 -0.367 . . . . 1.59 110.27 179.396 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.54 14.01 11.0 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.308 -0.405 . . . . 2.07 111.466 -179.418 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -150.04 143.5 25.19 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.721 -0.392 . . . . 0.96 111.061 179.573 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.9 -169.31 1.53 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.885 -179.425 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.723 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.79 125.94 9.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.442 -0.799 . . . . 1.19 109.793 179.305 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.467 HD11 HG23 ' A' ' 60' ' ' ILE . 66.6 mt -114.89 123.19 70.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.398 -0.521 . . . . 1.47 111.157 -179.73 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -126.47 163.32 23.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.895 -0.593 . . . . 3.0 110.467 179.695 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.443 ' N ' ' OD2' ' A' ' 159' ' ' ASP . . . 85.24 18.95 59.76 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.672 -0.971 . . . . 0.5 110.672 -179.963 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.54 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 73.6 mt -79.07 157.27 28.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.129 0.49 . . . . 1.21 111.302 -179.594 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.648 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 1.2 mptt -99.51 134.02 21.47 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.572 -0.74 . . . . 3.2 110.475 179.759 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.95 143.58 61.03 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.573 2.182 . . . . 1.09 111.912 179.835 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.62 75.34 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.1 -0.8 . . . . 0.72 111.1 179.732 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.64 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.14 158.74 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.704 0.288 . . . . 1.47 110.395 -179.564 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.17 139.95 42.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.067 0.46 . . . . 1.23 110.586 -179.861 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.648 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.3 m-85 -122.5 136.42 54.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.869 -0.605 . . . . 1.1 110.799 -179.9 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.3 pt-20 -98.85 131.06 45.24 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.553 -0.906 . . . . 1.87 108.553 177.557 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.47 153.84 16.65 Favored Glycine 0 C--O 1.227 -0.286 0 C-N-CA 120.364 -0.922 . . . . 0.39 112.043 -178.681 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.99 140.92 46.05 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.706 -0.479 . . . . 1.8 109.706 179.55 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.466 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.2 tp -115.77 119.01 34.62 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.421 -0.512 . . . . 1.11 110.504 179.684 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.1 mt -112.45 129.06 68.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 1.51 110.631 -179.865 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.8 120.75 43.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.343 -0.39 . . . . 1.47 110.754 -179.682 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.663 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.54 146.38 11.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.223 0.535 . . . . 1.33 111.023 -179.258 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.818 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.01 153.85 21.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.532 -0.758 . . . . 2.49 109.935 179.829 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.2 mt-30 -39.13 88.48 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.889 0.376 . . . . 4.2 110.416 -179.737 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.31 32.7 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.845 -0.616 . . . . 6.4 110.467 -179.922 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.18 -117.36 3.28 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.413 -0.675 . . . . 1.74 111.413 -179.776 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.441 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.34 177.44 8.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.295 0.569 . . . . 3.64 111.606 -179.192 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.22 149.46 31.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.423 -0.808 . . . . 1.7 110.486 179.149 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.07 144.64 38.85 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.549 -0.296 . . . . 2.7 110.591 179.952 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -127.94 136.07 61.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.036 0.446 . . . . 1.16 111.565 -179.832 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.57 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.16 141.38 52.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.675 -0.693 . . . . 1.14 110.241 179.645 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.439 ' N ' HG21 ' A' ' 85' ' ' THR . 42.4 ttp180 -117.64 138.86 51.69 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.572 -0.451 . . . . 4.33 111.511 -179.322 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.32 164.18 37.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.606 -0.724 . . . . 0.91 109.44 179.422 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.567 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.29 151.55 38.52 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.357 -0.537 . . . . 1.47 111.042 179.99 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.576 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.0 p90 -146.25 172.68 13.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.738 -0.665 . . . . 0.51 111.083 179.848 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.45 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.69 160.65 21.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.48 -0.782 . . . . 1.92 109.873 179.604 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.45 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.29 121.93 23.14 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.507 -0.477 . . . . 1.63 110.731 179.959 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.561 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.5 p -127.42 159.32 34.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 2.37 111.643 179.631 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.473 ' OG ' ' OH ' ' A' ' 157' ' ' TYR . 36.3 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.904 -0.589 . . . . 3.63 110.944 179.325 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.7 p . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.549 0.214 . . . . 1.25 111.17 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.481 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.81 167.56 0.25 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.181 -0.463 . . . . 1.16 110.954 179.893 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.65 145.49 50.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.807 -0.633 . . . . 0.78 110.136 -179.933 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.18 101.62 9.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.012 -0.736 . . . . 1.08 109.012 177.788 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.472 HG11 ' N ' ' A' ' 131' ' ' SER . 71.6 t -112.97 139.62 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.1 -0.5 . . . . 1.1 111.149 -178.965 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.472 ' N ' HG11 ' A' ' 130' ' ' VAL . 66.4 p -128.63 152.62 48.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.66 -0.7 . . . . 0.87 109.891 179.564 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.654 ' CD1' HD12 ' A' ' 194' ' ' ILE . 40.0 p90 -144.77 -165.06 2.06 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.74 -0.384 . . . . 0.37 110.704 -179.669 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.735 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.6 t -123.87 127.08 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 1.14 110.897 -179.903 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.176 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.85 58.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.159 -0.473 . . . . 1.91 110.388 179.767 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.735 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.22 24.47 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.949 -0.569 . . . . 1.56 111.433 -179.597 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.176 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.17 128.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.617 -0.433 . . . . 1.56 110.991 179.915 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.36 -9.71 55.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.95 -0.568 . . . . 1.88 110.293 179.829 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.07 0.2 55.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 1.63 110.253 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.966 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.21 137.17 25.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 1.11 109.974 179.68 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 185' ' ' ILE . 70.5 m -96.22 -15.58 21.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.227 0.537 . . . . 1.01 110.011 -179.66 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.61 175.52 45.76 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.821 -1.312 . . . . 0.14 109.821 179.722 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.37 151.62 42.35 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.694 -0.402 . . . . 0.21 110.489 179.706 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.85 ' HE ' ' NE2' ' A' ' 191' ' ' GLN . 55.1 ttp85 -132.36 121.21 23.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.172 -0.467 . . . . 1.54 109.954 179.736 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.492 HG23 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.13 136.53 38.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.716 -0.675 . . . . 1.08 110.622 -179.7 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 79.5 tt0 -129.39 129.91 45.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.961 -0.563 . . . . 1.32 110.128 179.963 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.9 p90 -138.67 135.32 34.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.006 -0.543 . . . . 1.05 110.675 -179.658 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.401 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.39 161.33 39.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.805 -0.634 . . . . 1.16 109.685 179.849 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.939 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -71.04 124.89 25.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.974 0.416 . . . . 1.23 110.737 -179.597 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.73 -7.78 50.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.741 -0.663 . . . . 0.86 110.908 -179.791 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -109.76 -69.59 0.85 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.958 0.408 . . . . 1.66 111.467 -179.253 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.445 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.4 mt-10 -60.85 -35.23 76.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.059 -0.519 . . . . 1.66 111.454 -179.084 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.072 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.12 7.18 88.62 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.893 -0.883 . . . . 1.62 110.893 -179.836 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.335 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.97 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.757 0.313 . . . . 1.86 110.326 179.873 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.335 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.19 139.1 45.39 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.95 0.405 . . . . 1.98 110.226 179.649 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.401 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.2 Cg_endo -70.97 145.79 51.08 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.768 2.312 . . . . 0.62 112.327 -179.499 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.85 145.68 42.65 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.28 -0.637 . . . . 1.14 109.28 179.19 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.537 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 85.5 m-85 -123.27 141.41 52.01 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.314 -0.554 . . . . 1.44 111.518 -179.053 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.4 mt -128.11 127.69 43.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.306 -0.861 . . . . 1.08 108.915 179.06 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.443 ' OD2' ' N ' ' A' ' 62' ' ' GLY . 45.0 t0 -101.68 131.13 48.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.148 0.499 . . . . 1.09 111.761 -178.783 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.51 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -127.92 157.62 73.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.266 -0.879 . . . . 1.04 109.6 179.619 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -69.87 158.03 58.19 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.423 2.082 . . . . 0.21 112.197 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.26 -12.18 5.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.729 -0.669 . . . . 0.88 110.693 -179.808 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.2 p -92.86 -8.73 42.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 1.06 110.657 -179.855 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.27 135.39 34.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.393 -0.367 . . . . 1.05 110.344 179.73 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 p -133.14 16.62 4.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.335 -0.393 . . . . 1.07 110.54 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.7 p -167.45 147.15 5.16 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.659 -0.497 . . . . 0.92 109.659 179.874 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.51 ' HB ' HD13 ' A' ' 160' ' ' LEU . 5.9 p -152.19 150.36 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.011 0.434 . . . . 1.09 111.618 -179.605 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.493 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 124.96 50.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.622 -0.717 . . . . 1.31 109.799 179.47 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.526 HG21 HD21 ' A' ' 172' ' ' LEU . 1.8 mt -99.47 104.97 30.47 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.015 0.436 . . . . 1.09 111.062 -179.903 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.5 Cg_endo -91.04 -179.46 1.47 Allowed 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 123.144 2.563 . . . . 0.48 112.221 179.914 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.66 32.67 18.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.399 -0.819 . . . . 1.26 111.501 179.31 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.526 HD21 HG21 ' A' ' 169' ' ' ILE . 24.2 mt -86.41 148.57 25.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.442 -0.345 . . . . 1.12 110.431 179.656 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.778 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.38 114.86 61.4 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.074 0.464 . . . . 1.3 110.714 -179.742 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -58.9 140.53 95.62 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.926 2.417 . . . . 0.92 112.024 179.882 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.06 21.3 74.14 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.044 -0.823 . . . . 0.44 111.044 179.861 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.445 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -127.0 150.14 49.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.942 0.401 . . . . 3.05 110.528 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.491 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.13 131.67 45.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.878 -0.601 . . . . 1.48 109.78 179.316 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.939 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.54 148.36 43.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.1 -0.5 . . . . 0.89 111.035 -179.852 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.4 mt -105.39 125.33 60.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.221 -1.029 . . . . 1.12 108.221 177.793 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.55 132.51 63.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.157 0.503 . . . . 1.1 111.228 -178.642 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.43 122.65 20.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.492 -0.776 . . . . 0.43 109.602 179.253 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.592 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.07 125.44 55.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.224 -0.444 . . . . 1.07 110.581 -179.53 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.67 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.9 m-85 -117.3 137.9 52.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.923 -0.581 . . . . 0.92 109.85 179.479 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.574 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.72 135.12 42.67 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.71 -0.848 . . . . 0.49 108.71 178.911 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.563 ' O ' ' N ' ' A' ' 140' ' ' SER . 85.2 mt -99.13 122.97 51.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.131 0.491 . . . . 1.08 110.977 -178.826 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.448 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.0 p -83.87 169.74 14.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.498 -0.774 . . . . 0.89 110.478 -179.672 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.472 ' O ' ' CG2' ' A' ' 59' ' ' THR . 97.4 mt-10 -59.81 -14.45 14.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.056 -0.52 . . . . 1.6 111.027 -179.571 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.448 ' H ' ' HG ' ' A' ' 186' ' ' SER . 96.7 m-20 -96.16 -4.25 42.98 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.791 -0.364 . . . . 1.18 110.842 -179.781 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.4 ' HA2' ' OG1' ' A' ' 59' ' ' THR . . . 87.83 13.84 64.02 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.362 -0.695 . . . . 0.34 111.362 179.879 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -84.64 139.16 32.25 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.047 -0.261 . . . . 1.22 110.391 179.769 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.85 ' NE2' ' HE ' ' A' ' 143' ' ' ARG . 91.0 mt-30 -106.79 141.06 38.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.41 -0.359 . . . . 1.44 110.469 179.788 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.68 127.08 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 1.39 110.33 179.872 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.67 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.4 tp -68.21 117.25 9.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.327 -0.397 . . . . 1.08 110.518 -179.918 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.654 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -108.99 -21.81 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 1.08 110.739 -179.711 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -157.0 125.75 5.81 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.48 -0.488 . . . . 1.1 111.458 -179.847 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.497 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.66 120.21 21.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.69 -0.686 . . . . 0.94 109.591 179.208 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.61 151.71 29.15 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.543 -0.463 . . . . 1.07 110.875 -179.294 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.44 158.62 18.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.035 -0.53 . . . . 0.89 110.452 179.686 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.13 157.89 43.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.14 -0.482 . . . . 0.67 110.656 179.99 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.18 104.36 9.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.755 -0.657 . . . . 1.17 110.03 179.584 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.484 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 68.2 p . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.959 -1.02 . . . . 1.26 110.52 -179.656 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.1 m . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.188 -0.671 . . . . 3.83 109.188 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.421 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.7 18.53 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.927 -0.869 . . . . 1.39 110.927 179.8 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -35.62 142.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.046 0 C-N-CA 123.991 3.127 . . . . 0.86 113.793 -179.239 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.567 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -80.09 173.51 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.184 -1.371 . . . . 1.43 108.815 178.476 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.63 125.89 51.51 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.381 -0.527 . . . . 1.94 111.351 -179.51 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.5 144.02 33.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.698 -0.683 . . . . 1.19 110.65 179.838 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.09 168.3 25.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.972 0.415 . . . . 3.92 111.09 -179.715 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.588 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.88 131.01 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.974 -0.557 . . . . 3.88 110.102 179.884 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.2 p -141.16 162.29 35.83 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.815 0.34 . . . . 3.92 111.252 -179.951 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 96.9 mt-10 36.1 31.57 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.618 -0.512 . . . . 6.08 109.618 179.828 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.588 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.53 32.5 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.975 -0.557 . . . . 4.01 111.609 -178.782 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.643 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.29 -29.04 72.66 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.395 2.063 . . . . 4.51 111.893 179.322 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.643 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 3.51 110.464 179.949 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.543 ' O ' ' O ' ' A' ' 92' ' ' THR . 0.4 OUTLIER -123.9 158.32 60.41 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.366 -0.379 . . . . 4.3 110.515 179.956 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.699 ' CG ' ' NH1' ' A' ' 143' ' ' ARG . 97.7 Cg_endo -82.08 -64.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.926 2.417 . . . . 1.96 113.461 -178.994 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.566 ' OD1' ' N ' ' A' ' 62' ' ' GLY . 20.5 t-20 -108.42 -19.66 13.38 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.097 0.406 . . . . 3.33 112.097 -178.504 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 36.4 m -107.32 152.09 24.6 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.45 -0.5 . . . . 1.53 111.345 -179.425 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.578 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.3 102.93 2.22 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.722 -0.672 . . . . 2.29 110.649 179.877 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.7 145.64 12.98 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.871 2.381 . . . . 0.88 112.635 179.967 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.416 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.77 167.95 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 2.12 109.922 179.609 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.22 147.89 28.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.743 -0.466 . . . . 2.67 109.743 178.879 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.493 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.5 p90 -142.23 157.29 45.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.054 0.454 . . . . 0.32 111.206 179.95 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.473 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.8 m-20 -127.99 155.21 44.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.818 -0.628 . . . . 2.77 110.149 178.971 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.56 173.12 6.26 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.155 -0.475 . . . . 1.25 110.795 -179.296 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.73 173.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.842 0 C-N-CA 122.884 2.389 . . . . 1.12 111.494 179.425 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.484 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -51.02 0.69 Allowed Pre-proline 0 C--N 1.328 -0.354 0 C-N-CA 120.671 -0.412 . . . . 4.05 110.158 179.815 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.659 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.83 152.3 82.64 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.786 2.324 . . . . 2.12 111.454 179.139 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.68 42.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.403 0.621 . . . . 2.85 110.588 -179.906 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.821 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.54 -41.66 98.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.976 -1.011 . . . . 3.11 110.648 179.721 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.439 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.6 mt -109.89 137.83 40.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.738 -0.665 . . . . 1.86 111.286 -179.398 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.99 -72.92 0.7 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.055 -0.521 . . . . 1.61 111.816 -178.922 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.15 148.34 24.47 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.59 0.589 . . . . 1.67 112.59 -179.599 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.8 124.85 45.15 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.385 -0.598 . . . . 1.07 109.385 177.474 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.4 mt -117.98 134.69 60.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.669 -0.412 . . . . 1.55 110.698 179.973 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.48 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -119.98 128.6 53.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.294 -0.412 . . . . 1.33 111.287 179.765 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.06 139.0 49.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.758 -0.656 . . . . 2.36 110.153 178.992 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.42 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.12 163.16 35.16 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 121.105 0.479 . . . . 0.38 112.045 -178.126 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.495 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.44 139.57 7.89 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.417 -0.811 . . . . 2.31 110.493 178.857 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.46 115.43 3.02 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.336 2.024 . . . . 0.86 111.773 179.97 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.675 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.92 81.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.884 -0.414 . . . . 3.44 109.884 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.697 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.2 -20.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.012 -0.54 . . . . 2.72 111.893 -179.517 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.5 157.92 34.73 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.815 -0.354 . . . . 2.78 110.565 179.7 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.403 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 16.0 m -120.5 27.85 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.145 -0.479 . . . . 2.3 110.081 179.616 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -75.96 1.31 Allowed Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.165 -0.541 . . . . 1.8 111.764 -179.234 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.79 152.17 35.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.846 0.355 . . . . 5.48 111.025 -179.253 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.672 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.14 -169.14 2.55 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.127 -0.488 . . . . 1.84 112.021 179.324 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.1 149.63 29.76 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.455 0.645 . . . . 2.27 112.597 -177.864 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.06 156.48 46.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.835 -1.075 . . . . 1.92 110.272 178.648 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.25 158.23 41.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.984 -0.553 . . . . 1.09 111.835 -179.319 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.1 m -115.08 135.65 53.98 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.461 -0.79 . . . . 1.16 109.795 179.307 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.45 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.38 121.95 23.79 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.462 -0.335 . . . . 1.39 111.5 -179.136 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.1 Cg_exo -46.32 151.66 1.65 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.63 2.22 . . . . 0.72 112.111 178.979 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.88 -23.06 63.03 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 116.055 -0.52 . . . . 0.74 112.817 -179.211 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.515 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.69 -16.97 46.13 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.278 -0.569 . . . . 1.26 111.829 -178.391 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.483 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.6 mt -91.53 138.44 31.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.795 -0.362 . . . . 1.59 110.333 179.388 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -121.6 13.97 10.94 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.366 -0.379 . . . . 2.07 111.467 -179.331 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.0 143.43 25.17 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.665 -0.414 . . . . 0.96 111.011 179.64 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.724 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.81 -169.36 1.53 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.204 0.526 . . . . 1.0 110.852 -179.478 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.736 ' HG1' ' N ' ' A' ' 189' ' ' GLY . 1.3 m -151.77 125.96 9.28 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.373 -0.83 . . . . 1.19 109.782 179.249 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.465 HD11 HG23 ' A' ' 60' ' ' ILE . 66.2 mt -114.82 123.15 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.467 -0.493 . . . . 1.47 111.255 -179.798 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.536 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 64.7 pttt -126.38 163.39 23.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.87 -0.604 . . . . 3.0 110.5 179.682 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.566 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.11 19.07 59.75 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.699 -0.96 . . . . 0.5 110.699 179.987 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.438 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 74.2 mt -79.11 157.24 28.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.091 0.472 . . . . 1.21 111.342 -179.637 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.648 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -99.56 134.06 21.42 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.611 -0.722 . . . . 3.2 110.442 179.792 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.96 143.55 60.83 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.554 2.169 . . . . 1.09 111.98 179.851 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.97 25.51 75.49 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.043 -0.823 . . . . 0.72 111.043 179.689 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.639 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.18 158.82 40.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.697 0.284 . . . . 1.47 110.404 -179.593 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.18 139.89 42.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.922 0.391 . . . . 1.23 110.556 -179.692 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.648 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.53 136.53 54.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.046 -0.525 . . . . 1.1 110.762 -179.931 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.495 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.98 131.04 45.33 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.456 -0.942 . . . . 1.87 108.456 177.701 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.45 153.91 16.64 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.391 -0.909 . . . . 0.39 111.971 -178.588 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.07 141.0 45.99 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.595 -0.52 . . . . 1.8 109.595 179.593 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.468 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.2 tp -115.76 118.87 34.25 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.469 -0.492 . . . . 1.11 110.496 179.686 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.8 mt -112.44 129.05 68.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.373 -0.376 . . . . 1.51 110.613 -179.918 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.85 120.73 43.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.235 -0.439 . . . . 1.47 110.724 -179.655 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.662 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.54 146.59 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.22 0.533 . . . . 1.33 111.01 -179.281 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.821 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.08 153.87 21.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.458 -0.792 . . . . 2.49 109.95 179.859 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.2 88.56 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.896 0.379 . . . . 4.2 110.361 -179.702 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.33 32.72 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.79 -0.641 . . . . 6.4 110.532 -179.99 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.18 -117.4 3.28 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.388 -0.685 . . . . 1.74 111.388 -179.712 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.444 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.39 177.36 9.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.206 0.527 . . . . 3.64 111.625 -179.182 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.1 149.51 32.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.397 -0.82 . . . . 1.7 110.404 179.178 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.23 144.66 38.56 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.463 -0.335 . . . . 2.7 110.532 179.857 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -128.05 135.94 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 121.077 0.465 . . . . 1.16 111.497 -179.711 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.01 141.38 52.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.663 -0.699 . . . . 1.14 110.259 179.637 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.439 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.64 138.81 51.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.159 0.504 . . . . 4.33 111.499 -179.348 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.19 164.23 37.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.563 -0.744 . . . . 0.91 109.503 179.317 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.567 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.31 151.48 38.39 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.406 -0.518 . . . . 1.47 111.05 179.967 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.578 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.5 p90 -146.15 172.69 13.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.725 -0.671 . . . . 0.51 111.062 179.856 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.451 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.69 160.73 21.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.452 -0.795 . . . . 1.92 109.874 179.61 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.451 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.37 121.89 22.99 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.637 -0.425 . . . . 1.63 110.737 179.985 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.543 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.5 p -127.47 163.63 23.67 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.185 0.809 . . . . 2.37 113.185 179.638 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.581 ' HG ' ' HH ' ' A' ' 157' ' ' TYR . 40.1 t . . . . . 0 C--O 1.232 0.152 0 CA-C-N 114.407 -1.269 . . . . 3.63 110.636 178.848 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.463 0.212 0 CA-C-O 120.682 0.277 . . . . 1.25 110.781 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.472 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.82 167.57 0.25 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.017 -0.538 . . . . 1.16 110.925 -179.593 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.57 145.56 50.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.656 -0.702 . . . . 0.78 110.073 -179.918 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.29 101.62 9.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.146 -0.687 . . . . 1.08 109.146 177.609 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.472 HG11 ' N ' ' A' ' 131' ' ' SER . 72.1 t -112.84 139.74 36.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.896 -0.593 . . . . 1.1 111.038 -178.851 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.472 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.6 p -128.76 152.66 48.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.622 -0.717 . . . . 0.87 109.743 179.528 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.654 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.7 p90 -144.85 -164.97 2.04 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.659 -0.416 . . . . 0.37 110.621 -179.808 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.744 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.8 t -123.9 127.18 73.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.193 -0.458 . . . . 1.14 110.787 -179.805 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.17 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.96 58.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 1.91 110.316 179.792 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.744 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.07 24.44 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.873 -0.603 . . . . 1.56 111.614 -179.772 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.17 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.14 128.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.685 -0.406 . . . . 1.56 111.023 179.896 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.43 -9.57 56.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.891 -0.595 . . . . 1.88 110.359 179.817 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.06 0.3 55.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.037 -0.529 . . . . 1.63 110.446 179.839 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.962 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.23 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.904 -0.589 . . . . 1.11 110.038 179.665 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 185' ' ' ILE . 91.9 p -96.31 -15.41 21.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.29 0.567 . . . . 1.01 109.987 -179.577 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.461 ' HA3' ' HZ1' ' A' ' 61' ' ' LYS . . . 178.59 175.52 45.74 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.758 -1.337 . . . . 0.14 109.758 179.688 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.43 151.64 42.45 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.607 -0.437 . . . . 0.21 110.462 179.687 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.879 ' NH1' HE22 ' A' ' 191' ' ' GLN . 52.0 ttp180 -132.35 121.1 22.98 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.111 -0.495 . . . . 1.54 109.937 179.787 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.489 HG23 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.07 136.58 38.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.678 -0.692 . . . . 1.08 110.66 -179.747 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.592 ' OE2' ' OH ' ' A' ' 157' ' ' TYR . 84.7 tt0 -129.38 129.85 45.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.942 -0.572 . . . . 1.32 110.079 -179.912 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.594 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.7 p90 -138.68 135.26 34.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.051 -0.522 . . . . 1.05 110.635 -179.63 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.404 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.33 161.28 40.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.776 -0.647 . . . . 1.16 109.697 179.877 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.937 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.4 mt -71.0 124.81 25.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.993 0.425 . . . . 1.23 110.793 -179.648 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.486 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.7 p -71.82 -7.7 49.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.758 -0.655 . . . . 0.86 110.807 -179.678 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -109.81 -69.62 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.398 -0.365 . . . . 1.66 111.427 -179.351 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.441 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.68 -35.32 75.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.116 -0.493 . . . . 1.66 111.521 -179.105 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.084 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.05 7.3 88.54 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.812 -0.915 . . . . 1.62 110.812 -179.796 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.312 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.96 -171.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.851 0.358 . . . . 1.86 110.282 179.84 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.312 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.31 139.19 45.01 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.01 0.434 . . . . 1.98 110.158 179.628 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.404 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.4 Cg_endo -70.96 145.74 50.96 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 122.707 2.271 . . . . 0.62 112.381 -179.591 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.72 145.73 42.5 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.368 -0.604 . . . . 1.14 109.368 179.148 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.592 ' OH ' ' OE2' ' A' ' 145' ' ' GLU . 89.9 m-85 -123.27 141.41 52.01 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.335 -0.546 . . . . 1.44 111.491 -179.074 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.426 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.8 mt -128.17 127.66 43.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.302 -0.863 . . . . 1.08 108.882 178.975 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -101.62 131.12 48.01 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.137 0.494 . . . . 1.09 111.782 -178.785 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.514 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -127.93 157.5 73.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.349 -0.842 . . . . 1.04 109.533 179.776 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -69.89 158.01 58.22 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.403 2.069 . . . . 0.21 112.184 179.951 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.29 -12.14 5.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.704 -0.68 . . . . 0.88 110.785 -179.778 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.8 p -92.73 -8.84 42.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.083 -0.508 . . . . 1.06 110.75 -179.978 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.18 135.41 34.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 1.05 110.358 179.739 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.11 16.67 4.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 1.07 110.556 179.933 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.5 p -167.54 147.17 5.09 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.65 -0.5 . . . . 0.92 109.65 179.899 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.514 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.3 150.44 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.52 -0.472 . . . . 1.09 111.591 -179.648 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.25 125.03 50.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.597 -0.729 . . . . 1.31 109.776 179.562 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.519 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.46 104.88 29.93 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.43 -0.35 . . . . 1.09 111.021 -179.883 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.9 Cg_endo -91.01 -179.4 1.47 Allowed 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 123.088 2.526 . . . . 0.48 112.229 179.856 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.56 32.7 18.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.359 -0.837 . . . . 1.26 111.461 179.311 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.519 HD21 HG21 ' A' ' 169' ' ' ILE . 24.1 mt -86.34 148.57 25.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.472 -0.331 . . . . 1.12 110.437 179.547 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.772 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.31 114.88 61.41 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.002 0.429 . . . . 1.3 110.644 -179.757 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.07 140.55 95.71 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.883 2.389 . . . . 0.92 111.94 179.835 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.17 21.07 74.37 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.047 -0.821 . . . . 0.44 111.047 179.835 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.441 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.76 150.14 49.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.341 . . . . 3.05 110.673 -179.984 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.486 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.14 131.58 46.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.138 -0.483 . . . . 1.48 109.878 179.252 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.937 ' CE2' HD21 ' A' ' 148' ' ' LEU . 75.1 m-85 -120.44 148.25 44.05 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.192 -0.458 . . . . 0.89 111.107 -179.817 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.7 mt -105.33 125.41 60.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.252 -1.018 . . . . 1.12 108.252 177.749 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.59 132.58 63.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.185 0.516 . . . . 1.1 111.266 -178.645 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.53 122.61 20.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.608 -0.724 . . . . 0.43 109.621 179.303 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.59 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.04 125.35 54.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.169 -0.469 . . . . 1.07 110.707 -179.535 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.676 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.4 m-85 -117.17 137.93 52.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.017 -0.538 . . . . 0.92 109.876 179.526 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.575 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.69 135.0 42.82 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.783 -0.821 . . . . 0.49 108.783 178.864 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.565 ' O ' ' N ' ' A' ' 140' ' ' SER . 82.7 mt -99.17 123.05 51.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.153 0.501 . . . . 1.08 110.898 -178.78 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.45 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.4 p -83.89 169.72 14.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.498 -0.773 . . . . 0.89 110.477 -179.719 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.81 -14.47 15.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.985 -0.552 . . . . 1.6 111.051 -179.589 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.482 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.7 m-20 -96.04 -4.31 43.28 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.842 -0.343 . . . . 1.18 110.812 -179.855 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.736 ' N ' ' HG1' ' A' ' 59' ' ' THR . . . 87.82 13.85 64.02 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.341 -0.703 . . . . 0.34 111.341 179.858 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -84.59 139.07 32.35 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.121 -0.231 . . . . 1.22 110.479 179.699 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.879 HE22 ' NH1' ' A' ' 143' ' ' ARG . 78.2 mt-30 -106.77 141.02 38.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.875 0.369 . . . . 1.44 110.499 179.843 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.67 126.98 26.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 1.39 110.481 179.844 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.676 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.4 tp -68.02 117.34 9.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.362 -0.381 . . . . 1.08 110.492 -179.839 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.654 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -109.17 -21.7 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.465 . . . . 1.08 110.685 -179.762 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.92 125.63 5.81 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.601 -0.44 . . . . 1.1 111.537 -179.783 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.497 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.68 120.26 21.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.726 -0.67 . . . . 0.94 109.547 179.188 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.65 29.04 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.606 -0.438 . . . . 1.07 110.893 -179.273 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.44 158.61 18.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.89 110.345 179.752 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.11 157.96 43.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.055 -0.52 . . . . 0.67 110.642 179.954 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.29 104.44 9.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.817 -0.629 . . . . 1.17 110.012 179.558 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.477 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 68.7 p . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 117.942 -1.027 . . . . 1.26 110.56 -179.631 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.1 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.261 -0.644 . . . . 3.83 109.261 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.39 150.71 18.53 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.078 -0.809 . . . . 1.39 111.078 179.649 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -35.63 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.066 0 C-N-CA 124.013 3.142 . . . . 0.86 113.743 -179.134 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.575 ' N ' ' OG1' ' A' ' 85' ' ' THR . 15.9 t -79.84 173.32 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.289 -1.323 . . . . 1.43 108.916 178.341 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.4 ' H ' ' CG1' ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.52 125.82 51.42 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.476 -0.489 . . . . 1.94 111.47 -179.626 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 144.06 33.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.739 -0.664 . . . . 1.19 110.606 179.84 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.36 25.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.898 0.38 . . . . 3.92 111.149 -179.705 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.586 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.4 mt -109.01 131.13 60.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.968 -0.56 . . . . 3.88 110.03 179.921 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 69.3 p -141.26 162.42 35.53 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.894 0.378 . . . . 3.92 111.122 -179.915 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 32.5 tp10 36.07 31.57 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 109.631 -0.507 . . . . 6.08 109.631 179.843 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.586 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.5 69.62 33.32 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.939 -0.573 . . . . 4.01 111.611 -178.8 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.641 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.31 -29.14 72.55 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.437 2.092 . . . . 4.51 111.753 179.391 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.641 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.7 125.57 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 3.51 110.469 179.997 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.623 HE22 ' H ' ' A' ' 13' ' ' SER . 1.6 mp0 -123.99 158.36 60.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 4.3 110.415 -179.979 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.526 ' HG3' ' NH1' ' A' ' 143' ' ' ARG . 97.1 Cg_endo -82.04 -64.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.92 2.413 . . . . 1.96 113.483 -178.96 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.476 ' H ' ' HG2' ' A' ' 15' ' ' PRO . 98.7 m-20 -108.39 -19.61 13.4 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.097 0.406 . . . . 3.33 112.097 -178.501 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 63.1 m -107.47 152.11 24.66 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.403 -0.519 . . . . 1.53 111.248 -179.361 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.579 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.27 102.83 2.23 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.654 -0.703 . . . . 2.29 110.692 179.922 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.69 145.71 13.03 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.818 2.345 . . . . 0.88 112.561 -179.984 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.409 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.79 167.9 24.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.805 -0.634 . . . . 2.12 109.883 179.604 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -149.1 148.04 29.21 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.757 -0.46 . . . . 2.67 109.757 178.821 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.5 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.7 p90 -142.37 157.28 44.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.036 0.446 . . . . 0.32 111.163 179.933 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.468 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.1 m-20 -128.01 155.27 44.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.77 -0.65 . . . . 2.77 110.102 178.999 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.56 173.0 6.4 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 121.118 0.485 . . . . 1.25 110.73 -179.204 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.61 173.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.844 2.363 . . . . 1.12 111.532 179.303 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.485 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -51.09 0.69 Allowed Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.714 -0.394 . . . . 4.05 110.048 179.926 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.647 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.81 152.34 82.49 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.721 2.28 . . . . 2.12 111.527 179.147 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.65 42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.362 0.601 . . . . 2.85 110.599 -179.915 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.813 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.52 -41.62 98.48 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.963 -1.017 . . . . 3.11 110.725 179.661 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.441 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.5 mt -109.89 137.92 39.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.756 -0.656 . . . . 1.86 111.287 -179.44 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.12 -72.84 0.71 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.097 -0.502 . . . . 1.61 111.839 -178.911 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.34 24.45 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.575 0.583 . . . . 1.67 112.575 -179.633 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.89 124.88 45.14 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.267 -0.642 . . . . 1.07 109.267 177.556 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.1 134.75 60.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.545 -0.462 . . . . 1.55 110.648 179.926 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.487 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -120.01 128.67 53.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.058 0.456 . . . . 1.33 111.247 179.781 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.548 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 139.02 49.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.729 -0.668 . . . . 2.36 110.062 179.012 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.42 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -145.11 163.21 35.0 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.443 -0.503 . . . . 0.38 112.058 -178.114 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.51 139.51 7.8 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.533 -0.758 . . . . 2.31 110.45 178.909 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.51 115.47 3.05 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.327 2.018 . . . . 0.86 111.803 179.968 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.67 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.99 81.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.902 -0.407 . . . . 3.44 109.902 -179.878 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.693 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.19 -20.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.954 -0.567 . . . . 2.72 111.919 -179.549 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 p -157.55 157.8 34.43 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.856 -0.338 . . . . 2.78 110.626 179.726 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.37 27.85 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.27 -0.423 . . . . 2.3 110.195 179.527 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.84 -75.91 1.31 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.036 -0.602 . . . . 1.8 111.811 -179.255 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.83 152.41 35.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.982 0.42 . . . . 5.48 110.991 -179.351 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.637 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.28 -169.19 2.54 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.075 -0.511 . . . . 1.84 112.007 179.413 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.6 mttp -110.06 149.6 29.78 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.43 0.633 . . . . 2.27 112.595 -177.86 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.08 156.41 46.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.815 -1.084 . . . . 1.92 110.214 178.679 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.16 158.42 41.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.934 -0.576 . . . . 1.09 111.788 -179.353 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.2 135.58 54.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.46 -0.791 . . . . 1.16 109.809 179.317 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.441 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.38 121.96 23.8 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.429 -0.351 . . . . 1.39 111.528 -179.149 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.512 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.3 Cg_exo -46.31 151.63 1.65 Allowed 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.694 2.263 . . . . 0.72 112.145 178.977 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.81 -23.09 62.91 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 116.043 -0.526 . . . . 0.74 112.814 -179.277 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.5 p-80 -82.81 -16.81 46.34 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.192 -0.603 . . . . 1.26 111.809 -178.323 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.49 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.6 mt -91.67 138.4 31.59 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.719 -0.392 . . . . 1.59 110.266 179.395 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.48 13.96 11.04 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.334 -0.393 . . . . 2.07 111.501 -179.369 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -150.04 143.52 25.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.633 -0.427 . . . . 0.96 111.029 179.525 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.717 ' CE2' ' O ' ' A' ' 59' ' ' THR . 65.0 t80 -114.8 -169.37 1.53 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.815 -179.373 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.717 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.79 125.95 9.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.343 -0.844 . . . . 1.19 109.852 179.21 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.448 HD11 HG23 ' A' ' 60' ' ' ILE . 66.3 mt -114.91 123.24 70.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.369 -0.532 . . . . 1.47 111.192 -179.73 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.804 ' HZ2' ' C ' ' A' ' 140' ' ' SER . 98.4 mttt -126.49 163.41 23.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.812 -0.631 . . . . 3.0 110.514 179.673 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.08 19.05 59.83 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.774 -0.93 . . . . 0.5 110.774 -179.845 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.429 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.6 mt -79.06 157.25 28.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.107 0.48 . . . . 1.21 111.4 -179.717 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.638 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -99.46 133.93 21.57 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.635 -0.712 . . . . 3.2 110.466 179.774 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.89 143.53 61.19 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.599 2.2 . . . . 1.09 111.971 179.81 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.89 25.57 75.41 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.045 -0.822 . . . . 0.72 111.045 179.722 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.637 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.14 158.74 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.653 0.263 . . . . 1.47 110.459 -179.636 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.07 139.95 41.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.986 0.422 . . . . 1.23 110.553 -179.772 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.638 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.64 136.47 54.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.914 -0.584 . . . . 1.1 110.788 -179.955 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.97 130.98 45.36 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.516 -0.92 . . . . 1.87 108.516 177.741 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.484 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.44 153.89 16.63 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.306 -0.95 . . . . 0.39 111.947 -178.556 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.03 141.0 46.07 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.739 -0.467 . . . . 1.8 109.739 179.503 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.465 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.8 tp -115.83 118.95 34.43 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.422 -0.511 . . . . 1.11 110.354 179.831 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.1 mt -112.48 129.11 68.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 1.51 110.625 -179.97 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.86 120.75 43.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.324 -0.398 . . . . 1.47 110.737 -179.663 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.675 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.47 146.52 11.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.18 0.514 . . . . 1.33 111.068 -179.292 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.813 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.08 153.89 21.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.56 -0.746 . . . . 2.49 109.861 179.877 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.22 88.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.742 -0.383 . . . . 4.2 110.426 -179.772 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.14 32.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.807 -0.633 . . . . 6.4 110.545 -179.905 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.22 -117.37 3.27 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.391 -0.683 . . . . 1.74 111.391 -179.77 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.45 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.1 m170 -81.4 177.44 8.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.202 0.525 . . . . 3.64 111.587 -179.111 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.16 149.48 32.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.428 -0.805 . . . . 1.7 110.488 179.09 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.15 144.69 38.73 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.499 -0.318 . . . . 2.7 110.556 179.874 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -127.99 136.09 61.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 120.577 -0.449 . . . . 1.16 111.544 -179.795 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.11 141.3 52.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.607 -0.724 . . . . 1.14 110.244 179.664 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.458 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.4 ttp180 -117.59 138.84 51.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.166 0.508 . . . . 4.33 111.486 -179.379 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.484 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.24 164.11 38.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.501 -0.772 . . . . 0.91 109.475 179.338 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.574 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.13 151.56 38.68 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.456 -0.498 . . . . 1.47 111.122 179.918 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.579 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.9 p90 -146.14 172.75 12.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.812 -0.631 . . . . 0.51 111.02 179.875 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.448 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.5 t -118.82 160.77 21.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.418 -0.81 . . . . 1.92 109.841 179.512 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.448 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.38 121.9 22.98 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.591 -0.444 . . . . 1.63 110.748 -179.991 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.583 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.6 p -128.81 167.19 17.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.048 -0.524 . . . . 2.37 112.286 179.676 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 C--N 1.331 -0.225 0 N-CA-C 109.001 -0.74 . . . . 3.63 109.001 177.431 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.8 p . . . . . 0 CA--C 1.523 -0.062 0 CA-C-O 121.112 0.482 . . . . 1.25 110.121 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.476 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.94 167.51 0.27 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.621 -0.718 . . . . 1.16 110.99 179.693 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.49 145.6 50.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.731 -0.668 . . . . 0.78 110.139 -179.902 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.36 101.77 9.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.076 -0.713 . . . . 1.08 109.076 177.675 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.468 HG11 ' N ' ' A' ' 131' ' ' SER . 70.5 t -113.01 139.74 36.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.589 . . . . 1.1 110.946 -178.758 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.468 ' N ' HG11 ' A' ' 130' ' ' VAL . 68.6 p -128.75 152.6 48.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.61 -0.723 . . . . 0.87 109.837 179.532 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.641 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.6 p90 -144.82 -164.99 2.04 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.672 -0.411 . . . . 0.37 110.653 -179.727 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.732 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.9 t -123.94 127.13 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 1.14 110.834 -179.821 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.167 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.125 -0.489 . . . . 1.91 110.316 179.841 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.09 24.39 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.9 -0.591 . . . . 1.56 111.481 -179.698 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.167 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.25 128.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.587 -0.445 . . . . 1.56 110.902 179.883 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.46 -9.66 55.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.92 -0.582 . . . . 1.88 110.246 179.78 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.1 0.31 55.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.123 -0.489 . . . . 1.63 110.35 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.963 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.26 137.07 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.984 -0.553 . . . . 1.11 109.982 179.624 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.804 ' C ' ' HZ2' ' A' ' 61' ' ' LYS . 10.1 p -96.21 -15.48 22.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.233 0.539 . . . . 1.01 110.028 -179.648 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.786 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.59 175.54 45.76 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.711 -1.355 . . . . 0.14 109.711 179.659 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -123.42 151.66 42.41 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.635 -0.426 . . . . 0.21 110.556 179.637 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.72 ' NH1' ' CE1' ' A' ' 157' ' ' TYR . 38.9 ttp85 -132.44 121.17 22.99 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.125 -0.489 . . . . 1.54 109.881 179.845 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.484 HG23 HG11 ' A' ' 167' ' ' VAL . 46.0 t -105.0 136.51 38.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.646 -0.706 . . . . 1.08 110.728 -179.77 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 78.5 tt0 -129.36 129.95 45.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.015 -0.539 . . . . 1.32 110.006 -179.919 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.84 135.26 34.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.044 -0.525 . . . . 1.05 110.525 -179.679 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.402 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.41 39.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.633 -0.712 . . . . 1.16 109.665 179.805 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.931 HD21 ' CE2' ' A' ' 178' ' ' TYR . 85.7 mt -71.09 124.86 25.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.952 0.406 . . . . 1.23 110.676 -179.536 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.49 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.71 -7.77 50.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.717 -0.674 . . . . 0.86 110.874 -179.815 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.73 -69.65 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 1.66 111.464 -179.284 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.43 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.63 -35.45 76.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.015 -0.539 . . . . 1.66 111.461 -179.168 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.089 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.18 7.24 88.59 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.748 -0.941 . . . . 1.62 110.748 -179.836 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.326 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.97 -171.73 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.689 0.28 . . . . 1.86 110.294 179.848 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.326 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.22 139.12 45.3 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.945 0.402 . . . . 1.98 110.172 179.666 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.402 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.7 Cg_endo -70.94 145.84 51.39 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 C-N-CA 122.725 2.283 . . . . 0.62 112.303 -179.537 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.9 145.75 42.63 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.234 -0.654 . . . . 1.14 109.234 179.183 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.72 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 94.1 m-85 -123.28 141.35 52.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.25 0.547 . . . . 1.44 111.478 -179.047 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.429 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.9 mt -128.14 127.73 43.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.274 -0.876 . . . . 1.08 108.892 178.942 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 27.8 t0 -101.59 131.18 47.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.165 0.507 . . . . 1.09 111.733 -178.772 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.516 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -128.0 157.53 73.6 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.348 -0.842 . . . . 1.04 109.571 179.645 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -69.76 158.03 58.35 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.395 2.063 . . . . 0.21 112.245 179.927 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.32 -12.13 5.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.753 -0.658 . . . . 0.88 110.732 -179.852 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.1 p -92.8 -8.77 42.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 1.06 110.743 -179.959 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.39 34.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.314 -0.403 . . . . 1.05 110.429 179.686 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.5 p -133.1 16.68 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.401 -0.363 . . . . 1.07 110.532 -179.988 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.7 p -167.55 147.13 5.08 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.614 -0.514 . . . . 0.92 109.614 179.905 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.516 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.2 150.48 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.565 -0.454 . . . . 1.09 111.619 -179.664 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.36 124.96 50.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.618 -0.719 . . . . 1.31 109.783 179.536 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.523 HG21 HD21 ' A' ' 172' ' ' LEU . 1.8 mt -99.48 104.93 30.28 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.907 0.384 . . . . 1.09 111.03 -179.835 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.1 Cg_endo -91.05 -179.49 1.48 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 123.155 2.57 . . . . 0.48 112.172 179.922 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.66 32.64 18.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.329 -0.851 . . . . 1.26 111.489 179.306 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.523 HD21 HG21 ' A' ' 169' ' ' ILE . 24.3 mt -86.34 148.46 25.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.49 -0.323 . . . . 1.12 110.467 179.611 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.764 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.25 114.87 61.36 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.042 0.448 . . . . 1.3 110.706 -179.799 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.07 140.58 95.84 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.754 2.303 . . . . 0.92 112.025 179.864 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.2 21.16 74.08 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.027 -0.829 . . . . 0.44 111.027 179.857 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.43 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.9 150.18 49.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 3.05 110.606 -179.941 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.49 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.1 tttt -100.11 131.68 45.92 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.084 -0.507 . . . . 1.48 109.82 179.282 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.931 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.54 148.35 43.97 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.118 -0.492 . . . . 0.89 110.991 -179.824 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.31 125.31 60.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.228 -1.027 . . . . 1.12 108.228 177.767 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.55 132.46 63.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.053 0.454 . . . . 1.1 111.284 -178.646 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.46 122.66 20.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.566 -0.743 . . . . 0.43 109.613 179.299 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.591 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.05 125.36 54.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.271 -0.422 . . . . 1.07 110.694 -179.496 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.668 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.6 m-85 -117.25 137.88 52.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.041 -0.527 . . . . 0.92 109.828 179.583 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.569 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.69 135.01 42.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.798 -0.815 . . . . 0.49 108.798 178.861 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.547 ' O ' ' N ' ' A' ' 140' ' ' SER . 14.0 mt -99.14 122.97 51.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.095 0.474 . . . . 1.08 110.931 -178.734 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.451 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.3 p -83.79 169.7 14.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.497 -0.774 . . . . 0.89 110.499 -179.675 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -59.71 -14.65 15.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.047 -0.524 . . . . 1.6 111.018 -179.663 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.451 ' H ' ' HG ' ' A' ' 186' ' ' SER . 95.5 m-20 -95.91 -4.39 43.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.828 0.347 . . . . 1.18 110.902 -179.819 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.79 13.97 63.87 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.301 -0.719 . . . . 0.34 111.301 179.919 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -84.63 139.11 32.29 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.059 -0.256 . . . . 1.22 110.465 179.585 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.715 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 85.9 mt-30 -106.75 141.08 38.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.893 0.378 . . . . 1.44 110.543 179.723 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.0 m -136.7 126.99 26.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.062 -0.517 . . . . 1.39 110.373 179.938 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.668 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.6 tp -68.23 117.38 9.97 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.644 -0.422 . . . . 1.08 110.537 -179.923 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.641 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -109.02 -21.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 1.08 110.746 -179.754 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.89 125.72 5.86 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.519 -0.472 . . . . 1.1 111.496 -179.776 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.496 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.83 120.25 21.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.772 -0.649 . . . . 0.94 109.574 179.143 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.72 29.13 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.568 -0.453 . . . . 1.07 110.806 -179.224 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.8 p -110.47 158.53 18.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.953 -0.567 . . . . 0.89 110.447 179.681 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -145.98 157.97 43.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.102 -0.499 . . . . 0.67 110.644 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.34 104.35 9.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.733 -0.667 . . . . 1.17 109.986 179.558 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.485 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.4 p . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.862 -1.066 . . . . 1.26 110.599 -179.656 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.224 -0.658 . . . . 3.83 109.224 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.7 18.54 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.023 -0.831 . . . . 1.39 111.023 179.73 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -35.61 142.41 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.048 0 C-N-CA 123.914 3.076 . . . . 0.86 113.826 -179.203 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.569 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -79.95 173.44 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.204 -1.362 . . . . 1.43 108.817 178.425 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 23' ' ' ASN . 96.2 mt-10 -105.69 125.89 51.52 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.433 -0.507 . . . . 1.94 111.368 -179.536 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.49 143.96 34.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.682 -0.69 . . . . 1.19 110.702 179.865 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.03 168.38 25.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.923 0.392 . . . . 3.92 111.044 -179.684 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.589 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -109.03 131.11 60.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.963 -0.562 . . . . 3.88 110.067 179.888 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 69.0 p -141.24 162.41 35.55 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.871 0.367 . . . . 3.92 111.121 -179.872 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.3 mt-10 36.03 31.49 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.631 -0.507 . . . . 6.08 109.631 179.862 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.589 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.3 69.56 31.1 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.971 -0.559 . . . . 4.01 111.663 -178.809 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.37 -29.02 71.92 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.467 2.112 . . . . 4.51 111.822 179.46 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 3.51 110.477 179.98 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.612 ' O ' ' O ' ' A' ' 92' ' ' THR . 10.7 mp0 -123.89 158.41 60.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 4.3 110.447 179.941 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.523 ' CG ' ' NH1' ' A' ' 143' ' ' ARG . 98.6 Cg_endo -82.17 -64.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.866 2.378 . . . . 1.96 113.46 -178.981 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.692 ' CG ' ' CE1' ' A' ' 157' ' ' TYR . 50.0 t30 -108.44 -19.52 13.43 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.11 0.411 . . . . 3.33 112.11 -178.536 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.536 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 99.0 p -107.34 152.1 24.6 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.452 -0.499 . . . . 1.53 111.281 -179.418 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.0 t-80 -155.36 102.83 2.21 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.696 -0.684 . . . . 2.29 110.676 179.885 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.544 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.3 Cg_endo -82.56 145.6 13.19 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.814 2.343 . . . . 0.88 112.675 179.904 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.414 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.81 167.89 24.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.894 -0.594 . . . . 2.12 109.862 179.561 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.1 148.0 29.16 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.737 -0.468 . . . . 2.67 109.737 178.866 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.491 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.8 p90 -142.24 157.25 45.05 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.659 -0.416 . . . . 0.32 111.16 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.471 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.9 m-20 -128.02 155.3 44.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.823 -0.626 . . . . 2.77 110.122 178.905 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.63 173.07 6.32 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.135 -0.484 . . . . 1.25 110.777 -179.184 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.75 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.907 2.405 . . . . 1.12 111.502 179.429 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -51.05 0.69 Allowed Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.679 -0.408 . . . . 4.05 110.171 179.797 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.658 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.85 152.35 82.47 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.7 2.267 . . . . 2.12 111.481 179.169 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.74 42.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.357 0.599 . . . . 2.85 110.525 -179.808 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.822 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.67 -41.61 98.15 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.052 -0.976 . . . . 3.11 110.639 179.735 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.439 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.3 mt -109.85 137.84 40.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.784 -0.644 . . . . 1.86 111.224 -179.449 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.93 -72.9 0.7 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.027 -0.533 . . . . 1.61 111.953 -179.069 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.17 148.37 24.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.588 0.588 . . . . 1.67 112.588 -179.649 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.85 124.91 45.25 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.346 -0.613 . . . . 1.07 109.346 177.498 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.04 134.65 60.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.646 -0.422 . . . . 1.55 110.662 -179.997 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.481 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -119.98 128.67 53.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.994 0.426 . . . . 1.33 111.261 179.742 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.21 138.94 49.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.787 -0.642 . . . . 2.36 110.096 179.018 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.423 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.04 163.1 35.27 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.166 0.508 . . . . 0.38 112.083 -178.083 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.495 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.46 139.67 7.92 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.406 -0.815 . . . . 2.31 110.451 178.766 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.696 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.2 Cg_endo -63.57 115.51 3.09 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.279 1.986 . . . . 0.86 111.801 -179.972 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.667 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.99 81.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.87 -0.419 . . . . 3.44 109.87 -179.865 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.696 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.19 -20.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.981 -0.554 . . . . 2.72 111.895 -179.548 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 p -157.58 157.82 34.42 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.784 -0.367 . . . . 2.78 110.548 179.782 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.404 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.42 27.84 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 2.3 110.138 179.575 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.78 -75.82 1.31 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.181 -0.533 . . . . 1.8 111.895 -179.294 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.93 152.34 35.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.983 0.42 . . . . 5.48 110.912 -179.327 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.67 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.31 -169.13 2.52 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.049 -0.523 . . . . 1.84 111.939 179.318 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.423 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.1 149.62 29.78 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.464 0.649 . . . . 2.27 112.571 -177.811 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.01 156.47 46.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.851 -1.068 . . . . 1.92 110.268 178.637 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.2 158.39 41.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.993 -0.549 . . . . 1.09 111.766 -179.336 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.6 m -115.2 135.58 54.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.415 -0.811 . . . . 1.16 109.834 179.296 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.449 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.39 121.94 23.78 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.479 -0.328 . . . . 1.39 111.527 -179.11 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.514 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.9 Cg_exo -46.36 151.75 1.65 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.632 2.221 . . . . 0.72 112.168 179.017 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.99 -23.04 63.24 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 116.039 -0.528 . . . . 0.74 112.755 -179.108 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.514 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.73 -16.96 46.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.35 0.575 . . . . 1.26 111.778 -178.345 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.481 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.3 mt -91.49 138.42 31.59 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.779 -0.368 . . . . 1.59 110.299 179.342 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -121.55 13.91 10.97 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.333 -0.394 . . . . 2.07 111.468 -179.382 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -149.99 143.5 25.24 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.589 -0.444 . . . . 0.96 111.026 179.56 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.726 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.81 -169.33 1.53 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.199 0.523 . . . . 1.0 110.845 -179.396 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.726 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.74 125.99 9.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.39 -0.823 . . . . 1.19 109.832 179.236 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.435 HG23 HD11 ' A' ' 60' ' ' ILE . 66.8 mt -114.95 123.29 70.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.383 -0.527 . . . . 1.47 111.17 -179.758 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -126.5 163.33 23.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.849 -0.614 . . . . 3.0 110.529 179.687 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.522 ' CA ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.2 19.07 59.61 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.685 -0.966 . . . . 0.5 110.685 -179.972 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.626 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 74.0 mt -79.14 157.27 27.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.138 0.494 . . . . 1.21 111.286 -179.604 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.639 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 13.2 mptt -99.57 134.03 21.43 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.551 -0.749 . . . . 3.2 110.393 179.85 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.98 143.55 60.76 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.554 2.169 . . . . 1.09 111.88 179.871 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.85 25.71 75.24 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.972 -0.851 . . . . 0.72 110.972 179.685 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.643 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.3 p -128.23 158.77 40.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.597 0.237 . . . . 1.47 110.434 -179.658 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.07 139.98 41.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.875 0.369 . . . . 1.23 110.623 -179.824 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.643 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.7 m-85 -122.67 136.47 54.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.897 -0.592 . . . . 1.1 110.76 -179.918 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.495 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.5 pt-20 -98.91 131.01 45.32 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.524 -0.917 . . . . 1.87 108.524 177.656 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.48 153.85 16.65 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.29 -0.957 . . . . 0.39 111.935 -178.585 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.98 140.95 46.1 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.716 -0.476 . . . . 1.8 109.716 179.537 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.462 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.0 tp -115.73 118.98 34.56 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.406 -0.518 . . . . 1.11 110.486 179.705 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.1 mt -112.51 129.03 68.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.909 0.385 . . . . 1.51 110.583 -179.878 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.85 120.82 43.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.299 -0.409 . . . . 1.47 110.701 -179.646 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.665 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.57 146.53 11.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.118 0.485 . . . . 1.33 110.977 -179.227 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.822 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.09 153.85 21.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.483 -0.78 . . . . 2.49 109.974 179.8 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.22 88.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.965 0.412 . . . . 4.2 110.444 -179.689 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.31 32.62 0.21 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.806 -0.634 . . . . 6.4 110.561 -179.936 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.3 3.29 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.496 -0.642 . . . . 1.74 111.496 -179.804 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.443 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.48 177.38 8.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.146 0.498 . . . . 3.64 111.623 -179.203 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.14 149.54 32.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.411 -0.813 . . . . 1.7 110.459 179.145 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.16 144.62 38.67 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.477 -0.329 . . . . 2.7 110.54 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.98 135.98 61.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 121.092 0.472 . . . . 1.16 111.573 -179.81 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.08 141.35 52.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.664 -0.698 . . . . 1.14 110.279 179.62 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.442 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.65 138.93 51.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.105 0.479 . . . . 4.33 111.5 -179.368 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.38 164.04 38.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.526 -0.761 . . . . 0.91 109.516 179.417 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.572 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.1 p30 -145.18 151.56 38.62 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.415 -0.514 . . . . 1.47 111.092 -179.995 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.574 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.0 p90 -146.24 172.71 13.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.759 -0.655 . . . . 0.51 111.039 179.875 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.455 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.73 160.69 21.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.455 -0.793 . . . . 1.92 109.777 179.658 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.455 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.37 121.9 22.99 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.636 -0.426 . . . . 1.63 110.764 179.91 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.612 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -127.61 167.98 15.63 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.675 0.621 . . . . 2.37 112.675 179.679 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.7 m . . . . . 0 N--CA 1.463 0.212 0 CA-C-N 115.195 -0.911 . . . . 3.63 109.997 179.225 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 31.6 p . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 121.749 0.785 . . . . 1.25 109.0 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.482 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.92 167.62 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.025 -0.989 . . . . 1.16 110.907 179.873 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.488 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.8 m-30 -133.68 145.47 49.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.672 -0.694 . . . . 0.78 110.102 -179.894 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.19 101.76 9.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.108 -0.701 . . . . 1.08 109.108 177.702 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.471 HG11 ' N ' ' A' ' 131' ' ' SER . 70.3 t -113.04 139.71 36.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.045 -0.525 . . . . 1.1 110.966 -178.76 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.471 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.0 p -128.64 152.54 48.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.544 -0.753 . . . . 0.87 109.869 179.622 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.647 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.7 p90 -144.88 -165.01 2.05 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.769 -0.372 . . . . 0.37 110.64 -179.788 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.3 t -123.91 127.13 73.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.281 -0.418 . . . . 1.14 110.922 -179.839 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.171 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.96 58.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.115 -0.493 . . . . 1.91 110.333 179.921 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.26 24.62 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.949 -0.569 . . . . 1.56 111.456 -179.592 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.171 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.14 128.62 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.624 -0.43 . . . . 1.56 110.998 179.897 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.39 -9.65 55.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.96 -0.564 . . . . 1.88 110.267 179.804 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.7 p -87.11 0.28 55.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 1.63 110.341 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.965 HG11 ' O ' ' A' ' 136' ' ' SER . 2.6 p -65.23 137.19 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.949 -0.569 . . . . 1.11 109.981 179.63 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 185' ' ' ILE . 7.8 m -96.29 -15.45 21.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.132 0.492 . . . . 1.01 110.006 -179.738 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.62 175.59 45.82 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 109.838 -1.305 . . . . 0.14 109.838 179.61 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.45 151.59 42.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.002 0.429 . . . . 0.21 110.437 179.775 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.523 ' NH1' ' CG ' ' A' ' 15' ' ' PRO . 23.9 ttp85 -132.33 121.09 22.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.168 -0.469 . . . . 1.54 109.988 179.751 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.491 HG23 HG11 ' A' ' 167' ' ' VAL . 46.1 t -104.99 136.53 38.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.742 -0.663 . . . . 1.08 110.703 -179.749 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 82.6 tt0 -129.35 129.96 45.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.05 -0.523 . . . . 1.32 110.042 -179.932 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.592 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.77 135.25 34.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.053 -0.521 . . . . 1.05 110.615 -179.67 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.403 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.27 161.35 39.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.809 -0.632 . . . . 1.16 109.629 179.847 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.935 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -71.01 124.82 25.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.994 0.426 . . . . 1.23 110.804 -179.721 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.494 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.77 -7.64 49.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.719 -0.673 . . . . 0.86 110.891 -179.754 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -109.87 -69.76 0.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.932 0.396 . . . . 1.66 111.306 -179.189 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.431 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.6 -35.4 76.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.06 -0.518 . . . . 1.66 111.486 -179.094 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.077 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.2 88.62 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.787 -0.925 . . . . 1.62 110.787 -179.811 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.339 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.3 t0 -27.93 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.814 0.34 . . . . 1.86 110.218 179.873 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.339 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.2 pm0 -82.24 139.07 45.22 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 1.98 110.214 179.626 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.403 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.1 Cg_endo -70.85 145.85 51.91 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.652 2.235 . . . . 0.62 112.368 -179.56 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.87 145.7 42.64 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.231 -0.655 . . . . 1.14 109.231 179.18 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.692 ' CE1' ' CG ' ' A' ' 16' ' ' ASN . 1.7 p90 -123.21 141.24 52.18 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.401 -0.52 . . . . 1.44 111.577 -179.099 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' A' ' 158' ' ' LEU . 71.0 mt -128.05 127.78 43.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.311 -0.858 . . . . 1.08 108.945 178.903 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.474 ' HB2' HD22 ' A' ' 16' ' ' ASN . 18.0 t0 -101.67 131.13 48.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.155 0.502 . . . . 1.09 111.742 -178.728 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.508 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -127.94 157.56 73.41 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.294 -0.866 . . . . 1.04 109.53 179.682 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -69.69 157.94 58.79 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 C-N-CA 122.491 2.127 . . . . 0.21 112.252 179.908 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.4 p -59.22 -12.14 4.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.786 -0.643 . . . . 0.88 110.775 -179.91 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.2 p -92.86 -8.74 42.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 1.06 110.704 -179.859 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.27 135.35 34.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 1.05 110.345 179.76 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.15 16.72 4.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.418 -0.355 . . . . 1.07 110.515 179.967 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.1 p -167.53 147.06 5.07 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.617 -0.512 . . . . 0.92 109.617 179.927 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.508 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.22 150.5 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.485 -0.486 . . . . 1.09 111.55 -179.707 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.495 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.27 124.95 50.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.525 -0.762 . . . . 1.31 109.818 179.49 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.528 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.37 104.94 29.92 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.476 -0.329 . . . . 1.09 111.092 -179.921 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 84.8 Cg_endo -91.07 -179.47 1.47 Allowed 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 123.19 2.594 . . . . 0.48 112.169 179.93 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.62 32.68 18.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.369 -0.832 . . . . 1.26 111.477 179.247 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.528 HD21 HG21 ' A' ' 169' ' ' ILE . 23.8 mt -86.34 148.39 25.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.432 -0.349 . . . . 1.12 110.47 179.6 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.774 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.16 114.78 60.88 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.964 0.411 . . . . 1.3 110.734 -179.778 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.92 140.44 95.25 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.925 2.417 . . . . 0.92 112.005 179.844 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.16 21.25 73.97 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.005 -0.838 . . . . 0.44 111.005 179.832 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.431 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.94 150.21 49.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.879 0.371 . . . . 3.05 110.623 179.931 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.494 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.23 131.61 46.08 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.013 -0.54 . . . . 1.48 109.786 179.365 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.935 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.4 148.32 43.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.076 -0.511 . . . . 0.89 111.066 -179.842 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.35 125.29 60.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.228 -1.027 . . . . 1.12 108.228 177.796 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.52 132.57 63.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.136 0.493 . . . . 1.1 111.204 -178.61 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.52 122.46 20.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.468 -0.787 . . . . 0.43 109.636 179.324 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.59 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.03 125.33 54.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.274 -0.421 . . . . 1.07 110.694 -179.521 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.667 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.6 m-85 -117.18 137.89 52.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.97 -0.559 . . . . 0.92 109.87 179.562 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.75 135.05 42.8 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.756 -0.831 . . . . 0.49 108.756 178.863 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' A' ' 140' ' ' SER . 76.7 mt -99.04 122.96 51.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.062 0.458 . . . . 1.08 110.89 -178.715 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.448 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.3 p -83.98 169.7 14.73 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.574 -0.739 . . . . 0.89 110.455 -179.7 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.422 ' HA ' ' HG ' ' A' ' 140' ' ' SER . 51.8 tp10 -59.7 -14.56 14.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.067 -0.515 . . . . 1.6 110.967 -179.535 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.544 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.9 m-20 -96.06 -4.26 43.29 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.845 -0.342 . . . . 1.18 110.792 -179.815 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.467 ' HA2' ' OG1' ' A' ' 59' ' ' THR . . . 87.78 13.89 64.02 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.383 -0.687 . . . . 0.34 111.383 179.903 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -84.73 139.15 32.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.644 0.259 . . . . 1.22 110.394 179.766 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.492 ' NE2' ' NE ' ' A' ' 143' ' ' ARG . 84.3 mt-30 -106.83 141.14 38.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 1.44 110.496 179.781 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.5 m -136.75 127.06 26.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.506 . . . . 1.39 110.411 179.903 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.667 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.4 tp -68.22 117.27 9.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.297 -0.41 . . . . 1.08 110.499 -179.822 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.647 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -108.96 -21.89 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 1.08 110.676 -179.709 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.89 125.68 5.84 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.456 -0.497 . . . . 1.1 111.516 -179.77 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.497 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.68 120.25 21.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.721 -0.672 . . . . 0.94 109.516 179.231 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.56 151.73 29.21 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.7 -0.4 . . . . 1.07 110.933 -179.321 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.47 158.61 18.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 0.89 110.393 179.677 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.06 157.92 43.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.103 -0.499 . . . . 0.67 110.702 179.919 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.17 104.39 9.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.82 -0.627 . . . . 1.17 110.009 179.524 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.488 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.5 p . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 117.95 -1.024 . . . . 1.26 110.585 -179.744 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.548 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.9 m . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.223 -0.658 . . . . 3.83 109.223 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.45 150.68 18.53 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.023 -0.831 . . . . 1.39 111.023 179.755 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.69 142.34 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.056 0 C-N-CA 124.067 3.178 . . . . 0.86 113.761 -179.199 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.568 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -79.89 173.47 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.194 -1.366 . . . . 1.43 108.893 178.389 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 23' ' ' ASN . 96.1 mt-10 -105.61 125.89 51.51 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.406 -0.518 . . . . 1.94 111.349 -179.548 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 144.07 33.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.636 -0.711 . . . . 1.19 110.662 179.75 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.02 168.32 25.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.404 -0.362 . . . . 3.92 111.104 -179.649 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.59 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.98 131.08 60.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.925 -0.58 . . . . 3.88 110.06 179.869 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.26 162.26 35.92 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.882 0.372 . . . . 3.92 111.209 -179.916 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 34.3 tp10 36.2 31.54 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.648 -0.501 . . . . 6.08 109.648 179.85 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.59 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.5 69.57 33.2 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.982 -0.554 . . . . 4.01 111.468 -178.644 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.28 -29.09 72.71 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.432 2.088 . . . . 4.51 111.845 179.346 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 3.51 110.472 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.535 ' CB ' ' O ' ' A' ' 17' ' ' SER . 7.7 mp0 -123.93 158.39 60.27 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.311 -0.404 . . . . 4.3 110.441 179.99 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.521 ' HB3' ' CB ' ' A' ' 93' ' ' SER . 98.1 Cg_endo -82.19 -64.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.941 2.427 . . . . 1.96 113.444 -178.991 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.664 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 41.2 t30 -108.48 -19.52 13.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.322 -0.399 . . . . 3.33 112.07 -178.513 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.535 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 12.6 t -107.4 152.01 24.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.19 0.519 . . . . 1.53 111.252 -179.339 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.25 102.92 2.23 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.712 -0.676 . . . . 2.29 110.67 179.796 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.554 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.4 Cg_endo -82.59 145.65 13.16 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.878 2.385 . . . . 0.88 112.666 179.871 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.413 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.88 167.99 24.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.892 -0.594 . . . . 2.12 109.859 179.591 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -149.18 147.91 28.99 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.783 -0.451 . . . . 2.67 109.783 178.954 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.494 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.7 p90 -142.29 157.25 45.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.027 0.442 . . . . 0.32 111.183 179.976 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.47 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.9 m-20 -127.96 155.26 44.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.796 -0.638 . . . . 2.77 110.133 178.969 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.56 173.02 6.37 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 121.074 0.464 . . . . 1.25 110.758 -179.223 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.61 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.888 0 C-N-CA 122.88 2.387 . . . . 1.12 111.517 179.304 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.483 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -51.08 0.69 Allowed Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 120.706 -0.398 . . . . 4.05 110.089 179.813 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.657 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.86 152.39 82.38 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.7 2.267 . . . . 2.12 111.474 179.243 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.73 42.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.42 0.629 . . . . 2.85 110.576 -179.869 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.824 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.57 -41.67 98.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.941 -1.027 . . . . 3.11 110.653 179.689 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.44 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.6 mt -109.87 137.77 40.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.771 -0.649 . . . . 1.86 111.327 -179.426 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.85 -72.95 0.7 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.106 -0.497 . . . . 1.61 111.925 -179.007 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.21 148.43 24.38 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.549 0.574 . . . . 1.67 112.549 -179.55 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.8 124.85 45.16 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.3 -0.63 . . . . 1.07 109.3 177.563 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.3 mt -117.95 134.7 60.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.721 -0.391 . . . . 1.55 110.654 179.905 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.483 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -119.99 128.7 53.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.065 0.46 . . . . 1.33 111.269 179.634 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.541 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.26 138.96 49.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.707 -0.679 . . . . 2.36 110.125 178.966 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.421 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.01 163.11 35.21 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.118 0.485 . . . . 0.38 112.146 -178.065 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.46 139.59 7.88 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.515 -0.766 . . . . 2.31 110.504 178.815 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.58 115.53 3.1 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.31 2.007 . . . . 0.86 111.733 -179.946 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.01 81.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.888 -0.412 . . . . 3.44 109.888 -179.926 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.17 -20.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.93 -0.577 . . . . 2.72 111.97 -179.558 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.8 p -157.65 157.81 34.29 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.813 0.34 . . . . 2.78 110.579 179.745 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.401 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.43 27.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 2.3 110.233 179.58 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.84 -75.87 1.31 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.126 -0.559 . . . . 1.8 111.864 -179.261 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.89 152.34 35.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.988 0.423 . . . . 5.48 110.953 -179.353 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.672 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.24 -169.17 2.54 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.029 -0.532 . . . . 1.84 111.919 179.37 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.1 149.65 29.73 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.395 0.617 . . . . 2.27 112.63 -177.88 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.06 156.5 45.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.842 -1.072 . . . . 1.92 110.226 178.659 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.22 158.34 41.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.906 -0.588 . . . . 1.09 111.785 -179.261 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 m -115.17 135.58 54.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.515 -0.766 . . . . 1.16 109.716 179.382 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.449 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.36 121.9 23.8 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 1.39 111.574 -179.229 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.518 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 73.8 Cg_exo -46.3 151.71 1.62 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.684 2.256 . . . . 0.72 112.046 179.042 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.91 -23.01 63.03 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 116.046 -0.524 . . . . 0.74 112.796 -179.233 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.518 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.84 -16.81 46.25 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.251 -0.579 . . . . 1.26 111.823 -178.329 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.483 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.5 mt -91.67 138.46 31.55 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.684 -0.406 . . . . 1.59 110.289 179.37 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -121.58 14.04 10.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.369 -0.378 . . . . 2.07 111.588 -179.394 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.48 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -150.07 143.5 25.16 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.601 -0.44 . . . . 0.96 111.003 179.579 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.725 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.85 -169.4 1.54 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.188 0.518 . . . . 1.0 110.869 -179.405 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.725 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.9 m -151.74 125.92 9.27 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.43 -0.805 . . . . 1.19 109.807 179.277 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.425 HG23 HD11 ' A' ' 60' ' ' ILE . 66.5 mt -114.86 123.28 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.369 -0.533 . . . . 1.47 111.243 -179.798 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -126.53 163.34 23.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.885 -0.598 . . . . 3.0 110.442 179.76 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.442 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.08 19.08 59.77 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.733 -0.947 . . . . 0.5 110.733 -179.89 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.664 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.7 mt -79.01 157.21 28.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.032 0.444 . . . . 1.21 111.36 -179.64 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.642 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 3.9 mmtt -99.5 133.93 21.54 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.691 -0.686 . . . . 3.2 110.522 179.716 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.549 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.86 143.57 61.5 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.491 2.128 . . . . 1.09 112.007 179.854 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.89 25.66 75.3 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.997 -0.841 . . . . 0.72 110.997 179.694 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.641 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.22 158.72 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.649 0.262 . . . . 1.47 110.398 -179.55 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.11 139.88 42.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.846 0.355 . . . . 1.23 110.644 -179.79 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.642 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.6 m-85 -122.51 136.48 54.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.973 -0.558 . . . . 1.1 110.8 -179.883 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.5 pt-20 -98.96 131.06 45.31 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.462 -0.94 . . . . 1.87 108.462 177.699 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.47 153.92 16.64 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.341 -0.933 . . . . 0.39 111.944 -178.616 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.98 140.95 46.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.706 -0.479 . . . . 1.8 109.706 179.559 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.461 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.8 tp -115.85 118.93 34.35 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.427 -0.509 . . . . 1.11 110.531 179.616 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.8 mt -112.46 129.08 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 1.51 110.676 -179.942 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.77 120.8 43.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.215 -0.448 . . . . 1.47 110.732 -179.639 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.668 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.56 146.43 11.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.163 0.506 . . . . 1.33 111.06 -179.261 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.824 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -105.98 153.88 21.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.528 -0.76 . . . . 2.49 109.907 179.845 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.16 88.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.899 0.38 . . . . 4.2 110.476 -179.814 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.35 32.54 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.834 -0.621 . . . . 6.4 110.628 -179.915 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.08 -117.35 3.29 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.471 -0.652 . . . . 1.74 111.471 -179.652 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.442 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.38 177.45 8.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.175 0.512 . . . . 3.64 111.609 -179.21 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.2 149.54 32.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.416 -0.811 . . . . 1.7 110.376 179.149 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.548 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.19 144.67 38.64 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.4 -0.364 . . . . 2.7 110.574 179.823 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -128.0 135.99 61.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 121.037 0.446 . . . . 1.16 111.581 -179.79 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.06 141.27 52.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.689 -0.687 . . . . 1.14 110.302 179.649 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.444 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.55 138.91 51.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.07 0.462 . . . . 4.33 111.535 -179.387 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.31 164.23 37.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.579 -0.737 . . . . 0.91 109.494 179.349 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.574 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.2 p30 -145.29 151.45 38.36 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.394 -0.523 . . . . 1.47 111.083 -179.952 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.574 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.4 p90 -146.16 172.78 12.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.835 -0.62 . . . . 0.51 111.053 179.84 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.456 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.83 160.6 21.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.468 -0.787 . . . . 1.92 109.874 179.627 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.456 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.33 121.8 22.9 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.685 -0.406 . . . . 1.63 110.745 -179.962 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.7 p -128.68 169.02 14.98 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 115.78 1.77 . . . . 2.37 115.78 179.579 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.521 ' CB ' ' HB3' ' A' ' 15' ' ' PRO . 18.2 t . . . . . 0 N--CA 1.452 -0.373 0 CA-C-N 111.87 -2.423 . . . . 3.63 108.603 177.507 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 122.162 0.982 . . . . 1.25 110.832 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.481 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.85 167.65 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.68 -1.146 . . . . 1.16 110.937 -179.264 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.488 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.9 m-30 -133.7 145.57 50.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.688 -0.687 . . . . 0.78 110.166 -179.962 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.23 101.66 9.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.088 -0.708 . . . . 1.08 109.088 177.751 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.47 HG11 ' N ' ' A' ' 131' ' ' SER . 71.2 t -113.02 139.65 37.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.99 -0.55 . . . . 1.1 111.066 -178.884 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.47 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.2 p -128.63 152.57 48.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.643 -0.708 . . . . 0.87 109.84 179.644 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.645 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.8 p90 -144.83 -165.07 2.06 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.687 -0.405 . . . . 0.37 110.642 -179.765 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -123.81 127.17 73.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 1.14 110.918 -179.905 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.168 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.96 58.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.198 -0.455 . . . . 1.91 110.346 179.814 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.12 24.46 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.902 -0.59 . . . . 1.56 111.515 -179.732 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.168 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.18 128.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.619 -0.432 . . . . 1.56 111.011 179.8 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.33 -9.66 55.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.915 -0.584 . . . . 1.88 110.353 179.814 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.7 p -87.09 0.3 55.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.095 -0.502 . . . . 1.63 110.337 179.991 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.965 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.36 137.24 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.892 -0.594 . . . . 1.11 109.936 179.734 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 185' ' ' ILE . 5.4 m -96.26 -15.45 21.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.286 0.565 . . . . 1.01 110.12 -179.716 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.58 175.55 45.75 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 109.806 -1.318 . . . . 0.14 109.806 179.593 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.46 151.63 42.52 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.602 -0.439 . . . . 0.21 110.558 179.718 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.784 ' NE ' HE22 ' A' ' 191' ' ' GLN . 41.9 ttp85 -132.32 121.08 22.99 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.178 -0.464 . . . . 1.54 109.957 179.939 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.487 HG23 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.1 136.55 38.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.716 -0.674 . . . . 1.08 110.629 -179.708 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 82.7 tt0 -129.4 129.9 45.3 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.939 -0.573 . . . . 1.32 110.05 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.4 p90 -138.66 135.27 34.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.957 -0.565 . . . . 1.05 110.644 -179.693 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.401 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.35 161.37 39.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.809 -0.632 . . . . 1.16 109.747 179.729 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.933 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.3 mt -71.02 124.84 25.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.064 0.459 . . . . 1.23 110.716 -179.52 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.65 -7.8 50.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.702 -0.681 . . . . 0.86 110.919 -179.818 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.86 -69.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 1.66 111.431 -179.257 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.425 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.66 -35.42 76.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.112 -0.495 . . . . 1.66 111.491 -179.147 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.081 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.22 88.61 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.799 -0.92 . . . . 1.62 110.799 -179.817 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.338 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -28.03 -171.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.762 0.315 . . . . 1.86 110.319 179.913 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.338 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.03 45.19 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-O 120.917 0.389 . . . . 1.98 110.213 179.657 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.401 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.7 Cg_endo -70.86 145.83 51.8 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.716 2.277 . . . . 0.62 112.394 -179.578 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.9 145.74 42.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.189 -0.671 . . . . 1.14 109.189 179.255 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.549 ' CE1' ' HD3' ' A' ' 65' ' ' PRO . 35.3 p90 -123.26 141.39 52.03 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.33 -0.548 . . . . 1.44 111.46 -179.062 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.416 ' HA ' HD22 ' A' ' 158' ' ' LEU . 71.5 mt -128.17 127.68 43.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.271 -0.877 . . . . 1.08 108.918 178.919 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.6 ' HB2' ' ND2' ' A' ' 16' ' ' ASN . 38.1 t0 -101.6 131.21 47.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.24 0.543 . . . . 1.09 111.702 -178.743 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.51 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -128.04 157.43 74.0 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.349 -0.841 . . . . 1.04 109.575 179.677 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.71 157.89 58.93 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 122.406 2.071 . . . . 0.21 112.334 179.902 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.18 -12.22 4.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.813 -0.63 . . . . 0.88 110.781 -179.799 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.9 p -92.74 -8.79 42.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.042 -0.526 . . . . 1.06 110.764 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.21 135.4 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.355 -0.384 . . . . 1.05 110.436 179.691 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.6 p -133.13 16.69 4.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.328 -0.396 . . . . 1.07 110.461 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.61 147.12 5.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.697 -0.483 . . . . 0.92 109.697 179.838 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.51 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.15 150.42 12.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.501 -0.48 . . . . 1.09 111.597 -179.533 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.497 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.38 124.92 50.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.62 -0.718 . . . . 1.31 109.858 179.469 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.528 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.35 104.82 29.17 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.333 -0.394 . . . . 1.09 111.077 -179.791 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.4 Cg_endo -90.87 -179.47 1.53 Allowed 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 123.21 2.607 . . . . 0.48 112.25 179.882 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.61 32.73 18.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.416 -0.811 . . . . 1.26 111.376 179.224 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.528 HD21 HG21 ' A' ' 169' ' ' ILE . 24.2 mt -86.36 148.49 25.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.544 -0.298 . . . . 1.12 110.45 179.541 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.77 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.33 114.89 61.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.066 0.46 . . . . 1.3 110.656 -179.763 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.1 140.64 96.04 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.915 2.41 . . . . 0.92 111.982 179.885 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.0 21.28 74.35 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.091 -0.804 . . . . 0.44 111.091 179.974 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.425 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.99 150.2 49.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.862 0.363 . . . . 3.05 110.587 -179.979 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.495 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.11 131.65 45.93 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.999 -0.546 . . . . 1.48 109.794 179.37 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.933 ' CE2' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.56 148.33 44.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.134 -0.484 . . . . 0.89 111.011 -179.874 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.38 125.31 60.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.198 -1.038 . . . . 1.12 108.198 177.796 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.54 132.56 63.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.119 0.485 . . . . 1.1 111.318 -178.694 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.9 m-20 -136.47 122.5 20.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.54 -0.755 . . . . 0.43 109.719 179.327 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.589 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.02 125.45 54.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.314 -0.403 . . . . 1.07 110.715 -179.527 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.666 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.0 m-85 -117.2 137.87 52.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.04 -0.527 . . . . 0.92 109.886 179.574 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.569 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.74 135.13 42.66 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.805 -0.813 . . . . 0.49 108.805 178.82 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.548 ' O ' ' N ' ' A' ' 140' ' ' SER . 88.9 mt -99.16 123.02 51.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.178 0.513 . . . . 1.08 110.904 -178.713 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.45 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 89.2 p -83.95 169.83 14.63 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.497 -0.774 . . . . 0.89 110.432 -179.614 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.45 ' HA ' ' HG ' ' A' ' 140' ' ' SER . 97.9 mt-10 -59.77 -14.64 15.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.046 -0.524 . . . . 1.6 110.946 -179.598 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.605 ' C ' ' OG1' ' A' ' 59' ' ' THR . 96.4 m-20 -96.03 -4.28 43.36 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.778 -0.369 . . . . 1.18 110.842 -179.763 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.724 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.8 13.98 63.84 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.376 -0.689 . . . . 0.34 111.376 179.875 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -84.69 139.02 32.32 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.781 -0.246 . . . . 1.22 110.386 179.733 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.784 HE22 ' NE ' ' A' ' 143' ' ' ARG . 84.3 mt-30 -106.81 141.05 38.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.929 0.395 . . . . 1.44 110.511 179.758 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.8 m -136.65 126.94 26.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 1.39 110.45 179.913 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.666 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.4 tp -68.06 117.28 9.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.335 -0.393 . . . . 1.08 110.527 -179.856 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.645 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -109.03 -21.79 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 1.08 110.752 -179.783 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.85 125.77 5.91 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.519 -0.473 . . . . 1.1 111.488 -179.824 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.498 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.79 120.14 21.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.743 -0.662 . . . . 0.94 109.6 179.215 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.58 151.67 29.12 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.715 -0.394 . . . . 1.07 111.009 -179.296 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.46 158.61 18.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 0.89 110.403 179.704 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.02 157.94 43.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.098 -0.501 . . . . 0.67 110.669 179.997 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.24 104.29 9.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.743 -0.662 . . . . 1.17 110.086 179.482 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.488 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 66.5 p . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.947 -1.025 . . . . 1.26 110.568 -179.687 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.236 -0.653 . . . . 3.83 109.236 . . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.73 18.52 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.007 -0.837 . . . . 1.39 111.007 179.708 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.66 142.32 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.06 0 C-N-CA 124.04 3.16 . . . . 0.86 113.729 -179.205 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.577 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -79.86 173.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.189 -1.369 . . . . 1.43 108.832 178.402 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 23' ' ' ASN . 96.1 mt-10 -105.54 125.8 51.41 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.503 -0.479 . . . . 1.94 111.416 -179.569 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 144.01 33.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.731 -0.668 . . . . 1.19 110.578 179.886 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.05 168.25 25.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.864 0.364 . . . . 3.92 111.139 -179.695 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.589 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.87 131.04 60.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.026 -0.533 . . . . 3.88 110.141 179.877 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.5 p -141.16 162.33 35.73 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.84 0.352 . . . . 3.92 111.239 -179.932 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 71.5 tt0 36.05 31.65 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.655 -0.498 . . . . 6.08 109.655 179.849 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.589 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.53 69.61 33.56 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.918 -0.583 . . . . 4.01 111.533 -178.75 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.639 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.27 -29.23 72.9 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.564 2.176 . . . . 4.51 111.772 179.389 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.639 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.73 125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 3.51 110.453 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 17' ' ' SER . 15.5 mt-30 -123.86 158.38 60.09 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.376 -0.375 . . . . 4.3 110.446 179.939 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.754 ' HG2' ' NE ' ' A' ' 143' ' ' ARG . 97.4 Cg_endo -82.08 -64.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.816 2.344 . . . . 1.96 113.528 -179.029 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.824 ' ND2' ' H ' ' A' ' 62' ' ' GLY . 31.6 t30 -108.38 -19.71 13.37 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.041 0.386 . . . . 3.33 112.041 -178.498 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 15.1 p -107.28 152.03 24.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.093 0.473 . . . . 1.53 111.347 -179.332 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.581 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.4 t-80 -155.35 102.98 2.22 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.738 -0.664 . . . . 2.29 110.558 179.876 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.41 ' HD3' HE22 ' A' ' 14' ' ' GLN . 73.6 Cg_endo -82.68 145.67 13.03 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.8 2.333 . . . . 0.88 112.675 179.879 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.413 HG12 ' HB3' ' A' ' 58' ' ' TYR . 7.0 pt -130.84 167.93 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.893 -0.594 . . . . 2.12 109.822 179.618 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.1 147.93 29.08 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.72 -0.474 . . . . 2.67 109.72 178.901 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.502 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.4 p90 -142.21 157.29 45.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.948 0.404 . . . . 0.32 111.263 179.858 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.459 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.9 m-20 -128.02 155.23 44.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.782 -0.645 . . . . 2.77 110.105 178.968 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.4 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . . . -132.55 173.08 6.3 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.158 -0.474 . . . . 1.25 110.845 -179.294 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.71 173.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.88 2.386 . . . . 1.12 111.49 179.412 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.01 -51.03 0.69 Allowed Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 120.578 -0.449 . . . . 4.05 110.143 179.856 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.651 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.84 152.37 82.39 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.696 2.264 . . . . 2.12 111.455 179.179 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.67 42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.372 0.606 . . . . 2.85 110.584 -179.9 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.816 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.49 -41.75 98.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.986 -1.006 . . . . 3.11 110.715 179.65 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.433 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.2 mt -109.85 137.82 40.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.708 -0.678 . . . . 1.86 111.293 -179.445 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.89 -72.87 0.7 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.001 -0.545 . . . . 1.61 111.923 -178.968 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.2 148.4 24.39 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.557 0.577 . . . . 1.67 112.557 -179.62 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -121.88 124.82 45.02 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.349 -0.611 . . . . 1.07 109.349 177.527 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.0 134.79 60.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.598 -0.441 . . . . 1.55 110.638 179.949 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.489 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -120.03 128.52 53.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 1.33 111.323 179.721 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -130.97 139.01 49.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.78 -0.646 . . . . 2.36 110.097 179.074 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.419 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.2 p90 -145.16 163.08 35.47 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 120.574 -0.45 . . . . 0.38 112.072 -178.128 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.489 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.39 139.52 7.91 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.474 -0.785 . . . . 2.31 110.542 178.848 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.9 Cg_endo -63.53 115.48 3.07 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.353 2.036 . . . . 0.86 111.849 179.954 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.97 81.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.904 -0.406 . . . . 3.44 109.904 -179.859 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.952 -0.567 . . . . 2.72 111.835 -179.501 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.6 p -157.57 157.78 34.38 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.878 -0.329 . . . . 2.78 110.615 179.793 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.401 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.38 27.82 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.236 -0.438 . . . . 2.3 110.122 179.568 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.7 -75.99 1.32 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.18 -0.533 . . . . 1.8 111.814 -179.223 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.89 152.32 35.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.932 0.396 . . . . 5.48 110.963 -179.306 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.03 2.5 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.983 -0.553 . . . . 1.84 111.929 179.337 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.414 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.2 149.66 29.79 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.512 0.672 . . . . 2.27 112.504 -177.829 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.07 156.47 45.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.764 -1.107 . . . . 1.92 110.247 178.609 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.22 158.35 41.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.933 -0.576 . . . . 1.09 111.824 -179.341 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.08 135.61 54.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.496 -0.774 . . . . 1.16 109.859 179.267 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.447 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.36 121.92 23.81 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.464 -0.335 . . . . 1.39 111.6 -179.204 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.519 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.4 Cg_exo -46.32 151.74 1.62 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.695 2.263 . . . . 0.72 112.057 179.101 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.03 -22.9 63.18 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 116.035 -0.529 . . . . 0.74 112.743 -179.205 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.519 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.86 -16.85 46.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.392 0.596 . . . . 1.26 111.746 -178.334 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.485 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.63 138.4 31.59 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.771 -0.372 . . . . 1.59 110.293 179.386 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -121.47 13.86 11.03 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.366 -0.379 . . . . 2.07 111.549 -179.363 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.477 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.93 143.53 25.31 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.624 -0.43 . . . . 0.96 111.008 179.648 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.719 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.84 -169.38 1.54 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.875 -179.46 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.719 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 94.7 m -151.8 125.89 9.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.357 -0.838 . . . . 1.19 109.882 179.208 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.44 HD11 HG23 ' A' ' 60' ' ' ILE . 66.5 mt -114.9 123.28 70.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.365 -0.534 . . . . 1.47 111.185 -179.711 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.835 ' NZ ' ' N ' ' A' ' 141' ' ' GLY . 82.1 mttt -126.51 163.38 23.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.839 -0.619 . . . . 3.0 110.469 179.733 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.824 ' H ' ' ND2' ' A' ' 16' ' ' ASN . . . 85.17 18.88 60.0 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.723 -0.951 . . . . 0.5 110.723 -179.892 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.433 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.6 mt -78.91 157.19 28.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 1.21 111.379 -179.629 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.635 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 2.3 mttt -99.5 133.92 21.54 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.637 -0.711 . . . . 3.2 110.438 179.781 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.92 143.62 61.34 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.597 2.198 . . . . 1.09 111.941 179.812 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.82 25.52 75.47 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.063 -0.815 . . . . 0.72 111.063 179.795 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.64 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.05 158.86 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.763 0.316 . . . . 1.47 110.446 -179.631 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.23 139.93 42.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.98 0.419 . . . . 1.23 110.534 -179.786 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.64 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.6 m-85 -122.61 136.44 54.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.932 -0.576 . . . . 1.1 110.797 -179.95 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.489 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.9 131.04 45.29 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.528 -0.915 . . . . 1.87 108.528 177.684 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.487 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.57 153.9 16.67 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.207 -0.997 . . . . 0.39 111.923 -178.541 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.01 140.84 45.98 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.73 -0.471 . . . . 1.8 109.73 179.646 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.46 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.4 tp -115.66 118.89 34.36 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.45 -0.5 . . . . 1.11 110.504 179.759 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.48 129.07 68.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.887 0.375 . . . . 1.51 110.646 -179.939 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.75 120.9 43.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.256 -0.429 . . . . 1.47 110.761 -179.726 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.673 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.64 146.37 11.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.159 0.504 . . . . 1.33 111.079 -179.288 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.816 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -105.98 153.85 21.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.559 -0.746 . . . . 2.49 109.938 179.884 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.24 88.66 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.995 0.426 . . . . 4.2 110.412 -179.73 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.618 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.26 32.55 0.21 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.759 -0.655 . . . . 6.4 110.682 -179.912 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.01 -117.26 3.29 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.93 -0.652 . . . . 1.74 111.489 -179.731 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.446 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.1 m170 -81.54 177.42 8.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.23 0.538 . . . . 3.64 111.537 -179.159 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.15 149.54 32.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.407 -0.815 . . . . 1.7 110.381 179.179 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.19 144.68 38.64 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.462 -0.335 . . . . 2.7 110.589 179.829 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -128.0 136.04 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.078 0.466 . . . . 1.16 111.557 -179.775 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.577 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.07 141.39 52.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.706 -0.679 . . . . 1.14 110.257 179.647 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.447 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.73 138.88 51.72 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.499 -0.481 . . . . 4.33 111.497 -179.32 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.487 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.26 164.2 37.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.574 -0.739 . . . . 0.91 109.479 179.473 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.577 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.36 151.48 38.34 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.443 -0.503 . . . . 1.47 111.032 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.581 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.0 p90 -146.13 172.77 12.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.7 -0.682 . . . . 0.51 111.028 179.878 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.453 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.86 160.74 21.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.479 -0.782 . . . . 1.92 109.861 179.527 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.453 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.33 121.83 22.94 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.61 -0.436 . . . . 1.63 110.798 -179.962 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -128.83 154.67 46.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 2.37 111.081 179.652 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 C--N 1.33 -0.239 0 C-N-CA 120.032 -0.667 . . . . 3.63 109.479 177.352 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.719 0 CA-C-O 122.358 1.075 . . . . 1.25 111.135 . . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.47 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.81 167.6 0.25 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.397 -1.274 . . . . 1.16 110.977 -178.83 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.487 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.9 m-30 -133.62 145.51 50.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.691 -0.686 . . . . 0.78 110.099 -179.833 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.31 101.62 9.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.075 -0.713 . . . . 1.08 109.075 177.707 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.46 HG11 ' N ' ' A' ' 131' ' ' SER . 71.8 t -112.9 139.7 36.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.978 -0.556 . . . . 1.1 111.143 -178.915 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.46 ' N ' HG11 ' A' ' 130' ' ' VAL . 68.1 p -128.71 152.56 48.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.642 -0.708 . . . . 0.87 109.747 179.681 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . 0.648 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.8 p90 -144.74 -164.9 2.02 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.731 -0.387 . . . . 0.37 110.64 -179.839 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.733 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -124.02 127.12 73.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.156 -0.474 . . . . 1.14 110.833 -179.87 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 1.148 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.87 58.28 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.102 -0.499 . . . . 1.91 110.351 179.825 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.28 24.69 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.981 -0.554 . . . . 1.56 111.535 -179.589 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.148 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.14 128.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.597 -0.441 . . . . 1.56 110.907 179.818 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.39 -9.64 55.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.901 -0.591 . . . . 1.88 110.255 179.725 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.7 p -86.98 0.23 55.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 1.63 110.338 179.954 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.967 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.3 137.31 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 116.0 -0.545 . . . . 1.11 110.016 179.775 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.74 ' C ' ' HZ3' ' A' ' 61' ' ' LYS . 5.7 m -96.31 -15.6 21.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.234 0.54 . . . . 1.01 109.99 -179.585 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.835 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.63 175.62 45.85 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.821 -1.311 . . . . 0.14 109.821 179.58 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.48 151.57 42.61 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.619 -0.432 . . . . 0.21 110.465 179.801 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.754 ' NE ' ' HG2' ' A' ' 15' ' ' PRO . 19.7 ttt85 -132.25 121.22 23.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.131 -0.486 . . . . 1.54 109.96 179.759 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.482 HG23 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.13 136.54 38.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.776 -0.647 . . . . 1.08 110.619 -179.703 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 85.2 tt0 -129.36 129.88 45.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.969 -0.56 . . . . 1.32 110.001 -179.862 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.71 135.22 34.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.099 -0.501 . . . . 1.05 110.652 -179.673 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.413 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.26 161.44 39.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.809 -0.632 . . . . 1.16 109.657 179.834 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.927 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -71.11 124.87 25.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.935 0.397 . . . . 1.23 110.769 -179.616 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.71 -7.76 50.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.808 -0.633 . . . . 0.86 110.837 -179.748 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.83 -69.77 0.85 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.356 -0.384 . . . . 1.66 111.394 -179.249 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 1.429 ' CD ' HH21 ' A' ' 176' ' ' ARG . 53.9 mt-10 -60.58 -35.36 75.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.083 -0.508 . . . . 1.66 111.57 -179.167 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 1.096 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.18 7.24 88.59 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.839 -0.904 . . . . 1.62 110.839 -179.843 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 1.313 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.95 -171.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.756 0.312 . . . . 1.86 110.293 179.849 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.313 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.25 139.06 45.15 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.982 0.42 . . . . 1.98 110.182 179.653 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.413 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.87 145.87 51.86 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 C-N-CA 122.694 2.262 . . . . 0.62 112.361 -179.553 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.9 145.74 42.64 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.131 -0.692 . . . . 1.14 109.131 179.261 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.627 ' HB3' ' CZ ' ' A' ' 143' ' ' ARG . 71.7 m-85 -123.27 141.34 52.08 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.344 -0.542 . . . . 1.44 111.552 -179.143 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.437 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.5 mt -128.09 127.61 43.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.291 -0.868 . . . . 1.08 108.973 178.995 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.629 ' OD2' ' ND2' ' A' ' 16' ' ' ASN . 34.6 t0 -101.61 131.22 47.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.088 0.471 . . . . 1.09 111.733 -178.741 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.604 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -128.01 157.57 73.49 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.321 -0.854 . . . . 1.04 109.572 179.672 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -69.87 158.04 58.15 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 C-N-CA 122.475 2.117 . . . . 0.21 112.153 -179.987 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.34 -12.13 5.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.687 -0.688 . . . . 0.88 110.721 -179.779 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.6 p -92.78 -8.79 42.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 1.06 110.709 -179.917 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.38 34.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 1.05 110.358 179.743 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 p -133.13 16.61 4.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.373 -0.376 . . . . 1.07 110.461 -179.986 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.4 p -167.52 147.12 5.09 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.556 -0.535 . . . . 0.92 109.556 179.906 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.519 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.1 p -152.2 150.44 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.452 -0.499 . . . . 1.09 111.592 -179.634 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.492 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.36 125.03 50.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.695 -0.684 . . . . 1.31 109.776 179.504 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.525 HG21 HD21 ' A' ' 172' ' ' LEU . 1.8 mt -99.4 104.91 29.87 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 1.09 111.016 -179.826 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -91.01 -179.52 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 123.189 2.593 . . . . 0.48 112.203 179.884 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 61.67 32.6 18.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.409 -0.814 . . . . 1.26 111.497 179.316 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.525 HD21 HG21 ' A' ' 169' ' ' ILE . 24.2 mt -86.37 148.57 25.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.483 -0.326 . . . . 1.12 110.485 179.601 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.766 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.4 114.88 61.5 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.048 0.451 . . . . 1.3 110.616 -179.657 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.96 140.62 96.11 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.81 2.34 . . . . 0.92 111.993 179.825 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.11 21.15 74.34 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.072 -0.811 . . . . 0.44 111.072 179.885 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 1.429 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.91 150.16 49.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.351 . . . . 3.05 110.632 -179.925 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.17 131.65 45.99 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.044 -0.525 . . . . 1.48 109.804 179.351 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.927 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.7 m-85 -120.61 148.26 44.13 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.187 -0.46 . . . . 0.89 110.989 -179.788 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.7 mt -105.22 125.35 60.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.321 -0.992 . . . . 1.12 108.321 177.76 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.67 132.57 63.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.218 0.532 . . . . 1.1 111.189 -178.581 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.49 122.62 20.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.49 -0.777 . . . . 0.43 109.614 179.319 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.592 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.2 t -101.15 125.42 55.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.195 -0.457 . . . . 1.07 110.648 -179.514 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 183' ' ' TYR . . . . . 0.666 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.5 m-85 -117.23 137.87 52.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.018 -0.537 . . . . 0.92 109.843 179.602 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.567 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.7 135.04 42.78 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.878 -0.786 . . . . 0.49 108.878 178.817 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.597 ' HB ' ' HZ2' ' A' ' 61' ' ' LYS . 68.1 mt -99.1 122.97 51.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.144 0.497 . . . . 1.08 110.953 -178.73 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.45 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.5 p -83.94 169.68 14.79 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.518 -0.765 . . . . 0.89 110.453 -179.636 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.77 -14.46 14.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.094 -0.503 . . . . 1.6 110.913 -179.542 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.45 ' H ' ' HG ' ' A' ' 186' ' ' SER . 95.5 m-20 -96.15 -4.33 42.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.773 0.321 . . . . 1.18 110.787 -179.796 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.9 13.83 63.9 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.254 -0.738 . . . . 0.34 111.254 179.76 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -84.68 139.1 32.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.715 0.293 . . . . 1.22 110.431 179.708 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -106.71 141.05 38.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.929 0.395 . . . . 1.44 110.643 179.69 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.71 127.01 26.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 1.39 110.388 179.927 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.666 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.1 tp -68.02 117.27 9.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.23 -0.441 . . . . 1.08 110.548 -179.928 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.648 HD12 ' CD1' ' A' ' 132' ' ' TRP . 43.9 pt -109.03 -21.88 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 1.08 110.78 -179.753 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.82 125.78 5.93 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.535 -0.466 . . . . 1.1 111.511 -179.846 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.495 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.76 120.16 21.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.801 -0.636 . . . . 0.94 109.522 179.218 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.58 151.7 29.17 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.624 -0.43 . . . . 1.07 110.873 -179.29 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.5 158.6 18.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.015 -0.538 . . . . 0.89 110.41 179.686 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.09 157.88 43.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.07 -0.513 . . . . 0.67 110.677 -179.977 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.23 104.37 9.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.787 -0.642 . . . . 1.17 110.011 179.563 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.487 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 66.5 p . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.894 -1.051 . . . . 1.26 110.705 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.19 -0.67 . . . . 3.83 109.19 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.39 150.7 18.54 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.991 -0.844 . . . . 1.39 110.991 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -35.56 142.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 124.015 3.143 . . . . 0.86 113.76 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.563 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -80.06 173.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.268 -1.333 . . . . 1.43 108.802 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -105.62 125.86 51.47 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.394 -0.522 . . . . 1.94 111.407 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.49 144.02 33.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.662 -0.699 . . . . 1.19 110.629 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.03 168.3 25.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.891 0.377 . . . . 3.92 111.145 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.586 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.98 131.08 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.01 -0.541 . . . . 3.88 110.074 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.16 162.31 35.78 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.861 0.362 . . . . 3.92 111.217 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 9' ' ' THR . 79.8 mm-40 36.07 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.611 -0.514 . . . . 6.08 109.611 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.586 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.6 32.57 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.973 -0.558 . . . . 4.01 111.6 -178.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.636 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.32 -29.1 72.43 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.487 2.125 . . . . 4.51 111.819 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.636 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.64 125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 3.51 110.443 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 17' ' ' SER . 2.8 mp0 -123.91 158.29 60.56 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 4.3 110.435 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.646 ' HG2' ' NE ' ' A' ' 143' ' ' ARG . 97.7 Cg_endo -82.02 -64.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.94 2.427 . . . . 1.96 113.428 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.725 HD21 ' N ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -108.35 -19.53 13.44 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.067 0.395 . . . . 3.33 112.067 -178.495 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.725 ' N ' HD21 ' A' ' 16' ' ' ASN . 9.8 p -107.31 152.04 24.67 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.484 -0.486 . . . . 1.53 111.338 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.26 102.9 2.23 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.769 -0.65 . . . . 2.29 110.675 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.68 145.61 13.01 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.853 2.369 . . . . 0.88 112.664 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.413 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.74 167.92 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.899 -0.591 . . . . 2.12 109.919 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.12 147.95 29.09 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.829 -0.434 . . . . 2.67 109.829 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.499 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.6 p90 -142.29 157.29 44.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.972 0.415 . . . . 0.32 111.194 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.466 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.05 155.34 44.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.797 -0.638 . . . . 2.77 110.092 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.65 173.05 6.34 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.118 0.485 . . . . 1.25 110.743 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.68 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.873 2.382 . . . . 1.12 111.515 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.11 -51.0 0.69 Allowed Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.674 -0.411 . . . . 4.05 110.098 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.655 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.84 152.32 82.58 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.791 2.327 . . . . 2.12 111.426 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.67 42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.413 0.625 . . . . 2.85 110.606 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.822 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.63 -41.67 98.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.976 -1.011 . . . . 3.11 110.632 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.443 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.7 mt -109.83 137.81 40.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.821 -0.627 . . . . 1.86 111.343 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.9 -72.94 0.7 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.109 -0.496 . . . . 1.61 111.938 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.12 148.4 24.46 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.623 0.601 . . . . 1.67 112.623 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.81 124.82 45.07 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.424 -0.584 . . . . 1.07 109.424 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.07 134.73 60.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.626 -0.43 . . . . 1.55 110.625 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.488 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -120.0 128.66 53.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.054 0.454 . . . . 1.33 111.241 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 138.96 49.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.779 -0.646 . . . . 2.36 110.141 178.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.418 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.01 163.18 35.01 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.125 0.488 . . . . 0.38 112.119 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.489 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.47 139.59 7.87 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 115.484 -0.78 . . . . 2.31 110.506 178.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.684 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.8 Cg_endo -63.55 115.46 3.06 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.33 2.02 . . . . 0.86 111.784 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.674 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.96 81.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.891 -0.411 . . . . 3.44 109.891 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.23 -20.67 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.998 -0.546 . . . . 2.72 111.906 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -157.66 157.82 34.3 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.78 -0.368 . . . . 2.78 110.465 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.42 27.85 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 2.3 110.151 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -75.88 1.31 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.122 -0.561 . . . . 1.8 111.812 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.93 152.34 35.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.984 0.421 . . . . 5.48 110.995 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.12 2.53 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.992 -0.549 . . . . 1.84 111.886 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.17 149.63 29.81 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.457 0.646 . . . . 2.27 112.565 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.97 156.46 46.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.781 -1.099 . . . . 1.92 110.285 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.21 158.43 41.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.967 -0.56 . . . . 1.09 111.776 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.6 m -115.24 135.6 53.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.422 -0.808 . . . . 1.16 109.79 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.445 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.45 121.98 23.71 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.418 -0.355 . . . . 1.39 111.568 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.51 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.5 Cg_exo -46.27 151.75 1.58 Allowed 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.624 2.216 . . . . 0.72 112.121 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.96 -22.98 63.11 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 116.029 -0.532 . . . . 0.74 112.81 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.51 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.8 -16.9 45.99 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 120.244 -0.582 . . . . 1.26 111.804 -178.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.49 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.57 138.39 31.61 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.707 -0.397 . . . . 1.59 110.329 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -121.46 13.96 11.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.391 -0.368 . . . . 2.07 111.569 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.475 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.0 143.48 25.21 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.648 -0.421 . . . . 0.96 111.064 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.716 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.9 t80 -114.84 -169.3 1.52 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.864 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.716 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.76 125.95 9.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.422 -0.808 . . . . 1.19 109.818 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.477 HG23 HD11 ' A' ' 60' ' ' ILE . 66.9 mt -114.96 123.27 70.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.346 -0.542 . . . . 1.47 111.166 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -126.47 163.4 23.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.807 -0.633 . . . . 3.0 110.498 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.18 18.94 59.88 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.714 -0.954 . . . . 0.5 110.714 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.434 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.9 mt -79.06 157.27 28.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.065 0.46 . . . . 1.21 111.326 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.664 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -99.55 134.01 21.45 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.608 -0.723 . . . . 3.2 110.399 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.98 143.54 60.71 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.519 2.146 . . . . 1.09 111.944 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.0 25.57 75.43 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.997 -0.841 . . . . 0.72 110.997 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.643 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.19 158.8 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.72 0.295 . . . . 1.47 110.43 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.15 139.9 42.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.884 0.373 . . . . 1.23 110.583 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.664 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.6 m-85 -122.54 136.49 54.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.923 -0.581 . . . . 1.1 110.69 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.489 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.3 pt-20 -98.89 131.04 45.28 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.545 -0.909 . . . . 1.87 108.545 177.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.46 153.9 16.64 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.326 -0.94 . . . . 0.39 111.969 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.0 140.93 46.05 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.675 -0.491 . . . . 1.8 109.675 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.466 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.0 tp -115.76 118.87 34.24 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.474 -0.49 . . . . 1.11 110.468 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.43 129.08 68.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.388 . . . . 1.51 110.68 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.79 120.79 43.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.27 -0.423 . . . . 1.47 110.732 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.667 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.5 146.42 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.115 0.483 . . . . 1.33 111.082 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.822 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.02 153.85 21.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.496 -0.775 . . . . 2.49 109.89 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.1 88.55 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.88 0.372 . . . . 4.2 110.43 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.622 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.25 32.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.829 -0.623 . . . . 6.4 110.614 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.1 -117.37 3.29 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.447 -0.661 . . . . 1.74 111.447 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.449 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.37 177.43 8.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.222 0.534 . . . . 3.64 111.601 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.18 149.49 32.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.405 -0.816 . . . . 1.7 110.41 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.13 144.68 38.76 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.467 -0.333 . . . . 2.7 110.6 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -128.0 136.01 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.05 0.453 . . . . 1.16 111.555 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.09 141.33 52.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.681 -0.691 . . . . 1.14 110.279 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.449 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.63 138.86 51.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.126 0.489 . . . . 4.33 111.501 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.25 164.19 37.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.564 -0.744 . . . . 0.91 109.471 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.571 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.31 151.49 38.4 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.422 -0.511 . . . . 1.47 111.042 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.574 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.7 p90 -146.18 172.7 13.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.788 -0.642 . . . . 0.51 111.017 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.449 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.69 160.65 21.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.455 -0.793 . . . . 1.92 109.897 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.449 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.42 121.8 22.8 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.653 -0.419 . . . . 1.63 110.816 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.1 p -128.33 146.42 50.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.048 -0.524 . . . . 2.37 111.858 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.567 ' O ' ' CG2' ' A' ' 94' ' ' THR . 23.1 t -66.79 -36.95 83.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.798 -0.637 . . . . 3.63 109.974 176.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.567 ' CG2' ' O ' ' A' ' 93' ' ' SER . 1.3 p 144.35 -123.56 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.4 t -117.64 138.45 51.96 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.556 ' O ' ' OG1' ' A' ' 99' ' ' THR . 11.4 p -139.12 156.93 72.02 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-O 120.752 0.31 . . . . 0.0 111.37 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.439 ' C ' ' H ' ' A' ' 99' ' ' THR . 31.0 Cg_endo -62.28 154.19 65.05 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.87 2.38 . . . . 0.0 112.063 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.6 t 61.05 -0.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.973 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.556 ' OG1' ' O ' ' A' ' 96' ' ' THR . 63.8 m -56.95 -36.79 70.67 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.086 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.8 p -66.58 163.24 19.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.161 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -99.06 141.95 31.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.939 0.4 . . . . 0.0 110.919 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.6 p -83.03 162.66 21.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.436 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.5 t -115.7 135.49 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.706 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 48.5 m -79.51 139.11 37.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.003 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -160.15 -173.23 28.41 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.586 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -66.14 -16.11 63.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.526 -0.337 . . . . 0.0 111.257 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.3 m -68.28 137.66 54.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.941 0.401 . . . . 0.0 110.424 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 91.5 m -122.44 85.48 48.0 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.738 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.23 150.99 18.25 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.52 2.147 . . . . 0.0 111.98 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -67.15 147.98 52.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.927 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 58.3 p -123.6 82.05 54.11 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.737 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 113' ' ' LEU . 50.0 Cg_exo -52.09 150.42 18.95 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.653 2.235 . . . . 0.0 112.149 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 112' ' ' PRO . 8.2 mp 57.16 151.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.963 -0.562 . . . . 10.52 110.452 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 115' ' ' ALA . 41.5 t -114.61 135.6 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 115.921 -0.581 . . . . 7.48 110.848 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 114' ' ' VAL . . . 43.64 -175.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.825 -0.625 . . . . 7.69 111.585 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.4 m -122.93 142.91 50.29 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.681 -0.691 . . . . 6.46 110.499 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.5 m -60.93 156.48 17.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 4.59 110.39 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.53 -34.59 67.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.295 -0.412 . . . . 3.21 110.481 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 28.4 t -120.47 140.96 50.65 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.857 0.36 . . . . 3.64 110.421 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.3 m -129.96 159.61 41.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.998 -0.546 . . . . 3.39 110.485 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 22.5 p -119.81 160.91 21.7 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.305 -0.407 . . . . 2.23 110.246 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -103.6 -134.44 0.32 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.012 -0.54 . . . . 4.53 111.141 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.455 ' CG2' ' O ' ' A' ' 172' ' ' LEU . 66.6 mt -111.07 143.53 20.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.974 -0.557 . . . . 2.01 110.123 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.6 t -131.99 156.1 46.82 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.292 0.568 . . . . 2.22 111.672 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.576 ' C ' ' H ' ' A' ' 127' ' ' SER . . . 32.17 -124.18 0.06 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.171 -0.922 . . . . 1.29 112.725 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 4.6 p 48.33 4.78 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.597 -0.729 . . . . 1.25 111.988 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.576 ' H ' ' C ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.9 167.6 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.097 0.475 . . . . 1.16 110.932 179.474 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.62 145.56 50.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.704 -0.68 . . . . 0.78 110.123 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.26 101.66 9.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.063 -0.717 . . . . 1.08 109.063 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.462 HG11 ' N ' ' A' ' 131' ' ' SER . 71.7 t -112.93 139.69 36.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.026 -0.534 . . . . 1.1 111.109 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.462 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.2 p -128.66 152.47 48.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.7 -0.682 . . . . 0.87 109.929 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.647 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.6 p90 -144.8 -165.01 2.05 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.692 -0.403 . . . . 0.37 110.569 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -123.95 127.17 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 1.14 110.809 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.176 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.97 58.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.126 -0.488 . . . . 1.91 110.31 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.21 24.57 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.892 -0.595 . . . . 1.56 111.52 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.176 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.11 128.76 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.638 -0.425 . . . . 1.56 110.919 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.5 -9.51 56.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.883 -0.599 . . . . 1.88 110.289 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.16 0.25 55.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.14 -0.482 . . . . 1.63 110.289 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.958 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.21 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 1.11 109.899 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 185' ' ' ILE . 94.2 p -96.28 -15.47 21.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.259 0.552 . . . . 1.01 110.056 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.54 175.6 45.76 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.887 -1.285 . . . . 0.14 109.887 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -123.48 151.57 42.61 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.69 -0.404 . . . . 0.21 110.509 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.646 ' NE ' ' HG2' ' A' ' 15' ' ' PRO . 73.0 ttt-85 -132.34 121.22 23.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.136 -0.484 . . . . 1.54 109.881 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.494 HG23 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.15 136.51 38.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.664 -0.698 . . . . 1.08 110.707 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 79.5 tt0 -129.29 129.95 45.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.038 -0.528 . . . . 1.32 110.057 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.9 p90 -138.79 135.31 34.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.985 -0.552 . . . . 1.05 110.567 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.415 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.28 39.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.762 -0.654 . . . . 1.16 109.733 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.939 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -70.99 124.87 25.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.978 0.418 . . . . 1.23 110.713 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.499 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.76 -7.7 49.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.687 -0.688 . . . . 0.86 110.891 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.85 -69.69 0.85 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 1.66 111.343 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.451 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.7 -35.35 76.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.017 -0.538 . . . . 1.66 111.492 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.093 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.19 7.25 88.58 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.806 -0.918 . . . . 1.62 110.806 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.318 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.99 -171.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.779 0.323 . . . . 1.86 110.275 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.318 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.32 139.09 44.95 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.947 0.403 . . . . 1.98 110.187 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.415 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.1 Cg_endo -70.81 145.75 51.91 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 122.725 2.284 . . . . 0.62 112.31 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.85 145.71 42.62 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.195 -0.669 . . . . 1.14 109.195 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.531 ' HH ' ' CE ' ' A' ' 64' ' ' LYS . 6.2 p90 -123.21 141.36 52.06 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.378 -0.529 . . . . 1.44 111.573 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.7 mt -128.1 127.67 43.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.338 -0.846 . . . . 1.08 108.952 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 52.4 t0 -101.63 131.22 47.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.172 0.511 . . . . 1.09 111.763 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.506 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -127.97 157.57 73.44 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.317 -0.856 . . . . 1.04 109.566 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.75 158.04 58.34 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.439 2.093 . . . . 0.21 112.262 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.3 -12.18 5.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.842 -0.617 . . . . 0.88 110.725 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.4 p -92.81 -8.74 42.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 1.06 110.711 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.42 34.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.378 -0.374 . . . . 1.05 110.391 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.19 16.66 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.354 -0.385 . . . . 1.07 110.491 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.0 p -167.53 147.18 5.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.644 -0.502 . . . . 0.92 109.644 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.506 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.19 150.39 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.538 -0.465 . . . . 1.09 111.576 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.497 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.28 124.94 50.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.624 -0.716 . . . . 1.31 109.809 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.515 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.37 104.88 29.57 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.924 0.392 . . . . 1.09 111.105 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.5 Cg_endo -90.94 -179.54 1.52 Allowed 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 123.197 2.598 . . . . 0.48 112.243 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.72 32.63 18.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.394 -0.821 . . . . 1.26 111.417 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.515 HD21 HG21 ' A' ' 169' ' ' ILE . 24.4 mt -86.33 148.51 25.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.496 -0.32 . . . . 1.12 110.521 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.767 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.24 114.82 61.1 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.912 0.387 . . . . 1.3 110.696 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.0 140.53 95.76 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.858 2.372 . . . . 0.92 112.014 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.16 21.2 74.1 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.009 -0.837 . . . . 0.44 111.009 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.451 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.81 150.12 49.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.732 0.301 . . . . 3.05 110.688 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.499 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.14 131.59 46.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 1.48 109.833 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.939 ' CE2' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.48 148.28 44.03 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.143 -0.48 . . . . 0.89 111.038 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.3 mt -105.33 125.29 60.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.27 -1.011 . . . . 1.12 108.27 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.5 132.47 63.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.183 0.516 . . . . 1.1 111.274 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.9 m-20 -136.46 122.59 20.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.532 -0.758 . . . . 0.43 109.636 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.596 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.03 125.39 54.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.187 -0.46 . . . . 1.07 110.665 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.671 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.9 m-85 -117.25 137.97 52.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.007 -0.542 . . . . 0.92 109.835 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.76 135.07 42.78 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.786 -0.82 . . . . 0.49 108.786 178.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 140' ' ' SER . 85.3 mt -99.09 122.92 51.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.07 0.462 . . . . 1.08 110.96 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.449 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.5 p -83.79 169.7 14.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.534 -0.757 . . . . 0.89 110.484 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.83 -14.51 15.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.04 -0.527 . . . . 1.6 110.934 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.505 ' C ' ' OG1' ' A' ' 59' ' ' THR . 79.2 m-20 -96.1 -4.29 43.12 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.833 -0.347 . . . . 1.18 110.825 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.516 ' N ' ' HG1' ' A' ' 59' ' ' THR . . . 87.78 13.89 64.02 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.379 -0.689 . . . . 0.34 111.379 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -84.62 139.05 32.34 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.058 -0.257 . . . . 1.22 110.518 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -106.76 141.11 38.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.903 0.382 . . . . 1.44 110.513 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.6 m -136.72 126.97 26.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 1.39 110.36 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.671 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.5 tp -68.06 117.25 9.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.329 -0.396 . . . . 1.08 110.528 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.647 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.1 pt -109.03 -21.84 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 1.08 110.712 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.87 125.79 5.9 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.514 -0.475 . . . . 1.1 111.485 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.487 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.75 120.24 21.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.79 -0.641 . . . . 0.94 109.578 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.71 29.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.955 0.407 . . . . 1.07 110.927 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.47 158.66 18.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.052 -0.522 . . . . 0.89 110.413 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.09 157.96 43.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.03 -0.532 . . . . 0.67 110.659 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 104.26 9.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.721 -0.672 . . . . 1.17 110.047 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.477 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 66.6 p . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.876 -1.059 . . . . 1.26 110.665 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.197 -0.668 . . . . 3.83 109.197 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.72 18.54 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.049 -0.821 . . . . 1.39 111.049 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.73 142.41 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.09 0 C-N-CA 123.94 3.093 . . . . 0.86 113.748 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.572 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.0 t -79.93 173.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.205 -1.361 . . . . 1.43 108.83 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.64 125.89 51.51 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.482 -0.487 . . . . 1.94 111.409 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 p -136.52 143.99 33.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.573 -0.74 . . . . 1.19 110.622 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.06 168.25 25.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.936 0.398 . . . . 3.92 111.072 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.587 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.4 mt -108.87 131.1 60.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.019 -0.537 . . . . 3.88 110.155 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.21 162.32 35.77 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.931 0.396 . . . . 3.92 111.149 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.1 mt-10 36.06 31.68 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.559 -0.534 . . . . 6.08 109.559 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.587 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.53 69.63 33.56 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.939 -0.573 . . . . 4.01 111.533 -178.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.28 -29.09 72.75 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.501 2.134 . . . . 4.51 111.881 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.64 125.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 3.51 110.477 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.701 HE22 ' CD ' ' A' ' 191' ' ' GLN . 18.7 mm-40 -123.9 158.33 60.37 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 4.3 110.462 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.54 ' CG ' ' NE ' ' A' ' 143' ' ' ARG . 98.8 Cg_endo -82.08 -64.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.901 2.401 . . . . 1.96 113.494 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.673 ' OD1' ' O ' ' A' ' 63' ' ' LEU . 51.6 t30 -108.43 -19.56 13.41 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.119 0.415 . . . . 3.33 112.119 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 1.3 p -107.27 152.03 24.66 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.499 -0.48 . . . . 1.53 111.346 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.28 102.88 2.23 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.737 -0.665 . . . . 2.29 110.689 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.57 145.63 13.19 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.914 2.409 . . . . 0.88 112.639 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.411 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.8 167.98 24.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.808 -0.633 . . . . 2.12 109.924 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.16 147.93 29.03 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.74 -0.467 . . . . 2.67 109.74 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.499 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.4 p90 -142.3 157.3 44.97 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.624 -0.43 . . . . 0.32 111.212 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.462 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.9 m-20 -128.04 155.22 44.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.831 -0.622 . . . . 2.77 110.187 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.62 172.99 6.42 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.097 0.475 . . . . 1.25 110.743 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.54 173.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.885 2.39 . . . . 1.12 111.513 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.01 -51.15 0.69 Allowed Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.746 -0.381 . . . . 4.05 110.093 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.651 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.8 Cg_exo -64.89 152.4 82.38 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.743 2.295 . . . . 2.12 111.423 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.68 42.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.423 0.63 . . . . 2.85 110.587 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.815 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.59 -41.65 98.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.011 -0.995 . . . . 3.11 110.671 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.438 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.2 mt -109.92 137.87 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.783 -0.644 . . . . 1.86 111.251 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.95 -72.92 0.7 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.025 -0.534 . . . . 1.61 111.856 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.15 148.4 24.44 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.557 0.577 . . . . 1.67 112.557 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.8 124.87 45.19 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.41 -0.589 . . . . 1.07 109.41 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.8 mt -118.15 134.8 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.618 -0.433 . . . . 1.55 110.553 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.487 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -120.09 128.66 53.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.071 0.462 . . . . 1.33 111.149 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.547 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.14 139.01 49.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.656 -0.702 . . . . 2.36 110.097 178.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.416 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -145.09 163.19 35.06 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.076 0.465 . . . . 0.38 112.108 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.488 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.49 139.58 7.85 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 115.453 -0.794 . . . . 2.31 110.437 178.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.57 115.46 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.316 2.011 . . . . 0.86 111.784 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.672 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.9 81.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.94 -0.392 . . . . 3.44 109.94 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.14 -20.64 0.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.998 -0.547 . . . . 2.72 111.946 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.56 157.77 34.37 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.815 -0.354 . . . . 2.78 110.559 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.39 27.88 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.23 -0.441 . . . . 2.3 110.17 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.87 -75.9 1.31 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.825 -0.51 . . . . 1.8 111.825 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.89 152.26 35.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.871 0.367 . . . . 5.48 111.051 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.676 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.21 -169.16 2.54 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.077 -0.511 . . . . 1.84 111.925 179.417 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.412 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.11 149.69 29.68 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.409 0.623 . . . . 2.27 112.557 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.08 156.47 45.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.82 -1.082 . . . . 1.92 110.262 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.26 158.33 41.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.938 -0.574 . . . . 1.09 111.791 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 m -115.13 135.67 53.94 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.368 -0.833 . . . . 1.16 109.86 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.443 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.44 121.9 23.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.444 -0.344 . . . . 1.39 111.555 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.2 Cg_exo -46.3 151.74 1.61 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.634 2.223 . . . . 0.72 112.2 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.02 -22.95 63.2 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 116.157 -0.474 . . . . 0.74 112.808 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.515 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.77 -16.88 46.2 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.21 -0.596 . . . . 1.26 111.787 -178.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.488 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.5 mt -91.54 138.46 31.56 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.83 -0.348 . . . . 1.59 110.271 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -121.58 13.93 10.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.362 -0.381 . . . . 2.07 111.548 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.93 143.49 25.28 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.626 -0.43 . . . . 0.96 111.08 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.713 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.85 -169.35 1.53 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.212 0.53 . . . . 1.0 110.829 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.713 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 84.9 m -151.75 125.95 9.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.334 -0.848 . . . . 1.19 109.832 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.432 HD11 HG23 ' A' ' 60' ' ' ILE . 66.6 mt -114.82 123.19 70.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.428 -0.509 . . . . 1.47 111.28 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.576 ' CE ' HG13 ' A' ' 185' ' ' ILE . 8.6 mmtt -126.44 163.31 23.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.906 -0.588 . . . . 3.0 110.482 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.581 ' HA2' HD22 ' A' ' 16' ' ' ASN . . . 85.14 19.06 59.71 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.678 -0.969 . . . . 0.5 110.678 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.673 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 73.9 mt -79.09 157.25 28.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.053 0.454 . . . . 1.21 111.339 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.742 ' HZ3' ' HH ' ' A' ' 157' ' ' TYR . 0.0 OUTLIER -99.45 133.9 21.59 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.568 -0.742 . . . . 3.2 110.491 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.82 143.55 61.68 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.54 2.16 . . . . 1.09 112.029 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.77 25.66 75.3 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.033 -0.827 . . . . 0.72 111.033 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.638 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.13 158.86 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.684 0.278 . . . . 1.47 110.466 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.21 139.96 42.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.967 0.413 . . . . 1.23 110.495 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.638 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.58 136.46 54.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.863 -0.608 . . . . 1.1 110.74 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.95 131.09 45.28 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.541 -0.911 . . . . 1.87 108.541 177.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.487 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.57 153.91 16.67 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.201 -0.999 . . . . 0.39 111.947 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -134.97 140.89 46.05 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.681 -0.489 . . . . 1.8 109.681 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.465 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.0 tp -115.73 118.97 34.53 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.418 -0.513 . . . . 1.11 110.503 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.2 mt -112.45 129.12 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.287 -0.415 . . . . 1.51 110.592 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.9 120.88 43.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.253 -0.43 . . . . 1.47 110.715 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.671 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.69 146.57 11.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.292 0.568 . . . . 1.33 110.921 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.815 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.12 153.88 21.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.513 -0.767 . . . . 2.49 109.941 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.21 88.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.963 0.411 . . . . 4.2 110.371 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.62 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.38 32.45 0.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.784 -0.644 . . . . 6.4 110.577 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.01 -117.39 3.3 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.452 -0.659 . . . . 1.74 111.452 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.448 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.41 177.47 8.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.252 0.548 . . . . 3.64 111.58 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.22 149.47 31.98 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.373 -0.83 . . . . 1.7 110.312 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.15 144.7 38.73 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.463 -0.335 . . . . 2.7 110.528 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -128.03 136.0 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 121.041 0.448 . . . . 1.16 111.538 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.05 141.37 52.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.687 -0.688 . . . . 1.14 110.292 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.449 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.67 138.81 51.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.128 0.49 . . . . 4.33 111.479 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.487 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.19 164.25 37.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.527 -0.761 . . . . 0.91 109.494 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.574 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.33 151.49 38.4 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.442 -0.503 . . . . 1.47 111.075 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.8 p90 -146.15 172.72 13.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.724 -0.671 . . . . 0.51 111.04 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.45 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.67 160.69 21.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.431 -0.804 . . . . 1.92 109.843 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.45 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.4 121.85 22.89 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.573 -0.451 . . . . 1.63 110.752 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.5 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.6 p -126.6 161.34 28.25 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 114.003 1.112 . . . . 2.37 114.003 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.408 ' C ' ' H ' ' A' ' 95' ' ' SER . 25.8 t -131.1 153.1 49.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 113.272 -1.786 . . . . 3.63 108.886 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 61.0 p -60.93 -10.51 5.84 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 93' ' ' SER . 51.5 p -69.0 163.02 25.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.251 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.98 164.93 14.84 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.629 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.42 145.82 35.18 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.137 1.891 . . . . 0.0 112.113 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 100' ' ' SER . 40.8 t -114.1 135.26 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.293 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.1 p -66.64 -28.39 68.44 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.201 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.49 ' H ' HG12 ' A' ' 98' ' ' VAL . 26.9 m 50.27 -144.71 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 110.771 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.29 45.19 14.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.011 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 48.1 m -86.16 139.21 31.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.249 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.5 p -130.56 142.38 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.817 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.2 m -123.67 141.99 51.49 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.228 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.96 10.09 61.68 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -56.66 -33.12 66.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.621 0.248 . . . . 0.0 110.492 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.5 p -120.85 162.32 20.02 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.681 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.4 m -126.16 79.66 69.41 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.487 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.69 145.62 48.12 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.473 2.115 . . . . 0.0 112.409 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -99.07 135.7 40.09 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.77 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.0 m -113.75 94.36 32.7 Favored Pre-proline 0 N--CA 1.468 0.427 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.227 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.41 -15.53 45.88 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.383 2.055 . . . . 0.0 111.773 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 27.8 tp -54.57 -37.29 65.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.854 -0.612 . . . . 10.52 111.028 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.0 m -127.13 153.06 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.076 0.465 . . . . 7.48 111.512 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.76 -32.34 73.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.624 -0.716 . . . . 7.69 111.727 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.7 m -119.94 140.44 50.89 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.991 0.424 . . . . 6.46 110.814 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.4 m -63.06 154.35 31.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.544 . . . . 4.59 110.853 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -110.81 159.92 17.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.616 -0.72 . . . . 3.21 110.149 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 54.2 p -65.51 162.21 18.5 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.503 -0.554 . . . . 3.64 109.503 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 43.4 t -113.18 134.5 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 121.181 0.515 . . . . 3.39 111.488 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.1 p -123.47 162.98 21.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.347 -0.842 . . . . 2.23 109.178 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.87 140.72 51.28 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.947 -0.701 . . . . 4.53 109.832 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.4 tp -125.45 140.36 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.257 -0.429 . . . . 2.01 111.083 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 17.8 p -122.14 159.52 27.01 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.03 -0.532 . . . . 2.22 109.695 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 127' ' ' SER . . . -148.24 155.58 41.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.547 -0.297 . . . . 1.29 110.862 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 41.03 19.64 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.19 0.519 . . . . 1.25 111.418 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.85 167.57 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.525 -0.761 . . . . 1.16 110.984 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.489 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.9 m-30 -133.64 145.5 50.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.733 -0.667 . . . . 0.78 110.081 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.23 101.67 9.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.124 -0.695 . . . . 1.08 109.124 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.465 HG11 ' N ' ' A' ' 131' ' ' SER . 71.4 t -112.95 139.7 36.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.974 -0.557 . . . . 1.1 111.069 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.465 ' N ' HG11 ' A' ' 130' ' ' VAL . 69.0 p -128.8 152.48 48.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.612 -0.722 . . . . 0.87 109.776 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.641 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.7 p90 -144.71 -164.9 2.02 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.668 -0.413 . . . . 0.37 110.632 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.732 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.4 t -123.97 127.1 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.218 -0.446 . . . . 1.14 110.788 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.157 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.216 -0.447 . . . . 1.91 110.374 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.14 24.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.928 -0.578 . . . . 1.56 111.469 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.157 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.16 128.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.54 -0.464 . . . . 1.56 110.952 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.39 -9.59 56.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.975 -0.557 . . . . 1.88 110.249 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.18 0.17 55.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.218 -0.446 . . . . 1.63 110.299 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.966 HG11 ' O ' ' A' ' 136' ' ' SER . 2.6 p -65.19 137.17 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.954 -0.566 . . . . 1.11 110.027 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 185' ' ' ILE . 92.5 p -96.14 -15.56 22.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.263 0.554 . . . . 1.01 110.101 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.62 175.58 45.81 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 109.772 -1.331 . . . . 0.14 109.772 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.4 151.59 42.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.971 0.415 . . . . 0.21 110.516 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.558 ' NH2' ' HB3' ' A' ' 157' ' ' TYR . 78.1 ttt-85 -132.42 121.17 23.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.103 -0.499 . . . . 1.54 109.964 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.48 HG23 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.14 136.56 38.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.708 -0.678 . . . . 1.08 110.684 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 84.1 tt0 -129.34 129.8 45.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.961 -0.563 . . . . 1.32 110.085 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.59 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.64 135.24 34.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.033 -0.53 . . . . 1.05 110.703 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.401 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.25 161.3 39.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.865 -0.607 . . . . 1.16 109.763 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.931 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -71.0 124.89 25.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.006 0.432 . . . . 1.23 110.763 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.87 -7.66 49.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.816 -0.629 . . . . 0.86 110.84 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -109.79 -69.67 0.85 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.01 0.433 . . . . 1.66 111.514 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.44 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.3 mt-10 -60.76 -35.22 75.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.033 -0.53 . . . . 1.66 111.51 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.094 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.07 7.27 88.56 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.804 -0.919 . . . . 1.62 110.804 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.323 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.9 t0 -27.95 -171.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.761 0.315 . . . . 1.86 110.314 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.323 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.2 pm0 -82.27 139.11 45.11 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.044 0.449 . . . . 1.98 110.226 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.401 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.94 145.87 51.46 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.726 2.284 . . . . 0.62 112.32 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.81 145.7 42.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.217 -0.66 . . . . 1.14 109.217 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.742 ' HH ' ' HZ3' ' A' ' 64' ' ' LYS . 4.0 p90 -123.31 141.32 52.11 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.349 -0.54 . . . . 1.44 111.537 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.429 ' HA ' HD22 ' A' ' 158' ' ' LEU . 71.4 mt -128.05 127.66 43.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.239 -0.892 . . . . 1.08 108.932 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.671 ' OD2' ' ND2' ' A' ' 16' ' ' ASN . 63.3 t0 -101.49 131.12 47.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.135 0.493 . . . . 1.09 111.879 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.516 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -127.93 157.57 73.34 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.358 -0.837 . . . . 1.04 109.566 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.83 157.98 58.41 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.492 2.128 . . . . 0.21 112.311 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.22 -12.16 4.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.855 -0.611 . . . . 0.88 110.822 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.5 p -92.77 -8.69 42.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.058 -0.519 . . . . 1.06 110.734 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.2 135.39 34.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.413 . . . . 1.05 110.357 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.16 16.68 4.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.439 -0.346 . . . . 1.07 110.504 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.1 p -167.59 147.13 5.04 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.63 -0.507 . . . . 0.92 109.63 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.516 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.1 p -152.21 150.61 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 1.09 111.525 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.37 124.9 50.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.559 -0.746 . . . . 1.31 109.789 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.526 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.28 104.87 29.22 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.424 -0.353 . . . . 1.09 111.088 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.0 Cg_endo -91.0 -179.5 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 123.235 2.624 . . . . 0.48 112.251 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.71 32.58 18.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.413 -0.812 . . . . 1.26 111.438 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.526 HD21 HG21 ' A' ' 169' ' ' ILE . 24.0 mt -86.35 148.5 25.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.772 0.32 . . . . 1.12 110.486 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.763 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.3 114.83 61.22 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.075 0.464 . . . . 1.3 110.704 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.01 140.57 95.94 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.821 2.348 . . . . 0.92 112.04 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.17 74.42 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.101 -0.8 . . . . 0.44 111.101 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.44 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.84 150.23 49.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.896 0.379 . . . . 3.05 110.598 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.491 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.1 tttt -100.14 131.75 45.91 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.997 -0.547 . . . . 1.48 109.799 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.931 ' CE2' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.62 148.26 44.13 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.114 -0.494 . . . . 0.89 110.992 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.2 mt -105.32 125.37 60.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.298 -1.001 . . . . 1.12 108.298 177.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.5 132.57 63.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.154 0.502 . . . . 1.1 111.305 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.57 122.58 20.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.494 -0.775 . . . . 0.43 109.537 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.583 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.0 125.33 54.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.227 -0.442 . . . . 1.07 110.739 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.662 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.3 m-85 -117.21 137.76 52.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.064 -0.516 . . . . 0.92 109.926 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.565 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.66 134.96 42.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.805 -0.813 . . . . 0.49 108.805 178.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.576 HG13 ' CE ' ' A' ' 61' ' ' LYS . 7.7 mm -99.11 122.91 51.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.177 0.513 . . . . 1.08 110.922 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.452 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.6 p -83.76 169.74 14.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.533 -0.758 . . . . 0.89 110.494 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.706 ' O ' ' OG1' ' A' ' 59' ' ' THR . 97.5 mt-10 -59.74 -14.59 15.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.011 -0.541 . . . . 1.6 111.028 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.452 ' H ' ' HG ' ' A' ' 186' ' ' SER . 96.1 m-20 -96.12 -4.22 43.16 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.804 -0.358 . . . . 1.18 110.792 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.79 13.85 64.07 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.388 -0.685 . . . . 0.34 111.388 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -84.58 139.01 32.4 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.107 -0.237 . . . . 1.22 110.506 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.701 ' CD ' HE22 ' A' ' 14' ' ' GLN . 11.8 mt-30 -106.68 141.09 38.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.815 0.34 . . . . 1.44 110.584 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.1 m -136.71 126.93 26.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 1.39 110.359 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.662 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.6 tp -68.07 117.3 9.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.278 -0.419 . . . . 1.08 110.551 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.641 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -109.05 -21.7 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 1.08 110.764 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.91 125.69 5.84 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.542 -0.463 . . . . 1.1 111.459 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.497 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.8 120.28 21.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.726 -0.67 . . . . 0.94 109.517 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.63 151.62 29.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.917 0.389 . . . . 1.07 110.984 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.43 158.5 18.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.049 -0.523 . . . . 0.89 110.464 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -145.97 157.93 43.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.235 -0.439 . . . . 0.67 110.768 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 104.54 9.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.784 -0.644 . . . . 1.17 109.972 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.489 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 68.1 p . . . . . 0 C--O 1.219 -0.534 0 CA-C-O 117.882 -1.056 . . . . 1.26 110.617 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.6 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.199 -0.667 . . . . 3.83 109.199 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.38 150.7 18.54 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.024 -0.83 . . . . 1.39 111.024 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -35.66 142.4 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.101 0 C-N-CA 124.025 3.15 . . . . 0.86 113.742 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.562 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -79.97 173.32 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.29 -1.323 . . . . 1.43 108.769 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.55 125.93 51.55 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.411 -0.516 . . . . 1.94 111.44 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.55 143.95 34.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.618 -0.719 . . . . 1.19 110.622 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.05 168.31 25.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.931 0.396 . . . . 3.92 111.12 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.577 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -108.98 131.06 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.957 -0.565 . . . . 3.88 110.076 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.2 162.31 35.79 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.954 0.407 . . . . 3.92 111.194 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 10' ' ' GLU . 73.1 tt0 36.14 31.53 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.637 -0.505 . . . . 6.08 109.637 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.577 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.42 69.58 32.41 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.958 -0.564 . . . . 4.01 111.621 -178.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.29 -29.09 72.62 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.529 2.153 . . . . 4.51 111.802 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.52 125.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 3.51 110.548 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.529 ' CB ' ' O ' ' A' ' 17' ' ' SER . 11.7 mt-30 -123.89 158.34 60.33 Favored Pre-proline 0 C--O 1.234 0.26 0 CA-C-N 116.241 -0.436 . . . . 4.3 110.537 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.486 ' CG ' ' NH1' ' A' ' 143' ' ' ARG . 98.3 Cg_endo -82.12 -64.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.931 2.42 . . . . 1.96 113.457 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.627 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 61.9 t30 -108.4 -19.5 13.44 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.114 0.413 . . . . 3.33 112.114 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.554 ' HG ' ' N ' ' A' ' 18' ' ' HIS . 29.7 t -107.31 152.1 24.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.148 0.499 . . . . 1.53 111.339 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.578 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.24 102.92 2.23 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.687 -0.688 . . . . 2.29 110.61 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.72 145.64 12.95 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.888 2.392 . . . . 0.88 112.568 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.411 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.81 167.98 24.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.896 -0.593 . . . . 2.12 109.961 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.23 147.89 28.94 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.776 -0.453 . . . . 2.67 109.776 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.506 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.4 p90 -142.24 157.29 45.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.017 0.437 . . . . 0.32 111.196 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.465 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.04 155.26 44.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.715 -0.675 . . . . 2.77 110.064 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.6 173.05 6.34 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 121.111 0.481 . . . . 1.25 110.728 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.69 173.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.779 2.319 . . . . 1.12 111.533 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.484 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.1 -51.03 0.69 Allowed Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 120.694 -0.402 . . . . 4.05 110.111 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.654 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.81 152.32 82.52 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.737 2.291 . . . . 2.12 111.483 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.64 42.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.332 0.587 . . . . 2.85 110.564 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.814 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.65 -41.55 98.21 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.953 -1.021 . . . . 3.11 110.722 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.451 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.1 mt -109.87 137.89 40.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.842 -0.617 . . . . 1.86 111.276 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.93 -72.95 0.7 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.063 -0.517 . . . . 1.61 111.911 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.09 148.28 24.54 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.593 0.59 . . . . 1.67 112.593 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.81 124.94 45.36 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.324 -0.621 . . . . 1.07 109.324 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.03 134.75 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.619 -0.433 . . . . 1.55 110.705 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.488 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -119.99 128.59 53.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.998 0.428 . . . . 1.33 111.281 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.541 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.06 138.95 49.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.741 -0.663 . . . . 2.36 110.14 179.008 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.418 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.2 p90 -145.08 163.14 35.2 Favored 'General case' 0 C--N 1.335 -0.065 0 CA-C-O 121.197 0.523 . . . . 0.38 112.036 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.488 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.48 139.63 7.89 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.38 -0.827 . . . . 2.31 110.482 178.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.63 115.47 3.07 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.392 2.061 . . . . 0.86 111.767 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.684 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.0 81.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.927 -0.397 . . . . 3.44 109.927 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.931 -0.577 . . . . 2.72 111.943 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.2 p -157.59 157.8 34.37 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.865 -0.334 . . . . 2.78 110.577 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.401 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.4 m -120.38 27.8 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 2.3 110.213 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.7 -75.9 1.31 Allowed Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.11 -0.566 . . . . 1.8 111.878 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.88 152.29 35.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.411 . . . . 5.48 110.949 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.665 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.18 -169.07 2.52 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.032 -0.531 . . . . 1.84 111.96 179.343 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.411 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.77 29.59 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 121.48 0.657 . . . . 2.27 112.539 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.15 156.47 45.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.784 -1.098 . . . . 1.92 110.242 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.2 158.35 41.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.931 -0.577 . . . . 1.09 111.841 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.14 135.67 53.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.539 -0.755 . . . . 1.16 109.832 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.45 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.44 121.91 23.71 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.474 -0.33 . . . . 1.39 111.55 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.514 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.4 Cg_exo -46.26 151.7 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.65 2.234 . . . . 0.72 112.124 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.97 -22.97 63.12 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 116.026 -0.533 . . . . 0.74 112.843 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.514 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.82 -16.79 46.39 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.213 -0.595 . . . . 1.26 111.837 -178.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.491 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.3 mt -91.64 138.39 31.6 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.798 -0.361 . . . . 1.59 110.323 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.54 14.01 11.0 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.426 -0.352 . . . . 2.07 111.527 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.07 143.46 25.14 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.671 -0.411 . . . . 0.96 111.075 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.716 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.78 -169.39 1.54 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.888 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.716 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 m -151.69 125.89 9.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.4 -0.818 . . . . 1.19 109.882 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.437 HG23 HD11 ' A' ' 60' ' ' ILE . 66.9 mt -114.88 123.23 70.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.409 -0.516 . . . . 1.47 111.117 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.563 ' HG2' ' N ' ' A' ' 62' ' ' GLY . 37.8 ttpt -126.42 163.38 23.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.824 -0.625 . . . . 3.0 110.49 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.563 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.07 19.04 59.86 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.795 -0.922 . . . . 0.5 110.795 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.627 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.8 mt -79.06 157.17 28.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.043 0.449 . . . . 1.21 111.345 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.594 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 1.5 tttp -99.44 133.93 21.58 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.569 -0.741 . . . . 3.2 110.451 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.46 ' HD3' ' CD1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.84 143.61 61.76 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.505 2.137 . . . . 1.09 112.01 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.75 25.67 75.28 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.071 -0.812 . . . . 0.72 111.071 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.651 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.3 p -128.07 158.74 39.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.715 0.293 . . . . 1.47 110.484 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.11 139.92 42.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.88 0.371 . . . . 1.23 110.581 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.651 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.9 m-85 -122.6 136.51 54.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 1.1 110.764 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.91 131.05 45.28 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.485 -0.932 . . . . 1.87 108.485 177.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.52 153.93 16.65 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.251 -0.976 . . . . 0.39 111.927 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.05 140.89 45.93 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.68 -0.489 . . . . 1.8 109.68 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.471 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.1 tp -115.78 118.88 34.25 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.508 -0.477 . . . . 1.11 110.468 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.9 mt -112.43 129.05 68.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 1.51 110.578 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.84 120.86 43.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.213 -0.449 . . . . 1.47 110.75 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.663 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.63 146.46 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.175 0.512 . . . . 1.33 111.032 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.814 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.0 mt-30 -105.97 153.85 21.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.565 -0.743 . . . . 2.49 110.001 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.2 mt-30 -39.21 88.58 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.92 0.391 . . . . 4.2 110.442 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.23 32.72 0.21 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.77 -0.65 . . . . 6.4 110.558 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.34 3.29 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.499 -0.64 . . . . 1.74 111.499 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.453 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.4 177.4 9.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.244 0.545 . . . . 3.64 111.596 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.15 149.55 32.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.407 -0.815 . . . . 1.7 110.495 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.14 144.65 38.72 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.489 -0.323 . . . . 2.7 110.596 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -128.0 135.94 61.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 121.052 0.453 . . . . 1.16 111.573 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -123.99 141.35 52.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.688 -0.687 . . . . 1.14 110.306 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.466 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.6 138.81 51.69 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.113 0.482 . . . . 4.33 111.528 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.19 164.18 37.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.568 -0.742 . . . . 0.91 109.514 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.561 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.1 p30 -145.29 151.54 38.51 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.351 -0.54 . . . . 1.47 111.008 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.578 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.0 p90 -146.16 172.71 13.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.747 -0.66 . . . . 0.51 111.015 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.444 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.68 160.73 21.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.414 -0.812 . . . . 1.92 109.915 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.444 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.44 121.86 22.86 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.548 -0.461 . . . . 1.63 110.8 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.4 p -128.55 165.39 20.83 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.458 0.91 . . . . 2.37 113.458 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 94' ' ' THR . 76.2 p -127.99 -118.59 0.25 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 113.894 -1.503 . . . . 3.63 107.552 177.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.505 ' N ' ' OG ' ' A' ' 93' ' ' SER . 22.7 p -121.96 158.99 27.86 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.468 ' O ' ' OG1' ' A' ' 96' ' ' THR . 84.0 p -147.86 156.99 43.3 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.506 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 95' ' ' SER . 21.0 m -172.04 62.62 0.33 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.829 178.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 96' ' ' THR . 38.7 Cg_exo -58.87 134.7 61.95 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.321 2.014 . . . . 0.0 113.515 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.81 157.3 42.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.458 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.8 m -81.87 132.66 35.28 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.239 -0.585 . . . . 0.0 109.831 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.8 m -71.96 151.25 43.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.055 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -89.6 4.51 49.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.116 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.2 t -136.65 161.85 34.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.929 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 p -128.82 142.82 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.269 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.6 m -78.94 139.08 38.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -160.29 -176.56 32.52 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -58.7 143.65 46.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.794 0.331 . . . . 0.0 110.673 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.5 p -82.82 162.39 21.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.543 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.9 p -66.14 145.21 98.99 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.375 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.86 145.2 97.63 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.307 2.005 . . . . 0.0 112.52 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -97.76 5.06 49.67 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.593 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.59 160.94 16.1 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.958 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.14 -13.99 5.66 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.939 2.426 . . . . 0.0 112.117 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.0 mt -76.98 147.77 36.67 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.352 -0.61 . . . . 10.52 109.352 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' A' ' 115' ' ' ALA . 26.5 m -58.63 132.59 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.706 -0.398 . . . . 7.48 111.011 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 114' ' ' VAL . . . 149.24 -0.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.312 -0.858 . . . . 7.69 109.25 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.521 HG23 ' H ' ' A' ' 118' ' ' GLU . 38.7 m -79.78 137.64 37.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.864 -0.607 . . . . 6.46 110.657 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 118' ' ' GLU . 87.0 p -62.04 -27.02 68.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 4.59 110.782 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.521 ' H ' HG23 ' A' ' 116' ' ' THR . 84.3 tt0 56.45 125.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 3.21 110.688 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 57.1 p -71.56 160.46 32.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.093 -0.503 . . . . 3.64 110.741 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.491 HG23 ' H ' ' A' ' 122' ' ' GLU . 11.7 p -132.74 145.19 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.989 -0.551 . . . . 3.39 110.157 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 62.1 p -65.77 -10.35 36.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.31 -0.405 . . . . 2.23 111.812 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.491 ' H ' HG23 ' A' ' 120' ' ' VAL . 95.3 mt-10 -98.5 159.08 15.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.724 0.297 . . . . 4.53 110.243 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.8 pt -118.65 156.13 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.144 0.497 . . . . 2.01 111.262 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 8.4 t -123.97 33.16 5.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.381 -0.827 . . . . 2.22 110.709 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 127' ' ' SER . . . -59.91 -30.87 69.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 1.29 111.756 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.481 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.3 OUTLIER 44.46 17.6 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.976 0.893 . . . . 1.25 110.399 -179.257 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.9 167.54 0.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.875 -1.057 . . . . 1.16 110.868 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.488 ' CZ ' HG22 ' A' ' 201' ' ' THR . 8.0 m-30 -133.5 145.52 50.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.664 -0.698 . . . . 0.78 110.16 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.23 101.64 9.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.104 -0.702 . . . . 1.08 109.104 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.469 HG11 ' N ' ' A' ' 131' ' ' SER . 71.0 t -113.02 139.68 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.078 -0.51 . . . . 1.1 111.033 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.469 ' N ' HG11 ' A' ' 130' ' ' VAL . 66.6 p -128.7 152.49 48.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.6 -0.727 . . . . 0.87 109.827 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.649 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.5 p90 -144.72 -164.92 2.02 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.759 -0.376 . . . . 0.37 110.668 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.3 t -123.94 127.21 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 1.14 110.812 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.174 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -58.03 58.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 1.91 110.313 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.743 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.1 24.48 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.881 -0.6 . . . . 1.56 111.52 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.174 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.23 128.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.633 -0.427 . . . . 1.56 110.994 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.46 -9.58 55.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.009 -0.542 . . . . 1.88 110.38 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.4 p -87.16 0.4 55.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.043 -0.526 . . . . 1.63 110.307 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.948 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.31 137.22 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 116.018 -0.537 . . . . 1.11 109.939 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 185' ' ' ILE . 60.9 m -96.33 -15.45 21.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.276 0.56 . . . . 1.01 110.003 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.454 ' HA3' ' HZ1' ' A' ' 61' ' ' LYS . . . 178.57 175.57 45.76 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 109.876 -1.289 . . . . 0.14 109.876 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.39 151.63 42.38 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.716 -0.394 . . . . 0.21 110.541 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.695 ' NH1' ' OE1' ' A' ' 191' ' ' GLN . 20.6 ttm180 -132.43 121.12 22.91 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.18 -0.464 . . . . 1.54 109.955 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.502 HG23 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.11 136.56 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.652 -0.704 . . . . 1.08 110.635 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 84.7 tt0 -129.37 129.97 45.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.951 -0.568 . . . . 1.32 109.992 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.601 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.79 135.21 34.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.983 -0.553 . . . . 1.05 110.616 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.407 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.32 39.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.775 -0.648 . . . . 1.16 109.668 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.936 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.4 mt -70.98 124.84 25.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.077 0.465 . . . . 1.23 110.738 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.0 p -71.6 -7.88 50.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.735 -0.666 . . . . 0.86 110.879 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.79 -69.59 0.85 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.316 -0.402 . . . . 1.66 111.473 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.478 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.61 -35.45 76.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.16 -0.473 . . . . 1.66 111.477 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.085 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.21 88.61 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.783 -0.927 . . . . 1.62 110.783 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.328 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.9 t0 -27.9 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.675 0.274 . . . . 1.86 110.351 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.328 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.2 pm0 -82.2 139.02 45.31 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.925 0.393 . . . . 1.98 110.25 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.407 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.9 Cg_endo -70.9 145.8 51.47 Favored 'Trans proline' 0 C--N 1.302 -1.91 0 C-N-CA 122.671 2.247 . . . . 0.62 112.392 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.77 145.82 42.47 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.237 -0.653 . . . . 1.14 109.237 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.485 ' CD2' ' HB2' ' A' ' 16' ' ' ASN . 6.1 p90 -123.39 141.32 52.11 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.385 -0.526 . . . . 1.44 111.486 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.42 ' HA ' HD22 ' A' ' 158' ' ' LEU . 71.0 mt -128.17 127.69 43.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.247 -0.888 . . . . 1.08 108.922 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 68.3 t0 -101.7 131.21 48.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.184 0.516 . . . . 1.09 111.683 -178.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.519 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -127.93 157.48 73.66 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.276 -0.875 . . . . 1.04 109.614 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -69.74 158.03 58.4 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.37 2.047 . . . . 0.21 112.304 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.28 -12.2 5.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.825 -0.625 . . . . 0.88 110.677 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.3 p -92.73 -8.83 42.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 1.06 110.749 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.47 34.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 1.05 110.407 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.8 p -133.15 16.52 4.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.38 . . . . 1.07 110.579 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.5 p -167.53 147.17 5.1 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.626 -0.509 . . . . 0.92 109.626 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.519 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.2 150.44 12.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.518 -0.473 . . . . 1.09 111.54 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.496 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.31 125.01 50.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.634 -0.712 . . . . 1.31 109.789 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.524 HG21 HD21 ' A' ' 172' ' ' LEU . 1.8 mt -99.51 104.88 30.09 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.911 0.386 . . . . 1.09 111.054 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.4 Cg_endo -90.93 -179.53 1.52 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 123.2 2.6 . . . . 0.48 112.24 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.74 32.58 18.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.415 -0.812 . . . . 1.26 111.394 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.524 HD21 HG21 ' A' ' 169' ' ' ILE . 24.2 mt -86.27 148.56 25.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.528 -0.305 . . . . 1.12 110.586 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.763 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.33 114.8 61.1 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.007 0.432 . . . . 1.3 110.707 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.0 140.62 96.17 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.878 2.385 . . . . 0.92 112.009 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.03 21.27 74.31 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.021 -0.831 . . . . 0.44 111.021 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.478 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.86 150.13 49.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.759 0.314 . . . . 3.05 110.685 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.495 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.17 131.61 46.02 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.052 -0.522 . . . . 1.48 109.825 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.936 ' CE2' HD21 ' A' ' 148' ' ' LEU . 75.1 m-85 -120.48 148.27 44.04 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.161 -0.472 . . . . 0.89 111.018 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.28 125.37 60.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.279 -1.008 . . . . 1.12 108.279 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.52 132.5 63.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.138 0.494 . . . . 1.1 111.202 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.5 122.54 20.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.585 -0.734 . . . . 0.43 109.673 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.591 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -100.95 125.46 54.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.296 -0.411 . . . . 1.07 110.609 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.674 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.0 m-85 -117.31 137.93 52.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.043 -0.526 . . . . 0.92 109.823 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.562 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.73 135.0 42.86 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.774 -0.824 . . . . 0.49 108.774 178.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' A' ' 140' ' ' SER . 89.1 mt -99.04 122.96 51.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.102 0.477 . . . . 1.08 110.988 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.451 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.0 p -83.85 169.65 14.91 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.538 -0.756 . . . . 0.89 110.444 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -59.72 -14.6 14.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.012 -0.54 . . . . 1.6 110.937 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.477 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.0 m-20 -95.97 -4.37 43.4 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.83 -0.348 . . . . 1.18 110.834 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.85 13.95 63.79 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.347 -0.701 . . . . 0.34 111.347 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -84.71 138.97 32.33 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.999 -0.281 . . . . 1.22 110.481 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.695 ' OE1' ' NH1' ' A' ' 143' ' ' ARG . 14.9 pt20 -106.6 141.08 38.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 1.44 110.553 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.0 m -136.64 127.1 26.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 1.39 110.409 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.674 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.5 tp -68.29 117.36 9.99 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.683 -0.407 . . . . 1.08 110.481 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.649 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.1 pt -109.03 -21.84 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 1.08 110.677 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.89 125.75 5.88 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.565 -0.454 . . . . 1.1 111.452 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.494 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.74 120.26 21.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.683 -0.69 . . . . 0.94 109.505 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.61 151.73 29.17 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.653 -0.419 . . . . 1.07 110.938 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.46 158.67 18.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.055 -0.521 . . . . 0.89 110.404 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.14 157.89 43.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.174 -0.466 . . . . 0.67 110.67 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.25 104.41 9.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.734 -0.666 . . . . 1.17 110.1 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.488 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.9 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.853 -1.07 . . . . 1.26 110.667 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.2 m . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.191 -0.67 . . . . 3.83 109.191 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.34 150.65 18.55 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.057 -0.817 . . . . 1.39 111.057 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -35.67 142.41 0.1 Allowed 'Trans proline' 0 C--N 1.297 -2.166 0 C-N-CA 124.115 3.21 . . . . 0.86 113.718 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.573 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.4 t -80.07 173.53 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.205 -1.361 . . . . 1.43 108.742 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -105.68 125.81 51.42 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.41 -0.516 . . . . 1.94 111.522 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.44 143.97 34.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.684 -0.689 . . . . 1.19 110.699 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.98 168.25 25.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.971 0.415 . . . . 3.92 111.097 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.588 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.0 mt -108.94 131.05 60.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.935 -0.575 . . . . 3.88 110.118 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.21 162.34 35.72 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.468 -0.333 . . . . 3.92 111.257 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 10' ' ' GLU . 72.7 tt0 36.14 31.47 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 109.653 -0.499 . . . . 6.08 109.653 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.588 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.35 69.54 31.59 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.935 -0.575 . . . . 4.01 111.582 -178.753 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.632 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.22 -29.2 73.35 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.592 2.195 . . . . 4.51 111.814 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.668 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 3.2 m 149.63 125.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 3.51 110.413 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.668 ' NE2' ' O ' ' A' ' 13' ' ' SER . 1.8 mp0 -123.95 158.35 60.46 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.265 -0.425 . . . . 4.3 110.481 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.646 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 98.3 Cg_endo -82.14 -64.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.83 2.353 . . . . 1.96 113.498 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.642 ' OD1' ' N ' ' A' ' 17' ' ' SER . 23.5 p-10 -108.44 -19.61 13.4 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.027 0.38 . . . . 3.33 112.027 -178.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.642 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 93.6 p -107.4 151.93 24.86 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.469 -0.492 . . . . 1.53 111.297 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.576 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.11 102.98 2.26 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.684 -0.689 . . . . 2.29 110.671 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.7 Cg_endo -82.72 145.72 12.99 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.872 2.381 . . . . 0.88 112.556 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.413 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.84 167.97 24.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.849 -0.614 . . . . 2.12 109.879 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.15 147.94 29.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.795 -0.446 . . . . 2.67 109.795 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.499 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.7 p90 -142.26 157.31 44.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.038 0.447 . . . . 0.32 111.248 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.464 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.04 155.33 44.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.813 -0.631 . . . . 2.77 110.09 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.4 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . . . -132.6 173.19 6.18 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.085 -0.507 . . . . 1.25 110.779 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.72 173.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.844 2.363 . . . . 1.12 111.51 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.479 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -51.03 0.69 Allowed Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.723 -0.391 . . . . 4.05 110.141 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.654 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.8 152.31 82.57 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.765 2.31 . . . . 2.12 111.449 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.68 42.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.428 0.632 . . . . 2.85 110.631 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.821 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.56 -41.63 98.4 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.931 -1.031 . . . . 3.11 110.676 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.435 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.2 mt -109.86 137.91 39.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.763 -0.653 . . . . 1.86 111.234 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.01 -72.9 0.7 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.987 -0.551 . . . . 1.61 111.843 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.21 148.4 24.39 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.547 0.573 . . . . 1.67 112.547 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.76 124.82 45.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.458 -0.571 . . . . 1.07 109.458 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.7 mt -118.07 134.72 60.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.665 -0.414 . . . . 1.55 110.632 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.487 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -119.99 128.64 53.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.062 0.458 . . . . 1.33 111.277 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.12 138.98 49.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.73 -0.668 . . . . 2.36 110.145 178.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.418 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.05 163.14 35.16 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.178 0.513 . . . . 0.38 112.055 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.45 139.53 7.86 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.377 -0.829 . . . . 2.31 110.451 178.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.49 115.45 3.04 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.285 1.99 . . . . 0.86 111.796 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.667 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.91 81.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.933 -0.395 . . . . 3.44 109.933 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.688 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.24 -20.58 0.06 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.059 -0.519 . . . . 2.72 111.971 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.9 p -157.67 157.79 34.22 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.836 -0.345 . . . . 2.78 110.604 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.402 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.41 27.77 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 2.3 110.195 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.86 -75.84 1.31 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.022 -0.609 . . . . 1.8 111.805 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.86 152.4 35.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.946 0.403 . . . . 5.48 110.954 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.28 -169.18 2.54 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.0 -0.546 . . . . 1.84 111.972 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.74 29.63 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.379 0.609 . . . . 2.27 112.611 -177.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.03 156.46 46.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.768 -1.105 . . . . 1.92 110.291 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.18 158.36 41.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.004 -0.544 . . . . 1.09 111.83 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 m -115.16 135.59 54.02 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.433 -0.803 . . . . 1.16 109.893 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.446 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.3 121.94 23.89 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.509 -0.314 . . . . 1.39 111.545 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.519 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.7 Cg_exo -46.28 151.74 1.59 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.744 2.296 . . . . 0.72 112.084 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.0 -23.03 63.27 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 116.045 -0.525 . . . . 0.74 112.779 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.519 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.75 -16.88 46.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.384 0.592 . . . . 1.26 111.81 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.485 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.6 mt -91.6 138.43 31.57 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.768 -0.373 . . . . 1.59 110.254 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.54 14.0 11.0 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.302 -0.408 . . . . 2.07 111.458 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.476 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.0 p -149.99 143.46 25.21 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.684 -0.406 . . . . 0.96 111.081 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.722 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.82 -169.39 1.54 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.22 0.533 . . . . 1.0 110.83 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.722 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.8 m -151.75 125.94 9.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.406 -0.815 . . . . 1.19 109.832 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.425 HG23 HD11 ' A' ' 60' ' ' ILE . 67.0 mt -114.93 123.34 70.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.36 -0.536 . . . . 1.47 111.134 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.747 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 16.6 ptpt -126.55 163.4 23.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.742 -0.663 . . . . 3.0 110.388 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.02 19.22 59.64 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.721 -0.951 . . . . 0.5 110.721 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.435 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 74.2 mt -79.16 157.23 27.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.127 0.489 . . . . 1.21 111.306 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.625 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -99.47 133.98 21.52 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.588 -0.733 . . . . 3.2 110.486 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.429 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.88 143.62 61.6 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.554 2.169 . . . . 1.09 111.915 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.82 25.55 75.43 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.084 -0.806 . . . . 0.72 111.084 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.639 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.3 p -128.09 158.75 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.691 0.281 . . . . 1.47 110.51 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.06 139.99 41.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.908 0.385 . . . . 1.23 110.591 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.639 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.62 136.43 54.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.948 -0.569 . . . . 1.1 110.801 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.91 131.07 45.27 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.479 -0.934 . . . . 1.87 108.479 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.488 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.57 153.89 16.67 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.281 -0.961 . . . . 0.39 111.974 -178.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.01 140.9 46.02 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.628 -0.508 . . . . 1.8 109.628 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.46 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.1 tp -115.74 118.92 34.39 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.447 -0.501 . . . . 1.11 110.551 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.42 129.1 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.378 -0.373 . . . . 1.51 110.635 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.84 120.9 43.93 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.326 -0.397 . . . . 1.47 110.683 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.67 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.64 146.45 11.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.143 0.497 . . . . 1.33 111.099 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.821 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.5 mt-30 -106.0 153.92 21.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.58 -0.736 . . . . 2.49 109.91 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.24 88.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.93 0.395 . . . . 4.2 110.441 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.33 32.58 0.22 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.8 -0.636 . . . . 6.4 110.543 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.03 -117.4 3.3 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.436 -0.666 . . . . 1.74 111.436 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.445 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.32 177.36 9.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.134 0.492 . . . . 3.64 111.697 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.19 149.49 32.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.44 -0.8 . . . . 1.7 110.422 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.11 144.65 38.78 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.438 -0.346 . . . . 2.7 110.624 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.97 136.02 61.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.135 0.493 . . . . 1.16 111.527 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.09 141.37 52.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.681 -0.691 . . . . 1.14 110.299 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.62 138.89 51.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.074 0.464 . . . . 4.33 111.446 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.33 164.1 38.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.575 -0.739 . . . . 0.91 109.485 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.577 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.28 151.51 38.47 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.393 -0.523 . . . . 1.47 111.048 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.576 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.2 p90 -146.21 172.79 12.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 0.51 110.972 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.455 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.82 160.72 21.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.345 -0.843 . . . . 1.92 109.804 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.455 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.4 121.94 23.01 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.582 -0.447 . . . . 1.63 110.745 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.547 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -126.63 158.61 35.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.385 0.612 . . . . 2.37 112.279 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.654 ' O ' ' OG1' ' A' ' 94' ' ' THR . 22.6 t -59.33 -36.1 75.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.29 -0.868 . . . . 3.63 111.185 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.654 ' OG1' ' O ' ' A' ' 93' ' ' SER . 9.8 p 131.7 37.92 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.381 1.051 . . . . 0.0 109.6 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.2 m -61.24 150.85 33.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.944 0.402 . . . . 0.0 110.63 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 44.8 p -128.96 76.47 79.17 Favored Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.719 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.93 141.76 96.2 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.631 1.554 . . . . 0.0 111.299 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.4 m -112.68 8.99 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.441 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.3 p -123.41 158.74 30.47 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.876 0.37 . . . . 0.0 110.891 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.0 m -85.31 5.2 31.56 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.443 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -100.29 145.04 28.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.937 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 50.2 m -75.13 139.05 42.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.221 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.0 m -64.48 134.47 29.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.4 t -108.4 5.65 25.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.224 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -167.35 -171.44 33.38 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -56.64 143.67 35.13 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.194 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.4 p -81.6 159.9 23.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.909 0.385 . . . . 0.0 110.909 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.95 77.85 75.97 Favored Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.398 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -55.21 142.33 78.63 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.097 1.865 . . . . 0.0 111.505 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.449 ' O ' ' CB ' ' A' ' 111' ' ' SER . 68.7 t80 -102.78 127.8 49.78 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.903 0.382 . . . . 0.0 110.799 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.458 ' CB ' ' CD ' ' A' ' 112' ' ' PRO . 0.5 OUTLIER 162.82 -66.22 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.474 179.255 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.458 ' CD ' ' CB ' ' A' ' 111' ' ' SER . 24.9 Cg_endo -60.21 148.53 89.47 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.583 2.189 . . . . 0.0 112.598 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 150' ' ' GLU . 53.1 mt -89.46 146.04 24.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.116 -0.698 . . . . 10.52 109.116 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.6 p -128.28 142.31 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.374 0.607 . . . . 7.48 111.258 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -145.43 161.49 39.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.069 -0.969 . . . . 7.69 109.635 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.7 p -74.84 158.03 34.1 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.729 -0.388 . . . . 6.46 110.123 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.6 t -138.76 147.49 42.69 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.298 -0.41 . . . . 4.59 111.449 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -61.96 -30.23 70.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.867 -0.606 . . . . 3.21 110.082 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.7 m 65.51 99.5 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.544 -0.753 . . . . 3.64 111.074 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.8 t -119.76 141.39 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.205 -0.907 . . . . 3.39 109.545 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 25.3 p -73.98 159.98 31.97 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.575 -0.45 . . . . 2.23 110.033 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.58 140.53 54.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.113 0.482 . . . . 4.53 112.131 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.5 tt -126.51 138.71 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.423 -0.808 . . . . 2.01 109.479 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 38.4 m 41.56 -99.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.597 -0.274 . . . . 2.22 110.741 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -150.52 146.84 26.84 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.603 -0.439 . . . . 1.29 111.251 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.634 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 4.5 p -133.48 11.46 4.11 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.473 0.654 . . . . 1.25 110.167 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.479 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.9 167.55 0.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.297 -0.865 . . . . 1.16 110.932 -179.636 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.54 145.56 50.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.707 -0.679 . . . . 0.78 110.112 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.24 101.69 9.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.08 -0.711 . . . . 1.08 109.08 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.471 HG11 ' N ' ' A' ' 131' ' ' SER . 71.3 t -113.0 139.62 37.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.108 -0.497 . . . . 1.1 111.063 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.471 ' N ' HG11 ' A' ' 130' ' ' VAL . 65.9 p -128.7 152.59 48.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.651 -0.704 . . . . 0.87 109.877 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.647 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.6 p90 -144.84 -164.96 2.04 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.63 -0.428 . . . . 0.37 110.621 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.9 t -123.97 127.23 73.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 1.14 110.819 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.172 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.92 58.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.49 . . . . 1.91 110.37 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.17 24.62 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.925 -0.58 . . . . 1.56 111.538 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.172 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.1 128.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.61 -0.436 . . . . 1.56 110.932 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -86.38 -9.68 55.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.895 -0.593 . . . . 1.88 110.332 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.07 0.21 55.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.115 -0.493 . . . . 1.63 110.304 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.963 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.26 137.16 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 1.11 109.952 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.747 ' O ' ' NZ ' ' A' ' 61' ' ' LYS . 69.3 m -96.19 -15.56 21.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.242 0.544 . . . . 1.01 110.019 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.61 175.56 45.78 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 109.915 -1.274 . . . . 0.14 109.915 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.44 151.66 42.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.027 0.442 . . . . 0.21 110.465 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.764 ' NH2' ' OE2' ' A' ' 145' ' ' GLU . 31.6 ttt85 -132.43 121.23 23.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.058 -0.519 . . . . 1.54 109.887 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.489 HG23 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.11 136.47 38.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.697 -0.683 . . . . 1.08 110.655 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.764 ' OE2' ' NH2' ' A' ' 143' ' ' ARG . 97.6 mt-10 -129.37 129.86 45.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.097 -0.501 . . . . 1.32 109.991 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.592 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.7 135.4 34.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.954 -0.566 . . . . 1.05 110.614 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.403 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.44 161.27 40.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.78 -0.646 . . . . 1.16 109.702 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.936 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.4 mt -71.0 124.81 25.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.029 0.442 . . . . 1.23 110.736 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.66 -7.82 50.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.726 -0.67 . . . . 0.86 110.872 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.4 ' O ' ' O ' ' A' ' 113' ' ' LEU . 81.1 mt-10 -109.75 -69.6 0.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 1.66 111.484 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.431 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.64 -35.39 76.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.053 -0.521 . . . . 1.66 111.557 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.086 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.26 88.57 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.807 -0.917 . . . . 1.62 110.807 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.337 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.89 -171.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 1.86 110.278 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.337 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.09 45.2 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.021 0.439 . . . . 1.98 110.236 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.403 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.3 Cg_endo -70.96 145.86 51.26 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 C-N-CA 122.7 2.267 . . . . 0.62 112.35 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.83 145.78 42.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.202 -0.666 . . . . 1.14 109.202 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.521 ' CB ' ' NH1' ' A' ' 143' ' ' ARG . 35.9 p90 -123.33 141.31 52.11 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.303 -0.559 . . . . 1.44 111.484 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.418 ' HA ' HD22 ' A' ' 158' ' ' LEU . 71.0 mt -128.1 127.7 43.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.317 -0.856 . . . . 1.08 108.94 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.527 ' OD1' ' O ' ' A' ' 159' ' ' ASP . 54.7 p-10 -101.65 131.2 48.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.206 0.526 . . . . 1.09 111.794 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.512 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -127.96 157.55 73.48 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.286 -0.87 . . . . 1.04 109.533 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.91 157.95 58.4 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 122.369 2.046 . . . . 0.21 112.261 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.2 p -59.24 -12.04 4.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.832 -0.622 . . . . 0.88 110.761 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.8 p -92.92 -8.74 42.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.451 . . . . 1.06 110.642 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.25 135.47 34.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.349 -0.387 . . . . 1.05 110.353 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.8 p -133.21 16.79 4.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 1.07 110.52 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.0 p -167.6 147.11 5.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.633 -0.506 . . . . 0.92 109.633 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.512 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.12 150.46 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.516 -0.473 . . . . 1.09 111.521 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.497 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 124.88 50.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.659 -0.7 . . . . 1.31 109.849 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.525 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.31 104.91 29.58 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.377 -0.374 . . . . 1.09 111.143 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.2 Cg_endo -91.0 -179.49 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.926 0 C-N-CA 123.135 2.557 . . . . 0.48 112.218 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.69 32.59 18.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.31 -0.859 . . . . 1.26 111.465 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.634 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.1 mt -86.33 148.56 25.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.812 0.339 . . . . 1.12 110.404 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.771 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.32 114.82 61.21 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.093 0.473 . . . . 1.3 110.665 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.96 140.61 96.07 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.916 2.41 . . . . 0.92 111.935 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.11 21.06 74.57 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.132 -0.787 . . . . 0.44 111.132 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.431 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.76 150.16 49.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.746 0.308 . . . . 3.05 110.668 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.495 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.21 131.61 46.06 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.105 -0.498 . . . . 1.48 109.767 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.936 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.48 148.26 44.06 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.039 -0.528 . . . . 0.89 110.948 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.6 mt -105.33 125.43 60.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.308 -0.997 . . . . 1.12 108.308 177.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.64 132.5 63.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.199 0.523 . . . . 1.1 111.174 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.64 20.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.549 -0.75 . . . . 0.43 109.617 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.59 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.16 125.44 55.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.175 -0.466 . . . . 1.07 110.65 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.669 ' CE1' HD11 ' A' ' 193' ' ' LEU . 47.9 m-85 -117.17 137.86 52.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.99 -0.55 . . . . 0.92 109.883 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.68 135.05 42.74 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.76 -0.83 . . . . 0.49 108.76 178.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 140' ' ' SER . 79.6 mt -99.06 123.0 51.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.151 0.501 . . . . 1.08 110.964 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.45 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.2 p -83.91 169.66 14.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.531 -0.759 . . . . 0.89 110.443 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.523 ' O ' ' OG1' ' A' ' 59' ' ' THR . 97.0 mt-10 -59.67 -14.53 14.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.031 -0.531 . . . . 1.6 111.069 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.45 ' H ' ' HG ' ' A' ' 186' ' ' SER . 95.3 m-20 -96.15 -4.26 42.99 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.855 -0.338 . . . . 1.18 110.825 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.44 ' N ' ' HG1' ' A' ' 59' ' ' THR . . . 87.81 13.93 63.9 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.301 -0.72 . . . . 0.34 111.301 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -84.65 139.12 32.27 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.994 -0.282 . . . . 1.22 110.476 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -106.71 141.06 38.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.897 0.38 . . . . 1.44 110.527 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.72 126.97 26.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 1.39 110.408 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.669 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.6 tp -68.1 117.31 9.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.247 -0.433 . . . . 1.08 110.532 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.647 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -109.0 -21.9 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 1.08 110.699 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.85 125.86 5.95 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.52 -0.472 . . . . 1.1 111.51 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.497 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.93 120.22 21.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.741 -0.663 . . . . 0.94 109.501 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.59 151.66 29.1 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.621 -0.432 . . . . 1.07 110.941 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.41 158.5 18.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.518 . . . . 0.89 110.45 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.03 157.95 43.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.135 -0.484 . . . . 0.67 110.671 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 104.3 9.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.711 -0.677 . . . . 1.17 110.056 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.485 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 66.6 p . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.981 -1.009 . . . . 1.26 110.637 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.157 -0.683 . . . . 3.83 109.157 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.455 ' H ' ' HB3' ' A' ' 1' ' ' SER . . . -116.31 150.62 18.56 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.078 -0.809 . . . . 1.39 111.078 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -35.61 142.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 123.944 3.096 . . . . 0.86 113.835 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.566 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.1 t -79.89 173.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.275 -1.329 . . . . 1.43 108.898 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.402 ' H ' ' CG1' ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.59 125.9 51.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.164 0.507 . . . . 1.94 111.464 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 p -136.55 144.06 33.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.625 -0.716 . . . . 1.19 110.602 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.07 168.27 25.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.908 0.385 . . . . 3.92 111.112 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.585 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -108.99 131.2 60.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.947 -0.569 . . . . 3.88 110.04 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 69.3 p -141.25 162.31 35.79 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.368 -0.378 . . . . 3.92 111.162 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 9' ' ' THR . 29.9 tt0 36.12 31.56 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.659 -0.497 . . . . 6.08 109.659 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.585 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.48 69.56 32.91 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.881 -0.599 . . . . 4.01 111.489 -178.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.2 -29.2 73.56 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.618 2.212 . . . . 4.51 111.808 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.6 125.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.14 -0.482 . . . . 3.51 110.528 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.53 HE22 ' H ' ' A' ' 13' ' ' SER . 2.0 mp0 -124.0 158.31 60.74 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.348 -0.387 . . . . 4.3 110.408 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.502 ' HG2' ' CD ' ' A' ' 143' ' ' ARG . 97.3 Cg_endo -81.98 -64.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.812 2.342 . . . . 1.96 113.58 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.472 ' H ' ' HG2' ' A' ' 15' ' ' PRO . 99.4 m-20 -108.51 -19.51 13.42 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.072 0.397 . . . . 3.33 112.072 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 2.6 m -107.38 152.0 24.75 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.13 0.491 . . . . 1.53 111.265 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.4 t-80 -155.25 102.98 2.23 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.691 -0.686 . . . . 2.29 110.677 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -82.69 145.61 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.936 2.424 . . . . 0.88 112.601 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.406 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.8 167.91 24.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.932 -0.576 . . . . 2.12 109.883 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.09 147.97 29.12 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.795 -0.446 . . . . 2.67 109.795 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.497 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.4 p90 -142.32 157.31 44.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.047 0.451 . . . . 0.32 111.112 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.469 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.1 m-20 -128.07 155.31 44.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.789 -0.641 . . . . 2.77 110.127 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.59 172.93 6.51 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.17 -0.468 . . . . 1.25 110.815 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.52 173.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 122.869 2.379 . . . . 1.12 111.573 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.12 -51.03 0.68 Allowed Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 120.68 -0.408 . . . . 4.05 110.126 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.646 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.79 152.39 82.27 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.744 2.296 . . . . 2.12 111.49 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.67 42.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.379 0.609 . . . . 2.85 110.552 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.816 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.56 -41.58 98.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.011 -0.995 . . . . 3.11 110.707 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.437 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.4 mt -109.93 137.79 40.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.765 -0.652 . . . . 1.86 111.255 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.92 -72.9 0.7 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.096 -0.502 . . . . 1.61 111.902 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.24 148.44 24.35 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.597 0.592 . . . . 1.67 112.597 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.84 124.93 45.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.328 -0.619 . . . . 1.07 109.328 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.7 mt -118.16 134.74 60.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.635 -0.426 . . . . 1.55 110.623 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.485 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -120.03 128.57 53.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.057 0.456 . . . . 1.33 111.216 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.548 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.12 139.04 49.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.708 -0.678 . . . . 2.36 110.069 178.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.415 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.2 p90 -145.14 163.14 35.25 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-O 121.215 0.531 . . . . 0.38 112.017 -178.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.42 139.59 7.92 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 115.421 -0.809 . . . . 2.31 110.431 178.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.55 115.51 3.09 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.256 1.971 . . . . 0.86 111.825 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.67 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.08 81.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.885 -0.413 . . . . 3.44 109.885 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.21 -20.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.985 -0.552 . . . . 2.72 111.886 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 p -157.65 157.78 34.23 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.789 -0.364 . . . . 2.78 110.548 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 m -120.39 27.84 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.239 -0.437 . . . . 2.3 110.224 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.89 -75.83 1.31 Allowed Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.141 -0.552 . . . . 1.8 111.832 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.91 152.39 35.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.398 . . . . 5.48 111.015 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.63 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.23 -169.15 2.54 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.166 -0.47 . . . . 1.84 111.943 179.452 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.411 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.11 149.71 29.65 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.485 0.66 . . . . 2.27 112.532 -177.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.12 156.5 45.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.756 -1.111 . . . . 1.92 110.281 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.25 158.33 41.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.981 -0.554 . . . . 1.09 111.783 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 m -115.23 135.68 53.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.545 -0.752 . . . . 1.16 109.757 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.442 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.45 121.96 23.71 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 1.39 111.512 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.516 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.5 Cg_exo -46.41 151.77 1.68 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.699 2.266 . . . . 0.72 112.135 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.01 -23.02 63.27 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 116.106 -0.497 . . . . 0.74 112.735 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.516 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.1 p-80 -82.68 -16.97 46.16 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 117.379 0.59 . . . . 1.26 111.811 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.494 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.2 mt -91.56 138.44 31.56 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.728 -0.389 . . . . 1.59 110.278 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.57 13.98 10.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.39 -0.368 . . . . 2.07 111.572 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.4 p -150.0 143.49 25.22 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.593 -0.443 . . . . 0.96 111.071 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.84 -169.4 1.54 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.261 0.553 . . . . 1.0 110.818 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.781 ' HG1' ' NZ ' ' A' ' 61' ' ' LYS . 1.7 t -151.75 125.87 9.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.361 -0.836 . . . . 1.19 109.792 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.44 HD11 HG23 ' A' ' 60' ' ' ILE . 66.6 mt -114.81 123.25 70.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.401 -0.52 . . . . 1.47 111.248 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.781 ' NZ ' ' HG1' ' A' ' 59' ' ' THR . 59.6 mttp -126.47 163.33 23.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.838 -0.619 . . . . 3.0 110.426 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.19 18.97 59.79 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.712 -0.955 . . . . 0.5 110.712 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.427 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 74.2 mt -79.05 157.29 28.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.116 0.484 . . . . 1.21 111.319 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.63 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -99.48 134.04 21.47 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.604 -0.725 . . . . 3.2 110.384 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.99 143.62 60.99 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.551 2.167 . . . . 1.09 111.902 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.65 75.31 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.081 -0.808 . . . . 0.72 111.081 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.639 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.21 158.79 40.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.743 0.306 . . . . 1.47 110.44 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.16 139.96 41.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.974 0.416 . . . . 1.23 110.547 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.639 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.55 136.51 54.9 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.855 -0.611 . . . . 1.1 110.75 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.98 131.09 45.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.538 -0.912 . . . . 1.87 108.538 177.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.485 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.53 153.84 16.66 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.322 -0.942 . . . . 0.39 112.006 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.87 140.94 46.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.702 -0.481 . . . . 1.8 109.702 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.468 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.0 tp -115.83 118.88 34.23 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.496 -0.482 . . . . 1.11 110.468 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.8 mt -112.36 129.04 68.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.293 -0.412 . . . . 1.51 110.749 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.81 120.93 44.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.356 -0.383 . . . . 1.47 110.655 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.67 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.62 146.42 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.115 0.483 . . . . 1.33 111.03 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.816 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.5 mt-30 -106.07 153.91 21.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.494 -0.776 . . . . 2.49 109.843 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.14 88.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.958 0.409 . . . . 4.2 110.479 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.32 32.52 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.847 -0.615 . . . . 6.4 110.653 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.27 3.28 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.95 -0.643 . . . . 1.74 111.533 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.452 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.42 177.38 9.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.143 0.497 . . . . 3.64 111.635 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.13 149.54 32.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.382 -0.827 . . . . 1.7 110.331 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.15 144.7 38.74 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.354 -0.385 . . . . 2.7 110.6 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -128.0 136.0 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-O 121.047 0.451 . . . . 1.16 111.587 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.07 141.39 52.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.66 -0.7 . . . . 1.14 110.245 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.456 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.61 138.81 51.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.094 0.473 . . . . 4.33 111.485 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.485 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.21 164.19 37.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.597 -0.729 . . . . 0.91 109.51 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.574 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 46.9 p30 -145.21 151.56 38.59 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.441 -0.504 . . . . 1.47 111.071 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.8 p90 -146.28 172.68 13.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.729 -0.669 . . . . 0.51 110.994 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.448 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.73 160.68 21.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.443 -0.799 . . . . 1.92 109.864 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.448 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.42 121.9 22.94 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.547 -0.461 . . . . 1.63 110.771 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.528 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.2 p -127.16 164.9 20.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 122.5 1.143 . . . . 2.37 114.033 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.569 ' OG ' ' CE2' ' A' ' 157' ' ' TYR . 22.4 t -133.75 162.48 31.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.198 -1.819 . . . . 3.63 109.128 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 64.2 p -58.03 -7.61 0.82 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 93' ' ' SER . 52.0 p -65.3 162.73 16.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.529 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.1 m -124.03 74.41 57.56 Favored Pre-proline 0 N--CA 1.464 0.251 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.125 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.57 145.82 96.96 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.564 2.176 . . . . 0.0 112.534 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.9 p -113.96 26.61 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.397 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.0 p 48.3 36.19 6.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.769 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.2 t -129.89 141.72 50.76 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.122 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -107.53 129.3 54.98 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.814 0.34 . . . . 0.0 110.529 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -39.34 93.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.25 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.2 p -131.67 144.24 38.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.372 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 49.8 m -117.59 138.92 51.61 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.213 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.35 -171.43 41.66 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.63 -33.26 72.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.831 0.348 . . . . 0.0 110.41 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.8 p -123.43 163.32 21.08 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.725 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.0 p -124.12 74.04 57.93 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.766 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -61.0 145.7 98.77 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.556 2.171 . . . . 0.0 113.293 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -58.04 -37.04 73.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.853 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.66 ' H ' ' CD ' ' A' ' 112' ' ' PRO . 1.3 p -167.56 -38.44 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.993 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.66 ' CD ' ' H ' ' A' ' 111' ' ' SER . 51.6 Cg_exo -54.8 142.06 75.14 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.029 1.819 . . . . 0.0 112.595 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.591 ' O ' ' O ' ' A' ' 114' ' ' VAL . 56.6 mt -85.15 -4.61 59.22 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.84 -0.618 . . . . 10.52 110.995 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.591 ' O ' ' O ' ' A' ' 113' ' ' LEU . 2.5 m 27.54 111.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 123.611 0.569 . . . . 7.48 112.473 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.29 145.04 52.74 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.573 -0.528 . . . . 7.69 109.573 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.5 m -57.55 -41.68 81.49 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.247 -0.581 . . . . 6.46 110.093 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.703 ' O ' ' O ' ' A' ' 118' ' ' GLU . 55.0 m -126.19 150.83 48.07 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.727 -0.669 . . . . 4.59 110.265 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.75 ' O ' ' O ' ' A' ' 119' ' ' SER . 57.6 mp0 -23.82 -114.57 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.675 0.609 . . . . 3.21 112.026 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.75 ' O ' ' O ' ' A' ' 118' ' ' GLU . 83.6 p 25.67 -167.3 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.816 0.673 . . . . 3.64 112.816 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.614 ' O ' ' O ' ' A' ' 119' ' ' SER . 41.5 t 48.81 128.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.59 -0.732 . . . . 3.39 111.753 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.5 p -120.14 160.38 23.0 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.09 -0.504 . . . . 2.23 110.108 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -107.37 141.1 39.27 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.168 -0.469 . . . . 4.53 111.081 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.1 mt -113.54 134.1 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.847 -0.797 . . . . 2.01 108.847 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.93 110.65 10.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.107 0.48 . . . . 2.22 111.65 -178.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -116.91 -93.98 0.5 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.759 -0.83 . . . . 1.29 108.759 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 67.5 p -66.1 -14.69 62.2 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.557 -0.905 . . . . 1.25 108.557 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.473 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.76 167.61 0.24 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.878 -1.056 . . . . 1.16 110.897 -179.184 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.65 145.52 50.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.688 -0.687 . . . . 0.78 110.117 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.28 101.63 9.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.076 -0.713 . . . . 1.08 109.076 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.465 HG11 ' N ' ' A' ' 131' ' ' SER . 71.4 t -112.87 139.73 36.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.056 -0.52 . . . . 1.1 111.097 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.465 ' N ' HG11 ' A' ' 130' ' ' VAL . 68.0 p -128.75 152.56 48.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.599 -0.728 . . . . 0.87 109.816 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.646 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.8 p90 -144.8 -164.93 2.03 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.742 -0.383 . . . . 0.37 110.67 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.731 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.7 t -123.98 127.17 73.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.18 -0.463 . . . . 1.14 110.718 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.162 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.98 58.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.135 -0.484 . . . . 1.91 110.297 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.731 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.05 24.42 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.991 -0.55 . . . . 1.56 111.533 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.162 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.23 128.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.549 -0.46 . . . . 1.56 110.954 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.44 -9.61 55.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.979 -0.555 . . . . 1.88 110.288 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.8 p -87.09 0.27 55.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 1.63 110.282 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.958 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.29 137.26 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.064 -0.517 . . . . 1.11 109.913 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.668 ' OG ' ' NZ ' ' A' ' 61' ' ' LYS . 10.9 p -96.26 -15.49 21.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.287 0.565 . . . . 1.01 110.076 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.57 175.57 45.76 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.91 -1.276 . . . . 0.14 109.91 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.48 151.63 42.54 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.578 -0.449 . . . . 0.21 110.458 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.723 ' NH2' ' OE1' ' A' ' 191' ' ' GLN . 52.3 ttp85 -132.38 121.17 23.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.108 -0.496 . . . . 1.54 109.997 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.479 HG23 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.08 136.59 38.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.686 -0.688 . . . . 1.08 110.694 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 73.8 tt0 -129.34 129.87 45.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.981 -0.554 . . . . 1.32 110.109 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.72 135.27 34.57 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.027 -0.533 . . . . 1.05 110.602 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.406 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.32 39.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.83 -0.623 . . . . 1.16 109.739 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.945 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -71.0 124.89 25.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.995 0.426 . . . . 1.23 110.694 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.494 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.9 -7.63 49.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.757 -0.656 . . . . 0.86 110.856 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.81 -69.6 0.85 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.924 0.393 . . . . 1.66 111.468 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.44 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.7 -35.27 75.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.02 -0.537 . . . . 1.66 111.498 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.099 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.01 7.29 88.54 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.838 -0.905 . . . . 1.62 110.838 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.324 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.97 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.817 0.342 . . . . 1.86 110.261 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.324 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.17 139.04 45.43 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.407 . . . . 1.98 110.199 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.406 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.9 Cg_endo -70.86 145.8 51.75 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.753 2.302 . . . . 0.62 112.376 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.79 145.63 42.65 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.276 -0.639 . . . . 1.14 109.276 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.633 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 88.1 m-85 -123.31 141.46 51.96 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.311 -0.556 . . . . 1.44 111.516 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.439 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.7 mt -128.17 127.63 43.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.306 -0.861 . . . . 1.08 108.951 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -101.61 131.21 47.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.075 0.464 . . . . 1.09 111.687 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.517 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -127.96 157.59 73.37 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.347 -0.842 . . . . 1.04 109.553 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.85 158.02 58.23 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 122.413 2.075 . . . . 0.21 112.247 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.31 -12.15 5.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.742 -0.663 . . . . 0.88 110.684 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.9 p -92.8 -8.76 42.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.148 -0.478 . . . . 1.06 110.783 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.46 34.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 1.05 110.435 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.25 16.78 4.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 1.07 110.52 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.5 p -167.58 147.1 5.04 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.596 -0.52 . . . . 0.92 109.596 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.517 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.21 150.49 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.458 -0.497 . . . . 1.09 111.55 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.499 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.25 125.03 50.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.606 -0.725 . . . . 1.31 109.822 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.517 HG21 HD21 ' A' ' 172' ' ' LEU . 1.8 mt -99.49 104.88 30.05 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.378 -0.374 . . . . 1.09 111.011 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.8 Cg_endo -90.97 -179.5 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 123.195 2.597 . . . . 0.48 112.24 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.409 ' CG ' ' HG ' ' A' ' 111' ' ' SER . 71.0 m-20 61.67 32.64 18.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.381 -0.827 . . . . 1.26 111.435 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 169' ' ' ILE . 24.0 mt -86.29 148.59 25.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.467 -0.333 . . . . 1.12 110.563 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.771 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.37 114.86 61.37 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.016 0.436 . . . . 1.3 110.624 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.07 140.61 95.97 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.83 2.353 . . . . 0.92 111.93 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.1 21.21 74.25 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.006 -0.838 . . . . 0.44 111.006 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.44 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.87 150.13 49.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.752 0.311 . . . . 3.05 110.756 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.494 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.15 131.7 45.94 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.091 -0.504 . . . . 1.48 109.728 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.945 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.7 m-85 -120.49 148.31 44.0 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.091 -0.504 . . . . 0.89 111.02 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.7 mt -105.25 125.25 60.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.347 -0.983 . . . . 1.12 108.347 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.51 132.45 63.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.198 0.523 . . . . 1.1 111.303 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.44 122.6 20.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.542 -0.754 . . . . 0.43 109.655 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.591 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.12 125.38 55.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.257 -0.429 . . . . 1.07 110.627 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.669 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.7 m-85 -117.15 137.86 52.04 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.534 . . . . 0.92 109.882 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.564 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.68 135.11 42.64 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.846 -0.798 . . . . 0.49 108.846 178.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.547 ' O ' ' N ' ' A' ' 140' ' ' SER . 26.6 mt -99.09 123.01 51.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.074 0.464 . . . . 1.08 110.918 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.592 ' OG ' ' OD1' ' A' ' 188' ' ' ASP . 87.4 p -83.91 169.73 14.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.515 -0.766 . . . . 0.89 110.529 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.77 -14.55 15.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.096 -0.502 . . . . 1.6 110.953 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.671 ' OD1' ' N ' ' A' ' 190' ' ' GLU . 37.1 p30 -96.18 -4.16 43.08 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.785 -0.366 . . . . 1.18 110.773 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.74 13.86 64.17 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.339 -0.705 . . . . 0.34 111.339 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.671 ' N ' ' OD1' ' A' ' 188' ' ' ASP . 84.4 tt0 -84.59 139.03 32.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.705 0.288 . . . . 1.22 110.456 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.723 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 87.4 mt-30 -106.74 141.03 38.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 1.44 110.557 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.0 m -136.72 127.15 26.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 1.39 110.326 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.669 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.7 tp -68.21 117.38 9.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 1.08 110.454 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.646 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.4 pt -109.08 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 1.08 110.71 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.5 tp -156.91 125.74 5.86 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.511 -0.476 . . . . 1.1 111.448 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.495 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.77 120.28 21.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.775 -0.648 . . . . 0.94 109.504 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.67 151.68 29.06 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.628 -0.429 . . . . 1.07 110.901 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.43 158.58 18.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.986 -0.552 . . . . 0.89 110.492 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -146.05 158.04 43.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.67 110.633 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.35 104.31 9.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.717 -0.674 . . . . 1.17 109.981 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.483 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 66.9 p . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.94 -1.028 . . . . 1.26 110.701 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.0 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.223 -0.658 . . . . 3.83 109.223 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.46 150.67 18.53 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.971 -0.852 . . . . 1.39 110.971 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -35.58 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.056 0 C-N-CA 124.009 3.139 . . . . 0.86 113.811 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.567 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -79.94 173.47 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.219 -1.355 . . . . 1.43 108.882 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.64 125.92 51.54 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.376 -0.529 . . . . 1.94 111.444 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.51 143.96 34.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.671 -0.695 . . . . 1.19 110.691 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.01 168.3 25.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.923 0.392 . . . . 3.92 111.093 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.589 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.7 mt -109.06 131.08 60.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.975 -0.557 . . . . 3.88 110.098 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.16 162.26 35.92 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.466 -0.334 . . . . 3.92 111.255 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 73.7 mm-40 36.15 31.63 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.558 -0.534 . . . . 6.08 109.558 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.589 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.53 69.6 33.5 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.006 -0.543 . . . . 4.01 111.521 -178.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.639 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.37 -28.99 71.87 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.433 2.089 . . . . 4.51 111.906 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.681 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 3.2 m 149.58 125.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 3.51 110.481 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.681 ' NE2' ' O ' ' A' ' 13' ' ' SER . 3.4 mp0 -123.96 158.39 60.39 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.314 -0.403 . . . . 4.3 110.409 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.619 ' CG ' ' NH1' ' A' ' 143' ' ' ARG . 97.2 Cg_endo -82.03 -64.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.902 2.402 . . . . 1.96 113.488 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.62 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 64.6 t30 -108.46 -19.59 13.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.305 -0.407 . . . . 3.33 112.012 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 5.3 p -107.3 152.11 24.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.187 0.518 . . . . 1.53 111.242 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.573 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.34 102.89 2.22 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.7 -0.682 . . . . 2.29 110.685 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.527 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.67 145.57 13.01 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.923 2.415 . . . . 0.88 112.605 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.415 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.75 167.95 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.881 -0.6 . . . . 2.12 109.895 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.21 147.94 29.01 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.674 -0.491 . . . . 2.67 109.674 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.494 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.5 p90 -142.27 157.33 44.95 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.605 -0.438 . . . . 0.32 111.195 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.47 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.2 m-20 -128.04 155.29 44.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.781 -0.645 . . . . 2.77 110.017 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.63 172.99 6.41 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.128 -0.487 . . . . 1.25 110.737 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.68 173.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.851 2.367 . . . . 1.12 111.598 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.483 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.98 -51.15 0.69 Allowed Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 120.725 -0.39 . . . . 4.05 110.051 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.656 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.4 Cg_exo -64.75 152.36 82.31 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.783 2.322 . . . . 2.12 111.477 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.75 42.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.35 0.595 . . . . 2.85 110.46 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.824 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.6 -41.64 98.3 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.059 -0.973 . . . . 3.11 110.625 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.436 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.4 mt -109.82 137.76 40.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.811 -0.631 . . . . 1.86 111.276 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.88 -72.91 0.7 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.053 -0.522 . . . . 1.61 111.965 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.18 148.4 24.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.617 0.599 . . . . 1.67 112.617 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -121.78 124.89 45.27 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.315 -0.624 . . . . 1.07 109.315 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.02 134.68 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.623 -0.431 . . . . 1.55 110.67 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.483 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -119.93 128.6 53.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.978 0.418 . . . . 1.33 111.283 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.541 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.92 49.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.724 -0.671 . . . . 2.36 110.217 178.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.421 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.0 163.21 34.89 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.169 0.509 . . . . 0.38 112.054 -178.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.56 139.56 7.78 Favored Pre-proline 0 C--N 1.333 -0.12 0 CA-C-N 115.346 -0.843 . . . . 2.31 110.428 178.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.46 115.42 3.01 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.318 2.012 . . . . 0.86 111.802 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.97 81.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.92 -0.4 . . . . 3.44 109.92 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.23 -20.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 2.72 111.936 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.2 p -157.68 157.76 34.13 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.737 -0.385 . . . . 2.78 110.51 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.402 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.4 m -120.29 27.82 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.182 -0.463 . . . . 2.3 110.186 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.83 -75.87 1.31 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.178 -0.534 . . . . 1.8 111.829 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.89 152.2 35.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.898 0.38 . . . . 5.48 111.055 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.11 -169.14 2.55 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.113 -0.494 . . . . 1.84 111.954 179.394 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.12 149.68 29.71 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.456 0.646 . . . . 2.27 112.672 -177.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.07 156.5 45.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.858 -1.065 . . . . 1.92 110.285 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.24 158.34 41.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.903 -0.589 . . . . 1.09 111.873 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 m -115.19 135.58 54.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.472 -0.785 . . . . 1.16 109.865 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.448 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.35 121.93 23.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.467 -0.333 . . . . 1.39 111.538 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.7 Cg_exo -46.41 151.77 1.68 Allowed 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.666 2.244 . . . . 0.72 112.059 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.04 -22.85 63.14 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-N 115.957 -0.565 . . . . 0.74 112.81 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.515 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.84 -16.89 45.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.371 0.586 . . . . 1.26 111.825 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.485 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.53 138.42 31.59 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.725 -0.39 . . . . 1.59 110.375 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.55 13.95 10.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.387 -0.369 . . . . 2.07 111.551 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.99 143.4 25.17 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.681 -0.408 . . . . 0.96 111.098 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.75 -169.25 1.51 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.037 -0.528 . . . . 1.0 110.906 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.76 ' OG1' ' N ' ' A' ' 189' ' ' GLY . 1.3 m -151.82 125.86 9.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.432 -0.804 . . . . 1.19 109.805 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.428 HG23 HD11 ' A' ' 60' ' ' ILE . 66.5 mt -114.8 123.25 70.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.429 -0.508 . . . . 1.47 111.21 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -126.48 163.41 23.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.842 -0.617 . . . . 3.0 110.436 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.457 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.17 18.99 59.79 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.631 -0.988 . . . . 0.5 110.631 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.62 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 74.1 mt -79.07 157.26 28.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.149 0.5 . . . . 1.21 111.309 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.65 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 10.9 mttp -99.44 133.95 21.56 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.588 -0.733 . . . . 3.2 110.494 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.84 143.6 61.72 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.637 2.225 . . . . 1.09 111.916 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.79 25.5 75.48 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.105 -0.798 . . . . 0.72 111.105 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.639 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.09 158.79 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.321 . . . . 1.47 110.449 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.19 139.91 42.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.94 0.4 . . . . 1.23 110.534 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.65 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.7 m-85 -122.53 136.45 54.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.944 -0.571 . . . . 1.1 110.776 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.84 131.02 45.27 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.483 -0.932 . . . . 1.87 108.483 177.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.49 153.9 16.65 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.301 -0.952 . . . . 0.39 111.943 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.96 140.93 46.09 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.71 -0.478 . . . . 1.8 109.71 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.463 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.9 tp -115.67 118.93 34.44 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.476 -0.489 . . . . 1.11 110.488 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.51 129.19 68.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.342 -0.39 . . . . 1.51 110.647 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.92 120.7 43.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.242 -0.436 . . . . 1.47 110.774 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.667 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.52 146.5 11.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.217 0.532 . . . . 1.33 111.02 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.824 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.01 153.85 21.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.536 -0.756 . . . . 2.49 109.982 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.13 88.47 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.898 0.38 . . . . 4.2 110.521 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.36 32.6 0.22 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.78 -0.645 . . . . 6.4 110.589 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.33 3.29 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.504 -0.638 . . . . 1.74 111.504 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.443 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.36 177.38 9.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.135 0.493 . . . . 3.64 111.687 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.17 149.5 32.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.401 -0.818 . . . . 1.7 110.401 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.13 144.68 38.75 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.459 -0.337 . . . . 2.7 110.613 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -128.04 135.95 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.049 0.452 . . . . 1.16 111.473 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.02 141.34 52.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.599 -0.728 . . . . 1.14 110.236 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.446 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.64 138.85 51.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.117 0.484 . . . . 4.33 111.541 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.491 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.25 164.18 37.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.506 -0.77 . . . . 0.91 109.493 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.572 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.1 p30 -145.25 151.51 38.49 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.41 -0.516 . . . . 1.47 111.084 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.573 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.5 p90 -146.19 172.65 13.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.762 -0.654 . . . . 0.51 111.104 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.454 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.61 160.67 21.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.467 -0.788 . . . . 1.92 109.861 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.454 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.37 121.98 23.12 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 120.63 -0.428 . . . . 1.63 110.747 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.564 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.8 p -127.83 164.23 22.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.647 0.737 . . . . 2.37 112.689 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.539 ' C ' ' H ' ' A' ' 95' ' ' SER . 30.5 t -115.75 149.18 38.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.63 -1.168 . . . . 3.63 109.682 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 58.6 p -59.48 -3.52 0.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.335 0.588 . . . . 0.0 109.863 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.539 ' H ' ' C ' ' A' ' 93' ' ' SER . 13.0 m -53.89 -33.54 56.84 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.52 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.9 m 63.29 68.19 0.95 Allowed Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.88 150.33 23.36 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.768 2.312 . . . . 0.0 112.457 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.5 m -60.02 136.67 23.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.126 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.1 m -58.56 -40.34 82.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.608 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 65.0 m -163.45 10.2 0.05 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.114 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -54.8 -36.93 65.47 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.247 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.9 m -79.72 138.4 37.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.067 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.8 m -128.69 155.55 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.929 0.395 . . . . 0.0 110.97 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 45.6 m -123.54 140.42 53.02 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.76 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -155.54 134.73 4.28 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.729 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -59.55 -31.77 69.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.077 0.465 . . . . 0.0 110.251 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.4 m -55.16 -36.09 65.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.411 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.8 p -53.92 147.06 25.57 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.682 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.93 147.59 80.95 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.655 2.236 . . . . 0.0 112.995 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -94.49 6.15 49.65 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.722 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.1 p -108.32 102.48 46.92 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.755 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -53.85 150.89 28.21 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.463 2.109 . . . . 0.0 112.417 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.5 mt -58.1 -32.74 68.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.67 -0.696 . . . . 10.52 110.87 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 25.8 m -126.01 158.32 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.922 0.392 . . . . 7.48 110.731 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.95 144.75 52.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.02 -0.536 . . . . 7.69 111.032 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.6 p -70.5 -15.67 62.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.677 -0.692 . . . . 6.46 111.011 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.0 m -60.09 152.94 22.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.816 0.341 . . . . 4.59 110.546 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.95 -33.65 75.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.997 -0.547 . . . . 3.21 111.192 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 47.7 m -65.13 150.71 47.68 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.68 -0.408 . . . . 3.64 110.856 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.1 m -131.2 156.36 42.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.002 -0.544 . . . . 3.39 110.446 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 49.9 m -84.85 136.04 33.83 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.708 -0.479 . . . . 2.23 109.708 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -60.51 139.99 57.5 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.595 -0.442 . . . . 4.53 110.548 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.417 ' C ' ' OG1' ' A' ' 124' ' ' THR . 83.3 mt -94.42 -76.3 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.145 -0.48 . . . . 2.01 110.106 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.417 ' OG1' ' C ' ' A' ' 123' ' ' ILE . 0.1 OUTLIER -177.91 50.04 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.821 -0.627 . . . . 2.22 109.589 179.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 63.74 23.43 13.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.822 -0.626 . . . . 1.29 110.504 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.5 p -63.45 -25.78 68.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.596 . . . . 1.25 110.312 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.479 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.85 167.57 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.483 -0.78 . . . . 1.16 111.003 -179.283 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.58 145.57 50.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.746 -0.661 . . . . 0.78 110.141 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.28 101.7 9.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.073 -0.714 . . . . 1.08 109.073 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.47 HG11 ' N ' ' A' ' 131' ' ' SER . 71.5 t -112.93 139.63 37.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 1.1 111.069 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.47 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.7 p -128.7 152.58 48.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.621 -0.718 . . . . 0.87 109.834 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.648 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.9 p90 -144.78 -165.01 2.05 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.687 -0.405 . . . . 0.37 110.675 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -123.95 127.16 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.198 -0.455 . . . . 1.14 110.861 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.175 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.88 58.32 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.086 -0.506 . . . . 1.91 110.402 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.12 24.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.934 -0.576 . . . . 1.56 111.435 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.175 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.12 128.69 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.594 -0.443 . . . . 1.56 110.98 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.4 -9.55 56.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.58 . . . . 1.88 110.278 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.0 p -87.09 0.2 55.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.08 0.467 . . . . 1.63 110.358 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.963 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.22 137.07 25.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.951 -0.568 . . . . 1.11 109.961 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 185' ' ' ILE . 89.4 p -96.12 -15.54 22.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.262 0.553 . . . . 1.01 110.057 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.56 175.6 45.78 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 109.861 -1.296 . . . . 0.14 109.861 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -123.45 151.65 42.47 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.65 -0.42 . . . . 0.21 110.529 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.619 ' NH1' ' CG ' ' A' ' 15' ' ' PRO . 36.7 ttp85 -132.33 121.16 23.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.131 -0.486 . . . . 1.54 109.919 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.49 HG23 HG11 ' A' ' 167' ' ' VAL . 46.5 t -105.09 136.48 38.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.705 -0.679 . . . . 1.08 110.661 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 85.2 tt0 -129.33 129.88 45.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.029 -0.532 . . . . 1.32 110.013 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.75 135.25 34.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.005 -0.543 . . . . 1.05 110.638 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.405 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.26 161.3 39.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.659 -0.7 . . . . 1.16 109.704 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.939 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.1 mt -70.98 124.87 25.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.068 0.461 . . . . 1.23 110.729 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.497 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.73 -7.77 50.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.766 -0.652 . . . . 0.86 110.874 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.79 -69.67 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.35 -0.386 . . . . 1.66 111.416 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.44 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.74 -35.33 76.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.076 -0.511 . . . . 1.66 111.42 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.088 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.22 88.6 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.785 -0.926 . . . . 1.62 110.785 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.336 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.89 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.778 0.323 . . . . 1.86 110.25 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.336 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.33 138.99 44.87 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.941 0.401 . . . . 1.98 110.145 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.477 ' CG ' ' OG ' ' A' ' 95' ' ' SER . 47.2 Cg_endo -70.79 145.76 52.05 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.635 2.223 . . . . 0.62 112.406 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.79 145.66 42.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.264 -0.643 . . . . 1.14 109.264 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.581 ' CE1' ' CG ' ' A' ' 16' ' ' ASN . 6.3 p90 -123.27 141.23 52.19 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.453 -0.499 . . . . 1.44 111.567 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.418 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.6 mt -128.03 127.66 43.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.35 -0.841 . . . . 1.08 108.964 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.571 ' HB2' HD22 ' A' ' 16' ' ' ASN . 30.1 t0 -101.65 131.16 48.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.185 0.517 . . . . 1.09 111.767 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.508 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -127.99 157.57 73.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.31 -0.859 . . . . 1.04 109.508 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -69.8 157.96 58.52 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.437 2.091 . . . . 0.21 112.197 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.4 p -59.11 -12.27 4.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.737 -0.665 . . . . 0.88 110.813 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.4 p -92.83 -8.71 42.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.128 -0.487 . . . . 1.06 110.633 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.31 34.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.454 -0.339 . . . . 1.05 110.364 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.1 p -133.05 16.65 4.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.454 -0.339 . . . . 1.07 110.624 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.6 p -167.55 147.11 5.07 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.61 -0.515 . . . . 0.92 109.61 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.508 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.1 p -152.21 150.42 12.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.548 -0.461 . . . . 1.09 111.598 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.499 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 124.95 50.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.628 -0.715 . . . . 1.31 109.811 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.523 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.4 104.87 29.68 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.428 -0.351 . . . . 1.09 111.038 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.8 Cg_endo -91.04 -179.58 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 123.224 2.616 . . . . 0.48 112.179 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.78 32.59 18.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.324 -0.853 . . . . 1.26 111.427 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.523 HD21 HG21 ' A' ' 169' ' ' ILE . 24.1 mt -86.36 148.51 25.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.476 -0.329 . . . . 1.12 110.532 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.772 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.22 114.77 60.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.982 0.42 . . . . 1.3 110.688 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -58.97 140.57 95.91 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.891 2.394 . . . . 0.92 112.017 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.06 21.25 74.25 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.047 -0.821 . . . . 0.44 111.047 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.44 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.97 150.23 49.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 3.05 110.62 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.497 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.2 131.64 46.02 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.077 -0.511 . . . . 1.48 109.809 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.939 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.54 148.33 43.99 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.136 -0.484 . . . . 0.89 110.992 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.1 mt -105.35 125.41 60.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.281 -1.007 . . . . 1.12 108.281 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.58 132.57 63.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.126 0.489 . . . . 1.1 111.247 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.58 122.52 20.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.57 -0.741 . . . . 0.43 109.69 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.593 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -100.94 125.36 54.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.242 -0.436 . . . . 1.07 110.62 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.671 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.2 m-85 -117.17 137.86 52.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.023 -0.535 . . . . 0.92 109.956 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.573 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.67 134.95 42.88 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.838 -0.801 . . . . 0.49 108.838 178.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.564 ' O ' ' N ' ' A' ' 140' ' ' SER . 84.3 mt -99.1 122.94 51.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.09 0.471 . . . . 1.08 110.962 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.449 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.9 p -83.88 169.68 14.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.518 -0.764 . . . . 0.89 110.461 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.667 ' C ' ' HG1' ' A' ' 59' ' ' THR . 43.3 tt0 -59.67 -14.63 14.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.077 -0.511 . . . . 1.6 110.936 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.732 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.6 m-20 -96.07 -4.27 43.26 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.866 -0.333 . . . . 1.18 110.818 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.76 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.79 13.87 64.04 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.312 -0.715 . . . . 0.34 111.312 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -84.62 139.13 32.29 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.015 -0.274 . . . . 1.22 110.449 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.489 ' NE2' ' HG3' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -106.73 141.11 38.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.797 0.332 . . . . 1.44 110.601 179.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.75 126.97 26.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 1.39 110.402 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.671 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.4 tp -68.12 117.22 9.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.386 -0.37 . . . . 1.08 110.543 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.648 HD12 ' CD1' ' A' ' 132' ' ' TRP . 43.8 pt -108.97 -21.8 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.457 . . . . 1.08 110.838 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.93 125.74 5.85 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.467 -0.493 . . . . 1.1 111.49 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.496 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.7 120.17 21.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.702 -0.681 . . . . 0.94 109.576 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.58 151.76 29.23 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.594 -0.443 . . . . 1.07 110.929 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.48 158.56 18.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.007 -0.542 . . . . 0.89 110.38 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.08 157.9 43.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 0.67 110.646 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.14 104.34 9.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.748 -0.66 . . . . 1.17 110.043 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.484 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 66.5 p . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.01 -0.995 . . . . 1.26 110.653 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.553 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.6 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.226 -0.657 . . . . 3.83 109.226 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.64 18.54 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.071 -0.811 . . . . 1.39 111.071 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -35.62 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.297 -2.147 0 C-N-CA 124.039 3.159 . . . . 0.86 113.773 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.575 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.0 t -79.83 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.296 -1.32 . . . . 1.43 108.912 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.66 125.9 51.53 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.489 -0.484 . . . . 1.94 111.424 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.57 143.91 34.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.677 -0.692 . . . . 1.19 110.57 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.97 168.33 25.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.966 0.412 . . . . 3.92 111.142 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.587 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.0 130.99 60.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.976 -0.557 . . . . 3.88 110.101 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.8 p -141.14 162.26 35.9 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.902 0.382 . . . . 3.92 111.164 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 21.3 pt-20 36.12 31.61 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.695 -0.483 . . . . 6.08 109.695 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.587 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.59 32.61 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.867 -0.606 . . . . 4.01 111.578 -178.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.633 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.28 -29.1 72.79 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.465 2.11 . . . . 4.51 111.884 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.633 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.61 125.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 3.51 110.511 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.577 ' O ' ' O ' ' A' ' 92' ' ' THR . 1.5 mp0 -123.91 158.36 60.31 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.304 -0.407 . . . . 4.3 110.378 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.6 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 96.3 Cg_endo -82.11 -64.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.874 2.382 . . . . 1.96 113.542 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.66 ' ND2' ' N ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -108.48 -19.66 13.37 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.081 0.4 . . . . 3.33 112.081 -178.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.66 ' N ' ' ND2' ' A' ' 16' ' ' ASN . 95.8 p -107.2 152.02 24.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.164 0.507 . . . . 1.53 111.333 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.25 102.98 2.23 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.79 -0.641 . . . . 2.29 110.669 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.6 145.58 13.11 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.932 2.422 . . . . 0.88 112.59 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.416 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.82 167.91 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.911 -0.586 . . . . 2.12 109.899 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.14 147.85 28.96 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.855 -0.424 . . . . 2.67 109.855 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.499 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.5 p90 -142.18 157.34 44.97 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.663 -0.415 . . . . 0.32 111.223 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.466 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.2 m-20 -128.12 155.3 44.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.81 -0.632 . . . . 2.77 110.024 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.58 173.02 6.38 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.065 -0.516 . . . . 1.25 110.723 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.6 173.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.876 2.384 . . . . 1.12 111.543 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.04 -50.99 0.69 Allowed Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.68 -0.408 . . . . 4.05 110.166 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.658 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.84 152.38 82.38 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.797 2.331 . . . . 2.12 111.438 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.8 42.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.415 0.626 . . . . 2.85 110.538 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.819 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.54 -41.62 98.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.01 -0.996 . . . . 3.11 110.697 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.441 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.4 mt -109.86 137.82 40.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.815 -0.63 . . . . 1.86 111.274 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.9 -72.96 0.7 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.057 -0.52 . . . . 1.61 111.913 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.09 148.33 24.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.638 0.606 . . . . 1.67 112.638 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.84 124.88 45.2 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.318 -0.623 . . . . 1.07 109.318 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.0 134.79 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.647 -0.421 . . . . 1.55 110.649 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.484 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -120.03 128.66 53.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.297 -0.41 . . . . 1.33 111.191 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.54 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.17 138.97 49.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.807 -0.633 . . . . 2.36 110.023 179.003 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.415 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.03 163.11 35.23 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.119 0.485 . . . . 0.38 112.074 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.43 139.51 7.87 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.413 -0.812 . . . . 2.31 110.42 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.52 115.45 3.04 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.336 2.024 . . . . 0.86 111.77 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.679 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.94 81.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.868 -0.419 . . . . 3.44 109.868 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.21 -20.74 0.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.983 -0.553 . . . . 2.72 111.919 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -157.55 157.81 34.44 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.806 -0.358 . . . . 2.78 110.592 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.404 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.34 27.68 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 2.3 110.22 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.79 -75.86 1.31 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.08 -0.581 . . . . 1.8 111.884 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.82 152.28 35.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.845 0.355 . . . . 5.48 111.045 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.18 -169.16 2.55 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.071 -0.513 . . . . 1.84 111.955 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.415 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.73 29.65 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.431 0.634 . . . . 2.27 112.589 -177.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.13 156.53 45.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.87 -1.059 . . . . 1.92 110.16 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.25 158.33 41.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.898 -0.592 . . . . 1.09 111.826 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.0 m -115.23 135.71 53.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.386 -0.824 . . . . 1.16 109.758 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.451 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.39 121.91 23.77 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.371 -0.377 . . . . 1.39 111.546 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.513 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.7 Cg_exo -46.41 151.76 1.68 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.653 2.235 . . . . 0.72 112.08 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.91 -23.04 63.06 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 116.028 -0.533 . . . . 0.74 112.854 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.513 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.69 -17.03 45.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.343 0.572 . . . . 1.26 111.803 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.487 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.49 138.46 31.56 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.699 -0.4 . . . . 1.59 110.32 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.59 14.02 10.96 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.398 -0.365 . . . . 2.07 111.551 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.474 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.1 143.42 25.08 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.675 -0.41 . . . . 0.96 111.048 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.716 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.74 -169.42 1.54 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.938 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.716 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.5 t -151.72 125.91 9.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.438 -0.801 . . . . 1.19 109.828 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.467 HG23 HD11 ' A' ' 60' ' ' ILE . 66.5 mt -114.77 123.29 70.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.373 -0.531 . . . . 1.47 111.207 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.646 ' NZ ' ' N ' ' A' ' 142' ' ' PHE . 88.9 tttt -126.52 163.34 23.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.898 -0.592 . . . . 3.0 110.417 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.513 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.17 18.96 59.84 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.793 -0.923 . . . . 0.5 110.793 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.44 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.8 mt -79.15 157.28 27.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.108 0.48 . . . . 1.21 111.299 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.616 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 4.5 mttp -99.47 133.92 21.57 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.531 -0.759 . . . . 3.2 110.536 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.535 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.87 143.56 61.38 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.584 2.189 . . . . 1.09 111.95 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.77 25.71 75.24 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.088 -0.805 . . . . 0.72 111.088 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.64 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.25 158.73 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.717 0.294 . . . . 1.47 110.371 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.11 139.93 41.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.946 0.403 . . . . 1.23 110.516 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.64 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.63 136.42 54.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.905 -0.589 . . . . 1.1 110.782 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.87 131.04 45.27 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.442 -0.947 . . . . 1.87 108.442 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.49 153.97 16.64 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.313 -0.946 . . . . 0.39 111.935 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.05 140.85 45.91 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.726 -0.472 . . . . 1.8 109.726 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.462 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.8 tp -115.72 118.95 34.47 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.411 -0.516 . . . . 1.11 110.53 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.9 mt -112.44 129.03 68.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.332 -0.395 . . . . 1.51 110.582 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.85 120.78 43.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.294 -0.412 . . . . 1.47 110.764 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.668 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.45 146.47 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.173 0.511 . . . . 1.33 111.069 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.819 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.08 153.85 21.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.525 -0.761 . . . . 2.49 109.947 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.425 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.15 88.62 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.938 0.399 . . . . 4.2 110.408 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.613 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.61 0.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.85 -0.614 . . . . 6.4 110.592 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.17 -117.35 3.28 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.424 -0.67 . . . . 1.74 111.424 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.445 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.1 m170 -81.43 177.36 9.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.194 0.521 . . . . 3.64 111.637 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.08 149.61 32.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.398 -0.819 . . . . 1.7 110.353 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.553 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.21 144.71 38.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.449 -0.341 . . . . 2.7 110.528 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -128.03 135.97 61.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.002 0.43 . . . . 1.16 111.534 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.07 141.36 52.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.677 -0.692 . . . . 1.14 110.211 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.442 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.62 138.86 51.67 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.083 0.468 . . . . 4.33 111.577 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.491 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.27 164.09 38.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.623 -0.717 . . . . 0.91 109.468 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.57 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.18 151.62 38.72 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.473 -0.491 . . . . 1.47 111.046 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.574 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.7 p90 -146.35 172.71 13.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.734 -0.666 . . . . 0.51 111.033 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.449 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.5 t -118.78 160.65 21.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.479 -0.782 . . . . 1.92 109.828 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.449 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.34 121.82 22.92 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.627 -0.429 . . . . 1.63 110.83 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.577 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.0 p -128.18 162.99 25.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.082 -0.508 . . . . 2.37 111.667 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.6 m -63.21 154.57 30.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 3.63 110.028 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 12.0 t -60.49 -39.4 87.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.97 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 81.5 p -98.58 159.53 14.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.412 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.6 m -59.65 131.94 88.65 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.47 136.98 66.75 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.492 1.461 . . . . 0.0 112.931 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.84 -24.41 34.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.695 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 66.4 p -60.68 -15.98 34.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.524 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.9 p -67.65 156.54 36.61 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.31 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -116.56 127.95 54.98 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.451 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 56.6 m -75.54 135.34 40.6 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.59 144.71 36.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.156 0.503 . . . . 0.0 112.353 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 107' ' ' THR . 20.0 p -120.26 157.55 28.89 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.982 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.35 -39.95 95.39 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.401 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -63.5 -39.06 93.45 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 104' ' ' THR . 27.2 m -128.95 145.22 51.29 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.507 0.194 . . . . 0.0 111.278 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.7 m -124.02 75.65 58.49 Favored Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.553 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -63.76 146.54 92.11 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.961 2.441 . . . . 0.0 112.908 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -107.61 133.54 51.9 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.5 m -127.58 78.42 74.83 Favored Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.226 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -54.76 144.06 67.41 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.287 1.992 . . . . 0.0 111.784 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.7 mt -94.32 144.43 25.55 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.165 -0.47 . . . . 10.52 110.631 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.423 HG13 ' H ' ' A' ' 116' ' ' THR . 42.5 t -110.67 132.22 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.22 -0.446 . . . . 7.48 109.967 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.48 25.77 11.34 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.362 0.504 . . . . 7.69 112.362 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.423 ' H ' HG13 ' A' ' 114' ' ' VAL . 44.1 p -78.22 155.83 30.1 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.19 -0.604 . . . . 6.46 110.85 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.675 ' HG ' ' H ' ' A' ' 119' ' ' SER . 85.7 p -65.77 -27.21 68.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.759 -0.655 . . . . 4.59 111.82 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 118' ' ' GLU . 82.9 tt0 55.41 17.73 2.3 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.76 -0.83 . . . . 3.21 108.76 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.675 ' H ' ' HG ' ' A' ' 117' ' ' SER . 60.4 p -71.94 166.7 21.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.165 -0.925 . . . . 3.64 111.471 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.1 t 64.51 15.35 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 CA-C-N 115.595 -0.729 . . . . 3.39 111.387 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.8 t -72.07 135.37 46.27 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.548 -0.461 . . . . 2.23 109.887 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.14 142.29 56.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.484 -0.326 . . . . 4.53 110.777 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 32.9 pt -124.43 155.98 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.361 -0.382 . . . . 2.01 110.763 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.468 ' OG1' ' CG ' ' A' ' 174' ' ' PRO . 24.2 p -126.78 161.76 27.43 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.055 -0.521 . . . . 2.22 110.406 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' A' ' 126' ' ' SER . . . -69.56 138.5 53.29 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.713 -0.395 . . . . 1.29 110.337 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.3 OUTLIER 166.49 14.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.888 0.851 . . . . 1.25 109.317 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.477 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.82 167.54 0.25 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.959 -1.018 . . . . 1.16 110.944 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.481 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.9 m-30 -133.66 145.48 49.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.757 -0.656 . . . . 0.78 110.178 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.23 101.76 9.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.075 -0.713 . . . . 1.08 109.075 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.468 HG11 ' N ' ' A' ' 131' ' ' SER . 72.0 t -112.96 139.68 36.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.982 -0.554 . . . . 1.1 111.077 -178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.468 ' N ' HG11 ' A' ' 130' ' ' VAL . 68.1 p -128.79 152.6 48.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.625 -0.716 . . . . 0.87 109.812 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.65 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.6 p90 -144.76 -164.97 2.04 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.731 -0.388 . . . . 0.37 110.666 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.5 t -123.87 127.12 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 1.14 110.853 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.18 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -58.03 58.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 1.91 110.383 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.11 24.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.831 -0.622 . . . . 1.56 111.482 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.18 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.18 128.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.59 -0.444 . . . . 1.56 110.904 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.42 -9.59 55.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.926 -0.579 . . . . 1.88 110.332 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.419 ' HB ' ' OE2' ' A' ' 187' ' ' GLU . 28.5 p -87.09 0.2 55.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.094 -0.503 . . . . 1.63 110.348 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.965 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.28 137.21 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.987 -0.551 . . . . 1.11 109.905 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 185' ' ' ILE . 81.8 p -96.19 -15.59 21.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.301 0.572 . . . . 1.01 110.04 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.613 ' C ' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.61 175.57 45.79 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 109.929 -1.269 . . . . 0.14 109.929 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.646 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . 76.2 m-85 -123.45 151.63 42.48 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.605 -0.438 . . . . 0.21 110.521 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.6 ' CZ ' ' CG ' ' A' ' 15' ' ' PRO . 73.8 ttt-85 -132.38 121.18 23.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.14 -0.482 . . . . 1.54 109.938 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.5 HG23 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.09 136.49 38.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.646 -0.707 . . . . 1.08 110.705 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 81.4 tt0 -129.3 129.82 45.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.966 -0.561 . . . . 1.32 110.132 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.606 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 36.1 p90 -138.65 135.3 34.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.06 -0.518 . . . . 1.05 110.659 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.407 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.31 161.35 39.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.723 -0.672 . . . . 1.16 109.699 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.949 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.3 mt -71.01 124.84 25.31 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.666 -0.414 . . . . 1.23 110.814 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.82 -7.66 49.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.764 -0.653 . . . . 0.86 110.76 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -109.78 -69.69 0.85 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.003 0.43 . . . . 1.66 111.477 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.473 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.58 -35.4 75.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.995 -0.548 . . . . 1.66 111.561 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.076 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.14 88.66 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.905 -0.878 . . . . 1.62 110.905 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.332 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.92 -171.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.742 0.306 . . . . 1.86 110.24 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.332 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.3 139.04 44.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 1.98 110.198 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.407 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 48.1 Cg_endo -70.83 145.79 51.88 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 122.755 2.304 . . . . 0.62 112.299 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.83 145.83 42.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.263 -0.643 . . . . 1.14 109.263 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.535 ' CE1' ' CD ' ' A' ' 65' ' ' PRO . 14.5 p90 -123.37 141.24 52.19 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.356 -0.538 . . . . 1.44 111.54 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.408 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.5 mt -128.03 127.68 43.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.356 -0.838 . . . . 1.08 108.95 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.482 ' OD2' ' HA2' ' A' ' 62' ' ' GLY . 95.2 m-20 -101.69 131.1 48.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.127 0.489 . . . . 1.09 111.76 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.495 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -127.91 157.59 73.26 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.323 -0.853 . . . . 1.04 109.557 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -69.76 158.0 58.46 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.467 2.111 . . . . 0.21 112.239 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.28 -12.14 5.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.754 -0.657 . . . . 0.88 110.79 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.7 p -92.85 -8.75 42.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 1.06 110.662 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.15 135.36 34.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.394 -0.366 . . . . 1.05 110.361 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.17 16.72 4.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.358 -0.383 . . . . 1.07 110.502 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.0 p -167.55 147.04 5.05 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.694 -0.484 . . . . 0.92 109.694 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.5 HG11 HG23 ' A' ' 144' ' ' VAL . 6.1 p -152.11 150.53 12.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.514 -0.474 . . . . 1.09 111.509 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.499 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.34 124.89 50.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.541 -0.754 . . . . 1.31 109.825 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.522 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.43 104.86 29.69 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.404 -0.362 . . . . 1.09 111.117 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 84.3 Cg_endo -90.99 -179.42 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 123.046 2.497 . . . . 0.48 112.163 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.61 32.68 18.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.393 -0.821 . . . . 1.26 111.501 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.522 HD21 HG21 ' A' ' 169' ' ' ILE . 24.4 mt -86.4 148.64 25.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 1.12 110.467 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.78 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.42 114.85 61.39 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.976 0.417 . . . . 1.3 110.585 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.468 ' CG ' ' OG1' ' A' ' 124' ' ' THR . 21.9 Cg_exo -59.0 140.62 96.16 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.866 2.377 . . . . 0.92 111.962 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.27 74.19 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.042 -0.823 . . . . 0.44 111.042 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.473 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.99 150.1 49.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.333 . . . . 3.05 110.62 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.5 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.08 131.62 45.92 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.026 -0.533 . . . . 1.48 109.745 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.949 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.5 148.47 43.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.16 -0.473 . . . . 0.89 111.036 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.5 mt -105.42 125.32 60.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.271 -1.011 . . . . 1.12 108.271 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.58 132.51 63.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.164 0.507 . . . . 1.1 111.192 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.47 122.57 20.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.565 -0.743 . . . . 0.43 109.628 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.596 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.02 125.42 54.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.286 -0.415 . . . . 1.07 110.713 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.674 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.5 m-85 -117.26 137.81 52.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.07 -0.514 . . . . 0.92 109.837 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.574 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.61 135.03 42.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.828 -0.805 . . . . 0.49 108.828 178.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.594 ' O ' ' N ' ' A' ' 140' ' ' SER . 50.0 mm -99.11 122.91 51.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.148 0.499 . . . . 1.08 111.015 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.445 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.1 p -83.84 169.62 14.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.547 -0.752 . . . . 0.89 110.49 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.597 ' O ' ' CG2' ' A' ' 59' ' ' THR . 0.0 OUTLIER -59.67 -14.59 14.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.06 -0.518 . . . . 1.6 110.954 -179.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.445 ' H ' ' HG ' ' A' ' 186' ' ' SER . 87.2 m-20 -96.03 -4.35 43.24 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.784 -0.366 . . . . 1.18 110.793 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.78 14.0 63.82 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.356 -0.697 . . . . 0.34 111.356 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -84.66 139.07 32.3 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.093 -0.243 . . . . 1.22 110.439 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.492 ' NE2' ' HG3' ' A' ' 14' ' ' GLN . 4.1 mt-30 -106.78 141.05 38.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.868 0.366 . . . . 1.44 110.537 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.4 m -136.67 127.05 26.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 1.39 110.367 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.674 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.6 tp -68.18 117.25 9.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.319 -0.4 . . . . 1.08 110.486 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.65 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.1 pt -109.01 -21.69 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 1.08 110.725 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.96 125.78 5.85 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.55 -0.46 . . . . 1.1 111.466 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.488 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.82 120.19 21.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.739 -0.664 . . . . 0.94 109.591 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.62 151.66 29.08 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.608 -0.437 . . . . 1.07 110.895 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.8 p -110.38 158.61 18.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.99 -0.55 . . . . 0.89 110.451 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.13 157.95 43.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.068 -0.514 . . . . 0.67 110.639 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.36 9.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.689 -0.687 . . . . 1.17 109.99 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.481 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.5 p . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.966 -1.016 . . . . 1.26 110.556 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.9 m . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.18 -0.674 . . . . 3.83 109.18 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.36 150.72 18.54 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.956 -0.858 . . . . 1.39 110.956 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -35.52 142.39 0.1 OUTLIER 'Trans proline' 0 C--N 1.3 -2.024 0 C-N-CA 123.965 3.11 . . . . 0.86 113.845 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.563 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.1 t -79.96 173.47 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.25 -1.341 . . . . 1.43 108.904 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.401 ' H ' ' CG1' ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.59 125.91 51.53 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.416 -0.513 . . . . 1.94 111.423 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.62 144.01 33.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.688 -0.687 . . . . 1.19 110.693 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.04 168.29 25.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.852 0.358 . . . . 3.92 111.093 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.587 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.92 131.03 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.019 -0.537 . . . . 3.88 110.109 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.21 162.22 36.0 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.917 0.389 . . . . 3.92 111.213 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 32.6 tp10 36.23 31.47 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.651 -0.5 . . . . 6.08 109.651 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.587 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.65 32.74 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.914 -0.585 . . . . 4.01 111.575 -178.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.632 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.29 -29.16 72.68 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.494 2.129 . . . . 4.51 111.81 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.632 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.7 125.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 3.51 110.377 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.646 ' O ' ' O ' ' A' ' 92' ' ' THR . 11.7 mp0 -123.97 158.41 60.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.321 -0.399 . . . . 4.3 110.49 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.551 ' HB2' HH21 ' A' ' 143' ' ' ARG . 96.9 Cg_endo -82.11 -64.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.852 2.368 . . . . 1.96 113.47 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.577 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 63.5 t30 -108.35 -19.67 13.39 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.081 0.4 . . . . 3.33 112.081 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 66.1 p -107.31 152.13 24.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.206 0.527 . . . . 1.53 111.246 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.573 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.33 102.96 2.22 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.702 -0.681 . . . . 2.29 110.63 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.75 145.58 12.88 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.912 2.408 . . . . 0.88 112.611 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.41 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.73 167.96 24.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.938 -0.573 . . . . 2.12 109.879 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -149.14 147.99 29.11 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.609 -0.515 . . . . 2.67 109.609 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.496 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.8 p90 -142.28 157.26 45.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.019 0.437 . . . . 0.32 111.229 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.464 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.9 m-20 -128.05 155.24 44.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.853 -0.612 . . . . 2.77 110.098 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.57 172.99 6.41 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.137 0.494 . . . . 1.25 110.801 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.61 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.913 2.409 . . . . 1.12 111.534 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.479 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.14 -51.06 0.68 Allowed Pre-proline 0 C--N 1.328 -0.344 0 C-N-CA 120.709 -0.397 . . . . 4.05 110.052 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.652 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.79 152.32 82.53 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.808 2.339 . . . . 2.12 111.442 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.66 42.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.373 0.606 . . . . 2.85 110.571 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.82 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.73 -41.56 98.04 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.037 -0.983 . . . . 3.11 110.653 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.438 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.2 mt -109.91 137.85 40.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.767 -0.651 . . . . 1.86 111.211 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.91 -72.94 0.7 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.004 -0.544 . . . . 1.61 111.936 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.15 148.37 24.45 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.651 0.611 . . . . 1.67 112.651 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.82 124.82 45.06 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.35 -0.611 . . . . 1.07 109.35 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.9 mt -118.08 134.73 60.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.646 -0.422 . . . . 1.55 110.566 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.488 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -119.99 128.63 53.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.434 . . . . 1.33 111.288 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.547 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.14 139.01 49.73 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.746 -0.661 . . . . 2.36 110.115 178.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.418 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.0 p90 -145.14 163.13 35.3 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.176 0.512 . . . . 0.38 112.018 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.489 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.48 139.49 7.81 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 115.399 -0.818 . . . . 2.31 110.484 178.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.53 115.5 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.309 2.006 . . . . 0.86 111.839 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.667 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.03 81.21 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.81 -0.441 . . . . 3.44 109.81 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.15 -20.75 0.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.027 -0.533 . . . . 2.72 111.843 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.4 p -157.52 157.75 34.4 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.937 -0.305 . . . . 2.78 110.65 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.43 27.9 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.27 -0.423 . . . . 2.3 110.241 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.89 -75.83 1.31 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.066 -0.587 . . . . 1.8 111.834 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.91 152.27 35.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.964 0.411 . . . . 5.48 110.927 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.676 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.24 -169.14 2.53 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.068 -0.514 . . . . 1.84 111.938 179.298 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.11 149.69 29.68 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.463 0.649 . . . . 2.27 112.569 -177.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -140.98 156.53 46.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.745 -1.116 . . . . 1.92 110.257 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.3 158.47 41.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.967 -0.56 . . . . 1.09 111.706 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.7 m -115.24 135.69 53.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.385 -0.825 . . . . 1.16 109.799 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.443 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.43 122.05 23.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.403 -0.362 . . . . 1.39 111.48 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.514 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.1 Cg_exo -46.45 151.75 1.71 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.675 2.25 . . . . 0.72 112.115 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.98 -22.87 63.03 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 116.092 -0.504 . . . . 0.74 112.798 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.514 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.9 -16.9 45.66 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.259 -0.576 . . . . 1.26 111.763 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.491 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.5 mt -91.52 138.37 31.63 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.848 -0.341 . . . . 1.59 110.366 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.56 13.92 10.97 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.409 -0.359 . . . . 2.07 111.561 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.475 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -150.01 143.49 25.21 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.658 -0.417 . . . . 0.96 111.061 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.72 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.82 -169.38 1.54 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.961 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.72 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.3 m -151.69 125.92 9.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.483 -0.78 . . . . 1.19 109.867 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 60' ' ' ILE . 66.9 mt -114.94 123.29 70.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.404 -0.518 . . . . 1.47 111.186 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -126.48 163.48 23.25 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.824 -0.625 . . . . 3.0 110.37 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.436 ' HA2' HD22 ' A' ' 16' ' ' ASN . . . 85.09 18.9 60.09 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.735 -0.946 . . . . 0.5 110.735 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.577 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.4 mt -78.9 157.22 28.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.065 0.459 . . . . 1.21 111.438 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.617 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -99.52 133.94 21.52 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.684 -0.689 . . . . 3.2 110.396 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.433 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.95 143.62 61.18 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.519 2.146 . . . . 1.09 111.97 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.73 25.79 75.15 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.041 -0.823 . . . . 0.72 111.041 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.637 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.16 158.85 39.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.705 0.288 . . . . 1.47 110.456 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.23 139.95 42.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.946 0.403 . . . . 1.23 110.562 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.637 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.6 m-85 -122.59 136.42 54.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.949 -0.568 . . . . 1.1 110.729 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.489 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.9 131.01 45.31 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.488 -0.93 . . . . 1.87 108.488 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.488 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.46 153.85 16.64 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.261 -0.971 . . . . 0.39 111.917 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.93 140.9 46.1 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.73 -0.47 . . . . 1.8 109.73 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.467 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.9 tp -115.7 118.9 34.35 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.493 -0.483 . . . . 1.11 110.553 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.2 mt -112.43 129.08 68.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.303 -0.408 . . . . 1.51 110.669 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.78 120.84 43.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.289 -0.414 . . . . 1.47 110.715 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.67 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.52 146.43 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.241 0.543 . . . . 1.33 111.01 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.82 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.02 153.9 21.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.524 -0.762 . . . . 2.49 109.956 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.26 88.65 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.932 0.396 . . . . 4.2 110.42 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.622 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.21 32.73 0.21 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.793 -0.639 . . . . 6.4 110.609 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.12 -117.38 3.29 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.437 -0.665 . . . . 1.74 111.437 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.449 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.5 177.37 8.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.158 0.504 . . . . 3.64 111.661 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.1 149.51 32.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.481 -0.781 . . . . 1.7 110.359 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.16 144.72 38.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.417 -0.356 . . . . 2.7 110.558 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -128.01 136.01 61.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 121.048 0.451 . . . . 1.16 111.506 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.04 141.37 52.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.624 -0.716 . . . . 1.14 110.279 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.45 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.68 138.93 51.66 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.441 -0.503 . . . . 4.33 111.466 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 53.0 p90 -152.32 164.23 37.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.521 -0.763 . . . . 0.91 109.467 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.575 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.1 p30 -145.24 151.52 38.51 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.503 -0.479 . . . . 1.47 111.084 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.573 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.1 p90 -146.22 172.7 13.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.782 -0.645 . . . . 0.51 111.068 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.453 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.5 t -118.8 160.61 21.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.496 -0.774 . . . . 1.92 109.821 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.453 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.36 121.83 22.92 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 120.587 -0.445 . . . . 1.63 110.781 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.646 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -128.08 163.55 24.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.156 -0.475 . . . . 2.37 110.309 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.6 t -109.95 132.45 54.15 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.312 -0.555 . . . . 3.63 110.628 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.8 p -130.09 163.91 25.54 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.25 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 29.6 t -118.18 135.24 54.36 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 38.9 m -132.9 78.33 66.21 Favored Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.527 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.15 136.08 66.59 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 121.899 1.733 . . . . 0.0 112.145 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 83.4 t -64.28 -37.76 80.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.258 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.2 p -79.21 162.25 25.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.459 0.647 . . . . 0.0 112.047 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.5 p -69.26 -10.34 57.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.046 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -57.73 166.68 1.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.933 0.397 . . . . 0.0 110.695 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.2 p -78.19 164.17 25.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.24 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 71.6 t -58.85 -39.3 77.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.428 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.7 p -80.58 157.93 25.9 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.154 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 153.52 -173.59 32.25 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -114.19 -96.63 0.45 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.49 ' OG1' ' NZ ' ' A' ' 177' ' ' LYS . 47.4 m -126.78 137.52 53.23 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.593 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.1 p -78.72 141.0 59.35 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.6 141.61 86.67 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.767 1.645 . . . . 0.0 111.787 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.501 ' O ' ' OG ' ' A' ' 111' ' ' SER . 49.3 p90 -140.23 157.35 45.72 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.956 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.501 ' OG ' ' O ' ' A' ' 110' ' ' PHE . 49.0 m -171.95 63.5 0.35 Allowed Pre-proline 0 C--N 1.332 -0.152 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.812 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -54.62 139.28 76.23 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.995 1.797 . . . . 0.0 112.12 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.2 mt -62.2 -34.55 76.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 10.52 110.566 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 26.2 m -69.83 135.77 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.096 -0.502 . . . . 7.48 111.336 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.22 148.12 52.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.859 -0.609 . . . . 7.69 110.283 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.41 HG21 ' H ' ' A' ' 118' ' ' GLU . 47.6 m -73.61 135.98 43.89 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.826 -0.35 . . . . 6.46 110.218 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.6 m -58.35 -35.13 71.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.053 -0.522 . . . . 4.59 111.383 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.468 ' HG2' ' H ' ' A' ' 120' ' ' VAL . 84.2 tt0 -99.0 140.58 32.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.414 -0.357 . . . . 3.21 110.256 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.0 t -57.76 -34.0 69.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 3.64 111.033 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.568 HG22 ' H ' ' A' ' 122' ' ' GLU . 12.4 p -129.64 142.74 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.251 -0.431 . . . . 3.39 110.136 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 59.5 p -67.9 -24.88 65.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.338 -0.392 . . . . 2.23 111.668 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.568 ' H ' HG22 ' A' ' 120' ' ' VAL . 77.7 mm-40 -58.71 142.4 49.99 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.817 -0.353 . . . . 4.53 110.427 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 16.8 tt -123.84 139.12 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.038 -0.528 . . . . 2.01 110.633 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.45 ' O ' ' CB ' ' A' ' 125' ' ' ALA . 45.2 m -72.83 137.29 45.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.414 -0.357 . . . . 2.22 110.14 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 124' ' ' THR . . . 81.88 144.32 0.07 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.012 -0.54 . . . . 1.29 109.686 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.3 p -61.47 -32.74 72.75 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.53 -0.468 . . . . 1.25 110.818 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.471 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.86 167.55 0.26 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 1.16 110.959 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.54 145.6 50.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.692 -0.685 . . . . 0.78 110.186 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.29 101.65 9.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.086 -0.709 . . . . 1.08 109.086 177.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.459 HG11 ' N ' ' A' ' 131' ' ' SER . 71.1 t -113.0 139.78 36.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.985 -0.552 . . . . 1.1 111.063 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.459 ' N ' HG11 ' A' ' 130' ' ' VAL . 66.7 p -128.71 152.49 48.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.67 -0.696 . . . . 0.87 109.832 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.649 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.9 p90 -144.7 -164.89 2.02 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.722 -0.391 . . . . 0.37 110.691 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.734 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -124.06 127.24 73.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.198 -0.456 . . . . 1.14 110.73 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.172 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.099 -0.501 . . . . 1.91 110.342 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -37.96 24.45 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.946 -0.57 . . . . 1.56 111.566 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.172 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.13 128.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.724 -0.391 . . . . 1.56 111.002 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -86.45 -9.51 56.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.942 -0.572 . . . . 1.88 110.281 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.14 0.16 55.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 1.63 110.315 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.962 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.06 137.15 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 116.008 -0.542 . . . . 1.11 109.985 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 185' ' ' ILE . 87.3 p -96.26 -15.48 21.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.242 0.544 . . . . 1.01 110.066 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.64 175.61 45.86 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 109.881 -1.288 . . . . 0.14 109.881 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.51 151.6 42.63 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.673 -0.411 . . . . 0.21 110.434 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.551 HH21 ' HB2' ' A' ' 15' ' ' PRO . 69.4 ttt-85 -132.36 121.16 23.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.122 -0.49 . . . . 1.54 109.926 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.491 HG23 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.04 136.6 38.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.681 -0.691 . . . . 1.08 110.69 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 83.7 tt0 -129.43 129.84 45.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.067 -0.515 . . . . 1.32 110.01 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.6 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.7 135.32 34.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.965 -0.561 . . . . 1.05 110.656 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.414 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.38 39.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.77 -0.65 . . . . 1.16 109.641 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.938 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.3 mt -71.13 124.85 25.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.039 0.447 . . . . 1.23 110.673 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.73 -7.72 49.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.684 -0.689 . . . . 0.86 110.883 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.77 -69.74 0.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.315 -0.402 . . . . 1.66 111.432 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.442 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.68 -35.21 75.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.027 -0.533 . . . . 1.66 111.563 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.093 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.07 7.29 88.54 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.814 -0.914 . . . . 1.62 110.814 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.322 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.93 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.773 0.321 . . . . 1.86 110.256 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.322 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.33 139.05 44.89 Favored Pre-proline 0 N--CA 1.454 -0.261 0 CA-C-N 116.302 -0.408 . . . . 1.98 110.157 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.414 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.2 Cg_endo -70.85 145.89 52.06 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 C-N-CA 122.656 2.237 . . . . 0.62 112.398 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.6 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.82 145.68 42.63 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.232 -0.655 . . . . 1.14 109.232 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.57 ' CE2' ' CG ' ' A' ' 16' ' ' ASN . 37.3 p90 -123.24 141.37 52.05 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.345 -0.542 . . . . 1.44 111.463 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.423 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.7 mt -128.12 127.74 43.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.313 -0.858 . . . . 1.08 108.966 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -101.68 131.17 48.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.097 0.475 . . . . 1.09 111.779 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.505 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -127.89 157.56 73.33 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.373 -0.831 . . . . 1.04 109.61 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -69.84 158.0 58.32 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.382 2.054 . . . . 0.21 112.27 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.1 p -59.24 -12.17 5.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.792 -0.64 . . . . 0.88 110.714 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.3 p -92.79 -8.74 42.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 1.06 110.714 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.41 34.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.363 -0.38 . . . . 1.05 110.434 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.4 p -133.14 16.58 4.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.348 -0.387 . . . . 1.07 110.475 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.6 p -167.48 147.23 5.15 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.642 -0.503 . . . . 0.92 109.642 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.505 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.18 150.35 13.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.617 -0.433 . . . . 1.09 111.606 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.5 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.25 124.95 50.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.67 -0.695 . . . . 1.31 109.803 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.519 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.42 104.9 29.84 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.426 -0.352 . . . . 1.09 111.117 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.3 Cg_endo -90.91 -179.46 1.51 Allowed 'Trans proline' 0 C--N 1.3 -1.988 0 C-N-CA 123.231 2.621 . . . . 0.48 112.282 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 61.56 32.65 18.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.475 -0.784 . . . . 1.26 111.499 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.519 HD21 HG21 ' A' ' 169' ' ' ILE . 23.6 mt -86.4 148.58 25.51 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.887 -0.325 . . . . 1.12 110.433 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.766 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.27 114.87 61.36 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.051 0.453 . . . . 1.3 110.69 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.95 140.52 95.66 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.951 2.434 . . . . 0.92 111.955 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.27 74.16 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.023 -0.831 . . . . 0.44 111.023 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.442 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.89 150.13 49.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 3.05 110.643 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.501 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.11 131.58 45.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.094 -0.503 . . . . 1.48 109.814 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.938 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.49 148.3 44.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.022 -0.536 . . . . 0.89 111.043 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.1 mt -105.27 125.29 60.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.286 -1.005 . . . . 1.12 108.286 177.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.46 132.47 63.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.193 0.52 . . . . 1.1 111.315 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.6 20.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.501 -0.772 . . . . 0.43 109.638 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.594 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -101.03 125.39 54.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.217 -0.447 . . . . 1.07 110.73 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.674 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.9 m-85 -117.25 137.9 52.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.954 -0.566 . . . . 0.92 109.823 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.569 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.71 135.02 42.81 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.797 -0.816 . . . . 0.49 108.797 178.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 140' ' ' SER . 44.5 mm -99.08 123.0 51.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.136 0.493 . . . . 1.08 110.937 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.449 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.0 p -83.94 169.73 14.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.568 -0.742 . . . . 0.89 110.466 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -59.82 -14.44 14.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.057 -0.519 . . . . 1.6 110.888 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.507 ' C ' ' OG1' ' A' ' 59' ' ' THR . 96.4 m-20 -96.19 -4.34 42.71 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.834 -0.347 . . . . 1.18 110.708 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.62 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.85 13.93 63.83 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.3 -0.72 . . . . 0.34 111.3 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -84.64 139.03 32.34 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.099 -0.24 . . . . 1.22 110.49 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.43 ' NE2' ' OG ' ' A' ' 17' ' ' SER . 1.6 mt-30 -106.64 141.05 38.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.436 -0.347 . . . . 1.44 110.542 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.5 m -136.7 127.07 26.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 1.39 110.374 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.674 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.8 tp -68.11 117.3 9.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.329 -0.396 . . . . 1.08 110.502 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.649 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.3 pt -109.09 -21.81 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 1.08 110.625 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.91 125.72 5.85 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.523 -0.471 . . . . 1.1 111.48 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.484 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.76 120.22 21.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.799 -0.637 . . . . 0.94 109.541 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.62 151.68 29.11 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.663 -0.415 . . . . 1.07 110.938 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.42 158.61 18.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.062 -0.517 . . . . 0.89 110.408 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.1 157.96 43.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.107 -0.497 . . . . 0.67 110.667 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 104.29 9.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.714 -0.676 . . . . 1.17 110.032 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.478 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 68.2 p . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.858 -1.068 . . . . 1.26 110.664 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.55 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.3 m . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.141 -0.688 . . . . 3.83 109.141 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.32 150.72 18.54 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.048 -0.821 . . . . 1.39 111.048 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -35.59 142.42 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.121 0 C-N-CA 124.009 3.139 . . . . 0.86 113.824 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.571 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.3 t -80.02 173.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.199 -1.364 . . . . 1.43 108.775 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 23' ' ' ASN . 96.1 mt-10 -105.62 125.92 51.55 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.385 -0.526 . . . . 1.94 111.371 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.48 143.99 34.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.629 -0.714 . . . . 1.19 110.689 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.4 25.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.833 0.349 . . . . 3.92 111.145 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.589 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.07 131.0 61.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 3.88 109.989 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.16 162.44 35.48 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.882 0.372 . . . . 3.92 111.169 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 9' ' ' THR . 71.0 tt0 36.02 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.088 -0.505 . . . . 6.08 109.689 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.589 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.59 33.07 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.924 -0.58 . . . . 4.01 111.62 -178.777 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.636 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.33 -29.04 72.25 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.438 2.092 . . . . 4.51 111.868 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.636 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.57 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 3.51 110.518 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.675 HE21 HE21 ' A' ' 191' ' ' GLN . 23.2 mt-30 -123.96 158.22 60.92 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.36 -0.382 . . . . 4.3 110.468 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.469 ' HG2' ' CZ ' ' A' ' 143' ' ' ARG . 96.4 Cg_endo -81.94 -64.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.903 2.402 . . . . 1.96 113.568 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.64 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 56.6 t30 -108.49 -19.55 13.41 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.027 0.38 . . . . 3.33 112.027 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.535 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 43.3 t -107.36 152.1 24.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.091 0.472 . . . . 1.53 111.29 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.3 102.87 2.22 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.675 -0.693 . . . . 2.29 110.666 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.68 145.59 13.0 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.882 2.388 . . . . 0.88 112.59 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.413 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.81 167.88 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 2.12 109.863 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.08 148.0 29.17 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.804 -0.443 . . . . 2.67 109.804 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.496 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.8 p90 -142.31 157.29 44.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.065 0.46 . . . . 0.32 111.168 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.469 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.02 155.24 44.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.751 -0.659 . . . . 2.77 110.122 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.53 173.13 6.25 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 121.168 0.509 . . . . 1.25 110.665 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -50.65 173.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.816 2.344 . . . . 1.12 111.551 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.09 -51.13 0.68 Allowed Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.775 -0.37 . . . . 4.05 110.062 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.659 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.72 152.22 82.81 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.856 2.371 . . . . 2.12 111.481 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.63 42.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.479 0.657 . . . . 2.85 110.624 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.824 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.68 -41.62 98.13 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.89 -1.05 . . . . 3.11 110.569 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.438 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.8 mt -109.79 137.79 40.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.846 -0.616 . . . . 1.86 111.262 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.87 -72.96 0.7 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.043 -0.526 . . . . 1.61 111.939 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.12 148.35 24.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.593 0.59 . . . . 1.67 112.593 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.84 124.82 45.05 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.304 -0.628 . . . . 1.07 109.304 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.6 mt -117.99 134.69 60.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.683 -0.407 . . . . 1.55 110.658 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.484 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -120.0 128.58 53.68 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.053 0.454 . . . . 1.33 111.277 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.1 139.05 49.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.778 -0.646 . . . . 2.36 110.133 178.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.42 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.1 163.16 35.17 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.145 0.498 . . . . 0.38 112.067 -178.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.494 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.4 139.69 7.99 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.452 -0.795 . . . . 2.31 110.479 178.793 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.58 115.49 3.08 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.273 1.982 . . . . 0.86 111.879 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.666 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.04 81.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.865 -0.42 . . . . 3.44 109.865 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.693 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.925 -0.58 . . . . 2.72 111.939 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.8 p -157.56 157.81 34.43 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.877 -0.329 . . . . 2.78 110.617 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.403 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.8 m -120.38 27.8 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 2.3 110.16 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -75.83 1.31 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.143 -0.551 . . . . 1.8 111.846 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.85 152.25 35.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.91 0.386 . . . . 5.48 111.084 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.673 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.16 -169.01 2.5 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.103 -0.498 . . . . 1.84 111.919 179.352 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.17 149.72 29.68 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.434 0.635 . . . . 2.27 112.582 -177.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.08 156.48 45.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.856 -1.065 . . . . 1.92 110.316 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.21 158.39 41.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.027 -0.533 . . . . 1.09 111.75 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.8 m -115.22 135.61 53.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.445 -0.798 . . . . 1.16 109.751 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.448 HD13 ' N ' ' A' ' 51' ' ' ILE . 5.2 mp -126.41 121.98 23.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.394 -0.367 . . . . 1.39 111.513 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.519 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.9 Cg_exo -46.33 151.66 1.66 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.656 2.237 . . . . 0.72 112.097 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.83 -23.11 62.98 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 116.0 -0.545 . . . . 0.74 112.771 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.519 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.71 -16.87 46.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.371 0.586 . . . . 1.26 111.882 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.483 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.55 138.29 31.69 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.804 -0.359 . . . . 1.59 110.368 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.39 13.8 11.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.391 -0.368 . . . . 2.07 111.578 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.83 143.52 25.39 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.662 -0.415 . . . . 0.96 111.084 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.725 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.85 -169.39 1.54 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.222 0.534 . . . . 1.0 110.883 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.725 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.7 t -151.74 125.88 9.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.418 -0.81 . . . . 1.19 109.806 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.42 HG23 HD11 ' A' ' 60' ' ' ILE . 66.9 mt -114.89 123.29 70.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.369 -0.532 . . . . 1.47 111.24 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.482 ' CD ' ' CD1' ' A' ' 185' ' ' ILE . 1.2 mtmt -126.49 163.44 23.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.773 -0.649 . . . . 3.0 110.405 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.439 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.07 19.0 59.94 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.776 -0.93 . . . . 0.5 110.776 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.64 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.6 mt -79.07 157.23 28.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.124 0.488 . . . . 1.21 111.411 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.646 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -99.49 133.9 21.57 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.677 -0.692 . . . . 3.2 110.439 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.479 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.74 143.55 62.12 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.61 2.207 . . . . 1.09 111.948 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.86 25.63 75.34 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.98 -0.848 . . . . 0.72 110.98 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.642 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.16 158.76 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.747 0.308 . . . . 1.47 110.406 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.18 139.94 42.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.941 0.4 . . . . 1.23 110.566 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.646 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.55 136.5 54.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.944 -0.571 . . . . 1.1 110.763 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.494 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.96 131.03 45.32 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.522 -0.918 . . . . 1.87 108.522 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.44 153.9 16.63 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.354 -0.927 . . . . 0.39 111.945 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.15 140.91 45.78 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.632 -0.507 . . . . 1.8 109.632 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.46 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.1 tp -115.69 118.93 34.45 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.422 -0.511 . . . . 1.11 110.469 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.2 mt -112.45 129.11 68.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.322 -0.399 . . . . 1.51 110.614 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.87 120.86 43.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.305 -0.407 . . . . 1.47 110.636 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.669 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.61 146.47 11.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.305 0.574 . . . . 1.33 110.969 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.824 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -105.96 153.84 21.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.459 -0.791 . . . . 2.49 109.943 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.2 mt-30 -39.24 88.61 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.955 0.407 . . . . 4.2 110.439 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.624 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.757 -0.656 . . . . 6.4 110.57 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.11 -117.35 3.29 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.433 -0.667 . . . . 1.74 111.433 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.442 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.45 177.43 8.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.132 0.491 . . . . 3.64 111.688 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.2 149.48 32.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.448 -0.797 . . . . 1.7 110.391 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.55 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.1 144.62 38.8 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.444 -0.344 . . . . 2.7 110.588 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -127.99 135.93 61.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.075 0.464 . . . . 1.16 111.589 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.571 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.01 141.4 52.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.661 . . . . 1.14 110.237 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.445 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.69 138.82 51.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.214 0.531 . . . . 4.33 111.501 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.21 164.27 37.71 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.532 -0.758 . . . . 0.91 109.468 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.573 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 46.9 p30 -145.29 151.53 38.49 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.335 -0.546 . . . . 1.47 111.042 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.2 p90 -146.3 172.67 13.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.842 -0.617 . . . . 0.51 110.959 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.455 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.5 t -118.77 160.66 21.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.43 -0.805 . . . . 1.92 109.856 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.455 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.38 121.94 23.05 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.585 -0.446 . . . . 1.63 110.742 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.2 p -130.6 162.37 29.49 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 112.963 0.727 . . . . 2.37 112.963 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.576 ' HB2' ' H ' ' A' ' 114' ' ' VAL . 44.6 t -63.6 -37.05 85.85 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.39 -1.277 . . . . 3.63 111.522 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.3 m -153.13 -52.83 0.11 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.409 ' OG ' ' OG1' ' A' ' 92' ' ' THR . 41.4 m 56.68 177.57 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.382 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.29 73.89 39.87 Favored Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.573 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.51 145.19 98.73 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.512 2.141 . . . . 0.0 112.418 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.412 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 7.3 p -161.9 6.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.798 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.522 ' OG1' ' OD1' ' A' ' 101' ' ' ASN . 29.9 p -83.32 164.68 19.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.393 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 86.1 p -63.29 -22.16 66.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.58 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.522 ' OD1' ' OG1' ' A' ' 99' ' ' THR . 31.7 p-10 -81.91 6.35 16.13 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.613 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.3 p -83.49 163.14 20.66 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.422 HG22 ' H ' ' A' ' 105' ' ' GLY . 7.6 p -63.76 129.26 27.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.959 0.409 . . . . 0.0 110.702 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 56.7 p -73.19 -21.34 60.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.592 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.422 ' H ' HG22 ' A' ' 103' ' ' VAL . . . -83.88 178.46 52.2 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.648 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.95 142.33 57.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.729 0.3 . . . . 0.0 110.933 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.3 m -123.92 138.24 54.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.623 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.424 ' O ' ' CD2' ' A' ' 110' ' ' PHE . 0.1 OUTLIER -71.66 139.73 83.69 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.401 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.44 136.35 75.45 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.905 1.737 . . . . 0.0 113.385 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.424 ' CD2' ' O ' ' A' ' 108' ' ' THR . 96.0 m-85 -125.38 157.29 37.17 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.678 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.602 ' H ' ' CD ' ' A' ' 112' ' ' PRO . 1.2 t -165.94 -39.65 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.602 ' CD ' ' H ' ' A' ' 111' ' ' SER . 41.3 Cg_exo -56.13 141.07 87.83 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 122.413 2.075 . . . . 0.0 114.283 -177.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.871 ' O ' ' HD2' ' A' ' 155' ' ' PRO . 26.9 tp -105.61 133.32 50.54 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.256 -0.884 . . . . 10.52 108.869 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.576 ' H ' ' HB2' ' A' ' 93' ' ' SER . 19.1 t -103.0 132.82 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 121.216 0.531 . . . . 7.48 110.67 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.69 149.6 38.07 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.411 -0.813 . . . . 7.69 111.856 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.579 ' O ' ' CB ' ' A' ' 117' ' ' SER . 11.9 p -85.15 163.22 18.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.56 -0.745 . . . . 6.46 110.283 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.579 ' CB ' ' O ' ' A' ' 116' ' ' THR . 35.5 p 105.47 171.47 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.756 0.66 . . . . 4.59 111.174 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.483 ' HG3' ' HZ2' ' A' ' 64' ' ' LYS . 94.0 mt-10 -110.78 154.08 24.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.91 -0.586 . . . . 3.21 110.623 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.4 m -64.33 157.82 25.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 3.64 110.25 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.561 HG12 ' H ' ' A' ' 122' ' ' GLU . 38.8 t -110.57 134.14 53.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.868 0.366 . . . . 3.39 110.493 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 58.5 p -70.95 -20.53 62.45 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.016 -0.538 . . . . 2.23 111.919 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.561 ' H ' HG12 ' A' ' 120' ' ' VAL . 96.5 mt-10 -56.46 145.92 26.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.984 0.421 . . . . 4.53 110.986 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 122' ' ' GLU . 87.3 mt 52.97 117.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.534 -0.757 . . . . 2.01 111.356 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.415 ' O ' ' HB3' ' A' ' 127' ' ' SER . 7.3 t -107.47 19.88 19.65 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.314 -0.857 . . . . 2.22 109.823 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 127' ' ' SER . . . -65.95 150.57 48.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.725 -0.671 . . . . 1.29 111.994 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.9 OUTLIER 46.95 14.51 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.24 -0.891 . . . . 1.25 113.086 178.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.482 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.91 167.53 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.997 0.427 . . . . 1.16 110.94 179.169 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.486 ' CZ ' HG22 ' A' ' 201' ' ' THR . 8.0 m-30 -133.51 145.51 50.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.677 -0.692 . . . . 0.78 110.178 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.3 t -124.31 101.77 9.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.049 -0.723 . . . . 1.08 109.049 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.471 HG11 ' N ' ' A' ' 131' ' ' SER . 72.0 t -112.99 139.62 37.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.985 -0.552 . . . . 1.1 111.09 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.471 ' N ' HG11 ' A' ' 130' ' ' VAL . 66.6 p -128.68 152.62 48.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.669 -0.696 . . . . 0.87 109.822 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.648 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.7 p90 -144.86 -165.0 2.05 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.737 -0.385 . . . . 0.37 110.653 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -123.95 127.21 73.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.189 -0.459 . . . . 1.14 110.793 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.173 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.98 58.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.149 -0.478 . . . . 1.91 110.367 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.19 24.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.867 -0.606 . . . . 1.56 111.451 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.173 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.22 128.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.998 0.428 . . . . 1.56 110.933 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.53 -9.5 56.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.94 -0.573 . . . . 1.88 110.319 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.22 0.33 55.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.052 -0.522 . . . . 1.63 110.288 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.963 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.38 137.3 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 115.988 -0.551 . . . . 1.11 109.908 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 185' ' ' ILE . 1.9 m -96.24 -15.51 21.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.282 0.563 . . . . 1.01 110.076 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.586 ' N ' HG12 ' A' ' 185' ' ' ILE . . . 178.65 175.55 45.81 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 109.844 -1.303 . . . . 0.14 109.844 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.45 151.6 42.52 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.668 -0.413 . . . . 0.21 110.449 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.536 ' NH2' ' HB3' ' A' ' 157' ' ' TYR . 74.4 ttt-85 -132.31 121.17 23.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.116 -0.493 . . . . 1.54 109.948 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.492 HG23 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.14 136.61 38.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.718 -0.674 . . . . 1.08 110.62 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 80.7 tt0 -129.33 129.87 45.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.902 -0.59 . . . . 1.32 110.072 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.76 135.29 34.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.163 0.506 . . . . 1.05 110.595 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.402 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.25 161.42 39.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.754 -0.657 . . . . 1.16 109.695 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.939 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -71.14 124.89 25.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.039 0.447 . . . . 1.23 110.684 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.77 -7.7 49.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.745 -0.662 . . . . 0.86 110.885 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -109.85 -69.64 0.85 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 1.66 111.331 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.441 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.7 -35.33 76.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.079 -0.51 . . . . 1.66 111.445 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.082 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.2 7.13 88.66 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.828 -0.909 . . . . 1.62 110.828 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.339 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.96 -171.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 1.86 110.272 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.339 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.22 139.07 45.28 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.941 0.401 . . . . 1.98 110.196 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.871 ' HD2' ' O ' ' A' ' 113' ' ' LEU . 46.4 Cg_endo -70.89 145.79 51.55 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 122.789 2.326 . . . . 0.62 112.295 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.8 145.77 42.54 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.264 -0.643 . . . . 1.14 109.264 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.536 ' HB3' ' NH2' ' A' ' 143' ' ' ARG . 34.5 p90 -123.33 141.31 52.12 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.364 -0.534 . . . . 1.44 111.449 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.412 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.8 mt -128.1 127.79 43.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.226 -0.897 . . . . 1.08 108.915 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.487 ' HB2' ' ND2' ' A' ' 16' ' ' ASN . 67.8 t0 -101.69 131.21 48.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.16 0.505 . . . . 1.09 111.732 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.508 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -128.03 157.62 73.41 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.334 -0.848 . . . . 1.04 109.541 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -69.83 158.08 58.08 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.385 2.057 . . . . 0.21 112.248 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.31 -12.19 5.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.839 -0.618 . . . . 0.88 110.673 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.9 p -92.83 -8.74 42.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 1.06 110.661 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.23 135.45 34.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.405 -0.362 . . . . 1.05 110.346 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.0 p -133.13 16.6 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.396 . . . . 1.07 110.524 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.8 p -167.54 147.05 5.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.707 -0.479 . . . . 0.92 109.707 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.508 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.12 150.56 12.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.533 -0.467 . . . . 1.09 111.568 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.495 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.43 124.98 50.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.567 -0.742 . . . . 1.31 109.768 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.527 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.31 104.9 29.5 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.344 -0.389 . . . . 1.09 111.034 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.9 Cg_endo -91.03 -179.56 1.49 Allowed 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 123.215 2.61 . . . . 0.48 112.212 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.77 32.61 18.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.427 -0.806 . . . . 1.26 111.458 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.527 HD21 HG21 ' A' ' 169' ' ' ILE . 24.0 mt -86.42 148.5 25.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.442 -0.345 . . . . 1.12 110.391 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.773 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.4 mt -88.24 114.92 61.56 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.987 0.422 . . . . 1.3 110.69 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.12 140.55 95.55 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.879 2.386 . . . . 0.92 111.978 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.21 74.33 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.102 -0.799 . . . . 0.44 111.102 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.441 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.81 150.26 49.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.781 0.324 . . . . 3.05 110.661 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.31 131.61 46.15 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.105 -0.498 . . . . 1.48 109.769 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.939 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.47 148.4 43.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.012 -0.54 . . . . 0.89 110.962 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.36 125.37 60.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.262 -1.014 . . . . 1.12 108.262 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.56 132.5 63.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.158 0.504 . . . . 1.1 111.249 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.9 m-20 -136.48 122.63 20.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.48 -0.782 . . . . 0.43 109.693 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.592 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.07 125.39 55.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.241 -0.436 . . . . 1.07 110.63 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.67 ' CE1' HD11 ' A' ' 193' ' ' LEU . 47.9 m-85 -117.2 137.88 52.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.974 -0.557 . . . . 0.92 109.912 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.571 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.7 135.09 42.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.734 -0.839 . . . . 0.49 108.734 178.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.586 HG12 ' N ' ' A' ' 141' ' ' GLY . 0.8 OUTLIER -99.24 123.01 51.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.216 0.531 . . . . 1.08 110.866 -178.722 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.447 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.4 p -83.84 169.81 14.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.512 -0.767 . . . . 0.89 110.399 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.507 ' OE1' ' OG ' ' A' ' 140' ' ' SER . 48.0 tp10 -59.89 -14.52 15.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.948 -0.569 . . . . 1.6 110.962 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.447 ' H ' ' HG ' ' A' ' 186' ' ' SER . 95.5 m-20 -96.09 -4.25 43.2 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.818 -0.353 . . . . 1.18 110.825 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.89 13.82 63.93 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.297 -0.721 . . . . 0.34 111.297 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -84.53 139.04 32.41 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.116 -0.233 . . . . 1.22 110.519 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.675 HE21 HE21 ' A' ' 14' ' ' GLN . 74.3 mt-30 -106.77 141.06 38.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.852 0.358 . . . . 1.44 110.596 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.0 m -136.69 126.97 26.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 1.39 110.345 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.67 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.4 tp -68.0 117.22 9.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.254 -0.43 . . . . 1.08 110.502 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.648 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.1 pt -109.09 -21.69 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.241 -0.436 . . . . 1.08 110.728 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.92 125.71 5.84 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.527 -0.469 . . . . 1.1 111.5 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.496 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.76 120.31 21.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.764 -0.653 . . . . 0.94 109.539 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.72 151.6 28.93 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.587 -0.445 . . . . 1.07 110.89 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.41 158.58 18.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.052 -0.522 . . . . 0.89 110.461 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -145.99 158.06 43.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.67 110.651 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.37 104.38 9.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.775 -0.648 . . . . 1.17 110.012 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.486 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.2 p . . . . . 0 C--O 1.222 -0.39 0 CA-C-O 117.887 -1.054 . . . . 1.26 110.659 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.553 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.148 -0.686 . . . . 3.83 109.148 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.41 150.63 18.55 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.992 -0.843 . . . . 1.39 110.992 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -35.51 142.32 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.085 0 C-N-CA 124.083 3.189 . . . . 0.86 113.799 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.573 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.3 t -79.98 173.38 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.281 -1.327 . . . . 1.43 108.779 178.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.57 125.88 51.5 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.378 -0.529 . . . . 1.94 111.439 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.5 144.02 33.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.653 -0.703 . . . . 1.19 110.633 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -151.98 168.39 25.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.908 0.385 . . . . 3.92 111.162 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.588 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.12 131.06 60.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.053 -0.521 . . . . 3.88 110.055 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.1 p -141.16 162.22 36.02 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.88 0.371 . . . . 3.92 111.26 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 98.1 mt-10 36.17 31.59 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.587 -0.523 . . . . 6.08 109.587 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.588 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.4 69.53 32.08 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.97 -0.559 . . . . 4.01 111.547 -178.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.27 -29.08 72.81 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.494 2.129 . . . . 4.51 111.858 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.61 125.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.118 -0.492 . . . . 3.51 110.48 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.677 ' NE2' ' OE1' ' A' ' 191' ' ' GLN . 0.6 OUTLIER -123.98 158.4 60.37 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.313 -0.403 . . . . 4.3 110.453 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.549 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 99.0 Cg_endo -82.12 -64.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.942 2.428 . . . . 1.96 113.437 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.489 ' ND2' ' H ' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -108.49 -19.57 13.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.019 0.377 . . . . 3.33 112.019 -178.439 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.577 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 7.7 p -107.26 152.09 24.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.21 0.529 . . . . 1.53 111.252 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.37 102.94 2.21 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.67 -0.696 . . . . 2.29 110.647 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.63 145.61 13.09 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.884 2.389 . . . . 0.88 112.598 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.417 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.84 167.91 24.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.897 -0.592 . . . . 2.12 109.939 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.14 148.0 29.13 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.751 -0.463 . . . . 2.67 109.751 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.496 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.7 p90 -142.19 157.25 45.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.017 0.437 . . . . 0.32 111.242 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.467 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.9 m-20 -128.06 155.32 44.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.856 -0.611 . . . . 2.77 110.137 178.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.61 173.03 6.36 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 121.105 0.479 . . . . 1.25 110.741 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.69 173.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.932 2.422 . . . . 1.12 111.498 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -51.05 0.69 Allowed Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 120.714 -0.395 . . . . 4.05 110.155 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.659 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.84 152.39 82.33 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.756 2.304 . . . . 2.12 111.452 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.73 42.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.309 0.576 . . . . 2.85 110.496 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.82 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.66 -41.67 98.18 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.974 -1.012 . . . . 3.11 110.645 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.44 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.4 mt -109.82 137.9 39.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.795 -0.639 . . . . 1.86 111.242 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.06 -72.87 0.71 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.009 -0.541 . . . . 1.61 111.863 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.12 148.52 24.4 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.58 0.585 . . . . 1.67 112.58 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.96 124.9 45.12 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.301 -0.629 . . . . 1.07 109.301 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.07 134.7 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.645 -0.422 . . . . 1.55 110.594 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.484 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -120.02 128.67 53.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.04 0.448 . . . . 1.33 111.237 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.54 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.11 138.94 49.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.735 -0.666 . . . . 2.36 110.088 179.031 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.415 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.04 163.16 35.09 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.181 0.515 . . . . 0.38 112.061 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.491 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.42 139.6 7.92 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.45 -0.795 . . . . 2.31 110.462 178.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.54 115.45 3.04 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.307 2.004 . . . . 0.86 111.837 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.676 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.97 81.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.834 -0.432 . . . . 3.44 109.834 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.693 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.979 -0.555 . . . . 2.72 111.886 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 p -157.59 157.84 34.44 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.79 -0.364 . . . . 2.78 110.569 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.44 27.87 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.256 -0.429 . . . . 2.3 110.189 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.91 -75.89 1.31 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.115 -0.564 . . . . 1.8 111.766 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.94 152.33 35.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.011 0.434 . . . . 5.48 110.91 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.2 -169.19 2.56 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.98 -0.555 . . . . 1.84 111.946 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.415 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.6 mttp -110.08 149.56 29.84 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.471 0.653 . . . . 2.27 112.633 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.01 156.51 46.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.836 -1.074 . . . . 1.92 110.242 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.22 158.42 41.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.931 -0.577 . . . . 1.09 111.718 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.1 m -115.26 135.62 53.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.4 -0.818 . . . . 1.16 109.814 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.448 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.43 121.9 23.73 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.407 -0.36 . . . . 1.39 111.591 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.3 Cg_exo -46.23 151.69 1.57 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.626 2.217 . . . . 0.72 112.135 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.79 -23.15 62.93 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 116.071 -0.513 . . . . 0.74 112.826 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.515 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.81 -16.83 46.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.371 0.586 . . . . 1.26 111.831 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.485 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.3 mt -91.57 138.43 31.58 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.767 -0.373 . . . . 1.59 110.307 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -121.54 13.92 10.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.418 -0.356 . . . . 2.07 111.548 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.477 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.0 p -150.02 143.36 25.12 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.721 -0.392 . . . . 0.96 111.06 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.721 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.77 -169.35 1.53 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.918 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.721 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 t -151.75 125.83 9.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.431 -0.804 . . . . 1.19 109.87 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.471 HG23 HD11 ' A' ' 60' ' ' ILE . 66.7 mt -114.84 123.26 70.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.42 -0.512 . . . . 1.47 111.18 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -126.57 163.34 23.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.732 -0.667 . . . . 3.0 110.412 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.489 ' H ' ' ND2' ' A' ' 16' ' ' ASN . . . 85.18 18.95 59.84 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.742 -0.943 . . . . 0.5 110.742 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.44 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 74.1 mt -79.1 157.23 28.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.052 0.453 . . . . 1.21 111.357 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.614 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -99.48 133.96 21.53 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.584 -0.735 . . . . 3.2 110.433 179.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.92 143.59 61.23 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.614 2.209 . . . . 1.09 111.89 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.78 25.69 75.26 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.068 -0.813 . . . . 0.72 111.068 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.641 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.23 158.78 40.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.679 0.276 . . . . 1.47 110.423 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.27 139.95 42.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.034 0.445 . . . . 1.23 110.57 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.641 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.7 m-85 -122.54 136.4 54.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.967 -0.56 . . . . 1.1 110.745 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.491 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.91 131.05 45.29 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.474 -0.936 . . . . 1.87 108.474 177.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.52 153.84 16.66 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.283 -0.96 . . . . 0.39 112.011 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.93 140.88 46.09 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.671 -0.492 . . . . 1.8 109.671 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.462 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.3 tp -115.77 118.9 34.33 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.458 -0.497 . . . . 1.11 110.476 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.45 129.12 68.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.26 -0.427 . . . . 1.51 110.619 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.9 120.77 43.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.273 -0.421 . . . . 1.47 110.713 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.668 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.52 146.46 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.107 0.48 . . . . 1.33 111.044 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.82 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.02 153.9 21.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.54 -0.755 . . . . 2.49 109.929 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.15 88.67 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.912 0.387 . . . . 4.2 110.401 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.616 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.16 32.64 0.2 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.835 -0.621 . . . . 6.4 110.659 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.02 -117.36 3.3 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.495 -0.642 . . . . 1.74 111.495 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.443 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.45 177.49 8.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.17 0.509 . . . . 3.64 111.642 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.2 149.47 31.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.427 -0.806 . . . . 1.7 110.377 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.553 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.09 144.63 38.81 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.506 -0.315 . . . . 2.7 110.616 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -127.93 136.0 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.026 0.441 . . . . 1.16 111.601 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.06 141.31 52.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.676 -0.693 . . . . 1.14 110.3 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.441 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.65 138.74 51.77 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.095 0.474 . . . . 4.33 111.54 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.17 164.14 37.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.562 -0.744 . . . . 0.91 109.498 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.571 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.18 151.57 38.64 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.428 -0.509 . . . . 1.47 111.062 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.575 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.0 p90 -146.18 172.76 12.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.748 -0.66 . . . . 0.51 111.028 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.45 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.83 160.63 21.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.432 -0.804 . . . . 1.92 109.804 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.45 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.31 121.9 23.07 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.593 -0.443 . . . . 1.63 110.798 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.632 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.7 p -127.37 168.16 15.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.256 0.55 . . . . 2.37 112.351 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.0 p -63.14 160.23 15.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.514 -0.766 . . . . 3.63 110.931 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.4 t -64.7 -35.29 80.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.272 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.3 t -72.97 142.69 47.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.006 0.432 . . . . 0.0 111.063 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.72 ' H ' ' CD ' ' A' ' 97' ' ' PRO . 14.0 m -123.66 -33.86 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.932 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.72 ' CD ' ' H ' ' A' ' 96' ' ' THR . 49.4 Cg_exo -55.22 -19.93 22.93 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.228 1.952 . . . . 0.0 112.801 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.9 m -127.06 156.4 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.095 0.474 . . . . 0.0 110.962 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.7 p -92.2 164.41 13.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.789 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.3 t -77.23 149.69 35.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.27 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -100.56 140.44 34.81 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.838 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 49.6 m -78.79 140.31 38.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.524 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.4 m -63.25 138.45 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.491 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 t -134.85 159.88 39.99 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.678 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -138.92 176.62 20.79 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -108.79 153.29 23.69 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.802 0.334 . . . . 0.0 110.598 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.411 ' O ' ' OG1' ' A' ' 108' ' ' THR . 20.4 p -122.08 162.83 20.51 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.37 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 107' ' ' THR . 16.6 p 55.7 66.86 3.34 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.733 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -54.29 146.36 50.98 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.558 2.172 . . . . 0.0 112.02 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -108.05 138.73 43.81 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.509 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 63.8 p -124.44 73.46 60.24 Favored Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.545 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.27 147.97 81.56 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.462 2.108 . . . . 0.0 111.941 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 27.5 tp -96.23 131.63 42.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.475 . . . . 10.52 110.005 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.483 HG22 ' H ' ' A' ' 116' ' ' THR . 12.2 p -129.96 142.59 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.079 -0.51 . . . . 7.48 110.955 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.63 75.91 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.968 -0.56 . . . . 7.69 111.878 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.483 ' H ' HG22 ' A' ' 114' ' ' VAL . 22.6 p -121.18 160.82 22.99 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.897 0.379 . . . . 6.46 110.87 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.5 m -119.78 149.85 41.37 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.988 -0.551 . . . . 4.59 110.984 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 46.18 -164.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.862 -0.608 . . . . 3.21 111.19 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.2 p -119.93 158.49 26.59 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.829 -0.623 . . . . 3.64 110.86 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 74.9 t -58.77 -37.92 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.974 -0.557 . . . . 3.39 110.111 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.4 t -132.01 156.14 46.78 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.433 -0.349 . . . . 2.23 110.332 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.96 141.22 57.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.127 0.489 . . . . 4.53 111.442 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.9 pt -125.79 159.85 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.524 -0.762 . . . . 2.01 109.917 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 42.0 m -81.5 132.96 35.33 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.474 -0.49 . . . . 2.22 109.887 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.546 ' O ' ' CB ' ' A' ' 126' ' ' SER . . . -64.95 -36.91 85.91 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.848 -0.341 . . . . 1.29 110.884 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 125' ' ' ALA . 3.6 p 144.43 0.93 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.939 -0.763 . . . . 1.25 108.939 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.478 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.77 167.5 0.25 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.288 -0.869 . . . . 1.16 111.004 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.57 145.6 50.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.785 -0.643 . . . . 0.78 110.118 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.3 101.55 9.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.126 -0.694 . . . . 1.08 109.126 177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.472 HG11 ' N ' ' A' ' 131' ' ' SER . 70.8 t -112.93 139.8 36.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.006 -0.543 . . . . 1.1 110.988 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.472 ' N ' HG11 ' A' ' 130' ' ' VAL . 68.1 p -128.74 152.63 48.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.575 -0.739 . . . . 0.87 109.778 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.655 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.7 p90 -144.89 -164.96 2.04 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.717 -0.393 . . . . 0.37 110.622 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.734 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -123.92 127.22 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 1.14 110.815 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.179 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -58.05 58.34 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.168 -0.469 . . . . 1.91 110.326 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.09 24.42 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.905 -0.589 . . . . 1.56 111.447 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.179 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.28 128.7 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.638 -0.425 . . . . 1.56 110.913 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -86.37 -9.58 56.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.971 -0.559 . . . . 1.88 110.381 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.7 p -87.13 0.28 55.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 1.63 110.279 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.961 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.33 137.27 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.988 -0.551 . . . . 1.11 109.888 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.581 ' N ' ' O ' ' A' ' 185' ' ' ILE . 88.8 p -96.25 -15.53 21.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.25 0.548 . . . . 1.01 109.999 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.6 175.56 45.78 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 109.832 -1.307 . . . . 0.14 109.832 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.43 151.54 42.56 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.719 -0.392 . . . . 0.21 110.538 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.843 ' NE ' HE22 ' A' ' 191' ' ' GLN . 8.5 tmm_? -132.22 121.19 23.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.153 -0.476 . . . . 1.54 109.899 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.498 HG23 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.13 136.61 38.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.739 -0.664 . . . . 1.08 110.653 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 77.6 tt0 -129.36 129.86 45.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 1.32 110.03 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.605 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.8 135.23 34.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.066 -0.516 . . . . 1.05 110.638 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.406 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.27 161.38 39.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.723 -0.672 . . . . 1.16 109.665 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.944 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.4 mt -71.02 124.88 25.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.991 0.424 . . . . 1.23 110.755 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.1 p -71.74 -7.67 49.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.725 -0.671 . . . . 0.86 110.866 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -109.83 -69.57 0.86 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 1.66 111.481 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.462 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.69 -35.41 76.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.11 -0.496 . . . . 1.66 111.451 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.077 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.2 7.18 88.63 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.76 -0.936 . . . . 1.62 110.76 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.331 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.86 -171.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.779 0.323 . . . . 1.86 110.324 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.331 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.16 139.11 45.48 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.96 0.409 . . . . 1.98 110.216 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.406 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.5 Cg_endo -70.98 145.84 51.14 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 C-N-CA 122.746 2.297 . . . . 0.62 112.288 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.83 145.77 42.56 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.224 -0.658 . . . . 1.14 109.224 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.474 ' CZ ' ' HB3' ' A' ' 15' ' ' PRO . 7.8 m-85 -123.28 141.37 52.05 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.344 -0.543 . . . . 1.44 111.526 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.7 mt -128.16 127.69 43.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.286 -0.87 . . . . 1.08 108.932 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.533 ' OD1' ' O ' ' A' ' 159' ' ' ASP . 55.4 p-10 -101.62 131.19 47.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.125 0.488 . . . . 1.09 111.818 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.503 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -128.04 157.58 73.53 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.393 -0.821 . . . . 1.04 109.514 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -69.88 158.09 57.96 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.335 2.023 . . . . 0.21 112.24 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.36 -12.08 5.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.842 -0.617 . . . . 0.88 110.734 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.3 p -92.79 -8.8 42.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.101 -0.5 . . . . 1.06 110.762 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.36 34.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.304 -0.407 . . . . 1.05 110.434 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.9 p -133.11 16.58 4.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.447 -0.342 . . . . 1.07 110.515 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.8 p -167.47 147.21 5.16 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.607 -0.516 . . . . 0.92 109.607 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.503 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.24 150.51 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.551 -0.459 . . . . 1.09 111.57 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.36 124.89 50.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.604 -0.725 . . . . 1.31 109.786 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.523 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.34 104.84 29.26 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.358 -0.383 . . . . 1.09 111.028 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.9 Cg_endo -91.04 -179.43 1.47 Allowed 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 123.103 2.535 . . . . 0.48 112.237 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.72 32.62 18.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.381 -0.827 . . . . 1.26 111.381 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.526 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.1 mt -86.34 148.51 25.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.788 0.328 . . . . 1.12 110.476 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.78 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.26 114.83 61.18 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.969 0.414 . . . . 1.3 110.725 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.05 140.57 95.82 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.882 2.388 . . . . 0.92 111.977 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.17 21.12 74.25 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.078 -0.809 . . . . 0.44 111.078 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.462 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.83 150.2 49.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.833 0.349 . . . . 3.05 110.623 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.493 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.12 131.65 45.95 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.983 -0.553 . . . . 1.48 109.818 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.944 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.5 148.34 43.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.138 -0.483 . . . . 0.89 111.01 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.38 125.38 60.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.258 -1.015 . . . . 1.12 108.258 177.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.5 132.55 63.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.092 0.473 . . . . 1.1 111.283 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.55 122.55 20.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.624 -0.717 . . . . 0.43 109.659 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.595 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -100.95 125.33 54.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.219 -0.446 . . . . 1.07 110.709 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.67 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.4 m-85 -117.21 137.98 52.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.997 -0.547 . . . . 0.92 109.887 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.575 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.76 135.0 42.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.779 -0.823 . . . . 0.49 108.779 178.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.581 ' O ' ' N ' ' A' ' 140' ' ' SER . 74.6 mt -99.17 122.98 51.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.161 0.505 . . . . 1.08 110.893 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.444 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.7 p -83.94 169.7 14.76 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.539 -0.755 . . . . 0.89 110.383 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -59.74 -14.53 14.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.05 -0.523 . . . . 1.6 110.964 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.444 ' H ' ' HG ' ' A' ' 186' ' ' SER . 95.5 m-20 -96.07 -4.4 43.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.795 0.331 . . . . 1.18 110.829 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.426 ' N ' ' HB ' ' A' ' 59' ' ' THR . . . 87.85 13.84 63.97 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.364 -0.694 . . . . 0.34 111.364 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -84.58 139.09 32.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.059 -0.256 . . . . 1.22 110.482 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.843 HE22 ' NE ' ' A' ' 143' ' ' ARG . 88.5 mt-30 -106.81 141.08 38.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.91 0.386 . . . . 1.44 110.526 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.4 m -136.71 126.94 26.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 1.39 110.349 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.67 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.4 tp -68.11 117.26 9.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.317 -0.401 . . . . 1.08 110.564 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.655 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -109.01 -21.81 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 1.08 110.77 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.85 125.71 5.89 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.547 -0.461 . . . . 1.1 111.501 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.492 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.74 120.27 21.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.821 -0.627 . . . . 0.94 109.542 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.69 151.65 28.99 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.752 -0.379 . . . . 1.07 110.922 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.43 158.49 18.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.967 -0.56 . . . . 0.89 110.447 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.01 157.95 43.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.127 -0.488 . . . . 0.67 110.669 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.26 104.37 9.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.774 -0.648 . . . . 1.17 109.964 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.479 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 66.6 p . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.948 -1.025 . . . . 1.26 110.638 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.1 m . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.285 -0.635 . . . . 3.83 109.285 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.45 150.76 18.52 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.012 -0.835 . . . . 1.39 111.012 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -35.7 142.39 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.067 0 C-N-CA 123.999 3.133 . . . . 0.86 113.759 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.575 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -79.9 173.36 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.222 -1.354 . . . . 1.43 108.822 178.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' A' ' 23' ' ' ASN . 96.2 mt-10 -105.62 125.88 51.5 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.435 -0.506 . . . . 1.94 111.438 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 143.93 34.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.655 -0.702 . . . . 1.19 110.73 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.28 25.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 3.92 111.129 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.589 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.99 131.07 60.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.008 -0.542 . . . . 3.88 110.082 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.8 p -141.19 162.3 35.82 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.759 0.314 . . . . 3.92 111.249 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 10' ' ' GLU . 70.6 tt0 36.02 31.6 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.69 -0.485 . . . . 6.08 109.69 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.589 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.56 32.42 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.896 -0.593 . . . . 4.01 111.568 -178.744 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.3 -29.08 72.53 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.449 2.1 . . . . 4.51 111.818 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.64 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 3.51 110.513 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.582 ' HG3' ' NE2' ' A' ' 191' ' ' GLN . 7.0 mp0 -124.01 158.35 60.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.392 -0.367 . . . . 4.3 110.426 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.681 ' HD2' HH12 ' A' ' 143' ' ' ARG . 96.5 Cg_endo -82.0 -64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.835 2.356 . . . . 1.96 113.57 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.838 ' ND2' ' H ' ' A' ' 62' ' ' GLY . 9.9 t30 -108.46 -19.55 13.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.265 -0.425 . . . . 3.33 112.074 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 18.0 p -107.31 152.09 24.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.163 0.506 . . . . 1.53 111.387 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.578 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.19 102.9 2.24 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.726 -0.67 . . . . 2.29 110.691 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.406 ' HB3' ' HA3' ' A' ' 189' ' ' GLY . 73.6 Cg_endo -82.63 145.63 13.1 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.915 2.41 . . . . 0.88 112.607 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.414 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.87 167.92 24.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.906 -0.588 . . . . 2.12 109.904 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.1 148.02 29.18 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.783 -0.451 . . . . 2.67 109.783 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.502 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.4 p90 -142.29 157.27 45.01 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.621 -0.432 . . . . 0.32 111.137 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.463 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.9 m-20 -128.02 155.31 44.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.732 -0.667 . . . . 2.77 110.051 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.4 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . . . -132.63 173.12 6.26 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.214 0.531 . . . . 1.25 110.68 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.69 173.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.819 2.346 . . . . 1.12 111.497 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -50.97 0.69 Allowed Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.666 -0.414 . . . . 4.05 110.191 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.655 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.82 152.3 82.63 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.821 2.347 . . . . 2.12 111.466 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.64 42.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.331 0.586 . . . . 2.85 110.543 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.821 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.54 -41.66 98.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.047 -0.978 . . . . 3.11 110.683 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.434 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.8 mt -109.8 137.87 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.813 -0.63 . . . . 1.86 111.296 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.02 -72.88 0.7 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.095 -0.502 . . . . 1.61 111.84 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.19 148.35 24.43 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.558 0.577 . . . . 1.67 112.558 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.77 124.86 45.19 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.348 -0.612 . . . . 1.07 109.348 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.3 mt -117.99 134.73 60.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.724 -0.391 . . . . 1.55 110.61 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.486 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -119.99 128.62 53.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.067 0.46 . . . . 1.33 111.252 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.14 138.96 49.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.799 -0.637 . . . . 2.36 110.073 179.05 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.416 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.0 p90 -145.11 163.24 34.92 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.14 0.495 . . . . 0.38 112.059 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.5 139.55 7.83 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.423 -0.808 . . . . 2.31 110.428 178.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.62 115.47 3.07 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.347 2.032 . . . . 0.86 111.823 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.668 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.97 81.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.887 -0.412 . . . . 3.44 109.887 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.25 -20.59 0.06 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.05 -0.523 . . . . 2.72 111.969 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 p -157.61 157.81 34.35 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.822 -0.351 . . . . 2.78 110.535 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.403 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.48 27.88 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 2.3 110.123 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.82 -75.94 1.31 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.17 -0.538 . . . . 1.8 111.839 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.87 152.36 35.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.946 0.403 . . . . 5.48 111.058 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.09 2.52 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.101 -0.499 . . . . 1.84 111.998 179.43 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.416 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.18 149.64 29.8 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.464 0.649 . . . . 2.27 112.565 -177.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.03 156.47 46.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.893 -1.048 . . . . 1.92 110.302 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.18 158.44 41.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.931 -0.577 . . . . 1.09 111.796 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.27 135.53 54.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.438 -0.801 . . . . 1.16 109.848 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.448 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.31 121.98 23.89 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.506 -0.315 . . . . 1.39 111.529 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.521 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.6 Cg_exo -46.39 151.76 1.67 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.716 2.277 . . . . 0.72 112.098 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.94 -23.01 63.11 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 116.076 -0.511 . . . . 0.74 112.792 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.521 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.78 -16.94 45.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.425 0.613 . . . . 1.26 111.821 -178.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.482 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.3 mt -91.49 138.44 31.57 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.737 -0.385 . . . . 1.59 110.352 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -121.48 13.93 11.03 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.442 -0.345 . . . . 2.07 111.638 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.473 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.02 143.49 25.2 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.607 -0.437 . . . . 0.96 111.022 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.72 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.79 -169.38 1.53 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.212 0.529 . . . . 1.0 110.886 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.864 ' HG1' ' N ' ' A' ' 189' ' ' GLY . 1.2 m -151.74 125.86 9.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.437 -0.801 . . . . 1.19 109.893 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.431 HD11 HG23 ' A' ' 60' ' ' ILE . 66.4 mt -114.84 123.34 70.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.366 -0.533 . . . . 1.47 111.234 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.87 ' HZ3' ' CA ' ' A' ' 141' ' ' GLY . 15.9 mtpt -126.59 163.42 23.46 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.753 -0.658 . . . . 3.0 110.394 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.838 ' H ' ' ND2' ' A' ' 16' ' ' ASN . . . 85.11 19.07 59.76 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.682 -0.967 . . . . 0.5 110.682 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.435 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 74.0 mt -79.11 157.19 28.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.996 0.427 . . . . 1.21 111.36 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.63 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 4.3 mttp -99.48 133.87 21.6 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.71 -0.677 . . . . 3.2 110.464 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.89 143.63 61.6 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.497 2.131 . . . . 1.09 111.906 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.79 25.67 75.28 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.073 -0.811 . . . . 0.72 111.073 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.642 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.3 p -128.14 158.73 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.683 0.278 . . . . 1.47 110.461 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.03 140.03 41.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.909 0.385 . . . . 1.23 110.648 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.642 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.68 136.52 54.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.948 -0.569 . . . . 1.1 110.71 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.96 131.1 45.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.436 -0.95 . . . . 1.87 108.436 177.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.48 153.87 16.65 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.355 -0.926 . . . . 0.39 111.918 -178.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.03 141.01 46.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.624 -0.51 . . . . 1.8 109.624 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.458 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.9 tp -115.71 119.02 34.69 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.422 -0.511 . . . . 1.11 110.545 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.53 129.1 68.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.359 -0.382 . . . . 1.51 110.601 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.88 120.76 43.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.332 -0.395 . . . . 1.47 110.724 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.672 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.5 146.38 11.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.192 0.52 . . . . 1.33 111.032 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.821 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -105.98 153.81 21.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.512 -0.767 . . . . 2.49 109.986 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.07 88.49 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.9 0.381 . . . . 4.2 110.525 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.3 32.61 0.21 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.864 -0.607 . . . . 6.4 110.661 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.05 -117.37 3.29 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.437 -0.665 . . . . 1.74 111.437 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.444 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.39 177.38 9.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.153 0.501 . . . . 3.64 111.597 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.18 149.55 32.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.39 -0.823 . . . . 1.7 110.4 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.16 144.71 38.7 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.455 -0.339 . . . . 2.7 110.591 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -128.08 135.94 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 121.088 0.47 . . . . 1.16 111.5 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.01 141.35 52.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.668 -0.696 . . . . 1.14 110.373 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.445 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.6 138.8 51.7 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.553 -0.459 . . . . 4.33 111.575 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.489 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.21 164.14 37.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.572 -0.74 . . . . 0.91 109.618 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.576 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.2 151.57 38.63 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.411 -0.516 . . . . 1.47 111.027 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.578 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.9 p90 -146.26 172.64 13.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.767 -0.651 . . . . 0.51 111.023 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.454 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.7 t -118.61 160.7 21.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.479 -0.782 . . . . 1.92 109.922 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.454 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.45 121.87 22.87 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.623 -0.431 . . . . 1.63 110.774 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.6 p -126.92 155.57 42.84 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 114.62 1.341 . . . . 2.37 114.62 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.657 ' C ' ' H ' ' A' ' 95' ' ' SER . 82.2 p -132.19 8.6 4.37 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 112.996 -1.911 . . . . 3.63 109.102 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 93' ' ' SER . 7.1 p 58.37 -1.61 0.09 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.294 0.569 . . . . 0.0 109.8 -177.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.657 ' H ' ' C ' ' A' ' 93' ' ' SER . 83.3 p -66.44 -19.01 65.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.873 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 m -116.08 71.7 4.35 Favored Pre-proline 0 N--CA 1.465 0.294 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -176.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.17 161.73 36.09 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.554 2.169 . . . . 0.0 109.448 176.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.2 p -121.14 136.6 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.299 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 101' ' ' ASN . 47.3 m -129.01 149.31 50.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.939 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.896 ' O ' ' OD1' ' A' ' 101' ' ' ASN . 23.8 m -53.78 -34.19 58.28 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.896 ' OD1' ' O ' ' A' ' 100' ' ' SER . 14.9 p-10 54.93 45.3 26.76 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.376 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 49.1 m -116.86 135.57 53.63 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.5 t -121.69 136.27 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.855 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.2 p -122.14 160.43 25.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.044 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.09 -165.53 41.59 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -111.65 155.84 22.78 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.695 0.283 . . . . 0.0 110.396 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.7 p -120.39 161.1 21.77 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.216 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.5 m -126.73 79.96 71.15 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.218 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.02 146.97 45.22 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.251 1.967 . . . . 0.0 111.323 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -104.92 132.03 51.68 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.146 0.498 . . . . 0.0 111.408 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 85.9 p 44.54 57.84 14.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.728 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.16 143.98 91.17 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.232 1.955 . . . . 0.0 111.399 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.93 135.9 35.89 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.755 -0.461 . . . . 10.52 109.755 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.5 m -73.49 -34.58 42.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.846 -0.342 . . . . 7.48 111.591 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -153.83 155.66 36.2 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.909 0.385 . . . . 7.69 111.54 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.7 m -122.32 139.89 53.29 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.193 -0.669 . . . . 6.46 109.193 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 99.4 p -121.74 151.28 40.71 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.222 0.534 . . . . 4.59 111.643 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.88 -29.07 70.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.292 -0.867 . . . . 3.21 111.256 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.5 p -58.11 -25.12 60.97 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.685 0.624 . . . . 3.64 112.685 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.9 m -59.99 130.25 23.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 119.884 -0.727 . . . . 3.39 109.892 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.633 ' O ' ' N ' ' A' ' 123' ' ' ILE . 48.0 p -70.67 -31.73 68.74 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.521 0.563 . . . . 2.23 112.521 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.518 ' C ' ' O ' ' A' ' 121' ' ' THR . 97.6 mt-10 15.34 46.87 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.955 0.724 . . . . 4.53 112.955 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.633 ' N ' ' O ' ' A' ' 121' ' ' THR . 17.4 tt -123.4 135.19 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 110.237 -0.283 . . . . 2.01 110.237 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.7 t -137.99 157.85 45.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.479 -0.328 . . . . 2.22 111.079 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -105.43 143.39 33.66 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.099 -0.501 . . . . 1.29 110.33 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 2.0 p -176.61 8.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.151 0.5 . . . . 1.25 110.417 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.482 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.91 167.58 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.613 -0.721 . . . . 1.16 110.92 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.485 ' CZ ' HG22 ' A' ' 201' ' ' THR . 8.0 m-30 -133.56 145.55 50.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.675 -0.693 . . . . 0.78 110.146 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.33 101.72 9.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.021 -0.733 . . . . 1.08 109.021 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.472 HG11 ' N ' ' A' ' 131' ' ' SER . 72.0 t -112.94 139.74 36.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.0 -0.545 . . . . 1.1 111.078 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.472 ' N ' HG11 ' A' ' 130' ' ' VAL . 68.1 p -128.82 152.45 48.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.681 -0.69 . . . . 0.87 109.868 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.649 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.7 p90 -144.71 -164.88 2.02 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.667 -0.413 . . . . 0.37 110.711 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -124.0 127.11 73.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 1.14 110.833 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.176 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 1.91 110.315 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.15 24.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.916 -0.584 . . . . 1.56 111.471 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.176 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.16 128.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.599 -0.441 . . . . 1.56 110.929 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.4 -9.65 55.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.975 -0.557 . . . . 1.88 110.306 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.1 0.27 55.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 1.63 110.376 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.961 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.31 137.18 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.976 -0.556 . . . . 1.11 109.945 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.701 ' C ' ' HZ1' ' A' ' 61' ' ' LYS . 75.7 m -96.16 -15.52 22.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.337 0.589 . . . . 1.01 110.077 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.87 ' CA ' ' HZ3' ' A' ' 61' ' ' LYS . . . 178.54 175.51 45.68 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 109.793 -1.323 . . . . 0.14 109.793 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.4 151.61 42.43 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.574 -0.45 . . . . 0.21 110.466 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.681 HH12 ' HD2' ' A' ' 15' ' ' PRO . 60.0 ttp180 -132.28 121.25 23.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.11 -0.495 . . . . 1.54 109.954 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.494 HG23 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.19 136.58 38.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.634 -0.712 . . . . 1.08 110.665 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.522 ' CD ' ' CE2' ' A' ' 157' ' ' TYR . 80.8 tt0 -129.35 129.82 45.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.858 -0.61 . . . . 1.32 110.065 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.71 135.31 34.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.98 -0.554 . . . . 1.05 110.619 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.404 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.32 161.37 39.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.781 -0.645 . . . . 1.16 109.634 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.941 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.3 mt -71.07 124.77 25.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.019 0.438 . . . . 1.23 110.783 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.62 -7.77 49.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.74 -0.664 . . . . 0.86 110.9 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -109.77 -69.74 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 1.66 111.421 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.444 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.66 -35.34 75.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.065 -0.516 . . . . 1.66 111.497 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.083 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.14 7.29 88.55 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.772 -0.931 . . . . 1.62 110.772 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.34 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.97 -171.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 1.86 110.207 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.34 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.39 139.01 44.66 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 1.98 110.17 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.404 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.3 Cg_endo -70.84 145.8 51.88 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 C-N-CA 122.752 2.301 . . . . 0.62 112.343 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.84 145.68 42.64 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.222 -0.659 . . . . 1.14 109.222 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.522 ' CE2' ' CD ' ' A' ' 145' ' ' GLU . 83.1 m-85 -123.3 141.39 52.04 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.289 -0.564 . . . . 1.44 111.526 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.409 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.6 mt -128.07 127.66 43.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.288 -0.869 . . . . 1.08 108.917 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.712 ' OD1' ' ND2' ' A' ' 16' ' ' ASN . 13.6 m-20 -101.57 131.1 47.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.099 0.476 . . . . 1.09 111.751 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.506 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -127.95 157.57 73.39 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.396 -0.82 . . . . 1.04 109.602 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.78 158.03 58.31 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.453 2.102 . . . . 0.21 112.268 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.0 p -59.33 -12.12 5.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.782 -0.645 . . . . 0.88 110.75 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.0 p -92.81 -8.79 42.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.068 -0.514 . . . . 1.06 110.753 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.1 135.4 34.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 1.05 110.408 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.17 16.57 4.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.435 -0.348 . . . . 1.07 110.459 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.5 p -167.5 147.16 5.12 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.612 -0.514 . . . . 0.92 109.612 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.506 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.21 150.48 12.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.6 -0.44 . . . . 1.09 111.629 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 4.0 t-20 -106.36 124.96 50.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.625 -0.716 . . . . 1.31 109.758 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.527 HG21 HD21 ' A' ' 172' ' ' LEU . 1.8 mt -99.43 104.99 30.5 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 1.09 111.088 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.9 Cg_endo -91.17 -179.5 1.45 Allowed 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 123.099 2.532 . . . . 0.48 112.138 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.67 32.75 18.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.414 -0.812 . . . . 1.26 111.391 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.527 HD21 HG21 ' A' ' 169' ' ' ILE . 23.7 mt -86.46 148.54 25.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.474 -0.33 . . . . 1.12 110.436 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.774 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.3 114.91 61.57 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.059 0.457 . . . . 1.3 110.699 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.01 140.54 95.81 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.873 2.382 . . . . 0.92 112.041 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.18 21.06 74.35 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.061 -0.815 . . . . 0.44 111.061 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.444 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.79 150.22 49.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.786 0.327 . . . . 3.05 110.681 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.1 131.58 45.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.068 -0.514 . . . . 1.48 109.811 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.941 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.3 m-85 -120.45 148.3 43.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.153 -0.476 . . . . 0.89 111.055 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.3 125.36 60.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.261 -1.014 . . . . 1.12 108.261 177.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.49 132.39 63.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.155 0.502 . . . . 1.1 111.26 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.39 122.61 20.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.637 -0.71 . . . . 0.43 109.645 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.593 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.05 125.43 54.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.214 -0.448 . . . . 1.07 110.631 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.67 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.7 m-85 -117.27 137.92 52.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.027 -0.533 . . . . 0.92 109.842 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.572 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.78 135.07 42.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.773 -0.825 . . . . 0.49 108.773 178.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.567 ' O ' ' N ' ' A' ' 140' ' ' SER . 50.6 mm -99.12 122.96 51.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.137 0.494 . . . . 1.08 110.864 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.448 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.3 p -83.83 169.71 14.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.565 -0.743 . . . . 0.89 110.503 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -59.78 -14.53 15.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.006 -0.543 . . . . 1.6 110.963 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.448 ' H ' ' HG ' ' A' ' 186' ' ' SER . 94.9 m-20 -96.03 -4.29 43.34 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.872 -0.331 . . . . 1.18 110.795 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.864 ' N ' ' HG1' ' A' ' 59' ' ' THR . . . 87.76 13.93 64.01 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.403 -0.679 . . . . 0.34 111.403 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -84.76 139.14 32.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.736 0.303 . . . . 1.22 110.349 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.582 ' NE2' ' HG3' ' A' ' 14' ' ' GLN . 7.7 pt20 -106.83 141.05 38.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.968 0.413 . . . . 1.44 110.465 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.73 126.99 26.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 1.39 110.402 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.67 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.5 tp -68.08 117.27 9.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.371 -0.377 . . . . 1.08 110.502 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.649 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.3 pt -109.06 -21.82 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.471 . . . . 1.08 110.741 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.84 125.84 5.94 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.558 -0.457 . . . . 1.1 111.495 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.495 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.84 120.21 21.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.708 -0.678 . . . . 0.94 109.497 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.59 151.69 29.14 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.712 -0.395 . . . . 1.07 110.987 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.48 158.57 18.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.081 -0.509 . . . . 0.89 110.382 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.07 157.97 43.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.084 -0.507 . . . . 0.67 110.624 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.37 9.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.662 -0.699 . . . . 1.17 109.972 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.485 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.4 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.894 -1.051 . . . . 1.26 110.719 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.145 -0.687 . . . . 3.83 109.145 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.426 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.77 18.53 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.061 -0.815 . . . . 1.39 111.061 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -35.66 142.44 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.057 0 C-N-CA 123.959 3.106 . . . . 0.86 113.808 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.57 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -79.98 173.4 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 114.286 -1.325 . . . . 1.43 108.853 178.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.4 ' H ' ' CG1' ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.67 125.9 51.52 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.429 -0.508 . . . . 1.94 111.384 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.45 143.95 34.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.586 -0.734 . . . . 1.19 110.705 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.02 168.31 25.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.88 0.371 . . . . 3.92 111.13 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.575 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.5 mt -108.97 131.02 60.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.993 -0.549 . . . . 3.88 110.154 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.15 162.35 35.69 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.954 0.407 . . . . 3.92 111.202 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 10' ' ' GLU . 76.1 tt0 36.04 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.659 -0.497 . . . . 6.08 109.659 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.575 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.5 32.32 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.921 -0.581 . . . . 4.01 111.606 -178.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.641 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.1 Cg_endo -63.17 -29.12 73.77 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.445 2.097 . . . . 4.51 111.906 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.641 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.65 125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 3.51 110.494 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.553 ' O ' ' O ' ' A' ' 92' ' ' THR . 2.4 mm-40 -123.9 158.39 60.19 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.32 -0.4 . . . . 4.3 110.409 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.521 ' HG3' ' CZ ' ' A' ' 143' ' ' ARG . 97.0 Cg_endo -82.0 -64.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.976 2.451 . . . . 1.96 113.556 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.619 ' ND2' ' CD2' ' A' ' 157' ' ' TYR . 11.1 m120 -108.42 -19.71 13.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.277 -0.419 . . . . 3.33 112.074 -178.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 7.1 p -107.26 152.08 24.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.143 0.497 . . . . 1.53 111.354 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.569 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.3 102.9 2.22 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.708 -0.678 . . . . 2.29 110.632 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.6 145.61 13.13 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.927 2.418 . . . . 0.88 112.589 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.402 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.84 168.01 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.919 -0.582 . . . . 2.12 109.889 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.15 147.85 28.94 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.763 -0.458 . . . . 2.67 109.763 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.504 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.6 p90 -142.23 157.38 44.91 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.593 -0.443 . . . . 0.32 111.241 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.467 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.8 m-20 -127.98 155.31 44.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.863 -0.608 . . . . 2.77 110.128 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.63 173.01 6.39 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 121.125 0.488 . . . . 1.25 110.749 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.68 174.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.822 2.348 . . . . 1.12 111.557 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.15 -51.06 0.68 Allowed Pre-proline 0 C--N 1.328 -0.342 0 C-N-CA 120.719 -0.392 . . . . 4.05 110.068 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.649 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.82 152.38 82.35 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.711 2.274 . . . . 2.12 111.451 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.64 42.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.322 0.582 . . . . 2.85 110.575 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.813 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.69 -41.58 98.11 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.027 -0.988 . . . . 3.11 110.63 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.446 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.4 mt -109.89 137.91 39.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.771 -0.65 . . . . 1.86 111.207 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.98 -72.88 0.7 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.965 -0.561 . . . . 1.61 111.927 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.27 148.34 24.38 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.594 0.591 . . . . 1.67 112.594 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -121.8 124.86 45.17 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.396 -0.594 . . . . 1.07 109.396 177.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.08 134.78 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.614 -0.434 . . . . 1.55 110.644 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.486 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -120.01 128.52 53.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.03 0.443 . . . . 1.33 111.267 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.04 139.07 49.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.81 -0.632 . . . . 2.36 110.064 178.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.414 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.2 p90 -145.09 163.15 35.18 Favored 'General case' 0 N--CA 1.458 -0.056 0 C-N-CA 120.559 -0.456 . . . . 0.38 112.134 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.4 139.69 7.99 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.478 -0.783 . . . . 2.31 110.449 178.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.65 115.44 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.366 2.044 . . . . 0.86 111.799 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.686 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.03 81.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.901 -0.407 . . . . 3.44 109.901 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.697 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.21 -20.61 0.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.97 -0.559 . . . . 2.72 111.933 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.6 p -157.68 157.77 34.16 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.801 -0.36 . . . . 2.78 110.596 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.4 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.26 27.79 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.247 -0.433 . . . . 2.3 110.159 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.81 -75.95 1.31 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.175 -0.536 . . . . 1.8 111.826 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.87 152.27 35.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.942 0.401 . . . . 5.48 110.944 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.648 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.16 -169.15 2.55 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.031 -0.532 . . . . 1.84 111.927 179.386 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.412 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.18 149.67 29.76 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.483 0.659 . . . . 2.27 112.463 -177.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.03 156.59 46.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.702 -1.135 . . . . 1.92 110.216 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.28 158.27 41.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.98 -0.554 . . . . 1.09 111.842 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.09 135.66 53.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.493 -0.776 . . . . 1.16 109.82 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.448 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.46 122.02 23.72 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.427 -0.351 . . . . 1.39 111.534 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.52 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.2 Cg_exo -46.39 151.75 1.67 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.717 2.278 . . . . 0.72 112.053 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.92 -23.05 63.11 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 115.958 -0.564 . . . . 0.74 112.79 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.52 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.87 -16.7 46.57 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.213 -0.595 . . . . 1.26 111.809 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.491 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.5 mt -91.66 138.42 31.57 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.83 -0.348 . . . . 1.59 110.248 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -121.57 13.92 10.96 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.375 -0.375 . . . . 2.07 111.462 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.482 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 86.8 p -149.93 143.46 25.26 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.651 -0.42 . . . . 0.96 111.088 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.82 -169.4 1.54 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.203 0.525 . . . . 1.0 110.897 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.723 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 20.2 m -151.68 125.89 9.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.444 -0.798 . . . . 1.19 109.863 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.447 HD11 HG23 ' A' ' 60' ' ' ILE . 66.6 mt -114.87 123.29 70.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.304 -0.558 . . . . 1.47 111.217 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.568 ' HG2' ' N ' ' A' ' 62' ' ' GLY . 87.5 tttt -126.55 163.4 23.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.863 -0.608 . . . . 3.0 110.396 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.568 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.07 19.07 59.81 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.771 -0.932 . . . . 0.5 110.771 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.435 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.7 mt -79.12 157.17 28.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.147 0.498 . . . . 1.21 111.304 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.606 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -99.42 133.9 21.62 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.544 -0.753 . . . . 3.2 110.56 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.666 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.85 143.49 61.27 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.615 2.21 . . . . 1.09 111.937 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.84 25.64 75.32 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.087 -0.805 . . . . 0.72 111.087 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.65 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.2 158.84 40.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.754 0.311 . . . . 1.47 110.377 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.479 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.18 139.86 42.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.364 -0.38 . . . . 1.23 110.554 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.65 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.55 136.42 54.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.985 -0.552 . . . . 1.1 110.779 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.9 131.02 45.3 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.493 -0.928 . . . . 1.87 108.493 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.38 153.92 16.62 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.315 -0.945 . . . . 0.39 111.985 -178.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.98 140.95 46.09 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.693 -0.484 . . . . 1.8 109.693 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.473 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.1 tp -115.71 118.82 34.12 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.558 -0.457 . . . . 1.11 110.482 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.45 129.11 68.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.371 -0.377 . . . . 1.51 110.675 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.85 120.87 43.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.272 -0.422 . . . . 1.47 110.687 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.671 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.56 146.45 11.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.068 0.461 . . . . 1.33 111.035 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.813 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.0 153.88 21.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.514 -0.766 . . . . 2.49 109.934 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.27 88.6 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.996 0.426 . . . . 4.2 110.469 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.28 32.63 0.21 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.823 -0.626 . . . . 6.4 110.6 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.35 3.29 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.483 -0.647 . . . . 1.74 111.483 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.452 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.48 177.4 8.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 3.64 111.577 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.13 149.41 31.96 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.423 -0.808 . . . . 1.7 110.369 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.06 144.71 38.9 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.43 -0.35 . . . . 2.7 110.6 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.98 136.0 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 121.07 0.462 . . . . 1.16 111.603 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.57 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.6 m -124.13 141.23 52.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.668 -0.697 . . . . 1.14 110.302 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.487 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.64 138.88 51.67 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.493 -0.483 . . . . 4.33 111.485 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.23 164.22 37.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.501 -0.772 . . . . 0.91 109.48 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.565 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 46.9 p30 -145.25 151.55 38.55 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.429 -0.509 . . . . 1.47 111.037 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.569 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.0 p90 -146.25 172.77 12.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.739 -0.664 . . . . 0.51 111.007 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.448 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.84 160.58 21.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.529 -0.76 . . . . 1.92 109.826 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.448 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.3 121.79 22.92 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.567 -0.453 . . . . 1.63 110.803 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.553 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.0 p -127.37 161.11 29.42 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.226 0.454 . . . . 2.37 112.226 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.2 t -121.58 135.75 54.98 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.766 -0.652 . . . . 3.63 110.361 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.412 HG21 ' H ' ' A' ' 96' ' ' THR . 40.8 m -130.21 134.53 47.34 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.084 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.554 ' O ' ' HB ' ' A' ' 96' ' ' THR . 86.0 p -64.57 -29.91 70.94 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.928 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.554 ' HB ' ' O ' ' A' ' 95' ' ' SER . 44.7 m 109.35 -76.44 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 124.557 1.143 . . . . 0.0 110.953 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.444 ' CD ' ' HB ' ' A' ' 96' ' ' THR . 48.0 Cg_endo -66.28 144.69 75.44 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 121.185 1.459 . . . . 0.0 111.427 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.0 m -129.13 149.8 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.923 0.392 . . . . 0.0 110.412 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.5 t -140.69 158.15 44.4 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.814 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.9 m -66.39 156.8 33.57 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -100.37 127.94 46.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.898 0.38 . . . . 0.0 110.488 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.4 p -71.56 -21.16 61.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.12 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 p -130.89 141.87 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.905 0.383 . . . . 0.0 110.968 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 47.6 m -124.43 140.36 53.02 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.445 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 131.51 142.2 4.95 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.6 -33.38 74.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.683 0.278 . . . . 0.0 110.833 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 65.6 p -67.33 -24.19 65.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.74 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.7 m 53.98 66.06 4.78 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.076 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -55.95 148.61 56.52 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.147 1.898 . . . . 0.0 111.373 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -102.99 134.26 46.73 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.064 0.459 . . . . 0.0 111.111 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.15 158.3 87.77 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.45 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 113' ' ' LEU . 10.9 Cg_endo -54.27 150.85 31.31 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.531 2.154 . . . . 0.0 111.714 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 112' ' ' PRO . 50.2 mt 58.71 149.7 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.133 -0.485 . . . . 10.52 110.255 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.461 ' O ' ' C ' ' A' ' 115' ' ' ALA . 25.1 m -128.86 159.08 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.004 -0.544 . . . . 7.48 111.046 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 114' ' ' VAL . . . 25.94 92.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.686 -0.688 . . . . 7.69 111.966 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.9 m -57.93 -37.54 74.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.028 -0.533 . . . . 6.46 110.242 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 55.8 p -68.39 163.29 23.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.028 -0.533 . . . . 4.59 110.805 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -96.27 140.88 30.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.061 -0.518 . . . . 3.21 110.435 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -115.6 145.53 42.6 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.911 -0.586 . . . . 3.64 110.626 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.5 t -110.54 137.96 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-N 116.135 -0.484 . . . . 3.39 110.09 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 8.0 t -53.13 -41.64 65.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.058 -0.519 . . . . 2.23 112.17 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -80.76 137.43 36.25 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.29 -0.564 . . . . 4.53 110.244 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.8 mt -117.18 130.06 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.149 -0.478 . . . . 2.01 110.66 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.49 ' O ' ' CB ' ' A' ' 125' ' ' ALA . 56.4 p -71.53 -28.97 64.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.466 -0.333 . . . . 2.22 110.603 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 124' ' ' THR . . . 153.05 109.43 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.754 -0.657 . . . . 1.29 109.403 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.9 p -61.12 -32.09 71.79 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.576 -0.45 . . . . 1.25 110.676 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.478 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.9 167.55 0.26 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 1.16 110.914 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.61 145.53 50.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.677 -0.692 . . . . 0.78 110.099 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.28 101.69 9.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.096 -0.705 . . . . 1.08 109.096 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.472 HG11 ' N ' ' A' ' 131' ' ' SER . 71.0 t -112.96 139.64 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.059 -0.519 . . . . 1.1 111.078 -178.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.472 ' N ' HG11 ' A' ' 130' ' ' VAL . 69.5 p -128.73 152.61 48.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.721 -0.672 . . . . 0.87 109.776 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.657 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.4 p90 -144.8 -164.95 2.04 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.682 -0.407 . . . . 0.37 110.549 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.733 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.9 t -123.91 127.19 73.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.103 -0.499 . . . . 1.14 110.817 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.157 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.97 58.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 1.91 110.376 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.12 24.47 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.856 -0.611 . . . . 1.56 111.524 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.157 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.13 128.76 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.542 -0.463 . . . . 1.56 110.868 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.43 -9.71 55.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.849 -0.614 . . . . 1.88 110.31 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.0 0.22 55.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 1.63 110.414 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.964 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.25 137.21 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.951 -0.568 . . . . 1.11 109.955 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.559 ' N ' ' O ' ' A' ' 185' ' ' ILE . 5.6 m -96.32 -15.41 21.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.219 0.533 . . . . 1.01 110.016 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.452 ' HA3' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.51 175.56 45.7 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 109.839 -1.304 . . . . 0.14 109.839 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -123.53 151.61 42.65 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.64 -0.424 . . . . 0.21 110.485 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.728 ' NH2' ' CD2' ' A' ' 183' ' ' TYR . 69.8 ttp85 -132.33 121.15 23.07 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.081 -0.509 . . . . 1.54 109.931 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.494 HG23 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.08 136.53 38.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.689 -0.687 . . . . 1.08 110.65 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.486 ' HB2' HH12 ' A' ' 143' ' ' ARG . 81.1 tt0 -129.36 129.91 45.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.993 -0.548 . . . . 1.32 110.07 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.603 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.7 p90 -138.75 135.4 34.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.023 -0.535 . . . . 1.05 110.558 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.405 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.38 161.36 39.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.723 -0.671 . . . . 1.16 109.717 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.929 HD21 ' CE2' ' A' ' 178' ' ' TYR . 85.9 mt -71.09 124.86 25.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.018 0.437 . . . . 1.23 110.725 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.76 -7.56 48.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.813 -0.631 . . . . 0.86 110.887 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -109.89 -69.77 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 1.66 111.428 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.448 ' CD ' HH21 ' A' ' 176' ' ' ARG . 53.8 mt-10 -60.56 -35.46 76.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.028 -0.533 . . . . 1.66 111.535 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.074 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.26 88.58 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.8 -0.92 . . . . 1.62 110.8 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.327 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.96 -171.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 1.86 110.243 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.327 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.27 139.13 45.12 Favored Pre-proline 0 N--CA 1.454 -0.262 0 CA-C-O 120.997 0.427 . . . . 1.98 110.243 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.405 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.3 Cg_endo -70.93 145.77 51.22 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 C-N-CA 122.782 2.321 . . . . 0.62 112.302 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.78 145.71 42.58 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.238 -0.653 . . . . 1.14 109.238 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.666 ' CE1' ' CD ' ' A' ' 65' ' ' PRO . 35.6 p90 -123.28 141.31 52.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.234 0.54 . . . . 1.44 111.577 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.402 ' HA ' HD22 ' A' ' 158' ' ' LEU . 71.2 mt -128.09 127.72 43.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.274 -0.875 . . . . 1.08 108.944 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 5.0 t0 -101.63 131.17 48.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.102 0.477 . . . . 1.09 111.722 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.518 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.1 mt -127.94 157.66 73.1 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.277 -0.874 . . . . 1.04 109.601 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -69.92 158.03 58.12 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 122.439 2.093 . . . . 0.21 112.226 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.1 p -59.32 -12.13 5.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.773 -0.649 . . . . 0.88 110.7 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.0 p -92.84 -8.76 42.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.094 -0.503 . . . . 1.06 110.675 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.15 135.43 34.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.326 -0.397 . . . . 1.05 110.391 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.7 p -133.18 16.65 4.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.443 -0.344 . . . . 1.07 110.462 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.5 p -167.6 147.11 5.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.607 -0.516 . . . . 0.92 109.607 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.517 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.21 150.43 12.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.5 -0.48 . . . . 1.09 111.594 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.493 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.28 125.0 50.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.619 -0.719 . . . . 1.31 109.792 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.522 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.46 104.97 30.44 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.391 -0.368 . . . . 1.09 110.99 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.4 Cg_endo -90.99 -179.48 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 123.117 2.545 . . . . 0.48 112.162 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.61 32.64 18.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.341 -0.845 . . . . 1.26 111.493 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.522 HD21 HG21 ' A' ' 169' ' ' ILE . 23.7 mt -86.39 148.49 25.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.339 . . . . 1.12 110.494 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.776 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.23 114.83 61.18 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.311 -0.404 . . . . 1.3 110.658 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.98 140.5 95.63 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.837 2.358 . . . . 0.92 112.08 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.16 21.21 74.04 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.036 -0.825 . . . . 0.44 111.036 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.448 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.87 150.18 49.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 3.05 110.686 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.21 131.73 45.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.088 -0.506 . . . . 1.48 109.747 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.929 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.55 148.19 44.19 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.129 -0.487 . . . . 0.89 111.08 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.26 125.3 60.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.303 -0.999 . . . . 1.12 108.303 177.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.52 132.46 63.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.162 0.506 . . . . 1.1 111.197 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.45 122.5 20.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.555 -0.748 . . . . 0.43 109.636 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.588 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.96 125.49 54.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.255 -0.43 . . . . 1.07 110.647 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.728 ' CD2' ' NH2' ' A' ' 143' ' ' ARG . 48.5 m-85 -117.34 137.84 52.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.985 -0.552 . . . . 0.92 109.891 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.569 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.73 135.02 42.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.729 -0.841 . . . . 0.49 108.729 179.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.559 ' O ' ' N ' ' A' ' 140' ' ' SER . 83.3 mt -99.05 122.86 51.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.11 0.481 . . . . 1.08 110.961 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.445 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.5 p -83.81 169.73 14.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.542 -0.754 . . . . 0.89 110.525 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.82 -14.54 15.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.119 -0.491 . . . . 1.6 110.956 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.505 ' C ' ' HG1' ' A' ' 59' ' ' THR . 97.0 m-20 -96.03 -4.25 43.42 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.852 -0.339 . . . . 1.18 110.879 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.452 ' N ' HG21 ' A' ' 59' ' ' THR . . . 87.81 13.83 64.08 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.336 -0.706 . . . . 0.34 111.336 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -84.6 139.17 32.28 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.027 -0.269 . . . . 1.22 110.458 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.507 HE22 ' HG2' ' A' ' 15' ' ' PRO . 86.2 mt-30 -106.77 141.04 38.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 1.44 110.535 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.1 m -136.65 127.06 26.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 1.39 110.388 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.669 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.7 tp -68.24 117.29 9.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.92 0.39 . . . . 1.08 110.448 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.657 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.1 pt -109.07 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 1.08 110.714 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.1 tp -156.88 125.68 5.85 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.554 -0.459 . . . . 1.1 111.486 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.497 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.75 120.27 21.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.77 -0.65 . . . . 0.94 109.536 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.66 29.06 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.602 -0.439 . . . . 1.07 110.903 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.45 158.65 18.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.092 -0.504 . . . . 0.89 110.442 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.15 157.99 43.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.171 -0.468 . . . . 0.67 110.654 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 104.33 9.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.699 -0.682 . . . . 1.17 110.025 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.48 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 66.5 p . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.888 -1.053 . . . . 1.26 110.672 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.55 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.201 -0.666 . . . . 3.83 109.201 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.459 ' H ' ' HB3' ' A' ' 1' ' ' SER . . . -116.37 150.64 18.55 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.983 -0.847 . . . . 1.39 110.983 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -35.58 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.092 0 C-N-CA 124.03 3.153 . . . . 0.86 113.754 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.569 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.1 t -80.04 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.208 -1.36 . . . . 1.43 108.857 178.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.4 ' H ' ' CG1' ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.64 125.8 51.4 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.426 -0.51 . . . . 1.94 111.434 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.5 143.96 34.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.625 -0.716 . . . . 1.19 110.583 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.93 168.37 25.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.386 -0.37 . . . . 3.92 111.09 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.586 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.02 131.09 60.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.008 -0.542 . . . . 3.88 110.047 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.1 p -141.18 162.27 35.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.84 0.352 . . . . 3.92 111.27 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.8 mt-10 36.09 31.62 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.601 -0.518 . . . . 6.08 109.601 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.586 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.41 69.52 32.19 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.932 -0.576 . . . . 4.01 111.558 -178.752 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.24 -29.2 73.23 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.57 2.18 . . . . 4.51 111.837 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.71 125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 3.51 110.449 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.72 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -123.93 158.34 60.44 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.329 -0.396 . . . . 4.3 110.444 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.474 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 96.9 Cg_endo -81.94 -64.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.965 2.443 . . . . 1.96 113.574 -179.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.474 ' H ' ' HG2' ' A' ' 15' ' ' PRO . 10.2 m120 -108.47 -19.62 13.39 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.088 0.403 . . . . 3.33 112.088 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.72 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 89.1 p -107.32 152.05 24.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.101 0.477 . . . . 1.53 111.346 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.578 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.26 102.92 2.23 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.711 -0.677 . . . . 2.29 110.583 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.75 145.68 12.93 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.781 2.321 . . . . 0.88 112.554 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.407 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.78 167.96 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.845 -0.616 . . . . 2.12 109.903 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.16 147.95 29.05 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.742 -0.466 . . . . 2.67 109.742 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.499 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.3 p90 -142.23 157.3 45.0 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.567 -0.453 . . . . 0.32 111.169 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.467 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.8 m-20 -127.97 155.26 44.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.773 -0.649 . . . . 2.77 110.199 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.64 173.05 6.34 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.113 0.482 . . . . 1.25 110.702 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -50.74 173.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.834 2.356 . . . . 1.12 111.505 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.92 -51.08 0.7 Allowed Pre-proline 0 C--N 1.33 -0.265 0 C-N-CA 120.717 -0.393 . . . . 4.05 110.212 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.648 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.8 152.41 82.22 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.683 2.255 . . . . 2.12 111.501 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.68 42.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.343 0.592 . . . . 2.85 110.601 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.815 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.64 -41.66 98.22 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.004 -0.998 . . . . 3.11 110.655 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.437 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.5 mt -109.73 137.84 40.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.784 -0.643 . . . . 1.86 111.308 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.02 -72.89 0.7 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.075 -0.512 . . . . 1.61 111.906 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.22 148.43 24.37 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.581 0.586 . . . . 1.67 112.581 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -121.76 124.82 45.12 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.448 -0.575 . . . . 1.07 109.448 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.7 mt -118.08 134.75 60.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.55 -0.46 . . . . 1.55 110.569 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.486 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -120.02 128.72 53.79 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.057 0.456 . . . . 1.33 111.268 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.547 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.97 49.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.707 -0.678 . . . . 2.36 110.159 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.417 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.2 p90 -144.98 163.19 34.93 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.092 0.473 . . . . 0.38 112.172 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.55 139.49 7.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.512 -0.767 . . . . 2.31 110.502 178.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.694 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.44 115.45 3.03 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.296 1.997 . . . . 0.86 111.846 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.96 81.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.9 -0.407 . . . . 3.44 109.9 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.694 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.14 -20.6 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.993 -0.549 . . . . 2.72 111.887 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.7 p -157.69 157.76 34.12 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.884 -0.326 . . . . 2.78 110.596 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.36 27.8 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.466 . . . . 2.3 110.205 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.73 -75.88 1.31 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.116 -0.564 . . . . 1.8 111.926 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.89 152.25 35.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.966 0.412 . . . . 5.48 110.959 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.633 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.23 -169.18 2.55 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.06 -0.518 . . . . 1.84 111.97 179.367 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.411 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.08 149.74 29.59 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.392 0.615 . . . . 2.27 112.564 -177.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.08 156.45 45.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.81 -1.086 . . . . 1.92 110.287 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.22 158.28 41.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.925 -0.579 . . . . 1.09 111.8 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.04 135.69 53.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.476 -0.783 . . . . 1.16 109.801 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.442 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.42 121.94 23.75 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.481 -0.327 . . . . 1.39 111.526 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.514 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.0 Cg_exo -46.37 151.66 1.68 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.688 2.259 . . . . 0.72 112.151 178.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.87 -23.03 62.99 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 116.043 -0.526 . . . . 0.74 112.784 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.514 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.6 p-80 -82.81 -16.86 46.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.391 0.596 . . . . 1.26 111.804 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.491 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.63 138.4 31.6 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.751 -0.379 . . . . 1.59 110.323 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.47 13.87 11.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.383 -0.371 . . . . 2.07 111.542 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.48 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.0 p -149.95 143.45 25.24 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.617 -0.433 . . . . 0.96 111.04 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.87 -169.25 1.51 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.913 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.714 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 97.4 m -151.83 125.95 9.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.417 -0.811 . . . . 1.19 109.8 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.444 HD11 HG23 ' A' ' 60' ' ' ILE . 66.6 mt -114.88 123.25 70.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.376 -0.53 . . . . 1.47 111.2 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.809 ' NZ ' ' N ' ' A' ' 141' ' ' GLY . 96.7 mttt -126.53 163.37 23.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.879 -0.601 . . . . 3.0 110.41 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.17 18.94 59.89 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.697 -0.961 . . . . 0.5 110.697 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.427 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.8 mt -79.04 157.27 28.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.13 0.491 . . . . 1.21 111.363 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.632 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -99.45 134.01 21.51 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.598 -0.728 . . . . 3.2 110.451 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.91 143.58 61.26 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.555 2.17 . . . . 1.09 111.867 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.72 75.23 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.998 -0.841 . . . . 0.72 110.998 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.637 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.15 158.76 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.567 0.223 . . . . 1.47 110.46 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.15 139.95 41.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.944 0.402 . . . . 1.23 110.627 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.637 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.57 136.43 54.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.041 -0.527 . . . . 1.1 110.77 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.92 130.99 45.33 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.53 -0.915 . . . . 1.87 108.53 177.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.485 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.45 153.92 16.63 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.349 -0.929 . . . . 0.39 111.913 -178.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.04 140.94 46.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.642 -0.503 . . . . 1.8 109.642 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.466 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.0 tp -115.78 118.86 34.21 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.505 -0.478 . . . . 1.11 110.46 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.8 mt -112.43 128.94 68.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.223 -0.444 . . . . 1.51 110.65 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.73 120.9 43.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.324 -0.398 . . . . 1.47 110.707 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.671 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.57 146.51 11.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.137 0.494 . . . . 1.33 111.015 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.815 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.11 153.86 21.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.585 -0.734 . . . . 2.49 109.955 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.14 88.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.004 0.43 . . . . 4.2 110.503 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.22 32.7 0.21 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.808 -0.633 . . . . 6.4 110.511 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.09 -117.37 3.29 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.443 -0.663 . . . . 1.74 111.443 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.451 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.37 177.35 9.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.177 0.513 . . . . 3.64 111.69 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.1 149.59 32.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.476 -0.783 . . . . 1.7 110.371 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.55 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.2 144.78 38.67 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.407 -0.361 . . . . 2.7 110.501 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -128.07 136.03 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 121.071 0.463 . . . . 1.16 111.487 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.11 141.39 52.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.697 -0.683 . . . . 1.14 110.212 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.4 ttp180 -117.69 138.93 51.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.185 0.517 . . . . 4.33 111.406 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.485 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.34 164.15 38.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.539 -0.755 . . . . 0.91 109.531 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.574 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.29 151.49 38.42 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.391 -0.523 . . . . 1.47 111.072 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.578 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.3 p90 -146.11 172.79 12.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.713 -0.676 . . . . 0.51 111.044 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.45 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.8 160.63 21.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.46 -0.791 . . . . 1.92 109.809 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.45 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.35 121.91 23.04 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.535 -0.466 . . . . 1.63 110.776 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.549 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -128.2 164.31 22.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.668 0.747 . . . . 2.37 112.682 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.552 ' OG ' ' CE2' ' A' ' 157' ' ' TYR . 30.3 t -118.98 150.24 40.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.712 -1.131 . . . . 3.63 109.001 177.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -40.12 140.16 0.62 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.926 0.393 . . . . 0.0 110.708 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.4 m -61.75 153.46 28.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.706 -178.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.8 p -73.46 153.69 89.9 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.577 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.93 150.64 22.68 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 121.842 1.695 . . . . 0.0 111.199 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 74.3 t -58.78 -40.3 79.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.478 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.5 p -68.78 -27.41 65.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.763 0.316 . . . . 0.0 111.142 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.2 m -66.35 156.97 32.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -102.38 139.66 37.69 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.342 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.8 p -85.47 163.46 18.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.833 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.8 m -127.66 157.65 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.41 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 57.3 p -66.6 -27.22 67.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.078 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.69 -176.21 45.53 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.35 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 59.1 mp0 -59.28 143.67 48.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.961 0.41 . . . . 0.0 110.914 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.2 t -62.0 -37.0 83.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.676 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.2 p -123.51 80.94 54.03 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.792 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.39 148.29 33.97 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.579 2.186 . . . . 0.0 112.296 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.474 ' CD2' ' OG ' ' A' ' 111' ' ' SER . 67.6 t80 -97.99 133.76 42.03 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.188 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.474 ' OG ' ' CD2' ' A' ' 110' ' ' PHE . 16.0 m 57.99 64.65 3.73 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.338 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -57.25 146.0 84.3 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.53 2.154 . . . . 0.0 112.185 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.455 ' H ' ' CD1' ' A' ' 113' ' ' LEU . 6.5 mp -60.65 -32.7 71.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.781 -0.645 . . . . 10.52 110.98 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.1 m -126.45 160.28 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.948 0.404 . . . . 7.48 110.691 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.68 145.37 45.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.941 -0.572 . . . . 7.69 110.826 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 p -122.72 166.56 14.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.531 -0.758 . . . . 6.46 110.613 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.1 m -58.88 159.31 7.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.008 -0.542 . . . . 4.59 110.306 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -54.2 143.64 22.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.048 0.452 . . . . 3.21 110.827 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 43.8 m -63.55 156.32 26.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.454 -0.794 . . . . 3.64 111.645 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.6 t -114.07 137.69 46.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.334 -0.848 . . . . 3.39 109.565 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 45.1 m -68.65 134.01 49.28 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.524 -0.47 . . . . 2.23 110.404 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.75 142.22 57.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.683 -0.69 . . . . 4.53 111.739 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.401 ' O ' ' OD1' ' A' ' 171' ' ' ASP . 32.0 pt -125.23 159.05 32.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.444 -0.798 . . . . 2.01 109.226 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 19.3 p -123.27 154.34 38.97 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.133 0.492 . . . . 2.22 111.152 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.581 ' O ' ' N ' ' A' ' 127' ' ' SER . . . -162.46 152.74 16.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.611 -0.722 . . . . 1.29 109.869 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 125' ' ' ALA . 0.1 OUTLIER 34.83 28.12 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 122.137 0.97 . . . . 1.25 110.926 178.913 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.581 ' N ' ' O ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.91 167.53 0.26 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.626 -1.17 . . . . 1.16 110.946 -179.193 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.484 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.8 m-30 -133.65 145.54 50.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.678 -0.692 . . . . 0.78 110.102 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.28 101.68 9.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.075 -0.713 . . . . 1.08 109.075 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.464 HG11 ' N ' ' A' ' 131' ' ' SER . 71.8 t -112.86 139.7 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.987 -0.551 . . . . 1.1 111.133 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.464 ' N ' HG11 ' A' ' 130' ' ' VAL . 68.2 p -128.73 152.5 48.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.624 -0.716 . . . . 0.87 109.786 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.642 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.7 p90 -144.79 -165.04 2.05 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.705 -0.398 . . . . 0.37 110.629 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.729 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -123.81 127.19 73.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 1.14 110.836 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.162 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.99 58.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.222 -0.444 . . . . 1.91 110.38 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.729 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.19 24.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.855 -0.612 . . . . 1.56 111.518 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.162 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.15 128.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.628 -0.429 . . . . 1.56 110.897 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -86.56 -9.6 55.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.938 -0.573 . . . . 1.88 110.215 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.2 p -87.09 0.22 55.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.153 -0.476 . . . . 1.63 110.344 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.962 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.38 137.33 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.969 -0.56 . . . . 1.11 109.9 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.73 ' C ' ' HZ2' ' A' ' 61' ' ' LYS . 3.5 p -96.29 -15.53 21.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.262 0.553 . . . . 1.01 110.045 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.809 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.59 175.52 45.74 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.786 -1.325 . . . . 0.14 109.786 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -123.34 151.59 42.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.954 0.407 . . . . 0.21 110.551 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.728 ' NH2' ' OE1' ' A' ' 191' ' ' GLN . 64.1 ttp85 -132.34 121.18 23.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.153 -0.476 . . . . 1.54 109.989 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.48 HG23 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.07 136.49 38.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.706 -0.679 . . . . 1.08 110.747 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 81.3 tt0 -129.33 129.92 45.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.994 -0.548 . . . . 1.32 110.105 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.3 p90 -138.73 135.27 34.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.957 -0.565 . . . . 1.05 110.57 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.404 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.31 161.43 39.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.737 -0.665 . . . . 1.16 109.662 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.939 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.3 mt -70.99 124.85 25.32 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.672 -0.411 . . . . 1.23 110.775 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.84 -7.6 49.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.779 -0.646 . . . . 0.86 110.814 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -109.91 -69.63 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.845 0.355 . . . . 1.66 111.399 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.439 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.3 mt-10 -60.75 -35.29 76.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 1.66 111.471 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.095 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.15 7.18 88.62 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.789 -0.924 . . . . 1.62 110.789 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.324 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.95 -171.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.765 0.316 . . . . 1.86 110.301 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.324 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.2 139.02 45.33 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 1.98 110.221 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.404 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 45.8 Cg_endo -70.9 145.79 51.45 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.675 2.25 . . . . 0.62 112.32 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.83 145.74 42.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.196 -0.668 . . . . 1.14 109.196 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.673 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 86.7 m-85 -123.29 141.31 52.11 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.366 -0.534 . . . . 1.44 111.513 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.434 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.8 mt -128.05 127.66 43.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.286 -0.87 . . . . 1.08 108.925 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -101.58 131.05 47.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.127 0.489 . . . . 1.09 111.751 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.516 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -127.86 157.56 73.25 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.388 -0.824 . . . . 1.04 109.6 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.72 158.06 58.32 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.479 2.12 . . . . 0.21 112.225 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.38 -12.17 5.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.744 -0.662 . . . . 0.88 110.675 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.7 p -92.78 -8.75 42.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 1.06 110.778 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.34 34.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 1.05 110.329 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.5 p -133.05 16.55 4.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.396 -0.366 . . . . 1.07 110.531 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.52 147.05 5.08 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.642 -0.503 . . . . 0.92 109.642 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.516 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.18 150.44 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.46 -0.496 . . . . 1.09 111.564 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.35 124.93 50.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.6 -0.727 . . . . 1.31 109.837 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.521 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.36 104.91 29.72 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.879 0.371 . . . . 1.09 111.065 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -91.0 -179.49 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.922 0 C-N-CA 123.241 2.628 . . . . 0.48 112.191 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 123' ' ' ILE . 71.2 m-20 61.61 32.65 18.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.328 -0.851 . . . . 1.26 111.467 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.521 HD21 HG21 ' A' ' 169' ' ' ILE . 23.8 mt -86.41 148.54 25.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.782 0.325 . . . . 1.12 110.4 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.767 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.26 114.86 61.3 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.919 0.39 . . . . 1.3 110.642 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.02 140.57 95.94 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.915 2.41 . . . . 0.92 111.922 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.05 21.2 74.4 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.087 -0.805 . . . . 0.44 111.087 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.439 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.9 150.2 49.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.913 0.387 . . . . 3.05 110.529 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.493 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.16 131.63 45.99 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.974 -0.557 . . . . 1.48 109.813 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.939 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.51 148.35 43.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.127 -0.488 . . . . 0.89 111.063 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.32 125.29 60.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.323 -0.991 . . . . 1.12 108.323 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.46 132.45 63.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.174 0.511 . . . . 1.1 111.346 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.44 122.49 20.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.541 -0.754 . . . . 0.43 109.684 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.589 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -100.95 125.38 54.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.281 -0.418 . . . . 1.07 110.723 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.668 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.7 m-85 -117.22 137.86 52.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.045 -0.525 . . . . 0.92 109.854 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.565 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.71 134.97 42.89 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.809 -0.811 . . . . 0.49 108.809 178.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.545 ' O ' ' N ' ' A' ' 140' ' ' SER . 11.6 mt -99.05 122.94 51.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.123 0.487 . . . . 1.08 110.926 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.451 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.3 p -83.8 169.7 14.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.582 -0.735 . . . . 0.89 110.481 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -59.82 -14.48 15.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.016 -0.538 . . . . 1.6 110.979 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.451 ' H ' ' HG ' ' A' ' 186' ' ' SER . 95.3 m-20 -96.03 -4.35 43.26 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.877 -0.329 . . . . 1.18 110.796 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.79 13.91 63.97 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.36 -0.696 . . . . 0.34 111.36 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -84.73 139.14 32.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.632 0.253 . . . . 1.22 110.437 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.728 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 86.0 mt-30 -106.73 141.07 38.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.406 -0.361 . . . . 1.44 110.527 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.76 127.02 26.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.125 -0.488 . . . . 1.39 110.363 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.668 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.6 tp -68.15 117.37 9.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.293 -0.412 . . . . 1.08 110.486 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.642 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -109.11 -21.65 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.119 -0.491 . . . . 1.08 110.724 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.89 125.6 5.82 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.601 -0.44 . . . . 1.1 111.482 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.497 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.75 120.2 21.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.774 -0.648 . . . . 0.94 109.562 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.65 151.74 29.14 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.642 -0.423 . . . . 1.07 110.89 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.54 158.55 18.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.043 -0.526 . . . . 0.89 110.439 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.05 157.91 43.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.67 110.723 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 104.34 9.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.855 -0.611 . . . . 1.17 110.04 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.484 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.1 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.89 -1.052 . . . . 1.26 110.608 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.553 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.9 m . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.242 -0.651 . . . . 3.83 109.242 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.27 150.59 18.57 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.041 -0.823 . . . . 1.39 111.041 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.64 142.45 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 123.967 3.111 . . . . 0.86 113.748 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.573 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -80.0 173.41 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.176 -1.374 . . . . 1.43 108.758 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.59 125.91 51.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.157 0.503 . . . . 1.94 111.431 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 143.96 34.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.593 -0.73 . . . . 1.19 110.607 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.07 168.25 25.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.916 0.389 . . . . 3.92 111.123 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.589 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.83 131.07 60.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.986 -0.552 . . . . 3.88 110.103 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.24 162.35 35.69 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.777 0.322 . . . . 3.92 111.255 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 67.7 tt0 36.04 31.67 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.58 -0.526 . . . . 6.08 109.58 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.589 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.56 32.58 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.917 -0.583 . . . . 4.01 111.585 -178.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.636 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.33 -29.14 72.33 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.499 2.133 . . . . 4.51 111.796 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.673 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 3.2 m 149.66 125.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.143 -0.48 . . . . 3.51 110.495 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.673 ' NE2' ' O ' ' A' ' 13' ' ' SER . 5.8 mp0 -124.02 158.36 60.61 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 4.3 110.47 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.468 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 97.5 Cg_endo -82.08 -64.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.865 2.377 . . . . 1.96 113.51 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.653 ' OD1' ' N ' ' A' ' 17' ' ' SER . 1.1 p-10 -108.44 -19.54 13.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.36 -0.382 . . . . 3.33 112.029 -178.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.653 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 95.9 p -107.36 152.04 24.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.174 0.512 . . . . 1.53 111.29 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.5 t-80 -155.32 102.95 2.22 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.662 -0.699 . . . . 2.29 110.565 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.501 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.7 Cg_endo -82.63 145.61 13.09 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.85 2.367 . . . . 0.88 112.667 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.417 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.78 167.86 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.924 -0.58 . . . . 2.12 109.899 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.06 148.06 29.26 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.74 -0.467 . . . . 2.67 109.74 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.498 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.5 p90 -142.36 157.28 44.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.005 0.431 . . . . 0.32 111.169 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.467 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.1 m-20 -128.09 155.31 44.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.745 -0.661 . . . . 2.77 110.112 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.6 173.0 6.4 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.175 -0.466 . . . . 1.25 110.756 -179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.63 173.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.877 2.384 . . . . 1.12 111.605 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.01 -51.16 0.69 Allowed Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 120.74 -0.384 . . . . 4.05 110.083 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.658 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.75 152.33 82.44 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.798 2.332 . . . . 2.12 111.437 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.69 42.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.456 0.646 . . . . 2.85 110.554 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.819 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.63 -41.54 98.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.993 -1.003 . . . . 3.11 110.718 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.44 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.8 mt -109.87 137.77 40.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.791 -0.641 . . . . 1.86 111.255 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.96 -72.99 0.7 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.028 -0.533 . . . . 1.61 111.837 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.13 148.5 24.41 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.556 0.576 . . . . 1.67 112.556 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.95 124.87 45.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.263 -0.643 . . . . 1.07 109.263 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.4 mt -118.05 134.72 60.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.715 -0.394 . . . . 1.55 110.698 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.485 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -120.02 128.55 53.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.047 0.451 . . . . 1.33 111.271 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.541 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.08 139.1 49.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.722 -0.672 . . . . 2.36 110.126 178.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.415 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.09 163.11 35.31 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.134 0.492 . . . . 0.38 112.05 -178.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.489 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.53 139.73 7.9 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.453 -0.794 . . . . 2.31 110.421 178.727 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.65 115.47 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.322 2.015 . . . . 0.86 111.769 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.679 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.9 81.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.925 -0.398 . . . . 3.44 109.925 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.049 -0.523 . . . . 2.72 111.893 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.7 p -157.56 157.81 34.44 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.804 -0.358 . . . . 2.78 110.538 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.403 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.32 27.69 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.215 -0.448 . . . . 2.3 110.204 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.77 -75.81 1.31 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 121.157 -0.544 . . . . 1.8 111.875 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -117.95 152.34 35.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.959 0.409 . . . . 5.48 110.983 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.29 -169.1 2.51 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.052 -0.522 . . . . 1.84 111.925 179.424 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.415 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.22 149.67 29.79 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.497 0.665 . . . . 2.27 112.511 -177.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.08 156.44 45.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.773 -1.103 . . . . 1.92 110.225 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.1 158.35 41.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.826 -0.624 . . . . 1.09 111.785 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.0 m -115.21 135.71 53.89 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.458 -0.792 . . . . 1.16 109.847 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.451 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.42 121.93 23.74 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.418 -0.355 . . . . 1.39 111.576 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.513 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.5 Cg_exo -46.36 151.76 1.64 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.683 2.255 . . . . 0.72 112.107 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.9 -23.12 63.14 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 116.057 -0.519 . . . . 0.74 112.765 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.513 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.5 p-80 -82.75 -16.9 46.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.37 0.585 . . . . 1.26 111.802 -178.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.488 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.3 mt -91.58 138.41 31.59 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.802 -0.359 . . . . 1.59 110.334 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.52 13.83 10.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.37 -0.377 . . . . 2.07 111.56 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.475 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.9 143.46 25.29 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.643 -0.423 . . . . 0.96 111.09 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.717 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.77 -169.39 1.54 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.888 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.719 ' HG1' ' C ' ' A' ' 188' ' ' ASP . 2.5 m -151.79 125.92 9.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.386 -0.824 . . . . 1.19 109.739 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.463 HG23 HD11 ' A' ' 60' ' ' ILE . 66.5 mt -114.81 123.29 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.416 -0.514 . . . . 1.47 111.161 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.624 ' CG ' ' N ' ' A' ' 62' ' ' GLY . 18.1 ttpt -126.49 163.45 23.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.874 -0.603 . . . . 3.0 110.432 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.624 ' N ' ' CG ' ' A' ' 61' ' ' LYS . . . 85.09 18.99 59.91 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.731 -0.948 . . . . 0.5 110.731 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.44 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.6 mt -79.1 157.19 28.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.074 0.464 . . . . 1.21 111.412 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.615 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 1.2 mttp -99.37 133.92 21.63 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.702 -0.681 . . . . 3.2 110.504 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.88 143.54 61.24 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.541 2.161 . . . . 1.09 112.059 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.91 25.58 75.41 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.063 -0.815 . . . . 0.72 111.063 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.64 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.15 158.78 39.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.687 0.279 . . . . 1.47 110.381 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.14 139.91 42.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.89 0.376 . . . . 1.23 110.569 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.64 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.2 m-85 -122.49 136.42 54.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.007 -0.542 . . . . 1.1 110.842 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.489 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.95 131.02 45.33 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.464 -0.939 . . . . 1.87 108.464 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.49 153.89 16.65 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.281 -0.961 . . . . 0.39 111.915 -178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.99 140.92 46.06 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.677 -0.49 . . . . 1.8 109.677 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.461 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.9 tp -115.76 118.89 34.29 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.42 -0.512 . . . . 1.11 110.539 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.6 mt -112.32 129.03 68.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.369 -0.378 . . . . 1.51 110.699 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.84 120.92 43.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.319 -0.4 . . . . 1.47 110.743 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.667 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.6 146.45 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.109 0.48 . . . . 1.33 111.066 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.819 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.08 153.88 21.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.546 -0.752 . . . . 2.49 110.018 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.2 mt-30 -39.15 88.51 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.868 0.366 . . . . 4.2 110.409 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.31 32.61 0.21 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.853 -0.612 . . . . 6.4 110.582 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.1 -117.37 3.29 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.419 -0.672 . . . . 1.74 111.419 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.446 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.44 177.44 8.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.249 0.547 . . . . 3.64 111.613 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.17 149.47 32.04 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.37 -0.832 . . . . 1.7 110.363 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.553 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.15 144.7 38.73 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.441 -0.345 . . . . 2.7 110.578 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -127.98 135.98 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 120.616 -0.434 . . . . 1.16 111.597 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -123.99 141.26 52.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.701 -0.681 . . . . 1.14 110.342 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.441 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.51 138.96 51.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.142 0.496 . . . . 4.33 111.503 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.36 164.13 38.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.53 -0.759 . . . . 0.91 109.428 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.57 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.2 151.62 38.7 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.314 -0.554 . . . . 1.47 110.972 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.574 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.8 p90 -146.29 172.69 13.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.69 -0.686 . . . . 0.51 111.008 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.448 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.76 160.74 21.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.446 -0.797 . . . . 1.92 109.866 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.448 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.41 121.84 22.87 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.563 -0.455 . . . . 1.63 110.771 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.2 p -126.92 154.6 44.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.646 0.736 . . . . 2.37 112.759 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.444 ' OG ' ' OH ' ' A' ' 157' ' ' TYR . 22.8 t -62.7 -38.72 91.51 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.616 -1.175 . . . . 3.63 111.91 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.2 t -139.74 158.03 44.78 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.254 0.549 . . . . 0.0 111.86 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 79.1 p -75.44 -14.61 60.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.273 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.6 p -63.0 141.08 97.7 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.112 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.31 150.06 42.91 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.298 1.998 . . . . 0.0 112.367 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.6 m -126.73 156.18 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.869 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.9 m -87.23 136.0 33.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.988 0.423 . . . . 0.0 110.935 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.6 m -66.95 156.61 35.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.436 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.462 ' O ' ' O ' ' A' ' 102' ' ' THR . 78.1 m-20 -84.26 4.03 32.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.259 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.462 ' O ' ' O ' ' A' ' 101' ' ' ASN . 28.0 p 33.68 -157.77 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.814 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.608 ' C ' ' H ' ' A' ' 105' ' ' GLY . 42.6 t -117.29 135.37 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.303 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.7 m 56.68 -3.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.992 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.608 ' H ' ' C ' ' A' ' 103' ' ' VAL . . . -55.41 -33.32 58.5 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.82 144.0 40.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 110.642 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.0 p -81.72 162.59 22.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.445 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.542 ' O ' ' CD2' ' A' ' 110' ' ' PHE . 72.3 p -125.36 79.11 67.05 Favored Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.78 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 110' ' ' PHE . 38.7 Cg_exo -59.18 -17.94 41.65 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 122.813 2.342 . . . . 0.0 112.817 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.542 ' CD2' ' O ' ' A' ' 108' ' ' THR . 89.0 m-85 49.54 178.5 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.287 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.3 t 54.57 67.09 3.57 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.417 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.54 145.27 48.17 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.575 2.184 . . . . 0.0 112.137 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 26.2 tp -99.07 131.96 44.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.963 -0.562 . . . . 10.52 110.26 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.16 134.91 54.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.156 -0.474 . . . . 7.48 110.343 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.78 144.75 57.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 7.69 110.625 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.66 ' C ' ' H ' ' A' ' 118' ' ' GLU . 24.5 p -83.3 161.48 21.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.175 -0.466 . . . . 6.46 110.591 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 118' ' ' GLU . 6.4 t 62.17 -17.07 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 4.59 111.295 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.66 ' H ' ' C ' ' A' ' 116' ' ' THR . 96.3 mt-10 42.32 -169.62 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.606 0.241 . . . . 3.21 111.21 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.541 ' C ' ' O ' ' A' ' 118' ' ' GLU . 9.4 t 17.62 81.83 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.978 -0.555 . . . . 3.64 111.689 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.1 p -131.78 143.15 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.253 -0.43 . . . . 3.39 110.659 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 44.5 m -79.79 138.63 37.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.076 -0.511 . . . . 2.23 110.147 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -58.28 141.84 49.67 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.708 -0.397 . . . . 4.53 110.575 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 71.1 mt -117.11 135.62 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.93 -0.577 . . . . 2.01 110.573 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 23.3 p -83.59 161.1 21.27 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.997 -0.371 . . . . 2.22 109.997 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.683 ' O ' ' N ' ' A' ' 127' ' ' SER . . . -145.36 152.82 40.48 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.884 -0.326 . . . . 1.29 111.29 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.61 ' HG ' ' CG2' ' A' ' 201' ' ' THR . 92.6 p 10.73 48.74 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 122.617 1.199 . . . . 1.25 113.195 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.683 ' N ' ' O ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.91 167.5 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.243 -1.344 . . . . 1.16 110.938 179.797 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.56 145.64 50.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.736 -0.665 . . . . 0.78 110.156 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.26 101.47 9.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.157 -0.683 . . . . 1.08 109.157 177.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.472 HG11 ' N ' ' A' ' 131' ' ' SER . 71.7 t -112.91 139.65 36.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.099 -0.5 . . . . 1.1 111.101 -178.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.472 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.3 p -128.61 152.55 48.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.605 -0.725 . . . . 0.87 109.83 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.654 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.4 p90 -144.75 -164.87 2.01 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.634 -0.426 . . . . 0.37 110.606 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.735 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -124.06 127.19 73.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.246 -0.434 . . . . 1.14 110.784 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.179 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.99 58.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.028 -0.533 . . . . 1.91 110.358 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.735 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.15 24.61 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.872 -0.604 . . . . 1.56 111.527 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.179 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.08 128.73 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.614 -0.434 . . . . 1.56 110.942 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.31 -9.77 55.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.862 -0.608 . . . . 1.88 110.309 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.12 0.31 55.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 1.63 110.366 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.962 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.16 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.891 -0.595 . . . . 1.11 109.99 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.579 ' N ' ' O ' ' A' ' 185' ' ' ILE . 32.2 t -96.21 -15.51 22.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.311 0.576 . . . . 1.01 110.062 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.408 ' HA3' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.58 175.62 45.81 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 109.795 -1.322 . . . . 0.14 109.795 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.53 151.59 42.68 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.661 -0.416 . . . . 0.21 110.435 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.691 ' NH2' ' OE1' ' A' ' 191' ' ' GLN . 60.3 ttp85 -132.35 121.22 23.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.129 -0.487 . . . . 1.54 109.872 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.497 HG23 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.15 136.52 38.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.702 -0.681 . . . . 1.08 110.68 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 75.8 tt0 -129.33 129.84 45.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.01 -0.541 . . . . 1.32 110.121 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.605 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.4 p90 -138.73 135.37 34.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.049 -0.523 . . . . 1.05 110.596 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.405 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.38 161.38 39.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.702 -0.681 . . . . 1.16 109.697 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.945 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.0 mt -71.07 124.92 25.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.004 0.43 . . . . 1.23 110.766 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.75 -7.81 50.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.756 -0.656 . . . . 0.86 110.9 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.73 -69.65 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 1.66 111.453 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.461 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.68 -35.25 75.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 1.66 111.519 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.079 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 78.98 7.33 88.5 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.862 -0.895 . . . . 1.62 110.862 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.334 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -28.01 -171.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.784 0.326 . . . . 1.86 110.275 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.334 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.14 45.23 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.909 0.385 . . . . 1.98 110.186 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.405 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 45.9 Cg_endo -71.01 145.84 50.97 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 122.688 2.259 . . . . 0.62 112.383 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.78 145.74 42.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.249 -0.648 . . . . 1.14 109.249 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.57 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 93.5 m-85 -123.35 141.36 52.07 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.292 -0.563 . . . . 1.44 111.511 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.413 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.9 mt -128.12 127.72 43.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.334 -0.848 . . . . 1.08 108.934 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.62 ' HB2' HD21 ' A' ' 16' ' ' ASN . 4.0 t0 -101.65 131.07 48.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.183 0.516 . . . . 1.09 111.72 -178.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.542 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.1 mt -127.88 157.6 73.16 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.262 -0.881 . . . . 1.04 109.567 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -69.89 158.16 57.73 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.332 2.021 . . . . 0.21 112.203 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.4 -12.1 5.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.778 -0.646 . . . . 0.88 110.76 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.0 p -92.91 -8.64 42.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.072 -0.513 . . . . 1.06 110.677 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.2 135.33 34.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.318 -0.401 . . . . 1.05 110.406 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.4 p -133.13 16.72 4.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.426 -0.352 . . . . 1.07 110.493 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.55 147.18 5.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.663 -0.495 . . . . 0.92 109.663 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.503 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.26 150.42 12.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.498 -0.481 . . . . 1.09 111.521 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.497 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.32 124.96 50.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.57 -0.741 . . . . 1.31 109.754 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.522 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.32 104.88 29.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.343 -0.39 . . . . 1.09 111.119 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 84.7 Cg_endo -91.01 -179.47 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.909 0 C-N-CA 123.152 2.568 . . . . 0.48 112.153 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.61 32.71 18.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.314 -0.857 . . . . 1.26 111.398 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.522 HD21 HG21 ' A' ' 169' ' ' ILE . 23.9 mt -86.44 148.59 25.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.781 0.324 . . . . 1.12 110.43 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.779 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.4 mt -88.36 114.85 61.33 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.055 0.455 . . . . 1.3 110.664 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.03 140.63 96.15 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.928 2.418 . . . . 0.92 111.936 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.02 21.24 74.4 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.081 -0.808 . . . . 0.44 111.081 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.461 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.88 150.19 49.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 3.05 110.626 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.493 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.2 131.63 46.03 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.021 -0.536 . . . . 1.48 109.805 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.945 ' CE2' HD21 ' A' ' 148' ' ' LEU . 75.2 m-85 -120.47 148.28 44.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.06 -0.518 . . . . 0.89 111.048 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.2 mt -105.31 125.37 60.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.274 -1.01 . . . . 1.12 108.274 177.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.62 132.48 63.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.19 0.519 . . . . 1.1 111.223 -178.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.51 122.59 20.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.509 -0.768 . . . . 0.43 109.585 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.595 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.0 125.33 54.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 1.07 110.67 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.671 ' CE1' HD11 ' A' ' 193' ' ' LEU . 49.0 m-85 -117.2 137.93 52.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.031 -0.531 . . . . 0.92 109.77 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.575 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.68 135.06 42.71 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.798 -0.816 . . . . 0.49 108.798 178.786 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 140' ' ' SER . 72.5 mt -99.14 122.92 51.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.08 0.467 . . . . 1.08 110.903 -178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.444 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.4 p -83.84 169.77 14.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.559 -0.746 . . . . 0.89 110.522 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.555 ' O ' ' OG1' ' A' ' 59' ' ' THR . 17.1 pt-20 -59.75 -14.59 15.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.096 -0.502 . . . . 1.6 110.966 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.719 ' C ' ' HG1' ' A' ' 59' ' ' THR . 95.3 m-20 -96.02 -4.3 43.36 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.843 -0.343 . . . . 1.18 110.841 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.623 ' N ' ' HG1' ' A' ' 59' ' ' THR . . . 87.83 13.78 64.11 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.409 -0.677 . . . . 0.34 111.409 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -84.66 139.05 32.32 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.803 -0.233 . . . . 1.22 110.461 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.691 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 87.4 mt-30 -106.75 141.09 38.56 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.835 -0.346 . . . . 1.44 110.558 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.4 m -136.68 126.94 26.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 1.39 110.42 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.671 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.5 tp -68.09 117.26 9.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.915 0.388 . . . . 1.08 110.528 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.654 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.4 pt -109.07 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 1.08 110.653 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.9 125.61 5.81 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.524 -0.471 . . . . 1.1 111.6 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.495 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.71 120.23 21.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.841 -0.618 . . . . 0.94 109.604 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.59 151.68 29.12 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.697 -0.401 . . . . 1.07 110.893 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.41 158.66 18.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.005 -0.543 . . . . 0.89 110.439 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.12 157.91 43.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.089 -0.505 . . . . 0.67 110.649 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.43 9.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.711 -0.677 . . . . 1.17 109.992 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.61 ' CG2' ' HG ' ' A' ' 126' ' ' SER . 68.3 p . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.986 -1.006 . . . . 1.26 110.598 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.196 -0.668 . . . . 3.83 109.196 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.44 150.69 18.53 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.982 -0.847 . . . . 1.39 110.982 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.55 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 124.035 3.157 . . . . 0.86 113.772 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.569 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -79.93 173.43 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.264 -1.334 . . . . 1.43 108.853 178.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -105.64 125.84 51.45 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.437 -0.505 . . . . 1.94 111.49 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.51 143.93 34.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.661 -0.7 . . . . 1.19 110.712 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.31 25.62 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.874 0.369 . . . . 3.92 111.081 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.59 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.0 mt -108.96 131.08 60.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.926 -0.579 . . . . 3.88 110.044 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.15 162.28 35.87 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.838 0.352 . . . . 3.92 111.252 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.4 mt-10 36.13 31.57 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.592 -0.521 . . . . 6.08 109.592 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.59 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.45 69.56 32.61 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.94 -0.573 . . . . 4.01 111.627 -178.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.37 -29.0 71.88 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.431 2.087 . . . . 4.51 111.854 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.61 125.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 3.51 110.498 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.616 HE21 ' C ' ' A' ' 17' ' ' SER . 14.0 mt-30 -124.04 158.38 60.63 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.348 -0.387 . . . . 4.3 110.414 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.465 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 98.4 Cg_endo -82.14 -64.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.905 2.403 . . . . 1.96 113.428 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.764 ' ND2' ' CD2' ' A' ' 157' ' ' TYR . 1.3 m120 -108.42 -19.62 13.39 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.08 0.4 . . . . 3.33 112.08 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.616 ' C ' HE21 ' A' ' 14' ' ' GLN . 57.7 m -107.33 152.14 24.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.164 0.507 . . . . 1.53 111.302 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.34 103.0 2.22 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.681 -0.69 . . . . 2.29 110.569 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.652 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.7 145.67 13.01 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.823 2.348 . . . . 0.88 112.6 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.417 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.82 167.96 24.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.898 -0.592 . . . . 2.12 109.928 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.13 147.9 29.02 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.777 -0.453 . . . . 2.67 109.777 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.498 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.5 p90 -142.22 157.33 44.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.0 0.428 . . . . 0.32 111.225 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.468 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.04 155.27 44.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.779 -0.646 . . . . 2.77 110.106 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.56 173.1 6.27 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 121.118 0.485 . . . . 1.25 110.743 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.72 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.864 2.376 . . . . 1.12 111.507 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.48 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -51.05 0.69 Allowed Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.76 -0.376 . . . . 4.05 110.142 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.658 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.87 152.31 82.66 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.837 2.358 . . . . 2.12 111.369 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.71 42.25 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.426 0.631 . . . . 2.85 110.588 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.821 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.58 -41.59 98.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.019 -0.991 . . . . 3.11 110.644 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.441 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.8 mt -109.85 137.87 40.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.748 -0.66 . . . . 1.86 111.329 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.99 -72.93 0.7 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.099 -0.501 . . . . 1.61 111.886 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.22 148.41 24.38 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.607 0.595 . . . . 1.67 112.607 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -121.88 124.81 44.99 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.397 -0.594 . . . . 1.07 109.397 177.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.05 134.71 60.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.66 -0.416 . . . . 1.55 110.647 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.485 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -119.96 128.63 53.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.036 0.446 . . . . 1.33 111.249 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.541 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.03 139.01 49.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.738 -0.665 . . . . 2.36 110.143 178.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.417 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.03 163.11 35.24 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 120.55 -0.46 . . . . 0.38 112.135 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.46 139.62 7.9 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.498 -0.774 . . . . 2.31 110.485 178.763 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.62 115.46 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.302 2.001 . . . . 0.86 111.827 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.677 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.92 81.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.84 -0.43 . . . . 3.44 109.84 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.52 0.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.016 -0.538 . . . . 2.72 111.898 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.4 p -157.67 157.81 34.24 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.862 -0.335 . . . . 2.78 110.554 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.402 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.36 27.77 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.181 -0.463 . . . . 2.3 110.222 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -75.8 1.31 Allowed Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.103 -0.57 . . . . 1.8 111.892 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.89 152.36 35.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.927 0.394 . . . . 5.48 110.965 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.673 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.27 -169.14 2.53 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.059 -0.519 . . . . 1.84 111.965 179.373 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.09 149.57 29.84 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.468 0.651 . . . . 2.27 112.606 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.99 156.47 46.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.807 -1.088 . . . . 1.92 110.234 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.2 158.36 41.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.951 -0.568 . . . . 1.09 111.792 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.0 m -115.16 135.68 53.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.446 -0.797 . . . . 1.16 109.817 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.449 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.45 121.92 23.7 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.422 -0.353 . . . . 1.39 111.567 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.512 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.1 Cg_exo -46.41 151.71 1.7 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.753 2.302 . . . . 0.72 112.029 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.89 -23.02 63.01 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 115.989 -0.551 . . . . 0.74 112.742 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.81 -16.88 46.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.436 0.618 . . . . 1.26 111.758 -178.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.487 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.6 138.36 31.63 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.799 -0.36 . . . . 1.59 110.368 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.47 13.85 11.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.399 -0.364 . . . . 2.07 111.447 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.477 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.95 143.52 25.28 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.657 -0.417 . . . . 0.96 111.101 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.719 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.4 t80 -114.74 -169.36 1.53 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.981 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.719 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.85 125.9 9.19 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.449 -0.796 . . . . 1.19 109.826 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.469 HG23 HD11 ' A' ' 60' ' ' ILE . 66.8 mt -114.87 123.33 70.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.364 -0.534 . . . . 1.47 111.153 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.43 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 63.9 pttt -126.54 163.36 23.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.843 -0.617 . . . . 3.0 110.425 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.16 18.87 60.05 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.749 -0.941 . . . . 0.5 110.749 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.438 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.7 mt -79.03 157.23 28.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.091 0.472 . . . . 1.21 111.376 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.661 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 1.8 mtmm -99.48 133.89 21.58 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.593 -0.73 . . . . 3.2 110.454 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.64 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.9 Cg_endo -67.87 143.66 61.83 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.451 2.101 . . . . 1.09 111.942 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.87 25.49 75.5 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.063 -0.815 . . . . 0.72 111.063 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.641 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.08 158.86 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.744 0.307 . . . . 1.47 110.403 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.2 139.92 42.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.945 0.402 . . . . 1.23 110.508 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.661 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.4 m-85 -122.54 136.41 54.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.922 -0.581 . . . . 1.1 110.726 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.93 131.09 45.26 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.51 -0.922 . . . . 1.87 108.51 177.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.5 153.93 16.65 Favored Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.338 -0.934 . . . . 0.39 111.943 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.04 140.96 46.01 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.702 -0.481 . . . . 1.8 109.702 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.464 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.6 tp -115.67 118.99 34.61 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.478 -0.489 . . . . 1.11 110.503 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.9 mt -112.52 129.15 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.301 -0.409 . . . . 1.51 110.594 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.9 120.92 43.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.29 -0.413 . . . . 1.47 110.696 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.667 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.58 146.47 11.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.133 0.492 . . . . 1.33 111.019 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.821 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.12 153.97 21.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.566 -0.743 . . . . 2.49 109.852 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.24 88.61 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.966 0.413 . . . . 4.2 110.347 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.616 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.28 32.62 0.21 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.828 -0.624 . . . . 6.4 110.558 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.35 3.29 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.482 -0.647 . . . . 1.74 111.482 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.447 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.41 177.41 8.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.028 0.442 . . . . 3.64 111.699 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.23 149.48 31.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.512 -0.767 . . . . 1.7 110.378 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.18 144.65 38.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.436 -0.347 . . . . 2.7 110.526 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -128.02 136.05 61.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-O 121.155 0.502 . . . . 1.16 111.538 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.04 141.29 52.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.573 -0.74 . . . . 1.14 110.318 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.445 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.62 138.87 51.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.082 0.468 . . . . 4.33 111.486 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.491 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.32 164.1 38.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.536 -0.756 . . . . 0.91 109.523 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.571 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.22 151.64 38.71 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.354 -0.538 . . . . 1.47 111.027 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.575 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.0 p90 -146.24 172.77 12.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.644 -0.707 . . . . 0.51 110.995 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.451 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.81 160.66 21.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.391 -0.822 . . . . 1.92 109.854 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.451 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.38 121.89 22.97 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.536 -0.466 . . . . 1.63 110.74 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.576 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.4 p -131.76 -136.55 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 122.284 1.04 . . . . 2.37 111.303 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.629 ' C ' ' H ' ' A' ' 95' ' ' SER . 30.4 t 138.02 144.49 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 112.712 -2.04 . . . . 3.63 106.222 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.78 -10.83 0.18 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.629 ' H ' ' C ' ' A' ' 93' ' ' SER . 39.7 p -86.42 1.74 50.22 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.771 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.445 HG23 ' N ' ' A' ' 93' ' ' SER . 19.8 p -105.5 115.41 61.88 Favored Pre-proline 0 N--CA 1.475 0.817 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -177.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.516 ' HG2' ' H ' ' A' ' 98' ' ' VAL . 0.5 OUTLIER -98.43 -106.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 123.864 3.043 . . . . 0.0 112.391 178.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.516 ' H ' ' HG2' ' A' ' 97' ' ' PRO . 35.3 t -120.58 143.69 31.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.228 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 61.2 p -54.33 -10.33 0.38 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.613 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.438 ' H ' ' C ' ' A' ' 98' ' ' VAL . 49.7 m -63.46 164.79 8.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.763 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 64.99 51.96 1.62 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.075 0.464 . . . . 0.0 111.102 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.8 t -131.79 161.09 33.73 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.541 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.497 ' CG1' ' N ' ' A' ' 104' ' ' THR . 76.3 t 61.44 165.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.708 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.497 ' N ' ' CG1' ' A' ' 103' ' ' VAL . 42.7 m -120.15 143.67 48.08 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.924 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -153.69 -175.64 25.22 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -102.12 144.36 30.79 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.618 0.247 . . . . 0.0 110.702 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 121' ' ' THR . 55.5 m -117.5 141.58 48.18 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.213 0.53 . . . . 0.0 111.156 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.9 p -66.69 160.62 66.91 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.54 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.02 -20.13 9.87 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.186 1.924 . . . . 0.0 112.23 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -68.29 153.91 42.8 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.5 m -120.54 79.63 29.9 Favored Pre-proline 0 N--CA 1.467 0.378 0 CA-C-O 120.671 0.272 . . . . 0.0 111.527 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -54.23 160.21 6.83 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 123.082 2.522 . . . . 0.0 112.055 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.2 mt -68.6 154.54 41.7 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.201 -0.666 . . . . 10.52 109.201 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' A' ' 115' ' ' ALA . 18.6 m -54.52 131.36 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.405 -0.518 . . . . 7.48 110.961 -177.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 114' ' ' VAL . . . 149.74 115.24 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 114.775 -1.102 . . . . 7.69 108.679 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.6 p -81.36 160.39 24.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.106 0.479 . . . . 6.46 111.14 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 119' ' ' SER . 83.1 p -146.6 167.63 23.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.626 -0.716 . . . . 4.59 110.575 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.64 -30.01 69.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.911 -0.586 . . . . 3.21 110.643 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.423 ' O ' ' OG ' ' A' ' 117' ' ' SER . 50.9 m -113.66 150.79 32.7 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.239 -0.437 . . . . 3.64 110.676 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.6 t 60.22 109.22 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.932 -0.576 . . . . 3.39 110.816 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.453 ' O ' ' OG1' ' A' ' 107' ' ' THR . 43.8 m -123.29 143.29 50.17 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.716 -0.675 . . . . 2.23 110.22 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -96.81 143.64 27.53 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.994 0.426 . . . . 4.53 111.626 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 16.7 tt -118.8 136.19 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 115.607 -0.724 . . . . 2.01 109.165 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 172' ' ' LEU . 26.1 p -122.88 161.6 23.8 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.238 0.542 . . . . 2.22 112.167 -177.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.681 ' O ' ' HG3' ' A' ' 174' ' ' PRO . . . -111.28 153.37 26.02 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.422 -0.808 . . . . 1.29 110.547 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.621 ' CB ' ' O ' ' A' ' 125' ' ' ALA . 70.4 p 123.88 39.43 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 123.697 1.713 . . . . 1.25 108.726 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.479 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.8 167.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 113.047 -1.888 . . . . 1.16 110.988 -178.372 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.58 145.6 50.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.729 -0.668 . . . . 0.78 110.127 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.3 101.61 9.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.121 -0.696 . . . . 1.08 109.121 177.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.469 HG11 ' N ' ' A' ' 131' ' ' SER . 71.1 t -112.94 139.64 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.027 -0.533 . . . . 1.1 111.068 -178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.469 ' N ' HG11 ' A' ' 130' ' ' VAL . 68.7 p -128.67 152.65 48.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.667 -0.697 . . . . 0.87 109.793 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.651 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.7 p90 -144.76 -164.92 2.03 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.672 -0.411 . . . . 0.37 110.636 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.738 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -124.03 127.13 73.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 1.14 110.905 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.177 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.87 58.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 1.91 110.306 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.738 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.1 24.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.004 -0.544 . . . . 1.56 111.426 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.177 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.24 128.73 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.657 -0.417 . . . . 1.56 110.954 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -86.35 -9.53 56.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.933 -0.576 . . . . 1.88 110.393 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.0 p -87.18 0.21 55.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.47 . . . . 1.63 110.264 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.96 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.26 137.16 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.001 -0.545 . . . . 1.11 109.988 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.577 ' N ' ' O ' ' A' ' 185' ' ' ILE . 0.9 OUTLIER -96.19 -15.47 22.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.294 0.569 . . . . 1.01 110.1 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.622 ' N ' HG12 ' A' ' 185' ' ' ILE . . . 178.52 175.57 45.72 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 109.814 -1.315 . . . . 0.14 109.814 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.5 151.66 42.54 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.595 -0.442 . . . . 0.21 110.465 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.673 ' NH2' ' OE1' ' A' ' 191' ' ' GLN . 58.6 ttp85 -132.42 121.2 23.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.139 -0.482 . . . . 1.54 109.943 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.497 HG23 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.15 136.57 38.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.68 -0.691 . . . . 1.08 110.648 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 81.3 tt0 -129.38 129.85 45.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.957 -0.565 . . . . 1.32 110.016 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 36.2 p90 -138.62 135.29 34.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.972 -0.558 . . . . 1.05 110.731 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.408 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.29 161.35 39.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.839 -0.619 . . . . 1.16 109.632 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.943 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.1 mt -71.09 124.84 25.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.072 0.463 . . . . 1.23 110.73 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.71 -7.79 50.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.723 -0.671 . . . . 0.86 110.881 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -109.77 -69.58 0.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 1.66 111.519 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.454 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.69 -35.46 76.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.115 -0.493 . . . . 1.66 111.435 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.085 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.21 88.62 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.797 -0.921 . . . . 1.62 110.797 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.336 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.91 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 1.86 110.224 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.336 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.31 139.07 44.97 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.247 -0.433 . . . . 1.98 110.164 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.603 ' HG2' ' O ' ' A' ' 95' ' ' SER . 46.3 Cg_endo -70.92 145.81 51.38 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 122.756 2.304 . . . . 0.62 112.363 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.91 145.74 42.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.186 -0.672 . . . . 1.14 109.186 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.764 ' CD2' ' ND2' ' A' ' 16' ' ' ASN . 35.4 p90 -123.21 141.29 52.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.164 0.507 . . . . 1.44 111.599 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.7 mt -128.03 127.72 43.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.282 -0.872 . . . . 1.08 108.987 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.493 ' OD1' ' O ' ' A' ' 159' ' ' ASP . 53.8 p-10 -101.62 131.09 48.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.207 0.527 . . . . 1.09 111.821 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.503 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -127.92 157.53 73.45 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.363 -0.835 . . . . 1.04 109.604 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.77 158.06 58.24 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.366 2.044 . . . . 0.21 112.268 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.32 -12.13 5.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.787 -0.642 . . . . 0.88 110.685 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.86 -8.71 42.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.154 -0.475 . . . . 1.06 110.679 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.39 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.354 -0.384 . . . . 1.05 110.404 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.7 p -133.15 16.7 4.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.429 -0.35 . . . . 1.07 110.52 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.56 147.12 5.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.664 -0.495 . . . . 0.92 109.664 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.503 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.18 150.41 12.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.541 -0.464 . . . . 1.09 111.572 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.34 125.0 50.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.624 -0.716 . . . . 1.31 109.794 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.524 HG21 HD21 ' A' ' 172' ' ' LEU . 1.8 mt -99.44 104.86 29.7 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 1.09 111.064 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.8 Cg_endo -90.92 -179.58 1.53 Allowed 'Trans proline' 0 C--N 1.302 -1.895 0 C-N-CA 123.184 2.59 . . . . 0.48 112.219 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 61.77 32.65 18.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.382 -0.826 . . . . 1.26 111.37 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.524 HD21 HG21 ' A' ' 169' ' ' ILE . 24.0 mt -86.38 148.49 25.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.784 0.326 . . . . 1.12 110.498 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.776 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.33 114.84 61.29 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.989 0.423 . . . . 1.3 110.6 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.681 ' HG3' ' O ' ' A' ' 125' ' ' ALA . 21.9 Cg_exo -59.01 140.57 95.96 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.835 2.356 . . . . 0.92 111.994 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.31 74.08 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.0 -0.84 . . . . 0.44 111.0 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.454 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.8 mmm-85 -126.94 150.24 49.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 3.05 110.604 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.18 131.7 45.97 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.052 -0.522 . . . . 1.48 109.81 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.943 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.7 m-85 -120.57 148.34 44.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.052 -0.522 . . . . 0.89 111.013 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.35 125.33 60.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.262 -1.014 . . . . 1.12 108.262 177.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.6 132.59 63.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.139 0.495 . . . . 1.1 111.206 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.5 122.47 20.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.483 -0.78 . . . . 0.43 109.666 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.595 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.04 125.39 54.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.382 -0.372 . . . . 1.07 110.586 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.672 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.8 m-85 -117.24 137.86 52.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.973 -0.558 . . . . 0.92 109.918 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.573 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.63 135.02 42.73 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.829 -0.804 . . . . 0.49 108.829 178.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.622 HG12 ' N ' ' A' ' 141' ' ' GLY . 0.8 OUTLIER -99.03 123.0 51.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.156 0.503 . . . . 1.08 110.934 -178.828 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.444 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.9 p -83.98 169.71 14.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.566 -0.743 . . . . 0.89 110.411 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.637 ' C ' ' HG1' ' A' ' 59' ' ' THR . 82.2 tt0 -59.62 -14.67 14.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.036 -0.529 . . . . 1.6 110.964 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.652 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 87.8 m-20 -96.0 -4.38 43.28 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.862 -0.335 . . . . 1.18 110.83 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.85 13.79 64.07 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.376 -0.69 . . . . 0.34 111.376 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -84.53 139.05 32.41 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.096 -0.241 . . . . 1.22 110.569 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.673 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 88.9 mt-30 -106.73 140.97 38.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.48 -0.327 . . . . 1.44 110.623 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.67 127.03 26.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.171 -0.468 . . . . 1.39 110.407 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.672 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.5 tp -68.23 117.33 9.89 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.717 -0.393 . . . . 1.08 110.508 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.651 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.0 pt -108.94 -21.9 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 1.08 110.752 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.87 125.75 5.88 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.509 -0.476 . . . . 1.1 111.486 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.493 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.78 120.2 21.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.701 -0.681 . . . . 0.94 109.586 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.64 151.66 29.06 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.621 -0.432 . . . . 1.07 110.904 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.41 158.57 18.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.02 -0.536 . . . . 0.89 110.417 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -146.08 157.88 43.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.089 -0.505 . . . . 0.67 110.725 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.25 104.49 9.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.772 -0.649 . . . . 1.17 110.022 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.607 ' HB ' ' HB2' ' A' ' 126' ' ' SER . 68.0 p . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.842 -1.075 . . . . 1.26 110.588 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.55 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.142 -0.688 . . . . 3.83 109.142 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.426 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.37 150.75 18.53 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.925 -0.87 . . . . 1.39 110.925 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -35.74 142.42 0.1 Allowed 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 123.902 3.068 . . . . 0.86 113.857 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.566 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.3 t -79.96 173.34 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.254 -1.339 . . . . 1.43 108.825 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -105.57 125.89 51.5 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.412 -0.515 . . . . 1.94 111.422 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.52 144.08 33.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.618 -0.719 . . . . 1.19 110.599 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.08 168.19 26.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.875 0.369 . . . . 3.92 111.127 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.591 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.93 131.19 60.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.964 -0.562 . . . . 3.88 110.124 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.21 162.36 35.67 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.806 0.336 . . . . 3.92 111.208 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.7 mt-10 35.94 31.76 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.592 -0.521 . . . . 6.08 109.592 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.591 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.54 69.58 33.63 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.959 -0.564 . . . . 4.01 111.587 -178.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.29 -29.13 72.68 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.532 2.154 . . . . 4.51 111.865 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 3.51 110.532 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.717 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -124.0 158.38 60.51 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.352 -0.385 . . . . 4.3 110.347 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.563 ' CG ' ' NH2' ' A' ' 143' ' ' ARG . 97.0 Cg_endo -82.02 -64.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.877 2.385 . . . . 1.96 113.547 -179.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.69 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 63.2 t30 -108.4 -19.62 13.4 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.11 0.411 . . . . 3.33 112.11 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.717 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 27.6 t -107.37 152.07 24.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.184 0.516 . . . . 1.53 111.285 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.22 102.97 2.24 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.722 -0.672 . . . . 2.29 110.606 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.7 Cg_endo -82.81 145.69 12.83 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.888 2.392 . . . . 0.88 112.557 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.415 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.82 167.84 25.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.876 -0.602 . . . . 2.12 109.858 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.06 147.91 29.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.796 -0.446 . . . . 2.67 109.796 178.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.496 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.6 p90 -142.21 157.25 45.07 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.686 -0.406 . . . . 0.32 111.177 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.468 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.1 155.3 44.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.873 -0.603 . . . . 2.77 110.102 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.63 173.01 6.39 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.156 0.503 . . . . 1.25 110.696 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.62 173.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.892 2.394 . . . . 1.12 111.481 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.48 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.1 -51.07 0.68 Allowed Pre-proline 0 C--N 1.33 -0.265 0 C-N-CA 120.686 -0.406 . . . . 4.05 110.085 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.657 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.81 152.39 82.28 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.729 2.286 . . . . 2.12 111.44 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.77 42.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.399 0.618 . . . . 2.85 110.522 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.823 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.55 -41.74 98.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.002 -0.999 . . . . 3.11 110.651 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.435 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.1 mt -109.77 137.88 39.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.814 -0.63 . . . . 1.86 111.293 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.97 -72.87 0.7 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.008 -0.542 . . . . 1.61 111.97 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.19 148.47 24.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.532 0.567 . . . . 1.67 112.532 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -121.87 124.81 44.99 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.397 -0.594 . . . . 1.07 109.397 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.4 mt -117.97 134.8 60.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.616 -0.434 . . . . 1.55 110.604 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.484 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -120.05 128.6 53.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.983 0.42 . . . . 1.33 111.207 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.18 139.02 49.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.772 -0.649 . . . . 2.36 110.102 178.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.42 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.05 163.19 35.01 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 121.133 0.492 . . . . 0.38 112.066 -178.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.49 139.53 7.82 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.434 -0.803 . . . . 2.31 110.416 178.85 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 41' ' ' ASN . 18.0 Cg_endo -63.43 115.41 3.0 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.351 2.034 . . . . 0.86 111.847 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.668 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.99 81.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.866 -0.42 . . . . 3.44 109.866 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.688 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.24 -20.66 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.968 -0.56 . . . . 2.72 111.923 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.65 157.79 34.26 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.835 -0.346 . . . . 2.78 110.559 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.38 27.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 2.3 110.163 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.84 -75.88 1.31 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.118 -0.563 . . . . 1.8 111.867 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.87 152.29 35.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.973 0.416 . . . . 5.48 111.0 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.15 -169.02 2.51 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.061 -0.518 . . . . 1.84 111.981 179.335 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.19 149.71 29.72 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.482 0.658 . . . . 2.27 112.533 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.07 156.51 45.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.791 -1.095 . . . . 1.92 110.213 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.21 158.4 41.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.976 -0.557 . . . . 1.09 111.802 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.3 m -115.15 135.63 53.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.435 -0.802 . . . . 1.16 109.906 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.445 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.4 122.06 23.79 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.512 -0.313 . . . . 1.39 111.523 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.516 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.0 Cg_exo -46.46 151.74 1.73 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.689 2.259 . . . . 0.72 112.077 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.87 -23.09 63.03 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 116.065 -0.516 . . . . 0.74 112.805 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.516 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.75 -16.83 46.44 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.225 -0.59 . . . . 1.26 111.821 -178.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.484 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.6 mt -91.67 138.43 31.57 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.807 -0.357 . . . . 1.59 110.232 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.48 13.81 11.02 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.277 -0.42 . . . . 2.07 111.482 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.4 p -149.92 143.48 25.29 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.631 -0.428 . . . . 0.96 111.058 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.81 -169.29 1.52 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.209 0.528 . . . . 1.0 110.851 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.723 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 0.6 OUTLIER -151.84 125.91 9.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.433 -0.803 . . . . 1.19 109.765 179.281 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.419 HG23 HD11 ' A' ' 60' ' ' ILE . 66.3 mt -114.81 123.25 70.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.435 -0.506 . . . . 1.47 111.219 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.496 ' HB3' ' CD1' ' A' ' 185' ' ' ILE . 25.7 pttm -126.48 163.43 23.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.888 -0.596 . . . . 3.0 110.497 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.479 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.02 19.08 59.87 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.781 -0.928 . . . . 0.5 110.781 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.69 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.8 mt -79.1 157.3 28.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.09 0.472 . . . . 1.21 111.311 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.654 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 4.0 mttt -99.58 133.96 21.48 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.616 -0.72 . . . . 3.2 110.434 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.425 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.94 143.6 61.15 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.539 2.16 . . . . 1.09 111.936 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.84 25.58 75.39 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.091 -0.803 . . . . 0.72 111.091 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.637 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.17 158.84 39.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.715 0.293 . . . . 1.47 110.415 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.23 139.96 42.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.913 0.387 . . . . 1.23 110.56 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.654 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.9 m-85 -122.59 136.46 54.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.967 -0.56 . . . . 1.1 110.778 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.82 131.05 45.23 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.491 -0.929 . . . . 1.87 108.491 177.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.58 153.92 16.67 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.214 -0.993 . . . . 0.39 111.933 -178.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.03 140.9 45.99 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.698 -0.482 . . . . 1.8 109.698 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.462 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.1 tp -115.75 118.91 34.36 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.426 -0.51 . . . . 1.11 110.462 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.2 mt -112.41 129.15 68.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 1.51 110.608 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.82 120.86 43.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.242 -0.435 . . . . 1.47 110.747 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.669 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.58 146.46 11.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.169 0.509 . . . . 1.33 111.022 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.823 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.01 153.92 21.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.519 -0.764 . . . . 2.49 109.888 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.19 88.52 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.937 0.399 . . . . 4.2 110.428 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.41 32.53 0.22 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.841 -0.618 . . . . 6.4 110.53 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.04 -117.34 3.29 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.472 -0.651 . . . . 1.74 111.472 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.445 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.4 177.37 9.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.218 0.532 . . . . 3.64 111.643 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.2 149.5 32.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.435 -0.802 . . . . 1.7 110.385 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.55 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.21 144.7 38.61 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.432 -0.349 . . . . 2.7 110.511 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -127.98 135.93 61.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-O 121.087 0.47 . . . . 1.16 111.508 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.03 141.52 51.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.59 -0.732 . . . . 1.14 110.192 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.448 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.66 138.93 51.65 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.482 -0.487 . . . . 4.33 111.481 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.489 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.29 164.23 37.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.582 -0.736 . . . . 0.91 109.399 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.574 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 46.9 p30 -145.29 151.51 38.45 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.434 -0.506 . . . . 1.47 111.064 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.572 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.2 p90 -146.2 172.72 13.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.768 -0.651 . . . . 0.51 111.005 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.454 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.78 160.76 21.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.442 -0.799 . . . . 1.92 109.807 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.454 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.5 121.86 22.79 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.565 -0.454 . . . . 1.63 110.722 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.587 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.0 p -127.02 161.87 27.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.222 0.534 . . . . 2.37 111.864 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.1 t -115.74 148.96 39.22 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.516 -0.766 . . . . 3.63 110.531 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.0 p -111.44 165.17 12.2 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.035 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.4 p -111.2 155.1 23.44 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.138 0.494 . . . . 0.0 111.297 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.419 ' N ' ' HD3' ' A' ' 97' ' ' PRO . 11.1 m 57.31 63.46 4.96 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.127 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 96' ' ' THR . 41.7 Cg_exo -56.77 147.56 71.31 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.577 2.185 . . . . 0.0 111.531 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.57 136.64 26.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.985 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 35.5 m -118.9 139.3 51.88 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.089 0.471 . . . . 0.0 111.092 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.8 t -120.99 145.05 48.17 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.016 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -100.47 136.1 40.87 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.044 0.449 . . . . 0.0 110.669 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.6 m -123.19 143.36 50.08 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.285 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.9 p -63.34 136.95 25.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.928 0.394 . . . . 0.0 110.485 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 47.5 m -78.38 139.31 38.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.652 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 106' ' ' GLU . . . -164.67 -174.85 34.86 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 105' ' ' GLY . 95.4 mt-10 32.92 42.64 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.983 0.42 . . . . 0.0 110.934 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 58.1 p -67.92 -16.55 64.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.96 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.2 p -125.48 77.61 68.69 Favored Pre-proline 0 N--CA 1.467 0.421 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.988 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.05 149.92 50.33 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.745 2.297 . . . . 0.0 111.96 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -54.86 -40.48 69.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.262 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.22 159.03 32.45 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.248 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -54.95 147.35 52.57 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.581 2.187 . . . . 0.0 111.72 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.7 mt -57.63 -35.78 70.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 10.52 110.781 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 23.2 m -130.02 151.13 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.764 0.316 . . . . 7.48 110.395 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.03 21.15 13.96 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.134 -0.485 . . . . 7.69 110.586 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.3 t -136.77 160.32 39.19 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.075 0.464 . . . . 6.46 111.339 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.9 m -63.38 158.09 21.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.687 -0.688 . . . . 4.59 110.337 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.44 -34.09 64.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.456 -0.338 . . . . 3.21 110.28 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 96.3 p -120.5 151.64 39.1 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.34 -0.391 . . . . 3.64 109.999 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.615 HG23 ' H ' ' A' ' 122' ' ' GLU . 12.4 p -133.27 142.0 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.51 -0.314 . . . . 3.39 110.533 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 69.2 p -70.36 -24.73 63.02 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.334 -0.394 . . . . 2.23 111.25 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.615 ' H ' HG23 ' A' ' 120' ' ' VAL . 96.4 mt-10 -58.68 145.21 40.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.321 -0.399 . . . . 4.53 110.545 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.4 mt -111.63 134.36 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.156 -0.475 . . . . 2.01 109.846 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.9 p -123.7 161.59 24.83 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.079 -0.509 . . . . 2.22 110.627 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.19 -45.07 0.63 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.166 -0.47 . . . . 1.29 110.299 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.0 p -153.81 -0.87 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 1.25 110.311 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.478 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.68 167.5 0.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.883 -0.599 . . . . 1.16 110.949 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.56 145.53 50.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.685 -0.688 . . . . 0.78 110.197 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.23 101.62 9.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.106 -0.702 . . . . 1.08 109.106 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.467 HG11 ' N ' ' A' ' 131' ' ' SER . 72.1 t -112.94 139.67 36.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.071 -0.513 . . . . 1.1 111.103 -178.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.467 ' N ' HG11 ' A' ' 130' ' ' VAL . 68.0 p -128.76 152.59 48.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.677 -0.692 . . . . 0.87 109.846 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.645 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.7 p90 -144.81 -164.91 2.03 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.688 -0.405 . . . . 0.37 110.675 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -123.97 127.19 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 1.14 110.784 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.174 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -58.0 58.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.188 -0.46 . . . . 1.91 110.349 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.21 24.62 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.857 -0.611 . . . . 1.56 111.485 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.174 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.11 128.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.626 -0.43 . . . . 1.56 110.923 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.47 -9.62 55.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.837 -0.62 . . . . 1.88 110.329 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 29.0 p -86.96 0.13 55.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.061 -0.518 . . . . 1.63 110.391 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.963 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.23 137.3 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.96 -0.564 . . . . 1.11 109.989 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.575 ' N ' ' O ' ' A' ' 185' ' ' ILE . 7.1 p -96.33 -15.56 21.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.37 0.605 . . . . 1.01 110.029 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.589 ' H ' HG21 ' A' ' 185' ' ' ILE . . . 178.58 175.53 45.74 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 109.809 -1.316 . . . . 0.14 109.809 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -123.42 151.52 42.55 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.63 -0.428 . . . . 0.21 110.492 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.847 ' NH2' HE22 ' A' ' 191' ' ' GLN . 8.7 tmm_? -132.29 121.16 23.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.126 -0.488 . . . . 1.54 109.956 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.493 HG23 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.05 136.62 38.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.632 -0.713 . . . . 1.08 110.621 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 75.9 tt0 -129.39 129.89 45.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.95 -0.568 . . . . 1.32 110.043 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.7 p90 -138.75 135.27 34.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.034 -0.53 . . . . 1.05 110.673 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.408 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.36 39.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.694 -0.685 . . . . 1.16 109.697 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.94 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.4 mt -70.97 124.79 25.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.992 0.425 . . . . 1.23 110.718 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.76 -7.64 49.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.768 -0.651 . . . . 0.86 110.989 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.8 -69.72 0.85 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.264 -0.426 . . . . 1.66 111.387 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.445 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.3 mt-10 -60.8 -35.25 75.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 1.66 111.459 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.09 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.26 7.12 88.68 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.829 -0.908 . . . . 1.62 110.829 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.336 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.3 t0 -27.98 -171.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.801 0.334 . . . . 1.86 110.322 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.336 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.25 139.11 45.19 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-O 120.979 0.419 . . . . 1.98 110.238 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.408 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.0 Cg_endo -70.85 145.76 51.69 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 122.77 2.313 . . . . 0.62 112.325 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.82 145.69 42.62 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.25 -0.648 . . . . 1.14 109.25 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.646 ' CE2' ' CG ' ' A' ' 16' ' ' ASN . 25.0 p90 -123.24 141.38 52.04 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.348 -0.541 . . . . 1.44 111.532 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.413 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.9 mt -128.18 127.69 43.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.275 -0.875 . . . . 1.08 108.953 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.53 ' HB2' HD22 ' A' ' 16' ' ' ASN . 33.2 t0 -101.61 131.2 47.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.19 0.519 . . . . 1.09 111.779 -178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.504 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -128.0 157.52 73.65 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.348 -0.842 . . . . 1.04 109.585 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -69.87 157.95 58.45 Favored 'Trans proline' 0 C--N 1.302 -1.904 0 C-N-CA 122.49 2.126 . . . . 0.21 112.23 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.4 p -59.14 -12.19 4.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.743 -0.662 . . . . 0.88 110.817 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.1 p -92.79 -8.76 42.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 1.06 110.73 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.09 135.37 34.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.325 -0.398 . . . . 1.05 110.481 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.19 16.69 4.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.452 -0.34 . . . . 1.07 110.514 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.4 p -167.51 147.16 5.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.609 -0.515 . . . . 0.92 109.609 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.504 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.21 150.5 12.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.489 -0.484 . . . . 1.09 111.503 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.5 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 4.0 t-20 -106.35 124.98 50.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.585 -0.734 . . . . 1.31 109.81 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.524 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.36 104.92 29.83 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 1.09 111.081 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.1 Cg_endo -90.97 -179.51 1.5 Allowed 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 123.231 2.621 . . . . 0.48 112.204 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.69 32.63 18.35 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.385 -0.825 . . . . 1.26 111.411 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.524 HD21 HG21 ' A' ' 169' ' ' ILE . 23.9 mt -86.39 148.51 25.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.448 -0.342 . . . . 1.12 110.489 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.771 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.5 mt -88.23 114.91 61.52 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.029 0.442 . . . . 1.3 110.686 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.01 140.53 95.77 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.897 2.398 . . . . 0.92 111.992 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.16 21.14 74.23 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.032 -0.827 . . . . 0.44 111.032 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.445 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.83 150.14 49.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.768 0.318 . . . . 3.05 110.73 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.5 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.27 131.78 46.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.139 -0.482 . . . . 1.48 109.757 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.94 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.57 148.28 44.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.031 -0.532 . . . . 0.89 110.99 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.2 mt -105.32 125.4 60.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.222 -1.029 . . . . 1.12 108.222 177.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.58 132.56 63.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.205 0.526 . . . . 1.1 111.216 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.64 20.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.575 -0.739 . . . . 0.43 109.617 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.593 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.05 125.32 55.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.269 -0.423 . . . . 1.07 110.657 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.673 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.9 m-85 -117.21 137.94 52.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.031 -0.531 . . . . 0.92 109.835 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.74 135.07 42.76 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.785 -0.82 . . . . 0.49 108.785 178.863 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.589 HG21 ' H ' ' A' ' 141' ' ' GLY . 11.7 tt -99.15 123.01 51.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.167 0.508 . . . . 1.08 110.873 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.585 ' OG ' ' OD1' ' A' ' 188' ' ' ASP . 88.6 p -83.98 169.77 14.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.516 -0.766 . . . . 0.89 110.485 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -59.8 -14.5 15.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.095 -0.502 . . . . 1.6 110.897 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.671 ' OD1' ' N ' ' A' ' 190' ' ' GLU . 37.0 p30 -96.17 -4.2 43.01 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.782 -0.367 . . . . 1.18 110.731 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.463 ' N ' ' HB ' ' A' ' 59' ' ' THR . . . 87.82 13.85 64.03 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.377 -0.689 . . . . 0.34 111.377 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.671 ' N ' ' OD1' ' A' ' 188' ' ' ASP . 82.2 tt0 -84.67 139.0 32.34 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.04 -0.264 . . . . 1.22 110.472 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.847 HE22 ' NH2' ' A' ' 143' ' ' ARG . 90.3 mt-30 -106.72 141.11 38.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.873 0.368 . . . . 1.44 110.523 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 61.8 m -136.72 127.07 26.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.078 -0.51 . . . . 1.39 110.276 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.673 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.4 tp -68.14 117.21 9.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.284 -0.416 . . . . 1.08 110.554 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.645 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.0 pt -108.99 -21.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 1.08 110.795 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.84 125.68 5.88 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.519 -0.472 . . . . 1.1 111.465 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.492 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.71 120.3 21.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.799 -0.637 . . . . 0.94 109.585 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.66 151.74 29.13 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.667 -0.413 . . . . 1.07 110.916 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.47 158.57 18.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.015 -0.538 . . . . 0.89 110.41 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.1 157.86 43.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.123 -0.49 . . . . 0.67 110.696 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.26 104.28 9.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.78 -0.646 . . . . 1.17 110.096 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.482 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.0 p . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 117.845 -1.074 . . . . 1.26 110.655 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.224 -0.658 . . . . 3.83 109.224 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.39 150.62 18.55 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.012 -0.835 . . . . 1.39 111.012 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -35.62 142.35 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.05 0 C-N-CA 124.022 3.148 . . . . 0.86 113.828 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.568 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.0 t -79.91 173.3 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.283 -1.326 . . . . 1.43 108.891 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -105.49 125.86 51.47 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.479 -0.488 . . . . 1.94 111.482 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 143.99 33.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.665 -0.698 . . . . 1.19 110.689 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.94 168.23 25.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.922 0.391 . . . . 3.92 111.101 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.59 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.94 131.06 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.004 -0.544 . . . . 3.88 110.079 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.17 162.27 35.88 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.836 0.35 . . . . 3.92 111.239 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.6 mt-10 36.18 31.5 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.648 -0.501 . . . . 6.08 109.648 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.59 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.63 32.6 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.97 -0.559 . . . . 4.01 111.574 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.2 Cg_endo -63.16 -29.18 73.92 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.484 2.123 . . . . 4.51 111.888 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 3.51 110.518 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.619 ' NE2' ' O ' ' A' ' 13' ' ' SER . 6.0 mp0 -123.98 158.29 60.74 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 4.3 110.368 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.524 ' HA ' ' HG ' ' A' ' 93' ' ' SER . 97.5 Cg_endo -81.98 -64.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.958 2.439 . . . . 1.96 113.431 -179.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.933 HD22 ' HB2' ' A' ' 157' ' ' TYR . 5.7 m-20 -108.48 -19.53 13.42 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.07 0.396 . . . . 3.33 112.07 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 60.3 m -107.36 152.0 24.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.159 0.504 . . . . 1.53 111.258 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.4 t-80 -155.26 102.97 2.23 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.623 -0.717 . . . . 2.29 110.618 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.597 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.5 Cg_endo -82.7 145.63 12.99 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.885 2.39 . . . . 0.88 112.601 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.416 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.8 167.96 24.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.815 -0.63 . . . . 2.12 109.909 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.16 147.98 29.09 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.712 -0.477 . . . . 2.67 109.712 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.494 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.6 p90 -142.28 157.23 45.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.026 0.441 . . . . 0.32 111.165 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.47 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.06 155.23 44.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.752 -0.658 . . . . 2.77 110.116 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.55 173.05 6.34 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 121.091 0.472 . . . . 1.25 110.748 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.65 173.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.851 2.367 . . . . 1.12 111.502 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.484 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.06 -51.12 0.69 Allowed Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.643 -0.423 . . . . 4.05 110.08 179.819 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.658 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.76 152.31 82.49 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.796 2.33 . . . . 2.12 111.416 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.66 42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.35 0.595 . . . . 2.85 110.607 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.822 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.52 -41.63 98.5 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.017 -0.992 . . . . 3.11 110.68 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.439 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.2 mt -109.86 137.79 40.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.818 -0.628 . . . . 1.86 111.287 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.88 -72.83 0.71 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.013 -0.539 . . . . 1.61 111.986 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.21 148.43 24.38 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.517 0.562 . . . . 1.67 112.517 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.86 124.86 45.12 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.312 -0.625 . . . . 1.07 109.312 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.04 134.78 60.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.614 -0.434 . . . . 1.55 110.689 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.482 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -120.02 128.63 53.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 1.33 111.246 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.541 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.96 49.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.751 -0.659 . . . . 2.36 110.178 178.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.42 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.07 163.17 35.09 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.16 0.505 . . . . 0.38 112.128 -178.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.47 139.54 7.84 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.468 -0.787 . . . . 2.31 110.468 178.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.695 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.57 115.52 3.09 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.313 2.009 . . . . 0.86 111.791 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.674 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.01 81.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.885 -0.413 . . . . 3.44 109.885 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.695 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.51 0.06 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.987 -0.551 . . . . 2.72 111.889 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.8 p -157.72 157.69 33.96 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.82 0.343 . . . . 2.78 110.552 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.34 27.89 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 2.3 110.194 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.81 -75.96 1.31 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.2 -0.524 . . . . 1.8 111.81 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.79 152.29 35.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.824 0.345 . . . . 5.48 111.042 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.24 -169.11 2.52 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.107 -0.497 . . . . 1.84 111.884 179.334 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.67 29.73 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.524 0.678 . . . . 2.27 112.514 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.05 156.46 46.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.689 -1.141 . . . . 1.92 110.263 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.16 158.34 41.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.91 -0.586 . . . . 1.09 111.818 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.1 m -115.08 135.61 54.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.505 -0.77 . . . . 1.16 109.86 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.449 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.36 121.95 23.82 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.439 -0.346 . . . . 1.39 111.55 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.511 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.0 Cg_exo -46.37 151.79 1.64 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.653 2.235 . . . . 0.72 112.116 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.98 -23.01 63.19 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 116.052 -0.522 . . . . 0.74 112.763 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.511 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.1 p-80 -82.8 -16.84 46.26 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.216 -0.594 . . . . 1.26 111.861 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.485 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.66 138.51 31.5 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.657 -0.417 . . . . 1.59 110.281 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.55 13.94 10.98 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.314 -0.403 . . . . 2.07 111.568 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.01 143.35 25.12 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.611 -0.436 . . . . 0.96 111.068 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.722 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.63 -169.29 1.51 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.188 0.518 . . . . 1.0 110.941 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.722 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.3 t -151.8 125.97 9.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.416 -0.811 . . . . 1.19 109.808 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.472 HG23 HD11 ' A' ' 60' ' ' ILE . 66.6 mt -114.93 123.2 70.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.404 -0.518 . . . . 1.47 111.217 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -126.47 163.39 23.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.829 -0.623 . . . . 3.0 110.426 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.19 18.97 59.79 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.705 -0.958 . . . . 0.5 110.705 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.439 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.9 mt -79.1 157.14 28.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.093 0.473 . . . . 1.21 111.324 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.653 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 3.0 mtpp -99.39 133.97 21.57 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 3.2 110.463 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.89 143.58 61.36 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.586 2.191 . . . . 1.09 111.963 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.87 25.58 75.4 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.023 -0.831 . . . . 0.72 111.023 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.639 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.15 158.74 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.706 0.288 . . . . 1.47 110.466 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.13 139.93 42.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.883 0.373 . . . . 1.23 110.602 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.653 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.3 m-85 -122.49 136.48 54.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.55 . . . . 1.1 110.775 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.98 130.98 45.36 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.539 -0.911 . . . . 1.87 108.539 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.43 153.91 16.63 Favored Glycine 0 C--O 1.227 -0.344 0 C-N-CA 120.299 -0.953 . . . . 0.39 111.962 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.97 140.91 46.07 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.73 -0.47 . . . . 1.8 109.73 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.465 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.7 tp -115.73 118.95 34.48 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.456 -0.498 . . . . 1.11 110.533 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.9 mt -112.42 129.05 68.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.323 -0.399 . . . . 1.51 110.628 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.9 120.8 43.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.287 -0.415 . . . . 1.47 110.713 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.665 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.53 146.46 11.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.231 0.538 . . . . 1.33 111.058 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.822 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.03 153.94 21.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.495 -0.775 . . . . 2.49 109.949 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.2 mt-30 -39.21 88.6 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.895 0.379 . . . . 4.2 110.446 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.24 32.62 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.822 -0.626 . . . . 6.4 110.598 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.08 -117.33 3.29 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.457 -0.657 . . . . 1.74 111.457 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.442 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.51 177.42 8.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.197 0.522 . . . . 3.64 111.6 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.16 149.44 31.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.451 -0.795 . . . . 1.7 110.451 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.14 144.65 38.73 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.479 -0.328 . . . . 2.7 110.533 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.5 p -128.01 135.99 61.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-O 121.036 0.446 . . . . 1.16 111.555 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.05 141.32 52.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.662 -0.699 . . . . 1.14 110.304 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.443 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.63 138.82 51.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.053 0.454 . . . . 4.33 111.577 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.491 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.25 164.21 37.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.548 -0.751 . . . . 0.91 109.435 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.57 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.28 151.47 38.4 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.399 -0.52 . . . . 1.47 111.058 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.575 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.2 p90 -146.18 172.66 13.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.802 -0.636 . . . . 0.51 111.039 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.451 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.6 160.71 21.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.456 -0.793 . . . . 1.92 109.897 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.451 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.43 121.81 22.8 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.591 -0.444 . . . . 1.63 110.778 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.494 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -127.64 163.88 23.28 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 114.03 1.122 . . . . 2.37 114.03 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.524 ' HG ' ' HA ' ' A' ' 15' ' ' PRO . 55.2 m -120.57 154.74 34.97 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 113.55 -1.659 . . . . 3.63 108.815 177.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.6 t -43.52 -41.22 4.32 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.146 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.2 t -115.45 144.31 44.01 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.8 113.37 62.71 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.037 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.36 147.17 69.18 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.289 1.993 . . . . 0.0 112.633 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.4 t -114.74 134.99 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.873 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.4 p -85.11 161.31 19.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.794 0.33 . . . . 0.0 110.954 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.2 t -118.73 143.37 46.93 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.278 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -86.96 6.01 34.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.129 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.5 p -84.08 160.04 21.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.773 0.321 . . . . 0.0 110.656 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.3 m -112.98 9.18 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.703 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.7 p -83.69 161.89 20.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.913 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.94 5.23 64.42 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.832 ' O ' ' O ' ' A' ' 107' ' ' THR . 21.8 pt-20 -106.66 145.99 31.3 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.53 0.205 . . . . 0.0 110.949 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.832 ' O ' ' O ' ' A' ' 106' ' ' GLU . 5.6 m 30.86 138.68 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.6 p -126.32 78.68 71.25 Favored Pre-proline 0 N--CA 1.465 0.314 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.33 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -55.35 143.64 75.69 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.432 2.088 . . . . 0.0 112.45 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.444 ' O ' ' OG ' ' A' ' 111' ' ' SER . 65.9 t80 -57.63 -39.64 77.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.564 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 110' ' ' PHE . 22.6 p 61.97 66.76 1.39 Allowed Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.028 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -56.48 -19.49 29.42 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.841 2.361 . . . . 0.0 111.979 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 66.6 mt -57.71 -34.33 69.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 10.52 110.687 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.7 t -66.62 134.19 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.745 -0.382 . . . . 7.48 110.287 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -120.43 -113.24 0.33 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.134 -0.485 . . . . 7.69 110.608 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.7 m -75.99 137.0 39.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.41 -0.359 . . . . 6.46 110.466 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 84.1 p -140.89 163.9 31.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.018 -0.537 . . . . 4.59 110.65 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -56.24 146.57 23.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.048 -0.524 . . . . 3.21 110.124 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.2 t -61.26 144.29 54.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.049 0.452 . . . . 3.64 110.606 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.9 t -119.15 138.22 50.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.654 -0.703 . . . . 3.39 110.72 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 26.4 p -77.18 163.21 26.77 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.814 -0.439 . . . . 2.23 109.814 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.12 141.48 45.98 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.636 -0.426 . . . . 4.53 110.918 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.06 162.36 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.751 -0.658 . . . . 2.01 111.09 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.6 p -120.79 160.78 22.69 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.433 -0.58 . . . . 2.22 109.433 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.97 123.42 29.42 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.586 -0.446 . . . . 1.29 110.76 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.5 p -65.0 -27.19 68.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.943 -0.571 . . . . 1.25 110.365 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.48 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.86 167.59 0.25 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.602 -0.726 . . . . 1.16 110.955 -179.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.62 145.48 50.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.731 -0.668 . . . . 0.78 110.156 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.16 101.64 9.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.095 -0.706 . . . . 1.08 109.095 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.471 HG11 ' N ' ' A' ' 131' ' ' SER . 71.1 t -112.92 139.78 36.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.056 -0.52 . . . . 1.1 110.95 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.471 ' N ' HG11 ' A' ' 130' ' ' VAL . 66.9 p -128.74 152.57 48.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.598 -0.728 . . . . 0.87 109.792 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.652 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.7 p90 -144.8 -164.87 2.02 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.741 -0.384 . . . . 0.37 110.667 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.5 t -123.98 127.12 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 1.14 110.823 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.176 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.87 58.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.126 -0.488 . . . . 1.91 110.368 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -37.95 24.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.934 -0.575 . . . . 1.56 111.579 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.176 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.23 128.68 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.659 -0.417 . . . . 1.56 110.96 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.42 -9.53 56.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.0 -0.545 . . . . 1.88 110.32 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.8 p -87.16 0.25 55.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 1.63 110.29 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.961 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.26 137.26 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.994 -0.548 . . . . 1.11 109.956 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.571 ' N ' ' O ' ' A' ' 185' ' ' ILE . 90.3 p -96.29 -15.5 21.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.27 0.557 . . . . 1.01 110.048 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.58 175.57 45.77 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 109.88 -1.288 . . . . 0.14 109.88 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.47 151.62 42.54 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.569 -0.452 . . . . 0.21 110.496 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.787 HH22 ' NE2' ' A' ' 191' ' ' GLN . 41.8 ttp180 -132.26 121.14 23.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.15 -0.477 . . . . 1.54 109.924 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.494 HG23 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.14 136.63 38.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.734 -0.666 . . . . 1.08 110.649 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 99.2 mt-10 -129.45 129.86 45.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.942 -0.572 . . . . 1.32 110.044 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.601 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.7 p90 -138.68 135.35 34.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.046 -0.525 . . . . 1.05 110.611 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.404 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.41 161.36 39.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.793 -0.64 . . . . 1.16 109.621 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.943 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -71.05 124.99 25.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.036 0.446 . . . . 1.23 110.694 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.497 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.7 p -71.94 -7.7 50.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.766 -0.652 . . . . 0.86 110.797 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -109.72 -69.67 0.85 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.967 0.413 . . . . 1.66 111.455 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.451 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.71 -35.28 75.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.998 -0.546 . . . . 1.66 111.522 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.081 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.11 7.23 88.59 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.825 -0.91 . . . . 1.62 110.825 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.34 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.83 -171.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.324 . . . . 1.86 110.256 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.34 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.26 139.02 45.14 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-O 120.945 0.402 . . . . 1.98 110.205 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.404 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.9 Cg_endo -70.75 145.73 52.2 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 122.808 2.339 . . . . 0.62 112.361 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.86 145.69 42.65 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.312 -0.625 . . . . 1.14 109.312 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.933 ' HB2' HD22 ' A' ' 16' ' ' ASN . 0.2 OUTLIER -123.26 141.32 52.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.31 0.576 . . . . 1.44 111.421 -178.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.408 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.9 mt -128.14 127.61 43.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.271 -0.877 . . . . 1.08 108.921 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 159' ' ' ASP . 51.4 p-10 -101.61 131.21 47.94 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.194 0.521 . . . . 1.09 111.731 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.505 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -128.02 157.58 73.5 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.237 -0.892 . . . . 1.04 109.493 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.81 158.02 58.33 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.435 2.09 . . . . 0.21 112.267 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.36 -12.11 5.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.792 -0.64 . . . . 0.88 110.708 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.7 p -92.82 -8.67 42.9 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.129 -0.487 . . . . 1.06 110.715 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.38 34.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.319 -0.4 . . . . 1.05 110.394 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.12 16.53 4.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.398 -0.365 . . . . 1.07 110.558 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.4 p -167.45 147.23 5.18 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.661 -0.496 . . . . 0.92 109.661 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.505 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.32 150.42 12.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.565 -0.454 . . . . 1.09 111.602 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.496 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.26 124.94 50.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.559 -0.746 . . . . 1.31 109.843 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.525 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.45 104.86 29.72 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.918 0.389 . . . . 1.09 111.098 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 84.4 Cg_endo -91.05 -179.42 1.47 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 123.132 2.555 . . . . 0.48 112.163 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.56 32.73 18.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.366 -0.834 . . . . 1.26 111.419 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.525 HD21 HG21 ' A' ' 169' ' ' ILE . 24.1 mt -86.37 148.52 25.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.454 -0.339 . . . . 1.12 110.454 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.776 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.31 114.88 61.44 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.018 0.437 . . . . 1.3 110.64 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -58.98 140.62 96.14 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.815 2.343 . . . . 0.92 112.051 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.16 74.4 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.088 -0.805 . . . . 0.44 111.088 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.451 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.86 150.21 49.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.313 . . . . 3.05 110.634 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.497 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.13 131.63 45.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.519 . . . . 1.48 109.789 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.943 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.55 148.38 43.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.066 -0.515 . . . . 0.89 110.995 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.4 125.28 60.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.363 -0.977 . . . . 1.12 108.363 177.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.47 132.51 63.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.149 0.5 . . . . 1.1 111.217 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.49 122.66 20.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.54 -0.755 . . . . 0.43 109.729 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.594 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.09 125.37 55.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.284 -0.417 . . . . 1.07 110.664 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.672 ' CE1' HD11 ' A' ' 193' ' ' LEU . 49.1 m-85 -117.18 138.04 51.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.978 -0.555 . . . . 0.92 109.875 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.571 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.81 134.97 43.0 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.77 -0.826 . . . . 0.49 108.77 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.571 ' O ' ' N ' ' A' ' 140' ' ' SER . 85.4 mt -99.09 122.93 51.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.145 0.498 . . . . 1.08 110.961 -178.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.447 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.2 p -83.89 169.65 14.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.526 -0.761 . . . . 0.89 110.447 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.63 ' O ' ' CG2' ' A' ' 59' ' ' THR . 51.5 tp10 -59.79 -14.39 14.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.034 -0.53 . . . . 1.6 110.982 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.597 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.1 m-20 -96.18 -4.24 42.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.857 0.361 . . . . 1.18 110.817 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.8 13.88 64.0 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.384 -0.687 . . . . 0.34 111.384 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.5 tp10 -84.7 139.09 32.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.712 0.292 . . . . 1.22 110.422 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.787 ' NE2' HH22 ' A' ' 143' ' ' ARG . 6.9 pt20 -106.71 141.03 38.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.405 -0.362 . . . . 1.44 110.602 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.4 m -136.72 127.06 26.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 1.39 110.301 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.672 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.5 tp -68.19 117.27 9.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.244 -0.434 . . . . 1.08 110.577 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.652 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.1 pt -108.97 -21.86 5.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 1.08 110.711 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.83 125.72 5.9 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.551 -0.46 . . . . 1.1 111.535 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.495 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.79 120.12 21.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.854 -0.612 . . . . 0.94 109.603 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.58 151.66 29.11 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.676 -0.409 . . . . 1.07 110.97 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.49 158.66 18.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.89 110.411 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.14 157.87 43.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.043 -0.526 . . . . 0.67 110.627 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.2 104.31 9.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.722 -0.672 . . . . 1.17 110.119 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.483 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 66.7 p . . . . . 0 C--O 1.221 -0.414 0 CA-C-O 117.902 -1.047 . . . . 1.26 110.666 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.4 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.267 -0.642 . . . . 3.83 109.267 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.425 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.39 150.72 18.53 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.006 -0.838 . . . . 1.39 111.006 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -35.61 142.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 124.007 3.138 . . . . 0.86 113.789 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.567 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.3 t -80.04 173.39 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.288 -1.324 . . . . 1.43 108.745 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.66 125.86 51.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.398 -0.521 . . . . 1.94 111.444 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.48 144.06 33.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.564 -0.744 . . . . 1.19 110.631 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.09 168.33 25.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.944 0.402 . . . . 3.92 111.127 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.59 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -108.99 131.06 60.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.972 -0.558 . . . . 3.88 110.116 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.2 p -141.14 162.25 35.93 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.875 0.369 . . . . 3.92 111.24 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 75.0 mm-40 36.1 31.61 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.633 -0.506 . . . . 6.08 109.633 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.59 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.55 69.69 33.96 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.952 -0.567 . . . . 4.01 111.618 -178.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.34 -29.07 72.2 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.498 2.132 . . . . 4.51 111.851 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.64 125.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.098 -0.501 . . . . 3.51 110.477 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.82 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -123.99 158.31 60.71 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 4.3 110.437 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 97.1 Cg_endo -81.95 -64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.858 2.372 . . . . 1.96 113.553 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.7 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 52.1 t30 -108.48 -19.55 13.41 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.119 0.414 . . . . 3.33 112.119 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.82 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 47.1 m -107.31 152.05 24.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.136 0.493 . . . . 1.53 111.281 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.569 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.5 t-80 -155.32 102.86 2.22 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.72 -0.673 . . . . 2.29 110.682 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.6 145.72 13.17 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.875 2.383 . . . . 0.88 112.627 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.415 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.88 167.98 24.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.896 -0.593 . . . . 2.12 109.879 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.15 148.03 29.15 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.786 -0.45 . . . . 2.67 109.786 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.495 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.8 p90 -142.32 157.3 44.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.936 0.398 . . . . 0.32 111.303 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.467 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.07 155.34 44.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.841 -0.618 . . . . 2.77 110.092 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.67 173.08 6.31 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 121.122 0.487 . . . . 1.25 110.76 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.74 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.841 2.361 . . . . 1.12 111.512 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.48 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.14 -50.97 0.69 Allowed Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.62 -0.432 . . . . 4.05 110.133 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.656 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.85 152.4 82.32 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.678 2.252 . . . . 2.12 111.559 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.75 42.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.401 0.62 . . . . 2.85 110.528 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.822 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.63 -41.63 98.24 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.008 -0.996 . . . . 3.11 110.616 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.438 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.9 mt -109.79 137.86 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.84 -0.618 . . . . 1.86 111.227 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.0 -72.84 0.71 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.042 -0.526 . . . . 1.61 111.937 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.29 148.38 24.34 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.549 0.574 . . . . 1.67 112.549 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.82 124.89 45.23 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.345 -0.613 . . . . 1.07 109.345 177.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.4 mt -118.06 134.75 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.608 -0.437 . . . . 1.55 110.616 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.486 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -119.98 128.66 53.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.996 0.427 . . . . 1.33 111.245 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.93 49.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.79 -0.641 . . . . 2.36 110.213 178.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.418 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -144.98 163.17 35.01 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.118 0.485 . . . . 0.38 112.043 -178.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.52 139.57 7.82 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.417 -0.811 . . . . 2.31 110.503 178.746 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.3 Cg_endo -63.54 115.47 3.06 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.347 2.032 . . . . 0.86 111.818 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.3 tttp -46.85 81.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.883 -0.414 . . . . 3.44 109.883 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.7 0.06 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.109 -0.496 . . . . 2.72 111.914 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 p -157.55 157.81 34.46 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.857 -0.337 . . . . 2.78 110.592 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.33 27.77 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.213 -0.449 . . . . 2.3 110.183 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.77 -75.97 1.31 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.198 -0.525 . . . . 1.8 111.811 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.86 152.25 35.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.947 0.403 . . . . 5.48 111.019 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.676 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.17 -169.14 2.54 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.996 -0.547 . . . . 1.84 112.048 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.16 149.67 29.74 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 121.476 0.655 . . . . 2.27 112.561 -177.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.99 156.42 46.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.763 -1.108 . . . . 1.92 110.347 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.13 158.39 41.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.209 0.528 . . . . 1.09 111.828 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.1 m -115.22 135.57 54.03 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.57 -0.741 . . . . 1.16 109.794 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.446 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.36 121.96 23.82 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.33 -0.396 . . . . 1.39 111.495 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.516 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.9 Cg_exo -46.3 151.65 1.64 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.733 2.289 . . . . 0.72 112.081 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.84 -23.06 62.94 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-N 116.037 -0.529 . . . . 0.74 112.814 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.516 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.87 -16.74 46.38 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.236 -0.585 . . . . 1.26 111.779 -178.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.486 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.6 mt -91.69 138.41 31.59 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.807 -0.357 . . . . 1.59 110.308 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.54 13.98 10.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.315 -0.402 . . . . 2.07 111.482 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 86.8 p -149.97 143.5 25.25 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.696 -0.402 . . . . 0.96 111.03 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.721 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.87 -169.43 1.55 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.286 0.565 . . . . 1.0 110.808 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.721 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.4 t -151.77 125.89 9.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.375 -0.83 . . . . 1.19 109.908 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.42 HG23 HD11 ' A' ' 60' ' ' ILE . 66.4 mt -114.74 123.27 70.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.424 -0.51 . . . . 1.47 111.257 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.75 ' HZ3' ' HG ' ' A' ' 140' ' ' SER . 21.5 mtmt -126.48 163.33 23.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.88 -0.6 . . . . 3.0 110.464 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.473 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.14 18.99 59.84 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.77 -0.932 . . . . 0.5 110.77 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.7 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.6 mt -79.05 157.35 28.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.043 0.449 . . . . 1.21 111.408 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.654 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 6.6 mttp -99.54 133.95 21.51 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.666 -0.697 . . . . 3.2 110.412 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.54 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.92 143.66 61.53 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.495 2.13 . . . . 1.09 111.945 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.78 25.47 75.52 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.161 -0.776 . . . . 0.72 111.161 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.639 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.04 158.84 39.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.655 0.264 . . . . 1.47 110.51 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.23 139.89 42.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.916 0.388 . . . . 1.23 110.516 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.654 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.6 136.41 54.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.959 -0.564 . . . . 1.1 110.799 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.88 130.91 45.3 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.51 -0.922 . . . . 1.87 108.51 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.36 153.79 16.63 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.298 -0.953 . . . . 0.39 112.07 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.91 140.97 46.18 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.696 -0.483 . . . . 1.8 109.696 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.462 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.0 tp -115.78 118.96 34.49 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.456 -0.498 . . . . 1.11 110.483 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.9 mt -112.5 129.02 68.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.334 -0.394 . . . . 1.51 110.645 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.82 120.84 43.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.326 -0.397 . . . . 1.47 110.766 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.668 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.6 146.47 11.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.144 0.497 . . . . 1.33 110.985 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.822 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.0 153.88 21.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.575 -0.738 . . . . 2.49 109.902 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.18 88.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.901 0.382 . . . . 4.2 110.427 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.62 0.21 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.8 -0.636 . . . . 6.4 110.56 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.34 3.29 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.406 -0.678 . . . . 1.74 111.406 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.446 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.38 177.39 9.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.132 0.492 . . . . 3.64 111.652 -179.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.12 149.5 32.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.504 -0.771 . . . . 1.7 110.421 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.17 144.65 38.67 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.402 -0.363 . . . . 2.7 110.623 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -128.0 135.96 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.997 0.427 . . . . 1.16 111.568 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.0 141.35 52.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.667 -0.697 . . . . 1.14 110.289 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.447 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.65 138.8 51.73 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.089 0.471 . . . . 4.33 111.529 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.491 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.17 164.22 37.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.553 -0.749 . . . . 0.91 109.556 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.573 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.3 151.48 38.4 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.432 -0.507 . . . . 1.47 111.004 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.569 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.0 p90 -146.15 172.75 12.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.714 -0.676 . . . . 0.51 111.024 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.453 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.69 160.71 21.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.454 -0.794 . . . . 1.92 109.849 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.605 ' CG2' HE22 ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.43 121.89 22.91 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.575 -0.45 . . . . 1.63 110.778 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.634 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.8 p -127.62 165.52 19.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 2.37 111.415 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.5 t -99.1 142.55 30.44 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 109.617 -0.512 . . . . 3.63 109.617 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 43.4 m -84.16 137.97 33.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.102 0.477 . . . . 0.0 111.79 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.475 ' O ' ' OG1' ' A' ' 96' ' ' THR . 31.5 t -121.88 143.46 49.42 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.585 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.615 ' N ' ' CD ' ' A' ' 97' ' ' PRO . 1.1 m 168.12 -35.28 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.595 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 96' ' ' THR . 51.1 Cg_exo -53.29 145.29 45.28 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.869 1.713 . . . . 0.0 112.357 -179.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 40.9 t -114.73 137.11 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.322 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.6 t -133.19 158.38 43.01 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.837 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 92.0 p -123.01 157.9 31.69 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.445 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.7 p-10 -130.17 176.22 8.27 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.92 0.39 . . . . 0.0 110.749 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.4 t -135.98 160.94 37.08 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.592 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.4 t -111.42 135.01 51.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.325 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 45.8 m -121.34 142.06 50.34 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.647 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -134.7 170.64 22.67 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -59.28 141.47 54.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.812 0.339 . . . . 0.0 110.615 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.474 ' O ' ' OG1' ' A' ' 108' ' ' THR . 64.1 p -71.72 -21.57 61.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.68 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.636 ' N ' ' HD2' ' A' ' 109' ' ' PRO . 1.2 m 166.99 -49.63 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.705 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 108' ' ' THR . 16.2 Cg_endo -56.94 149.72 59.77 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.324 2.016 . . . . 0.0 112.011 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -103.71 134.81 46.41 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.429 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.404 ' N ' ' HD3' ' A' ' 112' ' ' PRO . 11.5 t 56.64 64.77 4.46 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.549 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.404 ' HD3' ' N ' ' A' ' 111' ' ' SER . 31.7 Cg_exo -56.6 147.12 72.19 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.662 2.241 . . . . 0.0 112.149 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.434 ' H ' ' CD1' ' A' ' 113' ' ' LEU . 6.5 mp -61.12 -33.64 73.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.862 -0.608 . . . . 10.52 110.802 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 113' ' ' LEU . 91.0 t 55.8 159.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.2 -0.454 . . . . 7.48 110.654 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.28 146.31 54.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.011 -0.541 . . . . 7.69 110.836 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.2 p -81.49 164.24 22.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.067 -0.515 . . . . 6.46 110.355 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.626 ' O ' ' N ' ' A' ' 119' ' ' SER . 87.6 p -60.83 -26.51 67.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 4.59 111.183 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' A' ' 120' ' ' VAL . 95.8 mt-10 44.12 -82.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.507 -0.315 . . . . 3.21 111.323 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.626 ' N ' ' O ' ' A' ' 117' ' ' SER . 7.4 p 66.21 -47.73 0.42 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.296 -0.411 . . . . 3.64 110.815 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.468 ' H ' ' C ' ' A' ' 118' ' ' GLU . 19.8 m -69.64 -27.91 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.459 -0.337 . . . . 3.39 110.669 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.9 m -121.09 139.92 52.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.248 -0.433 . . . . 2.23 110.291 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -103.98 134.12 47.8 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.332 -0.395 . . . . 4.53 110.18 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.624 ' C ' ' H ' ' A' ' 125' ' ' ALA . 32.6 mm -116.78 132.68 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.815 0.341 . . . . 2.01 111.299 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.563 ' O ' ' O ' ' A' ' 125' ' ' ALA . 19.6 m 52.5 -2.85 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.94 -0.573 . . . . 2.22 112.082 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.624 ' H ' ' C ' ' A' ' 123' ' ' ILE . . . 48.46 115.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.201 0.524 . . . . 1.29 111.271 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.9 p -61.31 -27.53 68.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.92 -0.582 . . . . 1.25 110.546 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.478 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.91 167.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.873 -0.603 . . . . 1.16 110.916 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.484 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.9 m-30 -133.61 145.56 50.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.674 -0.693 . . . . 0.78 110.138 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.21 101.63 9.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.086 -0.709 . . . . 1.08 109.086 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.468 HG11 ' N ' ' A' ' 131' ' ' SER . 71.7 t -112.93 139.64 36.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.033 -0.531 . . . . 1.1 111.076 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.468 ' N ' HG11 ' A' ' 130' ' ' VAL . 68.8 p -128.71 152.54 48.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.669 -0.696 . . . . 0.87 109.869 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.644 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.8 p90 -144.71 -164.93 2.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.688 -0.405 . . . . 0.37 110.716 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -124.01 127.19 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 1.14 110.83 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.175 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.94 58.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.059 -0.519 . . . . 1.91 110.388 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.16 24.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.876 -0.602 . . . . 1.56 111.507 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.175 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.18 128.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.618 -0.433 . . . . 1.56 110.921 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -86.53 -9.51 56.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.942 -0.572 . . . . 1.88 110.339 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.18 0.34 55.47 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.045 -0.525 . . . . 1.63 110.444 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.962 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.23 137.23 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.847 -0.615 . . . . 1.11 109.93 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.75 ' HG ' ' HZ3' ' A' ' 61' ' ' LYS . 87.2 p -96.34 -15.4 21.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.324 0.583 . . . . 1.01 110.068 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.56 175.54 45.73 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 109.836 -1.306 . . . . 0.14 109.836 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.44 151.61 42.5 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.637 -0.425 . . . . 0.21 110.488 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.614 ' NH1' ' OE1' ' A' ' 191' ' ' GLN . 55.9 ttp180 -132.36 121.2 23.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.141 -0.481 . . . . 1.54 109.92 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.493 HG23 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.16 136.62 38.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.753 -0.658 . . . . 1.08 110.652 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 22.4 tp10 -129.35 129.93 45.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.981 -0.554 . . . . 1.32 109.974 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.6 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.75 135.35 34.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.993 -0.549 . . . . 1.05 110.507 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.409 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.38 161.37 39.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.721 -0.672 . . . . 1.16 109.666 179.778 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.94 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -71.06 124.88 25.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.946 0.403 . . . . 1.23 110.772 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.499 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.7 p -71.75 -7.78 50.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.75 -0.659 . . . . 0.86 110.853 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -109.8 -69.76 0.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.318 -0.401 . . . . 1.66 111.394 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.444 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.5 mt-10 -60.65 -35.32 75.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.033 -0.531 . . . . 1.66 111.441 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.091 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.16 7.32 88.53 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.785 -0.926 . . . . 1.62 110.785 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.334 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.4 t0 -28.15 -171.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.807 0.337 . . . . 1.86 110.266 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.334 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.15 45.23 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-O 120.918 0.389 . . . . 1.98 110.139 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.409 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.1 Cg_endo -70.98 145.81 51.07 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 C-N-CA 122.717 2.278 . . . . 0.62 112.318 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.6 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.83 145.83 42.51 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.243 -0.651 . . . . 1.14 109.243 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.572 ' CE2' ' CG ' ' A' ' 16' ' ' ASN . 27.5 p90 -123.37 141.32 52.11 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.372 -0.531 . . . . 1.44 111.514 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.418 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.7 mt -128.11 127.62 43.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.318 -0.855 . . . . 1.08 108.994 178.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.547 ' HB3' ' ND2' ' A' ' 16' ' ' ASN . 37.6 p-10 -101.55 131.14 47.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.08 0.467 . . . . 1.09 111.771 -178.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.506 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -127.94 157.51 73.57 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.376 -0.829 . . . . 1.04 109.58 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.74 157.94 58.69 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 122.429 2.086 . . . . 0.21 112.269 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.1 p -59.26 -12.14 5.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.776 -0.647 . . . . 0.88 110.682 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.0 p -92.87 -8.7 42.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 1.06 110.711 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.11 135.31 34.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.284 -0.416 . . . . 1.05 110.394 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.1 p -133.12 16.7 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 1.07 110.502 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.8 p -167.52 147.11 5.09 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.602 -0.518 . . . . 0.92 109.602 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.506 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.1 p -152.18 150.38 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.476 -0.489 . . . . 1.09 111.589 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.22 124.94 50.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.63 -0.714 . . . . 1.31 109.792 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.523 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.44 104.91 30.02 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.917 0.389 . . . . 1.09 111.112 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -90.97 -179.47 1.5 Allowed 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 123.18 2.586 . . . . 0.48 112.23 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.64 32.67 18.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.395 -0.821 . . . . 1.26 111.387 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.523 HD21 HG21 ' A' ' 169' ' ' ILE . 23.9 mt -86.39 148.56 25.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.79 0.328 . . . . 1.12 110.489 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.771 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.4 114.77 61.01 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.978 0.418 . . . . 1.3 110.595 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -58.92 140.52 95.62 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.823 2.348 . . . . 0.92 112.06 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.15 21.18 74.15 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.061 -0.815 . . . . 0.44 111.061 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.444 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.88 150.15 49.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.808 0.337 . . . . 3.05 110.691 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.499 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.15 131.65 45.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.117 -0.492 . . . . 1.48 109.772 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.94 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.5 m-85 -120.45 148.27 44.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.172 -0.467 . . . . 0.89 111.09 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.2 mt -105.35 125.28 60.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.342 -0.985 . . . . 1.12 108.342 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.43 132.51 63.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.096 0.474 . . . . 1.1 111.353 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.47 122.44 20.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.523 -0.762 . . . . 0.43 109.651 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.593 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.98 125.39 54.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.333 -0.394 . . . . 1.07 110.651 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.672 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.5 m-85 -117.19 137.9 52.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.017 -0.538 . . . . 0.92 109.888 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.571 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.65 134.98 42.81 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.758 -0.83 . . . . 0.49 108.758 178.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.574 ' O ' ' N ' ' A' ' 140' ' ' SER . 65.3 mt -99.08 123.08 51.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.214 0.53 . . . . 1.08 110.927 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.446 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.7 p -83.99 169.73 14.69 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.498 -0.773 . . . . 0.89 110.362 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -59.82 -14.47 15.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.978 -0.555 . . . . 1.6 110.966 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.446 ' H ' ' HG ' ' A' ' 186' ' ' SER . 95.2 m-20 -96.05 -4.32 43.22 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.837 -0.345 . . . . 1.18 110.856 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.487 ' HA2' ' HG1' ' A' ' 59' ' ' THR . . . 87.79 13.95 63.9 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.359 -0.696 . . . . 0.34 111.359 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -84.78 139.06 32.22 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.01 -0.276 . . . . 1.22 110.437 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.614 ' OE1' ' NH1' ' A' ' 143' ' ' ARG . 6.9 pt20 -106.7 141.06 38.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.893 0.378 . . . . 1.44 110.532 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.2 m -136.78 127.05 26.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.113 -0.494 . . . . 1.39 110.39 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.672 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.2 tp -68.15 117.28 9.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.294 -0.412 . . . . 1.08 110.527 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.644 HD12 ' CD1' ' A' ' 132' ' ' TRP . 43.9 pt -108.97 -21.87 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 1.08 110.724 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.87 125.81 5.91 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.457 -0.497 . . . . 1.1 111.468 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.492 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.71 120.21 21.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.75 -0.659 . . . . 0.94 109.56 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.7 29.11 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.6 -0.44 . . . . 1.07 110.892 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.45 158.54 18.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.89 110.472 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.07 157.88 43.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.133 -0.485 . . . . 0.67 110.649 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.21 104.35 9.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.703 -0.681 . . . . 1.17 110.05 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.484 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.2 p . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.866 -1.064 . . . . 1.26 110.669 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.5 m . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.179 -0.675 . . . . 3.83 109.179 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.32 150.7 18.54 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.05 -0.82 . . . . 1.39 111.05 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -35.57 142.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.076 0 C-N-CA 124.004 3.136 . . . . 0.86 113.815 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.563 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -80.02 173.52 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.256 -1.338 . . . . 1.43 108.846 178.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.6 125.88 51.49 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.453 -0.499 . . . . 1.94 111.352 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 144.02 33.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.678 -0.692 . . . . 1.19 110.726 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.0 168.32 25.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.895 0.379 . . . . 3.92 111.149 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.581 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.6 mt -109.06 131.12 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.993 -0.549 . . . . 3.88 110.076 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.2 162.33 35.74 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.862 0.363 . . . . 3.92 111.159 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 9' ' ' THR . 71.7 tt0 36.0 31.68 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 109.652 -0.499 . . . . 6.08 109.652 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.581 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.53 69.61 33.55 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.916 -0.584 . . . . 4.01 111.493 -178.735 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.38 -29.03 71.83 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.474 2.116 . . . . 4.51 111.832 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.6 125.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 3.51 110.433 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.697 ' O ' ' O ' ' A' ' 92' ' ' THR . 14.2 mm-40 -123.89 158.4 60.11 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.256 -0.429 . . . . 4.3 110.434 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HG3' HE22 ' A' ' 191' ' ' GLN . 96.3 Cg_endo -81.99 -64.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.895 2.396 . . . . 1.96 113.534 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.562 HD21 ' CG ' ' A' ' 159' ' ' ASP . 43.2 p-10 -108.38 -19.56 13.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.3 -0.409 . . . . 3.33 112.048 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 3.5 m -107.44 152.13 24.61 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.428 -0.509 . . . . 1.53 111.314 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.58 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.0 t-80 -155.32 102.92 2.22 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.608 -0.724 . . . . 2.29 110.674 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.68 145.67 13.02 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.823 2.349 . . . . 0.88 112.627 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.414 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.78 168.0 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.867 -0.606 . . . . 2.12 109.874 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.23 148.02 29.1 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.688 -0.486 . . . . 2.67 109.688 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.505 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.6 p90 -142.34 157.34 44.9 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.615 -0.434 . . . . 0.32 111.187 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.469 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.9 m-20 -128.09 155.31 44.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.789 -0.641 . . . . 2.77 110.163 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.62 173.02 6.38 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 121.112 0.482 . . . . 1.25 110.741 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.68 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.913 2.408 . . . . 1.12 111.502 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.485 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.07 -51.01 0.69 Allowed Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.719 -0.392 . . . . 4.05 110.165 179.841 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.656 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.85 152.38 82.39 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.757 2.305 . . . . 2.12 111.404 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.77 42.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.363 0.601 . . . . 2.85 110.517 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.82 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.62 -41.72 98.25 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.006 -0.997 . . . . 3.11 110.634 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.451 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.5 mt -109.8 137.85 40.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.741 -0.663 . . . . 1.86 111.287 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.93 -72.92 0.7 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.061 -0.518 . . . . 1.61 111.897 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.37 24.44 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.618 0.599 . . . . 1.67 112.618 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.87 124.92 45.25 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.331 -0.618 . . . . 1.07 109.331 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.11 134.77 60.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.624 -0.43 . . . . 1.55 110.551 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.485 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -120.09 128.57 53.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.064 0.459 . . . . 1.33 111.244 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.539 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.04 138.96 49.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.75 -0.659 . . . . 2.36 110.175 179.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.416 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.0 p90 -145.11 163.23 34.93 Favored 'General case' 0 CA--C 1.523 -0.067 0 CA-C-O 121.194 0.521 . . . . 0.38 112.052 -178.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.487 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.52 139.54 7.81 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 115.389 -0.823 . . . . 2.31 110.494 178.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.47 115.49 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.286 1.991 . . . . 0.86 111.856 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.681 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.04 81.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.803 -0.443 . . . . 3.44 109.803 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.65 0.06 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.971 -0.559 . . . . 2.72 111.942 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 p -157.66 157.72 34.11 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.744 -0.383 . . . . 2.78 110.538 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.403 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.26 27.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.224 -0.444 . . . . 2.3 110.181 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.91 -75.9 1.31 Allowed Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.133 -0.556 . . . . 1.8 111.8 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.79 152.24 35.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.895 0.378 . . . . 5.48 110.995 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.667 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.21 -169.14 2.54 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.132 -0.486 . . . . 1.84 111.882 179.337 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.416 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.58 29.86 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.462 0.649 . . . . 2.27 112.594 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.99 156.37 46.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.794 -1.094 . . . . 1.92 110.316 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.09 158.44 41.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.988 -0.551 . . . . 1.09 111.87 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.7 m -115.21 135.66 53.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.511 -0.768 . . . . 1.16 109.832 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.453 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.31 121.91 23.87 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.403 -0.362 . . . . 1.39 111.554 -179.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.511 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.2 Cg_exo -46.39 151.74 1.67 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.636 2.224 . . . . 0.72 112.156 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.85 -23.11 63.03 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 116.029 -0.532 . . . . 0.74 112.794 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.511 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.76 -16.89 46.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.375 0.587 . . . . 1.26 111.84 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.491 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.53 138.39 31.61 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.803 -0.359 . . . . 1.59 110.323 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.5 13.86 11.01 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.406 -0.361 . . . . 2.07 111.554 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.476 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.96 143.46 25.24 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.659 -0.416 . . . . 0.96 111.057 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.713 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.8 -169.37 1.53 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.895 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.713 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.0 t -151.77 125.8 9.19 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.366 -0.834 . . . . 1.19 109.853 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.439 HG23 HD11 ' A' ' 60' ' ' ILE . 66.8 mt -114.8 123.4 70.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.28 -0.568 . . . . 1.47 111.156 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -126.53 163.4 23.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.831 -0.622 . . . . 3.0 110.423 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.14 18.92 59.98 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.757 -0.937 . . . . 0.5 110.757 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.437 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 74.0 mt -79.03 157.18 28.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.039 0.447 . . . . 1.21 111.314 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.666 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 3.1 mttm -99.38 133.9 21.63 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.627 -0.715 . . . . 3.2 110.51 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.95 143.58 61.01 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.5 2.133 . . . . 1.09 111.95 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.86 25.7 75.25 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.049 -0.821 . . . . 0.72 111.049 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.649 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.2 158.78 40.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.649 0.262 . . . . 1.47 110.468 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.476 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.2 139.95 42.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.915 0.388 . . . . 1.23 110.579 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.666 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.3 m-85 -122.56 136.42 54.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.936 -0.575 . . . . 1.1 110.81 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.487 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.93 131.03 45.32 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.516 -0.92 . . . . 1.87 108.516 177.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.46 153.93 16.64 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.2 -1.0 . . . . 0.39 111.97 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.98 140.99 46.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.708 -0.478 . . . . 1.8 109.708 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.468 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.8 tp -115.83 118.87 34.22 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.47 -0.492 . . . . 1.11 110.523 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.4 mt -112.44 129.14 68.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.289 -0.414 . . . . 1.51 110.578 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.85 120.89 43.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.256 -0.429 . . . . 1.47 110.685 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.663 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.59 146.53 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.169 0.509 . . . . 1.33 111.018 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.82 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.08 153.87 21.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.519 -0.764 . . . . 2.49 109.935 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.11 88.53 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.909 0.385 . . . . 4.2 110.386 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.622 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.67 0.21 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.822 -0.626 . . . . 6.4 110.532 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.12 -117.33 3.28 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.394 -0.682 . . . . 1.74 111.394 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.45 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.38 177.41 8.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.165 0.507 . . . . 3.64 111.646 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.24 149.55 32.1 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.446 -0.797 . . . . 1.7 110.413 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.14 144.63 38.71 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.444 -0.344 . . . . 2.7 110.599 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -127.97 135.91 61.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 120.69 -0.404 . . . . 1.16 111.607 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.0 141.36 52.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.755 -0.657 . . . . 1.14 110.325 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.73 138.91 51.71 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.181 0.515 . . . . 4.33 111.478 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.29 164.1 38.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.47 -0.787 . . . . 0.91 109.539 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.563 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.23 151.64 38.72 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.412 -0.515 . . . . 1.47 111.005 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.58 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.3 p90 -146.23 172.74 13.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.688 -0.687 . . . . 0.51 111.092 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.44 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.77 160.68 21.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.492 -0.777 . . . . 1.92 109.887 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.44 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.36 121.96 23.1 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.559 -0.456 . . . . 1.63 110.761 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.697 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -130.99 -145.26 0.27 Allowed 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 121.941 0.877 . . . . 2.37 111.478 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.479 ' OG ' ' HB ' ' A' ' 102' ' ' THR . 94.9 p -123.08 162.88 21.59 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.191 -1.368 . . . . 3.63 107.897 177.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.669 ' O ' ' O ' ' A' ' 95' ' ' SER . 27.2 p -74.37 169.01 18.54 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -177.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.669 ' O ' ' O ' ' A' ' 94' ' ' THR . 9.9 t -3.94 -140.84 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -178.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.35 161.91 74.94 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.044 -176.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.727 ' O ' ' O ' ' A' ' 98' ' ' VAL . 21.6 Cg_exo -64.35 -20.66 66.68 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 123.397 2.732 . . . . 0.0 113.155 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.727 ' O ' ' O ' ' A' ' 97' ' ' PRO . 30.4 m -40.92 -135.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.9 m -54.91 -36.77 65.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.029 0.443 . . . . 0.0 110.38 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.487 ' OG ' ' OG1' ' A' ' 94' ' ' THR . 13.5 t -56.38 -30.37 62.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.998 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.712 ' O ' ' OE2' ' A' ' 145' ' ' GLU . 17.6 m120 63.88 55.97 1.54 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.407 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.601 ' CG2' ' O ' ' A' ' 94' ' ' THR . 43.1 p -116.95 160.39 20.99 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.424 HG22 ' OG ' ' A' ' 93' ' ' SER . 3.4 m -72.76 -30.93 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.693 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 45.8 m -71.74 136.12 47.04 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.388 -178.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -170.09 -173.94 37.86 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -66.94 -21.17 65.99 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.6 p -76.93 156.15 32.25 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.053 0.454 . . . . 0.0 111.169 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.622 ' N ' ' HD2' ' A' ' 109' ' ' PRO . 65.3 m -78.36 -48.31 1.92 Allowed Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.836 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 108' ' ' THR . 10.1 Cg_endo -52.47 143.98 42.79 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.128 1.885 . . . . 0.0 112.846 -178.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.483 ' O ' ' C ' ' A' ' 111' ' ' SER . 49.3 p90 -137.1 168.25 19.96 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.363 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.483 ' C ' ' O ' ' A' ' 110' ' ' PHE . 15.0 m -23.86 91.83 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.498 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.903 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.422 ' N ' ' O ' ' A' ' 110' ' ' PHE . 47.0 Cg_exo -54.74 149.04 42.59 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 123.001 2.467 . . . . 0.0 112.469 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.542 ' CD2' ' N ' ' A' ' 113' ' ' LEU . 1.5 mm? -91.45 142.53 27.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.943 -0.571 . . . . 10.52 110.179 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.0 t -117.01 135.58 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.175 -0.466 . . . . 7.48 110.453 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.93 142.92 58.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.384 -0.371 . . . . 7.69 110.505 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 57.4 p -70.81 -24.16 62.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 6.46 111.187 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.6 m -64.26 153.15 39.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.853 0.359 . . . . 4.59 110.998 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.01 141.93 56.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.257 -0.429 . . . . 3.21 110.34 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 31.1 t -136.74 145.27 44.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.524 -0.307 . . . . 3.64 111.14 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.1 p -130.84 140.83 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 109.446 -0.576 . . . . 3.39 109.446 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 20.9 p -126.08 161.64 27.15 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.434 0.635 . . . . 2.23 112.222 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.2 -24.37 67.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.884 -1.053 . . . . 4.53 110.065 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 80.9 mt -48.78 152.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.316 -0.856 . . . . 2.01 111.444 -177.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.4 p -116.73 167.07 11.42 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.174 -0.921 . . . . 2.22 110.134 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.09 142.91 34.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.44 0.638 . . . . 1.29 111.628 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.62 23.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 122.746 1.26 . . . . 1.25 107.853 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.471 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.78 167.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.005 -1.452 . . . . 1.16 111.022 -178.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.6 145.54 50.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.765 -0.652 . . . . 0.78 110.14 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.22 101.59 9.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.099 -0.704 . . . . 1.08 109.099 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.469 HG11 ' N ' ' A' ' 131' ' ' SER . 71.6 t -112.94 139.7 36.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.071 -0.513 . . . . 1.1 111.052 -178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.469 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.3 p -128.62 152.58 48.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.642 -0.708 . . . . 0.87 109.842 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.641 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.4 p90 -144.78 -164.89 2.02 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.736 -0.386 . . . . 0.37 110.708 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.741 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -123.99 127.2 73.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.256 -0.429 . . . . 1.14 110.833 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.161 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.99 58.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.075 -0.512 . . . . 1.91 110.332 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.741 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.12 24.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.88 -0.6 . . . . 1.56 111.481 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.161 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.2 128.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.619 -0.433 . . . . 1.56 110.891 179.782 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.38 -9.7 55.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.896 -0.593 . . . . 1.88 110.325 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.07 0.31 55.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.058 -0.519 . . . . 1.63 110.39 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.962 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.34 137.17 25.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.919 -0.582 . . . . 1.11 109.955 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 185' ' ' ILE . 1.8 m -96.15 -15.51 22.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.313 0.578 . . . . 1.01 110.044 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.616 ' N ' HG12 ' A' ' 185' ' ' ILE . . . 178.62 175.63 45.85 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.846 -1.301 . . . . 0.14 109.846 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -123.4 151.57 42.47 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.705 -0.398 . . . . 0.21 110.504 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.878 HH21 ' N ' ' A' ' 159' ' ' ASP . 1.5 tpm_? -132.39 121.25 23.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.111 -0.495 . . . . 1.54 109.878 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.479 HG23 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.06 136.56 38.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.654 -0.703 . . . . 1.08 110.649 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.712 ' OE2' ' O ' ' A' ' 101' ' ' ASN . 85.3 tt0 -129.37 129.9 45.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.016 -0.538 . . . . 1.32 110.0 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.592 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.66 135.31 34.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.928 -0.578 . . . . 1.05 110.632 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.401 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.29 161.37 39.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.758 -0.655 . . . . 1.16 109.688 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.933 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -71.06 124.87 25.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.981 0.419 . . . . 1.23 110.72 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.489 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.84 -7.67 49.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.759 -0.655 . . . . 0.86 110.886 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.79 -69.74 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 1.66 111.429 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.421 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.59 -35.39 75.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.083 -0.508 . . . . 1.66 111.441 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.092 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.15 7.24 88.59 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.776 -0.929 . . . . 1.62 110.776 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.308 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.4 t0 -27.94 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.759 0.314 . . . . 1.86 110.246 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.308 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.32 139.03 44.92 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.947 0.403 . . . . 1.98 110.14 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.401 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.7 Cg_endo -70.78 145.86 52.37 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 C-N-CA 122.751 2.301 . . . . 0.62 112.327 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.88 145.69 42.66 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.223 -0.658 . . . . 1.14 109.223 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.487 ' HB3' ' CZ ' ' A' ' 143' ' ' ARG . 83.5 m-85 -123.28 141.34 52.09 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.354 -0.539 . . . . 1.44 111.54 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.651 ' C ' HH21 ' A' ' 143' ' ' ARG . 70.8 mt -128.09 127.7 43.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.298 -0.865 . . . . 1.08 108.935 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.878 ' N ' HH21 ' A' ' 143' ' ' ARG . 55.9 t0 -101.68 131.16 48.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.258 0.551 . . . . 1.09 111.661 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.519 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -127.94 157.55 73.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.333 -0.849 . . . . 1.04 109.636 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -69.81 158.02 58.29 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.394 2.063 . . . . 0.21 112.238 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.28 -12.12 5.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.806 -0.634 . . . . 0.88 110.76 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.8 p -92.8 -8.82 42.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.124 -0.489 . . . . 1.06 110.687 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.21 135.31 34.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.383 . . . . 1.05 110.338 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.5 p -133.09 16.75 4.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 1.07 110.502 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.9 p -167.64 147.06 4.97 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.627 -0.508 . . . . 0.92 109.627 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.519 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.1 p -152.19 150.45 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.398 -0.521 . . . . 1.09 111.51 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.28 124.96 50.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.626 -0.716 . . . . 1.31 109.81 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.517 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.41 104.89 29.78 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.403 -0.362 . . . . 1.09 111.094 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.4 Cg_endo -90.98 -179.49 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 123.158 2.572 . . . . 0.48 112.198 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.75 32.61 18.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.435 -0.802 . . . . 1.26 111.359 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 169' ' ' ILE . 24.1 mt -86.31 148.5 25.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.54 -0.3 . . . . 1.12 110.487 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.766 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.5 mt -88.29 114.8 61.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.986 0.422 . . . . 1.3 110.636 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.95 140.51 95.61 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.98 2.453 . . . . 0.92 111.93 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.03 21.32 74.18 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.025 -0.83 . . . . 0.44 111.025 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.421 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.86 150.21 49.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.864 0.364 . . . . 3.05 110.589 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.489 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.2 131.65 46.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.993 -0.549 . . . . 1.48 109.801 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.933 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.5 m-85 -120.5 148.37 43.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.069 -0.514 . . . . 0.89 110.999 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.39 125.27 60.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.243 -1.021 . . . . 1.12 108.243 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.49 132.59 63.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.211 0.529 . . . . 1.1 111.227 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.59 20.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.526 -0.761 . . . . 0.43 109.622 179.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.588 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -101.07 125.38 55.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.293 -0.412 . . . . 1.07 110.711 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.674 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.8 m-85 -117.21 137.92 52.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.967 -0.56 . . . . 0.92 109.866 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.78 135.07 42.8 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.763 -0.829 . . . . 0.49 108.763 178.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.616 HG12 ' N ' ' A' ' 141' ' ' GLY . 0.8 OUTLIER -99.08 122.89 51.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.175 0.512 . . . . 1.08 110.938 -178.718 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.452 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.6 p -83.84 169.66 14.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.586 -0.734 . . . . 0.89 110.408 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.461 ' HA ' ' HG ' ' A' ' 140' ' ' SER . 97.0 mt-10 -59.72 -14.52 14.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.959 -0.564 . . . . 1.6 111.023 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.452 ' H ' ' HG ' ' A' ' 186' ' ' SER . 95.6 m-20 -96.12 -4.27 43.07 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.779 -0.368 . . . . 1.18 110.793 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.84 13.92 63.86 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.346 -0.702 . . . . 0.34 111.346 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -84.59 139.09 32.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.574 0.225 . . . . 1.22 110.433 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.514 HE22 ' HG3' ' A' ' 15' ' ' PRO . 83.8 mt-30 -106.82 141.08 38.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.373 . . . . 1.44 110.545 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.8 m -136.74 127.03 26.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.093 -0.503 . . . . 1.39 110.374 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.674 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.5 tp -68.07 117.3 9.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 1.08 110.53 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.641 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -109.07 -21.75 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 1.08 110.7 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.92 125.7 5.84 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.489 -0.484 . . . . 1.1 111.514 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.497 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.68 120.2 21.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.685 -0.689 . . . . 0.94 109.563 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.6 151.68 29.13 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.692 -0.403 . . . . 1.07 110.943 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.43 158.59 18.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 0.89 110.409 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.1 157.91 43.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.099 -0.501 . . . . 0.67 110.66 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.37 9.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.732 -0.667 . . . . 1.17 109.995 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.48 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.5 p . . . . . 0 C--O 1.218 -0.555 0 CA-C-O 117.949 -1.024 . . . . 1.26 110.531 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.8 m . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.253 -0.647 . . . . 3.83 109.253 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.36 150.69 18.54 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.986 -0.846 . . . . 1.39 110.986 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -35.67 142.39 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 123.953 3.102 . . . . 0.86 113.789 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.574 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.1 t -80.0 173.38 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.282 -1.326 . . . . 1.43 108.9 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.59 125.88 51.49 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.395 -0.522 . . . . 1.94 111.413 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.46 144.03 33.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.63 -0.714 . . . . 1.19 110.686 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.02 168.36 25.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.947 0.403 . . . . 3.92 111.117 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.589 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.08 130.94 61.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.983 -0.553 . . . . 3.88 110.013 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.5 p -141.03 162.3 35.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.85 0.357 . . . . 3.92 111.226 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 9' ' ' THR . 70.6 tt0 36.13 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.624 -0.509 . . . . 6.08 109.624 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.589 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.57 33.07 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.968 -0.56 . . . . 4.01 111.637 -178.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.22 -29.12 73.32 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.453 2.102 . . . . 4.51 111.872 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 3.51 110.422 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 17' ' ' SER . 3.3 mp0 -123.86 158.4 60.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 4.3 110.438 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.586 ' N ' ' OG ' ' A' ' 93' ' ' SER . 98.1 Cg_endo -82.13 -64.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.81 2.34 . . . . 1.96 113.592 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.496 ' ND2' ' HB2' ' A' ' 157' ' ' TYR . 72.8 m-20 -108.47 -19.47 13.44 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.107 0.41 . . . . 3.33 112.107 -178.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 4.9 p -107.47 152.05 24.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.18 0.514 . . . . 1.53 111.277 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.26 102.89 2.23 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.622 -0.717 . . . . 2.29 110.637 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.502 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.7 Cg_endo -82.71 145.66 12.97 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.851 2.368 . . . . 0.88 112.595 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.416 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.83 167.99 24.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.833 -0.621 . . . . 2.12 109.864 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -149.17 147.88 28.98 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.781 -0.451 . . . . 2.67 109.781 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.495 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.5 p90 -142.27 157.32 44.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.078 0.466 . . . . 0.32 111.177 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.471 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.09 155.23 44.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.766 -0.652 . . . . 2.77 110.033 179.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.58 173.1 6.28 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.037 -0.529 . . . . 1.25 110.747 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.66 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.858 2.372 . . . . 1.12 111.548 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.05 -51.11 0.69 Allowed Pre-proline 0 C--N 1.33 -0.271 0 C-N-CA 120.687 -0.405 . . . . 4.05 110.01 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.66 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.4 Cg_exo -64.77 152.35 82.36 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.751 2.301 . . . . 2.12 111.484 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.77 42.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.363 0.602 . . . . 2.85 110.581 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.82 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.69 -41.69 98.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.969 -1.014 . . . . 3.11 110.55 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.434 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.3 mt -109.82 137.91 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.846 -0.615 . . . . 1.86 111.258 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.06 -72.96 0.7 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.978 -0.555 . . . . 1.61 111.828 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.19 148.31 24.45 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.583 0.586 . . . . 1.67 112.583 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.82 124.92 45.31 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.302 -0.629 . . . . 1.07 109.302 177.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.0 mt -118.09 134.83 60.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.616 -0.434 . . . . 1.55 110.604 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.483 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -120.08 128.56 53.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 1.33 111.243 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.11 139.07 49.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.757 -0.656 . . . . 2.36 110.064 179.006 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.418 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.18 163.1 35.41 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 121.176 0.512 . . . . 0.38 112.014 -178.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.42 139.62 7.93 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.448 -0.796 . . . . 2.31 110.449 178.852 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.696 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.55 115.5 3.08 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.251 1.968 . . . . 0.86 111.85 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.673 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.95 81.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.908 -0.405 . . . . 3.44 109.908 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.696 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.2 -20.73 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.034 -0.53 . . . . 2.72 112.03 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.6 p -157.6 157.74 34.24 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.879 -0.328 . . . . 2.78 110.599 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.407 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.8 m -120.37 27.83 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 2.3 110.207 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.83 -75.9 1.31 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.121 -0.562 . . . . 1.8 111.886 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.83 152.29 35.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.073 0.463 . . . . 5.48 110.919 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.2 -169.14 2.54 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.991 -0.55 . . . . 1.84 111.997 179.292 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.09 149.61 29.78 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-O 121.431 0.634 . . . . 2.27 112.684 -177.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.96 156.52 46.05 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 114.809 -1.087 . . . . 1.92 110.302 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.2 158.43 41.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.872 -0.604 . . . . 1.09 111.785 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.7 m -115.25 135.55 54.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.517 -0.765 . . . . 1.16 109.755 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.453 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.4 121.97 23.78 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.433 -0.348 . . . . 1.39 111.584 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.514 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.4 Cg_exo -46.28 151.72 1.6 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.73 2.287 . . . . 0.72 112.12 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.93 -23.02 63.09 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 116.055 -0.521 . . . . 0.74 112.785 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.514 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.77 -16.89 46.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.407 0.604 . . . . 1.26 111.803 -178.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.48 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.2 mt -91.57 138.41 31.59 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.841 -0.344 . . . . 1.59 110.348 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.58 13.91 10.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.364 -0.38 . . . . 2.07 111.544 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -149.98 143.46 25.22 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.714 -0.394 . . . . 0.96 111.003 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.724 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.8 -169.37 1.53 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.942 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.724 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 t -151.81 125.86 9.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.443 -0.799 . . . . 1.19 109.816 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.423 HG23 HD11 ' A' ' 60' ' ' ILE . 66.5 mt -114.86 123.4 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.312 -0.555 . . . . 1.47 111.195 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.694 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 63.1 pttt -126.63 163.37 23.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.782 -0.644 . . . . 3.0 110.402 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.12 19.03 59.8 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.733 -0.947 . . . . 0.5 110.733 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.44 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.3 mt -78.97 157.18 28.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.045 0.45 . . . . 1.21 111.378 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.647 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -99.48 133.87 21.6 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.62 -0.718 . . . . 3.2 110.486 179.737 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.8 143.5 61.54 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.594 2.196 . . . . 1.09 111.988 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.93 25.59 75.4 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.034 -0.826 . . . . 0.72 111.034 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.645 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.18 158.74 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.73 0.3 . . . . 1.47 110.409 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.12 139.97 41.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.926 0.394 . . . . 1.23 110.522 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.647 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.8 m-85 -122.59 136.43 54.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.986 -0.552 . . . . 1.1 110.757 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.91 131.01 45.31 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.463 -0.94 . . . . 1.87 108.463 177.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.43 153.9 16.63 Favored Glycine 0 C--O 1.228 -0.269 0 C-N-CA 120.357 -0.925 . . . . 0.39 111.968 -178.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.08 140.85 45.85 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.723 -0.473 . . . . 1.8 109.723 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.461 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.2 tp -115.7 118.93 34.43 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.483 -0.487 . . . . 1.11 110.573 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.2 mt -112.55 129.09 68.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.409 . . . . 1.51 110.603 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.78 120.74 43.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.259 -0.428 . . . . 1.47 110.739 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.667 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.58 146.5 11.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.098 0.475 . . . . 1.33 111.058 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.82 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.11 153.91 21.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.505 -0.771 . . . . 2.49 109.835 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.18 88.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.928 0.395 . . . . 4.2 110.381 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.622 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.859 -0.609 . . . . 6.4 110.549 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.09 -117.36 3.29 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.43 -0.668 . . . . 1.74 111.43 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.439 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.29 177.41 9.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.182 0.515 . . . . 3.64 111.638 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.27 149.5 31.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.466 -0.788 . . . . 1.7 110.425 179.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.21 144.67 38.61 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.482 -0.326 . . . . 2.7 110.576 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -128.02 136.0 61.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 121.139 0.495 . . . . 1.16 111.499 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.574 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.09 141.45 52.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.622 -0.717 . . . . 1.14 110.248 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.75 138.91 51.72 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 120.492 -0.483 . . . . 4.33 111.438 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.28 164.18 37.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.545 -0.752 . . . . 0.91 109.521 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.57 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.1 p30 -145.27 151.54 38.52 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.327 -0.549 . . . . 1.47 111.009 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.574 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.9 p90 -146.2 172.75 12.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.743 -0.662 . . . . 0.51 111.033 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.452 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.5 t -118.77 160.7 21.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.459 -0.791 . . . . 1.92 109.806 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.452 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.34 121.91 23.05 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.54 -0.464 . . . . 1.63 110.749 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.512 ' OG1' ' N ' ' A' ' 93' ' ' SER . 70.3 p -128.92 -114.48 0.26 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.392 0.886 . . . . 2.37 113.392 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.586 ' OG ' ' N ' ' A' ' 15' ' ' PRO . 48.0 p 72.39 63.87 0.12 Allowed 'General case' 0 C--N 1.343 0.317 0 CA-C-N 114.956 -1.02 . . . . 3.63 110.789 -178.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.6 p -120.16 165.54 14.63 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.823 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.5 m -56.34 -33.6 65.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.062 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.7 p -124.5 77.36 62.86 Favored Pre-proline 0 N--CA 1.466 0.354 0 CA-C-O 120.507 0.194 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.62 147.27 88.04 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.612 2.208 . . . . 0.0 112.138 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.7 m -68.23 -27.95 38.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.2 m -57.61 -36.9 72.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.935 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.2 t 62.83 12.6 5.86 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.665 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -104.04 143.85 32.34 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.723 0.297 . . . . 0.0 110.297 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.2 t -133.86 160.01 38.93 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.433 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.615 HG22 ' H ' ' A' ' 105' ' ' GLY . 11.7 p -130.01 143.53 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.497 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 56.2 p -67.81 -9.45 44.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.371 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.615 ' H ' HG22 ' A' ' 103' ' ' VAL . . . -51.98 -32.33 34.37 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -58.01 142.8 45.49 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.551 -0.459 . . . . 0.0 109.888 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.5 p -123.24 160.9 25.62 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.084 0.469 . . . . 0.0 111.221 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.613 ' O ' ' CD2' ' A' ' 110' ' ' PHE . 25.0 m -126.65 78.88 72.32 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.783 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.6 -23.06 69.71 Favored 'Trans proline' 0 N--CA 1.499 1.794 0 C-N-CA 122.335 2.024 . . . . 0.0 113.303 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.613 ' CD2' ' O ' ' A' ' 108' ' ' THR . 94.3 m-85 62.78 31.45 16.49 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.0 p -123.44 75.61 53.43 Favored Pre-proline 0 N--CA 1.465 0.31 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.127 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.479 ' O ' ' N ' ' A' ' 114' ' ' VAL . 63.9 Cg_endo -75.62 -57.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.376 2.05 . . . . 0.0 111.691 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.5 mt 38.16 26.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.975 -0.557 . . . . 10.52 111.425 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 112' ' ' PRO . 31.3 m -67.34 134.69 29.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 7.48 110.593 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.72 144.2 32.8 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.12 -0.491 . . . . 7.69 110.586 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.0 m -122.59 139.27 54.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.298 -0.41 . . . . 6.46 110.153 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 119' ' ' SER . 23.2 m -59.02 -36.53 75.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.376 0.509 . . . . 4.59 112.376 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 117' ' ' SER . 96.7 mt-10 30.29 35.32 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 111.953 0.353 . . . . 3.21 111.953 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 117' ' ' SER . 22.3 m -57.4 -37.3 72.5 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.617 -0.433 . . . . 3.64 110.516 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.9 t -123.16 134.13 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 109.539 -0.541 . . . . 3.39 109.539 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.9 m -58.93 -41.22 86.83 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.655 -0.418 . . . . 2.23 111.018 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -127.05 151.08 49.08 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.491 -0.322 . . . . 4.53 111.036 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 71.5 mt -116.77 132.0 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.709 -0.478 . . . . 2.01 109.709 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 42.8 m -58.98 -40.2 84.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.42 . . . . 2.22 111.663 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -106.8 144.9 32.78 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.888 0.375 . . . . 1.29 111.266 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.3 p -62.89 -28.4 70.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.422 0.629 . . . . 1.25 109.672 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.482 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.77 167.57 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.427 -0.806 . . . . 1.16 110.983 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.486 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.9 m-30 -133.65 145.47 50.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.809 -0.632 . . . . 0.78 110.133 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.19 101.44 9.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.165 -0.68 . . . . 1.08 109.165 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.471 HG11 ' N ' ' A' ' 131' ' ' SER . 71.5 t -112.87 139.71 36.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.094 -0.503 . . . . 1.1 111.09 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.471 ' N ' HG11 ' A' ' 130' ' ' VAL . 68.8 p -128.69 152.59 48.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.59 -0.732 . . . . 0.87 109.75 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.648 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.7 p90 -144.84 -164.88 2.02 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.641 -0.423 . . . . 0.37 110.675 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -123.98 127.22 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.436 . . . . 1.14 110.82 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.169 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -58.06 58.4 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.123 -0.49 . . . . 1.91 110.368 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.17 24.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.809 -0.632 . . . . 1.56 111.437 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.169 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.14 128.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.646 -0.422 . . . . 1.56 111.036 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.41 -9.59 56.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.935 -0.575 . . . . 1.88 110.295 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.22 0.38 55.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 1.63 110.286 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.968 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.22 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.029 -0.532 . . . . 1.11 109.938 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.694 ' O ' ' NZ ' ' A' ' 61' ' ' LYS . 70.5 m -96.24 -15.58 21.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.256 0.55 . . . . 1.01 110.022 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.576 ' HA3' ' HZ2' ' A' ' 61' ' ' LYS . . . 178.62 175.61 45.83 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 109.858 -1.297 . . . . 0.14 109.858 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.49 151.61 42.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.961 0.41 . . . . 0.21 110.426 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.733 HH12 ' NE2' ' A' ' 191' ' ' GLN . 50.8 ttp180 -132.31 121.16 23.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.119 -0.491 . . . . 1.54 109.918 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.489 HG23 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.05 136.49 38.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.761 -0.654 . . . . 1.08 110.693 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.52 ' HG2' ' CD2' ' A' ' 157' ' ' TYR . 94.4 mt-10 -129.36 129.86 45.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.06 -0.518 . . . . 1.32 110.056 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.591 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.67 135.27 34.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.987 -0.552 . . . . 1.05 110.622 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.28 161.34 39.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.751 -0.659 . . . . 1.16 109.665 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.934 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.5 mt -70.92 124.76 25.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.975 0.417 . . . . 1.23 110.735 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.7 p -71.71 -7.79 50.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.768 -0.651 . . . . 0.86 110.833 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -109.81 -69.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.295 -0.411 . . . . 1.66 111.332 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.428 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.64 -35.39 76.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.106 -0.497 . . . . 1.66 111.469 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.074 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.1 7.23 88.59 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.853 -0.899 . . . . 1.62 110.853 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.331 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.89 -171.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.753 0.311 . . . . 1.86 110.365 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.331 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.23 139.11 45.24 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.965 0.412 . . . . 1.98 110.23 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.403 ' HG2' ' OH ' ' A' ' 157' ' ' TYR . 46.4 Cg_endo -70.94 145.76 51.17 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.762 2.308 . . . . 0.62 112.332 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.77 145.76 42.52 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.24 -0.652 . . . . 1.14 109.24 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.702 ' CD1' ' N ' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -123.37 141.3 52.13 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.312 -0.555 . . . . 1.44 111.5 -179.048 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.3 mt -128.04 127.67 43.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.333 -0.848 . . . . 1.08 109.016 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -101.73 131.21 48.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.15 0.5 . . . . 1.09 111.708 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.509 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -127.94 157.64 73.15 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.273 -0.876 . . . . 1.04 109.54 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.9 157.99 58.27 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.376 2.051 . . . . 0.21 112.282 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.3 -12.1 5.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 0.88 110.743 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.1 p -92.83 -8.75 42.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 1.06 110.722 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.15 135.33 34.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.406 . . . . 1.05 110.428 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 p -133.17 16.75 4.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.478 -0.328 . . . . 1.07 110.506 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.9 p -167.57 147.09 5.05 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.598 -0.519 . . . . 0.92 109.598 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.509 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.14 150.48 12.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.508 -0.477 . . . . 1.09 111.589 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.49 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 124.97 50.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.596 -0.729 . . . . 1.31 109.78 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.529 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.46 104.86 29.79 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.872 0.368 . . . . 1.09 111.025 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.2 Cg_endo -90.96 -179.53 1.51 Allowed 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 123.216 2.611 . . . . 0.48 112.203 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 61.7 32.66 18.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.374 -0.83 . . . . 1.26 111.403 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.529 HD21 HG21 ' A' ' 169' ' ' ILE . 24.1 mt -86.42 148.52 25.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.444 -0.343 . . . . 1.12 110.471 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.778 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.8 mt -88.28 114.96 61.75 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.06 0.457 . . . . 1.3 110.677 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.14 140.6 95.71 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.824 2.349 . . . . 0.92 112.026 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.23 74.23 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.046 -0.822 . . . . 0.44 111.046 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.428 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.91 150.22 49.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.803 0.335 . . . . 3.05 110.641 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.488 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.2 131.63 46.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.008 -0.542 . . . . 1.48 109.756 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.934 ' CE2' HD21 ' A' ' 148' ' ' LEU . 75.2 m-85 -120.5 148.27 44.05 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.105 -0.498 . . . . 0.89 111.062 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.7 mt -105.36 125.38 60.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.194 -1.039 . . . . 1.12 108.194 177.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.54 132.52 63.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.172 0.511 . . . . 1.1 111.3 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.47 122.62 20.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.549 -0.751 . . . . 0.43 109.613 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.587 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.1 125.35 55.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.268 -0.424 . . . . 1.07 110.622 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.665 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.5 m-85 -117.28 137.91 52.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.946 -0.57 . . . . 0.92 109.84 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.571 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.63 135.07 42.65 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.745 -0.835 . . . . 0.49 108.745 178.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.546 ' O ' ' N ' ' A' ' 140' ' ' SER . 47.2 mm -99.1 122.93 51.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.155 0.502 . . . . 1.08 110.969 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.451 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.5 p -83.91 169.59 14.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.591 -0.731 . . . . 0.89 110.496 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -59.62 -14.56 14.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.046 -0.524 . . . . 1.6 110.966 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.502 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.6 m-20 -96.13 -4.29 43.01 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.905 -0.318 . . . . 1.18 110.749 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.86 13.78 64.06 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.389 -0.684 . . . . 0.34 111.389 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -84.59 139.01 32.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.625 0.25 . . . . 1.22 110.415 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.733 ' NE2' HH12 ' A' ' 143' ' ' ARG . 3.3 mt-30 -106.68 141.15 38.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.339 . . . . 1.44 110.565 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 61.9 m -136.72 127.04 26.49 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.216 -0.447 . . . . 1.39 110.383 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.665 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.6 tp -68.14 117.43 9.96 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.699 -0.401 . . . . 1.08 110.519 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.648 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -109.1 -21.73 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 1.08 110.767 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.98 125.72 5.81 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.422 -0.511 . . . . 1.1 111.448 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.497 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.69 120.2 21.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.787 -0.642 . . . . 0.94 109.601 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.62 151.68 29.1 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.757 -0.377 . . . . 1.07 110.916 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.5 158.56 18.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.002 -0.545 . . . . 0.89 110.438 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.02 157.89 43.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.119 -0.491 . . . . 0.67 110.609 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.29 104.39 9.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.779 -0.646 . . . . 1.17 110.069 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.486 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 68.7 p . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.99 -1.005 . . . . 1.26 110.56 -179.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.208 -0.664 . . . . 3.83 109.208 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.69 18.54 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.032 -0.827 . . . . 1.39 111.032 179.729 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -35.66 142.4 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.042 0 C-N-CA 123.97 3.113 . . . . 0.86 113.826 -179.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.569 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.0 t -79.98 173.33 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.308 -1.315 . . . . 1.43 108.846 178.431 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 23' ' ' ASN . 96.1 mt-10 -105.55 125.87 51.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.435 -0.506 . . . . 1.94 111.393 -179.538 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 144.01 33.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.628 -0.715 . . . . 1.19 110.564 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.98 168.4 25.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.319 -0.401 . . . . 3.92 111.131 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.581 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -109.06 131.1 60.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.98 -0.554 . . . . 3.88 110.048 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.14 162.25 35.94 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.442 -0.345 . . . . 3.92 111.284 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.4 mt-10 36.21 31.51 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.607 -0.516 . . . . 6.08 109.607 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.581 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.58 32.55 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.019 -0.537 . . . . 4.01 111.558 -178.737 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.637 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.29 -29.14 72.69 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.494 2.129 . . . . 4.51 111.854 179.395 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.637 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.65 125.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.016 -0.538 . . . . 3.51 110.502 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.613 ' N ' ' NE2' ' A' ' 14' ' ' GLN . 0.8 OUTLIER -123.91 158.33 60.43 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.368 -0.378 . . . . 4.3 110.486 179.995 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.469 ' HG2' HE22 ' A' ' 191' ' ' GLN . 97.6 Cg_endo -82.11 -64.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.808 2.339 . . . . 1.96 113.446 -178.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.736 ' ND2' ' HZ2' ' A' ' 61' ' ' LYS . 52.9 t30 -108.42 -19.54 13.42 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.087 0.403 . . . . 3.33 112.087 -178.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 27.2 m -107.33 152.07 24.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.214 0.531 . . . . 1.53 111.256 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.0 t-80 -155.22 102.91 2.24 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.705 -0.68 . . . . 2.29 110.66 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.476 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.4 Cg_endo -82.6 145.59 13.12 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.882 2.388 . . . . 0.88 112.676 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.412 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.77 167.99 24.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 2.12 109.982 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.14 147.95 29.07 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.75 -0.463 . . . . 2.67 109.75 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.504 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.6 p90 -142.27 157.28 45.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.017 0.437 . . . . 0.32 111.242 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.464 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.8 m-20 -127.96 155.3 44.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.786 -0.643 . . . . 2.77 110.132 178.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.66 173.06 6.33 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 121.14 0.495 . . . . 1.25 110.666 -179.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.66 173.88 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.882 2.388 . . . . 1.12 111.506 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.06 -50.93 0.69 Allowed Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 120.717 -0.393 . . . . 4.05 110.134 179.902 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.654 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.8 Cg_exo -64.96 152.43 82.35 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.697 2.264 . . . . 2.12 111.451 179.187 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.77 42.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.385 0.612 . . . . 2.85 110.518 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.813 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.67 -41.68 98.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.02 -0.991 . . . . 3.11 110.722 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.447 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.5 mt -109.78 137.86 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.723 -0.672 . . . . 1.86 111.311 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.98 -72.82 0.71 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.013 -0.54 . . . . 1.61 111.92 -178.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.23 148.4 24.37 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.593 0.59 . . . . 1.67 112.593 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.85 124.74 44.84 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.413 -0.588 . . . . 1.07 109.413 177.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.4 mt -117.88 134.72 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.666 -0.414 . . . . 1.55 110.701 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.489 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -120.02 128.55 53.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 1.33 111.228 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.15 138.99 49.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.708 -0.678 . . . . 2.36 110.11 178.974 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.414 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -144.99 163.23 34.83 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.152 0.501 . . . . 0.38 112.066 -178.081 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.488 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.59 139.65 7.81 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.435 -0.802 . . . . 2.31 110.397 178.808 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.66 115.54 3.12 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.284 1.989 . . . . 0.86 111.793 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.683 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.03 81.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.899 -0.408 . . . . 3.44 109.899 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.688 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.22 -20.54 0.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.969 -0.56 . . . . 2.72 111.9 -179.526 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 p -157.65 157.69 34.05 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 120.855 -0.338 . . . . 2.78 110.569 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.3 27.79 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.249 -0.432 . . . . 2.3 110.223 179.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.79 -75.91 1.31 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.184 -0.531 . . . . 1.8 111.831 -179.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.93 152.31 35.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.981 0.419 . . . . 5.48 110.939 -179.285 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.669 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.2 -169.14 2.54 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.001 -0.545 . . . . 1.84 111.873 179.415 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.413 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.6 mttp -110.13 149.66 29.74 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.48 0.657 . . . . 2.27 112.568 -177.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.01 156.42 46.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.757 -1.111 . . . . 1.92 110.325 178.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.21 158.27 41.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.978 -0.555 . . . . 1.09 111.788 -179.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.8 m -115.07 135.58 54.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.502 -0.772 . . . . 1.16 109.889 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.452 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.33 121.96 23.86 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.422 -0.353 . . . . 1.39 111.588 -179.171 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.514 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.3 Cg_exo -46.29 151.7 1.62 Allowed 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.706 2.271 . . . . 0.72 112.181 178.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.01 -23.02 63.28 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 116.133 -0.485 . . . . 0.74 112.708 -179.107 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.514 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.78 -16.79 46.49 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.223 -0.591 . . . . 1.26 111.854 -178.341 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.492 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.5 mt -91.6 138.45 31.56 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.779 -0.368 . . . . 1.59 110.321 179.338 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.54 13.79 10.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.433 -0.349 . . . . 2.07 111.475 -179.285 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.477 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.91 143.56 25.35 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.591 -0.444 . . . . 0.96 111.003 179.633 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.4 t80 -114.88 -169.41 1.54 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.127 0.489 . . . . 1.0 110.904 -179.455 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.714 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.74 125.85 9.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.408 -0.815 . . . . 1.19 109.805 179.288 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.449 HD11 HG23 ' A' ' 60' ' ' ILE . 66.7 mt -114.77 123.21 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.415 -0.514 . . . . 1.47 111.268 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.749 ' HZ1' ' CD1' ' A' ' 185' ' ' ILE . 50.4 tttp -126.5 163.4 23.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.884 -0.598 . . . . 3.0 110.431 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.598 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.15 19.02 59.78 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.737 -0.945 . . . . 0.5 110.737 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.437 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.5 mt -79.09 157.18 28.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.077 0.465 . . . . 1.21 111.327 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.609 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -99.41 134.05 21.5 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.525 -0.762 . . . . 3.2 110.49 179.722 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.587 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -68.03 143.66 60.89 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.463 2.109 . . . . 1.09 111.908 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.79 25.64 75.32 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.031 -0.828 . . . . 0.72 111.031 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.648 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.15 158.8 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.735 0.302 . . . . 1.47 110.369 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.09 139.94 41.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.333 -0.394 . . . . 1.23 110.565 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.648 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.58 136.46 54.89 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.954 -0.566 . . . . 1.1 110.82 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.98 131.06 45.32 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.481 -0.933 . . . . 1.87 108.481 177.67 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.5 153.87 16.65 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.221 -0.99 . . . . 0.39 111.935 -178.566 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.93 140.94 46.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.648 -0.501 . . . . 1.8 109.648 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.471 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.2 tp -115.79 118.86 34.21 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.488 -0.485 . . . . 1.11 110.524 179.64 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.8 mt -112.4 129.08 68.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 1.51 110.66 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.82 120.89 43.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.261 -0.427 . . . . 1.47 110.701 -179.649 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.668 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.55 146.44 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.184 0.516 . . . . 1.33 111.001 -179.284 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.813 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.06 153.82 21.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.499 -0.773 . . . . 2.49 109.974 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.23 88.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.959 0.409 . . . . 4.2 110.433 -179.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.43 32.56 0.23 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.74 -0.664 . . . . 6.4 110.604 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.16 -117.33 3.28 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.443 -0.663 . . . . 1.74 111.443 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.451 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.48 177.42 8.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.157 0.503 . . . . 3.64 111.655 -179.131 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.17 149.59 32.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.468 -0.787 . . . . 1.7 110.35 179.181 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.2 144.62 38.59 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.386 -0.37 . . . . 2.7 110.527 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -127.94 136.01 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 121.032 0.444 . . . . 1.16 111.617 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.1 141.35 52.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.634 -0.712 . . . . 1.14 110.285 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.463 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.62 138.87 51.67 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.085 0.469 . . . . 4.33 111.535 -179.354 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.491 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.28 164.15 38.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.524 -0.762 . . . . 0.91 109.53 179.371 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.565 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.1 p30 -145.22 151.52 38.53 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.411 -0.516 . . . . 1.47 111.049 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.575 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.2 p90 -146.19 172.73 13.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.781 -0.645 . . . . 0.51 111.053 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.44 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.73 160.67 21.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.414 -0.812 . . . . 1.92 109.841 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.44 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.47 121.9 22.88 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.563 -0.455 . . . . 1.63 110.768 179.927 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.413 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -128.28 151.03 49.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.051 -0.522 . . . . 2.37 111.421 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.8 t -65.0 -43.19 93.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.357 0.599 . . . . 3.63 110.337 177.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.7 p -130.62 165.15 23.42 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.06 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.0 t -58.91 -36.72 75.19 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.503 -0.479 . . . . 0.0 109.917 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 48.9 p -129.99 77.15 77.1 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.281 179.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -58.14 143.89 96.04 Favored 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.905 2.403 . . . . 0.0 113.37 -178.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.472 ' O ' ' ND2' ' A' ' 101' ' ' ASN . 19.9 m -113.25 14.2 8.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.643 178.621 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.7 t -56.04 -38.79 71.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.506 -179.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 91.9 p -58.88 -30.24 67.6 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.366 -179.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.472 ' ND2' ' O ' ' A' ' 98' ' ' VAL . 18.4 m120 56.63 43.79 24.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.825 179.105 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.2 t -58.67 -39.75 81.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.79 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 77.5 t -60.51 -38.12 77.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.851 -179.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 38.8 m -72.71 138.16 46.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.024 0.44 . . . . 0.0 111.059 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 96.5 -2.62 62.88 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -68.75 -23.31 64.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.999 0.428 . . . . 0.0 110.492 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 30.1 p -79.98 160.62 25.85 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.116 -179.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.418 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 90.8 m -52.15 -45.57 93.86 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.163 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 108' ' ' THR . 58.2 Cg_exo -50.76 142.96 30.96 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.719 1.612 . . . . 0.0 112.689 -179.228 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.423 ' CD2' ' O ' ' A' ' 111' ' ' SER . 68.0 t80 -101.47 135.49 42.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.06 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.423 ' O ' ' CD2' ' A' ' 110' ' ' PHE . 5.2 t -59.45 147.37 76.92 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 120.936 -0.305 . . . . 0.0 110.52 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.7 146.66 34.12 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.264 1.976 . . . . 0.0 113.003 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 70.8 mt -60.01 -33.31 71.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.478 -0.783 . . . . 10.52 110.73 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.583 ' O ' ' CB ' ' A' ' 115' ' ' ALA . 45.9 t -107.9 135.38 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.267 -0.424 . . . . 7.48 110.931 -178.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 114' ' ' VAL . . . 114.0 -29.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.326 1.016 . . . . 7.69 109.698 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.2 p -73.3 -15.51 61.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.853 -0.612 . . . . 6.46 110.641 179.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.9 m -60.75 155.25 19.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.111 -0.495 . . . . 4.59 111.156 -179.046 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -61.89 -32.22 72.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.641 -0.708 . . . . 3.21 111.357 -179.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 31.8 t -112.67 139.85 47.93 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.985 0.421 . . . . 3.64 110.967 -179.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 40.4 t -123.47 138.58 52.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.499 -0.773 . . . . 3.39 110.436 -179.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 24.6 p -77.23 161.2 28.34 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.538 -0.541 . . . . 2.23 109.538 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -85.31 124.38 31.86 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.347 -0.541 . . . . 4.53 111.246 -178.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 76.6 mt -68.97 -30.36 46.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.663 -0.699 . . . . 2.01 110.153 178.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 43.5 p 49.46 42.28 22.28 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.771 -0.649 . . . . 2.22 110.598 -178.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.431 ' C ' ' OG ' ' A' ' 126' ' ' SER . . . -151.35 165.68 33.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.928 -0.578 . . . . 1.29 110.755 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.431 ' OG ' ' C ' ' A' ' 125' ' ' ALA . 0.3 OUTLIER 54.32 19.26 2.17 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.878 -0.601 . . . . 1.25 112.286 178.883 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.48 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.9 167.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.064 -0.516 . . . . 1.16 110.931 179.124 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.479 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.9 m-30 -133.66 145.52 50.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.772 -0.649 . . . . 0.78 110.111 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.29 101.62 9.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.087 -0.708 . . . . 1.08 109.087 177.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.459 HG11 ' N ' ' A' ' 131' ' ' SER . 72.4 t -112.85 139.67 36.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.015 -0.538 . . . . 1.1 111.129 -178.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.459 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.4 p -128.72 152.49 48.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.692 -0.685 . . . . 0.87 109.852 179.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.647 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.7 p90 -144.72 -164.84 2.01 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.705 -0.398 . . . . 0.37 110.678 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.734 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.3 t -124.01 127.17 73.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 1.14 110.799 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.172 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.95 58.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.138 -0.483 . . . . 1.91 110.283 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.07 24.4 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.003 -0.544 . . . . 1.56 111.442 -179.721 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.172 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.2 128.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.688 -0.405 . . . . 1.56 111.002 179.823 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -86.41 -9.6 55.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.885 -0.598 . . . . 1.88 110.294 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.15 0.25 55.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.471 . . . . 1.63 110.351 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.959 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.22 137.3 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.943 -0.571 . . . . 1.11 109.955 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 185' ' ' ILE . 69.3 m -96.38 -15.51 21.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.336 0.588 . . . . 1.01 110.011 -179.65 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.55 175.56 45.74 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 109.847 -1.301 . . . . 0.14 109.847 179.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.43 151.65 42.44 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.601 -0.439 . . . . 0.21 110.488 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.495 ' NH2' ' CD2' ' A' ' 183' ' ' TYR . 68.8 ttp85 -132.37 121.13 23.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.175 -0.466 . . . . 1.54 109.87 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.502 HG23 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.03 136.61 38.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.678 -0.692 . . . . 1.08 110.687 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 83.3 tt0 -129.37 129.95 45.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.942 -0.572 . . . . 1.32 110.031 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.9 p90 -138.77 135.26 34.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.998 -0.547 . . . . 1.05 110.582 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.408 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.32 161.4 39.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.769 -0.65 . . . . 1.16 109.638 179.804 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.944 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -71.05 124.79 25.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.99 0.424 . . . . 1.23 110.666 -179.585 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.74 -7.65 49.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.756 -0.656 . . . . 0.86 110.909 -179.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.9 -69.71 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.301 -0.409 . . . . 1.66 111.357 -179.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.472 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.65 -35.35 76.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.083 -0.508 . . . . 1.66 111.471 -179.09 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.076 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.12 88.67 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.771 -0.932 . . . . 1.62 110.771 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.324 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.9 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.74 0.305 . . . . 1.86 110.334 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.324 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.35 139.11 44.85 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.01 0.433 . . . . 1.98 110.165 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.408 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.5 Cg_endo -70.97 145.89 51.34 Favored 'Trans proline' 0 C--N 1.301 -1.936 0 C-N-CA 122.601 2.201 . . . . 0.62 112.365 -179.472 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.89 145.67 42.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.147 -0.686 . . . . 1.14 109.147 179.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.587 ' CE1' ' CD ' ' A' ' 65' ' ' PRO . 11.5 p90 -123.2 141.41 52.0 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.363 -0.535 . . . . 1.44 111.6 -179.2 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.407 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.7 mt -128.14 127.61 43.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.326 -0.852 . . . . 1.08 108.911 179.016 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.593 ' OD2' ' ND2' ' A' ' 16' ' ' ASN . 66.9 m-20 -101.59 131.23 47.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.143 0.497 . . . . 1.09 111.781 -178.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.506 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -128.03 157.52 73.71 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.324 -0.853 . . . . 1.04 109.477 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -69.78 158.05 58.25 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.433 2.089 . . . . 0.21 112.218 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.1 p -59.33 -12.14 5.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.824 -0.626 . . . . 0.88 110.698 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.1 p -92.8 -8.8 42.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 1.06 110.742 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.39 34.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 1.05 110.433 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.7 p -133.14 16.68 4.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.413 -0.358 . . . . 1.07 110.483 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.58 147.09 5.04 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.658 -0.497 . . . . 0.92 109.658 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.506 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.14 150.49 12.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.515 -0.474 . . . . 1.09 111.588 -179.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 125.0 50.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.667 -0.697 . . . . 1.31 109.761 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.512 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.6 105.01 31.17 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.985 0.422 . . . . 1.09 110.999 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.0 Cg_endo -91.03 -179.51 1.48 Allowed 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 123.158 2.572 . . . . 0.48 112.174 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.69 32.64 18.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.428 -0.805 . . . . 1.26 111.443 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.512 HD21 HG21 ' A' ' 169' ' ' ILE . 24.0 mt -86.34 148.47 25.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.47 -0.332 . . . . 1.12 110.487 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.777 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.14 114.91 61.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.982 0.42 . . . . 1.3 110.666 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.1 140.61 95.89 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.901 2.401 . . . . 0.92 111.971 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.1 21.12 74.47 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.072 -0.811 . . . . 0.44 111.072 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.472 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.79 150.24 49.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.849 0.357 . . . . 3.05 110.641 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.501 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.3 131.69 46.09 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.062 -0.517 . . . . 1.48 109.755 179.335 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.944 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.61 148.36 44.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.07 -0.514 . . . . 0.89 110.94 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.39 125.41 60.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.255 -1.017 . . . . 1.12 108.255 177.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.53 132.53 63.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.084 0.469 . . . . 1.1 111.251 -178.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.9 m-20 -136.47 122.54 20.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.604 -0.725 . . . . 0.43 109.669 179.297 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.595 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.02 125.41 54.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.281 -0.418 . . . . 1.07 110.682 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.672 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.2 m-85 -117.23 137.8 52.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.999 -0.546 . . . . 0.92 109.9 179.538 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.573 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.64 135.01 42.74 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.853 -0.795 . . . . 0.49 108.853 178.816 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.749 ' CD1' ' HZ1' ' A' ' 61' ' ' LYS . 81.3 mt -99.12 122.94 51.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.212 0.53 . . . . 1.08 110.909 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.45 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.7 p -83.87 169.72 14.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.512 -0.767 . . . . 0.89 110.501 -179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 187' ' ' GLU . 49.5 tp10 -59.74 -14.59 15.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.01 -0.541 . . . . 1.6 110.902 -179.563 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.55 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.8 m-20 -96.06 -4.27 43.3 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.836 -0.346 . . . . 1.18 110.809 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.82 13.89 63.94 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.346 -0.701 . . . . 0.34 111.346 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -84.73 139.1 32.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.67 0.271 . . . . 1.22 110.437 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.469 HE22 ' HG2' ' A' ' 15' ' ' PRO . 87.1 mt-30 -106.75 141.08 38.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.361 . . . . 1.44 110.551 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.0 m -136.72 127.05 26.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 1.39 110.35 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.672 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.6 tp -68.17 117.29 9.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.266 -0.424 . . . . 1.08 110.566 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.647 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.0 pt -108.96 -21.89 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 1.08 110.706 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.86 125.76 5.89 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.412 -0.515 . . . . 1.1 111.449 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.491 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.72 120.21 21.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.793 -0.64 . . . . 0.94 109.643 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.63 151.7 29.11 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.642 -0.423 . . . . 1.07 110.954 -179.272 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.54 158.58 18.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.04 -0.527 . . . . 0.89 110.38 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.04 157.95 43.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.67 110.645 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.29 104.34 9.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.732 -0.667 . . . . 1.17 110.061 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.479 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 68.2 p . . . . . 0 C--O 1.221 -0.407 0 CA-C-O 117.837 -1.078 . . . . 1.26 110.593 -179.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.9 m . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.244 -0.65 . . . . 3.83 109.244 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.434 ' H ' ' HB3' ' A' ' 1' ' ' SER . . . -116.33 150.73 18.54 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.03 -0.828 . . . . 1.39 111.03 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -35.67 142.41 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.054 0 C-N-CA 123.934 3.089 . . . . 0.86 113.813 -179.23 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.559 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.1 t -79.94 173.43 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.257 -1.338 . . . . 1.43 108.804 178.42 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.403 ' H ' ' CG1' ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.64 125.85 51.47 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.424 -0.51 . . . . 1.94 111.392 -179.553 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.58 144.06 33.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.655 -0.702 . . . . 1.19 110.597 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.04 168.36 25.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.857 0.361 . . . . 3.92 111.105 -179.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.579 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.4 mt -109.0 131.08 60.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.002 -0.545 . . . . 3.88 110.063 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.5 p -141.17 162.3 35.82 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.829 0.347 . . . . 3.92 111.202 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 69.3 mm-40 36.1 31.57 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.563 -0.532 . . . . 6.08 109.563 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.579 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.41 69.59 32.3 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.968 -0.56 . . . . 4.01 111.625 -178.833 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.639 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.21 -29.23 73.47 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.496 2.131 . . . . 4.51 111.864 179.339 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.639 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.72 125.58 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.142 -0.481 . . . . 3.51 110.512 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.534 ' CB ' ' O ' ' A' ' 17' ' ' SER . 28.2 mt-30 -124.02 158.34 60.69 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.406 -0.361 . . . . 4.3 110.466 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.539 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 98.1 Cg_endo -82.01 -64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.843 2.362 . . . . 1.96 113.503 -178.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.811 ' ND2' ' CE2' ' A' ' 157' ' ' TYR . 5.1 t-20 -108.38 -19.65 13.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.326 -0.397 . . . . 3.33 112.064 -178.553 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 31.1 m -107.3 152.05 24.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.145 0.498 . . . . 1.53 111.266 -179.358 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.569 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.31 102.96 2.22 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.677 -0.692 . . . . 2.29 110.637 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.69 145.55 12.97 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.915 2.41 . . . . 0.88 112.646 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 pt -130.74 167.98 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.881 -0.6 . . . . 2.12 109.922 179.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.15 147.96 29.07 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.738 -0.467 . . . . 2.67 109.738 178.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.501 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.6 p90 -142.29 157.25 45.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.017 0.437 . . . . 0.32 111.204 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.473 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.9 m-20 -127.99 155.31 44.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.817 -0.629 . . . . 2.77 110.087 178.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.62 173.05 6.33 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.187 -0.461 . . . . 1.25 110.741 -179.199 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -50.72 173.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.885 0 C-N-CA 122.867 2.378 . . . . 1.12 111.497 179.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.95 -50.97 0.7 Allowed Pre-proline 0 C--N 1.33 -0.255 0 C-N-CA 120.672 -0.411 . . . . 4.05 110.134 179.847 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.648 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.97 152.4 82.48 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.652 2.235 . . . . 2.12 111.419 179.219 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.68 42.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.427 0.632 . . . . 2.85 110.615 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.82 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.65 -41.56 98.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.97 -1.014 . . . . 3.11 110.691 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.442 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.6 mt -109.95 137.92 40.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.728 -0.669 . . . . 1.86 111.259 -179.462 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.03 -72.87 0.7 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.039 -0.528 . . . . 1.61 111.894 -178.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.35 24.45 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.581 0.586 . . . . 1.67 112.581 -179.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -121.84 124.9 45.22 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.338 -0.616 . . . . 1.07 109.338 177.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.9 mt -118.04 134.7 60.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.651 -0.42 . . . . 1.55 110.61 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.48 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -119.99 128.6 53.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.978 0.418 . . . . 1.33 111.334 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.549 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.07 138.99 49.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.715 -0.675 . . . . 2.36 110.215 178.972 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.418 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.06 163.12 35.23 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.109 0.48 . . . . 0.38 112.093 -178.065 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.4 139.58 7.93 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.466 -0.788 . . . . 2.31 110.538 178.777 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.694 ' O ' ' N ' ' A' ' 41' ' ' ASN . 18.2 Cg_endo -63.46 115.4 3.01 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.322 2.014 . . . . 0.86 111.94 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.674 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.98 81.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.837 -0.431 . . . . 3.44 109.837 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.694 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.31 -20.65 0.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.015 -0.538 . . . . 2.72 111.927 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.2 p -157.56 157.83 34.48 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.809 -0.356 . . . . 2.78 110.56 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.42 27.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 2.3 110.125 179.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.87 -75.84 1.31 Allowed Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.178 -0.534 . . . . 1.8 111.89 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.91 152.31 35.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.961 0.41 . . . . 5.48 111.056 -179.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.645 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.13 2.53 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.126 -0.488 . . . . 1.84 111.985 179.364 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.08 149.67 29.69 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.464 0.649 . . . . 2.27 112.563 -177.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.04 156.52 46.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.762 -1.108 . . . . 1.92 110.259 178.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.22 158.34 41.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.916 -0.584 . . . . 1.09 111.82 -179.306 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.6 m -115.23 135.7 53.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.479 -0.782 . . . . 1.16 109.75 179.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.441 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.31 121.96 23.88 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.353 -0.385 . . . . 1.39 111.546 -179.153 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.519 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.4 Cg_exo -46.41 151.71 1.7 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.731 2.287 . . . . 0.72 112.083 179.029 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.99 -22.92 63.11 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.076 -0.511 . . . . 0.74 112.747 -179.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.519 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.85 -16.83 46.1 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 117.382 0.591 . . . . 1.26 111.786 -178.34 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.497 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.5 mt -91.58 138.42 31.58 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.766 -0.373 . . . . 1.59 110.385 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.55 13.88 10.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.442 -0.344 . . . . 2.07 111.587 -179.318 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.48 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.4 p -150.03 143.37 25.12 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.595 -0.442 . . . . 0.96 111.03 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.72 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.67 -169.36 1.53 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.969 -179.452 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.72 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.81 125.86 9.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.411 -0.813 . . . . 1.19 109.841 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.442 HD11 HG23 ' A' ' 60' ' ' ILE . 66.4 mt -114.78 123.25 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.429 -0.508 . . . . 1.47 111.208 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -126.5 163.38 23.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.77 -0.65 . . . . 3.0 110.469 179.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.681 ' C ' HD22 ' A' ' 16' ' ' ASN . . . 85.11 19.14 59.63 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.662 -0.975 . . . . 0.5 110.662 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.687 ' N ' ' ND2' ' A' ' 16' ' ' ASN . 73.6 mt -79.13 157.17 27.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.975 0.417 . . . . 1.21 111.331 -179.658 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.621 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 2.7 mttm -99.46 133.87 21.61 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.571 -0.74 . . . . 3.2 110.43 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.84 143.62 61.8 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.548 2.165 . . . . 1.09 111.908 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.81 25.61 75.35 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.071 -0.812 . . . . 0.72 111.071 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.644 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.3 p -128.15 158.67 40.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.651 0.262 . . . . 1.47 110.475 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.12 139.85 42.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.988 0.423 . . . . 1.23 110.571 -179.73 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.644 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.3 m-85 -122.46 136.52 54.91 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.902 -0.59 . . . . 1.1 110.766 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -99.02 131.07 45.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.468 -0.938 . . . . 1.87 108.468 177.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.483 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.54 153.82 16.67 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.341 -0.933 . . . . 0.39 112.0 -178.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.94 140.96 46.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.689 -0.486 . . . . 1.8 109.689 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.471 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.4 tp -115.75 118.88 34.27 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.454 -0.498 . . . . 1.11 110.48 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.9 mt -112.46 129.14 68.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.347 -0.388 . . . . 1.51 110.63 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.9 120.74 43.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.287 -0.415 . . . . 1.47 110.69 -179.568 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.675 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.47 146.36 11.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.139 0.495 . . . . 1.33 111.076 -179.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.82 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -105.95 153.86 21.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.559 -0.746 . . . . 2.49 109.925 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.16 88.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.865 0.364 . . . . 4.2 110.42 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.633 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.39 32.55 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.826 -0.624 . . . . 6.4 110.558 -179.942 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.04 -117.44 3.3 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.418 -0.673 . . . . 1.74 111.418 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.453 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.38 177.31 9.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.209 0.528 . . . . 3.64 111.665 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.11 149.43 32.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.442 -0.799 . . . . 1.7 110.403 179.221 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.08 144.65 38.85 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.458 -0.337 . . . . 2.7 110.594 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.94 135.97 61.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 121.118 0.485 . . . . 1.16 111.582 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.559 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -123.95 141.37 52.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.657 -0.701 . . . . 1.14 110.359 179.531 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.482 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.6 138.89 51.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.08 0.467 . . . . 4.33 111.527 -179.365 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.483 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.31 164.15 38.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.577 -0.738 . . . . 0.91 109.526 179.353 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.574 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 46.8 p30 -145.21 151.59 38.64 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.392 -0.523 . . . . 1.47 111.069 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.569 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.9 p90 -146.2 172.72 13.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.767 -0.652 . . . . 0.51 111.045 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.445 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.71 160.69 21.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.47 -0.786 . . . . 1.92 109.815 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.445 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.35 121.84 22.93 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.582 -0.447 . . . . 1.63 110.759 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -127.45 154.65 44.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 2.37 112.109 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.759 ' O ' ' O ' ' A' ' 94' ' ' THR . 84.2 p -68.05 -32.35 72.64 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.662 -0.699 . . . . 3.63 111.459 178.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.759 ' O ' ' O ' ' A' ' 93' ' ' SER . 87.7 m 30.96 178.76 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 O-C-N 123.64 0.587 . . . . 0.0 112.502 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.628 ' H ' ' CG2' ' A' ' 94' ' ' THR . 89.8 p -64.48 -22.93 67.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.609 -179.331 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.519 ' OG1' ' O ' ' A' ' 95' ' ' SER . 17.2 p 62.6 64.61 1.62 Allowed Pre-proline 0 N--CA 1.465 0.286 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.992 -178.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.82 151.98 52.92 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.672 2.248 . . . . 0.0 111.736 179.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.5 t -104.01 133.27 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.873 0.368 . . . . 0.0 110.152 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.2 m -58.69 -39.84 81.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.68 -179.159 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.3 t -58.33 -39.17 78.74 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.755 -179.157 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 53.4 44.68 29.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.7 179.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 55.6 m -122.39 135.88 54.78 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.936 0.398 . . . . 0.0 111.24 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 m -116.74 13.93 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.677 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.5 p -121.17 164.11 17.41 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.142 0.496 . . . . 0.0 111.475 -178.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.96 -176.06 43.76 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.334 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -115.38 155.79 26.73 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.612 0.244 . . . . 0.0 110.574 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.9 p -82.05 158.31 23.82 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.552 ' N ' ' HD2' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -53.16 -52.4 66.19 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.362 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 108' ' ' THR . 17.9 Cg_endo -58.47 144.38 96.84 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.227 1.951 . . . . 0.0 112.234 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.415 ' CD2' ' N ' ' A' ' 111' ' ' SER . 68.3 t80 -146.1 -97.6 0.09 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.464 179.68 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.415 ' N ' ' CD2' ' A' ' 110' ' ' PHE . 40.7 p -127.78 79.23 73.95 Favored Pre-proline 0 N--CA 1.467 0.415 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.002 -179.737 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -52.49 141.19 52.54 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.18 1.92 . . . . 0.0 112.163 -179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.9 tp -59.44 -36.74 76.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.798 -0.637 . . . . 10.52 111.552 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.4 p -129.82 144.42 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.068 0.461 . . . . 7.48 111.423 -178.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.11 147.41 43.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.634 -0.712 . . . . 7.69 110.751 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.481 ' OG1' ' N ' ' A' ' 117' ' ' SER . 9.9 t -66.26 -147.96 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.88 -0.6 . . . . 6.46 111.462 -179.371 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.481 ' N ' ' OG1' ' A' ' 116' ' ' THR . 90.6 p -59.93 -23.71 63.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.845 -0.616 . . . . 4.59 112.247 -178.538 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.14 -34.21 71.8 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.502 -0.479 . . . . 3.21 110.553 -179.181 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.1 p 39.32 -124.89 0.36 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.276 -0.42 . . . . 3.64 111.012 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.6 p -133.14 -17.38 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.39 -0.368 . . . . 3.39 110.519 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.546 ' O ' ' O ' ' A' ' 122' ' ' GLU . 24.0 p -92.96 162.33 14.1 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.18 -0.464 . . . . 2.23 110.995 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.546 ' O ' ' O ' ' A' ' 121' ' ' THR . 48.0 tp10 52.38 126.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.994 -0.548 . . . . 4.53 111.079 179.695 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 31.5 pt -123.5 157.09 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.046 -0.524 . . . . 2.01 110.663 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 16.3 p -125.76 164.06 21.5 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.066 -0.515 . . . . 2.22 110.247 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.48 -94.83 0.47 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 121.014 -0.274 . . . . 1.29 111.148 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 84.6 p -63.42 -36.53 84.04 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.481 -0.488 . . . . 1.25 111.259 -179.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.469 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.84 167.57 0.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.977 -0.556 . . . . 1.16 110.855 179.743 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.483 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.9 m-30 -133.61 145.61 50.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.665 -0.698 . . . . 0.78 110.154 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.32 101.65 9.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.108 -0.701 . . . . 1.08 109.108 177.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.468 HG11 ' N ' ' A' ' 131' ' ' SER . 71.6 t -112.91 139.75 36.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.997 -0.547 . . . . 1.1 111.132 -178.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.468 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.7 p -128.74 152.56 48.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.686 -0.688 . . . . 0.87 109.883 179.585 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.644 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.5 p90 -144.82 -164.98 2.04 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.738 -0.385 . . . . 0.37 110.612 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.74 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.4 t -123.93 127.13 73.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 1.14 110.801 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.149 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 1.91 110.378 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.74 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.06 24.41 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.932 -0.576 . . . . 1.56 111.4 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.149 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.21 128.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.652 -0.419 . . . . 1.56 110.937 179.819 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -86.36 -9.62 56.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.869 -0.605 . . . . 1.88 110.376 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.12 0.26 55.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 1.63 110.307 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.964 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.34 137.28 25.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.993 -0.549 . . . . 1.11 109.894 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 185' ' ' ILE . 72.0 m -96.25 -15.5 21.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.305 0.574 . . . . 1.01 110.053 -179.698 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.54 175.57 45.73 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 109.822 -1.311 . . . . 0.14 109.822 179.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -123.48 151.62 42.56 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.65 -0.42 . . . . 0.21 110.545 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.64 ' NH2' ' CD2' ' A' ' 183' ' ' TYR . 69.2 ttp85 -132.26 121.11 23.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.12 -0.491 . . . . 1.54 109.979 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.487 HG23 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.01 136.49 38.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.744 -0.662 . . . . 1.08 110.658 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 80.0 tt0 -129.34 129.88 45.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.987 -0.551 . . . . 1.32 110.096 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.72 135.34 34.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.998 -0.546 . . . . 1.05 110.605 -179.708 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.41 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.31 161.36 39.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.679 -0.692 . . . . 1.16 109.627 179.844 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.943 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.3 mt -71.02 124.9 25.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.054 0.454 . . . . 1.23 110.708 -179.676 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.503 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.78 -7.6 49.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.713 -0.676 . . . . 0.86 110.952 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -109.86 -69.7 0.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.405 . . . . 1.66 111.417 -179.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.426 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.66 -35.34 76.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.108 -0.496 . . . . 1.66 111.486 -179.142 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.094 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.19 7.21 88.61 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.806 -0.918 . . . . 1.62 110.806 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.312 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.91 -171.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.739 0.304 . . . . 1.86 110.23 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.312 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.37 139.07 44.75 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.973 0.416 . . . . 1.98 110.205 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.41 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.8 Cg_endo -70.89 145.87 51.72 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.662 2.241 . . . . 0.62 112.391 -179.526 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.9 145.75 42.62 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.217 -0.66 . . . . 1.14 109.217 179.276 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.811 ' CE2' ' ND2' ' A' ' 16' ' ' ASN . 49.2 p90 -123.26 141.22 52.21 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.418 -0.513 . . . . 1.44 111.536 -179.013 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.425 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.9 mt -128.05 127.67 43.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.329 -0.85 . . . . 1.08 109.068 178.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -101.74 131.2 48.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.236 0.541 . . . . 1.09 111.726 -178.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.515 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -127.97 157.55 73.51 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.226 -0.897 . . . . 1.04 109.558 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.78 157.96 58.56 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 122.521 2.148 . . . . 0.21 112.178 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.1 p -59.28 -12.11 5.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.77 -0.65 . . . . 0.88 110.74 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.79 -8.83 42.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.085 -0.507 . . . . 1.06 110.703 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.13 135.39 34.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 1.05 110.364 179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.1 p -133.21 16.71 4.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.339 -0.392 . . . . 1.07 110.521 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.7 p -167.56 147.14 5.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.65 -0.5 . . . . 0.92 109.65 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.515 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.22 150.5 12.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.561 -0.456 . . . . 1.09 111.545 -179.619 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.487 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.39 124.93 50.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.644 -0.707 . . . . 1.31 109.827 179.466 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.515 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.32 104.82 29.08 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.428 -0.351 . . . . 1.09 111.158 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.7 Cg_endo -91.02 -179.47 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 123.188 2.592 . . . . 0.48 112.188 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.53 32.8 18.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.444 -0.798 . . . . 1.26 111.467 179.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.515 HD21 HG21 ' A' ' 169' ' ' ILE . 24.1 mt -86.43 148.49 25.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.468 -0.333 . . . . 1.12 110.409 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.769 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.29 114.83 61.2 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.091 0.472 . . . . 1.3 110.722 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.01 140.63 96.19 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.878 2.385 . . . . 0.92 111.952 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.03 21.25 74.35 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.087 -0.805 . . . . 0.44 111.087 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.426 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.97 150.25 49.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.928 0.394 . . . . 3.05 110.541 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.503 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.18 131.66 45.99 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.983 -0.553 . . . . 1.48 109.792 179.316 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.943 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.56 148.22 44.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.07 -0.513 . . . . 0.89 111.101 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.24 125.4 60.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.263 -1.014 . . . . 1.12 108.263 177.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.6 132.43 63.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.202 0.525 . . . . 1.1 111.338 -178.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.46 122.62 20.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.477 -0.783 . . . . 0.43 109.63 179.342 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.585 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.07 125.39 55.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.176 -0.465 . . . . 1.07 110.654 -179.493 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.67 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.7 m-85 -117.3 137.93 52.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.001 -0.545 . . . . 0.92 109.839 179.533 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.563 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.63 135.06 42.66 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.79 -0.819 . . . . 0.49 108.79 178.916 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.546 ' O ' ' N ' ' A' ' 140' ' ' SER . 81.3 mt -99.14 122.83 51.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.101 0.477 . . . . 1.08 111.022 -178.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.448 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.5 p -83.73 169.74 14.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.568 -0.742 . . . . 0.89 110.499 -179.694 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.81 -14.5 15.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.028 -0.533 . . . . 1.6 110.975 -179.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.448 ' H ' ' HG ' ' A' ' 186' ' ' SER . 95.3 m-20 -96.09 -4.26 43.21 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.854 -0.339 . . . . 1.18 110.86 -179.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.7 14.03 63.94 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.365 -0.694 . . . . 0.34 111.365 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -84.73 139.08 32.24 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.03 -0.268 . . . . 1.22 110.484 179.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -106.72 141.03 38.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.871 0.367 . . . . 1.44 110.517 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.0 m -136.74 126.99 26.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 1.39 110.337 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.67 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.5 tp -68.05 117.35 9.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.308 -0.406 . . . . 1.08 110.534 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.644 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -109.09 -21.82 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 1.08 110.68 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.8 125.72 5.92 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.489 -0.484 . . . . 1.1 111.487 -179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.496 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.78 120.26 21.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.835 -0.62 . . . . 0.94 109.554 179.123 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.66 29.05 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.71 -0.396 . . . . 1.07 110.942 -179.28 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.8 p -110.4 158.64 18.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.521 . . . . 0.89 110.382 179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.11 157.83 43.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.057 -0.519 . . . . 0.67 110.691 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.22 104.31 9.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.762 -0.654 . . . . 1.17 110.058 179.513 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.483 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.2 p . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.991 -1.005 . . . . 1.26 110.577 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.0 m . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.196 -0.668 . . . . 3.83 109.196 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.425 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.36 150.7 18.54 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.981 -0.848 . . . . 1.39 110.981 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -35.68 142.38 0.1 Allowed 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 123.982 3.122 . . . . 0.86 113.835 -179.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.568 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -79.92 173.41 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.306 -1.316 . . . . 1.43 108.81 178.413 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.402 ' H ' ' CG1' ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.55 125.84 51.45 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.484 -0.486 . . . . 1.94 111.46 -179.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.5 144.01 33.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.638 -0.71 . . . . 1.19 110.689 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.36 25.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.946 0.403 . . . . 3.92 111.089 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.576 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -109.01 131.15 60.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.99 -0.55 . . . . 3.88 110.05 179.833 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.25 162.33 35.74 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.823 0.344 . . . . 3.92 111.236 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.3 mt-10 35.99 31.69 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.626 -0.509 . . . . 6.08 109.626 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.576 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.55 32.99 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.944 -0.571 . . . . 4.01 111.541 -178.816 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.643 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.21 -29.09 73.38 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.478 2.119 . . . . 4.51 111.883 179.333 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.643 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.55 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 3.51 110.487 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.62 ' NE2' ' O ' ' A' ' 13' ' ' SER . 1.7 mp0 -124.0 158.3 60.77 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.32 -0.4 . . . . 4.3 110.456 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.542 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 97.0 Cg_endo -82.0 -64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.939 2.426 . . . . 1.96 113.511 -178.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.558 HD21 ' CD ' ' A' ' 143' ' ' ARG . 78.2 m-20 -108.52 -19.48 13.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.311 -0.404 . . . . 3.33 112.082 -178.531 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 27.5 m -107.29 152.01 24.7 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.44 -0.504 . . . . 1.53 111.329 -179.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.571 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.0 t-80 -155.17 102.87 2.25 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.796 -0.638 . . . . 2.29 110.742 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.61 145.71 13.16 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.862 2.375 . . . . 0.88 112.55 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.4 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.85 167.94 24.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.795 -0.639 . . . . 2.12 109.847 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.17 147.88 28.97 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.754 -0.462 . . . . 2.67 109.754 178.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.504 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.6 p90 -142.23 157.34 44.96 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.673 -0.411 . . . . 0.32 111.252 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.47 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.1 m-20 -128.06 155.31 44.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.866 -0.607 . . . . 2.77 110.085 179.029 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.67 172.98 6.44 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.128 -0.487 . . . . 1.25 110.798 -179.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.6 174.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 122.859 2.373 . . . . 1.12 111.552 179.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.07 -51.15 0.68 Allowed Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 120.664 -0.414 . . . . 4.05 110.112 179.795 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.65 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.83 152.33 82.52 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.757 2.304 . . . . 2.12 111.44 179.225 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.68 42.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.426 0.632 . . . . 2.85 110.628 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.813 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.66 -41.58 98.17 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.966 -1.015 . . . . 3.11 110.651 179.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.448 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.9 mt -109.82 137.85 40.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.851 -0.613 . . . . 1.86 111.311 -179.511 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.06 -72.9 0.7 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.054 -0.521 . . . . 1.61 111.853 -178.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.16 148.41 24.43 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.59 0.589 . . . . 1.67 112.59 -179.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.79 124.86 45.18 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.327 -0.62 . . . . 1.07 109.327 177.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.05 134.76 60.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.678 -0.409 . . . . 1.55 110.636 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.484 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -119.99 128.49 53.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.437 . . . . 1.33 111.237 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -130.99 139.07 49.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.756 -0.657 . . . . 2.36 110.151 178.899 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.414 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.2 p90 -145.12 163.18 35.11 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.165 0.507 . . . . 0.38 112.094 -178.162 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.51 139.59 7.84 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.431 -0.804 . . . . 2.31 110.479 178.829 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.698 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.9 Cg_endo -63.51 115.43 3.03 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.436 2.091 . . . . 0.86 111.787 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.685 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.08 81.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.984 0.421 . . . . 3.44 109.874 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.698 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.94 -0.573 . . . . 2.72 111.946 -179.532 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.8 p -157.52 157.79 34.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.759 0.314 . . . . 2.78 110.601 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.402 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 16.0 m -120.43 27.92 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 2.3 110.092 179.586 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.92 -75.89 1.31 Allowed Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.083 -0.58 . . . . 1.8 111.764 -179.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.84 152.3 35.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 5.48 110.973 -179.295 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.649 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.24 -169.17 2.54 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.084 -0.507 . . . . 1.84 111.936 179.337 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.414 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.09 149.65 29.73 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.495 0.664 . . . . 2.27 112.556 -177.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.05 156.49 46.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.789 -1.096 . . . . 1.92 110.274 178.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.15 158.39 41.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.981 -0.554 . . . . 1.09 111.837 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.1 m -115.19 135.64 53.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.476 -0.784 . . . . 1.16 109.784 179.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.45 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.38 121.94 23.79 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.432 -0.349 . . . . 1.39 111.548 -179.158 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.52 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.4 Cg_exo -46.32 151.74 1.62 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.658 2.239 . . . . 0.72 112.101 179.023 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.91 -23.01 63.04 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 116.015 -0.539 . . . . 0.74 112.799 -179.289 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.52 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.87 -16.87 45.9 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.208 -0.597 . . . . 1.26 111.755 -178.306 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.49 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.2 mt -91.47 138.44 31.58 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.809 -0.356 . . . . 1.59 110.321 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.62 13.95 10.93 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.36 -0.382 . . . . 2.07 111.464 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.482 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.5 p -150.05 143.48 25.16 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.648 -0.421 . . . . 0.96 111.005 179.602 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.722 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.78 -169.31 1.52 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.857 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.722 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.79 125.83 9.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.333 -0.849 . . . . 1.19 109.841 179.275 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.445 HG23 HD11 ' A' ' 60' ' ' ILE . 66.6 mt -114.74 123.19 70.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.417 -0.513 . . . . 1.47 111.23 -179.733 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.753 ' NZ ' ' OG ' ' A' ' 140' ' ' SER . 66.4 mttt -126.47 163.44 23.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.928 -0.578 . . . . 3.0 110.441 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.01 19.14 59.78 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.759 -0.937 . . . . 0.5 110.759 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.435 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 74.1 mt -79.12 157.31 27.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.078 0.466 . . . . 1.21 111.291 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.602 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 1.2 mttm -99.55 134.0 21.46 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.659 -0.7 . . . . 3.2 110.393 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.654 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.92 143.53 61.0 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.579 2.186 . . . . 1.09 111.925 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.92 25.57 75.41 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.035 -0.826 . . . . 0.72 111.035 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.651 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.19 158.74 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.64 0.257 . . . . 1.47 110.421 -179.521 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.17 139.86 42.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.925 0.393 . . . . 1.23 110.582 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.651 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.46 136.41 54.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.969 -0.56 . . . . 1.1 110.878 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.86 131.01 45.29 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.545 -0.909 . . . . 1.87 108.545 177.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.52 153.87 16.66 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.237 -0.982 . . . . 0.39 111.867 -178.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.97 140.99 46.13 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.684 -0.487 . . . . 1.8 109.684 179.561 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.472 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.0 tp -115.79 118.92 34.36 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.459 -0.496 . . . . 1.11 110.507 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.9 mt -112.49 129.1 68.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.349 -0.387 . . . . 1.51 110.564 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.8 120.89 43.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.251 -0.432 . . . . 1.47 110.669 -179.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.671 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.64 146.5 11.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.246 0.546 . . . . 1.33 111.005 -179.332 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.813 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.09 153.94 21.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.499 -0.773 . . . . 2.49 109.924 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.13 88.57 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.85 0.357 . . . . 4.2 110.427 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.24 32.59 0.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.869 -0.605 . . . . 6.4 110.616 -179.887 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.06 -117.33 3.29 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.471 -0.652 . . . . 1.74 111.471 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.453 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.36 177.35 9.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.198 0.523 . . . . 3.64 111.692 -179.256 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.12 149.61 32.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.464 -0.789 . . . . 1.7 110.478 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.15 144.68 38.72 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.501 -0.318 . . . . 2.7 110.529 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.5 p -128.0 136.01 61.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 120.615 -0.434 . . . . 1.16 111.549 -179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.03 141.37 52.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.677 -0.692 . . . . 1.14 110.27 179.656 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.489 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.61 138.91 51.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.128 0.489 . . . . 4.33 111.506 -179.379 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 53.0 p90 -152.39 164.19 38.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.554 -0.748 . . . . 0.91 109.4 179.365 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.564 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.1 p30 -145.24 151.54 38.54 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.327 -0.549 . . . . 1.47 111.051 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.571 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.2 p90 -146.2 172.72 13.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.719 -0.673 . . . . 0.51 110.997 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.448 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.5 t -118.72 160.76 21.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.426 -0.807 . . . . 1.92 109.82 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.448 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.46 121.9 22.9 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 120.514 -0.475 . . . . 1.63 110.735 179.942 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.5 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -128.23 163.84 23.84 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.495 0.924 . . . . 2.37 113.495 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.2 t -118.55 144.23 46.22 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.16 -1.422 . . . . 3.63 107.16 176.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.3 p -77.93 151.76 33.56 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.562 -178.011 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 78.2 p -80.38 -14.77 58.06 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.7 179.334 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.8 p -124.27 80.67 58.99 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.905 -178.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -56.1 -22.26 38.78 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.812 1.674 . . . . 0.0 110.923 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.411 ' CG2' ' HG ' ' A' ' 196' ' ' SER . 44.9 t -117.69 134.35 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.021 178.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.0 t -62.43 -39.56 93.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.035 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 84.2 p -62.29 -24.29 67.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.133 -179.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -84.85 131.32 34.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.033 0.444 . . . . 0.0 111.028 -179.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.2 p -79.26 164.2 24.33 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.625 -179.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 p -61.15 133.45 26.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.106 0.479 . . . . 0.0 110.829 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 42.2 m -123.58 142.48 50.99 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.239 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.03 11.89 60.92 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 43.14 -112.52 0.22 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.539 0.209 . . . . 0.0 110.946 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.9 p -80.16 160.8 25.55 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.948 0.404 . . . . 0.0 110.622 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.583 ' O ' ' CD2' ' A' ' 110' ' ' PHE . 43.9 p -126.93 80.1 71.69 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.688 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.76 -21.28 39.08 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.578 2.185 . . . . 0.0 112.49 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 108' ' ' THR . 89.0 m-85 69.91 23.35 5.55 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.588 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.9 t -128.18 75.33 78.89 Favored Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.182 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -56.4 144.01 84.81 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.246 1.964 . . . . 0.0 111.736 179.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.3 mt -95.8 139.76 31.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.444 -0.344 . . . . 10.52 110.33 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.3 t -120.08 134.61 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.255 -0.43 . . . . 7.48 110.408 179.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.54 ' O ' ' O ' ' A' ' 116' ' ' THR . . . 169.31 -14.97 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.308 -0.405 . . . . 7.69 110.399 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.54 ' O ' ' O ' ' A' ' 115' ' ' ALA . 32.7 m 45.24 174.96 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.175 -0.466 . . . . 6.46 111.156 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.525 ' H ' ' CG2' ' A' ' 116' ' ' THR . 60.7 p -71.53 160.42 32.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.392 . . . . 4.59 110.773 -179.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.05 -33.2 74.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 3.21 111.221 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.445 ' O ' ' OG ' ' A' ' 117' ' ' SER . 28.6 t -118.25 144.47 45.77 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.381 -0.372 . . . . 3.64 110.797 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.8 t -112.6 134.92 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.173 -0.467 . . . . 3.39 110.421 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 44.6 m -121.87 142.38 50.31 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.82 -0.627 . . . . 2.23 110.351 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -57.45 143.41 40.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.385 -0.37 . . . . 4.53 110.148 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 70.7 mt -114.55 134.97 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.157 -0.474 . . . . 2.01 110.778 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 22.3 p -84.07 162.75 20.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.015 -0.539 . . . . 2.22 110.056 179.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.83 142.18 57.49 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.67 -0.412 . . . . 1.29 110.478 -179.691 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.1 OUTLIER -153.74 17.69 0.52 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.343 0.592 . . . . 1.25 110.081 -179.884 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.479 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.86 167.56 0.25 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.351 -0.84 . . . . 1.16 110.906 -179.696 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.479 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.9 m-30 -133.64 145.59 50.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.671 -0.695 . . . . 0.78 110.112 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.23 101.66 9.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.124 -0.695 . . . . 1.08 109.124 177.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.472 HG11 ' N ' ' A' ' 131' ' ' SER . 72.0 t -112.94 139.6 37.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.031 -0.531 . . . . 1.1 111.075 -178.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.472 ' N ' HG11 ' A' ' 130' ' ' VAL . 68.1 p -128.63 152.5 48.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.638 -0.71 . . . . 0.87 109.87 179.606 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.655 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.5 p90 -144.8 -164.88 2.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.67 -0.412 . . . . 0.37 110.631 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.732 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -124.0 127.21 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.298 -0.41 . . . . 1.14 110.83 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.154 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -58.11 58.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 1.91 110.239 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.23 24.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.882 -0.599 . . . . 1.56 111.435 -179.661 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.154 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.14 128.75 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.586 -0.446 . . . . 1.56 110.894 179.872 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.32 -9.75 55.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.886 -0.597 . . . . 1.88 110.339 179.78 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.59 ' O ' ' CD ' ' A' ' 187' ' ' GLU . 27.8 p -87.12 0.3 55.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.004 -0.543 . . . . 1.63 110.314 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.964 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.37 137.23 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.915 -0.584 . . . . 1.11 109.959 179.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.753 ' OG ' ' NZ ' ' A' ' 61' ' ' LYS . 89.3 p -96.27 -15.49 21.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.304 0.573 . . . . 1.01 110.017 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.58 175.56 45.76 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.788 -1.325 . . . . 0.14 109.788 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.52 151.65 42.59 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.614 -0.435 . . . . 0.21 110.455 179.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.58 ' NH1' HD12 ' A' ' 185' ' ' ILE . 38.3 ttp-105 -132.37 121.18 23.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.038 -0.528 . . . . 1.54 109.884 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.494 HG23 HG11 ' A' ' 167' ' ' VAL . 46.1 t -104.97 136.57 38.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.752 -0.658 . . . . 1.08 110.669 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 97.5 mt-10 -129.43 129.82 45.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.998 -0.547 . . . . 1.32 110.091 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.6 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.63 135.34 34.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.079 -0.51 . . . . 1.05 110.587 -179.646 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.403 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.36 161.38 39.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.783 -0.644 . . . . 1.16 109.647 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.931 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.3 mt -71.1 124.88 25.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.063 0.459 . . . . 1.23 110.709 -179.623 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.91 -7.57 49.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.745 -0.661 . . . . 0.86 110.869 -179.74 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.81 -69.63 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 1.66 111.439 -179.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.447 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.71 -35.35 76.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.006 -0.543 . . . . 1.66 111.47 -179.094 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.078 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.17 88.64 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.763 -0.935 . . . . 1.62 110.763 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.326 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.4 t0 -27.88 -171.7 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.792 0.33 . . . . 1.86 110.275 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.326 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.27 139.12 45.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.408 . . . . 1.98 110.152 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.403 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 48.1 Cg_endo -70.86 145.85 51.86 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 122.695 2.264 . . . . 0.62 112.299 -179.591 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.6 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.92 145.75 42.65 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.173 -0.677 . . . . 1.14 109.173 179.157 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.654 ' CE1' ' CD ' ' A' ' 65' ' ' PRO . 48.4 p90 -123.34 141.33 52.1 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.336 -0.546 . . . . 1.44 111.564 -179.117 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.4 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.8 mt -128.04 127.6 43.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.349 -0.841 . . . . 1.08 109.001 179.008 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -101.65 131.1 48.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.207 0.527 . . . . 1.09 111.783 -178.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.515 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -127.87 157.62 73.09 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.308 -0.86 . . . . 1.04 109.586 179.647 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -69.75 157.98 58.56 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 C-N-CA 122.431 2.087 . . . . 0.21 112.29 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.1 p -59.23 -12.22 5.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.871 -0.604 . . . . 0.88 110.725 -179.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.9 p -92.83 -8.73 42.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.107 -0.497 . . . . 1.06 110.753 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.15 135.35 34.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.451 . . . . 1.05 110.436 179.672 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 p -133.11 16.71 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.437 -0.347 . . . . 1.07 110.536 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.9 p -167.52 147.04 5.07 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.639 -0.504 . . . . 0.92 109.639 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.515 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.21 150.42 12.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.567 -0.453 . . . . 1.09 111.63 -179.658 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.496 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.32 124.96 50.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.595 -0.729 . . . . 1.31 109.832 179.519 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.519 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.38 104.92 29.88 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.882 0.372 . . . . 1.09 111.03 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.1 Cg_endo -91.0 -179.44 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 123.175 2.583 . . . . 0.48 112.137 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.54 32.69 18.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.362 -0.835 . . . . 1.26 111.49 179.325 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.519 HD21 HG21 ' A' ' 169' ' ' ILE . 24.1 mt -86.33 148.54 25.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.427 -0.351 . . . . 1.12 110.435 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.775 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.35 114.82 61.19 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.026 0.441 . . . . 1.3 110.705 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.96 140.55 95.82 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.904 2.403 . . . . 0.92 111.969 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.1 21.24 74.17 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.064 -0.814 . . . . 0.44 111.064 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.447 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.87 150.18 49.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.808 0.337 . . . . 3.05 110.631 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.26 131.61 46.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 1.48 109.737 179.381 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.931 ' CE2' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.45 148.2 44.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.107 -0.497 . . . . 0.89 111.119 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.31 125.4 60.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.275 -1.009 . . . . 1.12 108.275 177.728 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.5 132.54 63.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.156 0.503 . . . . 1.1 111.249 -178.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.55 122.63 20.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.485 -0.78 . . . . 0.43 109.553 179.288 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.585 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.0 125.4 54.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.224 -0.443 . . . . 1.07 110.658 -179.526 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.669 ' CE1' HD11 ' A' ' 193' ' ' LEU . 47.9 m-85 -117.23 137.79 52.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.101 -0.5 . . . . 0.92 109.921 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.569 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.74 135.01 42.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.743 -0.836 . . . . 0.49 108.743 178.922 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.58 HD12 ' NH1' ' A' ' 143' ' ' ARG . 42.1 mm -99.1 122.91 51.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.107 0.479 . . . . 1.08 110.949 -178.757 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.447 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.6 p -83.86 169.67 14.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.483 -0.78 . . . . 0.89 110.447 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.59 ' CD ' ' O ' ' A' ' 138' ' ' THR . 41.0 mp0 -59.64 -14.6 14.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.975 -0.557 . . . . 1.6 111.036 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.447 ' H ' ' HG ' ' A' ' 186' ' ' SER . 95.8 m-20 -96.16 -4.21 43.06 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.853 -0.339 . . . . 1.18 110.765 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.736 ' O ' ' NE2' ' A' ' 191' ' ' GLN . . . 87.69 13.94 64.13 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.366 -0.693 . . . . 0.34 111.366 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -84.61 139.1 32.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.63 0.252 . . . . 1.22 110.484 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.736 ' NE2' ' O ' ' A' ' 189' ' ' GLY . 0.0 OUTLIER -106.69 141.06 38.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 1.44 110.564 179.733 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.67 127.0 26.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 1.39 110.392 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.669 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.4 tp -68.11 117.35 9.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.323 -0.399 . . . . 1.08 110.531 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.655 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -109.04 -21.91 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 1.08 110.659 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.9 125.78 5.88 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.527 -0.469 . . . . 1.1 111.507 -179.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.498 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.77 120.2 21.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.77 -0.65 . . . . 0.94 109.539 179.249 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.6 151.66 29.09 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.724 -0.39 . . . . 1.07 110.938 -179.271 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.42 158.61 18.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 0.89 110.404 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -146.16 157.91 43.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.502 . . . . 0.67 110.666 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.27 104.3 9.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.801 -0.636 . . . . 1.17 110.007 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.479 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.5 p . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 117.948 -1.025 . . . . 1.26 110.641 -179.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.203 -0.666 . . . . 3.83 109.203 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.452 ' H ' ' HB3' ' A' ' 1' ' ' SER . . . -116.34 150.67 18.55 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.037 -0.825 . . . . 1.39 111.037 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -35.67 142.38 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 124.039 3.159 . . . . 0.86 113.792 -179.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.563 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.1 t -79.98 173.41 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.281 -1.327 . . . . 1.43 108.881 178.428 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.402 ' H ' ' CG1' ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.6 125.86 51.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.214 0.531 . . . . 1.94 111.354 -179.526 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 143.98 33.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.564 -0.744 . . . . 1.19 110.596 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -151.99 168.35 25.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.943 0.401 . . . . 3.92 111.076 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.583 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.97 131.02 60.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.974 -0.557 . . . . 3.88 110.076 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.19 162.33 35.74 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.834 0.349 . . . . 3.92 111.197 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 79.9 mm-40 36.13 31.59 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 109.547 -0.538 . . . . 6.08 109.547 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.583 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.48 69.56 32.95 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.964 -0.562 . . . . 4.01 111.624 -178.831 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.22 -29.11 73.27 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.414 2.076 . . . . 4.51 111.856 179.351 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.124 -0.489 . . . . 3.51 110.49 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.534 ' OE1' ' O ' ' A' ' 13' ' ' SER . 2.0 mp0 -123.93 158.4 60.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.304 -0.407 . . . . 4.3 110.379 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.609 ' CB ' ' HG1' ' A' ' 94' ' ' THR . 98.3 Cg_endo -82.09 -64.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.922 2.415 . . . . 1.96 113.431 -178.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.627 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 60.7 t30 -108.46 -19.53 13.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.312 -0.404 . . . . 3.33 112.065 -178.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 4.2 p -107.26 152.02 24.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.149 0.499 . . . . 1.53 111.313 -179.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.25 102.94 2.23 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.723 -0.671 . . . . 2.29 110.68 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.65 145.61 13.05 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.847 2.365 . . . . 0.88 112.651 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.405 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.84 167.84 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.949 -0.569 . . . . 2.12 109.843 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.05 148.02 29.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.826 -0.435 . . . . 2.67 109.826 178.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.499 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.5 p90 -142.25 157.2 45.1 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.66 -0.416 . . . . 0.32 111.203 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.468 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -127.98 155.29 44.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.783 -0.644 . . . . 2.77 110.129 178.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.57 173.05 6.34 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.172 -0.467 . . . . 1.25 110.807 -179.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -50.74 173.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 122.839 2.359 . . . . 1.12 111.449 179.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.48 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.03 -51.04 0.69 Allowed Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.688 -0.405 . . . . 4.05 110.062 179.868 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.647 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.8 Cg_exo -64.87 152.32 82.62 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.789 2.326 . . . . 2.12 111.441 179.258 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.75 42.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.465 0.65 . . . . 2.85 110.547 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.817 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.66 -41.73 98.16 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.962 -1.017 . . . . 3.11 110.65 179.722 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.441 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.5 mt -109.73 137.91 39.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.711 -0.677 . . . . 1.86 111.343 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.93 -73.01 0.7 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.084 -0.507 . . . . 1.61 111.874 -178.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.19 148.41 24.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.575 0.583 . . . . 1.67 112.575 -179.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -121.86 124.81 45.0 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.341 -0.615 . . . . 1.07 109.341 177.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.09 134.68 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.721 -0.391 . . . . 1.55 110.614 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.486 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -119.98 128.59 53.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.055 0.455 . . . . 1.33 111.326 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.04 138.95 49.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.738 -0.664 . . . . 2.36 110.153 179.014 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.417 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -145.04 163.17 35.07 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 121.133 0.492 . . . . 0.38 112.098 -178.166 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.491 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.48 139.57 7.86 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.42 -0.809 . . . . 2.31 110.482 178.85 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.8 Cg_endo -63.64 115.53 3.11 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.25 1.966 . . . . 0.86 111.852 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.67 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.93 81.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.871 -0.418 . . . . 3.44 109.871 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.16 -20.62 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.015 -0.538 . . . . 2.72 111.899 -179.546 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 p -157.7 157.76 34.12 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.812 -0.355 . . . . 2.78 110.56 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.36 27.87 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.173 -0.467 . . . . 2.3 110.178 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.83 -75.94 1.31 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.129 -0.557 . . . . 1.8 111.808 -179.243 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.88 152.29 35.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.918 0.389 . . . . 5.48 111.021 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.12 2.53 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.093 -0.503 . . . . 1.84 111.902 179.44 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.411 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.18 149.77 29.62 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 121.433 0.635 . . . . 2.27 112.543 -177.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.12 156.45 45.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.834 -1.076 . . . . 1.92 110.154 178.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.22 158.4 41.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.848 -0.614 . . . . 1.09 111.773 -179.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.9 m -115.17 135.64 53.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.476 -0.783 . . . . 1.16 109.839 179.308 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.44 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.44 121.91 23.71 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.483 -0.326 . . . . 1.39 111.528 -179.09 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.5 Cg_exo -46.26 151.67 1.6 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.663 2.242 . . . . 0.72 112.212 178.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.97 -22.96 63.1 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 116.097 -0.502 . . . . 0.74 112.755 -179.162 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.515 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.1 p-80 -82.75 -16.95 46.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.432 0.616 . . . . 1.26 111.815 -178.372 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.493 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.3 mt -91.58 138.31 31.67 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.773 -0.371 . . . . 1.59 110.354 179.354 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -121.48 13.95 11.04 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.353 -0.385 . . . . 2.07 111.564 -179.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.0 p -149.96 143.51 25.27 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.654 -0.418 . . . . 0.96 111.034 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.84 -169.38 1.54 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.894 -179.463 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.711 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 t -151.77 125.89 9.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.427 -0.806 . . . . 1.19 109.795 179.273 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.435 HD11 HG23 ' A' ' 60' ' ' ILE . 66.7 mt -114.91 123.22 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.396 -0.522 . . . . 1.47 111.196 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.405 ' HZ3' ' CB ' ' A' ' 140' ' ' SER . 53.1 mtmt -126.4 163.31 23.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.809 -0.632 . . . . 3.0 110.514 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.477 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.2 18.83 60.07 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.823 -0.911 . . . . 0.5 110.823 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.627 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.7 mt -78.93 157.3 28.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.002 0.43 . . . . 1.21 111.446 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.626 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 2.9 mptp? -99.53 133.98 21.49 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.638 -0.71 . . . . 3.2 110.422 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.937 ' HB3' ' O ' ' A' ' 93' ' ' SER . 36.6 Cg_endo -67.82 143.51 61.47 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.613 2.209 . . . . 1.09 111.901 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.96 25.55 75.45 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.987 -0.845 . . . . 0.72 110.987 179.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.64 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.1 158.71 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.654 0.264 . . . . 1.47 110.408 -179.532 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.09 139.98 41.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.85 0.357 . . . . 1.23 110.593 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.64 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.53 136.45 54.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.035 -0.53 . . . . 1.1 110.687 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.491 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.89 131.08 45.25 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.522 -0.918 . . . . 1.87 108.522 177.482 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.485 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.58 153.9 16.67 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.273 -0.965 . . . . 0.39 111.924 -178.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.98 140.91 46.06 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.699 -0.482 . . . . 1.8 109.699 179.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.469 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.1 tp -115.71 118.86 34.22 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.398 -0.521 . . . . 1.11 110.494 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.8 mt -112.45 129.11 68.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.372 -0.377 . . . . 1.51 110.66 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.83 120.84 43.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.289 -0.414 . . . . 1.47 110.726 -179.657 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.673 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.52 146.41 11.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.099 0.476 . . . . 1.33 111.042 -179.238 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.817 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.03 153.89 21.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.586 -0.733 . . . . 2.49 109.963 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.18 88.55 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.856 0.36 . . . . 4.2 110.425 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.34 32.58 0.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.814 -0.63 . . . . 6.4 110.605 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.15 -117.32 3.28 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.471 -0.652 . . . . 1.74 111.471 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.453 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.42 177.4 8.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.293 0.568 . . . . 3.64 111.593 -179.188 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.19 149.57 32.18 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.397 -0.82 . . . . 1.7 110.365 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.22 144.59 38.55 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.396 -0.365 . . . . 2.7 110.59 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -127.91 136.02 61.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 121.13 0.49 . . . . 1.16 111.462 -179.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.09 141.27 52.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.593 -0.73 . . . . 1.14 110.34 179.55 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.457 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.4 ttp180 -117.56 138.88 51.62 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.573 -0.451 . . . . 4.33 111.598 -179.4 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.485 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.23 164.15 37.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.59 -0.732 . . . . 0.91 109.513 179.452 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.572 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 46.9 p30 -145.27 151.56 38.55 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.374 -0.53 . . . . 1.47 111.059 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.572 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.0 p90 -146.28 172.76 13.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.74 -0.664 . . . . 0.51 111.012 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.447 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.71 160.61 21.54 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.483 -0.781 . . . . 1.92 109.937 179.636 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.447 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.38 121.88 22.96 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.548 -0.461 . . . . 1.63 110.742 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.541 ' O ' ' CB ' ' A' ' 93' ' ' SER . 70.1 p -124.86 154.63 40.75 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 113.092 0.775 . . . . 2.37 113.092 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.937 ' O ' ' HB3' ' A' ' 65' ' ' PRO . 27.6 t 109.94 142.86 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 113.607 -1.633 . . . . 3.63 108.04 -178.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.943 ' HA ' ' HG2' ' A' ' 155' ' ' PRO . 36.4 p 70.7 35.74 1.75 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -179.236 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 154' ' ' GLU . 29.9 t -44.01 150.3 0.28 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.988 -0.445 . . . . 0.0 110.606 179.176 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 p -107.58 151.93 41.22 Favored Pre-proline 0 N--CA 1.468 0.434 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.764 -178.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.408 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 38.2 Cg_endo -64.91 144.41 82.79 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 122.917 2.411 . . . . 0.0 113.499 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.6 m -129.9 154.64 40.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.4 p -124.88 156.78 37.37 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.622 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.6 t 175.38 107.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.679 178.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -111.43 120.69 43.02 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.673 0.273 . . . . 0.0 111.03 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.3 p -74.08 -23.36 59.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.268 179.019 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.9 m -129.46 161.07 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.825 -179.311 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.1 p -78.75 162.83 25.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.161 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.12 -178.43 52.28 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -179.131 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -112.62 157.1 21.63 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.797 0.332 . . . . 0.0 110.68 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.6 m -76.22 138.58 40.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.198 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.407 ' H ' ' HG1' ' A' ' 108' ' ' THR . 4.4 p -108.6 160.04 28.68 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.387 -179.337 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -51.7 145.49 30.49 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.191 1.927 . . . . 0.0 112.102 179.621 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -58.92 -37.59 77.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.405 -178.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.702 ' H ' ' HD2' ' A' ' 112' ' ' PRO . 1.0 OUTLIER -163.26 -37.65 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.805 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.702 ' HD2' ' H ' ' A' ' 111' ' ' SER . 79.8 Cg_exo -46.6 -140.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 122.528 2.152 . . . . 0.0 113.463 -178.204 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' A' ' 113' ' ' LEU . 1.4 mm? -85.21 144.48 28.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.266 -0.425 . . . . 10.52 110.074 -179.171 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.7 m -127.14 158.26 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.946 -0.57 . . . . 7.48 110.803 -179.171 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.57 148.12 25.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.874 -0.603 . . . . 7.69 109.872 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.8 m -71.42 135.05 47.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.132 0.491 . . . . 6.46 110.872 -179.122 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.482 ' OG ' ' N ' ' A' ' 118' ' ' GLU . 27.8 t 177.78 -122.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.228 -0.897 . . . . 4.59 109.221 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.482 ' N ' ' OG ' ' A' ' 117' ' ' SER . 84.4 tt0 -57.83 -32.17 67.35 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.347 -0.612 . . . . 3.21 109.347 178.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 118' ' ' GLU . 11.7 t 51.83 168.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.443 -0.799 . . . . 3.64 111.633 179.737 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 44.8 t -116.6 136.9 52.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.395 -0.82 . . . . 3.39 110.306 -179.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 43.7 m -75.64 137.44 40.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.315 -0.402 . . . . 2.23 110.372 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -105.55 153.11 22.22 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.133 -0.485 . . . . 4.53 110.55 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 16.3 pt -69.01 -9.82 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 2.01 110.935 -179.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 19.1 p -119.43 159.31 24.47 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.781 -0.451 . . . . 2.22 109.781 178.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -148.59 155.47 41.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.996 0.426 . . . . 1.29 110.915 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.593 ' CB ' ' HB ' ' A' ' 201' ' ' THR . 33.5 p -75.76 63.93 1.7 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 122.571 1.177 . . . . 1.25 109.69 179.163 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.471 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.93 167.58 0.26 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.208 -1.36 . . . . 1.16 110.979 -178.914 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.52 145.57 50.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.727 -0.669 . . . . 0.78 110.169 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.28 101.67 9.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.075 -0.713 . . . . 1.08 109.075 177.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.454 HG11 ' N ' ' A' ' 131' ' ' SER . 72.1 t -112.94 139.6 37.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.018 -0.537 . . . . 1.1 111.117 -178.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.454 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.9 p -128.58 152.55 48.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.692 -0.686 . . . . 0.87 109.839 179.62 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.649 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.6 p90 -144.82 -164.97 2.04 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.661 -0.416 . . . . 0.37 110.655 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.734 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.9 t -123.88 127.23 73.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 1.14 110.891 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.168 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.98 58.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 1.91 110.322 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.07 24.5 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 1.56 111.574 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.168 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.2 128.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.622 -0.431 . . . . 1.56 110.919 179.905 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.55 -9.51 55.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.92 -0.582 . . . . 1.88 110.354 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.18 0.18 55.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.086 -0.506 . . . . 1.63 110.275 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.95 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.16 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.976 -0.556 . . . . 1.11 109.881 179.757 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 185' ' ' ILE . 89.3 p -96.2 -15.53 21.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.313 0.578 . . . . 1.01 110.101 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.64 175.64 45.87 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 109.891 -1.284 . . . . 0.14 109.891 179.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.51 151.54 42.69 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.605 -0.438 . . . . 0.21 110.55 179.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.501 ' CZ ' ' CG ' ' A' ' 15' ' ' PRO . 64.1 ttp85 -132.2 121.14 23.21 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.148 -0.478 . . . . 1.54 109.936 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.49 HG23 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.11 136.48 38.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.782 -0.644 . . . . 1.08 110.713 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 80.2 tt0 -129.28 129.85 45.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.879 -0.6 . . . . 1.32 110.121 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.3 p90 -138.66 135.34 34.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.998 -0.546 . . . . 1.05 110.614 -179.686 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.412 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.41 161.4 39.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.792 -0.64 . . . . 1.16 109.617 179.84 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.935 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -71.15 124.95 25.61 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.606 -0.438 . . . . 1.23 110.749 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.504 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.84 -7.57 49.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.753 -0.658 . . . . 0.86 110.916 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -109.87 -69.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.01 0.433 . . . . 1.66 111.354 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.442 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.65 -35.36 76.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.066 -0.515 . . . . 1.66 111.466 -179.093 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.091 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.13 7.23 88.59 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.763 -0.935 . . . . 1.62 110.763 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.314 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.96 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.777 0.322 . . . . 1.86 110.32 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.314 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.33 139.08 44.92 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.036 0.446 . . . . 1.98 110.192 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.943 ' HG2' ' HA ' ' A' ' 94' ' ' THR . 46.8 Cg_endo -70.89 145.81 51.61 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.778 2.318 . . . . 0.62 112.309 -179.48 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.85 145.73 42.61 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.184 -0.673 . . . . 1.14 109.184 179.237 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.624 ' CE1' ' CG ' ' A' ' 16' ' ' ASN . 7.6 p90 -123.35 141.36 52.06 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.249 -0.58 . . . . 1.44 111.449 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.424 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.4 mt -128.11 127.64 43.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.228 -0.896 . . . . 1.08 109.039 178.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -101.66 131.18 48.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.199 0.523 . . . . 1.09 111.72 -178.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.5 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -127.98 157.53 73.58 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.315 -0.857 . . . . 1.04 109.521 179.737 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -69.81 158.02 58.3 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 122.307 2.005 . . . . 0.21 112.291 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.2 p -59.13 -12.25 4.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.831 -0.622 . . . . 0.88 110.759 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.86 -8.82 42.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.103 -0.499 . . . . 1.06 110.676 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.06 135.27 34.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.35 -0.386 . . . . 1.05 110.473 179.675 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.9 p -133.06 16.66 4.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.489 -0.323 . . . . 1.07 110.573 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.1 p -167.53 147.12 5.09 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.624 -0.51 . . . . 0.92 109.624 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.5 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.18 150.5 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.564 -0.455 . . . . 1.09 111.526 -179.663 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.24 124.91 50.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.566 -0.743 . . . . 1.31 109.832 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.511 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.39 104.84 29.43 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.83 0.348 . . . . 1.09 111.08 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.0 Cg_endo -90.92 -179.47 1.51 Allowed 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 123.186 2.591 . . . . 0.48 112.172 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 61.59 32.61 18.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.331 -0.85 . . . . 1.26 111.476 179.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.511 HD21 HG21 ' A' ' 169' ' ' ILE . 23.8 mt -86.27 148.53 25.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.469 -0.332 . . . . 1.12 110.522 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.766 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.4 mt -88.28 114.89 61.45 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.959 0.409 . . . . 1.3 110.721 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.12 140.61 95.81 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.826 2.351 . . . . 0.92 112.01 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.11 21.17 74.32 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.028 -0.829 . . . . 0.44 111.028 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.442 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.8 mmm-85 -126.83 150.31 49.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 3.05 110.625 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.504 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.28 131.65 46.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.978 -0.555 . . . . 1.48 109.814 179.316 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.935 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.55 148.36 43.96 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.113 -0.494 . . . . 0.89 110.974 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.5 mt -105.35 125.38 60.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.296 -1.002 . . . . 1.12 108.296 177.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.52 132.44 63.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.177 0.513 . . . . 1.1 111.222 -178.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.62 20.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.64 -0.709 . . . . 0.43 109.633 179.216 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.593 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.97 125.46 54.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 1.07 110.71 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.671 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.5 m-85 -117.26 137.87 52.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.048 -0.524 . . . . 0.92 109.891 179.51 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.566 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.73 135.06 42.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.765 -0.828 . . . . 0.49 108.765 178.887 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 140' ' ' SER . 63.1 mt -99.03 122.91 51.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.106 0.479 . . . . 1.08 110.956 -178.75 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.451 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.4 p -83.88 169.66 14.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.563 -0.744 . . . . 0.89 110.54 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -59.76 -14.49 14.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.085 -0.507 . . . . 1.6 110.914 -179.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.451 ' H ' ' HG ' ' A' ' 186' ' ' SER . 94.7 m-20 -96.13 -4.31 42.97 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.79 -0.364 . . . . 1.18 110.769 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.82 13.96 63.83 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.316 -0.713 . . . . 0.34 111.316 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -84.64 139.13 32.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.642 0.258 . . . . 1.22 110.443 179.658 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.516 HE22 ' HD2' ' A' ' 15' ' ' PRO . 41.0 mt-30 -106.79 141.06 38.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.97 0.414 . . . . 1.44 110.552 179.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.1 m -136.62 127.11 26.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.487 . . . . 1.39 110.408 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.671 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.6 tp -68.2 117.31 9.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.39 -0.368 . . . . 1.08 110.438 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.649 HD12 ' CD1' ' A' ' 132' ' ' TRP . 43.9 pt -109.09 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 1.08 110.744 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.92 125.68 5.83 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.477 -0.489 . . . . 1.1 111.475 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.491 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.71 120.21 21.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.731 -0.668 . . . . 0.94 109.58 179.191 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.58 151.69 29.15 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.71 -0.396 . . . . 1.07 110.881 -179.242 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.54 158.58 18.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.89 110.339 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -146.03 157.94 43.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.031 -0.531 . . . . 0.67 110.714 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.39 9.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.753 -0.658 . . . . 1.17 110.05 179.568 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.593 ' HB ' ' CB ' ' A' ' 126' ' ' SER . 67.9 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 117.829 -1.081 . . . . 1.26 110.619 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.5 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.196 -0.668 . . . . 3.83 109.196 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.452 ' H ' ' HB3' ' A' ' 1' ' ' SER . . . -116.35 150.64 18.55 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.999 -0.84 . . . . 1.39 110.999 179.753 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -35.5 142.39 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 124.002 3.135 . . . . 0.86 113.794 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.559 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.3 t -80.06 173.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.246 -1.343 . . . . 1.43 108.825 178.451 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -105.55 125.98 51.6 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.45 -0.5 . . . . 1.94 111.412 -179.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.62 143.91 34.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.658 -0.701 . . . . 1.19 110.667 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.4 25.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.925 0.393 . . . . 3.92 111.042 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.583 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -109.06 131.05 60.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.926 -0.579 . . . . 3.88 110.091 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.8 p -141.17 162.37 35.64 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.438 -0.347 . . . . 3.92 111.249 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 9' ' ' THR . 96.3 mt-10 35.98 31.65 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.616 -0.513 . . . . 6.08 109.616 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.583 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.51 69.64 33.42 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.007 -0.542 . . . . 4.01 111.609 -178.833 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.23 -29.18 73.3 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.5 2.133 . . . . 4.51 111.868 179.32 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.63 125.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.493 . . . . 3.51 110.514 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.717 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -123.89 158.39 60.17 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.306 -0.407 . . . . 4.3 110.45 -179.988 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.53 ' HG3' ' CZ ' ' A' ' 143' ' ' ARG . 98.2 Cg_endo -82.1 -64.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.916 2.411 . . . . 1.96 113.44 -178.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.461 ' H ' ' HG2' ' A' ' 15' ' ' PRO . 6.5 m120 -108.4 -19.52 13.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.065 0.394 . . . . 3.33 112.065 -178.48 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.717 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 7.0 p -107.48 152.0 24.81 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.436 -0.506 . . . . 1.53 111.28 -179.361 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.57 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.18 102.94 2.25 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.709 -0.678 . . . . 2.29 110.654 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -82.74 145.64 12.93 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.879 2.386 . . . . 0.88 112.577 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.409 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.85 167.96 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.871 -0.604 . . . . 2.12 109.892 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -149.12 147.97 29.12 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.708 -0.478 . . . . 2.67 109.708 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.502 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.5 p90 -142.3 157.23 45.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.04 0.448 . . . . 0.32 111.188 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.464 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.1 m-20 -128.03 155.19 44.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.705 -0.679 . . . . 2.77 110.101 179.055 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.58 173.01 6.39 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.155 0.503 . . . . 1.25 110.688 -179.153 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.62 173.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 122.831 2.354 . . . . 1.12 111.555 179.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.484 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.04 -51.13 0.69 Allowed Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.76 -0.376 . . . . 4.05 110.074 179.831 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.65 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.81 152.35 82.45 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.813 2.342 . . . . 2.12 111.426 179.259 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.76 42.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.418 0.628 . . . . 2.85 110.526 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.818 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.54 -41.71 98.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.964 -1.016 . . . . 3.11 110.642 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.445 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.7 mt -109.8 137.79 40.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.857 -0.611 . . . . 1.86 111.305 -179.416 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.95 -72.92 0.7 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.105 -0.498 . . . . 1.61 111.891 -178.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.16 148.43 24.42 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.571 0.582 . . . . 1.67 112.571 -179.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.79 124.83 45.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.36 -0.607 . . . . 1.07 109.36 177.493 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.6 mt -117.97 134.72 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.685 -0.406 . . . . 1.55 110.676 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.489 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -120.01 128.65 53.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.421 . . . . 1.33 111.233 179.742 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 138.89 49.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.766 -0.652 . . . . 2.36 110.156 178.998 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.421 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -144.99 163.25 34.76 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.118 0.485 . . . . 0.38 112.113 -178.114 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.488 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.53 139.55 7.81 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.493 -0.776 . . . . 2.31 110.485 178.887 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.59 115.44 3.05 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.279 1.986 . . . . 0.86 111.865 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.673 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.95 81.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.925 -0.398 . . . . 3.44 109.925 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.921 -0.582 . . . . 2.72 111.95 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -157.68 157.76 34.15 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.813 -0.355 . . . . 2.78 110.523 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.37 27.9 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 2.3 110.147 179.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.83 -75.91 1.31 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.154 -0.546 . . . . 1.8 111.832 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.4 mtp180 -117.82 152.33 35.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.943 0.401 . . . . 5.48 110.959 -179.32 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.35 -169.11 2.51 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.976 -0.556 . . . . 1.84 111.954 179.271 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.414 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.05 149.61 29.76 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.483 0.659 . . . . 2.27 112.532 -177.772 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.02 156.5 46.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.788 -1.096 . . . . 1.92 110.199 178.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.24 158.42 41.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.932 -0.576 . . . . 1.09 111.777 -179.407 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.3 m -115.13 135.62 54.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.479 -0.782 . . . . 1.16 109.838 179.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.443 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.4 122.04 23.79 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.444 -0.344 . . . . 1.39 111.497 -179.164 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.516 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.4 Cg_exo -46.43 151.78 1.69 Allowed 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.692 2.261 . . . . 0.72 112.128 179.046 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.0 -22.99 63.21 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 116.044 -0.526 . . . . 0.74 112.728 -179.116 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.516 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.83 -16.8 46.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.383 0.592 . . . . 1.26 111.818 -178.352 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.493 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.3 mt -91.68 138.37 31.62 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.716 -0.393 . . . . 1.59 110.25 179.387 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.5 14.06 11.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.342 -0.39 . . . . 2.07 111.601 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.472 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -150.0 143.39 25.16 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.682 -0.407 . . . . 0.96 111.07 179.607 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.709 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.84 -169.33 1.53 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.222 0.534 . . . . 1.0 110.844 -179.439 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.709 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.75 125.87 9.23 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.439 -0.8 . . . . 1.19 109.887 179.283 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.476 HG23 HD11 ' A' ' 60' ' ' ILE . 66.7 mt -114.85 123.3 70.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.372 -0.531 . . . . 1.47 111.143 -179.673 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.43 ' HD3' ' CD1' ' A' ' 185' ' ' ILE . 56.1 mtmt -126.59 163.4 23.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.827 -0.624 . . . . 3.0 110.381 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.11 18.93 60.01 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.817 -0.913 . . . . 0.5 110.817 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.431 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 74.3 mt -79.04 157.32 28.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.106 0.479 . . . . 1.21 111.369 -179.65 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.604 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -99.53 134.0 21.48 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.601 -0.727 . . . . 3.2 110.404 179.811 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.94 143.59 61.1 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.533 2.155 . . . . 1.09 111.925 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.88 25.51 75.48 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 111.056 -0.818 . . . . 0.72 111.056 179.685 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.645 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.07 158.91 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.667 0.27 . . . . 1.47 110.421 -179.639 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.23 139.96 42.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.393 -0.367 . . . . 1.23 110.588 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.645 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 94.0 m-85 -122.65 136.52 54.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.906 -0.588 . . . . 1.1 110.713 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.94 131.03 45.32 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.527 -0.916 . . . . 1.87 108.527 177.661 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.48 153.89 16.65 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.331 -0.937 . . . . 0.39 111.931 -178.558 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.02 140.88 45.99 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.69 -0.485 . . . . 1.8 109.69 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.469 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.0 tp -115.71 118.8 34.08 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.513 -0.475 . . . . 1.11 110.509 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.7 mt -112.32 129.0 68.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.357 -0.383 . . . . 1.51 110.707 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.79 120.76 43.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.374 -0.375 . . . . 1.47 110.785 -179.694 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.668 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.55 146.57 11.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.219 0.533 . . . . 1.33 111.017 -179.255 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.818 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.11 153.81 21.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.523 -0.762 . . . . 2.49 109.948 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.25 88.66 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.012 0.434 . . . . 4.2 110.448 -179.68 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.22 32.74 0.21 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.786 -0.643 . . . . 6.4 110.56 -179.871 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.22 -117.41 3.27 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.443 -0.663 . . . . 1.74 111.443 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.452 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.31 177.3 9.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.168 0.509 . . . . 3.64 111.635 -179.229 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.09 149.57 32.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.428 -0.805 . . . . 1.7 110.34 179.186 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.14 144.64 38.72 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.429 -0.35 . . . . 2.7 110.509 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -128.06 136.09 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 121.056 0.455 . . . . 1.16 111.525 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.559 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.05 141.26 52.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.653 -0.703 . . . . 1.14 110.277 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.451 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.61 138.86 51.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.127 0.489 . . . . 4.33 111.481 -179.374 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.489 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.3 164.2 37.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.534 -0.757 . . . . 0.91 109.518 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.57 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.23 151.61 38.66 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.43 -0.508 . . . . 1.47 111.131 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.57 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.9 p90 -146.32 172.69 13.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.82 -0.627 . . . . 0.51 110.998 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.447 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.76 160.75 21.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.455 -0.793 . . . . 1.92 109.897 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.447 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.39 121.91 22.98 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.584 -0.446 . . . . 1.63 110.67 -179.943 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.592 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.6 p -127.44 165.36 19.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.469 0.652 . . . . 2.37 112.562 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.6 t -65.49 161.4 20.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.211 -0.904 . . . . 3.63 109.978 178.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 12.9 t -67.88 166.19 16.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.18 0.514 . . . . 0.0 111.442 -178.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.794 ' O ' ' O ' ' A' ' 96' ' ' THR . 60.7 p -64.58 169.09 5.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.716 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.794 ' O ' ' O ' ' A' ' 95' ' ' SER . 0.1 OUTLIER -14.62 153.1 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.831 0 O-C-N 123.982 0.801 . . . . 0.0 112.348 -178.753 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.48 138.38 65.87 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.948 1.766 . . . . 0.0 112.476 -178.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 82.4 t -63.89 -34.92 71.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.774 179.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.9 m -67.06 136.66 55.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.289 0.566 . . . . 0.0 110.995 -178.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.7 m -119.57 153.06 36.0 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.15 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.478 ' O ' ' OE2' ' A' ' 106' ' ' GLU . 25.4 t30 61.49 50.53 4.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.953 0.406 . . . . 0.0 110.677 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 69.4 p -61.16 -7.54 2.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.421 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -59.36 137.47 21.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.459 -179.609 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.0 p -77.87 166.86 22.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.529 -178.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.41 -2.05 56.09 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.478 ' OE2' ' O ' ' A' ' 101' ' ' ASN . 96.1 mt-10 -61.08 145.94 49.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.769 0.319 . . . . 0.0 110.522 178.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.7 m -73.11 139.08 46.19 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.2 p -121.7 77.09 37.83 Favored Pre-proline 0 N--CA 1.465 0.315 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -178.453 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.21 -17.3 51.78 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.232 1.955 . . . . 0.0 110.849 178.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -86.52 8.36 22.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.787 -179.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.1 m -120.71 80.1 31.7 Favored Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.498 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.59 152.8 20.32 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 123.057 2.505 . . . . 0.0 113.178 -179.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 26.9 tp -90.67 139.75 30.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.226 -0.897 . . . . 10.52 109.141 179.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.475 HG21 ' H ' ' A' ' 116' ' ' THR . 11.5 p -121.64 143.01 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.442 0.639 . . . . 7.48 111.052 -178.385 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.44 -22.18 66.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.914 -1.039 . . . . 7.69 112.823 -178.268 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.475 ' H ' HG21 ' A' ' 114' ' ' VAL . 43.1 p -71.14 155.23 41.0 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.041 -0.663 . . . . 6.46 111.197 -178.52 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.0 m -71.96 157.96 36.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.145 -0.934 . . . . 4.59 112.579 -178.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -59.53 -24.26 63.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.917 -1.038 . . . . 3.21 110.017 178.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -53.95 -21.92 9.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.615 -0.72 . . . . 3.64 111.796 -178.066 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.2 m -55.62 144.39 7.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.948 -0.76 . . . . 3.39 108.948 179.065 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.598 HG22 ' H ' ' A' ' 123' ' ' ILE . 33.7 m -65.98 129.27 39.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.268 0.556 . . . . 2.23 111.266 -177.562 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -97.68 11.36 37.33 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.178 -0.919 . . . . 4.53 112.598 -179.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.598 ' H ' HG22 ' A' ' 121' ' ' THR . 15.5 tt -117.64 137.94 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.626 0.727 . . . . 2.01 111.937 -178.318 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.543 ' O ' ' C ' ' A' ' 125' ' ' ALA . 49.1 m -120.01 144.98 47.23 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 114.747 -1.115 . . . . 2.22 109.739 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.543 ' C ' ' O ' ' A' ' 124' ' ' THR . . . -16.25 -76.92 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.434 0.459 . . . . 1.29 112.204 -178.64 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.9 p 179.64 -58.92 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.643 -0.423 . . . . 1.25 111.652 179.652 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.468 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.96 167.56 0.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.075 -0.511 . . . . 1.16 110.946 -179.033 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.57 145.52 50.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.79 -0.641 . . . . 0.78 110.078 -179.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.26 101.78 9.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.055 -0.72 . . . . 1.08 109.055 177.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.462 HG11 ' N ' ' A' ' 131' ' ' SER . 71.2 t -113.05 139.72 36.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 1.1 110.942 -178.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.462 ' N ' HG11 ' A' ' 130' ' ' VAL . 69.2 p -128.74 152.63 48.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.588 -0.733 . . . . 0.87 109.781 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.645 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.8 p90 -144.83 -165.06 2.06 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.793 -0.363 . . . . 0.37 110.638 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -123.89 127.15 73.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.466 . . . . 1.14 110.896 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.173 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.84 58.26 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.123 -0.489 . . . . 1.91 110.365 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.743 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.08 24.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.936 -0.575 . . . . 1.56 111.44 -179.705 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.173 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.14 128.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.619 -0.432 . . . . 1.56 110.881 179.853 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -86.49 -9.56 55.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.915 -0.584 . . . . 1.88 110.311 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.5 p -87.17 0.27 55.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.141 -0.481 . . . . 1.63 110.286 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.943 HG11 ' O ' ' A' ' 136' ' ' SER . 2.6 p -65.18 137.16 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.011 -0.54 . . . . 1.11 110.037 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.575 ' N ' ' O ' ' A' ' 185' ' ' ILE . 69.4 m -96.19 -15.54 22.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.356 0.598 . . . . 1.01 110.065 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.582 ' H ' HG23 ' A' ' 185' ' ' ILE . . . 178.6 175.55 45.77 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 109.881 -1.288 . . . . 0.14 109.881 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -123.36 151.64 42.32 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.698 -0.401 . . . . 0.21 110.484 179.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.835 ' NH2' ' CE1' ' A' ' 157' ' ' TYR . 70.3 ttt-85 -132.42 121.26 23.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.059 0.457 . . . . 1.54 109.803 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.486 HG23 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.16 136.47 38.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.635 -0.711 . . . . 1.08 110.66 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.58 ' C ' ' CD ' ' A' ' 145' ' ' GLU . 0.3 OUTLIER -129.31 129.89 45.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.014 -0.539 . . . . 1.32 110.037 -179.937 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.603 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.67 135.21 34.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.07 -0.513 . . . . 1.05 110.673 -179.7 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.415 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.28 161.38 39.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.875 -0.602 . . . . 1.16 109.728 179.823 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.942 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.0 mt -71.14 124.91 25.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.038 0.447 . . . . 1.23 110.649 -179.459 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.75 -7.76 50.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.787 -0.642 . . . . 0.86 110.874 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -109.78 -69.68 0.85 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.913 0.387 . . . . 1.66 111.347 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.438 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.67 -35.29 75.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.118 -0.492 . . . . 1.66 111.505 -179.101 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.102 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.1 7.12 88.66 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.864 -0.894 . . . . 1.62 110.864 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.327 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.89 -171.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.811 0.339 . . . . 1.86 110.264 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.327 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.32 139.09 44.94 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-O 120.98 0.419 . . . . 1.98 110.211 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.415 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.89 145.86 51.7 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 C-N-CA 122.741 2.294 . . . . 0.62 112.321 -179.516 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.95 145.73 42.69 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.211 -0.663 . . . . 1.14 109.211 179.216 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.835 ' CE1' ' NH2' ' A' ' 143' ' ' ARG . 8.3 m-85 -123.22 141.37 52.05 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.358 -0.537 . . . . 1.44 111.54 -179.089 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.446 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.2 mt -128.07 127.65 43.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.269 -0.878 . . . . 1.08 108.986 178.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -101.62 131.19 47.97 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.162 0.506 . . . . 1.09 111.791 -178.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.515 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -127.97 157.55 73.5 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.257 -0.883 . . . . 1.04 109.552 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.73 157.98 58.57 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.473 2.115 . . . . 0.21 112.207 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.35 -12.08 5.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.764 -0.653 . . . . 0.88 110.721 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.3 p -92.88 -8.68 42.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.185 -0.461 . . . . 1.06 110.713 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.21 135.4 34.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 1.05 110.383 179.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.9 p -133.09 16.61 4.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.386 -0.37 . . . . 1.07 110.548 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.5 p -167.54 147.11 5.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.58 -0.526 . . . . 0.92 109.58 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.515 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.1 p -152.23 150.43 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.519 -0.472 . . . . 1.09 111.542 -179.634 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.499 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.23 124.98 50.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.66 -0.7 . . . . 1.31 109.845 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.504 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.45 104.92 30.11 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.43 -0.35 . . . . 1.09 110.986 -179.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.5 Cg_endo -91.02 -179.49 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 123.116 2.544 . . . . 0.48 112.201 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.67 32.68 18.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.401 -0.818 . . . . 1.26 111.463 179.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.504 HD21 HG21 ' A' ' 169' ' ' ILE . 24.2 mt -86.39 148.51 25.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.455 -0.339 . . . . 1.12 110.496 179.554 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.773 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.25 114.86 61.32 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.029 0.442 . . . . 1.3 110.662 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.98 140.51 95.67 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.921 2.414 . . . . 0.92 112.026 179.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.18 21.14 74.19 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.052 -0.819 . . . . 0.44 111.052 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.438 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.86 150.21 49.36 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.966 -0.293 . . . . 3.05 110.671 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.495 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.23 131.67 46.03 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.094 -0.503 . . . . 1.48 109.782 179.32 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.942 ' CE2' HD21 ' A' ' 148' ' ' LEU . 75.1 m-85 -120.46 148.33 43.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.09 -0.504 . . . . 0.89 111.056 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.4 125.3 60.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.284 -1.006 . . . . 1.12 108.284 177.696 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.49 132.47 63.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.154 0.502 . . . . 1.1 111.236 -178.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.43 122.56 20.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.509 -0.769 . . . . 0.43 109.644 179.268 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.595 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.99 125.41 54.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.318 -0.401 . . . . 1.07 110.672 -179.512 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.667 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.8 m-85 -117.31 137.95 52.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.987 -0.551 . . . . 0.92 109.793 179.585 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.562 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.75 134.99 42.9 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.778 -0.823 . . . . 0.49 108.778 178.917 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.582 HG23 ' H ' ' A' ' 141' ' ' GLY . 5.3 tt -99.18 122.99 51.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.204 0.526 . . . . 1.08 110.891 -178.692 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.448 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.7 p -83.78 169.7 14.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.524 -0.762 . . . . 0.89 110.46 -179.662 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.81 -14.49 15.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.09 -0.505 . . . . 1.6 110.933 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.448 ' H ' ' HG ' ' A' ' 186' ' ' SER . 96.8 m-20 -96.14 -4.23 43.07 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.827 -0.349 . . . . 1.18 110.807 -179.792 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.83 13.8 64.08 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.349 -0.701 . . . . 0.34 111.349 179.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -84.63 139.11 32.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.675 0.274 . . . . 1.22 110.453 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.49 HE22 ' HD2' ' A' ' 15' ' ' PRO . 77.3 mt-30 -106.71 141.02 38.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.36 . . . . 1.44 110.588 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.2 m -136.71 127.01 26.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 1.39 110.43 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.667 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.4 tp -68.09 117.28 9.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.254 -0.43 . . . . 1.08 110.507 -179.869 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.645 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -109.03 -21.75 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 1.08 110.693 -179.746 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.1 tp -156.88 125.64 5.84 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.542 -0.463 . . . . 1.1 111.477 -179.707 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.487 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.74 120.16 21.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.843 -0.617 . . . . 0.94 109.554 179.188 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.6 151.74 29.18 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.642 -0.423 . . . . 1.07 110.91 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.44 158.53 18.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.015 -0.539 . . . . 0.89 110.406 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -146.03 157.93 43.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 0.67 110.719 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.18 104.32 9.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.826 -0.624 . . . . 1.17 110.083 179.526 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.477 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.7 p . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.914 -1.041 . . . . 1.26 110.637 -179.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.3 m . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.231 -0.655 . . . . 3.83 109.231 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.72 18.53 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.952 -0.859 . . . . 1.39 110.952 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -35.54 142.4 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.106 0 C-N-CA 123.99 3.127 . . . . 0.86 113.733 -179.293 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.568 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -80.06 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 114.189 -1.369 . . . . 1.43 108.837 178.372 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.401 ' H ' ' CG1' ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.62 125.82 51.43 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.407 -0.517 . . . . 1.94 111.496 -179.568 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.46 144.02 33.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.685 -0.689 . . . . 1.19 110.636 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.03 168.35 25.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.985 0.421 . . . . 3.92 111.054 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.583 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.99 131.07 60.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.905 -0.589 . . . . 3.88 110.087 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 69.0 p -141.22 162.36 35.67 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.853 0.359 . . . . 3.92 111.178 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 9' ' ' THR . 53.2 mp0 35.94 31.69 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.638 -0.505 . . . . 6.08 109.638 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.583 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.55 32.47 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.932 -0.577 . . . . 4.01 111.563 -178.817 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.24 -29.22 73.25 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.466 2.11 . . . . 4.51 111.815 179.348 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.72 125.49 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.123 -0.489 . . . . 3.51 110.574 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.658 ' O ' ' O ' ' A' ' 92' ' ' THR . 39.6 mt-30 -123.86 158.28 60.44 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.862 0.363 . . . . 4.3 110.474 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.469 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 98.1 Cg_endo -82.05 -64.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.875 2.383 . . . . 1.96 113.474 -178.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.702 ' CG ' ' CD2' ' A' ' 157' ' ' TYR . 64.4 t30 -108.41 -19.68 13.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.287 -0.415 . . . . 3.33 112.063 -178.468 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 43.0 t -107.26 152.07 24.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.14 0.495 . . . . 1.53 111.38 -179.438 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.573 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.3 102.92 2.22 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.725 -0.67 . . . . 2.29 110.688 179.868 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.62 145.61 13.1 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.935 2.423 . . . . 0.88 112.574 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.407 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.83 167.92 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.95 -0.568 . . . . 2.12 109.926 179.506 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.16 147.95 29.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.73 -0.47 . . . . 2.67 109.73 178.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.501 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.5 p90 -142.27 157.28 45.01 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.597 -0.441 . . . . 0.32 111.215 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.466 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.02 155.29 44.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.754 -0.657 . . . . 2.77 110.12 178.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.55 173.1 6.28 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.172 -0.467 . . . . 1.25 110.785 -179.229 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.61 173.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.902 2.401 . . . . 1.12 111.555 179.32 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.48 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.05 -51.06 0.69 Allowed Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.757 -0.377 . . . . 4.05 110.13 179.777 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.65 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.9 152.34 82.6 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.72 2.28 . . . . 2.12 111.419 179.202 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.64 42.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.411 0.624 . . . . 2.85 110.614 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.814 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.66 -41.68 98.18 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.001 -0.999 . . . . 3.11 110.626 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.44 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.7 mt -109.77 137.87 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.793 -0.64 . . . . 1.86 111.315 -179.516 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.99 -72.93 0.7 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.996 -0.547 . . . . 1.61 111.84 -178.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -88.12 148.37 24.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.582 0.586 . . . . 1.67 112.582 -179.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.78 124.91 45.31 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.328 -0.619 . . . . 1.07 109.328 177.43 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.11 134.78 60.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.658 -0.417 . . . . 1.55 110.617 179.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.488 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -120.01 128.61 53.7 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.222 -0.445 . . . . 1.33 111.236 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.07 138.97 49.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.814 -0.63 . . . . 2.36 110.18 178.956 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.415 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.2 p90 -145.07 163.14 35.17 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.1 0.476 . . . . 0.38 112.094 -178.115 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.46 139.58 7.88 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.438 -0.801 . . . . 2.31 110.493 178.836 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.687 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.3 Cg_endo -63.65 115.52 3.11 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.265 1.977 . . . . 0.86 111.807 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.676 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.94 81.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.908 -0.404 . . . . 3.44 109.908 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.687 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.992 -0.549 . . . . 2.72 111.901 -179.517 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.9 p -157.64 157.71 34.11 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.882 -0.327 . . . . 2.78 110.575 179.766 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.27 27.76 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.169 -0.469 . . . . 2.3 110.19 179.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.77 -75.95 1.31 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.785 -0.526 . . . . 1.8 111.785 -179.217 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.86 152.3 35.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 5.48 111.0 -179.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.676 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.14 -169.11 2.54 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.028 -0.533 . . . . 1.84 111.926 179.382 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.17 149.66 29.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.416 0.627 . . . . 2.27 112.598 -177.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.05 156.41 46.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.843 -1.072 . . . . 1.92 110.262 178.667 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.23 158.29 41.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.933 -0.576 . . . . 1.09 111.773 -179.31 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.04 135.67 53.96 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.483 -0.781 . . . . 1.16 109.859 179.303 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.443 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.47 121.99 23.69 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.533 -0.303 . . . . 1.39 111.585 -179.186 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.0 Cg_exo -46.31 151.71 1.63 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.727 2.285 . . . . 0.72 112.029 179.119 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.81 -23.19 63.04 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 116.049 -0.523 . . . . 0.74 112.782 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.515 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.79 -16.74 46.64 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.213 -0.595 . . . . 1.26 111.761 -178.259 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.493 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.6 mt -91.7 138.44 31.56 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.709 -0.396 . . . . 1.59 110.298 179.381 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.46 13.85 11.04 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.392 -0.367 . . . . 2.07 111.518 -179.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.475 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.7 p -150.01 143.45 25.18 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.65 -0.42 . . . . 0.96 110.973 179.7 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.9 t80 -114.84 -169.48 1.56 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.869 -179.404 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.711 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 t -151.67 125.91 9.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.412 -0.813 . . . . 1.19 109.797 179.292 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 60' ' ' ILE . 66.9 mt -114.85 123.32 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.356 -0.538 . . . . 1.47 111.189 -179.808 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -126.56 163.3 23.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.894 -0.594 . . . . 3.0 110.448 179.746 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.476 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.14 19.03 59.77 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.75 -0.94 . . . . 0.5 110.75 -179.897 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.676 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.9 mt -79.05 157.3 28.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.124 0.488 . . . . 1.21 111.301 -179.642 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.62 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -99.52 133.85 21.59 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.575 -0.739 . . . . 3.2 110.489 179.741 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.408 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.8 Cg_endo -67.81 143.74 62.47 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.454 2.103 . . . . 1.09 112.001 179.773 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.7 25.59 75.37 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.125 -0.79 . . . . 0.72 111.125 179.774 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.643 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.21 158.66 40.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.648 0.261 . . . . 1.47 110.439 -179.533 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.09 139.98 41.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.0 0.429 . . . . 1.23 110.535 -179.737 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.643 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.59 136.49 54.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.89 -0.595 . . . . 1.1 110.689 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.92 130.96 45.32 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.523 -0.917 . . . . 1.87 108.523 177.566 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.488 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.43 153.93 16.63 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.318 -0.944 . . . . 0.39 111.999 -178.658 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.03 140.85 45.95 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.779 -0.452 . . . . 1.8 109.779 179.585 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.468 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.5 tp -115.71 119.0 34.62 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.422 -0.511 . . . . 1.11 110.48 179.757 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.9 mt -112.51 129.02 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.332 -0.395 . . . . 1.51 110.578 -179.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.7 120.86 43.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.283 -0.417 . . . . 1.47 110.749 -179.754 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.671 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.53 146.47 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.116 0.484 . . . . 1.33 111.104 -179.375 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.814 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.06 153.82 21.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.581 -0.736 . . . . 2.49 109.965 179.776 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.12 88.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.913 0.387 . . . . 4.2 110.467 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.41 32.56 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.809 -0.632 . . . . 6.4 110.51 179.998 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.02 -117.37 3.3 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.479 -0.648 . . . . 1.74 111.479 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.452 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.41 177.37 9.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.268 0.556 . . . . 3.64 111.634 -179.244 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.17 149.48 32.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.485 -0.78 . . . . 1.7 110.415 179.179 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.1 144.69 38.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.489 -0.323 . . . . 2.7 110.598 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -128.02 136.05 61.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-O 121.063 0.459 . . . . 1.16 111.544 -179.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.11 141.31 52.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.624 -0.717 . . . . 1.14 110.214 179.695 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.457 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.55 138.88 51.62 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.111 0.481 . . . . 4.33 111.538 -179.391 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.34 164.19 37.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.569 -0.741 . . . . 0.91 109.405 179.37 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.572 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.1 p30 -145.28 151.6 38.6 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.369 -0.533 . . . . 1.47 111.062 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.573 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.8 p90 -146.23 172.7 13.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.778 -0.646 . . . . 0.51 111.033 179.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.446 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.72 160.69 21.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.483 -0.781 . . . . 1.92 109.939 179.515 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.446 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.38 121.93 23.04 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.547 -0.461 . . . . 1.63 110.671 -179.932 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.658 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.7 p -128.45 165.74 20.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.099 -0.501 . . . . 2.37 110.497 179.636 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.4 t -101.36 136.14 41.7 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.468 -0.493 . . . . 3.63 109.914 178.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 69.6 p -110.54 13.12 22.71 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.603 -179.074 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.2 t -68.12 145.29 54.52 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.709 -179.127 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.6 t -68.65 145.87 97.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.375 -179.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.41 ' HG2' ' H ' ' A' ' 98' ' ' VAL . 69.1 Cg_endo -75.09 -61.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.927 1.751 . . . . 0.0 112.128 179.823 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.41 ' H ' ' HG2' ' A' ' 97' ' ' PRO . 47.3 t -122.44 133.99 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 111.319 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.4 m -124.87 138.57 54.25 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.6 178.493 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.9 t -122.35 139.63 53.6 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.942 0.401 . . . . 0.0 111.076 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -123.1 17.85 9.99 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.241 179.207 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 47.2 m -121.43 143.0 49.48 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.936 -179.158 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.7 t -111.18 135.47 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.052 179.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.0 p -82.74 162.29 21.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.048 -179.372 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -141.49 177.48 21.14 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 179.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.49 -34.18 75.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.736 0.303 . . . . 0.0 110.701 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.79 66.79 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.097 0.475 . . . . 0.0 109.938 179.918 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.53 ' O ' ' CD2' ' A' ' 110' ' ' PHE . 6.5 m -125.48 74.31 68.8 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.407 -179.76 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -61.78 -15.46 42.63 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.76 2.307 . . . . 0.0 112.926 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.53 ' CD2' ' O ' ' A' ' 108' ' ' THR . 96.4 m-85 53.21 173.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 110.038 -178.328 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 m -65.71 152.58 92.63 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.325 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -56.8 146.74 76.53 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.477 2.118 . . . . 0.0 112.0 -179.591 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.2 tp -57.24 -36.9 71.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.596 . . . . 10.52 110.39 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.14 134.37 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.909 0.385 . . . . 7.48 110.572 -179.788 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -118.22 -83.94 0.65 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.899 -0.591 . . . . 7.69 110.616 -179.831 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.3 t -80.98 170.16 16.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.97 -0.559 . . . . 6.46 110.933 -179.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.2 p -66.51 163.63 18.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.955 -0.566 . . . . 4.59 110.795 -179.549 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -56.65 143.77 34.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.982 -0.554 . . . . 3.21 110.893 -179.387 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.3 p -124.74 158.78 32.44 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.569 -0.741 . . . . 3.64 110.352 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.3 t -109.1 135.66 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.317 -0.401 . . . . 3.39 110.115 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 49.8 m -119.88 142.09 49.0 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.9 -0.591 . . . . 2.23 110.901 -179.28 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.601 ' C ' ' H ' ' A' ' 124' ' ' THR . 59.3 mp0 -56.87 145.71 28.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.885 -0.598 . . . . 4.53 110.601 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.556 ' C ' ' H ' ' A' ' 125' ' ' ALA . 19.1 mm 68.18 -30.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.82 -0.627 . . . . 2.01 110.454 -179.726 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.642 ' C ' ' H ' ' A' ' 126' ' ' SER . 25.9 m 57.3 -1.56 0.06 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.688 -0.233 . . . . 2.22 111.566 179.424 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.556 ' H ' ' C ' ' A' ' 123' ' ' ILE . . . -62.45 26.26 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.666 -0.243 . . . . 1.29 111.234 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.642 ' H ' ' C ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 47.57 17.29 0.08 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.264 0.554 . . . . 1.25 110.79 -179.933 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.477 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.8 167.52 0.25 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.503 -0.771 . . . . 1.16 110.942 179.419 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.6 145.51 50.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.704 -0.68 . . . . 0.78 110.128 -179.879 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.27 101.65 9.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.087 -0.708 . . . . 1.08 109.087 177.693 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.465 HG11 ' N ' ' A' ' 131' ' ' SER . 71.2 t -112.94 139.74 36.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.055 -0.52 . . . . 1.1 111.033 -178.862 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.465 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.7 p -128.7 152.54 48.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.549 -0.75 . . . . 0.87 109.81 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.647 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.8 p90 -144.79 -164.93 2.03 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.769 -0.373 . . . . 0.37 110.64 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -123.99 127.15 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.183 -0.462 . . . . 1.14 110.814 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.164 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.92 58.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 1.91 110.339 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.06 24.48 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.923 -0.581 . . . . 1.56 111.465 -179.698 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.164 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.13 128.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.601 -0.44 . . . . 1.56 110.918 179.801 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.46 -9.54 56.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.855 -0.611 . . . . 1.88 110.309 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.8 p -87.1 0.25 55.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.073 -0.512 . . . . 1.63 110.343 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.956 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.29 137.26 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.016 -0.538 . . . . 1.11 109.982 179.69 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 185' ' ' ILE . 71.1 m -96.24 -15.55 21.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.239 0.542 . . . . 1.01 110.0 -179.629 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.59 175.54 45.76 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 109.845 -1.302 . . . . 0.14 109.845 179.707 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.48 151.58 42.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.989 0.423 . . . . 0.21 110.43 179.78 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.806 ' NH2' ' CD2' ' A' ' 183' ' ' TYR . 62.5 ttp85 -132.38 121.18 23.07 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.145 -0.479 . . . . 1.54 109.977 179.744 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.493 HG23 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.01 136.62 37.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.615 -0.721 . . . . 1.08 110.655 -179.755 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.501 ' CD ' ' O ' ' A' ' 156' ' ' GLN . 24.8 tp10 -129.41 129.9 45.28 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.933 -0.576 . . . . 1.32 110.067 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.594 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.2 p90 -138.72 135.3 34.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.962 -0.563 . . . . 1.05 110.627 -179.717 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.403 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.33 161.35 39.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.815 -0.629 . . . . 1.16 109.682 179.79 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.939 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -71.02 124.83 25.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.049 0.452 . . . . 1.23 110.747 -179.596 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.502 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.74 -7.69 49.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.704 -0.68 . . . . 0.86 110.779 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -109.86 -69.76 0.85 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.937 0.399 . . . . 1.66 111.336 -179.231 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.452 ' CD ' HH21 ' A' ' 176' ' ' ARG . 53.9 mt-10 -60.61 -35.39 76.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.111 -0.495 . . . . 1.66 111.493 -179.083 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.089 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.18 7.23 88.6 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.808 -0.917 . . . . 1.62 110.808 -179.854 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.32 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.91 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.835 0.35 . . . . 1.86 110.262 179.861 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.32 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.29 139.1 45.05 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.974 0.416 . . . . 1.98 110.126 179.619 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.403 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.5 Cg_endo -70.92 145.81 51.38 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 122.71 2.273 . . . . 0.62 112.275 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.85 145.75 42.59 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.243 -0.651 . . . . 1.14 109.243 179.16 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.702 ' CD2' ' CG ' ' A' ' 16' ' ' ASN . 27.3 p90 -123.26 141.34 52.08 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.296 -0.561 . . . . 1.44 111.57 -179.115 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.7 mt -128.09 127.76 43.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.313 -0.858 . . . . 1.08 108.978 178.923 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -101.68 131.1 48.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.171 0.51 . . . . 1.09 111.747 -178.733 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.506 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -127.88 157.51 73.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.248 -0.887 . . . . 1.04 109.624 179.686 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.76 158.02 58.4 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.464 2.109 . . . . 0.21 112.297 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.3 p -59.21 -12.25 5.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.879 -0.6 . . . . 0.88 110.696 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.2 p -92.81 -8.73 42.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 1.06 110.724 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.23 135.33 34.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.348 -0.387 . . . . 1.05 110.374 179.713 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.1 p -133.12 16.68 4.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 1.07 110.499 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.7 p -167.54 147.12 5.08 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.617 -0.512 . . . . 0.92 109.617 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.506 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.12 150.49 12.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.495 -0.482 . . . . 1.09 111.538 -179.636 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.32 124.8 50.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 1.31 109.833 179.452 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.513 HG21 HD21 ' A' ' 172' ' ' LEU . 1.8 mt -99.31 104.93 29.7 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.915 0.388 . . . . 1.09 111.077 -179.909 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.2 Cg_endo -91.02 -179.47 1.48 Allowed 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 123.177 2.585 . . . . 0.48 112.18 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.69 32.59 18.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.382 -0.826 . . . . 1.26 111.422 179.276 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.513 HD21 HG21 ' A' ' 169' ' ' ILE . 24.1 mt -86.31 148.53 25.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.52 -0.309 . . . . 1.12 110.501 179.562 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.771 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.34 114.84 61.28 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.041 0.448 . . . . 1.3 110.631 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.0 140.6 96.09 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.871 2.381 . . . . 0.92 111.94 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.03 21.2 74.47 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.032 -0.827 . . . . 0.44 111.032 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.452 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.81 150.31 49.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.784 0.326 . . . . 3.05 110.677 179.882 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.502 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.28 131.58 46.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.097 -0.501 . . . . 1.48 109.773 179.377 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.939 ' CE2' HD21 ' A' ' 148' ' ' LEU . 75.2 m-85 -120.45 148.31 43.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.111 -0.495 . . . . 0.89 111.022 -179.806 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.32 125.36 60.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.271 -1.011 . . . . 1.12 108.271 177.726 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.55 132.45 63.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.139 0.495 . . . . 1.1 111.218 -178.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.46 20.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.594 -0.73 . . . . 0.43 109.682 179.286 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.591 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.7 t -100.84 125.32 54.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.291 -0.413 . . . . 1.07 110.798 -179.585 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.806 ' CD2' ' NH2' ' A' ' 143' ' ' ARG . 48.5 m-85 -117.18 137.84 52.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.103 -0.499 . . . . 0.92 109.875 179.535 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.62 135.03 42.69 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.853 -0.795 . . . . 0.49 108.853 178.814 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' A' ' 140' ' ' SER . 84.8 mt -99.09 122.93 51.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.1 0.476 . . . . 1.08 110.923 -178.724 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.451 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.1 p -83.91 169.75 14.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.566 -0.743 . . . . 0.89 110.481 -179.702 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -59.82 -14.47 15.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.096 -0.502 . . . . 1.6 110.938 -179.539 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.451 ' H ' ' HG ' ' A' ' 186' ' ' SER . 88.4 m-20 -96.11 -4.25 43.15 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.863 -0.335 . . . . 1.18 110.758 -179.804 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.44 ' N ' ' HB ' ' A' ' 59' ' ' THR . . . 87.75 13.84 64.18 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.431 -0.668 . . . . 0.34 111.431 179.884 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -84.62 139.0 32.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.622 0.248 . . . . 1.22 110.443 179.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.804 ' NE2' ' HE ' ' A' ' 143' ' ' ARG . 86.6 mt-30 -106.62 141.02 38.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.871 0.367 . . . . 1.44 110.639 179.682 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.6 m -136.68 127.04 26.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 1.39 110.431 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.672 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.4 tp -68.17 117.35 9.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.348 -0.387 . . . . 1.08 110.507 -179.885 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.647 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.1 pt -109.1 -21.81 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.125 -0.489 . . . . 1.08 110.652 -179.674 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.9 125.68 5.84 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.489 -0.484 . . . . 1.1 111.479 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.495 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.73 120.33 21.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.756 -0.656 . . . . 0.94 109.504 179.165 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.67 151.67 29.04 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.659 -0.416 . . . . 1.07 110.952 -179.314 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.45 158.58 18.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.523 . . . . 0.89 110.467 179.707 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.08 157.93 43.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.046 -0.525 . . . . 0.67 110.527 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.21 104.41 9.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.728 -0.669 . . . . 1.17 110.088 179.44 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.474 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.4 p . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 117.839 -1.077 . . . . 1.26 110.659 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.219 -0.66 . . . . 3.83 109.219 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.36 150.81 18.52 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.012 -0.835 . . . . 1.39 111.012 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -35.81 142.43 0.11 Allowed 'Trans proline' 0 C--N 1.297 -2.141 0 C-N-CA 123.975 3.117 . . . . 0.86 113.761 -179.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.572 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.1 t -79.9 173.4 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.196 -1.365 . . . . 1.43 108.839 178.425 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.62 125.9 51.52 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.412 -0.515 . . . . 1.94 111.421 -179.662 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.47 144.01 33.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.613 -0.721 . . . . 1.19 110.649 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.01 168.33 25.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.837 0.351 . . . . 3.92 111.215 -179.762 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.584 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 65.9 mt -108.95 131.16 60.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.053 -0.521 . . . . 3.88 110.074 179.864 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.8 p -141.26 162.25 35.93 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.835 0.35 . . . . 3.92 111.223 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 9' ' ' THR . 98.0 mt-10 36.21 31.51 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.636 -0.505 . . . . 6.08 109.636 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.584 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.66 32.71 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.939 -0.573 . . . . 4.01 111.587 -178.787 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.641 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.24 -29.28 73.21 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.529 2.153 . . . . 4.51 111.82 179.391 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.641 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.71 125.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 3.51 110.43 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.631 ' CG ' HE22 ' A' ' 191' ' ' GLN . 10.2 mp0 -124.05 158.28 60.97 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.405 . . . . 4.3 110.432 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.555 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 96.4 Cg_endo -81.94 -64.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.935 2.423 . . . . 1.96 113.547 -179.037 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.813 ' ND2' ' CD1' ' A' ' 157' ' ' TYR . 7.3 m-20 -108.39 -19.55 13.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.262 -0.426 . . . . 3.33 112.084 -178.551 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 37.5 t -107.3 152.08 24.61 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.488 -0.485 . . . . 1.53 111.322 -179.435 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.573 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.29 102.92 2.23 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.716 -0.675 . . . . 2.29 110.705 179.803 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.63 145.68 13.12 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.928 2.419 . . . . 0.88 112.522 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.408 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.9 168.02 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.86 -0.609 . . . . 2.12 109.919 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.17 147.94 29.04 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.736 -0.468 . . . . 2.67 109.736 178.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.501 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.6 p90 -142.26 157.27 45.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.994 0.426 . . . . 0.32 111.229 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.467 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.8 m-20 -128.02 155.27 44.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.86 -0.609 . . . . 2.77 110.163 178.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.6 172.95 6.48 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.082 0.467 . . . . 1.25 110.777 -179.197 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.59 173.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.836 2.357 . . . . 1.12 111.597 179.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.06 -51.01 0.69 Allowed Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.729 -0.388 . . . . 4.05 110.051 179.89 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.65 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.83 152.37 82.39 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.797 2.331 . . . . 2.12 111.449 179.22 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.78 42.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.433 0.635 . . . . 2.85 110.554 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.813 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.65 -41.65 98.21 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.019 -0.991 . . . . 3.11 110.702 179.727 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.44 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.4 mt -109.84 137.86 40.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.659 -0.701 . . . . 1.86 111.24 -179.437 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.96 -72.89 0.7 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.017 -0.538 . . . . 1.61 111.933 -179.018 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.12 148.28 24.51 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.594 0.59 . . . . 1.67 112.594 -179.661 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.74 124.83 45.16 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.43 -0.582 . . . . 1.07 109.43 177.432 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.02 134.75 60.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.612 -0.435 . . . . 1.55 110.611 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.487 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -119.97 128.65 53.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.042 0.448 . . . . 1.33 111.309 179.674 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.548 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.19 139.02 49.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.679 -0.692 . . . . 2.36 110.114 178.967 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.418 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.2 p90 -145.0 163.15 35.07 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.119 0.485 . . . . 0.38 112.099 -178.094 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.49 139.6 7.86 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.406 -0.816 . . . . 2.31 110.533 178.728 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.686 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.8 Cg_endo -63.43 115.39 2.99 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.313 2.008 . . . . 0.86 111.893 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.676 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.89 81.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.92 -0.4 . . . . 3.44 109.92 -179.856 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.686 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.023 -0.535 . . . . 2.72 111.875 -179.41 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.2 p -157.63 157.87 34.44 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.787 -0.365 . . . . 2.78 110.506 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.45 27.83 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.478 . . . . 2.3 110.164 179.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.8 -75.87 1.31 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.157 -0.544 . . . . 1.8 111.859 -179.255 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.89 152.29 35.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 5.48 111.037 -179.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.637 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.23 -169.17 2.55 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.041 -0.527 . . . . 1.84 111.928 179.422 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.412 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.13 149.69 29.69 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.397 0.617 . . . . 2.27 112.615 -177.854 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.01 156.46 46.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.891 -1.05 . . . . 1.92 110.326 178.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.19 158.37 41.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.038 -0.528 . . . . 1.09 111.85 -179.317 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.8 m -115.17 135.67 53.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.5 -0.773 . . . . 1.16 109.815 179.296 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.445 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.43 122.01 23.75 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.515 -0.311 . . . . 1.39 111.511 -179.141 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.4 Cg_exo -46.48 151.81 1.71 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.668 2.245 . . . . 0.72 112.083 179.04 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.91 -23.08 63.13 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 116.033 -0.53 . . . . 0.74 112.821 -179.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.515 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.5 p-80 -82.79 -16.77 46.56 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.167 -0.613 . . . . 1.26 111.762 -178.293 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.49 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.69 138.47 31.54 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.766 -0.374 . . . . 1.59 110.266 179.399 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.61 13.93 10.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.409 -0.36 . . . . 2.07 111.476 -179.341 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -150.0 143.47 25.2 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.65 -0.42 . . . . 0.96 111.093 179.522 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.9 t80 -114.77 -169.32 1.52 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.263 0.554 . . . . 1.0 110.853 -179.386 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.714 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 5.4 p -151.83 125.95 9.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.403 -0.817 . . . . 1.19 109.737 179.284 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.428 HD11 HG23 ' A' ' 60' ' ' ILE . 66.7 mt -114.97 123.32 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.278 -0.569 . . . . 1.47 111.146 -179.797 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.628 ' HZ2' ' HA3' ' A' ' 141' ' ' GLY . 55.9 mtpt -126.57 163.41 23.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.835 -0.621 . . . . 3.0 110.371 179.776 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.04 19.04 59.9 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.743 -0.943 . . . . 0.5 110.743 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.433 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.4 mt -79.08 157.27 28.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.125 0.488 . . . . 1.21 111.361 -179.694 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.623 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -99.49 133.9 21.57 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.562 -0.744 . . . . 3.2 110.406 179.838 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.421 ' HD3' ' CE2' ' A' ' 157' ' ' TYR . 36.9 Cg_endo -67.84 143.56 61.6 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.563 2.175 . . . . 1.09 111.893 179.799 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.88 25.58 75.39 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.999 -0.841 . . . . 0.72 110.999 179.649 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.643 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.16 158.82 39.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.689 0.28 . . . . 1.47 110.426 -179.641 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.12 139.98 41.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.344 -0.389 . . . . 1.23 110.637 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.643 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.6 m-85 -122.63 136.39 54.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 1.1 110.753 -179.878 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.3 pt-20 -98.83 130.95 45.27 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.51 -0.922 . . . . 1.87 108.51 177.615 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.488 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.42 153.86 16.63 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.365 -0.922 . . . . 0.39 112.082 -178.711 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.98 140.86 46.02 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.709 -0.478 . . . . 1.8 109.709 179.647 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.469 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.3 tp -115.69 118.91 34.38 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.493 -0.483 . . . . 1.11 110.526 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.9 mt -112.48 129.08 68.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.298 -0.41 . . . . 1.51 110.648 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.82 120.8 43.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.325 -0.398 . . . . 1.47 110.669 -179.558 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.671 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.56 146.4 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.089 0.471 . . . . 1.33 111.098 -179.299 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.813 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.1 mt-30 -106.01 153.86 21.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.601 -0.727 . . . . 2.49 109.989 179.798 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.11 88.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.899 0.38 . . . . 4.2 110.439 -179.756 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.3 32.66 0.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.791 -0.64 . . . . 6.4 110.539 -179.915 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.16 -117.29 3.27 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.464 -0.654 . . . . 1.74 111.464 -179.765 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.451 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.1 m170 -81.5 177.45 8.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.234 0.54 . . . . 3.64 111.571 -179.173 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.1 149.59 32.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.392 -0.822 . . . . 1.7 110.406 179.18 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.19 144.58 38.6 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.453 -0.34 . . . . 2.7 110.629 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.96 136.02 61.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 120.582 -0.447 . . . . 1.16 111.536 -179.76 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.06 141.3 52.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.671 -0.695 . . . . 1.14 110.347 179.595 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.461 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.55 138.88 51.62 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 120.588 -0.445 . . . . 4.33 111.546 -179.329 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.35 164.17 38.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.604 -0.725 . . . . 0.91 109.474 179.336 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.571 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.24 151.62 38.67 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.4 -0.52 . . . . 1.47 111.065 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.573 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.3 p90 -146.28 172.63 13.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.727 -0.67 . . . . 0.51 111.047 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.444 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.5 t -118.68 160.72 21.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.485 -0.78 . . . . 1.92 109.846 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.444 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.39 121.89 22.97 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.558 -0.457 . . . . 1.63 110.784 179.913 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.601 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.8 p -128.0 162.8 25.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.14 -0.482 . . . . 2.37 111.126 179.706 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.6 t -114.4 136.01 53.46 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.914 -0.402 . . . . 3.63 109.914 178.427 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.2 t -141.67 159.74 41.61 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.993 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 92.3 p -123.18 151.95 41.69 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.45 135.48 8.74 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.417 -179.926 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.03 146.58 95.7 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.871 1.714 . . . . 0.0 111.417 179.066 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.592 ' C ' ' H ' ' A' ' 100' ' ' SER . 74.6 t -60.09 -42.41 89.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.339 -179.806 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 90.5 m 50.59 -2.85 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 178.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.592 ' H ' ' C ' ' A' ' 98' ' ' VAL . 16.5 m -62.53 152.71 33.96 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.907 -179.258 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -57.47 -34.03 68.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.818 179.72 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.3 p -121.69 164.84 16.7 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.801 -179.488 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.5 p -105.87 17.38 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.063 -179.834 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.4 t -134.43 159.14 41.99 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.222 179.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.9 137.05 41.13 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.661 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -59.96 -34.19 72.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.741 0.305 . . . . 0.0 110.894 -179.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.1 p -84.48 160.68 20.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.017 0.437 . . . . 0.0 111.173 -179.37 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.6 m -72.06 137.97 81.99 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.183 179.664 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.03 145.48 41.68 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.47 1.447 . . . . 0.0 111.403 179.173 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.542 ' O ' ' O ' ' A' ' 111' ' ' SER . 99.0 m-85 -88.84 -2.5 58.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.057 -179.422 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.542 ' O ' ' O ' ' A' ' 110' ' ' PHE . 45.1 p 55.47 132.3 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.575 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.69 143.36 98.76 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.681 1.587 . . . . 0.0 111.711 -179.186 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 66.5 mt -60.18 -35.76 76.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 10.52 110.552 -179.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.7 p -133.16 142.71 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.229 -0.441 . . . . 7.48 110.781 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.68 146.17 54.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 7.69 110.252 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.0 p -121.12 160.81 22.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.863 0.363 . . . . 6.46 110.76 -179.847 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.6 t -122.39 145.4 48.31 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.766 -0.652 . . . . 4.59 110.307 -179.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -103.69 148.42 26.07 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.363 -0.38 . . . . 3.21 110.543 179.889 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.559 ' O ' ' O ' ' A' ' 120' ' ' VAL . 20.5 m -59.32 -35.31 73.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 3.64 111.15 -179.733 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.559 ' O ' ' O ' ' A' ' 119' ' ' SER . 57.6 t 51.7 151.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.165 -0.47 . . . . 3.39 111.029 -179.584 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.3 m 43.89 41.26 3.74 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.175 -0.466 . . . . 2.23 110.614 -179.458 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -105.03 139.78 39.2 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.111 -0.495 . . . . 4.53 110.659 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.9 mt -115.47 135.15 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.013 -0.54 . . . . 2.01 109.66 179.552 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.9 t -135.56 158.78 43.53 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.944 0.402 . . . . 2.22 111.196 -179.529 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -73.18 -147.24 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.752 -0.658 . . . . 1.29 110.317 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.4 p -59.2 -27.93 66.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 1.25 110.278 -179.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.47 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.88 167.54 0.26 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.917 -0.583 . . . . 1.16 110.916 179.932 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.53 145.51 50.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.707 -0.679 . . . . 0.78 110.196 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.21 101.74 9.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.064 -0.717 . . . . 1.08 109.064 177.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.461 HG11 ' N ' ' A' ' 131' ' ' SER . 71.2 t -112.99 139.75 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.03 -0.532 . . . . 1.1 111.008 -178.902 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.461 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.4 p -128.76 152.54 48.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.574 -0.739 . . . . 0.87 109.746 179.615 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.645 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.6 p90 -144.8 -164.96 2.04 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.657 -0.417 . . . . 0.37 110.578 -179.781 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -124.0 127.22 73.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.122 -0.49 . . . . 1.14 110.793 -179.794 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.175 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -58.1 58.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.141 -0.481 . . . . 1.91 110.299 179.918 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.18 24.52 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.863 -0.608 . . . . 1.56 111.476 -179.674 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.175 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.14 128.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.654 -0.418 . . . . 1.56 111.0 179.842 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.39 -9.56 56.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.931 -0.577 . . . . 1.88 110.352 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.6 p -87.1 0.17 55.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.073 -0.512 . . . . 1.63 110.297 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.96 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.22 137.22 25.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.977 -0.556 . . . . 1.11 109.972 179.69 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.589 ' N ' ' O ' ' A' ' 185' ' ' ILE . 72.3 m -96.22 -15.66 21.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.296 0.569 . . . . 1.01 110.055 -179.674 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.628 ' HA3' ' HZ2' ' A' ' 61' ' ' LYS . . . 178.67 175.63 45.9 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 109.888 -1.285 . . . . 0.14 109.888 179.57 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.4 151.69 42.34 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.605 -0.438 . . . . 0.21 110.501 179.719 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.847 HH12 ' NE2' ' A' ' 191' ' ' GLN . 52.9 ttp180 -132.37 121.27 23.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.128 -0.487 . . . . 1.54 109.883 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.496 HG23 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.1 136.49 38.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.698 -0.683 . . . . 1.08 110.693 -179.826 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 82.7 tt0 -129.34 129.89 45.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.973 -0.558 . . . . 1.32 110.047 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.71 135.28 34.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.053 -0.521 . . . . 1.05 110.623 -179.706 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.414 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.33 161.27 40.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.773 -0.649 . . . . 1.16 109.705 179.84 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.94 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.0 mt -71.0 124.91 25.45 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.641 -0.424 . . . . 1.23 110.751 -179.568 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.76 -7.72 49.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.763 -0.653 . . . . 0.86 110.913 -179.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -109.77 -69.69 0.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 1.66 111.393 -179.28 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.455 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.4 mt-10 -60.64 -35.39 76.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.003 -0.544 . . . . 1.66 111.45 -179.077 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.089 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.15 88.64 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.785 -0.926 . . . . 1.62 110.785 -179.793 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.315 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.3 t0 -27.94 -171.71 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.725 0.297 . . . . 1.86 110.283 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.315 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.14 45.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.043 0.449 . . . . 1.98 110.224 179.595 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.414 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 45.4 Cg_endo -70.96 145.88 51.34 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.729 2.286 . . . . 0.62 112.248 -179.467 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.83 145.75 42.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.228 -0.656 . . . . 1.14 109.228 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.813 ' CD1' ' ND2' ' A' ' 16' ' ' ASN . 21.3 p90 -123.31 141.33 52.1 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.377 -0.529 . . . . 1.44 111.491 -179.115 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.422 ' HA ' HD22 ' A' ' 158' ' ' LEU . 71.6 mt -128.16 127.71 43.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.269 -0.878 . . . . 1.08 108.872 178.926 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.499 ' OD1' ' O ' ' A' ' 159' ' ' ASP . 54.2 p-10 -101.62 131.1 48.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.195 0.522 . . . . 1.09 111.751 -178.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.502 HD13 ' HB ' ' A' ' 167' ' ' VAL . 5.9 mt -127.87 157.55 73.29 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.318 -0.855 . . . . 1.04 109.617 179.653 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -69.89 158.07 58.01 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.297 1.998 . . . . 0.21 112.251 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.2 p -59.25 -12.16 5.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.785 -0.643 . . . . 0.88 110.684 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.78 -8.8 42.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 1.06 110.7 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.24 135.39 34.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 1.05 110.351 179.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.7 p -133.09 16.65 4.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.388 -0.369 . . . . 1.07 110.573 179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.3 p -167.56 147.17 5.07 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.59 -0.522 . . . . 0.92 109.59 179.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.502 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.21 150.55 12.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.532 -0.467 . . . . 1.09 111.535 -179.658 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.497 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.38 124.9 50.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.572 -0.74 . . . . 1.31 109.851 179.463 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.516 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.33 104.85 29.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.385 -0.37 . . . . 1.09 111.062 -179.818 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -90.96 -179.58 1.52 Allowed 'Trans proline' 0 C--N 1.301 -1.951 0 C-N-CA 123.28 2.653 . . . . 0.48 112.211 179.909 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.73 32.64 18.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.407 -0.815 . . . . 1.26 111.449 179.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.516 HD21 HG21 ' A' ' 169' ' ' ILE . 24.2 mt -86.33 148.44 25.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.551 -0.295 . . . . 1.12 110.509 179.592 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.771 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.4 mt -88.17 114.89 61.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.349 -0.387 . . . . 1.3 110.702 -179.75 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.12 140.63 95.91 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.744 2.296 . . . . 0.92 111.99 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.14 21.15 74.26 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.012 -0.835 . . . . 0.44 111.012 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.455 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.86 150.24 49.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.847 0.356 . . . . 3.05 110.682 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.501 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.26 131.65 46.08 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.044 -0.525 . . . . 1.48 109.733 179.426 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.94 ' CE2' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.55 148.3 44.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.064 -0.516 . . . . 0.89 111.048 -179.84 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.3 mt -105.31 125.41 60.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.218 -1.03 . . . . 1.12 108.218 177.787 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.61 132.43 63.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.13 0.491 . . . . 1.1 111.285 -178.632 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.41 122.46 20.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.519 -0.764 . . . . 0.43 109.655 179.369 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.594 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.95 125.44 54.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.3 -0.409 . . . . 1.07 110.632 -179.516 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.673 ' CE1' HD11 ' A' ' 193' ' ' LEU . 49.4 m-85 -117.31 137.89 52.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.981 -0.554 . . . . 0.92 109.802 179.53 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.68 135.08 42.69 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.776 -0.824 . . . . 0.49 108.776 178.837 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 140' ' ' SER . 78.1 mt -99.13 122.93 51.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.126 0.489 . . . . 1.08 111.003 -178.805 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.449 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.9 p -83.9 169.71 14.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.546 -0.752 . . . . 0.89 110.489 -179.646 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.612 ' O ' ' CG2' ' A' ' 59' ' ' THR . 97.8 mt-10 -59.74 -14.52 14.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.08 -0.509 . . . . 1.6 111.01 -179.564 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.449 ' H ' ' HG ' ' A' ' 186' ' ' SER . 91.4 m-20 -96.02 -4.32 43.34 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.837 -0.345 . . . . 1.18 110.868 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.8 13.9 63.97 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.329 -0.708 . . . . 0.34 111.329 179.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -84.72 139.0 32.31 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.01 -0.276 . . . . 1.22 110.462 179.652 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.847 ' NE2' HH12 ' A' ' 143' ' ' ARG . 2.3 mt-30 -106.61 141.11 38.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.877 0.37 . . . . 1.44 110.536 179.789 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.0 m -136.8 127.0 26.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 1.39 110.386 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.673 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.3 tp -68.17 117.2 9.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.318 -0.401 . . . . 1.08 110.549 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.645 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.1 pt -108.94 -21.84 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 1.08 110.7 -179.694 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.86 125.76 5.9 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.559 -0.456 . . . . 1.1 111.513 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.484 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.69 120.2 21.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.756 -0.656 . . . . 0.94 109.585 179.189 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.65 29.05 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.718 -0.393 . . . . 1.07 110.87 -179.264 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.36 158.57 18.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.89 110.48 179.664 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -146.09 158.01 43.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.095 -0.502 . . . . 0.67 110.648 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.35 9.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.772 -0.649 . . . . 1.17 110.013 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.477 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 66.7 p . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.94 -1.028 . . . . 1.26 110.66 -179.686 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.2 m . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.206 -0.664 . . . . 3.83 109.206 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.438 ' H ' ' HB3' ' A' ' 1' ' ' SER . . . -116.33 150.73 18.54 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.999 -0.841 . . . . 1.39 110.999 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.62 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.061 0 C-N-CA 123.98 3.12 . . . . 0.86 113.788 -179.236 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.561 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.1 t -80.02 173.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.329 -1.305 . . . . 1.43 108.772 178.412 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.404 ' H ' ' CG1' ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.63 125.89 51.51 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.41 -0.516 . . . . 1.94 111.438 -179.558 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.55 143.93 34.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.656 -0.702 . . . . 1.19 110.662 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.95 168.37 25.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.934 0.397 . . . . 3.92 110.996 -179.625 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.579 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.98 131.08 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.893 -0.594 . . . . 3.88 110.057 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.18 162.37 35.66 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.828 0.347 . . . . 3.92 111.253 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.2 mt-10 35.93 31.74 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.159 0.504 . . . . 6.08 109.696 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.579 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.57 69.58 33.92 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.814 -0.63 . . . . 4.01 111.492 -178.728 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.615 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.23 -29.16 73.24 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.444 2.096 . . . . 4.51 111.794 179.318 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.615 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.68 125.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.228 -0.442 . . . . 3.51 110.447 -179.926 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 17' ' ' SER . 3.1 mp0 -123.91 158.31 60.48 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 4.3 110.494 179.852 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.469 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 97.6 Cg_endo -81.93 -64.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.0 2.467 . . . . 1.96 113.532 -179.005 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.716 ' CG ' ' CD1' ' A' ' 157' ' ' TYR . 66.5 t30 -108.37 -19.64 13.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.268 -0.424 . . . . 3.33 112.08 -178.559 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 29.1 t -107.3 152.08 24.61 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.46 -0.496 . . . . 1.53 111.339 -179.398 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.33 102.98 2.22 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.734 -0.666 . . . . 2.29 110.583 179.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.69 145.6 12.99 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.93 2.42 . . . . 0.88 112.569 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 pt -130.8 167.9 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.916 -0.584 . . . . 2.12 109.835 179.563 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.15 147.97 29.08 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.756 -0.461 . . . . 2.67 109.756 178.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.496 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.6 p90 -142.24 157.28 45.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.026 0.441 . . . . 0.32 111.235 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.473 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.0 155.35 44.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.83 -0.623 . . . . 2.77 110.176 178.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.62 173.05 6.34 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.145 0.498 . . . . 1.25 110.682 -179.129 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.71 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.851 2.368 . . . . 1.12 111.501 179.367 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.48 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.98 -51.06 0.69 Allowed Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 120.767 -0.373 . . . . 4.05 110.139 179.856 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.65 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.9 152.31 82.7 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.782 2.322 . . . . 2.12 111.428 179.232 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.73 42.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.388 0.613 . . . . 2.85 110.526 -179.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.82 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.58 -41.64 98.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.988 -1.005 . . . . 3.11 110.685 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.443 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.6 mt -109.93 137.84 40.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.771 -0.649 . . . . 1.86 111.31 -179.488 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.0 -72.83 0.71 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.022 -0.536 . . . . 1.61 111.851 -178.948 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.24 148.33 24.4 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.604 0.594 . . . . 1.67 112.604 -179.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.84 124.93 45.31 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.307 -0.627 . . . . 1.07 109.307 177.572 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.8 mt -118.09 134.77 60.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.589 -0.444 . . . . 1.55 110.685 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.481 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -120.06 128.61 53.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.036 0.446 . . . . 1.33 111.216 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.549 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.08 138.98 49.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.809 -0.632 . . . . 2.36 110.104 178.981 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.417 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.03 163.22 34.89 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 121.168 0.509 . . . . 0.38 112.126 -178.222 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.494 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.47 139.62 7.89 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.444 -0.798 . . . . 2.31 110.449 178.861 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.68 115.62 3.17 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.261 1.974 . . . . 0.86 111.781 179.998 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.02 81.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.879 -0.415 . . . . 3.44 109.879 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.23 -20.49 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.053 -0.522 . . . . 2.72 111.898 -179.546 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 p -157.7 157.79 34.17 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.803 -0.359 . . . . 2.78 110.527 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.4 m -120.34 27.76 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 2.3 110.179 179.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.69 -76.05 1.32 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.793 -0.523 . . . . 1.8 111.793 -179.211 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.88 152.33 35.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.922 0.391 . . . . 5.48 111.023 -179.323 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.642 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.06 2.51 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.081 -0.509 . . . . 1.84 111.948 179.372 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.17 149.66 29.77 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 112.59 0.589 . . . . 2.27 112.59 -177.812 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.01 156.45 46.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.826 -1.079 . . . . 1.92 110.268 178.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.21 158.34 41.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.961 -0.563 . . . . 1.09 111.778 -179.37 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 m -115.2 135.63 53.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.44 -0.8 . . . . 1.16 109.759 179.291 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.442 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.31 121.98 23.89 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.341 -0.39 . . . . 1.39 111.576 -179.157 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.518 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.5 Cg_exo -46.42 151.69 1.71 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.731 2.287 . . . . 0.72 112.068 179.052 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.8 -23.15 62.96 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 116.053 -0.521 . . . . 0.74 112.783 -179.258 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.518 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.1 p-80 -82.66 -17.02 46.08 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.264 -0.574 . . . . 1.26 111.798 -178.294 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.497 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.54 138.4 31.6 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.745 -0.382 . . . . 1.59 110.29 179.506 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.51 13.93 11.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.487 -0.324 . . . . 2.07 111.558 -179.385 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -150.04 143.54 25.21 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.633 -0.427 . . . . 0.96 111.016 179.598 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.718 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.9 t80 -114.87 -169.35 1.53 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.209 0.528 . . . . 1.0 110.836 -179.336 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.718 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.78 125.9 9.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.389 -0.823 . . . . 1.19 109.806 179.278 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.454 HD11 HG23 ' A' ' 60' ' ' ILE . 66.8 mt -114.9 123.33 70.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.328 -0.549 . . . . 1.47 111.111 -179.759 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.513 ' HZ1' ' CG1' ' A' ' 185' ' ' ILE . 51.6 mtpt -126.57 163.31 23.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.788 -0.642 . . . . 3.0 110.491 179.667 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.44 ' HA2' HD22 ' A' ' 16' ' ' ASN . . . 85.25 18.91 59.83 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.749 -0.941 . . . . 0.5 110.749 -179.876 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.581 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 74.1 mt -79.12 157.34 27.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.099 0.476 . . . . 1.21 111.381 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.631 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 8.7 mttm -99.55 133.94 21.51 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.642 -0.708 . . . . 3.2 110.416 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.85 143.66 61.91 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.538 2.159 . . . . 1.09 111.931 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.82 25.44 75.56 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.098 -0.801 . . . . 0.72 111.098 179.716 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.64 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.0 158.82 39.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.755 0.312 . . . . 1.47 110.419 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.12 139.94 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.307 -0.406 . . . . 1.23 110.642 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.64 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.58 136.54 54.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.534 . . . . 1.1 110.704 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.494 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -99.0 131.17 45.25 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.422 -0.955 . . . . 1.87 108.422 177.647 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.488 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.66 153.84 16.69 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.246 -0.978 . . . . 0.39 111.907 -178.595 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.94 140.9 46.1 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.734 -0.469 . . . . 1.8 109.734 179.584 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.469 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.1 tp -115.75 118.89 34.31 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.462 -0.495 . . . . 1.11 110.522 179.679 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.2 mt -112.4 129.18 68.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.282 -0.417 . . . . 1.51 110.6 -179.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.9 120.83 43.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.227 -0.442 . . . . 1.47 110.698 -179.677 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.675 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.58 146.42 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.22 0.533 . . . . 1.33 111.018 -179.269 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.82 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.02 153.9 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.472 -0.786 . . . . 2.49 109.864 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.434 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.05 88.47 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.875 0.369 . . . . 4.2 110.499 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.631 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.26 32.63 0.21 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.868 -0.605 . . . . 6.4 110.625 -179.867 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.14 -117.28 3.28 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.447 -0.661 . . . . 1.74 111.447 -179.746 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.454 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.39 177.35 9.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.126 0.489 . . . . 3.64 111.681 -179.218 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.14 149.56 32.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.454 -0.794 . . . . 1.7 110.367 179.162 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.19 144.68 38.64 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.484 -0.325 . . . . 2.7 110.593 179.865 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -128.04 135.93 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.065 0.46 . . . . 1.16 111.53 -179.706 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -123.98 141.3 52.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.625 -0.716 . . . . 1.14 110.247 179.692 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.473 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.61 138.87 51.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.091 0.472 . . . . 4.33 111.527 -179.421 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.31 164.22 37.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.55 -0.75 . . . . 0.91 109.455 179.393 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.576 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.28 151.56 38.54 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.384 -0.526 . . . . 1.47 110.985 -179.962 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.574 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.9 p90 -146.24 172.72 13.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.75 -0.659 . . . . 0.51 111.013 179.84 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.446 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.73 160.71 21.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.431 -0.804 . . . . 1.92 109.889 179.572 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.446 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.34 121.82 22.92 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.612 -0.435 . . . . 1.63 110.757 -179.995 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.457 ' OG1' ' N ' ' A' ' 93' ' ' SER . 70.3 p -129.54 -122.56 0.22 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.252 0.549 . . . . 2.37 112.0 179.609 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.457 ' N ' ' OG1' ' A' ' 92' ' ' THR . 8.1 t 86.19 6.47 0.37 Allowed 'General case' 0 C--N 1.347 0.457 0 CA-C-N 114.8 -1.091 . . . . 3.63 111.057 -179.707 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 44.4 p -106.41 10.72 31.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.792 179.44 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.2 m -56.89 -36.9 70.65 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.256 -178.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 40.2 p 44.3 64.8 6.75 Favored Pre-proline 0 N--CA 1.463 0.21 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.43 136.92 78.98 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.244 1.963 . . . . 0.0 113.371 -178.165 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.9 m -131.59 160.49 42.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.874 178.566 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 101' ' ' ASN . 40.8 m -72.2 127.96 34.19 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.388 -0.925 . . . . 0.0 108.654 179.445 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.7 p -88.13 -5.28 58.52 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.414 ' H ' HG22 ' A' ' 99' ' ' THR . 78.0 m-20 57.13 48.57 15.14 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.213 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.7 p -46.53 132.71 10.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.688 0.756 . . . . 0.0 112.703 -177.086 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.581 ' O ' ' O ' ' A' ' 106' ' ' GLU . 43.7 t -124.74 137.37 57.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.181 178.101 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 51.5 p -60.21 -38.81 84.47 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.617 -178.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.73 -38.0 95.75 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.331 -0.461 . . . . 0.0 112.198 179.417 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.581 ' O ' ' O ' ' A' ' 103' ' ' VAL . 84.7 tt0 -112.61 147.1 37.4 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.946 0.403 . . . . 0.0 111.662 -178.323 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.3 p -115.1 161.91 17.73 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.792 179.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.8 77.54 57.12 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.125 -179.006 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -57.13 150.49 56.72 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.343 2.029 . . . . 0.0 111.939 179.751 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -58.14 156.74 9.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.793 -179.757 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.0 t 72.44 64.11 0.36 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.541 -178.802 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.81 148.39 83.84 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.855 2.37 . . . . 0.0 112.219 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.5 mt -88.97 145.98 25.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.894 -0.593 . . . . 10.52 110.273 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.0 p -128.29 142.54 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.335 -0.393 . . . . 7.48 110.467 -179.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.31 147.37 28.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.036 -0.529 . . . . 7.69 111.413 -179.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.6 m -119.85 141.88 49.16 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.691 -0.686 . . . . 6.46 109.478 179.332 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 41.1 m -60.79 147.67 41.75 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.406 -0.518 . . . . 4.59 110.814 -179.014 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -72.51 -25.18 61.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.653 -0.703 . . . . 3.21 112.099 -179.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.9 m -119.38 149.34 41.99 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.312 0.577 . . . . 3.64 112.254 -178.186 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 43.0 t -116.38 138.19 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 115.068 -0.969 . . . . 3.39 109.33 179.302 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.1 p -116.53 161.83 18.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.239 0.543 . . . . 2.23 111.474 -178.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -58.67 145.37 40.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.306 -0.861 . . . . 4.53 111.537 -179.51 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 17.0 tt -120.6 138.92 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 115.625 -0.716 . . . . 2.01 110.022 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.496 ' O ' ' OG ' ' A' ' 126' ' ' SER . 15.8 p -118.46 165.67 13.62 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.341 -0.39 . . . . 2.22 110.408 -179.627 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 127' ' ' SER . . . -29.62 -74.88 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.258 0.836 . . . . 1.29 113.258 -178.39 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 43.8 17.23 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.124 0.964 . . . . 1.25 110.191 -178.206 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.79 167.54 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.676 -1.147 . . . . 1.16 110.955 -179.956 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.486 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.9 m-30 -133.55 145.65 50.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.626 -0.715 . . . . 0.78 110.087 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.38 101.65 9.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.027 -0.731 . . . . 1.08 109.027 177.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.466 HG11 ' N ' ' A' ' 131' ' ' SER . 71.4 t -112.9 139.66 36.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.018 -0.537 . . . . 1.1 111.049 -178.837 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.466 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.0 p -128.7 152.5 48.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.598 -0.728 . . . . 0.87 109.83 179.588 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.647 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.9 p90 -144.74 -164.86 2.01 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.738 -0.385 . . . . 0.37 110.727 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -124.01 127.18 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.259 -0.428 . . . . 1.14 110.838 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.144 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.97 58.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 1.91 110.292 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.2 24.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.993 -0.549 . . . . 1.56 111.514 -179.66 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.144 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.14 128.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.639 -0.425 . . . . 1.56 110.961 179.828 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.47 -9.57 55.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.918 -0.583 . . . . 1.88 110.357 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.2 p -87.06 0.17 55.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 1.63 110.332 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.965 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.29 137.19 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.951 -0.568 . . . . 1.11 110.009 179.776 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 185' ' ' ILE . 84.8 p -96.16 -15.58 22.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.355 0.597 . . . . 1.01 110.062 -179.602 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.61 175.59 45.81 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 109.882 -1.287 . . . . 0.14 109.882 179.651 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.42 151.49 42.57 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.701 -0.4 . . . . 0.21 110.558 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.841 ' NH2' ' CD2' ' A' ' 183' ' ' TYR . 66.7 ttp85 -132.27 121.27 23.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.19 -0.459 . . . . 1.54 109.94 179.751 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.485 HG23 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.1 136.62 38.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.738 -0.664 . . . . 1.08 110.695 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 21.7 tp10 -129.46 129.85 45.13 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.004 -0.543 . . . . 1.32 110.013 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.593 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.4 p90 -138.74 135.26 34.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.983 -0.553 . . . . 1.05 110.537 -179.678 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.406 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.28 161.34 39.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.729 -0.669 . . . . 1.16 109.679 179.766 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.939 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.3 mt -70.96 124.77 25.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.04 0.448 . . . . 1.23 110.772 -179.624 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.504 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.76 -7.62 49.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.737 -0.665 . . . . 0.86 110.908 -179.781 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -109.83 -69.69 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.304 -0.407 . . . . 1.66 111.433 -179.314 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.433 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.72 -35.26 75.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.056 -0.52 . . . . 1.66 111.529 -179.119 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.096 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.19 88.62 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.828 -0.909 . . . . 1.62 110.828 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.318 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -28.06 -171.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 1.86 110.317 179.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.318 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.16 139.05 45.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 1.98 110.237 179.61 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.406 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.91 145.82 51.49 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 122.702 2.268 . . . . 0.62 112.366 -179.554 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.593 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.8 145.7 42.6 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.287 -0.635 . . . . 1.14 109.287 179.235 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.716 ' CD1' ' CG ' ' A' ' 16' ' ' ASN . 49.3 p90 -123.29 141.43 51.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.209 0.528 . . . . 1.44 111.489 -179.069 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.6 mt -128.17 127.61 43.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.25 -0.886 . . . . 1.08 108.988 178.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 40.7 t0 -101.67 131.22 48.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.202 0.525 . . . . 1.09 111.679 -178.698 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.578 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -127.88 157.59 73.19 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.23 -0.896 . . . . 1.04 109.679 179.614 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.78 157.91 58.72 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 C-N-CA 122.51 2.14 . . . . 0.21 112.241 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.3 p -59.2 -12.18 4.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.781 -0.645 . . . . 0.88 110.768 -179.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.6 p -92.85 -8.69 42.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.068 -0.515 . . . . 1.06 110.717 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.29 135.46 34.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.349 -0.387 . . . . 1.05 110.349 179.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.4 p -133.19 16.64 4.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.402 -0.363 . . . . 1.07 110.531 -179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.7 p -167.55 147.09 5.06 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.651 -0.5 . . . . 0.92 109.651 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.509 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.18 150.51 12.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.462 -0.495 . . . . 1.09 111.588 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.492 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.38 125.02 50.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.626 -0.715 . . . . 1.31 109.772 179.483 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.508 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.42 104.88 29.77 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.334 -0.394 . . . . 1.09 111.036 -179.891 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -90.94 -179.49 1.51 Allowed 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 123.146 2.564 . . . . 0.48 112.277 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 61.64 32.7 18.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.373 -0.831 . . . . 1.26 111.479 179.315 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.508 HD21 HG21 ' A' ' 169' ' ' ILE . 24.2 mt -86.51 148.59 25.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.778 0.323 . . . . 1.12 110.388 179.632 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.765 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.35 114.86 61.36 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.093 0.473 . . . . 1.3 110.58 -179.648 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.05 140.59 95.93 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.974 2.449 . . . . 0.92 111.858 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.02 21.3 74.26 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.049 -0.821 . . . . 0.44 111.049 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.433 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.9 150.16 49.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.758 0.314 . . . . 3.05 110.584 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.504 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.22 131.64 46.05 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.018 -0.537 . . . . 1.48 109.767 179.327 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.939 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.55 148.26 44.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.091 -0.504 . . . . 0.89 111.049 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.1 mt -105.3 125.3 60.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.288 -1.004 . . . . 1.12 108.288 177.812 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.52 132.51 63.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.169 0.509 . . . . 1.1 111.261 -178.591 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.53 122.64 20.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.527 -0.76 . . . . 0.43 109.552 179.321 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.582 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.14 125.35 55.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.157 -0.474 . . . . 1.07 110.666 -179.545 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.841 ' CD2' ' NH2' ' A' ' 143' ' ' ARG . 48.3 m-85 -117.2 137.95 52.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.912 -0.586 . . . . 0.92 109.869 179.556 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.562 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.73 134.92 42.98 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.817 -0.808 . . . . 0.49 108.817 178.895 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' A' ' 140' ' ' SER . 51.6 mm -99.05 123.01 51.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.107 0.479 . . . . 1.08 110.962 -178.769 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.45 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.0 p -83.97 169.73 14.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.557 -0.747 . . . . 0.89 110.492 -179.698 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.84 -14.4 14.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.956 -0.566 . . . . 1.6 110.916 -179.448 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.45 ' H ' ' HG ' ' A' ' 186' ' ' SER . 94.2 m-20 -96.13 -4.28 43.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.839 0.352 . . . . 1.18 110.875 -179.853 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.85 13.91 63.86 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.285 -0.726 . . . . 0.34 111.285 179.792 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -84.66 139.14 32.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.728 0.299 . . . . 1.22 110.432 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -106.81 141.05 38.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.424 -0.353 . . . . 1.44 110.545 179.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.2 m -136.64 126.99 26.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 1.39 110.375 179.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.665 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.6 tp -68.18 117.31 9.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.32 -0.4 . . . . 1.08 110.467 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.647 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.3 pt -108.99 -21.84 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 1.08 110.676 -179.742 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.89 125.68 5.85 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.526 -0.47 . . . . 1.1 111.555 -179.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.497 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.77 120.24 21.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.814 -0.63 . . . . 0.94 109.538 179.259 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.65 151.69 29.08 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.619 -0.432 . . . . 1.07 110.85 -179.259 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.4 158.65 18.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.042 -0.526 . . . . 0.89 110.382 179.714 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -146.08 157.89 43.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.097 -0.501 . . . . 0.67 110.643 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.24 104.31 9.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.819 -0.628 . . . . 1.17 110.068 179.523 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.486 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.2 p . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.909 -1.043 . . . . 1.26 110.635 -179.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.2 m . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.189 -0.671 . . . . 3.83 109.189 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.73 18.54 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.045 -0.822 . . . . 1.39 111.045 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -35.68 142.37 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.086 0 C-N-CA 123.97 3.113 . . . . 0.86 113.832 -179.271 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.574 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -79.96 173.5 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 114.192 -1.367 . . . . 1.43 108.817 178.451 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 23' ' ' ASN . 96.2 mt-10 -105.62 125.88 51.5 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.406 -0.518 . . . . 1.94 111.41 -179.571 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 143.97 34.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.615 -0.721 . . . . 1.19 110.71 179.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.27 25.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.893 0.378 . . . . 3.92 111.133 -179.641 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.59 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.89 131.09 60.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.989 -0.551 . . . . 3.88 110.085 179.883 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.19 162.39 35.6 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.479 -0.328 . . . . 3.92 111.257 -179.995 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 95.0 mt-10 36.06 31.56 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.642 -0.503 . . . . 6.08 109.642 179.901 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.59 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.35 69.52 31.59 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.881 -0.599 . . . . 4.01 111.564 -178.721 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.23 -29.16 73.21 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.522 2.148 . . . . 4.51 111.821 179.39 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.65 125.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 3.51 110.367 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.534 ' OE1' ' O ' ' A' ' 13' ' ' SER . 3.1 mp0 -123.97 158.31 60.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.394 . . . . 4.3 110.479 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.47 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 97.0 Cg_endo -81.99 -64.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.935 2.424 . . . . 1.96 113.551 -179.035 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.836 HD22 ' CB ' ' A' ' 157' ' ' TYR . 28.1 m-80 -108.41 -19.64 13.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.051 0.389 . . . . 3.33 112.051 -178.546 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 79.3 p -107.35 152.08 24.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.159 0.504 . . . . 1.53 111.302 -179.369 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.29 102.9 2.23 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.671 -0.695 . . . . 2.29 110.656 179.918 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.7 145.59 12.97 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.872 2.381 . . . . 0.88 112.614 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.414 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.73 167.97 24.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.858 -0.61 . . . . 2.12 109.834 179.642 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.2 148.01 29.11 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.67 -0.493 . . . . 2.67 109.67 178.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.5 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.7 p90 -142.27 157.2 45.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.979 0.419 . . . . 0.32 111.223 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.463 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.1 m-20 -127.99 155.37 44.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.851 -0.613 . . . . 2.77 110.094 178.88 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.401 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . . . -132.64 173.13 6.24 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.07 -0.514 . . . . 1.25 110.716 -179.22 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.401 ' CD ' ' CB ' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.65 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.849 2.366 . . . . 1.12 111.515 179.393 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -51.08 0.69 Allowed Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.741 -0.383 . . . . 4.05 110.072 179.838 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.654 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.88 152.34 82.57 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.754 2.303 . . . . 2.12 111.456 179.245 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.66 42.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.446 0.641 . . . . 2.85 110.647 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.821 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.59 -41.64 98.33 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.004 -0.998 . . . . 3.11 110.669 179.742 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.433 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.8 mt -109.82 137.8 40.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.814 -0.63 . . . . 1.86 111.349 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.01 -72.89 0.7 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.125 -0.489 . . . . 1.61 111.833 -178.906 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -88.19 148.41 24.4 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.546 0.573 . . . . 1.67 112.546 -179.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.76 124.82 45.12 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.34 -0.615 . . . . 1.07 109.34 177.542 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.01 134.66 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.731 -0.388 . . . . 1.55 110.74 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.487 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -120.01 128.71 53.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.008 0.432 . . . . 1.33 111.213 179.78 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 139.02 49.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.693 -0.685 . . . . 2.36 110.112 179.004 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.416 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.12 163.21 35.01 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.162 0.506 . . . . 0.38 112.077 -178.135 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.491 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.46 139.52 7.84 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.473 -0.785 . . . . 2.31 110.487 178.927 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.55 115.55 3.1 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.279 1.986 . . . . 0.86 111.82 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.667 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.98 81.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.894 -0.409 . . . . 3.44 109.894 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.688 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.3 -20.68 0.06 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.025 -0.534 . . . . 2.72 111.932 -179.48 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.62 157.81 34.33 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.819 -0.352 . . . . 2.78 110.598 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.402 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.33 27.78 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 2.3 110.203 179.611 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.89 -75.78 1.31 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.088 -0.577 . . . . 1.8 111.836 -179.242 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.95 152.29 35.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.991 0.424 . . . . 5.48 110.946 -179.35 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.18 -169.07 2.52 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.009 -0.542 . . . . 1.84 111.911 179.373 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.416 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.19 149.61 29.85 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.473 0.654 . . . . 2.27 112.543 -177.822 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.03 156.47 46.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.8 -1.091 . . . . 1.92 110.25 178.633 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.23 158.38 41.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.964 -0.562 . . . . 1.09 111.866 -179.368 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.3 m -115.19 135.57 54.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.519 -0.764 . . . . 1.16 109.862 179.33 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.446 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.36 121.97 23.82 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.415 -0.357 . . . . 1.39 111.493 -179.073 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.518 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.4 Cg_exo -46.33 151.74 1.63 Allowed 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.593 2.195 . . . . 0.72 112.177 178.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.89 -23.01 62.99 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 116.128 -0.487 . . . . 0.74 112.77 -179.252 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.518 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.86 -16.91 45.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.456 0.628 . . . . 1.26 111.734 -178.264 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.484 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.56 138.37 31.62 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.873 -0.331 . . . . 1.59 110.314 179.361 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.58 14.05 10.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.32 -0.4 . . . . 2.07 111.479 -179.402 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.474 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.4 p -150.04 143.4 25.13 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.599 -0.441 . . . . 0.96 110.961 179.644 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.721 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.78 -169.37 1.53 Allowed 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.242 0.544 . . . . 1.0 110.874 -179.505 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.739 ' OG1' ' C ' ' A' ' 188' ' ' ASP . 2.6 m -151.78 125.92 9.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.371 -0.832 . . . . 1.19 109.814 179.276 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.427 HG23 HD11 ' A' ' 60' ' ' ILE . 66.8 mt -114.88 123.25 70.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.448 -0.501 . . . . 1.47 111.199 -179.699 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -126.49 163.35 23.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.842 -0.617 . . . . 3.0 110.394 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.614 ' H ' HH22 ' A' ' 143' ' ' ARG . . . 85.04 19.07 59.86 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.728 -0.949 . . . . 0.5 110.728 -179.954 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.436 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.5 mt -79.11 157.22 28.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.06 0.457 . . . . 1.21 111.362 -179.679 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.628 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 3.7 mtpp -99.46 134.02 21.5 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.561 -0.745 . . . . 3.2 110.473 179.779 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.91 143.58 61.24 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.573 2.182 . . . . 1.09 111.899 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.81 25.63 75.33 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.034 -0.826 . . . . 0.72 111.034 179.686 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.641 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.14 158.81 39.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.694 0.283 . . . . 1.47 110.398 -179.592 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.16 140.02 41.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.843 0.354 . . . . 1.23 110.565 -179.813 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.641 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.7 m-85 -122.63 136.38 54.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.901 -0.59 . . . . 1.1 110.792 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.491 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.76 131.03 45.21 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.593 -0.892 . . . . 1.87 108.593 177.574 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.488 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.55 153.83 16.67 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.244 -0.979 . . . . 0.39 111.981 -178.635 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.89 140.98 46.2 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.782 -0.451 . . . . 1.8 109.782 179.534 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.46 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.4 tp -115.78 118.92 34.38 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.39 -0.524 . . . . 1.11 110.525 179.72 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.9 mt -112.42 129.05 68.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.372 -0.376 . . . . 1.51 110.632 -179.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.75 120.82 43.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.333 -0.394 . . . . 1.47 110.756 -179.7 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.671 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.55 146.52 11.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.182 0.515 . . . . 1.33 111.04 -179.302 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.821 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.03 153.9 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.515 -0.766 . . . . 2.49 109.973 179.816 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.2 88.6 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.965 0.412 . . . . 4.2 110.392 -179.768 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.618 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.27 32.69 0.21 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.786 -0.643 . . . . 6.4 110.582 -179.94 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.12 -117.43 3.29 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.405 -0.678 . . . . 1.74 111.405 -179.684 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.445 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.5 177.37 8.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.168 0.509 . . . . 3.64 111.652 -179.181 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -148.12 149.54 32.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.38 -0.827 . . . . 1.7 110.375 179.223 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.18 144.63 38.64 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.485 -0.325 . . . . 2.7 110.513 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -127.97 136.02 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 120.619 -0.432 . . . . 1.16 111.519 -179.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.574 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.15 141.32 52.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.645 -0.707 . . . . 1.14 110.284 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.447 ' N ' HG21 ' A' ' 85' ' ' THR . 42.4 ttp180 -117.66 138.9 51.67 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.502 -0.479 . . . . 4.33 111.531 -179.32 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.25 164.21 37.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.524 -0.762 . . . . 0.91 109.502 179.467 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.575 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.31 151.53 38.48 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.37 -0.532 . . . . 1.47 110.974 179.977 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.9 p90 -146.19 172.81 12.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.754 -0.657 . . . . 0.51 111.027 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.454 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.77 160.63 21.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.523 -0.762 . . . . 1.92 109.892 179.621 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.454 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.33 121.89 23.03 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.568 -0.453 . . . . 1.63 110.777 179.972 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.2 p -127.56 147.96 50.34 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.119 -0.491 . . . . 2.37 112.292 179.728 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.1 t -66.36 -36.91 84.07 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.417 -0.811 . . . . 3.63 113.008 178.691 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.9 p -81.97 163.51 22.12 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.715 -177.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 82.9 p -112.06 148.63 33.49 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.534 179.696 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.413 ' N ' ' CD ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER -54.98 -50.58 85.58 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.742 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 96' ' ' THR . 34.4 Cg_exo -59.85 140.81 94.91 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.279 1.986 . . . . 0.0 113.05 -178.828 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.2 m -130.64 157.54 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.533 178.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 19.9 p -122.34 154.2 37.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.011 0.434 . . . . 0.0 110.821 179.534 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.9 p -90.57 -0.56 57.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.311 179.704 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.657 ' C ' ' H ' ' A' ' 103' ' ' VAL . 80.9 m-20 -74.24 -70.83 0.37 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.183 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 78.7 m 54.75 -2.4 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.893 0.378 . . . . 0.0 110.641 -179.293 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.657 ' H ' ' C ' ' A' ' 101' ' ' ASN . 80.8 t -61.91 -36.37 73.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.187 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 45.5 m -65.66 136.64 56.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.212 0.53 . . . . 0.0 111.407 -178.403 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 149.04 -51.06 0.55 Allowed Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.521 ' C ' ' H ' ' A' ' 108' ' ' THR . 97.0 mt-10 -62.7 -30.48 71.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.933 0.397 . . . . 0.0 110.714 179.27 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -53.91 -4.45 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.405 -179.238 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.521 ' H ' ' C ' ' A' ' 106' ' ' GLU . 33.7 p -119.79 75.19 19.65 Favored Pre-proline 0 N--CA 1.465 0.306 0 CA-C-O 120.595 0.236 . . . . 0.0 110.43 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.43 151.85 50.72 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.657 2.238 . . . . 0.0 111.871 179.646 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -100.68 129.7 46.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.09 0.472 . . . . 0.0 111.45 -179.425 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.5 p -128.98 76.09 79.62 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.653 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.61 148.19 45.39 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.422 2.081 . . . . 0.0 112.703 -179.544 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.504 ' CD1' ' N ' ' A' ' 113' ' ' LEU . 4.7 mp -84.29 150.5 25.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.527 -0.761 . . . . 10.52 110.416 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.7 t -61.18 135.26 26.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.159 0.504 . . . . 7.48 110.797 -179.187 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.72 151.08 34.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.453 -0.794 . . . . 7.69 111.513 -179.403 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.2 p -76.98 165.32 24.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.694 -0.684 . . . . 6.46 109.686 179.816 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.5 p -65.21 157.85 27.72 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.409 -0.516 . . . . 4.59 110.922 -178.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -63.9 -31.58 72.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.572 -0.74 . . . . 3.21 111.764 -179.425 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.9 t -56.42 -38.46 71.6 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.756 -0.378 . . . . 3.64 111.689 -177.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.8 m -132.32 150.96 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 120.644 -0.423 . . . . 3.39 111.55 179.73 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 52.5 p -115.39 9.75 15.65 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.589 -0.732 . . . . 2.23 109.531 178.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.58 144.47 42.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.526 -0.761 . . . . 4.53 112.002 -178.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.1 mm -112.49 136.69 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.37 -0.832 . . . . 2.01 109.085 179.145 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 125' ' ' ALA . 65.5 p -62.69 -34.31 76.88 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.684 -0.407 . . . . 2.22 111.344 -178.781 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 124' ' ' THR . . . 157.63 92.13 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.127 0.267 . . . . 1.29 110.395 179.679 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.5 p -61.79 -30.73 71.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.259 0.552 . . . . 1.25 109.881 179.449 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.481 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.85 167.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.536 -0.756 . . . . 1.16 110.96 179.939 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.484 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.9 m-30 -133.59 145.57 50.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.664 -0.698 . . . . 0.78 110.125 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.25 101.68 9.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.051 -0.722 . . . . 1.08 109.051 177.725 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.467 HG11 ' N ' ' A' ' 131' ' ' SER . 71.3 t -112.95 139.7 36.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.992 -0.549 . . . . 1.1 111.107 -178.911 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.467 ' N ' HG11 ' A' ' 130' ' ' VAL . 68.0 p -128.76 152.55 48.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.705 -0.679 . . . . 0.87 109.795 179.609 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.645 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.6 p90 -144.75 -164.85 2.01 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.62 -0.432 . . . . 0.37 110.651 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.6 t -123.97 127.17 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 1.14 110.804 -179.835 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.174 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.1 p -57.89 58.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.111 -0.495 . . . . 1.91 110.44 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.743 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.13 24.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.971 -0.559 . . . . 1.56 111.478 -179.591 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.174 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.1 128.62 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.674 -0.41 . . . . 1.56 110.999 179.833 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.35 -9.52 56.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.883 -0.599 . . . . 1.88 110.381 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.8 p -87.16 0.32 55.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.52 . . . . 1.63 110.27 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.967 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.33 137.19 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.023 -0.535 . . . . 1.11 109.977 179.717 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.583 ' N ' ' O ' ' A' ' 185' ' ' ILE . 93.8 p -96.2 -15.56 21.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.248 0.547 . . . . 1.01 110.046 -179.673 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.61 175.67 45.88 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 109.859 -1.297 . . . . 0.14 109.859 179.595 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.46 151.6 42.54 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.683 -0.407 . . . . 0.21 110.525 179.778 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.622 ' NH1' ' HB2' ' A' ' 159' ' ' ASP . 10.3 tpp180 -132.35 121.18 23.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.172 -0.467 . . . . 1.54 109.911 179.809 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.496 HG23 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.08 136.63 38.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.74 -0.664 . . . . 1.08 110.632 -179.777 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 79.3 tt0 -129.41 129.89 45.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.996 -0.547 . . . . 1.32 110.044 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.601 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.4 p90 -138.71 135.24 34.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.055 -0.52 . . . . 1.05 110.611 -179.669 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.408 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.27 161.32 39.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.841 -0.618 . . . . 1.16 109.734 179.834 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.945 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.4 mt -71.02 124.78 25.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.011 0.434 . . . . 1.23 110.767 -179.644 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.67 -7.7 49.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.777 -0.647 . . . . 0.86 110.915 -179.814 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.88 -69.58 0.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.303 -0.408 . . . . 1.66 111.449 -179.283 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.454 ' CD ' HH21 ' A' ' 176' ' ' ARG . 53.9 mt-10 -60.74 -35.33 76.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 1.66 111.506 -179.184 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.08 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.15 7.26 88.57 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.857 -0.897 . . . . 1.62 110.857 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.341 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.4 t0 -27.9 -171.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 1.86 110.229 179.798 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.341 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.4 139.1 44.67 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.036 0.446 . . . . 1.98 110.185 179.614 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.408 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 45.8 Cg_endo -70.91 145.79 51.39 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 122.675 2.25 . . . . 0.62 112.302 -179.466 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.75 145.72 42.54 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.318 -0.623 . . . . 1.14 109.318 179.157 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.836 ' CB ' HD22 ' A' ' 16' ' ' ASN . 22.3 p90 -123.27 141.34 52.09 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.384 -0.526 . . . . 1.44 111.536 -179.067 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.402 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.9 mt -128.14 127.66 43.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.314 -0.857 . . . . 1.08 108.936 178.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.622 ' HB2' ' NH1' ' A' ' 143' ' ' ARG . 29.5 t0 -101.6 131.09 47.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.171 0.51 . . . . 1.09 111.738 -178.77 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.497 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -127.91 157.52 73.49 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.2 -0.909 . . . . 1.04 109.583 179.643 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -69.8 158.14 57.94 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.351 2.034 . . . . 0.21 112.3 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.2 p -59.36 -12.19 5.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.733 -0.667 . . . . 0.88 110.744 -179.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.9 p -92.77 -8.71 42.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.086 -0.506 . . . . 1.06 110.718 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.14 135.38 34.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 1.05 110.378 179.67 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.5 p -133.18 16.72 4.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 1.07 110.552 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.1 p -167.59 147.12 5.04 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.619 -0.512 . . . . 0.92 109.619 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.497 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.2 150.46 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.548 -0.461 . . . . 1.09 111.59 -179.653 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.499 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.31 124.98 50.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.637 -0.71 . . . . 1.31 109.812 179.493 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.526 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.37 104.9 29.71 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.412 -0.358 . . . . 1.09 111.107 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.7 Cg_endo -91.06 -179.49 1.47 Allowed 'Trans proline' 0 C--N 1.301 -1.964 0 C-N-CA 123.178 2.585 . . . . 0.48 112.213 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 61.63 32.71 18.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.463 -0.79 . . . . 1.26 111.439 179.302 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.526 HD21 HG21 ' A' ' 169' ' ' ILE . 24.1 mt -86.35 148.51 25.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.436 -0.347 . . . . 1.12 110.469 179.547 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.776 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.29 114.83 61.2 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.076 0.465 . . . . 1.3 110.645 -179.75 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.98 140.58 95.96 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.908 2.405 . . . . 0.92 111.959 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.15 74.45 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.006 -0.837 . . . . 0.44 111.006 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.454 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.8 mmm-85 -126.87 150.27 49.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.38 . . . . 3.05 110.6 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.5 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.23 131.63 46.06 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.011 -0.54 . . . . 1.48 109.737 179.392 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.945 ' CE2' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.44 148.36 43.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.099 -0.501 . . . . 0.89 111.037 -179.868 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.34 125.34 60.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.258 -1.016 . . . . 1.12 108.258 177.745 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.54 132.53 63.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.085 0.469 . . . . 1.1 111.221 -178.595 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.54 122.56 20.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.591 -0.732 . . . . 0.43 109.626 179.258 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.593 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.03 125.37 54.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.181 -0.463 . . . . 1.07 110.729 -179.556 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.674 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.5 m-85 -117.14 137.83 52.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.014 -0.539 . . . . 0.92 109.903 179.565 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.574 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.63 134.98 42.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.815 -0.809 . . . . 0.49 108.815 178.832 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.583 ' O ' ' N ' ' A' ' 140' ' ' SER . 46.0 mm -99.05 122.94 51.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.131 0.491 . . . . 1.08 111.024 -178.826 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.443 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.6 p -83.76 169.66 14.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.571 -0.74 . . . . 0.89 110.511 -179.688 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.87 -14.43 15.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.034 -0.53 . . . . 1.6 110.979 -179.593 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.739 ' C ' ' OG1' ' A' ' 59' ' ' THR . 96.3 m-20 -96.03 -4.3 43.31 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.894 -0.323 . . . . 1.18 110.861 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.508 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.79 13.9 63.99 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.354 -0.699 . . . . 0.34 111.354 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -84.72 139.06 32.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.696 0.284 . . . . 1.22 110.389 179.731 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -106.61 141.02 38.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.423 -0.353 . . . . 1.44 110.674 179.646 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.0 m -136.73 127.09 26.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 1.39 110.338 179.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.674 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.5 tp -68.19 117.38 9.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.959 0.409 . . . . 1.08 110.451 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.645 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.1 pt -109.06 -21.86 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 1.08 110.71 -179.699 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.86 125.73 5.88 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 120.442 -0.503 . . . . 1.1 111.508 -179.757 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.488 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.81 120.21 21.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.792 -0.64 . . . . 0.94 109.581 179.195 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.63 151.7 29.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.96 0.41 . . . . 1.07 110.883 -179.239 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.45 158.6 18.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.009 -0.542 . . . . 0.89 110.409 179.725 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -146.11 157.92 43.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 0.67 110.678 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 104.34 9.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.811 -0.631 . . . . 1.17 110.053 179.582 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.484 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.3 p . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.964 -1.017 . . . . 1.26 110.61 -179.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.548 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.209 -0.663 . . . . 3.83 109.209 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.455 ' H ' ' HB3' ' A' ' 1' ' ' SER . . . -116.4 150.66 18.54 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.023 -0.831 . . . . 1.39 111.023 179.814 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -35.65 142.37 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.114 0 C-N-CA 123.956 3.104 . . . . 0.86 113.881 -179.23 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.567 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -79.96 173.35 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.261 -1.336 . . . . 1.43 108.841 178.507 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.402 ' H ' ' CG1' ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.49 125.89 51.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.127 0.489 . . . . 1.94 111.454 -179.639 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.56 144.01 33.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.575 -0.739 . . . . 1.19 110.621 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.08 168.24 25.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.914 0.388 . . . . 3.92 111.118 -179.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.583 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.5 mt -108.91 131.07 60.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.042 -0.526 . . . . 3.88 110.06 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.5 p -141.24 162.27 35.88 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.853 0.358 . . . . 3.92 111.203 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 48.1 mt-10 36.1 31.61 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.625 -0.509 . . . . 6.08 109.625 179.847 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.583 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.6 33.11 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.951 -0.568 . . . . 4.01 111.609 -178.844 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.639 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.24 -29.13 73.12 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.486 2.124 . . . . 4.51 111.838 179.325 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.639 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.58 125.62 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 3.51 110.527 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.707 ' O ' ' O ' ' A' ' 92' ' ' THR . 1.8 mp0 -123.99 158.3 60.75 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 4.3 110.411 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.552 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 98.3 Cg_endo -82.05 -64.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.874 2.383 . . . . 1.96 113.491 -178.983 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.727 ' ND2' ' CD1' ' A' ' 157' ' ' TYR . 1.2 m120 -108.44 -19.6 13.4 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.12 0.415 . . . . 3.33 112.12 -178.562 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.797 ' HG ' ' HZ3' ' A' ' 61' ' ' LYS . 55.8 m -107.3 152.03 24.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.171 0.51 . . . . 1.53 111.298 -179.411 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.571 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.21 102.88 2.24 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.681 -0.69 . . . . 2.29 110.618 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.66 145.64 13.04 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.925 2.417 . . . . 0.88 112.643 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.407 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.8 167.9 24.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.89 -0.595 . . . . 2.12 109.885 179.561 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -149.12 147.97 29.1 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.677 -0.49 . . . . 2.67 109.677 178.859 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.501 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.3 p90 -142.21 157.35 44.96 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.623 -0.431 . . . . 0.32 111.167 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.467 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.05 155.24 44.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.822 -0.626 . . . . 2.77 110.119 178.962 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.58 173.09 6.29 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.081 -0.508 . . . . 1.25 110.765 -179.217 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.68 174.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.909 2.406 . . . . 1.12 111.518 179.362 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.11 -51.16 0.68 Allowed Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.727 -0.389 . . . . 4.05 110.054 179.899 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.647 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.74 152.32 82.44 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.769 2.312 . . . . 2.12 111.442 179.189 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.69 42.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.351 0.596 . . . . 2.85 110.531 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.815 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.58 -41.72 98.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.05 -0.977 . . . . 3.11 110.609 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.44 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.2 mt -109.86 137.83 40.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.782 -0.644 . . . . 1.86 111.23 -179.363 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.94 -72.88 0.7 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.031 -0.531 . . . . 1.61 111.937 -178.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.15 148.36 24.46 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.559 0.577 . . . . 1.67 112.559 -179.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.87 124.84 45.06 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.302 -0.629 . . . . 1.07 109.302 177.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.4 mt -117.97 134.68 60.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.787 -0.365 . . . . 1.55 110.642 179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.487 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.8 mt -120.01 128.63 53.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 1.33 111.292 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.549 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.14 138.97 49.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.727 -0.67 . . . . 2.36 110.145 179.014 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.416 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -145.07 163.26 34.81 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 121.265 0.555 . . . . 0.38 112.037 -178.117 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.491 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.55 139.51 7.76 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 115.431 -0.804 . . . . 2.31 110.506 178.873 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.3 Cg_endo -63.5 115.46 3.05 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.344 2.03 . . . . 0.86 111.81 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.674 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.02 81.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.882 -0.414 . . . . 3.44 109.882 -179.81 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.72 0.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.943 -0.571 . . . . 2.72 111.916 -179.467 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.4 p -157.55 157.82 34.48 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.848 -0.341 . . . . 2.78 110.613 179.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.8 m -120.42 27.85 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.438 . . . . 2.3 110.144 179.558 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.78 -75.9 1.31 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.107 -0.568 . . . . 1.8 111.886 -179.284 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.88 152.34 35.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.944 0.402 . . . . 5.48 110.994 -179.42 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.676 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.21 -169.1 2.53 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.033 -0.53 . . . . 1.84 111.989 179.367 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.19 149.68 29.75 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.412 0.625 . . . . 2.27 112.583 -177.848 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.06 156.52 45.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.837 -1.074 . . . . 1.92 110.241 178.688 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.2 158.46 41.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.968 -0.56 . . . . 1.09 111.822 -179.349 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.6 m -115.31 135.72 53.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.479 -0.782 . . . . 1.16 109.747 179.291 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.441 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.46 121.93 23.69 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.385 -0.371 . . . . 1.39 111.579 -179.182 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.517 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.0 Cg_exo -46.24 151.67 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.729 2.286 . . . . 0.72 112.129 179.042 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.84 -23.11 63.01 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 116.083 -0.508 . . . . 0.74 112.77 -179.227 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.517 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.81 -16.83 46.24 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.224 -0.59 . . . . 1.26 111.819 -178.319 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.494 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.67 138.49 31.52 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.709 -0.397 . . . . 1.59 110.246 179.398 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.54 13.9 10.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.345 -0.389 . . . . 2.07 111.542 -179.363 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.476 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.97 143.41 25.19 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.63 -0.428 . . . . 0.96 111.059 179.676 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.4 t80 -114.76 -169.37 1.53 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.167 0.508 . . . . 1.0 110.899 -179.432 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.714 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.81 125.78 9.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.454 -0.794 . . . . 1.19 109.858 179.278 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.427 HD11 HG23 ' A' ' 60' ' ' ILE . 66.7 mt -114.81 123.16 70.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.382 -0.527 . . . . 1.47 111.282 -179.798 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.797 ' HZ3' ' HG ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -126.41 163.4 23.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.882 -0.599 . . . . 3.0 110.426 179.749 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.635 ' H ' ' HD3' ' A' ' 61' ' ' LYS . . . 85.11 19.0 59.86 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.759 -0.936 . . . . 0.5 110.759 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.431 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.9 mt -78.98 157.25 28.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.111 0.482 . . . . 1.21 111.3 -179.631 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.621 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.0 OUTLIER -99.51 133.9 21.56 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.627 -0.715 . . . . 3.2 110.415 179.743 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.76 143.61 62.21 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.571 2.181 . . . . 1.09 112.022 179.731 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.76 25.6 75.37 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.061 -0.816 . . . . 0.72 111.061 179.715 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.644 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.14 158.77 39.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.751 0.31 . . . . 1.47 110.444 -179.673 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.13 140.08 41.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.932 0.396 . . . . 1.23 110.516 -179.765 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.644 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.65 136.46 54.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.886 -0.597 . . . . 1.1 110.75 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.491 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.86 131.02 45.28 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.506 -0.924 . . . . 1.87 108.506 177.637 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.487 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.46 153.92 16.64 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 120.321 -0.942 . . . . 0.39 111.985 -178.685 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.98 140.87 46.03 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.71 -0.478 . . . . 1.8 109.71 179.61 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.469 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.8 tp -115.71 118.9 34.34 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.526 -0.47 . . . . 1.11 110.534 179.691 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.5 129.09 68.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 1.51 110.647 -179.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.86 120.76 43.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.327 -0.397 . . . . 1.47 110.691 -179.577 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.673 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.54 146.47 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.197 0.523 . . . . 1.33 111.0 -179.266 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.815 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.09 153.9 21.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.501 -0.772 . . . . 2.49 109.924 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.21 88.51 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.938 0.399 . . . . 4.2 110.426 -179.653 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.628 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.42 32.61 0.23 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.807 -0.633 . . . . 6.4 110.581 -179.906 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.14 -117.28 3.28 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.492 -0.643 . . . . 1.74 111.492 -179.722 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.452 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.1 m170 -81.55 177.41 8.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.18 0.514 . . . . 3.64 111.516 -179.106 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.2 149.58 32.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.444 -0.798 . . . . 1.7 110.415 179.107 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.548 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.22 144.58 38.54 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.454 -0.339 . . . . 2.7 110.592 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -127.91 135.97 61.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.597 -0.441 . . . . 1.16 111.586 -179.761 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -123.99 141.32 52.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.733 -0.667 . . . . 1.14 110.259 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.46 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.65 138.96 51.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.134 0.492 . . . . 4.33 111.463 -179.414 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.487 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.37 164.15 38.07 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.514 -0.766 . . . . 0.91 109.442 179.352 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.569 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.15 151.59 38.69 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.366 -0.534 . . . . 1.47 110.985 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.571 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.9 p90 -146.3 172.75 13.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.689 -0.687 . . . . 0.51 111.018 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.446 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.5 t -118.74 160.67 21.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.443 -0.799 . . . . 1.92 109.846 179.66 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.446 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.38 121.8 22.84 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.624 -0.43 . . . . 1.63 110.833 179.962 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.707 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.2 p -127.85 170.0 13.28 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 116.09 -0.504 . . . . 2.37 110.677 179.683 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.9 m -106.22 146.07 30.77 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.11 0.481 . . . . 3.63 110.119 179.415 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.3 t -78.0 -15.92 58.54 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.393 -178.254 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 61.7 m -60.07 151.21 27.18 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.187 -178.89 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.438 ' CB ' ' CD ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER -177.69 -63.86 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.982 179.799 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 96' ' ' THR . 19.2 Cg_endo -58.27 142.49 97.48 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.358 2.038 . . . . 0.0 111.964 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.2 p -133.59 141.58 43.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.842 179.621 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' ' 149' ' ' SER . 18.9 p -125.49 157.26 37.43 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 84.8 p -146.36 157.75 43.82 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.075 0.464 . . . . 0.0 111.536 179.608 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.677 ' ND2' ' HZ2' ' A' ' 177' ' ' LYS . 35.7 p-10 -125.8 15.06 8.06 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.298 178.536 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 58.0 m -84.72 141.26 30.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.757 -178.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.8 t -65.9 139.71 20.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.024 179.367 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.3 t -128.25 159.89 33.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.539 -179.098 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.09 -89.05 1.01 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -178.263 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.43 -31.42 72.11 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 47.5 m -73.93 142.72 45.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.709 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.34 156.76 14.45 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.304 -179.637 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -49.91 149.29 11.45 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.395 2.063 . . . . 0.0 112.864 -179.359 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -56.92 -34.14 67.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.021 -179.748 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.1 t -123.47 80.24 54.04 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.178 -179.157 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.41 149.9 28.43 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.51 2.14 . . . . 0.0 111.602 179.487 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.9 tp -55.49 -37.48 67.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.374 -0.375 . . . . 10.52 110.382 -179.66 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.0 t -114.9 134.29 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.304 -0.407 . . . . 7.48 110.449 179.634 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.93 144.51 56.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 7.69 110.653 179.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.2 m -57.85 -39.0 76.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.288 -0.415 . . . . 6.46 110.445 179.755 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 92.4 p -124.15 155.3 38.7 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.127 -0.488 . . . . 4.59 110.447 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.56 142.8 51.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 3.21 110.747 -179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.2 p -62.35 -25.9 68.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 3.64 110.726 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 121' ' ' THR . 71.2 t -59.66 -39.79 80.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 3.39 110.474 -179.572 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 120' ' ' VAL . 25.0 m 37.17 78.18 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.306 -0.406 . . . . 2.23 111.062 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.63 -32.73 72.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.062 -0.517 . . . . 4.53 111.09 -179.559 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 17.2 tt -121.48 137.76 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.834 0.349 . . . . 2.01 110.685 -179.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.2 p -120.99 161.08 22.22 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.068 -0.515 . . . . 2.22 110.463 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' A' ' 127' ' ' SER . . . -174.1 -121.7 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.998 -0.546 . . . . 1.29 110.21 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.3 OUTLIER 42.93 17.04 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.272 -0.422 . . . . 1.25 111.511 179.709 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.83 167.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.917 -0.583 . . . . 1.16 110.99 179.868 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.478 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.9 m-30 -133.59 145.59 50.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.748 -0.66 . . . . 0.78 110.11 -179.881 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.35 101.65 9.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.08 -0.711 . . . . 1.08 109.08 177.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.469 HG11 ' N ' ' A' ' 131' ' ' SER . 71.5 t -112.96 139.74 36.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.978 -0.555 . . . . 1.1 111.071 -178.836 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.469 ' N ' HG11 ' A' ' 130' ' ' VAL . 69.1 p -128.78 152.5 48.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.613 -0.721 . . . . 0.87 109.741 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.647 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.8 p90 -144.8 -165.0 2.05 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.675 -0.41 . . . . 0.37 110.618 -179.775 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.738 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -123.86 127.15 73.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.218 -0.446 . . . . 1.14 110.894 -179.881 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.158 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.8 58.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 1.91 110.36 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.738 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.19 24.56 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.99 -0.55 . . . . 1.56 111.541 -179.583 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.158 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.16 128.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.615 -0.434 . . . . 1.56 110.95 179.831 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -86.45 -9.66 55.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.973 -0.558 . . . . 1.88 110.295 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.09 0.2 55.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 1.63 110.313 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.961 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.25 137.16 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.957 -0.565 . . . . 1.11 109.997 179.711 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.562 ' N ' ' O ' ' A' ' 185' ' ' ILE . 0.2 OUTLIER -96.2 -15.55 21.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.32 0.581 . . . . 1.01 110.021 -179.613 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.6 175.52 45.74 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 109.863 -1.295 . . . . 0.14 109.863 179.685 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -123.39 151.63 42.38 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.655 -0.418 . . . . 0.21 110.523 179.711 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.632 ' NH1' ' CB ' ' A' ' 157' ' ' TYR . 10.4 ttt85 -132.34 121.22 23.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.078 -0.51 . . . . 1.54 109.954 179.754 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.492 HG23 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.09 136.53 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.666 -0.697 . . . . 1.08 110.678 -179.752 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 84.2 tt0 -129.37 129.88 45.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.017 -0.538 . . . . 1.32 110.128 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.593 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.73 135.29 34.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.001 -0.545 . . . . 1.05 110.653 -179.684 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.401 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.26 161.34 39.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.721 -0.672 . . . . 1.16 109.682 179.883 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.935 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -71.06 124.83 25.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.971 0.415 . . . . 1.23 110.764 -179.662 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.503 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.74 -7.63 49.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.709 -0.678 . . . . 0.86 110.872 -179.775 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -109.87 -69.67 0.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.979 0.418 . . . . 1.66 111.386 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.443 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.74 -35.28 75.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.03 -0.532 . . . . 1.66 111.44 -179.095 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.09 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.08 7.26 88.56 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.858 -0.897 . . . . 1.62 110.858 -179.787 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.315 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.98 -171.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.331 . . . . 1.86 110.218 179.86 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.315 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.19 139.03 45.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.962 0.41 . . . . 1.98 110.233 179.627 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.401 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.1 Cg_endo -70.88 145.87 51.79 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 C-N-CA 122.751 2.301 . . . . 0.62 112.286 -179.469 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.593 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.91 145.7 42.68 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.199 -0.667 . . . . 1.14 109.199 179.237 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.727 ' CD1' ' ND2' ' A' ' 16' ' ' ASN . 43.2 p90 -123.31 141.33 52.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.269 0.557 . . . . 1.44 111.506 -179.102 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.3 mt -128.08 127.62 43.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.297 -0.865 . . . . 1.08 109.021 178.949 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -101.58 131.11 47.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.178 0.513 . . . . 1.09 111.812 -178.736 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.506 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -127.93 157.51 73.56 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.315 -0.857 . . . . 1.04 109.658 179.653 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.83 158.08 58.08 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 C-N-CA 122.389 2.059 . . . . 0.21 112.215 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.2 p -59.28 -12.2 5.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.754 -0.657 . . . . 0.88 110.736 -179.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.7 p -92.8 -8.68 42.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.132 -0.486 . . . . 1.06 110.79 -179.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.39 34.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.247 -0.433 . . . . 1.05 110.354 179.701 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.8 p -133.16 16.73 4.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.394 -0.367 . . . . 1.07 110.492 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.4 p -167.54 147.13 5.08 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.569 -0.53 . . . . 0.92 109.569 179.841 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.506 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.14 150.52 12.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.467 -0.493 . . . . 1.09 111.592 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.496 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.34 124.9 50.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.674 -0.694 . . . . 1.31 109.803 179.504 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.514 HD13 HG22 ' A' ' 169' ' ' ILE . 1.7 mt -99.33 104.82 29.06 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.382 -0.372 . . . . 1.09 111.131 -179.933 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.5 Cg_endo -90.92 -179.48 1.51 Allowed 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 123.192 2.595 . . . . 0.48 112.296 179.883 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.7 32.59 18.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.46 -0.791 . . . . 1.26 111.462 179.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.511 HD21 HG21 ' A' ' 169' ' ' ILE . 24.1 mt -86.32 148.51 25.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.457 -0.338 . . . . 1.12 110.44 179.615 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.77 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.28 114.83 61.19 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.008 0.432 . . . . 1.3 110.7 -179.767 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -58.98 140.59 96.03 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.851 2.367 . . . . 0.92 112.039 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.06 21.24 74.27 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.028 -0.829 . . . . 0.44 111.028 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.443 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.9 150.17 49.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.857 0.36 . . . . 3.05 110.578 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.677 ' HZ2' ' ND2' ' A' ' 101' ' ' ASN . 75.2 tttt -100.19 131.62 46.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.039 -0.528 . . . . 1.48 109.795 179.335 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.935 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.48 148.25 44.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.117 -0.492 . . . . 0.89 111.089 -179.863 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.21 125.28 60.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.342 -0.984 . . . . 1.12 108.342 177.742 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.53 132.58 63.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.129 0.49 . . . . 1.1 111.238 -178.593 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.55 122.52 20.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.461 -0.791 . . . . 0.43 109.574 179.362 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.589 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.99 125.39 54.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.337 -0.392 . . . . 1.07 110.706 -179.563 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.67 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.5 m-85 -117.24 137.92 52.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.086 -0.506 . . . . 0.92 109.833 179.573 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.83 134.96 43.02 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.802 -0.814 . . . . 0.49 108.802 178.865 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.562 ' O ' ' N ' ' A' ' 140' ' ' SER . 3.7 mt -99.01 122.92 51.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.09 0.472 . . . . 1.08 111.001 -178.736 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.45 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.8 p -83.84 169.82 14.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.562 -0.744 . . . . 0.89 110.469 -179.685 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.84 -14.51 15.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.058 -0.519 . . . . 1.6 110.928 -179.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.45 ' H ' ' HG ' ' A' ' 186' ' ' SER . 95.4 m-20 -96.07 -4.42 42.97 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.878 -0.329 . . . . 1.18 110.83 -179.815 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.9 13.85 63.86 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.368 -0.693 . . . . 0.34 111.368 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -84.62 139.04 32.35 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.775 -0.25 . . . . 1.22 110.446 179.694 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.415 HE22 ' HG2' ' A' ' 14' ' ' GLN . 4.0 mp0 -106.71 141.07 38.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.485 -0.325 . . . . 1.44 110.63 179.708 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.4 m -136.7 127.02 26.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 1.39 110.329 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.67 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.6 tp -68.11 117.29 9.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.327 -0.397 . . . . 1.08 110.477 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.647 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.1 pt -109.03 -21.85 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 1.08 110.716 -179.785 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.1 tp -156.87 125.8 5.91 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.566 -0.454 . . . . 1.1 111.564 -179.829 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.498 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.7 120.16 21.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.731 -0.668 . . . . 0.94 109.579 179.289 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.65 151.75 29.16 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.714 -0.394 . . . . 1.07 110.884 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.55 158.6 18.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.054 -0.521 . . . . 0.89 110.469 179.675 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.09 157.87 43.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.191 -0.459 . . . . 0.67 110.725 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.27 104.41 9.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.771 -0.649 . . . . 1.17 110.024 179.559 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.478 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.1 p . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 117.88 -1.057 . . . . 1.26 110.638 -179.691 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.9 m . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.248 -0.649 . . . . 3.83 109.248 . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.42 150.73 18.53 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.037 -0.825 . . . . 1.39 111.037 179.692 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -35.65 142.43 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 123.988 3.125 . . . . 0.86 113.795 -179.197 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.571 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.3 t -80.04 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 114.295 -1.321 . . . . 1.43 108.808 178.447 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.405 ' H ' ' CG1' ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.68 125.87 51.49 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.415 -0.514 . . . . 1.94 111.395 -179.533 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 144.03 33.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.555 -0.748 . . . . 1.19 110.646 179.921 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.05 168.33 25.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.894 0.378 . . . . 3.92 111.096 -179.614 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.574 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.4 mt -109.03 131.14 60.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.006 -0.543 . . . . 3.88 110.074 179.861 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.505 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.3 p -141.21 162.3 35.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.859 0.361 . . . . 3.92 111.217 -179.903 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 10' ' ' GLU . 80.1 tt0 36.13 31.57 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.629 -0.508 . . . . 6.08 109.629 179.811 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.574 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.55 69.58 33.73 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.945 -0.57 . . . . 4.01 111.58 -178.753 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.17 -29.14 73.74 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.525 2.15 . . . . 4.51 111.868 179.304 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.63 125.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 3.51 110.41 -179.973 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.669 HE21 ' C ' ' A' ' 17' ' ' SER . 14.3 mt-30 -123.96 158.38 60.41 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 4.3 110.405 179.942 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.573 ' HD2' HH12 ' A' ' 143' ' ' ARG . 97.4 Cg_endo -82.03 -64.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.942 2.428 . . . . 1.96 113.558 -179.086 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.552 ' ND2' ' OD1' ' A' ' 159' ' ' ASP . 98.7 m-20 -108.48 -19.51 13.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.075 0.398 . . . . 3.33 112.075 -178.54 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.669 ' C ' HE21 ' A' ' 14' ' ' GLN . 29.1 t -107.35 151.99 24.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.083 0.468 . . . . 1.53 111.296 -179.405 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.2 102.92 2.24 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.656 -0.702 . . . . 2.29 110.722 179.786 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.72 145.59 12.93 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.962 2.441 . . . . 0.88 112.636 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.407 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.75 167.92 24.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.894 -0.594 . . . . 2.12 109.853 179.672 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -149.12 148.02 29.17 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.768 -0.456 . . . . 2.67 109.768 178.816 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.505 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.5 p90 -142.34 157.29 44.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.031 0.443 . . . . 0.32 111.212 179.954 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.461 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.9 m-20 -128.02 155.29 44.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.777 -0.647 . . . . 2.77 110.111 179.072 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.69 172.95 6.49 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.155 0.502 . . . . 1.25 110.701 -179.171 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.6 173.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.844 0 C-N-CA 122.876 2.384 . . . . 1.12 111.475 179.421 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.479 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.1 -51.07 0.68 Allowed Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 120.68 -0.408 . . . . 4.05 110.111 179.881 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.654 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.81 152.33 82.49 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.716 2.277 . . . . 2.12 111.497 179.139 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.66 42.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.417 0.627 . . . . 2.85 110.58 -179.881 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.814 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.69 -41.54 98.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.959 -1.019 . . . . 3.11 110.7 179.775 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.449 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.8 mt -109.9 137.82 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.738 -0.665 . . . . 1.86 111.29 -179.479 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.89 -72.96 0.7 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.056 -0.52 . . . . 1.61 111.982 -179.006 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.43 24.41 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.62 0.6 . . . . 1.67 112.62 -179.689 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.78 124.88 45.24 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.365 -0.606 . . . . 1.07 109.365 177.524 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.06 134.82 60.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.724 -0.391 . . . . 1.55 110.63 179.913 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.489 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -120.15 128.68 53.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.078 0.466 . . . . 1.33 111.138 179.792 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.541 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.99 49.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.716 -0.674 . . . . 2.36 110.162 178.92 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.416 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -145.0 163.22 34.87 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.153 0.502 . . . . 0.38 112.097 -178.127 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.488 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.56 139.53 7.76 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.483 -0.781 . . . . 2.31 110.443 178.805 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.43 115.5 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.283 1.989 . . . . 0.86 111.855 179.946 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.686 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.06 81.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.914 0.388 . . . . 3.44 109.964 -179.853 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.14 -20.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.962 -0.563 . . . . 2.72 111.901 -179.466 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -157.62 157.75 34.22 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.885 -0.326 . . . . 2.78 110.586 179.819 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.402 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.34 27.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.173 -0.467 . . . . 2.3 110.232 179.567 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.84 -75.86 1.31 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.144 -0.55 . . . . 1.8 111.796 -179.204 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.86 152.3 35.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.959 0.409 . . . . 5.48 110.951 -179.268 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.66 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.26 -169.16 2.54 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.033 -0.53 . . . . 1.84 111.938 179.352 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.416 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.08 149.58 29.83 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.436 0.636 . . . . 2.27 112.634 -177.903 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.0 156.48 46.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.83 -1.077 . . . . 1.92 110.318 178.562 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.16 158.45 41.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.926 -0.579 . . . . 1.09 111.82 -179.373 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 m -115.22 135.62 53.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.483 -0.781 . . . . 1.16 109.8 179.322 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.452 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.48 121.95 23.67 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.459 -0.337 . . . . 1.39 111.489 -179.14 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.2 Cg_exo -46.25 151.68 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.67 2.246 . . . . 0.72 112.141 178.993 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.88 -22.98 62.95 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.998 -0.547 . . . . 0.74 112.882 -179.268 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.515 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.83 -16.81 46.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.346 0.573 . . . . 1.26 111.839 -178.38 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.494 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.5 mt -91.73 138.36 31.62 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.749 -0.38 . . . . 1.59 110.335 179.371 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.45 13.93 11.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.353 -0.385 . . . . 2.07 111.546 -179.3 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.8 p -149.98 143.54 25.27 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.612 -0.435 . . . . 0.96 111.028 179.594 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.721 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.85 -169.32 1.53 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.174 0.511 . . . . 1.0 110.855 -179.423 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.721 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 50.1 m -151.8 125.93 9.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.332 -0.849 . . . . 1.19 109.783 179.247 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.431 HG23 HD11 ' A' ' 60' ' ' ILE . 66.6 mt -114.91 123.28 70.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.336 -0.546 . . . . 1.47 111.162 -179.793 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.561 ' HG2' ' N ' ' A' ' 62' ' ' GLY . 88.2 tttt -126.48 163.4 23.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.788 -0.642 . . . . 3.0 110.431 179.709 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.561 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.1 18.99 59.89 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.833 -0.907 . . . . 0.5 110.833 -179.906 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.44 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.9 mt -79.03 157.23 28.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.054 0.454 . . . . 1.21 111.33 -179.589 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.601 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 3.6 mttp -99.55 134.05 21.43 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.571 -0.741 . . . . 3.2 110.413 179.77 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.94 143.62 61.22 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.501 2.134 . . . . 1.09 111.948 179.82 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.64 75.32 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.054 -0.818 . . . . 0.72 111.054 179.721 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.649 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.17 158.79 40.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.743 0.306 . . . . 1.47 110.428 -179.662 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.14 139.93 42.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.971 0.415 . . . . 1.23 110.582 -179.778 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.649 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.3 m-85 -122.5 136.43 54.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.0 -0.546 . . . . 1.1 110.803 -179.886 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.95 130.95 45.34 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.548 -0.908 . . . . 1.87 108.548 177.639 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.47 153.86 16.65 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.332 -0.937 . . . . 0.39 111.89 -178.517 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.01 140.89 46.01 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.717 -0.475 . . . . 1.8 109.717 179.529 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.472 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.8 tp -115.72 119.01 34.67 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.498 -0.481 . . . . 1.11 110.477 179.683 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.53 129.15 68.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 1.51 110.579 -179.904 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.83 120.74 43.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.322 -0.399 . . . . 1.47 110.715 -179.67 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.67 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.53 146.52 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.184 0.516 . . . . 1.33 111.025 -179.349 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.814 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.01 153.86 21.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.482 -0.781 . . . . 2.49 109.986 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.16 88.57 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.953 0.406 . . . . 4.2 110.375 -179.758 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.624 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.33 32.51 0.21 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.843 -0.617 . . . . 6.4 110.602 -179.966 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.99 -117.35 3.3 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.502 -0.639 . . . . 1.74 111.502 -179.758 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.451 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.44 177.36 9.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.254 0.55 . . . . 3.64 111.604 -179.239 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.06 149.47 32.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.428 -0.806 . . . . 1.7 110.502 179.185 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.13 144.73 38.77 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.479 -0.328 . . . . 2.7 110.544 179.854 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.5 p -128.01 135.91 61.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-O 120.936 0.398 . . . . 1.16 111.597 -179.775 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.571 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -123.94 141.34 52.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.678 -0.692 . . . . 1.14 110.301 179.634 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.482 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.68 138.86 51.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.136 0.493 . . . . 4.33 111.451 -179.382 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.25 164.14 37.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.567 -0.742 . . . . 0.91 109.464 179.403 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.561 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.23 151.56 38.58 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.391 -0.524 . . . . 1.47 111.015 179.983 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.0 p90 -146.19 172.74 13.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.81 -0.632 . . . . 0.51 111.058 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.451 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.75 160.78 21.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.46 -0.791 . . . . 1.92 109.89 179.529 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.451 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.42 121.92 22.98 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.556 -0.458 . . . . 1.63 110.722 179.955 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.521 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.3 p -130.01 166.07 20.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.673 0.749 . . . . 2.37 112.861 179.669 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.529 ' HB2' ' CE1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -88.01 -16.16 34.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.692 -1.14 . . . . 3.63 110.563 177.226 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 19.0 p -124.22 167.1 14.74 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.911 -178.153 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.651 ' O ' ' OG1' ' A' ' 96' ' ' THR . 23.9 m -56.85 -31.8 65.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.612 179.496 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.651 ' OG1' ' O ' ' A' ' 95' ' ' SER . 20.1 p 93.93 56.12 0.01 OUTLIER Pre-proline 0 N--CA 1.471 0.576 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.875 -179.69 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.86 150.96 68.24 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.743 2.295 . . . . 0.0 111.161 178.789 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.0 m -59.38 135.28 24.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.138 -179.718 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.458 HG22 ' H ' ' A' ' 101' ' ' ASN . 50.2 m -121.45 141.52 50.92 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.802 -179.243 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 86.2 p -61.65 -24.89 67.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.578 -179.994 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.458 ' H ' HG22 ' A' ' 99' ' ' THR . 76.5 m-20 60.4 44.38 12.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.702 -179.699 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.413 ' O ' ' O ' ' A' ' 101' ' ' ASN . 69.2 p 37.79 -161.94 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.75 179.627 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.602 HG13 ' H ' ' A' ' 105' ' ' GLY . 36.2 t -115.34 136.19 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.048 -179.552 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 56.0 p -66.08 -19.32 65.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.855 0.36 . . . . 0.0 110.899 -179.201 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.602 ' H ' HG13 ' A' ' 103' ' ' VAL . . . -54.07 -29.64 44.55 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 179.75 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -90.33 141.12 29.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.845 0.355 . . . . 0.0 110.148 -179.787 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.1 p -119.86 164.9 15.32 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.872 -179.133 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.69 80.12 31.58 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.232 -179.583 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.01 152.06 31.39 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.546 2.164 . . . . 0.0 112.36 -179.472 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.426 ' O ' ' CB ' ' A' ' 111' ' ' SER . 45.6 p90 -46.94 161.93 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.136 -179.571 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 110' ' ' PHE . 1.2 t 80.13 57.74 0.14 Allowed Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.273 -179.036 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.06 150.63 77.7 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.883 2.389 . . . . 0.0 112.008 179.435 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.2 mt -86.88 143.5 27.4 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.814 -0.439 . . . . 10.52 109.814 179.775 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.3 p -129.89 143.52 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.051 0.453 . . . . 7.48 111.094 -179.186 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.56 149.17 46.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.582 -0.735 . . . . 7.69 110.557 179.762 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.0 m -70.82 138.6 50.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 6.46 110.38 -179.751 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.3 m -61.57 153.59 27.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.042 -0.526 . . . . 4.59 111.102 -179.256 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 22.9 pt-20 -126.77 52.35 1.77 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.623 -0.717 . . . . 3.21 110.66 -179.969 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 74.2 m -81.03 6.12 14.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.962 -0.563 . . . . 3.64 110.72 -179.838 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.2 t -110.6 135.68 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.146 -0.479 . . . . 3.39 110.083 179.824 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.1 p -121.29 161.67 21.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.089 -0.505 . . . . 2.23 110.771 -179.464 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -111.76 156.65 21.6 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.807 -0.633 . . . . 4.53 110.573 -179.847 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 19.7 tt -58.07 -24.96 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 2.01 110.293 179.868 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 56.8 p -66.85 -14.17 62.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.999 -0.546 . . . . 2.22 110.194 179.61 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 53.95 91.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.934 -0.576 . . . . 1.29 110.886 -179.888 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.9 p -62.9 -25.06 68.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.601 -0.727 . . . . 1.25 110.753 179.653 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.467 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.92 167.57 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.74 -0.664 . . . . 1.16 110.985 -179.359 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.493 ' CZ ' HG22 ' A' ' 201' ' ' THR . 8.0 m-30 -133.57 145.49 50.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.808 -0.633 . . . . 0.78 110.182 -179.92 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.27 101.67 9.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.083 -0.71 . . . . 1.08 109.083 177.714 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.468 HG11 ' N ' ' A' ' 131' ' ' SER . 71.1 t -112.96 139.77 36.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.943 -0.572 . . . . 1.1 111.004 -178.834 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.468 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.4 p -128.79 152.53 48.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.642 -0.708 . . . . 0.87 109.799 179.619 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.652 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.8 p90 -144.82 -165.02 2.05 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.776 -0.37 . . . . 0.37 110.674 -179.737 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.745 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -123.97 127.2 73.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.198 -0.455 . . . . 1.14 110.815 -179.856 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.175 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.89 58.37 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.076 -0.511 . . . . 1.91 110.363 179.821 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.745 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.21 24.6 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 1.56 111.509 -179.705 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.175 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.18 128.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.627 -0.429 . . . . 1.56 110.95 179.822 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.45 -9.55 56.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.977 -0.556 . . . . 1.88 110.379 179.703 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.0 p -87.09 0.19 55.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.119 -0.491 . . . . 1.63 110.278 179.924 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.941 HG11 ' O ' ' A' ' 136' ' ' SER . 2.6 p -65.27 137.15 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.02 -0.537 . . . . 1.11 109.994 179.711 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 185' ' ' ILE . 91.1 p -96.23 -15.53 21.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.236 0.541 . . . . 1.01 109.992 -179.608 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.439 ' HA3' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.62 175.55 45.79 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 109.88 -1.288 . . . . 0.14 109.88 179.662 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.4 151.56 42.47 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.957 0.408 . . . . 0.21 110.487 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.81 HH22 ' NE2' ' A' ' 191' ' ' GLN . 77.1 mtm180 -132.29 121.1 23.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.112 -0.495 . . . . 1.54 109.966 179.758 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.507 HG23 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.05 136.62 38.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.781 -0.645 . . . . 1.08 110.661 -179.779 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.552 ' CD ' ' HH ' ' A' ' 157' ' ' TYR . 85.5 tt0 -129.42 129.84 45.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.914 -0.584 . . . . 1.32 110.041 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.605 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 36.0 p90 -138.7 135.36 34.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.024 -0.535 . . . . 1.05 110.66 -179.742 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.408 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.36 161.33 39.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.778 -0.646 . . . . 1.16 109.6 179.897 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.938 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.3 mt -71.11 124.88 25.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.104 0.478 . . . . 1.23 110.768 -179.674 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.499 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.79 -7.61 49.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.664 -0.698 . . . . 0.86 110.861 -179.724 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -109.85 -69.71 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.354 -0.384 . . . . 1.66 111.395 -179.305 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.491 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.61 -35.36 75.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.04 -0.527 . . . . 1.66 111.582 -179.165 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.08 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.12 7.2 88.61 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.895 -0.882 . . . . 1.62 110.895 -179.798 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.335 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.92 -171.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.849 0.357 . . . . 1.86 110.257 179.897 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.335 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.21 138.98 45.29 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.948 0.404 . . . . 1.98 110.229 179.599 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.408 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 48.3 Cg_endo -70.73 145.74 52.33 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 C-N-CA 122.729 2.286 . . . . 0.62 112.377 -179.586 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.79 145.75 42.54 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.251 -0.648 . . . . 1.14 109.251 179.155 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.552 ' HH ' ' CD ' ' A' ' 145' ' ' GLU . 96.4 m-85 -123.31 141.33 52.1 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.346 -0.542 . . . . 1.44 111.553 -179.124 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.419 ' HA ' HD22 ' A' ' 158' ' ' LEU . 71.5 mt -128.08 127.68 43.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.372 -0.831 . . . . 1.08 108.959 178.987 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.552 ' OD1' ' ND2' ' A' ' 16' ' ' ASN . 67.3 m-20 -101.63 131.15 48.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.154 0.502 . . . . 1.09 111.725 -178.726 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.521 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -127.99 157.49 73.73 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.316 -0.857 . . . . 1.04 109.581 179.667 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.67 157.99 58.64 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.414 2.076 . . . . 0.21 112.261 179.936 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.32 -12.09 5.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.823 -0.626 . . . . 0.88 110.689 -179.855 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.9 -8.7 42.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 1.06 110.67 -179.933 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.24 135.41 34.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.368 -0.378 . . . . 1.05 110.425 179.662 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.17 16.71 4.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.348 -0.387 . . . . 1.07 110.476 179.983 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.4 p -167.59 147.1 5.03 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.629 -0.508 . . . . 0.92 109.629 179.797 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.521 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.14 150.49 12.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.567 -0.453 . . . . 1.09 111.592 -179.573 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.494 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.32 124.91 50.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.657 -0.701 . . . . 1.31 109.812 179.499 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.526 HG21 HD21 ' A' ' 172' ' ' LEU . 1.8 mt -99.42 104.93 30.04 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.912 0.387 . . . . 1.09 111.058 -179.884 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.3 Cg_endo -91.0 -179.53 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 123.256 2.638 . . . . 0.48 112.243 179.86 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.69 32.61 18.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.36 -0.836 . . . . 1.26 111.461 179.308 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.526 HD21 HG21 ' A' ' 169' ' ' ILE . 24.5 mt -86.36 148.54 25.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.51 -0.314 . . . . 1.12 110.464 179.619 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.761 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.32 114.93 61.66 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.986 0.422 . . . . 1.3 110.643 -179.701 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -58.95 140.54 95.78 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.949 2.433 . . . . 0.92 111.922 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.1 21.16 74.36 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.018 -0.833 . . . . 0.44 111.018 179.785 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.491 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.81 150.17 49.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 3.05 110.669 179.996 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.499 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.15 131.66 45.97 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.074 -0.512 . . . . 1.48 109.783 179.371 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.938 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.5 m-85 -120.61 148.26 44.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.159 -0.473 . . . . 0.89 111.039 -179.822 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.3 mt -105.35 125.36 60.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.244 -1.021 . . . . 1.12 108.244 177.804 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.53 132.54 63.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.143 0.496 . . . . 1.1 111.228 -178.586 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.51 122.51 20.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.502 -0.772 . . . . 0.43 109.689 179.276 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.591 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.95 125.32 54.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.199 -0.455 . . . . 1.07 110.716 -179.55 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.67 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.7 m-85 -117.15 137.99 51.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.955 -0.566 . . . . 0.92 109.889 179.443 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.555 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.74 134.98 42.9 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.806 -0.813 . . . . 0.49 108.806 178.882 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.784 ' CD1' ' NE ' ' A' ' 143' ' ' ARG . 13.2 mt -99.04 122.9 51.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.116 0.484 . . . . 1.08 110.959 -178.738 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.449 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.7 p -83.83 169.72 14.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.609 -0.723 . . . . 0.89 110.479 -179.693 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -59.86 -14.46 15.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.053 -0.521 . . . . 1.6 110.92 -179.555 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.449 ' H ' ' HG ' ' A' ' 186' ' ' SER . 94.5 m-20 -96.15 -4.24 43.03 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.825 -0.35 . . . . 1.18 110.809 -179.825 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.81 13.89 63.97 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.342 -0.703 . . . . 0.34 111.342 179.835 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -84.63 139.01 32.37 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.076 -0.25 . . . . 1.22 110.424 179.686 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.81 ' NE2' HH22 ' A' ' 143' ' ' ARG . 0.0 OUTLIER -106.69 141.12 38.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.87 0.367 . . . . 1.44 110.558 179.718 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.3 m -136.7 127.03 26.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 1.39 110.327 179.952 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.67 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.5 tp -68.16 117.38 9.91 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.675 -0.41 . . . . 1.08 110.533 -179.95 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.652 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.1 pt -109.01 -21.82 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 1.08 110.773 -179.778 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.5 tp -156.95 125.75 5.84 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.523 -0.471 . . . . 1.1 111.475 -179.77 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.494 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.8 120.23 21.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.787 -0.642 . . . . 0.94 109.519 179.253 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.68 29.08 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.591 -0.444 . . . . 1.07 110.868 -179.265 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.43 158.57 18.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.014 -0.539 . . . . 0.89 110.44 179.702 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.02 157.89 43.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.088 -0.505 . . . . 0.67 110.698 179.995 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.19 104.32 9.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.761 -0.654 . . . . 1.17 110.101 179.493 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.493 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 66.8 p . . . . . 0 C--O 1.221 -0.414 0 CA-C-O 117.953 -1.022 . . . . 1.26 110.631 -179.628 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.553 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.1 m . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.161 -0.681 . . . . 3.83 109.161 . . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.69 18.54 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.011 -0.835 . . . . 1.39 111.011 179.809 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -35.67 142.4 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.084 0 C-N-CA 123.933 3.089 . . . . 0.86 113.76 -179.222 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.566 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.1 t -79.93 173.43 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.173 -1.376 . . . . 1.43 108.785 178.416 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.66 125.78 51.38 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.425 -0.51 . . . . 1.94 111.44 -179.559 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.38 144.01 34.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.692 -0.685 . . . . 1.19 110.652 179.959 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.1 168.24 25.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.97 0.414 . . . . 3.92 111.111 -179.67 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.582 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.96 131.04 60.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.002 -0.544 . . . . 3.88 110.123 179.868 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.12 162.34 35.71 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.822 0.344 . . . . 3.92 111.274 -179.924 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 98.9 mt-10 36.14 31.51 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.592 -0.521 . . . . 6.08 109.592 179.819 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.582 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.59 32.58 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.001 -0.545 . . . . 4.01 111.512 -178.721 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.3 -28.98 72.54 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.424 2.083 . . . . 4.51 111.92 179.301 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.64 125.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.101 -0.499 . . . . 3.51 110.442 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.618 ' O ' ' O ' ' A' ' 92' ' ' THR . 4.7 mt-30 -123.87 158.33 60.32 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 4.3 110.491 179.914 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 143' ' ' ARG . 97.5 Cg_endo -82.07 -64.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.927 2.418 . . . . 1.96 113.515 -179.047 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.662 ' OD1' ' NH1' ' A' ' 143' ' ' ARG . 9.7 m120 -108.49 -19.59 13.4 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.076 0.399 . . . . 3.33 112.076 -178.509 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 8.3 p -107.32 152.06 24.64 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.479 -0.488 . . . . 1.53 111.338 -179.442 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.28 102.94 2.23 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.653 -0.703 . . . . 2.29 110.634 179.894 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.551 ' CD ' HE22 ' A' ' 14' ' ' GLN . 73.8 Cg_endo -82.72 145.53 12.91 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.974 2.45 . . . . 0.88 112.575 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.41 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.76 167.92 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.884 -0.598 . . . . 2.12 109.892 179.579 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.15 147.91 29.02 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.682 -0.488 . . . . 2.67 109.682 178.913 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.503 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.9 p90 -142.2 157.37 44.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.979 0.419 . . . . 0.32 111.242 179.907 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.463 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.12 155.26 44.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.819 -0.628 . . . . 2.77 110.095 179.0 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.59 173.03 6.36 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.105 0.478 . . . . 1.25 110.774 -179.243 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -50.58 173.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.818 2.346 . . . . 1.12 111.588 179.29 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -50.95 0.7 Allowed Pre-proline 0 C--N 1.33 -0.245 0 C-N-CA 120.713 -0.395 . . . . 4.05 110.159 179.81 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.653 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.99 152.36 82.65 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.752 2.301 . . . . 2.12 111.404 179.197 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.5 p -63.76 42.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.355 0.598 . . . . 2.85 110.495 -179.769 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.815 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.7 -41.6 98.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.997 -1.001 . . . . 3.11 110.579 179.8 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.445 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.6 mt -109.79 137.89 39.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.823 -0.626 . . . . 1.86 111.262 -179.421 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.04 -72.9 0.7 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.023 -0.535 . . . . 1.61 111.887 -179.029 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.47 24.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.521 0.564 . . . . 1.67 112.521 -179.609 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.89 124.92 45.24 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.311 -0.626 . . . . 1.07 109.311 177.483 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.2 mt -118.02 134.76 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.703 -0.399 . . . . 1.55 110.666 179.917 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.487 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -120.07 128.64 53.67 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.985 0.422 . . . . 1.33 111.22 179.748 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.547 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.11 139.02 49.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.753 -0.658 . . . . 2.36 110.057 179.001 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.417 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.2 p90 -145.06 163.14 35.18 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.162 0.506 . . . . 0.38 112.086 -178.166 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.488 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.43 139.69 7.97 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 115.472 -0.785 . . . . 2.31 110.441 178.743 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.687 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.3 Cg_endo -63.58 115.45 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.364 2.043 . . . . 0.86 111.836 179.995 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.68 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.05 81.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.973 0.416 . . . . 3.44 109.884 -179.786 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.687 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.26 -20.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.003 -0.544 . . . . 2.72 111.942 -179.442 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.64 157.78 34.24 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 120.887 -0.325 . . . . 2.78 110.561 179.78 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.4 27.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.166 -0.47 . . . . 2.3 110.235 179.517 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.86 -75.89 1.31 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.029 -0.605 . . . . 1.8 111.796 -179.224 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.81 152.34 35.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.92 0.39 . . . . 5.48 110.957 -179.286 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.23 -169.06 2.51 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.043 -0.526 . . . . 1.84 111.938 179.332 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.413 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.18 149.64 29.8 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.449 0.643 . . . . 2.27 112.581 -177.858 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.02 156.49 46.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.853 -1.067 . . . . 1.92 110.236 178.718 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.33 158.35 41.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.966 -0.561 . . . . 1.09 111.722 -179.327 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 m -115.18 135.56 54.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.441 -0.799 . . . . 1.16 109.829 179.314 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.447 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.37 122.04 23.83 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.391 -0.368 . . . . 1.39 111.529 -179.17 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.7 Cg_exo -46.31 151.75 1.62 Allowed 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.734 2.289 . . . . 0.72 112.081 178.987 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.92 -23.0 63.06 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 115.957 -0.565 . . . . 0.74 112.809 -179.312 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.515 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.85 -16.85 46.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.369 0.584 . . . . 1.26 111.756 -178.268 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.492 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.3 mt -91.63 138.47 31.54 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.76 -0.376 . . . . 1.59 110.323 179.362 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.54 13.86 10.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.295 -0.411 . . . . 2.07 111.512 -179.297 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.473 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.98 143.41 25.19 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.664 -0.415 . . . . 0.96 110.998 179.7 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.74 -169.43 1.54 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.932 -179.512 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.711 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 7.7 m -151.66 125.93 9.33 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.429 -0.805 . . . . 1.19 109.946 179.118 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.467 HG23 HD11 ' A' ' 60' ' ' ILE . 66.5 mt -114.85 123.2 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.412 -0.515 . . . . 1.47 111.17 -179.712 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.507 ' HG2' ' N ' ' A' ' 62' ' ' GLY . 86.3 tttt -126.43 163.4 23.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.812 -0.631 . . . . 3.0 110.5 179.645 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.507 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.11 18.97 59.92 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.775 -0.93 . . . . 0.5 110.775 -179.922 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.434 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.4 mt -78.95 157.22 28.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.135 0.493 . . . . 1.21 111.385 -179.696 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.61 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 2.9 mttp -99.52 133.95 21.52 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.593 -0.73 . . . . 3.2 110.442 179.758 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.528 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.81 143.57 61.82 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.553 2.169 . . . . 1.09 111.975 179.794 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.87 25.55 75.43 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.016 -0.834 . . . . 0.72 111.016 179.716 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.645 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.1 158.82 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.709 0.29 . . . . 1.47 110.448 -179.591 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.15 139.79 42.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.924 0.392 . . . . 1.23 110.575 -179.74 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.645 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.51 136.52 54.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.001 -0.545 . . . . 1.1 110.78 -179.984 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.89 131.06 45.27 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.492 -0.929 . . . . 1.87 108.492 177.622 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.49 153.85 16.65 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.3 -0.952 . . . . 0.39 111.965 -178.664 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.92 141.02 46.19 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.687 -0.486 . . . . 1.8 109.687 179.504 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.47 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.8 tp -115.83 118.89 34.26 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.499 -0.48 . . . . 1.11 110.534 179.651 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.1 mt -112.42 129.11 68.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.239 -0.437 . . . . 1.51 110.585 -179.874 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.81 120.86 43.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.326 -0.397 . . . . 1.47 110.707 -179.726 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.668 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.6 146.43 11.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.491 . . . . 1.33 110.978 -179.271 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.815 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.1 mt-30 -106.03 153.87 21.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.508 -0.769 . . . . 2.49 109.938 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.16 88.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.917 0.389 . . . . 4.2 110.45 -179.729 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.624 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.25 32.72 0.21 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.819 -0.628 . . . . 6.4 110.573 -179.923 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.23 -117.39 3.27 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.407 -0.677 . . . . 1.74 111.407 -179.727 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.45 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.25 177.41 9.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.238 0.542 . . . . 3.64 111.604 -179.218 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.21 149.47 31.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.401 -0.818 . . . . 1.7 110.418 179.108 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.553 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.15 144.62 38.69 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.487 -0.324 . . . . 2.7 110.562 179.905 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -127.89 135.99 61.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 120.649 -0.421 . . . . 1.16 111.552 -179.761 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.03 141.41 52.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.714 -0.675 . . . . 1.14 110.318 179.544 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.456 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.78 138.92 51.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.184 0.516 . . . . 4.33 111.428 -179.324 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.29 164.23 37.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.513 -0.767 . . . . 0.91 109.42 179.438 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.57 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.32 151.52 38.45 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.384 -0.526 . . . . 1.47 110.996 -179.994 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.572 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.9 p90 -146.17 172.76 12.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.754 -0.657 . . . . 0.51 111.0 179.844 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.445 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.74 160.74 21.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.42 -0.809 . . . . 1.92 109.863 179.561 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.445 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.43 121.85 22.85 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.645 -0.422 . . . . 1.63 110.766 179.974 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.618 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.8 p -126.42 163.75 22.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.346 0.593 . . . . 2.37 112.08 179.72 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.2 t -103.66 150.17 24.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.413 -0.812 . . . . 3.63 110.665 -179.686 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.0 t -59.98 167.79 2.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.952 -179.164 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 54.9 p -65.44 162.33 18.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.432 -178.749 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.6 83.93 53.42 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.542 -179.386 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.56 147.42 30.37 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.006 1.804 . . . . 0.0 111.618 -179.439 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.638 HG12 ' H ' ' A' ' 100' ' ' SER . 23.5 t -111.02 136.97 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.76 -178.721 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.1 p -66.88 -5.49 12.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.274 -179.469 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.638 ' H ' HG12 ' A' ' 98' ' ' VAL . 32.6 t -57.26 162.61 2.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.366 -179.438 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.3 m120 62.61 44.19 7.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.225 0.536 . . . . 0.0 109.878 -178.535 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.427 HG21 ' H ' ' A' ' 104' ' ' THR . 39.9 m -77.99 141.84 38.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.369 179.863 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 78.1 t -58.13 -39.5 73.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.439 -179.426 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.427 ' H ' HG21 ' A' ' 102' ' ' THR . 19.4 p -120.8 159.63 25.05 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.748 0.308 . . . . 0.0 110.348 179.764 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -159.69 47.86 0.41 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.831 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -91.4 151.96 20.61 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.127 0.489 . . . . 0.0 111.021 -179.692 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 48.0 m -56.13 -37.04 68.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.143 -178.759 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 50.2 m -121.92 80.55 42.04 Favored Pre-proline 0 N--CA 1.467 0.388 0 CA-C-O 120.581 0.229 . . . . 0.0 111.4 -179.007 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -55.28 150.24 41.77 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.592 2.195 . . . . 0.0 111.779 179.422 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.404 ' O ' ' CB ' ' A' ' 111' ' ' SER . 49.7 p90 -66.4 144.03 56.77 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.961 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.616 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 0.2 OUTLIER 168.0 -36.79 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.566 -179.464 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 111' ' ' SER . 53.2 Cg_exo -55.19 -18.05 16.93 Favored 'Trans proline' 0 N--CA 1.501 1.952 0 C-N-CA 122.772 2.315 . . . . 0.0 113.323 -178.958 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.5 mt -85.56 143.02 28.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.91 0.386 . . . . 10.52 110.776 -179.309 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.4 p -57.16 -34.27 45.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.903 -0.59 . . . . 7.48 110.779 -179.484 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.94 -24.72 67.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.073 -0.512 . . . . 7.69 109.938 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.9 p -116.06 164.38 14.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.48 -0.782 . . . . 6.46 110.602 -179.338 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 111' ' ' SER . 26.2 t -69.9 156.29 39.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.087 -0.506 . . . . 4.59 110.883 -179.383 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.495 ' HG2' ' H ' ' A' ' 120' ' ' VAL . 84.2 tt0 -87.41 139.72 30.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.206 -0.452 . . . . 3.21 110.041 -179.63 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.574 ' O ' ' O ' ' A' ' 120' ' ' VAL . 85.8 p -61.52 -29.07 69.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 3.64 111.675 -178.678 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.574 ' O ' ' O ' ' A' ' 119' ' ' SER . 61.1 t 50.18 117.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.742 0.306 . . . . 3.39 110.722 -179.809 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 47.6 m -117.55 137.37 52.62 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.039 0.447 . . . . 2.23 110.726 -179.841 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.48 ' OE2' ' CB ' ' A' ' 125' ' ' ALA . 83.0 tt0 -113.51 141.55 47.0 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.895 -0.78 . . . . 4.53 108.895 -179.991 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.63 ' O ' ' N ' ' A' ' 125' ' ' ALA . 72.2 mt -115.22 135.14 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 113.746 1.017 . . . . 2.01 113.746 -176.999 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 82.4 p 33.26 17.72 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.499 -1.228 . . . . 2.22 113.922 177.795 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.63 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . -64.44 -28.85 69.95 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.709 -0.396 . . . . 1.29 111.057 179.606 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 95.7 p 49.88 -89.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.715 -0.476 . . . . 1.25 109.715 -178.374 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.7 167.48 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.019 0.438 . . . . 1.16 111.005 179.481 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.56 145.6 50.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.718 -0.674 . . . . 0.78 110.101 -179.949 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.3 101.72 9.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.986 -0.746 . . . . 1.08 108.986 177.755 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.465 HG11 ' N ' ' A' ' 131' ' ' SER . 70.9 t -112.99 139.7 36.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.089 -0.505 . . . . 1.1 111.054 -178.904 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.465 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.7 p -128.74 152.5 48.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.603 -0.726 . . . . 0.87 109.849 179.603 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.645 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.7 p90 -144.72 -164.98 2.04 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.732 -0.387 . . . . 0.37 110.688 -179.736 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -123.93 127.17 73.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 1.14 110.843 -179.885 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.164 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.95 58.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.178 -0.464 . . . . 1.91 110.329 179.862 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.07 24.41 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.916 -0.584 . . . . 1.56 111.499 -179.673 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.164 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.22 128.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.568 -0.453 . . . . 1.56 110.899 179.829 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.31 -9.76 55.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.879 -0.601 . . . . 1.88 110.323 179.76 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.4 p -87.04 0.26 55.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 1.63 110.4 179.994 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.955 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.29 137.25 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.877 -0.601 . . . . 1.11 109.969 179.74 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 185' ' ' ILE . 88.8 p -96.27 -15.54 21.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.279 0.562 . . . . 1.01 110.035 -179.643 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.441 ' HA3' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.58 175.56 45.77 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.83 -1.308 . . . . 0.14 109.83 179.679 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -123.49 151.59 42.6 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.621 -0.431 . . . . 0.21 110.468 179.723 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.662 ' NH1' ' OD1' ' A' ' 16' ' ' ASN . 12.7 ttt85 -132.29 121.1 23.04 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.086 -0.506 . . . . 1.54 110.005 179.805 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.496 HG23 HG11 ' A' ' 167' ' ' VAL . 46.0 t -105.03 136.49 38.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.777 -0.647 . . . . 1.08 110.724 -179.759 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 78.8 tt0 -129.27 129.91 45.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.061 -0.518 . . . . 1.32 110.151 179.98 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.595 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.71 135.34 34.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.994 -0.548 . . . . 1.05 110.623 -179.709 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.403 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.34 161.38 39.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.703 -0.68 . . . . 1.16 109.716 179.846 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.94 HD21 ' CE2' ' A' ' 178' ' ' TYR . 85.8 mt -71.12 124.91 25.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.986 0.422 . . . . 1.23 110.689 -179.534 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.502 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.8 -7.68 49.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.739 -0.664 . . . . 0.86 110.862 -179.81 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -109.84 -69.58 0.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.365 -0.38 . . . . 1.66 111.519 -179.381 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.455 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.69 -35.32 76.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.095 -0.502 . . . . 1.66 111.569 -179.192 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.086 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.2 7.2 88.62 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.75 -0.94 . . . . 1.62 110.75 -179.936 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.325 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.85 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 1.86 110.291 179.801 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.325 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.25 139.08 45.17 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 1.98 110.165 179.64 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.403 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.3 Cg_endo -70.94 145.84 51.38 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 C-N-CA 122.712 2.275 . . . . 0.62 112.31 -179.546 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.87 145.81 42.56 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.182 -0.673 . . . . 1.14 109.182 179.267 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.657 ' CD2' ' OD1' ' A' ' 16' ' ' ASN . 51.0 p90 -123.38 141.27 52.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.185 0.517 . . . . 1.44 111.536 -179.093 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.406 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.5 mt -128.05 127.65 43.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.242 -0.89 . . . . 1.08 108.92 179.007 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 19.1 t0 -101.58 131.05 47.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.15 0.5 . . . . 1.09 111.824 -178.85 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.517 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.1 mt -127.83 157.61 73.04 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.303 -0.862 . . . . 1.04 109.624 179.624 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.84 158.04 58.21 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.395 2.063 . . . . 0.21 112.239 179.938 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.2 p -59.24 -12.22 5.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.739 -0.664 . . . . 0.88 110.746 -179.824 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.4 p -92.81 -8.68 42.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.09 -0.505 . . . . 1.06 110.689 -179.883 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.3 135.35 34.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.332 -0.395 . . . . 1.05 110.318 179.734 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.4 p -133.08 16.69 4.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.322 -0.399 . . . . 1.07 110.508 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.0 p -167.54 147.05 5.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.579 -0.526 . . . . 0.92 109.579 179.851 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.506 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.11 150.48 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.095 0.474 . . . . 1.09 111.585 -179.695 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.3 125.01 50.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.571 -0.741 . . . . 1.31 109.828 179.456 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.515 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.4 104.93 30.03 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.358 -0.383 . . . . 1.09 111.066 -179.895 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.5 Cg_endo -90.98 -179.5 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 123.22 2.613 . . . . 0.48 112.15 179.916 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.74 32.53 18.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.371 -0.831 . . . . 1.26 111.418 179.175 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.515 HD21 HG21 ' A' ' 169' ' ' ILE . 24.2 mt -86.33 148.53 25.56 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.911 -0.315 . . . . 1.12 110.505 179.587 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.776 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.32 114.88 61.43 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 121.069 0.461 . . . . 1.3 110.688 -179.732 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.97 140.5 95.62 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.877 2.384 . . . . 0.92 112.1 179.815 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.18 21.13 74.2 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.029 -0.828 . . . . 0.44 111.029 179.907 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.455 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.77 150.25 49.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.75 0.31 . . . . 3.05 110.747 179.881 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.502 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.22 131.65 46.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.063 -0.517 . . . . 1.48 109.799 179.333 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.94 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.47 148.33 43.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.079 -0.51 . . . . 0.89 111.077 -179.892 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.34 125.4 60.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.281 -1.007 . . . . 1.12 108.281 177.701 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.63 132.55 63.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.308 0.575 . . . . 1.1 111.17 -178.595 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.5 122.59 20.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.433 -0.803 . . . . 0.43 109.642 179.285 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.591 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.3 t -101.05 125.39 55.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.2 -0.454 . . . . 1.07 110.598 -179.436 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.67 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.3 m-85 -117.25 137.88 52.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.017 -0.538 . . . . 0.92 109.899 179.456 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.573 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.68 135.02 42.79 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.811 -0.811 . . . . 0.49 108.811 178.872 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 140' ' ' SER . 5.2 mp -99.04 122.94 51.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.16 0.505 . . . . 1.08 110.926 -178.747 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.451 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.3 p -83.86 169.79 14.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.517 -0.765 . . . . 0.89 110.453 -179.71 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.89 -14.53 15.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.048 -0.523 . . . . 1.6 110.823 -179.504 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.548 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.3 m-20 -96.11 -4.22 43.21 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.817 -0.353 . . . . 1.18 110.847 -179.811 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.466 ' N ' HG22 ' A' ' 59' ' ' THR . . . 87.74 13.9 64.09 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.376 -0.69 . . . . 0.34 111.376 179.858 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.62 139.03 32.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.652 0.263 . . . . 1.22 110.438 179.652 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.448 ' NE2' ' HD3' ' A' ' 143' ' ' ARG . 97.1 mt-30 -106.69 141.04 38.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.809 0.337 . . . . 1.44 110.617 179.675 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 61.8 m -136.65 127.12 26.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 1.39 110.316 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.67 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.4 tp -68.1 117.36 9.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.287 -0.415 . . . . 1.08 110.584 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.645 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.0 pt -109.18 -21.67 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 1.08 110.732 -179.69 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.97 125.73 5.82 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.542 -0.463 . . . . 1.1 111.521 -179.879 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.496 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.79 120.13 21.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.777 -0.647 . . . . 0.94 109.58 179.248 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.55 151.71 29.19 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.639 -0.424 . . . . 1.07 110.882 -179.276 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.8 p -110.36 158.56 18.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.019 -0.537 . . . . 0.89 110.442 179.709 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -146.05 157.86 43.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.67 110.663 -179.969 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.31 104.36 9.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.801 -0.636 . . . . 1.17 110.043 179.49 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.474 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 66.9 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.843 -1.075 . . . . 1.26 110.621 -179.655 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.2 m . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.189 -0.671 . . . . 3.83 109.189 . . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.66 18.54 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.988 -0.845 . . . . 1.39 110.988 179.72 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -35.47 142.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.058 0 C-N-CA 123.934 3.089 . . . . 0.86 113.832 -179.283 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.569 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -79.99 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.274 -1.33 . . . . 1.43 108.83 178.368 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -105.62 125.94 51.57 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.376 -0.529 . . . . 1.94 111.461 -179.601 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.47 144.01 33.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.63 -0.713 . . . . 1.19 110.72 179.869 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.03 168.34 25.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.925 0.393 . . . . 3.92 111.137 -179.674 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.585 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.5 mt -109.06 131.02 60.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.957 -0.565 . . . . 3.88 110.024 179.928 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.15 162.36 35.67 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.865 0.364 . . . . 3.92 111.219 -179.961 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 16.9 pt-20 36.16 31.45 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.682 -0.488 . . . . 6.08 109.682 179.847 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.585 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.4 69.61 32.3 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.934 -0.575 . . . . 4.01 111.593 -178.747 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.28 -29.08 72.73 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.497 2.132 . . . . 4.51 111.822 179.354 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.58 125.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 3.51 110.481 -179.947 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 17' ' ' SER . 13.2 mp0 -123.8 158.41 59.85 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.294 -0.412 . . . . 4.3 110.456 179.959 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.468 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 97.2 Cg_endo -82.1 -64.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.861 2.374 . . . . 1.96 113.456 -179.039 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.674 ' OD1' ' N ' ' A' ' 17' ' ' SER . 1.4 p-10 -108.39 -19.61 13.4 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.106 0.41 . . . . 3.33 112.106 -178.498 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.674 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 33.4 m -107.34 152.1 24.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.116 0.484 . . . . 1.53 111.328 -179.421 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.37 102.96 2.21 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.693 -0.685 . . . . 2.29 110.652 179.804 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.6 145.57 13.12 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.921 2.414 . . . . 0.88 112.61 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.414 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.78 167.9 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.955 -0.566 . . . . 2.12 109.842 179.567 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.17 147.9 28.99 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.812 -0.44 . . . . 2.67 109.812 178.822 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.503 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.5 p90 -142.21 157.32 44.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.005 0.431 . . . . 0.32 111.11 -179.951 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.463 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.0 m-20 -128.09 155.19 44.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.699 -0.682 . . . . 2.77 110.086 178.978 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.55 173.04 6.35 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.185 -0.462 . . . . 1.25 110.732 -179.193 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.58 173.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.974 2.449 . . . . 1.12 111.492 179.333 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.479 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.09 -51.03 0.69 Allowed Pre-proline 0 C--N 1.328 -0.349 0 C-N-CA 120.666 -0.414 . . . . 4.05 110.078 179.853 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.654 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.84 152.32 82.57 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.798 2.332 . . . . 2.12 111.483 179.219 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.67 42.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.38 0.61 . . . . 2.85 110.534 -179.869 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.817 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.67 -41.58 98.17 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.032 -0.985 . . . . 3.11 110.68 179.709 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.444 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.6 mt -109.93 137.82 40.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.773 -0.648 . . . . 1.86 111.271 -179.439 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.92 -72.98 0.7 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.999 -0.546 . . . . 1.61 111.865 -178.963 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.16 148.42 24.42 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.587 0.588 . . . . 1.67 112.587 -179.625 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.85 124.87 45.14 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.319 -0.623 . . . . 1.07 109.319 177.572 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.02 134.67 60.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.718 -0.393 . . . . 1.55 110.72 179.939 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.489 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -119.96 128.67 53.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.055 0.455 . . . . 1.33 111.275 179.788 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 138.88 49.64 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.758 -0.655 . . . . 2.36 110.08 179.087 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.414 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -145.0 163.23 34.84 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.158 0.504 . . . . 0.38 112.086 -178.198 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.486 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.51 139.57 7.83 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.482 -0.781 . . . . 2.31 110.451 178.846 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.684 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.9 Cg_endo -63.54 115.44 3.04 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.279 1.986 . . . . 0.86 111.891 179.938 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.679 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.3 tttp -46.99 81.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.871 -0.418 . . . . 3.44 109.871 -179.827 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.58 0.06 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.92 -0.582 . . . . 2.72 111.874 -179.584 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 p -157.7 157.81 34.21 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 120.747 -0.381 . . . . 2.78 110.561 179.764 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.42 27.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 2.3 110.161 179.659 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.81 -75.89 1.31 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.19 -0.528 . . . . 1.8 111.861 -179.243 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.96 152.32 35.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.968 0.413 . . . . 5.48 110.988 -179.383 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.18 -169.14 2.54 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.993 -0.549 . . . . 1.84 111.922 179.425 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.414 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.6 mttp -110.14 149.62 29.81 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.477 0.656 . . . . 2.27 112.599 -177.922 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.0 156.58 46.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.768 -1.105 . . . . 1.92 110.306 178.6 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.3 158.39 41.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.901 -0.59 . . . . 1.09 111.785 -179.311 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.8 m -115.25 135.67 53.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.459 -0.791 . . . . 1.16 109.784 179.317 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.449 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.43 121.95 23.73 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.419 -0.355 . . . . 1.39 111.505 -179.105 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.513 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.0 Cg_exo -46.34 151.73 1.64 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.639 2.226 . . . . 0.72 112.189 179.019 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.89 -23.07 63.07 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-N 116.063 -0.517 . . . . 0.74 112.81 -179.189 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.513 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.79 -16.9 46.07 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.237 -0.585 . . . . 1.26 111.761 -178.274 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.489 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.54 138.48 31.54 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.689 -0.404 . . . . 1.59 110.309 179.372 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.6 13.98 10.95 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.404 -0.362 . . . . 2.07 111.567 -179.416 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.472 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.98 143.44 25.21 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.607 -0.437 . . . . 0.96 111.052 179.586 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.708 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.82 -169.36 1.53 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.203 0.525 . . . . 1.0 110.916 -179.523 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.708 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 t -151.69 125.89 9.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.448 -0.796 . . . . 1.19 109.84 179.262 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.466 HG23 HD11 ' A' ' 60' ' ' ILE . 66.7 mt -114.83 123.27 70.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.33 -0.548 . . . . 1.47 111.205 -179.785 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -126.43 163.41 23.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.872 -0.603 . . . . 3.0 110.379 179.788 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.16 18.83 60.11 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.783 -0.927 . . . . 0.5 110.783 -179.953 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.437 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 74.2 mt -79.05 157.31 28.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.156 0.503 . . . . 1.21 111.28 -179.521 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.613 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 4.8 mptp? -99.59 134.0 21.44 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.554 -0.748 . . . . 3.2 110.414 179.8 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.401 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.9 Cg_endo -67.8 143.64 62.09 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.591 2.194 . . . . 1.09 111.971 179.784 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.75 25.62 75.34 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.101 -0.8 . . . . 0.72 111.101 179.705 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.645 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.15 158.78 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.692 0.282 . . . . 1.47 110.397 -179.574 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.17 139.96 41.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.882 0.372 . . . . 1.23 110.621 -179.825 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.645 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.2 m-85 -122.56 136.33 54.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.994 -0.548 . . . . 1.1 110.818 -179.901 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.486 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.79 131.05 45.22 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.546 -0.909 . . . . 1.87 108.546 177.593 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.48 153.79 16.66 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.308 -0.949 . . . . 0.39 111.986 -178.579 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.92 140.92 46.13 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.658 -0.497 . . . . 1.8 109.658 179.584 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.467 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.1 tp -115.75 118.84 34.15 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.452 -0.499 . . . . 1.11 110.536 179.672 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.42 129.05 68.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.339 -0.391 . . . . 1.51 110.658 -179.862 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.74 120.88 43.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.27 -0.423 . . . . 1.47 110.73 -179.634 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.667 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.62 146.5 11.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.17 0.51 . . . . 1.33 110.944 -179.223 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.817 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.06 153.93 21.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.46 -0.791 . . . . 2.49 109.891 179.826 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.18 88.52 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.896 0.379 . . . . 4.2 110.424 -179.809 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.36 32.52 0.22 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.873 -0.603 . . . . 6.4 110.628 -179.953 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.02 -117.38 3.3 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.431 -0.667 . . . . 1.74 111.431 -179.693 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.451 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.43 177.42 8.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.135 0.493 . . . . 3.64 111.658 -179.189 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.1 149.54 32.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.503 -0.771 . . . . 1.7 110.391 179.167 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.18 144.66 38.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.471 -0.331 . . . . 2.7 110.515 179.863 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -127.94 136.09 61.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 121.035 0.445 . . . . 1.16 111.57 -179.806 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.7 m -124.15 141.29 52.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.753 -0.658 . . . . 1.14 110.316 179.635 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.451 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.58 138.91 51.62 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.125 0.488 . . . . 4.33 111.524 -179.339 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.3 164.14 38.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.575 -0.739 . . . . 0.91 109.474 179.386 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.57 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.1 p30 -145.29 151.57 38.56 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.293 -0.563 . . . . 1.47 111.011 179.937 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.572 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.0 p90 -146.21 172.72 13.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.792 -0.64 . . . . 0.51 111.079 179.895 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.446 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.77 160.7 21.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.57 -0.741 . . . . 1.92 109.847 179.644 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.446 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.46 121.89 22.88 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.524 -0.47 . . . . 1.63 110.712 -179.965 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.6 p -125.41 151.83 45.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.909 0.862 . . . . 2.37 112.908 179.695 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.9 t -63.55 -33.94 76.7 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 114.053 -1.43 . . . . 3.63 113.876 -179.402 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.2 p -78.78 158.53 28.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.438 0.637 . . . . 0.0 112.43 -176.966 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.622 ' O ' ' C ' ' A' ' 96' ' ' THR . 83.2 p -147.15 160.19 42.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.414 179.158 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.622 ' C ' ' O ' ' A' ' 95' ' ' SER . 30.1 p 0.21 76.37 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.714 0 O-C-N 123.237 0.336 . . . . 0.0 111.603 179.667 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.467 ' N ' ' O ' ' A' ' 95' ' ' SER . 31.4 Cg_exo -56.65 139.26 87.75 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.198 1.932 . . . . 0.0 112.321 -179.118 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.614 ' C ' ' H ' ' A' ' 100' ' ' SER . 5.9 p -61.94 -34.37 62.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.758 179.565 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 98' ' ' VAL . 70.0 p 53.99 -4.9 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.197 -179.382 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.614 ' H ' ' C ' ' A' ' 98' ' ' VAL . 32.3 t -60.84 -35.3 76.18 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.0 179.285 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -87.62 7.19 30.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.891 -178.893 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.0 m -76.9 134.58 38.92 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.797 -179.774 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.6 p -133.64 143.26 39.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.201 179.721 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.2 p -82.33 160.66 22.8 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.614 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.1 37.68 37.04 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.938 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -56.27 143.26 34.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.013 0.435 . . . . 0.0 110.745 -179.258 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.0 p -87.17 163.26 17.04 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.95 -179.706 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.41 81.46 59.17 Favored Pre-proline 0 N--CA 1.465 0.313 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.002 179.722 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.47 143.95 53.1 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.509 2.139 . . . . 0.0 112.626 -179.124 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.514 ' CD2' ' OG ' ' A' ' 111' ' ' SER . 68.4 t80 -102.15 135.78 43.15 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.305 179.888 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.514 ' OG ' ' CD2' ' A' ' 110' ' ' PHE . 14.7 m 62.13 71.17 0.75 Allowed Pre-proline 0 N--CA 1.464 0.23 0 CA-C-O 120.793 0.33 . . . . 0.0 110.785 -179.724 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -50.64 149.87 13.06 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.899 2.399 . . . . 0.0 112.224 -179.609 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.4 mt -58.24 -34.12 70.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.835 -0.62 . . . . 10.52 111.104 -179.285 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.477 ' O ' ' CB ' ' A' ' 115' ' ' ALA . 41.4 t -110.73 133.63 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.765 0.316 . . . . 7.48 110.674 -179.689 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 114' ' ' VAL . . . 156.65 17.67 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.621 -0.718 . . . . 7.69 109.625 179.957 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.3 p -84.24 162.25 20.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.057 -0.519 . . . . 6.46 111.167 -179.265 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.686 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 47.0 m -65.03 159.05 24.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.598 -0.728 . . . . 4.59 110.861 179.835 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.686 ' HG3' ' O ' ' A' ' 117' ' ' SER . 95.0 mt-10 132.09 69.12 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.479 1.112 . . . . 3.21 110.46 179.929 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.4 p -62.8 -25.82 68.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.916 -0.583 . . . . 3.64 110.488 179.494 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.4 t -112.43 135.85 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.932 -0.576 . . . . 3.39 110.158 -179.928 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 21.1 p -121.83 161.94 21.81 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.116 0.484 . . . . 2.23 111.157 -179.326 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -103.41 146.48 28.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.516 -0.766 . . . . 4.53 109.656 179.821 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 70.8 mt -108.8 132.32 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.204 0.526 . . . . 2.01 110.63 -179.368 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 67.1 m -124.18 145.59 49.23 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.298 -0.865 . . . . 2.22 110.472 -179.576 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -58.09 142.1 48.03 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.28 0.562 . . . . 1.29 111.112 -179.234 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 170.77 19.92 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 122.668 1.223 . . . . 1.25 108.137 -179.445 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.478 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.82 167.6 0.25 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.121 -1.399 . . . . 1.16 110.904 -178.85 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.69 145.56 50.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.692 -0.686 . . . . 0.78 110.084 -179.934 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.26 101.7 9.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.07 -0.715 . . . . 1.08 109.07 177.678 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.458 HG11 ' N ' ' A' ' 131' ' ' SER . 71.2 t -112.88 139.69 36.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.989 -0.551 . . . . 1.1 111.073 -178.914 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.458 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.9 p -128.68 152.55 48.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.637 -0.71 . . . . 0.87 109.84 179.568 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.645 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.8 p90 -144.81 -164.98 2.04 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.693 -0.403 . . . . 0.37 110.64 -179.764 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.733 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.6 t -123.95 127.16 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 1.14 110.844 -179.88 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.174 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.94 58.36 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.103 -0.499 . . . . 1.91 110.415 179.808 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.29 24.59 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.931 -0.577 . . . . 1.56 111.479 -179.541 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.174 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.2 128.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.686 -0.405 . . . . 1.56 111.004 179.8 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -86.45 -9.62 55.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.886 -0.597 . . . . 1.88 110.337 179.775 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.12 0.35 55.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.094 -0.503 . . . . 1.63 110.289 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.959 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.34 137.19 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 1.11 109.977 179.663 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 185' ' ' ILE . 76.6 p -96.28 -15.4 21.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.304 0.574 . . . . 1.01 110.044 -179.649 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.52 175.58 45.72 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.856 -1.297 . . . . 0.14 109.856 179.59 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.45 151.63 42.49 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.62 -0.432 . . . . 0.21 110.484 179.745 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.443 ' NH1' ' HG2' ' A' ' 15' ' ' PRO . 45.2 ttp180 -132.33 121.22 23.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.143 -0.48 . . . . 1.54 109.899 179.814 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.5 HG23 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.13 136.54 38.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.732 -0.667 . . . . 1.08 110.634 -179.711 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 80.7 tt0 -129.5 129.86 45.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.975 -0.557 . . . . 1.32 110.006 -179.91 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.69 135.32 34.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.937 -0.574 . . . . 1.05 110.633 -179.676 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.409 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.32 161.4 39.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.753 -0.658 . . . . 1.16 109.619 179.875 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.942 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.1 mt -71.04 124.8 25.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.973 0.416 . . . . 1.23 110.772 -179.642 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.79 -7.64 49.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.832 -0.622 . . . . 0.86 110.875 -179.738 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -109.82 -69.72 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.963 0.411 . . . . 1.66 111.407 -179.267 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.47 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.69 -35.31 75.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.014 -0.539 . . . . 1.66 111.563 -179.155 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.076 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.07 7.29 88.55 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.829 -0.908 . . . . 1.62 110.829 -179.83 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.319 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.95 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.734 0.302 . . . . 1.86 110.322 179.818 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.319 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.13 45.22 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.976 0.417 . . . . 1.98 110.193 179.624 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.409 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.8 Cg_endo -70.85 145.9 52.06 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 C-N-CA 122.621 2.214 . . . . 0.62 112.368 -179.568 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.87 145.73 42.63 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.21 -0.663 . . . . 1.14 109.21 179.21 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.455 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 6.0 p90 -123.24 141.31 52.11 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.399 -0.52 . . . . 1.44 111.57 -179.108 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.409 ' HA ' HD22 ' A' ' 158' ' ' LEU . 71.3 mt -128.18 127.73 43.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.337 -0.847 . . . . 1.08 108.844 178.956 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.548 ' OD1' ' O ' ' A' ' 159' ' ' ASP . 54.4 p-10 -101.65 131.15 48.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.174 0.511 . . . . 1.09 111.751 -178.76 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.504 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -127.92 157.49 73.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.362 -0.836 . . . . 1.04 109.559 179.768 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -69.76 158.0 58.47 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.485 2.123 . . . . 0.21 112.203 179.903 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.2 p -59.27 -12.16 5.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.755 -0.657 . . . . 0.88 110.75 -179.842 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.81 -8.84 42.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.113 -0.494 . . . . 1.06 110.678 -179.823 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.11 135.32 34.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.325 -0.398 . . . . 1.05 110.463 179.68 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 32.1 p -133.07 16.6 4.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.465 -0.334 . . . . 1.07 110.582 179.953 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.1 p -167.53 147.09 5.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.61 -0.515 . . . . 0.92 109.61 179.897 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.504 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.2 p -152.2 150.52 12.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.518 -0.473 . . . . 1.09 111.528 -179.632 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.39 124.98 50.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.608 -0.724 . . . . 1.31 109.763 179.517 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.515 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.39 104.93 29.96 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.909 0.385 . . . . 1.09 111.02 -179.879 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.0 Cg_endo -91.03 -179.56 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 123.12 2.547 . . . . 0.48 112.179 179.89 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 61.81 32.54 18.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.372 -0.831 . . . . 1.26 111.435 179.246 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.515 HD21 HG21 ' A' ' 169' ' ' ILE . 24.0 mt -86.46 148.5 25.52 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.918 -0.313 . . . . 1.12 110.474 179.592 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.777 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.27 114.85 61.27 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 121.06 0.457 . . . . 1.3 110.674 -179.64 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -58.95 140.63 96.15 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.9 2.4 . . . . 0.92 111.99 179.853 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 76.99 21.26 74.44 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.082 -0.807 . . . . 0.44 111.082 179.864 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.47 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.84 150.15 49.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.783 0.325 . . . . 3.05 110.669 179.944 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.5 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.17 131.66 45.99 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.047 -0.524 . . . . 1.48 109.784 179.28 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.942 ' CE2' HD21 ' A' ' 148' ' ' LEU . 75.2 m-85 -120.5 148.32 43.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.096 -0.502 . . . . 0.89 110.951 -179.813 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.35 125.39 60.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.295 -1.002 . . . . 1.12 108.295 177.657 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.59 132.45 63.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.206 0.527 . . . . 1.1 111.274 -178.61 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.45 122.6 20.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.46 -0.791 . . . . 0.43 109.64 179.278 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.595 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -101.02 125.41 54.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.234 -0.439 . . . . 1.07 110.72 -179.566 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.673 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.3 m-85 -117.22 137.91 52.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.992 -0.549 . . . . 0.92 109.884 179.535 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.571 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.75 135.04 42.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.801 -0.815 . . . . 0.49 108.801 178.872 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 140' ' ' SER . 80.6 mt -98.98 122.93 51.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.134 0.492 . . . . 1.08 110.981 -178.774 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.45 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.8 p -83.89 169.67 14.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.593 -0.73 . . . . 0.89 110.447 -179.709 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.82 -14.49 15.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.996 -0.547 . . . . 1.6 110.928 -179.552 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.45 ' H ' ' HG ' ' A' ' 186' ' ' SER . 95.2 m-20 -96.05 -4.3 43.24 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.857 -0.337 . . . . 1.18 110.808 -179.832 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.445 ' CA ' ' HG1' ' A' ' 59' ' ' THR . . . 87.83 13.84 64.01 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.351 -0.699 . . . . 0.34 111.351 179.848 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -84.64 139.1 32.3 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.774 -0.251 . . . . 1.22 110.43 179.737 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.4 ' OE1' ' NH1' ' A' ' 143' ' ' ARG . 15.2 pt20 -106.72 141.07 38.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.423 -0.353 . . . . 1.44 110.53 179.773 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.75 127.06 26.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 1.39 110.332 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.673 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.8 tp -68.13 117.21 9.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.247 -0.433 . . . . 1.08 110.42 -179.876 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.645 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.1 pt -108.98 -21.83 5.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 1.08 110.688 -179.787 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.82 125.82 5.95 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.512 -0.475 . . . . 1.1 111.476 -179.803 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.489 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.82 120.15 21.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.764 -0.653 . . . . 0.94 109.564 179.174 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.63 151.63 29.03 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.691 -0.404 . . . . 1.07 110.932 -179.284 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.31 158.64 18.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.041 -0.527 . . . . 0.89 110.431 179.723 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -146.12 157.86 43.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.078 -0.51 . . . . 0.67 110.652 -179.997 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.22 104.29 9.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.827 -0.624 . . . . 1.17 110.086 179.522 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.478 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.0 p . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.851 -1.071 . . . . 1.26 110.727 -179.727 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.4 m . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.269 -0.641 . . . . 3.83 109.269 . . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.74 18.53 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.032 -0.827 . . . . 1.39 111.032 179.683 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -35.7 142.38 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.113 0 C-N-CA 124.004 3.136 . . . . 0.86 113.806 -179.247 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.57 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.0 t -79.93 173.4 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.14 -1.391 . . . . 1.43 108.888 178.41 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.53 125.86 51.46 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.448 -0.501 . . . . 1.94 111.496 -179.618 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.51 143.99 33.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.687 -0.688 . . . . 1.19 110.585 179.967 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.07 168.27 25.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.934 0.397 . . . . 3.92 111.074 -179.671 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.59 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 65.9 mt -108.93 131.01 60.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.946 -0.57 . . . . 3.88 110.139 179.877 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.14 162.27 35.88 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.869 0.366 . . . . 3.92 111.247 -179.88 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.7 mt-10 36.21 31.5 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.601 -0.518 . . . . 6.08 109.601 179.781 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.59 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.63 33.17 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.962 -0.563 . . . . 4.01 111.555 -178.764 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.642 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.24 -29.22 73.2 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.531 2.154 . . . . 4.51 111.849 179.304 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.642 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.71 125.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 3.51 110.474 179.971 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.561 ' O ' ' O ' ' A' ' 92' ' ' THR . 2.3 mp0 -123.98 158.34 60.59 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.362 -0.381 . . . . 4.3 110.436 179.965 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.471 ' HG3' ' NH1' ' A' ' 143' ' ' ARG . 96.7 Cg_endo -82.12 -64.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.837 2.358 . . . . 1.96 113.485 -179.023 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.54 ' OD1' ' O ' ' A' ' 63' ' ' LEU . 2.5 t-20 -108.5 -19.51 13.42 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.06 0.393 . . . . 3.33 112.06 -178.501 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 9.1 p -107.36 152.02 24.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.103 0.477 . . . . 1.53 111.299 -179.456 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.576 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.25 102.89 2.23 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.694 -0.684 . . . . 2.29 110.649 179.844 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.4 Cg_endo -82.62 145.66 13.12 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.885 2.39 . . . . 0.88 112.621 179.896 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.417 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.84 167.93 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.901 -0.59 . . . . 2.12 109.856 179.595 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -149.17 147.85 28.94 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.819 -0.437 . . . . 2.67 109.819 178.872 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.492 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.6 p90 -142.19 157.34 44.97 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.685 -0.406 . . . . 0.32 111.228 179.946 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.472 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.1 m-20 -128.03 155.23 44.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.737 -0.665 . . . . 2.77 110.117 179.023 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.6 173.04 6.35 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.024 0.44 . . . . 1.25 110.79 -179.266 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.71 173.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.914 2.41 . . . . 1.12 111.528 179.402 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.94 -51.01 0.7 Allowed Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.616 -0.434 . . . . 4.05 110.17 179.867 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.66 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.9 152.35 82.57 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.681 2.254 . . . . 2.12 111.48 179.183 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.71 42.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.406 0.622 . . . . 2.85 110.562 -179.82 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.818 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.7 -41.51 98.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.943 -1.026 . . . . 3.11 110.657 179.784 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.438 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.3 mt -110.0 137.87 40.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.72 -0.673 . . . . 1.86 111.181 -179.409 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.99 -72.97 0.7 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.939 -0.573 . . . . 1.61 111.819 -178.944 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.19 148.44 24.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.591 0.589 . . . . 1.67 112.591 -179.592 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.79 124.75 44.93 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.363 -0.606 . . . . 1.07 109.363 177.556 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.6 mt -117.99 134.71 60.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.696 -0.402 . . . . 1.55 110.67 179.89 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.481 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -119.98 128.58 53.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.043 0.449 . . . . 1.33 111.225 179.767 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.07 138.98 49.83 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.768 -0.651 . . . . 2.36 110.138 178.954 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.42 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.0 163.25 34.77 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 121.165 0.507 . . . . 0.38 112.061 -178.151 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.56 139.63 7.82 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.415 -0.811 . . . . 2.31 110.399 178.825 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.71 115.52 3.12 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.308 2.005 . . . . 0.86 111.822 179.985 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.675 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.96 81.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.897 -0.408 . . . . 3.44 109.897 -179.801 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.697 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.012 -0.54 . . . . 2.72 111.936 -179.496 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.2 p -157.65 157.79 34.25 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.839 -0.345 . . . . 2.78 110.568 179.77 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.407 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.38 27.79 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 2.3 110.165 179.574 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.75 -75.79 1.31 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.183 -0.532 . . . . 1.8 111.888 -179.245 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -118.03 152.29 35.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.931 0.396 . . . . 5.48 110.968 -179.317 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.673 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.15 2.54 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.106 -0.497 . . . . 1.84 112.007 179.39 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.04 149.67 29.66 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.457 0.646 . . . . 2.27 112.543 -177.836 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.15 156.44 45.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.789 -1.096 . . . . 1.92 110.161 178.635 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.21 158.35 41.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.905 -0.589 . . . . 1.09 111.745 -179.351 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.3 m -115.11 135.59 54.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.454 -0.794 . . . . 1.16 109.831 179.287 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.451 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.34 121.86 23.82 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.411 -0.359 . . . . 1.39 111.596 -179.156 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.0 Cg_exo -46.23 151.67 1.58 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.695 2.263 . . . . 0.72 112.173 178.992 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.83 -23.16 63.05 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 116.096 -0.502 . . . . 0.74 112.796 -179.205 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.515 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.7 -16.95 46.17 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.245 -0.582 . . . . 1.26 111.824 -178.316 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.481 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.5 mt -91.51 138.39 31.61 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.782 -0.367 . . . . 1.59 110.27 179.396 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.54 14.01 11.0 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.308 -0.405 . . . . 2.07 111.466 -179.418 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -150.04 143.5 25.19 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.721 -0.392 . . . . 0.96 111.061 179.573 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.9 -169.31 1.53 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.885 -179.425 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.723 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.79 125.94 9.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.442 -0.799 . . . . 1.19 109.793 179.305 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.467 HD11 HG23 ' A' ' 60' ' ' ILE . 66.6 mt -114.89 123.19 70.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.398 -0.521 . . . . 1.47 111.157 -179.73 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -126.47 163.32 23.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.895 -0.593 . . . . 3.0 110.467 179.695 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.443 ' N ' ' OD2' ' A' ' 159' ' ' ASP . . . 85.24 18.95 59.76 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.672 -0.971 . . . . 0.5 110.672 -179.963 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.54 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 73.6 mt -79.07 157.27 28.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.129 0.49 . . . . 1.21 111.302 -179.594 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.648 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 1.2 mptt -99.51 134.02 21.47 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.572 -0.74 . . . . 3.2 110.475 179.759 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.95 143.58 61.03 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.573 2.182 . . . . 1.09 111.912 179.835 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.62 75.34 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.1 -0.8 . . . . 0.72 111.1 179.732 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.64 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.14 158.74 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.704 0.288 . . . . 1.47 110.395 -179.564 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.17 139.95 42.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.067 0.46 . . . . 1.23 110.586 -179.861 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.648 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.3 m-85 -122.5 136.42 54.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.869 -0.605 . . . . 1.1 110.799 -179.9 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.3 pt-20 -98.85 131.06 45.24 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.553 -0.906 . . . . 1.87 108.553 177.557 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.47 153.84 16.65 Favored Glycine 0 C--O 1.227 -0.286 0 C-N-CA 120.364 -0.922 . . . . 0.39 112.043 -178.681 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.99 140.92 46.05 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.706 -0.479 . . . . 1.8 109.706 179.55 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.466 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.2 tp -115.77 119.01 34.62 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.421 -0.512 . . . . 1.11 110.504 179.684 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.1 mt -112.45 129.06 68.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 1.51 110.631 -179.865 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.8 120.75 43.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.343 -0.39 . . . . 1.47 110.754 -179.682 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.663 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.54 146.38 11.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.223 0.535 . . . . 1.33 111.023 -179.258 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.818 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.01 153.85 21.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.532 -0.758 . . . . 2.49 109.935 179.829 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.2 mt-30 -39.13 88.48 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.889 0.376 . . . . 4.2 110.416 -179.737 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.31 32.7 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.845 -0.616 . . . . 6.4 110.467 -179.922 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.18 -117.36 3.28 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.413 -0.675 . . . . 1.74 111.413 -179.776 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.441 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.34 177.44 8.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.295 0.569 . . . . 3.64 111.606 -179.192 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.22 149.46 31.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.423 -0.808 . . . . 1.7 110.486 179.149 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.07 144.64 38.85 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.549 -0.296 . . . . 2.7 110.591 179.952 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -127.94 136.07 61.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.036 0.446 . . . . 1.16 111.565 -179.832 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.57 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.16 141.38 52.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.675 -0.693 . . . . 1.14 110.241 179.645 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.439 ' N ' HG21 ' A' ' 85' ' ' THR . 42.4 ttp180 -117.64 138.86 51.69 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.572 -0.451 . . . . 4.33 111.511 -179.322 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.32 164.18 37.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.606 -0.724 . . . . 0.91 109.44 179.422 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.567 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.29 151.55 38.52 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.357 -0.537 . . . . 1.47 111.042 179.99 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.576 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.0 p90 -146.25 172.68 13.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.738 -0.665 . . . . 0.51 111.083 179.848 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.45 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.69 160.65 21.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.48 -0.782 . . . . 1.92 109.873 179.604 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.45 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.29 121.93 23.14 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.507 -0.477 . . . . 1.63 110.731 179.959 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.561 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.5 p -127.42 159.32 34.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 2.37 111.643 179.631 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.473 ' OG ' ' OH ' ' A' ' 157' ' ' TYR . 36.3 t -67.7 -82.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.904 -0.589 . . . . 3.63 110.944 179.325 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 69.4 p -114.52 10.5 16.88 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.663 179.81 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.697 ' HG ' ' H ' ' A' ' 96' ' ' THR . 32.2 t 51.67 -147.71 0.42 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.897 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.697 ' H ' ' HG ' ' A' ' 95' ' ' SER . 30.6 p 52.12 68.83 2.82 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.866 179.59 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -54.66 -20.0 20.2 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.791 2.328 . . . . 0.0 112.114 -179.595 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.1 m -126.89 156.9 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.0 -179.794 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 47.9 m -57.24 -39.09 74.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.947 -179.192 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.3 t -115.86 138.41 51.18 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.065 0.46 . . . . 0.0 111.151 -179.311 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -57.06 -33.04 66.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.005 179.398 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.558 ' O ' ' O ' ' A' ' 103' ' ' VAL . 50.1 m -116.87 139.32 50.76 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.075 -178.776 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.558 ' O ' ' O ' ' A' ' 102' ' ' THR . 62.9 t 50.3 155.7 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.526 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.5 p -123.97 163.52 21.18 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.986 179.971 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -164.37 -178.08 37.54 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.488 179.877 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -59.77 145.02 46.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.952 0.406 . . . . 0.0 110.984 -179.824 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.9 m -74.65 140.58 44.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.849 179.565 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.27 82.1 30.54 Favored Pre-proline 0 N--CA 1.465 0.286 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.191 -178.883 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.56 151.15 47.88 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.157 1.905 . . . . 0.0 111.504 179.73 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -102.41 135.09 44.65 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.161 0.505 . . . . 0.0 110.911 -179.242 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.5 m -124.18 80.7 58.37 Favored Pre-proline 0 CA--C 1.529 0.158 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.97 179.963 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.73 144.4 54.16 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.069 1.846 . . . . 0.0 112.359 -178.746 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 66.5 mt -60.1 -32.62 71.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.277 -0.874 . . . . 10.52 111.47 -179.463 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 43.2 t -106.04 134.85 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.268 0.556 . . . . 7.48 111.38 -178.654 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -104.84 151.54 23.69 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.222 -0.899 . . . . 7.69 110.193 179.925 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 48.9 m -70.69 137.29 49.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.906 0.384 . . . . 6.46 110.412 -179.63 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.0 m -62.91 155.05 28.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.946 -0.57 . . . . 4.59 111.324 -179.287 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -58.43 145.49 38.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.725 -0.67 . . . . 3.21 110.585 179.838 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.3 p -114.43 155.01 27.13 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.121 -0.49 . . . . 3.64 110.489 -179.879 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.9 t -113.11 135.89 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.016 -0.538 . . . . 3.39 110.59 -179.596 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 24.0 p -82.14 161.8 22.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 2.23 110.941 -179.605 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -114.02 -91.22 0.51 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.714 -0.676 . . . . 4.53 110.505 -179.779 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 32.1 pt -121.43 161.83 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.997 -0.547 . . . . 2.01 110.098 -179.819 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.499 ' O ' ' CB ' ' A' ' 125' ' ' ALA . 44.4 m -71.65 134.34 46.28 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.718 -0.393 . . . . 2.22 110.476 -179.18 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.499 ' CB ' ' O ' ' A' ' 124' ' ' THR . . . 151.61 75.64 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.451 -0.795 . . . . 1.29 109.021 -179.607 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.7 p -60.66 -31.33 70.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.324 -0.398 . . . . 1.25 111.17 -178.768 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.481 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.81 167.56 0.25 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.181 -0.463 . . . . 1.16 110.954 179.893 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.65 145.49 50.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.807 -0.633 . . . . 0.78 110.136 -179.933 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.18 101.62 9.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.012 -0.736 . . . . 1.08 109.012 177.788 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.472 HG11 ' N ' ' A' ' 131' ' ' SER . 71.6 t -112.97 139.62 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.1 -0.5 . . . . 1.1 111.149 -178.965 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.472 ' N ' HG11 ' A' ' 130' ' ' VAL . 66.4 p -128.63 152.62 48.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.66 -0.7 . . . . 0.87 109.891 179.564 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.654 ' CD1' HD12 ' A' ' 194' ' ' ILE . 40.0 p90 -144.77 -165.06 2.06 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.74 -0.384 . . . . 0.37 110.704 -179.669 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.735 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.6 t -123.87 127.08 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 1.14 110.897 -179.903 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.176 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.85 58.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.159 -0.473 . . . . 1.91 110.388 179.767 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.735 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.22 24.47 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.949 -0.569 . . . . 1.56 111.433 -179.597 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.176 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.17 128.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.617 -0.433 . . . . 1.56 110.991 179.915 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.36 -9.71 55.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.95 -0.568 . . . . 1.88 110.293 179.829 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.07 0.2 55.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 1.63 110.253 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.966 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.21 137.17 25.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 1.11 109.974 179.68 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 185' ' ' ILE . 70.5 m -96.22 -15.58 21.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.227 0.537 . . . . 1.01 110.011 -179.66 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.61 175.52 45.76 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.821 -1.312 . . . . 0.14 109.821 179.722 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.37 151.62 42.35 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.694 -0.402 . . . . 0.21 110.489 179.706 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.85 ' HE ' ' NE2' ' A' ' 191' ' ' GLN . 55.1 ttp85 -132.36 121.21 23.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.172 -0.467 . . . . 1.54 109.954 179.736 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.492 HG23 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.13 136.53 38.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.716 -0.675 . . . . 1.08 110.622 -179.7 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 79.5 tt0 -129.39 129.91 45.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.961 -0.563 . . . . 1.32 110.128 179.963 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.9 p90 -138.67 135.32 34.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.006 -0.543 . . . . 1.05 110.675 -179.658 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.401 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.39 161.33 39.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.805 -0.634 . . . . 1.16 109.685 179.849 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.939 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -71.04 124.89 25.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.974 0.416 . . . . 1.23 110.737 -179.597 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.73 -7.78 50.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.741 -0.663 . . . . 0.86 110.908 -179.791 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -109.76 -69.59 0.85 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.958 0.408 . . . . 1.66 111.467 -179.253 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.445 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.4 mt-10 -60.85 -35.23 76.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.059 -0.519 . . . . 1.66 111.454 -179.084 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.072 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.12 7.18 88.62 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.893 -0.883 . . . . 1.62 110.893 -179.836 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.335 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.97 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.757 0.313 . . . . 1.86 110.326 179.873 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.335 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.19 139.1 45.39 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.95 0.405 . . . . 1.98 110.226 179.649 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.401 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.2 Cg_endo -70.97 145.79 51.08 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.768 2.312 . . . . 0.62 112.327 -179.499 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.85 145.68 42.65 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.28 -0.637 . . . . 1.14 109.28 179.19 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.537 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 85.5 m-85 -123.27 141.41 52.01 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.314 -0.554 . . . . 1.44 111.518 -179.053 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.4 mt -128.11 127.69 43.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.306 -0.861 . . . . 1.08 108.915 179.06 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.443 ' OD2' ' N ' ' A' ' 62' ' ' GLY . 45.0 t0 -101.68 131.13 48.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.148 0.499 . . . . 1.09 111.761 -178.783 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.51 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.1 mt -127.92 157.62 73.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.266 -0.879 . . . . 1.04 109.6 179.619 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -69.87 158.03 58.19 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.423 2.082 . . . . 0.21 112.197 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.26 -12.18 5.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.729 -0.669 . . . . 0.88 110.693 -179.808 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.2 p -92.86 -8.73 42.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 1.06 110.657 -179.855 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.27 135.39 34.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.393 -0.367 . . . . 1.05 110.344 179.73 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 p -133.14 16.62 4.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.335 -0.393 . . . . 1.07 110.54 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.7 p -167.45 147.15 5.16 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.659 -0.497 . . . . 0.92 109.659 179.874 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.51 ' HB ' HD13 ' A' ' 160' ' ' LEU . 5.9 p -152.19 150.36 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.011 0.434 . . . . 1.09 111.618 -179.605 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.493 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 124.96 50.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.622 -0.717 . . . . 1.31 109.799 179.47 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.526 HG21 HD21 ' A' ' 172' ' ' LEU . 1.8 mt -99.47 104.97 30.47 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.015 0.436 . . . . 1.09 111.062 -179.903 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.5 Cg_endo -91.04 -179.46 1.47 Allowed 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 123.144 2.563 . . . . 0.48 112.221 179.914 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.66 32.67 18.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.399 -0.819 . . . . 1.26 111.501 179.31 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.526 HD21 HG21 ' A' ' 169' ' ' ILE . 24.2 mt -86.41 148.57 25.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.442 -0.345 . . . . 1.12 110.431 179.656 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.778 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.38 114.86 61.4 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.074 0.464 . . . . 1.3 110.714 -179.742 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -58.9 140.53 95.62 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.926 2.417 . . . . 0.92 112.024 179.882 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.06 21.3 74.14 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.044 -0.823 . . . . 0.44 111.044 179.861 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.445 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -127.0 150.14 49.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.942 0.401 . . . . 3.05 110.528 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.491 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.13 131.67 45.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.878 -0.601 . . . . 1.48 109.78 179.316 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.939 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.54 148.36 43.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.1 -0.5 . . . . 0.89 111.035 -179.852 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.4 mt -105.39 125.33 60.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.221 -1.029 . . . . 1.12 108.221 177.793 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.55 132.51 63.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.157 0.503 . . . . 1.1 111.228 -178.642 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.43 122.65 20.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.492 -0.776 . . . . 0.43 109.602 179.253 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.592 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.07 125.44 55.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.224 -0.444 . . . . 1.07 110.581 -179.53 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.67 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.9 m-85 -117.3 137.9 52.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.923 -0.581 . . . . 0.92 109.85 179.479 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.574 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.72 135.12 42.67 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.71 -0.848 . . . . 0.49 108.71 178.911 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.563 ' O ' ' N ' ' A' ' 140' ' ' SER . 85.2 mt -99.13 122.97 51.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.131 0.491 . . . . 1.08 110.977 -178.826 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.448 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.0 p -83.87 169.74 14.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.498 -0.774 . . . . 0.89 110.478 -179.672 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.472 ' O ' ' CG2' ' A' ' 59' ' ' THR . 97.4 mt-10 -59.81 -14.45 14.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.056 -0.52 . . . . 1.6 111.027 -179.571 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.448 ' H ' ' HG ' ' A' ' 186' ' ' SER . 96.7 m-20 -96.16 -4.25 42.98 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.791 -0.364 . . . . 1.18 110.842 -179.781 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.4 ' HA2' ' OG1' ' A' ' 59' ' ' THR . . . 87.83 13.84 64.02 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.362 -0.695 . . . . 0.34 111.362 179.879 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -84.64 139.16 32.25 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.047 -0.261 . . . . 1.22 110.391 179.769 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.85 ' NE2' ' HE ' ' A' ' 143' ' ' ARG . 91.0 mt-30 -106.79 141.06 38.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.41 -0.359 . . . . 1.44 110.469 179.788 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.68 127.08 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 1.39 110.33 179.872 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.67 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.4 tp -68.21 117.25 9.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.327 -0.397 . . . . 1.08 110.518 -179.918 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.654 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -108.99 -21.81 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 1.08 110.739 -179.711 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -157.0 125.75 5.81 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.48 -0.488 . . . . 1.1 111.458 -179.847 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.497 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.66 120.21 21.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.69 -0.686 . . . . 0.94 109.591 179.208 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.61 151.71 29.15 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.543 -0.463 . . . . 1.07 110.875 -179.294 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.44 158.62 18.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.035 -0.53 . . . . 0.89 110.452 179.686 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.13 157.89 43.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.14 -0.482 . . . . 0.67 110.656 179.99 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.18 104.36 9.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.755 -0.657 . . . . 1.17 110.03 179.584 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.484 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 68.2 p . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.959 -1.02 . . . . 1.26 110.52 -179.656 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.1 m . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.188 -0.671 . . . . 3.83 109.188 . . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.421 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.7 18.53 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.927 -0.869 . . . . 1.39 110.927 179.8 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -35.62 142.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.046 0 C-N-CA 123.991 3.127 . . . . 0.86 113.793 -179.239 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.567 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -80.09 173.51 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.184 -1.371 . . . . 1.43 108.815 178.476 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.63 125.89 51.51 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.381 -0.527 . . . . 1.94 111.351 -179.51 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.5 144.02 33.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.698 -0.683 . . . . 1.19 110.65 179.838 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.09 168.3 25.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.972 0.415 . . . . 3.92 111.09 -179.715 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.588 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.88 131.01 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.974 -0.557 . . . . 3.88 110.102 179.884 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.2 p -141.16 162.29 35.83 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.815 0.34 . . . . 3.92 111.252 -179.951 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 96.9 mt-10 36.1 31.57 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.618 -0.512 . . . . 6.08 109.618 179.828 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.588 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.53 32.5 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.975 -0.557 . . . . 4.01 111.609 -178.782 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.643 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.29 -29.04 72.66 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.395 2.063 . . . . 4.51 111.893 179.322 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.643 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 3.51 110.464 179.949 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.543 ' O ' ' O ' ' A' ' 92' ' ' THR . 0.4 OUTLIER -123.9 158.32 60.41 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.366 -0.379 . . . . 4.3 110.515 179.956 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.699 ' CG ' ' NH1' ' A' ' 143' ' ' ARG . 97.7 Cg_endo -82.08 -64.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.926 2.417 . . . . 1.96 113.461 -178.994 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.566 ' OD1' ' N ' ' A' ' 62' ' ' GLY . 20.5 t-20 -108.42 -19.66 13.38 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.097 0.406 . . . . 3.33 112.097 -178.504 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 36.4 m -107.32 152.09 24.6 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.45 -0.5 . . . . 1.53 111.345 -179.425 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.578 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.3 102.93 2.22 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.722 -0.672 . . . . 2.29 110.649 179.877 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.7 145.64 12.98 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.871 2.381 . . . . 0.88 112.635 179.967 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.416 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.77 167.95 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 2.12 109.922 179.609 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.22 147.89 28.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.743 -0.466 . . . . 2.67 109.743 178.879 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.493 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.5 p90 -142.23 157.29 45.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.054 0.454 . . . . 0.32 111.206 179.95 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.473 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.8 m-20 -127.99 155.21 44.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.818 -0.628 . . . . 2.77 110.149 178.971 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.56 173.12 6.26 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.155 -0.475 . . . . 1.25 110.795 -179.296 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.73 173.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.842 0 C-N-CA 122.884 2.389 . . . . 1.12 111.494 179.425 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.484 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -51.02 0.69 Allowed Pre-proline 0 C--N 1.328 -0.354 0 C-N-CA 120.671 -0.412 . . . . 4.05 110.158 179.815 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.659 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.83 152.3 82.64 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.786 2.324 . . . . 2.12 111.454 179.139 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.68 42.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.403 0.621 . . . . 2.85 110.588 -179.906 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.821 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.54 -41.66 98.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.976 -1.011 . . . . 3.11 110.648 179.721 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.439 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.6 mt -109.89 137.83 40.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.738 -0.665 . . . . 1.86 111.286 -179.398 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.99 -72.92 0.7 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.055 -0.521 . . . . 1.61 111.816 -178.922 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.15 148.34 24.47 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.59 0.589 . . . . 1.67 112.59 -179.599 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.8 124.85 45.15 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.385 -0.598 . . . . 1.07 109.385 177.474 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.4 mt -117.98 134.69 60.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.669 -0.412 . . . . 1.55 110.698 179.973 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.48 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -119.98 128.6 53.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.294 -0.412 . . . . 1.33 111.287 179.765 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.06 139.0 49.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.758 -0.656 . . . . 2.36 110.153 178.992 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.42 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.12 163.16 35.16 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 121.105 0.479 . . . . 0.38 112.045 -178.126 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.495 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.44 139.57 7.89 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.417 -0.811 . . . . 2.31 110.493 178.857 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.46 115.43 3.02 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.336 2.024 . . . . 0.86 111.773 179.97 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.675 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.92 81.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.884 -0.414 . . . . 3.44 109.884 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.697 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.2 -20.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.012 -0.54 . . . . 2.72 111.893 -179.517 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.5 157.92 34.73 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.815 -0.354 . . . . 2.78 110.565 179.7 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.403 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 16.0 m -120.5 27.85 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.145 -0.479 . . . . 2.3 110.081 179.616 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -75.96 1.31 Allowed Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.165 -0.541 . . . . 1.8 111.764 -179.234 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.79 152.17 35.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.846 0.355 . . . . 5.48 111.025 -179.253 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.672 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.14 -169.14 2.55 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.127 -0.488 . . . . 1.84 112.021 179.324 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.1 149.63 29.76 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.455 0.645 . . . . 2.27 112.597 -177.864 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.06 156.48 46.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.835 -1.075 . . . . 1.92 110.272 178.648 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.25 158.23 41.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.984 -0.553 . . . . 1.09 111.835 -179.319 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.1 m -115.08 135.65 53.98 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.461 -0.79 . . . . 1.16 109.795 179.307 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.45 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.38 121.95 23.79 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.462 -0.335 . . . . 1.39 111.5 -179.136 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.1 Cg_exo -46.32 151.66 1.65 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.63 2.22 . . . . 0.72 112.111 178.979 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.88 -23.06 63.03 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 116.055 -0.52 . . . . 0.74 112.817 -179.211 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.515 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.69 -16.97 46.13 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.278 -0.569 . . . . 1.26 111.829 -178.391 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.483 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.6 mt -91.53 138.44 31.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.795 -0.362 . . . . 1.59 110.333 179.388 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -121.6 13.97 10.94 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.366 -0.379 . . . . 2.07 111.467 -179.331 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.0 143.43 25.17 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.665 -0.414 . . . . 0.96 111.011 179.64 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.724 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.81 -169.36 1.53 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.204 0.526 . . . . 1.0 110.852 -179.478 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.736 ' HG1' ' N ' ' A' ' 189' ' ' GLY . 1.3 m -151.77 125.96 9.28 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.373 -0.83 . . . . 1.19 109.782 179.249 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.465 HD11 HG23 ' A' ' 60' ' ' ILE . 66.2 mt -114.82 123.15 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.467 -0.493 . . . . 1.47 111.255 -179.798 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.536 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 64.7 pttt -126.38 163.39 23.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.87 -0.604 . . . . 3.0 110.5 179.682 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.566 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.11 19.07 59.75 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.699 -0.96 . . . . 0.5 110.699 179.987 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.438 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 74.2 mt -79.11 157.24 28.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.091 0.472 . . . . 1.21 111.342 -179.637 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.648 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -99.56 134.06 21.42 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.611 -0.722 . . . . 3.2 110.442 179.792 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.96 143.55 60.83 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.554 2.169 . . . . 1.09 111.98 179.851 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.97 25.51 75.49 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.043 -0.823 . . . . 0.72 111.043 179.689 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.639 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.18 158.82 40.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.697 0.284 . . . . 1.47 110.404 -179.593 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.18 139.89 42.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.922 0.391 . . . . 1.23 110.556 -179.692 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.648 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.53 136.53 54.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.046 -0.525 . . . . 1.1 110.762 -179.931 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.495 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.98 131.04 45.33 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.456 -0.942 . . . . 1.87 108.456 177.701 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.45 153.91 16.64 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.391 -0.909 . . . . 0.39 111.971 -178.588 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.07 141.0 45.99 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.595 -0.52 . . . . 1.8 109.595 179.593 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.468 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.2 tp -115.76 118.87 34.25 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.469 -0.492 . . . . 1.11 110.496 179.686 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.8 mt -112.44 129.05 68.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.373 -0.376 . . . . 1.51 110.613 -179.918 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.85 120.73 43.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.235 -0.439 . . . . 1.47 110.724 -179.655 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.662 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.54 146.59 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.22 0.533 . . . . 1.33 111.01 -179.281 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.821 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.08 153.87 21.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.458 -0.792 . . . . 2.49 109.95 179.859 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.2 88.56 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.896 0.379 . . . . 4.2 110.361 -179.702 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.33 32.72 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.79 -0.641 . . . . 6.4 110.532 -179.99 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.18 -117.4 3.28 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.388 -0.685 . . . . 1.74 111.388 -179.712 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.444 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.39 177.36 9.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.206 0.527 . . . . 3.64 111.625 -179.182 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.1 149.51 32.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.397 -0.82 . . . . 1.7 110.404 179.178 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.23 144.66 38.56 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.463 -0.335 . . . . 2.7 110.532 179.857 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -128.05 135.94 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 121.077 0.465 . . . . 1.16 111.497 -179.711 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.01 141.38 52.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.663 -0.699 . . . . 1.14 110.259 179.637 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.439 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.64 138.81 51.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.159 0.504 . . . . 4.33 111.499 -179.348 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.19 164.23 37.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.563 -0.744 . . . . 0.91 109.503 179.317 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.567 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.31 151.48 38.39 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.406 -0.518 . . . . 1.47 111.05 179.967 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.578 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.5 p90 -146.15 172.69 13.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.725 -0.671 . . . . 0.51 111.062 179.856 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.451 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.69 160.73 21.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.452 -0.795 . . . . 1.92 109.874 179.61 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.451 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.37 121.89 22.99 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.637 -0.425 . . . . 1.63 110.737 179.985 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.543 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.5 p -127.47 163.63 23.67 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.185 0.809 . . . . 2.37 113.185 179.638 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.581 ' HG ' ' HH ' ' A' ' 157' ' ' TYR . 40.1 t -123.67 147.9 46.99 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.407 -1.269 . . . . 3.63 110.636 178.848 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.5 m 58.68 -2.09 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.251 179.169 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 93' ' ' SER . 84.6 p -60.64 -29.03 69.01 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.411 179.678 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.8 m -127.3 78.74 74.16 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.434 178.942 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -54.57 138.08 74.31 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.3 2.0 . . . . 0.0 112.835 -178.475 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.4 t -123.6 137.03 58.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.075 179.389 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.8 m -116.68 135.82 53.47 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.964 0.411 . . . . 0.0 110.082 179.702 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.8 t -142.47 151.38 41.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.973 -179.422 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -95.18 126.9 40.83 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.254 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 48.0 m -117.33 141.14 48.67 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.226 0.536 . . . . 0.0 111.389 -178.839 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.9 t -115.4 138.35 46.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.777 179.762 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 t -131.42 158.1 41.7 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.135 0.493 . . . . 0.0 111.076 -179.246 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 96.27 -2.34 63.21 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -179.143 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.19 -31.77 70.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.468 -0.366 . . . . 0.0 110.525 179.368 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.433 ' O ' ' OG1' ' A' ' 108' ' ' THR . 18.4 p -118.38 164.47 15.19 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.033 -178.992 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.628 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 1.2 m 170.64 -36.42 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.496 -179.467 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 108' ' ' THR . 51.0 Cg_exo -54.14 152.49 24.48 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.289 1.992 . . . . 0.0 111.941 179.732 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -89.27 135.32 33.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.592 -179.407 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.626 ' N ' ' HD2' ' A' ' 112' ' ' PRO . 1.2 t 169.44 -48.9 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.924 -179.55 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 111' ' ' SER . 14.0 Cg_endo -56.74 145.85 80.47 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.02 1.813 . . . . 0.0 111.8 179.417 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.7 mt -93.04 141.75 28.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.285 -0.416 . . . . 10.52 110.431 -179.689 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.61 154.98 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.075 -0.511 . . . . 7.48 110.475 179.748 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.16 143.22 34.6 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.273 -0.421 . . . . 7.69 110.534 179.882 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.8 p -123.86 159.05 30.48 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.367 -0.378 . . . . 6.46 110.426 179.493 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.2 t -134.27 141.24 46.9 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.47 -0.332 . . . . 4.59 110.499 179.504 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.21 -33.28 75.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.995 0.426 . . . . 3.21 110.238 179.334 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 120' ' ' VAL . 57.5 p -70.94 162.67 28.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.799 -0.637 . . . . 3.64 110.958 -179.809 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 119' ' ' SER . 42.5 t 55.68 120.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.935 -0.575 . . . . 3.39 111.076 179.622 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 123' ' ' ILE . 24.8 p -80.92 163.51 23.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.896 -0.593 . . . . 2.23 110.618 179.898 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.38 -33.35 67.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.077 -0.511 . . . . 4.53 110.806 -179.441 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.4 ' O ' ' OG1' ' A' ' 121' ' ' THR . 70.8 mt -114.23 133.64 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.74 0.305 . . . . 2.01 110.427 -179.888 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.4 p -122.85 161.08 24.75 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.108 -0.497 . . . . 2.22 110.555 -179.908 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.88 -33.99 76.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.024 -0.535 . . . . 1.29 111.49 -179.452 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.9 p -161.43 -28.45 0.05 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.807 -0.357 . . . . 1.25 110.781 -179.654 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.472 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.82 167.57 0.25 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.017 -0.538 . . . . 1.16 110.925 -179.593 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.57 145.56 50.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.656 -0.702 . . . . 0.78 110.073 -179.918 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.29 101.62 9.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.146 -0.687 . . . . 1.08 109.146 177.609 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.472 HG11 ' N ' ' A' ' 131' ' ' SER . 72.1 t -112.84 139.74 36.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.896 -0.593 . . . . 1.1 111.038 -178.851 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.472 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.6 p -128.76 152.66 48.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.622 -0.717 . . . . 0.87 109.743 179.528 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.654 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.7 p90 -144.85 -164.97 2.04 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.659 -0.416 . . . . 0.37 110.621 -179.808 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.744 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.8 t -123.9 127.18 73.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.193 -0.458 . . . . 1.14 110.787 -179.805 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.17 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.96 58.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 1.91 110.316 179.792 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.744 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.07 24.44 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.873 -0.603 . . . . 1.56 111.614 -179.772 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.17 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.14 128.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.685 -0.406 . . . . 1.56 111.023 179.896 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.43 -9.57 56.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.891 -0.595 . . . . 1.88 110.359 179.817 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.06 0.3 55.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.037 -0.529 . . . . 1.63 110.446 179.839 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.962 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.23 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.904 -0.589 . . . . 1.11 110.038 179.665 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 185' ' ' ILE . 91.9 p -96.31 -15.41 21.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.29 0.567 . . . . 1.01 109.987 -179.577 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.461 ' HA3' ' HZ1' ' A' ' 61' ' ' LYS . . . 178.59 175.52 45.74 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.758 -1.337 . . . . 0.14 109.758 179.688 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.43 151.64 42.45 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.607 -0.437 . . . . 0.21 110.462 179.687 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.879 ' NH1' HE22 ' A' ' 191' ' ' GLN . 52.0 ttp180 -132.35 121.1 22.98 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.111 -0.495 . . . . 1.54 109.937 179.787 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.489 HG23 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.07 136.58 38.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.678 -0.692 . . . . 1.08 110.66 -179.747 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.592 ' OE2' ' OH ' ' A' ' 157' ' ' TYR . 84.7 tt0 -129.38 129.85 45.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.942 -0.572 . . . . 1.32 110.079 -179.912 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.594 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.7 p90 -138.68 135.26 34.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.051 -0.522 . . . . 1.05 110.635 -179.63 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.404 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.33 161.28 40.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.776 -0.647 . . . . 1.16 109.697 179.877 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.937 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.4 mt -71.0 124.81 25.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.993 0.425 . . . . 1.23 110.793 -179.648 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.486 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.7 p -71.82 -7.7 49.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.758 -0.655 . . . . 0.86 110.807 -179.678 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -109.81 -69.62 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.398 -0.365 . . . . 1.66 111.427 -179.351 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.441 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.68 -35.32 75.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.116 -0.493 . . . . 1.66 111.521 -179.105 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.084 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.05 7.3 88.54 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.812 -0.915 . . . . 1.62 110.812 -179.796 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.312 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.96 -171.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.851 0.358 . . . . 1.86 110.282 179.84 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.312 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.31 139.19 45.01 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.01 0.434 . . . . 1.98 110.158 179.628 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.404 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.4 Cg_endo -70.96 145.74 50.96 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 122.707 2.271 . . . . 0.62 112.381 -179.591 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.72 145.73 42.5 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.368 -0.604 . . . . 1.14 109.368 179.148 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.592 ' OH ' ' OE2' ' A' ' 145' ' ' GLU . 89.9 m-85 -123.27 141.41 52.01 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.335 -0.546 . . . . 1.44 111.491 -179.074 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.426 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.8 mt -128.17 127.66 43.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.302 -0.863 . . . . 1.08 108.882 178.975 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -101.62 131.12 48.01 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.137 0.494 . . . . 1.09 111.782 -178.785 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.514 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -127.93 157.5 73.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.349 -0.842 . . . . 1.04 109.533 179.776 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -69.89 158.01 58.22 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.403 2.069 . . . . 0.21 112.184 179.951 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.29 -12.14 5.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.704 -0.68 . . . . 0.88 110.785 -179.778 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.8 p -92.73 -8.84 42.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.083 -0.508 . . . . 1.06 110.75 -179.978 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.18 135.41 34.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 1.05 110.358 179.739 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.11 16.67 4.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 1.07 110.556 179.933 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.5 p -167.54 147.17 5.09 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.65 -0.5 . . . . 0.92 109.65 179.899 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.514 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.3 150.44 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.52 -0.472 . . . . 1.09 111.591 -179.648 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.25 125.03 50.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.597 -0.729 . . . . 1.31 109.776 179.562 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.519 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.46 104.88 29.93 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.43 -0.35 . . . . 1.09 111.021 -179.883 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.9 Cg_endo -91.01 -179.4 1.47 Allowed 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 123.088 2.526 . . . . 0.48 112.229 179.856 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.56 32.7 18.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.359 -0.837 . . . . 1.26 111.461 179.311 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.519 HD21 HG21 ' A' ' 169' ' ' ILE . 24.1 mt -86.34 148.57 25.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.472 -0.331 . . . . 1.12 110.437 179.547 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.772 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.31 114.88 61.41 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.002 0.429 . . . . 1.3 110.644 -179.757 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.07 140.55 95.71 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.883 2.389 . . . . 0.92 111.94 179.835 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.17 21.07 74.37 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.047 -0.821 . . . . 0.44 111.047 179.835 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.441 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.76 150.14 49.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.341 . . . . 3.05 110.673 -179.984 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.486 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.14 131.58 46.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.138 -0.483 . . . . 1.48 109.878 179.252 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.937 ' CE2' HD21 ' A' ' 148' ' ' LEU . 75.1 m-85 -120.44 148.25 44.05 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.192 -0.458 . . . . 0.89 111.107 -179.817 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.7 mt -105.33 125.41 60.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.252 -1.018 . . . . 1.12 108.252 177.749 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.59 132.58 63.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.185 0.516 . . . . 1.1 111.266 -178.645 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.53 122.61 20.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.608 -0.724 . . . . 0.43 109.621 179.303 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.59 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.04 125.35 54.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.169 -0.469 . . . . 1.07 110.707 -179.535 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.676 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.4 m-85 -117.17 137.93 52.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.017 -0.538 . . . . 0.92 109.876 179.526 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.575 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.69 135.0 42.82 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.783 -0.821 . . . . 0.49 108.783 178.864 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.565 ' O ' ' N ' ' A' ' 140' ' ' SER . 82.7 mt -99.17 123.05 51.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.153 0.501 . . . . 1.08 110.898 -178.78 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.45 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 87.4 p -83.89 169.72 14.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.498 -0.773 . . . . 0.89 110.477 -179.719 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.81 -14.47 15.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.985 -0.552 . . . . 1.6 111.051 -179.589 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.482 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.7 m-20 -96.04 -4.31 43.28 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.842 -0.343 . . . . 1.18 110.812 -179.855 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.736 ' N ' ' HG1' ' A' ' 59' ' ' THR . . . 87.82 13.85 64.02 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.341 -0.703 . . . . 0.34 111.341 179.858 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -84.59 139.07 32.35 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.121 -0.231 . . . . 1.22 110.479 179.699 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.879 HE22 ' NH1' ' A' ' 143' ' ' ARG . 78.2 mt-30 -106.77 141.02 38.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.875 0.369 . . . . 1.44 110.499 179.843 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.67 126.98 26.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 1.39 110.481 179.844 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.676 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.4 tp -68.02 117.34 9.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.362 -0.381 . . . . 1.08 110.492 -179.839 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.654 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -109.17 -21.7 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.465 . . . . 1.08 110.685 -179.762 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.92 125.63 5.81 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.601 -0.44 . . . . 1.1 111.537 -179.783 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.497 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.68 120.26 21.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.726 -0.67 . . . . 0.94 109.547 179.188 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.65 29.04 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.606 -0.438 . . . . 1.07 110.893 -179.273 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.44 158.61 18.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.89 110.345 179.752 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.11 157.96 43.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.055 -0.52 . . . . 0.67 110.642 179.954 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.29 104.44 9.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.817 -0.629 . . . . 1.17 110.012 179.558 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.477 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 68.7 p . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 117.942 -1.027 . . . . 1.26 110.56 -179.631 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.1 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.261 -0.644 . . . . 3.83 109.261 . . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.39 150.71 18.53 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.078 -0.809 . . . . 1.39 111.078 179.649 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -35.63 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.066 0 C-N-CA 124.013 3.142 . . . . 0.86 113.743 -179.134 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.575 ' N ' ' OG1' ' A' ' 85' ' ' THR . 15.9 t -79.84 173.32 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.289 -1.323 . . . . 1.43 108.916 178.341 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.4 ' H ' ' CG1' ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.52 125.82 51.42 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.476 -0.489 . . . . 1.94 111.47 -179.626 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 144.06 33.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.739 -0.664 . . . . 1.19 110.606 179.84 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.36 25.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.898 0.38 . . . . 3.92 111.149 -179.705 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.586 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.4 mt -109.01 131.13 60.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.968 -0.56 . . . . 3.88 110.03 179.921 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 69.3 p -141.26 162.42 35.53 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.894 0.378 . . . . 3.92 111.122 -179.915 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 32.5 tp10 36.07 31.57 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 109.631 -0.507 . . . . 6.08 109.631 179.843 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.586 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.5 69.62 33.32 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.939 -0.573 . . . . 4.01 111.611 -178.8 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.641 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.31 -29.14 72.55 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.437 2.092 . . . . 4.51 111.753 179.391 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.641 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.7 125.57 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 3.51 110.469 179.997 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.623 HE22 ' H ' ' A' ' 13' ' ' SER . 1.6 mp0 -123.99 158.36 60.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 4.3 110.415 -179.979 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.526 ' HG3' ' NH1' ' A' ' 143' ' ' ARG . 97.1 Cg_endo -82.04 -64.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.92 2.413 . . . . 1.96 113.483 -178.96 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.476 ' H ' ' HG2' ' A' ' 15' ' ' PRO . 98.7 m-20 -108.39 -19.61 13.4 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.097 0.406 . . . . 3.33 112.097 -178.501 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 63.1 m -107.47 152.11 24.66 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.403 -0.519 . . . . 1.53 111.248 -179.361 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.579 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.27 102.83 2.23 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.654 -0.703 . . . . 2.29 110.692 179.922 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.69 145.71 13.03 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.818 2.345 . . . . 0.88 112.561 -179.984 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.409 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.79 167.9 24.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.805 -0.634 . . . . 2.12 109.883 179.604 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -149.1 148.04 29.21 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.757 -0.46 . . . . 2.67 109.757 178.821 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.5 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.7 p90 -142.37 157.28 44.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.036 0.446 . . . . 0.32 111.163 179.933 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.468 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 85.1 m-20 -128.01 155.27 44.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.77 -0.65 . . . . 2.77 110.102 178.999 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.56 173.0 6.4 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 121.118 0.485 . . . . 1.25 110.73 -179.204 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.61 173.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.844 2.363 . . . . 1.12 111.532 179.303 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.485 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -51.09 0.69 Allowed Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.714 -0.394 . . . . 4.05 110.048 179.926 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.647 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.81 152.34 82.49 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.721 2.28 . . . . 2.12 111.527 179.147 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.65 42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.362 0.601 . . . . 2.85 110.599 -179.915 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.813 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.52 -41.62 98.48 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.963 -1.017 . . . . 3.11 110.725 179.661 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.441 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.5 mt -109.89 137.92 39.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.756 -0.656 . . . . 1.86 111.287 -179.44 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.12 -72.84 0.71 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.097 -0.502 . . . . 1.61 111.839 -178.911 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.34 24.45 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.575 0.583 . . . . 1.67 112.575 -179.633 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.89 124.88 45.14 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.267 -0.642 . . . . 1.07 109.267 177.556 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.1 134.75 60.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.545 -0.462 . . . . 1.55 110.648 179.926 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.487 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.6 mt -120.01 128.67 53.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.058 0.456 . . . . 1.33 111.247 179.781 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.548 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 139.02 49.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.729 -0.668 . . . . 2.36 110.062 179.012 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.42 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -145.11 163.21 35.0 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.443 -0.503 . . . . 0.38 112.058 -178.114 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.51 139.51 7.8 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.533 -0.758 . . . . 2.31 110.45 178.909 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.51 115.47 3.05 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.327 2.018 . . . . 0.86 111.803 179.968 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.67 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.99 81.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.902 -0.407 . . . . 3.44 109.902 -179.878 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.693 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.19 -20.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.954 -0.567 . . . . 2.72 111.919 -179.549 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 p -157.55 157.8 34.43 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.856 -0.338 . . . . 2.78 110.626 179.726 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.37 27.85 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.27 -0.423 . . . . 2.3 110.195 179.527 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.84 -75.91 1.31 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.036 -0.602 . . . . 1.8 111.811 -179.255 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.83 152.41 35.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.982 0.42 . . . . 5.48 110.991 -179.351 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.637 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.28 -169.19 2.54 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.075 -0.511 . . . . 1.84 112.007 179.413 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.417 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.6 mttp -110.06 149.6 29.78 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.43 0.633 . . . . 2.27 112.595 -177.86 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.08 156.41 46.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.815 -1.084 . . . . 1.92 110.214 178.679 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.16 158.42 41.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.934 -0.576 . . . . 1.09 111.788 -179.353 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.2 135.58 54.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.46 -0.791 . . . . 1.16 109.809 179.317 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.441 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.38 121.96 23.8 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.429 -0.351 . . . . 1.39 111.528 -179.149 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.512 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 75.3 Cg_exo -46.31 151.63 1.65 Allowed 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.694 2.263 . . . . 0.72 112.145 178.977 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.81 -23.09 62.91 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 116.043 -0.526 . . . . 0.74 112.814 -179.277 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.5 p-80 -82.81 -16.81 46.34 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.192 -0.603 . . . . 1.26 111.809 -178.323 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.49 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.6 mt -91.67 138.4 31.59 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.719 -0.392 . . . . 1.59 110.266 179.395 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.48 13.96 11.04 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.334 -0.393 . . . . 2.07 111.501 -179.369 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -150.04 143.52 25.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.633 -0.427 . . . . 0.96 111.029 179.525 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.717 ' CE2' ' O ' ' A' ' 59' ' ' THR . 65.0 t80 -114.8 -169.37 1.53 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.815 -179.373 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.717 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.79 125.95 9.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.343 -0.844 . . . . 1.19 109.852 179.21 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.448 HD11 HG23 ' A' ' 60' ' ' ILE . 66.3 mt -114.91 123.24 70.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.369 -0.532 . . . . 1.47 111.192 -179.73 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.804 ' HZ2' ' C ' ' A' ' 140' ' ' SER . 98.4 mttt -126.49 163.41 23.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.812 -0.631 . . . . 3.0 110.514 179.673 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.08 19.05 59.83 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.774 -0.93 . . . . 0.5 110.774 -179.845 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.429 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.6 mt -79.06 157.25 28.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.107 0.48 . . . . 1.21 111.4 -179.717 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.638 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -99.46 133.93 21.57 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.635 -0.712 . . . . 3.2 110.466 179.774 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.89 143.53 61.19 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.599 2.2 . . . . 1.09 111.971 179.81 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.89 25.57 75.41 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.045 -0.822 . . . . 0.72 111.045 179.722 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.637 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.14 158.74 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.653 0.263 . . . . 1.47 110.459 -179.636 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.07 139.95 41.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.986 0.422 . . . . 1.23 110.553 -179.772 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.638 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.64 136.47 54.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.914 -0.584 . . . . 1.1 110.788 -179.955 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.97 130.98 45.36 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.516 -0.92 . . . . 1.87 108.516 177.741 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.484 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.44 153.89 16.63 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.306 -0.95 . . . . 0.39 111.947 -178.556 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.03 141.0 46.07 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.739 -0.467 . . . . 1.8 109.739 179.503 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.465 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.8 tp -115.83 118.95 34.43 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.422 -0.511 . . . . 1.11 110.354 179.831 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.1 mt -112.48 129.11 68.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 1.51 110.625 -179.97 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.86 120.75 43.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.324 -0.398 . . . . 1.47 110.737 -179.663 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.675 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.47 146.52 11.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.18 0.514 . . . . 1.33 111.068 -179.292 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.813 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.08 153.89 21.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.56 -0.746 . . . . 2.49 109.861 179.877 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.22 88.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.742 -0.383 . . . . 4.2 110.426 -179.772 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.14 32.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.807 -0.633 . . . . 6.4 110.545 -179.905 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.22 -117.37 3.27 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.391 -0.683 . . . . 1.74 111.391 -179.77 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.45 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.1 m170 -81.4 177.44 8.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.202 0.525 . . . . 3.64 111.587 -179.111 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.16 149.48 32.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.428 -0.805 . . . . 1.7 110.488 179.09 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.15 144.69 38.73 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.499 -0.318 . . . . 2.7 110.556 179.874 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -127.99 136.09 61.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 120.577 -0.449 . . . . 1.16 111.544 -179.795 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.11 141.3 52.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.607 -0.724 . . . . 1.14 110.244 179.664 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.458 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.4 ttp180 -117.59 138.84 51.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.166 0.508 . . . . 4.33 111.486 -179.379 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.484 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.24 164.11 38.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.501 -0.772 . . . . 0.91 109.475 179.338 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.574 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.13 151.56 38.68 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.456 -0.498 . . . . 1.47 111.122 179.918 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.579 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 38.9 p90 -146.14 172.75 12.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.812 -0.631 . . . . 0.51 111.02 179.875 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.448 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.5 t -118.82 160.77 21.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.418 -0.81 . . . . 1.92 109.841 179.512 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.448 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.38 121.9 22.98 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.591 -0.444 . . . . 1.63 110.748 -179.991 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.583 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.6 p -128.81 167.19 17.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.048 -0.524 . . . . 2.37 112.286 179.676 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.2 t -66.54 161.93 21.93 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.001 -0.74 . . . . 3.63 109.001 177.431 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.7 p -75.76 157.56 33.34 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.525 0.679 . . . . 0.0 112.109 -178.054 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.8 m -86.55 11.47 12.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.13 179.832 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 24.8 p -46.72 144.73 3.43 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.945 -177.993 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.64 148.15 92.39 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.999 2.466 . . . . 0.0 113.42 -178.491 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.3 m -128.6 158.82 40.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.21 178.985 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.5 t -133.29 154.97 50.23 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.284 0.564 . . . . 0.0 111.954 -179.444 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.6 m -127.78 152.9 47.2 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.904 -179.797 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 61.5 47.45 6.62 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 178.708 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.7 p -67.52 -9.63 44.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.273 178.895 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.1 t 60.44 104.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.883 -179.339 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.5 p -124.27 168.27 13.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.854 -179.995 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.64 18.51 37.87 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.534 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.37 146.45 15.71 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.517 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 43.6 m -68.08 133.6 49.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.428 0.632 . . . . 0.0 111.173 -178.129 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.518 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 36.9 m -154.74 140.96 12.94 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.696 179.822 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.72 140.47 46.6 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 CA-C-N 120.131 1.082 . . . . 0.0 111.311 179.488 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.518 ' CE2' ' O ' ' A' ' 108' ' ' THR . 99.4 m-85 -119.9 154.42 34.41 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.238 -179.446 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.28 165.61 37.65 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.445 178.855 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.0 -26.37 31.71 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.74 1.627 . . . . 0.0 111.802 -179.647 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.8 mt -98.23 139.85 33.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.236 -0.438 . . . . 10.52 109.83 179.123 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 80.5 t -61.72 -40.95 88.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.556 -0.458 . . . . 7.48 110.146 179.931 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -148.69 154.16 39.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.992 -0.549 . . . . 7.69 109.976 179.532 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.7 p -123.14 159.04 29.4 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.06 0.457 . . . . 6.46 110.906 179.838 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.8 m -59.73 -33.32 71.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.706 -0.679 . . . . 4.59 110.811 179.629 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -99.43 153.23 19.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.104 -0.498 . . . . 3.21 111.292 -178.803 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 28.5 m -102.01 -123.5 0.18 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.685 -0.688 . . . . 3.64 110.557 179.806 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 92.8 t -61.36 -41.9 91.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.892 -0.323 . . . . 3.39 110.672 -179.574 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 20.6 p -125.36 154.83 41.26 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.722 0.296 . . . . 2.23 110.702 179.345 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.01 -37.2 83.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.296 -0.411 . . . . 4.53 111.566 179.526 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 10.1 tp -63.79 -26.42 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.28 0.474 . . . . 2.01 112.28 -178.765 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 29.8 p -122.46 162.64 21.32 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.41 0.624 . . . . 2.22 111.945 -179.522 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.78 -117.58 0.32 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.108 -0.951 . . . . 1.29 109.716 179.183 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.8 p -61.01 -30.34 70.24 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.112 0.482 . . . . 1.25 110.121 179.661 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.476 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.94 167.51 0.27 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.621 -0.718 . . . . 1.16 110.99 179.693 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.49 145.6 50.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.731 -0.668 . . . . 0.78 110.139 -179.902 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.36 101.77 9.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.076 -0.713 . . . . 1.08 109.076 177.675 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.468 HG11 ' N ' ' A' ' 131' ' ' SER . 70.5 t -113.01 139.74 36.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.589 . . . . 1.1 110.946 -178.758 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.468 ' N ' HG11 ' A' ' 130' ' ' VAL . 68.6 p -128.75 152.6 48.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.61 -0.723 . . . . 0.87 109.837 179.532 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.641 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.6 p90 -144.82 -164.99 2.04 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.672 -0.411 . . . . 0.37 110.653 -179.727 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.732 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.9 t -123.94 127.13 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 1.14 110.834 -179.821 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.167 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.125 -0.489 . . . . 1.91 110.316 179.841 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.09 24.39 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.9 -0.591 . . . . 1.56 111.481 -179.698 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.167 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.25 128.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.587 -0.445 . . . . 1.56 110.902 179.883 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.46 -9.66 55.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.92 -0.582 . . . . 1.88 110.246 179.78 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.1 0.31 55.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.123 -0.489 . . . . 1.63 110.35 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.963 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.26 137.07 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.984 -0.553 . . . . 1.11 109.982 179.624 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.804 ' C ' ' HZ2' ' A' ' 61' ' ' LYS . 10.1 p -96.21 -15.48 22.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.233 0.539 . . . . 1.01 110.028 -179.648 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.786 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.59 175.54 45.76 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.711 -1.355 . . . . 0.14 109.711 179.659 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -123.42 151.66 42.41 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.635 -0.426 . . . . 0.21 110.556 179.637 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.72 ' NH1' ' CE1' ' A' ' 157' ' ' TYR . 38.9 ttp85 -132.44 121.17 22.99 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.125 -0.489 . . . . 1.54 109.881 179.845 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.484 HG23 HG11 ' A' ' 167' ' ' VAL . 46.0 t -105.0 136.51 38.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.646 -0.706 . . . . 1.08 110.728 -179.77 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 78.5 tt0 -129.36 129.95 45.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.015 -0.539 . . . . 1.32 110.006 -179.919 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.84 135.26 34.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.044 -0.525 . . . . 1.05 110.525 -179.679 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.402 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.41 39.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.633 -0.712 . . . . 1.16 109.665 179.805 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.931 HD21 ' CE2' ' A' ' 178' ' ' TYR . 85.7 mt -71.09 124.86 25.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.952 0.406 . . . . 1.23 110.676 -179.536 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.49 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.71 -7.77 50.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.717 -0.674 . . . . 0.86 110.874 -179.815 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.73 -69.65 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 1.66 111.464 -179.284 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.43 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.63 -35.45 76.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.015 -0.539 . . . . 1.66 111.461 -179.168 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.089 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.18 7.24 88.59 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.748 -0.941 . . . . 1.62 110.748 -179.836 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.326 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.97 -171.73 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.689 0.28 . . . . 1.86 110.294 179.848 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.326 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.22 139.12 45.3 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.945 0.402 . . . . 1.98 110.172 179.666 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.402 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.7 Cg_endo -70.94 145.84 51.39 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 C-N-CA 122.725 2.283 . . . . 0.62 112.303 -179.537 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.9 145.75 42.63 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.234 -0.654 . . . . 1.14 109.234 179.183 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.72 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 94.1 m-85 -123.28 141.35 52.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.25 0.547 . . . . 1.44 111.478 -179.047 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.429 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.9 mt -128.14 127.73 43.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.274 -0.876 . . . . 1.08 108.892 178.942 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 27.8 t0 -101.59 131.18 47.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.165 0.507 . . . . 1.09 111.733 -178.772 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.516 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -128.0 157.53 73.6 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.348 -0.842 . . . . 1.04 109.571 179.645 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -69.76 158.03 58.35 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.395 2.063 . . . . 0.21 112.245 179.927 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.32 -12.13 5.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.753 -0.658 . . . . 0.88 110.732 -179.852 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.1 p -92.8 -8.77 42.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 1.06 110.743 -179.959 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.39 34.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.314 -0.403 . . . . 1.05 110.429 179.686 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.5 p -133.1 16.68 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.401 -0.363 . . . . 1.07 110.532 -179.988 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.7 p -167.55 147.13 5.08 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.614 -0.514 . . . . 0.92 109.614 179.905 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.516 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.2 150.48 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.565 -0.454 . . . . 1.09 111.619 -179.664 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.498 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.36 124.96 50.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.618 -0.719 . . . . 1.31 109.783 179.536 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.523 HG21 HD21 ' A' ' 172' ' ' LEU . 1.8 mt -99.48 104.93 30.28 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.907 0.384 . . . . 1.09 111.03 -179.835 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.1 Cg_endo -91.05 -179.49 1.48 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 123.155 2.57 . . . . 0.48 112.172 179.922 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.66 32.64 18.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.329 -0.851 . . . . 1.26 111.489 179.306 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.523 HD21 HG21 ' A' ' 169' ' ' ILE . 24.3 mt -86.34 148.46 25.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.49 -0.323 . . . . 1.12 110.467 179.611 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.764 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.25 114.87 61.36 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.042 0.448 . . . . 1.3 110.706 -179.799 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.07 140.58 95.84 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.754 2.303 . . . . 0.92 112.025 179.864 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.2 21.16 74.08 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.027 -0.829 . . . . 0.44 111.027 179.857 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.43 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.9 150.18 49.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 3.05 110.606 -179.941 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.49 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.1 tttt -100.11 131.68 45.92 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.084 -0.507 . . . . 1.48 109.82 179.282 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.931 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.54 148.35 43.97 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.118 -0.492 . . . . 0.89 110.991 -179.824 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.31 125.31 60.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.228 -1.027 . . . . 1.12 108.228 177.767 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.55 132.46 63.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.053 0.454 . . . . 1.1 111.284 -178.646 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.46 122.66 20.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.566 -0.743 . . . . 0.43 109.613 179.299 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.591 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.05 125.36 54.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.271 -0.422 . . . . 1.07 110.694 -179.496 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.668 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.6 m-85 -117.25 137.88 52.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.041 -0.527 . . . . 0.92 109.828 179.583 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.569 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.69 135.01 42.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.798 -0.815 . . . . 0.49 108.798 178.861 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.547 ' O ' ' N ' ' A' ' 140' ' ' SER . 14.0 mt -99.14 122.97 51.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.095 0.474 . . . . 1.08 110.931 -178.734 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.451 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.3 p -83.79 169.7 14.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.497 -0.774 . . . . 0.89 110.499 -179.675 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -59.71 -14.65 15.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.047 -0.524 . . . . 1.6 111.018 -179.663 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.451 ' H ' ' HG ' ' A' ' 186' ' ' SER . 95.5 m-20 -95.91 -4.39 43.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.828 0.347 . . . . 1.18 110.902 -179.819 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.79 13.97 63.87 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.301 -0.719 . . . . 0.34 111.301 179.919 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -84.63 139.11 32.29 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.059 -0.256 . . . . 1.22 110.465 179.585 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.715 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 85.9 mt-30 -106.75 141.08 38.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.893 0.378 . . . . 1.44 110.543 179.723 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.0 m -136.7 126.99 26.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.062 -0.517 . . . . 1.39 110.373 179.938 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.668 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.6 tp -68.23 117.38 9.97 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.644 -0.422 . . . . 1.08 110.537 -179.923 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.641 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -109.02 -21.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 1.08 110.746 -179.754 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.89 125.72 5.86 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.519 -0.472 . . . . 1.1 111.496 -179.776 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.496 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.83 120.25 21.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.772 -0.649 . . . . 0.94 109.574 179.143 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.72 29.13 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.568 -0.453 . . . . 1.07 110.806 -179.224 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.8 p -110.47 158.53 18.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.953 -0.567 . . . . 0.89 110.447 179.681 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -145.98 157.97 43.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.102 -0.499 . . . . 0.67 110.644 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.34 104.35 9.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.733 -0.667 . . . . 1.17 109.986 179.558 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.485 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.4 p . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.862 -1.066 . . . . 1.26 110.599 -179.656 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.224 -0.658 . . . . 3.83 109.224 . . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.7 18.54 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.023 -0.831 . . . . 1.39 111.023 179.73 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -35.61 142.41 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.048 0 C-N-CA 123.914 3.076 . . . . 0.86 113.826 -179.203 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.569 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -79.95 173.44 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.204 -1.362 . . . . 1.43 108.817 178.425 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 23' ' ' ASN . 96.2 mt-10 -105.69 125.89 51.52 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.433 -0.507 . . . . 1.94 111.368 -179.536 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.49 143.96 34.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.682 -0.69 . . . . 1.19 110.702 179.865 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.03 168.38 25.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.923 0.392 . . . . 3.92 111.044 -179.684 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.589 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -109.03 131.11 60.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.963 -0.562 . . . . 3.88 110.067 179.888 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 69.0 p -141.24 162.41 35.55 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.871 0.367 . . . . 3.92 111.121 -179.872 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.3 mt-10 36.03 31.49 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.631 -0.507 . . . . 6.08 109.631 179.862 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.589 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.3 69.56 31.1 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.971 -0.559 . . . . 4.01 111.663 -178.809 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.37 -29.02 71.92 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.467 2.112 . . . . 4.51 111.822 179.46 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 3.51 110.477 179.98 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.612 ' O ' ' O ' ' A' ' 92' ' ' THR . 10.7 mp0 -123.89 158.41 60.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 4.3 110.447 179.941 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.523 ' CG ' ' NH1' ' A' ' 143' ' ' ARG . 98.6 Cg_endo -82.17 -64.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.866 2.378 . . . . 1.96 113.46 -178.981 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.692 ' CG ' ' CE1' ' A' ' 157' ' ' TYR . 50.0 t30 -108.44 -19.52 13.43 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.11 0.411 . . . . 3.33 112.11 -178.536 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.536 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 99.0 p -107.34 152.1 24.6 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.452 -0.499 . . . . 1.53 111.281 -179.418 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.0 t-80 -155.36 102.83 2.21 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.696 -0.684 . . . . 2.29 110.676 179.885 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.544 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.3 Cg_endo -82.56 145.6 13.19 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.814 2.343 . . . . 0.88 112.675 179.904 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.414 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.8 pt -130.81 167.89 24.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.894 -0.594 . . . . 2.12 109.862 179.561 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.1 148.0 29.16 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.737 -0.468 . . . . 2.67 109.737 178.866 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.491 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.8 p90 -142.24 157.25 45.05 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.659 -0.416 . . . . 0.32 111.16 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.471 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.9 m-20 -128.02 155.3 44.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.823 -0.626 . . . . 2.77 110.122 178.905 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.63 173.07 6.32 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.135 -0.484 . . . . 1.25 110.777 -179.184 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.75 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.907 2.405 . . . . 1.12 111.502 179.429 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -51.05 0.69 Allowed Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.679 -0.408 . . . . 4.05 110.171 179.797 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.658 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.85 152.35 82.47 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.7 2.267 . . . . 2.12 111.481 179.169 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.74 42.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.357 0.599 . . . . 2.85 110.525 -179.808 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.822 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.67 -41.61 98.15 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.052 -0.976 . . . . 3.11 110.639 179.735 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.439 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.3 mt -109.85 137.84 40.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.784 -0.644 . . . . 1.86 111.224 -179.449 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.93 -72.9 0.7 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.027 -0.533 . . . . 1.61 111.953 -179.069 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.17 148.37 24.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.588 0.588 . . . . 1.67 112.588 -179.649 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.85 124.91 45.25 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.346 -0.613 . . . . 1.07 109.346 177.498 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.04 134.65 60.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.646 -0.422 . . . . 1.55 110.662 -179.997 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.481 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -119.98 128.67 53.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.994 0.426 . . . . 1.33 111.261 179.742 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.21 138.94 49.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.787 -0.642 . . . . 2.36 110.096 179.018 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.423 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.04 163.1 35.27 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.166 0.508 . . . . 0.38 112.083 -178.083 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.495 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.46 139.67 7.92 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.406 -0.815 . . . . 2.31 110.451 178.766 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.696 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.2 Cg_endo -63.57 115.51 3.09 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.279 1.986 . . . . 0.86 111.801 -179.972 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.667 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.99 81.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.87 -0.419 . . . . 3.44 109.87 -179.865 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.696 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.19 -20.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.981 -0.554 . . . . 2.72 111.895 -179.548 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 p -157.58 157.82 34.42 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.784 -0.367 . . . . 2.78 110.548 179.782 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.404 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.42 27.84 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 2.3 110.138 179.575 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.78 -75.82 1.31 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.181 -0.533 . . . . 1.8 111.895 -179.294 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.93 152.34 35.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.983 0.42 . . . . 5.48 110.912 -179.327 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.67 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.31 -169.13 2.52 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.049 -0.523 . . . . 1.84 111.939 179.318 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.423 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.1 149.62 29.78 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.464 0.649 . . . . 2.27 112.571 -177.811 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.01 156.47 46.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.851 -1.068 . . . . 1.92 110.268 178.637 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.2 158.39 41.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.993 -0.549 . . . . 1.09 111.766 -179.336 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.6 m -115.2 135.58 54.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.415 -0.811 . . . . 1.16 109.834 179.296 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.449 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.39 121.94 23.78 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.479 -0.328 . . . . 1.39 111.527 -179.11 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.514 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.9 Cg_exo -46.36 151.75 1.65 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.632 2.221 . . . . 0.72 112.168 179.017 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.99 -23.04 63.24 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 116.039 -0.528 . . . . 0.74 112.755 -179.108 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.514 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.73 -16.96 46.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.35 0.575 . . . . 1.26 111.778 -178.345 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.481 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.3 mt -91.49 138.42 31.59 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.779 -0.368 . . . . 1.59 110.299 179.342 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -121.55 13.91 10.97 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.333 -0.394 . . . . 2.07 111.468 -179.382 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -149.99 143.5 25.24 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.589 -0.444 . . . . 0.96 111.026 179.56 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.726 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.81 -169.33 1.53 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.199 0.523 . . . . 1.0 110.845 -179.396 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.726 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.74 125.99 9.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.39 -0.823 . . . . 1.19 109.832 179.236 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.435 HG23 HD11 ' A' ' 60' ' ' ILE . 66.8 mt -114.95 123.29 70.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.383 -0.527 . . . . 1.47 111.17 -179.758 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -126.5 163.33 23.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.849 -0.614 . . . . 3.0 110.529 179.687 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.522 ' CA ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.2 19.07 59.61 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.685 -0.966 . . . . 0.5 110.685 -179.972 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.626 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 74.0 mt -79.14 157.27 27.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.138 0.494 . . . . 1.21 111.286 -179.604 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.639 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 13.2 mptt -99.57 134.03 21.43 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.551 -0.749 . . . . 3.2 110.393 179.85 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.98 143.55 60.76 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.554 2.169 . . . . 1.09 111.88 179.871 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.85 25.71 75.24 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.972 -0.851 . . . . 0.72 110.972 179.685 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.643 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.3 p -128.23 158.77 40.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.597 0.237 . . . . 1.47 110.434 -179.658 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.07 139.98 41.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.875 0.369 . . . . 1.23 110.623 -179.824 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.643 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.7 m-85 -122.67 136.47 54.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.897 -0.592 . . . . 1.1 110.76 -179.918 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.495 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.5 pt-20 -98.91 131.01 45.32 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.524 -0.917 . . . . 1.87 108.524 177.656 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.48 153.85 16.65 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.29 -0.957 . . . . 0.39 111.935 -178.585 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.98 140.95 46.1 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.716 -0.476 . . . . 1.8 109.716 179.537 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.462 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.0 tp -115.73 118.98 34.56 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.406 -0.518 . . . . 1.11 110.486 179.705 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.1 mt -112.51 129.03 68.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.909 0.385 . . . . 1.51 110.583 -179.878 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.85 120.82 43.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.299 -0.409 . . . . 1.47 110.701 -179.646 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.665 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.57 146.53 11.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.118 0.485 . . . . 1.33 110.977 -179.227 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.822 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.09 153.85 21.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.483 -0.78 . . . . 2.49 109.974 179.8 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.22 88.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.965 0.412 . . . . 4.2 110.444 -179.689 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.31 32.62 0.21 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.806 -0.634 . . . . 6.4 110.561 -179.936 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.3 3.29 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.496 -0.642 . . . . 1.74 111.496 -179.804 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.443 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.48 177.38 8.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.146 0.498 . . . . 3.64 111.623 -179.203 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.14 149.54 32.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.411 -0.813 . . . . 1.7 110.459 179.145 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.16 144.62 38.67 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.477 -0.329 . . . . 2.7 110.54 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.98 135.98 61.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 121.092 0.472 . . . . 1.16 111.573 -179.81 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.08 141.35 52.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.664 -0.698 . . . . 1.14 110.279 179.62 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.442 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.65 138.93 51.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.105 0.479 . . . . 4.33 111.5 -179.368 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.38 164.04 38.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.526 -0.761 . . . . 0.91 109.516 179.417 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.572 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.1 p30 -145.18 151.56 38.62 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.415 -0.514 . . . . 1.47 111.092 -179.995 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.574 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.0 p90 -146.24 172.71 13.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.759 -0.655 . . . . 0.51 111.039 179.875 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.455 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.73 160.69 21.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.455 -0.793 . . . . 1.92 109.777 179.658 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.455 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.37 121.9 22.99 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.636 -0.426 . . . . 1.63 110.764 179.91 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.612 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -127.61 167.98 15.63 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.675 0.621 . . . . 2.37 112.675 179.679 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.7 m -111.64 153.38 26.45 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.195 -0.911 . . . . 3.63 109.997 179.225 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 58.0 p -62.53 -11.77 18.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.999 -178.908 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 47.5 m -115.3 147.96 39.79 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.868 0.366 . . . . 0.0 110.204 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 28.5 p -96.88 119.36 63.73 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.883 -179.546 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.42 147.68 36.62 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.032 1.821 . . . . 0.0 111.829 179.226 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.8 m -127.82 158.22 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.479 -179.824 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 48.8 m -119.76 141.19 49.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.509 -179.695 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 93.8 p -121.63 156.68 32.47 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.465 -179.776 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -132.78 -179.88 5.74 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.476 -179.832 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.9 p -122.07 162.97 20.26 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.826 -179.574 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 75.2 t -60.44 -38.39 77.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.399 179.984 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 45.6 m -73.02 138.23 45.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.374 -179.736 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -82.77 -176.22 51.34 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.524 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -98.14 139.28 34.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.852 0.358 . . . . 0.0 110.554 -179.598 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.6 m -138.11 -122.51 0.13 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.936 179.78 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.478 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 81.8 p -63.65 151.1 89.2 Favored Pre-proline 0 C--N 1.331 -0.208 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.75 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.84 142.94 50.31 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.742 1.628 . . . . 0.0 112.067 -179.783 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.478 ' CE2' ' O ' ' A' ' 108' ' ' THR . 99.1 m-85 -120.41 155.9 32.51 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.561 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.8 m -123.57 71.19 47.91 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.972 179.37 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.9 -21.94 60.24 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.568 2.178 . . . . 0.0 112.586 -179.736 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.3 mt -90.68 140.58 29.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.019 0.438 . . . . 10.52 110.423 -179.465 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.17 160.46 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.653 -0.703 . . . . 7.48 110.538 -179.68 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.5 147.07 38.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.421 -0.354 . . . . 7.69 110.076 -179.978 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 57.2 m -116.65 143.08 46.07 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.133 0.492 . . . . 6.46 111.086 -179.051 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.9 t -110.7 148.59 31.97 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.481 -0.781 . . . . 4.59 109.893 -179.916 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -53.08 -34.34 56.14 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.806 -0.358 . . . . 3.21 110.409 -179.02 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 54.5 p -71.51 160.84 32.0 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.407 -0.59 . . . . 3.64 109.407 178.776 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.64 132.52 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.99 0.424 . . . . 3.39 111.191 -179.772 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.1 3.42 1.78 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.611 -0.722 . . . . 2.23 109.742 179.013 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -110.79 159.24 17.83 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.77 -0.65 . . . . 4.53 110.862 -179.45 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 18.3 mm 38.89 58.1 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.966 -0.561 . . . . 2.01 110.556 179.796 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 47.0 m -55.28 -38.25 68.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.971 -0.559 . . . . 2.22 110.714 -179.545 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.542 ' O ' ' CB ' ' A' ' 126' ' ' SER . . . -140.97 150.33 42.95 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.542 -0.299 . . . . 1.29 110.548 179.677 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.542 ' CB ' ' O ' ' A' ' 125' ' ' ALA . 31.6 p 144.72 -30.94 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.308 -0.86 . . . . 1.25 109.0 179.912 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.482 ' HG ' HD22 ' A' ' 168' ' ' ASN . 0.9 OUTLIER -53.92 167.62 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.025 -0.989 . . . . 1.16 110.907 179.873 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.488 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.8 m-30 -133.68 145.47 49.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.672 -0.694 . . . . 0.78 110.102 -179.894 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.19 101.76 9.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.108 -0.701 . . . . 1.08 109.108 177.702 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.471 HG11 ' N ' ' A' ' 131' ' ' SER . 70.3 t -113.04 139.71 36.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.045 -0.525 . . . . 1.1 110.966 -178.76 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.471 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.0 p -128.64 152.54 48.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.544 -0.753 . . . . 0.87 109.869 179.622 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.647 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.7 p90 -144.88 -165.01 2.05 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.769 -0.372 . . . . 0.37 110.64 -179.788 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.3 t -123.91 127.13 73.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.281 -0.418 . . . . 1.14 110.922 -179.839 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.171 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.96 58.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.115 -0.493 . . . . 1.91 110.333 179.921 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.26 24.62 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.949 -0.569 . . . . 1.56 111.456 -179.592 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.171 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.14 128.62 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.624 -0.43 . . . . 1.56 110.998 179.897 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.39 -9.65 55.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.96 -0.564 . . . . 1.88 110.267 179.804 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.7 p -87.11 0.28 55.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 1.63 110.341 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.965 HG11 ' O ' ' A' ' 136' ' ' SER . 2.6 p -65.23 137.19 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.949 -0.569 . . . . 1.11 109.981 179.63 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 185' ' ' ILE . 7.8 m -96.29 -15.45 21.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.132 0.492 . . . . 1.01 110.006 -179.738 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.62 175.59 45.82 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 109.838 -1.305 . . . . 0.14 109.838 179.61 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.45 151.59 42.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.002 0.429 . . . . 0.21 110.437 179.775 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.523 ' NH1' ' CG ' ' A' ' 15' ' ' PRO . 23.9 ttp85 -132.33 121.09 22.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.168 -0.469 . . . . 1.54 109.988 179.751 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.491 HG23 HG11 ' A' ' 167' ' ' VAL . 46.1 t -104.99 136.53 38.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.742 -0.663 . . . . 1.08 110.703 -179.749 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 82.6 tt0 -129.35 129.96 45.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.05 -0.523 . . . . 1.32 110.042 -179.932 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.592 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.77 135.25 34.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.053 -0.521 . . . . 1.05 110.615 -179.67 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.403 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.27 161.35 39.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.809 -0.632 . . . . 1.16 109.629 179.847 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.935 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -71.01 124.82 25.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.994 0.426 . . . . 1.23 110.804 -179.721 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.494 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.77 -7.64 49.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.719 -0.673 . . . . 0.86 110.891 -179.754 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -109.87 -69.76 0.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.932 0.396 . . . . 1.66 111.306 -179.189 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.431 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.6 -35.4 76.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.06 -0.518 . . . . 1.66 111.486 -179.094 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.077 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.2 88.62 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.787 -0.925 . . . . 1.62 110.787 -179.811 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.339 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.3 t0 -27.93 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.814 0.34 . . . . 1.86 110.218 179.873 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.339 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.2 pm0 -82.24 139.07 45.22 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 1.98 110.214 179.626 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.403 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.1 Cg_endo -70.85 145.85 51.91 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.652 2.235 . . . . 0.62 112.368 -179.56 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.87 145.7 42.64 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.231 -0.655 . . . . 1.14 109.231 179.18 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.692 ' CE1' ' CG ' ' A' ' 16' ' ' ASN . 1.7 p90 -123.21 141.24 52.18 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.401 -0.52 . . . . 1.44 111.577 -179.099 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' A' ' 158' ' ' LEU . 71.0 mt -128.05 127.78 43.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.311 -0.858 . . . . 1.08 108.945 178.903 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.474 ' HB2' HD22 ' A' ' 16' ' ' ASN . 18.0 t0 -101.67 131.13 48.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.155 0.502 . . . . 1.09 111.742 -178.728 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.508 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -127.94 157.56 73.41 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.294 -0.866 . . . . 1.04 109.53 179.682 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -69.69 157.94 58.79 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 C-N-CA 122.491 2.127 . . . . 0.21 112.252 179.908 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.4 p -59.22 -12.14 4.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.786 -0.643 . . . . 0.88 110.775 -179.91 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.2 p -92.86 -8.74 42.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 1.06 110.704 -179.859 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.27 135.35 34.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 1.05 110.345 179.76 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.15 16.72 4.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.418 -0.355 . . . . 1.07 110.515 179.967 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.1 p -167.53 147.06 5.07 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.617 -0.512 . . . . 0.92 109.617 179.927 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.508 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.22 150.5 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.485 -0.486 . . . . 1.09 111.55 -179.707 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.495 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.27 124.95 50.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.525 -0.762 . . . . 1.31 109.818 179.49 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.528 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.37 104.94 29.92 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.476 -0.329 . . . . 1.09 111.092 -179.921 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 84.8 Cg_endo -91.07 -179.47 1.47 Allowed 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 123.19 2.594 . . . . 0.48 112.169 179.93 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.62 32.68 18.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.369 -0.832 . . . . 1.26 111.477 179.247 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.528 HD21 HG21 ' A' ' 169' ' ' ILE . 23.8 mt -86.34 148.39 25.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.432 -0.349 . . . . 1.12 110.47 179.6 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.774 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.16 114.78 60.88 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.964 0.411 . . . . 1.3 110.734 -179.778 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.92 140.44 95.25 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.925 2.417 . . . . 0.92 112.005 179.844 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.16 21.25 73.97 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.005 -0.838 . . . . 0.44 111.005 179.832 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.431 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.94 150.21 49.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.879 0.371 . . . . 3.05 110.623 179.931 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.494 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.23 131.61 46.08 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.013 -0.54 . . . . 1.48 109.786 179.365 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.935 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.4 148.32 43.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.076 -0.511 . . . . 0.89 111.066 -179.842 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.35 125.29 60.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.228 -1.027 . . . . 1.12 108.228 177.796 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.52 132.57 63.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.136 0.493 . . . . 1.1 111.204 -178.61 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.52 122.46 20.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.468 -0.787 . . . . 0.43 109.636 179.324 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.59 HG12 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.03 125.33 54.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.274 -0.421 . . . . 1.07 110.694 -179.521 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.667 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.6 m-85 -117.18 137.89 52.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.97 -0.559 . . . . 0.92 109.87 179.562 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.75 135.05 42.8 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.756 -0.831 . . . . 0.49 108.756 178.863 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' A' ' 140' ' ' SER . 76.7 mt -99.04 122.96 51.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.062 0.458 . . . . 1.08 110.89 -178.715 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.448 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.3 p -83.98 169.7 14.73 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.574 -0.739 . . . . 0.89 110.455 -179.7 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.422 ' HA ' ' HG ' ' A' ' 140' ' ' SER . 51.8 tp10 -59.7 -14.56 14.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.067 -0.515 . . . . 1.6 110.967 -179.535 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.544 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.9 m-20 -96.06 -4.26 43.29 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.845 -0.342 . . . . 1.18 110.792 -179.815 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.467 ' HA2' ' OG1' ' A' ' 59' ' ' THR . . . 87.78 13.89 64.02 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.383 -0.687 . . . . 0.34 111.383 179.903 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -84.73 139.15 32.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.644 0.259 . . . . 1.22 110.394 179.766 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.492 ' NE2' ' NE ' ' A' ' 143' ' ' ARG . 84.3 mt-30 -106.83 141.14 38.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 1.44 110.496 179.781 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.5 m -136.75 127.06 26.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.506 . . . . 1.39 110.411 179.903 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.667 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.4 tp -68.22 117.27 9.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.297 -0.41 . . . . 1.08 110.499 -179.822 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.647 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -108.96 -21.89 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 1.08 110.676 -179.709 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.89 125.68 5.84 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.456 -0.497 . . . . 1.1 111.516 -179.77 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.497 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.68 120.25 21.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.721 -0.672 . . . . 0.94 109.516 179.231 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.56 151.73 29.21 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.7 -0.4 . . . . 1.07 110.933 -179.321 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.47 158.61 18.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 0.89 110.393 179.677 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.06 157.92 43.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.103 -0.499 . . . . 0.67 110.702 179.919 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.17 104.39 9.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.82 -0.627 . . . . 1.17 110.009 179.524 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.488 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 67.5 p . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 117.95 -1.024 . . . . 1.26 110.585 -179.744 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.548 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.9 m . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.223 -0.658 . . . . 3.83 109.223 . . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.45 150.68 18.53 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.023 -0.831 . . . . 1.39 111.023 179.755 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.69 142.34 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.056 0 C-N-CA 124.067 3.178 . . . . 0.86 113.761 -179.199 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.568 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -79.89 173.47 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.194 -1.366 . . . . 1.43 108.893 178.389 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 23' ' ' ASN . 96.1 mt-10 -105.61 125.89 51.51 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.406 -0.518 . . . . 1.94 111.349 -179.548 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 144.07 33.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.636 -0.711 . . . . 1.19 110.662 179.75 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.02 168.32 25.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.404 -0.362 . . . . 3.92 111.104 -179.649 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.59 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.98 131.08 60.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.925 -0.58 . . . . 3.88 110.06 179.869 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.26 162.26 35.92 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.882 0.372 . . . . 3.92 111.209 -179.916 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 34.3 tp10 36.2 31.54 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.648 -0.501 . . . . 6.08 109.648 179.85 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.59 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.5 69.57 33.2 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.982 -0.554 . . . . 4.01 111.468 -178.644 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.28 -29.09 72.71 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.432 2.088 . . . . 4.51 111.845 179.346 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 3.51 110.472 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.535 ' CB ' ' O ' ' A' ' 17' ' ' SER . 7.7 mp0 -123.93 158.39 60.27 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.311 -0.404 . . . . 4.3 110.441 179.99 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.521 ' HB3' ' CB ' ' A' ' 93' ' ' SER . 98.1 Cg_endo -82.19 -64.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.941 2.427 . . . . 1.96 113.444 -178.991 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.664 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 41.2 t30 -108.48 -19.52 13.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.322 -0.399 . . . . 3.33 112.07 -178.513 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.535 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 12.6 t -107.4 152.01 24.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.19 0.519 . . . . 1.53 111.252 -179.339 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.25 102.92 2.23 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.712 -0.676 . . . . 2.29 110.67 179.796 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.554 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.4 Cg_endo -82.59 145.65 13.16 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.878 2.385 . . . . 0.88 112.666 179.871 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.413 HG12 ' HB3' ' A' ' 58' ' ' TYR . 6.9 pt -130.88 167.99 24.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.892 -0.594 . . . . 2.12 109.859 179.591 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -149.18 147.91 28.99 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.783 -0.451 . . . . 2.67 109.783 178.954 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.494 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.7 p90 -142.29 157.25 45.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.027 0.442 . . . . 0.32 111.183 179.976 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.47 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.9 m-20 -127.96 155.26 44.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.796 -0.638 . . . . 2.77 110.133 178.969 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.56 173.02 6.37 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 121.074 0.464 . . . . 1.25 110.758 -179.223 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -50.61 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.888 0 C-N-CA 122.88 2.387 . . . . 1.12 111.517 179.304 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.483 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -51.08 0.69 Allowed Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 120.706 -0.398 . . . . 4.05 110.089 179.813 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.657 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.86 152.39 82.38 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.7 2.267 . . . . 2.12 111.474 179.243 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.73 42.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.42 0.629 . . . . 2.85 110.576 -179.869 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.824 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.57 -41.67 98.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.941 -1.027 . . . . 3.11 110.653 179.689 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.44 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.6 mt -109.87 137.77 40.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.771 -0.649 . . . . 1.86 111.327 -179.426 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.85 -72.95 0.7 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.106 -0.497 . . . . 1.61 111.925 -179.007 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.21 148.43 24.38 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.549 0.574 . . . . 1.67 112.549 -179.55 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.8 124.85 45.16 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.3 -0.63 . . . . 1.07 109.3 177.563 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.3 mt -117.95 134.7 60.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.721 -0.391 . . . . 1.55 110.654 179.905 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.483 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -119.99 128.7 53.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.065 0.46 . . . . 1.33 111.269 179.634 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.541 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.26 138.96 49.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.707 -0.679 . . . . 2.36 110.125 178.966 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.421 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.01 163.11 35.21 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.118 0.485 . . . . 0.38 112.146 -178.065 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.46 139.59 7.88 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.515 -0.766 . . . . 2.31 110.504 178.815 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.58 115.53 3.1 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.31 2.007 . . . . 0.86 111.733 -179.946 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.01 81.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.888 -0.412 . . . . 3.44 109.888 -179.926 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.17 -20.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.93 -0.577 . . . . 2.72 111.97 -179.558 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.8 p -157.65 157.81 34.29 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.813 0.34 . . . . 2.78 110.579 179.745 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.401 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.43 27.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 2.3 110.233 179.58 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.84 -75.87 1.31 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.126 -0.559 . . . . 1.8 111.864 -179.261 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.89 152.34 35.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.988 0.423 . . . . 5.48 110.953 -179.353 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.672 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.24 -169.17 2.54 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.029 -0.532 . . . . 1.84 111.919 179.37 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.1 149.65 29.73 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.395 0.617 . . . . 2.27 112.63 -177.88 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.06 156.5 45.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.842 -1.072 . . . . 1.92 110.226 178.659 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.22 158.34 41.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.906 -0.588 . . . . 1.09 111.785 -179.261 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 m -115.17 135.58 54.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.515 -0.766 . . . . 1.16 109.716 179.382 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.449 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.36 121.9 23.8 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 1.39 111.574 -179.229 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.518 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 73.8 Cg_exo -46.3 151.71 1.62 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.684 2.256 . . . . 0.72 112.046 179.042 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.91 -23.01 63.03 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 116.046 -0.524 . . . . 0.74 112.796 -179.233 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.518 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.84 -16.81 46.25 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.251 -0.579 . . . . 1.26 111.823 -178.329 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.483 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.5 mt -91.67 138.46 31.55 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.684 -0.406 . . . . 1.59 110.289 179.37 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -121.58 14.04 10.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.369 -0.378 . . . . 2.07 111.588 -179.394 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.48 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -150.07 143.5 25.16 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.601 -0.44 . . . . 0.96 111.003 179.579 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.725 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.85 -169.4 1.54 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.188 0.518 . . . . 1.0 110.869 -179.405 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.725 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.9 m -151.74 125.92 9.27 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.43 -0.805 . . . . 1.19 109.807 179.277 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.425 HG23 HD11 ' A' ' 60' ' ' ILE . 66.5 mt -114.86 123.28 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.369 -0.533 . . . . 1.47 111.243 -179.798 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -126.53 163.34 23.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.885 -0.598 . . . . 3.0 110.442 179.76 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.442 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.08 19.08 59.77 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.733 -0.947 . . . . 0.5 110.733 -179.89 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.664 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.7 mt -79.01 157.21 28.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.032 0.444 . . . . 1.21 111.36 -179.64 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.642 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 3.9 mmtt -99.5 133.93 21.54 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.691 -0.686 . . . . 3.2 110.522 179.716 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.549 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.86 143.57 61.5 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.491 2.128 . . . . 1.09 112.007 179.854 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.89 25.66 75.3 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.997 -0.841 . . . . 0.72 110.997 179.694 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.641 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.22 158.72 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.649 0.262 . . . . 1.47 110.398 -179.55 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.11 139.88 42.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.846 0.355 . . . . 1.23 110.644 -179.79 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.642 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.6 m-85 -122.51 136.48 54.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.973 -0.558 . . . . 1.1 110.8 -179.883 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.5 pt-20 -98.96 131.06 45.31 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.462 -0.94 . . . . 1.87 108.462 177.699 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.47 153.92 16.64 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.341 -0.933 . . . . 0.39 111.944 -178.616 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.98 140.95 46.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.706 -0.479 . . . . 1.8 109.706 179.559 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.461 HD23 ' CG ' ' A' ' 22' ' ' TRP . 40.8 tp -115.85 118.93 34.35 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.427 -0.509 . . . . 1.11 110.531 179.616 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.8 mt -112.46 129.08 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 1.51 110.676 -179.942 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.77 120.8 43.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.215 -0.448 . . . . 1.47 110.732 -179.639 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.668 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.56 146.43 11.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.163 0.506 . . . . 1.33 111.06 -179.261 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.824 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -105.98 153.88 21.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.528 -0.76 . . . . 2.49 109.907 179.845 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.16 88.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.899 0.38 . . . . 4.2 110.476 -179.814 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.35 32.54 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.834 -0.621 . . . . 6.4 110.628 -179.915 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.08 -117.35 3.29 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.471 -0.652 . . . . 1.74 111.471 -179.652 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.442 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.38 177.45 8.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.175 0.512 . . . . 3.64 111.609 -179.21 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.2 149.54 32.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.416 -0.811 . . . . 1.7 110.376 179.149 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.548 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.19 144.67 38.64 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.4 -0.364 . . . . 2.7 110.574 179.823 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -128.0 135.99 61.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 121.037 0.446 . . . . 1.16 111.581 -179.79 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.06 141.27 52.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.689 -0.687 . . . . 1.14 110.302 179.649 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.444 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.55 138.91 51.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.07 0.462 . . . . 4.33 111.535 -179.387 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.31 164.23 37.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.579 -0.737 . . . . 0.91 109.494 179.349 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.574 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.2 p30 -145.29 151.45 38.36 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.394 -0.523 . . . . 1.47 111.083 -179.952 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.574 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.4 p90 -146.16 172.78 12.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.835 -0.62 . . . . 0.51 111.053 179.84 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.456 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.83 160.6 21.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.468 -0.787 . . . . 1.92 109.874 179.627 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.456 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.33 121.8 22.9 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.685 -0.406 . . . . 1.63 110.745 -179.962 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.7 p -128.68 169.02 14.98 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 115.78 1.77 . . . . 2.37 115.78 179.579 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.521 ' CB ' ' HB3' ' A' ' 15' ' ' PRO . 18.2 t 174.18 -62.29 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 111.87 -2.423 . . . . 3.63 108.603 177.507 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.8 t -140.78 165.69 26.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.563 178.896 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.4 m -114.19 145.71 41.33 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.306 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 46.8 p -147.39 122.33 5.19 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.788 -178.906 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.07 142.48 54.14 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.626 1.551 . . . . 0.0 111.522 178.772 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.3 p -59.32 -30.5 44.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.435 -179.626 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 25.4 p -120.18 160.82 22.16 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.164 0.507 . . . . 0.0 110.976 179.704 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 87.0 p -140.35 158.61 43.75 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.863 179.157 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.447 ' C ' HD21 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -142.58 176.44 9.02 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.912 0.387 . . . . 0.0 110.9 179.889 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 103' ' ' VAL . 24.6 p -95.43 162.82 13.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.971 179.583 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 102' ' ' THR . 53.8 t 42.8 94.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 120.831 0.348 . . . . 0.0 110.506 -179.677 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 26.4 p -81.25 161.83 23.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.087 0.47 . . . . 0.0 111.183 -179.317 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -146.74 -99.71 0.25 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.966 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -95.14 140.27 30.31 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.413 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.8 p -81.41 159.35 24.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.861 0.362 . . . . 0.0 110.711 -179.378 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 37.3 p -108.9 113.75 59.13 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.519 -179.945 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.61 -19.15 58.83 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.709 1.606 . . . . 0.0 111.588 -179.813 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -108.81 141.94 40.1 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.165 179.955 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.2 t -124.56 80.13 61.42 Favored Pre-proline 0 N--CA 1.465 0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.024 -179.368 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -54.03 147.75 42.06 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 122.436 2.091 . . . . 0.0 111.66 179.691 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.5 mt -90.42 139.89 30.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.895 0.379 . . . . 10.52 110.758 -179.488 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 115' ' ' ALA . 43.1 t -121.24 135.88 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.731 -0.668 . . . . 7.48 110.048 179.599 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 114' ' ' VAL . . . -33.0 -83.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.406 -0.361 . . . . 7.69 111.301 -179.857 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.2 p -124.17 160.76 27.14 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.291 -0.413 . . . . 6.46 110.321 179.516 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.0 t -124.42 142.93 50.92 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.279 -0.419 . . . . 4.59 110.755 179.718 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -115.66 153.31 31.55 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.085 -0.507 . . . . 3.21 109.99 179.547 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.8 p -122.65 152.69 40.25 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.912 0.387 . . . . 3.64 110.665 179.91 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 43.7 t -123.35 136.4 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.801 -0.636 . . . . 3.39 110.454 179.713 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.9 p -122.65 158.26 30.41 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.53 -0.304 . . . . 2.23 110.333 179.442 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -121.5 151.87 39.79 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.198 -0.456 . . . . 4.53 110.612 179.89 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.418 HD12 HG23 ' A' ' 123' ' ' ILE . 90.5 mt -58.78 -38.92 75.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.825 -0.435 . . . . 2.01 109.825 179.126 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 56.5 m -123.65 139.67 53.76 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.609 -0.723 . . . . 2.22 109.754 179.352 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 127' ' ' SER . . . -178.35 65.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.506 -0.478 . . . . 1.29 111.276 179.99 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 125' ' ' ALA . 0.1 OUTLIER 36.76 27.61 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.162 0.982 . . . . 1.25 110.832 178.998 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.85 167.65 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.68 -1.146 . . . . 1.16 110.937 -179.264 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.488 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.9 m-30 -133.7 145.57 50.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.688 -0.687 . . . . 0.78 110.166 -179.962 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.23 101.66 9.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.088 -0.708 . . . . 1.08 109.088 177.751 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.47 HG11 ' N ' ' A' ' 131' ' ' SER . 71.2 t -113.02 139.65 37.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.99 -0.55 . . . . 1.1 111.066 -178.884 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.47 ' N ' HG11 ' A' ' 130' ' ' VAL . 67.2 p -128.63 152.57 48.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.643 -0.708 . . . . 0.87 109.84 179.644 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.645 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.8 p90 -144.83 -165.07 2.06 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.687 -0.405 . . . . 0.37 110.642 -179.765 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -123.81 127.17 73.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 1.14 110.918 -179.905 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.168 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.96 58.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.198 -0.455 . . . . 1.91 110.346 179.814 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.12 24.46 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.902 -0.59 . . . . 1.56 111.515 -179.732 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.168 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.18 128.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.619 -0.432 . . . . 1.56 111.011 179.8 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.33 -9.66 55.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.915 -0.584 . . . . 1.88 110.353 179.814 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.7 p -87.09 0.3 55.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.095 -0.502 . . . . 1.63 110.337 179.991 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.965 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.36 137.24 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.892 -0.594 . . . . 1.11 109.936 179.734 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 185' ' ' ILE . 5.4 m -96.26 -15.45 21.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.286 0.565 . . . . 1.01 110.12 -179.716 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.58 175.55 45.75 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 109.806 -1.318 . . . . 0.14 109.806 179.593 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.46 151.63 42.52 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.602 -0.439 . . . . 0.21 110.558 179.718 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.784 ' NE ' HE22 ' A' ' 191' ' ' GLN . 41.9 ttp85 -132.32 121.08 22.99 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.178 -0.464 . . . . 1.54 109.957 179.939 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.487 HG23 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.1 136.55 38.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.716 -0.674 . . . . 1.08 110.629 -179.708 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 82.7 tt0 -129.4 129.9 45.3 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.939 -0.573 . . . . 1.32 110.05 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.4 p90 -138.66 135.27 34.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.957 -0.565 . . . . 1.05 110.644 -179.693 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.401 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.35 161.37 39.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.809 -0.632 . . . . 1.16 109.747 179.729 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.933 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.3 mt -71.02 124.84 25.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.064 0.459 . . . . 1.23 110.716 -179.52 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.65 -7.8 50.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.702 -0.681 . . . . 0.86 110.919 -179.818 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.86 -69.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 1.66 111.431 -179.257 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.425 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.66 -35.42 76.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.112 -0.495 . . . . 1.66 111.491 -179.147 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.081 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.22 88.61 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.799 -0.92 . . . . 1.62 110.799 -179.817 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.338 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -28.03 -171.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.762 0.315 . . . . 1.86 110.319 179.913 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.338 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.03 45.19 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-O 120.917 0.389 . . . . 1.98 110.213 179.657 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.401 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.7 Cg_endo -70.86 145.83 51.8 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.716 2.277 . . . . 0.62 112.394 -179.578 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.9 145.74 42.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.189 -0.671 . . . . 1.14 109.189 179.255 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.549 ' CE1' ' HD3' ' A' ' 65' ' ' PRO . 35.3 p90 -123.26 141.39 52.03 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.33 -0.548 . . . . 1.44 111.46 -179.062 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.416 ' HA ' HD22 ' A' ' 158' ' ' LEU . 71.5 mt -128.17 127.68 43.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.271 -0.877 . . . . 1.08 108.918 178.919 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.6 ' HB2' ' ND2' ' A' ' 16' ' ' ASN . 38.1 t0 -101.6 131.21 47.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.24 0.543 . . . . 1.09 111.702 -178.743 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.51 HD13 ' HB ' ' A' ' 167' ' ' VAL . 6.0 mt -128.04 157.43 74.0 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.349 -0.841 . . . . 1.04 109.575 179.677 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.71 157.89 58.93 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 122.406 2.071 . . . . 0.21 112.334 179.902 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.18 -12.22 4.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.813 -0.63 . . . . 0.88 110.781 -179.799 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.9 p -92.74 -8.79 42.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.042 -0.526 . . . . 1.06 110.764 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.21 135.4 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.355 -0.384 . . . . 1.05 110.436 179.691 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.6 p -133.13 16.69 4.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.328 -0.396 . . . . 1.07 110.461 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.61 147.12 5.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.697 -0.483 . . . . 0.92 109.697 179.838 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.51 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.0 p -152.15 150.42 12.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.501 -0.48 . . . . 1.09 111.597 -179.533 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.497 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.38 124.92 50.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.62 -0.718 . . . . 1.31 109.858 179.469 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.528 HG21 HD21 ' A' ' 172' ' ' LEU . 1.7 mt -99.35 104.82 29.17 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.333 -0.394 . . . . 1.09 111.077 -179.791 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.4 Cg_endo -90.87 -179.47 1.53 Allowed 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 123.21 2.607 . . . . 0.48 112.25 179.882 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.61 32.73 18.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.416 -0.811 . . . . 1.26 111.376 179.224 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.528 HD21 HG21 ' A' ' 169' ' ' ILE . 24.2 mt -86.36 148.49 25.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.544 -0.298 . . . . 1.12 110.45 179.541 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.77 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.33 114.89 61.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.066 0.46 . . . . 1.3 110.656 -179.763 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.1 140.64 96.04 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.915 2.41 . . . . 0.92 111.982 179.885 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.0 21.28 74.35 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.091 -0.804 . . . . 0.44 111.091 179.974 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.425 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.99 150.2 49.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.862 0.363 . . . . 3.05 110.587 -179.979 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.495 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.11 131.65 45.93 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.999 -0.546 . . . . 1.48 109.794 179.37 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.933 ' CE2' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.56 148.33 44.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.134 -0.484 . . . . 0.89 111.011 -179.874 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.38 125.31 60.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.198 -1.038 . . . . 1.12 108.198 177.796 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.54 132.56 63.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.119 0.485 . . . . 1.1 111.318 -178.694 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.9 m-20 -136.47 122.5 20.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.54 -0.755 . . . . 0.43 109.719 179.327 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.589 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.02 125.45 54.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.314 -0.403 . . . . 1.07 110.715 -179.527 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.666 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.0 m-85 -117.2 137.87 52.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.04 -0.527 . . . . 0.92 109.886 179.574 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.569 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.74 135.13 42.66 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.805 -0.813 . . . . 0.49 108.805 178.82 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.548 ' O ' ' N ' ' A' ' 140' ' ' SER . 88.9 mt -99.16 123.02 51.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.178 0.513 . . . . 1.08 110.904 -178.713 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.45 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 89.2 p -83.95 169.83 14.63 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.497 -0.774 . . . . 0.89 110.432 -179.614 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.45 ' HA ' ' HG ' ' A' ' 140' ' ' SER . 97.9 mt-10 -59.77 -14.64 15.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.046 -0.524 . . . . 1.6 110.946 -179.598 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.605 ' C ' ' OG1' ' A' ' 59' ' ' THR . 96.4 m-20 -96.03 -4.28 43.36 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.778 -0.369 . . . . 1.18 110.842 -179.763 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.724 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.8 13.98 63.84 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.376 -0.689 . . . . 0.34 111.376 179.875 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -84.69 139.02 32.32 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.781 -0.246 . . . . 1.22 110.386 179.733 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.784 HE22 ' NE ' ' A' ' 143' ' ' ARG . 84.3 mt-30 -106.81 141.05 38.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.929 0.395 . . . . 1.44 110.511 179.758 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.8 m -136.65 126.94 26.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 1.39 110.45 179.913 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.666 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.4 tp -68.06 117.28 9.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.335 -0.393 . . . . 1.08 110.527 -179.856 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.645 HD12 ' CD1' ' A' ' 132' ' ' TRP . 44.2 pt -109.03 -21.79 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 1.08 110.752 -179.783 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.85 125.77 5.91 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.519 -0.473 . . . . 1.1 111.488 -179.824 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.498 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.79 120.14 21.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.743 -0.662 . . . . 0.94 109.6 179.215 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.58 151.67 29.12 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.715 -0.394 . . . . 1.07 111.009 -179.296 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.46 158.61 18.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 0.89 110.403 179.704 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.02 157.94 43.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.098 -0.501 . . . . 0.67 110.669 179.997 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.24 104.29 9.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.743 -0.662 . . . . 1.17 110.086 179.482 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.488 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 66.5 p . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.947 -1.025 . . . . 1.26 110.568 -179.687 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.236 -0.653 . . . . 3.83 109.236 . . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.73 18.52 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.007 -0.837 . . . . 1.39 111.007 179.708 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.66 142.32 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.06 0 C-N-CA 124.04 3.16 . . . . 0.86 113.729 -179.205 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.577 ' N ' ' OG1' ' A' ' 85' ' ' THR . 16.2 t -79.86 173.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.189 -1.369 . . . . 1.43 108.832 178.402 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 23' ' ' ASN . 96.1 mt-10 -105.54 125.8 51.41 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.503 -0.479 . . . . 1.94 111.416 -179.569 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 144.01 33.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.731 -0.668 . . . . 1.19 110.578 179.886 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.05 168.25 25.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.864 0.364 . . . . 3.92 111.139 -179.695 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.589 ' CG2' ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.87 131.04 60.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.026 -0.533 . . . . 3.88 110.141 179.877 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.5 p -141.16 162.33 35.73 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.84 0.352 . . . . 3.92 111.239 -179.932 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 71.5 tt0 36.05 31.65 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.655 -0.498 . . . . 6.08 109.655 179.849 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.589 ' OG1' ' CG2' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.53 69.61 33.56 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.918 -0.583 . . . . 4.01 111.533 -178.75 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.639 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.27 -29.23 72.9 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.564 2.176 . . . . 4.51 111.772 179.389 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.639 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.73 125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 3.51 110.453 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 17' ' ' SER . 15.5 mt-30 -123.86 158.38 60.09 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.376 -0.375 . . . . 4.3 110.446 179.939 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.754 ' HG2' ' NE ' ' A' ' 143' ' ' ARG . 97.4 Cg_endo -82.08 -64.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.816 2.344 . . . . 1.96 113.528 -179.029 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.824 ' ND2' ' H ' ' A' ' 62' ' ' GLY . 31.6 t30 -108.38 -19.71 13.37 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.041 0.386 . . . . 3.33 112.041 -178.498 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 15.1 p -107.28 152.03 24.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.093 0.473 . . . . 1.53 111.347 -179.332 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.581 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.4 t-80 -155.35 102.98 2.22 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.738 -0.664 . . . . 2.29 110.558 179.876 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.41 ' HD3' HE22 ' A' ' 14' ' ' GLN . 73.6 Cg_endo -82.68 145.67 13.03 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.8 2.333 . . . . 0.88 112.675 179.879 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.413 HG12 ' HB3' ' A' ' 58' ' ' TYR . 7.0 pt -130.84 167.93 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.893 -0.594 . . . . 2.12 109.822 179.618 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.1 147.93 29.08 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.72 -0.474 . . . . 2.67 109.72 178.901 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.502 ' CZ3' ' N ' ' A' ' 58' ' ' TYR . 42.4 p90 -142.21 157.29 45.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.948 0.404 . . . . 0.32 111.263 179.858 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.459 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 84.9 m-20 -128.02 155.23 44.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.782 -0.645 . . . . 2.77 110.105 178.968 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.4 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . . . -132.55 173.08 6.3 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.158 -0.474 . . . . 1.25 110.845 -179.294 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.71 173.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.88 2.386 . . . . 1.12 111.49 179.412 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.01 -51.03 0.69 Allowed Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 120.578 -0.449 . . . . 4.05 110.143 179.856 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.651 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.84 152.37 82.39 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.696 2.264 . . . . 2.12 111.455 179.179 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.67 42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.372 0.606 . . . . 2.85 110.584 -179.9 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.816 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.49 -41.75 98.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.986 -1.006 . . . . 3.11 110.715 179.65 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.433 HG13 ' HD1' ' A' ' 29' ' ' HIS . 74.2 mt -109.85 137.82 40.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.708 -0.678 . . . . 1.86 111.293 -179.445 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.89 -72.87 0.7 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.001 -0.545 . . . . 1.61 111.923 -178.968 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.2 148.4 24.39 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.557 0.577 . . . . 1.67 112.557 -179.62 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -121.88 124.82 45.02 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.349 -0.611 . . . . 1.07 109.349 177.527 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.0 134.79 60.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.598 -0.441 . . . . 1.55 110.638 179.949 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.489 HD11 ' CZ3' ' A' ' 22' ' ' TRP . 8.7 mt -120.03 128.52 53.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 1.33 111.323 179.721 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -130.97 139.01 49.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.78 -0.646 . . . . 2.36 110.097 179.074 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.419 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.2 p90 -145.16 163.08 35.47 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 120.574 -0.45 . . . . 0.38 112.072 -178.128 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.489 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.39 139.52 7.91 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.474 -0.785 . . . . 2.31 110.542 178.848 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.9 Cg_endo -63.53 115.48 3.07 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.353 2.036 . . . . 0.86 111.849 179.954 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.97 81.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.904 -0.406 . . . . 3.44 109.904 -179.859 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.952 -0.567 . . . . 2.72 111.835 -179.501 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.6 p -157.57 157.78 34.38 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.878 -0.329 . . . . 2.78 110.615 179.793 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.401 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.38 27.82 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.236 -0.438 . . . . 2.3 110.122 179.568 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.7 -75.99 1.32 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.18 -0.533 . . . . 1.8 111.814 -179.223 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.89 152.32 35.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.932 0.396 . . . . 5.48 110.963 -179.306 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.03 2.5 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.983 -0.553 . . . . 1.84 111.929 179.337 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.414 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.2 149.66 29.79 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.512 0.672 . . . . 2.27 112.504 -177.829 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.07 156.47 45.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.764 -1.107 . . . . 1.92 110.247 178.609 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.22 158.35 41.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.933 -0.576 . . . . 1.09 111.824 -179.341 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.08 135.61 54.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.496 -0.774 . . . . 1.16 109.859 179.267 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.447 ' N ' HD13 ' A' ' 51' ' ' ILE . 5.2 mp -126.36 121.92 23.81 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.464 -0.335 . . . . 1.39 111.6 -179.204 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.519 ' HB2' ' CE1' ' A' ' 54' ' ' HIS . 74.4 Cg_exo -46.32 151.74 1.62 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.695 2.263 . . . . 0.72 112.057 179.101 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.03 -22.9 63.18 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 116.035 -0.529 . . . . 0.74 112.743 -179.205 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.519 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.86 -16.85 46.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.392 0.596 . . . . 1.26 111.746 -178.334 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.485 HD23 ' CD2' ' A' ' 54' ' ' HIS . 80.4 mt -91.63 138.4 31.59 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.771 -0.372 . . . . 1.59 110.293 179.386 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -121.47 13.86 11.03 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.366 -0.379 . . . . 2.07 111.549 -179.363 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.477 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.93 143.53 25.31 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.624 -0.43 . . . . 0.96 111.008 179.648 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.719 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.84 -169.38 1.54 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.875 -179.46 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.719 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 94.7 m -151.8 125.89 9.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.357 -0.838 . . . . 1.19 109.882 179.208 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.44 HD11 HG23 ' A' ' 60' ' ' ILE . 66.5 mt -114.9 123.28 70.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.365 -0.534 . . . . 1.47 111.185 -179.711 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.835 ' NZ ' ' N ' ' A' ' 141' ' ' GLY . 82.1 mttt -126.51 163.38 23.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.839 -0.619 . . . . 3.0 110.469 179.733 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.824 ' H ' ' ND2' ' A' ' 16' ' ' ASN . . . 85.17 18.88 60.0 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.723 -0.951 . . . . 0.5 110.723 -179.892 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.433 ' CD1' ' CB ' ' A' ' 18' ' ' HIS . 73.6 mt -78.91 157.19 28.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 1.21 111.379 -179.629 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.635 ' N ' ' OH ' ' A' ' 69' ' ' TYR . 2.3 mttt -99.5 133.92 21.54 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.637 -0.711 . . . . 3.2 110.438 179.781 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.92 143.62 61.34 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.597 2.198 . . . . 1.09 111.941 179.812 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.82 25.52 75.47 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.063 -0.815 . . . . 0.72 111.063 179.795 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.64 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -128.05 158.86 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.763 0.316 . . . . 1.47 110.446 -179.631 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.23 139.93 42.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.98 0.419 . . . . 1.23 110.534 -179.786 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.64 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.6 m-85 -122.61 136.44 54.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.932 -0.576 . . . . 1.1 110.797 -179.95 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.489 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.9 131.04 45.29 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.528 -0.915 . . . . 1.87 108.528 177.684 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.487 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.57 153.9 16.67 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.207 -0.997 . . . . 0.39 111.923 -178.541 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.01 140.84 45.98 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.73 -0.471 . . . . 1.8 109.73 179.646 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.46 HD23 ' CG ' ' A' ' 22' ' ' TRP . 41.4 tp -115.66 118.89 34.36 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.45 -0.5 . . . . 1.11 110.504 179.759 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.0 mt -112.48 129.07 68.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.887 0.375 . . . . 1.51 110.646 -179.939 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.75 120.9 43.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.256 -0.429 . . . . 1.47 110.761 -179.726 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.673 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.64 146.37 11.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.159 0.504 . . . . 1.33 111.079 -179.288 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.816 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -105.98 153.85 21.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.559 -0.746 . . . . 2.49 109.938 179.884 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.24 88.66 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.995 0.426 . . . . 4.2 110.412 -179.73 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.618 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.26 32.55 0.21 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.759 -0.655 . . . . 6.4 110.682 -179.912 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.01 -117.26 3.29 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.93 -0.652 . . . . 1.74 111.489 -179.731 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.446 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.1 m170 -81.54 177.42 8.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.23 0.538 . . . . 3.64 111.537 -179.159 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.15 149.54 32.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.407 -0.815 . . . . 1.7 110.381 179.179 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.19 144.68 38.64 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.462 -0.335 . . . . 2.7 110.589 179.829 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -128.0 136.04 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.078 0.466 . . . . 1.16 111.557 -179.775 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.577 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.07 141.39 52.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.706 -0.679 . . . . 1.14 110.257 179.647 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.447 ' N ' HG21 ' A' ' 85' ' ' THR . 42.5 ttp180 -117.73 138.88 51.72 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.499 -0.481 . . . . 4.33 111.497 -179.32 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.487 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.26 164.2 37.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.574 -0.739 . . . . 0.91 109.479 179.473 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.577 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.36 151.48 38.34 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.443 -0.503 . . . . 1.47 111.032 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.581 ' CD2' ' CE1' ' A' ' 18' ' ' HIS . 39.0 p90 -146.13 172.77 12.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.7 -0.682 . . . . 0.51 111.028 179.878 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.453 ' HG1' ' N ' ' A' ' 91' ' ' THR . 5.6 t -118.86 160.74 21.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.479 -0.782 . . . . 1.92 109.861 179.527 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.453 ' N ' ' HG1' ' A' ' 90' ' ' THR . 0.2 OUTLIER -133.33 121.83 22.94 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.61 -0.436 . . . . 1.63 110.798 -179.962 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -128.83 154.67 46.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 2.37 111.081 179.652 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.3 t -63.16 -41.21 99.21 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.032 -0.667 . . . . 3.63 109.479 177.352 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.437 ' O ' ' OG1' ' A' ' 92' ' ' THR . 18.5 p -129.73 164.38 24.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.396 179.029 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 54.5 p -69.29 156.96 37.91 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.317 178.959 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.63 158.95 42.41 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.903 -179.423 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.9 155.05 29.4 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.508 2.139 . . . . 0.0 110.885 178.301 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 39.0 t -60.03 134.76 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.151 -179.245 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.2 p -121.64 165.16 16.16 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.839 -179.051 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.2 p -67.15 164.09 18.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.597 -179.89 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -61.37 136.45 58.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.277 -179.362 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.4 m 46.48 91.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.083 -179.947 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 83.0 t -62.96 -37.52 79.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.022 179.91 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 26.0 p -75.39 165.4 25.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -178.842 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.94 26.71 36.59 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.293 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 58.3 mp0 -56.42 143.97 32.75 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.957 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.4 m -58.95 -39.1 80.63 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.374 -179.62 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.5 m -126.66 78.69 72.58 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.442 -179.138 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -58.8 142.81 99.21 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 121.705 1.603 . . . . 0.0 111.393 -179.992 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -59.65 -38.63 81.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.209 -179.365 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.3 m -127.65 78.74 74.5 Favored Pre-proline 0 N--CA 1.465 0.297 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.977 -179.695 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.733 ' O ' ' O ' ' A' ' 113' ' ' LEU . 31.9 Cg_exo -55.78 142.98 82.6 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.315 2.01 . . . . 0.0 111.882 -179.773 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.733 ' O ' ' O ' ' A' ' 112' ' ' PRO . 49.7 mt 43.28 149.34 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.365 0.602 . . . . 10.52 112.082 179.583 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.412 ' O ' ' O ' ' A' ' 113' ' ' LEU . 44.4 t 42.77 97.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.813 -0.63 . . . . 7.48 111.237 179.725 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -173.32 20.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.326 -0.397 . . . . 7.69 110.826 179.531 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.3 p -83.69 159.0 21.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.046 0.45 . . . . 6.46 110.897 -179.717 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.4 p -83.74 -2.01 55.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.76 -0.654 . . . . 4.59 110.817 179.695 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.46 -34.25 73.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.293 -0.412 . . . . 3.21 111.43 -178.731 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.0 m -65.79 150.54 48.37 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.495 -0.482 . . . . 3.64 110.419 179.928 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.9 t -124.1 133.07 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.408 -0.36 . . . . 3.39 110.39 179.246 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.46 ' OG1' ' N ' ' A' ' 122' ' ' GLU . 68.9 p -99.62 -76.07 0.55 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.044 0.45 . . . . 2.23 110.51 179.226 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.46 ' N ' ' OG1' ' A' ' 121' ' ' THR . 48.8 tp10 -116.0 145.05 43.29 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.589 -0.732 . . . . 4.53 109.967 179.722 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 31.9 pt -118.66 152.39 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.93 0.395 . . . . 2.01 110.652 179.647 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.3 p -128.15 166.52 18.33 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.797 -0.638 . . . . 2.22 110.98 -179.512 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.663 ' O ' ' N ' ' A' ' 127' ' ' SER . . . -113.54 -94.61 0.46 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.572 -0.529 . . . . 1.29 109.572 179.146 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 125' ' ' ALA . 0.1 OUTLIER 29.94 29.89 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 122.358 1.075 . . . . 1.25 111.135 178.806 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.663 ' N ' ' O ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.81 167.6 0.25 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.397 -1.274 . . . . 1.16 110.977 -178.83 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.487 ' CZ ' HG22 ' A' ' 201' ' ' THR . 7.9 m-30 -133.62 145.51 50.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.691 -0.686 . . . . 0.78 110.099 -179.833 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.31 101.62 9.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.075 -0.713 . . . . 1.08 109.075 177.707 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.46 HG11 ' N ' ' A' ' 131' ' ' SER . 71.8 t -112.9 139.7 36.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.978 -0.556 . . . . 1.1 111.143 -178.915 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.46 ' N ' HG11 ' A' ' 130' ' ' VAL . 68.1 p -128.71 152.56 48.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.642 -0.708 . . . . 0.87 109.747 179.681 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . 0.648 ' CD1' HD12 ' A' ' 194' ' ' ILE . 39.8 p90 -144.74 -164.9 2.02 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.731 -0.387 . . . . 0.37 110.64 -179.839 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.733 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -124.02 127.12 73.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.156 -0.474 . . . . 1.14 110.833 -179.87 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 1.148 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.87 58.28 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.102 -0.499 . . . . 1.91 110.351 179.825 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.28 24.69 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.981 -0.554 . . . . 1.56 111.535 -179.589 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.148 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.14 128.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.597 -0.441 . . . . 1.56 110.907 179.818 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.39 -9.64 55.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.901 -0.591 . . . . 1.88 110.255 179.725 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.7 p -86.98 0.23 55.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 1.63 110.338 179.954 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.967 HG11 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.3 137.31 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 116.0 -0.545 . . . . 1.11 110.016 179.775 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.74 ' C ' ' HZ3' ' A' ' 61' ' ' LYS . 5.7 m -96.31 -15.6 21.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.234 0.54 . . . . 1.01 109.99 -179.585 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.835 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.63 175.62 45.85 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.821 -1.311 . . . . 0.14 109.821 179.58 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.48 151.57 42.61 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.619 -0.432 . . . . 0.21 110.465 179.801 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.754 ' NE ' ' HG2' ' A' ' 15' ' ' PRO . 19.7 ttt85 -132.25 121.22 23.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.131 -0.486 . . . . 1.54 109.96 179.759 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.482 HG23 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.13 136.54 38.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.776 -0.647 . . . . 1.08 110.619 -179.703 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 85.2 tt0 -129.36 129.88 45.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.969 -0.56 . . . . 1.32 110.001 -179.862 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.71 135.22 34.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.099 -0.501 . . . . 1.05 110.652 -179.673 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.413 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.26 161.44 39.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.809 -0.632 . . . . 1.16 109.657 179.834 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.927 HD21 ' CE2' ' A' ' 178' ' ' TYR . 86.2 mt -71.11 124.87 25.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.935 0.397 . . . . 1.23 110.769 -179.616 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.71 -7.76 50.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.808 -0.633 . . . . 0.86 110.837 -179.748 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.83 -69.77 0.85 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.356 -0.384 . . . . 1.66 111.394 -179.249 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 1.429 ' CD ' HH21 ' A' ' 176' ' ' ARG . 53.9 mt-10 -60.58 -35.36 75.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.083 -0.508 . . . . 1.66 111.57 -179.167 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 1.096 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.18 7.24 88.59 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.839 -0.904 . . . . 1.62 110.839 -179.843 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 1.313 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.95 -171.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.756 0.312 . . . . 1.86 110.293 179.849 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.313 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.25 139.06 45.15 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.982 0.42 . . . . 1.98 110.182 179.653 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.413 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.87 145.87 51.86 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 C-N-CA 122.694 2.262 . . . . 0.62 112.361 -179.553 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.9 145.74 42.64 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.131 -0.692 . . . . 1.14 109.131 179.261 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.627 ' HB3' ' CZ ' ' A' ' 143' ' ' ARG . 71.7 m-85 -123.27 141.34 52.08 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.344 -0.542 . . . . 1.44 111.552 -179.143 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.437 ' HA ' HD22 ' A' ' 158' ' ' LEU . 70.5 mt -128.09 127.61 43.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.291 -0.868 . . . . 1.08 108.973 178.995 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.629 ' OD2' ' ND2' ' A' ' 16' ' ' ASN . 34.6 t0 -101.61 131.22 47.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.088 0.471 . . . . 1.09 111.733 -178.741 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.604 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -128.01 157.57 73.49 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.321 -0.854 . . . . 1.04 109.572 179.672 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -69.87 158.04 58.15 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 C-N-CA 122.475 2.117 . . . . 0.21 112.153 -179.987 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.34 -12.13 5.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.687 -0.688 . . . . 0.88 110.721 -179.779 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.6 p -92.78 -8.79 42.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 1.06 110.709 -179.917 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.38 34.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 1.05 110.358 179.743 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 p -133.13 16.61 4.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.373 -0.376 . . . . 1.07 110.461 -179.986 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.4 p -167.52 147.12 5.09 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.556 -0.535 . . . . 0.92 109.556 179.906 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.519 ' HB ' HD13 ' A' ' 160' ' ' LEU . 6.1 p -152.2 150.44 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.452 -0.499 . . . . 1.09 111.592 -179.634 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.492 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.36 125.03 50.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.695 -0.684 . . . . 1.31 109.776 179.504 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.525 HG21 HD21 ' A' ' 172' ' ' LEU . 1.8 mt -99.4 104.91 29.87 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 1.09 111.016 -179.826 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -91.01 -179.52 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 123.189 2.593 . . . . 0.48 112.203 179.884 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 61.67 32.6 18.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.409 -0.814 . . . . 1.26 111.497 179.316 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.525 HD21 HG21 ' A' ' 169' ' ' ILE . 24.2 mt -86.37 148.57 25.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.483 -0.326 . . . . 1.12 110.485 179.601 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.766 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.4 114.88 61.5 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.048 0.451 . . . . 1.3 110.616 -179.657 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.96 140.62 96.11 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.81 2.34 . . . . 0.92 111.993 179.825 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.11 21.15 74.34 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.072 -0.811 . . . . 0.44 111.072 179.885 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 1.429 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.91 150.16 49.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.351 . . . . 3.05 110.632 -179.925 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.17 131.65 45.99 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.044 -0.525 . . . . 1.48 109.804 179.351 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.927 ' CE2' HD21 ' A' ' 148' ' ' LEU . 74.7 m-85 -120.61 148.26 44.13 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.187 -0.46 . . . . 0.89 110.989 -179.788 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.586 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.7 mt -105.22 125.35 60.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.321 -0.992 . . . . 1.12 108.321 177.76 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.67 132.57 63.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.218 0.532 . . . . 1.1 111.189 -178.581 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.49 122.62 20.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.49 -0.777 . . . . 0.43 109.614 179.319 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.592 HG12 ' CD2' ' A' ' 132' ' ' TRP . 14.2 t -101.15 125.42 55.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.195 -0.457 . . . . 1.07 110.648 -179.514 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 183' ' ' TYR . . . . . 0.666 ' CE1' HD11 ' A' ' 193' ' ' LEU . 48.5 m-85 -117.23 137.87 52.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.018 -0.537 . . . . 0.92 109.843 179.602 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.567 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.7 135.04 42.78 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.878 -0.786 . . . . 0.49 108.878 178.817 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.597 ' HB ' ' HZ2' ' A' ' 61' ' ' LYS . 68.1 mt -99.1 122.97 51.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.144 0.497 . . . . 1.08 110.953 -178.73 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.45 ' HG ' ' H ' ' A' ' 188' ' ' ASP . 88.5 p -83.94 169.68 14.79 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.518 -0.765 . . . . 0.89 110.453 -179.636 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.77 -14.46 14.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.094 -0.503 . . . . 1.6 110.913 -179.542 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.45 ' H ' ' HG ' ' A' ' 186' ' ' SER . 95.5 m-20 -96.15 -4.33 42.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.773 0.321 . . . . 1.18 110.787 -179.796 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.9 13.83 63.9 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.254 -0.738 . . . . 0.34 111.254 179.76 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -84.68 139.1 32.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.715 0.293 . . . . 1.22 110.431 179.708 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -106.71 141.05 38.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.929 0.395 . . . . 1.44 110.643 179.69 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.71 127.01 26.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 1.39 110.388 179.927 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.666 HD11 ' CE1' ' A' ' 183' ' ' TYR . 25.1 tp -68.02 117.27 9.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.23 -0.441 . . . . 1.08 110.548 -179.928 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.648 HD12 ' CD1' ' A' ' 132' ' ' TRP . 43.9 pt -109.03 -21.88 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 1.08 110.78 -179.753 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.82 125.78 5.93 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.535 -0.466 . . . . 1.1 111.511 -179.846 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.495 ' OG ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.76 120.16 21.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.801 -0.636 . . . . 0.94 109.522 179.218 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.58 151.7 29.17 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.624 -0.43 . . . . 1.07 110.873 -179.29 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.5 158.6 18.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.015 -0.538 . . . . 0.89 110.41 179.686 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.09 157.88 43.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.07 -0.513 . . . . 0.67 110.677 -179.977 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.23 104.37 9.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.787 -0.642 . . . . 1.17 110.011 179.563 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.487 HG22 ' CZ ' ' A' ' 128' ' ' PHE . 66.5 p . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.894 -1.051 . . . . 1.26 110.705 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.19 -0.67 . . . . 3.4399999999999999 109.19 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.39 150.7 18.54 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.991 -0.844 . . . . 1.22 110.991 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -35.56 142.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 124.015 3.143 . . . . 0.75 113.76 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.604 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -80.06 173.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.268 -1.333 . . . . 0.79000000000000004 108.802 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.604 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.62 125.86 51.47 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.394 -0.522 . . . . 1.9399999999999999 111.407 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.49 144.02 33.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.662 -0.699 . . . . 0.59999999999999998 110.629 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.03 168.3 25.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.891 0.377 . . . . 3.1400000000000001 111.145 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.742 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.98 131.08 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.01 -0.541 . . . . 3.23 110.074 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.16 162.31 35.78 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.861 0.362 . . . . 3.6299999999999999 111.217 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 9' ' ' THR . 79.8 mm-40 36.07 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.611 -0.514 . . . . 6.0800000000000001 109.611 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.742 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.6 32.57 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.973 -0.558 . . . . 3.3799999999999999 111.6 -178.81 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.636 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.32 -29.1 72.43 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.487 2.125 . . . . 3.9300000000000002 111.819 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.636 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.64 125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 3.3599999999999999 110.443 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 17' ' ' SER . 2.8 mp0 -123.91 158.29 60.56 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 3.6099999999999999 110.435 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.662 ' HG2' ' NE ' ' A' ' 143' ' ' ARG . 97.7 Cg_endo -82.02 -64.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.94 2.427 . . . . 1.51 113.428 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.538 ' C ' ' OD1' ' A' ' 16' ' ' ASN . 0.2 OUTLIER -108.35 -19.53 13.44 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.067 0.395 . . . . 2.6800000000000002 112.067 -178.495 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 9.8 p -107.31 152.04 24.67 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.484 -0.486 . . . . 1.21 111.338 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.26 102.9 2.23 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.769 -0.65 . . . . 1.5600000000000001 110.675 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.425 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.5 Cg_endo -82.68 145.61 13.01 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.853 2.369 . . . . 0.81000000000000005 112.664 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.916 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.74 167.92 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.899 -0.591 . . . . 1.52 109.919 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.12 147.95 29.09 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.829 -0.434 . . . . 2.1400000000000001 109.829 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.59 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.29 157.29 44.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.972 0.415 . . . . 0.32000000000000001 111.194 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.493 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.05 155.34 44.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.797 -0.638 . . . . 2.1699999999999999 110.092 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.839 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.65 173.05 6.34 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.118 0.485 . . . . 0.58999999999999997 110.743 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.839 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.68 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.873 2.382 . . . . 0.90000000000000002 111.515 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.11 -51.0 0.69 Allowed Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.674 -0.411 . . . . 3.3399999999999999 110.098 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.626 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.84 152.32 82.58 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.791 2.327 . . . . 1.8500000000000001 111.426 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.67 42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.413 0.625 . . . . 2.54 110.606 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.626 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.8 t60 -63.63 -41.67 98.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.976 -1.011 . . . . 2.5299999999999998 110.632 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.562 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.7 mt -109.83 137.81 40.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.821 -0.627 . . . . 1.1699999999999999 111.343 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.9 -72.94 0.7 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.109 -0.496 . . . . 1.27 111.938 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.12 148.4 24.46 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.623 0.601 . . . . 1.1200000000000001 112.623 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.81 124.82 45.07 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.424 -0.584 . . . . 0.41999999999999998 109.424 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.07 134.73 60.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.626 -0.43 . . . . 0.78000000000000003 110.625 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.916 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.0 128.66 53.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.054 0.454 . . . . 0.62 111.241 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 138.96 49.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.779 -0.646 . . . . 1.97 110.141 178.967 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.439 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.01 163.18 35.01 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.125 0.488 . . . . 0.34999999999999998 112.119 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.491 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.47 139.59 7.87 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 115.484 -0.78 . . . . 1.8 110.506 178.809 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.684 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.8 Cg_endo -63.55 115.46 3.06 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.33 2.02 . . . . 0.57999999999999996 111.784 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.674 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.96 81.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.891 -0.411 . . . . 3.04 109.891 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.23 -20.67 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.998 -0.546 . . . . 2.4700000000000002 111.906 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -157.66 157.82 34.3 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.78 -0.368 . . . . 2.5099999999999998 110.465 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.42 27.85 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 1.8600000000000001 110.151 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -75.88 1.31 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.122 -0.561 . . . . 1.4399999999999999 111.812 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.93 152.34 35.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.984 0.421 . . . . 4.6900000000000004 110.995 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.12 2.53 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.992 -0.549 . . . . 1.4299999999999999 111.886 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.17 149.63 29.81 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.457 0.646 . . . . 1.74 112.565 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.97 156.46 46.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.781 -1.099 . . . . 1.9199999999999999 110.285 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.21 158.43 41.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.967 -0.56 . . . . 0.34000000000000002 111.776 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.6 m -115.24 135.6 53.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.422 -0.808 . . . . 0.40999999999999998 109.79 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.59 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.45 121.98 23.71 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.418 -0.355 . . . . 0.55000000000000004 111.568 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.5 Cg_exo -46.27 151.75 1.58 Allowed 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.624 2.216 . . . . 0.44 112.121 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.96 -22.98 63.11 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 116.029 -0.532 . . . . 0.73999999999999999 112.81 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.54 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.8 -16.9 45.99 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 120.244 -0.582 . . . . 0.93000000000000005 111.804 -178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.603 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.57 138.39 31.61 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.707 -0.397 . . . . 0.96999999999999997 110.329 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -121.46 13.96 11.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.391 -0.368 . . . . 1.3400000000000001 111.569 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.475 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.0 143.48 25.21 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.648 -0.421 . . . . 0.39000000000000001 111.064 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.716 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.9 t80 -114.84 -169.3 1.52 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.051 -0.522 . . . . 0.41999999999999998 110.864 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.716 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.76 125.95 9.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.422 -0.808 . . . . 0.39000000000000001 109.818 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.516 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.9 mt -114.96 123.27 70.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.346 -0.542 . . . . 0.73999999999999999 111.166 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -126.47 163.4 23.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.807 -0.633 . . . . 2.48 110.498 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.18 18.94 59.88 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.714 -0.954 . . . . 0.5 110.714 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.516 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.9 mt -79.06 157.27 28.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.065 0.46 . . . . 0.57999999999999996 111.326 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.846 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -99.55 134.01 21.45 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.608 -0.723 . . . . 2.79 110.399 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.424 ' HD3' ' CE2' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.98 143.54 60.71 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.519 2.146 . . . . 0.87 111.944 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.0 25.57 75.43 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.997 -0.841 . . . . 0.64000000000000001 110.997 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.846 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.19 158.8 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.72 0.295 . . . . 0.82999999999999996 110.43 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.15 139.9 42.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.884 0.373 . . . . 0.5 110.583 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.664 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.6 m-85 -122.54 136.49 54.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.923 -0.581 . . . . 0.53000000000000003 110.69 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.489 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.3 pt-20 -98.89 131.04 45.28 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.545 -0.909 . . . . 1.8700000000000001 108.545 177.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.46 153.9 16.64 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.326 -0.94 . . . . 0.28999999999999998 111.969 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -135.0 140.93 46.05 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.675 -0.491 . . . . 1.4299999999999999 109.675 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.76 118.87 34.24 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.474 -0.49 . . . . 0.32000000000000001 110.468 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.721 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.43 129.08 68.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.388 . . . . 0.79000000000000004 110.68 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.707 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.79 120.79 43.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.27 -0.423 . . . . 1.02 110.732 -179.622 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.851 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.5 146.42 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.115 0.483 . . . . 0.62 111.082 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.622 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.02 153.85 21.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.496 -0.775 . . . . 2.4399999999999999 109.89 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.1 88.55 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.88 0.372 . . . . 3.6899999999999999 110.43 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.622 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.25 32.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.829 -0.623 . . . . 6.0800000000000001 110.614 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.1 -117.37 3.29 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.447 -0.661 . . . . 1.22 111.447 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.37 177.43 8.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.222 0.534 . . . . 2.8799999999999999 111.601 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.18 149.49 32.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.405 -0.816 . . . . 1.47 110.41 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.13 144.68 38.76 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.467 -0.333 . . . . 2.7000000000000002 110.6 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.721 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.0 136.01 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.05 0.453 . . . . 0.46000000000000002 111.555 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.09 141.33 52.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.681 -0.691 . . . . 0.34999999999999998 110.279 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.63 138.86 51.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.126 0.489 . . . . 3.6699999999999999 111.501 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.25 164.19 37.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.564 -0.744 . . . . 0.67000000000000004 109.471 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.571 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.31 151.49 38.4 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.422 -0.511 . . . . 1.47 111.042 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.7 p90 -146.18 172.7 13.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.788 -0.642 . . . . 0.44 111.017 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.69 160.65 21.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.455 -0.793 . . . . 1.3700000000000001 109.897 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.519 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.42 121.8 22.8 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.653 -0.419 . . . . 1.28 110.816 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.1 p -128.33 146.42 50.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.048 -0.524 . . . . 1.97 111.858 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.798 -0.637 . . . . 3.2799999999999998 109.974 176.792 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.505 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 4.6 p . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 111.988 0.366 . . . . 0.66000000000000003 111.988 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.433 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.9 167.6 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.097 0.475 . . . . 0.68999999999999995 110.932 179.474 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.62 145.56 50.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.704 -0.68 . . . . 0.52000000000000002 110.123 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.26 101.66 9.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.063 -0.717 . . . . 0.32000000000000001 109.063 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.7 t -112.93 139.69 36.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.026 -0.534 . . . . 0.28999999999999998 111.109 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.2 p -128.66 152.47 48.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.7 -0.682 . . . . 0.25 109.929 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.595 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.8 -165.01 2.05 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.692 -0.403 . . . . 0.31 110.569 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -123.95 127.17 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 0.48999999999999999 110.809 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.176 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.97 58.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.126 -0.488 . . . . 1.53 110.31 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.21 24.57 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.892 -0.595 . . . . 0.96999999999999997 111.52 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.176 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.11 128.76 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.638 -0.425 . . . . 1.5600000000000001 110.919 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.5 -9.51 56.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.883 -0.599 . . . . 1.8799999999999999 110.289 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.16 0.25 55.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.14 -0.482 . . . . 1.04 110.289 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.21 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 0.23999999999999999 109.899 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 185' ' ' ILE . 94.2 p -96.28 -15.47 21.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.259 0.552 . . . . 0.28999999999999998 110.056 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.54 175.6 45.76 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.887 -1.285 . . . . 0.13 109.887 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -123.48 151.57 42.61 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.69 -0.404 . . . . 0.17000000000000001 110.509 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.662 ' NE ' ' HG2' ' A' ' 15' ' ' PRO . 73.0 ttt-85 -132.34 121.22 23.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.136 -0.484 . . . . 1.29 109.881 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.558 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.15 136.51 38.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.664 -0.698 . . . . 0.25 110.707 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 79.5 tt0 -129.29 129.95 45.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.038 -0.528 . . . . 1.3200000000000001 110.057 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.9 p90 -138.79 135.31 34.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.985 -0.552 . . . . 0.56999999999999995 110.567 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.427 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.28 39.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.762 -0.654 . . . . 1.1599999999999999 109.733 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.959 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -70.99 124.87 25.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.978 0.418 . . . . 0.38 110.713 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.497 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.76 -7.7 49.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.687 -0.688 . . . . 0.40999999999999998 110.891 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.85 -69.69 0.85 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 1.6599999999999999 111.343 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.447 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.7 -35.35 76.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.017 -0.538 . . . . 1.6599999999999999 111.492 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.093 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.19 7.25 88.58 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.806 -0.918 . . . . 1.1699999999999999 110.806 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.318 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.99 -171.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.779 0.323 . . . . 1.8600000000000001 110.275 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.318 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.32 139.09 44.95 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.947 0.403 . . . . 1.98 110.187 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.427 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.1 Cg_endo -70.81 145.75 51.91 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 122.725 2.284 . . . . 0.55000000000000004 112.31 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.85 145.71 42.62 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.195 -0.669 . . . . 1.1399999999999999 109.195 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.516 ' CE1' ' HB2' ' A' ' 16' ' ' ASN . 6.2 p90 -123.21 141.36 52.06 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.378 -0.529 . . . . 0.93000000000000005 111.573 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.1 127.67 43.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.338 -0.846 . . . . 0.34000000000000002 108.952 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 52.4 t0 -101.63 131.22 47.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.172 0.511 . . . . 1.0900000000000001 111.763 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.42 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -127.97 157.57 73.44 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.317 -0.856 . . . . 0.19 109.566 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.75 158.04 58.34 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.439 2.093 . . . . 0.17999999999999999 112.262 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.3 -12.18 5.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.842 -0.617 . . . . 0.20999999999999999 110.725 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.4 p -92.81 -8.74 42.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.28999999999999998 110.711 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.42 34.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.378 -0.374 . . . . 0.5 110.391 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.19 16.66 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.354 -0.385 . . . . 0.29999999999999999 110.491 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.0 p -167.53 147.18 5.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.644 -0.502 . . . . 0.23000000000000001 109.644 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.19 150.39 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.538 -0.465 . . . . 0.28000000000000003 111.576 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.28 124.94 50.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.624 -0.716 . . . . 1.0700000000000001 109.809 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.37 104.88 29.57 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.924 0.392 . . . . 0.28999999999999998 111.105 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.5 Cg_endo -90.94 -179.54 1.52 Allowed 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 123.197 2.598 . . . . 0.42999999999999999 112.243 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.72 32.63 18.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.394 -0.821 . . . . 1.26 111.417 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.505 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.4 mt -86.33 148.51 25.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.496 -0.32 . . . . 0.32000000000000001 110.521 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.766 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.24 114.82 61.1 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.912 0.387 . . . . 0.57999999999999996 110.696 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.0 140.53 95.76 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.858 2.372 . . . . 0.66000000000000003 112.014 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.16 21.2 74.1 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.009 -0.837 . . . . 0.28999999999999998 111.009 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.447 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.81 150.12 49.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.732 0.301 . . . . 2.3300000000000001 110.688 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.497 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.14 131.59 46.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 0.85999999999999999 109.833 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.959 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.48 148.28 44.03 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.143 -0.48 . . . . 0.52000000000000002 111.038 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.3 mt -105.33 125.29 60.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.27 -1.011 . . . . 0.29999999999999999 108.27 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.5 132.47 63.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.183 0.516 . . . . 0.23000000000000001 111.274 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.9 m-20 -136.46 122.59 20.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.532 -0.758 . . . . 0.35999999999999999 109.636 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.595 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.03 125.39 54.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.187 -0.46 . . . . 0.19 110.665 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.9 m-85 -117.25 137.97 52.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.007 -0.542 . . . . 0.29999999999999999 109.835 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.425 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.76 135.07 42.78 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.786 -0.82 . . . . 0.37 108.786 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 140' ' ' SER . 85.3 mt -99.09 122.92 51.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.07 0.462 . . . . 0.26000000000000001 110.96 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.5 p -83.79 169.7 14.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.534 -0.757 . . . . 0.28000000000000003 110.484 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.83 -14.51 15.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.04 -0.527 . . . . 1.6000000000000001 110.934 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.505 ' C ' ' OG1' ' A' ' 59' ' ' THR . 79.2 m-20 -96.1 -4.29 43.12 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.833 -0.347 . . . . 1.1799999999999999 110.825 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.49 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.78 13.89 64.02 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.379 -0.689 . . . . 0.29999999999999999 111.379 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -84.62 139.05 32.34 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.058 -0.257 . . . . 1.22 110.518 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -106.76 141.11 38.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.903 0.382 . . . . 0.97999999999999998 110.513 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.6 m -136.72 126.97 26.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.82999999999999996 110.36 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.06 117.25 9.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.329 -0.396 . . . . 0.26000000000000001 110.528 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.03 -21.84 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.29999999999999999 110.712 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.87 125.79 5.9 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.514 -0.475 . . . . 0.31 111.485 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.75 120.24 21.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.79 -0.641 . . . . 0.28000000000000003 109.578 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.71 29.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.955 0.407 . . . . 0.23999999999999999 110.927 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.47 158.66 18.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.052 -0.522 . . . . 0.23000000000000001 110.413 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -146.09 157.96 43.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.03 -0.532 . . . . 0.67000000000000004 110.659 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 104.26 9.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.721 -0.672 . . . . 0.64000000000000001 110.047 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.876 -1.059 . . . . 1.26 110.665 -179.729 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.197 -0.668 . . . . 3.4399999999999999 109.197 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.72 18.54 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.049 -0.821 . . . . 1.22 111.049 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.73 142.41 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.09 0 C-N-CA 123.94 3.093 . . . . 0.75 113.748 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.0 t -79.93 173.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.205 -1.361 . . . . 0.79000000000000004 108.83 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.614 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.64 125.89 51.51 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.482 -0.487 . . . . 1.9399999999999999 111.409 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 p -136.52 143.99 33.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.573 -0.74 . . . . 0.59999999999999998 110.622 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.06 168.25 25.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.936 0.398 . . . . 3.1400000000000001 111.072 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.743 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.4 mt -108.87 131.1 60.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.019 -0.537 . . . . 3.23 110.155 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.21 162.32 35.77 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.931 0.396 . . . . 3.6299999999999999 111.149 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.1 mt-10 36.06 31.68 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.559 -0.534 . . . . 6.0800000000000001 109.559 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.743 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.53 69.63 33.56 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.939 -0.573 . . . . 3.3799999999999999 111.533 -178.809 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.28 -29.09 72.75 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.501 2.134 . . . . 3.9300000000000002 111.881 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.64 125.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 3.3599999999999999 110.477 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.724 HE22 ' CD ' ' A' ' 191' ' ' GLN . 18.7 mm-40 -123.9 158.33 60.37 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 3.6099999999999999 110.462 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.54 ' CG ' ' NE ' ' A' ' 143' ' ' ARG . 98.8 Cg_endo -82.08 -64.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.901 2.401 . . . . 1.51 113.494 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.814 ' ND2' ' O ' ' A' ' 63' ' ' LEU . 3.4 t-20 -108.43 -19.56 13.41 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.119 0.415 . . . . 2.6800000000000002 112.119 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 1.3 p -107.27 152.03 24.66 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.499 -0.48 . . . . 1.21 111.346 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.28 102.88 2.23 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.737 -0.665 . . . . 1.5600000000000001 110.689 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.57 145.63 13.19 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.914 2.409 . . . . 0.81000000000000005 112.639 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.919 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.8 167.98 24.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.808 -0.633 . . . . 1.52 109.924 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.16 147.93 29.03 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.74 -0.467 . . . . 2.1400000000000001 109.74 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.595 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.4 p90 -142.3 157.3 44.97 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.624 -0.43 . . . . 0.32000000000000001 111.212 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.49 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.04 155.22 44.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.831 -0.622 . . . . 2.1699999999999999 110.187 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.83 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.62 172.99 6.42 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.097 0.475 . . . . 0.58999999999999997 110.743 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.83 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.54 173.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.885 2.39 . . . . 0.90000000000000002 111.513 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.01 -51.15 0.69 Allowed Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.746 -0.381 . . . . 3.3399999999999999 110.093 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.622 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.8 Cg_exo -64.89 152.4 82.38 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.743 2.295 . . . . 1.8500000000000001 111.423 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.68 42.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.423 0.63 . . . . 2.54 110.587 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.622 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.7 t60 -63.59 -41.65 98.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.011 -0.995 . . . . 2.5299999999999998 110.671 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.559 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.2 mt -109.92 137.87 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.783 -0.644 . . . . 1.1699999999999999 111.251 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.95 -72.92 0.7 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.025 -0.534 . . . . 1.27 111.856 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.15 148.4 24.44 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.557 0.577 . . . . 1.1200000000000001 112.557 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.8 124.87 45.19 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.41 -0.589 . . . . 0.41999999999999998 109.41 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.8 mt -118.15 134.8 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.618 -0.433 . . . . 0.78000000000000003 110.553 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.919 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.09 128.66 53.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.071 0.462 . . . . 0.62 111.149 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.549 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.14 139.01 49.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.656 -0.702 . . . . 1.97 110.097 178.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.09 163.19 35.06 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.076 0.465 . . . . 0.34999999999999998 112.108 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.489 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.49 139.58 7.85 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 115.453 -0.794 . . . . 1.8 110.437 178.882 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.57 115.46 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.316 2.011 . . . . 0.57999999999999996 111.784 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.672 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.9 81.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.94 -0.392 . . . . 3.04 109.94 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.14 -20.64 0.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.998 -0.547 . . . . 2.4700000000000002 111.946 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.56 157.77 34.37 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.815 -0.354 . . . . 2.5099999999999998 110.559 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.403 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.39 27.88 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.23 -0.441 . . . . 1.8600000000000001 110.17 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.87 -75.9 1.31 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.825 -0.51 . . . . 1.4399999999999999 111.825 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.89 152.26 35.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.871 0.367 . . . . 4.6900000000000004 111.051 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.676 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.21 -169.16 2.54 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.077 -0.511 . . . . 1.4299999999999999 111.925 179.417 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.11 149.69 29.68 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.409 0.623 . . . . 1.74 112.557 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.08 156.47 45.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.82 -1.082 . . . . 1.9199999999999999 110.262 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.26 158.33 41.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.938 -0.574 . . . . 0.34000000000000002 111.791 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 m -115.13 135.67 53.94 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.368 -0.833 . . . . 0.40999999999999998 109.86 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.595 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.44 121.9 23.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.444 -0.344 . . . . 0.55000000000000004 111.555 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.2 Cg_exo -46.3 151.74 1.61 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.634 2.223 . . . . 0.44 112.2 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.02 -22.95 63.2 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 116.157 -0.474 . . . . 0.73999999999999999 112.808 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.77 -16.88 46.2 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.21 -0.596 . . . . 0.93000000000000005 111.787 -178.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.605 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.54 138.46 31.56 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.83 -0.348 . . . . 0.96999999999999997 110.271 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -121.58 13.93 10.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.362 -0.381 . . . . 1.3400000000000001 111.548 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.93 143.49 25.28 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.626 -0.43 . . . . 0.39000000000000001 111.08 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.713 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.85 -169.35 1.53 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.212 0.53 . . . . 0.41999999999999998 110.829 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.713 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 84.9 m -151.75 125.95 9.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.334 -0.848 . . . . 0.39000000000000001 109.832 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.515 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.82 123.19 70.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.428 -0.509 . . . . 0.73999999999999999 111.28 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.577 ' HE2' HG21 ' A' ' 185' ' ' ILE . 8.6 mmtt -126.44 163.31 23.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.906 -0.588 . . . . 2.48 110.482 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.404 ' C ' HD22 ' A' ' 16' ' ' ASN . . . 85.14 19.06 59.71 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.678 -0.969 . . . . 0.5 110.678 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.814 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 73.9 mt -79.09 157.25 28.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.053 0.454 . . . . 0.57999999999999996 111.339 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.857 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -99.45 133.9 21.59 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.568 -0.742 . . . . 2.79 110.491 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.82 143.55 61.68 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.54 2.16 . . . . 0.87 112.029 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.77 25.66 75.3 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.033 -0.827 . . . . 0.64000000000000001 111.033 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.857 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.13 158.86 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.684 0.278 . . . . 0.82999999999999996 110.466 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.21 139.96 42.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.967 0.413 . . . . 0.5 110.495 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.638 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.58 136.46 54.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.863 -0.608 . . . . 0.53000000000000003 110.74 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.95 131.09 45.28 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.541 -0.911 . . . . 1.8700000000000001 108.541 177.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.487 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.57 153.91 16.67 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.201 -0.999 . . . . 0.28999999999999998 111.947 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -134.97 140.89 46.05 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.681 -0.489 . . . . 1.4299999999999999 109.681 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.73 118.97 34.53 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.418 -0.513 . . . . 0.32000000000000001 110.503 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 84' ' ' VAL . 64.2 mt -112.45 129.12 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.287 -0.415 . . . . 0.79000000000000004 110.592 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.9 120.88 43.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.253 -0.43 . . . . 1.02 110.715 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.859 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.69 146.57 11.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.292 0.568 . . . . 0.62 110.921 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.62 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.12 153.88 21.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.513 -0.767 . . . . 2.4399999999999999 109.941 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.21 88.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.963 0.411 . . . . 3.6899999999999999 110.371 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.62 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.38 32.45 0.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.784 -0.644 . . . . 6.0800000000000001 110.577 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.01 -117.39 3.3 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.452 -0.659 . . . . 1.22 111.452 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.41 177.47 8.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.252 0.548 . . . . 2.8799999999999999 111.58 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.22 149.47 31.98 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.373 -0.83 . . . . 1.47 110.312 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.15 144.7 38.73 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.463 -0.335 . . . . 2.7000000000000002 110.528 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.727 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.03 136.0 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 121.041 0.448 . . . . 0.46000000000000002 111.538 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.05 141.37 52.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.687 -0.688 . . . . 0.34999999999999998 110.292 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.67 138.81 51.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.128 0.49 . . . . 3.6699999999999999 111.479 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.487 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.19 164.25 37.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.527 -0.761 . . . . 0.67000000000000004 109.494 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.33 151.49 38.4 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.442 -0.503 . . . . 1.47 111.075 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.8 p90 -146.15 172.72 13.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.724 -0.671 . . . . 0.44 111.04 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.67 160.69 21.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.431 -0.804 . . . . 1.3700000000000001 109.843 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.4 121.85 22.89 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.573 -0.451 . . . . 1.28 110.752 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.5 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.6 p -126.6 161.34 28.25 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 114.003 1.112 . . . . 1.97 114.003 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.8 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 113.272 -1.786 . . . . 3.2799999999999998 108.886 178.831 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.536 0.405 0 CA-C-O 121.19 0.519 . . . . 0.66000000000000003 111.418 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.444 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.85 167.57 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.525 -0.761 . . . . 0.68999999999999995 110.984 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.64 145.5 50.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.733 -0.667 . . . . 0.52000000000000002 110.081 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.23 101.67 9.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.124 -0.695 . . . . 0.32000000000000001 109.124 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.4 t -112.95 139.7 36.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.974 -0.557 . . . . 0.28999999999999998 111.069 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.0 p -128.8 152.48 48.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.612 -0.722 . . . . 0.25 109.776 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.585 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.71 -164.9 2.02 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.668 -0.413 . . . . 0.31 110.632 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.732 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.4 t -123.97 127.1 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.218 -0.446 . . . . 0.48999999999999999 110.788 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.157 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.216 -0.447 . . . . 1.53 110.374 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.14 24.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.928 -0.578 . . . . 0.96999999999999997 111.469 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.157 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.16 128.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.54 -0.464 . . . . 1.5600000000000001 110.952 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.39 -9.59 56.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.975 -0.557 . . . . 1.8799999999999999 110.249 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.18 0.17 55.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.218 -0.446 . . . . 1.04 110.299 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 136' ' ' SER . 2.6 p -65.19 137.17 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.954 -0.566 . . . . 0.23999999999999999 110.027 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 185' ' ' ILE . 92.5 p -96.14 -15.56 22.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.263 0.554 . . . . 0.28999999999999998 110.101 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.62 175.58 45.81 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 109.772 -1.331 . . . . 0.13 109.772 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.4 151.59 42.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.971 0.415 . . . . 0.17000000000000001 110.516 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.583 ' NH2' ' HB3' ' A' ' 157' ' ' TYR . 78.1 ttt-85 -132.42 121.17 23.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.103 -0.499 . . . . 1.29 109.964 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.557 HG21 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.14 136.56 38.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.708 -0.678 . . . . 0.25 110.684 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 84.1 tt0 -129.34 129.8 45.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.961 -0.563 . . . . 1.3200000000000001 110.085 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.64 135.24 34.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.033 -0.53 . . . . 0.56999999999999995 110.703 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.41 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.25 161.3 39.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.865 -0.607 . . . . 1.1599999999999999 109.763 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.956 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.0 124.89 25.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.006 0.432 . . . . 0.38 110.763 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.87 -7.66 49.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.816 -0.629 . . . . 0.40999999999999998 110.84 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -109.79 -69.67 0.85 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.01 0.433 . . . . 1.6599999999999999 111.514 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.461 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.3 mt-10 -60.76 -35.22 75.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.033 -0.53 . . . . 1.6599999999999999 111.51 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.094 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.07 7.27 88.56 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.804 -0.919 . . . . 1.1699999999999999 110.804 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.323 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.9 t0 -27.95 -171.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.761 0.315 . . . . 1.8600000000000001 110.314 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.323 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.2 pm0 -82.27 139.11 45.11 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.044 0.449 . . . . 1.98 110.226 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.41 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.94 145.87 51.46 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.726 2.284 . . . . 0.55000000000000004 112.32 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.81 145.7 42.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.217 -0.66 . . . . 1.1399999999999999 109.217 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.583 ' HB3' ' NH2' ' A' ' 143' ' ' ARG . 4.0 p90 -123.31 141.32 52.11 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.349 -0.54 . . . . 0.93000000000000005 111.537 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.4 mt -128.05 127.66 43.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.239 -0.892 . . . . 0.34000000000000002 108.932 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.513 ' OD2' ' OD1' ' A' ' 16' ' ' ASN . 63.3 t0 -101.49 131.12 47.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.135 0.493 . . . . 1.0900000000000001 111.879 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.437 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.1 mt -127.93 157.57 73.34 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.358 -0.837 . . . . 0.19 109.566 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.83 157.98 58.41 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.492 2.128 . . . . 0.17999999999999999 112.311 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.22 -12.16 4.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.855 -0.611 . . . . 0.20999999999999999 110.822 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.5 p -92.77 -8.69 42.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.058 -0.519 . . . . 0.28999999999999998 110.734 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.2 135.39 34.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.413 . . . . 0.5 110.357 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.16 16.68 4.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.439 -0.346 . . . . 0.29999999999999999 110.504 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.1 p -167.59 147.13 5.04 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.63 -0.507 . . . . 0.23000000000000001 109.63 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.21 150.61 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 0.28000000000000003 111.525 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.508 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.37 124.9 50.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.559 -0.746 . . . . 1.0700000000000001 109.789 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.28 104.87 29.22 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.424 -0.353 . . . . 0.28999999999999998 111.088 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.0 Cg_endo -91.0 -179.5 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 123.235 2.624 . . . . 0.42999999999999999 112.251 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.71 32.58 18.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.413 -0.812 . . . . 1.26 111.438 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.45 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.0 mt -86.35 148.5 25.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.772 0.32 . . . . 0.32000000000000001 110.486 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.762 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.3 114.83 61.22 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.075 0.464 . . . . 0.57999999999999996 110.704 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.01 140.57 95.94 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.821 2.348 . . . . 0.66000000000000003 112.04 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.17 74.42 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.101 -0.8 . . . . 0.28999999999999998 111.101 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.461 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.84 150.23 49.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.896 0.379 . . . . 2.3300000000000001 110.598 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.488 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.1 tttt -100.14 131.75 45.91 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.997 -0.547 . . . . 0.85999999999999999 109.799 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.956 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.62 148.26 44.13 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.114 -0.494 . . . . 0.52000000000000002 110.992 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.2 mt -105.32 125.37 60.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.298 -1.001 . . . . 0.29999999999999999 108.298 177.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.5 132.57 63.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.154 0.502 . . . . 0.23000000000000001 111.305 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.57 122.58 20.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.494 -0.775 . . . . 0.35999999999999999 109.537 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.585 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.0 125.33 54.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.227 -0.442 . . . . 0.19 110.739 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.3 m-85 -117.21 137.76 52.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.064 -0.516 . . . . 0.29999999999999999 109.926 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.42 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.66 134.96 42.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.805 -0.813 . . . . 0.37 108.805 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.6 ' O ' ' N ' ' A' ' 140' ' ' SER . 7.7 mm -99.11 122.91 51.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.177 0.513 . . . . 0.26000000000000001 110.922 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.6 p -83.76 169.74 14.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.533 -0.758 . . . . 0.28000000000000003 110.494 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.706 ' O ' ' OG1' ' A' ' 59' ' ' THR . 97.5 mt-10 -59.74 -14.59 15.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.011 -0.541 . . . . 1.6000000000000001 111.028 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -96.12 -4.22 43.16 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.804 -0.358 . . . . 1.1799999999999999 110.792 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.79 13.85 64.07 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.388 -0.685 . . . . 0.29999999999999999 111.388 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -84.58 139.01 32.4 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.107 -0.237 . . . . 1.22 110.506 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.724 ' CD ' HE22 ' A' ' 14' ' ' GLN . 11.8 mt-30 -106.68 141.09 38.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.815 0.34 . . . . 0.97999999999999998 110.584 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.1 m -136.71 126.93 26.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.82999999999999996 110.359 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.07 117.3 9.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.278 -0.419 . . . . 0.26000000000000001 110.551 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.05 -21.7 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.29999999999999999 110.764 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.91 125.69 5.84 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.542 -0.463 . . . . 0.31 111.459 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.471 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.8 120.28 21.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.726 -0.67 . . . . 0.28000000000000003 109.517 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.63 151.62 29.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.917 0.389 . . . . 0.23999999999999999 110.984 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.43 158.5 18.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.049 -0.523 . . . . 0.23000000000000001 110.464 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -145.97 157.93 43.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.235 -0.439 . . . . 0.67000000000000004 110.768 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 104.54 9.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.784 -0.644 . . . . 0.64000000000000001 109.972 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 68.1 p . . . . . 0 C--O 1.219 -0.534 0 CA-C-O 117.882 -1.056 . . . . 1.26 110.617 -179.706 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.6 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.199 -0.667 . . . . 3.4399999999999999 109.199 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.38 150.7 18.54 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.024 -0.83 . . . . 1.22 111.024 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -35.66 142.4 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.101 0 C-N-CA 124.025 3.15 . . . . 0.75 113.742 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.97 173.32 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.29 -1.323 . . . . 0.79000000000000004 108.769 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.614 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.55 125.93 51.55 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.411 -0.516 . . . . 1.9399999999999999 111.44 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.55 143.95 34.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.618 -0.719 . . . . 0.59999999999999998 110.622 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.05 168.31 25.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.931 0.396 . . . . 3.1400000000000001 111.12 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.748 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -108.98 131.06 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.957 -0.565 . . . . 3.23 110.076 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.2 162.31 35.79 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.954 0.407 . . . . 3.6299999999999999 111.194 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.469 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 73.1 tt0 36.14 31.53 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.637 -0.505 . . . . 6.0800000000000001 109.637 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.748 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.42 69.58 32.41 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.958 -0.564 . . . . 3.3799999999999999 111.621 -178.788 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.29 -29.09 72.62 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.529 2.153 . . . . 3.9300000000000002 111.802 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.52 125.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 3.3599999999999999 110.548 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.529 ' CB ' ' O ' ' A' ' 17' ' ' SER . 11.7 mt-30 -123.89 158.34 60.33 Favored Pre-proline 0 C--O 1.234 0.26 0 CA-C-N 116.241 -0.436 . . . . 3.6099999999999999 110.537 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.486 ' CG ' ' NH1' ' A' ' 143' ' ' ARG . 98.3 Cg_endo -82.12 -64.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.931 2.42 . . . . 1.51 113.457 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.627 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 61.9 t30 -108.4 -19.5 13.44 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.114 0.413 . . . . 2.6800000000000002 112.114 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 29.7 t -107.31 152.1 24.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.148 0.499 . . . . 1.21 111.339 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.578 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.24 102.92 2.23 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.687 -0.688 . . . . 1.5600000000000001 110.61 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.72 145.64 12.95 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.888 2.392 . . . . 0.81000000000000005 112.568 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.932 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.81 167.98 24.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.896 -0.593 . . . . 1.52 109.961 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.23 147.89 28.94 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.776 -0.453 . . . . 2.1400000000000001 109.776 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.597 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.4 p90 -142.24 157.29 45.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.017 0.437 . . . . 0.32000000000000001 111.196 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.499 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.04 155.26 44.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.715 -0.675 . . . . 2.1699999999999999 110.064 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.835 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.6 173.05 6.34 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 121.111 0.481 . . . . 0.58999999999999997 110.728 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.835 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.69 173.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.779 2.319 . . . . 0.90000000000000002 111.533 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.484 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.1 -51.03 0.69 Allowed Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 120.694 -0.402 . . . . 3.3399999999999999 110.111 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.617 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.81 152.32 82.52 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.737 2.291 . . . . 1.8500000000000001 111.483 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.64 42.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.332 0.587 . . . . 2.54 110.564 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.617 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.8 t60 -63.65 -41.55 98.21 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.953 -1.021 . . . . 2.5299999999999998 110.722 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.569 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.1 mt -109.87 137.89 40.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.842 -0.617 . . . . 1.1699999999999999 111.276 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.93 -72.95 0.7 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.063 -0.517 . . . . 1.27 111.911 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.09 148.28 24.54 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.593 0.59 . . . . 1.1200000000000001 112.593 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.81 124.94 45.36 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.324 -0.621 . . . . 0.41999999999999998 109.324 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.03 134.75 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.619 -0.433 . . . . 0.78000000000000003 110.705 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.932 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.99 128.59 53.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.998 0.428 . . . . 0.62 111.281 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.06 138.95 49.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.741 -0.663 . . . . 1.97 110.14 179.008 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.434 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.2 p90 -145.08 163.14 35.2 Favored 'General case' 0 C--N 1.335 -0.065 0 CA-C-O 121.197 0.523 . . . . 0.34999999999999998 112.036 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.488 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.48 139.63 7.89 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.38 -0.827 . . . . 1.8 110.482 178.854 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.63 115.47 3.07 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.392 2.061 . . . . 0.57999999999999996 111.767 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.684 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.0 81.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.927 -0.397 . . . . 3.04 109.927 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.931 -0.577 . . . . 2.4700000000000002 111.943 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.2 p -157.59 157.8 34.37 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.865 -0.334 . . . . 2.5099999999999998 110.577 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.408 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.4 m -120.38 27.8 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 1.8600000000000001 110.213 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.7 -75.9 1.31 Allowed Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.11 -0.566 . . . . 1.4399999999999999 111.878 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.88 152.29 35.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.411 . . . . 4.6900000000000004 110.949 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.665 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.18 -169.07 2.52 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.032 -0.531 . . . . 1.4299999999999999 111.96 179.343 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.77 29.59 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 121.48 0.657 . . . . 1.74 112.539 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.15 156.47 45.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.784 -1.098 . . . . 1.9199999999999999 110.242 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.2 158.35 41.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.931 -0.577 . . . . 0.34000000000000002 111.841 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.14 135.67 53.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.539 -0.755 . . . . 0.40999999999999998 109.832 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.597 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.44 121.91 23.71 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.474 -0.33 . . . . 0.55000000000000004 111.55 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.607 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.4 Cg_exo -46.26 151.7 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.65 2.234 . . . . 0.44 112.124 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.97 -22.97 63.12 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 116.026 -0.533 . . . . 0.73999999999999999 112.843 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.82 -16.79 46.39 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.213 -0.595 . . . . 0.93000000000000005 111.837 -178.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.607 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.64 138.39 31.6 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.798 -0.361 . . . . 0.96999999999999997 110.323 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.54 14.01 11.0 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.426 -0.352 . . . . 1.3400000000000001 111.527 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.07 143.46 25.14 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.671 -0.411 . . . . 0.39000000000000001 111.075 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.716 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.78 -169.39 1.54 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.006 -0.543 . . . . 0.41999999999999998 110.888 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.716 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 m -151.69 125.89 9.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.4 -0.818 . . . . 0.39000000000000001 109.882 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.51 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.9 mt -114.88 123.23 70.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.409 -0.516 . . . . 0.73999999999999999 111.117 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.576 ' HG2' ' N ' ' A' ' 62' ' ' GLY . 37.8 ttpt -126.42 163.38 23.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.824 -0.625 . . . . 2.48 110.49 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.576 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.07 19.04 59.86 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.795 -0.922 . . . . 0.5 110.795 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.627 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.8 mt -79.06 157.17 28.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.043 0.449 . . . . 0.57999999999999996 111.345 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.844 ' O ' HG12 ' A' ' 67' ' ' VAL . 1.5 tttp -99.44 133.93 21.58 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.569 -0.741 . . . . 2.79 110.451 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.491 ' HD3' ' CD1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.84 143.61 61.76 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.505 2.137 . . . . 0.87 112.01 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.75 25.67 75.28 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.071 -0.812 . . . . 0.64000000000000001 111.071 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.3 p -128.07 158.74 39.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.715 0.293 . . . . 0.82999999999999996 110.484 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.11 139.92 42.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.88 0.371 . . . . 0.5 110.581 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.651 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.9 m-85 -122.6 136.51 54.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 0.53000000000000003 110.764 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.91 131.05 45.28 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.485 -0.932 . . . . 1.8700000000000001 108.485 177.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.52 153.93 16.65 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.251 -0.976 . . . . 0.28999999999999998 111.927 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -135.05 140.89 45.93 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.68 -0.489 . . . . 1.4299999999999999 109.68 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.78 118.88 34.25 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.508 -0.477 . . . . 0.32000000000000001 110.468 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.736 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.43 129.05 68.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 0.79000000000000004 110.578 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.699 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.84 120.86 43.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.213 -0.449 . . . . 1.02 110.75 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.859 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.63 146.46 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.175 0.512 . . . . 0.62 111.032 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.625 ' O ' ' N ' ' A' ' 79' ' ' TYR . 20.8 mt-30 -105.97 153.85 21.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.565 -0.743 . . . . 2.4399999999999999 110.001 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.21 88.58 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.92 0.391 . . . . 3.6899999999999999 110.442 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.23 32.72 0.21 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.77 -0.65 . . . . 6.0800000000000001 110.558 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.34 3.29 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.499 -0.64 . . . . 1.22 111.499 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.4 177.4 9.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.244 0.545 . . . . 2.8799999999999999 111.596 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.15 149.55 32.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.407 -0.815 . . . . 1.47 110.495 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.14 144.65 38.72 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.489 -0.323 . . . . 2.7000000000000002 110.596 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.736 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.0 135.94 61.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 121.052 0.453 . . . . 0.46000000000000002 111.573 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -123.99 141.35 52.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.688 -0.687 . . . . 0.34999999999999998 110.306 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.477 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.6 138.81 51.69 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.113 0.482 . . . . 3.6699999999999999 111.528 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.19 164.18 37.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.568 -0.742 . . . . 0.67000000000000004 109.514 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.561 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.29 151.54 38.51 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.351 -0.54 . . . . 1.47 111.008 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.807 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.16 172.71 13.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.747 -0.66 . . . . 0.44 111.015 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.68 160.73 21.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.414 -0.812 . . . . 1.3700000000000001 109.915 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.44 121.86 22.86 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.548 -0.461 . . . . 1.28 110.8 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.4 p -128.55 165.39 20.83 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.458 0.91 . . . . 1.97 113.458 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 76.2 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 113.894 -1.503 . . . . 3.2799999999999998 107.552 177.146 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.481 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 121.976 0.893 . . . . 0.66000000000000003 110.399 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.435 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.9 167.54 0.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.875 -1.057 . . . . 0.68999999999999995 110.868 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.5 145.52 50.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.664 -0.698 . . . . 0.52000000000000002 110.16 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.23 101.64 9.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.104 -0.702 . . . . 0.32000000000000001 109.104 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.0 t -113.02 139.68 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.078 -0.51 . . . . 0.28999999999999998 111.033 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.6 p -128.7 152.49 48.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.6 -0.727 . . . . 0.25 109.827 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.59 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.5 p90 -144.72 -164.92 2.02 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.759 -0.376 . . . . 0.31 110.668 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.3 t -123.94 127.21 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.48999999999999999 110.812 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.174 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -58.03 58.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 1.53 110.313 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.743 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.1 24.48 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.881 -0.6 . . . . 0.96999999999999997 111.52 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.174 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.23 128.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.633 -0.427 . . . . 1.5600000000000001 110.994 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.46 -9.58 55.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.009 -0.542 . . . . 1.8799999999999999 110.38 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.4 p -87.16 0.4 55.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.043 -0.526 . . . . 1.04 110.307 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.31 137.22 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 116.018 -0.537 . . . . 0.23999999999999999 109.939 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 185' ' ' ILE . 60.9 m -96.33 -15.45 21.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.276 0.56 . . . . 0.28999999999999998 110.003 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.57 175.57 45.76 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 109.876 -1.289 . . . . 0.13 109.876 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.39 151.63 42.38 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.716 -0.394 . . . . 0.17000000000000001 110.541 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.695 ' NH1' ' OE1' ' A' ' 191' ' ' GLN . 20.6 ttm180 -132.43 121.12 22.91 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.18 -0.464 . . . . 1.29 109.955 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.555 HG21 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.11 136.56 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.652 -0.704 . . . . 0.25 110.635 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 84.7 tt0 -129.37 129.97 45.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.951 -0.568 . . . . 1.3200000000000001 109.992 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.624 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.79 135.21 34.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.983 -0.553 . . . . 0.56999999999999995 110.616 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.418 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.32 39.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.775 -0.648 . . . . 1.1599999999999999 109.668 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.972 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.4 mt -70.98 124.84 25.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.077 0.465 . . . . 0.38 110.738 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.0 p -71.6 -7.88 50.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.735 -0.666 . . . . 0.40999999999999998 110.879 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.79 -69.59 0.85 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.316 -0.402 . . . . 1.6599999999999999 111.473 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.478 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.61 -35.45 76.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.16 -0.473 . . . . 1.6599999999999999 111.477 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.085 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.21 88.61 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.783 -0.927 . . . . 1.1699999999999999 110.783 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.328 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.9 t0 -27.9 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.675 0.274 . . . . 1.8600000000000001 110.351 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.328 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.2 pm0 -82.2 139.02 45.31 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.925 0.393 . . . . 1.98 110.25 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.418 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.9 Cg_endo -70.9 145.8 51.47 Favored 'Trans proline' 0 C--N 1.302 -1.91 0 C-N-CA 122.671 2.247 . . . . 0.55000000000000004 112.392 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.77 145.82 42.47 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.237 -0.653 . . . . 1.1399999999999999 109.237 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.491 ' CD1' ' HD3' ' A' ' 65' ' ' PRO . 6.1 p90 -123.39 141.32 52.11 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.385 -0.526 . . . . 0.93000000000000005 111.486 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.0 mt -128.17 127.69 43.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.247 -0.888 . . . . 0.34000000000000002 108.922 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 68.3 t0 -101.7 131.21 48.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.184 0.516 . . . . 1.0900000000000001 111.683 -178.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.479 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -127.93 157.48 73.66 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.276 -0.875 . . . . 0.19 109.614 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -69.74 158.03 58.4 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.37 2.047 . . . . 0.17999999999999999 112.304 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.28 -12.2 5.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.825 -0.625 . . . . 0.20999999999999999 110.677 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.3 p -92.73 -8.83 42.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.28999999999999998 110.749 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.47 34.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.5 110.407 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.8 p -133.15 16.52 4.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.38 . . . . 0.29999999999999999 110.579 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.5 p -167.53 147.17 5.1 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.626 -0.509 . . . . 0.23000000000000001 109.626 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.555 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.2 150.44 12.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.518 -0.473 . . . . 0.28000000000000003 111.54 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.506 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.31 125.01 50.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.634 -0.712 . . . . 1.0700000000000001 109.789 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.51 104.88 30.09 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.911 0.386 . . . . 0.28999999999999998 111.054 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.4 Cg_endo -90.93 -179.53 1.52 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 123.2 2.6 . . . . 0.42999999999999999 112.24 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.74 32.58 18.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.415 -0.812 . . . . 1.26 111.394 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.481 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.2 mt -86.27 148.56 25.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.528 -0.305 . . . . 0.32000000000000001 110.586 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.76 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.33 114.8 61.1 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.007 0.432 . . . . 0.57999999999999996 110.707 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.0 140.62 96.17 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.878 2.385 . . . . 0.66000000000000003 112.009 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.03 21.27 74.31 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.021 -0.831 . . . . 0.28999999999999998 111.021 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.478 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.86 150.13 49.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.759 0.314 . . . . 2.3300000000000001 110.685 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.17 131.61 46.02 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.052 -0.522 . . . . 0.85999999999999999 109.825 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.972 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.1 m-85 -120.48 148.27 44.04 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.161 -0.472 . . . . 0.52000000000000002 111.018 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.28 125.37 60.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.279 -1.008 . . . . 0.29999999999999999 108.279 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.52 132.5 63.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.138 0.494 . . . . 0.23000000000000001 111.202 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.5 122.54 20.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.585 -0.734 . . . . 0.35999999999999999 109.673 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.59 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -100.95 125.46 54.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.296 -0.411 . . . . 0.19 110.609 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.0 m-85 -117.31 137.93 52.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.043 -0.526 . . . . 0.29999999999999999 109.823 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.426 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.73 135.0 42.86 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.774 -0.824 . . . . 0.37 108.774 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.554 ' O ' ' N ' ' A' ' 140' ' ' SER . 89.1 mt -99.04 122.96 51.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.102 0.477 . . . . 0.26000000000000001 110.988 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.0 p -83.85 169.65 14.91 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.538 -0.756 . . . . 0.28000000000000003 110.444 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -59.72 -14.6 14.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.012 -0.54 . . . . 1.6000000000000001 110.937 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.477 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.0 m-20 -95.97 -4.37 43.4 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.83 -0.348 . . . . 1.1799999999999999 110.834 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.85 13.95 63.79 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.347 -0.701 . . . . 0.29999999999999999 111.347 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -84.71 138.97 32.33 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.999 -0.281 . . . . 1.22 110.481 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.695 ' OE1' ' NH1' ' A' ' 143' ' ' ARG . 14.9 pt20 -106.6 141.08 38.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.97999999999999998 110.553 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.0 m -136.64 127.1 26.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.82999999999999996 110.409 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.29 117.36 9.99 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.683 -0.407 . . . . 0.26000000000000001 110.481 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.03 -21.84 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.29999999999999999 110.677 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.89 125.75 5.88 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.565 -0.454 . . . . 0.31 111.452 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.473 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.74 120.26 21.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.683 -0.69 . . . . 0.28000000000000003 109.505 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.61 151.73 29.17 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.653 -0.419 . . . . 0.23999999999999999 110.938 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.46 158.67 18.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.055 -0.521 . . . . 0.23000000000000001 110.404 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.4 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 68.1 mt-30 -146.14 157.89 43.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.174 -0.466 . . . . 0.67000000000000004 110.67 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.25 104.41 9.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.734 -0.666 . . . . 0.64000000000000001 110.1 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.9 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.853 -1.07 . . . . 1.26 110.667 -179.675 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.2 m . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.191 -0.67 . . . . 3.4399999999999999 109.191 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.34 150.65 18.55 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.057 -0.817 . . . . 1.22 111.057 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -35.67 142.41 0.1 Allowed 'Trans proline' 0 C--N 1.297 -2.166 0 C-N-CA 124.115 3.21 . . . . 0.75 113.718 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.605 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.4 t -80.07 173.53 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.205 -1.361 . . . . 0.79000000000000004 108.742 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.605 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.68 125.81 51.42 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.41 -0.516 . . . . 1.9399999999999999 111.522 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.44 143.97 34.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.684 -0.689 . . . . 0.59999999999999998 110.699 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.98 168.25 25.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.971 0.415 . . . . 3.1400000000000001 111.097 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.746 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.0 mt -108.94 131.05 60.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.935 -0.575 . . . . 3.23 110.118 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.21 162.34 35.72 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.468 -0.333 . . . . 3.6299999999999999 111.257 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 72.7 tt0 36.14 31.47 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 109.653 -0.499 . . . . 6.0800000000000001 109.653 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.746 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.35 69.54 31.59 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.935 -0.575 . . . . 3.3799999999999999 111.582 -178.753 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.632 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.22 -29.2 73.35 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.592 2.195 . . . . 3.9300000000000002 111.814 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.668 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 3.2 m 149.63 125.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 3.3599999999999999 110.413 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.668 ' NE2' ' O ' ' A' ' 13' ' ' SER . 1.8 mp0 -123.95 158.35 60.46 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.265 -0.425 . . . . 3.6099999999999999 110.481 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.646 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 98.3 Cg_endo -82.14 -64.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.83 2.353 . . . . 1.51 113.498 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.642 ' OD1' ' N ' ' A' ' 17' ' ' SER . 23.5 p-10 -108.44 -19.61 13.4 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.027 0.38 . . . . 2.6800000000000002 112.027 -178.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.642 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 93.6 p -107.4 151.93 24.86 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.469 -0.492 . . . . 1.21 111.297 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.576 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.11 102.98 2.26 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.684 -0.689 . . . . 1.5600000000000001 110.671 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.476 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.7 Cg_endo -82.72 145.72 12.99 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.872 2.381 . . . . 0.81000000000000005 112.556 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.909 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.84 167.97 24.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.849 -0.614 . . . . 1.52 109.879 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.15 147.94 29.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.795 -0.446 . . . . 2.1400000000000001 109.795 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.585 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.7 p90 -142.26 157.31 44.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.038 0.447 . . . . 0.32000000000000001 111.248 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.494 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.04 155.33 44.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.813 -0.631 . . . . 2.1699999999999999 110.09 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.831 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.6 173.19 6.18 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.085 -0.507 . . . . 0.58999999999999997 110.779 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.831 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.72 173.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.844 2.363 . . . . 0.90000000000000002 111.51 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.479 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -51.03 0.69 Allowed Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.723 -0.391 . . . . 3.3399999999999999 110.141 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.634 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.8 152.31 82.57 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.765 2.31 . . . . 1.8500000000000001 111.449 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.68 42.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.428 0.632 . . . . 2.54 110.631 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.9 t60 -63.56 -41.63 98.4 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.931 -1.031 . . . . 2.5299999999999998 110.676 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.556 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.2 mt -109.86 137.91 39.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.763 -0.653 . . . . 1.1699999999999999 111.234 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.01 -72.9 0.7 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.987 -0.551 . . . . 1.27 111.843 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.21 148.4 24.39 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.547 0.573 . . . . 1.1200000000000001 112.547 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.76 124.82 45.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.458 -0.571 . . . . 0.41999999999999998 109.458 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.7 mt -118.07 134.72 60.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.665 -0.414 . . . . 0.78000000000000003 110.632 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.909 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.99 128.64 53.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.062 0.458 . . . . 0.62 111.277 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.12 138.98 49.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.73 -0.668 . . . . 1.97 110.145 178.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.437 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.05 163.14 35.16 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.178 0.513 . . . . 0.34999999999999998 112.055 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.45 139.53 7.86 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.377 -0.829 . . . . 1.8 110.451 178.859 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.49 115.45 3.04 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.285 1.99 . . . . 0.57999999999999996 111.796 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.667 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.91 81.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.933 -0.395 . . . . 3.04 109.933 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.688 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.24 -20.58 0.06 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.059 -0.519 . . . . 2.4700000000000002 111.971 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.9 p -157.67 157.79 34.22 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.836 -0.345 . . . . 2.5099999999999998 110.604 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.404 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.41 27.77 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 1.8600000000000001 110.195 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.86 -75.84 1.31 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.022 -0.609 . . . . 1.4399999999999999 111.805 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.86 152.4 35.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.946 0.403 . . . . 4.6900000000000004 110.954 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.28 -169.18 2.54 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.0 -0.546 . . . . 1.4299999999999999 111.972 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.74 29.63 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.379 0.609 . . . . 1.74 112.611 -177.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.03 156.46 46.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.768 -1.105 . . . . 1.9199999999999999 110.291 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.18 158.36 41.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.004 -0.544 . . . . 0.34000000000000002 111.83 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 m -115.16 135.59 54.02 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.433 -0.803 . . . . 0.40999999999999998 109.893 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.585 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.3 121.94 23.89 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.509 -0.314 . . . . 0.55000000000000004 111.545 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.602 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.7 Cg_exo -46.28 151.74 1.59 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.744 2.296 . . . . 0.44 112.084 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.0 -23.03 63.27 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 116.045 -0.525 . . . . 0.73999999999999999 112.779 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.547 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.75 -16.88 46.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.384 0.592 . . . . 0.93000000000000005 111.81 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.602 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.6 mt -91.6 138.43 31.57 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.768 -0.373 . . . . 0.96999999999999997 110.254 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.54 14.0 11.0 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.302 -0.408 . . . . 1.3400000000000001 111.458 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.476 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.0 p -149.99 143.46 25.21 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.684 -0.406 . . . . 0.39000000000000001 111.081 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.722 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.82 -169.39 1.54 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.22 0.533 . . . . 0.41999999999999998 110.83 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.722 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.8 m -151.75 125.94 9.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.406 -0.815 . . . . 0.39000000000000001 109.832 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 67.0 mt -114.93 123.34 70.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.36 -0.536 . . . . 0.73999999999999999 111.134 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.747 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 16.6 ptpt -126.55 163.4 23.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.742 -0.663 . . . . 2.48 110.388 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.02 19.22 59.64 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.721 -0.951 . . . . 0.5 110.721 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.514 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.2 mt -79.16 157.23 27.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.127 0.489 . . . . 0.57999999999999996 111.306 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.85 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -99.47 133.98 21.52 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.588 -0.733 . . . . 2.79 110.486 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.458 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.88 143.62 61.6 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.554 2.169 . . . . 0.87 111.915 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.82 25.55 75.43 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.084 -0.806 . . . . 0.64000000000000001 111.084 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.85 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.3 p -128.09 158.75 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.691 0.281 . . . . 0.82999999999999996 110.51 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.06 139.99 41.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.908 0.385 . . . . 0.5 110.591 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.657 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.4 m-85 -122.62 136.43 54.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.948 -0.569 . . . . 0.53000000000000003 110.801 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.91 131.07 45.27 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.479 -0.934 . . . . 1.8700000000000001 108.479 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.57 153.89 16.67 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.281 -0.961 . . . . 0.28999999999999998 111.974 -178.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -135.01 140.9 46.02 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.628 -0.508 . . . . 1.4299999999999999 109.628 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.525 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.74 118.92 34.39 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.447 -0.501 . . . . 0.32000000000000001 110.551 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.738 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.42 129.1 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.378 -0.373 . . . . 0.79000000000000004 110.635 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.84 120.9 43.93 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.326 -0.397 . . . . 1.02 110.683 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.86 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.64 146.45 11.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.143 0.497 . . . . 0.62 111.099 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.621 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.1 mt-30 -106.0 153.92 21.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.58 -0.736 . . . . 2.4399999999999999 109.91 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.24 88.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.93 0.395 . . . . 3.6899999999999999 110.441 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.33 32.58 0.22 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.8 -0.636 . . . . 6.0800000000000001 110.543 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.03 -117.4 3.3 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.436 -0.666 . . . . 1.22 111.436 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -81.32 177.36 9.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.134 0.492 . . . . 2.8799999999999999 111.697 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.19 149.49 32.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.44 -0.8 . . . . 1.47 110.422 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.11 144.65 38.78 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.438 -0.346 . . . . 2.7000000000000002 110.624 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.738 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -127.97 136.02 61.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.135 0.493 . . . . 0.46000000000000002 111.527 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.09 141.37 52.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.681 -0.691 . . . . 0.34999999999999998 110.299 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.47 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.62 138.89 51.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.074 0.464 . . . . 3.6699999999999999 111.446 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.489 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.33 164.1 38.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.575 -0.739 . . . . 0.67000000000000004 109.485 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.577 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.28 151.51 38.47 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.393 -0.523 . . . . 1.47 111.048 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.804 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.2 p90 -146.21 172.79 12.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 0.44 110.972 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.82 160.72 21.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.345 -0.843 . . . . 1.3700000000000001 109.804 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.4 121.94 23.01 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.582 -0.447 . . . . 1.28 110.745 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.547 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -126.63 158.61 35.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.385 0.612 . . . . 1.97 112.279 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.29 -0.868 . . . . 3.2799999999999998 111.185 179.698 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.634 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 4.5 p . . . . . 0 N--CA 1.466 0.333 0 CA-C-O 121.473 0.654 . . . . 0.66000000000000003 110.167 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.438 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.9 167.55 0.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.297 -0.865 . . . . 0.68999999999999995 110.932 -179.636 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.54 145.56 50.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.707 -0.679 . . . . 0.52000000000000002 110.112 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.24 101.69 9.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.08 -0.711 . . . . 0.32000000000000001 109.08 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.3 t -113.0 139.62 37.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.108 -0.497 . . . . 0.28999999999999998 111.063 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.9 p -128.7 152.59 48.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.651 -0.704 . . . . 0.25 109.877 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.59 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.84 -164.96 2.04 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.63 -0.428 . . . . 0.31 110.621 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.9 t -123.97 127.23 73.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.48999999999999999 110.819 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.172 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.92 58.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.49 . . . . 1.53 110.37 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.17 24.62 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.925 -0.58 . . . . 0.96999999999999997 111.538 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.172 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.1 128.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.61 -0.436 . . . . 1.5600000000000001 110.932 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -86.38 -9.68 55.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.895 -0.593 . . . . 1.8799999999999999 110.332 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.07 0.21 55.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.115 -0.493 . . . . 1.04 110.304 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.26 137.16 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 0.23999999999999999 109.952 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.747 ' O ' ' NZ ' ' A' ' 61' ' ' LYS . 69.3 m -96.19 -15.56 21.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.242 0.544 . . . . 0.28999999999999998 110.019 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.61 175.56 45.78 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 109.915 -1.274 . . . . 0.13 109.915 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.44 151.66 42.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.027 0.442 . . . . 0.17000000000000001 110.465 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.764 ' NH2' ' OE2' ' A' ' 145' ' ' GLU . 31.6 ttt85 -132.43 121.23 23.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.058 -0.519 . . . . 1.29 109.887 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.11 136.47 38.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.697 -0.683 . . . . 0.25 110.655 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.764 ' OE2' ' NH2' ' A' ' 143' ' ' ARG . 97.6 mt-10 -129.37 129.86 45.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.097 -0.501 . . . . 1.3200000000000001 109.991 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.618 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.7 135.4 34.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.954 -0.566 . . . . 0.56999999999999995 110.614 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.417 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.44 161.27 40.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.78 -0.646 . . . . 1.1599999999999999 109.702 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.4 mt -71.0 124.81 25.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.029 0.442 . . . . 0.38 110.736 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.66 -7.82 50.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.726 -0.67 . . . . 0.40999999999999998 110.872 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -109.75 -69.6 0.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 1.6599999999999999 111.484 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.441 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.64 -35.39 76.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.053 -0.521 . . . . 1.6599999999999999 111.557 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.086 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.26 88.57 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.807 -0.917 . . . . 1.1699999999999999 110.807 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.337 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.89 -171.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 1.8600000000000001 110.278 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.337 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.09 45.2 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.021 0.439 . . . . 1.98 110.236 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.417 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.3 Cg_endo -70.96 145.86 51.26 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 C-N-CA 122.7 2.267 . . . . 0.55000000000000004 112.35 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.83 145.78 42.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.202 -0.666 . . . . 1.1399999999999999 109.202 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.521 ' CB ' ' NH1' ' A' ' 143' ' ' ARG . 35.9 p90 -123.33 141.31 52.11 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.303 -0.559 . . . . 0.93000000000000005 111.484 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.0 mt -128.1 127.7 43.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.317 -0.856 . . . . 0.34000000000000002 108.94 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.527 ' O ' ' OD1' ' A' ' 159' ' ' ASP . 54.7 p-10 -101.65 131.2 48.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.206 0.526 . . . . 1.0900000000000001 111.794 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.96 157.55 73.48 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.286 -0.87 . . . . 0.19 109.533 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.91 157.95 58.4 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 122.369 2.046 . . . . 0.17999999999999999 112.261 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.24 -12.04 4.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.832 -0.622 . . . . 0.20999999999999999 110.761 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.8 p -92.92 -8.74 42.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.451 . . . . 0.28999999999999998 110.642 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.25 135.47 34.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.349 -0.387 . . . . 0.5 110.353 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.8 p -133.21 16.79 4.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 0.29999999999999999 110.52 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.0 p -167.6 147.11 5.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.633 -0.506 . . . . 0.23000000000000001 109.633 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.12 150.46 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.516 -0.473 . . . . 0.28000000000000003 111.521 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.509 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 124.88 50.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.659 -0.7 . . . . 1.0700000000000001 109.849 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.31 104.91 29.58 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.377 -0.374 . . . . 0.28999999999999998 111.143 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.2 Cg_endo -91.0 -179.49 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.926 0 C-N-CA 123.135 2.557 . . . . 0.42999999999999999 112.218 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.69 32.59 18.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.31 -0.859 . . . . 1.26 111.465 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.634 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.1 mt -86.33 148.56 25.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.812 0.339 . . . . 0.32000000000000001 110.404 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.769 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.32 114.82 61.21 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.093 0.473 . . . . 0.57999999999999996 110.665 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.96 140.61 96.07 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.916 2.41 . . . . 0.66000000000000003 111.935 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.11 21.06 74.57 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.132 -0.787 . . . . 0.28999999999999998 111.132 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.441 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.76 150.16 49.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.746 0.308 . . . . 2.3300000000000001 110.668 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.495 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.21 131.61 46.06 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.105 -0.498 . . . . 0.85999999999999999 109.767 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.955 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.48 148.26 44.06 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.039 -0.528 . . . . 0.52000000000000002 110.948 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.6 mt -105.33 125.43 60.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.308 -0.997 . . . . 0.29999999999999999 108.308 177.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.64 132.5 63.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.199 0.523 . . . . 0.23000000000000001 111.174 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.64 20.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.549 -0.75 . . . . 0.35999999999999999 109.617 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.59 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.16 125.44 55.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.175 -0.466 . . . . 0.19 110.65 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 47.9 m-85 -117.17 137.86 52.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.99 -0.55 . . . . 0.29999999999999999 109.883 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.424 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.68 135.05 42.74 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.76 -0.83 . . . . 0.37 108.76 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.598 ' O ' ' N ' ' A' ' 140' ' ' SER . 79.6 mt -99.06 123.0 51.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.151 0.501 . . . . 0.26000000000000001 110.964 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.2 p -83.91 169.66 14.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.531 -0.759 . . . . 0.28000000000000003 110.443 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.523 ' O ' ' OG1' ' A' ' 59' ' ' THR . 97.0 mt-10 -59.67 -14.53 14.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.031 -0.531 . . . . 1.6000000000000001 111.069 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.3 m-20 -96.15 -4.26 42.99 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.855 -0.338 . . . . 1.1799999999999999 110.825 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.81 13.93 63.9 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.301 -0.72 . . . . 0.29999999999999999 111.301 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -84.65 139.12 32.27 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.994 -0.282 . . . . 1.22 110.476 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -106.71 141.06 38.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.897 0.38 . . . . 0.97999999999999998 110.527 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.72 126.97 26.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.82999999999999996 110.408 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.406 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.1 117.31 9.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.247 -0.433 . . . . 0.26000000000000001 110.532 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.0 -21.9 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.29999999999999999 110.699 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.85 125.86 5.95 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.52 -0.472 . . . . 0.31 111.51 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.469 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.93 120.22 21.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.741 -0.663 . . . . 0.28000000000000003 109.501 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.59 151.66 29.1 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.621 -0.432 . . . . 0.23999999999999999 110.941 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.41 158.5 18.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.518 . . . . 0.23000000000000001 110.45 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -146.03 157.95 43.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.135 -0.484 . . . . 0.67000000000000004 110.671 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 104.3 9.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.711 -0.677 . . . . 0.64000000000000001 110.056 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.981 -1.009 . . . . 1.26 110.637 -179.691 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.157 -0.683 . . . . 3.4399999999999999 109.157 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.31 150.62 18.56 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.078 -0.809 . . . . 1.22 111.078 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -35.61 142.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 123.944 3.096 . . . . 0.75 113.835 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.621 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -79.89 173.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.275 -1.329 . . . . 0.79000000000000004 108.898 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.621 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.59 125.9 51.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.164 0.507 . . . . 1.9399999999999999 111.464 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 p -136.55 144.06 33.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.625 -0.716 . . . . 0.59999999999999998 110.602 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.07 168.27 25.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.908 0.385 . . . . 3.1400000000000001 111.112 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.737 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -108.99 131.2 60.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.947 -0.569 . . . . 3.23 110.04 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 69.3 p -141.25 162.31 35.79 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.368 -0.378 . . . . 3.6299999999999999 111.162 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 9' ' ' THR . 29.9 tt0 36.12 31.56 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.659 -0.497 . . . . 6.0800000000000001 109.659 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.737 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.48 69.56 32.91 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.881 -0.599 . . . . 3.3799999999999999 111.489 -178.724 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.2 -29.2 73.56 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.618 2.212 . . . . 3.9300000000000002 111.808 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.6 125.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.14 -0.482 . . . . 3.3599999999999999 110.528 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.528 ' O ' ' O ' ' A' ' 92' ' ' THR . 7.0 mp0 -124.0 158.31 60.74 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.348 -0.387 . . . . 3.6099999999999999 110.408 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.528 ' HG2' ' CD ' ' A' ' 143' ' ' ARG . 97.3 Cg_endo -81.98 -64.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.812 2.342 . . . . 1.51 113.58 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.442 ' H ' ' HG2' ' A' ' 15' ' ' PRO . 99.4 m-20 -108.51 -19.51 13.42 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.072 0.397 . . . . 2.6800000000000002 112.072 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.649 ' OG ' HD13 ' A' ' 185' ' ' ILE . 2.6 m -107.38 152.0 24.75 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.13 0.491 . . . . 1.21 111.265 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.4 t-80 -155.25 102.98 2.23 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.691 -0.686 . . . . 1.5600000000000001 110.677 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -82.69 145.61 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.936 2.424 . . . . 0.81000000000000005 112.601 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.91 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.8 167.91 24.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.932 -0.576 . . . . 1.52 109.883 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.09 147.97 29.12 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.795 -0.446 . . . . 2.1400000000000001 109.795 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.4 p90 -142.32 157.31 44.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.047 0.451 . . . . 0.32000000000000001 111.112 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.494 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -128.07 155.31 44.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.789 -0.641 . . . . 2.1699999999999999 110.127 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.827 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.59 172.93 6.51 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.17 -0.468 . . . . 0.58999999999999997 110.815 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.827 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.52 173.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 122.869 2.379 . . . . 0.90000000000000002 111.573 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.12 -51.03 0.68 Allowed Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 120.68 -0.408 . . . . 3.3399999999999999 110.126 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.621 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.79 152.39 82.27 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.744 2.296 . . . . 1.8500000000000001 111.49 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.67 42.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.379 0.609 . . . . 2.54 110.552 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.621 ' H ' ' C ' ' A' ' 27' ' ' PRO . 73.9 t60 -63.56 -41.58 98.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.011 -0.995 . . . . 2.5299999999999998 110.707 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.557 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.4 mt -109.93 137.79 40.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.765 -0.652 . . . . 1.1699999999999999 111.255 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.92 -72.9 0.7 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.096 -0.502 . . . . 1.27 111.902 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.24 148.44 24.35 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.597 0.592 . . . . 1.1200000000000001 112.597 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.84 124.93 45.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.328 -0.619 . . . . 0.41999999999999998 109.328 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.7 mt -118.16 134.74 60.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.635 -0.426 . . . . 0.78000000000000003 110.623 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.91 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.03 128.57 53.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.057 0.456 . . . . 0.62 111.216 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.12 139.04 49.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.708 -0.678 . . . . 1.97 110.069 178.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.433 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.14 163.14 35.25 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-O 121.215 0.531 . . . . 0.34999999999999998 112.017 -178.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.42 139.59 7.92 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 115.421 -0.809 . . . . 1.8 110.431 178.906 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.55 115.51 3.09 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.256 1.971 . . . . 0.57999999999999996 111.825 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.67 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.08 81.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.885 -0.413 . . . . 3.04 109.885 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.21 -20.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.985 -0.552 . . . . 2.4700000000000002 111.886 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 p -157.65 157.78 34.23 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.789 -0.364 . . . . 2.5099999999999998 110.548 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 m -120.39 27.84 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.239 -0.437 . . . . 1.8600000000000001 110.224 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.89 -75.83 1.31 Allowed Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.141 -0.552 . . . . 1.4399999999999999 111.832 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.91 152.39 35.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.398 . . . . 4.6900000000000004 111.015 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.63 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.23 -169.15 2.54 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.166 -0.47 . . . . 1.4299999999999999 111.943 179.452 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.11 149.71 29.65 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.485 0.66 . . . . 1.74 112.532 -177.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.12 156.5 45.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.756 -1.111 . . . . 1.9199999999999999 110.281 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.25 158.33 41.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.981 -0.554 . . . . 0.34000000000000002 111.783 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 m -115.23 135.68 53.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.545 -0.752 . . . . 0.40999999999999998 109.757 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.596 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.45 121.96 23.71 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.55000000000000004 111.512 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.5 Cg_exo -46.41 151.77 1.68 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.699 2.266 . . . . 0.44 112.135 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.01 -23.02 63.27 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 116.106 -0.497 . . . . 0.73999999999999999 112.735 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.1 p-80 -82.68 -16.97 46.16 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 117.379 0.59 . . . . 0.93000000000000005 111.811 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.605 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.2 mt -91.56 138.44 31.56 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.728 -0.389 . . . . 0.96999999999999997 110.278 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.57 13.98 10.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.39 -0.368 . . . . 1.3400000000000001 111.572 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.4 p -150.0 143.49 25.22 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.593 -0.443 . . . . 0.39000000000000001 111.071 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.84 -169.4 1.54 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.261 0.553 . . . . 0.41999999999999998 110.818 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.714 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.75 125.87 9.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.361 -0.836 . . . . 0.39000000000000001 109.792 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.51 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.81 123.25 70.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.401 -0.52 . . . . 0.73999999999999999 111.248 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.668 ' NZ ' ' OG ' ' A' ' 140' ' ' SER . 59.6 mttp -126.47 163.33 23.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.838 -0.619 . . . . 2.48 110.426 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.19 18.97 59.79 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.712 -0.955 . . . . 0.5 110.712 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.51 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.2 mt -79.05 157.29 28.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.116 0.484 . . . . 0.57999999999999996 111.319 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.858 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -99.48 134.04 21.47 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.604 -0.725 . . . . 2.79 110.384 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.99 143.62 60.99 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.551 2.167 . . . . 0.87 111.902 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.65 75.31 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.081 -0.808 . . . . 0.64000000000000001 111.081 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.858 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.21 158.79 40.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.743 0.306 . . . . 0.82999999999999996 110.44 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.16 139.96 41.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.974 0.416 . . . . 0.5 110.547 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.639 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.55 136.51 54.9 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.855 -0.611 . . . . 0.53000000000000003 110.75 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.98 131.09 45.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.538 -0.912 . . . . 1.8700000000000001 108.538 177.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.487 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.53 153.84 16.66 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.322 -0.942 . . . . 0.28999999999999998 112.006 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -134.87 140.94 46.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.702 -0.481 . . . . 1.4299999999999999 109.702 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.83 118.88 34.23 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.496 -0.482 . . . . 0.32000000000000001 110.468 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.732 HG12 HG23 ' A' ' 84' ' ' VAL . 63.8 mt -112.36 129.04 68.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.293 -0.412 . . . . 0.79000000000000004 110.749 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.71 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.81 120.93 44.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.356 -0.383 . . . . 1.02 110.655 -179.637 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.854 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.62 146.42 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.115 0.483 . . . . 0.62 111.03 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.625 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.1 mt-30 -106.07 153.91 21.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.494 -0.776 . . . . 2.4399999999999999 109.843 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.14 88.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.958 0.409 . . . . 3.6899999999999999 110.479 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.32 32.52 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.847 -0.615 . . . . 6.0800000000000001 110.653 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.27 3.28 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.95 -0.643 . . . . 1.22 111.533 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -81.42 177.38 9.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.143 0.497 . . . . 2.8799999999999999 111.635 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.13 149.54 32.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.382 -0.827 . . . . 1.47 110.331 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.15 144.7 38.74 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.354 -0.385 . . . . 2.7000000000000002 110.6 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.732 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.0 136.0 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-O 121.047 0.451 . . . . 0.46000000000000002 111.587 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.599 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.07 141.39 52.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.66 -0.7 . . . . 0.34999999999999998 110.245 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.466 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.61 138.81 51.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.094 0.473 . . . . 3.6699999999999999 111.485 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.487 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.21 164.19 37.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.597 -0.729 . . . . 0.67000000000000004 109.51 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 46.9 p30 -145.21 151.56 38.59 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.441 -0.504 . . . . 1.47 111.071 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.81 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.8 p90 -146.28 172.68 13.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.729 -0.669 . . . . 0.44 110.994 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.73 160.68 21.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.443 -0.799 . . . . 1.3700000000000001 109.864 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.42 121.9 22.94 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.547 -0.461 . . . . 1.28 110.771 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.528 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.2 p -127.16 164.9 20.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 122.5 1.143 . . . . 1.97 114.033 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.522 ' OG ' ' CE2' ' A' ' 157' ' ' TYR . 22.4 t . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 113.198 -1.819 . . . . 3.2799999999999998 109.128 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 67.5 p . . . . . 0 CA--C 1.517 -0.309 0 N-CA-C 108.557 -0.905 . . . . 0.66000000000000003 108.557 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.438 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.76 167.61 0.24 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.878 -1.056 . . . . 0.68999999999999995 110.897 -179.184 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.65 145.52 50.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.688 -0.687 . . . . 0.52000000000000002 110.117 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.28 101.63 9.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.076 -0.713 . . . . 0.32000000000000001 109.076 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.4 t -112.87 139.73 36.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.056 -0.52 . . . . 0.28999999999999998 111.097 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.0 p -128.75 152.56 48.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.599 -0.728 . . . . 0.25 109.816 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.59 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.8 -164.93 2.03 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.742 -0.383 . . . . 0.31 110.67 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.731 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.7 t -123.98 127.17 73.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.18 -0.463 . . . . 0.48999999999999999 110.718 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.162 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.98 58.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.135 -0.484 . . . . 1.53 110.297 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.731 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.05 24.42 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.991 -0.55 . . . . 0.96999999999999997 111.533 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.162 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.23 128.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.549 -0.46 . . . . 1.5600000000000001 110.954 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.44 -9.61 55.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.979 -0.555 . . . . 1.8799999999999999 110.288 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.8 p -87.09 0.27 55.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 1.04 110.282 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.29 137.26 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.064 -0.517 . . . . 0.23999999999999999 109.913 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.668 ' OG ' ' NZ ' ' A' ' 61' ' ' LYS . 10.9 p -96.26 -15.49 21.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.287 0.565 . . . . 0.28999999999999998 110.076 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.57 175.57 45.76 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.91 -1.276 . . . . 0.13 109.91 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.48 151.63 42.54 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.578 -0.449 . . . . 0.17000000000000001 110.458 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.723 ' NH2' ' OE1' ' A' ' 191' ' ' GLN . 52.3 ttp85 -132.38 121.17 23.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.108 -0.496 . . . . 1.29 109.997 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.557 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.08 136.59 38.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.686 -0.688 . . . . 0.25 110.694 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 73.8 tt0 -129.34 129.87 45.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.981 -0.554 . . . . 1.3200000000000001 110.109 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.72 135.27 34.57 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.027 -0.533 . . . . 0.56999999999999995 110.602 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.421 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.32 39.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.83 -0.623 . . . . 1.1599999999999999 109.739 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.951 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.0 124.89 25.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.995 0.426 . . . . 0.38 110.694 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.494 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.9 -7.63 49.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.757 -0.656 . . . . 0.40999999999999998 110.856 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.81 -69.6 0.85 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.924 0.393 . . . . 1.6599999999999999 111.468 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.46 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.7 -35.27 75.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.02 -0.537 . . . . 1.6599999999999999 111.498 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.099 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.01 7.29 88.54 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.838 -0.905 . . . . 1.1699999999999999 110.838 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.324 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.97 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.817 0.342 . . . . 1.8600000000000001 110.261 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.324 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.17 139.04 45.43 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.407 . . . . 1.98 110.199 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.9 Cg_endo -70.86 145.8 51.75 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.753 2.302 . . . . 0.55000000000000004 112.376 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.79 145.63 42.65 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.276 -0.639 . . . . 1.1399999999999999 109.276 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.633 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 88.1 m-85 -123.31 141.46 51.96 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.311 -0.556 . . . . 0.93000000000000005 111.516 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.17 127.63 43.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.306 -0.861 . . . . 0.34000000000000002 108.951 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -101.61 131.21 47.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.075 0.464 . . . . 1.0900000000000001 111.687 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.96 157.59 73.37 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.347 -0.842 . . . . 0.19 109.553 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.85 158.02 58.23 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 122.413 2.075 . . . . 0.17999999999999999 112.247 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.31 -12.15 5.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.742 -0.663 . . . . 0.20999999999999999 110.684 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.9 p -92.8 -8.76 42.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.148 -0.478 . . . . 0.28999999999999998 110.783 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.46 34.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.5 110.435 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.25 16.78 4.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.29999999999999999 110.52 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.5 p -167.58 147.1 5.04 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.596 -0.52 . . . . 0.23000000000000001 109.596 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.21 150.49 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.458 -0.497 . . . . 0.28000000000000003 111.55 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.25 125.03 50.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.606 -0.725 . . . . 1.0700000000000001 109.822 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.49 104.88 30.05 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.378 -0.374 . . . . 0.28999999999999998 111.011 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.8 Cg_endo -90.97 -179.5 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 123.195 2.597 . . . . 0.42999999999999999 112.24 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.67 32.64 18.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.381 -0.827 . . . . 1.26 111.435 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.0 mt -86.29 148.59 25.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.467 -0.333 . . . . 0.32000000000000001 110.563 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.76 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.37 114.86 61.37 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.016 0.436 . . . . 0.57999999999999996 110.624 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.07 140.61 95.97 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.83 2.353 . . . . 0.66000000000000003 111.93 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.1 21.21 74.25 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.006 -0.838 . . . . 0.28999999999999998 111.006 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.46 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.87 150.13 49.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.752 0.311 . . . . 2.3300000000000001 110.756 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.494 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.15 131.7 45.94 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.85999999999999999 109.728 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.951 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.7 m-85 -120.49 148.31 44.0 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.091 -0.504 . . . . 0.52000000000000002 111.02 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.7 mt -105.25 125.25 60.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.347 -0.983 . . . . 0.29999999999999999 108.347 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.51 132.45 63.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.198 0.523 . . . . 0.23000000000000001 111.303 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.44 122.6 20.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.542 -0.754 . . . . 0.35999999999999999 109.655 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.59 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.12 125.38 55.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.257 -0.429 . . . . 0.19 110.627 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.7 m-85 -117.15 137.86 52.04 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.534 . . . . 0.29999999999999999 109.882 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.418 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.68 135.11 42.64 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.846 -0.798 . . . . 0.37 108.846 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.649 HD13 ' OG ' ' A' ' 17' ' ' SER . 26.6 mt -99.09 123.01 51.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.074 0.464 . . . . 0.26000000000000001 110.918 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.592 ' OG ' ' OD1' ' A' ' 188' ' ' ASP . 87.4 p -83.91 169.73 14.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.515 -0.766 . . . . 0.28000000000000003 110.529 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.77 -14.55 15.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.096 -0.502 . . . . 1.6000000000000001 110.953 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.671 ' OD1' ' N ' ' A' ' 190' ' ' GLU . 37.1 p30 -96.18 -4.16 43.08 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.785 -0.366 . . . . 1.1799999999999999 110.773 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.74 13.86 64.17 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.339 -0.705 . . . . 0.29999999999999999 111.339 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.671 ' N ' ' OD1' ' A' ' 188' ' ' ASP . 84.4 tt0 -84.59 139.03 32.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.705 0.288 . . . . 1.22 110.456 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.723 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 87.4 mt-30 -106.74 141.03 38.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.97999999999999998 110.557 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.0 m -136.72 127.15 26.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 0.82999999999999996 110.326 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.7 tp -68.21 117.38 9.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.26000000000000001 110.454 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.4 pt -109.08 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.29999999999999999 110.71 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.5 tp -156.91 125.74 5.86 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.511 -0.476 . . . . 0.31 111.448 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.463 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.77 120.28 21.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.775 -0.648 . . . . 0.28000000000000003 109.504 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.67 151.68 29.06 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.628 -0.429 . . . . 0.23999999999999999 110.901 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.43 158.58 18.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.986 -0.552 . . . . 0.23000000000000001 110.492 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -146.05 158.04 43.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.67000000000000004 110.633 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.35 104.31 9.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.717 -0.674 . . . . 0.64000000000000001 109.981 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.9 p . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.94 -1.028 . . . . 1.26 110.701 -179.767 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.0 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.223 -0.658 . . . . 3.4399999999999999 109.223 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.46 150.67 18.53 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.971 -0.852 . . . . 1.22 110.971 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -35.58 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.056 0 C-N-CA 124.009 3.139 . . . . 0.75 113.811 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.6 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.94 173.47 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.219 -1.355 . . . . 0.79000000000000004 108.882 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.6 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.64 125.92 51.54 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.376 -0.529 . . . . 1.9399999999999999 111.444 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.51 143.96 34.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.671 -0.695 . . . . 0.59999999999999998 110.691 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.01 168.3 25.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.923 0.392 . . . . 3.1400000000000001 111.093 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.749 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.7 mt -109.06 131.08 60.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.975 -0.557 . . . . 3.23 110.098 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.16 162.26 35.92 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.466 -0.334 . . . . 3.6299999999999999 111.255 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 73.7 mm-40 36.15 31.63 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.558 -0.534 . . . . 6.0800000000000001 109.558 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.749 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.53 69.6 33.5 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.006 -0.543 . . . . 3.3799999999999999 111.521 -178.736 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.639 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.37 -28.99 71.87 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.433 2.089 . . . . 3.9300000000000002 111.906 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.681 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 3.2 m 149.58 125.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 3.3599999999999999 110.481 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.681 ' NE2' ' O ' ' A' ' 13' ' ' SER . 3.4 mp0 -123.96 158.39 60.39 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.314 -0.403 . . . . 3.6099999999999999 110.409 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.619 ' CG ' ' NH1' ' A' ' 143' ' ' ARG . 97.2 Cg_endo -82.03 -64.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.902 2.402 . . . . 1.51 113.488 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.62 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 64.6 t30 -108.46 -19.59 13.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.305 -0.407 . . . . 2.6800000000000002 112.012 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 5.3 p -107.3 152.11 24.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.187 0.518 . . . . 1.21 111.242 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.573 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.34 102.89 2.22 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.7 -0.682 . . . . 1.5600000000000001 110.685 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.559 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.67 145.57 13.01 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.923 2.415 . . . . 0.81000000000000005 112.605 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.909 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.75 167.95 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.881 -0.6 . . . . 1.52 109.895 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.21 147.94 29.01 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.674 -0.491 . . . . 2.1400000000000001 109.674 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.58 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.27 157.33 44.95 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.605 -0.438 . . . . 0.32000000000000001 111.195 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.494 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.2 m-20 -128.04 155.29 44.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.781 -0.645 . . . . 2.1699999999999999 110.017 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.838 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.63 172.99 6.41 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.128 -0.487 . . . . 0.58999999999999997 110.737 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.838 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.68 173.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.851 2.367 . . . . 0.90000000000000002 111.598 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.98 -51.15 0.69 Allowed Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 120.725 -0.39 . . . . 3.3399999999999999 110.051 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.637 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.4 Cg_exo -64.75 152.36 82.31 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.783 2.322 . . . . 1.8500000000000001 111.477 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.75 42.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.35 0.595 . . . . 2.54 110.46 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.637 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.8 t60 -63.6 -41.64 98.3 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.059 -0.973 . . . . 2.5299999999999998 110.625 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.559 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.4 mt -109.82 137.76 40.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.811 -0.631 . . . . 1.1699999999999999 111.276 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.88 -72.91 0.7 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.053 -0.522 . . . . 1.27 111.965 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.18 148.4 24.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.617 0.599 . . . . 1.1200000000000001 112.617 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -121.78 124.89 45.27 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.315 -0.624 . . . . 0.41999999999999998 109.315 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.02 134.68 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.623 -0.431 . . . . 0.78000000000000003 110.67 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.909 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.93 128.6 53.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.978 0.418 . . . . 0.62 111.283 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.92 49.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.724 -0.671 . . . . 1.97 110.217 178.933 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.441 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.0 163.21 34.89 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.169 0.509 . . . . 0.34999999999999998 112.054 -178.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.56 139.56 7.78 Favored Pre-proline 0 C--N 1.333 -0.12 0 CA-C-N 115.346 -0.843 . . . . 1.8 110.428 178.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.46 115.42 3.01 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.318 2.012 . . . . 0.57999999999999996 111.802 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.97 81.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.92 -0.4 . . . . 3.04 109.92 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.23 -20.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 2.4700000000000002 111.936 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.2 p -157.68 157.76 34.13 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.737 -0.385 . . . . 2.5099999999999998 110.51 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.4 m -120.29 27.82 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.182 -0.463 . . . . 1.8600000000000001 110.186 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.83 -75.87 1.31 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.178 -0.534 . . . . 1.4399999999999999 111.829 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.89 152.2 35.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.898 0.38 . . . . 4.6900000000000004 111.055 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.11 -169.14 2.55 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.113 -0.494 . . . . 1.4299999999999999 111.954 179.394 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.441 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.12 149.68 29.71 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.456 0.646 . . . . 1.74 112.672 -177.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.07 156.5 45.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.858 -1.065 . . . . 1.9199999999999999 110.285 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.24 158.34 41.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.903 -0.589 . . . . 0.34000000000000002 111.873 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 m -115.19 135.58 54.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.472 -0.785 . . . . 0.40999999999999998 109.865 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.58 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.35 121.93 23.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.467 -0.333 . . . . 0.55000000000000004 111.538 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.598 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.7 Cg_exo -46.41 151.77 1.68 Allowed 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.666 2.244 . . . . 0.44 112.059 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.04 -22.85 63.14 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-N 115.957 -0.565 . . . . 0.73999999999999999 112.81 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.84 -16.89 45.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.371 0.586 . . . . 0.93000000000000005 111.825 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.598 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.53 138.42 31.59 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.725 -0.39 . . . . 0.96999999999999997 110.375 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.55 13.95 10.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.387 -0.369 . . . . 1.3400000000000001 111.551 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.99 143.4 25.17 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.681 -0.408 . . . . 0.39000000000000001 111.098 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.75 -169.25 1.51 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.037 -0.528 . . . . 0.41999999999999998 110.906 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.76 ' OG1' ' N ' ' A' ' 189' ' ' GLY . 1.3 m -151.82 125.86 9.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.432 -0.804 . . . . 0.39000000000000001 109.805 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.517 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.8 123.25 70.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.429 -0.508 . . . . 0.73999999999999999 111.21 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -126.48 163.41 23.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.842 -0.617 . . . . 2.48 110.436 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.457 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.17 18.99 59.79 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.631 -0.988 . . . . 0.5 110.631 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.62 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 74.1 mt -79.07 157.26 28.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.149 0.5 . . . . 0.57999999999999996 111.309 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.843 ' O ' HG12 ' A' ' 67' ' ' VAL . 10.9 mttp -99.44 133.95 21.56 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.588 -0.733 . . . . 2.79 110.494 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.421 ' HD3' ' CE2' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.84 143.6 61.72 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.637 2.225 . . . . 0.87 111.916 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.79 25.5 75.48 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.105 -0.798 . . . . 0.64000000000000001 111.105 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.843 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.09 158.79 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.321 . . . . 0.82999999999999996 110.449 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.19 139.91 42.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.94 0.4 . . . . 0.5 110.534 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.65 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.7 m-85 -122.53 136.45 54.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.944 -0.571 . . . . 0.53000000000000003 110.776 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.84 131.02 45.27 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.483 -0.932 . . . . 1.8700000000000001 108.483 177.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.49 153.9 16.65 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.301 -0.952 . . . . 0.28999999999999998 111.943 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -134.96 140.93 46.09 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.71 -0.478 . . . . 1.4299999999999999 109.71 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.9 tp -115.67 118.93 34.44 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.476 -0.489 . . . . 0.32000000000000001 110.488 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.733 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.51 129.19 68.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.342 -0.39 . . . . 0.79000000000000004 110.647 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.705 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.92 120.7 43.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.242 -0.436 . . . . 1.02 110.774 -179.632 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.853 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.52 146.5 11.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.217 0.532 . . . . 0.62 111.02 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.623 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.01 153.85 21.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.536 -0.756 . . . . 2.4399999999999999 109.982 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.13 88.47 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.898 0.38 . . . . 3.6899999999999999 110.521 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.36 32.6 0.22 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.78 -0.645 . . . . 6.0800000000000001 110.589 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.33 3.29 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.504 -0.638 . . . . 1.22 111.504 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -81.36 177.38 9.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.135 0.493 . . . . 2.8799999999999999 111.687 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.17 149.5 32.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.401 -0.818 . . . . 1.47 110.401 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.13 144.68 38.75 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.459 -0.337 . . . . 2.7000000000000002 110.613 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.733 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.04 135.95 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.049 0.452 . . . . 0.46000000000000002 111.473 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.02 141.34 52.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.599 -0.728 . . . . 0.34999999999999998 110.236 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.64 138.85 51.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.117 0.484 . . . . 3.6699999999999999 111.541 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.25 164.18 37.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.506 -0.77 . . . . 0.67000000000000004 109.493 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.572 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.25 151.51 38.49 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.41 -0.516 . . . . 1.47 111.084 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.802 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.5 p90 -146.19 172.65 13.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.762 -0.654 . . . . 0.44 111.104 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.61 160.67 21.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.467 -0.788 . . . . 1.3700000000000001 109.861 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.37 121.98 23.12 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 120.63 -0.428 . . . . 1.28 110.747 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.564 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.8 p -127.83 164.23 22.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.647 0.737 . . . . 1.97 112.689 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.5 t . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 114.63 -1.168 . . . . 3.2799999999999998 109.682 178.593 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.5 p . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 121.295 0.569 . . . . 0.66000000000000003 110.312 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.438 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.85 167.57 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.483 -0.78 . . . . 0.68999999999999995 111.003 -179.283 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.58 145.57 50.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.746 -0.661 . . . . 0.52000000000000002 110.141 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.28 101.7 9.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.073 -0.714 . . . . 0.32000000000000001 109.073 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.5 t -112.93 139.63 37.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.28999999999999998 111.069 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 p -128.7 152.58 48.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.621 -0.718 . . . . 0.25 109.834 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.59 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.9 p90 -144.78 -165.01 2.05 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.687 -0.405 . . . . 0.31 110.675 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -123.95 127.16 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.198 -0.455 . . . . 0.48999999999999999 110.861 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.175 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.88 58.32 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.086 -0.506 . . . . 1.53 110.402 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.12 24.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.934 -0.576 . . . . 0.96999999999999997 111.435 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.175 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.12 128.69 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.594 -0.443 . . . . 1.5600000000000001 110.98 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.4 -9.55 56.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.58 . . . . 1.8799999999999999 110.278 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.0 p -87.09 0.2 55.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.08 0.467 . . . . 1.04 110.358 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.22 137.07 25.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.951 -0.568 . . . . 0.23999999999999999 109.961 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.602 ' N ' ' O ' ' A' ' 185' ' ' ILE . 89.4 p -96.12 -15.54 22.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.262 0.553 . . . . 0.28999999999999998 110.057 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.56 175.6 45.78 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 109.861 -1.296 . . . . 0.13 109.861 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -123.45 151.65 42.47 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.65 -0.42 . . . . 0.17000000000000001 110.529 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.619 ' NH1' ' CG ' ' A' ' 15' ' ' PRO . 36.7 ttp85 -132.33 121.16 23.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.131 -0.486 . . . . 1.29 109.919 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 167' ' ' VAL . 46.5 t -105.09 136.48 38.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.705 -0.679 . . . . 0.25 110.661 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 85.2 tt0 -129.33 129.88 45.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.029 -0.532 . . . . 1.3200000000000001 110.013 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.75 135.25 34.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.56999999999999995 110.638 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.42 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.26 161.3 39.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.659 -0.7 . . . . 1.1599999999999999 109.704 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.951 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.1 mt -70.98 124.87 25.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.068 0.461 . . . . 0.38 110.729 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.73 -7.77 50.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.766 -0.652 . . . . 0.40999999999999998 110.874 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.79 -69.67 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.35 -0.386 . . . . 1.6599999999999999 111.416 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.435 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.74 -35.33 76.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.076 -0.511 . . . . 1.6599999999999999 111.42 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.088 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.22 88.6 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.785 -0.926 . . . . 1.1699999999999999 110.785 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.336 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.89 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.778 0.323 . . . . 1.8600000000000001 110.25 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.336 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.33 138.99 44.87 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.941 0.401 . . . . 1.98 110.145 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.42 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.2 Cg_endo -70.79 145.76 52.05 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.635 2.223 . . . . 0.55000000000000004 112.406 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.79 145.66 42.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.264 -0.643 . . . . 1.1399999999999999 109.264 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.581 ' CE1' ' CG ' ' A' ' 16' ' ' ASN . 6.3 p90 -123.27 141.23 52.19 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.453 -0.499 . . . . 0.93000000000000005 111.567 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.6 mt -128.03 127.66 43.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.35 -0.841 . . . . 0.34000000000000002 108.964 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.593 ' HB2' HD21 ' A' ' 16' ' ' ASN . 30.1 t0 -101.65 131.16 48.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.185 0.517 . . . . 1.0900000000000001 111.767 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.99 157.57 73.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.31 -0.859 . . . . 0.19 109.508 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -69.8 157.96 58.52 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.437 2.091 . . . . 0.17999999999999999 112.197 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.4 p -59.11 -12.27 4.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.737 -0.665 . . . . 0.20999999999999999 110.813 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.4 p -92.83 -8.71 42.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.128 -0.487 . . . . 0.28999999999999998 110.633 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.31 34.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.454 -0.339 . . . . 0.5 110.364 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.1 p -133.05 16.65 4.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.454 -0.339 . . . . 0.29999999999999999 110.624 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.6 p -167.55 147.11 5.07 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.61 -0.515 . . . . 0.23000000000000001 109.61 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.21 150.42 12.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.548 -0.461 . . . . 0.28000000000000003 111.598 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 124.95 50.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.628 -0.715 . . . . 1.0700000000000001 109.811 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.4 104.87 29.68 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.428 -0.351 . . . . 0.28999999999999998 111.038 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.8 Cg_endo -91.04 -179.58 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 123.224 2.616 . . . . 0.42999999999999999 112.179 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.78 32.59 18.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.324 -0.853 . . . . 1.26 111.427 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.1 mt -86.36 148.51 25.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.476 -0.329 . . . . 0.32000000000000001 110.532 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.77 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.22 114.77 60.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.982 0.42 . . . . 0.57999999999999996 110.688 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -58.97 140.57 95.91 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.891 2.394 . . . . 0.66000000000000003 112.017 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.06 21.25 74.25 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.047 -0.821 . . . . 0.28999999999999998 111.047 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.435 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.97 150.23 49.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 2.3300000000000001 110.62 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.2 131.64 46.02 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.077 -0.511 . . . . 0.85999999999999999 109.809 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.951 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.54 148.33 43.99 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.136 -0.484 . . . . 0.52000000000000002 110.992 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.1 mt -105.35 125.41 60.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.281 -1.007 . . . . 0.29999999999999999 108.281 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.58 132.57 63.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.126 0.489 . . . . 0.23000000000000001 111.247 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.58 122.52 20.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.57 -0.741 . . . . 0.35999999999999999 109.69 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.59 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -100.94 125.36 54.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.242 -0.436 . . . . 0.19 110.62 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.2 m-85 -117.17 137.86 52.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.023 -0.535 . . . . 0.29999999999999999 109.956 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.426 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.67 134.95 42.88 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.838 -0.801 . . . . 0.37 108.838 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.602 ' O ' ' N ' ' A' ' 140' ' ' SER . 84.3 mt -99.1 122.94 51.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.09 0.471 . . . . 0.26000000000000001 110.962 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.9 p -83.88 169.68 14.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.518 -0.764 . . . . 0.28000000000000003 110.461 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 187' ' ' GLU . 43.3 tt0 -59.67 -14.63 14.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.077 -0.511 . . . . 1.6000000000000001 110.936 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.732 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.6 m-20 -96.07 -4.27 43.26 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.866 -0.333 . . . . 1.1799999999999999 110.818 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.76 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.79 13.87 64.04 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.312 -0.715 . . . . 0.29999999999999999 111.312 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -84.62 139.13 32.29 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.015 -0.274 . . . . 1.22 110.449 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.73 141.11 38.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.797 0.332 . . . . 0.97999999999999998 110.601 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.75 126.97 26.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.82999999999999996 110.402 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.12 117.22 9.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.386 -0.37 . . . . 0.26000000000000001 110.543 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 43.8 pt -108.97 -21.8 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.457 . . . . 0.29999999999999999 110.838 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.93 125.74 5.85 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.467 -0.493 . . . . 0.31 111.49 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.7 120.17 21.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.702 -0.681 . . . . 0.28000000000000003 109.576 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.58 151.76 29.23 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.594 -0.443 . . . . 0.23999999999999999 110.929 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.48 158.56 18.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.007 -0.542 . . . . 0.23000000000000001 110.38 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -146.08 157.9 43.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 0.67000000000000004 110.646 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.14 104.34 9.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.748 -0.66 . . . . 0.64000000000000001 110.043 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.01 -0.995 . . . . 1.26 110.653 -179.791 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.553 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.6 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.226 -0.657 . . . . 3.4399999999999999 109.226 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.64 18.54 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.071 -0.811 . . . . 1.22 111.071 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -35.62 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.297 -2.147 0 C-N-CA 124.039 3.159 . . . . 0.75 113.773 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.606 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.0 t -79.83 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.296 -1.32 . . . . 0.79000000000000004 108.912 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.606 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.66 125.9 51.53 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.489 -0.484 . . . . 1.9399999999999999 111.424 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.57 143.91 34.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.677 -0.692 . . . . 0.59999999999999998 110.57 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.97 168.33 25.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.966 0.412 . . . . 3.1400000000000001 111.142 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.742 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.0 130.99 60.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.976 -0.557 . . . . 3.23 110.101 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.8 p -141.14 162.26 35.9 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.902 0.382 . . . . 3.6299999999999999 111.164 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 21.3 pt-20 36.12 31.61 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.695 -0.483 . . . . 6.0800000000000001 109.695 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.742 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.59 32.61 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.867 -0.606 . . . . 3.3799999999999999 111.578 -178.842 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.633 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.28 -29.1 72.79 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.465 2.11 . . . . 3.9300000000000002 111.884 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.633 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.61 125.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 3.3599999999999999 110.511 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.577 ' O ' ' O ' ' A' ' 92' ' ' THR . 1.5 mp0 -123.91 158.36 60.31 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.304 -0.407 . . . . 3.6099999999999999 110.378 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.6 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 96.3 Cg_endo -82.11 -64.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.874 2.382 . . . . 1.51 113.542 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.66 ' ND2' ' N ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -108.48 -19.66 13.37 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.081 0.4 . . . . 2.6800000000000002 112.081 -178.55 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.66 ' N ' ' ND2' ' A' ' 16' ' ' ASN . 95.8 p -107.2 152.02 24.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.164 0.507 . . . . 1.21 111.333 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.25 102.98 2.23 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.79 -0.641 . . . . 1.5600000000000001 110.669 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.6 145.58 13.11 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.932 2.422 . . . . 0.81000000000000005 112.59 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.928 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.82 167.91 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.911 -0.586 . . . . 1.52 109.899 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.14 147.85 28.96 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.855 -0.424 . . . . 2.1400000000000001 109.855 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.592 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.18 157.34 44.97 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.663 -0.415 . . . . 0.32000000000000001 111.223 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.497 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.2 m-20 -128.12 155.3 44.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.81 -0.632 . . . . 2.1699999999999999 110.024 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.837 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.58 173.02 6.38 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.065 -0.516 . . . . 0.58999999999999997 110.723 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.837 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.6 173.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.876 2.384 . . . . 0.90000000000000002 111.543 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.04 -50.99 0.69 Allowed Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.68 -0.408 . . . . 3.3399999999999999 110.166 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.635 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.84 152.38 82.38 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.797 2.331 . . . . 1.8500000000000001 111.438 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.8 42.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.415 0.626 . . . . 2.54 110.538 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.635 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.8 t60 -63.54 -41.62 98.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.01 -0.996 . . . . 2.5299999999999998 110.697 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.564 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.4 mt -109.86 137.82 40.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.815 -0.63 . . . . 1.1699999999999999 111.274 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.9 -72.96 0.7 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.057 -0.52 . . . . 1.27 111.913 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.09 148.33 24.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.638 0.606 . . . . 1.1200000000000001 112.638 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.84 124.88 45.2 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.318 -0.623 . . . . 0.41999999999999998 109.318 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.0 134.79 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.647 -0.421 . . . . 0.78000000000000003 110.649 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.928 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.03 128.66 53.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.297 -0.41 . . . . 0.62 111.191 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.17 138.97 49.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.807 -0.633 . . . . 1.97 110.023 179.003 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.436 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.03 163.11 35.23 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.119 0.485 . . . . 0.34999999999999998 112.074 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.43 139.51 7.87 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.413 -0.812 . . . . 1.8 110.42 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.52 115.45 3.04 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.336 2.024 . . . . 0.57999999999999996 111.77 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.679 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.94 81.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.868 -0.419 . . . . 3.04 109.868 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.21 -20.74 0.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.983 -0.553 . . . . 2.4700000000000002 111.919 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -157.55 157.81 34.44 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.806 -0.358 . . . . 2.5099999999999998 110.592 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.406 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.34 27.68 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 1.8600000000000001 110.22 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.79 -75.86 1.31 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.08 -0.581 . . . . 1.4399999999999999 111.884 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.82 152.28 35.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.845 0.355 . . . . 4.6900000000000004 111.045 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.18 -169.16 2.55 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.071 -0.513 . . . . 1.4299999999999999 111.955 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.436 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.73 29.65 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.431 0.634 . . . . 1.74 112.589 -177.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.13 156.53 45.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.87 -1.059 . . . . 1.9199999999999999 110.16 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.25 158.33 41.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.898 -0.592 . . . . 0.34000000000000002 111.826 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.0 m -115.23 135.71 53.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.386 -0.824 . . . . 0.40999999999999998 109.758 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.592 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.39 121.91 23.77 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.371 -0.377 . . . . 0.55000000000000004 111.546 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.7 Cg_exo -46.41 151.76 1.68 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.653 2.235 . . . . 0.44 112.08 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.91 -23.04 63.06 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 116.028 -0.533 . . . . 0.73999999999999999 112.854 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.69 -17.03 45.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.343 0.572 . . . . 0.93000000000000005 111.803 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.601 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.49 138.46 31.56 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.699 -0.4 . . . . 0.96999999999999997 110.32 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.59 14.02 10.96 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.398 -0.365 . . . . 1.3400000000000001 111.551 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.474 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.1 143.42 25.08 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.675 -0.41 . . . . 0.39000000000000001 111.048 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.716 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.74 -169.42 1.54 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.069 -0.514 . . . . 0.41999999999999998 110.938 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.716 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.5 t -151.72 125.91 9.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.438 -0.801 . . . . 0.39000000000000001 109.828 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.519 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.77 123.29 70.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.373 -0.531 . . . . 0.73999999999999999 111.207 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.646 ' NZ ' ' N ' ' A' ' 142' ' ' PHE . 88.9 tttt -126.52 163.34 23.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.898 -0.592 . . . . 2.48 110.417 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.52 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.17 18.96 59.84 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.793 -0.923 . . . . 0.5 110.793 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.519 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.8 mt -79.15 157.28 27.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.108 0.48 . . . . 0.57999999999999996 111.299 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.848 ' O ' HG12 ' A' ' 67' ' ' VAL . 4.5 mttp -99.47 133.92 21.57 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.531 -0.759 . . . . 2.79 110.536 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.535 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.87 143.56 61.38 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.584 2.189 . . . . 0.87 111.95 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.77 25.71 75.24 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.088 -0.805 . . . . 0.64000000000000001 111.088 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.848 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.25 158.73 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.717 0.294 . . . . 0.82999999999999996 110.371 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.11 139.93 41.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.946 0.403 . . . . 0.5 110.516 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.664 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.4 m-85 -122.63 136.42 54.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.905 -0.589 . . . . 0.53000000000000003 110.782 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.87 131.04 45.27 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.442 -0.947 . . . . 1.8700000000000001 108.442 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.49 153.97 16.64 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.313 -0.946 . . . . 0.28999999999999998 111.935 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -135.05 140.85 45.91 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.726 -0.472 . . . . 1.4299999999999999 109.726 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.72 118.95 34.47 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.411 -0.516 . . . . 0.32000000000000001 110.53 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.722 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.44 129.03 68.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.332 -0.395 . . . . 0.79000000000000004 110.582 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.701 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.85 120.78 43.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.294 -0.412 . . . . 1.02 110.764 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.852 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.45 146.47 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.173 0.511 . . . . 0.62 111.069 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.613 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.08 153.85 21.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.525 -0.761 . . . . 2.4399999999999999 109.947 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.425 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.15 88.62 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.938 0.399 . . . . 3.6899999999999999 110.408 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.613 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.61 0.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.85 -0.614 . . . . 6.0800000000000001 110.592 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.17 -117.35 3.28 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.424 -0.67 . . . . 1.22 111.424 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -81.43 177.36 9.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.194 0.521 . . . . 2.8799999999999999 111.637 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.08 149.61 32.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.398 -0.819 . . . . 1.47 110.353 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.553 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.21 144.71 38.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.449 -0.341 . . . . 2.7000000000000002 110.528 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.722 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.03 135.97 61.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.002 0.43 . . . . 0.46000000000000002 111.534 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.07 141.36 52.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.677 -0.692 . . . . 0.34999999999999998 110.211 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.62 138.86 51.67 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.083 0.468 . . . . 3.6699999999999999 111.577 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.27 164.09 38.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.623 -0.717 . . . . 0.67000000000000004 109.468 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.18 151.62 38.72 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.473 -0.491 . . . . 1.47 111.046 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.804 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.7 p90 -146.35 172.71 13.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.734 -0.666 . . . . 0.44 111.033 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.78 160.65 21.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.479 -0.782 . . . . 1.3700000000000001 109.828 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.34 121.82 22.92 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.627 -0.429 . . . . 1.28 110.83 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.577 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.0 p -128.18 162.99 25.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.082 -0.508 . . . . 1.97 111.667 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.6 m . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 3.2799999999999998 110.028 178.388 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 121.888 0.851 . . . . 0.66000000000000003 109.317 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.444 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.82 167.54 0.25 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.959 -1.018 . . . . 0.68999999999999995 110.944 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.66 145.48 49.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.757 -0.656 . . . . 0.52000000000000002 110.178 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.23 101.76 9.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.075 -0.713 . . . . 0.32000000000000001 109.075 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.0 t -112.96 139.68 36.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.982 -0.554 . . . . 0.28999999999999998 111.077 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.1 p -128.79 152.6 48.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.625 -0.716 . . . . 0.25 109.812 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.594 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.76 -164.97 2.04 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.731 -0.388 . . . . 0.31 110.666 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.5 t -123.87 127.12 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.48999999999999999 110.853 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.18 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -58.03 58.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 1.53 110.383 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.11 24.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.831 -0.622 . . . . 0.96999999999999997 111.482 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.18 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.18 128.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.59 -0.444 . . . . 1.5600000000000001 110.904 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.42 -9.59 55.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.926 -0.579 . . . . 1.8799999999999999 110.332 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.432 ' HB ' ' OE2' ' A' ' 187' ' ' GLU . 28.5 p -87.09 0.2 55.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.094 -0.503 . . . . 1.04 110.348 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.28 137.21 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.987 -0.551 . . . . 0.23999999999999999 109.905 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 185' ' ' ILE . 81.8 p -96.19 -15.59 21.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.301 0.572 . . . . 0.28999999999999998 110.04 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.627 ' HA3' ' HZ2' ' A' ' 61' ' ' LYS . . . 178.61 175.57 45.79 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 109.929 -1.269 . . . . 0.13 109.929 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.646 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . 76.2 m-85 -123.45 151.63 42.48 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.605 -0.438 . . . . 0.17000000000000001 110.521 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.6 ' CZ ' ' CG ' ' A' ' 15' ' ' PRO . 73.8 ttt-85 -132.38 121.18 23.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.14 -0.482 . . . . 1.29 109.938 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.556 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.09 136.49 38.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.646 -0.707 . . . . 0.25 110.705 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 81.4 tt0 -129.3 129.82 45.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.966 -0.561 . . . . 1.3200000000000001 110.132 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.627 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 36.1 p90 -138.65 135.3 34.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.06 -0.518 . . . . 0.56999999999999995 110.659 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.421 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.31 161.35 39.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.723 -0.672 . . . . 1.1599999999999999 109.699 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.961 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.01 124.84 25.31 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.666 -0.414 . . . . 0.38 110.814 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.82 -7.66 49.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.764 -0.653 . . . . 0.40999999999999998 110.76 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -109.78 -69.69 0.85 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.003 0.43 . . . . 1.6599999999999999 111.477 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.47 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.58 -35.4 75.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.995 -0.548 . . . . 1.6599999999999999 111.561 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.076 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.14 88.66 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.905 -0.878 . . . . 1.1699999999999999 110.905 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.332 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.92 -171.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.742 0.306 . . . . 1.8600000000000001 110.24 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.332 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.3 139.04 44.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 1.98 110.198 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 48.1 Cg_endo -70.83 145.79 51.88 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 122.755 2.304 . . . . 0.55000000000000004 112.299 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.627 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.83 145.83 42.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.263 -0.643 . . . . 1.1399999999999999 109.263 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.535 ' CE1' ' CD ' ' A' ' 65' ' ' PRO . 14.5 p90 -123.37 141.24 52.19 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.356 -0.538 . . . . 0.93000000000000005 111.54 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.5 mt -128.03 127.68 43.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.356 -0.838 . . . . 0.34000000000000002 108.95 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.479 ' OD2' ' HA2' ' A' ' 62' ' ' GLY . 95.2 m-20 -101.69 131.1 48.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.127 0.489 . . . . 1.0900000000000001 111.76 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.91 157.59 73.26 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.323 -0.853 . . . . 0.19 109.557 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -69.76 158.0 58.46 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.467 2.111 . . . . 0.17999999999999999 112.239 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.417 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.28 -12.14 5.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.754 -0.657 . . . . 0.20999999999999999 110.79 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.7 p -92.85 -8.75 42.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.28999999999999998 110.662 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.15 135.36 34.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.394 -0.366 . . . . 0.5 110.361 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.17 16.72 4.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.358 -0.383 . . . . 0.29999999999999999 110.502 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.0 p -167.55 147.04 5.05 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.694 -0.484 . . . . 0.23000000000000001 109.694 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.11 150.53 12.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.514 -0.474 . . . . 0.28000000000000003 111.509 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.512 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.34 124.89 50.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.541 -0.754 . . . . 1.0700000000000001 109.825 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.43 104.86 29.69 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.404 -0.362 . . . . 0.28999999999999998 111.117 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 84.3 Cg_endo -90.99 -179.42 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 123.046 2.497 . . . . 0.42999999999999999 112.163 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.61 32.68 18.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.393 -0.821 . . . . 1.26 111.501 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.449 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.4 mt -86.4 148.64 25.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 0.32000000000000001 110.467 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.776 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.42 114.85 61.39 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.976 0.417 . . . . 0.57999999999999996 110.585 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.0 140.62 96.16 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.866 2.377 . . . . 0.66000000000000003 111.962 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.27 74.19 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.042 -0.823 . . . . 0.28999999999999998 111.042 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.47 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.99 150.1 49.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.333 . . . . 2.3300000000000001 110.62 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.08 131.62 45.92 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.026 -0.533 . . . . 0.85999999999999999 109.745 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.961 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.5 148.47 43.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.16 -0.473 . . . . 0.52000000000000002 111.036 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.5 mt -105.42 125.32 60.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.271 -1.011 . . . . 0.29999999999999999 108.271 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.58 132.51 63.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.164 0.507 . . . . 0.23000000000000001 111.192 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.47 122.57 20.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.565 -0.743 . . . . 0.35999999999999999 109.628 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.594 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.02 125.42 54.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.286 -0.415 . . . . 0.19 110.713 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.26 137.81 52.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.07 -0.514 . . . . 0.29999999999999999 109.837 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.431 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.61 135.03 42.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.828 -0.805 . . . . 0.37 108.828 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.594 ' O ' ' N ' ' A' ' 140' ' ' SER . 50.0 mm -99.11 122.91 51.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.148 0.499 . . . . 0.26000000000000001 111.015 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.1 p -83.84 169.62 14.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.547 -0.752 . . . . 0.28000000000000003 110.49 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.612 ' O ' HG21 ' A' ' 59' ' ' THR . 0.0 OUTLIER -59.67 -14.59 14.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.06 -0.518 . . . . 1.6000000000000001 110.954 -179.572 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 87.2 m-20 -96.03 -4.35 43.24 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.784 -0.366 . . . . 1.1799999999999999 110.793 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.78 14.0 63.82 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.356 -0.697 . . . . 0.29999999999999999 111.356 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -84.66 139.07 32.3 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.093 -0.243 . . . . 1.22 110.439 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.41 ' HG2' ' CD1' ' A' ' 185' ' ' ILE . 1.9 mt-30 -106.78 141.05 38.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.868 0.366 . . . . 0.97999999999999998 110.537 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.4 m -136.67 127.05 26.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.82999999999999996 110.367 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 25.6 tp -68.18 117.25 9.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.319 -0.4 . . . . 0.26000000000000001 110.486 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.01 -21.69 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.29999999999999999 110.725 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.96 125.78 5.85 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.55 -0.46 . . . . 0.31 111.466 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.461 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.82 120.19 21.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.739 -0.664 . . . . 0.28000000000000003 109.591 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.62 151.66 29.08 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.608 -0.437 . . . . 0.23999999999999999 110.895 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.8 p -110.38 158.61 18.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.99 -0.55 . . . . 0.23000000000000001 110.451 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -146.13 157.95 43.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.068 -0.514 . . . . 0.67000000000000004 110.639 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.36 9.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.689 -0.687 . . . . 0.64000000000000001 109.99 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.5 p . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.966 -1.016 . . . . 1.26 110.556 -179.711 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.9 m . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.18 -0.674 . . . . 3.4399999999999999 109.18 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.36 150.72 18.54 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.956 -0.858 . . . . 1.22 110.956 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -35.52 142.39 0.1 OUTLIER 'Trans proline' 0 C--N 1.3 -2.024 0 C-N-CA 123.965 3.11 . . . . 0.75 113.845 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -79.96 173.47 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.25 -1.341 . . . . 0.79000000000000004 108.904 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.612 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.59 125.91 51.53 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.416 -0.513 . . . . 1.9399999999999999 111.423 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.62 144.01 33.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.688 -0.687 . . . . 0.59999999999999998 110.693 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.04 168.29 25.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.852 0.358 . . . . 3.1400000000000001 111.093 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.744 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.92 131.03 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.019 -0.537 . . . . 3.23 110.109 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.21 162.22 36.0 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.917 0.389 . . . . 3.6299999999999999 111.213 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 32.6 tp10 36.23 31.47 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.651 -0.5 . . . . 6.0800000000000001 109.651 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.744 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.65 32.74 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.914 -0.585 . . . . 3.3799999999999999 111.575 -178.737 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.632 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.29 -29.16 72.68 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.494 2.129 . . . . 3.9300000000000002 111.81 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.632 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.7 125.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 3.3599999999999999 110.377 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.646 ' O ' ' O ' ' A' ' 92' ' ' THR . 3.3 mp0 -123.97 158.41 60.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.321 -0.399 . . . . 3.6099999999999999 110.49 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.566 ' HB2' HH21 ' A' ' 143' ' ' ARG . 96.9 Cg_endo -82.11 -64.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.852 2.368 . . . . 1.51 113.47 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.577 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 63.5 t30 -108.35 -19.67 13.39 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.081 0.4 . . . . 2.6800000000000002 112.081 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 66.1 p -107.31 152.13 24.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.206 0.527 . . . . 1.21 111.246 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.573 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.33 102.96 2.22 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.702 -0.681 . . . . 1.5600000000000001 110.63 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.8 Cg_endo -82.75 145.58 12.88 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.912 2.408 . . . . 0.81000000000000005 112.611 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.906 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.73 167.96 24.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.938 -0.573 . . . . 1.52 109.879 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -149.14 147.99 29.11 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.609 -0.515 . . . . 2.1400000000000001 109.609 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.591 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.8 p90 -142.28 157.26 45.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.019 0.437 . . . . 0.32000000000000001 111.229 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.487 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.05 155.24 44.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.853 -0.612 . . . . 2.1699999999999999 110.098 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.835 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.57 172.99 6.41 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.137 0.494 . . . . 0.58999999999999997 110.801 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.835 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.61 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.913 2.409 . . . . 0.90000000000000002 111.534 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.477 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.14 -51.06 0.68 Allowed Pre-proline 0 C--N 1.328 -0.344 0 C-N-CA 120.709 -0.397 . . . . 3.3399999999999999 110.052 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.79 152.32 82.53 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.808 2.339 . . . . 1.8500000000000001 111.442 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.66 42.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.373 0.606 . . . . 2.54 110.571 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.624 ' N ' ' O ' ' A' ' 27' ' ' PRO . 74.0 t60 -63.73 -41.56 98.04 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.037 -0.983 . . . . 2.5299999999999998 110.653 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.56 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.2 mt -109.91 137.85 40.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.767 -0.651 . . . . 1.1699999999999999 111.211 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.91 -72.94 0.7 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.004 -0.544 . . . . 1.27 111.936 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.15 148.37 24.45 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.651 0.611 . . . . 1.1200000000000001 112.651 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.82 124.82 45.06 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.35 -0.611 . . . . 0.41999999999999998 109.35 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.9 mt -118.08 134.73 60.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.646 -0.422 . . . . 0.78000000000000003 110.566 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.906 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.99 128.63 53.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.434 . . . . 0.62 111.288 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.548 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.14 139.01 49.73 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.746 -0.661 . . . . 1.97 110.115 178.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.438 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.14 163.13 35.3 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.176 0.512 . . . . 0.34999999999999998 112.018 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.48 139.49 7.81 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 115.399 -0.818 . . . . 1.8 110.484 178.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.53 115.5 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.309 2.006 . . . . 0.57999999999999996 111.839 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.667 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.03 81.21 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.81 -0.441 . . . . 3.04 109.81 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.15 -20.75 0.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.027 -0.533 . . . . 2.4700000000000002 111.843 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.4 p -157.52 157.75 34.4 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.937 -0.305 . . . . 2.5099999999999998 110.65 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.43 27.9 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.27 -0.423 . . . . 1.8600000000000001 110.241 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.89 -75.83 1.31 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.066 -0.587 . . . . 1.4399999999999999 111.834 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.91 152.27 35.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.964 0.411 . . . . 4.6900000000000004 110.927 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.676 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.24 -169.14 2.53 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.068 -0.514 . . . . 1.4299999999999999 111.938 179.298 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.11 149.69 29.68 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.463 0.649 . . . . 1.74 112.569 -177.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -140.98 156.53 46.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.745 -1.116 . . . . 1.9199999999999999 110.257 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.3 158.47 41.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.967 -0.56 . . . . 0.34000000000000002 111.706 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.7 m -115.24 135.69 53.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.385 -0.825 . . . . 0.40999999999999998 109.799 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.591 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.43 122.05 23.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.403 -0.362 . . . . 0.55000000000000004 111.48 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.1 Cg_exo -46.45 151.75 1.71 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.675 2.25 . . . . 0.44 112.115 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.98 -22.87 63.03 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 116.092 -0.504 . . . . 0.73999999999999999 112.798 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.9 -16.9 45.66 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.259 -0.576 . . . . 0.93000000000000005 111.763 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.604 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.52 138.37 31.63 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.848 -0.341 . . . . 0.96999999999999997 110.366 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.56 13.92 10.97 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.409 -0.359 . . . . 1.3400000000000001 111.561 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.475 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -150.01 143.49 25.21 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.658 -0.417 . . . . 0.39000000000000001 111.061 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.72 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.82 -169.38 1.54 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.076 -0.511 . . . . 0.41999999999999998 110.961 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.72 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.3 m -151.69 125.92 9.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.483 -0.78 . . . . 0.39000000000000001 109.867 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.511 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.9 mt -114.94 123.29 70.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.404 -0.518 . . . . 0.73999999999999999 111.186 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -126.48 163.48 23.25 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.824 -0.625 . . . . 2.48 110.37 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.46 ' HA2' HD21 ' A' ' 16' ' ' ASN . . . 85.09 18.9 60.09 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.735 -0.946 . . . . 0.5 110.735 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.577 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.4 mt -78.9 157.22 28.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.065 0.459 . . . . 0.57999999999999996 111.438 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.851 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -99.52 133.94 21.52 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.684 -0.689 . . . . 2.79 110.396 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.472 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.95 143.62 61.18 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.519 2.146 . . . . 0.87 111.97 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.73 25.79 75.15 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.041 -0.823 . . . . 0.64000000000000001 111.041 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.851 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.16 158.85 39.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.705 0.288 . . . . 0.82999999999999996 110.456 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.23 139.95 42.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.946 0.403 . . . . 0.5 110.562 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.662 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.6 m-85 -122.59 136.42 54.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.949 -0.568 . . . . 0.53000000000000003 110.729 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.489 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.9 131.01 45.31 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.488 -0.93 . . . . 1.8700000000000001 108.488 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.46 153.85 16.64 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.261 -0.971 . . . . 0.28999999999999998 111.917 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -134.93 140.9 46.1 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.73 -0.47 . . . . 1.4299999999999999 109.73 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.9 tp -115.7 118.9 34.35 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.493 -0.483 . . . . 0.32000000000000001 110.553 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.726 HG12 HG23 ' A' ' 84' ' ' VAL . 64.2 mt -112.43 129.08 68.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.303 -0.408 . . . . 0.79000000000000004 110.669 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.708 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.78 120.84 43.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.289 -0.414 . . . . 1.02 110.715 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.849 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.52 146.43 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.241 0.543 . . . . 0.62 111.01 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.622 ' O ' ' N ' ' A' ' 79' ' ' TYR . 20.9 mt-30 -106.02 153.9 21.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.524 -0.762 . . . . 2.4399999999999999 109.956 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.26 88.65 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.932 0.396 . . . . 3.6899999999999999 110.42 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.622 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.21 32.73 0.21 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.793 -0.639 . . . . 6.0800000000000001 110.609 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.12 -117.38 3.29 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.437 -0.665 . . . . 1.22 111.437 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.5 177.37 8.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.158 0.504 . . . . 2.8799999999999999 111.661 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.1 149.51 32.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.481 -0.781 . . . . 1.47 110.359 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.16 144.72 38.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.417 -0.356 . . . . 2.7000000000000002 110.558 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.726 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.01 136.01 61.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 121.048 0.451 . . . . 0.46000000000000002 111.506 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.6 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.04 141.37 52.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.624 -0.716 . . . . 0.34999999999999998 110.279 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.68 138.93 51.66 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.441 -0.503 . . . . 3.6699999999999999 111.466 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.491 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 53.0 p90 -152.32 164.23 37.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.521 -0.763 . . . . 0.67000000000000004 109.467 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.575 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.24 151.52 38.51 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.503 -0.479 . . . . 1.47 111.084 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.807 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.1 p90 -146.22 172.7 13.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.782 -0.645 . . . . 0.44 111.068 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.8 160.61 21.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.496 -0.774 . . . . 1.3700000000000001 109.821 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.36 121.83 22.92 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 120.587 -0.445 . . . . 1.28 110.781 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.646 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -128.08 163.55 24.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.156 -0.475 . . . . 1.97 110.309 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.464 0.272 0 C-N-CA 120.312 -0.555 . . . . 3.2799999999999998 110.628 178.847 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.3 p . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.657 0.265 . . . . 0.66000000000000003 110.818 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.431 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.86 167.55 0.26 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 0.68999999999999995 110.959 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.54 145.6 50.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.692 -0.685 . . . . 0.52000000000000002 110.186 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.29 101.65 9.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.086 -0.709 . . . . 0.32000000000000001 109.086 177.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.1 t -113.0 139.78 36.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.985 -0.552 . . . . 0.28999999999999998 111.063 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.7 p -128.71 152.49 48.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.67 -0.696 . . . . 0.25 109.832 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.594 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.9 p90 -144.7 -164.89 2.02 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.722 -0.391 . . . . 0.31 110.691 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.734 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -124.06 127.24 73.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.198 -0.456 . . . . 0.48999999999999999 110.73 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.172 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.099 -0.501 . . . . 1.53 110.342 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -37.96 24.45 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.946 -0.57 . . . . 0.96999999999999997 111.566 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.172 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.13 128.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.724 -0.391 . . . . 1.5600000000000001 111.002 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -86.45 -9.51 56.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.942 -0.572 . . . . 1.8799999999999999 110.281 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.14 0.16 55.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 1.04 110.315 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.06 137.15 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 116.008 -0.542 . . . . 0.23999999999999999 109.985 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 185' ' ' ILE . 87.3 p -96.26 -15.48 21.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.242 0.544 . . . . 0.28999999999999998 110.066 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.64 175.61 45.86 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 109.881 -1.288 . . . . 0.13 109.881 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.51 151.6 42.63 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.673 -0.411 . . . . 0.17000000000000001 110.434 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.566 HH21 ' HB2' ' A' ' 15' ' ' PRO . 69.4 ttt-85 -132.36 121.16 23.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.122 -0.49 . . . . 1.29 109.926 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.556 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.04 136.6 38.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.681 -0.691 . . . . 0.25 110.69 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 83.7 tt0 -129.43 129.84 45.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.067 -0.515 . . . . 1.3200000000000001 110.01 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.623 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.7 135.32 34.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.965 -0.561 . . . . 0.56999999999999995 110.656 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.425 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.38 39.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.77 -0.65 . . . . 1.1599999999999999 109.641 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.957 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.13 124.85 25.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.039 0.447 . . . . 0.38 110.673 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.73 -7.72 49.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.684 -0.689 . . . . 0.40999999999999998 110.883 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.77 -69.74 0.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.315 -0.402 . . . . 1.6599999999999999 111.432 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.438 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.68 -35.21 75.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.027 -0.533 . . . . 1.6599999999999999 111.563 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.093 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.07 7.29 88.54 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.814 -0.914 . . . . 1.1699999999999999 110.814 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.322 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.93 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.773 0.321 . . . . 1.8600000000000001 110.256 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.322 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.33 139.05 44.89 Favored Pre-proline 0 N--CA 1.454 -0.261 0 CA-C-N 116.302 -0.408 . . . . 1.98 110.157 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.425 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.2 Cg_endo -70.85 145.89 52.06 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 C-N-CA 122.656 2.237 . . . . 0.55000000000000004 112.398 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.82 145.68 42.63 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.232 -0.655 . . . . 1.1399999999999999 109.232 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.57 ' CE2' ' CG ' ' A' ' 16' ' ' ASN . 37.3 p90 -123.24 141.37 52.05 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.345 -0.542 . . . . 0.93000000000000005 111.463 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.12 127.74 43.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.313 -0.858 . . . . 0.34000000000000002 108.966 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -101.68 131.17 48.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.097 0.475 . . . . 1.0900000000000001 111.779 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.89 157.56 73.33 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.373 -0.831 . . . . 0.19 109.61 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -69.84 158.0 58.32 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.382 2.054 . . . . 0.17999999999999999 112.27 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.24 -12.17 5.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.792 -0.64 . . . . 0.20999999999999999 110.714 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.3 p -92.79 -8.74 42.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.28999999999999998 110.714 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.41 34.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.363 -0.38 . . . . 0.5 110.434 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.4 p -133.14 16.58 4.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.348 -0.387 . . . . 0.29999999999999999 110.475 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.6 p -167.48 147.23 5.15 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.642 -0.503 . . . . 0.23000000000000001 109.642 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.18 150.35 13.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.617 -0.433 . . . . 0.28000000000000003 111.606 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.25 124.95 50.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.67 -0.695 . . . . 1.0700000000000001 109.803 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.42 104.9 29.84 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.426 -0.352 . . . . 0.28999999999999998 111.117 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.3 Cg_endo -90.91 -179.46 1.51 Allowed 'Trans proline' 0 C--N 1.3 -1.988 0 C-N-CA 123.231 2.621 . . . . 0.42999999999999999 112.282 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 61.56 32.65 18.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.475 -0.784 . . . . 1.26 111.499 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.6 mt -86.4 148.58 25.51 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.887 -0.325 . . . . 0.32000000000000001 110.433 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.766 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.27 114.87 61.36 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.051 0.453 . . . . 0.57999999999999996 110.69 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.95 140.52 95.66 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.951 2.434 . . . . 0.66000000000000003 111.955 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.27 74.16 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.023 -0.831 . . . . 0.28999999999999998 111.023 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.438 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.89 150.13 49.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 2.3300000000000001 110.643 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.501 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.11 131.58 45.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.85999999999999999 109.814 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.957 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.49 148.3 44.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.022 -0.536 . . . . 0.52000000000000002 111.043 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.1 mt -105.27 125.29 60.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.286 -1.005 . . . . 0.29999999999999999 108.286 177.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.46 132.47 63.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.193 0.52 . . . . 0.23000000000000001 111.315 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.6 20.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.501 -0.772 . . . . 0.35999999999999999 109.638 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.594 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -101.03 125.39 54.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.217 -0.447 . . . . 0.19 110.73 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.9 m-85 -117.25 137.9 52.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.954 -0.566 . . . . 0.29999999999999999 109.823 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.424 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.71 135.02 42.81 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.797 -0.816 . . . . 0.37 108.797 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 140' ' ' SER . 44.5 mm -99.08 123.0 51.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.136 0.493 . . . . 0.26000000000000001 110.937 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.0 p -83.94 169.73 14.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.568 -0.742 . . . . 0.28000000000000003 110.466 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -59.82 -14.44 14.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.057 -0.519 . . . . 1.6000000000000001 110.888 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.507 ' C ' ' OG1' ' A' ' 59' ' ' THR . 96.4 m-20 -96.19 -4.34 42.71 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.834 -0.347 . . . . 1.1799999999999999 110.708 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.62 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.85 13.93 63.83 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.3 -0.72 . . . . 0.29999999999999999 111.3 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -84.64 139.03 32.34 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.099 -0.24 . . . . 1.22 110.49 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -106.64 141.05 38.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.436 -0.347 . . . . 0.97999999999999998 110.542 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.5 m -136.7 127.07 26.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.82999999999999996 110.374 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.8 tp -68.11 117.3 9.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.329 -0.396 . . . . 0.26000000000000001 110.502 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.3 pt -109.09 -21.81 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.29999999999999999 110.625 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.91 125.72 5.85 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.523 -0.471 . . . . 0.31 111.48 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.468 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.76 120.22 21.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.799 -0.637 . . . . 0.28000000000000003 109.541 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.62 151.68 29.11 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.663 -0.415 . . . . 0.23999999999999999 110.938 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.42 158.61 18.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.062 -0.517 . . . . 0.23000000000000001 110.408 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -146.1 157.96 43.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.107 -0.497 . . . . 0.67000000000000004 110.667 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 104.29 9.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.714 -0.676 . . . . 0.64000000000000001 110.032 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.858 -1.068 . . . . 1.26 110.664 -179.761 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.55 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.3 m . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.141 -0.688 . . . . 3.4399999999999999 109.141 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.32 150.72 18.54 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.048 -0.821 . . . . 1.22 111.048 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -35.59 142.42 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.121 0 C-N-CA 124.009 3.139 . . . . 0.75 113.824 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.3 t -80.02 173.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.199 -1.364 . . . . 0.79000000000000004 108.775 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.601 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.62 125.92 51.55 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.385 -0.526 . . . . 1.9399999999999999 111.371 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.48 143.99 34.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.629 -0.714 . . . . 0.59999999999999998 110.689 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.4 25.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.833 0.349 . . . . 3.1400000000000001 111.145 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.749 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.07 131.0 61.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 3.23 109.989 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.16 162.44 35.48 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.882 0.372 . . . . 3.6299999999999999 111.169 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 9' ' ' THR . 71.0 tt0 36.02 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.088 -0.505 . . . . 6.0800000000000001 109.689 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.749 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.59 33.07 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.924 -0.58 . . . . 3.3799999999999999 111.62 -178.777 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.636 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.33 -29.04 72.25 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.438 2.092 . . . . 3.9300000000000002 111.868 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.636 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.57 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 3.3599999999999999 110.518 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.535 ' CB ' ' O ' ' A' ' 17' ' ' SER . 23.2 mt-30 -123.96 158.22 60.92 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.36 -0.382 . . . . 3.6099999999999999 110.468 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.492 ' HG2' ' CZ ' ' A' ' 143' ' ' ARG . 96.4 Cg_endo -81.94 -64.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.903 2.402 . . . . 1.51 113.568 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.64 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 56.6 t30 -108.49 -19.55 13.41 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.027 0.38 . . . . 2.6800000000000002 112.027 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.535 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 43.3 t -107.36 152.1 24.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.091 0.472 . . . . 1.21 111.29 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.3 102.87 2.22 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.675 -0.693 . . . . 1.5600000000000001 110.666 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.68 145.59 13.0 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.882 2.388 . . . . 0.81000000000000005 112.59 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.904 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.81 167.88 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 1.52 109.863 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.08 148.0 29.17 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.804 -0.443 . . . . 2.1400000000000001 109.804 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.581 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.8 p90 -142.31 157.29 44.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.065 0.46 . . . . 0.32000000000000001 111.168 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.497 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.02 155.24 44.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.751 -0.659 . . . . 2.1699999999999999 110.122 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.833 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.53 173.13 6.25 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 121.168 0.509 . . . . 0.58999999999999997 110.665 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.833 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.8 Cg_exo -50.65 173.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.816 2.344 . . . . 0.90000000000000002 111.551 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.483 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.09 -51.13 0.68 Allowed Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.775 -0.37 . . . . 3.3399999999999999 110.062 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.64 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.72 152.22 82.81 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.856 2.371 . . . . 1.8500000000000001 111.481 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.63 42.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.479 0.657 . . . . 2.54 110.624 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.64 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.8 t60 -63.68 -41.62 98.13 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.89 -1.05 . . . . 2.5299999999999998 110.569 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.555 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.8 mt -109.79 137.79 40.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.846 -0.616 . . . . 1.1699999999999999 111.262 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.87 -72.96 0.7 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.043 -0.526 . . . . 1.27 111.939 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.12 148.35 24.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.593 0.59 . . . . 1.1200000000000001 112.593 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.84 124.82 45.05 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.304 -0.628 . . . . 0.41999999999999998 109.304 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -117.99 134.69 60.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.683 -0.407 . . . . 0.78000000000000003 110.658 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.904 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.0 128.58 53.68 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.053 0.454 . . . . 0.62 111.277 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.1 139.05 49.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.778 -0.646 . . . . 1.97 110.133 178.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.439 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.1 163.16 35.17 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.145 0.498 . . . . 0.34999999999999998 112.067 -178.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.494 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.4 139.69 7.99 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.452 -0.795 . . . . 1.8 110.479 178.793 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.58 115.49 3.08 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.273 1.982 . . . . 0.57999999999999996 111.879 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.666 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.04 81.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.865 -0.42 . . . . 3.04 109.865 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.693 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.925 -0.58 . . . . 2.4700000000000002 111.939 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.8 p -157.56 157.81 34.43 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.877 -0.329 . . . . 2.5099999999999998 110.617 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.406 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.8 m -120.38 27.8 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 1.8600000000000001 110.16 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -75.83 1.31 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.143 -0.551 . . . . 1.4399999999999999 111.846 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.85 152.25 35.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.91 0.386 . . . . 4.6900000000000004 111.084 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.673 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.16 -169.01 2.5 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.103 -0.498 . . . . 1.4299999999999999 111.919 179.352 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.17 149.72 29.68 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.434 0.635 . . . . 1.74 112.582 -177.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.08 156.48 45.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.856 -1.065 . . . . 1.9199999999999999 110.316 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.469 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.21 158.39 41.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.027 -0.533 . . . . 0.34000000000000002 111.75 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.8 m -115.22 135.61 53.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.445 -0.798 . . . . 0.40999999999999998 109.751 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.581 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.41 121.98 23.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.394 -0.367 . . . . 0.55000000000000004 111.513 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.597 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.9 Cg_exo -46.33 151.66 1.66 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.656 2.237 . . . . 0.44 112.097 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.83 -23.11 62.98 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 116.0 -0.545 . . . . 0.73999999999999999 112.771 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.545 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.71 -16.87 46.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.371 0.586 . . . . 0.93000000000000005 111.882 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.597 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.55 138.29 31.69 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.804 -0.359 . . . . 0.96999999999999997 110.368 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.39 13.8 11.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.391 -0.368 . . . . 1.3400000000000001 111.578 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.83 143.52 25.39 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.662 -0.415 . . . . 0.39000000000000001 111.084 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.725 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.85 -169.39 1.54 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.222 0.534 . . . . 0.41999999999999998 110.883 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.725 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.7 t -151.74 125.88 9.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.418 -0.81 . . . . 0.39000000000000001 109.806 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.516 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.9 mt -114.89 123.29 70.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.369 -0.532 . . . . 0.73999999999999999 111.24 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.749 ' CD ' HD12 ' A' ' 185' ' ' ILE . 1.2 mtmt -126.49 163.44 23.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.773 -0.649 . . . . 2.48 110.405 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.439 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.07 19.0 59.94 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.776 -0.93 . . . . 0.5 110.776 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.64 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.6 mt -79.07 157.23 28.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.124 0.488 . . . . 0.57999999999999996 111.411 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.845 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -99.49 133.9 21.57 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.677 -0.692 . . . . 2.79 110.439 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.512 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.74 143.55 62.12 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.61 2.207 . . . . 0.87 111.948 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.86 25.63 75.34 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.98 -0.848 . . . . 0.64000000000000001 110.98 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.845 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.16 158.76 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.747 0.308 . . . . 0.82999999999999996 110.406 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.18 139.94 42.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.941 0.4 . . . . 0.5 110.566 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.646 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.55 136.5 54.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.944 -0.571 . . . . 0.53000000000000003 110.763 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.494 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.96 131.03 45.32 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.522 -0.918 . . . . 1.8700000000000001 108.522 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.44 153.9 16.63 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.354 -0.927 . . . . 0.28999999999999998 111.945 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -135.15 140.91 45.78 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.632 -0.507 . . . . 1.4299999999999999 109.632 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.525 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.69 118.93 34.45 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.422 -0.511 . . . . 0.32000000000000001 110.469 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.74 HG12 HG23 ' A' ' 84' ' ' VAL . 64.2 mt -112.45 129.11 68.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.322 -0.399 . . . . 0.79000000000000004 110.614 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.707 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.87 120.86 43.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.305 -0.407 . . . . 1.02 110.636 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.86 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.61 146.47 11.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.305 0.574 . . . . 0.62 110.969 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.624 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -105.96 153.84 21.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.459 -0.791 . . . . 2.4399999999999999 109.943 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.24 88.61 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.955 0.407 . . . . 3.6899999999999999 110.439 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.624 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.757 -0.656 . . . . 6.0800000000000001 110.57 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.11 -117.35 3.29 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.433 -0.667 . . . . 1.22 111.433 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.45 177.43 8.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.132 0.491 . . . . 2.8799999999999999 111.688 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.2 149.48 32.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.448 -0.797 . . . . 1.47 110.391 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.55 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.1 144.62 38.8 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.444 -0.344 . . . . 2.7000000000000002 110.588 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.74 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.99 135.93 61.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.075 0.464 . . . . 0.46000000000000002 111.589 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.571 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.01 141.4 52.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.661 . . . . 0.34999999999999998 110.237 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.459 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.69 138.82 51.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.214 0.531 . . . . 3.6699999999999999 111.501 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.21 164.27 37.71 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.532 -0.758 . . . . 0.67000000000000004 109.468 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.573 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 46.9 p30 -145.29 151.53 38.49 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.335 -0.546 . . . . 1.47 111.042 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.801 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.2 p90 -146.3 172.67 13.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.842 -0.617 . . . . 0.44 110.959 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.77 160.66 21.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.43 -0.805 . . . . 1.3700000000000001 109.856 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.38 121.94 23.05 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.585 -0.446 . . . . 1.28 110.742 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.2 p -130.6 162.37 29.49 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 112.963 0.727 . . . . 1.97 112.963 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.6 t . . . . . 0 C--N 1.316 -0.868 0 CA-C-N 114.39 -1.277 . . . . 3.2799999999999998 111.522 175.837 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.537 0.447 0 N-CA-C 113.086 0.773 . . . . 0.66000000000000003 113.086 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.436 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.91 167.53 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.997 0.427 . . . . 0.68999999999999995 110.94 179.169 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.51 145.51 50.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.677 -0.692 . . . . 0.52000000000000002 110.178 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.3 t -124.31 101.77 9.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.049 -0.723 . . . . 0.32000000000000001 109.049 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.0 t -112.99 139.62 37.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.985 -0.552 . . . . 0.28999999999999998 111.09 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.6 p -128.68 152.62 48.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.669 -0.696 . . . . 0.25 109.822 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.592 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.86 -165.0 2.05 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.737 -0.385 . . . . 0.31 110.653 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -123.95 127.21 73.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.189 -0.459 . . . . 0.48999999999999999 110.793 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.173 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.98 58.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.149 -0.478 . . . . 1.53 110.367 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.19 24.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.867 -0.606 . . . . 0.96999999999999997 111.451 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.173 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.22 128.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.998 0.428 . . . . 1.5600000000000001 110.933 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.53 -9.5 56.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.94 -0.573 . . . . 1.8799999999999999 110.319 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.22 0.33 55.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.052 -0.522 . . . . 1.04 110.288 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.38 137.3 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 115.988 -0.551 . . . . 0.23999999999999999 109.908 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 185' ' ' ILE . 1.9 m -96.24 -15.51 21.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.282 0.563 . . . . 0.28999999999999998 110.076 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.655 ' HA3' HD11 ' A' ' 185' ' ' ILE . . . 178.65 175.55 45.81 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 109.844 -1.303 . . . . 0.13 109.844 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.45 151.6 42.52 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.668 -0.413 . . . . 0.17000000000000001 110.449 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.558 ' NH2' ' HB3' ' A' ' 157' ' ' TYR . 74.4 ttt-85 -132.31 121.17 23.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.116 -0.493 . . . . 1.29 109.948 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.14 136.61 38.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.718 -0.674 . . . . 0.25 110.62 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 80.7 tt0 -129.33 129.87 45.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.902 -0.59 . . . . 1.3200000000000001 110.072 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.76 135.29 34.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.163 0.506 . . . . 0.56999999999999995 110.595 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.417 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.25 161.42 39.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.754 -0.657 . . . . 1.1599999999999999 109.695 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.14 124.89 25.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.039 0.447 . . . . 0.38 110.684 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.494 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.77 -7.7 49.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.745 -0.662 . . . . 0.40999999999999998 110.885 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -109.85 -69.64 0.85 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 1.6599999999999999 111.331 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.435 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.7 -35.33 76.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.079 -0.51 . . . . 1.6599999999999999 111.445 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.082 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.2 7.13 88.66 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.828 -0.909 . . . . 1.1699999999999999 110.828 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.339 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.96 -171.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 1.8600000000000001 110.272 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.339 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.22 139.07 45.28 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.941 0.401 . . . . 1.98 110.196 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.417 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.4 Cg_endo -70.89 145.79 51.55 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 122.789 2.326 . . . . 0.55000000000000004 112.295 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.8 145.77 42.54 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.264 -0.643 . . . . 1.1399999999999999 109.264 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.558 ' HB3' ' NH2' ' A' ' 143' ' ' ARG . 34.5 p90 -123.33 141.31 52.12 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.364 -0.534 . . . . 0.93000000000000005 111.449 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.8 mt -128.1 127.79 43.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.226 -0.897 . . . . 0.34000000000000002 108.915 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.499 ' HB2' ' ND2' ' A' ' 16' ' ' ASN . 67.8 t0 -101.69 131.21 48.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.16 0.505 . . . . 1.0900000000000001 111.732 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.476 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -128.03 157.62 73.41 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.334 -0.848 . . . . 0.19 109.541 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -69.83 158.08 58.08 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.385 2.057 . . . . 0.17999999999999999 112.248 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.31 -12.19 5.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.839 -0.618 . . . . 0.20999999999999999 110.673 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.9 p -92.83 -8.74 42.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.28999999999999998 110.661 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.23 135.45 34.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.405 -0.362 . . . . 0.5 110.346 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.0 p -133.13 16.6 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.396 . . . . 0.29999999999999999 110.524 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.8 p -167.54 147.05 5.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.707 -0.479 . . . . 0.23000000000000001 109.707 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.12 150.56 12.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.533 -0.467 . . . . 0.28000000000000003 111.568 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.508 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.43 124.98 50.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.567 -0.742 . . . . 1.0700000000000001 109.768 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.31 104.9 29.5 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.344 -0.389 . . . . 0.28999999999999998 111.034 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.9 Cg_endo -91.03 -179.56 1.49 Allowed 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 123.215 2.61 . . . . 0.42999999999999999 112.212 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.77 32.61 18.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.427 -0.806 . . . . 1.26 111.458 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.433 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.0 mt -86.42 148.5 25.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.442 -0.345 . . . . 0.32000000000000001 110.391 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.771 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.4 mt -88.24 114.92 61.56 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.987 0.422 . . . . 0.57999999999999996 110.69 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.12 140.55 95.55 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.879 2.386 . . . . 0.66000000000000003 111.978 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.21 74.33 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.102 -0.799 . . . . 0.28999999999999998 111.102 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.435 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.81 150.26 49.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.781 0.324 . . . . 2.3300000000000001 110.661 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.494 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.31 131.61 46.15 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.105 -0.498 . . . . 0.85999999999999999 109.769 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.955 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.47 148.4 43.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.012 -0.54 . . . . 0.52000000000000002 110.962 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.36 125.37 60.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.262 -1.014 . . . . 0.29999999999999999 108.262 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.56 132.5 63.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.158 0.504 . . . . 0.23000000000000001 111.249 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.9 m-20 -136.48 122.63 20.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.48 -0.782 . . . . 0.35999999999999999 109.693 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.592 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.07 125.39 55.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.241 -0.436 . . . . 0.19 110.63 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 47.9 m-85 -117.2 137.88 52.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.974 -0.557 . . . . 0.29999999999999999 109.912 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.426 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.7 135.09 42.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.734 -0.839 . . . . 0.37 108.734 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.749 HD12 ' CD ' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -99.24 123.01 51.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.216 0.531 . . . . 0.26000000000000001 110.866 -178.722 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.4 p -83.84 169.81 14.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.512 -0.767 . . . . 0.28000000000000003 110.399 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.507 ' OE1' ' OG ' ' A' ' 140' ' ' SER . 48.0 tp10 -59.89 -14.52 15.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.948 -0.569 . . . . 1.6000000000000001 110.962 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -96.09 -4.25 43.2 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.818 -0.353 . . . . 1.1799999999999999 110.825 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.89 13.82 63.93 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.297 -0.721 . . . . 0.29999999999999999 111.297 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -84.53 139.04 32.41 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.116 -0.233 . . . . 1.22 110.519 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -106.77 141.06 38.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.852 0.358 . . . . 0.97999999999999998 110.596 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.0 m -136.69 126.97 26.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.82999999999999996 110.345 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.0 117.22 9.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.254 -0.43 . . . . 0.26000000000000001 110.502 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.09 -21.69 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.241 -0.436 . . . . 0.29999999999999999 110.728 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.92 125.71 5.84 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.527 -0.469 . . . . 0.31 111.5 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.469 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.76 120.31 21.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.764 -0.653 . . . . 0.28000000000000003 109.539 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.72 151.6 28.93 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.587 -0.445 . . . . 0.23999999999999999 110.89 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.41 158.58 18.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.052 -0.522 . . . . 0.23000000000000001 110.461 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -145.99 158.06 43.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.67000000000000004 110.651 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.37 104.38 9.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.775 -0.648 . . . . 0.64000000000000001 110.012 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.2 p . . . . . 0 C--O 1.222 -0.39 0 CA-C-O 117.887 -1.054 . . . . 1.26 110.659 -179.751 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.553 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.148 -0.686 . . . . 3.4399999999999999 109.148 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.41 150.63 18.55 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.992 -0.843 . . . . 1.22 110.992 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -35.51 142.32 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.085 0 C-N-CA 124.083 3.189 . . . . 0.75 113.799 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.3 t -79.98 173.38 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.281 -1.327 . . . . 0.79000000000000004 108.779 178.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.601 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.57 125.88 51.5 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.378 -0.529 . . . . 1.9399999999999999 111.439 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.5 144.02 33.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.653 -0.703 . . . . 0.59999999999999998 110.633 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -151.98 168.39 25.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.908 0.385 . . . . 3.1400000000000001 111.162 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.744 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.12 131.06 60.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.053 -0.521 . . . . 3.23 110.055 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.1 p -141.16 162.22 36.02 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.88 0.371 . . . . 3.6299999999999999 111.26 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 98.1 mt-10 36.17 31.59 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.587 -0.523 . . . . 6.0800000000000001 109.587 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.744 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.4 69.53 32.08 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.97 -0.559 . . . . 3.3799999999999999 111.547 -178.777 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.27 -29.08 72.81 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.494 2.129 . . . . 3.9300000000000002 111.858 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.61 125.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.118 -0.492 . . . . 3.3599999999999999 110.48 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.745 ' NE2' ' OE1' ' A' ' 191' ' ' GLN . 10.4 mm-40 -123.98 158.4 60.37 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.313 -0.403 . . . . 3.6099999999999999 110.453 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.549 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 99.0 Cg_endo -82.12 -64.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.942 2.428 . . . . 1.51 113.437 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.492 ' ND2' ' C ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -108.49 -19.57 13.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.019 0.377 . . . . 2.6800000000000002 112.019 -178.439 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.599 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 7.7 p -107.26 152.09 24.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.21 0.529 . . . . 1.21 111.252 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.37 102.94 2.21 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.67 -0.696 . . . . 1.5600000000000001 110.647 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.63 145.61 13.09 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.884 2.389 . . . . 0.81000000000000005 112.598 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.924 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.84 167.91 24.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.897 -0.592 . . . . 1.52 109.939 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.14 148.0 29.13 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.751 -0.463 . . . . 2.1400000000000001 109.751 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.586 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.7 p90 -142.19 157.25 45.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.017 0.437 . . . . 0.32000000000000001 111.242 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.497 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.06 155.32 44.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.856 -0.611 . . . . 2.1699999999999999 110.137 178.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.838 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.61 173.03 6.36 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 121.105 0.479 . . . . 0.58999999999999997 110.741 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.838 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.69 173.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.932 2.422 . . . . 0.90000000000000002 111.498 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -51.05 0.69 Allowed Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 120.714 -0.395 . . . . 3.3399999999999999 110.155 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.638 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.84 152.39 82.33 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.756 2.304 . . . . 1.8500000000000001 111.452 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.73 42.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.309 0.576 . . . . 2.54 110.496 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.638 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.7 t60 -63.66 -41.67 98.18 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.974 -1.012 . . . . 2.5299999999999998 110.645 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.562 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.4 mt -109.82 137.9 39.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.795 -0.639 . . . . 1.1699999999999999 111.242 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.06 -72.87 0.71 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.009 -0.541 . . . . 1.27 111.863 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.12 148.52 24.4 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.58 0.585 . . . . 1.1200000000000001 112.58 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.96 124.9 45.12 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.301 -0.629 . . . . 0.41999999999999998 109.301 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.07 134.7 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.645 -0.422 . . . . 0.78000000000000003 110.594 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.924 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.02 128.67 53.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.04 0.448 . . . . 0.62 111.237 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.542 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.11 138.94 49.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.735 -0.666 . . . . 1.97 110.088 179.031 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.436 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.04 163.16 35.09 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.181 0.515 . . . . 0.34999999999999998 112.061 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.491 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.42 139.6 7.92 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.45 -0.795 . . . . 1.8 110.462 178.837 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.54 115.45 3.04 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.307 2.004 . . . . 0.57999999999999996 111.837 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.676 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.97 81.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.834 -0.432 . . . . 3.04 109.834 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.693 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.979 -0.555 . . . . 2.4700000000000002 111.886 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 p -157.59 157.84 34.44 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.79 -0.364 . . . . 2.5099999999999998 110.569 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.44 27.87 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.256 -0.429 . . . . 1.8600000000000001 110.189 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.91 -75.89 1.31 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.115 -0.564 . . . . 1.4399999999999999 111.766 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.94 152.33 35.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.011 0.434 . . . . 4.6900000000000004 110.91 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.2 -169.19 2.56 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.98 -0.555 . . . . 1.4299999999999999 111.946 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.436 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.6 mttp -110.08 149.56 29.84 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.471 0.653 . . . . 1.74 112.633 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.01 156.51 46.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.836 -1.074 . . . . 1.9199999999999999 110.242 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.22 158.42 41.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.931 -0.577 . . . . 0.34000000000000002 111.718 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.1 m -115.26 135.62 53.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.4 -0.818 . . . . 0.40999999999999998 109.814 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.586 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.43 121.9 23.73 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.407 -0.36 . . . . 0.55000000000000004 111.591 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.599 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.3 Cg_exo -46.23 151.69 1.57 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.626 2.217 . . . . 0.44 112.135 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.79 -23.15 62.93 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 116.071 -0.513 . . . . 0.73999999999999999 112.826 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.81 -16.83 46.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.371 0.586 . . . . 0.93000000000000005 111.831 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.599 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.57 138.43 31.58 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.767 -0.373 . . . . 0.96999999999999997 110.307 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -121.54 13.92 10.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.418 -0.356 . . . . 1.3400000000000001 111.548 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.477 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.0 p -150.02 143.36 25.12 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.721 -0.392 . . . . 0.39000000000000001 111.06 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.721 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.77 -169.35 1.53 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.065 -0.516 . . . . 0.41999999999999998 110.918 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.721 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 t -151.75 125.83 9.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.431 -0.804 . . . . 0.39000000000000001 109.87 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.518 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.84 123.26 70.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.42 -0.512 . . . . 0.73999999999999999 111.18 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -126.57 163.34 23.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.732 -0.667 . . . . 2.48 110.412 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.18 18.95 59.84 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.742 -0.943 . . . . 0.5 110.742 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.518 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.1 mt -79.1 157.23 28.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.052 0.453 . . . . 0.57999999999999996 111.357 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.847 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -99.48 133.96 21.53 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.584 -0.735 . . . . 2.79 110.433 179.832 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.92 143.59 61.23 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.614 2.209 . . . . 0.87 111.89 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.78 25.69 75.26 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.068 -0.813 . . . . 0.64000000000000001 111.068 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.847 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.23 158.78 40.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.679 0.276 . . . . 0.82999999999999996 110.423 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.27 139.95 42.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.034 0.445 . . . . 0.5 110.57 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.658 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.7 m-85 -122.54 136.4 54.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.967 -0.56 . . . . 0.53000000000000003 110.745 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.491 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.91 131.05 45.29 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.474 -0.936 . . . . 1.8700000000000001 108.474 177.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.494 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.52 153.84 16.66 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.283 -0.96 . . . . 0.28999999999999998 112.011 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -134.93 140.88 46.09 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.671 -0.492 . . . . 1.4299999999999999 109.671 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.3 tp -115.77 118.9 34.33 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.458 -0.497 . . . . 0.32000000000000001 110.476 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.726 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.45 129.12 68.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.26 -0.427 . . . . 0.79000000000000004 110.619 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.702 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.9 120.77 43.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.273 -0.421 . . . . 1.02 110.713 -179.638 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.854 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.52 146.46 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.107 0.48 . . . . 0.62 111.044 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.616 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.02 153.9 21.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.54 -0.755 . . . . 2.4399999999999999 109.929 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.15 88.67 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.912 0.387 . . . . 3.6899999999999999 110.401 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.616 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.16 32.64 0.2 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.835 -0.621 . . . . 6.0800000000000001 110.659 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.02 -117.36 3.3 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.495 -0.642 . . . . 1.22 111.495 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.45 177.49 8.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.17 0.509 . . . . 2.8799999999999999 111.642 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.2 149.47 31.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.427 -0.806 . . . . 1.47 110.377 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.553 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.09 144.63 38.81 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.506 -0.315 . . . . 2.7000000000000002 110.616 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.726 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.93 136.0 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.026 0.441 . . . . 0.46000000000000002 111.601 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.06 141.31 52.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.676 -0.693 . . . . 0.34999999999999998 110.3 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.466 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.65 138.74 51.77 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.095 0.474 . . . . 3.6699999999999999 111.54 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.494 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.17 164.14 37.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.562 -0.744 . . . . 0.67000000000000004 109.498 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.571 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.18 151.57 38.64 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.428 -0.509 . . . . 1.47 111.062 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.8 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.18 172.76 12.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.748 -0.66 . . . . 0.44 111.028 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.83 160.63 21.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.432 -0.804 . . . . 1.3700000000000001 109.804 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.31 121.9 23.07 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.593 -0.443 . . . . 1.28 110.798 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.632 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.7 p -127.37 168.16 15.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.256 0.55 . . . . 1.97 112.351 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.0 p . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.514 -0.766 . . . . 3.2799999999999998 110.931 179.745 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.48 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 3.6 p . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 108.939 -0.763 . . . . 0.66000000000000003 108.939 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.437 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.77 167.5 0.25 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.288 -0.869 . . . . 0.68999999999999995 111.004 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.57 145.6 50.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.785 -0.643 . . . . 0.52000000000000002 110.118 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.3 101.55 9.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.126 -0.694 . . . . 0.32000000000000001 109.126 177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.8 t -112.93 139.8 36.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.006 -0.543 . . . . 0.28999999999999998 110.988 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.1 p -128.74 152.63 48.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.575 -0.739 . . . . 0.25 109.778 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.592 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.89 -164.96 2.04 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.717 -0.393 . . . . 0.31 110.622 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.734 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -123.92 127.22 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 0.48999999999999999 110.815 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.179 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -58.05 58.34 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.168 -0.469 . . . . 1.53 110.326 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.09 24.42 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.905 -0.589 . . . . 0.96999999999999997 111.447 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.179 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.28 128.7 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.638 -0.425 . . . . 1.5600000000000001 110.913 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -86.37 -9.58 56.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.971 -0.559 . . . . 1.8799999999999999 110.381 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.7 p -87.13 0.28 55.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 1.04 110.279 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.33 137.27 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.988 -0.551 . . . . 0.23999999999999999 109.888 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 185' ' ' ILE . 88.8 p -96.25 -15.53 21.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.25 0.548 . . . . 0.28999999999999998 109.999 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.6 175.56 45.78 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 109.832 -1.307 . . . . 0.13 109.832 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.43 151.54 42.56 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.719 -0.392 . . . . 0.17000000000000001 110.538 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.872 ' NE ' HE22 ' A' ' 191' ' ' GLN . 8.5 tmm_? -132.22 121.19 23.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.153 -0.476 . . . . 1.29 109.899 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.13 136.61 38.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.739 -0.664 . . . . 0.25 110.653 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 77.6 tt0 -129.36 129.86 45.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 1.3200000000000001 110.03 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.627 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.8 135.23 34.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.066 -0.516 . . . . 0.56999999999999995 110.638 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.42 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.27 161.38 39.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.723 -0.672 . . . . 1.1599999999999999 109.665 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.4 mt -71.02 124.88 25.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.991 0.424 . . . . 0.38 110.755 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.489 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.1 p -71.74 -7.67 49.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.725 -0.671 . . . . 0.40999999999999998 110.866 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -109.83 -69.57 0.86 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 1.6599999999999999 111.481 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.459 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.69 -35.41 76.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.11 -0.496 . . . . 1.6599999999999999 111.451 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.077 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.2 7.18 88.63 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.76 -0.936 . . . . 1.1699999999999999 110.76 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.331 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.86 -171.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.779 0.323 . . . . 1.8600000000000001 110.324 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.331 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.16 139.11 45.48 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.96 0.409 . . . . 1.98 110.216 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.42 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.5 Cg_endo -70.98 145.84 51.14 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 C-N-CA 122.746 2.297 . . . . 0.55000000000000004 112.288 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.627 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.83 145.77 42.56 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.224 -0.658 . . . . 1.1399999999999999 109.224 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 15' ' ' PRO . 7.8 m-85 -123.28 141.37 52.05 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.344 -0.543 . . . . 0.93000000000000005 111.526 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.16 127.69 43.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.286 -0.87 . . . . 0.34000000000000002 108.932 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.533 ' O ' ' OD1' ' A' ' 159' ' ' ASP . 55.4 p-10 -101.62 131.19 47.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.125 0.488 . . . . 1.0900000000000001 111.818 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -128.04 157.58 73.53 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.393 -0.821 . . . . 0.19 109.514 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -69.88 158.09 57.96 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.335 2.023 . . . . 0.17999999999999999 112.24 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.36 -12.08 5.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.842 -0.617 . . . . 0.20999999999999999 110.734 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.3 p -92.79 -8.8 42.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.101 -0.5 . . . . 0.28999999999999998 110.762 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.36 34.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.304 -0.407 . . . . 0.5 110.434 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.9 p -133.11 16.58 4.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.447 -0.342 . . . . 0.29999999999999999 110.515 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.8 p -167.47 147.21 5.16 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.607 -0.516 . . . . 0.23000000000000001 109.607 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.24 150.51 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.551 -0.459 . . . . 0.28000000000000003 111.57 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.509 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.36 124.89 50.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.604 -0.725 . . . . 1.0700000000000001 109.786 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.34 104.84 29.26 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.358 -0.383 . . . . 0.28999999999999998 111.028 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.9 Cg_endo -91.04 -179.43 1.47 Allowed 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 123.103 2.535 . . . . 0.42999999999999999 112.237 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.72 32.62 18.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.381 -0.827 . . . . 1.26 111.381 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.48 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.1 mt -86.34 148.51 25.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.788 0.328 . . . . 0.32000000000000001 110.476 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.777 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.26 114.83 61.18 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.969 0.414 . . . . 0.57999999999999996 110.725 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.05 140.57 95.82 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.882 2.388 . . . . 0.66000000000000003 111.977 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.17 21.12 74.25 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.078 -0.809 . . . . 0.28999999999999998 111.078 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.459 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.83 150.2 49.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.833 0.349 . . . . 2.3300000000000001 110.623 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.489 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.12 131.65 45.95 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.983 -0.553 . . . . 0.85999999999999999 109.818 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.955 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.5 148.34 43.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.138 -0.483 . . . . 0.52000000000000002 111.01 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.38 125.38 60.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.258 -1.015 . . . . 0.29999999999999999 108.258 177.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.5 132.55 63.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.092 0.473 . . . . 0.23000000000000001 111.283 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.55 122.55 20.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.624 -0.717 . . . . 0.35999999999999999 109.659 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.592 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -100.95 125.33 54.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.219 -0.446 . . . . 0.19 110.709 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.4 m-85 -117.21 137.98 52.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.997 -0.547 . . . . 0.29999999999999999 109.887 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.431 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.76 135.0 42.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.779 -0.823 . . . . 0.37 108.779 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.603 ' O ' ' N ' ' A' ' 140' ' ' SER . 74.6 mt -99.17 122.98 51.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.161 0.505 . . . . 0.26000000000000001 110.893 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.7 p -83.94 169.7 14.76 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.539 -0.755 . . . . 0.28000000000000003 110.383 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -59.74 -14.53 14.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.05 -0.523 . . . . 1.6000000000000001 110.964 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -96.07 -4.4 43.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.795 0.331 . . . . 1.1799999999999999 110.829 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.435 ' N ' ' HB ' ' A' ' 59' ' ' THR . . . 87.85 13.84 63.97 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.364 -0.694 . . . . 0.29999999999999999 111.364 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -84.58 139.09 32.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.059 -0.256 . . . . 1.22 110.482 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.872 HE22 ' NE ' ' A' ' 143' ' ' ARG . 88.5 mt-30 -106.81 141.08 38.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.91 0.386 . . . . 0.97999999999999998 110.526 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.4 m -136.71 126.94 26.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.82999999999999996 110.349 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.11 117.26 9.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.317 -0.401 . . . . 0.26000000000000001 110.564 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.01 -21.81 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.29999999999999999 110.77 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.85 125.71 5.89 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.547 -0.461 . . . . 0.31 111.501 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.74 120.27 21.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.821 -0.627 . . . . 0.28000000000000003 109.542 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.69 151.65 28.99 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.752 -0.379 . . . . 0.23999999999999999 110.922 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.43 158.49 18.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.967 -0.56 . . . . 0.23000000000000001 110.447 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -146.01 157.95 43.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.127 -0.488 . . . . 0.67000000000000004 110.669 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.26 104.37 9.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.774 -0.648 . . . . 0.64000000000000001 109.964 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.948 -1.025 . . . . 1.26 110.638 -179.774 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.1 m . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.285 -0.635 . . . . 3.4399999999999999 109.285 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.45 150.76 18.52 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.012 -0.835 . . . . 1.22 111.012 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -35.7 142.39 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.067 0 C-N-CA 123.999 3.133 . . . . 0.75 113.759 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.607 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.9 173.36 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.222 -1.354 . . . . 0.79000000000000004 108.822 178.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.607 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.62 125.88 51.5 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.435 -0.506 . . . . 1.9399999999999999 111.438 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 143.93 34.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.655 -0.702 . . . . 0.59999999999999998 110.73 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.28 25.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 3.1400000000000001 111.129 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.748 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.99 131.07 60.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.008 -0.542 . . . . 3.23 110.082 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.8 p -141.19 162.3 35.82 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.759 0.314 . . . . 3.6299999999999999 111.249 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 70.6 tt0 36.02 31.6 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.69 -0.485 . . . . 6.0800000000000001 109.69 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.748 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.56 32.42 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.896 -0.593 . . . . 3.3799999999999999 111.568 -178.744 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.3 -29.08 72.53 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.449 2.1 . . . . 3.9300000000000002 111.818 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.64 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 3.3599999999999999 110.513 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.604 ' HG3' ' NE2' ' A' ' 191' ' ' GLN . 7.0 mp0 -124.01 158.35 60.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.392 -0.367 . . . . 3.6099999999999999 110.426 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.699 ' HD2' HH12 ' A' ' 143' ' ' ARG . 96.5 Cg_endo -82.0 -64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.835 2.356 . . . . 1.51 113.57 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.913 ' ND2' ' H ' ' A' ' 62' ' ' GLY . 9.9 t30 -108.46 -19.55 13.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.265 -0.425 . . . . 2.6800000000000002 112.074 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 18.0 p -107.31 152.09 24.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.163 0.506 . . . . 1.21 111.387 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.578 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.19 102.9 2.24 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.726 -0.67 . . . . 1.5600000000000001 110.691 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.406 ' HB3' ' HA3' ' A' ' 189' ' ' GLY . 73.6 Cg_endo -82.63 145.63 13.1 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.915 2.41 . . . . 0.81000000000000005 112.607 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.911 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.87 167.92 24.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.906 -0.588 . . . . 1.52 109.904 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.1 148.02 29.18 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.783 -0.451 . . . . 2.1400000000000001 109.783 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.588 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.4 p90 -142.29 157.27 45.01 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.621 -0.432 . . . . 0.32000000000000001 111.137 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.494 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.02 155.31 44.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.732 -0.667 . . . . 2.1699999999999999 110.051 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.827 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.63 173.12 6.26 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.214 0.531 . . . . 0.58999999999999997 110.68 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.827 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.69 173.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.819 2.346 . . . . 0.90000000000000002 111.497 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -50.97 0.69 Allowed Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.666 -0.414 . . . . 3.3399999999999999 110.191 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.634 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.82 152.3 82.63 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.821 2.347 . . . . 1.8500000000000001 111.466 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.64 42.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.331 0.586 . . . . 2.54 110.543 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.7 t60 -63.54 -41.66 98.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.047 -0.978 . . . . 2.5299999999999998 110.683 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.551 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.8 mt -109.8 137.87 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.813 -0.63 . . . . 1.1699999999999999 111.296 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.02 -72.88 0.7 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.095 -0.502 . . . . 1.27 111.84 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.19 148.35 24.43 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.558 0.577 . . . . 1.1200000000000001 112.558 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.77 124.86 45.19 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.348 -0.612 . . . . 0.41999999999999998 109.348 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.3 mt -117.99 134.73 60.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.724 -0.391 . . . . 0.78000000000000003 110.61 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.911 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -119.99 128.62 53.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.067 0.46 . . . . 0.62 111.252 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.14 138.96 49.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.799 -0.637 . . . . 1.97 110.073 179.05 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.435 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.11 163.24 34.92 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.14 0.495 . . . . 0.34999999999999998 112.059 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.5 139.55 7.83 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.423 -0.808 . . . . 1.8 110.428 178.951 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.62 115.47 3.07 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.347 2.032 . . . . 0.57999999999999996 111.823 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.668 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.97 81.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.887 -0.412 . . . . 3.04 109.887 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.25 -20.59 0.06 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.05 -0.523 . . . . 2.4700000000000002 111.969 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 p -157.61 157.81 34.35 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.822 -0.351 . . . . 2.5099999999999998 110.535 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.406 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.48 27.88 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 1.8600000000000001 110.123 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.82 -75.94 1.31 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.17 -0.538 . . . . 1.4399999999999999 111.839 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.87 152.36 35.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.946 0.403 . . . . 4.6900000000000004 111.058 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.09 2.52 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.101 -0.499 . . . . 1.4299999999999999 111.998 179.43 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.18 149.64 29.8 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.464 0.649 . . . . 1.74 112.565 -177.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.03 156.47 46.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.893 -1.048 . . . . 1.9199999999999999 110.302 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.18 158.44 41.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.931 -0.577 . . . . 0.34000000000000002 111.796 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.27 135.53 54.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.438 -0.801 . . . . 0.40999999999999998 109.848 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.588 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.31 121.98 23.89 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.506 -0.315 . . . . 0.55000000000000004 111.529 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.6 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.6 Cg_exo -46.39 151.76 1.67 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.716 2.277 . . . . 0.44 112.098 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.94 -23.01 63.11 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 116.076 -0.511 . . . . 0.73999999999999999 112.792 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.547 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.78 -16.94 45.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.425 0.613 . . . . 0.93000000000000005 111.821 -178.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.6 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.49 138.44 31.57 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.737 -0.385 . . . . 0.96999999999999997 110.352 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -121.48 13.93 11.03 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.442 -0.345 . . . . 1.3400000000000001 111.638 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.473 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.02 143.49 25.2 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.607 -0.437 . . . . 0.39000000000000001 111.022 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.72 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.79 -169.38 1.53 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.212 0.529 . . . . 0.41999999999999998 110.886 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.72 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.74 125.86 9.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.437 -0.801 . . . . 0.39000000000000001 109.893 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.4 mt -114.84 123.34 70.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.366 -0.533 . . . . 0.73999999999999999 111.234 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.838 ' NZ ' ' N ' ' A' ' 141' ' ' GLY . 15.9 mtpt -126.59 163.42 23.46 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.753 -0.658 . . . . 2.48 110.394 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.913 ' H ' ' ND2' ' A' ' 16' ' ' ASN . . . 85.11 19.07 59.76 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.682 -0.967 . . . . 0.5 110.682 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.514 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.0 mt -79.11 157.19 28.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.996 0.427 . . . . 0.57999999999999996 111.36 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.854 ' O ' HG12 ' A' ' 67' ' ' VAL . 4.3 mttp -99.48 133.87 21.6 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.71 -0.677 . . . . 2.79 110.464 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.89 143.63 61.6 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.497 2.131 . . . . 0.87 111.906 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.79 25.67 75.28 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.073 -0.811 . . . . 0.64000000000000001 111.073 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.854 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.3 p -128.14 158.73 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.683 0.278 . . . . 0.82999999999999996 110.461 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.03 140.03 41.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.909 0.385 . . . . 0.5 110.648 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.658 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.68 136.52 54.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.948 -0.569 . . . . 0.53000000000000003 110.71 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.96 131.1 45.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.436 -0.95 . . . . 1.8700000000000001 108.436 177.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.48 153.87 16.65 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.355 -0.926 . . . . 0.28999999999999998 111.918 -178.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -135.03 141.01 46.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.624 -0.51 . . . . 1.4299999999999999 109.624 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.525 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.9 tp -115.71 119.02 34.69 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.422 -0.511 . . . . 0.32000000000000001 110.545 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.74 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.53 129.1 68.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.359 -0.382 . . . . 0.79000000000000004 110.601 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.707 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.88 120.76 43.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.332 -0.395 . . . . 1.02 110.724 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.866 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.5 146.38 11.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.192 0.52 . . . . 0.62 111.032 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.619 ' O ' ' N ' ' A' ' 79' ' ' TYR . 20.9 mt-30 -105.98 153.81 21.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.512 -0.767 . . . . 2.4399999999999999 109.986 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.07 88.49 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.9 0.381 . . . . 3.6899999999999999 110.525 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.3 32.61 0.21 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.864 -0.607 . . . . 6.0800000000000001 110.661 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.05 -117.37 3.29 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.437 -0.665 . . . . 1.22 111.437 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.39 177.38 9.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.153 0.501 . . . . 2.8799999999999999 111.597 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.18 149.55 32.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.39 -0.823 . . . . 1.47 110.4 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.16 144.71 38.7 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.455 -0.339 . . . . 2.7000000000000002 110.591 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.74 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.08 135.94 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 121.088 0.47 . . . . 0.46000000000000002 111.5 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.01 141.35 52.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.668 -0.696 . . . . 0.34999999999999998 110.373 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.6 138.8 51.7 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.553 -0.459 . . . . 3.6699999999999999 111.575 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.21 164.14 37.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.572 -0.74 . . . . 0.67000000000000004 109.618 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.576 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.2 151.57 38.63 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.411 -0.516 . . . . 1.47 111.027 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.802 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.26 172.64 13.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.767 -0.651 . . . . 0.44 111.023 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.7 t -118.61 160.7 21.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.479 -0.782 . . . . 1.3700000000000001 109.922 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.45 121.87 22.87 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.623 -0.431 . . . . 1.28 110.774 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.6 p -126.92 155.57 42.84 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 114.62 1.341 . . . . 1.97 114.62 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 82.2 p . . . . . 0 N--CA 1.456 -0.142 0 CA-C-N 112.996 -1.911 . . . . 3.2799999999999998 109.102 177.317 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.491 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 2.0 p . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 121.151 0.5 . . . . 0.66000000000000003 110.417 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.436 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.91 167.58 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.613 -0.721 . . . . 0.68999999999999995 110.92 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.56 145.55 50.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.675 -0.693 . . . . 0.52000000000000002 110.146 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.33 101.72 9.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.021 -0.733 . . . . 0.32000000000000001 109.021 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.0 t -112.94 139.74 36.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.0 -0.545 . . . . 0.28999999999999998 111.078 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.1 p -128.82 152.45 48.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.681 -0.69 . . . . 0.25 109.868 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.591 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.71 -164.88 2.02 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.667 -0.413 . . . . 0.31 110.711 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -124.0 127.11 73.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 0.48999999999999999 110.833 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.176 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 1.53 110.315 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.15 24.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.916 -0.584 . . . . 0.96999999999999997 111.471 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.176 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.16 128.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.599 -0.441 . . . . 1.5600000000000001 110.929 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.4 -9.65 55.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.975 -0.557 . . . . 1.8799999999999999 110.306 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.1 0.27 55.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 1.04 110.376 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.31 137.18 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.976 -0.556 . . . . 0.23999999999999999 109.945 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.72 ' C ' ' HZ3' ' A' ' 61' ' ' LYS . 75.7 m -96.16 -15.52 22.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.337 0.589 . . . . 0.28999999999999998 110.077 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.838 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.54 175.51 45.68 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 109.793 -1.323 . . . . 0.13 109.793 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.4 151.61 42.43 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.574 -0.45 . . . . 0.17000000000000001 110.466 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.699 HH12 ' HD2' ' A' ' 15' ' ' PRO . 60.0 ttp180 -132.28 121.25 23.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.11 -0.495 . . . . 1.29 109.954 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.559 HG21 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.19 136.58 38.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.634 -0.712 . . . . 0.25 110.665 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.522 ' CD ' ' CE2' ' A' ' 157' ' ' TYR . 80.8 tt0 -129.35 129.82 45.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.858 -0.61 . . . . 1.3200000000000001 110.065 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.71 135.31 34.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.98 -0.554 . . . . 0.56999999999999995 110.619 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.418 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.32 161.37 39.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.781 -0.645 . . . . 1.1599999999999999 109.634 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.954 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.07 124.77 25.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.019 0.438 . . . . 0.38 110.783 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.62 -7.77 49.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.74 -0.664 . . . . 0.40999999999999998 110.9 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -109.77 -69.74 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 1.6599999999999999 111.421 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.439 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.66 -35.34 75.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.065 -0.516 . . . . 1.6599999999999999 111.497 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.083 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.14 7.29 88.55 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.772 -0.931 . . . . 1.1699999999999999 110.772 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.34 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.97 -171.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 1.8600000000000001 110.207 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.34 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.39 139.01 44.66 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 1.98 110.17 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.418 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.3 Cg_endo -70.84 145.8 51.88 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 C-N-CA 122.752 2.301 . . . . 0.55000000000000004 112.343 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.84 145.68 42.64 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.222 -0.659 . . . . 1.1399999999999999 109.222 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.522 ' CE2' ' CD ' ' A' ' 145' ' ' GLU . 83.1 m-85 -123.3 141.39 52.04 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.289 -0.564 . . . . 0.93000000000000005 111.526 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.6 mt -128.07 127.66 43.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.288 -0.869 . . . . 0.34000000000000002 108.917 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.712 ' OD1' ' ND2' ' A' ' 16' ' ' ASN . 13.6 m-20 -101.57 131.1 47.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.099 0.476 . . . . 1.0900000000000001 111.751 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.95 157.57 73.39 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.396 -0.82 . . . . 0.19 109.602 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.78 158.03 58.31 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.453 2.102 . . . . 0.17999999999999999 112.268 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.33 -12.12 5.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.782 -0.645 . . . . 0.20999999999999999 110.75 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.0 p -92.81 -8.79 42.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.068 -0.514 . . . . 0.28999999999999998 110.753 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.1 135.4 34.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.5 110.408 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.17 16.57 4.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.435 -0.348 . . . . 0.29999999999999999 110.459 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.5 p -167.5 147.16 5.12 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.612 -0.514 . . . . 0.23000000000000001 109.612 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.559 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.21 150.48 12.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.6 -0.44 . . . . 0.28000000000000003 111.629 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.508 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 4.0 t-20 -106.36 124.96 50.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.625 -0.716 . . . . 1.0700000000000001 109.758 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.43 104.99 30.5 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.28999999999999998 111.088 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.9 Cg_endo -91.17 -179.5 1.45 Allowed 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 123.099 2.532 . . . . 0.42999999999999999 112.138 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.67 32.75 18.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.414 -0.812 . . . . 1.26 111.391 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.491 ' O ' ' OG ' ' A' ' 126' ' ' SER . 23.7 mt -86.46 148.54 25.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.474 -0.33 . . . . 0.32000000000000001 110.436 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.77 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.3 114.91 61.57 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.059 0.457 . . . . 0.57999999999999996 110.699 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.01 140.54 95.81 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.873 2.382 . . . . 0.66000000000000003 112.041 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.18 21.06 74.35 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.061 -0.815 . . . . 0.28999999999999998 111.061 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.439 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.79 150.22 49.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.786 0.327 . . . . 2.3300000000000001 110.681 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.1 131.58 45.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.068 -0.514 . . . . 0.85999999999999999 109.811 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.954 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.3 m-85 -120.45 148.3 43.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.153 -0.476 . . . . 0.52000000000000002 111.055 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.3 125.36 60.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.261 -1.014 . . . . 0.29999999999999999 108.261 177.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.49 132.39 63.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.155 0.502 . . . . 0.23000000000000001 111.26 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.39 122.61 20.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.637 -0.71 . . . . 0.35999999999999999 109.645 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.591 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.05 125.43 54.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.214 -0.448 . . . . 0.19 110.631 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.7 m-85 -117.27 137.92 52.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.027 -0.533 . . . . 0.29999999999999999 109.842 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.425 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.78 135.07 42.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.773 -0.825 . . . . 0.37 108.773 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.602 ' O ' ' N ' ' A' ' 140' ' ' SER . 50.6 mm -99.12 122.96 51.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.137 0.494 . . . . 0.26000000000000001 110.864 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.3 p -83.83 169.71 14.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.565 -0.743 . . . . 0.28000000000000003 110.503 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -59.78 -14.53 15.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.006 -0.543 . . . . 1.6000000000000001 110.963 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.404 ' C ' ' OG1' ' A' ' 59' ' ' THR . 94.9 m-20 -96.03 -4.29 43.34 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.872 -0.331 . . . . 1.1799999999999999 110.795 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.631 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.76 13.93 64.01 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.403 -0.679 . . . . 0.29999999999999999 111.403 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -84.76 139.14 32.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.736 0.303 . . . . 1.22 110.349 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.604 ' NE2' ' HG3' ' A' ' 14' ' ' GLN . 7.7 pt20 -106.83 141.05 38.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.968 0.413 . . . . 0.97999999999999998 110.465 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.73 126.99 26.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.82999999999999996 110.402 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.08 117.27 9.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.371 -0.377 . . . . 0.26000000000000001 110.502 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.3 pt -109.06 -21.82 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.471 . . . . 0.29999999999999999 110.741 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.84 125.84 5.94 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.558 -0.457 . . . . 0.31 111.495 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.84 120.21 21.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.708 -0.678 . . . . 0.28000000000000003 109.497 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.59 151.69 29.14 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.712 -0.395 . . . . 0.23999999999999999 110.987 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.48 158.57 18.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.081 -0.509 . . . . 0.23000000000000001 110.382 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -146.07 157.97 43.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.084 -0.507 . . . . 0.67000000000000004 110.624 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.37 9.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.662 -0.699 . . . . 0.64000000000000001 109.972 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.894 -1.051 . . . . 1.26 110.719 -179.788 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.145 -0.687 . . . . 3.4399999999999999 109.145 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.77 18.53 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.061 -0.815 . . . . 1.22 111.061 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -35.66 142.44 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.057 0 C-N-CA 123.959 3.106 . . . . 0.75 113.808 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.62 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.98 173.4 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 114.286 -1.325 . . . . 0.79000000000000004 108.853 178.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.62 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.67 125.9 51.52 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.429 -0.508 . . . . 1.9399999999999999 111.384 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.45 143.95 34.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.586 -0.734 . . . . 0.59999999999999998 110.705 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.02 168.31 25.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.88 0.371 . . . . 3.1400000000000001 111.13 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.748 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.5 mt -108.97 131.02 60.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.993 -0.549 . . . . 3.23 110.154 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.15 162.35 35.69 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.954 0.407 . . . . 3.6299999999999999 111.202 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 76.1 tt0 36.04 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.659 -0.497 . . . . 6.0800000000000001 109.659 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.748 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.5 32.32 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.921 -0.581 . . . . 3.3799999999999999 111.606 -178.828 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.641 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.1 Cg_endo -63.17 -29.12 73.77 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.445 2.097 . . . . 3.9300000000000002 111.906 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.641 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.65 125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 3.3599999999999999 110.494 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.553 ' O ' ' O ' ' A' ' 92' ' ' THR . 2.4 mm-40 -123.9 158.39 60.19 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.32 -0.4 . . . . 3.6099999999999999 110.409 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.555 ' HG3' ' CZ ' ' A' ' 143' ' ' ARG . 97.0 Cg_endo -82.0 -64.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.976 2.451 . . . . 1.51 113.556 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.619 ' ND2' ' CD2' ' A' ' 157' ' ' TYR . 11.1 m120 -108.42 -19.71 13.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.277 -0.419 . . . . 2.6800000000000002 112.074 -178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 7.1 p -107.26 152.08 24.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.143 0.497 . . . . 1.21 111.354 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.569 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.3 102.9 2.22 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.708 -0.678 . . . . 1.5600000000000001 110.632 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.6 145.61 13.13 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.927 2.418 . . . . 0.81000000000000005 112.589 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.926 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.84 168.01 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.919 -0.582 . . . . 1.52 109.889 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.15 147.85 28.94 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.763 -0.458 . . . . 2.1400000000000001 109.763 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.602 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.23 157.38 44.91 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.593 -0.443 . . . . 0.32000000000000001 111.241 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.486 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.8 m-20 -127.98 155.31 44.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.863 -0.608 . . . . 2.1699999999999999 110.128 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.821 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.63 173.01 6.39 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 121.125 0.488 . . . . 0.58999999999999997 110.749 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.821 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.68 174.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.822 2.348 . . . . 0.90000000000000002 111.557 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.484 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.15 -51.06 0.68 Allowed Pre-proline 0 C--N 1.328 -0.342 0 C-N-CA 120.719 -0.392 . . . . 3.3399999999999999 110.068 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.616 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.82 152.38 82.35 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.711 2.274 . . . . 1.8500000000000001 111.451 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.64 42.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.322 0.582 . . . . 2.54 110.575 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.616 ' H ' ' C ' ' A' ' 27' ' ' PRO . 73.9 t60 -63.69 -41.58 98.11 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.027 -0.988 . . . . 2.5299999999999998 110.63 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.564 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.4 mt -109.89 137.91 39.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.771 -0.65 . . . . 1.1699999999999999 111.207 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.98 -72.88 0.7 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.965 -0.561 . . . . 1.27 111.927 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.27 148.34 24.38 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.594 0.591 . . . . 1.1200000000000001 112.594 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -121.8 124.86 45.17 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.396 -0.594 . . . . 0.41999999999999998 109.396 177.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.08 134.78 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.614 -0.434 . . . . 0.78000000000000003 110.644 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.926 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.01 128.52 53.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.03 0.443 . . . . 0.62 111.267 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.548 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.04 139.07 49.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.81 -0.632 . . . . 1.97 110.064 178.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.435 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.09 163.15 35.18 Favored 'General case' 0 N--CA 1.458 -0.056 0 C-N-CA 120.559 -0.456 . . . . 0.34999999999999998 112.134 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.4 139.69 7.99 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.478 -0.783 . . . . 1.8 110.449 178.838 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.65 115.44 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.366 2.044 . . . . 0.57999999999999996 111.799 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.686 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.03 81.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.901 -0.407 . . . . 3.04 109.901 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.697 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.21 -20.61 0.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.97 -0.559 . . . . 2.4700000000000002 111.933 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.6 p -157.68 157.77 34.16 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.801 -0.36 . . . . 2.5099999999999998 110.596 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.408 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.26 27.79 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.247 -0.433 . . . . 1.8600000000000001 110.159 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.81 -75.95 1.31 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.175 -0.536 . . . . 1.4399999999999999 111.826 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.87 152.27 35.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.942 0.401 . . . . 4.6900000000000004 110.944 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.648 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.16 -169.15 2.55 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.031 -0.532 . . . . 1.4299999999999999 111.927 179.386 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.18 149.67 29.76 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.483 0.659 . . . . 1.74 112.463 -177.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.03 156.59 46.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.702 -1.135 . . . . 1.9199999999999999 110.216 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.465 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.28 158.27 41.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.98 -0.554 . . . . 0.34000000000000002 111.842 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.09 135.66 53.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.493 -0.776 . . . . 0.40999999999999998 109.82 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.602 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.46 122.02 23.72 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.427 -0.351 . . . . 0.55000000000000004 111.534 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.2 Cg_exo -46.39 151.75 1.67 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.717 2.278 . . . . 0.44 112.053 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.92 -23.05 63.11 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 115.958 -0.564 . . . . 0.73999999999999999 112.79 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.545 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.87 -16.7 46.57 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.213 -0.595 . . . . 0.93000000000000005 111.809 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.604 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.66 138.42 31.57 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.83 -0.348 . . . . 0.96999999999999997 110.248 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -121.57 13.92 10.96 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.375 -0.375 . . . . 1.3400000000000001 111.462 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.482 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 86.8 p -149.93 143.46 25.26 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.651 -0.42 . . . . 0.39000000000000001 111.088 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.82 -169.4 1.54 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.203 0.525 . . . . 0.41999999999999998 110.897 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.723 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 20.2 m -151.68 125.89 9.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.444 -0.798 . . . . 0.39000000000000001 109.863 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.513 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.87 123.29 70.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.304 -0.558 . . . . 0.73999999999999999 111.217 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.578 ' HG2' ' N ' ' A' ' 62' ' ' GLY . 87.5 tttt -126.55 163.4 23.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.863 -0.608 . . . . 2.48 110.396 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.578 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.07 19.07 59.81 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.771 -0.932 . . . . 0.5 110.771 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.513 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.7 mt -79.12 157.17 28.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.147 0.498 . . . . 0.57999999999999996 111.304 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.844 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -99.42 133.9 21.62 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.544 -0.753 . . . . 2.79 110.56 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.666 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.85 143.49 61.27 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.615 2.21 . . . . 0.87 111.937 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.84 25.64 75.32 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.087 -0.805 . . . . 0.64000000000000001 111.087 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.2 158.84 40.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.754 0.311 . . . . 0.82999999999999996 110.377 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.18 139.86 42.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.364 -0.38 . . . . 0.5 110.554 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.65 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.55 136.42 54.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.985 -0.552 . . . . 0.53000000000000003 110.779 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.9 131.02 45.3 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.493 -0.928 . . . . 1.8700000000000001 108.493 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.494 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.38 153.92 16.62 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.315 -0.945 . . . . 0.28999999999999998 111.985 -178.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -134.98 140.95 46.09 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.693 -0.484 . . . . 1.4299999999999999 109.693 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.517 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.71 118.82 34.12 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.558 -0.457 . . . . 0.32000000000000001 110.482 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.737 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.45 129.11 68.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.371 -0.377 . . . . 0.79000000000000004 110.675 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.704 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.85 120.87 43.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.272 -0.422 . . . . 1.02 110.687 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.855 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.56 146.45 11.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.068 0.461 . . . . 0.62 111.035 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.626 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.0 153.88 21.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.514 -0.766 . . . . 2.4399999999999999 109.934 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.27 88.6 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.996 0.426 . . . . 3.6899999999999999 110.469 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.28 32.63 0.21 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.823 -0.626 . . . . 6.0800000000000001 110.6 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.35 3.29 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.483 -0.647 . . . . 1.22 111.483 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.48 177.4 8.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 2.8799999999999999 111.577 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.13 149.41 31.96 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.423 -0.808 . . . . 1.47 110.369 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.06 144.71 38.9 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.43 -0.35 . . . . 2.7000000000000002 110.6 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.737 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -127.98 136.0 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 121.07 0.462 . . . . 0.46000000000000002 111.603 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.57 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.6 m -124.13 141.23 52.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.668 -0.697 . . . . 0.34999999999999998 110.302 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.497 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.64 138.88 51.67 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.493 -0.483 . . . . 3.6699999999999999 111.485 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.494 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.23 164.22 37.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.501 -0.772 . . . . 0.67000000000000004 109.48 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.565 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 46.9 p30 -145.25 151.55 38.55 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.429 -0.509 . . . . 1.47 111.037 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.25 172.77 12.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.739 -0.664 . . . . 0.44 111.007 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.84 160.58 21.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.529 -0.76 . . . . 1.3700000000000001 109.826 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.3 121.79 22.92 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.567 -0.453 . . . . 1.28 110.803 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.553 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.0 p -127.37 161.11 29.42 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.226 0.454 . . . . 1.97 112.226 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.464 0.263 0 CA-C-N 115.766 -0.652 . . . . 3.2799999999999998 110.361 178.489 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.9 p . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.843 0.354 . . . . 0.66000000000000003 110.676 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.441 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.9 167.55 0.26 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 0.68999999999999995 110.914 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.61 145.53 50.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.677 -0.692 . . . . 0.52000000000000002 110.099 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.28 101.69 9.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.096 -0.705 . . . . 0.32000000000000001 109.096 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.0 t -112.96 139.64 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.059 -0.519 . . . . 0.28999999999999998 111.078 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.5 p -128.73 152.61 48.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.721 -0.672 . . . . 0.25 109.776 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.584 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.4 p90 -144.8 -164.95 2.04 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.682 -0.407 . . . . 0.31 110.549 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.733 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.9 t -123.91 127.19 73.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.103 -0.499 . . . . 0.48999999999999999 110.817 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.157 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.97 58.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 1.53 110.376 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.12 24.47 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.856 -0.611 . . . . 0.96999999999999997 111.524 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.157 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.13 128.76 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.542 -0.463 . . . . 1.5600000000000001 110.868 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.43 -9.71 55.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.849 -0.614 . . . . 1.8799999999999999 110.31 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.0 0.22 55.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 1.04 110.414 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.725 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.25 137.21 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.951 -0.568 . . . . 0.23999999999999999 109.955 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.579 ' N ' ' O ' ' A' ' 185' ' ' ILE . 5.6 m -96.32 -15.41 21.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.219 0.533 . . . . 0.28999999999999998 110.016 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.454 ' HA3' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.51 175.56 45.7 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 109.839 -1.304 . . . . 0.13 109.839 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -123.53 151.61 42.65 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.64 -0.424 . . . . 0.17000000000000001 110.485 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.728 ' NH2' ' CD2' ' A' ' 183' ' ' TYR . 69.8 ttp85 -132.33 121.15 23.07 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.081 -0.509 . . . . 1.29 109.931 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.545 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.08 136.53 38.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.689 -0.687 . . . . 0.25 110.65 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.516 ' HB2' HH12 ' A' ' 143' ' ' ARG . 81.1 tt0 -129.36 129.91 45.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.993 -0.548 . . . . 1.3200000000000001 110.07 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.625 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.7 p90 -138.75 135.4 34.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.023 -0.535 . . . . 0.56999999999999995 110.558 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.419 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.38 161.36 39.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.723 -0.671 . . . . 1.1599999999999999 109.717 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.969 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 85.9 mt -71.09 124.86 25.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.018 0.437 . . . . 0.38 110.725 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.492 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.76 -7.56 48.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.813 -0.631 . . . . 0.40999999999999998 110.887 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -109.89 -69.77 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 1.6599999999999999 111.428 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.45 ' CD ' HH21 ' A' ' 176' ' ' ARG . 53.8 mt-10 -60.56 -35.46 76.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.028 -0.533 . . . . 1.6599999999999999 111.535 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.074 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.26 88.58 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.8 -0.92 . . . . 1.1699999999999999 110.8 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.327 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.96 -171.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 1.8600000000000001 110.243 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.327 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.27 139.13 45.12 Favored Pre-proline 0 N--CA 1.454 -0.262 0 CA-C-O 120.997 0.427 . . . . 1.98 110.243 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.419 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.3 Cg_endo -70.93 145.77 51.22 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 C-N-CA 122.782 2.321 . . . . 0.55000000000000004 112.302 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.625 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.78 145.71 42.58 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.238 -0.653 . . . . 1.1399999999999999 109.238 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.666 ' CE1' ' CD ' ' A' ' 65' ' ' PRO . 35.6 p90 -123.28 141.31 52.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.234 0.54 . . . . 0.93000000000000005 111.577 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.2 mt -128.09 127.72 43.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.274 -0.875 . . . . 0.34000000000000002 108.944 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 5.0 t0 -101.63 131.17 48.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.102 0.477 . . . . 1.0900000000000001 111.722 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.518 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.1 mt -127.94 157.66 73.1 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.277 -0.874 . . . . 0.19 109.601 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -69.92 158.03 58.12 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 122.439 2.093 . . . . 0.17999999999999999 112.226 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.32 -12.13 5.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.773 -0.649 . . . . 0.20999999999999999 110.7 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.0 p -92.84 -8.76 42.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.094 -0.503 . . . . 0.28999999999999998 110.675 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.15 135.43 34.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.326 -0.397 . . . . 0.5 110.391 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.7 p -133.18 16.65 4.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.443 -0.344 . . . . 0.29999999999999999 110.462 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.5 p -167.6 147.11 5.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.607 -0.516 . . . . 0.23000000000000001 109.607 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.545 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.21 150.43 12.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.5 -0.48 . . . . 0.28000000000000003 111.594 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.503 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.28 125.0 50.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.619 -0.719 . . . . 1.0700000000000001 109.792 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.46 104.97 30.44 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.391 -0.368 . . . . 0.28999999999999998 110.99 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.4 Cg_endo -90.99 -179.48 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 123.117 2.545 . . . . 0.42999999999999999 112.162 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.61 32.64 18.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.341 -0.845 . . . . 1.26 111.493 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.7 mt -86.39 148.49 25.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.339 . . . . 0.32000000000000001 110.494 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.772 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.23 114.83 61.18 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.311 -0.404 . . . . 0.57999999999999996 110.658 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.98 140.5 95.63 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.837 2.358 . . . . 0.66000000000000003 112.08 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.16 21.21 74.04 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.036 -0.825 . . . . 0.28999999999999998 111.036 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.45 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.87 150.18 49.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 2.3300000000000001 110.686 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.492 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.21 131.73 45.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.088 -0.506 . . . . 0.85999999999999999 109.747 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.969 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.55 148.19 44.19 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.129 -0.487 . . . . 0.52000000000000002 111.08 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.26 125.3 60.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.303 -0.999 . . . . 0.29999999999999999 108.303 177.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.52 132.46 63.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.162 0.506 . . . . 0.23000000000000001 111.197 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.45 122.5 20.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.555 -0.748 . . . . 0.35999999999999999 109.636 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.584 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.96 125.49 54.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.255 -0.43 . . . . 0.19 110.647 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.728 ' CD2' ' NH2' ' A' ' 143' ' ' ARG . 48.5 m-85 -117.34 137.84 52.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.985 -0.552 . . . . 0.29999999999999999 109.891 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.429 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.73 135.02 42.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.729 -0.841 . . . . 0.37 108.729 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 140' ' ' SER . 83.3 mt -99.05 122.86 51.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.11 0.481 . . . . 0.26000000000000001 110.961 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.5 p -83.81 169.73 14.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.542 -0.754 . . . . 0.28000000000000003 110.525 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.82 -14.54 15.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.119 -0.491 . . . . 1.6000000000000001 110.956 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -96.03 -4.25 43.42 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.852 -0.339 . . . . 1.1799999999999999 110.879 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.585 ' HA3' HG23 ' A' ' 59' ' ' THR . . . 87.81 13.83 64.08 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.336 -0.706 . . . . 0.29999999999999999 111.336 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -84.6 139.17 32.28 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.027 -0.269 . . . . 1.22 110.458 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.553 HE22 ' HG2' ' A' ' 15' ' ' PRO . 86.2 mt-30 -106.77 141.04 38.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 0.97999999999999998 110.535 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.1 m -136.65 127.06 26.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.82999999999999996 110.388 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.7 tp -68.24 117.29 9.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.92 0.39 . . . . 0.26000000000000001 110.448 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.07 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.29999999999999999 110.714 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.1 tp -156.88 125.68 5.85 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.554 -0.459 . . . . 0.31 111.486 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.472 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.75 120.27 21.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.77 -0.65 . . . . 0.28000000000000003 109.536 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.66 29.06 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.602 -0.439 . . . . 0.23999999999999999 110.903 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.45 158.65 18.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.092 -0.504 . . . . 0.23000000000000001 110.442 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -146.15 157.99 43.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.171 -0.468 . . . . 0.67000000000000004 110.654 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 104.33 9.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.699 -0.682 . . . . 0.64000000000000001 110.025 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.888 -1.053 . . . . 1.26 110.672 -179.694 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.55 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.201 -0.666 . . . . 3.4399999999999999 109.201 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.37 150.64 18.55 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.983 -0.847 . . . . 1.22 110.983 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -35.58 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.092 0 C-N-CA 124.03 3.153 . . . . 0.75 113.754 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.622 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -80.04 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.208 -1.36 . . . . 0.79000000000000004 108.857 178.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.622 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.64 125.8 51.4 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.426 -0.51 . . . . 1.9399999999999999 111.434 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.5 143.96 34.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.625 -0.716 . . . . 0.59999999999999998 110.583 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.93 168.37 25.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.386 -0.37 . . . . 3.1400000000000001 111.09 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.738 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.02 131.09 60.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.008 -0.542 . . . . 3.23 110.047 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.1 p -141.18 162.27 35.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.84 0.352 . . . . 3.6299999999999999 111.27 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.8 mt-10 36.09 31.62 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.601 -0.518 . . . . 6.0800000000000001 109.601 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.738 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.41 69.52 32.19 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.932 -0.576 . . . . 3.3799999999999999 111.558 -178.752 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.24 -29.2 73.23 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.57 2.18 . . . . 3.9300000000000002 111.837 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.71 125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 3.3599999999999999 110.449 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.718 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -123.93 158.34 60.44 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.329 -0.396 . . . . 3.6099999999999999 110.444 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.497 ' HG2' ' CD ' ' A' ' 143' ' ' ARG . 96.9 Cg_endo -81.94 -64.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.965 2.443 . . . . 1.51 113.574 -179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.44 ' H ' ' HG2' ' A' ' 15' ' ' PRO . 97.7 m-20 -108.47 -19.62 13.39 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.088 0.403 . . . . 2.6800000000000002 112.088 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.718 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 89.1 p -107.32 152.05 24.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.101 0.477 . . . . 1.21 111.346 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.578 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.26 102.92 2.23 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.711 -0.677 . . . . 1.5600000000000001 110.583 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.75 145.68 12.93 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.781 2.321 . . . . 0.81000000000000005 112.554 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.915 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.78 167.96 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.845 -0.616 . . . . 1.52 109.903 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.16 147.95 29.05 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.742 -0.466 . . . . 2.1400000000000001 109.742 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.3 p90 -142.23 157.3 45.0 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.567 -0.453 . . . . 0.32000000000000001 111.169 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.494 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.8 m-20 -127.97 155.26 44.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.773 -0.649 . . . . 2.1699999999999999 110.199 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.825 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.64 173.05 6.34 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.113 0.482 . . . . 0.58999999999999997 110.702 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.825 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.8 Cg_exo -50.74 173.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.834 2.356 . . . . 0.90000000000000002 111.505 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.92 -51.08 0.7 Allowed Pre-proline 0 C--N 1.33 -0.265 0 C-N-CA 120.717 -0.393 . . . . 3.3399999999999999 110.212 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.62 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.8 152.41 82.22 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.683 2.255 . . . . 1.8500000000000001 111.501 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.68 42.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.343 0.592 . . . . 2.54 110.601 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.62 ' H ' ' C ' ' A' ' 27' ' ' PRO . 74.0 t60 -63.64 -41.66 98.22 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.004 -0.998 . . . . 2.5299999999999998 110.655 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.558 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.5 mt -109.73 137.84 40.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.784 -0.643 . . . . 1.1699999999999999 111.308 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.02 -72.89 0.7 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.075 -0.512 . . . . 1.27 111.906 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.22 148.43 24.37 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.581 0.586 . . . . 1.1200000000000001 112.581 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -121.76 124.82 45.12 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.448 -0.575 . . . . 0.41999999999999998 109.448 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.7 mt -118.08 134.75 60.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.55 -0.46 . . . . 0.78000000000000003 110.569 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.915 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.02 128.72 53.79 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.057 0.456 . . . . 0.62 111.268 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.549 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.97 49.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.707 -0.678 . . . . 1.97 110.159 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -144.98 163.19 34.93 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.092 0.473 . . . . 0.34999999999999998 112.172 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.55 139.49 7.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.512 -0.767 . . . . 1.8 110.502 178.836 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.694 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.44 115.45 3.03 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.296 1.997 . . . . 0.57999999999999996 111.846 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.96 81.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.9 -0.407 . . . . 3.04 109.9 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.694 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.14 -20.6 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.993 -0.549 . . . . 2.4700000000000002 111.887 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.7 p -157.69 157.76 34.12 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.884 -0.326 . . . . 2.5099999999999998 110.596 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.4 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.36 27.8 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.466 . . . . 1.8600000000000001 110.205 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.73 -75.88 1.31 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.116 -0.564 . . . . 1.4399999999999999 111.926 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.89 152.25 35.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.966 0.412 . . . . 4.6900000000000004 110.959 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.633 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.23 -169.18 2.55 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.06 -0.518 . . . . 1.4299999999999999 111.97 179.367 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.08 149.74 29.59 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.392 0.615 . . . . 1.74 112.564 -177.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.08 156.45 45.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.81 -1.086 . . . . 1.9199999999999999 110.287 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.22 158.28 41.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.925 -0.579 . . . . 0.34000000000000002 111.8 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.04 135.69 53.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.476 -0.783 . . . . 0.40999999999999998 109.801 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.596 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.42 121.94 23.75 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.481 -0.327 . . . . 0.55000000000000004 111.526 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.0 Cg_exo -46.37 151.66 1.68 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.688 2.259 . . . . 0.44 112.151 178.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.87 -23.03 62.99 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 116.043 -0.526 . . . . 0.73999999999999999 112.784 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.6 p-80 -82.81 -16.86 46.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.391 0.596 . . . . 0.93000000000000005 111.804 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.605 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.63 138.4 31.6 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.751 -0.379 . . . . 0.96999999999999997 110.323 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.47 13.87 11.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.383 -0.371 . . . . 1.3400000000000001 111.542 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.48 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.0 p -149.95 143.45 25.24 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.617 -0.433 . . . . 0.39000000000000001 111.04 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.87 -169.25 1.51 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.045 -0.525 . . . . 0.41999999999999998 110.913 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.714 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 97.4 m -151.83 125.95 9.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.417 -0.811 . . . . 0.39000000000000001 109.8 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.509 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.88 123.25 70.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.376 -0.53 . . . . 0.73999999999999999 111.2 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.809 ' NZ ' ' N ' ' A' ' 141' ' ' GLY . 96.7 mttt -126.53 163.37 23.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.879 -0.601 . . . . 2.48 110.41 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.17 18.94 59.89 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.697 -0.961 . . . . 0.5 110.697 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.509 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.8 mt -79.04 157.27 28.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.13 0.491 . . . . 0.57999999999999996 111.363 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.859 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -99.45 134.01 21.51 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.598 -0.728 . . . . 2.79 110.451 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.91 143.58 61.26 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.555 2.17 . . . . 0.87 111.867 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.72 75.23 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.998 -0.841 . . . . 0.64000000000000001 110.998 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.859 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.15 158.76 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.567 0.223 . . . . 0.82999999999999996 110.46 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.15 139.95 41.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.944 0.402 . . . . 0.5 110.627 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.637 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.57 136.43 54.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.041 -0.527 . . . . 0.53000000000000003 110.77 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.92 130.99 45.33 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.53 -0.915 . . . . 1.8700000000000001 108.53 177.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.488 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.45 153.92 16.63 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.349 -0.929 . . . . 0.28999999999999998 111.913 -178.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -135.04 140.94 46.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.642 -0.503 . . . . 1.4299999999999999 109.642 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.52 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.78 118.86 34.21 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.505 -0.478 . . . . 0.32000000000000001 110.46 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.731 HG12 HG23 ' A' ' 84' ' ' VAL . 63.8 mt -112.43 128.94 68.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.79000000000000004 110.65 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.73 120.9 43.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.324 -0.398 . . . . 1.02 110.707 -179.685 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.858 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.57 146.51 11.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.137 0.494 . . . . 0.62 111.015 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.625 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.1 mt-30 -106.11 153.86 21.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.585 -0.734 . . . . 2.4399999999999999 109.955 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.14 88.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.004 0.43 . . . . 3.6899999999999999 110.503 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.22 32.7 0.21 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.808 -0.633 . . . . 6.0800000000000001 110.511 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.09 -117.37 3.29 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.443 -0.663 . . . . 1.22 111.443 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -81.37 177.35 9.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.177 0.513 . . . . 2.8799999999999999 111.69 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.1 149.59 32.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.476 -0.783 . . . . 1.47 110.371 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.55 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.2 144.78 38.67 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.407 -0.361 . . . . 2.7000000000000002 110.501 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.731 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.07 136.03 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 121.071 0.463 . . . . 0.46000000000000002 111.487 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.11 141.39 52.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.697 -0.683 . . . . 0.34999999999999998 110.212 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.461 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.4 ttp180 -117.69 138.93 51.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.185 0.517 . . . . 3.6699999999999999 111.406 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.34 164.15 38.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.539 -0.755 . . . . 0.67000000000000004 109.531 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.29 151.49 38.42 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.391 -0.523 . . . . 1.47 111.072 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.81 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.3 p90 -146.11 172.79 12.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.713 -0.676 . . . . 0.44 111.044 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.8 160.63 21.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.46 -0.791 . . . . 1.3700000000000001 109.809 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.35 121.91 23.04 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.535 -0.466 . . . . 1.28 110.776 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.549 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -128.2 164.31 22.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.668 0.747 . . . . 1.97 112.682 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.49 ' OG ' ' CE2' ' A' ' 157' ' ' TYR . 30.3 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 114.712 -1.131 . . . . 3.2799999999999998 109.001 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 122.137 0.97 . . . . 0.66000000000000003 110.926 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.442 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.91 167.53 0.26 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.626 -1.17 . . . . 0.68999999999999995 110.946 -179.193 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.8 m-30 -133.65 145.54 50.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.678 -0.692 . . . . 0.52000000000000002 110.102 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.28 101.68 9.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.075 -0.713 . . . . 0.32000000000000001 109.075 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.8 t -112.86 139.7 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.987 -0.551 . . . . 0.28999999999999998 111.133 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.2 p -128.73 152.5 48.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.624 -0.716 . . . . 0.25 109.786 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.587 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.79 -165.04 2.05 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.705 -0.398 . . . . 0.31 110.629 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.729 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -123.81 127.19 73.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.48999999999999999 110.836 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.162 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.99 58.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.222 -0.444 . . . . 1.53 110.38 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.729 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.19 24.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.855 -0.612 . . . . 0.96999999999999997 111.518 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.162 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.15 128.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.628 -0.429 . . . . 1.5600000000000001 110.897 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -86.56 -9.6 55.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.938 -0.573 . . . . 1.8799999999999999 110.215 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.2 p -87.09 0.22 55.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.153 -0.476 . . . . 1.04 110.344 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.38 137.33 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.969 -0.56 . . . . 0.23999999999999999 109.9 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.754 ' C ' ' HZ2' ' A' ' 61' ' ' LYS . 3.5 p -96.29 -15.53 21.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.262 0.553 . . . . 0.28999999999999998 110.045 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.809 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.59 175.52 45.74 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.786 -1.325 . . . . 0.13 109.786 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -123.34 151.59 42.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.954 0.407 . . . . 0.17000000000000001 110.551 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.728 ' NH2' ' OE1' ' A' ' 191' ' ' GLN . 64.1 ttp85 -132.34 121.18 23.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.153 -0.476 . . . . 1.29 109.989 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.558 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.07 136.49 38.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.706 -0.679 . . . . 0.25 110.747 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 81.3 tt0 -129.33 129.92 45.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.994 -0.548 . . . . 1.3200000000000001 110.105 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.3 p90 -138.73 135.27 34.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.957 -0.565 . . . . 0.56999999999999995 110.57 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.417 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.31 161.43 39.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.737 -0.665 . . . . 1.1599999999999999 109.662 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.949 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -70.99 124.85 25.32 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.672 -0.411 . . . . 0.38 110.775 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.492 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.84 -7.6 49.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.779 -0.646 . . . . 0.40999999999999998 110.814 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -109.91 -69.63 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.845 0.355 . . . . 1.6599999999999999 111.399 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.459 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.3 mt-10 -60.75 -35.29 76.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 1.6599999999999999 111.471 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.095 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.15 7.18 88.62 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.789 -0.924 . . . . 1.1699999999999999 110.789 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.324 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.95 -171.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.765 0.316 . . . . 1.8600000000000001 110.301 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.324 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.2 139.02 45.33 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 1.98 110.221 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.417 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 45.8 Cg_endo -70.9 145.79 51.45 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.675 2.25 . . . . 0.55000000000000004 112.32 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.83 145.74 42.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.196 -0.668 . . . . 1.1399999999999999 109.196 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.673 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 86.7 m-85 -123.29 141.31 52.11 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.366 -0.534 . . . . 0.93000000000000005 111.513 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.8 mt -128.05 127.66 43.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.286 -0.87 . . . . 0.34000000000000002 108.925 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -101.58 131.05 47.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.127 0.489 . . . . 1.0900000000000001 111.751 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.86 157.56 73.25 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.388 -0.824 . . . . 0.19 109.6 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.72 158.06 58.32 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.479 2.12 . . . . 0.17999999999999999 112.225 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.38 -12.17 5.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.744 -0.662 . . . . 0.20999999999999999 110.675 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.7 p -92.78 -8.75 42.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.28999999999999998 110.778 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.34 34.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.5 110.329 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.5 p -133.05 16.55 4.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.396 -0.366 . . . . 0.29999999999999999 110.531 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.52 147.05 5.08 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.642 -0.503 . . . . 0.23000000000000001 109.642 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.18 150.44 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.46 -0.496 . . . . 0.28000000000000003 111.564 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.35 124.93 50.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.6 -0.727 . . . . 1.0700000000000001 109.837 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.36 104.91 29.72 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.879 0.371 . . . . 0.28999999999999998 111.065 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -91.0 -179.49 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.922 0 C-N-CA 123.241 2.628 . . . . 0.42999999999999999 112.191 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.61 32.65 18.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.328 -0.851 . . . . 1.26 111.467 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.8 mt -86.41 148.54 25.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.782 0.325 . . . . 0.32000000000000001 110.4 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.759 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.26 114.86 61.3 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.919 0.39 . . . . 0.57999999999999996 110.642 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.02 140.57 95.94 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.915 2.41 . . . . 0.66000000000000003 111.922 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.05 21.2 74.4 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.087 -0.805 . . . . 0.28999999999999998 111.087 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.459 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.9 150.2 49.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.913 0.387 . . . . 2.3300000000000001 110.529 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.492 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.16 131.63 45.99 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.974 -0.557 . . . . 0.85999999999999999 109.813 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.949 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.51 148.35 43.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.127 -0.488 . . . . 0.52000000000000002 111.063 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.32 125.29 60.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.323 -0.991 . . . . 0.29999999999999999 108.323 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.46 132.45 63.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.174 0.511 . . . . 0.23000000000000001 111.346 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.44 122.49 20.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.541 -0.754 . . . . 0.35999999999999999 109.684 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.587 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -100.95 125.38 54.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.281 -0.418 . . . . 0.19 110.723 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.7 m-85 -117.22 137.86 52.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.045 -0.525 . . . . 0.29999999999999999 109.854 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.417 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.71 134.97 42.89 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.809 -0.811 . . . . 0.37 108.809 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.653 HG21 ' HE2' ' A' ' 61' ' ' LYS . 11.6 mt -99.05 122.94 51.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.123 0.487 . . . . 0.26000000000000001 110.926 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.3 p -83.8 169.7 14.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.582 -0.735 . . . . 0.28000000000000003 110.481 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -59.82 -14.48 15.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.016 -0.538 . . . . 1.6000000000000001 110.979 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -96.03 -4.35 43.26 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.877 -0.329 . . . . 1.1799999999999999 110.796 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.79 13.91 63.97 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.36 -0.696 . . . . 0.29999999999999999 111.36 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -84.73 139.14 32.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.632 0.253 . . . . 1.22 110.437 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.728 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 86.0 mt-30 -106.73 141.07 38.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.406 -0.361 . . . . 0.97999999999999998 110.527 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.76 127.02 26.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.125 -0.488 . . . . 0.82999999999999996 110.363 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.15 117.37 9.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.293 -0.412 . . . . 0.26000000000000001 110.486 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.11 -21.65 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.119 -0.491 . . . . 0.29999999999999999 110.724 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.89 125.6 5.82 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.601 -0.44 . . . . 0.31 111.482 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.75 120.2 21.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.774 -0.648 . . . . 0.28000000000000003 109.562 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.65 151.74 29.14 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.642 -0.423 . . . . 0.23999999999999999 110.89 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.54 158.55 18.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.043 -0.526 . . . . 0.23000000000000001 110.439 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -146.05 157.91 43.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.67000000000000004 110.723 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 104.34 9.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.855 -0.611 . . . . 0.64000000000000001 110.04 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.89 -1.052 . . . . 1.26 110.608 -179.659 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.553 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.9 m . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.242 -0.651 . . . . 3.4399999999999999 109.242 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.27 150.59 18.57 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.041 -0.823 . . . . 1.22 111.041 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.64 142.45 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 123.967 3.111 . . . . 0.75 113.748 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.605 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -80.0 173.41 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.176 -1.374 . . . . 0.79000000000000004 108.758 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.605 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.59 125.91 51.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.157 0.503 . . . . 1.9399999999999999 111.431 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 143.96 34.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.593 -0.73 . . . . 0.59999999999999998 110.607 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.07 168.25 25.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.916 0.389 . . . . 3.1400000000000001 111.123 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.743 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.83 131.07 60.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.986 -0.552 . . . . 3.23 110.103 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.24 162.35 35.69 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.777 0.322 . . . . 3.6299999999999999 111.255 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 67.7 tt0 36.04 31.67 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.58 -0.526 . . . . 6.0800000000000001 109.58 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.743 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.56 32.58 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.917 -0.583 . . . . 3.3799999999999999 111.585 -178.788 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.636 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.33 -29.14 72.33 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.499 2.133 . . . . 3.9300000000000002 111.796 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.636 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.143 -0.48 . . . . 3.3599999999999999 110.495 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.528 ' CB ' ' O ' ' A' ' 17' ' ' SER . 3.3 mp0 -124.02 158.36 60.61 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 3.6099999999999999 110.47 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.453 ' HG3' ' NH1' ' A' ' 143' ' ' ARG . 97.5 Cg_endo -82.08 -64.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.865 2.377 . . . . 1.51 113.51 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.657 HD22 ' HB2' ' A' ' 159' ' ' ASP . 1.1 p-10 -108.44 -19.54 13.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.36 -0.382 . . . . 2.6800000000000002 112.029 -178.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.653 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 95.9 p -107.36 152.04 24.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.174 0.512 . . . . 1.21 111.29 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.5 t-80 -155.32 102.95 2.22 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.662 -0.699 . . . . 1.5600000000000001 110.565 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.531 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.7 Cg_endo -82.63 145.61 13.09 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.85 2.367 . . . . 0.81000000000000005 112.667 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.929 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.78 167.86 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.924 -0.58 . . . . 1.52 109.899 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.06 148.06 29.26 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.74 -0.467 . . . . 2.1400000000000001 109.74 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.59 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.36 157.28 44.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.005 0.431 . . . . 0.32000000000000001 111.169 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.498 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -128.09 155.31 44.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.745 -0.661 . . . . 2.1699999999999999 110.112 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.837 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.6 173.0 6.4 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.175 -0.466 . . . . 0.58999999999999997 110.756 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.837 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.63 173.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.877 2.384 . . . . 0.90000000000000002 111.605 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.01 -51.16 0.69 Allowed Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 120.74 -0.384 . . . . 3.3399999999999999 110.083 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.635 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.75 152.33 82.44 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.798 2.332 . . . . 1.8500000000000001 111.437 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.69 42.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.456 0.646 . . . . 2.54 110.554 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.635 ' N ' ' O ' ' A' ' 27' ' ' PRO . 74.0 t60 -63.63 -41.54 98.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.993 -1.003 . . . . 2.5299999999999998 110.718 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.564 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.8 mt -109.87 137.77 40.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.791 -0.641 . . . . 1.1699999999999999 111.255 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.96 -72.99 0.7 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.028 -0.533 . . . . 1.27 111.837 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.13 148.5 24.41 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.556 0.576 . . . . 1.1200000000000001 112.556 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.95 124.87 45.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.263 -0.643 . . . . 0.41999999999999998 109.263 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 mt -118.05 134.72 60.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.715 -0.394 . . . . 0.78000000000000003 110.698 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.929 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.02 128.55 53.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.047 0.451 . . . . 0.62 111.271 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.08 139.1 49.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.722 -0.672 . . . . 1.97 110.126 178.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.09 163.11 35.31 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.134 0.492 . . . . 0.34999999999999998 112.05 -178.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.489 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.53 139.73 7.9 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.453 -0.794 . . . . 1.8 110.421 178.727 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.65 115.47 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.322 2.015 . . . . 0.57999999999999996 111.769 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.679 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.9 81.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.925 -0.398 . . . . 3.04 109.925 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.049 -0.523 . . . . 2.4700000000000002 111.893 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.7 p -157.56 157.81 34.44 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.804 -0.358 . . . . 2.5099999999999998 110.538 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.406 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.32 27.69 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.215 -0.448 . . . . 1.8600000000000001 110.204 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.77 -75.81 1.31 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 121.157 -0.544 . . . . 1.4399999999999999 111.875 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -117.95 152.34 35.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.959 0.409 . . . . 4.6900000000000004 110.983 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.29 -169.1 2.51 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.052 -0.522 . . . . 1.4299999999999999 111.925 179.424 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.22 149.67 29.79 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.497 0.665 . . . . 1.74 112.511 -177.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.08 156.44 45.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.773 -1.103 . . . . 1.9199999999999999 110.225 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.469 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.1 158.35 41.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.826 -0.624 . . . . 0.34000000000000002 111.785 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.0 m -115.21 135.71 53.89 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.458 -0.792 . . . . 0.40999999999999998 109.847 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.59 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.42 121.93 23.74 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.418 -0.355 . . . . 0.55000000000000004 111.576 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.6 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.5 Cg_exo -46.36 151.76 1.64 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.683 2.255 . . . . 0.44 112.107 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.9 -23.12 63.14 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 116.057 -0.519 . . . . 0.73999999999999999 112.765 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.5 p-80 -82.75 -16.9 46.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.37 0.585 . . . . 0.93000000000000005 111.802 -178.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.6 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.58 138.41 31.59 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.802 -0.359 . . . . 0.96999999999999997 110.334 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.52 13.83 10.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.37 -0.377 . . . . 1.3400000000000001 111.56 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.475 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.9 143.46 25.29 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.643 -0.423 . . . . 0.39000000000000001 111.09 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.717 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.77 -169.39 1.54 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.06 -0.518 . . . . 0.41999999999999998 110.888 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.717 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.5 m -151.79 125.92 9.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.386 -0.824 . . . . 0.39000000000000001 109.739 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.518 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.81 123.29 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.416 -0.514 . . . . 0.73999999999999999 111.161 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.624 ' CG ' ' N ' ' A' ' 62' ' ' GLY . 18.1 ttpt -126.49 163.45 23.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.874 -0.603 . . . . 2.48 110.432 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.624 ' N ' ' CG ' ' A' ' 61' ' ' LYS . . . 85.09 18.99 59.91 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.731 -0.948 . . . . 0.5 110.731 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.518 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.6 mt -79.1 157.19 28.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.074 0.464 . . . . 0.57999999999999996 111.412 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.847 ' O ' HG12 ' A' ' 67' ' ' VAL . 1.2 mttp -99.37 133.92 21.63 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.702 -0.681 . . . . 2.79 110.504 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.88 143.54 61.24 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.541 2.161 . . . . 0.87 112.059 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.91 25.58 75.41 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.063 -0.815 . . . . 0.64000000000000001 111.063 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.847 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.15 158.78 39.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.687 0.279 . . . . 0.82999999999999996 110.381 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.14 139.91 42.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.89 0.376 . . . . 0.5 110.569 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.663 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.2 m-85 -122.49 136.42 54.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.007 -0.542 . . . . 0.53000000000000003 110.842 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.489 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.95 131.02 45.33 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.464 -0.939 . . . . 1.8700000000000001 108.464 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.494 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.49 153.89 16.65 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.281 -0.961 . . . . 0.28999999999999998 111.915 -178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -134.99 140.92 46.06 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.677 -0.49 . . . . 1.4299999999999999 109.677 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.9 tp -115.76 118.89 34.29 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.42 -0.512 . . . . 0.32000000000000001 110.539 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.721 HG12 HG23 ' A' ' 84' ' ' VAL . 63.6 mt -112.32 129.03 68.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.369 -0.378 . . . . 0.79000000000000004 110.699 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.702 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.84 120.92 43.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.319 -0.4 . . . . 1.02 110.743 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.85 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.6 146.45 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.109 0.48 . . . . 0.62 111.066 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.612 ' O ' ' N ' ' A' ' 79' ' ' TYR . 20.9 mt-30 -106.08 153.88 21.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.546 -0.752 . . . . 2.4399999999999999 110.018 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.15 88.51 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.868 0.366 . . . . 3.6899999999999999 110.409 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.31 32.61 0.21 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.853 -0.612 . . . . 6.0800000000000001 110.582 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.1 -117.37 3.29 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.419 -0.672 . . . . 1.22 111.419 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.44 177.44 8.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.249 0.547 . . . . 2.8799999999999999 111.613 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.17 149.47 32.04 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.37 -0.832 . . . . 1.47 110.363 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.553 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.15 144.7 38.73 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.441 -0.345 . . . . 2.7000000000000002 110.578 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.721 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -127.98 135.98 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 120.616 -0.434 . . . . 0.46000000000000002 111.597 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -123.99 141.26 52.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.701 -0.681 . . . . 0.34999999999999998 110.342 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.51 138.96 51.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.142 0.496 . . . . 3.6699999999999999 111.503 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.494 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.36 164.13 38.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.53 -0.759 . . . . 0.67000000000000004 109.428 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.2 151.62 38.7 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.314 -0.554 . . . . 1.47 110.972 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.802 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.8 p90 -146.29 172.69 13.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.69 -0.686 . . . . 0.44 111.008 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.76 160.74 21.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.446 -0.797 . . . . 1.3700000000000001 109.866 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.41 121.84 22.87 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.563 -0.455 . . . . 1.28 110.771 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.2 p -126.92 154.6 44.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.646 0.736 . . . . 1.97 112.759 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.401 ' OG ' ' OH ' ' A' ' 157' ' ' TYR . 22.8 t . . . . . 0 N--CA 1.455 -0.199 0 CA-C-N 114.616 -1.175 . . . . 3.2799999999999998 111.91 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.632 ' HB2' ' HB ' ' A' ' 201' ' ' THR . 92.6 p . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 122.617 1.199 . . . . 0.66000000000000003 113.195 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.436 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.91 167.5 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.243 -1.344 . . . . 0.68999999999999995 110.938 179.797 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.56 145.64 50.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.736 -0.665 . . . . 0.52000000000000002 110.156 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.26 101.47 9.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.157 -0.683 . . . . 0.32000000000000001 109.157 177.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.7 t -112.91 139.65 36.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.099 -0.5 . . . . 0.28999999999999998 111.101 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.3 p -128.61 152.55 48.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.605 -0.725 . . . . 0.25 109.83 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.594 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.4 p90 -144.75 -164.87 2.01 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.634 -0.426 . . . . 0.31 110.606 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.735 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -124.06 127.19 73.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.246 -0.434 . . . . 0.48999999999999999 110.784 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.179 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.99 58.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.028 -0.533 . . . . 1.53 110.358 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.735 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.15 24.61 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.872 -0.604 . . . . 0.96999999999999997 111.527 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.179 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.08 128.73 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.614 -0.434 . . . . 1.5600000000000001 110.942 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.31 -9.77 55.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.862 -0.608 . . . . 1.8799999999999999 110.309 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.12 0.31 55.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 1.04 110.366 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.16 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.891 -0.595 . . . . 0.23999999999999999 109.99 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.602 ' N ' ' O ' ' A' ' 185' ' ' ILE . 32.2 t -96.21 -15.51 22.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.311 0.576 . . . . 0.28999999999999998 110.062 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.433 ' HA3' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.58 175.62 45.81 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 109.795 -1.322 . . . . 0.13 109.795 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.53 151.59 42.68 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.661 -0.416 . . . . 0.17000000000000001 110.435 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.691 ' NH2' ' OE1' ' A' ' 191' ' ' GLN . 60.3 ttp85 -132.35 121.22 23.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.129 -0.487 . . . . 1.29 109.872 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.15 136.52 38.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.702 -0.681 . . . . 0.25 110.68 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 75.8 tt0 -129.33 129.84 45.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.01 -0.541 . . . . 1.3200000000000001 110.121 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.628 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.4 p90 -138.73 135.37 34.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.049 -0.523 . . . . 0.56999999999999995 110.596 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.419 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.38 161.38 39.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.702 -0.681 . . . . 1.1599999999999999 109.697 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.0 mt -71.07 124.92 25.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.004 0.43 . . . . 0.38 110.766 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.75 -7.81 50.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.756 -0.656 . . . . 0.40999999999999998 110.9 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.73 -69.65 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 1.6599999999999999 111.453 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.459 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.68 -35.25 75.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 1.6599999999999999 111.519 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.079 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 78.98 7.33 88.5 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.862 -0.895 . . . . 1.1699999999999999 110.862 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.334 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -28.01 -171.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.784 0.326 . . . . 1.8600000000000001 110.275 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.334 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.14 45.23 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.909 0.385 . . . . 1.98 110.186 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.419 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 45.9 Cg_endo -71.01 145.84 50.97 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 122.688 2.259 . . . . 0.55000000000000004 112.383 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.628 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.78 145.74 42.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.249 -0.648 . . . . 1.1399999999999999 109.249 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.57 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 93.5 m-85 -123.35 141.36 52.07 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.292 -0.563 . . . . 0.93000000000000005 111.511 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.9 mt -128.12 127.72 43.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.334 -0.848 . . . . 0.34000000000000002 108.934 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.657 ' HB2' HD22 ' A' ' 16' ' ' ASN . 4.0 t0 -101.65 131.07 48.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.183 0.516 . . . . 1.0900000000000001 111.72 -178.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.542 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.1 mt -127.88 157.6 73.16 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.262 -0.881 . . . . 0.19 109.567 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -69.89 158.16 57.73 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.332 2.021 . . . . 0.17999999999999999 112.203 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.4 -12.1 5.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.778 -0.646 . . . . 0.20999999999999999 110.76 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.0 p -92.91 -8.64 42.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.072 -0.513 . . . . 0.28999999999999998 110.677 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.2 135.33 34.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.318 -0.401 . . . . 0.5 110.406 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.4 p -133.13 16.72 4.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.426 -0.352 . . . . 0.29999999999999999 110.493 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.55 147.18 5.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.663 -0.495 . . . . 0.23000000000000001 109.663 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.26 150.42 12.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.498 -0.481 . . . . 0.28000000000000003 111.521 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.32 124.96 50.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.57 -0.741 . . . . 1.0700000000000001 109.754 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.32 104.88 29.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.343 -0.39 . . . . 0.28999999999999998 111.119 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 84.7 Cg_endo -91.01 -179.47 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.909 0 C-N-CA 123.152 2.568 . . . . 0.42999999999999999 112.153 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.61 32.71 18.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.314 -0.857 . . . . 1.26 111.398 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.9 mt -86.44 148.59 25.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.781 0.324 . . . . 0.32000000000000001 110.43 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.776 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.4 mt -88.36 114.85 61.33 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.055 0.455 . . . . 0.57999999999999996 110.664 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.03 140.63 96.15 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.928 2.418 . . . . 0.66000000000000003 111.936 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.02 21.24 74.4 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.081 -0.808 . . . . 0.28999999999999998 111.081 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.459 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.88 150.19 49.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 2.3300000000000001 110.626 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.491 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.2 131.63 46.03 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.021 -0.536 . . . . 0.85999999999999999 109.805 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.955 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.2 m-85 -120.47 148.28 44.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.06 -0.518 . . . . 0.52000000000000002 111.048 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.2 mt -105.31 125.37 60.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.274 -1.01 . . . . 0.29999999999999999 108.274 177.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.62 132.48 63.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.19 0.519 . . . . 0.23000000000000001 111.223 -178.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.51 122.59 20.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.509 -0.768 . . . . 0.35999999999999999 109.585 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.594 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.0 125.33 54.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 0.19 110.67 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 49.0 m-85 -117.2 137.93 52.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.031 -0.531 . . . . 0.29999999999999999 109.77 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.431 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.68 135.06 42.71 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.798 -0.816 . . . . 0.37 108.798 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.602 ' O ' ' N ' ' A' ' 140' ' ' SER . 72.5 mt -99.14 122.92 51.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.08 0.467 . . . . 0.26000000000000001 110.903 -178.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.4 p -83.84 169.77 14.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.559 -0.746 . . . . 0.28000000000000003 110.522 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.555 ' O ' ' OG1' ' A' ' 59' ' ' THR . 17.1 pt-20 -59.75 -14.59 15.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.096 -0.502 . . . . 1.6000000000000001 110.966 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.544 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.3 m-20 -96.02 -4.3 43.36 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.843 -0.343 . . . . 1.1799999999999999 110.841 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.83 13.78 64.11 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.409 -0.677 . . . . 0.29999999999999999 111.409 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -84.66 139.05 32.32 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.803 -0.233 . . . . 1.22 110.461 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.691 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 87.4 mt-30 -106.75 141.09 38.56 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.835 -0.346 . . . . 0.97999999999999998 110.558 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.4 m -136.68 126.94 26.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.82999999999999996 110.42 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.09 117.26 9.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.915 0.388 . . . . 0.26000000000000001 110.528 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.4 pt -109.07 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.29999999999999999 110.653 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.9 125.61 5.81 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.524 -0.471 . . . . 0.31 111.6 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.468 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.71 120.23 21.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.841 -0.618 . . . . 0.28000000000000003 109.604 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.59 151.68 29.12 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.697 -0.401 . . . . 0.23999999999999999 110.893 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.41 158.66 18.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.005 -0.543 . . . . 0.23000000000000001 110.439 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -146.12 157.91 43.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.089 -0.505 . . . . 0.67000000000000004 110.649 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.43 9.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.711 -0.677 . . . . 0.64000000000000001 109.992 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' ' 126' ' ' SER . 68.3 p . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.986 -1.006 . . . . 1.26 110.598 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.196 -0.668 . . . . 3.4399999999999999 109.196 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.44 150.69 18.53 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.982 -0.847 . . . . 1.22 110.982 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.55 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 124.035 3.157 . . . . 0.75 113.772 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.93 173.43 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.264 -1.334 . . . . 0.79000000000000004 108.853 178.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.601 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.64 125.84 51.45 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.437 -0.505 . . . . 1.9399999999999999 111.49 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.51 143.93 34.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.661 -0.7 . . . . 0.59999999999999998 110.712 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.31 25.62 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.874 0.369 . . . . 3.1400000000000001 111.081 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.744 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.0 mt -108.96 131.08 60.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.926 -0.579 . . . . 3.23 110.044 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.15 162.28 35.87 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.838 0.352 . . . . 3.6299999999999999 111.252 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.4 mt-10 36.13 31.57 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.592 -0.521 . . . . 6.0800000000000001 109.592 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.744 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.45 69.56 32.61 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.94 -0.573 . . . . 3.3799999999999999 111.627 -178.799 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.37 -29.0 71.88 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.431 2.087 . . . . 3.9300000000000002 111.854 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.61 125.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 3.3599999999999999 110.498 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.576 ' O ' ' O ' ' A' ' 92' ' ' THR . 42.2 mt-30 -124.04 158.38 60.63 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.348 -0.387 . . . . 3.6099999999999999 110.414 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.433 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 98.4 Cg_endo -82.14 -64.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.905 2.403 . . . . 1.51 113.428 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.764 ' ND2' ' CD2' ' A' ' 157' ' ' TYR . 1.3 m120 -108.42 -19.62 13.39 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.08 0.4 . . . . 2.6800000000000002 112.08 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 57.7 m -107.33 152.14 24.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.164 0.507 . . . . 1.21 111.302 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.34 103.0 2.22 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.681 -0.69 . . . . 1.5600000000000001 110.569 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.675 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.7 145.67 13.01 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.823 2.348 . . . . 0.81000000000000005 112.6 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.922 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.82 167.96 24.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.898 -0.592 . . . . 1.52 109.928 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.13 147.9 29.02 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.777 -0.453 . . . . 2.1400000000000001 109.777 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.587 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.22 157.33 44.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.0 0.428 . . . . 0.32000000000000001 111.225 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.496 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.04 155.27 44.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.779 -0.646 . . . . 2.1699999999999999 110.106 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.84 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.56 173.1 6.27 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 121.118 0.485 . . . . 0.58999999999999997 110.743 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.84 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.72 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.864 2.376 . . . . 0.90000000000000002 111.507 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.479 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -51.05 0.69 Allowed Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.76 -0.376 . . . . 3.3399999999999999 110.142 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.634 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.87 152.31 82.66 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.837 2.358 . . . . 1.8500000000000001 111.369 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.71 42.25 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.426 0.631 . . . . 2.54 110.588 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.6 t60 -63.58 -41.59 98.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.019 -0.991 . . . . 2.5299999999999998 110.644 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.564 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.8 mt -109.85 137.87 40.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.748 -0.66 . . . . 1.1699999999999999 111.329 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.99 -72.93 0.7 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.099 -0.501 . . . . 1.27 111.886 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.22 148.41 24.38 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.607 0.595 . . . . 1.1200000000000001 112.607 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -121.88 124.81 44.99 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.397 -0.594 . . . . 0.41999999999999998 109.397 177.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.05 134.71 60.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.66 -0.416 . . . . 0.78000000000000003 110.647 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.922 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.96 128.63 53.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.036 0.446 . . . . 0.62 111.249 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.03 139.01 49.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.738 -0.665 . . . . 1.97 110.143 178.95 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.436 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.03 163.11 35.24 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 120.55 -0.46 . . . . 0.34999999999999998 112.135 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.46 139.62 7.9 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.498 -0.774 . . . . 1.8 110.485 178.763 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.62 115.46 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.302 2.001 . . . . 0.57999999999999996 111.827 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.677 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.92 81.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.84 -0.43 . . . . 3.04 109.84 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.52 0.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.016 -0.538 . . . . 2.4700000000000002 111.898 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.4 p -157.67 157.81 34.24 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.862 -0.335 . . . . 2.5099999999999998 110.554 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.36 27.77 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.181 -0.463 . . . . 1.8600000000000001 110.222 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -75.8 1.31 Allowed Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.103 -0.57 . . . . 1.4399999999999999 111.892 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.89 152.36 35.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.927 0.394 . . . . 4.6900000000000004 110.965 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.673 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.27 -169.14 2.53 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.059 -0.519 . . . . 1.4299999999999999 111.965 179.373 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.436 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.09 149.57 29.84 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.468 0.651 . . . . 1.74 112.606 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.99 156.47 46.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.807 -1.088 . . . . 1.9199999999999999 110.234 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.2 158.36 41.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.951 -0.568 . . . . 0.34000000000000002 111.792 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.0 m -115.16 135.68 53.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.446 -0.797 . . . . 0.40999999999999998 109.817 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.587 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.45 121.92 23.7 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.422 -0.353 . . . . 0.55000000000000004 111.567 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.6 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.1 Cg_exo -46.41 151.71 1.7 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.753 2.302 . . . . 0.44 112.029 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.89 -23.02 63.01 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 115.989 -0.551 . . . . 0.73999999999999999 112.742 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.54 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.81 -16.88 46.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.436 0.618 . . . . 0.93000000000000005 111.758 -178.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.6 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.6 138.36 31.63 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.799 -0.36 . . . . 0.96999999999999997 110.368 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.47 13.85 11.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.399 -0.364 . . . . 1.3400000000000001 111.447 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.477 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.95 143.52 25.28 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.657 -0.417 . . . . 0.39000000000000001 111.101 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.719 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.4 t80 -114.74 -169.36 1.53 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.089 -0.505 . . . . 0.41999999999999998 110.981 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.719 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.85 125.9 9.19 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.449 -0.796 . . . . 0.39000000000000001 109.826 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.519 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.8 mt -114.87 123.33 70.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.364 -0.534 . . . . 0.73999999999999999 111.153 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.429 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 63.9 pttt -126.54 163.36 23.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.843 -0.617 . . . . 2.48 110.425 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.16 18.87 60.05 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.749 -0.941 . . . . 0.5 110.749 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.519 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.7 mt -79.03 157.23 28.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.091 0.472 . . . . 0.57999999999999996 111.376 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.844 ' O ' HG12 ' A' ' 67' ' ' VAL . 1.8 mtmm -99.48 133.89 21.58 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.593 -0.73 . . . . 2.79 110.454 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.64 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.9 Cg_endo -67.87 143.66 61.83 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.451 2.101 . . . . 0.87 111.942 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.87 25.49 75.5 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.063 -0.815 . . . . 0.64000000000000001 111.063 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.08 158.86 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.744 0.307 . . . . 0.82999999999999996 110.403 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.2 139.92 42.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.945 0.402 . . . . 0.5 110.508 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.661 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.4 m-85 -122.54 136.41 54.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.922 -0.581 . . . . 0.53000000000000003 110.726 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.93 131.09 45.26 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.51 -0.922 . . . . 1.8700000000000001 108.51 177.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.495 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.5 153.93 16.65 Favored Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.338 -0.934 . . . . 0.28999999999999998 111.943 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -135.04 140.96 46.01 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.702 -0.481 . . . . 1.4299999999999999 109.702 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.526 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.6 tp -115.67 118.99 34.61 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.478 -0.489 . . . . 0.32000000000000001 110.503 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.724 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.52 129.15 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.301 -0.409 . . . . 0.79000000000000004 110.594 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.705 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.9 120.92 43.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.29 -0.413 . . . . 1.02 110.696 -179.714 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.853 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.58 146.47 11.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.133 0.492 . . . . 0.62 111.019 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.616 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.12 153.97 21.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.566 -0.743 . . . . 2.4399999999999999 109.852 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.24 88.61 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.966 0.413 . . . . 3.6899999999999999 110.347 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.616 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.28 32.62 0.21 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.828 -0.624 . . . . 6.0800000000000001 110.558 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.35 3.29 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.482 -0.647 . . . . 1.22 111.482 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -81.41 177.41 8.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.028 0.442 . . . . 2.8799999999999999 111.699 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.23 149.48 31.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.512 -0.767 . . . . 1.47 110.378 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.18 144.65 38.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.436 -0.347 . . . . 2.7000000000000002 110.526 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.724 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.02 136.05 61.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-O 121.155 0.502 . . . . 0.46000000000000002 111.538 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.04 141.29 52.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.573 -0.74 . . . . 0.34999999999999998 110.318 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.463 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.62 138.87 51.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.082 0.468 . . . . 3.6699999999999999 111.486 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.495 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.32 164.1 38.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.536 -0.756 . . . . 0.67000000000000004 109.523 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.571 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.22 151.64 38.71 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.354 -0.538 . . . . 1.47 111.027 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.804 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.24 172.77 12.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.644 -0.707 . . . . 0.44 110.995 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.81 160.66 21.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.391 -0.822 . . . . 1.3700000000000001 109.854 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.38 121.89 22.97 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.536 -0.466 . . . . 1.28 110.74 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.576 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.4 p -131.76 -136.55 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 122.284 1.04 . . . . 1.97 111.303 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 92' ' ' THR . 30.4 t . . . . . 0 N--CA 1.449 -0.478 0 CA-C-N 112.712 -2.04 . . . . 3.2799999999999998 106.222 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.66 ' HB2' ' HB ' ' A' ' 201' ' ' THR . 70.4 p . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 123.697 1.713 . . . . 0.66000000000000003 108.726 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.437 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.8 167.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 113.047 -1.888 . . . . 0.68999999999999995 110.988 -178.372 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.58 145.6 50.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.729 -0.668 . . . . 0.52000000000000002 110.127 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.3 101.61 9.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.121 -0.696 . . . . 0.32000000000000001 109.121 177.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.1 t -112.94 139.64 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.027 -0.533 . . . . 0.28999999999999998 111.068 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.7 p -128.67 152.65 48.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.667 -0.697 . . . . 0.25 109.793 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.76 -164.92 2.03 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.672 -0.411 . . . . 0.31 110.636 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.738 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -124.03 127.13 73.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.48999999999999999 110.905 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.177 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.87 58.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 1.53 110.306 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.738 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.1 24.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.004 -0.544 . . . . 0.96999999999999997 111.426 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.177 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.24 128.73 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.657 -0.417 . . . . 1.5600000000000001 110.954 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -86.35 -9.53 56.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.933 -0.576 . . . . 1.8799999999999999 110.393 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.0 p -87.18 0.21 55.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.47 . . . . 1.04 110.264 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.26 137.16 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.001 -0.545 . . . . 0.23999999999999999 109.988 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 185' ' ' ILE . 0.9 OUTLIER -96.19 -15.47 22.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.294 0.569 . . . . 0.28999999999999998 110.1 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.633 ' N ' HG12 ' A' ' 185' ' ' ILE . . . 178.52 175.57 45.72 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 109.814 -1.315 . . . . 0.13 109.814 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.5 151.66 42.54 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.595 -0.442 . . . . 0.17000000000000001 110.465 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.673 ' NH2' ' OE1' ' A' ' 191' ' ' GLN . 58.6 ttp85 -132.42 121.2 23.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.139 -0.482 . . . . 1.29 109.943 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.559 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.15 136.57 38.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.68 -0.691 . . . . 0.25 110.648 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 81.3 tt0 -129.38 129.85 45.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.957 -0.565 . . . . 1.3200000000000001 110.016 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 36.2 p90 -138.62 135.29 34.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.972 -0.558 . . . . 0.56999999999999995 110.731 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.421 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.29 161.35 39.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.839 -0.619 . . . . 1.1599999999999999 109.632 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.954 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.1 mt -71.09 124.84 25.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.072 0.463 . . . . 0.38 110.73 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.71 -7.79 50.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.723 -0.671 . . . . 0.40999999999999998 110.881 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -109.77 -69.58 0.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 1.6599999999999999 111.519 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.449 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.69 -35.46 76.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.115 -0.493 . . . . 1.6599999999999999 111.435 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.085 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.21 88.62 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.797 -0.921 . . . . 1.1699999999999999 110.797 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.336 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.91 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 1.8600000000000001 110.224 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.336 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.31 139.07 44.97 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.247 -0.433 . . . . 1.98 110.164 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.3 Cg_endo -70.92 145.81 51.38 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 122.756 2.304 . . . . 0.55000000000000004 112.363 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.91 145.74 42.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.186 -0.672 . . . . 1.1399999999999999 109.186 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.764 ' CD2' ' ND2' ' A' ' 16' ' ' ASN . 35.4 p90 -123.21 141.29 52.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.164 0.507 . . . . 0.93000000000000005 111.599 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.03 127.72 43.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.282 -0.872 . . . . 0.34000000000000002 108.987 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.493 ' O ' ' OD1' ' A' ' 159' ' ' ASP . 53.8 p-10 -101.62 131.09 48.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.207 0.527 . . . . 1.0900000000000001 111.821 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.92 157.53 73.45 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.363 -0.835 . . . . 0.19 109.604 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.77 158.06 58.24 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.366 2.044 . . . . 0.17999999999999999 112.268 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.32 -12.13 5.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.787 -0.642 . . . . 0.20999999999999999 110.685 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.86 -8.71 42.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.154 -0.475 . . . . 0.28999999999999998 110.679 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.39 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.354 -0.384 . . . . 0.5 110.404 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.7 p -133.15 16.7 4.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.429 -0.35 . . . . 0.29999999999999999 110.52 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.56 147.12 5.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.664 -0.495 . . . . 0.23000000000000001 109.664 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.559 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.18 150.41 12.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.541 -0.464 . . . . 0.28000000000000003 111.572 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.34 125.0 50.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.624 -0.716 . . . . 1.0700000000000001 109.794 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.44 104.86 29.7 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 0.28999999999999998 111.064 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.8 Cg_endo -90.92 -179.58 1.53 Allowed 'Trans proline' 0 C--N 1.302 -1.895 0 C-N-CA 123.184 2.59 . . . . 0.42999999999999999 112.219 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 61.77 32.65 18.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.382 -0.826 . . . . 1.26 111.37 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.0 mt -86.38 148.49 25.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.784 0.326 . . . . 0.32000000000000001 110.498 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.773 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.33 114.84 61.29 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.989 0.423 . . . . 0.57999999999999996 110.6 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.01 140.57 95.96 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.835 2.356 . . . . 0.66000000000000003 111.994 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.31 74.08 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.0 -0.84 . . . . 0.28999999999999998 111.0 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.449 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.8 mmm-85 -126.94 150.24 49.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 2.3300000000000001 110.604 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.495 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.18 131.7 45.97 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.052 -0.522 . . . . 0.85999999999999999 109.81 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.954 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.7 m-85 -120.57 148.34 44.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.052 -0.522 . . . . 0.52000000000000002 111.013 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.35 125.33 60.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.262 -1.014 . . . . 0.29999999999999999 108.262 177.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.6 132.59 63.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.139 0.495 . . . . 0.23000000000000001 111.206 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.5 122.47 20.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.483 -0.78 . . . . 0.35999999999999999 109.666 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.04 125.39 54.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.382 -0.372 . . . . 0.19 110.586 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.8 m-85 -117.24 137.86 52.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.973 -0.558 . . . . 0.29999999999999999 109.918 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.428 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.63 135.02 42.73 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.829 -0.804 . . . . 0.37 108.829 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.633 HG12 ' N ' ' A' ' 141' ' ' GLY . 0.8 OUTLIER -99.03 123.0 51.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.156 0.503 . . . . 0.26000000000000001 110.934 -178.828 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.9 p -83.98 169.71 14.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.566 -0.743 . . . . 0.28000000000000003 110.411 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.618 ' O ' ' OG1' ' A' ' 59' ' ' THR . 82.2 tt0 -59.62 -14.67 14.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.036 -0.529 . . . . 1.6000000000000001 110.964 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.675 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 87.8 m-20 -96.0 -4.38 43.28 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.862 -0.335 . . . . 1.1799999999999999 110.83 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.85 13.79 64.07 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.376 -0.69 . . . . 0.29999999999999999 111.376 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -84.53 139.05 32.41 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.096 -0.241 . . . . 1.22 110.569 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.673 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 88.9 mt-30 -106.73 140.97 38.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.48 -0.327 . . . . 0.97999999999999998 110.623 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.67 127.03 26.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.171 -0.468 . . . . 0.82999999999999996 110.407 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.23 117.33 9.89 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.717 -0.393 . . . . 0.26000000000000001 110.508 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.0 pt -108.94 -21.9 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.29999999999999999 110.752 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.87 125.75 5.88 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.509 -0.476 . . . . 0.31 111.486 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.464 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.78 120.2 21.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.701 -0.681 . . . . 0.28000000000000003 109.586 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.64 151.66 29.06 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.621 -0.432 . . . . 0.23999999999999999 110.904 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.41 158.57 18.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.02 -0.536 . . . . 0.23000000000000001 110.417 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -146.08 157.88 43.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.089 -0.505 . . . . 0.67000000000000004 110.725 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.25 104.49 9.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.772 -0.649 . . . . 0.64000000000000001 110.022 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.66 ' HB ' ' HB2' ' A' ' 126' ' ' SER . 68.0 p . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.842 -1.075 . . . . 1.26 110.588 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.55 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.142 -0.688 . . . . 3.4399999999999999 109.142 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.37 150.75 18.53 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.925 -0.87 . . . . 1.22 110.925 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -35.74 142.42 0.1 Allowed 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 123.902 3.068 . . . . 0.75 113.857 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.599 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.3 t -79.96 173.34 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.254 -1.339 . . . . 0.79000000000000004 108.825 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.599 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.57 125.89 51.5 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.412 -0.515 . . . . 1.9399999999999999 111.422 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.52 144.08 33.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.618 -0.719 . . . . 0.59999999999999998 110.599 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.08 168.19 26.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.875 0.369 . . . . 3.1400000000000001 111.127 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.748 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.93 131.19 60.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.964 -0.562 . . . . 3.23 110.124 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.21 162.36 35.67 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.806 0.336 . . . . 3.6299999999999999 111.208 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.7 mt-10 35.94 31.76 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.592 -0.521 . . . . 6.0800000000000001 109.592 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.748 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.54 69.58 33.63 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.959 -0.564 . . . . 3.3799999999999999 111.587 -178.809 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.29 -29.13 72.68 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.532 2.154 . . . . 3.9300000000000002 111.865 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 3.3599999999999999 110.532 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.717 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -124.0 158.38 60.51 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.352 -0.385 . . . . 3.6099999999999999 110.347 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.563 ' CG ' ' NH2' ' A' ' 143' ' ' ARG . 97.0 Cg_endo -82.02 -64.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.877 2.385 . . . . 1.51 113.547 -179.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.69 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 63.2 t30 -108.4 -19.62 13.4 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.11 0.411 . . . . 2.6800000000000002 112.11 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.717 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 27.6 t -107.37 152.07 24.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.184 0.516 . . . . 1.21 111.285 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.22 102.97 2.24 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.722 -0.672 . . . . 1.5600000000000001 110.606 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.442 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.7 Cg_endo -82.81 145.69 12.83 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.888 2.392 . . . . 0.81000000000000005 112.557 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.907 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.82 167.84 25.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.876 -0.602 . . . . 1.52 109.858 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.06 147.91 29.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.796 -0.446 . . . . 2.1400000000000001 109.796 178.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.586 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.21 157.25 45.07 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.686 -0.406 . . . . 0.32000000000000001 111.177 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.492 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.1 155.3 44.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.873 -0.603 . . . . 2.1699999999999999 110.102 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.836 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.63 173.01 6.39 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.156 0.503 . . . . 0.58999999999999997 110.696 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.836 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.62 173.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.892 2.394 . . . . 0.90000000000000002 111.481 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.481 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.1 -51.07 0.68 Allowed Pre-proline 0 C--N 1.33 -0.265 0 C-N-CA 120.686 -0.406 . . . . 3.3399999999999999 110.085 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.632 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.81 152.39 82.28 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.729 2.286 . . . . 1.8500000000000001 111.44 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.77 42.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.399 0.618 . . . . 2.54 110.522 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.632 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.9 t60 -63.55 -41.74 98.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.002 -0.999 . . . . 2.5299999999999998 110.651 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.558 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.1 mt -109.77 137.88 39.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.814 -0.63 . . . . 1.1699999999999999 111.293 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.97 -72.87 0.7 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.008 -0.542 . . . . 1.27 111.97 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.19 148.47 24.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.532 0.567 . . . . 1.1200000000000001 112.532 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -121.87 124.81 44.99 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.397 -0.594 . . . . 0.41999999999999998 109.397 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 mt -117.97 134.8 60.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.616 -0.434 . . . . 0.78000000000000003 110.604 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.907 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.05 128.6 53.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.983 0.42 . . . . 0.62 111.207 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.18 139.02 49.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.772 -0.649 . . . . 1.97 110.102 178.951 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.439 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.05 163.19 35.01 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 121.133 0.492 . . . . 0.34999999999999998 112.066 -178.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.49 139.53 7.82 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.434 -0.803 . . . . 1.8 110.416 178.85 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 41' ' ' ASN . 18.0 Cg_endo -63.43 115.41 3.0 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.351 2.034 . . . . 0.57999999999999996 111.847 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.668 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.99 81.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.866 -0.42 . . . . 3.04 109.866 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.688 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.24 -20.66 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.968 -0.56 . . . . 2.4700000000000002 111.923 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.65 157.79 34.26 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.835 -0.346 . . . . 2.5099999999999998 110.559 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.403 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.38 27.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 1.8600000000000001 110.163 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.84 -75.88 1.31 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.118 -0.563 . . . . 1.4399999999999999 111.867 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.87 152.29 35.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.973 0.416 . . . . 4.6900000000000004 111.0 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.15 -169.02 2.51 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.061 -0.518 . . . . 1.4299999999999999 111.981 179.335 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.19 149.71 29.72 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.482 0.658 . . . . 1.74 112.533 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.07 156.51 45.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.791 -1.095 . . . . 1.9199999999999999 110.213 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.469 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.21 158.4 41.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.976 -0.557 . . . . 0.34000000000000002 111.802 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.3 m -115.15 135.63 53.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.435 -0.802 . . . . 0.40999999999999998 109.906 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.586 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.4 122.06 23.79 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.512 -0.313 . . . . 0.55000000000000004 111.523 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.6 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.0 Cg_exo -46.46 151.74 1.73 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.689 2.259 . . . . 0.44 112.077 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.87 -23.09 63.03 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 116.065 -0.516 . . . . 0.73999999999999999 112.805 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.544 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.75 -16.83 46.44 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.225 -0.59 . . . . 0.93000000000000005 111.821 -178.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.6 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.6 mt -91.67 138.43 31.57 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.807 -0.357 . . . . 0.96999999999999997 110.232 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.48 13.81 11.02 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.277 -0.42 . . . . 1.3400000000000001 111.482 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.4 p -149.92 143.48 25.29 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.631 -0.428 . . . . 0.39000000000000001 111.058 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.81 -169.29 1.52 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.209 0.528 . . . . 0.41999999999999998 110.851 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.723 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 0.6 OUTLIER -151.84 125.91 9.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.433 -0.803 . . . . 0.39000000000000001 109.765 179.281 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.3 mt -114.81 123.25 70.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.435 -0.506 . . . . 0.73999999999999999 111.219 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.518 ' HB3' ' CD1' ' A' ' 185' ' ' ILE . 25.7 pttm -126.48 163.43 23.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.888 -0.596 . . . . 2.48 110.497 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.479 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.02 19.08 59.87 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.781 -0.928 . . . . 0.5 110.781 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.69 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.8 mt -79.1 157.3 28.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.09 0.472 . . . . 0.57999999999999996 111.311 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.847 ' O ' HG12 ' A' ' 67' ' ' VAL . 4.0 mttt -99.58 133.96 21.48 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.616 -0.72 . . . . 2.79 110.434 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.462 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.94 143.6 61.15 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.539 2.16 . . . . 0.87 111.936 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.84 25.58 75.39 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.091 -0.803 . . . . 0.64000000000000001 111.091 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.847 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.17 158.84 39.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.715 0.293 . . . . 0.82999999999999996 110.415 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.23 139.96 42.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.913 0.387 . . . . 0.5 110.56 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.654 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.9 m-85 -122.59 136.46 54.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.967 -0.56 . . . . 0.53000000000000003 110.778 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.82 131.05 45.23 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.491 -0.929 . . . . 1.8700000000000001 108.491 177.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.58 153.92 16.67 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.214 -0.993 . . . . 0.28999999999999998 111.933 -178.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -135.03 140.9 45.99 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.698 -0.482 . . . . 1.4299999999999999 109.698 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.75 118.91 34.36 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.426 -0.51 . . . . 0.32000000000000001 110.462 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.735 HG12 HG23 ' A' ' 84' ' ' VAL . 64.2 mt -112.41 129.15 68.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.79000000000000004 110.608 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.708 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.82 120.86 43.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.242 -0.435 . . . . 1.02 110.747 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.854 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.58 146.46 11.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.169 0.509 . . . . 0.62 111.022 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.623 ' O ' ' N ' ' A' ' 79' ' ' TYR . 20.9 mt-30 -106.01 153.92 21.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.519 -0.764 . . . . 2.4399999999999999 109.888 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.19 88.52 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.937 0.399 . . . . 3.6899999999999999 110.428 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.41 32.53 0.22 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.841 -0.618 . . . . 6.0800000000000001 110.53 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.04 -117.34 3.29 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.472 -0.651 . . . . 1.22 111.472 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -81.4 177.37 9.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.218 0.532 . . . . 2.8799999999999999 111.643 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.2 149.5 32.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.435 -0.802 . . . . 1.47 110.385 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.55 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.21 144.7 38.61 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.432 -0.349 . . . . 2.7000000000000002 110.511 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.735 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -127.98 135.93 61.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-O 121.087 0.47 . . . . 0.46000000000000002 111.508 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.03 141.52 51.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.59 -0.732 . . . . 0.34999999999999998 110.192 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.462 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.66 138.93 51.65 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.482 -0.487 . . . . 3.6699999999999999 111.481 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.491 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.29 164.23 37.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.582 -0.736 . . . . 0.67000000000000004 109.399 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 46.9 p30 -145.29 151.51 38.45 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.434 -0.506 . . . . 1.47 111.064 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.804 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.2 p90 -146.2 172.72 13.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.768 -0.651 . . . . 0.44 111.005 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.78 160.76 21.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.442 -0.799 . . . . 1.3700000000000001 109.807 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.5 121.86 22.79 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.565 -0.454 . . . . 1.28 110.722 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.587 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.0 p -127.02 161.87 27.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.222 0.534 . . . . 1.97 111.864 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 115.516 -0.766 . . . . 3.2799999999999998 110.531 179.368 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 6.0 p . . . . . 0 N--CA 1.461 0.121 0 CA-C-O 120.925 0.393 . . . . 0.66000000000000003 110.311 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.435 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.68 167.5 0.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.883 -0.599 . . . . 0.68999999999999995 110.949 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.56 145.53 50.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.685 -0.688 . . . . 0.52000000000000002 110.197 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.23 101.62 9.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.106 -0.702 . . . . 0.32000000000000001 109.106 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.1 t -112.94 139.67 36.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.071 -0.513 . . . . 0.28999999999999998 111.103 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.0 p -128.76 152.59 48.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.677 -0.692 . . . . 0.25 109.846 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.81 -164.91 2.03 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.688 -0.405 . . . . 0.31 110.675 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -123.97 127.19 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.48999999999999999 110.784 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.174 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -58.0 58.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.188 -0.46 . . . . 1.53 110.349 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.21 24.62 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.857 -0.611 . . . . 0.96999999999999997 111.485 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.174 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.11 128.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.626 -0.43 . . . . 1.5600000000000001 110.923 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.47 -9.62 55.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.837 -0.62 . . . . 1.8799999999999999 110.329 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 29.0 p -86.96 0.13 55.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.061 -0.518 . . . . 1.04 110.391 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.23 137.3 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.96 -0.564 . . . . 0.23999999999999999 109.989 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.613 ' N ' ' O ' ' A' ' 185' ' ' ILE . 7.1 p -96.33 -15.56 21.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.37 0.605 . . . . 0.28999999999999998 110.029 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 1.015 ' O ' HG22 ' A' ' 185' ' ' ILE . . . 178.58 175.53 45.74 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 109.809 -1.316 . . . . 0.13 109.809 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -123.42 151.52 42.55 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.63 -0.428 . . . . 0.17000000000000001 110.492 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.97 ' NH2' HE22 ' A' ' 191' ' ' GLN . 8.7 tmm_? -132.29 121.16 23.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.126 -0.488 . . . . 1.29 109.956 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.556 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.05 136.62 38.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.632 -0.713 . . . . 0.25 110.621 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 75.9 tt0 -129.39 129.89 45.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.95 -0.568 . . . . 1.3200000000000001 110.043 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.623 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.7 p90 -138.75 135.27 34.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.034 -0.53 . . . . 0.56999999999999995 110.673 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.422 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.36 39.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.694 -0.685 . . . . 1.1599999999999999 109.697 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.952 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.4 mt -70.97 124.79 25.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.992 0.425 . . . . 0.38 110.718 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.76 -7.64 49.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.768 -0.651 . . . . 0.40999999999999998 110.989 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.8 -69.72 0.85 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.264 -0.426 . . . . 1.6599999999999999 111.387 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.439 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.3 mt-10 -60.8 -35.25 75.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 1.6599999999999999 111.459 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.09 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.26 7.12 88.68 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.829 -0.908 . . . . 1.1699999999999999 110.829 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.336 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.3 t0 -27.98 -171.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.801 0.334 . . . . 1.8600000000000001 110.322 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.336 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.25 139.11 45.19 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-O 120.979 0.419 . . . . 1.98 110.238 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.422 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.0 Cg_endo -70.85 145.76 51.69 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 122.77 2.313 . . . . 0.55000000000000004 112.325 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.82 145.69 42.62 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.25 -0.648 . . . . 1.1399999999999999 109.25 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.646 ' CE2' ' CG ' ' A' ' 16' ' ' ASN . 25.0 p90 -123.24 141.38 52.04 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.348 -0.541 . . . . 0.93000000000000005 111.532 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.9 mt -128.18 127.69 43.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.275 -0.875 . . . . 0.34000000000000002 108.953 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.558 ' HB2' HD21 ' A' ' 16' ' ' ASN . 33.2 t0 -101.61 131.2 47.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.19 0.519 . . . . 1.0900000000000001 111.779 -178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -128.0 157.52 73.65 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.348 -0.842 . . . . 0.19 109.585 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -69.87 157.95 58.45 Favored 'Trans proline' 0 C--N 1.302 -1.904 0 C-N-CA 122.49 2.126 . . . . 0.17999999999999999 112.23 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.4 p -59.14 -12.19 4.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.743 -0.662 . . . . 0.20999999999999999 110.817 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.1 p -92.79 -8.76 42.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 0.28999999999999998 110.73 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.09 135.37 34.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.325 -0.398 . . . . 0.5 110.481 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.19 16.69 4.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.452 -0.34 . . . . 0.29999999999999999 110.514 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.4 p -167.51 147.16 5.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.609 -0.515 . . . . 0.23000000000000001 109.609 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.21 150.5 12.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.489 -0.484 . . . . 0.28000000000000003 111.503 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 4.0 t-20 -106.35 124.98 50.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.585 -0.734 . . . . 1.0700000000000001 109.81 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.36 104.92 29.83 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 0.28999999999999998 111.081 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.1 Cg_endo -90.97 -179.51 1.5 Allowed 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 123.231 2.621 . . . . 0.42999999999999999 112.204 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.69 32.63 18.35 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.385 -0.825 . . . . 1.26 111.411 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.448 ' O ' ' OG ' ' A' ' 126' ' ' SER . 23.9 mt -86.39 148.51 25.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.448 -0.342 . . . . 0.32000000000000001 110.489 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.77 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.5 mt -88.23 114.91 61.52 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.029 0.442 . . . . 0.57999999999999996 110.686 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.01 140.53 95.77 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.897 2.398 . . . . 0.66000000000000003 111.992 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.16 21.14 74.23 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.032 -0.827 . . . . 0.28999999999999998 111.032 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.439 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.83 150.14 49.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.768 0.318 . . . . 2.3300000000000001 110.73 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.27 131.78 46.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.139 -0.482 . . . . 0.85999999999999999 109.757 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.952 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.57 148.28 44.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.031 -0.532 . . . . 0.52000000000000002 110.99 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.2 mt -105.32 125.4 60.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.222 -1.029 . . . . 0.29999999999999999 108.222 177.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.58 132.56 63.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.205 0.526 . . . . 0.23000000000000001 111.216 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.64 20.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.575 -0.739 . . . . 0.35999999999999999 109.617 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.05 125.32 55.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.269 -0.423 . . . . 0.19 110.657 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.9 m-85 -117.21 137.94 52.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.031 -0.531 . . . . 0.29999999999999999 109.835 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.425 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.74 135.07 42.76 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.785 -0.82 . . . . 0.37 108.785 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 1.015 HG22 ' O ' ' A' ' 141' ' ' GLY . 11.7 tt -99.15 123.01 51.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.167 0.508 . . . . 0.26000000000000001 110.873 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.585 ' OG ' ' OD1' ' A' ' 188' ' ' ASP . 88.6 p -83.98 169.77 14.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.516 -0.766 . . . . 0.28000000000000003 110.485 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -59.8 -14.5 15.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.095 -0.502 . . . . 1.6000000000000001 110.897 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.671 ' OD1' ' N ' ' A' ' 190' ' ' GLU . 37.0 p30 -96.17 -4.2 43.01 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.782 -0.367 . . . . 1.1799999999999999 110.731 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.47 ' N ' ' HB ' ' A' ' 59' ' ' THR . . . 87.82 13.85 64.03 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.377 -0.689 . . . . 0.29999999999999999 111.377 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.671 ' N ' ' OD1' ' A' ' 188' ' ' ASP . 82.2 tt0 -84.67 139.0 32.34 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.04 -0.264 . . . . 1.22 110.472 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.97 HE22 ' NH2' ' A' ' 143' ' ' ARG . 31.0 mt-30 -106.72 141.11 38.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.873 0.368 . . . . 0.97999999999999998 110.523 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 61.8 m -136.72 127.07 26.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.078 -0.51 . . . . 0.82999999999999996 110.276 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.14 117.21 9.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.284 -0.416 . . . . 0.26000000000000001 110.554 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.0 pt -108.99 -21.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.29999999999999999 110.795 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.84 125.68 5.88 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.519 -0.472 . . . . 0.31 111.465 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.461 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.71 120.3 21.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.799 -0.637 . . . . 0.28000000000000003 109.585 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.66 151.74 29.13 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.667 -0.413 . . . . 0.23999999999999999 110.916 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.47 158.57 18.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.015 -0.538 . . . . 0.23000000000000001 110.41 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -146.1 157.86 43.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.123 -0.49 . . . . 0.67000000000000004 110.696 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.26 104.28 9.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.78 -0.646 . . . . 0.64000000000000001 110.096 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.0 p . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 117.845 -1.074 . . . . 1.26 110.655 -179.688 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.224 -0.658 . . . . 3.4399999999999999 109.224 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.39 150.62 18.55 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.012 -0.835 . . . . 1.22 111.012 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -35.62 142.35 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.05 0 C-N-CA 124.022 3.148 . . . . 0.75 113.828 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.6 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.0 t -79.91 173.3 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.283 -1.326 . . . . 0.79000000000000004 108.891 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.6 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.49 125.86 51.47 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.479 -0.488 . . . . 1.9399999999999999 111.482 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 143.99 33.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.665 -0.698 . . . . 0.59999999999999998 110.689 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.94 168.23 25.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.922 0.391 . . . . 3.1400000000000001 111.101 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.746 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.94 131.06 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.004 -0.544 . . . . 3.23 110.079 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.17 162.27 35.88 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.836 0.35 . . . . 3.6299999999999999 111.239 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.6 mt-10 36.18 31.5 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.648 -0.501 . . . . 6.0800000000000001 109.648 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.746 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.63 32.6 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.97 -0.559 . . . . 3.3799999999999999 111.574 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.2 Cg_endo -63.16 -29.18 73.92 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.484 2.123 . . . . 3.9300000000000002 111.888 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 3.3599999999999999 110.518 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.619 ' NE2' ' O ' ' A' ' 13' ' ' SER . 6.0 mp0 -123.98 158.29 60.74 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 3.6099999999999999 110.368 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.515 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 97.5 Cg_endo -81.98 -64.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.958 2.439 . . . . 1.51 113.431 -179.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.744 ' OD1' ' CD1' ' A' ' 157' ' ' TYR . 2.0 m120 -108.48 -19.53 13.42 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.07 0.396 . . . . 2.6800000000000002 112.07 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 60.3 m -107.36 152.0 24.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.159 0.504 . . . . 1.21 111.258 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.4 t-80 -155.26 102.97 2.23 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.623 -0.717 . . . . 1.5600000000000001 110.618 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.621 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.5 Cg_endo -82.7 145.63 12.99 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.885 2.39 . . . . 0.81000000000000005 112.601 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.916 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.8 167.96 24.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.815 -0.63 . . . . 1.52 109.909 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.16 147.98 29.09 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.712 -0.477 . . . . 2.1400000000000001 109.712 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.582 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.28 157.23 45.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.026 0.441 . . . . 0.32000000000000001 111.165 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.498 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.06 155.23 44.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.752 -0.658 . . . . 2.1699999999999999 110.116 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.841 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.55 173.05 6.34 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 121.091 0.472 . . . . 0.58999999999999997 110.748 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.841 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.65 173.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.851 2.367 . . . . 0.90000000000000002 111.502 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.484 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.06 -51.12 0.69 Allowed Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.643 -0.423 . . . . 3.3399999999999999 110.08 179.819 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.638 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.76 152.31 82.49 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.796 2.33 . . . . 1.8500000000000001 111.416 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.66 42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.35 0.595 . . . . 2.54 110.607 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.638 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.9 t60 -63.52 -41.63 98.5 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.017 -0.992 . . . . 2.5299999999999998 110.68 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.561 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.2 mt -109.86 137.79 40.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.818 -0.628 . . . . 1.1699999999999999 111.287 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.88 -72.83 0.71 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.013 -0.539 . . . . 1.27 111.986 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.21 148.43 24.38 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.517 0.562 . . . . 1.1200000000000001 112.517 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.86 124.86 45.12 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.312 -0.625 . . . . 0.41999999999999998 109.312 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.04 134.78 60.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.614 -0.434 . . . . 0.78000000000000003 110.689 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.916 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.02 128.63 53.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.62 111.246 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.96 49.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.751 -0.659 . . . . 1.97 110.178 178.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.438 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.07 163.17 35.09 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.16 0.505 . . . . 0.34999999999999998 112.128 -178.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.47 139.54 7.84 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.468 -0.787 . . . . 1.8 110.468 178.918 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.695 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.57 115.52 3.09 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.313 2.009 . . . . 0.57999999999999996 111.791 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.674 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.01 81.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.885 -0.413 . . . . 3.04 109.885 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.695 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.51 0.06 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.987 -0.551 . . . . 2.4700000000000002 111.889 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.8 p -157.72 157.69 33.96 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.82 0.343 . . . . 2.5099999999999998 110.552 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.34 27.89 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 1.8600000000000001 110.194 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.81 -75.96 1.31 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.2 -0.524 . . . . 1.4399999999999999 111.81 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.79 152.29 35.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.824 0.345 . . . . 4.6900000000000004 111.042 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.24 -169.11 2.52 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.107 -0.497 . . . . 1.4299999999999999 111.884 179.334 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.67 29.73 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.524 0.678 . . . . 1.74 112.514 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.05 156.46 46.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.689 -1.141 . . . . 1.9199999999999999 110.263 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.16 158.34 41.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.91 -0.586 . . . . 0.34000000000000002 111.818 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.1 m -115.08 135.61 54.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.505 -0.77 . . . . 0.40999999999999998 109.86 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.582 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.36 121.95 23.82 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.439 -0.346 . . . . 0.55000000000000004 111.55 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.597 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.0 Cg_exo -46.37 151.79 1.64 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.653 2.235 . . . . 0.44 112.116 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.98 -23.01 63.19 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 116.052 -0.522 . . . . 0.73999999999999999 112.763 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.1 p-80 -82.8 -16.84 46.26 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.216 -0.594 . . . . 0.93000000000000005 111.861 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.597 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.66 138.51 31.5 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.657 -0.417 . . . . 0.96999999999999997 110.281 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.55 13.94 10.98 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.314 -0.403 . . . . 1.3400000000000001 111.568 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.01 143.35 25.12 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.611 -0.436 . . . . 0.39000000000000001 111.068 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.722 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.63 -169.29 1.51 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.188 0.518 . . . . 0.41999999999999998 110.941 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.722 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.3 t -151.8 125.97 9.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.416 -0.811 . . . . 0.39000000000000001 109.808 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.517 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.93 123.2 70.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.404 -0.518 . . . . 0.73999999999999999 111.217 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -126.47 163.39 23.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.829 -0.623 . . . . 2.48 110.426 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.19 18.97 59.79 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.705 -0.958 . . . . 0.5 110.705 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.517 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.9 mt -79.1 157.14 28.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.093 0.473 . . . . 0.57999999999999996 111.324 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.84 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.0 mtpp -99.39 133.97 21.57 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 2.79 110.463 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.89 143.58 61.36 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.586 2.191 . . . . 0.87 111.963 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.87 25.58 75.4 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.023 -0.831 . . . . 0.64000000000000001 111.023 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.84 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.15 158.74 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.706 0.288 . . . . 0.82999999999999996 110.466 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.13 139.93 42.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.883 0.373 . . . . 0.5 110.602 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.653 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.3 m-85 -122.49 136.48 54.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.55 . . . . 0.53000000000000003 110.775 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.98 130.98 45.36 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.539 -0.911 . . . . 1.8700000000000001 108.539 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.43 153.91 16.63 Favored Glycine 0 C--O 1.227 -0.344 0 C-N-CA 120.299 -0.953 . . . . 0.28999999999999998 111.962 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -134.97 140.91 46.07 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.73 -0.47 . . . . 1.4299999999999999 109.73 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.7 tp -115.73 118.95 34.48 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.456 -0.498 . . . . 0.32000000000000001 110.533 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.728 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.42 129.05 68.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.323 -0.399 . . . . 0.79000000000000004 110.628 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.703 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.9 120.8 43.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.287 -0.415 . . . . 1.02 110.713 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.855 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.53 146.46 11.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.231 0.538 . . . . 0.62 111.058 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.619 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.03 153.94 21.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.495 -0.775 . . . . 2.4399999999999999 109.949 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.21 88.6 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.895 0.379 . . . . 3.6899999999999999 110.446 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.24 32.62 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.822 -0.626 . . . . 6.0800000000000001 110.598 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.08 -117.33 3.29 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.457 -0.657 . . . . 1.22 111.457 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.51 177.42 8.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.197 0.522 . . . . 2.8799999999999999 111.6 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.16 149.44 31.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.451 -0.795 . . . . 1.47 110.451 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.14 144.65 38.73 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.479 -0.328 . . . . 2.7000000000000002 110.533 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.728 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -128.01 135.99 61.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-O 121.036 0.446 . . . . 0.46000000000000002 111.555 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.05 141.32 52.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.662 -0.699 . . . . 0.34999999999999998 110.304 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.453 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.63 138.82 51.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.053 0.454 . . . . 3.6699999999999999 111.577 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.25 164.21 37.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.548 -0.751 . . . . 0.67000000000000004 109.435 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.28 151.47 38.4 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.399 -0.52 . . . . 1.47 111.058 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.804 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.2 p90 -146.18 172.66 13.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.802 -0.636 . . . . 0.44 111.039 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.6 160.71 21.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.456 -0.793 . . . . 1.3700000000000001 109.897 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.43 121.81 22.8 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.591 -0.444 . . . . 1.28 110.778 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.494 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -127.64 163.88 23.28 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 114.03 1.122 . . . . 1.97 114.03 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 C--O 1.232 0.183 0 CA-C-N 113.55 -1.659 . . . . 3.2799999999999998 108.815 177.659 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.5 p . . . . . 0 CA--C 1.521 -0.138 0 CA-C-O 121.139 0.495 . . . . 0.66000000000000003 110.365 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.436 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.86 167.59 0.25 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.602 -0.726 . . . . 0.68999999999999995 110.955 -179.231 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.62 145.48 50.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.731 -0.668 . . . . 0.52000000000000002 110.156 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.16 101.64 9.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.095 -0.706 . . . . 0.32000000000000001 109.095 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.1 t -112.92 139.78 36.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.056 -0.52 . . . . 0.28999999999999998 110.95 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.9 p -128.74 152.57 48.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.598 -0.728 . . . . 0.25 109.792 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.592 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.8 -164.87 2.02 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.741 -0.384 . . . . 0.31 110.667 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.5 t -123.98 127.12 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.48999999999999999 110.823 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.176 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.87 58.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.126 -0.488 . . . . 1.53 110.368 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -37.95 24.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.934 -0.575 . . . . 0.96999999999999997 111.579 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.176 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.23 128.68 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.659 -0.417 . . . . 1.5600000000000001 110.96 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.42 -9.53 56.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.0 -0.545 . . . . 1.8799999999999999 110.32 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.8 p -87.16 0.25 55.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 1.04 110.29 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.26 137.26 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.994 -0.548 . . . . 0.23999999999999999 109.956 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.601 ' N ' ' O ' ' A' ' 185' ' ' ILE . 90.3 p -96.29 -15.5 21.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.27 0.557 . . . . 0.28999999999999998 110.048 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.58 175.57 45.77 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 109.88 -1.288 . . . . 0.13 109.88 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.47 151.62 42.54 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.569 -0.452 . . . . 0.17000000000000001 110.496 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.653 ' NH2' ' CD ' ' A' ' 191' ' ' GLN . 41.8 ttp180 -132.26 121.14 23.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.15 -0.477 . . . . 1.29 109.924 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.558 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.14 136.63 38.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.734 -0.666 . . . . 0.25 110.649 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 99.2 mt-10 -129.45 129.86 45.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.942 -0.572 . . . . 1.3200000000000001 110.044 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.625 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.7 p90 -138.68 135.35 34.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.046 -0.525 . . . . 0.56999999999999995 110.611 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.419 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.41 161.36 39.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.793 -0.64 . . . . 1.1599999999999999 109.621 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.05 124.99 25.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.036 0.446 . . . . 0.38 110.694 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.7 p -71.94 -7.7 50.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.766 -0.652 . . . . 0.40999999999999998 110.797 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -109.72 -69.67 0.85 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.967 0.413 . . . . 1.6599999999999999 111.455 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.445 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.71 -35.28 75.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.998 -0.546 . . . . 1.6599999999999999 111.522 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.081 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.11 7.23 88.59 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.825 -0.91 . . . . 1.1699999999999999 110.825 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.34 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.83 -171.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.324 . . . . 1.8600000000000001 110.256 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.34 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.26 139.02 45.14 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-O 120.945 0.402 . . . . 1.98 110.205 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.419 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.9 Cg_endo -70.75 145.73 52.2 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 122.808 2.339 . . . . 0.55000000000000004 112.361 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.625 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.86 145.69 42.65 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.312 -0.625 . . . . 1.1399999999999999 109.312 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.744 ' CD1' ' OD1' ' A' ' 16' ' ' ASN . 0.2 OUTLIER -123.26 141.32 52.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.31 0.576 . . . . 0.93000000000000005 111.421 -178.966 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.9 mt -128.14 127.61 43.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.271 -0.877 . . . . 0.34000000000000002 108.921 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 159' ' ' ASP . 51.4 p-10 -101.61 131.21 47.94 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.194 0.521 . . . . 1.0900000000000001 111.731 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -128.02 157.58 73.5 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.237 -0.892 . . . . 0.19 109.493 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.81 158.02 58.33 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.435 2.09 . . . . 0.17999999999999999 112.267 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.36 -12.11 5.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.792 -0.64 . . . . 0.20999999999999999 110.708 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.7 p -92.82 -8.67 42.9 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.129 -0.487 . . . . 0.28999999999999998 110.715 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.38 34.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.319 -0.4 . . . . 0.5 110.394 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.12 16.53 4.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.398 -0.365 . . . . 0.29999999999999999 110.558 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.4 p -167.45 147.23 5.18 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.661 -0.496 . . . . 0.23000000000000001 109.661 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.32 150.42 12.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.565 -0.454 . . . . 0.28000000000000003 111.602 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.507 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.26 124.94 50.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.559 -0.746 . . . . 1.0700000000000001 109.843 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.45 104.86 29.72 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.918 0.389 . . . . 0.28999999999999998 111.098 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 84.4 Cg_endo -91.05 -179.42 1.47 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 123.132 2.555 . . . . 0.42999999999999999 112.163 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.56 32.73 18.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.366 -0.834 . . . . 1.26 111.419 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.1 mt -86.37 148.52 25.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.454 -0.339 . . . . 0.32000000000000001 110.454 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.773 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.31 114.88 61.44 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.018 0.437 . . . . 0.57999999999999996 110.64 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -58.98 140.62 96.14 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.815 2.343 . . . . 0.66000000000000003 112.051 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.16 74.4 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.088 -0.805 . . . . 0.28999999999999998 111.088 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.445 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.86 150.21 49.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.313 . . . . 2.3300000000000001 110.634 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.495 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.13 131.63 45.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.519 . . . . 0.85999999999999999 109.789 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.955 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.55 148.38 43.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.066 -0.515 . . . . 0.52000000000000002 110.995 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.4 125.28 60.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.363 -0.977 . . . . 0.29999999999999999 108.363 177.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.47 132.51 63.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.149 0.5 . . . . 0.23000000000000001 111.217 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.49 122.66 20.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.54 -0.755 . . . . 0.35999999999999999 109.729 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.592 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.09 125.37 55.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.284 -0.417 . . . . 0.19 110.664 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 49.1 m-85 -117.18 138.04 51.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.978 -0.555 . . . . 0.29999999999999999 109.875 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.427 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.81 134.97 43.0 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.77 -0.826 . . . . 0.37 108.77 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.601 ' O ' ' N ' ' A' ' 140' ' ' SER . 85.4 mt -99.09 122.93 51.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.145 0.498 . . . . 0.26000000000000001 110.961 -178.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.2 p -83.89 169.65 14.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.526 -0.761 . . . . 0.28000000000000003 110.447 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.63 ' O ' ' CG2' ' A' ' 59' ' ' THR . 51.5 tp10 -59.79 -14.39 14.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.034 -0.53 . . . . 1.6000000000000001 110.982 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.621 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.1 m-20 -96.18 -4.24 42.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.857 0.361 . . . . 1.1799999999999999 110.817 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.8 13.88 64.0 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.384 -0.687 . . . . 0.29999999999999999 111.384 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.5 tp10 -84.7 139.09 32.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.712 0.292 . . . . 1.22 110.422 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.653 ' CD ' ' NH2' ' A' ' 143' ' ' ARG . 21.1 pt20 -106.71 141.03 38.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.405 -0.362 . . . . 0.97999999999999998 110.602 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.4 m -136.72 127.06 26.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.82999999999999996 110.301 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.19 117.27 9.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.244 -0.434 . . . . 0.26000000000000001 110.577 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -108.97 -21.86 5.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.29999999999999999 110.711 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.83 125.72 5.9 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.551 -0.46 . . . . 0.31 111.535 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.79 120.12 21.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.854 -0.612 . . . . 0.28000000000000003 109.603 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.58 151.66 29.11 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.676 -0.409 . . . . 0.23999999999999999 110.97 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.49 158.66 18.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.23000000000000001 110.411 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -146.14 157.87 43.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.043 -0.526 . . . . 0.67000000000000004 110.627 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.2 104.31 9.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.722 -0.672 . . . . 0.64000000000000001 110.119 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.7 p . . . . . 0 C--O 1.221 -0.414 0 CA-C-O 117.902 -1.047 . . . . 1.26 110.666 -179.621 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.4 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.267 -0.642 . . . . 3.4399999999999999 109.267 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.39 150.72 18.53 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.006 -0.838 . . . . 1.22 111.006 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -35.61 142.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 124.007 3.138 . . . . 0.75 113.789 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.6 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.3 t -80.04 173.39 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.288 -1.324 . . . . 0.79000000000000004 108.745 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.6 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.66 125.86 51.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.398 -0.521 . . . . 1.9399999999999999 111.444 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.48 144.06 33.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.564 -0.744 . . . . 0.59999999999999998 110.631 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.09 168.33 25.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.944 0.402 . . . . 3.1400000000000001 111.127 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.748 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -108.99 131.06 60.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.972 -0.558 . . . . 3.23 110.116 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.2 p -141.14 162.25 35.93 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.875 0.369 . . . . 3.6299999999999999 111.24 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 75.0 mm-40 36.1 31.61 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.633 -0.506 . . . . 6.0800000000000001 109.633 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.748 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.55 69.69 33.96 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.952 -0.567 . . . . 3.3799999999999999 111.618 -178.83 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.34 -29.07 72.2 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.498 2.132 . . . . 3.9300000000000002 111.851 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.64 125.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.098 -0.501 . . . . 3.3599999999999999 110.477 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.825 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -123.99 158.31 60.71 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 3.6099999999999999 110.437 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.444 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 97.1 Cg_endo -81.95 -64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.858 2.372 . . . . 1.51 113.553 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.7 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 52.1 t30 -108.48 -19.55 13.41 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.119 0.414 . . . . 2.6800000000000002 112.119 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.825 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 47.1 m -107.31 152.05 24.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.136 0.493 . . . . 1.21 111.281 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.484 ' CD2' ' CE2' ' A' ' 89' ' ' PHE . 61.8 t60 -155.32 102.86 2.22 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.72 -0.673 . . . . 1.5600000000000001 110.682 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.452 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.6 145.72 13.17 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.875 2.383 . . . . 0.81000000000000005 112.627 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.907 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.88 167.98 24.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.896 -0.593 . . . . 1.52 109.879 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.15 148.03 29.15 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.786 -0.45 . . . . 2.1400000000000001 109.786 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.586 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.8 p90 -142.32 157.3 44.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.936 0.398 . . . . 0.32000000000000001 111.303 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.493 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.07 155.34 44.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.841 -0.618 . . . . 2.1699999999999999 110.092 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.838 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.67 173.08 6.31 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 121.122 0.487 . . . . 0.58999999999999997 110.76 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.838 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.74 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.841 2.361 . . . . 0.90000000000000002 111.512 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.481 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.14 -50.97 0.69 Allowed Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.62 -0.432 . . . . 3.3399999999999999 110.133 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.634 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.85 152.4 82.32 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.678 2.252 . . . . 1.8500000000000001 111.559 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.75 42.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.401 0.62 . . . . 2.54 110.528 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 27' ' ' PRO . 74.0 t60 -63.63 -41.63 98.24 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.008 -0.996 . . . . 2.5299999999999998 110.616 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.559 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.9 mt -109.79 137.86 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.84 -0.618 . . . . 1.1699999999999999 111.227 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.0 -72.84 0.71 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.042 -0.526 . . . . 1.27 111.937 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.29 148.38 24.34 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.549 0.574 . . . . 1.1200000000000001 112.549 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.82 124.89 45.23 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.345 -0.613 . . . . 0.41999999999999998 109.345 177.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 mt -118.06 134.75 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.608 -0.437 . . . . 0.78000000000000003 110.616 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.907 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -119.98 128.66 53.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.996 0.427 . . . . 0.62 111.245 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.93 49.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.79 -0.641 . . . . 1.97 110.213 178.914 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.439 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -144.98 163.17 35.01 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.118 0.485 . . . . 0.34999999999999998 112.043 -178.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.52 139.57 7.82 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.417 -0.811 . . . . 1.8 110.503 178.746 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.3 Cg_endo -63.54 115.47 3.06 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.347 2.032 . . . . 0.57999999999999996 111.818 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.3 tttp -46.85 81.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.883 -0.414 . . . . 3.04 109.883 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.7 0.06 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.109 -0.496 . . . . 2.4700000000000002 111.914 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 p -157.55 157.81 34.46 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.857 -0.337 . . . . 2.5099999999999998 110.592 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.402 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.33 27.77 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.213 -0.449 . . . . 1.8600000000000001 110.183 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.77 -75.97 1.31 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.198 -0.525 . . . . 1.4399999999999999 111.811 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.86 152.25 35.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.947 0.403 . . . . 4.6900000000000004 111.019 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.676 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.17 -169.14 2.54 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.996 -0.547 . . . . 1.4299999999999999 112.048 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.16 149.67 29.74 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 121.476 0.655 . . . . 1.74 112.561 -177.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.99 156.42 46.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.763 -1.108 . . . . 1.9199999999999999 110.347 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.13 158.39 41.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.209 0.528 . . . . 0.34000000000000002 111.828 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.1 m -115.22 135.57 54.03 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.57 -0.741 . . . . 0.40999999999999998 109.794 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.586 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.36 121.96 23.82 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.33 -0.396 . . . . 0.55000000000000004 111.495 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.9 Cg_exo -46.3 151.65 1.64 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.733 2.289 . . . . 0.44 112.081 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.84 -23.06 62.94 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-N 116.037 -0.529 . . . . 0.73999999999999999 112.814 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.87 -16.74 46.38 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.236 -0.585 . . . . 0.93000000000000005 111.779 -178.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.601 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.6 mt -91.69 138.41 31.59 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.807 -0.357 . . . . 0.96999999999999997 110.308 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.54 13.98 10.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.315 -0.402 . . . . 1.3400000000000001 111.482 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 86.8 p -149.97 143.5 25.25 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.696 -0.402 . . . . 0.39000000000000001 111.03 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.721 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.87 -169.43 1.55 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.286 0.565 . . . . 0.41999999999999998 110.808 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.721 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.4 t -151.77 125.89 9.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.375 -0.83 . . . . 0.39000000000000001 109.908 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.4 mt -114.74 123.27 70.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.424 -0.51 . . . . 0.73999999999999999 111.257 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.59 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 21.5 mtmt -126.48 163.33 23.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.88 -0.6 . . . . 2.48 110.464 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.473 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.14 18.99 59.84 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.77 -0.932 . . . . 0.5 110.77 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.7 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.6 mt -79.05 157.35 28.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.043 0.449 . . . . 0.57999999999999996 111.408 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.846 ' O ' HG12 ' A' ' 67' ' ' VAL . 6.6 mttp -99.54 133.95 21.51 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.666 -0.697 . . . . 2.79 110.412 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.575 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.92 143.66 61.53 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.495 2.13 . . . . 0.87 111.945 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.78 25.47 75.52 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.161 -0.776 . . . . 0.64000000000000001 111.161 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.846 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.04 158.84 39.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.655 0.264 . . . . 0.82999999999999996 110.51 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.23 139.89 42.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.916 0.388 . . . . 0.5 110.516 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.654 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.6 136.41 54.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.959 -0.564 . . . . 0.53000000000000003 110.799 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.88 130.91 45.3 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.51 -0.922 . . . . 1.8700000000000001 108.51 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.36 153.79 16.63 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.298 -0.953 . . . . 0.28999999999999998 112.07 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -134.91 140.97 46.18 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.696 -0.483 . . . . 1.4299999999999999 109.696 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.78 118.96 34.49 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.456 -0.498 . . . . 0.32000000000000001 110.483 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.735 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.5 129.02 68.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.334 -0.394 . . . . 0.79000000000000004 110.645 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.707 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.82 120.84 43.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.326 -0.397 . . . . 1.02 110.766 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.852 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.6 146.47 11.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.144 0.497 . . . . 0.62 110.985 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.621 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.0 153.88 21.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.575 -0.738 . . . . 2.4399999999999999 109.902 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.18 88.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.901 0.382 . . . . 3.6899999999999999 110.427 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.62 0.21 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.8 -0.636 . . . . 6.0800000000000001 110.56 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.34 3.29 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.406 -0.678 . . . . 1.22 111.406 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.38 177.39 9.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.132 0.492 . . . . 2.8799999999999999 111.652 -179.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.12 149.5 32.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.504 -0.771 . . . . 1.47 110.421 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.17 144.65 38.67 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.402 -0.363 . . . . 2.7000000000000002 110.623 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.735 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.0 135.96 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.997 0.427 . . . . 0.46000000000000002 111.568 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.0 141.35 52.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.667 -0.697 . . . . 0.34999999999999998 110.289 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.462 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.65 138.8 51.73 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.089 0.471 . . . . 3.6699999999999999 111.529 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.17 164.22 37.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.553 -0.749 . . . . 0.67000000000000004 109.556 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.573 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.3 151.48 38.4 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.432 -0.507 . . . . 1.47 111.004 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.805 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.15 172.75 12.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.714 -0.676 . . . . 0.44 111.024 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.69 160.71 21.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.454 -0.794 . . . . 1.3700000000000001 109.849 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.741 HG23 ' OE1' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.43 121.89 22.91 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.575 -0.45 . . . . 1.28 110.778 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.634 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.8 p -127.62 165.52 19.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 1.97 111.415 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 N--CA 1.462 0.141 0 N-CA-C 109.617 -0.512 . . . . 3.2799999999999998 109.617 179.018 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.9 p . . . . . 0 CA--C 1.522 -0.097 0 CA-C-O 120.866 0.365 . . . . 0.66000000000000003 110.546 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.437 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.91 167.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.873 -0.603 . . . . 0.68999999999999995 110.916 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.61 145.56 50.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.674 -0.693 . . . . 0.52000000000000002 110.138 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.21 101.63 9.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.086 -0.709 . . . . 0.32000000000000001 109.086 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.7 t -112.93 139.64 36.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.033 -0.531 . . . . 0.28999999999999998 111.076 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 p -128.71 152.54 48.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.669 -0.696 . . . . 0.25 109.869 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.591 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.71 -164.93 2.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.688 -0.405 . . . . 0.31 110.716 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -124.01 127.19 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.48999999999999999 110.83 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.175 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.94 58.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.059 -0.519 . . . . 1.53 110.388 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.16 24.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.876 -0.602 . . . . 0.96999999999999997 111.507 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.175 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.18 128.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.618 -0.433 . . . . 1.5600000000000001 110.921 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -86.53 -9.51 56.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.942 -0.572 . . . . 1.8799999999999999 110.339 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.18 0.34 55.47 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.045 -0.525 . . . . 1.04 110.444 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.23 137.23 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.847 -0.615 . . . . 0.23999999999999999 109.93 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.612 ' N ' ' O ' ' A' ' 185' ' ' ILE . 87.2 p -96.34 -15.4 21.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.324 0.583 . . . . 0.28999999999999998 110.068 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.56 175.54 45.73 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 109.836 -1.306 . . . . 0.13 109.836 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.44 151.61 42.5 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.637 -0.425 . . . . 0.17000000000000001 110.488 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.614 ' NH1' ' OE1' ' A' ' 191' ' ' GLN . 55.9 ttp180 -132.36 121.2 23.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.141 -0.481 . . . . 1.29 109.92 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.555 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.16 136.62 38.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.753 -0.658 . . . . 0.25 110.652 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 22.4 tp10 -129.35 129.93 45.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.981 -0.554 . . . . 1.3200000000000001 109.974 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.623 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.75 135.35 34.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.993 -0.549 . . . . 0.56999999999999995 110.507 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.422 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.38 161.37 39.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.721 -0.672 . . . . 1.1599999999999999 109.666 179.778 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.952 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.06 124.88 25.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.946 0.403 . . . . 0.38 110.772 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.7 p -71.75 -7.78 50.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.75 -0.659 . . . . 0.40999999999999998 110.853 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -109.8 -69.76 0.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.318 -0.401 . . . . 1.6599999999999999 111.394 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.439 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.5 mt-10 -60.65 -35.32 75.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.033 -0.531 . . . . 1.6599999999999999 111.441 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.091 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.16 7.32 88.53 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.785 -0.926 . . . . 1.1699999999999999 110.785 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.334 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.4 t0 -28.15 -171.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.807 0.337 . . . . 1.8600000000000001 110.266 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.334 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.15 45.23 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-O 120.918 0.389 . . . . 1.98 110.139 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.422 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.1 Cg_endo -70.98 145.81 51.07 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 C-N-CA 122.717 2.278 . . . . 0.55000000000000004 112.318 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.83 145.83 42.51 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.243 -0.651 . . . . 1.1399999999999999 109.243 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.575 ' CE1' ' HD3' ' A' ' 65' ' ' PRO . 27.5 p90 -123.37 141.32 52.11 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.372 -0.531 . . . . 0.93000000000000005 111.514 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.11 127.62 43.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.318 -0.855 . . . . 0.34000000000000002 108.994 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.549 ' HB3' ' ND2' ' A' ' 16' ' ' ASN . 37.6 p-10 -101.55 131.14 47.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.08 0.467 . . . . 1.0900000000000001 111.771 -178.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.94 157.51 73.57 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.376 -0.829 . . . . 0.19 109.58 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.74 157.94 58.69 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 122.429 2.086 . . . . 0.17999999999999999 112.269 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.26 -12.14 5.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.776 -0.647 . . . . 0.20999999999999999 110.682 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.0 p -92.87 -8.7 42.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.28999999999999998 110.711 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.11 135.31 34.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.284 -0.416 . . . . 0.5 110.394 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.1 p -133.12 16.7 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 0.29999999999999999 110.502 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.8 p -167.52 147.11 5.09 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.602 -0.518 . . . . 0.23000000000000001 109.602 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.555 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.18 150.38 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.476 -0.489 . . . . 0.28000000000000003 111.589 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.509 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.22 124.94 50.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.63 -0.714 . . . . 1.0700000000000001 109.792 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.44 104.91 30.02 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.917 0.389 . . . . 0.28999999999999998 111.112 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -90.97 -179.47 1.5 Allowed 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 123.18 2.586 . . . . 0.42999999999999999 112.23 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.64 32.67 18.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.395 -0.821 . . . . 1.26 111.387 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.9 mt -86.39 148.56 25.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.79 0.328 . . . . 0.32000000000000001 110.489 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.769 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.4 114.77 61.01 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.978 0.418 . . . . 0.57999999999999996 110.595 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -58.92 140.52 95.62 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.823 2.348 . . . . 0.66000000000000003 112.06 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.15 21.18 74.15 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.061 -0.815 . . . . 0.28999999999999998 111.061 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.439 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.88 150.15 49.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.808 0.337 . . . . 2.3300000000000001 110.691 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.15 131.65 45.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.117 -0.492 . . . . 0.85999999999999999 109.772 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.952 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.5 m-85 -120.45 148.27 44.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.172 -0.467 . . . . 0.52000000000000002 111.09 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.2 mt -105.35 125.28 60.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.342 -0.985 . . . . 0.29999999999999999 108.342 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.43 132.51 63.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.096 0.474 . . . . 0.23000000000000001 111.353 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.47 122.44 20.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.523 -0.762 . . . . 0.35999999999999999 109.651 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.591 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.98 125.39 54.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.333 -0.394 . . . . 0.19 110.651 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.19 137.9 52.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.017 -0.538 . . . . 0.29999999999999999 109.888 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.423 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.65 134.98 42.81 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.758 -0.83 . . . . 0.37 108.758 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.612 ' O ' ' N ' ' A' ' 140' ' ' SER . 65.3 mt -99.08 123.08 51.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.214 0.53 . . . . 0.26000000000000001 110.927 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.7 p -83.99 169.73 14.69 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.498 -0.773 . . . . 0.28000000000000003 110.362 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -59.82 -14.47 15.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.978 -0.555 . . . . 1.6000000000000001 110.966 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.2 m-20 -96.05 -4.32 43.22 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.837 -0.345 . . . . 1.1799999999999999 110.856 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.79 13.95 63.9 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.359 -0.696 . . . . 0.29999999999999999 111.359 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -84.78 139.06 32.22 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.01 -0.276 . . . . 1.22 110.437 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.614 ' OE1' ' NH1' ' A' ' 143' ' ' ARG . 6.9 pt20 -106.7 141.06 38.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.893 0.378 . . . . 0.97999999999999998 110.532 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.2 m -136.78 127.05 26.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.113 -0.494 . . . . 0.82999999999999996 110.39 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.2 tp -68.15 117.28 9.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.294 -0.412 . . . . 0.26000000000000001 110.527 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 43.9 pt -108.97 -21.87 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.29999999999999999 110.724 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.87 125.81 5.91 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.457 -0.497 . . . . 0.31 111.468 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.46 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.71 120.21 21.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.75 -0.659 . . . . 0.28000000000000003 109.56 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.7 29.11 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.6 -0.44 . . . . 0.23999999999999999 110.892 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.45 158.54 18.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.23000000000000001 110.472 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -146.07 157.88 43.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.133 -0.485 . . . . 0.67000000000000004 110.649 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.21 104.35 9.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.703 -0.681 . . . . 0.64000000000000001 110.05 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.2 p . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.866 -1.064 . . . . 1.26 110.669 -179.682 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.5 m . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.179 -0.675 . . . . 3.4399999999999999 109.179 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.32 150.7 18.54 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.05 -0.82 . . . . 1.22 111.05 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -35.57 142.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.076 0 C-N-CA 124.004 3.136 . . . . 0.75 113.815 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.61 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -80.02 173.52 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.256 -1.338 . . . . 0.79000000000000004 108.846 178.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.61 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.6 125.88 51.49 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.453 -0.499 . . . . 1.9399999999999999 111.352 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 144.02 33.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.678 -0.692 . . . . 0.59999999999999998 110.726 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.0 168.32 25.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.895 0.379 . . . . 3.1400000000000001 111.149 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.746 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.6 mt -109.06 131.12 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.993 -0.549 . . . . 3.23 110.076 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.2 162.33 35.74 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.862 0.363 . . . . 3.6299999999999999 111.159 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 71.7 tt0 36.0 31.68 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 109.652 -0.499 . . . . 6.0800000000000001 109.652 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.746 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.53 69.61 33.55 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.916 -0.584 . . . . 3.3799999999999999 111.493 -178.735 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.38 -29.03 71.83 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.474 2.116 . . . . 3.9300000000000002 111.832 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.6 125.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 3.3599999999999999 110.433 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.697 ' O ' ' O ' ' A' ' 92' ' ' THR . 14.2 mm-40 -123.89 158.4 60.11 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.256 -0.429 . . . . 3.6099999999999999 110.434 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.577 ' HG3' HE22 ' A' ' 191' ' ' GLN . 96.3 Cg_endo -81.99 -64.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.895 2.396 . . . . 1.51 113.534 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.591 HD22 ' CG ' ' A' ' 159' ' ' ASP . 43.2 p-10 -108.38 -19.56 13.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.3 -0.409 . . . . 2.6800000000000002 112.048 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 3.5 m -107.44 152.13 24.61 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.428 -0.509 . . . . 1.21 111.314 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.58 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.0 t-80 -155.32 102.92 2.22 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.608 -0.724 . . . . 1.5600000000000001 110.674 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.68 145.67 13.02 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.823 2.349 . . . . 0.81000000000000005 112.627 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.93 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.78 168.0 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.867 -0.606 . . . . 1.52 109.874 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.23 148.02 29.1 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.688 -0.486 . . . . 2.1400000000000001 109.688 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.59 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.34 157.34 44.9 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.615 -0.434 . . . . 0.32000000000000001 111.187 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.503 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.09 155.31 44.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.789 -0.641 . . . . 2.1699999999999999 110.163 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.841 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.62 173.02 6.38 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 121.112 0.482 . . . . 0.58999999999999997 110.741 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.841 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.68 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.913 2.408 . . . . 0.90000000000000002 111.502 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.485 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.07 -51.01 0.69 Allowed Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.719 -0.392 . . . . 3.3399999999999999 110.165 179.841 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.626 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.85 152.38 82.39 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.757 2.305 . . . . 1.8500000000000001 111.404 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.77 42.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.363 0.601 . . . . 2.54 110.517 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.626 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.8 t60 -63.62 -41.72 98.25 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.006 -0.997 . . . . 2.5299999999999998 110.634 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.571 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.5 mt -109.8 137.85 40.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.741 -0.663 . . . . 1.1699999999999999 111.287 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.93 -72.92 0.7 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.061 -0.518 . . . . 1.27 111.897 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.37 24.44 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.618 0.599 . . . . 1.1200000000000001 112.618 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.87 124.92 45.25 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.331 -0.618 . . . . 0.41999999999999998 109.331 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.11 134.77 60.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.624 -0.43 . . . . 0.78000000000000003 110.551 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.93 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.09 128.57 53.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.064 0.459 . . . . 0.62 111.244 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.04 138.96 49.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.75 -0.659 . . . . 1.97 110.175 179.0 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.435 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.11 163.23 34.93 Favored 'General case' 0 CA--C 1.523 -0.067 0 CA-C-O 121.194 0.521 . . . . 0.34999999999999998 112.052 -178.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.487 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.52 139.54 7.81 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 115.389 -0.823 . . . . 1.8 110.494 178.896 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.47 115.49 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.286 1.991 . . . . 0.57999999999999996 111.856 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.681 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.04 81.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.803 -0.443 . . . . 3.04 109.803 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.65 0.06 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.971 -0.559 . . . . 2.4700000000000002 111.942 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 p -157.66 157.72 34.11 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.744 -0.383 . . . . 2.5099999999999998 110.538 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.26 27.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.224 -0.444 . . . . 1.8600000000000001 110.181 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.91 -75.9 1.31 Allowed Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.133 -0.556 . . . . 1.4399999999999999 111.8 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.79 152.24 35.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.895 0.378 . . . . 4.6900000000000004 110.995 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.667 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.21 -169.14 2.54 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.132 -0.486 . . . . 1.4299999999999999 111.882 179.337 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.58 29.86 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.462 0.649 . . . . 1.74 112.594 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.99 156.37 46.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.794 -1.094 . . . . 1.9199999999999999 110.316 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.09 158.44 41.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.988 -0.551 . . . . 0.34000000000000002 111.87 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.7 m -115.21 135.66 53.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.511 -0.768 . . . . 0.40999999999999998 109.832 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.59 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.31 121.91 23.87 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.403 -0.362 . . . . 0.55000000000000004 111.554 -179.081 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.2 Cg_exo -46.39 151.74 1.67 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.636 2.224 . . . . 0.44 112.156 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.85 -23.11 63.03 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 116.029 -0.532 . . . . 0.73999999999999999 112.794 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.537 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.76 -16.89 46.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.375 0.587 . . . . 0.93000000000000005 111.84 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.603 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.53 138.39 31.61 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.803 -0.359 . . . . 0.96999999999999997 110.323 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.5 13.86 11.01 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.406 -0.361 . . . . 1.3400000000000001 111.554 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.476 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.96 143.46 25.24 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.659 -0.416 . . . . 0.39000000000000001 111.057 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.713 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.8 -169.37 1.53 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.019 -0.537 . . . . 0.41999999999999998 110.895 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.713 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.0 t -151.77 125.8 9.19 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.366 -0.834 . . . . 0.39000000000000001 109.853 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.511 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.8 mt -114.8 123.4 70.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.28 -0.568 . . . . 0.73999999999999999 111.156 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -126.53 163.4 23.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.831 -0.622 . . . . 2.48 110.423 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.14 18.92 59.98 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.757 -0.937 . . . . 0.5 110.757 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.511 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.0 mt -79.03 157.18 28.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.039 0.447 . . . . 0.57999999999999996 111.314 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.855 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.1 mttm -99.38 133.9 21.63 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.627 -0.715 . . . . 2.79 110.51 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.95 143.58 61.01 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.5 2.133 . . . . 0.87 111.95 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.86 25.7 75.25 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.049 -0.821 . . . . 0.64000000000000001 111.049 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.855 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.2 158.78 40.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.649 0.262 . . . . 0.82999999999999996 110.468 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.2 139.95 42.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.915 0.388 . . . . 0.5 110.579 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.666 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.3 m-85 -122.56 136.42 54.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.936 -0.575 . . . . 0.53000000000000003 110.81 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.487 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.93 131.03 45.32 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.516 -0.92 . . . . 1.8700000000000001 108.516 177.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.46 153.93 16.64 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.2 -1.0 . . . . 0.28999999999999998 111.97 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -134.98 140.99 46.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.708 -0.478 . . . . 1.4299999999999999 109.708 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.83 118.87 34.22 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.47 -0.492 . . . . 0.32000000000000001 110.523 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.731 HG12 HG23 ' A' ' 84' ' ' VAL . 64.4 mt -112.44 129.14 68.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.289 -0.414 . . . . 0.79000000000000004 110.578 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.7 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.85 120.89 43.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.256 -0.429 . . . . 1.02 110.685 -179.7 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.862 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.59 146.53 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.169 0.509 . . . . 0.62 111.018 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.622 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.08 153.87 21.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.519 -0.764 . . . . 2.4399999999999999 109.935 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.11 88.53 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.909 0.385 . . . . 3.6899999999999999 110.386 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.622 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.67 0.21 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.822 -0.626 . . . . 6.0800000000000001 110.532 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.12 -117.33 3.28 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.394 -0.682 . . . . 1.22 111.394 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.38 177.41 8.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.165 0.507 . . . . 2.8799999999999999 111.646 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.24 149.55 32.1 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.446 -0.797 . . . . 1.47 110.413 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.14 144.63 38.71 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.444 -0.344 . . . . 2.7000000000000002 110.599 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.731 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.97 135.91 61.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 120.69 -0.404 . . . . 0.46000000000000002 111.607 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.0 141.36 52.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.755 -0.657 . . . . 0.34999999999999998 110.325 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.458 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.73 138.91 51.71 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.181 0.515 . . . . 3.6699999999999999 111.478 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.29 164.1 38.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.47 -0.787 . . . . 0.67000000000000004 109.539 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.563 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.23 151.64 38.72 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.412 -0.515 . . . . 1.47 111.005 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.807 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.3 p90 -146.23 172.74 13.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.688 -0.687 . . . . 0.44 111.092 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.77 160.68 21.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.492 -0.777 . . . . 1.3700000000000001 109.887 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.36 121.96 23.1 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.559 -0.456 . . . . 1.28 110.761 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.697 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -130.99 -145.26 0.27 Allowed 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 121.941 0.877 . . . . 1.97 111.478 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.9 p . . . . . 0 CA--C 1.537 0.465 0 CA-C-N 114.191 -1.368 . . . . 3.2799999999999998 107.897 177.8 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 122.746 1.26 . . . . 0.66000000000000003 107.853 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.447 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.78 167.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.005 -1.452 . . . . 0.68999999999999995 111.022 -178.833 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.6 145.54 50.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.765 -0.652 . . . . 0.52000000000000002 110.14 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.22 101.59 9.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.099 -0.704 . . . . 0.32000000000000001 109.099 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.6 t -112.94 139.7 36.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.071 -0.513 . . . . 0.28999999999999998 111.052 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.3 p -128.62 152.58 48.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.642 -0.708 . . . . 0.25 109.842 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.586 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.4 p90 -144.78 -164.89 2.02 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.736 -0.386 . . . . 0.31 110.708 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.741 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -123.99 127.2 73.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.256 -0.429 . . . . 0.48999999999999999 110.833 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.161 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.99 58.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.075 -0.512 . . . . 1.53 110.332 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.741 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.12 24.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.88 -0.6 . . . . 0.96999999999999997 111.481 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.161 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.2 128.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.619 -0.433 . . . . 1.5600000000000001 110.891 179.782 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.38 -9.7 55.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.896 -0.593 . . . . 1.8799999999999999 110.325 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.07 0.31 55.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.058 -0.519 . . . . 1.04 110.39 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.34 137.17 25.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.919 -0.582 . . . . 0.23999999999999999 109.955 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 185' ' ' ILE . 1.8 m -96.15 -15.51 22.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.313 0.578 . . . . 0.28999999999999998 110.044 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.642 ' H ' HG12 ' A' ' 185' ' ' ILE . . . 178.62 175.63 45.85 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.846 -1.301 . . . . 0.13 109.846 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -123.4 151.57 42.47 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.705 -0.398 . . . . 0.17000000000000001 110.504 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.895 HH21 ' N ' ' A' ' 159' ' ' ASP . 1.5 tpm_? -132.39 121.25 23.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.111 -0.495 . . . . 1.29 109.878 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.559 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.06 136.56 38.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.654 -0.703 . . . . 0.25 110.649 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 85.3 tt0 -129.37 129.9 45.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.016 -0.538 . . . . 1.3200000000000001 110.0 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.613 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.66 135.31 34.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.928 -0.578 . . . . 0.56999999999999995 110.632 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.415 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.29 161.37 39.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.758 -0.655 . . . . 1.1599999999999999 109.688 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.959 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.06 124.87 25.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.981 0.419 . . . . 0.38 110.72 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.485 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.84 -7.67 49.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.759 -0.655 . . . . 0.40999999999999998 110.886 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.79 -69.74 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 1.6599999999999999 111.429 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.44 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.59 -35.39 75.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.083 -0.508 . . . . 1.6599999999999999 111.441 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.092 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.15 7.24 88.59 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.776 -0.929 . . . . 1.1699999999999999 110.776 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.308 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.4 t0 -27.94 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.759 0.314 . . . . 1.8600000000000001 110.246 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.308 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.32 139.03 44.92 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.947 0.403 . . . . 1.98 110.14 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.415 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.7 Cg_endo -70.78 145.86 52.37 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 C-N-CA 122.751 2.301 . . . . 0.55000000000000004 112.327 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.88 145.69 42.66 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.223 -0.658 . . . . 1.1399999999999999 109.223 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 143' ' ' ARG . 83.5 m-85 -123.28 141.34 52.09 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.354 -0.539 . . . . 0.93000000000000005 111.54 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.67 ' C ' HH21 ' A' ' 143' ' ' ARG . 70.8 mt -128.09 127.7 43.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.298 -0.865 . . . . 0.34000000000000002 108.935 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.895 ' N ' HH21 ' A' ' 143' ' ' ARG . 55.9 t0 -101.68 131.16 48.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.258 0.551 . . . . 1.0900000000000001 111.661 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.94 157.55 73.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.333 -0.849 . . . . 0.19 109.636 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -69.81 158.02 58.29 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.394 2.063 . . . . 0.17999999999999999 112.238 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.28 -12.12 5.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.806 -0.634 . . . . 0.20999999999999999 110.76 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.8 p -92.8 -8.82 42.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.124 -0.489 . . . . 0.28999999999999998 110.687 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.21 135.31 34.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.383 . . . . 0.5 110.338 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.5 p -133.09 16.75 4.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 0.29999999999999999 110.502 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.9 p -167.64 147.06 4.97 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.627 -0.508 . . . . 0.23000000000000001 109.627 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.559 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.19 150.45 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.398 -0.521 . . . . 0.28000000000000003 111.51 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.28 124.96 50.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.626 -0.716 . . . . 1.0700000000000001 109.81 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.41 104.89 29.78 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.403 -0.362 . . . . 0.28999999999999998 111.094 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.4 Cg_endo -90.98 -179.49 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 123.158 2.572 . . . . 0.42999999999999999 112.198 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.75 32.61 18.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.435 -0.802 . . . . 1.26 111.359 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.428 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.1 mt -86.31 148.5 25.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.54 -0.3 . . . . 0.32000000000000001 110.487 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.764 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.5 mt -88.29 114.8 61.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.986 0.422 . . . . 0.57999999999999996 110.636 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.95 140.51 95.61 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.98 2.453 . . . . 0.66000000000000003 111.93 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.03 21.32 74.18 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.025 -0.83 . . . . 0.28999999999999998 111.025 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.44 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.86 150.21 49.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.864 0.364 . . . . 2.3300000000000001 110.589 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.485 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.2 131.65 46.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.993 -0.549 . . . . 0.85999999999999999 109.801 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.959 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.5 m-85 -120.5 148.37 43.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.069 -0.514 . . . . 0.52000000000000002 110.999 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.39 125.27 60.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.243 -1.021 . . . . 0.29999999999999999 108.243 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.49 132.59 63.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.211 0.529 . . . . 0.23000000000000001 111.227 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.59 20.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.526 -0.761 . . . . 0.35999999999999999 109.622 179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.586 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -101.07 125.38 55.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.293 -0.412 . . . . 0.19 110.711 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.8 m-85 -117.21 137.92 52.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.967 -0.56 . . . . 0.29999999999999999 109.866 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.425 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.78 135.07 42.8 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.763 -0.829 . . . . 0.37 108.763 178.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.642 HG12 ' H ' ' A' ' 141' ' ' GLY . 0.8 OUTLIER -99.08 122.89 51.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.175 0.512 . . . . 0.26000000000000001 110.938 -178.718 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.6 p -83.84 169.66 14.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.586 -0.734 . . . . 0.28000000000000003 110.408 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.414 ' O ' ' HB ' ' A' ' 59' ' ' THR . 97.0 mt-10 -59.72 -14.52 14.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.959 -0.564 . . . . 1.6000000000000001 111.023 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -96.12 -4.27 43.07 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.779 -0.368 . . . . 1.1799999999999999 110.793 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.84 13.92 63.86 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.346 -0.702 . . . . 0.29999999999999999 111.346 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -84.59 139.09 32.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.574 0.225 . . . . 1.22 110.433 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.577 HE22 ' HG3' ' A' ' 15' ' ' PRO . 83.8 mt-30 -106.82 141.08 38.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.373 . . . . 0.97999999999999998 110.545 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.8 m -136.74 127.03 26.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.093 -0.503 . . . . 0.82999999999999996 110.374 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.07 117.3 9.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.26000000000000001 110.53 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.07 -21.75 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.29999999999999999 110.7 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.92 125.7 5.84 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.489 -0.484 . . . . 0.31 111.514 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.47 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.68 120.2 21.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.685 -0.689 . . . . 0.28000000000000003 109.563 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.6 151.68 29.13 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.692 -0.403 . . . . 0.23999999999999999 110.943 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.43 158.59 18.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 0.23000000000000001 110.409 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -146.1 157.91 43.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.099 -0.501 . . . . 0.67000000000000004 110.66 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.37 9.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.732 -0.667 . . . . 0.64000000000000001 109.995 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.5 p . . . . . 0 C--O 1.218 -0.555 0 CA-C-O 117.949 -1.024 . . . . 1.26 110.531 -179.673 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.8 m . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.253 -0.647 . . . . 3.4399999999999999 109.253 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.36 150.69 18.54 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.986 -0.846 . . . . 1.22 110.986 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -35.67 142.39 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 123.953 3.102 . . . . 0.75 113.789 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -80.0 173.38 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.282 -1.326 . . . . 0.79000000000000004 108.9 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.608 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.59 125.88 51.49 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.395 -0.522 . . . . 1.9399999999999999 111.413 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.46 144.03 33.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.63 -0.714 . . . . 0.59999999999999998 110.686 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.02 168.36 25.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.947 0.403 . . . . 3.1400000000000001 111.117 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.745 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.08 130.94 61.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.983 -0.553 . . . . 3.23 110.013 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.5 p -141.03 162.3 35.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.85 0.357 . . . . 3.6299999999999999 111.226 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 9' ' ' THR . 70.6 tt0 36.13 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.624 -0.509 . . . . 6.0800000000000001 109.624 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.745 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.57 33.07 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.968 -0.56 . . . . 3.3799999999999999 111.637 -178.824 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.22 -29.12 73.32 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.453 2.102 . . . . 3.9300000000000002 111.872 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 3.3599999999999999 110.422 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 17' ' ' SER . 3.3 mp0 -123.86 158.4 60.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 3.6099999999999999 110.438 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.586 ' N ' ' OG ' ' A' ' 93' ' ' SER . 98.1 Cg_endo -82.13 -64.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.81 2.34 . . . . 1.51 113.592 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.521 ' ND2' ' HB2' ' A' ' 157' ' ' TYR . 72.8 m-20 -108.47 -19.47 13.44 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.107 0.41 . . . . 2.6800000000000002 112.107 -178.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 4.9 p -107.47 152.05 24.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.18 0.514 . . . . 1.21 111.277 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.26 102.89 2.23 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.622 -0.717 . . . . 1.5600000000000001 110.637 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.535 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.7 Cg_endo -82.71 145.66 12.97 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.851 2.368 . . . . 0.81000000000000005 112.595 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.916 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.83 167.99 24.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.833 -0.621 . . . . 1.52 109.864 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -149.17 147.88 28.98 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.781 -0.451 . . . . 2.1400000000000001 109.781 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.583 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.27 157.32 44.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.078 0.466 . . . . 0.32000000000000001 111.177 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.502 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.09 155.23 44.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.766 -0.652 . . . . 2.1699999999999999 110.033 179.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.838 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.58 173.1 6.28 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.037 -0.529 . . . . 0.58999999999999997 110.747 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.838 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.66 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.858 2.372 . . . . 0.90000000000000002 111.548 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.483 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.05 -51.11 0.69 Allowed Pre-proline 0 C--N 1.33 -0.271 0 C-N-CA 120.687 -0.405 . . . . 3.3399999999999999 110.01 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.643 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.4 Cg_exo -64.77 152.35 82.36 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.751 2.301 . . . . 1.8500000000000001 111.484 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.77 42.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.363 0.602 . . . . 2.54 110.581 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.643 ' N ' ' O ' ' A' ' 27' ' ' PRO . 74.1 t60 -63.69 -41.69 98.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.969 -1.014 . . . . 2.5299999999999998 110.55 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.559 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.3 mt -109.82 137.91 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.846 -0.615 . . . . 1.1699999999999999 111.258 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.06 -72.96 0.7 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.978 -0.555 . . . . 1.27 111.828 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.19 148.31 24.45 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.583 0.586 . . . . 1.1200000000000001 112.583 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.82 124.92 45.31 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.302 -0.629 . . . . 0.41999999999999998 109.302 177.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 49' ' ' ALA . 72.0 mt -118.09 134.83 60.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.616 -0.434 . . . . 0.78000000000000003 110.604 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.916 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.08 128.56 53.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.62 111.243 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.54 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.11 139.07 49.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.757 -0.656 . . . . 1.97 110.064 179.006 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.437 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.18 163.1 35.41 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 121.176 0.512 . . . . 0.34999999999999998 112.014 -178.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.42 139.62 7.93 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.448 -0.796 . . . . 1.8 110.449 178.852 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.696 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.55 115.5 3.08 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.251 1.968 . . . . 0.57999999999999996 111.85 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.673 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.95 81.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.908 -0.405 . . . . 3.04 109.908 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.696 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.2 -20.73 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.034 -0.53 . . . . 2.4700000000000002 112.03 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.6 p -157.6 157.74 34.24 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.879 -0.328 . . . . 2.5099999999999998 110.599 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.8 m -120.37 27.83 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 1.8600000000000001 110.207 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.83 -75.9 1.31 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.121 -0.562 . . . . 1.4399999999999999 111.886 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.83 152.29 35.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.073 0.463 . . . . 4.6900000000000004 110.919 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.2 -169.14 2.54 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.991 -0.55 . . . . 1.4299999999999999 111.997 179.292 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.09 149.61 29.78 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-O 121.431 0.634 . . . . 1.74 112.684 -177.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.96 156.52 46.05 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 114.809 -1.087 . . . . 1.9199999999999999 110.302 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.2 158.43 41.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.872 -0.604 . . . . 0.34000000000000002 111.785 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.7 m -115.25 135.55 54.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.517 -0.765 . . . . 0.40999999999999998 109.755 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.583 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.4 121.97 23.78 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.433 -0.348 . . . . 0.55000000000000004 111.584 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.593 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.4 Cg_exo -46.28 151.72 1.6 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.73 2.287 . . . . 0.44 112.12 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.93 -23.02 63.09 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 116.055 -0.521 . . . . 0.73999999999999999 112.785 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.77 -16.89 46.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.407 0.604 . . . . 0.93000000000000005 111.803 -178.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.593 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.2 mt -91.57 138.41 31.59 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.841 -0.344 . . . . 0.96999999999999997 110.348 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.58 13.91 10.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.364 -0.38 . . . . 1.3400000000000001 111.544 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -149.98 143.46 25.22 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.714 -0.394 . . . . 0.39000000000000001 111.003 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.724 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.8 -169.37 1.53 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.071 -0.513 . . . . 0.41999999999999998 110.942 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.724 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 t -151.81 125.86 9.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.443 -0.799 . . . . 0.39000000000000001 109.816 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.519 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.86 123.4 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.312 -0.555 . . . . 0.73999999999999999 111.195 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.694 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 63.1 pttt -126.63 163.37 23.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.782 -0.644 . . . . 2.48 110.402 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.12 19.03 59.8 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.733 -0.947 . . . . 0.5 110.733 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.519 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.3 mt -78.97 157.18 28.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.045 0.45 . . . . 0.57999999999999996 111.378 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.844 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -99.48 133.87 21.6 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.62 -0.718 . . . . 2.79 110.486 179.737 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.8 143.5 61.54 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.594 2.196 . . . . 0.87 111.988 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.93 25.59 75.4 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.034 -0.826 . . . . 0.64000000000000001 111.034 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.18 158.74 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.73 0.3 . . . . 0.82999999999999996 110.409 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.12 139.97 41.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.926 0.394 . . . . 0.5 110.522 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.647 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.8 m-85 -122.59 136.43 54.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.986 -0.552 . . . . 0.53000000000000003 110.757 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.91 131.01 45.31 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.463 -0.94 . . . . 1.8700000000000001 108.463 177.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.494 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.43 153.9 16.63 Favored Glycine 0 C--O 1.228 -0.269 0 C-N-CA 120.357 -0.925 . . . . 0.28999999999999998 111.968 -178.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -135.08 140.85 45.85 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.723 -0.473 . . . . 1.4299999999999999 109.723 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.2 tp -115.7 118.93 34.43 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.483 -0.487 . . . . 0.32000000000000001 110.573 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.732 HG12 HG23 ' A' ' 84' ' ' VAL . 64.2 mt -112.55 129.09 68.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.409 . . . . 0.79000000000000004 110.603 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.701 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.78 120.74 43.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.259 -0.428 . . . . 1.02 110.739 -179.599 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.855 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.58 146.5 11.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.098 0.475 . . . . 0.62 111.058 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.622 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.11 153.91 21.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.505 -0.771 . . . . 2.4399999999999999 109.835 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.18 88.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.928 0.395 . . . . 3.6899999999999999 110.381 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.622 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.859 -0.609 . . . . 6.0800000000000001 110.549 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.09 -117.36 3.29 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.43 -0.668 . . . . 1.22 111.43 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -81.29 177.41 9.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.182 0.515 . . . . 2.8799999999999999 111.638 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.27 149.5 31.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.466 -0.788 . . . . 1.47 110.425 179.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.21 144.67 38.61 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.482 -0.326 . . . . 2.7000000000000002 110.576 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.732 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.02 136.0 61.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 121.139 0.495 . . . . 0.46000000000000002 111.499 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.574 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.09 141.45 52.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.622 -0.717 . . . . 0.34999999999999998 110.248 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.457 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.75 138.91 51.72 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 120.492 -0.483 . . . . 3.6699999999999999 111.438 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.494 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.28 164.18 37.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.545 -0.752 . . . . 0.67000000000000004 109.521 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.27 151.54 38.52 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.327 -0.549 . . . . 1.47 111.009 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.797 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.2 172.75 12.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.743 -0.662 . . . . 0.44 111.033 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.77 160.7 21.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.459 -0.791 . . . . 1.3700000000000001 109.806 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.34 121.91 23.05 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.54 -0.464 . . . . 1.28 110.749 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.512 ' O ' ' OG ' ' A' ' 93' ' ' SER . 70.3 p -128.92 -114.48 0.26 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.392 0.886 . . . . 1.97 113.392 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.586 ' OG ' ' N ' ' A' ' 15' ' ' PRO . 48.0 p . . . . . 0 C--N 1.343 0.317 0 CA-C-N 114.956 -1.02 . . . . 3.2799999999999998 110.789 -178.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.3 p . . . . . 0 CA--C 1.521 -0.145 0 CA-C-O 121.422 0.629 . . . . 0.66000000000000003 109.672 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.439 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.77 167.57 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.427 -0.806 . . . . 0.68999999999999995 110.983 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.65 145.47 50.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.809 -0.632 . . . . 0.52000000000000002 110.133 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.19 101.44 9.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.165 -0.68 . . . . 0.32000000000000001 109.165 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.5 t -112.87 139.71 36.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.094 -0.503 . . . . 0.28999999999999998 111.09 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 p -128.69 152.59 48.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.59 -0.732 . . . . 0.25 109.75 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.585 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.84 -164.88 2.02 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.641 -0.423 . . . . 0.31 110.675 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -123.98 127.22 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.436 . . . . 0.48999999999999999 110.82 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.169 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -58.06 58.4 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.123 -0.49 . . . . 1.53 110.368 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.17 24.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.809 -0.632 . . . . 0.96999999999999997 111.437 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.169 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.14 128.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.646 -0.422 . . . . 1.5600000000000001 111.036 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.41 -9.59 56.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.935 -0.575 . . . . 1.8799999999999999 110.295 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.22 0.38 55.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 1.04 110.286 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.22 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.23999999999999999 109.938 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.694 ' O ' ' NZ ' ' A' ' 61' ' ' LYS . 70.5 m -96.24 -15.58 21.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.256 0.55 . . . . 0.28999999999999998 110.022 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.62 175.61 45.83 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 109.858 -1.297 . . . . 0.13 109.858 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.49 151.61 42.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.961 0.41 . . . . 0.17000000000000001 110.426 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.75 HH12 ' NE2' ' A' ' 191' ' ' GLN . 50.8 ttp180 -132.31 121.16 23.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.119 -0.491 . . . . 1.29 109.918 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.563 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.05 136.49 38.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.761 -0.654 . . . . 0.25 110.693 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.525 ' HG2' ' CD2' ' A' ' 157' ' ' TYR . 94.4 mt-10 -129.36 129.86 45.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.06 -0.518 . . . . 1.3200000000000001 110.056 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.613 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.67 135.27 34.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.987 -0.552 . . . . 0.56999999999999995 110.622 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.407 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.28 161.34 39.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.751 -0.659 . . . . 1.1599999999999999 109.665 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.967 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.5 mt -70.92 124.76 25.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.975 0.417 . . . . 0.38 110.735 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.486 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.7 p -71.71 -7.79 50.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.768 -0.651 . . . . 0.40999999999999998 110.833 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -109.81 -69.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.295 -0.411 . . . . 1.6599999999999999 111.332 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.429 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.64 -35.39 76.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.106 -0.497 . . . . 1.6599999999999999 111.469 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.074 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.1 7.23 88.59 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.853 -0.899 . . . . 1.1699999999999999 110.853 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.331 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.89 -171.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.753 0.311 . . . . 1.8600000000000001 110.365 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.331 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.23 139.11 45.24 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.965 0.412 . . . . 1.98 110.23 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.419 ' HG2' ' OH ' ' A' ' 157' ' ' TYR . 46.4 Cg_endo -70.94 145.76 51.17 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.762 2.308 . . . . 0.55000000000000004 112.332 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.77 145.76 42.52 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.24 -0.652 . . . . 1.1399999999999999 109.24 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.702 ' N ' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -123.37 141.3 52.13 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.312 -0.555 . . . . 0.93000000000000005 111.5 -179.048 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.3 mt -128.04 127.67 43.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.333 -0.848 . . . . 0.34000000000000002 109.016 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -101.73 131.21 48.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.15 0.5 . . . . 1.0900000000000001 111.708 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.94 157.64 73.15 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.273 -0.876 . . . . 0.19 109.54 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.9 157.99 58.27 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.376 2.051 . . . . 0.17999999999999999 112.282 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.3 -12.1 5.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 0.20999999999999999 110.743 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.1 p -92.83 -8.75 42.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.28999999999999998 110.722 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.15 135.33 34.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.406 . . . . 0.5 110.428 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 p -133.17 16.75 4.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.478 -0.328 . . . . 0.29999999999999999 110.506 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.9 p -167.57 147.09 5.05 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.598 -0.519 . . . . 0.23000000000000001 109.598 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.563 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.14 150.48 12.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.508 -0.477 . . . . 0.28000000000000003 111.589 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.501 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 124.97 50.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.596 -0.729 . . . . 1.0700000000000001 109.78 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.46 104.86 29.79 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.872 0.368 . . . . 0.28999999999999998 111.025 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.2 Cg_endo -90.96 -179.53 1.51 Allowed 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 123.216 2.611 . . . . 0.42999999999999999 112.203 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 61.7 32.66 18.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.374 -0.83 . . . . 1.26 111.403 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 172' ' ' LEU . 24.1 mt -86.42 148.52 25.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.444 -0.343 . . . . 0.32000000000000001 110.471 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.774 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.8 mt -88.28 114.96 61.75 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.06 0.457 . . . . 0.57999999999999996 110.677 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.14 140.6 95.71 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.824 2.349 . . . . 0.66000000000000003 112.026 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.23 74.23 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.046 -0.822 . . . . 0.28999999999999998 111.046 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.429 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.91 150.22 49.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.803 0.335 . . . . 2.3300000000000001 110.641 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.486 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.2 131.63 46.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.008 -0.542 . . . . 0.85999999999999999 109.756 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.967 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.2 m-85 -120.5 148.27 44.05 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.105 -0.498 . . . . 0.52000000000000002 111.062 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.7 mt -105.36 125.38 60.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.194 -1.039 . . . . 0.29999999999999999 108.194 177.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.54 132.52 63.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.172 0.511 . . . . 0.23000000000000001 111.3 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.47 122.62 20.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.549 -0.751 . . . . 0.35999999999999999 109.613 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.585 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.1 125.35 55.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.268 -0.424 . . . . 0.19 110.622 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.28 137.91 52.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.946 -0.57 . . . . 0.29999999999999999 109.84 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.427 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.63 135.07 42.65 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.745 -0.835 . . . . 0.37 108.745 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.573 ' O ' ' N ' ' A' ' 140' ' ' SER . 47.2 mm -99.1 122.93 51.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.155 0.502 . . . . 0.26000000000000001 110.969 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.5 p -83.91 169.59 14.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.591 -0.731 . . . . 0.28000000000000003 110.496 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -59.62 -14.56 14.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.046 -0.524 . . . . 1.6000000000000001 110.966 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.535 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.6 m-20 -96.13 -4.29 43.01 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.905 -0.318 . . . . 1.1799999999999999 110.749 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.86 13.78 64.06 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.389 -0.684 . . . . 0.29999999999999999 111.389 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -84.59 139.01 32.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.625 0.25 . . . . 1.22 110.415 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.75 ' NE2' HH12 ' A' ' 143' ' ' ARG . 3.3 mt-30 -106.68 141.15 38.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.339 . . . . 0.97999999999999998 110.565 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 61.9 m -136.72 127.04 26.49 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.216 -0.447 . . . . 0.82999999999999996 110.383 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.14 117.43 9.96 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.699 -0.401 . . . . 0.26000000000000001 110.519 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.1 -21.73 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.29999999999999999 110.767 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.98 125.72 5.81 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.422 -0.511 . . . . 0.31 111.448 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.475 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.69 120.2 21.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.787 -0.642 . . . . 0.28000000000000003 109.601 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.62 151.68 29.1 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.757 -0.377 . . . . 0.23999999999999999 110.916 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.5 158.56 18.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.002 -0.545 . . . . 0.23000000000000001 110.438 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -146.02 157.89 43.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.119 -0.491 . . . . 0.67000000000000004 110.609 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.29 104.39 9.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.779 -0.646 . . . . 0.64000000000000001 110.069 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.99 -1.005 . . . . 1.26 110.56 -179.578 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.208 -0.664 . . . . 3.4399999999999999 109.208 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.69 18.54 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.032 -0.827 . . . . 1.22 111.032 179.729 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -35.66 142.4 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.042 0 C-N-CA 123.97 3.113 . . . . 0.75 113.826 -179.218 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.0 t -79.98 173.33 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.308 -1.315 . . . . 0.79000000000000004 108.846 178.431 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.614 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.55 125.87 51.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.435 -0.506 . . . . 1.9399999999999999 111.393 -179.538 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 144.01 33.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.628 -0.715 . . . . 0.59999999999999998 110.564 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.98 168.4 25.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.319 -0.401 . . . . 3.1400000000000001 111.131 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.746 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -109.06 131.1 60.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.98 -0.554 . . . . 3.23 110.048 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.14 162.25 35.94 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.442 -0.345 . . . . 3.6299999999999999 111.284 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.4 mt-10 36.21 31.51 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.607 -0.516 . . . . 6.0800000000000001 109.607 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.746 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.58 32.55 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.019 -0.537 . . . . 3.3799999999999999 111.558 -178.737 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.637 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.29 -29.14 72.69 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.494 2.129 . . . . 3.9300000000000002 111.854 179.395 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.637 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.65 125.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.016 -0.538 . . . . 3.3599999999999999 110.502 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.525 ' CB ' ' O ' ' A' ' 17' ' ' SER . 9.6 mp0 -123.91 158.33 60.43 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.368 -0.378 . . . . 3.6099999999999999 110.486 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.474 ' HG3' ' CZ ' ' A' ' 143' ' ' ARG . 97.6 Cg_endo -82.11 -64.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.808 2.339 . . . . 1.51 113.446 -178.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.789 HD22 ' CA ' ' A' ' 62' ' ' GLY . 14.5 t-20 -108.42 -19.54 13.42 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.087 0.403 . . . . 2.6800000000000002 112.087 -178.496 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 27.2 m -107.33 152.07 24.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.214 0.531 . . . . 1.21 111.256 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.0 t-80 -155.22 102.91 2.24 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.705 -0.68 . . . . 1.5600000000000001 110.66 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.5 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.4 Cg_endo -82.6 145.59 13.12 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.882 2.388 . . . . 0.81000000000000005 112.676 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.933 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.77 167.99 24.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 1.52 109.982 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.14 147.95 29.07 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.75 -0.463 . . . . 2.1400000000000001 109.75 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.27 157.28 45.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.017 0.437 . . . . 0.32000000000000001 111.242 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.497 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.8 m-20 -127.96 155.3 44.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.786 -0.643 . . . . 2.1699999999999999 110.132 178.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.835 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.66 173.06 6.33 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 121.14 0.495 . . . . 0.58999999999999997 110.666 -179.214 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.835 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.66 173.88 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.882 2.388 . . . . 0.90000000000000002 111.506 179.338 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.06 -50.93 0.69 Allowed Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 120.717 -0.393 . . . . 3.3399999999999999 110.134 179.902 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.62 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.8 Cg_exo -64.96 152.43 82.35 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.697 2.264 . . . . 1.8500000000000001 111.451 179.187 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.77 42.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.385 0.612 . . . . 2.54 110.518 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.62 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.8 t60 -63.67 -41.68 98.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.02 -0.991 . . . . 2.5299999999999998 110.722 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.565 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.5 mt -109.78 137.86 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.723 -0.672 . . . . 1.1699999999999999 111.311 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.98 -72.82 0.71 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.013 -0.54 . . . . 1.27 111.92 -178.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.23 148.4 24.37 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.593 0.59 . . . . 1.1200000000000001 112.593 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.85 124.74 44.84 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.413 -0.588 . . . . 0.41999999999999998 109.413 177.514 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 mt -117.88 134.72 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.666 -0.414 . . . . 0.78000000000000003 110.701 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.933 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.02 128.55 53.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 0.62 111.228 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.15 138.99 49.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.708 -0.678 . . . . 1.97 110.11 178.974 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -144.99 163.23 34.83 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.152 0.501 . . . . 0.34999999999999998 112.066 -178.081 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.488 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.59 139.65 7.81 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.435 -0.802 . . . . 1.8 110.397 178.808 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.66 115.54 3.12 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.284 1.989 . . . . 0.57999999999999996 111.793 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.683 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.03 81.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.899 -0.408 . . . . 3.04 109.899 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.688 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.22 -20.54 0.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.969 -0.56 . . . . 2.4700000000000002 111.9 -179.526 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 p -157.65 157.69 34.05 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 120.855 -0.338 . . . . 2.5099999999999998 110.569 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.403 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.3 27.79 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.249 -0.432 . . . . 1.8600000000000001 110.223 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.79 -75.91 1.31 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.184 -0.531 . . . . 1.4399999999999999 111.831 -179.246 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.93 152.31 35.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.981 0.419 . . . . 4.6900000000000004 110.939 -179.285 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.669 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.2 -169.14 2.54 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.001 -0.545 . . . . 1.4299999999999999 111.873 179.415 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.6 mttp -110.13 149.66 29.74 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.48 0.657 . . . . 1.74 112.568 -177.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.01 156.42 46.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.757 -1.111 . . . . 1.9199999999999999 110.325 178.638 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.21 158.27 41.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.978 -0.555 . . . . 0.34000000000000002 111.788 -179.296 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.8 m -115.07 135.58 54.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.502 -0.772 . . . . 0.40999999999999998 109.889 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.596 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.33 121.96 23.86 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.422 -0.353 . . . . 0.55000000000000004 111.588 -179.171 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.607 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.3 Cg_exo -46.29 151.7 1.62 Allowed 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.706 2.271 . . . . 0.44 112.181 178.98 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.01 -23.02 63.28 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 116.133 -0.485 . . . . 0.73999999999999999 112.708 -179.107 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.78 -16.79 46.49 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.223 -0.591 . . . . 0.93000000000000005 111.854 -178.341 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.607 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.6 138.45 31.56 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.779 -0.368 . . . . 0.96999999999999997 110.321 179.338 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.54 13.79 10.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.433 -0.349 . . . . 1.3400000000000001 111.475 -179.285 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.477 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.91 143.56 25.35 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.591 -0.444 . . . . 0.39000000000000001 111.003 179.633 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.4 t80 -114.88 -169.41 1.54 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.127 0.489 . . . . 0.41999999999999998 110.904 -179.455 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.714 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.74 125.85 9.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.408 -0.815 . . . . 0.39000000000000001 109.805 179.288 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.515 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.77 123.21 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.415 -0.514 . . . . 0.73999999999999999 111.268 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.869 ' HZ3' ' CD1' ' A' ' 185' ' ' ILE . 50.4 tttp -126.5 163.4 23.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.884 -0.598 . . . . 2.48 110.431 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.789 ' CA ' HD22 ' A' ' 16' ' ' ASN . . . 85.15 19.02 59.78 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.737 -0.945 . . . . 0.5 110.737 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.523 ' N ' ' ND2' ' A' ' 16' ' ' ASN . 73.5 mt -79.09 157.18 28.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.077 0.465 . . . . 0.57999999999999996 111.327 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.844 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -99.41 134.05 21.5 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.525 -0.762 . . . . 2.79 110.49 179.722 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.587 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -68.03 143.66 60.89 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.463 2.109 . . . . 0.87 111.908 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.79 25.64 75.32 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.031 -0.828 . . . . 0.64000000000000001 111.031 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.15 158.8 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.735 0.302 . . . . 0.82999999999999996 110.369 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.09 139.94 41.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.333 -0.394 . . . . 0.5 110.565 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.648 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.58 136.46 54.89 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.954 -0.566 . . . . 0.53000000000000003 110.82 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.98 131.06 45.32 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.481 -0.933 . . . . 1.8700000000000001 108.481 177.67 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.5 153.87 16.65 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.221 -0.99 . . . . 0.28999999999999998 111.935 -178.566 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -134.93 140.94 46.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.648 -0.501 . . . . 1.4299999999999999 109.648 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.2 tp -115.79 118.86 34.21 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.488 -0.485 . . . . 0.32000000000000001 110.524 179.64 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 84' ' ' VAL . 63.8 mt -112.4 129.08 68.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 0.79000000000000004 110.66 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.703 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.82 120.89 43.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.261 -0.427 . . . . 1.02 110.701 -179.649 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.857 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.55 146.44 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.184 0.516 . . . . 0.62 111.001 -179.284 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.623 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.06 153.82 21.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.499 -0.773 . . . . 2.4399999999999999 109.974 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.23 88.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.959 0.409 . . . . 3.6899999999999999 110.433 -179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.43 32.56 0.23 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.74 -0.664 . . . . 6.0800000000000001 110.604 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.16 -117.33 3.28 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.443 -0.663 . . . . 1.22 111.443 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.48 177.42 8.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.157 0.503 . . . . 2.8799999999999999 111.655 -179.131 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.17 149.59 32.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.468 -0.787 . . . . 1.47 110.35 179.181 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.2 144.62 38.59 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.386 -0.37 . . . . 2.7000000000000002 110.527 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.727 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.94 136.01 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 121.032 0.444 . . . . 0.46000000000000002 111.617 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.1 141.35 52.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.634 -0.712 . . . . 0.34999999999999998 110.285 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.471 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.62 138.87 51.67 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.085 0.469 . . . . 3.6699999999999999 111.535 -179.354 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.28 164.15 38.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.524 -0.762 . . . . 0.67000000000000004 109.53 179.371 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.565 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.22 151.52 38.53 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.411 -0.516 . . . . 1.47 111.049 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.807 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.2 p90 -146.19 172.73 13.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.781 -0.645 . . . . 0.44 111.053 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.73 160.67 21.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.414 -0.812 . . . . 1.3700000000000001 109.841 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.47 121.9 22.88 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.563 -0.455 . . . . 1.28 110.768 179.927 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.413 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -128.28 151.03 49.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.051 -0.522 . . . . 1.97 111.421 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--N 1.332 -0.18 0 CA-C-O 121.357 0.599 . . . . 3.2799999999999998 110.337 177.66 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 112.286 0.476 . . . . 0.66000000000000003 112.286 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.441 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.9 167.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.064 -0.516 . . . . 0.68999999999999995 110.931 179.124 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.66 145.52 50.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.772 -0.649 . . . . 0.52000000000000002 110.111 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.29 101.62 9.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.087 -0.708 . . . . 0.32000000000000001 109.087 177.756 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.4 t -112.85 139.67 36.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.015 -0.538 . . . . 0.28999999999999998 111.129 -178.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.4 p -128.72 152.49 48.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.692 -0.685 . . . . 0.25 109.852 179.606 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.72 -164.84 2.01 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.705 -0.398 . . . . 0.31 110.678 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.734 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.3 t -124.01 127.17 73.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 0.48999999999999999 110.799 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.172 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.95 58.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.138 -0.483 . . . . 1.53 110.283 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.07 24.4 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.003 -0.544 . . . . 0.96999999999999997 111.442 -179.721 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.172 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.2 128.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.688 -0.405 . . . . 1.5600000000000001 111.002 179.823 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -86.41 -9.6 55.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.885 -0.598 . . . . 1.8799999999999999 110.294 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.15 0.25 55.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.471 . . . . 1.04 110.351 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.22 137.3 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.943 -0.571 . . . . 0.23999999999999999 109.955 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.61 ' N ' ' O ' ' A' ' 185' ' ' ILE . 69.3 m -96.38 -15.51 21.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.336 0.588 . . . . 0.28999999999999998 110.011 -179.65 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.55 175.56 45.74 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 109.847 -1.301 . . . . 0.13 109.847 179.611 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.43 151.65 42.44 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.601 -0.439 . . . . 0.17000000000000001 110.488 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.495 ' NH2' ' CD2' ' A' ' 183' ' ' TYR . 68.8 ttp85 -132.37 121.13 23.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.175 -0.466 . . . . 1.29 109.87 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.554 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.03 136.61 38.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.678 -0.692 . . . . 0.25 110.687 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 83.3 tt0 -129.37 129.95 45.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.942 -0.572 . . . . 1.3200000000000001 110.031 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.62 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.9 p90 -138.77 135.26 34.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.998 -0.547 . . . . 0.56999999999999995 110.582 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.418 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.32 161.4 39.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.769 -0.65 . . . . 1.1599999999999999 109.638 179.804 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.969 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.05 124.79 25.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.99 0.424 . . . . 0.38 110.666 -179.585 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.74 -7.65 49.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.756 -0.656 . . . . 0.40999999999999998 110.909 -179.866 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.9 -69.71 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.301 -0.409 . . . . 1.6599999999999999 111.357 -179.292 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.472 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.65 -35.35 76.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.083 -0.508 . . . . 1.6599999999999999 111.471 -179.09 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.076 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.12 88.67 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.771 -0.932 . . . . 1.1699999999999999 110.771 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.324 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.9 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.74 0.305 . . . . 1.8600000000000001 110.334 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.324 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.35 139.11 44.85 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.01 0.433 . . . . 1.98 110.165 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.418 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.5 Cg_endo -70.97 145.89 51.34 Favored 'Trans proline' 0 C--N 1.301 -1.936 0 C-N-CA 122.601 2.201 . . . . 0.55000000000000004 112.365 -179.472 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.89 145.67 42.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.147 -0.686 . . . . 1.1399999999999999 109.147 179.308 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.587 ' CE1' ' CD ' ' A' ' 65' ' ' PRO . 11.5 p90 -123.2 141.41 52.0 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.363 -0.535 . . . . 0.93000000000000005 111.6 -179.2 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.14 127.61 43.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.326 -0.852 . . . . 0.34000000000000002 108.911 179.016 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.544 ' OD2' ' CG ' ' A' ' 16' ' ' ASN . 66.9 m-20 -101.59 131.23 47.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.143 0.497 . . . . 1.0900000000000001 111.781 -178.829 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -128.03 157.52 73.71 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.324 -0.853 . . . . 0.19 109.477 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -69.78 158.05 58.25 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.433 2.089 . . . . 0.17999999999999999 112.218 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.417 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.33 -12.14 5.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.824 -0.626 . . . . 0.20999999999999999 110.698 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.1 p -92.8 -8.8 42.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.28999999999999998 110.742 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.39 34.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.5 110.433 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.7 p -133.14 16.68 4.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.413 -0.358 . . . . 0.29999999999999999 110.483 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.58 147.09 5.04 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.658 -0.497 . . . . 0.23000000000000001 109.658 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.554 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.14 150.49 12.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.515 -0.474 . . . . 0.28000000000000003 111.588 -179.576 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 125.0 50.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.667 -0.697 . . . . 1.0700000000000001 109.761 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.6 105.01 31.17 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.985 0.422 . . . . 0.28999999999999998 110.999 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.0 Cg_endo -91.03 -179.51 1.48 Allowed 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 123.158 2.572 . . . . 0.42999999999999999 112.174 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.69 32.64 18.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.428 -0.805 . . . . 1.26 111.443 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.44 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.0 mt -86.34 148.47 25.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.47 -0.332 . . . . 0.32000000000000001 110.487 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.773 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.14 114.91 61.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.982 0.42 . . . . 0.57999999999999996 110.666 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.1 140.61 95.89 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.901 2.401 . . . . 0.66000000000000003 111.971 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.1 21.12 74.47 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.072 -0.811 . . . . 0.28999999999999998 111.072 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.472 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.79 150.24 49.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.849 0.357 . . . . 2.3300000000000001 110.641 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.3 131.69 46.09 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.062 -0.517 . . . . 0.85999999999999999 109.755 179.335 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.969 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.61 148.36 44.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.07 -0.514 . . . . 0.52000000000000002 110.94 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.39 125.41 60.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.255 -1.017 . . . . 0.29999999999999999 108.255 177.76 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.53 132.53 63.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.084 0.469 . . . . 0.23000000000000001 111.251 -178.574 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.9 m-20 -136.47 122.54 20.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.604 -0.725 . . . . 0.35999999999999999 109.669 179.297 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.02 125.41 54.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.281 -0.418 . . . . 0.19 110.682 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.2 m-85 -117.23 137.8 52.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.999 -0.546 . . . . 0.29999999999999999 109.9 179.538 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.431 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.64 135.01 42.74 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.853 -0.795 . . . . 0.37 108.853 178.816 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.869 ' CD1' ' HZ3' ' A' ' 61' ' ' LYS . 81.3 mt -99.12 122.94 51.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.212 0.53 . . . . 0.26000000000000001 110.909 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.7 p -83.87 169.72 14.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.512 -0.767 . . . . 0.28000000000000003 110.501 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 187' ' ' GLU . 49.5 tp10 -59.74 -14.59 15.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.01 -0.541 . . . . 1.6000000000000001 110.902 -179.563 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.55 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.8 m-20 -96.06 -4.27 43.3 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.836 -0.346 . . . . 1.1799999999999999 110.809 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.82 13.89 63.94 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.346 -0.701 . . . . 0.29999999999999999 111.346 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -84.73 139.1 32.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.67 0.271 . . . . 1.22 110.437 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -106.75 141.08 38.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.361 . . . . 0.97999999999999998 110.551 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.0 m -136.72 127.05 26.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 0.82999999999999996 110.35 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 25.6 tp -68.17 117.29 9.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.266 -0.424 . . . . 0.26000000000000001 110.566 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.0 pt -108.96 -21.89 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.29999999999999999 110.706 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.86 125.76 5.89 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.412 -0.515 . . . . 0.31 111.449 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.471 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.72 120.21 21.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.793 -0.64 . . . . 0.28000000000000003 109.643 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.63 151.7 29.11 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.642 -0.423 . . . . 0.23999999999999999 110.954 -179.272 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.54 158.58 18.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.04 -0.527 . . . . 0.23000000000000001 110.38 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.402 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 68.1 mt-30 -146.04 157.95 43.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.67000000000000004 110.645 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.29 104.34 9.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.732 -0.667 . . . . 0.64000000000000001 110.061 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 C--O 1.221 -0.407 0 CA-C-O 117.837 -1.078 . . . . 1.26 110.593 -179.607 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.9 m . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.244 -0.65 . . . . 3.4399999999999999 109.244 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.442 ' H ' ' HB3' ' A' ' 1' ' ' SER . . . -116.33 150.73 18.54 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.03 -0.828 . . . . 1.22 111.03 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -35.67 142.41 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.054 0 C-N-CA 123.934 3.089 . . . . 0.75 113.813 -179.23 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.629 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -79.94 173.43 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.257 -1.338 . . . . 0.79000000000000004 108.804 178.42 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.629 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.64 125.85 51.47 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.424 -0.51 . . . . 1.9399999999999999 111.392 -179.553 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.58 144.06 33.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.655 -0.702 . . . . 0.59999999999999998 110.597 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.04 168.36 25.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.857 0.361 . . . . 3.1400000000000001 111.105 -179.636 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.739 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.4 mt -109.0 131.08 60.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.002 -0.545 . . . . 3.23 110.063 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.5 p -141.17 162.3 35.82 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.829 0.347 . . . . 3.6299999999999999 111.202 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 69.3 mm-40 36.1 31.57 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.563 -0.532 . . . . 6.0800000000000001 109.563 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.739 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.41 69.59 32.3 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.968 -0.56 . . . . 3.3799999999999999 111.625 -178.833 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.639 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.21 -29.23 73.47 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.496 2.131 . . . . 3.9300000000000002 111.864 179.339 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.639 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.72 125.58 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.142 -0.481 . . . . 3.3599999999999999 110.512 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.585 HE21 ' HB2' ' A' ' 17' ' ' SER . 28.2 mt-30 -124.02 158.34 60.69 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.406 -0.361 . . . . 3.6099999999999999 110.466 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.539 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 98.1 Cg_endo -82.01 -64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.843 2.362 . . . . 1.51 113.503 -178.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.666 ' OD1' ' CE2' ' A' ' 157' ' ' TYR . 66.1 t30 -108.38 -19.65 13.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.326 -0.397 . . . . 2.6800000000000002 112.064 -178.553 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.585 ' HB2' HE21 ' A' ' 14' ' ' GLN . 31.1 m -107.3 152.05 24.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.145 0.498 . . . . 1.21 111.266 -179.358 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.569 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.31 102.96 2.22 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.677 -0.692 . . . . 1.5600000000000001 110.637 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.69 145.55 12.97 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.915 2.41 . . . . 0.81000000000000005 112.646 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.902 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.74 167.98 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.881 -0.6 . . . . 1.52 109.922 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.15 147.96 29.07 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.738 -0.467 . . . . 2.1400000000000001 109.738 178.873 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.598 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.29 157.25 45.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.017 0.437 . . . . 0.32000000000000001 111.204 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.498 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -127.99 155.31 44.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.817 -0.629 . . . . 2.1699999999999999 110.087 178.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.819 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.62 173.05 6.33 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.187 -0.461 . . . . 0.58999999999999997 110.741 -179.199 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.819 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.8 Cg_exo -50.72 173.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.885 0 C-N-CA 122.867 2.378 . . . . 0.90000000000000002 111.497 179.33 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.485 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.95 -50.97 0.7 Allowed Pre-proline 0 C--N 1.33 -0.255 0 C-N-CA 120.672 -0.411 . . . . 3.3399999999999999 110.134 179.847 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.623 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.97 152.4 82.48 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.652 2.235 . . . . 1.8500000000000001 111.419 179.219 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.68 42.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.427 0.632 . . . . 2.54 110.615 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.623 ' H ' ' C ' ' A' ' 27' ' ' PRO . 73.8 t60 -63.65 -41.56 98.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.97 -1.014 . . . . 2.5299999999999998 110.691 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.558 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.6 mt -109.95 137.92 40.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.728 -0.669 . . . . 1.1699999999999999 111.259 -179.462 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.03 -72.87 0.7 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.039 -0.528 . . . . 1.27 111.894 -178.941 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.35 24.45 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.581 0.586 . . . . 1.1200000000000001 112.581 -179.631 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -121.84 124.9 45.22 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.338 -0.616 . . . . 0.41999999999999998 109.338 177.476 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.9 mt -118.04 134.7 60.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.651 -0.42 . . . . 0.78000000000000003 110.61 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.902 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.99 128.6 53.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.978 0.418 . . . . 0.62 111.334 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.551 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.07 138.99 49.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.715 -0.675 . . . . 1.97 110.215 178.972 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.437 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.06 163.12 35.23 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.109 0.48 . . . . 0.34999999999999998 112.093 -178.065 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.4 139.58 7.93 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.466 -0.788 . . . . 1.8 110.538 178.777 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.694 ' O ' ' N ' ' A' ' 41' ' ' ASN . 18.2 Cg_endo -63.46 115.4 3.01 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.322 2.014 . . . . 0.57999999999999996 111.94 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.674 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.98 81.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.837 -0.431 . . . . 3.04 109.837 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.694 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.31 -20.65 0.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.015 -0.538 . . . . 2.4700000000000002 111.927 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.2 p -157.56 157.83 34.48 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.809 -0.356 . . . . 2.5099999999999998 110.56 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.42 27.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 1.8600000000000001 110.125 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.87 -75.84 1.31 Allowed Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.178 -0.534 . . . . 1.4399999999999999 111.89 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.91 152.31 35.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.961 0.41 . . . . 4.6900000000000004 111.056 -179.453 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.645 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.13 2.53 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.126 -0.488 . . . . 1.4299999999999999 111.985 179.364 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.08 149.67 29.69 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.464 0.649 . . . . 1.74 112.563 -177.851 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.04 156.52 46.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.762 -1.108 . . . . 1.9199999999999999 110.259 178.582 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.22 158.34 41.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.916 -0.584 . . . . 0.34000000000000002 111.82 -179.306 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.6 m -115.23 135.7 53.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.479 -0.782 . . . . 0.40999999999999998 109.75 179.266 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.598 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.31 121.96 23.88 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.55000000000000004 111.546 -179.153 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.4 Cg_exo -46.41 151.71 1.7 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.731 2.287 . . . . 0.44 112.083 179.029 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.99 -22.92 63.11 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.076 -0.511 . . . . 0.73999999999999999 112.747 -179.163 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.544 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.85 -16.83 46.1 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 117.382 0.591 . . . . 0.93000000000000005 111.786 -178.34 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.604 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.58 138.42 31.58 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.766 -0.373 . . . . 0.96999999999999997 110.385 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.55 13.88 10.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.442 -0.344 . . . . 1.3400000000000001 111.587 -179.318 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.48 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.4 p -150.03 143.37 25.12 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.595 -0.442 . . . . 0.39000000000000001 111.03 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.72 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.67 -169.36 1.53 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.98 -0.554 . . . . 0.41999999999999998 110.969 -179.452 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.72 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.81 125.86 9.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.411 -0.813 . . . . 0.39000000000000001 109.841 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.506 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.4 mt -114.78 123.25 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.429 -0.508 . . . . 0.73999999999999999 111.208 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.756 ' HD3' HG21 ' A' ' 185' ' ' ILE . 52.0 mtmt -126.5 163.38 23.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.77 -0.65 . . . . 2.48 110.469 179.686 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.551 ' HA2' HD22 ' A' ' 16' ' ' ASN . . . 85.11 19.14 59.63 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.662 -0.975 . . . . 0.5 110.662 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.541 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 73.6 mt -79.13 157.17 27.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.975 0.417 . . . . 0.57999999999999996 111.331 -179.658 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.854 ' O ' HG12 ' A' ' 67' ' ' VAL . 2.7 mttm -99.46 133.87 21.61 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.571 -0.74 . . . . 2.79 110.43 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.84 143.62 61.8 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.548 2.165 . . . . 0.87 111.908 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.81 25.61 75.35 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.071 -0.812 . . . . 0.64000000000000001 111.071 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.854 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.3 p -128.15 158.67 40.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.651 0.262 . . . . 0.82999999999999996 110.475 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.12 139.85 42.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.988 0.423 . . . . 0.5 110.571 -179.73 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.644 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.3 m-85 -122.46 136.52 54.91 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.902 -0.59 . . . . 0.53000000000000003 110.766 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -99.02 131.07 45.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.468 -0.938 . . . . 1.8700000000000001 108.468 177.634 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.482 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.54 153.82 16.67 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.341 -0.933 . . . . 0.28999999999999998 112.0 -178.605 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -134.94 140.96 46.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.689 -0.486 . . . . 1.4299999999999999 109.689 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.513 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.4 tp -115.75 118.88 34.27 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.454 -0.498 . . . . 0.32000000000000001 110.48 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.746 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.46 129.14 68.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.347 -0.388 . . . . 0.79000000000000004 110.63 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.9 120.74 43.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.287 -0.415 . . . . 1.02 110.69 -179.568 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.841 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.47 146.36 11.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.139 0.495 . . . . 0.62 111.076 -179.24 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.633 ' O ' ' N ' ' A' ' 79' ' ' TYR . 20.9 mt-30 -105.95 153.86 21.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.559 -0.746 . . . . 2.4399999999999999 109.925 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.16 88.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.865 0.364 . . . . 3.6899999999999999 110.42 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.633 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.39 32.55 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.826 -0.624 . . . . 6.0800000000000001 110.558 -179.942 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.04 -117.44 3.3 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.418 -0.673 . . . . 1.22 111.418 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.38 177.31 9.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.209 0.528 . . . . 2.8799999999999999 111.665 -179.209 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.11 149.43 32.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.442 -0.799 . . . . 1.47 110.403 179.221 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.08 144.65 38.85 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.458 -0.337 . . . . 2.7000000000000002 110.594 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.746 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -127.94 135.97 61.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 121.118 0.485 . . . . 0.46000000000000002 111.582 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.601 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -123.95 141.37 52.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.657 -0.701 . . . . 0.34999999999999998 110.359 179.531 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.492 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.6 138.89 51.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.08 0.467 . . . . 3.6699999999999999 111.527 -179.365 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.482 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.31 164.15 38.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.577 -0.738 . . . . 0.67000000000000004 109.526 179.353 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 46.8 p30 -145.21 151.59 38.64 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.392 -0.523 . . . . 1.47 111.069 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.812 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.2 172.72 13.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.767 -0.652 . . . . 0.44 111.045 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.71 160.69 21.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.47 -0.786 . . . . 1.3700000000000001 109.815 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.35 121.84 22.93 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.582 -0.447 . . . . 1.28 110.759 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -127.45 154.65 44.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 1.97 112.109 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.2 p . . . . . 0 CA--C 1.528 0.128 0 CA-C-N 115.662 -0.699 . . . . 3.2799999999999998 111.459 178.856 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 84.6 p . . . . . 0 N--CA 1.462 0.134 0 CA-C-O 120.81 0.338 . . . . 0.66000000000000003 111.259 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.447 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.84 167.57 0.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.977 -0.556 . . . . 0.68999999999999995 110.855 179.743 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.61 145.61 50.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.665 -0.698 . . . . 0.52000000000000002 110.154 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.32 101.65 9.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.108 -0.701 . . . . 0.32000000000000001 109.108 177.691 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.6 t -112.91 139.75 36.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.997 -0.547 . . . . 0.28999999999999998 111.132 -178.909 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 p -128.74 152.56 48.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.686 -0.688 . . . . 0.25 109.883 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.584 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.5 p90 -144.82 -164.98 2.04 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.738 -0.385 . . . . 0.31 110.612 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.74 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.4 t -123.93 127.13 73.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.48999999999999999 110.801 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.149 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 1.53 110.378 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.74 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.06 24.41 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.932 -0.576 . . . . 0.96999999999999997 111.4 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.149 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.21 128.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.652 -0.419 . . . . 1.5600000000000001 110.937 179.819 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -86.36 -9.62 56.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.869 -0.605 . . . . 1.8799999999999999 110.376 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.12 0.26 55.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 1.04 110.307 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.34 137.28 25.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.993 -0.549 . . . . 0.23999999999999999 109.894 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 185' ' ' ILE . 72.0 m -96.25 -15.5 21.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.305 0.574 . . . . 0.28999999999999998 110.053 -179.698 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.54 175.57 45.73 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 109.822 -1.311 . . . . 0.13 109.822 179.627 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -123.48 151.62 42.56 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.65 -0.42 . . . . 0.17000000000000001 110.545 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.64 ' NH2' ' CD2' ' A' ' 183' ' ' TYR . 69.2 ttp85 -132.26 121.11 23.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.12 -0.491 . . . . 1.29 109.979 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.541 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.01 136.49 38.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.744 -0.662 . . . . 0.25 110.658 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.497 ' HB2' HH12 ' A' ' 143' ' ' ARG . 80.0 tt0 -129.34 129.88 45.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.987 -0.551 . . . . 1.3200000000000001 110.096 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.619 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.72 135.34 34.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.998 -0.546 . . . . 0.56999999999999995 110.605 -179.708 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.423 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.31 161.36 39.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.679 -0.692 . . . . 1.1599999999999999 109.627 179.844 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.96 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.02 124.9 25.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.054 0.454 . . . . 0.38 110.708 -179.676 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.78 -7.6 49.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.713 -0.676 . . . . 0.40999999999999998 110.952 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -109.86 -69.7 0.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.405 . . . . 1.6599999999999999 111.417 -179.31 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.445 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.66 -35.34 76.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.108 -0.496 . . . . 1.6599999999999999 111.486 -179.142 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.094 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.19 7.21 88.61 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.806 -0.918 . . . . 1.1699999999999999 110.806 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.312 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.91 -171.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.739 0.304 . . . . 1.8600000000000001 110.23 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.312 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.37 139.07 44.75 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.973 0.416 . . . . 1.98 110.205 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.423 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.8 Cg_endo -70.89 145.87 51.72 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.662 2.241 . . . . 0.55000000000000004 112.391 -179.526 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.619 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.9 145.75 42.62 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.217 -0.66 . . . . 1.1399999999999999 109.217 179.276 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.666 ' CE2' ' OD1' ' A' ' 16' ' ' ASN . 49.2 p90 -123.26 141.22 52.21 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.418 -0.513 . . . . 0.93000000000000005 111.536 -179.013 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.9 mt -128.05 127.67 43.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.329 -0.85 . . . . 0.34000000000000002 109.068 178.866 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -101.74 131.2 48.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.236 0.541 . . . . 1.0900000000000001 111.726 -178.681 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.97 157.55 73.51 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.226 -0.897 . . . . 0.19 109.558 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.78 157.96 58.56 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 122.521 2.148 . . . . 0.17999999999999999 112.178 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.28 -12.11 5.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.77 -0.65 . . . . 0.20999999999999999 110.74 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.79 -8.83 42.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.085 -0.507 . . . . 0.28999999999999998 110.703 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.13 135.39 34.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 0.5 110.364 179.765 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.1 p -133.21 16.71 4.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.339 -0.392 . . . . 0.29999999999999999 110.521 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.7 p -167.56 147.14 5.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.65 -0.5 . . . . 0.23000000000000001 109.65 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.541 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.22 150.5 12.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.561 -0.456 . . . . 0.28000000000000003 111.545 -179.619 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.497 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.39 124.93 50.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.644 -0.707 . . . . 1.0700000000000001 109.827 179.466 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.32 104.82 29.08 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.428 -0.351 . . . . 0.28999999999999998 111.158 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.7 Cg_endo -91.02 -179.47 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 123.188 2.592 . . . . 0.42999999999999999 112.188 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.53 32.8 18.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.444 -0.798 . . . . 1.26 111.467 179.338 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.1 mt -86.43 148.49 25.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.468 -0.333 . . . . 0.32000000000000001 110.409 179.582 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.761 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.29 114.83 61.2 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.091 0.472 . . . . 0.57999999999999996 110.722 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.01 140.63 96.19 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.878 2.385 . . . . 0.66000000000000003 111.952 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.03 21.25 74.35 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.087 -0.805 . . . . 0.28999999999999998 111.087 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.445 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.97 150.25 49.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.928 0.394 . . . . 2.3300000000000001 110.541 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.18 131.66 45.99 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.983 -0.553 . . . . 0.85999999999999999 109.792 179.316 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.96 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.56 148.22 44.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.07 -0.513 . . . . 0.52000000000000002 111.101 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.24 125.4 60.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.263 -1.014 . . . . 0.29999999999999999 108.263 177.777 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.6 132.43 63.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.202 0.525 . . . . 0.23000000000000001 111.338 -178.672 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.46 122.62 20.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.477 -0.783 . . . . 0.35999999999999999 109.63 179.342 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.584 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.07 125.39 55.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.176 -0.465 . . . . 0.19 110.654 -179.493 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.64 ' CD2' ' NH2' ' A' ' 143' ' ' ARG . 48.7 m-85 -117.3 137.93 52.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.001 -0.545 . . . . 0.29999999999999999 109.839 179.533 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.422 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.63 135.06 42.66 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.79 -0.819 . . . . 0.37 108.79 178.916 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.756 HG21 ' HD3' ' A' ' 61' ' ' LYS . 81.3 mt -99.14 122.83 51.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.101 0.477 . . . . 0.26000000000000001 111.022 -178.812 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.5 p -83.73 169.74 14.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.568 -0.742 . . . . 0.28000000000000003 110.499 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.81 -14.5 15.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.028 -0.533 . . . . 1.6000000000000001 110.975 -179.59 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -96.09 -4.26 43.21 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.854 -0.339 . . . . 1.1799999999999999 110.86 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.7 14.03 63.94 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.365 -0.694 . . . . 0.29999999999999999 111.365 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -84.73 139.08 32.24 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.03 -0.268 . . . . 1.22 110.484 179.651 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -106.72 141.03 38.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.871 0.367 . . . . 0.97999999999999998 110.517 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.0 m -136.74 126.99 26.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.82999999999999996 110.337 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.05 117.35 9.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.308 -0.406 . . . . 0.26000000000000001 110.534 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.09 -21.82 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.29999999999999999 110.68 -179.745 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.8 125.72 5.92 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.489 -0.484 . . . . 0.31 111.487 -179.771 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.78 120.26 21.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.835 -0.62 . . . . 0.28000000000000003 109.554 179.123 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.66 29.05 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.71 -0.396 . . . . 0.23999999999999999 110.942 -179.28 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.8 p -110.4 158.64 18.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.521 . . . . 0.23000000000000001 110.382 179.751 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -146.11 157.83 43.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.057 -0.519 . . . . 0.67000000000000004 110.691 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.22 104.31 9.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.762 -0.654 . . . . 0.64000000000000001 110.058 179.513 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.2 p . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.991 -1.005 . . . . 1.26 110.577 -179.674 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.0 m . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.196 -0.668 . . . . 3.4399999999999999 109.196 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.36 150.7 18.54 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.981 -0.848 . . . . 1.22 110.981 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -35.68 142.38 0.1 Allowed 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 123.982 3.122 . . . . 0.75 113.835 -179.233 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.622 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.92 173.41 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.306 -1.316 . . . . 0.79000000000000004 108.81 178.413 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.622 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.55 125.84 51.45 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.484 -0.486 . . . . 1.9399999999999999 111.46 -179.634 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.5 144.01 33.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.638 -0.71 . . . . 0.59999999999999998 110.689 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.36 25.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.946 0.403 . . . . 3.1400000000000001 111.089 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.747 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -109.01 131.15 60.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.99 -0.55 . . . . 3.23 110.05 179.833 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.25 162.33 35.74 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.823 0.344 . . . . 3.6299999999999999 111.236 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.3 mt-10 35.99 31.69 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.626 -0.509 . . . . 6.0800000000000001 109.626 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.747 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.55 32.99 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.944 -0.571 . . . . 3.3799999999999999 111.541 -178.816 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.643 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.21 -29.09 73.38 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.478 2.119 . . . . 3.9300000000000002 111.883 179.333 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.643 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.55 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 3.3599999999999999 110.487 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.62 ' NE2' ' O ' ' A' ' 13' ' ' SER . 1.7 mp0 -124.0 158.3 60.77 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.32 -0.4 . . . . 3.6099999999999999 110.456 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.542 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 97.0 Cg_endo -82.0 -64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.939 2.426 . . . . 1.51 113.511 -178.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.617 ' ND2' ' CD2' ' A' ' 157' ' ' TYR . 26.0 m120 -108.52 -19.48 13.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.311 -0.404 . . . . 2.6800000000000002 112.082 -178.531 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 27.5 m -107.29 152.01 24.7 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.44 -0.504 . . . . 1.21 111.329 -179.475 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.571 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.0 t-80 -155.17 102.87 2.25 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.796 -0.638 . . . . 1.5600000000000001 110.742 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.429 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.61 145.71 13.16 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.862 2.375 . . . . 0.81000000000000005 112.55 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.922 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.85 167.94 24.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.795 -0.639 . . . . 1.52 109.847 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.17 147.88 28.97 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.754 -0.462 . . . . 2.1400000000000001 109.754 178.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.6 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.23 157.34 44.96 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.673 -0.411 . . . . 0.32000000000000001 111.252 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.488 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -128.06 155.31 44.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.866 -0.607 . . . . 2.1699999999999999 110.085 179.029 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.822 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.67 172.98 6.44 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.128 -0.487 . . . . 0.58999999999999997 110.798 -179.189 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.822 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.6 174.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 122.859 2.373 . . . . 0.90000000000000002 111.552 179.434 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.07 -51.15 0.68 Allowed Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 120.664 -0.414 . . . . 3.3399999999999999 110.112 179.795 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.617 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.83 152.33 82.52 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.757 2.304 . . . . 1.8500000000000001 111.44 179.225 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.68 42.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.426 0.632 . . . . 2.54 110.628 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.617 ' H ' ' C ' ' A' ' 27' ' ' PRO . 74.0 t60 -63.66 -41.58 98.17 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.966 -1.015 . . . . 2.5299999999999998 110.651 179.755 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.563 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.9 mt -109.82 137.85 40.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.851 -0.613 . . . . 1.1699999999999999 111.311 -179.511 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.06 -72.9 0.7 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.054 -0.521 . . . . 1.27 111.853 -178.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.16 148.41 24.43 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.59 0.589 . . . . 1.1200000000000001 112.59 -179.66 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.79 124.86 45.18 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.327 -0.62 . . . . 0.41999999999999998 109.327 177.53 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.05 134.76 60.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.678 -0.409 . . . . 0.78000000000000003 110.636 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.922 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.99 128.49 53.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.437 . . . . 0.62 111.237 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.547 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -130.99 139.07 49.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.756 -0.657 . . . . 1.97 110.151 178.899 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.12 163.18 35.11 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.165 0.507 . . . . 0.34999999999999998 112.094 -178.162 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.51 139.59 7.84 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.431 -0.804 . . . . 1.8 110.479 178.829 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.698 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.9 Cg_endo -63.51 115.43 3.03 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.436 2.091 . . . . 0.57999999999999996 111.787 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.685 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.08 81.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.984 0.421 . . . . 3.04 109.874 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.698 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.94 -0.573 . . . . 2.4700000000000002 111.946 -179.532 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.8 p -157.52 157.79 34.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.759 0.314 . . . . 2.5099999999999998 110.601 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 16.0 m -120.43 27.92 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 1.8600000000000001 110.092 179.586 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.92 -75.89 1.31 Allowed Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.083 -0.58 . . . . 1.4399999999999999 111.764 -179.207 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.84 152.3 35.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 4.6900000000000004 110.973 -179.295 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.649 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.24 -169.17 2.54 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.084 -0.507 . . . . 1.4299999999999999 111.936 179.337 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.09 149.65 29.73 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.495 0.664 . . . . 1.74 112.556 -177.891 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.05 156.49 46.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.789 -1.096 . . . . 1.9199999999999999 110.274 178.574 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.15 158.39 41.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.981 -0.554 . . . . 0.34000000000000002 111.837 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.1 m -115.19 135.64 53.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.476 -0.784 . . . . 0.40999999999999998 109.784 179.292 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.6 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.38 121.94 23.79 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.432 -0.349 . . . . 0.55000000000000004 111.548 -179.158 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.4 Cg_exo -46.32 151.74 1.62 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.658 2.239 . . . . 0.44 112.101 179.023 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.91 -23.01 63.04 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 116.015 -0.539 . . . . 0.73999999999999999 112.799 -179.289 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.544 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.87 -16.87 45.9 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.208 -0.597 . . . . 0.93000000000000005 111.755 -178.306 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.603 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.2 mt -91.47 138.44 31.58 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.809 -0.356 . . . . 0.96999999999999997 110.321 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.62 13.95 10.93 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.36 -0.382 . . . . 1.3400000000000001 111.464 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.482 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.5 p -150.05 143.48 25.16 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.648 -0.421 . . . . 0.39000000000000001 111.005 179.602 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.722 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.78 -169.31 1.52 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.016 -0.538 . . . . 0.41999999999999998 110.857 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.722 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.79 125.83 9.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.333 -0.849 . . . . 0.39000000000000001 109.841 179.275 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.511 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.74 123.19 70.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.417 -0.513 . . . . 0.73999999999999999 111.23 -179.733 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.863 ' HZ3' ' CB ' ' A' ' 140' ' ' SER . 66.4 mttt -126.47 163.44 23.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.928 -0.578 . . . . 2.48 110.441 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.01 19.14 59.78 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.759 -0.937 . . . . 0.5 110.759 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.511 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.1 mt -79.12 157.31 27.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.078 0.466 . . . . 0.57999999999999996 111.291 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.844 ' O ' HG12 ' A' ' 67' ' ' VAL . 1.2 mttm -99.55 134.0 21.46 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.659 -0.7 . . . . 2.79 110.393 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.654 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.92 143.53 61.0 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.579 2.186 . . . . 0.87 111.925 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.92 25.57 75.41 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.035 -0.826 . . . . 0.64000000000000001 111.035 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.19 158.74 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.64 0.257 . . . . 0.82999999999999996 110.421 -179.521 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.17 139.86 42.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.925 0.393 . . . . 0.5 110.582 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.651 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.46 136.41 54.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.969 -0.56 . . . . 0.53000000000000003 110.878 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.86 131.01 45.29 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.545 -0.909 . . . . 1.8700000000000001 108.545 177.634 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.52 153.87 16.66 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.237 -0.982 . . . . 0.28999999999999998 111.867 -178.524 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -134.97 140.99 46.13 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.684 -0.487 . . . . 1.4299999999999999 109.684 179.561 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.518 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.79 118.92 34.36 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.459 -0.496 . . . . 0.32000000000000001 110.507 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.738 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.49 129.1 68.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.349 -0.387 . . . . 0.79000000000000004 110.564 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.704 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.8 120.89 43.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.251 -0.432 . . . . 1.02 110.669 -179.695 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.855 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.64 146.5 11.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.246 0.546 . . . . 0.62 111.005 -179.332 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.626 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.09 153.94 21.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.499 -0.773 . . . . 2.4399999999999999 109.924 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.13 88.57 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.85 0.357 . . . . 3.6899999999999999 110.427 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.24 32.59 0.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.869 -0.605 . . . . 6.0800000000000001 110.616 -179.887 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.06 -117.33 3.29 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.471 -0.652 . . . . 1.22 111.471 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.36 177.35 9.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.198 0.523 . . . . 2.8799999999999999 111.692 -179.256 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.12 149.61 32.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.464 -0.789 . . . . 1.47 110.478 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.15 144.68 38.72 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.501 -0.318 . . . . 2.7000000000000002 110.529 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.738 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -128.0 136.01 61.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 120.615 -0.434 . . . . 0.46000000000000002 111.549 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.03 141.37 52.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.677 -0.692 . . . . 0.34999999999999998 110.27 179.656 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.501 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.61 138.91 51.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.128 0.489 . . . . 3.6699999999999999 111.506 -179.379 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 53.0 p90 -152.39 164.19 38.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.554 -0.748 . . . . 0.67000000000000004 109.4 179.365 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.564 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.24 151.54 38.54 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.327 -0.549 . . . . 1.47 111.051 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.2 p90 -146.2 172.72 13.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.719 -0.673 . . . . 0.44 110.997 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.72 160.76 21.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.426 -0.807 . . . . 1.3700000000000001 109.82 179.569 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.46 121.9 22.9 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 120.514 -0.475 . . . . 1.28 110.735 179.942 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.5 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -128.23 163.84 23.84 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.495 0.924 . . . . 1.97 113.495 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.2 t . . . . . 0 C--N 1.331 -0.205 0 N-CA-C 107.16 -1.422 . . . . 3.2799999999999998 107.16 176.64 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 121.343 0.592 . . . . 0.66000000000000003 110.081 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.443 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.86 167.56 0.25 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.351 -0.84 . . . . 0.68999999999999995 110.906 -179.696 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.64 145.59 50.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.671 -0.695 . . . . 0.52000000000000002 110.112 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.23 101.66 9.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.124 -0.695 . . . . 0.32000000000000001 109.124 177.738 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.0 t -112.94 139.6 37.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.031 -0.531 . . . . 0.28999999999999998 111.075 -178.808 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.1 p -128.63 152.5 48.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.638 -0.71 . . . . 0.25 109.87 179.606 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.584 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.5 p90 -144.8 -164.88 2.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.67 -0.412 . . . . 0.31 110.631 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.732 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -124.0 127.21 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.298 -0.41 . . . . 0.48999999999999999 110.83 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.154 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -58.11 58.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 1.53 110.239 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.23 24.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.882 -0.599 . . . . 0.96999999999999997 111.435 -179.661 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.154 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.14 128.75 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.586 -0.446 . . . . 1.5600000000000001 110.894 179.872 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.32 -9.75 55.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.886 -0.597 . . . . 1.8799999999999999 110.339 179.78 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.59 ' O ' ' CD ' ' A' ' 187' ' ' GLU . 27.8 p -87.12 0.3 55.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.004 -0.543 . . . . 1.04 110.314 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.723 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.37 137.23 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.915 -0.584 . . . . 0.23999999999999999 109.959 179.719 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.863 ' CB ' ' HZ3' ' A' ' 61' ' ' LYS . 89.3 p -96.27 -15.49 21.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.304 0.573 . . . . 0.28999999999999998 110.017 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.58 175.56 45.76 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.788 -1.325 . . . . 0.13 109.788 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.52 151.65 42.59 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.614 -0.435 . . . . 0.17000000000000001 110.455 179.743 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.647 ' NH1' HD11 ' A' ' 185' ' ' ILE . 38.3 ttp-105 -132.37 121.18 23.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.038 -0.528 . . . . 1.29 109.884 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.545 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -104.97 136.57 38.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.752 -0.658 . . . . 0.25 110.669 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 97.5 mt-10 -129.43 129.82 45.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.998 -0.547 . . . . 1.3200000000000001 110.091 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.624 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.63 135.34 34.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.079 -0.51 . . . . 0.56999999999999995 110.587 -179.646 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.417 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.36 161.38 39.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.783 -0.644 . . . . 1.1599999999999999 109.647 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.969 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.1 124.88 25.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.063 0.459 . . . . 0.38 110.709 -179.623 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.91 -7.57 49.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.745 -0.661 . . . . 0.40999999999999998 110.869 -179.74 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.81 -69.63 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 1.6599999999999999 111.439 -179.386 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.445 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.71 -35.35 76.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.006 -0.543 . . . . 1.6599999999999999 111.47 -179.094 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.078 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.17 88.64 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.763 -0.935 . . . . 1.1699999999999999 110.763 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.326 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.4 t0 -27.88 -171.7 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.792 0.33 . . . . 1.8600000000000001 110.275 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.326 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.27 139.12 45.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.408 . . . . 1.98 110.152 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.417 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 48.1 Cg_endo -70.86 145.85 51.86 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 122.695 2.264 . . . . 0.55000000000000004 112.299 -179.591 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.92 145.75 42.65 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.173 -0.677 . . . . 1.1399999999999999 109.173 179.157 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.654 ' CE1' ' CD ' ' A' ' 65' ' ' PRO . 48.4 p90 -123.34 141.33 52.1 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.336 -0.546 . . . . 0.93000000000000005 111.564 -179.117 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.8 mt -128.04 127.6 43.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.349 -0.841 . . . . 0.34000000000000002 109.001 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -101.65 131.1 48.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.207 0.527 . . . . 1.0900000000000001 111.783 -178.761 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.87 157.62 73.09 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.308 -0.86 . . . . 0.19 109.586 179.647 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -69.75 157.98 58.56 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 C-N-CA 122.431 2.087 . . . . 0.17999999999999999 112.29 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.23 -12.22 5.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.871 -0.604 . . . . 0.20999999999999999 110.725 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.9 p -92.83 -8.73 42.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.107 -0.497 . . . . 0.28999999999999998 110.753 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.15 135.35 34.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.451 . . . . 0.5 110.436 179.672 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 p -133.11 16.71 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.437 -0.347 . . . . 0.29999999999999999 110.536 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.9 p -167.52 147.04 5.07 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.639 -0.504 . . . . 0.23000000000000001 109.639 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.545 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.21 150.42 12.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.567 -0.453 . . . . 0.28000000000000003 111.63 -179.658 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.505 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.32 124.96 50.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.595 -0.729 . . . . 1.0700000000000001 109.832 179.519 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.38 104.92 29.88 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.882 0.372 . . . . 0.28999999999999998 111.03 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.1 Cg_endo -91.0 -179.44 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 123.175 2.583 . . . . 0.42999999999999999 112.137 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.54 32.69 18.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.362 -0.835 . . . . 1.26 111.49 179.325 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.425 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.1 mt -86.33 148.54 25.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.427 -0.351 . . . . 0.32000000000000001 110.435 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.771 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.35 114.82 61.19 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.026 0.441 . . . . 0.57999999999999996 110.705 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.96 140.55 95.82 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.904 2.403 . . . . 0.66000000000000003 111.969 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.1 21.24 74.17 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.064 -0.814 . . . . 0.28999999999999998 111.064 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.445 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.87 150.18 49.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.808 0.337 . . . . 2.3300000000000001 110.631 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.493 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.26 131.61 46.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.85999999999999999 109.737 179.381 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.969 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.45 148.2 44.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.107 -0.497 . . . . 0.52000000000000002 111.119 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.31 125.4 60.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.275 -1.009 . . . . 0.29999999999999999 108.275 177.728 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.5 132.54 63.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.156 0.503 . . . . 0.23000000000000001 111.249 -178.613 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.55 122.63 20.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.485 -0.78 . . . . 0.35999999999999999 109.553 179.288 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.584 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.0 125.4 54.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.224 -0.443 . . . . 0.19 110.658 -179.526 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 47.9 m-85 -117.23 137.79 52.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.101 -0.5 . . . . 0.29999999999999999 109.921 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.43 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.74 135.01 42.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.743 -0.836 . . . . 0.37 108.743 178.922 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.647 HD11 ' NH1' ' A' ' 143' ' ' ARG . 42.1 mm -99.1 122.91 51.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.107 0.479 . . . . 0.26000000000000001 110.949 -178.757 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.6 p -83.86 169.67 14.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.483 -0.78 . . . . 0.28000000000000003 110.447 -179.679 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.59 ' CD ' ' O ' ' A' ' 138' ' ' THR . 41.0 mp0 -59.64 -14.6 14.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.975 -0.557 . . . . 1.6000000000000001 111.036 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.8 m-20 -96.16 -4.21 43.06 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.853 -0.339 . . . . 1.1799999999999999 110.765 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.736 ' O ' ' NE2' ' A' ' 191' ' ' GLN . . . 87.69 13.94 64.13 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.366 -0.693 . . . . 0.29999999999999999 111.366 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -84.61 139.1 32.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.63 0.252 . . . . 1.22 110.484 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.736 ' NE2' ' O ' ' A' ' 189' ' ' GLY . 0.0 OUTLIER -106.69 141.06 38.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 0.97999999999999998 110.564 179.733 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.67 127.0 26.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.82999999999999996 110.392 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.11 117.35 9.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.323 -0.399 . . . . 0.26000000000000001 110.531 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.04 -21.91 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.29999999999999999 110.659 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.9 125.78 5.88 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.527 -0.469 . . . . 0.31 111.507 -179.758 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.473 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.77 120.2 21.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.77 -0.65 . . . . 0.28000000000000003 109.539 179.249 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.6 151.66 29.09 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.724 -0.39 . . . . 0.23999999999999999 110.938 -179.271 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.42 158.61 18.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 0.23000000000000001 110.404 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -146.16 157.91 43.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.502 . . . . 0.67000000000000004 110.666 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.27 104.3 9.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.801 -0.636 . . . . 0.64000000000000001 110.007 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.5 p . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 117.948 -1.025 . . . . 1.26 110.641 -179.743 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.203 -0.666 . . . . 3.4399999999999999 109.203 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.34 150.67 18.55 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.037 -0.825 . . . . 1.22 111.037 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -35.67 142.38 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 124.039 3.159 . . . . 0.75 113.792 -179.226 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.622 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -79.98 173.41 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.281 -1.327 . . . . 0.79000000000000004 108.881 178.428 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.622 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.6 125.86 51.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.214 0.531 . . . . 1.9399999999999999 111.354 -179.526 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 143.98 33.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.564 -0.744 . . . . 0.59999999999999998 110.596 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -151.99 168.35 25.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.943 0.401 . . . . 3.1400000000000001 111.076 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.738 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.97 131.02 60.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.974 -0.557 . . . . 3.23 110.076 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.19 162.33 35.74 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.834 0.349 . . . . 3.6299999999999999 111.197 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 79.9 mm-40 36.13 31.59 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 109.547 -0.538 . . . . 6.0800000000000001 109.547 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.738 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.48 69.56 32.95 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.964 -0.562 . . . . 3.3799999999999999 111.624 -178.831 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.22 -29.11 73.27 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.414 2.076 . . . . 3.9300000000000002 111.856 179.351 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.124 -0.489 . . . . 3.3599999999999999 110.49 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.534 ' OE1' ' O ' ' A' ' 13' ' ' SER . 2.0 mp0 -123.93 158.4 60.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.304 -0.407 . . . . 3.6099999999999999 110.379 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.571 ' HD2' HE22 ' A' ' 191' ' ' GLN . 98.3 Cg_endo -82.09 -64.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.922 2.415 . . . . 1.51 113.431 -178.963 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.627 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 60.7 t30 -108.46 -19.53 13.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.312 -0.404 . . . . 2.6800000000000002 112.065 -178.477 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 4.2 p -107.26 152.02 24.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.149 0.499 . . . . 1.21 111.313 -179.489 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.25 102.94 2.23 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.723 -0.671 . . . . 1.5600000000000001 110.68 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.65 145.61 13.05 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.847 2.365 . . . . 0.81000000000000005 112.651 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.91 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.84 167.84 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.949 -0.569 . . . . 1.52 109.843 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.05 148.02 29.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.826 -0.435 . . . . 2.1400000000000001 109.826 178.814 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.594 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.25 157.2 45.1 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.66 -0.416 . . . . 0.32000000000000001 111.203 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.492 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -127.98 155.29 44.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.783 -0.644 . . . . 2.1699999999999999 110.129 178.903 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.83 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.57 173.05 6.34 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.172 -0.467 . . . . 0.58999999999999997 110.807 -179.224 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.83 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.1 Cg_exo -50.74 173.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 122.839 2.359 . . . . 0.90000000000000002 111.449 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.48 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.03 -51.04 0.69 Allowed Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.688 -0.405 . . . . 3.3399999999999999 110.062 179.868 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.619 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.8 Cg_exo -64.87 152.32 82.62 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.789 2.326 . . . . 1.8500000000000001 111.441 179.258 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.75 42.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.465 0.65 . . . . 2.54 110.547 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.619 ' H ' ' C ' ' A' ' 27' ' ' PRO . 73.9 t60 -63.66 -41.73 98.16 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.962 -1.017 . . . . 2.5299999999999998 110.65 179.722 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.561 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.5 mt -109.73 137.91 39.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.711 -0.677 . . . . 1.1699999999999999 111.343 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.93 -73.01 0.7 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.084 -0.507 . . . . 1.27 111.874 -178.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.19 148.41 24.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.575 0.583 . . . . 1.1200000000000001 112.575 -179.545 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -121.86 124.81 45.0 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.341 -0.615 . . . . 0.41999999999999998 109.341 177.6 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.09 134.68 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.721 -0.391 . . . . 0.78000000000000003 110.614 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.91 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.98 128.59 53.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.055 0.455 . . . . 0.62 111.326 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.549 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.04 138.95 49.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.738 -0.664 . . . . 1.97 110.153 179.014 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.433 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -145.04 163.17 35.07 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 121.133 0.492 . . . . 0.34999999999999998 112.098 -178.166 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.491 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.48 139.57 7.86 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.42 -0.809 . . . . 1.8 110.482 178.85 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.8 Cg_endo -63.64 115.53 3.11 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.25 1.966 . . . . 0.57999999999999996 111.852 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.67 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.93 81.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.871 -0.418 . . . . 3.04 109.871 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.16 -20.62 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.015 -0.538 . . . . 2.4700000000000002 111.899 -179.546 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 p -157.7 157.76 34.12 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.812 -0.355 . . . . 2.5099999999999998 110.56 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.36 27.87 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.173 -0.467 . . . . 1.8600000000000001 110.178 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.83 -75.94 1.31 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.129 -0.557 . . . . 1.4399999999999999 111.808 -179.243 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.88 152.29 35.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.918 0.389 . . . . 4.6900000000000004 111.021 -179.312 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.12 2.53 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.093 -0.503 . . . . 1.4299999999999999 111.902 179.44 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.431 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.18 149.77 29.62 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 121.433 0.635 . . . . 1.74 112.543 -177.867 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.12 156.45 45.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.834 -1.076 . . . . 1.9199999999999999 110.154 178.684 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.22 158.4 41.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.848 -0.614 . . . . 0.34000000000000002 111.773 -179.403 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.9 m -115.17 135.64 53.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.476 -0.783 . . . . 0.40999999999999998 109.839 179.308 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.594 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.44 121.91 23.71 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.483 -0.326 . . . . 0.55000000000000004 111.528 -179.09 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.5 Cg_exo -46.26 151.67 1.6 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.663 2.242 . . . . 0.44 112.212 178.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.97 -22.96 63.1 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 116.097 -0.502 . . . . 0.73999999999999999 112.755 -179.162 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.54 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.1 p-80 -82.75 -16.95 46.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.432 0.616 . . . . 0.93000000000000005 111.815 -178.372 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.605 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.58 138.31 31.67 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.773 -0.371 . . . . 0.96999999999999997 110.354 179.354 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -121.48 13.95 11.04 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.353 -0.385 . . . . 1.3400000000000001 111.564 -179.383 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.0 p -149.96 143.51 25.27 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.654 -0.418 . . . . 0.39000000000000001 111.034 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.84 -169.38 1.54 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.052 -0.522 . . . . 0.41999999999999998 110.894 -179.463 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.711 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 t -151.77 125.89 9.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.427 -0.806 . . . . 0.39000000000000001 109.795 179.273 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.511 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.91 123.22 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.396 -0.522 . . . . 0.73999999999999999 111.196 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.744 ' HD3' HG21 ' A' ' 185' ' ' ILE . 53.1 mtmt -126.4 163.31 23.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.809 -0.632 . . . . 2.48 110.514 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.477 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.2 18.83 60.07 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.823 -0.911 . . . . 0.5 110.823 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.627 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.7 mt -78.93 157.3 28.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.002 0.43 . . . . 0.57999999999999996 111.446 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.855 ' O ' HG12 ' A' ' 67' ' ' VAL . 2.9 mptp? -99.53 133.98 21.49 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.638 -0.71 . . . . 2.79 110.422 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.96 ' HB3' ' O ' ' A' ' 93' ' ' SER . 36.6 Cg_endo -67.82 143.51 61.47 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.613 2.209 . . . . 0.87 111.901 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.96 25.55 75.45 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.987 -0.845 . . . . 0.64000000000000001 110.987 179.566 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.855 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.1 158.71 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.654 0.264 . . . . 0.82999999999999996 110.408 -179.532 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.09 139.98 41.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.85 0.357 . . . . 0.5 110.593 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.64 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.53 136.45 54.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.035 -0.53 . . . . 0.53000000000000003 110.687 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.491 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.89 131.08 45.25 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.522 -0.918 . . . . 1.8700000000000001 108.522 177.482 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.486 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.58 153.9 16.67 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.273 -0.965 . . . . 0.28999999999999998 111.924 -178.67 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -134.98 140.91 46.06 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.699 -0.482 . . . . 1.4299999999999999 109.699 179.616 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.71 118.86 34.22 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.398 -0.521 . . . . 0.32000000000000001 110.494 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.735 HG12 HG23 ' A' ' 84' ' ' VAL . 63.8 mt -112.45 129.11 68.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.372 -0.377 . . . . 0.79000000000000004 110.66 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.83 120.84 43.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.289 -0.414 . . . . 1.02 110.726 -179.657 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.849 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.52 146.41 11.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.099 0.476 . . . . 0.62 111.042 -179.238 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.626 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.03 153.89 21.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.586 -0.733 . . . . 2.4399999999999999 109.963 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.18 88.55 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.856 0.36 . . . . 3.6899999999999999 110.425 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.34 32.58 0.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.814 -0.63 . . . . 6.0800000000000001 110.605 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.15 -117.32 3.28 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.471 -0.652 . . . . 1.22 111.471 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.42 177.4 8.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.293 0.568 . . . . 2.8799999999999999 111.593 -179.188 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.19 149.57 32.18 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.397 -0.82 . . . . 1.47 110.365 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.22 144.59 38.55 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.396 -0.365 . . . . 2.7000000000000002 110.59 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.735 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.91 136.02 61.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 121.13 0.49 . . . . 0.46000000000000002 111.462 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.09 141.27 52.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.593 -0.73 . . . . 0.34999999999999998 110.34 179.55 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.467 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.4 ttp180 -117.56 138.88 51.62 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.573 -0.451 . . . . 3.6699999999999999 111.598 -179.4 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.486 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.23 164.15 37.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.59 -0.732 . . . . 0.67000000000000004 109.513 179.452 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.572 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 46.9 p30 -145.27 151.56 38.55 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.374 -0.53 . . . . 1.47 111.059 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.28 172.76 13.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.74 -0.664 . . . . 0.44 111.012 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.71 160.61 21.54 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.483 -0.781 . . . . 1.3700000000000001 109.937 179.636 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.38 121.88 22.96 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.548 -0.461 . . . . 1.28 110.742 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.541 ' O ' ' CB ' ' A' ' 93' ' ' SER . 70.1 p -124.86 154.63 40.75 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 113.092 0.775 . . . . 1.97 113.092 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.96 ' O ' ' HB3' ' A' ' 65' ' ' PRO . 27.6 t . . . . . 0 C--O 1.216 -0.674 0 CA-C-N 113.607 -1.633 . . . . 3.2799999999999998 108.04 -178.92 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.601 ' CB ' ' HB ' ' A' ' 201' ' ' THR . 33.5 p . . . . . 0 CA--C 1.52 -0.174 0 CA-C-O 122.571 1.177 . . . . 0.66000000000000003 109.69 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.436 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.93 167.58 0.26 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.208 -1.36 . . . . 0.68999999999999995 110.979 -178.914 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.52 145.57 50.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.727 -0.669 . . . . 0.52000000000000002 110.169 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.28 101.67 9.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.075 -0.713 . . . . 0.32000000000000001 109.075 177.702 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.1 t -112.94 139.6 37.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.018 -0.537 . . . . 0.28999999999999998 111.117 -178.911 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.9 p -128.58 152.55 48.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.692 -0.686 . . . . 0.25 109.839 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.594 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.82 -164.97 2.04 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.661 -0.416 . . . . 0.31 110.655 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.734 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.9 t -123.88 127.23 73.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.48999999999999999 110.891 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.168 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.98 58.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 1.53 110.322 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.07 24.5 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 0.96999999999999997 111.574 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.168 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.2 128.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.622 -0.431 . . . . 1.5600000000000001 110.919 179.905 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.55 -9.51 55.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.92 -0.582 . . . . 1.8799999999999999 110.354 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.18 0.18 55.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.086 -0.506 . . . . 1.04 110.275 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.721 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.16 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.976 -0.556 . . . . 0.23999999999999999 109.881 179.757 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 185' ' ' ILE . 89.3 p -96.2 -15.53 21.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.313 0.578 . . . . 0.28999999999999998 110.101 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.64 175.64 45.87 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 109.891 -1.284 . . . . 0.13 109.891 179.573 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.51 151.54 42.69 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.605 -0.438 . . . . 0.17000000000000001 110.55 179.769 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.536 ' CZ ' ' HG3' ' A' ' 15' ' ' PRO . 64.1 ttp85 -132.2 121.14 23.21 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.148 -0.478 . . . . 1.29 109.936 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.551 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.11 136.48 38.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.782 -0.644 . . . . 0.25 110.713 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 80.2 tt0 -129.28 129.85 45.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.879 -0.6 . . . . 1.3200000000000001 110.121 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.618 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.3 p90 -138.66 135.34 34.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.998 -0.546 . . . . 0.56999999999999995 110.614 -179.686 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.422 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.41 161.4 39.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.792 -0.64 . . . . 1.1599999999999999 109.617 179.84 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.961 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.15 124.95 25.61 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.606 -0.438 . . . . 0.38 110.749 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.502 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.84 -7.57 49.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.753 -0.658 . . . . 0.40999999999999998 110.916 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -109.87 -69.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.01 0.433 . . . . 1.6599999999999999 111.354 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.438 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.65 -35.36 76.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.066 -0.515 . . . . 1.6599999999999999 111.466 -179.093 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.091 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.13 7.23 88.59 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.763 -0.935 . . . . 1.1699999999999999 110.763 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.314 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.96 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.777 0.322 . . . . 1.8600000000000001 110.32 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.314 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.33 139.08 44.92 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.036 0.446 . . . . 1.98 110.192 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.422 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.89 145.81 51.61 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.778 2.318 . . . . 0.55000000000000004 112.309 -179.48 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.85 145.73 42.61 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.184 -0.673 . . . . 1.1399999999999999 109.184 179.237 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.624 ' CE1' ' CG ' ' A' ' 16' ' ' ASN . 7.6 p90 -123.35 141.36 52.06 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.249 -0.58 . . . . 0.93000000000000005 111.449 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.4 mt -128.11 127.64 43.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.228 -0.896 . . . . 0.34000000000000002 109.039 178.916 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -101.66 131.18 48.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.199 0.523 . . . . 1.0900000000000001 111.72 -178.67 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.98 157.53 73.58 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.315 -0.857 . . . . 0.19 109.521 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -69.81 158.02 58.3 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 122.307 2.005 . . . . 0.17999999999999999 112.291 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.13 -12.25 4.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.831 -0.622 . . . . 0.20999999999999999 110.759 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.86 -8.82 42.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.103 -0.499 . . . . 0.28999999999999998 110.676 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.06 135.27 34.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.35 -0.386 . . . . 0.5 110.473 179.675 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.9 p -133.06 16.66 4.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.489 -0.323 . . . . 0.29999999999999999 110.573 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.1 p -167.53 147.12 5.09 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.624 -0.51 . . . . 0.23000000000000001 109.624 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.551 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.18 150.5 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.564 -0.455 . . . . 0.28000000000000003 111.526 -179.663 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.507 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.24 124.91 50.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.566 -0.743 . . . . 1.0700000000000001 109.832 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.39 104.84 29.43 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.83 0.348 . . . . 0.28999999999999998 111.08 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.0 Cg_endo -90.92 -179.47 1.51 Allowed 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 123.186 2.591 . . . . 0.42999999999999999 112.172 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 61.59 32.61 18.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.331 -0.85 . . . . 1.26 111.476 179.256 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.8 mt -86.27 148.53 25.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.469 -0.332 . . . . 0.32000000000000001 110.522 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.766 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.4 mt -88.28 114.89 61.45 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.959 0.409 . . . . 0.57999999999999996 110.721 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.12 140.61 95.81 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.826 2.351 . . . . 0.66000000000000003 112.01 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.11 21.17 74.32 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.028 -0.829 . . . . 0.28999999999999998 111.028 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.438 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.8 mmm-85 -126.83 150.31 49.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 2.3300000000000001 110.625 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.502 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.28 131.65 46.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.978 -0.555 . . . . 0.85999999999999999 109.814 179.316 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.961 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.55 148.36 43.96 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.113 -0.494 . . . . 0.52000000000000002 110.974 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.5 mt -105.35 125.38 60.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.296 -1.002 . . . . 0.29999999999999999 108.296 177.723 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.52 132.44 63.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.177 0.513 . . . . 0.23000000000000001 111.222 -178.527 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.62 20.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.64 -0.709 . . . . 0.35999999999999999 109.633 179.216 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.594 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.97 125.46 54.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 0.19 110.71 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.26 137.87 52.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.048 -0.524 . . . . 0.29999999999999999 109.891 179.51 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.42 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.73 135.06 42.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.765 -0.828 . . . . 0.37 108.765 178.887 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.744 HG21 ' HD3' ' A' ' 61' ' ' LYS . 63.1 mt -99.03 122.91 51.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.106 0.479 . . . . 0.26000000000000001 110.956 -178.75 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.4 p -83.88 169.66 14.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.563 -0.744 . . . . 0.28000000000000003 110.54 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -59.76 -14.49 14.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.085 -0.507 . . . . 1.6000000000000001 110.914 -179.466 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 94.7 m-20 -96.13 -4.31 42.97 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.79 -0.364 . . . . 1.1799999999999999 110.769 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.82 13.96 63.83 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.316 -0.713 . . . . 0.29999999999999999 111.316 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -84.64 139.13 32.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.642 0.258 . . . . 1.22 110.443 179.658 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.571 HE22 ' HD2' ' A' ' 15' ' ' PRO . 41.0 mt-30 -106.79 141.06 38.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.97 0.414 . . . . 0.97999999999999998 110.552 179.709 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.1 m -136.62 127.11 26.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.487 . . . . 0.82999999999999996 110.408 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.2 117.31 9.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.39 -0.368 . . . . 0.26000000000000001 110.438 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 43.9 pt -109.09 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.29999999999999999 110.744 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.92 125.68 5.83 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.477 -0.489 . . . . 0.31 111.475 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.474 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.71 120.21 21.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.731 -0.668 . . . . 0.28000000000000003 109.58 179.191 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.58 151.69 29.15 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.71 -0.396 . . . . 0.23999999999999999 110.881 -179.242 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.54 158.58 18.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.23000000000000001 110.339 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.4 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 68.2 mt-30 -146.03 157.94 43.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.031 -0.531 . . . . 0.67000000000000004 110.714 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.39 9.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.753 -0.658 . . . . 0.64000000000000001 110.05 179.568 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.601 ' HB ' ' CB ' ' A' ' 126' ' ' SER . 67.9 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 117.829 -1.081 . . . . 1.26 110.619 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.5 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.196 -0.668 . . . . 3.4399999999999999 109.196 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.64 18.55 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.999 -0.84 . . . . 1.22 110.999 179.753 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -35.5 142.39 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 124.002 3.135 . . . . 0.75 113.794 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.607 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.3 t -80.06 173.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.246 -1.343 . . . . 0.79000000000000004 108.825 178.451 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.607 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.55 125.98 51.6 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.45 -0.5 . . . . 1.9399999999999999 111.412 -179.567 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.62 143.91 34.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.658 -0.701 . . . . 0.59999999999999998 110.667 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.4 25.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.925 0.393 . . . . 3.1400000000000001 111.042 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.742 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -109.06 131.05 60.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.926 -0.579 . . . . 3.23 110.091 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.8 p -141.17 162.37 35.64 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.438 -0.347 . . . . 3.6299999999999999 111.249 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 9' ' ' THR . 96.3 mt-10 35.98 31.65 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.616 -0.513 . . . . 6.0800000000000001 109.616 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.742 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.51 69.64 33.42 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.007 -0.542 . . . . 3.3799999999999999 111.609 -178.833 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.23 -29.18 73.3 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.5 2.133 . . . . 3.9300000000000002 111.868 179.32 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.63 125.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.493 . . . . 3.3599999999999999 110.514 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.716 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -123.89 158.39 60.17 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.306 -0.407 . . . . 3.6099999999999999 110.45 -179.988 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.562 ' HG3' ' CZ ' ' A' ' 143' ' ' ARG . 98.2 Cg_endo -82.1 -64.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.916 2.411 . . . . 1.51 113.44 -178.992 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.462 ' OD1' ' HB2' ' A' ' 157' ' ' TYR . 6.5 m120 -108.4 -19.52 13.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.065 0.394 . . . . 2.6800000000000002 112.065 -178.48 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.716 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 7.0 p -107.48 152.0 24.81 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.436 -0.506 . . . . 1.21 111.28 -179.361 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.57 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.18 102.94 2.25 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.709 -0.678 . . . . 1.5600000000000001 110.654 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -82.74 145.64 12.93 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.879 2.386 . . . . 0.81000000000000005 112.577 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.912 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.85 167.96 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.871 -0.604 . . . . 1.52 109.892 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -149.12 147.97 29.12 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.708 -0.478 . . . . 2.1400000000000001 109.708 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.593 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.3 157.23 45.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.04 0.448 . . . . 0.32000000000000001 111.188 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.49 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -128.03 155.19 44.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.705 -0.679 . . . . 2.1699999999999999 110.101 179.055 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.84 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.58 173.01 6.39 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.155 0.503 . . . . 0.58999999999999997 110.688 -179.153 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.84 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.62 173.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 122.831 2.354 . . . . 0.90000000000000002 111.555 179.365 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.484 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.04 -51.13 0.69 Allowed Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.76 -0.376 . . . . 3.3399999999999999 110.074 179.831 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.623 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.81 152.35 82.45 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.813 2.342 . . . . 1.8500000000000001 111.426 179.259 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.76 42.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.418 0.628 . . . . 2.54 110.526 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.623 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.6 t60 -63.54 -41.71 98.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.964 -1.016 . . . . 2.5299999999999998 110.642 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.568 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.7 mt -109.8 137.79 40.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.857 -0.611 . . . . 1.1699999999999999 111.305 -179.416 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.95 -72.92 0.7 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.105 -0.498 . . . . 1.27 111.891 -178.955 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.16 148.43 24.42 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.571 0.582 . . . . 1.1200000000000001 112.571 -179.649 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.79 124.83 45.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.36 -0.607 . . . . 0.41999999999999998 109.36 177.493 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -117.97 134.72 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.685 -0.406 . . . . 0.78000000000000003 110.676 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.912 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.01 128.65 53.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.421 . . . . 0.62 111.233 179.742 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.551 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 138.89 49.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.766 -0.652 . . . . 1.97 110.156 178.998 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.438 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -144.99 163.25 34.76 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.118 0.485 . . . . 0.34999999999999998 112.113 -178.114 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.491 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.53 139.55 7.81 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.493 -0.776 . . . . 1.8 110.485 178.887 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.59 115.44 3.05 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.279 1.986 . . . . 0.57999999999999996 111.865 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.673 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.95 81.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.925 -0.398 . . . . 3.04 109.925 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.921 -0.582 . . . . 2.4700000000000002 111.95 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -157.68 157.76 34.15 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.813 -0.355 . . . . 2.5099999999999998 110.523 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.37 27.9 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 1.8600000000000001 110.147 179.569 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.83 -75.91 1.31 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.154 -0.546 . . . . 1.4399999999999999 111.832 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.4 mtp180 -117.82 152.33 35.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.943 0.401 . . . . 4.6900000000000004 110.959 -179.32 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.35 -169.11 2.51 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.976 -0.556 . . . . 1.4299999999999999 111.954 179.271 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.436 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.05 149.61 29.76 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.483 0.659 . . . . 1.74 112.532 -177.772 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.02 156.5 46.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.788 -1.096 . . . . 1.9199999999999999 110.199 178.588 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.24 158.42 41.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.932 -0.576 . . . . 0.34000000000000002 111.777 -179.407 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.3 m -115.13 135.62 54.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.479 -0.782 . . . . 0.40999999999999998 109.838 179.324 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.593 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.4 122.04 23.79 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.444 -0.344 . . . . 0.55000000000000004 111.497 -179.164 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.4 Cg_exo -46.43 151.78 1.69 Allowed 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.692 2.261 . . . . 0.44 112.128 179.046 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.0 -22.99 63.21 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 116.044 -0.526 . . . . 0.73999999999999999 112.728 -179.116 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.54 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.83 -16.8 46.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.383 0.592 . . . . 0.93000000000000005 111.818 -178.352 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.603 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.68 138.37 31.62 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.716 -0.393 . . . . 0.96999999999999997 110.25 179.387 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.5 14.06 11.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.342 -0.39 . . . . 1.3400000000000001 111.601 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.472 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -150.0 143.39 25.16 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.682 -0.407 . . . . 0.39000000000000001 111.07 179.607 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.709 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.84 -169.33 1.53 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.222 0.534 . . . . 0.41999999999999998 110.844 -179.439 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.709 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.75 125.87 9.23 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.439 -0.8 . . . . 0.39000000000000001 109.887 179.283 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.513 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.85 123.3 70.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.372 -0.531 . . . . 0.73999999999999999 111.143 -179.673 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.632 ' CD ' HD13 ' A' ' 185' ' ' ILE . 56.1 mtmt -126.59 163.4 23.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.827 -0.624 . . . . 2.48 110.381 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.11 18.93 60.01 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.817 -0.913 . . . . 0.5 110.817 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.513 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.3 mt -79.04 157.32 28.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.106 0.479 . . . . 0.57999999999999996 111.369 -179.65 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.846 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -99.53 134.0 21.48 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.601 -0.727 . . . . 2.79 110.404 179.811 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.94 143.59 61.1 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.533 2.155 . . . . 0.87 111.925 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.88 25.51 75.48 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 111.056 -0.818 . . . . 0.64000000000000001 111.056 179.685 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.846 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.07 158.91 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.667 0.27 . . . . 0.82999999999999996 110.421 -179.639 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.23 139.96 42.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.393 -0.367 . . . . 0.5 110.588 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.668 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 94.0 m-85 -122.65 136.52 54.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.906 -0.588 . . . . 0.53000000000000003 110.713 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.94 131.03 45.32 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.527 -0.916 . . . . 1.8700000000000001 108.527 177.661 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.48 153.89 16.65 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.331 -0.937 . . . . 0.28999999999999998 111.931 -178.558 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -135.02 140.88 45.99 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.69 -0.485 . . . . 1.4299999999999999 109.69 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.71 118.8 34.08 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.513 -0.475 . . . . 0.32000000000000001 110.509 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.725 HG12 HG23 ' A' ' 84' ' ' VAL . 63.7 mt -112.32 129.0 68.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.357 -0.383 . . . . 0.79000000000000004 110.707 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.708 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.79 120.76 43.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.374 -0.375 . . . . 1.02 110.785 -179.694 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.849 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.55 146.57 11.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.219 0.533 . . . . 0.62 111.017 -179.255 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.625 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.11 153.81 21.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.523 -0.762 . . . . 2.4399999999999999 109.948 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.25 88.66 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.012 0.434 . . . . 3.6899999999999999 110.448 -179.68 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.22 32.74 0.21 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.786 -0.643 . . . . 6.0800000000000001 110.56 -179.871 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.22 -117.41 3.27 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.443 -0.663 . . . . 1.22 111.443 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.31 177.3 9.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.168 0.509 . . . . 2.8799999999999999 111.635 -179.229 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.09 149.57 32.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.428 -0.805 . . . . 1.47 110.34 179.186 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.14 144.64 38.72 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.429 -0.35 . . . . 2.7000000000000002 110.509 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.725 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.06 136.09 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 121.056 0.455 . . . . 0.46000000000000002 111.525 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.559 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.05 141.26 52.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.653 -0.703 . . . . 0.34999999999999998 110.277 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.453 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.61 138.86 51.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.127 0.489 . . . . 3.6699999999999999 111.481 -179.374 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.3 164.2 37.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.534 -0.757 . . . . 0.67000000000000004 109.518 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.23 151.61 38.66 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.43 -0.508 . . . . 1.47 111.131 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.811 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.32 172.69 13.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.82 -0.627 . . . . 0.44 110.998 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.76 160.75 21.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.455 -0.793 . . . . 1.3700000000000001 109.897 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.39 121.91 22.98 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.584 -0.446 . . . . 1.28 110.67 -179.943 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.592 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.6 p -127.44 165.36 19.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.469 0.652 . . . . 1.97 112.562 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.211 -0.904 . . . . 3.2799999999999998 109.978 178.727 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.402 ' O ' HD12 ' A' ' 172' ' ' LEU . 20.9 p . . . . . 0 N--CA 1.464 0.267 0 CA-C-O 120.708 0.29 . . . . 0.66000000000000003 111.652 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.437 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.96 167.56 0.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.075 -0.511 . . . . 0.68999999999999995 110.946 -179.033 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.57 145.52 50.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.79 -0.641 . . . . 0.52000000000000002 110.078 -179.884 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.26 101.78 9.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.055 -0.72 . . . . 0.32000000000000001 109.055 177.648 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.2 t -113.05 139.72 36.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.28999999999999998 110.942 -178.818 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.2 p -128.74 152.63 48.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.588 -0.733 . . . . 0.25 109.781 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.594 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.83 -165.06 2.06 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.793 -0.363 . . . . 0.31 110.638 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -123.89 127.15 73.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.466 . . . . 0.48999999999999999 110.896 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.173 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.84 58.26 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.123 -0.489 . . . . 1.53 110.365 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.743 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.08 24.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.936 -0.575 . . . . 0.96999999999999997 111.44 -179.705 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.173 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.14 128.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.619 -0.432 . . . . 1.5600000000000001 110.881 179.853 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -86.49 -9.56 55.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.915 -0.584 . . . . 1.8799999999999999 110.311 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.5 p -87.17 0.27 55.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.141 -0.481 . . . . 1.04 110.286 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.725 HG12 ' O ' ' A' ' 136' ' ' SER . 2.6 p -65.18 137.16 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.011 -0.54 . . . . 0.23999999999999999 110.037 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.591 ' HB3' ' HZ1' ' A' ' 61' ' ' LYS . 69.4 m -96.19 -15.54 22.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.356 0.598 . . . . 0.28999999999999998 110.065 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 1.012 ' O ' HG22 ' A' ' 185' ' ' ILE . . . 178.6 175.55 45.77 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 109.881 -1.288 . . . . 0.13 109.881 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -123.36 151.64 42.32 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.698 -0.401 . . . . 0.17000000000000001 110.484 179.732 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.835 ' NH2' ' CE1' ' A' ' 157' ' ' TYR . 70.3 ttt-85 -132.42 121.26 23.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.059 0.457 . . . . 1.29 109.803 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.559 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.16 136.47 38.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.635 -0.711 . . . . 0.25 110.66 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.58 ' C ' ' CD ' ' A' ' 145' ' ' GLU . 0.3 OUTLIER -129.31 129.89 45.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.014 -0.539 . . . . 1.3200000000000001 110.037 -179.937 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.67 135.21 34.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.07 -0.513 . . . . 0.56999999999999995 110.673 -179.7 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.425 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.28 161.38 39.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.875 -0.602 . . . . 1.1599999999999999 109.728 179.823 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.957 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.0 mt -71.14 124.91 25.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.038 0.447 . . . . 0.38 110.649 -179.459 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.75 -7.76 50.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.787 -0.642 . . . . 0.40999999999999998 110.874 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -109.78 -69.68 0.85 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.913 0.387 . . . . 1.6599999999999999 111.347 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.435 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.67 -35.29 75.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.118 -0.492 . . . . 1.6599999999999999 111.505 -179.101 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.102 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.1 7.12 88.66 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.864 -0.894 . . . . 1.1699999999999999 110.864 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.327 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.89 -171.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.811 0.339 . . . . 1.8600000000000001 110.264 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.327 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.32 139.09 44.94 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-O 120.98 0.419 . . . . 1.98 110.211 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.425 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.89 145.86 51.7 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 C-N-CA 122.741 2.294 . . . . 0.55000000000000004 112.321 -179.516 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.95 145.73 42.69 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.211 -0.663 . . . . 1.1399999999999999 109.211 179.216 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.835 ' CE1' ' NH2' ' A' ' 143' ' ' ARG . 8.3 m-85 -123.22 141.37 52.05 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.358 -0.537 . . . . 0.93000000000000005 111.54 -179.089 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.2 mt -128.07 127.65 43.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.269 -0.878 . . . . 0.34000000000000002 108.986 178.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -101.62 131.19 47.97 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.162 0.506 . . . . 1.0900000000000001 111.791 -178.812 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.97 157.55 73.5 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.257 -0.883 . . . . 0.19 109.552 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.73 157.98 58.57 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.473 2.115 . . . . 0.17999999999999999 112.207 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.35 -12.08 5.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.764 -0.653 . . . . 0.20999999999999999 110.721 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.3 p -92.88 -8.68 42.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.185 -0.461 . . . . 0.28999999999999998 110.713 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.21 135.4 34.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.5 110.383 179.655 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.9 p -133.09 16.61 4.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.386 -0.37 . . . . 0.29999999999999999 110.548 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.5 p -167.54 147.11 5.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.58 -0.526 . . . . 0.23000000000000001 109.58 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.559 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.23 150.43 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.519 -0.472 . . . . 0.28000000000000003 111.542 -179.634 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.509 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.23 124.98 50.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.66 -0.7 . . . . 1.0700000000000001 109.845 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.45 104.92 30.11 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.43 -0.35 . . . . 0.28999999999999998 110.986 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.5 Cg_endo -91.02 -179.49 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 123.116 2.544 . . . . 0.42999999999999999 112.201 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.67 32.68 18.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.401 -0.818 . . . . 1.26 111.463 179.261 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 126' ' ' SER . 24.2 mt -86.39 148.51 25.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.455 -0.339 . . . . 0.32000000000000001 110.496 179.554 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.765 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.25 114.86 61.32 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.029 0.442 . . . . 0.57999999999999996 110.662 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.98 140.51 95.67 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.921 2.414 . . . . 0.66000000000000003 112.026 179.818 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.18 21.14 74.19 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.052 -0.819 . . . . 0.28999999999999998 111.052 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.435 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.86 150.21 49.36 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.966 -0.293 . . . . 2.3300000000000001 110.671 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.491 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.23 131.67 46.03 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.094 -0.503 . . . . 0.85999999999999999 109.782 179.32 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.957 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.1 m-85 -120.46 148.33 43.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.09 -0.504 . . . . 0.52000000000000002 111.056 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.4 125.3 60.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.284 -1.006 . . . . 0.29999999999999999 108.284 177.696 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.49 132.47 63.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.154 0.502 . . . . 0.23000000000000001 111.236 -178.579 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.43 122.56 20.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.509 -0.769 . . . . 0.35999999999999999 109.644 179.268 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.594 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.99 125.41 54.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.318 -0.401 . . . . 0.19 110.672 -179.512 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.8 m-85 -117.31 137.95 52.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.987 -0.551 . . . . 0.29999999999999999 109.793 179.585 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.42 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.75 134.99 42.9 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.778 -0.823 . . . . 0.37 108.778 178.917 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 1.012 HG22 ' O ' ' A' ' 141' ' ' GLY . 5.3 tt -99.18 122.99 51.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.204 0.526 . . . . 0.26000000000000001 110.891 -178.692 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.7 p -83.78 169.7 14.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.524 -0.762 . . . . 0.28000000000000003 110.46 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.81 -14.49 15.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.09 -0.505 . . . . 1.6000000000000001 110.933 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -96.14 -4.23 43.07 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.827 -0.349 . . . . 1.1799999999999999 110.807 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.83 13.8 64.08 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.349 -0.701 . . . . 0.29999999999999999 111.349 179.802 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -84.63 139.11 32.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.675 0.274 . . . . 1.22 110.453 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -106.71 141.02 38.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.36 . . . . 0.97999999999999998 110.588 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.2 m -136.71 127.01 26.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.82999999999999996 110.43 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.09 117.28 9.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.254 -0.43 . . . . 0.26000000000000001 110.507 -179.869 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.03 -21.75 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.29999999999999999 110.693 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.1 tp -156.88 125.64 5.84 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.542 -0.463 . . . . 0.31 111.477 -179.707 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.468 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.74 120.16 21.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.843 -0.617 . . . . 0.28000000000000003 109.554 179.188 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.6 151.74 29.18 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.642 -0.423 . . . . 0.23999999999999999 110.91 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.44 158.53 18.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.015 -0.539 . . . . 0.23000000000000001 110.406 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -146.03 157.93 43.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 0.67000000000000004 110.719 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.18 104.32 9.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.826 -0.624 . . . . 0.64000000000000001 110.083 179.526 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.7 p . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.914 -1.041 . . . . 1.26 110.637 -179.679 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.3 m . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.231 -0.655 . . . . 3.4399999999999999 109.231 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.72 18.53 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.952 -0.859 . . . . 1.22 110.952 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -35.54 142.4 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.106 0 C-N-CA 123.99 3.127 . . . . 0.75 113.733 -179.293 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.618 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -80.06 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 114.189 -1.369 . . . . 0.79000000000000004 108.837 178.372 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.618 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.62 125.82 51.43 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.407 -0.517 . . . . 1.9399999999999999 111.496 -179.568 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.46 144.02 33.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.685 -0.689 . . . . 0.59999999999999998 110.636 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.03 168.35 25.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.985 0.421 . . . . 3.1400000000000001 111.054 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.741 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.99 131.07 60.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.905 -0.589 . . . . 3.23 110.087 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 69.0 p -141.22 162.36 35.67 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.853 0.359 . . . . 3.6299999999999999 111.178 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 9' ' ' THR . 53.2 mp0 35.94 31.69 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.638 -0.505 . . . . 6.0800000000000001 109.638 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.741 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.55 32.47 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.932 -0.577 . . . . 3.3799999999999999 111.563 -178.817 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.24 -29.22 73.25 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.466 2.11 . . . . 3.9300000000000002 111.815 179.348 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.72 125.49 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.123 -0.489 . . . . 3.3599999999999999 110.574 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.658 ' O ' ' O ' ' A' ' 92' ' ' THR . 39.6 mt-30 -123.86 158.28 60.44 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.862 0.363 . . . . 3.6099999999999999 110.474 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.443 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 98.1 Cg_endo -82.05 -64.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.875 2.383 . . . . 1.51 113.474 -178.992 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.702 ' CG ' ' CD2' ' A' ' 157' ' ' TYR . 64.4 t30 -108.41 -19.68 13.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.287 -0.415 . . . . 2.6800000000000002 112.063 -178.468 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 43.0 t -107.26 152.07 24.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.14 0.495 . . . . 1.21 111.38 -179.438 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.573 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.3 102.92 2.22 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.725 -0.67 . . . . 1.5600000000000001 110.688 179.868 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.62 145.61 13.1 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.935 2.423 . . . . 0.81000000000000005 112.574 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.919 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.83 167.92 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.95 -0.568 . . . . 1.52 109.926 179.506 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.16 147.95 29.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.73 -0.47 . . . . 2.1400000000000001 109.73 178.914 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.597 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.27 157.28 45.01 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.597 -0.441 . . . . 0.32000000000000001 111.215 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.488 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.02 155.29 44.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.754 -0.657 . . . . 2.1699999999999999 110.12 178.983 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.831 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.55 173.1 6.28 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.172 -0.467 . . . . 0.58999999999999997 110.785 -179.229 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.831 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.61 173.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.902 2.401 . . . . 0.90000000000000002 111.555 179.32 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.48 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.05 -51.06 0.69 Allowed Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.757 -0.377 . . . . 3.3399999999999999 110.13 179.777 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.617 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.9 152.34 82.6 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.72 2.28 . . . . 1.8500000000000001 111.419 179.202 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.64 42.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.411 0.624 . . . . 2.54 110.614 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.617 ' H ' ' C ' ' A' ' 27' ' ' PRO . 73.7 t60 -63.66 -41.68 98.18 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.001 -0.999 . . . . 2.5299999999999998 110.626 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.561 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.7 mt -109.77 137.87 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.793 -0.64 . . . . 1.1699999999999999 111.315 -179.516 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.99 -72.93 0.7 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.996 -0.547 . . . . 1.27 111.84 -178.956 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -88.12 148.37 24.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.582 0.586 . . . . 1.1200000000000001 112.582 -179.611 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.78 124.91 45.31 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.328 -0.619 . . . . 0.41999999999999998 109.328 177.43 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.11 134.78 60.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.658 -0.417 . . . . 0.78000000000000003 110.617 179.867 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.919 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.01 128.61 53.7 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.62 111.236 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.07 138.97 49.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.814 -0.63 . . . . 1.97 110.18 178.956 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.432 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.07 163.14 35.17 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.1 0.476 . . . . 0.34999999999999998 112.094 -178.115 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.46 139.58 7.88 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.438 -0.801 . . . . 1.8 110.493 178.836 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.687 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.3 Cg_endo -63.65 115.52 3.11 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.265 1.977 . . . . 0.57999999999999996 111.807 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.676 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.94 81.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.908 -0.404 . . . . 3.04 109.908 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.687 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.992 -0.549 . . . . 2.4700000000000002 111.901 -179.517 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.9 p -157.64 157.71 34.11 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.882 -0.327 . . . . 2.5099999999999998 110.575 179.766 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.4 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.27 27.76 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.169 -0.469 . . . . 1.8600000000000001 110.19 179.544 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.77 -75.95 1.31 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.785 -0.526 . . . . 1.4399999999999999 111.785 -179.217 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.86 152.3 35.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 4.6900000000000004 111.0 -179.322 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.676 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.14 -169.11 2.54 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.028 -0.533 . . . . 1.4299999999999999 111.926 179.382 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.17 149.66 29.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.416 0.627 . . . . 1.74 112.598 -177.904 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.05 156.41 46.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.843 -1.072 . . . . 1.9199999999999999 110.262 178.667 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.23 158.29 41.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.933 -0.576 . . . . 0.34000000000000002 111.773 -179.31 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.04 135.67 53.96 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.483 -0.781 . . . . 0.40999999999999998 109.859 179.303 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.597 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.47 121.99 23.69 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.533 -0.303 . . . . 0.55000000000000004 111.585 -179.186 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.606 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.0 Cg_exo -46.31 151.71 1.63 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.727 2.285 . . . . 0.44 112.029 179.119 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.81 -23.19 63.04 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 116.049 -0.523 . . . . 0.73999999999999999 112.782 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.79 -16.74 46.64 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.213 -0.595 . . . . 0.93000000000000005 111.761 -178.259 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.606 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.6 mt -91.7 138.44 31.56 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.709 -0.396 . . . . 0.96999999999999997 110.298 179.381 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.46 13.85 11.04 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.392 -0.367 . . . . 1.3400000000000001 111.518 -179.357 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.475 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.7 p -150.01 143.45 25.18 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.65 -0.42 . . . . 0.39000000000000001 110.973 179.7 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.9 t80 -114.84 -169.48 1.56 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.043 -0.526 . . . . 0.41999999999999998 110.869 -179.404 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.711 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 t -151.67 125.91 9.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.412 -0.813 . . . . 0.39000000000000001 109.797 179.292 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.513 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.9 mt -114.85 123.32 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.356 -0.538 . . . . 0.73999999999999999 111.189 -179.808 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -126.56 163.3 23.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.894 -0.594 . . . . 2.48 110.448 179.746 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.476 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.14 19.03 59.77 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.75 -0.94 . . . . 0.5 110.75 -179.897 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.676 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.9 mt -79.05 157.3 28.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.124 0.488 . . . . 0.57999999999999996 111.301 -179.642 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.853 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -99.52 133.85 21.59 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.575 -0.739 . . . . 2.79 110.489 179.741 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.447 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.8 Cg_endo -67.81 143.74 62.47 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.454 2.103 . . . . 0.87 112.001 179.773 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.7 25.59 75.37 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.125 -0.79 . . . . 0.64000000000000001 111.125 179.774 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.853 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.21 158.66 40.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.648 0.261 . . . . 0.82999999999999996 110.439 -179.533 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.09 139.98 41.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.0 0.429 . . . . 0.5 110.535 -179.737 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.643 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.59 136.49 54.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.89 -0.595 . . . . 0.53000000000000003 110.689 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.92 130.96 45.32 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.523 -0.917 . . . . 1.8700000000000001 108.523 177.566 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.43 153.93 16.63 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.318 -0.944 . . . . 0.28999999999999998 111.999 -178.658 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -135.03 140.85 45.95 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.779 -0.452 . . . . 1.4299999999999999 109.779 179.585 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.5 tp -115.71 119.0 34.62 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.422 -0.511 . . . . 0.32000000000000001 110.48 179.757 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.51 129.02 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.332 -0.395 . . . . 0.79000000000000004 110.578 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.7 120.86 43.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.283 -0.417 . . . . 1.02 110.749 -179.754 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.853 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.53 146.47 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.116 0.484 . . . . 0.62 111.104 -179.375 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.626 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.06 153.82 21.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.581 -0.736 . . . . 2.4399999999999999 109.965 179.776 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.12 88.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.913 0.387 . . . . 3.6899999999999999 110.467 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.41 32.56 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.809 -0.632 . . . . 6.0800000000000001 110.51 179.998 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.02 -117.37 3.3 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.479 -0.648 . . . . 1.22 111.479 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -81.41 177.37 9.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.268 0.556 . . . . 2.8799999999999999 111.634 -179.244 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.17 149.48 32.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.485 -0.78 . . . . 1.47 110.415 179.179 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.1 144.69 38.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.489 -0.323 . . . . 2.7000000000000002 110.598 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.727 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.02 136.05 61.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-O 121.063 0.459 . . . . 0.46000000000000002 111.544 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.11 141.31 52.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.624 -0.717 . . . . 0.34999999999999998 110.214 179.695 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.469 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.55 138.88 51.62 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.111 0.481 . . . . 3.6699999999999999 111.538 -179.391 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.489 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.34 164.19 37.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.569 -0.741 . . . . 0.67000000000000004 109.405 179.37 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.572 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.28 151.6 38.6 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.369 -0.533 . . . . 1.47 111.062 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.8 p90 -146.23 172.7 13.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.778 -0.646 . . . . 0.44 111.033 179.919 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.72 160.69 21.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.483 -0.781 . . . . 1.3700000000000001 109.939 179.515 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.38 121.93 23.04 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.547 -0.461 . . . . 1.28 110.671 -179.932 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.658 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.7 p -128.45 165.74 20.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.099 -0.501 . . . . 1.97 110.497 179.636 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.4 t . . . . . 0 N--CA 1.464 0.242 0 C-N-CA 120.468 -0.493 . . . . 3.2799999999999998 109.914 178.812 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 121.264 0.554 . . . . 0.66000000000000003 110.79 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.438 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.8 167.52 0.25 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.503 -0.771 . . . . 0.68999999999999995 110.942 179.419 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.6 145.51 50.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.704 -0.68 . . . . 0.52000000000000002 110.128 -179.879 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.27 101.65 9.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.087 -0.708 . . . . 0.32000000000000001 109.087 177.693 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.2 t -112.94 139.74 36.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.055 -0.52 . . . . 0.28999999999999998 111.033 -178.862 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 p -128.7 152.54 48.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.549 -0.75 . . . . 0.25 109.81 179.631 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.591 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.79 -164.93 2.03 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.769 -0.373 . . . . 0.31 110.64 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -123.99 127.15 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.183 -0.462 . . . . 0.48999999999999999 110.814 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.164 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.92 58.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 1.53 110.339 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.06 24.48 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.923 -0.581 . . . . 0.96999999999999997 111.465 -179.698 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.164 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.13 128.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.601 -0.44 . . . . 1.5600000000000001 110.918 179.801 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.46 -9.54 56.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.855 -0.611 . . . . 1.8799999999999999 110.309 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.8 p -87.1 0.25 55.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.073 -0.512 . . . . 1.04 110.343 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.29 137.26 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.016 -0.538 . . . . 0.23999999999999999 109.982 179.69 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 185' ' ' ILE . 71.1 m -96.24 -15.55 21.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.239 0.542 . . . . 0.28999999999999998 110.0 -179.629 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.59 175.54 45.76 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 109.845 -1.302 . . . . 0.13 109.845 179.707 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.48 151.58 42.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.989 0.423 . . . . 0.17000000000000001 110.43 179.78 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.834 ' HE ' ' NE2' ' A' ' 191' ' ' GLN . 62.5 ttp85 -132.38 121.18 23.07 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.145 -0.479 . . . . 1.29 109.977 179.744 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.546 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.01 136.62 37.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.615 -0.721 . . . . 0.25 110.655 -179.755 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.501 ' CD ' ' O ' ' A' ' 156' ' ' GLN . 24.8 tp10 -129.41 129.9 45.28 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.933 -0.576 . . . . 1.3200000000000001 110.067 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.2 p90 -138.72 135.3 34.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.962 -0.563 . . . . 0.56999999999999995 110.627 -179.717 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.415 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.33 161.35 39.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.815 -0.629 . . . . 1.1599999999999999 109.682 179.79 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.967 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.02 124.83 25.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.049 0.452 . . . . 0.38 110.747 -179.596 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.499 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.74 -7.69 49.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.704 -0.68 . . . . 0.40999999999999998 110.779 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -109.86 -69.76 0.85 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.937 0.399 . . . . 1.6599999999999999 111.336 -179.231 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.447 ' CD ' HH21 ' A' ' 176' ' ' ARG . 53.9 mt-10 -60.61 -35.39 76.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.111 -0.495 . . . . 1.6599999999999999 111.493 -179.083 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.089 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.18 7.23 88.6 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.808 -0.917 . . . . 1.1699999999999999 110.808 -179.854 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.32 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.91 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.835 0.35 . . . . 1.8600000000000001 110.262 179.861 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.32 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.29 139.1 45.05 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.974 0.416 . . . . 1.98 110.126 179.619 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.415 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.5 Cg_endo -70.92 145.81 51.38 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 122.71 2.273 . . . . 0.55000000000000004 112.275 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.85 145.75 42.59 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.243 -0.651 . . . . 1.1399999999999999 109.243 179.16 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.702 ' CD2' ' CG ' ' A' ' 16' ' ' ASN . 27.3 p90 -123.26 141.34 52.08 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.296 -0.561 . . . . 0.93000000000000005 111.57 -179.115 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.09 127.76 43.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.313 -0.858 . . . . 0.34000000000000002 108.978 178.923 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -101.68 131.1 48.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.171 0.51 . . . . 1.0900000000000001 111.747 -178.733 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.88 157.51 73.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.248 -0.887 . . . . 0.19 109.624 179.686 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.76 158.02 58.4 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.464 2.109 . . . . 0.17999999999999999 112.297 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.21 -12.25 5.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.879 -0.6 . . . . 0.20999999999999999 110.696 -179.839 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.2 p -92.81 -8.73 42.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.28999999999999998 110.724 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.23 135.33 34.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.348 -0.387 . . . . 0.5 110.374 179.713 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.1 p -133.12 16.68 4.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 0.29999999999999999 110.499 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.7 p -167.54 147.12 5.08 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.617 -0.512 . . . . 0.23000000000000001 109.617 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.546 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.12 150.49 12.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.495 -0.482 . . . . 0.28000000000000003 111.538 -179.636 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.507 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.32 124.8 50.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 1.0700000000000001 109.833 179.452 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.31 104.93 29.7 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.915 0.388 . . . . 0.28999999999999998 111.077 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.2 Cg_endo -91.02 -179.47 1.48 Allowed 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 123.177 2.585 . . . . 0.42999999999999999 112.18 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.69 32.59 18.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.382 -0.826 . . . . 1.26 111.422 179.276 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.1 mt -86.31 148.53 25.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.52 -0.309 . . . . 0.32000000000000001 110.501 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.77 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.34 114.84 61.28 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.041 0.448 . . . . 0.57999999999999996 110.631 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.0 140.6 96.09 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.871 2.381 . . . . 0.66000000000000003 111.94 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.03 21.2 74.47 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.032 -0.827 . . . . 0.28999999999999998 111.032 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.447 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.81 150.31 49.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.784 0.326 . . . . 2.3300000000000001 110.677 179.882 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.499 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.28 131.58 46.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.097 -0.501 . . . . 0.85999999999999999 109.773 179.377 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.967 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.2 m-85 -120.45 148.31 43.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.111 -0.495 . . . . 0.52000000000000002 111.022 -179.806 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.32 125.36 60.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.271 -1.011 . . . . 0.29999999999999999 108.271 177.726 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.55 132.45 63.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.139 0.495 . . . . 0.23000000000000001 111.218 -178.545 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.46 20.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.594 -0.73 . . . . 0.35999999999999999 109.682 179.286 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.591 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.7 t -100.84 125.32 54.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.291 -0.413 . . . . 0.19 110.798 -179.585 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.806 ' CD2' ' NH2' ' A' ' 143' ' ' ARG . 48.5 m-85 -117.18 137.84 52.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.103 -0.499 . . . . 0.29999999999999999 109.875 179.535 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.427 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.62 135.03 42.69 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.853 -0.795 . . . . 0.37 108.853 178.814 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.606 ' O ' ' N ' ' A' ' 140' ' ' SER . 84.8 mt -99.09 122.93 51.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.1 0.476 . . . . 0.26000000000000001 110.923 -178.724 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.1 p -83.91 169.75 14.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.566 -0.743 . . . . 0.28000000000000003 110.481 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -59.82 -14.47 15.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.096 -0.502 . . . . 1.6000000000000001 110.938 -179.539 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -96.11 -4.25 43.15 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.863 -0.335 . . . . 1.1799999999999999 110.758 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.449 ' N ' ' HB ' ' A' ' 59' ' ' THR . . . 87.75 13.84 64.18 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.431 -0.668 . . . . 0.29999999999999999 111.431 179.884 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -84.62 139.0 32.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.622 0.248 . . . . 1.22 110.443 179.716 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.834 ' NE2' ' HE ' ' A' ' 143' ' ' ARG . 86.6 mt-30 -106.62 141.02 38.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.871 0.367 . . . . 0.97999999999999998 110.639 179.682 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.6 m -136.68 127.04 26.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 0.82999999999999996 110.431 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.17 117.35 9.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.348 -0.387 . . . . 0.26000000000000001 110.507 -179.885 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.1 -21.81 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.125 -0.489 . . . . 0.29999999999999999 110.652 -179.674 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.9 125.68 5.84 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.489 -0.484 . . . . 0.31 111.479 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.473 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.73 120.33 21.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.756 -0.656 . . . . 0.28000000000000003 109.504 179.165 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.67 151.67 29.04 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.659 -0.416 . . . . 0.23999999999999999 110.952 -179.314 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.45 158.58 18.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.523 . . . . 0.23000000000000001 110.467 179.707 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.4 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 67.9 mt-30 -146.08 157.93 43.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.046 -0.525 . . . . 0.67000000000000004 110.527 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.21 104.41 9.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.728 -0.669 . . . . 0.64000000000000001 110.088 179.44 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 117.839 -1.077 . . . . 1.26 110.659 -179.712 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.219 -0.66 . . . . 3.4399999999999999 109.219 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.36 150.81 18.52 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.012 -0.835 . . . . 1.22 111.012 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -35.81 142.43 0.11 Allowed 'Trans proline' 0 C--N 1.297 -2.141 0 C-N-CA 123.975 3.117 . . . . 0.75 113.761 -179.184 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -79.9 173.4 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.196 -1.365 . . . . 0.79000000000000004 108.839 178.425 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.616 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.62 125.9 51.52 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.412 -0.515 . . . . 1.9399999999999999 111.421 -179.662 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.47 144.01 33.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.613 -0.721 . . . . 0.59999999999999998 110.649 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.01 168.33 25.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.837 0.351 . . . . 3.1400000000000001 111.215 -179.762 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.74 HG22 ' OG1' ' A' ' 11' ' ' THR . 65.9 mt -108.95 131.16 60.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.053 -0.521 . . . . 3.23 110.074 179.864 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.8 p -141.26 162.25 35.93 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.835 0.35 . . . . 3.6299999999999999 111.223 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 9' ' ' THR . 98.0 mt-10 36.21 31.51 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.636 -0.505 . . . . 6.0800000000000001 109.636 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.74 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.66 32.71 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.939 -0.573 . . . . 3.3799999999999999 111.587 -178.787 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.641 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.24 -29.28 73.21 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.529 2.153 . . . . 3.9300000000000002 111.82 179.391 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.641 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.71 125.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 3.3599999999999999 110.43 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.601 ' O ' ' O ' ' A' ' 92' ' ' THR . 3.0 mp0 -124.05 158.28 60.97 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.405 . . . . 3.6099999999999999 110.432 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.57 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 96.4 Cg_endo -81.94 -64.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.935 2.423 . . . . 1.51 113.547 -179.037 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.868 ' ND2' ' CD1' ' A' ' 157' ' ' TYR . 3.0 m120 -108.39 -19.55 13.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.262 -0.426 . . . . 2.6800000000000002 112.084 -178.551 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 37.5 t -107.3 152.08 24.61 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.488 -0.485 . . . . 1.21 111.322 -179.435 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.573 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.29 102.92 2.23 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.716 -0.675 . . . . 1.5600000000000001 110.705 179.803 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.63 145.68 13.12 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.928 2.419 . . . . 0.81000000000000005 112.522 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.923 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.9 168.02 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.86 -0.609 . . . . 1.52 109.919 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.17 147.94 29.04 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.736 -0.468 . . . . 2.1400000000000001 109.736 178.972 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.599 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.26 157.27 45.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.994 0.426 . . . . 0.32000000000000001 111.229 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.491 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.8 m-20 -128.02 155.27 44.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.86 -0.609 . . . . 2.1699999999999999 110.163 178.94 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.829 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.6 172.95 6.48 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.082 0.467 . . . . 0.58999999999999997 110.777 -179.197 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.829 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.59 173.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.836 2.357 . . . . 0.90000000000000002 111.597 179.351 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.06 -51.01 0.69 Allowed Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.729 -0.388 . . . . 3.3399999999999999 110.051 179.89 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.615 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.83 152.37 82.39 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.797 2.331 . . . . 1.8500000000000001 111.449 179.22 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.78 42.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.433 0.635 . . . . 2.54 110.554 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.615 ' H ' ' C ' ' A' ' 27' ' ' PRO . 73.9 t60 -63.65 -41.65 98.21 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.019 -0.991 . . . . 2.5299999999999998 110.702 179.727 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.562 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.4 mt -109.84 137.86 40.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.659 -0.701 . . . . 1.1699999999999999 111.24 -179.437 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.96 -72.89 0.7 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.017 -0.538 . . . . 1.27 111.933 -179.018 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.12 148.28 24.51 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.594 0.59 . . . . 1.1200000000000001 112.594 -179.661 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.74 124.83 45.16 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.43 -0.582 . . . . 0.41999999999999998 109.43 177.432 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.02 134.75 60.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.612 -0.435 . . . . 0.78000000000000003 110.611 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.923 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.97 128.65 53.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.042 0.448 . . . . 0.62 111.309 179.674 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.19 139.02 49.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.679 -0.692 . . . . 1.97 110.114 178.967 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.0 163.15 35.07 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.119 0.485 . . . . 0.34999999999999998 112.099 -178.094 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.49 139.6 7.86 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.406 -0.816 . . . . 1.8 110.533 178.728 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.686 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.8 Cg_endo -63.43 115.39 2.99 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.313 2.008 . . . . 0.57999999999999996 111.893 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.676 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.89 81.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.92 -0.4 . . . . 3.04 109.92 -179.856 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.686 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.023 -0.535 . . . . 2.4700000000000002 111.875 -179.41 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.2 p -157.63 157.87 34.44 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.787 -0.365 . . . . 2.5099999999999998 110.506 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.45 27.83 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.478 . . . . 1.8600000000000001 110.164 179.566 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.8 -75.87 1.31 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.157 -0.544 . . . . 1.4399999999999999 111.859 -179.255 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.89 152.29 35.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 4.6900000000000004 111.037 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.637 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.23 -169.17 2.55 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.041 -0.527 . . . . 1.4299999999999999 111.928 179.422 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.13 149.69 29.69 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.397 0.617 . . . . 1.74 112.615 -177.854 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.01 156.46 46.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.891 -1.05 . . . . 1.9199999999999999 110.326 178.666 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.19 158.37 41.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.038 -0.528 . . . . 0.34000000000000002 111.85 -179.317 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.8 m -115.17 135.67 53.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.5 -0.773 . . . . 0.40999999999999998 109.815 179.296 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.599 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.43 122.01 23.75 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.515 -0.311 . . . . 0.55000000000000004 111.511 -179.141 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.607 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.4 Cg_exo -46.48 151.81 1.71 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.668 2.245 . . . . 0.44 112.083 179.04 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.91 -23.08 63.13 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 116.033 -0.53 . . . . 0.73999999999999999 112.821 -179.249 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.5 p-80 -82.79 -16.77 46.56 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.167 -0.613 . . . . 0.93000000000000005 111.762 -178.293 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.607 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.69 138.47 31.54 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.766 -0.374 . . . . 0.96999999999999997 110.266 179.399 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.61 13.93 10.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.409 -0.36 . . . . 1.3400000000000001 111.476 -179.341 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -150.0 143.47 25.2 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.65 -0.42 . . . . 0.39000000000000001 111.093 179.522 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.9 t80 -114.77 -169.32 1.52 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.263 0.554 . . . . 0.41999999999999998 110.853 -179.386 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' THR . . . . . 1.003 HG21 ' O ' ' A' ' 187' ' ' GLU . 5.4 p -151.83 125.95 9.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.403 -0.817 . . . . 0.39000000000000001 109.737 179.284 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.97 123.32 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.278 -0.569 . . . . 0.73999999999999999 111.146 -179.797 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -126.57 163.41 23.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.835 -0.621 . . . . 2.48 110.371 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.04 19.04 59.9 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.743 -0.943 . . . . 0.5 110.743 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.514 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.4 mt -79.08 157.27 28.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.125 0.488 . . . . 0.57999999999999996 111.361 -179.694 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.856 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -99.49 133.9 21.57 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.562 -0.744 . . . . 2.79 110.406 179.838 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.446 ' HD3' ' CE2' ' A' ' 157' ' ' TYR . 36.9 Cg_endo -67.84 143.56 61.6 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.563 2.175 . . . . 0.87 111.893 179.799 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.88 25.58 75.39 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.999 -0.841 . . . . 0.64000000000000001 110.999 179.649 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.856 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.16 158.82 39.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.689 0.28 . . . . 0.82999999999999996 110.426 -179.641 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.12 139.98 41.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.344 -0.389 . . . . 0.5 110.637 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.643 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.6 m-85 -122.63 136.39 54.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.53000000000000003 110.753 -179.878 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.3 pt-20 -98.83 130.95 45.27 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.51 -0.922 . . . . 1.8700000000000001 108.51 177.615 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.42 153.86 16.63 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.365 -0.922 . . . . 0.28999999999999998 112.082 -178.711 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -134.98 140.86 46.02 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.709 -0.478 . . . . 1.4299999999999999 109.709 179.647 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.519 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.3 tp -115.69 118.91 34.38 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.493 -0.483 . . . . 0.32000000000000001 110.526 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.725 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.48 129.08 68.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.298 -0.41 . . . . 0.79000000000000004 110.648 -179.895 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.707 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.82 120.8 43.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.325 -0.398 . . . . 1.02 110.669 -179.558 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.854 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.56 146.4 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.089 0.471 . . . . 0.62 111.098 -179.299 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.625 ' O ' ' N ' ' A' ' 79' ' ' TYR . 20.9 mt-30 -106.01 153.86 21.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.601 -0.727 . . . . 2.4399999999999999 109.989 179.798 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.11 88.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.899 0.38 . . . . 3.6899999999999999 110.439 -179.756 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.3 32.66 0.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.791 -0.64 . . . . 6.0800000000000001 110.539 -179.915 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.16 -117.29 3.27 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.464 -0.654 . . . . 1.22 111.464 -179.765 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -81.5 177.45 8.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.234 0.54 . . . . 2.8799999999999999 111.571 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.1 149.59 32.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.392 -0.822 . . . . 1.47 110.406 179.18 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.19 144.58 38.6 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.453 -0.34 . . . . 2.7000000000000002 110.629 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.725 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -127.96 136.02 61.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 120.582 -0.447 . . . . 0.46000000000000002 111.536 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.06 141.3 52.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.671 -0.695 . . . . 0.34999999999999998 110.347 179.595 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.472 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.55 138.88 51.62 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 120.588 -0.445 . . . . 3.6699999999999999 111.546 -179.329 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.35 164.17 38.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.604 -0.725 . . . . 0.67000000000000004 109.474 179.336 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.571 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.24 151.62 38.67 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.4 -0.52 . . . . 1.47 111.065 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.811 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.3 p90 -146.28 172.63 13.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.727 -0.67 . . . . 0.44 111.047 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.68 160.72 21.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.485 -0.78 . . . . 1.3700000000000001 109.846 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.39 121.89 22.97 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.558 -0.457 . . . . 1.28 110.784 179.913 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.601 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.8 p -128.0 162.8 25.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.14 -0.482 . . . . 1.97 111.126 179.706 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 109.914 -0.402 . . . . 3.2799999999999998 109.914 178.427 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 CA--C 1.522 -0.117 0 CA-C-O 120.904 0.383 . . . . 0.66000000000000003 110.278 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.435 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.88 167.54 0.26 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.917 -0.583 . . . . 0.68999999999999995 110.916 179.932 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.53 145.51 50.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.707 -0.679 . . . . 0.52000000000000002 110.196 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.21 101.74 9.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.064 -0.717 . . . . 0.32000000000000001 109.064 177.658 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.2 t -112.99 139.75 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.03 -0.532 . . . . 0.28999999999999998 111.008 -178.902 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.4 p -128.76 152.54 48.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.574 -0.739 . . . . 0.25 109.746 179.615 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.8 -164.96 2.04 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.657 -0.417 . . . . 0.31 110.578 -179.781 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -124.0 127.22 73.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.122 -0.49 . . . . 0.48999999999999999 110.793 -179.794 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.175 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -58.1 58.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.141 -0.481 . . . . 1.53 110.299 179.918 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.18 24.52 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.863 -0.608 . . . . 0.96999999999999997 111.476 -179.674 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.175 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.14 128.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.654 -0.418 . . . . 1.5600000000000001 111.0 179.842 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.39 -9.56 56.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.931 -0.577 . . . . 1.8799999999999999 110.352 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.6 p -87.1 0.17 55.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.073 -0.512 . . . . 1.04 110.297 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.22 137.22 25.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.977 -0.556 . . . . 0.23999999999999999 109.972 179.69 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.589 ' N ' ' O ' ' A' ' 185' ' ' ILE . 72.3 m -96.22 -15.66 21.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.296 0.569 . . . . 0.28999999999999998 110.055 -179.674 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.67 175.63 45.9 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 109.888 -1.285 . . . . 0.13 109.888 179.57 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.4 151.69 42.34 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.605 -0.438 . . . . 0.17000000000000001 110.501 179.719 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.609 HH22 ' CD ' ' A' ' 191' ' ' GLN . 52.9 ttp180 -132.37 121.27 23.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.128 -0.487 . . . . 1.29 109.883 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.557 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.1 136.49 38.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.698 -0.683 . . . . 0.25 110.693 -179.826 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 82.7 tt0 -129.34 129.89 45.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.973 -0.558 . . . . 1.3200000000000001 110.047 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.71 135.28 34.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.053 -0.521 . . . . 0.56999999999999995 110.623 -179.706 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.425 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.33 161.27 40.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.773 -0.649 . . . . 1.1599999999999999 109.705 179.84 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.962 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.0 mt -71.0 124.91 25.45 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.641 -0.424 . . . . 0.38 110.751 -179.568 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.76 -7.72 49.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.763 -0.653 . . . . 0.40999999999999998 110.913 -179.782 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -109.77 -69.69 0.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 1.6599999999999999 111.393 -179.28 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.45 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.4 mt-10 -60.64 -35.39 76.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.003 -0.544 . . . . 1.6599999999999999 111.45 -179.077 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.089 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.15 88.64 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.785 -0.926 . . . . 1.1699999999999999 110.785 -179.793 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.315 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.3 t0 -27.94 -171.71 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.725 0.297 . . . . 1.8600000000000001 110.283 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.315 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.14 45.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.043 0.449 . . . . 1.98 110.224 179.595 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.425 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 45.4 Cg_endo -70.96 145.88 51.34 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.729 2.286 . . . . 0.55000000000000004 112.248 -179.467 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.83 145.75 42.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.228 -0.656 . . . . 1.1399999999999999 109.228 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.868 ' CD1' ' ND2' ' A' ' 16' ' ' ASN . 21.3 p90 -123.31 141.33 52.1 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.377 -0.529 . . . . 0.93000000000000005 111.491 -179.115 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.6 mt -128.16 127.71 43.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.269 -0.878 . . . . 0.34000000000000002 108.872 178.926 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.499 ' O ' ' OD1' ' A' ' 159' ' ' ASP . 54.2 p-10 -101.62 131.1 48.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.195 0.522 . . . . 1.0900000000000001 111.751 -178.782 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.9 mt -127.87 157.55 73.29 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.318 -0.855 . . . . 0.19 109.617 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -69.89 158.07 58.01 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.297 1.998 . . . . 0.17999999999999999 112.251 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.25 -12.16 5.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.785 -0.643 . . . . 0.20999999999999999 110.684 -179.831 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.78 -8.8 42.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.28999999999999998 110.7 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.24 135.39 34.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.5 110.351 179.788 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.7 p -133.09 16.65 4.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.388 -0.369 . . . . 0.29999999999999999 110.573 179.937 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.3 p -167.56 147.17 5.07 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.59 -0.522 . . . . 0.23000000000000001 109.59 179.881 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.21 150.55 12.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.532 -0.467 . . . . 0.28000000000000003 111.535 -179.658 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.38 124.9 50.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.572 -0.74 . . . . 1.0700000000000001 109.851 179.463 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.33 104.85 29.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.385 -0.37 . . . . 0.28999999999999998 111.062 -179.818 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -90.96 -179.58 1.52 Allowed 'Trans proline' 0 C--N 1.301 -1.951 0 C-N-CA 123.28 2.653 . . . . 0.42999999999999999 112.211 179.909 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.73 32.64 18.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.407 -0.815 . . . . 1.26 111.449 179.271 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.2 mt -86.33 148.44 25.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.551 -0.295 . . . . 0.32000000000000001 110.509 179.592 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.767 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.4 mt -88.17 114.89 61.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.349 -0.387 . . . . 0.57999999999999996 110.702 -179.75 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.12 140.63 95.91 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.744 2.296 . . . . 0.66000000000000003 111.99 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.14 21.15 74.26 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.012 -0.835 . . . . 0.28999999999999998 111.012 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.45 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.86 150.24 49.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.847 0.356 . . . . 2.3300000000000001 110.682 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.26 131.65 46.08 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.044 -0.525 . . . . 0.85999999999999999 109.733 179.426 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.962 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.55 148.3 44.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.064 -0.516 . . . . 0.52000000000000002 111.048 -179.84 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.3 mt -105.31 125.41 60.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.218 -1.03 . . . . 0.29999999999999999 108.218 177.787 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.61 132.43 63.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.13 0.491 . . . . 0.23000000000000001 111.285 -178.632 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.41 122.46 20.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.519 -0.764 . . . . 0.35999999999999999 109.655 179.369 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.95 125.44 54.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.3 -0.409 . . . . 0.19 110.632 -179.516 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 49.4 m-85 -117.31 137.89 52.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.981 -0.554 . . . . 0.29999999999999999 109.802 179.53 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.426 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.68 135.08 42.69 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.776 -0.824 . . . . 0.37 108.776 178.837 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 140' ' ' SER . 78.1 mt -99.13 122.93 51.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.126 0.489 . . . . 0.26000000000000001 111.003 -178.805 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.9 p -83.9 169.71 14.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.546 -0.752 . . . . 0.28000000000000003 110.489 -179.646 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 1.003 ' O ' HG21 ' A' ' 59' ' ' THR . 97.8 mt-10 -59.74 -14.52 14.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.08 -0.509 . . . . 1.6000000000000001 111.01 -179.564 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -96.02 -4.32 43.34 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.837 -0.345 . . . . 1.1799999999999999 110.868 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.8 13.9 63.97 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.329 -0.708 . . . . 0.29999999999999999 111.329 179.842 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -84.72 139.0 32.31 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.01 -0.276 . . . . 1.22 110.462 179.652 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.609 ' CD ' HH22 ' A' ' 143' ' ' ARG . 0.0 OUTLIER -106.61 141.11 38.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.877 0.37 . . . . 0.97999999999999998 110.536 179.789 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.0 m -136.8 127.0 26.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.82999999999999996 110.386 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.3 tp -68.17 117.2 9.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.318 -0.401 . . . . 0.26000000000000001 110.549 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -108.94 -21.84 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.29999999999999999 110.7 -179.694 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.86 125.76 5.9 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.559 -0.456 . . . . 0.31 111.513 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.69 120.2 21.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.756 -0.656 . . . . 0.28000000000000003 109.585 179.189 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.65 29.05 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.718 -0.393 . . . . 0.23999999999999999 110.87 -179.264 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.36 158.57 18.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.23000000000000001 110.48 179.664 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -146.09 158.01 43.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.095 -0.502 . . . . 0.67000000000000004 110.648 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.35 9.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.772 -0.649 . . . . 0.64000000000000001 110.013 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.7 p . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.94 -1.028 . . . . 1.26 110.66 -179.686 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.2 m . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.206 -0.664 . . . . 3.4399999999999999 109.206 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.438 ' H ' ' HB3' ' A' ' 1' ' ' SER . . . -116.33 150.73 18.54 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.999 -0.841 . . . . 1.22 110.999 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.62 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.061 0 C-N-CA 123.98 3.12 . . . . 0.75 113.788 -179.236 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.629 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -80.02 173.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.329 -1.305 . . . . 0.79000000000000004 108.772 178.412 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.629 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.63 125.89 51.51 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.41 -0.516 . . . . 1.9399999999999999 111.438 -179.558 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.55 143.93 34.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.656 -0.702 . . . . 0.59999999999999998 110.662 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.95 168.37 25.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.934 0.397 . . . . 3.1400000000000001 110.996 -179.625 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.737 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.98 131.08 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.893 -0.594 . . . . 3.23 110.057 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.18 162.37 35.66 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.828 0.347 . . . . 3.6299999999999999 111.253 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.2 mt-10 35.93 31.74 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.159 0.504 . . . . 6.0800000000000001 109.696 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.737 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.57 69.58 33.92 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.814 -0.63 . . . . 3.3799999999999999 111.492 -178.728 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.615 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.23 -29.16 73.24 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.444 2.096 . . . . 3.9300000000000002 111.794 179.318 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.615 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.68 125.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.228 -0.442 . . . . 3.3599999999999999 110.447 -179.926 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 17' ' ' SER . 3.1 mp0 -123.91 158.31 60.48 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 3.6099999999999999 110.494 179.852 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.443 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 97.6 Cg_endo -81.93 -64.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.0 2.467 . . . . 1.51 113.532 -179.005 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.716 ' CG ' ' CD1' ' A' ' 157' ' ' TYR . 66.5 t30 -108.37 -19.64 13.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.268 -0.424 . . . . 2.6800000000000002 112.08 -178.559 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 29.1 t -107.3 152.08 24.61 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.46 -0.496 . . . . 1.21 111.339 -179.398 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.33 102.98 2.22 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.734 -0.666 . . . . 1.5600000000000001 110.583 179.916 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.69 145.6 12.99 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.93 2.42 . . . . 0.81000000000000005 112.569 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.906 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.8 167.9 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.916 -0.584 . . . . 1.52 109.835 179.563 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.15 147.97 29.08 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.756 -0.461 . . . . 2.1400000000000001 109.756 178.783 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.598 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.24 157.28 45.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.026 0.441 . . . . 0.32000000000000001 111.235 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.499 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.0 155.35 44.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.83 -0.623 . . . . 2.1699999999999999 110.176 178.935 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.818 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.62 173.05 6.34 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.145 0.498 . . . . 0.58999999999999997 110.682 -179.129 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.818 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.71 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.851 2.368 . . . . 0.90000000000000002 111.501 179.367 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.98 -51.06 0.69 Allowed Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 120.767 -0.373 . . . . 3.3399999999999999 110.139 179.856 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.624 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.9 152.31 82.7 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.782 2.322 . . . . 1.8500000000000001 111.428 179.232 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.73 42.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.388 0.613 . . . . 2.54 110.526 -179.832 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.624 ' H ' ' C ' ' A' ' 27' ' ' PRO . 73.6 t60 -63.58 -41.64 98.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.988 -1.005 . . . . 2.5299999999999998 110.685 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.556 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.6 mt -109.93 137.84 40.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.771 -0.649 . . . . 1.1699999999999999 111.31 -179.488 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.0 -72.83 0.71 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.022 -0.536 . . . . 1.27 111.851 -178.948 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.24 148.33 24.4 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.604 0.594 . . . . 1.1200000000000001 112.604 -179.619 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.84 124.93 45.31 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.307 -0.627 . . . . 0.41999999999999998 109.307 177.572 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.8 mt -118.09 134.77 60.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.589 -0.444 . . . . 0.78000000000000003 110.685 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.906 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.06 128.61 53.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.036 0.446 . . . . 0.62 111.216 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.551 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.08 138.98 49.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.809 -0.632 . . . . 1.97 110.104 178.981 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.435 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.03 163.22 34.89 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 121.168 0.509 . . . . 0.34999999999999998 112.126 -178.222 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.494 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.47 139.62 7.89 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.444 -0.798 . . . . 1.8 110.449 178.861 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.68 115.62 3.17 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.261 1.974 . . . . 0.57999999999999996 111.781 179.998 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.02 81.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.879 -0.415 . . . . 3.04 109.879 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.23 -20.49 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.053 -0.522 . . . . 2.4700000000000002 111.898 -179.546 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 p -157.7 157.79 34.17 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.803 -0.359 . . . . 2.5099999999999998 110.527 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.402 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.4 m -120.34 27.76 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 1.8600000000000001 110.179 179.631 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.69 -76.05 1.32 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.793 -0.523 . . . . 1.4399999999999999 111.793 -179.211 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.403 ' HD2' HH11 ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.88 152.33 35.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.922 0.391 . . . . 4.6900000000000004 111.023 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.642 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.06 2.51 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.081 -0.509 . . . . 1.4299999999999999 111.948 179.372 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.17 149.66 29.77 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 112.59 0.589 . . . . 1.74 112.59 -177.812 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.01 156.45 46.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.826 -1.079 . . . . 1.9199999999999999 110.268 178.679 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.21 158.34 41.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.961 -0.563 . . . . 0.34000000000000002 111.778 -179.37 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 m -115.2 135.63 53.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.44 -0.8 . . . . 0.40999999999999998 109.759 179.291 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.598 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.31 121.98 23.89 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.341 -0.39 . . . . 0.55000000000000004 111.576 -179.157 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.5 Cg_exo -46.42 151.69 1.71 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.731 2.287 . . . . 0.44 112.068 179.052 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.8 -23.15 62.96 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 116.053 -0.521 . . . . 0.73999999999999999 112.783 -179.258 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.1 p-80 -82.66 -17.02 46.08 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.264 -0.574 . . . . 0.93000000000000005 111.798 -178.294 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.601 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.54 138.4 31.6 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.745 -0.382 . . . . 0.96999999999999997 110.29 179.506 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.51 13.93 11.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.487 -0.324 . . . . 1.3400000000000001 111.558 -179.385 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -150.04 143.54 25.21 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.633 -0.427 . . . . 0.39000000000000001 111.016 179.598 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.718 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.9 t80 -114.87 -169.35 1.53 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.209 0.528 . . . . 0.41999999999999998 110.836 -179.336 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.718 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.78 125.9 9.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.389 -0.823 . . . . 0.39000000000000001 109.806 179.278 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.504 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.8 mt -114.9 123.33 70.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.328 -0.549 . . . . 0.73999999999999999 111.111 -179.759 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.88 ' HD2' HG21 ' A' ' 185' ' ' ILE . 51.6 mtpt -126.57 163.31 23.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.788 -0.642 . . . . 2.48 110.491 179.667 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.464 ' HA2' HD21 ' A' ' 16' ' ' ASN . . . 85.25 18.91 59.83 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.749 -0.941 . . . . 0.5 110.749 -179.876 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.581 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 74.1 mt -79.12 157.34 27.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.099 0.476 . . . . 0.57999999999999996 111.381 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.861 ' O ' HG12 ' A' ' 67' ' ' VAL . 8.7 mttm -99.55 133.94 21.51 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.642 -0.708 . . . . 2.79 110.416 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.85 143.66 61.91 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.538 2.159 . . . . 0.87 111.931 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.82 25.44 75.56 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.098 -0.801 . . . . 0.64000000000000001 111.098 179.716 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.861 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.0 158.82 39.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.755 0.312 . . . . 0.82999999999999996 110.419 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.12 139.94 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.307 -0.406 . . . . 0.5 110.642 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.64 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.58 136.54 54.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.534 . . . . 0.53000000000000003 110.704 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.494 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -99.0 131.17 45.25 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.422 -0.955 . . . . 1.8700000000000001 108.422 177.647 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.485 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.66 153.84 16.69 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.246 -0.978 . . . . 0.28999999999999998 111.907 -178.595 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -134.94 140.9 46.1 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.734 -0.469 . . . . 1.4299999999999999 109.734 179.584 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.513 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.75 118.89 34.31 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.462 -0.495 . . . . 0.32000000000000001 110.522 179.679 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.744 HG12 HG23 ' A' ' 84' ' ' VAL . 64.2 mt -112.4 129.18 68.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.282 -0.417 . . . . 0.79000000000000004 110.6 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.71 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.9 120.83 43.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.227 -0.442 . . . . 1.02 110.698 -179.677 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.846 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.58 146.42 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.22 0.533 . . . . 0.62 111.018 -179.269 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.631 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.1 mt-30 -106.02 153.9 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.472 -0.786 . . . . 2.4399999999999999 109.864 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.434 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.05 88.47 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.875 0.369 . . . . 3.6899999999999999 110.499 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.631 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.26 32.63 0.21 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.868 -0.605 . . . . 6.0800000000000001 110.625 -179.867 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.14 -117.28 3.28 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.447 -0.661 . . . . 1.22 111.447 -179.746 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -81.39 177.35 9.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.126 0.489 . . . . 2.8799999999999999 111.681 -179.218 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.14 149.56 32.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.454 -0.794 . . . . 1.47 110.367 179.162 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.19 144.68 38.64 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.484 -0.325 . . . . 2.7000000000000002 110.593 179.865 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.744 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.04 135.93 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.065 0.46 . . . . 0.46000000000000002 111.53 -179.706 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.599 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -123.98 141.3 52.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.625 -0.716 . . . . 0.34999999999999998 110.247 179.692 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.481 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.61 138.87 51.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.091 0.472 . . . . 3.6699999999999999 111.527 -179.421 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.485 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.31 164.22 37.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.55 -0.75 . . . . 0.67000000000000004 109.455 179.393 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.576 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.28 151.56 38.54 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.384 -0.526 . . . . 1.47 110.985 -179.962 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.812 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.24 172.72 13.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.75 -0.659 . . . . 0.44 111.013 179.84 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.73 160.71 21.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.431 -0.804 . . . . 1.3700000000000001 109.889 179.572 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.34 121.82 22.92 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.612 -0.435 . . . . 1.28 110.757 -179.995 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.457 ' OG1' ' N ' ' A' ' 93' ' ' SER . 70.3 p -129.54 -122.56 0.22 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.252 0.549 . . . . 1.97 112.0 179.609 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.457 ' N ' ' OG1' ' A' ' 92' ' ' THR . 8.1 t . . . . . 0 C--N 1.347 0.457 0 CA-C-N 114.8 -1.091 . . . . 3.2799999999999998 111.057 -179.707 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 122.124 0.964 . . . . 0.66000000000000003 110.191 . . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.446 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.79 167.54 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.676 -1.147 . . . . 0.68999999999999995 110.955 -179.956 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.55 145.65 50.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.626 -0.715 . . . . 0.52000000000000002 110.087 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.38 101.65 9.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.027 -0.731 . . . . 0.32000000000000001 109.027 177.724 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.4 t -112.9 139.66 36.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.018 -0.537 . . . . 0.28999999999999998 111.049 -178.837 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.0 p -128.7 152.5 48.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.598 -0.728 . . . . 0.25 109.83 179.588 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.584 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.9 p90 -144.74 -164.86 2.01 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.738 -0.385 . . . . 0.31 110.727 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -124.01 127.18 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.259 -0.428 . . . . 0.48999999999999999 110.838 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.144 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.97 58.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 1.53 110.292 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.2 24.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.993 -0.549 . . . . 0.96999999999999997 111.514 -179.66 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.144 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.14 128.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.639 -0.425 . . . . 1.5600000000000001 110.961 179.828 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.47 -9.57 55.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.918 -0.583 . . . . 1.8799999999999999 110.357 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.2 p -87.06 0.17 55.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 1.04 110.332 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.29 137.19 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.951 -0.568 . . . . 0.23999999999999999 110.009 179.776 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.583 ' N ' ' O ' ' A' ' 185' ' ' ILE . 84.8 p -96.16 -15.58 22.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.355 0.597 . . . . 0.28999999999999998 110.062 -179.602 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.61 175.59 45.81 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 109.882 -1.287 . . . . 0.13 109.882 179.651 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.42 151.49 42.57 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.701 -0.4 . . . . 0.17000000000000001 110.558 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.841 ' NH2' ' CD2' ' A' ' 183' ' ' TYR . 66.7 ttp85 -132.27 121.27 23.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.19 -0.459 . . . . 1.29 109.94 179.751 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.537 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.1 136.62 38.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.738 -0.664 . . . . 0.25 110.695 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 21.7 tp10 -129.46 129.85 45.13 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.004 -0.543 . . . . 1.3200000000000001 110.013 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.613 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.4 p90 -138.74 135.26 34.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.983 -0.553 . . . . 0.56999999999999995 110.537 -179.678 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.421 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.28 161.34 39.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.729 -0.669 . . . . 1.1599999999999999 109.679 179.766 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.961 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -70.96 124.77 25.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.04 0.448 . . . . 0.38 110.772 -179.624 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.76 -7.62 49.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.737 -0.665 . . . . 0.40999999999999998 110.908 -179.781 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -109.83 -69.69 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.304 -0.407 . . . . 1.6599999999999999 111.433 -179.314 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.452 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.72 -35.26 75.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.056 -0.52 . . . . 1.6599999999999999 111.529 -179.119 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.096 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.19 88.62 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.828 -0.909 . . . . 1.1699999999999999 110.828 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.318 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -28.06 -171.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 1.8600000000000001 110.317 179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.318 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.16 139.05 45.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 1.98 110.237 179.61 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.91 145.82 51.49 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 122.702 2.268 . . . . 0.55000000000000004 112.366 -179.554 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.8 145.7 42.6 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.287 -0.635 . . . . 1.1399999999999999 109.287 179.235 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.716 ' CD1' ' CG ' ' A' ' 16' ' ' ASN . 49.3 p90 -123.29 141.43 51.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.209 0.528 . . . . 0.93000000000000005 111.489 -179.069 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.6 mt -128.17 127.61 43.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.25 -0.886 . . . . 0.34000000000000002 108.988 178.961 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 40.7 t0 -101.67 131.22 48.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.202 0.525 . . . . 1.0900000000000001 111.679 -178.698 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.578 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -127.88 157.59 73.19 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.23 -0.896 . . . . 0.19 109.679 179.614 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.78 157.91 58.72 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 C-N-CA 122.51 2.14 . . . . 0.17999999999999999 112.241 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.2 -12.18 4.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.781 -0.645 . . . . 0.20999999999999999 110.768 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.6 p -92.85 -8.69 42.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.068 -0.515 . . . . 0.28999999999999998 110.717 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.29 135.46 34.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.349 -0.387 . . . . 0.5 110.349 179.728 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.4 p -133.19 16.64 4.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.402 -0.363 . . . . 0.29999999999999999 110.531 -179.972 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.7 p -167.55 147.09 5.06 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.651 -0.5 . . . . 0.23000000000000001 109.651 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.537 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.18 150.51 12.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.462 -0.495 . . . . 0.28000000000000003 111.588 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.501 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.38 125.02 50.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.626 -0.715 . . . . 1.0700000000000001 109.772 179.483 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.42 104.88 29.77 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.334 -0.394 . . . . 0.28999999999999998 111.036 -179.891 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -90.94 -179.49 1.51 Allowed 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 123.146 2.564 . . . . 0.42999999999999999 112.277 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 61.64 32.7 18.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.373 -0.831 . . . . 1.26 111.479 179.315 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.463 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.2 mt -86.51 148.59 25.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.778 0.323 . . . . 0.32000000000000001 110.388 179.632 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.767 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.35 114.86 61.36 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.093 0.473 . . . . 0.57999999999999996 110.58 -179.648 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.05 140.59 95.93 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.974 2.449 . . . . 0.66000000000000003 111.858 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.02 21.3 74.26 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.049 -0.821 . . . . 0.28999999999999998 111.049 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.452 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.9 150.16 49.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.758 0.314 . . . . 2.3300000000000001 110.584 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.5 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.22 131.64 46.05 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.018 -0.537 . . . . 0.85999999999999999 109.767 179.327 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.961 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.55 148.26 44.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.091 -0.504 . . . . 0.52000000000000002 111.049 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.1 mt -105.3 125.3 60.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.288 -1.004 . . . . 0.29999999999999999 108.288 177.812 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.52 132.51 63.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.169 0.509 . . . . 0.23000000000000001 111.261 -178.591 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.53 122.64 20.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.527 -0.76 . . . . 0.35999999999999999 109.552 179.321 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.584 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.14 125.35 55.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.157 -0.474 . . . . 0.19 110.666 -179.545 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.841 ' CD2' ' NH2' ' A' ' 143' ' ' ARG . 48.3 m-85 -117.2 137.95 52.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.912 -0.586 . . . . 0.29999999999999999 109.869 179.556 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.418 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.73 134.92 42.98 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.817 -0.808 . . . . 0.37 108.817 178.895 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.88 HG21 ' HD2' ' A' ' 61' ' ' LYS . 51.6 mm -99.05 123.01 51.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.107 0.479 . . . . 0.26000000000000001 110.962 -178.769 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.0 p -83.97 169.73 14.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.557 -0.747 . . . . 0.28000000000000003 110.492 -179.698 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.84 -14.4 14.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.956 -0.566 . . . . 1.6000000000000001 110.916 -179.448 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -96.13 -4.28 43.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.839 0.352 . . . . 1.1799999999999999 110.875 -179.853 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.85 13.91 63.86 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.285 -0.726 . . . . 0.29999999999999999 111.285 179.792 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -84.66 139.14 32.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.728 0.299 . . . . 1.22 110.432 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -106.81 141.05 38.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.424 -0.353 . . . . 0.97999999999999998 110.545 179.764 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.2 m -136.64 126.99 26.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.82999999999999996 110.375 179.933 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.18 117.31 9.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.32 -0.4 . . . . 0.26000000000000001 110.467 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.3 pt -108.99 -21.84 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.29999999999999999 110.676 -179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.89 125.68 5.85 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.526 -0.47 . . . . 0.31 111.555 -179.728 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.47 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.77 120.24 21.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.814 -0.63 . . . . 0.28000000000000003 109.538 179.259 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.65 151.69 29.08 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.619 -0.432 . . . . 0.23999999999999999 110.85 -179.259 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.4 158.65 18.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.042 -0.526 . . . . 0.23000000000000001 110.382 179.714 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -146.08 157.89 43.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.097 -0.501 . . . . 0.67000000000000004 110.643 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.24 104.31 9.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.819 -0.628 . . . . 0.64000000000000001 110.068 179.523 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.2 p . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.909 -1.043 . . . . 1.26 110.635 -179.657 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.2 m . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.189 -0.671 . . . . 3.4399999999999999 109.189 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.73 18.54 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.045 -0.822 . . . . 1.22 111.045 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -35.68 142.37 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.086 0 C-N-CA 123.97 3.113 . . . . 0.75 113.832 -179.271 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.604 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.96 173.5 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 114.192 -1.367 . . . . 0.79000000000000004 108.817 178.451 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.604 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.62 125.88 51.5 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.406 -0.518 . . . . 1.9399999999999999 111.41 -179.571 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 143.97 34.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.615 -0.721 . . . . 0.59999999999999998 110.71 179.82 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.27 25.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.893 0.378 . . . . 3.1400000000000001 111.133 -179.641 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.748 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.89 131.09 60.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.989 -0.551 . . . . 3.23 110.085 179.883 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.19 162.39 35.6 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.479 -0.328 . . . . 3.6299999999999999 111.257 -179.995 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 95.0 mt-10 36.06 31.56 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.642 -0.503 . . . . 6.0800000000000001 109.642 179.901 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.748 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.35 69.52 31.59 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.881 -0.599 . . . . 3.3799999999999999 111.564 -178.721 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.23 -29.16 73.21 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.522 2.148 . . . . 3.9300000000000002 111.821 179.39 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.65 125.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 3.3599999999999999 110.367 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.534 ' OE1' ' O ' ' A' ' 13' ' ' SER . 3.1 mp0 -123.97 158.31 60.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.394 . . . . 3.6099999999999999 110.479 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.434 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 97.0 Cg_endo -81.99 -64.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.935 2.424 . . . . 1.51 113.551 -179.035 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.841 ' ND2' ' CD2' ' A' ' 157' ' ' TYR . 18.5 m120 -108.41 -19.64 13.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.051 0.389 . . . . 2.6800000000000002 112.051 -178.546 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 79.3 p -107.35 152.08 24.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.159 0.504 . . . . 1.21 111.302 -179.369 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.29 102.9 2.23 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.671 -0.695 . . . . 1.5600000000000001 110.656 179.918 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.5 Cg_endo -82.7 145.59 12.97 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.872 2.381 . . . . 0.81000000000000005 112.614 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.912 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.73 167.97 24.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.858 -0.61 . . . . 1.52 109.834 179.642 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.2 148.01 29.11 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.67 -0.493 . . . . 2.1400000000000001 109.67 178.822 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.59 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.7 p90 -142.27 157.2 45.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.979 0.419 . . . . 0.32000000000000001 111.223 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.494 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -127.99 155.37 44.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.851 -0.613 . . . . 2.1699999999999999 110.094 178.88 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.83 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.64 173.13 6.24 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.07 -0.514 . . . . 0.58999999999999997 110.716 -179.22 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.83 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.65 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.849 2.366 . . . . 0.90000000000000002 111.515 179.393 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -51.08 0.69 Allowed Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.741 -0.383 . . . . 3.3399999999999999 110.072 179.838 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.633 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.88 152.34 82.57 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.754 2.303 . . . . 1.8500000000000001 111.456 179.245 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.66 42.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.446 0.641 . . . . 2.54 110.647 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.633 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.7 t60 -63.59 -41.64 98.33 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.004 -0.998 . . . . 2.5299999999999998 110.669 179.742 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.556 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.8 mt -109.82 137.8 40.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.814 -0.63 . . . . 1.1699999999999999 111.349 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.01 -72.89 0.7 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.125 -0.489 . . . . 1.27 111.833 -178.906 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -88.19 148.41 24.4 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.546 0.573 . . . . 1.1200000000000001 112.546 -179.651 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.76 124.82 45.12 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.34 -0.615 . . . . 0.41999999999999998 109.34 177.542 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.01 134.66 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.731 -0.388 . . . . 0.78000000000000003 110.74 179.876 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.912 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.01 128.71 53.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.008 0.432 . . . . 0.62 111.213 179.78 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 139.02 49.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.693 -0.685 . . . . 1.97 110.112 179.004 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.435 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.12 163.21 35.01 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.162 0.506 . . . . 0.34999999999999998 112.077 -178.135 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.491 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.46 139.52 7.84 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.473 -0.785 . . . . 1.8 110.487 178.927 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.55 115.55 3.1 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.279 1.986 . . . . 0.57999999999999996 111.82 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.667 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.98 81.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.894 -0.409 . . . . 3.04 109.894 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.688 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.3 -20.68 0.06 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.025 -0.534 . . . . 2.4700000000000002 111.932 -179.48 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.62 157.81 34.33 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.819 -0.352 . . . . 2.5099999999999998 110.598 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.406 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.33 27.78 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 1.8600000000000001 110.203 179.611 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.89 -75.78 1.31 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.088 -0.577 . . . . 1.4399999999999999 111.836 -179.242 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.95 152.29 35.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.991 0.424 . . . . 4.6900000000000004 110.946 -179.35 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.18 -169.07 2.52 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.009 -0.542 . . . . 1.4299999999999999 111.911 179.373 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.19 149.61 29.85 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.473 0.654 . . . . 1.74 112.543 -177.822 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.03 156.47 46.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.8 -1.091 . . . . 1.9199999999999999 110.25 178.633 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.466 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.23 158.38 41.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.964 -0.562 . . . . 0.34000000000000002 111.866 -179.368 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.3 m -115.19 135.57 54.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.519 -0.764 . . . . 0.40999999999999998 109.862 179.33 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.59 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.36 121.97 23.82 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.415 -0.357 . . . . 0.55000000000000004 111.493 -179.073 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.6 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.4 Cg_exo -46.33 151.74 1.63 Allowed 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.593 2.195 . . . . 0.44 112.177 178.987 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.89 -23.01 62.99 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 116.128 -0.487 . . . . 0.73999999999999999 112.77 -179.252 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.546 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.86 -16.91 45.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.456 0.628 . . . . 0.93000000000000005 111.734 -178.264 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.6 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.56 138.37 31.62 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.873 -0.331 . . . . 0.96999999999999997 110.314 179.361 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.58 14.05 10.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.32 -0.4 . . . . 1.3400000000000001 111.479 -179.402 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.474 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.4 p -150.04 143.4 25.13 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.599 -0.441 . . . . 0.39000000000000001 110.961 179.644 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.721 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.78 -169.37 1.53 Allowed 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.242 0.544 . . . . 0.41999999999999998 110.874 -179.505 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.739 ' OG1' ' C ' ' A' ' 188' ' ' ASP . 2.6 m -151.78 125.92 9.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.371 -0.832 . . . . 0.39000000000000001 109.814 179.276 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.515 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.8 mt -114.88 123.25 70.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.448 -0.501 . . . . 0.73999999999999999 111.199 -179.699 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -126.49 163.35 23.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.842 -0.617 . . . . 2.48 110.394 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.684 ' H ' HH22 ' A' ' 143' ' ' ARG . . . 85.04 19.07 59.86 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.728 -0.949 . . . . 0.5 110.728 -179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.515 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.5 mt -79.11 157.22 28.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.06 0.457 . . . . 0.57999999999999996 111.362 -179.679 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.854 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.7 mtpp -99.46 134.02 21.5 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.561 -0.745 . . . . 2.79 110.473 179.779 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.91 143.58 61.24 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.573 2.182 . . . . 0.87 111.899 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.81 25.63 75.33 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.034 -0.826 . . . . 0.64000000000000001 111.034 179.686 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.854 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.14 158.81 39.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.694 0.283 . . . . 0.82999999999999996 110.398 -179.592 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.16 140.02 41.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.843 0.354 . . . . 0.5 110.565 -179.813 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.658 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.7 m-85 -122.63 136.38 54.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.901 -0.59 . . . . 0.53000000000000003 110.792 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.491 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.76 131.03 45.21 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.593 -0.892 . . . . 1.8700000000000001 108.593 177.574 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.55 153.83 16.67 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.244 -0.979 . . . . 0.28999999999999998 111.981 -178.635 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -134.89 140.98 46.2 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.782 -0.451 . . . . 1.4299999999999999 109.782 179.534 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.525 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.4 tp -115.78 118.92 34.38 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.39 -0.524 . . . . 0.32000000000000001 110.525 179.72 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.738 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.42 129.05 68.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.372 -0.376 . . . . 0.79000000000000004 110.632 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.708 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.75 120.82 43.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.333 -0.394 . . . . 1.02 110.756 -179.7 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.864 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.55 146.52 11.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.182 0.515 . . . . 0.62 111.04 -179.302 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.618 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.03 153.9 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.515 -0.766 . . . . 2.4399999999999999 109.973 179.816 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.2 88.6 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.965 0.412 . . . . 3.6899999999999999 110.392 -179.768 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.618 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.27 32.69 0.21 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.786 -0.643 . . . . 6.0800000000000001 110.582 -179.94 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.12 -117.43 3.29 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.405 -0.678 . . . . 1.22 111.405 -179.684 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.5 177.37 8.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.168 0.509 . . . . 2.8799999999999999 111.652 -179.181 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -148.12 149.54 32.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.38 -0.827 . . . . 1.47 110.375 179.223 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.18 144.63 38.64 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.485 -0.325 . . . . 2.7000000000000002 110.513 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.738 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.97 136.02 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 120.619 -0.432 . . . . 0.46000000000000002 111.519 -179.777 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.574 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.15 141.32 52.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.645 -0.707 . . . . 0.34999999999999998 110.284 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.4 ttp180 -117.66 138.9 51.67 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.502 -0.479 . . . . 3.6699999999999999 111.531 -179.32 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.25 164.21 37.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.524 -0.762 . . . . 0.67000000000000004 109.502 179.467 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.575 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.31 151.53 38.48 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.37 -0.532 . . . . 1.47 110.974 179.977 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.802 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.19 172.81 12.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.754 -0.657 . . . . 0.44 111.027 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.77 160.63 21.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.523 -0.762 . . . . 1.3700000000000001 109.892 179.621 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.33 121.89 23.03 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.568 -0.453 . . . . 1.28 110.777 179.972 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.2 p -127.56 147.96 50.34 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.119 -0.491 . . . . 1.97 112.292 179.728 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 CA--C 1.532 0.279 0 CA-C-N 115.417 -0.811 . . . . 3.2799999999999998 113.008 178.691 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.5 p . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 121.259 0.552 . . . . 0.66000000000000003 109.881 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.444 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.85 167.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.536 -0.756 . . . . 0.68999999999999995 110.96 179.939 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.59 145.57 50.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.664 -0.698 . . . . 0.52000000000000002 110.125 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.25 101.68 9.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.051 -0.722 . . . . 0.32000000000000001 109.051 177.725 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.3 t -112.95 139.7 36.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.992 -0.549 . . . . 0.28999999999999998 111.107 -178.911 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.0 p -128.76 152.55 48.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.705 -0.679 . . . . 0.25 109.795 179.609 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.75 -164.85 2.01 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.62 -0.432 . . . . 0.31 110.651 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.6 t -123.97 127.17 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.48999999999999999 110.804 -179.835 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.174 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.1 p -57.89 58.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.111 -0.495 . . . . 1.53 110.44 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.743 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.13 24.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.971 -0.559 . . . . 0.96999999999999997 111.478 -179.591 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.174 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.1 128.62 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.674 -0.41 . . . . 1.5600000000000001 110.999 179.833 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.35 -9.52 56.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.883 -0.599 . . . . 1.8799999999999999 110.381 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.8 p -87.16 0.32 55.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.52 . . . . 1.04 110.27 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.33 137.19 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.023 -0.535 . . . . 0.23999999999999999 109.977 179.717 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.614 ' N ' ' O ' ' A' ' 185' ' ' ILE . 93.8 p -96.2 -15.56 21.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.248 0.547 . . . . 0.28999999999999998 110.046 -179.673 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.61 175.67 45.88 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 109.859 -1.297 . . . . 0.13 109.859 179.595 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.46 151.6 42.54 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.683 -0.407 . . . . 0.17000000000000001 110.525 179.778 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.684 HH22 ' H ' ' A' ' 62' ' ' GLY . 10.3 tpp180 -132.35 121.18 23.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.172 -0.467 . . . . 1.29 109.911 179.809 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.555 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.08 136.63 38.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.74 -0.664 . . . . 0.25 110.632 -179.777 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 79.3 tt0 -129.41 129.89 45.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.996 -0.547 . . . . 1.3200000000000001 110.044 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.625 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.4 p90 -138.71 135.24 34.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.055 -0.52 . . . . 0.56999999999999995 110.611 -179.669 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.418 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.27 161.32 39.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.841 -0.618 . . . . 1.1599999999999999 109.734 179.834 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.4 mt -71.02 124.78 25.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.011 0.434 . . . . 0.38 110.767 -179.644 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.67 -7.7 49.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.777 -0.647 . . . . 0.40999999999999998 110.915 -179.814 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.88 -69.58 0.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.303 -0.408 . . . . 1.6599999999999999 111.449 -179.283 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.449 ' CD ' HH21 ' A' ' 176' ' ' ARG . 53.9 mt-10 -60.74 -35.33 76.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 1.6599999999999999 111.506 -179.184 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.08 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.15 7.26 88.57 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.857 -0.897 . . . . 1.1699999999999999 110.857 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.341 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.4 t0 -27.9 -171.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 1.8600000000000001 110.229 179.798 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.341 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.4 139.1 44.67 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.036 0.446 . . . . 1.98 110.185 179.614 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.418 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 45.8 Cg_endo -70.91 145.79 51.39 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 122.675 2.25 . . . . 0.55000000000000004 112.302 -179.466 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.625 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.75 145.72 42.54 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.318 -0.623 . . . . 1.1399999999999999 109.318 179.157 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.841 ' CD2' ' ND2' ' A' ' 16' ' ' ASN . 22.3 p90 -123.27 141.34 52.09 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.384 -0.526 . . . . 0.93000000000000005 111.536 -179.067 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.9 mt -128.14 127.66 43.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.314 -0.857 . . . . 0.34000000000000002 108.936 178.967 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.625 ' HB2' ' NH1' ' A' ' 143' ' ' ARG . 29.5 t0 -101.6 131.09 47.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.171 0.51 . . . . 1.0900000000000001 111.738 -178.77 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.91 157.52 73.49 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.2 -0.909 . . . . 0.19 109.583 179.643 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -69.8 158.14 57.94 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.351 2.034 . . . . 0.17999999999999999 112.3 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.36 -12.19 5.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.733 -0.667 . . . . 0.20999999999999999 110.744 -179.782 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.9 p -92.77 -8.71 42.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.086 -0.506 . . . . 0.28999999999999998 110.718 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.14 135.38 34.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 0.5 110.378 179.67 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.5 p -133.18 16.72 4.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.29999999999999999 110.552 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.1 p -167.59 147.12 5.04 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.619 -0.512 . . . . 0.23000000000000001 109.619 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.555 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.2 150.46 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.548 -0.461 . . . . 0.28000000000000003 111.59 -179.653 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.509 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.31 124.98 50.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.637 -0.71 . . . . 1.0700000000000001 109.812 179.493 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.37 104.9 29.71 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.412 -0.358 . . . . 0.28999999999999998 111.107 -179.897 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.7 Cg_endo -91.06 -179.49 1.47 Allowed 'Trans proline' 0 C--N 1.301 -1.964 0 C-N-CA 123.178 2.585 . . . . 0.42999999999999999 112.213 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 61.63 32.71 18.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.463 -0.79 . . . . 1.26 111.439 179.302 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.1 mt -86.35 148.51 25.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.436 -0.347 . . . . 0.32000000000000001 110.469 179.547 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.774 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.29 114.83 61.2 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.076 0.465 . . . . 0.57999999999999996 110.645 -179.75 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.98 140.58 95.96 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.908 2.405 . . . . 0.66000000000000003 111.959 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.15 74.45 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.006 -0.837 . . . . 0.28999999999999998 111.006 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.449 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.8 mmm-85 -126.87 150.27 49.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.38 . . . . 2.3300000000000001 110.6 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.5 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.23 131.63 46.06 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.011 -0.54 . . . . 0.85999999999999999 109.737 179.392 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.955 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.44 148.36 43.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.099 -0.501 . . . . 0.52000000000000002 111.037 -179.868 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.34 125.34 60.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.258 -1.016 . . . . 0.29999999999999999 108.258 177.745 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.54 132.53 63.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.085 0.469 . . . . 0.23000000000000001 111.221 -178.595 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.54 122.56 20.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.591 -0.732 . . . . 0.35999999999999999 109.626 179.258 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.03 125.37 54.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.181 -0.463 . . . . 0.19 110.729 -179.556 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.14 137.83 52.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.014 -0.539 . . . . 0.29999999999999999 109.903 179.565 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.429 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.63 134.98 42.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.815 -0.809 . . . . 0.37 108.815 178.832 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.614 ' O ' ' N ' ' A' ' 140' ' ' SER . 46.0 mm -99.05 122.94 51.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.131 0.491 . . . . 0.26000000000000001 111.024 -178.826 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.6 p -83.76 169.66 14.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.571 -0.74 . . . . 0.28000000000000003 110.511 -179.688 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.87 -14.43 15.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.034 -0.53 . . . . 1.6000000000000001 110.979 -179.593 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.739 ' C ' ' OG1' ' A' ' 59' ' ' THR . 96.3 m-20 -96.03 -4.3 43.31 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.894 -0.323 . . . . 1.1799999999999999 110.861 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.508 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.79 13.9 63.99 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.354 -0.699 . . . . 0.29999999999999999 111.354 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -84.72 139.06 32.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.696 0.284 . . . . 1.22 110.389 179.731 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -106.61 141.02 38.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.423 -0.353 . . . . 0.97999999999999998 110.674 179.646 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.0 m -136.73 127.09 26.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.82999999999999996 110.338 179.88 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 25.5 tp -68.19 117.38 9.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.959 0.409 . . . . 0.26000000000000001 110.451 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.06 -21.86 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.29999999999999999 110.71 -179.699 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.86 125.73 5.88 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 120.442 -0.503 . . . . 0.31 111.508 -179.757 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.46 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.81 120.21 21.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.792 -0.64 . . . . 0.28000000000000003 109.581 179.195 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.63 151.7 29.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.96 0.41 . . . . 0.23999999999999999 110.883 -179.239 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.45 158.6 18.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.009 -0.542 . . . . 0.23000000000000001 110.409 179.725 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -146.11 157.92 43.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 0.67000000000000004 110.678 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 104.34 9.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.811 -0.631 . . . . 0.64000000000000001 110.053 179.582 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.3 p . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.964 -1.017 . . . . 1.26 110.61 -179.641 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.548 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.209 -0.663 . . . . 3.4399999999999999 109.209 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.4 150.66 18.54 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.023 -0.831 . . . . 1.22 111.023 179.814 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -35.65 142.37 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.114 0 C-N-CA 123.956 3.104 . . . . 0.75 113.881 -179.23 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.617 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.96 173.35 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.261 -1.336 . . . . 0.79000000000000004 108.841 178.507 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.617 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.49 125.89 51.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.127 0.489 . . . . 1.9399999999999999 111.454 -179.639 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.56 144.01 33.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.575 -0.739 . . . . 0.59999999999999998 110.621 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.08 168.24 25.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.914 0.388 . . . . 3.1400000000000001 111.118 -179.637 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.741 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.5 mt -108.91 131.07 60.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.042 -0.526 . . . . 3.23 110.06 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.5 p -141.24 162.27 35.88 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.853 0.358 . . . . 3.6299999999999999 111.203 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 48.1 mt-10 36.1 31.61 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.625 -0.509 . . . . 6.0800000000000001 109.625 179.847 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.741 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.6 33.11 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.951 -0.568 . . . . 3.3799999999999999 111.609 -178.844 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.639 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.24 -29.13 73.12 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.486 2.124 . . . . 3.9300000000000002 111.838 179.325 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.693 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 3.2 m 149.58 125.62 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 3.3599999999999999 110.527 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.707 ' O ' ' O ' ' A' ' 92' ' ' THR . 1.8 mp0 -123.99 158.3 60.75 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 3.6099999999999999 110.411 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.552 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 98.3 Cg_endo -82.05 -64.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.874 2.383 . . . . 1.51 113.491 -178.983 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.727 ' ND2' ' CD1' ' A' ' 157' ' ' TYR . 1.2 m120 -108.44 -19.6 13.4 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.12 0.415 . . . . 2.6800000000000002 112.12 -178.562 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.736 ' OG ' ' NZ ' ' A' ' 61' ' ' LYS . 55.8 m -107.3 152.03 24.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.171 0.51 . . . . 1.21 111.298 -179.411 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.571 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.21 102.88 2.24 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.681 -0.69 . . . . 1.5600000000000001 110.618 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.66 145.64 13.04 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.925 2.417 . . . . 0.81000000000000005 112.643 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.915 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.8 167.9 24.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.89 -0.595 . . . . 1.52 109.885 179.561 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -149.12 147.97 29.1 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.677 -0.49 . . . . 2.1400000000000001 109.677 178.859 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.597 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.3 p90 -142.21 157.35 44.96 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.623 -0.431 . . . . 0.32000000000000001 111.167 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.49 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.05 155.24 44.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.822 -0.626 . . . . 2.1699999999999999 110.119 178.962 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.83 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.58 173.09 6.29 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.081 -0.508 . . . . 0.58999999999999997 110.765 -179.217 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.83 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.68 174.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.909 2.406 . . . . 0.90000000000000002 111.518 179.362 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.11 -51.16 0.68 Allowed Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.727 -0.389 . . . . 3.3399999999999999 110.054 179.899 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.617 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.74 152.32 82.44 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.769 2.312 . . . . 1.8500000000000001 111.442 179.189 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.69 42.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.351 0.596 . . . . 2.54 110.531 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.617 ' H ' ' C ' ' A' ' 27' ' ' PRO . 73.8 t60 -63.58 -41.72 98.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.05 -0.977 . . . . 2.5299999999999998 110.609 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.562 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.2 mt -109.86 137.83 40.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.782 -0.644 . . . . 1.1699999999999999 111.23 -179.363 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.94 -72.88 0.7 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.031 -0.531 . . . . 1.27 111.937 -178.984 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.15 148.36 24.46 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.559 0.577 . . . . 1.1200000000000001 112.559 -179.665 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.87 124.84 45.06 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.302 -0.629 . . . . 0.41999999999999998 109.302 177.543 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 mt -117.97 134.68 60.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.787 -0.365 . . . . 0.78000000000000003 110.642 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.915 HD13 HD11 ' A' ' 20' ' ' ILE . 8.8 mt -120.01 128.63 53.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 0.62 111.292 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.14 138.97 49.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.727 -0.67 . . . . 1.97 110.145 179.014 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.433 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -145.07 163.26 34.81 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 121.265 0.555 . . . . 0.34999999999999998 112.037 -178.117 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.491 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.55 139.51 7.76 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 115.431 -0.804 . . . . 1.8 110.506 178.873 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.3 Cg_endo -63.5 115.46 3.05 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.344 2.03 . . . . 0.57999999999999996 111.81 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.674 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.02 81.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.882 -0.414 . . . . 3.04 109.882 -179.81 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.72 0.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.943 -0.571 . . . . 2.4700000000000002 111.916 -179.467 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.4 p -157.55 157.82 34.48 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.848 -0.341 . . . . 2.5099999999999998 110.613 179.769 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.4 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.8 m -120.42 27.85 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.438 . . . . 1.8600000000000001 110.144 179.558 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.78 -75.9 1.31 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.107 -0.568 . . . . 1.4399999999999999 111.886 -179.284 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.88 152.34 35.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.944 0.402 . . . . 4.6900000000000004 110.994 -179.42 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.676 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.21 -169.1 2.53 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.033 -0.53 . . . . 1.4299999999999999 111.989 179.367 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.431 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.19 149.68 29.75 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.412 0.625 . . . . 1.74 112.583 -177.848 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.06 156.52 45.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.837 -1.074 . . . . 1.9199999999999999 110.241 178.688 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.2 158.46 41.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.968 -0.56 . . . . 0.34000000000000002 111.822 -179.349 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.6 m -115.31 135.72 53.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.479 -0.782 . . . . 0.40999999999999998 109.747 179.291 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.597 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.46 121.93 23.69 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.385 -0.371 . . . . 0.55000000000000004 111.579 -179.182 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.0 Cg_exo -46.24 151.67 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.729 2.286 . . . . 0.44 112.129 179.042 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.84 -23.11 63.01 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 116.083 -0.508 . . . . 0.73999999999999999 112.77 -179.227 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.81 -16.83 46.24 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.224 -0.59 . . . . 0.93000000000000005 111.819 -178.319 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.604 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.67 138.49 31.52 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.709 -0.397 . . . . 0.96999999999999997 110.246 179.398 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.54 13.9 10.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.345 -0.389 . . . . 1.3400000000000001 111.542 -179.363 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.476 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.97 143.41 25.19 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.63 -0.428 . . . . 0.39000000000000001 111.059 179.676 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.4 t80 -114.76 -169.37 1.53 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.167 0.508 . . . . 0.41999999999999998 110.899 -179.432 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.714 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.81 125.78 9.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.454 -0.794 . . . . 0.39000000000000001 109.858 179.278 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.513 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.81 123.16 70.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.382 -0.527 . . . . 0.73999999999999999 111.282 -179.798 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.736 ' NZ ' ' OG ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -126.41 163.4 23.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.882 -0.599 . . . . 2.48 110.426 179.749 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.642 ' H ' ' HD3' ' A' ' 61' ' ' LYS . . . 85.11 19.0 59.86 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.759 -0.936 . . . . 0.5 110.759 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.513 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.9 mt -78.98 157.25 28.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.111 0.482 . . . . 0.57999999999999996 111.3 -179.631 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.855 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -99.51 133.9 21.56 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.627 -0.715 . . . . 2.79 110.415 179.743 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.423 ' HD3' ' CE2' ' A' ' 157' ' ' TYR . 36.9 Cg_endo -67.76 143.61 62.21 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.571 2.181 . . . . 0.87 112.022 179.731 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.76 25.6 75.37 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.061 -0.816 . . . . 0.64000000000000001 111.061 179.715 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.855 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.14 158.77 39.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.751 0.31 . . . . 0.82999999999999996 110.444 -179.673 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.13 140.08 41.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.932 0.396 . . . . 0.5 110.516 -179.765 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.644 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.65 136.46 54.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.886 -0.597 . . . . 0.53000000000000003 110.75 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.491 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.86 131.02 45.28 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.506 -0.924 . . . . 1.8700000000000001 108.506 177.637 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.46 153.92 16.64 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 120.321 -0.942 . . . . 0.28999999999999998 111.985 -178.685 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -134.98 140.87 46.03 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.71 -0.478 . . . . 1.4299999999999999 109.71 179.61 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.71 118.9 34.34 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.526 -0.47 . . . . 0.32000000000000001 110.534 179.691 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.731 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.5 129.09 68.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 0.79000000000000004 110.647 -179.883 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.708 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.86 120.76 43.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.327 -0.397 . . . . 1.02 110.691 -179.577 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.85 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.54 146.47 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.197 0.523 . . . . 0.62 111.0 -179.266 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.628 ' O ' ' N ' ' A' ' 79' ' ' TYR . 20.9 mt-30 -106.09 153.9 21.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.501 -0.772 . . . . 2.4399999999999999 109.924 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.21 88.51 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.938 0.399 . . . . 3.6899999999999999 110.426 -179.653 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.628 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.42 32.61 0.23 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.807 -0.633 . . . . 6.0800000000000001 110.581 -179.906 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.14 -117.28 3.28 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.492 -0.643 . . . . 1.22 111.492 -179.722 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -81.55 177.41 8.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.18 0.514 . . . . 2.8799999999999999 111.516 -179.106 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.2 149.58 32.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.444 -0.798 . . . . 1.47 110.415 179.107 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.548 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.22 144.58 38.54 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.454 -0.339 . . . . 2.7000000000000002 110.592 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.731 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.91 135.97 61.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.597 -0.441 . . . . 0.46000000000000002 111.586 -179.761 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -123.99 141.32 52.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.733 -0.667 . . . . 0.34999999999999998 110.259 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.468 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.65 138.96 51.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.134 0.492 . . . . 3.6699999999999999 111.463 -179.414 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.37 164.15 38.07 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.514 -0.766 . . . . 0.67000000000000004 109.442 179.352 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.569 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.15 151.59 38.69 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.366 -0.534 . . . . 1.47 110.985 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.3 172.75 13.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.689 -0.687 . . . . 0.44 111.018 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.74 160.67 21.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.443 -0.799 . . . . 1.3700000000000001 109.846 179.66 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.38 121.8 22.84 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.624 -0.43 . . . . 1.28 110.833 179.962 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.707 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.2 p -127.85 170.0 13.28 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 116.09 -0.504 . . . . 1.97 110.677 179.683 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.466 0.329 0 CA-C-O 121.11 0.481 . . . . 3.2799999999999998 110.119 179.415 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.44 0 CA-C-O 120.92 0.39 . . . . 0.66000000000000003 111.511 . . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.44 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.83 167.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.917 -0.583 . . . . 0.68999999999999995 110.99 179.868 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.59 145.59 50.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.748 -0.66 . . . . 0.52000000000000002 110.11 -179.881 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.35 101.65 9.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.08 -0.711 . . . . 0.32000000000000001 109.08 177.734 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.5 t -112.96 139.74 36.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.978 -0.555 . . . . 0.28999999999999998 111.071 -178.836 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.1 p -128.78 152.5 48.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.613 -0.721 . . . . 0.25 109.741 179.745 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.588 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.8 -165.0 2.05 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.675 -0.41 . . . . 0.31 110.618 -179.775 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.738 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -123.86 127.15 73.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.218 -0.446 . . . . 0.48999999999999999 110.894 -179.881 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.158 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.8 58.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 1.53 110.36 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.738 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.19 24.56 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.99 -0.55 . . . . 0.96999999999999997 111.541 -179.583 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.158 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.16 128.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.615 -0.434 . . . . 1.5600000000000001 110.95 179.831 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -86.45 -9.66 55.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.973 -0.558 . . . . 1.8799999999999999 110.295 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.09 0.2 55.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 1.04 110.313 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.25 137.16 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.957 -0.565 . . . . 0.23999999999999999 109.997 179.711 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 185' ' ' ILE . 0.2 OUTLIER -96.2 -15.55 21.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.32 0.581 . . . . 0.28999999999999998 110.021 -179.613 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.6 175.52 45.74 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 109.863 -1.295 . . . . 0.13 109.863 179.685 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -123.39 151.63 42.38 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.655 -0.418 . . . . 0.17000000000000001 110.523 179.711 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.632 ' NH1' ' CB ' ' A' ' 157' ' ' TYR . 10.4 ttt85 -132.34 121.22 23.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.078 -0.51 . . . . 1.29 109.954 179.754 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.542 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.09 136.53 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.666 -0.697 . . . . 0.25 110.678 -179.752 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 84.2 tt0 -129.37 129.88 45.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.017 -0.538 . . . . 1.3200000000000001 110.128 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.73 135.29 34.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.001 -0.545 . . . . 0.56999999999999995 110.653 -179.684 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.412 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.26 161.34 39.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.721 -0.672 . . . . 1.1599999999999999 109.682 179.883 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.965 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.06 124.83 25.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.971 0.415 . . . . 0.38 110.764 -179.662 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.74 -7.63 49.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.709 -0.678 . . . . 0.40999999999999998 110.872 -179.775 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -109.87 -69.67 0.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.979 0.418 . . . . 1.6599999999999999 111.386 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.441 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.74 -35.28 75.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.03 -0.532 . . . . 1.6599999999999999 111.44 -179.095 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.09 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.08 7.26 88.56 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.858 -0.897 . . . . 1.1699999999999999 110.858 -179.787 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.315 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.98 -171.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.331 . . . . 1.8600000000000001 110.218 179.86 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.315 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.19 139.03 45.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.962 0.41 . . . . 1.98 110.233 179.627 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.412 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.1 Cg_endo -70.88 145.87 51.79 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 C-N-CA 122.751 2.301 . . . . 0.55000000000000004 112.286 -179.469 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.91 145.7 42.68 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.199 -0.667 . . . . 1.1399999999999999 109.199 179.237 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.727 ' CD1' ' ND2' ' A' ' 16' ' ' ASN . 43.2 p90 -123.31 141.33 52.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.269 0.557 . . . . 0.93000000000000005 111.506 -179.102 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.3 mt -128.08 127.62 43.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.297 -0.865 . . . . 0.34000000000000002 109.021 178.949 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -101.58 131.11 47.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.178 0.513 . . . . 1.0900000000000001 111.812 -178.736 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.93 157.51 73.56 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.315 -0.857 . . . . 0.19 109.658 179.653 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.83 158.08 58.08 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 C-N-CA 122.389 2.059 . . . . 0.17999999999999999 112.215 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.28 -12.2 5.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.754 -0.657 . . . . 0.20999999999999999 110.736 -179.775 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.7 p -92.8 -8.68 42.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.132 -0.486 . . . . 0.28999999999999998 110.79 -179.93 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.39 34.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.247 -0.433 . . . . 0.5 110.354 179.701 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.8 p -133.16 16.73 4.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.394 -0.367 . . . . 0.29999999999999999 110.492 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.4 p -167.54 147.13 5.08 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.569 -0.53 . . . . 0.23000000000000001 109.569 179.841 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.542 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.14 150.52 12.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.467 -0.493 . . . . 0.28000000000000003 111.592 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.506 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.34 124.9 50.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.674 -0.694 . . . . 1.0700000000000001 109.803 179.504 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.33 104.82 29.06 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.382 -0.372 . . . . 0.28999999999999998 111.131 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.5 Cg_endo -90.92 -179.48 1.51 Allowed 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 123.192 2.595 . . . . 0.42999999999999999 112.296 179.883 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.7 32.59 18.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.46 -0.791 . . . . 1.26 111.462 179.262 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.44 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.1 mt -86.32 148.51 25.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.457 -0.338 . . . . 0.32000000000000001 110.44 179.615 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.769 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.28 114.83 61.19 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.008 0.432 . . . . 0.57999999999999996 110.7 -179.767 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -58.98 140.59 96.03 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.851 2.367 . . . . 0.66000000000000003 112.039 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.06 21.24 74.27 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.028 -0.829 . . . . 0.28999999999999998 111.028 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.441 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.9 150.17 49.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.857 0.36 . . . . 2.3300000000000001 110.578 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.501 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.19 131.62 46.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.039 -0.528 . . . . 0.85999999999999999 109.795 179.335 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.965 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.48 148.25 44.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.117 -0.492 . . . . 0.52000000000000002 111.089 -179.863 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.21 125.28 60.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.342 -0.984 . . . . 0.29999999999999999 108.342 177.742 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.53 132.58 63.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.129 0.49 . . . . 0.23000000000000001 111.238 -178.593 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.55 122.52 20.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.461 -0.791 . . . . 0.35999999999999999 109.574 179.362 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.588 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.99 125.39 54.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.337 -0.392 . . . . 0.19 110.706 -179.563 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.24 137.92 52.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.086 -0.506 . . . . 0.29999999999999999 109.833 179.573 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.427 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.83 134.96 43.02 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.802 -0.814 . . . . 0.37 108.802 178.865 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.606 ' O ' ' N ' ' A' ' 140' ' ' SER . 3.7 mt -99.01 122.92 51.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.09 0.472 . . . . 0.26000000000000001 111.001 -178.736 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.8 p -83.84 169.82 14.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.562 -0.744 . . . . 0.28000000000000003 110.469 -179.685 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.84 -14.51 15.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.058 -0.519 . . . . 1.6000000000000001 110.928 -179.556 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -96.07 -4.42 42.97 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.878 -0.329 . . . . 1.1799999999999999 110.83 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.9 13.85 63.86 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.368 -0.693 . . . . 0.29999999999999999 111.368 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -84.62 139.04 32.35 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.775 -0.25 . . . . 1.22 110.446 179.694 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.453 HE22 ' HG2' ' A' ' 14' ' ' GLN . 4.0 mp0 -106.71 141.07 38.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.485 -0.325 . . . . 0.97999999999999998 110.63 179.708 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.4 m -136.7 127.02 26.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.82999999999999996 110.329 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.11 117.29 9.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.327 -0.397 . . . . 0.26000000000000001 110.477 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.03 -21.85 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 0.29999999999999999 110.716 -179.785 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.1 tp -156.87 125.8 5.91 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.566 -0.454 . . . . 0.31 111.564 -179.829 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.474 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.7 120.16 21.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.731 -0.668 . . . . 0.28000000000000003 109.579 179.289 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.65 151.75 29.16 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.714 -0.394 . . . . 0.23999999999999999 110.884 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.55 158.6 18.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.054 -0.521 . . . . 0.23000000000000001 110.469 179.675 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -146.09 157.87 43.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.191 -0.459 . . . . 0.67000000000000004 110.725 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.27 104.41 9.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.771 -0.649 . . . . 0.64000000000000001 110.024 179.559 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 117.88 -1.057 . . . . 1.26 110.638 -179.691 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.9 m . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.248 -0.649 . . . . 3.4399999999999999 109.248 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.42 150.73 18.53 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.037 -0.825 . . . . 1.22 111.037 179.692 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -35.65 142.43 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 123.988 3.125 . . . . 0.75 113.795 -179.197 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.624 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.3 t -80.04 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 114.295 -1.321 . . . . 0.79000000000000004 108.808 178.447 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.624 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.68 125.87 51.49 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.415 -0.514 . . . . 1.9399999999999999 111.395 -179.533 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 144.03 33.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.555 -0.748 . . . . 0.59999999999999998 110.646 179.921 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.05 168.33 25.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.894 0.378 . . . . 3.1400000000000001 111.096 -179.614 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.747 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.4 mt -109.03 131.14 60.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.006 -0.543 . . . . 3.23 110.074 179.861 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.505 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.3 p -141.21 162.3 35.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.859 0.361 . . . . 3.6299999999999999 111.217 -179.903 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.582 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 80.1 tt0 36.13 31.57 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.629 -0.508 . . . . 6.0800000000000001 109.629 179.811 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.747 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.55 69.58 33.73 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.945 -0.57 . . . . 3.3799999999999999 111.58 -178.753 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.17 -29.14 73.74 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.525 2.15 . . . . 3.9300000000000002 111.868 179.304 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.63 125.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 3.3599999999999999 110.41 -179.973 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 17' ' ' SER . 39.5 mt-30 -123.96 158.38 60.41 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 3.6099999999999999 110.405 179.942 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.587 ' HD2' HH12 ' A' ' 143' ' ' ARG . 97.4 Cg_endo -82.03 -64.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.942 2.428 . . . . 1.51 113.558 -179.086 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.552 ' ND2' ' OD1' ' A' ' 159' ' ' ASP . 98.7 m-20 -108.48 -19.51 13.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.075 0.398 . . . . 2.6800000000000002 112.075 -178.54 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 29.1 t -107.35 151.99 24.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.083 0.468 . . . . 1.21 111.296 -179.405 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.2 102.92 2.24 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.656 -0.702 . . . . 1.5600000000000001 110.722 179.786 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.72 145.59 12.93 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.962 2.441 . . . . 0.81000000000000005 112.636 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.937 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.75 167.92 24.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.894 -0.594 . . . . 1.52 109.853 179.672 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -149.12 148.02 29.17 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.768 -0.456 . . . . 2.1400000000000001 109.768 178.816 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.601 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.34 157.29 44.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.031 0.443 . . . . 0.32000000000000001 111.212 179.954 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.496 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.02 155.29 44.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.777 -0.647 . . . . 2.1699999999999999 110.111 179.072 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.825 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.69 172.95 6.49 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.155 0.502 . . . . 0.58999999999999997 110.701 -179.171 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.825 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.6 173.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.844 0 C-N-CA 122.876 2.384 . . . . 0.90000000000000002 111.475 179.421 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.481 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.1 -51.07 0.68 Allowed Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 120.68 -0.408 . . . . 3.3399999999999999 110.111 179.881 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.613 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.81 152.33 82.49 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.716 2.277 . . . . 1.8500000000000001 111.497 179.139 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.66 42.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.417 0.627 . . . . 2.54 110.58 -179.881 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.613 ' N ' ' O ' ' A' ' 27' ' ' PRO . 74.1 t60 -63.69 -41.54 98.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.959 -1.019 . . . . 2.5299999999999998 110.7 179.775 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.567 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.8 mt -109.9 137.82 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.738 -0.665 . . . . 1.1699999999999999 111.29 -179.479 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.89 -72.96 0.7 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.056 -0.52 . . . . 1.27 111.982 -179.006 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.43 24.41 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.62 0.6 . . . . 1.1200000000000001 112.62 -179.689 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.78 124.88 45.24 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.365 -0.606 . . . . 0.41999999999999998 109.365 177.524 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.06 134.82 60.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.724 -0.391 . . . . 0.78000000000000003 110.63 179.913 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.937 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.15 128.68 53.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.078 0.466 . . . . 0.62 111.138 179.792 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.99 49.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.716 -0.674 . . . . 1.97 110.162 178.92 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.437 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.0 163.22 34.87 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.153 0.502 . . . . 0.34999999999999998 112.097 -178.127 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.488 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.56 139.53 7.76 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.483 -0.781 . . . . 1.8 110.443 178.805 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.43 115.5 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.283 1.989 . . . . 0.57999999999999996 111.855 179.946 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.686 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.06 81.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.914 0.388 . . . . 3.04 109.964 -179.853 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.14 -20.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.962 -0.563 . . . . 2.4700000000000002 111.901 -179.466 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -157.62 157.75 34.22 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.885 -0.326 . . . . 2.5099999999999998 110.586 179.819 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.406 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.34 27.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.173 -0.467 . . . . 1.8600000000000001 110.232 179.567 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.84 -75.86 1.31 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.144 -0.55 . . . . 1.4399999999999999 111.796 -179.204 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.86 152.3 35.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.959 0.409 . . . . 4.6900000000000004 110.951 -179.268 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.66 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.26 -169.16 2.54 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.033 -0.53 . . . . 1.4299999999999999 111.938 179.352 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.08 149.58 29.83 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.436 0.636 . . . . 1.74 112.634 -177.903 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.0 156.48 46.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.83 -1.077 . . . . 1.9199999999999999 110.318 178.562 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.16 158.45 41.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.926 -0.579 . . . . 0.34000000000000002 111.82 -179.373 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 m -115.22 135.62 53.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.483 -0.781 . . . . 0.40999999999999998 109.8 179.322 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.601 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.48 121.95 23.67 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.459 -0.337 . . . . 0.55000000000000004 111.489 -179.14 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.607 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.2 Cg_exo -46.25 151.68 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.67 2.246 . . . . 0.44 112.141 178.993 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.88 -22.98 62.95 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.998 -0.547 . . . . 0.73999999999999999 112.882 -179.268 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.83 -16.81 46.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.346 0.573 . . . . 0.93000000000000005 111.839 -178.38 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.607 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.73 138.36 31.62 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.749 -0.38 . . . . 0.96999999999999997 110.335 179.371 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.45 13.93 11.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.353 -0.385 . . . . 1.3400000000000001 111.546 -179.3 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.8 p -149.98 143.54 25.27 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.612 -0.435 . . . . 0.39000000000000001 111.028 179.594 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.721 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.85 -169.32 1.53 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.174 0.511 . . . . 0.41999999999999998 110.855 -179.423 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.721 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 50.1 m -151.8 125.93 9.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.332 -0.849 . . . . 0.39000000000000001 109.783 179.247 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.511 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.91 123.28 70.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.336 -0.546 . . . . 0.73999999999999999 111.162 -179.793 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.57 ' HG2' ' N ' ' A' ' 62' ' ' GLY . 88.2 tttt -126.48 163.4 23.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.788 -0.642 . . . . 2.48 110.431 179.709 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.57 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.1 18.99 59.89 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.833 -0.907 . . . . 0.5 110.833 -179.906 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.511 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.9 mt -79.03 157.23 28.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.054 0.454 . . . . 0.57999999999999996 111.33 -179.589 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.839 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.6 mttp -99.55 134.05 21.43 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.571 -0.741 . . . . 2.79 110.413 179.77 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.94 143.62 61.22 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.501 2.134 . . . . 0.87 111.948 179.82 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.64 75.32 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.054 -0.818 . . . . 0.64000000000000001 111.054 179.721 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.839 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.17 158.79 40.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.743 0.306 . . . . 0.82999999999999996 110.428 -179.662 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.14 139.93 42.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.971 0.415 . . . . 0.5 110.582 -179.778 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.649 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.3 m-85 -122.5 136.43 54.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.0 -0.546 . . . . 0.53000000000000003 110.803 -179.886 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.95 130.95 45.34 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.548 -0.908 . . . . 1.8700000000000001 108.548 177.639 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.495 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.47 153.86 16.65 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.332 -0.937 . . . . 0.28999999999999998 111.89 -178.517 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -135.01 140.89 46.01 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.717 -0.475 . . . . 1.4299999999999999 109.717 179.529 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.72 119.01 34.67 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.498 -0.481 . . . . 0.32000000000000001 110.477 179.683 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.742 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.53 129.15 68.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.79000000000000004 110.579 -179.904 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.699 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.83 120.74 43.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.322 -0.399 . . . . 1.02 110.715 -179.67 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.839 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.53 146.52 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.184 0.516 . . . . 0.62 111.025 -179.349 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.624 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.01 153.86 21.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.482 -0.781 . . . . 2.4399999999999999 109.986 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.16 88.57 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.953 0.406 . . . . 3.6899999999999999 110.375 -179.758 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.624 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.33 32.51 0.21 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.843 -0.617 . . . . 6.0800000000000001 110.602 -179.966 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.99 -117.35 3.3 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.502 -0.639 . . . . 1.22 111.502 -179.758 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.44 177.36 9.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.254 0.55 . . . . 2.8799999999999999 111.604 -179.239 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.06 149.47 32.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.428 -0.806 . . . . 1.47 110.502 179.185 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.13 144.73 38.77 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.479 -0.328 . . . . 2.7000000000000002 110.544 179.854 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.742 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -128.01 135.91 61.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-O 120.936 0.398 . . . . 0.46000000000000002 111.597 -179.775 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.571 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -123.94 141.34 52.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.678 -0.692 . . . . 0.34999999999999998 110.301 179.634 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.493 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.68 138.86 51.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.136 0.493 . . . . 3.6699999999999999 111.451 -179.382 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.495 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.25 164.14 37.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.567 -0.742 . . . . 0.67000000000000004 109.464 179.403 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.561 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.23 151.56 38.58 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.391 -0.524 . . . . 1.47 111.015 179.983 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.805 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.19 172.74 13.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.81 -0.632 . . . . 0.44 111.058 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.75 160.78 21.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.46 -0.791 . . . . 1.3700000000000001 109.89 179.529 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.42 121.92 22.98 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.556 -0.458 . . . . 1.28 110.722 179.955 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.521 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.3 p -130.01 166.07 20.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.673 0.749 . . . . 1.97 112.861 179.669 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.55 ' HB2' ' CE1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 114.692 -1.14 . . . . 3.2799999999999998 110.563 177.226 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.9 p . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 121.005 0.431 . . . . 0.66000000000000003 110.753 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.437 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.92 167.57 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.74 -0.664 . . . . 0.68999999999999995 110.985 -179.359 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.57 145.49 50.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.808 -0.633 . . . . 0.52000000000000002 110.182 -179.92 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.27 101.67 9.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.083 -0.71 . . . . 0.32000000000000001 109.083 177.714 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.1 t -112.96 139.77 36.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.943 -0.572 . . . . 0.28999999999999998 111.004 -178.834 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.4 p -128.79 152.53 48.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.642 -0.708 . . . . 0.25 109.799 179.619 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.587 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.82 -165.02 2.05 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.776 -0.37 . . . . 0.31 110.674 -179.737 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.745 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -123.97 127.2 73.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.198 -0.455 . . . . 0.48999999999999999 110.815 -179.856 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.175 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.89 58.37 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.076 -0.511 . . . . 1.53 110.363 179.821 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.745 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.21 24.6 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 0.96999999999999997 111.509 -179.705 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.175 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.18 128.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.627 -0.429 . . . . 1.5600000000000001 110.95 179.822 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.45 -9.55 56.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.977 -0.556 . . . . 1.8799999999999999 110.379 179.703 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.0 p -87.09 0.19 55.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.119 -0.491 . . . . 1.04 110.278 179.924 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 136' ' ' SER . 2.6 p -65.27 137.15 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.02 -0.537 . . . . 0.23999999999999999 109.994 179.711 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 185' ' ' ILE . 91.1 p -96.23 -15.53 21.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.236 0.541 . . . . 0.28999999999999998 109.992 -179.608 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.437 ' HA3' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.62 175.55 45.79 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 109.88 -1.288 . . . . 0.13 109.88 179.662 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.4 151.56 42.47 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.957 0.408 . . . . 0.17000000000000001 110.487 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 1.168 ' NE ' HD11 ' A' ' 185' ' ' ILE . 77.1 mtm180 -132.29 121.1 23.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.112 -0.495 . . . . 1.29 109.966 179.758 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.557 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.05 136.62 38.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.781 -0.645 . . . . 0.25 110.661 -179.779 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.495 ' OE2' ' OH ' ' A' ' 157' ' ' TYR . 85.5 tt0 -129.42 129.84 45.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.914 -0.584 . . . . 1.3200000000000001 110.041 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.627 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 36.0 p90 -138.7 135.36 34.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.024 -0.535 . . . . 0.56999999999999995 110.66 -179.742 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.42 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.36 161.33 39.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.778 -0.646 . . . . 1.1599999999999999 109.6 179.897 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.974 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.11 124.88 25.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.104 0.478 . . . . 0.38 110.768 -179.674 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.79 -7.61 49.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.664 -0.698 . . . . 0.40999999999999998 110.861 -179.724 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -109.85 -69.71 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.354 -0.384 . . . . 1.6599999999999999 111.395 -179.305 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.495 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.61 -35.36 75.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.04 -0.527 . . . . 1.6599999999999999 111.582 -179.165 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.08 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.12 7.2 88.61 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.895 -0.882 . . . . 1.1699999999999999 110.895 -179.798 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.335 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.92 -171.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.849 0.357 . . . . 1.8600000000000001 110.257 179.897 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.335 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.21 138.98 45.29 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.948 0.404 . . . . 1.98 110.229 179.599 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.42 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 48.3 Cg_endo -70.73 145.74 52.33 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 C-N-CA 122.729 2.286 . . . . 0.55000000000000004 112.377 -179.586 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.627 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.79 145.75 42.54 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.251 -0.648 . . . . 1.1399999999999999 109.251 179.155 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.55 ' CE1' ' HB2' ' A' ' 93' ' ' SER . 96.4 m-85 -123.31 141.33 52.1 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.346 -0.542 . . . . 0.93000000000000005 111.553 -179.124 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.5 mt -128.08 127.68 43.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.372 -0.831 . . . . 0.34000000000000002 108.959 178.987 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.552 ' OD1' ' ND2' ' A' ' 16' ' ' ASN . 67.3 m-20 -101.63 131.15 48.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.154 0.502 . . . . 1.0900000000000001 111.725 -178.726 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.99 157.49 73.73 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.316 -0.857 . . . . 0.19 109.581 179.667 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.67 157.99 58.64 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.414 2.076 . . . . 0.17999999999999999 112.261 179.936 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.32 -12.09 5.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.823 -0.626 . . . . 0.20999999999999999 110.689 -179.855 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.9 -8.7 42.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.28999999999999998 110.67 -179.933 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.24 135.41 34.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.368 -0.378 . . . . 0.5 110.425 179.662 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.17 16.71 4.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.348 -0.387 . . . . 0.29999999999999999 110.476 179.983 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.4 p -167.59 147.1 5.03 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.629 -0.508 . . . . 0.23000000000000001 109.629 179.797 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.14 150.49 12.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.567 -0.453 . . . . 0.28000000000000003 111.592 -179.573 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.502 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.32 124.91 50.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.657 -0.701 . . . . 1.0700000000000001 109.812 179.499 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.42 104.93 30.04 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.912 0.387 . . . . 0.28999999999999998 111.058 -179.884 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.3 Cg_endo -91.0 -179.53 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 123.256 2.638 . . . . 0.42999999999999999 112.243 179.86 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.69 32.61 18.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.36 -0.836 . . . . 1.26 111.461 179.308 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 172' ' ' LEU . 24.5 mt -86.36 148.54 25.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.51 -0.314 . . . . 0.32000000000000001 110.464 179.619 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.757 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.32 114.93 61.66 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.986 0.422 . . . . 0.57999999999999996 110.643 -179.701 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -58.95 140.54 95.78 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.949 2.433 . . . . 0.66000000000000003 111.922 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.1 21.16 74.36 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.018 -0.833 . . . . 0.28999999999999998 111.018 179.785 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.495 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.81 150.17 49.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 2.3300000000000001 110.669 179.996 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.5 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.15 131.66 45.97 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.074 -0.512 . . . . 0.85999999999999999 109.783 179.371 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.974 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.5 m-85 -120.61 148.26 44.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.159 -0.473 . . . . 0.52000000000000002 111.039 -179.822 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.3 mt -105.35 125.36 60.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.244 -1.021 . . . . 0.29999999999999999 108.244 177.804 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.53 132.54 63.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.143 0.496 . . . . 0.23000000000000001 111.228 -178.586 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.51 122.51 20.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.502 -0.772 . . . . 0.35999999999999999 109.689 179.276 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.587 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.95 125.32 54.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.199 -0.455 . . . . 0.19 110.716 -179.55 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.7 m-85 -117.15 137.99 51.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.955 -0.566 . . . . 0.29999999999999999 109.889 179.443 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.423 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.74 134.98 42.9 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.806 -0.813 . . . . 0.37 108.806 178.882 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 1.168 HD11 ' NE ' ' A' ' 143' ' ' ARG . 13.2 mt -99.04 122.9 51.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.116 0.484 . . . . 0.26000000000000001 110.959 -178.738 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.7 p -83.83 169.72 14.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.609 -0.723 . . . . 0.28000000000000003 110.479 -179.693 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -59.86 -14.46 15.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.053 -0.521 . . . . 1.6000000000000001 110.92 -179.555 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -96.15 -4.24 43.03 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.825 -0.35 . . . . 1.1799999999999999 110.809 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.81 13.89 63.97 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.342 -0.703 . . . . 0.29999999999999999 111.342 179.835 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -84.63 139.01 32.37 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.076 -0.25 . . . . 1.22 110.424 179.686 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.737 ' CD ' HH22 ' A' ' 143' ' ' ARG . 0.0 OUTLIER -106.69 141.12 38.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.87 0.367 . . . . 0.97999999999999998 110.558 179.718 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.3 m -136.7 127.03 26.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.82999999999999996 110.327 179.952 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.16 117.38 9.91 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.675 -0.41 . . . . 0.26000000000000001 110.533 -179.95 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.01 -21.82 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.29999999999999999 110.773 -179.778 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.5 tp -156.95 125.75 5.84 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.523 -0.471 . . . . 0.31 111.475 -179.77 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.474 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.8 120.23 21.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.787 -0.642 . . . . 0.28000000000000003 109.519 179.253 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.68 29.08 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.591 -0.444 . . . . 0.23999999999999999 110.868 -179.265 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.43 158.57 18.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.014 -0.539 . . . . 0.23000000000000001 110.44 179.702 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -146.02 157.89 43.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.088 -0.505 . . . . 0.67000000000000004 110.698 179.995 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.19 104.32 9.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.761 -0.654 . . . . 0.64000000000000001 110.101 179.493 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.8 p . . . . . 0 C--O 1.221 -0.414 0 CA-C-O 117.953 -1.022 . . . . 1.26 110.631 -179.628 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.553 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.1 m . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.161 -0.681 . . . . 3.4399999999999999 109.161 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.69 18.54 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.011 -0.835 . . . . 1.22 111.011 179.809 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -35.67 142.4 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.084 0 C-N-CA 123.933 3.089 . . . . 0.75 113.76 -179.222 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.61 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -79.93 173.43 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.173 -1.376 . . . . 0.79000000000000004 108.785 178.416 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.61 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.66 125.78 51.38 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.425 -0.51 . . . . 1.9399999999999999 111.44 -179.559 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.38 144.01 34.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.692 -0.685 . . . . 0.59999999999999998 110.652 179.959 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.1 168.24 25.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.97 0.414 . . . . 3.1400000000000001 111.111 -179.67 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.742 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.96 131.04 60.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.002 -0.544 . . . . 3.23 110.123 179.868 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.12 162.34 35.71 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.822 0.344 . . . . 3.6299999999999999 111.274 -179.924 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 98.9 mt-10 36.14 31.51 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.592 -0.521 . . . . 6.0800000000000001 109.592 179.819 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.742 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.59 32.58 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.001 -0.545 . . . . 3.3799999999999999 111.512 -178.721 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.3 -28.98 72.54 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.424 2.083 . . . . 3.9300000000000002 111.92 179.301 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.64 125.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.101 -0.499 . . . . 3.3599999999999999 110.442 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.618 ' O ' ' O ' ' A' ' 92' ' ' THR . 4.7 mt-30 -123.87 158.33 60.32 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 3.6099999999999999 110.491 179.914 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 143' ' ' ARG . 97.5 Cg_endo -82.07 -64.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.927 2.418 . . . . 1.51 113.515 -179.047 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.662 ' OD1' ' NH1' ' A' ' 143' ' ' ARG . 9.7 m120 -108.49 -19.59 13.4 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.076 0.399 . . . . 2.6800000000000002 112.076 -178.509 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 8.3 p -107.32 152.06 24.64 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.479 -0.488 . . . . 1.21 111.338 -179.442 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.28 102.94 2.23 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.653 -0.703 . . . . 1.5600000000000001 110.634 179.894 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.578 ' CD ' HE22 ' A' ' 14' ' ' GLN . 73.8 Cg_endo -82.72 145.53 12.91 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.974 2.45 . . . . 0.81000000000000005 112.575 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.925 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.76 167.92 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.884 -0.598 . . . . 1.52 109.892 179.579 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.15 147.91 29.02 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.682 -0.488 . . . . 2.1400000000000001 109.682 178.913 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.9 p90 -142.2 157.37 44.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.979 0.419 . . . . 0.32000000000000001 111.242 179.907 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.49 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.12 155.26 44.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.819 -0.628 . . . . 2.1699999999999999 110.095 179.0 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.836 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.59 173.03 6.36 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.105 0.478 . . . . 0.58999999999999997 110.774 -179.243 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.836 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.8 Cg_exo -50.58 173.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.818 2.346 . . . . 0.90000000000000002 111.588 179.29 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -50.95 0.7 Allowed Pre-proline 0 C--N 1.33 -0.245 0 C-N-CA 120.713 -0.395 . . . . 3.3399999999999999 110.159 179.81 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.62 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.99 152.36 82.65 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.752 2.301 . . . . 1.8500000000000001 111.404 179.197 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.5 p -63.76 42.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.355 0.598 . . . . 2.54 110.495 -179.769 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.62 ' N ' ' O ' ' A' ' 27' ' ' PRO . 74.0 t60 -63.7 -41.6 98.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.997 -1.001 . . . . 2.5299999999999998 110.579 179.8 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.565 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.6 mt -109.79 137.89 39.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.823 -0.626 . . . . 1.1699999999999999 111.262 -179.421 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.04 -72.9 0.7 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.023 -0.535 . . . . 1.27 111.887 -179.029 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.47 24.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.521 0.564 . . . . 1.1200000000000001 112.521 -179.609 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.89 124.92 45.24 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.311 -0.626 . . . . 0.41999999999999998 109.311 177.483 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.2 mt -118.02 134.76 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.703 -0.399 . . . . 0.78000000000000003 110.666 179.917 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.925 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.07 128.64 53.67 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.985 0.422 . . . . 0.62 111.22 179.748 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.548 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.11 139.02 49.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.753 -0.658 . . . . 1.97 110.057 179.001 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.433 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.2 p90 -145.06 163.14 35.18 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.162 0.506 . . . . 0.34999999999999998 112.086 -178.166 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.488 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.43 139.69 7.97 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 115.472 -0.785 . . . . 1.8 110.441 178.743 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.687 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.3 Cg_endo -63.58 115.45 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.364 2.043 . . . . 0.57999999999999996 111.836 179.995 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.68 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.05 81.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.973 0.416 . . . . 3.04 109.884 -179.786 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.687 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.26 -20.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.003 -0.544 . . . . 2.4700000000000002 111.942 -179.442 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.64 157.78 34.24 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 120.887 -0.325 . . . . 2.5099999999999998 110.561 179.78 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.401 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.4 27.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.166 -0.47 . . . . 1.8600000000000001 110.235 179.517 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.86 -75.89 1.31 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.029 -0.605 . . . . 1.4399999999999999 111.796 -179.224 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.81 152.34 35.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.92 0.39 . . . . 4.6900000000000004 110.957 -179.286 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.23 -169.06 2.51 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.043 -0.526 . . . . 1.4299999999999999 111.938 179.332 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.18 149.64 29.8 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.449 0.643 . . . . 1.74 112.581 -177.858 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.02 156.49 46.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.853 -1.067 . . . . 1.9199999999999999 110.236 178.718 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.466 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.33 158.35 41.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.966 -0.561 . . . . 0.34000000000000002 111.722 -179.327 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 m -115.18 135.56 54.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.441 -0.799 . . . . 0.40999999999999998 109.829 179.314 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.596 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.37 122.04 23.83 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.391 -0.368 . . . . 0.55000000000000004 111.529 -179.17 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.606 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.7 Cg_exo -46.31 151.75 1.62 Allowed 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.734 2.289 . . . . 0.44 112.081 178.987 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.92 -23.0 63.06 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 115.957 -0.565 . . . . 0.73999999999999999 112.809 -179.312 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.85 -16.85 46.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.369 0.584 . . . . 0.93000000000000005 111.756 -178.268 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.606 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.63 138.47 31.54 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.76 -0.376 . . . . 0.96999999999999997 110.323 179.362 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.54 13.86 10.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.295 -0.411 . . . . 1.3400000000000001 111.512 -179.297 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.473 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.98 143.41 25.19 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.664 -0.415 . . . . 0.39000000000000001 110.998 179.7 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.74 -169.43 1.54 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.035 -0.53 . . . . 0.41999999999999998 110.932 -179.512 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.711 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 7.7 m -151.66 125.93 9.33 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.429 -0.805 . . . . 0.39000000000000001 109.946 179.118 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.516 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.85 123.2 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.412 -0.515 . . . . 0.73999999999999999 111.17 -179.712 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.723 ' NZ ' HD13 ' A' ' 185' ' ' ILE . 86.3 tttt -126.43 163.4 23.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.812 -0.631 . . . . 2.48 110.5 179.645 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.513 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.11 18.97 59.92 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.775 -0.93 . . . . 0.5 110.775 -179.922 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.516 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.4 mt -78.95 157.22 28.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.135 0.493 . . . . 0.57999999999999996 111.385 -179.696 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.848 ' O ' HG12 ' A' ' 67' ' ' VAL . 2.9 mttp -99.52 133.95 21.52 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.593 -0.73 . . . . 2.79 110.442 179.758 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.528 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.81 143.57 61.82 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.553 2.169 . . . . 0.87 111.975 179.794 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.87 25.55 75.43 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.016 -0.834 . . . . 0.64000000000000001 111.016 179.716 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.848 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.1 158.82 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.709 0.29 . . . . 0.82999999999999996 110.448 -179.591 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.15 139.79 42.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.924 0.392 . . . . 0.5 110.575 -179.74 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.645 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.51 136.52 54.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.001 -0.545 . . . . 0.53000000000000003 110.78 -179.984 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.89 131.06 45.27 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.492 -0.929 . . . . 1.8700000000000001 108.492 177.622 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.49 153.85 16.65 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.3 -0.952 . . . . 0.28999999999999998 111.965 -178.664 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -134.92 141.02 46.19 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.687 -0.486 . . . . 1.4299999999999999 109.687 179.504 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.522 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.83 118.89 34.26 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.499 -0.48 . . . . 0.32000000000000001 110.534 179.651 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.722 HG12 HG23 ' A' ' 84' ' ' VAL . 64.1 mt -112.42 129.11 68.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.239 -0.437 . . . . 0.79000000000000004 110.585 -179.874 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.706 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.81 120.86 43.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.326 -0.397 . . . . 1.02 110.707 -179.726 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.849 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.6 146.43 11.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.491 . . . . 0.62 110.978 -179.271 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.624 ' O ' ' N ' ' A' ' 79' ' ' TYR . 20.9 mt-30 -106.03 153.87 21.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.508 -0.769 . . . . 2.4399999999999999 109.938 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.16 88.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.917 0.389 . . . . 3.6899999999999999 110.45 -179.729 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.624 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.25 32.72 0.21 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.819 -0.628 . . . . 6.0800000000000001 110.573 -179.923 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.23 -117.39 3.27 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.407 -0.677 . . . . 1.22 111.407 -179.727 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.25 177.41 9.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.238 0.542 . . . . 2.8799999999999999 111.604 -179.218 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.21 149.47 31.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.401 -0.818 . . . . 1.47 110.418 179.108 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.553 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.15 144.62 38.69 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.487 -0.324 . . . . 2.7000000000000002 110.562 179.905 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.722 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.89 135.99 61.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 120.649 -0.421 . . . . 0.46000000000000002 111.552 -179.761 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.03 141.41 52.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.714 -0.675 . . . . 0.34999999999999998 110.318 179.544 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.465 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.78 138.92 51.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.184 0.516 . . . . 3.6699999999999999 111.428 -179.324 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.29 164.23 37.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.513 -0.767 . . . . 0.67000000000000004 109.42 179.438 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.32 151.52 38.45 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.384 -0.526 . . . . 1.47 110.996 -179.994 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.81 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.17 172.76 12.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.754 -0.657 . . . . 0.44 111.0 179.844 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.74 160.74 21.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.42 -0.809 . . . . 1.3700000000000001 109.863 179.561 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.43 121.85 22.85 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.645 -0.422 . . . . 1.28 110.766 179.974 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.618 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.8 p -126.42 163.75 22.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.346 0.593 . . . . 1.97 112.08 179.72 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.413 -0.812 . . . . 3.2799999999999998 110.665 -179.686 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.496 ' OG ' ' N ' ' A' ' 127' ' ' SER . 95.7 p . . . . . 0 N--CA 1.461 0.085 0 N-CA-C 109.715 -0.476 . . . . 0.66000000000000003 109.715 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.496 ' N ' ' OG ' ' A' ' 126' ' ' SER . 0.9 OUTLIER -53.7 167.48 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.019 0.438 . . . . 0.68999999999999995 111.005 179.481 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.56 145.6 50.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.718 -0.674 . . . . 0.52000000000000002 110.101 -179.949 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.3 101.72 9.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.986 -0.746 . . . . 0.32000000000000001 108.986 177.755 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.9 t -112.99 139.7 36.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.089 -0.505 . . . . 0.28999999999999998 111.054 -178.904 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 p -128.74 152.5 48.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.603 -0.726 . . . . 0.25 109.849 179.603 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.72 -164.98 2.04 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.732 -0.387 . . . . 0.31 110.688 -179.736 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -123.93 127.17 73.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.48999999999999999 110.843 -179.885 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.164 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.95 58.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.178 -0.464 . . . . 1.53 110.329 179.862 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.07 24.41 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.916 -0.584 . . . . 0.96999999999999997 111.499 -179.673 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.164 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.22 128.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.568 -0.453 . . . . 1.5600000000000001 110.899 179.829 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.31 -9.76 55.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.879 -0.601 . . . . 1.8799999999999999 110.323 179.76 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.4 p -87.04 0.26 55.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 1.04 110.4 179.994 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.725 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.29 137.25 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.877 -0.601 . . . . 0.23999999999999999 109.969 179.74 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 185' ' ' ILE . 88.8 p -96.27 -15.54 21.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.279 0.562 . . . . 0.28999999999999998 110.035 -179.643 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.432 ' HA3' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.58 175.56 45.77 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.83 -1.308 . . . . 0.13 109.83 179.679 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -123.49 151.59 42.6 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.621 -0.431 . . . . 0.17000000000000001 110.468 179.723 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.662 ' NH1' ' OD1' ' A' ' 16' ' ' ASN . 12.7 ttt85 -132.29 121.1 23.04 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.086 -0.506 . . . . 1.29 110.005 179.805 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.548 HG21 HG11 ' A' ' 167' ' ' VAL . 46.0 t -105.03 136.49 38.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.777 -0.647 . . . . 0.25 110.724 -179.759 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 78.8 tt0 -129.27 129.91 45.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.061 -0.518 . . . . 1.3200000000000001 110.151 179.98 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.618 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.71 135.34 34.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.994 -0.548 . . . . 0.56999999999999995 110.623 -179.709 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.413 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.34 161.38 39.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.703 -0.68 . . . . 1.1599999999999999 109.716 179.846 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.969 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 85.8 mt -71.12 124.91 25.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.986 0.422 . . . . 0.38 110.689 -179.534 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.499 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.8 -7.68 49.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.739 -0.664 . . . . 0.40999999999999998 110.862 -179.81 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -109.84 -69.58 0.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.365 -0.38 . . . . 1.6599999999999999 111.519 -179.381 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.453 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.69 -35.32 76.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.095 -0.502 . . . . 1.6599999999999999 111.569 -179.192 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.086 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.2 7.2 88.62 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.75 -0.94 . . . . 1.1699999999999999 110.75 -179.936 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.325 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.85 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 1.8600000000000001 110.291 179.801 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.325 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.25 139.08 45.17 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 1.98 110.165 179.64 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.413 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.3 Cg_endo -70.94 145.84 51.38 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 C-N-CA 122.712 2.275 . . . . 0.55000000000000004 112.31 -179.546 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.87 145.81 42.56 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.182 -0.673 . . . . 1.1399999999999999 109.182 179.267 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.657 ' CD2' ' OD1' ' A' ' 16' ' ' ASN . 51.0 p90 -123.38 141.27 52.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.185 0.517 . . . . 0.93000000000000005 111.536 -179.093 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.5 mt -128.05 127.65 43.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.242 -0.89 . . . . 0.34000000000000002 108.92 179.007 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 19.1 t0 -101.58 131.05 47.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.15 0.5 . . . . 1.0900000000000001 111.824 -178.85 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.517 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.1 mt -127.83 157.61 73.04 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.303 -0.862 . . . . 0.19 109.624 179.624 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.84 158.04 58.21 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.395 2.063 . . . . 0.17999999999999999 112.239 179.938 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.24 -12.22 5.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.739 -0.664 . . . . 0.20999999999999999 110.746 -179.824 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.4 p -92.81 -8.68 42.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.09 -0.505 . . . . 0.28999999999999998 110.689 -179.883 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.3 135.35 34.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.332 -0.395 . . . . 0.5 110.318 179.734 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.4 p -133.08 16.69 4.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.322 -0.399 . . . . 0.29999999999999999 110.508 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.0 p -167.54 147.05 5.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.579 -0.526 . . . . 0.23000000000000001 109.579 179.851 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.548 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.11 150.48 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.095 0.474 . . . . 0.28000000000000003 111.585 -179.695 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.507 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.3 125.01 50.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.571 -0.741 . . . . 1.0700000000000001 109.828 179.456 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.4 104.93 30.03 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.358 -0.383 . . . . 0.28999999999999998 111.066 -179.895 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.5 Cg_endo -90.98 -179.5 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 123.22 2.613 . . . . 0.42999999999999999 112.15 179.916 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.74 32.53 18.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.371 -0.831 . . . . 1.26 111.418 179.175 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 172' ' ' LEU . 24.2 mt -86.33 148.53 25.56 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.911 -0.315 . . . . 0.32000000000000001 110.505 179.587 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.774 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.32 114.88 61.43 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 121.069 0.461 . . . . 0.57999999999999996 110.688 -179.732 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.97 140.5 95.62 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.877 2.384 . . . . 0.66000000000000003 112.1 179.815 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.18 21.13 74.2 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.029 -0.828 . . . . 0.28999999999999998 111.029 179.907 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.453 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.77 150.25 49.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.75 0.31 . . . . 2.3300000000000001 110.747 179.881 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.499 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.22 131.65 46.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.063 -0.517 . . . . 0.85999999999999999 109.799 179.333 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.969 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.47 148.33 43.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.079 -0.51 . . . . 0.52000000000000002 111.077 -179.892 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.34 125.4 60.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.281 -1.007 . . . . 0.29999999999999999 108.281 177.701 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.63 132.55 63.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.308 0.575 . . . . 0.23000000000000001 111.17 -178.595 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.5 122.59 20.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.433 -0.803 . . . . 0.35999999999999999 109.642 179.285 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.3 t -101.05 125.39 55.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.2 -0.454 . . . . 0.19 110.598 -179.436 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.3 m-85 -117.25 137.88 52.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.017 -0.538 . . . . 0.29999999999999999 109.899 179.456 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.43 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.68 135.02 42.79 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.811 -0.811 . . . . 0.37 108.811 178.872 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.723 HD13 ' NZ ' ' A' ' 61' ' ' LYS . 5.2 mp -99.04 122.94 51.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.16 0.505 . . . . 0.26000000000000001 110.926 -178.747 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.3 p -83.86 169.79 14.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.517 -0.765 . . . . 0.28000000000000003 110.453 -179.71 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.89 -14.53 15.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.048 -0.523 . . . . 1.6000000000000001 110.823 -179.504 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.548 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.3 m-20 -96.11 -4.22 43.21 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.817 -0.353 . . . . 1.1799999999999999 110.847 -179.811 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.566 ' HA3' HG23 ' A' ' 59' ' ' THR . . . 87.74 13.9 64.09 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.376 -0.69 . . . . 0.29999999999999999 111.376 179.858 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.62 139.03 32.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.652 0.263 . . . . 1.22 110.438 179.652 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.467 ' NE2' ' HD3' ' A' ' 143' ' ' ARG . 97.1 mt-30 -106.69 141.04 38.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.809 0.337 . . . . 0.97999999999999998 110.617 179.675 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 61.8 m -136.65 127.12 26.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.82999999999999996 110.316 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.1 117.36 9.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.287 -0.415 . . . . 0.26000000000000001 110.584 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.0 pt -109.18 -21.67 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.29999999999999999 110.732 -179.69 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.97 125.73 5.82 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.542 -0.463 . . . . 0.31 111.521 -179.879 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.475 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.79 120.13 21.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.777 -0.647 . . . . 0.28000000000000003 109.58 179.248 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.55 151.71 29.19 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.639 -0.424 . . . . 0.23999999999999999 110.882 -179.276 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.8 p -110.36 158.56 18.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.019 -0.537 . . . . 0.23000000000000001 110.442 179.709 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.401 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 68.2 mt-30 -146.05 157.86 43.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.67000000000000004 110.663 -179.969 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.31 104.36 9.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.801 -0.636 . . . . 0.64000000000000001 110.043 179.49 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.9 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.843 -1.075 . . . . 1.26 110.621 -179.655 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.2 m . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.189 -0.671 . . . . 3.4399999999999999 109.189 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.66 18.54 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.988 -0.845 . . . . 1.22 110.988 179.72 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -35.47 142.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.058 0 C-N-CA 123.934 3.089 . . . . 0.75 113.832 -179.283 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.609 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.99 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.274 -1.33 . . . . 0.79000000000000004 108.83 178.368 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.609 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.62 125.94 51.57 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.376 -0.529 . . . . 1.9399999999999999 111.461 -179.601 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.47 144.01 33.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.63 -0.713 . . . . 0.59999999999999998 110.72 179.869 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.03 168.34 25.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.925 0.393 . . . . 3.1400000000000001 111.137 -179.674 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.745 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.5 mt -109.06 131.02 60.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.957 -0.565 . . . . 3.23 110.024 179.928 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.15 162.36 35.67 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.865 0.364 . . . . 3.6299999999999999 111.219 -179.961 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 16.9 pt-20 36.16 31.45 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.682 -0.488 . . . . 6.0800000000000001 109.682 179.847 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.745 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.4 69.61 32.3 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.934 -0.575 . . . . 3.3799999999999999 111.593 -178.747 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.28 -29.08 72.73 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.497 2.132 . . . . 3.9300000000000002 111.822 179.354 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.58 125.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 3.3599999999999999 110.481 -179.947 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 17' ' ' SER . 3.2 mp0 -123.8 158.41 59.85 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.294 -0.412 . . . . 3.6099999999999999 110.456 179.959 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.459 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 97.2 Cg_endo -82.1 -64.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.861 2.374 . . . . 1.51 113.456 -179.039 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.674 ' OD1' ' N ' ' A' ' 17' ' ' SER . 1.4 p-10 -108.39 -19.61 13.4 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.106 0.41 . . . . 2.6800000000000002 112.106 -178.498 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.674 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 33.4 m -107.34 152.1 24.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.116 0.484 . . . . 1.21 111.328 -179.421 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.37 102.96 2.21 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.693 -0.685 . . . . 1.5600000000000001 110.652 179.804 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.6 145.57 13.12 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.921 2.414 . . . . 0.81000000000000005 112.61 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.928 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.78 167.9 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.955 -0.566 . . . . 1.52 109.842 179.567 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.17 147.9 28.99 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.812 -0.44 . . . . 2.1400000000000001 109.812 178.822 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.595 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.21 157.32 44.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.005 0.431 . . . . 0.32000000000000001 111.11 -179.951 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.492 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.09 155.19 44.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.699 -0.682 . . . . 2.1699999999999999 110.086 178.978 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.836 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.55 173.04 6.35 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.185 -0.462 . . . . 0.58999999999999997 110.732 -179.193 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.836 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.58 173.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.974 2.449 . . . . 0.90000000000000002 111.492 179.333 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.479 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.09 -51.03 0.69 Allowed Pre-proline 0 C--N 1.328 -0.349 0 C-N-CA 120.666 -0.414 . . . . 3.3399999999999999 110.078 179.853 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.84 152.32 82.57 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.798 2.332 . . . . 1.8500000000000001 111.483 179.219 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.67 42.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.38 0.61 . . . . 2.54 110.534 -179.869 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.624 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.7 t60 -63.67 -41.58 98.17 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.032 -0.985 . . . . 2.5299999999999998 110.68 179.709 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.566 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.6 mt -109.93 137.82 40.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.773 -0.648 . . . . 1.1699999999999999 111.271 -179.439 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.92 -72.98 0.7 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.999 -0.546 . . . . 1.27 111.865 -178.963 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.16 148.42 24.42 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.587 0.588 . . . . 1.1200000000000001 112.587 -179.625 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.85 124.87 45.14 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.319 -0.623 . . . . 0.41999999999999998 109.319 177.572 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.02 134.67 60.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.718 -0.393 . . . . 0.78000000000000003 110.72 179.939 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.928 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -119.96 128.67 53.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.055 0.455 . . . . 0.62 111.275 179.788 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.547 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 138.88 49.64 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.758 -0.655 . . . . 1.97 110.08 179.087 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.433 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.0 163.23 34.84 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.158 0.504 . . . . 0.34999999999999998 112.086 -178.198 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.489 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.51 139.57 7.83 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.482 -0.781 . . . . 1.8 110.451 178.846 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.684 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.9 Cg_endo -63.54 115.44 3.04 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.279 1.986 . . . . 0.57999999999999996 111.891 179.938 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.679 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.3 tttp -46.99 81.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.871 -0.418 . . . . 3.04 109.871 -179.827 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.58 0.06 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.92 -0.582 . . . . 2.4700000000000002 111.874 -179.584 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 p -157.7 157.81 34.21 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 120.747 -0.381 . . . . 2.5099999999999998 110.561 179.764 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.401 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.42 27.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 1.8600000000000001 110.161 179.659 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.81 -75.89 1.31 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.19 -0.528 . . . . 1.4399999999999999 111.861 -179.243 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.96 152.32 35.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.968 0.413 . . . . 4.6900000000000004 110.988 -179.383 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.18 -169.14 2.54 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.993 -0.549 . . . . 1.4299999999999999 111.922 179.425 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.6 mttp -110.14 149.62 29.81 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.477 0.656 . . . . 1.74 112.599 -177.922 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.0 156.58 46.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.768 -1.105 . . . . 1.9199999999999999 110.306 178.6 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.3 158.39 41.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.901 -0.59 . . . . 0.34000000000000002 111.785 -179.311 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.8 m -115.25 135.67 53.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.459 -0.791 . . . . 0.40999999999999998 109.784 179.317 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.595 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.43 121.95 23.73 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.419 -0.355 . . . . 0.55000000000000004 111.505 -179.105 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.0 Cg_exo -46.34 151.73 1.64 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.639 2.226 . . . . 0.44 112.189 179.019 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.89 -23.07 63.07 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-N 116.063 -0.517 . . . . 0.73999999999999999 112.81 -179.189 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.538 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.79 -16.9 46.07 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.237 -0.585 . . . . 0.93000000000000005 111.761 -178.274 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.603 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.54 138.48 31.54 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.689 -0.404 . . . . 0.96999999999999997 110.309 179.372 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.6 13.98 10.95 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.404 -0.362 . . . . 1.3400000000000001 111.567 -179.416 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.472 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.98 143.44 25.21 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.607 -0.437 . . . . 0.39000000000000001 111.052 179.586 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.708 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.82 -169.36 1.53 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.203 0.525 . . . . 0.41999999999999998 110.916 -179.523 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.708 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 t -151.69 125.89 9.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.448 -0.796 . . . . 0.39000000000000001 109.84 179.262 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.517 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.83 123.27 70.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.33 -0.548 . . . . 0.73999999999999999 111.205 -179.785 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -126.43 163.41 23.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.872 -0.603 . . . . 2.48 110.379 179.788 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.16 18.83 60.11 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.783 -0.927 . . . . 0.5 110.783 -179.953 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.517 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.2 mt -79.05 157.31 28.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.156 0.503 . . . . 0.57999999999999996 111.28 -179.521 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.848 ' O ' HG12 ' A' ' 67' ' ' VAL . 4.8 mptp? -99.59 134.0 21.44 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.554 -0.748 . . . . 2.79 110.414 179.8 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.439 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.9 Cg_endo -67.8 143.64 62.09 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.591 2.194 . . . . 0.87 111.971 179.784 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.75 25.62 75.34 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.101 -0.8 . . . . 0.64000000000000001 111.101 179.705 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.848 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.15 158.78 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.692 0.282 . . . . 0.82999999999999996 110.397 -179.574 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.17 139.96 41.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.882 0.372 . . . . 0.5 110.621 -179.825 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.672 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.2 m-85 -122.56 136.33 54.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.994 -0.548 . . . . 0.53000000000000003 110.818 -179.901 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.486 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.79 131.05 45.22 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.546 -0.909 . . . . 1.8700000000000001 108.546 177.593 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.48 153.79 16.66 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.308 -0.949 . . . . 0.28999999999999998 111.986 -178.579 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -134.92 140.92 46.13 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.658 -0.497 . . . . 1.4299999999999999 109.658 179.584 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.525 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.75 118.84 34.15 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.452 -0.499 . . . . 0.32000000000000001 110.536 179.672 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.714 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.42 129.05 68.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.339 -0.391 . . . . 0.79000000000000004 110.658 -179.862 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.704 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.74 120.88 43.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.27 -0.423 . . . . 1.02 110.73 -179.634 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.85 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.62 146.5 11.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.17 0.51 . . . . 0.62 110.944 -179.223 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.621 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.06 153.93 21.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.46 -0.791 . . . . 2.4399999999999999 109.891 179.826 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.18 88.52 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.896 0.379 . . . . 3.6899999999999999 110.424 -179.809 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.36 32.52 0.22 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.873 -0.603 . . . . 6.0800000000000001 110.628 -179.953 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.02 -117.38 3.3 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.431 -0.667 . . . . 1.22 111.431 -179.693 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.43 177.42 8.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.135 0.493 . . . . 2.8799999999999999 111.658 -179.189 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.1 149.54 32.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.503 -0.771 . . . . 1.47 110.391 179.167 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.18 144.66 38.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.471 -0.331 . . . . 2.7000000000000002 110.515 179.863 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.714 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.94 136.09 61.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 121.035 0.445 . . . . 0.46000000000000002 111.57 -179.806 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.7 m -124.15 141.29 52.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.753 -0.658 . . . . 0.34999999999999998 110.316 179.635 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.46 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.58 138.91 51.62 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.125 0.488 . . . . 3.6699999999999999 111.524 -179.339 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.3 164.14 38.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.575 -0.739 . . . . 0.67000000000000004 109.474 179.386 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.29 151.57 38.56 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.293 -0.563 . . . . 1.47 111.011 179.937 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.808 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.21 172.72 13.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.792 -0.64 . . . . 0.44 111.079 179.895 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.77 160.7 21.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.57 -0.741 . . . . 1.3700000000000001 109.847 179.644 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.46 121.89 22.88 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.524 -0.47 . . . . 1.28 110.712 -179.965 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.6 p -125.41 151.83 45.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.909 0.862 . . . . 1.97 112.908 179.695 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.462 0.161 0 CA-C-N 114.053 -1.43 . . . . 3.2799999999999998 113.876 -179.402 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 122.668 1.223 . . . . 0.66000000000000003 108.137 . . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.442 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.82 167.6 0.25 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.121 -1.399 . . . . 0.68999999999999995 110.904 -178.85 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.69 145.56 50.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.692 -0.686 . . . . 0.52000000000000002 110.084 -179.934 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.26 101.7 9.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.07 -0.715 . . . . 0.32000000000000001 109.07 177.678 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.2 t -112.88 139.69 36.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.989 -0.551 . . . . 0.28999999999999998 111.073 -178.914 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.9 p -128.68 152.55 48.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.637 -0.71 . . . . 0.25 109.84 179.568 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.81 -164.98 2.04 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.693 -0.403 . . . . 0.31 110.64 -179.764 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.733 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.6 t -123.95 127.16 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.48999999999999999 110.844 -179.88 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.174 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.94 58.36 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.103 -0.499 . . . . 1.53 110.415 179.808 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.29 24.59 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.931 -0.577 . . . . 0.96999999999999997 111.479 -179.541 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.174 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.2 128.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.686 -0.405 . . . . 1.5600000000000001 111.004 179.8 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -86.45 -9.62 55.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.886 -0.597 . . . . 1.8799999999999999 110.337 179.775 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.12 0.35 55.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.094 -0.503 . . . . 1.04 110.289 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.34 137.19 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.23999999999999999 109.977 179.663 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 185' ' ' ILE . 76.6 p -96.28 -15.4 21.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.304 0.574 . . . . 0.28999999999999998 110.044 -179.649 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.52 175.58 45.72 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.856 -1.297 . . . . 0.13 109.856 179.59 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.45 151.63 42.49 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.62 -0.432 . . . . 0.17000000000000001 110.484 179.745 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.459 ' NH1' ' HG2' ' A' ' 15' ' ' PRO . 45.2 ttp180 -132.33 121.22 23.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.143 -0.48 . . . . 1.29 109.899 179.814 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.554 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.13 136.54 38.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.732 -0.667 . . . . 0.25 110.634 -179.711 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 80.7 tt0 -129.5 129.86 45.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.975 -0.557 . . . . 1.3200000000000001 110.006 -179.91 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.622 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.69 135.32 34.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.937 -0.574 . . . . 0.56999999999999995 110.633 -179.676 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.421 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.32 161.4 39.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.753 -0.658 . . . . 1.1599999999999999 109.619 179.875 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.968 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.1 mt -71.04 124.8 25.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.973 0.416 . . . . 0.38 110.772 -179.642 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.79 -7.64 49.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.832 -0.622 . . . . 0.40999999999999998 110.875 -179.738 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -109.82 -69.72 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.963 0.411 . . . . 1.6599999999999999 111.407 -179.267 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.468 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.69 -35.31 75.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.014 -0.539 . . . . 1.6599999999999999 111.563 -179.155 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.076 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.07 7.29 88.55 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.829 -0.908 . . . . 1.1699999999999999 110.829 -179.83 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.319 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.95 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.734 0.302 . . . . 1.8600000000000001 110.322 179.818 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.319 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.13 45.22 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.976 0.417 . . . . 1.98 110.193 179.624 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.8 Cg_endo -70.85 145.9 52.06 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 C-N-CA 122.621 2.214 . . . . 0.55000000000000004 112.368 -179.568 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.622 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.87 145.73 42.63 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.21 -0.663 . . . . 1.1399999999999999 109.21 179.21 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 6.0 p90 -123.24 141.31 52.11 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.399 -0.52 . . . . 0.93000000000000005 111.57 -179.108 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.3 mt -128.18 127.73 43.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.337 -0.847 . . . . 0.34000000000000002 108.844 178.956 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.548 ' O ' ' OD1' ' A' ' 159' ' ' ASP . 54.4 p-10 -101.65 131.15 48.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.174 0.511 . . . . 1.0900000000000001 111.751 -178.76 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.92 157.49 73.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.362 -0.836 . . . . 0.19 109.559 179.768 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -69.76 158.0 58.47 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.485 2.123 . . . . 0.17999999999999999 112.203 179.903 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.27 -12.16 5.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.755 -0.657 . . . . 0.20999999999999999 110.75 -179.842 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.81 -8.84 42.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.113 -0.494 . . . . 0.28999999999999998 110.678 -179.823 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.11 135.32 34.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.325 -0.398 . . . . 0.5 110.463 179.68 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 32.1 p -133.07 16.6 4.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.465 -0.334 . . . . 0.29999999999999999 110.582 179.953 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.1 p -167.53 147.09 5.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.61 -0.515 . . . . 0.23000000000000001 109.61 179.897 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.554 HG11 HG21 ' A' ' 144' ' ' VAL . 6.2 p -152.2 150.52 12.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.518 -0.473 . . . . 0.28000000000000003 111.528 -179.632 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.512 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.39 124.98 50.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.608 -0.724 . . . . 1.0700000000000001 109.763 179.517 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.39 104.93 29.96 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.909 0.385 . . . . 0.28999999999999998 111.02 -179.879 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.0 Cg_endo -91.03 -179.56 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 123.12 2.547 . . . . 0.42999999999999999 112.179 179.89 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 61.81 32.54 18.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.372 -0.831 . . . . 1.26 111.435 179.246 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.456 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.0 mt -86.46 148.5 25.52 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.918 -0.313 . . . . 0.32000000000000001 110.474 179.592 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.774 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.27 114.85 61.27 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 121.06 0.457 . . . . 0.57999999999999996 110.674 -179.64 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -58.95 140.63 96.15 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.9 2.4 . . . . 0.66000000000000003 111.99 179.853 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 76.99 21.26 74.44 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.082 -0.807 . . . . 0.28999999999999998 111.082 179.864 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.468 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.84 150.15 49.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.783 0.325 . . . . 2.3300000000000001 110.669 179.944 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.17 131.66 45.99 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.85999999999999999 109.784 179.28 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.968 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.2 m-85 -120.5 148.32 43.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.096 -0.502 . . . . 0.52000000000000002 110.951 -179.813 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.35 125.39 60.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.295 -1.002 . . . . 0.29999999999999999 108.295 177.657 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.59 132.45 63.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.206 0.527 . . . . 0.23000000000000001 111.274 -178.61 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.45 122.6 20.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.46 -0.791 . . . . 0.35999999999999999 109.64 179.278 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -101.02 125.41 54.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.234 -0.439 . . . . 0.19 110.72 -179.566 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.3 m-85 -117.22 137.91 52.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.992 -0.549 . . . . 0.29999999999999999 109.884 179.535 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.429 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.75 135.04 42.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.801 -0.815 . . . . 0.37 108.801 178.872 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.606 ' O ' ' N ' ' A' ' 140' ' ' SER . 80.6 mt -98.98 122.93 51.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.134 0.492 . . . . 0.26000000000000001 110.981 -178.774 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.8 p -83.89 169.67 14.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.593 -0.73 . . . . 0.28000000000000003 110.447 -179.709 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.82 -14.49 15.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.996 -0.547 . . . . 1.6000000000000001 110.928 -179.552 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -96.05 -4.3 43.24 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.857 -0.337 . . . . 1.1799999999999999 110.808 -179.832 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.83 13.84 64.01 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.351 -0.699 . . . . 0.29999999999999999 111.351 179.848 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -84.64 139.1 32.3 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.774 -0.251 . . . . 1.22 110.43 179.737 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.4 ' OE1' ' NH1' ' A' ' 143' ' ' ARG . 15.2 pt20 -106.72 141.07 38.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.423 -0.353 . . . . 0.97999999999999998 110.53 179.773 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.75 127.06 26.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.82999999999999996 110.332 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 25.8 tp -68.13 117.21 9.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.247 -0.433 . . . . 0.26000000000000001 110.42 -179.876 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -108.98 -21.83 5.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.29999999999999999 110.688 -179.787 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.82 125.82 5.95 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.512 -0.475 . . . . 0.31 111.476 -179.803 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.47 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.82 120.15 21.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.764 -0.653 . . . . 0.28000000000000003 109.564 179.174 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.63 151.63 29.03 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.691 -0.404 . . . . 0.23999999999999999 110.932 -179.284 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.31 158.64 18.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.041 -0.527 . . . . 0.23000000000000001 110.431 179.723 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.4 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 67.8 mt-30 -146.12 157.86 43.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.078 -0.51 . . . . 0.67000000000000004 110.652 -179.997 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.22 104.29 9.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.827 -0.624 . . . . 0.64000000000000001 110.086 179.522 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.0 p . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.851 -1.071 . . . . 1.26 110.727 -179.727 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.4 m . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.269 -0.641 . . . . 3.4399999999999999 109.269 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.74 18.53 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.032 -0.827 . . . . 1.22 111.032 179.683 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -35.7 142.38 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.113 0 C-N-CA 124.004 3.136 . . . . 0.75 113.806 -179.247 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.0 t -79.93 173.4 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.14 -1.391 . . . . 0.79000000000000004 108.888 178.41 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.608 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.53 125.86 51.46 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.448 -0.501 . . . . 1.9399999999999999 111.496 -179.618 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.51 143.99 33.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.687 -0.688 . . . . 0.59999999999999998 110.585 179.967 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.07 168.27 25.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.934 0.397 . . . . 3.1400000000000001 111.074 -179.671 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.744 HG22 ' OG1' ' A' ' 11' ' ' THR . 65.9 mt -108.93 131.01 60.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.946 -0.57 . . . . 3.23 110.139 179.877 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.14 162.27 35.88 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.869 0.366 . . . . 3.6299999999999999 111.247 -179.88 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.7 mt-10 36.21 31.5 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.601 -0.518 . . . . 6.0800000000000001 109.601 179.781 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.744 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.63 33.17 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.962 -0.563 . . . . 3.3799999999999999 111.555 -178.764 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.642 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.24 -29.22 73.2 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.531 2.154 . . . . 3.9300000000000002 111.849 179.304 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.642 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.71 125.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 3.3599999999999999 110.474 179.971 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.561 ' O ' ' O ' ' A' ' 92' ' ' THR . 10.9 mp0 -123.98 158.34 60.59 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.362 -0.381 . . . . 3.6099999999999999 110.436 179.965 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.506 ' HG3' ' NH1' ' A' ' 143' ' ' ARG . 96.7 Cg_endo -82.12 -64.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.837 2.358 . . . . 1.51 113.485 -179.023 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.54 ' OD1' ' O ' ' A' ' 63' ' ' LEU . 2.5 t-20 -108.5 -19.51 13.42 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.06 0.393 . . . . 2.6800000000000002 112.06 -178.501 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 9.1 p -107.36 152.02 24.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.103 0.477 . . . . 1.21 111.299 -179.456 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.576 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.25 102.89 2.23 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.694 -0.684 . . . . 1.5600000000000001 110.649 179.844 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.443 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.4 Cg_endo -82.62 145.66 13.12 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.885 2.39 . . . . 0.81000000000000005 112.621 179.896 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.917 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.84 167.93 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.901 -0.59 . . . . 1.52 109.856 179.595 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -149.17 147.85 28.94 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.819 -0.437 . . . . 2.1400000000000001 109.819 178.872 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.584 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.19 157.34 44.97 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.685 -0.406 . . . . 0.32000000000000001 111.228 179.946 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.501 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -128.03 155.23 44.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.737 -0.665 . . . . 2.1699999999999999 110.117 179.023 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.843 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.6 173.04 6.35 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.024 0.44 . . . . 0.58999999999999997 110.79 -179.266 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.843 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.71 173.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.914 2.41 . . . . 0.90000000000000002 111.528 179.402 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.94 -51.01 0.7 Allowed Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.616 -0.434 . . . . 3.3399999999999999 110.17 179.867 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.643 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.9 152.35 82.57 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.681 2.254 . . . . 1.8500000000000001 111.48 179.183 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.71 42.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.406 0.622 . . . . 2.54 110.562 -179.82 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.643 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.9 t60 -63.7 -41.51 98.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.943 -1.026 . . . . 2.5299999999999998 110.657 179.784 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.56 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.3 mt -110.0 137.87 40.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.72 -0.673 . . . . 1.1699999999999999 111.181 -179.409 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.99 -72.97 0.7 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.939 -0.573 . . . . 1.27 111.819 -178.944 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.19 148.44 24.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.591 0.589 . . . . 1.1200000000000001 112.591 -179.592 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.79 124.75 44.93 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.363 -0.606 . . . . 0.41999999999999998 109.363 177.556 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -117.99 134.71 60.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.696 -0.402 . . . . 0.78000000000000003 110.67 179.89 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.917 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -119.98 128.58 53.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.043 0.449 . . . . 0.62 111.225 179.767 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.542 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.07 138.98 49.83 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.768 -0.651 . . . . 1.97 110.138 178.954 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.44 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.0 163.25 34.77 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 121.165 0.507 . . . . 0.34999999999999998 112.061 -178.151 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.56 139.63 7.82 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.415 -0.811 . . . . 1.8 110.399 178.825 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.71 115.52 3.12 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.308 2.005 . . . . 0.57999999999999996 111.822 179.985 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.675 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.96 81.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.897 -0.408 . . . . 3.04 109.897 -179.801 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.697 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.012 -0.54 . . . . 2.4700000000000002 111.936 -179.496 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.2 p -157.65 157.79 34.25 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.839 -0.345 . . . . 2.5099999999999998 110.568 179.77 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.38 27.79 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 1.8600000000000001 110.165 179.574 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.75 -75.79 1.31 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.183 -0.532 . . . . 1.4399999999999999 111.888 -179.245 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.4 ' HD2' HH11 ' A' ' 45' ' ' ARG . 21.4 mtp180 -118.03 152.29 35.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.931 0.396 . . . . 4.6900000000000004 110.968 -179.317 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.673 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.15 2.54 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.106 -0.497 . . . . 1.4299999999999999 112.007 179.39 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.04 149.67 29.66 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.457 0.646 . . . . 1.74 112.543 -177.836 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.15 156.44 45.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.789 -1.096 . . . . 1.9199999999999999 110.161 178.635 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.21 158.35 41.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.905 -0.589 . . . . 0.34000000000000002 111.745 -179.351 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.3 m -115.11 135.59 54.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.454 -0.794 . . . . 0.40999999999999998 109.831 179.287 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.584 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.34 121.86 23.82 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.411 -0.359 . . . . 0.55000000000000004 111.596 -179.156 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.595 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.0 Cg_exo -46.23 151.67 1.58 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.695 2.263 . . . . 0.44 112.173 178.992 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.83 -23.16 63.05 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 116.096 -0.502 . . . . 0.73999999999999999 112.796 -179.205 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.54 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.7 -16.95 46.17 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.245 -0.582 . . . . 0.93000000000000005 111.824 -178.316 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.595 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.51 138.39 31.61 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.782 -0.367 . . . . 0.96999999999999997 110.27 179.396 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.54 14.01 11.0 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.308 -0.405 . . . . 1.3400000000000001 111.466 -179.418 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -150.04 143.5 25.19 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.721 -0.392 . . . . 0.39000000000000001 111.061 179.573 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.9 -169.31 1.53 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.065 -0.516 . . . . 0.41999999999999998 110.885 -179.425 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.723 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.79 125.94 9.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.442 -0.799 . . . . 0.39000000000000001 109.793 179.305 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.519 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.89 123.19 70.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.398 -0.521 . . . . 0.73999999999999999 111.157 -179.73 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -126.47 163.32 23.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.895 -0.593 . . . . 2.48 110.467 179.695 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.443 ' N ' ' OD2' ' A' ' 159' ' ' ASP . . . 85.24 18.95 59.76 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.672 -0.971 . . . . 0.5 110.672 -179.963 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.54 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 73.6 mt -79.07 157.27 28.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.129 0.49 . . . . 0.57999999999999996 111.302 -179.594 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.84 ' O ' HG12 ' A' ' 67' ' ' VAL . 1.2 mptt -99.51 134.02 21.47 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.572 -0.74 . . . . 2.79 110.475 179.759 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.95 143.58 61.03 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.573 2.182 . . . . 0.87 111.912 179.835 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.62 75.34 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.1 -0.8 . . . . 0.64000000000000001 111.1 179.732 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.84 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.14 158.74 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.704 0.288 . . . . 0.82999999999999996 110.395 -179.564 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.17 139.95 42.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.067 0.46 . . . . 0.5 110.586 -179.861 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.648 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.3 m-85 -122.5 136.42 54.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.869 -0.605 . . . . 0.53000000000000003 110.799 -179.9 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.3 pt-20 -98.85 131.06 45.24 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.553 -0.906 . . . . 1.8700000000000001 108.553 177.557 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.495 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.47 153.84 16.65 Favored Glycine 0 C--O 1.227 -0.286 0 C-N-CA 120.364 -0.922 . . . . 0.28999999999999998 112.043 -178.681 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -134.99 140.92 46.05 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.706 -0.479 . . . . 1.4299999999999999 109.706 179.55 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.2 tp -115.77 119.01 34.62 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.421 -0.512 . . . . 0.32000000000000001 110.504 179.684 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 84' ' ' VAL . 64.1 mt -112.45 129.06 68.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 0.79000000000000004 110.631 -179.865 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.7 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.8 120.75 43.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.343 -0.39 . . . . 1.02 110.754 -179.682 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.856 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.54 146.38 11.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.223 0.535 . . . . 0.62 111.023 -179.258 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.619 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.01 153.85 21.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.532 -0.758 . . . . 2.4399999999999999 109.935 179.829 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.13 88.48 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.889 0.376 . . . . 3.6899999999999999 110.416 -179.737 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.31 32.7 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.845 -0.616 . . . . 6.0800000000000001 110.467 -179.922 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.18 -117.36 3.28 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.413 -0.675 . . . . 1.22 111.413 -179.776 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.34 177.44 8.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.295 0.569 . . . . 2.8799999999999999 111.606 -179.192 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.22 149.46 31.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.423 -0.808 . . . . 1.47 110.486 179.149 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.07 144.64 38.85 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.549 -0.296 . . . . 2.7000000000000002 110.591 179.952 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.727 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.94 136.07 61.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.036 0.446 . . . . 0.46000000000000002 111.565 -179.832 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.57 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.16 141.38 52.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.675 -0.693 . . . . 0.34999999999999998 110.241 179.645 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.4 ttp180 -117.64 138.86 51.69 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.572 -0.451 . . . . 3.6699999999999999 111.511 -179.322 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.495 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.32 164.18 37.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.606 -0.724 . . . . 0.67000000000000004 109.44 179.422 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.567 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.29 151.55 38.52 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.357 -0.537 . . . . 1.47 111.042 179.99 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.8 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.25 172.68 13.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.738 -0.665 . . . . 0.44 111.083 179.848 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.69 160.65 21.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.48 -0.782 . . . . 1.3700000000000001 109.873 179.604 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.29 121.93 23.14 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.507 -0.477 . . . . 1.28 110.731 179.959 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.561 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.5 p -127.42 159.32 34.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 1.97 111.643 179.631 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 36.3 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.904 -0.589 . . . . 3.2799999999999998 110.944 179.325 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.7 p . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.549 0.214 . . . . 0.66000000000000003 111.17 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.44 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.81 167.56 0.25 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.181 -0.463 . . . . 0.68999999999999995 110.954 179.893 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.65 145.49 50.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.807 -0.633 . . . . 0.52000000000000002 110.136 -179.933 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.18 101.62 9.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.012 -0.736 . . . . 0.32000000000000001 109.012 177.788 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.6 t -112.97 139.62 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.1 -0.5 . . . . 0.28999999999999998 111.149 -178.965 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.4 p -128.63 152.62 48.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.66 -0.7 . . . . 0.25 109.891 179.564 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.588 ' CD2' HG11 ' A' ' 182' ' ' VAL . 40.0 p90 -144.77 -165.06 2.06 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.74 -0.384 . . . . 0.31 110.704 -179.669 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.735 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.6 t -123.87 127.08 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.48999999999999999 110.897 -179.903 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.176 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.85 58.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.159 -0.473 . . . . 1.53 110.388 179.767 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.735 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.22 24.47 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.949 -0.569 . . . . 0.96999999999999997 111.433 -179.597 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.176 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.17 128.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.617 -0.433 . . . . 1.5600000000000001 110.991 179.915 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.36 -9.71 55.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.95 -0.568 . . . . 1.8799999999999999 110.293 179.829 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.07 0.2 55.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 1.04 110.253 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.21 137.17 25.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.23999999999999999 109.974 179.68 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 185' ' ' ILE . 70.5 m -96.22 -15.58 21.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.227 0.537 . . . . 0.28999999999999998 110.011 -179.66 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.61 175.52 45.76 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.821 -1.312 . . . . 0.13 109.821 179.722 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.37 151.62 42.35 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.694 -0.402 . . . . 0.17000000000000001 110.489 179.706 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.635 ' NE ' ' OE1' ' A' ' 191' ' ' GLN . 55.1 ttp85 -132.36 121.21 23.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.172 -0.467 . . . . 1.29 109.954 179.736 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.563 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.13 136.53 38.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.716 -0.675 . . . . 0.25 110.622 -179.7 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 79.5 tt0 -129.39 129.91 45.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.961 -0.563 . . . . 1.3200000000000001 110.128 179.963 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.9 p90 -138.67 135.32 34.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.006 -0.543 . . . . 0.56999999999999995 110.675 -179.658 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.414 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.39 161.33 39.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.805 -0.634 . . . . 1.1599999999999999 109.685 179.849 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.962 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.04 124.89 25.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.974 0.416 . . . . 0.38 110.737 -179.597 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.489 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.73 -7.78 50.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.741 -0.663 . . . . 0.40999999999999998 110.908 -179.791 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -109.76 -69.59 0.85 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.958 0.408 . . . . 1.6599999999999999 111.467 -179.253 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.441 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.4 mt-10 -60.85 -35.23 76.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.059 -0.519 . . . . 1.6599999999999999 111.454 -179.084 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.072 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.12 7.18 88.62 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.893 -0.883 . . . . 1.1699999999999999 110.893 -179.836 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.335 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.97 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.757 0.313 . . . . 1.8600000000000001 110.326 179.873 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.335 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.19 139.1 45.39 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.95 0.405 . . . . 1.98 110.226 179.649 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.414 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.2 Cg_endo -70.97 145.79 51.08 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.768 2.312 . . . . 0.55000000000000004 112.327 -179.499 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.85 145.68 42.65 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.28 -0.637 . . . . 1.1399999999999999 109.28 179.19 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.537 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 85.5 m-85 -123.27 141.41 52.01 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.314 -0.554 . . . . 0.93000000000000005 111.518 -179.053 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.4 mt -128.11 127.69 43.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.306 -0.861 . . . . 0.34000000000000002 108.915 179.06 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.443 ' OD2' ' N ' ' A' ' 62' ' ' GLY . 45.0 t0 -101.68 131.13 48.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.148 0.499 . . . . 1.0900000000000001 111.761 -178.783 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.92 157.62 73.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.266 -0.879 . . . . 0.19 109.6 179.619 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -69.87 158.03 58.19 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.423 2.082 . . . . 0.17999999999999999 112.197 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.26 -12.18 5.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.729 -0.669 . . . . 0.20999999999999999 110.693 -179.808 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.2 p -92.86 -8.73 42.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.28999999999999998 110.657 -179.855 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.27 135.39 34.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.393 -0.367 . . . . 0.5 110.344 179.73 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 p -133.14 16.62 4.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.335 -0.393 . . . . 0.29999999999999999 110.54 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.7 p -167.45 147.15 5.16 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.659 -0.497 . . . . 0.23000000000000001 109.659 179.874 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.563 HG11 HG21 ' A' ' 144' ' ' VAL . 5.9 p -152.19 150.36 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.011 0.434 . . . . 0.28000000000000003 111.618 -179.605 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.504 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 124.96 50.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.622 -0.717 . . . . 1.0700000000000001 109.799 179.47 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.47 104.97 30.47 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.015 0.436 . . . . 0.28999999999999998 111.062 -179.903 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.5 Cg_endo -91.04 -179.46 1.47 Allowed 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 123.144 2.563 . . . . 0.42999999999999999 112.221 179.914 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.66 32.67 18.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.399 -0.819 . . . . 1.26 111.501 179.31 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.2 mt -86.41 148.57 25.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.442 -0.345 . . . . 0.32000000000000001 110.431 179.656 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.777 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.38 114.86 61.4 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.074 0.464 . . . . 0.57999999999999996 110.714 -179.742 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -58.9 140.53 95.62 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.926 2.417 . . . . 0.66000000000000003 112.024 179.882 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.06 21.3 74.14 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.044 -0.823 . . . . 0.28999999999999998 111.044 179.861 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.441 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -127.0 150.14 49.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.942 0.401 . . . . 2.3300000000000001 110.528 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.489 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.13 131.67 45.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.878 -0.601 . . . . 0.85999999999999999 109.78 179.316 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.962 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.54 148.36 43.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.1 -0.5 . . . . 0.52000000000000002 111.035 -179.852 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.4 mt -105.39 125.33 60.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.221 -1.029 . . . . 0.29999999999999999 108.221 177.793 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.55 132.51 63.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.157 0.503 . . . . 0.23000000000000001 111.228 -178.642 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.43 122.65 20.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.492 -0.776 . . . . 0.35999999999999999 109.602 179.253 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.588 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.07 125.44 55.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.224 -0.444 . . . . 0.19 110.581 -179.53 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.9 m-85 -117.3 137.9 52.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.923 -0.581 . . . . 0.29999999999999999 109.85 179.479 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.432 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.9 pt20 -100.72 135.12 42.67 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.71 -0.848 . . . . 0.37 108.71 178.911 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.588 ' O ' ' N ' ' A' ' 140' ' ' SER . 85.2 mt -99.13 122.97 51.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.131 0.491 . . . . 0.26000000000000001 110.977 -178.826 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.0 p -83.87 169.74 14.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.498 -0.774 . . . . 0.28000000000000003 110.478 -179.672 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.472 ' O ' ' CG2' ' A' ' 59' ' ' THR . 97.4 mt-10 -59.81 -14.45 14.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.056 -0.52 . . . . 1.6000000000000001 111.027 -179.571 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 96.7 m-20 -96.16 -4.25 42.98 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.791 -0.364 . . . . 1.1799999999999999 110.842 -179.781 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.407 ' HA2' ' OG1' ' A' ' 59' ' ' THR . . . 87.83 13.84 64.02 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.362 -0.695 . . . . 0.29999999999999999 111.362 179.879 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -84.64 139.16 32.25 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.047 -0.261 . . . . 1.22 110.391 179.769 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.635 ' OE1' ' NE ' ' A' ' 143' ' ' ARG . 18.8 mt-30 -106.79 141.06 38.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.41 -0.359 . . . . 0.97999999999999998 110.469 179.788 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.68 127.08 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.82999999999999996 110.33 179.872 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.21 117.25 9.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.327 -0.397 . . . . 0.26000000000000001 110.518 -179.918 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -108.99 -21.81 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.29999999999999999 110.739 -179.711 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -157.0 125.75 5.81 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.48 -0.488 . . . . 0.31 111.458 -179.847 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.473 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.66 120.21 21.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.69 -0.686 . . . . 0.28000000000000003 109.591 179.208 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.61 151.71 29.15 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.543 -0.463 . . . . 0.23999999999999999 110.875 -179.294 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.44 158.62 18.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.035 -0.53 . . . . 0.23000000000000001 110.452 179.686 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -146.13 157.89 43.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.14 -0.482 . . . . 0.67000000000000004 110.656 179.99 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.18 104.36 9.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.755 -0.657 . . . . 0.64000000000000001 110.03 179.584 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.959 -1.02 . . . . 1.26 110.52 -179.656 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.1 m . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.188 -0.671 . . . . 3.4399999999999999 109.188 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.7 18.53 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.927 -0.869 . . . . 1.22 110.927 179.8 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -35.62 142.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.046 0 C-N-CA 123.991 3.127 . . . . 0.75 113.793 -179.239 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -80.09 173.51 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.184 -1.371 . . . . 0.79000000000000004 108.815 178.476 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.614 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.63 125.89 51.51 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.381 -0.527 . . . . 1.9399999999999999 111.351 -179.51 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.5 144.02 33.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.698 -0.683 . . . . 0.59999999999999998 110.65 179.838 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.09 168.3 25.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.972 0.415 . . . . 3.1400000000000001 111.09 -179.715 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.741 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.88 131.01 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.974 -0.557 . . . . 3.23 110.102 179.884 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.2 p -141.16 162.29 35.83 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.815 0.34 . . . . 3.6299999999999999 111.252 -179.951 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 96.9 mt-10 36.1 31.57 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.618 -0.512 . . . . 6.0800000000000001 109.618 179.828 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.741 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.53 32.5 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.975 -0.557 . . . . 3.3799999999999999 111.609 -178.782 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.643 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.29 -29.04 72.66 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.395 2.063 . . . . 3.9300000000000002 111.893 179.322 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.643 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 3.3599999999999999 110.464 179.949 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.543 ' O ' ' O ' ' A' ' 92' ' ' THR . 10.5 mp0 -123.9 158.32 60.41 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.366 -0.379 . . . . 3.6099999999999999 110.515 179.956 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.699 ' CG ' ' NH1' ' A' ' 143' ' ' ARG . 97.7 Cg_endo -82.08 -64.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.926 2.417 . . . . 1.51 113.461 -178.994 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 62' ' ' GLY . 20.5 t-20 -108.42 -19.66 13.38 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.097 0.406 . . . . 2.6800000000000002 112.097 -178.504 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 36.4 m -107.32 152.09 24.6 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.45 -0.5 . . . . 1.21 111.345 -179.425 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.578 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.3 102.93 2.22 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.722 -0.672 . . . . 1.5600000000000001 110.649 179.877 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.7 145.64 12.98 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.871 2.381 . . . . 0.81000000000000005 112.635 179.967 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.916 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.77 167.95 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 1.52 109.922 179.609 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.22 147.89 28.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.743 -0.466 . . . . 2.1400000000000001 109.743 178.879 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.584 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.23 157.29 45.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.054 0.454 . . . . 0.32000000000000001 111.206 179.95 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.503 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.8 m-20 -127.99 155.21 44.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.818 -0.628 . . . . 2.1699999999999999 110.149 178.971 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.842 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.56 173.12 6.26 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.155 -0.475 . . . . 0.58999999999999997 110.795 -179.296 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.842 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.73 173.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.842 0 C-N-CA 122.884 2.389 . . . . 0.90000000000000002 111.494 179.425 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.484 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -51.02 0.69 Allowed Pre-proline 0 C--N 1.328 -0.354 0 C-N-CA 120.671 -0.412 . . . . 3.3399999999999999 110.158 179.815 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.641 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.83 152.3 82.64 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.786 2.324 . . . . 1.8500000000000001 111.454 179.139 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.68 42.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.403 0.621 . . . . 2.54 110.588 -179.906 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.641 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.6 t60 -63.54 -41.66 98.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.976 -1.011 . . . . 2.5299999999999998 110.648 179.721 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.561 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.6 mt -109.89 137.83 40.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.738 -0.665 . . . . 1.1699999999999999 111.286 -179.398 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.99 -72.92 0.7 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.055 -0.521 . . . . 1.27 111.816 -178.922 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.15 148.34 24.47 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.59 0.589 . . . . 1.1200000000000001 112.59 -179.599 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.8 124.85 45.15 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.385 -0.598 . . . . 0.41999999999999998 109.385 177.474 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 mt -117.98 134.69 60.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.669 -0.412 . . . . 0.78000000000000003 110.698 179.973 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.916 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -119.98 128.6 53.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.294 -0.412 . . . . 0.62 111.287 179.765 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.54 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.06 139.0 49.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.758 -0.656 . . . . 1.97 110.153 178.992 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.44 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.12 163.16 35.16 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 121.105 0.479 . . . . 0.34999999999999998 112.045 -178.126 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.495 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.44 139.57 7.89 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.417 -0.811 . . . . 1.8 110.493 178.857 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.46 115.43 3.02 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.336 2.024 . . . . 0.57999999999999996 111.773 179.97 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.675 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.92 81.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.884 -0.414 . . . . 3.04 109.884 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.697 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.2 -20.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.012 -0.54 . . . . 2.4700000000000002 111.893 -179.517 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.5 157.92 34.73 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.815 -0.354 . . . . 2.5099999999999998 110.565 179.7 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.407 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 16.0 m -120.5 27.85 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.145 -0.479 . . . . 1.8600000000000001 110.081 179.616 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -75.96 1.31 Allowed Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.165 -0.541 . . . . 1.4399999999999999 111.764 -179.234 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.79 152.17 35.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.846 0.355 . . . . 4.6900000000000004 111.025 -179.253 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.672 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.14 -169.14 2.55 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.127 -0.488 . . . . 1.4299999999999999 112.021 179.324 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.1 149.63 29.76 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.455 0.645 . . . . 1.74 112.597 -177.864 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.06 156.48 46.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.835 -1.075 . . . . 1.9199999999999999 110.272 178.648 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.25 158.23 41.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.984 -0.553 . . . . 0.34000000000000002 111.835 -179.319 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.1 m -115.08 135.65 53.98 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.461 -0.79 . . . . 0.40999999999999998 109.795 179.307 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.584 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.38 121.95 23.79 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.462 -0.335 . . . . 0.55000000000000004 111.5 -179.136 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.592 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.1 Cg_exo -46.32 151.66 1.65 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.63 2.22 . . . . 0.44 112.111 178.979 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.88 -23.06 63.03 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 116.055 -0.52 . . . . 0.73999999999999999 112.817 -179.211 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.69 -16.97 46.13 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.278 -0.569 . . . . 0.93000000000000005 111.829 -178.391 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.592 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.6 mt -91.53 138.44 31.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.795 -0.362 . . . . 0.96999999999999997 110.333 179.388 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -121.6 13.97 10.94 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.366 -0.379 . . . . 1.3400000000000001 111.467 -179.331 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.0 143.43 25.17 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.665 -0.414 . . . . 0.39000000000000001 111.011 179.64 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.724 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.81 -169.36 1.53 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.204 0.526 . . . . 0.41999999999999998 110.852 -179.478 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.724 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.3 m -151.77 125.96 9.28 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.373 -0.83 . . . . 0.39000000000000001 109.782 179.249 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.518 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.2 mt -114.82 123.15 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.467 -0.493 . . . . 0.73999999999999999 111.255 -179.798 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.53 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 64.7 pttt -126.38 163.39 23.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.87 -0.604 . . . . 2.48 110.5 179.682 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.503 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.11 19.07 59.75 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.699 -0.96 . . . . 0.5 110.699 179.987 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.518 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.2 mt -79.11 157.24 28.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.091 0.472 . . . . 0.57999999999999996 111.342 -179.637 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.841 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -99.56 134.06 21.42 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.611 -0.722 . . . . 2.79 110.442 179.792 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.96 143.55 60.83 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.554 2.169 . . . . 0.87 111.98 179.851 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.97 25.51 75.49 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.043 -0.823 . . . . 0.64000000000000001 111.043 179.689 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.841 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.18 158.82 40.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.697 0.284 . . . . 0.82999999999999996 110.404 -179.593 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.18 139.89 42.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.922 0.391 . . . . 0.5 110.556 -179.692 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.648 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.53 136.53 54.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.046 -0.525 . . . . 0.53000000000000003 110.762 -179.931 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.495 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.98 131.04 45.33 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.456 -0.942 . . . . 1.8700000000000001 108.456 177.701 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.45 153.91 16.64 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.391 -0.909 . . . . 0.28999999999999998 111.971 -178.588 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -135.07 141.0 45.99 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.595 -0.52 . . . . 1.4299999999999999 109.595 179.593 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.2 tp -115.76 118.87 34.25 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.469 -0.492 . . . . 0.32000000000000001 110.496 179.686 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.725 HG12 HG23 ' A' ' 84' ' ' VAL . 63.8 mt -112.44 129.05 68.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.373 -0.376 . . . . 0.79000000000000004 110.613 -179.918 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.699 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.85 120.73 43.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.235 -0.439 . . . . 1.02 110.724 -179.655 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.857 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.54 146.59 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.22 0.533 . . . . 0.62 111.01 -179.281 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.621 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.08 153.87 21.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.458 -0.792 . . . . 2.4399999999999999 109.95 179.859 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.2 88.56 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.896 0.379 . . . . 3.6899999999999999 110.361 -179.702 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.33 32.72 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.79 -0.641 . . . . 6.0800000000000001 110.532 -179.99 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.18 -117.4 3.28 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.388 -0.685 . . . . 1.22 111.388 -179.712 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -81.39 177.36 9.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.206 0.527 . . . . 2.8799999999999999 111.625 -179.182 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.1 149.51 32.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.397 -0.82 . . . . 1.47 110.404 179.178 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.23 144.66 38.56 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.463 -0.335 . . . . 2.7000000000000002 110.532 179.857 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.725 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.05 135.94 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 121.077 0.465 . . . . 0.46000000000000002 111.497 -179.711 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.01 141.38 52.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.663 -0.699 . . . . 0.34999999999999998 110.259 179.637 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.64 138.81 51.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.159 0.504 . . . . 3.6699999999999999 111.499 -179.348 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.19 164.23 37.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.563 -0.744 . . . . 0.67000000000000004 109.503 179.317 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.567 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.31 151.48 38.39 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.406 -0.518 . . . . 1.47 111.05 179.967 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.801 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.5 p90 -146.15 172.69 13.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.725 -0.671 . . . . 0.44 111.062 179.856 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.69 160.73 21.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.452 -0.795 . . . . 1.3700000000000001 109.874 179.61 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.37 121.89 22.99 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.637 -0.425 . . . . 1.28 110.737 179.985 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.543 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.5 p -127.47 163.63 23.67 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.185 0.809 . . . . 1.97 113.185 179.638 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.519 ' OG ' ' OH ' ' A' ' 157' ' ' TYR . 40.1 t . . . . . 0 C--O 1.232 0.152 0 CA-C-N 114.407 -1.269 . . . . 3.2799999999999998 110.636 178.848 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.402 ' O ' HD12 ' A' ' 172' ' ' LEU . 4.9 p . . . . . 0 N--CA 1.463 0.212 0 CA-C-O 120.682 0.277 . . . . 0.66000000000000003 110.781 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.444 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.82 167.57 0.25 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.017 -0.538 . . . . 0.68999999999999995 110.925 -179.593 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.57 145.56 50.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.656 -0.702 . . . . 0.52000000000000002 110.073 -179.918 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.29 101.62 9.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.146 -0.687 . . . . 0.32000000000000001 109.146 177.609 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.1 t -112.84 139.74 36.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.896 -0.593 . . . . 0.28999999999999998 111.038 -178.851 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.6 p -128.76 152.66 48.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.622 -0.717 . . . . 0.25 109.743 179.528 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.588 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.85 -164.97 2.04 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.659 -0.416 . . . . 0.31 110.621 -179.808 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.744 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.8 t -123.9 127.18 73.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.193 -0.458 . . . . 0.48999999999999999 110.787 -179.805 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.17 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.96 58.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 1.53 110.316 179.792 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.744 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.07 24.44 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.873 -0.603 . . . . 0.96999999999999997 111.614 -179.772 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.17 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.14 128.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.685 -0.406 . . . . 1.5600000000000001 111.023 179.896 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.43 -9.57 56.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.891 -0.595 . . . . 1.8799999999999999 110.359 179.817 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.06 0.3 55.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.037 -0.529 . . . . 1.04 110.446 179.839 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.23 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.904 -0.589 . . . . 0.23999999999999999 110.038 179.665 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.592 ' N ' ' O ' ' A' ' 185' ' ' ILE . 91.9 p -96.31 -15.41 21.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.29 0.567 . . . . 0.28999999999999998 109.987 -179.577 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.59 175.52 45.74 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.758 -1.337 . . . . 0.13 109.758 179.688 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.43 151.64 42.45 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.607 -0.437 . . . . 0.17000000000000001 110.462 179.687 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.906 ' NH1' HE22 ' A' ' 191' ' ' GLN . 52.0 ttp180 -132.35 121.1 22.98 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.111 -0.495 . . . . 1.29 109.937 179.787 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.563 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.07 136.58 38.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.678 -0.692 . . . . 0.25 110.66 -179.747 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.592 ' OE2' ' OH ' ' A' ' 157' ' ' TYR . 84.7 tt0 -129.38 129.85 45.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.942 -0.572 . . . . 1.3200000000000001 110.079 -179.912 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.7 p90 -138.68 135.26 34.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.051 -0.522 . . . . 0.56999999999999995 110.635 -179.63 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.419 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.33 161.28 40.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.776 -0.647 . . . . 1.1599999999999999 109.697 179.877 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.959 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.4 mt -71.0 124.81 25.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.993 0.425 . . . . 0.38 110.793 -179.648 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.482 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.7 p -71.82 -7.7 49.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.758 -0.655 . . . . 0.40999999999999998 110.807 -179.678 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -109.81 -69.62 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.398 -0.365 . . . . 1.6599999999999999 111.427 -179.351 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.438 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.68 -35.32 75.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.116 -0.493 . . . . 1.6599999999999999 111.521 -179.105 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.084 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.05 7.3 88.54 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.812 -0.915 . . . . 1.1699999999999999 110.812 -179.796 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.312 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.96 -171.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.851 0.358 . . . . 1.8600000000000001 110.282 179.84 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.312 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.31 139.19 45.01 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.01 0.434 . . . . 1.98 110.158 179.628 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.419 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.4 Cg_endo -70.96 145.74 50.96 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 122.707 2.271 . . . . 0.55000000000000004 112.381 -179.591 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.72 145.73 42.5 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.368 -0.604 . . . . 1.1399999999999999 109.368 179.148 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.592 ' OH ' ' OE2' ' A' ' 145' ' ' GLU . 89.9 m-85 -123.27 141.41 52.01 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.335 -0.546 . . . . 0.93000000000000005 111.491 -179.074 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.8 mt -128.17 127.66 43.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.302 -0.863 . . . . 0.34000000000000002 108.882 178.975 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -101.62 131.12 48.01 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.137 0.494 . . . . 1.0900000000000001 111.782 -178.785 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.93 157.5 73.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.349 -0.842 . . . . 0.19 109.533 179.776 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -69.89 158.01 58.22 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.403 2.069 . . . . 0.17999999999999999 112.184 179.951 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.29 -12.14 5.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.704 -0.68 . . . . 0.20999999999999999 110.785 -179.778 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.8 p -92.73 -8.84 42.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.083 -0.508 . . . . 0.28999999999999998 110.75 -179.978 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.18 135.41 34.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.5 110.358 179.739 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.11 16.67 4.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.29999999999999999 110.556 179.933 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.5 p -167.54 147.17 5.09 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.65 -0.5 . . . . 0.23000000000000001 109.65 179.899 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.563 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.3 150.44 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.52 -0.472 . . . . 0.28000000000000003 111.591 -179.648 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.508 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.25 125.03 50.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.597 -0.729 . . . . 1.0700000000000001 109.776 179.562 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.46 104.88 29.93 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.43 -0.35 . . . . 0.28999999999999998 111.021 -179.883 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.9 Cg_endo -91.01 -179.4 1.47 Allowed 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 123.088 2.526 . . . . 0.42999999999999999 112.229 179.856 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.56 32.7 18.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.359 -0.837 . . . . 1.26 111.461 179.311 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 126' ' ' SER . 24.1 mt -86.34 148.57 25.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.472 -0.331 . . . . 0.32000000000000001 110.437 179.547 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.772 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.31 114.88 61.41 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.002 0.429 . . . . 0.57999999999999996 110.644 -179.757 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.07 140.55 95.71 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.883 2.389 . . . . 0.66000000000000003 111.94 179.835 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.17 21.07 74.37 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.047 -0.821 . . . . 0.28999999999999998 111.047 179.835 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.438 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.76 150.14 49.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.341 . . . . 2.3300000000000001 110.673 -179.984 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.482 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.14 131.58 46.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.138 -0.483 . . . . 0.85999999999999999 109.878 179.252 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.959 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.1 m-85 -120.44 148.25 44.05 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.192 -0.458 . . . . 0.52000000000000002 111.107 -179.817 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.7 mt -105.33 125.41 60.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.252 -1.018 . . . . 0.29999999999999999 108.252 177.749 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.59 132.58 63.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.185 0.516 . . . . 0.23000000000000001 111.266 -178.645 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.53 122.61 20.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.608 -0.724 . . . . 0.35999999999999999 109.621 179.303 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.588 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.04 125.35 54.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.169 -0.469 . . . . 0.19 110.707 -179.535 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.4 m-85 -117.17 137.93 52.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.017 -0.538 . . . . 0.29999999999999999 109.876 179.526 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.432 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.69 135.0 42.82 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.783 -0.821 . . . . 0.37 108.783 178.864 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.592 ' O ' ' N ' ' A' ' 140' ' ' SER . 82.7 mt -99.17 123.05 51.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.153 0.501 . . . . 0.26000000000000001 110.898 -178.78 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.4 p -83.89 169.72 14.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.498 -0.773 . . . . 0.28000000000000003 110.477 -179.719 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.81 -14.47 15.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.985 -0.552 . . . . 1.6000000000000001 111.051 -179.589 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.482 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.7 m-20 -96.04 -4.31 43.28 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.842 -0.343 . . . . 1.1799999999999999 110.812 -179.855 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.699 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.82 13.85 64.02 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.341 -0.703 . . . . 0.29999999999999999 111.341 179.858 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -84.59 139.07 32.35 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.121 -0.231 . . . . 1.22 110.479 179.699 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.906 HE22 ' NH1' ' A' ' 143' ' ' ARG . 78.2 mt-30 -106.77 141.02 38.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.875 0.369 . . . . 0.97999999999999998 110.499 179.843 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.67 126.98 26.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.82999999999999996 110.481 179.844 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.407 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.02 117.34 9.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.362 -0.381 . . . . 0.26000000000000001 110.492 -179.839 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.17 -21.7 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.465 . . . . 0.29999999999999999 110.685 -179.762 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.92 125.63 5.81 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.601 -0.44 . . . . 0.31 111.537 -179.783 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.47 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.68 120.26 21.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.726 -0.67 . . . . 0.28000000000000003 109.547 179.188 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.65 29.04 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.606 -0.438 . . . . 0.23999999999999999 110.893 -179.273 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.44 158.61 18.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.23000000000000001 110.345 179.752 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -146.11 157.96 43.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.055 -0.52 . . . . 0.67000000000000004 110.642 179.954 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.29 104.44 9.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.817 -0.629 . . . . 0.64000000000000001 110.012 179.558 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 117.942 -1.027 . . . . 1.26 110.56 -179.631 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.1 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.261 -0.644 . . . . 3.4399999999999999 109.261 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.39 150.71 18.53 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.078 -0.809 . . . . 1.22 111.078 179.649 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -35.63 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.066 0 C-N-CA 124.013 3.142 . . . . 0.75 113.743 -179.134 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.62 HG12 ' H ' ' A' ' 5' ' ' GLU . 15.9 t -79.84 173.32 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.289 -1.323 . . . . 0.79000000000000004 108.916 178.341 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.62 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.52 125.82 51.42 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.476 -0.489 . . . . 1.9399999999999999 111.47 -179.626 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 144.06 33.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.739 -0.664 . . . . 0.59999999999999998 110.606 179.84 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.36 25.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.898 0.38 . . . . 3.1400000000000001 111.149 -179.705 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.737 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.4 mt -109.01 131.13 60.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.968 -0.56 . . . . 3.23 110.03 179.921 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 69.3 p -141.26 162.42 35.53 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.894 0.378 . . . . 3.6299999999999999 111.122 -179.915 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 32.5 tp10 36.07 31.57 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 109.631 -0.507 . . . . 6.0800000000000001 109.631 179.843 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.737 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.5 69.62 33.32 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.939 -0.573 . . . . 3.3799999999999999 111.611 -178.8 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.641 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.31 -29.14 72.55 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.437 2.092 . . . . 3.9300000000000002 111.753 179.391 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.641 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.7 125.57 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 3.3599999999999999 110.469 179.997 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.583 ' O ' ' O ' ' A' ' 92' ' ' THR . 3.7 mp0 -123.99 158.36 60.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 3.6099999999999999 110.415 -179.979 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.55 ' HG3' ' NH1' ' A' ' 143' ' ' ARG . 97.1 Cg_endo -82.04 -64.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.92 2.413 . . . . 1.51 113.483 -178.96 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.444 ' H ' ' HG2' ' A' ' 15' ' ' PRO . 98.7 m-20 -108.39 -19.61 13.4 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.097 0.406 . . . . 2.6800000000000002 112.097 -178.501 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 63.1 m -107.47 152.11 24.66 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.403 -0.519 . . . . 1.21 111.248 -179.361 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.579 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.27 102.83 2.23 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.654 -0.703 . . . . 1.5600000000000001 110.692 179.922 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.69 145.71 13.03 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.818 2.345 . . . . 0.81000000000000005 112.561 -179.984 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.918 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.79 167.9 24.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.805 -0.634 . . . . 1.52 109.883 179.604 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -149.1 148.04 29.21 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.757 -0.46 . . . . 2.1400000000000001 109.757 178.821 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.7 p90 -142.37 157.28 44.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.036 0.446 . . . . 0.32000000000000001 111.163 179.933 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.497 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -128.01 155.27 44.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.77 -0.65 . . . . 2.1699999999999999 110.102 178.999 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.822 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.56 173.0 6.4 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 121.118 0.485 . . . . 0.58999999999999997 110.73 -179.204 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.822 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.61 173.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.844 2.363 . . . . 0.90000000000000002 111.532 179.303 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.485 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -51.09 0.69 Allowed Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.714 -0.394 . . . . 3.3399999999999999 110.048 179.926 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.62 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.81 152.34 82.49 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.721 2.28 . . . . 1.8500000000000001 111.527 179.147 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.65 42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.362 0.601 . . . . 2.54 110.599 -179.915 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.62 ' H ' ' C ' ' A' ' 27' ' ' PRO . 74.2 t60 -63.52 -41.62 98.48 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.963 -1.017 . . . . 2.5299999999999998 110.725 179.661 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.557 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.5 mt -109.89 137.92 39.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.756 -0.656 . . . . 1.1699999999999999 111.287 -179.44 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.12 -72.84 0.71 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.097 -0.502 . . . . 1.27 111.839 -178.911 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.34 24.45 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.575 0.583 . . . . 1.1200000000000001 112.575 -179.633 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.89 124.88 45.14 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.267 -0.642 . . . . 0.41999999999999998 109.267 177.556 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.1 134.75 60.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.545 -0.462 . . . . 0.78000000000000003 110.648 179.926 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.918 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.01 128.67 53.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.058 0.456 . . . . 0.62 111.247 179.781 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 139.02 49.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.729 -0.668 . . . . 1.97 110.062 179.012 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.439 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.11 163.21 35.0 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.443 -0.503 . . . . 0.34999999999999998 112.058 -178.114 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.51 139.51 7.8 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.533 -0.758 . . . . 1.8 110.45 178.909 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.51 115.47 3.05 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.327 2.018 . . . . 0.57999999999999996 111.803 179.968 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.67 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.99 81.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.902 -0.407 . . . . 3.04 109.902 -179.878 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.693 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.19 -20.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.954 -0.567 . . . . 2.4700000000000002 111.919 -179.549 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 p -157.55 157.8 34.43 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.856 -0.338 . . . . 2.5099999999999998 110.626 179.726 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.401 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.37 27.85 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.27 -0.423 . . . . 1.8600000000000001 110.195 179.527 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.84 -75.91 1.31 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.036 -0.602 . . . . 1.4399999999999999 111.811 -179.255 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.83 152.41 35.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.982 0.42 . . . . 4.6900000000000004 110.991 -179.351 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.637 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.28 -169.19 2.54 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.075 -0.511 . . . . 1.4299999999999999 112.007 179.413 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.6 mttp -110.06 149.6 29.78 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.43 0.633 . . . . 1.74 112.595 -177.86 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.08 156.41 46.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.815 -1.084 . . . . 1.9199999999999999 110.214 178.679 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.457 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.16 158.42 41.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.934 -0.576 . . . . 0.34000000000000002 111.788 -179.353 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.2 135.58 54.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.46 -0.791 . . . . 0.40999999999999998 109.809 179.317 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.596 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.38 121.96 23.8 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.429 -0.351 . . . . 0.55000000000000004 111.528 -179.149 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.606 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.3 Cg_exo -46.31 151.63 1.65 Allowed 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.694 2.263 . . . . 0.44 112.145 178.977 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.81 -23.09 62.91 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 116.043 -0.526 . . . . 0.73999999999999999 112.814 -179.277 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.5 p-80 -82.81 -16.81 46.34 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.192 -0.603 . . . . 0.93000000000000005 111.809 -178.323 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.606 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.6 mt -91.67 138.4 31.59 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.719 -0.392 . . . . 0.96999999999999997 110.266 179.395 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.48 13.96 11.04 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.334 -0.393 . . . . 1.3400000000000001 111.501 -179.369 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -150.04 143.52 25.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.633 -0.427 . . . . 0.39000000000000001 111.029 179.525 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.717 ' CE2' ' O ' ' A' ' 59' ' ' THR . 65.0 t80 -114.8 -169.37 1.53 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.019 -0.537 . . . . 0.41999999999999998 110.815 -179.373 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.717 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.79 125.95 9.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.343 -0.844 . . . . 0.39000000000000001 109.852 179.21 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.513 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.3 mt -114.91 123.24 70.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.369 -0.532 . . . . 0.73999999999999999 111.192 -179.73 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.786 ' NZ ' ' N ' ' A' ' 141' ' ' GLY . 98.4 mttt -126.49 163.41 23.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.812 -0.631 . . . . 2.48 110.514 179.673 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.08 19.05 59.83 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.774 -0.93 . . . . 0.5 110.774 -179.845 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.513 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.6 mt -79.06 157.25 28.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.107 0.48 . . . . 0.57999999999999996 111.4 -179.717 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.859 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -99.46 133.93 21.57 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.635 -0.712 . . . . 2.79 110.466 179.774 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.89 143.53 61.19 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.599 2.2 . . . . 0.87 111.971 179.81 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.89 25.57 75.41 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.045 -0.822 . . . . 0.64000000000000001 111.045 179.722 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.859 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.14 158.74 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.653 0.263 . . . . 0.82999999999999996 110.459 -179.636 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.07 139.95 41.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.986 0.422 . . . . 0.5 110.553 -179.772 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.638 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.64 136.47 54.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.914 -0.584 . . . . 0.53000000000000003 110.788 -179.955 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.97 130.98 45.36 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.516 -0.92 . . . . 1.8700000000000001 108.516 177.741 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.487 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.44 153.89 16.63 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.306 -0.95 . . . . 0.28999999999999998 111.947 -178.556 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -135.03 141.0 46.07 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.739 -0.467 . . . . 1.4299999999999999 109.739 179.503 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.522 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.83 118.95 34.43 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.422 -0.511 . . . . 0.32000000000000001 110.354 179.831 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 84' ' ' VAL . 64.1 mt -112.48 129.11 68.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.79000000000000004 110.625 -179.97 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.707 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.86 120.75 43.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.324 -0.398 . . . . 1.02 110.737 -179.663 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.866 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.47 146.52 11.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.18 0.514 . . . . 0.62 111.068 -179.292 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.623 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.08 153.89 21.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.56 -0.746 . . . . 2.4399999999999999 109.861 179.877 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.22 88.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.742 -0.383 . . . . 3.6899999999999999 110.426 -179.772 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.14 32.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.807 -0.633 . . . . 6.0800000000000001 110.545 -179.905 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.22 -117.37 3.27 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.391 -0.683 . . . . 1.22 111.391 -179.77 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -81.4 177.44 8.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.202 0.525 . . . . 2.8799999999999999 111.587 -179.111 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.16 149.48 32.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.428 -0.805 . . . . 1.47 110.488 179.09 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.15 144.69 38.73 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.499 -0.318 . . . . 2.7000000000000002 110.556 179.874 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.727 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.99 136.09 61.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 120.577 -0.449 . . . . 0.46000000000000002 111.544 -179.795 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.11 141.3 52.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.607 -0.724 . . . . 0.34999999999999998 110.244 179.664 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.466 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.4 ttp180 -117.59 138.84 51.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.166 0.508 . . . . 3.6699999999999999 111.486 -179.379 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.487 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.24 164.11 38.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.501 -0.772 . . . . 0.67000000000000004 109.475 179.338 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.13 151.56 38.68 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.456 -0.498 . . . . 1.47 111.122 179.918 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.14 172.75 12.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.812 -0.631 . . . . 0.44 111.02 179.875 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.82 160.77 21.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.418 -0.81 . . . . 1.3700000000000001 109.841 179.512 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.38 121.9 22.98 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.591 -0.444 . . . . 1.28 110.748 -179.991 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.583 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.6 p -128.81 167.19 17.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.048 -0.524 . . . . 1.97 112.286 179.676 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 C--N 1.331 -0.225 0 N-CA-C 109.001 -0.74 . . . . 3.2799999999999998 109.001 177.431 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.8 p . . . . . 0 CA--C 1.523 -0.062 0 CA-C-O 121.112 0.482 . . . . 0.66000000000000003 110.121 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.441 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.94 167.51 0.27 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.621 -0.718 . . . . 0.68999999999999995 110.99 179.693 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.49 145.6 50.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.731 -0.668 . . . . 0.52000000000000002 110.139 -179.902 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.36 101.77 9.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.076 -0.713 . . . . 0.32000000000000001 109.076 177.675 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.5 t -113.01 139.74 36.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.589 . . . . 0.28999999999999998 110.946 -178.758 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.6 p -128.75 152.6 48.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.61 -0.723 . . . . 0.25 109.837 179.532 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.588 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.82 -164.99 2.04 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.672 -0.411 . . . . 0.31 110.653 -179.727 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.732 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.9 t -123.94 127.13 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.48999999999999999 110.834 -179.821 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.167 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.125 -0.489 . . . . 1.53 110.316 179.841 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.09 24.39 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.9 -0.591 . . . . 0.96999999999999997 111.481 -179.698 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.167 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.25 128.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.587 -0.445 . . . . 1.5600000000000001 110.902 179.883 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.46 -9.66 55.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.92 -0.582 . . . . 1.8799999999999999 110.246 179.78 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.1 0.31 55.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.123 -0.489 . . . . 1.04 110.35 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.26 137.07 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.984 -0.553 . . . . 0.23999999999999999 109.982 179.624 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.725 ' C ' ' HZ2' ' A' ' 61' ' ' LYS . 10.1 p -96.21 -15.48 22.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.233 0.539 . . . . 0.28999999999999998 110.028 -179.648 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.786 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.59 175.54 45.76 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.711 -1.355 . . . . 0.13 109.711 179.659 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -123.42 151.66 42.41 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.635 -0.426 . . . . 0.17000000000000001 110.556 179.637 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.72 ' NH1' ' CE1' ' A' ' 157' ' ' TYR . 38.9 ttp85 -132.44 121.17 22.99 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.125 -0.489 . . . . 1.29 109.881 179.845 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 167' ' ' VAL . 46.0 t -105.0 136.51 38.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.646 -0.706 . . . . 0.25 110.728 -179.77 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 78.5 tt0 -129.36 129.95 45.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.015 -0.539 . . . . 1.3200000000000001 110.006 -179.919 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.84 135.26 34.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.044 -0.525 . . . . 0.56999999999999995 110.525 -179.679 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.416 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.41 39.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.633 -0.712 . . . . 1.1599999999999999 109.665 179.805 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.953 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 85.7 mt -71.09 124.86 25.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.952 0.406 . . . . 0.38 110.676 -179.536 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.71 -7.77 50.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.717 -0.674 . . . . 0.40999999999999998 110.874 -179.815 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.73 -69.65 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 1.6599999999999999 111.464 -179.284 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.451 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.63 -35.45 76.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.015 -0.539 . . . . 1.6599999999999999 111.461 -179.168 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.089 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.18 7.24 88.59 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.748 -0.941 . . . . 1.1699999999999999 110.748 -179.836 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.326 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.97 -171.73 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.689 0.28 . . . . 1.8600000000000001 110.294 179.848 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.326 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.22 139.12 45.3 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.945 0.402 . . . . 1.98 110.172 179.666 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.416 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.7 Cg_endo -70.94 145.84 51.39 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 C-N-CA 122.725 2.283 . . . . 0.55000000000000004 112.303 -179.537 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.9 145.75 42.63 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.234 -0.654 . . . . 1.1399999999999999 109.234 179.183 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.72 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 94.1 m-85 -123.28 141.35 52.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.25 0.547 . . . . 0.93000000000000005 111.478 -179.047 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.9 mt -128.14 127.73 43.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.274 -0.876 . . . . 0.34000000000000002 108.892 178.942 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 27.8 t0 -101.59 131.18 47.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.165 0.507 . . . . 1.0900000000000001 111.733 -178.772 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.491 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -128.0 157.53 73.6 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.348 -0.842 . . . . 0.19 109.571 179.645 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -69.76 158.03 58.35 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.395 2.063 . . . . 0.17999999999999999 112.245 179.927 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.32 -12.13 5.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.753 -0.658 . . . . 0.20999999999999999 110.732 -179.852 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.1 p -92.8 -8.77 42.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 0.28999999999999998 110.743 -179.959 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.39 34.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.314 -0.403 . . . . 0.5 110.429 179.686 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.5 p -133.1 16.68 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.401 -0.363 . . . . 0.29999999999999999 110.532 -179.988 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.7 p -167.55 147.13 5.08 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.614 -0.514 . . . . 0.23000000000000001 109.614 179.905 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.2 150.48 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.565 -0.454 . . . . 0.28000000000000003 111.619 -179.664 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.36 124.96 50.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.618 -0.719 . . . . 1.0700000000000001 109.783 179.536 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.48 104.93 30.28 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.907 0.384 . . . . 0.28999999999999998 111.03 -179.835 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.1 Cg_endo -91.05 -179.49 1.48 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 123.155 2.57 . . . . 0.42999999999999999 112.172 179.922 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.66 32.64 18.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.329 -0.851 . . . . 1.26 111.489 179.306 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.3 mt -86.34 148.46 25.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.49 -0.323 . . . . 0.32000000000000001 110.467 179.611 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.764 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.25 114.87 61.36 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.042 0.448 . . . . 0.57999999999999996 110.706 -179.799 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.07 140.58 95.84 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.754 2.303 . . . . 0.66000000000000003 112.025 179.864 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.2 21.16 74.08 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.027 -0.829 . . . . 0.28999999999999998 111.027 179.857 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.451 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.9 150.18 49.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 2.3300000000000001 110.606 -179.941 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.491 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.1 tttt -100.11 131.68 45.92 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.85999999999999999 109.82 179.282 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.953 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.54 148.35 43.97 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.118 -0.492 . . . . 0.52000000000000002 110.991 -179.824 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.31 125.31 60.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.228 -1.027 . . . . 0.29999999999999999 108.228 177.767 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.55 132.46 63.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.053 0.454 . . . . 0.23000000000000001 111.284 -178.646 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.46 122.66 20.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.566 -0.743 . . . . 0.35999999999999999 109.613 179.299 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.588 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.05 125.36 54.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.271 -0.422 . . . . 0.19 110.694 -179.496 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.6 m-85 -117.25 137.88 52.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.041 -0.527 . . . . 0.29999999999999999 109.828 179.583 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.421 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.69 135.01 42.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.798 -0.815 . . . . 0.37 108.798 178.861 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.683 HG21 ' HE2' ' A' ' 61' ' ' LYS . 14.0 mt -99.14 122.97 51.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.095 0.474 . . . . 0.26000000000000001 110.931 -178.734 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.3 p -83.79 169.7 14.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.497 -0.774 . . . . 0.28000000000000003 110.499 -179.675 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -59.71 -14.65 15.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.047 -0.524 . . . . 1.6000000000000001 111.018 -179.663 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -95.91 -4.39 43.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.828 0.347 . . . . 1.1799999999999999 110.902 -179.819 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.79 13.97 63.87 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.301 -0.719 . . . . 0.29999999999999999 111.301 179.919 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -84.63 139.11 32.29 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.059 -0.256 . . . . 1.22 110.465 179.585 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.715 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 85.9 mt-30 -106.75 141.08 38.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.893 0.378 . . . . 0.97999999999999998 110.543 179.723 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.0 m -136.7 126.99 26.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.062 -0.517 . . . . 0.82999999999999996 110.373 179.938 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.23 117.38 9.97 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.644 -0.422 . . . . 0.26000000000000001 110.537 -179.923 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.02 -21.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.29999999999999999 110.746 -179.754 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.89 125.72 5.86 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.519 -0.472 . . . . 0.31 111.496 -179.776 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.47 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.83 120.25 21.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.772 -0.649 . . . . 0.28000000000000003 109.574 179.143 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.72 29.13 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.568 -0.453 . . . . 0.23999999999999999 110.806 -179.224 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.8 p -110.47 158.53 18.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.953 -0.567 . . . . 0.23000000000000001 110.447 179.681 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -145.98 157.97 43.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.102 -0.499 . . . . 0.67000000000000004 110.644 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.34 104.35 9.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.733 -0.667 . . . . 0.64000000000000001 109.986 179.558 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.862 -1.066 . . . . 1.26 110.599 -179.656 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.224 -0.658 . . . . 3.4399999999999999 109.224 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.7 18.54 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.023 -0.831 . . . . 1.22 111.023 179.73 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -35.61 142.41 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.048 0 C-N-CA 123.914 3.076 . . . . 0.75 113.826 -179.203 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.606 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.95 173.44 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.204 -1.362 . . . . 0.79000000000000004 108.817 178.425 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.606 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.69 125.89 51.52 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.433 -0.507 . . . . 1.9399999999999999 111.368 -179.536 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.49 143.96 34.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.682 -0.69 . . . . 0.59999999999999998 110.702 179.865 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.03 168.38 25.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.923 0.392 . . . . 3.1400000000000001 111.044 -179.684 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.746 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -109.03 131.11 60.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.963 -0.562 . . . . 3.23 110.067 179.888 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 69.0 p -141.24 162.41 35.55 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.871 0.367 . . . . 3.6299999999999999 111.121 -179.872 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.3 mt-10 36.03 31.49 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.631 -0.507 . . . . 6.0800000000000001 109.631 179.862 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.746 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.3 69.56 31.1 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.971 -0.559 . . . . 3.3799999999999999 111.663 -178.809 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.37 -29.02 71.92 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.467 2.112 . . . . 3.9300000000000002 111.822 179.46 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 3.3599999999999999 110.477 179.98 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.612 ' O ' ' O ' ' A' ' 92' ' ' THR . 3.2 mp0 -123.89 158.41 60.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 3.6099999999999999 110.447 179.941 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.523 ' CG ' ' NH1' ' A' ' 143' ' ' ARG . 98.6 Cg_endo -82.17 -64.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.866 2.378 . . . . 1.51 113.46 -178.981 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.692 ' CG ' ' CE1' ' A' ' 157' ' ' TYR . 50.0 t30 -108.44 -19.52 13.43 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.11 0.411 . . . . 2.6800000000000002 112.11 -178.536 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.536 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 99.0 p -107.34 152.1 24.6 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.452 -0.499 . . . . 1.21 111.281 -179.418 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.0 t-80 -155.36 102.83 2.21 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.696 -0.684 . . . . 1.5600000000000001 110.676 179.885 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.574 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.3 Cg_endo -82.56 145.6 13.19 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.814 2.343 . . . . 0.81000000000000005 112.675 179.904 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.903 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.81 167.89 24.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.894 -0.594 . . . . 1.52 109.862 179.561 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.1 148.0 29.16 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.737 -0.468 . . . . 2.1400000000000001 109.737 178.866 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.582 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.8 p90 -142.24 157.25 45.05 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.659 -0.416 . . . . 0.32000000000000001 111.16 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.496 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.02 155.3 44.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.823 -0.626 . . . . 2.1699999999999999 110.122 178.905 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.835 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.63 173.07 6.32 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.135 -0.484 . . . . 0.58999999999999997 110.777 -179.184 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.835 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.75 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.907 2.405 . . . . 0.90000000000000002 111.502 179.429 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.485 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -51.05 0.69 Allowed Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.679 -0.408 . . . . 3.3399999999999999 110.171 179.797 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.639 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.85 152.35 82.47 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.7 2.267 . . . . 1.8500000000000001 111.481 179.169 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.74 42.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.357 0.599 . . . . 2.54 110.525 -179.808 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.639 ' N ' ' O ' ' A' ' 27' ' ' PRO . 74.0 t60 -63.67 -41.61 98.15 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.052 -0.976 . . . . 2.5299999999999998 110.639 179.735 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.557 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.3 mt -109.85 137.84 40.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.784 -0.644 . . . . 1.1699999999999999 111.224 -179.449 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.93 -72.9 0.7 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.027 -0.533 . . . . 1.27 111.953 -179.069 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.17 148.37 24.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.588 0.588 . . . . 1.1200000000000001 112.588 -179.649 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.85 124.91 45.25 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.346 -0.613 . . . . 0.41999999999999998 109.346 177.498 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.04 134.65 60.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.646 -0.422 . . . . 0.78000000000000003 110.662 -179.997 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.903 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.98 128.67 53.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.994 0.426 . . . . 0.62 111.261 179.742 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.21 138.94 49.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.787 -0.642 . . . . 1.97 110.096 179.018 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.441 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.04 163.1 35.27 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.166 0.508 . . . . 0.34999999999999998 112.083 -178.083 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.495 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.46 139.67 7.92 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.406 -0.815 . . . . 1.8 110.451 178.766 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.696 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.2 Cg_endo -63.57 115.51 3.09 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.279 1.986 . . . . 0.57999999999999996 111.801 -179.972 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.667 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.99 81.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.87 -0.419 . . . . 3.04 109.87 -179.865 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.696 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.19 -20.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.981 -0.554 . . . . 2.4700000000000002 111.895 -179.548 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 p -157.58 157.82 34.42 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.784 -0.367 . . . . 2.5099999999999998 110.548 179.782 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.408 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.42 27.84 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 1.8600000000000001 110.138 179.575 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.78 -75.82 1.31 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.181 -0.533 . . . . 1.4399999999999999 111.895 -179.294 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.93 152.34 35.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.983 0.42 . . . . 4.6900000000000004 110.912 -179.327 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.67 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.31 -169.13 2.52 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.049 -0.523 . . . . 1.4299999999999999 111.939 179.318 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.441 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.1 149.62 29.78 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.464 0.649 . . . . 1.74 112.571 -177.811 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.01 156.47 46.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.851 -1.068 . . . . 1.9199999999999999 110.268 178.637 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.2 158.39 41.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.993 -0.549 . . . . 0.34000000000000002 111.766 -179.336 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.6 m -115.2 135.58 54.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.415 -0.811 . . . . 0.40999999999999998 109.834 179.296 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.582 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.39 121.94 23.78 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.479 -0.328 . . . . 0.55000000000000004 111.527 -179.11 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.593 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.9 Cg_exo -46.36 151.75 1.65 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.632 2.221 . . . . 0.44 112.168 179.017 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.99 -23.04 63.24 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 116.039 -0.528 . . . . 0.73999999999999999 112.755 -179.108 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.73 -16.96 46.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.35 0.575 . . . . 0.93000000000000005 111.778 -178.345 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.593 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.49 138.42 31.59 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.779 -0.368 . . . . 0.96999999999999997 110.299 179.342 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -121.55 13.91 10.97 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.333 -0.394 . . . . 1.3400000000000001 111.468 -179.382 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -149.99 143.5 25.24 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.589 -0.444 . . . . 0.39000000000000001 111.026 179.56 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.726 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.81 -169.33 1.53 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.199 0.523 . . . . 0.41999999999999998 110.845 -179.396 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.726 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.74 125.99 9.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.39 -0.823 . . . . 0.39000000000000001 109.832 179.236 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.518 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.8 mt -114.95 123.29 70.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.383 -0.527 . . . . 0.73999999999999999 111.17 -179.758 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -126.5 163.33 23.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.849 -0.614 . . . . 2.48 110.529 179.687 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.522 ' CA ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.2 19.07 59.61 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.685 -0.966 . . . . 0.5 110.685 -179.972 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.626 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 74.0 mt -79.14 157.27 27.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.138 0.494 . . . . 0.57999999999999996 111.286 -179.604 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.835 ' O ' HG12 ' A' ' 67' ' ' VAL . 13.2 mptt -99.57 134.03 21.43 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.551 -0.749 . . . . 2.79 110.393 179.85 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.98 143.55 60.76 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.554 2.169 . . . . 0.87 111.88 179.871 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.85 25.71 75.24 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.972 -0.851 . . . . 0.64000000000000001 110.972 179.685 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.835 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.3 p -128.23 158.77 40.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.597 0.237 . . . . 0.82999999999999996 110.434 -179.658 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.07 139.98 41.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.875 0.369 . . . . 0.5 110.623 -179.824 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.643 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.7 m-85 -122.67 136.47 54.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.897 -0.592 . . . . 0.53000000000000003 110.76 -179.918 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.495 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.5 pt-20 -98.91 131.01 45.32 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.524 -0.917 . . . . 1.8700000000000001 108.524 177.656 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.48 153.85 16.65 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.29 -0.957 . . . . 0.28999999999999998 111.935 -178.585 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -134.98 140.95 46.1 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.716 -0.476 . . . . 1.4299999999999999 109.716 179.537 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.73 118.98 34.56 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.406 -0.518 . . . . 0.32000000000000001 110.486 179.705 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.74 HG12 HG23 ' A' ' 84' ' ' VAL . 64.1 mt -112.51 129.03 68.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.909 0.385 . . . . 0.79000000000000004 110.583 -179.878 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.705 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.85 120.82 43.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.299 -0.409 . . . . 1.02 110.701 -179.646 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.855 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.57 146.53 11.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.118 0.485 . . . . 0.62 110.977 -179.227 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.626 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.09 153.85 21.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.483 -0.78 . . . . 2.4399999999999999 109.974 179.8 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.22 88.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.965 0.412 . . . . 3.6899999999999999 110.444 -179.689 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.31 32.62 0.21 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.806 -0.634 . . . . 6.0800000000000001 110.561 -179.936 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.3 3.29 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.496 -0.642 . . . . 1.22 111.496 -179.804 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.48 177.38 8.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.146 0.498 . . . . 2.8799999999999999 111.623 -179.203 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.14 149.54 32.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.411 -0.813 . . . . 1.47 110.459 179.145 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.16 144.62 38.67 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.477 -0.329 . . . . 2.7000000000000002 110.54 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.74 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -127.98 135.98 61.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 121.092 0.472 . . . . 0.46000000000000002 111.573 -179.81 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.08 141.35 52.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.664 -0.698 . . . . 0.34999999999999998 110.279 179.62 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.447 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.65 138.93 51.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.105 0.479 . . . . 3.6699999999999999 111.5 -179.368 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.38 164.04 38.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.526 -0.761 . . . . 0.67000000000000004 109.516 179.417 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.572 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.18 151.56 38.62 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.415 -0.514 . . . . 1.47 111.092 -179.995 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.8 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.24 172.71 13.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.759 -0.655 . . . . 0.44 111.039 179.875 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.73 160.69 21.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.455 -0.793 . . . . 1.3700000000000001 109.777 179.658 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.37 121.9 22.99 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.636 -0.426 . . . . 1.28 110.764 179.91 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.612 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -127.61 167.98 15.63 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.675 0.621 . . . . 1.97 112.675 179.679 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.7 m . . . . . 0 N--CA 1.463 0.212 0 CA-C-N 115.195 -0.911 . . . . 3.2799999999999998 109.997 179.225 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 31.6 p . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 121.749 0.785 . . . . 0.66000000000000003 109.0 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.442 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.92 167.62 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.025 -0.989 . . . . 0.68999999999999995 110.907 179.873 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.8 m-30 -133.68 145.47 49.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.672 -0.694 . . . . 0.52000000000000002 110.102 -179.894 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.19 101.76 9.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.108 -0.701 . . . . 0.32000000000000001 109.108 177.702 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.3 t -113.04 139.71 36.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.045 -0.525 . . . . 0.28999999999999998 110.966 -178.76 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.0 p -128.64 152.54 48.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.544 -0.753 . . . . 0.25 109.869 179.622 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.588 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.88 -165.01 2.05 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.769 -0.372 . . . . 0.31 110.64 -179.788 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.3 t -123.91 127.13 73.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.281 -0.418 . . . . 0.48999999999999999 110.922 -179.839 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.171 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.96 58.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.115 -0.493 . . . . 1.53 110.333 179.921 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.26 24.62 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.949 -0.569 . . . . 0.96999999999999997 111.456 -179.592 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.171 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.14 128.62 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.624 -0.43 . . . . 1.5600000000000001 110.998 179.897 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.39 -9.65 55.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.96 -0.564 . . . . 1.8799999999999999 110.267 179.804 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.7 p -87.11 0.28 55.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 1.04 110.341 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 136' ' ' SER . 2.6 p -65.23 137.19 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.949 -0.569 . . . . 0.23999999999999999 109.981 179.63 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 185' ' ' ILE . 7.8 m -96.29 -15.45 21.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.132 0.492 . . . . 0.28999999999999998 110.006 -179.738 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.62 175.59 45.82 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 109.838 -1.305 . . . . 0.13 109.838 179.61 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.45 151.59 42.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.002 0.429 . . . . 0.17000000000000001 110.437 179.775 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.523 ' NH1' ' CG ' ' A' ' 15' ' ' PRO . 23.9 ttp85 -132.33 121.09 22.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.168 -0.469 . . . . 1.29 109.988 179.751 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -104.99 136.53 38.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.742 -0.663 . . . . 0.25 110.703 -179.749 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 82.6 tt0 -129.35 129.96 45.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.05 -0.523 . . . . 1.3200000000000001 110.042 -179.932 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.77 135.25 34.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.053 -0.521 . . . . 0.56999999999999995 110.615 -179.67 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.412 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.27 161.35 39.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.809 -0.632 . . . . 1.1599999999999999 109.629 179.847 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.959 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.01 124.82 25.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.994 0.426 . . . . 0.38 110.804 -179.721 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.77 -7.64 49.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.719 -0.673 . . . . 0.40999999999999998 110.891 -179.754 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -109.87 -69.76 0.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.932 0.396 . . . . 1.6599999999999999 111.306 -179.189 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.437 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.6 -35.4 76.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.06 -0.518 . . . . 1.6599999999999999 111.486 -179.094 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.077 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.2 88.62 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.787 -0.925 . . . . 1.1699999999999999 110.787 -179.811 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.339 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.3 t0 -27.93 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.814 0.34 . . . . 1.8600000000000001 110.218 179.873 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.339 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.2 pm0 -82.24 139.07 45.22 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 1.98 110.214 179.626 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.412 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.1 Cg_endo -70.85 145.85 51.91 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.652 2.235 . . . . 0.55000000000000004 112.368 -179.56 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.87 145.7 42.64 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.231 -0.655 . . . . 1.1399999999999999 109.231 179.18 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.692 ' CE1' ' CG ' ' A' ' 16' ' ' ASN . 1.7 p90 -123.21 141.24 52.18 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.401 -0.52 . . . . 0.93000000000000005 111.577 -179.099 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.0 mt -128.05 127.78 43.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.311 -0.858 . . . . 0.34000000000000002 108.945 178.903 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.492 ' HB2' HD21 ' A' ' 16' ' ' ASN . 18.0 t0 -101.67 131.13 48.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.155 0.502 . . . . 1.0900000000000001 111.742 -178.728 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.94 157.56 73.41 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.294 -0.866 . . . . 0.19 109.53 179.682 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -69.69 157.94 58.79 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 C-N-CA 122.491 2.127 . . . . 0.17999999999999999 112.252 179.908 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.417 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.4 p -59.22 -12.14 4.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.786 -0.643 . . . . 0.20999999999999999 110.775 -179.91 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.2 p -92.86 -8.74 42.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.28999999999999998 110.704 -179.859 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.27 135.35 34.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.5 110.345 179.76 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.15 16.72 4.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.418 -0.355 . . . . 0.29999999999999999 110.515 179.967 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.1 p -167.53 147.06 5.07 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.617 -0.512 . . . . 0.23000000000000001 109.617 179.927 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.22 150.5 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.485 -0.486 . . . . 0.28000000000000003 111.55 -179.707 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.506 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.27 124.95 50.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.525 -0.762 . . . . 1.0700000000000001 109.818 179.49 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.37 104.94 29.92 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.476 -0.329 . . . . 0.28999999999999998 111.092 -179.921 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 84.8 Cg_endo -91.07 -179.47 1.47 Allowed 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 123.19 2.594 . . . . 0.42999999999999999 112.169 179.93 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.62 32.68 18.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.369 -0.832 . . . . 1.26 111.477 179.247 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 172' ' ' LEU . 23.8 mt -86.34 148.39 25.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.432 -0.349 . . . . 0.32000000000000001 110.47 179.6 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.772 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.16 114.78 60.88 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.964 0.411 . . . . 0.57999999999999996 110.734 -179.778 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.92 140.44 95.25 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.925 2.417 . . . . 0.66000000000000003 112.005 179.844 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.16 21.25 73.97 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.005 -0.838 . . . . 0.28999999999999998 111.005 179.832 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.437 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.94 150.21 49.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.879 0.371 . . . . 2.3300000000000001 110.623 179.931 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.491 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.23 131.61 46.08 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.013 -0.54 . . . . 0.85999999999999999 109.786 179.365 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.959 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.4 148.32 43.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.076 -0.511 . . . . 0.52000000000000002 111.066 -179.842 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.35 125.29 60.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.228 -1.027 . . . . 0.29999999999999999 108.228 177.796 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.52 132.57 63.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.136 0.493 . . . . 0.23000000000000001 111.204 -178.61 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.52 122.46 20.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.468 -0.787 . . . . 0.35999999999999999 109.636 179.324 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.588 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.03 125.33 54.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.274 -0.421 . . . . 0.19 110.694 -179.521 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.6 m-85 -117.18 137.89 52.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.97 -0.559 . . . . 0.29999999999999999 109.87 179.562 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.424 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.75 135.05 42.8 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.756 -0.831 . . . . 0.37 108.756 178.863 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.588 ' O ' ' N ' ' A' ' 140' ' ' SER . 76.7 mt -99.04 122.96 51.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.062 0.458 . . . . 0.26000000000000001 110.89 -178.715 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.3 p -83.98 169.7 14.73 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.574 -0.739 . . . . 0.28000000000000003 110.455 -179.7 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 187' ' ' GLU . 51.8 tp10 -59.7 -14.56 14.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.067 -0.515 . . . . 1.6000000000000001 110.967 -179.535 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.574 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.9 m-20 -96.06 -4.26 43.29 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.845 -0.342 . . . . 1.1799999999999999 110.792 -179.815 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.473 ' HA2' ' OG1' ' A' ' 59' ' ' THR . . . 87.78 13.89 64.02 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.383 -0.687 . . . . 0.29999999999999999 111.383 179.903 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -84.73 139.15 32.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.644 0.259 . . . . 1.22 110.394 179.766 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -106.83 141.14 38.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.97999999999999998 110.496 179.781 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.5 m -136.75 127.06 26.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.506 . . . . 0.82999999999999996 110.411 179.903 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.22 117.27 9.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.297 -0.41 . . . . 0.26000000000000001 110.499 -179.822 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -108.96 -21.89 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.29999999999999999 110.676 -179.709 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.89 125.68 5.84 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.456 -0.497 . . . . 0.31 111.516 -179.77 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.471 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.68 120.25 21.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.721 -0.672 . . . . 0.28000000000000003 109.516 179.231 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.56 151.73 29.21 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.7 -0.4 . . . . 0.23999999999999999 110.933 -179.321 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.47 158.61 18.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 0.23000000000000001 110.393 179.677 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -146.06 157.92 43.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.103 -0.499 . . . . 0.67000000000000004 110.702 179.919 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.17 104.39 9.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.82 -0.627 . . . . 0.64000000000000001 110.009 179.524 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.5 p . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 117.95 -1.024 . . . . 1.26 110.585 -179.744 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.548 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.9 m . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.223 -0.658 . . . . 3.4399999999999999 109.223 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.45 150.68 18.53 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.023 -0.831 . . . . 1.22 111.023 179.755 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.69 142.34 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.056 0 C-N-CA 124.067 3.178 . . . . 0.75 113.761 -179.199 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.605 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.89 173.47 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.194 -1.366 . . . . 0.79000000000000004 108.893 178.389 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.605 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.61 125.89 51.51 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.406 -0.518 . . . . 1.9399999999999999 111.349 -179.548 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 144.07 33.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.636 -0.711 . . . . 0.59999999999999998 110.662 179.75 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.02 168.32 25.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.404 -0.362 . . . . 3.1400000000000001 111.104 -179.649 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.749 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.98 131.08 60.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.925 -0.58 . . . . 3.23 110.06 179.869 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.26 162.26 35.92 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.882 0.372 . . . . 3.6299999999999999 111.209 -179.916 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 34.3 tp10 36.2 31.54 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.648 -0.501 . . . . 6.0800000000000001 109.648 179.85 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.749 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.5 69.57 33.2 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.982 -0.554 . . . . 3.3799999999999999 111.468 -178.644 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.28 -29.09 72.71 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.432 2.088 . . . . 3.9300000000000002 111.845 179.346 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 3.3599999999999999 110.472 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.535 ' CB ' ' O ' ' A' ' 17' ' ' SER . 7.7 mp0 -123.93 158.39 60.27 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.311 -0.404 . . . . 3.6099999999999999 110.441 179.99 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HB3' ' CB ' ' A' ' 93' ' ' SER . 98.1 Cg_endo -82.19 -64.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.941 2.427 . . . . 1.51 113.444 -178.991 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.664 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 41.2 t30 -108.48 -19.52 13.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.322 -0.399 . . . . 2.6800000000000002 112.07 -178.513 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.535 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 12.6 t -107.4 152.01 24.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.19 0.519 . . . . 1.21 111.252 -179.339 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.25 102.92 2.23 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.712 -0.676 . . . . 1.5600000000000001 110.67 179.796 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.584 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.4 Cg_endo -82.59 145.65 13.16 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.878 2.385 . . . . 0.81000000000000005 112.666 179.871 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.9 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.88 167.99 24.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.892 -0.594 . . . . 1.52 109.859 179.591 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -149.18 147.91 28.99 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.783 -0.451 . . . . 2.1400000000000001 109.783 178.954 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.579 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.7 p90 -142.29 157.25 45.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.027 0.442 . . . . 0.32000000000000001 111.183 179.976 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.495 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -127.96 155.26 44.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.796 -0.638 . . . . 2.1699999999999999 110.133 178.969 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.833 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.56 173.02 6.37 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 121.074 0.464 . . . . 0.58999999999999997 110.758 -179.223 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.833 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.61 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.888 0 C-N-CA 122.88 2.387 . . . . 0.90000000000000002 111.517 179.304 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.486 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -51.08 0.69 Allowed Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 120.706 -0.398 . . . . 3.3399999999999999 110.089 179.813 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.64 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.86 152.39 82.38 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.7 2.267 . . . . 1.8500000000000001 111.474 179.243 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.73 42.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.42 0.629 . . . . 2.54 110.576 -179.869 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.64 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.9 t60 -63.57 -41.67 98.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.941 -1.027 . . . . 2.5299999999999998 110.653 179.689 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.553 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.6 mt -109.87 137.77 40.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.771 -0.649 . . . . 1.1699999999999999 111.327 -179.426 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.85 -72.95 0.7 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.106 -0.497 . . . . 1.27 111.925 -179.007 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.21 148.43 24.38 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.549 0.574 . . . . 1.1200000000000001 112.549 -179.55 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.8 124.85 45.16 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.3 -0.63 . . . . 0.41999999999999998 109.3 177.563 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.3 mt -117.95 134.7 60.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.721 -0.391 . . . . 0.78000000000000003 110.654 179.905 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.9 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.99 128.7 53.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.065 0.46 . . . . 0.62 111.269 179.634 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.26 138.96 49.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.707 -0.679 . . . . 1.97 110.125 178.966 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.441 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.01 163.11 35.21 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.118 0.485 . . . . 0.34999999999999998 112.146 -178.065 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.46 139.59 7.88 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.515 -0.766 . . . . 1.8 110.504 178.815 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.58 115.53 3.1 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.31 2.007 . . . . 0.57999999999999996 111.733 -179.946 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.01 81.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.888 -0.412 . . . . 3.04 109.888 -179.926 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.17 -20.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.93 -0.577 . . . . 2.4700000000000002 111.97 -179.558 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.8 p -157.65 157.81 34.29 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.813 0.34 . . . . 2.5099999999999998 110.579 179.745 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.43 27.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 1.8600000000000001 110.233 179.58 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.84 -75.87 1.31 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.126 -0.559 . . . . 1.4399999999999999 111.864 -179.261 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.89 152.34 35.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.988 0.423 . . . . 4.6900000000000004 110.953 -179.353 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.672 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.24 -169.17 2.54 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.029 -0.532 . . . . 1.4299999999999999 111.919 179.37 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.441 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.1 149.65 29.73 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.395 0.617 . . . . 1.74 112.63 -177.88 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.06 156.5 45.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.842 -1.072 . . . . 1.9199999999999999 110.226 178.659 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.22 158.34 41.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.906 -0.588 . . . . 0.34000000000000002 111.785 -179.261 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 m -115.17 135.58 54.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.515 -0.766 . . . . 0.40999999999999998 109.716 179.382 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.579 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.36 121.9 23.8 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 0.55000000000000004 111.574 -179.229 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.597 ' HD2' HD12 ' A' ' 55' ' ' LEU . 73.8 Cg_exo -46.3 151.71 1.62 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.684 2.256 . . . . 0.44 112.046 179.042 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.91 -23.01 63.03 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 116.046 -0.524 . . . . 0.73999999999999999 112.796 -179.233 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.84 -16.81 46.25 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.251 -0.579 . . . . 0.93000000000000005 111.823 -178.329 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.597 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.67 138.46 31.55 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.684 -0.406 . . . . 0.96999999999999997 110.289 179.37 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -121.58 14.04 10.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.369 -0.378 . . . . 1.3400000000000001 111.588 -179.394 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.48 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -150.07 143.5 25.16 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.601 -0.44 . . . . 0.39000000000000001 111.003 179.579 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.725 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.85 -169.4 1.54 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.188 0.518 . . . . 0.41999999999999998 110.869 -179.405 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.725 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.9 m -151.74 125.92 9.27 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.43 -0.805 . . . . 0.39000000000000001 109.807 179.277 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.86 123.28 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.369 -0.533 . . . . 0.73999999999999999 111.243 -179.798 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -126.53 163.34 23.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.885 -0.598 . . . . 2.48 110.442 179.76 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.442 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.08 19.08 59.77 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.733 -0.947 . . . . 0.5 110.733 -179.89 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.664 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.7 mt -79.01 157.21 28.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.032 0.444 . . . . 0.57999999999999996 111.36 -179.64 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.841 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.9 mmtt -99.5 133.93 21.54 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.691 -0.686 . . . . 2.79 110.522 179.716 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.581 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.86 143.57 61.5 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.491 2.128 . . . . 0.87 112.007 179.854 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.89 25.66 75.3 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.997 -0.841 . . . . 0.64000000000000001 110.997 179.694 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.841 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.22 158.72 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.649 0.262 . . . . 0.82999999999999996 110.398 -179.55 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.11 139.88 42.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.846 0.355 . . . . 0.5 110.644 -179.79 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.642 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.6 m-85 -122.51 136.48 54.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.973 -0.558 . . . . 0.53000000000000003 110.8 -179.883 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.5 pt-20 -98.96 131.06 45.31 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.462 -0.94 . . . . 1.8700000000000001 108.462 177.699 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.47 153.92 16.64 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.341 -0.933 . . . . 0.28999999999999998 111.944 -178.616 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -134.98 140.95 46.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.706 -0.479 . . . . 1.4299999999999999 109.706 179.559 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.85 118.93 34.35 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.427 -0.509 . . . . 0.32000000000000001 110.531 179.616 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.744 HG12 HG23 ' A' ' 84' ' ' VAL . 63.8 mt -112.46 129.08 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.79000000000000004 110.676 -179.942 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.706 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.77 120.8 43.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.215 -0.448 . . . . 1.02 110.732 -179.639 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.857 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.56 146.43 11.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.163 0.506 . . . . 0.62 111.06 -179.261 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.626 ' O ' ' N ' ' A' ' 79' ' ' TYR . 20.9 mt-30 -105.98 153.88 21.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.528 -0.76 . . . . 2.4399999999999999 109.907 179.845 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.16 88.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.899 0.38 . . . . 3.6899999999999999 110.476 -179.814 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.35 32.54 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.834 -0.621 . . . . 6.0800000000000001 110.628 -179.915 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.08 -117.35 3.29 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.471 -0.652 . . . . 1.22 111.471 -179.652 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.38 177.45 8.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.175 0.512 . . . . 2.8799999999999999 111.609 -179.21 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.2 149.54 32.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.416 -0.811 . . . . 1.47 110.376 179.149 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.548 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.19 144.67 38.64 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.4 -0.364 . . . . 2.7000000000000002 110.574 179.823 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.744 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.0 135.99 61.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 121.037 0.446 . . . . 0.46000000000000002 111.581 -179.79 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.06 141.27 52.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.689 -0.687 . . . . 0.34999999999999998 110.302 179.649 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.453 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.55 138.91 51.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.07 0.462 . . . . 3.6699999999999999 111.535 -179.387 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.31 164.23 37.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.579 -0.737 . . . . 0.67000000000000004 109.494 179.349 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.2 p30 -145.29 151.45 38.36 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.394 -0.523 . . . . 1.47 111.083 -179.952 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.8 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.4 p90 -146.16 172.78 12.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.835 -0.62 . . . . 0.44 111.053 179.84 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.83 160.6 21.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.468 -0.787 . . . . 1.3700000000000001 109.874 179.627 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.33 121.8 22.9 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.685 -0.406 . . . . 1.28 110.745 -179.962 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.7 p -128.68 169.02 14.98 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 115.78 1.77 . . . . 1.97 115.78 179.579 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.52 ' CB ' ' HB3' ' A' ' 15' ' ' PRO . 18.2 t . . . . . 0 N--CA 1.452 -0.373 0 CA-C-N 111.87 -2.423 . . . . 3.2799999999999998 108.603 177.507 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 122.162 0.982 . . . . 0.66000000000000003 110.832 . . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.442 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.85 167.65 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.68 -1.146 . . . . 0.68999999999999995 110.937 -179.264 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.7 145.57 50.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.688 -0.687 . . . . 0.52000000000000002 110.166 -179.962 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.23 101.66 9.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.088 -0.708 . . . . 0.32000000000000001 109.088 177.751 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.2 t -113.02 139.65 37.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.99 -0.55 . . . . 0.28999999999999998 111.066 -178.884 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.2 p -128.63 152.57 48.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.643 -0.708 . . . . 0.25 109.84 179.644 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.589 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.83 -165.07 2.06 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.687 -0.405 . . . . 0.31 110.642 -179.765 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -123.81 127.17 73.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.48999999999999999 110.918 -179.905 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.168 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.96 58.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.198 -0.455 . . . . 1.53 110.346 179.814 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.12 24.46 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.902 -0.59 . . . . 0.96999999999999997 111.515 -179.732 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.168 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.18 128.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.619 -0.432 . . . . 1.5600000000000001 111.011 179.8 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.33 -9.66 55.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.915 -0.584 . . . . 1.8799999999999999 110.353 179.814 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.7 p -87.09 0.3 55.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.095 -0.502 . . . . 1.04 110.337 179.991 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.36 137.24 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.892 -0.594 . . . . 0.23999999999999999 109.936 179.734 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 185' ' ' ILE . 5.4 m -96.26 -15.45 21.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.286 0.565 . . . . 0.28999999999999998 110.12 -179.716 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.58 175.55 45.75 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 109.806 -1.318 . . . . 0.13 109.806 179.593 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.46 151.63 42.52 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.602 -0.439 . . . . 0.17000000000000001 110.558 179.718 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.525 ' NE ' ' OE1' ' A' ' 191' ' ' GLN . 41.9 ttp85 -132.32 121.08 22.99 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.178 -0.464 . . . . 1.29 109.957 179.939 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.1 136.55 38.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.716 -0.674 . . . . 0.25 110.629 -179.708 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 82.7 tt0 -129.4 129.9 45.3 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.939 -0.573 . . . . 1.3200000000000001 110.05 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.4 p90 -138.66 135.27 34.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.957 -0.565 . . . . 0.56999999999999995 110.644 -179.693 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.411 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.35 161.37 39.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.809 -0.632 . . . . 1.1599999999999999 109.747 179.729 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.958 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.02 124.84 25.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.064 0.459 . . . . 0.38 110.716 -179.52 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.65 -7.8 50.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.702 -0.681 . . . . 0.40999999999999998 110.919 -179.818 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.86 -69.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 1.6599999999999999 111.431 -179.257 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.444 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.66 -35.42 76.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.112 -0.495 . . . . 1.6599999999999999 111.491 -179.147 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.081 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.22 88.61 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.799 -0.92 . . . . 1.1699999999999999 110.799 -179.817 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.338 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -28.03 -171.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.762 0.315 . . . . 1.8600000000000001 110.319 179.913 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.338 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.03 45.19 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-O 120.917 0.389 . . . . 1.98 110.213 179.657 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.411 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.7 Cg_endo -70.86 145.83 51.8 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.716 2.277 . . . . 0.55000000000000004 112.394 -179.578 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.9 145.74 42.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.189 -0.671 . . . . 1.1399999999999999 109.189 179.255 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.581 ' CE1' ' HD3' ' A' ' 65' ' ' PRO . 35.3 p90 -123.26 141.39 52.03 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.33 -0.548 . . . . 0.93000000000000005 111.46 -179.062 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.5 mt -128.17 127.68 43.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.271 -0.877 . . . . 0.34000000000000002 108.918 178.919 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.609 ' HB2' ' ND2' ' A' ' 16' ' ' ASN . 38.1 t0 -101.6 131.21 47.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.24 0.543 . . . . 1.0900000000000001 111.702 -178.743 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -128.04 157.43 74.0 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.349 -0.841 . . . . 0.19 109.575 179.677 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.71 157.89 58.93 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 122.406 2.071 . . . . 0.17999999999999999 112.334 179.902 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.18 -12.22 4.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.813 -0.63 . . . . 0.20999999999999999 110.781 -179.799 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.9 p -92.74 -8.79 42.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.042 -0.526 . . . . 0.28999999999999998 110.764 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.21 135.4 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.355 -0.384 . . . . 0.5 110.436 179.691 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.6 p -133.13 16.69 4.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.328 -0.396 . . . . 0.29999999999999999 110.461 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.61 147.12 5.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.697 -0.483 . . . . 0.23000000000000001 109.697 179.838 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.15 150.42 12.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.501 -0.48 . . . . 0.28000000000000003 111.597 -179.533 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.506 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.38 124.92 50.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.62 -0.718 . . . . 1.0700000000000001 109.858 179.469 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.35 104.82 29.17 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.333 -0.394 . . . . 0.28999999999999998 111.077 -179.791 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.4 Cg_endo -90.87 -179.47 1.53 Allowed 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 123.21 2.607 . . . . 0.42999999999999999 112.25 179.882 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.61 32.73 18.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.416 -0.811 . . . . 1.26 111.376 179.224 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.408 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.2 mt -86.36 148.49 25.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.544 -0.298 . . . . 0.32000000000000001 110.45 179.541 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.767 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.33 114.89 61.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.066 0.46 . . . . 0.57999999999999996 110.656 -179.763 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.1 140.64 96.04 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.915 2.41 . . . . 0.66000000000000003 111.982 179.885 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.0 21.28 74.35 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.091 -0.804 . . . . 0.28999999999999998 111.091 179.974 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.444 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.99 150.2 49.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.862 0.363 . . . . 2.3300000000000001 110.587 -179.979 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.493 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.11 131.65 45.93 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.999 -0.546 . . . . 0.85999999999999999 109.794 179.37 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.958 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.56 148.33 44.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.134 -0.484 . . . . 0.52000000000000002 111.011 -179.874 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.38 125.31 60.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.198 -1.038 . . . . 0.29999999999999999 108.198 177.796 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.54 132.56 63.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.119 0.485 . . . . 0.23000000000000001 111.318 -178.694 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.9 m-20 -136.47 122.5 20.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.54 -0.755 . . . . 0.35999999999999999 109.719 179.327 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.589 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.02 125.45 54.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.314 -0.403 . . . . 0.19 110.715 -179.527 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.0 m-85 -117.2 137.87 52.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.04 -0.527 . . . . 0.29999999999999999 109.886 179.574 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.423 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.74 135.13 42.66 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.805 -0.813 . . . . 0.37 108.805 178.82 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.588 ' O ' ' N ' ' A' ' 140' ' ' SER . 88.9 mt -99.16 123.02 51.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.178 0.513 . . . . 0.26000000000000001 110.904 -178.713 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 89.2 p -83.95 169.83 14.63 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.497 -0.774 . . . . 0.28000000000000003 110.432 -179.614 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.448 ' O ' ' OG1' ' A' ' 59' ' ' THR . 97.9 mt-10 -59.77 -14.64 15.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.046 -0.524 . . . . 1.6000000000000001 110.946 -179.598 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 188' ' ' ASP . . . . . 0.605 ' C ' ' OG1' ' A' ' 59' ' ' THR . 96.4 m-20 -96.03 -4.28 43.36 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.778 -0.369 . . . . 1.1799999999999999 110.842 -179.763 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.724 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.8 13.98 63.84 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.376 -0.689 . . . . 0.29999999999999999 111.376 179.875 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -84.69 139.02 32.32 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.781 -0.246 . . . . 1.22 110.386 179.733 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.525 ' OE1' ' NE ' ' A' ' 143' ' ' ARG . 31.7 mt-30 -106.81 141.05 38.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.929 0.395 . . . . 0.97999999999999998 110.511 179.758 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.8 m -136.65 126.94 26.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.82999999999999996 110.45 179.913 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.406 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.06 117.28 9.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.335 -0.393 . . . . 0.26000000000000001 110.527 -179.856 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.03 -21.79 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.29999999999999999 110.752 -179.783 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.85 125.77 5.91 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.519 -0.473 . . . . 0.31 111.488 -179.824 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.47 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.79 120.14 21.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.743 -0.662 . . . . 0.28000000000000003 109.6 179.215 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.58 151.67 29.12 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.715 -0.394 . . . . 0.23999999999999999 111.009 -179.296 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.46 158.61 18.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 0.23000000000000001 110.403 179.704 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -146.02 157.94 43.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.098 -0.501 . . . . 0.67000000000000004 110.669 179.997 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.24 104.29 9.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.743 -0.662 . . . . 0.64000000000000001 110.086 179.482 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.947 -1.025 . . . . 1.26 110.568 -179.687 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.236 -0.653 . . . . 3.4399999999999999 109.236 . . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.73 18.52 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.007 -0.837 . . . . 1.22 111.007 179.708 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.66 142.32 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.06 0 C-N-CA 124.04 3.16 . . . . 0.75 113.729 -179.205 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.86 173.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.189 -1.369 . . . . 0.79000000000000004 108.832 178.402 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.615 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.54 125.8 51.41 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.503 -0.479 . . . . 1.9399999999999999 111.416 -179.569 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 144.01 33.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.731 -0.668 . . . . 0.59999999999999998 110.578 179.886 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.05 168.25 25.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.864 0.364 . . . . 3.1400000000000001 111.139 -179.695 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.745 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.87 131.04 60.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.026 -0.533 . . . . 3.23 110.141 179.877 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.5 p -141.16 162.33 35.73 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.84 0.352 . . . . 3.6299999999999999 111.239 -179.932 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 71.5 tt0 36.05 31.65 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.655 -0.498 . . . . 6.0800000000000001 109.655 179.849 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.745 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.53 69.61 33.56 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.918 -0.583 . . . . 3.3799999999999999 111.533 -178.75 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.639 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.27 -29.23 72.9 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.564 2.176 . . . . 3.9300000000000002 111.772 179.389 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.639 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.73 125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 3.3599999999999999 110.453 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 17' ' ' SER . 19.9 mt-30 -123.86 158.38 60.09 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.376 -0.375 . . . . 3.6099999999999999 110.446 179.939 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.777 ' HG2' ' NE ' ' A' ' 143' ' ' ARG . 97.4 Cg_endo -82.08 -64.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.816 2.344 . . . . 1.51 113.528 -179.029 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.651 ' HB3' ' NH1' ' A' ' 143' ' ' ARG . 16.7 t-20 -108.38 -19.71 13.37 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.041 0.386 . . . . 2.6800000000000002 112.041 -178.498 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 15.1 p -107.28 152.03 24.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.093 0.473 . . . . 1.21 111.347 -179.332 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.581 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.4 t-80 -155.35 102.98 2.22 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.738 -0.664 . . . . 1.5600000000000001 110.558 179.876 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.68 145.67 13.03 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.8 2.333 . . . . 0.81000000000000005 112.675 179.879 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.917 HD11 HD13 ' A' ' 35' ' ' LEU . 7.0 pt -130.84 167.93 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.893 -0.594 . . . . 1.52 109.822 179.618 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.1 147.93 29.08 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.72 -0.474 . . . . 2.1400000000000001 109.72 178.901 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.592 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.4 p90 -142.21 157.29 45.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.948 0.404 . . . . 0.32000000000000001 111.263 179.858 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.491 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.02 155.23 44.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.782 -0.645 . . . . 2.1699999999999999 110.105 178.968 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.825 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.55 173.08 6.3 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.158 -0.474 . . . . 0.58999999999999997 110.845 -179.294 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.825 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.71 173.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.88 2.386 . . . . 0.90000000000000002 111.49 179.412 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.01 -51.03 0.69 Allowed Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 120.578 -0.449 . . . . 3.3399999999999999 110.143 179.856 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.63 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.84 152.37 82.39 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.696 2.264 . . . . 1.8500000000000001 111.455 179.179 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.67 42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.372 0.606 . . . . 2.54 110.584 -179.9 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.63 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.6 t60 -63.49 -41.75 98.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.986 -1.006 . . . . 2.5299999999999998 110.715 179.65 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.554 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.2 mt -109.85 137.82 40.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.708 -0.678 . . . . 1.1699999999999999 111.293 -179.445 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.89 -72.87 0.7 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.001 -0.545 . . . . 1.27 111.923 -178.968 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.2 148.4 24.39 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.557 0.577 . . . . 1.1200000000000001 112.557 -179.62 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -121.88 124.82 45.02 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.349 -0.611 . . . . 0.41999999999999998 109.349 177.527 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.0 134.79 60.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.598 -0.441 . . . . 0.78000000000000003 110.638 179.949 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.917 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.03 128.52 53.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.62 111.323 179.721 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.548 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -130.97 139.01 49.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.78 -0.646 . . . . 1.97 110.097 179.074 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.16 163.08 35.47 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 120.574 -0.45 . . . . 0.34999999999999998 112.072 -178.128 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.39 139.52 7.91 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.474 -0.785 . . . . 1.8 110.542 178.848 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.9 Cg_endo -63.53 115.48 3.07 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.353 2.036 . . . . 0.57999999999999996 111.849 179.954 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.97 81.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.904 -0.406 . . . . 3.04 109.904 -179.859 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.952 -0.567 . . . . 2.4700000000000002 111.835 -179.501 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.6 p -157.57 157.78 34.38 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.878 -0.329 . . . . 2.5099999999999998 110.615 179.793 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.38 27.82 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.236 -0.438 . . . . 1.8600000000000001 110.122 179.568 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.7 -75.99 1.32 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.18 -0.533 . . . . 1.4399999999999999 111.814 -179.223 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.89 152.32 35.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.932 0.396 . . . . 4.6900000000000004 110.963 -179.306 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.03 2.5 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.983 -0.553 . . . . 1.4299999999999999 111.929 179.337 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.2 149.66 29.79 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.512 0.672 . . . . 1.74 112.504 -177.829 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.07 156.47 45.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.764 -1.107 . . . . 1.9199999999999999 110.247 178.609 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.22 158.35 41.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.933 -0.576 . . . . 0.34000000000000002 111.824 -179.341 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.08 135.61 54.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.496 -0.774 . . . . 0.40999999999999998 109.859 179.267 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.592 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.36 121.92 23.81 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.464 -0.335 . . . . 0.55000000000000004 111.6 -179.204 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.4 Cg_exo -46.32 151.74 1.62 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.695 2.263 . . . . 0.44 112.057 179.101 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.03 -22.9 63.18 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 116.035 -0.529 . . . . 0.73999999999999999 112.743 -179.205 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.545 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.86 -16.85 46.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.392 0.596 . . . . 0.93000000000000005 111.746 -178.334 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.601 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.63 138.4 31.59 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.771 -0.372 . . . . 0.96999999999999997 110.293 179.386 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -121.47 13.86 11.03 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.366 -0.379 . . . . 1.3400000000000001 111.549 -179.363 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.477 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.93 143.53 25.31 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.624 -0.43 . . . . 0.39000000000000001 111.008 179.648 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.719 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.84 -169.38 1.54 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.069 -0.514 . . . . 0.41999999999999998 110.875 -179.46 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.719 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 94.7 m -151.8 125.89 9.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.357 -0.838 . . . . 0.39000000000000001 109.882 179.208 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.9 123.28 70.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.365 -0.534 . . . . 0.73999999999999999 111.185 -179.711 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.835 ' NZ ' ' N ' ' A' ' 141' ' ' GLY . 82.1 mttt -126.51 163.38 23.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.839 -0.619 . . . . 2.48 110.469 179.733 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.549 ' HA2' HD22 ' A' ' 16' ' ' ASN . . . 85.17 18.88 60.0 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.723 -0.951 . . . . 0.5 110.723 -179.892 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.514 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.6 mt -78.91 157.19 28.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 0.57999999999999996 111.379 -179.629 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.859 ' O ' HG12 ' A' ' 67' ' ' VAL . 2.3 mttt -99.5 133.92 21.54 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.637 -0.711 . . . . 2.79 110.438 179.781 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.92 143.62 61.34 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.597 2.198 . . . . 0.87 111.941 179.812 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.82 25.52 75.47 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.063 -0.815 . . . . 0.64000000000000001 111.063 179.795 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.859 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.05 158.86 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.763 0.316 . . . . 0.82999999999999996 110.446 -179.631 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.23 139.93 42.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.98 0.419 . . . . 0.5 110.534 -179.786 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.665 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.6 m-85 -122.61 136.44 54.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.932 -0.576 . . . . 0.53000000000000003 110.797 -179.95 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.489 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.9 131.04 45.29 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.528 -0.915 . . . . 1.8700000000000001 108.528 177.684 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.488 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.57 153.9 16.67 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.207 -0.997 . . . . 0.28999999999999998 111.923 -178.541 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -135.01 140.84 45.98 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.73 -0.471 . . . . 1.4299999999999999 109.73 179.646 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.4 tp -115.66 118.89 34.36 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.45 -0.5 . . . . 0.32000000000000001 110.504 179.759 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.736 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.48 129.07 68.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.887 0.375 . . . . 0.79000000000000004 110.646 -179.939 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.75 120.9 43.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.256 -0.429 . . . . 1.02 110.761 -179.726 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.867 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.64 146.37 11.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.159 0.504 . . . . 0.62 111.079 -179.288 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.618 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -105.98 153.85 21.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.559 -0.746 . . . . 2.4399999999999999 109.938 179.884 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.24 88.66 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.995 0.426 . . . . 3.6899999999999999 110.412 -179.73 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.618 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.26 32.55 0.21 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.759 -0.655 . . . . 6.0800000000000001 110.682 -179.912 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.01 -117.26 3.29 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.93 -0.652 . . . . 1.22 111.489 -179.731 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -81.54 177.42 8.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.23 0.538 . . . . 2.8799999999999999 111.537 -179.159 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.15 149.54 32.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.407 -0.815 . . . . 1.47 110.381 179.179 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.19 144.68 38.64 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.462 -0.335 . . . . 2.7000000000000002 110.589 179.829 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.736 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.0 136.04 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.078 0.466 . . . . 0.46000000000000002 111.557 -179.775 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.577 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.07 141.39 52.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.706 -0.679 . . . . 0.34999999999999998 110.257 179.647 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.73 138.88 51.72 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.499 -0.481 . . . . 3.6699999999999999 111.497 -179.32 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.26 164.2 37.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.574 -0.739 . . . . 0.67000000000000004 109.479 179.473 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.577 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.36 151.48 38.34 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.443 -0.503 . . . . 1.47 111.032 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.802 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.13 172.77 12.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.7 -0.682 . . . . 0.44 111.028 179.878 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.86 160.74 21.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.479 -0.782 . . . . 1.3700000000000001 109.861 179.527 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.33 121.83 22.94 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.61 -0.436 . . . . 1.28 110.798 -179.962 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -128.83 154.67 46.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 1.97 111.081 179.652 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 C--N 1.33 -0.239 0 C-N-CA 120.032 -0.667 . . . . 3.2799999999999998 109.479 177.352 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.401 ' O ' HD12 ' A' ' 172' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.719 0 CA-C-O 122.358 1.075 . . . . 0.66000000000000003 111.135 . . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.447 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.81 167.6 0.25 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.397 -1.274 . . . . 0.68999999999999995 110.977 -178.83 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.62 145.51 50.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.691 -0.686 . . . . 0.52000000000000002 110.099 -179.833 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.31 101.62 9.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.075 -0.713 . . . . 0.32000000000000001 109.075 177.707 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.8 t -112.9 139.7 36.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.978 -0.556 . . . . 0.28999999999999998 111.143 -178.915 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.1 p -128.71 152.56 48.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.642 -0.708 . . . . 0.25 109.747 179.681 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.74 -164.9 2.02 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.731 -0.387 . . . . 0.31 110.64 -179.839 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.733 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -124.02 127.12 73.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.156 -0.474 . . . . 0.48999999999999999 110.833 -179.87 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 134' ' ' SER . . . . . 1.148 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.87 58.28 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.102 -0.499 . . . . 1.53 110.351 179.825 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.28 24.69 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.981 -0.554 . . . . 0.96999999999999997 111.535 -179.589 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.148 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.14 128.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.597 -0.441 . . . . 1.5600000000000001 110.907 179.818 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.39 -9.64 55.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.901 -0.591 . . . . 1.8799999999999999 110.255 179.725 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.7 p -86.98 0.23 55.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 1.04 110.338 179.954 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.3 137.31 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 116.0 -0.545 . . . . 0.23999999999999999 110.016 179.775 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.812 ' C ' ' HZ2' ' A' ' 61' ' ' LYS . 5.7 m -96.31 -15.6 21.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.234 0.54 . . . . 0.28999999999999998 109.99 -179.585 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.835 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.63 175.62 45.85 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.821 -1.311 . . . . 0.13 109.821 179.58 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.48 151.57 42.61 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.619 -0.432 . . . . 0.17000000000000001 110.465 179.801 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.777 ' NE ' ' HG2' ' A' ' 15' ' ' PRO . 19.7 ttt85 -132.25 121.22 23.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.131 -0.486 . . . . 1.29 109.96 179.759 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.556 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.13 136.54 38.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.776 -0.647 . . . . 0.25 110.619 -179.703 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 85.2 tt0 -129.36 129.88 45.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.969 -0.56 . . . . 1.3200000000000001 110.001 -179.862 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.619 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.71 135.22 34.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.099 -0.501 . . . . 0.56999999999999995 110.652 -179.673 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.424 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.26 161.44 39.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.809 -0.632 . . . . 1.1599999999999999 109.657 179.834 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.963 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.11 124.87 25.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.935 0.397 . . . . 0.38 110.769 -179.616 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.71 -7.76 50.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.808 -0.633 . . . . 0.40999999999999998 110.837 -179.748 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.83 -69.77 0.85 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.356 -0.384 . . . . 1.6599999999999999 111.394 -179.249 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 1.449 ' CD ' HH21 ' A' ' 176' ' ' ARG . 53.9 mt-10 -60.58 -35.36 75.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.083 -0.508 . . . . 1.6599999999999999 111.57 -179.167 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 1.096 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.18 7.24 88.59 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.839 -0.904 . . . . 1.1699999999999999 110.839 -179.843 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 1.313 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.95 -171.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.756 0.312 . . . . 1.8600000000000001 110.293 179.849 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.313 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.25 139.06 45.15 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.982 0.42 . . . . 1.98 110.182 179.653 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.424 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.87 145.87 51.86 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 C-N-CA 122.694 2.262 . . . . 0.55000000000000004 112.361 -179.553 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.619 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.9 145.74 42.64 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.131 -0.692 . . . . 1.1399999999999999 109.131 179.261 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 143' ' ' ARG . 71.7 m-85 -123.27 141.34 52.08 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.344 -0.542 . . . . 0.93000000000000005 111.552 -179.143 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.5 mt -128.09 127.61 43.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.291 -0.868 . . . . 0.34000000000000002 108.973 178.995 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.604 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 34.6 t0 -101.61 131.22 47.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.088 0.471 . . . . 1.0900000000000001 111.733 -178.741 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.604 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -128.01 157.57 73.49 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.321 -0.854 . . . . 0.19 109.572 179.672 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -69.87 158.04 58.15 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 C-N-CA 122.475 2.117 . . . . 0.17999999999999999 112.153 -179.987 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.34 -12.13 5.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.687 -0.688 . . . . 0.20999999999999999 110.721 -179.779 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.6 p -92.78 -8.79 42.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.28999999999999998 110.709 -179.917 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.38 34.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.5 110.358 179.743 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 p -133.13 16.61 4.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.373 -0.376 . . . . 0.29999999999999999 110.461 -179.986 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.4 p -167.52 147.12 5.09 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.556 -0.535 . . . . 0.23000000000000001 109.556 179.906 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.2 150.44 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.452 -0.499 . . . . 0.28000000000000003 111.592 -179.634 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.502 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.36 125.03 50.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.695 -0.684 . . . . 1.0700000000000001 109.776 179.504 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.4 104.91 29.87 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 0.28999999999999998 111.016 -179.826 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -91.01 -179.52 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 123.189 2.593 . . . . 0.42999999999999999 112.203 179.884 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 61.67 32.6 18.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.409 -0.814 . . . . 1.26 111.497 179.316 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.401 HD12 ' O ' ' A' ' 126' ' ' SER . 24.2 mt -86.37 148.57 25.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.483 -0.326 . . . . 0.32000000000000001 110.485 179.601 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.763 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.4 114.88 61.5 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.048 0.451 . . . . 0.57999999999999996 110.616 -179.657 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.96 140.62 96.11 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.81 2.34 . . . . 0.66000000000000003 111.993 179.825 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.11 21.15 74.34 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.072 -0.811 . . . . 0.28999999999999998 111.072 179.885 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 1.449 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.91 150.16 49.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.351 . . . . 2.3300000000000001 110.632 -179.925 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.493 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.17 131.65 45.99 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.044 -0.525 . . . . 0.85999999999999999 109.804 179.351 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.963 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.7 m-85 -120.61 148.26 44.13 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.187 -0.46 . . . . 0.52000000000000002 110.989 -179.788 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.7 mt -105.22 125.35 60.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.321 -0.992 . . . . 0.29999999999999999 108.321 177.76 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.67 132.57 63.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.218 0.532 . . . . 0.23000000000000001 111.189 -178.581 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.49 122.62 20.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.49 -0.777 . . . . 0.35999999999999999 109.614 179.319 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.2 t -101.15 125.42 55.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.195 -0.457 . . . . 0.19 110.648 -179.514 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 183' ' ' TYR . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.23 137.87 52.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.018 -0.537 . . . . 0.29999999999999999 109.843 179.602 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.42 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.7 135.04 42.78 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.878 -0.786 . . . . 0.37 108.878 178.817 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.605 HG21 ' HE2' ' A' ' 61' ' ' LYS . 68.1 mt -99.1 122.97 51.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.144 0.497 . . . . 0.26000000000000001 110.953 -178.73 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.5 p -83.94 169.68 14.79 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.518 -0.765 . . . . 0.28000000000000003 110.453 -179.636 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.77 -14.46 14.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.094 -0.503 . . . . 1.6000000000000001 110.913 -179.542 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -96.15 -4.33 42.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.773 0.321 . . . . 1.1799999999999999 110.787 -179.796 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.9 13.83 63.9 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.254 -0.738 . . . . 0.29999999999999999 111.254 179.76 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -84.68 139.1 32.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.715 0.293 . . . . 1.22 110.431 179.708 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -106.71 141.05 38.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.929 0.395 . . . . 0.97999999999999998 110.643 179.69 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.71 127.01 26.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.82999999999999996 110.388 179.927 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.1 tp -68.02 117.27 9.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.23 -0.441 . . . . 0.26000000000000001 110.548 -179.928 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 43.9 pt -109.03 -21.88 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.29999999999999999 110.78 -179.753 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.82 125.78 5.93 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.535 -0.466 . . . . 0.31 111.511 -179.846 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.473 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.76 120.16 21.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.801 -0.636 . . . . 0.28000000000000003 109.522 179.218 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.58 151.7 29.17 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.624 -0.43 . . . . 0.23999999999999999 110.873 -179.29 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.5 158.6 18.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.015 -0.538 . . . . 0.23000000000000001 110.41 179.686 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.4 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 68.1 mt-30 -146.09 157.88 43.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.07 -0.513 . . . . 0.67000000000000004 110.677 -179.977 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.23 104.37 9.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.787 -0.642 . . . . 0.64000000000000001 110.011 179.563 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.894 -1.051 . . . . 1.26 110.705 -179.725 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.19 -0.67 . . . . 3.4399999999999999 109.19 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.39 150.7 18.54 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.991 -0.844 . . . . 1.22 110.991 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -35.56 142.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 124.015 3.143 . . . . 0.75 113.76 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.604 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -80.06 173.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.268 -1.333 . . . . 0.79000000000000004 108.802 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.604 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.62 125.86 51.47 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.394 -0.522 . . . . 1.9399999999999999 111.407 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.49 144.02 33.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.662 -0.699 . . . . 0.59999999999999998 110.629 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.03 168.3 25.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.891 0.377 . . . . 3.1400000000000001 111.145 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.742 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.98 131.08 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.01 -0.541 . . . . 3.23 110.074 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.16 162.31 35.78 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.861 0.362 . . . . 3.6299999999999999 111.217 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 9' ' ' THR . 79.8 mm-40 36.07 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.611 -0.514 . . . . 6.0800000000000001 109.611 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.742 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.6 32.57 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.973 -0.558 . . . . 3.3799999999999999 111.6 -178.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.636 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.32 -29.1 72.43 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.487 2.125 . . . . 3.9300000000000002 111.819 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.636 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.64 125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 3.3599999999999999 110.443 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 17' ' ' SER . 2.8 mp0 -123.91 158.29 60.56 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 3.6099999999999999 110.435 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.662 ' HG2' ' NE ' ' A' ' 143' ' ' ARG . 97.7 Cg_endo -82.02 -64.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.94 2.427 . . . . 1.51 113.428 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.538 ' C ' ' OD1' ' A' ' 16' ' ' ASN . 0.2 OUTLIER -108.35 -19.53 13.44 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.067 0.395 . . . . 2.6800000000000002 112.067 -178.495 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 9.8 p -107.31 152.04 24.67 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.484 -0.486 . . . . 1.21 111.338 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.26 102.9 2.23 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.769 -0.65 . . . . 1.5600000000000001 110.675 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.425 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.5 Cg_endo -82.68 145.61 13.01 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.853 2.369 . . . . 0.81000000000000005 112.664 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.916 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.74 167.92 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.899 -0.591 . . . . 1.52 109.919 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.12 147.95 29.09 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.829 -0.434 . . . . 2.1400000000000001 109.829 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.59 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.29 157.29 44.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.972 0.415 . . . . 0.32000000000000001 111.194 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.493 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.05 155.34 44.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.797 -0.638 . . . . 2.1699999999999999 110.092 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.839 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.65 173.05 6.34 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.118 0.485 . . . . 0.58999999999999997 110.743 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.839 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.68 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.873 2.382 . . . . 0.90000000000000002 111.515 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.11 -51.0 0.69 Allowed Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.674 -0.411 . . . . 3.3399999999999999 110.098 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.626 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.84 152.32 82.58 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.791 2.327 . . . . 1.8500000000000001 111.426 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.67 42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.413 0.625 . . . . 2.54 110.606 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.626 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.8 t60 -63.63 -41.67 98.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.976 -1.011 . . . . 2.5299999999999998 110.632 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.562 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.7 mt -109.83 137.81 40.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.821 -0.627 . . . . 1.1699999999999999 111.343 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.9 -72.94 0.7 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.109 -0.496 . . . . 1.27 111.938 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.12 148.4 24.46 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.623 0.601 . . . . 1.1200000000000001 112.623 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.81 124.82 45.07 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.424 -0.584 . . . . 0.41999999999999998 109.424 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.07 134.73 60.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.626 -0.43 . . . . 0.78000000000000003 110.625 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.916 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.0 128.66 53.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.054 0.454 . . . . 0.62 111.241 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 138.96 49.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.779 -0.646 . . . . 1.97 110.141 178.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.439 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.01 163.18 35.01 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.125 0.488 . . . . 0.34999999999999998 112.119 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.491 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.47 139.59 7.87 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 115.484 -0.78 . . . . 1.8 110.506 178.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.684 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.8 Cg_endo -63.55 115.46 3.06 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.33 2.02 . . . . 0.57999999999999996 111.784 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.674 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.96 81.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.891 -0.411 . . . . 3.04 109.891 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.23 -20.67 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.998 -0.546 . . . . 2.4700000000000002 111.906 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -157.66 157.82 34.3 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.78 -0.368 . . . . 2.5099999999999998 110.465 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.42 27.85 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 1.8600000000000001 110.151 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -75.88 1.31 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.122 -0.561 . . . . 1.4399999999999999 111.812 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.93 152.34 35.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.984 0.421 . . . . 4.6900000000000004 110.995 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.12 2.53 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.992 -0.549 . . . . 1.4299999999999999 111.886 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.17 149.63 29.81 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.457 0.646 . . . . 1.74 112.565 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.97 156.46 46.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.781 -1.099 . . . . 1.9199999999999999 110.285 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.21 158.43 41.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.967 -0.56 . . . . 0.34000000000000002 111.776 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.6 m -115.24 135.6 53.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.422 -0.808 . . . . 0.40999999999999998 109.79 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.59 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.45 121.98 23.71 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.418 -0.355 . . . . 0.55000000000000004 111.568 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.5 Cg_exo -46.27 151.75 1.58 Allowed 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.624 2.216 . . . . 0.44 112.121 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.96 -22.98 63.11 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 116.029 -0.532 . . . . 0.73999999999999999 112.81 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.54 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.8 -16.9 45.99 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 120.244 -0.582 . . . . 0.93000000000000005 111.804 -178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.603 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.57 138.39 31.61 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.707 -0.397 . . . . 0.96999999999999997 110.329 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -121.46 13.96 11.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.391 -0.368 . . . . 1.3400000000000001 111.569 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.475 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.0 143.48 25.21 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.648 -0.421 . . . . 0.39000000000000001 111.064 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.716 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.9 t80 -114.84 -169.3 1.52 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.051 -0.522 . . . . 0.41999999999999998 110.864 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.716 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.76 125.95 9.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.422 -0.808 . . . . 0.39000000000000001 109.818 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.516 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.9 mt -114.96 123.27 70.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.346 -0.542 . . . . 0.73999999999999999 111.166 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -126.47 163.4 23.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.807 -0.633 . . . . 2.48 110.498 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.18 18.94 59.88 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.714 -0.954 . . . . 0.5 110.714 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.516 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.9 mt -79.06 157.27 28.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.065 0.46 . . . . 0.57999999999999996 111.326 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.846 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -99.55 134.01 21.45 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.608 -0.723 . . . . 2.79 110.399 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.424 ' HD3' ' CE2' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.98 143.54 60.71 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.519 2.146 . . . . 0.87 111.944 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.0 25.57 75.43 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.997 -0.841 . . . . 0.64000000000000001 110.997 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.846 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.19 158.8 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.72 0.295 . . . . 0.82999999999999996 110.43 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.15 139.9 42.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.884 0.373 . . . . 0.5 110.583 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.664 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.6 m-85 -122.54 136.49 54.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.923 -0.581 . . . . 0.53000000000000003 110.69 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.489 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.3 pt-20 -98.89 131.04 45.28 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.545 -0.909 . . . . 1.8700000000000001 108.545 177.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.46 153.9 16.64 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.326 -0.94 . . . . 0.28999999999999998 111.969 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -135.0 140.93 46.05 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.675 -0.491 . . . . 1.4299999999999999 109.675 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.76 118.87 34.24 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.474 -0.49 . . . . 0.32000000000000001 110.468 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.721 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.43 129.08 68.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.388 . . . . 0.79000000000000004 110.68 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.707 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.79 120.79 43.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.27 -0.423 . . . . 1.02 110.732 -179.622 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.851 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.5 146.42 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.115 0.483 . . . . 0.62 111.082 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.622 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.02 153.85 21.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.496 -0.775 . . . . 2.4399999999999999 109.89 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.1 88.55 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.88 0.372 . . . . 3.6899999999999999 110.43 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.622 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.25 32.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.829 -0.623 . . . . 6.0800000000000001 110.614 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.1 -117.37 3.29 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.447 -0.661 . . . . 1.22 111.447 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.37 177.43 8.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.222 0.534 . . . . 2.8799999999999999 111.601 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.18 149.49 32.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.405 -0.816 . . . . 1.47 110.41 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.13 144.68 38.76 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.467 -0.333 . . . . 2.7000000000000002 110.6 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.721 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.0 136.01 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.05 0.453 . . . . 0.46000000000000002 111.555 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.09 141.33 52.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.681 -0.691 . . . . 0.34999999999999998 110.279 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.63 138.86 51.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.126 0.489 . . . . 3.6699999999999999 111.501 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.25 164.19 37.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.564 -0.744 . . . . 0.67000000000000004 109.471 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.571 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.31 151.49 38.4 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.422 -0.511 . . . . 1.47 111.042 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.7 p90 -146.18 172.7 13.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.788 -0.642 . . . . 0.44 111.017 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.69 160.65 21.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.455 -0.793 . . . . 1.3700000000000001 109.897 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.519 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.42 121.8 22.8 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.653 -0.419 . . . . 1.28 110.816 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.1 p -128.33 146.42 50.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.048 -0.524 . . . . 1.97 111.858 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.787 ' O ' HG23 ' A' ' 94' ' ' THR . 23.1 t -66.79 -36.95 83.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.798 -0.637 . . . . 3.2799999999999998 109.974 176.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.787 HG23 ' O ' ' A' ' 93' ' ' SER . 1.3 p 144.35 -123.56 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.4 t -117.64 138.45 51.96 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.518 ' O ' ' OG1' ' A' ' 99' ' ' THR . 11.4 p -139.12 156.93 72.02 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-O 120.752 0.31 . . . . 0.0 111.37 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.414 ' C ' ' H ' ' A' ' 99' ' ' THR . 31.0 Cg_endo -62.28 154.19 65.05 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.87 2.38 . . . . 0.0 112.063 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.512 ' O ' HG12 ' A' ' 98' ' ' VAL . 22.6 t 61.05 -0.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.973 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 96' ' ' THR . 63.8 m -56.95 -36.79 70.67 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.086 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.8 p -66.58 163.24 19.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.161 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -99.06 141.95 31.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.939 0.4 . . . . 0.0 110.919 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.6 p -83.03 162.66 21.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.436 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.5 t -115.7 135.49 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.706 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 48.5 m -79.51 139.11 37.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.003 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -160.15 -173.23 28.41 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.586 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -66.14 -16.11 63.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.526 -0.337 . . . . 0.0 111.257 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.3 m -68.28 137.66 54.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.941 0.401 . . . . 0.0 110.424 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 91.5 m -122.44 85.48 48.0 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.738 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.23 150.99 18.25 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.52 2.147 . . . . 0.0 111.98 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -67.15 147.98 52.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.927 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 58.3 p -123.6 82.05 54.11 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.737 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 113' ' ' LEU . 50.0 Cg_exo -52.09 150.42 18.95 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.653 2.235 . . . . 0.0 112.149 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.53 HD12 ' N ' ' A' ' 113' ' ' LEU . 8.2 mp 57.16 151.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.963 -0.562 . . . . 10.19 110.452 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 115' ' ' ALA . 41.5 t -114.61 135.6 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 115.921 -0.581 . . . . 7.2800000000000002 110.848 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 114' ' ' VAL . . . 43.64 -175.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.825 -0.625 . . . . 7.2999999999999998 111.585 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.4 m -122.93 142.91 50.29 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.681 -0.691 . . . . 6.4400000000000004 110.499 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.5 m -60.93 156.48 17.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 4.4199999999999999 110.39 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.53 -34.59 67.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.295 -0.412 . . . . 3.0499999999999998 110.481 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 28.4 t -120.47 140.96 50.65 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.857 0.36 . . . . 3.4300000000000002 110.421 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.3 m -129.96 159.61 41.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.998 -0.546 . . . . 2.8799999999999999 110.485 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 22.5 p -119.81 160.91 21.7 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.305 -0.407 . . . . 2.0899999999999999 110.246 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -103.6 -134.44 0.32 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.012 -0.54 . . . . 4.5300000000000002 111.141 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.455 ' CG2' ' O ' ' A' ' 172' ' ' LEU . 66.6 mt -111.07 143.53 20.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.974 -0.557 . . . . 1.4399999999999999 110.123 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.6 t -131.99 156.1 46.82 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.292 0.568 . . . . 1.78 111.672 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.549 ' C ' ' H ' ' A' ' 127' ' ' SER . . . 32.17 -124.18 0.06 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.171 -0.922 . . . . 0.64000000000000001 112.725 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.505 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 4.6 p 48.33 4.78 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.597 -0.729 . . . . 0.66000000000000003 111.988 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.549 ' H ' ' C ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.9 167.6 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.097 0.475 . . . . 0.68999999999999995 110.932 179.474 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.62 145.56 50.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.704 -0.68 . . . . 0.52000000000000002 110.123 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.26 101.66 9.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.063 -0.717 . . . . 0.32000000000000001 109.063 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.7 t -112.93 139.69 36.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.026 -0.534 . . . . 0.28999999999999998 111.109 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.2 p -128.66 152.47 48.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.7 -0.682 . . . . 0.25 109.929 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.595 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.8 -165.01 2.05 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.692 -0.403 . . . . 0.31 110.569 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -123.95 127.17 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 0.48999999999999999 110.809 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.176 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.97 58.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.126 -0.488 . . . . 1.53 110.31 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.21 24.57 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.892 -0.595 . . . . 0.96999999999999997 111.52 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.176 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.11 128.76 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.638 -0.425 . . . . 1.5600000000000001 110.919 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.5 -9.51 56.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.883 -0.599 . . . . 1.8799999999999999 110.289 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.16 0.25 55.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.14 -0.482 . . . . 1.04 110.289 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.21 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 0.23999999999999999 109.899 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 185' ' ' ILE . 94.2 p -96.28 -15.47 21.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.259 0.552 . . . . 0.28999999999999998 110.056 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.54 175.6 45.76 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.887 -1.285 . . . . 0.13 109.887 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -123.48 151.57 42.61 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.69 -0.404 . . . . 0.17000000000000001 110.509 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.662 ' NE ' ' HG2' ' A' ' 15' ' ' PRO . 73.0 ttt-85 -132.34 121.22 23.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.136 -0.484 . . . . 1.29 109.881 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.558 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.15 136.51 38.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.664 -0.698 . . . . 0.25 110.707 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 79.5 tt0 -129.29 129.95 45.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.038 -0.528 . . . . 1.3200000000000001 110.057 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.9 p90 -138.79 135.31 34.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.985 -0.552 . . . . 0.56999999999999995 110.567 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.427 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.28 39.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.762 -0.654 . . . . 1.1599999999999999 109.733 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.959 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -70.99 124.87 25.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.978 0.418 . . . . 0.38 110.713 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.497 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.76 -7.7 49.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.687 -0.688 . . . . 0.40999999999999998 110.891 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.85 -69.69 0.85 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 1.6599999999999999 111.343 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.447 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.7 -35.35 76.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.017 -0.538 . . . . 1.6599999999999999 111.492 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.093 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.19 7.25 88.58 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.806 -0.918 . . . . 1.1699999999999999 110.806 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.318 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.99 -171.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.779 0.323 . . . . 1.8600000000000001 110.275 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.318 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.32 139.09 44.95 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.947 0.403 . . . . 1.98 110.187 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.427 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.1 Cg_endo -70.81 145.75 51.91 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 122.725 2.284 . . . . 0.55000000000000004 112.31 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.85 145.71 42.62 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.195 -0.669 . . . . 1.1399999999999999 109.195 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.516 ' CE1' ' HB2' ' A' ' 16' ' ' ASN . 6.2 p90 -123.21 141.36 52.06 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.378 -0.529 . . . . 0.93000000000000005 111.573 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.1 127.67 43.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.338 -0.846 . . . . 0.34000000000000002 108.952 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 52.4 t0 -101.63 131.22 47.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.172 0.511 . . . . 1.0900000000000001 111.763 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.42 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -127.97 157.57 73.44 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.317 -0.856 . . . . 0.19 109.566 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.75 158.04 58.34 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.439 2.093 . . . . 0.17999999999999999 112.262 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.3 -12.18 5.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.842 -0.617 . . . . 0.20999999999999999 110.725 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.4 p -92.81 -8.74 42.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.28999999999999998 110.711 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.42 34.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.378 -0.374 . . . . 0.5 110.391 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.19 16.66 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.354 -0.385 . . . . 0.29999999999999999 110.491 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.0 p -167.53 147.18 5.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.644 -0.502 . . . . 0.23000000000000001 109.644 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.19 150.39 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.538 -0.465 . . . . 0.28000000000000003 111.576 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.28 124.94 50.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.624 -0.716 . . . . 1.0700000000000001 109.809 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.37 104.88 29.57 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.924 0.392 . . . . 0.28999999999999998 111.105 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.5 Cg_endo -90.94 -179.54 1.52 Allowed 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 123.197 2.598 . . . . 0.42999999999999999 112.243 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.72 32.63 18.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.394 -0.821 . . . . 1.26 111.417 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.505 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.4 mt -86.33 148.51 25.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.496 -0.32 . . . . 0.32000000000000001 110.521 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.766 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.24 114.82 61.1 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.912 0.387 . . . . 0.57999999999999996 110.696 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.0 140.53 95.76 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.858 2.372 . . . . 0.66000000000000003 112.014 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.16 21.2 74.1 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.009 -0.837 . . . . 0.28999999999999998 111.009 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.447 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.81 150.12 49.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.732 0.301 . . . . 2.3300000000000001 110.688 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.497 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.14 131.59 46.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 0.85999999999999999 109.833 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.959 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.48 148.28 44.03 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.143 -0.48 . . . . 0.52000000000000002 111.038 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.3 mt -105.33 125.29 60.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.27 -1.011 . . . . 0.29999999999999999 108.27 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.5 132.47 63.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.183 0.516 . . . . 0.23000000000000001 111.274 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.9 m-20 -136.46 122.59 20.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.532 -0.758 . . . . 0.35999999999999999 109.636 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.595 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.03 125.39 54.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.187 -0.46 . . . . 0.19 110.665 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.9 m-85 -117.25 137.97 52.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.007 -0.542 . . . . 0.29999999999999999 109.835 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.425 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.76 135.07 42.78 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.786 -0.82 . . . . 0.37 108.786 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 140' ' ' SER . 85.3 mt -99.09 122.92 51.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.07 0.462 . . . . 0.26000000000000001 110.96 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.5 p -83.79 169.7 14.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.534 -0.757 . . . . 0.28000000000000003 110.484 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.83 -14.51 15.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.04 -0.527 . . . . 1.6000000000000001 110.934 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.505 ' C ' ' OG1' ' A' ' 59' ' ' THR . 79.2 m-20 -96.1 -4.29 43.12 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.833 -0.347 . . . . 1.1799999999999999 110.825 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.49 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.78 13.89 64.02 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.379 -0.689 . . . . 0.29999999999999999 111.379 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -84.62 139.05 32.34 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.058 -0.257 . . . . 1.22 110.518 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -106.76 141.11 38.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.903 0.382 . . . . 0.97999999999999998 110.513 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.6 m -136.72 126.97 26.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.82999999999999996 110.36 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.06 117.25 9.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.329 -0.396 . . . . 0.26000000000000001 110.528 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.03 -21.84 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.29999999999999999 110.712 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.87 125.79 5.9 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.514 -0.475 . . . . 0.31 111.485 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.75 120.24 21.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.79 -0.641 . . . . 0.28000000000000003 109.578 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.71 29.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.955 0.407 . . . . 0.23999999999999999 110.927 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.47 158.66 18.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.052 -0.522 . . . . 0.23000000000000001 110.413 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -146.09 157.96 43.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.03 -0.532 . . . . 0.67000000000000004 110.659 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 104.26 9.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.721 -0.672 . . . . 0.64000000000000001 110.047 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.876 -1.059 . . . . 1.26 110.665 -179.729 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.197 -0.668 . . . . 3.4399999999999999 109.197 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.72 18.54 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.049 -0.821 . . . . 1.22 111.049 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.73 142.41 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.09 0 C-N-CA 123.94 3.093 . . . . 0.75 113.748 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.0 t -79.93 173.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.205 -1.361 . . . . 0.79000000000000004 108.83 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.614 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.64 125.89 51.51 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.482 -0.487 . . . . 1.9399999999999999 111.409 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 p -136.52 143.99 33.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.573 -0.74 . . . . 0.59999999999999998 110.622 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.06 168.25 25.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.936 0.398 . . . . 3.1400000000000001 111.072 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.743 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.4 mt -108.87 131.1 60.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.019 -0.537 . . . . 3.23 110.155 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.21 162.32 35.77 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.931 0.396 . . . . 3.6299999999999999 111.149 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.1 mt-10 36.06 31.68 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.559 -0.534 . . . . 6.0800000000000001 109.559 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.743 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.53 69.63 33.56 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.939 -0.573 . . . . 3.3799999999999999 111.533 -178.809 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.28 -29.09 72.75 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.501 2.134 . . . . 3.9300000000000002 111.881 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.64 125.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 3.3599999999999999 110.477 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.724 HE22 ' CD ' ' A' ' 191' ' ' GLN . 18.7 mm-40 -123.9 158.33 60.37 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 3.6099999999999999 110.462 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.54 ' CG ' ' NE ' ' A' ' 143' ' ' ARG . 98.8 Cg_endo -82.08 -64.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.901 2.401 . . . . 1.51 113.494 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.814 ' ND2' ' O ' ' A' ' 63' ' ' LEU . 3.4 t-20 -108.43 -19.56 13.41 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.119 0.415 . . . . 2.6800000000000002 112.119 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 1.3 p -107.27 152.03 24.66 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.499 -0.48 . . . . 1.21 111.346 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.28 102.88 2.23 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.737 -0.665 . . . . 1.5600000000000001 110.689 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.57 145.63 13.19 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.914 2.409 . . . . 0.81000000000000005 112.639 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.919 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.8 167.98 24.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.808 -0.633 . . . . 1.52 109.924 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.16 147.93 29.03 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.74 -0.467 . . . . 2.1400000000000001 109.74 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.595 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.4 p90 -142.3 157.3 44.97 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.624 -0.43 . . . . 0.32000000000000001 111.212 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.49 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.04 155.22 44.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.831 -0.622 . . . . 2.1699999999999999 110.187 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.83 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.62 172.99 6.42 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.097 0.475 . . . . 0.58999999999999997 110.743 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.83 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.54 173.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.885 2.39 . . . . 0.90000000000000002 111.513 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.01 -51.15 0.69 Allowed Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.746 -0.381 . . . . 3.3399999999999999 110.093 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.622 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.8 Cg_exo -64.89 152.4 82.38 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.743 2.295 . . . . 1.8500000000000001 111.423 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.68 42.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.423 0.63 . . . . 2.54 110.587 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.622 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.7 t60 -63.59 -41.65 98.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.011 -0.995 . . . . 2.5299999999999998 110.671 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.559 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.2 mt -109.92 137.87 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.783 -0.644 . . . . 1.1699999999999999 111.251 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.95 -72.92 0.7 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.025 -0.534 . . . . 1.27 111.856 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.15 148.4 24.44 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.557 0.577 . . . . 1.1200000000000001 112.557 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.8 124.87 45.19 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.41 -0.589 . . . . 0.41999999999999998 109.41 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.8 mt -118.15 134.8 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.618 -0.433 . . . . 0.78000000000000003 110.553 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.919 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.09 128.66 53.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.071 0.462 . . . . 0.62 111.149 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.549 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.14 139.01 49.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.656 -0.702 . . . . 1.97 110.097 178.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.09 163.19 35.06 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.076 0.465 . . . . 0.34999999999999998 112.108 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.489 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.49 139.58 7.85 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 115.453 -0.794 . . . . 1.8 110.437 178.882 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.57 115.46 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.316 2.011 . . . . 0.57999999999999996 111.784 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.672 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.9 81.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.94 -0.392 . . . . 3.04 109.94 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.14 -20.64 0.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.998 -0.547 . . . . 2.4700000000000002 111.946 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.56 157.77 34.37 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.815 -0.354 . . . . 2.5099999999999998 110.559 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.403 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.39 27.88 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.23 -0.441 . . . . 1.8600000000000001 110.17 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.87 -75.9 1.31 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.825 -0.51 . . . . 1.4399999999999999 111.825 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.89 152.26 35.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.871 0.367 . . . . 4.6900000000000004 111.051 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.676 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.21 -169.16 2.54 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.077 -0.511 . . . . 1.4299999999999999 111.925 179.417 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.11 149.69 29.68 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.409 0.623 . . . . 1.74 112.557 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.08 156.47 45.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.82 -1.082 . . . . 1.9199999999999999 110.262 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.26 158.33 41.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.938 -0.574 . . . . 0.34000000000000002 111.791 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 m -115.13 135.67 53.94 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.368 -0.833 . . . . 0.40999999999999998 109.86 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.595 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.44 121.9 23.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.444 -0.344 . . . . 0.55000000000000004 111.555 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.2 Cg_exo -46.3 151.74 1.61 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.634 2.223 . . . . 0.44 112.2 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.02 -22.95 63.2 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 116.157 -0.474 . . . . 0.73999999999999999 112.808 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.77 -16.88 46.2 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.21 -0.596 . . . . 0.93000000000000005 111.787 -178.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.605 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.54 138.46 31.56 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.83 -0.348 . . . . 0.96999999999999997 110.271 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -121.58 13.93 10.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.362 -0.381 . . . . 1.3400000000000001 111.548 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.93 143.49 25.28 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.626 -0.43 . . . . 0.39000000000000001 111.08 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.713 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.85 -169.35 1.53 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.212 0.53 . . . . 0.41999999999999998 110.829 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.713 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 84.9 m -151.75 125.95 9.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.334 -0.848 . . . . 0.39000000000000001 109.832 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.515 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.82 123.19 70.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.428 -0.509 . . . . 0.73999999999999999 111.28 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.577 ' HE2' HG21 ' A' ' 185' ' ' ILE . 8.6 mmtt -126.44 163.31 23.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.906 -0.588 . . . . 2.48 110.482 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.404 ' C ' HD22 ' A' ' 16' ' ' ASN . . . 85.14 19.06 59.71 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.678 -0.969 . . . . 0.5 110.678 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.814 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 73.9 mt -79.09 157.25 28.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.053 0.454 . . . . 0.57999999999999996 111.339 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.857 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -99.45 133.9 21.59 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.568 -0.742 . . . . 2.79 110.491 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.82 143.55 61.68 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.54 2.16 . . . . 0.87 112.029 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.77 25.66 75.3 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.033 -0.827 . . . . 0.64000000000000001 111.033 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.857 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.13 158.86 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.684 0.278 . . . . 0.82999999999999996 110.466 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.21 139.96 42.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.967 0.413 . . . . 0.5 110.495 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.638 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.58 136.46 54.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.863 -0.608 . . . . 0.53000000000000003 110.74 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.95 131.09 45.28 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.541 -0.911 . . . . 1.8700000000000001 108.541 177.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.487 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.57 153.91 16.67 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.201 -0.999 . . . . 0.28999999999999998 111.947 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -134.97 140.89 46.05 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.681 -0.489 . . . . 1.4299999999999999 109.681 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.73 118.97 34.53 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.418 -0.513 . . . . 0.32000000000000001 110.503 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 84' ' ' VAL . 64.2 mt -112.45 129.12 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.287 -0.415 . . . . 0.79000000000000004 110.592 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.9 120.88 43.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.253 -0.43 . . . . 1.02 110.715 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.859 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.69 146.57 11.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.292 0.568 . . . . 0.62 110.921 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.62 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.12 153.88 21.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.513 -0.767 . . . . 2.4399999999999999 109.941 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.21 88.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.963 0.411 . . . . 3.6899999999999999 110.371 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.62 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.38 32.45 0.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.784 -0.644 . . . . 6.0800000000000001 110.577 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.01 -117.39 3.3 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.452 -0.659 . . . . 1.22 111.452 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.41 177.47 8.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.252 0.548 . . . . 2.8799999999999999 111.58 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.22 149.47 31.98 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.373 -0.83 . . . . 1.47 110.312 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.15 144.7 38.73 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.463 -0.335 . . . . 2.7000000000000002 110.528 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.727 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.03 136.0 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 121.041 0.448 . . . . 0.46000000000000002 111.538 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.05 141.37 52.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.687 -0.688 . . . . 0.34999999999999998 110.292 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.67 138.81 51.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.128 0.49 . . . . 3.6699999999999999 111.479 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.487 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.19 164.25 37.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.527 -0.761 . . . . 0.67000000000000004 109.494 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.33 151.49 38.4 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.442 -0.503 . . . . 1.47 111.075 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.8 p90 -146.15 172.72 13.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.724 -0.671 . . . . 0.44 111.04 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.67 160.69 21.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.431 -0.804 . . . . 1.3700000000000001 109.843 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.4 121.85 22.89 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.573 -0.451 . . . . 1.28 110.752 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.5 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.6 p -126.6 161.34 28.25 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 114.003 1.112 . . . . 1.97 114.003 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.8 t -131.1 153.1 49.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 113.272 -1.786 . . . . 3.2799999999999998 108.886 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 61.0 p -60.93 -10.51 5.84 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 51.5 p -69.0 163.02 25.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.251 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.98 164.93 14.84 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.629 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.42 145.82 35.18 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.137 1.891 . . . . 0.0 112.113 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.59 HG12 ' H ' ' A' ' 100' ' ' SER . 40.8 t -114.1 135.26 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.293 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.1 p -66.64 -28.39 68.44 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.201 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.59 ' H ' HG12 ' A' ' 98' ' ' VAL . 26.9 m 50.27 -144.71 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 110.771 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 59.29 45.19 14.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.011 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 48.1 m -86.16 139.21 31.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.249 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.5 p -130.56 142.38 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.817 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.2 m -123.67 141.99 51.49 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.228 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.96 10.09 61.68 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -56.66 -33.12 66.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.621 0.248 . . . . 0.0 110.492 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.5 p -120.85 162.32 20.02 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.681 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.4 m -126.16 79.66 69.41 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.487 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.69 145.62 48.12 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.473 2.115 . . . . 0.0 112.409 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -99.07 135.7 40.09 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.77 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.0 m -113.75 94.36 32.7 Favored Pre-proline 0 N--CA 1.468 0.427 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.227 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.41 -15.53 45.88 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.383 2.055 . . . . 0.0 111.773 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 27.8 tp -54.57 -37.29 65.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.854 -0.612 . . . . 10.19 111.028 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.0 m -127.13 153.06 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.076 0.465 . . . . 7.2800000000000002 111.512 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.76 -32.34 73.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.624 -0.716 . . . . 7.2999999999999998 111.727 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.7 m -119.94 140.44 50.89 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.991 0.424 . . . . 6.4400000000000004 110.814 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.4 m -63.06 154.35 31.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.544 . . . . 4.4199999999999999 110.853 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -110.81 159.92 17.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.616 -0.72 . . . . 3.0499999999999998 110.149 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 54.2 p -65.51 162.21 18.5 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.503 -0.554 . . . . 3.4300000000000002 109.503 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 43.4 t -113.18 134.5 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 121.181 0.515 . . . . 2.8799999999999999 111.488 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.1 p -123.47 162.98 21.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.347 -0.842 . . . . 2.0899999999999999 109.178 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.87 140.72 51.28 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.947 -0.701 . . . . 4.5300000000000002 109.832 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.4 tp -125.45 140.36 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.257 -0.429 . . . . 1.4399999999999999 111.083 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 17.8 p -122.14 159.52 27.01 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.03 -0.532 . . . . 1.78 109.695 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 127' ' ' SER . . . -148.24 155.58 41.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.547 -0.297 . . . . 0.64000000000000001 110.862 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.2 OUTLIER 41.03 19.64 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.19 0.519 . . . . 0.66000000000000003 111.418 179.434 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.85 167.57 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.525 -0.761 . . . . 0.68999999999999995 110.984 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.64 145.5 50.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.733 -0.667 . . . . 0.52000000000000002 110.081 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.23 101.67 9.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.124 -0.695 . . . . 0.32000000000000001 109.124 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.4 t -112.95 139.7 36.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.974 -0.557 . . . . 0.28999999999999998 111.069 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.0 p -128.8 152.48 48.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.612 -0.722 . . . . 0.25 109.776 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.585 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.71 -164.9 2.02 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.668 -0.413 . . . . 0.31 110.632 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.732 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.4 t -123.97 127.1 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.218 -0.446 . . . . 0.48999999999999999 110.788 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.157 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.216 -0.447 . . . . 1.53 110.374 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.14 24.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.928 -0.578 . . . . 0.96999999999999997 111.469 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.157 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.16 128.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.54 -0.464 . . . . 1.5600000000000001 110.952 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.39 -9.59 56.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.975 -0.557 . . . . 1.8799999999999999 110.249 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.18 0.17 55.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.218 -0.446 . . . . 1.04 110.299 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 136' ' ' SER . 2.6 p -65.19 137.17 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.954 -0.566 . . . . 0.23999999999999999 110.027 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 185' ' ' ILE . 92.5 p -96.14 -15.56 22.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.263 0.554 . . . . 0.28999999999999998 110.101 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.62 175.58 45.81 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 109.772 -1.331 . . . . 0.13 109.772 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.4 151.59 42.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.971 0.415 . . . . 0.17000000000000001 110.516 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.583 ' NH2' ' HB3' ' A' ' 157' ' ' TYR . 78.1 ttt-85 -132.42 121.17 23.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.103 -0.499 . . . . 1.29 109.964 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.557 HG21 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.14 136.56 38.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.708 -0.678 . . . . 0.25 110.684 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 84.1 tt0 -129.34 129.8 45.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.961 -0.563 . . . . 1.3200000000000001 110.085 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.64 135.24 34.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.033 -0.53 . . . . 0.56999999999999995 110.703 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.41 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.25 161.3 39.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.865 -0.607 . . . . 1.1599999999999999 109.763 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.956 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.0 124.89 25.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.006 0.432 . . . . 0.38 110.763 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.87 -7.66 49.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.816 -0.629 . . . . 0.40999999999999998 110.84 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -109.79 -69.67 0.85 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.01 0.433 . . . . 1.6599999999999999 111.514 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.461 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.3 mt-10 -60.76 -35.22 75.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.033 -0.53 . . . . 1.6599999999999999 111.51 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.094 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.07 7.27 88.56 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.804 -0.919 . . . . 1.1699999999999999 110.804 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.323 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.9 t0 -27.95 -171.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.761 0.315 . . . . 1.8600000000000001 110.314 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.323 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.2 pm0 -82.27 139.11 45.11 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.044 0.449 . . . . 1.98 110.226 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.41 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.94 145.87 51.46 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.726 2.284 . . . . 0.55000000000000004 112.32 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.81 145.7 42.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.217 -0.66 . . . . 1.1399999999999999 109.217 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.583 ' HB3' ' NH2' ' A' ' 143' ' ' ARG . 4.0 p90 -123.31 141.32 52.11 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.349 -0.54 . . . . 0.93000000000000005 111.537 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.4 mt -128.05 127.66 43.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.239 -0.892 . . . . 0.34000000000000002 108.932 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.513 ' OD2' ' OD1' ' A' ' 16' ' ' ASN . 63.3 t0 -101.49 131.12 47.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.135 0.493 . . . . 1.0900000000000001 111.879 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.437 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.1 mt -127.93 157.57 73.34 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.358 -0.837 . . . . 0.19 109.566 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.83 157.98 58.41 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.492 2.128 . . . . 0.17999999999999999 112.311 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.22 -12.16 4.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.855 -0.611 . . . . 0.20999999999999999 110.822 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.5 p -92.77 -8.69 42.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.058 -0.519 . . . . 0.28999999999999998 110.734 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.2 135.39 34.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.413 . . . . 0.5 110.357 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.16 16.68 4.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.439 -0.346 . . . . 0.29999999999999999 110.504 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.1 p -167.59 147.13 5.04 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.63 -0.507 . . . . 0.23000000000000001 109.63 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.21 150.61 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 0.28000000000000003 111.525 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.508 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.37 124.9 50.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.559 -0.746 . . . . 1.0700000000000001 109.789 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.28 104.87 29.22 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.424 -0.353 . . . . 0.28999999999999998 111.088 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.0 Cg_endo -91.0 -179.5 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 123.235 2.624 . . . . 0.42999999999999999 112.251 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.71 32.58 18.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.413 -0.812 . . . . 1.26 111.438 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.45 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.0 mt -86.35 148.5 25.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.772 0.32 . . . . 0.32000000000000001 110.486 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.762 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.3 114.83 61.22 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.075 0.464 . . . . 0.57999999999999996 110.704 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.01 140.57 95.94 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.821 2.348 . . . . 0.66000000000000003 112.04 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.17 74.42 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.101 -0.8 . . . . 0.28999999999999998 111.101 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.461 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.84 150.23 49.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.896 0.379 . . . . 2.3300000000000001 110.598 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.488 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.1 tttt -100.14 131.75 45.91 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.997 -0.547 . . . . 0.85999999999999999 109.799 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.956 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.62 148.26 44.13 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.114 -0.494 . . . . 0.52000000000000002 110.992 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.2 mt -105.32 125.37 60.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.298 -1.001 . . . . 0.29999999999999999 108.298 177.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.5 132.57 63.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.154 0.502 . . . . 0.23000000000000001 111.305 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.57 122.58 20.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.494 -0.775 . . . . 0.35999999999999999 109.537 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.585 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.0 125.33 54.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.227 -0.442 . . . . 0.19 110.739 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.3 m-85 -117.21 137.76 52.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.064 -0.516 . . . . 0.29999999999999999 109.926 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.42 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.66 134.96 42.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.805 -0.813 . . . . 0.37 108.805 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.6 ' O ' ' N ' ' A' ' 140' ' ' SER . 7.7 mm -99.11 122.91 51.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.177 0.513 . . . . 0.26000000000000001 110.922 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.6 p -83.76 169.74 14.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.533 -0.758 . . . . 0.28000000000000003 110.494 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.706 ' O ' ' OG1' ' A' ' 59' ' ' THR . 97.5 mt-10 -59.74 -14.59 15.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.011 -0.541 . . . . 1.6000000000000001 111.028 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -96.12 -4.22 43.16 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.804 -0.358 . . . . 1.1799999999999999 110.792 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.79 13.85 64.07 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.388 -0.685 . . . . 0.29999999999999999 111.388 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -84.58 139.01 32.4 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.107 -0.237 . . . . 1.22 110.506 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.724 ' CD ' HE22 ' A' ' 14' ' ' GLN . 11.8 mt-30 -106.68 141.09 38.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.815 0.34 . . . . 0.97999999999999998 110.584 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.1 m -136.71 126.93 26.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.82999999999999996 110.359 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.07 117.3 9.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.278 -0.419 . . . . 0.26000000000000001 110.551 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.05 -21.7 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.29999999999999999 110.764 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.91 125.69 5.84 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.542 -0.463 . . . . 0.31 111.459 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.471 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.8 120.28 21.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.726 -0.67 . . . . 0.28000000000000003 109.517 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.63 151.62 29.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.917 0.389 . . . . 0.23999999999999999 110.984 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.43 158.5 18.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.049 -0.523 . . . . 0.23000000000000001 110.464 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -145.97 157.93 43.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.235 -0.439 . . . . 0.67000000000000004 110.768 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 104.54 9.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.784 -0.644 . . . . 0.64000000000000001 109.972 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 68.1 p . . . . . 0 C--O 1.219 -0.534 0 CA-C-O 117.882 -1.056 . . . . 1.26 110.617 -179.706 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.6 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.199 -0.667 . . . . 3.4399999999999999 109.199 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.38 150.7 18.54 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.024 -0.83 . . . . 1.22 111.024 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -35.66 142.4 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.101 0 C-N-CA 124.025 3.15 . . . . 0.75 113.742 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.97 173.32 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.29 -1.323 . . . . 0.79000000000000004 108.769 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.614 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.55 125.93 51.55 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.411 -0.516 . . . . 1.9399999999999999 111.44 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.55 143.95 34.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.618 -0.719 . . . . 0.59999999999999998 110.622 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.05 168.31 25.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.931 0.396 . . . . 3.1400000000000001 111.12 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.748 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -108.98 131.06 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.957 -0.565 . . . . 3.23 110.076 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.2 162.31 35.79 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.954 0.407 . . . . 3.6299999999999999 111.194 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.469 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 73.1 tt0 36.14 31.53 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.637 -0.505 . . . . 6.0800000000000001 109.637 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.748 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.42 69.58 32.41 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.958 -0.564 . . . . 3.3799999999999999 111.621 -178.788 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.29 -29.09 72.62 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.529 2.153 . . . . 3.9300000000000002 111.802 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.52 125.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 3.3599999999999999 110.548 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.529 ' CB ' ' O ' ' A' ' 17' ' ' SER . 11.7 mt-30 -123.89 158.34 60.33 Favored Pre-proline 0 C--O 1.234 0.26 0 CA-C-N 116.241 -0.436 . . . . 3.6099999999999999 110.537 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.486 ' CG ' ' NH1' ' A' ' 143' ' ' ARG . 98.3 Cg_endo -82.12 -64.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.931 2.42 . . . . 1.51 113.457 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.627 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 61.9 t30 -108.4 -19.5 13.44 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.114 0.413 . . . . 2.6800000000000002 112.114 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 29.7 t -107.31 152.1 24.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.148 0.499 . . . . 1.21 111.339 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.578 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.24 102.92 2.23 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.687 -0.688 . . . . 1.5600000000000001 110.61 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.72 145.64 12.95 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.888 2.392 . . . . 0.81000000000000005 112.568 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.932 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.81 167.98 24.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.896 -0.593 . . . . 1.52 109.961 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.23 147.89 28.94 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.776 -0.453 . . . . 2.1400000000000001 109.776 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.597 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.4 p90 -142.24 157.29 45.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.017 0.437 . . . . 0.32000000000000001 111.196 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.499 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.04 155.26 44.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.715 -0.675 . . . . 2.1699999999999999 110.064 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.835 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.6 173.05 6.34 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 121.111 0.481 . . . . 0.58999999999999997 110.728 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.835 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.69 173.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.779 2.319 . . . . 0.90000000000000002 111.533 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.484 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.1 -51.03 0.69 Allowed Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 120.694 -0.402 . . . . 3.3399999999999999 110.111 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.617 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.81 152.32 82.52 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.737 2.291 . . . . 1.8500000000000001 111.483 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.64 42.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.332 0.587 . . . . 2.54 110.564 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.617 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.8 t60 -63.65 -41.55 98.21 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.953 -1.021 . . . . 2.5299999999999998 110.722 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.569 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.1 mt -109.87 137.89 40.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.842 -0.617 . . . . 1.1699999999999999 111.276 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.93 -72.95 0.7 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.063 -0.517 . . . . 1.27 111.911 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.09 148.28 24.54 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.593 0.59 . . . . 1.1200000000000001 112.593 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.81 124.94 45.36 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.324 -0.621 . . . . 0.41999999999999998 109.324 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.03 134.75 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.619 -0.433 . . . . 0.78000000000000003 110.705 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.932 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.99 128.59 53.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.998 0.428 . . . . 0.62 111.281 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.06 138.95 49.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.741 -0.663 . . . . 1.97 110.14 179.008 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.434 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.2 p90 -145.08 163.14 35.2 Favored 'General case' 0 C--N 1.335 -0.065 0 CA-C-O 121.197 0.523 . . . . 0.34999999999999998 112.036 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.488 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.48 139.63 7.89 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.38 -0.827 . . . . 1.8 110.482 178.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.63 115.47 3.07 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.392 2.061 . . . . 0.57999999999999996 111.767 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.684 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.0 81.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.927 -0.397 . . . . 3.04 109.927 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.931 -0.577 . . . . 2.4700000000000002 111.943 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.2 p -157.59 157.8 34.37 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.865 -0.334 . . . . 2.5099999999999998 110.577 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.408 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.4 m -120.38 27.8 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 1.8600000000000001 110.213 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.7 -75.9 1.31 Allowed Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.11 -0.566 . . . . 1.4399999999999999 111.878 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.88 152.29 35.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.411 . . . . 4.6900000000000004 110.949 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.665 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.18 -169.07 2.52 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.032 -0.531 . . . . 1.4299999999999999 111.96 179.343 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.77 29.59 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 121.48 0.657 . . . . 1.74 112.539 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.15 156.47 45.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.784 -1.098 . . . . 1.9199999999999999 110.242 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.2 158.35 41.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.931 -0.577 . . . . 0.34000000000000002 111.841 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.14 135.67 53.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.539 -0.755 . . . . 0.40999999999999998 109.832 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.597 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.44 121.91 23.71 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.474 -0.33 . . . . 0.55000000000000004 111.55 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.607 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.4 Cg_exo -46.26 151.7 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.65 2.234 . . . . 0.44 112.124 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.97 -22.97 63.12 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 116.026 -0.533 . . . . 0.73999999999999999 112.843 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.82 -16.79 46.39 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.213 -0.595 . . . . 0.93000000000000005 111.837 -178.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.607 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.64 138.39 31.6 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.798 -0.361 . . . . 0.96999999999999997 110.323 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.54 14.01 11.0 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.426 -0.352 . . . . 1.3400000000000001 111.527 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.07 143.46 25.14 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.671 -0.411 . . . . 0.39000000000000001 111.075 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.716 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.78 -169.39 1.54 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.006 -0.543 . . . . 0.41999999999999998 110.888 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.716 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 m -151.69 125.89 9.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.4 -0.818 . . . . 0.39000000000000001 109.882 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.51 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.9 mt -114.88 123.23 70.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.409 -0.516 . . . . 0.73999999999999999 111.117 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.576 ' HG2' ' N ' ' A' ' 62' ' ' GLY . 37.8 ttpt -126.42 163.38 23.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.824 -0.625 . . . . 2.48 110.49 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.576 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.07 19.04 59.86 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.795 -0.922 . . . . 0.5 110.795 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.627 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.8 mt -79.06 157.17 28.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.043 0.449 . . . . 0.57999999999999996 111.345 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.844 ' O ' HG12 ' A' ' 67' ' ' VAL . 1.5 tttp -99.44 133.93 21.58 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.569 -0.741 . . . . 2.79 110.451 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.491 ' HD3' ' CD1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.84 143.61 61.76 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.505 2.137 . . . . 0.87 112.01 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.75 25.67 75.28 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.071 -0.812 . . . . 0.64000000000000001 111.071 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.3 p -128.07 158.74 39.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.715 0.293 . . . . 0.82999999999999996 110.484 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.11 139.92 42.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.88 0.371 . . . . 0.5 110.581 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.651 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.9 m-85 -122.6 136.51 54.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 0.53000000000000003 110.764 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.91 131.05 45.28 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.485 -0.932 . . . . 1.8700000000000001 108.485 177.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.52 153.93 16.65 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.251 -0.976 . . . . 0.28999999999999998 111.927 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -135.05 140.89 45.93 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.68 -0.489 . . . . 1.4299999999999999 109.68 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.78 118.88 34.25 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.508 -0.477 . . . . 0.32000000000000001 110.468 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.736 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.43 129.05 68.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 0.79000000000000004 110.578 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.699 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.84 120.86 43.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.213 -0.449 . . . . 1.02 110.75 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.859 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.63 146.46 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.175 0.512 . . . . 0.62 111.032 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.625 ' O ' ' N ' ' A' ' 79' ' ' TYR . 20.8 mt-30 -105.97 153.85 21.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.565 -0.743 . . . . 2.4399999999999999 110.001 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.21 88.58 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.92 0.391 . . . . 3.6899999999999999 110.442 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.23 32.72 0.21 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.77 -0.65 . . . . 6.0800000000000001 110.558 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.34 3.29 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.499 -0.64 . . . . 1.22 111.499 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.4 177.4 9.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.244 0.545 . . . . 2.8799999999999999 111.596 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.15 149.55 32.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.407 -0.815 . . . . 1.47 110.495 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.14 144.65 38.72 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.489 -0.323 . . . . 2.7000000000000002 110.596 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.736 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.0 135.94 61.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 121.052 0.453 . . . . 0.46000000000000002 111.573 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -123.99 141.35 52.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.688 -0.687 . . . . 0.34999999999999998 110.306 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.477 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.6 138.81 51.69 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.113 0.482 . . . . 3.6699999999999999 111.528 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.19 164.18 37.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.568 -0.742 . . . . 0.67000000000000004 109.514 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.561 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.29 151.54 38.51 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.351 -0.54 . . . . 1.47 111.008 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.807 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.16 172.71 13.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.747 -0.66 . . . . 0.44 111.015 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.68 160.73 21.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.414 -0.812 . . . . 1.3700000000000001 109.915 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.44 121.86 22.86 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.548 -0.461 . . . . 1.28 110.8 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.4 p -128.55 165.39 20.83 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.458 0.91 . . . . 1.97 113.458 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 94' ' ' THR . 76.2 p -127.99 -118.59 0.25 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 113.894 -1.503 . . . . 3.2799999999999998 107.552 177.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.505 ' N ' ' OG ' ' A' ' 93' ' ' SER . 22.7 p -121.96 158.99 27.86 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.439 ' O ' ' OG1' ' A' ' 96' ' ' THR . 84.0 p -147.86 156.99 43.3 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.506 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 95' ' ' SER . 21.0 m -172.04 62.62 0.33 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.829 178.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 96' ' ' THR . 38.7 Cg_exo -58.87 134.7 61.95 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.321 2.014 . . . . 0.0 113.515 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.81 157.3 42.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.458 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.8 m -81.87 132.66 35.28 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.239 -0.585 . . . . 0.0 109.831 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.8 m -71.96 151.25 43.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.055 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -89.6 4.51 49.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.116 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.2 t -136.65 161.85 34.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.929 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 p -128.82 142.82 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.269 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.6 m -78.94 139.08 38.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -160.29 -176.56 32.52 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -58.7 143.65 46.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.794 0.331 . . . . 0.0 110.673 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.5 p -82.82 162.39 21.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.543 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.9 p -66.14 145.21 98.99 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.375 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.86 145.2 97.63 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.307 2.005 . . . . 0.0 112.52 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -97.76 5.06 49.67 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.593 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.59 160.94 16.1 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.958 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.14 -13.99 5.66 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.939 2.426 . . . . 0.0 112.117 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.0 mt -76.98 147.77 36.67 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.352 -0.61 . . . . 10.19 109.352 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.631 ' O ' ' HB2' ' A' ' 115' ' ' ALA . 26.5 m -58.63 132.59 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.706 -0.398 . . . . 7.2800000000000002 111.011 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 114' ' ' VAL . . . 149.24 -0.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.312 -0.858 . . . . 7.2999999999999998 109.25 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.679 HG22 ' H ' ' A' ' 118' ' ' GLU . 38.7 m -79.78 137.64 37.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.864 -0.607 . . . . 6.4400000000000004 110.657 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 118' ' ' GLU . 87.0 p -62.04 -27.02 68.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 4.4199999999999999 110.782 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.679 ' H ' HG22 ' A' ' 116' ' ' THR . 84.3 tt0 56.45 125.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 3.0499999999999998 110.688 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 57.1 p -71.56 160.46 32.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.093 -0.503 . . . . 3.4300000000000002 110.741 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.532 HG22 ' H ' ' A' ' 122' ' ' GLU . 11.7 p -132.74 145.19 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.989 -0.551 . . . . 2.8799999999999999 110.157 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 62.1 p -65.77 -10.35 36.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.31 -0.405 . . . . 2.0899999999999999 111.812 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.532 ' H ' HG22 ' A' ' 120' ' ' VAL . 95.3 mt-10 -98.5 159.08 15.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.724 0.297 . . . . 4.5300000000000002 110.243 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.8 pt -118.65 156.13 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.144 0.497 . . . . 1.4399999999999999 111.262 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 8.4 t -123.97 33.16 5.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.381 -0.827 . . . . 1.78 110.709 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 127' ' ' SER . . . -59.91 -30.87 69.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 0.64000000000000001 111.756 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.481 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.3 OUTLIER 44.46 17.6 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.976 0.893 . . . . 0.66000000000000003 110.399 -179.257 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.9 167.54 0.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.875 -1.057 . . . . 0.68999999999999995 110.868 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.5 145.52 50.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.664 -0.698 . . . . 0.52000000000000002 110.16 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.23 101.64 9.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.104 -0.702 . . . . 0.32000000000000001 109.104 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.0 t -113.02 139.68 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.078 -0.51 . . . . 0.28999999999999998 111.033 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.6 p -128.7 152.49 48.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.6 -0.727 . . . . 0.25 109.827 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.59 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.5 p90 -144.72 -164.92 2.02 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.759 -0.376 . . . . 0.31 110.668 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.3 t -123.94 127.21 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.48999999999999999 110.812 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.174 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -58.03 58.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 1.53 110.313 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.743 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.1 24.48 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.881 -0.6 . . . . 0.96999999999999997 111.52 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.174 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.23 128.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.633 -0.427 . . . . 1.5600000000000001 110.994 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.46 -9.58 55.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.009 -0.542 . . . . 1.8799999999999999 110.38 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.4 p -87.16 0.4 55.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.043 -0.526 . . . . 1.04 110.307 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.31 137.22 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 116.018 -0.537 . . . . 0.23999999999999999 109.939 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 185' ' ' ILE . 60.9 m -96.33 -15.45 21.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.276 0.56 . . . . 0.28999999999999998 110.003 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.57 175.57 45.76 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 109.876 -1.289 . . . . 0.13 109.876 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.39 151.63 42.38 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.716 -0.394 . . . . 0.17000000000000001 110.541 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.695 ' NH1' ' OE1' ' A' ' 191' ' ' GLN . 20.6 ttm180 -132.43 121.12 22.91 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.18 -0.464 . . . . 1.29 109.955 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.555 HG21 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.11 136.56 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.652 -0.704 . . . . 0.25 110.635 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 84.7 tt0 -129.37 129.97 45.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.951 -0.568 . . . . 1.3200000000000001 109.992 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.624 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.79 135.21 34.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.983 -0.553 . . . . 0.56999999999999995 110.616 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.418 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.32 39.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.775 -0.648 . . . . 1.1599999999999999 109.668 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.972 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.4 mt -70.98 124.84 25.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.077 0.465 . . . . 0.38 110.738 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.0 p -71.6 -7.88 50.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.735 -0.666 . . . . 0.40999999999999998 110.879 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.79 -69.59 0.85 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.316 -0.402 . . . . 1.6599999999999999 111.473 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.478 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.61 -35.45 76.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.16 -0.473 . . . . 1.6599999999999999 111.477 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.085 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.21 88.61 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.783 -0.927 . . . . 1.1699999999999999 110.783 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.328 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.9 t0 -27.9 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.675 0.274 . . . . 1.8600000000000001 110.351 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.328 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.2 pm0 -82.2 139.02 45.31 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.925 0.393 . . . . 1.98 110.25 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.418 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.9 Cg_endo -70.9 145.8 51.47 Favored 'Trans proline' 0 C--N 1.302 -1.91 0 C-N-CA 122.671 2.247 . . . . 0.55000000000000004 112.392 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.77 145.82 42.47 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.237 -0.653 . . . . 1.1399999999999999 109.237 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.491 ' CD1' ' HD3' ' A' ' 65' ' ' PRO . 6.1 p90 -123.39 141.32 52.11 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.385 -0.526 . . . . 0.93000000000000005 111.486 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.0 mt -128.17 127.69 43.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.247 -0.888 . . . . 0.34000000000000002 108.922 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 68.3 t0 -101.7 131.21 48.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.184 0.516 . . . . 1.0900000000000001 111.683 -178.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.479 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -127.93 157.48 73.66 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.276 -0.875 . . . . 0.19 109.614 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -69.74 158.03 58.4 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.37 2.047 . . . . 0.17999999999999999 112.304 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.28 -12.2 5.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.825 -0.625 . . . . 0.20999999999999999 110.677 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.3 p -92.73 -8.83 42.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.28999999999999998 110.749 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.47 34.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.5 110.407 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.8 p -133.15 16.52 4.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.38 . . . . 0.29999999999999999 110.579 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.5 p -167.53 147.17 5.1 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.626 -0.509 . . . . 0.23000000000000001 109.626 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.555 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.2 150.44 12.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.518 -0.473 . . . . 0.28000000000000003 111.54 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.506 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.31 125.01 50.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.634 -0.712 . . . . 1.0700000000000001 109.789 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.51 104.88 30.09 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.911 0.386 . . . . 0.28999999999999998 111.054 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.4 Cg_endo -90.93 -179.53 1.52 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 123.2 2.6 . . . . 0.42999999999999999 112.24 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.74 32.58 18.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.415 -0.812 . . . . 1.26 111.394 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.481 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.2 mt -86.27 148.56 25.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.528 -0.305 . . . . 0.32000000000000001 110.586 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.76 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.33 114.8 61.1 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.007 0.432 . . . . 0.57999999999999996 110.707 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.0 140.62 96.17 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.878 2.385 . . . . 0.66000000000000003 112.009 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.03 21.27 74.31 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.021 -0.831 . . . . 0.28999999999999998 111.021 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.478 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.86 150.13 49.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.759 0.314 . . . . 2.3300000000000001 110.685 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.17 131.61 46.02 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.052 -0.522 . . . . 0.85999999999999999 109.825 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.972 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.1 m-85 -120.48 148.27 44.04 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.161 -0.472 . . . . 0.52000000000000002 111.018 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.28 125.37 60.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.279 -1.008 . . . . 0.29999999999999999 108.279 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.52 132.5 63.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.138 0.494 . . . . 0.23000000000000001 111.202 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.5 122.54 20.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.585 -0.734 . . . . 0.35999999999999999 109.673 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.59 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -100.95 125.46 54.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.296 -0.411 . . . . 0.19 110.609 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.0 m-85 -117.31 137.93 52.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.043 -0.526 . . . . 0.29999999999999999 109.823 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.426 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.73 135.0 42.86 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.774 -0.824 . . . . 0.37 108.774 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.554 ' O ' ' N ' ' A' ' 140' ' ' SER . 89.1 mt -99.04 122.96 51.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.102 0.477 . . . . 0.26000000000000001 110.988 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.0 p -83.85 169.65 14.91 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.538 -0.756 . . . . 0.28000000000000003 110.444 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -59.72 -14.6 14.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.012 -0.54 . . . . 1.6000000000000001 110.937 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.477 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.0 m-20 -95.97 -4.37 43.4 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.83 -0.348 . . . . 1.1799999999999999 110.834 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.85 13.95 63.79 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.347 -0.701 . . . . 0.29999999999999999 111.347 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -84.71 138.97 32.33 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.999 -0.281 . . . . 1.22 110.481 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.695 ' OE1' ' NH1' ' A' ' 143' ' ' ARG . 14.9 pt20 -106.6 141.08 38.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.97999999999999998 110.553 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.0 m -136.64 127.1 26.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.82999999999999996 110.409 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.29 117.36 9.99 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.683 -0.407 . . . . 0.26000000000000001 110.481 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.03 -21.84 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.29999999999999999 110.677 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.89 125.75 5.88 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.565 -0.454 . . . . 0.31 111.452 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.473 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.74 120.26 21.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.683 -0.69 . . . . 0.28000000000000003 109.505 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.61 151.73 29.17 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.653 -0.419 . . . . 0.23999999999999999 110.938 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.46 158.67 18.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.055 -0.521 . . . . 0.23000000000000001 110.404 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.4 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 68.1 mt-30 -146.14 157.89 43.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.174 -0.466 . . . . 0.67000000000000004 110.67 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.25 104.41 9.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.734 -0.666 . . . . 0.64000000000000001 110.1 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.9 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.853 -1.07 . . . . 1.26 110.667 -179.675 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.2 m . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.191 -0.67 . . . . 3.4399999999999999 109.191 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.34 150.65 18.55 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.057 -0.817 . . . . 1.22 111.057 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -35.67 142.41 0.1 Allowed 'Trans proline' 0 C--N 1.297 -2.166 0 C-N-CA 124.115 3.21 . . . . 0.75 113.718 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.605 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.4 t -80.07 173.53 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.205 -1.361 . . . . 0.79000000000000004 108.742 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.605 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.68 125.81 51.42 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.41 -0.516 . . . . 1.9399999999999999 111.522 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.44 143.97 34.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.684 -0.689 . . . . 0.59999999999999998 110.699 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.98 168.25 25.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.971 0.415 . . . . 3.1400000000000001 111.097 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.746 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.0 mt -108.94 131.05 60.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.935 -0.575 . . . . 3.23 110.118 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.21 162.34 35.72 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.468 -0.333 . . . . 3.6299999999999999 111.257 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 72.7 tt0 36.14 31.47 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 109.653 -0.499 . . . . 6.0800000000000001 109.653 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.746 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.35 69.54 31.59 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.935 -0.575 . . . . 3.3799999999999999 111.582 -178.753 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.632 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.22 -29.2 73.35 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.592 2.195 . . . . 3.9300000000000002 111.814 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.668 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 3.2 m 149.63 125.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 3.3599999999999999 110.413 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.668 ' NE2' ' O ' ' A' ' 13' ' ' SER . 1.8 mp0 -123.95 158.35 60.46 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.265 -0.425 . . . . 3.6099999999999999 110.481 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.646 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 98.3 Cg_endo -82.14 -64.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.83 2.353 . . . . 1.51 113.498 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.642 ' OD1' ' N ' ' A' ' 17' ' ' SER . 23.5 p-10 -108.44 -19.61 13.4 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.027 0.38 . . . . 2.6800000000000002 112.027 -178.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.642 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 93.6 p -107.4 151.93 24.86 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.469 -0.492 . . . . 1.21 111.297 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.576 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.11 102.98 2.26 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.684 -0.689 . . . . 1.5600000000000001 110.671 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.476 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.7 Cg_endo -82.72 145.72 12.99 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.872 2.381 . . . . 0.81000000000000005 112.556 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.909 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.84 167.97 24.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.849 -0.614 . . . . 1.52 109.879 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.15 147.94 29.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.795 -0.446 . . . . 2.1400000000000001 109.795 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.585 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.7 p90 -142.26 157.31 44.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.038 0.447 . . . . 0.32000000000000001 111.248 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.494 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.04 155.33 44.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.813 -0.631 . . . . 2.1699999999999999 110.09 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.831 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.6 173.19 6.18 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.085 -0.507 . . . . 0.58999999999999997 110.779 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.831 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.72 173.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.844 2.363 . . . . 0.90000000000000002 111.51 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.479 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -51.03 0.69 Allowed Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.723 -0.391 . . . . 3.3399999999999999 110.141 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.634 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.8 152.31 82.57 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.765 2.31 . . . . 1.8500000000000001 111.449 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.68 42.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.428 0.632 . . . . 2.54 110.631 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.9 t60 -63.56 -41.63 98.4 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.931 -1.031 . . . . 2.5299999999999998 110.676 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.556 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.2 mt -109.86 137.91 39.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.763 -0.653 . . . . 1.1699999999999999 111.234 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.01 -72.9 0.7 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.987 -0.551 . . . . 1.27 111.843 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.21 148.4 24.39 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.547 0.573 . . . . 1.1200000000000001 112.547 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.76 124.82 45.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.458 -0.571 . . . . 0.41999999999999998 109.458 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.7 mt -118.07 134.72 60.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.665 -0.414 . . . . 0.78000000000000003 110.632 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.909 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.99 128.64 53.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.062 0.458 . . . . 0.62 111.277 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.12 138.98 49.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.73 -0.668 . . . . 1.97 110.145 178.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.437 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.05 163.14 35.16 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.178 0.513 . . . . 0.34999999999999998 112.055 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.45 139.53 7.86 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.377 -0.829 . . . . 1.8 110.451 178.859 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.49 115.45 3.04 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.285 1.99 . . . . 0.57999999999999996 111.796 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.667 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.91 81.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.933 -0.395 . . . . 3.04 109.933 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.688 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.24 -20.58 0.06 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.059 -0.519 . . . . 2.4700000000000002 111.971 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.9 p -157.67 157.79 34.22 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.836 -0.345 . . . . 2.5099999999999998 110.604 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.404 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.41 27.77 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 1.8600000000000001 110.195 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.86 -75.84 1.31 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.022 -0.609 . . . . 1.4399999999999999 111.805 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.86 152.4 35.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.946 0.403 . . . . 4.6900000000000004 110.954 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.28 -169.18 2.54 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.0 -0.546 . . . . 1.4299999999999999 111.972 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.74 29.63 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.379 0.609 . . . . 1.74 112.611 -177.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.03 156.46 46.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.768 -1.105 . . . . 1.9199999999999999 110.291 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.18 158.36 41.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.004 -0.544 . . . . 0.34000000000000002 111.83 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 m -115.16 135.59 54.02 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.433 -0.803 . . . . 0.40999999999999998 109.893 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.585 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.3 121.94 23.89 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.509 -0.314 . . . . 0.55000000000000004 111.545 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.602 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.7 Cg_exo -46.28 151.74 1.59 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.744 2.296 . . . . 0.44 112.084 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.0 -23.03 63.27 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 116.045 -0.525 . . . . 0.73999999999999999 112.779 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.547 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.75 -16.88 46.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.384 0.592 . . . . 0.93000000000000005 111.81 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.602 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.6 mt -91.6 138.43 31.57 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.768 -0.373 . . . . 0.96999999999999997 110.254 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.54 14.0 11.0 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.302 -0.408 . . . . 1.3400000000000001 111.458 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.476 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.0 p -149.99 143.46 25.21 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.684 -0.406 . . . . 0.39000000000000001 111.081 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.722 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.82 -169.39 1.54 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.22 0.533 . . . . 0.41999999999999998 110.83 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.722 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.8 m -151.75 125.94 9.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.406 -0.815 . . . . 0.39000000000000001 109.832 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 67.0 mt -114.93 123.34 70.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.36 -0.536 . . . . 0.73999999999999999 111.134 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.747 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 16.6 ptpt -126.55 163.4 23.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.742 -0.663 . . . . 2.48 110.388 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.02 19.22 59.64 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.721 -0.951 . . . . 0.5 110.721 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.514 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.2 mt -79.16 157.23 27.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.127 0.489 . . . . 0.57999999999999996 111.306 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.85 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -99.47 133.98 21.52 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.588 -0.733 . . . . 2.79 110.486 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.458 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.88 143.62 61.6 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.554 2.169 . . . . 0.87 111.915 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.82 25.55 75.43 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.084 -0.806 . . . . 0.64000000000000001 111.084 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.85 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.3 p -128.09 158.75 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.691 0.281 . . . . 0.82999999999999996 110.51 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.06 139.99 41.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.908 0.385 . . . . 0.5 110.591 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.657 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.4 m-85 -122.62 136.43 54.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.948 -0.569 . . . . 0.53000000000000003 110.801 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.91 131.07 45.27 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.479 -0.934 . . . . 1.8700000000000001 108.479 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.57 153.89 16.67 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.281 -0.961 . . . . 0.28999999999999998 111.974 -178.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -135.01 140.9 46.02 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.628 -0.508 . . . . 1.4299999999999999 109.628 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.525 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.74 118.92 34.39 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.447 -0.501 . . . . 0.32000000000000001 110.551 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.738 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.42 129.1 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.378 -0.373 . . . . 0.79000000000000004 110.635 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.84 120.9 43.93 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.326 -0.397 . . . . 1.02 110.683 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.86 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.64 146.45 11.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.143 0.497 . . . . 0.62 111.099 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.621 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.1 mt-30 -106.0 153.92 21.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.58 -0.736 . . . . 2.4399999999999999 109.91 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.24 88.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.93 0.395 . . . . 3.6899999999999999 110.441 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.33 32.58 0.22 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.8 -0.636 . . . . 6.0800000000000001 110.543 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.03 -117.4 3.3 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.436 -0.666 . . . . 1.22 111.436 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -81.32 177.36 9.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.134 0.492 . . . . 2.8799999999999999 111.697 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.19 149.49 32.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.44 -0.8 . . . . 1.47 110.422 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.11 144.65 38.78 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.438 -0.346 . . . . 2.7000000000000002 110.624 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.738 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -127.97 136.02 61.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.135 0.493 . . . . 0.46000000000000002 111.527 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.09 141.37 52.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.681 -0.691 . . . . 0.34999999999999998 110.299 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.47 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.62 138.89 51.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.074 0.464 . . . . 3.6699999999999999 111.446 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.489 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.33 164.1 38.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.575 -0.739 . . . . 0.67000000000000004 109.485 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.577 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.28 151.51 38.47 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.393 -0.523 . . . . 1.47 111.048 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.804 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.2 p90 -146.21 172.79 12.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 0.44 110.972 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.82 160.72 21.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.345 -0.843 . . . . 1.3700000000000001 109.804 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.4 121.94 23.01 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.582 -0.447 . . . . 1.28 110.745 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.547 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -126.63 158.61 35.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.385 0.612 . . . . 1.97 112.279 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.739 ' O ' HG23 ' A' ' 94' ' ' THR . 22.6 t -59.33 -36.1 75.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.29 -0.868 . . . . 3.2799999999999998 111.185 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.739 HG23 ' O ' ' A' ' 93' ' ' SER . 9.8 p 131.7 37.92 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.381 1.051 . . . . 0.0 109.6 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.2 m -61.24 150.85 33.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.944 0.402 . . . . 0.0 110.63 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 44.8 p -128.96 76.47 79.17 Favored Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.719 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.93 141.76 96.2 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.631 1.554 . . . . 0.0 111.299 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.4 m -112.68 8.99 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.441 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.3 p -123.41 158.74 30.47 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.876 0.37 . . . . 0.0 110.891 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.0 m -85.31 5.2 31.56 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.443 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -100.29 145.04 28.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.937 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 50.2 m -75.13 139.05 42.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.221 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.0 m -64.48 134.47 29.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.4 t -108.4 5.65 25.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.224 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -167.35 -171.44 33.38 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -56.64 143.67 35.13 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.194 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.4 p -81.6 159.9 23.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.909 0.385 . . . . 0.0 110.909 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.95 77.85 75.97 Favored Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.398 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -55.21 142.33 78.63 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.097 1.865 . . . . 0.0 111.505 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.449 ' O ' ' CB ' ' A' ' 111' ' ' SER . 68.7 t80 -102.78 127.8 49.78 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.903 0.382 . . . . 0.0 110.799 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.458 ' CB ' ' CD ' ' A' ' 112' ' ' PRO . 0.5 OUTLIER 162.82 -66.22 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.474 179.255 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.458 ' CD ' ' CB ' ' A' ' 111' ' ' SER . 24.9 Cg_endo -60.21 148.53 89.47 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.583 2.189 . . . . 0.0 112.598 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 150' ' ' GLU . 53.1 mt -89.46 146.04 24.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.116 -0.698 . . . . 10.19 109.116 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.6 p -128.28 142.31 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.374 0.607 . . . . 7.2800000000000002 111.258 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -145.43 161.49 39.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.069 -0.969 . . . . 7.2999999999999998 109.635 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.7 p -74.84 158.03 34.1 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.729 -0.388 . . . . 6.4400000000000004 110.123 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.6 t -138.76 147.49 42.69 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.298 -0.41 . . . . 4.4199999999999999 111.449 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -61.96 -30.23 70.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.867 -0.606 . . . . 3.0499999999999998 110.082 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.7 m 65.51 99.5 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.544 -0.753 . . . . 3.4300000000000002 111.074 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.8 t -119.76 141.39 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.205 -0.907 . . . . 2.8799999999999999 109.545 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 25.3 p -73.98 159.98 31.97 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.575 -0.45 . . . . 2.0899999999999999 110.033 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.58 140.53 54.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.113 0.482 . . . . 4.5300000000000002 112.131 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.414 ' H ' ' HG2' ' A' ' 174' ' ' PRO . 15.5 tt -126.51 138.71 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.423 -0.808 . . . . 1.4399999999999999 109.479 178.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 38.4 m 41.56 -99.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.597 -0.274 . . . . 1.78 110.741 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -150.52 146.84 26.84 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.603 -0.439 . . . . 0.64000000000000001 111.251 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.634 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 4.5 p -133.48 11.46 4.11 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.473 0.654 . . . . 0.66000000000000003 110.167 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.438 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.9 167.55 0.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.297 -0.865 . . . . 0.68999999999999995 110.932 -179.636 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.54 145.56 50.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.707 -0.679 . . . . 0.52000000000000002 110.112 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.24 101.69 9.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.08 -0.711 . . . . 0.32000000000000001 109.08 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.3 t -113.0 139.62 37.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.108 -0.497 . . . . 0.28999999999999998 111.063 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.9 p -128.7 152.59 48.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.651 -0.704 . . . . 0.25 109.877 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.59 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.84 -164.96 2.04 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.63 -0.428 . . . . 0.31 110.621 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.9 t -123.97 127.23 73.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.48999999999999999 110.819 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.172 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.92 58.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.49 . . . . 1.53 110.37 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.17 24.62 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.925 -0.58 . . . . 0.96999999999999997 111.538 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.172 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.1 128.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.61 -0.436 . . . . 1.5600000000000001 110.932 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -86.38 -9.68 55.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.895 -0.593 . . . . 1.8799999999999999 110.332 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.07 0.21 55.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.115 -0.493 . . . . 1.04 110.304 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.26 137.16 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 0.23999999999999999 109.952 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.747 ' O ' ' NZ ' ' A' ' 61' ' ' LYS . 69.3 m -96.19 -15.56 21.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.242 0.544 . . . . 0.28999999999999998 110.019 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.61 175.56 45.78 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 109.915 -1.274 . . . . 0.13 109.915 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.44 151.66 42.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.027 0.442 . . . . 0.17000000000000001 110.465 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.764 ' NH2' ' OE2' ' A' ' 145' ' ' GLU . 31.6 ttt85 -132.43 121.23 23.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.058 -0.519 . . . . 1.29 109.887 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.11 136.47 38.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.697 -0.683 . . . . 0.25 110.655 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.764 ' OE2' ' NH2' ' A' ' 143' ' ' ARG . 97.6 mt-10 -129.37 129.86 45.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.097 -0.501 . . . . 1.3200000000000001 109.991 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.618 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.7 135.4 34.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.954 -0.566 . . . . 0.56999999999999995 110.614 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.417 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.44 161.27 40.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.78 -0.646 . . . . 1.1599999999999999 109.702 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.4 mt -71.0 124.81 25.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.029 0.442 . . . . 0.38 110.736 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.66 -7.82 50.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.726 -0.67 . . . . 0.40999999999999998 110.872 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.4 ' O ' ' O ' ' A' ' 113' ' ' LEU . 81.1 mt-10 -109.75 -69.6 0.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 1.6599999999999999 111.484 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.441 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.64 -35.39 76.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.053 -0.521 . . . . 1.6599999999999999 111.557 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.086 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.26 88.57 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.807 -0.917 . . . . 1.1699999999999999 110.807 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.337 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.89 -171.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 1.8600000000000001 110.278 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.337 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.09 45.2 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.021 0.439 . . . . 1.98 110.236 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.417 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.3 Cg_endo -70.96 145.86 51.26 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 C-N-CA 122.7 2.267 . . . . 0.55000000000000004 112.35 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.83 145.78 42.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.202 -0.666 . . . . 1.1399999999999999 109.202 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.521 ' CB ' ' NH1' ' A' ' 143' ' ' ARG . 35.9 p90 -123.33 141.31 52.11 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.303 -0.559 . . . . 0.93000000000000005 111.484 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.0 mt -128.1 127.7 43.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.317 -0.856 . . . . 0.34000000000000002 108.94 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.527 ' O ' ' OD1' ' A' ' 159' ' ' ASP . 54.7 p-10 -101.65 131.2 48.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.206 0.526 . . . . 1.0900000000000001 111.794 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.96 157.55 73.48 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.286 -0.87 . . . . 0.19 109.533 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.91 157.95 58.4 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 122.369 2.046 . . . . 0.17999999999999999 112.261 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.24 -12.04 4.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.832 -0.622 . . . . 0.20999999999999999 110.761 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.8 p -92.92 -8.74 42.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.451 . . . . 0.28999999999999998 110.642 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.25 135.47 34.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.349 -0.387 . . . . 0.5 110.353 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.8 p -133.21 16.79 4.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 0.29999999999999999 110.52 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.0 p -167.6 147.11 5.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.633 -0.506 . . . . 0.23000000000000001 109.633 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.12 150.46 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.516 -0.473 . . . . 0.28000000000000003 111.521 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.509 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 124.88 50.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.659 -0.7 . . . . 1.0700000000000001 109.849 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.31 104.91 29.58 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.377 -0.374 . . . . 0.28999999999999998 111.143 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.2 Cg_endo -91.0 -179.49 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.926 0 C-N-CA 123.135 2.557 . . . . 0.42999999999999999 112.218 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.69 32.59 18.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.31 -0.859 . . . . 1.26 111.465 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.634 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.1 mt -86.33 148.56 25.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.812 0.339 . . . . 0.32000000000000001 110.404 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.769 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.32 114.82 61.21 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.093 0.473 . . . . 0.57999999999999996 110.665 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.414 ' HG2' ' H ' ' A' ' 123' ' ' ILE . 21.9 Cg_exo -58.96 140.61 96.07 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.916 2.41 . . . . 0.66000000000000003 111.935 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.11 21.06 74.57 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.132 -0.787 . . . . 0.28999999999999998 111.132 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.441 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.76 150.16 49.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.746 0.308 . . . . 2.3300000000000001 110.668 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.495 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.21 131.61 46.06 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.105 -0.498 . . . . 0.85999999999999999 109.767 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.955 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.48 148.26 44.06 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.039 -0.528 . . . . 0.52000000000000002 110.948 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.6 mt -105.33 125.43 60.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.308 -0.997 . . . . 0.29999999999999999 108.308 177.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.64 132.5 63.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.199 0.523 . . . . 0.23000000000000001 111.174 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.64 20.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.549 -0.75 . . . . 0.35999999999999999 109.617 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.59 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.16 125.44 55.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.175 -0.466 . . . . 0.19 110.65 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 47.9 m-85 -117.17 137.86 52.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.99 -0.55 . . . . 0.29999999999999999 109.883 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.424 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.68 135.05 42.74 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.76 -0.83 . . . . 0.37 108.76 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.598 ' O ' ' N ' ' A' ' 140' ' ' SER . 79.6 mt -99.06 123.0 51.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.151 0.501 . . . . 0.26000000000000001 110.964 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.2 p -83.91 169.66 14.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.531 -0.759 . . . . 0.28000000000000003 110.443 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.523 ' O ' ' OG1' ' A' ' 59' ' ' THR . 97.0 mt-10 -59.67 -14.53 14.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.031 -0.531 . . . . 1.6000000000000001 111.069 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.3 m-20 -96.15 -4.26 42.99 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.855 -0.338 . . . . 1.1799999999999999 110.825 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.81 13.93 63.9 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.301 -0.72 . . . . 0.29999999999999999 111.301 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -84.65 139.12 32.27 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.994 -0.282 . . . . 1.22 110.476 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -106.71 141.06 38.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.897 0.38 . . . . 0.97999999999999998 110.527 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.72 126.97 26.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.82999999999999996 110.408 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.406 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.1 117.31 9.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.247 -0.433 . . . . 0.26000000000000001 110.532 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.0 -21.9 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.29999999999999999 110.699 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.85 125.86 5.95 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.52 -0.472 . . . . 0.31 111.51 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.469 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.93 120.22 21.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.741 -0.663 . . . . 0.28000000000000003 109.501 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.59 151.66 29.1 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.621 -0.432 . . . . 0.23999999999999999 110.941 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.41 158.5 18.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.518 . . . . 0.23000000000000001 110.45 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -146.03 157.95 43.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.135 -0.484 . . . . 0.67000000000000004 110.671 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 104.3 9.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.711 -0.677 . . . . 0.64000000000000001 110.056 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.981 -1.009 . . . . 1.26 110.637 -179.691 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.157 -0.683 . . . . 3.4399999999999999 109.157 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.31 150.62 18.56 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.078 -0.809 . . . . 1.22 111.078 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -35.61 142.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 123.944 3.096 . . . . 0.75 113.835 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.621 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -79.89 173.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.275 -1.329 . . . . 0.79000000000000004 108.898 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.621 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.59 125.9 51.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.164 0.507 . . . . 1.9399999999999999 111.464 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 p -136.55 144.06 33.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.625 -0.716 . . . . 0.59999999999999998 110.602 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.07 168.27 25.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.908 0.385 . . . . 3.1400000000000001 111.112 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.737 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -108.99 131.2 60.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.947 -0.569 . . . . 3.23 110.04 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 69.3 p -141.25 162.31 35.79 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.368 -0.378 . . . . 3.6299999999999999 111.162 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 9' ' ' THR . 29.9 tt0 36.12 31.56 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.659 -0.497 . . . . 6.0800000000000001 109.659 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.737 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.48 69.56 32.91 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.881 -0.599 . . . . 3.3799999999999999 111.489 -178.724 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.2 -29.2 73.56 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.618 2.212 . . . . 3.9300000000000002 111.808 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.6 125.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.14 -0.482 . . . . 3.3599999999999999 110.528 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.528 ' O ' ' O ' ' A' ' 92' ' ' THR . 7.0 mp0 -124.0 158.31 60.74 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.348 -0.387 . . . . 3.6099999999999999 110.408 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.528 ' HG2' ' CD ' ' A' ' 143' ' ' ARG . 97.3 Cg_endo -81.98 -64.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.812 2.342 . . . . 1.51 113.58 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.442 ' H ' ' HG2' ' A' ' 15' ' ' PRO . 99.4 m-20 -108.51 -19.51 13.42 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.072 0.397 . . . . 2.6800000000000002 112.072 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.649 ' OG ' HD13 ' A' ' 185' ' ' ILE . 2.6 m -107.38 152.0 24.75 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.13 0.491 . . . . 1.21 111.265 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.4 t-80 -155.25 102.98 2.23 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.691 -0.686 . . . . 1.5600000000000001 110.677 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -82.69 145.61 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.936 2.424 . . . . 0.81000000000000005 112.601 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.91 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.8 167.91 24.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.932 -0.576 . . . . 1.52 109.883 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.09 147.97 29.12 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.795 -0.446 . . . . 2.1400000000000001 109.795 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.4 p90 -142.32 157.31 44.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.047 0.451 . . . . 0.32000000000000001 111.112 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.494 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -128.07 155.31 44.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.789 -0.641 . . . . 2.1699999999999999 110.127 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.827 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.59 172.93 6.51 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.17 -0.468 . . . . 0.58999999999999997 110.815 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.827 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.52 173.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 122.869 2.379 . . . . 0.90000000000000002 111.573 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.12 -51.03 0.68 Allowed Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 120.68 -0.408 . . . . 3.3399999999999999 110.126 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.621 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.79 152.39 82.27 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.744 2.296 . . . . 1.8500000000000001 111.49 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.67 42.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.379 0.609 . . . . 2.54 110.552 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.621 ' H ' ' C ' ' A' ' 27' ' ' PRO . 73.9 t60 -63.56 -41.58 98.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.011 -0.995 . . . . 2.5299999999999998 110.707 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.557 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.4 mt -109.93 137.79 40.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.765 -0.652 . . . . 1.1699999999999999 111.255 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.92 -72.9 0.7 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.096 -0.502 . . . . 1.27 111.902 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.24 148.44 24.35 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.597 0.592 . . . . 1.1200000000000001 112.597 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.84 124.93 45.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.328 -0.619 . . . . 0.41999999999999998 109.328 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.7 mt -118.16 134.74 60.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.635 -0.426 . . . . 0.78000000000000003 110.623 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.91 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.03 128.57 53.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.057 0.456 . . . . 0.62 111.216 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.12 139.04 49.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.708 -0.678 . . . . 1.97 110.069 178.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.433 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.14 163.14 35.25 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-O 121.215 0.531 . . . . 0.34999999999999998 112.017 -178.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.42 139.59 7.92 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 115.421 -0.809 . . . . 1.8 110.431 178.906 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.55 115.51 3.09 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.256 1.971 . . . . 0.57999999999999996 111.825 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.67 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.08 81.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.885 -0.413 . . . . 3.04 109.885 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.21 -20.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.985 -0.552 . . . . 2.4700000000000002 111.886 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 p -157.65 157.78 34.23 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.789 -0.364 . . . . 2.5099999999999998 110.548 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 m -120.39 27.84 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.239 -0.437 . . . . 1.8600000000000001 110.224 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.89 -75.83 1.31 Allowed Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.141 -0.552 . . . . 1.4399999999999999 111.832 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.91 152.39 35.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.398 . . . . 4.6900000000000004 111.015 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.63 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.23 -169.15 2.54 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.166 -0.47 . . . . 1.4299999999999999 111.943 179.452 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.11 149.71 29.65 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.485 0.66 . . . . 1.74 112.532 -177.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.12 156.5 45.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.756 -1.111 . . . . 1.9199999999999999 110.281 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.25 158.33 41.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.981 -0.554 . . . . 0.34000000000000002 111.783 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 m -115.23 135.68 53.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.545 -0.752 . . . . 0.40999999999999998 109.757 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.596 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.45 121.96 23.71 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.55000000000000004 111.512 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.5 Cg_exo -46.41 151.77 1.68 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.699 2.266 . . . . 0.44 112.135 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.01 -23.02 63.27 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 116.106 -0.497 . . . . 0.73999999999999999 112.735 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.1 p-80 -82.68 -16.97 46.16 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 117.379 0.59 . . . . 0.93000000000000005 111.811 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.605 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.2 mt -91.56 138.44 31.56 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.728 -0.389 . . . . 0.96999999999999997 110.278 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.57 13.98 10.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.39 -0.368 . . . . 1.3400000000000001 111.572 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.4 p -150.0 143.49 25.22 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.593 -0.443 . . . . 0.39000000000000001 111.071 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.84 -169.4 1.54 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.261 0.553 . . . . 0.41999999999999998 110.818 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.714 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.75 125.87 9.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.361 -0.836 . . . . 0.39000000000000001 109.792 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.51 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.81 123.25 70.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.401 -0.52 . . . . 0.73999999999999999 111.248 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.668 ' NZ ' ' OG ' ' A' ' 140' ' ' SER . 59.6 mttp -126.47 163.33 23.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.838 -0.619 . . . . 2.48 110.426 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.19 18.97 59.79 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.712 -0.955 . . . . 0.5 110.712 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.51 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.2 mt -79.05 157.29 28.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.116 0.484 . . . . 0.57999999999999996 111.319 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.858 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -99.48 134.04 21.47 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.604 -0.725 . . . . 2.79 110.384 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.99 143.62 60.99 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.551 2.167 . . . . 0.87 111.902 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.65 75.31 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.081 -0.808 . . . . 0.64000000000000001 111.081 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.858 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.21 158.79 40.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.743 0.306 . . . . 0.82999999999999996 110.44 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.16 139.96 41.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.974 0.416 . . . . 0.5 110.547 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.639 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.55 136.51 54.9 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.855 -0.611 . . . . 0.53000000000000003 110.75 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.98 131.09 45.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.538 -0.912 . . . . 1.8700000000000001 108.538 177.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.487 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.53 153.84 16.66 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.322 -0.942 . . . . 0.28999999999999998 112.006 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -134.87 140.94 46.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.702 -0.481 . . . . 1.4299999999999999 109.702 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.83 118.88 34.23 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.496 -0.482 . . . . 0.32000000000000001 110.468 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.732 HG12 HG23 ' A' ' 84' ' ' VAL . 63.8 mt -112.36 129.04 68.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.293 -0.412 . . . . 0.79000000000000004 110.749 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.71 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.81 120.93 44.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.356 -0.383 . . . . 1.02 110.655 -179.637 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.854 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.62 146.42 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.115 0.483 . . . . 0.62 111.03 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.625 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.1 mt-30 -106.07 153.91 21.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.494 -0.776 . . . . 2.4399999999999999 109.843 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.14 88.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.958 0.409 . . . . 3.6899999999999999 110.479 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.32 32.52 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.847 -0.615 . . . . 6.0800000000000001 110.653 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.27 3.28 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.95 -0.643 . . . . 1.22 111.533 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -81.42 177.38 9.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.143 0.497 . . . . 2.8799999999999999 111.635 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.13 149.54 32.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.382 -0.827 . . . . 1.47 110.331 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.15 144.7 38.74 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.354 -0.385 . . . . 2.7000000000000002 110.6 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.732 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.0 136.0 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-O 121.047 0.451 . . . . 0.46000000000000002 111.587 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.599 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.07 141.39 52.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.66 -0.7 . . . . 0.34999999999999998 110.245 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.466 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.61 138.81 51.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.094 0.473 . . . . 3.6699999999999999 111.485 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.487 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.21 164.19 37.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.597 -0.729 . . . . 0.67000000000000004 109.51 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 46.9 p30 -145.21 151.56 38.59 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.441 -0.504 . . . . 1.47 111.071 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.81 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.8 p90 -146.28 172.68 13.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.729 -0.669 . . . . 0.44 110.994 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.73 160.68 21.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.443 -0.799 . . . . 1.3700000000000001 109.864 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.42 121.9 22.94 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.547 -0.461 . . . . 1.28 110.771 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.528 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.2 p -127.16 164.9 20.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 122.5 1.143 . . . . 1.97 114.033 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.522 ' OG ' ' CE2' ' A' ' 157' ' ' TYR . 22.4 t -133.75 162.48 31.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.198 -1.819 . . . . 3.2799999999999998 109.128 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 64.2 p -58.03 -7.61 0.82 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 93' ' ' SER . 52.0 p -65.3 162.73 16.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.529 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.1 m -124.03 74.41 57.56 Favored Pre-proline 0 N--CA 1.464 0.251 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.125 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.57 145.82 96.96 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.564 2.176 . . . . 0.0 112.534 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 98' ' ' VAL . 3.9 p -113.96 26.61 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.397 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.0 p 48.3 36.19 6.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.769 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.2 t -129.89 141.72 50.76 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.122 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -107.53 129.3 54.98 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.814 0.34 . . . . 0.0 110.529 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.478 ' H ' HG22 ' A' ' 102' ' ' THR . 0.0 OUTLIER -64.41 -39.34 93.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.25 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.2 p -131.67 144.24 38.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.372 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 49.8 m -117.59 138.92 51.61 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.213 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.35 -171.43 41.66 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.63 -33.26 72.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.831 0.348 . . . . 0.0 110.41 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.8 p -123.43 163.32 21.08 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.725 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.0 p -124.12 74.04 57.93 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.766 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -61.0 145.7 98.77 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.556 2.171 . . . . 0.0 113.293 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -58.04 -37.04 73.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.853 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.746 ' H ' ' CD ' ' A' ' 112' ' ' PRO . 1.3 p -167.56 -38.44 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.993 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.746 ' CD ' ' H ' ' A' ' 111' ' ' SER . 51.6 Cg_exo -54.8 142.06 75.14 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.029 1.819 . . . . 0.0 112.595 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.591 ' O ' ' O ' ' A' ' 114' ' ' VAL . 56.6 mt -85.15 -4.61 59.22 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.84 -0.618 . . . . 10.19 110.995 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.591 ' O ' ' O ' ' A' ' 113' ' ' LEU . 2.5 m 27.54 111.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 123.611 0.569 . . . . 7.2800000000000002 112.473 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.29 145.04 52.74 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.573 -0.528 . . . . 7.2999999999999998 109.573 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.5 m -57.55 -41.68 81.49 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.247 -0.581 . . . . 6.4400000000000004 110.093 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.703 ' O ' ' O ' ' A' ' 118' ' ' GLU . 55.0 m -126.19 150.83 48.07 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.727 -0.669 . . . . 4.4199999999999999 110.265 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.75 ' O ' ' O ' ' A' ' 119' ' ' SER . 57.6 mp0 -23.82 -114.57 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.675 0.609 . . . . 3.0499999999999998 112.026 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.75 ' O ' ' O ' ' A' ' 118' ' ' GLU . 83.6 p 25.67 -167.3 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.816 0.673 . . . . 3.4300000000000002 112.816 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.614 ' O ' ' O ' ' A' ' 119' ' ' SER . 41.5 t 48.81 128.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.59 -0.732 . . . . 2.8799999999999999 111.753 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.5 p -120.14 160.38 23.0 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.09 -0.504 . . . . 2.0899999999999999 110.108 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -107.37 141.1 39.27 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.168 -0.469 . . . . 4.5300000000000002 111.081 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.1 mt -113.54 134.1 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.847 -0.797 . . . . 1.4399999999999999 108.847 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 124' ' ' THR . 0.0 OUTLIER -75.93 110.65 10.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.107 0.48 . . . . 1.78 111.65 -178.63 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -116.91 -93.98 0.5 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.759 -0.83 . . . . 0.64000000000000001 108.759 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 67.5 p -66.1 -14.69 62.2 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.557 -0.905 . . . . 0.66000000000000003 108.557 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.438 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.76 167.61 0.24 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.878 -1.056 . . . . 0.68999999999999995 110.897 -179.184 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.65 145.52 50.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.688 -0.687 . . . . 0.52000000000000002 110.117 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.28 101.63 9.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.076 -0.713 . . . . 0.32000000000000001 109.076 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.4 t -112.87 139.73 36.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.056 -0.52 . . . . 0.28999999999999998 111.097 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.0 p -128.75 152.56 48.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.599 -0.728 . . . . 0.25 109.816 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.59 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.8 -164.93 2.03 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.742 -0.383 . . . . 0.31 110.67 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.731 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.7 t -123.98 127.17 73.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.18 -0.463 . . . . 0.48999999999999999 110.718 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.162 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.98 58.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.135 -0.484 . . . . 1.53 110.297 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.731 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.05 24.42 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.991 -0.55 . . . . 0.96999999999999997 111.533 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.162 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.23 128.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.549 -0.46 . . . . 1.5600000000000001 110.954 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.44 -9.61 55.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.979 -0.555 . . . . 1.8799999999999999 110.288 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.8 p -87.09 0.27 55.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 1.04 110.282 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.29 137.26 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.064 -0.517 . . . . 0.23999999999999999 109.913 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.668 ' OG ' ' NZ ' ' A' ' 61' ' ' LYS . 10.9 p -96.26 -15.49 21.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.287 0.565 . . . . 0.28999999999999998 110.076 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.57 175.57 45.76 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.91 -1.276 . . . . 0.13 109.91 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.48 151.63 42.54 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.578 -0.449 . . . . 0.17000000000000001 110.458 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.723 ' NH2' ' OE1' ' A' ' 191' ' ' GLN . 52.3 ttp85 -132.38 121.17 23.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.108 -0.496 . . . . 1.29 109.997 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.557 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.08 136.59 38.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.686 -0.688 . . . . 0.25 110.694 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 73.8 tt0 -129.34 129.87 45.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.981 -0.554 . . . . 1.3200000000000001 110.109 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.72 135.27 34.57 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.027 -0.533 . . . . 0.56999999999999995 110.602 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.421 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.32 39.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.83 -0.623 . . . . 1.1599999999999999 109.739 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.951 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.0 124.89 25.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.995 0.426 . . . . 0.38 110.694 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.494 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.9 -7.63 49.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.757 -0.656 . . . . 0.40999999999999998 110.856 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.81 -69.6 0.85 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.924 0.393 . . . . 1.6599999999999999 111.468 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.46 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.7 -35.27 75.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.02 -0.537 . . . . 1.6599999999999999 111.498 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.099 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.01 7.29 88.54 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.838 -0.905 . . . . 1.1699999999999999 110.838 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.324 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.97 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.817 0.342 . . . . 1.8600000000000001 110.261 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.324 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.17 139.04 45.43 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.407 . . . . 1.98 110.199 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.9 Cg_endo -70.86 145.8 51.75 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.753 2.302 . . . . 0.55000000000000004 112.376 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.79 145.63 42.65 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.276 -0.639 . . . . 1.1399999999999999 109.276 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.633 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 88.1 m-85 -123.31 141.46 51.96 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.311 -0.556 . . . . 0.93000000000000005 111.516 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.17 127.63 43.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.306 -0.861 . . . . 0.34000000000000002 108.951 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -101.61 131.21 47.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.075 0.464 . . . . 1.0900000000000001 111.687 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.96 157.59 73.37 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.347 -0.842 . . . . 0.19 109.553 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.85 158.02 58.23 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 122.413 2.075 . . . . 0.17999999999999999 112.247 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.31 -12.15 5.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.742 -0.663 . . . . 0.20999999999999999 110.684 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.9 p -92.8 -8.76 42.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.148 -0.478 . . . . 0.28999999999999998 110.783 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.46 34.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.5 110.435 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.25 16.78 4.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.29999999999999999 110.52 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.5 p -167.58 147.1 5.04 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.596 -0.52 . . . . 0.23000000000000001 109.596 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.21 150.49 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.458 -0.497 . . . . 0.28000000000000003 111.55 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.25 125.03 50.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.606 -0.725 . . . . 1.0700000000000001 109.822 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.49 104.88 30.05 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.378 -0.374 . . . . 0.28999999999999998 111.011 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.8 Cg_endo -90.97 -179.5 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 123.195 2.597 . . . . 0.42999999999999999 112.24 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.67 32.64 18.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.381 -0.827 . . . . 1.26 111.435 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.0 mt -86.29 148.59 25.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.467 -0.333 . . . . 0.32000000000000001 110.563 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.76 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.37 114.86 61.37 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.016 0.436 . . . . 0.57999999999999996 110.624 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.07 140.61 95.97 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.83 2.353 . . . . 0.66000000000000003 111.93 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.1 21.21 74.25 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.006 -0.838 . . . . 0.28999999999999998 111.006 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.46 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.87 150.13 49.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.752 0.311 . . . . 2.3300000000000001 110.756 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.494 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.15 131.7 45.94 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.85999999999999999 109.728 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.951 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.7 m-85 -120.49 148.31 44.0 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.091 -0.504 . . . . 0.52000000000000002 111.02 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.7 mt -105.25 125.25 60.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.347 -0.983 . . . . 0.29999999999999999 108.347 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.51 132.45 63.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.198 0.523 . . . . 0.23000000000000001 111.303 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.44 122.6 20.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.542 -0.754 . . . . 0.35999999999999999 109.655 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.59 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.12 125.38 55.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.257 -0.429 . . . . 0.19 110.627 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.7 m-85 -117.15 137.86 52.04 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.534 . . . . 0.29999999999999999 109.882 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.418 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.68 135.11 42.64 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.846 -0.798 . . . . 0.37 108.846 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.649 HD13 ' OG ' ' A' ' 17' ' ' SER . 26.6 mt -99.09 123.01 51.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.074 0.464 . . . . 0.26000000000000001 110.918 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.592 ' OG ' ' OD1' ' A' ' 188' ' ' ASP . 87.4 p -83.91 169.73 14.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.515 -0.766 . . . . 0.28000000000000003 110.529 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.77 -14.55 15.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.096 -0.502 . . . . 1.6000000000000001 110.953 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.671 ' OD1' ' N ' ' A' ' 190' ' ' GLU . 37.1 p30 -96.18 -4.16 43.08 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.785 -0.366 . . . . 1.1799999999999999 110.773 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.74 13.86 64.17 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.339 -0.705 . . . . 0.29999999999999999 111.339 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.671 ' N ' ' OD1' ' A' ' 188' ' ' ASP . 84.4 tt0 -84.59 139.03 32.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.705 0.288 . . . . 1.22 110.456 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.723 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 87.4 mt-30 -106.74 141.03 38.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.97999999999999998 110.557 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.0 m -136.72 127.15 26.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 0.82999999999999996 110.326 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.7 tp -68.21 117.38 9.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.26000000000000001 110.454 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.4 pt -109.08 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.29999999999999999 110.71 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.5 tp -156.91 125.74 5.86 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.511 -0.476 . . . . 0.31 111.448 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.463 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.77 120.28 21.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.775 -0.648 . . . . 0.28000000000000003 109.504 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.67 151.68 29.06 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.628 -0.429 . . . . 0.23999999999999999 110.901 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.43 158.58 18.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.986 -0.552 . . . . 0.23000000000000001 110.492 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -146.05 158.04 43.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.67000000000000004 110.633 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.35 104.31 9.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.717 -0.674 . . . . 0.64000000000000001 109.981 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.9 p . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.94 -1.028 . . . . 1.26 110.701 -179.767 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.0 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.223 -0.658 . . . . 3.4399999999999999 109.223 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.46 150.67 18.53 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.971 -0.852 . . . . 1.22 110.971 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -35.58 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.056 0 C-N-CA 124.009 3.139 . . . . 0.75 113.811 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.6 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.94 173.47 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.219 -1.355 . . . . 0.79000000000000004 108.882 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.6 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.64 125.92 51.54 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.376 -0.529 . . . . 1.9399999999999999 111.444 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.51 143.96 34.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.671 -0.695 . . . . 0.59999999999999998 110.691 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.01 168.3 25.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.923 0.392 . . . . 3.1400000000000001 111.093 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.749 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.7 mt -109.06 131.08 60.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.975 -0.557 . . . . 3.23 110.098 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.16 162.26 35.92 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.466 -0.334 . . . . 3.6299999999999999 111.255 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 73.7 mm-40 36.15 31.63 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.558 -0.534 . . . . 6.0800000000000001 109.558 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.749 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.53 69.6 33.5 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.006 -0.543 . . . . 3.3799999999999999 111.521 -178.736 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.639 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.37 -28.99 71.87 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.433 2.089 . . . . 3.9300000000000002 111.906 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.681 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 3.2 m 149.58 125.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 3.3599999999999999 110.481 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.681 ' NE2' ' O ' ' A' ' 13' ' ' SER . 3.4 mp0 -123.96 158.39 60.39 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.314 -0.403 . . . . 3.6099999999999999 110.409 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.619 ' CG ' ' NH1' ' A' ' 143' ' ' ARG . 97.2 Cg_endo -82.03 -64.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.902 2.402 . . . . 1.51 113.488 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.62 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 64.6 t30 -108.46 -19.59 13.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.305 -0.407 . . . . 2.6800000000000002 112.012 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 5.3 p -107.3 152.11 24.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.187 0.518 . . . . 1.21 111.242 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.573 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.34 102.89 2.22 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.7 -0.682 . . . . 1.5600000000000001 110.685 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.559 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.67 145.57 13.01 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.923 2.415 . . . . 0.81000000000000005 112.605 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.909 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.75 167.95 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.881 -0.6 . . . . 1.52 109.895 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.21 147.94 29.01 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.674 -0.491 . . . . 2.1400000000000001 109.674 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.58 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.27 157.33 44.95 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.605 -0.438 . . . . 0.32000000000000001 111.195 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.494 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.2 m-20 -128.04 155.29 44.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.781 -0.645 . . . . 2.1699999999999999 110.017 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.838 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.63 172.99 6.41 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.128 -0.487 . . . . 0.58999999999999997 110.737 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.838 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.68 173.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.851 2.367 . . . . 0.90000000000000002 111.598 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.98 -51.15 0.69 Allowed Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 120.725 -0.39 . . . . 3.3399999999999999 110.051 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.637 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.4 Cg_exo -64.75 152.36 82.31 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.783 2.322 . . . . 1.8500000000000001 111.477 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.75 42.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.35 0.595 . . . . 2.54 110.46 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.637 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.8 t60 -63.6 -41.64 98.3 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.059 -0.973 . . . . 2.5299999999999998 110.625 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.559 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.4 mt -109.82 137.76 40.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.811 -0.631 . . . . 1.1699999999999999 111.276 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.88 -72.91 0.7 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.053 -0.522 . . . . 1.27 111.965 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.18 148.4 24.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.617 0.599 . . . . 1.1200000000000001 112.617 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -121.78 124.89 45.27 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.315 -0.624 . . . . 0.41999999999999998 109.315 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.02 134.68 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.623 -0.431 . . . . 0.78000000000000003 110.67 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.909 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.93 128.6 53.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.978 0.418 . . . . 0.62 111.283 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.92 49.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.724 -0.671 . . . . 1.97 110.217 178.933 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.441 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.0 163.21 34.89 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.169 0.509 . . . . 0.34999999999999998 112.054 -178.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.56 139.56 7.78 Favored Pre-proline 0 C--N 1.333 -0.12 0 CA-C-N 115.346 -0.843 . . . . 1.8 110.428 178.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.46 115.42 3.01 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.318 2.012 . . . . 0.57999999999999996 111.802 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.97 81.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.92 -0.4 . . . . 3.04 109.92 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.23 -20.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 2.4700000000000002 111.936 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.2 p -157.68 157.76 34.13 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.737 -0.385 . . . . 2.5099999999999998 110.51 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.4 m -120.29 27.82 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.182 -0.463 . . . . 1.8600000000000001 110.186 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.83 -75.87 1.31 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.178 -0.534 . . . . 1.4399999999999999 111.829 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.89 152.2 35.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.898 0.38 . . . . 4.6900000000000004 111.055 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.11 -169.14 2.55 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.113 -0.494 . . . . 1.4299999999999999 111.954 179.394 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.441 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.12 149.68 29.71 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.456 0.646 . . . . 1.74 112.672 -177.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.07 156.5 45.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.858 -1.065 . . . . 1.9199999999999999 110.285 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.24 158.34 41.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.903 -0.589 . . . . 0.34000000000000002 111.873 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 m -115.19 135.58 54.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.472 -0.785 . . . . 0.40999999999999998 109.865 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.58 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.35 121.93 23.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.467 -0.333 . . . . 0.55000000000000004 111.538 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.598 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.7 Cg_exo -46.41 151.77 1.68 Allowed 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.666 2.244 . . . . 0.44 112.059 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.04 -22.85 63.14 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-N 115.957 -0.565 . . . . 0.73999999999999999 112.81 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.84 -16.89 45.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.371 0.586 . . . . 0.93000000000000005 111.825 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.598 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.53 138.42 31.59 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.725 -0.39 . . . . 0.96999999999999997 110.375 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.55 13.95 10.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.387 -0.369 . . . . 1.3400000000000001 111.551 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.99 143.4 25.17 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.681 -0.408 . . . . 0.39000000000000001 111.098 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.75 -169.25 1.51 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.037 -0.528 . . . . 0.41999999999999998 110.906 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.76 ' OG1' ' N ' ' A' ' 189' ' ' GLY . 1.3 m -151.82 125.86 9.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.432 -0.804 . . . . 0.39000000000000001 109.805 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.517 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.8 123.25 70.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.429 -0.508 . . . . 0.73999999999999999 111.21 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -126.48 163.41 23.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.842 -0.617 . . . . 2.48 110.436 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.457 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.17 18.99 59.79 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.631 -0.988 . . . . 0.5 110.631 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.62 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 74.1 mt -79.07 157.26 28.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.149 0.5 . . . . 0.57999999999999996 111.309 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.843 ' O ' HG12 ' A' ' 67' ' ' VAL . 10.9 mttp -99.44 133.95 21.56 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.588 -0.733 . . . . 2.79 110.494 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.421 ' HD3' ' CE2' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.84 143.6 61.72 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.637 2.225 . . . . 0.87 111.916 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.79 25.5 75.48 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.105 -0.798 . . . . 0.64000000000000001 111.105 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.843 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.09 158.79 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.321 . . . . 0.82999999999999996 110.449 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.19 139.91 42.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.94 0.4 . . . . 0.5 110.534 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.65 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.7 m-85 -122.53 136.45 54.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.944 -0.571 . . . . 0.53000000000000003 110.776 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.84 131.02 45.27 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.483 -0.932 . . . . 1.8700000000000001 108.483 177.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.49 153.9 16.65 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.301 -0.952 . . . . 0.28999999999999998 111.943 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -134.96 140.93 46.09 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.71 -0.478 . . . . 1.4299999999999999 109.71 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.9 tp -115.67 118.93 34.44 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.476 -0.489 . . . . 0.32000000000000001 110.488 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.733 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.51 129.19 68.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.342 -0.39 . . . . 0.79000000000000004 110.647 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.705 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.92 120.7 43.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.242 -0.436 . . . . 1.02 110.774 -179.632 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.853 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.52 146.5 11.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.217 0.532 . . . . 0.62 111.02 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.623 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.01 153.85 21.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.536 -0.756 . . . . 2.4399999999999999 109.982 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.13 88.47 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.898 0.38 . . . . 3.6899999999999999 110.521 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.36 32.6 0.22 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.78 -0.645 . . . . 6.0800000000000001 110.589 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.33 3.29 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.504 -0.638 . . . . 1.22 111.504 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -81.36 177.38 9.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.135 0.493 . . . . 2.8799999999999999 111.687 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.17 149.5 32.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.401 -0.818 . . . . 1.47 110.401 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.13 144.68 38.75 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.459 -0.337 . . . . 2.7000000000000002 110.613 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.733 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.04 135.95 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.049 0.452 . . . . 0.46000000000000002 111.473 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.02 141.34 52.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.599 -0.728 . . . . 0.34999999999999998 110.236 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.64 138.85 51.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.117 0.484 . . . . 3.6699999999999999 111.541 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.25 164.18 37.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.506 -0.77 . . . . 0.67000000000000004 109.493 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.572 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.25 151.51 38.49 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.41 -0.516 . . . . 1.47 111.084 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.802 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.5 p90 -146.19 172.65 13.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.762 -0.654 . . . . 0.44 111.104 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.61 160.67 21.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.467 -0.788 . . . . 1.3700000000000001 109.861 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.37 121.98 23.12 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 120.63 -0.428 . . . . 1.28 110.747 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.564 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.8 p -127.83 164.23 22.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.647 0.737 . . . . 1.97 112.689 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.525 ' C ' ' H ' ' A' ' 95' ' ' SER . 30.5 t -115.75 149.18 38.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.63 -1.168 . . . . 3.2799999999999998 109.682 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 58.6 p -59.48 -3.52 0.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.335 0.588 . . . . 0.0 109.863 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.525 ' H ' ' C ' ' A' ' 93' ' ' SER . 13.0 m -53.89 -33.54 56.84 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.52 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.9 m 63.29 68.19 0.95 Allowed Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.88 150.33 23.36 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.768 2.312 . . . . 0.0 112.457 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.5 m -60.02 136.67 23.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.126 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.1 m -58.56 -40.34 82.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.608 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 65.0 m -163.45 10.2 0.05 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.114 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -54.8 -36.93 65.47 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.247 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.9 m -79.72 138.4 37.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.067 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.8 m -128.69 155.55 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.929 0.395 . . . . 0.0 110.97 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 45.6 m -123.54 140.42 53.02 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.76 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -155.54 134.73 4.28 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.729 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -59.55 -31.77 69.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.077 0.465 . . . . 0.0 110.251 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.4 m -55.16 -36.09 65.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.411 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.8 p -53.92 147.06 25.57 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.682 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.93 147.59 80.95 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.655 2.236 . . . . 0.0 112.995 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -94.49 6.15 49.65 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.722 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.1 p -108.32 102.48 46.92 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.755 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -53.85 150.89 28.21 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.463 2.109 . . . . 0.0 112.417 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.5 mt -58.1 -32.74 68.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.67 -0.696 . . . . 10.19 110.87 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 25.8 m -126.01 158.32 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.922 0.392 . . . . 7.2800000000000002 110.731 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.95 144.75 52.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.02 -0.536 . . . . 7.2999999999999998 111.032 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.6 p -70.5 -15.67 62.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.677 -0.692 . . . . 6.4400000000000004 111.011 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.0 m -60.09 152.94 22.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.816 0.341 . . . . 4.4199999999999999 110.546 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.95 -33.65 75.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.997 -0.547 . . . . 3.0499999999999998 111.192 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 47.7 m -65.13 150.71 47.68 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.68 -0.408 . . . . 3.4300000000000002 110.856 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.1 m -131.2 156.36 42.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.002 -0.544 . . . . 2.8799999999999999 110.446 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 49.9 m -84.85 136.04 33.83 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.708 -0.479 . . . . 2.0899999999999999 109.708 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -60.51 139.99 57.5 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.595 -0.442 . . . . 4.5300000000000002 110.548 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.417 ' C ' ' OG1' ' A' ' 124' ' ' THR . 83.3 mt -94.42 -76.3 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.145 -0.48 . . . . 1.4399999999999999 110.106 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.417 ' OG1' ' C ' ' A' ' 123' ' ' ILE . 0.1 OUTLIER -177.91 50.04 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.821 -0.627 . . . . 1.78 109.589 179.476 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 63.74 23.43 13.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.822 -0.626 . . . . 0.64000000000000001 110.504 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.5 p -63.45 -25.78 68.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.596 . . . . 0.66000000000000003 110.312 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.438 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.85 167.57 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.483 -0.78 . . . . 0.68999999999999995 111.003 -179.283 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.58 145.57 50.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.746 -0.661 . . . . 0.52000000000000002 110.141 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.28 101.7 9.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.073 -0.714 . . . . 0.32000000000000001 109.073 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.5 t -112.93 139.63 37.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.28999999999999998 111.069 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 p -128.7 152.58 48.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.621 -0.718 . . . . 0.25 109.834 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.59 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.9 p90 -144.78 -165.01 2.05 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.687 -0.405 . . . . 0.31 110.675 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -123.95 127.16 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.198 -0.455 . . . . 0.48999999999999999 110.861 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.175 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.88 58.32 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.086 -0.506 . . . . 1.53 110.402 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.12 24.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.934 -0.576 . . . . 0.96999999999999997 111.435 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.175 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.12 128.69 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.594 -0.443 . . . . 1.5600000000000001 110.98 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.4 -9.55 56.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.58 . . . . 1.8799999999999999 110.278 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.0 p -87.09 0.2 55.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.08 0.467 . . . . 1.04 110.358 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.22 137.07 25.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.951 -0.568 . . . . 0.23999999999999999 109.961 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.602 ' N ' ' O ' ' A' ' 185' ' ' ILE . 89.4 p -96.12 -15.54 22.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.262 0.553 . . . . 0.28999999999999998 110.057 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.56 175.6 45.78 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 109.861 -1.296 . . . . 0.13 109.861 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -123.45 151.65 42.47 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.65 -0.42 . . . . 0.17000000000000001 110.529 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.619 ' NH1' ' CG ' ' A' ' 15' ' ' PRO . 36.7 ttp85 -132.33 121.16 23.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.131 -0.486 . . . . 1.29 109.919 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 167' ' ' VAL . 46.5 t -105.09 136.48 38.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.705 -0.679 . . . . 0.25 110.661 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 85.2 tt0 -129.33 129.88 45.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.029 -0.532 . . . . 1.3200000000000001 110.013 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.75 135.25 34.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.56999999999999995 110.638 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.42 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.26 161.3 39.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.659 -0.7 . . . . 1.1599999999999999 109.704 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.951 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.1 mt -70.98 124.87 25.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.068 0.461 . . . . 0.38 110.729 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.73 -7.77 50.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.766 -0.652 . . . . 0.40999999999999998 110.874 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.79 -69.67 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.35 -0.386 . . . . 1.6599999999999999 111.416 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.435 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.74 -35.33 76.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.076 -0.511 . . . . 1.6599999999999999 111.42 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.088 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.22 88.6 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.785 -0.926 . . . . 1.1699999999999999 110.785 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.336 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.89 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.778 0.323 . . . . 1.8600000000000001 110.25 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.336 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.33 138.99 44.87 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.941 0.401 . . . . 1.98 110.145 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.477 ' CG ' ' OG ' ' A' ' 95' ' ' SER . 47.2 Cg_endo -70.79 145.76 52.05 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.635 2.223 . . . . 0.55000000000000004 112.406 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.79 145.66 42.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.264 -0.643 . . . . 1.1399999999999999 109.264 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.581 ' CE1' ' CG ' ' A' ' 16' ' ' ASN . 6.3 p90 -123.27 141.23 52.19 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.453 -0.499 . . . . 0.93000000000000005 111.567 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.6 mt -128.03 127.66 43.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.35 -0.841 . . . . 0.34000000000000002 108.964 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.593 ' HB2' HD21 ' A' ' 16' ' ' ASN . 30.1 t0 -101.65 131.16 48.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.185 0.517 . . . . 1.0900000000000001 111.767 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.99 157.57 73.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.31 -0.859 . . . . 0.19 109.508 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -69.8 157.96 58.52 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.437 2.091 . . . . 0.17999999999999999 112.197 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.4 p -59.11 -12.27 4.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.737 -0.665 . . . . 0.20999999999999999 110.813 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.4 p -92.83 -8.71 42.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.128 -0.487 . . . . 0.28999999999999998 110.633 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.31 34.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.454 -0.339 . . . . 0.5 110.364 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.1 p -133.05 16.65 4.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.454 -0.339 . . . . 0.29999999999999999 110.624 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.6 p -167.55 147.11 5.07 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.61 -0.515 . . . . 0.23000000000000001 109.61 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.21 150.42 12.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.548 -0.461 . . . . 0.28000000000000003 111.598 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 124.95 50.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.628 -0.715 . . . . 1.0700000000000001 109.811 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.4 104.87 29.68 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.428 -0.351 . . . . 0.28999999999999998 111.038 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.8 Cg_endo -91.04 -179.58 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 123.224 2.616 . . . . 0.42999999999999999 112.179 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.78 32.59 18.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.324 -0.853 . . . . 1.26 111.427 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.1 mt -86.36 148.51 25.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.476 -0.329 . . . . 0.32000000000000001 110.532 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.77 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.22 114.77 60.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.982 0.42 . . . . 0.57999999999999996 110.688 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -58.97 140.57 95.91 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.891 2.394 . . . . 0.66000000000000003 112.017 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.06 21.25 74.25 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.047 -0.821 . . . . 0.28999999999999998 111.047 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.435 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.97 150.23 49.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 2.3300000000000001 110.62 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.2 131.64 46.02 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.077 -0.511 . . . . 0.85999999999999999 109.809 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.951 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.54 148.33 43.99 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.136 -0.484 . . . . 0.52000000000000002 110.992 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.1 mt -105.35 125.41 60.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.281 -1.007 . . . . 0.29999999999999999 108.281 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.58 132.57 63.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.126 0.489 . . . . 0.23000000000000001 111.247 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.58 122.52 20.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.57 -0.741 . . . . 0.35999999999999999 109.69 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.59 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -100.94 125.36 54.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.242 -0.436 . . . . 0.19 110.62 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.2 m-85 -117.17 137.86 52.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.023 -0.535 . . . . 0.29999999999999999 109.956 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.426 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.67 134.95 42.88 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.838 -0.801 . . . . 0.37 108.838 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.602 ' O ' ' N ' ' A' ' 140' ' ' SER . 84.3 mt -99.1 122.94 51.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.09 0.471 . . . . 0.26000000000000001 110.962 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.9 p -83.88 169.68 14.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.518 -0.764 . . . . 0.28000000000000003 110.461 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 187' ' ' GLU . 43.3 tt0 -59.67 -14.63 14.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.077 -0.511 . . . . 1.6000000000000001 110.936 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.732 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.6 m-20 -96.07 -4.27 43.26 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.866 -0.333 . . . . 1.1799999999999999 110.818 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.76 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.79 13.87 64.04 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.312 -0.715 . . . . 0.29999999999999999 111.312 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -84.62 139.13 32.29 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.015 -0.274 . . . . 1.22 110.449 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.73 141.11 38.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.797 0.332 . . . . 0.97999999999999998 110.601 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.75 126.97 26.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.82999999999999996 110.402 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.12 117.22 9.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.386 -0.37 . . . . 0.26000000000000001 110.543 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 43.8 pt -108.97 -21.8 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.457 . . . . 0.29999999999999999 110.838 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.93 125.74 5.85 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.467 -0.493 . . . . 0.31 111.49 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.7 120.17 21.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.702 -0.681 . . . . 0.28000000000000003 109.576 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.58 151.76 29.23 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.594 -0.443 . . . . 0.23999999999999999 110.929 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.48 158.56 18.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.007 -0.542 . . . . 0.23000000000000001 110.38 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -146.08 157.9 43.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 0.67000000000000004 110.646 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.14 104.34 9.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.748 -0.66 . . . . 0.64000000000000001 110.043 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.01 -0.995 . . . . 1.26 110.653 -179.791 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.553 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.6 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.226 -0.657 . . . . 3.4399999999999999 109.226 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.64 18.54 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.071 -0.811 . . . . 1.22 111.071 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -35.62 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.297 -2.147 0 C-N-CA 124.039 3.159 . . . . 0.75 113.773 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.606 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.0 t -79.83 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.296 -1.32 . . . . 0.79000000000000004 108.912 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.606 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.66 125.9 51.53 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.489 -0.484 . . . . 1.9399999999999999 111.424 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.57 143.91 34.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.677 -0.692 . . . . 0.59999999999999998 110.57 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.97 168.33 25.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.966 0.412 . . . . 3.1400000000000001 111.142 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.742 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.0 130.99 60.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.976 -0.557 . . . . 3.23 110.101 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.8 p -141.14 162.26 35.9 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.902 0.382 . . . . 3.6299999999999999 111.164 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 21.3 pt-20 36.12 31.61 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.695 -0.483 . . . . 6.0800000000000001 109.695 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.742 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.59 32.61 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.867 -0.606 . . . . 3.3799999999999999 111.578 -178.842 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.633 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.28 -29.1 72.79 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.465 2.11 . . . . 3.9300000000000002 111.884 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.633 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.61 125.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 3.3599999999999999 110.511 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.577 ' O ' ' O ' ' A' ' 92' ' ' THR . 1.5 mp0 -123.91 158.36 60.31 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.304 -0.407 . . . . 3.6099999999999999 110.378 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.6 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 96.3 Cg_endo -82.11 -64.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.874 2.382 . . . . 1.51 113.542 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.66 ' ND2' ' N ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -108.48 -19.66 13.37 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.081 0.4 . . . . 2.6800000000000002 112.081 -178.55 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.66 ' N ' ' ND2' ' A' ' 16' ' ' ASN . 95.8 p -107.2 152.02 24.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.164 0.507 . . . . 1.21 111.333 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.25 102.98 2.23 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.79 -0.641 . . . . 1.5600000000000001 110.669 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.6 145.58 13.11 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.932 2.422 . . . . 0.81000000000000005 112.59 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.928 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.82 167.91 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.911 -0.586 . . . . 1.52 109.899 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.14 147.85 28.96 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.855 -0.424 . . . . 2.1400000000000001 109.855 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.592 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.18 157.34 44.97 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.663 -0.415 . . . . 0.32000000000000001 111.223 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.497 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.2 m-20 -128.12 155.3 44.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.81 -0.632 . . . . 2.1699999999999999 110.024 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.837 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.58 173.02 6.38 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.065 -0.516 . . . . 0.58999999999999997 110.723 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.837 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.6 173.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.876 2.384 . . . . 0.90000000000000002 111.543 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.04 -50.99 0.69 Allowed Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.68 -0.408 . . . . 3.3399999999999999 110.166 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.635 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.84 152.38 82.38 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.797 2.331 . . . . 1.8500000000000001 111.438 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.8 42.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.415 0.626 . . . . 2.54 110.538 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.635 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.8 t60 -63.54 -41.62 98.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.01 -0.996 . . . . 2.5299999999999998 110.697 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.564 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.4 mt -109.86 137.82 40.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.815 -0.63 . . . . 1.1699999999999999 111.274 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.9 -72.96 0.7 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.057 -0.52 . . . . 1.27 111.913 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.09 148.33 24.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.638 0.606 . . . . 1.1200000000000001 112.638 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.84 124.88 45.2 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.318 -0.623 . . . . 0.41999999999999998 109.318 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.0 134.79 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.647 -0.421 . . . . 0.78000000000000003 110.649 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.928 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.03 128.66 53.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.297 -0.41 . . . . 0.62 111.191 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.17 138.97 49.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.807 -0.633 . . . . 1.97 110.023 179.003 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.436 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.03 163.11 35.23 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.119 0.485 . . . . 0.34999999999999998 112.074 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.43 139.51 7.87 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.413 -0.812 . . . . 1.8 110.42 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.52 115.45 3.04 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.336 2.024 . . . . 0.57999999999999996 111.77 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.679 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.94 81.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.868 -0.419 . . . . 3.04 109.868 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.21 -20.74 0.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.983 -0.553 . . . . 2.4700000000000002 111.919 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -157.55 157.81 34.44 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.806 -0.358 . . . . 2.5099999999999998 110.592 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.406 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.34 27.68 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 1.8600000000000001 110.22 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.79 -75.86 1.31 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.08 -0.581 . . . . 1.4399999999999999 111.884 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.82 152.28 35.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.845 0.355 . . . . 4.6900000000000004 111.045 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.18 -169.16 2.55 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.071 -0.513 . . . . 1.4299999999999999 111.955 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.436 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.73 29.65 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.431 0.634 . . . . 1.74 112.589 -177.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.13 156.53 45.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.87 -1.059 . . . . 1.9199999999999999 110.16 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.25 158.33 41.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.898 -0.592 . . . . 0.34000000000000002 111.826 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.0 m -115.23 135.71 53.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.386 -0.824 . . . . 0.40999999999999998 109.758 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.592 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.39 121.91 23.77 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.371 -0.377 . . . . 0.55000000000000004 111.546 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.7 Cg_exo -46.41 151.76 1.68 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.653 2.235 . . . . 0.44 112.08 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.91 -23.04 63.06 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 116.028 -0.533 . . . . 0.73999999999999999 112.854 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.69 -17.03 45.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.343 0.572 . . . . 0.93000000000000005 111.803 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.601 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.49 138.46 31.56 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.699 -0.4 . . . . 0.96999999999999997 110.32 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.59 14.02 10.96 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.398 -0.365 . . . . 1.3400000000000001 111.551 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.474 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.1 143.42 25.08 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.675 -0.41 . . . . 0.39000000000000001 111.048 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.716 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.74 -169.42 1.54 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.069 -0.514 . . . . 0.41999999999999998 110.938 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.716 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.5 t -151.72 125.91 9.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.438 -0.801 . . . . 0.39000000000000001 109.828 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.519 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.77 123.29 70.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.373 -0.531 . . . . 0.73999999999999999 111.207 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.646 ' NZ ' ' N ' ' A' ' 142' ' ' PHE . 88.9 tttt -126.52 163.34 23.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.898 -0.592 . . . . 2.48 110.417 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.52 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.17 18.96 59.84 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.793 -0.923 . . . . 0.5 110.793 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.519 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.8 mt -79.15 157.28 27.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.108 0.48 . . . . 0.57999999999999996 111.299 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.848 ' O ' HG12 ' A' ' 67' ' ' VAL . 4.5 mttp -99.47 133.92 21.57 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.531 -0.759 . . . . 2.79 110.536 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.535 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.87 143.56 61.38 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.584 2.189 . . . . 0.87 111.95 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.77 25.71 75.24 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.088 -0.805 . . . . 0.64000000000000001 111.088 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.848 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.25 158.73 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.717 0.294 . . . . 0.82999999999999996 110.371 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.11 139.93 41.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.946 0.403 . . . . 0.5 110.516 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.664 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.4 m-85 -122.63 136.42 54.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.905 -0.589 . . . . 0.53000000000000003 110.782 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.87 131.04 45.27 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.442 -0.947 . . . . 1.8700000000000001 108.442 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.49 153.97 16.64 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.313 -0.946 . . . . 0.28999999999999998 111.935 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -135.05 140.85 45.91 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.726 -0.472 . . . . 1.4299999999999999 109.726 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.72 118.95 34.47 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.411 -0.516 . . . . 0.32000000000000001 110.53 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.722 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.44 129.03 68.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.332 -0.395 . . . . 0.79000000000000004 110.582 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.701 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.85 120.78 43.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.294 -0.412 . . . . 1.02 110.764 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.852 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.45 146.47 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.173 0.511 . . . . 0.62 111.069 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.613 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.08 153.85 21.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.525 -0.761 . . . . 2.4399999999999999 109.947 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.425 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.15 88.62 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.938 0.399 . . . . 3.6899999999999999 110.408 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.613 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.61 0.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.85 -0.614 . . . . 6.0800000000000001 110.592 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.17 -117.35 3.28 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.424 -0.67 . . . . 1.22 111.424 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -81.43 177.36 9.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.194 0.521 . . . . 2.8799999999999999 111.637 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.08 149.61 32.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.398 -0.819 . . . . 1.47 110.353 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.553 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.21 144.71 38.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.449 -0.341 . . . . 2.7000000000000002 110.528 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.722 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.03 135.97 61.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.002 0.43 . . . . 0.46000000000000002 111.534 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.07 141.36 52.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.677 -0.692 . . . . 0.34999999999999998 110.211 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.62 138.86 51.67 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.083 0.468 . . . . 3.6699999999999999 111.577 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.27 164.09 38.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.623 -0.717 . . . . 0.67000000000000004 109.468 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.18 151.62 38.72 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.473 -0.491 . . . . 1.47 111.046 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.804 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.7 p90 -146.35 172.71 13.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.734 -0.666 . . . . 0.44 111.033 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.78 160.65 21.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.479 -0.782 . . . . 1.3700000000000001 109.828 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.34 121.82 22.92 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.627 -0.429 . . . . 1.28 110.83 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.577 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.0 p -128.18 162.99 25.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.082 -0.508 . . . . 1.97 111.667 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.6 m -63.21 154.57 30.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 3.2799999999999998 110.028 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.417 HG23 ' N ' ' A' ' 95' ' ' SER . 12.0 t -60.49 -39.4 87.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.97 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.417 ' N ' HG23 ' A' ' 94' ' ' THR . 81.5 p -98.58 159.53 14.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.412 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.6 m -59.65 131.94 88.65 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.47 136.98 66.75 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.492 1.461 . . . . 0.0 112.931 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.84 -24.41 34.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.695 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 66.4 p -60.68 -15.98 34.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.524 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.9 p -67.65 156.54 36.61 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.31 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -116.56 127.95 54.98 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.451 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 56.6 m -75.54 135.34 40.6 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.59 144.71 36.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.156 0.503 . . . . 0.0 112.353 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 107' ' ' THR . 20.0 p -120.26 157.55 28.89 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.982 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.35 -39.95 95.39 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.401 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -63.5 -39.06 93.45 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 104' ' ' THR . 27.2 m -128.95 145.22 51.29 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.507 0.194 . . . . 0.0 111.278 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.7 m -124.02 75.65 58.49 Favored Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.553 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -63.76 146.54 92.11 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.961 2.441 . . . . 0.0 112.908 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -107.61 133.54 51.9 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.5 m -127.58 78.42 74.83 Favored Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.226 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -54.76 144.06 67.41 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.287 1.992 . . . . 0.0 111.784 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.7 mt -94.32 144.43 25.55 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.165 -0.47 . . . . 10.19 110.631 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 116' ' ' THR . 42.5 t -110.67 132.22 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.22 -0.446 . . . . 7.2800000000000002 109.967 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.48 25.77 11.34 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.362 0.504 . . . . 7.2999999999999998 112.362 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.524 ' H ' HG12 ' A' ' 114' ' ' VAL . 44.1 p -78.22 155.83 30.1 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.19 -0.604 . . . . 6.4400000000000004 110.85 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 85.7 p -65.77 -27.21 68.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.759 -0.655 . . . . 4.4199999999999999 111.82 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 118' ' ' GLU . 82.9 tt0 55.41 17.73 2.3 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.76 -0.83 . . . . 3.0499999999999998 108.76 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 60.4 p -71.94 166.7 21.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.165 -0.925 . . . . 3.4300000000000002 111.471 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.524 ' O ' HG12 ' A' ' 120' ' ' VAL . 12.1 t 64.51 15.35 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 CA-C-N 115.595 -0.729 . . . . 2.8799999999999999 111.387 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.8 t -72.07 135.37 46.27 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.548 -0.461 . . . . 2.0899999999999999 109.887 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.14 142.29 56.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.484 -0.326 . . . . 4.5300000000000002 110.777 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 32.9 pt -124.43 155.98 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.361 -0.382 . . . . 1.4399999999999999 110.763 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.468 ' OG1' ' CG ' ' A' ' 174' ' ' PRO . 24.2 p -126.78 161.76 27.43 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.055 -0.521 . . . . 1.78 110.406 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' A' ' 126' ' ' SER . . . -69.56 138.5 53.29 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.713 -0.395 . . . . 0.64000000000000001 110.337 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.3 OUTLIER 166.49 14.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.888 0.851 . . . . 0.66000000000000003 109.317 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.444 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.82 167.54 0.25 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.959 -1.018 . . . . 0.68999999999999995 110.944 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.66 145.48 49.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.757 -0.656 . . . . 0.52000000000000002 110.178 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.23 101.76 9.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.075 -0.713 . . . . 0.32000000000000001 109.075 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.0 t -112.96 139.68 36.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.982 -0.554 . . . . 0.28999999999999998 111.077 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.1 p -128.79 152.6 48.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.625 -0.716 . . . . 0.25 109.812 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.594 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.76 -164.97 2.04 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.731 -0.388 . . . . 0.31 110.666 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.5 t -123.87 127.12 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.48999999999999999 110.853 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.18 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -58.03 58.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 1.53 110.383 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.11 24.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.831 -0.622 . . . . 0.96999999999999997 111.482 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.18 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.18 128.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.59 -0.444 . . . . 1.5600000000000001 110.904 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.42 -9.59 55.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.926 -0.579 . . . . 1.8799999999999999 110.332 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.432 ' HB ' ' OE2' ' A' ' 187' ' ' GLU . 28.5 p -87.09 0.2 55.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.094 -0.503 . . . . 1.04 110.348 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.28 137.21 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.987 -0.551 . . . . 0.23999999999999999 109.905 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 185' ' ' ILE . 81.8 p -96.19 -15.59 21.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.301 0.572 . . . . 0.28999999999999998 110.04 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.627 ' HA3' ' HZ2' ' A' ' 61' ' ' LYS . . . 178.61 175.57 45.79 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 109.929 -1.269 . . . . 0.13 109.929 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.646 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . 76.2 m-85 -123.45 151.63 42.48 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.605 -0.438 . . . . 0.17000000000000001 110.521 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.6 ' CZ ' ' CG ' ' A' ' 15' ' ' PRO . 73.8 ttt-85 -132.38 121.18 23.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.14 -0.482 . . . . 1.29 109.938 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.556 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.09 136.49 38.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.646 -0.707 . . . . 0.25 110.705 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 81.4 tt0 -129.3 129.82 45.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.966 -0.561 . . . . 1.3200000000000001 110.132 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.627 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 36.1 p90 -138.65 135.3 34.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.06 -0.518 . . . . 0.56999999999999995 110.659 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.421 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.31 161.35 39.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.723 -0.672 . . . . 1.1599999999999999 109.699 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.961 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.01 124.84 25.31 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.666 -0.414 . . . . 0.38 110.814 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.82 -7.66 49.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.764 -0.653 . . . . 0.40999999999999998 110.76 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -109.78 -69.69 0.85 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.003 0.43 . . . . 1.6599999999999999 111.477 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.47 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.58 -35.4 75.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.995 -0.548 . . . . 1.6599999999999999 111.561 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.076 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.14 88.66 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.905 -0.878 . . . . 1.1699999999999999 110.905 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.332 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.92 -171.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.742 0.306 . . . . 1.8600000000000001 110.24 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.332 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.3 139.04 44.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 1.98 110.198 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 48.1 Cg_endo -70.83 145.79 51.88 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 122.755 2.304 . . . . 0.55000000000000004 112.299 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.627 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.83 145.83 42.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.263 -0.643 . . . . 1.1399999999999999 109.263 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.535 ' CE1' ' CD ' ' A' ' 65' ' ' PRO . 14.5 p90 -123.37 141.24 52.19 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.356 -0.538 . . . . 0.93000000000000005 111.54 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.5 mt -128.03 127.68 43.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.356 -0.838 . . . . 0.34000000000000002 108.95 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.479 ' OD2' ' HA2' ' A' ' 62' ' ' GLY . 95.2 m-20 -101.69 131.1 48.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.127 0.489 . . . . 1.0900000000000001 111.76 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.91 157.59 73.26 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.323 -0.853 . . . . 0.19 109.557 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -69.76 158.0 58.46 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.467 2.111 . . . . 0.17999999999999999 112.239 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.417 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.28 -12.14 5.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.754 -0.657 . . . . 0.20999999999999999 110.79 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.7 p -92.85 -8.75 42.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.28999999999999998 110.662 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.15 135.36 34.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.394 -0.366 . . . . 0.5 110.361 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.17 16.72 4.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.358 -0.383 . . . . 0.29999999999999999 110.502 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.0 p -167.55 147.04 5.05 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.694 -0.484 . . . . 0.23000000000000001 109.694 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.11 150.53 12.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.514 -0.474 . . . . 0.28000000000000003 111.509 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.512 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.34 124.89 50.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.541 -0.754 . . . . 1.0700000000000001 109.825 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.43 104.86 29.69 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.404 -0.362 . . . . 0.28999999999999998 111.117 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 84.3 Cg_endo -90.99 -179.42 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 123.046 2.497 . . . . 0.42999999999999999 112.163 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.61 32.68 18.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.393 -0.821 . . . . 1.26 111.501 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.449 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.4 mt -86.4 148.64 25.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 0.32000000000000001 110.467 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.776 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.42 114.85 61.39 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.976 0.417 . . . . 0.57999999999999996 110.585 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.468 ' CG ' ' OG1' ' A' ' 124' ' ' THR . 21.9 Cg_exo -59.0 140.62 96.16 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.866 2.377 . . . . 0.66000000000000003 111.962 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.27 74.19 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.042 -0.823 . . . . 0.28999999999999998 111.042 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.47 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.99 150.1 49.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.333 . . . . 2.3300000000000001 110.62 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.08 131.62 45.92 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.026 -0.533 . . . . 0.85999999999999999 109.745 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.961 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.5 148.47 43.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.16 -0.473 . . . . 0.52000000000000002 111.036 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.5 mt -105.42 125.32 60.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.271 -1.011 . . . . 0.29999999999999999 108.271 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.58 132.51 63.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.164 0.507 . . . . 0.23000000000000001 111.192 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.47 122.57 20.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.565 -0.743 . . . . 0.35999999999999999 109.628 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.594 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.02 125.42 54.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.286 -0.415 . . . . 0.19 110.713 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.26 137.81 52.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.07 -0.514 . . . . 0.29999999999999999 109.837 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.431 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.61 135.03 42.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.828 -0.805 . . . . 0.37 108.828 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.594 ' O ' ' N ' ' A' ' 140' ' ' SER . 50.0 mm -99.11 122.91 51.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.148 0.499 . . . . 0.26000000000000001 111.015 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.1 p -83.84 169.62 14.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.547 -0.752 . . . . 0.28000000000000003 110.49 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.612 ' O ' HG21 ' A' ' 59' ' ' THR . 0.0 OUTLIER -59.67 -14.59 14.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.06 -0.518 . . . . 1.6000000000000001 110.954 -179.572 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 87.2 m-20 -96.03 -4.35 43.24 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.784 -0.366 . . . . 1.1799999999999999 110.793 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.78 14.0 63.82 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.356 -0.697 . . . . 0.29999999999999999 111.356 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -84.66 139.07 32.3 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.093 -0.243 . . . . 1.22 110.439 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.41 ' HG2' ' CD1' ' A' ' 185' ' ' ILE . 1.9 mt-30 -106.78 141.05 38.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.868 0.366 . . . . 0.97999999999999998 110.537 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.4 m -136.67 127.05 26.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.82999999999999996 110.367 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 25.6 tp -68.18 117.25 9.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.319 -0.4 . . . . 0.26000000000000001 110.486 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.01 -21.69 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.29999999999999999 110.725 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.96 125.78 5.85 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.55 -0.46 . . . . 0.31 111.466 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.461 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.82 120.19 21.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.739 -0.664 . . . . 0.28000000000000003 109.591 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.62 151.66 29.08 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.608 -0.437 . . . . 0.23999999999999999 110.895 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.8 p -110.38 158.61 18.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.99 -0.55 . . . . 0.23000000000000001 110.451 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -146.13 157.95 43.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.068 -0.514 . . . . 0.67000000000000004 110.639 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.36 9.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.689 -0.687 . . . . 0.64000000000000001 109.99 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.5 p . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.966 -1.016 . . . . 1.26 110.556 -179.711 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.9 m . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.18 -0.674 . . . . 3.4399999999999999 109.18 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.36 150.72 18.54 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.956 -0.858 . . . . 1.22 110.956 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -35.52 142.39 0.1 OUTLIER 'Trans proline' 0 C--N 1.3 -2.024 0 C-N-CA 123.965 3.11 . . . . 0.75 113.845 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -79.96 173.47 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.25 -1.341 . . . . 0.79000000000000004 108.904 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.612 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.59 125.91 51.53 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.416 -0.513 . . . . 1.9399999999999999 111.423 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.62 144.01 33.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.688 -0.687 . . . . 0.59999999999999998 110.693 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.04 168.29 25.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.852 0.358 . . . . 3.1400000000000001 111.093 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.744 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.92 131.03 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.019 -0.537 . . . . 3.23 110.109 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.21 162.22 36.0 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.917 0.389 . . . . 3.6299999999999999 111.213 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 32.6 tp10 36.23 31.47 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.651 -0.5 . . . . 6.0800000000000001 109.651 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.744 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.65 32.74 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.914 -0.585 . . . . 3.3799999999999999 111.575 -178.737 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.632 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.29 -29.16 72.68 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.494 2.129 . . . . 3.9300000000000002 111.81 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.632 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.7 125.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 3.3599999999999999 110.377 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.646 ' O ' ' O ' ' A' ' 92' ' ' THR . 3.3 mp0 -123.97 158.41 60.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.321 -0.399 . . . . 3.6099999999999999 110.49 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.566 ' HB2' HH21 ' A' ' 143' ' ' ARG . 96.9 Cg_endo -82.11 -64.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.852 2.368 . . . . 1.51 113.47 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.577 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 63.5 t30 -108.35 -19.67 13.39 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.081 0.4 . . . . 2.6800000000000002 112.081 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 66.1 p -107.31 152.13 24.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.206 0.527 . . . . 1.21 111.246 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.573 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.33 102.96 2.22 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.702 -0.681 . . . . 1.5600000000000001 110.63 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.8 Cg_endo -82.75 145.58 12.88 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.912 2.408 . . . . 0.81000000000000005 112.611 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.906 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.73 167.96 24.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.938 -0.573 . . . . 1.52 109.879 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -149.14 147.99 29.11 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.609 -0.515 . . . . 2.1400000000000001 109.609 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.591 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.8 p90 -142.28 157.26 45.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.019 0.437 . . . . 0.32000000000000001 111.229 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.487 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.05 155.24 44.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.853 -0.612 . . . . 2.1699999999999999 110.098 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.835 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.57 172.99 6.41 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.137 0.494 . . . . 0.58999999999999997 110.801 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.835 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.61 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.913 2.409 . . . . 0.90000000000000002 111.534 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.477 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.14 -51.06 0.68 Allowed Pre-proline 0 C--N 1.328 -0.344 0 C-N-CA 120.709 -0.397 . . . . 3.3399999999999999 110.052 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.79 152.32 82.53 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.808 2.339 . . . . 1.8500000000000001 111.442 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.66 42.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.373 0.606 . . . . 2.54 110.571 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.624 ' N ' ' O ' ' A' ' 27' ' ' PRO . 74.0 t60 -63.73 -41.56 98.04 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.037 -0.983 . . . . 2.5299999999999998 110.653 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.56 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.2 mt -109.91 137.85 40.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.767 -0.651 . . . . 1.1699999999999999 111.211 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.91 -72.94 0.7 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.004 -0.544 . . . . 1.27 111.936 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.15 148.37 24.45 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.651 0.611 . . . . 1.1200000000000001 112.651 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.82 124.82 45.06 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.35 -0.611 . . . . 0.41999999999999998 109.35 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.9 mt -118.08 134.73 60.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.646 -0.422 . . . . 0.78000000000000003 110.566 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.906 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.99 128.63 53.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.434 . . . . 0.62 111.288 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.548 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.14 139.01 49.73 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.746 -0.661 . . . . 1.97 110.115 178.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.438 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.14 163.13 35.3 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.176 0.512 . . . . 0.34999999999999998 112.018 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.48 139.49 7.81 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 115.399 -0.818 . . . . 1.8 110.484 178.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.53 115.5 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.309 2.006 . . . . 0.57999999999999996 111.839 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.667 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.03 81.21 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.81 -0.441 . . . . 3.04 109.81 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.15 -20.75 0.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.027 -0.533 . . . . 2.4700000000000002 111.843 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.4 p -157.52 157.75 34.4 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.937 -0.305 . . . . 2.5099999999999998 110.65 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.43 27.9 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.27 -0.423 . . . . 1.8600000000000001 110.241 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.89 -75.83 1.31 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.066 -0.587 . . . . 1.4399999999999999 111.834 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.91 152.27 35.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.964 0.411 . . . . 4.6900000000000004 110.927 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.676 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.24 -169.14 2.53 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.068 -0.514 . . . . 1.4299999999999999 111.938 179.298 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.11 149.69 29.68 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.463 0.649 . . . . 1.74 112.569 -177.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -140.98 156.53 46.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.745 -1.116 . . . . 1.9199999999999999 110.257 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.3 158.47 41.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.967 -0.56 . . . . 0.34000000000000002 111.706 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.7 m -115.24 135.69 53.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.385 -0.825 . . . . 0.40999999999999998 109.799 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.591 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.43 122.05 23.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.403 -0.362 . . . . 0.55000000000000004 111.48 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.1 Cg_exo -46.45 151.75 1.71 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.675 2.25 . . . . 0.44 112.115 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.98 -22.87 63.03 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 116.092 -0.504 . . . . 0.73999999999999999 112.798 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.9 -16.9 45.66 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.259 -0.576 . . . . 0.93000000000000005 111.763 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.604 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.52 138.37 31.63 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.848 -0.341 . . . . 0.96999999999999997 110.366 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.56 13.92 10.97 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.409 -0.359 . . . . 1.3400000000000001 111.561 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.475 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -150.01 143.49 25.21 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.658 -0.417 . . . . 0.39000000000000001 111.061 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.72 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.82 -169.38 1.54 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.076 -0.511 . . . . 0.41999999999999998 110.961 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.72 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.3 m -151.69 125.92 9.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.483 -0.78 . . . . 0.39000000000000001 109.867 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.511 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.9 mt -114.94 123.29 70.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.404 -0.518 . . . . 0.73999999999999999 111.186 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -126.48 163.48 23.25 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.824 -0.625 . . . . 2.48 110.37 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.46 ' HA2' HD21 ' A' ' 16' ' ' ASN . . . 85.09 18.9 60.09 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.735 -0.946 . . . . 0.5 110.735 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.577 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.4 mt -78.9 157.22 28.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.065 0.459 . . . . 0.57999999999999996 111.438 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.851 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -99.52 133.94 21.52 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.684 -0.689 . . . . 2.79 110.396 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.472 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.95 143.62 61.18 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.519 2.146 . . . . 0.87 111.97 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.73 25.79 75.15 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.041 -0.823 . . . . 0.64000000000000001 111.041 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.851 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.16 158.85 39.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.705 0.288 . . . . 0.82999999999999996 110.456 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.23 139.95 42.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.946 0.403 . . . . 0.5 110.562 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.662 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.6 m-85 -122.59 136.42 54.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.949 -0.568 . . . . 0.53000000000000003 110.729 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.489 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.9 131.01 45.31 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.488 -0.93 . . . . 1.8700000000000001 108.488 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.46 153.85 16.64 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.261 -0.971 . . . . 0.28999999999999998 111.917 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -134.93 140.9 46.1 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.73 -0.47 . . . . 1.4299999999999999 109.73 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.9 tp -115.7 118.9 34.35 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.493 -0.483 . . . . 0.32000000000000001 110.553 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.726 HG12 HG23 ' A' ' 84' ' ' VAL . 64.2 mt -112.43 129.08 68.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.303 -0.408 . . . . 0.79000000000000004 110.669 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.708 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.78 120.84 43.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.289 -0.414 . . . . 1.02 110.715 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.849 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.52 146.43 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.241 0.543 . . . . 0.62 111.01 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.622 ' O ' ' N ' ' A' ' 79' ' ' TYR . 20.9 mt-30 -106.02 153.9 21.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.524 -0.762 . . . . 2.4399999999999999 109.956 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.26 88.65 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.932 0.396 . . . . 3.6899999999999999 110.42 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.622 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.21 32.73 0.21 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.793 -0.639 . . . . 6.0800000000000001 110.609 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.12 -117.38 3.29 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.437 -0.665 . . . . 1.22 111.437 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.5 177.37 8.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.158 0.504 . . . . 2.8799999999999999 111.661 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.1 149.51 32.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.481 -0.781 . . . . 1.47 110.359 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.16 144.72 38.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.417 -0.356 . . . . 2.7000000000000002 110.558 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.726 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.01 136.01 61.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 121.048 0.451 . . . . 0.46000000000000002 111.506 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.6 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.04 141.37 52.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.624 -0.716 . . . . 0.34999999999999998 110.279 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.68 138.93 51.66 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.441 -0.503 . . . . 3.6699999999999999 111.466 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.491 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 53.0 p90 -152.32 164.23 37.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.521 -0.763 . . . . 0.67000000000000004 109.467 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.575 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.24 151.52 38.51 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.503 -0.479 . . . . 1.47 111.084 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.807 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.1 p90 -146.22 172.7 13.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.782 -0.645 . . . . 0.44 111.068 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.8 160.61 21.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.496 -0.774 . . . . 1.3700000000000001 109.821 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.36 121.83 22.92 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 120.587 -0.445 . . . . 1.28 110.781 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.646 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -128.08 163.55 24.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.156 -0.475 . . . . 1.97 110.309 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.6 t -109.95 132.45 54.15 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.312 -0.555 . . . . 3.2799999999999998 110.628 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.8 p -130.09 163.91 25.54 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.25 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 29.6 t -118.18 135.24 54.36 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 38.9 m -132.9 78.33 66.21 Favored Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.527 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.15 136.08 66.59 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 121.899 1.733 . . . . 0.0 112.145 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 83.4 t -64.28 -37.76 80.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.258 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.2 p -79.21 162.25 25.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.459 0.647 . . . . 0.0 112.047 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.5 p -69.26 -10.34 57.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.046 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -57.73 166.68 1.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.933 0.397 . . . . 0.0 110.695 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.2 p -78.19 164.17 25.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.24 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 71.6 t -58.85 -39.3 77.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.428 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.7 p -80.58 157.93 25.9 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.154 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 153.52 -173.59 32.25 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -114.19 -96.63 0.45 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.49 ' OG1' ' NZ ' ' A' ' 177' ' ' LYS . 47.4 m -126.78 137.52 53.23 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.593 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.1 p -78.72 141.0 59.35 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.6 141.61 86.67 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.767 1.645 . . . . 0.0 111.787 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.445 ' O ' ' OG ' ' A' ' 111' ' ' SER . 49.3 p90 -140.23 157.35 45.72 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.956 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 110' ' ' PHE . 49.0 m -171.95 63.5 0.35 Allowed Pre-proline 0 C--N 1.332 -0.152 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.812 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -54.62 139.28 76.23 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.995 1.797 . . . . 0.0 112.12 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.2 mt -62.2 -34.55 76.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 10.19 110.566 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 26.2 m -69.83 135.77 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.096 -0.502 . . . . 7.2800000000000002 111.336 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.22 148.12 52.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.859 -0.609 . . . . 7.2999999999999998 110.283 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.515 HG22 ' H ' ' A' ' 118' ' ' GLU . 47.6 m -73.61 135.98 43.89 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.826 -0.35 . . . . 6.4400000000000004 110.218 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.6 m -58.35 -35.13 71.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.053 -0.522 . . . . 4.4199999999999999 111.383 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.522 ' HG2' ' H ' ' A' ' 120' ' ' VAL . 84.2 tt0 -99.0 140.58 32.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.414 -0.357 . . . . 3.0499999999999998 110.256 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.0 t -57.76 -34.0 69.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 3.4300000000000002 111.033 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.618 HG22 ' H ' ' A' ' 122' ' ' GLU . 12.4 p -129.64 142.74 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.251 -0.431 . . . . 2.8799999999999999 110.136 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 59.5 p -67.9 -24.88 65.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.338 -0.392 . . . . 2.0899999999999999 111.668 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.618 ' H ' HG22 ' A' ' 120' ' ' VAL . 77.7 mm-40 -58.71 142.4 49.99 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.817 -0.353 . . . . 4.5300000000000002 110.427 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 16.8 tt -123.84 139.12 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.038 -0.528 . . . . 1.4399999999999999 110.633 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.614 ' O ' ' HB3' ' A' ' 125' ' ' ALA . 45.2 m -72.83 137.29 45.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.414 -0.357 . . . . 1.78 110.14 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 124' ' ' THR . . . 81.88 144.32 0.07 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.012 -0.54 . . . . 0.64000000000000001 109.686 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.3 p -61.47 -32.74 72.75 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.53 -0.468 . . . . 0.66000000000000003 110.818 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.431 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.86 167.55 0.26 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 0.68999999999999995 110.959 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.54 145.6 50.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.692 -0.685 . . . . 0.52000000000000002 110.186 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.29 101.65 9.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.086 -0.709 . . . . 0.32000000000000001 109.086 177.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.1 t -113.0 139.78 36.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.985 -0.552 . . . . 0.28999999999999998 111.063 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.7 p -128.71 152.49 48.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.67 -0.696 . . . . 0.25 109.832 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.594 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.9 p90 -144.7 -164.89 2.02 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.722 -0.391 . . . . 0.31 110.691 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.734 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -124.06 127.24 73.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.198 -0.456 . . . . 0.48999999999999999 110.73 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.172 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.099 -0.501 . . . . 1.53 110.342 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -37.96 24.45 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.946 -0.57 . . . . 0.96999999999999997 111.566 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.172 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.13 128.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.724 -0.391 . . . . 1.5600000000000001 111.002 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -86.45 -9.51 56.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.942 -0.572 . . . . 1.8799999999999999 110.281 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.14 0.16 55.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 1.04 110.315 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.06 137.15 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 116.008 -0.542 . . . . 0.23999999999999999 109.985 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 185' ' ' ILE . 87.3 p -96.26 -15.48 21.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.242 0.544 . . . . 0.28999999999999998 110.066 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.64 175.61 45.86 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 109.881 -1.288 . . . . 0.13 109.881 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.51 151.6 42.63 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.673 -0.411 . . . . 0.17000000000000001 110.434 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.566 HH21 ' HB2' ' A' ' 15' ' ' PRO . 69.4 ttt-85 -132.36 121.16 23.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.122 -0.49 . . . . 1.29 109.926 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.556 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.04 136.6 38.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.681 -0.691 . . . . 0.25 110.69 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 83.7 tt0 -129.43 129.84 45.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.067 -0.515 . . . . 1.3200000000000001 110.01 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.623 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.7 135.32 34.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.965 -0.561 . . . . 0.56999999999999995 110.656 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.425 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.38 39.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.77 -0.65 . . . . 1.1599999999999999 109.641 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.957 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.13 124.85 25.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.039 0.447 . . . . 0.38 110.673 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.73 -7.72 49.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.684 -0.689 . . . . 0.40999999999999998 110.883 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.77 -69.74 0.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.315 -0.402 . . . . 1.6599999999999999 111.432 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.438 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.68 -35.21 75.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.027 -0.533 . . . . 1.6599999999999999 111.563 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.093 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.07 7.29 88.54 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.814 -0.914 . . . . 1.1699999999999999 110.814 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.322 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.93 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.773 0.321 . . . . 1.8600000000000001 110.256 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.322 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.33 139.05 44.89 Favored Pre-proline 0 N--CA 1.454 -0.261 0 CA-C-N 116.302 -0.408 . . . . 1.98 110.157 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.425 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.2 Cg_endo -70.85 145.89 52.06 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 C-N-CA 122.656 2.237 . . . . 0.55000000000000004 112.398 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.82 145.68 42.63 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.232 -0.655 . . . . 1.1399999999999999 109.232 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.57 ' CE2' ' CG ' ' A' ' 16' ' ' ASN . 37.3 p90 -123.24 141.37 52.05 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.345 -0.542 . . . . 0.93000000000000005 111.463 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.12 127.74 43.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.313 -0.858 . . . . 0.34000000000000002 108.966 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -101.68 131.17 48.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.097 0.475 . . . . 1.0900000000000001 111.779 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.89 157.56 73.33 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.373 -0.831 . . . . 0.19 109.61 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -69.84 158.0 58.32 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.382 2.054 . . . . 0.17999999999999999 112.27 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.24 -12.17 5.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.792 -0.64 . . . . 0.20999999999999999 110.714 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.3 p -92.79 -8.74 42.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.28999999999999998 110.714 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.41 34.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.363 -0.38 . . . . 0.5 110.434 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.4 p -133.14 16.58 4.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.348 -0.387 . . . . 0.29999999999999999 110.475 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.6 p -167.48 147.23 5.15 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.642 -0.503 . . . . 0.23000000000000001 109.642 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.18 150.35 13.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.617 -0.433 . . . . 0.28000000000000003 111.606 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.25 124.95 50.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.67 -0.695 . . . . 1.0700000000000001 109.803 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.42 104.9 29.84 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.426 -0.352 . . . . 0.28999999999999998 111.117 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.3 Cg_endo -90.91 -179.46 1.51 Allowed 'Trans proline' 0 C--N 1.3 -1.988 0 C-N-CA 123.231 2.621 . . . . 0.42999999999999999 112.282 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 61.56 32.65 18.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.475 -0.784 . . . . 1.26 111.499 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.6 mt -86.4 148.58 25.51 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.887 -0.325 . . . . 0.32000000000000001 110.433 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.766 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.27 114.87 61.36 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.051 0.453 . . . . 0.57999999999999996 110.69 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.95 140.52 95.66 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.951 2.434 . . . . 0.66000000000000003 111.955 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.27 74.16 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.023 -0.831 . . . . 0.28999999999999998 111.023 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.438 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.89 150.13 49.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 2.3300000000000001 110.643 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.501 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.11 131.58 45.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.85999999999999999 109.814 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.957 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.49 148.3 44.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.022 -0.536 . . . . 0.52000000000000002 111.043 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.1 mt -105.27 125.29 60.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.286 -1.005 . . . . 0.29999999999999999 108.286 177.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.46 132.47 63.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.193 0.52 . . . . 0.23000000000000001 111.315 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.6 20.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.501 -0.772 . . . . 0.35999999999999999 109.638 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.594 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -101.03 125.39 54.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.217 -0.447 . . . . 0.19 110.73 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.9 m-85 -117.25 137.9 52.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.954 -0.566 . . . . 0.29999999999999999 109.823 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.424 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.71 135.02 42.81 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.797 -0.816 . . . . 0.37 108.797 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 140' ' ' SER . 44.5 mm -99.08 123.0 51.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.136 0.493 . . . . 0.26000000000000001 110.937 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.0 p -83.94 169.73 14.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.568 -0.742 . . . . 0.28000000000000003 110.466 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -59.82 -14.44 14.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.057 -0.519 . . . . 1.6000000000000001 110.888 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.507 ' C ' ' OG1' ' A' ' 59' ' ' THR . 96.4 m-20 -96.19 -4.34 42.71 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.834 -0.347 . . . . 1.1799999999999999 110.708 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.62 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.85 13.93 63.83 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.3 -0.72 . . . . 0.29999999999999999 111.3 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -84.64 139.03 32.34 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.099 -0.24 . . . . 1.22 110.49 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -106.64 141.05 38.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.436 -0.347 . . . . 0.97999999999999998 110.542 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.5 m -136.7 127.07 26.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.82999999999999996 110.374 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.8 tp -68.11 117.3 9.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.329 -0.396 . . . . 0.26000000000000001 110.502 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.3 pt -109.09 -21.81 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.29999999999999999 110.625 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.91 125.72 5.85 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.523 -0.471 . . . . 0.31 111.48 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.468 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.76 120.22 21.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.799 -0.637 . . . . 0.28000000000000003 109.541 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.62 151.68 29.11 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.663 -0.415 . . . . 0.23999999999999999 110.938 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.42 158.61 18.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.062 -0.517 . . . . 0.23000000000000001 110.408 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -146.1 157.96 43.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.107 -0.497 . . . . 0.67000000000000004 110.667 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 104.29 9.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.714 -0.676 . . . . 0.64000000000000001 110.032 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.858 -1.068 . . . . 1.26 110.664 -179.761 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.55 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.3 m . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.141 -0.688 . . . . 3.4399999999999999 109.141 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.32 150.72 18.54 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.048 -0.821 . . . . 1.22 111.048 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -35.59 142.42 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.121 0 C-N-CA 124.009 3.139 . . . . 0.75 113.824 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.3 t -80.02 173.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.199 -1.364 . . . . 0.79000000000000004 108.775 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.601 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.62 125.92 51.55 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.385 -0.526 . . . . 1.9399999999999999 111.371 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.48 143.99 34.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.629 -0.714 . . . . 0.59999999999999998 110.689 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.4 25.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.833 0.349 . . . . 3.1400000000000001 111.145 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.749 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.07 131.0 61.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 3.23 109.989 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.16 162.44 35.48 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.882 0.372 . . . . 3.6299999999999999 111.169 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 9' ' ' THR . 71.0 tt0 36.02 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.088 -0.505 . . . . 6.0800000000000001 109.689 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.749 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.59 33.07 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.924 -0.58 . . . . 3.3799999999999999 111.62 -178.777 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.636 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.33 -29.04 72.25 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.438 2.092 . . . . 3.9300000000000002 111.868 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.636 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.57 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 3.3599999999999999 110.518 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.535 ' CB ' ' O ' ' A' ' 17' ' ' SER . 23.2 mt-30 -123.96 158.22 60.92 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.36 -0.382 . . . . 3.6099999999999999 110.468 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.492 ' HG2' ' CZ ' ' A' ' 143' ' ' ARG . 96.4 Cg_endo -81.94 -64.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.903 2.402 . . . . 1.51 113.568 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.64 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 56.6 t30 -108.49 -19.55 13.41 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.027 0.38 . . . . 2.6800000000000002 112.027 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.535 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 43.3 t -107.36 152.1 24.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.091 0.472 . . . . 1.21 111.29 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.3 102.87 2.22 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.675 -0.693 . . . . 1.5600000000000001 110.666 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.68 145.59 13.0 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.882 2.388 . . . . 0.81000000000000005 112.59 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.904 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.81 167.88 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 1.52 109.863 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.08 148.0 29.17 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.804 -0.443 . . . . 2.1400000000000001 109.804 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.581 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.8 p90 -142.31 157.29 44.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.065 0.46 . . . . 0.32000000000000001 111.168 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.497 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.02 155.24 44.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.751 -0.659 . . . . 2.1699999999999999 110.122 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.833 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.53 173.13 6.25 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 121.168 0.509 . . . . 0.58999999999999997 110.665 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.833 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.8 Cg_exo -50.65 173.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.816 2.344 . . . . 0.90000000000000002 111.551 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.483 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.09 -51.13 0.68 Allowed Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.775 -0.37 . . . . 3.3399999999999999 110.062 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.64 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.72 152.22 82.81 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.856 2.371 . . . . 1.8500000000000001 111.481 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.63 42.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.479 0.657 . . . . 2.54 110.624 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.64 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.8 t60 -63.68 -41.62 98.13 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.89 -1.05 . . . . 2.5299999999999998 110.569 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.555 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.8 mt -109.79 137.79 40.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.846 -0.616 . . . . 1.1699999999999999 111.262 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.87 -72.96 0.7 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.043 -0.526 . . . . 1.27 111.939 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.12 148.35 24.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.593 0.59 . . . . 1.1200000000000001 112.593 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.84 124.82 45.05 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.304 -0.628 . . . . 0.41999999999999998 109.304 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -117.99 134.69 60.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.683 -0.407 . . . . 0.78000000000000003 110.658 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.904 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.0 128.58 53.68 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.053 0.454 . . . . 0.62 111.277 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.1 139.05 49.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.778 -0.646 . . . . 1.97 110.133 178.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.439 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.1 163.16 35.17 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.145 0.498 . . . . 0.34999999999999998 112.067 -178.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.494 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.4 139.69 7.99 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.452 -0.795 . . . . 1.8 110.479 178.793 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.58 115.49 3.08 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.273 1.982 . . . . 0.57999999999999996 111.879 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.666 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.04 81.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.865 -0.42 . . . . 3.04 109.865 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.693 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.925 -0.58 . . . . 2.4700000000000002 111.939 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.8 p -157.56 157.81 34.43 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.877 -0.329 . . . . 2.5099999999999998 110.617 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.406 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.8 m -120.38 27.8 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 1.8600000000000001 110.16 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -75.83 1.31 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.143 -0.551 . . . . 1.4399999999999999 111.846 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.85 152.25 35.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.91 0.386 . . . . 4.6900000000000004 111.084 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.673 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.16 -169.01 2.5 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.103 -0.498 . . . . 1.4299999999999999 111.919 179.352 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.17 149.72 29.68 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.434 0.635 . . . . 1.74 112.582 -177.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.08 156.48 45.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.856 -1.065 . . . . 1.9199999999999999 110.316 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.469 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.21 158.39 41.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.027 -0.533 . . . . 0.34000000000000002 111.75 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.8 m -115.22 135.61 53.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.445 -0.798 . . . . 0.40999999999999998 109.751 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.581 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.41 121.98 23.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.394 -0.367 . . . . 0.55000000000000004 111.513 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.597 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.9 Cg_exo -46.33 151.66 1.66 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.656 2.237 . . . . 0.44 112.097 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.83 -23.11 62.98 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 116.0 -0.545 . . . . 0.73999999999999999 112.771 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.545 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.71 -16.87 46.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.371 0.586 . . . . 0.93000000000000005 111.882 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.597 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.55 138.29 31.69 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.804 -0.359 . . . . 0.96999999999999997 110.368 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.39 13.8 11.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.391 -0.368 . . . . 1.3400000000000001 111.578 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.83 143.52 25.39 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.662 -0.415 . . . . 0.39000000000000001 111.084 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.725 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.85 -169.39 1.54 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.222 0.534 . . . . 0.41999999999999998 110.883 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.725 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.7 t -151.74 125.88 9.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.418 -0.81 . . . . 0.39000000000000001 109.806 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.516 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.9 mt -114.89 123.29 70.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.369 -0.532 . . . . 0.73999999999999999 111.24 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.749 ' CD ' HD12 ' A' ' 185' ' ' ILE . 1.2 mtmt -126.49 163.44 23.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.773 -0.649 . . . . 2.48 110.405 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.439 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.07 19.0 59.94 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.776 -0.93 . . . . 0.5 110.776 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.64 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.6 mt -79.07 157.23 28.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.124 0.488 . . . . 0.57999999999999996 111.411 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.845 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -99.49 133.9 21.57 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.677 -0.692 . . . . 2.79 110.439 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.828 ' O ' HG22 ' A' ' 116' ' ' THR . 36.7 Cg_endo -67.74 143.55 62.12 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.61 2.207 . . . . 0.87 111.948 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.86 25.63 75.34 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.98 -0.848 . . . . 0.64000000000000001 110.98 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.845 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.16 158.76 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.747 0.308 . . . . 0.82999999999999996 110.406 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.18 139.94 42.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.941 0.4 . . . . 0.5 110.566 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.646 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.55 136.5 54.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.944 -0.571 . . . . 0.53000000000000003 110.763 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.494 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.96 131.03 45.32 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.522 -0.918 . . . . 1.8700000000000001 108.522 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.44 153.9 16.63 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.354 -0.927 . . . . 0.28999999999999998 111.945 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -135.15 140.91 45.78 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.632 -0.507 . . . . 1.4299999999999999 109.632 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.525 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.69 118.93 34.45 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.422 -0.511 . . . . 0.32000000000000001 110.469 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.74 HG12 HG23 ' A' ' 84' ' ' VAL . 64.2 mt -112.45 129.11 68.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.322 -0.399 . . . . 0.79000000000000004 110.614 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.707 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.87 120.86 43.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.305 -0.407 . . . . 1.02 110.636 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.86 HD12 ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.61 146.47 11.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.305 0.574 . . . . 0.62 110.969 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.624 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -105.96 153.84 21.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.459 -0.791 . . . . 2.4399999999999999 109.943 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.24 88.61 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.955 0.407 . . . . 3.6899999999999999 110.439 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.624 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.757 -0.656 . . . . 6.0800000000000001 110.57 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.11 -117.35 3.29 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.433 -0.667 . . . . 1.22 111.433 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.45 177.43 8.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.132 0.491 . . . . 2.8799999999999999 111.688 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.2 149.48 32.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.448 -0.797 . . . . 1.47 110.391 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.55 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.1 144.62 38.8 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.444 -0.344 . . . . 2.7000000000000002 110.588 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.74 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.99 135.93 61.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.075 0.464 . . . . 0.46000000000000002 111.589 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.571 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.01 141.4 52.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.661 . . . . 0.34999999999999998 110.237 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.459 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.69 138.82 51.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.214 0.531 . . . . 3.6699999999999999 111.501 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.21 164.27 37.71 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.532 -0.758 . . . . 0.67000000000000004 109.468 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.573 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 46.9 p30 -145.29 151.53 38.49 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.335 -0.546 . . . . 1.47 111.042 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.801 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.2 p90 -146.3 172.67 13.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.842 -0.617 . . . . 0.44 110.959 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.77 160.66 21.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.43 -0.805 . . . . 1.3700000000000001 109.856 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.38 121.94 23.05 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.585 -0.446 . . . . 1.28 110.742 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.582 HG21 ' OG ' ' A' ' 95' ' ' SER . 70.2 p -130.6 162.37 29.49 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 112.963 0.727 . . . . 1.97 112.963 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.937 ' OG ' HG23 ' A' ' 114' ' ' VAL . 44.6 t -63.6 -37.05 85.85 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.39 -1.277 . . . . 3.2799999999999998 111.522 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 95' ' ' SER . 1.3 m -153.13 -52.83 0.11 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.582 ' OG ' HG21 ' A' ' 92' ' ' THR . 41.4 m 56.68 177.57 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.382 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.29 73.89 39.87 Favored Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.573 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.51 145.19 98.73 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.512 2.141 . . . . 0.0 112.418 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 98' ' ' VAL . 7.3 p -161.9 6.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.798 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.522 ' OG1' ' OD1' ' A' ' 101' ' ' ASN . 29.9 p -83.32 164.68 19.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.393 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 86.1 p -63.29 -22.16 66.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.58 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.522 ' OD1' ' OG1' ' A' ' 99' ' ' THR . 31.7 p-10 -81.91 6.35 16.13 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.613 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 99' ' ' THR . 44.3 p -83.49 163.14 20.66 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.485 HG22 ' H ' ' A' ' 105' ' ' GLY . 7.6 p -63.76 129.26 27.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.959 0.409 . . . . 0.0 110.702 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 56.7 p -73.19 -21.34 60.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.592 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.485 ' H ' HG22 ' A' ' 103' ' ' VAL . . . -83.88 178.46 52.2 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.648 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.95 142.33 57.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.729 0.3 . . . . 0.0 110.933 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.3 m -123.92 138.24 54.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.623 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.426 HG23 ' CZ ' ' A' ' 110' ' ' PHE . 0.1 OUTLIER -71.66 139.73 83.69 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.401 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.44 136.35 75.45 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.905 1.737 . . . . 0.0 113.385 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.426 ' CZ ' HG23 ' A' ' 108' ' ' THR . 96.0 m-85 -125.38 157.29 37.17 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.678 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.69 ' H ' ' CD ' ' A' ' 112' ' ' PRO . 1.2 t -165.94 -39.65 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.69 ' CD ' ' H ' ' A' ' 111' ' ' SER . 41.3 Cg_exo -56.13 141.07 87.83 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 122.413 2.075 . . . . 0.0 114.283 -177.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.893 ' O ' ' HD2' ' A' ' 155' ' ' PRO . 26.9 tp -105.61 133.32 50.54 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.256 -0.884 . . . . 10.19 108.869 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.937 HG23 ' OG ' ' A' ' 93' ' ' SER . 19.1 t -103.0 132.82 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 121.216 0.531 . . . . 7.2800000000000002 110.67 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.48 ' HB2' ' HG3' ' A' ' 154' ' ' GLU . . . -75.69 149.6 38.07 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.411 -0.813 . . . . 7.2999999999999998 111.856 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.828 HG22 ' O ' ' A' ' 65' ' ' PRO . 11.9 p -85.15 163.22 18.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.56 -0.745 . . . . 6.4400000000000004 110.283 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.579 ' CB ' ' O ' ' A' ' 116' ' ' THR . 35.5 p 105.47 171.47 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.756 0.66 . . . . 4.4199999999999999 111.174 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.441 ' HG3' ' HZ1' ' A' ' 64' ' ' LYS . 94.0 mt-10 -110.78 154.08 24.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.91 -0.586 . . . . 3.0499999999999998 110.623 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.4 m -64.33 157.82 25.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 3.4300000000000002 110.25 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.674 HG12 ' H ' ' A' ' 122' ' ' GLU . 38.8 t -110.57 134.14 53.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.868 0.366 . . . . 2.8799999999999999 110.493 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 58.5 p -70.95 -20.53 62.45 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.016 -0.538 . . . . 2.0899999999999999 111.919 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.674 ' H ' HG12 ' A' ' 120' ' ' VAL . 96.5 mt-10 -56.46 145.92 26.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.984 0.421 . . . . 4.5300000000000002 110.986 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 122' ' ' GLU . 87.3 mt 52.97 117.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.534 -0.757 . . . . 1.4399999999999999 111.356 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 127' ' ' SER . 7.3 t -107.47 19.88 19.65 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.314 -0.857 . . . . 1.78 109.823 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.404 ' H ' HG22 ' A' ' 123' ' ' ILE . . . -65.95 150.57 48.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.725 -0.671 . . . . 0.64000000000000001 111.994 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.9 OUTLIER 46.95 14.51 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.24 -0.891 . . . . 0.66000000000000003 113.086 178.716 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.436 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.91 167.53 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.997 0.427 . . . . 0.68999999999999995 110.94 179.169 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.51 145.51 50.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.677 -0.692 . . . . 0.52000000000000002 110.178 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.3 t -124.31 101.77 9.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.049 -0.723 . . . . 0.32000000000000001 109.049 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.0 t -112.99 139.62 37.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.985 -0.552 . . . . 0.28999999999999998 111.09 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.6 p -128.68 152.62 48.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.669 -0.696 . . . . 0.25 109.822 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.592 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.86 -165.0 2.05 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.737 -0.385 . . . . 0.31 110.653 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -123.95 127.21 73.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.189 -0.459 . . . . 0.48999999999999999 110.793 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.173 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.98 58.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.149 -0.478 . . . . 1.53 110.367 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.19 24.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.867 -0.606 . . . . 0.96999999999999997 111.451 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.173 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.22 128.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.998 0.428 . . . . 1.5600000000000001 110.933 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.53 -9.5 56.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.94 -0.573 . . . . 1.8799999999999999 110.319 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.22 0.33 55.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.052 -0.522 . . . . 1.04 110.288 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.38 137.3 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 115.988 -0.551 . . . . 0.23999999999999999 109.908 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 185' ' ' ILE . 1.9 m -96.24 -15.51 21.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.282 0.563 . . . . 0.28999999999999998 110.076 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.655 ' HA3' HD11 ' A' ' 185' ' ' ILE . . . 178.65 175.55 45.81 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 109.844 -1.303 . . . . 0.13 109.844 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.45 151.6 42.52 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.668 -0.413 . . . . 0.17000000000000001 110.449 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.558 ' NH2' ' HB3' ' A' ' 157' ' ' TYR . 74.4 ttt-85 -132.31 121.17 23.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.116 -0.493 . . . . 1.29 109.948 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.14 136.61 38.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.718 -0.674 . . . . 0.25 110.62 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 80.7 tt0 -129.33 129.87 45.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.902 -0.59 . . . . 1.3200000000000001 110.072 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.76 135.29 34.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.163 0.506 . . . . 0.56999999999999995 110.595 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.417 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.25 161.42 39.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.754 -0.657 . . . . 1.1599999999999999 109.695 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.14 124.89 25.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.039 0.447 . . . . 0.38 110.684 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.494 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.77 -7.7 49.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.745 -0.662 . . . . 0.40999999999999998 110.885 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -109.85 -69.64 0.85 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 1.6599999999999999 111.331 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.435 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.7 -35.33 76.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.079 -0.51 . . . . 1.6599999999999999 111.445 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.082 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.2 7.13 88.66 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.828 -0.909 . . . . 1.1699999999999999 110.828 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.339 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.96 -171.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 1.8600000000000001 110.272 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.339 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.22 139.07 45.28 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.941 0.401 . . . . 1.98 110.196 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.9 ' HG2' HG22 ' A' ' 114' ' ' VAL . 46.4 Cg_endo -70.89 145.79 51.55 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 122.789 2.326 . . . . 0.55000000000000004 112.295 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.8 145.77 42.54 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.264 -0.643 . . . . 1.1399999999999999 109.264 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.558 ' HB3' ' NH2' ' A' ' 143' ' ' ARG . 34.5 p90 -123.33 141.31 52.12 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.364 -0.534 . . . . 0.93000000000000005 111.449 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.8 mt -128.1 127.79 43.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.226 -0.897 . . . . 0.34000000000000002 108.915 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.499 ' HB2' ' ND2' ' A' ' 16' ' ' ASN . 67.8 t0 -101.69 131.21 48.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.16 0.505 . . . . 1.0900000000000001 111.732 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.476 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -128.03 157.62 73.41 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.334 -0.848 . . . . 0.19 109.541 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -69.83 158.08 58.08 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.385 2.057 . . . . 0.17999999999999999 112.248 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.31 -12.19 5.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.839 -0.618 . . . . 0.20999999999999999 110.673 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.9 p -92.83 -8.74 42.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.28999999999999998 110.661 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.23 135.45 34.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.405 -0.362 . . . . 0.5 110.346 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.0 p -133.13 16.6 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.396 . . . . 0.29999999999999999 110.524 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.8 p -167.54 147.05 5.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.707 -0.479 . . . . 0.23000000000000001 109.707 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.12 150.56 12.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.533 -0.467 . . . . 0.28000000000000003 111.568 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.508 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.43 124.98 50.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.567 -0.742 . . . . 1.0700000000000001 109.768 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.31 104.9 29.5 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.344 -0.389 . . . . 0.28999999999999998 111.034 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.9 Cg_endo -91.03 -179.56 1.49 Allowed 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 123.215 2.61 . . . . 0.42999999999999999 112.212 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.77 32.61 18.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.427 -0.806 . . . . 1.26 111.458 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.433 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.0 mt -86.42 148.5 25.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.442 -0.345 . . . . 0.32000000000000001 110.391 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.771 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.4 mt -88.24 114.92 61.56 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.987 0.422 . . . . 0.57999999999999996 110.69 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.12 140.55 95.55 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.879 2.386 . . . . 0.66000000000000003 111.978 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.21 74.33 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.102 -0.799 . . . . 0.28999999999999998 111.102 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.435 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.81 150.26 49.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.781 0.324 . . . . 2.3300000000000001 110.661 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.494 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.31 131.61 46.15 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.105 -0.498 . . . . 0.85999999999999999 109.769 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.955 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.47 148.4 43.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.012 -0.54 . . . . 0.52000000000000002 110.962 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.36 125.37 60.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.262 -1.014 . . . . 0.29999999999999999 108.262 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.56 132.5 63.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.158 0.504 . . . . 0.23000000000000001 111.249 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.9 m-20 -136.48 122.63 20.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.48 -0.782 . . . . 0.35999999999999999 109.693 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.592 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.07 125.39 55.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.241 -0.436 . . . . 0.19 110.63 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 47.9 m-85 -117.2 137.88 52.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.974 -0.557 . . . . 0.29999999999999999 109.912 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.426 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.7 135.09 42.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.734 -0.839 . . . . 0.37 108.734 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.749 HD12 ' CD ' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -99.24 123.01 51.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.216 0.531 . . . . 0.26000000000000001 110.866 -178.722 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.4 p -83.84 169.81 14.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.512 -0.767 . . . . 0.28000000000000003 110.399 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.507 ' OE1' ' OG ' ' A' ' 140' ' ' SER . 48.0 tp10 -59.89 -14.52 15.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.948 -0.569 . . . . 1.6000000000000001 110.962 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -96.09 -4.25 43.2 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.818 -0.353 . . . . 1.1799999999999999 110.825 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.89 13.82 63.93 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.297 -0.721 . . . . 0.29999999999999999 111.297 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -84.53 139.04 32.41 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.116 -0.233 . . . . 1.22 110.519 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -106.77 141.06 38.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.852 0.358 . . . . 0.97999999999999998 110.596 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.0 m -136.69 126.97 26.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.82999999999999996 110.345 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.0 117.22 9.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.254 -0.43 . . . . 0.26000000000000001 110.502 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.09 -21.69 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.241 -0.436 . . . . 0.29999999999999999 110.728 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.92 125.71 5.84 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.527 -0.469 . . . . 0.31 111.5 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.469 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.76 120.31 21.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.764 -0.653 . . . . 0.28000000000000003 109.539 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.72 151.6 28.93 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.587 -0.445 . . . . 0.23999999999999999 110.89 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.41 158.58 18.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.052 -0.522 . . . . 0.23000000000000001 110.461 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -145.99 158.06 43.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.67000000000000004 110.651 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.37 104.38 9.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.775 -0.648 . . . . 0.64000000000000001 110.012 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.2 p . . . . . 0 C--O 1.222 -0.39 0 CA-C-O 117.887 -1.054 . . . . 1.26 110.659 -179.751 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.553 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.148 -0.686 . . . . 3.4399999999999999 109.148 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.41 150.63 18.55 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.992 -0.843 . . . . 1.22 110.992 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -35.51 142.32 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.085 0 C-N-CA 124.083 3.189 . . . . 0.75 113.799 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.3 t -79.98 173.38 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.281 -1.327 . . . . 0.79000000000000004 108.779 178.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.601 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.57 125.88 51.5 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.378 -0.529 . . . . 1.9399999999999999 111.439 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.5 144.02 33.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.653 -0.703 . . . . 0.59999999999999998 110.633 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -151.98 168.39 25.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.908 0.385 . . . . 3.1400000000000001 111.162 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.744 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.12 131.06 60.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.053 -0.521 . . . . 3.23 110.055 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.1 p -141.16 162.22 36.02 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.88 0.371 . . . . 3.6299999999999999 111.26 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 98.1 mt-10 36.17 31.59 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.587 -0.523 . . . . 6.0800000000000001 109.587 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.744 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.4 69.53 32.08 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.97 -0.559 . . . . 3.3799999999999999 111.547 -178.777 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.27 -29.08 72.81 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.494 2.129 . . . . 3.9300000000000002 111.858 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.61 125.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.118 -0.492 . . . . 3.3599999999999999 110.48 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.745 ' NE2' ' OE1' ' A' ' 191' ' ' GLN . 10.4 mm-40 -123.98 158.4 60.37 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.313 -0.403 . . . . 3.6099999999999999 110.453 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.549 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 99.0 Cg_endo -82.12 -64.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.942 2.428 . . . . 1.51 113.437 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.492 ' ND2' ' C ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -108.49 -19.57 13.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.019 0.377 . . . . 2.6800000000000002 112.019 -178.439 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.599 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 7.7 p -107.26 152.09 24.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.21 0.529 . . . . 1.21 111.252 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.37 102.94 2.21 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.67 -0.696 . . . . 1.5600000000000001 110.647 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.63 145.61 13.09 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.884 2.389 . . . . 0.81000000000000005 112.598 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.924 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.84 167.91 24.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.897 -0.592 . . . . 1.52 109.939 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.14 148.0 29.13 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.751 -0.463 . . . . 2.1400000000000001 109.751 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.586 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.7 p90 -142.19 157.25 45.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.017 0.437 . . . . 0.32000000000000001 111.242 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.497 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.06 155.32 44.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.856 -0.611 . . . . 2.1699999999999999 110.137 178.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.838 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.61 173.03 6.36 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 121.105 0.479 . . . . 0.58999999999999997 110.741 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.838 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.69 173.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.932 2.422 . . . . 0.90000000000000002 111.498 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -51.05 0.69 Allowed Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 120.714 -0.395 . . . . 3.3399999999999999 110.155 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.638 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.84 152.39 82.33 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.756 2.304 . . . . 1.8500000000000001 111.452 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.73 42.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.309 0.576 . . . . 2.54 110.496 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.638 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.7 t60 -63.66 -41.67 98.18 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.974 -1.012 . . . . 2.5299999999999998 110.645 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.562 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.4 mt -109.82 137.9 39.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.795 -0.639 . . . . 1.1699999999999999 111.242 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.06 -72.87 0.71 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.009 -0.541 . . . . 1.27 111.863 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.12 148.52 24.4 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.58 0.585 . . . . 1.1200000000000001 112.58 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.96 124.9 45.12 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.301 -0.629 . . . . 0.41999999999999998 109.301 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.07 134.7 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.645 -0.422 . . . . 0.78000000000000003 110.594 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.924 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.02 128.67 53.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.04 0.448 . . . . 0.62 111.237 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.542 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.11 138.94 49.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.735 -0.666 . . . . 1.97 110.088 179.031 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.436 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.04 163.16 35.09 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.181 0.515 . . . . 0.34999999999999998 112.061 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.491 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.42 139.6 7.92 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.45 -0.795 . . . . 1.8 110.462 178.837 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.54 115.45 3.04 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.307 2.004 . . . . 0.57999999999999996 111.837 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.676 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.97 81.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.834 -0.432 . . . . 3.04 109.834 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.693 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.979 -0.555 . . . . 2.4700000000000002 111.886 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 p -157.59 157.84 34.44 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.79 -0.364 . . . . 2.5099999999999998 110.569 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.44 27.87 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.256 -0.429 . . . . 1.8600000000000001 110.189 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.91 -75.89 1.31 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.115 -0.564 . . . . 1.4399999999999999 111.766 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.94 152.33 35.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.011 0.434 . . . . 4.6900000000000004 110.91 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.2 -169.19 2.56 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.98 -0.555 . . . . 1.4299999999999999 111.946 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.436 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.6 mttp -110.08 149.56 29.84 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.471 0.653 . . . . 1.74 112.633 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.01 156.51 46.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.836 -1.074 . . . . 1.9199999999999999 110.242 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.22 158.42 41.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.931 -0.577 . . . . 0.34000000000000002 111.718 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.1 m -115.26 135.62 53.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.4 -0.818 . . . . 0.40999999999999998 109.814 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.586 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.43 121.9 23.73 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.407 -0.36 . . . . 0.55000000000000004 111.591 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.599 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.3 Cg_exo -46.23 151.69 1.57 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.626 2.217 . . . . 0.44 112.135 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.79 -23.15 62.93 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 116.071 -0.513 . . . . 0.73999999999999999 112.826 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.81 -16.83 46.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.371 0.586 . . . . 0.93000000000000005 111.831 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.599 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.57 138.43 31.58 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.767 -0.373 . . . . 0.96999999999999997 110.307 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -121.54 13.92 10.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.418 -0.356 . . . . 1.3400000000000001 111.548 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.477 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.0 p -150.02 143.36 25.12 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.721 -0.392 . . . . 0.39000000000000001 111.06 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.721 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.77 -169.35 1.53 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.065 -0.516 . . . . 0.41999999999999998 110.918 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.721 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 t -151.75 125.83 9.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.431 -0.804 . . . . 0.39000000000000001 109.87 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.518 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.84 123.26 70.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.42 -0.512 . . . . 0.73999999999999999 111.18 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -126.57 163.34 23.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.732 -0.667 . . . . 2.48 110.412 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.18 18.95 59.84 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.742 -0.943 . . . . 0.5 110.742 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.518 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.1 mt -79.1 157.23 28.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.052 0.453 . . . . 0.57999999999999996 111.357 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.847 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -99.48 133.96 21.53 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.584 -0.735 . . . . 2.79 110.433 179.832 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.92 143.59 61.23 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.614 2.209 . . . . 0.87 111.89 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.78 25.69 75.26 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.068 -0.813 . . . . 0.64000000000000001 111.068 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.847 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.23 158.78 40.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.679 0.276 . . . . 0.82999999999999996 110.423 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.27 139.95 42.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.034 0.445 . . . . 0.5 110.57 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.658 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.7 m-85 -122.54 136.4 54.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.967 -0.56 . . . . 0.53000000000000003 110.745 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.491 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.91 131.05 45.29 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.474 -0.936 . . . . 1.8700000000000001 108.474 177.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.494 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.52 153.84 16.66 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.283 -0.96 . . . . 0.28999999999999998 112.011 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -134.93 140.88 46.09 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.671 -0.492 . . . . 1.4299999999999999 109.671 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.3 tp -115.77 118.9 34.33 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.458 -0.497 . . . . 0.32000000000000001 110.476 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.726 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.45 129.12 68.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.26 -0.427 . . . . 0.79000000000000004 110.619 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.702 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.9 120.77 43.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.273 -0.421 . . . . 1.02 110.713 -179.638 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.854 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.52 146.46 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.107 0.48 . . . . 0.62 111.044 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.616 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.02 153.9 21.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.54 -0.755 . . . . 2.4399999999999999 109.929 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.15 88.67 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.912 0.387 . . . . 3.6899999999999999 110.401 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.616 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.16 32.64 0.2 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.835 -0.621 . . . . 6.0800000000000001 110.659 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.02 -117.36 3.3 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.495 -0.642 . . . . 1.22 111.495 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.45 177.49 8.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.17 0.509 . . . . 2.8799999999999999 111.642 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.2 149.47 31.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.427 -0.806 . . . . 1.47 110.377 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.553 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.09 144.63 38.81 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.506 -0.315 . . . . 2.7000000000000002 110.616 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.726 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.93 136.0 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.026 0.441 . . . . 0.46000000000000002 111.601 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.06 141.31 52.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.676 -0.693 . . . . 0.34999999999999998 110.3 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.466 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.65 138.74 51.77 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.095 0.474 . . . . 3.6699999999999999 111.54 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.494 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.17 164.14 37.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.562 -0.744 . . . . 0.67000000000000004 109.498 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.571 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.18 151.57 38.64 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.428 -0.509 . . . . 1.47 111.062 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.8 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.18 172.76 12.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.748 -0.66 . . . . 0.44 111.028 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.83 160.63 21.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.432 -0.804 . . . . 1.3700000000000001 109.804 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.31 121.9 23.07 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.593 -0.443 . . . . 1.28 110.798 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.632 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.7 p -127.37 168.16 15.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.256 0.55 . . . . 1.97 112.351 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.0 p -63.14 160.23 15.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.514 -0.766 . . . . 3.2799999999999998 110.931 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.4 t -64.7 -35.29 80.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.272 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.3 t -72.97 142.69 47.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.006 0.432 . . . . 0.0 111.063 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.794 ' H ' ' CD ' ' A' ' 97' ' ' PRO . 14.0 m -123.66 -33.86 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.932 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.794 ' CD ' ' H ' ' A' ' 96' ' ' THR . 49.4 Cg_exo -55.22 -19.93 22.93 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.228 1.952 . . . . 0.0 112.801 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.9 m -127.06 156.4 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.095 0.474 . . . . 0.0 110.962 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.7 p -92.2 164.41 13.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.789 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.3 t -77.23 149.69 35.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.27 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -100.56 140.44 34.81 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.838 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 49.6 m -78.79 140.31 38.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.524 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.4 m -63.25 138.45 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.491 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 t -134.85 159.88 39.99 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.678 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -138.92 176.62 20.79 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -108.79 153.29 23.69 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.802 0.334 . . . . 0.0 110.598 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.409 ' O ' ' OG1' ' A' ' 108' ' ' THR . 20.4 p -122.08 162.83 20.51 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.37 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 107' ' ' THR . 16.6 p 55.7 66.86 3.34 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.733 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -54.29 146.36 50.98 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.558 2.172 . . . . 0.0 112.02 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -108.05 138.73 43.81 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.509 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 63.8 p -124.44 73.46 60.24 Favored Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.545 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.27 147.97 81.56 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.462 2.108 . . . . 0.0 111.941 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 27.5 tp -96.23 131.63 42.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.475 . . . . 10.19 110.005 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.567 HG22 ' H ' ' A' ' 116' ' ' THR . 12.2 p -129.96 142.59 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.079 -0.51 . . . . 7.2800000000000002 110.955 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.63 75.91 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.968 -0.56 . . . . 7.2999999999999998 111.878 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.567 ' H ' HG22 ' A' ' 114' ' ' VAL . 22.6 p -121.18 160.82 22.99 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.897 0.379 . . . . 6.4400000000000004 110.87 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.5 m -119.78 149.85 41.37 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.988 -0.551 . . . . 4.4199999999999999 110.984 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 46.18 -164.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.862 -0.608 . . . . 3.0499999999999998 111.19 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.2 p -119.93 158.49 26.59 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.829 -0.623 . . . . 3.4300000000000002 110.86 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 74.9 t -58.77 -37.92 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.974 -0.557 . . . . 2.8799999999999999 110.111 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.4 t -132.01 156.14 46.78 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.433 -0.349 . . . . 2.0899999999999999 110.332 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.96 141.22 57.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.127 0.489 . . . . 4.5300000000000002 111.442 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.9 pt -125.79 159.85 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.524 -0.762 . . . . 1.4399999999999999 109.917 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 126' ' ' SER . 42.0 m -81.5 132.96 35.33 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.474 -0.49 . . . . 1.78 109.887 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.546 ' O ' ' CB ' ' A' ' 126' ' ' SER . . . -64.95 -36.91 85.91 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.848 -0.341 . . . . 0.64000000000000001 110.884 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 125' ' ' ALA . 3.6 p 144.43 0.93 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.939 -0.763 . . . . 0.66000000000000003 108.939 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.437 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.77 167.5 0.25 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.288 -0.869 . . . . 0.68999999999999995 111.004 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.57 145.6 50.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.785 -0.643 . . . . 0.52000000000000002 110.118 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.3 101.55 9.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.126 -0.694 . . . . 0.32000000000000001 109.126 177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.8 t -112.93 139.8 36.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.006 -0.543 . . . . 0.28999999999999998 110.988 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.1 p -128.74 152.63 48.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.575 -0.739 . . . . 0.25 109.778 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.592 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.89 -164.96 2.04 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.717 -0.393 . . . . 0.31 110.622 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.734 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -123.92 127.22 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 0.48999999999999999 110.815 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.179 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -58.05 58.34 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.168 -0.469 . . . . 1.53 110.326 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.09 24.42 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.905 -0.589 . . . . 0.96999999999999997 111.447 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.179 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.28 128.7 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.638 -0.425 . . . . 1.5600000000000001 110.913 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -86.37 -9.58 56.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.971 -0.559 . . . . 1.8799999999999999 110.381 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.7 p -87.13 0.28 55.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 1.04 110.279 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.33 137.27 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.988 -0.551 . . . . 0.23999999999999999 109.888 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 185' ' ' ILE . 88.8 p -96.25 -15.53 21.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.25 0.548 . . . . 0.28999999999999998 109.999 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.6 175.56 45.78 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 109.832 -1.307 . . . . 0.13 109.832 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.43 151.54 42.56 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.719 -0.392 . . . . 0.17000000000000001 110.538 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.872 ' NE ' HE22 ' A' ' 191' ' ' GLN . 8.5 tmm_? -132.22 121.19 23.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.153 -0.476 . . . . 1.29 109.899 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.13 136.61 38.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.739 -0.664 . . . . 0.25 110.653 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 77.6 tt0 -129.36 129.86 45.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 1.3200000000000001 110.03 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.627 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.8 135.23 34.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.066 -0.516 . . . . 0.56999999999999995 110.638 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.42 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.27 161.38 39.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.723 -0.672 . . . . 1.1599999999999999 109.665 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.4 mt -71.02 124.88 25.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.991 0.424 . . . . 0.38 110.755 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.489 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.1 p -71.74 -7.67 49.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.725 -0.671 . . . . 0.40999999999999998 110.866 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -109.83 -69.57 0.86 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 1.6599999999999999 111.481 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.459 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.69 -35.41 76.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.11 -0.496 . . . . 1.6599999999999999 111.451 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.077 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.2 7.18 88.63 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.76 -0.936 . . . . 1.1699999999999999 110.76 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.331 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.86 -171.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.779 0.323 . . . . 1.8600000000000001 110.324 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.331 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.16 139.11 45.48 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.96 0.409 . . . . 1.98 110.216 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.42 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.5 Cg_endo -70.98 145.84 51.14 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 C-N-CA 122.746 2.297 . . . . 0.55000000000000004 112.288 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.627 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.83 145.77 42.56 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.224 -0.658 . . . . 1.1399999999999999 109.224 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 15' ' ' PRO . 7.8 m-85 -123.28 141.37 52.05 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.344 -0.543 . . . . 0.93000000000000005 111.526 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.16 127.69 43.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.286 -0.87 . . . . 0.34000000000000002 108.932 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.533 ' O ' ' OD1' ' A' ' 159' ' ' ASP . 55.4 p-10 -101.62 131.19 47.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.125 0.488 . . . . 1.0900000000000001 111.818 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -128.04 157.58 73.53 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.393 -0.821 . . . . 0.19 109.514 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -69.88 158.09 57.96 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.335 2.023 . . . . 0.17999999999999999 112.24 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.36 -12.08 5.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.842 -0.617 . . . . 0.20999999999999999 110.734 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.3 p -92.79 -8.8 42.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.101 -0.5 . . . . 0.28999999999999998 110.762 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.36 34.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.304 -0.407 . . . . 0.5 110.434 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.9 p -133.11 16.58 4.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.447 -0.342 . . . . 0.29999999999999999 110.515 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.8 p -167.47 147.21 5.16 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.607 -0.516 . . . . 0.23000000000000001 109.607 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.24 150.51 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.551 -0.459 . . . . 0.28000000000000003 111.57 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.509 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.36 124.89 50.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.604 -0.725 . . . . 1.0700000000000001 109.786 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.34 104.84 29.26 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.358 -0.383 . . . . 0.28999999999999998 111.028 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.9 Cg_endo -91.04 -179.43 1.47 Allowed 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 123.103 2.535 . . . . 0.42999999999999999 112.237 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.72 32.62 18.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.381 -0.827 . . . . 1.26 111.381 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.48 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.1 mt -86.34 148.51 25.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.788 0.328 . . . . 0.32000000000000001 110.476 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.777 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.26 114.83 61.18 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.969 0.414 . . . . 0.57999999999999996 110.725 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.05 140.57 95.82 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.882 2.388 . . . . 0.66000000000000003 111.977 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.17 21.12 74.25 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.078 -0.809 . . . . 0.28999999999999998 111.078 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.459 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.83 150.2 49.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.833 0.349 . . . . 2.3300000000000001 110.623 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.489 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.12 131.65 45.95 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.983 -0.553 . . . . 0.85999999999999999 109.818 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.955 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.5 148.34 43.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.138 -0.483 . . . . 0.52000000000000002 111.01 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.38 125.38 60.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.258 -1.015 . . . . 0.29999999999999999 108.258 177.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.5 132.55 63.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.092 0.473 . . . . 0.23000000000000001 111.283 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.55 122.55 20.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.624 -0.717 . . . . 0.35999999999999999 109.659 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.592 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -100.95 125.33 54.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.219 -0.446 . . . . 0.19 110.709 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.4 m-85 -117.21 137.98 52.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.997 -0.547 . . . . 0.29999999999999999 109.887 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.431 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.76 135.0 42.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.779 -0.823 . . . . 0.37 108.779 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.603 ' O ' ' N ' ' A' ' 140' ' ' SER . 74.6 mt -99.17 122.98 51.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.161 0.505 . . . . 0.26000000000000001 110.893 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.7 p -83.94 169.7 14.76 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.539 -0.755 . . . . 0.28000000000000003 110.383 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -59.74 -14.53 14.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.05 -0.523 . . . . 1.6000000000000001 110.964 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -96.07 -4.4 43.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.795 0.331 . . . . 1.1799999999999999 110.829 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.435 ' N ' ' HB ' ' A' ' 59' ' ' THR . . . 87.85 13.84 63.97 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.364 -0.694 . . . . 0.29999999999999999 111.364 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -84.58 139.09 32.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.059 -0.256 . . . . 1.22 110.482 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.872 HE22 ' NE ' ' A' ' 143' ' ' ARG . 88.5 mt-30 -106.81 141.08 38.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.91 0.386 . . . . 0.97999999999999998 110.526 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.4 m -136.71 126.94 26.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.82999999999999996 110.349 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.11 117.26 9.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.317 -0.401 . . . . 0.26000000000000001 110.564 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.01 -21.81 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.29999999999999999 110.77 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.85 125.71 5.89 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.547 -0.461 . . . . 0.31 111.501 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.74 120.27 21.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.821 -0.627 . . . . 0.28000000000000003 109.542 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.69 151.65 28.99 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.752 -0.379 . . . . 0.23999999999999999 110.922 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.43 158.49 18.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.967 -0.56 . . . . 0.23000000000000001 110.447 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -146.01 157.95 43.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.127 -0.488 . . . . 0.67000000000000004 110.669 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.26 104.37 9.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.774 -0.648 . . . . 0.64000000000000001 109.964 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.948 -1.025 . . . . 1.26 110.638 -179.774 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.1 m . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.285 -0.635 . . . . 3.4399999999999999 109.285 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.45 150.76 18.52 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.012 -0.835 . . . . 1.22 111.012 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -35.7 142.39 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.067 0 C-N-CA 123.999 3.133 . . . . 0.75 113.759 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.607 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.9 173.36 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.222 -1.354 . . . . 0.79000000000000004 108.822 178.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.607 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.62 125.88 51.5 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.435 -0.506 . . . . 1.9399999999999999 111.438 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 143.93 34.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.655 -0.702 . . . . 0.59999999999999998 110.73 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.28 25.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 3.1400000000000001 111.129 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.748 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.99 131.07 60.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.008 -0.542 . . . . 3.23 110.082 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.8 p -141.19 162.3 35.82 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.759 0.314 . . . . 3.6299999999999999 111.249 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 10' ' ' GLU . 70.6 tt0 36.02 31.6 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.69 -0.485 . . . . 6.0800000000000001 109.69 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.748 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.56 32.42 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.896 -0.593 . . . . 3.3799999999999999 111.568 -178.744 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.3 -29.08 72.53 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.449 2.1 . . . . 3.9300000000000002 111.818 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.64 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 3.3599999999999999 110.513 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.604 ' HG3' ' NE2' ' A' ' 191' ' ' GLN . 7.0 mp0 -124.01 158.35 60.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.392 -0.367 . . . . 3.6099999999999999 110.426 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.699 ' HD2' HH12 ' A' ' 143' ' ' ARG . 96.5 Cg_endo -82.0 -64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.835 2.356 . . . . 1.51 113.57 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.913 ' ND2' ' H ' ' A' ' 62' ' ' GLY . 9.9 t30 -108.46 -19.55 13.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.265 -0.425 . . . . 2.6800000000000002 112.074 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 18.0 p -107.31 152.09 24.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.163 0.506 . . . . 1.21 111.387 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.578 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.19 102.9 2.24 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.726 -0.67 . . . . 1.5600000000000001 110.691 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.406 ' HB3' ' HA3' ' A' ' 189' ' ' GLY . 73.6 Cg_endo -82.63 145.63 13.1 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.915 2.41 . . . . 0.81000000000000005 112.607 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.911 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.87 167.92 24.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.906 -0.588 . . . . 1.52 109.904 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.1 148.02 29.18 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.783 -0.451 . . . . 2.1400000000000001 109.783 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.588 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.4 p90 -142.29 157.27 45.01 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.621 -0.432 . . . . 0.32000000000000001 111.137 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.494 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.02 155.31 44.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.732 -0.667 . . . . 2.1699999999999999 110.051 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.827 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.63 173.12 6.26 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.214 0.531 . . . . 0.58999999999999997 110.68 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.827 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.69 173.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.819 2.346 . . . . 0.90000000000000002 111.497 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -50.97 0.69 Allowed Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.666 -0.414 . . . . 3.3399999999999999 110.191 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.634 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.82 152.3 82.63 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.821 2.347 . . . . 1.8500000000000001 111.466 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.64 42.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.331 0.586 . . . . 2.54 110.543 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.7 t60 -63.54 -41.66 98.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.047 -0.978 . . . . 2.5299999999999998 110.683 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.551 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.8 mt -109.8 137.87 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.813 -0.63 . . . . 1.1699999999999999 111.296 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.02 -72.88 0.7 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.095 -0.502 . . . . 1.27 111.84 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.19 148.35 24.43 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.558 0.577 . . . . 1.1200000000000001 112.558 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.77 124.86 45.19 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.348 -0.612 . . . . 0.41999999999999998 109.348 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.3 mt -117.99 134.73 60.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.724 -0.391 . . . . 0.78000000000000003 110.61 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.911 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -119.99 128.62 53.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.067 0.46 . . . . 0.62 111.252 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.14 138.96 49.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.799 -0.637 . . . . 1.97 110.073 179.05 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.435 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.11 163.24 34.92 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.14 0.495 . . . . 0.34999999999999998 112.059 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.5 139.55 7.83 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.423 -0.808 . . . . 1.8 110.428 178.951 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.62 115.47 3.07 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.347 2.032 . . . . 0.57999999999999996 111.823 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.668 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.97 81.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.887 -0.412 . . . . 3.04 109.887 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.25 -20.59 0.06 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.05 -0.523 . . . . 2.4700000000000002 111.969 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 p -157.61 157.81 34.35 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.822 -0.351 . . . . 2.5099999999999998 110.535 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.406 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.48 27.88 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 1.8600000000000001 110.123 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.82 -75.94 1.31 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.17 -0.538 . . . . 1.4399999999999999 111.839 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.87 152.36 35.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.946 0.403 . . . . 4.6900000000000004 111.058 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.09 2.52 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.101 -0.499 . . . . 1.4299999999999999 111.998 179.43 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.18 149.64 29.8 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.464 0.649 . . . . 1.74 112.565 -177.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.03 156.47 46.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.893 -1.048 . . . . 1.9199999999999999 110.302 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.18 158.44 41.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.931 -0.577 . . . . 0.34000000000000002 111.796 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.27 135.53 54.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.438 -0.801 . . . . 0.40999999999999998 109.848 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.588 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.31 121.98 23.89 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.506 -0.315 . . . . 0.55000000000000004 111.529 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.6 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.6 Cg_exo -46.39 151.76 1.67 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.716 2.277 . . . . 0.44 112.098 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.94 -23.01 63.11 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 116.076 -0.511 . . . . 0.73999999999999999 112.792 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.547 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.78 -16.94 45.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.425 0.613 . . . . 0.93000000000000005 111.821 -178.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.6 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.49 138.44 31.57 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.737 -0.385 . . . . 0.96999999999999997 110.352 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -121.48 13.93 11.03 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.442 -0.345 . . . . 1.3400000000000001 111.638 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.473 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.02 143.49 25.2 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.607 -0.437 . . . . 0.39000000000000001 111.022 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.72 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.79 -169.38 1.53 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.212 0.529 . . . . 0.41999999999999998 110.886 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.72 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.74 125.86 9.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.437 -0.801 . . . . 0.39000000000000001 109.893 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.4 mt -114.84 123.34 70.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.366 -0.533 . . . . 0.73999999999999999 111.234 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.838 ' NZ ' ' N ' ' A' ' 141' ' ' GLY . 15.9 mtpt -126.59 163.42 23.46 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.753 -0.658 . . . . 2.48 110.394 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.913 ' H ' ' ND2' ' A' ' 16' ' ' ASN . . . 85.11 19.07 59.76 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.682 -0.967 . . . . 0.5 110.682 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.514 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.0 mt -79.11 157.19 28.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.996 0.427 . . . . 0.57999999999999996 111.36 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.854 ' O ' HG12 ' A' ' 67' ' ' VAL . 4.3 mttp -99.48 133.87 21.6 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.71 -0.677 . . . . 2.79 110.464 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.89 143.63 61.6 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.497 2.131 . . . . 0.87 111.906 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.79 25.67 75.28 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.073 -0.811 . . . . 0.64000000000000001 111.073 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.854 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.3 p -128.14 158.73 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.683 0.278 . . . . 0.82999999999999996 110.461 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.03 140.03 41.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.909 0.385 . . . . 0.5 110.648 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.658 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.68 136.52 54.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.948 -0.569 . . . . 0.53000000000000003 110.71 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.96 131.1 45.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.436 -0.95 . . . . 1.8700000000000001 108.436 177.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.48 153.87 16.65 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.355 -0.926 . . . . 0.28999999999999998 111.918 -178.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -135.03 141.01 46.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.624 -0.51 . . . . 1.4299999999999999 109.624 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.525 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.9 tp -115.71 119.02 34.69 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.422 -0.511 . . . . 0.32000000000000001 110.545 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.74 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.53 129.1 68.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.359 -0.382 . . . . 0.79000000000000004 110.601 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.707 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.88 120.76 43.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.332 -0.395 . . . . 1.02 110.724 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.866 HD12 ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.5 146.38 11.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.192 0.52 . . . . 0.62 111.032 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.619 ' O ' ' N ' ' A' ' 79' ' ' TYR . 20.9 mt-30 -105.98 153.81 21.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.512 -0.767 . . . . 2.4399999999999999 109.986 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.07 88.49 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.9 0.381 . . . . 3.6899999999999999 110.525 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.3 32.61 0.21 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.864 -0.607 . . . . 6.0800000000000001 110.661 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.05 -117.37 3.29 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.437 -0.665 . . . . 1.22 111.437 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.39 177.38 9.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.153 0.501 . . . . 2.8799999999999999 111.597 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.18 149.55 32.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.39 -0.823 . . . . 1.47 110.4 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.16 144.71 38.7 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.455 -0.339 . . . . 2.7000000000000002 110.591 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.74 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.08 135.94 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 121.088 0.47 . . . . 0.46000000000000002 111.5 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.01 141.35 52.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.668 -0.696 . . . . 0.34999999999999998 110.373 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.6 138.8 51.7 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.553 -0.459 . . . . 3.6699999999999999 111.575 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.21 164.14 37.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.572 -0.74 . . . . 0.67000000000000004 109.618 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.576 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.2 151.57 38.63 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.411 -0.516 . . . . 1.47 111.027 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.802 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.26 172.64 13.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.767 -0.651 . . . . 0.44 111.023 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.7 t -118.61 160.7 21.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.479 -0.782 . . . . 1.3700000000000001 109.922 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.45 121.87 22.87 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.623 -0.431 . . . . 1.28 110.774 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.6 p -126.92 155.57 42.84 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 114.62 1.341 . . . . 1.97 114.62 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.627 ' C ' ' H ' ' A' ' 95' ' ' SER . 82.2 p -132.19 8.6 4.37 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 112.996 -1.911 . . . . 3.2799999999999998 109.102 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.1 p 58.37 -1.61 0.09 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.294 0.569 . . . . 0.0 109.8 -177.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.627 ' H ' ' C ' ' A' ' 93' ' ' SER . 83.3 p -66.44 -19.01 65.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.873 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 m -116.08 71.7 4.35 Favored Pre-proline 0 N--CA 1.465 0.294 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -176.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.17 161.73 36.09 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.554 2.169 . . . . 0.0 109.448 176.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.2 p -121.14 136.6 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.299 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.537 HG22 ' H ' ' A' ' 101' ' ' ASN . 47.3 m -129.01 149.31 50.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.939 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.896 ' O ' ' OD1' ' A' ' 101' ' ' ASN . 23.8 m -53.78 -34.19 58.28 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.896 ' OD1' ' O ' ' A' ' 100' ' ' SER . 14.9 p-10 54.93 45.3 26.76 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.376 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 49.1 m -116.86 135.57 53.63 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.5 t -121.69 136.27 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.855 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.2 p -122.14 160.43 25.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.044 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.09 -165.53 41.59 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -111.65 155.84 22.78 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.695 0.283 . . . . 0.0 110.396 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.7 p -120.39 161.1 21.77 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.216 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.5 m -126.73 79.96 71.15 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.218 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.02 146.97 45.22 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.251 1.967 . . . . 0.0 111.323 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -104.92 132.03 51.68 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.146 0.498 . . . . 0.0 111.408 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 85.9 p 44.54 57.84 14.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.728 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.16 143.98 91.17 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.232 1.955 . . . . 0.0 111.399 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.93 135.9 35.89 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.755 -0.461 . . . . 10.19 109.755 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.5 m -73.49 -34.58 42.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.846 -0.342 . . . . 7.2800000000000002 111.591 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -153.83 155.66 36.2 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.909 0.385 . . . . 7.2999999999999998 111.54 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.7 m -122.32 139.89 53.29 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.193 -0.669 . . . . 6.4400000000000004 109.193 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.442 ' O ' HG22 ' A' ' 120' ' ' VAL . 99.4 p -121.74 151.28 40.71 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.222 0.534 . . . . 4.4199999999999999 111.643 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.88 -29.07 70.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.292 -0.867 . . . . 3.0499999999999998 111.256 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.5 p -58.11 -25.12 60.97 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.685 0.624 . . . . 3.4300000000000002 112.685 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 117' ' ' SER . 10.9 m -59.99 130.25 23.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 119.884 -0.727 . . . . 2.8799999999999999 109.892 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.633 ' O ' ' N ' ' A' ' 123' ' ' ILE . 48.0 p -70.67 -31.73 68.74 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.521 0.563 . . . . 2.0899999999999999 112.521 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.518 ' C ' ' O ' ' A' ' 121' ' ' THR . 97.6 mt-10 15.34 46.87 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.955 0.724 . . . . 4.5300000000000002 112.955 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.633 ' N ' ' O ' ' A' ' 121' ' ' THR . 17.4 tt -123.4 135.19 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 110.237 -0.283 . . . . 1.4399999999999999 110.237 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.7 t -137.99 157.85 45.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.479 -0.328 . . . . 1.78 111.079 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -105.43 143.39 33.66 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.099 -0.501 . . . . 0.64000000000000001 110.33 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.491 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 2.0 p -176.61 8.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.151 0.5 . . . . 0.66000000000000003 110.417 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.436 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.91 167.58 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.613 -0.721 . . . . 0.68999999999999995 110.92 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.56 145.55 50.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.675 -0.693 . . . . 0.52000000000000002 110.146 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.33 101.72 9.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.021 -0.733 . . . . 0.32000000000000001 109.021 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.0 t -112.94 139.74 36.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.0 -0.545 . . . . 0.28999999999999998 111.078 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.1 p -128.82 152.45 48.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.681 -0.69 . . . . 0.25 109.868 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.591 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.71 -164.88 2.02 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.667 -0.413 . . . . 0.31 110.711 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -124.0 127.11 73.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 0.48999999999999999 110.833 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.176 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 1.53 110.315 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.15 24.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.916 -0.584 . . . . 0.96999999999999997 111.471 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.176 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.16 128.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.599 -0.441 . . . . 1.5600000000000001 110.929 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.4 -9.65 55.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.975 -0.557 . . . . 1.8799999999999999 110.306 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.1 0.27 55.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 1.04 110.376 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.31 137.18 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.976 -0.556 . . . . 0.23999999999999999 109.945 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.72 ' C ' ' HZ3' ' A' ' 61' ' ' LYS . 75.7 m -96.16 -15.52 22.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.337 0.589 . . . . 0.28999999999999998 110.077 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.838 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.54 175.51 45.68 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 109.793 -1.323 . . . . 0.13 109.793 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.4 151.61 42.43 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.574 -0.45 . . . . 0.17000000000000001 110.466 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.699 HH12 ' HD2' ' A' ' 15' ' ' PRO . 60.0 ttp180 -132.28 121.25 23.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.11 -0.495 . . . . 1.29 109.954 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.559 HG21 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.19 136.58 38.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.634 -0.712 . . . . 0.25 110.665 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.522 ' CD ' ' CE2' ' A' ' 157' ' ' TYR . 80.8 tt0 -129.35 129.82 45.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.858 -0.61 . . . . 1.3200000000000001 110.065 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.71 135.31 34.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.98 -0.554 . . . . 0.56999999999999995 110.619 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.418 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.32 161.37 39.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.781 -0.645 . . . . 1.1599999999999999 109.634 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.954 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.07 124.77 25.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.019 0.438 . . . . 0.38 110.783 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.62 -7.77 49.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.74 -0.664 . . . . 0.40999999999999998 110.9 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -109.77 -69.74 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 1.6599999999999999 111.421 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.439 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.66 -35.34 75.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.065 -0.516 . . . . 1.6599999999999999 111.497 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.083 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.14 7.29 88.55 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.772 -0.931 . . . . 1.1699999999999999 110.772 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.34 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.97 -171.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 1.8600000000000001 110.207 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.34 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.39 139.01 44.66 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 1.98 110.17 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.418 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.3 Cg_endo -70.84 145.8 51.88 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 C-N-CA 122.752 2.301 . . . . 0.55000000000000004 112.343 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.84 145.68 42.64 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.222 -0.659 . . . . 1.1399999999999999 109.222 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.522 ' CE2' ' CD ' ' A' ' 145' ' ' GLU . 83.1 m-85 -123.3 141.39 52.04 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.289 -0.564 . . . . 0.93000000000000005 111.526 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.6 mt -128.07 127.66 43.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.288 -0.869 . . . . 0.34000000000000002 108.917 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.712 ' OD1' ' ND2' ' A' ' 16' ' ' ASN . 13.6 m-20 -101.57 131.1 47.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.099 0.476 . . . . 1.0900000000000001 111.751 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.95 157.57 73.39 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.396 -0.82 . . . . 0.19 109.602 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.78 158.03 58.31 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.453 2.102 . . . . 0.17999999999999999 112.268 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.33 -12.12 5.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.782 -0.645 . . . . 0.20999999999999999 110.75 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.0 p -92.81 -8.79 42.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.068 -0.514 . . . . 0.28999999999999998 110.753 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.1 135.4 34.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.5 110.408 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.17 16.57 4.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.435 -0.348 . . . . 0.29999999999999999 110.459 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.5 p -167.5 147.16 5.12 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.612 -0.514 . . . . 0.23000000000000001 109.612 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.559 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.21 150.48 12.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.6 -0.44 . . . . 0.28000000000000003 111.629 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.508 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 4.0 t-20 -106.36 124.96 50.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.625 -0.716 . . . . 1.0700000000000001 109.758 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.43 104.99 30.5 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.28999999999999998 111.088 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.9 Cg_endo -91.17 -179.5 1.45 Allowed 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 123.099 2.532 . . . . 0.42999999999999999 112.138 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.67 32.75 18.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.414 -0.812 . . . . 1.26 111.391 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.491 ' O ' ' OG ' ' A' ' 126' ' ' SER . 23.7 mt -86.46 148.54 25.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.474 -0.33 . . . . 0.32000000000000001 110.436 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.77 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.3 114.91 61.57 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.059 0.457 . . . . 0.57999999999999996 110.699 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.01 140.54 95.81 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.873 2.382 . . . . 0.66000000000000003 112.041 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.18 21.06 74.35 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.061 -0.815 . . . . 0.28999999999999998 111.061 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.439 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.79 150.22 49.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.786 0.327 . . . . 2.3300000000000001 110.681 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.1 131.58 45.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.068 -0.514 . . . . 0.85999999999999999 109.811 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.954 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.3 m-85 -120.45 148.3 43.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.153 -0.476 . . . . 0.52000000000000002 111.055 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.3 125.36 60.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.261 -1.014 . . . . 0.29999999999999999 108.261 177.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.49 132.39 63.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.155 0.502 . . . . 0.23000000000000001 111.26 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.39 122.61 20.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.637 -0.71 . . . . 0.35999999999999999 109.645 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.591 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.05 125.43 54.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.214 -0.448 . . . . 0.19 110.631 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.7 m-85 -117.27 137.92 52.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.027 -0.533 . . . . 0.29999999999999999 109.842 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.425 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.78 135.07 42.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.773 -0.825 . . . . 0.37 108.773 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.602 ' O ' ' N ' ' A' ' 140' ' ' SER . 50.6 mm -99.12 122.96 51.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.137 0.494 . . . . 0.26000000000000001 110.864 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.3 p -83.83 169.71 14.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.565 -0.743 . . . . 0.28000000000000003 110.503 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -59.78 -14.53 15.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.006 -0.543 . . . . 1.6000000000000001 110.963 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.404 ' C ' ' OG1' ' A' ' 59' ' ' THR . 94.9 m-20 -96.03 -4.29 43.34 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.872 -0.331 . . . . 1.1799999999999999 110.795 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.631 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.76 13.93 64.01 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.403 -0.679 . . . . 0.29999999999999999 111.403 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -84.76 139.14 32.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.736 0.303 . . . . 1.22 110.349 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.604 ' NE2' ' HG3' ' A' ' 14' ' ' GLN . 7.7 pt20 -106.83 141.05 38.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.968 0.413 . . . . 0.97999999999999998 110.465 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.73 126.99 26.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.82999999999999996 110.402 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.08 117.27 9.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.371 -0.377 . . . . 0.26000000000000001 110.502 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.3 pt -109.06 -21.82 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.471 . . . . 0.29999999999999999 110.741 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.84 125.84 5.94 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.558 -0.457 . . . . 0.31 111.495 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.84 120.21 21.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.708 -0.678 . . . . 0.28000000000000003 109.497 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.59 151.69 29.14 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.712 -0.395 . . . . 0.23999999999999999 110.987 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.48 158.57 18.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.081 -0.509 . . . . 0.23000000000000001 110.382 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -146.07 157.97 43.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.084 -0.507 . . . . 0.67000000000000004 110.624 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.37 9.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.662 -0.699 . . . . 0.64000000000000001 109.972 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.894 -1.051 . . . . 1.26 110.719 -179.788 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.145 -0.687 . . . . 3.4399999999999999 109.145 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.77 18.53 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.061 -0.815 . . . . 1.22 111.061 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -35.66 142.44 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.057 0 C-N-CA 123.959 3.106 . . . . 0.75 113.808 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.62 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.98 173.4 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 114.286 -1.325 . . . . 0.79000000000000004 108.853 178.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.62 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.67 125.9 51.52 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.429 -0.508 . . . . 1.9399999999999999 111.384 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.45 143.95 34.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.586 -0.734 . . . . 0.59999999999999998 110.705 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.02 168.31 25.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.88 0.371 . . . . 3.1400000000000001 111.13 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.748 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.5 mt -108.97 131.02 60.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.993 -0.549 . . . . 3.23 110.154 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.15 162.35 35.69 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.954 0.407 . . . . 3.6299999999999999 111.202 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 76.1 tt0 36.04 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.659 -0.497 . . . . 6.0800000000000001 109.659 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.748 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.5 32.32 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.921 -0.581 . . . . 3.3799999999999999 111.606 -178.828 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.641 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.1 Cg_endo -63.17 -29.12 73.77 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.445 2.097 . . . . 3.9300000000000002 111.906 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.641 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.65 125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 3.3599999999999999 110.494 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.553 ' O ' ' O ' ' A' ' 92' ' ' THR . 2.4 mm-40 -123.9 158.39 60.19 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.32 -0.4 . . . . 3.6099999999999999 110.409 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.555 ' HG3' ' CZ ' ' A' ' 143' ' ' ARG . 97.0 Cg_endo -82.0 -64.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.976 2.451 . . . . 1.51 113.556 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.619 ' ND2' ' CD2' ' A' ' 157' ' ' TYR . 11.1 m120 -108.42 -19.71 13.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.277 -0.419 . . . . 2.6800000000000002 112.074 -178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 7.1 p -107.26 152.08 24.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.143 0.497 . . . . 1.21 111.354 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.569 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.3 102.9 2.22 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.708 -0.678 . . . . 1.5600000000000001 110.632 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.6 145.61 13.13 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.927 2.418 . . . . 0.81000000000000005 112.589 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.926 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.84 168.01 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.919 -0.582 . . . . 1.52 109.889 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.15 147.85 28.94 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.763 -0.458 . . . . 2.1400000000000001 109.763 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.602 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.23 157.38 44.91 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.593 -0.443 . . . . 0.32000000000000001 111.241 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.486 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.8 m-20 -127.98 155.31 44.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.863 -0.608 . . . . 2.1699999999999999 110.128 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.821 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.63 173.01 6.39 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 121.125 0.488 . . . . 0.58999999999999997 110.749 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.821 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.68 174.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.822 2.348 . . . . 0.90000000000000002 111.557 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.484 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.15 -51.06 0.68 Allowed Pre-proline 0 C--N 1.328 -0.342 0 C-N-CA 120.719 -0.392 . . . . 3.3399999999999999 110.068 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.616 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.82 152.38 82.35 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.711 2.274 . . . . 1.8500000000000001 111.451 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.64 42.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.322 0.582 . . . . 2.54 110.575 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.616 ' H ' ' C ' ' A' ' 27' ' ' PRO . 73.9 t60 -63.69 -41.58 98.11 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.027 -0.988 . . . . 2.5299999999999998 110.63 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.564 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.4 mt -109.89 137.91 39.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.771 -0.65 . . . . 1.1699999999999999 111.207 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.98 -72.88 0.7 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.965 -0.561 . . . . 1.27 111.927 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.27 148.34 24.38 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.594 0.591 . . . . 1.1200000000000001 112.594 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -121.8 124.86 45.17 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.396 -0.594 . . . . 0.41999999999999998 109.396 177.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.08 134.78 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.614 -0.434 . . . . 0.78000000000000003 110.644 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.926 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.01 128.52 53.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.03 0.443 . . . . 0.62 111.267 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.548 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.04 139.07 49.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.81 -0.632 . . . . 1.97 110.064 178.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.435 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.09 163.15 35.18 Favored 'General case' 0 N--CA 1.458 -0.056 0 C-N-CA 120.559 -0.456 . . . . 0.34999999999999998 112.134 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.4 139.69 7.99 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.478 -0.783 . . . . 1.8 110.449 178.838 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.65 115.44 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.366 2.044 . . . . 0.57999999999999996 111.799 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.686 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.03 81.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.901 -0.407 . . . . 3.04 109.901 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.697 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.21 -20.61 0.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.97 -0.559 . . . . 2.4700000000000002 111.933 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.6 p -157.68 157.77 34.16 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.801 -0.36 . . . . 2.5099999999999998 110.596 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.408 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.26 27.79 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.247 -0.433 . . . . 1.8600000000000001 110.159 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.81 -75.95 1.31 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.175 -0.536 . . . . 1.4399999999999999 111.826 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.87 152.27 35.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.942 0.401 . . . . 4.6900000000000004 110.944 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.648 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.16 -169.15 2.55 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.031 -0.532 . . . . 1.4299999999999999 111.927 179.386 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.18 149.67 29.76 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.483 0.659 . . . . 1.74 112.463 -177.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.03 156.59 46.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.702 -1.135 . . . . 1.9199999999999999 110.216 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.465 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.28 158.27 41.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.98 -0.554 . . . . 0.34000000000000002 111.842 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.09 135.66 53.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.493 -0.776 . . . . 0.40999999999999998 109.82 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.602 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.46 122.02 23.72 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.427 -0.351 . . . . 0.55000000000000004 111.534 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.2 Cg_exo -46.39 151.75 1.67 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.717 2.278 . . . . 0.44 112.053 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.92 -23.05 63.11 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 115.958 -0.564 . . . . 0.73999999999999999 112.79 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.545 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.87 -16.7 46.57 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.213 -0.595 . . . . 0.93000000000000005 111.809 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.604 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.66 138.42 31.57 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.83 -0.348 . . . . 0.96999999999999997 110.248 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -121.57 13.92 10.96 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.375 -0.375 . . . . 1.3400000000000001 111.462 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.482 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 86.8 p -149.93 143.46 25.26 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.651 -0.42 . . . . 0.39000000000000001 111.088 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.82 -169.4 1.54 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.203 0.525 . . . . 0.41999999999999998 110.897 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.723 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 20.2 m -151.68 125.89 9.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.444 -0.798 . . . . 0.39000000000000001 109.863 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.513 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.87 123.29 70.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.304 -0.558 . . . . 0.73999999999999999 111.217 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.578 ' HG2' ' N ' ' A' ' 62' ' ' GLY . 87.5 tttt -126.55 163.4 23.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.863 -0.608 . . . . 2.48 110.396 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.578 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.07 19.07 59.81 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.771 -0.932 . . . . 0.5 110.771 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.513 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.7 mt -79.12 157.17 28.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.147 0.498 . . . . 0.57999999999999996 111.304 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.844 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -99.42 133.9 21.62 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.544 -0.753 . . . . 2.79 110.56 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.666 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.85 143.49 61.27 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.615 2.21 . . . . 0.87 111.937 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.84 25.64 75.32 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.087 -0.805 . . . . 0.64000000000000001 111.087 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.2 158.84 40.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.754 0.311 . . . . 0.82999999999999996 110.377 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.18 139.86 42.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.364 -0.38 . . . . 0.5 110.554 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.65 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.55 136.42 54.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.985 -0.552 . . . . 0.53000000000000003 110.779 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.9 131.02 45.3 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.493 -0.928 . . . . 1.8700000000000001 108.493 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.494 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.38 153.92 16.62 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.315 -0.945 . . . . 0.28999999999999998 111.985 -178.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -134.98 140.95 46.09 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.693 -0.484 . . . . 1.4299999999999999 109.693 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.517 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.71 118.82 34.12 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.558 -0.457 . . . . 0.32000000000000001 110.482 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.737 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.45 129.11 68.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.371 -0.377 . . . . 0.79000000000000004 110.675 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.704 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.85 120.87 43.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.272 -0.422 . . . . 1.02 110.687 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.855 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.56 146.45 11.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.068 0.461 . . . . 0.62 111.035 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.626 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.0 153.88 21.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.514 -0.766 . . . . 2.4399999999999999 109.934 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.27 88.6 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.996 0.426 . . . . 3.6899999999999999 110.469 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.28 32.63 0.21 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.823 -0.626 . . . . 6.0800000000000001 110.6 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.35 3.29 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.483 -0.647 . . . . 1.22 111.483 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.48 177.4 8.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 2.8799999999999999 111.577 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.13 149.41 31.96 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.423 -0.808 . . . . 1.47 110.369 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.06 144.71 38.9 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.43 -0.35 . . . . 2.7000000000000002 110.6 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.737 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -127.98 136.0 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 121.07 0.462 . . . . 0.46000000000000002 111.603 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.57 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.6 m -124.13 141.23 52.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.668 -0.697 . . . . 0.34999999999999998 110.302 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.497 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.64 138.88 51.67 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.493 -0.483 . . . . 3.6699999999999999 111.485 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.494 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.23 164.22 37.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.501 -0.772 . . . . 0.67000000000000004 109.48 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.565 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 46.9 p30 -145.25 151.55 38.55 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.429 -0.509 . . . . 1.47 111.037 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.25 172.77 12.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.739 -0.664 . . . . 0.44 111.007 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.84 160.58 21.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.529 -0.76 . . . . 1.3700000000000001 109.826 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.3 121.79 22.92 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.567 -0.453 . . . . 1.28 110.803 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.553 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.0 p -127.37 161.11 29.42 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.226 0.454 . . . . 1.97 112.226 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.2 t -121.58 135.75 54.98 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.766 -0.652 . . . . 3.2799999999999998 110.361 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.641 HG22 ' H ' ' A' ' 96' ' ' THR . 40.8 m -130.21 134.53 47.34 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.084 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.566 ' O ' ' HB ' ' A' ' 96' ' ' THR . 86.0 p -64.57 -29.91 70.94 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.928 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.641 ' H ' HG22 ' A' ' 94' ' ' THR . 44.7 m 109.35 -76.44 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 124.557 1.143 . . . . 0.0 110.953 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.479 ' CD ' ' HB ' ' A' ' 96' ' ' THR . 48.0 Cg_endo -66.28 144.69 75.44 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 121.185 1.459 . . . . 0.0 111.427 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.0 m -129.13 149.8 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.923 0.392 . . . . 0.0 110.412 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.5 t -140.69 158.15 44.4 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.814 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.9 m -66.39 156.8 33.57 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -100.37 127.94 46.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.898 0.38 . . . . 0.0 110.488 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.4 p -71.56 -21.16 61.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.12 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 p -130.89 141.87 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.905 0.383 . . . . 0.0 110.968 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 47.6 m -124.43 140.36 53.02 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.445 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 131.51 142.2 4.95 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.6 -33.38 74.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.683 0.278 . . . . 0.0 110.833 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 65.6 p -67.33 -24.19 65.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.74 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.7 m 53.98 66.06 4.78 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.076 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -55.95 148.61 56.52 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.147 1.898 . . . . 0.0 111.373 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -102.99 134.26 46.73 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.064 0.459 . . . . 0.0 111.111 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.15 158.3 87.77 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.45 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 113' ' ' LEU . 10.9 Cg_endo -54.27 150.85 31.31 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.531 2.154 . . . . 0.0 111.714 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 112' ' ' PRO . 50.2 mt 58.71 149.7 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.133 -0.485 . . . . 10.19 110.255 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.461 ' O ' ' C ' ' A' ' 115' ' ' ALA . 25.1 m -128.86 159.08 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.004 -0.544 . . . . 7.2800000000000002 111.046 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 114' ' ' VAL . . . 25.94 92.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.686 -0.688 . . . . 7.2999999999999998 111.966 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.9 m -57.93 -37.54 74.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.028 -0.533 . . . . 6.4400000000000004 110.242 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 55.8 p -68.39 163.29 23.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.028 -0.533 . . . . 4.4199999999999999 110.805 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -96.27 140.88 30.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.061 -0.518 . . . . 3.0499999999999998 110.435 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -115.6 145.53 42.6 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.911 -0.586 . . . . 3.4300000000000002 110.626 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.5 t -110.54 137.96 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-N 116.135 -0.484 . . . . 2.8799999999999999 110.09 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.434 HG23 ' N ' ' A' ' 122' ' ' GLU . 8.0 t -53.13 -41.64 65.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.058 -0.519 . . . . 2.0899999999999999 112.17 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.434 ' N ' HG23 ' A' ' 121' ' ' THR . 19.8 pt-20 -80.76 137.43 36.25 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.29 -0.564 . . . . 4.5300000000000002 110.244 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.472 HG22 ' H ' ' A' ' 125' ' ' ALA . 72.8 mt -117.18 130.06 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.149 -0.478 . . . . 1.4399999999999999 110.66 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.62 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 56.4 p -71.53 -28.97 64.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.466 -0.333 . . . . 1.78 110.603 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 124' ' ' THR . . . 153.05 109.43 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.754 -0.657 . . . . 0.64000000000000001 109.403 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.9 p -61.12 -32.09 71.79 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.576 -0.45 . . . . 0.66000000000000003 110.676 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.441 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.9 167.55 0.26 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 0.68999999999999995 110.914 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.61 145.53 50.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.677 -0.692 . . . . 0.52000000000000002 110.099 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.28 101.69 9.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.096 -0.705 . . . . 0.32000000000000001 109.096 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.0 t -112.96 139.64 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.059 -0.519 . . . . 0.28999999999999998 111.078 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.5 p -128.73 152.61 48.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.721 -0.672 . . . . 0.25 109.776 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.584 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.4 p90 -144.8 -164.95 2.04 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.682 -0.407 . . . . 0.31 110.549 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.733 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.9 t -123.91 127.19 73.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.103 -0.499 . . . . 0.48999999999999999 110.817 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.157 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.97 58.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 1.53 110.376 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.12 24.47 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.856 -0.611 . . . . 0.96999999999999997 111.524 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.157 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.13 128.76 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.542 -0.463 . . . . 1.5600000000000001 110.868 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.43 -9.71 55.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.849 -0.614 . . . . 1.8799999999999999 110.31 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.0 0.22 55.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 1.04 110.414 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.725 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.25 137.21 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.951 -0.568 . . . . 0.23999999999999999 109.955 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.579 ' N ' ' O ' ' A' ' 185' ' ' ILE . 5.6 m -96.32 -15.41 21.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.219 0.533 . . . . 0.28999999999999998 110.016 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.454 ' HA3' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.51 175.56 45.7 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 109.839 -1.304 . . . . 0.13 109.839 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -123.53 151.61 42.65 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.64 -0.424 . . . . 0.17000000000000001 110.485 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.728 ' NH2' ' CD2' ' A' ' 183' ' ' TYR . 69.8 ttp85 -132.33 121.15 23.07 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.081 -0.509 . . . . 1.29 109.931 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.545 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.08 136.53 38.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.689 -0.687 . . . . 0.25 110.65 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.516 ' HB2' HH12 ' A' ' 143' ' ' ARG . 81.1 tt0 -129.36 129.91 45.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.993 -0.548 . . . . 1.3200000000000001 110.07 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.625 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.7 p90 -138.75 135.4 34.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.023 -0.535 . . . . 0.56999999999999995 110.558 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.419 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.38 161.36 39.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.723 -0.671 . . . . 1.1599999999999999 109.717 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.969 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 85.9 mt -71.09 124.86 25.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.018 0.437 . . . . 0.38 110.725 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.492 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.76 -7.56 48.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.813 -0.631 . . . . 0.40999999999999998 110.887 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -109.89 -69.77 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 1.6599999999999999 111.428 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.45 ' CD ' HH21 ' A' ' 176' ' ' ARG . 53.8 mt-10 -60.56 -35.46 76.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.028 -0.533 . . . . 1.6599999999999999 111.535 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.074 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.26 88.58 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.8 -0.92 . . . . 1.1699999999999999 110.8 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.327 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.96 -171.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 1.8600000000000001 110.243 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.327 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.27 139.13 45.12 Favored Pre-proline 0 N--CA 1.454 -0.262 0 CA-C-O 120.997 0.427 . . . . 1.98 110.243 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.419 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.3 Cg_endo -70.93 145.77 51.22 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 C-N-CA 122.782 2.321 . . . . 0.55000000000000004 112.302 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.625 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.78 145.71 42.58 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.238 -0.653 . . . . 1.1399999999999999 109.238 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.666 ' CE1' ' CD ' ' A' ' 65' ' ' PRO . 35.6 p90 -123.28 141.31 52.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.234 0.54 . . . . 0.93000000000000005 111.577 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.2 mt -128.09 127.72 43.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.274 -0.875 . . . . 0.34000000000000002 108.944 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 5.0 t0 -101.63 131.17 48.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.102 0.477 . . . . 1.0900000000000001 111.722 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.518 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.1 mt -127.94 157.66 73.1 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.277 -0.874 . . . . 0.19 109.601 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -69.92 158.03 58.12 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 122.439 2.093 . . . . 0.17999999999999999 112.226 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.32 -12.13 5.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.773 -0.649 . . . . 0.20999999999999999 110.7 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.0 p -92.84 -8.76 42.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.094 -0.503 . . . . 0.28999999999999998 110.675 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.15 135.43 34.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.326 -0.397 . . . . 0.5 110.391 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.7 p -133.18 16.65 4.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.443 -0.344 . . . . 0.29999999999999999 110.462 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.5 p -167.6 147.11 5.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.607 -0.516 . . . . 0.23000000000000001 109.607 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.545 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.21 150.43 12.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.5 -0.48 . . . . 0.28000000000000003 111.594 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.503 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.28 125.0 50.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.619 -0.719 . . . . 1.0700000000000001 109.792 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.46 104.97 30.44 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.391 -0.368 . . . . 0.28999999999999998 110.99 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.4 Cg_endo -90.99 -179.48 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 123.117 2.545 . . . . 0.42999999999999999 112.162 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.61 32.64 18.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.341 -0.845 . . . . 1.26 111.493 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.7 mt -86.39 148.49 25.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.339 . . . . 0.32000000000000001 110.494 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.772 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.23 114.83 61.18 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.311 -0.404 . . . . 0.57999999999999996 110.658 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.98 140.5 95.63 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.837 2.358 . . . . 0.66000000000000003 112.08 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.16 21.21 74.04 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.036 -0.825 . . . . 0.28999999999999998 111.036 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.45 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.87 150.18 49.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 2.3300000000000001 110.686 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.492 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.21 131.73 45.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.088 -0.506 . . . . 0.85999999999999999 109.747 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.969 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.55 148.19 44.19 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.129 -0.487 . . . . 0.52000000000000002 111.08 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.26 125.3 60.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.303 -0.999 . . . . 0.29999999999999999 108.303 177.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.52 132.46 63.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.162 0.506 . . . . 0.23000000000000001 111.197 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.45 122.5 20.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.555 -0.748 . . . . 0.35999999999999999 109.636 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.584 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.96 125.49 54.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.255 -0.43 . . . . 0.19 110.647 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.728 ' CD2' ' NH2' ' A' ' 143' ' ' ARG . 48.5 m-85 -117.34 137.84 52.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.985 -0.552 . . . . 0.29999999999999999 109.891 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.429 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.73 135.02 42.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.729 -0.841 . . . . 0.37 108.729 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 140' ' ' SER . 83.3 mt -99.05 122.86 51.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.11 0.481 . . . . 0.26000000000000001 110.961 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.5 p -83.81 169.73 14.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.542 -0.754 . . . . 0.28000000000000003 110.525 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.82 -14.54 15.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.119 -0.491 . . . . 1.6000000000000001 110.956 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -96.03 -4.25 43.42 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.852 -0.339 . . . . 1.1799999999999999 110.879 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.585 ' HA3' HG23 ' A' ' 59' ' ' THR . . . 87.81 13.83 64.08 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.336 -0.706 . . . . 0.29999999999999999 111.336 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -84.6 139.17 32.28 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.027 -0.269 . . . . 1.22 110.458 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.553 HE22 ' HG2' ' A' ' 15' ' ' PRO . 86.2 mt-30 -106.77 141.04 38.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 0.97999999999999998 110.535 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.1 m -136.65 127.06 26.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.82999999999999996 110.388 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.7 tp -68.24 117.29 9.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.92 0.39 . . . . 0.26000000000000001 110.448 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.07 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.29999999999999999 110.714 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.1 tp -156.88 125.68 5.85 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.554 -0.459 . . . . 0.31 111.486 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.472 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.75 120.27 21.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.77 -0.65 . . . . 0.28000000000000003 109.536 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.66 29.06 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.602 -0.439 . . . . 0.23999999999999999 110.903 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.45 158.65 18.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.092 -0.504 . . . . 0.23000000000000001 110.442 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -146.15 157.99 43.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.171 -0.468 . . . . 0.67000000000000004 110.654 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 104.33 9.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.699 -0.682 . . . . 0.64000000000000001 110.025 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.888 -1.053 . . . . 1.26 110.672 -179.694 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.55 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.201 -0.666 . . . . 3.4399999999999999 109.201 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.37 150.64 18.55 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.983 -0.847 . . . . 1.22 110.983 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -35.58 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.092 0 C-N-CA 124.03 3.153 . . . . 0.75 113.754 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.622 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -80.04 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.208 -1.36 . . . . 0.79000000000000004 108.857 178.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.622 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.64 125.8 51.4 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.426 -0.51 . . . . 1.9399999999999999 111.434 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.5 143.96 34.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.625 -0.716 . . . . 0.59999999999999998 110.583 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.93 168.37 25.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.386 -0.37 . . . . 3.1400000000000001 111.09 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.738 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.02 131.09 60.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.008 -0.542 . . . . 3.23 110.047 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.1 p -141.18 162.27 35.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.84 0.352 . . . . 3.6299999999999999 111.27 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.8 mt-10 36.09 31.62 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.601 -0.518 . . . . 6.0800000000000001 109.601 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.738 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.41 69.52 32.19 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.932 -0.576 . . . . 3.3799999999999999 111.558 -178.752 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.24 -29.2 73.23 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.57 2.18 . . . . 3.9300000000000002 111.837 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.71 125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 3.3599999999999999 110.449 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.718 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -123.93 158.34 60.44 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.329 -0.396 . . . . 3.6099999999999999 110.444 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.497 ' HG2' ' CD ' ' A' ' 143' ' ' ARG . 96.9 Cg_endo -81.94 -64.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.965 2.443 . . . . 1.51 113.574 -179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.44 ' H ' ' HG2' ' A' ' 15' ' ' PRO . 97.7 m-20 -108.47 -19.62 13.39 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.088 0.403 . . . . 2.6800000000000002 112.088 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.718 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 89.1 p -107.32 152.05 24.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.101 0.477 . . . . 1.21 111.346 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.578 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.26 102.92 2.23 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.711 -0.677 . . . . 1.5600000000000001 110.583 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.75 145.68 12.93 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.781 2.321 . . . . 0.81000000000000005 112.554 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.915 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.78 167.96 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.845 -0.616 . . . . 1.52 109.903 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.16 147.95 29.05 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.742 -0.466 . . . . 2.1400000000000001 109.742 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.3 p90 -142.23 157.3 45.0 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.567 -0.453 . . . . 0.32000000000000001 111.169 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.494 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.8 m-20 -127.97 155.26 44.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.773 -0.649 . . . . 2.1699999999999999 110.199 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.825 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.64 173.05 6.34 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.113 0.482 . . . . 0.58999999999999997 110.702 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.825 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.8 Cg_exo -50.74 173.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.834 2.356 . . . . 0.90000000000000002 111.505 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.92 -51.08 0.7 Allowed Pre-proline 0 C--N 1.33 -0.265 0 C-N-CA 120.717 -0.393 . . . . 3.3399999999999999 110.212 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.62 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.8 152.41 82.22 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.683 2.255 . . . . 1.8500000000000001 111.501 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.68 42.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.343 0.592 . . . . 2.54 110.601 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.62 ' H ' ' C ' ' A' ' 27' ' ' PRO . 74.0 t60 -63.64 -41.66 98.22 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.004 -0.998 . . . . 2.5299999999999998 110.655 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.558 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.5 mt -109.73 137.84 40.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.784 -0.643 . . . . 1.1699999999999999 111.308 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.02 -72.89 0.7 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.075 -0.512 . . . . 1.27 111.906 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.22 148.43 24.37 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.581 0.586 . . . . 1.1200000000000001 112.581 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -121.76 124.82 45.12 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.448 -0.575 . . . . 0.41999999999999998 109.448 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.7 mt -118.08 134.75 60.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.55 -0.46 . . . . 0.78000000000000003 110.569 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.915 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.02 128.72 53.79 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.057 0.456 . . . . 0.62 111.268 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.549 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.97 49.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.707 -0.678 . . . . 1.97 110.159 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -144.98 163.19 34.93 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.092 0.473 . . . . 0.34999999999999998 112.172 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.55 139.49 7.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.512 -0.767 . . . . 1.8 110.502 178.836 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.694 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.44 115.45 3.03 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.296 1.997 . . . . 0.57999999999999996 111.846 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.96 81.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.9 -0.407 . . . . 3.04 109.9 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.694 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.14 -20.6 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.993 -0.549 . . . . 2.4700000000000002 111.887 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.7 p -157.69 157.76 34.12 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.884 -0.326 . . . . 2.5099999999999998 110.596 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.4 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.36 27.8 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.466 . . . . 1.8600000000000001 110.205 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.73 -75.88 1.31 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.116 -0.564 . . . . 1.4399999999999999 111.926 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.89 152.25 35.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.966 0.412 . . . . 4.6900000000000004 110.959 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.633 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.23 -169.18 2.55 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.06 -0.518 . . . . 1.4299999999999999 111.97 179.367 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.08 149.74 29.59 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.392 0.615 . . . . 1.74 112.564 -177.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.08 156.45 45.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.81 -1.086 . . . . 1.9199999999999999 110.287 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.22 158.28 41.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.925 -0.579 . . . . 0.34000000000000002 111.8 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.04 135.69 53.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.476 -0.783 . . . . 0.40999999999999998 109.801 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.596 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.42 121.94 23.75 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.481 -0.327 . . . . 0.55000000000000004 111.526 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.0 Cg_exo -46.37 151.66 1.68 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.688 2.259 . . . . 0.44 112.151 178.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.87 -23.03 62.99 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 116.043 -0.526 . . . . 0.73999999999999999 112.784 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.6 p-80 -82.81 -16.86 46.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.391 0.596 . . . . 0.93000000000000005 111.804 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.605 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.63 138.4 31.6 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.751 -0.379 . . . . 0.96999999999999997 110.323 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.47 13.87 11.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.383 -0.371 . . . . 1.3400000000000001 111.542 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.48 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.0 p -149.95 143.45 25.24 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.617 -0.433 . . . . 0.39000000000000001 111.04 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.87 -169.25 1.51 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.045 -0.525 . . . . 0.41999999999999998 110.913 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.714 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 97.4 m -151.83 125.95 9.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.417 -0.811 . . . . 0.39000000000000001 109.8 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.509 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.88 123.25 70.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.376 -0.53 . . . . 0.73999999999999999 111.2 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.809 ' NZ ' ' N ' ' A' ' 141' ' ' GLY . 96.7 mttt -126.53 163.37 23.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.879 -0.601 . . . . 2.48 110.41 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.17 18.94 59.89 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.697 -0.961 . . . . 0.5 110.697 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.509 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.8 mt -79.04 157.27 28.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.13 0.491 . . . . 0.57999999999999996 111.363 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.859 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -99.45 134.01 21.51 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.598 -0.728 . . . . 2.79 110.451 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.91 143.58 61.26 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.555 2.17 . . . . 0.87 111.867 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.72 75.23 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.998 -0.841 . . . . 0.64000000000000001 110.998 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.859 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.15 158.76 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.567 0.223 . . . . 0.82999999999999996 110.46 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.15 139.95 41.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.944 0.402 . . . . 0.5 110.627 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.637 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.57 136.43 54.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.041 -0.527 . . . . 0.53000000000000003 110.77 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.92 130.99 45.33 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.53 -0.915 . . . . 1.8700000000000001 108.53 177.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.488 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.45 153.92 16.63 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.349 -0.929 . . . . 0.28999999999999998 111.913 -178.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -135.04 140.94 46.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.642 -0.503 . . . . 1.4299999999999999 109.642 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.52 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.78 118.86 34.21 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.505 -0.478 . . . . 0.32000000000000001 110.46 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.731 HG12 HG23 ' A' ' 84' ' ' VAL . 63.8 mt -112.43 128.94 68.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.79000000000000004 110.65 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.73 120.9 43.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.324 -0.398 . . . . 1.02 110.707 -179.685 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.858 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.57 146.51 11.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.137 0.494 . . . . 0.62 111.015 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.625 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.1 mt-30 -106.11 153.86 21.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.585 -0.734 . . . . 2.4399999999999999 109.955 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.14 88.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.004 0.43 . . . . 3.6899999999999999 110.503 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.22 32.7 0.21 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.808 -0.633 . . . . 6.0800000000000001 110.511 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.09 -117.37 3.29 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.443 -0.663 . . . . 1.22 111.443 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -81.37 177.35 9.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.177 0.513 . . . . 2.8799999999999999 111.69 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.1 149.59 32.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.476 -0.783 . . . . 1.47 110.371 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.55 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.2 144.78 38.67 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.407 -0.361 . . . . 2.7000000000000002 110.501 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.731 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.07 136.03 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 121.071 0.463 . . . . 0.46000000000000002 111.487 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.11 141.39 52.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.697 -0.683 . . . . 0.34999999999999998 110.212 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.461 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.4 ttp180 -117.69 138.93 51.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.185 0.517 . . . . 3.6699999999999999 111.406 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.34 164.15 38.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.539 -0.755 . . . . 0.67000000000000004 109.531 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.29 151.49 38.42 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.391 -0.523 . . . . 1.47 111.072 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.81 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.3 p90 -146.11 172.79 12.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.713 -0.676 . . . . 0.44 111.044 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.8 160.63 21.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.46 -0.791 . . . . 1.3700000000000001 109.809 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.35 121.91 23.04 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.535 -0.466 . . . . 1.28 110.776 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.549 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -128.2 164.31 22.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.668 0.747 . . . . 1.97 112.682 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.49 ' OG ' ' CE2' ' A' ' 157' ' ' TYR . 30.3 t -118.98 150.24 40.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.712 -1.131 . . . . 3.2799999999999998 109.001 177.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -40.12 140.16 0.62 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.926 0.393 . . . . 0.0 110.708 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.4 m -61.75 153.46 28.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.706 -178.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.8 p -73.46 153.69 89.9 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.577 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.93 150.64 22.68 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 121.842 1.695 . . . . 0.0 111.199 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 74.3 t -58.78 -40.3 79.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.478 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.5 p -68.78 -27.41 65.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.763 0.316 . . . . 0.0 111.142 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.2 m -66.35 156.97 32.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -102.38 139.66 37.69 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.342 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.8 p -85.47 163.46 18.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.833 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.8 m -127.66 157.65 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.41 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 57.3 p -66.6 -27.22 67.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.078 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.69 -176.21 45.53 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.35 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.432 ' H ' ' CD ' ' A' ' 106' ' ' GLU . 59.1 mp0 -59.28 143.67 48.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.961 0.41 . . . . 0.0 110.914 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.411 ' H ' HG22 ' A' ' 107' ' ' THR . 1.2 t -62.0 -37.0 83.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.676 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.2 p -123.51 80.94 54.03 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.792 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.39 148.29 33.97 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.579 2.186 . . . . 0.0 112.296 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.461 ' CE2' ' OG ' ' A' ' 111' ' ' SER . 67.6 t80 -97.99 133.76 42.03 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.188 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.461 ' OG ' ' CE2' ' A' ' 110' ' ' PHE . 16.0 m 57.99 64.65 3.73 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.338 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -57.25 146.0 84.3 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.53 2.154 . . . . 0.0 112.185 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.667 ' H ' HD12 ' A' ' 113' ' ' LEU . 6.5 mp -60.65 -32.7 71.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.781 -0.645 . . . . 10.19 110.98 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.1 m -126.45 160.28 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.948 0.404 . . . . 7.2800000000000002 110.691 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.68 145.37 45.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.941 -0.572 . . . . 7.2999999999999998 110.826 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 p -122.72 166.56 14.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.531 -0.758 . . . . 6.4400000000000004 110.613 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.1 m -58.88 159.31 7.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.008 -0.542 . . . . 4.4199999999999999 110.306 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -54.2 143.64 22.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.048 0.452 . . . . 3.0499999999999998 110.827 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 43.8 m -63.55 156.32 26.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.454 -0.794 . . . . 3.4300000000000002 111.645 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.6 t -114.07 137.69 46.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.334 -0.848 . . . . 2.8799999999999999 109.565 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 45.1 m -68.65 134.01 49.28 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.524 -0.47 . . . . 2.0899999999999999 110.404 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.75 142.22 57.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.683 -0.69 . . . . 4.5300000000000002 111.739 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.401 ' O ' ' OD1' ' A' ' 171' ' ' ASP . 32.0 pt -125.23 159.05 32.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.444 -0.798 . . . . 1.4399999999999999 109.226 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 19.3 p -123.27 154.34 38.97 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.133 0.492 . . . . 1.78 111.152 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.581 ' O ' ' N ' ' A' ' 127' ' ' SER . . . -162.46 152.74 16.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.611 -0.722 . . . . 0.64000000000000001 109.869 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 125' ' ' ALA . 0.1 OUTLIER 34.83 28.12 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 122.137 0.97 . . . . 0.66000000000000003 110.926 178.913 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.581 ' N ' ' O ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.91 167.53 0.26 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.626 -1.17 . . . . 0.68999999999999995 110.946 -179.193 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.8 m-30 -133.65 145.54 50.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.678 -0.692 . . . . 0.52000000000000002 110.102 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.28 101.68 9.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.075 -0.713 . . . . 0.32000000000000001 109.075 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.8 t -112.86 139.7 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.987 -0.551 . . . . 0.28999999999999998 111.133 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.2 p -128.73 152.5 48.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.624 -0.716 . . . . 0.25 109.786 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.587 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.79 -165.04 2.05 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.705 -0.398 . . . . 0.31 110.629 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.729 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -123.81 127.19 73.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.48999999999999999 110.836 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.162 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.99 58.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.222 -0.444 . . . . 1.53 110.38 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.729 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.19 24.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.855 -0.612 . . . . 0.96999999999999997 111.518 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.162 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.15 128.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.628 -0.429 . . . . 1.5600000000000001 110.897 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -86.56 -9.6 55.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.938 -0.573 . . . . 1.8799999999999999 110.215 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.2 p -87.09 0.22 55.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.153 -0.476 . . . . 1.04 110.344 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.38 137.33 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.969 -0.56 . . . . 0.23999999999999999 109.9 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.754 ' C ' ' HZ2' ' A' ' 61' ' ' LYS . 3.5 p -96.29 -15.53 21.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.262 0.553 . . . . 0.28999999999999998 110.045 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.809 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.59 175.52 45.74 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.786 -1.325 . . . . 0.13 109.786 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -123.34 151.59 42.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.954 0.407 . . . . 0.17000000000000001 110.551 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.728 ' NH2' ' OE1' ' A' ' 191' ' ' GLN . 64.1 ttp85 -132.34 121.18 23.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.153 -0.476 . . . . 1.29 109.989 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.558 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.07 136.49 38.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.706 -0.679 . . . . 0.25 110.747 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 81.3 tt0 -129.33 129.92 45.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.994 -0.548 . . . . 1.3200000000000001 110.105 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.3 p90 -138.73 135.27 34.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.957 -0.565 . . . . 0.56999999999999995 110.57 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.417 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.31 161.43 39.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.737 -0.665 . . . . 1.1599999999999999 109.662 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.949 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -70.99 124.85 25.32 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.672 -0.411 . . . . 0.38 110.775 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.492 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.84 -7.6 49.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.779 -0.646 . . . . 0.40999999999999998 110.814 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -109.91 -69.63 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.845 0.355 . . . . 1.6599999999999999 111.399 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.459 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.3 mt-10 -60.75 -35.29 76.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 1.6599999999999999 111.471 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.095 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.15 7.18 88.62 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.789 -0.924 . . . . 1.1699999999999999 110.789 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.324 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.95 -171.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.765 0.316 . . . . 1.8600000000000001 110.301 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.324 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.2 139.02 45.33 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 1.98 110.221 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.417 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 45.8 Cg_endo -70.9 145.79 51.45 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.675 2.25 . . . . 0.55000000000000004 112.32 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.83 145.74 42.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.196 -0.668 . . . . 1.1399999999999999 109.196 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.673 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 86.7 m-85 -123.29 141.31 52.11 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.366 -0.534 . . . . 0.93000000000000005 111.513 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.8 mt -128.05 127.66 43.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.286 -0.87 . . . . 0.34000000000000002 108.925 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -101.58 131.05 47.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.127 0.489 . . . . 1.0900000000000001 111.751 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.86 157.56 73.25 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.388 -0.824 . . . . 0.19 109.6 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.72 158.06 58.32 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.479 2.12 . . . . 0.17999999999999999 112.225 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.38 -12.17 5.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.744 -0.662 . . . . 0.20999999999999999 110.675 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.7 p -92.78 -8.75 42.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.28999999999999998 110.778 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.34 34.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.5 110.329 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.5 p -133.05 16.55 4.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.396 -0.366 . . . . 0.29999999999999999 110.531 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.52 147.05 5.08 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.642 -0.503 . . . . 0.23000000000000001 109.642 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.18 150.44 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.46 -0.496 . . . . 0.28000000000000003 111.564 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.35 124.93 50.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.6 -0.727 . . . . 1.0700000000000001 109.837 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.36 104.91 29.72 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.879 0.371 . . . . 0.28999999999999998 111.065 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -91.0 -179.49 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.922 0 C-N-CA 123.241 2.628 . . . . 0.42999999999999999 112.191 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 123' ' ' ILE . 71.2 m-20 61.61 32.65 18.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.328 -0.851 . . . . 1.26 111.467 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.8 mt -86.41 148.54 25.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.782 0.325 . . . . 0.32000000000000001 110.4 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.759 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.26 114.86 61.3 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.919 0.39 . . . . 0.57999999999999996 110.642 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.02 140.57 95.94 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.915 2.41 . . . . 0.66000000000000003 111.922 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.05 21.2 74.4 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.087 -0.805 . . . . 0.28999999999999998 111.087 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.459 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.9 150.2 49.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.913 0.387 . . . . 2.3300000000000001 110.529 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.492 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.16 131.63 45.99 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.974 -0.557 . . . . 0.85999999999999999 109.813 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.949 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.51 148.35 43.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.127 -0.488 . . . . 0.52000000000000002 111.063 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.32 125.29 60.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.323 -0.991 . . . . 0.29999999999999999 108.323 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.46 132.45 63.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.174 0.511 . . . . 0.23000000000000001 111.346 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.44 122.49 20.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.541 -0.754 . . . . 0.35999999999999999 109.684 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.587 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -100.95 125.38 54.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.281 -0.418 . . . . 0.19 110.723 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.7 m-85 -117.22 137.86 52.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.045 -0.525 . . . . 0.29999999999999999 109.854 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.417 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.71 134.97 42.89 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.809 -0.811 . . . . 0.37 108.809 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.653 HG21 ' HE2' ' A' ' 61' ' ' LYS . 11.6 mt -99.05 122.94 51.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.123 0.487 . . . . 0.26000000000000001 110.926 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.3 p -83.8 169.7 14.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.582 -0.735 . . . . 0.28000000000000003 110.481 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -59.82 -14.48 15.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.016 -0.538 . . . . 1.6000000000000001 110.979 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -96.03 -4.35 43.26 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.877 -0.329 . . . . 1.1799999999999999 110.796 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.79 13.91 63.97 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.36 -0.696 . . . . 0.29999999999999999 111.36 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -84.73 139.14 32.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.632 0.253 . . . . 1.22 110.437 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.728 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 86.0 mt-30 -106.73 141.07 38.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.406 -0.361 . . . . 0.97999999999999998 110.527 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.76 127.02 26.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.125 -0.488 . . . . 0.82999999999999996 110.363 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.15 117.37 9.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.293 -0.412 . . . . 0.26000000000000001 110.486 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.11 -21.65 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.119 -0.491 . . . . 0.29999999999999999 110.724 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.89 125.6 5.82 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.601 -0.44 . . . . 0.31 111.482 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.75 120.2 21.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.774 -0.648 . . . . 0.28000000000000003 109.562 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.65 151.74 29.14 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.642 -0.423 . . . . 0.23999999999999999 110.89 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.54 158.55 18.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.043 -0.526 . . . . 0.23000000000000001 110.439 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -146.05 157.91 43.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.67000000000000004 110.723 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 104.34 9.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.855 -0.611 . . . . 0.64000000000000001 110.04 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.89 -1.052 . . . . 1.26 110.608 -179.659 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.553 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.9 m . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.242 -0.651 . . . . 3.4399999999999999 109.242 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.27 150.59 18.57 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.041 -0.823 . . . . 1.22 111.041 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.64 142.45 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 123.967 3.111 . . . . 0.75 113.748 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.605 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -80.0 173.41 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.176 -1.374 . . . . 0.79000000000000004 108.758 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.605 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.59 125.91 51.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.157 0.503 . . . . 1.9399999999999999 111.431 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 143.96 34.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.593 -0.73 . . . . 0.59999999999999998 110.607 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.07 168.25 25.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.916 0.389 . . . . 3.1400000000000001 111.123 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.743 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.83 131.07 60.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.986 -0.552 . . . . 3.23 110.103 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.24 162.35 35.69 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.777 0.322 . . . . 3.6299999999999999 111.255 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 67.7 tt0 36.04 31.67 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.58 -0.526 . . . . 6.0800000000000001 109.58 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.743 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.56 32.58 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.917 -0.583 . . . . 3.3799999999999999 111.585 -178.788 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.636 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.33 -29.14 72.33 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.499 2.133 . . . . 3.9300000000000002 111.796 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.636 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.143 -0.48 . . . . 3.3599999999999999 110.495 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.528 ' CB ' ' O ' ' A' ' 17' ' ' SER . 3.3 mp0 -124.02 158.36 60.61 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 3.6099999999999999 110.47 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.453 ' HG3' ' NH1' ' A' ' 143' ' ' ARG . 97.5 Cg_endo -82.08 -64.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.865 2.377 . . . . 1.51 113.51 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.657 HD22 ' HB2' ' A' ' 159' ' ' ASP . 1.1 p-10 -108.44 -19.54 13.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.36 -0.382 . . . . 2.6800000000000002 112.029 -178.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.653 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 95.9 p -107.36 152.04 24.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.174 0.512 . . . . 1.21 111.29 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.5 t-80 -155.32 102.95 2.22 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.662 -0.699 . . . . 1.5600000000000001 110.565 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.531 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.7 Cg_endo -82.63 145.61 13.09 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.85 2.367 . . . . 0.81000000000000005 112.667 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.929 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.78 167.86 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.924 -0.58 . . . . 1.52 109.899 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.06 148.06 29.26 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.74 -0.467 . . . . 2.1400000000000001 109.74 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.59 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.36 157.28 44.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.005 0.431 . . . . 0.32000000000000001 111.169 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.498 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -128.09 155.31 44.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.745 -0.661 . . . . 2.1699999999999999 110.112 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.837 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.6 173.0 6.4 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.175 -0.466 . . . . 0.58999999999999997 110.756 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.837 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.63 173.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.877 2.384 . . . . 0.90000000000000002 111.605 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.01 -51.16 0.69 Allowed Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 120.74 -0.384 . . . . 3.3399999999999999 110.083 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.635 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.75 152.33 82.44 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.798 2.332 . . . . 1.8500000000000001 111.437 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.69 42.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.456 0.646 . . . . 2.54 110.554 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.635 ' N ' ' O ' ' A' ' 27' ' ' PRO . 74.0 t60 -63.63 -41.54 98.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.993 -1.003 . . . . 2.5299999999999998 110.718 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.564 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.8 mt -109.87 137.77 40.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.791 -0.641 . . . . 1.1699999999999999 111.255 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.96 -72.99 0.7 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.028 -0.533 . . . . 1.27 111.837 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.13 148.5 24.41 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.556 0.576 . . . . 1.1200000000000001 112.556 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.95 124.87 45.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.263 -0.643 . . . . 0.41999999999999998 109.263 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 mt -118.05 134.72 60.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.715 -0.394 . . . . 0.78000000000000003 110.698 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.929 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.02 128.55 53.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.047 0.451 . . . . 0.62 111.271 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.08 139.1 49.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.722 -0.672 . . . . 1.97 110.126 178.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.09 163.11 35.31 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.134 0.492 . . . . 0.34999999999999998 112.05 -178.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.489 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.53 139.73 7.9 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.453 -0.794 . . . . 1.8 110.421 178.727 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.65 115.47 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.322 2.015 . . . . 0.57999999999999996 111.769 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.679 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.9 81.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.925 -0.398 . . . . 3.04 109.925 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.049 -0.523 . . . . 2.4700000000000002 111.893 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.7 p -157.56 157.81 34.44 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.804 -0.358 . . . . 2.5099999999999998 110.538 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.406 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.32 27.69 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.215 -0.448 . . . . 1.8600000000000001 110.204 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.77 -75.81 1.31 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 121.157 -0.544 . . . . 1.4399999999999999 111.875 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -117.95 152.34 35.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.959 0.409 . . . . 4.6900000000000004 110.983 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.29 -169.1 2.51 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.052 -0.522 . . . . 1.4299999999999999 111.925 179.424 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.22 149.67 29.79 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.497 0.665 . . . . 1.74 112.511 -177.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.08 156.44 45.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.773 -1.103 . . . . 1.9199999999999999 110.225 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.469 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.1 158.35 41.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.826 -0.624 . . . . 0.34000000000000002 111.785 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.0 m -115.21 135.71 53.89 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.458 -0.792 . . . . 0.40999999999999998 109.847 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.59 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.42 121.93 23.74 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.418 -0.355 . . . . 0.55000000000000004 111.576 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.6 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.5 Cg_exo -46.36 151.76 1.64 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.683 2.255 . . . . 0.44 112.107 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.9 -23.12 63.14 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 116.057 -0.519 . . . . 0.73999999999999999 112.765 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.5 p-80 -82.75 -16.9 46.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.37 0.585 . . . . 0.93000000000000005 111.802 -178.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.6 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.58 138.41 31.59 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.802 -0.359 . . . . 0.96999999999999997 110.334 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.52 13.83 10.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.37 -0.377 . . . . 1.3400000000000001 111.56 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.475 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.9 143.46 25.29 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.643 -0.423 . . . . 0.39000000000000001 111.09 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.717 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.77 -169.39 1.54 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.06 -0.518 . . . . 0.41999999999999998 110.888 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.717 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.5 m -151.79 125.92 9.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.386 -0.824 . . . . 0.39000000000000001 109.739 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.518 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.81 123.29 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.416 -0.514 . . . . 0.73999999999999999 111.161 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.624 ' CG ' ' N ' ' A' ' 62' ' ' GLY . 18.1 ttpt -126.49 163.45 23.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.874 -0.603 . . . . 2.48 110.432 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.624 ' N ' ' CG ' ' A' ' 61' ' ' LYS . . . 85.09 18.99 59.91 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.731 -0.948 . . . . 0.5 110.731 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.518 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.6 mt -79.1 157.19 28.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.074 0.464 . . . . 0.57999999999999996 111.412 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.847 ' O ' HG12 ' A' ' 67' ' ' VAL . 1.2 mttp -99.37 133.92 21.63 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.702 -0.681 . . . . 2.79 110.504 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.88 143.54 61.24 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.541 2.161 . . . . 0.87 112.059 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.91 25.58 75.41 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.063 -0.815 . . . . 0.64000000000000001 111.063 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.847 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.15 158.78 39.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.687 0.279 . . . . 0.82999999999999996 110.381 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.14 139.91 42.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.89 0.376 . . . . 0.5 110.569 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.663 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.2 m-85 -122.49 136.42 54.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.007 -0.542 . . . . 0.53000000000000003 110.842 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.489 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.95 131.02 45.33 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.464 -0.939 . . . . 1.8700000000000001 108.464 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.494 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.49 153.89 16.65 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.281 -0.961 . . . . 0.28999999999999998 111.915 -178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -134.99 140.92 46.06 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.677 -0.49 . . . . 1.4299999999999999 109.677 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.9 tp -115.76 118.89 34.29 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.42 -0.512 . . . . 0.32000000000000001 110.539 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.721 HG12 HG23 ' A' ' 84' ' ' VAL . 63.6 mt -112.32 129.03 68.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.369 -0.378 . . . . 0.79000000000000004 110.699 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.702 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.84 120.92 43.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.319 -0.4 . . . . 1.02 110.743 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.85 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.6 146.45 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.109 0.48 . . . . 0.62 111.066 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.612 ' O ' ' N ' ' A' ' 79' ' ' TYR . 20.9 mt-30 -106.08 153.88 21.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.546 -0.752 . . . . 2.4399999999999999 110.018 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.15 88.51 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.868 0.366 . . . . 3.6899999999999999 110.409 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.31 32.61 0.21 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.853 -0.612 . . . . 6.0800000000000001 110.582 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.1 -117.37 3.29 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.419 -0.672 . . . . 1.22 111.419 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.44 177.44 8.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.249 0.547 . . . . 2.8799999999999999 111.613 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.17 149.47 32.04 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.37 -0.832 . . . . 1.47 110.363 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.553 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.15 144.7 38.73 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.441 -0.345 . . . . 2.7000000000000002 110.578 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.721 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -127.98 135.98 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 120.616 -0.434 . . . . 0.46000000000000002 111.597 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -123.99 141.26 52.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.701 -0.681 . . . . 0.34999999999999998 110.342 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.51 138.96 51.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.142 0.496 . . . . 3.6699999999999999 111.503 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.494 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.36 164.13 38.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.53 -0.759 . . . . 0.67000000000000004 109.428 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.2 151.62 38.7 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.314 -0.554 . . . . 1.47 110.972 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.802 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.8 p90 -146.29 172.69 13.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.69 -0.686 . . . . 0.44 111.008 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.76 160.74 21.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.446 -0.797 . . . . 1.3700000000000001 109.866 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.41 121.84 22.87 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.563 -0.455 . . . . 1.28 110.771 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.2 p -126.92 154.6 44.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.646 0.736 . . . . 1.97 112.759 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.401 ' OG ' ' OH ' ' A' ' 157' ' ' TYR . 22.8 t -62.7 -38.72 91.51 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.616 -1.175 . . . . 3.2799999999999998 111.91 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.2 t -139.74 158.03 44.78 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.254 0.549 . . . . 0.0 111.86 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 79.1 p -75.44 -14.61 60.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.273 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.6 p -63.0 141.08 97.7 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.112 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.31 150.06 42.91 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.298 1.998 . . . . 0.0 112.367 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.6 m -126.73 156.18 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.869 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.9 m -87.23 136.0 33.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.988 0.423 . . . . 0.0 110.935 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.6 m -66.95 156.61 35.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.436 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.462 ' O ' ' O ' ' A' ' 102' ' ' THR . 78.1 m-20 -84.26 4.03 32.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.259 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.462 ' O ' ' O ' ' A' ' 101' ' ' ASN . 28.0 p 33.68 -157.77 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.814 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.596 ' C ' ' H ' ' A' ' 105' ' ' GLY . 42.6 t -117.29 135.37 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.303 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.7 m 56.68 -3.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.992 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 103' ' ' VAL . . . -55.41 -33.32 58.5 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.82 144.0 40.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 110.642 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.0 p -81.72 162.59 22.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.445 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.542 ' O ' ' CD2' ' A' ' 110' ' ' PHE . 72.3 p -125.36 79.11 67.05 Favored Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.78 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 110' ' ' PHE . 38.7 Cg_exo -59.18 -17.94 41.65 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 122.813 2.342 . . . . 0.0 112.817 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.542 ' CD2' ' O ' ' A' ' 108' ' ' THR . 89.0 m-85 49.54 178.5 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.287 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.3 t 54.57 67.09 3.57 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.417 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.54 145.27 48.17 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.575 2.184 . . . . 0.0 112.137 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 26.2 tp -99.07 131.96 44.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.963 -0.562 . . . . 10.19 110.26 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.16 134.91 54.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.156 -0.474 . . . . 7.2800000000000002 110.343 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.78 144.75 57.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 7.2999999999999998 110.625 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.622 ' C ' ' H ' ' A' ' 118' ' ' GLU . 24.5 p -83.3 161.48 21.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.175 -0.466 . . . . 6.4400000000000004 110.591 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 118' ' ' GLU . 6.4 t 62.17 -17.07 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 4.4199999999999999 111.295 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.622 ' H ' ' C ' ' A' ' 116' ' ' THR . 96.3 mt-10 42.32 -169.62 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.606 0.241 . . . . 3.0499999999999998 111.21 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.541 ' C ' ' O ' ' A' ' 118' ' ' GLU . 9.4 t 17.62 81.83 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.978 -0.555 . . . . 3.4300000000000002 111.689 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.1 p -131.78 143.15 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.253 -0.43 . . . . 2.8799999999999999 110.659 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 44.5 m -79.79 138.63 37.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.076 -0.511 . . . . 2.0899999999999999 110.147 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -58.28 141.84 49.67 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.708 -0.397 . . . . 4.5300000000000002 110.575 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 71.1 mt -117.11 135.62 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.93 -0.577 . . . . 1.4399999999999999 110.573 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 23.3 p -83.59 161.1 21.27 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.997 -0.371 . . . . 1.78 109.997 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.683 ' O ' ' N ' ' A' ' 127' ' ' SER . . . -145.36 152.82 40.48 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.884 -0.326 . . . . 0.64000000000000001 111.29 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.632 ' HB2' ' HB ' ' A' ' 201' ' ' THR . 92.6 p 10.73 48.74 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 122.617 1.199 . . . . 0.66000000000000003 113.195 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.683 ' N ' ' O ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.91 167.5 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.243 -1.344 . . . . 0.68999999999999995 110.938 179.797 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.56 145.64 50.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.736 -0.665 . . . . 0.52000000000000002 110.156 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.26 101.47 9.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.157 -0.683 . . . . 0.32000000000000001 109.157 177.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.7 t -112.91 139.65 36.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.099 -0.5 . . . . 0.28999999999999998 111.101 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.3 p -128.61 152.55 48.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.605 -0.725 . . . . 0.25 109.83 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.594 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.4 p90 -144.75 -164.87 2.01 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.634 -0.426 . . . . 0.31 110.606 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.735 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -124.06 127.19 73.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.246 -0.434 . . . . 0.48999999999999999 110.784 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.179 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.99 58.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.028 -0.533 . . . . 1.53 110.358 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.735 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.15 24.61 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.872 -0.604 . . . . 0.96999999999999997 111.527 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.179 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.08 128.73 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.614 -0.434 . . . . 1.5600000000000001 110.942 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.31 -9.77 55.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.862 -0.608 . . . . 1.8799999999999999 110.309 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.12 0.31 55.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 1.04 110.366 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.16 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.891 -0.595 . . . . 0.23999999999999999 109.99 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.602 ' N ' ' O ' ' A' ' 185' ' ' ILE . 32.2 t -96.21 -15.51 22.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.311 0.576 . . . . 0.28999999999999998 110.062 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.433 ' HA3' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.58 175.62 45.81 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 109.795 -1.322 . . . . 0.13 109.795 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.53 151.59 42.68 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.661 -0.416 . . . . 0.17000000000000001 110.435 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.691 ' NH2' ' OE1' ' A' ' 191' ' ' GLN . 60.3 ttp85 -132.35 121.22 23.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.129 -0.487 . . . . 1.29 109.872 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.15 136.52 38.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.702 -0.681 . . . . 0.25 110.68 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 75.8 tt0 -129.33 129.84 45.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.01 -0.541 . . . . 1.3200000000000001 110.121 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.628 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.4 p90 -138.73 135.37 34.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.049 -0.523 . . . . 0.56999999999999995 110.596 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.419 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.38 161.38 39.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.702 -0.681 . . . . 1.1599999999999999 109.697 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.0 mt -71.07 124.92 25.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.004 0.43 . . . . 0.38 110.766 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.75 -7.81 50.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.756 -0.656 . . . . 0.40999999999999998 110.9 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.73 -69.65 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 1.6599999999999999 111.453 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.459 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.68 -35.25 75.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 1.6599999999999999 111.519 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.079 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 78.98 7.33 88.5 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.862 -0.895 . . . . 1.1699999999999999 110.862 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.334 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -28.01 -171.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.784 0.326 . . . . 1.8600000000000001 110.275 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.334 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.14 45.23 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.909 0.385 . . . . 1.98 110.186 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.419 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 45.9 Cg_endo -71.01 145.84 50.97 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 122.688 2.259 . . . . 0.55000000000000004 112.383 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.628 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.78 145.74 42.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.249 -0.648 . . . . 1.1399999999999999 109.249 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.57 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 93.5 m-85 -123.35 141.36 52.07 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.292 -0.563 . . . . 0.93000000000000005 111.511 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.9 mt -128.12 127.72 43.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.334 -0.848 . . . . 0.34000000000000002 108.934 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.657 ' HB2' HD22 ' A' ' 16' ' ' ASN . 4.0 t0 -101.65 131.07 48.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.183 0.516 . . . . 1.0900000000000001 111.72 -178.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.542 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.1 mt -127.88 157.6 73.16 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.262 -0.881 . . . . 0.19 109.567 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -69.89 158.16 57.73 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.332 2.021 . . . . 0.17999999999999999 112.203 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.4 -12.1 5.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.778 -0.646 . . . . 0.20999999999999999 110.76 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.0 p -92.91 -8.64 42.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.072 -0.513 . . . . 0.28999999999999998 110.677 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.2 135.33 34.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.318 -0.401 . . . . 0.5 110.406 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.4 p -133.13 16.72 4.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.426 -0.352 . . . . 0.29999999999999999 110.493 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.55 147.18 5.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.663 -0.495 . . . . 0.23000000000000001 109.663 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.26 150.42 12.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.498 -0.481 . . . . 0.28000000000000003 111.521 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.32 124.96 50.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.57 -0.741 . . . . 1.0700000000000001 109.754 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.32 104.88 29.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.343 -0.39 . . . . 0.28999999999999998 111.119 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 84.7 Cg_endo -91.01 -179.47 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.909 0 C-N-CA 123.152 2.568 . . . . 0.42999999999999999 112.153 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.61 32.71 18.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.314 -0.857 . . . . 1.26 111.398 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.9 mt -86.44 148.59 25.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.781 0.324 . . . . 0.32000000000000001 110.43 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.776 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.4 mt -88.36 114.85 61.33 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.055 0.455 . . . . 0.57999999999999996 110.664 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.03 140.63 96.15 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.928 2.418 . . . . 0.66000000000000003 111.936 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.02 21.24 74.4 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.081 -0.808 . . . . 0.28999999999999998 111.081 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.459 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.88 150.19 49.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 2.3300000000000001 110.626 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.491 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.2 131.63 46.03 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.021 -0.536 . . . . 0.85999999999999999 109.805 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.955 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.2 m-85 -120.47 148.28 44.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.06 -0.518 . . . . 0.52000000000000002 111.048 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.2 mt -105.31 125.37 60.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.274 -1.01 . . . . 0.29999999999999999 108.274 177.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.62 132.48 63.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.19 0.519 . . . . 0.23000000000000001 111.223 -178.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.51 122.59 20.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.509 -0.768 . . . . 0.35999999999999999 109.585 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.594 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.0 125.33 54.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 0.19 110.67 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 49.0 m-85 -117.2 137.93 52.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.031 -0.531 . . . . 0.29999999999999999 109.77 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.431 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.68 135.06 42.71 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.798 -0.816 . . . . 0.37 108.798 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.602 ' O ' ' N ' ' A' ' 140' ' ' SER . 72.5 mt -99.14 122.92 51.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.08 0.467 . . . . 0.26000000000000001 110.903 -178.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.4 p -83.84 169.77 14.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.559 -0.746 . . . . 0.28000000000000003 110.522 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.555 ' O ' ' OG1' ' A' ' 59' ' ' THR . 17.1 pt-20 -59.75 -14.59 15.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.096 -0.502 . . . . 1.6000000000000001 110.966 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.544 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.3 m-20 -96.02 -4.3 43.36 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.843 -0.343 . . . . 1.1799999999999999 110.841 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.83 13.78 64.11 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.409 -0.677 . . . . 0.29999999999999999 111.409 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -84.66 139.05 32.32 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.803 -0.233 . . . . 1.22 110.461 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.691 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 87.4 mt-30 -106.75 141.09 38.56 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.835 -0.346 . . . . 0.97999999999999998 110.558 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.4 m -136.68 126.94 26.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.82999999999999996 110.42 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.09 117.26 9.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.915 0.388 . . . . 0.26000000000000001 110.528 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.4 pt -109.07 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.29999999999999999 110.653 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.9 125.61 5.81 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.524 -0.471 . . . . 0.31 111.6 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.468 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.71 120.23 21.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.841 -0.618 . . . . 0.28000000000000003 109.604 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.59 151.68 29.12 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.697 -0.401 . . . . 0.23999999999999999 110.893 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.41 158.66 18.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.005 -0.543 . . . . 0.23000000000000001 110.439 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -146.12 157.91 43.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.089 -0.505 . . . . 0.67000000000000004 110.649 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.43 9.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.711 -0.677 . . . . 0.64000000000000001 109.992 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' ' 126' ' ' SER . 68.3 p . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.986 -1.006 . . . . 1.26 110.598 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.196 -0.668 . . . . 3.4399999999999999 109.196 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.44 150.69 18.53 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.982 -0.847 . . . . 1.22 110.982 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.55 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 124.035 3.157 . . . . 0.75 113.772 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.93 173.43 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.264 -1.334 . . . . 0.79000000000000004 108.853 178.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.601 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.64 125.84 51.45 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.437 -0.505 . . . . 1.9399999999999999 111.49 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.51 143.93 34.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.661 -0.7 . . . . 0.59999999999999998 110.712 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.31 25.62 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.874 0.369 . . . . 3.1400000000000001 111.081 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.744 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.0 mt -108.96 131.08 60.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.926 -0.579 . . . . 3.23 110.044 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.15 162.28 35.87 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.838 0.352 . . . . 3.6299999999999999 111.252 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.4 mt-10 36.13 31.57 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.592 -0.521 . . . . 6.0800000000000001 109.592 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.744 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.45 69.56 32.61 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.94 -0.573 . . . . 3.3799999999999999 111.627 -178.799 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.37 -29.0 71.88 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.431 2.087 . . . . 3.9300000000000002 111.854 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.61 125.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 3.3599999999999999 110.498 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.576 ' O ' ' O ' ' A' ' 92' ' ' THR . 42.2 mt-30 -124.04 158.38 60.63 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.348 -0.387 . . . . 3.6099999999999999 110.414 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.433 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 98.4 Cg_endo -82.14 -64.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.905 2.403 . . . . 1.51 113.428 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.764 ' ND2' ' CD2' ' A' ' 157' ' ' TYR . 1.3 m120 -108.42 -19.62 13.39 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.08 0.4 . . . . 2.6800000000000002 112.08 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 57.7 m -107.33 152.14 24.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.164 0.507 . . . . 1.21 111.302 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.34 103.0 2.22 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.681 -0.69 . . . . 1.5600000000000001 110.569 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.675 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.7 145.67 13.01 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.823 2.348 . . . . 0.81000000000000005 112.6 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.922 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.82 167.96 24.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.898 -0.592 . . . . 1.52 109.928 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.13 147.9 29.02 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.777 -0.453 . . . . 2.1400000000000001 109.777 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.587 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.22 157.33 44.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.0 0.428 . . . . 0.32000000000000001 111.225 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.496 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.04 155.27 44.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.779 -0.646 . . . . 2.1699999999999999 110.106 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.84 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.56 173.1 6.27 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 121.118 0.485 . . . . 0.58999999999999997 110.743 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.84 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.72 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.864 2.376 . . . . 0.90000000000000002 111.507 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.479 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -51.05 0.69 Allowed Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.76 -0.376 . . . . 3.3399999999999999 110.142 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.634 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.87 152.31 82.66 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.837 2.358 . . . . 1.8500000000000001 111.369 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.71 42.25 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.426 0.631 . . . . 2.54 110.588 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.6 t60 -63.58 -41.59 98.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.019 -0.991 . . . . 2.5299999999999998 110.644 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.564 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.8 mt -109.85 137.87 40.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.748 -0.66 . . . . 1.1699999999999999 111.329 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.99 -72.93 0.7 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.099 -0.501 . . . . 1.27 111.886 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.22 148.41 24.38 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.607 0.595 . . . . 1.1200000000000001 112.607 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -121.88 124.81 44.99 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.397 -0.594 . . . . 0.41999999999999998 109.397 177.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.05 134.71 60.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.66 -0.416 . . . . 0.78000000000000003 110.647 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.922 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.96 128.63 53.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.036 0.446 . . . . 0.62 111.249 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.03 139.01 49.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.738 -0.665 . . . . 1.97 110.143 178.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.436 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.03 163.11 35.24 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 120.55 -0.46 . . . . 0.34999999999999998 112.135 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.46 139.62 7.9 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.498 -0.774 . . . . 1.8 110.485 178.763 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.62 115.46 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.302 2.001 . . . . 0.57999999999999996 111.827 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.677 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.92 81.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.84 -0.43 . . . . 3.04 109.84 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.52 0.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.016 -0.538 . . . . 2.4700000000000002 111.898 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.4 p -157.67 157.81 34.24 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.862 -0.335 . . . . 2.5099999999999998 110.554 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.36 27.77 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.181 -0.463 . . . . 1.8600000000000001 110.222 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -75.8 1.31 Allowed Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.103 -0.57 . . . . 1.4399999999999999 111.892 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.89 152.36 35.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.927 0.394 . . . . 4.6900000000000004 110.965 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.673 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.27 -169.14 2.53 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.059 -0.519 . . . . 1.4299999999999999 111.965 179.373 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.436 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.09 149.57 29.84 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.468 0.651 . . . . 1.74 112.606 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.99 156.47 46.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.807 -1.088 . . . . 1.9199999999999999 110.234 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.2 158.36 41.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.951 -0.568 . . . . 0.34000000000000002 111.792 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.0 m -115.16 135.68 53.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.446 -0.797 . . . . 0.40999999999999998 109.817 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.587 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.45 121.92 23.7 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.422 -0.353 . . . . 0.55000000000000004 111.567 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.6 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.1 Cg_exo -46.41 151.71 1.7 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.753 2.302 . . . . 0.44 112.029 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.89 -23.02 63.01 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 115.989 -0.551 . . . . 0.73999999999999999 112.742 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.54 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.81 -16.88 46.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.436 0.618 . . . . 0.93000000000000005 111.758 -178.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.6 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.6 138.36 31.63 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.799 -0.36 . . . . 0.96999999999999997 110.368 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.47 13.85 11.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.399 -0.364 . . . . 1.3400000000000001 111.447 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.477 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.95 143.52 25.28 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.657 -0.417 . . . . 0.39000000000000001 111.101 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.719 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.4 t80 -114.74 -169.36 1.53 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.089 -0.505 . . . . 0.41999999999999998 110.981 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.719 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.85 125.9 9.19 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.449 -0.796 . . . . 0.39000000000000001 109.826 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.519 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.8 mt -114.87 123.33 70.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.364 -0.534 . . . . 0.73999999999999999 111.153 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.429 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 63.9 pttt -126.54 163.36 23.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.843 -0.617 . . . . 2.48 110.425 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.16 18.87 60.05 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.749 -0.941 . . . . 0.5 110.749 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.519 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.7 mt -79.03 157.23 28.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.091 0.472 . . . . 0.57999999999999996 111.376 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.844 ' O ' HG12 ' A' ' 67' ' ' VAL . 1.8 mtmm -99.48 133.89 21.58 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.593 -0.73 . . . . 2.79 110.454 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.64 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.9 Cg_endo -67.87 143.66 61.83 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.451 2.101 . . . . 0.87 111.942 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.87 25.49 75.5 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.063 -0.815 . . . . 0.64000000000000001 111.063 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.08 158.86 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.744 0.307 . . . . 0.82999999999999996 110.403 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.2 139.92 42.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.945 0.402 . . . . 0.5 110.508 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.661 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.4 m-85 -122.54 136.41 54.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.922 -0.581 . . . . 0.53000000000000003 110.726 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.93 131.09 45.26 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.51 -0.922 . . . . 1.8700000000000001 108.51 177.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.495 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.5 153.93 16.65 Favored Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.338 -0.934 . . . . 0.28999999999999998 111.943 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -135.04 140.96 46.01 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.702 -0.481 . . . . 1.4299999999999999 109.702 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.526 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.6 tp -115.67 118.99 34.61 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.478 -0.489 . . . . 0.32000000000000001 110.503 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.724 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.52 129.15 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.301 -0.409 . . . . 0.79000000000000004 110.594 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.705 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.9 120.92 43.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.29 -0.413 . . . . 1.02 110.696 -179.714 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.853 HD12 ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.58 146.47 11.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.133 0.492 . . . . 0.62 111.019 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.616 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.12 153.97 21.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.566 -0.743 . . . . 2.4399999999999999 109.852 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.24 88.61 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.966 0.413 . . . . 3.6899999999999999 110.347 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.616 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.28 32.62 0.21 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.828 -0.624 . . . . 6.0800000000000001 110.558 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.35 3.29 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.482 -0.647 . . . . 1.22 111.482 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -81.41 177.41 8.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.028 0.442 . . . . 2.8799999999999999 111.699 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.23 149.48 31.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.512 -0.767 . . . . 1.47 110.378 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.18 144.65 38.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.436 -0.347 . . . . 2.7000000000000002 110.526 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.724 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.02 136.05 61.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-O 121.155 0.502 . . . . 0.46000000000000002 111.538 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.04 141.29 52.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.573 -0.74 . . . . 0.34999999999999998 110.318 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.463 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.62 138.87 51.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.082 0.468 . . . . 3.6699999999999999 111.486 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.495 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.32 164.1 38.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.536 -0.756 . . . . 0.67000000000000004 109.523 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.571 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.22 151.64 38.71 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.354 -0.538 . . . . 1.47 111.027 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.804 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.24 172.77 12.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.644 -0.707 . . . . 0.44 110.995 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.81 160.66 21.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.391 -0.822 . . . . 1.3700000000000001 109.854 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.38 121.89 22.97 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.536 -0.466 . . . . 1.28 110.74 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.576 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.4 p -131.76 -136.55 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 122.284 1.04 . . . . 1.97 111.303 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.594 ' C ' ' H ' ' A' ' 95' ' ' SER . 30.4 t 138.02 144.49 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 112.712 -2.04 . . . . 3.2799999999999998 106.222 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.78 -10.83 0.18 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.616 ' O ' ' HG2' ' A' ' 155' ' ' PRO . 39.7 p -86.42 1.74 50.22 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.771 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.604 HG22 ' CB ' ' A' ' 65' ' ' PRO . 19.8 p -105.5 115.41 61.88 Favored Pre-proline 0 N--CA 1.475 0.817 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -177.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.496 ' HG2' ' H ' ' A' ' 98' ' ' VAL . 0.5 OUTLIER -98.43 -106.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 123.864 3.043 . . . . 0.0 112.391 178.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.496 ' H ' ' HG2' ' A' ' 97' ' ' PRO . 35.3 t -120.58 143.69 31.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.228 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 61.2 p -54.33 -10.33 0.38 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.613 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.409 ' H ' HG12 ' A' ' 98' ' ' VAL . 49.7 m -63.46 164.79 8.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.763 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.567 ' CG ' HG21 ' A' ' 116' ' ' THR . 30.4 t-20 64.99 51.96 1.62 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.075 0.464 . . . . 0.0 111.102 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.8 t -131.79 161.09 33.73 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.541 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.584 HG12 ' N ' ' A' ' 104' ' ' THR . 76.3 t 61.44 165.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.708 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.584 ' N ' HG12 ' A' ' 103' ' ' VAL . 42.7 m -120.15 143.67 48.08 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.924 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -153.69 -175.64 25.22 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -102.12 144.36 30.79 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.618 0.247 . . . . 0.0 110.702 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 121' ' ' THR . 55.5 m -117.5 141.58 48.18 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.213 0.53 . . . . 0.0 111.156 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.9 p -66.69 160.62 66.91 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.54 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.02 -20.13 9.87 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.186 1.924 . . . . 0.0 112.23 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -68.29 153.91 42.8 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.5 m -120.54 79.63 29.9 Favored Pre-proline 0 N--CA 1.467 0.378 0 CA-C-O 120.671 0.272 . . . . 0.0 111.527 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -54.23 160.21 6.83 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 123.082 2.522 . . . . 0.0 112.055 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.2 mt -68.6 154.54 41.7 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.201 -0.666 . . . . 10.19 109.201 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.615 ' O ' ' HB2' ' A' ' 115' ' ' ALA . 18.6 m -54.52 131.36 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.405 -0.518 . . . . 7.2800000000000002 110.961 -177.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 114' ' ' VAL . . . 149.74 115.24 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 114.775 -1.102 . . . . 7.2999999999999998 108.679 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.567 HG21 ' CG ' ' A' ' 101' ' ' ASN . 24.6 p -81.36 160.39 24.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.106 0.479 . . . . 6.4400000000000004 111.14 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 119' ' ' SER . 83.1 p -146.6 167.63 23.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.626 -0.716 . . . . 4.4199999999999999 110.575 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.64 -30.01 69.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.911 -0.586 . . . . 3.0499999999999998 110.643 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.423 ' O ' ' OG ' ' A' ' 117' ' ' SER . 50.9 m -113.66 150.79 32.7 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.239 -0.437 . . . . 3.4300000000000002 110.676 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.6 t 60.22 109.22 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.932 -0.576 . . . . 2.8799999999999999 110.816 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.437 ' O ' ' OG1' ' A' ' 107' ' ' THR . 43.8 m -123.29 143.29 50.17 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.716 -0.675 . . . . 2.0899999999999999 110.22 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -96.81 143.64 27.53 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.994 0.426 . . . . 4.5300000000000002 111.626 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 16.7 tt -118.8 136.19 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 115.607 -0.724 . . . . 1.4399999999999999 109.165 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 172' ' ' LEU . 26.1 p -122.88 161.6 23.8 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.238 0.542 . . . . 1.78 112.167 -177.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.672 ' O ' ' HG3' ' A' ' 174' ' ' PRO . . . -111.28 153.37 26.02 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.422 -0.808 . . . . 0.64000000000000001 110.547 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.66 ' HB2' ' HB ' ' A' ' 201' ' ' THR . 70.4 p 123.88 39.43 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 123.697 1.713 . . . . 0.66000000000000003 108.726 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.437 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.8 167.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 113.047 -1.888 . . . . 0.68999999999999995 110.988 -178.372 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.58 145.6 50.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.729 -0.668 . . . . 0.52000000000000002 110.127 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.3 101.61 9.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.121 -0.696 . . . . 0.32000000000000001 109.121 177.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.1 t -112.94 139.64 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.027 -0.533 . . . . 0.28999999999999998 111.068 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.7 p -128.67 152.65 48.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.667 -0.697 . . . . 0.25 109.793 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.76 -164.92 2.03 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.672 -0.411 . . . . 0.31 110.636 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.738 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -124.03 127.13 73.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.48999999999999999 110.905 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.177 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.87 58.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 1.53 110.306 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.738 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.1 24.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.004 -0.544 . . . . 0.96999999999999997 111.426 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.177 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.24 128.73 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.657 -0.417 . . . . 1.5600000000000001 110.954 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -86.35 -9.53 56.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.933 -0.576 . . . . 1.8799999999999999 110.393 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.0 p -87.18 0.21 55.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.47 . . . . 1.04 110.264 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.26 137.16 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.001 -0.545 . . . . 0.23999999999999999 109.988 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 185' ' ' ILE . 0.9 OUTLIER -96.19 -15.47 22.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.294 0.569 . . . . 0.28999999999999998 110.1 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.633 ' N ' HG12 ' A' ' 185' ' ' ILE . . . 178.52 175.57 45.72 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 109.814 -1.315 . . . . 0.13 109.814 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.5 151.66 42.54 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.595 -0.442 . . . . 0.17000000000000001 110.465 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.673 ' NH2' ' OE1' ' A' ' 191' ' ' GLN . 58.6 ttp85 -132.42 121.2 23.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.139 -0.482 . . . . 1.29 109.943 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.559 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.15 136.57 38.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.68 -0.691 . . . . 0.25 110.648 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 81.3 tt0 -129.38 129.85 45.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.957 -0.565 . . . . 1.3200000000000001 110.016 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 36.2 p90 -138.62 135.29 34.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.972 -0.558 . . . . 0.56999999999999995 110.731 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.421 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.29 161.35 39.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.839 -0.619 . . . . 1.1599999999999999 109.632 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.954 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.1 mt -71.09 124.84 25.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.072 0.463 . . . . 0.38 110.73 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.71 -7.79 50.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.723 -0.671 . . . . 0.40999999999999998 110.881 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -109.77 -69.58 0.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 1.6599999999999999 111.519 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.449 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.69 -35.46 76.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.115 -0.493 . . . . 1.6599999999999999 111.435 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.085 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.21 88.62 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.797 -0.921 . . . . 1.1699999999999999 110.797 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.336 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.91 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 1.8600000000000001 110.224 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.336 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.31 139.07 44.97 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.247 -0.433 . . . . 1.98 110.164 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.616 ' HG2' ' O ' ' A' ' 95' ' ' SER . 46.3 Cg_endo -70.92 145.81 51.38 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 122.756 2.304 . . . . 0.55000000000000004 112.363 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.91 145.74 42.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.186 -0.672 . . . . 1.1399999999999999 109.186 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.764 ' CD2' ' ND2' ' A' ' 16' ' ' ASN . 35.4 p90 -123.21 141.29 52.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.164 0.507 . . . . 0.93000000000000005 111.599 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.03 127.72 43.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.282 -0.872 . . . . 0.34000000000000002 108.987 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.493 ' OD1' ' O ' ' A' ' 159' ' ' ASP . 53.8 p-10 -101.62 131.09 48.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.207 0.527 . . . . 1.0900000000000001 111.821 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.92 157.53 73.45 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.363 -0.835 . . . . 0.19 109.604 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.77 158.06 58.24 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.366 2.044 . . . . 0.17999999999999999 112.268 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.32 -12.13 5.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.787 -0.642 . . . . 0.20999999999999999 110.685 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.86 -8.71 42.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.154 -0.475 . . . . 0.28999999999999998 110.679 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.39 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.354 -0.384 . . . . 0.5 110.404 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.7 p -133.15 16.7 4.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.429 -0.35 . . . . 0.29999999999999999 110.52 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.56 147.12 5.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.664 -0.495 . . . . 0.23000000000000001 109.664 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.559 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.18 150.41 12.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.541 -0.464 . . . . 0.28000000000000003 111.572 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.34 125.0 50.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.624 -0.716 . . . . 1.0700000000000001 109.794 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.44 104.86 29.7 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 0.28999999999999998 111.064 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.8 Cg_endo -90.92 -179.58 1.53 Allowed 'Trans proline' 0 C--N 1.302 -1.895 0 C-N-CA 123.184 2.59 . . . . 0.42999999999999999 112.219 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 61.77 32.65 18.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.382 -0.826 . . . . 1.26 111.37 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.481 ' O ' ' OG1' ' A' ' 124' ' ' THR . 24.0 mt -86.38 148.49 25.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.784 0.326 . . . . 0.32000000000000001 110.498 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.773 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.33 114.84 61.29 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.989 0.423 . . . . 0.57999999999999996 110.6 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.672 ' HG3' ' O ' ' A' ' 125' ' ' ALA . 21.9 Cg_exo -59.01 140.57 95.96 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.835 2.356 . . . . 0.66000000000000003 111.994 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.31 74.08 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.0 -0.84 . . . . 0.28999999999999998 111.0 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.449 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.8 mmm-85 -126.94 150.24 49.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 2.3300000000000001 110.604 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.495 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.18 131.7 45.97 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.052 -0.522 . . . . 0.85999999999999999 109.81 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.954 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.7 m-85 -120.57 148.34 44.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.052 -0.522 . . . . 0.52000000000000002 111.013 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.35 125.33 60.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.262 -1.014 . . . . 0.29999999999999999 108.262 177.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.6 132.59 63.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.139 0.495 . . . . 0.23000000000000001 111.206 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.5 122.47 20.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.483 -0.78 . . . . 0.35999999999999999 109.666 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.04 125.39 54.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.382 -0.372 . . . . 0.19 110.586 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.8 m-85 -117.24 137.86 52.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.973 -0.558 . . . . 0.29999999999999999 109.918 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.428 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.63 135.02 42.73 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.829 -0.804 . . . . 0.37 108.829 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.633 HG12 ' N ' ' A' ' 141' ' ' GLY . 0.8 OUTLIER -99.03 123.0 51.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.156 0.503 . . . . 0.26000000000000001 110.934 -178.828 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.9 p -83.98 169.71 14.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.566 -0.743 . . . . 0.28000000000000003 110.411 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.618 ' O ' ' OG1' ' A' ' 59' ' ' THR . 82.2 tt0 -59.62 -14.67 14.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.036 -0.529 . . . . 1.6000000000000001 110.964 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.675 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 87.8 m-20 -96.0 -4.38 43.28 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.862 -0.335 . . . . 1.1799999999999999 110.83 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.85 13.79 64.07 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.376 -0.69 . . . . 0.29999999999999999 111.376 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -84.53 139.05 32.41 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.096 -0.241 . . . . 1.22 110.569 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.673 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 88.9 mt-30 -106.73 140.97 38.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.48 -0.327 . . . . 0.97999999999999998 110.623 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.67 127.03 26.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.171 -0.468 . . . . 0.82999999999999996 110.407 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.23 117.33 9.89 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.717 -0.393 . . . . 0.26000000000000001 110.508 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.0 pt -108.94 -21.9 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.29999999999999999 110.752 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.87 125.75 5.88 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.509 -0.476 . . . . 0.31 111.486 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.464 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.78 120.2 21.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.701 -0.681 . . . . 0.28000000000000003 109.586 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.64 151.66 29.06 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.621 -0.432 . . . . 0.23999999999999999 110.904 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.41 158.57 18.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.02 -0.536 . . . . 0.23000000000000001 110.417 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -146.08 157.88 43.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.089 -0.505 . . . . 0.67000000000000004 110.725 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.25 104.49 9.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.772 -0.649 . . . . 0.64000000000000001 110.022 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.66 ' HB ' ' HB2' ' A' ' 126' ' ' SER . 68.0 p . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.842 -1.075 . . . . 1.26 110.588 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.55 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.142 -0.688 . . . . 3.4399999999999999 109.142 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.37 150.75 18.53 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.925 -0.87 . . . . 1.22 110.925 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -35.74 142.42 0.1 Allowed 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 123.902 3.068 . . . . 0.75 113.857 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.599 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.3 t -79.96 173.34 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.254 -1.339 . . . . 0.79000000000000004 108.825 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.599 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.57 125.89 51.5 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.412 -0.515 . . . . 1.9399999999999999 111.422 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.52 144.08 33.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.618 -0.719 . . . . 0.59999999999999998 110.599 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.08 168.19 26.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.875 0.369 . . . . 3.1400000000000001 111.127 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.748 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.93 131.19 60.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.964 -0.562 . . . . 3.23 110.124 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.21 162.36 35.67 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.806 0.336 . . . . 3.6299999999999999 111.208 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.7 mt-10 35.94 31.76 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.592 -0.521 . . . . 6.0800000000000001 109.592 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.748 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.54 69.58 33.63 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.959 -0.564 . . . . 3.3799999999999999 111.587 -178.809 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.29 -29.13 72.68 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.532 2.154 . . . . 3.9300000000000002 111.865 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 3.3599999999999999 110.532 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.717 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -124.0 158.38 60.51 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.352 -0.385 . . . . 3.6099999999999999 110.347 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.563 ' CG ' ' NH2' ' A' ' 143' ' ' ARG . 97.0 Cg_endo -82.02 -64.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.877 2.385 . . . . 1.51 113.547 -179.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.69 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 63.2 t30 -108.4 -19.62 13.4 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.11 0.411 . . . . 2.6800000000000002 112.11 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.717 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 27.6 t -107.37 152.07 24.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.184 0.516 . . . . 1.21 111.285 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.22 102.97 2.24 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.722 -0.672 . . . . 1.5600000000000001 110.606 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.442 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.7 Cg_endo -82.81 145.69 12.83 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.888 2.392 . . . . 0.81000000000000005 112.557 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.907 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.82 167.84 25.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.876 -0.602 . . . . 1.52 109.858 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.06 147.91 29.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.796 -0.446 . . . . 2.1400000000000001 109.796 178.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.586 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.21 157.25 45.07 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.686 -0.406 . . . . 0.32000000000000001 111.177 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.492 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.1 155.3 44.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.873 -0.603 . . . . 2.1699999999999999 110.102 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.836 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.63 173.01 6.39 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.156 0.503 . . . . 0.58999999999999997 110.696 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.836 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.62 173.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.892 2.394 . . . . 0.90000000000000002 111.481 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.1 -51.07 0.68 Allowed Pre-proline 0 C--N 1.33 -0.265 0 C-N-CA 120.686 -0.406 . . . . 3.3399999999999999 110.085 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.632 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.81 152.39 82.28 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.729 2.286 . . . . 1.8500000000000001 111.44 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.77 42.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.399 0.618 . . . . 2.54 110.522 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.632 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.9 t60 -63.55 -41.74 98.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.002 -0.999 . . . . 2.5299999999999998 110.651 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.558 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.1 mt -109.77 137.88 39.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.814 -0.63 . . . . 1.1699999999999999 111.293 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.97 -72.87 0.7 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.008 -0.542 . . . . 1.27 111.97 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.19 148.47 24.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.532 0.567 . . . . 1.1200000000000001 112.532 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -121.87 124.81 44.99 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.397 -0.594 . . . . 0.41999999999999998 109.397 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 mt -117.97 134.8 60.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.616 -0.434 . . . . 0.78000000000000003 110.604 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.907 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.05 128.6 53.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.983 0.42 . . . . 0.62 111.207 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.18 139.02 49.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.772 -0.649 . . . . 1.97 110.102 178.951 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.439 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.05 163.19 35.01 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 121.133 0.492 . . . . 0.34999999999999998 112.066 -178.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.49 139.53 7.82 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.434 -0.803 . . . . 1.8 110.416 178.85 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 41' ' ' ASN . 18.0 Cg_endo -63.43 115.41 3.0 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.351 2.034 . . . . 0.57999999999999996 111.847 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.668 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.99 81.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.866 -0.42 . . . . 3.04 109.866 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.688 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.24 -20.66 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.968 -0.56 . . . . 2.4700000000000002 111.923 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.65 157.79 34.26 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.835 -0.346 . . . . 2.5099999999999998 110.559 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.403 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.38 27.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 1.8600000000000001 110.163 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.84 -75.88 1.31 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.118 -0.563 . . . . 1.4399999999999999 111.867 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.87 152.29 35.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.973 0.416 . . . . 4.6900000000000004 111.0 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.15 -169.02 2.51 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.061 -0.518 . . . . 1.4299999999999999 111.981 179.335 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.19 149.71 29.72 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.482 0.658 . . . . 1.74 112.533 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.07 156.51 45.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.791 -1.095 . . . . 1.9199999999999999 110.213 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.469 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.21 158.4 41.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.976 -0.557 . . . . 0.34000000000000002 111.802 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.3 m -115.15 135.63 53.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.435 -0.802 . . . . 0.40999999999999998 109.906 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.586 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.4 122.06 23.79 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.512 -0.313 . . . . 0.55000000000000004 111.523 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.6 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.0 Cg_exo -46.46 151.74 1.73 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.689 2.259 . . . . 0.44 112.077 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.87 -23.09 63.03 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 116.065 -0.516 . . . . 0.73999999999999999 112.805 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.544 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.75 -16.83 46.44 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.225 -0.59 . . . . 0.93000000000000005 111.821 -178.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.6 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.6 mt -91.67 138.43 31.57 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.807 -0.357 . . . . 0.96999999999999997 110.232 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.48 13.81 11.02 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.277 -0.42 . . . . 1.3400000000000001 111.482 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.4 p -149.92 143.48 25.29 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.631 -0.428 . . . . 0.39000000000000001 111.058 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.81 -169.29 1.52 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.209 0.528 . . . . 0.41999999999999998 110.851 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.723 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 0.6 OUTLIER -151.84 125.91 9.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.433 -0.803 . . . . 0.39000000000000001 109.765 179.281 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.3 mt -114.81 123.25 70.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.435 -0.506 . . . . 0.73999999999999999 111.219 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.518 ' HB3' ' CD1' ' A' ' 185' ' ' ILE . 25.7 pttm -126.48 163.43 23.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.888 -0.596 . . . . 2.48 110.497 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.479 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.02 19.08 59.87 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.781 -0.928 . . . . 0.5 110.781 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.69 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.8 mt -79.1 157.3 28.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.09 0.472 . . . . 0.57999999999999996 111.311 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.847 ' O ' HG12 ' A' ' 67' ' ' VAL . 4.0 mttt -99.58 133.96 21.48 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.616 -0.72 . . . . 2.79 110.434 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.462 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.94 143.6 61.15 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.539 2.16 . . . . 0.87 111.936 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.84 25.58 75.39 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.091 -0.803 . . . . 0.64000000000000001 111.091 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.847 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.17 158.84 39.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.715 0.293 . . . . 0.82999999999999996 110.415 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.23 139.96 42.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.913 0.387 . . . . 0.5 110.56 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.654 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.9 m-85 -122.59 136.46 54.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.967 -0.56 . . . . 0.53000000000000003 110.778 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.82 131.05 45.23 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.491 -0.929 . . . . 1.8700000000000001 108.491 177.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.58 153.92 16.67 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.214 -0.993 . . . . 0.28999999999999998 111.933 -178.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -135.03 140.9 45.99 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.698 -0.482 . . . . 1.4299999999999999 109.698 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.75 118.91 34.36 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.426 -0.51 . . . . 0.32000000000000001 110.462 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.735 HG12 HG23 ' A' ' 84' ' ' VAL . 64.2 mt -112.41 129.15 68.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.79000000000000004 110.608 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.708 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.82 120.86 43.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.242 -0.435 . . . . 1.02 110.747 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.854 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.58 146.46 11.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.169 0.509 . . . . 0.62 111.022 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.623 ' O ' ' N ' ' A' ' 79' ' ' TYR . 20.9 mt-30 -106.01 153.92 21.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.519 -0.764 . . . . 2.4399999999999999 109.888 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.19 88.52 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.937 0.399 . . . . 3.6899999999999999 110.428 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.41 32.53 0.22 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.841 -0.618 . . . . 6.0800000000000001 110.53 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.04 -117.34 3.29 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.472 -0.651 . . . . 1.22 111.472 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -81.4 177.37 9.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.218 0.532 . . . . 2.8799999999999999 111.643 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.2 149.5 32.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.435 -0.802 . . . . 1.47 110.385 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.55 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.21 144.7 38.61 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.432 -0.349 . . . . 2.7000000000000002 110.511 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.735 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -127.98 135.93 61.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-O 121.087 0.47 . . . . 0.46000000000000002 111.508 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.03 141.52 51.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.59 -0.732 . . . . 0.34999999999999998 110.192 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.462 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.66 138.93 51.65 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.482 -0.487 . . . . 3.6699999999999999 111.481 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.491 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.29 164.23 37.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.582 -0.736 . . . . 0.67000000000000004 109.399 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 46.9 p30 -145.29 151.51 38.45 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.434 -0.506 . . . . 1.47 111.064 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.804 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.2 p90 -146.2 172.72 13.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.768 -0.651 . . . . 0.44 111.005 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.78 160.76 21.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.442 -0.799 . . . . 1.3700000000000001 109.807 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.5 121.86 22.79 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.565 -0.454 . . . . 1.28 110.722 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.587 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.0 p -127.02 161.87 27.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.222 0.534 . . . . 1.97 111.864 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.1 t -115.74 148.96 39.22 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.516 -0.766 . . . . 3.2799999999999998 110.531 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.0 p -111.44 165.17 12.2 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.035 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.4 p -111.2 155.1 23.44 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.138 0.494 . . . . 0.0 111.297 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.426 ' N ' ' HD3' ' A' ' 97' ' ' PRO . 11.1 m 57.31 63.46 4.96 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.127 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.426 ' HD3' ' N ' ' A' ' 96' ' ' THR . 41.7 Cg_exo -56.77 147.56 71.31 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.577 2.185 . . . . 0.0 111.531 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.57 136.64 26.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.985 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 35.5 m -118.9 139.3 51.88 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.089 0.471 . . . . 0.0 111.092 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.8 t -120.99 145.05 48.17 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.016 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -100.47 136.1 40.87 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.044 0.449 . . . . 0.0 110.669 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.6 m -123.19 143.36 50.08 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.285 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.9 p -63.34 136.95 25.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.928 0.394 . . . . 0.0 110.485 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 47.5 m -78.38 139.31 38.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.652 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 106' ' ' GLU . . . -164.67 -174.85 34.86 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 105' ' ' GLY . 95.4 mt-10 32.92 42.64 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.983 0.42 . . . . 0.0 110.934 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 58.1 p -67.92 -16.55 64.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.96 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.2 p -125.48 77.61 68.69 Favored Pre-proline 0 N--CA 1.467 0.421 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.988 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.05 149.92 50.33 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.745 2.297 . . . . 0.0 111.96 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -54.86 -40.48 69.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.262 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.22 159.03 32.45 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.248 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -54.95 147.35 52.57 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.581 2.187 . . . . 0.0 111.72 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.7 mt -57.63 -35.78 70.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 10.19 110.781 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 23.2 m -130.02 151.13 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.764 0.316 . . . . 7.2800000000000002 110.395 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.03 21.15 13.96 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.134 -0.485 . . . . 7.2999999999999998 110.586 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.3 t -136.77 160.32 39.19 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.075 0.464 . . . . 6.4400000000000004 111.339 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.9 m -63.38 158.09 21.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.687 -0.688 . . . . 4.4199999999999999 110.337 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.44 -34.09 64.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.456 -0.338 . . . . 3.0499999999999998 110.28 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 96.3 p -120.5 151.64 39.1 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.34 -0.391 . . . . 3.4300000000000002 109.999 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.684 HG22 ' H ' ' A' ' 122' ' ' GLU . 12.4 p -133.27 142.0 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.51 -0.314 . . . . 2.8799999999999999 110.533 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 69.2 p -70.36 -24.73 63.02 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.334 -0.394 . . . . 2.0899999999999999 111.25 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.684 ' H ' HG22 ' A' ' 120' ' ' VAL . 96.4 mt-10 -58.68 145.21 40.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.321 -0.399 . . . . 4.5300000000000002 110.545 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.4 mt -111.63 134.36 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.156 -0.475 . . . . 1.4399999999999999 109.846 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.9 p -123.7 161.59 24.83 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.079 -0.509 . . . . 1.78 110.627 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.19 -45.07 0.63 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.166 -0.47 . . . . 0.64000000000000001 110.299 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 6.0 p -153.81 -0.87 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.66000000000000003 110.311 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.435 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.68 167.5 0.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.883 -0.599 . . . . 0.68999999999999995 110.949 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.56 145.53 50.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.685 -0.688 . . . . 0.52000000000000002 110.197 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.23 101.62 9.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.106 -0.702 . . . . 0.32000000000000001 109.106 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.1 t -112.94 139.67 36.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.071 -0.513 . . . . 0.28999999999999998 111.103 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.0 p -128.76 152.59 48.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.677 -0.692 . . . . 0.25 109.846 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.81 -164.91 2.03 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.688 -0.405 . . . . 0.31 110.675 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -123.97 127.19 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.48999999999999999 110.784 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.174 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -58.0 58.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.188 -0.46 . . . . 1.53 110.349 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.21 24.62 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.857 -0.611 . . . . 0.96999999999999997 111.485 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.174 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.11 128.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.626 -0.43 . . . . 1.5600000000000001 110.923 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.47 -9.62 55.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.837 -0.62 . . . . 1.8799999999999999 110.329 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 29.0 p -86.96 0.13 55.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.061 -0.518 . . . . 1.04 110.391 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.23 137.3 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.96 -0.564 . . . . 0.23999999999999999 109.989 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.613 ' N ' ' O ' ' A' ' 185' ' ' ILE . 7.1 p -96.33 -15.56 21.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.37 0.605 . . . . 0.28999999999999998 110.029 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 1.015 ' O ' HG22 ' A' ' 185' ' ' ILE . . . 178.58 175.53 45.74 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 109.809 -1.316 . . . . 0.13 109.809 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -123.42 151.52 42.55 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.63 -0.428 . . . . 0.17000000000000001 110.492 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.97 ' NH2' HE22 ' A' ' 191' ' ' GLN . 8.7 tmm_? -132.29 121.16 23.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.126 -0.488 . . . . 1.29 109.956 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.556 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.05 136.62 38.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.632 -0.713 . . . . 0.25 110.621 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 75.9 tt0 -129.39 129.89 45.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.95 -0.568 . . . . 1.3200000000000001 110.043 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.623 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.7 p90 -138.75 135.27 34.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.034 -0.53 . . . . 0.56999999999999995 110.673 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.422 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.36 39.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.694 -0.685 . . . . 1.1599999999999999 109.697 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.952 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.4 mt -70.97 124.79 25.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.992 0.425 . . . . 0.38 110.718 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.76 -7.64 49.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.768 -0.651 . . . . 0.40999999999999998 110.989 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.8 -69.72 0.85 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.264 -0.426 . . . . 1.6599999999999999 111.387 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.439 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.3 mt-10 -60.8 -35.25 75.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 1.6599999999999999 111.459 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.09 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.26 7.12 88.68 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.829 -0.908 . . . . 1.1699999999999999 110.829 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.336 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.3 t0 -27.98 -171.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.801 0.334 . . . . 1.8600000000000001 110.322 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.336 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.25 139.11 45.19 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-O 120.979 0.419 . . . . 1.98 110.238 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.422 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.0 Cg_endo -70.85 145.76 51.69 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 122.77 2.313 . . . . 0.55000000000000004 112.325 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.82 145.69 42.62 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.25 -0.648 . . . . 1.1399999999999999 109.25 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.646 ' CE2' ' CG ' ' A' ' 16' ' ' ASN . 25.0 p90 -123.24 141.38 52.04 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.348 -0.541 . . . . 0.93000000000000005 111.532 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.9 mt -128.18 127.69 43.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.275 -0.875 . . . . 0.34000000000000002 108.953 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.558 ' HB2' HD21 ' A' ' 16' ' ' ASN . 33.2 t0 -101.61 131.2 47.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.19 0.519 . . . . 1.0900000000000001 111.779 -178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -128.0 157.52 73.65 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.348 -0.842 . . . . 0.19 109.585 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -69.87 157.95 58.45 Favored 'Trans proline' 0 C--N 1.302 -1.904 0 C-N-CA 122.49 2.126 . . . . 0.17999999999999999 112.23 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.4 p -59.14 -12.19 4.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.743 -0.662 . . . . 0.20999999999999999 110.817 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.1 p -92.79 -8.76 42.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 0.28999999999999998 110.73 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.09 135.37 34.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.325 -0.398 . . . . 0.5 110.481 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.19 16.69 4.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.452 -0.34 . . . . 0.29999999999999999 110.514 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.4 p -167.51 147.16 5.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.609 -0.515 . . . . 0.23000000000000001 109.609 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.21 150.5 12.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.489 -0.484 . . . . 0.28000000000000003 111.503 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 4.0 t-20 -106.35 124.98 50.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.585 -0.734 . . . . 1.0700000000000001 109.81 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.36 104.92 29.83 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 0.28999999999999998 111.081 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.1 Cg_endo -90.97 -179.51 1.5 Allowed 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 123.231 2.621 . . . . 0.42999999999999999 112.204 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.69 32.63 18.35 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.385 -0.825 . . . . 1.26 111.411 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.448 ' O ' ' OG ' ' A' ' 126' ' ' SER . 23.9 mt -86.39 148.51 25.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.448 -0.342 . . . . 0.32000000000000001 110.489 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.77 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.5 mt -88.23 114.91 61.52 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.029 0.442 . . . . 0.57999999999999996 110.686 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.01 140.53 95.77 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.897 2.398 . . . . 0.66000000000000003 111.992 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.16 21.14 74.23 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.032 -0.827 . . . . 0.28999999999999998 111.032 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.439 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.83 150.14 49.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.768 0.318 . . . . 2.3300000000000001 110.73 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.27 131.78 46.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.139 -0.482 . . . . 0.85999999999999999 109.757 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.952 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.57 148.28 44.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.031 -0.532 . . . . 0.52000000000000002 110.99 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.2 mt -105.32 125.4 60.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.222 -1.029 . . . . 0.29999999999999999 108.222 177.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.58 132.56 63.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.205 0.526 . . . . 0.23000000000000001 111.216 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.64 20.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.575 -0.739 . . . . 0.35999999999999999 109.617 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.05 125.32 55.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.269 -0.423 . . . . 0.19 110.657 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.9 m-85 -117.21 137.94 52.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.031 -0.531 . . . . 0.29999999999999999 109.835 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.425 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.74 135.07 42.76 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.785 -0.82 . . . . 0.37 108.785 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 1.015 HG22 ' O ' ' A' ' 141' ' ' GLY . 11.7 tt -99.15 123.01 51.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.167 0.508 . . . . 0.26000000000000001 110.873 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.585 ' OG ' ' OD1' ' A' ' 188' ' ' ASP . 88.6 p -83.98 169.77 14.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.516 -0.766 . . . . 0.28000000000000003 110.485 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -59.8 -14.5 15.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.095 -0.502 . . . . 1.6000000000000001 110.897 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.671 ' OD1' ' N ' ' A' ' 190' ' ' GLU . 37.0 p30 -96.17 -4.2 43.01 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.782 -0.367 . . . . 1.1799999999999999 110.731 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.47 ' N ' ' HB ' ' A' ' 59' ' ' THR . . . 87.82 13.85 64.03 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.377 -0.689 . . . . 0.29999999999999999 111.377 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.671 ' N ' ' OD1' ' A' ' 188' ' ' ASP . 82.2 tt0 -84.67 139.0 32.34 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.04 -0.264 . . . . 1.22 110.472 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.97 HE22 ' NH2' ' A' ' 143' ' ' ARG . 31.0 mt-30 -106.72 141.11 38.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.873 0.368 . . . . 0.97999999999999998 110.523 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 61.8 m -136.72 127.07 26.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.078 -0.51 . . . . 0.82999999999999996 110.276 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.14 117.21 9.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.284 -0.416 . . . . 0.26000000000000001 110.554 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.0 pt -108.99 -21.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.29999999999999999 110.795 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.84 125.68 5.88 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.519 -0.472 . . . . 0.31 111.465 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.461 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.71 120.3 21.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.799 -0.637 . . . . 0.28000000000000003 109.585 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.66 151.74 29.13 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.667 -0.413 . . . . 0.23999999999999999 110.916 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.47 158.57 18.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.015 -0.538 . . . . 0.23000000000000001 110.41 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -146.1 157.86 43.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.123 -0.49 . . . . 0.67000000000000004 110.696 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.26 104.28 9.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.78 -0.646 . . . . 0.64000000000000001 110.096 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.0 p . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 117.845 -1.074 . . . . 1.26 110.655 -179.688 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.224 -0.658 . . . . 3.4399999999999999 109.224 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.39 150.62 18.55 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.012 -0.835 . . . . 1.22 111.012 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -35.62 142.35 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.05 0 C-N-CA 124.022 3.148 . . . . 0.75 113.828 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.6 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.0 t -79.91 173.3 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.283 -1.326 . . . . 0.79000000000000004 108.891 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.6 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.49 125.86 51.47 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.479 -0.488 . . . . 1.9399999999999999 111.482 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 143.99 33.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.665 -0.698 . . . . 0.59999999999999998 110.689 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.94 168.23 25.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.922 0.391 . . . . 3.1400000000000001 111.101 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.746 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.94 131.06 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.004 -0.544 . . . . 3.23 110.079 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.17 162.27 35.88 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.836 0.35 . . . . 3.6299999999999999 111.239 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.6 mt-10 36.18 31.5 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.648 -0.501 . . . . 6.0800000000000001 109.648 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.746 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.63 32.6 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.97 -0.559 . . . . 3.3799999999999999 111.574 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.2 Cg_endo -63.16 -29.18 73.92 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.484 2.123 . . . . 3.9300000000000002 111.888 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 3.3599999999999999 110.518 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.619 ' NE2' ' O ' ' A' ' 13' ' ' SER . 6.0 mp0 -123.98 158.29 60.74 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 3.6099999999999999 110.368 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.515 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 97.5 Cg_endo -81.98 -64.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.958 2.439 . . . . 1.51 113.431 -179.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.744 ' OD1' ' CD1' ' A' ' 157' ' ' TYR . 2.0 m120 -108.48 -19.53 13.42 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.07 0.396 . . . . 2.6800000000000002 112.07 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 60.3 m -107.36 152.0 24.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.159 0.504 . . . . 1.21 111.258 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.4 t-80 -155.26 102.97 2.23 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.623 -0.717 . . . . 1.5600000000000001 110.618 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.621 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.5 Cg_endo -82.7 145.63 12.99 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.885 2.39 . . . . 0.81000000000000005 112.601 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.916 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.8 167.96 24.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.815 -0.63 . . . . 1.52 109.909 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.16 147.98 29.09 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.712 -0.477 . . . . 2.1400000000000001 109.712 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.582 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.28 157.23 45.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.026 0.441 . . . . 0.32000000000000001 111.165 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.498 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.06 155.23 44.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.752 -0.658 . . . . 2.1699999999999999 110.116 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.841 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.55 173.05 6.34 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 121.091 0.472 . . . . 0.58999999999999997 110.748 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.841 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.65 173.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.851 2.367 . . . . 0.90000000000000002 111.502 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.484 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.06 -51.12 0.69 Allowed Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.643 -0.423 . . . . 3.3399999999999999 110.08 179.819 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.638 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.76 152.31 82.49 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.796 2.33 . . . . 1.8500000000000001 111.416 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.66 42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.35 0.595 . . . . 2.54 110.607 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.638 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.9 t60 -63.52 -41.63 98.5 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.017 -0.992 . . . . 2.5299999999999998 110.68 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.561 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.2 mt -109.86 137.79 40.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.818 -0.628 . . . . 1.1699999999999999 111.287 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.88 -72.83 0.71 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.013 -0.539 . . . . 1.27 111.986 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.21 148.43 24.38 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.517 0.562 . . . . 1.1200000000000001 112.517 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.86 124.86 45.12 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.312 -0.625 . . . . 0.41999999999999998 109.312 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.04 134.78 60.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.614 -0.434 . . . . 0.78000000000000003 110.689 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.916 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.02 128.63 53.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.62 111.246 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.96 49.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.751 -0.659 . . . . 1.97 110.178 178.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.438 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.07 163.17 35.09 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.16 0.505 . . . . 0.34999999999999998 112.128 -178.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.47 139.54 7.84 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.468 -0.787 . . . . 1.8 110.468 178.918 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.695 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.57 115.52 3.09 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.313 2.009 . . . . 0.57999999999999996 111.791 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.674 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.01 81.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.885 -0.413 . . . . 3.04 109.885 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.695 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.51 0.06 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.987 -0.551 . . . . 2.4700000000000002 111.889 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.8 p -157.72 157.69 33.96 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.82 0.343 . . . . 2.5099999999999998 110.552 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.34 27.89 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 1.8600000000000001 110.194 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.81 -75.96 1.31 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.2 -0.524 . . . . 1.4399999999999999 111.81 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.79 152.29 35.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.824 0.345 . . . . 4.6900000000000004 111.042 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.24 -169.11 2.52 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.107 -0.497 . . . . 1.4299999999999999 111.884 179.334 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.67 29.73 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.524 0.678 . . . . 1.74 112.514 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.05 156.46 46.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.689 -1.141 . . . . 1.9199999999999999 110.263 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.16 158.34 41.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.91 -0.586 . . . . 0.34000000000000002 111.818 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.1 m -115.08 135.61 54.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.505 -0.77 . . . . 0.40999999999999998 109.86 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.582 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.36 121.95 23.82 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.439 -0.346 . . . . 0.55000000000000004 111.55 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.597 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.0 Cg_exo -46.37 151.79 1.64 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.653 2.235 . . . . 0.44 112.116 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.98 -23.01 63.19 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 116.052 -0.522 . . . . 0.73999999999999999 112.763 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.1 p-80 -82.8 -16.84 46.26 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.216 -0.594 . . . . 0.93000000000000005 111.861 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.597 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.66 138.51 31.5 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.657 -0.417 . . . . 0.96999999999999997 110.281 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.55 13.94 10.98 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.314 -0.403 . . . . 1.3400000000000001 111.568 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.01 143.35 25.12 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.611 -0.436 . . . . 0.39000000000000001 111.068 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.722 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.63 -169.29 1.51 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.188 0.518 . . . . 0.41999999999999998 110.941 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.722 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.3 t -151.8 125.97 9.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.416 -0.811 . . . . 0.39000000000000001 109.808 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.517 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.93 123.2 70.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.404 -0.518 . . . . 0.73999999999999999 111.217 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -126.47 163.39 23.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.829 -0.623 . . . . 2.48 110.426 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.19 18.97 59.79 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.705 -0.958 . . . . 0.5 110.705 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.517 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.9 mt -79.1 157.14 28.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.093 0.473 . . . . 0.57999999999999996 111.324 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.84 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.0 mtpp -99.39 133.97 21.57 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 2.79 110.463 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.89 143.58 61.36 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.586 2.191 . . . . 0.87 111.963 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.87 25.58 75.4 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.023 -0.831 . . . . 0.64000000000000001 111.023 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.84 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.15 158.74 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.706 0.288 . . . . 0.82999999999999996 110.466 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.13 139.93 42.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.883 0.373 . . . . 0.5 110.602 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.653 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.3 m-85 -122.49 136.48 54.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.55 . . . . 0.53000000000000003 110.775 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.98 130.98 45.36 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.539 -0.911 . . . . 1.8700000000000001 108.539 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.43 153.91 16.63 Favored Glycine 0 C--O 1.227 -0.344 0 C-N-CA 120.299 -0.953 . . . . 0.28999999999999998 111.962 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -134.97 140.91 46.07 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.73 -0.47 . . . . 1.4299999999999999 109.73 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.7 tp -115.73 118.95 34.48 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.456 -0.498 . . . . 0.32000000000000001 110.533 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.728 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.42 129.05 68.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.323 -0.399 . . . . 0.79000000000000004 110.628 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.703 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.9 120.8 43.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.287 -0.415 . . . . 1.02 110.713 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.855 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.53 146.46 11.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.231 0.538 . . . . 0.62 111.058 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.619 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.03 153.94 21.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.495 -0.775 . . . . 2.4399999999999999 109.949 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.21 88.6 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.895 0.379 . . . . 3.6899999999999999 110.446 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.24 32.62 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.822 -0.626 . . . . 6.0800000000000001 110.598 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.08 -117.33 3.29 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.457 -0.657 . . . . 1.22 111.457 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.51 177.42 8.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.197 0.522 . . . . 2.8799999999999999 111.6 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.16 149.44 31.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.451 -0.795 . . . . 1.47 110.451 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.14 144.65 38.73 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.479 -0.328 . . . . 2.7000000000000002 110.533 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.728 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -128.01 135.99 61.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-O 121.036 0.446 . . . . 0.46000000000000002 111.555 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.05 141.32 52.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.662 -0.699 . . . . 0.34999999999999998 110.304 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.453 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.63 138.82 51.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.053 0.454 . . . . 3.6699999999999999 111.577 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.25 164.21 37.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.548 -0.751 . . . . 0.67000000000000004 109.435 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.28 151.47 38.4 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.399 -0.52 . . . . 1.47 111.058 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.804 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.2 p90 -146.18 172.66 13.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.802 -0.636 . . . . 0.44 111.039 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.6 160.71 21.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.456 -0.793 . . . . 1.3700000000000001 109.897 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.43 121.81 22.8 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.591 -0.444 . . . . 1.28 110.778 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.494 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -127.64 163.88 23.28 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 114.03 1.122 . . . . 1.97 114.03 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 55.2 m -120.57 154.74 34.97 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 113.55 -1.659 . . . . 3.2799999999999998 108.815 177.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.438 HG23 ' N ' ' A' ' 95' ' ' SER . 5.6 t -43.52 -41.22 4.32 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.146 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.438 ' N ' HG23 ' A' ' 94' ' ' THR . 28.2 t -115.45 144.31 44.01 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.8 113.37 62.71 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.037 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.36 147.17 69.18 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.289 1.993 . . . . 0.0 112.633 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.4 t -114.74 134.99 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.873 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.4 p -85.11 161.31 19.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.794 0.33 . . . . 0.0 110.954 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.2 t -118.73 143.37 46.93 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.278 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -86.96 6.01 34.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.129 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.5 p -84.08 160.04 21.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.773 0.321 . . . . 0.0 110.656 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.3 m -112.98 9.18 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.703 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.7 p -83.69 161.89 20.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.913 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.94 5.23 64.42 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.832 ' O ' ' O ' ' A' ' 107' ' ' THR . 21.8 pt-20 -106.66 145.99 31.3 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.53 0.205 . . . . 0.0 110.949 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.832 ' O ' ' O ' ' A' ' 106' ' ' GLU . 5.6 m 30.86 138.68 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.6 p -126.32 78.68 71.25 Favored Pre-proline 0 N--CA 1.465 0.314 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.33 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -55.35 143.64 75.69 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.432 2.088 . . . . 0.0 112.45 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -57.63 -39.64 77.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.564 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.427 ' O ' ' OG ' ' A' ' 111' ' ' SER . 22.6 p 61.97 66.76 1.39 Allowed Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.028 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -56.48 -19.49 29.42 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.841 2.361 . . . . 0.0 111.979 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 66.6 mt -57.71 -34.33 69.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 10.19 110.687 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.7 t -66.62 134.19 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.745 -0.382 . . . . 7.2800000000000002 110.287 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -120.43 -113.24 0.33 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.134 -0.485 . . . . 7.2999999999999998 110.608 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.7 m -75.99 137.0 39.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.41 -0.359 . . . . 6.4400000000000004 110.466 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 84.1 p -140.89 163.9 31.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.018 -0.537 . . . . 4.4199999999999999 110.65 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -56.24 146.57 23.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.048 -0.524 . . . . 3.0499999999999998 110.124 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.2 t -61.26 144.29 54.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.049 0.452 . . . . 3.4300000000000002 110.606 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.9 t -119.15 138.22 50.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.654 -0.703 . . . . 2.8799999999999999 110.72 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 26.4 p -77.18 163.21 26.77 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.814 -0.439 . . . . 2.0899999999999999 109.814 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.12 141.48 45.98 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.636 -0.426 . . . . 4.5300000000000002 110.918 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.06 162.36 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.751 -0.658 . . . . 1.4399999999999999 111.09 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.6 p -120.79 160.78 22.69 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.433 -0.58 . . . . 1.78 109.433 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.97 123.42 29.42 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.586 -0.446 . . . . 0.64000000000000001 110.76 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.5 p -65.0 -27.19 68.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.943 -0.571 . . . . 0.66000000000000003 110.365 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.436 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.86 167.59 0.25 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.602 -0.726 . . . . 0.68999999999999995 110.955 -179.231 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.62 145.48 50.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.731 -0.668 . . . . 0.52000000000000002 110.156 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.16 101.64 9.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.095 -0.706 . . . . 0.32000000000000001 109.095 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.1 t -112.92 139.78 36.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.056 -0.52 . . . . 0.28999999999999998 110.95 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.9 p -128.74 152.57 48.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.598 -0.728 . . . . 0.25 109.792 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.592 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.8 -164.87 2.02 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.741 -0.384 . . . . 0.31 110.667 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.5 t -123.98 127.12 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.48999999999999999 110.823 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.176 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.87 58.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.126 -0.488 . . . . 1.53 110.368 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -37.95 24.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.934 -0.575 . . . . 0.96999999999999997 111.579 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.176 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.23 128.68 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.659 -0.417 . . . . 1.5600000000000001 110.96 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.42 -9.53 56.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.0 -0.545 . . . . 1.8799999999999999 110.32 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.8 p -87.16 0.25 55.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 1.04 110.29 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.26 137.26 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.994 -0.548 . . . . 0.23999999999999999 109.956 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.601 ' N ' ' O ' ' A' ' 185' ' ' ILE . 90.3 p -96.29 -15.5 21.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.27 0.557 . . . . 0.28999999999999998 110.048 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.58 175.57 45.77 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 109.88 -1.288 . . . . 0.13 109.88 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.47 151.62 42.54 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.569 -0.452 . . . . 0.17000000000000001 110.496 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.653 ' NH2' ' CD ' ' A' ' 191' ' ' GLN . 41.8 ttp180 -132.26 121.14 23.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.15 -0.477 . . . . 1.29 109.924 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.558 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.14 136.63 38.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.734 -0.666 . . . . 0.25 110.649 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 99.2 mt-10 -129.45 129.86 45.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.942 -0.572 . . . . 1.3200000000000001 110.044 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.625 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.7 p90 -138.68 135.35 34.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.046 -0.525 . . . . 0.56999999999999995 110.611 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.419 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.41 161.36 39.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.793 -0.64 . . . . 1.1599999999999999 109.621 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.05 124.99 25.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.036 0.446 . . . . 0.38 110.694 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.7 p -71.94 -7.7 50.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.766 -0.652 . . . . 0.40999999999999998 110.797 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -109.72 -69.67 0.85 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.967 0.413 . . . . 1.6599999999999999 111.455 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.445 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.71 -35.28 75.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.998 -0.546 . . . . 1.6599999999999999 111.522 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.081 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.11 7.23 88.59 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.825 -0.91 . . . . 1.1699999999999999 110.825 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.34 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.83 -171.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.324 . . . . 1.8600000000000001 110.256 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.34 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.26 139.02 45.14 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-O 120.945 0.402 . . . . 1.98 110.205 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.419 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.9 Cg_endo -70.75 145.73 52.2 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 122.808 2.339 . . . . 0.55000000000000004 112.361 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.625 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.86 145.69 42.65 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.312 -0.625 . . . . 1.1399999999999999 109.312 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.744 ' CD1' ' OD1' ' A' ' 16' ' ' ASN . 0.2 OUTLIER -123.26 141.32 52.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.31 0.576 . . . . 0.93000000000000005 111.421 -178.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.9 mt -128.14 127.61 43.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.271 -0.877 . . . . 0.34000000000000002 108.921 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 159' ' ' ASP . 51.4 p-10 -101.61 131.21 47.94 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.194 0.521 . . . . 1.0900000000000001 111.731 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -128.02 157.58 73.5 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.237 -0.892 . . . . 0.19 109.493 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.81 158.02 58.33 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.435 2.09 . . . . 0.17999999999999999 112.267 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.36 -12.11 5.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.792 -0.64 . . . . 0.20999999999999999 110.708 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.7 p -92.82 -8.67 42.9 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.129 -0.487 . . . . 0.28999999999999998 110.715 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.38 34.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.319 -0.4 . . . . 0.5 110.394 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.12 16.53 4.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.398 -0.365 . . . . 0.29999999999999999 110.558 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.4 p -167.45 147.23 5.18 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.661 -0.496 . . . . 0.23000000000000001 109.661 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.32 150.42 12.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.565 -0.454 . . . . 0.28000000000000003 111.602 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.507 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.26 124.94 50.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.559 -0.746 . . . . 1.0700000000000001 109.843 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.45 104.86 29.72 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.918 0.389 . . . . 0.28999999999999998 111.098 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 84.4 Cg_endo -91.05 -179.42 1.47 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 123.132 2.555 . . . . 0.42999999999999999 112.163 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.56 32.73 18.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.366 -0.834 . . . . 1.26 111.419 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.1 mt -86.37 148.52 25.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.454 -0.339 . . . . 0.32000000000000001 110.454 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.773 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.31 114.88 61.44 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.018 0.437 . . . . 0.57999999999999996 110.64 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -58.98 140.62 96.14 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.815 2.343 . . . . 0.66000000000000003 112.051 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.16 74.4 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.088 -0.805 . . . . 0.28999999999999998 111.088 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.445 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.86 150.21 49.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.313 . . . . 2.3300000000000001 110.634 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.495 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.13 131.63 45.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.519 . . . . 0.85999999999999999 109.789 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.955 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.55 148.38 43.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.066 -0.515 . . . . 0.52000000000000002 110.995 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.4 125.28 60.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.363 -0.977 . . . . 0.29999999999999999 108.363 177.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.47 132.51 63.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.149 0.5 . . . . 0.23000000000000001 111.217 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.49 122.66 20.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.54 -0.755 . . . . 0.35999999999999999 109.729 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.592 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.09 125.37 55.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.284 -0.417 . . . . 0.19 110.664 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 49.1 m-85 -117.18 138.04 51.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.978 -0.555 . . . . 0.29999999999999999 109.875 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.427 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.81 134.97 43.0 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.77 -0.826 . . . . 0.37 108.77 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.601 ' O ' ' N ' ' A' ' 140' ' ' SER . 85.4 mt -99.09 122.93 51.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.145 0.498 . . . . 0.26000000000000001 110.961 -178.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.2 p -83.89 169.65 14.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.526 -0.761 . . . . 0.28000000000000003 110.447 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.63 ' O ' ' CG2' ' A' ' 59' ' ' THR . 51.5 tp10 -59.79 -14.39 14.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.034 -0.53 . . . . 1.6000000000000001 110.982 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.621 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.1 m-20 -96.18 -4.24 42.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.857 0.361 . . . . 1.1799999999999999 110.817 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.8 13.88 64.0 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.384 -0.687 . . . . 0.29999999999999999 111.384 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.5 tp10 -84.7 139.09 32.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.712 0.292 . . . . 1.22 110.422 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.653 ' CD ' ' NH2' ' A' ' 143' ' ' ARG . 21.1 pt20 -106.71 141.03 38.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.405 -0.362 . . . . 0.97999999999999998 110.602 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.4 m -136.72 127.06 26.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.82999999999999996 110.301 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.19 117.27 9.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.244 -0.434 . . . . 0.26000000000000001 110.577 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -108.97 -21.86 5.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.29999999999999999 110.711 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.83 125.72 5.9 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.551 -0.46 . . . . 0.31 111.535 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.79 120.12 21.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.854 -0.612 . . . . 0.28000000000000003 109.603 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.58 151.66 29.11 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.676 -0.409 . . . . 0.23999999999999999 110.97 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.49 158.66 18.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.23000000000000001 110.411 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -146.14 157.87 43.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.043 -0.526 . . . . 0.67000000000000004 110.627 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.2 104.31 9.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.722 -0.672 . . . . 0.64000000000000001 110.119 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.7 p . . . . . 0 C--O 1.221 -0.414 0 CA-C-O 117.902 -1.047 . . . . 1.26 110.666 -179.621 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.4 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.267 -0.642 . . . . 3.4399999999999999 109.267 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.39 150.72 18.53 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.006 -0.838 . . . . 1.22 111.006 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -35.61 142.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 124.007 3.138 . . . . 0.75 113.789 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.6 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.3 t -80.04 173.39 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.288 -1.324 . . . . 0.79000000000000004 108.745 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.6 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.66 125.86 51.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.398 -0.521 . . . . 1.9399999999999999 111.444 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.48 144.06 33.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.564 -0.744 . . . . 0.59999999999999998 110.631 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.09 168.33 25.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.944 0.402 . . . . 3.1400000000000001 111.127 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.748 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -108.99 131.06 60.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.972 -0.558 . . . . 3.23 110.116 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.2 p -141.14 162.25 35.93 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.875 0.369 . . . . 3.6299999999999999 111.24 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 75.0 mm-40 36.1 31.61 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.633 -0.506 . . . . 6.0800000000000001 109.633 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.748 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.55 69.69 33.96 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.952 -0.567 . . . . 3.3799999999999999 111.618 -178.83 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.34 -29.07 72.2 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.498 2.132 . . . . 3.9300000000000002 111.851 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.64 125.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.098 -0.501 . . . . 3.3599999999999999 110.477 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.825 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -123.99 158.31 60.71 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 3.6099999999999999 110.437 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.444 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 97.1 Cg_endo -81.95 -64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.858 2.372 . . . . 1.51 113.553 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.7 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 52.1 t30 -108.48 -19.55 13.41 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.119 0.414 . . . . 2.6800000000000002 112.119 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.825 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 47.1 m -107.31 152.05 24.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.136 0.493 . . . . 1.21 111.281 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.484 ' CD2' ' CE2' ' A' ' 89' ' ' PHE . 61.8 t60 -155.32 102.86 2.22 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.72 -0.673 . . . . 1.5600000000000001 110.682 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.452 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.6 145.72 13.17 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.875 2.383 . . . . 0.81000000000000005 112.627 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.907 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.88 167.98 24.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.896 -0.593 . . . . 1.52 109.879 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.15 148.03 29.15 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.786 -0.45 . . . . 2.1400000000000001 109.786 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.586 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.8 p90 -142.32 157.3 44.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.936 0.398 . . . . 0.32000000000000001 111.303 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.493 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.07 155.34 44.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.841 -0.618 . . . . 2.1699999999999999 110.092 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.838 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.67 173.08 6.31 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 121.122 0.487 . . . . 0.58999999999999997 110.76 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.838 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.74 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.841 2.361 . . . . 0.90000000000000002 111.512 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.14 -50.97 0.69 Allowed Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.62 -0.432 . . . . 3.3399999999999999 110.133 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.634 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.85 152.4 82.32 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.678 2.252 . . . . 1.8500000000000001 111.559 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.75 42.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.401 0.62 . . . . 2.54 110.528 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.634 ' N ' ' O ' ' A' ' 27' ' ' PRO . 74.0 t60 -63.63 -41.63 98.24 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.008 -0.996 . . . . 2.5299999999999998 110.616 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.559 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.9 mt -109.79 137.86 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.84 -0.618 . . . . 1.1699999999999999 111.227 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.0 -72.84 0.71 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.042 -0.526 . . . . 1.27 111.937 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.29 148.38 24.34 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.549 0.574 . . . . 1.1200000000000001 112.549 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.82 124.89 45.23 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.345 -0.613 . . . . 0.41999999999999998 109.345 177.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 mt -118.06 134.75 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.608 -0.437 . . . . 0.78000000000000003 110.616 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.907 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -119.98 128.66 53.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.996 0.427 . . . . 0.62 111.245 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.93 49.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.79 -0.641 . . . . 1.97 110.213 178.914 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.439 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -144.98 163.17 35.01 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.118 0.485 . . . . 0.34999999999999998 112.043 -178.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.52 139.57 7.82 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.417 -0.811 . . . . 1.8 110.503 178.746 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.3 Cg_endo -63.54 115.47 3.06 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.347 2.032 . . . . 0.57999999999999996 111.818 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.3 tttp -46.85 81.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.883 -0.414 . . . . 3.04 109.883 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.7 0.06 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.109 -0.496 . . . . 2.4700000000000002 111.914 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 p -157.55 157.81 34.46 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.857 -0.337 . . . . 2.5099999999999998 110.592 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.402 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.33 27.77 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.213 -0.449 . . . . 1.8600000000000001 110.183 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.77 -75.97 1.31 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.198 -0.525 . . . . 1.4399999999999999 111.811 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.86 152.25 35.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.947 0.403 . . . . 4.6900000000000004 111.019 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.676 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.17 -169.14 2.54 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.996 -0.547 . . . . 1.4299999999999999 112.048 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.16 149.67 29.74 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 121.476 0.655 . . . . 1.74 112.561 -177.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.99 156.42 46.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.763 -1.108 . . . . 1.9199999999999999 110.347 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.13 158.39 41.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.209 0.528 . . . . 0.34000000000000002 111.828 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.1 m -115.22 135.57 54.03 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.57 -0.741 . . . . 0.40999999999999998 109.794 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.586 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.36 121.96 23.82 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.33 -0.396 . . . . 0.55000000000000004 111.495 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.9 Cg_exo -46.3 151.65 1.64 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.733 2.289 . . . . 0.44 112.081 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.84 -23.06 62.94 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-N 116.037 -0.529 . . . . 0.73999999999999999 112.814 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.87 -16.74 46.38 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.236 -0.585 . . . . 0.93000000000000005 111.779 -178.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.601 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.6 mt -91.69 138.41 31.59 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.807 -0.357 . . . . 0.96999999999999997 110.308 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.54 13.98 10.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.315 -0.402 . . . . 1.3400000000000001 111.482 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 86.8 p -149.97 143.5 25.25 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.696 -0.402 . . . . 0.39000000000000001 111.03 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.721 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.87 -169.43 1.55 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.286 0.565 . . . . 0.41999999999999998 110.808 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.721 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.4 t -151.77 125.89 9.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.375 -0.83 . . . . 0.39000000000000001 109.908 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.4 mt -114.74 123.27 70.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.424 -0.51 . . . . 0.73999999999999999 111.257 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.59 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 21.5 mtmt -126.48 163.33 23.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.88 -0.6 . . . . 2.48 110.464 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.473 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.14 18.99 59.84 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.77 -0.932 . . . . 0.5 110.77 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.7 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.6 mt -79.05 157.35 28.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.043 0.449 . . . . 0.57999999999999996 111.408 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.846 ' O ' HG12 ' A' ' 67' ' ' VAL . 6.6 mttp -99.54 133.95 21.51 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.666 -0.697 . . . . 2.79 110.412 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.575 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.92 143.66 61.53 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.495 2.13 . . . . 0.87 111.945 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.78 25.47 75.52 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.161 -0.776 . . . . 0.64000000000000001 111.161 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.846 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.04 158.84 39.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.655 0.264 . . . . 0.82999999999999996 110.51 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.23 139.89 42.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.916 0.388 . . . . 0.5 110.516 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.654 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.6 136.41 54.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.959 -0.564 . . . . 0.53000000000000003 110.799 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.88 130.91 45.3 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.51 -0.922 . . . . 1.8700000000000001 108.51 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.36 153.79 16.63 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.298 -0.953 . . . . 0.28999999999999998 112.07 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -134.91 140.97 46.18 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.696 -0.483 . . . . 1.4299999999999999 109.696 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.78 118.96 34.49 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.456 -0.498 . . . . 0.32000000000000001 110.483 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.735 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.5 129.02 68.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.334 -0.394 . . . . 0.79000000000000004 110.645 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.707 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.82 120.84 43.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.326 -0.397 . . . . 1.02 110.766 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.852 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.6 146.47 11.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.144 0.497 . . . . 0.62 110.985 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.621 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.0 153.88 21.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.575 -0.738 . . . . 2.4399999999999999 109.902 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.18 88.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.901 0.382 . . . . 3.6899999999999999 110.427 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.62 0.21 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.8 -0.636 . . . . 6.0800000000000001 110.56 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.34 3.29 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.406 -0.678 . . . . 1.22 111.406 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.38 177.39 9.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.132 0.492 . . . . 2.8799999999999999 111.652 -179.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.12 149.5 32.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.504 -0.771 . . . . 1.47 110.421 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.17 144.65 38.67 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.402 -0.363 . . . . 2.7000000000000002 110.623 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.735 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.0 135.96 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.997 0.427 . . . . 0.46000000000000002 111.568 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.0 141.35 52.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.667 -0.697 . . . . 0.34999999999999998 110.289 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.462 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.65 138.8 51.73 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.089 0.471 . . . . 3.6699999999999999 111.529 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.17 164.22 37.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.553 -0.749 . . . . 0.67000000000000004 109.556 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.573 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.3 151.48 38.4 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.432 -0.507 . . . . 1.47 111.004 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.805 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.15 172.75 12.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.714 -0.676 . . . . 0.44 111.024 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.69 160.71 21.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.454 -0.794 . . . . 1.3700000000000001 109.849 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.741 HG23 ' OE1' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.43 121.89 22.91 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.575 -0.45 . . . . 1.28 110.778 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.634 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.8 p -127.62 165.52 19.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 1.97 111.415 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.5 t -99.1 142.55 30.44 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 109.617 -0.512 . . . . 3.2799999999999998 109.617 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 43.4 m -84.16 137.97 33.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.102 0.477 . . . . 0.0 111.79 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.445 ' O ' ' OG1' ' A' ' 96' ' ' THR . 31.5 t -121.88 143.46 49.42 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.585 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.615 ' N ' ' CD ' ' A' ' 97' ' ' PRO . 1.1 m 168.12 -35.28 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.595 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 96' ' ' THR . 51.1 Cg_exo -53.29 145.29 45.28 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.869 1.713 . . . . 0.0 112.357 -179.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 40.9 t -114.73 137.11 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.322 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.6 t -133.19 158.38 43.01 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.837 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 92.0 p -123.01 157.9 31.69 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.445 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.7 p-10 -130.17 176.22 8.27 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.92 0.39 . . . . 0.0 110.749 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.4 t -135.98 160.94 37.08 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.592 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.4 t -111.42 135.01 51.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.325 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 45.8 m -121.34 142.06 50.34 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.647 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -134.7 170.64 22.67 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -59.28 141.47 54.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.812 0.339 . . . . 0.0 110.615 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.432 ' O ' ' OG1' ' A' ' 108' ' ' THR . 64.1 p -71.72 -21.57 61.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.68 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.655 ' N ' ' HD2' ' A' ' 109' ' ' PRO . 1.2 m 166.99 -49.63 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.705 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 108' ' ' THR . 16.2 Cg_endo -56.94 149.72 59.77 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.324 2.016 . . . . 0.0 112.011 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -103.71 134.81 46.41 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.429 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.407 ' N ' ' HD3' ' A' ' 112' ' ' PRO . 11.5 t 56.64 64.77 4.46 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.549 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' A' ' 111' ' ' SER . 31.7 Cg_exo -56.6 147.12 72.19 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.662 2.241 . . . . 0.0 112.149 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.649 ' H ' HD12 ' A' ' 113' ' ' LEU . 6.5 mp -61.12 -33.64 73.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.862 -0.608 . . . . 10.19 110.802 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 115' ' ' ALA . 91.0 t 55.8 159.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.2 -0.454 . . . . 7.2800000000000002 110.654 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.514 ' N ' HG12 ' A' ' 114' ' ' VAL . . . -64.28 146.31 54.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.011 -0.541 . . . . 7.2999999999999998 110.836 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.2 p -81.49 164.24 22.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.067 -0.515 . . . . 6.4400000000000004 110.355 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.626 ' O ' ' N ' ' A' ' 119' ' ' SER . 87.6 p -60.83 -26.51 67.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 4.4199999999999999 111.183 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 120' ' ' VAL . 95.8 mt-10 44.12 -82.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.507 -0.315 . . . . 3.0499999999999998 111.323 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.626 ' N ' ' O ' ' A' ' 117' ' ' SER . 7.4 p 66.21 -47.73 0.42 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.296 -0.411 . . . . 3.4300000000000002 110.815 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.449 ' N ' ' O ' ' A' ' 118' ' ' GLU . 19.8 m -69.64 -27.91 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.459 -0.337 . . . . 2.8799999999999999 110.669 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.9 m -121.09 139.92 52.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.248 -0.433 . . . . 2.0899999999999999 110.291 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -103.98 134.12 47.8 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.332 -0.395 . . . . 4.5300000000000002 110.18 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.604 ' C ' ' H ' ' A' ' 125' ' ' ALA . 32.6 mm -116.78 132.68 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.815 0.341 . . . . 1.4399999999999999 111.299 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.563 ' O ' ' O ' ' A' ' 125' ' ' ALA . 19.6 m 52.5 -2.85 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.94 -0.573 . . . . 1.78 112.082 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.604 ' H ' ' C ' ' A' ' 123' ' ' ILE . . . 48.46 115.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.201 0.524 . . . . 0.64000000000000001 111.271 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.9 p -61.31 -27.53 68.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.92 -0.582 . . . . 0.66000000000000003 110.546 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.437 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.91 167.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.873 -0.603 . . . . 0.68999999999999995 110.916 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.61 145.56 50.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.674 -0.693 . . . . 0.52000000000000002 110.138 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.21 101.63 9.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.086 -0.709 . . . . 0.32000000000000001 109.086 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.7 t -112.93 139.64 36.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.033 -0.531 . . . . 0.28999999999999998 111.076 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 p -128.71 152.54 48.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.669 -0.696 . . . . 0.25 109.869 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.591 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.71 -164.93 2.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.688 -0.405 . . . . 0.31 110.716 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -124.01 127.19 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.48999999999999999 110.83 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.175 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.94 58.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.059 -0.519 . . . . 1.53 110.388 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.16 24.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.876 -0.602 . . . . 0.96999999999999997 111.507 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.175 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.18 128.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.618 -0.433 . . . . 1.5600000000000001 110.921 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -86.53 -9.51 56.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.942 -0.572 . . . . 1.8799999999999999 110.339 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.18 0.34 55.47 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.045 -0.525 . . . . 1.04 110.444 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.23 137.23 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.847 -0.615 . . . . 0.23999999999999999 109.93 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.612 ' N ' ' O ' ' A' ' 185' ' ' ILE . 87.2 p -96.34 -15.4 21.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.324 0.583 . . . . 0.28999999999999998 110.068 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.56 175.54 45.73 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 109.836 -1.306 . . . . 0.13 109.836 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.44 151.61 42.5 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.637 -0.425 . . . . 0.17000000000000001 110.488 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.614 ' NH1' ' OE1' ' A' ' 191' ' ' GLN . 55.9 ttp180 -132.36 121.2 23.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.141 -0.481 . . . . 1.29 109.92 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.555 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.16 136.62 38.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.753 -0.658 . . . . 0.25 110.652 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 22.4 tp10 -129.35 129.93 45.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.981 -0.554 . . . . 1.3200000000000001 109.974 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.623 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.75 135.35 34.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.993 -0.549 . . . . 0.56999999999999995 110.507 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.422 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.38 161.37 39.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.721 -0.672 . . . . 1.1599999999999999 109.666 179.778 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.952 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.06 124.88 25.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.946 0.403 . . . . 0.38 110.772 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.7 p -71.75 -7.78 50.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.75 -0.659 . . . . 0.40999999999999998 110.853 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -109.8 -69.76 0.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.318 -0.401 . . . . 1.6599999999999999 111.394 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.439 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.5 mt-10 -60.65 -35.32 75.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.033 -0.531 . . . . 1.6599999999999999 111.441 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.091 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.16 7.32 88.53 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.785 -0.926 . . . . 1.1699999999999999 110.785 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.334 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.4 t0 -28.15 -171.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.807 0.337 . . . . 1.8600000000000001 110.266 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.334 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.15 45.23 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-O 120.918 0.389 . . . . 1.98 110.139 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.422 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.1 Cg_endo -70.98 145.81 51.07 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 C-N-CA 122.717 2.278 . . . . 0.55000000000000004 112.318 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.83 145.83 42.51 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.243 -0.651 . . . . 1.1399999999999999 109.243 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.575 ' CE1' ' HD3' ' A' ' 65' ' ' PRO . 27.5 p90 -123.37 141.32 52.11 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.372 -0.531 . . . . 0.93000000000000005 111.514 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.11 127.62 43.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.318 -0.855 . . . . 0.34000000000000002 108.994 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.549 ' HB3' ' ND2' ' A' ' 16' ' ' ASN . 37.6 p-10 -101.55 131.14 47.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.08 0.467 . . . . 1.0900000000000001 111.771 -178.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.94 157.51 73.57 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.376 -0.829 . . . . 0.19 109.58 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.74 157.94 58.69 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 122.429 2.086 . . . . 0.17999999999999999 112.269 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.26 -12.14 5.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.776 -0.647 . . . . 0.20999999999999999 110.682 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.0 p -92.87 -8.7 42.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.28999999999999998 110.711 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.11 135.31 34.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.284 -0.416 . . . . 0.5 110.394 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.1 p -133.12 16.7 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 0.29999999999999999 110.502 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.8 p -167.52 147.11 5.09 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.602 -0.518 . . . . 0.23000000000000001 109.602 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.555 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.18 150.38 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.476 -0.489 . . . . 0.28000000000000003 111.589 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.509 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.22 124.94 50.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.63 -0.714 . . . . 1.0700000000000001 109.792 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.44 104.91 30.02 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.917 0.389 . . . . 0.28999999999999998 111.112 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -90.97 -179.47 1.5 Allowed 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 123.18 2.586 . . . . 0.42999999999999999 112.23 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.64 32.67 18.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.395 -0.821 . . . . 1.26 111.387 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.9 mt -86.39 148.56 25.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.79 0.328 . . . . 0.32000000000000001 110.489 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.769 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.4 114.77 61.01 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.978 0.418 . . . . 0.57999999999999996 110.595 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -58.92 140.52 95.62 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.823 2.348 . . . . 0.66000000000000003 112.06 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.15 21.18 74.15 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.061 -0.815 . . . . 0.28999999999999998 111.061 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.439 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.88 150.15 49.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.808 0.337 . . . . 2.3300000000000001 110.691 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.15 131.65 45.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.117 -0.492 . . . . 0.85999999999999999 109.772 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.952 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.5 m-85 -120.45 148.27 44.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.172 -0.467 . . . . 0.52000000000000002 111.09 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.2 mt -105.35 125.28 60.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.342 -0.985 . . . . 0.29999999999999999 108.342 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.43 132.51 63.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.096 0.474 . . . . 0.23000000000000001 111.353 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.47 122.44 20.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.523 -0.762 . . . . 0.35999999999999999 109.651 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.591 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.98 125.39 54.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.333 -0.394 . . . . 0.19 110.651 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.19 137.9 52.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.017 -0.538 . . . . 0.29999999999999999 109.888 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.423 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.65 134.98 42.81 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.758 -0.83 . . . . 0.37 108.758 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.612 ' O ' ' N ' ' A' ' 140' ' ' SER . 65.3 mt -99.08 123.08 51.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.214 0.53 . . . . 0.26000000000000001 110.927 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.7 p -83.99 169.73 14.69 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.498 -0.773 . . . . 0.28000000000000003 110.362 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -59.82 -14.47 15.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.978 -0.555 . . . . 1.6000000000000001 110.966 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.2 m-20 -96.05 -4.32 43.22 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.837 -0.345 . . . . 1.1799999999999999 110.856 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.79 13.95 63.9 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.359 -0.696 . . . . 0.29999999999999999 111.359 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -84.78 139.06 32.22 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.01 -0.276 . . . . 1.22 110.437 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.614 ' OE1' ' NH1' ' A' ' 143' ' ' ARG . 6.9 pt20 -106.7 141.06 38.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.893 0.378 . . . . 0.97999999999999998 110.532 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.2 m -136.78 127.05 26.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.113 -0.494 . . . . 0.82999999999999996 110.39 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.2 tp -68.15 117.28 9.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.294 -0.412 . . . . 0.26000000000000001 110.527 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 43.9 pt -108.97 -21.87 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.29999999999999999 110.724 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.87 125.81 5.91 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.457 -0.497 . . . . 0.31 111.468 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.46 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.71 120.21 21.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.75 -0.659 . . . . 0.28000000000000003 109.56 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.7 29.11 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.6 -0.44 . . . . 0.23999999999999999 110.892 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.45 158.54 18.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.23000000000000001 110.472 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -146.07 157.88 43.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.133 -0.485 . . . . 0.67000000000000004 110.649 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.21 104.35 9.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.703 -0.681 . . . . 0.64000000000000001 110.05 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.2 p . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.866 -1.064 . . . . 1.26 110.669 -179.682 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.5 m . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.179 -0.675 . . . . 3.4399999999999999 109.179 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.32 150.7 18.54 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.05 -0.82 . . . . 1.22 111.05 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -35.57 142.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.076 0 C-N-CA 124.004 3.136 . . . . 0.75 113.815 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.61 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -80.02 173.52 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.256 -1.338 . . . . 0.79000000000000004 108.846 178.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.61 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.6 125.88 51.49 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.453 -0.499 . . . . 1.9399999999999999 111.352 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 144.02 33.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.678 -0.692 . . . . 0.59999999999999998 110.726 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.0 168.32 25.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.895 0.379 . . . . 3.1400000000000001 111.149 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.746 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.6 mt -109.06 131.12 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.993 -0.549 . . . . 3.23 110.076 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.2 162.33 35.74 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.862 0.363 . . . . 3.6299999999999999 111.159 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 71.7 tt0 36.0 31.68 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 109.652 -0.499 . . . . 6.0800000000000001 109.652 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.746 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.53 69.61 33.55 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.916 -0.584 . . . . 3.3799999999999999 111.493 -178.735 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.38 -29.03 71.83 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.474 2.116 . . . . 3.9300000000000002 111.832 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.6 125.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 3.3599999999999999 110.433 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.697 ' O ' ' O ' ' A' ' 92' ' ' THR . 14.2 mm-40 -123.89 158.4 60.11 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.256 -0.429 . . . . 3.6099999999999999 110.434 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.577 ' HG3' HE22 ' A' ' 191' ' ' GLN . 96.3 Cg_endo -81.99 -64.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.895 2.396 . . . . 1.51 113.534 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.591 HD22 ' CG ' ' A' ' 159' ' ' ASP . 43.2 p-10 -108.38 -19.56 13.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.3 -0.409 . . . . 2.6800000000000002 112.048 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 3.5 m -107.44 152.13 24.61 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.428 -0.509 . . . . 1.21 111.314 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.58 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.0 t-80 -155.32 102.92 2.22 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.608 -0.724 . . . . 1.5600000000000001 110.674 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.68 145.67 13.02 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.823 2.349 . . . . 0.81000000000000005 112.627 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.93 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.78 168.0 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.867 -0.606 . . . . 1.52 109.874 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.23 148.02 29.1 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.688 -0.486 . . . . 2.1400000000000001 109.688 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.59 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.34 157.34 44.9 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.615 -0.434 . . . . 0.32000000000000001 111.187 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.503 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.09 155.31 44.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.789 -0.641 . . . . 2.1699999999999999 110.163 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.841 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.62 173.02 6.38 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 121.112 0.482 . . . . 0.58999999999999997 110.741 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.841 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.68 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.913 2.408 . . . . 0.90000000000000002 111.502 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.485 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.07 -51.01 0.69 Allowed Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.719 -0.392 . . . . 3.3399999999999999 110.165 179.841 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.626 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.85 152.38 82.39 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.757 2.305 . . . . 1.8500000000000001 111.404 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.77 42.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.363 0.601 . . . . 2.54 110.517 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.626 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.8 t60 -63.62 -41.72 98.25 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.006 -0.997 . . . . 2.5299999999999998 110.634 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.571 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.5 mt -109.8 137.85 40.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.741 -0.663 . . . . 1.1699999999999999 111.287 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.93 -72.92 0.7 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.061 -0.518 . . . . 1.27 111.897 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.37 24.44 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.618 0.599 . . . . 1.1200000000000001 112.618 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.87 124.92 45.25 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.331 -0.618 . . . . 0.41999999999999998 109.331 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.11 134.77 60.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.624 -0.43 . . . . 0.78000000000000003 110.551 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.93 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.09 128.57 53.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.064 0.459 . . . . 0.62 111.244 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.04 138.96 49.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.75 -0.659 . . . . 1.97 110.175 179.0 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.435 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.11 163.23 34.93 Favored 'General case' 0 CA--C 1.523 -0.067 0 CA-C-O 121.194 0.521 . . . . 0.34999999999999998 112.052 -178.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.487 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.52 139.54 7.81 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 115.389 -0.823 . . . . 1.8 110.494 178.896 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.47 115.49 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.286 1.991 . . . . 0.57999999999999996 111.856 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.681 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.04 81.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.803 -0.443 . . . . 3.04 109.803 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.65 0.06 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.971 -0.559 . . . . 2.4700000000000002 111.942 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 p -157.66 157.72 34.11 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.744 -0.383 . . . . 2.5099999999999998 110.538 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.26 27.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.224 -0.444 . . . . 1.8600000000000001 110.181 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.91 -75.9 1.31 Allowed Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.133 -0.556 . . . . 1.4399999999999999 111.8 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.79 152.24 35.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.895 0.378 . . . . 4.6900000000000004 110.995 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.667 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.21 -169.14 2.54 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.132 -0.486 . . . . 1.4299999999999999 111.882 179.337 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.58 29.86 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.462 0.649 . . . . 1.74 112.594 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.99 156.37 46.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.794 -1.094 . . . . 1.9199999999999999 110.316 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.09 158.44 41.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.988 -0.551 . . . . 0.34000000000000002 111.87 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.7 m -115.21 135.66 53.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.511 -0.768 . . . . 0.40999999999999998 109.832 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.59 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.31 121.91 23.87 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.403 -0.362 . . . . 0.55000000000000004 111.554 -179.081 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.2 Cg_exo -46.39 151.74 1.67 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.636 2.224 . . . . 0.44 112.156 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.85 -23.11 63.03 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 116.029 -0.532 . . . . 0.73999999999999999 112.794 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.537 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.76 -16.89 46.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.375 0.587 . . . . 0.93000000000000005 111.84 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.603 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.53 138.39 31.61 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.803 -0.359 . . . . 0.96999999999999997 110.323 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.5 13.86 11.01 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.406 -0.361 . . . . 1.3400000000000001 111.554 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.476 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.96 143.46 25.24 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.659 -0.416 . . . . 0.39000000000000001 111.057 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.713 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.8 -169.37 1.53 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.019 -0.537 . . . . 0.41999999999999998 110.895 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.713 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.0 t -151.77 125.8 9.19 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.366 -0.834 . . . . 0.39000000000000001 109.853 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.511 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.8 mt -114.8 123.4 70.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.28 -0.568 . . . . 0.73999999999999999 111.156 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -126.53 163.4 23.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.831 -0.622 . . . . 2.48 110.423 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.14 18.92 59.98 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.757 -0.937 . . . . 0.5 110.757 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.511 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.0 mt -79.03 157.18 28.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.039 0.447 . . . . 0.57999999999999996 111.314 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.855 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.1 mttm -99.38 133.9 21.63 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.627 -0.715 . . . . 2.79 110.51 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.95 143.58 61.01 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.5 2.133 . . . . 0.87 111.95 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.86 25.7 75.25 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.049 -0.821 . . . . 0.64000000000000001 111.049 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.855 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.2 158.78 40.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.649 0.262 . . . . 0.82999999999999996 110.468 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.2 139.95 42.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.915 0.388 . . . . 0.5 110.579 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.666 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.3 m-85 -122.56 136.42 54.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.936 -0.575 . . . . 0.53000000000000003 110.81 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.487 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.93 131.03 45.32 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.516 -0.92 . . . . 1.8700000000000001 108.516 177.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.46 153.93 16.64 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.2 -1.0 . . . . 0.28999999999999998 111.97 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -134.98 140.99 46.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.708 -0.478 . . . . 1.4299999999999999 109.708 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.83 118.87 34.22 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.47 -0.492 . . . . 0.32000000000000001 110.523 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.731 HG12 HG23 ' A' ' 84' ' ' VAL . 64.4 mt -112.44 129.14 68.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.289 -0.414 . . . . 0.79000000000000004 110.578 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.7 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.85 120.89 43.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.256 -0.429 . . . . 1.02 110.685 -179.7 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.862 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.59 146.53 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.169 0.509 . . . . 0.62 111.018 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.622 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.08 153.87 21.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.519 -0.764 . . . . 2.4399999999999999 109.935 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.11 88.53 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.909 0.385 . . . . 3.6899999999999999 110.386 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.622 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.67 0.21 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.822 -0.626 . . . . 6.0800000000000001 110.532 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.12 -117.33 3.28 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.394 -0.682 . . . . 1.22 111.394 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.38 177.41 8.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.165 0.507 . . . . 2.8799999999999999 111.646 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.24 149.55 32.1 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.446 -0.797 . . . . 1.47 110.413 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.14 144.63 38.71 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.444 -0.344 . . . . 2.7000000000000002 110.599 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.731 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.97 135.91 61.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 120.69 -0.404 . . . . 0.46000000000000002 111.607 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.0 141.36 52.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.755 -0.657 . . . . 0.34999999999999998 110.325 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.458 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.73 138.91 51.71 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.181 0.515 . . . . 3.6699999999999999 111.478 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.29 164.1 38.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.47 -0.787 . . . . 0.67000000000000004 109.539 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.563 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.23 151.64 38.72 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.412 -0.515 . . . . 1.47 111.005 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.807 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.3 p90 -146.23 172.74 13.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.688 -0.687 . . . . 0.44 111.092 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.77 160.68 21.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.492 -0.777 . . . . 1.3700000000000001 109.887 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.36 121.96 23.1 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.559 -0.456 . . . . 1.28 110.761 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.697 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -130.99 -145.26 0.27 Allowed 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 121.941 0.877 . . . . 1.97 111.478 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.53 ' OG ' HG22 ' A' ' 103' ' ' VAL . 94.9 p -123.08 162.88 21.59 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.191 -1.368 . . . . 3.2799999999999998 107.897 177.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.801 ' O ' HG21 ' A' ' 102' ' ' THR . 27.2 p -74.37 169.01 18.54 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -177.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.669 ' O ' ' O ' ' A' ' 94' ' ' THR . 9.9 t -3.94 -140.84 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -178.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.35 161.91 74.94 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.044 -176.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.727 ' O ' ' O ' ' A' ' 98' ' ' VAL . 21.6 Cg_exo -64.35 -20.66 66.68 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 123.397 2.732 . . . . 0.0 113.155 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.727 ' O ' ' O ' ' A' ' 97' ' ' PRO . 30.4 m -40.92 -135.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.9 m -54.91 -36.77 65.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.029 0.443 . . . . 0.0 110.38 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.487 ' OG ' ' OG1' ' A' ' 94' ' ' THR . 13.5 t -56.38 -30.37 62.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.998 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.712 ' O ' ' OE2' ' A' ' 145' ' ' GLU . 69.8 m-20 63.88 55.97 1.54 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.407 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.801 HG21 ' O ' ' A' ' 94' ' ' THR . 43.1 p -116.95 160.39 20.99 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.53 HG22 ' OG ' ' A' ' 93' ' ' SER . 3.4 m -72.76 -30.93 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.693 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 45.8 m -71.74 136.12 47.04 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.388 -178.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -170.09 -173.94 37.86 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -66.94 -21.17 65.99 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.6 p -76.93 156.15 32.25 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.053 0.454 . . . . 0.0 111.169 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.637 ' N ' ' HD2' ' A' ' 109' ' ' PRO . 65.3 m -78.36 -48.31 1.92 Allowed Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.836 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 108' ' ' THR . 10.1 Cg_endo -52.47 143.98 42.79 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.128 1.885 . . . . 0.0 112.846 -178.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.483 ' O ' ' C ' ' A' ' 111' ' ' SER . 49.3 p90 -137.1 168.25 19.96 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.363 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.483 ' C ' ' O ' ' A' ' 110' ' ' PHE . 15.0 m -23.86 91.83 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.498 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.903 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.422 ' N ' ' O ' ' A' ' 110' ' ' PHE . 47.0 Cg_exo -54.74 149.04 42.59 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 123.001 2.467 . . . . 0.0 112.469 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.813 ' N ' HD22 ' A' ' 113' ' ' LEU . 1.5 mm? -91.45 142.53 27.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.943 -0.571 . . . . 10.19 110.179 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.0 t -117.01 135.58 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.175 -0.466 . . . . 7.2800000000000002 110.453 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.93 142.92 58.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.384 -0.371 . . . . 7.2999999999999998 110.505 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 57.4 p -70.81 -24.16 62.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 6.4400000000000004 111.187 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.6 m -64.26 153.15 39.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.853 0.359 . . . . 4.4199999999999999 110.998 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.01 141.93 56.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.257 -0.429 . . . . 3.0499999999999998 110.34 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 31.1 t -136.74 145.27 44.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.524 -0.307 . . . . 3.4300000000000002 111.14 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.1 p -130.84 140.83 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 109.446 -0.576 . . . . 2.8799999999999999 109.446 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 20.9 p -126.08 161.64 27.15 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.434 0.635 . . . . 2.0899999999999999 112.222 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.2 -24.37 67.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.884 -1.053 . . . . 4.5300000000000002 110.065 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 124' ' ' THR . 80.9 mt -48.78 152.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.316 -0.856 . . . . 1.4399999999999999 111.444 -177.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.403 ' N ' HG22 ' A' ' 123' ' ' ILE . 18.4 p -116.73 167.07 11.42 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.174 -0.921 . . . . 1.78 110.134 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.09 142.91 34.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.44 0.638 . . . . 0.64000000000000001 111.628 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.1 OUTLIER -170.62 23.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 122.746 1.26 . . . . 0.66000000000000003 107.853 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.447 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.78 167.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.005 -1.452 . . . . 0.68999999999999995 111.022 -178.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.6 145.54 50.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.765 -0.652 . . . . 0.52000000000000002 110.14 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.22 101.59 9.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.099 -0.704 . . . . 0.32000000000000001 109.099 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.6 t -112.94 139.7 36.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.071 -0.513 . . . . 0.28999999999999998 111.052 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.3 p -128.62 152.58 48.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.642 -0.708 . . . . 0.25 109.842 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.586 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.4 p90 -144.78 -164.89 2.02 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.736 -0.386 . . . . 0.31 110.708 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.741 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -123.99 127.2 73.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.256 -0.429 . . . . 0.48999999999999999 110.833 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.161 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.99 58.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.075 -0.512 . . . . 1.53 110.332 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.741 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.12 24.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.88 -0.6 . . . . 0.96999999999999997 111.481 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.161 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.2 128.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.619 -0.433 . . . . 1.5600000000000001 110.891 179.782 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.38 -9.7 55.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.896 -0.593 . . . . 1.8799999999999999 110.325 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.07 0.31 55.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.058 -0.519 . . . . 1.04 110.39 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.34 137.17 25.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.919 -0.582 . . . . 0.23999999999999999 109.955 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 185' ' ' ILE . 1.8 m -96.15 -15.51 22.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.313 0.578 . . . . 0.28999999999999998 110.044 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.642 ' H ' HG12 ' A' ' 185' ' ' ILE . . . 178.62 175.63 45.85 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.846 -1.301 . . . . 0.13 109.846 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -123.4 151.57 42.47 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.705 -0.398 . . . . 0.17000000000000001 110.504 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.895 HH21 ' N ' ' A' ' 159' ' ' ASP . 1.5 tpm_? -132.39 121.25 23.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.111 -0.495 . . . . 1.29 109.878 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.559 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.06 136.56 38.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.654 -0.703 . . . . 0.25 110.649 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.712 ' OE2' ' O ' ' A' ' 101' ' ' ASN . 85.3 tt0 -129.37 129.9 45.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.016 -0.538 . . . . 1.3200000000000001 110.0 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.613 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.66 135.31 34.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.928 -0.578 . . . . 0.56999999999999995 110.632 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.415 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.29 161.37 39.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.758 -0.655 . . . . 1.1599999999999999 109.688 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.959 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.06 124.87 25.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.981 0.419 . . . . 0.38 110.72 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.485 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.84 -7.67 49.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.759 -0.655 . . . . 0.40999999999999998 110.886 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.79 -69.74 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 1.6599999999999999 111.429 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.44 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.59 -35.39 75.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.083 -0.508 . . . . 1.6599999999999999 111.441 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.092 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.15 7.24 88.59 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.776 -0.929 . . . . 1.1699999999999999 110.776 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.308 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.4 t0 -27.94 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.759 0.314 . . . . 1.8600000000000001 110.246 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.308 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.32 139.03 44.92 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.947 0.403 . . . . 1.98 110.14 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.48 ' HG2' HG12 ' A' ' 103' ' ' VAL . 47.7 Cg_endo -70.78 145.86 52.37 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 C-N-CA 122.751 2.301 . . . . 0.55000000000000004 112.327 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.88 145.69 42.66 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.223 -0.658 . . . . 1.1399999999999999 109.223 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 143' ' ' ARG . 83.5 m-85 -123.28 141.34 52.09 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.354 -0.539 . . . . 0.93000000000000005 111.54 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.67 ' C ' HH21 ' A' ' 143' ' ' ARG . 70.8 mt -128.09 127.7 43.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.298 -0.865 . . . . 0.34000000000000002 108.935 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.895 ' N ' HH21 ' A' ' 143' ' ' ARG . 55.9 t0 -101.68 131.16 48.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.258 0.551 . . . . 1.0900000000000001 111.661 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.94 157.55 73.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.333 -0.849 . . . . 0.19 109.636 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -69.81 158.02 58.29 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.394 2.063 . . . . 0.17999999999999999 112.238 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.28 -12.12 5.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.806 -0.634 . . . . 0.20999999999999999 110.76 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.8 p -92.8 -8.82 42.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.124 -0.489 . . . . 0.28999999999999998 110.687 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.21 135.31 34.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.383 . . . . 0.5 110.338 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.5 p -133.09 16.75 4.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 0.29999999999999999 110.502 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.9 p -167.64 147.06 4.97 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.627 -0.508 . . . . 0.23000000000000001 109.627 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.559 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.19 150.45 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.398 -0.521 . . . . 0.28000000000000003 111.51 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.28 124.96 50.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.626 -0.716 . . . . 1.0700000000000001 109.81 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.41 104.89 29.78 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.403 -0.362 . . . . 0.28999999999999998 111.094 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.4 Cg_endo -90.98 -179.49 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 123.158 2.572 . . . . 0.42999999999999999 112.198 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.75 32.61 18.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.435 -0.802 . . . . 1.26 111.359 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.428 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.1 mt -86.31 148.5 25.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.54 -0.3 . . . . 0.32000000000000001 110.487 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.764 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.5 mt -88.29 114.8 61.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.986 0.422 . . . . 0.57999999999999996 110.636 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.95 140.51 95.61 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.98 2.453 . . . . 0.66000000000000003 111.93 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.03 21.32 74.18 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.025 -0.83 . . . . 0.28999999999999998 111.025 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.44 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.86 150.21 49.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.864 0.364 . . . . 2.3300000000000001 110.589 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.485 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.2 131.65 46.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.993 -0.549 . . . . 0.85999999999999999 109.801 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.959 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.5 m-85 -120.5 148.37 43.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.069 -0.514 . . . . 0.52000000000000002 110.999 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.39 125.27 60.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.243 -1.021 . . . . 0.29999999999999999 108.243 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.49 132.59 63.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.211 0.529 . . . . 0.23000000000000001 111.227 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.59 20.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.526 -0.761 . . . . 0.35999999999999999 109.622 179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.586 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -101.07 125.38 55.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.293 -0.412 . . . . 0.19 110.711 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.8 m-85 -117.21 137.92 52.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.967 -0.56 . . . . 0.29999999999999999 109.866 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.425 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.78 135.07 42.8 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.763 -0.829 . . . . 0.37 108.763 178.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.642 HG12 ' H ' ' A' ' 141' ' ' GLY . 0.8 OUTLIER -99.08 122.89 51.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.175 0.512 . . . . 0.26000000000000001 110.938 -178.718 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.6 p -83.84 169.66 14.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.586 -0.734 . . . . 0.28000000000000003 110.408 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.414 ' O ' ' HB ' ' A' ' 59' ' ' THR . 97.0 mt-10 -59.72 -14.52 14.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.959 -0.564 . . . . 1.6000000000000001 111.023 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -96.12 -4.27 43.07 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.779 -0.368 . . . . 1.1799999999999999 110.793 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.84 13.92 63.86 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.346 -0.702 . . . . 0.29999999999999999 111.346 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -84.59 139.09 32.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.574 0.225 . . . . 1.22 110.433 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.577 HE22 ' HG3' ' A' ' 15' ' ' PRO . 83.8 mt-30 -106.82 141.08 38.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.373 . . . . 0.97999999999999998 110.545 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.8 m -136.74 127.03 26.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.093 -0.503 . . . . 0.82999999999999996 110.374 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.07 117.3 9.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.26000000000000001 110.53 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.07 -21.75 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.29999999999999999 110.7 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.92 125.7 5.84 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.489 -0.484 . . . . 0.31 111.514 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.47 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.68 120.2 21.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.685 -0.689 . . . . 0.28000000000000003 109.563 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.6 151.68 29.13 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.692 -0.403 . . . . 0.23999999999999999 110.943 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.43 158.59 18.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 0.23000000000000001 110.409 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -146.1 157.91 43.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.099 -0.501 . . . . 0.67000000000000004 110.66 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.37 9.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.732 -0.667 . . . . 0.64000000000000001 109.995 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.5 p . . . . . 0 C--O 1.218 -0.555 0 CA-C-O 117.949 -1.024 . . . . 1.26 110.531 -179.673 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.8 m . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.253 -0.647 . . . . 3.4399999999999999 109.253 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.36 150.69 18.54 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.986 -0.846 . . . . 1.22 110.986 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -35.67 142.39 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 123.953 3.102 . . . . 0.75 113.789 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -80.0 173.38 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.282 -1.326 . . . . 0.79000000000000004 108.9 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.608 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.59 125.88 51.49 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.395 -0.522 . . . . 1.9399999999999999 111.413 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.46 144.03 33.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.63 -0.714 . . . . 0.59999999999999998 110.686 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.02 168.36 25.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.947 0.403 . . . . 3.1400000000000001 111.117 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.745 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.08 130.94 61.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.983 -0.553 . . . . 3.23 110.013 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.5 p -141.03 162.3 35.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.85 0.357 . . . . 3.6299999999999999 111.226 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 9' ' ' THR . 70.6 tt0 36.13 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.624 -0.509 . . . . 6.0800000000000001 109.624 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.745 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.57 33.07 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.968 -0.56 . . . . 3.3799999999999999 111.637 -178.824 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.22 -29.12 73.32 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.453 2.102 . . . . 3.9300000000000002 111.872 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 3.3599999999999999 110.422 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 17' ' ' SER . 3.3 mp0 -123.86 158.4 60.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 3.6099999999999999 110.438 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.586 ' N ' ' OG ' ' A' ' 93' ' ' SER . 98.1 Cg_endo -82.13 -64.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.81 2.34 . . . . 1.51 113.592 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.521 ' ND2' ' HB2' ' A' ' 157' ' ' TYR . 72.8 m-20 -108.47 -19.47 13.44 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.107 0.41 . . . . 2.6800000000000002 112.107 -178.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 4.9 p -107.47 152.05 24.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.18 0.514 . . . . 1.21 111.277 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.26 102.89 2.23 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.622 -0.717 . . . . 1.5600000000000001 110.637 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.535 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.7 Cg_endo -82.71 145.66 12.97 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.851 2.368 . . . . 0.81000000000000005 112.595 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.916 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.83 167.99 24.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.833 -0.621 . . . . 1.52 109.864 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -149.17 147.88 28.98 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.781 -0.451 . . . . 2.1400000000000001 109.781 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.583 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.27 157.32 44.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.078 0.466 . . . . 0.32000000000000001 111.177 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.502 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.09 155.23 44.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.766 -0.652 . . . . 2.1699999999999999 110.033 179.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.838 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.58 173.1 6.28 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.037 -0.529 . . . . 0.58999999999999997 110.747 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.838 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.66 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.858 2.372 . . . . 0.90000000000000002 111.548 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.483 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.05 -51.11 0.69 Allowed Pre-proline 0 C--N 1.33 -0.271 0 C-N-CA 120.687 -0.405 . . . . 3.3399999999999999 110.01 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.643 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.4 Cg_exo -64.77 152.35 82.36 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.751 2.301 . . . . 1.8500000000000001 111.484 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.77 42.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.363 0.602 . . . . 2.54 110.581 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.643 ' N ' ' O ' ' A' ' 27' ' ' PRO . 74.1 t60 -63.69 -41.69 98.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.969 -1.014 . . . . 2.5299999999999998 110.55 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.559 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.3 mt -109.82 137.91 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.846 -0.615 . . . . 1.1699999999999999 111.258 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.06 -72.96 0.7 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.978 -0.555 . . . . 1.27 111.828 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.19 148.31 24.45 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.583 0.586 . . . . 1.1200000000000001 112.583 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.82 124.92 45.31 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.302 -0.629 . . . . 0.41999999999999998 109.302 177.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 49' ' ' ALA . 72.0 mt -118.09 134.83 60.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.616 -0.434 . . . . 0.78000000000000003 110.604 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.916 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.08 128.56 53.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.62 111.243 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.54 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.11 139.07 49.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.757 -0.656 . . . . 1.97 110.064 179.006 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.437 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.18 163.1 35.41 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 121.176 0.512 . . . . 0.34999999999999998 112.014 -178.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.42 139.62 7.93 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.448 -0.796 . . . . 1.8 110.449 178.852 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.696 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.55 115.5 3.08 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.251 1.968 . . . . 0.57999999999999996 111.85 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.673 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.95 81.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.908 -0.405 . . . . 3.04 109.908 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.696 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.2 -20.73 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.034 -0.53 . . . . 2.4700000000000002 112.03 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.6 p -157.6 157.74 34.24 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.879 -0.328 . . . . 2.5099999999999998 110.599 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.8 m -120.37 27.83 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 1.8600000000000001 110.207 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.83 -75.9 1.31 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.121 -0.562 . . . . 1.4399999999999999 111.886 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.83 152.29 35.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.073 0.463 . . . . 4.6900000000000004 110.919 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.2 -169.14 2.54 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.991 -0.55 . . . . 1.4299999999999999 111.997 179.292 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.09 149.61 29.78 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-O 121.431 0.634 . . . . 1.74 112.684 -177.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.96 156.52 46.05 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 114.809 -1.087 . . . . 1.9199999999999999 110.302 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.2 158.43 41.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.872 -0.604 . . . . 0.34000000000000002 111.785 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.7 m -115.25 135.55 54.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.517 -0.765 . . . . 0.40999999999999998 109.755 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.583 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.4 121.97 23.78 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.433 -0.348 . . . . 0.55000000000000004 111.584 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.593 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.4 Cg_exo -46.28 151.72 1.6 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.73 2.287 . . . . 0.44 112.12 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.93 -23.02 63.09 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 116.055 -0.521 . . . . 0.73999999999999999 112.785 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.77 -16.89 46.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.407 0.604 . . . . 0.93000000000000005 111.803 -178.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.593 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.2 mt -91.57 138.41 31.59 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.841 -0.344 . . . . 0.96999999999999997 110.348 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.58 13.91 10.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.364 -0.38 . . . . 1.3400000000000001 111.544 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -149.98 143.46 25.22 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.714 -0.394 . . . . 0.39000000000000001 111.003 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.724 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.8 -169.37 1.53 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.071 -0.513 . . . . 0.41999999999999998 110.942 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.724 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 t -151.81 125.86 9.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.443 -0.799 . . . . 0.39000000000000001 109.816 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.519 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.86 123.4 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.312 -0.555 . . . . 0.73999999999999999 111.195 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.694 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 63.1 pttt -126.63 163.37 23.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.782 -0.644 . . . . 2.48 110.402 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.12 19.03 59.8 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.733 -0.947 . . . . 0.5 110.733 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.519 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.3 mt -78.97 157.18 28.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.045 0.45 . . . . 0.57999999999999996 111.378 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.844 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -99.48 133.87 21.6 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.62 -0.718 . . . . 2.79 110.486 179.737 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.8 143.5 61.54 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.594 2.196 . . . . 0.87 111.988 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.93 25.59 75.4 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.034 -0.826 . . . . 0.64000000000000001 111.034 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.18 158.74 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.73 0.3 . . . . 0.82999999999999996 110.409 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.12 139.97 41.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.926 0.394 . . . . 0.5 110.522 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.647 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.8 m-85 -122.59 136.43 54.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.986 -0.552 . . . . 0.53000000000000003 110.757 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.91 131.01 45.31 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.463 -0.94 . . . . 1.8700000000000001 108.463 177.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.494 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.43 153.9 16.63 Favored Glycine 0 C--O 1.228 -0.269 0 C-N-CA 120.357 -0.925 . . . . 0.28999999999999998 111.968 -178.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -135.08 140.85 45.85 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.723 -0.473 . . . . 1.4299999999999999 109.723 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.2 tp -115.7 118.93 34.43 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.483 -0.487 . . . . 0.32000000000000001 110.573 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.732 HG12 HG23 ' A' ' 84' ' ' VAL . 64.2 mt -112.55 129.09 68.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.409 . . . . 0.79000000000000004 110.603 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.701 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.78 120.74 43.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.259 -0.428 . . . . 1.02 110.739 -179.599 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.855 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.58 146.5 11.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.098 0.475 . . . . 0.62 111.058 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.622 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.11 153.91 21.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.505 -0.771 . . . . 2.4399999999999999 109.835 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.18 88.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.928 0.395 . . . . 3.6899999999999999 110.381 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.622 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.859 -0.609 . . . . 6.0800000000000001 110.549 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.09 -117.36 3.29 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.43 -0.668 . . . . 1.22 111.43 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -81.29 177.41 9.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.182 0.515 . . . . 2.8799999999999999 111.638 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.27 149.5 31.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.466 -0.788 . . . . 1.47 110.425 179.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.21 144.67 38.61 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.482 -0.326 . . . . 2.7000000000000002 110.576 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.732 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.02 136.0 61.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 121.139 0.495 . . . . 0.46000000000000002 111.499 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.574 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.09 141.45 52.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.622 -0.717 . . . . 0.34999999999999998 110.248 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.457 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.75 138.91 51.72 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 120.492 -0.483 . . . . 3.6699999999999999 111.438 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.494 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.28 164.18 37.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.545 -0.752 . . . . 0.67000000000000004 109.521 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.27 151.54 38.52 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.327 -0.549 . . . . 1.47 111.009 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.797 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.2 172.75 12.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.743 -0.662 . . . . 0.44 111.033 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.77 160.7 21.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.459 -0.791 . . . . 1.3700000000000001 109.806 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.34 121.91 23.05 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.54 -0.464 . . . . 1.28 110.749 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.512 ' O ' ' OG ' ' A' ' 93' ' ' SER . 70.3 p -128.92 -114.48 0.26 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.392 0.886 . . . . 1.97 113.392 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.586 ' OG ' ' N ' ' A' ' 15' ' ' PRO . 48.0 p 72.39 63.87 0.12 Allowed 'General case' 0 C--N 1.343 0.317 0 CA-C-N 114.956 -1.02 . . . . 3.2799999999999998 110.789 -178.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.6 p -120.16 165.54 14.63 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.823 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.5 m -56.34 -33.6 65.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.062 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.7 p -124.5 77.36 62.86 Favored Pre-proline 0 N--CA 1.466 0.354 0 CA-C-O 120.507 0.194 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.62 147.27 88.04 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.612 2.208 . . . . 0.0 112.138 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.7 m -68.23 -27.95 38.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.2 m -57.61 -36.9 72.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.935 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.2 t 62.83 12.6 5.86 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.665 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -104.04 143.85 32.34 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.723 0.297 . . . . 0.0 110.297 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.2 t -133.86 160.01 38.93 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.433 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.668 HG22 ' H ' ' A' ' 105' ' ' GLY . 11.7 p -130.01 143.53 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.497 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 56.2 p -67.81 -9.45 44.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.371 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.668 ' H ' HG22 ' A' ' 103' ' ' VAL . . . -51.98 -32.33 34.37 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -58.01 142.8 45.49 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.551 -0.459 . . . . 0.0 109.888 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.5 p -123.24 160.9 25.62 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.084 0.469 . . . . 0.0 111.221 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.613 ' O ' ' CD2' ' A' ' 110' ' ' PHE . 25.0 m -126.65 78.88 72.32 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.783 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.6 -23.06 69.71 Favored 'Trans proline' 0 N--CA 1.499 1.794 0 C-N-CA 122.335 2.024 . . . . 0.0 113.303 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.613 ' CD2' ' O ' ' A' ' 108' ' ' THR . 94.3 m-85 62.78 31.45 16.49 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.0 p -123.44 75.61 53.43 Favored Pre-proline 0 N--CA 1.465 0.31 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.127 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.479 ' O ' ' N ' ' A' ' 114' ' ' VAL . 63.9 Cg_endo -75.62 -57.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.376 2.05 . . . . 0.0 111.691 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.5 mt 38.16 26.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.975 -0.557 . . . . 10.19 111.425 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 112' ' ' PRO . 31.3 m -67.34 134.69 29.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 7.2800000000000002 110.593 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.72 144.2 32.8 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.12 -0.491 . . . . 7.2999999999999998 110.586 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 118' ' ' GLU . 40.0 m -122.59 139.27 54.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.298 -0.41 . . . . 6.4400000000000004 110.153 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 119' ' ' SER . 23.2 m -59.02 -36.53 75.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.376 0.509 . . . . 4.4199999999999999 112.376 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 117' ' ' SER . 96.7 mt-10 30.29 35.32 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 111.953 0.353 . . . . 3.0499999999999998 111.953 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 117' ' ' SER . 22.3 m -57.4 -37.3 72.5 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.617 -0.433 . . . . 3.4300000000000002 110.516 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.9 t -123.16 134.13 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 109.539 -0.541 . . . . 2.8799999999999999 109.539 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.9 m -58.93 -41.22 86.83 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.655 -0.418 . . . . 2.0899999999999999 111.018 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -127.05 151.08 49.08 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.491 -0.322 . . . . 4.5300000000000002 111.036 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 71.5 mt -116.77 132.0 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.709 -0.478 . . . . 1.4399999999999999 109.709 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 42.8 m -58.98 -40.2 84.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.42 . . . . 1.78 111.663 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -106.8 144.9 32.78 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.888 0.375 . . . . 0.64000000000000001 111.266 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.3 p -62.89 -28.4 70.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.422 0.629 . . . . 0.66000000000000003 109.672 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.439 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.77 167.57 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.427 -0.806 . . . . 0.68999999999999995 110.983 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.65 145.47 50.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.809 -0.632 . . . . 0.52000000000000002 110.133 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.19 101.44 9.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.165 -0.68 . . . . 0.32000000000000001 109.165 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.5 t -112.87 139.71 36.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.094 -0.503 . . . . 0.28999999999999998 111.09 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 p -128.69 152.59 48.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.59 -0.732 . . . . 0.25 109.75 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.585 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.84 -164.88 2.02 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.641 -0.423 . . . . 0.31 110.675 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -123.98 127.22 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.436 . . . . 0.48999999999999999 110.82 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.169 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -58.06 58.4 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.123 -0.49 . . . . 1.53 110.368 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.17 24.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.809 -0.632 . . . . 0.96999999999999997 111.437 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.169 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.14 128.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.646 -0.422 . . . . 1.5600000000000001 111.036 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.41 -9.59 56.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.935 -0.575 . . . . 1.8799999999999999 110.295 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.22 0.38 55.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 1.04 110.286 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.22 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.23999999999999999 109.938 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.694 ' O ' ' NZ ' ' A' ' 61' ' ' LYS . 70.5 m -96.24 -15.58 21.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.256 0.55 . . . . 0.28999999999999998 110.022 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.62 175.61 45.83 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 109.858 -1.297 . . . . 0.13 109.858 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.49 151.61 42.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.961 0.41 . . . . 0.17000000000000001 110.426 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.75 HH12 ' NE2' ' A' ' 191' ' ' GLN . 50.8 ttp180 -132.31 121.16 23.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.119 -0.491 . . . . 1.29 109.918 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.563 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.05 136.49 38.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.761 -0.654 . . . . 0.25 110.693 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.525 ' HG2' ' CD2' ' A' ' 157' ' ' TYR . 94.4 mt-10 -129.36 129.86 45.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.06 -0.518 . . . . 1.3200000000000001 110.056 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.613 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.67 135.27 34.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.987 -0.552 . . . . 0.56999999999999995 110.622 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.407 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.28 161.34 39.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.751 -0.659 . . . . 1.1599999999999999 109.665 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.967 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.5 mt -70.92 124.76 25.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.975 0.417 . . . . 0.38 110.735 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.486 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.7 p -71.71 -7.79 50.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.768 -0.651 . . . . 0.40999999999999998 110.833 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -109.81 -69.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.295 -0.411 . . . . 1.6599999999999999 111.332 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.429 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.64 -35.39 76.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.106 -0.497 . . . . 1.6599999999999999 111.469 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.074 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.1 7.23 88.59 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.853 -0.899 . . . . 1.1699999999999999 110.853 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.331 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.89 -171.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.753 0.311 . . . . 1.8600000000000001 110.365 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.331 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.23 139.11 45.24 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.965 0.412 . . . . 1.98 110.23 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.419 ' HG2' ' OH ' ' A' ' 157' ' ' TYR . 46.4 Cg_endo -70.94 145.76 51.17 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.762 2.308 . . . . 0.55000000000000004 112.332 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.77 145.76 42.52 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.24 -0.652 . . . . 1.1399999999999999 109.24 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.702 ' N ' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -123.37 141.3 52.13 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.312 -0.555 . . . . 0.93000000000000005 111.5 -179.048 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.3 mt -128.04 127.67 43.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.333 -0.848 . . . . 0.34000000000000002 109.016 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -101.73 131.21 48.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.15 0.5 . . . . 1.0900000000000001 111.708 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.94 157.64 73.15 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.273 -0.876 . . . . 0.19 109.54 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.9 157.99 58.27 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.376 2.051 . . . . 0.17999999999999999 112.282 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.3 -12.1 5.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 0.20999999999999999 110.743 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.1 p -92.83 -8.75 42.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.28999999999999998 110.722 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.15 135.33 34.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.406 . . . . 0.5 110.428 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 p -133.17 16.75 4.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.478 -0.328 . . . . 0.29999999999999999 110.506 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.9 p -167.57 147.09 5.05 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.598 -0.519 . . . . 0.23000000000000001 109.598 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.563 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.14 150.48 12.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.508 -0.477 . . . . 0.28000000000000003 111.589 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.501 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 124.97 50.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.596 -0.729 . . . . 1.0700000000000001 109.78 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.46 104.86 29.79 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.872 0.368 . . . . 0.28999999999999998 111.025 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.2 Cg_endo -90.96 -179.53 1.51 Allowed 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 123.216 2.611 . . . . 0.42999999999999999 112.203 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 61.7 32.66 18.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.374 -0.83 . . . . 1.26 111.403 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 172' ' ' LEU . 24.1 mt -86.42 148.52 25.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.444 -0.343 . . . . 0.32000000000000001 110.471 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.774 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.8 mt -88.28 114.96 61.75 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.06 0.457 . . . . 0.57999999999999996 110.677 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.14 140.6 95.71 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.824 2.349 . . . . 0.66000000000000003 112.026 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.23 74.23 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.046 -0.822 . . . . 0.28999999999999998 111.046 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.429 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.91 150.22 49.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.803 0.335 . . . . 2.3300000000000001 110.641 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.486 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.2 131.63 46.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.008 -0.542 . . . . 0.85999999999999999 109.756 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.967 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.2 m-85 -120.5 148.27 44.05 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.105 -0.498 . . . . 0.52000000000000002 111.062 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.7 mt -105.36 125.38 60.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.194 -1.039 . . . . 0.29999999999999999 108.194 177.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.54 132.52 63.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.172 0.511 . . . . 0.23000000000000001 111.3 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.47 122.62 20.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.549 -0.751 . . . . 0.35999999999999999 109.613 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.585 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.1 125.35 55.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.268 -0.424 . . . . 0.19 110.622 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.28 137.91 52.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.946 -0.57 . . . . 0.29999999999999999 109.84 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.427 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.63 135.07 42.65 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.745 -0.835 . . . . 0.37 108.745 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.573 ' O ' ' N ' ' A' ' 140' ' ' SER . 47.2 mm -99.1 122.93 51.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.155 0.502 . . . . 0.26000000000000001 110.969 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.5 p -83.91 169.59 14.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.591 -0.731 . . . . 0.28000000000000003 110.496 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -59.62 -14.56 14.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.046 -0.524 . . . . 1.6000000000000001 110.966 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.535 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.6 m-20 -96.13 -4.29 43.01 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.905 -0.318 . . . . 1.1799999999999999 110.749 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.86 13.78 64.06 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.389 -0.684 . . . . 0.29999999999999999 111.389 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -84.59 139.01 32.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.625 0.25 . . . . 1.22 110.415 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.75 ' NE2' HH12 ' A' ' 143' ' ' ARG . 3.3 mt-30 -106.68 141.15 38.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.339 . . . . 0.97999999999999998 110.565 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 61.9 m -136.72 127.04 26.49 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.216 -0.447 . . . . 0.82999999999999996 110.383 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.14 117.43 9.96 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.699 -0.401 . . . . 0.26000000000000001 110.519 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.1 -21.73 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.29999999999999999 110.767 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.98 125.72 5.81 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.422 -0.511 . . . . 0.31 111.448 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.475 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.69 120.2 21.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.787 -0.642 . . . . 0.28000000000000003 109.601 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.62 151.68 29.1 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.757 -0.377 . . . . 0.23999999999999999 110.916 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.5 158.56 18.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.002 -0.545 . . . . 0.23000000000000001 110.438 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -146.02 157.89 43.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.119 -0.491 . . . . 0.67000000000000004 110.609 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.29 104.39 9.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.779 -0.646 . . . . 0.64000000000000001 110.069 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.99 -1.005 . . . . 1.26 110.56 -179.578 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.208 -0.664 . . . . 3.4399999999999999 109.208 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.69 18.54 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.032 -0.827 . . . . 1.22 111.032 179.729 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -35.66 142.4 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.042 0 C-N-CA 123.97 3.113 . . . . 0.75 113.826 -179.218 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.0 t -79.98 173.33 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.308 -1.315 . . . . 0.79000000000000004 108.846 178.431 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.614 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.55 125.87 51.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.435 -0.506 . . . . 1.9399999999999999 111.393 -179.538 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 144.01 33.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.628 -0.715 . . . . 0.59999999999999998 110.564 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.98 168.4 25.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.319 -0.401 . . . . 3.1400000000000001 111.131 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.746 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -109.06 131.1 60.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.98 -0.554 . . . . 3.23 110.048 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.14 162.25 35.94 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.442 -0.345 . . . . 3.6299999999999999 111.284 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.4 mt-10 36.21 31.51 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.607 -0.516 . . . . 6.0800000000000001 109.607 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.746 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.58 32.55 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.019 -0.537 . . . . 3.3799999999999999 111.558 -178.737 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.637 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.29 -29.14 72.69 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.494 2.129 . . . . 3.9300000000000002 111.854 179.395 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.637 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.65 125.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.016 -0.538 . . . . 3.3599999999999999 110.502 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.525 ' CB ' ' O ' ' A' ' 17' ' ' SER . 9.6 mp0 -123.91 158.33 60.43 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.368 -0.378 . . . . 3.6099999999999999 110.486 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.474 ' HG3' ' CZ ' ' A' ' 143' ' ' ARG . 97.6 Cg_endo -82.11 -64.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.808 2.339 . . . . 1.51 113.446 -178.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.789 HD22 ' CA ' ' A' ' 62' ' ' GLY . 14.5 t-20 -108.42 -19.54 13.42 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.087 0.403 . . . . 2.6800000000000002 112.087 -178.496 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 27.2 m -107.33 152.07 24.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.214 0.531 . . . . 1.21 111.256 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.0 t-80 -155.22 102.91 2.24 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.705 -0.68 . . . . 1.5600000000000001 110.66 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.5 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.4 Cg_endo -82.6 145.59 13.12 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.882 2.388 . . . . 0.81000000000000005 112.676 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.933 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.77 167.99 24.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 1.52 109.982 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.14 147.95 29.07 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.75 -0.463 . . . . 2.1400000000000001 109.75 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.27 157.28 45.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.017 0.437 . . . . 0.32000000000000001 111.242 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.497 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.8 m-20 -127.96 155.3 44.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.786 -0.643 . . . . 2.1699999999999999 110.132 178.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.835 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.66 173.06 6.33 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 121.14 0.495 . . . . 0.58999999999999997 110.666 -179.214 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.835 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.66 173.88 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.882 2.388 . . . . 0.90000000000000002 111.506 179.338 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.06 -50.93 0.69 Allowed Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 120.717 -0.393 . . . . 3.3399999999999999 110.134 179.902 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.62 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.8 Cg_exo -64.96 152.43 82.35 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.697 2.264 . . . . 1.8500000000000001 111.451 179.187 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.77 42.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.385 0.612 . . . . 2.54 110.518 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.62 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.8 t60 -63.67 -41.68 98.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.02 -0.991 . . . . 2.5299999999999998 110.722 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.565 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.5 mt -109.78 137.86 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.723 -0.672 . . . . 1.1699999999999999 111.311 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.98 -72.82 0.71 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.013 -0.54 . . . . 1.27 111.92 -178.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.23 148.4 24.37 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.593 0.59 . . . . 1.1200000000000001 112.593 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.85 124.74 44.84 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.413 -0.588 . . . . 0.41999999999999998 109.413 177.514 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 mt -117.88 134.72 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.666 -0.414 . . . . 0.78000000000000003 110.701 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.933 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.02 128.55 53.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 0.62 111.228 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.15 138.99 49.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.708 -0.678 . . . . 1.97 110.11 178.974 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -144.99 163.23 34.83 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.152 0.501 . . . . 0.34999999999999998 112.066 -178.081 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.488 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.59 139.65 7.81 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.435 -0.802 . . . . 1.8 110.397 178.808 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.66 115.54 3.12 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.284 1.989 . . . . 0.57999999999999996 111.793 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.683 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.03 81.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.899 -0.408 . . . . 3.04 109.899 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.688 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.22 -20.54 0.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.969 -0.56 . . . . 2.4700000000000002 111.9 -179.526 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 p -157.65 157.69 34.05 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 120.855 -0.338 . . . . 2.5099999999999998 110.569 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.403 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.3 27.79 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.249 -0.432 . . . . 1.8600000000000001 110.223 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.79 -75.91 1.31 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.184 -0.531 . . . . 1.4399999999999999 111.831 -179.246 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.93 152.31 35.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.981 0.419 . . . . 4.6900000000000004 110.939 -179.285 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.669 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.2 -169.14 2.54 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.001 -0.545 . . . . 1.4299999999999999 111.873 179.415 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.6 mttp -110.13 149.66 29.74 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.48 0.657 . . . . 1.74 112.568 -177.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.01 156.42 46.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.757 -1.111 . . . . 1.9199999999999999 110.325 178.638 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.21 158.27 41.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.978 -0.555 . . . . 0.34000000000000002 111.788 -179.296 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.8 m -115.07 135.58 54.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.502 -0.772 . . . . 0.40999999999999998 109.889 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.596 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.33 121.96 23.86 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.422 -0.353 . . . . 0.55000000000000004 111.588 -179.171 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.607 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.3 Cg_exo -46.29 151.7 1.62 Allowed 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.706 2.271 . . . . 0.44 112.181 178.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.01 -23.02 63.28 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 116.133 -0.485 . . . . 0.73999999999999999 112.708 -179.107 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.78 -16.79 46.49 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.223 -0.591 . . . . 0.93000000000000005 111.854 -178.341 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.607 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.6 138.45 31.56 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.779 -0.368 . . . . 0.96999999999999997 110.321 179.338 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.54 13.79 10.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.433 -0.349 . . . . 1.3400000000000001 111.475 -179.285 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.477 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.91 143.56 25.35 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.591 -0.444 . . . . 0.39000000000000001 111.003 179.633 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.4 t80 -114.88 -169.41 1.54 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.127 0.489 . . . . 0.41999999999999998 110.904 -179.455 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.714 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.74 125.85 9.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.408 -0.815 . . . . 0.39000000000000001 109.805 179.288 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.515 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.77 123.21 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.415 -0.514 . . . . 0.73999999999999999 111.268 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.869 ' HZ3' ' CD1' ' A' ' 185' ' ' ILE . 50.4 tttp -126.5 163.4 23.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.884 -0.598 . . . . 2.48 110.431 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.789 ' CA ' HD22 ' A' ' 16' ' ' ASN . . . 85.15 19.02 59.78 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.737 -0.945 . . . . 0.5 110.737 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.523 ' N ' ' ND2' ' A' ' 16' ' ' ASN . 73.5 mt -79.09 157.18 28.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.077 0.465 . . . . 0.57999999999999996 111.327 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.844 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -99.41 134.05 21.5 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.525 -0.762 . . . . 2.79 110.49 179.722 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.587 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -68.03 143.66 60.89 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.463 2.109 . . . . 0.87 111.908 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.79 25.64 75.32 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.031 -0.828 . . . . 0.64000000000000001 111.031 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.15 158.8 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.735 0.302 . . . . 0.82999999999999996 110.369 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.09 139.94 41.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.333 -0.394 . . . . 0.5 110.565 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.648 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.58 136.46 54.89 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.954 -0.566 . . . . 0.53000000000000003 110.82 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.98 131.06 45.32 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.481 -0.933 . . . . 1.8700000000000001 108.481 177.67 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.5 153.87 16.65 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.221 -0.99 . . . . 0.28999999999999998 111.935 -178.566 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -134.93 140.94 46.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.648 -0.501 . . . . 1.4299999999999999 109.648 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.2 tp -115.79 118.86 34.21 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.488 -0.485 . . . . 0.32000000000000001 110.524 179.64 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 84' ' ' VAL . 63.8 mt -112.4 129.08 68.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 0.79000000000000004 110.66 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.703 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.82 120.89 43.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.261 -0.427 . . . . 1.02 110.701 -179.649 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.857 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.55 146.44 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.184 0.516 . . . . 0.62 111.001 -179.284 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.623 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.06 153.82 21.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.499 -0.773 . . . . 2.4399999999999999 109.974 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.23 88.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.959 0.409 . . . . 3.6899999999999999 110.433 -179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.43 32.56 0.23 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.74 -0.664 . . . . 6.0800000000000001 110.604 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.16 -117.33 3.28 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.443 -0.663 . . . . 1.22 111.443 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.48 177.42 8.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.157 0.503 . . . . 2.8799999999999999 111.655 -179.131 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.17 149.59 32.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.468 -0.787 . . . . 1.47 110.35 179.181 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.2 144.62 38.59 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.386 -0.37 . . . . 2.7000000000000002 110.527 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.727 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.94 136.01 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 121.032 0.444 . . . . 0.46000000000000002 111.617 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.1 141.35 52.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.634 -0.712 . . . . 0.34999999999999998 110.285 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.471 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.62 138.87 51.67 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.085 0.469 . . . . 3.6699999999999999 111.535 -179.354 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.28 164.15 38.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.524 -0.762 . . . . 0.67000000000000004 109.53 179.371 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.565 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.22 151.52 38.53 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.411 -0.516 . . . . 1.47 111.049 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.807 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.2 p90 -146.19 172.73 13.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.781 -0.645 . . . . 0.44 111.053 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.73 160.67 21.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.414 -0.812 . . . . 1.3700000000000001 109.841 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.47 121.9 22.88 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.563 -0.455 . . . . 1.28 110.768 179.927 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.413 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -128.28 151.03 49.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.051 -0.522 . . . . 1.97 111.421 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.8 t -65.0 -43.19 93.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.357 0.599 . . . . 3.2799999999999998 110.337 177.66 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.7 p -130.62 165.15 23.42 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.06 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.0 t -58.91 -36.72 75.19 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.503 -0.479 . . . . 0.0 109.917 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 48.9 p -129.99 77.15 77.1 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.281 179.429 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -58.14 143.89 96.04 Favored 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.905 2.403 . . . . 0.0 113.37 -178.894 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.9 m -113.25 14.2 8.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.643 178.621 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.417 HG23 ' N ' ' A' ' 100' ' ' SER . 8.7 t -56.04 -38.79 71.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.506 -179.184 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.417 ' N ' HG23 ' A' ' 99' ' ' THR . 91.9 p -58.88 -30.24 67.6 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.366 -179.319 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 56.63 43.79 24.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.825 179.105 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.447 HG23 ' N ' ' A' ' 103' ' ' VAL . 10.2 t -58.67 -39.75 81.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.79 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.447 ' N ' HG23 ' A' ' 102' ' ' THR . 77.5 t -60.51 -38.12 77.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.851 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 38.8 m -72.71 138.16 46.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.024 0.44 . . . . 0.0 111.059 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 96.5 -2.62 62.88 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -68.75 -23.31 64.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.999 0.428 . . . . 0.0 110.492 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 30.1 p -79.98 160.62 25.85 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.116 -179.429 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.418 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 90.8 m -52.15 -45.57 93.86 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.163 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 108' ' ' THR . 58.2 Cg_exo -50.76 142.96 30.96 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.719 1.612 . . . . 0.0 112.689 -179.228 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.423 ' CD2' ' O ' ' A' ' 111' ' ' SER . 68.0 t80 -101.47 135.49 42.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.06 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.423 ' O ' ' CD2' ' A' ' 110' ' ' PHE . 5.2 t -59.45 147.37 76.92 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 120.936 -0.305 . . . . 0.0 110.52 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.7 146.66 34.12 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.264 1.976 . . . . 0.0 113.003 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 70.8 mt -60.01 -33.31 71.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.478 -0.783 . . . . 10.19 110.73 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.583 ' O ' ' CB ' ' A' ' 115' ' ' ALA . 45.9 t -107.9 135.38 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.267 -0.424 . . . . 7.2800000000000002 110.931 -178.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 114' ' ' VAL . . . 114.0 -29.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.326 1.016 . . . . 7.2999999999999998 109.698 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.2 p -73.3 -15.51 61.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.853 -0.612 . . . . 6.4400000000000004 110.641 179.522 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.9 m -60.75 155.25 19.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.111 -0.495 . . . . 4.4199999999999999 111.156 -179.046 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -61.89 -32.22 72.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.641 -0.708 . . . . 3.0499999999999998 111.357 -179.503 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 31.8 t -112.67 139.85 47.93 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.985 0.421 . . . . 3.4300000000000002 110.967 -179.517 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 40.4 t -123.47 138.58 52.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.499 -0.773 . . . . 2.8799999999999999 110.436 -179.875 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 24.6 p -77.23 161.2 28.34 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.538 -0.541 . . . . 2.0899999999999999 109.538 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -85.31 124.38 31.86 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.347 -0.541 . . . . 4.5300000000000002 111.246 -178.71 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.496 HG22 ' HB3' ' A' ' 125' ' ' ALA . 76.6 mt -68.97 -30.36 46.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.663 -0.699 . . . . 1.4399999999999999 110.153 178.628 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 43.5 p 49.46 42.28 22.28 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.771 -0.649 . . . . 1.78 110.598 -178.717 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.496 ' HB3' HG22 ' A' ' 123' ' ' ILE . . . -151.35 165.68 33.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.928 -0.578 . . . . 0.64000000000000001 110.755 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.3 OUTLIER 54.32 19.26 2.17 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.878 -0.601 . . . . 0.66000000000000003 112.286 178.883 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.441 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.9 167.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.064 -0.516 . . . . 0.68999999999999995 110.931 179.124 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.66 145.52 50.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.772 -0.649 . . . . 0.52000000000000002 110.111 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.29 101.62 9.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.087 -0.708 . . . . 0.32000000000000001 109.087 177.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.4 t -112.85 139.67 36.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.015 -0.538 . . . . 0.28999999999999998 111.129 -178.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.4 p -128.72 152.49 48.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.692 -0.685 . . . . 0.25 109.852 179.606 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.72 -164.84 2.01 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.705 -0.398 . . . . 0.31 110.678 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.734 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.3 t -124.01 127.17 73.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 0.48999999999999999 110.799 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.172 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.95 58.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.138 -0.483 . . . . 1.53 110.283 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.07 24.4 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.003 -0.544 . . . . 0.96999999999999997 111.442 -179.721 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.172 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.2 128.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.688 -0.405 . . . . 1.5600000000000001 111.002 179.823 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -86.41 -9.6 55.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.885 -0.598 . . . . 1.8799999999999999 110.294 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.15 0.25 55.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.471 . . . . 1.04 110.351 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.22 137.3 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.943 -0.571 . . . . 0.23999999999999999 109.955 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.61 ' N ' ' O ' ' A' ' 185' ' ' ILE . 69.3 m -96.38 -15.51 21.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.336 0.588 . . . . 0.28999999999999998 110.011 -179.65 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.55 175.56 45.74 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 109.847 -1.301 . . . . 0.13 109.847 179.611 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.43 151.65 42.44 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.601 -0.439 . . . . 0.17000000000000001 110.488 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.495 ' NH2' ' CD2' ' A' ' 183' ' ' TYR . 68.8 ttp85 -132.37 121.13 23.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.175 -0.466 . . . . 1.29 109.87 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.554 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.03 136.61 38.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.678 -0.692 . . . . 0.25 110.687 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 83.3 tt0 -129.37 129.95 45.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.942 -0.572 . . . . 1.3200000000000001 110.031 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.62 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.9 p90 -138.77 135.26 34.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.998 -0.547 . . . . 0.56999999999999995 110.582 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.418 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.32 161.4 39.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.769 -0.65 . . . . 1.1599999999999999 109.638 179.804 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.969 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.05 124.79 25.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.99 0.424 . . . . 0.38 110.666 -179.585 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.74 -7.65 49.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.756 -0.656 . . . . 0.40999999999999998 110.909 -179.866 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.9 -69.71 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.301 -0.409 . . . . 1.6599999999999999 111.357 -179.292 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.472 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.65 -35.35 76.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.083 -0.508 . . . . 1.6599999999999999 111.471 -179.09 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.076 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.12 88.67 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.771 -0.932 . . . . 1.1699999999999999 110.771 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.324 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.9 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.74 0.305 . . . . 1.8600000000000001 110.334 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.324 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.35 139.11 44.85 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.01 0.433 . . . . 1.98 110.165 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.418 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.5 Cg_endo -70.97 145.89 51.34 Favored 'Trans proline' 0 C--N 1.301 -1.936 0 C-N-CA 122.601 2.201 . . . . 0.55000000000000004 112.365 -179.472 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.89 145.67 42.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.147 -0.686 . . . . 1.1399999999999999 109.147 179.308 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.587 ' CE1' ' CD ' ' A' ' 65' ' ' PRO . 11.5 p90 -123.2 141.41 52.0 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.363 -0.535 . . . . 0.93000000000000005 111.6 -179.2 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.14 127.61 43.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.326 -0.852 . . . . 0.34000000000000002 108.911 179.016 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.544 ' OD2' ' CG ' ' A' ' 16' ' ' ASN . 66.9 m-20 -101.59 131.23 47.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.143 0.497 . . . . 1.0900000000000001 111.781 -178.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -128.03 157.52 73.71 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.324 -0.853 . . . . 0.19 109.477 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -69.78 158.05 58.25 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.433 2.089 . . . . 0.17999999999999999 112.218 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.417 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.33 -12.14 5.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.824 -0.626 . . . . 0.20999999999999999 110.698 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.1 p -92.8 -8.8 42.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.28999999999999998 110.742 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.39 34.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.5 110.433 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.7 p -133.14 16.68 4.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.413 -0.358 . . . . 0.29999999999999999 110.483 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.58 147.09 5.04 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.658 -0.497 . . . . 0.23000000000000001 109.658 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.554 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.14 150.49 12.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.515 -0.474 . . . . 0.28000000000000003 111.588 -179.576 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 125.0 50.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.667 -0.697 . . . . 1.0700000000000001 109.761 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.6 105.01 31.17 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.985 0.422 . . . . 0.28999999999999998 110.999 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.0 Cg_endo -91.03 -179.51 1.48 Allowed 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 123.158 2.572 . . . . 0.42999999999999999 112.174 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.69 32.64 18.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.428 -0.805 . . . . 1.26 111.443 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.443 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.0 mt -86.34 148.47 25.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.47 -0.332 . . . . 0.32000000000000001 110.487 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.773 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.14 114.91 61.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.982 0.42 . . . . 0.57999999999999996 110.666 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.1 140.61 95.89 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.901 2.401 . . . . 0.66000000000000003 111.971 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.1 21.12 74.47 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.072 -0.811 . . . . 0.28999999999999998 111.072 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.472 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.79 150.24 49.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.849 0.357 . . . . 2.3300000000000001 110.641 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.3 131.69 46.09 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.062 -0.517 . . . . 0.85999999999999999 109.755 179.335 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.969 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.61 148.36 44.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.07 -0.514 . . . . 0.52000000000000002 110.94 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.39 125.41 60.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.255 -1.017 . . . . 0.29999999999999999 108.255 177.76 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.53 132.53 63.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.084 0.469 . . . . 0.23000000000000001 111.251 -178.574 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.9 m-20 -136.47 122.54 20.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.604 -0.725 . . . . 0.35999999999999999 109.669 179.297 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.02 125.41 54.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.281 -0.418 . . . . 0.19 110.682 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.2 m-85 -117.23 137.8 52.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.999 -0.546 . . . . 0.29999999999999999 109.9 179.538 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.431 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.64 135.01 42.74 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.853 -0.795 . . . . 0.37 108.853 178.816 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.869 ' CD1' ' HZ3' ' A' ' 61' ' ' LYS . 81.3 mt -99.12 122.94 51.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.212 0.53 . . . . 0.26000000000000001 110.909 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.7 p -83.87 169.72 14.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.512 -0.767 . . . . 0.28000000000000003 110.501 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 187' ' ' GLU . 49.5 tp10 -59.74 -14.59 15.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.01 -0.541 . . . . 1.6000000000000001 110.902 -179.563 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.55 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.8 m-20 -96.06 -4.27 43.3 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.836 -0.346 . . . . 1.1799999999999999 110.809 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.82 13.89 63.94 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.346 -0.701 . . . . 0.29999999999999999 111.346 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -84.73 139.1 32.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.67 0.271 . . . . 1.22 110.437 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -106.75 141.08 38.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.361 . . . . 0.97999999999999998 110.551 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.0 m -136.72 127.05 26.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 0.82999999999999996 110.35 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 25.6 tp -68.17 117.29 9.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.266 -0.424 . . . . 0.26000000000000001 110.566 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.0 pt -108.96 -21.89 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.29999999999999999 110.706 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.86 125.76 5.89 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.412 -0.515 . . . . 0.31 111.449 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.471 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.72 120.21 21.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.793 -0.64 . . . . 0.28000000000000003 109.643 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.63 151.7 29.11 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.642 -0.423 . . . . 0.23999999999999999 110.954 -179.272 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.54 158.58 18.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.04 -0.527 . . . . 0.23000000000000001 110.38 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.402 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 68.1 mt-30 -146.04 157.95 43.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.67000000000000004 110.645 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.29 104.34 9.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.732 -0.667 . . . . 0.64000000000000001 110.061 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 C--O 1.221 -0.407 0 CA-C-O 117.837 -1.078 . . . . 1.26 110.593 -179.607 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.9 m . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.244 -0.65 . . . . 3.4399999999999999 109.244 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.442 ' H ' ' HB3' ' A' ' 1' ' ' SER . . . -116.33 150.73 18.54 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.03 -0.828 . . . . 1.22 111.03 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -35.67 142.41 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.054 0 C-N-CA 123.934 3.089 . . . . 0.75 113.813 -179.23 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.629 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -79.94 173.43 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.257 -1.338 . . . . 0.79000000000000004 108.804 178.42 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.629 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.64 125.85 51.47 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.424 -0.51 . . . . 1.9399999999999999 111.392 -179.553 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.58 144.06 33.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.655 -0.702 . . . . 0.59999999999999998 110.597 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.04 168.36 25.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.857 0.361 . . . . 3.1400000000000001 111.105 -179.636 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.739 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.4 mt -109.0 131.08 60.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.002 -0.545 . . . . 3.23 110.063 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.5 p -141.17 162.3 35.82 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.829 0.347 . . . . 3.6299999999999999 111.202 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 69.3 mm-40 36.1 31.57 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.563 -0.532 . . . . 6.0800000000000001 109.563 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.739 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.41 69.59 32.3 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.968 -0.56 . . . . 3.3799999999999999 111.625 -178.833 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.639 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.21 -29.23 73.47 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.496 2.131 . . . . 3.9300000000000002 111.864 179.339 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.639 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.72 125.58 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.142 -0.481 . . . . 3.3599999999999999 110.512 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.585 HE21 ' HB2' ' A' ' 17' ' ' SER . 28.2 mt-30 -124.02 158.34 60.69 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.406 -0.361 . . . . 3.6099999999999999 110.466 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.539 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 98.1 Cg_endo -82.01 -64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.843 2.362 . . . . 1.51 113.503 -178.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.666 ' OD1' ' CE2' ' A' ' 157' ' ' TYR . 66.1 t30 -108.38 -19.65 13.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.326 -0.397 . . . . 2.6800000000000002 112.064 -178.553 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.585 ' HB2' HE21 ' A' ' 14' ' ' GLN . 31.1 m -107.3 152.05 24.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.145 0.498 . . . . 1.21 111.266 -179.358 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.569 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.31 102.96 2.22 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.677 -0.692 . . . . 1.5600000000000001 110.637 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.69 145.55 12.97 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.915 2.41 . . . . 0.81000000000000005 112.646 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.902 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.74 167.98 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.881 -0.6 . . . . 1.52 109.922 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.15 147.96 29.07 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.738 -0.467 . . . . 2.1400000000000001 109.738 178.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.598 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.29 157.25 45.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.017 0.437 . . . . 0.32000000000000001 111.204 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.498 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -127.99 155.31 44.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.817 -0.629 . . . . 2.1699999999999999 110.087 178.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.819 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.62 173.05 6.33 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.187 -0.461 . . . . 0.58999999999999997 110.741 -179.199 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.819 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.8 Cg_exo -50.72 173.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.885 0 C-N-CA 122.867 2.378 . . . . 0.90000000000000002 111.497 179.33 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.485 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.95 -50.97 0.7 Allowed Pre-proline 0 C--N 1.33 -0.255 0 C-N-CA 120.672 -0.411 . . . . 3.3399999999999999 110.134 179.847 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.623 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.97 152.4 82.48 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.652 2.235 . . . . 1.8500000000000001 111.419 179.219 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.68 42.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.427 0.632 . . . . 2.54 110.615 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.623 ' H ' ' C ' ' A' ' 27' ' ' PRO . 73.8 t60 -63.65 -41.56 98.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.97 -1.014 . . . . 2.5299999999999998 110.691 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.558 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.6 mt -109.95 137.92 40.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.728 -0.669 . . . . 1.1699999999999999 111.259 -179.462 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.03 -72.87 0.7 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.039 -0.528 . . . . 1.27 111.894 -178.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.35 24.45 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.581 0.586 . . . . 1.1200000000000001 112.581 -179.631 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -121.84 124.9 45.22 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.338 -0.616 . . . . 0.41999999999999998 109.338 177.476 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.9 mt -118.04 134.7 60.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.651 -0.42 . . . . 0.78000000000000003 110.61 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.902 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.99 128.6 53.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.978 0.418 . . . . 0.62 111.334 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.551 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.07 138.99 49.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.715 -0.675 . . . . 1.97 110.215 178.972 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.437 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.06 163.12 35.23 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.109 0.48 . . . . 0.34999999999999998 112.093 -178.065 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.4 139.58 7.93 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.466 -0.788 . . . . 1.8 110.538 178.777 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.694 ' O ' ' N ' ' A' ' 41' ' ' ASN . 18.2 Cg_endo -63.46 115.4 3.01 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.322 2.014 . . . . 0.57999999999999996 111.94 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.674 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.98 81.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.837 -0.431 . . . . 3.04 109.837 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.694 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.31 -20.65 0.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.015 -0.538 . . . . 2.4700000000000002 111.927 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.2 p -157.56 157.83 34.48 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.809 -0.356 . . . . 2.5099999999999998 110.56 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.42 27.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 1.8600000000000001 110.125 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.87 -75.84 1.31 Allowed Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.178 -0.534 . . . . 1.4399999999999999 111.89 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.91 152.31 35.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.961 0.41 . . . . 4.6900000000000004 111.056 -179.453 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.645 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.13 2.53 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.126 -0.488 . . . . 1.4299999999999999 111.985 179.364 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.08 149.67 29.69 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.464 0.649 . . . . 1.74 112.563 -177.851 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.04 156.52 46.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.762 -1.108 . . . . 1.9199999999999999 110.259 178.582 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.22 158.34 41.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.916 -0.584 . . . . 0.34000000000000002 111.82 -179.306 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.6 m -115.23 135.7 53.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.479 -0.782 . . . . 0.40999999999999998 109.75 179.266 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.598 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.31 121.96 23.88 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.55000000000000004 111.546 -179.153 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.4 Cg_exo -46.41 151.71 1.7 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.731 2.287 . . . . 0.44 112.083 179.029 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.99 -22.92 63.11 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.076 -0.511 . . . . 0.73999999999999999 112.747 -179.163 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.544 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.85 -16.83 46.1 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 117.382 0.591 . . . . 0.93000000000000005 111.786 -178.34 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.604 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.58 138.42 31.58 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.766 -0.373 . . . . 0.96999999999999997 110.385 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.55 13.88 10.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.442 -0.344 . . . . 1.3400000000000001 111.587 -179.318 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.48 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.4 p -150.03 143.37 25.12 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.595 -0.442 . . . . 0.39000000000000001 111.03 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.72 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.67 -169.36 1.53 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.98 -0.554 . . . . 0.41999999999999998 110.969 -179.452 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.72 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.81 125.86 9.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.411 -0.813 . . . . 0.39000000000000001 109.841 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.506 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.4 mt -114.78 123.25 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.429 -0.508 . . . . 0.73999999999999999 111.208 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.756 ' HD3' HG21 ' A' ' 185' ' ' ILE . 52.0 mtmt -126.5 163.38 23.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.77 -0.65 . . . . 2.48 110.469 179.686 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.551 ' HA2' HD22 ' A' ' 16' ' ' ASN . . . 85.11 19.14 59.63 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.662 -0.975 . . . . 0.5 110.662 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.541 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 73.6 mt -79.13 157.17 27.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.975 0.417 . . . . 0.57999999999999996 111.331 -179.658 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.854 ' O ' HG12 ' A' ' 67' ' ' VAL . 2.7 mttm -99.46 133.87 21.61 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.571 -0.74 . . . . 2.79 110.43 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.84 143.62 61.8 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.548 2.165 . . . . 0.87 111.908 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.81 25.61 75.35 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.071 -0.812 . . . . 0.64000000000000001 111.071 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.854 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.3 p -128.15 158.67 40.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.651 0.262 . . . . 0.82999999999999996 110.475 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.12 139.85 42.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.988 0.423 . . . . 0.5 110.571 -179.73 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.644 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.3 m-85 -122.46 136.52 54.91 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.902 -0.59 . . . . 0.53000000000000003 110.766 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -99.02 131.07 45.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.468 -0.938 . . . . 1.8700000000000001 108.468 177.634 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.482 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.54 153.82 16.67 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.341 -0.933 . . . . 0.28999999999999998 112.0 -178.605 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -134.94 140.96 46.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.689 -0.486 . . . . 1.4299999999999999 109.689 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.513 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.4 tp -115.75 118.88 34.27 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.454 -0.498 . . . . 0.32000000000000001 110.48 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.746 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.46 129.14 68.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.347 -0.388 . . . . 0.79000000000000004 110.63 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.9 120.74 43.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.287 -0.415 . . . . 1.02 110.69 -179.568 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.841 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.47 146.36 11.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.139 0.495 . . . . 0.62 111.076 -179.24 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.633 ' O ' ' N ' ' A' ' 79' ' ' TYR . 20.9 mt-30 -105.95 153.86 21.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.559 -0.746 . . . . 2.4399999999999999 109.925 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.16 88.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.865 0.364 . . . . 3.6899999999999999 110.42 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.633 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.39 32.55 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.826 -0.624 . . . . 6.0800000000000001 110.558 -179.942 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.04 -117.44 3.3 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.418 -0.673 . . . . 1.22 111.418 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.38 177.31 9.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.209 0.528 . . . . 2.8799999999999999 111.665 -179.209 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.11 149.43 32.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.442 -0.799 . . . . 1.47 110.403 179.221 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.08 144.65 38.85 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.458 -0.337 . . . . 2.7000000000000002 110.594 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.746 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -127.94 135.97 61.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 121.118 0.485 . . . . 0.46000000000000002 111.582 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.601 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -123.95 141.37 52.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.657 -0.701 . . . . 0.34999999999999998 110.359 179.531 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.492 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.6 138.89 51.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.08 0.467 . . . . 3.6699999999999999 111.527 -179.365 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.482 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.31 164.15 38.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.577 -0.738 . . . . 0.67000000000000004 109.526 179.353 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 46.8 p30 -145.21 151.59 38.64 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.392 -0.523 . . . . 1.47 111.069 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.812 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.2 172.72 13.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.767 -0.652 . . . . 0.44 111.045 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.71 160.69 21.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.47 -0.786 . . . . 1.3700000000000001 109.815 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.35 121.84 22.93 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.582 -0.447 . . . . 1.28 110.759 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -127.45 154.65 44.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 1.97 112.109 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.759 ' O ' ' O ' ' A' ' 94' ' ' THR . 84.2 p -68.05 -32.35 72.64 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.662 -0.699 . . . . 3.2799999999999998 111.459 178.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.759 ' O ' ' O ' ' A' ' 93' ' ' SER . 87.7 m 30.96 178.76 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 O-C-N 123.64 0.587 . . . . 0.0 112.502 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.737 ' N ' HG22 ' A' ' 94' ' ' THR . 89.8 p -64.48 -22.93 67.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.609 -179.331 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 95' ' ' SER . 17.2 p 62.6 64.61 1.62 Allowed Pre-proline 0 N--CA 1.465 0.286 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.992 -178.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.82 151.98 52.92 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.672 2.248 . . . . 0.0 111.736 179.516 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.5 t -104.01 133.27 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.873 0.368 . . . . 0.0 110.152 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.2 m -58.69 -39.84 81.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.68 -179.159 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.3 t -58.33 -39.17 78.74 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.755 -179.157 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 53.4 44.68 29.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.7 179.246 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.641 HG22 ' H ' ' A' ' 104' ' ' THR . 55.6 m -122.39 135.88 54.78 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.936 0.398 . . . . 0.0 111.24 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 m -116.74 13.93 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.677 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.641 ' H ' HG22 ' A' ' 102' ' ' THR . 21.5 p -121.17 164.11 17.41 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.142 0.496 . . . . 0.0 111.475 -178.778 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.96 -176.06 43.76 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.334 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -115.38 155.79 26.73 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.612 0.244 . . . . 0.0 110.574 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.9 p -82.05 158.31 23.82 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.565 ' N ' ' HD2' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -53.16 -52.4 66.19 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.362 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 108' ' ' THR . 17.9 Cg_endo -58.47 144.38 96.84 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.227 1.951 . . . . 0.0 112.234 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.415 ' CD2' ' N ' ' A' ' 111' ' ' SER . 68.3 t80 -146.1 -97.6 0.09 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.464 179.68 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.415 ' N ' ' CD2' ' A' ' 110' ' ' PHE . 40.7 p -127.78 79.23 73.95 Favored Pre-proline 0 N--CA 1.467 0.415 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.002 -179.737 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -52.49 141.19 52.54 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.18 1.92 . . . . 0.0 112.163 -179.895 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.9 tp -59.44 -36.74 76.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.798 -0.637 . . . . 10.19 111.552 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.4 p -129.82 144.42 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.068 0.461 . . . . 7.2800000000000002 111.423 -178.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.11 147.41 43.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.634 -0.712 . . . . 7.2999999999999998 110.751 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.498 HG23 ' H ' ' A' ' 118' ' ' GLU . 9.9 t -66.26 -147.96 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.88 -0.6 . . . . 6.4400000000000004 111.462 -179.371 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.481 ' N ' ' OG1' ' A' ' 116' ' ' THR . 90.6 p -59.93 -23.71 63.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.845 -0.616 . . . . 4.4199999999999999 112.247 -178.538 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.498 ' H ' HG23 ' A' ' 116' ' ' THR . 96.9 mt-10 -59.14 -34.21 71.8 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.502 -0.479 . . . . 3.0499999999999998 110.553 -179.181 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.1 p 39.32 -124.89 0.36 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.276 -0.42 . . . . 3.4300000000000002 111.012 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.6 p -133.14 -17.38 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.39 -0.368 . . . . 2.8799999999999999 110.519 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.546 ' O ' ' O ' ' A' ' 122' ' ' GLU . 24.0 p -92.96 162.33 14.1 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.18 -0.464 . . . . 2.0899999999999999 110.995 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.546 ' O ' ' O ' ' A' ' 121' ' ' THR . 48.0 tp10 52.38 126.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.994 -0.548 . . . . 4.5300000000000002 111.079 179.695 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 31.5 pt -123.5 157.09 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.046 -0.524 . . . . 1.4399999999999999 110.663 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 16.3 p -125.76 164.06 21.5 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.066 -0.515 . . . . 1.78 110.247 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.48 -94.83 0.47 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 121.014 -0.274 . . . . 0.64000000000000001 111.148 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 84.6 p -63.42 -36.53 84.04 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.481 -0.488 . . . . 0.66000000000000003 111.259 -179.526 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.447 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.84 167.57 0.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.977 -0.556 . . . . 0.68999999999999995 110.855 179.743 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.61 145.61 50.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.665 -0.698 . . . . 0.52000000000000002 110.154 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.32 101.65 9.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.108 -0.701 . . . . 0.32000000000000001 109.108 177.691 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.6 t -112.91 139.75 36.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.997 -0.547 . . . . 0.28999999999999998 111.132 -178.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 p -128.74 152.56 48.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.686 -0.688 . . . . 0.25 109.883 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.584 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.5 p90 -144.82 -164.98 2.04 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.738 -0.385 . . . . 0.31 110.612 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.74 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.4 t -123.93 127.13 73.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.48999999999999999 110.801 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.149 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 1.53 110.378 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.74 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.06 24.41 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.932 -0.576 . . . . 0.96999999999999997 111.4 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.149 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.21 128.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.652 -0.419 . . . . 1.5600000000000001 110.937 179.819 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -86.36 -9.62 56.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.869 -0.605 . . . . 1.8799999999999999 110.376 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.12 0.26 55.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 1.04 110.307 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.34 137.28 25.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.993 -0.549 . . . . 0.23999999999999999 109.894 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 185' ' ' ILE . 72.0 m -96.25 -15.5 21.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.305 0.574 . . . . 0.28999999999999998 110.053 -179.698 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.54 175.57 45.73 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 109.822 -1.311 . . . . 0.13 109.822 179.627 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -123.48 151.62 42.56 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.65 -0.42 . . . . 0.17000000000000001 110.545 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.64 ' NH2' ' CD2' ' A' ' 183' ' ' TYR . 69.2 ttp85 -132.26 121.11 23.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.12 -0.491 . . . . 1.29 109.979 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.541 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.01 136.49 38.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.744 -0.662 . . . . 0.25 110.658 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.497 ' HB2' HH12 ' A' ' 143' ' ' ARG . 80.0 tt0 -129.34 129.88 45.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.987 -0.551 . . . . 1.3200000000000001 110.096 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.619 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.72 135.34 34.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.998 -0.546 . . . . 0.56999999999999995 110.605 -179.708 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.423 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.31 161.36 39.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.679 -0.692 . . . . 1.1599999999999999 109.627 179.844 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.96 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.02 124.9 25.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.054 0.454 . . . . 0.38 110.708 -179.676 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.78 -7.6 49.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.713 -0.676 . . . . 0.40999999999999998 110.952 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -109.86 -69.7 0.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.405 . . . . 1.6599999999999999 111.417 -179.31 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.445 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.66 -35.34 76.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.108 -0.496 . . . . 1.6599999999999999 111.486 -179.142 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.094 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.19 7.21 88.61 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.806 -0.918 . . . . 1.1699999999999999 110.806 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.312 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.91 -171.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.739 0.304 . . . . 1.8600000000000001 110.23 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.312 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.37 139.07 44.75 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.973 0.416 . . . . 1.98 110.205 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.423 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.8 Cg_endo -70.89 145.87 51.72 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.662 2.241 . . . . 0.55000000000000004 112.391 -179.526 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.619 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.9 145.75 42.62 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.217 -0.66 . . . . 1.1399999999999999 109.217 179.276 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.666 ' CE2' ' OD1' ' A' ' 16' ' ' ASN . 49.2 p90 -123.26 141.22 52.21 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.418 -0.513 . . . . 0.93000000000000005 111.536 -179.013 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.9 mt -128.05 127.67 43.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.329 -0.85 . . . . 0.34000000000000002 109.068 178.866 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -101.74 131.2 48.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.236 0.541 . . . . 1.0900000000000001 111.726 -178.681 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.97 157.55 73.51 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.226 -0.897 . . . . 0.19 109.558 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.78 157.96 58.56 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 122.521 2.148 . . . . 0.17999999999999999 112.178 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.28 -12.11 5.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.77 -0.65 . . . . 0.20999999999999999 110.74 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.79 -8.83 42.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.085 -0.507 . . . . 0.28999999999999998 110.703 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.13 135.39 34.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 0.5 110.364 179.765 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.1 p -133.21 16.71 4.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.339 -0.392 . . . . 0.29999999999999999 110.521 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.7 p -167.56 147.14 5.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.65 -0.5 . . . . 0.23000000000000001 109.65 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.541 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.22 150.5 12.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.561 -0.456 . . . . 0.28000000000000003 111.545 -179.619 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.497 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.39 124.93 50.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.644 -0.707 . . . . 1.0700000000000001 109.827 179.466 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.32 104.82 29.08 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.428 -0.351 . . . . 0.28999999999999998 111.158 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.7 Cg_endo -91.02 -179.47 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 123.188 2.592 . . . . 0.42999999999999999 112.188 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.53 32.8 18.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.444 -0.798 . . . . 1.26 111.467 179.338 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.1 mt -86.43 148.49 25.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.468 -0.333 . . . . 0.32000000000000001 110.409 179.582 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.761 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.29 114.83 61.2 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.091 0.472 . . . . 0.57999999999999996 110.722 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.01 140.63 96.19 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.878 2.385 . . . . 0.66000000000000003 111.952 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.03 21.25 74.35 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.087 -0.805 . . . . 0.28999999999999998 111.087 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.445 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.97 150.25 49.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.928 0.394 . . . . 2.3300000000000001 110.541 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.18 131.66 45.99 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.983 -0.553 . . . . 0.85999999999999999 109.792 179.316 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.96 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.56 148.22 44.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.07 -0.513 . . . . 0.52000000000000002 111.101 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.24 125.4 60.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.263 -1.014 . . . . 0.29999999999999999 108.263 177.777 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.6 132.43 63.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.202 0.525 . . . . 0.23000000000000001 111.338 -178.672 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.46 122.62 20.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.477 -0.783 . . . . 0.35999999999999999 109.63 179.342 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.584 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.07 125.39 55.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.176 -0.465 . . . . 0.19 110.654 -179.493 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.64 ' CD2' ' NH2' ' A' ' 143' ' ' ARG . 48.7 m-85 -117.3 137.93 52.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.001 -0.545 . . . . 0.29999999999999999 109.839 179.533 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.422 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.63 135.06 42.66 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.79 -0.819 . . . . 0.37 108.79 178.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.756 HG21 ' HD3' ' A' ' 61' ' ' LYS . 81.3 mt -99.14 122.83 51.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.101 0.477 . . . . 0.26000000000000001 111.022 -178.812 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.5 p -83.73 169.74 14.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.568 -0.742 . . . . 0.28000000000000003 110.499 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.81 -14.5 15.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.028 -0.533 . . . . 1.6000000000000001 110.975 -179.59 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -96.09 -4.26 43.21 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.854 -0.339 . . . . 1.1799999999999999 110.86 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.7 14.03 63.94 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.365 -0.694 . . . . 0.29999999999999999 111.365 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -84.73 139.08 32.24 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.03 -0.268 . . . . 1.22 110.484 179.651 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -106.72 141.03 38.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.871 0.367 . . . . 0.97999999999999998 110.517 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.0 m -136.74 126.99 26.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.82999999999999996 110.337 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.05 117.35 9.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.308 -0.406 . . . . 0.26000000000000001 110.534 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.09 -21.82 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.29999999999999999 110.68 -179.745 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.8 125.72 5.92 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.489 -0.484 . . . . 0.31 111.487 -179.771 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.78 120.26 21.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.835 -0.62 . . . . 0.28000000000000003 109.554 179.123 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.66 29.05 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.71 -0.396 . . . . 0.23999999999999999 110.942 -179.28 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.8 p -110.4 158.64 18.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.521 . . . . 0.23000000000000001 110.382 179.751 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -146.11 157.83 43.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.057 -0.519 . . . . 0.67000000000000004 110.691 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.22 104.31 9.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.762 -0.654 . . . . 0.64000000000000001 110.058 179.513 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.2 p . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.991 -1.005 . . . . 1.26 110.577 -179.674 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.0 m . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.196 -0.668 . . . . 3.4399999999999999 109.196 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.36 150.7 18.54 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.981 -0.848 . . . . 1.22 110.981 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -35.68 142.38 0.1 Allowed 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 123.982 3.122 . . . . 0.75 113.835 -179.233 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.622 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.92 173.41 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.306 -1.316 . . . . 0.79000000000000004 108.81 178.413 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.622 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.55 125.84 51.45 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.484 -0.486 . . . . 1.9399999999999999 111.46 -179.634 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.5 144.01 33.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.638 -0.71 . . . . 0.59999999999999998 110.689 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.36 25.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.946 0.403 . . . . 3.1400000000000001 111.089 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.747 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -109.01 131.15 60.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.99 -0.55 . . . . 3.23 110.05 179.833 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.25 162.33 35.74 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.823 0.344 . . . . 3.6299999999999999 111.236 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.3 mt-10 35.99 31.69 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.626 -0.509 . . . . 6.0800000000000001 109.626 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.747 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.55 32.99 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.944 -0.571 . . . . 3.3799999999999999 111.541 -178.816 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.643 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.21 -29.09 73.38 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.478 2.119 . . . . 3.9300000000000002 111.883 179.333 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.643 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.55 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 3.3599999999999999 110.487 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.62 ' NE2' ' O ' ' A' ' 13' ' ' SER . 1.7 mp0 -124.0 158.3 60.77 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.32 -0.4 . . . . 3.6099999999999999 110.456 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.542 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 97.0 Cg_endo -82.0 -64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.939 2.426 . . . . 1.51 113.511 -178.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.617 ' ND2' ' CD2' ' A' ' 157' ' ' TYR . 26.0 m120 -108.52 -19.48 13.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.311 -0.404 . . . . 2.6800000000000002 112.082 -178.531 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 27.5 m -107.29 152.01 24.7 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.44 -0.504 . . . . 1.21 111.329 -179.475 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.571 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.0 t-80 -155.17 102.87 2.25 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.796 -0.638 . . . . 1.5600000000000001 110.742 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.429 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.61 145.71 13.16 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.862 2.375 . . . . 0.81000000000000005 112.55 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.922 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.85 167.94 24.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.795 -0.639 . . . . 1.52 109.847 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.17 147.88 28.97 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.754 -0.462 . . . . 2.1400000000000001 109.754 178.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.6 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.23 157.34 44.96 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.673 -0.411 . . . . 0.32000000000000001 111.252 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.488 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -128.06 155.31 44.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.866 -0.607 . . . . 2.1699999999999999 110.085 179.029 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.822 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.67 172.98 6.44 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.128 -0.487 . . . . 0.58999999999999997 110.798 -179.189 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.822 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.6 174.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 122.859 2.373 . . . . 0.90000000000000002 111.552 179.434 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.07 -51.15 0.68 Allowed Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 120.664 -0.414 . . . . 3.3399999999999999 110.112 179.795 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.617 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.83 152.33 82.52 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.757 2.304 . . . . 1.8500000000000001 111.44 179.225 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.68 42.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.426 0.632 . . . . 2.54 110.628 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.617 ' H ' ' C ' ' A' ' 27' ' ' PRO . 74.0 t60 -63.66 -41.58 98.17 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.966 -1.015 . . . . 2.5299999999999998 110.651 179.755 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.563 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.9 mt -109.82 137.85 40.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.851 -0.613 . . . . 1.1699999999999999 111.311 -179.511 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.06 -72.9 0.7 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.054 -0.521 . . . . 1.27 111.853 -178.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.16 148.41 24.43 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.59 0.589 . . . . 1.1200000000000001 112.59 -179.66 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.79 124.86 45.18 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.327 -0.62 . . . . 0.41999999999999998 109.327 177.53 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.05 134.76 60.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.678 -0.409 . . . . 0.78000000000000003 110.636 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.922 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.99 128.49 53.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.437 . . . . 0.62 111.237 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.547 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -130.99 139.07 49.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.756 -0.657 . . . . 1.97 110.151 178.899 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.12 163.18 35.11 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.165 0.507 . . . . 0.34999999999999998 112.094 -178.162 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.51 139.59 7.84 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.431 -0.804 . . . . 1.8 110.479 178.829 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.698 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.9 Cg_endo -63.51 115.43 3.03 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.436 2.091 . . . . 0.57999999999999996 111.787 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.685 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.08 81.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.984 0.421 . . . . 3.04 109.874 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.698 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.94 -0.573 . . . . 2.4700000000000002 111.946 -179.532 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.8 p -157.52 157.79 34.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.759 0.314 . . . . 2.5099999999999998 110.601 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 16.0 m -120.43 27.92 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 1.8600000000000001 110.092 179.586 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.92 -75.89 1.31 Allowed Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.083 -0.58 . . . . 1.4399999999999999 111.764 -179.207 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.84 152.3 35.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 4.6900000000000004 110.973 -179.295 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.649 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.24 -169.17 2.54 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.084 -0.507 . . . . 1.4299999999999999 111.936 179.337 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.09 149.65 29.73 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.495 0.664 . . . . 1.74 112.556 -177.891 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.05 156.49 46.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.789 -1.096 . . . . 1.9199999999999999 110.274 178.574 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.15 158.39 41.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.981 -0.554 . . . . 0.34000000000000002 111.837 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.1 m -115.19 135.64 53.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.476 -0.784 . . . . 0.40999999999999998 109.784 179.292 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.6 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.38 121.94 23.79 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.432 -0.349 . . . . 0.55000000000000004 111.548 -179.158 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.4 Cg_exo -46.32 151.74 1.62 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.658 2.239 . . . . 0.44 112.101 179.023 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.91 -23.01 63.04 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 116.015 -0.539 . . . . 0.73999999999999999 112.799 -179.289 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.544 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.87 -16.87 45.9 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.208 -0.597 . . . . 0.93000000000000005 111.755 -178.306 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.603 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.2 mt -91.47 138.44 31.58 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.809 -0.356 . . . . 0.96999999999999997 110.321 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.62 13.95 10.93 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.36 -0.382 . . . . 1.3400000000000001 111.464 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.482 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.5 p -150.05 143.48 25.16 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.648 -0.421 . . . . 0.39000000000000001 111.005 179.602 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.722 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.78 -169.31 1.52 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.016 -0.538 . . . . 0.41999999999999998 110.857 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.722 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.79 125.83 9.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.333 -0.849 . . . . 0.39000000000000001 109.841 179.275 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.511 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.74 123.19 70.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.417 -0.513 . . . . 0.73999999999999999 111.23 -179.733 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.863 ' HZ3' ' CB ' ' A' ' 140' ' ' SER . 66.4 mttt -126.47 163.44 23.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.928 -0.578 . . . . 2.48 110.441 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.01 19.14 59.78 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.759 -0.937 . . . . 0.5 110.759 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.511 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.1 mt -79.12 157.31 27.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.078 0.466 . . . . 0.57999999999999996 111.291 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.844 ' O ' HG12 ' A' ' 67' ' ' VAL . 1.2 mttm -99.55 134.0 21.46 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.659 -0.7 . . . . 2.79 110.393 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.654 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.92 143.53 61.0 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.579 2.186 . . . . 0.87 111.925 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.92 25.57 75.41 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.035 -0.826 . . . . 0.64000000000000001 111.035 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.19 158.74 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.64 0.257 . . . . 0.82999999999999996 110.421 -179.521 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.17 139.86 42.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.925 0.393 . . . . 0.5 110.582 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.651 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.46 136.41 54.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.969 -0.56 . . . . 0.53000000000000003 110.878 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.86 131.01 45.29 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.545 -0.909 . . . . 1.8700000000000001 108.545 177.634 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.52 153.87 16.66 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.237 -0.982 . . . . 0.28999999999999998 111.867 -178.524 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -134.97 140.99 46.13 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.684 -0.487 . . . . 1.4299999999999999 109.684 179.561 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.518 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.79 118.92 34.36 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.459 -0.496 . . . . 0.32000000000000001 110.507 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.738 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.49 129.1 68.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.349 -0.387 . . . . 0.79000000000000004 110.564 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.704 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.8 120.89 43.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.251 -0.432 . . . . 1.02 110.669 -179.695 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.855 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.64 146.5 11.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.246 0.546 . . . . 0.62 111.005 -179.332 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.626 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.09 153.94 21.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.499 -0.773 . . . . 2.4399999999999999 109.924 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.13 88.57 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.85 0.357 . . . . 3.6899999999999999 110.427 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.24 32.59 0.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.869 -0.605 . . . . 6.0800000000000001 110.616 -179.887 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.06 -117.33 3.29 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.471 -0.652 . . . . 1.22 111.471 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.36 177.35 9.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.198 0.523 . . . . 2.8799999999999999 111.692 -179.256 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.12 149.61 32.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.464 -0.789 . . . . 1.47 110.478 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.15 144.68 38.72 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.501 -0.318 . . . . 2.7000000000000002 110.529 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.738 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -128.0 136.01 61.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 120.615 -0.434 . . . . 0.46000000000000002 111.549 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.03 141.37 52.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.677 -0.692 . . . . 0.34999999999999998 110.27 179.656 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.501 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.61 138.91 51.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.128 0.489 . . . . 3.6699999999999999 111.506 -179.379 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 53.0 p90 -152.39 164.19 38.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.554 -0.748 . . . . 0.67000000000000004 109.4 179.365 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.564 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.24 151.54 38.54 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.327 -0.549 . . . . 1.47 111.051 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.2 p90 -146.2 172.72 13.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.719 -0.673 . . . . 0.44 110.997 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.72 160.76 21.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.426 -0.807 . . . . 1.3700000000000001 109.82 179.569 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.46 121.9 22.9 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 120.514 -0.475 . . . . 1.28 110.735 179.942 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.5 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -128.23 163.84 23.84 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.495 0.924 . . . . 1.97 113.495 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.2 t -118.55 144.23 46.22 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.16 -1.422 . . . . 3.2799999999999998 107.16 176.64 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.3 p -77.93 151.76 33.56 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.562 -178.011 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 78.2 p -80.38 -14.77 58.06 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.7 179.334 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.8 p -124.27 80.67 58.99 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.905 -178.764 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -56.1 -22.26 38.78 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.812 1.674 . . . . 0.0 110.923 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.53 HG22 HD21 ' A' ' 181' ' ' ASN . 44.9 t -117.69 134.35 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.021 178.809 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.45 HG23 ' N ' ' A' ' 100' ' ' SER . 10.0 t -62.43 -39.56 93.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.035 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.45 ' N ' HG23 ' A' ' 99' ' ' THR . 84.2 p -62.29 -24.29 67.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.133 -179.575 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -84.85 131.32 34.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.033 0.444 . . . . 0.0 111.028 -179.403 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.2 p -79.26 164.2 24.33 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.625 -179.717 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 p -61.15 133.45 26.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.106 0.479 . . . . 0.0 110.829 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 42.2 m -123.58 142.48 50.99 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.239 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.03 11.89 60.92 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 43.14 -112.52 0.22 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.539 0.209 . . . . 0.0 110.946 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.9 p -80.16 160.8 25.55 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.948 0.404 . . . . 0.0 110.622 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.583 ' O ' ' CD2' ' A' ' 110' ' ' PHE . 43.9 p -126.93 80.1 71.69 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.688 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.76 -21.28 39.08 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.578 2.185 . . . . 0.0 112.49 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 108' ' ' THR . 89.0 m-85 69.91 23.35 5.55 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.588 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.9 t -128.18 75.33 78.89 Favored Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.182 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -56.4 144.01 84.81 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.246 1.964 . . . . 0.0 111.736 179.461 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.3 mt -95.8 139.76 31.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.444 -0.344 . . . . 10.19 110.33 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.553 ' O ' ' HB2' ' A' ' 115' ' ' ALA . 42.3 t -120.08 134.61 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.255 -0.43 . . . . 7.2800000000000002 110.408 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' A' ' 114' ' ' VAL . . . 169.31 -14.97 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.308 -0.405 . . . . 7.2999999999999998 110.399 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.674 HG22 ' N ' ' A' ' 117' ' ' SER . 32.7 m 45.24 174.96 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.175 -0.466 . . . . 6.4400000000000004 111.156 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.674 ' N ' HG22 ' A' ' 116' ' ' THR . 60.7 p -71.53 160.42 32.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.392 . . . . 4.4199999999999999 110.773 -179.71 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.05 -33.2 74.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 3.0499999999999998 111.221 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.445 ' O ' ' OG ' ' A' ' 117' ' ' SER . 28.6 t -118.25 144.47 45.77 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.381 -0.372 . . . . 3.4300000000000002 110.797 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.8 t -112.6 134.92 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.173 -0.467 . . . . 2.8799999999999999 110.421 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 44.6 m -121.87 142.38 50.31 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.82 -0.627 . . . . 2.0899999999999999 110.351 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 122' ' ' GLU . 59.3 mp0 -57.45 143.41 40.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.385 -0.37 . . . . 4.5300000000000002 110.148 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 70.7 mt -114.55 134.97 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.157 -0.474 . . . . 1.4399999999999999 110.778 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 22.3 p -84.07 162.75 20.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.015 -0.539 . . . . 1.78 110.056 179.635 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.83 142.18 57.49 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.67 -0.412 . . . . 0.64000000000000001 110.478 -179.691 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.1 OUTLIER -153.74 17.69 0.52 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.343 0.592 . . . . 0.66000000000000003 110.081 -179.884 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.443 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.86 167.56 0.25 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.351 -0.84 . . . . 0.68999999999999995 110.906 -179.696 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.64 145.59 50.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.671 -0.695 . . . . 0.52000000000000002 110.112 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.23 101.66 9.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.124 -0.695 . . . . 0.32000000000000001 109.124 177.738 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.0 t -112.94 139.6 37.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.031 -0.531 . . . . 0.28999999999999998 111.075 -178.808 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.1 p -128.63 152.5 48.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.638 -0.71 . . . . 0.25 109.87 179.606 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.584 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.5 p90 -144.8 -164.88 2.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.67 -0.412 . . . . 0.31 110.631 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.732 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -124.0 127.21 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.298 -0.41 . . . . 0.48999999999999999 110.83 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.154 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -58.11 58.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 1.53 110.239 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.23 24.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.882 -0.599 . . . . 0.96999999999999997 111.435 -179.661 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.154 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.14 128.75 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.586 -0.446 . . . . 1.5600000000000001 110.894 179.872 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.32 -9.75 55.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.886 -0.597 . . . . 1.8799999999999999 110.339 179.78 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.59 ' O ' ' CD ' ' A' ' 187' ' ' GLU . 27.8 p -87.12 0.3 55.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.004 -0.543 . . . . 1.04 110.314 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.723 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.37 137.23 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.915 -0.584 . . . . 0.23999999999999999 109.959 179.719 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.863 ' CB ' ' HZ3' ' A' ' 61' ' ' LYS . 89.3 p -96.27 -15.49 21.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.304 0.573 . . . . 0.28999999999999998 110.017 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.58 175.56 45.76 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.788 -1.325 . . . . 0.13 109.788 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.52 151.65 42.59 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.614 -0.435 . . . . 0.17000000000000001 110.455 179.743 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.647 ' NH1' HD11 ' A' ' 185' ' ' ILE . 38.3 ttp-105 -132.37 121.18 23.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.038 -0.528 . . . . 1.29 109.884 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.545 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -104.97 136.57 38.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.752 -0.658 . . . . 0.25 110.669 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 97.5 mt-10 -129.43 129.82 45.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.998 -0.547 . . . . 1.3200000000000001 110.091 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.624 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.63 135.34 34.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.079 -0.51 . . . . 0.56999999999999995 110.587 -179.646 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.417 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.36 161.38 39.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.783 -0.644 . . . . 1.1599999999999999 109.647 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.969 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.1 124.88 25.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.063 0.459 . . . . 0.38 110.709 -179.623 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.91 -7.57 49.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.745 -0.661 . . . . 0.40999999999999998 110.869 -179.74 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.81 -69.63 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 1.6599999999999999 111.439 -179.386 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.445 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.71 -35.35 76.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.006 -0.543 . . . . 1.6599999999999999 111.47 -179.094 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.078 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.17 88.64 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.763 -0.935 . . . . 1.1699999999999999 110.763 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.326 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.4 t0 -27.88 -171.7 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.792 0.33 . . . . 1.8600000000000001 110.275 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.326 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.27 139.12 45.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.408 . . . . 1.98 110.152 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.417 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 48.1 Cg_endo -70.86 145.85 51.86 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 122.695 2.264 . . . . 0.55000000000000004 112.299 -179.591 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.92 145.75 42.65 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.173 -0.677 . . . . 1.1399999999999999 109.173 179.157 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.654 ' CE1' ' CD ' ' A' ' 65' ' ' PRO . 48.4 p90 -123.34 141.33 52.1 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.336 -0.546 . . . . 0.93000000000000005 111.564 -179.117 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.8 mt -128.04 127.6 43.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.349 -0.841 . . . . 0.34000000000000002 109.001 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -101.65 131.1 48.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.207 0.527 . . . . 1.0900000000000001 111.783 -178.761 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.87 157.62 73.09 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.308 -0.86 . . . . 0.19 109.586 179.647 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -69.75 157.98 58.56 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 C-N-CA 122.431 2.087 . . . . 0.17999999999999999 112.29 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.23 -12.22 5.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.871 -0.604 . . . . 0.20999999999999999 110.725 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.9 p -92.83 -8.73 42.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.107 -0.497 . . . . 0.28999999999999998 110.753 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.15 135.35 34.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.451 . . . . 0.5 110.436 179.672 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 p -133.11 16.71 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.437 -0.347 . . . . 0.29999999999999999 110.536 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.9 p -167.52 147.04 5.07 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.639 -0.504 . . . . 0.23000000000000001 109.639 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.545 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.21 150.42 12.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.567 -0.453 . . . . 0.28000000000000003 111.63 -179.658 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.505 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.32 124.96 50.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.595 -0.729 . . . . 1.0700000000000001 109.832 179.519 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.38 104.92 29.88 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.882 0.372 . . . . 0.28999999999999998 111.03 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.1 Cg_endo -91.0 -179.44 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 123.175 2.583 . . . . 0.42999999999999999 112.137 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.54 32.69 18.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.362 -0.835 . . . . 1.26 111.49 179.325 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.425 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.1 mt -86.33 148.54 25.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.427 -0.351 . . . . 0.32000000000000001 110.435 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.771 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.35 114.82 61.19 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.026 0.441 . . . . 0.57999999999999996 110.705 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.96 140.55 95.82 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.904 2.403 . . . . 0.66000000000000003 111.969 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.1 21.24 74.17 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.064 -0.814 . . . . 0.28999999999999998 111.064 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.445 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.87 150.18 49.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.808 0.337 . . . . 2.3300000000000001 110.631 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.493 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.26 131.61 46.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.85999999999999999 109.737 179.381 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.969 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.45 148.2 44.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.107 -0.497 . . . . 0.52000000000000002 111.119 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.31 125.4 60.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.275 -1.009 . . . . 0.29999999999999999 108.275 177.728 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.5 132.54 63.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.156 0.503 . . . . 0.23000000000000001 111.249 -178.613 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.55 122.63 20.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.485 -0.78 . . . . 0.35999999999999999 109.553 179.288 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.584 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.0 125.4 54.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.224 -0.443 . . . . 0.19 110.658 -179.526 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 47.9 m-85 -117.23 137.79 52.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.101 -0.5 . . . . 0.29999999999999999 109.921 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.43 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.74 135.01 42.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.743 -0.836 . . . . 0.37 108.743 178.922 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.647 HD11 ' NH1' ' A' ' 143' ' ' ARG . 42.1 mm -99.1 122.91 51.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.107 0.479 . . . . 0.26000000000000001 110.949 -178.757 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.6 p -83.86 169.67 14.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.483 -0.78 . . . . 0.28000000000000003 110.447 -179.679 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.59 ' CD ' ' O ' ' A' ' 138' ' ' THR . 41.0 mp0 -59.64 -14.6 14.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.975 -0.557 . . . . 1.6000000000000001 111.036 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.8 m-20 -96.16 -4.21 43.06 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.853 -0.339 . . . . 1.1799999999999999 110.765 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.736 ' O ' ' NE2' ' A' ' 191' ' ' GLN . . . 87.69 13.94 64.13 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.366 -0.693 . . . . 0.29999999999999999 111.366 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -84.61 139.1 32.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.63 0.252 . . . . 1.22 110.484 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.736 ' NE2' ' O ' ' A' ' 189' ' ' GLY . 0.0 OUTLIER -106.69 141.06 38.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 0.97999999999999998 110.564 179.733 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.67 127.0 26.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.82999999999999996 110.392 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.11 117.35 9.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.323 -0.399 . . . . 0.26000000000000001 110.531 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.04 -21.91 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.29999999999999999 110.659 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.9 125.78 5.88 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.527 -0.469 . . . . 0.31 111.507 -179.758 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.473 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.77 120.2 21.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.77 -0.65 . . . . 0.28000000000000003 109.539 179.249 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.6 151.66 29.09 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.724 -0.39 . . . . 0.23999999999999999 110.938 -179.271 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.42 158.61 18.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 0.23000000000000001 110.404 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -146.16 157.91 43.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.502 . . . . 0.67000000000000004 110.666 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.27 104.3 9.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.801 -0.636 . . . . 0.64000000000000001 110.007 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.5 p . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 117.948 -1.025 . . . . 1.26 110.641 -179.743 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.203 -0.666 . . . . 3.4399999999999999 109.203 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.34 150.67 18.55 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.037 -0.825 . . . . 1.22 111.037 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -35.67 142.38 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 124.039 3.159 . . . . 0.75 113.792 -179.226 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.622 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -79.98 173.41 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.281 -1.327 . . . . 0.79000000000000004 108.881 178.428 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.622 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.6 125.86 51.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.214 0.531 . . . . 1.9399999999999999 111.354 -179.526 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 143.98 33.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.564 -0.744 . . . . 0.59999999999999998 110.596 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -151.99 168.35 25.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.943 0.401 . . . . 3.1400000000000001 111.076 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.738 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.97 131.02 60.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.974 -0.557 . . . . 3.23 110.076 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.19 162.33 35.74 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.834 0.349 . . . . 3.6299999999999999 111.197 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 79.9 mm-40 36.13 31.59 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 109.547 -0.538 . . . . 6.0800000000000001 109.547 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.738 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.48 69.56 32.95 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.964 -0.562 . . . . 3.3799999999999999 111.624 -178.831 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.22 -29.11 73.27 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.414 2.076 . . . . 3.9300000000000002 111.856 179.351 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.124 -0.489 . . . . 3.3599999999999999 110.49 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.534 ' OE1' ' O ' ' A' ' 13' ' ' SER . 2.0 mp0 -123.93 158.4 60.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.304 -0.407 . . . . 3.6099999999999999 110.379 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.571 ' HD2' HE22 ' A' ' 191' ' ' GLN . 98.3 Cg_endo -82.09 -64.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.922 2.415 . . . . 1.51 113.431 -178.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.627 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 60.7 t30 -108.46 -19.53 13.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.312 -0.404 . . . . 2.6800000000000002 112.065 -178.477 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 4.2 p -107.26 152.02 24.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.149 0.499 . . . . 1.21 111.313 -179.489 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.25 102.94 2.23 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.723 -0.671 . . . . 1.5600000000000001 110.68 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.65 145.61 13.05 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.847 2.365 . . . . 0.81000000000000005 112.651 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.91 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.84 167.84 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.949 -0.569 . . . . 1.52 109.843 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.05 148.02 29.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.826 -0.435 . . . . 2.1400000000000001 109.826 178.814 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.594 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.25 157.2 45.1 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.66 -0.416 . . . . 0.32000000000000001 111.203 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.492 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -127.98 155.29 44.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.783 -0.644 . . . . 2.1699999999999999 110.129 178.903 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.83 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.57 173.05 6.34 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.172 -0.467 . . . . 0.58999999999999997 110.807 -179.224 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.83 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.1 Cg_exo -50.74 173.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 122.839 2.359 . . . . 0.90000000000000002 111.449 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.48 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.03 -51.04 0.69 Allowed Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.688 -0.405 . . . . 3.3399999999999999 110.062 179.868 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.619 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.8 Cg_exo -64.87 152.32 82.62 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.789 2.326 . . . . 1.8500000000000001 111.441 179.258 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.75 42.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.465 0.65 . . . . 2.54 110.547 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.619 ' H ' ' C ' ' A' ' 27' ' ' PRO . 73.9 t60 -63.66 -41.73 98.16 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.962 -1.017 . . . . 2.5299999999999998 110.65 179.722 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.561 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.5 mt -109.73 137.91 39.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.711 -0.677 . . . . 1.1699999999999999 111.343 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.93 -73.01 0.7 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.084 -0.507 . . . . 1.27 111.874 -178.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.19 148.41 24.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.575 0.583 . . . . 1.1200000000000001 112.575 -179.545 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -121.86 124.81 45.0 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.341 -0.615 . . . . 0.41999999999999998 109.341 177.6 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.09 134.68 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.721 -0.391 . . . . 0.78000000000000003 110.614 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.91 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.98 128.59 53.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.055 0.455 . . . . 0.62 111.326 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.549 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.04 138.95 49.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.738 -0.664 . . . . 1.97 110.153 179.014 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.433 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -145.04 163.17 35.07 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 121.133 0.492 . . . . 0.34999999999999998 112.098 -178.166 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.491 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.48 139.57 7.86 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.42 -0.809 . . . . 1.8 110.482 178.85 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.8 Cg_endo -63.64 115.53 3.11 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.25 1.966 . . . . 0.57999999999999996 111.852 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.67 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.93 81.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.871 -0.418 . . . . 3.04 109.871 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.16 -20.62 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.015 -0.538 . . . . 2.4700000000000002 111.899 -179.546 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 p -157.7 157.76 34.12 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.812 -0.355 . . . . 2.5099999999999998 110.56 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.36 27.87 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.173 -0.467 . . . . 1.8600000000000001 110.178 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.83 -75.94 1.31 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.129 -0.557 . . . . 1.4399999999999999 111.808 -179.243 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.88 152.29 35.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.918 0.389 . . . . 4.6900000000000004 111.021 -179.312 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.12 2.53 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.093 -0.503 . . . . 1.4299999999999999 111.902 179.44 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.431 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.18 149.77 29.62 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 121.433 0.635 . . . . 1.74 112.543 -177.867 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.12 156.45 45.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.834 -1.076 . . . . 1.9199999999999999 110.154 178.684 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.22 158.4 41.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.848 -0.614 . . . . 0.34000000000000002 111.773 -179.403 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.9 m -115.17 135.64 53.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.476 -0.783 . . . . 0.40999999999999998 109.839 179.308 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.594 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.44 121.91 23.71 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.483 -0.326 . . . . 0.55000000000000004 111.528 -179.09 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.5 Cg_exo -46.26 151.67 1.6 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.663 2.242 . . . . 0.44 112.212 178.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.97 -22.96 63.1 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 116.097 -0.502 . . . . 0.73999999999999999 112.755 -179.162 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.54 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.1 p-80 -82.75 -16.95 46.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.432 0.616 . . . . 0.93000000000000005 111.815 -178.372 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.605 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.58 138.31 31.67 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.773 -0.371 . . . . 0.96999999999999997 110.354 179.354 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -121.48 13.95 11.04 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.353 -0.385 . . . . 1.3400000000000001 111.564 -179.383 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.0 p -149.96 143.51 25.27 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.654 -0.418 . . . . 0.39000000000000001 111.034 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.84 -169.38 1.54 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.052 -0.522 . . . . 0.41999999999999998 110.894 -179.463 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.711 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 t -151.77 125.89 9.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.427 -0.806 . . . . 0.39000000000000001 109.795 179.273 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.511 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.91 123.22 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.396 -0.522 . . . . 0.73999999999999999 111.196 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.744 ' HD3' HG21 ' A' ' 185' ' ' ILE . 53.1 mtmt -126.4 163.31 23.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.809 -0.632 . . . . 2.48 110.514 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.477 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.2 18.83 60.07 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.823 -0.911 . . . . 0.5 110.823 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.627 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.7 mt -78.93 157.3 28.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.002 0.43 . . . . 0.57999999999999996 111.446 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.855 ' O ' HG12 ' A' ' 67' ' ' VAL . 2.9 mptp? -99.53 133.98 21.49 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.638 -0.71 . . . . 2.79 110.422 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.96 ' HB3' ' O ' ' A' ' 93' ' ' SER . 36.6 Cg_endo -67.82 143.51 61.47 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.613 2.209 . . . . 0.87 111.901 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.96 25.55 75.45 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.987 -0.845 . . . . 0.64000000000000001 110.987 179.566 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.855 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.1 158.71 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.654 0.264 . . . . 0.82999999999999996 110.408 -179.532 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.09 139.98 41.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.85 0.357 . . . . 0.5 110.593 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.64 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.53 136.45 54.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.035 -0.53 . . . . 0.53000000000000003 110.687 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.491 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.89 131.08 45.25 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.522 -0.918 . . . . 1.8700000000000001 108.522 177.482 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.486 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.58 153.9 16.67 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.273 -0.965 . . . . 0.28999999999999998 111.924 -178.67 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -134.98 140.91 46.06 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.699 -0.482 . . . . 1.4299999999999999 109.699 179.616 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.71 118.86 34.22 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.398 -0.521 . . . . 0.32000000000000001 110.494 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.735 HG12 HG23 ' A' ' 84' ' ' VAL . 63.8 mt -112.45 129.11 68.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.372 -0.377 . . . . 0.79000000000000004 110.66 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.83 120.84 43.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.289 -0.414 . . . . 1.02 110.726 -179.657 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.849 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.52 146.41 11.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.099 0.476 . . . . 0.62 111.042 -179.238 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.626 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.03 153.89 21.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.586 -0.733 . . . . 2.4399999999999999 109.963 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.18 88.55 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.856 0.36 . . . . 3.6899999999999999 110.425 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.34 32.58 0.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.814 -0.63 . . . . 6.0800000000000001 110.605 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.15 -117.32 3.28 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.471 -0.652 . . . . 1.22 111.471 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.42 177.4 8.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.293 0.568 . . . . 2.8799999999999999 111.593 -179.188 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.19 149.57 32.18 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.397 -0.82 . . . . 1.47 110.365 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.22 144.59 38.55 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.396 -0.365 . . . . 2.7000000000000002 110.59 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.735 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.91 136.02 61.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 121.13 0.49 . . . . 0.46000000000000002 111.462 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.09 141.27 52.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.593 -0.73 . . . . 0.34999999999999998 110.34 179.55 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.467 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.4 ttp180 -117.56 138.88 51.62 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.573 -0.451 . . . . 3.6699999999999999 111.598 -179.4 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.486 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.23 164.15 37.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.59 -0.732 . . . . 0.67000000000000004 109.513 179.452 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.572 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 46.9 p30 -145.27 151.56 38.55 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.374 -0.53 . . . . 1.47 111.059 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.28 172.76 13.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.74 -0.664 . . . . 0.44 111.012 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.71 160.61 21.54 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.483 -0.781 . . . . 1.3700000000000001 109.937 179.636 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.38 121.88 22.96 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.548 -0.461 . . . . 1.28 110.742 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.541 ' O ' ' CB ' ' A' ' 93' ' ' SER . 70.1 p -124.86 154.63 40.75 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 113.092 0.775 . . . . 1.97 113.092 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.96 ' O ' ' HB3' ' A' ' 65' ' ' PRO . 27.6 t 109.94 142.86 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 113.607 -1.633 . . . . 3.2799999999999998 108.04 -178.92 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.965 ' HA ' ' HG2' ' A' ' 155' ' ' PRO . 36.4 p 70.7 35.74 1.75 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -179.236 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 154' ' ' GLU . 29.9 t -44.01 150.3 0.28 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.988 -0.445 . . . . 0.0 110.606 179.176 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 p -107.58 151.93 41.22 Favored Pre-proline 0 N--CA 1.468 0.434 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.764 -178.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.426 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 38.2 Cg_endo -64.91 144.41 82.79 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 122.917 2.411 . . . . 0.0 113.499 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.6 m -129.9 154.64 40.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.074 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.4 p -124.88 156.78 37.37 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.622 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.6 t 175.38 107.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.679 178.791 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -111.43 120.69 43.02 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.673 0.273 . . . . 0.0 111.03 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.3 p -74.08 -23.36 59.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.268 179.019 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.9 m -129.46 161.07 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.825 -179.311 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.1 p -78.75 162.83 25.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.161 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.12 -178.43 52.28 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -179.131 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -112.62 157.1 21.63 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.797 0.332 . . . . 0.0 110.68 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.6 m -76.22 138.58 40.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.198 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.4 p -108.6 160.04 28.68 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.387 -179.337 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -51.7 145.49 30.49 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.191 1.927 . . . . 0.0 112.102 179.621 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -58.92 -37.59 77.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.405 -178.714 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.804 ' H ' ' HD2' ' A' ' 112' ' ' PRO . 1.0 OUTLIER -163.26 -37.65 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.805 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.804 ' HD2' ' H ' ' A' ' 111' ' ' SER . 79.8 Cg_exo -46.6 -140.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 122.528 2.152 . . . . 0.0 113.463 -178.204 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.787 ' N ' HD22 ' A' ' 113' ' ' LEU . 1.4 mm? -85.21 144.48 28.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.266 -0.425 . . . . 10.19 110.074 -179.171 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.7 m -127.14 158.26 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.946 -0.57 . . . . 7.2800000000000002 110.803 -179.171 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.57 148.12 25.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.874 -0.603 . . . . 7.2999999999999998 109.872 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.8 m -71.42 135.05 47.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.132 0.491 . . . . 6.4400000000000004 110.872 -179.122 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.482 ' OG ' ' N ' ' A' ' 118' ' ' GLU . 27.8 t 177.78 -122.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.228 -0.897 . . . . 4.4199999999999999 109.221 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.482 ' N ' ' OG ' ' A' ' 117' ' ' SER . 84.4 tt0 -57.83 -32.17 67.35 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.347 -0.612 . . . . 3.0499999999999998 109.347 178.856 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 118' ' ' GLU . 11.7 t 51.83 168.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.443 -0.799 . . . . 3.4300000000000002 111.633 179.737 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 44.8 t -116.6 136.9 52.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.395 -0.82 . . . . 2.8799999999999999 110.306 -179.602 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 43.7 m -75.64 137.44 40.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.315 -0.402 . . . . 2.0899999999999999 110.372 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -105.55 153.11 22.22 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.133 -0.485 . . . . 4.5300000000000002 110.55 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 16.3 pt -69.01 -9.82 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 1.4399999999999999 110.935 -179.816 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 19.1 p -119.43 159.31 24.47 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.781 -0.451 . . . . 1.78 109.781 178.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -148.59 155.47 41.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.996 0.426 . . . . 0.64000000000000001 110.915 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.601 ' CB ' ' HB ' ' A' ' 201' ' ' THR . 33.5 p -75.76 63.93 1.7 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 122.571 1.177 . . . . 0.66000000000000003 109.69 179.163 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.436 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.93 167.58 0.26 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.208 -1.36 . . . . 0.68999999999999995 110.979 -178.914 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.52 145.57 50.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.727 -0.669 . . . . 0.52000000000000002 110.169 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.28 101.67 9.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.075 -0.713 . . . . 0.32000000000000001 109.075 177.702 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.1 t -112.94 139.6 37.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.018 -0.537 . . . . 0.28999999999999998 111.117 -178.911 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.9 p -128.58 152.55 48.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.692 -0.686 . . . . 0.25 109.839 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.594 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.82 -164.97 2.04 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.661 -0.416 . . . . 0.31 110.655 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.734 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.9 t -123.88 127.23 73.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.48999999999999999 110.891 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.168 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.98 58.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 1.53 110.322 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.07 24.5 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 0.96999999999999997 111.574 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.168 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.2 128.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.622 -0.431 . . . . 1.5600000000000001 110.919 179.905 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.55 -9.51 55.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.92 -0.582 . . . . 1.8799999999999999 110.354 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.18 0.18 55.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.086 -0.506 . . . . 1.04 110.275 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.721 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.16 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.976 -0.556 . . . . 0.23999999999999999 109.881 179.757 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 185' ' ' ILE . 89.3 p -96.2 -15.53 21.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.313 0.578 . . . . 0.28999999999999998 110.101 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.64 175.64 45.87 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 109.891 -1.284 . . . . 0.13 109.891 179.573 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.51 151.54 42.69 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.605 -0.438 . . . . 0.17000000000000001 110.55 179.769 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.536 ' CZ ' ' HG3' ' A' ' 15' ' ' PRO . 64.1 ttp85 -132.2 121.14 23.21 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.148 -0.478 . . . . 1.29 109.936 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.551 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.11 136.48 38.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.782 -0.644 . . . . 0.25 110.713 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 80.2 tt0 -129.28 129.85 45.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.879 -0.6 . . . . 1.3200000000000001 110.121 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.618 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.3 p90 -138.66 135.34 34.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.998 -0.546 . . . . 0.56999999999999995 110.614 -179.686 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.422 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.41 161.4 39.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.792 -0.64 . . . . 1.1599999999999999 109.617 179.84 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.961 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.15 124.95 25.61 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.606 -0.438 . . . . 0.38 110.749 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.502 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.84 -7.57 49.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.753 -0.658 . . . . 0.40999999999999998 110.916 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -109.87 -69.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.01 0.433 . . . . 1.6599999999999999 111.354 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.438 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.65 -35.36 76.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.066 -0.515 . . . . 1.6599999999999999 111.466 -179.093 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.091 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.13 7.23 88.59 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.763 -0.935 . . . . 1.1699999999999999 110.763 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.314 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.96 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.777 0.322 . . . . 1.8600000000000001 110.32 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.314 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.33 139.08 44.92 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.036 0.446 . . . . 1.98 110.192 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.965 ' HG2' ' HA ' ' A' ' 94' ' ' THR . 46.8 Cg_endo -70.89 145.81 51.61 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.778 2.318 . . . . 0.55000000000000004 112.309 -179.48 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.85 145.73 42.61 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.184 -0.673 . . . . 1.1399999999999999 109.184 179.237 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.624 ' CE1' ' CG ' ' A' ' 16' ' ' ASN . 7.6 p90 -123.35 141.36 52.06 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.249 -0.58 . . . . 0.93000000000000005 111.449 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.4 mt -128.11 127.64 43.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.228 -0.896 . . . . 0.34000000000000002 109.039 178.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -101.66 131.18 48.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.199 0.523 . . . . 1.0900000000000001 111.72 -178.67 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.98 157.53 73.58 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.315 -0.857 . . . . 0.19 109.521 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -69.81 158.02 58.3 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 122.307 2.005 . . . . 0.17999999999999999 112.291 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.13 -12.25 4.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.831 -0.622 . . . . 0.20999999999999999 110.759 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.86 -8.82 42.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.103 -0.499 . . . . 0.28999999999999998 110.676 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.06 135.27 34.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.35 -0.386 . . . . 0.5 110.473 179.675 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.9 p -133.06 16.66 4.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.489 -0.323 . . . . 0.29999999999999999 110.573 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.1 p -167.53 147.12 5.09 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.624 -0.51 . . . . 0.23000000000000001 109.624 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.551 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.18 150.5 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.564 -0.455 . . . . 0.28000000000000003 111.526 -179.663 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.507 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.24 124.91 50.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.566 -0.743 . . . . 1.0700000000000001 109.832 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.39 104.84 29.43 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.83 0.348 . . . . 0.28999999999999998 111.08 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.0 Cg_endo -90.92 -179.47 1.51 Allowed 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 123.186 2.591 . . . . 0.42999999999999999 112.172 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 61.59 32.61 18.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.331 -0.85 . . . . 1.26 111.476 179.256 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.8 mt -86.27 148.53 25.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.469 -0.332 . . . . 0.32000000000000001 110.522 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.766 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.4 mt -88.28 114.89 61.45 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.959 0.409 . . . . 0.57999999999999996 110.721 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.12 140.61 95.81 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.826 2.351 . . . . 0.66000000000000003 112.01 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.11 21.17 74.32 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.028 -0.829 . . . . 0.28999999999999998 111.028 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.438 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.8 mmm-85 -126.83 150.31 49.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 2.3300000000000001 110.625 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.502 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.28 131.65 46.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.978 -0.555 . . . . 0.85999999999999999 109.814 179.316 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.961 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.55 148.36 43.96 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.113 -0.494 . . . . 0.52000000000000002 110.974 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.5 mt -105.35 125.38 60.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.296 -1.002 . . . . 0.29999999999999999 108.296 177.723 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.52 132.44 63.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.177 0.513 . . . . 0.23000000000000001 111.222 -178.527 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.62 20.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.64 -0.709 . . . . 0.35999999999999999 109.633 179.216 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.594 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.97 125.46 54.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 0.19 110.71 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.26 137.87 52.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.048 -0.524 . . . . 0.29999999999999999 109.891 179.51 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.42 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.73 135.06 42.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.765 -0.828 . . . . 0.37 108.765 178.887 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.744 HG21 ' HD3' ' A' ' 61' ' ' LYS . 63.1 mt -99.03 122.91 51.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.106 0.479 . . . . 0.26000000000000001 110.956 -178.75 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.4 p -83.88 169.66 14.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.563 -0.744 . . . . 0.28000000000000003 110.54 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -59.76 -14.49 14.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.085 -0.507 . . . . 1.6000000000000001 110.914 -179.466 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 94.7 m-20 -96.13 -4.31 42.97 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.79 -0.364 . . . . 1.1799999999999999 110.769 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.82 13.96 63.83 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.316 -0.713 . . . . 0.29999999999999999 111.316 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -84.64 139.13 32.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.642 0.258 . . . . 1.22 110.443 179.658 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.571 HE22 ' HD2' ' A' ' 15' ' ' PRO . 41.0 mt-30 -106.79 141.06 38.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.97 0.414 . . . . 0.97999999999999998 110.552 179.709 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.1 m -136.62 127.11 26.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.487 . . . . 0.82999999999999996 110.408 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.2 117.31 9.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.39 -0.368 . . . . 0.26000000000000001 110.438 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 43.9 pt -109.09 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.29999999999999999 110.744 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.92 125.68 5.83 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.477 -0.489 . . . . 0.31 111.475 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.474 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.71 120.21 21.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.731 -0.668 . . . . 0.28000000000000003 109.58 179.191 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.58 151.69 29.15 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.71 -0.396 . . . . 0.23999999999999999 110.881 -179.242 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.54 158.58 18.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.23000000000000001 110.339 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.4 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 68.2 mt-30 -146.03 157.94 43.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.031 -0.531 . . . . 0.67000000000000004 110.714 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.39 9.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.753 -0.658 . . . . 0.64000000000000001 110.05 179.568 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.601 ' HB ' ' CB ' ' A' ' 126' ' ' SER . 67.9 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 117.829 -1.081 . . . . 1.26 110.619 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.5 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.196 -0.668 . . . . 3.4399999999999999 109.196 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.64 18.55 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.999 -0.84 . . . . 1.22 110.999 179.753 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -35.5 142.39 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 124.002 3.135 . . . . 0.75 113.794 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.607 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.3 t -80.06 173.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.246 -1.343 . . . . 0.79000000000000004 108.825 178.451 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.607 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.55 125.98 51.6 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.45 -0.5 . . . . 1.9399999999999999 111.412 -179.567 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.62 143.91 34.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.658 -0.701 . . . . 0.59999999999999998 110.667 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.4 25.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.925 0.393 . . . . 3.1400000000000001 111.042 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.742 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -109.06 131.05 60.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.926 -0.579 . . . . 3.23 110.091 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.8 p -141.17 162.37 35.64 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.438 -0.347 . . . . 3.6299999999999999 111.249 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 9' ' ' THR . 96.3 mt-10 35.98 31.65 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.616 -0.513 . . . . 6.0800000000000001 109.616 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.742 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.51 69.64 33.42 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.007 -0.542 . . . . 3.3799999999999999 111.609 -178.833 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.23 -29.18 73.3 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.5 2.133 . . . . 3.9300000000000002 111.868 179.32 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.63 125.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.493 . . . . 3.3599999999999999 110.514 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.716 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -123.89 158.39 60.17 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.306 -0.407 . . . . 3.6099999999999999 110.45 -179.988 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.562 ' HG3' ' CZ ' ' A' ' 143' ' ' ARG . 98.2 Cg_endo -82.1 -64.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.916 2.411 . . . . 1.51 113.44 -178.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.462 ' OD1' ' HB2' ' A' ' 157' ' ' TYR . 6.5 m120 -108.4 -19.52 13.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.065 0.394 . . . . 2.6800000000000002 112.065 -178.48 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.716 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 7.0 p -107.48 152.0 24.81 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.436 -0.506 . . . . 1.21 111.28 -179.361 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.57 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.18 102.94 2.25 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.709 -0.678 . . . . 1.5600000000000001 110.654 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -82.74 145.64 12.93 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.879 2.386 . . . . 0.81000000000000005 112.577 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.912 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.85 167.96 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.871 -0.604 . . . . 1.52 109.892 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -149.12 147.97 29.12 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.708 -0.478 . . . . 2.1400000000000001 109.708 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.593 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.3 157.23 45.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.04 0.448 . . . . 0.32000000000000001 111.188 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.49 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -128.03 155.19 44.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.705 -0.679 . . . . 2.1699999999999999 110.101 179.055 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.84 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.58 173.01 6.39 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.155 0.503 . . . . 0.58999999999999997 110.688 -179.153 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.84 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.62 173.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 122.831 2.354 . . . . 0.90000000000000002 111.555 179.365 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.484 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.04 -51.13 0.69 Allowed Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.76 -0.376 . . . . 3.3399999999999999 110.074 179.831 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.623 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.81 152.35 82.45 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.813 2.342 . . . . 1.8500000000000001 111.426 179.259 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.76 42.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.418 0.628 . . . . 2.54 110.526 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.623 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.6 t60 -63.54 -41.71 98.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.964 -1.016 . . . . 2.5299999999999998 110.642 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.568 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.7 mt -109.8 137.79 40.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.857 -0.611 . . . . 1.1699999999999999 111.305 -179.416 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.95 -72.92 0.7 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.105 -0.498 . . . . 1.27 111.891 -178.955 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.16 148.43 24.42 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.571 0.582 . . . . 1.1200000000000001 112.571 -179.649 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.79 124.83 45.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.36 -0.607 . . . . 0.41999999999999998 109.36 177.493 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -117.97 134.72 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.685 -0.406 . . . . 0.78000000000000003 110.676 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.912 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.01 128.65 53.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.421 . . . . 0.62 111.233 179.742 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.551 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 138.89 49.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.766 -0.652 . . . . 1.97 110.156 178.998 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.438 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -144.99 163.25 34.76 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.118 0.485 . . . . 0.34999999999999998 112.113 -178.114 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.491 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.53 139.55 7.81 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.493 -0.776 . . . . 1.8 110.485 178.887 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.59 115.44 3.05 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.279 1.986 . . . . 0.57999999999999996 111.865 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.673 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.95 81.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.925 -0.398 . . . . 3.04 109.925 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.921 -0.582 . . . . 2.4700000000000002 111.95 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -157.68 157.76 34.15 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.813 -0.355 . . . . 2.5099999999999998 110.523 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.37 27.9 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 1.8600000000000001 110.147 179.569 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.83 -75.91 1.31 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.154 -0.546 . . . . 1.4399999999999999 111.832 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.4 mtp180 -117.82 152.33 35.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.943 0.401 . . . . 4.6900000000000004 110.959 -179.32 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.35 -169.11 2.51 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.976 -0.556 . . . . 1.4299999999999999 111.954 179.271 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.436 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.05 149.61 29.76 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.483 0.659 . . . . 1.74 112.532 -177.772 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.02 156.5 46.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.788 -1.096 . . . . 1.9199999999999999 110.199 178.588 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.24 158.42 41.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.932 -0.576 . . . . 0.34000000000000002 111.777 -179.407 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.3 m -115.13 135.62 54.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.479 -0.782 . . . . 0.40999999999999998 109.838 179.324 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.593 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.4 122.04 23.79 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.444 -0.344 . . . . 0.55000000000000004 111.497 -179.164 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.4 Cg_exo -46.43 151.78 1.69 Allowed 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.692 2.261 . . . . 0.44 112.128 179.046 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.0 -22.99 63.21 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 116.044 -0.526 . . . . 0.73999999999999999 112.728 -179.116 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.54 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.83 -16.8 46.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.383 0.592 . . . . 0.93000000000000005 111.818 -178.352 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.603 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.68 138.37 31.62 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.716 -0.393 . . . . 0.96999999999999997 110.25 179.387 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.5 14.06 11.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.342 -0.39 . . . . 1.3400000000000001 111.601 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.472 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -150.0 143.39 25.16 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.682 -0.407 . . . . 0.39000000000000001 111.07 179.607 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.709 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.84 -169.33 1.53 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.222 0.534 . . . . 0.41999999999999998 110.844 -179.439 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.709 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.75 125.87 9.23 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.439 -0.8 . . . . 0.39000000000000001 109.887 179.283 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.513 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.85 123.3 70.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.372 -0.531 . . . . 0.73999999999999999 111.143 -179.673 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.632 ' CD ' HD13 ' A' ' 185' ' ' ILE . 56.1 mtmt -126.59 163.4 23.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.827 -0.624 . . . . 2.48 110.381 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.11 18.93 60.01 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.817 -0.913 . . . . 0.5 110.817 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.513 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.3 mt -79.04 157.32 28.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.106 0.479 . . . . 0.57999999999999996 111.369 -179.65 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.846 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -99.53 134.0 21.48 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.601 -0.727 . . . . 2.79 110.404 179.811 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.94 143.59 61.1 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.533 2.155 . . . . 0.87 111.925 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.88 25.51 75.48 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 111.056 -0.818 . . . . 0.64000000000000001 111.056 179.685 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.846 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.07 158.91 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.667 0.27 . . . . 0.82999999999999996 110.421 -179.639 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.23 139.96 42.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.393 -0.367 . . . . 0.5 110.588 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.668 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 94.0 m-85 -122.65 136.52 54.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.906 -0.588 . . . . 0.53000000000000003 110.713 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.94 131.03 45.32 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.527 -0.916 . . . . 1.8700000000000001 108.527 177.661 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.48 153.89 16.65 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.331 -0.937 . . . . 0.28999999999999998 111.931 -178.558 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -135.02 140.88 45.99 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.69 -0.485 . . . . 1.4299999999999999 109.69 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.71 118.8 34.08 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.513 -0.475 . . . . 0.32000000000000001 110.509 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.725 HG12 HG23 ' A' ' 84' ' ' VAL . 63.7 mt -112.32 129.0 68.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.357 -0.383 . . . . 0.79000000000000004 110.707 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.708 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.79 120.76 43.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.374 -0.375 . . . . 1.02 110.785 -179.694 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.849 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.55 146.57 11.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.219 0.533 . . . . 0.62 111.017 -179.255 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.625 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.11 153.81 21.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.523 -0.762 . . . . 2.4399999999999999 109.948 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.25 88.66 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.012 0.434 . . . . 3.6899999999999999 110.448 -179.68 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.22 32.74 0.21 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.786 -0.643 . . . . 6.0800000000000001 110.56 -179.871 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.22 -117.41 3.27 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.443 -0.663 . . . . 1.22 111.443 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.31 177.3 9.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.168 0.509 . . . . 2.8799999999999999 111.635 -179.229 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.09 149.57 32.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.428 -0.805 . . . . 1.47 110.34 179.186 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.14 144.64 38.72 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.429 -0.35 . . . . 2.7000000000000002 110.509 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.725 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.06 136.09 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 121.056 0.455 . . . . 0.46000000000000002 111.525 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.559 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.05 141.26 52.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.653 -0.703 . . . . 0.34999999999999998 110.277 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.453 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.61 138.86 51.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.127 0.489 . . . . 3.6699999999999999 111.481 -179.374 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.3 164.2 37.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.534 -0.757 . . . . 0.67000000000000004 109.518 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.23 151.61 38.66 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.43 -0.508 . . . . 1.47 111.131 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.811 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.32 172.69 13.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.82 -0.627 . . . . 0.44 110.998 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.76 160.75 21.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.455 -0.793 . . . . 1.3700000000000001 109.897 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.39 121.91 22.98 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.584 -0.446 . . . . 1.28 110.67 -179.943 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.592 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.6 p -127.44 165.36 19.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.469 0.652 . . . . 1.97 112.562 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.6 t -65.49 161.4 20.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.211 -0.904 . . . . 3.2799999999999998 109.978 178.727 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 12.9 t -67.88 166.19 16.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.18 0.514 . . . . 0.0 111.442 -178.757 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.794 ' O ' ' O ' ' A' ' 96' ' ' THR . 60.7 p -64.58 169.09 5.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.716 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.794 ' O ' ' O ' ' A' ' 95' ' ' SER . 0.1 OUTLIER -14.62 153.1 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.831 0 O-C-N 123.982 0.801 . . . . 0.0 112.348 -178.753 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.48 138.38 65.87 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.948 1.766 . . . . 0.0 112.476 -178.561 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 82.4 t -63.89 -34.92 71.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.774 179.783 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.9 m -67.06 136.66 55.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.289 0.566 . . . . 0.0 110.995 -178.475 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.7 m -119.57 153.06 36.0 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.15 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.478 ' O ' ' OE2' ' A' ' 106' ' ' GLU . 25.4 t30 61.49 50.53 4.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.953 0.406 . . . . 0.0 110.677 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 69.4 p -61.16 -7.54 2.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.421 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -59.36 137.47 21.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.459 -179.609 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.0 p -77.87 166.86 22.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.529 -178.662 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.41 -2.05 56.09 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.478 ' OE2' ' O ' ' A' ' 101' ' ' ASN . 96.1 mt-10 -61.08 145.94 49.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.769 0.319 . . . . 0.0 110.522 178.677 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.7 m -73.11 139.08 46.19 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.2 p -121.7 77.09 37.83 Favored Pre-proline 0 N--CA 1.465 0.315 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -178.453 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.21 -17.3 51.78 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.232 1.955 . . . . 0.0 110.849 178.814 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -86.52 8.36 22.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.787 -179.339 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.1 m -120.71 80.1 31.7 Favored Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.498 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.59 152.8 20.32 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 123.057 2.505 . . . . 0.0 113.178 -179.533 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 26.9 tp -90.67 139.75 30.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.226 -0.897 . . . . 10.19 109.141 179.342 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.553 HG22 ' H ' ' A' ' 116' ' ' THR . 11.5 p -121.64 143.01 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.442 0.639 . . . . 7.2800000000000002 111.052 -178.385 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.44 -22.18 66.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.914 -1.039 . . . . 7.2999999999999998 112.823 -178.268 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.553 ' H ' HG22 ' A' ' 114' ' ' VAL . 43.1 p -71.14 155.23 41.0 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.041 -0.663 . . . . 6.4400000000000004 111.197 -178.52 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.0 m -71.96 157.96 36.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.145 -0.934 . . . . 4.4199999999999999 112.579 -178.788 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -59.53 -24.26 63.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.917 -1.038 . . . . 3.0499999999999998 110.017 178.315 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -53.95 -21.92 9.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.615 -0.72 . . . . 3.4300000000000002 111.796 -178.066 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.2 m -55.62 144.39 7.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.948 -0.76 . . . . 2.8799999999999999 108.948 179.065 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.656 HG22 ' H ' ' A' ' 123' ' ' ILE . 33.7 m -65.98 129.27 39.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.268 0.556 . . . . 2.0899999999999999 111.266 -177.562 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -97.68 11.36 37.33 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.178 -0.919 . . . . 4.5300000000000002 112.598 -179.516 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.656 ' H ' HG22 ' A' ' 121' ' ' THR . 15.5 tt -117.64 137.94 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.626 0.727 . . . . 1.4399999999999999 111.937 -178.318 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.543 ' O ' ' C ' ' A' ' 125' ' ' ALA . 49.1 m -120.01 144.98 47.23 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 114.747 -1.115 . . . . 1.78 109.739 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.543 ' C ' ' O ' ' A' ' 124' ' ' THR . . . -16.25 -76.92 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.434 0.459 . . . . 0.64000000000000001 112.204 -178.64 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.402 ' O ' HD12 ' A' ' 172' ' ' LEU . 20.9 p 179.64 -58.92 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.643 -0.423 . . . . 0.66000000000000003 111.652 179.652 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.437 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.96 167.56 0.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.075 -0.511 . . . . 0.68999999999999995 110.946 -179.033 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.57 145.52 50.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.79 -0.641 . . . . 0.52000000000000002 110.078 -179.884 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.26 101.78 9.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.055 -0.72 . . . . 0.32000000000000001 109.055 177.648 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.2 t -113.05 139.72 36.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.28999999999999998 110.942 -178.818 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.2 p -128.74 152.63 48.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.588 -0.733 . . . . 0.25 109.781 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.594 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.83 -165.06 2.06 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.793 -0.363 . . . . 0.31 110.638 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -123.89 127.15 73.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.466 . . . . 0.48999999999999999 110.896 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.173 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.84 58.26 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.123 -0.489 . . . . 1.53 110.365 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.743 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.08 24.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.936 -0.575 . . . . 0.96999999999999997 111.44 -179.705 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.173 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.14 128.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.619 -0.432 . . . . 1.5600000000000001 110.881 179.853 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -86.49 -9.56 55.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.915 -0.584 . . . . 1.8799999999999999 110.311 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.5 p -87.17 0.27 55.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.141 -0.481 . . . . 1.04 110.286 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.725 HG12 ' O ' ' A' ' 136' ' ' SER . 2.6 p -65.18 137.16 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.011 -0.54 . . . . 0.23999999999999999 110.037 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.591 ' HB3' ' HZ1' ' A' ' 61' ' ' LYS . 69.4 m -96.19 -15.54 22.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.356 0.598 . . . . 0.28999999999999998 110.065 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 1.012 ' O ' HG22 ' A' ' 185' ' ' ILE . . . 178.6 175.55 45.77 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 109.881 -1.288 . . . . 0.13 109.881 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -123.36 151.64 42.32 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.698 -0.401 . . . . 0.17000000000000001 110.484 179.732 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.835 ' NH2' ' CE1' ' A' ' 157' ' ' TYR . 70.3 ttt-85 -132.42 121.26 23.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.059 0.457 . . . . 1.29 109.803 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.559 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.16 136.47 38.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.635 -0.711 . . . . 0.25 110.66 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.58 ' C ' ' CD ' ' A' ' 145' ' ' GLU . 0.3 OUTLIER -129.31 129.89 45.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.014 -0.539 . . . . 1.3200000000000001 110.037 -179.937 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.67 135.21 34.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.07 -0.513 . . . . 0.56999999999999995 110.673 -179.7 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.425 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.28 161.38 39.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.875 -0.602 . . . . 1.1599999999999999 109.728 179.823 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.957 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.0 mt -71.14 124.91 25.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.038 0.447 . . . . 0.38 110.649 -179.459 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.75 -7.76 50.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.787 -0.642 . . . . 0.40999999999999998 110.874 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -109.78 -69.68 0.85 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.913 0.387 . . . . 1.6599999999999999 111.347 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.435 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.67 -35.29 75.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.118 -0.492 . . . . 1.6599999999999999 111.505 -179.101 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.102 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.1 7.12 88.66 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.864 -0.894 . . . . 1.1699999999999999 110.864 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.327 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.89 -171.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.811 0.339 . . . . 1.8600000000000001 110.264 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.327 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.32 139.09 44.94 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-O 120.98 0.419 . . . . 1.98 110.211 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.425 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.89 145.86 51.7 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 C-N-CA 122.741 2.294 . . . . 0.55000000000000004 112.321 -179.516 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.95 145.73 42.69 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.211 -0.663 . . . . 1.1399999999999999 109.211 179.216 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.835 ' CE1' ' NH2' ' A' ' 143' ' ' ARG . 8.3 m-85 -123.22 141.37 52.05 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.358 -0.537 . . . . 0.93000000000000005 111.54 -179.089 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.2 mt -128.07 127.65 43.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.269 -0.878 . . . . 0.34000000000000002 108.986 178.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -101.62 131.19 47.97 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.162 0.506 . . . . 1.0900000000000001 111.791 -178.812 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.97 157.55 73.5 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.257 -0.883 . . . . 0.19 109.552 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.73 157.98 58.57 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.473 2.115 . . . . 0.17999999999999999 112.207 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.35 -12.08 5.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.764 -0.653 . . . . 0.20999999999999999 110.721 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.3 p -92.88 -8.68 42.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.185 -0.461 . . . . 0.28999999999999998 110.713 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.21 135.4 34.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.5 110.383 179.655 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.9 p -133.09 16.61 4.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.386 -0.37 . . . . 0.29999999999999999 110.548 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.5 p -167.54 147.11 5.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.58 -0.526 . . . . 0.23000000000000001 109.58 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.559 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.23 150.43 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.519 -0.472 . . . . 0.28000000000000003 111.542 -179.634 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.509 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.23 124.98 50.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.66 -0.7 . . . . 1.0700000000000001 109.845 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.45 104.92 30.11 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.43 -0.35 . . . . 0.28999999999999998 110.986 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.5 Cg_endo -91.02 -179.49 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 123.116 2.544 . . . . 0.42999999999999999 112.201 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.67 32.68 18.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.401 -0.818 . . . . 1.26 111.463 179.261 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 126' ' ' SER . 24.2 mt -86.39 148.51 25.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.455 -0.339 . . . . 0.32000000000000001 110.496 179.554 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.765 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.25 114.86 61.32 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.029 0.442 . . . . 0.57999999999999996 110.662 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.98 140.51 95.67 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.921 2.414 . . . . 0.66000000000000003 112.026 179.818 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.18 21.14 74.19 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.052 -0.819 . . . . 0.28999999999999998 111.052 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.435 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.86 150.21 49.36 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.966 -0.293 . . . . 2.3300000000000001 110.671 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.491 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.23 131.67 46.03 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.094 -0.503 . . . . 0.85999999999999999 109.782 179.32 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.957 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.1 m-85 -120.46 148.33 43.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.09 -0.504 . . . . 0.52000000000000002 111.056 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.4 125.3 60.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.284 -1.006 . . . . 0.29999999999999999 108.284 177.696 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.49 132.47 63.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.154 0.502 . . . . 0.23000000000000001 111.236 -178.579 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.43 122.56 20.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.509 -0.769 . . . . 0.35999999999999999 109.644 179.268 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.594 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.99 125.41 54.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.318 -0.401 . . . . 0.19 110.672 -179.512 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.8 m-85 -117.31 137.95 52.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.987 -0.551 . . . . 0.29999999999999999 109.793 179.585 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.42 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.75 134.99 42.9 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.778 -0.823 . . . . 0.37 108.778 178.917 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 1.012 HG22 ' O ' ' A' ' 141' ' ' GLY . 5.3 tt -99.18 122.99 51.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.204 0.526 . . . . 0.26000000000000001 110.891 -178.692 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.7 p -83.78 169.7 14.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.524 -0.762 . . . . 0.28000000000000003 110.46 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.81 -14.49 15.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.09 -0.505 . . . . 1.6000000000000001 110.933 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -96.14 -4.23 43.07 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.827 -0.349 . . . . 1.1799999999999999 110.807 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.83 13.8 64.08 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.349 -0.701 . . . . 0.29999999999999999 111.349 179.802 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -84.63 139.11 32.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.675 0.274 . . . . 1.22 110.453 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -106.71 141.02 38.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.36 . . . . 0.97999999999999998 110.588 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.2 m -136.71 127.01 26.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.82999999999999996 110.43 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.09 117.28 9.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.254 -0.43 . . . . 0.26000000000000001 110.507 -179.869 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.03 -21.75 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.29999999999999999 110.693 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.1 tp -156.88 125.64 5.84 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.542 -0.463 . . . . 0.31 111.477 -179.707 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.468 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.74 120.16 21.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.843 -0.617 . . . . 0.28000000000000003 109.554 179.188 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.6 151.74 29.18 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.642 -0.423 . . . . 0.23999999999999999 110.91 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.44 158.53 18.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.015 -0.539 . . . . 0.23000000000000001 110.406 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -146.03 157.93 43.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 0.67000000000000004 110.719 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.18 104.32 9.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.826 -0.624 . . . . 0.64000000000000001 110.083 179.526 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.7 p . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.914 -1.041 . . . . 1.26 110.637 -179.679 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.3 m . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.231 -0.655 . . . . 3.4399999999999999 109.231 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.72 18.53 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.952 -0.859 . . . . 1.22 110.952 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -35.54 142.4 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.106 0 C-N-CA 123.99 3.127 . . . . 0.75 113.733 -179.293 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.618 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -80.06 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 114.189 -1.369 . . . . 0.79000000000000004 108.837 178.372 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.618 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.62 125.82 51.43 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.407 -0.517 . . . . 1.9399999999999999 111.496 -179.568 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.46 144.02 33.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.685 -0.689 . . . . 0.59999999999999998 110.636 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.03 168.35 25.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.985 0.421 . . . . 3.1400000000000001 111.054 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.741 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.99 131.07 60.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.905 -0.589 . . . . 3.23 110.087 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 69.0 p -141.22 162.36 35.67 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.853 0.359 . . . . 3.6299999999999999 111.178 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 9' ' ' THR . 53.2 mp0 35.94 31.69 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.638 -0.505 . . . . 6.0800000000000001 109.638 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.741 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.55 32.47 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.932 -0.577 . . . . 3.3799999999999999 111.563 -178.817 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.24 -29.22 73.25 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.466 2.11 . . . . 3.9300000000000002 111.815 179.348 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.72 125.49 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.123 -0.489 . . . . 3.3599999999999999 110.574 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.658 ' O ' ' O ' ' A' ' 92' ' ' THR . 39.6 mt-30 -123.86 158.28 60.44 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.862 0.363 . . . . 3.6099999999999999 110.474 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.443 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 98.1 Cg_endo -82.05 -64.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.875 2.383 . . . . 1.51 113.474 -178.992 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.702 ' CG ' ' CD2' ' A' ' 157' ' ' TYR . 64.4 t30 -108.41 -19.68 13.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.287 -0.415 . . . . 2.6800000000000002 112.063 -178.468 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 43.0 t -107.26 152.07 24.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.14 0.495 . . . . 1.21 111.38 -179.438 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.573 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.3 102.92 2.22 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.725 -0.67 . . . . 1.5600000000000001 110.688 179.868 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.62 145.61 13.1 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.935 2.423 . . . . 0.81000000000000005 112.574 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.919 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.83 167.92 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.95 -0.568 . . . . 1.52 109.926 179.506 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.16 147.95 29.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.73 -0.47 . . . . 2.1400000000000001 109.73 178.914 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.597 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.27 157.28 45.01 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.597 -0.441 . . . . 0.32000000000000001 111.215 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.488 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.02 155.29 44.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.754 -0.657 . . . . 2.1699999999999999 110.12 178.983 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.831 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.55 173.1 6.28 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.172 -0.467 . . . . 0.58999999999999997 110.785 -179.229 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.831 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.61 173.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.902 2.401 . . . . 0.90000000000000002 111.555 179.32 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.48 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.05 -51.06 0.69 Allowed Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.757 -0.377 . . . . 3.3399999999999999 110.13 179.777 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.617 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.9 152.34 82.6 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.72 2.28 . . . . 1.8500000000000001 111.419 179.202 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.64 42.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.411 0.624 . . . . 2.54 110.614 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.617 ' H ' ' C ' ' A' ' 27' ' ' PRO . 73.7 t60 -63.66 -41.68 98.18 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.001 -0.999 . . . . 2.5299999999999998 110.626 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.561 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.7 mt -109.77 137.87 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.793 -0.64 . . . . 1.1699999999999999 111.315 -179.516 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.99 -72.93 0.7 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.996 -0.547 . . . . 1.27 111.84 -178.956 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -88.12 148.37 24.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.582 0.586 . . . . 1.1200000000000001 112.582 -179.611 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.78 124.91 45.31 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.328 -0.619 . . . . 0.41999999999999998 109.328 177.43 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.11 134.78 60.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.658 -0.417 . . . . 0.78000000000000003 110.617 179.867 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.919 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.01 128.61 53.7 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.62 111.236 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.07 138.97 49.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.814 -0.63 . . . . 1.97 110.18 178.956 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.432 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.07 163.14 35.17 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.1 0.476 . . . . 0.34999999999999998 112.094 -178.115 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.46 139.58 7.88 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.438 -0.801 . . . . 1.8 110.493 178.836 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.687 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.3 Cg_endo -63.65 115.52 3.11 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.265 1.977 . . . . 0.57999999999999996 111.807 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.676 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.94 81.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.908 -0.404 . . . . 3.04 109.908 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.687 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.992 -0.549 . . . . 2.4700000000000002 111.901 -179.517 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.9 p -157.64 157.71 34.11 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.882 -0.327 . . . . 2.5099999999999998 110.575 179.766 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.4 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.27 27.76 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.169 -0.469 . . . . 1.8600000000000001 110.19 179.544 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.77 -75.95 1.31 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.785 -0.526 . . . . 1.4399999999999999 111.785 -179.217 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.86 152.3 35.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 4.6900000000000004 111.0 -179.322 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.676 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.14 -169.11 2.54 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.028 -0.533 . . . . 1.4299999999999999 111.926 179.382 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.17 149.66 29.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.416 0.627 . . . . 1.74 112.598 -177.904 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.05 156.41 46.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.843 -1.072 . . . . 1.9199999999999999 110.262 178.667 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.23 158.29 41.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.933 -0.576 . . . . 0.34000000000000002 111.773 -179.31 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.04 135.67 53.96 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.483 -0.781 . . . . 0.40999999999999998 109.859 179.303 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.597 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.47 121.99 23.69 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.533 -0.303 . . . . 0.55000000000000004 111.585 -179.186 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.606 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.0 Cg_exo -46.31 151.71 1.63 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.727 2.285 . . . . 0.44 112.029 179.119 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.81 -23.19 63.04 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 116.049 -0.523 . . . . 0.73999999999999999 112.782 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.79 -16.74 46.64 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.213 -0.595 . . . . 0.93000000000000005 111.761 -178.259 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.606 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.6 mt -91.7 138.44 31.56 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.709 -0.396 . . . . 0.96999999999999997 110.298 179.381 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.46 13.85 11.04 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.392 -0.367 . . . . 1.3400000000000001 111.518 -179.357 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.475 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.7 p -150.01 143.45 25.18 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.65 -0.42 . . . . 0.39000000000000001 110.973 179.7 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.9 t80 -114.84 -169.48 1.56 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.043 -0.526 . . . . 0.41999999999999998 110.869 -179.404 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.711 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 t -151.67 125.91 9.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.412 -0.813 . . . . 0.39000000000000001 109.797 179.292 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.513 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.9 mt -114.85 123.32 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.356 -0.538 . . . . 0.73999999999999999 111.189 -179.808 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -126.56 163.3 23.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.894 -0.594 . . . . 2.48 110.448 179.746 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.476 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.14 19.03 59.77 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.75 -0.94 . . . . 0.5 110.75 -179.897 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.676 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.9 mt -79.05 157.3 28.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.124 0.488 . . . . 0.57999999999999996 111.301 -179.642 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.853 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -99.52 133.85 21.59 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.575 -0.739 . . . . 2.79 110.489 179.741 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.447 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.8 Cg_endo -67.81 143.74 62.47 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.454 2.103 . . . . 0.87 112.001 179.773 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.7 25.59 75.37 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.125 -0.79 . . . . 0.64000000000000001 111.125 179.774 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.853 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.21 158.66 40.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.648 0.261 . . . . 0.82999999999999996 110.439 -179.533 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.09 139.98 41.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.0 0.429 . . . . 0.5 110.535 -179.737 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.643 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.59 136.49 54.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.89 -0.595 . . . . 0.53000000000000003 110.689 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.92 130.96 45.32 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.523 -0.917 . . . . 1.8700000000000001 108.523 177.566 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.43 153.93 16.63 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.318 -0.944 . . . . 0.28999999999999998 111.999 -178.658 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -135.03 140.85 45.95 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.779 -0.452 . . . . 1.4299999999999999 109.779 179.585 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.5 tp -115.71 119.0 34.62 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.422 -0.511 . . . . 0.32000000000000001 110.48 179.757 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.51 129.02 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.332 -0.395 . . . . 0.79000000000000004 110.578 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.7 120.86 43.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.283 -0.417 . . . . 1.02 110.749 -179.754 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.853 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.53 146.47 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.116 0.484 . . . . 0.62 111.104 -179.375 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.626 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.06 153.82 21.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.581 -0.736 . . . . 2.4399999999999999 109.965 179.776 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.12 88.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.913 0.387 . . . . 3.6899999999999999 110.467 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.41 32.56 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.809 -0.632 . . . . 6.0800000000000001 110.51 179.998 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.02 -117.37 3.3 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.479 -0.648 . . . . 1.22 111.479 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -81.41 177.37 9.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.268 0.556 . . . . 2.8799999999999999 111.634 -179.244 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.17 149.48 32.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.485 -0.78 . . . . 1.47 110.415 179.179 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.1 144.69 38.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.489 -0.323 . . . . 2.7000000000000002 110.598 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.727 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.02 136.05 61.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-O 121.063 0.459 . . . . 0.46000000000000002 111.544 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.11 141.31 52.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.624 -0.717 . . . . 0.34999999999999998 110.214 179.695 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.469 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.55 138.88 51.62 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.111 0.481 . . . . 3.6699999999999999 111.538 -179.391 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.489 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.34 164.19 37.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.569 -0.741 . . . . 0.67000000000000004 109.405 179.37 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.572 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.28 151.6 38.6 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.369 -0.533 . . . . 1.47 111.062 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.8 p90 -146.23 172.7 13.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.778 -0.646 . . . . 0.44 111.033 179.919 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.72 160.69 21.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.483 -0.781 . . . . 1.3700000000000001 109.939 179.515 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.38 121.93 23.04 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.547 -0.461 . . . . 1.28 110.671 -179.932 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.658 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.7 p -128.45 165.74 20.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.099 -0.501 . . . . 1.97 110.497 179.636 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.4 t -101.36 136.14 41.7 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.468 -0.493 . . . . 3.2799999999999998 109.914 178.812 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 69.6 p -110.54 13.12 22.71 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.603 -179.074 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.2 t -68.12 145.29 54.52 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.709 -179.127 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 96' ' ' THR . 1.6 t -68.65 145.87 97.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.375 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.09 -61.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.927 1.751 . . . . 0.0 112.128 179.823 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.3 t -122.44 133.99 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 111.319 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.4 m -124.87 138.57 54.25 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.6 178.493 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.9 t -122.35 139.63 53.6 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.942 0.401 . . . . 0.0 111.076 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -123.1 17.85 9.99 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.241 179.207 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 47.2 m -121.43 143.0 49.48 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.936 -179.158 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.7 t -111.18 135.47 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.052 179.734 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.0 p -82.74 162.29 21.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.048 -179.372 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -141.49 177.48 21.14 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 179.891 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.49 -34.18 75.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.736 0.303 . . . . 0.0 110.701 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.79 66.79 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.097 0.475 . . . . 0.0 109.938 179.918 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.53 ' O ' ' CD2' ' A' ' 110' ' ' PHE . 6.5 m -125.48 74.31 68.8 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.407 -179.76 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -61.78 -15.46 42.63 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.76 2.307 . . . . 0.0 112.926 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.53 ' CD2' ' O ' ' A' ' 108' ' ' THR . 96.4 m-85 53.21 173.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 110.038 -178.328 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 m -65.71 152.58 92.63 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.325 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -56.8 146.74 76.53 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.477 2.118 . . . . 0.0 112.0 -179.591 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.2 tp -57.24 -36.9 71.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.596 . . . . 10.19 110.39 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.14 134.37 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.909 0.385 . . . . 7.2800000000000002 110.572 -179.788 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -118.22 -83.94 0.65 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.899 -0.591 . . . . 7.2999999999999998 110.616 -179.831 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.3 t -80.98 170.16 16.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.97 -0.559 . . . . 6.4400000000000004 110.933 -179.583 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.2 p -66.51 163.63 18.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.955 -0.566 . . . . 4.4199999999999999 110.795 -179.549 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -56.65 143.77 34.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.982 -0.554 . . . . 3.0499999999999998 110.893 -179.387 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.3 p -124.74 158.78 32.44 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.569 -0.741 . . . . 3.4300000000000002 110.352 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.3 t -109.1 135.66 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.317 -0.401 . . . . 2.8799999999999999 110.115 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 49.8 m -119.88 142.09 49.0 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.9 -0.591 . . . . 2.0899999999999999 110.901 -179.28 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.564 ' C ' ' H ' ' A' ' 124' ' ' THR . 59.3 mp0 -56.87 145.71 28.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.885 -0.598 . . . . 4.5300000000000002 110.601 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.54 ' C ' ' H ' ' A' ' 125' ' ' ALA . 19.1 mm 68.18 -30.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.82 -0.627 . . . . 1.4399999999999999 110.454 -179.726 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.628 ' C ' ' H ' ' A' ' 126' ' ' SER . 25.9 m 57.3 -1.56 0.06 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.688 -0.233 . . . . 1.78 111.566 179.424 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.54 ' H ' ' C ' ' A' ' 123' ' ' ILE . . . -62.45 26.26 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.666 -0.243 . . . . 0.64000000000000001 111.234 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.628 ' H ' ' C ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 47.57 17.29 0.08 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.264 0.554 . . . . 0.66000000000000003 110.79 -179.933 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.438 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.8 167.52 0.25 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.503 -0.771 . . . . 0.68999999999999995 110.942 179.419 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.6 145.51 50.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.704 -0.68 . . . . 0.52000000000000002 110.128 -179.879 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.27 101.65 9.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.087 -0.708 . . . . 0.32000000000000001 109.087 177.693 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.2 t -112.94 139.74 36.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.055 -0.52 . . . . 0.28999999999999998 111.033 -178.862 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 p -128.7 152.54 48.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.549 -0.75 . . . . 0.25 109.81 179.631 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.591 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.79 -164.93 2.03 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.769 -0.373 . . . . 0.31 110.64 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -123.99 127.15 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.183 -0.462 . . . . 0.48999999999999999 110.814 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.164 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.92 58.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 1.53 110.339 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.06 24.48 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.923 -0.581 . . . . 0.96999999999999997 111.465 -179.698 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.164 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.13 128.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.601 -0.44 . . . . 1.5600000000000001 110.918 179.801 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.46 -9.54 56.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.855 -0.611 . . . . 1.8799999999999999 110.309 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.8 p -87.1 0.25 55.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.073 -0.512 . . . . 1.04 110.343 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.29 137.26 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.016 -0.538 . . . . 0.23999999999999999 109.982 179.69 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 185' ' ' ILE . 71.1 m -96.24 -15.55 21.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.239 0.542 . . . . 0.28999999999999998 110.0 -179.629 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.59 175.54 45.76 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 109.845 -1.302 . . . . 0.13 109.845 179.707 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.48 151.58 42.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.989 0.423 . . . . 0.17000000000000001 110.43 179.78 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.834 ' HE ' ' NE2' ' A' ' 191' ' ' GLN . 62.5 ttp85 -132.38 121.18 23.07 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.145 -0.479 . . . . 1.29 109.977 179.744 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.546 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.01 136.62 37.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.615 -0.721 . . . . 0.25 110.655 -179.755 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.501 ' CD ' ' O ' ' A' ' 156' ' ' GLN . 24.8 tp10 -129.41 129.9 45.28 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.933 -0.576 . . . . 1.3200000000000001 110.067 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.2 p90 -138.72 135.3 34.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.962 -0.563 . . . . 0.56999999999999995 110.627 -179.717 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.415 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.33 161.35 39.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.815 -0.629 . . . . 1.1599999999999999 109.682 179.79 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.967 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.02 124.83 25.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.049 0.452 . . . . 0.38 110.747 -179.596 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.499 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.74 -7.69 49.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.704 -0.68 . . . . 0.40999999999999998 110.779 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -109.86 -69.76 0.85 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.937 0.399 . . . . 1.6599999999999999 111.336 -179.231 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.447 ' CD ' HH21 ' A' ' 176' ' ' ARG . 53.9 mt-10 -60.61 -35.39 76.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.111 -0.495 . . . . 1.6599999999999999 111.493 -179.083 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.089 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.18 7.23 88.6 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.808 -0.917 . . . . 1.1699999999999999 110.808 -179.854 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.32 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.91 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.835 0.35 . . . . 1.8600000000000001 110.262 179.861 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.32 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.29 139.1 45.05 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.974 0.416 . . . . 1.98 110.126 179.619 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.415 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.5 Cg_endo -70.92 145.81 51.38 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 122.71 2.273 . . . . 0.55000000000000004 112.275 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.85 145.75 42.59 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.243 -0.651 . . . . 1.1399999999999999 109.243 179.16 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.702 ' CD2' ' CG ' ' A' ' 16' ' ' ASN . 27.3 p90 -123.26 141.34 52.08 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.296 -0.561 . . . . 0.93000000000000005 111.57 -179.115 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.09 127.76 43.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.313 -0.858 . . . . 0.34000000000000002 108.978 178.923 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -101.68 131.1 48.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.171 0.51 . . . . 1.0900000000000001 111.747 -178.733 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.88 157.51 73.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.248 -0.887 . . . . 0.19 109.624 179.686 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.76 158.02 58.4 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.464 2.109 . . . . 0.17999999999999999 112.297 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.21 -12.25 5.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.879 -0.6 . . . . 0.20999999999999999 110.696 -179.839 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.2 p -92.81 -8.73 42.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.28999999999999998 110.724 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.23 135.33 34.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.348 -0.387 . . . . 0.5 110.374 179.713 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.1 p -133.12 16.68 4.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 0.29999999999999999 110.499 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.7 p -167.54 147.12 5.08 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.617 -0.512 . . . . 0.23000000000000001 109.617 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.546 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.12 150.49 12.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.495 -0.482 . . . . 0.28000000000000003 111.538 -179.636 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.507 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.32 124.8 50.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 1.0700000000000001 109.833 179.452 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.31 104.93 29.7 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.915 0.388 . . . . 0.28999999999999998 111.077 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.2 Cg_endo -91.02 -179.47 1.48 Allowed 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 123.177 2.585 . . . . 0.42999999999999999 112.18 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.69 32.59 18.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.382 -0.826 . . . . 1.26 111.422 179.276 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.1 mt -86.31 148.53 25.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.52 -0.309 . . . . 0.32000000000000001 110.501 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.77 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.34 114.84 61.28 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.041 0.448 . . . . 0.57999999999999996 110.631 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.0 140.6 96.09 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.871 2.381 . . . . 0.66000000000000003 111.94 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.03 21.2 74.47 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.032 -0.827 . . . . 0.28999999999999998 111.032 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.447 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.81 150.31 49.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.784 0.326 . . . . 2.3300000000000001 110.677 179.882 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.499 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.28 131.58 46.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.097 -0.501 . . . . 0.85999999999999999 109.773 179.377 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.967 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.2 m-85 -120.45 148.31 43.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.111 -0.495 . . . . 0.52000000000000002 111.022 -179.806 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.32 125.36 60.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.271 -1.011 . . . . 0.29999999999999999 108.271 177.726 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.55 132.45 63.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.139 0.495 . . . . 0.23000000000000001 111.218 -178.545 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.46 20.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.594 -0.73 . . . . 0.35999999999999999 109.682 179.286 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.591 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.7 t -100.84 125.32 54.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.291 -0.413 . . . . 0.19 110.798 -179.585 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.806 ' CD2' ' NH2' ' A' ' 143' ' ' ARG . 48.5 m-85 -117.18 137.84 52.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.103 -0.499 . . . . 0.29999999999999999 109.875 179.535 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.427 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.62 135.03 42.69 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.853 -0.795 . . . . 0.37 108.853 178.814 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.606 ' O ' ' N ' ' A' ' 140' ' ' SER . 84.8 mt -99.09 122.93 51.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.1 0.476 . . . . 0.26000000000000001 110.923 -178.724 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.1 p -83.91 169.75 14.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.566 -0.743 . . . . 0.28000000000000003 110.481 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -59.82 -14.47 15.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.096 -0.502 . . . . 1.6000000000000001 110.938 -179.539 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -96.11 -4.25 43.15 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.863 -0.335 . . . . 1.1799999999999999 110.758 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.449 ' N ' ' HB ' ' A' ' 59' ' ' THR . . . 87.75 13.84 64.18 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.431 -0.668 . . . . 0.29999999999999999 111.431 179.884 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -84.62 139.0 32.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.622 0.248 . . . . 1.22 110.443 179.716 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.834 ' NE2' ' HE ' ' A' ' 143' ' ' ARG . 86.6 mt-30 -106.62 141.02 38.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.871 0.367 . . . . 0.97999999999999998 110.639 179.682 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.6 m -136.68 127.04 26.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 0.82999999999999996 110.431 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.17 117.35 9.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.348 -0.387 . . . . 0.26000000000000001 110.507 -179.885 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.1 -21.81 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.125 -0.489 . . . . 0.29999999999999999 110.652 -179.674 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.9 125.68 5.84 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.489 -0.484 . . . . 0.31 111.479 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.473 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.73 120.33 21.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.756 -0.656 . . . . 0.28000000000000003 109.504 179.165 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.67 151.67 29.04 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.659 -0.416 . . . . 0.23999999999999999 110.952 -179.314 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.45 158.58 18.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.523 . . . . 0.23000000000000001 110.467 179.707 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.4 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 67.9 mt-30 -146.08 157.93 43.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.046 -0.525 . . . . 0.67000000000000004 110.527 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.21 104.41 9.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.728 -0.669 . . . . 0.64000000000000001 110.088 179.44 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 117.839 -1.077 . . . . 1.26 110.659 -179.712 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.219 -0.66 . . . . 3.4399999999999999 109.219 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.36 150.81 18.52 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.012 -0.835 . . . . 1.22 111.012 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -35.81 142.43 0.11 Allowed 'Trans proline' 0 C--N 1.297 -2.141 0 C-N-CA 123.975 3.117 . . . . 0.75 113.761 -179.184 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -79.9 173.4 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.196 -1.365 . . . . 0.79000000000000004 108.839 178.425 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.616 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.62 125.9 51.52 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.412 -0.515 . . . . 1.9399999999999999 111.421 -179.662 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.47 144.01 33.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.613 -0.721 . . . . 0.59999999999999998 110.649 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.01 168.33 25.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.837 0.351 . . . . 3.1400000000000001 111.215 -179.762 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.74 HG22 ' OG1' ' A' ' 11' ' ' THR . 65.9 mt -108.95 131.16 60.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.053 -0.521 . . . . 3.23 110.074 179.864 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.8 p -141.26 162.25 35.93 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.835 0.35 . . . . 3.6299999999999999 111.223 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 9' ' ' THR . 98.0 mt-10 36.21 31.51 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.636 -0.505 . . . . 6.0800000000000001 109.636 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.74 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.66 32.71 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.939 -0.573 . . . . 3.3799999999999999 111.587 -178.787 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.641 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.24 -29.28 73.21 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.529 2.153 . . . . 3.9300000000000002 111.82 179.391 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.641 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.71 125.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 3.3599999999999999 110.43 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.601 ' O ' ' O ' ' A' ' 92' ' ' THR . 3.0 mp0 -124.05 158.28 60.97 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.405 . . . . 3.6099999999999999 110.432 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.57 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 96.4 Cg_endo -81.94 -64.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.935 2.423 . . . . 1.51 113.547 -179.037 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.868 ' ND2' ' CD1' ' A' ' 157' ' ' TYR . 3.0 m120 -108.39 -19.55 13.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.262 -0.426 . . . . 2.6800000000000002 112.084 -178.551 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 37.5 t -107.3 152.08 24.61 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.488 -0.485 . . . . 1.21 111.322 -179.435 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.573 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.29 102.92 2.23 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.716 -0.675 . . . . 1.5600000000000001 110.705 179.803 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.63 145.68 13.12 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.928 2.419 . . . . 0.81000000000000005 112.522 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.923 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.9 168.02 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.86 -0.609 . . . . 1.52 109.919 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.17 147.94 29.04 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.736 -0.468 . . . . 2.1400000000000001 109.736 178.972 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.599 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.26 157.27 45.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.994 0.426 . . . . 0.32000000000000001 111.229 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.491 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.8 m-20 -128.02 155.27 44.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.86 -0.609 . . . . 2.1699999999999999 110.163 178.94 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.829 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.6 172.95 6.48 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.082 0.467 . . . . 0.58999999999999997 110.777 -179.197 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.829 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.59 173.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.836 2.357 . . . . 0.90000000000000002 111.597 179.351 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.06 -51.01 0.69 Allowed Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.729 -0.388 . . . . 3.3399999999999999 110.051 179.89 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.615 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.83 152.37 82.39 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.797 2.331 . . . . 1.8500000000000001 111.449 179.22 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.78 42.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.433 0.635 . . . . 2.54 110.554 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.615 ' H ' ' C ' ' A' ' 27' ' ' PRO . 73.9 t60 -63.65 -41.65 98.21 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.019 -0.991 . . . . 2.5299999999999998 110.702 179.727 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.562 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.4 mt -109.84 137.86 40.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.659 -0.701 . . . . 1.1699999999999999 111.24 -179.437 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.96 -72.89 0.7 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.017 -0.538 . . . . 1.27 111.933 -179.018 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.12 148.28 24.51 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.594 0.59 . . . . 1.1200000000000001 112.594 -179.661 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.74 124.83 45.16 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.43 -0.582 . . . . 0.41999999999999998 109.43 177.432 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.02 134.75 60.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.612 -0.435 . . . . 0.78000000000000003 110.611 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.923 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.97 128.65 53.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.042 0.448 . . . . 0.62 111.309 179.674 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.19 139.02 49.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.679 -0.692 . . . . 1.97 110.114 178.967 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.0 163.15 35.07 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.119 0.485 . . . . 0.34999999999999998 112.099 -178.094 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.49 139.6 7.86 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.406 -0.816 . . . . 1.8 110.533 178.728 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.686 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.8 Cg_endo -63.43 115.39 2.99 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.313 2.008 . . . . 0.57999999999999996 111.893 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.676 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.89 81.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.92 -0.4 . . . . 3.04 109.92 -179.856 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.686 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.023 -0.535 . . . . 2.4700000000000002 111.875 -179.41 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.2 p -157.63 157.87 34.44 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.787 -0.365 . . . . 2.5099999999999998 110.506 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.45 27.83 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.478 . . . . 1.8600000000000001 110.164 179.566 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.8 -75.87 1.31 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.157 -0.544 . . . . 1.4399999999999999 111.859 -179.255 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.89 152.29 35.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 4.6900000000000004 111.037 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.637 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.23 -169.17 2.55 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.041 -0.527 . . . . 1.4299999999999999 111.928 179.422 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.13 149.69 29.69 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.397 0.617 . . . . 1.74 112.615 -177.854 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.01 156.46 46.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.891 -1.05 . . . . 1.9199999999999999 110.326 178.666 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.19 158.37 41.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.038 -0.528 . . . . 0.34000000000000002 111.85 -179.317 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.8 m -115.17 135.67 53.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.5 -0.773 . . . . 0.40999999999999998 109.815 179.296 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.599 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.43 122.01 23.75 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.515 -0.311 . . . . 0.55000000000000004 111.511 -179.141 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.607 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.4 Cg_exo -46.48 151.81 1.71 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.668 2.245 . . . . 0.44 112.083 179.04 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.91 -23.08 63.13 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 116.033 -0.53 . . . . 0.73999999999999999 112.821 -179.249 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.5 p-80 -82.79 -16.77 46.56 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.167 -0.613 . . . . 0.93000000000000005 111.762 -178.293 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.607 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.69 138.47 31.54 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.766 -0.374 . . . . 0.96999999999999997 110.266 179.399 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.61 13.93 10.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.409 -0.36 . . . . 1.3400000000000001 111.476 -179.341 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -150.0 143.47 25.2 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.65 -0.42 . . . . 0.39000000000000001 111.093 179.522 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.9 t80 -114.77 -169.32 1.52 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.263 0.554 . . . . 0.41999999999999998 110.853 -179.386 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' THR . . . . . 1.003 HG21 ' O ' ' A' ' 187' ' ' GLU . 5.4 p -151.83 125.95 9.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.403 -0.817 . . . . 0.39000000000000001 109.737 179.284 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.97 123.32 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.278 -0.569 . . . . 0.73999999999999999 111.146 -179.797 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -126.57 163.41 23.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.835 -0.621 . . . . 2.48 110.371 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.04 19.04 59.9 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.743 -0.943 . . . . 0.5 110.743 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.514 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.4 mt -79.08 157.27 28.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.125 0.488 . . . . 0.57999999999999996 111.361 -179.694 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.856 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -99.49 133.9 21.57 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.562 -0.744 . . . . 2.79 110.406 179.838 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.446 ' HD3' ' CE2' ' A' ' 157' ' ' TYR . 36.9 Cg_endo -67.84 143.56 61.6 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.563 2.175 . . . . 0.87 111.893 179.799 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.88 25.58 75.39 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.999 -0.841 . . . . 0.64000000000000001 110.999 179.649 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.856 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.16 158.82 39.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.689 0.28 . . . . 0.82999999999999996 110.426 -179.641 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.12 139.98 41.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.344 -0.389 . . . . 0.5 110.637 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.643 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.6 m-85 -122.63 136.39 54.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.53000000000000003 110.753 -179.878 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.3 pt-20 -98.83 130.95 45.27 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.51 -0.922 . . . . 1.8700000000000001 108.51 177.615 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.42 153.86 16.63 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.365 -0.922 . . . . 0.28999999999999998 112.082 -178.711 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -134.98 140.86 46.02 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.709 -0.478 . . . . 1.4299999999999999 109.709 179.647 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.519 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.3 tp -115.69 118.91 34.38 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.493 -0.483 . . . . 0.32000000000000001 110.526 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.725 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.48 129.08 68.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.298 -0.41 . . . . 0.79000000000000004 110.648 -179.895 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.707 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.82 120.8 43.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.325 -0.398 . . . . 1.02 110.669 -179.558 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.854 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.56 146.4 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.089 0.471 . . . . 0.62 111.098 -179.299 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.625 ' O ' ' N ' ' A' ' 79' ' ' TYR . 20.9 mt-30 -106.01 153.86 21.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.601 -0.727 . . . . 2.4399999999999999 109.989 179.798 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.11 88.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.899 0.38 . . . . 3.6899999999999999 110.439 -179.756 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.3 32.66 0.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.791 -0.64 . . . . 6.0800000000000001 110.539 -179.915 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.16 -117.29 3.27 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.464 -0.654 . . . . 1.22 111.464 -179.765 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -81.5 177.45 8.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.234 0.54 . . . . 2.8799999999999999 111.571 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.1 149.59 32.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.392 -0.822 . . . . 1.47 110.406 179.18 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.19 144.58 38.6 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.453 -0.34 . . . . 2.7000000000000002 110.629 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.725 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -127.96 136.02 61.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 120.582 -0.447 . . . . 0.46000000000000002 111.536 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.06 141.3 52.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.671 -0.695 . . . . 0.34999999999999998 110.347 179.595 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.472 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.55 138.88 51.62 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 120.588 -0.445 . . . . 3.6699999999999999 111.546 -179.329 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.35 164.17 38.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.604 -0.725 . . . . 0.67000000000000004 109.474 179.336 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.571 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.24 151.62 38.67 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.4 -0.52 . . . . 1.47 111.065 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.811 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.3 p90 -146.28 172.63 13.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.727 -0.67 . . . . 0.44 111.047 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.68 160.72 21.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.485 -0.78 . . . . 1.3700000000000001 109.846 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.39 121.89 22.97 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.558 -0.457 . . . . 1.28 110.784 179.913 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.601 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.8 p -128.0 162.8 25.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.14 -0.482 . . . . 1.97 111.126 179.706 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.6 t -114.4 136.01 53.46 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.914 -0.402 . . . . 3.2799999999999998 109.914 178.427 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.2 t -141.67 159.74 41.61 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.993 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 92.3 p -123.18 151.95 41.69 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.45 135.48 8.74 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.417 -179.926 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.03 146.58 95.7 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.871 1.714 . . . . 0.0 111.417 179.066 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.694 HG12 ' H ' ' A' ' 100' ' ' SER . 74.6 t -60.09 -42.41 89.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.339 -179.806 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.576 ' O ' HG22 ' A' ' 99' ' ' THR . 90.5 m 50.59 -2.85 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 178.641 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.694 ' H ' HG12 ' A' ' 98' ' ' VAL . 16.5 m -62.53 152.71 33.96 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.907 -179.258 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -57.47 -34.03 68.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.818 179.72 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.3 p -121.69 164.84 16.7 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.801 -179.488 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 103' ' ' VAL . 14.5 p -105.87 17.38 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.063 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.4 t -134.43 159.14 41.99 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.222 179.712 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.9 137.05 41.13 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.661 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -59.96 -34.19 72.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.741 0.305 . . . . 0.0 110.894 -179.977 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.1 p -84.48 160.68 20.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.017 0.437 . . . . 0.0 111.173 -179.37 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.6 m -72.06 137.97 81.99 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.183 179.664 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.03 145.48 41.68 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.47 1.447 . . . . 0.0 111.403 179.173 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.542 ' O ' ' O ' ' A' ' 111' ' ' SER . 99.0 m-85 -88.84 -2.5 58.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.057 -179.422 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.542 ' O ' ' O ' ' A' ' 110' ' ' PHE . 45.1 p 55.47 132.3 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.575 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.69 143.36 98.76 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.681 1.587 . . . . 0.0 111.711 -179.186 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 66.5 mt -60.18 -35.76 76.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 10.19 110.552 -179.821 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.7 p -133.16 142.71 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.229 -0.441 . . . . 7.2800000000000002 110.781 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.68 146.17 54.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 7.2999999999999998 110.252 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.0 p -121.12 160.81 22.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.863 0.363 . . . . 6.4400000000000004 110.76 -179.847 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.6 t -122.39 145.4 48.31 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.766 -0.652 . . . . 4.4199999999999999 110.307 -179.878 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -103.69 148.42 26.07 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.363 -0.38 . . . . 3.0499999999999998 110.543 179.889 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.559 ' O ' ' O ' ' A' ' 120' ' ' VAL . 20.5 m -59.32 -35.31 73.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 3.4300000000000002 111.15 -179.733 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.559 ' O ' ' O ' ' A' ' 119' ' ' SER . 57.6 t 51.7 151.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.165 -0.47 . . . . 2.8799999999999999 111.029 -179.584 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.3 m 43.89 41.26 3.74 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.175 -0.466 . . . . 2.0899999999999999 110.614 -179.458 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -105.03 139.78 39.2 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.111 -0.495 . . . . 4.5300000000000002 110.659 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.9 mt -115.47 135.15 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.013 -0.54 . . . . 1.4399999999999999 109.66 179.552 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.9 t -135.56 158.78 43.53 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.944 0.402 . . . . 1.78 111.196 -179.529 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -73.18 -147.24 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.752 -0.658 . . . . 0.64000000000000001 110.317 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.4 p -59.2 -27.93 66.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 0.66000000000000003 110.278 -179.802 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.435 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.88 167.54 0.26 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.917 -0.583 . . . . 0.68999999999999995 110.916 179.932 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.53 145.51 50.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.707 -0.679 . . . . 0.52000000000000002 110.196 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.21 101.74 9.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.064 -0.717 . . . . 0.32000000000000001 109.064 177.658 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.2 t -112.99 139.75 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.03 -0.532 . . . . 0.28999999999999998 111.008 -178.902 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.4 p -128.76 152.54 48.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.574 -0.739 . . . . 0.25 109.746 179.615 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.8 -164.96 2.04 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.657 -0.417 . . . . 0.31 110.578 -179.781 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -124.0 127.22 73.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.122 -0.49 . . . . 0.48999999999999999 110.793 -179.794 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.175 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -58.1 58.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.141 -0.481 . . . . 1.53 110.299 179.918 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.18 24.52 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.863 -0.608 . . . . 0.96999999999999997 111.476 -179.674 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.175 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.14 128.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.654 -0.418 . . . . 1.5600000000000001 111.0 179.842 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.39 -9.56 56.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.931 -0.577 . . . . 1.8799999999999999 110.352 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.6 p -87.1 0.17 55.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.073 -0.512 . . . . 1.04 110.297 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.22 137.22 25.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.977 -0.556 . . . . 0.23999999999999999 109.972 179.69 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.589 ' N ' ' O ' ' A' ' 185' ' ' ILE . 72.3 m -96.22 -15.66 21.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.296 0.569 . . . . 0.28999999999999998 110.055 -179.674 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.67 175.63 45.9 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 109.888 -1.285 . . . . 0.13 109.888 179.57 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.4 151.69 42.34 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.605 -0.438 . . . . 0.17000000000000001 110.501 179.719 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.609 HH22 ' CD ' ' A' ' 191' ' ' GLN . 52.9 ttp180 -132.37 121.27 23.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.128 -0.487 . . . . 1.29 109.883 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.557 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.1 136.49 38.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.698 -0.683 . . . . 0.25 110.693 -179.826 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 82.7 tt0 -129.34 129.89 45.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.973 -0.558 . . . . 1.3200000000000001 110.047 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.71 135.28 34.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.053 -0.521 . . . . 0.56999999999999995 110.623 -179.706 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.425 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.33 161.27 40.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.773 -0.649 . . . . 1.1599999999999999 109.705 179.84 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.962 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.0 mt -71.0 124.91 25.45 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.641 -0.424 . . . . 0.38 110.751 -179.568 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.76 -7.72 49.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.763 -0.653 . . . . 0.40999999999999998 110.913 -179.782 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -109.77 -69.69 0.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 1.6599999999999999 111.393 -179.28 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.45 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.4 mt-10 -60.64 -35.39 76.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.003 -0.544 . . . . 1.6599999999999999 111.45 -179.077 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.089 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.15 88.64 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.785 -0.926 . . . . 1.1699999999999999 110.785 -179.793 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.315 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.3 t0 -27.94 -171.71 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.725 0.297 . . . . 1.8600000000000001 110.283 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.315 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.14 45.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.043 0.449 . . . . 1.98 110.224 179.595 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.425 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 45.4 Cg_endo -70.96 145.88 51.34 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.729 2.286 . . . . 0.55000000000000004 112.248 -179.467 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.83 145.75 42.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.228 -0.656 . . . . 1.1399999999999999 109.228 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.868 ' CD1' ' ND2' ' A' ' 16' ' ' ASN . 21.3 p90 -123.31 141.33 52.1 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.377 -0.529 . . . . 0.93000000000000005 111.491 -179.115 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.6 mt -128.16 127.71 43.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.269 -0.878 . . . . 0.34000000000000002 108.872 178.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.499 ' O ' ' OD1' ' A' ' 159' ' ' ASP . 54.2 p-10 -101.62 131.1 48.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.195 0.522 . . . . 1.0900000000000001 111.751 -178.782 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.9 mt -127.87 157.55 73.29 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.318 -0.855 . . . . 0.19 109.617 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -69.89 158.07 58.01 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.297 1.998 . . . . 0.17999999999999999 112.251 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.25 -12.16 5.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.785 -0.643 . . . . 0.20999999999999999 110.684 -179.831 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.78 -8.8 42.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.28999999999999998 110.7 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.24 135.39 34.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.5 110.351 179.788 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.7 p -133.09 16.65 4.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.388 -0.369 . . . . 0.29999999999999999 110.573 179.937 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.3 p -167.56 147.17 5.07 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.59 -0.522 . . . . 0.23000000000000001 109.59 179.881 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.21 150.55 12.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.532 -0.467 . . . . 0.28000000000000003 111.535 -179.658 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.38 124.9 50.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.572 -0.74 . . . . 1.0700000000000001 109.851 179.463 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.33 104.85 29.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.385 -0.37 . . . . 0.28999999999999998 111.062 -179.818 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -90.96 -179.58 1.52 Allowed 'Trans proline' 0 C--N 1.301 -1.951 0 C-N-CA 123.28 2.653 . . . . 0.42999999999999999 112.211 179.909 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.73 32.64 18.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.407 -0.815 . . . . 1.26 111.449 179.271 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.2 mt -86.33 148.44 25.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.551 -0.295 . . . . 0.32000000000000001 110.509 179.592 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.767 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.4 mt -88.17 114.89 61.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.349 -0.387 . . . . 0.57999999999999996 110.702 -179.75 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.12 140.63 95.91 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.744 2.296 . . . . 0.66000000000000003 111.99 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.14 21.15 74.26 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.012 -0.835 . . . . 0.28999999999999998 111.012 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.45 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.86 150.24 49.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.847 0.356 . . . . 2.3300000000000001 110.682 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.26 131.65 46.08 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.044 -0.525 . . . . 0.85999999999999999 109.733 179.426 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.962 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.55 148.3 44.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.064 -0.516 . . . . 0.52000000000000002 111.048 -179.84 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.3 mt -105.31 125.41 60.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.218 -1.03 . . . . 0.29999999999999999 108.218 177.787 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.61 132.43 63.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.13 0.491 . . . . 0.23000000000000001 111.285 -178.632 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.41 122.46 20.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.519 -0.764 . . . . 0.35999999999999999 109.655 179.369 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.95 125.44 54.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.3 -0.409 . . . . 0.19 110.632 -179.516 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 49.4 m-85 -117.31 137.89 52.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.981 -0.554 . . . . 0.29999999999999999 109.802 179.53 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.426 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.68 135.08 42.69 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.776 -0.824 . . . . 0.37 108.776 178.837 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 140' ' ' SER . 78.1 mt -99.13 122.93 51.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.126 0.489 . . . . 0.26000000000000001 111.003 -178.805 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.9 p -83.9 169.71 14.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.546 -0.752 . . . . 0.28000000000000003 110.489 -179.646 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 1.003 ' O ' HG21 ' A' ' 59' ' ' THR . 97.8 mt-10 -59.74 -14.52 14.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.08 -0.509 . . . . 1.6000000000000001 111.01 -179.564 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -96.02 -4.32 43.34 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.837 -0.345 . . . . 1.1799999999999999 110.868 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.8 13.9 63.97 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.329 -0.708 . . . . 0.29999999999999999 111.329 179.842 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -84.72 139.0 32.31 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.01 -0.276 . . . . 1.22 110.462 179.652 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.609 ' CD ' HH22 ' A' ' 143' ' ' ARG . 0.0 OUTLIER -106.61 141.11 38.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.877 0.37 . . . . 0.97999999999999998 110.536 179.789 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.0 m -136.8 127.0 26.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.82999999999999996 110.386 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.3 tp -68.17 117.2 9.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.318 -0.401 . . . . 0.26000000000000001 110.549 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -108.94 -21.84 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.29999999999999999 110.7 -179.694 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.86 125.76 5.9 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.559 -0.456 . . . . 0.31 111.513 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.69 120.2 21.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.756 -0.656 . . . . 0.28000000000000003 109.585 179.189 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.65 29.05 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.718 -0.393 . . . . 0.23999999999999999 110.87 -179.264 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.36 158.57 18.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.23000000000000001 110.48 179.664 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -146.09 158.01 43.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.095 -0.502 . . . . 0.67000000000000004 110.648 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.35 9.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.772 -0.649 . . . . 0.64000000000000001 110.013 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.7 p . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.94 -1.028 . . . . 1.26 110.66 -179.686 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.2 m . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.206 -0.664 . . . . 3.4399999999999999 109.206 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.438 ' H ' ' HB3' ' A' ' 1' ' ' SER . . . -116.33 150.73 18.54 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.999 -0.841 . . . . 1.22 110.999 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.62 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.061 0 C-N-CA 123.98 3.12 . . . . 0.75 113.788 -179.236 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.629 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -80.02 173.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.329 -1.305 . . . . 0.79000000000000004 108.772 178.412 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.629 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.63 125.89 51.51 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.41 -0.516 . . . . 1.9399999999999999 111.438 -179.558 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.55 143.93 34.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.656 -0.702 . . . . 0.59999999999999998 110.662 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.95 168.37 25.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.934 0.397 . . . . 3.1400000000000001 110.996 -179.625 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.737 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.98 131.08 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.893 -0.594 . . . . 3.23 110.057 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.18 162.37 35.66 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.828 0.347 . . . . 3.6299999999999999 111.253 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.2 mt-10 35.93 31.74 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.159 0.504 . . . . 6.0800000000000001 109.696 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.737 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.57 69.58 33.92 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.814 -0.63 . . . . 3.3799999999999999 111.492 -178.728 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.615 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.23 -29.16 73.24 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.444 2.096 . . . . 3.9300000000000002 111.794 179.318 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.615 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.68 125.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.228 -0.442 . . . . 3.3599999999999999 110.447 -179.926 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 17' ' ' SER . 3.1 mp0 -123.91 158.31 60.48 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 3.6099999999999999 110.494 179.852 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.443 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 97.6 Cg_endo -81.93 -64.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.0 2.467 . . . . 1.51 113.532 -179.005 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.716 ' CG ' ' CD1' ' A' ' 157' ' ' TYR . 66.5 t30 -108.37 -19.64 13.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.268 -0.424 . . . . 2.6800000000000002 112.08 -178.559 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 29.1 t -107.3 152.08 24.61 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.46 -0.496 . . . . 1.21 111.339 -179.398 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.33 102.98 2.22 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.734 -0.666 . . . . 1.5600000000000001 110.583 179.916 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.69 145.6 12.99 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.93 2.42 . . . . 0.81000000000000005 112.569 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.906 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.8 167.9 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.916 -0.584 . . . . 1.52 109.835 179.563 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.15 147.97 29.08 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.756 -0.461 . . . . 2.1400000000000001 109.756 178.783 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.598 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.24 157.28 45.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.026 0.441 . . . . 0.32000000000000001 111.235 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.499 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.0 155.35 44.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.83 -0.623 . . . . 2.1699999999999999 110.176 178.935 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.818 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.62 173.05 6.34 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.145 0.498 . . . . 0.58999999999999997 110.682 -179.129 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.818 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.71 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.851 2.368 . . . . 0.90000000000000002 111.501 179.367 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.98 -51.06 0.69 Allowed Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 120.767 -0.373 . . . . 3.3399999999999999 110.139 179.856 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.624 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.9 152.31 82.7 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.782 2.322 . . . . 1.8500000000000001 111.428 179.232 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.73 42.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.388 0.613 . . . . 2.54 110.526 -179.832 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.624 ' H ' ' C ' ' A' ' 27' ' ' PRO . 73.6 t60 -63.58 -41.64 98.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.988 -1.005 . . . . 2.5299999999999998 110.685 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.556 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.6 mt -109.93 137.84 40.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.771 -0.649 . . . . 1.1699999999999999 111.31 -179.488 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.0 -72.83 0.71 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.022 -0.536 . . . . 1.27 111.851 -178.948 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.24 148.33 24.4 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.604 0.594 . . . . 1.1200000000000001 112.604 -179.619 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.84 124.93 45.31 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.307 -0.627 . . . . 0.41999999999999998 109.307 177.572 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.8 mt -118.09 134.77 60.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.589 -0.444 . . . . 0.78000000000000003 110.685 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.906 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.06 128.61 53.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.036 0.446 . . . . 0.62 111.216 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.551 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.08 138.98 49.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.809 -0.632 . . . . 1.97 110.104 178.981 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.435 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.03 163.22 34.89 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 121.168 0.509 . . . . 0.34999999999999998 112.126 -178.222 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.494 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.47 139.62 7.89 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.444 -0.798 . . . . 1.8 110.449 178.861 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.68 115.62 3.17 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.261 1.974 . . . . 0.57999999999999996 111.781 179.998 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.02 81.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.879 -0.415 . . . . 3.04 109.879 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.23 -20.49 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.053 -0.522 . . . . 2.4700000000000002 111.898 -179.546 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 p -157.7 157.79 34.17 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.803 -0.359 . . . . 2.5099999999999998 110.527 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.402 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.4 m -120.34 27.76 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 1.8600000000000001 110.179 179.631 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.69 -76.05 1.32 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.793 -0.523 . . . . 1.4399999999999999 111.793 -179.211 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.403 ' HD2' HH11 ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.88 152.33 35.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.922 0.391 . . . . 4.6900000000000004 111.023 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.642 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.06 2.51 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.081 -0.509 . . . . 1.4299999999999999 111.948 179.372 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.17 149.66 29.77 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 112.59 0.589 . . . . 1.74 112.59 -177.812 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.01 156.45 46.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.826 -1.079 . . . . 1.9199999999999999 110.268 178.679 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.21 158.34 41.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.961 -0.563 . . . . 0.34000000000000002 111.778 -179.37 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 m -115.2 135.63 53.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.44 -0.8 . . . . 0.40999999999999998 109.759 179.291 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.598 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.31 121.98 23.89 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.341 -0.39 . . . . 0.55000000000000004 111.576 -179.157 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.5 Cg_exo -46.42 151.69 1.71 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.731 2.287 . . . . 0.44 112.068 179.052 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.8 -23.15 62.96 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 116.053 -0.521 . . . . 0.73999999999999999 112.783 -179.258 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.1 p-80 -82.66 -17.02 46.08 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.264 -0.574 . . . . 0.93000000000000005 111.798 -178.294 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.601 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.54 138.4 31.6 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.745 -0.382 . . . . 0.96999999999999997 110.29 179.506 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.51 13.93 11.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.487 -0.324 . . . . 1.3400000000000001 111.558 -179.385 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -150.04 143.54 25.21 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.633 -0.427 . . . . 0.39000000000000001 111.016 179.598 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.718 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.9 t80 -114.87 -169.35 1.53 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.209 0.528 . . . . 0.41999999999999998 110.836 -179.336 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.718 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.78 125.9 9.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.389 -0.823 . . . . 0.39000000000000001 109.806 179.278 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.504 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.8 mt -114.9 123.33 70.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.328 -0.549 . . . . 0.73999999999999999 111.111 -179.759 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.88 ' HD2' HG21 ' A' ' 185' ' ' ILE . 51.6 mtpt -126.57 163.31 23.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.788 -0.642 . . . . 2.48 110.491 179.667 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.464 ' HA2' HD21 ' A' ' 16' ' ' ASN . . . 85.25 18.91 59.83 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.749 -0.941 . . . . 0.5 110.749 -179.876 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.581 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 74.1 mt -79.12 157.34 27.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.099 0.476 . . . . 0.57999999999999996 111.381 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.861 ' O ' HG12 ' A' ' 67' ' ' VAL . 8.7 mttm -99.55 133.94 21.51 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.642 -0.708 . . . . 2.79 110.416 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.636 ' HB2' HG21 ' A' ' 94' ' ' THR . 36.8 Cg_endo -67.85 143.66 61.91 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.538 2.159 . . . . 0.87 111.931 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.82 25.44 75.56 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.098 -0.801 . . . . 0.64000000000000001 111.098 179.716 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.861 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.0 158.82 39.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.755 0.312 . . . . 0.82999999999999996 110.419 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.12 139.94 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.307 -0.406 . . . . 0.5 110.642 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.64 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.58 136.54 54.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.534 . . . . 0.53000000000000003 110.704 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.494 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -99.0 131.17 45.25 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.422 -0.955 . . . . 1.8700000000000001 108.422 177.647 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.485 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.66 153.84 16.69 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.246 -0.978 . . . . 0.28999999999999998 111.907 -178.595 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -134.94 140.9 46.1 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.734 -0.469 . . . . 1.4299999999999999 109.734 179.584 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.513 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.75 118.89 34.31 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.462 -0.495 . . . . 0.32000000000000001 110.522 179.679 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.744 HG12 HG23 ' A' ' 84' ' ' VAL . 64.2 mt -112.4 129.18 68.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.282 -0.417 . . . . 0.79000000000000004 110.6 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.71 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.9 120.83 43.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.227 -0.442 . . . . 1.02 110.698 -179.677 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.846 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.58 146.42 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.22 0.533 . . . . 0.62 111.018 -179.269 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.631 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.1 mt-30 -106.02 153.9 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.472 -0.786 . . . . 2.4399999999999999 109.864 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.434 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.05 88.47 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.875 0.369 . . . . 3.6899999999999999 110.499 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.631 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.26 32.63 0.21 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.868 -0.605 . . . . 6.0800000000000001 110.625 -179.867 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.14 -117.28 3.28 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.447 -0.661 . . . . 1.22 111.447 -179.746 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -81.39 177.35 9.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.126 0.489 . . . . 2.8799999999999999 111.681 -179.218 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.14 149.56 32.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.454 -0.794 . . . . 1.47 110.367 179.162 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.19 144.68 38.64 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.484 -0.325 . . . . 2.7000000000000002 110.593 179.865 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.744 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.04 135.93 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.065 0.46 . . . . 0.46000000000000002 111.53 -179.706 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.599 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -123.98 141.3 52.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.625 -0.716 . . . . 0.34999999999999998 110.247 179.692 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.481 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.61 138.87 51.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.091 0.472 . . . . 3.6699999999999999 111.527 -179.421 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.485 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.31 164.22 37.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.55 -0.75 . . . . 0.67000000000000004 109.455 179.393 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.576 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.28 151.56 38.54 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.384 -0.526 . . . . 1.47 110.985 -179.962 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.812 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.24 172.72 13.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.75 -0.659 . . . . 0.44 111.013 179.84 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.73 160.71 21.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.431 -0.804 . . . . 1.3700000000000001 109.889 179.572 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.34 121.82 22.92 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.612 -0.435 . . . . 1.28 110.757 -179.995 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.457 ' OG1' ' N ' ' A' ' 93' ' ' SER . 70.3 p -129.54 -122.56 0.22 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.252 0.549 . . . . 1.97 112.0 179.609 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.457 ' N ' ' OG1' ' A' ' 92' ' ' THR . 8.1 t 86.19 6.47 0.37 Allowed 'General case' 0 C--N 1.347 0.457 0 CA-C-N 114.8 -1.091 . . . . 3.2799999999999998 111.057 -179.707 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.636 HG21 ' HB2' ' A' ' 65' ' ' PRO . 44.4 p -106.41 10.72 31.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.792 179.44 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.2 m -56.89 -36.9 70.65 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.256 -178.931 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 40.2 p 44.3 64.8 6.75 Favored Pre-proline 0 N--CA 1.463 0.21 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.43 136.92 78.98 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.244 1.963 . . . . 0.0 113.371 -178.165 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.9 m -131.59 160.49 42.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.874 178.566 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.55 HG22 ' H ' ' A' ' 101' ' ' ASN . 40.8 m -72.2 127.96 34.19 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.388 -0.925 . . . . 0.0 108.654 179.445 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.7 p -88.13 -5.28 58.52 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.877 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.55 ' H ' HG22 ' A' ' 99' ' ' THR . 78.0 m-20 57.13 48.57 15.14 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.213 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.7 p -46.53 132.71 10.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.688 0.756 . . . . 0.0 112.703 -177.086 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.581 ' O ' ' O ' ' A' ' 106' ' ' GLU . 43.7 t -124.74 137.37 57.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.181 178.101 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 51.5 p -60.21 -38.81 84.47 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.617 -178.813 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.73 -38.0 95.75 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.331 -0.461 . . . . 0.0 112.198 179.417 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.581 ' O ' ' O ' ' A' ' 103' ' ' VAL . 84.7 tt0 -112.61 147.1 37.4 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.946 0.403 . . . . 0.0 111.662 -178.323 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.3 p -115.1 161.91 17.73 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.792 179.444 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.8 77.54 57.12 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.125 -179.006 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -57.13 150.49 56.72 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.343 2.029 . . . . 0.0 111.939 179.751 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -58.14 156.74 9.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.793 -179.757 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.0 t 72.44 64.11 0.36 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.541 -178.802 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.81 148.39 83.84 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.855 2.37 . . . . 0.0 112.219 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.5 mt -88.97 145.98 25.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.894 -0.593 . . . . 10.19 110.273 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.0 p -128.29 142.54 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.335 -0.393 . . . . 7.2800000000000002 110.467 -179.793 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.31 147.37 28.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.036 -0.529 . . . . 7.2999999999999998 111.413 -179.375 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.6 m -119.85 141.88 49.16 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.691 -0.686 . . . . 6.4400000000000004 109.478 179.332 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 41.1 m -60.79 147.67 41.75 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.406 -0.518 . . . . 4.4199999999999999 110.814 -179.014 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -72.51 -25.18 61.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.653 -0.703 . . . . 3.0499999999999998 112.099 -179.911 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.9 m -119.38 149.34 41.99 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.312 0.577 . . . . 3.4300000000000002 112.254 -178.186 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 43.0 t -116.38 138.19 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 115.068 -0.969 . . . . 2.8799999999999999 109.33 179.302 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.1 p -116.53 161.83 18.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.239 0.543 . . . . 2.0899999999999999 111.474 -178.784 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -58.67 145.37 40.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.306 -0.861 . . . . 4.5300000000000002 111.537 -179.51 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 17.0 tt -120.6 138.92 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 115.625 -0.716 . . . . 1.4399999999999999 110.022 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.496 ' O ' ' OG ' ' A' ' 126' ' ' SER . 15.8 p -118.46 165.67 13.62 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.341 -0.39 . . . . 1.78 110.408 -179.627 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 127' ' ' SER . . . -29.62 -74.88 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.258 0.836 . . . . 0.64000000000000001 113.258 -178.39 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 43.8 17.23 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.124 0.964 . . . . 0.66000000000000003 110.191 -178.206 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.79 167.54 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.676 -1.147 . . . . 0.68999999999999995 110.955 -179.956 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.55 145.65 50.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.626 -0.715 . . . . 0.52000000000000002 110.087 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.38 101.65 9.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.027 -0.731 . . . . 0.32000000000000001 109.027 177.724 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.4 t -112.9 139.66 36.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.018 -0.537 . . . . 0.28999999999999998 111.049 -178.837 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.0 p -128.7 152.5 48.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.598 -0.728 . . . . 0.25 109.83 179.588 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.584 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.9 p90 -144.74 -164.86 2.01 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.738 -0.385 . . . . 0.31 110.727 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -124.01 127.18 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.259 -0.428 . . . . 0.48999999999999999 110.838 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.144 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.97 58.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 1.53 110.292 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.2 24.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.993 -0.549 . . . . 0.96999999999999997 111.514 -179.66 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.144 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.14 128.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.639 -0.425 . . . . 1.5600000000000001 110.961 179.828 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.47 -9.57 55.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.918 -0.583 . . . . 1.8799999999999999 110.357 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.2 p -87.06 0.17 55.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 1.04 110.332 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.29 137.19 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.951 -0.568 . . . . 0.23999999999999999 110.009 179.776 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.583 ' N ' ' O ' ' A' ' 185' ' ' ILE . 84.8 p -96.16 -15.58 22.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.355 0.597 . . . . 0.28999999999999998 110.062 -179.602 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.61 175.59 45.81 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 109.882 -1.287 . . . . 0.13 109.882 179.651 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.42 151.49 42.57 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.701 -0.4 . . . . 0.17000000000000001 110.558 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.841 ' NH2' ' CD2' ' A' ' 183' ' ' TYR . 66.7 ttp85 -132.27 121.27 23.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.19 -0.459 . . . . 1.29 109.94 179.751 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.537 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.1 136.62 38.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.738 -0.664 . . . . 0.25 110.695 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 21.7 tp10 -129.46 129.85 45.13 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.004 -0.543 . . . . 1.3200000000000001 110.013 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.613 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.4 p90 -138.74 135.26 34.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.983 -0.553 . . . . 0.56999999999999995 110.537 -179.678 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.421 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.28 161.34 39.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.729 -0.669 . . . . 1.1599999999999999 109.679 179.766 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.961 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -70.96 124.77 25.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.04 0.448 . . . . 0.38 110.772 -179.624 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.76 -7.62 49.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.737 -0.665 . . . . 0.40999999999999998 110.908 -179.781 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -109.83 -69.69 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.304 -0.407 . . . . 1.6599999999999999 111.433 -179.314 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.452 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.72 -35.26 75.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.056 -0.52 . . . . 1.6599999999999999 111.529 -179.119 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.096 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.19 88.62 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.828 -0.909 . . . . 1.1699999999999999 110.828 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.318 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -28.06 -171.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 1.8600000000000001 110.317 179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.318 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.16 139.05 45.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 1.98 110.237 179.61 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.91 145.82 51.49 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 122.702 2.268 . . . . 0.55000000000000004 112.366 -179.554 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.8 145.7 42.6 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.287 -0.635 . . . . 1.1399999999999999 109.287 179.235 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.716 ' CD1' ' CG ' ' A' ' 16' ' ' ASN . 49.3 p90 -123.29 141.43 51.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.209 0.528 . . . . 0.93000000000000005 111.489 -179.069 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.6 mt -128.17 127.61 43.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.25 -0.886 . . . . 0.34000000000000002 108.988 178.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 40.7 t0 -101.67 131.22 48.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.202 0.525 . . . . 1.0900000000000001 111.679 -178.698 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.578 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -127.88 157.59 73.19 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.23 -0.896 . . . . 0.19 109.679 179.614 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.78 157.91 58.72 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 C-N-CA 122.51 2.14 . . . . 0.17999999999999999 112.241 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.2 -12.18 4.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.781 -0.645 . . . . 0.20999999999999999 110.768 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.6 p -92.85 -8.69 42.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.068 -0.515 . . . . 0.28999999999999998 110.717 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.29 135.46 34.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.349 -0.387 . . . . 0.5 110.349 179.728 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.4 p -133.19 16.64 4.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.402 -0.363 . . . . 0.29999999999999999 110.531 -179.972 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.7 p -167.55 147.09 5.06 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.651 -0.5 . . . . 0.23000000000000001 109.651 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.537 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.18 150.51 12.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.462 -0.495 . . . . 0.28000000000000003 111.588 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.501 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.38 125.02 50.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.626 -0.715 . . . . 1.0700000000000001 109.772 179.483 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.42 104.88 29.77 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.334 -0.394 . . . . 0.28999999999999998 111.036 -179.891 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -90.94 -179.49 1.51 Allowed 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 123.146 2.564 . . . . 0.42999999999999999 112.277 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 61.64 32.7 18.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.373 -0.831 . . . . 1.26 111.479 179.315 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.463 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.2 mt -86.51 148.59 25.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.778 0.323 . . . . 0.32000000000000001 110.388 179.632 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.767 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.35 114.86 61.36 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.093 0.473 . . . . 0.57999999999999996 110.58 -179.648 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.05 140.59 95.93 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.974 2.449 . . . . 0.66000000000000003 111.858 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.02 21.3 74.26 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.049 -0.821 . . . . 0.28999999999999998 111.049 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.452 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.9 150.16 49.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.758 0.314 . . . . 2.3300000000000001 110.584 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.5 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.22 131.64 46.05 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.018 -0.537 . . . . 0.85999999999999999 109.767 179.327 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.961 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.55 148.26 44.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.091 -0.504 . . . . 0.52000000000000002 111.049 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.1 mt -105.3 125.3 60.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.288 -1.004 . . . . 0.29999999999999999 108.288 177.812 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.52 132.51 63.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.169 0.509 . . . . 0.23000000000000001 111.261 -178.591 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.53 122.64 20.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.527 -0.76 . . . . 0.35999999999999999 109.552 179.321 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.584 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.14 125.35 55.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.157 -0.474 . . . . 0.19 110.666 -179.545 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.841 ' CD2' ' NH2' ' A' ' 143' ' ' ARG . 48.3 m-85 -117.2 137.95 52.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.912 -0.586 . . . . 0.29999999999999999 109.869 179.556 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.418 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.73 134.92 42.98 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.817 -0.808 . . . . 0.37 108.817 178.895 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.88 HG21 ' HD2' ' A' ' 61' ' ' LYS . 51.6 mm -99.05 123.01 51.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.107 0.479 . . . . 0.26000000000000001 110.962 -178.769 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.0 p -83.97 169.73 14.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.557 -0.747 . . . . 0.28000000000000003 110.492 -179.698 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.84 -14.4 14.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.956 -0.566 . . . . 1.6000000000000001 110.916 -179.448 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -96.13 -4.28 43.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.839 0.352 . . . . 1.1799999999999999 110.875 -179.853 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.85 13.91 63.86 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.285 -0.726 . . . . 0.29999999999999999 111.285 179.792 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -84.66 139.14 32.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.728 0.299 . . . . 1.22 110.432 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -106.81 141.05 38.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.424 -0.353 . . . . 0.97999999999999998 110.545 179.764 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.2 m -136.64 126.99 26.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.82999999999999996 110.375 179.933 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.18 117.31 9.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.32 -0.4 . . . . 0.26000000000000001 110.467 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.3 pt -108.99 -21.84 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.29999999999999999 110.676 -179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.89 125.68 5.85 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.526 -0.47 . . . . 0.31 111.555 -179.728 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.47 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.77 120.24 21.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.814 -0.63 . . . . 0.28000000000000003 109.538 179.259 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.65 151.69 29.08 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.619 -0.432 . . . . 0.23999999999999999 110.85 -179.259 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.4 158.65 18.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.042 -0.526 . . . . 0.23000000000000001 110.382 179.714 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -146.08 157.89 43.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.097 -0.501 . . . . 0.67000000000000004 110.643 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.24 104.31 9.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.819 -0.628 . . . . 0.64000000000000001 110.068 179.523 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.2 p . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.909 -1.043 . . . . 1.26 110.635 -179.657 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.2 m . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.189 -0.671 . . . . 3.4399999999999999 109.189 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.73 18.54 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.045 -0.822 . . . . 1.22 111.045 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -35.68 142.37 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.086 0 C-N-CA 123.97 3.113 . . . . 0.75 113.832 -179.271 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.604 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.96 173.5 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 114.192 -1.367 . . . . 0.79000000000000004 108.817 178.451 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.604 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.62 125.88 51.5 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.406 -0.518 . . . . 1.9399999999999999 111.41 -179.571 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 143.97 34.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.615 -0.721 . . . . 0.59999999999999998 110.71 179.82 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.27 25.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.893 0.378 . . . . 3.1400000000000001 111.133 -179.641 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.748 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.89 131.09 60.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.989 -0.551 . . . . 3.23 110.085 179.883 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.19 162.39 35.6 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.479 -0.328 . . . . 3.6299999999999999 111.257 -179.995 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 95.0 mt-10 36.06 31.56 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.642 -0.503 . . . . 6.0800000000000001 109.642 179.901 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.748 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.35 69.52 31.59 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.881 -0.599 . . . . 3.3799999999999999 111.564 -178.721 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.23 -29.16 73.21 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.522 2.148 . . . . 3.9300000000000002 111.821 179.39 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.65 125.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 3.3599999999999999 110.367 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.534 ' OE1' ' O ' ' A' ' 13' ' ' SER . 3.1 mp0 -123.97 158.31 60.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.394 . . . . 3.6099999999999999 110.479 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.434 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 97.0 Cg_endo -81.99 -64.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.935 2.424 . . . . 1.51 113.551 -179.035 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.841 ' ND2' ' CD2' ' A' ' 157' ' ' TYR . 18.5 m120 -108.41 -19.64 13.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.051 0.389 . . . . 2.6800000000000002 112.051 -178.546 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 79.3 p -107.35 152.08 24.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.159 0.504 . . . . 1.21 111.302 -179.369 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.29 102.9 2.23 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.671 -0.695 . . . . 1.5600000000000001 110.656 179.918 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.5 Cg_endo -82.7 145.59 12.97 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.872 2.381 . . . . 0.81000000000000005 112.614 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.912 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.73 167.97 24.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.858 -0.61 . . . . 1.52 109.834 179.642 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.2 148.01 29.11 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.67 -0.493 . . . . 2.1400000000000001 109.67 178.822 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.59 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.7 p90 -142.27 157.2 45.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.979 0.419 . . . . 0.32000000000000001 111.223 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.494 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -127.99 155.37 44.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.851 -0.613 . . . . 2.1699999999999999 110.094 178.88 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.83 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.64 173.13 6.24 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.07 -0.514 . . . . 0.58999999999999997 110.716 -179.22 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.83 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.65 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.849 2.366 . . . . 0.90000000000000002 111.515 179.393 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -51.08 0.69 Allowed Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.741 -0.383 . . . . 3.3399999999999999 110.072 179.838 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.633 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.88 152.34 82.57 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.754 2.303 . . . . 1.8500000000000001 111.456 179.245 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.66 42.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.446 0.641 . . . . 2.54 110.647 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.633 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.7 t60 -63.59 -41.64 98.33 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.004 -0.998 . . . . 2.5299999999999998 110.669 179.742 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.556 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.8 mt -109.82 137.8 40.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.814 -0.63 . . . . 1.1699999999999999 111.349 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.01 -72.89 0.7 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.125 -0.489 . . . . 1.27 111.833 -178.906 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -88.19 148.41 24.4 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.546 0.573 . . . . 1.1200000000000001 112.546 -179.651 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.76 124.82 45.12 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.34 -0.615 . . . . 0.41999999999999998 109.34 177.542 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.01 134.66 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.731 -0.388 . . . . 0.78000000000000003 110.74 179.876 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.912 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.01 128.71 53.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.008 0.432 . . . . 0.62 111.213 179.78 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 139.02 49.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.693 -0.685 . . . . 1.97 110.112 179.004 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.435 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.12 163.21 35.01 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.162 0.506 . . . . 0.34999999999999998 112.077 -178.135 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.491 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.46 139.52 7.84 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.473 -0.785 . . . . 1.8 110.487 178.927 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.55 115.55 3.1 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.279 1.986 . . . . 0.57999999999999996 111.82 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.667 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.98 81.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.894 -0.409 . . . . 3.04 109.894 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.688 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.3 -20.68 0.06 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.025 -0.534 . . . . 2.4700000000000002 111.932 -179.48 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.62 157.81 34.33 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.819 -0.352 . . . . 2.5099999999999998 110.598 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.406 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.33 27.78 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 1.8600000000000001 110.203 179.611 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.89 -75.78 1.31 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.088 -0.577 . . . . 1.4399999999999999 111.836 -179.242 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.95 152.29 35.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.991 0.424 . . . . 4.6900000000000004 110.946 -179.35 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.18 -169.07 2.52 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.009 -0.542 . . . . 1.4299999999999999 111.911 179.373 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.19 149.61 29.85 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.473 0.654 . . . . 1.74 112.543 -177.822 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.03 156.47 46.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.8 -1.091 . . . . 1.9199999999999999 110.25 178.633 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.466 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.23 158.38 41.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.964 -0.562 . . . . 0.34000000000000002 111.866 -179.368 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.3 m -115.19 135.57 54.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.519 -0.764 . . . . 0.40999999999999998 109.862 179.33 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.59 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.36 121.97 23.82 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.415 -0.357 . . . . 0.55000000000000004 111.493 -179.073 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.6 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.4 Cg_exo -46.33 151.74 1.63 Allowed 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.593 2.195 . . . . 0.44 112.177 178.987 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.89 -23.01 62.99 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 116.128 -0.487 . . . . 0.73999999999999999 112.77 -179.252 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.546 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.86 -16.91 45.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.456 0.628 . . . . 0.93000000000000005 111.734 -178.264 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.6 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.56 138.37 31.62 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.873 -0.331 . . . . 0.96999999999999997 110.314 179.361 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.58 14.05 10.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.32 -0.4 . . . . 1.3400000000000001 111.479 -179.402 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.474 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.4 p -150.04 143.4 25.13 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.599 -0.441 . . . . 0.39000000000000001 110.961 179.644 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.721 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.78 -169.37 1.53 Allowed 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.242 0.544 . . . . 0.41999999999999998 110.874 -179.505 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.739 ' OG1' ' C ' ' A' ' 188' ' ' ASP . 2.6 m -151.78 125.92 9.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.371 -0.832 . . . . 0.39000000000000001 109.814 179.276 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.515 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.8 mt -114.88 123.25 70.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.448 -0.501 . . . . 0.73999999999999999 111.199 -179.699 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -126.49 163.35 23.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.842 -0.617 . . . . 2.48 110.394 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.684 ' H ' HH22 ' A' ' 143' ' ' ARG . . . 85.04 19.07 59.86 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.728 -0.949 . . . . 0.5 110.728 -179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.515 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.5 mt -79.11 157.22 28.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.06 0.457 . . . . 0.57999999999999996 111.362 -179.679 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.854 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.7 mtpp -99.46 134.02 21.5 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.561 -0.745 . . . . 2.79 110.473 179.779 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.91 143.58 61.24 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.573 2.182 . . . . 0.87 111.899 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.81 25.63 75.33 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.034 -0.826 . . . . 0.64000000000000001 111.034 179.686 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.854 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.14 158.81 39.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.694 0.283 . . . . 0.82999999999999996 110.398 -179.592 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.16 140.02 41.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.843 0.354 . . . . 0.5 110.565 -179.813 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.658 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.7 m-85 -122.63 136.38 54.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.901 -0.59 . . . . 0.53000000000000003 110.792 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.491 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.76 131.03 45.21 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.593 -0.892 . . . . 1.8700000000000001 108.593 177.574 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.55 153.83 16.67 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.244 -0.979 . . . . 0.28999999999999998 111.981 -178.635 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -134.89 140.98 46.2 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.782 -0.451 . . . . 1.4299999999999999 109.782 179.534 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.525 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.4 tp -115.78 118.92 34.38 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.39 -0.524 . . . . 0.32000000000000001 110.525 179.72 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.738 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.42 129.05 68.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.372 -0.376 . . . . 0.79000000000000004 110.632 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.708 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.75 120.82 43.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.333 -0.394 . . . . 1.02 110.756 -179.7 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.864 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.55 146.52 11.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.182 0.515 . . . . 0.62 111.04 -179.302 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.618 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.03 153.9 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.515 -0.766 . . . . 2.4399999999999999 109.973 179.816 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.2 88.6 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.965 0.412 . . . . 3.6899999999999999 110.392 -179.768 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.618 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.27 32.69 0.21 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.786 -0.643 . . . . 6.0800000000000001 110.582 -179.94 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.12 -117.43 3.29 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.405 -0.678 . . . . 1.22 111.405 -179.684 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.5 177.37 8.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.168 0.509 . . . . 2.8799999999999999 111.652 -179.181 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -148.12 149.54 32.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.38 -0.827 . . . . 1.47 110.375 179.223 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.18 144.63 38.64 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.485 -0.325 . . . . 2.7000000000000002 110.513 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.738 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.97 136.02 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 120.619 -0.432 . . . . 0.46000000000000002 111.519 -179.777 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.574 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.15 141.32 52.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.645 -0.707 . . . . 0.34999999999999998 110.284 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.4 ttp180 -117.66 138.9 51.67 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.502 -0.479 . . . . 3.6699999999999999 111.531 -179.32 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.25 164.21 37.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.524 -0.762 . . . . 0.67000000000000004 109.502 179.467 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.575 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.31 151.53 38.48 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.37 -0.532 . . . . 1.47 110.974 179.977 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.802 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.19 172.81 12.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.754 -0.657 . . . . 0.44 111.027 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.77 160.63 21.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.523 -0.762 . . . . 1.3700000000000001 109.892 179.621 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.33 121.89 23.03 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.568 -0.453 . . . . 1.28 110.777 179.972 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.2 p -127.56 147.96 50.34 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.119 -0.491 . . . . 1.97 112.292 179.728 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.1 t -66.36 -36.91 84.07 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.417 -0.811 . . . . 3.2799999999999998 113.008 178.691 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.9 p -81.97 163.51 22.12 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.715 -177.598 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 82.9 p -112.06 148.63 33.49 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.534 179.696 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.413 ' N ' ' CD ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER -54.98 -50.58 85.58 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.742 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 96' ' ' THR . 34.4 Cg_exo -59.85 140.81 94.91 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.279 1.986 . . . . 0.0 113.05 -178.828 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.2 m -130.64 157.54 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.533 178.844 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 19.9 p -122.34 154.2 37.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.011 0.434 . . . . 0.0 110.821 179.534 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.9 p -90.57 -0.56 57.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.311 179.704 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.617 ' C ' ' H ' ' A' ' 103' ' ' VAL . 80.9 m-20 -74.24 -70.83 0.37 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.183 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.497 ' O ' HG22 ' A' ' 102' ' ' THR . 78.7 m 54.75 -2.4 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.893 0.378 . . . . 0.0 110.641 -179.293 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.617 ' H ' ' C ' ' A' ' 101' ' ' ASN . 80.8 t -61.91 -36.37 73.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.187 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 45.5 m -65.66 136.64 56.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.212 0.53 . . . . 0.0 111.407 -178.403 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.468 ' H ' HG22 ' A' ' 107' ' ' THR . . . 149.04 -51.06 0.55 Allowed Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.773 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.475 ' C ' ' H ' ' A' ' 108' ' ' THR . 97.0 mt-10 -62.7 -30.48 71.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.933 0.397 . . . . 0.0 110.714 179.27 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -53.91 -4.45 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.405 -179.238 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.475 ' H ' ' C ' ' A' ' 106' ' ' GLU . 33.7 p -119.79 75.19 19.65 Favored Pre-proline 0 N--CA 1.465 0.306 0 CA-C-O 120.595 0.236 . . . . 0.0 110.43 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.43 151.85 50.72 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.657 2.238 . . . . 0.0 111.871 179.646 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -100.68 129.7 46.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.09 0.472 . . . . 0.0 111.45 -179.425 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.5 p -128.98 76.09 79.62 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.653 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.61 148.19 45.39 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.422 2.081 . . . . 0.0 112.703 -179.544 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.744 HD12 ' N ' ' A' ' 113' ' ' LEU . 4.7 mp -84.29 150.5 25.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.527 -0.761 . . . . 10.19 110.416 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.7 t -61.18 135.26 26.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.159 0.504 . . . . 7.2800000000000002 110.797 -179.187 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.72 151.08 34.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.453 -0.794 . . . . 7.2999999999999998 111.513 -179.403 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.2 p -76.98 165.32 24.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.694 -0.684 . . . . 6.4400000000000004 109.686 179.816 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.5 p -65.21 157.85 27.72 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.409 -0.516 . . . . 4.4199999999999999 110.922 -178.78 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -63.9 -31.58 72.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.572 -0.74 . . . . 3.0499999999999998 111.764 -179.425 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.9 t -56.42 -38.46 71.6 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.756 -0.378 . . . . 3.4300000000000002 111.689 -177.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.8 m -132.32 150.96 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 120.644 -0.423 . . . . 2.8799999999999999 111.55 179.73 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 52.5 p -115.39 9.75 15.65 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.589 -0.732 . . . . 2.0899999999999999 109.531 178.204 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.58 144.47 42.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.526 -0.761 . . . . 4.5300000000000002 112.002 -178.981 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.454 HG22 ' H ' ' A' ' 125' ' ' ALA . 27.1 mm -112.49 136.69 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.37 -0.832 . . . . 1.4399999999999999 109.085 179.145 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.665 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 65.5 p -62.69 -34.31 76.88 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.684 -0.407 . . . . 1.78 111.344 -178.781 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' A' ' 124' ' ' THR . . . 157.63 92.13 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.127 0.267 . . . . 0.64000000000000001 110.395 179.679 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.5 p -61.79 -30.73 71.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.259 0.552 . . . . 0.66000000000000003 109.881 179.449 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.444 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.85 167.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.536 -0.756 . . . . 0.68999999999999995 110.96 179.939 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.59 145.57 50.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.664 -0.698 . . . . 0.52000000000000002 110.125 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.25 101.68 9.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.051 -0.722 . . . . 0.32000000000000001 109.051 177.725 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.3 t -112.95 139.7 36.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.992 -0.549 . . . . 0.28999999999999998 111.107 -178.911 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.0 p -128.76 152.55 48.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.705 -0.679 . . . . 0.25 109.795 179.609 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.75 -164.85 2.01 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.62 -0.432 . . . . 0.31 110.651 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.6 t -123.97 127.17 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.48999999999999999 110.804 -179.835 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.174 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.1 p -57.89 58.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.111 -0.495 . . . . 1.53 110.44 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.743 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.13 24.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.971 -0.559 . . . . 0.96999999999999997 111.478 -179.591 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.174 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.1 128.62 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.674 -0.41 . . . . 1.5600000000000001 110.999 179.833 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.35 -9.52 56.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.883 -0.599 . . . . 1.8799999999999999 110.381 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.8 p -87.16 0.32 55.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.52 . . . . 1.04 110.27 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.33 137.19 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.023 -0.535 . . . . 0.23999999999999999 109.977 179.717 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.614 ' N ' ' O ' ' A' ' 185' ' ' ILE . 93.8 p -96.2 -15.56 21.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.248 0.547 . . . . 0.28999999999999998 110.046 -179.673 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.61 175.67 45.88 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 109.859 -1.297 . . . . 0.13 109.859 179.595 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.46 151.6 42.54 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.683 -0.407 . . . . 0.17000000000000001 110.525 179.778 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.684 HH22 ' H ' ' A' ' 62' ' ' GLY . 10.3 tpp180 -132.35 121.18 23.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.172 -0.467 . . . . 1.29 109.911 179.809 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.555 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.08 136.63 38.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.74 -0.664 . . . . 0.25 110.632 -179.777 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 79.3 tt0 -129.41 129.89 45.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.996 -0.547 . . . . 1.3200000000000001 110.044 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.625 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.4 p90 -138.71 135.24 34.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.055 -0.52 . . . . 0.56999999999999995 110.611 -179.669 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.418 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.27 161.32 39.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.841 -0.618 . . . . 1.1599999999999999 109.734 179.834 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.4 mt -71.02 124.78 25.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.011 0.434 . . . . 0.38 110.767 -179.644 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.67 -7.7 49.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.777 -0.647 . . . . 0.40999999999999998 110.915 -179.814 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.88 -69.58 0.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.303 -0.408 . . . . 1.6599999999999999 111.449 -179.283 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.449 ' CD ' HH21 ' A' ' 176' ' ' ARG . 53.9 mt-10 -60.74 -35.33 76.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 1.6599999999999999 111.506 -179.184 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.08 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.15 7.26 88.57 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.857 -0.897 . . . . 1.1699999999999999 110.857 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.341 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.4 t0 -27.9 -171.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 1.8600000000000001 110.229 179.798 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.341 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.4 139.1 44.67 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.036 0.446 . . . . 1.98 110.185 179.614 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.418 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 45.8 Cg_endo -70.91 145.79 51.39 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 122.675 2.25 . . . . 0.55000000000000004 112.302 -179.466 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.625 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.75 145.72 42.54 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.318 -0.623 . . . . 1.1399999999999999 109.318 179.157 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.841 ' CD2' ' ND2' ' A' ' 16' ' ' ASN . 22.3 p90 -123.27 141.34 52.09 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.384 -0.526 . . . . 0.93000000000000005 111.536 -179.067 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.9 mt -128.14 127.66 43.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.314 -0.857 . . . . 0.34000000000000002 108.936 178.967 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.625 ' HB2' ' NH1' ' A' ' 143' ' ' ARG . 29.5 t0 -101.6 131.09 47.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.171 0.51 . . . . 1.0900000000000001 111.738 -178.77 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.91 157.52 73.49 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.2 -0.909 . . . . 0.19 109.583 179.643 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -69.8 158.14 57.94 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.351 2.034 . . . . 0.17999999999999999 112.3 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.36 -12.19 5.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.733 -0.667 . . . . 0.20999999999999999 110.744 -179.782 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.9 p -92.77 -8.71 42.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.086 -0.506 . . . . 0.28999999999999998 110.718 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.14 135.38 34.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 0.5 110.378 179.67 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.5 p -133.18 16.72 4.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.29999999999999999 110.552 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.1 p -167.59 147.12 5.04 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.619 -0.512 . . . . 0.23000000000000001 109.619 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.555 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.2 150.46 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.548 -0.461 . . . . 0.28000000000000003 111.59 -179.653 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.509 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.31 124.98 50.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.637 -0.71 . . . . 1.0700000000000001 109.812 179.493 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.37 104.9 29.71 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.412 -0.358 . . . . 0.28999999999999998 111.107 -179.897 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.7 Cg_endo -91.06 -179.49 1.47 Allowed 'Trans proline' 0 C--N 1.301 -1.964 0 C-N-CA 123.178 2.585 . . . . 0.42999999999999999 112.213 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 61.63 32.71 18.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.463 -0.79 . . . . 1.26 111.439 179.302 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.1 mt -86.35 148.51 25.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.436 -0.347 . . . . 0.32000000000000001 110.469 179.547 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.774 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.29 114.83 61.2 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.076 0.465 . . . . 0.57999999999999996 110.645 -179.75 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.98 140.58 95.96 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.908 2.405 . . . . 0.66000000000000003 111.959 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.15 74.45 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.006 -0.837 . . . . 0.28999999999999998 111.006 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.449 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.8 mmm-85 -126.87 150.27 49.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.38 . . . . 2.3300000000000001 110.6 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.5 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.23 131.63 46.06 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.011 -0.54 . . . . 0.85999999999999999 109.737 179.392 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.955 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.44 148.36 43.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.099 -0.501 . . . . 0.52000000000000002 111.037 -179.868 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.34 125.34 60.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.258 -1.016 . . . . 0.29999999999999999 108.258 177.745 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.54 132.53 63.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.085 0.469 . . . . 0.23000000000000001 111.221 -178.595 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.54 122.56 20.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.591 -0.732 . . . . 0.35999999999999999 109.626 179.258 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.03 125.37 54.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.181 -0.463 . . . . 0.19 110.729 -179.556 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.14 137.83 52.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.014 -0.539 . . . . 0.29999999999999999 109.903 179.565 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.429 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.63 134.98 42.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.815 -0.809 . . . . 0.37 108.815 178.832 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.614 ' O ' ' N ' ' A' ' 140' ' ' SER . 46.0 mm -99.05 122.94 51.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.131 0.491 . . . . 0.26000000000000001 111.024 -178.826 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.6 p -83.76 169.66 14.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.571 -0.74 . . . . 0.28000000000000003 110.511 -179.688 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.87 -14.43 15.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.034 -0.53 . . . . 1.6000000000000001 110.979 -179.593 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.739 ' C ' ' OG1' ' A' ' 59' ' ' THR . 96.3 m-20 -96.03 -4.3 43.31 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.894 -0.323 . . . . 1.1799999999999999 110.861 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.508 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.79 13.9 63.99 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.354 -0.699 . . . . 0.29999999999999999 111.354 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -84.72 139.06 32.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.696 0.284 . . . . 1.22 110.389 179.731 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -106.61 141.02 38.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.423 -0.353 . . . . 0.97999999999999998 110.674 179.646 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.0 m -136.73 127.09 26.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.82999999999999996 110.338 179.88 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 25.5 tp -68.19 117.38 9.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.959 0.409 . . . . 0.26000000000000001 110.451 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.06 -21.86 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.29999999999999999 110.71 -179.699 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.86 125.73 5.88 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 120.442 -0.503 . . . . 0.31 111.508 -179.757 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.46 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.81 120.21 21.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.792 -0.64 . . . . 0.28000000000000003 109.581 179.195 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.63 151.7 29.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.96 0.41 . . . . 0.23999999999999999 110.883 -179.239 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.45 158.6 18.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.009 -0.542 . . . . 0.23000000000000001 110.409 179.725 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -146.11 157.92 43.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 0.67000000000000004 110.678 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 104.34 9.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.811 -0.631 . . . . 0.64000000000000001 110.053 179.582 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.58 ' O ' HD13 ' A' ' 113' ' ' LEU . 67.3 p . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.964 -1.017 . . . . 1.26 110.61 -179.641 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.548 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.209 -0.663 . . . . 3.4399999999999999 109.209 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.4 150.66 18.54 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.023 -0.831 . . . . 1.22 111.023 179.814 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -35.65 142.37 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.114 0 C-N-CA 123.956 3.104 . . . . 0.75 113.881 -179.23 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.617 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.96 173.35 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.261 -1.336 . . . . 0.79000000000000004 108.841 178.507 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.617 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.49 125.89 51.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.127 0.489 . . . . 1.9399999999999999 111.454 -179.639 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.56 144.01 33.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.575 -0.739 . . . . 0.59999999999999998 110.621 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.08 168.24 25.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.914 0.388 . . . . 3.1400000000000001 111.118 -179.637 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.741 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.5 mt -108.91 131.07 60.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.042 -0.526 . . . . 3.23 110.06 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.5 p -141.24 162.27 35.88 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.853 0.358 . . . . 3.6299999999999999 111.203 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 48.1 mt-10 36.1 31.61 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.625 -0.509 . . . . 6.0800000000000001 109.625 179.847 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.741 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.6 33.11 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.951 -0.568 . . . . 3.3799999999999999 111.609 -178.844 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.639 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.24 -29.13 73.12 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.486 2.124 . . . . 3.9300000000000002 111.838 179.325 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.693 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 3.2 m 149.58 125.62 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 3.3599999999999999 110.527 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.707 ' O ' ' O ' ' A' ' 92' ' ' THR . 1.8 mp0 -123.99 158.3 60.75 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 3.6099999999999999 110.411 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.552 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 98.3 Cg_endo -82.05 -64.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.874 2.383 . . . . 1.51 113.491 -178.983 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.727 ' ND2' ' CD1' ' A' ' 157' ' ' TYR . 1.2 m120 -108.44 -19.6 13.4 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.12 0.415 . . . . 2.6800000000000002 112.12 -178.562 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.736 ' OG ' ' NZ ' ' A' ' 61' ' ' LYS . 55.8 m -107.3 152.03 24.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.171 0.51 . . . . 1.21 111.298 -179.411 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.571 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.21 102.88 2.24 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.681 -0.69 . . . . 1.5600000000000001 110.618 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.66 145.64 13.04 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.925 2.417 . . . . 0.81000000000000005 112.643 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.915 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.8 167.9 24.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.89 -0.595 . . . . 1.52 109.885 179.561 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -149.12 147.97 29.1 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.677 -0.49 . . . . 2.1400000000000001 109.677 178.859 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.597 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.3 p90 -142.21 157.35 44.96 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.623 -0.431 . . . . 0.32000000000000001 111.167 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.49 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.05 155.24 44.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.822 -0.626 . . . . 2.1699999999999999 110.119 178.962 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.83 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.58 173.09 6.29 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.081 -0.508 . . . . 0.58999999999999997 110.765 -179.217 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.83 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.68 174.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.909 2.406 . . . . 0.90000000000000002 111.518 179.362 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.11 -51.16 0.68 Allowed Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.727 -0.389 . . . . 3.3399999999999999 110.054 179.899 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.617 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.74 152.32 82.44 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.769 2.312 . . . . 1.8500000000000001 111.442 179.189 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.69 42.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.351 0.596 . . . . 2.54 110.531 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.617 ' H ' ' C ' ' A' ' 27' ' ' PRO . 73.8 t60 -63.58 -41.72 98.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.05 -0.977 . . . . 2.5299999999999998 110.609 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.562 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.2 mt -109.86 137.83 40.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.782 -0.644 . . . . 1.1699999999999999 111.23 -179.363 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.94 -72.88 0.7 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.031 -0.531 . . . . 1.27 111.937 -178.984 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.15 148.36 24.46 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.559 0.577 . . . . 1.1200000000000001 112.559 -179.665 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.87 124.84 45.06 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.302 -0.629 . . . . 0.41999999999999998 109.302 177.543 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 mt -117.97 134.68 60.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.787 -0.365 . . . . 0.78000000000000003 110.642 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.915 HD13 HD11 ' A' ' 20' ' ' ILE . 8.8 mt -120.01 128.63 53.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 0.62 111.292 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.14 138.97 49.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.727 -0.67 . . . . 1.97 110.145 179.014 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.433 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -145.07 163.26 34.81 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 121.265 0.555 . . . . 0.34999999999999998 112.037 -178.117 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.491 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.55 139.51 7.76 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 115.431 -0.804 . . . . 1.8 110.506 178.873 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.3 Cg_endo -63.5 115.46 3.05 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.344 2.03 . . . . 0.57999999999999996 111.81 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.674 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.02 81.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.882 -0.414 . . . . 3.04 109.882 -179.81 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.72 0.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.943 -0.571 . . . . 2.4700000000000002 111.916 -179.467 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.4 p -157.55 157.82 34.48 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.848 -0.341 . . . . 2.5099999999999998 110.613 179.769 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.4 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.8 m -120.42 27.85 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.438 . . . . 1.8600000000000001 110.144 179.558 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.78 -75.9 1.31 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.107 -0.568 . . . . 1.4399999999999999 111.886 -179.284 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.88 152.34 35.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.944 0.402 . . . . 4.6900000000000004 110.994 -179.42 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.676 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.21 -169.1 2.53 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.033 -0.53 . . . . 1.4299999999999999 111.989 179.367 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.431 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.19 149.68 29.75 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.412 0.625 . . . . 1.74 112.583 -177.848 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.06 156.52 45.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.837 -1.074 . . . . 1.9199999999999999 110.241 178.688 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.2 158.46 41.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.968 -0.56 . . . . 0.34000000000000002 111.822 -179.349 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.6 m -115.31 135.72 53.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.479 -0.782 . . . . 0.40999999999999998 109.747 179.291 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.597 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.46 121.93 23.69 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.385 -0.371 . . . . 0.55000000000000004 111.579 -179.182 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.0 Cg_exo -46.24 151.67 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.729 2.286 . . . . 0.44 112.129 179.042 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.84 -23.11 63.01 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 116.083 -0.508 . . . . 0.73999999999999999 112.77 -179.227 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.81 -16.83 46.24 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.224 -0.59 . . . . 0.93000000000000005 111.819 -178.319 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.604 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.67 138.49 31.52 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.709 -0.397 . . . . 0.96999999999999997 110.246 179.398 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.54 13.9 10.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.345 -0.389 . . . . 1.3400000000000001 111.542 -179.363 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.476 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.97 143.41 25.19 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.63 -0.428 . . . . 0.39000000000000001 111.059 179.676 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.4 t80 -114.76 -169.37 1.53 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.167 0.508 . . . . 0.41999999999999998 110.899 -179.432 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.714 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.81 125.78 9.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.454 -0.794 . . . . 0.39000000000000001 109.858 179.278 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.513 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.81 123.16 70.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.382 -0.527 . . . . 0.73999999999999999 111.282 -179.798 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.736 ' NZ ' ' OG ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -126.41 163.4 23.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.882 -0.599 . . . . 2.48 110.426 179.749 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.642 ' H ' ' HD3' ' A' ' 61' ' ' LYS . . . 85.11 19.0 59.86 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.759 -0.936 . . . . 0.5 110.759 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.513 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.9 mt -78.98 157.25 28.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.111 0.482 . . . . 0.57999999999999996 111.3 -179.631 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.855 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -99.51 133.9 21.56 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.627 -0.715 . . . . 2.79 110.415 179.743 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.423 ' HD3' ' CE2' ' A' ' 157' ' ' TYR . 36.9 Cg_endo -67.76 143.61 62.21 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.571 2.181 . . . . 0.87 112.022 179.731 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.76 25.6 75.37 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.061 -0.816 . . . . 0.64000000000000001 111.061 179.715 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.855 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.14 158.77 39.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.751 0.31 . . . . 0.82999999999999996 110.444 -179.673 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.13 140.08 41.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.932 0.396 . . . . 0.5 110.516 -179.765 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.644 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.65 136.46 54.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.886 -0.597 . . . . 0.53000000000000003 110.75 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.491 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.86 131.02 45.28 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.506 -0.924 . . . . 1.8700000000000001 108.506 177.637 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.46 153.92 16.64 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 120.321 -0.942 . . . . 0.28999999999999998 111.985 -178.685 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -134.98 140.87 46.03 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.71 -0.478 . . . . 1.4299999999999999 109.71 179.61 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.71 118.9 34.34 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.526 -0.47 . . . . 0.32000000000000001 110.534 179.691 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.731 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.5 129.09 68.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 0.79000000000000004 110.647 -179.883 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.708 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.86 120.76 43.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.327 -0.397 . . . . 1.02 110.691 -179.577 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.85 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.54 146.47 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.197 0.523 . . . . 0.62 111.0 -179.266 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.628 ' O ' ' N ' ' A' ' 79' ' ' TYR . 20.9 mt-30 -106.09 153.9 21.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.501 -0.772 . . . . 2.4399999999999999 109.924 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.21 88.51 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.938 0.399 . . . . 3.6899999999999999 110.426 -179.653 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.628 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.42 32.61 0.23 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.807 -0.633 . . . . 6.0800000000000001 110.581 -179.906 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.14 -117.28 3.28 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.492 -0.643 . . . . 1.22 111.492 -179.722 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -81.55 177.41 8.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.18 0.514 . . . . 2.8799999999999999 111.516 -179.106 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.2 149.58 32.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.444 -0.798 . . . . 1.47 110.415 179.107 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.548 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.22 144.58 38.54 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.454 -0.339 . . . . 2.7000000000000002 110.592 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.731 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.91 135.97 61.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.597 -0.441 . . . . 0.46000000000000002 111.586 -179.761 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -123.99 141.32 52.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.733 -0.667 . . . . 0.34999999999999998 110.259 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.468 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.65 138.96 51.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.134 0.492 . . . . 3.6699999999999999 111.463 -179.414 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.37 164.15 38.07 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.514 -0.766 . . . . 0.67000000000000004 109.442 179.352 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.569 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.15 151.59 38.69 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.366 -0.534 . . . . 1.47 110.985 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.3 172.75 13.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.689 -0.687 . . . . 0.44 111.018 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.74 160.67 21.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.443 -0.799 . . . . 1.3700000000000001 109.846 179.66 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.38 121.8 22.84 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.624 -0.43 . . . . 1.28 110.833 179.962 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.707 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.2 p -127.85 170.0 13.28 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 116.09 -0.504 . . . . 1.97 110.677 179.683 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.9 m -106.22 146.07 30.77 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.11 0.481 . . . . 3.2799999999999998 110.119 179.415 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.3 t -78.0 -15.92 58.54 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.393 -178.254 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 61.7 m -60.07 151.21 27.18 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.187 -178.89 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.438 ' CB ' ' CD ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER -177.69 -63.86 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.982 179.799 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 96' ' ' THR . 19.2 Cg_endo -58.27 142.49 97.48 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.358 2.038 . . . . 0.0 111.964 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.2 p -133.59 141.58 43.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.842 179.621 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' ' 149' ' ' SER . 18.9 p -125.49 157.26 37.43 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.706 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 84.8 p -146.36 157.75 43.82 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.075 0.464 . . . . 0.0 111.536 179.608 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.478 ' C ' ' ND2' ' A' ' 101' ' ' ASN . 0.1 OUTLIER -125.8 15.06 8.06 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.298 178.536 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 58.0 m -84.72 141.26 30.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.757 -178.965 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.8 t -65.9 139.71 20.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.024 179.367 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.3 t -128.25 159.89 33.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.539 -179.098 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.09 -89.05 1.01 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -178.263 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.43 -31.42 72.11 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.567 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 47.5 m -73.93 142.72 45.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.709 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.34 156.76 14.45 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.304 -179.637 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -49.91 149.29 11.45 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.395 2.063 . . . . 0.0 112.864 -179.359 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -56.92 -34.14 67.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.021 -179.748 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.1 t -123.47 80.24 54.04 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.178 -179.157 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.41 149.9 28.43 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.51 2.14 . . . . 0.0 111.602 179.487 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.9 tp -55.49 -37.48 67.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.374 -0.375 . . . . 10.19 110.382 -179.66 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.0 t -114.9 134.29 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.304 -0.407 . . . . 7.2800000000000002 110.449 179.634 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.93 144.51 56.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 7.2999999999999998 110.653 179.9 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.2 m -57.85 -39.0 76.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.288 -0.415 . . . . 6.4400000000000004 110.445 179.755 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 92.4 p -124.15 155.3 38.7 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.127 -0.488 . . . . 4.4199999999999999 110.447 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.56 142.8 51.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 3.0499999999999998 110.747 -179.931 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.2 p -62.35 -25.9 68.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 3.4300000000000002 110.726 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 121' ' ' THR . 71.2 t -59.66 -39.79 80.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 2.8799999999999999 110.474 -179.572 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 120' ' ' VAL . 25.0 m 37.17 78.18 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.306 -0.406 . . . . 2.0899999999999999 111.062 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.63 -32.73 72.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.062 -0.517 . . . . 4.5300000000000002 111.09 -179.559 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 17.2 tt -121.48 137.76 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.834 0.349 . . . . 1.4399999999999999 110.685 -179.58 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.2 p -120.99 161.08 22.22 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.068 -0.515 . . . . 1.78 110.463 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' A' ' 127' ' ' SER . . . -174.1 -121.7 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.998 -0.546 . . . . 0.64000000000000001 110.21 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.3 OUTLIER 42.93 17.04 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.272 -0.422 . . . . 0.66000000000000003 111.511 179.709 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.83 167.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.917 -0.583 . . . . 0.68999999999999995 110.99 179.868 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.59 145.59 50.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.748 -0.66 . . . . 0.52000000000000002 110.11 -179.881 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.35 101.65 9.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.08 -0.711 . . . . 0.32000000000000001 109.08 177.734 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.5 t -112.96 139.74 36.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.978 -0.555 . . . . 0.28999999999999998 111.071 -178.836 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.1 p -128.78 152.5 48.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.613 -0.721 . . . . 0.25 109.741 179.745 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.588 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.8 -165.0 2.05 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.675 -0.41 . . . . 0.31 110.618 -179.775 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.738 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -123.86 127.15 73.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.218 -0.446 . . . . 0.48999999999999999 110.894 -179.881 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.158 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.8 58.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 1.53 110.36 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.738 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.19 24.56 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.99 -0.55 . . . . 0.96999999999999997 111.541 -179.583 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.158 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.16 128.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.615 -0.434 . . . . 1.5600000000000001 110.95 179.831 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -86.45 -9.66 55.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.973 -0.558 . . . . 1.8799999999999999 110.295 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.09 0.2 55.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 1.04 110.313 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.25 137.16 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.957 -0.565 . . . . 0.23999999999999999 109.997 179.711 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 185' ' ' ILE . 0.2 OUTLIER -96.2 -15.55 21.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.32 0.581 . . . . 0.28999999999999998 110.021 -179.613 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.6 175.52 45.74 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 109.863 -1.295 . . . . 0.13 109.863 179.685 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -123.39 151.63 42.38 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.655 -0.418 . . . . 0.17000000000000001 110.523 179.711 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.632 ' NH1' ' CB ' ' A' ' 157' ' ' TYR . 10.4 ttt85 -132.34 121.22 23.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.078 -0.51 . . . . 1.29 109.954 179.754 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.542 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.09 136.53 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.666 -0.697 . . . . 0.25 110.678 -179.752 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 84.2 tt0 -129.37 129.88 45.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.017 -0.538 . . . . 1.3200000000000001 110.128 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.73 135.29 34.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.001 -0.545 . . . . 0.56999999999999995 110.653 -179.684 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.412 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.26 161.34 39.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.721 -0.672 . . . . 1.1599999999999999 109.682 179.883 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.965 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.06 124.83 25.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.971 0.415 . . . . 0.38 110.764 -179.662 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.74 -7.63 49.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.709 -0.678 . . . . 0.40999999999999998 110.872 -179.775 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -109.87 -69.67 0.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.979 0.418 . . . . 1.6599999999999999 111.386 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.441 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.74 -35.28 75.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.03 -0.532 . . . . 1.6599999999999999 111.44 -179.095 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.09 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.08 7.26 88.56 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.858 -0.897 . . . . 1.1699999999999999 110.858 -179.787 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.315 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.98 -171.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.331 . . . . 1.8600000000000001 110.218 179.86 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.315 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.19 139.03 45.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.962 0.41 . . . . 1.98 110.233 179.627 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.412 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.1 Cg_endo -70.88 145.87 51.79 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 C-N-CA 122.751 2.301 . . . . 0.55000000000000004 112.286 -179.469 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.91 145.7 42.68 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.199 -0.667 . . . . 1.1399999999999999 109.199 179.237 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.727 ' CD1' ' ND2' ' A' ' 16' ' ' ASN . 43.2 p90 -123.31 141.33 52.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.269 0.557 . . . . 0.93000000000000005 111.506 -179.102 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.3 mt -128.08 127.62 43.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.297 -0.865 . . . . 0.34000000000000002 109.021 178.949 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -101.58 131.11 47.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.178 0.513 . . . . 1.0900000000000001 111.812 -178.736 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.93 157.51 73.56 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.315 -0.857 . . . . 0.19 109.658 179.653 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.83 158.08 58.08 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 C-N-CA 122.389 2.059 . . . . 0.17999999999999999 112.215 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.28 -12.2 5.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.754 -0.657 . . . . 0.20999999999999999 110.736 -179.775 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.7 p -92.8 -8.68 42.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.132 -0.486 . . . . 0.28999999999999998 110.79 -179.93 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.39 34.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.247 -0.433 . . . . 0.5 110.354 179.701 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.8 p -133.16 16.73 4.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.394 -0.367 . . . . 0.29999999999999999 110.492 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.4 p -167.54 147.13 5.08 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.569 -0.53 . . . . 0.23000000000000001 109.569 179.841 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.542 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.14 150.52 12.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.467 -0.493 . . . . 0.28000000000000003 111.592 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.506 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.34 124.9 50.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.674 -0.694 . . . . 1.0700000000000001 109.803 179.504 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.33 104.82 29.06 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.382 -0.372 . . . . 0.28999999999999998 111.131 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.5 Cg_endo -90.92 -179.48 1.51 Allowed 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 123.192 2.595 . . . . 0.42999999999999999 112.296 179.883 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.7 32.59 18.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.46 -0.791 . . . . 1.26 111.462 179.262 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.44 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.1 mt -86.32 148.51 25.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.457 -0.338 . . . . 0.32000000000000001 110.44 179.615 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.769 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.28 114.83 61.19 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.008 0.432 . . . . 0.57999999999999996 110.7 -179.767 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -58.98 140.59 96.03 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.851 2.367 . . . . 0.66000000000000003 112.039 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.06 21.24 74.27 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.028 -0.829 . . . . 0.28999999999999998 111.028 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.441 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.9 150.17 49.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.857 0.36 . . . . 2.3300000000000001 110.578 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.501 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.19 131.62 46.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.039 -0.528 . . . . 0.85999999999999999 109.795 179.335 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.965 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.48 148.25 44.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.117 -0.492 . . . . 0.52000000000000002 111.089 -179.863 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.21 125.28 60.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.342 -0.984 . . . . 0.29999999999999999 108.342 177.742 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.53 132.58 63.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.129 0.49 . . . . 0.23000000000000001 111.238 -178.593 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.55 122.52 20.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.461 -0.791 . . . . 0.35999999999999999 109.574 179.362 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.588 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.99 125.39 54.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.337 -0.392 . . . . 0.19 110.706 -179.563 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.24 137.92 52.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.086 -0.506 . . . . 0.29999999999999999 109.833 179.573 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.427 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.83 134.96 43.02 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.802 -0.814 . . . . 0.37 108.802 178.865 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.606 ' O ' ' N ' ' A' ' 140' ' ' SER . 3.7 mt -99.01 122.92 51.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.09 0.472 . . . . 0.26000000000000001 111.001 -178.736 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.8 p -83.84 169.82 14.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.562 -0.744 . . . . 0.28000000000000003 110.469 -179.685 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.84 -14.51 15.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.058 -0.519 . . . . 1.6000000000000001 110.928 -179.556 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -96.07 -4.42 42.97 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.878 -0.329 . . . . 1.1799999999999999 110.83 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.9 13.85 63.86 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.368 -0.693 . . . . 0.29999999999999999 111.368 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -84.62 139.04 32.35 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.775 -0.25 . . . . 1.22 110.446 179.694 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.453 HE22 ' HG2' ' A' ' 14' ' ' GLN . 4.0 mp0 -106.71 141.07 38.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.485 -0.325 . . . . 0.97999999999999998 110.63 179.708 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.4 m -136.7 127.02 26.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.82999999999999996 110.329 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.11 117.29 9.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.327 -0.397 . . . . 0.26000000000000001 110.477 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.03 -21.85 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 0.29999999999999999 110.716 -179.785 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.1 tp -156.87 125.8 5.91 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.566 -0.454 . . . . 0.31 111.564 -179.829 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.474 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.7 120.16 21.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.731 -0.668 . . . . 0.28000000000000003 109.579 179.289 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.65 151.75 29.16 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.714 -0.394 . . . . 0.23999999999999999 110.884 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.55 158.6 18.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.054 -0.521 . . . . 0.23000000000000001 110.469 179.675 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -146.09 157.87 43.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.191 -0.459 . . . . 0.67000000000000004 110.725 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.27 104.41 9.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.771 -0.649 . . . . 0.64000000000000001 110.024 179.559 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 117.88 -1.057 . . . . 1.26 110.638 -179.691 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.9 m . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.248 -0.649 . . . . 3.4399999999999999 109.248 . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.42 150.73 18.53 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.037 -0.825 . . . . 1.22 111.037 179.692 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -35.65 142.43 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 123.988 3.125 . . . . 0.75 113.795 -179.197 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.624 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.3 t -80.04 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 114.295 -1.321 . . . . 0.79000000000000004 108.808 178.447 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.624 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.68 125.87 51.49 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.415 -0.514 . . . . 1.9399999999999999 111.395 -179.533 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 144.03 33.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.555 -0.748 . . . . 0.59999999999999998 110.646 179.921 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.05 168.33 25.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.894 0.378 . . . . 3.1400000000000001 111.096 -179.614 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.747 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.4 mt -109.03 131.14 60.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.006 -0.543 . . . . 3.23 110.074 179.861 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.505 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.3 p -141.21 162.3 35.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.859 0.361 . . . . 3.6299999999999999 111.217 -179.903 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.582 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 80.1 tt0 36.13 31.57 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.629 -0.508 . . . . 6.0800000000000001 109.629 179.811 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.747 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.55 69.58 33.73 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.945 -0.57 . . . . 3.3799999999999999 111.58 -178.753 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.17 -29.14 73.74 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.525 2.15 . . . . 3.9300000000000002 111.868 179.304 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.63 125.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 3.3599999999999999 110.41 -179.973 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 17' ' ' SER . 39.5 mt-30 -123.96 158.38 60.41 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 3.6099999999999999 110.405 179.942 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.587 ' HD2' HH12 ' A' ' 143' ' ' ARG . 97.4 Cg_endo -82.03 -64.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.942 2.428 . . . . 1.51 113.558 -179.086 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.552 ' ND2' ' OD1' ' A' ' 159' ' ' ASP . 98.7 m-20 -108.48 -19.51 13.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.075 0.398 . . . . 2.6800000000000002 112.075 -178.54 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 29.1 t -107.35 151.99 24.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.083 0.468 . . . . 1.21 111.296 -179.405 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.2 102.92 2.24 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.656 -0.702 . . . . 1.5600000000000001 110.722 179.786 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.72 145.59 12.93 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.962 2.441 . . . . 0.81000000000000005 112.636 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.937 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.75 167.92 24.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.894 -0.594 . . . . 1.52 109.853 179.672 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -149.12 148.02 29.17 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.768 -0.456 . . . . 2.1400000000000001 109.768 178.816 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.601 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.34 157.29 44.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.031 0.443 . . . . 0.32000000000000001 111.212 179.954 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.496 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.02 155.29 44.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.777 -0.647 . . . . 2.1699999999999999 110.111 179.072 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.825 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.69 172.95 6.49 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.155 0.502 . . . . 0.58999999999999997 110.701 -179.171 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.825 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.6 173.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.844 0 C-N-CA 122.876 2.384 . . . . 0.90000000000000002 111.475 179.421 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.1 -51.07 0.68 Allowed Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 120.68 -0.408 . . . . 3.3399999999999999 110.111 179.881 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.613 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.81 152.33 82.49 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.716 2.277 . . . . 1.8500000000000001 111.497 179.139 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.66 42.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.417 0.627 . . . . 2.54 110.58 -179.881 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.613 ' N ' ' O ' ' A' ' 27' ' ' PRO . 74.1 t60 -63.69 -41.54 98.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.959 -1.019 . . . . 2.5299999999999998 110.7 179.775 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.567 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.8 mt -109.9 137.82 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.738 -0.665 . . . . 1.1699999999999999 111.29 -179.479 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.89 -72.96 0.7 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.056 -0.52 . . . . 1.27 111.982 -179.006 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.43 24.41 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.62 0.6 . . . . 1.1200000000000001 112.62 -179.689 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.78 124.88 45.24 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.365 -0.606 . . . . 0.41999999999999998 109.365 177.524 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.06 134.82 60.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.724 -0.391 . . . . 0.78000000000000003 110.63 179.913 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.937 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.15 128.68 53.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.078 0.466 . . . . 0.62 111.138 179.792 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.99 49.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.716 -0.674 . . . . 1.97 110.162 178.92 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.437 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.0 163.22 34.87 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.153 0.502 . . . . 0.34999999999999998 112.097 -178.127 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.488 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.56 139.53 7.76 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.483 -0.781 . . . . 1.8 110.443 178.805 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.43 115.5 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.283 1.989 . . . . 0.57999999999999996 111.855 179.946 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.686 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.06 81.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.914 0.388 . . . . 3.04 109.964 -179.853 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.14 -20.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.962 -0.563 . . . . 2.4700000000000002 111.901 -179.466 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -157.62 157.75 34.22 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.885 -0.326 . . . . 2.5099999999999998 110.586 179.819 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.406 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.34 27.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.173 -0.467 . . . . 1.8600000000000001 110.232 179.567 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.84 -75.86 1.31 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.144 -0.55 . . . . 1.4399999999999999 111.796 -179.204 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.86 152.3 35.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.959 0.409 . . . . 4.6900000000000004 110.951 -179.268 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.66 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.26 -169.16 2.54 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.033 -0.53 . . . . 1.4299999999999999 111.938 179.352 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.08 149.58 29.83 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.436 0.636 . . . . 1.74 112.634 -177.903 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.0 156.48 46.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.83 -1.077 . . . . 1.9199999999999999 110.318 178.562 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.16 158.45 41.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.926 -0.579 . . . . 0.34000000000000002 111.82 -179.373 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 m -115.22 135.62 53.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.483 -0.781 . . . . 0.40999999999999998 109.8 179.322 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.601 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.48 121.95 23.67 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.459 -0.337 . . . . 0.55000000000000004 111.489 -179.14 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.607 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.2 Cg_exo -46.25 151.68 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.67 2.246 . . . . 0.44 112.141 178.993 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.88 -22.98 62.95 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.998 -0.547 . . . . 0.73999999999999999 112.882 -179.268 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.83 -16.81 46.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.346 0.573 . . . . 0.93000000000000005 111.839 -178.38 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.607 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.73 138.36 31.62 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.749 -0.38 . . . . 0.96999999999999997 110.335 179.371 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.45 13.93 11.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.353 -0.385 . . . . 1.3400000000000001 111.546 -179.3 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.8 p -149.98 143.54 25.27 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.612 -0.435 . . . . 0.39000000000000001 111.028 179.594 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.721 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.85 -169.32 1.53 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.174 0.511 . . . . 0.41999999999999998 110.855 -179.423 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.721 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 50.1 m -151.8 125.93 9.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.332 -0.849 . . . . 0.39000000000000001 109.783 179.247 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.511 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.91 123.28 70.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.336 -0.546 . . . . 0.73999999999999999 111.162 -179.793 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.57 ' HG2' ' N ' ' A' ' 62' ' ' GLY . 88.2 tttt -126.48 163.4 23.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.788 -0.642 . . . . 2.48 110.431 179.709 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.57 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.1 18.99 59.89 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.833 -0.907 . . . . 0.5 110.833 -179.906 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.511 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.9 mt -79.03 157.23 28.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.054 0.454 . . . . 0.57999999999999996 111.33 -179.589 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.839 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.6 mttp -99.55 134.05 21.43 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.571 -0.741 . . . . 2.79 110.413 179.77 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.94 143.62 61.22 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.501 2.134 . . . . 0.87 111.948 179.82 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.64 75.32 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.054 -0.818 . . . . 0.64000000000000001 111.054 179.721 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.839 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.17 158.79 40.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.743 0.306 . . . . 0.82999999999999996 110.428 -179.662 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.14 139.93 42.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.971 0.415 . . . . 0.5 110.582 -179.778 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.649 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.3 m-85 -122.5 136.43 54.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.0 -0.546 . . . . 0.53000000000000003 110.803 -179.886 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.95 130.95 45.34 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.548 -0.908 . . . . 1.8700000000000001 108.548 177.639 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.495 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.47 153.86 16.65 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.332 -0.937 . . . . 0.28999999999999998 111.89 -178.517 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -135.01 140.89 46.01 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.717 -0.475 . . . . 1.4299999999999999 109.717 179.529 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.72 119.01 34.67 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.498 -0.481 . . . . 0.32000000000000001 110.477 179.683 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.742 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.53 129.15 68.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.79000000000000004 110.579 -179.904 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.699 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.83 120.74 43.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.322 -0.399 . . . . 1.02 110.715 -179.67 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.839 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.53 146.52 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.184 0.516 . . . . 0.62 111.025 -179.349 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.624 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.01 153.86 21.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.482 -0.781 . . . . 2.4399999999999999 109.986 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.16 88.57 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.953 0.406 . . . . 3.6899999999999999 110.375 -179.758 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.624 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.33 32.51 0.21 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.843 -0.617 . . . . 6.0800000000000001 110.602 -179.966 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.99 -117.35 3.3 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.502 -0.639 . . . . 1.22 111.502 -179.758 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.44 177.36 9.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.254 0.55 . . . . 2.8799999999999999 111.604 -179.239 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.06 149.47 32.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.428 -0.806 . . . . 1.47 110.502 179.185 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.13 144.73 38.77 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.479 -0.328 . . . . 2.7000000000000002 110.544 179.854 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.742 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -128.01 135.91 61.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-O 120.936 0.398 . . . . 0.46000000000000002 111.597 -179.775 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.571 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -123.94 141.34 52.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.678 -0.692 . . . . 0.34999999999999998 110.301 179.634 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.493 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.68 138.86 51.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.136 0.493 . . . . 3.6699999999999999 111.451 -179.382 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.495 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.25 164.14 37.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.567 -0.742 . . . . 0.67000000000000004 109.464 179.403 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.561 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.23 151.56 38.58 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.391 -0.524 . . . . 1.47 111.015 179.983 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.805 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.19 172.74 13.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.81 -0.632 . . . . 0.44 111.058 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.75 160.78 21.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.46 -0.791 . . . . 1.3700000000000001 109.89 179.529 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.42 121.92 22.98 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.556 -0.458 . . . . 1.28 110.722 179.955 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.521 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.3 p -130.01 166.07 20.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.673 0.749 . . . . 1.97 112.861 179.669 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.55 ' HB2' ' CE1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -88.01 -16.16 34.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.692 -1.14 . . . . 3.2799999999999998 110.563 177.226 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 19.0 p -124.22 167.1 14.74 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.911 -178.153 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.616 ' O ' ' OG1' ' A' ' 96' ' ' THR . 23.9 m -56.85 -31.8 65.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.612 179.496 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.616 ' OG1' ' O ' ' A' ' 95' ' ' SER . 20.1 p 93.93 56.12 0.01 OUTLIER Pre-proline 0 N--CA 1.471 0.576 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.875 -179.69 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.86 150.96 68.24 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.743 2.295 . . . . 0.0 111.161 178.789 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.0 m -59.38 135.28 24.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.138 -179.718 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.762 HG22 ' H ' ' A' ' 101' ' ' ASN . 50.2 m -121.45 141.52 50.92 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.802 -179.243 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 86.2 p -61.65 -24.89 67.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.578 -179.994 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.762 ' H ' HG22 ' A' ' 99' ' ' THR . 76.5 m-20 60.4 44.38 12.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.702 -179.699 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.413 ' O ' ' O ' ' A' ' 101' ' ' ASN . 69.2 p 37.79 -161.94 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.75 179.627 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.739 HG12 ' H ' ' A' ' 105' ' ' GLY . 36.2 t -115.34 136.19 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.048 -179.552 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 56.0 p -66.08 -19.32 65.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.855 0.36 . . . . 0.0 110.899 -179.201 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.739 ' H ' HG12 ' A' ' 103' ' ' VAL . . . -54.07 -29.64 44.55 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 179.75 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -90.33 141.12 29.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.845 0.355 . . . . 0.0 110.148 -179.787 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.1 p -119.86 164.9 15.32 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.872 -179.133 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.69 80.12 31.58 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.232 -179.583 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.01 152.06 31.39 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.546 2.164 . . . . 0.0 112.36 -179.472 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.426 ' O ' ' CB ' ' A' ' 111' ' ' SER . 45.6 p90 -46.94 161.93 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.136 -179.571 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 110' ' ' PHE . 1.2 t 80.13 57.74 0.14 Allowed Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.273 -179.036 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.06 150.63 77.7 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.883 2.389 . . . . 0.0 112.008 179.435 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.2 mt -86.88 143.5 27.4 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.814 -0.439 . . . . 10.19 109.814 179.775 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.3 p -129.89 143.52 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.051 0.453 . . . . 7.2800000000000002 111.094 -179.186 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.56 149.17 46.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.582 -0.735 . . . . 7.2999999999999998 110.557 179.762 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.0 m -70.82 138.6 50.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 6.4400000000000004 110.38 -179.751 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.3 m -61.57 153.59 27.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.042 -0.526 . . . . 4.4199999999999999 111.102 -179.256 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 22.9 pt-20 -126.77 52.35 1.77 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.623 -0.717 . . . . 3.0499999999999998 110.66 -179.969 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 74.2 m -81.03 6.12 14.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.962 -0.563 . . . . 3.4300000000000002 110.72 -179.838 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.2 t -110.6 135.68 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.146 -0.479 . . . . 2.8799999999999999 110.083 179.824 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.1 p -121.29 161.67 21.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.089 -0.505 . . . . 2.0899999999999999 110.771 -179.464 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -111.76 156.65 21.6 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.807 -0.633 . . . . 4.5300000000000002 110.573 -179.847 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 19.7 tt -58.07 -24.96 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 1.4399999999999999 110.293 179.868 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 56.8 p -66.85 -14.17 62.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.999 -0.546 . . . . 1.78 110.194 179.61 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 53.95 91.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.934 -0.576 . . . . 0.64000000000000001 110.886 -179.888 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.9 p -62.9 -25.06 68.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.601 -0.727 . . . . 0.66000000000000003 110.753 179.653 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.437 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.92 167.57 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.74 -0.664 . . . . 0.68999999999999995 110.985 -179.359 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.57 145.49 50.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.808 -0.633 . . . . 0.52000000000000002 110.182 -179.92 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.27 101.67 9.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.083 -0.71 . . . . 0.32000000000000001 109.083 177.714 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.1 t -112.96 139.77 36.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.943 -0.572 . . . . 0.28999999999999998 111.004 -178.834 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.4 p -128.79 152.53 48.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.642 -0.708 . . . . 0.25 109.799 179.619 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.587 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.82 -165.02 2.05 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.776 -0.37 . . . . 0.31 110.674 -179.737 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.745 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -123.97 127.2 73.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.198 -0.455 . . . . 0.48999999999999999 110.815 -179.856 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.175 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.89 58.37 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.076 -0.511 . . . . 1.53 110.363 179.821 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.745 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.21 24.6 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 0.96999999999999997 111.509 -179.705 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.175 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.18 128.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.627 -0.429 . . . . 1.5600000000000001 110.95 179.822 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.45 -9.55 56.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.977 -0.556 . . . . 1.8799999999999999 110.379 179.703 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.0 p -87.09 0.19 55.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.119 -0.491 . . . . 1.04 110.278 179.924 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 136' ' ' SER . 2.6 p -65.27 137.15 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.02 -0.537 . . . . 0.23999999999999999 109.994 179.711 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 185' ' ' ILE . 91.1 p -96.23 -15.53 21.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.236 0.541 . . . . 0.28999999999999998 109.992 -179.608 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.437 ' HA3' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.62 175.55 45.79 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 109.88 -1.288 . . . . 0.13 109.88 179.662 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.4 151.56 42.47 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.957 0.408 . . . . 0.17000000000000001 110.487 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 1.168 ' NE ' HD11 ' A' ' 185' ' ' ILE . 77.1 mtm180 -132.29 121.1 23.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.112 -0.495 . . . . 1.29 109.966 179.758 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.557 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.05 136.62 38.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.781 -0.645 . . . . 0.25 110.661 -179.779 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.495 ' OE2' ' OH ' ' A' ' 157' ' ' TYR . 85.5 tt0 -129.42 129.84 45.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.914 -0.584 . . . . 1.3200000000000001 110.041 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.627 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 36.0 p90 -138.7 135.36 34.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.024 -0.535 . . . . 0.56999999999999995 110.66 -179.742 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.42 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.36 161.33 39.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.778 -0.646 . . . . 1.1599999999999999 109.6 179.897 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.974 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.11 124.88 25.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.104 0.478 . . . . 0.38 110.768 -179.674 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.79 -7.61 49.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.664 -0.698 . . . . 0.40999999999999998 110.861 -179.724 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -109.85 -69.71 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.354 -0.384 . . . . 1.6599999999999999 111.395 -179.305 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.495 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.61 -35.36 75.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.04 -0.527 . . . . 1.6599999999999999 111.582 -179.165 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.08 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.12 7.2 88.61 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.895 -0.882 . . . . 1.1699999999999999 110.895 -179.798 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.335 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.92 -171.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.849 0.357 . . . . 1.8600000000000001 110.257 179.897 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.335 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.21 138.98 45.29 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.948 0.404 . . . . 1.98 110.229 179.599 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.42 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 48.3 Cg_endo -70.73 145.74 52.33 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 C-N-CA 122.729 2.286 . . . . 0.55000000000000004 112.377 -179.586 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.627 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.79 145.75 42.54 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.251 -0.648 . . . . 1.1399999999999999 109.251 179.155 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.55 ' CE1' ' HB2' ' A' ' 93' ' ' SER . 96.4 m-85 -123.31 141.33 52.1 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.346 -0.542 . . . . 0.93000000000000005 111.553 -179.124 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.5 mt -128.08 127.68 43.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.372 -0.831 . . . . 0.34000000000000002 108.959 178.987 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.552 ' OD1' ' ND2' ' A' ' 16' ' ' ASN . 67.3 m-20 -101.63 131.15 48.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.154 0.502 . . . . 1.0900000000000001 111.725 -178.726 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.99 157.49 73.73 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.316 -0.857 . . . . 0.19 109.581 179.667 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.67 157.99 58.64 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.414 2.076 . . . . 0.17999999999999999 112.261 179.936 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.32 -12.09 5.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.823 -0.626 . . . . 0.20999999999999999 110.689 -179.855 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.9 -8.7 42.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.28999999999999998 110.67 -179.933 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.24 135.41 34.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.368 -0.378 . . . . 0.5 110.425 179.662 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.17 16.71 4.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.348 -0.387 . . . . 0.29999999999999999 110.476 179.983 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.4 p -167.59 147.1 5.03 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.629 -0.508 . . . . 0.23000000000000001 109.629 179.797 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.14 150.49 12.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.567 -0.453 . . . . 0.28000000000000003 111.592 -179.573 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.502 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.32 124.91 50.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.657 -0.701 . . . . 1.0700000000000001 109.812 179.499 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.42 104.93 30.04 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.912 0.387 . . . . 0.28999999999999998 111.058 -179.884 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.3 Cg_endo -91.0 -179.53 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 123.256 2.638 . . . . 0.42999999999999999 112.243 179.86 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.69 32.61 18.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.36 -0.836 . . . . 1.26 111.461 179.308 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 172' ' ' LEU . 24.5 mt -86.36 148.54 25.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.51 -0.314 . . . . 0.32000000000000001 110.464 179.619 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.757 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.32 114.93 61.66 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.986 0.422 . . . . 0.57999999999999996 110.643 -179.701 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -58.95 140.54 95.78 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.949 2.433 . . . . 0.66000000000000003 111.922 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.1 21.16 74.36 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.018 -0.833 . . . . 0.28999999999999998 111.018 179.785 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.495 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.81 150.17 49.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 2.3300000000000001 110.669 179.996 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.5 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.15 131.66 45.97 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.074 -0.512 . . . . 0.85999999999999999 109.783 179.371 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.974 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.5 m-85 -120.61 148.26 44.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.159 -0.473 . . . . 0.52000000000000002 111.039 -179.822 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.3 mt -105.35 125.36 60.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.244 -1.021 . . . . 0.29999999999999999 108.244 177.804 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.53 132.54 63.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.143 0.496 . . . . 0.23000000000000001 111.228 -178.586 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.51 122.51 20.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.502 -0.772 . . . . 0.35999999999999999 109.689 179.276 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.587 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.95 125.32 54.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.199 -0.455 . . . . 0.19 110.716 -179.55 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.7 m-85 -117.15 137.99 51.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.955 -0.566 . . . . 0.29999999999999999 109.889 179.443 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.423 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.74 134.98 42.9 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.806 -0.813 . . . . 0.37 108.806 178.882 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 1.168 HD11 ' NE ' ' A' ' 143' ' ' ARG . 13.2 mt -99.04 122.9 51.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.116 0.484 . . . . 0.26000000000000001 110.959 -178.738 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.7 p -83.83 169.72 14.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.609 -0.723 . . . . 0.28000000000000003 110.479 -179.693 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -59.86 -14.46 15.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.053 -0.521 . . . . 1.6000000000000001 110.92 -179.555 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -96.15 -4.24 43.03 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.825 -0.35 . . . . 1.1799999999999999 110.809 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.81 13.89 63.97 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.342 -0.703 . . . . 0.29999999999999999 111.342 179.835 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -84.63 139.01 32.37 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.076 -0.25 . . . . 1.22 110.424 179.686 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.737 ' CD ' HH22 ' A' ' 143' ' ' ARG . 0.0 OUTLIER -106.69 141.12 38.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.87 0.367 . . . . 0.97999999999999998 110.558 179.718 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.3 m -136.7 127.03 26.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.82999999999999996 110.327 179.952 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.16 117.38 9.91 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.675 -0.41 . . . . 0.26000000000000001 110.533 -179.95 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.01 -21.82 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.29999999999999999 110.773 -179.778 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.5 tp -156.95 125.75 5.84 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.523 -0.471 . . . . 0.31 111.475 -179.77 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.474 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.8 120.23 21.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.787 -0.642 . . . . 0.28000000000000003 109.519 179.253 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.68 29.08 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.591 -0.444 . . . . 0.23999999999999999 110.868 -179.265 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.43 158.57 18.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.014 -0.539 . . . . 0.23000000000000001 110.44 179.702 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -146.02 157.89 43.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.088 -0.505 . . . . 0.67000000000000004 110.698 179.995 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.19 104.32 9.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.761 -0.654 . . . . 0.64000000000000001 110.101 179.493 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.8 p . . . . . 0 C--O 1.221 -0.414 0 CA-C-O 117.953 -1.022 . . . . 1.26 110.631 -179.628 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.553 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.1 m . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.161 -0.681 . . . . 3.4399999999999999 109.161 . . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.69 18.54 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.011 -0.835 . . . . 1.22 111.011 179.809 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -35.67 142.4 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.084 0 C-N-CA 123.933 3.089 . . . . 0.75 113.76 -179.222 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.61 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -79.93 173.43 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.173 -1.376 . . . . 0.79000000000000004 108.785 178.416 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.61 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.66 125.78 51.38 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.425 -0.51 . . . . 1.9399999999999999 111.44 -179.559 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.38 144.01 34.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.692 -0.685 . . . . 0.59999999999999998 110.652 179.959 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.1 168.24 25.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.97 0.414 . . . . 3.1400000000000001 111.111 -179.67 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.742 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.96 131.04 60.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.002 -0.544 . . . . 3.23 110.123 179.868 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.12 162.34 35.71 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.822 0.344 . . . . 3.6299999999999999 111.274 -179.924 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 98.9 mt-10 36.14 31.51 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.592 -0.521 . . . . 6.0800000000000001 109.592 179.819 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.742 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.59 32.58 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.001 -0.545 . . . . 3.3799999999999999 111.512 -178.721 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.3 -28.98 72.54 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.424 2.083 . . . . 3.9300000000000002 111.92 179.301 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.64 125.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.101 -0.499 . . . . 3.3599999999999999 110.442 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.618 ' O ' ' O ' ' A' ' 92' ' ' THR . 4.7 mt-30 -123.87 158.33 60.32 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 3.6099999999999999 110.491 179.914 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 143' ' ' ARG . 97.5 Cg_endo -82.07 -64.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.927 2.418 . . . . 1.51 113.515 -179.047 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.662 ' OD1' ' NH1' ' A' ' 143' ' ' ARG . 9.7 m120 -108.49 -19.59 13.4 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.076 0.399 . . . . 2.6800000000000002 112.076 -178.509 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 8.3 p -107.32 152.06 24.64 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.479 -0.488 . . . . 1.21 111.338 -179.442 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.28 102.94 2.23 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.653 -0.703 . . . . 1.5600000000000001 110.634 179.894 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.578 ' CD ' HE22 ' A' ' 14' ' ' GLN . 73.8 Cg_endo -82.72 145.53 12.91 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.974 2.45 . . . . 0.81000000000000005 112.575 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.925 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.76 167.92 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.884 -0.598 . . . . 1.52 109.892 179.579 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.15 147.91 29.02 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.682 -0.488 . . . . 2.1400000000000001 109.682 178.913 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.9 p90 -142.2 157.37 44.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.979 0.419 . . . . 0.32000000000000001 111.242 179.907 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.49 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.12 155.26 44.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.819 -0.628 . . . . 2.1699999999999999 110.095 179.0 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.836 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.59 173.03 6.36 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.105 0.478 . . . . 0.58999999999999997 110.774 -179.243 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.836 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.8 Cg_exo -50.58 173.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.818 2.346 . . . . 0.90000000000000002 111.588 179.29 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -50.95 0.7 Allowed Pre-proline 0 C--N 1.33 -0.245 0 C-N-CA 120.713 -0.395 . . . . 3.3399999999999999 110.159 179.81 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.62 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.99 152.36 82.65 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.752 2.301 . . . . 1.8500000000000001 111.404 179.197 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.5 p -63.76 42.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.355 0.598 . . . . 2.54 110.495 -179.769 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.62 ' N ' ' O ' ' A' ' 27' ' ' PRO . 74.0 t60 -63.7 -41.6 98.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.997 -1.001 . . . . 2.5299999999999998 110.579 179.8 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.565 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.6 mt -109.79 137.89 39.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.823 -0.626 . . . . 1.1699999999999999 111.262 -179.421 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.04 -72.9 0.7 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.023 -0.535 . . . . 1.27 111.887 -179.029 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.47 24.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.521 0.564 . . . . 1.1200000000000001 112.521 -179.609 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.89 124.92 45.24 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.311 -0.626 . . . . 0.41999999999999998 109.311 177.483 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.2 mt -118.02 134.76 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.703 -0.399 . . . . 0.78000000000000003 110.666 179.917 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.925 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.07 128.64 53.67 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.985 0.422 . . . . 0.62 111.22 179.748 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.548 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.11 139.02 49.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.753 -0.658 . . . . 1.97 110.057 179.001 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.433 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.2 p90 -145.06 163.14 35.18 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.162 0.506 . . . . 0.34999999999999998 112.086 -178.166 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.488 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.43 139.69 7.97 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 115.472 -0.785 . . . . 1.8 110.441 178.743 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.687 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.3 Cg_endo -63.58 115.45 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.364 2.043 . . . . 0.57999999999999996 111.836 179.995 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.68 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.05 81.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.973 0.416 . . . . 3.04 109.884 -179.786 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.687 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.26 -20.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.003 -0.544 . . . . 2.4700000000000002 111.942 -179.442 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.64 157.78 34.24 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 120.887 -0.325 . . . . 2.5099999999999998 110.561 179.78 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.401 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.4 27.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.166 -0.47 . . . . 1.8600000000000001 110.235 179.517 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.86 -75.89 1.31 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.029 -0.605 . . . . 1.4399999999999999 111.796 -179.224 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.81 152.34 35.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.92 0.39 . . . . 4.6900000000000004 110.957 -179.286 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.23 -169.06 2.51 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.043 -0.526 . . . . 1.4299999999999999 111.938 179.332 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.18 149.64 29.8 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.449 0.643 . . . . 1.74 112.581 -177.858 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.02 156.49 46.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.853 -1.067 . . . . 1.9199999999999999 110.236 178.718 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.466 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.33 158.35 41.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.966 -0.561 . . . . 0.34000000000000002 111.722 -179.327 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 m -115.18 135.56 54.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.441 -0.799 . . . . 0.40999999999999998 109.829 179.314 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.596 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.37 122.04 23.83 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.391 -0.368 . . . . 0.55000000000000004 111.529 -179.17 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.606 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.7 Cg_exo -46.31 151.75 1.62 Allowed 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.734 2.289 . . . . 0.44 112.081 178.987 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.92 -23.0 63.06 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 115.957 -0.565 . . . . 0.73999999999999999 112.809 -179.312 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.85 -16.85 46.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.369 0.584 . . . . 0.93000000000000005 111.756 -178.268 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.606 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.63 138.47 31.54 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.76 -0.376 . . . . 0.96999999999999997 110.323 179.362 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.54 13.86 10.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.295 -0.411 . . . . 1.3400000000000001 111.512 -179.297 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.473 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.98 143.41 25.19 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.664 -0.415 . . . . 0.39000000000000001 110.998 179.7 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.74 -169.43 1.54 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.035 -0.53 . . . . 0.41999999999999998 110.932 -179.512 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.711 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 7.7 m -151.66 125.93 9.33 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.429 -0.805 . . . . 0.39000000000000001 109.946 179.118 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.516 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.85 123.2 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.412 -0.515 . . . . 0.73999999999999999 111.17 -179.712 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.723 ' NZ ' HD13 ' A' ' 185' ' ' ILE . 86.3 tttt -126.43 163.4 23.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.812 -0.631 . . . . 2.48 110.5 179.645 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.513 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.11 18.97 59.92 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.775 -0.93 . . . . 0.5 110.775 -179.922 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.516 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.4 mt -78.95 157.22 28.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.135 0.493 . . . . 0.57999999999999996 111.385 -179.696 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.848 ' O ' HG12 ' A' ' 67' ' ' VAL . 2.9 mttp -99.52 133.95 21.52 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.593 -0.73 . . . . 2.79 110.442 179.758 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.528 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.81 143.57 61.82 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.553 2.169 . . . . 0.87 111.975 179.794 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.87 25.55 75.43 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.016 -0.834 . . . . 0.64000000000000001 111.016 179.716 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.848 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.1 158.82 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.709 0.29 . . . . 0.82999999999999996 110.448 -179.591 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.15 139.79 42.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.924 0.392 . . . . 0.5 110.575 -179.74 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.645 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.51 136.52 54.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.001 -0.545 . . . . 0.53000000000000003 110.78 -179.984 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.89 131.06 45.27 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.492 -0.929 . . . . 1.8700000000000001 108.492 177.622 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.49 153.85 16.65 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.3 -0.952 . . . . 0.28999999999999998 111.965 -178.664 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -134.92 141.02 46.19 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.687 -0.486 . . . . 1.4299999999999999 109.687 179.504 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.522 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.83 118.89 34.26 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.499 -0.48 . . . . 0.32000000000000001 110.534 179.651 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.722 HG12 HG23 ' A' ' 84' ' ' VAL . 64.1 mt -112.42 129.11 68.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.239 -0.437 . . . . 0.79000000000000004 110.585 -179.874 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.706 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.81 120.86 43.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.326 -0.397 . . . . 1.02 110.707 -179.726 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.849 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.6 146.43 11.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.491 . . . . 0.62 110.978 -179.271 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.624 ' O ' ' N ' ' A' ' 79' ' ' TYR . 20.9 mt-30 -106.03 153.87 21.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.508 -0.769 . . . . 2.4399999999999999 109.938 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.16 88.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.917 0.389 . . . . 3.6899999999999999 110.45 -179.729 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.624 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.25 32.72 0.21 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.819 -0.628 . . . . 6.0800000000000001 110.573 -179.923 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.23 -117.39 3.27 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.407 -0.677 . . . . 1.22 111.407 -179.727 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.25 177.41 9.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.238 0.542 . . . . 2.8799999999999999 111.604 -179.218 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.21 149.47 31.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.401 -0.818 . . . . 1.47 110.418 179.108 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.553 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.15 144.62 38.69 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.487 -0.324 . . . . 2.7000000000000002 110.562 179.905 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.722 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.89 135.99 61.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 120.649 -0.421 . . . . 0.46000000000000002 111.552 -179.761 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.03 141.41 52.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.714 -0.675 . . . . 0.34999999999999998 110.318 179.544 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.465 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.78 138.92 51.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.184 0.516 . . . . 3.6699999999999999 111.428 -179.324 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.29 164.23 37.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.513 -0.767 . . . . 0.67000000000000004 109.42 179.438 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.32 151.52 38.45 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.384 -0.526 . . . . 1.47 110.996 -179.994 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.81 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.17 172.76 12.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.754 -0.657 . . . . 0.44 111.0 179.844 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.74 160.74 21.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.42 -0.809 . . . . 1.3700000000000001 109.863 179.561 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.43 121.85 22.85 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.645 -0.422 . . . . 1.28 110.766 179.974 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.618 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.8 p -126.42 163.75 22.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.346 0.593 . . . . 1.97 112.08 179.72 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.2 t -103.66 150.17 24.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.413 -0.812 . . . . 3.2799999999999998 110.665 -179.686 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.0 t -59.98 167.79 2.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.952 -179.164 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 54.9 p -65.44 162.33 18.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.432 -178.749 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.6 83.93 53.42 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.542 -179.386 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.56 147.42 30.37 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.006 1.804 . . . . 0.0 111.618 -179.439 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.703 HG12 ' H ' ' A' ' 100' ' ' SER . 23.5 t -111.02 136.97 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.76 -178.721 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.1 p -66.88 -5.49 12.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.274 -179.469 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.703 ' H ' HG12 ' A' ' 98' ' ' VAL . 32.6 t -57.26 162.61 2.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.366 -179.438 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.3 m120 62.61 44.19 7.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.225 0.536 . . . . 0.0 109.878 -178.535 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 104' ' ' THR . 39.9 m -77.99 141.84 38.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.369 179.863 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 78.1 t -58.13 -39.5 73.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.439 -179.426 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.461 ' H ' HG22 ' A' ' 102' ' ' THR . 19.4 p -120.8 159.63 25.05 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.748 0.308 . . . . 0.0 110.348 179.764 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -159.69 47.86 0.41 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.831 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -91.4 151.96 20.61 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.127 0.489 . . . . 0.0 111.021 -179.692 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 48.0 m -56.13 -37.04 68.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.143 -178.759 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 50.2 m -121.92 80.55 42.04 Favored Pre-proline 0 N--CA 1.467 0.388 0 CA-C-O 120.581 0.229 . . . . 0.0 111.4 -179.007 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -55.28 150.24 41.77 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.592 2.195 . . . . 0.0 111.779 179.422 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.404 ' O ' ' CB ' ' A' ' 111' ' ' SER . 49.7 p90 -66.4 144.03 56.77 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.961 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.616 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 0.2 OUTLIER 168.0 -36.79 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.566 -179.464 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 111' ' ' SER . 53.2 Cg_exo -55.19 -18.05 16.93 Favored 'Trans proline' 0 N--CA 1.501 1.952 0 C-N-CA 122.772 2.315 . . . . 0.0 113.323 -178.958 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.5 mt -85.56 143.02 28.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.91 0.386 . . . . 10.19 110.776 -179.309 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.4 p -57.16 -34.27 45.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.903 -0.59 . . . . 7.2800000000000002 110.779 -179.484 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.94 -24.72 67.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.073 -0.512 . . . . 7.2999999999999998 109.938 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.9 p -116.06 164.38 14.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.48 -0.782 . . . . 6.4400000000000004 110.602 -179.338 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 111' ' ' SER . 26.2 t -69.9 156.29 39.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.087 -0.506 . . . . 4.4199999999999999 110.883 -179.383 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.534 ' HG2' ' H ' ' A' ' 120' ' ' VAL . 84.2 tt0 -87.41 139.72 30.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.206 -0.452 . . . . 3.0499999999999998 110.041 -179.63 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.574 ' O ' ' O ' ' A' ' 120' ' ' VAL . 85.8 p -61.52 -29.07 69.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 3.4300000000000002 111.675 -178.678 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.574 ' O ' ' O ' ' A' ' 119' ' ' SER . 61.1 t 50.18 117.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.742 0.306 . . . . 2.8799999999999999 110.722 -179.809 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 47.6 m -117.55 137.37 52.62 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.039 0.447 . . . . 2.0899999999999999 110.726 -179.841 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.48 ' OE2' ' CB ' ' A' ' 125' ' ' ALA . 83.0 tt0 -113.51 141.55 47.0 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.895 -0.78 . . . . 4.5300000000000002 108.895 -179.991 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.63 ' O ' ' N ' ' A' ' 125' ' ' ALA . 72.2 mt -115.22 135.14 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 113.746 1.017 . . . . 1.4399999999999999 113.746 -176.999 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 82.4 p 33.26 17.72 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.499 -1.228 . . . . 1.78 113.922 177.795 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.63 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . -64.44 -28.85 69.95 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.709 -0.396 . . . . 0.64000000000000001 111.057 179.606 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.496 ' OG ' ' N ' ' A' ' 127' ' ' SER . 95.7 p 49.88 -89.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.715 -0.476 . . . . 0.66000000000000003 109.715 -178.374 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.496 ' N ' ' OG ' ' A' ' 126' ' ' SER . 0.9 OUTLIER -53.7 167.48 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.019 0.438 . . . . 0.68999999999999995 111.005 179.481 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.56 145.6 50.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.718 -0.674 . . . . 0.52000000000000002 110.101 -179.949 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.3 101.72 9.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.986 -0.746 . . . . 0.32000000000000001 108.986 177.755 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.9 t -112.99 139.7 36.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.089 -0.505 . . . . 0.28999999999999998 111.054 -178.904 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 p -128.74 152.5 48.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.603 -0.726 . . . . 0.25 109.849 179.603 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.72 -164.98 2.04 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.732 -0.387 . . . . 0.31 110.688 -179.736 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -123.93 127.17 73.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.48999999999999999 110.843 -179.885 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.164 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.95 58.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.178 -0.464 . . . . 1.53 110.329 179.862 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.07 24.41 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.916 -0.584 . . . . 0.96999999999999997 111.499 -179.673 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.164 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.22 128.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.568 -0.453 . . . . 1.5600000000000001 110.899 179.829 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.31 -9.76 55.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.879 -0.601 . . . . 1.8799999999999999 110.323 179.76 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.4 p -87.04 0.26 55.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 1.04 110.4 179.994 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.725 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.29 137.25 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.877 -0.601 . . . . 0.23999999999999999 109.969 179.74 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 185' ' ' ILE . 88.8 p -96.27 -15.54 21.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.279 0.562 . . . . 0.28999999999999998 110.035 -179.643 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.432 ' HA3' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.58 175.56 45.77 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.83 -1.308 . . . . 0.13 109.83 179.679 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -123.49 151.59 42.6 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.621 -0.431 . . . . 0.17000000000000001 110.468 179.723 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.662 ' NH1' ' OD1' ' A' ' 16' ' ' ASN . 12.7 ttt85 -132.29 121.1 23.04 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.086 -0.506 . . . . 1.29 110.005 179.805 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.548 HG21 HG11 ' A' ' 167' ' ' VAL . 46.0 t -105.03 136.49 38.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.777 -0.647 . . . . 0.25 110.724 -179.759 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 78.8 tt0 -129.27 129.91 45.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.061 -0.518 . . . . 1.3200000000000001 110.151 179.98 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.618 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.71 135.34 34.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.994 -0.548 . . . . 0.56999999999999995 110.623 -179.709 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.413 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.34 161.38 39.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.703 -0.68 . . . . 1.1599999999999999 109.716 179.846 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.969 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 85.8 mt -71.12 124.91 25.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.986 0.422 . . . . 0.38 110.689 -179.534 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.499 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.8 -7.68 49.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.739 -0.664 . . . . 0.40999999999999998 110.862 -179.81 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -109.84 -69.58 0.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.365 -0.38 . . . . 1.6599999999999999 111.519 -179.381 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.453 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.69 -35.32 76.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.095 -0.502 . . . . 1.6599999999999999 111.569 -179.192 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.086 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.2 7.2 88.62 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.75 -0.94 . . . . 1.1699999999999999 110.75 -179.936 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.325 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.85 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 1.8600000000000001 110.291 179.801 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.325 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.25 139.08 45.17 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 1.98 110.165 179.64 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.413 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.3 Cg_endo -70.94 145.84 51.38 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 C-N-CA 122.712 2.275 . . . . 0.55000000000000004 112.31 -179.546 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.87 145.81 42.56 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.182 -0.673 . . . . 1.1399999999999999 109.182 179.267 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.657 ' CD2' ' OD1' ' A' ' 16' ' ' ASN . 51.0 p90 -123.38 141.27 52.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.185 0.517 . . . . 0.93000000000000005 111.536 -179.093 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.5 mt -128.05 127.65 43.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.242 -0.89 . . . . 0.34000000000000002 108.92 179.007 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 19.1 t0 -101.58 131.05 47.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.15 0.5 . . . . 1.0900000000000001 111.824 -178.85 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.517 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.1 mt -127.83 157.61 73.04 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.303 -0.862 . . . . 0.19 109.624 179.624 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.84 158.04 58.21 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.395 2.063 . . . . 0.17999999999999999 112.239 179.938 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.24 -12.22 5.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.739 -0.664 . . . . 0.20999999999999999 110.746 -179.824 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.4 p -92.81 -8.68 42.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.09 -0.505 . . . . 0.28999999999999998 110.689 -179.883 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.3 135.35 34.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.332 -0.395 . . . . 0.5 110.318 179.734 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.4 p -133.08 16.69 4.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.322 -0.399 . . . . 0.29999999999999999 110.508 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.0 p -167.54 147.05 5.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.579 -0.526 . . . . 0.23000000000000001 109.579 179.851 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.548 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.11 150.48 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.095 0.474 . . . . 0.28000000000000003 111.585 -179.695 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.507 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.3 125.01 50.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.571 -0.741 . . . . 1.0700000000000001 109.828 179.456 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.4 104.93 30.03 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.358 -0.383 . . . . 0.28999999999999998 111.066 -179.895 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.5 Cg_endo -90.98 -179.5 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 123.22 2.613 . . . . 0.42999999999999999 112.15 179.916 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.74 32.53 18.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.371 -0.831 . . . . 1.26 111.418 179.175 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 172' ' ' LEU . 24.2 mt -86.33 148.53 25.56 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.911 -0.315 . . . . 0.32000000000000001 110.505 179.587 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.774 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.32 114.88 61.43 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 121.069 0.461 . . . . 0.57999999999999996 110.688 -179.732 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.97 140.5 95.62 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.877 2.384 . . . . 0.66000000000000003 112.1 179.815 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.18 21.13 74.2 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.029 -0.828 . . . . 0.28999999999999998 111.029 179.907 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.453 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.77 150.25 49.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.75 0.31 . . . . 2.3300000000000001 110.747 179.881 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.499 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.22 131.65 46.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.063 -0.517 . . . . 0.85999999999999999 109.799 179.333 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.969 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.47 148.33 43.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.079 -0.51 . . . . 0.52000000000000002 111.077 -179.892 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.34 125.4 60.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.281 -1.007 . . . . 0.29999999999999999 108.281 177.701 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.63 132.55 63.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.308 0.575 . . . . 0.23000000000000001 111.17 -178.595 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.5 122.59 20.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.433 -0.803 . . . . 0.35999999999999999 109.642 179.285 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.3 t -101.05 125.39 55.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.2 -0.454 . . . . 0.19 110.598 -179.436 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.3 m-85 -117.25 137.88 52.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.017 -0.538 . . . . 0.29999999999999999 109.899 179.456 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.43 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.68 135.02 42.79 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.811 -0.811 . . . . 0.37 108.811 178.872 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.723 HD13 ' NZ ' ' A' ' 61' ' ' LYS . 5.2 mp -99.04 122.94 51.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.16 0.505 . . . . 0.26000000000000001 110.926 -178.747 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.3 p -83.86 169.79 14.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.517 -0.765 . . . . 0.28000000000000003 110.453 -179.71 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.89 -14.53 15.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.048 -0.523 . . . . 1.6000000000000001 110.823 -179.504 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.548 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.3 m-20 -96.11 -4.22 43.21 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.817 -0.353 . . . . 1.1799999999999999 110.847 -179.811 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.566 ' HA3' HG23 ' A' ' 59' ' ' THR . . . 87.74 13.9 64.09 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.376 -0.69 . . . . 0.29999999999999999 111.376 179.858 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.62 139.03 32.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.652 0.263 . . . . 1.22 110.438 179.652 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.467 ' NE2' ' HD3' ' A' ' 143' ' ' ARG . 97.1 mt-30 -106.69 141.04 38.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.809 0.337 . . . . 0.97999999999999998 110.617 179.675 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 61.8 m -136.65 127.12 26.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.82999999999999996 110.316 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.1 117.36 9.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.287 -0.415 . . . . 0.26000000000000001 110.584 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.0 pt -109.18 -21.67 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.29999999999999999 110.732 -179.69 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.97 125.73 5.82 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.542 -0.463 . . . . 0.31 111.521 -179.879 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.475 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.79 120.13 21.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.777 -0.647 . . . . 0.28000000000000003 109.58 179.248 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.55 151.71 29.19 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.639 -0.424 . . . . 0.23999999999999999 110.882 -179.276 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.8 p -110.36 158.56 18.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.019 -0.537 . . . . 0.23000000000000001 110.442 179.709 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.401 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 68.2 mt-30 -146.05 157.86 43.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.67000000000000004 110.663 -179.969 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.31 104.36 9.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.801 -0.636 . . . . 0.64000000000000001 110.043 179.49 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.9 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.843 -1.075 . . . . 1.26 110.621 -179.655 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.2 m . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.189 -0.671 . . . . 3.4399999999999999 109.189 . . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.66 18.54 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.988 -0.845 . . . . 1.22 110.988 179.72 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -35.47 142.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.058 0 C-N-CA 123.934 3.089 . . . . 0.75 113.832 -179.283 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.609 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.99 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.274 -1.33 . . . . 0.79000000000000004 108.83 178.368 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.609 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.62 125.94 51.57 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.376 -0.529 . . . . 1.9399999999999999 111.461 -179.601 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.47 144.01 33.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.63 -0.713 . . . . 0.59999999999999998 110.72 179.869 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.03 168.34 25.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.925 0.393 . . . . 3.1400000000000001 111.137 -179.674 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.745 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.5 mt -109.06 131.02 60.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.957 -0.565 . . . . 3.23 110.024 179.928 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.15 162.36 35.67 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.865 0.364 . . . . 3.6299999999999999 111.219 -179.961 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 16.9 pt-20 36.16 31.45 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.682 -0.488 . . . . 6.0800000000000001 109.682 179.847 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.745 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.4 69.61 32.3 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.934 -0.575 . . . . 3.3799999999999999 111.593 -178.747 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.28 -29.08 72.73 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.497 2.132 . . . . 3.9300000000000002 111.822 179.354 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.58 125.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 3.3599999999999999 110.481 -179.947 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 17' ' ' SER . 3.2 mp0 -123.8 158.41 59.85 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.294 -0.412 . . . . 3.6099999999999999 110.456 179.959 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.459 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 97.2 Cg_endo -82.1 -64.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.861 2.374 . . . . 1.51 113.456 -179.039 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.674 ' OD1' ' N ' ' A' ' 17' ' ' SER . 1.4 p-10 -108.39 -19.61 13.4 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.106 0.41 . . . . 2.6800000000000002 112.106 -178.498 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.674 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 33.4 m -107.34 152.1 24.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.116 0.484 . . . . 1.21 111.328 -179.421 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.37 102.96 2.21 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.693 -0.685 . . . . 1.5600000000000001 110.652 179.804 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.6 145.57 13.12 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.921 2.414 . . . . 0.81000000000000005 112.61 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.928 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.78 167.9 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.955 -0.566 . . . . 1.52 109.842 179.567 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.17 147.9 28.99 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.812 -0.44 . . . . 2.1400000000000001 109.812 178.822 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.595 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.21 157.32 44.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.005 0.431 . . . . 0.32000000000000001 111.11 -179.951 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.492 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.09 155.19 44.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.699 -0.682 . . . . 2.1699999999999999 110.086 178.978 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.836 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.55 173.04 6.35 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.185 -0.462 . . . . 0.58999999999999997 110.732 -179.193 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.836 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.58 173.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.974 2.449 . . . . 0.90000000000000002 111.492 179.333 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.479 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.09 -51.03 0.69 Allowed Pre-proline 0 C--N 1.328 -0.349 0 C-N-CA 120.666 -0.414 . . . . 3.3399999999999999 110.078 179.853 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.84 152.32 82.57 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.798 2.332 . . . . 1.8500000000000001 111.483 179.219 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.67 42.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.38 0.61 . . . . 2.54 110.534 -179.869 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.624 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.7 t60 -63.67 -41.58 98.17 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.032 -0.985 . . . . 2.5299999999999998 110.68 179.709 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.566 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.6 mt -109.93 137.82 40.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.773 -0.648 . . . . 1.1699999999999999 111.271 -179.439 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.92 -72.98 0.7 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.999 -0.546 . . . . 1.27 111.865 -178.963 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.16 148.42 24.42 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.587 0.588 . . . . 1.1200000000000001 112.587 -179.625 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.85 124.87 45.14 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.319 -0.623 . . . . 0.41999999999999998 109.319 177.572 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.02 134.67 60.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.718 -0.393 . . . . 0.78000000000000003 110.72 179.939 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.928 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -119.96 128.67 53.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.055 0.455 . . . . 0.62 111.275 179.788 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.547 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 138.88 49.64 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.758 -0.655 . . . . 1.97 110.08 179.087 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.433 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.0 163.23 34.84 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.158 0.504 . . . . 0.34999999999999998 112.086 -178.198 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.489 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.51 139.57 7.83 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.482 -0.781 . . . . 1.8 110.451 178.846 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.684 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.9 Cg_endo -63.54 115.44 3.04 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.279 1.986 . . . . 0.57999999999999996 111.891 179.938 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.679 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.3 tttp -46.99 81.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.871 -0.418 . . . . 3.04 109.871 -179.827 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.58 0.06 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.92 -0.582 . . . . 2.4700000000000002 111.874 -179.584 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 p -157.7 157.81 34.21 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 120.747 -0.381 . . . . 2.5099999999999998 110.561 179.764 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.401 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.42 27.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 1.8600000000000001 110.161 179.659 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.81 -75.89 1.31 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.19 -0.528 . . . . 1.4399999999999999 111.861 -179.243 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.96 152.32 35.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.968 0.413 . . . . 4.6900000000000004 110.988 -179.383 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.18 -169.14 2.54 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.993 -0.549 . . . . 1.4299999999999999 111.922 179.425 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.6 mttp -110.14 149.62 29.81 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.477 0.656 . . . . 1.74 112.599 -177.922 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.0 156.58 46.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.768 -1.105 . . . . 1.9199999999999999 110.306 178.6 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.3 158.39 41.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.901 -0.59 . . . . 0.34000000000000002 111.785 -179.311 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.8 m -115.25 135.67 53.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.459 -0.791 . . . . 0.40999999999999998 109.784 179.317 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.595 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.43 121.95 23.73 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.419 -0.355 . . . . 0.55000000000000004 111.505 -179.105 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.0 Cg_exo -46.34 151.73 1.64 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.639 2.226 . . . . 0.44 112.189 179.019 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.89 -23.07 63.07 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-N 116.063 -0.517 . . . . 0.73999999999999999 112.81 -179.189 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.538 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.79 -16.9 46.07 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.237 -0.585 . . . . 0.93000000000000005 111.761 -178.274 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.603 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.54 138.48 31.54 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.689 -0.404 . . . . 0.96999999999999997 110.309 179.372 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.6 13.98 10.95 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.404 -0.362 . . . . 1.3400000000000001 111.567 -179.416 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.472 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.98 143.44 25.21 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.607 -0.437 . . . . 0.39000000000000001 111.052 179.586 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.708 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.82 -169.36 1.53 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.203 0.525 . . . . 0.41999999999999998 110.916 -179.523 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.708 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 t -151.69 125.89 9.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.448 -0.796 . . . . 0.39000000000000001 109.84 179.262 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.517 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.83 123.27 70.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.33 -0.548 . . . . 0.73999999999999999 111.205 -179.785 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -126.43 163.41 23.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.872 -0.603 . . . . 2.48 110.379 179.788 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.16 18.83 60.11 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.783 -0.927 . . . . 0.5 110.783 -179.953 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.517 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.2 mt -79.05 157.31 28.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.156 0.503 . . . . 0.57999999999999996 111.28 -179.521 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.848 ' O ' HG12 ' A' ' 67' ' ' VAL . 4.8 mptp? -99.59 134.0 21.44 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.554 -0.748 . . . . 2.79 110.414 179.8 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.439 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.9 Cg_endo -67.8 143.64 62.09 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.591 2.194 . . . . 0.87 111.971 179.784 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.75 25.62 75.34 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.101 -0.8 . . . . 0.64000000000000001 111.101 179.705 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.848 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.15 158.78 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.692 0.282 . . . . 0.82999999999999996 110.397 -179.574 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.17 139.96 41.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.882 0.372 . . . . 0.5 110.621 -179.825 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.672 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.2 m-85 -122.56 136.33 54.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.994 -0.548 . . . . 0.53000000000000003 110.818 -179.901 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.486 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.79 131.05 45.22 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.546 -0.909 . . . . 1.8700000000000001 108.546 177.593 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.48 153.79 16.66 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.308 -0.949 . . . . 0.28999999999999998 111.986 -178.579 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -134.92 140.92 46.13 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.658 -0.497 . . . . 1.4299999999999999 109.658 179.584 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.525 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.75 118.84 34.15 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.452 -0.499 . . . . 0.32000000000000001 110.536 179.672 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.714 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.42 129.05 68.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.339 -0.391 . . . . 0.79000000000000004 110.658 -179.862 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.704 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.74 120.88 43.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.27 -0.423 . . . . 1.02 110.73 -179.634 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.85 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.62 146.5 11.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.17 0.51 . . . . 0.62 110.944 -179.223 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.621 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.06 153.93 21.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.46 -0.791 . . . . 2.4399999999999999 109.891 179.826 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.18 88.52 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.896 0.379 . . . . 3.6899999999999999 110.424 -179.809 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.36 32.52 0.22 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.873 -0.603 . . . . 6.0800000000000001 110.628 -179.953 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.02 -117.38 3.3 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.431 -0.667 . . . . 1.22 111.431 -179.693 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.43 177.42 8.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.135 0.493 . . . . 2.8799999999999999 111.658 -179.189 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.1 149.54 32.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.503 -0.771 . . . . 1.47 110.391 179.167 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.18 144.66 38.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.471 -0.331 . . . . 2.7000000000000002 110.515 179.863 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.714 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.94 136.09 61.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 121.035 0.445 . . . . 0.46000000000000002 111.57 -179.806 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.7 m -124.15 141.29 52.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.753 -0.658 . . . . 0.34999999999999998 110.316 179.635 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.46 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.58 138.91 51.62 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.125 0.488 . . . . 3.6699999999999999 111.524 -179.339 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.3 164.14 38.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.575 -0.739 . . . . 0.67000000000000004 109.474 179.386 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.29 151.57 38.56 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.293 -0.563 . . . . 1.47 111.011 179.937 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.808 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.21 172.72 13.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.792 -0.64 . . . . 0.44 111.079 179.895 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.77 160.7 21.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.57 -0.741 . . . . 1.3700000000000001 109.847 179.644 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.46 121.89 22.88 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.524 -0.47 . . . . 1.28 110.712 -179.965 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.6 p -125.41 151.83 45.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.909 0.862 . . . . 1.97 112.908 179.695 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.9 t -63.55 -33.94 76.7 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 114.053 -1.43 . . . . 3.2799999999999998 113.876 -179.402 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.2 p -78.78 158.53 28.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.438 0.637 . . . . 0.0 112.43 -176.966 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.622 ' O ' ' C ' ' A' ' 96' ' ' THR . 83.2 p -147.15 160.19 42.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.414 179.158 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.622 ' C ' ' O ' ' A' ' 95' ' ' SER . 30.1 p 0.21 76.37 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.714 0 O-C-N 123.237 0.336 . . . . 0.0 111.603 179.667 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.467 ' N ' ' O ' ' A' ' 95' ' ' SER . 31.4 Cg_exo -56.65 139.26 87.75 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.198 1.932 . . . . 0.0 112.321 -179.118 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.581 ' C ' ' H ' ' A' ' 100' ' ' SER . 5.9 p -61.94 -34.37 62.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.758 179.565 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.0 p 53.99 -4.9 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.197 -179.382 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.581 ' H ' ' C ' ' A' ' 98' ' ' VAL . 32.3 t -60.84 -35.3 76.18 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.0 179.285 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -87.62 7.19 30.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.891 -178.893 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.0 m -76.9 134.58 38.92 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.797 -179.774 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.6 p -133.64 143.26 39.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.201 179.721 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.2 p -82.33 160.66 22.8 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.614 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.1 37.68 37.04 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.938 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 106' ' ' GLU . 59.3 mp0 -56.27 143.26 34.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.013 0.435 . . . . 0.0 110.745 -179.258 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.0 p -87.17 163.26 17.04 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.95 -179.706 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.41 81.46 59.17 Favored Pre-proline 0 N--CA 1.465 0.313 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.002 179.722 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.47 143.95 53.1 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.509 2.139 . . . . 0.0 112.626 -179.124 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.48 ' CD2' ' OG ' ' A' ' 111' ' ' SER . 68.4 t80 -102.15 135.78 43.15 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.305 179.888 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.48 ' OG ' ' CD2' ' A' ' 110' ' ' PHE . 14.7 m 62.13 71.17 0.75 Allowed Pre-proline 0 N--CA 1.464 0.23 0 CA-C-O 120.793 0.33 . . . . 0.0 110.785 -179.724 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -50.64 149.87 13.06 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.899 2.399 . . . . 0.0 112.224 -179.609 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.4 mt -58.24 -34.12 70.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.835 -0.62 . . . . 10.19 111.104 -179.285 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.631 ' O ' ' HB2' ' A' ' 115' ' ' ALA . 41.4 t -110.73 133.63 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.765 0.316 . . . . 7.2800000000000002 110.674 -179.689 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 114' ' ' VAL . . . 156.65 17.67 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.621 -0.718 . . . . 7.2999999999999998 109.625 179.957 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.402 ' H ' ' H ' ' A' ' 115' ' ' ALA . 23.3 p -84.24 162.25 20.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.057 -0.519 . . . . 6.4400000000000004 111.167 -179.265 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.7 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 47.0 m -65.03 159.05 24.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.598 -0.728 . . . . 4.4199999999999999 110.861 179.835 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.7 ' HG3' ' O ' ' A' ' 117' ' ' SER . 95.0 mt-10 132.09 69.12 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.479 1.112 . . . . 3.0499999999999998 110.46 179.929 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.4 p -62.8 -25.82 68.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.916 -0.583 . . . . 3.4300000000000002 110.488 179.494 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.4 t -112.43 135.85 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.932 -0.576 . . . . 2.8799999999999999 110.158 -179.928 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 21.1 p -121.83 161.94 21.81 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.116 0.484 . . . . 2.0899999999999999 111.157 -179.326 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -103.41 146.48 28.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.516 -0.766 . . . . 4.5300000000000002 109.656 179.821 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 70.8 mt -108.8 132.32 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.204 0.526 . . . . 1.4399999999999999 110.63 -179.368 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 67.1 m -124.18 145.59 49.23 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.298 -0.865 . . . . 1.78 110.472 -179.576 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -58.09 142.1 48.03 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.28 0.562 . . . . 0.64000000000000001 111.112 -179.234 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.1 OUTLIER 170.77 19.92 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 122.668 1.223 . . . . 0.66000000000000003 108.137 -179.445 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.454 ' H ' ' H ' ' A' ' 126' ' ' SER . 0.9 OUTLIER -53.82 167.6 0.25 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.121 -1.399 . . . . 0.68999999999999995 110.904 -178.85 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.69 145.56 50.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.692 -0.686 . . . . 0.52000000000000002 110.084 -179.934 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.26 101.7 9.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.07 -0.715 . . . . 0.32000000000000001 109.07 177.678 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.2 t -112.88 139.69 36.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.989 -0.551 . . . . 0.28999999999999998 111.073 -178.914 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.9 p -128.68 152.55 48.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.637 -0.71 . . . . 0.25 109.84 179.568 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.81 -164.98 2.04 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.693 -0.403 . . . . 0.31 110.64 -179.764 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.733 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.6 t -123.95 127.16 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.48999999999999999 110.844 -179.88 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.174 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.94 58.36 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.103 -0.499 . . . . 1.53 110.415 179.808 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.29 24.59 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.931 -0.577 . . . . 0.96999999999999997 111.479 -179.541 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.174 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.2 128.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.686 -0.405 . . . . 1.5600000000000001 111.004 179.8 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -86.45 -9.62 55.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.886 -0.597 . . . . 1.8799999999999999 110.337 179.775 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.12 0.35 55.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.094 -0.503 . . . . 1.04 110.289 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.34 137.19 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.23999999999999999 109.977 179.663 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 185' ' ' ILE . 76.6 p -96.28 -15.4 21.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.304 0.574 . . . . 0.28999999999999998 110.044 -179.649 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.52 175.58 45.72 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.856 -1.297 . . . . 0.13 109.856 179.59 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.45 151.63 42.49 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.62 -0.432 . . . . 0.17000000000000001 110.484 179.745 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.459 ' NH1' ' HG2' ' A' ' 15' ' ' PRO . 45.2 ttp180 -132.33 121.22 23.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.143 -0.48 . . . . 1.29 109.899 179.814 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.554 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.13 136.54 38.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.732 -0.667 . . . . 0.25 110.634 -179.711 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 80.7 tt0 -129.5 129.86 45.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.975 -0.557 . . . . 1.3200000000000001 110.006 -179.91 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.622 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.69 135.32 34.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.937 -0.574 . . . . 0.56999999999999995 110.633 -179.676 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.421 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.32 161.4 39.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.753 -0.658 . . . . 1.1599999999999999 109.619 179.875 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.968 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.1 mt -71.04 124.8 25.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.973 0.416 . . . . 0.38 110.772 -179.642 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.79 -7.64 49.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.832 -0.622 . . . . 0.40999999999999998 110.875 -179.738 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -109.82 -69.72 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.963 0.411 . . . . 1.6599999999999999 111.407 -179.267 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.468 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.69 -35.31 75.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.014 -0.539 . . . . 1.6599999999999999 111.563 -179.155 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.076 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.07 7.29 88.55 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.829 -0.908 . . . . 1.1699999999999999 110.829 -179.83 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.319 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.95 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.734 0.302 . . . . 1.8600000000000001 110.322 179.818 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.319 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.13 45.22 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.976 0.417 . . . . 1.98 110.193 179.624 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.8 Cg_endo -70.85 145.9 52.06 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 C-N-CA 122.621 2.214 . . . . 0.55000000000000004 112.368 -179.568 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.622 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.87 145.73 42.63 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.21 -0.663 . . . . 1.1399999999999999 109.21 179.21 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 6.0 p90 -123.24 141.31 52.11 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.399 -0.52 . . . . 0.93000000000000005 111.57 -179.108 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.3 mt -128.18 127.73 43.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.337 -0.847 . . . . 0.34000000000000002 108.844 178.956 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.548 ' O ' ' OD1' ' A' ' 159' ' ' ASP . 54.4 p-10 -101.65 131.15 48.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.174 0.511 . . . . 1.0900000000000001 111.751 -178.76 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.92 157.49 73.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.362 -0.836 . . . . 0.19 109.559 179.768 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -69.76 158.0 58.47 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.485 2.123 . . . . 0.17999999999999999 112.203 179.903 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.27 -12.16 5.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.755 -0.657 . . . . 0.20999999999999999 110.75 -179.842 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.81 -8.84 42.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.113 -0.494 . . . . 0.28999999999999998 110.678 -179.823 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.11 135.32 34.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.325 -0.398 . . . . 0.5 110.463 179.68 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 32.1 p -133.07 16.6 4.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.465 -0.334 . . . . 0.29999999999999999 110.582 179.953 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.1 p -167.53 147.09 5.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.61 -0.515 . . . . 0.23000000000000001 109.61 179.897 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.554 HG11 HG21 ' A' ' 144' ' ' VAL . 6.2 p -152.2 150.52 12.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.518 -0.473 . . . . 0.28000000000000003 111.528 -179.632 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.512 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.39 124.98 50.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.608 -0.724 . . . . 1.0700000000000001 109.763 179.517 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.39 104.93 29.96 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.909 0.385 . . . . 0.28999999999999998 111.02 -179.879 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.0 Cg_endo -91.03 -179.56 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 123.12 2.547 . . . . 0.42999999999999999 112.179 179.89 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 61.81 32.54 18.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.372 -0.831 . . . . 1.26 111.435 179.246 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.456 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.0 mt -86.46 148.5 25.52 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.918 -0.313 . . . . 0.32000000000000001 110.474 179.592 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.774 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.27 114.85 61.27 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 121.06 0.457 . . . . 0.57999999999999996 110.674 -179.64 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -58.95 140.63 96.15 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.9 2.4 . . . . 0.66000000000000003 111.99 179.853 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 76.99 21.26 74.44 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.082 -0.807 . . . . 0.28999999999999998 111.082 179.864 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.468 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.84 150.15 49.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.783 0.325 . . . . 2.3300000000000001 110.669 179.944 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.17 131.66 45.99 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.85999999999999999 109.784 179.28 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.968 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.2 m-85 -120.5 148.32 43.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.096 -0.502 . . . . 0.52000000000000002 110.951 -179.813 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.35 125.39 60.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.295 -1.002 . . . . 0.29999999999999999 108.295 177.657 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.59 132.45 63.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.206 0.527 . . . . 0.23000000000000001 111.274 -178.61 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.45 122.6 20.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.46 -0.791 . . . . 0.35999999999999999 109.64 179.278 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -101.02 125.41 54.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.234 -0.439 . . . . 0.19 110.72 -179.566 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.3 m-85 -117.22 137.91 52.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.992 -0.549 . . . . 0.29999999999999999 109.884 179.535 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.429 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.75 135.04 42.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.801 -0.815 . . . . 0.37 108.801 178.872 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.606 ' O ' ' N ' ' A' ' 140' ' ' SER . 80.6 mt -98.98 122.93 51.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.134 0.492 . . . . 0.26000000000000001 110.981 -178.774 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.8 p -83.89 169.67 14.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.593 -0.73 . . . . 0.28000000000000003 110.447 -179.709 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.82 -14.49 15.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.996 -0.547 . . . . 1.6000000000000001 110.928 -179.552 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -96.05 -4.3 43.24 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.857 -0.337 . . . . 1.1799999999999999 110.808 -179.832 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.83 13.84 64.01 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.351 -0.699 . . . . 0.29999999999999999 111.351 179.848 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -84.64 139.1 32.3 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.774 -0.251 . . . . 1.22 110.43 179.737 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.4 ' OE1' ' NH1' ' A' ' 143' ' ' ARG . 15.2 pt20 -106.72 141.07 38.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.423 -0.353 . . . . 0.97999999999999998 110.53 179.773 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.75 127.06 26.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.82999999999999996 110.332 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 25.8 tp -68.13 117.21 9.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.247 -0.433 . . . . 0.26000000000000001 110.42 -179.876 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -108.98 -21.83 5.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.29999999999999999 110.688 -179.787 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.82 125.82 5.95 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.512 -0.475 . . . . 0.31 111.476 -179.803 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.47 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.82 120.15 21.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.764 -0.653 . . . . 0.28000000000000003 109.564 179.174 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.63 151.63 29.03 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.691 -0.404 . . . . 0.23999999999999999 110.932 -179.284 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.31 158.64 18.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.041 -0.527 . . . . 0.23000000000000001 110.431 179.723 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.4 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 67.8 mt-30 -146.12 157.86 43.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.078 -0.51 . . . . 0.67000000000000004 110.652 -179.997 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.22 104.29 9.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.827 -0.624 . . . . 0.64000000000000001 110.086 179.522 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.0 p . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.851 -1.071 . . . . 1.26 110.727 -179.727 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.4 m . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.269 -0.641 . . . . 3.4399999999999999 109.269 . . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.74 18.53 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.032 -0.827 . . . . 1.22 111.032 179.683 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -35.7 142.38 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.113 0 C-N-CA 124.004 3.136 . . . . 0.75 113.806 -179.247 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.0 t -79.93 173.4 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.14 -1.391 . . . . 0.79000000000000004 108.888 178.41 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.608 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.53 125.86 51.46 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.448 -0.501 . . . . 1.9399999999999999 111.496 -179.618 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.51 143.99 33.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.687 -0.688 . . . . 0.59999999999999998 110.585 179.967 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.07 168.27 25.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.934 0.397 . . . . 3.1400000000000001 111.074 -179.671 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.744 HG22 ' OG1' ' A' ' 11' ' ' THR . 65.9 mt -108.93 131.01 60.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.946 -0.57 . . . . 3.23 110.139 179.877 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.14 162.27 35.88 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.869 0.366 . . . . 3.6299999999999999 111.247 -179.88 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.7 mt-10 36.21 31.5 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.601 -0.518 . . . . 6.0800000000000001 109.601 179.781 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.744 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.63 33.17 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.962 -0.563 . . . . 3.3799999999999999 111.555 -178.764 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.642 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.24 -29.22 73.2 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.531 2.154 . . . . 3.9300000000000002 111.849 179.304 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.642 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.71 125.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 3.3599999999999999 110.474 179.971 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.561 ' O ' ' O ' ' A' ' 92' ' ' THR . 10.9 mp0 -123.98 158.34 60.59 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.362 -0.381 . . . . 3.6099999999999999 110.436 179.965 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.506 ' HG3' ' NH1' ' A' ' 143' ' ' ARG . 96.7 Cg_endo -82.12 -64.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.837 2.358 . . . . 1.51 113.485 -179.023 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.54 ' OD1' ' O ' ' A' ' 63' ' ' LEU . 2.5 t-20 -108.5 -19.51 13.42 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.06 0.393 . . . . 2.6800000000000002 112.06 -178.501 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 9.1 p -107.36 152.02 24.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.103 0.477 . . . . 1.21 111.299 -179.456 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.576 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.25 102.89 2.23 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.694 -0.684 . . . . 1.5600000000000001 110.649 179.844 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.443 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.4 Cg_endo -82.62 145.66 13.12 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.885 2.39 . . . . 0.81000000000000005 112.621 179.896 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.917 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.84 167.93 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.901 -0.59 . . . . 1.52 109.856 179.595 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -149.17 147.85 28.94 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.819 -0.437 . . . . 2.1400000000000001 109.819 178.872 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.584 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.19 157.34 44.97 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.685 -0.406 . . . . 0.32000000000000001 111.228 179.946 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.501 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -128.03 155.23 44.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.737 -0.665 . . . . 2.1699999999999999 110.117 179.023 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.843 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.6 173.04 6.35 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.024 0.44 . . . . 0.58999999999999997 110.79 -179.266 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.843 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.71 173.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.914 2.41 . . . . 0.90000000000000002 111.528 179.402 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.94 -51.01 0.7 Allowed Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.616 -0.434 . . . . 3.3399999999999999 110.17 179.867 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.643 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.9 152.35 82.57 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.681 2.254 . . . . 1.8500000000000001 111.48 179.183 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.71 42.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.406 0.622 . . . . 2.54 110.562 -179.82 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.643 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.9 t60 -63.7 -41.51 98.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.943 -1.026 . . . . 2.5299999999999998 110.657 179.784 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.56 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.3 mt -110.0 137.87 40.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.72 -0.673 . . . . 1.1699999999999999 111.181 -179.409 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.99 -72.97 0.7 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.939 -0.573 . . . . 1.27 111.819 -178.944 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.19 148.44 24.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.591 0.589 . . . . 1.1200000000000001 112.591 -179.592 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.79 124.75 44.93 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.363 -0.606 . . . . 0.41999999999999998 109.363 177.556 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -117.99 134.71 60.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.696 -0.402 . . . . 0.78000000000000003 110.67 179.89 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.917 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -119.98 128.58 53.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.043 0.449 . . . . 0.62 111.225 179.767 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.542 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.07 138.98 49.83 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.768 -0.651 . . . . 1.97 110.138 178.954 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.44 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.0 163.25 34.77 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 121.165 0.507 . . . . 0.34999999999999998 112.061 -178.151 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.56 139.63 7.82 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.415 -0.811 . . . . 1.8 110.399 178.825 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.71 115.52 3.12 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.308 2.005 . . . . 0.57999999999999996 111.822 179.985 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.675 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.96 81.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.897 -0.408 . . . . 3.04 109.897 -179.801 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.697 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.012 -0.54 . . . . 2.4700000000000002 111.936 -179.496 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.2 p -157.65 157.79 34.25 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.839 -0.345 . . . . 2.5099999999999998 110.568 179.77 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.38 27.79 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 1.8600000000000001 110.165 179.574 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.75 -75.79 1.31 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.183 -0.532 . . . . 1.4399999999999999 111.888 -179.245 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.4 ' HD2' HH11 ' A' ' 45' ' ' ARG . 21.4 mtp180 -118.03 152.29 35.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.931 0.396 . . . . 4.6900000000000004 110.968 -179.317 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.673 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.15 2.54 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.106 -0.497 . . . . 1.4299999999999999 112.007 179.39 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.04 149.67 29.66 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.457 0.646 . . . . 1.74 112.543 -177.836 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.15 156.44 45.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.789 -1.096 . . . . 1.9199999999999999 110.161 178.635 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.21 158.35 41.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.905 -0.589 . . . . 0.34000000000000002 111.745 -179.351 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.3 m -115.11 135.59 54.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.454 -0.794 . . . . 0.40999999999999998 109.831 179.287 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.584 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.34 121.86 23.82 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.411 -0.359 . . . . 0.55000000000000004 111.596 -179.156 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.595 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.0 Cg_exo -46.23 151.67 1.58 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.695 2.263 . . . . 0.44 112.173 178.992 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.83 -23.16 63.05 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 116.096 -0.502 . . . . 0.73999999999999999 112.796 -179.205 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.54 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.7 -16.95 46.17 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.245 -0.582 . . . . 0.93000000000000005 111.824 -178.316 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.595 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.51 138.39 31.61 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.782 -0.367 . . . . 0.96999999999999997 110.27 179.396 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.54 14.01 11.0 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.308 -0.405 . . . . 1.3400000000000001 111.466 -179.418 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -150.04 143.5 25.19 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.721 -0.392 . . . . 0.39000000000000001 111.061 179.573 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.9 -169.31 1.53 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.065 -0.516 . . . . 0.41999999999999998 110.885 -179.425 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.723 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.79 125.94 9.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.442 -0.799 . . . . 0.39000000000000001 109.793 179.305 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.519 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.89 123.19 70.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.398 -0.521 . . . . 0.73999999999999999 111.157 -179.73 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -126.47 163.32 23.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.895 -0.593 . . . . 2.48 110.467 179.695 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.443 ' N ' ' OD2' ' A' ' 159' ' ' ASP . . . 85.24 18.95 59.76 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.672 -0.971 . . . . 0.5 110.672 -179.963 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.54 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 73.6 mt -79.07 157.27 28.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.129 0.49 . . . . 0.57999999999999996 111.302 -179.594 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.84 ' O ' HG12 ' A' ' 67' ' ' VAL . 1.2 mptt -99.51 134.02 21.47 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.572 -0.74 . . . . 2.79 110.475 179.759 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.95 143.58 61.03 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.573 2.182 . . . . 0.87 111.912 179.835 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.62 75.34 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.1 -0.8 . . . . 0.64000000000000001 111.1 179.732 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.84 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.14 158.74 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.704 0.288 . . . . 0.82999999999999996 110.395 -179.564 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.17 139.95 42.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.067 0.46 . . . . 0.5 110.586 -179.861 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.648 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.3 m-85 -122.5 136.42 54.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.869 -0.605 . . . . 0.53000000000000003 110.799 -179.9 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.3 pt-20 -98.85 131.06 45.24 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.553 -0.906 . . . . 1.8700000000000001 108.553 177.557 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.495 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.47 153.84 16.65 Favored Glycine 0 C--O 1.227 -0.286 0 C-N-CA 120.364 -0.922 . . . . 0.28999999999999998 112.043 -178.681 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -134.99 140.92 46.05 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.706 -0.479 . . . . 1.4299999999999999 109.706 179.55 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.2 tp -115.77 119.01 34.62 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.421 -0.512 . . . . 0.32000000000000001 110.504 179.684 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 84' ' ' VAL . 64.1 mt -112.45 129.06 68.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 0.79000000000000004 110.631 -179.865 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.7 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.8 120.75 43.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.343 -0.39 . . . . 1.02 110.754 -179.682 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.856 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.54 146.38 11.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.223 0.535 . . . . 0.62 111.023 -179.258 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.619 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.01 153.85 21.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.532 -0.758 . . . . 2.4399999999999999 109.935 179.829 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.13 88.48 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.889 0.376 . . . . 3.6899999999999999 110.416 -179.737 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.31 32.7 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.845 -0.616 . . . . 6.0800000000000001 110.467 -179.922 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.18 -117.36 3.28 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.413 -0.675 . . . . 1.22 111.413 -179.776 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.34 177.44 8.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.295 0.569 . . . . 2.8799999999999999 111.606 -179.192 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.22 149.46 31.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.423 -0.808 . . . . 1.47 110.486 179.149 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.07 144.64 38.85 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.549 -0.296 . . . . 2.7000000000000002 110.591 179.952 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.727 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.94 136.07 61.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.036 0.446 . . . . 0.46000000000000002 111.565 -179.832 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.57 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.16 141.38 52.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.675 -0.693 . . . . 0.34999999999999998 110.241 179.645 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.4 ttp180 -117.64 138.86 51.69 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.572 -0.451 . . . . 3.6699999999999999 111.511 -179.322 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.495 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.32 164.18 37.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.606 -0.724 . . . . 0.67000000000000004 109.44 179.422 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.567 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.29 151.55 38.52 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.357 -0.537 . . . . 1.47 111.042 179.99 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.8 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.25 172.68 13.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.738 -0.665 . . . . 0.44 111.083 179.848 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.69 160.65 21.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.48 -0.782 . . . . 1.3700000000000001 109.873 179.604 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.29 121.93 23.14 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.507 -0.477 . . . . 1.28 110.731 179.959 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.561 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.5 p -127.42 159.32 34.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 1.97 111.643 179.631 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 36.3 t -67.7 -82.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.904 -0.589 . . . . 3.2799999999999998 110.944 179.325 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 69.4 p -114.52 10.5 16.88 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.663 179.81 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.407 ' O ' ' OG1' ' A' ' 96' ' ' THR . 32.2 t 51.67 -147.71 0.42 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.897 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 95' ' ' SER . 30.6 p 52.12 68.83 2.82 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.866 179.59 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -54.66 -20.0 20.2 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.791 2.328 . . . . 0.0 112.114 -179.595 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 100' ' ' SER . 35.1 m -126.89 156.9 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.0 -179.794 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 47.9 m -57.24 -39.09 74.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.947 -179.192 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.511 ' O ' HG23 ' A' ' 98' ' ' VAL . 29.3 t -115.86 138.41 51.18 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.065 0.46 . . . . 0.0 111.151 -179.311 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -57.06 -33.04 66.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.005 179.398 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.558 ' O ' ' O ' ' A' ' 103' ' ' VAL . 50.1 m -116.87 139.32 50.76 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.075 -178.776 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.558 ' O ' ' O ' ' A' ' 102' ' ' THR . 62.9 t 50.3 155.7 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.526 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.404 ' N ' HG12 ' A' ' 103' ' ' VAL . 13.5 p -123.97 163.52 21.18 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.986 179.971 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -164.37 -178.08 37.54 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.488 179.877 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -59.77 145.02 46.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.952 0.406 . . . . 0.0 110.984 -179.824 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.9 m -74.65 140.58 44.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.849 179.565 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.27 82.1 30.54 Favored Pre-proline 0 N--CA 1.465 0.286 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.191 -178.883 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.56 151.15 47.88 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.157 1.905 . . . . 0.0 111.504 179.73 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -102.41 135.09 44.65 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.161 0.505 . . . . 0.0 110.911 -179.242 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.5 m -124.18 80.7 58.37 Favored Pre-proline 0 CA--C 1.529 0.158 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.97 179.963 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.73 144.4 54.16 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.069 1.846 . . . . 0.0 112.359 -178.746 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 66.5 mt -60.1 -32.62 71.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.277 -0.874 . . . . 10.19 111.47 -179.463 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 43.2 t -106.04 134.85 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.268 0.556 . . . . 7.2800000000000002 111.38 -178.654 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -104.84 151.54 23.69 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.222 -0.899 . . . . 7.2999999999999998 110.193 179.925 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 48.9 m -70.69 137.29 49.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.906 0.384 . . . . 6.4400000000000004 110.412 -179.63 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.0 m -62.91 155.05 28.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.946 -0.57 . . . . 4.4199999999999999 111.324 -179.287 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -58.43 145.49 38.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.725 -0.67 . . . . 3.0499999999999998 110.585 179.838 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.3 p -114.43 155.01 27.13 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.121 -0.49 . . . . 3.4300000000000002 110.489 -179.879 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.9 t -113.11 135.89 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.016 -0.538 . . . . 2.8799999999999999 110.59 -179.596 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 24.0 p -82.14 161.8 22.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 2.0899999999999999 110.941 -179.605 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -114.02 -91.22 0.51 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.714 -0.676 . . . . 4.5300000000000002 110.505 -179.779 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 32.1 pt -121.43 161.83 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.997 -0.547 . . . . 1.4399999999999999 110.098 -179.819 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.626 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 44.4 m -71.65 134.34 46.28 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.718 -0.393 . . . . 1.78 110.476 -179.18 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 124' ' ' THR . . . 151.61 75.64 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.451 -0.795 . . . . 0.64000000000000001 109.021 -179.607 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.7 p -60.66 -31.33 70.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.324 -0.398 . . . . 0.66000000000000003 111.17 -178.768 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.44 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.81 167.56 0.25 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.181 -0.463 . . . . 0.68999999999999995 110.954 179.893 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.65 145.49 50.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.807 -0.633 . . . . 0.52000000000000002 110.136 -179.933 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.18 101.62 9.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.012 -0.736 . . . . 0.32000000000000001 109.012 177.788 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.6 t -112.97 139.62 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.1 -0.5 . . . . 0.28999999999999998 111.149 -178.965 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.4 p -128.63 152.62 48.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.66 -0.7 . . . . 0.25 109.891 179.564 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.588 ' CD2' HG11 ' A' ' 182' ' ' VAL . 40.0 p90 -144.77 -165.06 2.06 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.74 -0.384 . . . . 0.31 110.704 -179.669 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.735 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.6 t -123.87 127.08 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.48999999999999999 110.897 -179.903 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.176 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.85 58.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.159 -0.473 . . . . 1.53 110.388 179.767 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.735 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.22 24.47 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.949 -0.569 . . . . 0.96999999999999997 111.433 -179.597 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.176 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.17 128.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.617 -0.433 . . . . 1.5600000000000001 110.991 179.915 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.36 -9.71 55.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.95 -0.568 . . . . 1.8799999999999999 110.293 179.829 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.07 0.2 55.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 1.04 110.253 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.21 137.17 25.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.23999999999999999 109.974 179.68 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 185' ' ' ILE . 70.5 m -96.22 -15.58 21.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.227 0.537 . . . . 0.28999999999999998 110.011 -179.66 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.61 175.52 45.76 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.821 -1.312 . . . . 0.13 109.821 179.722 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.37 151.62 42.35 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.694 -0.402 . . . . 0.17000000000000001 110.489 179.706 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.635 ' NE ' ' OE1' ' A' ' 191' ' ' GLN . 55.1 ttp85 -132.36 121.21 23.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.172 -0.467 . . . . 1.29 109.954 179.736 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.563 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.13 136.53 38.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.716 -0.675 . . . . 0.25 110.622 -179.7 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 79.5 tt0 -129.39 129.91 45.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.961 -0.563 . . . . 1.3200000000000001 110.128 179.963 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.9 p90 -138.67 135.32 34.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.006 -0.543 . . . . 0.56999999999999995 110.675 -179.658 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.414 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.39 161.33 39.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.805 -0.634 . . . . 1.1599999999999999 109.685 179.849 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.962 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.04 124.89 25.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.974 0.416 . . . . 0.38 110.737 -179.597 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.489 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.73 -7.78 50.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.741 -0.663 . . . . 0.40999999999999998 110.908 -179.791 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -109.76 -69.59 0.85 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.958 0.408 . . . . 1.6599999999999999 111.467 -179.253 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.441 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.4 mt-10 -60.85 -35.23 76.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.059 -0.519 . . . . 1.6599999999999999 111.454 -179.084 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.072 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.12 7.18 88.62 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.893 -0.883 . . . . 1.1699999999999999 110.893 -179.836 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.335 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.97 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.757 0.313 . . . . 1.8600000000000001 110.326 179.873 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.335 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.19 139.1 45.39 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.95 0.405 . . . . 1.98 110.226 179.649 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.414 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.2 Cg_endo -70.97 145.79 51.08 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.768 2.312 . . . . 0.55000000000000004 112.327 -179.499 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.85 145.68 42.65 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.28 -0.637 . . . . 1.1399999999999999 109.28 179.19 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.537 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 85.5 m-85 -123.27 141.41 52.01 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.314 -0.554 . . . . 0.93000000000000005 111.518 -179.053 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.4 mt -128.11 127.69 43.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.306 -0.861 . . . . 0.34000000000000002 108.915 179.06 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.443 ' OD2' ' N ' ' A' ' 62' ' ' GLY . 45.0 t0 -101.68 131.13 48.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.148 0.499 . . . . 1.0900000000000001 111.761 -178.783 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.92 157.62 73.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.266 -0.879 . . . . 0.19 109.6 179.619 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -69.87 158.03 58.19 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.423 2.082 . . . . 0.17999999999999999 112.197 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.26 -12.18 5.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.729 -0.669 . . . . 0.20999999999999999 110.693 -179.808 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.2 p -92.86 -8.73 42.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.28999999999999998 110.657 -179.855 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.27 135.39 34.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.393 -0.367 . . . . 0.5 110.344 179.73 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 p -133.14 16.62 4.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.335 -0.393 . . . . 0.29999999999999999 110.54 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.7 p -167.45 147.15 5.16 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.659 -0.497 . . . . 0.23000000000000001 109.659 179.874 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.563 HG11 HG21 ' A' ' 144' ' ' VAL . 5.9 p -152.19 150.36 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.011 0.434 . . . . 0.28000000000000003 111.618 -179.605 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.504 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 124.96 50.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.622 -0.717 . . . . 1.0700000000000001 109.799 179.47 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.47 104.97 30.47 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.015 0.436 . . . . 0.28999999999999998 111.062 -179.903 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.5 Cg_endo -91.04 -179.46 1.47 Allowed 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 123.144 2.563 . . . . 0.42999999999999999 112.221 179.914 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.66 32.67 18.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.399 -0.819 . . . . 1.26 111.501 179.31 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.2 mt -86.41 148.57 25.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.442 -0.345 . . . . 0.32000000000000001 110.431 179.656 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.777 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.38 114.86 61.4 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.074 0.464 . . . . 0.57999999999999996 110.714 -179.742 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -58.9 140.53 95.62 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.926 2.417 . . . . 0.66000000000000003 112.024 179.882 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.06 21.3 74.14 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.044 -0.823 . . . . 0.28999999999999998 111.044 179.861 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.441 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -127.0 150.14 49.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.942 0.401 . . . . 2.3300000000000001 110.528 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.489 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.13 131.67 45.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.878 -0.601 . . . . 0.85999999999999999 109.78 179.316 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.962 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.54 148.36 43.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.1 -0.5 . . . . 0.52000000000000002 111.035 -179.852 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.4 mt -105.39 125.33 60.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.221 -1.029 . . . . 0.29999999999999999 108.221 177.793 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.55 132.51 63.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.157 0.503 . . . . 0.23000000000000001 111.228 -178.642 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.43 122.65 20.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.492 -0.776 . . . . 0.35999999999999999 109.602 179.253 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.588 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.07 125.44 55.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.224 -0.444 . . . . 0.19 110.581 -179.53 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.9 m-85 -117.3 137.9 52.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.923 -0.581 . . . . 0.29999999999999999 109.85 179.479 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.432 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.9 pt20 -100.72 135.12 42.67 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.71 -0.848 . . . . 0.37 108.71 178.911 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.588 ' O ' ' N ' ' A' ' 140' ' ' SER . 85.2 mt -99.13 122.97 51.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.131 0.491 . . . . 0.26000000000000001 110.977 -178.826 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.0 p -83.87 169.74 14.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.498 -0.774 . . . . 0.28000000000000003 110.478 -179.672 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.472 ' O ' ' CG2' ' A' ' 59' ' ' THR . 97.4 mt-10 -59.81 -14.45 14.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.056 -0.52 . . . . 1.6000000000000001 111.027 -179.571 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 96.7 m-20 -96.16 -4.25 42.98 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.791 -0.364 . . . . 1.1799999999999999 110.842 -179.781 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.407 ' HA2' ' OG1' ' A' ' 59' ' ' THR . . . 87.83 13.84 64.02 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.362 -0.695 . . . . 0.29999999999999999 111.362 179.879 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -84.64 139.16 32.25 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.047 -0.261 . . . . 1.22 110.391 179.769 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.635 ' OE1' ' NE ' ' A' ' 143' ' ' ARG . 18.8 mt-30 -106.79 141.06 38.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.41 -0.359 . . . . 0.97999999999999998 110.469 179.788 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.68 127.08 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.82999999999999996 110.33 179.872 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.21 117.25 9.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.327 -0.397 . . . . 0.26000000000000001 110.518 -179.918 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -108.99 -21.81 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.29999999999999999 110.739 -179.711 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -157.0 125.75 5.81 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.48 -0.488 . . . . 0.31 111.458 -179.847 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.473 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.66 120.21 21.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.69 -0.686 . . . . 0.28000000000000003 109.591 179.208 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.61 151.71 29.15 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.543 -0.463 . . . . 0.23999999999999999 110.875 -179.294 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.44 158.62 18.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.035 -0.53 . . . . 0.23000000000000001 110.452 179.686 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -146.13 157.89 43.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.14 -0.482 . . . . 0.67000000000000004 110.656 179.99 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.18 104.36 9.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.755 -0.657 . . . . 0.64000000000000001 110.03 179.584 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.959 -1.02 . . . . 1.26 110.52 -179.656 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.1 m . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.188 -0.671 . . . . 3.4399999999999999 109.188 . . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.7 18.53 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.927 -0.869 . . . . 1.22 110.927 179.8 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -35.62 142.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.046 0 C-N-CA 123.991 3.127 . . . . 0.75 113.793 -179.239 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -80.09 173.51 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.184 -1.371 . . . . 0.79000000000000004 108.815 178.476 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.614 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.63 125.89 51.51 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.381 -0.527 . . . . 1.9399999999999999 111.351 -179.51 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.5 144.02 33.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.698 -0.683 . . . . 0.59999999999999998 110.65 179.838 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.09 168.3 25.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.972 0.415 . . . . 3.1400000000000001 111.09 -179.715 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.741 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.88 131.01 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.974 -0.557 . . . . 3.23 110.102 179.884 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.2 p -141.16 162.29 35.83 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.815 0.34 . . . . 3.6299999999999999 111.252 -179.951 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 96.9 mt-10 36.1 31.57 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.618 -0.512 . . . . 6.0800000000000001 109.618 179.828 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.741 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.53 32.5 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.975 -0.557 . . . . 3.3799999999999999 111.609 -178.782 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.643 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.29 -29.04 72.66 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.395 2.063 . . . . 3.9300000000000002 111.893 179.322 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.643 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 3.3599999999999999 110.464 179.949 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.543 ' O ' ' O ' ' A' ' 92' ' ' THR . 10.5 mp0 -123.9 158.32 60.41 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.366 -0.379 . . . . 3.6099999999999999 110.515 179.956 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.699 ' CG ' ' NH1' ' A' ' 143' ' ' ARG . 97.7 Cg_endo -82.08 -64.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.926 2.417 . . . . 1.51 113.461 -178.994 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 62' ' ' GLY . 20.5 t-20 -108.42 -19.66 13.38 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.097 0.406 . . . . 2.6800000000000002 112.097 -178.504 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 36.4 m -107.32 152.09 24.6 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.45 -0.5 . . . . 1.21 111.345 -179.425 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.578 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.3 102.93 2.22 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.722 -0.672 . . . . 1.5600000000000001 110.649 179.877 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.7 145.64 12.98 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.871 2.381 . . . . 0.81000000000000005 112.635 179.967 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.916 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.77 167.95 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 1.52 109.922 179.609 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.22 147.89 28.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.743 -0.466 . . . . 2.1400000000000001 109.743 178.879 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.584 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.23 157.29 45.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.054 0.454 . . . . 0.32000000000000001 111.206 179.95 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.503 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.8 m-20 -127.99 155.21 44.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.818 -0.628 . . . . 2.1699999999999999 110.149 178.971 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.842 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.56 173.12 6.26 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.155 -0.475 . . . . 0.58999999999999997 110.795 -179.296 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.842 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.73 173.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.842 0 C-N-CA 122.884 2.389 . . . . 0.90000000000000002 111.494 179.425 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.484 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -51.02 0.69 Allowed Pre-proline 0 C--N 1.328 -0.354 0 C-N-CA 120.671 -0.412 . . . . 3.3399999999999999 110.158 179.815 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.641 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.83 152.3 82.64 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.786 2.324 . . . . 1.8500000000000001 111.454 179.139 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.68 42.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.403 0.621 . . . . 2.54 110.588 -179.906 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.641 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.6 t60 -63.54 -41.66 98.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.976 -1.011 . . . . 2.5299999999999998 110.648 179.721 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.561 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.6 mt -109.89 137.83 40.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.738 -0.665 . . . . 1.1699999999999999 111.286 -179.398 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.99 -72.92 0.7 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.055 -0.521 . . . . 1.27 111.816 -178.922 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.15 148.34 24.47 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.59 0.589 . . . . 1.1200000000000001 112.59 -179.599 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.8 124.85 45.15 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.385 -0.598 . . . . 0.41999999999999998 109.385 177.474 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 mt -117.98 134.69 60.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.669 -0.412 . . . . 0.78000000000000003 110.698 179.973 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.916 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -119.98 128.6 53.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.294 -0.412 . . . . 0.62 111.287 179.765 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.54 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.06 139.0 49.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.758 -0.656 . . . . 1.97 110.153 178.992 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.44 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.12 163.16 35.16 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 121.105 0.479 . . . . 0.34999999999999998 112.045 -178.126 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.495 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.44 139.57 7.89 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.417 -0.811 . . . . 1.8 110.493 178.857 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.46 115.43 3.02 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.336 2.024 . . . . 0.57999999999999996 111.773 179.97 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.675 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.92 81.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.884 -0.414 . . . . 3.04 109.884 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.697 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.2 -20.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.012 -0.54 . . . . 2.4700000000000002 111.893 -179.517 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.5 157.92 34.73 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.815 -0.354 . . . . 2.5099999999999998 110.565 179.7 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.407 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 16.0 m -120.5 27.85 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.145 -0.479 . . . . 1.8600000000000001 110.081 179.616 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -75.96 1.31 Allowed Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.165 -0.541 . . . . 1.4399999999999999 111.764 -179.234 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.79 152.17 35.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.846 0.355 . . . . 4.6900000000000004 111.025 -179.253 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.672 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.14 -169.14 2.55 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.127 -0.488 . . . . 1.4299999999999999 112.021 179.324 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.1 149.63 29.76 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.455 0.645 . . . . 1.74 112.597 -177.864 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.06 156.48 46.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.835 -1.075 . . . . 1.9199999999999999 110.272 178.648 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.25 158.23 41.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.984 -0.553 . . . . 0.34000000000000002 111.835 -179.319 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.1 m -115.08 135.65 53.98 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.461 -0.79 . . . . 0.40999999999999998 109.795 179.307 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.584 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.38 121.95 23.79 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.462 -0.335 . . . . 0.55000000000000004 111.5 -179.136 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.592 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.1 Cg_exo -46.32 151.66 1.65 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.63 2.22 . . . . 0.44 112.111 178.979 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.88 -23.06 63.03 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 116.055 -0.52 . . . . 0.73999999999999999 112.817 -179.211 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.69 -16.97 46.13 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.278 -0.569 . . . . 0.93000000000000005 111.829 -178.391 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.592 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.6 mt -91.53 138.44 31.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.795 -0.362 . . . . 0.96999999999999997 110.333 179.388 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -121.6 13.97 10.94 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.366 -0.379 . . . . 1.3400000000000001 111.467 -179.331 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.0 143.43 25.17 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.665 -0.414 . . . . 0.39000000000000001 111.011 179.64 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.724 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.81 -169.36 1.53 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.204 0.526 . . . . 0.41999999999999998 110.852 -179.478 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.724 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.3 m -151.77 125.96 9.28 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.373 -0.83 . . . . 0.39000000000000001 109.782 179.249 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.518 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.2 mt -114.82 123.15 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.467 -0.493 . . . . 0.73999999999999999 111.255 -179.798 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.53 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 64.7 pttt -126.38 163.39 23.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.87 -0.604 . . . . 2.48 110.5 179.682 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.503 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.11 19.07 59.75 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.699 -0.96 . . . . 0.5 110.699 179.987 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.518 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.2 mt -79.11 157.24 28.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.091 0.472 . . . . 0.57999999999999996 111.342 -179.637 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.841 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -99.56 134.06 21.42 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.611 -0.722 . . . . 2.79 110.442 179.792 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.96 143.55 60.83 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.554 2.169 . . . . 0.87 111.98 179.851 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.97 25.51 75.49 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.043 -0.823 . . . . 0.64000000000000001 111.043 179.689 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.841 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.18 158.82 40.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.697 0.284 . . . . 0.82999999999999996 110.404 -179.593 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.18 139.89 42.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.922 0.391 . . . . 0.5 110.556 -179.692 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.648 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.53 136.53 54.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.046 -0.525 . . . . 0.53000000000000003 110.762 -179.931 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.495 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.98 131.04 45.33 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.456 -0.942 . . . . 1.8700000000000001 108.456 177.701 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.45 153.91 16.64 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.391 -0.909 . . . . 0.28999999999999998 111.971 -178.588 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -135.07 141.0 45.99 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.595 -0.52 . . . . 1.4299999999999999 109.595 179.593 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.2 tp -115.76 118.87 34.25 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.469 -0.492 . . . . 0.32000000000000001 110.496 179.686 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.725 HG12 HG23 ' A' ' 84' ' ' VAL . 63.8 mt -112.44 129.05 68.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.373 -0.376 . . . . 0.79000000000000004 110.613 -179.918 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.699 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.85 120.73 43.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.235 -0.439 . . . . 1.02 110.724 -179.655 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.857 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.54 146.59 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.22 0.533 . . . . 0.62 111.01 -179.281 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.621 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.08 153.87 21.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.458 -0.792 . . . . 2.4399999999999999 109.95 179.859 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.2 88.56 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.896 0.379 . . . . 3.6899999999999999 110.361 -179.702 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.33 32.72 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.79 -0.641 . . . . 6.0800000000000001 110.532 -179.99 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.18 -117.4 3.28 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.388 -0.685 . . . . 1.22 111.388 -179.712 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -81.39 177.36 9.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.206 0.527 . . . . 2.8799999999999999 111.625 -179.182 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.1 149.51 32.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.397 -0.82 . . . . 1.47 110.404 179.178 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.23 144.66 38.56 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.463 -0.335 . . . . 2.7000000000000002 110.532 179.857 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.725 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.05 135.94 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 121.077 0.465 . . . . 0.46000000000000002 111.497 -179.711 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.01 141.38 52.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.663 -0.699 . . . . 0.34999999999999998 110.259 179.637 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.64 138.81 51.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.159 0.504 . . . . 3.6699999999999999 111.499 -179.348 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.19 164.23 37.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.563 -0.744 . . . . 0.67000000000000004 109.503 179.317 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.567 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.31 151.48 38.39 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.406 -0.518 . . . . 1.47 111.05 179.967 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.801 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.5 p90 -146.15 172.69 13.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.725 -0.671 . . . . 0.44 111.062 179.856 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.69 160.73 21.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.452 -0.795 . . . . 1.3700000000000001 109.874 179.61 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.37 121.89 22.99 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.637 -0.425 . . . . 1.28 110.737 179.985 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.543 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.5 p -127.47 163.63 23.67 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.185 0.809 . . . . 1.97 113.185 179.638 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.519 ' OG ' ' OH ' ' A' ' 157' ' ' TYR . 40.1 t -123.67 147.9 46.99 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.407 -1.269 . . . . 3.2799999999999998 110.636 178.848 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.5 m 58.68 -2.09 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.251 179.169 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.453 ' H ' ' C ' ' A' ' 93' ' ' SER . 84.6 p -60.64 -29.03 69.01 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.411 179.678 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.8 m -127.3 78.74 74.16 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.434 178.942 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -54.57 138.08 74.31 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.3 2.0 . . . . 0.0 112.835 -178.475 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.4 t -123.6 137.03 58.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.075 179.389 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.8 m -116.68 135.82 53.47 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.964 0.411 . . . . 0.0 110.082 179.702 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.8 t -142.47 151.38 41.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.973 -179.422 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -95.18 126.9 40.83 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.254 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 48.0 m -117.33 141.14 48.67 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.226 0.536 . . . . 0.0 111.389 -178.839 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.9 t -115.4 138.35 46.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.777 179.762 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 t -131.42 158.1 41.7 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.135 0.493 . . . . 0.0 111.076 -179.246 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 96.27 -2.34 63.21 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -179.143 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.19 -31.77 70.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.468 -0.366 . . . . 0.0 110.525 179.368 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.4 p -118.38 164.47 15.19 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.033 -178.992 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.628 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 1.2 m 170.64 -36.42 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.496 -179.467 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 108' ' ' THR . 51.0 Cg_exo -54.14 152.49 24.48 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.289 1.992 . . . . 0.0 111.941 179.732 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -89.27 135.32 33.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.592 -179.407 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.644 ' N ' ' HD2' ' A' ' 112' ' ' PRO . 1.2 t 169.44 -48.9 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.924 -179.55 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 111' ' ' SER . 14.0 Cg_endo -56.74 145.85 80.47 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.02 1.813 . . . . 0.0 111.8 179.417 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.7 mt -93.04 141.75 28.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.285 -0.416 . . . . 10.19 110.431 -179.689 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.61 154.98 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.075 -0.511 . . . . 7.2800000000000002 110.475 179.748 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.16 143.22 34.6 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.273 -0.421 . . . . 7.2999999999999998 110.534 179.882 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.8 p -123.86 159.05 30.48 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.367 -0.378 . . . . 6.4400000000000004 110.426 179.493 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.2 t -134.27 141.24 46.9 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.47 -0.332 . . . . 4.4199999999999999 110.499 179.504 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.21 -33.28 75.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.995 0.426 . . . . 3.0499999999999998 110.238 179.334 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 120' ' ' VAL . 57.5 p -70.94 162.67 28.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.799 -0.637 . . . . 3.4300000000000002 110.958 -179.809 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 119' ' ' SER . 42.5 t 55.68 120.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.935 -0.575 . . . . 2.8799999999999999 111.076 179.622 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 123' ' ' ILE . 24.8 p -80.92 163.51 23.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.896 -0.593 . . . . 2.0899999999999999 110.618 179.898 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.38 -33.35 67.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.077 -0.511 . . . . 4.5300000000000002 110.806 -179.441 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.4 ' O ' ' OG1' ' A' ' 121' ' ' THR . 70.8 mt -114.23 133.64 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.74 0.305 . . . . 1.4399999999999999 110.427 -179.888 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.4 p -122.85 161.08 24.75 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.108 -0.497 . . . . 1.78 110.555 -179.908 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.88 -33.99 76.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.024 -0.535 . . . . 0.64000000000000001 111.49 -179.452 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.402 ' O ' HD12 ' A' ' 172' ' ' LEU . 4.9 p -161.43 -28.45 0.05 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.807 -0.357 . . . . 0.66000000000000003 110.781 -179.654 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.444 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.82 167.57 0.25 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.017 -0.538 . . . . 0.68999999999999995 110.925 -179.593 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.57 145.56 50.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.656 -0.702 . . . . 0.52000000000000002 110.073 -179.918 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.29 101.62 9.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.146 -0.687 . . . . 0.32000000000000001 109.146 177.609 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.1 t -112.84 139.74 36.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.896 -0.593 . . . . 0.28999999999999998 111.038 -178.851 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.6 p -128.76 152.66 48.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.622 -0.717 . . . . 0.25 109.743 179.528 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.588 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.85 -164.97 2.04 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.659 -0.416 . . . . 0.31 110.621 -179.808 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.744 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.8 t -123.9 127.18 73.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.193 -0.458 . . . . 0.48999999999999999 110.787 -179.805 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.17 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.96 58.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 1.53 110.316 179.792 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.744 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.07 24.44 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.873 -0.603 . . . . 0.96999999999999997 111.614 -179.772 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.17 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.14 128.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.685 -0.406 . . . . 1.5600000000000001 111.023 179.896 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.43 -9.57 56.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.891 -0.595 . . . . 1.8799999999999999 110.359 179.817 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.06 0.3 55.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.037 -0.529 . . . . 1.04 110.446 179.839 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.23 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.904 -0.589 . . . . 0.23999999999999999 110.038 179.665 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.592 ' N ' ' O ' ' A' ' 185' ' ' ILE . 91.9 p -96.31 -15.41 21.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.29 0.567 . . . . 0.28999999999999998 109.987 -179.577 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.59 175.52 45.74 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.758 -1.337 . . . . 0.13 109.758 179.688 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.43 151.64 42.45 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.607 -0.437 . . . . 0.17000000000000001 110.462 179.687 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.906 ' NH1' HE22 ' A' ' 191' ' ' GLN . 52.0 ttp180 -132.35 121.1 22.98 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.111 -0.495 . . . . 1.29 109.937 179.787 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.563 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.07 136.58 38.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.678 -0.692 . . . . 0.25 110.66 -179.747 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.592 ' OE2' ' OH ' ' A' ' 157' ' ' TYR . 84.7 tt0 -129.38 129.85 45.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.942 -0.572 . . . . 1.3200000000000001 110.079 -179.912 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.7 p90 -138.68 135.26 34.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.051 -0.522 . . . . 0.56999999999999995 110.635 -179.63 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.419 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.33 161.28 40.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.776 -0.647 . . . . 1.1599999999999999 109.697 179.877 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.959 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.4 mt -71.0 124.81 25.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.993 0.425 . . . . 0.38 110.793 -179.648 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.482 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.7 p -71.82 -7.7 49.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.758 -0.655 . . . . 0.40999999999999998 110.807 -179.678 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -109.81 -69.62 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.398 -0.365 . . . . 1.6599999999999999 111.427 -179.351 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.438 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.68 -35.32 75.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.116 -0.493 . . . . 1.6599999999999999 111.521 -179.105 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.084 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.05 7.3 88.54 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.812 -0.915 . . . . 1.1699999999999999 110.812 -179.796 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.312 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.96 -171.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.851 0.358 . . . . 1.8600000000000001 110.282 179.84 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.312 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.31 139.19 45.01 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.01 0.434 . . . . 1.98 110.158 179.628 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.419 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.4 Cg_endo -70.96 145.74 50.96 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 122.707 2.271 . . . . 0.55000000000000004 112.381 -179.591 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.72 145.73 42.5 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.368 -0.604 . . . . 1.1399999999999999 109.368 179.148 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.592 ' OH ' ' OE2' ' A' ' 145' ' ' GLU . 89.9 m-85 -123.27 141.41 52.01 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.335 -0.546 . . . . 0.93000000000000005 111.491 -179.074 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.8 mt -128.17 127.66 43.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.302 -0.863 . . . . 0.34000000000000002 108.882 178.975 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -101.62 131.12 48.01 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.137 0.494 . . . . 1.0900000000000001 111.782 -178.785 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.93 157.5 73.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.349 -0.842 . . . . 0.19 109.533 179.776 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -69.89 158.01 58.22 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.403 2.069 . . . . 0.17999999999999999 112.184 179.951 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.29 -12.14 5.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.704 -0.68 . . . . 0.20999999999999999 110.785 -179.778 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.8 p -92.73 -8.84 42.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.083 -0.508 . . . . 0.28999999999999998 110.75 -179.978 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.18 135.41 34.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.5 110.358 179.739 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.11 16.67 4.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.29999999999999999 110.556 179.933 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.5 p -167.54 147.17 5.09 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.65 -0.5 . . . . 0.23000000000000001 109.65 179.899 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.563 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.3 150.44 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.52 -0.472 . . . . 0.28000000000000003 111.591 -179.648 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.508 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.25 125.03 50.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.597 -0.729 . . . . 1.0700000000000001 109.776 179.562 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.46 104.88 29.93 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.43 -0.35 . . . . 0.28999999999999998 111.021 -179.883 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.9 Cg_endo -91.01 -179.4 1.47 Allowed 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 123.088 2.526 . . . . 0.42999999999999999 112.229 179.856 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.56 32.7 18.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.359 -0.837 . . . . 1.26 111.461 179.311 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 126' ' ' SER . 24.1 mt -86.34 148.57 25.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.472 -0.331 . . . . 0.32000000000000001 110.437 179.547 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.772 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.31 114.88 61.41 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.002 0.429 . . . . 0.57999999999999996 110.644 -179.757 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.07 140.55 95.71 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.883 2.389 . . . . 0.66000000000000003 111.94 179.835 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.17 21.07 74.37 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.047 -0.821 . . . . 0.28999999999999998 111.047 179.835 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.438 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.76 150.14 49.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.341 . . . . 2.3300000000000001 110.673 -179.984 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.482 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.14 131.58 46.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.138 -0.483 . . . . 0.85999999999999999 109.878 179.252 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.959 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.1 m-85 -120.44 148.25 44.05 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.192 -0.458 . . . . 0.52000000000000002 111.107 -179.817 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.7 mt -105.33 125.41 60.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.252 -1.018 . . . . 0.29999999999999999 108.252 177.749 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.59 132.58 63.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.185 0.516 . . . . 0.23000000000000001 111.266 -178.645 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.53 122.61 20.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.608 -0.724 . . . . 0.35999999999999999 109.621 179.303 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.588 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.04 125.35 54.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.169 -0.469 . . . . 0.19 110.707 -179.535 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.4 m-85 -117.17 137.93 52.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.017 -0.538 . . . . 0.29999999999999999 109.876 179.526 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.432 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.69 135.0 42.82 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.783 -0.821 . . . . 0.37 108.783 178.864 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.592 ' O ' ' N ' ' A' ' 140' ' ' SER . 82.7 mt -99.17 123.05 51.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.153 0.501 . . . . 0.26000000000000001 110.898 -178.78 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.4 p -83.89 169.72 14.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.498 -0.773 . . . . 0.28000000000000003 110.477 -179.719 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.81 -14.47 15.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.985 -0.552 . . . . 1.6000000000000001 111.051 -179.589 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.482 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.7 m-20 -96.04 -4.31 43.28 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.842 -0.343 . . . . 1.1799999999999999 110.812 -179.855 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.699 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.82 13.85 64.02 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.341 -0.703 . . . . 0.29999999999999999 111.341 179.858 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -84.59 139.07 32.35 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.121 -0.231 . . . . 1.22 110.479 179.699 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.906 HE22 ' NH1' ' A' ' 143' ' ' ARG . 78.2 mt-30 -106.77 141.02 38.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.875 0.369 . . . . 0.97999999999999998 110.499 179.843 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.67 126.98 26.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.82999999999999996 110.481 179.844 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.407 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.02 117.34 9.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.362 -0.381 . . . . 0.26000000000000001 110.492 -179.839 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.17 -21.7 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.465 . . . . 0.29999999999999999 110.685 -179.762 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.92 125.63 5.81 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.601 -0.44 . . . . 0.31 111.537 -179.783 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.47 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.68 120.26 21.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.726 -0.67 . . . . 0.28000000000000003 109.547 179.188 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.65 29.04 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.606 -0.438 . . . . 0.23999999999999999 110.893 -179.273 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.44 158.61 18.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.23000000000000001 110.345 179.752 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -146.11 157.96 43.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.055 -0.52 . . . . 0.67000000000000004 110.642 179.954 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.29 104.44 9.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.817 -0.629 . . . . 0.64000000000000001 110.012 179.558 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 117.942 -1.027 . . . . 1.26 110.56 -179.631 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.1 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.261 -0.644 . . . . 3.4399999999999999 109.261 . . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.39 150.71 18.53 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.078 -0.809 . . . . 1.22 111.078 179.649 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -35.63 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.066 0 C-N-CA 124.013 3.142 . . . . 0.75 113.743 -179.134 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.62 HG12 ' H ' ' A' ' 5' ' ' GLU . 15.9 t -79.84 173.32 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.289 -1.323 . . . . 0.79000000000000004 108.916 178.341 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.62 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.52 125.82 51.42 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.476 -0.489 . . . . 1.9399999999999999 111.47 -179.626 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 144.06 33.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.739 -0.664 . . . . 0.59999999999999998 110.606 179.84 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.36 25.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.898 0.38 . . . . 3.1400000000000001 111.149 -179.705 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.737 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.4 mt -109.01 131.13 60.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.968 -0.56 . . . . 3.23 110.03 179.921 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 69.3 p -141.26 162.42 35.53 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.894 0.378 . . . . 3.6299999999999999 111.122 -179.915 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 32.5 tp10 36.07 31.57 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 109.631 -0.507 . . . . 6.0800000000000001 109.631 179.843 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.737 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.5 69.62 33.32 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.939 -0.573 . . . . 3.3799999999999999 111.611 -178.8 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.641 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.31 -29.14 72.55 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.437 2.092 . . . . 3.9300000000000002 111.753 179.391 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.641 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.7 125.57 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 3.3599999999999999 110.469 179.997 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.583 ' O ' ' O ' ' A' ' 92' ' ' THR . 3.7 mp0 -123.99 158.36 60.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 3.6099999999999999 110.415 -179.979 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.55 ' HG3' ' NH1' ' A' ' 143' ' ' ARG . 97.1 Cg_endo -82.04 -64.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.92 2.413 . . . . 1.51 113.483 -178.96 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.444 ' H ' ' HG2' ' A' ' 15' ' ' PRO . 98.7 m-20 -108.39 -19.61 13.4 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.097 0.406 . . . . 2.6800000000000002 112.097 -178.501 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 63.1 m -107.47 152.11 24.66 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.403 -0.519 . . . . 1.21 111.248 -179.361 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.579 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.27 102.83 2.23 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.654 -0.703 . . . . 1.5600000000000001 110.692 179.922 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.69 145.71 13.03 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.818 2.345 . . . . 0.81000000000000005 112.561 -179.984 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.918 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.79 167.9 24.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.805 -0.634 . . . . 1.52 109.883 179.604 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -149.1 148.04 29.21 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.757 -0.46 . . . . 2.1400000000000001 109.757 178.821 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.7 p90 -142.37 157.28 44.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.036 0.446 . . . . 0.32000000000000001 111.163 179.933 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.497 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -128.01 155.27 44.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.77 -0.65 . . . . 2.1699999999999999 110.102 178.999 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.822 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.56 173.0 6.4 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 121.118 0.485 . . . . 0.58999999999999997 110.73 -179.204 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.822 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.61 173.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.844 2.363 . . . . 0.90000000000000002 111.532 179.303 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.485 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -51.09 0.69 Allowed Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.714 -0.394 . . . . 3.3399999999999999 110.048 179.926 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.62 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.81 152.34 82.49 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.721 2.28 . . . . 1.8500000000000001 111.527 179.147 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.65 42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.362 0.601 . . . . 2.54 110.599 -179.915 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.62 ' H ' ' C ' ' A' ' 27' ' ' PRO . 74.2 t60 -63.52 -41.62 98.48 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.963 -1.017 . . . . 2.5299999999999998 110.725 179.661 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.557 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.5 mt -109.89 137.92 39.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.756 -0.656 . . . . 1.1699999999999999 111.287 -179.44 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.12 -72.84 0.71 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.097 -0.502 . . . . 1.27 111.839 -178.911 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.34 24.45 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.575 0.583 . . . . 1.1200000000000001 112.575 -179.633 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.89 124.88 45.14 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.267 -0.642 . . . . 0.41999999999999998 109.267 177.556 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.1 134.75 60.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.545 -0.462 . . . . 0.78000000000000003 110.648 179.926 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.918 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.01 128.67 53.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.058 0.456 . . . . 0.62 111.247 179.781 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 139.02 49.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.729 -0.668 . . . . 1.97 110.062 179.012 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.439 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.11 163.21 35.0 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.443 -0.503 . . . . 0.34999999999999998 112.058 -178.114 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.51 139.51 7.8 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.533 -0.758 . . . . 1.8 110.45 178.909 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.51 115.47 3.05 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.327 2.018 . . . . 0.57999999999999996 111.803 179.968 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.67 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.99 81.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.902 -0.407 . . . . 3.04 109.902 -179.878 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.693 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.19 -20.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.954 -0.567 . . . . 2.4700000000000002 111.919 -179.549 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 p -157.55 157.8 34.43 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.856 -0.338 . . . . 2.5099999999999998 110.626 179.726 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.401 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.37 27.85 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.27 -0.423 . . . . 1.8600000000000001 110.195 179.527 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.84 -75.91 1.31 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.036 -0.602 . . . . 1.4399999999999999 111.811 -179.255 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.83 152.41 35.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.982 0.42 . . . . 4.6900000000000004 110.991 -179.351 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.637 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.28 -169.19 2.54 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.075 -0.511 . . . . 1.4299999999999999 112.007 179.413 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.6 mttp -110.06 149.6 29.78 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.43 0.633 . . . . 1.74 112.595 -177.86 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.08 156.41 46.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.815 -1.084 . . . . 1.9199999999999999 110.214 178.679 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.457 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.16 158.42 41.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.934 -0.576 . . . . 0.34000000000000002 111.788 -179.353 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.2 135.58 54.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.46 -0.791 . . . . 0.40999999999999998 109.809 179.317 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.596 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.38 121.96 23.8 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.429 -0.351 . . . . 0.55000000000000004 111.528 -179.149 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.606 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.3 Cg_exo -46.31 151.63 1.65 Allowed 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.694 2.263 . . . . 0.44 112.145 178.977 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.81 -23.09 62.91 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 116.043 -0.526 . . . . 0.73999999999999999 112.814 -179.277 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.5 p-80 -82.81 -16.81 46.34 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.192 -0.603 . . . . 0.93000000000000005 111.809 -178.323 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.606 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.6 mt -91.67 138.4 31.59 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.719 -0.392 . . . . 0.96999999999999997 110.266 179.395 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.48 13.96 11.04 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.334 -0.393 . . . . 1.3400000000000001 111.501 -179.369 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -150.04 143.52 25.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.633 -0.427 . . . . 0.39000000000000001 111.029 179.525 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.717 ' CE2' ' O ' ' A' ' 59' ' ' THR . 65.0 t80 -114.8 -169.37 1.53 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.019 -0.537 . . . . 0.41999999999999998 110.815 -179.373 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.717 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.79 125.95 9.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.343 -0.844 . . . . 0.39000000000000001 109.852 179.21 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.513 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.3 mt -114.91 123.24 70.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.369 -0.532 . . . . 0.73999999999999999 111.192 -179.73 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.786 ' NZ ' ' N ' ' A' ' 141' ' ' GLY . 98.4 mttt -126.49 163.41 23.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.812 -0.631 . . . . 2.48 110.514 179.673 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.08 19.05 59.83 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.774 -0.93 . . . . 0.5 110.774 -179.845 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.513 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.6 mt -79.06 157.25 28.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.107 0.48 . . . . 0.57999999999999996 111.4 -179.717 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.859 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -99.46 133.93 21.57 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.635 -0.712 . . . . 2.79 110.466 179.774 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.89 143.53 61.19 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.599 2.2 . . . . 0.87 111.971 179.81 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.89 25.57 75.41 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.045 -0.822 . . . . 0.64000000000000001 111.045 179.722 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.859 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.14 158.74 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.653 0.263 . . . . 0.82999999999999996 110.459 -179.636 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.07 139.95 41.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.986 0.422 . . . . 0.5 110.553 -179.772 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.638 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.64 136.47 54.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.914 -0.584 . . . . 0.53000000000000003 110.788 -179.955 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.97 130.98 45.36 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.516 -0.92 . . . . 1.8700000000000001 108.516 177.741 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.487 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.44 153.89 16.63 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.306 -0.95 . . . . 0.28999999999999998 111.947 -178.556 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -135.03 141.0 46.07 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.739 -0.467 . . . . 1.4299999999999999 109.739 179.503 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.522 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.83 118.95 34.43 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.422 -0.511 . . . . 0.32000000000000001 110.354 179.831 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 84' ' ' VAL . 64.1 mt -112.48 129.11 68.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.79000000000000004 110.625 -179.97 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.707 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.86 120.75 43.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.324 -0.398 . . . . 1.02 110.737 -179.663 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.866 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.47 146.52 11.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.18 0.514 . . . . 0.62 111.068 -179.292 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.623 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.08 153.89 21.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.56 -0.746 . . . . 2.4399999999999999 109.861 179.877 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.22 88.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.742 -0.383 . . . . 3.6899999999999999 110.426 -179.772 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.14 32.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.807 -0.633 . . . . 6.0800000000000001 110.545 -179.905 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.22 -117.37 3.27 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.391 -0.683 . . . . 1.22 111.391 -179.77 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -81.4 177.44 8.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.202 0.525 . . . . 2.8799999999999999 111.587 -179.111 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.16 149.48 32.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.428 -0.805 . . . . 1.47 110.488 179.09 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.15 144.69 38.73 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.499 -0.318 . . . . 2.7000000000000002 110.556 179.874 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.727 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.99 136.09 61.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 120.577 -0.449 . . . . 0.46000000000000002 111.544 -179.795 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.11 141.3 52.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.607 -0.724 . . . . 0.34999999999999998 110.244 179.664 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.466 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.4 ttp180 -117.59 138.84 51.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.166 0.508 . . . . 3.6699999999999999 111.486 -179.379 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.487 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.24 164.11 38.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.501 -0.772 . . . . 0.67000000000000004 109.475 179.338 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.13 151.56 38.68 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.456 -0.498 . . . . 1.47 111.122 179.918 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.14 172.75 12.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.812 -0.631 . . . . 0.44 111.02 179.875 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.82 160.77 21.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.418 -0.81 . . . . 1.3700000000000001 109.841 179.512 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.38 121.9 22.98 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.591 -0.444 . . . . 1.28 110.748 -179.991 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.583 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.6 p -128.81 167.19 17.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.048 -0.524 . . . . 1.97 112.286 179.676 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.2 t -66.54 161.93 21.93 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.001 -0.74 . . . . 3.2799999999999998 109.001 177.431 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.7 p -75.76 157.56 33.34 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.525 0.679 . . . . 0.0 112.109 -178.054 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.8 m -86.55 11.47 12.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.13 179.832 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 24.8 p -46.72 144.73 3.43 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.945 -177.993 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.64 148.15 92.39 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.999 2.466 . . . . 0.0 113.42 -178.491 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.3 m -128.6 158.82 40.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.21 178.985 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.5 t -133.29 154.97 50.23 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.284 0.564 . . . . 0.0 111.954 -179.444 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.6 m -127.78 152.9 47.2 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.904 -179.797 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 61.5 47.45 6.62 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 178.708 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.7 p -67.52 -9.63 44.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.273 178.895 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.1 t 60.44 104.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.883 -179.339 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.5 p -124.27 168.27 13.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.854 -179.995 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.64 18.51 37.87 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.534 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.37 146.45 15.71 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.517 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 43.6 m -68.08 133.6 49.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.428 0.632 . . . . 0.0 111.173 -178.129 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.518 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 36.9 m -154.74 140.96 12.94 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.696 179.822 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.72 140.47 46.6 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 CA-C-N 120.131 1.082 . . . . 0.0 111.311 179.488 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.518 ' CE2' ' O ' ' A' ' 108' ' ' THR . 99.4 m-85 -119.9 154.42 34.41 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.238 -179.446 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.28 165.61 37.65 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.445 178.855 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.0 -26.37 31.71 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.74 1.627 . . . . 0.0 111.802 -179.647 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.8 mt -98.23 139.85 33.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.236 -0.438 . . . . 10.19 109.83 179.123 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 80.5 t -61.72 -40.95 88.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.556 -0.458 . . . . 7.2800000000000002 110.146 179.931 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -148.69 154.16 39.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.992 -0.549 . . . . 7.2999999999999998 109.976 179.532 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.7 p -123.14 159.04 29.4 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.06 0.457 . . . . 6.4400000000000004 110.906 179.838 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.8 m -59.73 -33.32 71.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.706 -0.679 . . . . 4.4199999999999999 110.811 179.629 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -99.43 153.23 19.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.104 -0.498 . . . . 3.0499999999999998 111.292 -178.803 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 28.5 m -102.01 -123.5 0.18 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.685 -0.688 . . . . 3.4300000000000002 110.557 179.806 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 92.8 t -61.36 -41.9 91.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.892 -0.323 . . . . 2.8799999999999999 110.672 -179.574 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 20.6 p -125.36 154.83 41.26 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.722 0.296 . . . . 2.0899999999999999 110.702 179.345 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.01 -37.2 83.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.296 -0.411 . . . . 4.5300000000000002 111.566 179.526 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.934 HG23 HG23 ' A' ' 124' ' ' THR . 10.1 tp -63.79 -26.42 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.28 0.474 . . . . 1.4399999999999999 112.28 -178.765 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.934 HG23 HG23 ' A' ' 123' ' ' ILE . 29.8 p -122.46 162.64 21.32 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.41 0.624 . . . . 1.78 111.945 -179.522 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.78 -117.58 0.32 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.108 -0.951 . . . . 0.64000000000000001 109.716 179.183 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.8 p -61.01 -30.34 70.24 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.112 0.482 . . . . 0.66000000000000003 110.121 179.661 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.441 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.94 167.51 0.27 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.621 -0.718 . . . . 0.68999999999999995 110.99 179.693 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.49 145.6 50.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.731 -0.668 . . . . 0.52000000000000002 110.139 -179.902 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.36 101.77 9.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.076 -0.713 . . . . 0.32000000000000001 109.076 177.675 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.5 t -113.01 139.74 36.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.589 . . . . 0.28999999999999998 110.946 -178.758 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.6 p -128.75 152.6 48.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.61 -0.723 . . . . 0.25 109.837 179.532 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.588 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.82 -164.99 2.04 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.672 -0.411 . . . . 0.31 110.653 -179.727 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.732 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.9 t -123.94 127.13 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.48999999999999999 110.834 -179.821 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.167 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.125 -0.489 . . . . 1.53 110.316 179.841 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.09 24.39 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.9 -0.591 . . . . 0.96999999999999997 111.481 -179.698 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.167 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.25 128.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.587 -0.445 . . . . 1.5600000000000001 110.902 179.883 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.46 -9.66 55.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.92 -0.582 . . . . 1.8799999999999999 110.246 179.78 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.1 0.31 55.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.123 -0.489 . . . . 1.04 110.35 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.26 137.07 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.984 -0.553 . . . . 0.23999999999999999 109.982 179.624 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.725 ' C ' ' HZ2' ' A' ' 61' ' ' LYS . 10.1 p -96.21 -15.48 22.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.233 0.539 . . . . 0.28999999999999998 110.028 -179.648 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.786 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.59 175.54 45.76 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.711 -1.355 . . . . 0.13 109.711 179.659 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -123.42 151.66 42.41 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.635 -0.426 . . . . 0.17000000000000001 110.556 179.637 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.72 ' NH1' ' CE1' ' A' ' 157' ' ' TYR . 38.9 ttp85 -132.44 121.17 22.99 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.125 -0.489 . . . . 1.29 109.881 179.845 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 167' ' ' VAL . 46.0 t -105.0 136.51 38.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.646 -0.706 . . . . 0.25 110.728 -179.77 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 78.5 tt0 -129.36 129.95 45.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.015 -0.539 . . . . 1.3200000000000001 110.006 -179.919 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.84 135.26 34.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.044 -0.525 . . . . 0.56999999999999995 110.525 -179.679 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.416 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.41 39.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.633 -0.712 . . . . 1.1599999999999999 109.665 179.805 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.953 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 85.7 mt -71.09 124.86 25.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.952 0.406 . . . . 0.38 110.676 -179.536 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.71 -7.77 50.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.717 -0.674 . . . . 0.40999999999999998 110.874 -179.815 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.73 -69.65 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 1.6599999999999999 111.464 -179.284 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.451 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.63 -35.45 76.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.015 -0.539 . . . . 1.6599999999999999 111.461 -179.168 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.089 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.18 7.24 88.59 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.748 -0.941 . . . . 1.1699999999999999 110.748 -179.836 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.326 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.97 -171.73 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.689 0.28 . . . . 1.8600000000000001 110.294 179.848 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.326 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.22 139.12 45.3 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.945 0.402 . . . . 1.98 110.172 179.666 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.416 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.7 Cg_endo -70.94 145.84 51.39 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 C-N-CA 122.725 2.283 . . . . 0.55000000000000004 112.303 -179.537 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.9 145.75 42.63 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.234 -0.654 . . . . 1.1399999999999999 109.234 179.183 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.72 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 94.1 m-85 -123.28 141.35 52.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.25 0.547 . . . . 0.93000000000000005 111.478 -179.047 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.9 mt -128.14 127.73 43.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.274 -0.876 . . . . 0.34000000000000002 108.892 178.942 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 27.8 t0 -101.59 131.18 47.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.165 0.507 . . . . 1.0900000000000001 111.733 -178.772 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.491 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -128.0 157.53 73.6 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.348 -0.842 . . . . 0.19 109.571 179.645 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -69.76 158.03 58.35 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.395 2.063 . . . . 0.17999999999999999 112.245 179.927 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.32 -12.13 5.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.753 -0.658 . . . . 0.20999999999999999 110.732 -179.852 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.1 p -92.8 -8.77 42.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 0.28999999999999998 110.743 -179.959 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.39 34.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.314 -0.403 . . . . 0.5 110.429 179.686 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.5 p -133.1 16.68 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.401 -0.363 . . . . 0.29999999999999999 110.532 -179.988 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.7 p -167.55 147.13 5.08 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.614 -0.514 . . . . 0.23000000000000001 109.614 179.905 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.2 150.48 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.565 -0.454 . . . . 0.28000000000000003 111.619 -179.664 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.36 124.96 50.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.618 -0.719 . . . . 1.0700000000000001 109.783 179.536 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.48 104.93 30.28 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.907 0.384 . . . . 0.28999999999999998 111.03 -179.835 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.1 Cg_endo -91.05 -179.49 1.48 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 123.155 2.57 . . . . 0.42999999999999999 112.172 179.922 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.66 32.64 18.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.329 -0.851 . . . . 1.26 111.489 179.306 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.3 mt -86.34 148.46 25.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.49 -0.323 . . . . 0.32000000000000001 110.467 179.611 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.764 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.25 114.87 61.36 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.042 0.448 . . . . 0.57999999999999996 110.706 -179.799 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.07 140.58 95.84 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.754 2.303 . . . . 0.66000000000000003 112.025 179.864 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.2 21.16 74.08 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.027 -0.829 . . . . 0.28999999999999998 111.027 179.857 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.451 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.9 150.18 49.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 2.3300000000000001 110.606 -179.941 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.491 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.1 tttt -100.11 131.68 45.92 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.85999999999999999 109.82 179.282 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.953 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.54 148.35 43.97 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.118 -0.492 . . . . 0.52000000000000002 110.991 -179.824 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.31 125.31 60.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.228 -1.027 . . . . 0.29999999999999999 108.228 177.767 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.55 132.46 63.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.053 0.454 . . . . 0.23000000000000001 111.284 -178.646 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.46 122.66 20.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.566 -0.743 . . . . 0.35999999999999999 109.613 179.299 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.588 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.05 125.36 54.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.271 -0.422 . . . . 0.19 110.694 -179.496 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.6 m-85 -117.25 137.88 52.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.041 -0.527 . . . . 0.29999999999999999 109.828 179.583 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.421 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.69 135.01 42.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.798 -0.815 . . . . 0.37 108.798 178.861 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.683 HG21 ' HE2' ' A' ' 61' ' ' LYS . 14.0 mt -99.14 122.97 51.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.095 0.474 . . . . 0.26000000000000001 110.931 -178.734 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.3 p -83.79 169.7 14.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.497 -0.774 . . . . 0.28000000000000003 110.499 -179.675 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -59.71 -14.65 15.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.047 -0.524 . . . . 1.6000000000000001 111.018 -179.663 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -95.91 -4.39 43.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.828 0.347 . . . . 1.1799999999999999 110.902 -179.819 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.79 13.97 63.87 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.301 -0.719 . . . . 0.29999999999999999 111.301 179.919 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -84.63 139.11 32.29 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.059 -0.256 . . . . 1.22 110.465 179.585 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.715 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 85.9 mt-30 -106.75 141.08 38.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.893 0.378 . . . . 0.97999999999999998 110.543 179.723 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.0 m -136.7 126.99 26.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.062 -0.517 . . . . 0.82999999999999996 110.373 179.938 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.23 117.38 9.97 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.644 -0.422 . . . . 0.26000000000000001 110.537 -179.923 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.02 -21.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.29999999999999999 110.746 -179.754 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.89 125.72 5.86 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.519 -0.472 . . . . 0.31 111.496 -179.776 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.47 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.83 120.25 21.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.772 -0.649 . . . . 0.28000000000000003 109.574 179.143 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.72 29.13 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.568 -0.453 . . . . 0.23999999999999999 110.806 -179.224 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.8 p -110.47 158.53 18.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.953 -0.567 . . . . 0.23000000000000001 110.447 179.681 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -145.98 157.97 43.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.102 -0.499 . . . . 0.67000000000000004 110.644 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.34 104.35 9.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.733 -0.667 . . . . 0.64000000000000001 109.986 179.558 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.862 -1.066 . . . . 1.26 110.599 -179.656 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.224 -0.658 . . . . 3.4399999999999999 109.224 . . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.7 18.54 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.023 -0.831 . . . . 1.22 111.023 179.73 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -35.61 142.41 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.048 0 C-N-CA 123.914 3.076 . . . . 0.75 113.826 -179.203 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.606 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.95 173.44 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.204 -1.362 . . . . 0.79000000000000004 108.817 178.425 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.606 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.69 125.89 51.52 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.433 -0.507 . . . . 1.9399999999999999 111.368 -179.536 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.49 143.96 34.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.682 -0.69 . . . . 0.59999999999999998 110.702 179.865 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.03 168.38 25.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.923 0.392 . . . . 3.1400000000000001 111.044 -179.684 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.746 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -109.03 131.11 60.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.963 -0.562 . . . . 3.23 110.067 179.888 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 69.0 p -141.24 162.41 35.55 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.871 0.367 . . . . 3.6299999999999999 111.121 -179.872 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.3 mt-10 36.03 31.49 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.631 -0.507 . . . . 6.0800000000000001 109.631 179.862 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.746 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.3 69.56 31.1 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.971 -0.559 . . . . 3.3799999999999999 111.663 -178.809 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.37 -29.02 71.92 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.467 2.112 . . . . 3.9300000000000002 111.822 179.46 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 3.3599999999999999 110.477 179.98 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.612 ' O ' ' O ' ' A' ' 92' ' ' THR . 3.2 mp0 -123.89 158.41 60.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 3.6099999999999999 110.447 179.941 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.523 ' CG ' ' NH1' ' A' ' 143' ' ' ARG . 98.6 Cg_endo -82.17 -64.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.866 2.378 . . . . 1.51 113.46 -178.981 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.692 ' CG ' ' CE1' ' A' ' 157' ' ' TYR . 50.0 t30 -108.44 -19.52 13.43 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.11 0.411 . . . . 2.6800000000000002 112.11 -178.536 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.536 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 99.0 p -107.34 152.1 24.6 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.452 -0.499 . . . . 1.21 111.281 -179.418 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.0 t-80 -155.36 102.83 2.21 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.696 -0.684 . . . . 1.5600000000000001 110.676 179.885 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.574 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.3 Cg_endo -82.56 145.6 13.19 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.814 2.343 . . . . 0.81000000000000005 112.675 179.904 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.903 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.81 167.89 24.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.894 -0.594 . . . . 1.52 109.862 179.561 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.1 148.0 29.16 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.737 -0.468 . . . . 2.1400000000000001 109.737 178.866 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.582 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.8 p90 -142.24 157.25 45.05 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.659 -0.416 . . . . 0.32000000000000001 111.16 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.496 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.02 155.3 44.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.823 -0.626 . . . . 2.1699999999999999 110.122 178.905 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.835 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.63 173.07 6.32 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.135 -0.484 . . . . 0.58999999999999997 110.777 -179.184 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.835 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.75 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.907 2.405 . . . . 0.90000000000000002 111.502 179.429 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.485 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -51.05 0.69 Allowed Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.679 -0.408 . . . . 3.3399999999999999 110.171 179.797 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.639 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.85 152.35 82.47 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.7 2.267 . . . . 1.8500000000000001 111.481 179.169 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.74 42.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.357 0.599 . . . . 2.54 110.525 -179.808 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.639 ' N ' ' O ' ' A' ' 27' ' ' PRO . 74.0 t60 -63.67 -41.61 98.15 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.052 -0.976 . . . . 2.5299999999999998 110.639 179.735 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.557 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.3 mt -109.85 137.84 40.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.784 -0.644 . . . . 1.1699999999999999 111.224 -179.449 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.93 -72.9 0.7 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.027 -0.533 . . . . 1.27 111.953 -179.069 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.17 148.37 24.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.588 0.588 . . . . 1.1200000000000001 112.588 -179.649 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.85 124.91 45.25 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.346 -0.613 . . . . 0.41999999999999998 109.346 177.498 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.04 134.65 60.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.646 -0.422 . . . . 0.78000000000000003 110.662 -179.997 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.903 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.98 128.67 53.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.994 0.426 . . . . 0.62 111.261 179.742 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.21 138.94 49.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.787 -0.642 . . . . 1.97 110.096 179.018 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.441 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.04 163.1 35.27 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.166 0.508 . . . . 0.34999999999999998 112.083 -178.083 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.495 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.46 139.67 7.92 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.406 -0.815 . . . . 1.8 110.451 178.766 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.696 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.2 Cg_endo -63.57 115.51 3.09 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.279 1.986 . . . . 0.57999999999999996 111.801 -179.972 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.667 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.99 81.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.87 -0.419 . . . . 3.04 109.87 -179.865 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.696 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.19 -20.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.981 -0.554 . . . . 2.4700000000000002 111.895 -179.548 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 p -157.58 157.82 34.42 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.784 -0.367 . . . . 2.5099999999999998 110.548 179.782 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.408 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.42 27.84 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 1.8600000000000001 110.138 179.575 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.78 -75.82 1.31 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.181 -0.533 . . . . 1.4399999999999999 111.895 -179.294 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.93 152.34 35.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.983 0.42 . . . . 4.6900000000000004 110.912 -179.327 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.67 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.31 -169.13 2.52 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.049 -0.523 . . . . 1.4299999999999999 111.939 179.318 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.441 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.1 149.62 29.78 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.464 0.649 . . . . 1.74 112.571 -177.811 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.01 156.47 46.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.851 -1.068 . . . . 1.9199999999999999 110.268 178.637 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.2 158.39 41.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.993 -0.549 . . . . 0.34000000000000002 111.766 -179.336 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.6 m -115.2 135.58 54.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.415 -0.811 . . . . 0.40999999999999998 109.834 179.296 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.582 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.39 121.94 23.78 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.479 -0.328 . . . . 0.55000000000000004 111.527 -179.11 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.593 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.9 Cg_exo -46.36 151.75 1.65 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.632 2.221 . . . . 0.44 112.168 179.017 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.99 -23.04 63.24 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 116.039 -0.528 . . . . 0.73999999999999999 112.755 -179.108 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.73 -16.96 46.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.35 0.575 . . . . 0.93000000000000005 111.778 -178.345 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.593 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.49 138.42 31.59 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.779 -0.368 . . . . 0.96999999999999997 110.299 179.342 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -121.55 13.91 10.97 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.333 -0.394 . . . . 1.3400000000000001 111.468 -179.382 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -149.99 143.5 25.24 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.589 -0.444 . . . . 0.39000000000000001 111.026 179.56 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.726 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.81 -169.33 1.53 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.199 0.523 . . . . 0.41999999999999998 110.845 -179.396 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.726 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.74 125.99 9.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.39 -0.823 . . . . 0.39000000000000001 109.832 179.236 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.518 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.8 mt -114.95 123.29 70.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.383 -0.527 . . . . 0.73999999999999999 111.17 -179.758 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -126.5 163.33 23.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.849 -0.614 . . . . 2.48 110.529 179.687 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.522 ' CA ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.2 19.07 59.61 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.685 -0.966 . . . . 0.5 110.685 -179.972 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.626 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 74.0 mt -79.14 157.27 27.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.138 0.494 . . . . 0.57999999999999996 111.286 -179.604 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.835 ' O ' HG12 ' A' ' 67' ' ' VAL . 13.2 mptt -99.57 134.03 21.43 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.551 -0.749 . . . . 2.79 110.393 179.85 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.98 143.55 60.76 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.554 2.169 . . . . 0.87 111.88 179.871 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.85 25.71 75.24 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.972 -0.851 . . . . 0.64000000000000001 110.972 179.685 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.835 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.3 p -128.23 158.77 40.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.597 0.237 . . . . 0.82999999999999996 110.434 -179.658 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.07 139.98 41.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.875 0.369 . . . . 0.5 110.623 -179.824 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.643 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.7 m-85 -122.67 136.47 54.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.897 -0.592 . . . . 0.53000000000000003 110.76 -179.918 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.495 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.5 pt-20 -98.91 131.01 45.32 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.524 -0.917 . . . . 1.8700000000000001 108.524 177.656 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.48 153.85 16.65 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.29 -0.957 . . . . 0.28999999999999998 111.935 -178.585 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -134.98 140.95 46.1 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.716 -0.476 . . . . 1.4299999999999999 109.716 179.537 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.73 118.98 34.56 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.406 -0.518 . . . . 0.32000000000000001 110.486 179.705 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.74 HG12 HG23 ' A' ' 84' ' ' VAL . 64.1 mt -112.51 129.03 68.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.909 0.385 . . . . 0.79000000000000004 110.583 -179.878 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.705 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.85 120.82 43.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.299 -0.409 . . . . 1.02 110.701 -179.646 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.855 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.57 146.53 11.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.118 0.485 . . . . 0.62 110.977 -179.227 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.626 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -106.09 153.85 21.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.483 -0.78 . . . . 2.4399999999999999 109.974 179.8 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.22 88.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.965 0.412 . . . . 3.6899999999999999 110.444 -179.689 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.31 32.62 0.21 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.806 -0.634 . . . . 6.0800000000000001 110.561 -179.936 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.3 3.29 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.496 -0.642 . . . . 1.22 111.496 -179.804 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.48 177.38 8.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.146 0.498 . . . . 2.8799999999999999 111.623 -179.203 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.14 149.54 32.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.411 -0.813 . . . . 1.47 110.459 179.145 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.16 144.62 38.67 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.477 -0.329 . . . . 2.7000000000000002 110.54 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.74 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -127.98 135.98 61.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 121.092 0.472 . . . . 0.46000000000000002 111.573 -179.81 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.08 141.35 52.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.664 -0.698 . . . . 0.34999999999999998 110.279 179.62 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.447 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.65 138.93 51.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.105 0.479 . . . . 3.6699999999999999 111.5 -179.368 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.38 164.04 38.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.526 -0.761 . . . . 0.67000000000000004 109.516 179.417 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.572 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.18 151.56 38.62 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.415 -0.514 . . . . 1.47 111.092 -179.995 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.8 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.24 172.71 13.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.759 -0.655 . . . . 0.44 111.039 179.875 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.73 160.69 21.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.455 -0.793 . . . . 1.3700000000000001 109.777 179.658 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.37 121.9 22.99 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.636 -0.426 . . . . 1.28 110.764 179.91 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.612 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -127.61 167.98 15.63 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.675 0.621 . . . . 1.97 112.675 179.679 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.7 m -111.64 153.38 26.45 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.195 -0.911 . . . . 3.2799999999999998 109.997 179.225 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 58.0 p -62.53 -11.77 18.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.999 -178.908 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 47.5 m -115.3 147.96 39.79 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.868 0.366 . . . . 0.0 110.204 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 28.5 p -96.88 119.36 63.73 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.883 -179.546 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.42 147.68 36.62 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.032 1.821 . . . . 0.0 111.829 179.226 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.8 m -127.82 158.22 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.479 -179.824 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 48.8 m -119.76 141.19 49.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.509 -179.695 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 93.8 p -121.63 156.68 32.47 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.465 -179.776 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -132.78 -179.88 5.74 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.476 -179.832 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.9 p -122.07 162.97 20.26 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.826 -179.574 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 75.2 t -60.44 -38.39 77.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.399 179.984 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 45.6 m -73.02 138.23 45.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.374 -179.736 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -82.77 -176.22 51.34 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.524 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -98.14 139.28 34.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.852 0.358 . . . . 0.0 110.554 -179.598 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.6 m -138.11 -122.51 0.13 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.936 179.78 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.478 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 81.8 p -63.65 151.1 89.2 Favored Pre-proline 0 C--N 1.331 -0.208 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.75 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.84 142.94 50.31 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.742 1.628 . . . . 0.0 112.067 -179.783 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.478 ' CE2' ' O ' ' A' ' 108' ' ' THR . 99.1 m-85 -120.41 155.9 32.51 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.561 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.8 m -123.57 71.19 47.91 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.972 179.37 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.9 -21.94 60.24 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.568 2.178 . . . . 0.0 112.586 -179.736 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.3 mt -90.68 140.58 29.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.019 0.438 . . . . 10.19 110.423 -179.465 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.17 160.46 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.653 -0.703 . . . . 7.2800000000000002 110.538 -179.68 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.5 147.07 38.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.421 -0.354 . . . . 7.2999999999999998 110.076 -179.978 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 57.2 m -116.65 143.08 46.07 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.133 0.492 . . . . 6.4400000000000004 111.086 -179.051 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.9 t -110.7 148.59 31.97 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.481 -0.781 . . . . 4.4199999999999999 109.893 -179.916 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -53.08 -34.34 56.14 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.806 -0.358 . . . . 3.0499999999999998 110.409 -179.02 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 54.5 p -71.51 160.84 32.0 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.407 -0.59 . . . . 3.4300000000000002 109.407 178.776 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.64 132.52 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.99 0.424 . . . . 2.8799999999999999 111.191 -179.772 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.1 3.42 1.78 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.611 -0.722 . . . . 2.0899999999999999 109.742 179.013 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -110.79 159.24 17.83 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.77 -0.65 . . . . 4.5300000000000002 110.862 -179.45 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 18.3 mm 38.89 58.1 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.966 -0.561 . . . . 1.4399999999999999 110.556 179.796 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 47.0 m -55.28 -38.25 68.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.971 -0.559 . . . . 1.78 110.714 -179.545 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.542 ' O ' ' CB ' ' A' ' 126' ' ' SER . . . -140.97 150.33 42.95 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.542 -0.299 . . . . 0.64000000000000001 110.548 179.677 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.542 ' CB ' ' O ' ' A' ' 125' ' ' ALA . 31.6 p 144.72 -30.94 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.308 -0.86 . . . . 0.66000000000000003 109.0 179.912 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.442 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.92 167.62 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.025 -0.989 . . . . 0.68999999999999995 110.907 179.873 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.8 m-30 -133.68 145.47 49.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.672 -0.694 . . . . 0.52000000000000002 110.102 -179.894 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.19 101.76 9.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.108 -0.701 . . . . 0.32000000000000001 109.108 177.702 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.3 t -113.04 139.71 36.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.045 -0.525 . . . . 0.28999999999999998 110.966 -178.76 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.0 p -128.64 152.54 48.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.544 -0.753 . . . . 0.25 109.869 179.622 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.588 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.88 -165.01 2.05 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.769 -0.372 . . . . 0.31 110.64 -179.788 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.3 t -123.91 127.13 73.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.281 -0.418 . . . . 0.48999999999999999 110.922 -179.839 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.171 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.96 58.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.115 -0.493 . . . . 1.53 110.333 179.921 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.26 24.62 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.949 -0.569 . . . . 0.96999999999999997 111.456 -179.592 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.171 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.14 128.62 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.624 -0.43 . . . . 1.5600000000000001 110.998 179.897 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.39 -9.65 55.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.96 -0.564 . . . . 1.8799999999999999 110.267 179.804 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.7 p -87.11 0.28 55.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 1.04 110.341 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 136' ' ' SER . 2.6 p -65.23 137.19 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.949 -0.569 . . . . 0.23999999999999999 109.981 179.63 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 185' ' ' ILE . 7.8 m -96.29 -15.45 21.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.132 0.492 . . . . 0.28999999999999998 110.006 -179.738 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.62 175.59 45.82 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 109.838 -1.305 . . . . 0.13 109.838 179.61 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.45 151.59 42.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.002 0.429 . . . . 0.17000000000000001 110.437 179.775 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.523 ' NH1' ' CG ' ' A' ' 15' ' ' PRO . 23.9 ttp85 -132.33 121.09 22.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.168 -0.469 . . . . 1.29 109.988 179.751 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -104.99 136.53 38.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.742 -0.663 . . . . 0.25 110.703 -179.749 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 82.6 tt0 -129.35 129.96 45.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.05 -0.523 . . . . 1.3200000000000001 110.042 -179.932 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.77 135.25 34.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.053 -0.521 . . . . 0.56999999999999995 110.615 -179.67 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.412 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.27 161.35 39.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.809 -0.632 . . . . 1.1599999999999999 109.629 179.847 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.959 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.01 124.82 25.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.994 0.426 . . . . 0.38 110.804 -179.721 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.77 -7.64 49.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.719 -0.673 . . . . 0.40999999999999998 110.891 -179.754 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -109.87 -69.76 0.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.932 0.396 . . . . 1.6599999999999999 111.306 -179.189 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.437 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.6 -35.4 76.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.06 -0.518 . . . . 1.6599999999999999 111.486 -179.094 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.077 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.2 88.62 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.787 -0.925 . . . . 1.1699999999999999 110.787 -179.811 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.339 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.3 t0 -27.93 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.814 0.34 . . . . 1.8600000000000001 110.218 179.873 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.339 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.2 pm0 -82.24 139.07 45.22 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 1.98 110.214 179.626 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.412 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.1 Cg_endo -70.85 145.85 51.91 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.652 2.235 . . . . 0.55000000000000004 112.368 -179.56 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.87 145.7 42.64 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.231 -0.655 . . . . 1.1399999999999999 109.231 179.18 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.692 ' CE1' ' CG ' ' A' ' 16' ' ' ASN . 1.7 p90 -123.21 141.24 52.18 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.401 -0.52 . . . . 0.93000000000000005 111.577 -179.099 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.0 mt -128.05 127.78 43.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.311 -0.858 . . . . 0.34000000000000002 108.945 178.903 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.492 ' HB2' HD21 ' A' ' 16' ' ' ASN . 18.0 t0 -101.67 131.13 48.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.155 0.502 . . . . 1.0900000000000001 111.742 -178.728 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.94 157.56 73.41 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.294 -0.866 . . . . 0.19 109.53 179.682 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -69.69 157.94 58.79 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 C-N-CA 122.491 2.127 . . . . 0.17999999999999999 112.252 179.908 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.417 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.4 p -59.22 -12.14 4.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.786 -0.643 . . . . 0.20999999999999999 110.775 -179.91 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.2 p -92.86 -8.74 42.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.28999999999999998 110.704 -179.859 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.27 135.35 34.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.5 110.345 179.76 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.15 16.72 4.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.418 -0.355 . . . . 0.29999999999999999 110.515 179.967 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.1 p -167.53 147.06 5.07 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.617 -0.512 . . . . 0.23000000000000001 109.617 179.927 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.22 150.5 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.485 -0.486 . . . . 0.28000000000000003 111.55 -179.707 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.506 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.27 124.95 50.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.525 -0.762 . . . . 1.0700000000000001 109.818 179.49 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.37 104.94 29.92 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.476 -0.329 . . . . 0.28999999999999998 111.092 -179.921 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 84.8 Cg_endo -91.07 -179.47 1.47 Allowed 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 123.19 2.594 . . . . 0.42999999999999999 112.169 179.93 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.62 32.68 18.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.369 -0.832 . . . . 1.26 111.477 179.247 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 172' ' ' LEU . 23.8 mt -86.34 148.39 25.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.432 -0.349 . . . . 0.32000000000000001 110.47 179.6 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.772 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.16 114.78 60.88 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.964 0.411 . . . . 0.57999999999999996 110.734 -179.778 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.92 140.44 95.25 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.925 2.417 . . . . 0.66000000000000003 112.005 179.844 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.16 21.25 73.97 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.005 -0.838 . . . . 0.28999999999999998 111.005 179.832 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.437 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.94 150.21 49.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.879 0.371 . . . . 2.3300000000000001 110.623 179.931 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.491 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.23 131.61 46.08 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.013 -0.54 . . . . 0.85999999999999999 109.786 179.365 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.959 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.4 148.32 43.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.076 -0.511 . . . . 0.52000000000000002 111.066 -179.842 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.35 125.29 60.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.228 -1.027 . . . . 0.29999999999999999 108.228 177.796 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.52 132.57 63.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.136 0.493 . . . . 0.23000000000000001 111.204 -178.61 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.52 122.46 20.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.468 -0.787 . . . . 0.35999999999999999 109.636 179.324 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.588 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.03 125.33 54.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.274 -0.421 . . . . 0.19 110.694 -179.521 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.6 m-85 -117.18 137.89 52.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.97 -0.559 . . . . 0.29999999999999999 109.87 179.562 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.424 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.75 135.05 42.8 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.756 -0.831 . . . . 0.37 108.756 178.863 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.588 ' O ' ' N ' ' A' ' 140' ' ' SER . 76.7 mt -99.04 122.96 51.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.062 0.458 . . . . 0.26000000000000001 110.89 -178.715 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.3 p -83.98 169.7 14.73 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.574 -0.739 . . . . 0.28000000000000003 110.455 -179.7 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 187' ' ' GLU . 51.8 tp10 -59.7 -14.56 14.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.067 -0.515 . . . . 1.6000000000000001 110.967 -179.535 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.574 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.9 m-20 -96.06 -4.26 43.29 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.845 -0.342 . . . . 1.1799999999999999 110.792 -179.815 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.473 ' HA2' ' OG1' ' A' ' 59' ' ' THR . . . 87.78 13.89 64.02 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.383 -0.687 . . . . 0.29999999999999999 111.383 179.903 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -84.73 139.15 32.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.644 0.259 . . . . 1.22 110.394 179.766 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -106.83 141.14 38.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.97999999999999998 110.496 179.781 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.5 m -136.75 127.06 26.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.506 . . . . 0.82999999999999996 110.411 179.903 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.22 117.27 9.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.297 -0.41 . . . . 0.26000000000000001 110.499 -179.822 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -108.96 -21.89 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.29999999999999999 110.676 -179.709 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.89 125.68 5.84 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.456 -0.497 . . . . 0.31 111.516 -179.77 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.471 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.68 120.25 21.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.721 -0.672 . . . . 0.28000000000000003 109.516 179.231 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.56 151.73 29.21 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.7 -0.4 . . . . 0.23999999999999999 110.933 -179.321 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.47 158.61 18.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 0.23000000000000001 110.393 179.677 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -146.06 157.92 43.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.103 -0.499 . . . . 0.67000000000000004 110.702 179.919 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.17 104.39 9.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.82 -0.627 . . . . 0.64000000000000001 110.009 179.524 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.5 p . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 117.95 -1.024 . . . . 1.26 110.585 -179.744 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.548 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.9 m . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.223 -0.658 . . . . 3.4399999999999999 109.223 . . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.45 150.68 18.53 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.023 -0.831 . . . . 1.22 111.023 179.755 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.69 142.34 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.056 0 C-N-CA 124.067 3.178 . . . . 0.75 113.761 -179.199 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.605 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.89 173.47 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.194 -1.366 . . . . 0.79000000000000004 108.893 178.389 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.605 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.61 125.89 51.51 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.406 -0.518 . . . . 1.9399999999999999 111.349 -179.548 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 144.07 33.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.636 -0.711 . . . . 0.59999999999999998 110.662 179.75 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.02 168.32 25.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.404 -0.362 . . . . 3.1400000000000001 111.104 -179.649 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.749 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.98 131.08 60.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.925 -0.58 . . . . 3.23 110.06 179.869 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.26 162.26 35.92 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.882 0.372 . . . . 3.6299999999999999 111.209 -179.916 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 34.3 tp10 36.2 31.54 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.648 -0.501 . . . . 6.0800000000000001 109.648 179.85 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.749 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.5 69.57 33.2 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.982 -0.554 . . . . 3.3799999999999999 111.468 -178.644 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.28 -29.09 72.71 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.432 2.088 . . . . 3.9300000000000002 111.845 179.346 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 3.3599999999999999 110.472 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.535 ' CB ' ' O ' ' A' ' 17' ' ' SER . 7.7 mp0 -123.93 158.39 60.27 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.311 -0.404 . . . . 3.6099999999999999 110.441 179.99 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HB3' ' CB ' ' A' ' 93' ' ' SER . 98.1 Cg_endo -82.19 -64.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.941 2.427 . . . . 1.51 113.444 -178.991 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.664 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 41.2 t30 -108.48 -19.52 13.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.322 -0.399 . . . . 2.6800000000000002 112.07 -178.513 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.535 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 12.6 t -107.4 152.01 24.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.19 0.519 . . . . 1.21 111.252 -179.339 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.25 102.92 2.23 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.712 -0.676 . . . . 1.5600000000000001 110.67 179.796 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.584 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.4 Cg_endo -82.59 145.65 13.16 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.878 2.385 . . . . 0.81000000000000005 112.666 179.871 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.9 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.88 167.99 24.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.892 -0.594 . . . . 1.52 109.859 179.591 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -149.18 147.91 28.99 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.783 -0.451 . . . . 2.1400000000000001 109.783 178.954 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.579 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.7 p90 -142.29 157.25 45.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.027 0.442 . . . . 0.32000000000000001 111.183 179.976 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.495 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -127.96 155.26 44.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.796 -0.638 . . . . 2.1699999999999999 110.133 178.969 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.833 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.56 173.02 6.37 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 121.074 0.464 . . . . 0.58999999999999997 110.758 -179.223 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.833 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.61 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.888 0 C-N-CA 122.88 2.387 . . . . 0.90000000000000002 111.517 179.304 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.486 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -51.08 0.69 Allowed Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 120.706 -0.398 . . . . 3.3399999999999999 110.089 179.813 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.64 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.86 152.39 82.38 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.7 2.267 . . . . 1.8500000000000001 111.474 179.243 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.73 42.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.42 0.629 . . . . 2.54 110.576 -179.869 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.64 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.9 t60 -63.57 -41.67 98.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.941 -1.027 . . . . 2.5299999999999998 110.653 179.689 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.553 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.6 mt -109.87 137.77 40.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.771 -0.649 . . . . 1.1699999999999999 111.327 -179.426 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.85 -72.95 0.7 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.106 -0.497 . . . . 1.27 111.925 -179.007 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.21 148.43 24.38 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.549 0.574 . . . . 1.1200000000000001 112.549 -179.55 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.8 124.85 45.16 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.3 -0.63 . . . . 0.41999999999999998 109.3 177.563 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.3 mt -117.95 134.7 60.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.721 -0.391 . . . . 0.78000000000000003 110.654 179.905 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.9 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.99 128.7 53.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.065 0.46 . . . . 0.62 111.269 179.634 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.26 138.96 49.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.707 -0.679 . . . . 1.97 110.125 178.966 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.441 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.01 163.11 35.21 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.118 0.485 . . . . 0.34999999999999998 112.146 -178.065 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.46 139.59 7.88 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.515 -0.766 . . . . 1.8 110.504 178.815 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.58 115.53 3.1 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.31 2.007 . . . . 0.57999999999999996 111.733 -179.946 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.01 81.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.888 -0.412 . . . . 3.04 109.888 -179.926 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.17 -20.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.93 -0.577 . . . . 2.4700000000000002 111.97 -179.558 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.8 p -157.65 157.81 34.29 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.813 0.34 . . . . 2.5099999999999998 110.579 179.745 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.43 27.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 1.8600000000000001 110.233 179.58 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.84 -75.87 1.31 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.126 -0.559 . . . . 1.4399999999999999 111.864 -179.261 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.89 152.34 35.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.988 0.423 . . . . 4.6900000000000004 110.953 -179.353 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.672 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.24 -169.17 2.54 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.029 -0.532 . . . . 1.4299999999999999 111.919 179.37 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.441 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.1 149.65 29.73 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.395 0.617 . . . . 1.74 112.63 -177.88 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.06 156.5 45.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.842 -1.072 . . . . 1.9199999999999999 110.226 178.659 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.22 158.34 41.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.906 -0.588 . . . . 0.34000000000000002 111.785 -179.261 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 m -115.17 135.58 54.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.515 -0.766 . . . . 0.40999999999999998 109.716 179.382 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.579 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.36 121.9 23.8 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 0.55000000000000004 111.574 -179.229 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.597 ' HD2' HD12 ' A' ' 55' ' ' LEU . 73.8 Cg_exo -46.3 151.71 1.62 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.684 2.256 . . . . 0.44 112.046 179.042 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.91 -23.01 63.03 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 116.046 -0.524 . . . . 0.73999999999999999 112.796 -179.233 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.84 -16.81 46.25 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.251 -0.579 . . . . 0.93000000000000005 111.823 -178.329 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.597 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.67 138.46 31.55 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.684 -0.406 . . . . 0.96999999999999997 110.289 179.37 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -121.58 14.04 10.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.369 -0.378 . . . . 1.3400000000000001 111.588 -179.394 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.48 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -150.07 143.5 25.16 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.601 -0.44 . . . . 0.39000000000000001 111.003 179.579 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.725 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.85 -169.4 1.54 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.188 0.518 . . . . 0.41999999999999998 110.869 -179.405 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.725 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.9 m -151.74 125.92 9.27 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.43 -0.805 . . . . 0.39000000000000001 109.807 179.277 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.86 123.28 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.369 -0.533 . . . . 0.73999999999999999 111.243 -179.798 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -126.53 163.34 23.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.885 -0.598 . . . . 2.48 110.442 179.76 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.442 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.08 19.08 59.77 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.733 -0.947 . . . . 0.5 110.733 -179.89 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.664 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.7 mt -79.01 157.21 28.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.032 0.444 . . . . 0.57999999999999996 111.36 -179.64 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.841 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.9 mmtt -99.5 133.93 21.54 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.691 -0.686 . . . . 2.79 110.522 179.716 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.581 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.86 143.57 61.5 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.491 2.128 . . . . 0.87 112.007 179.854 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.89 25.66 75.3 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.997 -0.841 . . . . 0.64000000000000001 110.997 179.694 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.841 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.22 158.72 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.649 0.262 . . . . 0.82999999999999996 110.398 -179.55 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.11 139.88 42.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.846 0.355 . . . . 0.5 110.644 -179.79 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.642 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.6 m-85 -122.51 136.48 54.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.973 -0.558 . . . . 0.53000000000000003 110.8 -179.883 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.5 pt-20 -98.96 131.06 45.31 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.462 -0.94 . . . . 1.8700000000000001 108.462 177.699 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.47 153.92 16.64 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.341 -0.933 . . . . 0.28999999999999998 111.944 -178.616 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -134.98 140.95 46.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.706 -0.479 . . . . 1.4299999999999999 109.706 179.559 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.85 118.93 34.35 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.427 -0.509 . . . . 0.32000000000000001 110.531 179.616 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.744 HG12 HG23 ' A' ' 84' ' ' VAL . 63.8 mt -112.46 129.08 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.79000000000000004 110.676 -179.942 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.706 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.77 120.8 43.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.215 -0.448 . . . . 1.02 110.732 -179.639 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.857 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.56 146.43 11.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.163 0.506 . . . . 0.62 111.06 -179.261 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.626 ' O ' ' N ' ' A' ' 79' ' ' TYR . 20.9 mt-30 -105.98 153.88 21.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.528 -0.76 . . . . 2.4399999999999999 109.907 179.845 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 77' ' ' GLN . 82.9 mt-30 -39.16 88.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.899 0.38 . . . . 3.6899999999999999 110.476 -179.814 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.35 32.54 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.834 -0.621 . . . . 6.0800000000000001 110.628 -179.915 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.08 -117.35 3.29 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.471 -0.652 . . . . 1.22 111.471 -179.652 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.0 m170 -81.38 177.45 8.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.175 0.512 . . . . 2.8799999999999999 111.609 -179.21 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.2 149.54 32.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.416 -0.811 . . . . 1.47 110.376 179.149 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.548 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.19 144.67 38.64 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.4 -0.364 . . . . 2.7000000000000002 110.574 179.823 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.744 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.0 135.99 61.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 121.037 0.446 . . . . 0.46000000000000002 111.581 -179.79 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.06 141.27 52.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.689 -0.687 . . . . 0.34999999999999998 110.302 179.649 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.453 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.55 138.91 51.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.07 0.462 . . . . 3.6699999999999999 111.535 -179.387 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.31 164.23 37.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.579 -0.737 . . . . 0.67000000000000004 109.494 179.349 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.2 p30 -145.29 151.45 38.36 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.394 -0.523 . . . . 1.47 111.083 -179.952 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.8 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.4 p90 -146.16 172.78 12.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.835 -0.62 . . . . 0.44 111.053 179.84 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.83 160.6 21.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.468 -0.787 . . . . 1.3700000000000001 109.874 179.627 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.33 121.8 22.9 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.685 -0.406 . . . . 1.28 110.745 -179.962 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.7 p -128.68 169.02 14.98 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 115.78 1.77 . . . . 1.97 115.78 179.579 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.52 ' CB ' ' HB3' ' A' ' 15' ' ' PRO . 18.2 t 174.18 -62.29 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 111.87 -2.423 . . . . 3.2799999999999998 108.603 177.507 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.8 t -140.78 165.69 26.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.563 178.896 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.4 m -114.19 145.71 41.33 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.306 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 46.8 p -147.39 122.33 5.19 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.788 -178.906 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.07 142.48 54.14 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.626 1.551 . . . . 0.0 111.522 178.772 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.901 HG13 HG23 ' A' ' 99' ' ' THR . 8.3 p -59.32 -30.5 44.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.435 -179.626 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.901 HG23 HG13 ' A' ' 98' ' ' VAL . 25.4 p -120.18 160.82 22.16 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.164 0.507 . . . . 0.0 110.976 179.704 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 87.0 p -140.35 158.61 43.75 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.863 179.157 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -142.58 176.44 9.02 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.912 0.387 . . . . 0.0 110.9 179.889 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 103' ' ' VAL . 24.6 p -95.43 162.82 13.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.971 179.583 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 102' ' ' THR . 53.8 t 42.8 94.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 120.831 0.348 . . . . 0.0 110.506 -179.677 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 26.4 p -81.25 161.83 23.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.087 0.47 . . . . 0.0 111.183 -179.317 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -146.74 -99.71 0.25 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.966 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -95.14 140.27 30.31 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.413 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.8 p -81.41 159.35 24.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.861 0.362 . . . . 0.0 110.711 -179.378 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 37.3 p -108.9 113.75 59.13 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.519 -179.945 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.61 -19.15 58.83 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.709 1.606 . . . . 0.0 111.588 -179.813 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -108.81 141.94 40.1 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.165 179.955 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.2 t -124.56 80.13 61.42 Favored Pre-proline 0 N--CA 1.465 0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.024 -179.368 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -54.03 147.75 42.06 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 122.436 2.091 . . . . 0.0 111.66 179.691 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.5 mt -90.42 139.89 30.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.895 0.379 . . . . 10.19 110.758 -179.488 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 115' ' ' ALA . 43.1 t -121.24 135.88 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.731 -0.668 . . . . 7.2800000000000002 110.048 179.599 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 114' ' ' VAL . . . -33.0 -83.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.406 -0.361 . . . . 7.2999999999999998 111.301 -179.857 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.2 p -124.17 160.76 27.14 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.291 -0.413 . . . . 6.4400000000000004 110.321 179.516 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.0 t -124.42 142.93 50.92 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.279 -0.419 . . . . 4.4199999999999999 110.755 179.718 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -115.66 153.31 31.55 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.085 -0.507 . . . . 3.0499999999999998 109.99 179.547 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.8 p -122.65 152.69 40.25 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.912 0.387 . . . . 3.4300000000000002 110.665 179.91 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 43.7 t -123.35 136.4 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.801 -0.636 . . . . 2.8799999999999999 110.454 179.713 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.9 p -122.65 158.26 30.41 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.53 -0.304 . . . . 2.0899999999999999 110.333 179.442 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -121.5 151.87 39.79 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.198 -0.456 . . . . 4.5300000000000002 110.612 179.89 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 90.5 mt -58.78 -38.92 75.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.825 -0.435 . . . . 1.4399999999999999 109.825 179.126 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 56.5 m -123.65 139.67 53.76 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.609 -0.723 . . . . 1.78 109.754 179.352 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 127' ' ' SER . . . -178.35 65.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.506 -0.478 . . . . 0.64000000000000001 111.276 179.99 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.1 OUTLIER 36.76 27.61 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.162 0.982 . . . . 0.66000000000000003 110.832 178.998 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.85 167.65 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.68 -1.146 . . . . 0.68999999999999995 110.937 -179.264 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.7 145.57 50.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.688 -0.687 . . . . 0.52000000000000002 110.166 -179.962 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.23 101.66 9.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.088 -0.708 . . . . 0.32000000000000001 109.088 177.751 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.2 t -113.02 139.65 37.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.99 -0.55 . . . . 0.28999999999999998 111.066 -178.884 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.2 p -128.63 152.57 48.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.643 -0.708 . . . . 0.25 109.84 179.644 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.589 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.83 -165.07 2.06 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.687 -0.405 . . . . 0.31 110.642 -179.765 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -123.81 127.17 73.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.48999999999999999 110.918 -179.905 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.168 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.96 58.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.198 -0.455 . . . . 1.53 110.346 179.814 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.12 24.46 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.902 -0.59 . . . . 0.96999999999999997 111.515 -179.732 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.168 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.18 128.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.619 -0.432 . . . . 1.5600000000000001 111.011 179.8 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.33 -9.66 55.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.915 -0.584 . . . . 1.8799999999999999 110.353 179.814 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.7 p -87.09 0.3 55.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.095 -0.502 . . . . 1.04 110.337 179.991 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.36 137.24 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.892 -0.594 . . . . 0.23999999999999999 109.936 179.734 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 185' ' ' ILE . 5.4 m -96.26 -15.45 21.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.286 0.565 . . . . 0.28999999999999998 110.12 -179.716 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.58 175.55 45.75 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 109.806 -1.318 . . . . 0.13 109.806 179.593 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.46 151.63 42.52 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.602 -0.439 . . . . 0.17000000000000001 110.558 179.718 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.525 ' NE ' ' OE1' ' A' ' 191' ' ' GLN . 41.9 ttp85 -132.32 121.08 22.99 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.178 -0.464 . . . . 1.29 109.957 179.939 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.1 136.55 38.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.716 -0.674 . . . . 0.25 110.629 -179.708 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 82.7 tt0 -129.4 129.9 45.3 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.939 -0.573 . . . . 1.3200000000000001 110.05 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.4 p90 -138.66 135.27 34.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.957 -0.565 . . . . 0.56999999999999995 110.644 -179.693 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.411 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.35 161.37 39.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.809 -0.632 . . . . 1.1599999999999999 109.747 179.729 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.958 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.02 124.84 25.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.064 0.459 . . . . 0.38 110.716 -179.52 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.65 -7.8 50.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.702 -0.681 . . . . 0.40999999999999998 110.919 -179.818 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.86 -69.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 1.6599999999999999 111.431 -179.257 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.444 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.66 -35.42 76.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.112 -0.495 . . . . 1.6599999999999999 111.491 -179.147 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.081 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.22 88.61 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.799 -0.92 . . . . 1.1699999999999999 110.799 -179.817 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.338 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -28.03 -171.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.762 0.315 . . . . 1.8600000000000001 110.319 179.913 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.338 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.03 45.19 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-O 120.917 0.389 . . . . 1.98 110.213 179.657 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.411 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.7 Cg_endo -70.86 145.83 51.8 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.716 2.277 . . . . 0.55000000000000004 112.394 -179.578 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.9 145.74 42.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.189 -0.671 . . . . 1.1399999999999999 109.189 179.255 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.581 ' CE1' ' HD3' ' A' ' 65' ' ' PRO . 35.3 p90 -123.26 141.39 52.03 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.33 -0.548 . . . . 0.93000000000000005 111.46 -179.062 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.5 mt -128.17 127.68 43.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.271 -0.877 . . . . 0.34000000000000002 108.918 178.919 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.609 ' HB2' ' ND2' ' A' ' 16' ' ' ASN . 38.1 t0 -101.6 131.21 47.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.24 0.543 . . . . 1.0900000000000001 111.702 -178.743 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -128.04 157.43 74.0 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.349 -0.841 . . . . 0.19 109.575 179.677 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.71 157.89 58.93 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 122.406 2.071 . . . . 0.17999999999999999 112.334 179.902 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.18 -12.22 4.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.813 -0.63 . . . . 0.20999999999999999 110.781 -179.799 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.9 p -92.74 -8.79 42.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.042 -0.526 . . . . 0.28999999999999998 110.764 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.21 135.4 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.355 -0.384 . . . . 0.5 110.436 179.691 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.6 p -133.13 16.69 4.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.328 -0.396 . . . . 0.29999999999999999 110.461 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.61 147.12 5.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.697 -0.483 . . . . 0.23000000000000001 109.697 179.838 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.15 150.42 12.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.501 -0.48 . . . . 0.28000000000000003 111.597 -179.533 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.506 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.38 124.92 50.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.62 -0.718 . . . . 1.0700000000000001 109.858 179.469 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.35 104.82 29.17 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.333 -0.394 . . . . 0.28999999999999998 111.077 -179.791 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.4 Cg_endo -90.87 -179.47 1.53 Allowed 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 123.21 2.607 . . . . 0.42999999999999999 112.25 179.882 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.61 32.73 18.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.416 -0.811 . . . . 1.26 111.376 179.224 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.408 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.2 mt -86.36 148.49 25.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.544 -0.298 . . . . 0.32000000000000001 110.45 179.541 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.767 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.33 114.89 61.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.066 0.46 . . . . 0.57999999999999996 110.656 -179.763 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.1 140.64 96.04 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.915 2.41 . . . . 0.66000000000000003 111.982 179.885 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.0 21.28 74.35 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.091 -0.804 . . . . 0.28999999999999998 111.091 179.974 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.444 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.99 150.2 49.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.862 0.363 . . . . 2.3300000000000001 110.587 -179.979 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.493 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.11 131.65 45.93 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.999 -0.546 . . . . 0.85999999999999999 109.794 179.37 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.958 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.56 148.33 44.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.134 -0.484 . . . . 0.52000000000000002 111.011 -179.874 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.38 125.31 60.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.198 -1.038 . . . . 0.29999999999999999 108.198 177.796 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.54 132.56 63.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.119 0.485 . . . . 0.23000000000000001 111.318 -178.694 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.9 m-20 -136.47 122.5 20.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.54 -0.755 . . . . 0.35999999999999999 109.719 179.327 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.589 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.02 125.45 54.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.314 -0.403 . . . . 0.19 110.715 -179.527 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.0 m-85 -117.2 137.87 52.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.04 -0.527 . . . . 0.29999999999999999 109.886 179.574 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.423 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.74 135.13 42.66 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.805 -0.813 . . . . 0.37 108.805 178.82 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.588 ' O ' ' N ' ' A' ' 140' ' ' SER . 88.9 mt -99.16 123.02 51.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.178 0.513 . . . . 0.26000000000000001 110.904 -178.713 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 89.2 p -83.95 169.83 14.63 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.497 -0.774 . . . . 0.28000000000000003 110.432 -179.614 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.448 ' O ' ' OG1' ' A' ' 59' ' ' THR . 97.9 mt-10 -59.77 -14.64 15.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.046 -0.524 . . . . 1.6000000000000001 110.946 -179.598 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.605 ' C ' ' OG1' ' A' ' 59' ' ' THR . 96.4 m-20 -96.03 -4.28 43.36 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.778 -0.369 . . . . 1.1799999999999999 110.842 -179.763 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.724 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.8 13.98 63.84 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.376 -0.689 . . . . 0.29999999999999999 111.376 179.875 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -84.69 139.02 32.32 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.781 -0.246 . . . . 1.22 110.386 179.733 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.525 ' OE1' ' NE ' ' A' ' 143' ' ' ARG . 31.7 mt-30 -106.81 141.05 38.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.929 0.395 . . . . 0.97999999999999998 110.511 179.758 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.8 m -136.65 126.94 26.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.82999999999999996 110.45 179.913 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.406 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.06 117.28 9.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.335 -0.393 . . . . 0.26000000000000001 110.527 -179.856 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.03 -21.79 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.29999999999999999 110.752 -179.783 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.85 125.77 5.91 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.519 -0.473 . . . . 0.31 111.488 -179.824 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.47 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.79 120.14 21.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.743 -0.662 . . . . 0.28000000000000003 109.6 179.215 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.58 151.67 29.12 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.715 -0.394 . . . . 0.23999999999999999 111.009 -179.296 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.46 158.61 18.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 0.23000000000000001 110.403 179.704 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -146.02 157.94 43.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.098 -0.501 . . . . 0.67000000000000004 110.669 179.997 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.24 104.29 9.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.743 -0.662 . . . . 0.64000000000000001 110.086 179.482 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.947 -1.025 . . . . 1.26 110.568 -179.687 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.236 -0.653 . . . . 3.4399999999999999 109.236 . . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.73 18.52 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.007 -0.837 . . . . 1.22 111.007 179.708 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.66 142.32 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.06 0 C-N-CA 124.04 3.16 . . . . 0.75 113.729 -179.205 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.86 173.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.189 -1.369 . . . . 0.79000000000000004 108.832 178.402 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.615 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.54 125.8 51.41 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.503 -0.479 . . . . 1.9399999999999999 111.416 -179.569 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 144.01 33.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.731 -0.668 . . . . 0.59999999999999998 110.578 179.886 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.05 168.25 25.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.864 0.364 . . . . 3.1400000000000001 111.139 -179.695 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.745 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.87 131.04 60.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.026 -0.533 . . . . 3.23 110.141 179.877 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.5 p -141.16 162.33 35.73 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.84 0.352 . . . . 3.6299999999999999 111.239 -179.932 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 71.5 tt0 36.05 31.65 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.655 -0.498 . . . . 6.0800000000000001 109.655 179.849 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.745 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.53 69.61 33.56 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.918 -0.583 . . . . 3.3799999999999999 111.533 -178.75 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.639 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.27 -29.23 72.9 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.564 2.176 . . . . 3.9300000000000002 111.772 179.389 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.639 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.73 125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 3.3599999999999999 110.453 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 17' ' ' SER . 19.9 mt-30 -123.86 158.38 60.09 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.376 -0.375 . . . . 3.6099999999999999 110.446 179.939 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.777 ' HG2' ' NE ' ' A' ' 143' ' ' ARG . 97.4 Cg_endo -82.08 -64.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.816 2.344 . . . . 1.51 113.528 -179.029 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.651 ' HB3' ' NH1' ' A' ' 143' ' ' ARG . 16.7 t-20 -108.38 -19.71 13.37 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.041 0.386 . . . . 2.6800000000000002 112.041 -178.498 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 15.1 p -107.28 152.03 24.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.093 0.473 . . . . 1.21 111.347 -179.332 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.581 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.4 t-80 -155.35 102.98 2.22 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.738 -0.664 . . . . 1.5600000000000001 110.558 179.876 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.68 145.67 13.03 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.8 2.333 . . . . 0.81000000000000005 112.675 179.879 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.917 HD11 HD13 ' A' ' 35' ' ' LEU . 7.0 pt -130.84 167.93 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.893 -0.594 . . . . 1.52 109.822 179.618 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.1 147.93 29.08 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.72 -0.474 . . . . 2.1400000000000001 109.72 178.901 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.592 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.4 p90 -142.21 157.29 45.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.948 0.404 . . . . 0.32000000000000001 111.263 179.858 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.491 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.02 155.23 44.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.782 -0.645 . . . . 2.1699999999999999 110.105 178.968 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.825 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.55 173.08 6.3 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.158 -0.474 . . . . 0.58999999999999997 110.845 -179.294 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.825 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.71 173.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.88 2.386 . . . . 0.90000000000000002 111.49 179.412 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.01 -51.03 0.69 Allowed Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 120.578 -0.449 . . . . 3.3399999999999999 110.143 179.856 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.63 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.84 152.37 82.39 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.696 2.264 . . . . 1.8500000000000001 111.455 179.179 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.67 42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.372 0.606 . . . . 2.54 110.584 -179.9 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.63 ' N ' ' O ' ' A' ' 27' ' ' PRO . 73.6 t60 -63.49 -41.75 98.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.986 -1.006 . . . . 2.5299999999999998 110.715 179.65 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.554 HG13 ' HD2' ' A' ' 29' ' ' HIS . 74.2 mt -109.85 137.82 40.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.708 -0.678 . . . . 1.1699999999999999 111.293 -179.445 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.89 -72.87 0.7 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.001 -0.545 . . . . 1.27 111.923 -178.968 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.2 148.4 24.39 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.557 0.577 . . . . 1.1200000000000001 112.557 -179.62 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -121.88 124.82 45.02 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.349 -0.611 . . . . 0.41999999999999998 109.349 177.527 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.0 134.79 60.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.598 -0.441 . . . . 0.78000000000000003 110.638 179.949 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.917 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.03 128.52 53.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.62 111.323 179.721 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.548 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -130.97 139.01 49.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.78 -0.646 . . . . 1.97 110.097 179.074 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.16 163.08 35.47 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 120.574 -0.45 . . . . 0.34999999999999998 112.072 -178.128 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.39 139.52 7.91 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.474 -0.785 . . . . 1.8 110.542 178.848 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.9 Cg_endo -63.53 115.48 3.07 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.353 2.036 . . . . 0.57999999999999996 111.849 179.954 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.97 81.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.904 -0.406 . . . . 3.04 109.904 -179.859 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.952 -0.567 . . . . 2.4700000000000002 111.835 -179.501 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.6 p -157.57 157.78 34.38 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.878 -0.329 . . . . 2.5099999999999998 110.615 179.793 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.38 27.82 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.236 -0.438 . . . . 1.8600000000000001 110.122 179.568 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.7 -75.99 1.32 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.18 -0.533 . . . . 1.4399999999999999 111.814 -179.223 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.89 152.32 35.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.932 0.396 . . . . 4.6900000000000004 110.963 -179.306 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.03 2.5 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.983 -0.553 . . . . 1.4299999999999999 111.929 179.337 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.2 149.66 29.79 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.512 0.672 . . . . 1.74 112.504 -177.829 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.07 156.47 45.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.764 -1.107 . . . . 1.9199999999999999 110.247 178.609 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.22 158.35 41.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.933 -0.576 . . . . 0.34000000000000002 111.824 -179.341 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.08 135.61 54.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.496 -0.774 . . . . 0.40999999999999998 109.859 179.267 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.592 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.36 121.92 23.81 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.464 -0.335 . . . . 0.55000000000000004 111.6 -179.204 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.4 Cg_exo -46.32 151.74 1.62 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.695 2.263 . . . . 0.44 112.057 179.101 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.03 -22.9 63.18 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 116.035 -0.529 . . . . 0.73999999999999999 112.743 -179.205 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.545 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.86 -16.85 46.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.392 0.596 . . . . 0.93000000000000005 111.746 -178.334 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.601 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.63 138.4 31.59 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.771 -0.372 . . . . 0.96999999999999997 110.293 179.386 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -121.47 13.86 11.03 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.366 -0.379 . . . . 1.3400000000000001 111.549 -179.363 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.477 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.93 143.53 25.31 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.624 -0.43 . . . . 0.39000000000000001 111.008 179.648 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.719 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.84 -169.38 1.54 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.069 -0.514 . . . . 0.41999999999999998 110.875 -179.46 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.719 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 94.7 m -151.8 125.89 9.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.357 -0.838 . . . . 0.39000000000000001 109.882 179.208 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.9 123.28 70.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.365 -0.534 . . . . 0.73999999999999999 111.185 -179.711 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.835 ' NZ ' ' N ' ' A' ' 141' ' ' GLY . 82.1 mttt -126.51 163.38 23.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.839 -0.619 . . . . 2.48 110.469 179.733 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.549 ' HA2' HD22 ' A' ' 16' ' ' ASN . . . 85.17 18.88 60.0 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.723 -0.951 . . . . 0.5 110.723 -179.892 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.514 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.6 mt -78.91 157.19 28.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 0.57999999999999996 111.379 -179.629 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.859 ' O ' HG12 ' A' ' 67' ' ' VAL . 2.3 mttt -99.5 133.92 21.54 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.637 -0.711 . . . . 2.79 110.438 179.781 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.92 143.62 61.34 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.597 2.198 . . . . 0.87 111.941 179.812 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.82 25.52 75.47 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.063 -0.815 . . . . 0.64000000000000001 111.063 179.795 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.859 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.05 158.86 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.763 0.316 . . . . 0.82999999999999996 110.446 -179.631 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.23 139.93 42.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.98 0.419 . . . . 0.5 110.534 -179.786 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.665 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.6 m-85 -122.61 136.44 54.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.932 -0.576 . . . . 0.53000000000000003 110.797 -179.95 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.489 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.9 131.04 45.29 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.528 -0.915 . . . . 1.8700000000000001 108.528 177.684 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.488 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.57 153.9 16.67 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.207 -0.997 . . . . 0.28999999999999998 111.923 -178.541 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -135.01 140.84 45.98 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.73 -0.471 . . . . 1.4299999999999999 109.73 179.646 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.4 tp -115.66 118.89 34.36 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.45 -0.5 . . . . 0.32000000000000001 110.504 179.759 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.736 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.48 129.07 68.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.887 0.375 . . . . 0.79000000000000004 110.646 -179.939 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.75 120.9 43.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.256 -0.429 . . . . 1.02 110.761 -179.726 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.867 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.64 146.37 11.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.159 0.504 . . . . 0.62 111.079 -179.288 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.618 ' O ' ' N ' ' A' ' 79' ' ' TYR . 21.0 mt-30 -105.98 153.85 21.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.559 -0.746 . . . . 2.4399999999999999 109.938 179.884 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' GLN . 83.0 mt-30 -39.24 88.66 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.995 0.426 . . . . 3.6899999999999999 110.412 -179.73 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.618 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.26 32.55 0.21 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.759 -0.655 . . . . 6.0800000000000001 110.682 -179.912 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.01 -117.26 3.29 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.93 -0.652 . . . . 1.22 111.489 -179.731 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -81.54 177.42 8.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.23 0.538 . . . . 2.8799999999999999 111.537 -179.159 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.15 149.54 32.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.407 -0.815 . . . . 1.47 110.381 179.179 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.19 144.68 38.64 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.462 -0.335 . . . . 2.7000000000000002 110.589 179.829 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.736 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.0 136.04 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.078 0.466 . . . . 0.46000000000000002 111.557 -179.775 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.577 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.07 141.39 52.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.706 -0.679 . . . . 0.34999999999999998 110.257 179.647 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.73 138.88 51.72 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.499 -0.481 . . . . 3.6699999999999999 111.497 -179.32 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.26 164.2 37.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.574 -0.739 . . . . 0.67000000000000004 109.479 179.473 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.577 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.36 151.48 38.34 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.443 -0.503 . . . . 1.47 111.032 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.802 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.13 172.77 12.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.7 -0.682 . . . . 0.44 111.028 179.878 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.86 160.74 21.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.479 -0.782 . . . . 1.3700000000000001 109.861 179.527 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.33 121.83 22.94 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.61 -0.436 . . . . 1.28 110.798 -179.962 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -128.83 154.67 46.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 1.97 111.081 179.652 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.3 t -63.16 -41.21 99.21 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.032 -0.667 . . . . 3.2799999999999998 109.479 177.352 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.5 p -129.73 164.38 24.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.396 179.029 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 54.5 p -69.29 156.96 37.91 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.317 178.959 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.63 158.95 42.41 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.903 -179.423 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.9 155.05 29.4 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.508 2.139 . . . . 0.0 110.885 178.301 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 39.0 t -60.03 134.76 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.151 -179.245 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.2 p -121.64 165.16 16.16 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.839 -179.051 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.2 p -67.15 164.09 18.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.597 -179.89 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -61.37 136.45 58.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.277 -179.362 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 104' ' ' THR . 43.4 m 46.48 91.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.083 -179.947 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 83.0 t -62.96 -37.52 79.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.022 179.91 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 102' ' ' THR . 26.0 p -75.39 165.4 25.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -178.842 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.94 26.71 36.59 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.293 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.418 ' H ' ' CD ' ' A' ' 106' ' ' GLU . 58.3 mp0 -56.42 143.97 32.75 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.957 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.4 m -58.95 -39.1 80.63 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.374 -179.62 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.5 m -126.66 78.69 72.58 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.442 -179.138 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -58.8 142.81 99.21 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 121.705 1.603 . . . . 0.0 111.393 -179.992 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -59.65 -38.63 81.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.209 -179.365 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.3 m -127.65 78.74 74.5 Favored Pre-proline 0 N--CA 1.465 0.297 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.977 -179.695 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.733 ' O ' ' O ' ' A' ' 113' ' ' LEU . 31.9 Cg_exo -55.78 142.98 82.6 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.315 2.01 . . . . 0.0 111.882 -179.773 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.733 ' O ' ' O ' ' A' ' 112' ' ' PRO . 49.7 mt 43.28 149.34 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.365 0.602 . . . . 10.19 112.082 179.583 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.412 ' O ' ' O ' ' A' ' 113' ' ' LEU . 44.4 t 42.77 97.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.813 -0.63 . . . . 7.2800000000000002 111.237 179.725 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -173.32 20.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.326 -0.397 . . . . 7.2999999999999998 110.826 179.531 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.3 p -83.69 159.0 21.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.046 0.45 . . . . 6.4400000000000004 110.897 -179.717 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.4 p -83.74 -2.01 55.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.76 -0.654 . . . . 4.4199999999999999 110.817 179.695 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.46 -34.25 73.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.293 -0.412 . . . . 3.0499999999999998 111.43 -178.731 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.0 m -65.79 150.54 48.37 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.495 -0.482 . . . . 3.4300000000000002 110.419 179.928 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.9 t -124.1 133.07 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.408 -0.36 . . . . 2.8799999999999999 110.39 179.246 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.46 ' OG1' ' N ' ' A' ' 122' ' ' GLU . 68.9 p -99.62 -76.07 0.55 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.044 0.45 . . . . 2.0899999999999999 110.51 179.226 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.46 ' N ' ' OG1' ' A' ' 121' ' ' THR . 48.8 tp10 -116.0 145.05 43.29 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.589 -0.732 . . . . 4.5300000000000002 109.967 179.722 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 31.9 pt -118.66 152.39 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.93 0.395 . . . . 1.4399999999999999 110.652 179.647 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.3 p -128.15 166.52 18.33 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.797 -0.638 . . . . 1.78 110.98 -179.512 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.663 ' O ' ' N ' ' A' ' 127' ' ' SER . . . -113.54 -94.61 0.46 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.572 -0.529 . . . . 0.64000000000000001 109.572 179.146 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 125' ' ' ALA . 0.1 OUTLIER 29.94 29.89 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 122.358 1.075 . . . . 0.66000000000000003 111.135 178.806 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.663 ' N ' ' O ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.81 167.6 0.25 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.397 -1.274 . . . . 0.68999999999999995 110.977 -178.83 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.62 145.51 50.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.691 -0.686 . . . . 0.52000000000000002 110.099 -179.833 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.31 101.62 9.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.075 -0.713 . . . . 0.32000000000000001 109.075 177.707 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.8 t -112.9 139.7 36.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.978 -0.556 . . . . 0.28999999999999998 111.143 -178.915 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.1 p -128.71 152.56 48.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.642 -0.708 . . . . 0.25 109.747 179.681 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.74 -164.9 2.02 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.731 -0.387 . . . . 0.31 110.64 -179.839 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.733 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -124.02 127.12 73.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.156 -0.474 . . . . 0.48999999999999999 110.833 -179.87 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 134' ' ' SER . . . . . 1.148 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.87 58.28 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.102 -0.499 . . . . 1.53 110.351 179.825 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.28 24.69 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.981 -0.554 . . . . 0.96999999999999997 111.535 -179.589 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.148 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.14 128.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.597 -0.441 . . . . 1.5600000000000001 110.907 179.818 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.39 -9.64 55.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.901 -0.591 . . . . 1.8799999999999999 110.255 179.725 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.7 p -86.98 0.23 55.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 1.04 110.338 179.954 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.3 137.31 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 116.0 -0.545 . . . . 0.23999999999999999 110.016 179.775 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.812 ' C ' ' HZ2' ' A' ' 61' ' ' LYS . 5.7 m -96.31 -15.6 21.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.234 0.54 . . . . 0.28999999999999998 109.99 -179.585 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.835 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.63 175.62 45.85 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.821 -1.311 . . . . 0.13 109.821 179.58 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.48 151.57 42.61 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.619 -0.432 . . . . 0.17000000000000001 110.465 179.801 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.777 ' NE ' ' HG2' ' A' ' 15' ' ' PRO . 19.7 ttt85 -132.25 121.22 23.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.131 -0.486 . . . . 1.29 109.96 179.759 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.556 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.13 136.54 38.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.776 -0.647 . . . . 0.25 110.619 -179.703 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 85.2 tt0 -129.36 129.88 45.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.969 -0.56 . . . . 1.3200000000000001 110.001 -179.862 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.619 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.71 135.22 34.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.099 -0.501 . . . . 0.56999999999999995 110.652 -179.673 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.424 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.26 161.44 39.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.809 -0.632 . . . . 1.1599999999999999 109.657 179.834 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.963 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.11 124.87 25.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.935 0.397 . . . . 0.38 110.769 -179.616 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.71 -7.76 50.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.808 -0.633 . . . . 0.40999999999999998 110.837 -179.748 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.83 -69.77 0.85 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.356 -0.384 . . . . 1.6599999999999999 111.394 -179.249 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 1.449 ' CD ' HH21 ' A' ' 176' ' ' ARG . 53.9 mt-10 -60.58 -35.36 75.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.083 -0.508 . . . . 1.6599999999999999 111.57 -179.167 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 1.096 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.18 7.24 88.59 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.839 -0.904 . . . . 1.1699999999999999 110.839 -179.843 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 1.313 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.95 -171.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.756 0.312 . . . . 1.8600000000000001 110.293 179.849 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.313 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.25 139.06 45.15 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.982 0.42 . . . . 1.98 110.182 179.653 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.424 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.87 145.87 51.86 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 C-N-CA 122.694 2.262 . . . . 0.55000000000000004 112.361 -179.553 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.619 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.9 145.74 42.64 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.131 -0.692 . . . . 1.1399999999999999 109.131 179.261 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 143' ' ' ARG . 71.7 m-85 -123.27 141.34 52.08 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.344 -0.542 . . . . 0.93000000000000005 111.552 -179.143 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.5 mt -128.09 127.61 43.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.291 -0.868 . . . . 0.34000000000000002 108.973 178.995 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.604 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 34.6 t0 -101.61 131.22 47.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.088 0.471 . . . . 1.0900000000000001 111.733 -178.741 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.604 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -128.01 157.57 73.49 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.321 -0.854 . . . . 0.19 109.572 179.672 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -69.87 158.04 58.15 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 C-N-CA 122.475 2.117 . . . . 0.17999999999999999 112.153 -179.987 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.34 -12.13 5.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.687 -0.688 . . . . 0.20999999999999999 110.721 -179.779 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.6 p -92.78 -8.79 42.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.28999999999999998 110.709 -179.917 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.38 34.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.5 110.358 179.743 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 p -133.13 16.61 4.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.373 -0.376 . . . . 0.29999999999999999 110.461 -179.986 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.4 p -167.52 147.12 5.09 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.556 -0.535 . . . . 0.23000000000000001 109.556 179.906 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.2 150.44 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.452 -0.499 . . . . 0.28000000000000003 111.592 -179.634 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.502 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.36 125.03 50.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.695 -0.684 . . . . 1.0700000000000001 109.776 179.504 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.4 104.91 29.87 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 0.28999999999999998 111.016 -179.826 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -91.01 -179.52 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 123.189 2.593 . . . . 0.42999999999999999 112.203 179.884 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 61.67 32.6 18.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.409 -0.814 . . . . 1.26 111.497 179.316 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.401 HD12 ' O ' ' A' ' 126' ' ' SER . 24.2 mt -86.37 148.57 25.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.483 -0.326 . . . . 0.32000000000000001 110.485 179.601 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.763 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.4 114.88 61.5 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.048 0.451 . . . . 0.57999999999999996 110.616 -179.657 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.96 140.62 96.11 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.81 2.34 . . . . 0.66000000000000003 111.993 179.825 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.11 21.15 74.34 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.072 -0.811 . . . . 0.28999999999999998 111.072 179.885 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 1.449 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.91 150.16 49.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.351 . . . . 2.3300000000000001 110.632 -179.925 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.493 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.17 131.65 45.99 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.044 -0.525 . . . . 0.85999999999999999 109.804 179.351 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.963 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.7 m-85 -120.61 148.26 44.13 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.187 -0.46 . . . . 0.52000000000000002 110.989 -179.788 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.7 mt -105.22 125.35 60.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.321 -0.992 . . . . 0.29999999999999999 108.321 177.76 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.67 132.57 63.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.218 0.532 . . . . 0.23000000000000001 111.189 -178.581 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.49 122.62 20.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.49 -0.777 . . . . 0.35999999999999999 109.614 179.319 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.2 t -101.15 125.42 55.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.195 -0.457 . . . . 0.19 110.648 -179.514 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 183' ' ' TYR . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.23 137.87 52.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.018 -0.537 . . . . 0.29999999999999999 109.843 179.602 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.42 ' OE1' ' HB2' ' A' ' 136' ' ' SER . 6.8 pt20 -100.7 135.04 42.78 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.878 -0.786 . . . . 0.37 108.878 178.817 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.605 HG21 ' HE2' ' A' ' 61' ' ' LYS . 68.1 mt -99.1 122.97 51.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.144 0.497 . . . . 0.26000000000000001 110.953 -178.73 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.5 p -83.94 169.68 14.79 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.518 -0.765 . . . . 0.28000000000000003 110.453 -179.636 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.77 -14.46 14.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.094 -0.503 . . . . 1.6000000000000001 110.913 -179.542 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -96.15 -4.33 42.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.773 0.321 . . . . 1.1799999999999999 110.787 -179.796 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.9 13.83 63.9 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.254 -0.738 . . . . 0.29999999999999999 111.254 179.76 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -84.68 139.1 32.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.715 0.293 . . . . 1.22 110.431 179.708 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -106.71 141.05 38.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.929 0.395 . . . . 0.97999999999999998 110.643 179.69 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.71 127.01 26.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.82999999999999996 110.388 179.927 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.1 tp -68.02 117.27 9.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.23 -0.441 . . . . 0.26000000000000001 110.548 -179.928 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 43.9 pt -109.03 -21.88 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.29999999999999999 110.78 -179.753 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.82 125.78 5.93 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.535 -0.466 . . . . 0.31 111.511 -179.846 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.473 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.76 120.16 21.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.801 -0.636 . . . . 0.28000000000000003 109.522 179.218 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.58 151.7 29.17 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.624 -0.43 . . . . 0.23999999999999999 110.873 -179.29 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.5 158.6 18.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.015 -0.538 . . . . 0.23000000000000001 110.41 179.686 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.4 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 68.1 mt-30 -146.09 157.88 43.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.07 -0.513 . . . . 0.67000000000000004 110.677 -179.977 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.23 104.37 9.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.787 -0.642 . . . . 0.64000000000000001 110.011 179.563 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.894 -1.051 . . . . 1.26 110.705 -179.725 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.19 -0.67 . . . . 3.4399999999999999 109.19 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.39 150.7 18.54 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.991 -0.844 . . . . 1.22 110.991 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -35.56 142.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 124.015 3.143 . . . . 0.75 113.76 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.604 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -80.06 173.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.268 -1.333 . . . . 0.79000000000000004 108.802 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.604 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.62 125.86 51.47 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.394 -0.522 . . . . 1.9399999999999999 111.407 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.49 144.02 33.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.662 -0.699 . . . . 0.59999999999999998 110.629 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.03 168.3 25.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.891 0.377 . . . . 3.1400000000000001 111.145 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.742 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.98 131.08 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.01 -0.541 . . . . 3.23 110.074 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.16 162.31 35.78 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.861 0.362 . . . . 3.6299999999999999 111.217 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 9' ' ' THR . 79.8 mm-40 36.07 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.611 -0.514 . . . . 6.0800000000000001 109.611 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.742 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.6 32.57 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.973 -0.558 . . . . 3.3799999999999999 111.6 -178.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.636 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.32 -29.1 72.43 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.487 2.125 . . . . 3.9300000000000002 111.819 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.636 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.64 125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 3.3599999999999999 110.443 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 17' ' ' SER . 2.8 mp0 -123.91 158.29 60.56 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 3.6099999999999999 110.435 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.662 ' HG2' ' NE ' ' A' ' 143' ' ' ARG . 97.7 Cg_endo -82.02 -64.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.94 2.427 . . . . 1.51 113.428 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.742 HD22 ' N ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -108.35 -19.53 13.44 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.067 0.395 . . . . 2.6800000000000002 112.067 -178.495 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.742 ' N ' HD22 ' A' ' 16' ' ' ASN . 9.8 p -107.31 152.04 24.67 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.484 -0.486 . . . . 1.21 111.338 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.26 102.9 2.23 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.769 -0.65 . . . . 1.5600000000000001 110.675 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.425 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.5 Cg_endo -82.68 145.61 13.01 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.853 2.369 . . . . 0.81000000000000005 112.664 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.916 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.74 167.92 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.899 -0.591 . . . . 1.52 109.919 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.12 147.95 29.09 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.829 -0.434 . . . . 2.1400000000000001 109.829 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.59 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.29 157.29 44.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.972 0.415 . . . . 0.32000000000000001 111.194 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.493 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.05 155.34 44.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.797 -0.638 . . . . 2.1699999999999999 110.092 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.839 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.65 173.05 6.34 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.118 0.485 . . . . 0.58999999999999997 110.743 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.839 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.68 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.873 2.382 . . . . 0.90000000000000002 111.515 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.11 -51.0 0.69 Allowed Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.674 -0.411 . . . . 3.3399999999999999 110.098 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.626 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.84 152.32 82.58 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.791 2.327 . . . . 1.8500000000000001 111.426 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.67 42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.413 0.625 . . . . 2.54 110.606 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.822 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.63 -41.67 98.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.976 -1.011 . . . . 2.5299999999999998 110.632 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.7 mt -109.83 137.81 40.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.821 -0.627 . . . . 1.1699999999999999 111.343 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.9 -72.94 0.7 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.109 -0.496 . . . . 1.27 111.938 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.12 148.4 24.46 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.623 0.601 . . . . 1.1200000000000001 112.623 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.81 124.82 45.07 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.424 -0.584 . . . . 0.41999999999999998 109.424 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.07 134.73 60.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.626 -0.43 . . . . 0.78000000000000003 110.625 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.916 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.0 128.66 53.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.054 0.454 . . . . 0.62 111.241 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 138.96 49.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.779 -0.646 . . . . 1.97 110.141 178.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.439 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.01 163.18 35.01 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.125 0.488 . . . . 0.34999999999999998 112.119 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.491 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.47 139.59 7.87 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 115.484 -0.78 . . . . 1.8 110.506 178.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.684 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.8 Cg_endo -63.55 115.46 3.06 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.33 2.02 . . . . 0.57999999999999996 111.784 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.674 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.96 81.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.891 -0.411 . . . . 3.04 109.891 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.23 -20.67 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.998 -0.546 . . . . 2.4700000000000002 111.906 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -157.66 157.82 34.3 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.78 -0.368 . . . . 2.5099999999999998 110.465 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.42 27.85 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 1.8600000000000001 110.151 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -75.88 1.31 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.122 -0.561 . . . . 1.4399999999999999 111.812 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.93 152.34 35.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.984 0.421 . . . . 4.6900000000000004 110.995 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.12 2.53 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.992 -0.549 . . . . 1.4299999999999999 111.886 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.17 149.63 29.81 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.457 0.646 . . . . 1.74 112.565 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.97 156.46 46.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.781 -1.099 . . . . 1.9199999999999999 110.285 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.21 158.43 41.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.967 -0.56 . . . . 0.34000000000000002 111.776 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.6 m -115.24 135.6 53.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.422 -0.808 . . . . 0.40999999999999998 109.79 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.59 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.45 121.98 23.71 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.418 -0.355 . . . . 0.55000000000000004 111.568 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.5 Cg_exo -46.27 151.75 1.58 Allowed 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.624 2.216 . . . . 0.44 112.121 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.96 -22.98 63.11 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 116.029 -0.532 . . . . 0.73999999999999999 112.81 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.54 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.8 -16.9 45.99 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 120.244 -0.582 . . . . 0.93000000000000005 111.804 -178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.603 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.57 138.39 31.61 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.707 -0.397 . . . . 0.96999999999999997 110.329 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -121.46 13.96 11.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.391 -0.368 . . . . 1.3400000000000001 111.569 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.475 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.0 143.48 25.21 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.648 -0.421 . . . . 0.39000000000000001 111.064 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.716 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.9 t80 -114.84 -169.3 1.52 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.051 -0.522 . . . . 0.41999999999999998 110.864 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.716 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.76 125.95 9.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.422 -0.808 . . . . 0.39000000000000001 109.818 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.516 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.9 mt -114.96 123.27 70.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.346 -0.542 . . . . 0.73999999999999999 111.166 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -126.47 163.4 23.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.807 -0.633 . . . . 2.48 110.498 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.18 18.94 59.88 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.714 -0.954 . . . . 0.5 110.714 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.516 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.9 mt -79.06 157.27 28.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.065 0.46 . . . . 0.57999999999999996 111.326 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.846 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -99.55 134.01 21.45 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.608 -0.723 . . . . 2.79 110.399 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.424 ' HD3' ' CE2' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.98 143.54 60.71 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.519 2.146 . . . . 0.87 111.944 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.0 25.57 75.43 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.997 -0.841 . . . . 0.64000000000000001 110.997 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.846 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.19 158.8 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.72 0.295 . . . . 0.82999999999999996 110.43 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.15 139.9 42.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.884 0.373 . . . . 0.5 110.583 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.664 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.6 m-85 -122.54 136.49 54.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.923 -0.581 . . . . 0.53000000000000003 110.69 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.489 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.3 pt-20 -98.89 131.04 45.28 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.545 -0.909 . . . . 1.8700000000000001 108.545 177.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.46 153.9 16.64 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.326 -0.94 . . . . 0.28999999999999998 111.969 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.0 140.93 46.05 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.675 -0.491 . . . . 1.4299999999999999 109.675 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.76 118.87 34.24 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.474 -0.49 . . . . 0.32000000000000001 110.468 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.721 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.43 129.08 68.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.388 . . . . 0.79000000000000004 110.68 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.707 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.79 120.79 43.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.27 -0.423 . . . . 1.02 110.732 -179.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.851 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.5 146.42 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.115 0.483 . . . . 0.62 111.082 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.822 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.02 153.85 21.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.496 -0.775 . . . . 2.4399999999999999 109.89 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.1 88.55 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.88 0.372 . . . . 3.6899999999999999 110.43 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.622 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.25 32.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.829 -0.623 . . . . 6.0800000000000001 110.614 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.1 -117.37 3.29 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.447 -0.661 . . . . 1.22 111.447 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.468 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.37 177.43 8.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.222 0.534 . . . . 2.8799999999999999 111.601 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.18 149.49 32.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.405 -0.816 . . . . 1.47 110.41 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.13 144.68 38.76 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.467 -0.333 . . . . 2.7000000000000002 110.6 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.721 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.0 136.01 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.05 0.453 . . . . 0.46000000000000002 111.555 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.09 141.33 52.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.681 -0.691 . . . . 0.34999999999999998 110.279 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.63 138.86 51.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.126 0.489 . . . . 3.6699999999999999 111.501 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.25 164.19 37.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.564 -0.744 . . . . 0.67000000000000004 109.471 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.571 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.31 151.49 38.4 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.422 -0.511 . . . . 1.47 111.042 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.7 p90 -146.18 172.7 13.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.788 -0.642 . . . . 0.44 111.017 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.69 160.65 21.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.455 -0.793 . . . . 1.3700000000000001 109.897 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.519 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.42 121.8 22.8 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.653 -0.419 . . . . 1.28 110.816 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.1 p -128.33 146.42 50.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.048 -0.524 . . . . 1.97 111.858 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.798 -0.637 . . . . 3.2799999999999998 109.974 176.792 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.505 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 4.6 p . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 111.988 0.366 . . . . 0.66000000000000003 111.988 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.433 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.9 167.6 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.097 0.475 . . . . 0.68999999999999995 110.932 179.474 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.62 145.56 50.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.704 -0.68 . . . . 0.52000000000000002 110.123 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.26 101.66 9.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.063 -0.717 . . . . 0.32000000000000001 109.063 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.7 t -112.93 139.69 36.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.026 -0.534 . . . . 0.28999999999999998 111.109 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.2 p -128.66 152.47 48.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.7 -0.682 . . . . 0.25 109.929 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.595 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.8 -165.01 2.05 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.692 -0.403 . . . . 0.31 110.569 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -123.95 127.17 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 0.48999999999999999 110.809 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.176 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.97 58.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.126 -0.488 . . . . 1.53 110.31 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.21 24.57 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.892 -0.595 . . . . 0.96999999999999997 111.52 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.176 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.11 128.76 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.638 -0.425 . . . . 1.5600000000000001 110.919 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.5 -9.51 56.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.883 -0.599 . . . . 1.8799999999999999 110.289 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.16 0.25 55.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.14 -0.482 . . . . 1.04 110.289 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.21 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 0.23999999999999999 109.899 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 185' ' ' ILE . 94.2 p -96.28 -15.47 21.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.259 0.552 . . . . 0.28999999999999998 110.056 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.54 175.6 45.76 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.887 -1.285 . . . . 0.13 109.887 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -123.48 151.57 42.61 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.69 -0.404 . . . . 0.17000000000000001 110.509 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.662 ' NE ' ' HG2' ' A' ' 15' ' ' PRO . 73.0 ttt-85 -132.34 121.22 23.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.136 -0.484 . . . . 1.29 109.881 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.558 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.15 136.51 38.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.664 -0.698 . . . . 0.25 110.707 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 79.5 tt0 -129.29 129.95 45.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.038 -0.528 . . . . 1.3200000000000001 110.057 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.9 p90 -138.79 135.31 34.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.985 -0.552 . . . . 0.56999999999999995 110.567 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.427 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.28 39.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.762 -0.654 . . . . 1.1599999999999999 109.733 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.959 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -70.99 124.87 25.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.978 0.418 . . . . 0.38 110.713 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.497 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.76 -7.7 49.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.687 -0.688 . . . . 0.40999999999999998 110.891 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.85 -69.69 0.85 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 1.6599999999999999 111.343 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.447 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.7 -35.35 76.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.017 -0.538 . . . . 1.6599999999999999 111.492 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.093 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.19 7.25 88.58 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.806 -0.918 . . . . 1.1699999999999999 110.806 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.318 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.99 -171.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.779 0.323 . . . . 1.8600000000000001 110.275 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.318 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.32 139.09 44.95 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.947 0.403 . . . . 1.98 110.187 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.427 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.1 Cg_endo -70.81 145.75 51.91 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 122.725 2.284 . . . . 0.55000000000000004 112.31 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.85 145.71 42.62 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.195 -0.669 . . . . 1.1399999999999999 109.195 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.516 ' CE1' ' HB2' ' A' ' 16' ' ' ASN . 6.2 p90 -123.21 141.36 52.06 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.378 -0.529 . . . . 0.93000000000000005 111.573 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.1 127.67 43.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.338 -0.846 . . . . 0.34000000000000002 108.952 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 52.4 t0 -101.63 131.22 47.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.172 0.511 . . . . 1.0900000000000001 111.763 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.42 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -127.97 157.57 73.44 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.317 -0.856 . . . . 0.19 109.566 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.75 158.04 58.34 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.439 2.093 . . . . 0.17999999999999999 112.262 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.3 -12.18 5.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.842 -0.617 . . . . 0.20999999999999999 110.725 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.4 p -92.81 -8.74 42.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.28999999999999998 110.711 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.42 34.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.378 -0.374 . . . . 0.5 110.391 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.19 16.66 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.354 -0.385 . . . . 0.29999999999999999 110.491 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.0 p -167.53 147.18 5.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.644 -0.502 . . . . 0.23000000000000001 109.644 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.19 150.39 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.538 -0.465 . . . . 0.28000000000000003 111.576 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.28 124.94 50.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.624 -0.716 . . . . 1.0700000000000001 109.809 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.37 104.88 29.57 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.924 0.392 . . . . 0.28999999999999998 111.105 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.5 Cg_endo -90.94 -179.54 1.52 Allowed 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 123.197 2.598 . . . . 0.42999999999999999 112.243 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.72 32.63 18.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.394 -0.821 . . . . 1.26 111.417 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.505 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.4 mt -86.33 148.51 25.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.496 -0.32 . . . . 0.32000000000000001 110.521 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.766 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.24 114.82 61.1 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.912 0.387 . . . . 0.57999999999999996 110.696 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.0 140.53 95.76 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.858 2.372 . . . . 0.66000000000000003 112.014 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.16 21.2 74.1 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.009 -0.837 . . . . 0.28999999999999998 111.009 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.447 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.81 150.12 49.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.732 0.301 . . . . 2.3300000000000001 110.688 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.497 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.14 131.59 46.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 0.85999999999999999 109.833 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.959 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.48 148.28 44.03 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.143 -0.48 . . . . 0.52000000000000002 111.038 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.3 mt -105.33 125.29 60.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.27 -1.011 . . . . 0.29999999999999999 108.27 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.5 132.47 63.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.183 0.516 . . . . 0.23000000000000001 111.274 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.9 m-20 -136.46 122.59 20.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.532 -0.758 . . . . 0.35999999999999999 109.636 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.595 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.03 125.39 54.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.187 -0.46 . . . . 0.19 110.665 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.9 m-85 -117.25 137.97 52.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.007 -0.542 . . . . 0.29999999999999999 109.835 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.582 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.76 135.07 42.78 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.786 -0.82 . . . . 0.37 108.786 178.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 140' ' ' SER . 85.3 mt -99.09 122.92 51.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.07 0.462 . . . . 0.26000000000000001 110.96 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.5 p -83.79 169.7 14.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.534 -0.757 . . . . 0.28000000000000003 110.484 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.83 -14.51 15.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.04 -0.527 . . . . 1.6000000000000001 110.934 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.505 ' C ' ' OG1' ' A' ' 59' ' ' THR . 79.2 m-20 -96.1 -4.29 43.12 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.833 -0.347 . . . . 1.1799999999999999 110.825 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.49 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.78 13.89 64.02 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.379 -0.689 . . . . 0.29999999999999999 111.379 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -84.62 139.05 32.34 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.058 -0.257 . . . . 1.22 110.518 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -106.76 141.11 38.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.903 0.382 . . . . 0.97999999999999998 110.513 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.6 m -136.72 126.97 26.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.82999999999999996 110.36 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.06 117.25 9.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.329 -0.396 . . . . 0.26000000000000001 110.528 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.03 -21.84 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.29999999999999999 110.712 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.87 125.79 5.9 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.514 -0.475 . . . . 0.31 111.485 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.75 120.24 21.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.79 -0.641 . . . . 0.28000000000000003 109.578 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.71 29.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.955 0.407 . . . . 0.23999999999999999 110.927 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.47 158.66 18.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.052 -0.522 . . . . 0.23000000000000001 110.413 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.09 157.96 43.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.03 -0.532 . . . . 0.67000000000000004 110.659 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 104.26 9.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.721 -0.672 . . . . 0.64000000000000001 110.047 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.876 -1.059 . . . . 1.26 110.665 -179.729 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.197 -0.668 . . . . 3.4399999999999999 109.197 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.72 18.54 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.049 -0.821 . . . . 1.22 111.049 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.73 142.41 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.09 0 C-N-CA 123.94 3.093 . . . . 0.75 113.748 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.0 t -79.93 173.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.205 -1.361 . . . . 0.79000000000000004 108.83 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.614 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.64 125.89 51.51 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.482 -0.487 . . . . 1.9399999999999999 111.409 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 p -136.52 143.99 33.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.573 -0.74 . . . . 0.59999999999999998 110.622 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.06 168.25 25.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.936 0.398 . . . . 3.1400000000000001 111.072 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.743 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.4 mt -108.87 131.1 60.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.019 -0.537 . . . . 3.23 110.155 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.21 162.32 35.77 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.931 0.396 . . . . 3.6299999999999999 111.149 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.1 mt-10 36.06 31.68 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.559 -0.534 . . . . 6.0800000000000001 109.559 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.743 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.53 69.63 33.56 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.939 -0.573 . . . . 3.3799999999999999 111.533 -178.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.28 -29.09 72.75 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.501 2.134 . . . . 3.9300000000000002 111.881 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.64 125.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 3.3599999999999999 110.477 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.724 HE22 ' CD ' ' A' ' 191' ' ' GLN . 18.7 mm-40 -123.9 158.33 60.37 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 3.6099999999999999 110.462 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.54 ' CG ' ' NE ' ' A' ' 143' ' ' ARG . 98.8 Cg_endo -82.08 -64.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.901 2.401 . . . . 1.51 113.494 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.673 ' OD1' ' O ' ' A' ' 63' ' ' LEU . 51.6 t30 -108.43 -19.56 13.41 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.119 0.415 . . . . 2.6800000000000002 112.119 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 1.3 p -107.27 152.03 24.66 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.499 -0.48 . . . . 1.21 111.346 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.28 102.88 2.23 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.737 -0.665 . . . . 1.5600000000000001 110.689 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.57 145.63 13.19 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.914 2.409 . . . . 0.81000000000000005 112.639 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.919 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.8 167.98 24.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.808 -0.633 . . . . 1.52 109.924 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.16 147.93 29.03 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.74 -0.467 . . . . 2.1400000000000001 109.74 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.595 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.4 p90 -142.3 157.3 44.97 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.624 -0.43 . . . . 0.32000000000000001 111.212 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.49 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.04 155.22 44.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.831 -0.622 . . . . 2.1699999999999999 110.187 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.83 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.62 172.99 6.42 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.097 0.475 . . . . 0.58999999999999997 110.743 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.83 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.54 173.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.885 2.39 . . . . 0.90000000000000002 111.513 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.01 -51.15 0.69 Allowed Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.746 -0.381 . . . . 3.3399999999999999 110.093 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.622 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.8 Cg_exo -64.89 152.4 82.38 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.743 2.295 . . . . 1.8500000000000001 111.423 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.68 42.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.423 0.63 . . . . 2.54 110.587 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.815 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.59 -41.65 98.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.011 -0.995 . . . . 2.5299999999999998 110.671 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.2 mt -109.92 137.87 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.783 -0.644 . . . . 1.1699999999999999 111.251 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.95 -72.92 0.7 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.025 -0.534 . . . . 1.27 111.856 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.15 148.4 24.44 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.557 0.577 . . . . 1.1200000000000001 112.557 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.8 124.87 45.19 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.41 -0.589 . . . . 0.41999999999999998 109.41 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.8 mt -118.15 134.8 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.618 -0.433 . . . . 0.78000000000000003 110.553 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.919 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.09 128.66 53.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.071 0.462 . . . . 0.62 111.149 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.549 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.14 139.01 49.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.656 -0.702 . . . . 1.97 110.097 178.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.09 163.19 35.06 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.076 0.465 . . . . 0.34999999999999998 112.108 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.489 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.49 139.58 7.85 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 115.453 -0.794 . . . . 1.8 110.437 178.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.57 115.46 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.316 2.011 . . . . 0.57999999999999996 111.784 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.672 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.9 81.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.94 -0.392 . . . . 3.04 109.94 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.14 -20.64 0.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.998 -0.547 . . . . 2.4700000000000002 111.946 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.56 157.77 34.37 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.815 -0.354 . . . . 2.5099999999999998 110.559 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.403 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.39 27.88 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.23 -0.441 . . . . 1.8600000000000001 110.17 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.87 -75.9 1.31 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.825 -0.51 . . . . 1.4399999999999999 111.825 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.89 152.26 35.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.871 0.367 . . . . 4.6900000000000004 111.051 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.676 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.21 -169.16 2.54 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.077 -0.511 . . . . 1.4299999999999999 111.925 179.417 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.11 149.69 29.68 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.409 0.623 . . . . 1.74 112.557 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.08 156.47 45.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.82 -1.082 . . . . 1.9199999999999999 110.262 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.26 158.33 41.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.938 -0.574 . . . . 0.34000000000000002 111.791 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 m -115.13 135.67 53.94 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.368 -0.833 . . . . 0.40999999999999998 109.86 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.595 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.44 121.9 23.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.444 -0.344 . . . . 0.55000000000000004 111.555 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.2 Cg_exo -46.3 151.74 1.61 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.634 2.223 . . . . 0.44 112.2 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.02 -22.95 63.2 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 116.157 -0.474 . . . . 0.73999999999999999 112.808 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.77 -16.88 46.2 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.21 -0.596 . . . . 0.93000000000000005 111.787 -178.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.605 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.54 138.46 31.56 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.83 -0.348 . . . . 0.96999999999999997 110.271 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -121.58 13.93 10.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.362 -0.381 . . . . 1.3400000000000001 111.548 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.93 143.49 25.28 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.626 -0.43 . . . . 0.39000000000000001 111.08 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.713 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.85 -169.35 1.53 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.212 0.53 . . . . 0.41999999999999998 110.829 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.713 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 84.9 m -151.75 125.95 9.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.334 -0.848 . . . . 0.39000000000000001 109.832 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.515 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.82 123.19 70.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.428 -0.509 . . . . 0.73999999999999999 111.28 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.577 ' HE2' HG21 ' A' ' 185' ' ' ILE . 8.6 mmtt -126.44 163.31 23.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.906 -0.588 . . . . 2.48 110.482 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.607 ' HA2' HD21 ' A' ' 16' ' ' ASN . . . 85.14 19.06 59.71 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.678 -0.969 . . . . 0.5 110.678 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.673 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 73.9 mt -79.09 157.25 28.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.053 0.454 . . . . 0.57999999999999996 111.339 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.857 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -99.45 133.9 21.59 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.568 -0.742 . . . . 2.79 110.491 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.82 143.55 61.68 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.54 2.16 . . . . 0.87 112.029 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.77 25.66 75.3 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.033 -0.827 . . . . 0.64000000000000001 111.033 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.857 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.13 158.86 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.684 0.278 . . . . 0.82999999999999996 110.466 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.21 139.96 42.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.967 0.413 . . . . 0.5 110.495 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.638 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.58 136.46 54.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.863 -0.608 . . . . 0.53000000000000003 110.74 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.95 131.09 45.28 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.541 -0.911 . . . . 1.8700000000000001 108.541 177.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.487 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.57 153.91 16.67 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.201 -0.999 . . . . 0.28999999999999998 111.947 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -134.97 140.89 46.05 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.681 -0.489 . . . . 1.4299999999999999 109.681 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.73 118.97 34.53 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.418 -0.513 . . . . 0.32000000000000001 110.503 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 84' ' ' VAL . 64.2 mt -112.45 129.12 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.287 -0.415 . . . . 0.79000000000000004 110.592 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.9 120.88 43.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.253 -0.43 . . . . 1.02 110.715 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.859 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.69 146.57 11.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.292 0.568 . . . . 0.62 110.921 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.815 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.12 153.88 21.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.513 -0.767 . . . . 2.4399999999999999 109.941 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.21 88.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.963 0.411 . . . . 3.6899999999999999 110.371 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.62 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.38 32.45 0.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.784 -0.644 . . . . 6.0800000000000001 110.577 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.01 -117.39 3.3 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.452 -0.659 . . . . 1.22 111.452 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.467 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.41 177.47 8.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.252 0.548 . . . . 2.8799999999999999 111.58 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.22 149.47 31.98 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.373 -0.83 . . . . 1.47 110.312 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.15 144.7 38.73 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.463 -0.335 . . . . 2.7000000000000002 110.528 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.727 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.03 136.0 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 121.041 0.448 . . . . 0.46000000000000002 111.538 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.05 141.37 52.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.687 -0.688 . . . . 0.34999999999999998 110.292 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.67 138.81 51.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.128 0.49 . . . . 3.6699999999999999 111.479 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.487 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.19 164.25 37.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.527 -0.761 . . . . 0.67000000000000004 109.494 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.33 151.49 38.4 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.442 -0.503 . . . . 1.47 111.075 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.8 p90 -146.15 172.72 13.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.724 -0.671 . . . . 0.44 111.04 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.67 160.69 21.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.431 -0.804 . . . . 1.3700000000000001 109.843 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.4 121.85 22.89 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.573 -0.451 . . . . 1.28 110.752 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.5 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.6 p -126.6 161.34 28.25 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 114.003 1.112 . . . . 1.97 114.003 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.8 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 113.272 -1.786 . . . . 3.2799999999999998 108.886 178.831 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.536 0.405 0 CA-C-O 121.19 0.519 . . . . 0.66000000000000003 111.418 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.444 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.85 167.57 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.525 -0.761 . . . . 0.68999999999999995 110.984 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.64 145.5 50.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.733 -0.667 . . . . 0.52000000000000002 110.081 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.23 101.67 9.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.124 -0.695 . . . . 0.32000000000000001 109.124 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.4 t -112.95 139.7 36.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.974 -0.557 . . . . 0.28999999999999998 111.069 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.0 p -128.8 152.48 48.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.612 -0.722 . . . . 0.25 109.776 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.585 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.71 -164.9 2.02 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.668 -0.413 . . . . 0.31 110.632 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.732 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.4 t -123.97 127.1 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.218 -0.446 . . . . 0.48999999999999999 110.788 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.157 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.216 -0.447 . . . . 1.53 110.374 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.14 24.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.928 -0.578 . . . . 0.96999999999999997 111.469 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.157 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.16 128.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.54 -0.464 . . . . 1.5600000000000001 110.952 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.39 -9.59 56.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.975 -0.557 . . . . 1.8799999999999999 110.249 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.18 0.17 55.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.218 -0.446 . . . . 1.04 110.299 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 136' ' ' SER . 2.6 p -65.19 137.17 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.954 -0.566 . . . . 0.23999999999999999 110.027 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 185' ' ' ILE . 92.5 p -96.14 -15.56 22.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.263 0.554 . . . . 0.28999999999999998 110.101 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.62 175.58 45.81 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 109.772 -1.331 . . . . 0.13 109.772 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.4 151.59 42.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.971 0.415 . . . . 0.17000000000000001 110.516 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.583 ' NH2' ' HB3' ' A' ' 157' ' ' TYR . 78.1 ttt-85 -132.42 121.17 23.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.103 -0.499 . . . . 1.29 109.964 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.557 HG21 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.14 136.56 38.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.708 -0.678 . . . . 0.25 110.684 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 84.1 tt0 -129.34 129.8 45.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.961 -0.563 . . . . 1.3200000000000001 110.085 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.64 135.24 34.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.033 -0.53 . . . . 0.56999999999999995 110.703 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.41 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.25 161.3 39.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.865 -0.607 . . . . 1.1599999999999999 109.763 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.956 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.0 124.89 25.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.006 0.432 . . . . 0.38 110.763 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.87 -7.66 49.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.816 -0.629 . . . . 0.40999999999999998 110.84 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -109.79 -69.67 0.85 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.01 0.433 . . . . 1.6599999999999999 111.514 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.461 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.3 mt-10 -60.76 -35.22 75.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.033 -0.53 . . . . 1.6599999999999999 111.51 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.094 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.07 7.27 88.56 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.804 -0.919 . . . . 1.1699999999999999 110.804 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.323 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.9 t0 -27.95 -171.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.761 0.315 . . . . 1.8600000000000001 110.314 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.323 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.2 pm0 -82.27 139.11 45.11 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.044 0.449 . . . . 1.98 110.226 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.41 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.94 145.87 51.46 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.726 2.284 . . . . 0.55000000000000004 112.32 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.81 145.7 42.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.217 -0.66 . . . . 1.1399999999999999 109.217 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.583 ' HB3' ' NH2' ' A' ' 143' ' ' ARG . 4.0 p90 -123.31 141.32 52.11 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.349 -0.54 . . . . 0.93000000000000005 111.537 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.4 mt -128.05 127.66 43.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.239 -0.892 . . . . 0.34000000000000002 108.932 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.671 ' OD2' ' ND2' ' A' ' 16' ' ' ASN . 63.3 t0 -101.49 131.12 47.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.135 0.493 . . . . 1.0900000000000001 111.879 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.437 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.1 mt -127.93 157.57 73.34 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.358 -0.837 . . . . 0.19 109.566 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.83 157.98 58.41 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.492 2.128 . . . . 0.17999999999999999 112.311 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.22 -12.16 4.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.855 -0.611 . . . . 0.20999999999999999 110.822 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.5 p -92.77 -8.69 42.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.058 -0.519 . . . . 0.28999999999999998 110.734 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.2 135.39 34.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.413 . . . . 0.5 110.357 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.16 16.68 4.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.439 -0.346 . . . . 0.29999999999999999 110.504 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.1 p -167.59 147.13 5.04 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.63 -0.507 . . . . 0.23000000000000001 109.63 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.21 150.61 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 0.28000000000000003 111.525 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.508 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.37 124.9 50.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.559 -0.746 . . . . 1.0700000000000001 109.789 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.28 104.87 29.22 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.424 -0.353 . . . . 0.28999999999999998 111.088 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.0 Cg_endo -91.0 -179.5 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 123.235 2.624 . . . . 0.42999999999999999 112.251 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.71 32.58 18.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.413 -0.812 . . . . 1.26 111.438 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.45 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.0 mt -86.35 148.5 25.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.772 0.32 . . . . 0.32000000000000001 110.486 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.762 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.3 114.83 61.22 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.075 0.464 . . . . 0.57999999999999996 110.704 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.01 140.57 95.94 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.821 2.348 . . . . 0.66000000000000003 112.04 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.17 74.42 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.101 -0.8 . . . . 0.28999999999999998 111.101 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.461 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.84 150.23 49.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.896 0.379 . . . . 2.3300000000000001 110.598 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.488 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.1 tttt -100.14 131.75 45.91 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.997 -0.547 . . . . 0.85999999999999999 109.799 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.956 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.62 148.26 44.13 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.114 -0.494 . . . . 0.52000000000000002 110.992 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.2 mt -105.32 125.37 60.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.298 -1.001 . . . . 0.29999999999999999 108.298 177.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.5 132.57 63.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.154 0.502 . . . . 0.23000000000000001 111.305 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.57 122.58 20.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.494 -0.775 . . . . 0.35999999999999999 109.537 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.585 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.0 125.33 54.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.227 -0.442 . . . . 0.19 110.739 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.3 m-85 -117.21 137.76 52.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.064 -0.516 . . . . 0.29999999999999999 109.926 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.575 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.66 134.96 42.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.805 -0.813 . . . . 0.37 108.805 178.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.6 ' O ' ' N ' ' A' ' 140' ' ' SER . 7.7 mm -99.11 122.91 51.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.177 0.513 . . . . 0.26000000000000001 110.922 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.6 p -83.76 169.74 14.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.533 -0.758 . . . . 0.28000000000000003 110.494 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.706 ' O ' ' OG1' ' A' ' 59' ' ' THR . 97.5 mt-10 -59.74 -14.59 15.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.011 -0.541 . . . . 1.6000000000000001 111.028 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -96.12 -4.22 43.16 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.804 -0.358 . . . . 1.1799999999999999 110.792 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.79 13.85 64.07 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.388 -0.685 . . . . 0.29999999999999999 111.388 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -84.58 139.01 32.4 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.107 -0.237 . . . . 1.22 110.506 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.724 ' CD ' HE22 ' A' ' 14' ' ' GLN . 11.8 mt-30 -106.68 141.09 38.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.815 0.34 . . . . 0.97999999999999998 110.584 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.1 m -136.71 126.93 26.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.82999999999999996 110.359 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.07 117.3 9.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.278 -0.419 . . . . 0.26000000000000001 110.551 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.05 -21.7 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.29999999999999999 110.764 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.91 125.69 5.84 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.542 -0.463 . . . . 0.31 111.459 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.471 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.8 120.28 21.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.726 -0.67 . . . . 0.28000000000000003 109.517 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.63 151.62 29.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.917 0.389 . . . . 0.23999999999999999 110.984 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.43 158.5 18.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.049 -0.523 . . . . 0.23000000000000001 110.464 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -145.97 157.93 43.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.235 -0.439 . . . . 0.67000000000000004 110.768 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 104.54 9.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.784 -0.644 . . . . 0.64000000000000001 109.972 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 68.1 p . . . . . 0 C--O 1.219 -0.534 0 CA-C-O 117.882 -1.056 . . . . 1.26 110.617 -179.706 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.6 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.199 -0.667 . . . . 3.4399999999999999 109.199 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.38 150.7 18.54 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.024 -0.83 . . . . 1.22 111.024 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -35.66 142.4 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.101 0 C-N-CA 124.025 3.15 . . . . 0.75 113.742 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.97 173.32 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.29 -1.323 . . . . 0.79000000000000004 108.769 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.614 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.55 125.93 51.55 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.411 -0.516 . . . . 1.9399999999999999 111.44 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.55 143.95 34.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.618 -0.719 . . . . 0.59999999999999998 110.622 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.05 168.31 25.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.931 0.396 . . . . 3.1400000000000001 111.12 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.748 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -108.98 131.06 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.957 -0.565 . . . . 3.23 110.076 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.2 162.31 35.79 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.954 0.407 . . . . 3.6299999999999999 111.194 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.469 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 73.1 tt0 36.14 31.53 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.637 -0.505 . . . . 6.0800000000000001 109.637 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.748 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.42 69.58 32.41 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.958 -0.564 . . . . 3.3799999999999999 111.621 -178.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.29 -29.09 72.62 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.529 2.153 . . . . 3.9300000000000002 111.802 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.52 125.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 3.3599999999999999 110.548 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.529 ' CB ' ' O ' ' A' ' 17' ' ' SER . 11.7 mt-30 -123.89 158.34 60.33 Favored Pre-proline 0 C--O 1.234 0.26 0 CA-C-N 116.241 -0.436 . . . . 3.6099999999999999 110.537 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.486 ' CG ' ' NH1' ' A' ' 143' ' ' ARG . 98.3 Cg_endo -82.12 -64.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.931 2.42 . . . . 1.51 113.457 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.627 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 61.9 t30 -108.4 -19.5 13.44 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.114 0.413 . . . . 2.6800000000000002 112.114 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 29.7 t -107.31 152.1 24.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.148 0.499 . . . . 1.21 111.339 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.578 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.24 102.92 2.23 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.687 -0.688 . . . . 1.5600000000000001 110.61 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.72 145.64 12.95 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.888 2.392 . . . . 0.81000000000000005 112.568 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.932 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.81 167.98 24.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.896 -0.593 . . . . 1.52 109.961 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.23 147.89 28.94 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.776 -0.453 . . . . 2.1400000000000001 109.776 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.597 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.4 p90 -142.24 157.29 45.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.017 0.437 . . . . 0.32000000000000001 111.196 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.499 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.04 155.26 44.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.715 -0.675 . . . . 2.1699999999999999 110.064 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.835 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.6 173.05 6.34 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 121.111 0.481 . . . . 0.58999999999999997 110.728 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.835 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.69 173.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.779 2.319 . . . . 0.90000000000000002 111.533 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.484 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.1 -51.03 0.69 Allowed Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 120.694 -0.402 . . . . 3.3399999999999999 110.111 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.617 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.81 152.32 82.52 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.737 2.291 . . . . 1.8500000000000001 111.483 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.64 42.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.332 0.587 . . . . 2.54 110.564 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.814 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.65 -41.55 98.21 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.953 -1.021 . . . . 2.5299999999999998 110.722 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.1 mt -109.87 137.89 40.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.842 -0.617 . . . . 1.1699999999999999 111.276 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.93 -72.95 0.7 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.063 -0.517 . . . . 1.27 111.911 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.09 148.28 24.54 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.593 0.59 . . . . 1.1200000000000001 112.593 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.81 124.94 45.36 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.324 -0.621 . . . . 0.41999999999999998 109.324 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.03 134.75 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.619 -0.433 . . . . 0.78000000000000003 110.705 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.932 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.99 128.59 53.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.998 0.428 . . . . 0.62 111.281 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.06 138.95 49.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.741 -0.663 . . . . 1.97 110.14 179.008 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.434 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.2 p90 -145.08 163.14 35.2 Favored 'General case' 0 C--N 1.335 -0.065 0 CA-C-O 121.197 0.523 . . . . 0.34999999999999998 112.036 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.488 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.48 139.63 7.89 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.38 -0.827 . . . . 1.8 110.482 178.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.63 115.47 3.07 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.392 2.061 . . . . 0.57999999999999996 111.767 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.684 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.0 81.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.927 -0.397 . . . . 3.04 109.927 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.931 -0.577 . . . . 2.4700000000000002 111.943 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.2 p -157.59 157.8 34.37 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.865 -0.334 . . . . 2.5099999999999998 110.577 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.408 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.4 m -120.38 27.8 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 1.8600000000000001 110.213 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.7 -75.9 1.31 Allowed Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.11 -0.566 . . . . 1.4399999999999999 111.878 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.88 152.29 35.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.411 . . . . 4.6900000000000004 110.949 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.665 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.18 -169.07 2.52 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.032 -0.531 . . . . 1.4299999999999999 111.96 179.343 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.77 29.59 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 121.48 0.657 . . . . 1.74 112.539 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.15 156.47 45.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.784 -1.098 . . . . 1.9199999999999999 110.242 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.2 158.35 41.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.931 -0.577 . . . . 0.34000000000000002 111.841 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.14 135.67 53.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.539 -0.755 . . . . 0.40999999999999998 109.832 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.597 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.44 121.91 23.71 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.474 -0.33 . . . . 0.55000000000000004 111.55 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.607 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.4 Cg_exo -46.26 151.7 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.65 2.234 . . . . 0.44 112.124 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.97 -22.97 63.12 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 116.026 -0.533 . . . . 0.73999999999999999 112.843 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.82 -16.79 46.39 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.213 -0.595 . . . . 0.93000000000000005 111.837 -178.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.607 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.64 138.39 31.6 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.798 -0.361 . . . . 0.96999999999999997 110.323 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.54 14.01 11.0 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.426 -0.352 . . . . 1.3400000000000001 111.527 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.07 143.46 25.14 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.671 -0.411 . . . . 0.39000000000000001 111.075 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.716 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.78 -169.39 1.54 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.006 -0.543 . . . . 0.41999999999999998 110.888 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.716 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 m -151.69 125.89 9.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.4 -0.818 . . . . 0.39000000000000001 109.882 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.51 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.9 mt -114.88 123.23 70.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.409 -0.516 . . . . 0.73999999999999999 111.117 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.576 ' HG2' ' N ' ' A' ' 62' ' ' GLY . 37.8 ttpt -126.42 163.38 23.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.824 -0.625 . . . . 2.48 110.49 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.576 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.07 19.04 59.86 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.795 -0.922 . . . . 0.5 110.795 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.627 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.8 mt -79.06 157.17 28.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.043 0.449 . . . . 0.57999999999999996 111.345 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.844 ' O ' HG12 ' A' ' 67' ' ' VAL . 1.5 tttp -99.44 133.93 21.58 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.569 -0.741 . . . . 2.79 110.451 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.491 ' HD3' ' CD1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.84 143.61 61.76 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.505 2.137 . . . . 0.87 112.01 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.75 25.67 75.28 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.071 -0.812 . . . . 0.64000000000000001 111.071 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.3 p -128.07 158.74 39.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.715 0.293 . . . . 0.82999999999999996 110.484 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.11 139.92 42.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.88 0.371 . . . . 0.5 110.581 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.651 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.9 m-85 -122.6 136.51 54.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 0.53000000000000003 110.764 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.91 131.05 45.28 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.485 -0.932 . . . . 1.8700000000000001 108.485 177.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.52 153.93 16.65 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.251 -0.976 . . . . 0.28999999999999998 111.927 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.05 140.89 45.93 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.68 -0.489 . . . . 1.4299999999999999 109.68 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.78 118.88 34.25 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.508 -0.477 . . . . 0.32000000000000001 110.468 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.736 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.43 129.05 68.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 0.79000000000000004 110.578 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.699 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.84 120.86 43.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.213 -0.449 . . . . 1.02 110.75 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.859 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.63 146.46 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.175 0.512 . . . . 0.62 111.032 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.814 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.0 mt-30 -105.97 153.85 21.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.565 -0.743 . . . . 2.4399999999999999 110.001 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.2 mt-30 -39.21 88.58 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.92 0.391 . . . . 3.6899999999999999 110.442 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.23 32.72 0.21 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.77 -0.65 . . . . 6.0800000000000001 110.558 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.34 3.29 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.499 -0.64 . . . . 1.22 111.499 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.471 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.4 177.4 9.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.244 0.545 . . . . 2.8799999999999999 111.596 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.15 149.55 32.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.407 -0.815 . . . . 1.47 110.495 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.14 144.65 38.72 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.489 -0.323 . . . . 2.7000000000000002 110.596 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.736 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.0 135.94 61.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 121.052 0.453 . . . . 0.46000000000000002 111.573 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -123.99 141.35 52.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.688 -0.687 . . . . 0.34999999999999998 110.306 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.477 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.6 138.81 51.69 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.113 0.482 . . . . 3.6699999999999999 111.528 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.19 164.18 37.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.568 -0.742 . . . . 0.67000000000000004 109.514 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.561 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.29 151.54 38.51 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.351 -0.54 . . . . 1.47 111.008 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.807 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.16 172.71 13.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.747 -0.66 . . . . 0.44 111.015 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.68 160.73 21.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.414 -0.812 . . . . 1.3700000000000001 109.915 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.44 121.86 22.86 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.548 -0.461 . . . . 1.28 110.8 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.4 p -128.55 165.39 20.83 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.458 0.91 . . . . 1.97 113.458 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 76.2 p . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 113.894 -1.503 . . . . 3.2799999999999998 107.552 177.146 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.481 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 121.976 0.893 . . . . 0.66000000000000003 110.399 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.435 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.9 167.54 0.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.875 -1.057 . . . . 0.68999999999999995 110.868 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.5 145.52 50.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.664 -0.698 . . . . 0.52000000000000002 110.16 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.23 101.64 9.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.104 -0.702 . . . . 0.32000000000000001 109.104 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.0 t -113.02 139.68 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.078 -0.51 . . . . 0.28999999999999998 111.033 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.6 p -128.7 152.49 48.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.6 -0.727 . . . . 0.25 109.827 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.59 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.5 p90 -144.72 -164.92 2.02 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.759 -0.376 . . . . 0.31 110.668 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.3 t -123.94 127.21 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.48999999999999999 110.812 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.174 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -58.03 58.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 1.53 110.313 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.743 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.1 24.48 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.881 -0.6 . . . . 0.96999999999999997 111.52 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.174 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.23 128.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.633 -0.427 . . . . 1.5600000000000001 110.994 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.46 -9.58 55.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.009 -0.542 . . . . 1.8799999999999999 110.38 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.4 p -87.16 0.4 55.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.043 -0.526 . . . . 1.04 110.307 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.31 137.22 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 116.018 -0.537 . . . . 0.23999999999999999 109.939 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 185' ' ' ILE . 60.9 m -96.33 -15.45 21.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.276 0.56 . . . . 0.28999999999999998 110.003 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.57 175.57 45.76 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 109.876 -1.289 . . . . 0.13 109.876 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.39 151.63 42.38 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.716 -0.394 . . . . 0.17000000000000001 110.541 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.695 ' NH1' ' OE1' ' A' ' 191' ' ' GLN . 20.6 ttm180 -132.43 121.12 22.91 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.18 -0.464 . . . . 1.29 109.955 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.555 HG21 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.11 136.56 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.652 -0.704 . . . . 0.25 110.635 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 84.7 tt0 -129.37 129.97 45.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.951 -0.568 . . . . 1.3200000000000001 109.992 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.624 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.79 135.21 34.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.983 -0.553 . . . . 0.56999999999999995 110.616 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.418 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.32 39.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.775 -0.648 . . . . 1.1599999999999999 109.668 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.972 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.4 mt -70.98 124.84 25.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.077 0.465 . . . . 0.38 110.738 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.0 p -71.6 -7.88 50.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.735 -0.666 . . . . 0.40999999999999998 110.879 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.79 -69.59 0.85 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.316 -0.402 . . . . 1.6599999999999999 111.473 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.478 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.61 -35.45 76.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.16 -0.473 . . . . 1.6599999999999999 111.477 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.085 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.21 88.61 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.783 -0.927 . . . . 1.1699999999999999 110.783 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.328 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.9 t0 -27.9 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.675 0.274 . . . . 1.8600000000000001 110.351 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.328 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.2 pm0 -82.2 139.02 45.31 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.925 0.393 . . . . 1.98 110.25 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.418 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.9 Cg_endo -70.9 145.8 51.47 Favored 'Trans proline' 0 C--N 1.302 -1.91 0 C-N-CA 122.671 2.247 . . . . 0.55000000000000004 112.392 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.77 145.82 42.47 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.237 -0.653 . . . . 1.1399999999999999 109.237 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.491 ' CD1' ' HD3' ' A' ' 65' ' ' PRO . 6.1 p90 -123.39 141.32 52.11 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.385 -0.526 . . . . 0.93000000000000005 111.486 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.0 mt -128.17 127.69 43.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.247 -0.888 . . . . 0.34000000000000002 108.922 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 68.3 t0 -101.7 131.21 48.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.184 0.516 . . . . 1.0900000000000001 111.683 -178.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.479 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -127.93 157.48 73.66 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.276 -0.875 . . . . 0.19 109.614 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -69.74 158.03 58.4 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.37 2.047 . . . . 0.17999999999999999 112.304 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.28 -12.2 5.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.825 -0.625 . . . . 0.20999999999999999 110.677 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.3 p -92.73 -8.83 42.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.28999999999999998 110.749 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.47 34.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.5 110.407 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.8 p -133.15 16.52 4.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.38 . . . . 0.29999999999999999 110.579 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.5 p -167.53 147.17 5.1 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.626 -0.509 . . . . 0.23000000000000001 109.626 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.555 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.2 150.44 12.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.518 -0.473 . . . . 0.28000000000000003 111.54 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.506 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.31 125.01 50.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.634 -0.712 . . . . 1.0700000000000001 109.789 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.51 104.88 30.09 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.911 0.386 . . . . 0.28999999999999998 111.054 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.4 Cg_endo -90.93 -179.53 1.52 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 123.2 2.6 . . . . 0.42999999999999999 112.24 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.74 32.58 18.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.415 -0.812 . . . . 1.26 111.394 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.481 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.2 mt -86.27 148.56 25.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.528 -0.305 . . . . 0.32000000000000001 110.586 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.76 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.33 114.8 61.1 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.007 0.432 . . . . 0.57999999999999996 110.707 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.0 140.62 96.17 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.878 2.385 . . . . 0.66000000000000003 112.009 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.03 21.27 74.31 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.021 -0.831 . . . . 0.28999999999999998 111.021 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.478 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.86 150.13 49.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.759 0.314 . . . . 2.3300000000000001 110.685 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.17 131.61 46.02 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.052 -0.522 . . . . 0.85999999999999999 109.825 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.972 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.1 m-85 -120.48 148.27 44.04 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.161 -0.472 . . . . 0.52000000000000002 111.018 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.28 125.37 60.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.279 -1.008 . . . . 0.29999999999999999 108.279 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.52 132.5 63.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.138 0.494 . . . . 0.23000000000000001 111.202 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.5 122.54 20.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.585 -0.734 . . . . 0.35999999999999999 109.673 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.59 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -100.95 125.46 54.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.296 -0.411 . . . . 0.19 110.609 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.0 m-85 -117.31 137.93 52.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.043 -0.526 . . . . 0.29999999999999999 109.823 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.577 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.73 135.0 42.86 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.774 -0.824 . . . . 0.37 108.774 178.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.554 ' O ' ' N ' ' A' ' 140' ' ' SER . 89.1 mt -99.04 122.96 51.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.102 0.477 . . . . 0.26000000000000001 110.988 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.0 p -83.85 169.65 14.91 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.538 -0.756 . . . . 0.28000000000000003 110.444 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -59.72 -14.6 14.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.012 -0.54 . . . . 1.6000000000000001 110.937 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.477 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.0 m-20 -95.97 -4.37 43.4 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.83 -0.348 . . . . 1.1799999999999999 110.834 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.85 13.95 63.79 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.347 -0.701 . . . . 0.29999999999999999 111.347 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -84.71 138.97 32.33 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.999 -0.281 . . . . 1.22 110.481 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.695 ' OE1' ' NH1' ' A' ' 143' ' ' ARG . 14.9 pt20 -106.6 141.08 38.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.97999999999999998 110.553 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.0 m -136.64 127.1 26.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.82999999999999996 110.409 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.29 117.36 9.99 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.683 -0.407 . . . . 0.26000000000000001 110.481 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.03 -21.84 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.29999999999999999 110.677 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.89 125.75 5.88 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.565 -0.454 . . . . 0.31 111.452 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.473 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.74 120.26 21.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.683 -0.69 . . . . 0.28000000000000003 109.505 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.61 151.73 29.17 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.653 -0.419 . . . . 0.23999999999999999 110.938 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.46 158.67 18.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.055 -0.521 . . . . 0.23000000000000001 110.404 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.4 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 21.5 mt-30 -146.14 157.89 43.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.174 -0.466 . . . . 0.67000000000000004 110.67 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.25 104.41 9.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.734 -0.666 . . . . 0.64000000000000001 110.1 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.9 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.853 -1.07 . . . . 1.26 110.667 -179.675 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.2 m . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.191 -0.67 . . . . 3.4399999999999999 109.191 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.34 150.65 18.55 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.057 -0.817 . . . . 1.22 111.057 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -35.67 142.41 0.1 Allowed 'Trans proline' 0 C--N 1.297 -2.166 0 C-N-CA 124.115 3.21 . . . . 0.75 113.718 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.605 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.4 t -80.07 173.53 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.205 -1.361 . . . . 0.79000000000000004 108.742 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.605 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.68 125.81 51.42 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.41 -0.516 . . . . 1.9399999999999999 111.522 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.44 143.97 34.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.684 -0.689 . . . . 0.59999999999999998 110.699 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.98 168.25 25.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.971 0.415 . . . . 3.1400000000000001 111.097 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.746 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.0 mt -108.94 131.05 60.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.935 -0.575 . . . . 3.23 110.118 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.21 162.34 35.72 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.468 -0.333 . . . . 3.6299999999999999 111.257 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 72.7 tt0 36.14 31.47 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 109.653 -0.499 . . . . 6.0800000000000001 109.653 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.746 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.35 69.54 31.59 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.935 -0.575 . . . . 3.3799999999999999 111.582 -178.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.632 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.22 -29.2 73.35 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.592 2.195 . . . . 3.9300000000000002 111.814 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.668 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 3.2 m 149.63 125.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 3.3599999999999999 110.413 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.668 ' NE2' ' O ' ' A' ' 13' ' ' SER . 1.8 mp0 -123.95 158.35 60.46 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.265 -0.425 . . . . 3.6099999999999999 110.481 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.646 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 98.3 Cg_endo -82.14 -64.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.83 2.353 . . . . 1.51 113.498 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.642 ' OD1' ' N ' ' A' ' 17' ' ' SER . 23.5 p-10 -108.44 -19.61 13.4 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.027 0.38 . . . . 2.6800000000000002 112.027 -178.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.642 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 93.6 p -107.4 151.93 24.86 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.469 -0.492 . . . . 1.21 111.297 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.576 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.11 102.98 2.26 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.684 -0.689 . . . . 1.5600000000000001 110.671 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.476 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.7 Cg_endo -82.72 145.72 12.99 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.872 2.381 . . . . 0.81000000000000005 112.556 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.909 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.84 167.97 24.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.849 -0.614 . . . . 1.52 109.879 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.15 147.94 29.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.795 -0.446 . . . . 2.1400000000000001 109.795 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.585 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.7 p90 -142.26 157.31 44.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.038 0.447 . . . . 0.32000000000000001 111.248 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.494 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.04 155.33 44.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.813 -0.631 . . . . 2.1699999999999999 110.09 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.831 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.6 173.19 6.18 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.085 -0.507 . . . . 0.58999999999999997 110.779 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.831 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.72 173.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.844 2.363 . . . . 0.90000000000000002 111.51 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.479 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -51.03 0.69 Allowed Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.723 -0.391 . . . . 3.3399999999999999 110.141 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.634 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.8 152.31 82.57 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.765 2.31 . . . . 1.8500000000000001 111.449 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.68 42.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.428 0.632 . . . . 2.54 110.631 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.821 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.56 -41.63 98.4 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.931 -1.031 . . . . 2.5299999999999998 110.676 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.533 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.2 mt -109.86 137.91 39.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.763 -0.653 . . . . 1.1699999999999999 111.234 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.01 -72.9 0.7 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.987 -0.551 . . . . 1.27 111.843 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.21 148.4 24.39 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.547 0.573 . . . . 1.1200000000000001 112.547 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.76 124.82 45.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.458 -0.571 . . . . 0.41999999999999998 109.458 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.7 mt -118.07 134.72 60.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.665 -0.414 . . . . 0.78000000000000003 110.632 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.909 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.99 128.64 53.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.062 0.458 . . . . 0.62 111.277 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.12 138.98 49.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.73 -0.668 . . . . 1.97 110.145 178.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.437 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.05 163.14 35.16 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.178 0.513 . . . . 0.34999999999999998 112.055 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.45 139.53 7.86 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.377 -0.829 . . . . 1.8 110.451 178.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.49 115.45 3.04 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.285 1.99 . . . . 0.57999999999999996 111.796 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.667 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.91 81.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.933 -0.395 . . . . 3.04 109.933 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.688 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.24 -20.58 0.06 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.059 -0.519 . . . . 2.4700000000000002 111.971 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.9 p -157.67 157.79 34.22 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.836 -0.345 . . . . 2.5099999999999998 110.604 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.404 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.41 27.77 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 1.8600000000000001 110.195 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.86 -75.84 1.31 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.022 -0.609 . . . . 1.4399999999999999 111.805 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.86 152.4 35.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.946 0.403 . . . . 4.6900000000000004 110.954 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.28 -169.18 2.54 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.0 -0.546 . . . . 1.4299999999999999 111.972 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.74 29.63 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.379 0.609 . . . . 1.74 112.611 -177.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.03 156.46 46.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.768 -1.105 . . . . 1.9199999999999999 110.291 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.18 158.36 41.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.004 -0.544 . . . . 0.34000000000000002 111.83 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 m -115.16 135.59 54.02 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.433 -0.803 . . . . 0.40999999999999998 109.893 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.585 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.3 121.94 23.89 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.509 -0.314 . . . . 0.55000000000000004 111.545 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.602 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.7 Cg_exo -46.28 151.74 1.59 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.744 2.296 . . . . 0.44 112.084 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.0 -23.03 63.27 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 116.045 -0.525 . . . . 0.73999999999999999 112.779 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.547 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.75 -16.88 46.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.384 0.592 . . . . 0.93000000000000005 111.81 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.602 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.6 mt -91.6 138.43 31.57 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.768 -0.373 . . . . 0.96999999999999997 110.254 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.54 14.0 11.0 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.302 -0.408 . . . . 1.3400000000000001 111.458 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.476 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.0 p -149.99 143.46 25.21 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.684 -0.406 . . . . 0.39000000000000001 111.081 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.722 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.82 -169.39 1.54 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.22 0.533 . . . . 0.41999999999999998 110.83 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.722 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.8 m -151.75 125.94 9.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.406 -0.815 . . . . 0.39000000000000001 109.832 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 67.0 mt -114.93 123.34 70.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.36 -0.536 . . . . 0.73999999999999999 111.134 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.747 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 16.6 ptpt -126.55 163.4 23.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.742 -0.663 . . . . 2.48 110.388 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.02 19.22 59.64 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.721 -0.951 . . . . 0.5 110.721 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.514 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.2 mt -79.16 157.23 27.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.127 0.489 . . . . 0.57999999999999996 111.306 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.85 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -99.47 133.98 21.52 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.588 -0.733 . . . . 2.79 110.486 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.458 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.88 143.62 61.6 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.554 2.169 . . . . 0.87 111.915 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.82 25.55 75.43 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.084 -0.806 . . . . 0.64000000000000001 111.084 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.85 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.3 p -128.09 158.75 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.691 0.281 . . . . 0.82999999999999996 110.51 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.06 139.99 41.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.908 0.385 . . . . 0.5 110.591 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.657 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.4 m-85 -122.62 136.43 54.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.948 -0.569 . . . . 0.53000000000000003 110.801 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.91 131.07 45.27 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.479 -0.934 . . . . 1.8700000000000001 108.479 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.57 153.89 16.67 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.281 -0.961 . . . . 0.28999999999999998 111.974 -178.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.01 140.9 46.02 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.628 -0.508 . . . . 1.4299999999999999 109.628 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.525 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.74 118.92 34.39 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.447 -0.501 . . . . 0.32000000000000001 110.551 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.738 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.42 129.1 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.378 -0.373 . . . . 0.79000000000000004 110.635 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.84 120.9 43.93 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.326 -0.397 . . . . 1.02 110.683 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.86 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.64 146.45 11.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.143 0.497 . . . . 0.62 111.099 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.821 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.5 mt-30 -106.0 153.92 21.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.58 -0.736 . . . . 2.4399999999999999 109.91 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.24 88.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.93 0.395 . . . . 3.6899999999999999 110.441 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.33 32.58 0.22 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.8 -0.636 . . . . 6.0800000000000001 110.543 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.03 -117.4 3.3 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.436 -0.666 . . . . 1.22 111.436 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.464 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.32 177.36 9.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.134 0.492 . . . . 2.8799999999999999 111.697 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.19 149.49 32.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.44 -0.8 . . . . 1.47 110.422 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.11 144.65 38.78 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.438 -0.346 . . . . 2.7000000000000002 110.624 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.738 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -127.97 136.02 61.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.135 0.493 . . . . 0.46000000000000002 111.527 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.09 141.37 52.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.681 -0.691 . . . . 0.34999999999999998 110.299 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.47 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.62 138.89 51.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.074 0.464 . . . . 3.6699999999999999 111.446 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.489 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.33 164.1 38.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.575 -0.739 . . . . 0.67000000000000004 109.485 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.577 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.28 151.51 38.47 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.393 -0.523 . . . . 1.47 111.048 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.804 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.2 p90 -146.21 172.79 12.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 0.44 110.972 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.82 160.72 21.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.345 -0.843 . . . . 1.3700000000000001 109.804 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.4 121.94 23.01 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.582 -0.447 . . . . 1.28 110.745 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.547 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -126.63 158.61 35.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.385 0.612 . . . . 1.97 112.279 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 115.29 -0.868 . . . . 3.2799999999999998 111.185 179.698 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.634 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 4.5 p . . . . . 0 N--CA 1.466 0.333 0 CA-C-O 121.473 0.654 . . . . 0.66000000000000003 110.167 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.438 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.9 167.55 0.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.297 -0.865 . . . . 0.68999999999999995 110.932 -179.636 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.54 145.56 50.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.707 -0.679 . . . . 0.52000000000000002 110.112 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.24 101.69 9.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.08 -0.711 . . . . 0.32000000000000001 109.08 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.3 t -113.0 139.62 37.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.108 -0.497 . . . . 0.28999999999999998 111.063 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.9 p -128.7 152.59 48.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.651 -0.704 . . . . 0.25 109.877 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.59 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.84 -164.96 2.04 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.63 -0.428 . . . . 0.31 110.621 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.9 t -123.97 127.23 73.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.48999999999999999 110.819 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.172 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.92 58.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.49 . . . . 1.53 110.37 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.17 24.62 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.925 -0.58 . . . . 0.96999999999999997 111.538 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.172 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.1 128.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.61 -0.436 . . . . 1.5600000000000001 110.932 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -86.38 -9.68 55.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.895 -0.593 . . . . 1.8799999999999999 110.332 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.07 0.21 55.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.115 -0.493 . . . . 1.04 110.304 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.26 137.16 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 0.23999999999999999 109.952 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.747 ' O ' ' NZ ' ' A' ' 61' ' ' LYS . 69.3 m -96.19 -15.56 21.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.242 0.544 . . . . 0.28999999999999998 110.019 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.61 175.56 45.78 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 109.915 -1.274 . . . . 0.13 109.915 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.44 151.66 42.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.027 0.442 . . . . 0.17000000000000001 110.465 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.764 ' NH2' ' OE2' ' A' ' 145' ' ' GLU . 31.6 ttt85 -132.43 121.23 23.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.058 -0.519 . . . . 1.29 109.887 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.11 136.47 38.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.697 -0.683 . . . . 0.25 110.655 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.764 ' OE2' ' NH2' ' A' ' 143' ' ' ARG . 97.6 mt-10 -129.37 129.86 45.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.097 -0.501 . . . . 1.3200000000000001 109.991 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.618 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.7 135.4 34.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.954 -0.566 . . . . 0.56999999999999995 110.614 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.417 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.44 161.27 40.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.78 -0.646 . . . . 1.1599999999999999 109.702 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.4 mt -71.0 124.81 25.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.029 0.442 . . . . 0.38 110.736 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.66 -7.82 50.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.726 -0.67 . . . . 0.40999999999999998 110.872 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -109.75 -69.6 0.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 1.6599999999999999 111.484 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.441 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.64 -35.39 76.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.053 -0.521 . . . . 1.6599999999999999 111.557 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.086 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.26 88.57 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.807 -0.917 . . . . 1.1699999999999999 110.807 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.337 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.89 -171.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 1.8600000000000001 110.278 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.337 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.09 45.2 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.021 0.439 . . . . 1.98 110.236 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.417 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.3 Cg_endo -70.96 145.86 51.26 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 C-N-CA 122.7 2.267 . . . . 0.55000000000000004 112.35 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.83 145.78 42.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.202 -0.666 . . . . 1.1399999999999999 109.202 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.521 ' CB ' ' NH1' ' A' ' 143' ' ' ARG . 35.9 p90 -123.33 141.31 52.11 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.303 -0.559 . . . . 0.93000000000000005 111.484 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.0 mt -128.1 127.7 43.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.317 -0.856 . . . . 0.34000000000000002 108.94 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.527 ' O ' ' OD1' ' A' ' 159' ' ' ASP . 54.7 p-10 -101.65 131.2 48.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.206 0.526 . . . . 1.0900000000000001 111.794 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.96 157.55 73.48 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.286 -0.87 . . . . 0.19 109.533 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.91 157.95 58.4 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 122.369 2.046 . . . . 0.17999999999999999 112.261 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.24 -12.04 4.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.832 -0.622 . . . . 0.20999999999999999 110.761 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.8 p -92.92 -8.74 42.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.451 . . . . 0.28999999999999998 110.642 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.25 135.47 34.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.349 -0.387 . . . . 0.5 110.353 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.8 p -133.21 16.79 4.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 0.29999999999999999 110.52 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.0 p -167.6 147.11 5.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.633 -0.506 . . . . 0.23000000000000001 109.633 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.12 150.46 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.516 -0.473 . . . . 0.28000000000000003 111.521 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.509 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 124.88 50.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.659 -0.7 . . . . 1.0700000000000001 109.849 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.31 104.91 29.58 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.377 -0.374 . . . . 0.28999999999999998 111.143 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.2 Cg_endo -91.0 -179.49 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.926 0 C-N-CA 123.135 2.557 . . . . 0.42999999999999999 112.218 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.69 32.59 18.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.31 -0.859 . . . . 1.26 111.465 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.634 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.1 mt -86.33 148.56 25.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.812 0.339 . . . . 0.32000000000000001 110.404 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.769 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.32 114.82 61.21 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.093 0.473 . . . . 0.57999999999999996 110.665 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.96 140.61 96.07 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.916 2.41 . . . . 0.66000000000000003 111.935 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.11 21.06 74.57 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.132 -0.787 . . . . 0.28999999999999998 111.132 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.441 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.76 150.16 49.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.746 0.308 . . . . 2.3300000000000001 110.668 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.495 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.21 131.61 46.06 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.105 -0.498 . . . . 0.85999999999999999 109.767 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.955 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.48 148.26 44.06 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.039 -0.528 . . . . 0.52000000000000002 110.948 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.6 mt -105.33 125.43 60.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.308 -0.997 . . . . 0.29999999999999999 108.308 177.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.64 132.5 63.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.199 0.523 . . . . 0.23000000000000001 111.174 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.64 20.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.549 -0.75 . . . . 0.35999999999999999 109.617 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.59 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.16 125.44 55.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.175 -0.466 . . . . 0.19 110.65 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 47.9 m-85 -117.17 137.86 52.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.99 -0.55 . . . . 0.29999999999999999 109.883 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.581 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.68 135.05 42.74 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.76 -0.83 . . . . 0.37 108.76 178.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.598 ' O ' ' N ' ' A' ' 140' ' ' SER . 79.6 mt -99.06 123.0 51.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.151 0.501 . . . . 0.26000000000000001 110.964 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.2 p -83.91 169.66 14.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.531 -0.759 . . . . 0.28000000000000003 110.443 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.523 ' O ' ' OG1' ' A' ' 59' ' ' THR . 97.0 mt-10 -59.67 -14.53 14.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.031 -0.531 . . . . 1.6000000000000001 111.069 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.3 m-20 -96.15 -4.26 42.99 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.855 -0.338 . . . . 1.1799999999999999 110.825 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.81 13.93 63.9 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.301 -0.72 . . . . 0.29999999999999999 111.301 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -84.65 139.12 32.27 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.994 -0.282 . . . . 1.22 110.476 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -106.71 141.06 38.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.897 0.38 . . . . 0.97999999999999998 110.527 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.72 126.97 26.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.82999999999999996 110.408 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.406 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.1 117.31 9.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.247 -0.433 . . . . 0.26000000000000001 110.532 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.0 -21.9 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.29999999999999999 110.699 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.85 125.86 5.95 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.52 -0.472 . . . . 0.31 111.51 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.469 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.93 120.22 21.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.741 -0.663 . . . . 0.28000000000000003 109.501 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.59 151.66 29.1 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.621 -0.432 . . . . 0.23999999999999999 110.941 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.41 158.5 18.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.518 . . . . 0.23000000000000001 110.45 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.03 157.95 43.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.135 -0.484 . . . . 0.67000000000000004 110.671 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 104.3 9.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.711 -0.677 . . . . 0.64000000000000001 110.056 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.981 -1.009 . . . . 1.26 110.637 -179.691 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.157 -0.683 . . . . 3.4399999999999999 109.157 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.31 150.62 18.56 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.078 -0.809 . . . . 1.22 111.078 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -35.61 142.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 123.944 3.096 . . . . 0.75 113.835 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.621 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -79.89 173.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.275 -1.329 . . . . 0.79000000000000004 108.898 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.621 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.59 125.9 51.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.164 0.507 . . . . 1.9399999999999999 111.464 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 p -136.55 144.06 33.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.625 -0.716 . . . . 0.59999999999999998 110.602 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.07 168.27 25.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.908 0.385 . . . . 3.1400000000000001 111.112 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.737 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -108.99 131.2 60.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.947 -0.569 . . . . 3.23 110.04 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 69.3 p -141.25 162.31 35.79 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.368 -0.378 . . . . 3.6299999999999999 111.162 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 9' ' ' THR . 29.9 tt0 36.12 31.56 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.659 -0.497 . . . . 6.0800000000000001 109.659 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.737 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.48 69.56 32.91 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.881 -0.599 . . . . 3.3799999999999999 111.489 -178.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.2 -29.2 73.56 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.618 2.212 . . . . 3.9300000000000002 111.808 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.645 ' H ' HE22 ' A' ' 14' ' ' GLN . 3.2 m 149.6 125.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.14 -0.482 . . . . 3.3599999999999999 110.528 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.645 HE22 ' H ' ' A' ' 13' ' ' SER . 2.0 mp0 -124.0 158.31 60.74 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.348 -0.387 . . . . 3.6099999999999999 110.408 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.528 ' HG2' ' CD ' ' A' ' 143' ' ' ARG . 97.3 Cg_endo -81.98 -64.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.812 2.342 . . . . 1.51 113.58 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.442 ' H ' ' HG2' ' A' ' 15' ' ' PRO . 99.4 m-20 -108.51 -19.51 13.42 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.072 0.397 . . . . 2.6800000000000002 112.072 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.649 ' OG ' HD13 ' A' ' 185' ' ' ILE . 2.6 m -107.38 152.0 24.75 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.13 0.491 . . . . 1.21 111.265 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.4 t-80 -155.25 102.98 2.23 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.691 -0.686 . . . . 1.5600000000000001 110.677 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -82.69 145.61 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.936 2.424 . . . . 0.81000000000000005 112.601 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.91 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.8 167.91 24.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.932 -0.576 . . . . 1.52 109.883 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.09 147.97 29.12 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.795 -0.446 . . . . 2.1400000000000001 109.795 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.4 p90 -142.32 157.31 44.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.047 0.451 . . . . 0.32000000000000001 111.112 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.494 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -128.07 155.31 44.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.789 -0.641 . . . . 2.1699999999999999 110.127 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.827 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.59 172.93 6.51 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.17 -0.468 . . . . 0.58999999999999997 110.815 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.827 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.52 173.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 122.869 2.379 . . . . 0.90000000000000002 111.573 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.12 -51.03 0.68 Allowed Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 120.68 -0.408 . . . . 3.3399999999999999 110.126 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.621 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.79 152.39 82.27 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.744 2.296 . . . . 1.8500000000000001 111.49 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.67 42.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.379 0.609 . . . . 2.54 110.552 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.816 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.56 -41.58 98.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.011 -0.995 . . . . 2.5299999999999998 110.707 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.53 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.4 mt -109.93 137.79 40.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.765 -0.652 . . . . 1.1699999999999999 111.255 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.92 -72.9 0.7 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.096 -0.502 . . . . 1.27 111.902 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.24 148.44 24.35 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.597 0.592 . . . . 1.1200000000000001 112.597 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.84 124.93 45.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.328 -0.619 . . . . 0.41999999999999998 109.328 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.7 mt -118.16 134.74 60.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.635 -0.426 . . . . 0.78000000000000003 110.623 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.91 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.03 128.57 53.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.057 0.456 . . . . 0.62 111.216 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.12 139.04 49.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.708 -0.678 . . . . 1.97 110.069 178.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.433 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.14 163.14 35.25 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-O 121.215 0.531 . . . . 0.34999999999999998 112.017 -178.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.42 139.59 7.92 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 115.421 -0.809 . . . . 1.8 110.431 178.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.55 115.51 3.09 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.256 1.971 . . . . 0.57999999999999996 111.825 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.67 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.08 81.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.885 -0.413 . . . . 3.04 109.885 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.21 -20.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.985 -0.552 . . . . 2.4700000000000002 111.886 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 p -157.65 157.78 34.23 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.789 -0.364 . . . . 2.5099999999999998 110.548 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 m -120.39 27.84 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.239 -0.437 . . . . 1.8600000000000001 110.224 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.89 -75.83 1.31 Allowed Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.141 -0.552 . . . . 1.4399999999999999 111.832 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.91 152.39 35.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.398 . . . . 4.6900000000000004 111.015 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.63 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.23 -169.15 2.54 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.166 -0.47 . . . . 1.4299999999999999 111.943 179.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.11 149.71 29.65 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.485 0.66 . . . . 1.74 112.532 -177.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.12 156.5 45.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.756 -1.111 . . . . 1.9199999999999999 110.281 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.25 158.33 41.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.981 -0.554 . . . . 0.34000000000000002 111.783 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 m -115.23 135.68 53.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.545 -0.752 . . . . 0.40999999999999998 109.757 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.596 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.45 121.96 23.71 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.55000000000000004 111.512 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.5 Cg_exo -46.41 151.77 1.68 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.699 2.266 . . . . 0.44 112.135 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.01 -23.02 63.27 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 116.106 -0.497 . . . . 0.73999999999999999 112.735 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.1 p-80 -82.68 -16.97 46.16 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 117.379 0.59 . . . . 0.93000000000000005 111.811 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.605 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.2 mt -91.56 138.44 31.56 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.728 -0.389 . . . . 0.96999999999999997 110.278 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.57 13.98 10.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.39 -0.368 . . . . 1.3400000000000001 111.572 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.4 p -150.0 143.49 25.22 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.593 -0.443 . . . . 0.39000000000000001 111.071 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.84 -169.4 1.54 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.261 0.553 . . . . 0.41999999999999998 110.818 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.714 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.75 125.87 9.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.361 -0.836 . . . . 0.39000000000000001 109.792 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.51 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.81 123.25 70.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.401 -0.52 . . . . 0.73999999999999999 111.248 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.668 ' NZ ' ' OG ' ' A' ' 140' ' ' SER . 59.6 mttp -126.47 163.33 23.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.838 -0.619 . . . . 2.48 110.426 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.19 18.97 59.79 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.712 -0.955 . . . . 0.5 110.712 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.51 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.2 mt -79.05 157.29 28.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.116 0.484 . . . . 0.57999999999999996 111.319 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.858 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -99.48 134.04 21.47 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.604 -0.725 . . . . 2.79 110.384 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.99 143.62 60.99 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.551 2.167 . . . . 0.87 111.902 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.65 75.31 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.081 -0.808 . . . . 0.64000000000000001 111.081 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.858 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.21 158.79 40.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.743 0.306 . . . . 0.82999999999999996 110.44 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.16 139.96 41.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.974 0.416 . . . . 0.5 110.547 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.639 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.55 136.51 54.9 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.855 -0.611 . . . . 0.53000000000000003 110.75 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.98 131.09 45.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.538 -0.912 . . . . 1.8700000000000001 108.538 177.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.487 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.53 153.84 16.66 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.322 -0.942 . . . . 0.28999999999999998 112.006 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.87 140.94 46.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.702 -0.481 . . . . 1.4299999999999999 109.702 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.83 118.88 34.23 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.496 -0.482 . . . . 0.32000000000000001 110.468 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.732 HG12 HG23 ' A' ' 84' ' ' VAL . 63.8 mt -112.36 129.04 68.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.293 -0.412 . . . . 0.79000000000000004 110.749 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.71 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.81 120.93 44.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.356 -0.383 . . . . 1.02 110.655 -179.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.854 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.62 146.42 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.115 0.483 . . . . 0.62 111.03 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.816 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.5 mt-30 -106.07 153.91 21.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.494 -0.776 . . . . 2.4399999999999999 109.843 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.14 88.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.958 0.409 . . . . 3.6899999999999999 110.479 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.32 32.52 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.847 -0.615 . . . . 6.0800000000000001 110.653 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.27 3.28 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.95 -0.643 . . . . 1.22 111.533 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.47 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.42 177.38 9.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.143 0.497 . . . . 2.8799999999999999 111.635 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.13 149.54 32.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.382 -0.827 . . . . 1.47 110.331 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.15 144.7 38.74 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.354 -0.385 . . . . 2.7000000000000002 110.6 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.732 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.0 136.0 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-O 121.047 0.451 . . . . 0.46000000000000002 111.587 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.599 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.07 141.39 52.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.66 -0.7 . . . . 0.34999999999999998 110.245 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.466 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.61 138.81 51.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.094 0.473 . . . . 3.6699999999999999 111.485 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.487 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.21 164.19 37.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.597 -0.729 . . . . 0.67000000000000004 109.51 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 46.9 p30 -145.21 151.56 38.59 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.441 -0.504 . . . . 1.47 111.071 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.81 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.8 p90 -146.28 172.68 13.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.729 -0.669 . . . . 0.44 110.994 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.73 160.68 21.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.443 -0.799 . . . . 1.3700000000000001 109.864 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.42 121.9 22.94 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.547 -0.461 . . . . 1.28 110.771 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.528 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.2 p -127.16 164.9 20.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 122.5 1.143 . . . . 1.97 114.033 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.522 ' OG ' ' CE2' ' A' ' 157' ' ' TYR . 22.4 t . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 113.198 -1.819 . . . . 3.2799999999999998 109.128 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 67.5 p . . . . . 0 CA--C 1.517 -0.309 0 N-CA-C 108.557 -0.905 . . . . 0.66000000000000003 108.557 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.438 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.76 167.61 0.24 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.878 -1.056 . . . . 0.68999999999999995 110.897 -179.184 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.65 145.52 50.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.688 -0.687 . . . . 0.52000000000000002 110.117 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.28 101.63 9.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.076 -0.713 . . . . 0.32000000000000001 109.076 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.4 t -112.87 139.73 36.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.056 -0.52 . . . . 0.28999999999999998 111.097 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.0 p -128.75 152.56 48.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.599 -0.728 . . . . 0.25 109.816 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.59 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.8 -164.93 2.03 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.742 -0.383 . . . . 0.31 110.67 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.731 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.7 t -123.98 127.17 73.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.18 -0.463 . . . . 0.48999999999999999 110.718 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.162 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.98 58.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.135 -0.484 . . . . 1.53 110.297 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.731 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.05 24.42 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.991 -0.55 . . . . 0.96999999999999997 111.533 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.162 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.23 128.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.549 -0.46 . . . . 1.5600000000000001 110.954 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.44 -9.61 55.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.979 -0.555 . . . . 1.8799999999999999 110.288 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.8 p -87.09 0.27 55.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 1.04 110.282 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.29 137.26 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.064 -0.517 . . . . 0.23999999999999999 109.913 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.668 ' OG ' ' NZ ' ' A' ' 61' ' ' LYS . 10.9 p -96.26 -15.49 21.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.287 0.565 . . . . 0.28999999999999998 110.076 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.57 175.57 45.76 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.91 -1.276 . . . . 0.13 109.91 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.48 151.63 42.54 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.578 -0.449 . . . . 0.17000000000000001 110.458 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.723 ' NH2' ' OE1' ' A' ' 191' ' ' GLN . 52.3 ttp85 -132.38 121.17 23.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.108 -0.496 . . . . 1.29 109.997 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.557 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.08 136.59 38.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.686 -0.688 . . . . 0.25 110.694 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 73.8 tt0 -129.34 129.87 45.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.981 -0.554 . . . . 1.3200000000000001 110.109 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.72 135.27 34.57 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.027 -0.533 . . . . 0.56999999999999995 110.602 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.421 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.32 39.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.83 -0.623 . . . . 1.1599999999999999 109.739 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.951 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.0 124.89 25.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.995 0.426 . . . . 0.38 110.694 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.494 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.9 -7.63 49.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.757 -0.656 . . . . 0.40999999999999998 110.856 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.81 -69.6 0.85 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.924 0.393 . . . . 1.6599999999999999 111.468 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.46 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.7 -35.27 75.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.02 -0.537 . . . . 1.6599999999999999 111.498 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.099 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.01 7.29 88.54 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.838 -0.905 . . . . 1.1699999999999999 110.838 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.324 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.97 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.817 0.342 . . . . 1.8600000000000001 110.261 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.324 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.17 139.04 45.43 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.407 . . . . 1.98 110.199 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.9 Cg_endo -70.86 145.8 51.75 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.753 2.302 . . . . 0.55000000000000004 112.376 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.79 145.63 42.65 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.276 -0.639 . . . . 1.1399999999999999 109.276 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.633 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 88.1 m-85 -123.31 141.46 51.96 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.311 -0.556 . . . . 0.93000000000000005 111.516 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.17 127.63 43.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.306 -0.861 . . . . 0.34000000000000002 108.951 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -101.61 131.21 47.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.075 0.464 . . . . 1.0900000000000001 111.687 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.96 157.59 73.37 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.347 -0.842 . . . . 0.19 109.553 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.85 158.02 58.23 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 122.413 2.075 . . . . 0.17999999999999999 112.247 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.31 -12.15 5.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.742 -0.663 . . . . 0.20999999999999999 110.684 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.9 p -92.8 -8.76 42.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.148 -0.478 . . . . 0.28999999999999998 110.783 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.46 34.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.5 110.435 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.25 16.78 4.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.29999999999999999 110.52 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.5 p -167.58 147.1 5.04 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.596 -0.52 . . . . 0.23000000000000001 109.596 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.21 150.49 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.458 -0.497 . . . . 0.28000000000000003 111.55 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.25 125.03 50.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.606 -0.725 . . . . 1.0700000000000001 109.822 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.49 104.88 30.05 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.378 -0.374 . . . . 0.28999999999999998 111.011 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.8 Cg_endo -90.97 -179.5 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 123.195 2.597 . . . . 0.42999999999999999 112.24 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.67 32.64 18.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.381 -0.827 . . . . 1.26 111.435 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.0 mt -86.29 148.59 25.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.467 -0.333 . . . . 0.32000000000000001 110.563 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.76 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.37 114.86 61.37 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.016 0.436 . . . . 0.57999999999999996 110.624 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.07 140.61 95.97 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.83 2.353 . . . . 0.66000000000000003 111.93 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.1 21.21 74.25 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.006 -0.838 . . . . 0.28999999999999998 111.006 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.46 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.87 150.13 49.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.752 0.311 . . . . 2.3300000000000001 110.756 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.494 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.15 131.7 45.94 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.85999999999999999 109.728 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.951 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.7 m-85 -120.49 148.31 44.0 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.091 -0.504 . . . . 0.52000000000000002 111.02 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.7 mt -105.25 125.25 60.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.347 -0.983 . . . . 0.29999999999999999 108.347 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.51 132.45 63.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.198 0.523 . . . . 0.23000000000000001 111.303 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.44 122.6 20.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.542 -0.754 . . . . 0.35999999999999999 109.655 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.59 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.12 125.38 55.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.257 -0.429 . . . . 0.19 110.627 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.7 m-85 -117.15 137.86 52.04 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.534 . . . . 0.29999999999999999 109.882 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.575 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.68 135.11 42.64 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.846 -0.798 . . . . 0.37 108.846 178.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.649 HD13 ' OG ' ' A' ' 17' ' ' SER . 26.6 mt -99.09 123.01 51.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.074 0.464 . . . . 0.26000000000000001 110.918 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.592 ' OG ' ' OD1' ' A' ' 188' ' ' ASP . 87.4 p -83.91 169.73 14.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.515 -0.766 . . . . 0.28000000000000003 110.529 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.77 -14.55 15.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.096 -0.502 . . . . 1.6000000000000001 110.953 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.671 ' OD1' ' N ' ' A' ' 190' ' ' GLU . 37.1 p30 -96.18 -4.16 43.08 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.785 -0.366 . . . . 1.1799999999999999 110.773 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.74 13.86 64.17 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.339 -0.705 . . . . 0.29999999999999999 111.339 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.671 ' N ' ' OD1' ' A' ' 188' ' ' ASP . 84.4 tt0 -84.59 139.03 32.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.705 0.288 . . . . 1.22 110.456 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.723 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 87.4 mt-30 -106.74 141.03 38.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.97999999999999998 110.557 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.0 m -136.72 127.15 26.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 0.82999999999999996 110.326 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.7 tp -68.21 117.38 9.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.26000000000000001 110.454 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.4 pt -109.08 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.29999999999999999 110.71 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.5 tp -156.91 125.74 5.86 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.511 -0.476 . . . . 0.31 111.448 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.463 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.77 120.28 21.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.775 -0.648 . . . . 0.28000000000000003 109.504 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.67 151.68 29.06 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.628 -0.429 . . . . 0.23999999999999999 110.901 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.43 158.58 18.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.986 -0.552 . . . . 0.23000000000000001 110.492 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -146.05 158.04 43.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.67000000000000004 110.633 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.35 104.31 9.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.717 -0.674 . . . . 0.64000000000000001 109.981 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.9 p . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.94 -1.028 . . . . 1.26 110.701 -179.767 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.0 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.223 -0.658 . . . . 3.4399999999999999 109.223 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.46 150.67 18.53 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.971 -0.852 . . . . 1.22 110.971 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -35.58 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.056 0 C-N-CA 124.009 3.139 . . . . 0.75 113.811 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.6 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.94 173.47 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.219 -1.355 . . . . 0.79000000000000004 108.882 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.6 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.64 125.92 51.54 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.376 -0.529 . . . . 1.9399999999999999 111.444 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.51 143.96 34.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.671 -0.695 . . . . 0.59999999999999998 110.691 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.01 168.3 25.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.923 0.392 . . . . 3.1400000000000001 111.093 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.749 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.7 mt -109.06 131.08 60.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.975 -0.557 . . . . 3.23 110.098 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.16 162.26 35.92 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.466 -0.334 . . . . 3.6299999999999999 111.255 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 73.7 mm-40 36.15 31.63 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.558 -0.534 . . . . 6.0800000000000001 109.558 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.749 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.53 69.6 33.5 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.006 -0.543 . . . . 3.3799999999999999 111.521 -178.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.639 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.37 -28.99 71.87 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.433 2.089 . . . . 3.9300000000000002 111.906 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.681 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 3.2 m 149.58 125.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 3.3599999999999999 110.481 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.681 ' NE2' ' O ' ' A' ' 13' ' ' SER . 3.4 mp0 -123.96 158.39 60.39 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.314 -0.403 . . . . 3.6099999999999999 110.409 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.619 ' CG ' ' NH1' ' A' ' 143' ' ' ARG . 97.2 Cg_endo -82.03 -64.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.902 2.402 . . . . 1.51 113.488 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.62 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 64.6 t30 -108.46 -19.59 13.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.305 -0.407 . . . . 2.6800000000000002 112.012 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 5.3 p -107.3 152.11 24.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.187 0.518 . . . . 1.21 111.242 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.573 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.34 102.89 2.22 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.7 -0.682 . . . . 1.5600000000000001 110.685 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.559 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.67 145.57 13.01 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.923 2.415 . . . . 0.81000000000000005 112.605 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.909 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.75 167.95 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.881 -0.6 . . . . 1.52 109.895 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.21 147.94 29.01 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.674 -0.491 . . . . 2.1400000000000001 109.674 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.58 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.27 157.33 44.95 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.605 -0.438 . . . . 0.32000000000000001 111.195 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.494 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.2 m-20 -128.04 155.29 44.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.781 -0.645 . . . . 2.1699999999999999 110.017 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.838 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.63 172.99 6.41 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.128 -0.487 . . . . 0.58999999999999997 110.737 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.838 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.68 173.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.851 2.367 . . . . 0.90000000000000002 111.598 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.98 -51.15 0.69 Allowed Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 120.725 -0.39 . . . . 3.3399999999999999 110.051 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.637 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.4 Cg_exo -64.75 152.36 82.31 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.783 2.322 . . . . 1.8500000000000001 111.477 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.75 42.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.35 0.595 . . . . 2.54 110.46 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.824 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.6 -41.64 98.3 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.059 -0.973 . . . . 2.5299999999999998 110.625 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.532 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.4 mt -109.82 137.76 40.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.811 -0.631 . . . . 1.1699999999999999 111.276 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.88 -72.91 0.7 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.053 -0.522 . . . . 1.27 111.965 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.18 148.4 24.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.617 0.599 . . . . 1.1200000000000001 112.617 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -121.78 124.89 45.27 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.315 -0.624 . . . . 0.41999999999999998 109.315 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.02 134.68 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.623 -0.431 . . . . 0.78000000000000003 110.67 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.909 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.93 128.6 53.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.978 0.418 . . . . 0.62 111.283 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.92 49.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.724 -0.671 . . . . 1.97 110.217 178.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.441 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.0 163.21 34.89 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.169 0.509 . . . . 0.34999999999999998 112.054 -178.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.56 139.56 7.78 Favored Pre-proline 0 C--N 1.333 -0.12 0 CA-C-N 115.346 -0.843 . . . . 1.8 110.428 178.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.46 115.42 3.01 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.318 2.012 . . . . 0.57999999999999996 111.802 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.97 81.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.92 -0.4 . . . . 3.04 109.92 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.23 -20.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 2.4700000000000002 111.936 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.2 p -157.68 157.76 34.13 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.737 -0.385 . . . . 2.5099999999999998 110.51 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.4 m -120.29 27.82 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.182 -0.463 . . . . 1.8600000000000001 110.186 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.83 -75.87 1.31 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.178 -0.534 . . . . 1.4399999999999999 111.829 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.89 152.2 35.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.898 0.38 . . . . 4.6900000000000004 111.055 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.11 -169.14 2.55 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.113 -0.494 . . . . 1.4299999999999999 111.954 179.394 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.441 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.12 149.68 29.71 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.456 0.646 . . . . 1.74 112.672 -177.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.07 156.5 45.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.858 -1.065 . . . . 1.9199999999999999 110.285 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.24 158.34 41.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.903 -0.589 . . . . 0.34000000000000002 111.873 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 m -115.19 135.58 54.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.472 -0.785 . . . . 0.40999999999999998 109.865 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.58 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.35 121.93 23.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.467 -0.333 . . . . 0.55000000000000004 111.538 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.598 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.7 Cg_exo -46.41 151.77 1.68 Allowed 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.666 2.244 . . . . 0.44 112.059 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.04 -22.85 63.14 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-N 115.957 -0.565 . . . . 0.73999999999999999 112.81 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.84 -16.89 45.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.371 0.586 . . . . 0.93000000000000005 111.825 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.598 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.53 138.42 31.59 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.725 -0.39 . . . . 0.96999999999999997 110.375 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.55 13.95 10.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.387 -0.369 . . . . 1.3400000000000001 111.551 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.99 143.4 25.17 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.681 -0.408 . . . . 0.39000000000000001 111.098 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.75 -169.25 1.51 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.037 -0.528 . . . . 0.41999999999999998 110.906 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.76 ' OG1' ' N ' ' A' ' 189' ' ' GLY . 1.3 m -151.82 125.86 9.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.432 -0.804 . . . . 0.39000000000000001 109.805 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.517 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.8 123.25 70.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.429 -0.508 . . . . 0.73999999999999999 111.21 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -126.48 163.41 23.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.842 -0.617 . . . . 2.48 110.436 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.457 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.17 18.99 59.79 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.631 -0.988 . . . . 0.5 110.631 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.62 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 74.1 mt -79.07 157.26 28.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.149 0.5 . . . . 0.57999999999999996 111.309 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.843 ' O ' HG12 ' A' ' 67' ' ' VAL . 10.9 mttp -99.44 133.95 21.56 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.588 -0.733 . . . . 2.79 110.494 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.421 ' HD3' ' CE2' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.84 143.6 61.72 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.637 2.225 . . . . 0.87 111.916 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.79 25.5 75.48 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.105 -0.798 . . . . 0.64000000000000001 111.105 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.843 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.09 158.79 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.321 . . . . 0.82999999999999996 110.449 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.19 139.91 42.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.94 0.4 . . . . 0.5 110.534 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.65 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.7 m-85 -122.53 136.45 54.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.944 -0.571 . . . . 0.53000000000000003 110.776 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.84 131.02 45.27 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.483 -0.932 . . . . 1.8700000000000001 108.483 177.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.49 153.9 16.65 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.301 -0.952 . . . . 0.28999999999999998 111.943 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.96 140.93 46.09 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.71 -0.478 . . . . 1.4299999999999999 109.71 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.9 tp -115.67 118.93 34.44 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.476 -0.489 . . . . 0.32000000000000001 110.488 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.733 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.51 129.19 68.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.342 -0.39 . . . . 0.79000000000000004 110.647 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.705 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.92 120.7 43.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.242 -0.436 . . . . 1.02 110.774 -179.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.853 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.52 146.5 11.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.217 0.532 . . . . 0.62 111.02 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.824 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.01 153.85 21.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.536 -0.756 . . . . 2.4399999999999999 109.982 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.13 88.47 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.898 0.38 . . . . 3.6899999999999999 110.521 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.36 32.6 0.22 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.78 -0.645 . . . . 6.0800000000000001 110.589 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.33 3.29 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.504 -0.638 . . . . 1.22 111.504 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.463 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.36 177.38 9.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.135 0.493 . . . . 2.8799999999999999 111.687 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.17 149.5 32.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.401 -0.818 . . . . 1.47 110.401 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.13 144.68 38.75 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.459 -0.337 . . . . 2.7000000000000002 110.613 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.733 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.04 135.95 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.049 0.452 . . . . 0.46000000000000002 111.473 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.02 141.34 52.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.599 -0.728 . . . . 0.34999999999999998 110.236 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.64 138.85 51.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.117 0.484 . . . . 3.6699999999999999 111.541 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.25 164.18 37.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.506 -0.77 . . . . 0.67000000000000004 109.493 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.572 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.25 151.51 38.49 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.41 -0.516 . . . . 1.47 111.084 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.802 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.5 p90 -146.19 172.65 13.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.762 -0.654 . . . . 0.44 111.104 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.61 160.67 21.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.467 -0.788 . . . . 1.3700000000000001 109.861 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.37 121.98 23.12 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 120.63 -0.428 . . . . 1.28 110.747 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.564 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.8 p -127.83 164.23 22.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.647 0.737 . . . . 1.97 112.689 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.5 t . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 114.63 -1.168 . . . . 3.2799999999999998 109.682 178.593 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.5 p . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 121.295 0.569 . . . . 0.66000000000000003 110.312 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.438 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.85 167.57 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.483 -0.78 . . . . 0.68999999999999995 111.003 -179.283 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.58 145.57 50.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.746 -0.661 . . . . 0.52000000000000002 110.141 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.28 101.7 9.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.073 -0.714 . . . . 0.32000000000000001 109.073 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.5 t -112.93 139.63 37.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.28999999999999998 111.069 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 p -128.7 152.58 48.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.621 -0.718 . . . . 0.25 109.834 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.59 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.9 p90 -144.78 -165.01 2.05 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.687 -0.405 . . . . 0.31 110.675 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -123.95 127.16 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.198 -0.455 . . . . 0.48999999999999999 110.861 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.175 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.88 58.32 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.086 -0.506 . . . . 1.53 110.402 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.12 24.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.934 -0.576 . . . . 0.96999999999999997 111.435 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.175 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.12 128.69 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.594 -0.443 . . . . 1.5600000000000001 110.98 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.4 -9.55 56.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.58 . . . . 1.8799999999999999 110.278 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.0 p -87.09 0.2 55.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.08 0.467 . . . . 1.04 110.358 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.22 137.07 25.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.951 -0.568 . . . . 0.23999999999999999 109.961 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.602 ' N ' ' O ' ' A' ' 185' ' ' ILE . 89.4 p -96.12 -15.54 22.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.262 0.553 . . . . 0.28999999999999998 110.057 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.56 175.6 45.78 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 109.861 -1.296 . . . . 0.13 109.861 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -123.45 151.65 42.47 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.65 -0.42 . . . . 0.17000000000000001 110.529 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.619 ' NH1' ' CG ' ' A' ' 15' ' ' PRO . 36.7 ttp85 -132.33 121.16 23.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.131 -0.486 . . . . 1.29 109.919 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 167' ' ' VAL . 46.5 t -105.09 136.48 38.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.705 -0.679 . . . . 0.25 110.661 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 85.2 tt0 -129.33 129.88 45.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.029 -0.532 . . . . 1.3200000000000001 110.013 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.75 135.25 34.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.56999999999999995 110.638 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.42 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.26 161.3 39.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.659 -0.7 . . . . 1.1599999999999999 109.704 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.951 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.1 mt -70.98 124.87 25.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.068 0.461 . . . . 0.38 110.729 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.73 -7.77 50.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.766 -0.652 . . . . 0.40999999999999998 110.874 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.79 -69.67 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.35 -0.386 . . . . 1.6599999999999999 111.416 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.435 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.74 -35.33 76.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.076 -0.511 . . . . 1.6599999999999999 111.42 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.088 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.22 88.6 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.785 -0.926 . . . . 1.1699999999999999 110.785 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.336 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.89 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.778 0.323 . . . . 1.8600000000000001 110.25 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.336 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.33 138.99 44.87 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.941 0.401 . . . . 1.98 110.145 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.42 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.2 Cg_endo -70.79 145.76 52.05 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.635 2.223 . . . . 0.55000000000000004 112.406 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.79 145.66 42.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.264 -0.643 . . . . 1.1399999999999999 109.264 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.581 ' CE1' ' CG ' ' A' ' 16' ' ' ASN . 6.3 p90 -123.27 141.23 52.19 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.453 -0.499 . . . . 0.93000000000000005 111.567 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.6 mt -128.03 127.66 43.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.35 -0.841 . . . . 0.34000000000000002 108.964 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.593 ' HB2' HD21 ' A' ' 16' ' ' ASN . 30.1 t0 -101.65 131.16 48.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.185 0.517 . . . . 1.0900000000000001 111.767 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.99 157.57 73.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.31 -0.859 . . . . 0.19 109.508 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -69.8 157.96 58.52 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.437 2.091 . . . . 0.17999999999999999 112.197 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.4 p -59.11 -12.27 4.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.737 -0.665 . . . . 0.20999999999999999 110.813 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.4 p -92.83 -8.71 42.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.128 -0.487 . . . . 0.28999999999999998 110.633 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.31 34.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.454 -0.339 . . . . 0.5 110.364 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.1 p -133.05 16.65 4.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.454 -0.339 . . . . 0.29999999999999999 110.624 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.6 p -167.55 147.11 5.07 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.61 -0.515 . . . . 0.23000000000000001 109.61 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.21 150.42 12.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.548 -0.461 . . . . 0.28000000000000003 111.598 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 124.95 50.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.628 -0.715 . . . . 1.0700000000000001 109.811 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.4 104.87 29.68 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.428 -0.351 . . . . 0.28999999999999998 111.038 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.8 Cg_endo -91.04 -179.58 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 123.224 2.616 . . . . 0.42999999999999999 112.179 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.78 32.59 18.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.324 -0.853 . . . . 1.26 111.427 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.1 mt -86.36 148.51 25.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.476 -0.329 . . . . 0.32000000000000001 110.532 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.77 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.22 114.77 60.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.982 0.42 . . . . 0.57999999999999996 110.688 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -58.97 140.57 95.91 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.891 2.394 . . . . 0.66000000000000003 112.017 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.06 21.25 74.25 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.047 -0.821 . . . . 0.28999999999999998 111.047 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.435 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.97 150.23 49.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 2.3300000000000001 110.62 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.2 131.64 46.02 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.077 -0.511 . . . . 0.85999999999999999 109.809 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.951 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.54 148.33 43.99 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.136 -0.484 . . . . 0.52000000000000002 110.992 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.1 mt -105.35 125.41 60.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.281 -1.007 . . . . 0.29999999999999999 108.281 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.58 132.57 63.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.126 0.489 . . . . 0.23000000000000001 111.247 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.58 122.52 20.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.57 -0.741 . . . . 0.35999999999999999 109.69 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.59 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -100.94 125.36 54.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.242 -0.436 . . . . 0.19 110.62 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.2 m-85 -117.17 137.86 52.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.023 -0.535 . . . . 0.29999999999999999 109.956 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.582 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.67 134.95 42.88 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.838 -0.801 . . . . 0.37 108.838 178.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.602 ' O ' ' N ' ' A' ' 140' ' ' SER . 84.3 mt -99.1 122.94 51.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.09 0.471 . . . . 0.26000000000000001 110.962 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.9 p -83.88 169.68 14.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.518 -0.764 . . . . 0.28000000000000003 110.461 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 187' ' ' GLU . 43.3 tt0 -59.67 -14.63 14.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.077 -0.511 . . . . 1.6000000000000001 110.936 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.732 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.6 m-20 -96.07 -4.27 43.26 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.866 -0.333 . . . . 1.1799999999999999 110.818 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.76 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.79 13.87 64.04 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.312 -0.715 . . . . 0.29999999999999999 111.312 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -84.62 139.13 32.29 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.015 -0.274 . . . . 1.22 110.449 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.502 ' NE2' ' HG3' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -106.73 141.11 38.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.797 0.332 . . . . 0.97999999999999998 110.601 179.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.75 126.97 26.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.82999999999999996 110.402 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.12 117.22 9.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.386 -0.37 . . . . 0.26000000000000001 110.543 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 43.8 pt -108.97 -21.8 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.457 . . . . 0.29999999999999999 110.838 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.93 125.74 5.85 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.467 -0.493 . . . . 0.31 111.49 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.7 120.17 21.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.702 -0.681 . . . . 0.28000000000000003 109.576 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.58 151.76 29.23 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.594 -0.443 . . . . 0.23999999999999999 110.929 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.48 158.56 18.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.007 -0.542 . . . . 0.23000000000000001 110.38 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.08 157.9 43.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 0.67000000000000004 110.646 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.14 104.34 9.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.748 -0.66 . . . . 0.64000000000000001 110.043 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.01 -0.995 . . . . 1.26 110.653 -179.791 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.553 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.6 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.226 -0.657 . . . . 3.4399999999999999 109.226 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.64 18.54 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.071 -0.811 . . . . 1.22 111.071 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -35.62 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.297 -2.147 0 C-N-CA 124.039 3.159 . . . . 0.75 113.773 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.606 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.0 t -79.83 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.296 -1.32 . . . . 0.79000000000000004 108.912 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.606 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.66 125.9 51.53 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.489 -0.484 . . . . 1.9399999999999999 111.424 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.57 143.91 34.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.677 -0.692 . . . . 0.59999999999999998 110.57 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.97 168.33 25.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.966 0.412 . . . . 3.1400000000000001 111.142 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.742 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.0 130.99 60.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.976 -0.557 . . . . 3.23 110.101 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.8 p -141.14 162.26 35.9 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.902 0.382 . . . . 3.6299999999999999 111.164 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 21.3 pt-20 36.12 31.61 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.695 -0.483 . . . . 6.0800000000000001 109.695 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.742 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.59 32.61 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.867 -0.606 . . . . 3.3799999999999999 111.578 -178.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.633 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.28 -29.1 72.79 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.465 2.11 . . . . 3.9300000000000002 111.884 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.633 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.61 125.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 3.3599999999999999 110.511 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.577 ' O ' ' O ' ' A' ' 92' ' ' THR . 1.5 mp0 -123.91 158.36 60.31 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.304 -0.407 . . . . 3.6099999999999999 110.378 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.6 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 96.3 Cg_endo -82.11 -64.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.874 2.382 . . . . 1.51 113.542 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.66 ' ND2' ' N ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -108.48 -19.66 13.37 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.081 0.4 . . . . 2.6800000000000002 112.081 -178.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.66 ' N ' ' ND2' ' A' ' 16' ' ' ASN . 95.8 p -107.2 152.02 24.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.164 0.507 . . . . 1.21 111.333 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.25 102.98 2.23 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.79 -0.641 . . . . 1.5600000000000001 110.669 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.6 145.58 13.11 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.932 2.422 . . . . 0.81000000000000005 112.59 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.928 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.82 167.91 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.911 -0.586 . . . . 1.52 109.899 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.14 147.85 28.96 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.855 -0.424 . . . . 2.1400000000000001 109.855 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.592 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.18 157.34 44.97 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.663 -0.415 . . . . 0.32000000000000001 111.223 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.497 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.2 m-20 -128.12 155.3 44.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.81 -0.632 . . . . 2.1699999999999999 110.024 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.837 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.58 173.02 6.38 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.065 -0.516 . . . . 0.58999999999999997 110.723 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.837 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.6 173.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.876 2.384 . . . . 0.90000000000000002 111.543 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.04 -50.99 0.69 Allowed Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.68 -0.408 . . . . 3.3399999999999999 110.166 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.635 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.84 152.38 82.38 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.797 2.331 . . . . 1.8500000000000001 111.438 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.8 42.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.415 0.626 . . . . 2.54 110.538 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.819 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.54 -41.62 98.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.01 -0.996 . . . . 2.5299999999999998 110.697 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.4 mt -109.86 137.82 40.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.815 -0.63 . . . . 1.1699999999999999 111.274 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.9 -72.96 0.7 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.057 -0.52 . . . . 1.27 111.913 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.09 148.33 24.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.638 0.606 . . . . 1.1200000000000001 112.638 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.84 124.88 45.2 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.318 -0.623 . . . . 0.41999999999999998 109.318 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.0 134.79 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.647 -0.421 . . . . 0.78000000000000003 110.649 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.928 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.03 128.66 53.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.297 -0.41 . . . . 0.62 111.191 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.17 138.97 49.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.807 -0.633 . . . . 1.97 110.023 179.003 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.436 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.03 163.11 35.23 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.119 0.485 . . . . 0.34999999999999998 112.074 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.43 139.51 7.87 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.413 -0.812 . . . . 1.8 110.42 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.52 115.45 3.04 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.336 2.024 . . . . 0.57999999999999996 111.77 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.679 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.94 81.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.868 -0.419 . . . . 3.04 109.868 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.21 -20.74 0.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.983 -0.553 . . . . 2.4700000000000002 111.919 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -157.55 157.81 34.44 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.806 -0.358 . . . . 2.5099999999999998 110.592 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.406 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.34 27.68 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 1.8600000000000001 110.22 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.79 -75.86 1.31 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.08 -0.581 . . . . 1.4399999999999999 111.884 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.82 152.28 35.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.845 0.355 . . . . 4.6900000000000004 111.045 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.18 -169.16 2.55 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.071 -0.513 . . . . 1.4299999999999999 111.955 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.436 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.73 29.65 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.431 0.634 . . . . 1.74 112.589 -177.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.13 156.53 45.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.87 -1.059 . . . . 1.9199999999999999 110.16 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.25 158.33 41.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.898 -0.592 . . . . 0.34000000000000002 111.826 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.0 m -115.23 135.71 53.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.386 -0.824 . . . . 0.40999999999999998 109.758 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.592 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.39 121.91 23.77 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.371 -0.377 . . . . 0.55000000000000004 111.546 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.7 Cg_exo -46.41 151.76 1.68 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.653 2.235 . . . . 0.44 112.08 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.91 -23.04 63.06 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 116.028 -0.533 . . . . 0.73999999999999999 112.854 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.69 -17.03 45.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.343 0.572 . . . . 0.93000000000000005 111.803 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.601 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.49 138.46 31.56 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.699 -0.4 . . . . 0.96999999999999997 110.32 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.59 14.02 10.96 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.398 -0.365 . . . . 1.3400000000000001 111.551 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.474 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.1 143.42 25.08 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.675 -0.41 . . . . 0.39000000000000001 111.048 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.716 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.74 -169.42 1.54 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.069 -0.514 . . . . 0.41999999999999998 110.938 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.716 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.5 t -151.72 125.91 9.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.438 -0.801 . . . . 0.39000000000000001 109.828 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.519 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.77 123.29 70.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.373 -0.531 . . . . 0.73999999999999999 111.207 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.646 ' NZ ' ' N ' ' A' ' 142' ' ' PHE . 88.9 tttt -126.52 163.34 23.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.898 -0.592 . . . . 2.48 110.417 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.52 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.17 18.96 59.84 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.793 -0.923 . . . . 0.5 110.793 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.519 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.8 mt -79.15 157.28 27.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.108 0.48 . . . . 0.57999999999999996 111.299 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.848 ' O ' HG12 ' A' ' 67' ' ' VAL . 4.5 mttp -99.47 133.92 21.57 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.531 -0.759 . . . . 2.79 110.536 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.535 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.87 143.56 61.38 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.584 2.189 . . . . 0.87 111.95 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.77 25.71 75.24 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.088 -0.805 . . . . 0.64000000000000001 111.088 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.848 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.25 158.73 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.717 0.294 . . . . 0.82999999999999996 110.371 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.11 139.93 41.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.946 0.403 . . . . 0.5 110.516 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.664 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.4 m-85 -122.63 136.42 54.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.905 -0.589 . . . . 0.53000000000000003 110.782 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.87 131.04 45.27 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.442 -0.947 . . . . 1.8700000000000001 108.442 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.49 153.97 16.64 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.313 -0.946 . . . . 0.28999999999999998 111.935 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.05 140.85 45.91 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.726 -0.472 . . . . 1.4299999999999999 109.726 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.72 118.95 34.47 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.411 -0.516 . . . . 0.32000000000000001 110.53 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.722 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.44 129.03 68.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.332 -0.395 . . . . 0.79000000000000004 110.582 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.701 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.85 120.78 43.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.294 -0.412 . . . . 1.02 110.764 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.852 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.45 146.47 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.173 0.511 . . . . 0.62 111.069 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.819 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.08 153.85 21.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.525 -0.761 . . . . 2.4399999999999999 109.947 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.425 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.15 88.62 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.938 0.399 . . . . 3.6899999999999999 110.408 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.613 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.61 0.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.85 -0.614 . . . . 6.0800000000000001 110.592 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.17 -117.35 3.28 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.424 -0.67 . . . . 1.22 111.424 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.464 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.1 m170 -81.43 177.36 9.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.194 0.521 . . . . 2.8799999999999999 111.637 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.08 149.61 32.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.398 -0.819 . . . . 1.47 110.353 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.553 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.21 144.71 38.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.449 -0.341 . . . . 2.7000000000000002 110.528 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.722 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.03 135.97 61.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.002 0.43 . . . . 0.46000000000000002 111.534 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.07 141.36 52.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.677 -0.692 . . . . 0.34999999999999998 110.211 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.62 138.86 51.67 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.083 0.468 . . . . 3.6699999999999999 111.577 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.27 164.09 38.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.623 -0.717 . . . . 0.67000000000000004 109.468 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.18 151.62 38.72 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.473 -0.491 . . . . 1.47 111.046 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.804 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.7 p90 -146.35 172.71 13.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.734 -0.666 . . . . 0.44 111.033 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.78 160.65 21.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.479 -0.782 . . . . 1.3700000000000001 109.828 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.34 121.82 22.92 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.627 -0.429 . . . . 1.28 110.83 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.577 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.0 p -128.18 162.99 25.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.082 -0.508 . . . . 1.97 111.667 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.6 m . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 3.2799999999999998 110.028 178.388 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 121.888 0.851 . . . . 0.66000000000000003 109.317 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.444 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.82 167.54 0.25 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.959 -1.018 . . . . 0.68999999999999995 110.944 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.66 145.48 49.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.757 -0.656 . . . . 0.52000000000000002 110.178 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.23 101.76 9.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.075 -0.713 . . . . 0.32000000000000001 109.075 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.0 t -112.96 139.68 36.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.982 -0.554 . . . . 0.28999999999999998 111.077 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.1 p -128.79 152.6 48.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.625 -0.716 . . . . 0.25 109.812 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.594 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.76 -164.97 2.04 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.731 -0.388 . . . . 0.31 110.666 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.5 t -123.87 127.12 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.48999999999999999 110.853 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.18 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -58.03 58.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 1.53 110.383 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.11 24.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.831 -0.622 . . . . 0.96999999999999997 111.482 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.18 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.18 128.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.59 -0.444 . . . . 1.5600000000000001 110.904 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.42 -9.59 55.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.926 -0.579 . . . . 1.8799999999999999 110.332 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.432 ' HB ' ' OE2' ' A' ' 187' ' ' GLU . 28.5 p -87.09 0.2 55.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.094 -0.503 . . . . 1.04 110.348 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.28 137.21 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.987 -0.551 . . . . 0.23999999999999999 109.905 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 185' ' ' ILE . 81.8 p -96.19 -15.59 21.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.301 0.572 . . . . 0.28999999999999998 110.04 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.627 ' HA3' ' HZ2' ' A' ' 61' ' ' LYS . . . 178.61 175.57 45.79 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 109.929 -1.269 . . . . 0.13 109.929 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.646 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . 76.2 m-85 -123.45 151.63 42.48 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.605 -0.438 . . . . 0.17000000000000001 110.521 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.6 ' CZ ' ' CG ' ' A' ' 15' ' ' PRO . 73.8 ttt-85 -132.38 121.18 23.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.14 -0.482 . . . . 1.29 109.938 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.556 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.09 136.49 38.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.646 -0.707 . . . . 0.25 110.705 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 81.4 tt0 -129.3 129.82 45.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.966 -0.561 . . . . 1.3200000000000001 110.132 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.627 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 36.1 p90 -138.65 135.3 34.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.06 -0.518 . . . . 0.56999999999999995 110.659 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.421 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.31 161.35 39.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.723 -0.672 . . . . 1.1599999999999999 109.699 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.961 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.01 124.84 25.31 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.666 -0.414 . . . . 0.38 110.814 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.82 -7.66 49.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.764 -0.653 . . . . 0.40999999999999998 110.76 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -109.78 -69.69 0.85 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.003 0.43 . . . . 1.6599999999999999 111.477 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.47 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.58 -35.4 75.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.995 -0.548 . . . . 1.6599999999999999 111.561 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.076 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.14 88.66 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.905 -0.878 . . . . 1.1699999999999999 110.905 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.332 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.92 -171.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.742 0.306 . . . . 1.8600000000000001 110.24 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.332 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.3 139.04 44.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 1.98 110.198 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 48.1 Cg_endo -70.83 145.79 51.88 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 122.755 2.304 . . . . 0.55000000000000004 112.299 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.627 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.83 145.83 42.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.263 -0.643 . . . . 1.1399999999999999 109.263 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.535 ' CE1' ' CD ' ' A' ' 65' ' ' PRO . 14.5 p90 -123.37 141.24 52.19 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.356 -0.538 . . . . 0.93000000000000005 111.54 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.5 mt -128.03 127.68 43.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.356 -0.838 . . . . 0.34000000000000002 108.95 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.479 ' OD2' ' HA2' ' A' ' 62' ' ' GLY . 95.2 m-20 -101.69 131.1 48.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.127 0.489 . . . . 1.0900000000000001 111.76 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.91 157.59 73.26 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.323 -0.853 . . . . 0.19 109.557 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -69.76 158.0 58.46 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.467 2.111 . . . . 0.17999999999999999 112.239 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.417 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.28 -12.14 5.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.754 -0.657 . . . . 0.20999999999999999 110.79 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.7 p -92.85 -8.75 42.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.28999999999999998 110.662 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.15 135.36 34.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.394 -0.366 . . . . 0.5 110.361 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.17 16.72 4.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.358 -0.383 . . . . 0.29999999999999999 110.502 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.0 p -167.55 147.04 5.05 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.694 -0.484 . . . . 0.23000000000000001 109.694 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.11 150.53 12.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.514 -0.474 . . . . 0.28000000000000003 111.509 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.512 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.34 124.89 50.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.541 -0.754 . . . . 1.0700000000000001 109.825 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.43 104.86 29.69 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.404 -0.362 . . . . 0.28999999999999998 111.117 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 84.3 Cg_endo -90.99 -179.42 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 123.046 2.497 . . . . 0.42999999999999999 112.163 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.61 32.68 18.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.393 -0.821 . . . . 1.26 111.501 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.449 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.4 mt -86.4 148.64 25.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 0.32000000000000001 110.467 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.776 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.42 114.85 61.39 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.976 0.417 . . . . 0.57999999999999996 110.585 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.0 140.62 96.16 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.866 2.377 . . . . 0.66000000000000003 111.962 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.27 74.19 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.042 -0.823 . . . . 0.28999999999999998 111.042 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.47 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.99 150.1 49.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.333 . . . . 2.3300000000000001 110.62 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.08 131.62 45.92 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.026 -0.533 . . . . 0.85999999999999999 109.745 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.961 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.5 148.47 43.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.16 -0.473 . . . . 0.52000000000000002 111.036 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.5 mt -105.42 125.32 60.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.271 -1.011 . . . . 0.29999999999999999 108.271 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.58 132.51 63.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.164 0.507 . . . . 0.23000000000000001 111.192 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.47 122.57 20.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.565 -0.743 . . . . 0.35999999999999999 109.628 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.594 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.02 125.42 54.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.286 -0.415 . . . . 0.19 110.713 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.26 137.81 52.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.07 -0.514 . . . . 0.29999999999999999 109.837 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.584 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.61 135.03 42.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.828 -0.805 . . . . 0.37 108.828 178.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.594 ' O ' ' N ' ' A' ' 140' ' ' SER . 50.0 mm -99.11 122.91 51.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.148 0.499 . . . . 0.26000000000000001 111.015 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.1 p -83.84 169.62 14.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.547 -0.752 . . . . 0.28000000000000003 110.49 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.612 ' O ' HG21 ' A' ' 59' ' ' THR . 0.0 OUTLIER -59.67 -14.59 14.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.06 -0.518 . . . . 1.6000000000000001 110.954 -179.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 87.2 m-20 -96.03 -4.35 43.24 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.784 -0.366 . . . . 1.1799999999999999 110.793 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.78 14.0 63.82 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.356 -0.697 . . . . 0.29999999999999999 111.356 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -84.66 139.07 32.3 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.093 -0.243 . . . . 1.22 110.439 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.516 ' NE2' ' HG3' ' A' ' 14' ' ' GLN . 4.1 mt-30 -106.78 141.05 38.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.868 0.366 . . . . 0.97999999999999998 110.537 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.4 m -136.67 127.05 26.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.82999999999999996 110.367 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 25.6 tp -68.18 117.25 9.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.319 -0.4 . . . . 0.26000000000000001 110.486 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.01 -21.69 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.29999999999999999 110.725 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.96 125.78 5.85 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.55 -0.46 . . . . 0.31 111.466 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.461 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.82 120.19 21.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.739 -0.664 . . . . 0.28000000000000003 109.591 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.62 151.66 29.08 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.608 -0.437 . . . . 0.23999999999999999 110.895 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.8 p -110.38 158.61 18.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.99 -0.55 . . . . 0.23000000000000001 110.451 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.13 157.95 43.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.068 -0.514 . . . . 0.67000000000000004 110.639 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.36 9.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.689 -0.687 . . . . 0.64000000000000001 109.99 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.5 p . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.966 -1.016 . . . . 1.26 110.556 -179.711 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.9 m . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.18 -0.674 . . . . 3.4399999999999999 109.18 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.36 150.72 18.54 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.956 -0.858 . . . . 1.22 110.956 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -35.52 142.39 0.1 OUTLIER 'Trans proline' 0 C--N 1.3 -2.024 0 C-N-CA 123.965 3.11 . . . . 0.75 113.845 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -79.96 173.47 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.25 -1.341 . . . . 0.79000000000000004 108.904 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.612 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.59 125.91 51.53 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.416 -0.513 . . . . 1.9399999999999999 111.423 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.62 144.01 33.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.688 -0.687 . . . . 0.59999999999999998 110.693 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.04 168.29 25.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.852 0.358 . . . . 3.1400000000000001 111.093 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.744 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.92 131.03 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.019 -0.537 . . . . 3.23 110.109 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.21 162.22 36.0 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.917 0.389 . . . . 3.6299999999999999 111.213 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 32.6 tp10 36.23 31.47 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.651 -0.5 . . . . 6.0800000000000001 109.651 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.744 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.65 32.74 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.914 -0.585 . . . . 3.3799999999999999 111.575 -178.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.632 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.29 -29.16 72.68 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.494 2.129 . . . . 3.9300000000000002 111.81 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.632 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.7 125.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 3.3599999999999999 110.377 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.646 ' O ' ' O ' ' A' ' 92' ' ' THR . 11.7 mp0 -123.97 158.41 60.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.321 -0.399 . . . . 3.6099999999999999 110.49 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.566 ' HB2' HH21 ' A' ' 143' ' ' ARG . 96.9 Cg_endo -82.11 -64.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.852 2.368 . . . . 1.51 113.47 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.577 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 63.5 t30 -108.35 -19.67 13.39 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.081 0.4 . . . . 2.6800000000000002 112.081 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 66.1 p -107.31 152.13 24.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.206 0.527 . . . . 1.21 111.246 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.573 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.33 102.96 2.22 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.702 -0.681 . . . . 1.5600000000000001 110.63 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.8 Cg_endo -82.75 145.58 12.88 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.912 2.408 . . . . 0.81000000000000005 112.611 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.906 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.73 167.96 24.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.938 -0.573 . . . . 1.52 109.879 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -149.14 147.99 29.11 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.609 -0.515 . . . . 2.1400000000000001 109.609 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.591 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.8 p90 -142.28 157.26 45.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.019 0.437 . . . . 0.32000000000000001 111.229 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.487 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.05 155.24 44.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.853 -0.612 . . . . 2.1699999999999999 110.098 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.835 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.57 172.99 6.41 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.137 0.494 . . . . 0.58999999999999997 110.801 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.835 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.61 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.913 2.409 . . . . 0.90000000000000002 111.534 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.477 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.14 -51.06 0.68 Allowed Pre-proline 0 C--N 1.328 -0.344 0 C-N-CA 120.709 -0.397 . . . . 3.3399999999999999 110.052 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.79 152.32 82.53 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.808 2.339 . . . . 1.8500000000000001 111.442 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.66 42.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.373 0.606 . . . . 2.54 110.571 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.82 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.73 -41.56 98.04 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.037 -0.983 . . . . 2.5299999999999998 110.653 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.532 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.2 mt -109.91 137.85 40.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.767 -0.651 . . . . 1.1699999999999999 111.211 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.91 -72.94 0.7 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.004 -0.544 . . . . 1.27 111.936 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.15 148.37 24.45 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.651 0.611 . . . . 1.1200000000000001 112.651 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.82 124.82 45.06 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.35 -0.611 . . . . 0.41999999999999998 109.35 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.9 mt -118.08 134.73 60.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.646 -0.422 . . . . 0.78000000000000003 110.566 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.906 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.99 128.63 53.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.434 . . . . 0.62 111.288 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.548 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.14 139.01 49.73 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.746 -0.661 . . . . 1.97 110.115 178.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.438 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.14 163.13 35.3 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.176 0.512 . . . . 0.34999999999999998 112.018 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.48 139.49 7.81 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 115.399 -0.818 . . . . 1.8 110.484 178.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.53 115.5 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.309 2.006 . . . . 0.57999999999999996 111.839 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.667 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.03 81.21 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.81 -0.441 . . . . 3.04 109.81 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.15 -20.75 0.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.027 -0.533 . . . . 2.4700000000000002 111.843 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.4 p -157.52 157.75 34.4 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.937 -0.305 . . . . 2.5099999999999998 110.65 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.43 27.9 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.27 -0.423 . . . . 1.8600000000000001 110.241 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.89 -75.83 1.31 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.066 -0.587 . . . . 1.4399999999999999 111.834 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.91 152.27 35.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.964 0.411 . . . . 4.6900000000000004 110.927 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.676 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.24 -169.14 2.53 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.068 -0.514 . . . . 1.4299999999999999 111.938 179.298 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.11 149.69 29.68 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.463 0.649 . . . . 1.74 112.569 -177.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -140.98 156.53 46.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.745 -1.116 . . . . 1.9199999999999999 110.257 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.3 158.47 41.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.967 -0.56 . . . . 0.34000000000000002 111.706 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.7 m -115.24 135.69 53.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.385 -0.825 . . . . 0.40999999999999998 109.799 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.591 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.43 122.05 23.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.403 -0.362 . . . . 0.55000000000000004 111.48 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.1 Cg_exo -46.45 151.75 1.71 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.675 2.25 . . . . 0.44 112.115 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.98 -22.87 63.03 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 116.092 -0.504 . . . . 0.73999999999999999 112.798 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.9 -16.9 45.66 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.259 -0.576 . . . . 0.93000000000000005 111.763 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.604 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.52 138.37 31.63 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.848 -0.341 . . . . 0.96999999999999997 110.366 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.56 13.92 10.97 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.409 -0.359 . . . . 1.3400000000000001 111.561 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.475 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -150.01 143.49 25.21 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.658 -0.417 . . . . 0.39000000000000001 111.061 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.72 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.82 -169.38 1.54 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.076 -0.511 . . . . 0.41999999999999998 110.961 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.72 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.3 m -151.69 125.92 9.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.483 -0.78 . . . . 0.39000000000000001 109.867 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.511 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.9 mt -114.94 123.29 70.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.404 -0.518 . . . . 0.73999999999999999 111.186 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -126.48 163.48 23.25 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.824 -0.625 . . . . 2.48 110.37 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.46 ' HA2' HD21 ' A' ' 16' ' ' ASN . . . 85.09 18.9 60.09 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.735 -0.946 . . . . 0.5 110.735 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.577 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.4 mt -78.9 157.22 28.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.065 0.459 . . . . 0.57999999999999996 111.438 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.851 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -99.52 133.94 21.52 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.684 -0.689 . . . . 2.79 110.396 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.472 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.95 143.62 61.18 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.519 2.146 . . . . 0.87 111.97 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.73 25.79 75.15 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.041 -0.823 . . . . 0.64000000000000001 111.041 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.851 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.16 158.85 39.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.705 0.288 . . . . 0.82999999999999996 110.456 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.23 139.95 42.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.946 0.403 . . . . 0.5 110.562 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.662 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.6 m-85 -122.59 136.42 54.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.949 -0.568 . . . . 0.53000000000000003 110.729 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.489 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.9 131.01 45.31 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.488 -0.93 . . . . 1.8700000000000001 108.488 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.46 153.85 16.64 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.261 -0.971 . . . . 0.28999999999999998 111.917 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.93 140.9 46.1 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.73 -0.47 . . . . 1.4299999999999999 109.73 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.9 tp -115.7 118.9 34.35 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.493 -0.483 . . . . 0.32000000000000001 110.553 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.726 HG12 HG23 ' A' ' 84' ' ' VAL . 64.2 mt -112.43 129.08 68.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.303 -0.408 . . . . 0.79000000000000004 110.669 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.708 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.78 120.84 43.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.289 -0.414 . . . . 1.02 110.715 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.849 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.52 146.43 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.241 0.543 . . . . 0.62 111.01 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.82 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.02 153.9 21.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.524 -0.762 . . . . 2.4399999999999999 109.956 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.26 88.65 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.932 0.396 . . . . 3.6899999999999999 110.42 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.622 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.21 32.73 0.21 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.793 -0.639 . . . . 6.0800000000000001 110.609 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.12 -117.38 3.29 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.437 -0.665 . . . . 1.22 111.437 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.467 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.5 177.37 8.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.158 0.504 . . . . 2.8799999999999999 111.661 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.1 149.51 32.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.481 -0.781 . . . . 1.47 110.359 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.16 144.72 38.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.417 -0.356 . . . . 2.7000000000000002 110.558 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.726 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.01 136.01 61.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 121.048 0.451 . . . . 0.46000000000000002 111.506 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.6 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.04 141.37 52.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.624 -0.716 . . . . 0.34999999999999998 110.279 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.68 138.93 51.66 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.441 -0.503 . . . . 3.6699999999999999 111.466 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.491 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 53.0 p90 -152.32 164.23 37.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.521 -0.763 . . . . 0.67000000000000004 109.467 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.575 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.24 151.52 38.51 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.503 -0.479 . . . . 1.47 111.084 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.807 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.1 p90 -146.22 172.7 13.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.782 -0.645 . . . . 0.44 111.068 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.8 160.61 21.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.496 -0.774 . . . . 1.3700000000000001 109.821 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.36 121.83 22.92 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 120.587 -0.445 . . . . 1.28 110.781 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.646 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -128.08 163.55 24.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.156 -0.475 . . . . 1.97 110.309 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.464 0.272 0 C-N-CA 120.312 -0.555 . . . . 3.2799999999999998 110.628 178.847 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.3 p . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.657 0.265 . . . . 0.66000000000000003 110.818 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.431 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.86 167.55 0.26 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 0.68999999999999995 110.959 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.54 145.6 50.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.692 -0.685 . . . . 0.52000000000000002 110.186 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.29 101.65 9.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.086 -0.709 . . . . 0.32000000000000001 109.086 177.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.1 t -113.0 139.78 36.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.985 -0.552 . . . . 0.28999999999999998 111.063 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.7 p -128.71 152.49 48.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.67 -0.696 . . . . 0.25 109.832 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.594 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.9 p90 -144.7 -164.89 2.02 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.722 -0.391 . . . . 0.31 110.691 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.734 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -124.06 127.24 73.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.198 -0.456 . . . . 0.48999999999999999 110.73 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.172 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.099 -0.501 . . . . 1.53 110.342 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -37.96 24.45 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.946 -0.57 . . . . 0.96999999999999997 111.566 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.172 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.13 128.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.724 -0.391 . . . . 1.5600000000000001 111.002 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -86.45 -9.51 56.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.942 -0.572 . . . . 1.8799999999999999 110.281 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.14 0.16 55.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 1.04 110.315 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.06 137.15 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 116.008 -0.542 . . . . 0.23999999999999999 109.985 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 185' ' ' ILE . 87.3 p -96.26 -15.48 21.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.242 0.544 . . . . 0.28999999999999998 110.066 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.64 175.61 45.86 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 109.881 -1.288 . . . . 0.13 109.881 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.51 151.6 42.63 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.673 -0.411 . . . . 0.17000000000000001 110.434 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.566 HH21 ' HB2' ' A' ' 15' ' ' PRO . 69.4 ttt-85 -132.36 121.16 23.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.122 -0.49 . . . . 1.29 109.926 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.556 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.04 136.6 38.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.681 -0.691 . . . . 0.25 110.69 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 83.7 tt0 -129.43 129.84 45.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.067 -0.515 . . . . 1.3200000000000001 110.01 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.623 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.7 135.32 34.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.965 -0.561 . . . . 0.56999999999999995 110.656 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.425 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.38 39.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.77 -0.65 . . . . 1.1599999999999999 109.641 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.957 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.13 124.85 25.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.039 0.447 . . . . 0.38 110.673 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.73 -7.72 49.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.684 -0.689 . . . . 0.40999999999999998 110.883 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.77 -69.74 0.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.315 -0.402 . . . . 1.6599999999999999 111.432 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.438 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.68 -35.21 75.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.027 -0.533 . . . . 1.6599999999999999 111.563 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.093 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.07 7.29 88.54 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.814 -0.914 . . . . 1.1699999999999999 110.814 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.322 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.93 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.773 0.321 . . . . 1.8600000000000001 110.256 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.322 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.33 139.05 44.89 Favored Pre-proline 0 N--CA 1.454 -0.261 0 CA-C-N 116.302 -0.408 . . . . 1.98 110.157 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.425 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.2 Cg_endo -70.85 145.89 52.06 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 C-N-CA 122.656 2.237 . . . . 0.55000000000000004 112.398 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.82 145.68 42.63 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.232 -0.655 . . . . 1.1399999999999999 109.232 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.57 ' CE2' ' CG ' ' A' ' 16' ' ' ASN . 37.3 p90 -123.24 141.37 52.05 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.345 -0.542 . . . . 0.93000000000000005 111.463 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.12 127.74 43.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.313 -0.858 . . . . 0.34000000000000002 108.966 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -101.68 131.17 48.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.097 0.475 . . . . 1.0900000000000001 111.779 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.89 157.56 73.33 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.373 -0.831 . . . . 0.19 109.61 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -69.84 158.0 58.32 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.382 2.054 . . . . 0.17999999999999999 112.27 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.24 -12.17 5.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.792 -0.64 . . . . 0.20999999999999999 110.714 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.3 p -92.79 -8.74 42.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.28999999999999998 110.714 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.41 34.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.363 -0.38 . . . . 0.5 110.434 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.4 p -133.14 16.58 4.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.348 -0.387 . . . . 0.29999999999999999 110.475 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.6 p -167.48 147.23 5.15 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.642 -0.503 . . . . 0.23000000000000001 109.642 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.18 150.35 13.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.617 -0.433 . . . . 0.28000000000000003 111.606 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.25 124.95 50.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.67 -0.695 . . . . 1.0700000000000001 109.803 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.42 104.9 29.84 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.426 -0.352 . . . . 0.28999999999999998 111.117 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.3 Cg_endo -90.91 -179.46 1.51 Allowed 'Trans proline' 0 C--N 1.3 -1.988 0 C-N-CA 123.231 2.621 . . . . 0.42999999999999999 112.282 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 61.56 32.65 18.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.475 -0.784 . . . . 1.26 111.499 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.6 mt -86.4 148.58 25.51 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.887 -0.325 . . . . 0.32000000000000001 110.433 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.766 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.27 114.87 61.36 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.051 0.453 . . . . 0.57999999999999996 110.69 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.95 140.52 95.66 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.951 2.434 . . . . 0.66000000000000003 111.955 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.27 74.16 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.023 -0.831 . . . . 0.28999999999999998 111.023 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.438 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.89 150.13 49.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 2.3300000000000001 110.643 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.501 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.11 131.58 45.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.85999999999999999 109.814 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.957 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.49 148.3 44.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.022 -0.536 . . . . 0.52000000000000002 111.043 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.1 mt -105.27 125.29 60.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.286 -1.005 . . . . 0.29999999999999999 108.286 177.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.46 132.47 63.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.193 0.52 . . . . 0.23000000000000001 111.315 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.6 20.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.501 -0.772 . . . . 0.35999999999999999 109.638 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.594 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -101.03 125.39 54.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.217 -0.447 . . . . 0.19 110.73 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.9 m-85 -117.25 137.9 52.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.954 -0.566 . . . . 0.29999999999999999 109.823 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.582 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.71 135.02 42.81 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.797 -0.816 . . . . 0.37 108.797 178.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 140' ' ' SER . 44.5 mm -99.08 123.0 51.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.136 0.493 . . . . 0.26000000000000001 110.937 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.0 p -83.94 169.73 14.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.568 -0.742 . . . . 0.28000000000000003 110.466 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -59.82 -14.44 14.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.057 -0.519 . . . . 1.6000000000000001 110.888 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.507 ' C ' ' OG1' ' A' ' 59' ' ' THR . 96.4 m-20 -96.19 -4.34 42.71 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.834 -0.347 . . . . 1.1799999999999999 110.708 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.62 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.85 13.93 63.83 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.3 -0.72 . . . . 0.29999999999999999 111.3 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -84.64 139.03 32.34 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.099 -0.24 . . . . 1.22 110.49 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.43 ' NE2' ' OG ' ' A' ' 17' ' ' SER . 1.6 mt-30 -106.64 141.05 38.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.436 -0.347 . . . . 0.97999999999999998 110.542 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.5 m -136.7 127.07 26.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.82999999999999996 110.374 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.8 tp -68.11 117.3 9.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.329 -0.396 . . . . 0.26000000000000001 110.502 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.3 pt -109.09 -21.81 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.29999999999999999 110.625 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.91 125.72 5.85 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.523 -0.471 . . . . 0.31 111.48 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.468 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.76 120.22 21.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.799 -0.637 . . . . 0.28000000000000003 109.541 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.62 151.68 29.11 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.663 -0.415 . . . . 0.23999999999999999 110.938 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.42 158.61 18.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.062 -0.517 . . . . 0.23000000000000001 110.408 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.1 157.96 43.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.107 -0.497 . . . . 0.67000000000000004 110.667 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 104.29 9.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.714 -0.676 . . . . 0.64000000000000001 110.032 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.858 -1.068 . . . . 1.26 110.664 -179.761 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.55 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.3 m . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.141 -0.688 . . . . 3.4399999999999999 109.141 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.32 150.72 18.54 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.048 -0.821 . . . . 1.22 111.048 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -35.59 142.42 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.121 0 C-N-CA 124.009 3.139 . . . . 0.75 113.824 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.3 t -80.02 173.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.199 -1.364 . . . . 0.79000000000000004 108.775 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.601 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.62 125.92 51.55 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.385 -0.526 . . . . 1.9399999999999999 111.371 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.48 143.99 34.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.629 -0.714 . . . . 0.59999999999999998 110.689 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.4 25.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.833 0.349 . . . . 3.1400000000000001 111.145 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.749 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.07 131.0 61.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 3.23 109.989 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.16 162.44 35.48 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.882 0.372 . . . . 3.6299999999999999 111.169 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 9' ' ' THR . 71.0 tt0 36.02 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.088 -0.505 . . . . 6.0800000000000001 109.689 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.749 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.59 33.07 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.924 -0.58 . . . . 3.3799999999999999 111.62 -178.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.636 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.33 -29.04 72.25 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.438 2.092 . . . . 3.9300000000000002 111.868 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.636 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.57 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 3.3599999999999999 110.518 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.744 HE21 HE21 ' A' ' 191' ' ' GLN . 23.2 mt-30 -123.96 158.22 60.92 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.36 -0.382 . . . . 3.6099999999999999 110.468 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.492 ' HG2' ' CZ ' ' A' ' 143' ' ' ARG . 96.4 Cg_endo -81.94 -64.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.903 2.402 . . . . 1.51 113.568 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.64 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 56.6 t30 -108.49 -19.55 13.41 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.027 0.38 . . . . 2.6800000000000002 112.027 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.535 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 43.3 t -107.36 152.1 24.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.091 0.472 . . . . 1.21 111.29 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.3 102.87 2.22 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.675 -0.693 . . . . 1.5600000000000001 110.666 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.68 145.59 13.0 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.882 2.388 . . . . 0.81000000000000005 112.59 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.904 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.81 167.88 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 1.52 109.863 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.08 148.0 29.17 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.804 -0.443 . . . . 2.1400000000000001 109.804 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.581 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.8 p90 -142.31 157.29 44.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.065 0.46 . . . . 0.32000000000000001 111.168 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.497 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.02 155.24 44.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.751 -0.659 . . . . 2.1699999999999999 110.122 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.833 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.53 173.13 6.25 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 121.168 0.509 . . . . 0.58999999999999997 110.665 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.833 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.8 Cg_exo -50.65 173.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.816 2.344 . . . . 0.90000000000000002 111.551 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.483 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.09 -51.13 0.68 Allowed Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.775 -0.37 . . . . 3.3399999999999999 110.062 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.64 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.72 152.22 82.81 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.856 2.371 . . . . 1.8500000000000001 111.481 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.63 42.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.479 0.657 . . . . 2.54 110.624 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.824 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.68 -41.62 98.13 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.89 -1.05 . . . . 2.5299999999999998 110.569 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.533 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.8 mt -109.79 137.79 40.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.846 -0.616 . . . . 1.1699999999999999 111.262 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.87 -72.96 0.7 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.043 -0.526 . . . . 1.27 111.939 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.12 148.35 24.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.593 0.59 . . . . 1.1200000000000001 112.593 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.84 124.82 45.05 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.304 -0.628 . . . . 0.41999999999999998 109.304 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -117.99 134.69 60.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.683 -0.407 . . . . 0.78000000000000003 110.658 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.904 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.0 128.58 53.68 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.053 0.454 . . . . 0.62 111.277 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.1 139.05 49.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.778 -0.646 . . . . 1.97 110.133 178.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.439 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.1 163.16 35.17 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.145 0.498 . . . . 0.34999999999999998 112.067 -178.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.494 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.4 139.69 7.99 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.452 -0.795 . . . . 1.8 110.479 178.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.58 115.49 3.08 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.273 1.982 . . . . 0.57999999999999996 111.879 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.666 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.04 81.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.865 -0.42 . . . . 3.04 109.865 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.693 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.925 -0.58 . . . . 2.4700000000000002 111.939 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.8 p -157.56 157.81 34.43 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.877 -0.329 . . . . 2.5099999999999998 110.617 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.406 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.8 m -120.38 27.8 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 1.8600000000000001 110.16 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -75.83 1.31 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.143 -0.551 . . . . 1.4399999999999999 111.846 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.85 152.25 35.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.91 0.386 . . . . 4.6900000000000004 111.084 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.673 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.16 -169.01 2.5 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.103 -0.498 . . . . 1.4299999999999999 111.919 179.352 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.17 149.72 29.68 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.434 0.635 . . . . 1.74 112.582 -177.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.08 156.48 45.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.856 -1.065 . . . . 1.9199999999999999 110.316 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.469 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.21 158.39 41.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.027 -0.533 . . . . 0.34000000000000002 111.75 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.8 m -115.22 135.61 53.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.445 -0.798 . . . . 0.40999999999999998 109.751 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.581 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.41 121.98 23.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.394 -0.367 . . . . 0.55000000000000004 111.513 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.597 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.9 Cg_exo -46.33 151.66 1.66 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.656 2.237 . . . . 0.44 112.097 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.83 -23.11 62.98 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 116.0 -0.545 . . . . 0.73999999999999999 112.771 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.545 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.71 -16.87 46.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.371 0.586 . . . . 0.93000000000000005 111.882 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.597 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.55 138.29 31.69 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.804 -0.359 . . . . 0.96999999999999997 110.368 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.39 13.8 11.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.391 -0.368 . . . . 1.3400000000000001 111.578 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.83 143.52 25.39 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.662 -0.415 . . . . 0.39000000000000001 111.084 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.725 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.85 -169.39 1.54 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.222 0.534 . . . . 0.41999999999999998 110.883 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.725 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.7 t -151.74 125.88 9.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.418 -0.81 . . . . 0.39000000000000001 109.806 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.516 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.9 mt -114.89 123.29 70.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.369 -0.532 . . . . 0.73999999999999999 111.24 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.749 ' CD ' HD12 ' A' ' 185' ' ' ILE . 1.2 mtmt -126.49 163.44 23.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.773 -0.649 . . . . 2.48 110.405 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.439 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.07 19.0 59.94 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.776 -0.93 . . . . 0.5 110.776 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.64 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.6 mt -79.07 157.23 28.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.124 0.488 . . . . 0.57999999999999996 111.411 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.845 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -99.49 133.9 21.57 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.677 -0.692 . . . . 2.79 110.439 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.512 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.74 143.55 62.12 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.61 2.207 . . . . 0.87 111.948 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.86 25.63 75.34 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.98 -0.848 . . . . 0.64000000000000001 110.98 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.845 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.16 158.76 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.747 0.308 . . . . 0.82999999999999996 110.406 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.18 139.94 42.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.941 0.4 . . . . 0.5 110.566 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.646 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.55 136.5 54.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.944 -0.571 . . . . 0.53000000000000003 110.763 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.494 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.96 131.03 45.32 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.522 -0.918 . . . . 1.8700000000000001 108.522 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.44 153.9 16.63 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.354 -0.927 . . . . 0.28999999999999998 111.945 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.15 140.91 45.78 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.632 -0.507 . . . . 1.4299999999999999 109.632 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.525 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.69 118.93 34.45 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.422 -0.511 . . . . 0.32000000000000001 110.469 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.74 HG12 HG23 ' A' ' 84' ' ' VAL . 64.2 mt -112.45 129.11 68.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.322 -0.399 . . . . 0.79000000000000004 110.614 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.707 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.87 120.86 43.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.305 -0.407 . . . . 1.02 110.636 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.86 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.61 146.47 11.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.305 0.574 . . . . 0.62 110.969 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.824 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -105.96 153.84 21.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.459 -0.791 . . . . 2.4399999999999999 109.943 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.2 mt-30 -39.24 88.61 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.955 0.407 . . . . 3.6899999999999999 110.439 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.624 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.757 -0.656 . . . . 6.0800000000000001 110.57 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.11 -117.35 3.29 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.433 -0.667 . . . . 1.22 111.433 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.461 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.45 177.43 8.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.132 0.491 . . . . 2.8799999999999999 111.688 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.2 149.48 32.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.448 -0.797 . . . . 1.47 110.391 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.55 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.1 144.62 38.8 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.444 -0.344 . . . . 2.7000000000000002 110.588 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.74 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.99 135.93 61.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.075 0.464 . . . . 0.46000000000000002 111.589 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.571 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.01 141.4 52.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.661 . . . . 0.34999999999999998 110.237 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.459 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.69 138.82 51.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.214 0.531 . . . . 3.6699999999999999 111.501 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.21 164.27 37.71 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.532 -0.758 . . . . 0.67000000000000004 109.468 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.573 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 46.9 p30 -145.29 151.53 38.49 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.335 -0.546 . . . . 1.47 111.042 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.801 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.2 p90 -146.3 172.67 13.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.842 -0.617 . . . . 0.44 110.959 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.77 160.66 21.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.43 -0.805 . . . . 1.3700000000000001 109.856 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.38 121.94 23.05 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.585 -0.446 . . . . 1.28 110.742 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.2 p -130.6 162.37 29.49 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 112.963 0.727 . . . . 1.97 112.963 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.6 t . . . . . 0 C--N 1.316 -0.868 0 CA-C-N 114.39 -1.277 . . . . 3.2799999999999998 111.522 175.837 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.537 0.447 0 N-CA-C 113.086 0.773 . . . . 0.66000000000000003 113.086 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.436 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.91 167.53 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.997 0.427 . . . . 0.68999999999999995 110.94 179.169 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.51 145.51 50.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.677 -0.692 . . . . 0.52000000000000002 110.178 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.3 t -124.31 101.77 9.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.049 -0.723 . . . . 0.32000000000000001 109.049 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.0 t -112.99 139.62 37.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.985 -0.552 . . . . 0.28999999999999998 111.09 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.6 p -128.68 152.62 48.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.669 -0.696 . . . . 0.25 109.822 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.592 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.86 -165.0 2.05 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.737 -0.385 . . . . 0.31 110.653 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -123.95 127.21 73.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.189 -0.459 . . . . 0.48999999999999999 110.793 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.173 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.98 58.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.149 -0.478 . . . . 1.53 110.367 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.19 24.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.867 -0.606 . . . . 0.96999999999999997 111.451 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.173 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.22 128.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.998 0.428 . . . . 1.5600000000000001 110.933 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.53 -9.5 56.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.94 -0.573 . . . . 1.8799999999999999 110.319 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.22 0.33 55.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.052 -0.522 . . . . 1.04 110.288 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.38 137.3 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 115.988 -0.551 . . . . 0.23999999999999999 109.908 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 185' ' ' ILE . 1.9 m -96.24 -15.51 21.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.282 0.563 . . . . 0.28999999999999998 110.076 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.655 ' HA3' HD11 ' A' ' 185' ' ' ILE . . . 178.65 175.55 45.81 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 109.844 -1.303 . . . . 0.13 109.844 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.45 151.6 42.52 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.668 -0.413 . . . . 0.17000000000000001 110.449 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.558 ' NH2' ' HB3' ' A' ' 157' ' ' TYR . 74.4 ttt-85 -132.31 121.17 23.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.116 -0.493 . . . . 1.29 109.948 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.14 136.61 38.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.718 -0.674 . . . . 0.25 110.62 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 80.7 tt0 -129.33 129.87 45.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.902 -0.59 . . . . 1.3200000000000001 110.072 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.76 135.29 34.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.163 0.506 . . . . 0.56999999999999995 110.595 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.417 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.25 161.42 39.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.754 -0.657 . . . . 1.1599999999999999 109.695 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.14 124.89 25.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.039 0.447 . . . . 0.38 110.684 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.494 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.77 -7.7 49.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.745 -0.662 . . . . 0.40999999999999998 110.885 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -109.85 -69.64 0.85 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 1.6599999999999999 111.331 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.435 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.7 -35.33 76.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.079 -0.51 . . . . 1.6599999999999999 111.445 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.082 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.2 7.13 88.66 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.828 -0.909 . . . . 1.1699999999999999 110.828 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.339 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.96 -171.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 1.8600000000000001 110.272 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.339 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.22 139.07 45.28 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.941 0.401 . . . . 1.98 110.196 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.417 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.4 Cg_endo -70.89 145.79 51.55 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 122.789 2.326 . . . . 0.55000000000000004 112.295 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.8 145.77 42.54 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.264 -0.643 . . . . 1.1399999999999999 109.264 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.558 ' HB3' ' NH2' ' A' ' 143' ' ' ARG . 34.5 p90 -123.33 141.31 52.12 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.364 -0.534 . . . . 0.93000000000000005 111.449 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.8 mt -128.1 127.79 43.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.226 -0.897 . . . . 0.34000000000000002 108.915 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.499 ' HB2' ' ND2' ' A' ' 16' ' ' ASN . 67.8 t0 -101.69 131.21 48.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.16 0.505 . . . . 1.0900000000000001 111.732 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.476 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -128.03 157.62 73.41 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.334 -0.848 . . . . 0.19 109.541 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -69.83 158.08 58.08 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.385 2.057 . . . . 0.17999999999999999 112.248 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.31 -12.19 5.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.839 -0.618 . . . . 0.20999999999999999 110.673 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.9 p -92.83 -8.74 42.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.28999999999999998 110.661 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.23 135.45 34.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.405 -0.362 . . . . 0.5 110.346 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.0 p -133.13 16.6 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.396 . . . . 0.29999999999999999 110.524 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.8 p -167.54 147.05 5.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.707 -0.479 . . . . 0.23000000000000001 109.707 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.12 150.56 12.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.533 -0.467 . . . . 0.28000000000000003 111.568 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.508 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.43 124.98 50.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.567 -0.742 . . . . 1.0700000000000001 109.768 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.31 104.9 29.5 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.344 -0.389 . . . . 0.28999999999999998 111.034 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.9 Cg_endo -91.03 -179.56 1.49 Allowed 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 123.215 2.61 . . . . 0.42999999999999999 112.212 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.77 32.61 18.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.427 -0.806 . . . . 1.26 111.458 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.433 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.0 mt -86.42 148.5 25.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.442 -0.345 . . . . 0.32000000000000001 110.391 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.771 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.4 mt -88.24 114.92 61.56 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.987 0.422 . . . . 0.57999999999999996 110.69 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.12 140.55 95.55 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.879 2.386 . . . . 0.66000000000000003 111.978 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.21 74.33 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.102 -0.799 . . . . 0.28999999999999998 111.102 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.435 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.81 150.26 49.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.781 0.324 . . . . 2.3300000000000001 110.661 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.494 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.31 131.61 46.15 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.105 -0.498 . . . . 0.85999999999999999 109.769 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.955 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.47 148.4 43.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.012 -0.54 . . . . 0.52000000000000002 110.962 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.36 125.37 60.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.262 -1.014 . . . . 0.29999999999999999 108.262 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.56 132.5 63.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.158 0.504 . . . . 0.23000000000000001 111.249 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.9 m-20 -136.48 122.63 20.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.48 -0.782 . . . . 0.35999999999999999 109.693 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.592 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.07 125.39 55.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.241 -0.436 . . . . 0.19 110.63 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 47.9 m-85 -117.2 137.88 52.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.974 -0.557 . . . . 0.29999999999999999 109.912 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.582 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.7 135.09 42.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.734 -0.839 . . . . 0.37 108.734 178.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.749 HD12 ' CD ' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -99.24 123.01 51.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.216 0.531 . . . . 0.26000000000000001 110.866 -178.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.4 p -83.84 169.81 14.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.512 -0.767 . . . . 0.28000000000000003 110.399 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.507 ' OE1' ' OG ' ' A' ' 140' ' ' SER . 48.0 tp10 -59.89 -14.52 15.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.948 -0.569 . . . . 1.6000000000000001 110.962 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -96.09 -4.25 43.2 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.818 -0.353 . . . . 1.1799999999999999 110.825 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.89 13.82 63.93 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.297 -0.721 . . . . 0.29999999999999999 111.297 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -84.53 139.04 32.41 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.116 -0.233 . . . . 1.22 110.519 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.744 HE21 HE21 ' A' ' 14' ' ' GLN . 74.3 mt-30 -106.77 141.06 38.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.852 0.358 . . . . 0.97999999999999998 110.596 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.0 m -136.69 126.97 26.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.82999999999999996 110.345 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.0 117.22 9.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.254 -0.43 . . . . 0.26000000000000001 110.502 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.09 -21.69 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.241 -0.436 . . . . 0.29999999999999999 110.728 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.92 125.71 5.84 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.527 -0.469 . . . . 0.31 111.5 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.469 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.76 120.31 21.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.764 -0.653 . . . . 0.28000000000000003 109.539 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.72 151.6 28.93 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.587 -0.445 . . . . 0.23999999999999999 110.89 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.41 158.58 18.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.052 -0.522 . . . . 0.23000000000000001 110.461 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -145.99 158.06 43.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.67000000000000004 110.651 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.37 104.38 9.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.775 -0.648 . . . . 0.64000000000000001 110.012 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.2 p . . . . . 0 C--O 1.222 -0.39 0 CA-C-O 117.887 -1.054 . . . . 1.26 110.659 -179.751 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.553 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.148 -0.686 . . . . 3.4399999999999999 109.148 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.41 150.63 18.55 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.992 -0.843 . . . . 1.22 110.992 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -35.51 142.32 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.085 0 C-N-CA 124.083 3.189 . . . . 0.75 113.799 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.3 t -79.98 173.38 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.281 -1.327 . . . . 0.79000000000000004 108.779 178.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.601 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.57 125.88 51.5 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.378 -0.529 . . . . 1.9399999999999999 111.439 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.5 144.02 33.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.653 -0.703 . . . . 0.59999999999999998 110.633 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -151.98 168.39 25.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.908 0.385 . . . . 3.1400000000000001 111.162 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.744 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.12 131.06 60.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.053 -0.521 . . . . 3.23 110.055 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.1 p -141.16 162.22 36.02 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.88 0.371 . . . . 3.6299999999999999 111.26 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 98.1 mt-10 36.17 31.59 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.587 -0.523 . . . . 6.0800000000000001 109.587 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.744 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.4 69.53 32.08 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.97 -0.559 . . . . 3.3799999999999999 111.547 -178.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.27 -29.08 72.81 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.494 2.129 . . . . 3.9300000000000002 111.858 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.61 125.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.118 -0.492 . . . . 3.3599999999999999 110.48 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.677 ' NE2' ' OE1' ' A' ' 191' ' ' GLN . 0.6 OUTLIER -123.98 158.4 60.37 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.313 -0.403 . . . . 3.6099999999999999 110.453 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.549 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 99.0 Cg_endo -82.12 -64.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.942 2.428 . . . . 1.51 113.437 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.555 ' ND2' ' H ' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -108.49 -19.57 13.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.019 0.377 . . . . 2.6800000000000002 112.019 -178.439 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.599 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 7.7 p -107.26 152.09 24.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.21 0.529 . . . . 1.21 111.252 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.37 102.94 2.21 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.67 -0.696 . . . . 1.5600000000000001 110.647 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.63 145.61 13.09 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.884 2.389 . . . . 0.81000000000000005 112.598 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.924 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.84 167.91 24.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.897 -0.592 . . . . 1.52 109.939 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.14 148.0 29.13 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.751 -0.463 . . . . 2.1400000000000001 109.751 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.586 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.7 p90 -142.19 157.25 45.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.017 0.437 . . . . 0.32000000000000001 111.242 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.497 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.06 155.32 44.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.856 -0.611 . . . . 2.1699999999999999 110.137 178.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.838 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.61 173.03 6.36 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 121.105 0.479 . . . . 0.58999999999999997 110.741 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.838 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.69 173.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.932 2.422 . . . . 0.90000000000000002 111.498 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -51.05 0.69 Allowed Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 120.714 -0.395 . . . . 3.3399999999999999 110.155 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.638 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.84 152.39 82.33 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.756 2.304 . . . . 1.8500000000000001 111.452 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.73 42.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.309 0.576 . . . . 2.54 110.496 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.82 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.66 -41.67 98.18 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.974 -1.012 . . . . 2.5299999999999998 110.645 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.532 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.4 mt -109.82 137.9 39.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.795 -0.639 . . . . 1.1699999999999999 111.242 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.06 -72.87 0.71 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.009 -0.541 . . . . 1.27 111.863 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.12 148.52 24.4 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.58 0.585 . . . . 1.1200000000000001 112.58 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.96 124.9 45.12 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.301 -0.629 . . . . 0.41999999999999998 109.301 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.07 134.7 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.645 -0.422 . . . . 0.78000000000000003 110.594 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.924 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.02 128.67 53.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.04 0.448 . . . . 0.62 111.237 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.542 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.11 138.94 49.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.735 -0.666 . . . . 1.97 110.088 179.031 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.436 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.04 163.16 35.09 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.181 0.515 . . . . 0.34999999999999998 112.061 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.491 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.42 139.6 7.92 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.45 -0.795 . . . . 1.8 110.462 178.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.54 115.45 3.04 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.307 2.004 . . . . 0.57999999999999996 111.837 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.676 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.97 81.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.834 -0.432 . . . . 3.04 109.834 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.693 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.979 -0.555 . . . . 2.4700000000000002 111.886 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 p -157.59 157.84 34.44 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.79 -0.364 . . . . 2.5099999999999998 110.569 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.44 27.87 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.256 -0.429 . . . . 1.8600000000000001 110.189 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.91 -75.89 1.31 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.115 -0.564 . . . . 1.4399999999999999 111.766 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.94 152.33 35.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.011 0.434 . . . . 4.6900000000000004 110.91 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.2 -169.19 2.56 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.98 -0.555 . . . . 1.4299999999999999 111.946 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.436 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.6 mttp -110.08 149.56 29.84 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.471 0.653 . . . . 1.74 112.633 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.01 156.51 46.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.836 -1.074 . . . . 1.9199999999999999 110.242 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.22 158.42 41.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.931 -0.577 . . . . 0.34000000000000002 111.718 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.1 m -115.26 135.62 53.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.4 -0.818 . . . . 0.40999999999999998 109.814 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.586 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.43 121.9 23.73 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.407 -0.36 . . . . 0.55000000000000004 111.591 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.599 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.3 Cg_exo -46.23 151.69 1.57 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.626 2.217 . . . . 0.44 112.135 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.79 -23.15 62.93 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 116.071 -0.513 . . . . 0.73999999999999999 112.826 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.81 -16.83 46.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.371 0.586 . . . . 0.93000000000000005 111.831 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.599 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.57 138.43 31.58 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.767 -0.373 . . . . 0.96999999999999997 110.307 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -121.54 13.92 10.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.418 -0.356 . . . . 1.3400000000000001 111.548 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.477 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.0 p -150.02 143.36 25.12 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.721 -0.392 . . . . 0.39000000000000001 111.06 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.721 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.77 -169.35 1.53 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.065 -0.516 . . . . 0.41999999999999998 110.918 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.721 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 t -151.75 125.83 9.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.431 -0.804 . . . . 0.39000000000000001 109.87 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.518 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.84 123.26 70.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.42 -0.512 . . . . 0.73999999999999999 111.18 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -126.57 163.34 23.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.732 -0.667 . . . . 2.48 110.412 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.555 ' H ' ' ND2' ' A' ' 16' ' ' ASN . . . 85.18 18.95 59.84 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.742 -0.943 . . . . 0.5 110.742 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.518 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.1 mt -79.1 157.23 28.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.052 0.453 . . . . 0.57999999999999996 111.357 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.847 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -99.48 133.96 21.53 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.584 -0.735 . . . . 2.79 110.433 179.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.92 143.59 61.23 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.614 2.209 . . . . 0.87 111.89 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.78 25.69 75.26 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.068 -0.813 . . . . 0.64000000000000001 111.068 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.847 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.23 158.78 40.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.679 0.276 . . . . 0.82999999999999996 110.423 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.27 139.95 42.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.034 0.445 . . . . 0.5 110.57 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.658 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.7 m-85 -122.54 136.4 54.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.967 -0.56 . . . . 0.53000000000000003 110.745 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.491 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.91 131.05 45.29 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.474 -0.936 . . . . 1.8700000000000001 108.474 177.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.494 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.52 153.84 16.66 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.283 -0.96 . . . . 0.28999999999999998 112.011 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.93 140.88 46.09 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.671 -0.492 . . . . 1.4299999999999999 109.671 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.3 tp -115.77 118.9 34.33 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.458 -0.497 . . . . 0.32000000000000001 110.476 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.726 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.45 129.12 68.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.26 -0.427 . . . . 0.79000000000000004 110.619 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.702 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.9 120.77 43.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.273 -0.421 . . . . 1.02 110.713 -179.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.854 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.52 146.46 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.107 0.48 . . . . 0.62 111.044 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.82 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.02 153.9 21.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.54 -0.755 . . . . 2.4399999999999999 109.929 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.15 88.67 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.912 0.387 . . . . 3.6899999999999999 110.401 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.616 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.16 32.64 0.2 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.835 -0.621 . . . . 6.0800000000000001 110.659 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.02 -117.36 3.3 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.495 -0.642 . . . . 1.22 111.495 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.461 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.45 177.49 8.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.17 0.509 . . . . 2.8799999999999999 111.642 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.2 149.47 31.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.427 -0.806 . . . . 1.47 110.377 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.553 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.09 144.63 38.81 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.506 -0.315 . . . . 2.7000000000000002 110.616 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.726 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.93 136.0 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.026 0.441 . . . . 0.46000000000000002 111.601 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.06 141.31 52.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.676 -0.693 . . . . 0.34999999999999998 110.3 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.466 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.65 138.74 51.77 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.095 0.474 . . . . 3.6699999999999999 111.54 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.494 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.17 164.14 37.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.562 -0.744 . . . . 0.67000000000000004 109.498 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.571 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.18 151.57 38.64 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.428 -0.509 . . . . 1.47 111.062 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.8 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.18 172.76 12.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.748 -0.66 . . . . 0.44 111.028 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.83 160.63 21.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.432 -0.804 . . . . 1.3700000000000001 109.804 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.31 121.9 23.07 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.593 -0.443 . . . . 1.28 110.798 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.632 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.7 p -127.37 168.16 15.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.256 0.55 . . . . 1.97 112.351 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.0 p . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.514 -0.766 . . . . 3.2799999999999998 110.931 179.745 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.48 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 3.6 p . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 108.939 -0.763 . . . . 0.66000000000000003 108.939 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.437 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.77 167.5 0.25 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.288 -0.869 . . . . 0.68999999999999995 111.004 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.57 145.6 50.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.785 -0.643 . . . . 0.52000000000000002 110.118 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.3 101.55 9.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.126 -0.694 . . . . 0.32000000000000001 109.126 177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.8 t -112.93 139.8 36.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.006 -0.543 . . . . 0.28999999999999998 110.988 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.1 p -128.74 152.63 48.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.575 -0.739 . . . . 0.25 109.778 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.592 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.89 -164.96 2.04 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.717 -0.393 . . . . 0.31 110.622 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.734 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -123.92 127.22 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 0.48999999999999999 110.815 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.179 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -58.05 58.34 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.168 -0.469 . . . . 1.53 110.326 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.09 24.42 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.905 -0.589 . . . . 0.96999999999999997 111.447 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.179 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.28 128.7 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.638 -0.425 . . . . 1.5600000000000001 110.913 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -86.37 -9.58 56.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.971 -0.559 . . . . 1.8799999999999999 110.381 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.7 p -87.13 0.28 55.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 1.04 110.279 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.33 137.27 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.988 -0.551 . . . . 0.23999999999999999 109.888 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 185' ' ' ILE . 88.8 p -96.25 -15.53 21.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.25 0.548 . . . . 0.28999999999999998 109.999 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.6 175.56 45.78 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 109.832 -1.307 . . . . 0.13 109.832 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.43 151.54 42.56 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.719 -0.392 . . . . 0.17000000000000001 110.538 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.872 ' NE ' HE22 ' A' ' 191' ' ' GLN . 8.5 tmm_? -132.22 121.19 23.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.153 -0.476 . . . . 1.29 109.899 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.13 136.61 38.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.739 -0.664 . . . . 0.25 110.653 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 77.6 tt0 -129.36 129.86 45.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 1.3200000000000001 110.03 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.627 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.8 135.23 34.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.066 -0.516 . . . . 0.56999999999999995 110.638 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.42 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.27 161.38 39.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.723 -0.672 . . . . 1.1599999999999999 109.665 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.4 mt -71.02 124.88 25.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.991 0.424 . . . . 0.38 110.755 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.489 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.1 p -71.74 -7.67 49.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.725 -0.671 . . . . 0.40999999999999998 110.866 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -109.83 -69.57 0.86 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 1.6599999999999999 111.481 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.459 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.69 -35.41 76.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.11 -0.496 . . . . 1.6599999999999999 111.451 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.077 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.2 7.18 88.63 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.76 -0.936 . . . . 1.1699999999999999 110.76 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.331 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.86 -171.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.779 0.323 . . . . 1.8600000000000001 110.324 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.331 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.16 139.11 45.48 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.96 0.409 . . . . 1.98 110.216 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.42 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.5 Cg_endo -70.98 145.84 51.14 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 C-N-CA 122.746 2.297 . . . . 0.55000000000000004 112.288 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.627 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.83 145.77 42.56 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.224 -0.658 . . . . 1.1399999999999999 109.224 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 15' ' ' PRO . 7.8 m-85 -123.28 141.37 52.05 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.344 -0.543 . . . . 0.93000000000000005 111.526 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.16 127.69 43.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.286 -0.87 . . . . 0.34000000000000002 108.932 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.533 ' O ' ' OD1' ' A' ' 159' ' ' ASP . 55.4 p-10 -101.62 131.19 47.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.125 0.488 . . . . 1.0900000000000001 111.818 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -128.04 157.58 73.53 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.393 -0.821 . . . . 0.19 109.514 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -69.88 158.09 57.96 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.335 2.023 . . . . 0.17999999999999999 112.24 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.36 -12.08 5.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.842 -0.617 . . . . 0.20999999999999999 110.734 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.3 p -92.79 -8.8 42.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.101 -0.5 . . . . 0.28999999999999998 110.762 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.36 34.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.304 -0.407 . . . . 0.5 110.434 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.9 p -133.11 16.58 4.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.447 -0.342 . . . . 0.29999999999999999 110.515 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.8 p -167.47 147.21 5.16 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.607 -0.516 . . . . 0.23000000000000001 109.607 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.24 150.51 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.551 -0.459 . . . . 0.28000000000000003 111.57 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.509 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.36 124.89 50.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.604 -0.725 . . . . 1.0700000000000001 109.786 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.34 104.84 29.26 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.358 -0.383 . . . . 0.28999999999999998 111.028 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.9 Cg_endo -91.04 -179.43 1.47 Allowed 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 123.103 2.535 . . . . 0.42999999999999999 112.237 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.72 32.62 18.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.381 -0.827 . . . . 1.26 111.381 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.48 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.1 mt -86.34 148.51 25.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.788 0.328 . . . . 0.32000000000000001 110.476 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.777 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.26 114.83 61.18 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.969 0.414 . . . . 0.57999999999999996 110.725 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.05 140.57 95.82 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.882 2.388 . . . . 0.66000000000000003 111.977 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.17 21.12 74.25 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.078 -0.809 . . . . 0.28999999999999998 111.078 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.459 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.83 150.2 49.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.833 0.349 . . . . 2.3300000000000001 110.623 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.489 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.12 131.65 45.95 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.983 -0.553 . . . . 0.85999999999999999 109.818 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.955 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.5 148.34 43.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.138 -0.483 . . . . 0.52000000000000002 111.01 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.38 125.38 60.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.258 -1.015 . . . . 0.29999999999999999 108.258 177.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.5 132.55 63.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.092 0.473 . . . . 0.23000000000000001 111.283 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.55 122.55 20.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.624 -0.717 . . . . 0.35999999999999999 109.659 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.592 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -100.95 125.33 54.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.219 -0.446 . . . . 0.19 110.709 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.4 m-85 -117.21 137.98 52.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.997 -0.547 . . . . 0.29999999999999999 109.887 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.585 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.76 135.0 42.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.779 -0.823 . . . . 0.37 108.779 178.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.603 ' O ' ' N ' ' A' ' 140' ' ' SER . 74.6 mt -99.17 122.98 51.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.161 0.505 . . . . 0.26000000000000001 110.893 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.7 p -83.94 169.7 14.76 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.539 -0.755 . . . . 0.28000000000000003 110.383 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -59.74 -14.53 14.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.05 -0.523 . . . . 1.6000000000000001 110.964 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -96.07 -4.4 43.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.795 0.331 . . . . 1.1799999999999999 110.829 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.435 ' N ' ' HB ' ' A' ' 59' ' ' THR . . . 87.85 13.84 63.97 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.364 -0.694 . . . . 0.29999999999999999 111.364 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -84.58 139.09 32.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.059 -0.256 . . . . 1.22 110.482 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.872 HE22 ' NE ' ' A' ' 143' ' ' ARG . 88.5 mt-30 -106.81 141.08 38.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.91 0.386 . . . . 0.97999999999999998 110.526 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.4 m -136.71 126.94 26.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.82999999999999996 110.349 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.11 117.26 9.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.317 -0.401 . . . . 0.26000000000000001 110.564 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.01 -21.81 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.29999999999999999 110.77 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.85 125.71 5.89 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.547 -0.461 . . . . 0.31 111.501 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.74 120.27 21.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.821 -0.627 . . . . 0.28000000000000003 109.542 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.69 151.65 28.99 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.752 -0.379 . . . . 0.23999999999999999 110.922 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.43 158.49 18.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.967 -0.56 . . . . 0.23000000000000001 110.447 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.01 157.95 43.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.127 -0.488 . . . . 0.67000000000000004 110.669 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.26 104.37 9.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.774 -0.648 . . . . 0.64000000000000001 109.964 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.948 -1.025 . . . . 1.26 110.638 -179.774 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.1 m . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.285 -0.635 . . . . 3.4399999999999999 109.285 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.45 150.76 18.52 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.012 -0.835 . . . . 1.22 111.012 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -35.7 142.39 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.067 0 C-N-CA 123.999 3.133 . . . . 0.75 113.759 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.607 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.9 173.36 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.222 -1.354 . . . . 0.79000000000000004 108.822 178.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.607 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.62 125.88 51.5 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.435 -0.506 . . . . 1.9399999999999999 111.438 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 143.93 34.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.655 -0.702 . . . . 0.59999999999999998 110.73 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.28 25.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 3.1400000000000001 111.129 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.748 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.99 131.07 60.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.008 -0.542 . . . . 3.23 110.082 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.8 p -141.19 162.3 35.82 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.759 0.314 . . . . 3.6299999999999999 111.249 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 70.6 tt0 36.02 31.6 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.69 -0.485 . . . . 6.0800000000000001 109.69 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.748 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.56 32.42 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.896 -0.593 . . . . 3.3799999999999999 111.568 -178.744 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.3 -29.08 72.53 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.449 2.1 . . . . 3.9300000000000002 111.818 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.64 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 3.3599999999999999 110.513 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.604 ' HG3' ' NE2' ' A' ' 191' ' ' GLN . 7.0 mp0 -124.01 158.35 60.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.392 -0.367 . . . . 3.6099999999999999 110.426 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.699 ' HD2' HH12 ' A' ' 143' ' ' ARG . 96.5 Cg_endo -82.0 -64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.835 2.356 . . . . 1.51 113.57 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.913 ' ND2' ' H ' ' A' ' 62' ' ' GLY . 9.9 t30 -108.46 -19.55 13.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.265 -0.425 . . . . 2.6800000000000002 112.074 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 18.0 p -107.31 152.09 24.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.163 0.506 . . . . 1.21 111.387 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.578 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.19 102.9 2.24 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.726 -0.67 . . . . 1.5600000000000001 110.691 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.406 ' HB3' ' HA3' ' A' ' 189' ' ' GLY . 73.6 Cg_endo -82.63 145.63 13.1 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.915 2.41 . . . . 0.81000000000000005 112.607 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.911 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.87 167.92 24.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.906 -0.588 . . . . 1.52 109.904 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.1 148.02 29.18 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.783 -0.451 . . . . 2.1400000000000001 109.783 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.588 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.4 p90 -142.29 157.27 45.01 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.621 -0.432 . . . . 0.32000000000000001 111.137 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.494 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.02 155.31 44.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.732 -0.667 . . . . 2.1699999999999999 110.051 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.827 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.63 173.12 6.26 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.214 0.531 . . . . 0.58999999999999997 110.68 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.827 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.69 173.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.819 2.346 . . . . 0.90000000000000002 111.497 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -50.97 0.69 Allowed Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.666 -0.414 . . . . 3.3399999999999999 110.191 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.634 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.82 152.3 82.63 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.821 2.347 . . . . 1.8500000000000001 111.466 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.64 42.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.331 0.586 . . . . 2.54 110.543 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.821 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.54 -41.66 98.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.047 -0.978 . . . . 2.5299999999999998 110.683 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.8 mt -109.8 137.87 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.813 -0.63 . . . . 1.1699999999999999 111.296 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.02 -72.88 0.7 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.095 -0.502 . . . . 1.27 111.84 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.19 148.35 24.43 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.558 0.577 . . . . 1.1200000000000001 112.558 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.77 124.86 45.19 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.348 -0.612 . . . . 0.41999999999999998 109.348 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.3 mt -117.99 134.73 60.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.724 -0.391 . . . . 0.78000000000000003 110.61 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.911 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -119.99 128.62 53.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.067 0.46 . . . . 0.62 111.252 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.14 138.96 49.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.799 -0.637 . . . . 1.97 110.073 179.05 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.435 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.11 163.24 34.92 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.14 0.495 . . . . 0.34999999999999998 112.059 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.5 139.55 7.83 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.423 -0.808 . . . . 1.8 110.428 178.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.62 115.47 3.07 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.347 2.032 . . . . 0.57999999999999996 111.823 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.668 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.97 81.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.887 -0.412 . . . . 3.04 109.887 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.25 -20.59 0.06 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.05 -0.523 . . . . 2.4700000000000002 111.969 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 p -157.61 157.81 34.35 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.822 -0.351 . . . . 2.5099999999999998 110.535 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.406 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.48 27.88 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 1.8600000000000001 110.123 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.82 -75.94 1.31 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.17 -0.538 . . . . 1.4399999999999999 111.839 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.87 152.36 35.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.946 0.403 . . . . 4.6900000000000004 111.058 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.09 2.52 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.101 -0.499 . . . . 1.4299999999999999 111.998 179.43 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.18 149.64 29.8 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.464 0.649 . . . . 1.74 112.565 -177.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.03 156.47 46.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.893 -1.048 . . . . 1.9199999999999999 110.302 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.18 158.44 41.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.931 -0.577 . . . . 0.34000000000000002 111.796 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.27 135.53 54.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.438 -0.801 . . . . 0.40999999999999998 109.848 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.588 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.31 121.98 23.89 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.506 -0.315 . . . . 0.55000000000000004 111.529 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.6 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.6 Cg_exo -46.39 151.76 1.67 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.716 2.277 . . . . 0.44 112.098 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.94 -23.01 63.11 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 116.076 -0.511 . . . . 0.73999999999999999 112.792 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.547 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.78 -16.94 45.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.425 0.613 . . . . 0.93000000000000005 111.821 -178.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.6 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.49 138.44 31.57 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.737 -0.385 . . . . 0.96999999999999997 110.352 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -121.48 13.93 11.03 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.442 -0.345 . . . . 1.3400000000000001 111.638 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.473 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.02 143.49 25.2 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.607 -0.437 . . . . 0.39000000000000001 111.022 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.72 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.79 -169.38 1.53 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.212 0.529 . . . . 0.41999999999999998 110.886 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.72 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.74 125.86 9.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.437 -0.801 . . . . 0.39000000000000001 109.893 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.4 mt -114.84 123.34 70.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.366 -0.533 . . . . 0.73999999999999999 111.234 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.838 ' NZ ' ' N ' ' A' ' 141' ' ' GLY . 15.9 mtpt -126.59 163.42 23.46 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.753 -0.658 . . . . 2.48 110.394 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.913 ' H ' ' ND2' ' A' ' 16' ' ' ASN . . . 85.11 19.07 59.76 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.682 -0.967 . . . . 0.5 110.682 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.514 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.0 mt -79.11 157.19 28.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.996 0.427 . . . . 0.57999999999999996 111.36 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.854 ' O ' HG12 ' A' ' 67' ' ' VAL . 4.3 mttp -99.48 133.87 21.6 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.71 -0.677 . . . . 2.79 110.464 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.89 143.63 61.6 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.497 2.131 . . . . 0.87 111.906 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.79 25.67 75.28 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.073 -0.811 . . . . 0.64000000000000001 111.073 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.854 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.3 p -128.14 158.73 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.683 0.278 . . . . 0.82999999999999996 110.461 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.03 140.03 41.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.909 0.385 . . . . 0.5 110.648 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.658 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.68 136.52 54.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.948 -0.569 . . . . 0.53000000000000003 110.71 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.96 131.1 45.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.436 -0.95 . . . . 1.8700000000000001 108.436 177.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.48 153.87 16.65 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.355 -0.926 . . . . 0.28999999999999998 111.918 -178.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.03 141.01 46.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.624 -0.51 . . . . 1.4299999999999999 109.624 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.525 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.9 tp -115.71 119.02 34.69 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.422 -0.511 . . . . 0.32000000000000001 110.545 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.74 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.53 129.1 68.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.359 -0.382 . . . . 0.79000000000000004 110.601 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.707 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.88 120.76 43.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.332 -0.395 . . . . 1.02 110.724 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.866 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.5 146.38 11.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.192 0.52 . . . . 0.62 111.032 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.821 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -105.98 153.81 21.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.512 -0.767 . . . . 2.4399999999999999 109.986 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.07 88.49 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.9 0.381 . . . . 3.6899999999999999 110.525 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.3 32.61 0.21 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.864 -0.607 . . . . 6.0800000000000001 110.661 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.05 -117.37 3.29 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.437 -0.665 . . . . 1.22 111.437 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.462 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.39 177.38 9.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.153 0.501 . . . . 2.8799999999999999 111.597 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.18 149.55 32.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.39 -0.823 . . . . 1.47 110.4 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.16 144.71 38.7 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.455 -0.339 . . . . 2.7000000000000002 110.591 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.74 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.08 135.94 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 121.088 0.47 . . . . 0.46000000000000002 111.5 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.01 141.35 52.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.668 -0.696 . . . . 0.34999999999999998 110.373 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.6 138.8 51.7 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.553 -0.459 . . . . 3.6699999999999999 111.575 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.21 164.14 37.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.572 -0.74 . . . . 0.67000000000000004 109.618 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.576 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.2 151.57 38.63 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.411 -0.516 . . . . 1.47 111.027 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.802 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.26 172.64 13.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.767 -0.651 . . . . 0.44 111.023 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.7 t -118.61 160.7 21.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.479 -0.782 . . . . 1.3700000000000001 109.922 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.45 121.87 22.87 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.623 -0.431 . . . . 1.28 110.774 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.6 p -126.92 155.57 42.84 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 114.62 1.341 . . . . 1.97 114.62 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 82.2 p . . . . . 0 N--CA 1.456 -0.142 0 CA-C-N 112.996 -1.911 . . . . 3.2799999999999998 109.102 177.317 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.491 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 2.0 p . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 121.151 0.5 . . . . 0.66000000000000003 110.417 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.436 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.91 167.58 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.613 -0.721 . . . . 0.68999999999999995 110.92 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.56 145.55 50.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.675 -0.693 . . . . 0.52000000000000002 110.146 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.33 101.72 9.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.021 -0.733 . . . . 0.32000000000000001 109.021 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.0 t -112.94 139.74 36.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.0 -0.545 . . . . 0.28999999999999998 111.078 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.1 p -128.82 152.45 48.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.681 -0.69 . . . . 0.25 109.868 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.591 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.71 -164.88 2.02 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.667 -0.413 . . . . 0.31 110.711 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -124.0 127.11 73.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 0.48999999999999999 110.833 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.176 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 1.53 110.315 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.15 24.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.916 -0.584 . . . . 0.96999999999999997 111.471 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.176 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.16 128.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.599 -0.441 . . . . 1.5600000000000001 110.929 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.4 -9.65 55.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.975 -0.557 . . . . 1.8799999999999999 110.306 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.1 0.27 55.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 1.04 110.376 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.31 137.18 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.976 -0.556 . . . . 0.23999999999999999 109.945 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.72 ' C ' ' HZ3' ' A' ' 61' ' ' LYS . 75.7 m -96.16 -15.52 22.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.337 0.589 . . . . 0.28999999999999998 110.077 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.838 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.54 175.51 45.68 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 109.793 -1.323 . . . . 0.13 109.793 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.4 151.61 42.43 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.574 -0.45 . . . . 0.17000000000000001 110.466 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.699 HH12 ' HD2' ' A' ' 15' ' ' PRO . 60.0 ttp180 -132.28 121.25 23.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.11 -0.495 . . . . 1.29 109.954 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.559 HG21 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.19 136.58 38.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.634 -0.712 . . . . 0.25 110.665 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.522 ' CD ' ' CE2' ' A' ' 157' ' ' TYR . 80.8 tt0 -129.35 129.82 45.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.858 -0.61 . . . . 1.3200000000000001 110.065 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.71 135.31 34.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.98 -0.554 . . . . 0.56999999999999995 110.619 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.418 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.32 161.37 39.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.781 -0.645 . . . . 1.1599999999999999 109.634 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.954 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.07 124.77 25.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.019 0.438 . . . . 0.38 110.783 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.62 -7.77 49.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.74 -0.664 . . . . 0.40999999999999998 110.9 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -109.77 -69.74 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 1.6599999999999999 111.421 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.439 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.66 -35.34 75.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.065 -0.516 . . . . 1.6599999999999999 111.497 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.083 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.14 7.29 88.55 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.772 -0.931 . . . . 1.1699999999999999 110.772 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.34 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.97 -171.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 1.8600000000000001 110.207 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.34 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.39 139.01 44.66 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 1.98 110.17 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.418 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.3 Cg_endo -70.84 145.8 51.88 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 C-N-CA 122.752 2.301 . . . . 0.55000000000000004 112.343 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.84 145.68 42.64 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.222 -0.659 . . . . 1.1399999999999999 109.222 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.522 ' CE2' ' CD ' ' A' ' 145' ' ' GLU . 83.1 m-85 -123.3 141.39 52.04 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.289 -0.564 . . . . 0.93000000000000005 111.526 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.6 mt -128.07 127.66 43.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.288 -0.869 . . . . 0.34000000000000002 108.917 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.712 ' OD1' ' ND2' ' A' ' 16' ' ' ASN . 13.6 m-20 -101.57 131.1 47.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.099 0.476 . . . . 1.0900000000000001 111.751 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.95 157.57 73.39 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.396 -0.82 . . . . 0.19 109.602 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.78 158.03 58.31 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.453 2.102 . . . . 0.17999999999999999 112.268 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.33 -12.12 5.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.782 -0.645 . . . . 0.20999999999999999 110.75 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.0 p -92.81 -8.79 42.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.068 -0.514 . . . . 0.28999999999999998 110.753 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.1 135.4 34.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.5 110.408 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.17 16.57 4.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.435 -0.348 . . . . 0.29999999999999999 110.459 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.5 p -167.5 147.16 5.12 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.612 -0.514 . . . . 0.23000000000000001 109.612 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.559 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.21 150.48 12.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.6 -0.44 . . . . 0.28000000000000003 111.629 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.508 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 4.0 t-20 -106.36 124.96 50.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.625 -0.716 . . . . 1.0700000000000001 109.758 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.43 104.99 30.5 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.28999999999999998 111.088 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.9 Cg_endo -91.17 -179.5 1.45 Allowed 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 123.099 2.532 . . . . 0.42999999999999999 112.138 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.67 32.75 18.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.414 -0.812 . . . . 1.26 111.391 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.491 ' O ' ' OG ' ' A' ' 126' ' ' SER . 23.7 mt -86.46 148.54 25.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.474 -0.33 . . . . 0.32000000000000001 110.436 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.77 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.3 114.91 61.57 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.059 0.457 . . . . 0.57999999999999996 110.699 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.01 140.54 95.81 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.873 2.382 . . . . 0.66000000000000003 112.041 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.18 21.06 74.35 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.061 -0.815 . . . . 0.28999999999999998 111.061 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.439 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.79 150.22 49.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.786 0.327 . . . . 2.3300000000000001 110.681 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.1 131.58 45.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.068 -0.514 . . . . 0.85999999999999999 109.811 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.954 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.3 m-85 -120.45 148.3 43.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.153 -0.476 . . . . 0.52000000000000002 111.055 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.3 125.36 60.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.261 -1.014 . . . . 0.29999999999999999 108.261 177.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.49 132.39 63.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.155 0.502 . . . . 0.23000000000000001 111.26 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.39 122.61 20.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.637 -0.71 . . . . 0.35999999999999999 109.645 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.591 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.05 125.43 54.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.214 -0.448 . . . . 0.19 110.631 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.7 m-85 -117.27 137.92 52.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.027 -0.533 . . . . 0.29999999999999999 109.842 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.581 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.78 135.07 42.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.773 -0.825 . . . . 0.37 108.773 178.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.602 ' O ' ' N ' ' A' ' 140' ' ' SER . 50.6 mm -99.12 122.96 51.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.137 0.494 . . . . 0.26000000000000001 110.864 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.3 p -83.83 169.71 14.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.565 -0.743 . . . . 0.28000000000000003 110.503 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -59.78 -14.53 15.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.006 -0.543 . . . . 1.6000000000000001 110.963 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.404 ' C ' ' OG1' ' A' ' 59' ' ' THR . 94.9 m-20 -96.03 -4.29 43.34 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.872 -0.331 . . . . 1.1799999999999999 110.795 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.631 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.76 13.93 64.01 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.403 -0.679 . . . . 0.29999999999999999 111.403 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -84.76 139.14 32.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.736 0.303 . . . . 1.22 110.349 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.604 ' NE2' ' HG3' ' A' ' 14' ' ' GLN . 7.7 pt20 -106.83 141.05 38.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.968 0.413 . . . . 0.97999999999999998 110.465 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.73 126.99 26.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.82999999999999996 110.402 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.08 117.27 9.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.371 -0.377 . . . . 0.26000000000000001 110.502 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.3 pt -109.06 -21.82 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.471 . . . . 0.29999999999999999 110.741 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.84 125.84 5.94 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.558 -0.457 . . . . 0.31 111.495 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.84 120.21 21.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.708 -0.678 . . . . 0.28000000000000003 109.497 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.59 151.69 29.14 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.712 -0.395 . . . . 0.23999999999999999 110.987 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.48 158.57 18.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.081 -0.509 . . . . 0.23000000000000001 110.382 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.07 157.97 43.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.084 -0.507 . . . . 0.67000000000000004 110.624 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.37 9.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.662 -0.699 . . . . 0.64000000000000001 109.972 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.894 -1.051 . . . . 1.26 110.719 -179.788 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.145 -0.687 . . . . 3.4399999999999999 109.145 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.77 18.53 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.061 -0.815 . . . . 1.22 111.061 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -35.66 142.44 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.057 0 C-N-CA 123.959 3.106 . . . . 0.75 113.808 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.62 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.98 173.4 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 114.286 -1.325 . . . . 0.79000000000000004 108.853 178.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.62 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.67 125.9 51.52 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.429 -0.508 . . . . 1.9399999999999999 111.384 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.45 143.95 34.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.586 -0.734 . . . . 0.59999999999999998 110.705 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.02 168.31 25.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.88 0.371 . . . . 3.1400000000000001 111.13 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.748 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.5 mt -108.97 131.02 60.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.993 -0.549 . . . . 3.23 110.154 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.15 162.35 35.69 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.954 0.407 . . . . 3.6299999999999999 111.202 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 76.1 tt0 36.04 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.659 -0.497 . . . . 6.0800000000000001 109.659 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.748 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.5 32.32 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.921 -0.581 . . . . 3.3799999999999999 111.606 -178.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.641 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.1 Cg_endo -63.17 -29.12 73.77 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.445 2.097 . . . . 3.9300000000000002 111.906 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.641 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.65 125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 3.3599999999999999 110.494 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.553 ' O ' ' O ' ' A' ' 92' ' ' THR . 2.4 mm-40 -123.9 158.39 60.19 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.32 -0.4 . . . . 3.6099999999999999 110.409 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.555 ' HG3' ' CZ ' ' A' ' 143' ' ' ARG . 97.0 Cg_endo -82.0 -64.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.976 2.451 . . . . 1.51 113.556 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.619 ' ND2' ' CD2' ' A' ' 157' ' ' TYR . 11.1 m120 -108.42 -19.71 13.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.277 -0.419 . . . . 2.6800000000000002 112.074 -178.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 7.1 p -107.26 152.08 24.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.143 0.497 . . . . 1.21 111.354 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.569 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.3 102.9 2.22 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.708 -0.678 . . . . 1.5600000000000001 110.632 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.6 145.61 13.13 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.927 2.418 . . . . 0.81000000000000005 112.589 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.926 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.84 168.01 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.919 -0.582 . . . . 1.52 109.889 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.15 147.85 28.94 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.763 -0.458 . . . . 2.1400000000000001 109.763 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.602 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.23 157.38 44.91 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.593 -0.443 . . . . 0.32000000000000001 111.241 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.486 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.8 m-20 -127.98 155.31 44.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.863 -0.608 . . . . 2.1699999999999999 110.128 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.821 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.63 173.01 6.39 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 121.125 0.488 . . . . 0.58999999999999997 110.749 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.821 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.68 174.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.822 2.348 . . . . 0.90000000000000002 111.557 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.484 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.15 -51.06 0.68 Allowed Pre-proline 0 C--N 1.328 -0.342 0 C-N-CA 120.719 -0.392 . . . . 3.3399999999999999 110.068 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.616 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.82 152.38 82.35 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.711 2.274 . . . . 1.8500000000000001 111.451 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.64 42.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.322 0.582 . . . . 2.54 110.575 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.813 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.69 -41.58 98.11 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.027 -0.988 . . . . 2.5299999999999998 110.63 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.4 mt -109.89 137.91 39.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.771 -0.65 . . . . 1.1699999999999999 111.207 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.98 -72.88 0.7 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.965 -0.561 . . . . 1.27 111.927 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.27 148.34 24.38 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.594 0.591 . . . . 1.1200000000000001 112.594 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -121.8 124.86 45.17 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.396 -0.594 . . . . 0.41999999999999998 109.396 177.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.08 134.78 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.614 -0.434 . . . . 0.78000000000000003 110.644 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.926 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.01 128.52 53.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.03 0.443 . . . . 0.62 111.267 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.548 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.04 139.07 49.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.81 -0.632 . . . . 1.97 110.064 178.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.435 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.09 163.15 35.18 Favored 'General case' 0 N--CA 1.458 -0.056 0 C-N-CA 120.559 -0.456 . . . . 0.34999999999999998 112.134 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.4 139.69 7.99 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.478 -0.783 . . . . 1.8 110.449 178.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.65 115.44 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.366 2.044 . . . . 0.57999999999999996 111.799 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.686 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.03 81.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.901 -0.407 . . . . 3.04 109.901 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.697 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.21 -20.61 0.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.97 -0.559 . . . . 2.4700000000000002 111.933 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.6 p -157.68 157.77 34.16 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.801 -0.36 . . . . 2.5099999999999998 110.596 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.408 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.26 27.79 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.247 -0.433 . . . . 1.8600000000000001 110.159 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.81 -75.95 1.31 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.175 -0.536 . . . . 1.4399999999999999 111.826 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.87 152.27 35.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.942 0.401 . . . . 4.6900000000000004 110.944 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.648 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.16 -169.15 2.55 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.031 -0.532 . . . . 1.4299999999999999 111.927 179.386 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.18 149.67 29.76 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.483 0.659 . . . . 1.74 112.463 -177.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.03 156.59 46.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.702 -1.135 . . . . 1.9199999999999999 110.216 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.465 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.28 158.27 41.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.98 -0.554 . . . . 0.34000000000000002 111.842 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.09 135.66 53.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.493 -0.776 . . . . 0.40999999999999998 109.82 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.602 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.46 122.02 23.72 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.427 -0.351 . . . . 0.55000000000000004 111.534 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.2 Cg_exo -46.39 151.75 1.67 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.717 2.278 . . . . 0.44 112.053 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.92 -23.05 63.11 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 115.958 -0.564 . . . . 0.73999999999999999 112.79 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.545 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.87 -16.7 46.57 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.213 -0.595 . . . . 0.93000000000000005 111.809 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.604 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.66 138.42 31.57 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.83 -0.348 . . . . 0.96999999999999997 110.248 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -121.57 13.92 10.96 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.375 -0.375 . . . . 1.3400000000000001 111.462 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.482 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 86.8 p -149.93 143.46 25.26 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.651 -0.42 . . . . 0.39000000000000001 111.088 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.82 -169.4 1.54 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.203 0.525 . . . . 0.41999999999999998 110.897 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.723 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 20.2 m -151.68 125.89 9.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.444 -0.798 . . . . 0.39000000000000001 109.863 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.513 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.87 123.29 70.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.304 -0.558 . . . . 0.73999999999999999 111.217 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.578 ' HG2' ' N ' ' A' ' 62' ' ' GLY . 87.5 tttt -126.55 163.4 23.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.863 -0.608 . . . . 2.48 110.396 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.578 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.07 19.07 59.81 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.771 -0.932 . . . . 0.5 110.771 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.513 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.7 mt -79.12 157.17 28.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.147 0.498 . . . . 0.57999999999999996 111.304 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.844 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -99.42 133.9 21.62 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.544 -0.753 . . . . 2.79 110.56 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.666 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.85 143.49 61.27 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.615 2.21 . . . . 0.87 111.937 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.84 25.64 75.32 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.087 -0.805 . . . . 0.64000000000000001 111.087 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.2 158.84 40.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.754 0.311 . . . . 0.82999999999999996 110.377 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.18 139.86 42.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.364 -0.38 . . . . 0.5 110.554 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.65 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.55 136.42 54.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.985 -0.552 . . . . 0.53000000000000003 110.779 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.9 131.02 45.3 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.493 -0.928 . . . . 1.8700000000000001 108.493 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.494 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.38 153.92 16.62 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.315 -0.945 . . . . 0.28999999999999998 111.985 -178.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.98 140.95 46.09 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.693 -0.484 . . . . 1.4299999999999999 109.693 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.517 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.71 118.82 34.12 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.558 -0.457 . . . . 0.32000000000000001 110.482 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.737 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.45 129.11 68.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.371 -0.377 . . . . 0.79000000000000004 110.675 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.704 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.85 120.87 43.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.272 -0.422 . . . . 1.02 110.687 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.855 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.56 146.45 11.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.068 0.461 . . . . 0.62 111.035 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.813 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.0 153.88 21.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.514 -0.766 . . . . 2.4399999999999999 109.934 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.27 88.6 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.996 0.426 . . . . 3.6899999999999999 110.469 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.28 32.63 0.21 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.823 -0.626 . . . . 6.0800000000000001 110.6 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.35 3.29 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.483 -0.647 . . . . 1.22 111.483 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.471 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.48 177.4 8.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 2.8799999999999999 111.577 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.13 149.41 31.96 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.423 -0.808 . . . . 1.47 110.369 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.06 144.71 38.9 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.43 -0.35 . . . . 2.7000000000000002 110.6 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.737 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -127.98 136.0 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 121.07 0.462 . . . . 0.46000000000000002 111.603 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.57 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.6 m -124.13 141.23 52.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.668 -0.697 . . . . 0.34999999999999998 110.302 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.497 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.64 138.88 51.67 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.493 -0.483 . . . . 3.6699999999999999 111.485 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.494 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.23 164.22 37.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.501 -0.772 . . . . 0.67000000000000004 109.48 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.565 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 46.9 p30 -145.25 151.55 38.55 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.429 -0.509 . . . . 1.47 111.037 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.25 172.77 12.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.739 -0.664 . . . . 0.44 111.007 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.84 160.58 21.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.529 -0.76 . . . . 1.3700000000000001 109.826 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.3 121.79 22.92 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.567 -0.453 . . . . 1.28 110.803 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.553 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.0 p -127.37 161.11 29.42 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.226 0.454 . . . . 1.97 112.226 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.464 0.263 0 CA-C-N 115.766 -0.652 . . . . 3.2799999999999998 110.361 178.489 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.9 p . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.843 0.354 . . . . 0.66000000000000003 110.676 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.441 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.9 167.55 0.26 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 0.68999999999999995 110.914 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.61 145.53 50.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.677 -0.692 . . . . 0.52000000000000002 110.099 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.28 101.69 9.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.096 -0.705 . . . . 0.32000000000000001 109.096 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.0 t -112.96 139.64 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.059 -0.519 . . . . 0.28999999999999998 111.078 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.5 p -128.73 152.61 48.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.721 -0.672 . . . . 0.25 109.776 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.584 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.4 p90 -144.8 -164.95 2.04 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.682 -0.407 . . . . 0.31 110.549 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.733 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.9 t -123.91 127.19 73.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.103 -0.499 . . . . 0.48999999999999999 110.817 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.157 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.97 58.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 1.53 110.376 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.12 24.47 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.856 -0.611 . . . . 0.96999999999999997 111.524 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.157 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.13 128.76 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.542 -0.463 . . . . 1.5600000000000001 110.868 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.43 -9.71 55.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.849 -0.614 . . . . 1.8799999999999999 110.31 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.0 0.22 55.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 1.04 110.414 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.725 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.25 137.21 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.951 -0.568 . . . . 0.23999999999999999 109.955 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.579 ' N ' ' O ' ' A' ' 185' ' ' ILE . 5.6 m -96.32 -15.41 21.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.219 0.533 . . . . 0.28999999999999998 110.016 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.454 ' HA3' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.51 175.56 45.7 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 109.839 -1.304 . . . . 0.13 109.839 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -123.53 151.61 42.65 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.64 -0.424 . . . . 0.17000000000000001 110.485 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.728 ' NH2' ' CD2' ' A' ' 183' ' ' TYR . 69.8 ttp85 -132.33 121.15 23.07 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.081 -0.509 . . . . 1.29 109.931 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.545 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.08 136.53 38.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.689 -0.687 . . . . 0.25 110.65 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.516 ' HB2' HH12 ' A' ' 143' ' ' ARG . 81.1 tt0 -129.36 129.91 45.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.993 -0.548 . . . . 1.3200000000000001 110.07 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.625 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.7 p90 -138.75 135.4 34.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.023 -0.535 . . . . 0.56999999999999995 110.558 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.419 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.38 161.36 39.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.723 -0.671 . . . . 1.1599999999999999 109.717 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.969 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 85.9 mt -71.09 124.86 25.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.018 0.437 . . . . 0.38 110.725 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.492 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.76 -7.56 48.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.813 -0.631 . . . . 0.40999999999999998 110.887 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -109.89 -69.77 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 1.6599999999999999 111.428 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.45 ' CD ' HH21 ' A' ' 176' ' ' ARG . 53.8 mt-10 -60.56 -35.46 76.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.028 -0.533 . . . . 1.6599999999999999 111.535 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.074 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.26 88.58 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.8 -0.92 . . . . 1.1699999999999999 110.8 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.327 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.96 -171.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 1.8600000000000001 110.243 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.327 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.27 139.13 45.12 Favored Pre-proline 0 N--CA 1.454 -0.262 0 CA-C-O 120.997 0.427 . . . . 1.98 110.243 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.419 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.3 Cg_endo -70.93 145.77 51.22 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 C-N-CA 122.782 2.321 . . . . 0.55000000000000004 112.302 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.625 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.78 145.71 42.58 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.238 -0.653 . . . . 1.1399999999999999 109.238 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.666 ' CE1' ' CD ' ' A' ' 65' ' ' PRO . 35.6 p90 -123.28 141.31 52.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.234 0.54 . . . . 0.93000000000000005 111.577 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.2 mt -128.09 127.72 43.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.274 -0.875 . . . . 0.34000000000000002 108.944 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 5.0 t0 -101.63 131.17 48.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.102 0.477 . . . . 1.0900000000000001 111.722 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.518 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.1 mt -127.94 157.66 73.1 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.277 -0.874 . . . . 0.19 109.601 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -69.92 158.03 58.12 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 122.439 2.093 . . . . 0.17999999999999999 112.226 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.32 -12.13 5.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.773 -0.649 . . . . 0.20999999999999999 110.7 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.0 p -92.84 -8.76 42.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.094 -0.503 . . . . 0.28999999999999998 110.675 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.15 135.43 34.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.326 -0.397 . . . . 0.5 110.391 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.7 p -133.18 16.65 4.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.443 -0.344 . . . . 0.29999999999999999 110.462 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.5 p -167.6 147.11 5.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.607 -0.516 . . . . 0.23000000000000001 109.607 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.545 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.21 150.43 12.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.5 -0.48 . . . . 0.28000000000000003 111.594 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.503 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.28 125.0 50.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.619 -0.719 . . . . 1.0700000000000001 109.792 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.46 104.97 30.44 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.391 -0.368 . . . . 0.28999999999999998 110.99 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.4 Cg_endo -90.99 -179.48 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 123.117 2.545 . . . . 0.42999999999999999 112.162 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.61 32.64 18.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.341 -0.845 . . . . 1.26 111.493 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.7 mt -86.39 148.49 25.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.339 . . . . 0.32000000000000001 110.494 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.772 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.23 114.83 61.18 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.311 -0.404 . . . . 0.57999999999999996 110.658 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.98 140.5 95.63 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.837 2.358 . . . . 0.66000000000000003 112.08 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.16 21.21 74.04 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.036 -0.825 . . . . 0.28999999999999998 111.036 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.45 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.87 150.18 49.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 2.3300000000000001 110.686 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.492 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.21 131.73 45.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.088 -0.506 . . . . 0.85999999999999999 109.747 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.969 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.55 148.19 44.19 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.129 -0.487 . . . . 0.52000000000000002 111.08 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.26 125.3 60.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.303 -0.999 . . . . 0.29999999999999999 108.303 177.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.52 132.46 63.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.162 0.506 . . . . 0.23000000000000001 111.197 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.45 122.5 20.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.555 -0.748 . . . . 0.35999999999999999 109.636 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.584 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.96 125.49 54.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.255 -0.43 . . . . 0.19 110.647 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.728 ' CD2' ' NH2' ' A' ' 143' ' ' ARG . 48.5 m-85 -117.34 137.84 52.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.985 -0.552 . . . . 0.29999999999999999 109.891 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.581 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.73 135.02 42.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.729 -0.841 . . . . 0.37 108.729 179.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 140' ' ' SER . 83.3 mt -99.05 122.86 51.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.11 0.481 . . . . 0.26000000000000001 110.961 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.5 p -83.81 169.73 14.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.542 -0.754 . . . . 0.28000000000000003 110.525 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.82 -14.54 15.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.119 -0.491 . . . . 1.6000000000000001 110.956 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -96.03 -4.25 43.42 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.852 -0.339 . . . . 1.1799999999999999 110.879 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.585 ' HA3' HG23 ' A' ' 59' ' ' THR . . . 87.81 13.83 64.08 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.336 -0.706 . . . . 0.29999999999999999 111.336 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -84.6 139.17 32.28 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.027 -0.269 . . . . 1.22 110.458 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.553 HE22 ' HG2' ' A' ' 15' ' ' PRO . 86.2 mt-30 -106.77 141.04 38.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 0.97999999999999998 110.535 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.1 m -136.65 127.06 26.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.82999999999999996 110.388 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.7 tp -68.24 117.29 9.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.92 0.39 . . . . 0.26000000000000001 110.448 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.07 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.29999999999999999 110.714 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.1 tp -156.88 125.68 5.85 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.554 -0.459 . . . . 0.31 111.486 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.472 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.75 120.27 21.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.77 -0.65 . . . . 0.28000000000000003 109.536 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.66 29.06 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.602 -0.439 . . . . 0.23999999999999999 110.903 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.45 158.65 18.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.092 -0.504 . . . . 0.23000000000000001 110.442 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.15 157.99 43.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.171 -0.468 . . . . 0.67000000000000004 110.654 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 104.33 9.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.699 -0.682 . . . . 0.64000000000000001 110.025 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.888 -1.053 . . . . 1.26 110.672 -179.694 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.55 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.201 -0.666 . . . . 3.4399999999999999 109.201 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.37 150.64 18.55 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.983 -0.847 . . . . 1.22 110.983 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -35.58 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.092 0 C-N-CA 124.03 3.153 . . . . 0.75 113.754 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.622 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -80.04 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.208 -1.36 . . . . 0.79000000000000004 108.857 178.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.622 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.64 125.8 51.4 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.426 -0.51 . . . . 1.9399999999999999 111.434 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.5 143.96 34.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.625 -0.716 . . . . 0.59999999999999998 110.583 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.93 168.37 25.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.386 -0.37 . . . . 3.1400000000000001 111.09 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.738 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.02 131.09 60.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.008 -0.542 . . . . 3.23 110.047 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.1 p -141.18 162.27 35.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.84 0.352 . . . . 3.6299999999999999 111.27 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.8 mt-10 36.09 31.62 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.601 -0.518 . . . . 6.0800000000000001 109.601 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.738 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.41 69.52 32.19 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.932 -0.576 . . . . 3.3799999999999999 111.558 -178.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.24 -29.2 73.23 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.57 2.18 . . . . 3.9300000000000002 111.837 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.71 125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 3.3599999999999999 110.449 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.718 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -123.93 158.34 60.44 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.329 -0.396 . . . . 3.6099999999999999 110.444 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.497 ' HG2' ' CD ' ' A' ' 143' ' ' ARG . 96.9 Cg_endo -81.94 -64.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.965 2.443 . . . . 1.51 113.574 -179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.44 ' H ' ' HG2' ' A' ' 15' ' ' PRO . 10.2 m120 -108.47 -19.62 13.39 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.088 0.403 . . . . 2.6800000000000002 112.088 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.718 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 89.1 p -107.32 152.05 24.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.101 0.477 . . . . 1.21 111.346 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.578 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.26 102.92 2.23 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.711 -0.677 . . . . 1.5600000000000001 110.583 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.75 145.68 12.93 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.781 2.321 . . . . 0.81000000000000005 112.554 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.915 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.78 167.96 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.845 -0.616 . . . . 1.52 109.903 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.16 147.95 29.05 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.742 -0.466 . . . . 2.1400000000000001 109.742 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.3 p90 -142.23 157.3 45.0 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.567 -0.453 . . . . 0.32000000000000001 111.169 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.494 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.8 m-20 -127.97 155.26 44.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.773 -0.649 . . . . 2.1699999999999999 110.199 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.825 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.64 173.05 6.34 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.113 0.482 . . . . 0.58999999999999997 110.702 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.825 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.8 Cg_exo -50.74 173.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.834 2.356 . . . . 0.90000000000000002 111.505 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.92 -51.08 0.7 Allowed Pre-proline 0 C--N 1.33 -0.265 0 C-N-CA 120.717 -0.393 . . . . 3.3399999999999999 110.212 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.62 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.8 152.41 82.22 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.683 2.255 . . . . 1.8500000000000001 111.501 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.68 42.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.343 0.592 . . . . 2.54 110.601 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.815 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.64 -41.66 98.22 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.004 -0.998 . . . . 2.5299999999999998 110.655 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.53 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.5 mt -109.73 137.84 40.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.784 -0.643 . . . . 1.1699999999999999 111.308 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.02 -72.89 0.7 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.075 -0.512 . . . . 1.27 111.906 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.22 148.43 24.37 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.581 0.586 . . . . 1.1200000000000001 112.581 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -121.76 124.82 45.12 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.448 -0.575 . . . . 0.41999999999999998 109.448 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.7 mt -118.08 134.75 60.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.55 -0.46 . . . . 0.78000000000000003 110.569 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.915 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.02 128.72 53.79 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.057 0.456 . . . . 0.62 111.268 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.549 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.97 49.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.707 -0.678 . . . . 1.97 110.159 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -144.98 163.19 34.93 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.092 0.473 . . . . 0.34999999999999998 112.172 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.55 139.49 7.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.512 -0.767 . . . . 1.8 110.502 178.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.694 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.44 115.45 3.03 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.296 1.997 . . . . 0.57999999999999996 111.846 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.96 81.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.9 -0.407 . . . . 3.04 109.9 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.694 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.14 -20.6 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.993 -0.549 . . . . 2.4700000000000002 111.887 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.7 p -157.69 157.76 34.12 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.884 -0.326 . . . . 2.5099999999999998 110.596 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.4 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.36 27.8 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.466 . . . . 1.8600000000000001 110.205 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.73 -75.88 1.31 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.116 -0.564 . . . . 1.4399999999999999 111.926 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.89 152.25 35.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.966 0.412 . . . . 4.6900000000000004 110.959 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.633 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.23 -169.18 2.55 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.06 -0.518 . . . . 1.4299999999999999 111.97 179.367 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.08 149.74 29.59 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.392 0.615 . . . . 1.74 112.564 -177.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.08 156.45 45.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.81 -1.086 . . . . 1.9199999999999999 110.287 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.22 158.28 41.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.925 -0.579 . . . . 0.34000000000000002 111.8 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.04 135.69 53.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.476 -0.783 . . . . 0.40999999999999998 109.801 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.596 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.42 121.94 23.75 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.481 -0.327 . . . . 0.55000000000000004 111.526 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.0 Cg_exo -46.37 151.66 1.68 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.688 2.259 . . . . 0.44 112.151 178.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.87 -23.03 62.99 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 116.043 -0.526 . . . . 0.73999999999999999 112.784 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.6 p-80 -82.81 -16.86 46.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.391 0.596 . . . . 0.93000000000000005 111.804 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.605 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.63 138.4 31.6 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.751 -0.379 . . . . 0.96999999999999997 110.323 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.47 13.87 11.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.383 -0.371 . . . . 1.3400000000000001 111.542 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.48 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.0 p -149.95 143.45 25.24 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.617 -0.433 . . . . 0.39000000000000001 111.04 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.87 -169.25 1.51 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.045 -0.525 . . . . 0.41999999999999998 110.913 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.714 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 97.4 m -151.83 125.95 9.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.417 -0.811 . . . . 0.39000000000000001 109.8 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.509 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.88 123.25 70.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.376 -0.53 . . . . 0.73999999999999999 111.2 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.809 ' NZ ' ' N ' ' A' ' 141' ' ' GLY . 96.7 mttt -126.53 163.37 23.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.879 -0.601 . . . . 2.48 110.41 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.17 18.94 59.89 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.697 -0.961 . . . . 0.5 110.697 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.509 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.8 mt -79.04 157.27 28.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.13 0.491 . . . . 0.57999999999999996 111.363 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.859 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -99.45 134.01 21.51 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.598 -0.728 . . . . 2.79 110.451 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.91 143.58 61.26 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.555 2.17 . . . . 0.87 111.867 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.72 75.23 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.998 -0.841 . . . . 0.64000000000000001 110.998 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.859 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.15 158.76 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.567 0.223 . . . . 0.82999999999999996 110.46 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.15 139.95 41.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.944 0.402 . . . . 0.5 110.627 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.637 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.57 136.43 54.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.041 -0.527 . . . . 0.53000000000000003 110.77 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.92 130.99 45.33 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.53 -0.915 . . . . 1.8700000000000001 108.53 177.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.488 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.45 153.92 16.63 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.349 -0.929 . . . . 0.28999999999999998 111.913 -178.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.04 140.94 46.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.642 -0.503 . . . . 1.4299999999999999 109.642 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.52 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.78 118.86 34.21 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.505 -0.478 . . . . 0.32000000000000001 110.46 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.731 HG12 HG23 ' A' ' 84' ' ' VAL . 63.8 mt -112.43 128.94 68.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.79000000000000004 110.65 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.73 120.9 43.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.324 -0.398 . . . . 1.02 110.707 -179.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.858 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.57 146.51 11.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.137 0.494 . . . . 0.62 111.015 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.815 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.11 153.86 21.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.585 -0.734 . . . . 2.4399999999999999 109.955 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.14 88.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.004 0.43 . . . . 3.6899999999999999 110.503 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.22 32.7 0.21 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.808 -0.633 . . . . 6.0800000000000001 110.511 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.09 -117.37 3.29 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.443 -0.663 . . . . 1.22 111.443 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.468 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.37 177.35 9.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.177 0.513 . . . . 2.8799999999999999 111.69 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.1 149.59 32.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.476 -0.783 . . . . 1.47 110.371 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.55 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.2 144.78 38.67 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.407 -0.361 . . . . 2.7000000000000002 110.501 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.731 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.07 136.03 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 121.071 0.463 . . . . 0.46000000000000002 111.487 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.11 141.39 52.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.697 -0.683 . . . . 0.34999999999999998 110.212 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.461 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.4 ttp180 -117.69 138.93 51.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.185 0.517 . . . . 3.6699999999999999 111.406 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.34 164.15 38.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.539 -0.755 . . . . 0.67000000000000004 109.531 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.29 151.49 38.42 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.391 -0.523 . . . . 1.47 111.072 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.81 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.3 p90 -146.11 172.79 12.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.713 -0.676 . . . . 0.44 111.044 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.8 160.63 21.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.46 -0.791 . . . . 1.3700000000000001 109.809 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.35 121.91 23.04 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.535 -0.466 . . . . 1.28 110.776 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.549 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -128.2 164.31 22.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.668 0.747 . . . . 1.97 112.682 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.49 ' OG ' ' CE2' ' A' ' 157' ' ' TYR . 30.3 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 114.712 -1.131 . . . . 3.2799999999999998 109.001 177.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 122.137 0.97 . . . . 0.66000000000000003 110.926 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.442 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.91 167.53 0.26 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.626 -1.17 . . . . 0.68999999999999995 110.946 -179.193 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.8 m-30 -133.65 145.54 50.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.678 -0.692 . . . . 0.52000000000000002 110.102 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.28 101.68 9.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.075 -0.713 . . . . 0.32000000000000001 109.075 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.8 t -112.86 139.7 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.987 -0.551 . . . . 0.28999999999999998 111.133 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.2 p -128.73 152.5 48.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.624 -0.716 . . . . 0.25 109.786 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.587 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.79 -165.04 2.05 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.705 -0.398 . . . . 0.31 110.629 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.729 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -123.81 127.19 73.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.48999999999999999 110.836 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.162 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.99 58.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.222 -0.444 . . . . 1.53 110.38 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.729 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.19 24.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.855 -0.612 . . . . 0.96999999999999997 111.518 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.162 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.15 128.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.628 -0.429 . . . . 1.5600000000000001 110.897 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -86.56 -9.6 55.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.938 -0.573 . . . . 1.8799999999999999 110.215 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.2 p -87.09 0.22 55.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.153 -0.476 . . . . 1.04 110.344 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.38 137.33 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.969 -0.56 . . . . 0.23999999999999999 109.9 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.754 ' C ' ' HZ2' ' A' ' 61' ' ' LYS . 3.5 p -96.29 -15.53 21.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.262 0.553 . . . . 0.28999999999999998 110.045 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.809 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.59 175.52 45.74 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.786 -1.325 . . . . 0.13 109.786 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -123.34 151.59 42.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.954 0.407 . . . . 0.17000000000000001 110.551 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.728 ' NH2' ' OE1' ' A' ' 191' ' ' GLN . 64.1 ttp85 -132.34 121.18 23.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.153 -0.476 . . . . 1.29 109.989 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.558 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.07 136.49 38.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.706 -0.679 . . . . 0.25 110.747 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 81.3 tt0 -129.33 129.92 45.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.994 -0.548 . . . . 1.3200000000000001 110.105 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.3 p90 -138.73 135.27 34.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.957 -0.565 . . . . 0.56999999999999995 110.57 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.417 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.31 161.43 39.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.737 -0.665 . . . . 1.1599999999999999 109.662 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.949 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -70.99 124.85 25.32 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.672 -0.411 . . . . 0.38 110.775 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.492 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.84 -7.6 49.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.779 -0.646 . . . . 0.40999999999999998 110.814 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -109.91 -69.63 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.845 0.355 . . . . 1.6599999999999999 111.399 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.459 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.3 mt-10 -60.75 -35.29 76.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 1.6599999999999999 111.471 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.095 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.15 7.18 88.62 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.789 -0.924 . . . . 1.1699999999999999 110.789 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.324 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.95 -171.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.765 0.316 . . . . 1.8600000000000001 110.301 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.324 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.2 139.02 45.33 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 1.98 110.221 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.417 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 45.8 Cg_endo -70.9 145.79 51.45 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.675 2.25 . . . . 0.55000000000000004 112.32 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.83 145.74 42.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.196 -0.668 . . . . 1.1399999999999999 109.196 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.673 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 86.7 m-85 -123.29 141.31 52.11 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.366 -0.534 . . . . 0.93000000000000005 111.513 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.8 mt -128.05 127.66 43.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.286 -0.87 . . . . 0.34000000000000002 108.925 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -101.58 131.05 47.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.127 0.489 . . . . 1.0900000000000001 111.751 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.86 157.56 73.25 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.388 -0.824 . . . . 0.19 109.6 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.72 158.06 58.32 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.479 2.12 . . . . 0.17999999999999999 112.225 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.38 -12.17 5.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.744 -0.662 . . . . 0.20999999999999999 110.675 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.7 p -92.78 -8.75 42.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.28999999999999998 110.778 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.34 34.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.5 110.329 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.5 p -133.05 16.55 4.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.396 -0.366 . . . . 0.29999999999999999 110.531 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.52 147.05 5.08 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.642 -0.503 . . . . 0.23000000000000001 109.642 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.18 150.44 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.46 -0.496 . . . . 0.28000000000000003 111.564 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.35 124.93 50.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.6 -0.727 . . . . 1.0700000000000001 109.837 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.36 104.91 29.72 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.879 0.371 . . . . 0.28999999999999998 111.065 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -91.0 -179.49 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.922 0 C-N-CA 123.241 2.628 . . . . 0.42999999999999999 112.191 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.61 32.65 18.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.328 -0.851 . . . . 1.26 111.467 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.8 mt -86.41 148.54 25.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.782 0.325 . . . . 0.32000000000000001 110.4 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.759 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.26 114.86 61.3 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.919 0.39 . . . . 0.57999999999999996 110.642 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.02 140.57 95.94 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.915 2.41 . . . . 0.66000000000000003 111.922 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.05 21.2 74.4 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.087 -0.805 . . . . 0.28999999999999998 111.087 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.459 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.9 150.2 49.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.913 0.387 . . . . 2.3300000000000001 110.529 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.492 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.16 131.63 45.99 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.974 -0.557 . . . . 0.85999999999999999 109.813 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.949 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.51 148.35 43.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.127 -0.488 . . . . 0.52000000000000002 111.063 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.32 125.29 60.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.323 -0.991 . . . . 0.29999999999999999 108.323 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.46 132.45 63.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.174 0.511 . . . . 0.23000000000000001 111.346 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.44 122.49 20.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.541 -0.754 . . . . 0.35999999999999999 109.684 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.587 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -100.95 125.38 54.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.281 -0.418 . . . . 0.19 110.723 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.7 m-85 -117.22 137.86 52.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.045 -0.525 . . . . 0.29999999999999999 109.854 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.576 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.71 134.97 42.89 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.809 -0.811 . . . . 0.37 108.809 178.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.653 HG21 ' HE2' ' A' ' 61' ' ' LYS . 11.6 mt -99.05 122.94 51.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.123 0.487 . . . . 0.26000000000000001 110.926 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.3 p -83.8 169.7 14.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.582 -0.735 . . . . 0.28000000000000003 110.481 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -59.82 -14.48 15.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.016 -0.538 . . . . 1.6000000000000001 110.979 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -96.03 -4.35 43.26 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.877 -0.329 . . . . 1.1799999999999999 110.796 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.79 13.91 63.97 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.36 -0.696 . . . . 0.29999999999999999 111.36 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -84.73 139.14 32.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.632 0.253 . . . . 1.22 110.437 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.728 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 86.0 mt-30 -106.73 141.07 38.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.406 -0.361 . . . . 0.97999999999999998 110.527 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.76 127.02 26.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.125 -0.488 . . . . 0.82999999999999996 110.363 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.15 117.37 9.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.293 -0.412 . . . . 0.26000000000000001 110.486 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.11 -21.65 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.119 -0.491 . . . . 0.29999999999999999 110.724 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.89 125.6 5.82 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.601 -0.44 . . . . 0.31 111.482 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.75 120.2 21.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.774 -0.648 . . . . 0.28000000000000003 109.562 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.65 151.74 29.14 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.642 -0.423 . . . . 0.23999999999999999 110.89 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.54 158.55 18.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.043 -0.526 . . . . 0.23000000000000001 110.439 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.05 157.91 43.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.67000000000000004 110.723 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 104.34 9.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.855 -0.611 . . . . 0.64000000000000001 110.04 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.89 -1.052 . . . . 1.26 110.608 -179.659 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.553 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.9 m . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.242 -0.651 . . . . 3.4399999999999999 109.242 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.27 150.59 18.57 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.041 -0.823 . . . . 1.22 111.041 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.64 142.45 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 123.967 3.111 . . . . 0.75 113.748 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.605 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -80.0 173.41 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.176 -1.374 . . . . 0.79000000000000004 108.758 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.605 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.59 125.91 51.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.157 0.503 . . . . 1.9399999999999999 111.431 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 143.96 34.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.593 -0.73 . . . . 0.59999999999999998 110.607 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.07 168.25 25.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.916 0.389 . . . . 3.1400000000000001 111.123 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.743 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.83 131.07 60.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.986 -0.552 . . . . 3.23 110.103 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.24 162.35 35.69 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.777 0.322 . . . . 3.6299999999999999 111.255 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 67.7 tt0 36.04 31.67 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.58 -0.526 . . . . 6.0800000000000001 109.58 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.743 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.56 32.58 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.917 -0.583 . . . . 3.3799999999999999 111.585 -178.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.636 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.33 -29.14 72.33 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.499 2.133 . . . . 3.9300000000000002 111.796 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.673 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 3.2 m 149.66 125.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.143 -0.48 . . . . 3.3599999999999999 110.495 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.673 ' NE2' ' O ' ' A' ' 13' ' ' SER . 5.8 mp0 -124.02 158.36 60.61 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 3.6099999999999999 110.47 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.453 ' HG3' ' NH1' ' A' ' 143' ' ' ARG . 97.5 Cg_endo -82.08 -64.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.865 2.377 . . . . 1.51 113.51 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.657 HD22 ' HB2' ' A' ' 159' ' ' ASP . 1.1 p-10 -108.44 -19.54 13.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.36 -0.382 . . . . 2.6800000000000002 112.029 -178.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.653 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 95.9 p -107.36 152.04 24.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.174 0.512 . . . . 1.21 111.29 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.5 t-80 -155.32 102.95 2.22 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.662 -0.699 . . . . 1.5600000000000001 110.565 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.531 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.7 Cg_endo -82.63 145.61 13.09 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.85 2.367 . . . . 0.81000000000000005 112.667 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.929 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.78 167.86 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.924 -0.58 . . . . 1.52 109.899 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.06 148.06 29.26 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.74 -0.467 . . . . 2.1400000000000001 109.74 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.59 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.36 157.28 44.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.005 0.431 . . . . 0.32000000000000001 111.169 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.498 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -128.09 155.31 44.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.745 -0.661 . . . . 2.1699999999999999 110.112 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.837 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.6 173.0 6.4 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.175 -0.466 . . . . 0.58999999999999997 110.756 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.837 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.63 173.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.877 2.384 . . . . 0.90000000000000002 111.605 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.01 -51.16 0.69 Allowed Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 120.74 -0.384 . . . . 3.3399999999999999 110.083 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.635 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.75 152.33 82.44 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.798 2.332 . . . . 1.8500000000000001 111.437 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.69 42.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.456 0.646 . . . . 2.54 110.554 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.819 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.63 -41.54 98.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.993 -1.003 . . . . 2.5299999999999998 110.718 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.8 mt -109.87 137.77 40.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.791 -0.641 . . . . 1.1699999999999999 111.255 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.96 -72.99 0.7 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.028 -0.533 . . . . 1.27 111.837 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.13 148.5 24.41 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.556 0.576 . . . . 1.1200000000000001 112.556 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.95 124.87 45.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.263 -0.643 . . . . 0.41999999999999998 109.263 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 mt -118.05 134.72 60.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.715 -0.394 . . . . 0.78000000000000003 110.698 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.929 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.02 128.55 53.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.047 0.451 . . . . 0.62 111.271 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.08 139.1 49.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.722 -0.672 . . . . 1.97 110.126 178.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.09 163.11 35.31 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.134 0.492 . . . . 0.34999999999999998 112.05 -178.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.489 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.53 139.73 7.9 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.453 -0.794 . . . . 1.8 110.421 178.727 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.65 115.47 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.322 2.015 . . . . 0.57999999999999996 111.769 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.679 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.9 81.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.925 -0.398 . . . . 3.04 109.925 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.049 -0.523 . . . . 2.4700000000000002 111.893 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.7 p -157.56 157.81 34.44 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.804 -0.358 . . . . 2.5099999999999998 110.538 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.406 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.32 27.69 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.215 -0.448 . . . . 1.8600000000000001 110.204 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.77 -75.81 1.31 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 121.157 -0.544 . . . . 1.4399999999999999 111.875 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -117.95 152.34 35.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.959 0.409 . . . . 4.6900000000000004 110.983 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.29 -169.1 2.51 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.052 -0.522 . . . . 1.4299999999999999 111.925 179.424 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.22 149.67 29.79 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.497 0.665 . . . . 1.74 112.511 -177.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.08 156.44 45.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.773 -1.103 . . . . 1.9199999999999999 110.225 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.469 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.1 158.35 41.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.826 -0.624 . . . . 0.34000000000000002 111.785 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.0 m -115.21 135.71 53.89 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.458 -0.792 . . . . 0.40999999999999998 109.847 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.59 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.42 121.93 23.74 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.418 -0.355 . . . . 0.55000000000000004 111.576 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.6 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.5 Cg_exo -46.36 151.76 1.64 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.683 2.255 . . . . 0.44 112.107 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.9 -23.12 63.14 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 116.057 -0.519 . . . . 0.73999999999999999 112.765 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.5 p-80 -82.75 -16.9 46.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.37 0.585 . . . . 0.93000000000000005 111.802 -178.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.6 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.58 138.41 31.59 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.802 -0.359 . . . . 0.96999999999999997 110.334 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.52 13.83 10.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.37 -0.377 . . . . 1.3400000000000001 111.56 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.475 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.9 143.46 25.29 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.643 -0.423 . . . . 0.39000000000000001 111.09 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.717 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.77 -169.39 1.54 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.06 -0.518 . . . . 0.41999999999999998 110.888 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.717 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.5 m -151.79 125.92 9.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.386 -0.824 . . . . 0.39000000000000001 109.739 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.518 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.81 123.29 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.416 -0.514 . . . . 0.73999999999999999 111.161 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.624 ' CG ' ' N ' ' A' ' 62' ' ' GLY . 18.1 ttpt -126.49 163.45 23.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.874 -0.603 . . . . 2.48 110.432 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.624 ' N ' ' CG ' ' A' ' 61' ' ' LYS . . . 85.09 18.99 59.91 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.731 -0.948 . . . . 0.5 110.731 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.518 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.6 mt -79.1 157.19 28.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.074 0.464 . . . . 0.57999999999999996 111.412 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.847 ' O ' HG12 ' A' ' 67' ' ' VAL . 1.2 mttp -99.37 133.92 21.63 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.702 -0.681 . . . . 2.79 110.504 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.88 143.54 61.24 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.541 2.161 . . . . 0.87 112.059 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.91 25.58 75.41 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.063 -0.815 . . . . 0.64000000000000001 111.063 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.847 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.15 158.78 39.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.687 0.279 . . . . 0.82999999999999996 110.381 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.14 139.91 42.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.89 0.376 . . . . 0.5 110.569 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.663 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.2 m-85 -122.49 136.42 54.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.007 -0.542 . . . . 0.53000000000000003 110.842 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.489 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.95 131.02 45.33 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.464 -0.939 . . . . 1.8700000000000001 108.464 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.494 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.49 153.89 16.65 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.281 -0.961 . . . . 0.28999999999999998 111.915 -178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.99 140.92 46.06 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.677 -0.49 . . . . 1.4299999999999999 109.677 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.9 tp -115.76 118.89 34.29 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.42 -0.512 . . . . 0.32000000000000001 110.539 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.721 HG12 HG23 ' A' ' 84' ' ' VAL . 63.6 mt -112.32 129.03 68.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.369 -0.378 . . . . 0.79000000000000004 110.699 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.702 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.84 120.92 43.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.319 -0.4 . . . . 1.02 110.743 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.85 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.6 146.45 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.109 0.48 . . . . 0.62 111.066 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.819 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.08 153.88 21.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.546 -0.752 . . . . 2.4399999999999999 110.018 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.2 mt-30 -39.15 88.51 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.868 0.366 . . . . 3.6899999999999999 110.409 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.31 32.61 0.21 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.853 -0.612 . . . . 6.0800000000000001 110.582 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.1 -117.37 3.29 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.419 -0.672 . . . . 1.22 111.419 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.463 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.44 177.44 8.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.249 0.547 . . . . 2.8799999999999999 111.613 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.17 149.47 32.04 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.37 -0.832 . . . . 1.47 110.363 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.553 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.15 144.7 38.73 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.441 -0.345 . . . . 2.7000000000000002 110.578 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.721 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -127.98 135.98 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 120.616 -0.434 . . . . 0.46000000000000002 111.597 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -123.99 141.26 52.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.701 -0.681 . . . . 0.34999999999999998 110.342 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.51 138.96 51.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.142 0.496 . . . . 3.6699999999999999 111.503 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.494 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.36 164.13 38.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.53 -0.759 . . . . 0.67000000000000004 109.428 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.2 151.62 38.7 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.314 -0.554 . . . . 1.47 110.972 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.802 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.8 p90 -146.29 172.69 13.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.69 -0.686 . . . . 0.44 111.008 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.76 160.74 21.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.446 -0.797 . . . . 1.3700000000000001 109.866 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.41 121.84 22.87 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.563 -0.455 . . . . 1.28 110.771 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.2 p -126.92 154.6 44.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.646 0.736 . . . . 1.97 112.759 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.401 ' OG ' ' OH ' ' A' ' 157' ' ' TYR . 22.8 t . . . . . 0 N--CA 1.455 -0.199 0 CA-C-N 114.616 -1.175 . . . . 3.2799999999999998 111.91 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.632 ' HB2' ' HB ' ' A' ' 201' ' ' THR . 92.6 p . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 122.617 1.199 . . . . 0.66000000000000003 113.195 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.436 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.91 167.5 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.243 -1.344 . . . . 0.68999999999999995 110.938 179.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.56 145.64 50.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.736 -0.665 . . . . 0.52000000000000002 110.156 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.26 101.47 9.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.157 -0.683 . . . . 0.32000000000000001 109.157 177.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.7 t -112.91 139.65 36.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.099 -0.5 . . . . 0.28999999999999998 111.101 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.3 p -128.61 152.55 48.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.605 -0.725 . . . . 0.25 109.83 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.594 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.4 p90 -144.75 -164.87 2.01 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.634 -0.426 . . . . 0.31 110.606 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.735 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -124.06 127.19 73.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.246 -0.434 . . . . 0.48999999999999999 110.784 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.179 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.99 58.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.028 -0.533 . . . . 1.53 110.358 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.735 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.15 24.61 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.872 -0.604 . . . . 0.96999999999999997 111.527 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.179 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.08 128.73 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.614 -0.434 . . . . 1.5600000000000001 110.942 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.31 -9.77 55.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.862 -0.608 . . . . 1.8799999999999999 110.309 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.12 0.31 55.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 1.04 110.366 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.16 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.891 -0.595 . . . . 0.23999999999999999 109.99 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.602 ' N ' ' O ' ' A' ' 185' ' ' ILE . 32.2 t -96.21 -15.51 22.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.311 0.576 . . . . 0.28999999999999998 110.062 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.433 ' HA3' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.58 175.62 45.81 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 109.795 -1.322 . . . . 0.13 109.795 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.53 151.59 42.68 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.661 -0.416 . . . . 0.17000000000000001 110.435 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.691 ' NH2' ' OE1' ' A' ' 191' ' ' GLN . 60.3 ttp85 -132.35 121.22 23.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.129 -0.487 . . . . 1.29 109.872 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.15 136.52 38.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.702 -0.681 . . . . 0.25 110.68 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 75.8 tt0 -129.33 129.84 45.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.01 -0.541 . . . . 1.3200000000000001 110.121 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.628 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.4 p90 -138.73 135.37 34.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.049 -0.523 . . . . 0.56999999999999995 110.596 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.419 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.38 161.38 39.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.702 -0.681 . . . . 1.1599999999999999 109.697 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.0 mt -71.07 124.92 25.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.004 0.43 . . . . 0.38 110.766 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.75 -7.81 50.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.756 -0.656 . . . . 0.40999999999999998 110.9 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.73 -69.65 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 1.6599999999999999 111.453 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.459 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.68 -35.25 75.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 1.6599999999999999 111.519 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.079 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 78.98 7.33 88.5 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.862 -0.895 . . . . 1.1699999999999999 110.862 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.334 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -28.01 -171.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.784 0.326 . . . . 1.8600000000000001 110.275 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.334 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.14 45.23 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.909 0.385 . . . . 1.98 110.186 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.419 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 45.9 Cg_endo -71.01 145.84 50.97 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 122.688 2.259 . . . . 0.55000000000000004 112.383 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.628 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.78 145.74 42.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.249 -0.648 . . . . 1.1399999999999999 109.249 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.57 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 93.5 m-85 -123.35 141.36 52.07 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.292 -0.563 . . . . 0.93000000000000005 111.511 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.9 mt -128.12 127.72 43.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.334 -0.848 . . . . 0.34000000000000002 108.934 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.657 ' HB2' HD22 ' A' ' 16' ' ' ASN . 4.0 t0 -101.65 131.07 48.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.183 0.516 . . . . 1.0900000000000001 111.72 -178.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.542 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.1 mt -127.88 157.6 73.16 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.262 -0.881 . . . . 0.19 109.567 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -69.89 158.16 57.73 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.332 2.021 . . . . 0.17999999999999999 112.203 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.4 -12.1 5.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.778 -0.646 . . . . 0.20999999999999999 110.76 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.0 p -92.91 -8.64 42.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.072 -0.513 . . . . 0.28999999999999998 110.677 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.2 135.33 34.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.318 -0.401 . . . . 0.5 110.406 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.4 p -133.13 16.72 4.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.426 -0.352 . . . . 0.29999999999999999 110.493 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.55 147.18 5.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.663 -0.495 . . . . 0.23000000000000001 109.663 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.26 150.42 12.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.498 -0.481 . . . . 0.28000000000000003 111.521 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.32 124.96 50.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.57 -0.741 . . . . 1.0700000000000001 109.754 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.32 104.88 29.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.343 -0.39 . . . . 0.28999999999999998 111.119 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 84.7 Cg_endo -91.01 -179.47 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.909 0 C-N-CA 123.152 2.568 . . . . 0.42999999999999999 112.153 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.61 32.71 18.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.314 -0.857 . . . . 1.26 111.398 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.9 mt -86.44 148.59 25.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.781 0.324 . . . . 0.32000000000000001 110.43 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.776 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.4 mt -88.36 114.85 61.33 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.055 0.455 . . . . 0.57999999999999996 110.664 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.03 140.63 96.15 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.928 2.418 . . . . 0.66000000000000003 111.936 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.02 21.24 74.4 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.081 -0.808 . . . . 0.28999999999999998 111.081 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.459 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.88 150.19 49.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 2.3300000000000001 110.626 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.491 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.2 131.63 46.03 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.021 -0.536 . . . . 0.85999999999999999 109.805 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.955 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.2 m-85 -120.47 148.28 44.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.06 -0.518 . . . . 0.52000000000000002 111.048 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.2 mt -105.31 125.37 60.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.274 -1.01 . . . . 0.29999999999999999 108.274 177.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.62 132.48 63.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.19 0.519 . . . . 0.23000000000000001 111.223 -178.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.51 122.59 20.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.509 -0.768 . . . . 0.35999999999999999 109.585 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.594 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.0 125.33 54.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 0.19 110.67 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 49.0 m-85 -117.2 137.93 52.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.031 -0.531 . . . . 0.29999999999999999 109.77 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.585 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.68 135.06 42.71 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.798 -0.816 . . . . 0.37 108.798 178.786 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.602 ' O ' ' N ' ' A' ' 140' ' ' SER . 72.5 mt -99.14 122.92 51.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.08 0.467 . . . . 0.26000000000000001 110.903 -178.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.4 p -83.84 169.77 14.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.559 -0.746 . . . . 0.28000000000000003 110.522 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.555 ' O ' ' OG1' ' A' ' 59' ' ' THR . 17.1 pt-20 -59.75 -14.59 15.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.096 -0.502 . . . . 1.6000000000000001 110.966 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.544 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.3 m-20 -96.02 -4.3 43.36 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.843 -0.343 . . . . 1.1799999999999999 110.841 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.83 13.78 64.11 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.409 -0.677 . . . . 0.29999999999999999 111.409 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -84.66 139.05 32.32 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.803 -0.233 . . . . 1.22 110.461 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.691 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 87.4 mt-30 -106.75 141.09 38.56 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.835 -0.346 . . . . 0.97999999999999998 110.558 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.4 m -136.68 126.94 26.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.82999999999999996 110.42 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.09 117.26 9.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.915 0.388 . . . . 0.26000000000000001 110.528 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.4 pt -109.07 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.29999999999999999 110.653 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.9 125.61 5.81 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.524 -0.471 . . . . 0.31 111.6 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.468 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.71 120.23 21.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.841 -0.618 . . . . 0.28000000000000003 109.604 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.59 151.68 29.12 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.697 -0.401 . . . . 0.23999999999999999 110.893 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.41 158.66 18.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.005 -0.543 . . . . 0.23000000000000001 110.439 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.12 157.91 43.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.089 -0.505 . . . . 0.67000000000000004 110.649 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.43 9.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.711 -0.677 . . . . 0.64000000000000001 109.992 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' ' 126' ' ' SER . 68.3 p . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.986 -1.006 . . . . 1.26 110.598 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.196 -0.668 . . . . 3.4399999999999999 109.196 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.44 150.69 18.53 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.982 -0.847 . . . . 1.22 110.982 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.55 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 124.035 3.157 . . . . 0.75 113.772 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.93 173.43 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.264 -1.334 . . . . 0.79000000000000004 108.853 178.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.601 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.64 125.84 51.45 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.437 -0.505 . . . . 1.9399999999999999 111.49 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.51 143.93 34.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.661 -0.7 . . . . 0.59999999999999998 110.712 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.31 25.62 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.874 0.369 . . . . 3.1400000000000001 111.081 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.744 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.0 mt -108.96 131.08 60.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.926 -0.579 . . . . 3.23 110.044 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.15 162.28 35.87 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.838 0.352 . . . . 3.6299999999999999 111.252 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.4 mt-10 36.13 31.57 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.592 -0.521 . . . . 6.0800000000000001 109.592 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.744 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.45 69.56 32.61 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.94 -0.573 . . . . 3.3799999999999999 111.627 -178.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.37 -29.0 71.88 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.431 2.087 . . . . 3.9300000000000002 111.854 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.61 125.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 3.3599999999999999 110.498 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.633 HE21 ' C ' ' A' ' 17' ' ' SER . 14.0 mt-30 -124.04 158.38 60.63 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.348 -0.387 . . . . 3.6099999999999999 110.414 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.433 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 98.4 Cg_endo -82.14 -64.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.905 2.403 . . . . 1.51 113.428 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.764 ' ND2' ' CD2' ' A' ' 157' ' ' TYR . 1.3 m120 -108.42 -19.62 13.39 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.08 0.4 . . . . 2.6800000000000002 112.08 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.633 ' C ' HE21 ' A' ' 14' ' ' GLN . 57.7 m -107.33 152.14 24.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.164 0.507 . . . . 1.21 111.302 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.34 103.0 2.22 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.681 -0.69 . . . . 1.5600000000000001 110.569 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.675 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.7 145.67 13.01 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.823 2.348 . . . . 0.81000000000000005 112.6 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.922 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.82 167.96 24.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.898 -0.592 . . . . 1.52 109.928 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.13 147.9 29.02 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.777 -0.453 . . . . 2.1400000000000001 109.777 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.587 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.22 157.33 44.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.0 0.428 . . . . 0.32000000000000001 111.225 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.496 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.04 155.27 44.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.779 -0.646 . . . . 2.1699999999999999 110.106 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.84 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.56 173.1 6.27 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 121.118 0.485 . . . . 0.58999999999999997 110.743 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.84 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.72 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.864 2.376 . . . . 0.90000000000000002 111.507 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.479 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -51.05 0.69 Allowed Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.76 -0.376 . . . . 3.3399999999999999 110.142 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.634 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.87 152.31 82.66 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.837 2.358 . . . . 1.8500000000000001 111.369 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.71 42.25 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.426 0.631 . . . . 2.54 110.588 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.821 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.58 -41.59 98.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.019 -0.991 . . . . 2.5299999999999998 110.644 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.532 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.8 mt -109.85 137.87 40.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.748 -0.66 . . . . 1.1699999999999999 111.329 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.99 -72.93 0.7 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.099 -0.501 . . . . 1.27 111.886 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.22 148.41 24.38 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.607 0.595 . . . . 1.1200000000000001 112.607 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -121.88 124.81 44.99 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.397 -0.594 . . . . 0.41999999999999998 109.397 177.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.05 134.71 60.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.66 -0.416 . . . . 0.78000000000000003 110.647 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.922 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.96 128.63 53.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.036 0.446 . . . . 0.62 111.249 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.03 139.01 49.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.738 -0.665 . . . . 1.97 110.143 178.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.436 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.03 163.11 35.24 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 120.55 -0.46 . . . . 0.34999999999999998 112.135 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.46 139.62 7.9 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.498 -0.774 . . . . 1.8 110.485 178.763 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.62 115.46 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.302 2.001 . . . . 0.57999999999999996 111.827 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.677 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.92 81.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.84 -0.43 . . . . 3.04 109.84 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.52 0.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.016 -0.538 . . . . 2.4700000000000002 111.898 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.4 p -157.67 157.81 34.24 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.862 -0.335 . . . . 2.5099999999999998 110.554 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.36 27.77 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.181 -0.463 . . . . 1.8600000000000001 110.222 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -75.8 1.31 Allowed Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.103 -0.57 . . . . 1.4399999999999999 111.892 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.89 152.36 35.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.927 0.394 . . . . 4.6900000000000004 110.965 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.673 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.27 -169.14 2.53 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.059 -0.519 . . . . 1.4299999999999999 111.965 179.373 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.436 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.09 149.57 29.84 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.468 0.651 . . . . 1.74 112.606 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.99 156.47 46.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.807 -1.088 . . . . 1.9199999999999999 110.234 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.2 158.36 41.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.951 -0.568 . . . . 0.34000000000000002 111.792 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.0 m -115.16 135.68 53.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.446 -0.797 . . . . 0.40999999999999998 109.817 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.587 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.45 121.92 23.7 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.422 -0.353 . . . . 0.55000000000000004 111.567 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.6 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.1 Cg_exo -46.41 151.71 1.7 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.753 2.302 . . . . 0.44 112.029 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.89 -23.02 63.01 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 115.989 -0.551 . . . . 0.73999999999999999 112.742 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.54 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.81 -16.88 46.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.436 0.618 . . . . 0.93000000000000005 111.758 -178.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.6 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.6 138.36 31.63 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.799 -0.36 . . . . 0.96999999999999997 110.368 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.47 13.85 11.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.399 -0.364 . . . . 1.3400000000000001 111.447 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.477 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.95 143.52 25.28 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.657 -0.417 . . . . 0.39000000000000001 111.101 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.719 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.4 t80 -114.74 -169.36 1.53 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.089 -0.505 . . . . 0.41999999999999998 110.981 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.719 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.85 125.9 9.19 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.449 -0.796 . . . . 0.39000000000000001 109.826 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.519 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.8 mt -114.87 123.33 70.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.364 -0.534 . . . . 0.73999999999999999 111.153 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.429 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 63.9 pttt -126.54 163.36 23.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.843 -0.617 . . . . 2.48 110.425 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.16 18.87 60.05 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.749 -0.941 . . . . 0.5 110.749 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.519 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.7 mt -79.03 157.23 28.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.091 0.472 . . . . 0.57999999999999996 111.376 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.844 ' O ' HG12 ' A' ' 67' ' ' VAL . 1.8 mtmm -99.48 133.89 21.58 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.593 -0.73 . . . . 2.79 110.454 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.64 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.9 Cg_endo -67.87 143.66 61.83 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.451 2.101 . . . . 0.87 111.942 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.87 25.49 75.5 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.063 -0.815 . . . . 0.64000000000000001 111.063 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.08 158.86 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.744 0.307 . . . . 0.82999999999999996 110.403 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.2 139.92 42.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.945 0.402 . . . . 0.5 110.508 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.661 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.4 m-85 -122.54 136.41 54.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.922 -0.581 . . . . 0.53000000000000003 110.726 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.93 131.09 45.26 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.51 -0.922 . . . . 1.8700000000000001 108.51 177.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.495 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.5 153.93 16.65 Favored Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.338 -0.934 . . . . 0.28999999999999998 111.943 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.04 140.96 46.01 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.702 -0.481 . . . . 1.4299999999999999 109.702 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.526 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.6 tp -115.67 118.99 34.61 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.478 -0.489 . . . . 0.32000000000000001 110.503 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.724 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.52 129.15 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.301 -0.409 . . . . 0.79000000000000004 110.594 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.705 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.9 120.92 43.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.29 -0.413 . . . . 1.02 110.696 -179.714 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.853 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.58 146.47 11.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.133 0.492 . . . . 0.62 111.019 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.821 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.12 153.97 21.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.566 -0.743 . . . . 2.4399999999999999 109.852 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.24 88.61 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.966 0.413 . . . . 3.6899999999999999 110.347 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.616 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.28 32.62 0.21 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.828 -0.624 . . . . 6.0800000000000001 110.558 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.35 3.29 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.482 -0.647 . . . . 1.22 111.482 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.466 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.41 177.41 8.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.028 0.442 . . . . 2.8799999999999999 111.699 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.23 149.48 31.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.512 -0.767 . . . . 1.47 110.378 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.18 144.65 38.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.436 -0.347 . . . . 2.7000000000000002 110.526 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.724 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.02 136.05 61.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-O 121.155 0.502 . . . . 0.46000000000000002 111.538 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.04 141.29 52.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.573 -0.74 . . . . 0.34999999999999998 110.318 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.463 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.62 138.87 51.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.082 0.468 . . . . 3.6699999999999999 111.486 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.495 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.32 164.1 38.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.536 -0.756 . . . . 0.67000000000000004 109.523 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.571 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.22 151.64 38.71 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.354 -0.538 . . . . 1.47 111.027 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.804 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.24 172.77 12.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.644 -0.707 . . . . 0.44 110.995 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.81 160.66 21.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.391 -0.822 . . . . 1.3700000000000001 109.854 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.38 121.89 22.97 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.536 -0.466 . . . . 1.28 110.74 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.576 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.4 p -131.76 -136.55 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 122.284 1.04 . . . . 1.97 111.303 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 92' ' ' THR . 30.4 t . . . . . 0 N--CA 1.449 -0.478 0 CA-C-N 112.712 -2.04 . . . . 3.2799999999999998 106.222 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.66 ' HB2' ' HB ' ' A' ' 201' ' ' THR . 70.4 p . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 123.697 1.713 . . . . 0.66000000000000003 108.726 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.437 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.8 167.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 113.047 -1.888 . . . . 0.68999999999999995 110.988 -178.372 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.58 145.6 50.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.729 -0.668 . . . . 0.52000000000000002 110.127 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.3 101.61 9.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.121 -0.696 . . . . 0.32000000000000001 109.121 177.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.1 t -112.94 139.64 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.027 -0.533 . . . . 0.28999999999999998 111.068 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.7 p -128.67 152.65 48.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.667 -0.697 . . . . 0.25 109.793 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.76 -164.92 2.03 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.672 -0.411 . . . . 0.31 110.636 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.738 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -124.03 127.13 73.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.48999999999999999 110.905 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.177 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.87 58.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 1.53 110.306 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.738 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.1 24.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.004 -0.544 . . . . 0.96999999999999997 111.426 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.177 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.24 128.73 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.657 -0.417 . . . . 1.5600000000000001 110.954 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -86.35 -9.53 56.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.933 -0.576 . . . . 1.8799999999999999 110.393 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.0 p -87.18 0.21 55.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.47 . . . . 1.04 110.264 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.26 137.16 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.001 -0.545 . . . . 0.23999999999999999 109.988 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 185' ' ' ILE . 0.9 OUTLIER -96.19 -15.47 22.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.294 0.569 . . . . 0.28999999999999998 110.1 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.633 ' N ' HG12 ' A' ' 185' ' ' ILE . . . 178.52 175.57 45.72 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 109.814 -1.315 . . . . 0.13 109.814 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.5 151.66 42.54 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.595 -0.442 . . . . 0.17000000000000001 110.465 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.673 ' NH2' ' OE1' ' A' ' 191' ' ' GLN . 58.6 ttp85 -132.42 121.2 23.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.139 -0.482 . . . . 1.29 109.943 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.559 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.15 136.57 38.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.68 -0.691 . . . . 0.25 110.648 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 81.3 tt0 -129.38 129.85 45.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.957 -0.565 . . . . 1.3200000000000001 110.016 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 36.2 p90 -138.62 135.29 34.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.972 -0.558 . . . . 0.56999999999999995 110.731 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.421 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.29 161.35 39.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.839 -0.619 . . . . 1.1599999999999999 109.632 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.954 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.1 mt -71.09 124.84 25.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.072 0.463 . . . . 0.38 110.73 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.71 -7.79 50.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.723 -0.671 . . . . 0.40999999999999998 110.881 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -109.77 -69.58 0.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 1.6599999999999999 111.519 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.449 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.69 -35.46 76.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.115 -0.493 . . . . 1.6599999999999999 111.435 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.085 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.21 88.62 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.797 -0.921 . . . . 1.1699999999999999 110.797 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.336 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.91 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 1.8600000000000001 110.224 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.336 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.31 139.07 44.97 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.247 -0.433 . . . . 1.98 110.164 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.3 Cg_endo -70.92 145.81 51.38 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 122.756 2.304 . . . . 0.55000000000000004 112.363 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.91 145.74 42.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.186 -0.672 . . . . 1.1399999999999999 109.186 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.764 ' CD2' ' ND2' ' A' ' 16' ' ' ASN . 35.4 p90 -123.21 141.29 52.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.164 0.507 . . . . 0.93000000000000005 111.599 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.03 127.72 43.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.282 -0.872 . . . . 0.34000000000000002 108.987 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.493 ' O ' ' OD1' ' A' ' 159' ' ' ASP . 53.8 p-10 -101.62 131.09 48.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.207 0.527 . . . . 1.0900000000000001 111.821 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.92 157.53 73.45 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.363 -0.835 . . . . 0.19 109.604 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.77 158.06 58.24 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.366 2.044 . . . . 0.17999999999999999 112.268 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.32 -12.13 5.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.787 -0.642 . . . . 0.20999999999999999 110.685 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.86 -8.71 42.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.154 -0.475 . . . . 0.28999999999999998 110.679 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.39 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.354 -0.384 . . . . 0.5 110.404 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.7 p -133.15 16.7 4.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.429 -0.35 . . . . 0.29999999999999999 110.52 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.56 147.12 5.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.664 -0.495 . . . . 0.23000000000000001 109.664 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.559 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.18 150.41 12.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.541 -0.464 . . . . 0.28000000000000003 111.572 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.34 125.0 50.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.624 -0.716 . . . . 1.0700000000000001 109.794 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.44 104.86 29.7 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 0.28999999999999998 111.064 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.8 Cg_endo -90.92 -179.58 1.53 Allowed 'Trans proline' 0 C--N 1.302 -1.895 0 C-N-CA 123.184 2.59 . . . . 0.42999999999999999 112.219 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 61.77 32.65 18.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.382 -0.826 . . . . 1.26 111.37 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.0 mt -86.38 148.49 25.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.784 0.326 . . . . 0.32000000000000001 110.498 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.773 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.33 114.84 61.29 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.989 0.423 . . . . 0.57999999999999996 110.6 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.01 140.57 95.96 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.835 2.356 . . . . 0.66000000000000003 111.994 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.31 74.08 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.0 -0.84 . . . . 0.28999999999999998 111.0 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.449 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.8 mmm-85 -126.94 150.24 49.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 2.3300000000000001 110.604 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.495 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.18 131.7 45.97 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.052 -0.522 . . . . 0.85999999999999999 109.81 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.954 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.7 m-85 -120.57 148.34 44.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.052 -0.522 . . . . 0.52000000000000002 111.013 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.35 125.33 60.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.262 -1.014 . . . . 0.29999999999999999 108.262 177.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.6 132.59 63.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.139 0.495 . . . . 0.23000000000000001 111.206 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.5 122.47 20.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.483 -0.78 . . . . 0.35999999999999999 109.666 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.04 125.39 54.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.382 -0.372 . . . . 0.19 110.586 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.8 m-85 -117.24 137.86 52.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.973 -0.558 . . . . 0.29999999999999999 109.918 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.583 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.63 135.02 42.73 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.829 -0.804 . . . . 0.37 108.829 178.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.633 HG12 ' N ' ' A' ' 141' ' ' GLY . 0.8 OUTLIER -99.03 123.0 51.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.156 0.503 . . . . 0.26000000000000001 110.934 -178.828 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.9 p -83.98 169.71 14.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.566 -0.743 . . . . 0.28000000000000003 110.411 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.618 ' O ' ' OG1' ' A' ' 59' ' ' THR . 82.2 tt0 -59.62 -14.67 14.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.036 -0.529 . . . . 1.6000000000000001 110.964 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.675 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 87.8 m-20 -96.0 -4.38 43.28 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.862 -0.335 . . . . 1.1799999999999999 110.83 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.85 13.79 64.07 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.376 -0.69 . . . . 0.29999999999999999 111.376 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -84.53 139.05 32.41 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.096 -0.241 . . . . 1.22 110.569 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.673 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 88.9 mt-30 -106.73 140.97 38.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.48 -0.327 . . . . 0.97999999999999998 110.623 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.67 127.03 26.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.171 -0.468 . . . . 0.82999999999999996 110.407 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.23 117.33 9.89 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.717 -0.393 . . . . 0.26000000000000001 110.508 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.0 pt -108.94 -21.9 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.29999999999999999 110.752 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.87 125.75 5.88 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.509 -0.476 . . . . 0.31 111.486 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.464 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.78 120.2 21.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.701 -0.681 . . . . 0.28000000000000003 109.586 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.64 151.66 29.06 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.621 -0.432 . . . . 0.23999999999999999 110.904 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.41 158.57 18.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.02 -0.536 . . . . 0.23000000000000001 110.417 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -146.08 157.88 43.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.089 -0.505 . . . . 0.67000000000000004 110.725 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.25 104.49 9.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.772 -0.649 . . . . 0.64000000000000001 110.022 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.66 ' HB ' ' HB2' ' A' ' 126' ' ' SER . 68.0 p . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.842 -1.075 . . . . 1.26 110.588 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.55 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.142 -0.688 . . . . 3.4399999999999999 109.142 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.37 150.75 18.53 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.925 -0.87 . . . . 1.22 110.925 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -35.74 142.42 0.1 Allowed 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 123.902 3.068 . . . . 0.75 113.857 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.599 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.3 t -79.96 173.34 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.254 -1.339 . . . . 0.79000000000000004 108.825 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.599 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.57 125.89 51.5 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.412 -0.515 . . . . 1.9399999999999999 111.422 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.52 144.08 33.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.618 -0.719 . . . . 0.59999999999999998 110.599 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.08 168.19 26.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.875 0.369 . . . . 3.1400000000000001 111.127 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.748 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.93 131.19 60.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.964 -0.562 . . . . 3.23 110.124 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.21 162.36 35.67 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.806 0.336 . . . . 3.6299999999999999 111.208 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.7 mt-10 35.94 31.76 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.592 -0.521 . . . . 6.0800000000000001 109.592 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.748 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.54 69.58 33.63 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.959 -0.564 . . . . 3.3799999999999999 111.587 -178.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.29 -29.13 72.68 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.532 2.154 . . . . 3.9300000000000002 111.865 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 3.3599999999999999 110.532 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.717 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -124.0 158.38 60.51 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.352 -0.385 . . . . 3.6099999999999999 110.347 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.563 ' CG ' ' NH2' ' A' ' 143' ' ' ARG . 97.0 Cg_endo -82.02 -64.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.877 2.385 . . . . 1.51 113.547 -179.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.69 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 63.2 t30 -108.4 -19.62 13.4 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.11 0.411 . . . . 2.6800000000000002 112.11 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.717 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 27.6 t -107.37 152.07 24.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.184 0.516 . . . . 1.21 111.285 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.22 102.97 2.24 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.722 -0.672 . . . . 1.5600000000000001 110.606 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.442 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.7 Cg_endo -82.81 145.69 12.83 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.888 2.392 . . . . 0.81000000000000005 112.557 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.907 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.82 167.84 25.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.876 -0.602 . . . . 1.52 109.858 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.06 147.91 29.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.796 -0.446 . . . . 2.1400000000000001 109.796 178.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.586 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.21 157.25 45.07 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.686 -0.406 . . . . 0.32000000000000001 111.177 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.492 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.1 155.3 44.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.873 -0.603 . . . . 2.1699999999999999 110.102 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.836 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.63 173.01 6.39 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.156 0.503 . . . . 0.58999999999999997 110.696 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.836 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.62 173.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.892 2.394 . . . . 0.90000000000000002 111.481 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.481 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.1 -51.07 0.68 Allowed Pre-proline 0 C--N 1.33 -0.265 0 C-N-CA 120.686 -0.406 . . . . 3.3399999999999999 110.085 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.632 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.81 152.39 82.28 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.729 2.286 . . . . 1.8500000000000001 111.44 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.77 42.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.399 0.618 . . . . 2.54 110.522 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.823 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.55 -41.74 98.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.002 -0.999 . . . . 2.5299999999999998 110.651 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.1 mt -109.77 137.88 39.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.814 -0.63 . . . . 1.1699999999999999 111.293 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.97 -72.87 0.7 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.008 -0.542 . . . . 1.27 111.97 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.19 148.47 24.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.532 0.567 . . . . 1.1200000000000001 112.532 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -121.87 124.81 44.99 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.397 -0.594 . . . . 0.41999999999999998 109.397 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 mt -117.97 134.8 60.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.616 -0.434 . . . . 0.78000000000000003 110.604 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.907 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.05 128.6 53.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.983 0.42 . . . . 0.62 111.207 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.18 139.02 49.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.772 -0.649 . . . . 1.97 110.102 178.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.439 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.05 163.19 35.01 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 121.133 0.492 . . . . 0.34999999999999998 112.066 -178.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.49 139.53 7.82 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.434 -0.803 . . . . 1.8 110.416 178.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 41' ' ' ASN . 18.0 Cg_endo -63.43 115.41 3.0 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.351 2.034 . . . . 0.57999999999999996 111.847 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.668 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.99 81.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.866 -0.42 . . . . 3.04 109.866 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.688 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.24 -20.66 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.968 -0.56 . . . . 2.4700000000000002 111.923 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.65 157.79 34.26 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.835 -0.346 . . . . 2.5099999999999998 110.559 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.403 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.38 27.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 1.8600000000000001 110.163 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.84 -75.88 1.31 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.118 -0.563 . . . . 1.4399999999999999 111.867 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.87 152.29 35.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.973 0.416 . . . . 4.6900000000000004 111.0 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.15 -169.02 2.51 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.061 -0.518 . . . . 1.4299999999999999 111.981 179.335 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.19 149.71 29.72 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.482 0.658 . . . . 1.74 112.533 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.07 156.51 45.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.791 -1.095 . . . . 1.9199999999999999 110.213 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.469 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.21 158.4 41.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.976 -0.557 . . . . 0.34000000000000002 111.802 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.3 m -115.15 135.63 53.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.435 -0.802 . . . . 0.40999999999999998 109.906 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.586 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.4 122.06 23.79 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.512 -0.313 . . . . 0.55000000000000004 111.523 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.6 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.0 Cg_exo -46.46 151.74 1.73 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.689 2.259 . . . . 0.44 112.077 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.87 -23.09 63.03 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 116.065 -0.516 . . . . 0.73999999999999999 112.805 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.544 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.75 -16.83 46.44 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.225 -0.59 . . . . 0.93000000000000005 111.821 -178.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.6 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.6 mt -91.67 138.43 31.57 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.807 -0.357 . . . . 0.96999999999999997 110.232 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.48 13.81 11.02 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.277 -0.42 . . . . 1.3400000000000001 111.482 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.4 p -149.92 143.48 25.29 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.631 -0.428 . . . . 0.39000000000000001 111.058 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.81 -169.29 1.52 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.209 0.528 . . . . 0.41999999999999998 110.851 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.723 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 0.6 OUTLIER -151.84 125.91 9.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.433 -0.803 . . . . 0.39000000000000001 109.765 179.281 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.3 mt -114.81 123.25 70.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.435 -0.506 . . . . 0.73999999999999999 111.219 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.518 ' HB3' ' CD1' ' A' ' 185' ' ' ILE . 25.7 pttm -126.48 163.43 23.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.888 -0.596 . . . . 2.48 110.497 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.479 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.02 19.08 59.87 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.781 -0.928 . . . . 0.5 110.781 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.69 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.8 mt -79.1 157.3 28.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.09 0.472 . . . . 0.57999999999999996 111.311 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.847 ' O ' HG12 ' A' ' 67' ' ' VAL . 4.0 mttt -99.58 133.96 21.48 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.616 -0.72 . . . . 2.79 110.434 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.462 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.94 143.6 61.15 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.539 2.16 . . . . 0.87 111.936 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.84 25.58 75.39 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.091 -0.803 . . . . 0.64000000000000001 111.091 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.847 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.17 158.84 39.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.715 0.293 . . . . 0.82999999999999996 110.415 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.23 139.96 42.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.913 0.387 . . . . 0.5 110.56 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.654 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.9 m-85 -122.59 136.46 54.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.967 -0.56 . . . . 0.53000000000000003 110.778 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.82 131.05 45.23 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.491 -0.929 . . . . 1.8700000000000001 108.491 177.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.58 153.92 16.67 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.214 -0.993 . . . . 0.28999999999999998 111.933 -178.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.03 140.9 45.99 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.698 -0.482 . . . . 1.4299999999999999 109.698 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.75 118.91 34.36 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.426 -0.51 . . . . 0.32000000000000001 110.462 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.735 HG12 HG23 ' A' ' 84' ' ' VAL . 64.2 mt -112.41 129.15 68.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.79000000000000004 110.608 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.708 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.82 120.86 43.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.242 -0.435 . . . . 1.02 110.747 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.854 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.58 146.46 11.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.169 0.509 . . . . 0.62 111.022 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.823 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.01 153.92 21.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.519 -0.764 . . . . 2.4399999999999999 109.888 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.19 88.52 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.937 0.399 . . . . 3.6899999999999999 110.428 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.41 32.53 0.22 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.841 -0.618 . . . . 6.0800000000000001 110.53 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.04 -117.34 3.29 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.472 -0.651 . . . . 1.22 111.472 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.465 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.4 177.37 9.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.218 0.532 . . . . 2.8799999999999999 111.643 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.2 149.5 32.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.435 -0.802 . . . . 1.47 110.385 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.55 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.21 144.7 38.61 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.432 -0.349 . . . . 2.7000000000000002 110.511 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.735 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -127.98 135.93 61.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-O 121.087 0.47 . . . . 0.46000000000000002 111.508 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.03 141.52 51.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.59 -0.732 . . . . 0.34999999999999998 110.192 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.462 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.66 138.93 51.65 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.482 -0.487 . . . . 3.6699999999999999 111.481 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.491 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.29 164.23 37.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.582 -0.736 . . . . 0.67000000000000004 109.399 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 46.9 p30 -145.29 151.51 38.45 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.434 -0.506 . . . . 1.47 111.064 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.804 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.2 p90 -146.2 172.72 13.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.768 -0.651 . . . . 0.44 111.005 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.78 160.76 21.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.442 -0.799 . . . . 1.3700000000000001 109.807 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.5 121.86 22.79 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.565 -0.454 . . . . 1.28 110.722 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.587 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.0 p -127.02 161.87 27.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.222 0.534 . . . . 1.97 111.864 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 115.516 -0.766 . . . . 3.2799999999999998 110.531 179.368 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 6.0 p . . . . . 0 N--CA 1.461 0.121 0 CA-C-O 120.925 0.393 . . . . 0.66000000000000003 110.311 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.435 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.68 167.5 0.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.883 -0.599 . . . . 0.68999999999999995 110.949 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.56 145.53 50.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.685 -0.688 . . . . 0.52000000000000002 110.197 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.23 101.62 9.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.106 -0.702 . . . . 0.32000000000000001 109.106 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.1 t -112.94 139.67 36.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.071 -0.513 . . . . 0.28999999999999998 111.103 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.0 p -128.76 152.59 48.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.677 -0.692 . . . . 0.25 109.846 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.81 -164.91 2.03 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.688 -0.405 . . . . 0.31 110.675 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -123.97 127.19 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.48999999999999999 110.784 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.174 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -58.0 58.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.188 -0.46 . . . . 1.53 110.349 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.21 24.62 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.857 -0.611 . . . . 0.96999999999999997 111.485 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.174 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.11 128.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.626 -0.43 . . . . 1.5600000000000001 110.923 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.47 -9.62 55.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.837 -0.62 . . . . 1.8799999999999999 110.329 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 29.0 p -86.96 0.13 55.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.061 -0.518 . . . . 1.04 110.391 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.23 137.3 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.96 -0.564 . . . . 0.23999999999999999 109.989 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.613 ' N ' ' O ' ' A' ' 185' ' ' ILE . 7.1 p -96.33 -15.56 21.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.37 0.605 . . . . 0.28999999999999998 110.029 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 1.015 ' O ' HG22 ' A' ' 185' ' ' ILE . . . 178.58 175.53 45.74 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 109.809 -1.316 . . . . 0.13 109.809 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -123.42 151.52 42.55 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.63 -0.428 . . . . 0.17000000000000001 110.492 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.864 ' NH2' HE22 ' A' ' 191' ' ' GLN . 8.7 tmm_? -132.29 121.16 23.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.126 -0.488 . . . . 1.29 109.956 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.556 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.05 136.62 38.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.632 -0.713 . . . . 0.25 110.621 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 75.9 tt0 -129.39 129.89 45.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.95 -0.568 . . . . 1.3200000000000001 110.043 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.623 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.7 p90 -138.75 135.27 34.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.034 -0.53 . . . . 0.56999999999999995 110.673 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.422 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.36 39.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.694 -0.685 . . . . 1.1599999999999999 109.697 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.952 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.4 mt -70.97 124.79 25.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.992 0.425 . . . . 0.38 110.718 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.76 -7.64 49.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.768 -0.651 . . . . 0.40999999999999998 110.989 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.8 -69.72 0.85 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.264 -0.426 . . . . 1.6599999999999999 111.387 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.439 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.3 mt-10 -60.8 -35.25 75.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 1.6599999999999999 111.459 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.09 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.26 7.12 88.68 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.829 -0.908 . . . . 1.1699999999999999 110.829 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.336 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.3 t0 -27.98 -171.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.801 0.334 . . . . 1.8600000000000001 110.322 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.336 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.25 139.11 45.19 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-O 120.979 0.419 . . . . 1.98 110.238 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.422 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.0 Cg_endo -70.85 145.76 51.69 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 122.77 2.313 . . . . 0.55000000000000004 112.325 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.82 145.69 42.62 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.25 -0.648 . . . . 1.1399999999999999 109.25 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.646 ' CE2' ' CG ' ' A' ' 16' ' ' ASN . 25.0 p90 -123.24 141.38 52.04 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.348 -0.541 . . . . 0.93000000000000005 111.532 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.9 mt -128.18 127.69 43.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.275 -0.875 . . . . 0.34000000000000002 108.953 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.558 ' HB2' HD21 ' A' ' 16' ' ' ASN . 33.2 t0 -101.61 131.2 47.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.19 0.519 . . . . 1.0900000000000001 111.779 -178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -128.0 157.52 73.65 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.348 -0.842 . . . . 0.19 109.585 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -69.87 157.95 58.45 Favored 'Trans proline' 0 C--N 1.302 -1.904 0 C-N-CA 122.49 2.126 . . . . 0.17999999999999999 112.23 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.4 p -59.14 -12.19 4.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.743 -0.662 . . . . 0.20999999999999999 110.817 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.1 p -92.79 -8.76 42.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 0.28999999999999998 110.73 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.09 135.37 34.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.325 -0.398 . . . . 0.5 110.481 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.19 16.69 4.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.452 -0.34 . . . . 0.29999999999999999 110.514 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.4 p -167.51 147.16 5.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.609 -0.515 . . . . 0.23000000000000001 109.609 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.21 150.5 12.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.489 -0.484 . . . . 0.28000000000000003 111.503 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 4.0 t-20 -106.35 124.98 50.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.585 -0.734 . . . . 1.0700000000000001 109.81 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.36 104.92 29.83 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 0.28999999999999998 111.081 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.1 Cg_endo -90.97 -179.51 1.5 Allowed 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 123.231 2.621 . . . . 0.42999999999999999 112.204 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.69 32.63 18.35 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.385 -0.825 . . . . 1.26 111.411 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.448 ' O ' ' OG ' ' A' ' 126' ' ' SER . 23.9 mt -86.39 148.51 25.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.448 -0.342 . . . . 0.32000000000000001 110.489 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.77 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.5 mt -88.23 114.91 61.52 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.029 0.442 . . . . 0.57999999999999996 110.686 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.01 140.53 95.77 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.897 2.398 . . . . 0.66000000000000003 111.992 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.16 21.14 74.23 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.032 -0.827 . . . . 0.28999999999999998 111.032 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.439 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.83 150.14 49.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.768 0.318 . . . . 2.3300000000000001 110.73 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.27 131.78 46.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.139 -0.482 . . . . 0.85999999999999999 109.757 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.952 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.57 148.28 44.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.031 -0.532 . . . . 0.52000000000000002 110.99 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.2 mt -105.32 125.4 60.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.222 -1.029 . . . . 0.29999999999999999 108.222 177.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.58 132.56 63.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.205 0.526 . . . . 0.23000000000000001 111.216 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.64 20.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.575 -0.739 . . . . 0.35999999999999999 109.617 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.05 125.32 55.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.269 -0.423 . . . . 0.19 110.657 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.9 m-85 -117.21 137.94 52.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.031 -0.531 . . . . 0.29999999999999999 109.835 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.582 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.74 135.07 42.76 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.785 -0.82 . . . . 0.37 108.785 178.863 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 1.015 HG22 ' O ' ' A' ' 141' ' ' GLY . 11.7 tt -99.15 123.01 51.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.167 0.508 . . . . 0.26000000000000001 110.873 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.585 ' OG ' ' OD1' ' A' ' 188' ' ' ASP . 88.6 p -83.98 169.77 14.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.516 -0.766 . . . . 0.28000000000000003 110.485 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -59.8 -14.5 15.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.095 -0.502 . . . . 1.6000000000000001 110.897 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.671 ' OD1' ' N ' ' A' ' 190' ' ' GLU . 37.0 p30 -96.17 -4.2 43.01 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.782 -0.367 . . . . 1.1799999999999999 110.731 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.47 ' N ' ' HB ' ' A' ' 59' ' ' THR . . . 87.82 13.85 64.03 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.377 -0.689 . . . . 0.29999999999999999 111.377 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.671 ' N ' ' OD1' ' A' ' 188' ' ' ASP . 82.2 tt0 -84.67 139.0 32.34 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.04 -0.264 . . . . 1.22 110.472 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.864 HE22 ' NH2' ' A' ' 143' ' ' ARG . 90.3 mt-30 -106.72 141.11 38.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.873 0.368 . . . . 0.97999999999999998 110.523 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 61.8 m -136.72 127.07 26.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.078 -0.51 . . . . 0.82999999999999996 110.276 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.14 117.21 9.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.284 -0.416 . . . . 0.26000000000000001 110.554 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.0 pt -108.99 -21.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.29999999999999999 110.795 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.84 125.68 5.88 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.519 -0.472 . . . . 0.31 111.465 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.461 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.71 120.3 21.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.799 -0.637 . . . . 0.28000000000000003 109.585 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.66 151.74 29.13 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.667 -0.413 . . . . 0.23999999999999999 110.916 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.47 158.57 18.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.015 -0.538 . . . . 0.23000000000000001 110.41 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.1 157.86 43.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.123 -0.49 . . . . 0.67000000000000004 110.696 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.26 104.28 9.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.78 -0.646 . . . . 0.64000000000000001 110.096 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.0 p . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 117.845 -1.074 . . . . 1.26 110.655 -179.688 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.224 -0.658 . . . . 3.4399999999999999 109.224 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.39 150.62 18.55 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.012 -0.835 . . . . 1.22 111.012 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -35.62 142.35 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.05 0 C-N-CA 124.022 3.148 . . . . 0.75 113.828 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.6 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.0 t -79.91 173.3 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.283 -1.326 . . . . 0.79000000000000004 108.891 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.6 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.49 125.86 51.47 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.479 -0.488 . . . . 1.9399999999999999 111.482 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 143.99 33.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.665 -0.698 . . . . 0.59999999999999998 110.689 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.94 168.23 25.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.922 0.391 . . . . 3.1400000000000001 111.101 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.746 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.94 131.06 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.004 -0.544 . . . . 3.23 110.079 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.17 162.27 35.88 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.836 0.35 . . . . 3.6299999999999999 111.239 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.6 mt-10 36.18 31.5 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.648 -0.501 . . . . 6.0800000000000001 109.648 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.746 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.63 32.6 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.97 -0.559 . . . . 3.3799999999999999 111.574 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.2 Cg_endo -63.16 -29.18 73.92 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.484 2.123 . . . . 3.9300000000000002 111.888 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 3.3599999999999999 110.518 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.619 ' NE2' ' O ' ' A' ' 13' ' ' SER . 6.0 mp0 -123.98 158.29 60.74 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 3.6099999999999999 110.368 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.515 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 97.5 Cg_endo -81.98 -64.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.958 2.439 . . . . 1.51 113.431 -179.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.955 HD21 ' HB2' ' A' ' 157' ' ' TYR . 5.7 m-20 -108.48 -19.53 13.42 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.07 0.396 . . . . 2.6800000000000002 112.07 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 60.3 m -107.36 152.0 24.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.159 0.504 . . . . 1.21 111.258 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.4 t-80 -155.26 102.97 2.23 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.623 -0.717 . . . . 1.5600000000000001 110.618 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.621 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.5 Cg_endo -82.7 145.63 12.99 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.885 2.39 . . . . 0.81000000000000005 112.601 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.916 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.8 167.96 24.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.815 -0.63 . . . . 1.52 109.909 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.16 147.98 29.09 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.712 -0.477 . . . . 2.1400000000000001 109.712 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.582 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.28 157.23 45.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.026 0.441 . . . . 0.32000000000000001 111.165 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.498 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.06 155.23 44.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.752 -0.658 . . . . 2.1699999999999999 110.116 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.841 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.55 173.05 6.34 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 121.091 0.472 . . . . 0.58999999999999997 110.748 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.841 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.65 173.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.851 2.367 . . . . 0.90000000000000002 111.502 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.484 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.06 -51.12 0.69 Allowed Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.643 -0.423 . . . . 3.3399999999999999 110.08 179.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.638 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.76 152.31 82.49 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.796 2.33 . . . . 1.8500000000000001 111.416 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.66 42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.35 0.595 . . . . 2.54 110.607 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.822 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.52 -41.63 98.5 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.017 -0.992 . . . . 2.5299999999999998 110.68 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.532 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.2 mt -109.86 137.79 40.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.818 -0.628 . . . . 1.1699999999999999 111.287 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.88 -72.83 0.71 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.013 -0.539 . . . . 1.27 111.986 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.21 148.43 24.38 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.517 0.562 . . . . 1.1200000000000001 112.517 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.86 124.86 45.12 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.312 -0.625 . . . . 0.41999999999999998 109.312 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.04 134.78 60.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.614 -0.434 . . . . 0.78000000000000003 110.689 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.916 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.02 128.63 53.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.62 111.246 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.96 49.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.751 -0.659 . . . . 1.97 110.178 178.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.438 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.07 163.17 35.09 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.16 0.505 . . . . 0.34999999999999998 112.128 -178.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.47 139.54 7.84 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.468 -0.787 . . . . 1.8 110.468 178.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.695 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.57 115.52 3.09 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.313 2.009 . . . . 0.57999999999999996 111.791 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.674 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.01 81.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.885 -0.413 . . . . 3.04 109.885 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.695 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.51 0.06 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.987 -0.551 . . . . 2.4700000000000002 111.889 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.8 p -157.72 157.69 33.96 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.82 0.343 . . . . 2.5099999999999998 110.552 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.34 27.89 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 1.8600000000000001 110.194 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.81 -75.96 1.31 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.2 -0.524 . . . . 1.4399999999999999 111.81 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.79 152.29 35.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.824 0.345 . . . . 4.6900000000000004 111.042 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.24 -169.11 2.52 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.107 -0.497 . . . . 1.4299999999999999 111.884 179.334 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.67 29.73 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.524 0.678 . . . . 1.74 112.514 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.05 156.46 46.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.689 -1.141 . . . . 1.9199999999999999 110.263 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.16 158.34 41.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.91 -0.586 . . . . 0.34000000000000002 111.818 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.1 m -115.08 135.61 54.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.505 -0.77 . . . . 0.40999999999999998 109.86 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.582 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.36 121.95 23.82 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.439 -0.346 . . . . 0.55000000000000004 111.55 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.597 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.0 Cg_exo -46.37 151.79 1.64 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.653 2.235 . . . . 0.44 112.116 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.98 -23.01 63.19 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 116.052 -0.522 . . . . 0.73999999999999999 112.763 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.1 p-80 -82.8 -16.84 46.26 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.216 -0.594 . . . . 0.93000000000000005 111.861 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.597 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.66 138.51 31.5 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.657 -0.417 . . . . 0.96999999999999997 110.281 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.55 13.94 10.98 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.314 -0.403 . . . . 1.3400000000000001 111.568 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.01 143.35 25.12 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.611 -0.436 . . . . 0.39000000000000001 111.068 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.722 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.63 -169.29 1.51 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.188 0.518 . . . . 0.41999999999999998 110.941 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.722 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.3 t -151.8 125.97 9.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.416 -0.811 . . . . 0.39000000000000001 109.808 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.517 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.93 123.2 70.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.404 -0.518 . . . . 0.73999999999999999 111.217 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -126.47 163.39 23.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.829 -0.623 . . . . 2.48 110.426 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.19 18.97 59.79 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.705 -0.958 . . . . 0.5 110.705 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.517 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.9 mt -79.1 157.14 28.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.093 0.473 . . . . 0.57999999999999996 111.324 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.84 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.0 mtpp -99.39 133.97 21.57 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 2.79 110.463 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.89 143.58 61.36 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.586 2.191 . . . . 0.87 111.963 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.87 25.58 75.4 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.023 -0.831 . . . . 0.64000000000000001 111.023 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.84 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.15 158.74 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.706 0.288 . . . . 0.82999999999999996 110.466 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.13 139.93 42.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.883 0.373 . . . . 0.5 110.602 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.653 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.3 m-85 -122.49 136.48 54.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.55 . . . . 0.53000000000000003 110.775 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.98 130.98 45.36 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.539 -0.911 . . . . 1.8700000000000001 108.539 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.43 153.91 16.63 Favored Glycine 0 C--O 1.227 -0.344 0 C-N-CA 120.299 -0.953 . . . . 0.28999999999999998 111.962 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.97 140.91 46.07 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.73 -0.47 . . . . 1.4299999999999999 109.73 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.7 tp -115.73 118.95 34.48 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.456 -0.498 . . . . 0.32000000000000001 110.533 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.728 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.42 129.05 68.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.323 -0.399 . . . . 0.79000000000000004 110.628 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.703 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.9 120.8 43.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.287 -0.415 . . . . 1.02 110.713 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.855 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.53 146.46 11.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.231 0.538 . . . . 0.62 111.058 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.822 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.03 153.94 21.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.495 -0.775 . . . . 2.4399999999999999 109.949 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.2 mt-30 -39.21 88.6 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.895 0.379 . . . . 3.6899999999999999 110.446 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.24 32.62 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.822 -0.626 . . . . 6.0800000000000001 110.598 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.08 -117.33 3.29 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.457 -0.657 . . . . 1.22 111.457 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.462 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.51 177.42 8.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.197 0.522 . . . . 2.8799999999999999 111.6 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.16 149.44 31.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.451 -0.795 . . . . 1.47 110.451 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.14 144.65 38.73 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.479 -0.328 . . . . 2.7000000000000002 110.533 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.728 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -128.01 135.99 61.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-O 121.036 0.446 . . . . 0.46000000000000002 111.555 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.05 141.32 52.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.662 -0.699 . . . . 0.34999999999999998 110.304 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.453 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.63 138.82 51.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.053 0.454 . . . . 3.6699999999999999 111.577 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.25 164.21 37.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.548 -0.751 . . . . 0.67000000000000004 109.435 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.28 151.47 38.4 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.399 -0.52 . . . . 1.47 111.058 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.804 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.2 p90 -146.18 172.66 13.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.802 -0.636 . . . . 0.44 111.039 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.6 160.71 21.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.456 -0.793 . . . . 1.3700000000000001 109.897 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.43 121.81 22.8 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.591 -0.444 . . . . 1.28 110.778 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.494 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -127.64 163.88 23.28 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 114.03 1.122 . . . . 1.97 114.03 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 C--O 1.232 0.183 0 CA-C-N 113.55 -1.659 . . . . 3.2799999999999998 108.815 177.659 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.5 p . . . . . 0 CA--C 1.521 -0.138 0 CA-C-O 121.139 0.495 . . . . 0.66000000000000003 110.365 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.436 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.86 167.59 0.25 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.602 -0.726 . . . . 0.68999999999999995 110.955 -179.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.62 145.48 50.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.731 -0.668 . . . . 0.52000000000000002 110.156 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.16 101.64 9.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.095 -0.706 . . . . 0.32000000000000001 109.095 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.1 t -112.92 139.78 36.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.056 -0.52 . . . . 0.28999999999999998 110.95 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.9 p -128.74 152.57 48.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.598 -0.728 . . . . 0.25 109.792 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.592 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.8 -164.87 2.02 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.741 -0.384 . . . . 0.31 110.667 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.5 t -123.98 127.12 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.48999999999999999 110.823 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.176 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.87 58.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.126 -0.488 . . . . 1.53 110.368 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -37.95 24.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.934 -0.575 . . . . 0.96999999999999997 111.579 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.176 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.23 128.68 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.659 -0.417 . . . . 1.5600000000000001 110.96 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.42 -9.53 56.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.0 -0.545 . . . . 1.8799999999999999 110.32 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.8 p -87.16 0.25 55.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 1.04 110.29 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.26 137.26 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.994 -0.548 . . . . 0.23999999999999999 109.956 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.601 ' N ' ' O ' ' A' ' 185' ' ' ILE . 90.3 p -96.29 -15.5 21.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.27 0.557 . . . . 0.28999999999999998 110.048 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.58 175.57 45.77 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 109.88 -1.288 . . . . 0.13 109.88 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.47 151.62 42.54 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.569 -0.452 . . . . 0.17000000000000001 110.496 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.796 HH22 ' NE2' ' A' ' 191' ' ' GLN . 41.8 ttp180 -132.26 121.14 23.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.15 -0.477 . . . . 1.29 109.924 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.558 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.14 136.63 38.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.734 -0.666 . . . . 0.25 110.649 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 99.2 mt-10 -129.45 129.86 45.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.942 -0.572 . . . . 1.3200000000000001 110.044 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.625 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.7 p90 -138.68 135.35 34.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.046 -0.525 . . . . 0.56999999999999995 110.611 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.419 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.41 161.36 39.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.793 -0.64 . . . . 1.1599999999999999 109.621 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.05 124.99 25.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.036 0.446 . . . . 0.38 110.694 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.7 p -71.94 -7.7 50.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.766 -0.652 . . . . 0.40999999999999998 110.797 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -109.72 -69.67 0.85 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.967 0.413 . . . . 1.6599999999999999 111.455 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.445 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.71 -35.28 75.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.998 -0.546 . . . . 1.6599999999999999 111.522 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.081 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.11 7.23 88.59 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.825 -0.91 . . . . 1.1699999999999999 110.825 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.34 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.83 -171.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.324 . . . . 1.8600000000000001 110.256 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.34 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.26 139.02 45.14 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-O 120.945 0.402 . . . . 1.98 110.205 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.419 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.9 Cg_endo -70.75 145.73 52.2 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 122.808 2.339 . . . . 0.55000000000000004 112.361 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.625 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.86 145.69 42.65 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.312 -0.625 . . . . 1.1399999999999999 109.312 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.955 ' HB2' HD21 ' A' ' 16' ' ' ASN . 0.2 OUTLIER -123.26 141.32 52.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.31 0.576 . . . . 0.93000000000000005 111.421 -178.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.9 mt -128.14 127.61 43.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.271 -0.877 . . . . 0.34000000000000002 108.921 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 159' ' ' ASP . 51.4 p-10 -101.61 131.21 47.94 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.194 0.521 . . . . 1.0900000000000001 111.731 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -128.02 157.58 73.5 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.237 -0.892 . . . . 0.19 109.493 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.81 158.02 58.33 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.435 2.09 . . . . 0.17999999999999999 112.267 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.36 -12.11 5.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.792 -0.64 . . . . 0.20999999999999999 110.708 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.7 p -92.82 -8.67 42.9 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.129 -0.487 . . . . 0.28999999999999998 110.715 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.38 34.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.319 -0.4 . . . . 0.5 110.394 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.12 16.53 4.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.398 -0.365 . . . . 0.29999999999999999 110.558 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.4 p -167.45 147.23 5.18 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.661 -0.496 . . . . 0.23000000000000001 109.661 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.32 150.42 12.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.565 -0.454 . . . . 0.28000000000000003 111.602 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.507 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.26 124.94 50.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.559 -0.746 . . . . 1.0700000000000001 109.843 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.45 104.86 29.72 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.918 0.389 . . . . 0.28999999999999998 111.098 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 84.4 Cg_endo -91.05 -179.42 1.47 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 123.132 2.555 . . . . 0.42999999999999999 112.163 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.56 32.73 18.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.366 -0.834 . . . . 1.26 111.419 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.1 mt -86.37 148.52 25.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.454 -0.339 . . . . 0.32000000000000001 110.454 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.773 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.31 114.88 61.44 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.018 0.437 . . . . 0.57999999999999996 110.64 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -58.98 140.62 96.14 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.815 2.343 . . . . 0.66000000000000003 112.051 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.16 74.4 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.088 -0.805 . . . . 0.28999999999999998 111.088 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.445 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.86 150.21 49.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.313 . . . . 2.3300000000000001 110.634 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.495 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.13 131.63 45.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.519 . . . . 0.85999999999999999 109.789 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.955 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.55 148.38 43.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.066 -0.515 . . . . 0.52000000000000002 110.995 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.4 125.28 60.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.363 -0.977 . . . . 0.29999999999999999 108.363 177.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.47 132.51 63.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.149 0.5 . . . . 0.23000000000000001 111.217 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.49 122.66 20.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.54 -0.755 . . . . 0.35999999999999999 109.729 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.592 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.09 125.37 55.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.284 -0.417 . . . . 0.19 110.664 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 49.1 m-85 -117.18 138.04 51.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.978 -0.555 . . . . 0.29999999999999999 109.875 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.582 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.81 134.97 43.0 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.77 -0.826 . . . . 0.37 108.77 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.601 ' O ' ' N ' ' A' ' 140' ' ' SER . 85.4 mt -99.09 122.93 51.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.145 0.498 . . . . 0.26000000000000001 110.961 -178.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.2 p -83.89 169.65 14.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.526 -0.761 . . . . 0.28000000000000003 110.447 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.63 ' O ' ' CG2' ' A' ' 59' ' ' THR . 51.5 tp10 -59.79 -14.39 14.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.034 -0.53 . . . . 1.6000000000000001 110.982 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.621 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.1 m-20 -96.18 -4.24 42.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.857 0.361 . . . . 1.1799999999999999 110.817 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.8 13.88 64.0 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.384 -0.687 . . . . 0.29999999999999999 111.384 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.5 tp10 -84.7 139.09 32.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.712 0.292 . . . . 1.22 110.422 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.796 ' NE2' HH22 ' A' ' 143' ' ' ARG . 6.9 pt20 -106.71 141.03 38.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.405 -0.362 . . . . 0.97999999999999998 110.602 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.4 m -136.72 127.06 26.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.82999999999999996 110.301 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.19 117.27 9.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.244 -0.434 . . . . 0.26000000000000001 110.577 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -108.97 -21.86 5.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.29999999999999999 110.711 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.83 125.72 5.9 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.551 -0.46 . . . . 0.31 111.535 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.79 120.12 21.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.854 -0.612 . . . . 0.28000000000000003 109.603 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.58 151.66 29.11 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.676 -0.409 . . . . 0.23999999999999999 110.97 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.49 158.66 18.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.23000000000000001 110.411 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.14 157.87 43.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.043 -0.526 . . . . 0.67000000000000004 110.627 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.2 104.31 9.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.722 -0.672 . . . . 0.64000000000000001 110.119 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.7 p . . . . . 0 C--O 1.221 -0.414 0 CA-C-O 117.902 -1.047 . . . . 1.26 110.666 -179.621 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.4 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.267 -0.642 . . . . 3.4399999999999999 109.267 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.39 150.72 18.53 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.006 -0.838 . . . . 1.22 111.006 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -35.61 142.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 124.007 3.138 . . . . 0.75 113.789 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.6 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.3 t -80.04 173.39 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.288 -1.324 . . . . 0.79000000000000004 108.745 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.6 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.66 125.86 51.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.398 -0.521 . . . . 1.9399999999999999 111.444 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.48 144.06 33.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.564 -0.744 . . . . 0.59999999999999998 110.631 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.09 168.33 25.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.944 0.402 . . . . 3.1400000000000001 111.127 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.748 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -108.99 131.06 60.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.972 -0.558 . . . . 3.23 110.116 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.2 p -141.14 162.25 35.93 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.875 0.369 . . . . 3.6299999999999999 111.24 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 75.0 mm-40 36.1 31.61 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.633 -0.506 . . . . 6.0800000000000001 109.633 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.748 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.55 69.69 33.96 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.952 -0.567 . . . . 3.3799999999999999 111.618 -178.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.34 -29.07 72.2 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.498 2.132 . . . . 3.9300000000000002 111.851 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.64 125.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.098 -0.501 . . . . 3.3599999999999999 110.477 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 1.075 HE22 HG23 ' A' ' 91' ' ' THR . 0.0 OUTLIER -123.99 158.31 60.71 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 3.6099999999999999 110.437 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.444 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 97.1 Cg_endo -81.95 -64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.858 2.372 . . . . 1.51 113.553 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.7 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 52.1 t30 -108.48 -19.55 13.41 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.119 0.414 . . . . 2.6800000000000002 112.119 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.825 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 47.1 m -107.31 152.05 24.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.136 0.493 . . . . 1.21 111.281 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.569 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.5 t-80 -155.32 102.86 2.22 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.72 -0.673 . . . . 1.5600000000000001 110.682 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.452 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.6 145.72 13.17 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.875 2.383 . . . . 0.81000000000000005 112.627 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.907 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.88 167.98 24.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.896 -0.593 . . . . 1.52 109.879 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.15 148.03 29.15 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.786 -0.45 . . . . 2.1400000000000001 109.786 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.586 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.8 p90 -142.32 157.3 44.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.936 0.398 . . . . 0.32000000000000001 111.303 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.493 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.07 155.34 44.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.841 -0.618 . . . . 2.1699999999999999 110.092 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.838 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.67 173.08 6.31 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 121.122 0.487 . . . . 0.58999999999999997 110.76 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.838 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.74 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.841 2.361 . . . . 0.90000000000000002 111.512 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.481 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.14 -50.97 0.69 Allowed Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.62 -0.432 . . . . 3.3399999999999999 110.133 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.634 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.85 152.4 82.32 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.678 2.252 . . . . 1.8500000000000001 111.559 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.75 42.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.401 0.62 . . . . 2.54 110.528 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.822 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.63 -41.63 98.24 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.008 -0.996 . . . . 2.5299999999999998 110.616 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.9 mt -109.79 137.86 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.84 -0.618 . . . . 1.1699999999999999 111.227 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.0 -72.84 0.71 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.042 -0.526 . . . . 1.27 111.937 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.29 148.38 24.34 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.549 0.574 . . . . 1.1200000000000001 112.549 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.82 124.89 45.23 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.345 -0.613 . . . . 0.41999999999999998 109.345 177.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 mt -118.06 134.75 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.608 -0.437 . . . . 0.78000000000000003 110.616 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.907 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -119.98 128.66 53.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.996 0.427 . . . . 0.62 111.245 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.93 49.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.79 -0.641 . . . . 1.97 110.213 178.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.439 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -144.98 163.17 35.01 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.118 0.485 . . . . 0.34999999999999998 112.043 -178.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.52 139.57 7.82 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.417 -0.811 . . . . 1.8 110.503 178.746 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.3 Cg_endo -63.54 115.47 3.06 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.347 2.032 . . . . 0.57999999999999996 111.818 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.3 tttp -46.85 81.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.883 -0.414 . . . . 3.04 109.883 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.7 0.06 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.109 -0.496 . . . . 2.4700000000000002 111.914 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 p -157.55 157.81 34.46 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.857 -0.337 . . . . 2.5099999999999998 110.592 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.402 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.33 27.77 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.213 -0.449 . . . . 1.8600000000000001 110.183 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.77 -75.97 1.31 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.198 -0.525 . . . . 1.4399999999999999 111.811 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.86 152.25 35.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.947 0.403 . . . . 4.6900000000000004 111.019 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.676 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.17 -169.14 2.54 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.996 -0.547 . . . . 1.4299999999999999 112.048 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.16 149.67 29.74 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 121.476 0.655 . . . . 1.74 112.561 -177.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.99 156.42 46.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.763 -1.108 . . . . 1.9199999999999999 110.347 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.13 158.39 41.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.209 0.528 . . . . 0.34000000000000002 111.828 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.1 m -115.22 135.57 54.03 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.57 -0.741 . . . . 0.40999999999999998 109.794 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.586 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.36 121.96 23.82 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.33 -0.396 . . . . 0.55000000000000004 111.495 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.9 Cg_exo -46.3 151.65 1.64 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.733 2.289 . . . . 0.44 112.081 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.84 -23.06 62.94 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-N 116.037 -0.529 . . . . 0.73999999999999999 112.814 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.87 -16.74 46.38 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.236 -0.585 . . . . 0.93000000000000005 111.779 -178.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.601 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.6 mt -91.69 138.41 31.59 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.807 -0.357 . . . . 0.96999999999999997 110.308 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.54 13.98 10.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.315 -0.402 . . . . 1.3400000000000001 111.482 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 86.8 p -149.97 143.5 25.25 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.696 -0.402 . . . . 0.39000000000000001 111.03 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.721 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.87 -169.43 1.55 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.286 0.565 . . . . 0.41999999999999998 110.808 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.721 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.4 t -151.77 125.89 9.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.375 -0.83 . . . . 0.39000000000000001 109.908 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.4 mt -114.74 123.27 70.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.424 -0.51 . . . . 0.73999999999999999 111.257 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.59 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 21.5 mtmt -126.48 163.33 23.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.88 -0.6 . . . . 2.48 110.464 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.473 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.14 18.99 59.84 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.77 -0.932 . . . . 0.5 110.77 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.7 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.6 mt -79.05 157.35 28.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.043 0.449 . . . . 0.57999999999999996 111.408 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.846 ' O ' HG12 ' A' ' 67' ' ' VAL . 6.6 mttp -99.54 133.95 21.51 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.666 -0.697 . . . . 2.79 110.412 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.575 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.92 143.66 61.53 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.495 2.13 . . . . 0.87 111.945 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.78 25.47 75.52 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.161 -0.776 . . . . 0.64000000000000001 111.161 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.846 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.04 158.84 39.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.655 0.264 . . . . 0.82999999999999996 110.51 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.23 139.89 42.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.916 0.388 . . . . 0.5 110.516 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.654 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.6 136.41 54.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.959 -0.564 . . . . 0.53000000000000003 110.799 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.88 130.91 45.3 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.51 -0.922 . . . . 1.8700000000000001 108.51 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.36 153.79 16.63 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.298 -0.953 . . . . 0.28999999999999998 112.07 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.91 140.97 46.18 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.696 -0.483 . . . . 1.4299999999999999 109.696 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.78 118.96 34.49 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.456 -0.498 . . . . 0.32000000000000001 110.483 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.735 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.5 129.02 68.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.334 -0.394 . . . . 0.79000000000000004 110.645 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.707 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.82 120.84 43.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.326 -0.397 . . . . 1.02 110.766 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.852 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.6 146.47 11.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.144 0.497 . . . . 0.62 110.985 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.822 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.0 153.88 21.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.575 -0.738 . . . . 2.4399999999999999 109.902 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.18 88.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.901 0.382 . . . . 3.6899999999999999 110.427 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.62 0.21 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.8 -0.636 . . . . 6.0800000000000001 110.56 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.34 3.29 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.406 -0.678 . . . . 1.22 111.406 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.466 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.38 177.39 9.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.132 0.492 . . . . 2.8799999999999999 111.652 -179.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.12 149.5 32.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.504 -0.771 . . . . 1.47 110.421 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.17 144.65 38.67 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.402 -0.363 . . . . 2.7000000000000002 110.623 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.735 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.0 135.96 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.997 0.427 . . . . 0.46000000000000002 111.568 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.0 141.35 52.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.667 -0.697 . . . . 0.34999999999999998 110.289 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.462 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.65 138.8 51.73 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.089 0.471 . . . . 3.6699999999999999 111.529 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.17 164.22 37.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.553 -0.749 . . . . 0.67000000000000004 109.556 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.573 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.3 151.48 38.4 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.432 -0.507 . . . . 1.47 111.004 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.805 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.15 172.75 12.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.714 -0.676 . . . . 0.44 111.024 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.69 160.71 21.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.454 -0.794 . . . . 1.3700000000000001 109.849 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 1.075 HG23 HE22 ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.43 121.89 22.91 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.575 -0.45 . . . . 1.28 110.778 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.634 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.8 p -127.62 165.52 19.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 1.97 111.415 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 N--CA 1.462 0.141 0 N-CA-C 109.617 -0.512 . . . . 3.2799999999999998 109.617 179.018 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.9 p . . . . . 0 CA--C 1.522 -0.097 0 CA-C-O 120.866 0.365 . . . . 0.66000000000000003 110.546 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.437 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.91 167.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.873 -0.603 . . . . 0.68999999999999995 110.916 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.61 145.56 50.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.674 -0.693 . . . . 0.52000000000000002 110.138 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.21 101.63 9.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.086 -0.709 . . . . 0.32000000000000001 109.086 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.7 t -112.93 139.64 36.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.033 -0.531 . . . . 0.28999999999999998 111.076 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 p -128.71 152.54 48.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.669 -0.696 . . . . 0.25 109.869 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.591 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.71 -164.93 2.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.688 -0.405 . . . . 0.31 110.716 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -124.01 127.19 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.48999999999999999 110.83 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.175 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.94 58.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.059 -0.519 . . . . 1.53 110.388 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.16 24.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.876 -0.602 . . . . 0.96999999999999997 111.507 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.175 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.18 128.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.618 -0.433 . . . . 1.5600000000000001 110.921 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -86.53 -9.51 56.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.942 -0.572 . . . . 1.8799999999999999 110.339 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.18 0.34 55.47 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.045 -0.525 . . . . 1.04 110.444 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.23 137.23 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.847 -0.615 . . . . 0.23999999999999999 109.93 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.612 ' N ' ' O ' ' A' ' 185' ' ' ILE . 87.2 p -96.34 -15.4 21.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.324 0.583 . . . . 0.28999999999999998 110.068 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.56 175.54 45.73 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 109.836 -1.306 . . . . 0.13 109.836 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.44 151.61 42.5 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.637 -0.425 . . . . 0.17000000000000001 110.488 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.614 ' NH1' ' OE1' ' A' ' 191' ' ' GLN . 55.9 ttp180 -132.36 121.2 23.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.141 -0.481 . . . . 1.29 109.92 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.555 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.16 136.62 38.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.753 -0.658 . . . . 0.25 110.652 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 22.4 tp10 -129.35 129.93 45.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.981 -0.554 . . . . 1.3200000000000001 109.974 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.623 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.75 135.35 34.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.993 -0.549 . . . . 0.56999999999999995 110.507 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.422 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.38 161.37 39.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.721 -0.672 . . . . 1.1599999999999999 109.666 179.778 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.952 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.06 124.88 25.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.946 0.403 . . . . 0.38 110.772 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.7 p -71.75 -7.78 50.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.75 -0.659 . . . . 0.40999999999999998 110.853 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -109.8 -69.76 0.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.318 -0.401 . . . . 1.6599999999999999 111.394 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.439 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.5 mt-10 -60.65 -35.32 75.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.033 -0.531 . . . . 1.6599999999999999 111.441 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.091 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.16 7.32 88.53 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.785 -0.926 . . . . 1.1699999999999999 110.785 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.334 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.4 t0 -28.15 -171.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.807 0.337 . . . . 1.8600000000000001 110.266 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.334 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.15 45.23 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-O 120.918 0.389 . . . . 1.98 110.139 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.422 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.1 Cg_endo -70.98 145.81 51.07 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 C-N-CA 122.717 2.278 . . . . 0.55000000000000004 112.318 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.83 145.83 42.51 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.243 -0.651 . . . . 1.1399999999999999 109.243 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.575 ' CE1' ' HD3' ' A' ' 65' ' ' PRO . 27.5 p90 -123.37 141.32 52.11 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.372 -0.531 . . . . 0.93000000000000005 111.514 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.11 127.62 43.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.318 -0.855 . . . . 0.34000000000000002 108.994 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.549 ' HB3' ' ND2' ' A' ' 16' ' ' ASN . 37.6 p-10 -101.55 131.14 47.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.08 0.467 . . . . 1.0900000000000001 111.771 -178.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.94 157.51 73.57 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.376 -0.829 . . . . 0.19 109.58 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.74 157.94 58.69 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 122.429 2.086 . . . . 0.17999999999999999 112.269 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.26 -12.14 5.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.776 -0.647 . . . . 0.20999999999999999 110.682 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.0 p -92.87 -8.7 42.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.28999999999999998 110.711 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.11 135.31 34.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.284 -0.416 . . . . 0.5 110.394 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.1 p -133.12 16.7 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 0.29999999999999999 110.502 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.8 p -167.52 147.11 5.09 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.602 -0.518 . . . . 0.23000000000000001 109.602 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.555 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.18 150.38 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.476 -0.489 . . . . 0.28000000000000003 111.589 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.509 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.22 124.94 50.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.63 -0.714 . . . . 1.0700000000000001 109.792 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.44 104.91 30.02 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.917 0.389 . . . . 0.28999999999999998 111.112 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -90.97 -179.47 1.5 Allowed 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 123.18 2.586 . . . . 0.42999999999999999 112.23 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.64 32.67 18.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.395 -0.821 . . . . 1.26 111.387 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.9 mt -86.39 148.56 25.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.79 0.328 . . . . 0.32000000000000001 110.489 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.769 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.4 114.77 61.01 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.978 0.418 . . . . 0.57999999999999996 110.595 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -58.92 140.52 95.62 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.823 2.348 . . . . 0.66000000000000003 112.06 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.15 21.18 74.15 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.061 -0.815 . . . . 0.28999999999999998 111.061 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.439 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.88 150.15 49.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.808 0.337 . . . . 2.3300000000000001 110.691 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.15 131.65 45.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.117 -0.492 . . . . 0.85999999999999999 109.772 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.952 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.5 m-85 -120.45 148.27 44.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.172 -0.467 . . . . 0.52000000000000002 111.09 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.2 mt -105.35 125.28 60.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.342 -0.985 . . . . 0.29999999999999999 108.342 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.43 132.51 63.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.096 0.474 . . . . 0.23000000000000001 111.353 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.47 122.44 20.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.523 -0.762 . . . . 0.35999999999999999 109.651 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.591 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.98 125.39 54.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.333 -0.394 . . . . 0.19 110.651 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.19 137.9 52.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.017 -0.538 . . . . 0.29999999999999999 109.888 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.58 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.65 134.98 42.81 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.758 -0.83 . . . . 0.37 108.758 178.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.612 ' O ' ' N ' ' A' ' 140' ' ' SER . 65.3 mt -99.08 123.08 51.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.214 0.53 . . . . 0.26000000000000001 110.927 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.7 p -83.99 169.73 14.69 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.498 -0.773 . . . . 0.28000000000000003 110.362 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -59.82 -14.47 15.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.978 -0.555 . . . . 1.6000000000000001 110.966 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.2 m-20 -96.05 -4.32 43.22 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.837 -0.345 . . . . 1.1799999999999999 110.856 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.79 13.95 63.9 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.359 -0.696 . . . . 0.29999999999999999 111.359 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -84.78 139.06 32.22 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.01 -0.276 . . . . 1.22 110.437 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.614 ' OE1' ' NH1' ' A' ' 143' ' ' ARG . 6.9 pt20 -106.7 141.06 38.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.893 0.378 . . . . 0.97999999999999998 110.532 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.2 m -136.78 127.05 26.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.113 -0.494 . . . . 0.82999999999999996 110.39 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.2 tp -68.15 117.28 9.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.294 -0.412 . . . . 0.26000000000000001 110.527 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 43.9 pt -108.97 -21.87 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.29999999999999999 110.724 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.87 125.81 5.91 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.457 -0.497 . . . . 0.31 111.468 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.46 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.71 120.21 21.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.75 -0.659 . . . . 0.28000000000000003 109.56 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.7 29.11 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.6 -0.44 . . . . 0.23999999999999999 110.892 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.45 158.54 18.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.23000000000000001 110.472 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.07 157.88 43.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.133 -0.485 . . . . 0.67000000000000004 110.649 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.21 104.35 9.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.703 -0.681 . . . . 0.64000000000000001 110.05 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.2 p . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.866 -1.064 . . . . 1.26 110.669 -179.682 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.5 m . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.179 -0.675 . . . . 3.4399999999999999 109.179 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.32 150.7 18.54 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.05 -0.82 . . . . 1.22 111.05 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -35.57 142.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.076 0 C-N-CA 124.004 3.136 . . . . 0.75 113.815 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.61 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -80.02 173.52 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.256 -1.338 . . . . 0.79000000000000004 108.846 178.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.61 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.6 125.88 51.49 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.453 -0.499 . . . . 1.9399999999999999 111.352 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 144.02 33.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.678 -0.692 . . . . 0.59999999999999998 110.726 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.0 168.32 25.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.895 0.379 . . . . 3.1400000000000001 111.149 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.746 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.6 mt -109.06 131.12 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.993 -0.549 . . . . 3.23 110.076 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.2 162.33 35.74 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.862 0.363 . . . . 3.6299999999999999 111.159 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 71.7 tt0 36.0 31.68 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 109.652 -0.499 . . . . 6.0800000000000001 109.652 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.746 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.53 69.61 33.55 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.916 -0.584 . . . . 3.3799999999999999 111.493 -178.735 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.38 -29.03 71.83 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.474 2.116 . . . . 3.9300000000000002 111.832 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.6 125.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 3.3599999999999999 110.433 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.697 ' O ' ' O ' ' A' ' 92' ' ' THR . 14.2 mm-40 -123.89 158.4 60.11 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.256 -0.429 . . . . 3.6099999999999999 110.434 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.577 ' HG3' HE22 ' A' ' 191' ' ' GLN . 96.3 Cg_endo -81.99 -64.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.895 2.396 . . . . 1.51 113.534 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.591 HD22 ' CG ' ' A' ' 159' ' ' ASP . 43.2 p-10 -108.38 -19.56 13.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.3 -0.409 . . . . 2.6800000000000002 112.048 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 3.5 m -107.44 152.13 24.61 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.428 -0.509 . . . . 1.21 111.314 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.58 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.0 t-80 -155.32 102.92 2.22 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.608 -0.724 . . . . 1.5600000000000001 110.674 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.68 145.67 13.02 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.823 2.349 . . . . 0.81000000000000005 112.627 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.93 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.78 168.0 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.867 -0.606 . . . . 1.52 109.874 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.23 148.02 29.1 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.688 -0.486 . . . . 2.1400000000000001 109.688 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.59 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.34 157.34 44.9 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.615 -0.434 . . . . 0.32000000000000001 111.187 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.503 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.09 155.31 44.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.789 -0.641 . . . . 2.1699999999999999 110.163 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.841 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.62 173.02 6.38 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 121.112 0.482 . . . . 0.58999999999999997 110.741 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.841 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.68 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.913 2.408 . . . . 0.90000000000000002 111.502 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.485 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.07 -51.01 0.69 Allowed Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.719 -0.392 . . . . 3.3399999999999999 110.165 179.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.626 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.85 152.38 82.39 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.757 2.305 . . . . 1.8500000000000001 111.404 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.77 42.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.363 0.601 . . . . 2.54 110.517 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.82 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.62 -41.72 98.25 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.006 -0.997 . . . . 2.5299999999999998 110.634 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.5 mt -109.8 137.85 40.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.741 -0.663 . . . . 1.1699999999999999 111.287 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.93 -72.92 0.7 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.061 -0.518 . . . . 1.27 111.897 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.37 24.44 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.618 0.599 . . . . 1.1200000000000001 112.618 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.87 124.92 45.25 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.331 -0.618 . . . . 0.41999999999999998 109.331 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.11 134.77 60.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.624 -0.43 . . . . 0.78000000000000003 110.551 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.93 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.09 128.57 53.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.064 0.459 . . . . 0.62 111.244 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.04 138.96 49.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.75 -0.659 . . . . 1.97 110.175 179.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.435 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.11 163.23 34.93 Favored 'General case' 0 CA--C 1.523 -0.067 0 CA-C-O 121.194 0.521 . . . . 0.34999999999999998 112.052 -178.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.487 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.52 139.54 7.81 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 115.389 -0.823 . . . . 1.8 110.494 178.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.47 115.49 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.286 1.991 . . . . 0.57999999999999996 111.856 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.681 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.04 81.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.803 -0.443 . . . . 3.04 109.803 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.65 0.06 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.971 -0.559 . . . . 2.4700000000000002 111.942 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 p -157.66 157.72 34.11 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.744 -0.383 . . . . 2.5099999999999998 110.538 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.26 27.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.224 -0.444 . . . . 1.8600000000000001 110.181 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.91 -75.9 1.31 Allowed Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.133 -0.556 . . . . 1.4399999999999999 111.8 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.79 152.24 35.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.895 0.378 . . . . 4.6900000000000004 110.995 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.667 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.21 -169.14 2.54 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.132 -0.486 . . . . 1.4299999999999999 111.882 179.337 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.58 29.86 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.462 0.649 . . . . 1.74 112.594 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.99 156.37 46.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.794 -1.094 . . . . 1.9199999999999999 110.316 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.09 158.44 41.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.988 -0.551 . . . . 0.34000000000000002 111.87 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.7 m -115.21 135.66 53.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.511 -0.768 . . . . 0.40999999999999998 109.832 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.59 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.31 121.91 23.87 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.403 -0.362 . . . . 0.55000000000000004 111.554 -179.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.2 Cg_exo -46.39 151.74 1.67 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.636 2.224 . . . . 0.44 112.156 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.85 -23.11 63.03 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 116.029 -0.532 . . . . 0.73999999999999999 112.794 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.537 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.76 -16.89 46.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.375 0.587 . . . . 0.93000000000000005 111.84 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.603 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.53 138.39 31.61 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.803 -0.359 . . . . 0.96999999999999997 110.323 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.5 13.86 11.01 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.406 -0.361 . . . . 1.3400000000000001 111.554 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.476 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.96 143.46 25.24 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.659 -0.416 . . . . 0.39000000000000001 111.057 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.713 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.8 -169.37 1.53 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.019 -0.537 . . . . 0.41999999999999998 110.895 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.713 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.0 t -151.77 125.8 9.19 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.366 -0.834 . . . . 0.39000000000000001 109.853 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.511 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.8 mt -114.8 123.4 70.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.28 -0.568 . . . . 0.73999999999999999 111.156 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -126.53 163.4 23.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.831 -0.622 . . . . 2.48 110.423 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.14 18.92 59.98 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.757 -0.937 . . . . 0.5 110.757 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.511 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.0 mt -79.03 157.18 28.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.039 0.447 . . . . 0.57999999999999996 111.314 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.855 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.1 mttm -99.38 133.9 21.63 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.627 -0.715 . . . . 2.79 110.51 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.95 143.58 61.01 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.5 2.133 . . . . 0.87 111.95 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.86 25.7 75.25 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.049 -0.821 . . . . 0.64000000000000001 111.049 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.855 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.2 158.78 40.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.649 0.262 . . . . 0.82999999999999996 110.468 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.2 139.95 42.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.915 0.388 . . . . 0.5 110.579 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.666 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.3 m-85 -122.56 136.42 54.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.936 -0.575 . . . . 0.53000000000000003 110.81 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.487 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.93 131.03 45.32 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.516 -0.92 . . . . 1.8700000000000001 108.516 177.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.46 153.93 16.64 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.2 -1.0 . . . . 0.28999999999999998 111.97 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.98 140.99 46.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.708 -0.478 . . . . 1.4299999999999999 109.708 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.83 118.87 34.22 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.47 -0.492 . . . . 0.32000000000000001 110.523 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.731 HG12 HG23 ' A' ' 84' ' ' VAL . 64.4 mt -112.44 129.14 68.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.289 -0.414 . . . . 0.79000000000000004 110.578 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.7 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.85 120.89 43.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.256 -0.429 . . . . 1.02 110.685 -179.7 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.862 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.59 146.53 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.169 0.509 . . . . 0.62 111.018 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.82 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.08 153.87 21.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.519 -0.764 . . . . 2.4399999999999999 109.935 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.11 88.53 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.909 0.385 . . . . 3.6899999999999999 110.386 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.622 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.67 0.21 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.822 -0.626 . . . . 6.0800000000000001 110.532 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.12 -117.33 3.28 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.394 -0.682 . . . . 1.22 111.394 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.469 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.38 177.41 8.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.165 0.507 . . . . 2.8799999999999999 111.646 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.24 149.55 32.1 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.446 -0.797 . . . . 1.47 110.413 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.14 144.63 38.71 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.444 -0.344 . . . . 2.7000000000000002 110.599 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.731 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.97 135.91 61.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 120.69 -0.404 . . . . 0.46000000000000002 111.607 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.0 141.36 52.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.755 -0.657 . . . . 0.34999999999999998 110.325 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.458 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.73 138.91 51.71 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.181 0.515 . . . . 3.6699999999999999 111.478 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.29 164.1 38.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.47 -0.787 . . . . 0.67000000000000004 109.539 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.563 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.23 151.64 38.72 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.412 -0.515 . . . . 1.47 111.005 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.807 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.3 p90 -146.23 172.74 13.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.688 -0.687 . . . . 0.44 111.092 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.77 160.68 21.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.492 -0.777 . . . . 1.3700000000000001 109.887 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.36 121.96 23.1 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.559 -0.456 . . . . 1.28 110.761 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.697 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -130.99 -145.26 0.27 Allowed 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 121.941 0.877 . . . . 1.97 111.478 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.9 p . . . . . 0 CA--C 1.537 0.465 0 CA-C-N 114.191 -1.368 . . . . 3.2799999999999998 107.897 177.8 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 122.746 1.26 . . . . 0.66000000000000003 107.853 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.447 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.78 167.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.005 -1.452 . . . . 0.68999999999999995 111.022 -178.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.6 145.54 50.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.765 -0.652 . . . . 0.52000000000000002 110.14 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.22 101.59 9.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.099 -0.704 . . . . 0.32000000000000001 109.099 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.6 t -112.94 139.7 36.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.071 -0.513 . . . . 0.28999999999999998 111.052 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.3 p -128.62 152.58 48.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.642 -0.708 . . . . 0.25 109.842 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.586 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.4 p90 -144.78 -164.89 2.02 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.736 -0.386 . . . . 0.31 110.708 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.741 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -123.99 127.2 73.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.256 -0.429 . . . . 0.48999999999999999 110.833 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.161 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.99 58.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.075 -0.512 . . . . 1.53 110.332 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.741 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.12 24.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.88 -0.6 . . . . 0.96999999999999997 111.481 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.161 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.2 128.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.619 -0.433 . . . . 1.5600000000000001 110.891 179.782 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.38 -9.7 55.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.896 -0.593 . . . . 1.8799999999999999 110.325 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.07 0.31 55.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.058 -0.519 . . . . 1.04 110.39 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.34 137.17 25.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.919 -0.582 . . . . 0.23999999999999999 109.955 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 185' ' ' ILE . 1.8 m -96.15 -15.51 22.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.313 0.578 . . . . 0.28999999999999998 110.044 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.642 ' H ' HG12 ' A' ' 185' ' ' ILE . . . 178.62 175.63 45.85 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.846 -1.301 . . . . 0.13 109.846 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -123.4 151.57 42.47 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.705 -0.398 . . . . 0.17000000000000001 110.504 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.895 HH21 ' N ' ' A' ' 159' ' ' ASP . 1.5 tpm_? -132.39 121.25 23.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.111 -0.495 . . . . 1.29 109.878 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.559 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.06 136.56 38.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.654 -0.703 . . . . 0.25 110.649 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 85.3 tt0 -129.37 129.9 45.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.016 -0.538 . . . . 1.3200000000000001 110.0 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.613 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.66 135.31 34.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.928 -0.578 . . . . 0.56999999999999995 110.632 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.415 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.29 161.37 39.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.758 -0.655 . . . . 1.1599999999999999 109.688 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.959 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.06 124.87 25.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.981 0.419 . . . . 0.38 110.72 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.485 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.84 -7.67 49.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.759 -0.655 . . . . 0.40999999999999998 110.886 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.79 -69.74 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 1.6599999999999999 111.429 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.44 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.59 -35.39 75.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.083 -0.508 . . . . 1.6599999999999999 111.441 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.092 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.15 7.24 88.59 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.776 -0.929 . . . . 1.1699999999999999 110.776 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.308 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.4 t0 -27.94 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.759 0.314 . . . . 1.8600000000000001 110.246 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.308 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.32 139.03 44.92 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.947 0.403 . . . . 1.98 110.14 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.415 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.7 Cg_endo -70.78 145.86 52.37 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 C-N-CA 122.751 2.301 . . . . 0.55000000000000004 112.327 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.88 145.69 42.66 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.223 -0.658 . . . . 1.1399999999999999 109.223 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 143' ' ' ARG . 83.5 m-85 -123.28 141.34 52.09 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.354 -0.539 . . . . 0.93000000000000005 111.54 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.67 ' C ' HH21 ' A' ' 143' ' ' ARG . 70.8 mt -128.09 127.7 43.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.298 -0.865 . . . . 0.34000000000000002 108.935 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.895 ' N ' HH21 ' A' ' 143' ' ' ARG . 55.9 t0 -101.68 131.16 48.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.258 0.551 . . . . 1.0900000000000001 111.661 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.94 157.55 73.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.333 -0.849 . . . . 0.19 109.636 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -69.81 158.02 58.29 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.394 2.063 . . . . 0.17999999999999999 112.238 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.28 -12.12 5.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.806 -0.634 . . . . 0.20999999999999999 110.76 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.8 p -92.8 -8.82 42.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.124 -0.489 . . . . 0.28999999999999998 110.687 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.21 135.31 34.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.383 . . . . 0.5 110.338 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.5 p -133.09 16.75 4.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 0.29999999999999999 110.502 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.9 p -167.64 147.06 4.97 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.627 -0.508 . . . . 0.23000000000000001 109.627 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.559 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.19 150.45 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.398 -0.521 . . . . 0.28000000000000003 111.51 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.28 124.96 50.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.626 -0.716 . . . . 1.0700000000000001 109.81 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.41 104.89 29.78 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.403 -0.362 . . . . 0.28999999999999998 111.094 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.4 Cg_endo -90.98 -179.49 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 123.158 2.572 . . . . 0.42999999999999999 112.198 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.75 32.61 18.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.435 -0.802 . . . . 1.26 111.359 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.428 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.1 mt -86.31 148.5 25.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.54 -0.3 . . . . 0.32000000000000001 110.487 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.764 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.5 mt -88.29 114.8 61.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.986 0.422 . . . . 0.57999999999999996 110.636 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.95 140.51 95.61 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.98 2.453 . . . . 0.66000000000000003 111.93 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.03 21.32 74.18 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.025 -0.83 . . . . 0.28999999999999998 111.025 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.44 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.86 150.21 49.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.864 0.364 . . . . 2.3300000000000001 110.589 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.485 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.2 131.65 46.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.993 -0.549 . . . . 0.85999999999999999 109.801 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.959 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.5 m-85 -120.5 148.37 43.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.069 -0.514 . . . . 0.52000000000000002 110.999 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.39 125.27 60.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.243 -1.021 . . . . 0.29999999999999999 108.243 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.49 132.59 63.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.211 0.529 . . . . 0.23000000000000001 111.227 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.59 20.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.526 -0.761 . . . . 0.35999999999999999 109.622 179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.586 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -101.07 125.38 55.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.293 -0.412 . . . . 0.19 110.711 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.8 m-85 -117.21 137.92 52.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.967 -0.56 . . . . 0.29999999999999999 109.866 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.582 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.78 135.07 42.8 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.763 -0.829 . . . . 0.37 108.763 178.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.642 HG12 ' H ' ' A' ' 141' ' ' GLY . 0.8 OUTLIER -99.08 122.89 51.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.175 0.512 . . . . 0.26000000000000001 110.938 -178.718 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.6 p -83.84 169.66 14.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.586 -0.734 . . . . 0.28000000000000003 110.408 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.414 ' O ' ' HB ' ' A' ' 59' ' ' THR . 97.0 mt-10 -59.72 -14.52 14.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.959 -0.564 . . . . 1.6000000000000001 111.023 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -96.12 -4.27 43.07 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.779 -0.368 . . . . 1.1799999999999999 110.793 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.84 13.92 63.86 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.346 -0.702 . . . . 0.29999999999999999 111.346 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -84.59 139.09 32.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.574 0.225 . . . . 1.22 110.433 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.577 HE22 ' HG3' ' A' ' 15' ' ' PRO . 83.8 mt-30 -106.82 141.08 38.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.373 . . . . 0.97999999999999998 110.545 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.8 m -136.74 127.03 26.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.093 -0.503 . . . . 0.82999999999999996 110.374 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.07 117.3 9.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.26000000000000001 110.53 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.07 -21.75 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.29999999999999999 110.7 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.92 125.7 5.84 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.489 -0.484 . . . . 0.31 111.514 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.47 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.68 120.2 21.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.685 -0.689 . . . . 0.28000000000000003 109.563 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.6 151.68 29.13 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.692 -0.403 . . . . 0.23999999999999999 110.943 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.43 158.59 18.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 0.23000000000000001 110.409 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.1 157.91 43.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.099 -0.501 . . . . 0.67000000000000004 110.66 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.37 9.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.732 -0.667 . . . . 0.64000000000000001 109.995 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.5 p . . . . . 0 C--O 1.218 -0.555 0 CA-C-O 117.949 -1.024 . . . . 1.26 110.531 -179.673 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.8 m . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.253 -0.647 . . . . 3.4399999999999999 109.253 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.36 150.69 18.54 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.986 -0.846 . . . . 1.22 110.986 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -35.67 142.39 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 123.953 3.102 . . . . 0.75 113.789 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -80.0 173.38 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.282 -1.326 . . . . 0.79000000000000004 108.9 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.608 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.59 125.88 51.49 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.395 -0.522 . . . . 1.9399999999999999 111.413 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.46 144.03 33.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.63 -0.714 . . . . 0.59999999999999998 110.686 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.02 168.36 25.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.947 0.403 . . . . 3.1400000000000001 111.117 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.745 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.08 130.94 61.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.983 -0.553 . . . . 3.23 110.013 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.5 p -141.03 162.3 35.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.85 0.357 . . . . 3.6299999999999999 111.226 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 9' ' ' THR . 70.6 tt0 36.13 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.624 -0.509 . . . . 6.0800000000000001 109.624 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.745 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.57 33.07 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.968 -0.56 . . . . 3.3799999999999999 111.637 -178.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.22 -29.12 73.32 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.453 2.102 . . . . 3.9300000000000002 111.872 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 3.3599999999999999 110.422 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 17' ' ' SER . 3.3 mp0 -123.86 158.4 60.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 3.6099999999999999 110.438 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.586 ' N ' ' OG ' ' A' ' 93' ' ' SER . 98.1 Cg_endo -82.13 -64.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.81 2.34 . . . . 1.51 113.592 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.521 ' ND2' ' HB2' ' A' ' 157' ' ' TYR . 72.8 m-20 -108.47 -19.47 13.44 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.107 0.41 . . . . 2.6800000000000002 112.107 -178.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 4.9 p -107.47 152.05 24.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.18 0.514 . . . . 1.21 111.277 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.26 102.89 2.23 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.622 -0.717 . . . . 1.5600000000000001 110.637 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.535 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.7 Cg_endo -82.71 145.66 12.97 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.851 2.368 . . . . 0.81000000000000005 112.595 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.916 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.83 167.99 24.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.833 -0.621 . . . . 1.52 109.864 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -149.17 147.88 28.98 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.781 -0.451 . . . . 2.1400000000000001 109.781 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.583 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.27 157.32 44.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.078 0.466 . . . . 0.32000000000000001 111.177 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.502 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.09 155.23 44.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.766 -0.652 . . . . 2.1699999999999999 110.033 179.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.838 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.58 173.1 6.28 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.037 -0.529 . . . . 0.58999999999999997 110.747 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.838 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.66 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.858 2.372 . . . . 0.90000000000000002 111.548 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.483 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.05 -51.11 0.69 Allowed Pre-proline 0 C--N 1.33 -0.271 0 C-N-CA 120.687 -0.405 . . . . 3.3399999999999999 110.01 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.643 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.4 Cg_exo -64.77 152.35 82.36 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.751 2.301 . . . . 1.8500000000000001 111.484 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.77 42.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.363 0.602 . . . . 2.54 110.581 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.82 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.69 -41.69 98.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.969 -1.014 . . . . 2.5299999999999998 110.55 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.3 mt -109.82 137.91 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.846 -0.615 . . . . 1.1699999999999999 111.258 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.06 -72.96 0.7 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.978 -0.555 . . . . 1.27 111.828 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.19 148.31 24.45 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.583 0.586 . . . . 1.1200000000000001 112.583 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.82 124.92 45.31 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.302 -0.629 . . . . 0.41999999999999998 109.302 177.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 49' ' ' ALA . 72.0 mt -118.09 134.83 60.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.616 -0.434 . . . . 0.78000000000000003 110.604 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.916 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.08 128.56 53.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.62 111.243 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.54 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.11 139.07 49.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.757 -0.656 . . . . 1.97 110.064 179.006 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.437 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.18 163.1 35.41 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 121.176 0.512 . . . . 0.34999999999999998 112.014 -178.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.42 139.62 7.93 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.448 -0.796 . . . . 1.8 110.449 178.852 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.696 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.55 115.5 3.08 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.251 1.968 . . . . 0.57999999999999996 111.85 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.673 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.95 81.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.908 -0.405 . . . . 3.04 109.908 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.696 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.2 -20.73 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.034 -0.53 . . . . 2.4700000000000002 112.03 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.6 p -157.6 157.74 34.24 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.879 -0.328 . . . . 2.5099999999999998 110.599 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.8 m -120.37 27.83 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 1.8600000000000001 110.207 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.83 -75.9 1.31 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.121 -0.562 . . . . 1.4399999999999999 111.886 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.83 152.29 35.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.073 0.463 . . . . 4.6900000000000004 110.919 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.2 -169.14 2.54 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.991 -0.55 . . . . 1.4299999999999999 111.997 179.292 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.09 149.61 29.78 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-O 121.431 0.634 . . . . 1.74 112.684 -177.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.96 156.52 46.05 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 114.809 -1.087 . . . . 1.9199999999999999 110.302 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.2 158.43 41.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.872 -0.604 . . . . 0.34000000000000002 111.785 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.7 m -115.25 135.55 54.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.517 -0.765 . . . . 0.40999999999999998 109.755 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.583 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.4 121.97 23.78 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.433 -0.348 . . . . 0.55000000000000004 111.584 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.593 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.4 Cg_exo -46.28 151.72 1.6 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.73 2.287 . . . . 0.44 112.12 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.93 -23.02 63.09 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 116.055 -0.521 . . . . 0.73999999999999999 112.785 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.77 -16.89 46.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.407 0.604 . . . . 0.93000000000000005 111.803 -178.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.593 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.2 mt -91.57 138.41 31.59 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.841 -0.344 . . . . 0.96999999999999997 110.348 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.58 13.91 10.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.364 -0.38 . . . . 1.3400000000000001 111.544 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -149.98 143.46 25.22 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.714 -0.394 . . . . 0.39000000000000001 111.003 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.724 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.8 -169.37 1.53 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.071 -0.513 . . . . 0.41999999999999998 110.942 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.724 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 t -151.81 125.86 9.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.443 -0.799 . . . . 0.39000000000000001 109.816 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.519 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.86 123.4 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.312 -0.555 . . . . 0.73999999999999999 111.195 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.694 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 63.1 pttt -126.63 163.37 23.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.782 -0.644 . . . . 2.48 110.402 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.12 19.03 59.8 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.733 -0.947 . . . . 0.5 110.733 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.519 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.3 mt -78.97 157.18 28.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.045 0.45 . . . . 0.57999999999999996 111.378 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.844 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -99.48 133.87 21.6 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.62 -0.718 . . . . 2.79 110.486 179.737 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.8 143.5 61.54 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.594 2.196 . . . . 0.87 111.988 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.93 25.59 75.4 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.034 -0.826 . . . . 0.64000000000000001 111.034 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.18 158.74 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.73 0.3 . . . . 0.82999999999999996 110.409 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.12 139.97 41.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.926 0.394 . . . . 0.5 110.522 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.647 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.8 m-85 -122.59 136.43 54.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.986 -0.552 . . . . 0.53000000000000003 110.757 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.91 131.01 45.31 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.463 -0.94 . . . . 1.8700000000000001 108.463 177.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.494 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.43 153.9 16.63 Favored Glycine 0 C--O 1.228 -0.269 0 C-N-CA 120.357 -0.925 . . . . 0.28999999999999998 111.968 -178.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.08 140.85 45.85 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.723 -0.473 . . . . 1.4299999999999999 109.723 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.2 tp -115.7 118.93 34.43 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.483 -0.487 . . . . 0.32000000000000001 110.573 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.732 HG12 HG23 ' A' ' 84' ' ' VAL . 64.2 mt -112.55 129.09 68.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.409 . . . . 0.79000000000000004 110.603 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.701 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.78 120.74 43.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.259 -0.428 . . . . 1.02 110.739 -179.599 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.855 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.58 146.5 11.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.098 0.475 . . . . 0.62 111.058 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.82 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.11 153.91 21.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.505 -0.771 . . . . 2.4399999999999999 109.835 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.18 88.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.928 0.395 . . . . 3.6899999999999999 110.381 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.622 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.859 -0.609 . . . . 6.0800000000000001 110.549 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.09 -117.36 3.29 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.43 -0.668 . . . . 1.22 111.43 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.459 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.29 177.41 9.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.182 0.515 . . . . 2.8799999999999999 111.638 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.27 149.5 31.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.466 -0.788 . . . . 1.47 110.425 179.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.21 144.67 38.61 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.482 -0.326 . . . . 2.7000000000000002 110.576 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.732 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.02 136.0 61.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 121.139 0.495 . . . . 0.46000000000000002 111.499 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.574 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.09 141.45 52.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.622 -0.717 . . . . 0.34999999999999998 110.248 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.457 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.75 138.91 51.72 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 120.492 -0.483 . . . . 3.6699999999999999 111.438 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.494 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.28 164.18 37.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.545 -0.752 . . . . 0.67000000000000004 109.521 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.27 151.54 38.52 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.327 -0.549 . . . . 1.47 111.009 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.797 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.2 172.75 12.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.743 -0.662 . . . . 0.44 111.033 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.77 160.7 21.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.459 -0.791 . . . . 1.3700000000000001 109.806 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.34 121.91 23.05 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.54 -0.464 . . . . 1.28 110.749 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.512 ' O ' ' OG ' ' A' ' 93' ' ' SER . 70.3 p -128.92 -114.48 0.26 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.392 0.886 . . . . 1.97 113.392 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.586 ' OG ' ' N ' ' A' ' 15' ' ' PRO . 48.0 p . . . . . 0 C--N 1.343 0.317 0 CA-C-N 114.956 -1.02 . . . . 3.2799999999999998 110.789 -178.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.3 p . . . . . 0 CA--C 1.521 -0.145 0 CA-C-O 121.422 0.629 . . . . 0.66000000000000003 109.672 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.439 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.77 167.57 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.427 -0.806 . . . . 0.68999999999999995 110.983 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.65 145.47 50.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.809 -0.632 . . . . 0.52000000000000002 110.133 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.19 101.44 9.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.165 -0.68 . . . . 0.32000000000000001 109.165 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.5 t -112.87 139.71 36.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.094 -0.503 . . . . 0.28999999999999998 111.09 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 p -128.69 152.59 48.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.59 -0.732 . . . . 0.25 109.75 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.585 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.84 -164.88 2.02 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.641 -0.423 . . . . 0.31 110.675 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -123.98 127.22 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.436 . . . . 0.48999999999999999 110.82 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.169 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -58.06 58.4 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.123 -0.49 . . . . 1.53 110.368 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.17 24.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.809 -0.632 . . . . 0.96999999999999997 111.437 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.169 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.14 128.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.646 -0.422 . . . . 1.5600000000000001 111.036 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.41 -9.59 56.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.935 -0.575 . . . . 1.8799999999999999 110.295 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.22 0.38 55.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 1.04 110.286 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.22 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.23999999999999999 109.938 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.694 ' O ' ' NZ ' ' A' ' 61' ' ' LYS . 70.5 m -96.24 -15.58 21.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.256 0.55 . . . . 0.28999999999999998 110.022 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.62 175.61 45.83 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 109.858 -1.297 . . . . 0.13 109.858 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.49 151.61 42.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.961 0.41 . . . . 0.17000000000000001 110.426 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.75 HH12 ' NE2' ' A' ' 191' ' ' GLN . 50.8 ttp180 -132.31 121.16 23.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.119 -0.491 . . . . 1.29 109.918 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.563 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.05 136.49 38.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.761 -0.654 . . . . 0.25 110.693 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.525 ' HG2' ' CD2' ' A' ' 157' ' ' TYR . 94.4 mt-10 -129.36 129.86 45.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.06 -0.518 . . . . 1.3200000000000001 110.056 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.613 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.67 135.27 34.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.987 -0.552 . . . . 0.56999999999999995 110.622 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.407 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.28 161.34 39.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.751 -0.659 . . . . 1.1599999999999999 109.665 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.967 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.5 mt -70.92 124.76 25.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.975 0.417 . . . . 0.38 110.735 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.486 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.7 p -71.71 -7.79 50.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.768 -0.651 . . . . 0.40999999999999998 110.833 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -109.81 -69.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.295 -0.411 . . . . 1.6599999999999999 111.332 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.429 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.64 -35.39 76.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.106 -0.497 . . . . 1.6599999999999999 111.469 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.074 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.1 7.23 88.59 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.853 -0.899 . . . . 1.1699999999999999 110.853 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.331 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.89 -171.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.753 0.311 . . . . 1.8600000000000001 110.365 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.331 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.23 139.11 45.24 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.965 0.412 . . . . 1.98 110.23 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.419 ' HG2' ' OH ' ' A' ' 157' ' ' TYR . 46.4 Cg_endo -70.94 145.76 51.17 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.762 2.308 . . . . 0.55000000000000004 112.332 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.77 145.76 42.52 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.24 -0.652 . . . . 1.1399999999999999 109.24 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.702 ' N ' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -123.37 141.3 52.13 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.312 -0.555 . . . . 0.93000000000000005 111.5 -179.048 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.3 mt -128.04 127.67 43.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.333 -0.848 . . . . 0.34000000000000002 109.016 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -101.73 131.21 48.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.15 0.5 . . . . 1.0900000000000001 111.708 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.94 157.64 73.15 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.273 -0.876 . . . . 0.19 109.54 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.9 157.99 58.27 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.376 2.051 . . . . 0.17999999999999999 112.282 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.3 -12.1 5.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 0.20999999999999999 110.743 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.1 p -92.83 -8.75 42.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.28999999999999998 110.722 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.15 135.33 34.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.406 . . . . 0.5 110.428 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 p -133.17 16.75 4.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.478 -0.328 . . . . 0.29999999999999999 110.506 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.9 p -167.57 147.09 5.05 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.598 -0.519 . . . . 0.23000000000000001 109.598 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.563 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.14 150.48 12.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.508 -0.477 . . . . 0.28000000000000003 111.589 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.501 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 124.97 50.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.596 -0.729 . . . . 1.0700000000000001 109.78 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.46 104.86 29.79 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.872 0.368 . . . . 0.28999999999999998 111.025 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.2 Cg_endo -90.96 -179.53 1.51 Allowed 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 123.216 2.611 . . . . 0.42999999999999999 112.203 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 61.7 32.66 18.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.374 -0.83 . . . . 1.26 111.403 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 172' ' ' LEU . 24.1 mt -86.42 148.52 25.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.444 -0.343 . . . . 0.32000000000000001 110.471 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.774 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.8 mt -88.28 114.96 61.75 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.06 0.457 . . . . 0.57999999999999996 110.677 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.14 140.6 95.71 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.824 2.349 . . . . 0.66000000000000003 112.026 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.23 74.23 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.046 -0.822 . . . . 0.28999999999999998 111.046 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.429 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.91 150.22 49.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.803 0.335 . . . . 2.3300000000000001 110.641 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.486 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.2 131.63 46.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.008 -0.542 . . . . 0.85999999999999999 109.756 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.967 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.2 m-85 -120.5 148.27 44.05 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.105 -0.498 . . . . 0.52000000000000002 111.062 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.7 mt -105.36 125.38 60.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.194 -1.039 . . . . 0.29999999999999999 108.194 177.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.54 132.52 63.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.172 0.511 . . . . 0.23000000000000001 111.3 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.47 122.62 20.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.549 -0.751 . . . . 0.35999999999999999 109.613 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.585 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.1 125.35 55.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.268 -0.424 . . . . 0.19 110.622 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.28 137.91 52.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.946 -0.57 . . . . 0.29999999999999999 109.84 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.58 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.63 135.07 42.65 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.745 -0.835 . . . . 0.37 108.745 178.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.573 ' O ' ' N ' ' A' ' 140' ' ' SER . 47.2 mm -99.1 122.93 51.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.155 0.502 . . . . 0.26000000000000001 110.969 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.5 p -83.91 169.59 14.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.591 -0.731 . . . . 0.28000000000000003 110.496 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -59.62 -14.56 14.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.046 -0.524 . . . . 1.6000000000000001 110.966 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.535 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.6 m-20 -96.13 -4.29 43.01 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.905 -0.318 . . . . 1.1799999999999999 110.749 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.86 13.78 64.06 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.389 -0.684 . . . . 0.29999999999999999 111.389 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -84.59 139.01 32.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.625 0.25 . . . . 1.22 110.415 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.75 ' NE2' HH12 ' A' ' 143' ' ' ARG . 3.3 mt-30 -106.68 141.15 38.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.339 . . . . 0.97999999999999998 110.565 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 61.9 m -136.72 127.04 26.49 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.216 -0.447 . . . . 0.82999999999999996 110.383 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.14 117.43 9.96 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.699 -0.401 . . . . 0.26000000000000001 110.519 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.1 -21.73 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.29999999999999999 110.767 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.98 125.72 5.81 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.422 -0.511 . . . . 0.31 111.448 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.475 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.69 120.2 21.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.787 -0.642 . . . . 0.28000000000000003 109.601 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.62 151.68 29.1 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.757 -0.377 . . . . 0.23999999999999999 110.916 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.5 158.56 18.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.002 -0.545 . . . . 0.23000000000000001 110.438 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.02 157.89 43.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.119 -0.491 . . . . 0.67000000000000004 110.609 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.29 104.39 9.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.779 -0.646 . . . . 0.64000000000000001 110.069 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.99 -1.005 . . . . 1.26 110.56 -179.578 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.208 -0.664 . . . . 3.4399999999999999 109.208 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.69 18.54 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.032 -0.827 . . . . 1.22 111.032 179.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -35.66 142.4 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.042 0 C-N-CA 123.97 3.113 . . . . 0.75 113.826 -179.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.0 t -79.98 173.33 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.308 -1.315 . . . . 0.79000000000000004 108.846 178.431 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.614 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.55 125.87 51.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.435 -0.506 . . . . 1.9399999999999999 111.393 -179.538 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 144.01 33.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.628 -0.715 . . . . 0.59999999999999998 110.564 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.98 168.4 25.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.319 -0.401 . . . . 3.1400000000000001 111.131 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.746 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -109.06 131.1 60.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.98 -0.554 . . . . 3.23 110.048 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.14 162.25 35.94 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.442 -0.345 . . . . 3.6299999999999999 111.284 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.4 mt-10 36.21 31.51 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.607 -0.516 . . . . 6.0800000000000001 109.607 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.746 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.58 32.55 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.019 -0.537 . . . . 3.3799999999999999 111.558 -178.737 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.637 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.29 -29.14 72.69 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.494 2.129 . . . . 3.9300000000000002 111.854 179.395 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.637 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.65 125.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.016 -0.538 . . . . 3.3599999999999999 110.502 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.613 ' NE2' ' N ' ' A' ' 14' ' ' GLN . 0.8 OUTLIER -123.91 158.33 60.43 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.368 -0.378 . . . . 3.6099999999999999 110.486 179.995 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.512 ' HG2' HE22 ' A' ' 191' ' ' GLN . 97.6 Cg_endo -82.11 -64.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.808 2.339 . . . . 1.51 113.446 -178.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.657 HD22 ' NZ ' ' A' ' 61' ' ' LYS . 52.9 t30 -108.42 -19.54 13.42 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.087 0.403 . . . . 2.6800000000000002 112.087 -178.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 27.2 m -107.33 152.07 24.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.214 0.531 . . . . 1.21 111.256 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.0 t-80 -155.22 102.91 2.24 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.705 -0.68 . . . . 1.5600000000000001 110.66 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.5 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.4 Cg_endo -82.6 145.59 13.12 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.882 2.388 . . . . 0.81000000000000005 112.676 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.933 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.77 167.99 24.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 1.52 109.982 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.14 147.95 29.07 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.75 -0.463 . . . . 2.1400000000000001 109.75 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.27 157.28 45.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.017 0.437 . . . . 0.32000000000000001 111.242 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.497 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.8 m-20 -127.96 155.3 44.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.786 -0.643 . . . . 2.1699999999999999 110.132 178.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.835 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.66 173.06 6.33 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 121.14 0.495 . . . . 0.58999999999999997 110.666 -179.214 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.835 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.66 173.88 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.882 2.388 . . . . 0.90000000000000002 111.506 179.338 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.06 -50.93 0.69 Allowed Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 120.717 -0.393 . . . . 3.3399999999999999 110.134 179.902 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.62 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.8 Cg_exo -64.96 152.43 82.35 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.697 2.264 . . . . 1.8500000000000001 111.451 179.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.77 42.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.385 0.612 . . . . 2.54 110.518 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.813 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.67 -41.68 98.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.02 -0.991 . . . . 2.5299999999999998 110.722 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.533 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.5 mt -109.78 137.86 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.723 -0.672 . . . . 1.1699999999999999 111.311 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.98 -72.82 0.71 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.013 -0.54 . . . . 1.27 111.92 -178.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.23 148.4 24.37 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.593 0.59 . . . . 1.1200000000000001 112.593 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.85 124.74 44.84 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.413 -0.588 . . . . 0.41999999999999998 109.413 177.514 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 mt -117.88 134.72 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.666 -0.414 . . . . 0.78000000000000003 110.701 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.933 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.02 128.55 53.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 0.62 111.228 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.15 138.99 49.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.708 -0.678 . . . . 1.97 110.11 178.974 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -144.99 163.23 34.83 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.152 0.501 . . . . 0.34999999999999998 112.066 -178.081 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.488 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.59 139.65 7.81 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.435 -0.802 . . . . 1.8 110.397 178.808 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.66 115.54 3.12 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.284 1.989 . . . . 0.57999999999999996 111.793 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.683 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.03 81.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.899 -0.408 . . . . 3.04 109.899 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.688 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.22 -20.54 0.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.969 -0.56 . . . . 2.4700000000000002 111.9 -179.526 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 p -157.65 157.69 34.05 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 120.855 -0.338 . . . . 2.5099999999999998 110.569 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.403 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.3 27.79 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.249 -0.432 . . . . 1.8600000000000001 110.223 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.79 -75.91 1.31 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.184 -0.531 . . . . 1.4399999999999999 111.831 -179.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.93 152.31 35.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.981 0.419 . . . . 4.6900000000000004 110.939 -179.285 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.669 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.2 -169.14 2.54 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.001 -0.545 . . . . 1.4299999999999999 111.873 179.415 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.6 mttp -110.13 149.66 29.74 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.48 0.657 . . . . 1.74 112.568 -177.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.01 156.42 46.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.757 -1.111 . . . . 1.9199999999999999 110.325 178.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.21 158.27 41.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.978 -0.555 . . . . 0.34000000000000002 111.788 -179.296 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.8 m -115.07 135.58 54.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.502 -0.772 . . . . 0.40999999999999998 109.889 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.596 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.33 121.96 23.86 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.422 -0.353 . . . . 0.55000000000000004 111.588 -179.171 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.607 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.3 Cg_exo -46.29 151.7 1.62 Allowed 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.706 2.271 . . . . 0.44 112.181 178.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.01 -23.02 63.28 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 116.133 -0.485 . . . . 0.73999999999999999 112.708 -179.107 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.78 -16.79 46.49 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.223 -0.591 . . . . 0.93000000000000005 111.854 -178.341 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.607 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.6 138.45 31.56 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.779 -0.368 . . . . 0.96999999999999997 110.321 179.338 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.54 13.79 10.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.433 -0.349 . . . . 1.3400000000000001 111.475 -179.285 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.477 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.91 143.56 25.35 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.591 -0.444 . . . . 0.39000000000000001 111.003 179.633 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.4 t80 -114.88 -169.41 1.54 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.127 0.489 . . . . 0.41999999999999998 110.904 -179.455 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.714 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.74 125.85 9.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.408 -0.815 . . . . 0.39000000000000001 109.805 179.288 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.515 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.77 123.21 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.415 -0.514 . . . . 0.73999999999999999 111.268 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.657 ' NZ ' HD22 ' A' ' 16' ' ' ASN . 50.4 tttp -126.5 163.4 23.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.884 -0.598 . . . . 2.48 110.431 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.648 ' H ' ' ND2' ' A' ' 16' ' ' ASN . . . 85.15 19.02 59.78 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.737 -0.945 . . . . 0.5 110.737 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.515 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.5 mt -79.09 157.18 28.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.077 0.465 . . . . 0.57999999999999996 111.327 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.844 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -99.41 134.05 21.5 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.525 -0.762 . . . . 2.79 110.49 179.722 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.587 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -68.03 143.66 60.89 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.463 2.109 . . . . 0.87 111.908 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.79 25.64 75.32 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.031 -0.828 . . . . 0.64000000000000001 111.031 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.15 158.8 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.735 0.302 . . . . 0.82999999999999996 110.369 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.09 139.94 41.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.333 -0.394 . . . . 0.5 110.565 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.648 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.58 136.46 54.89 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.954 -0.566 . . . . 0.53000000000000003 110.82 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.98 131.06 45.32 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.481 -0.933 . . . . 1.8700000000000001 108.481 177.67 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.5 153.87 16.65 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.221 -0.99 . . . . 0.28999999999999998 111.935 -178.566 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.93 140.94 46.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.648 -0.501 . . . . 1.4299999999999999 109.648 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.2 tp -115.79 118.86 34.21 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.488 -0.485 . . . . 0.32000000000000001 110.524 179.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 84' ' ' VAL . 63.8 mt -112.4 129.08 68.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 0.79000000000000004 110.66 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.703 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.82 120.89 43.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.261 -0.427 . . . . 1.02 110.701 -179.649 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.857 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.55 146.44 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.184 0.516 . . . . 0.62 111.001 -179.284 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.813 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.06 153.82 21.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.499 -0.773 . . . . 2.4399999999999999 109.974 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.23 88.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.959 0.409 . . . . 3.6899999999999999 110.433 -179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.43 32.56 0.23 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.74 -0.664 . . . . 6.0800000000000001 110.604 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.16 -117.33 3.28 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.443 -0.663 . . . . 1.22 111.443 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.468 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.48 177.42 8.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.157 0.503 . . . . 2.8799999999999999 111.655 -179.131 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.17 149.59 32.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.468 -0.787 . . . . 1.47 110.35 179.181 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.2 144.62 38.59 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.386 -0.37 . . . . 2.7000000000000002 110.527 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.727 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.94 136.01 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 121.032 0.444 . . . . 0.46000000000000002 111.617 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.1 141.35 52.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.634 -0.712 . . . . 0.34999999999999998 110.285 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.471 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.62 138.87 51.67 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.085 0.469 . . . . 3.6699999999999999 111.535 -179.354 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.28 164.15 38.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.524 -0.762 . . . . 0.67000000000000004 109.53 179.371 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.565 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.22 151.52 38.53 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.411 -0.516 . . . . 1.47 111.049 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.807 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.2 p90 -146.19 172.73 13.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.781 -0.645 . . . . 0.44 111.053 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.73 160.67 21.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.414 -0.812 . . . . 1.3700000000000001 109.841 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.47 121.9 22.88 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.563 -0.455 . . . . 1.28 110.768 179.927 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.413 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -128.28 151.03 49.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.051 -0.522 . . . . 1.97 111.421 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--N 1.332 -0.18 0 CA-C-O 121.357 0.599 . . . . 3.2799999999999998 110.337 177.66 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 112.286 0.476 . . . . 0.66000000000000003 112.286 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.441 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.9 167.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.064 -0.516 . . . . 0.68999999999999995 110.931 179.124 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.66 145.52 50.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.772 -0.649 . . . . 0.52000000000000002 110.111 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.29 101.62 9.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.087 -0.708 . . . . 0.32000000000000001 109.087 177.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.4 t -112.85 139.67 36.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.015 -0.538 . . . . 0.28999999999999998 111.129 -178.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.4 p -128.72 152.49 48.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.692 -0.685 . . . . 0.25 109.852 179.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.72 -164.84 2.01 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.705 -0.398 . . . . 0.31 110.678 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.734 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.3 t -124.01 127.17 73.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 0.48999999999999999 110.799 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.172 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.95 58.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.138 -0.483 . . . . 1.53 110.283 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.07 24.4 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.003 -0.544 . . . . 0.96999999999999997 111.442 -179.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.172 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.2 128.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.688 -0.405 . . . . 1.5600000000000001 111.002 179.823 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -86.41 -9.6 55.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.885 -0.598 . . . . 1.8799999999999999 110.294 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.15 0.25 55.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.471 . . . . 1.04 110.351 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.22 137.3 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.943 -0.571 . . . . 0.23999999999999999 109.955 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.61 ' N ' ' O ' ' A' ' 185' ' ' ILE . 69.3 m -96.38 -15.51 21.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.336 0.588 . . . . 0.28999999999999998 110.011 -179.65 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.55 175.56 45.74 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 109.847 -1.301 . . . . 0.13 109.847 179.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.43 151.65 42.44 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.601 -0.439 . . . . 0.17000000000000001 110.488 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.495 ' NH2' ' CD2' ' A' ' 183' ' ' TYR . 68.8 ttp85 -132.37 121.13 23.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.175 -0.466 . . . . 1.29 109.87 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.554 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.03 136.61 38.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.678 -0.692 . . . . 0.25 110.687 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 83.3 tt0 -129.37 129.95 45.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.942 -0.572 . . . . 1.3200000000000001 110.031 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.62 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.9 p90 -138.77 135.26 34.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.998 -0.547 . . . . 0.56999999999999995 110.582 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.418 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.32 161.4 39.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.769 -0.65 . . . . 1.1599999999999999 109.638 179.804 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.969 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.05 124.79 25.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.99 0.424 . . . . 0.38 110.666 -179.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.74 -7.65 49.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.756 -0.656 . . . . 0.40999999999999998 110.909 -179.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.9 -69.71 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.301 -0.409 . . . . 1.6599999999999999 111.357 -179.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.472 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.65 -35.35 76.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.083 -0.508 . . . . 1.6599999999999999 111.471 -179.09 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.076 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.12 88.67 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.771 -0.932 . . . . 1.1699999999999999 110.771 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.324 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.9 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.74 0.305 . . . . 1.8600000000000001 110.334 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.324 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.35 139.11 44.85 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.01 0.433 . . . . 1.98 110.165 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.418 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.5 Cg_endo -70.97 145.89 51.34 Favored 'Trans proline' 0 C--N 1.301 -1.936 0 C-N-CA 122.601 2.201 . . . . 0.55000000000000004 112.365 -179.472 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.89 145.67 42.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.147 -0.686 . . . . 1.1399999999999999 109.147 179.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.587 ' CE1' ' CD ' ' A' ' 65' ' ' PRO . 11.5 p90 -123.2 141.41 52.0 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.363 -0.535 . . . . 0.93000000000000005 111.6 -179.2 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.14 127.61 43.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.326 -0.852 . . . . 0.34000000000000002 108.911 179.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.593 ' OD2' ' ND2' ' A' ' 16' ' ' ASN . 66.9 m-20 -101.59 131.23 47.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.143 0.497 . . . . 1.0900000000000001 111.781 -178.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -128.03 157.52 73.71 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.324 -0.853 . . . . 0.19 109.477 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -69.78 158.05 58.25 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.433 2.089 . . . . 0.17999999999999999 112.218 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.417 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.33 -12.14 5.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.824 -0.626 . . . . 0.20999999999999999 110.698 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.1 p -92.8 -8.8 42.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.28999999999999998 110.742 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.39 34.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.5 110.433 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.7 p -133.14 16.68 4.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.413 -0.358 . . . . 0.29999999999999999 110.483 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.58 147.09 5.04 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.658 -0.497 . . . . 0.23000000000000001 109.658 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.554 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.14 150.49 12.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.515 -0.474 . . . . 0.28000000000000003 111.588 -179.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 125.0 50.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.667 -0.697 . . . . 1.0700000000000001 109.761 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.6 105.01 31.17 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.985 0.422 . . . . 0.28999999999999998 110.999 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.0 Cg_endo -91.03 -179.51 1.48 Allowed 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 123.158 2.572 . . . . 0.42999999999999999 112.174 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.69 32.64 18.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.428 -0.805 . . . . 1.26 111.443 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.44 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.0 mt -86.34 148.47 25.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.47 -0.332 . . . . 0.32000000000000001 110.487 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.773 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.14 114.91 61.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.982 0.42 . . . . 0.57999999999999996 110.666 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.1 140.61 95.89 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.901 2.401 . . . . 0.66000000000000003 111.971 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.1 21.12 74.47 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.072 -0.811 . . . . 0.28999999999999998 111.072 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.472 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.79 150.24 49.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.849 0.357 . . . . 2.3300000000000001 110.641 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.3 131.69 46.09 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.062 -0.517 . . . . 0.85999999999999999 109.755 179.335 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.969 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.61 148.36 44.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.07 -0.514 . . . . 0.52000000000000002 110.94 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.39 125.41 60.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.255 -1.017 . . . . 0.29999999999999999 108.255 177.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.53 132.53 63.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.084 0.469 . . . . 0.23000000000000001 111.251 -178.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.9 m-20 -136.47 122.54 20.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.604 -0.725 . . . . 0.35999999999999999 109.669 179.297 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.02 125.41 54.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.281 -0.418 . . . . 0.19 110.682 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.2 m-85 -117.23 137.8 52.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.999 -0.546 . . . . 0.29999999999999999 109.9 179.538 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.585 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.64 135.01 42.74 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.853 -0.795 . . . . 0.37 108.853 178.816 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.61 ' O ' ' N ' ' A' ' 140' ' ' SER . 81.3 mt -99.12 122.94 51.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.212 0.53 . . . . 0.26000000000000001 110.909 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.7 p -83.87 169.72 14.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.512 -0.767 . . . . 0.28000000000000003 110.501 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 187' ' ' GLU . 49.5 tp10 -59.74 -14.59 15.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.01 -0.541 . . . . 1.6000000000000001 110.902 -179.563 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.55 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.8 m-20 -96.06 -4.27 43.3 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.836 -0.346 . . . . 1.1799999999999999 110.809 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.82 13.89 63.94 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.346 -0.701 . . . . 0.29999999999999999 111.346 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -84.73 139.1 32.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.67 0.271 . . . . 1.22 110.437 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.512 HE22 ' HG2' ' A' ' 15' ' ' PRO . 87.1 mt-30 -106.75 141.08 38.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.361 . . . . 0.97999999999999998 110.551 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.0 m -136.72 127.05 26.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 0.82999999999999996 110.35 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 25.6 tp -68.17 117.29 9.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.266 -0.424 . . . . 0.26000000000000001 110.566 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.0 pt -108.96 -21.89 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.29999999999999999 110.706 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.86 125.76 5.89 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.412 -0.515 . . . . 0.31 111.449 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.471 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.72 120.21 21.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.793 -0.64 . . . . 0.28000000000000003 109.643 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.63 151.7 29.11 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.642 -0.423 . . . . 0.23999999999999999 110.954 -179.272 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.54 158.58 18.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.04 -0.527 . . . . 0.23000000000000001 110.38 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.402 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 21.5 mt-30 -146.04 157.95 43.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.67000000000000004 110.645 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.29 104.34 9.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.732 -0.667 . . . . 0.64000000000000001 110.061 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 C--O 1.221 -0.407 0 CA-C-O 117.837 -1.078 . . . . 1.26 110.593 -179.607 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.9 m . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.244 -0.65 . . . . 3.4399999999999999 109.244 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.442 ' H ' ' HB3' ' A' ' 1' ' ' SER . . . -116.33 150.73 18.54 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.03 -0.828 . . . . 1.22 111.03 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -35.67 142.41 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.054 0 C-N-CA 123.934 3.089 . . . . 0.75 113.813 -179.23 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.629 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -79.94 173.43 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.257 -1.338 . . . . 0.79000000000000004 108.804 178.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.629 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.64 125.85 51.47 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.424 -0.51 . . . . 1.9399999999999999 111.392 -179.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.58 144.06 33.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.655 -0.702 . . . . 0.59999999999999998 110.597 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.04 168.36 25.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.857 0.361 . . . . 3.1400000000000001 111.105 -179.636 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.739 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.4 mt -109.0 131.08 60.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.002 -0.545 . . . . 3.23 110.063 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.5 p -141.17 162.3 35.82 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.829 0.347 . . . . 3.6299999999999999 111.202 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 69.3 mm-40 36.1 31.57 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.563 -0.532 . . . . 6.0800000000000001 109.563 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.739 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.41 69.59 32.3 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.968 -0.56 . . . . 3.3799999999999999 111.625 -178.833 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.639 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.21 -29.23 73.47 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.496 2.131 . . . . 3.9300000000000002 111.864 179.339 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.639 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.72 125.58 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.142 -0.481 . . . . 3.3599999999999999 110.512 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.585 HE21 ' HB2' ' A' ' 17' ' ' SER . 28.2 mt-30 -124.02 158.34 60.69 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.406 -0.361 . . . . 3.6099999999999999 110.466 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.539 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 98.1 Cg_endo -82.01 -64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.843 2.362 . . . . 1.51 113.503 -178.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.811 ' ND2' ' CE2' ' A' ' 157' ' ' TYR . 5.1 t-20 -108.38 -19.65 13.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.326 -0.397 . . . . 2.6800000000000002 112.064 -178.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.585 ' HB2' HE21 ' A' ' 14' ' ' GLN . 31.1 m -107.3 152.05 24.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.145 0.498 . . . . 1.21 111.266 -179.358 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.569 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.31 102.96 2.22 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.677 -0.692 . . . . 1.5600000000000001 110.637 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.69 145.55 12.97 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.915 2.41 . . . . 0.81000000000000005 112.646 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.902 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.74 167.98 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.881 -0.6 . . . . 1.52 109.922 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.15 147.96 29.07 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.738 -0.467 . . . . 2.1400000000000001 109.738 178.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.598 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.29 157.25 45.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.017 0.437 . . . . 0.32000000000000001 111.204 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.498 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -127.99 155.31 44.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.817 -0.629 . . . . 2.1699999999999999 110.087 178.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.819 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.62 173.05 6.33 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.187 -0.461 . . . . 0.58999999999999997 110.741 -179.199 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.819 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.8 Cg_exo -50.72 173.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.885 0 C-N-CA 122.867 2.378 . . . . 0.90000000000000002 111.497 179.33 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.485 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.95 -50.97 0.7 Allowed Pre-proline 0 C--N 1.33 -0.255 0 C-N-CA 120.672 -0.411 . . . . 3.3399999999999999 110.134 179.847 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.623 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.97 152.4 82.48 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.652 2.235 . . . . 1.8500000000000001 111.419 179.219 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.68 42.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.427 0.632 . . . . 2.54 110.615 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.82 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.65 -41.56 98.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.97 -1.014 . . . . 2.5299999999999998 110.691 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.529 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.6 mt -109.95 137.92 40.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.728 -0.669 . . . . 1.1699999999999999 111.259 -179.462 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.03 -72.87 0.7 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.039 -0.528 . . . . 1.27 111.894 -178.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.35 24.45 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.581 0.586 . . . . 1.1200000000000001 112.581 -179.631 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -121.84 124.9 45.22 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.338 -0.616 . . . . 0.41999999999999998 109.338 177.476 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.9 mt -118.04 134.7 60.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.651 -0.42 . . . . 0.78000000000000003 110.61 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.902 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.99 128.6 53.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.978 0.418 . . . . 0.62 111.334 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.551 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.07 138.99 49.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.715 -0.675 . . . . 1.97 110.215 178.972 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.437 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.06 163.12 35.23 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.109 0.48 . . . . 0.34999999999999998 112.093 -178.065 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.4 139.58 7.93 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.466 -0.788 . . . . 1.8 110.538 178.777 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.694 ' O ' ' N ' ' A' ' 41' ' ' ASN . 18.2 Cg_endo -63.46 115.4 3.01 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.322 2.014 . . . . 0.57999999999999996 111.94 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.674 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.98 81.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.837 -0.431 . . . . 3.04 109.837 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.694 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.31 -20.65 0.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.015 -0.538 . . . . 2.4700000000000002 111.927 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.2 p -157.56 157.83 34.48 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.809 -0.356 . . . . 2.5099999999999998 110.56 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.42 27.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 1.8600000000000001 110.125 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.87 -75.84 1.31 Allowed Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.178 -0.534 . . . . 1.4399999999999999 111.89 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.91 152.31 35.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.961 0.41 . . . . 4.6900000000000004 111.056 -179.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.645 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.13 2.53 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.126 -0.488 . . . . 1.4299999999999999 111.985 179.364 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.08 149.67 29.69 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.464 0.649 . . . . 1.74 112.563 -177.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.04 156.52 46.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.762 -1.108 . . . . 1.9199999999999999 110.259 178.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.22 158.34 41.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.916 -0.584 . . . . 0.34000000000000002 111.82 -179.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.6 m -115.23 135.7 53.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.479 -0.782 . . . . 0.40999999999999998 109.75 179.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.598 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.31 121.96 23.88 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.55000000000000004 111.546 -179.153 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.4 Cg_exo -46.41 151.71 1.7 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.731 2.287 . . . . 0.44 112.083 179.029 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.99 -22.92 63.11 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.076 -0.511 . . . . 0.73999999999999999 112.747 -179.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.544 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.85 -16.83 46.1 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 117.382 0.591 . . . . 0.93000000000000005 111.786 -178.34 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.604 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.58 138.42 31.58 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.766 -0.373 . . . . 0.96999999999999997 110.385 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.55 13.88 10.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.442 -0.344 . . . . 1.3400000000000001 111.587 -179.318 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.48 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.4 p -150.03 143.37 25.12 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.595 -0.442 . . . . 0.39000000000000001 111.03 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.72 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.67 -169.36 1.53 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.98 -0.554 . . . . 0.41999999999999998 110.969 -179.452 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.72 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.81 125.86 9.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.411 -0.813 . . . . 0.39000000000000001 109.841 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.506 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.4 mt -114.78 123.25 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.429 -0.508 . . . . 0.73999999999999999 111.208 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.756 ' HD3' HG21 ' A' ' 185' ' ' ILE . 52.0 mtmt -126.5 163.38 23.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.77 -0.65 . . . . 2.48 110.469 179.686 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.705 ' C ' HD21 ' A' ' 16' ' ' ASN . . . 85.11 19.14 59.63 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.662 -0.975 . . . . 0.5 110.662 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.687 ' N ' ' ND2' ' A' ' 16' ' ' ASN . 73.6 mt -79.13 157.17 27.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.975 0.417 . . . . 0.57999999999999996 111.331 -179.658 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.854 ' O ' HG12 ' A' ' 67' ' ' VAL . 2.7 mttm -99.46 133.87 21.61 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.571 -0.74 . . . . 2.79 110.43 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.84 143.62 61.8 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.548 2.165 . . . . 0.87 111.908 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.81 25.61 75.35 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.071 -0.812 . . . . 0.64000000000000001 111.071 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.854 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.3 p -128.15 158.67 40.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.651 0.262 . . . . 0.82999999999999996 110.475 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.12 139.85 42.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.988 0.423 . . . . 0.5 110.571 -179.73 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.644 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.3 m-85 -122.46 136.52 54.91 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.902 -0.59 . . . . 0.53000000000000003 110.766 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -99.02 131.07 45.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.468 -0.938 . . . . 1.8700000000000001 108.468 177.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.482 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.54 153.82 16.67 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.341 -0.933 . . . . 0.28999999999999998 112.0 -178.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.94 140.96 46.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.689 -0.486 . . . . 1.4299999999999999 109.689 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.513 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.4 tp -115.75 118.88 34.27 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.454 -0.498 . . . . 0.32000000000000001 110.48 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.746 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.46 129.14 68.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.347 -0.388 . . . . 0.79000000000000004 110.63 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.9 120.74 43.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.287 -0.415 . . . . 1.02 110.69 -179.568 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.841 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.47 146.36 11.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.139 0.495 . . . . 0.62 111.076 -179.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.82 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -105.95 153.86 21.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.559 -0.746 . . . . 2.4399999999999999 109.925 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.16 88.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.865 0.364 . . . . 3.6899999999999999 110.42 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.633 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.39 32.55 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.826 -0.624 . . . . 6.0800000000000001 110.558 -179.942 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.04 -117.44 3.3 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.418 -0.673 . . . . 1.22 111.418 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.471 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.38 177.31 9.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.209 0.528 . . . . 2.8799999999999999 111.665 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.11 149.43 32.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.442 -0.799 . . . . 1.47 110.403 179.221 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.08 144.65 38.85 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.458 -0.337 . . . . 2.7000000000000002 110.594 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.746 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -127.94 135.97 61.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 121.118 0.485 . . . . 0.46000000000000002 111.582 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.601 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -123.95 141.37 52.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.657 -0.701 . . . . 0.34999999999999998 110.359 179.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.492 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.6 138.89 51.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.08 0.467 . . . . 3.6699999999999999 111.527 -179.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.482 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.31 164.15 38.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.577 -0.738 . . . . 0.67000000000000004 109.526 179.353 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 46.8 p30 -145.21 151.59 38.64 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.392 -0.523 . . . . 1.47 111.069 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.812 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.2 172.72 13.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.767 -0.652 . . . . 0.44 111.045 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.71 160.69 21.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.47 -0.786 . . . . 1.3700000000000001 109.815 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.35 121.84 22.93 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.582 -0.447 . . . . 1.28 110.759 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -127.45 154.65 44.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 1.97 112.109 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.2 p . . . . . 0 CA--C 1.528 0.128 0 CA-C-N 115.662 -0.699 . . . . 3.2799999999999998 111.459 178.856 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 84.6 p . . . . . 0 N--CA 1.462 0.134 0 CA-C-O 120.81 0.338 . . . . 0.66000000000000003 111.259 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.447 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.84 167.57 0.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.977 -0.556 . . . . 0.68999999999999995 110.855 179.743 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.61 145.61 50.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.665 -0.698 . . . . 0.52000000000000002 110.154 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.32 101.65 9.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.108 -0.701 . . . . 0.32000000000000001 109.108 177.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.6 t -112.91 139.75 36.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.997 -0.547 . . . . 0.28999999999999998 111.132 -178.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 p -128.74 152.56 48.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.686 -0.688 . . . . 0.25 109.883 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.584 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.5 p90 -144.82 -164.98 2.04 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.738 -0.385 . . . . 0.31 110.612 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.74 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.4 t -123.93 127.13 73.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.48999999999999999 110.801 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.149 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 1.53 110.378 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.74 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.06 24.41 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.932 -0.576 . . . . 0.96999999999999997 111.4 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.149 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.21 128.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.652 -0.419 . . . . 1.5600000000000001 110.937 179.819 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -86.36 -9.62 56.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.869 -0.605 . . . . 1.8799999999999999 110.376 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.12 0.26 55.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 1.04 110.307 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.34 137.28 25.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.993 -0.549 . . . . 0.23999999999999999 109.894 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 185' ' ' ILE . 72.0 m -96.25 -15.5 21.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.305 0.574 . . . . 0.28999999999999998 110.053 -179.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.54 175.57 45.73 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 109.822 -1.311 . . . . 0.13 109.822 179.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -123.48 151.62 42.56 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.65 -0.42 . . . . 0.17000000000000001 110.545 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.64 ' NH2' ' CD2' ' A' ' 183' ' ' TYR . 69.2 ttp85 -132.26 121.11 23.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.12 -0.491 . . . . 1.29 109.979 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.541 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.01 136.49 38.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.744 -0.662 . . . . 0.25 110.658 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.497 ' HB2' HH12 ' A' ' 143' ' ' ARG . 80.0 tt0 -129.34 129.88 45.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.987 -0.551 . . . . 1.3200000000000001 110.096 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.619 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.72 135.34 34.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.998 -0.546 . . . . 0.56999999999999995 110.605 -179.708 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.423 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.31 161.36 39.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.679 -0.692 . . . . 1.1599999999999999 109.627 179.844 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.96 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.02 124.9 25.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.054 0.454 . . . . 0.38 110.708 -179.676 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.78 -7.6 49.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.713 -0.676 . . . . 0.40999999999999998 110.952 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -109.86 -69.7 0.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.405 . . . . 1.6599999999999999 111.417 -179.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.445 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.66 -35.34 76.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.108 -0.496 . . . . 1.6599999999999999 111.486 -179.142 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.094 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.19 7.21 88.61 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.806 -0.918 . . . . 1.1699999999999999 110.806 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.312 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.91 -171.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.739 0.304 . . . . 1.8600000000000001 110.23 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.312 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.37 139.07 44.75 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.973 0.416 . . . . 1.98 110.205 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.423 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.8 Cg_endo -70.89 145.87 51.72 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.662 2.241 . . . . 0.55000000000000004 112.391 -179.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.619 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.9 145.75 42.62 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.217 -0.66 . . . . 1.1399999999999999 109.217 179.276 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.811 ' CE2' ' ND2' ' A' ' 16' ' ' ASN . 49.2 p90 -123.26 141.22 52.21 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.418 -0.513 . . . . 0.93000000000000005 111.536 -179.013 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.9 mt -128.05 127.67 43.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.329 -0.85 . . . . 0.34000000000000002 109.068 178.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -101.74 131.2 48.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.236 0.541 . . . . 1.0900000000000001 111.726 -178.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.97 157.55 73.51 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.226 -0.897 . . . . 0.19 109.558 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.78 157.96 58.56 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 122.521 2.148 . . . . 0.17999999999999999 112.178 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.28 -12.11 5.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.77 -0.65 . . . . 0.20999999999999999 110.74 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.79 -8.83 42.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.085 -0.507 . . . . 0.28999999999999998 110.703 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.13 135.39 34.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 0.5 110.364 179.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.1 p -133.21 16.71 4.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.339 -0.392 . . . . 0.29999999999999999 110.521 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.7 p -167.56 147.14 5.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.65 -0.5 . . . . 0.23000000000000001 109.65 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.541 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.22 150.5 12.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.561 -0.456 . . . . 0.28000000000000003 111.545 -179.619 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.497 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.39 124.93 50.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.644 -0.707 . . . . 1.0700000000000001 109.827 179.466 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.32 104.82 29.08 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.428 -0.351 . . . . 0.28999999999999998 111.158 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.7 Cg_endo -91.02 -179.47 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 123.188 2.592 . . . . 0.42999999999999999 112.188 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.53 32.8 18.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.444 -0.798 . . . . 1.26 111.467 179.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.1 mt -86.43 148.49 25.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.468 -0.333 . . . . 0.32000000000000001 110.409 179.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.761 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.29 114.83 61.2 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.091 0.472 . . . . 0.57999999999999996 110.722 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.01 140.63 96.19 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.878 2.385 . . . . 0.66000000000000003 111.952 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.03 21.25 74.35 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.087 -0.805 . . . . 0.28999999999999998 111.087 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.445 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.97 150.25 49.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.928 0.394 . . . . 2.3300000000000001 110.541 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.18 131.66 45.99 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.983 -0.553 . . . . 0.85999999999999999 109.792 179.316 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.96 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.56 148.22 44.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.07 -0.513 . . . . 0.52000000000000002 111.101 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.24 125.4 60.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.263 -1.014 . . . . 0.29999999999999999 108.263 177.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.6 132.43 63.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.202 0.525 . . . . 0.23000000000000001 111.338 -178.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.46 122.62 20.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.477 -0.783 . . . . 0.35999999999999999 109.63 179.342 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.584 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.07 125.39 55.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.176 -0.465 . . . . 0.19 110.654 -179.493 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.64 ' CD2' ' NH2' ' A' ' 143' ' ' ARG . 48.7 m-85 -117.3 137.93 52.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.001 -0.545 . . . . 0.29999999999999999 109.839 179.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.573 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.63 135.06 42.66 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.79 -0.819 . . . . 0.37 108.79 178.916 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.756 HG21 ' HD3' ' A' ' 61' ' ' LYS . 81.3 mt -99.14 122.83 51.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.101 0.477 . . . . 0.26000000000000001 111.022 -178.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.5 p -83.73 169.74 14.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.568 -0.742 . . . . 0.28000000000000003 110.499 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.81 -14.5 15.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.028 -0.533 . . . . 1.6000000000000001 110.975 -179.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -96.09 -4.26 43.21 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.854 -0.339 . . . . 1.1799999999999999 110.86 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.7 14.03 63.94 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.365 -0.694 . . . . 0.29999999999999999 111.365 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -84.73 139.08 32.24 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.03 -0.268 . . . . 1.22 110.484 179.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -106.72 141.03 38.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.871 0.367 . . . . 0.97999999999999998 110.517 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.0 m -136.74 126.99 26.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.82999999999999996 110.337 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.05 117.35 9.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.308 -0.406 . . . . 0.26000000000000001 110.534 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.09 -21.82 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.29999999999999999 110.68 -179.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.8 125.72 5.92 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.489 -0.484 . . . . 0.31 111.487 -179.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.78 120.26 21.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.835 -0.62 . . . . 0.28000000000000003 109.554 179.123 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.66 29.05 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.71 -0.396 . . . . 0.23999999999999999 110.942 -179.28 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.8 p -110.4 158.64 18.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.521 . . . . 0.23000000000000001 110.382 179.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.11 157.83 43.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.057 -0.519 . . . . 0.67000000000000004 110.691 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.22 104.31 9.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.762 -0.654 . . . . 0.64000000000000001 110.058 179.513 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.2 p . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.991 -1.005 . . . . 1.26 110.577 -179.674 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.0 m . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.196 -0.668 . . . . 3.4399999999999999 109.196 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.36 150.7 18.54 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.981 -0.848 . . . . 1.22 110.981 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -35.68 142.38 0.1 Allowed 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 123.982 3.122 . . . . 0.75 113.835 -179.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.622 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.92 173.41 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.306 -1.316 . . . . 0.79000000000000004 108.81 178.413 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.622 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.55 125.84 51.45 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.484 -0.486 . . . . 1.9399999999999999 111.46 -179.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.5 144.01 33.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.638 -0.71 . . . . 0.59999999999999998 110.689 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.36 25.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.946 0.403 . . . . 3.1400000000000001 111.089 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.747 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -109.01 131.15 60.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.99 -0.55 . . . . 3.23 110.05 179.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.25 162.33 35.74 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.823 0.344 . . . . 3.6299999999999999 111.236 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.3 mt-10 35.99 31.69 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.626 -0.509 . . . . 6.0800000000000001 109.626 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.747 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.55 32.99 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.944 -0.571 . . . . 3.3799999999999999 111.541 -178.816 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.643 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.21 -29.09 73.38 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.478 2.119 . . . . 3.9300000000000002 111.883 179.333 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.643 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.55 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 3.3599999999999999 110.487 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.62 ' NE2' ' O ' ' A' ' 13' ' ' SER . 1.7 mp0 -124.0 158.3 60.77 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.32 -0.4 . . . . 3.6099999999999999 110.456 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.542 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 97.0 Cg_endo -82.0 -64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.939 2.426 . . . . 1.51 113.511 -178.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.585 HD22 ' CD ' ' A' ' 143' ' ' ARG . 78.2 m-20 -108.52 -19.48 13.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.311 -0.404 . . . . 2.6800000000000002 112.082 -178.531 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 27.5 m -107.29 152.01 24.7 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.44 -0.504 . . . . 1.21 111.329 -179.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.571 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.0 t-80 -155.17 102.87 2.25 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.796 -0.638 . . . . 1.5600000000000001 110.742 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.429 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.61 145.71 13.16 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.862 2.375 . . . . 0.81000000000000005 112.55 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.922 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.85 167.94 24.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.795 -0.639 . . . . 1.52 109.847 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.17 147.88 28.97 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.754 -0.462 . . . . 2.1400000000000001 109.754 178.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.6 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.23 157.34 44.96 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.673 -0.411 . . . . 0.32000000000000001 111.252 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.488 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -128.06 155.31 44.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.866 -0.607 . . . . 2.1699999999999999 110.085 179.029 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.822 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.67 172.98 6.44 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.128 -0.487 . . . . 0.58999999999999997 110.798 -179.189 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.822 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.6 174.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 122.859 2.373 . . . . 0.90000000000000002 111.552 179.434 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.07 -51.15 0.68 Allowed Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 120.664 -0.414 . . . . 3.3399999999999999 110.112 179.795 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.617 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.83 152.33 82.52 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.757 2.304 . . . . 1.8500000000000001 111.44 179.225 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.68 42.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.426 0.632 . . . . 2.54 110.628 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.813 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.66 -41.58 98.17 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.966 -1.015 . . . . 2.5299999999999998 110.651 179.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.533 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.9 mt -109.82 137.85 40.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.851 -0.613 . . . . 1.1699999999999999 111.311 -179.511 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.06 -72.9 0.7 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.054 -0.521 . . . . 1.27 111.853 -178.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.16 148.41 24.43 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.59 0.589 . . . . 1.1200000000000001 112.59 -179.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.79 124.86 45.18 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.327 -0.62 . . . . 0.41999999999999998 109.327 177.53 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.05 134.76 60.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.678 -0.409 . . . . 0.78000000000000003 110.636 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.922 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.99 128.49 53.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.437 . . . . 0.62 111.237 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.547 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -130.99 139.07 49.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.756 -0.657 . . . . 1.97 110.151 178.899 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.12 163.18 35.11 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.165 0.507 . . . . 0.34999999999999998 112.094 -178.162 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.51 139.59 7.84 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.431 -0.804 . . . . 1.8 110.479 178.829 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.698 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.9 Cg_endo -63.51 115.43 3.03 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.436 2.091 . . . . 0.57999999999999996 111.787 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.685 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.08 81.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.984 0.421 . . . . 3.04 109.874 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.698 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.94 -0.573 . . . . 2.4700000000000002 111.946 -179.532 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.8 p -157.52 157.79 34.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.759 0.314 . . . . 2.5099999999999998 110.601 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 16.0 m -120.43 27.92 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 1.8600000000000001 110.092 179.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.92 -75.89 1.31 Allowed Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.083 -0.58 . . . . 1.4399999999999999 111.764 -179.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.84 152.3 35.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 4.6900000000000004 110.973 -179.295 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.649 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.24 -169.17 2.54 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.084 -0.507 . . . . 1.4299999999999999 111.936 179.337 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.09 149.65 29.73 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.495 0.664 . . . . 1.74 112.556 -177.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.05 156.49 46.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.789 -1.096 . . . . 1.9199999999999999 110.274 178.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.15 158.39 41.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.981 -0.554 . . . . 0.34000000000000002 111.837 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.1 m -115.19 135.64 53.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.476 -0.784 . . . . 0.40999999999999998 109.784 179.292 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.6 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.38 121.94 23.79 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.432 -0.349 . . . . 0.55000000000000004 111.548 -179.158 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.4 Cg_exo -46.32 151.74 1.62 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.658 2.239 . . . . 0.44 112.101 179.023 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.91 -23.01 63.04 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 116.015 -0.539 . . . . 0.73999999999999999 112.799 -179.289 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.544 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.87 -16.87 45.9 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.208 -0.597 . . . . 0.93000000000000005 111.755 -178.306 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.603 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.2 mt -91.47 138.44 31.58 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.809 -0.356 . . . . 0.96999999999999997 110.321 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.62 13.95 10.93 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.36 -0.382 . . . . 1.3400000000000001 111.464 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.482 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.5 p -150.05 143.48 25.16 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.648 -0.421 . . . . 0.39000000000000001 111.005 179.602 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.722 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.78 -169.31 1.52 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.016 -0.538 . . . . 0.41999999999999998 110.857 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.722 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.79 125.83 9.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.333 -0.849 . . . . 0.39000000000000001 109.841 179.275 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.511 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.74 123.19 70.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.417 -0.513 . . . . 0.73999999999999999 111.23 -179.733 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.863 ' HZ3' ' CB ' ' A' ' 140' ' ' SER . 66.4 mttt -126.47 163.44 23.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.928 -0.578 . . . . 2.48 110.441 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.01 19.14 59.78 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.759 -0.937 . . . . 0.5 110.759 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.511 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.1 mt -79.12 157.31 27.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.078 0.466 . . . . 0.57999999999999996 111.291 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.844 ' O ' HG12 ' A' ' 67' ' ' VAL . 1.2 mttm -99.55 134.0 21.46 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.659 -0.7 . . . . 2.79 110.393 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.654 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.92 143.53 61.0 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.579 2.186 . . . . 0.87 111.925 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.92 25.57 75.41 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.035 -0.826 . . . . 0.64000000000000001 111.035 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.19 158.74 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.64 0.257 . . . . 0.82999999999999996 110.421 -179.521 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.17 139.86 42.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.925 0.393 . . . . 0.5 110.582 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.651 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.46 136.41 54.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.969 -0.56 . . . . 0.53000000000000003 110.878 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.86 131.01 45.29 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.545 -0.909 . . . . 1.8700000000000001 108.545 177.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.52 153.87 16.66 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.237 -0.982 . . . . 0.28999999999999998 111.867 -178.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.97 140.99 46.13 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.684 -0.487 . . . . 1.4299999999999999 109.684 179.561 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.518 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.79 118.92 34.36 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.459 -0.496 . . . . 0.32000000000000001 110.507 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.738 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.49 129.1 68.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.349 -0.387 . . . . 0.79000000000000004 110.564 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.704 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.8 120.89 43.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.251 -0.432 . . . . 1.02 110.669 -179.695 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.855 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.64 146.5 11.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.246 0.546 . . . . 0.62 111.005 -179.332 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.813 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.09 153.94 21.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.499 -0.773 . . . . 2.4399999999999999 109.924 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.13 88.57 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.85 0.357 . . . . 3.6899999999999999 110.427 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.24 32.59 0.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.869 -0.605 . . . . 6.0800000000000001 110.616 -179.887 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.06 -117.33 3.29 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.471 -0.652 . . . . 1.22 111.471 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.472 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.36 177.35 9.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.198 0.523 . . . . 2.8799999999999999 111.692 -179.256 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.12 149.61 32.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.464 -0.789 . . . . 1.47 110.478 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.15 144.68 38.72 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.501 -0.318 . . . . 2.7000000000000002 110.529 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.738 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -128.0 136.01 61.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 120.615 -0.434 . . . . 0.46000000000000002 111.549 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.03 141.37 52.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.677 -0.692 . . . . 0.34999999999999998 110.27 179.656 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.501 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.61 138.91 51.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.128 0.489 . . . . 3.6699999999999999 111.506 -179.379 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 53.0 p90 -152.39 164.19 38.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.554 -0.748 . . . . 0.67000000000000004 109.4 179.365 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.564 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.24 151.54 38.54 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.327 -0.549 . . . . 1.47 111.051 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.2 p90 -146.2 172.72 13.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.719 -0.673 . . . . 0.44 110.997 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.72 160.76 21.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.426 -0.807 . . . . 1.3700000000000001 109.82 179.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.46 121.9 22.9 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 120.514 -0.475 . . . . 1.28 110.735 179.942 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.5 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -128.23 163.84 23.84 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.495 0.924 . . . . 1.97 113.495 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.2 t . . . . . 0 C--N 1.331 -0.205 0 N-CA-C 107.16 -1.422 . . . . 3.2799999999999998 107.16 176.64 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 121.343 0.592 . . . . 0.66000000000000003 110.081 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.443 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.86 167.56 0.25 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.351 -0.84 . . . . 0.68999999999999995 110.906 -179.696 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.64 145.59 50.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.671 -0.695 . . . . 0.52000000000000002 110.112 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.23 101.66 9.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.124 -0.695 . . . . 0.32000000000000001 109.124 177.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.0 t -112.94 139.6 37.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.031 -0.531 . . . . 0.28999999999999998 111.075 -178.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.1 p -128.63 152.5 48.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.638 -0.71 . . . . 0.25 109.87 179.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.584 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.5 p90 -144.8 -164.88 2.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.67 -0.412 . . . . 0.31 110.631 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.732 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -124.0 127.21 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.298 -0.41 . . . . 0.48999999999999999 110.83 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.154 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -58.11 58.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 1.53 110.239 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.23 24.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.882 -0.599 . . . . 0.96999999999999997 111.435 -179.661 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.154 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.14 128.75 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.586 -0.446 . . . . 1.5600000000000001 110.894 179.872 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.32 -9.75 55.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.886 -0.597 . . . . 1.8799999999999999 110.339 179.78 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.59 ' O ' ' CD ' ' A' ' 187' ' ' GLU . 27.8 p -87.12 0.3 55.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.004 -0.543 . . . . 1.04 110.314 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.723 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.37 137.23 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.915 -0.584 . . . . 0.23999999999999999 109.959 179.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.863 ' CB ' ' HZ3' ' A' ' 61' ' ' LYS . 89.3 p -96.27 -15.49 21.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.304 0.573 . . . . 0.28999999999999998 110.017 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.58 175.56 45.76 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.788 -1.325 . . . . 0.13 109.788 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.52 151.65 42.59 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.614 -0.435 . . . . 0.17000000000000001 110.455 179.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.647 ' NH1' HD11 ' A' ' 185' ' ' ILE . 38.3 ttp-105 -132.37 121.18 23.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.038 -0.528 . . . . 1.29 109.884 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.545 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -104.97 136.57 38.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.752 -0.658 . . . . 0.25 110.669 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 97.5 mt-10 -129.43 129.82 45.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.998 -0.547 . . . . 1.3200000000000001 110.091 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.624 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.63 135.34 34.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.079 -0.51 . . . . 0.56999999999999995 110.587 -179.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.417 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.36 161.38 39.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.783 -0.644 . . . . 1.1599999999999999 109.647 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.969 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.1 124.88 25.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.063 0.459 . . . . 0.38 110.709 -179.623 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.91 -7.57 49.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.745 -0.661 . . . . 0.40999999999999998 110.869 -179.74 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.81 -69.63 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 1.6599999999999999 111.439 -179.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.445 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.71 -35.35 76.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.006 -0.543 . . . . 1.6599999999999999 111.47 -179.094 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.078 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.17 88.64 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.763 -0.935 . . . . 1.1699999999999999 110.763 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.326 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.4 t0 -27.88 -171.7 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.792 0.33 . . . . 1.8600000000000001 110.275 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.326 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.27 139.12 45.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.408 . . . . 1.98 110.152 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.417 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 48.1 Cg_endo -70.86 145.85 51.86 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 122.695 2.264 . . . . 0.55000000000000004 112.299 -179.591 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.92 145.75 42.65 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.173 -0.677 . . . . 1.1399999999999999 109.173 179.157 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.654 ' CE1' ' CD ' ' A' ' 65' ' ' PRO . 48.4 p90 -123.34 141.33 52.1 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.336 -0.546 . . . . 0.93000000000000005 111.564 -179.117 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.8 mt -128.04 127.6 43.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.349 -0.841 . . . . 0.34000000000000002 109.001 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -101.65 131.1 48.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.207 0.527 . . . . 1.0900000000000001 111.783 -178.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.87 157.62 73.09 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.308 -0.86 . . . . 0.19 109.586 179.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -69.75 157.98 58.56 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 C-N-CA 122.431 2.087 . . . . 0.17999999999999999 112.29 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.23 -12.22 5.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.871 -0.604 . . . . 0.20999999999999999 110.725 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.9 p -92.83 -8.73 42.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.107 -0.497 . . . . 0.28999999999999998 110.753 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.15 135.35 34.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.451 . . . . 0.5 110.436 179.672 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 p -133.11 16.71 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.437 -0.347 . . . . 0.29999999999999999 110.536 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.9 p -167.52 147.04 5.07 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.639 -0.504 . . . . 0.23000000000000001 109.639 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.545 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.21 150.42 12.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.567 -0.453 . . . . 0.28000000000000003 111.63 -179.658 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.505 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.32 124.96 50.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.595 -0.729 . . . . 1.0700000000000001 109.832 179.519 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.38 104.92 29.88 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.882 0.372 . . . . 0.28999999999999998 111.03 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.1 Cg_endo -91.0 -179.44 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 123.175 2.583 . . . . 0.42999999999999999 112.137 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.54 32.69 18.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.362 -0.835 . . . . 1.26 111.49 179.325 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.425 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.1 mt -86.33 148.54 25.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.427 -0.351 . . . . 0.32000000000000001 110.435 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.771 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.35 114.82 61.19 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.026 0.441 . . . . 0.57999999999999996 110.705 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.96 140.55 95.82 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.904 2.403 . . . . 0.66000000000000003 111.969 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.1 21.24 74.17 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.064 -0.814 . . . . 0.28999999999999998 111.064 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.445 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.87 150.18 49.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.808 0.337 . . . . 2.3300000000000001 110.631 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.493 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.26 131.61 46.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.85999999999999999 109.737 179.381 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.969 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.45 148.2 44.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.107 -0.497 . . . . 0.52000000000000002 111.119 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.31 125.4 60.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.275 -1.009 . . . . 0.29999999999999999 108.275 177.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.5 132.54 63.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.156 0.503 . . . . 0.23000000000000001 111.249 -178.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.55 122.63 20.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.485 -0.78 . . . . 0.35999999999999999 109.553 179.288 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.584 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.0 125.4 54.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.224 -0.443 . . . . 0.19 110.658 -179.526 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 47.9 m-85 -117.23 137.79 52.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.101 -0.5 . . . . 0.29999999999999999 109.921 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.583 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.74 135.01 42.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.743 -0.836 . . . . 0.37 108.743 178.922 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.647 HD11 ' NH1' ' A' ' 143' ' ' ARG . 42.1 mm -99.1 122.91 51.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.107 0.479 . . . . 0.26000000000000001 110.949 -178.757 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.6 p -83.86 169.67 14.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.483 -0.78 . . . . 0.28000000000000003 110.447 -179.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.59 ' CD ' ' O ' ' A' ' 138' ' ' THR . 41.0 mp0 -59.64 -14.6 14.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.975 -0.557 . . . . 1.6000000000000001 111.036 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.8 m-20 -96.16 -4.21 43.06 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.853 -0.339 . . . . 1.1799999999999999 110.765 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.736 ' O ' ' NE2' ' A' ' 191' ' ' GLN . . . 87.69 13.94 64.13 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.366 -0.693 . . . . 0.29999999999999999 111.366 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -84.61 139.1 32.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.63 0.252 . . . . 1.22 110.484 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.736 ' NE2' ' O ' ' A' ' 189' ' ' GLY . 0.0 OUTLIER -106.69 141.06 38.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 0.97999999999999998 110.564 179.733 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.67 127.0 26.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.82999999999999996 110.392 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.11 117.35 9.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.323 -0.399 . . . . 0.26000000000000001 110.531 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.04 -21.91 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.29999999999999999 110.659 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.9 125.78 5.88 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.527 -0.469 . . . . 0.31 111.507 -179.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.473 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.77 120.2 21.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.77 -0.65 . . . . 0.28000000000000003 109.539 179.249 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.6 151.66 29.09 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.724 -0.39 . . . . 0.23999999999999999 110.938 -179.271 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.42 158.61 18.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 0.23000000000000001 110.404 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -146.16 157.91 43.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.502 . . . . 0.67000000000000004 110.666 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.27 104.3 9.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.801 -0.636 . . . . 0.64000000000000001 110.007 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.5 p . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 117.948 -1.025 . . . . 1.26 110.641 -179.743 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.203 -0.666 . . . . 3.4399999999999999 109.203 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.34 150.67 18.55 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.037 -0.825 . . . . 1.22 111.037 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -35.67 142.38 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 124.039 3.159 . . . . 0.75 113.792 -179.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.622 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -79.98 173.41 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.281 -1.327 . . . . 0.79000000000000004 108.881 178.428 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.622 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.6 125.86 51.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.214 0.531 . . . . 1.9399999999999999 111.354 -179.526 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 143.98 33.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.564 -0.744 . . . . 0.59999999999999998 110.596 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -151.99 168.35 25.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.943 0.401 . . . . 3.1400000000000001 111.076 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.738 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.97 131.02 60.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.974 -0.557 . . . . 3.23 110.076 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.19 162.33 35.74 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.834 0.349 . . . . 3.6299999999999999 111.197 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 79.9 mm-40 36.13 31.59 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 109.547 -0.538 . . . . 6.0800000000000001 109.547 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.738 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.48 69.56 32.95 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.964 -0.562 . . . . 3.3799999999999999 111.624 -178.831 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.22 -29.11 73.27 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.414 2.076 . . . . 3.9300000000000002 111.856 179.351 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.124 -0.489 . . . . 3.3599999999999999 110.49 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.534 ' OE1' ' O ' ' A' ' 13' ' ' SER . 2.0 mp0 -123.93 158.4 60.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.304 -0.407 . . . . 3.6099999999999999 110.379 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.571 ' HD2' HE22 ' A' ' 191' ' ' GLN . 98.3 Cg_endo -82.09 -64.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.922 2.415 . . . . 1.51 113.431 -178.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.627 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 60.7 t30 -108.46 -19.53 13.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.312 -0.404 . . . . 2.6800000000000002 112.065 -178.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 4.2 p -107.26 152.02 24.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.149 0.499 . . . . 1.21 111.313 -179.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.25 102.94 2.23 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.723 -0.671 . . . . 1.5600000000000001 110.68 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.65 145.61 13.05 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.847 2.365 . . . . 0.81000000000000005 112.651 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.91 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.84 167.84 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.949 -0.569 . . . . 1.52 109.843 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.05 148.02 29.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.826 -0.435 . . . . 2.1400000000000001 109.826 178.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.594 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.25 157.2 45.1 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.66 -0.416 . . . . 0.32000000000000001 111.203 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.492 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -127.98 155.29 44.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.783 -0.644 . . . . 2.1699999999999999 110.129 178.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.83 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.57 173.05 6.34 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.172 -0.467 . . . . 0.58999999999999997 110.807 -179.224 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.83 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.1 Cg_exo -50.74 173.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 122.839 2.359 . . . . 0.90000000000000002 111.449 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.48 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.03 -51.04 0.69 Allowed Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.688 -0.405 . . . . 3.3399999999999999 110.062 179.868 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.619 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.8 Cg_exo -64.87 152.32 82.62 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.789 2.326 . . . . 1.8500000000000001 111.441 179.258 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.75 42.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.465 0.65 . . . . 2.54 110.547 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.817 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.66 -41.73 98.16 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.962 -1.017 . . . . 2.5299999999999998 110.65 179.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.53 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.5 mt -109.73 137.91 39.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.711 -0.677 . . . . 1.1699999999999999 111.343 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.93 -73.01 0.7 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.084 -0.507 . . . . 1.27 111.874 -178.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.19 148.41 24.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.575 0.583 . . . . 1.1200000000000001 112.575 -179.545 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -121.86 124.81 45.0 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.341 -0.615 . . . . 0.41999999999999998 109.341 177.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.09 134.68 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.721 -0.391 . . . . 0.78000000000000003 110.614 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.91 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.98 128.59 53.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.055 0.455 . . . . 0.62 111.326 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.549 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.04 138.95 49.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.738 -0.664 . . . . 1.97 110.153 179.014 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.433 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -145.04 163.17 35.07 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 121.133 0.492 . . . . 0.34999999999999998 112.098 -178.166 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.491 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.48 139.57 7.86 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.42 -0.809 . . . . 1.8 110.482 178.85 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.8 Cg_endo -63.64 115.53 3.11 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.25 1.966 . . . . 0.57999999999999996 111.852 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.67 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.93 81.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.871 -0.418 . . . . 3.04 109.871 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.16 -20.62 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.015 -0.538 . . . . 2.4700000000000002 111.899 -179.546 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 p -157.7 157.76 34.12 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.812 -0.355 . . . . 2.5099999999999998 110.56 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.36 27.87 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.173 -0.467 . . . . 1.8600000000000001 110.178 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.83 -75.94 1.31 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.129 -0.557 . . . . 1.4399999999999999 111.808 -179.243 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.88 152.29 35.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.918 0.389 . . . . 4.6900000000000004 111.021 -179.312 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.12 2.53 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.093 -0.503 . . . . 1.4299999999999999 111.902 179.44 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.431 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.18 149.77 29.62 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 121.433 0.635 . . . . 1.74 112.543 -177.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.12 156.45 45.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.834 -1.076 . . . . 1.9199999999999999 110.154 178.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.22 158.4 41.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.848 -0.614 . . . . 0.34000000000000002 111.773 -179.403 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.9 m -115.17 135.64 53.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.476 -0.783 . . . . 0.40999999999999998 109.839 179.308 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.594 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.44 121.91 23.71 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.483 -0.326 . . . . 0.55000000000000004 111.528 -179.09 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.5 Cg_exo -46.26 151.67 1.6 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.663 2.242 . . . . 0.44 112.212 178.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.97 -22.96 63.1 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 116.097 -0.502 . . . . 0.73999999999999999 112.755 -179.162 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.54 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.1 p-80 -82.75 -16.95 46.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.432 0.616 . . . . 0.93000000000000005 111.815 -178.372 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.605 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.58 138.31 31.67 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.773 -0.371 . . . . 0.96999999999999997 110.354 179.354 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -121.48 13.95 11.04 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.353 -0.385 . . . . 1.3400000000000001 111.564 -179.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.0 p -149.96 143.51 25.27 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.654 -0.418 . . . . 0.39000000000000001 111.034 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.84 -169.38 1.54 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.052 -0.522 . . . . 0.41999999999999998 110.894 -179.463 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.711 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 t -151.77 125.89 9.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.427 -0.806 . . . . 0.39000000000000001 109.795 179.273 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.511 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.91 123.22 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.396 -0.522 . . . . 0.73999999999999999 111.196 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.744 ' HD3' HG21 ' A' ' 185' ' ' ILE . 53.1 mtmt -126.4 163.31 23.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.809 -0.632 . . . . 2.48 110.514 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.477 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.2 18.83 60.07 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.823 -0.911 . . . . 0.5 110.823 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.627 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.7 mt -78.93 157.3 28.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.002 0.43 . . . . 0.57999999999999996 111.446 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.855 ' O ' HG12 ' A' ' 67' ' ' VAL . 2.9 mptp? -99.53 133.98 21.49 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.638 -0.71 . . . . 2.79 110.422 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.96 ' HB3' ' O ' ' A' ' 93' ' ' SER . 36.6 Cg_endo -67.82 143.51 61.47 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.613 2.209 . . . . 0.87 111.901 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.96 25.55 75.45 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.987 -0.845 . . . . 0.64000000000000001 110.987 179.566 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.855 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.1 158.71 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.654 0.264 . . . . 0.82999999999999996 110.408 -179.532 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.09 139.98 41.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.85 0.357 . . . . 0.5 110.593 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.64 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.53 136.45 54.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.035 -0.53 . . . . 0.53000000000000003 110.687 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.491 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.89 131.08 45.25 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.522 -0.918 . . . . 1.8700000000000001 108.522 177.482 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.486 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.58 153.9 16.67 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.273 -0.965 . . . . 0.28999999999999998 111.924 -178.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.98 140.91 46.06 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.699 -0.482 . . . . 1.4299999999999999 109.699 179.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.71 118.86 34.22 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.398 -0.521 . . . . 0.32000000000000001 110.494 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.735 HG12 HG23 ' A' ' 84' ' ' VAL . 63.8 mt -112.45 129.11 68.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.372 -0.377 . . . . 0.79000000000000004 110.66 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.83 120.84 43.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.289 -0.414 . . . . 1.02 110.726 -179.657 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.849 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.52 146.41 11.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.099 0.476 . . . . 0.62 111.042 -179.238 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.817 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.03 153.89 21.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.586 -0.733 . . . . 2.4399999999999999 109.963 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.18 88.55 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.856 0.36 . . . . 3.6899999999999999 110.425 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.34 32.58 0.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.814 -0.63 . . . . 6.0800000000000001 110.605 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.15 -117.32 3.28 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.471 -0.652 . . . . 1.22 111.471 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.472 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.42 177.4 8.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.293 0.568 . . . . 2.8799999999999999 111.593 -179.188 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.19 149.57 32.18 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.397 -0.82 . . . . 1.47 110.365 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.22 144.59 38.55 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.396 -0.365 . . . . 2.7000000000000002 110.59 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.735 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.91 136.02 61.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 121.13 0.49 . . . . 0.46000000000000002 111.462 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.09 141.27 52.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.593 -0.73 . . . . 0.34999999999999998 110.34 179.55 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.467 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.4 ttp180 -117.56 138.88 51.62 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.573 -0.451 . . . . 3.6699999999999999 111.598 -179.4 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.486 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.23 164.15 37.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.59 -0.732 . . . . 0.67000000000000004 109.513 179.452 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.572 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 46.9 p30 -145.27 151.56 38.55 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.374 -0.53 . . . . 1.47 111.059 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.28 172.76 13.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.74 -0.664 . . . . 0.44 111.012 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.71 160.61 21.54 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.483 -0.781 . . . . 1.3700000000000001 109.937 179.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.38 121.88 22.96 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.548 -0.461 . . . . 1.28 110.742 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.541 ' O ' ' CB ' ' A' ' 93' ' ' SER . 70.1 p -124.86 154.63 40.75 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 113.092 0.775 . . . . 1.97 113.092 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.96 ' O ' ' HB3' ' A' ' 65' ' ' PRO . 27.6 t . . . . . 0 C--O 1.216 -0.674 0 CA-C-N 113.607 -1.633 . . . . 3.2799999999999998 108.04 -178.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.601 ' CB ' ' HB ' ' A' ' 201' ' ' THR . 33.5 p . . . . . 0 CA--C 1.52 -0.174 0 CA-C-O 122.571 1.177 . . . . 0.66000000000000003 109.69 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.436 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.93 167.58 0.26 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.208 -1.36 . . . . 0.68999999999999995 110.979 -178.914 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.52 145.57 50.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.727 -0.669 . . . . 0.52000000000000002 110.169 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.28 101.67 9.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.075 -0.713 . . . . 0.32000000000000001 109.075 177.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.1 t -112.94 139.6 37.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.018 -0.537 . . . . 0.28999999999999998 111.117 -178.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.9 p -128.58 152.55 48.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.692 -0.686 . . . . 0.25 109.839 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.594 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.82 -164.97 2.04 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.661 -0.416 . . . . 0.31 110.655 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.734 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.9 t -123.88 127.23 73.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.48999999999999999 110.891 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.168 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.98 58.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 1.53 110.322 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.07 24.5 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 0.96999999999999997 111.574 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.168 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.2 128.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.622 -0.431 . . . . 1.5600000000000001 110.919 179.905 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.55 -9.51 55.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.92 -0.582 . . . . 1.8799999999999999 110.354 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.18 0.18 55.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.086 -0.506 . . . . 1.04 110.275 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.721 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.16 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.976 -0.556 . . . . 0.23999999999999999 109.881 179.757 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 185' ' ' ILE . 89.3 p -96.2 -15.53 21.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.313 0.578 . . . . 0.28999999999999998 110.101 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.64 175.64 45.87 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 109.891 -1.284 . . . . 0.13 109.891 179.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.51 151.54 42.69 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.605 -0.438 . . . . 0.17000000000000001 110.55 179.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.536 ' CZ ' ' HG3' ' A' ' 15' ' ' PRO . 64.1 ttp85 -132.2 121.14 23.21 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.148 -0.478 . . . . 1.29 109.936 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.551 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.11 136.48 38.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.782 -0.644 . . . . 0.25 110.713 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 80.2 tt0 -129.28 129.85 45.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.879 -0.6 . . . . 1.3200000000000001 110.121 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.618 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.3 p90 -138.66 135.34 34.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.998 -0.546 . . . . 0.56999999999999995 110.614 -179.686 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.422 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.41 161.4 39.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.792 -0.64 . . . . 1.1599999999999999 109.617 179.84 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.961 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.15 124.95 25.61 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.606 -0.438 . . . . 0.38 110.749 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.502 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.84 -7.57 49.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.753 -0.658 . . . . 0.40999999999999998 110.916 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -109.87 -69.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.01 0.433 . . . . 1.6599999999999999 111.354 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.438 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.65 -35.36 76.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.066 -0.515 . . . . 1.6599999999999999 111.466 -179.093 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.091 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.13 7.23 88.59 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.763 -0.935 . . . . 1.1699999999999999 110.763 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.314 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.96 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.777 0.322 . . . . 1.8600000000000001 110.32 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.314 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.33 139.08 44.92 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.036 0.446 . . . . 1.98 110.192 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.422 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.89 145.81 51.61 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.778 2.318 . . . . 0.55000000000000004 112.309 -179.48 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.85 145.73 42.61 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.184 -0.673 . . . . 1.1399999999999999 109.184 179.237 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.624 ' CE1' ' CG ' ' A' ' 16' ' ' ASN . 7.6 p90 -123.35 141.36 52.06 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.249 -0.58 . . . . 0.93000000000000005 111.449 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.4 mt -128.11 127.64 43.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.228 -0.896 . . . . 0.34000000000000002 109.039 178.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -101.66 131.18 48.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.199 0.523 . . . . 1.0900000000000001 111.72 -178.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.98 157.53 73.58 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.315 -0.857 . . . . 0.19 109.521 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -69.81 158.02 58.3 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 122.307 2.005 . . . . 0.17999999999999999 112.291 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.13 -12.25 4.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.831 -0.622 . . . . 0.20999999999999999 110.759 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.86 -8.82 42.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.103 -0.499 . . . . 0.28999999999999998 110.676 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.06 135.27 34.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.35 -0.386 . . . . 0.5 110.473 179.675 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.9 p -133.06 16.66 4.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.489 -0.323 . . . . 0.29999999999999999 110.573 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.1 p -167.53 147.12 5.09 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.624 -0.51 . . . . 0.23000000000000001 109.624 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.551 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.18 150.5 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.564 -0.455 . . . . 0.28000000000000003 111.526 -179.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.507 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.24 124.91 50.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.566 -0.743 . . . . 1.0700000000000001 109.832 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.39 104.84 29.43 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.83 0.348 . . . . 0.28999999999999998 111.08 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.0 Cg_endo -90.92 -179.47 1.51 Allowed 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 123.186 2.591 . . . . 0.42999999999999999 112.172 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 61.59 32.61 18.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.331 -0.85 . . . . 1.26 111.476 179.256 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.8 mt -86.27 148.53 25.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.469 -0.332 . . . . 0.32000000000000001 110.522 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.766 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.4 mt -88.28 114.89 61.45 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.959 0.409 . . . . 0.57999999999999996 110.721 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.12 140.61 95.81 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.826 2.351 . . . . 0.66000000000000003 112.01 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.11 21.17 74.32 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.028 -0.829 . . . . 0.28999999999999998 111.028 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.438 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.8 mmm-85 -126.83 150.31 49.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 2.3300000000000001 110.625 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.502 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.28 131.65 46.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.978 -0.555 . . . . 0.85999999999999999 109.814 179.316 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.961 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.55 148.36 43.96 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.113 -0.494 . . . . 0.52000000000000002 110.974 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.5 mt -105.35 125.38 60.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.296 -1.002 . . . . 0.29999999999999999 108.296 177.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.52 132.44 63.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.177 0.513 . . . . 0.23000000000000001 111.222 -178.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.62 20.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.64 -0.709 . . . . 0.35999999999999999 109.633 179.216 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.594 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.97 125.46 54.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 0.19 110.71 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.26 137.87 52.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.048 -0.524 . . . . 0.29999999999999999 109.891 179.51 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.579 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.73 135.06 42.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.765 -0.828 . . . . 0.37 108.765 178.887 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.744 HG21 ' HD3' ' A' ' 61' ' ' LYS . 63.1 mt -99.03 122.91 51.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.106 0.479 . . . . 0.26000000000000001 110.956 -178.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.4 p -83.88 169.66 14.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.563 -0.744 . . . . 0.28000000000000003 110.54 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -59.76 -14.49 14.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.085 -0.507 . . . . 1.6000000000000001 110.914 -179.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 94.7 m-20 -96.13 -4.31 42.97 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.79 -0.364 . . . . 1.1799999999999999 110.769 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.82 13.96 63.83 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.316 -0.713 . . . . 0.29999999999999999 111.316 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -84.64 139.13 32.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.642 0.258 . . . . 1.22 110.443 179.658 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.571 HE22 ' HD2' ' A' ' 15' ' ' PRO . 41.0 mt-30 -106.79 141.06 38.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.97 0.414 . . . . 0.97999999999999998 110.552 179.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.1 m -136.62 127.11 26.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.487 . . . . 0.82999999999999996 110.408 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.2 117.31 9.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.39 -0.368 . . . . 0.26000000000000001 110.438 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 43.9 pt -109.09 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.29999999999999999 110.744 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.92 125.68 5.83 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.477 -0.489 . . . . 0.31 111.475 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.474 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.71 120.21 21.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.731 -0.668 . . . . 0.28000000000000003 109.58 179.191 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.58 151.69 29.15 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.71 -0.396 . . . . 0.23999999999999999 110.881 -179.242 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.54 158.58 18.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.23000000000000001 110.339 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.4 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 21.6 mt-30 -146.03 157.94 43.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.031 -0.531 . . . . 0.67000000000000004 110.714 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.39 9.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.753 -0.658 . . . . 0.64000000000000001 110.05 179.568 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.601 ' HB ' ' CB ' ' A' ' 126' ' ' SER . 67.9 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 117.829 -1.081 . . . . 1.26 110.619 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.5 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.196 -0.668 . . . . 3.4399999999999999 109.196 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.64 18.55 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.999 -0.84 . . . . 1.22 110.999 179.753 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -35.5 142.39 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 124.002 3.135 . . . . 0.75 113.794 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.607 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.3 t -80.06 173.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.246 -1.343 . . . . 0.79000000000000004 108.825 178.451 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.607 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.55 125.98 51.6 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.45 -0.5 . . . . 1.9399999999999999 111.412 -179.567 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.62 143.91 34.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.658 -0.701 . . . . 0.59999999999999998 110.667 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.4 25.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.925 0.393 . . . . 3.1400000000000001 111.042 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.742 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -109.06 131.05 60.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.926 -0.579 . . . . 3.23 110.091 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.8 p -141.17 162.37 35.64 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.438 -0.347 . . . . 3.6299999999999999 111.249 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 9' ' ' THR . 96.3 mt-10 35.98 31.65 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.616 -0.513 . . . . 6.0800000000000001 109.616 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.742 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.51 69.64 33.42 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.007 -0.542 . . . . 3.3799999999999999 111.609 -178.833 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.23 -29.18 73.3 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.5 2.133 . . . . 3.9300000000000002 111.868 179.32 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.63 125.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.493 . . . . 3.3599999999999999 110.514 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.716 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -123.89 158.39 60.17 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.306 -0.407 . . . . 3.6099999999999999 110.45 -179.988 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.562 ' HG3' ' CZ ' ' A' ' 143' ' ' ARG . 98.2 Cg_endo -82.1 -64.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.916 2.411 . . . . 1.51 113.44 -178.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.462 ' OD1' ' HB2' ' A' ' 157' ' ' TYR . 6.5 m120 -108.4 -19.52 13.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.065 0.394 . . . . 2.6800000000000002 112.065 -178.48 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.716 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 7.0 p -107.48 152.0 24.81 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.436 -0.506 . . . . 1.21 111.28 -179.361 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.57 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.18 102.94 2.25 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.709 -0.678 . . . . 1.5600000000000001 110.654 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -82.74 145.64 12.93 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.879 2.386 . . . . 0.81000000000000005 112.577 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.912 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.85 167.96 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.871 -0.604 . . . . 1.52 109.892 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -149.12 147.97 29.12 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.708 -0.478 . . . . 2.1400000000000001 109.708 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.593 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.3 157.23 45.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.04 0.448 . . . . 0.32000000000000001 111.188 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.49 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -128.03 155.19 44.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.705 -0.679 . . . . 2.1699999999999999 110.101 179.055 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.84 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.58 173.01 6.39 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.155 0.503 . . . . 0.58999999999999997 110.688 -179.153 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.84 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.62 173.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 122.831 2.354 . . . . 0.90000000000000002 111.555 179.365 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.484 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.04 -51.13 0.69 Allowed Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.76 -0.376 . . . . 3.3399999999999999 110.074 179.831 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.623 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.81 152.35 82.45 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.813 2.342 . . . . 1.8500000000000001 111.426 179.259 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.76 42.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.418 0.628 . . . . 2.54 110.526 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.818 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.54 -41.71 98.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.964 -1.016 . . . . 2.5299999999999998 110.642 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.53 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.7 mt -109.8 137.79 40.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.857 -0.611 . . . . 1.1699999999999999 111.305 -179.416 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.95 -72.92 0.7 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.105 -0.498 . . . . 1.27 111.891 -178.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.16 148.43 24.42 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.571 0.582 . . . . 1.1200000000000001 112.571 -179.649 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.79 124.83 45.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.36 -0.607 . . . . 0.41999999999999998 109.36 177.493 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -117.97 134.72 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.685 -0.406 . . . . 0.78000000000000003 110.676 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.912 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.01 128.65 53.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.421 . . . . 0.62 111.233 179.742 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.551 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 138.89 49.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.766 -0.652 . . . . 1.97 110.156 178.998 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.438 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -144.99 163.25 34.76 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.118 0.485 . . . . 0.34999999999999998 112.113 -178.114 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.491 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.53 139.55 7.81 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.493 -0.776 . . . . 1.8 110.485 178.887 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.59 115.44 3.05 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.279 1.986 . . . . 0.57999999999999996 111.865 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.673 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.95 81.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.925 -0.398 . . . . 3.04 109.925 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.921 -0.582 . . . . 2.4700000000000002 111.95 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -157.68 157.76 34.15 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.813 -0.355 . . . . 2.5099999999999998 110.523 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.37 27.9 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 1.8600000000000001 110.147 179.569 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.83 -75.91 1.31 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.154 -0.546 . . . . 1.4399999999999999 111.832 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.4 mtp180 -117.82 152.33 35.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.943 0.401 . . . . 4.6900000000000004 110.959 -179.32 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.35 -169.11 2.51 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.976 -0.556 . . . . 1.4299999999999999 111.954 179.271 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.436 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.05 149.61 29.76 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.483 0.659 . . . . 1.74 112.532 -177.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.02 156.5 46.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.788 -1.096 . . . . 1.9199999999999999 110.199 178.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.24 158.42 41.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.932 -0.576 . . . . 0.34000000000000002 111.777 -179.407 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.3 m -115.13 135.62 54.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.479 -0.782 . . . . 0.40999999999999998 109.838 179.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.593 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.4 122.04 23.79 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.444 -0.344 . . . . 0.55000000000000004 111.497 -179.164 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.4 Cg_exo -46.43 151.78 1.69 Allowed 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.692 2.261 . . . . 0.44 112.128 179.046 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.0 -22.99 63.21 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 116.044 -0.526 . . . . 0.73999999999999999 112.728 -179.116 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.54 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.83 -16.8 46.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.383 0.592 . . . . 0.93000000000000005 111.818 -178.352 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.603 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.68 138.37 31.62 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.716 -0.393 . . . . 0.96999999999999997 110.25 179.387 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.5 14.06 11.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.342 -0.39 . . . . 1.3400000000000001 111.601 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.472 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -150.0 143.39 25.16 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.682 -0.407 . . . . 0.39000000000000001 111.07 179.607 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.709 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.84 -169.33 1.53 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.222 0.534 . . . . 0.41999999999999998 110.844 -179.439 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.709 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.75 125.87 9.23 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.439 -0.8 . . . . 0.39000000000000001 109.887 179.283 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.513 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.85 123.3 70.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.372 -0.531 . . . . 0.73999999999999999 111.143 -179.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.632 ' CD ' HD13 ' A' ' 185' ' ' ILE . 56.1 mtmt -126.59 163.4 23.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.827 -0.624 . . . . 2.48 110.381 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.11 18.93 60.01 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.817 -0.913 . . . . 0.5 110.817 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.513 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.3 mt -79.04 157.32 28.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.106 0.479 . . . . 0.57999999999999996 111.369 -179.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.846 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -99.53 134.0 21.48 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.601 -0.727 . . . . 2.79 110.404 179.811 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.94 143.59 61.1 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.533 2.155 . . . . 0.87 111.925 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.88 25.51 75.48 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 111.056 -0.818 . . . . 0.64000000000000001 111.056 179.685 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.846 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.07 158.91 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.667 0.27 . . . . 0.82999999999999996 110.421 -179.639 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.23 139.96 42.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.393 -0.367 . . . . 0.5 110.588 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.668 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 94.0 m-85 -122.65 136.52 54.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.906 -0.588 . . . . 0.53000000000000003 110.713 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.94 131.03 45.32 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.527 -0.916 . . . . 1.8700000000000001 108.527 177.661 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.48 153.89 16.65 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.331 -0.937 . . . . 0.28999999999999998 111.931 -178.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.02 140.88 45.99 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.69 -0.485 . . . . 1.4299999999999999 109.69 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.71 118.8 34.08 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.513 -0.475 . . . . 0.32000000000000001 110.509 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.725 HG12 HG23 ' A' ' 84' ' ' VAL . 63.7 mt -112.32 129.0 68.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.357 -0.383 . . . . 0.79000000000000004 110.707 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.708 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.79 120.76 43.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.374 -0.375 . . . . 1.02 110.785 -179.694 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.849 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.55 146.57 11.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.219 0.533 . . . . 0.62 111.017 -179.255 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.818 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.11 153.81 21.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.523 -0.762 . . . . 2.4399999999999999 109.948 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.25 88.66 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.012 0.434 . . . . 3.6899999999999999 110.448 -179.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.22 32.74 0.21 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.786 -0.643 . . . . 6.0800000000000001 110.56 -179.871 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.22 -117.41 3.27 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.443 -0.663 . . . . 1.22 111.443 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.471 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.31 177.3 9.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.168 0.509 . . . . 2.8799999999999999 111.635 -179.229 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.09 149.57 32.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.428 -0.805 . . . . 1.47 110.34 179.186 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.14 144.64 38.72 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.429 -0.35 . . . . 2.7000000000000002 110.509 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.725 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.06 136.09 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 121.056 0.455 . . . . 0.46000000000000002 111.525 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.559 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.05 141.26 52.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.653 -0.703 . . . . 0.34999999999999998 110.277 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.453 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.61 138.86 51.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.127 0.489 . . . . 3.6699999999999999 111.481 -179.374 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.3 164.2 37.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.534 -0.757 . . . . 0.67000000000000004 109.518 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.23 151.61 38.66 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.43 -0.508 . . . . 1.47 111.131 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.811 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.32 172.69 13.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.82 -0.627 . . . . 0.44 110.998 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.76 160.75 21.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.455 -0.793 . . . . 1.3700000000000001 109.897 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.39 121.91 22.98 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.584 -0.446 . . . . 1.28 110.67 -179.943 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.592 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.6 p -127.44 165.36 19.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.469 0.652 . . . . 1.97 112.562 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.211 -0.904 . . . . 3.2799999999999998 109.978 178.727 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.402 ' O ' HD12 ' A' ' 172' ' ' LEU . 20.9 p . . . . . 0 N--CA 1.464 0.267 0 CA-C-O 120.708 0.29 . . . . 0.66000000000000003 111.652 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.437 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.96 167.56 0.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.075 -0.511 . . . . 0.68999999999999995 110.946 -179.033 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.57 145.52 50.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.79 -0.641 . . . . 0.52000000000000002 110.078 -179.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.26 101.78 9.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.055 -0.72 . . . . 0.32000000000000001 109.055 177.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.2 t -113.05 139.72 36.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.28999999999999998 110.942 -178.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.2 p -128.74 152.63 48.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.588 -0.733 . . . . 0.25 109.781 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.594 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.83 -165.06 2.06 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.793 -0.363 . . . . 0.31 110.638 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -123.89 127.15 73.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.466 . . . . 0.48999999999999999 110.896 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.173 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.84 58.26 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.123 -0.489 . . . . 1.53 110.365 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.743 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.08 24.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.936 -0.575 . . . . 0.96999999999999997 111.44 -179.705 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.173 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.14 128.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.619 -0.432 . . . . 1.5600000000000001 110.881 179.853 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -86.49 -9.56 55.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.915 -0.584 . . . . 1.8799999999999999 110.311 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.5 p -87.17 0.27 55.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.141 -0.481 . . . . 1.04 110.286 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.725 HG12 ' O ' ' A' ' 136' ' ' SER . 2.6 p -65.18 137.16 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.011 -0.54 . . . . 0.23999999999999999 110.037 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.591 ' HB3' ' HZ1' ' A' ' 61' ' ' LYS . 69.4 m -96.19 -15.54 22.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.356 0.598 . . . . 0.28999999999999998 110.065 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 1.012 ' O ' HG22 ' A' ' 185' ' ' ILE . . . 178.6 175.55 45.77 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 109.881 -1.288 . . . . 0.13 109.881 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -123.36 151.64 42.32 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.698 -0.401 . . . . 0.17000000000000001 110.484 179.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.835 ' NH2' ' CE1' ' A' ' 157' ' ' TYR . 70.3 ttt-85 -132.42 121.26 23.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.059 0.457 . . . . 1.29 109.803 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.559 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.16 136.47 38.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.635 -0.711 . . . . 0.25 110.66 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.58 ' C ' ' CD ' ' A' ' 145' ' ' GLU . 0.3 OUTLIER -129.31 129.89 45.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.014 -0.539 . . . . 1.3200000000000001 110.037 -179.937 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.67 135.21 34.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.07 -0.513 . . . . 0.56999999999999995 110.673 -179.7 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.425 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.28 161.38 39.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.875 -0.602 . . . . 1.1599999999999999 109.728 179.823 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.957 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.0 mt -71.14 124.91 25.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.038 0.447 . . . . 0.38 110.649 -179.459 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.75 -7.76 50.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.787 -0.642 . . . . 0.40999999999999998 110.874 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -109.78 -69.68 0.85 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.913 0.387 . . . . 1.6599999999999999 111.347 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.435 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.67 -35.29 75.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.118 -0.492 . . . . 1.6599999999999999 111.505 -179.101 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.102 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.1 7.12 88.66 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.864 -0.894 . . . . 1.1699999999999999 110.864 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.327 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.89 -171.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.811 0.339 . . . . 1.8600000000000001 110.264 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.327 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.32 139.09 44.94 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-O 120.98 0.419 . . . . 1.98 110.211 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.425 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.89 145.86 51.7 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 C-N-CA 122.741 2.294 . . . . 0.55000000000000004 112.321 -179.516 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.95 145.73 42.69 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.211 -0.663 . . . . 1.1399999999999999 109.211 179.216 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.835 ' CE1' ' NH2' ' A' ' 143' ' ' ARG . 8.3 m-85 -123.22 141.37 52.05 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.358 -0.537 . . . . 0.93000000000000005 111.54 -179.089 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.2 mt -128.07 127.65 43.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.269 -0.878 . . . . 0.34000000000000002 108.986 178.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -101.62 131.19 47.97 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.162 0.506 . . . . 1.0900000000000001 111.791 -178.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.97 157.55 73.5 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.257 -0.883 . . . . 0.19 109.552 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.73 157.98 58.57 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.473 2.115 . . . . 0.17999999999999999 112.207 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.35 -12.08 5.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.764 -0.653 . . . . 0.20999999999999999 110.721 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.3 p -92.88 -8.68 42.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.185 -0.461 . . . . 0.28999999999999998 110.713 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.21 135.4 34.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.5 110.383 179.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.9 p -133.09 16.61 4.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.386 -0.37 . . . . 0.29999999999999999 110.548 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.5 p -167.54 147.11 5.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.58 -0.526 . . . . 0.23000000000000001 109.58 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.559 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.23 150.43 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.519 -0.472 . . . . 0.28000000000000003 111.542 -179.634 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.509 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.23 124.98 50.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.66 -0.7 . . . . 1.0700000000000001 109.845 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.45 104.92 30.11 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.43 -0.35 . . . . 0.28999999999999998 110.986 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.5 Cg_endo -91.02 -179.49 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 123.116 2.544 . . . . 0.42999999999999999 112.201 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.67 32.68 18.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.401 -0.818 . . . . 1.26 111.463 179.261 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 126' ' ' SER . 24.2 mt -86.39 148.51 25.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.455 -0.339 . . . . 0.32000000000000001 110.496 179.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.765 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.25 114.86 61.32 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.029 0.442 . . . . 0.57999999999999996 110.662 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.98 140.51 95.67 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.921 2.414 . . . . 0.66000000000000003 112.026 179.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.18 21.14 74.19 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.052 -0.819 . . . . 0.28999999999999998 111.052 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.435 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.86 150.21 49.36 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.966 -0.293 . . . . 2.3300000000000001 110.671 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.491 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.23 131.67 46.03 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.094 -0.503 . . . . 0.85999999999999999 109.782 179.32 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.957 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.1 m-85 -120.46 148.33 43.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.09 -0.504 . . . . 0.52000000000000002 111.056 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.4 125.3 60.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.284 -1.006 . . . . 0.29999999999999999 108.284 177.696 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.49 132.47 63.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.154 0.502 . . . . 0.23000000000000001 111.236 -178.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.43 122.56 20.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.509 -0.769 . . . . 0.35999999999999999 109.644 179.268 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.594 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.99 125.41 54.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.318 -0.401 . . . . 0.19 110.672 -179.512 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.8 m-85 -117.31 137.95 52.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.987 -0.551 . . . . 0.29999999999999999 109.793 179.585 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.576 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.75 134.99 42.9 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.778 -0.823 . . . . 0.37 108.778 178.917 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 1.012 HG22 ' O ' ' A' ' 141' ' ' GLY . 5.3 tt -99.18 122.99 51.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.204 0.526 . . . . 0.26000000000000001 110.891 -178.692 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.7 p -83.78 169.7 14.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.524 -0.762 . . . . 0.28000000000000003 110.46 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.81 -14.49 15.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.09 -0.505 . . . . 1.6000000000000001 110.933 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -96.14 -4.23 43.07 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.827 -0.349 . . . . 1.1799999999999999 110.807 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.83 13.8 64.08 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.349 -0.701 . . . . 0.29999999999999999 111.349 179.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -84.63 139.11 32.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.675 0.274 . . . . 1.22 110.453 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.522 HE22 ' HD2' ' A' ' 15' ' ' PRO . 77.3 mt-30 -106.71 141.02 38.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.36 . . . . 0.97999999999999998 110.588 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.2 m -136.71 127.01 26.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.82999999999999996 110.43 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.09 117.28 9.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.254 -0.43 . . . . 0.26000000000000001 110.507 -179.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.03 -21.75 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.29999999999999999 110.693 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.1 tp -156.88 125.64 5.84 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.542 -0.463 . . . . 0.31 111.477 -179.707 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.468 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.74 120.16 21.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.843 -0.617 . . . . 0.28000000000000003 109.554 179.188 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.6 151.74 29.18 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.642 -0.423 . . . . 0.23999999999999999 110.91 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.44 158.53 18.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.015 -0.539 . . . . 0.23000000000000001 110.406 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -146.03 157.93 43.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 0.67000000000000004 110.719 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.18 104.32 9.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.826 -0.624 . . . . 0.64000000000000001 110.083 179.526 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.7 p . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.914 -1.041 . . . . 1.26 110.637 -179.679 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.3 m . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.231 -0.655 . . . . 3.4399999999999999 109.231 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.72 18.53 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.952 -0.859 . . . . 1.22 110.952 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -35.54 142.4 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.106 0 C-N-CA 123.99 3.127 . . . . 0.75 113.733 -179.293 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.618 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -80.06 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 114.189 -1.369 . . . . 0.79000000000000004 108.837 178.372 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.618 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.62 125.82 51.43 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.407 -0.517 . . . . 1.9399999999999999 111.496 -179.568 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.46 144.02 33.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.685 -0.689 . . . . 0.59999999999999998 110.636 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.03 168.35 25.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.985 0.421 . . . . 3.1400000000000001 111.054 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.741 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.99 131.07 60.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.905 -0.589 . . . . 3.23 110.087 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 69.0 p -141.22 162.36 35.67 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.853 0.359 . . . . 3.6299999999999999 111.178 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 9' ' ' THR . 53.2 mp0 35.94 31.69 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.638 -0.505 . . . . 6.0800000000000001 109.638 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.741 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.55 32.47 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.932 -0.577 . . . . 3.3799999999999999 111.563 -178.817 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.24 -29.22 73.25 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.466 2.11 . . . . 3.9300000000000002 111.815 179.348 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.72 125.49 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.123 -0.489 . . . . 3.3599999999999999 110.574 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.658 ' O ' ' O ' ' A' ' 92' ' ' THR . 39.6 mt-30 -123.86 158.28 60.44 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.862 0.363 . . . . 3.6099999999999999 110.474 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.443 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 98.1 Cg_endo -82.05 -64.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.875 2.383 . . . . 1.51 113.474 -178.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.702 ' CG ' ' CD2' ' A' ' 157' ' ' TYR . 64.4 t30 -108.41 -19.68 13.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.287 -0.415 . . . . 2.6800000000000002 112.063 -178.468 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 43.0 t -107.26 152.07 24.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.14 0.495 . . . . 1.21 111.38 -179.438 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.573 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.3 102.92 2.22 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.725 -0.67 . . . . 1.5600000000000001 110.688 179.868 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.62 145.61 13.1 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.935 2.423 . . . . 0.81000000000000005 112.574 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.919 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.83 167.92 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.95 -0.568 . . . . 1.52 109.926 179.506 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.16 147.95 29.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.73 -0.47 . . . . 2.1400000000000001 109.73 178.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.597 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.27 157.28 45.01 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.597 -0.441 . . . . 0.32000000000000001 111.215 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.488 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.02 155.29 44.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.754 -0.657 . . . . 2.1699999999999999 110.12 178.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.831 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.55 173.1 6.28 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.172 -0.467 . . . . 0.58999999999999997 110.785 -179.229 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.831 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.61 173.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.902 2.401 . . . . 0.90000000000000002 111.555 179.32 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.48 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.05 -51.06 0.69 Allowed Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.757 -0.377 . . . . 3.3399999999999999 110.13 179.777 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.617 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.9 152.34 82.6 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.72 2.28 . . . . 1.8500000000000001 111.419 179.202 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.64 42.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.411 0.624 . . . . 2.54 110.614 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.814 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.66 -41.68 98.18 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.001 -0.999 . . . . 2.5299999999999998 110.626 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.7 mt -109.77 137.87 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.793 -0.64 . . . . 1.1699999999999999 111.315 -179.516 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.99 -72.93 0.7 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.996 -0.547 . . . . 1.27 111.84 -178.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -88.12 148.37 24.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.582 0.586 . . . . 1.1200000000000001 112.582 -179.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.78 124.91 45.31 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.328 -0.619 . . . . 0.41999999999999998 109.328 177.43 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.11 134.78 60.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.658 -0.417 . . . . 0.78000000000000003 110.617 179.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.919 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.01 128.61 53.7 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.62 111.236 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.07 138.97 49.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.814 -0.63 . . . . 1.97 110.18 178.956 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.432 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.07 163.14 35.17 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.1 0.476 . . . . 0.34999999999999998 112.094 -178.115 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.46 139.58 7.88 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.438 -0.801 . . . . 1.8 110.493 178.836 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.687 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.3 Cg_endo -63.65 115.52 3.11 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.265 1.977 . . . . 0.57999999999999996 111.807 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.676 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.94 81.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.908 -0.404 . . . . 3.04 109.908 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.687 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.992 -0.549 . . . . 2.4700000000000002 111.901 -179.517 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.9 p -157.64 157.71 34.11 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.882 -0.327 . . . . 2.5099999999999998 110.575 179.766 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.4 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.27 27.76 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.169 -0.469 . . . . 1.8600000000000001 110.19 179.544 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.77 -75.95 1.31 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.785 -0.526 . . . . 1.4399999999999999 111.785 -179.217 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.86 152.3 35.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 4.6900000000000004 111.0 -179.322 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.676 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.14 -169.11 2.54 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.028 -0.533 . . . . 1.4299999999999999 111.926 179.382 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.17 149.66 29.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.416 0.627 . . . . 1.74 112.598 -177.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.05 156.41 46.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.843 -1.072 . . . . 1.9199999999999999 110.262 178.667 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.23 158.29 41.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.933 -0.576 . . . . 0.34000000000000002 111.773 -179.31 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.04 135.67 53.96 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.483 -0.781 . . . . 0.40999999999999998 109.859 179.303 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.597 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.47 121.99 23.69 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.533 -0.303 . . . . 0.55000000000000004 111.585 -179.186 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.606 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.0 Cg_exo -46.31 151.71 1.63 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.727 2.285 . . . . 0.44 112.029 179.119 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.81 -23.19 63.04 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 116.049 -0.523 . . . . 0.73999999999999999 112.782 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.79 -16.74 46.64 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.213 -0.595 . . . . 0.93000000000000005 111.761 -178.259 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.606 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.6 mt -91.7 138.44 31.56 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.709 -0.396 . . . . 0.96999999999999997 110.298 179.381 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.46 13.85 11.04 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.392 -0.367 . . . . 1.3400000000000001 111.518 -179.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.475 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.7 p -150.01 143.45 25.18 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.65 -0.42 . . . . 0.39000000000000001 110.973 179.7 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.9 t80 -114.84 -169.48 1.56 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.043 -0.526 . . . . 0.41999999999999998 110.869 -179.404 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.711 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 t -151.67 125.91 9.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.412 -0.813 . . . . 0.39000000000000001 109.797 179.292 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.513 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.9 mt -114.85 123.32 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.356 -0.538 . . . . 0.73999999999999999 111.189 -179.808 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -126.56 163.3 23.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.894 -0.594 . . . . 2.48 110.448 179.746 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.476 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.14 19.03 59.77 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.75 -0.94 . . . . 0.5 110.75 -179.897 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.676 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.9 mt -79.05 157.3 28.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.124 0.488 . . . . 0.57999999999999996 111.301 -179.642 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.853 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -99.52 133.85 21.59 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.575 -0.739 . . . . 2.79 110.489 179.741 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.447 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.8 Cg_endo -67.81 143.74 62.47 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.454 2.103 . . . . 0.87 112.001 179.773 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.7 25.59 75.37 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.125 -0.79 . . . . 0.64000000000000001 111.125 179.774 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.853 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.21 158.66 40.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.648 0.261 . . . . 0.82999999999999996 110.439 -179.533 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.09 139.98 41.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.0 0.429 . . . . 0.5 110.535 -179.737 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.643 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.59 136.49 54.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.89 -0.595 . . . . 0.53000000000000003 110.689 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.92 130.96 45.32 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.523 -0.917 . . . . 1.8700000000000001 108.523 177.566 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.43 153.93 16.63 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.318 -0.944 . . . . 0.28999999999999998 111.999 -178.658 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.03 140.85 45.95 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.779 -0.452 . . . . 1.4299999999999999 109.779 179.585 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.5 tp -115.71 119.0 34.62 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.422 -0.511 . . . . 0.32000000000000001 110.48 179.757 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.51 129.02 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.332 -0.395 . . . . 0.79000000000000004 110.578 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.7 120.86 43.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.283 -0.417 . . . . 1.02 110.749 -179.754 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.853 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.53 146.47 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.116 0.484 . . . . 0.62 111.104 -179.375 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.814 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.06 153.82 21.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.581 -0.736 . . . . 2.4399999999999999 109.965 179.776 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.12 88.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.913 0.387 . . . . 3.6899999999999999 110.467 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.41 32.56 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.809 -0.632 . . . . 6.0800000000000001 110.51 179.998 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.02 -117.37 3.3 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.479 -0.648 . . . . 1.22 111.479 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.471 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.41 177.37 9.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.268 0.556 . . . . 2.8799999999999999 111.634 -179.244 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.17 149.48 32.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.485 -0.78 . . . . 1.47 110.415 179.179 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.1 144.69 38.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.489 -0.323 . . . . 2.7000000000000002 110.598 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.727 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.02 136.05 61.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-O 121.063 0.459 . . . . 0.46000000000000002 111.544 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.11 141.31 52.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.624 -0.717 . . . . 0.34999999999999998 110.214 179.695 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.469 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.55 138.88 51.62 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.111 0.481 . . . . 3.6699999999999999 111.538 -179.391 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.489 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.34 164.19 37.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.569 -0.741 . . . . 0.67000000000000004 109.405 179.37 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.572 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.28 151.6 38.6 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.369 -0.533 . . . . 1.47 111.062 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.8 p90 -146.23 172.7 13.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.778 -0.646 . . . . 0.44 111.033 179.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.72 160.69 21.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.483 -0.781 . . . . 1.3700000000000001 109.939 179.515 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.38 121.93 23.04 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.547 -0.461 . . . . 1.28 110.671 -179.932 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.658 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.7 p -128.45 165.74 20.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.099 -0.501 . . . . 1.97 110.497 179.636 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.4 t . . . . . 0 N--CA 1.464 0.242 0 C-N-CA 120.468 -0.493 . . . . 3.2799999999999998 109.914 178.812 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.272 0 CA-C-O 121.264 0.554 . . . . 0.66000000000000003 110.79 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.438 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.8 167.52 0.25 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.503 -0.771 . . . . 0.68999999999999995 110.942 179.419 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.6 145.51 50.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.704 -0.68 . . . . 0.52000000000000002 110.128 -179.879 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.27 101.65 9.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.087 -0.708 . . . . 0.32000000000000001 109.087 177.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.2 t -112.94 139.74 36.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.055 -0.52 . . . . 0.28999999999999998 111.033 -178.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 p -128.7 152.54 48.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.549 -0.75 . . . . 0.25 109.81 179.631 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.591 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.79 -164.93 2.03 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.769 -0.373 . . . . 0.31 110.64 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -123.99 127.15 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.183 -0.462 . . . . 0.48999999999999999 110.814 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.164 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.92 58.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 1.53 110.339 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.06 24.48 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.923 -0.581 . . . . 0.96999999999999997 111.465 -179.698 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.164 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.13 128.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.601 -0.44 . . . . 1.5600000000000001 110.918 179.801 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.46 -9.54 56.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.855 -0.611 . . . . 1.8799999999999999 110.309 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.8 p -87.1 0.25 55.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.073 -0.512 . . . . 1.04 110.343 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.29 137.26 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.016 -0.538 . . . . 0.23999999999999999 109.982 179.69 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 185' ' ' ILE . 71.1 m -96.24 -15.55 21.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.239 0.542 . . . . 0.28999999999999998 110.0 -179.629 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.59 175.54 45.76 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 109.845 -1.302 . . . . 0.13 109.845 179.707 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.48 151.58 42.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.989 0.423 . . . . 0.17000000000000001 110.43 179.78 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.834 ' HE ' ' NE2' ' A' ' 191' ' ' GLN . 62.5 ttp85 -132.38 121.18 23.07 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.145 -0.479 . . . . 1.29 109.977 179.744 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.546 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.01 136.62 37.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.615 -0.721 . . . . 0.25 110.655 -179.755 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.501 ' CD ' ' O ' ' A' ' 156' ' ' GLN . 24.8 tp10 -129.41 129.9 45.28 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.933 -0.576 . . . . 1.3200000000000001 110.067 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.2 p90 -138.72 135.3 34.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.962 -0.563 . . . . 0.56999999999999995 110.627 -179.717 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.415 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.33 161.35 39.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.815 -0.629 . . . . 1.1599999999999999 109.682 179.79 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.967 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.02 124.83 25.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.049 0.452 . . . . 0.38 110.747 -179.596 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.499 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.74 -7.69 49.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.704 -0.68 . . . . 0.40999999999999998 110.779 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -109.86 -69.76 0.85 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.937 0.399 . . . . 1.6599999999999999 111.336 -179.231 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.447 ' CD ' HH21 ' A' ' 176' ' ' ARG . 53.9 mt-10 -60.61 -35.39 76.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.111 -0.495 . . . . 1.6599999999999999 111.493 -179.083 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.089 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.18 7.23 88.6 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.808 -0.917 . . . . 1.1699999999999999 110.808 -179.854 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.32 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.91 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.835 0.35 . . . . 1.8600000000000001 110.262 179.861 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.32 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.29 139.1 45.05 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.974 0.416 . . . . 1.98 110.126 179.619 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.415 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.5 Cg_endo -70.92 145.81 51.38 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 122.71 2.273 . . . . 0.55000000000000004 112.275 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.85 145.75 42.59 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.243 -0.651 . . . . 1.1399999999999999 109.243 179.16 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.702 ' CD2' ' CG ' ' A' ' 16' ' ' ASN . 27.3 p90 -123.26 141.34 52.08 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.296 -0.561 . . . . 0.93000000000000005 111.57 -179.115 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.09 127.76 43.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.313 -0.858 . . . . 0.34000000000000002 108.978 178.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -101.68 131.1 48.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.171 0.51 . . . . 1.0900000000000001 111.747 -178.733 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.88 157.51 73.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.248 -0.887 . . . . 0.19 109.624 179.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.76 158.02 58.4 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.464 2.109 . . . . 0.17999999999999999 112.297 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.21 -12.25 5.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.879 -0.6 . . . . 0.20999999999999999 110.696 -179.839 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.2 p -92.81 -8.73 42.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.28999999999999998 110.724 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.23 135.33 34.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.348 -0.387 . . . . 0.5 110.374 179.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.1 p -133.12 16.68 4.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 0.29999999999999999 110.499 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.7 p -167.54 147.12 5.08 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.617 -0.512 . . . . 0.23000000000000001 109.617 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.546 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.12 150.49 12.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.495 -0.482 . . . . 0.28000000000000003 111.538 -179.636 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.507 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.32 124.8 50.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 1.0700000000000001 109.833 179.452 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.31 104.93 29.7 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.915 0.388 . . . . 0.28999999999999998 111.077 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.2 Cg_endo -91.02 -179.47 1.48 Allowed 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 123.177 2.585 . . . . 0.42999999999999999 112.18 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.69 32.59 18.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.382 -0.826 . . . . 1.26 111.422 179.276 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.1 mt -86.31 148.53 25.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.52 -0.309 . . . . 0.32000000000000001 110.501 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.77 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.34 114.84 61.28 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.041 0.448 . . . . 0.57999999999999996 110.631 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.0 140.6 96.09 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.871 2.381 . . . . 0.66000000000000003 111.94 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.03 21.2 74.47 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.032 -0.827 . . . . 0.28999999999999998 111.032 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.447 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.81 150.31 49.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.784 0.326 . . . . 2.3300000000000001 110.677 179.882 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.499 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.28 131.58 46.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.097 -0.501 . . . . 0.85999999999999999 109.773 179.377 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.967 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.2 m-85 -120.45 148.31 43.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.111 -0.495 . . . . 0.52000000000000002 111.022 -179.806 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.32 125.36 60.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.271 -1.011 . . . . 0.29999999999999999 108.271 177.726 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.55 132.45 63.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.139 0.495 . . . . 0.23000000000000001 111.218 -178.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.46 20.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.594 -0.73 . . . . 0.35999999999999999 109.682 179.286 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.591 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.7 t -100.84 125.32 54.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.291 -0.413 . . . . 0.19 110.798 -179.585 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.806 ' CD2' ' NH2' ' A' ' 143' ' ' ARG . 48.5 m-85 -117.18 137.84 52.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.103 -0.499 . . . . 0.29999999999999999 109.875 179.535 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.584 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.62 135.03 42.69 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.853 -0.795 . . . . 0.37 108.853 178.814 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.606 ' O ' ' N ' ' A' ' 140' ' ' SER . 84.8 mt -99.09 122.93 51.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.1 0.476 . . . . 0.26000000000000001 110.923 -178.724 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.1 p -83.91 169.75 14.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.566 -0.743 . . . . 0.28000000000000003 110.481 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -59.82 -14.47 15.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.096 -0.502 . . . . 1.6000000000000001 110.938 -179.539 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -96.11 -4.25 43.15 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.863 -0.335 . . . . 1.1799999999999999 110.758 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.449 ' N ' ' HB ' ' A' ' 59' ' ' THR . . . 87.75 13.84 64.18 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.431 -0.668 . . . . 0.29999999999999999 111.431 179.884 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -84.62 139.0 32.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.622 0.248 . . . . 1.22 110.443 179.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.834 ' NE2' ' HE ' ' A' ' 143' ' ' ARG . 86.6 mt-30 -106.62 141.02 38.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.871 0.367 . . . . 0.97999999999999998 110.639 179.682 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.6 m -136.68 127.04 26.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 0.82999999999999996 110.431 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.17 117.35 9.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.348 -0.387 . . . . 0.26000000000000001 110.507 -179.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.1 -21.81 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.125 -0.489 . . . . 0.29999999999999999 110.652 -179.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.9 125.68 5.84 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.489 -0.484 . . . . 0.31 111.479 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.473 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.73 120.33 21.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.756 -0.656 . . . . 0.28000000000000003 109.504 179.165 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.67 151.67 29.04 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.659 -0.416 . . . . 0.23999999999999999 110.952 -179.314 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.45 158.58 18.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.523 . . . . 0.23000000000000001 110.467 179.707 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.4 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 21.5 mt-30 -146.08 157.93 43.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.046 -0.525 . . . . 0.67000000000000004 110.527 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.21 104.41 9.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.728 -0.669 . . . . 0.64000000000000001 110.088 179.44 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 117.839 -1.077 . . . . 1.26 110.659 -179.712 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.219 -0.66 . . . . 3.4399999999999999 109.219 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.36 150.81 18.52 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.012 -0.835 . . . . 1.22 111.012 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -35.81 142.43 0.11 Allowed 'Trans proline' 0 C--N 1.297 -2.141 0 C-N-CA 123.975 3.117 . . . . 0.75 113.761 -179.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -79.9 173.4 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.196 -1.365 . . . . 0.79000000000000004 108.839 178.425 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.616 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.62 125.9 51.52 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.412 -0.515 . . . . 1.9399999999999999 111.421 -179.662 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.47 144.01 33.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.613 -0.721 . . . . 0.59999999999999998 110.649 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.01 168.33 25.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.837 0.351 . . . . 3.1400000000000001 111.215 -179.762 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.74 HG22 ' OG1' ' A' ' 11' ' ' THR . 65.9 mt -108.95 131.16 60.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.053 -0.521 . . . . 3.23 110.074 179.864 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.8 p -141.26 162.25 35.93 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.835 0.35 . . . . 3.6299999999999999 111.223 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 9' ' ' THR . 98.0 mt-10 36.21 31.51 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.636 -0.505 . . . . 6.0800000000000001 109.636 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.74 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.66 32.71 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.939 -0.573 . . . . 3.3799999999999999 111.587 -178.787 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.641 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.24 -29.28 73.21 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.529 2.153 . . . . 3.9300000000000002 111.82 179.391 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.641 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.71 125.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 3.3599999999999999 110.43 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.666 ' CG ' HE22 ' A' ' 191' ' ' GLN . 10.2 mp0 -124.05 158.28 60.97 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.405 . . . . 3.6099999999999999 110.432 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.57 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 96.4 Cg_endo -81.94 -64.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.935 2.423 . . . . 1.51 113.547 -179.037 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.813 ' ND2' ' CD1' ' A' ' 157' ' ' TYR . 7.3 m-20 -108.39 -19.55 13.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.262 -0.426 . . . . 2.6800000000000002 112.084 -178.551 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 37.5 t -107.3 152.08 24.61 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.488 -0.485 . . . . 1.21 111.322 -179.435 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.573 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.29 102.92 2.23 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.716 -0.675 . . . . 1.5600000000000001 110.705 179.803 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.63 145.68 13.12 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.928 2.419 . . . . 0.81000000000000005 112.522 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.923 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.9 168.02 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.86 -0.609 . . . . 1.52 109.919 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.17 147.94 29.04 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.736 -0.468 . . . . 2.1400000000000001 109.736 178.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.599 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.26 157.27 45.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.994 0.426 . . . . 0.32000000000000001 111.229 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.491 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.8 m-20 -128.02 155.27 44.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.86 -0.609 . . . . 2.1699999999999999 110.163 178.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.829 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.6 172.95 6.48 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.082 0.467 . . . . 0.58999999999999997 110.777 -179.197 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.829 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.59 173.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.836 2.357 . . . . 0.90000000000000002 111.597 179.351 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.06 -51.01 0.69 Allowed Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.729 -0.388 . . . . 3.3399999999999999 110.051 179.89 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.615 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.83 152.37 82.39 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.797 2.331 . . . . 1.8500000000000001 111.449 179.22 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.78 42.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.433 0.635 . . . . 2.54 110.554 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.813 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.65 -41.65 98.21 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.019 -0.991 . . . . 2.5299999999999998 110.702 179.727 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.4 mt -109.84 137.86 40.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.659 -0.701 . . . . 1.1699999999999999 111.24 -179.437 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.96 -72.89 0.7 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.017 -0.538 . . . . 1.27 111.933 -179.018 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.12 148.28 24.51 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.594 0.59 . . . . 1.1200000000000001 112.594 -179.661 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.74 124.83 45.16 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.43 -0.582 . . . . 0.41999999999999998 109.43 177.432 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.02 134.75 60.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.612 -0.435 . . . . 0.78000000000000003 110.611 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.923 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.97 128.65 53.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.042 0.448 . . . . 0.62 111.309 179.674 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.19 139.02 49.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.679 -0.692 . . . . 1.97 110.114 178.967 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.0 163.15 35.07 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.119 0.485 . . . . 0.34999999999999998 112.099 -178.094 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.49 139.6 7.86 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.406 -0.816 . . . . 1.8 110.533 178.728 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.686 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.8 Cg_endo -63.43 115.39 2.99 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.313 2.008 . . . . 0.57999999999999996 111.893 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.676 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.89 81.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.92 -0.4 . . . . 3.04 109.92 -179.856 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.686 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.023 -0.535 . . . . 2.4700000000000002 111.875 -179.41 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.2 p -157.63 157.87 34.44 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.787 -0.365 . . . . 2.5099999999999998 110.506 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.45 27.83 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.478 . . . . 1.8600000000000001 110.164 179.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.8 -75.87 1.31 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.157 -0.544 . . . . 1.4399999999999999 111.859 -179.255 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.89 152.29 35.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 4.6900000000000004 111.037 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.637 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.23 -169.17 2.55 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.041 -0.527 . . . . 1.4299999999999999 111.928 179.422 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.13 149.69 29.69 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.397 0.617 . . . . 1.74 112.615 -177.854 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.01 156.46 46.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.891 -1.05 . . . . 1.9199999999999999 110.326 178.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.19 158.37 41.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.038 -0.528 . . . . 0.34000000000000002 111.85 -179.317 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.8 m -115.17 135.67 53.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.5 -0.773 . . . . 0.40999999999999998 109.815 179.296 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.599 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.43 122.01 23.75 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.515 -0.311 . . . . 0.55000000000000004 111.511 -179.141 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.607 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.4 Cg_exo -46.48 151.81 1.71 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.668 2.245 . . . . 0.44 112.083 179.04 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.91 -23.08 63.13 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 116.033 -0.53 . . . . 0.73999999999999999 112.821 -179.249 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.5 p-80 -82.79 -16.77 46.56 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.167 -0.613 . . . . 0.93000000000000005 111.762 -178.293 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.607 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.69 138.47 31.54 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.766 -0.374 . . . . 0.96999999999999997 110.266 179.399 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.61 13.93 10.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.409 -0.36 . . . . 1.3400000000000001 111.476 -179.341 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -150.0 143.47 25.2 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.65 -0.42 . . . . 0.39000000000000001 111.093 179.522 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.9 t80 -114.77 -169.32 1.52 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.263 0.554 . . . . 0.41999999999999998 110.853 -179.386 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 1.003 HG21 ' O ' ' A' ' 187' ' ' GLU . 5.4 p -151.83 125.95 9.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.403 -0.817 . . . . 0.39000000000000001 109.737 179.284 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.97 123.32 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.278 -0.569 . . . . 0.73999999999999999 111.146 -179.797 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -126.57 163.41 23.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.835 -0.621 . . . . 2.48 110.371 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.04 19.04 59.9 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.743 -0.943 . . . . 0.5 110.743 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.514 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.4 mt -79.08 157.27 28.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.125 0.488 . . . . 0.57999999999999996 111.361 -179.694 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.856 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -99.49 133.9 21.57 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.562 -0.744 . . . . 2.79 110.406 179.838 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.446 ' HD3' ' CE2' ' A' ' 157' ' ' TYR . 36.9 Cg_endo -67.84 143.56 61.6 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.563 2.175 . . . . 0.87 111.893 179.799 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.88 25.58 75.39 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.999 -0.841 . . . . 0.64000000000000001 110.999 179.649 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.856 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.16 158.82 39.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.689 0.28 . . . . 0.82999999999999996 110.426 -179.641 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.12 139.98 41.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.344 -0.389 . . . . 0.5 110.637 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.643 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.6 m-85 -122.63 136.39 54.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.53000000000000003 110.753 -179.878 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.3 pt-20 -98.83 130.95 45.27 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.51 -0.922 . . . . 1.8700000000000001 108.51 177.615 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.42 153.86 16.63 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.365 -0.922 . . . . 0.28999999999999998 112.082 -178.711 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.98 140.86 46.02 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.709 -0.478 . . . . 1.4299999999999999 109.709 179.647 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.519 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.3 tp -115.69 118.91 34.38 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.493 -0.483 . . . . 0.32000000000000001 110.526 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.725 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.48 129.08 68.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.298 -0.41 . . . . 0.79000000000000004 110.648 -179.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.707 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.82 120.8 43.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.325 -0.398 . . . . 1.02 110.669 -179.558 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.854 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.56 146.4 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.089 0.471 . . . . 0.62 111.098 -179.299 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.813 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.1 mt-30 -106.01 153.86 21.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.601 -0.727 . . . . 2.4399999999999999 109.989 179.798 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.11 88.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.899 0.38 . . . . 3.6899999999999999 110.439 -179.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.3 32.66 0.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.791 -0.64 . . . . 6.0800000000000001 110.539 -179.915 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.16 -117.29 3.27 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.464 -0.654 . . . . 1.22 111.464 -179.765 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.469 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.1 m170 -81.5 177.45 8.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.234 0.54 . . . . 2.8799999999999999 111.571 -179.173 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.1 149.59 32.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.392 -0.822 . . . . 1.47 110.406 179.18 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.19 144.58 38.6 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.453 -0.34 . . . . 2.7000000000000002 110.629 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.725 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -127.96 136.02 61.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 120.582 -0.447 . . . . 0.46000000000000002 111.536 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.06 141.3 52.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.671 -0.695 . . . . 0.34999999999999998 110.347 179.595 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.472 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.55 138.88 51.62 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 120.588 -0.445 . . . . 3.6699999999999999 111.546 -179.329 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.35 164.17 38.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.604 -0.725 . . . . 0.67000000000000004 109.474 179.336 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.571 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.24 151.62 38.67 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.4 -0.52 . . . . 1.47 111.065 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.811 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.3 p90 -146.28 172.63 13.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.727 -0.67 . . . . 0.44 111.047 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.68 160.72 21.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.485 -0.78 . . . . 1.3700000000000001 109.846 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.39 121.89 22.97 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.558 -0.457 . . . . 1.28 110.784 179.913 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.601 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.8 p -128.0 162.8 25.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.14 -0.482 . . . . 1.97 111.126 179.706 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 109.914 -0.402 . . . . 3.2799999999999998 109.914 178.427 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 CA--C 1.522 -0.117 0 CA-C-O 120.904 0.383 . . . . 0.66000000000000003 110.278 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.435 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.88 167.54 0.26 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.917 -0.583 . . . . 0.68999999999999995 110.916 179.932 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.53 145.51 50.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.707 -0.679 . . . . 0.52000000000000002 110.196 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.21 101.74 9.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.064 -0.717 . . . . 0.32000000000000001 109.064 177.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.2 t -112.99 139.75 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.03 -0.532 . . . . 0.28999999999999998 111.008 -178.902 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.4 p -128.76 152.54 48.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.574 -0.739 . . . . 0.25 109.746 179.615 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.8 -164.96 2.04 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.657 -0.417 . . . . 0.31 110.578 -179.781 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -124.0 127.22 73.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.122 -0.49 . . . . 0.48999999999999999 110.793 -179.794 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.175 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -58.1 58.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.141 -0.481 . . . . 1.53 110.299 179.918 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.18 24.52 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.863 -0.608 . . . . 0.96999999999999997 111.476 -179.674 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.175 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.14 128.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.654 -0.418 . . . . 1.5600000000000001 111.0 179.842 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.39 -9.56 56.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.931 -0.577 . . . . 1.8799999999999999 110.352 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.6 p -87.1 0.17 55.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.073 -0.512 . . . . 1.04 110.297 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.22 137.22 25.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.977 -0.556 . . . . 0.23999999999999999 109.972 179.69 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.589 ' N ' ' O ' ' A' ' 185' ' ' ILE . 72.3 m -96.22 -15.66 21.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.296 0.569 . . . . 0.28999999999999998 110.055 -179.674 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.67 175.63 45.9 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 109.888 -1.285 . . . . 0.13 109.888 179.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.4 151.69 42.34 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.605 -0.438 . . . . 0.17000000000000001 110.501 179.719 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.865 HH12 ' NE2' ' A' ' 191' ' ' GLN . 52.9 ttp180 -132.37 121.27 23.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.128 -0.487 . . . . 1.29 109.883 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.557 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.1 136.49 38.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.698 -0.683 . . . . 0.25 110.693 -179.826 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 82.7 tt0 -129.34 129.89 45.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.973 -0.558 . . . . 1.3200000000000001 110.047 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.71 135.28 34.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.053 -0.521 . . . . 0.56999999999999995 110.623 -179.706 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.425 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.33 161.27 40.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.773 -0.649 . . . . 1.1599999999999999 109.705 179.84 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.962 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.0 mt -71.0 124.91 25.45 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.641 -0.424 . . . . 0.38 110.751 -179.568 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.76 -7.72 49.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.763 -0.653 . . . . 0.40999999999999998 110.913 -179.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -109.77 -69.69 0.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 1.6599999999999999 111.393 -179.28 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.45 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.4 mt-10 -60.64 -35.39 76.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.003 -0.544 . . . . 1.6599999999999999 111.45 -179.077 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.089 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.15 88.64 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.785 -0.926 . . . . 1.1699999999999999 110.785 -179.793 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.315 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.3 t0 -27.94 -171.71 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.725 0.297 . . . . 1.8600000000000001 110.283 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.315 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.14 45.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.043 0.449 . . . . 1.98 110.224 179.595 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.425 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 45.4 Cg_endo -70.96 145.88 51.34 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.729 2.286 . . . . 0.55000000000000004 112.248 -179.467 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.83 145.75 42.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.228 -0.656 . . . . 1.1399999999999999 109.228 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.813 ' CD1' ' ND2' ' A' ' 16' ' ' ASN . 21.3 p90 -123.31 141.33 52.1 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.377 -0.529 . . . . 0.93000000000000005 111.491 -179.115 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.6 mt -128.16 127.71 43.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.269 -0.878 . . . . 0.34000000000000002 108.872 178.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.499 ' O ' ' OD1' ' A' ' 159' ' ' ASP . 54.2 p-10 -101.62 131.1 48.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.195 0.522 . . . . 1.0900000000000001 111.751 -178.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.9 mt -127.87 157.55 73.29 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.318 -0.855 . . . . 0.19 109.617 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -69.89 158.07 58.01 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.297 1.998 . . . . 0.17999999999999999 112.251 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.25 -12.16 5.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.785 -0.643 . . . . 0.20999999999999999 110.684 -179.831 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.78 -8.8 42.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.28999999999999998 110.7 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.24 135.39 34.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.5 110.351 179.788 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.7 p -133.09 16.65 4.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.388 -0.369 . . . . 0.29999999999999999 110.573 179.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.3 p -167.56 147.17 5.07 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.59 -0.522 . . . . 0.23000000000000001 109.59 179.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.21 150.55 12.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.532 -0.467 . . . . 0.28000000000000003 111.535 -179.658 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.38 124.9 50.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.572 -0.74 . . . . 1.0700000000000001 109.851 179.463 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.33 104.85 29.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.385 -0.37 . . . . 0.28999999999999998 111.062 -179.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -90.96 -179.58 1.52 Allowed 'Trans proline' 0 C--N 1.301 -1.951 0 C-N-CA 123.28 2.653 . . . . 0.42999999999999999 112.211 179.909 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.73 32.64 18.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.407 -0.815 . . . . 1.26 111.449 179.271 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.2 mt -86.33 148.44 25.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.551 -0.295 . . . . 0.32000000000000001 110.509 179.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.767 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.4 mt -88.17 114.89 61.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.349 -0.387 . . . . 0.57999999999999996 110.702 -179.75 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.12 140.63 95.91 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.744 2.296 . . . . 0.66000000000000003 111.99 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.14 21.15 74.26 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.012 -0.835 . . . . 0.28999999999999998 111.012 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.45 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.86 150.24 49.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.847 0.356 . . . . 2.3300000000000001 110.682 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.26 131.65 46.08 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.044 -0.525 . . . . 0.85999999999999999 109.733 179.426 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.962 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.55 148.3 44.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.064 -0.516 . . . . 0.52000000000000002 111.048 -179.84 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.3 mt -105.31 125.41 60.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.218 -1.03 . . . . 0.29999999999999999 108.218 177.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.61 132.43 63.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.13 0.491 . . . . 0.23000000000000001 111.285 -178.632 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.41 122.46 20.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.519 -0.764 . . . . 0.35999999999999999 109.655 179.369 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.95 125.44 54.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.3 -0.409 . . . . 0.19 110.632 -179.516 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 49.4 m-85 -117.31 137.89 52.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.981 -0.554 . . . . 0.29999999999999999 109.802 179.53 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.583 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.68 135.08 42.69 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.776 -0.824 . . . . 0.37 108.776 178.837 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 140' ' ' SER . 78.1 mt -99.13 122.93 51.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.126 0.489 . . . . 0.26000000000000001 111.003 -178.805 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.9 p -83.9 169.71 14.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.546 -0.752 . . . . 0.28000000000000003 110.489 -179.646 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 1.003 ' O ' HG21 ' A' ' 59' ' ' THR . 97.8 mt-10 -59.74 -14.52 14.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.08 -0.509 . . . . 1.6000000000000001 111.01 -179.564 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -96.02 -4.32 43.34 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.837 -0.345 . . . . 1.1799999999999999 110.868 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.8 13.9 63.97 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.329 -0.708 . . . . 0.29999999999999999 111.329 179.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -84.72 139.0 32.31 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.01 -0.276 . . . . 1.22 110.462 179.652 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.865 ' NE2' HH12 ' A' ' 143' ' ' ARG . 2.3 mt-30 -106.61 141.11 38.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.877 0.37 . . . . 0.97999999999999998 110.536 179.789 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.0 m -136.8 127.0 26.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.82999999999999996 110.386 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.3 tp -68.17 117.2 9.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.318 -0.401 . . . . 0.26000000000000001 110.549 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -108.94 -21.84 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.29999999999999999 110.7 -179.694 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.86 125.76 5.9 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.559 -0.456 . . . . 0.31 111.513 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.69 120.2 21.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.756 -0.656 . . . . 0.28000000000000003 109.585 179.189 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.65 29.05 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.718 -0.393 . . . . 0.23999999999999999 110.87 -179.264 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.36 158.57 18.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.23000000000000001 110.48 179.664 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -146.09 158.01 43.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.095 -0.502 . . . . 0.67000000000000004 110.648 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.35 9.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.772 -0.649 . . . . 0.64000000000000001 110.013 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.7 p . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.94 -1.028 . . . . 1.26 110.66 -179.686 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.2 m . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.206 -0.664 . . . . 3.4399999999999999 109.206 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.438 ' H ' ' HB3' ' A' ' 1' ' ' SER . . . -116.33 150.73 18.54 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.999 -0.841 . . . . 1.22 110.999 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.62 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.061 0 C-N-CA 123.98 3.12 . . . . 0.75 113.788 -179.236 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.629 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -80.02 173.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.329 -1.305 . . . . 0.79000000000000004 108.772 178.412 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.629 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.63 125.89 51.51 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.41 -0.516 . . . . 1.9399999999999999 111.438 -179.558 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.55 143.93 34.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.656 -0.702 . . . . 0.59999999999999998 110.662 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.95 168.37 25.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.934 0.397 . . . . 3.1400000000000001 110.996 -179.625 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.737 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.98 131.08 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.893 -0.594 . . . . 3.23 110.057 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.18 162.37 35.66 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.828 0.347 . . . . 3.6299999999999999 111.253 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.2 mt-10 35.93 31.74 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.159 0.504 . . . . 6.0800000000000001 109.696 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.737 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.57 69.58 33.92 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.814 -0.63 . . . . 3.3799999999999999 111.492 -178.728 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.615 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.23 -29.16 73.24 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.444 2.096 . . . . 3.9300000000000002 111.794 179.318 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.615 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.68 125.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.228 -0.442 . . . . 3.3599999999999999 110.447 -179.926 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 17' ' ' SER . 3.1 mp0 -123.91 158.31 60.48 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 3.6099999999999999 110.494 179.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.443 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 97.6 Cg_endo -81.93 -64.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.0 2.467 . . . . 1.51 113.532 -179.005 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.716 ' CG ' ' CD1' ' A' ' 157' ' ' TYR . 66.5 t30 -108.37 -19.64 13.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.268 -0.424 . . . . 2.6800000000000002 112.08 -178.559 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 29.1 t -107.3 152.08 24.61 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.46 -0.496 . . . . 1.21 111.339 -179.398 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.33 102.98 2.22 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.734 -0.666 . . . . 1.5600000000000001 110.583 179.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.69 145.6 12.99 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.93 2.42 . . . . 0.81000000000000005 112.569 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.906 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.8 167.9 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.916 -0.584 . . . . 1.52 109.835 179.563 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.15 147.97 29.08 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.756 -0.461 . . . . 2.1400000000000001 109.756 178.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.598 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.24 157.28 45.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.026 0.441 . . . . 0.32000000000000001 111.235 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.499 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.0 155.35 44.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.83 -0.623 . . . . 2.1699999999999999 110.176 178.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.818 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.62 173.05 6.34 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.145 0.498 . . . . 0.58999999999999997 110.682 -179.129 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.818 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.71 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.851 2.368 . . . . 0.90000000000000002 111.501 179.367 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.98 -51.06 0.69 Allowed Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 120.767 -0.373 . . . . 3.3399999999999999 110.139 179.856 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.624 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.9 152.31 82.7 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.782 2.322 . . . . 1.8500000000000001 111.428 179.232 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.73 42.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.388 0.613 . . . . 2.54 110.526 -179.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.82 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.58 -41.64 98.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.988 -1.005 . . . . 2.5299999999999998 110.685 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.528 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.6 mt -109.93 137.84 40.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.771 -0.649 . . . . 1.1699999999999999 111.31 -179.488 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.0 -72.83 0.71 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.022 -0.536 . . . . 1.27 111.851 -178.948 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.24 148.33 24.4 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.604 0.594 . . . . 1.1200000000000001 112.604 -179.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.84 124.93 45.31 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.307 -0.627 . . . . 0.41999999999999998 109.307 177.572 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.8 mt -118.09 134.77 60.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.589 -0.444 . . . . 0.78000000000000003 110.685 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.906 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.06 128.61 53.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.036 0.446 . . . . 0.62 111.216 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.551 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.08 138.98 49.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.809 -0.632 . . . . 1.97 110.104 178.981 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.435 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.03 163.22 34.89 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 121.168 0.509 . . . . 0.34999999999999998 112.126 -178.222 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.494 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.47 139.62 7.89 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.444 -0.798 . . . . 1.8 110.449 178.861 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.68 115.62 3.17 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.261 1.974 . . . . 0.57999999999999996 111.781 179.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.02 81.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.879 -0.415 . . . . 3.04 109.879 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.23 -20.49 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.053 -0.522 . . . . 2.4700000000000002 111.898 -179.546 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 p -157.7 157.79 34.17 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.803 -0.359 . . . . 2.5099999999999998 110.527 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.402 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.4 m -120.34 27.76 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 1.8600000000000001 110.179 179.631 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.69 -76.05 1.32 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.793 -0.523 . . . . 1.4399999999999999 111.793 -179.211 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.403 ' HD2' HH11 ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.88 152.33 35.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.922 0.391 . . . . 4.6900000000000004 111.023 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.642 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.06 2.51 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.081 -0.509 . . . . 1.4299999999999999 111.948 179.372 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.17 149.66 29.77 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 112.59 0.589 . . . . 1.74 112.59 -177.812 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.01 156.45 46.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.826 -1.079 . . . . 1.9199999999999999 110.268 178.679 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.21 158.34 41.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.961 -0.563 . . . . 0.34000000000000002 111.778 -179.37 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 m -115.2 135.63 53.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.44 -0.8 . . . . 0.40999999999999998 109.759 179.291 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.598 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.31 121.98 23.89 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.341 -0.39 . . . . 0.55000000000000004 111.576 -179.157 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.5 Cg_exo -46.42 151.69 1.71 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.731 2.287 . . . . 0.44 112.068 179.052 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.8 -23.15 62.96 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 116.053 -0.521 . . . . 0.73999999999999999 112.783 -179.258 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.1 p-80 -82.66 -17.02 46.08 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.264 -0.574 . . . . 0.93000000000000005 111.798 -178.294 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.601 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.54 138.4 31.6 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.745 -0.382 . . . . 0.96999999999999997 110.29 179.506 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.51 13.93 11.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.487 -0.324 . . . . 1.3400000000000001 111.558 -179.385 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -150.04 143.54 25.21 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.633 -0.427 . . . . 0.39000000000000001 111.016 179.598 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.718 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.9 t80 -114.87 -169.35 1.53 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.209 0.528 . . . . 0.41999999999999998 110.836 -179.336 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.718 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.78 125.9 9.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.389 -0.823 . . . . 0.39000000000000001 109.806 179.278 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.504 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.8 mt -114.9 123.33 70.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.328 -0.549 . . . . 0.73999999999999999 111.111 -179.759 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.88 ' HD2' HG21 ' A' ' 185' ' ' ILE . 51.6 mtpt -126.57 163.31 23.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.788 -0.642 . . . . 2.48 110.491 179.667 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.464 ' HA2' HD21 ' A' ' 16' ' ' ASN . . . 85.25 18.91 59.83 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.749 -0.941 . . . . 0.5 110.749 -179.876 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.581 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 74.1 mt -79.12 157.34 27.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.099 0.476 . . . . 0.57999999999999996 111.381 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.861 ' O ' HG12 ' A' ' 67' ' ' VAL . 8.7 mttm -99.55 133.94 21.51 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.642 -0.708 . . . . 2.79 110.416 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.85 143.66 61.91 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.538 2.159 . . . . 0.87 111.931 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.82 25.44 75.56 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.098 -0.801 . . . . 0.64000000000000001 111.098 179.716 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.861 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.0 158.82 39.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.755 0.312 . . . . 0.82999999999999996 110.419 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.12 139.94 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.307 -0.406 . . . . 0.5 110.642 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.64 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.58 136.54 54.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.534 . . . . 0.53000000000000003 110.704 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.494 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -99.0 131.17 45.25 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.422 -0.955 . . . . 1.8700000000000001 108.422 177.647 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.485 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.66 153.84 16.69 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.246 -0.978 . . . . 0.28999999999999998 111.907 -178.595 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.94 140.9 46.1 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.734 -0.469 . . . . 1.4299999999999999 109.734 179.584 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.513 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.75 118.89 34.31 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.462 -0.495 . . . . 0.32000000000000001 110.522 179.679 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.744 HG12 HG23 ' A' ' 84' ' ' VAL . 64.2 mt -112.4 129.18 68.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.282 -0.417 . . . . 0.79000000000000004 110.6 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.71 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.9 120.83 43.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.227 -0.442 . . . . 1.02 110.698 -179.677 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.846 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.58 146.42 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.22 0.533 . . . . 0.62 111.018 -179.269 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.82 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.02 153.9 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.472 -0.786 . . . . 2.4399999999999999 109.864 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.434 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.05 88.47 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.875 0.369 . . . . 3.6899999999999999 110.499 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.631 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.26 32.63 0.21 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.868 -0.605 . . . . 6.0800000000000001 110.625 -179.867 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.14 -117.28 3.28 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.447 -0.661 . . . . 1.22 111.447 -179.746 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.472 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.39 177.35 9.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.126 0.489 . . . . 2.8799999999999999 111.681 -179.218 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.14 149.56 32.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.454 -0.794 . . . . 1.47 110.367 179.162 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.19 144.68 38.64 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.484 -0.325 . . . . 2.7000000000000002 110.593 179.865 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.744 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.04 135.93 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.065 0.46 . . . . 0.46000000000000002 111.53 -179.706 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.599 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -123.98 141.3 52.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.625 -0.716 . . . . 0.34999999999999998 110.247 179.692 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.481 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.61 138.87 51.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.091 0.472 . . . . 3.6699999999999999 111.527 -179.421 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.485 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.31 164.22 37.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.55 -0.75 . . . . 0.67000000000000004 109.455 179.393 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.576 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.28 151.56 38.54 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.384 -0.526 . . . . 1.47 110.985 -179.962 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.812 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.24 172.72 13.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.75 -0.659 . . . . 0.44 111.013 179.84 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.73 160.71 21.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.431 -0.804 . . . . 1.3700000000000001 109.889 179.572 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.34 121.82 22.92 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.612 -0.435 . . . . 1.28 110.757 -179.995 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.457 ' OG1' ' N ' ' A' ' 93' ' ' SER . 70.3 p -129.54 -122.56 0.22 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.252 0.549 . . . . 1.97 112.0 179.609 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.457 ' N ' ' OG1' ' A' ' 92' ' ' THR . 8.1 t . . . . . 0 C--N 1.347 0.457 0 CA-C-N 114.8 -1.091 . . . . 3.2799999999999998 111.057 -179.707 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 122.124 0.964 . . . . 0.66000000000000003 110.191 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.446 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.79 167.54 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.676 -1.147 . . . . 0.68999999999999995 110.955 -179.956 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.55 145.65 50.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.626 -0.715 . . . . 0.52000000000000002 110.087 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.38 101.65 9.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.027 -0.731 . . . . 0.32000000000000001 109.027 177.724 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.4 t -112.9 139.66 36.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.018 -0.537 . . . . 0.28999999999999998 111.049 -178.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.0 p -128.7 152.5 48.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.598 -0.728 . . . . 0.25 109.83 179.588 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.584 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.9 p90 -144.74 -164.86 2.01 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.738 -0.385 . . . . 0.31 110.727 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -124.01 127.18 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.259 -0.428 . . . . 0.48999999999999999 110.838 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.144 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.97 58.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 1.53 110.292 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.2 24.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.993 -0.549 . . . . 0.96999999999999997 111.514 -179.66 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.144 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.14 128.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.639 -0.425 . . . . 1.5600000000000001 110.961 179.828 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.47 -9.57 55.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.918 -0.583 . . . . 1.8799999999999999 110.357 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.2 p -87.06 0.17 55.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 1.04 110.332 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.29 137.19 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.951 -0.568 . . . . 0.23999999999999999 110.009 179.776 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.583 ' N ' ' O ' ' A' ' 185' ' ' ILE . 84.8 p -96.16 -15.58 22.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.355 0.597 . . . . 0.28999999999999998 110.062 -179.602 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.61 175.59 45.81 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 109.882 -1.287 . . . . 0.13 109.882 179.651 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.42 151.49 42.57 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.701 -0.4 . . . . 0.17000000000000001 110.558 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.841 ' NH2' ' CD2' ' A' ' 183' ' ' TYR . 66.7 ttp85 -132.27 121.27 23.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.19 -0.459 . . . . 1.29 109.94 179.751 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.537 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.1 136.62 38.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.738 -0.664 . . . . 0.25 110.695 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 21.7 tp10 -129.46 129.85 45.13 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.004 -0.543 . . . . 1.3200000000000001 110.013 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.613 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.4 p90 -138.74 135.26 34.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.983 -0.553 . . . . 0.56999999999999995 110.537 -179.678 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.421 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.28 161.34 39.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.729 -0.669 . . . . 1.1599999999999999 109.679 179.766 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.961 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -70.96 124.77 25.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.04 0.448 . . . . 0.38 110.772 -179.624 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.76 -7.62 49.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.737 -0.665 . . . . 0.40999999999999998 110.908 -179.781 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -109.83 -69.69 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.304 -0.407 . . . . 1.6599999999999999 111.433 -179.314 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.452 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.72 -35.26 75.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.056 -0.52 . . . . 1.6599999999999999 111.529 -179.119 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.096 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.19 88.62 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.828 -0.909 . . . . 1.1699999999999999 110.828 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.318 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -28.06 -171.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 1.8600000000000001 110.317 179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.318 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.16 139.05 45.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 1.98 110.237 179.61 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.91 145.82 51.49 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 122.702 2.268 . . . . 0.55000000000000004 112.366 -179.554 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.8 145.7 42.6 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.287 -0.635 . . . . 1.1399999999999999 109.287 179.235 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.716 ' CD1' ' CG ' ' A' ' 16' ' ' ASN . 49.3 p90 -123.29 141.43 51.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.209 0.528 . . . . 0.93000000000000005 111.489 -179.069 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.6 mt -128.17 127.61 43.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.25 -0.886 . . . . 0.34000000000000002 108.988 178.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 40.7 t0 -101.67 131.22 48.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.202 0.525 . . . . 1.0900000000000001 111.679 -178.698 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.578 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -127.88 157.59 73.19 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.23 -0.896 . . . . 0.19 109.679 179.614 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.78 157.91 58.72 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 C-N-CA 122.51 2.14 . . . . 0.17999999999999999 112.241 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.2 -12.18 4.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.781 -0.645 . . . . 0.20999999999999999 110.768 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.6 p -92.85 -8.69 42.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.068 -0.515 . . . . 0.28999999999999998 110.717 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.29 135.46 34.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.349 -0.387 . . . . 0.5 110.349 179.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.4 p -133.19 16.64 4.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.402 -0.363 . . . . 0.29999999999999999 110.531 -179.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.7 p -167.55 147.09 5.06 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.651 -0.5 . . . . 0.23000000000000001 109.651 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.537 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.18 150.51 12.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.462 -0.495 . . . . 0.28000000000000003 111.588 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.501 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.38 125.02 50.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.626 -0.715 . . . . 1.0700000000000001 109.772 179.483 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.42 104.88 29.77 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.334 -0.394 . . . . 0.28999999999999998 111.036 -179.891 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -90.94 -179.49 1.51 Allowed 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 123.146 2.564 . . . . 0.42999999999999999 112.277 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 61.64 32.7 18.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.373 -0.831 . . . . 1.26 111.479 179.315 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.463 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.2 mt -86.51 148.59 25.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.778 0.323 . . . . 0.32000000000000001 110.388 179.632 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.767 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.35 114.86 61.36 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.093 0.473 . . . . 0.57999999999999996 110.58 -179.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.05 140.59 95.93 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.974 2.449 . . . . 0.66000000000000003 111.858 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.02 21.3 74.26 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.049 -0.821 . . . . 0.28999999999999998 111.049 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.452 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.9 150.16 49.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.758 0.314 . . . . 2.3300000000000001 110.584 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.5 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.22 131.64 46.05 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.018 -0.537 . . . . 0.85999999999999999 109.767 179.327 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.961 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.55 148.26 44.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.091 -0.504 . . . . 0.52000000000000002 111.049 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.1 mt -105.3 125.3 60.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.288 -1.004 . . . . 0.29999999999999999 108.288 177.812 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.52 132.51 63.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.169 0.509 . . . . 0.23000000000000001 111.261 -178.591 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.53 122.64 20.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.527 -0.76 . . . . 0.35999999999999999 109.552 179.321 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.584 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.14 125.35 55.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.157 -0.474 . . . . 0.19 110.666 -179.545 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.841 ' CD2' ' NH2' ' A' ' 143' ' ' ARG . 48.3 m-85 -117.2 137.95 52.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.912 -0.586 . . . . 0.29999999999999999 109.869 179.556 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.576 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.73 134.92 42.98 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.817 -0.808 . . . . 0.37 108.817 178.895 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.88 HG21 ' HD2' ' A' ' 61' ' ' LYS . 51.6 mm -99.05 123.01 51.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.107 0.479 . . . . 0.26000000000000001 110.962 -178.769 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.0 p -83.97 169.73 14.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.557 -0.747 . . . . 0.28000000000000003 110.492 -179.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.84 -14.4 14.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.956 -0.566 . . . . 1.6000000000000001 110.916 -179.448 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -96.13 -4.28 43.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.839 0.352 . . . . 1.1799999999999999 110.875 -179.853 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.85 13.91 63.86 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.285 -0.726 . . . . 0.29999999999999999 111.285 179.792 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -84.66 139.14 32.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.728 0.299 . . . . 1.22 110.432 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -106.81 141.05 38.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.424 -0.353 . . . . 0.97999999999999998 110.545 179.764 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.2 m -136.64 126.99 26.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.82999999999999996 110.375 179.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.18 117.31 9.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.32 -0.4 . . . . 0.26000000000000001 110.467 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.3 pt -108.99 -21.84 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.29999999999999999 110.676 -179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.89 125.68 5.85 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.526 -0.47 . . . . 0.31 111.555 -179.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.47 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.77 120.24 21.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.814 -0.63 . . . . 0.28000000000000003 109.538 179.259 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.65 151.69 29.08 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.619 -0.432 . . . . 0.23999999999999999 110.85 -179.259 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.4 158.65 18.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.042 -0.526 . . . . 0.23000000000000001 110.382 179.714 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -146.08 157.89 43.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.097 -0.501 . . . . 0.67000000000000004 110.643 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.24 104.31 9.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.819 -0.628 . . . . 0.64000000000000001 110.068 179.523 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.2 p . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.909 -1.043 . . . . 1.26 110.635 -179.657 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.2 m . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.189 -0.671 . . . . 3.4399999999999999 109.189 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.73 18.54 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.045 -0.822 . . . . 1.22 111.045 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -35.68 142.37 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.086 0 C-N-CA 123.97 3.113 . . . . 0.75 113.832 -179.271 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.604 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.96 173.5 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 114.192 -1.367 . . . . 0.79000000000000004 108.817 178.451 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.604 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.62 125.88 51.5 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.406 -0.518 . . . . 1.9399999999999999 111.41 -179.571 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 143.97 34.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.615 -0.721 . . . . 0.59999999999999998 110.71 179.82 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.27 25.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.893 0.378 . . . . 3.1400000000000001 111.133 -179.641 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.748 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.89 131.09 60.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.989 -0.551 . . . . 3.23 110.085 179.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.19 162.39 35.6 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.479 -0.328 . . . . 3.6299999999999999 111.257 -179.995 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 95.0 mt-10 36.06 31.56 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.642 -0.503 . . . . 6.0800000000000001 109.642 179.901 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.748 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.35 69.52 31.59 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.881 -0.599 . . . . 3.3799999999999999 111.564 -178.721 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.23 -29.16 73.21 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.522 2.148 . . . . 3.9300000000000002 111.821 179.39 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.65 125.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 3.3599999999999999 110.367 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.534 ' OE1' ' O ' ' A' ' 13' ' ' SER . 3.1 mp0 -123.97 158.31 60.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.394 . . . . 3.6099999999999999 110.479 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.434 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 97.0 Cg_endo -81.99 -64.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.935 2.424 . . . . 1.51 113.551 -179.035 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.863 HD21 ' CB ' ' A' ' 157' ' ' TYR . 28.1 m-80 -108.41 -19.64 13.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.051 0.389 . . . . 2.6800000000000002 112.051 -178.546 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 79.3 p -107.35 152.08 24.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.159 0.504 . . . . 1.21 111.302 -179.369 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.29 102.9 2.23 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.671 -0.695 . . . . 1.5600000000000001 110.656 179.918 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.5 Cg_endo -82.7 145.59 12.97 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.872 2.381 . . . . 0.81000000000000005 112.614 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.912 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.73 167.97 24.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.858 -0.61 . . . . 1.52 109.834 179.642 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.2 148.01 29.11 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.67 -0.493 . . . . 2.1400000000000001 109.67 178.822 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.59 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.7 p90 -142.27 157.2 45.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.979 0.419 . . . . 0.32000000000000001 111.223 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.494 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -127.99 155.37 44.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.851 -0.613 . . . . 2.1699999999999999 110.094 178.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.83 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.64 173.13 6.24 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.07 -0.514 . . . . 0.58999999999999997 110.716 -179.22 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.83 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.65 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.849 2.366 . . . . 0.90000000000000002 111.515 179.393 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -51.08 0.69 Allowed Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.741 -0.383 . . . . 3.3399999999999999 110.072 179.838 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.633 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.88 152.34 82.57 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.754 2.303 . . . . 1.8500000000000001 111.456 179.245 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.66 42.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.446 0.641 . . . . 2.54 110.647 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.821 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.59 -41.64 98.33 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.004 -0.998 . . . . 2.5299999999999998 110.669 179.742 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.532 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.8 mt -109.82 137.8 40.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.814 -0.63 . . . . 1.1699999999999999 111.349 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.01 -72.89 0.7 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.125 -0.489 . . . . 1.27 111.833 -178.906 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -88.19 148.41 24.4 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.546 0.573 . . . . 1.1200000000000001 112.546 -179.651 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.76 124.82 45.12 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.34 -0.615 . . . . 0.41999999999999998 109.34 177.542 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.01 134.66 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.731 -0.388 . . . . 0.78000000000000003 110.74 179.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.912 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.01 128.71 53.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.008 0.432 . . . . 0.62 111.213 179.78 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 139.02 49.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.693 -0.685 . . . . 1.97 110.112 179.004 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.435 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.12 163.21 35.01 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.162 0.506 . . . . 0.34999999999999998 112.077 -178.135 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.491 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.46 139.52 7.84 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.473 -0.785 . . . . 1.8 110.487 178.927 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.55 115.55 3.1 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.279 1.986 . . . . 0.57999999999999996 111.82 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.667 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.98 81.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.894 -0.409 . . . . 3.04 109.894 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.688 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.3 -20.68 0.06 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.025 -0.534 . . . . 2.4700000000000002 111.932 -179.48 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.62 157.81 34.33 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.819 -0.352 . . . . 2.5099999999999998 110.598 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.406 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.33 27.78 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 1.8600000000000001 110.203 179.611 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.89 -75.78 1.31 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.088 -0.577 . . . . 1.4399999999999999 111.836 -179.242 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.95 152.29 35.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.991 0.424 . . . . 4.6900000000000004 110.946 -179.35 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.18 -169.07 2.52 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.009 -0.542 . . . . 1.4299999999999999 111.911 179.373 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.19 149.61 29.85 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.473 0.654 . . . . 1.74 112.543 -177.822 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.03 156.47 46.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.8 -1.091 . . . . 1.9199999999999999 110.25 178.633 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.466 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.23 158.38 41.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.964 -0.562 . . . . 0.34000000000000002 111.866 -179.368 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.3 m -115.19 135.57 54.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.519 -0.764 . . . . 0.40999999999999998 109.862 179.33 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.59 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.36 121.97 23.82 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.415 -0.357 . . . . 0.55000000000000004 111.493 -179.073 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.6 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.4 Cg_exo -46.33 151.74 1.63 Allowed 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.593 2.195 . . . . 0.44 112.177 178.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.89 -23.01 62.99 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 116.128 -0.487 . . . . 0.73999999999999999 112.77 -179.252 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.546 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.86 -16.91 45.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.456 0.628 . . . . 0.93000000000000005 111.734 -178.264 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.6 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.56 138.37 31.62 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.873 -0.331 . . . . 0.96999999999999997 110.314 179.361 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.58 14.05 10.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.32 -0.4 . . . . 1.3400000000000001 111.479 -179.402 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.474 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.4 p -150.04 143.4 25.13 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.599 -0.441 . . . . 0.39000000000000001 110.961 179.644 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.721 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.78 -169.37 1.53 Allowed 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.242 0.544 . . . . 0.41999999999999998 110.874 -179.505 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.739 ' OG1' ' C ' ' A' ' 188' ' ' ASP . 2.6 m -151.78 125.92 9.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.371 -0.832 . . . . 0.39000000000000001 109.814 179.276 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.515 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.8 mt -114.88 123.25 70.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.448 -0.501 . . . . 0.73999999999999999 111.199 -179.699 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -126.49 163.35 23.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.842 -0.617 . . . . 2.48 110.394 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.684 ' H ' HH22 ' A' ' 143' ' ' ARG . . . 85.04 19.07 59.86 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.728 -0.949 . . . . 0.5 110.728 -179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.515 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.5 mt -79.11 157.22 28.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.06 0.457 . . . . 0.57999999999999996 111.362 -179.679 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.854 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.7 mtpp -99.46 134.02 21.5 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.561 -0.745 . . . . 2.79 110.473 179.779 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.91 143.58 61.24 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.573 2.182 . . . . 0.87 111.899 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.81 25.63 75.33 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.034 -0.826 . . . . 0.64000000000000001 111.034 179.686 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.854 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.14 158.81 39.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.694 0.283 . . . . 0.82999999999999996 110.398 -179.592 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.16 140.02 41.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.843 0.354 . . . . 0.5 110.565 -179.813 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.658 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.7 m-85 -122.63 136.38 54.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.901 -0.59 . . . . 0.53000000000000003 110.792 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.491 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.76 131.03 45.21 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.593 -0.892 . . . . 1.8700000000000001 108.593 177.574 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.55 153.83 16.67 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.244 -0.979 . . . . 0.28999999999999998 111.981 -178.635 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.89 140.98 46.2 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.782 -0.451 . . . . 1.4299999999999999 109.782 179.534 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.525 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.4 tp -115.78 118.92 34.38 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.39 -0.524 . . . . 0.32000000000000001 110.525 179.72 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.738 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.42 129.05 68.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.372 -0.376 . . . . 0.79000000000000004 110.632 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.708 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.75 120.82 43.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.333 -0.394 . . . . 1.02 110.756 -179.7 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.864 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.55 146.52 11.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.182 0.515 . . . . 0.62 111.04 -179.302 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.821 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.03 153.9 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.515 -0.766 . . . . 2.4399999999999999 109.973 179.816 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.2 88.6 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.965 0.412 . . . . 3.6899999999999999 110.392 -179.768 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.618 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.27 32.69 0.21 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.786 -0.643 . . . . 6.0800000000000001 110.582 -179.94 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.12 -117.43 3.29 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.405 -0.678 . . . . 1.22 111.405 -179.684 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.464 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.5 177.37 8.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.168 0.509 . . . . 2.8799999999999999 111.652 -179.181 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -148.12 149.54 32.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.38 -0.827 . . . . 1.47 110.375 179.223 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.18 144.63 38.64 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.485 -0.325 . . . . 2.7000000000000002 110.513 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.738 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.97 136.02 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 120.619 -0.432 . . . . 0.46000000000000002 111.519 -179.777 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.574 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.15 141.32 52.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.645 -0.707 . . . . 0.34999999999999998 110.284 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.4 ttp180 -117.66 138.9 51.67 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.502 -0.479 . . . . 3.6699999999999999 111.531 -179.32 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.25 164.21 37.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.524 -0.762 . . . . 0.67000000000000004 109.502 179.467 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.575 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.31 151.53 38.48 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.37 -0.532 . . . . 1.47 110.974 179.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.802 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.19 172.81 12.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.754 -0.657 . . . . 0.44 111.027 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.77 160.63 21.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.523 -0.762 . . . . 1.3700000000000001 109.892 179.621 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.33 121.89 23.03 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.568 -0.453 . . . . 1.28 110.777 179.972 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.2 p -127.56 147.96 50.34 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.119 -0.491 . . . . 1.97 112.292 179.728 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.1 t . . . . . 0 CA--C 1.532 0.279 0 CA-C-N 115.417 -0.811 . . . . 3.2799999999999998 113.008 178.691 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.5 p . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 121.259 0.552 . . . . 0.66000000000000003 109.881 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.444 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.85 167.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.536 -0.756 . . . . 0.68999999999999995 110.96 179.939 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.59 145.57 50.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.664 -0.698 . . . . 0.52000000000000002 110.125 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.25 101.68 9.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.051 -0.722 . . . . 0.32000000000000001 109.051 177.725 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.3 t -112.95 139.7 36.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.992 -0.549 . . . . 0.28999999999999998 111.107 -178.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.0 p -128.76 152.55 48.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.705 -0.679 . . . . 0.25 109.795 179.609 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.75 -164.85 2.01 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.62 -0.432 . . . . 0.31 110.651 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.6 t -123.97 127.17 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.48999999999999999 110.804 -179.835 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.174 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.1 p -57.89 58.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.111 -0.495 . . . . 1.53 110.44 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.743 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.13 24.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.971 -0.559 . . . . 0.96999999999999997 111.478 -179.591 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.174 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.1 128.62 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.674 -0.41 . . . . 1.5600000000000001 110.999 179.833 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.35 -9.52 56.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.883 -0.599 . . . . 1.8799999999999999 110.381 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.8 p -87.16 0.32 55.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.52 . . . . 1.04 110.27 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.33 137.19 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.023 -0.535 . . . . 0.23999999999999999 109.977 179.717 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.614 ' N ' ' O ' ' A' ' 185' ' ' ILE . 93.8 p -96.2 -15.56 21.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.248 0.547 . . . . 0.28999999999999998 110.046 -179.673 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.61 175.67 45.88 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 109.859 -1.297 . . . . 0.13 109.859 179.595 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.46 151.6 42.54 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.683 -0.407 . . . . 0.17000000000000001 110.525 179.778 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.684 HH22 ' H ' ' A' ' 62' ' ' GLY . 10.3 tpp180 -132.35 121.18 23.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.172 -0.467 . . . . 1.29 109.911 179.809 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.555 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.08 136.63 38.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.74 -0.664 . . . . 0.25 110.632 -179.777 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 79.3 tt0 -129.41 129.89 45.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.996 -0.547 . . . . 1.3200000000000001 110.044 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.625 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.4 p90 -138.71 135.24 34.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.055 -0.52 . . . . 0.56999999999999995 110.611 -179.669 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.418 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.27 161.32 39.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.841 -0.618 . . . . 1.1599999999999999 109.734 179.834 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.4 mt -71.02 124.78 25.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.011 0.434 . . . . 0.38 110.767 -179.644 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.67 -7.7 49.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.777 -0.647 . . . . 0.40999999999999998 110.915 -179.814 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.88 -69.58 0.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.303 -0.408 . . . . 1.6599999999999999 111.449 -179.283 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.449 ' CD ' HH21 ' A' ' 176' ' ' ARG . 53.9 mt-10 -60.74 -35.33 76.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 1.6599999999999999 111.506 -179.184 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.08 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.15 7.26 88.57 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.857 -0.897 . . . . 1.1699999999999999 110.857 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.341 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.4 t0 -27.9 -171.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 1.8600000000000001 110.229 179.798 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.341 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.4 139.1 44.67 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.036 0.446 . . . . 1.98 110.185 179.614 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.418 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 45.8 Cg_endo -70.91 145.79 51.39 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 122.675 2.25 . . . . 0.55000000000000004 112.302 -179.466 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.625 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.75 145.72 42.54 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.318 -0.623 . . . . 1.1399999999999999 109.318 179.157 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.863 ' CB ' HD21 ' A' ' 16' ' ' ASN . 22.3 p90 -123.27 141.34 52.09 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.384 -0.526 . . . . 0.93000000000000005 111.536 -179.067 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.9 mt -128.14 127.66 43.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.314 -0.857 . . . . 0.34000000000000002 108.936 178.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.625 ' HB2' ' NH1' ' A' ' 143' ' ' ARG . 29.5 t0 -101.6 131.09 47.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.171 0.51 . . . . 1.0900000000000001 111.738 -178.77 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.91 157.52 73.49 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.2 -0.909 . . . . 0.19 109.583 179.643 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -69.8 158.14 57.94 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.351 2.034 . . . . 0.17999999999999999 112.3 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.36 -12.19 5.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.733 -0.667 . . . . 0.20999999999999999 110.744 -179.782 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.9 p -92.77 -8.71 42.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.086 -0.506 . . . . 0.28999999999999998 110.718 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.14 135.38 34.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 0.5 110.378 179.67 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.5 p -133.18 16.72 4.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.29999999999999999 110.552 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.1 p -167.59 147.12 5.04 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.619 -0.512 . . . . 0.23000000000000001 109.619 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.555 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.2 150.46 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.548 -0.461 . . . . 0.28000000000000003 111.59 -179.653 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.509 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.31 124.98 50.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.637 -0.71 . . . . 1.0700000000000001 109.812 179.493 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.37 104.9 29.71 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.412 -0.358 . . . . 0.28999999999999998 111.107 -179.897 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.7 Cg_endo -91.06 -179.49 1.47 Allowed 'Trans proline' 0 C--N 1.301 -1.964 0 C-N-CA 123.178 2.585 . . . . 0.42999999999999999 112.213 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 61.63 32.71 18.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.463 -0.79 . . . . 1.26 111.439 179.302 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.1 mt -86.35 148.51 25.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.436 -0.347 . . . . 0.32000000000000001 110.469 179.547 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.774 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.29 114.83 61.2 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.076 0.465 . . . . 0.57999999999999996 110.645 -179.75 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.98 140.58 95.96 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.908 2.405 . . . . 0.66000000000000003 111.959 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.15 74.45 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.006 -0.837 . . . . 0.28999999999999998 111.006 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.449 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.8 mmm-85 -126.87 150.27 49.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.38 . . . . 2.3300000000000001 110.6 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.5 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.23 131.63 46.06 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.011 -0.54 . . . . 0.85999999999999999 109.737 179.392 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.955 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.44 148.36 43.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.099 -0.501 . . . . 0.52000000000000002 111.037 -179.868 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.34 125.34 60.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.258 -1.016 . . . . 0.29999999999999999 108.258 177.745 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.54 132.53 63.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.085 0.469 . . . . 0.23000000000000001 111.221 -178.595 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.54 122.56 20.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.591 -0.732 . . . . 0.35999999999999999 109.626 179.258 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.03 125.37 54.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.181 -0.463 . . . . 0.19 110.729 -179.556 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.14 137.83 52.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.014 -0.539 . . . . 0.29999999999999999 109.903 179.565 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.584 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.63 134.98 42.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.815 -0.809 . . . . 0.37 108.815 178.832 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.614 ' O ' ' N ' ' A' ' 140' ' ' SER . 46.0 mm -99.05 122.94 51.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.131 0.491 . . . . 0.26000000000000001 111.024 -178.826 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.6 p -83.76 169.66 14.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.571 -0.74 . . . . 0.28000000000000003 110.511 -179.688 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.87 -14.43 15.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.034 -0.53 . . . . 1.6000000000000001 110.979 -179.593 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.739 ' C ' ' OG1' ' A' ' 59' ' ' THR . 96.3 m-20 -96.03 -4.3 43.31 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.894 -0.323 . . . . 1.1799999999999999 110.861 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.508 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.79 13.9 63.99 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.354 -0.699 . . . . 0.29999999999999999 111.354 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -84.72 139.06 32.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.696 0.284 . . . . 1.22 110.389 179.731 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -106.61 141.02 38.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.423 -0.353 . . . . 0.97999999999999998 110.674 179.646 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.0 m -136.73 127.09 26.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.82999999999999996 110.338 179.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 25.5 tp -68.19 117.38 9.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.959 0.409 . . . . 0.26000000000000001 110.451 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.06 -21.86 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.29999999999999999 110.71 -179.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.86 125.73 5.88 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 120.442 -0.503 . . . . 0.31 111.508 -179.757 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.46 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.81 120.21 21.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.792 -0.64 . . . . 0.28000000000000003 109.581 179.195 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.63 151.7 29.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.96 0.41 . . . . 0.23999999999999999 110.883 -179.239 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.45 158.6 18.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.009 -0.542 . . . . 0.23000000000000001 110.409 179.725 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -146.11 157.92 43.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 0.67000000000000004 110.678 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 104.34 9.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.811 -0.631 . . . . 0.64000000000000001 110.053 179.582 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.3 p . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.964 -1.017 . . . . 1.26 110.61 -179.641 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.548 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.209 -0.663 . . . . 3.4399999999999999 109.209 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.4 150.66 18.54 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.023 -0.831 . . . . 1.22 111.023 179.814 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -35.65 142.37 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.114 0 C-N-CA 123.956 3.104 . . . . 0.75 113.881 -179.23 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.617 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.96 173.35 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.261 -1.336 . . . . 0.79000000000000004 108.841 178.507 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.617 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.49 125.89 51.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.127 0.489 . . . . 1.9399999999999999 111.454 -179.639 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.56 144.01 33.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.575 -0.739 . . . . 0.59999999999999998 110.621 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.08 168.24 25.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.914 0.388 . . . . 3.1400000000000001 111.118 -179.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.741 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.5 mt -108.91 131.07 60.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.042 -0.526 . . . . 3.23 110.06 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.5 p -141.24 162.27 35.88 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.853 0.358 . . . . 3.6299999999999999 111.203 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 48.1 mt-10 36.1 31.61 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.625 -0.509 . . . . 6.0800000000000001 109.625 179.847 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.741 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.6 33.11 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.951 -0.568 . . . . 3.3799999999999999 111.609 -178.844 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.639 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.24 -29.13 73.12 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.486 2.124 . . . . 3.9300000000000002 111.838 179.325 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.683 ' H ' HE22 ' A' ' 14' ' ' GLN . 3.2 m 149.58 125.62 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 3.3599999999999999 110.527 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.707 ' O ' ' O ' ' A' ' 92' ' ' THR . 1.8 mp0 -123.99 158.3 60.75 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 3.6099999999999999 110.411 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.552 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 98.3 Cg_endo -82.05 -64.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.874 2.383 . . . . 1.51 113.491 -178.983 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.727 ' ND2' ' CD1' ' A' ' 157' ' ' TYR . 1.2 m120 -108.44 -19.6 13.4 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.12 0.415 . . . . 2.6800000000000002 112.12 -178.562 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.736 ' OG ' ' NZ ' ' A' ' 61' ' ' LYS . 55.8 m -107.3 152.03 24.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.171 0.51 . . . . 1.21 111.298 -179.411 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.571 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.21 102.88 2.24 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.681 -0.69 . . . . 1.5600000000000001 110.618 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.66 145.64 13.04 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.925 2.417 . . . . 0.81000000000000005 112.643 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.915 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.8 167.9 24.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.89 -0.595 . . . . 1.52 109.885 179.561 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -149.12 147.97 29.1 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.677 -0.49 . . . . 2.1400000000000001 109.677 178.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.597 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.3 p90 -142.21 157.35 44.96 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.623 -0.431 . . . . 0.32000000000000001 111.167 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.49 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.05 155.24 44.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.822 -0.626 . . . . 2.1699999999999999 110.119 178.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.83 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.58 173.09 6.29 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.081 -0.508 . . . . 0.58999999999999997 110.765 -179.217 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.83 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.68 174.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.909 2.406 . . . . 0.90000000000000002 111.518 179.362 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.11 -51.16 0.68 Allowed Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.727 -0.389 . . . . 3.3399999999999999 110.054 179.899 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.617 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.74 152.32 82.44 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.769 2.312 . . . . 1.8500000000000001 111.442 179.189 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.69 42.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.351 0.596 . . . . 2.54 110.531 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.815 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.58 -41.72 98.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.05 -0.977 . . . . 2.5299999999999998 110.609 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.532 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.2 mt -109.86 137.83 40.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.782 -0.644 . . . . 1.1699999999999999 111.23 -179.363 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.94 -72.88 0.7 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.031 -0.531 . . . . 1.27 111.937 -178.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.15 148.36 24.46 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.559 0.577 . . . . 1.1200000000000001 112.559 -179.665 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.87 124.84 45.06 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.302 -0.629 . . . . 0.41999999999999998 109.302 177.543 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 mt -117.97 134.68 60.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.787 -0.365 . . . . 0.78000000000000003 110.642 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.915 HD13 HD11 ' A' ' 20' ' ' ILE . 8.8 mt -120.01 128.63 53.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 0.62 111.292 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.14 138.97 49.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.727 -0.67 . . . . 1.97 110.145 179.014 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.433 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -145.07 163.26 34.81 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 121.265 0.555 . . . . 0.34999999999999998 112.037 -178.117 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.491 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.55 139.51 7.76 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 115.431 -0.804 . . . . 1.8 110.506 178.873 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.3 Cg_endo -63.5 115.46 3.05 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.344 2.03 . . . . 0.57999999999999996 111.81 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.674 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.02 81.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.882 -0.414 . . . . 3.04 109.882 -179.81 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.72 0.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.943 -0.571 . . . . 2.4700000000000002 111.916 -179.467 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.4 p -157.55 157.82 34.48 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.848 -0.341 . . . . 2.5099999999999998 110.613 179.769 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.4 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.8 m -120.42 27.85 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.438 . . . . 1.8600000000000001 110.144 179.558 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.78 -75.9 1.31 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.107 -0.568 . . . . 1.4399999999999999 111.886 -179.284 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.88 152.34 35.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.944 0.402 . . . . 4.6900000000000004 110.994 -179.42 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.676 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.21 -169.1 2.53 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.033 -0.53 . . . . 1.4299999999999999 111.989 179.367 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.431 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.19 149.68 29.75 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.412 0.625 . . . . 1.74 112.583 -177.848 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.06 156.52 45.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.837 -1.074 . . . . 1.9199999999999999 110.241 178.688 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.2 158.46 41.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.968 -0.56 . . . . 0.34000000000000002 111.822 -179.349 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.6 m -115.31 135.72 53.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.479 -0.782 . . . . 0.40999999999999998 109.747 179.291 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.597 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.46 121.93 23.69 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.385 -0.371 . . . . 0.55000000000000004 111.579 -179.182 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.0 Cg_exo -46.24 151.67 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.729 2.286 . . . . 0.44 112.129 179.042 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.84 -23.11 63.01 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 116.083 -0.508 . . . . 0.73999999999999999 112.77 -179.227 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.81 -16.83 46.24 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.224 -0.59 . . . . 0.93000000000000005 111.819 -178.319 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.604 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.67 138.49 31.52 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.709 -0.397 . . . . 0.96999999999999997 110.246 179.398 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.54 13.9 10.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.345 -0.389 . . . . 1.3400000000000001 111.542 -179.363 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.476 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.97 143.41 25.19 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.63 -0.428 . . . . 0.39000000000000001 111.059 179.676 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.4 t80 -114.76 -169.37 1.53 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.167 0.508 . . . . 0.41999999999999998 110.899 -179.432 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.714 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.81 125.78 9.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.454 -0.794 . . . . 0.39000000000000001 109.858 179.278 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.513 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.81 123.16 70.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.382 -0.527 . . . . 0.73999999999999999 111.282 -179.798 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.736 ' NZ ' ' OG ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -126.41 163.4 23.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.882 -0.599 . . . . 2.48 110.426 179.749 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.642 ' H ' ' HD3' ' A' ' 61' ' ' LYS . . . 85.11 19.0 59.86 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.759 -0.936 . . . . 0.5 110.759 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.513 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.9 mt -78.98 157.25 28.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.111 0.482 . . . . 0.57999999999999996 111.3 -179.631 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.855 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -99.51 133.9 21.56 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.627 -0.715 . . . . 2.79 110.415 179.743 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.423 ' HD3' ' CE2' ' A' ' 157' ' ' TYR . 36.9 Cg_endo -67.76 143.61 62.21 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.571 2.181 . . . . 0.87 112.022 179.731 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.76 25.6 75.37 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.061 -0.816 . . . . 0.64000000000000001 111.061 179.715 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.855 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.14 158.77 39.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.751 0.31 . . . . 0.82999999999999996 110.444 -179.673 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.13 140.08 41.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.932 0.396 . . . . 0.5 110.516 -179.765 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.644 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.65 136.46 54.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.886 -0.597 . . . . 0.53000000000000003 110.75 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.491 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.86 131.02 45.28 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.506 -0.924 . . . . 1.8700000000000001 108.506 177.637 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.46 153.92 16.64 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 120.321 -0.942 . . . . 0.28999999999999998 111.985 -178.685 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.98 140.87 46.03 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.71 -0.478 . . . . 1.4299999999999999 109.71 179.61 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.71 118.9 34.34 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.526 -0.47 . . . . 0.32000000000000001 110.534 179.691 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.731 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.5 129.09 68.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 0.79000000000000004 110.647 -179.883 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.708 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.86 120.76 43.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.327 -0.397 . . . . 1.02 110.691 -179.577 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.85 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.54 146.47 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.197 0.523 . . . . 0.62 111.0 -179.266 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.815 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.09 153.9 21.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.501 -0.772 . . . . 2.4399999999999999 109.924 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.21 88.51 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.938 0.399 . . . . 3.6899999999999999 110.426 -179.653 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.628 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.42 32.61 0.23 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.807 -0.633 . . . . 6.0800000000000001 110.581 -179.906 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.14 -117.28 3.28 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.492 -0.643 . . . . 1.22 111.492 -179.722 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.47 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.1 m170 -81.55 177.41 8.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.18 0.514 . . . . 2.8799999999999999 111.516 -179.106 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.2 149.58 32.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.444 -0.798 . . . . 1.47 110.415 179.107 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.548 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.22 144.58 38.54 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.454 -0.339 . . . . 2.7000000000000002 110.592 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.731 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.91 135.97 61.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.597 -0.441 . . . . 0.46000000000000002 111.586 -179.761 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -123.99 141.32 52.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.733 -0.667 . . . . 0.34999999999999998 110.259 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.468 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.65 138.96 51.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.134 0.492 . . . . 3.6699999999999999 111.463 -179.414 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.37 164.15 38.07 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.514 -0.766 . . . . 0.67000000000000004 109.442 179.352 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.569 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.15 151.59 38.69 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.366 -0.534 . . . . 1.47 110.985 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.3 172.75 13.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.689 -0.687 . . . . 0.44 111.018 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.74 160.67 21.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.443 -0.799 . . . . 1.3700000000000001 109.846 179.66 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.38 121.8 22.84 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.624 -0.43 . . . . 1.28 110.833 179.962 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.707 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.2 p -127.85 170.0 13.28 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 116.09 -0.504 . . . . 1.97 110.677 179.683 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.466 0.329 0 CA-C-O 121.11 0.481 . . . . 3.2799999999999998 110.119 179.415 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.44 0 CA-C-O 120.92 0.39 . . . . 0.66000000000000003 111.511 . . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.44 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.83 167.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.917 -0.583 . . . . 0.68999999999999995 110.99 179.868 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.59 145.59 50.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.748 -0.66 . . . . 0.52000000000000002 110.11 -179.881 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.35 101.65 9.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.08 -0.711 . . . . 0.32000000000000001 109.08 177.734 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.5 t -112.96 139.74 36.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.978 -0.555 . . . . 0.28999999999999998 111.071 -178.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.1 p -128.78 152.5 48.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.613 -0.721 . . . . 0.25 109.741 179.745 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.588 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.8 -165.0 2.05 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.675 -0.41 . . . . 0.31 110.618 -179.775 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.738 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -123.86 127.15 73.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.218 -0.446 . . . . 0.48999999999999999 110.894 -179.881 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.158 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.8 58.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 1.53 110.36 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.738 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.19 24.56 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.99 -0.55 . . . . 0.96999999999999997 111.541 -179.583 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.158 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.16 128.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.615 -0.434 . . . . 1.5600000000000001 110.95 179.831 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -86.45 -9.66 55.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.973 -0.558 . . . . 1.8799999999999999 110.295 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.09 0.2 55.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 1.04 110.313 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.25 137.16 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.957 -0.565 . . . . 0.23999999999999999 109.997 179.711 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 185' ' ' ILE . 0.2 OUTLIER -96.2 -15.55 21.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.32 0.581 . . . . 0.28999999999999998 110.021 -179.613 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.6 175.52 45.74 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 109.863 -1.295 . . . . 0.13 109.863 179.685 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -123.39 151.63 42.38 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.655 -0.418 . . . . 0.17000000000000001 110.523 179.711 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.632 ' NH1' ' CB ' ' A' ' 157' ' ' TYR . 10.4 ttt85 -132.34 121.22 23.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.078 -0.51 . . . . 1.29 109.954 179.754 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.542 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.09 136.53 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.666 -0.697 . . . . 0.25 110.678 -179.752 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 84.2 tt0 -129.37 129.88 45.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.017 -0.538 . . . . 1.3200000000000001 110.128 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.73 135.29 34.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.001 -0.545 . . . . 0.56999999999999995 110.653 -179.684 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.412 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.26 161.34 39.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.721 -0.672 . . . . 1.1599999999999999 109.682 179.883 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.965 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.06 124.83 25.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.971 0.415 . . . . 0.38 110.764 -179.662 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.74 -7.63 49.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.709 -0.678 . . . . 0.40999999999999998 110.872 -179.775 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -109.87 -69.67 0.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.979 0.418 . . . . 1.6599999999999999 111.386 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.441 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.74 -35.28 75.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.03 -0.532 . . . . 1.6599999999999999 111.44 -179.095 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.09 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.08 7.26 88.56 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.858 -0.897 . . . . 1.1699999999999999 110.858 -179.787 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.315 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.98 -171.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.331 . . . . 1.8600000000000001 110.218 179.86 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.315 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.19 139.03 45.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.962 0.41 . . . . 1.98 110.233 179.627 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.412 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.1 Cg_endo -70.88 145.87 51.79 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 C-N-CA 122.751 2.301 . . . . 0.55000000000000004 112.286 -179.469 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.91 145.7 42.68 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.199 -0.667 . . . . 1.1399999999999999 109.199 179.237 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.727 ' CD1' ' ND2' ' A' ' 16' ' ' ASN . 43.2 p90 -123.31 141.33 52.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.269 0.557 . . . . 0.93000000000000005 111.506 -179.102 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.3 mt -128.08 127.62 43.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.297 -0.865 . . . . 0.34000000000000002 109.021 178.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -101.58 131.11 47.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.178 0.513 . . . . 1.0900000000000001 111.812 -178.736 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.93 157.51 73.56 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.315 -0.857 . . . . 0.19 109.658 179.653 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.83 158.08 58.08 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 C-N-CA 122.389 2.059 . . . . 0.17999999999999999 112.215 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.28 -12.2 5.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.754 -0.657 . . . . 0.20999999999999999 110.736 -179.775 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.7 p -92.8 -8.68 42.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.132 -0.486 . . . . 0.28999999999999998 110.79 -179.93 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.39 34.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.247 -0.433 . . . . 0.5 110.354 179.701 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.8 p -133.16 16.73 4.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.394 -0.367 . . . . 0.29999999999999999 110.492 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.4 p -167.54 147.13 5.08 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.569 -0.53 . . . . 0.23000000000000001 109.569 179.841 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.542 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.14 150.52 12.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.467 -0.493 . . . . 0.28000000000000003 111.592 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.506 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.34 124.9 50.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.674 -0.694 . . . . 1.0700000000000001 109.803 179.504 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.33 104.82 29.06 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.382 -0.372 . . . . 0.28999999999999998 111.131 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.5 Cg_endo -90.92 -179.48 1.51 Allowed 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 123.192 2.595 . . . . 0.42999999999999999 112.296 179.883 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.7 32.59 18.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.46 -0.791 . . . . 1.26 111.462 179.262 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.44 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.1 mt -86.32 148.51 25.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.457 -0.338 . . . . 0.32000000000000001 110.44 179.615 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.769 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.28 114.83 61.19 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.008 0.432 . . . . 0.57999999999999996 110.7 -179.767 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -58.98 140.59 96.03 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.851 2.367 . . . . 0.66000000000000003 112.039 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.06 21.24 74.27 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.028 -0.829 . . . . 0.28999999999999998 111.028 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.441 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.9 150.17 49.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.857 0.36 . . . . 2.3300000000000001 110.578 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.501 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.19 131.62 46.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.039 -0.528 . . . . 0.85999999999999999 109.795 179.335 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.965 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.48 148.25 44.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.117 -0.492 . . . . 0.52000000000000002 111.089 -179.863 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.21 125.28 60.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.342 -0.984 . . . . 0.29999999999999999 108.342 177.742 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.53 132.58 63.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.129 0.49 . . . . 0.23000000000000001 111.238 -178.593 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.55 122.52 20.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.461 -0.791 . . . . 0.35999999999999999 109.574 179.362 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.588 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.99 125.39 54.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.337 -0.392 . . . . 0.19 110.706 -179.563 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.24 137.92 52.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.086 -0.506 . . . . 0.29999999999999999 109.833 179.573 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.584 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.83 134.96 43.02 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.802 -0.814 . . . . 0.37 108.802 178.865 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.606 ' O ' ' N ' ' A' ' 140' ' ' SER . 3.7 mt -99.01 122.92 51.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.09 0.472 . . . . 0.26000000000000001 111.001 -178.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.8 p -83.84 169.82 14.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.562 -0.744 . . . . 0.28000000000000003 110.469 -179.685 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.84 -14.51 15.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.058 -0.519 . . . . 1.6000000000000001 110.928 -179.556 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -96.07 -4.42 42.97 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.878 -0.329 . . . . 1.1799999999999999 110.83 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.9 13.85 63.86 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.368 -0.693 . . . . 0.29999999999999999 111.368 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -84.62 139.04 32.35 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.775 -0.25 . . . . 1.22 110.446 179.694 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.453 HE22 ' HG2' ' A' ' 14' ' ' GLN . 4.0 mp0 -106.71 141.07 38.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.485 -0.325 . . . . 0.97999999999999998 110.63 179.708 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.4 m -136.7 127.02 26.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.82999999999999996 110.329 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.11 117.29 9.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.327 -0.397 . . . . 0.26000000000000001 110.477 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.03 -21.85 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 0.29999999999999999 110.716 -179.785 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.1 tp -156.87 125.8 5.91 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.566 -0.454 . . . . 0.31 111.564 -179.829 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.474 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.7 120.16 21.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.731 -0.668 . . . . 0.28000000000000003 109.579 179.289 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.65 151.75 29.16 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.714 -0.394 . . . . 0.23999999999999999 110.884 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.55 158.6 18.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.054 -0.521 . . . . 0.23000000000000001 110.469 179.675 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.09 157.87 43.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.191 -0.459 . . . . 0.67000000000000004 110.725 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.27 104.41 9.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.771 -0.649 . . . . 0.64000000000000001 110.024 179.559 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 117.88 -1.057 . . . . 1.26 110.638 -179.691 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.9 m . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.248 -0.649 . . . . 3.4399999999999999 109.248 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.42 150.73 18.53 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.037 -0.825 . . . . 1.22 111.037 179.692 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -35.65 142.43 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 123.988 3.125 . . . . 0.75 113.795 -179.197 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.624 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.3 t -80.04 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 114.295 -1.321 . . . . 0.79000000000000004 108.808 178.447 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.624 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.68 125.87 51.49 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.415 -0.514 . . . . 1.9399999999999999 111.395 -179.533 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 144.03 33.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.555 -0.748 . . . . 0.59999999999999998 110.646 179.921 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.05 168.33 25.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.894 0.378 . . . . 3.1400000000000001 111.096 -179.614 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.747 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.4 mt -109.03 131.14 60.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.006 -0.543 . . . . 3.23 110.074 179.861 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.505 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.3 p -141.21 162.3 35.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.859 0.361 . . . . 3.6299999999999999 111.217 -179.903 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.582 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 80.1 tt0 36.13 31.57 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.629 -0.508 . . . . 6.0800000000000001 109.629 179.811 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.747 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.55 69.58 33.73 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.945 -0.57 . . . . 3.3799999999999999 111.58 -178.753 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.17 -29.14 73.74 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.525 2.15 . . . . 3.9300000000000002 111.868 179.304 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.63 125.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 3.3599999999999999 110.41 -179.973 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.699 HE21 ' C ' ' A' ' 17' ' ' SER . 14.3 mt-30 -123.96 158.38 60.41 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 3.6099999999999999 110.405 179.942 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.587 ' HD2' HH12 ' A' ' 143' ' ' ARG . 97.4 Cg_endo -82.03 -64.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.942 2.428 . . . . 1.51 113.558 -179.086 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.552 ' ND2' ' OD1' ' A' ' 159' ' ' ASP . 98.7 m-20 -108.48 -19.51 13.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.075 0.398 . . . . 2.6800000000000002 112.075 -178.54 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.699 ' C ' HE21 ' A' ' 14' ' ' GLN . 29.1 t -107.35 151.99 24.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.083 0.468 . . . . 1.21 111.296 -179.405 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.2 102.92 2.24 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.656 -0.702 . . . . 1.5600000000000001 110.722 179.786 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.72 145.59 12.93 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.962 2.441 . . . . 0.81000000000000005 112.636 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.937 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.75 167.92 24.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.894 -0.594 . . . . 1.52 109.853 179.672 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -149.12 148.02 29.17 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.768 -0.456 . . . . 2.1400000000000001 109.768 178.816 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.601 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.34 157.29 44.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.031 0.443 . . . . 0.32000000000000001 111.212 179.954 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.496 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.02 155.29 44.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.777 -0.647 . . . . 2.1699999999999999 110.111 179.072 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.825 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.69 172.95 6.49 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.155 0.502 . . . . 0.58999999999999997 110.701 -179.171 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.825 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.6 173.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.844 0 C-N-CA 122.876 2.384 . . . . 0.90000000000000002 111.475 179.421 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.481 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.1 -51.07 0.68 Allowed Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 120.68 -0.408 . . . . 3.3399999999999999 110.111 179.881 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.613 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.81 152.33 82.49 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.716 2.277 . . . . 1.8500000000000001 111.497 179.139 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.66 42.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.417 0.627 . . . . 2.54 110.58 -179.881 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.814 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.69 -41.54 98.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.959 -1.019 . . . . 2.5299999999999998 110.7 179.775 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.533 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.8 mt -109.9 137.82 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.738 -0.665 . . . . 1.1699999999999999 111.29 -179.479 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.89 -72.96 0.7 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.056 -0.52 . . . . 1.27 111.982 -179.006 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.43 24.41 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.62 0.6 . . . . 1.1200000000000001 112.62 -179.689 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.78 124.88 45.24 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.365 -0.606 . . . . 0.41999999999999998 109.365 177.524 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.06 134.82 60.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.724 -0.391 . . . . 0.78000000000000003 110.63 179.913 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.937 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.15 128.68 53.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.078 0.466 . . . . 0.62 111.138 179.792 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.99 49.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.716 -0.674 . . . . 1.97 110.162 178.92 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.437 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.0 163.22 34.87 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.153 0.502 . . . . 0.34999999999999998 112.097 -178.127 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.488 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.56 139.53 7.76 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.483 -0.781 . . . . 1.8 110.443 178.805 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.43 115.5 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.283 1.989 . . . . 0.57999999999999996 111.855 179.946 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.686 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.06 81.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.914 0.388 . . . . 3.04 109.964 -179.853 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.14 -20.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.962 -0.563 . . . . 2.4700000000000002 111.901 -179.466 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -157.62 157.75 34.22 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.885 -0.326 . . . . 2.5099999999999998 110.586 179.819 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.406 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.34 27.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.173 -0.467 . . . . 1.8600000000000001 110.232 179.567 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.84 -75.86 1.31 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.144 -0.55 . . . . 1.4399999999999999 111.796 -179.204 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.86 152.3 35.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.959 0.409 . . . . 4.6900000000000004 110.951 -179.268 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.66 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.26 -169.16 2.54 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.033 -0.53 . . . . 1.4299999999999999 111.938 179.352 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.08 149.58 29.83 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.436 0.636 . . . . 1.74 112.634 -177.903 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.0 156.48 46.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.83 -1.077 . . . . 1.9199999999999999 110.318 178.562 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.16 158.45 41.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.926 -0.579 . . . . 0.34000000000000002 111.82 -179.373 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 m -115.22 135.62 53.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.483 -0.781 . . . . 0.40999999999999998 109.8 179.322 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.601 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.48 121.95 23.67 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.459 -0.337 . . . . 0.55000000000000004 111.489 -179.14 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.607 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.2 Cg_exo -46.25 151.68 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.67 2.246 . . . . 0.44 112.141 178.993 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.88 -22.98 62.95 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.998 -0.547 . . . . 0.73999999999999999 112.882 -179.268 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.83 -16.81 46.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.346 0.573 . . . . 0.93000000000000005 111.839 -178.38 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.607 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.73 138.36 31.62 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.749 -0.38 . . . . 0.96999999999999997 110.335 179.371 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.45 13.93 11.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.353 -0.385 . . . . 1.3400000000000001 111.546 -179.3 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.8 p -149.98 143.54 25.27 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.612 -0.435 . . . . 0.39000000000000001 111.028 179.594 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.721 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.85 -169.32 1.53 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.174 0.511 . . . . 0.41999999999999998 110.855 -179.423 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.721 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 50.1 m -151.8 125.93 9.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.332 -0.849 . . . . 0.39000000000000001 109.783 179.247 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.511 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.91 123.28 70.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.336 -0.546 . . . . 0.73999999999999999 111.162 -179.793 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.57 ' HG2' ' N ' ' A' ' 62' ' ' GLY . 88.2 tttt -126.48 163.4 23.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.788 -0.642 . . . . 2.48 110.431 179.709 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.57 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.1 18.99 59.89 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.833 -0.907 . . . . 0.5 110.833 -179.906 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.511 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.9 mt -79.03 157.23 28.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.054 0.454 . . . . 0.57999999999999996 111.33 -179.589 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.839 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.6 mttp -99.55 134.05 21.43 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.571 -0.741 . . . . 2.79 110.413 179.77 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.94 143.62 61.22 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.501 2.134 . . . . 0.87 111.948 179.82 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.64 75.32 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.054 -0.818 . . . . 0.64000000000000001 111.054 179.721 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.839 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.17 158.79 40.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.743 0.306 . . . . 0.82999999999999996 110.428 -179.662 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.14 139.93 42.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.971 0.415 . . . . 0.5 110.582 -179.778 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.649 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.3 m-85 -122.5 136.43 54.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.0 -0.546 . . . . 0.53000000000000003 110.803 -179.886 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.95 130.95 45.34 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.548 -0.908 . . . . 1.8700000000000001 108.548 177.639 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.495 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.47 153.86 16.65 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.332 -0.937 . . . . 0.28999999999999998 111.89 -178.517 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.01 140.89 46.01 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.717 -0.475 . . . . 1.4299999999999999 109.717 179.529 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.72 119.01 34.67 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.498 -0.481 . . . . 0.32000000000000001 110.477 179.683 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.742 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.53 129.15 68.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.79000000000000004 110.579 -179.904 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.699 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.83 120.74 43.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.322 -0.399 . . . . 1.02 110.715 -179.67 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.839 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.53 146.52 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.184 0.516 . . . . 0.62 111.025 -179.349 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.814 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.01 153.86 21.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.482 -0.781 . . . . 2.4399999999999999 109.986 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.16 88.57 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.953 0.406 . . . . 3.6899999999999999 110.375 -179.758 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.624 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.33 32.51 0.21 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.843 -0.617 . . . . 6.0800000000000001 110.602 -179.966 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.99 -117.35 3.3 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.502 -0.639 . . . . 1.22 111.502 -179.758 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.47 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.44 177.36 9.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.254 0.55 . . . . 2.8799999999999999 111.604 -179.239 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.06 149.47 32.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.428 -0.806 . . . . 1.47 110.502 179.185 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.13 144.73 38.77 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.479 -0.328 . . . . 2.7000000000000002 110.544 179.854 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.742 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -128.01 135.91 61.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-O 120.936 0.398 . . . . 0.46000000000000002 111.597 -179.775 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.571 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -123.94 141.34 52.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.678 -0.692 . . . . 0.34999999999999998 110.301 179.634 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.493 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.68 138.86 51.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.136 0.493 . . . . 3.6699999999999999 111.451 -179.382 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.495 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.25 164.14 37.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.567 -0.742 . . . . 0.67000000000000004 109.464 179.403 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.561 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.23 151.56 38.58 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.391 -0.524 . . . . 1.47 111.015 179.983 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.805 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.19 172.74 13.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.81 -0.632 . . . . 0.44 111.058 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.75 160.78 21.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.46 -0.791 . . . . 1.3700000000000001 109.89 179.529 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.42 121.92 22.98 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.556 -0.458 . . . . 1.28 110.722 179.955 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.521 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.3 p -130.01 166.07 20.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.673 0.749 . . . . 1.97 112.861 179.669 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.55 ' HB2' ' CE1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 114.692 -1.14 . . . . 3.2799999999999998 110.563 177.226 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.9 p . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 121.005 0.431 . . . . 0.66000000000000003 110.753 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.437 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.92 167.57 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.74 -0.664 . . . . 0.68999999999999995 110.985 -179.359 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.57 145.49 50.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.808 -0.633 . . . . 0.52000000000000002 110.182 -179.92 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.27 101.67 9.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.083 -0.71 . . . . 0.32000000000000001 109.083 177.714 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.1 t -112.96 139.77 36.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.943 -0.572 . . . . 0.28999999999999998 111.004 -178.834 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.4 p -128.79 152.53 48.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.642 -0.708 . . . . 0.25 109.799 179.619 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.587 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.82 -165.02 2.05 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.776 -0.37 . . . . 0.31 110.674 -179.737 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.745 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -123.97 127.2 73.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.198 -0.455 . . . . 0.48999999999999999 110.815 -179.856 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.175 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.89 58.37 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.076 -0.511 . . . . 1.53 110.363 179.821 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.745 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.21 24.6 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 0.96999999999999997 111.509 -179.705 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.175 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.18 128.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.627 -0.429 . . . . 1.5600000000000001 110.95 179.822 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.45 -9.55 56.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.977 -0.556 . . . . 1.8799999999999999 110.379 179.703 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.0 p -87.09 0.19 55.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.119 -0.491 . . . . 1.04 110.278 179.924 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 136' ' ' SER . 2.6 p -65.27 137.15 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.02 -0.537 . . . . 0.23999999999999999 109.994 179.711 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 185' ' ' ILE . 91.1 p -96.23 -15.53 21.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.236 0.541 . . . . 0.28999999999999998 109.992 -179.608 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.437 ' HA3' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.62 175.55 45.79 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 109.88 -1.288 . . . . 0.13 109.88 179.662 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.4 151.56 42.47 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.957 0.408 . . . . 0.17000000000000001 110.487 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 1.168 ' NE ' HD11 ' A' ' 185' ' ' ILE . 77.1 mtm180 -132.29 121.1 23.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.112 -0.495 . . . . 1.29 109.966 179.758 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.557 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.05 136.62 38.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.781 -0.645 . . . . 0.25 110.661 -179.779 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.495 ' OE2' ' OH ' ' A' ' 157' ' ' TYR . 85.5 tt0 -129.42 129.84 45.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.914 -0.584 . . . . 1.3200000000000001 110.041 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.627 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 36.0 p90 -138.7 135.36 34.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.024 -0.535 . . . . 0.56999999999999995 110.66 -179.742 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.42 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.36 161.33 39.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.778 -0.646 . . . . 1.1599999999999999 109.6 179.897 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.974 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.11 124.88 25.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.104 0.478 . . . . 0.38 110.768 -179.674 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.79 -7.61 49.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.664 -0.698 . . . . 0.40999999999999998 110.861 -179.724 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -109.85 -69.71 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.354 -0.384 . . . . 1.6599999999999999 111.395 -179.305 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.495 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.61 -35.36 75.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.04 -0.527 . . . . 1.6599999999999999 111.582 -179.165 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.08 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.12 7.2 88.61 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.895 -0.882 . . . . 1.1699999999999999 110.895 -179.798 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.335 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.92 -171.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.849 0.357 . . . . 1.8600000000000001 110.257 179.897 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.335 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.21 138.98 45.29 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.948 0.404 . . . . 1.98 110.229 179.599 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.42 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 48.3 Cg_endo -70.73 145.74 52.33 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 C-N-CA 122.729 2.286 . . . . 0.55000000000000004 112.377 -179.586 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.627 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.79 145.75 42.54 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.251 -0.648 . . . . 1.1399999999999999 109.251 179.155 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.55 ' CE1' ' HB2' ' A' ' 93' ' ' SER . 96.4 m-85 -123.31 141.33 52.1 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.346 -0.542 . . . . 0.93000000000000005 111.553 -179.124 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.5 mt -128.08 127.68 43.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.372 -0.831 . . . . 0.34000000000000002 108.959 178.987 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.552 ' OD1' ' ND2' ' A' ' 16' ' ' ASN . 67.3 m-20 -101.63 131.15 48.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.154 0.502 . . . . 1.0900000000000001 111.725 -178.726 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.99 157.49 73.73 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.316 -0.857 . . . . 0.19 109.581 179.667 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.67 157.99 58.64 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.414 2.076 . . . . 0.17999999999999999 112.261 179.936 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.32 -12.09 5.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.823 -0.626 . . . . 0.20999999999999999 110.689 -179.855 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.9 -8.7 42.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.28999999999999998 110.67 -179.933 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.24 135.41 34.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.368 -0.378 . . . . 0.5 110.425 179.662 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.17 16.71 4.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.348 -0.387 . . . . 0.29999999999999999 110.476 179.983 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.4 p -167.59 147.1 5.03 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.629 -0.508 . . . . 0.23000000000000001 109.629 179.797 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.14 150.49 12.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.567 -0.453 . . . . 0.28000000000000003 111.592 -179.573 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.502 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.32 124.91 50.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.657 -0.701 . . . . 1.0700000000000001 109.812 179.499 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.42 104.93 30.04 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.912 0.387 . . . . 0.28999999999999998 111.058 -179.884 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.3 Cg_endo -91.0 -179.53 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 123.256 2.638 . . . . 0.42999999999999999 112.243 179.86 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.69 32.61 18.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.36 -0.836 . . . . 1.26 111.461 179.308 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 172' ' ' LEU . 24.5 mt -86.36 148.54 25.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.51 -0.314 . . . . 0.32000000000000001 110.464 179.619 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.757 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.32 114.93 61.66 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.986 0.422 . . . . 0.57999999999999996 110.643 -179.701 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -58.95 140.54 95.78 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.949 2.433 . . . . 0.66000000000000003 111.922 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.1 21.16 74.36 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.018 -0.833 . . . . 0.28999999999999998 111.018 179.785 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.495 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.81 150.17 49.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 2.3300000000000001 110.669 179.996 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.5 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.15 131.66 45.97 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.074 -0.512 . . . . 0.85999999999999999 109.783 179.371 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.974 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.5 m-85 -120.61 148.26 44.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.159 -0.473 . . . . 0.52000000000000002 111.039 -179.822 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.3 mt -105.35 125.36 60.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.244 -1.021 . . . . 0.29999999999999999 108.244 177.804 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.53 132.54 63.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.143 0.496 . . . . 0.23000000000000001 111.228 -178.586 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.51 122.51 20.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.502 -0.772 . . . . 0.35999999999999999 109.689 179.276 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.587 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.95 125.32 54.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.199 -0.455 . . . . 0.19 110.716 -179.55 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.7 m-85 -117.15 137.99 51.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.955 -0.566 . . . . 0.29999999999999999 109.889 179.443 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.74 134.98 42.9 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.806 -0.813 . . . . 0.37 108.806 178.882 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 1.168 HD11 ' NE ' ' A' ' 143' ' ' ARG . 13.2 mt -99.04 122.9 51.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.116 0.484 . . . . 0.26000000000000001 110.959 -178.738 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.7 p -83.83 169.72 14.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.609 -0.723 . . . . 0.28000000000000003 110.479 -179.693 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -59.86 -14.46 15.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.053 -0.521 . . . . 1.6000000000000001 110.92 -179.555 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -96.15 -4.24 43.03 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.825 -0.35 . . . . 1.1799999999999999 110.809 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.81 13.89 63.97 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.342 -0.703 . . . . 0.29999999999999999 111.342 179.835 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -84.63 139.01 32.37 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.076 -0.25 . . . . 1.22 110.424 179.686 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.828 ' NE2' HH22 ' A' ' 143' ' ' ARG . 0.0 OUTLIER -106.69 141.12 38.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.87 0.367 . . . . 0.97999999999999998 110.558 179.718 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.3 m -136.7 127.03 26.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.82999999999999996 110.327 179.952 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.16 117.38 9.91 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.675 -0.41 . . . . 0.26000000000000001 110.533 -179.95 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.01 -21.82 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.29999999999999999 110.773 -179.778 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.5 tp -156.95 125.75 5.84 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.523 -0.471 . . . . 0.31 111.475 -179.77 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.474 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.8 120.23 21.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.787 -0.642 . . . . 0.28000000000000003 109.519 179.253 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.68 29.08 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.591 -0.444 . . . . 0.23999999999999999 110.868 -179.265 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.43 158.57 18.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.014 -0.539 . . . . 0.23000000000000001 110.44 179.702 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.02 157.89 43.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.088 -0.505 . . . . 0.67000000000000004 110.698 179.995 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.19 104.32 9.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.761 -0.654 . . . . 0.64000000000000001 110.101 179.493 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.8 p . . . . . 0 C--O 1.221 -0.414 0 CA-C-O 117.953 -1.022 . . . . 1.26 110.631 -179.628 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.553 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.1 m . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.161 -0.681 . . . . 3.4399999999999999 109.161 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.69 18.54 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.011 -0.835 . . . . 1.22 111.011 179.809 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -35.67 142.4 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.084 0 C-N-CA 123.933 3.089 . . . . 0.75 113.76 -179.222 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.61 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -79.93 173.43 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.173 -1.376 . . . . 0.79000000000000004 108.785 178.416 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.61 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.66 125.78 51.38 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.425 -0.51 . . . . 1.9399999999999999 111.44 -179.559 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.38 144.01 34.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.692 -0.685 . . . . 0.59999999999999998 110.652 179.959 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.1 168.24 25.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.97 0.414 . . . . 3.1400000000000001 111.111 -179.67 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.742 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.96 131.04 60.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.002 -0.544 . . . . 3.23 110.123 179.868 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.12 162.34 35.71 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.822 0.344 . . . . 3.6299999999999999 111.274 -179.924 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 98.9 mt-10 36.14 31.51 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.592 -0.521 . . . . 6.0800000000000001 109.592 179.819 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.742 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.59 32.58 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.001 -0.545 . . . . 3.3799999999999999 111.512 -178.721 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.3 -28.98 72.54 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.424 2.083 . . . . 3.9300000000000002 111.92 179.301 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.64 125.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.101 -0.499 . . . . 3.3599999999999999 110.442 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.618 ' O ' ' O ' ' A' ' 92' ' ' THR . 4.7 mt-30 -123.87 158.33 60.32 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 3.6099999999999999 110.491 179.914 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 143' ' ' ARG . 97.5 Cg_endo -82.07 -64.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.927 2.418 . . . . 1.51 113.515 -179.047 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.662 ' OD1' ' NH1' ' A' ' 143' ' ' ARG . 9.7 m120 -108.49 -19.59 13.4 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.076 0.399 . . . . 2.6800000000000002 112.076 -178.509 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 8.3 p -107.32 152.06 24.64 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.479 -0.488 . . . . 1.21 111.338 -179.442 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.28 102.94 2.23 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.653 -0.703 . . . . 1.5600000000000001 110.634 179.894 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.578 ' CD ' HE22 ' A' ' 14' ' ' GLN . 73.8 Cg_endo -82.72 145.53 12.91 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.974 2.45 . . . . 0.81000000000000005 112.575 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.925 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.76 167.92 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.884 -0.598 . . . . 1.52 109.892 179.579 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.15 147.91 29.02 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.682 -0.488 . . . . 2.1400000000000001 109.682 178.913 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.9 p90 -142.2 157.37 44.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.979 0.419 . . . . 0.32000000000000001 111.242 179.907 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.49 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.12 155.26 44.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.819 -0.628 . . . . 2.1699999999999999 110.095 179.0 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.836 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.59 173.03 6.36 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.105 0.478 . . . . 0.58999999999999997 110.774 -179.243 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.836 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.8 Cg_exo -50.58 173.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.818 2.346 . . . . 0.90000000000000002 111.588 179.29 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -50.95 0.7 Allowed Pre-proline 0 C--N 1.33 -0.245 0 C-N-CA 120.713 -0.395 . . . . 3.3399999999999999 110.159 179.81 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.62 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.99 152.36 82.65 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.752 2.301 . . . . 1.8500000000000001 111.404 179.197 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.5 p -63.76 42.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.355 0.598 . . . . 2.54 110.495 -179.769 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.815 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.7 -41.6 98.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.997 -1.001 . . . . 2.5299999999999998 110.579 179.8 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.532 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.6 mt -109.79 137.89 39.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.823 -0.626 . . . . 1.1699999999999999 111.262 -179.421 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.04 -72.9 0.7 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.023 -0.535 . . . . 1.27 111.887 -179.029 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.47 24.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.521 0.564 . . . . 1.1200000000000001 112.521 -179.609 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.89 124.92 45.24 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.311 -0.626 . . . . 0.41999999999999998 109.311 177.483 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.2 mt -118.02 134.76 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.703 -0.399 . . . . 0.78000000000000003 110.666 179.917 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.925 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.07 128.64 53.67 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.985 0.422 . . . . 0.62 111.22 179.748 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.548 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.11 139.02 49.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.753 -0.658 . . . . 1.97 110.057 179.001 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.433 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.2 p90 -145.06 163.14 35.18 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.162 0.506 . . . . 0.34999999999999998 112.086 -178.166 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.488 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.43 139.69 7.97 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 115.472 -0.785 . . . . 1.8 110.441 178.743 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.687 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.3 Cg_endo -63.58 115.45 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.364 2.043 . . . . 0.57999999999999996 111.836 179.995 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.68 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.05 81.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.973 0.416 . . . . 3.04 109.884 -179.786 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.687 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.26 -20.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.003 -0.544 . . . . 2.4700000000000002 111.942 -179.442 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.64 157.78 34.24 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 120.887 -0.325 . . . . 2.5099999999999998 110.561 179.78 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.401 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.4 27.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.166 -0.47 . . . . 1.8600000000000001 110.235 179.517 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.86 -75.89 1.31 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.029 -0.605 . . . . 1.4399999999999999 111.796 -179.224 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.81 152.34 35.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.92 0.39 . . . . 4.6900000000000004 110.957 -179.286 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.23 -169.06 2.51 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.043 -0.526 . . . . 1.4299999999999999 111.938 179.332 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.18 149.64 29.8 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.449 0.643 . . . . 1.74 112.581 -177.858 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.02 156.49 46.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.853 -1.067 . . . . 1.9199999999999999 110.236 178.718 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.466 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.33 158.35 41.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.966 -0.561 . . . . 0.34000000000000002 111.722 -179.327 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 m -115.18 135.56 54.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.441 -0.799 . . . . 0.40999999999999998 109.829 179.314 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.596 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.37 122.04 23.83 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.391 -0.368 . . . . 0.55000000000000004 111.529 -179.17 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.606 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.7 Cg_exo -46.31 151.75 1.62 Allowed 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.734 2.289 . . . . 0.44 112.081 178.987 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.92 -23.0 63.06 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 115.957 -0.565 . . . . 0.73999999999999999 112.809 -179.312 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.85 -16.85 46.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.369 0.584 . . . . 0.93000000000000005 111.756 -178.268 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.606 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.63 138.47 31.54 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.76 -0.376 . . . . 0.96999999999999997 110.323 179.362 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.54 13.86 10.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.295 -0.411 . . . . 1.3400000000000001 111.512 -179.297 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.473 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.98 143.41 25.19 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.664 -0.415 . . . . 0.39000000000000001 110.998 179.7 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.74 -169.43 1.54 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.035 -0.53 . . . . 0.41999999999999998 110.932 -179.512 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.711 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 7.7 m -151.66 125.93 9.33 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.429 -0.805 . . . . 0.39000000000000001 109.946 179.118 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.516 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.85 123.2 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.412 -0.515 . . . . 0.73999999999999999 111.17 -179.712 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.723 ' NZ ' HD13 ' A' ' 185' ' ' ILE . 86.3 tttt -126.43 163.4 23.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.812 -0.631 . . . . 2.48 110.5 179.645 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.513 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.11 18.97 59.92 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.775 -0.93 . . . . 0.5 110.775 -179.922 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.516 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.4 mt -78.95 157.22 28.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.135 0.493 . . . . 0.57999999999999996 111.385 -179.696 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.848 ' O ' HG12 ' A' ' 67' ' ' VAL . 2.9 mttp -99.52 133.95 21.52 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.593 -0.73 . . . . 2.79 110.442 179.758 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.528 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.81 143.57 61.82 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.553 2.169 . . . . 0.87 111.975 179.794 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.87 25.55 75.43 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.016 -0.834 . . . . 0.64000000000000001 111.016 179.716 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.848 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.1 158.82 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.709 0.29 . . . . 0.82999999999999996 110.448 -179.591 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.15 139.79 42.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.924 0.392 . . . . 0.5 110.575 -179.74 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.645 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.51 136.52 54.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.001 -0.545 . . . . 0.53000000000000003 110.78 -179.984 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.89 131.06 45.27 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.492 -0.929 . . . . 1.8700000000000001 108.492 177.622 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.49 153.85 16.65 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.3 -0.952 . . . . 0.28999999999999998 111.965 -178.664 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.92 141.02 46.19 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.687 -0.486 . . . . 1.4299999999999999 109.687 179.504 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.522 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.83 118.89 34.26 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.499 -0.48 . . . . 0.32000000000000001 110.534 179.651 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.722 HG12 HG23 ' A' ' 84' ' ' VAL . 64.1 mt -112.42 129.11 68.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.239 -0.437 . . . . 0.79000000000000004 110.585 -179.874 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.706 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.81 120.86 43.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.326 -0.397 . . . . 1.02 110.707 -179.726 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.849 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.6 146.43 11.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.491 . . . . 0.62 110.978 -179.271 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.815 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.1 mt-30 -106.03 153.87 21.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.508 -0.769 . . . . 2.4399999999999999 109.938 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.16 88.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.917 0.389 . . . . 3.6899999999999999 110.45 -179.729 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.624 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.25 32.72 0.21 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.819 -0.628 . . . . 6.0800000000000001 110.573 -179.923 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.23 -117.39 3.27 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.407 -0.677 . . . . 1.22 111.407 -179.727 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.469 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.25 177.41 9.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.238 0.542 . . . . 2.8799999999999999 111.604 -179.218 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.21 149.47 31.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.401 -0.818 . . . . 1.47 110.418 179.108 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.553 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.15 144.62 38.69 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.487 -0.324 . . . . 2.7000000000000002 110.562 179.905 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.722 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.89 135.99 61.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 120.649 -0.421 . . . . 0.46000000000000002 111.552 -179.761 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.03 141.41 52.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.714 -0.675 . . . . 0.34999999999999998 110.318 179.544 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.465 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.78 138.92 51.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.184 0.516 . . . . 3.6699999999999999 111.428 -179.324 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.29 164.23 37.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.513 -0.767 . . . . 0.67000000000000004 109.42 179.438 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.32 151.52 38.45 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.384 -0.526 . . . . 1.47 110.996 -179.994 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.81 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.17 172.76 12.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.754 -0.657 . . . . 0.44 111.0 179.844 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.74 160.74 21.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.42 -0.809 . . . . 1.3700000000000001 109.863 179.561 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.43 121.85 22.85 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.645 -0.422 . . . . 1.28 110.766 179.974 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.618 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.8 p -126.42 163.75 22.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.346 0.593 . . . . 1.97 112.08 179.72 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.413 -0.812 . . . . 3.2799999999999998 110.665 -179.686 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.496 ' OG ' ' N ' ' A' ' 127' ' ' SER . 95.7 p . . . . . 0 N--CA 1.461 0.085 0 N-CA-C 109.715 -0.476 . . . . 0.66000000000000003 109.715 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.496 ' N ' ' OG ' ' A' ' 126' ' ' SER . 0.9 OUTLIER -53.7 167.48 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.019 0.438 . . . . 0.68999999999999995 111.005 179.481 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.56 145.6 50.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.718 -0.674 . . . . 0.52000000000000002 110.101 -179.949 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.3 101.72 9.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.986 -0.746 . . . . 0.32000000000000001 108.986 177.755 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.9 t -112.99 139.7 36.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.089 -0.505 . . . . 0.28999999999999998 111.054 -178.904 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 p -128.74 152.5 48.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.603 -0.726 . . . . 0.25 109.849 179.603 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.72 -164.98 2.04 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.732 -0.387 . . . . 0.31 110.688 -179.736 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -123.93 127.17 73.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.48999999999999999 110.843 -179.885 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.164 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.95 58.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.178 -0.464 . . . . 1.53 110.329 179.862 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.07 24.41 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.916 -0.584 . . . . 0.96999999999999997 111.499 -179.673 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.164 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.22 128.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.568 -0.453 . . . . 1.5600000000000001 110.899 179.829 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.31 -9.76 55.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.879 -0.601 . . . . 1.8799999999999999 110.323 179.76 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.4 p -87.04 0.26 55.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 1.04 110.4 179.994 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.725 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.29 137.25 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.877 -0.601 . . . . 0.23999999999999999 109.969 179.74 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 185' ' ' ILE . 88.8 p -96.27 -15.54 21.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.279 0.562 . . . . 0.28999999999999998 110.035 -179.643 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.432 ' HA3' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.58 175.56 45.77 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.83 -1.308 . . . . 0.13 109.83 179.679 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -123.49 151.59 42.6 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.621 -0.431 . . . . 0.17000000000000001 110.468 179.723 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.662 ' NH1' ' OD1' ' A' ' 16' ' ' ASN . 12.7 ttt85 -132.29 121.1 23.04 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.086 -0.506 . . . . 1.29 110.005 179.805 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.548 HG21 HG11 ' A' ' 167' ' ' VAL . 46.0 t -105.03 136.49 38.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.777 -0.647 . . . . 0.25 110.724 -179.759 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 78.8 tt0 -129.27 129.91 45.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.061 -0.518 . . . . 1.3200000000000001 110.151 179.98 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.618 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.71 135.34 34.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.994 -0.548 . . . . 0.56999999999999995 110.623 -179.709 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.413 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.34 161.38 39.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.703 -0.68 . . . . 1.1599999999999999 109.716 179.846 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.969 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 85.8 mt -71.12 124.91 25.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.986 0.422 . . . . 0.38 110.689 -179.534 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.499 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.8 -7.68 49.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.739 -0.664 . . . . 0.40999999999999998 110.862 -179.81 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -109.84 -69.58 0.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.365 -0.38 . . . . 1.6599999999999999 111.519 -179.381 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.453 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.69 -35.32 76.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.095 -0.502 . . . . 1.6599999999999999 111.569 -179.192 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.086 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.2 7.2 88.62 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.75 -0.94 . . . . 1.1699999999999999 110.75 -179.936 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.325 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.85 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 1.8600000000000001 110.291 179.801 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.325 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.25 139.08 45.17 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 1.98 110.165 179.64 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.413 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.3 Cg_endo -70.94 145.84 51.38 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 C-N-CA 122.712 2.275 . . . . 0.55000000000000004 112.31 -179.546 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.87 145.81 42.56 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.182 -0.673 . . . . 1.1399999999999999 109.182 179.267 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.657 ' CD2' ' OD1' ' A' ' 16' ' ' ASN . 51.0 p90 -123.38 141.27 52.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.185 0.517 . . . . 0.93000000000000005 111.536 -179.093 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.5 mt -128.05 127.65 43.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.242 -0.89 . . . . 0.34000000000000002 108.92 179.007 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 19.1 t0 -101.58 131.05 47.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.15 0.5 . . . . 1.0900000000000001 111.824 -178.85 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.517 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.1 mt -127.83 157.61 73.04 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.303 -0.862 . . . . 0.19 109.624 179.624 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.84 158.04 58.21 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.395 2.063 . . . . 0.17999999999999999 112.239 179.938 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.24 -12.22 5.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.739 -0.664 . . . . 0.20999999999999999 110.746 -179.824 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.4 p -92.81 -8.68 42.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.09 -0.505 . . . . 0.28999999999999998 110.689 -179.883 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.3 135.35 34.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.332 -0.395 . . . . 0.5 110.318 179.734 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.4 p -133.08 16.69 4.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.322 -0.399 . . . . 0.29999999999999999 110.508 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.0 p -167.54 147.05 5.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.579 -0.526 . . . . 0.23000000000000001 109.579 179.851 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.548 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.11 150.48 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.095 0.474 . . . . 0.28000000000000003 111.585 -179.695 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.507 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.3 125.01 50.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.571 -0.741 . . . . 1.0700000000000001 109.828 179.456 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.4 104.93 30.03 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.358 -0.383 . . . . 0.28999999999999998 111.066 -179.895 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.5 Cg_endo -90.98 -179.5 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 123.22 2.613 . . . . 0.42999999999999999 112.15 179.916 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.74 32.53 18.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.371 -0.831 . . . . 1.26 111.418 179.175 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 172' ' ' LEU . 24.2 mt -86.33 148.53 25.56 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.911 -0.315 . . . . 0.32000000000000001 110.505 179.587 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.774 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.32 114.88 61.43 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 121.069 0.461 . . . . 0.57999999999999996 110.688 -179.732 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.97 140.5 95.62 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.877 2.384 . . . . 0.66000000000000003 112.1 179.815 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.18 21.13 74.2 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.029 -0.828 . . . . 0.28999999999999998 111.029 179.907 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.453 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.77 150.25 49.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.75 0.31 . . . . 2.3300000000000001 110.747 179.881 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.499 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.22 131.65 46.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.063 -0.517 . . . . 0.85999999999999999 109.799 179.333 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.969 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.47 148.33 43.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.079 -0.51 . . . . 0.52000000000000002 111.077 -179.892 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.34 125.4 60.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.281 -1.007 . . . . 0.29999999999999999 108.281 177.701 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.63 132.55 63.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.308 0.575 . . . . 0.23000000000000001 111.17 -178.595 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.5 122.59 20.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.433 -0.803 . . . . 0.35999999999999999 109.642 179.285 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.3 t -101.05 125.39 55.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.2 -0.454 . . . . 0.19 110.598 -179.436 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.3 m-85 -117.25 137.88 52.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.017 -0.538 . . . . 0.29999999999999999 109.899 179.456 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.586 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.68 135.02 42.79 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.811 -0.811 . . . . 0.37 108.811 178.872 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.723 HD13 ' NZ ' ' A' ' 61' ' ' LYS . 5.2 mp -99.04 122.94 51.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.16 0.505 . . . . 0.26000000000000001 110.926 -178.747 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.3 p -83.86 169.79 14.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.517 -0.765 . . . . 0.28000000000000003 110.453 -179.71 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.89 -14.53 15.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.048 -0.523 . . . . 1.6000000000000001 110.823 -179.504 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.548 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.3 m-20 -96.11 -4.22 43.21 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.817 -0.353 . . . . 1.1799999999999999 110.847 -179.811 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.566 ' HA3' HG23 ' A' ' 59' ' ' THR . . . 87.74 13.9 64.09 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.376 -0.69 . . . . 0.29999999999999999 111.376 179.858 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.62 139.03 32.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.652 0.263 . . . . 1.22 110.438 179.652 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.467 ' NE2' ' HD3' ' A' ' 143' ' ' ARG . 97.1 mt-30 -106.69 141.04 38.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.809 0.337 . . . . 0.97999999999999998 110.617 179.675 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 61.8 m -136.65 127.12 26.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.82999999999999996 110.316 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.1 117.36 9.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.287 -0.415 . . . . 0.26000000000000001 110.584 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.0 pt -109.18 -21.67 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.29999999999999999 110.732 -179.69 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.97 125.73 5.82 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.542 -0.463 . . . . 0.31 111.521 -179.879 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.475 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.79 120.13 21.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.777 -0.647 . . . . 0.28000000000000003 109.58 179.248 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.55 151.71 29.19 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.639 -0.424 . . . . 0.23999999999999999 110.882 -179.276 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.8 p -110.36 158.56 18.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.019 -0.537 . . . . 0.23000000000000001 110.442 179.709 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.401 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 21.6 mt-30 -146.05 157.86 43.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.67000000000000004 110.663 -179.969 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.31 104.36 9.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.801 -0.636 . . . . 0.64000000000000001 110.043 179.49 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.9 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.843 -1.075 . . . . 1.26 110.621 -179.655 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.2 m . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.189 -0.671 . . . . 3.4399999999999999 109.189 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.66 18.54 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.988 -0.845 . . . . 1.22 110.988 179.72 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -35.47 142.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.058 0 C-N-CA 123.934 3.089 . . . . 0.75 113.832 -179.283 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.609 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.99 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.274 -1.33 . . . . 0.79000000000000004 108.83 178.368 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.609 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.62 125.94 51.57 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.376 -0.529 . . . . 1.9399999999999999 111.461 -179.601 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.47 144.01 33.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.63 -0.713 . . . . 0.59999999999999998 110.72 179.869 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.03 168.34 25.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.925 0.393 . . . . 3.1400000000000001 111.137 -179.674 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.745 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.5 mt -109.06 131.02 60.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.957 -0.565 . . . . 3.23 110.024 179.928 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.15 162.36 35.67 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.865 0.364 . . . . 3.6299999999999999 111.219 -179.961 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 16.9 pt-20 36.16 31.45 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.682 -0.488 . . . . 6.0800000000000001 109.682 179.847 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.745 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.4 69.61 32.3 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.934 -0.575 . . . . 3.3799999999999999 111.593 -178.747 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.28 -29.08 72.73 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.497 2.132 . . . . 3.9300000000000002 111.822 179.354 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.58 125.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 3.3599999999999999 110.481 -179.947 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 17' ' ' SER . 13.2 mp0 -123.8 158.41 59.85 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.294 -0.412 . . . . 3.6099999999999999 110.456 179.959 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.459 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 97.2 Cg_endo -82.1 -64.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.861 2.374 . . . . 1.51 113.456 -179.039 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.674 ' OD1' ' N ' ' A' ' 17' ' ' SER . 1.4 p-10 -108.39 -19.61 13.4 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.106 0.41 . . . . 2.6800000000000002 112.106 -178.498 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.674 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 33.4 m -107.34 152.1 24.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.116 0.484 . . . . 1.21 111.328 -179.421 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.37 102.96 2.21 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.693 -0.685 . . . . 1.5600000000000001 110.652 179.804 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.6 145.57 13.12 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.921 2.414 . . . . 0.81000000000000005 112.61 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.928 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.78 167.9 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.955 -0.566 . . . . 1.52 109.842 179.567 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.17 147.9 28.99 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.812 -0.44 . . . . 2.1400000000000001 109.812 178.822 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.595 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.21 157.32 44.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.005 0.431 . . . . 0.32000000000000001 111.11 -179.951 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.492 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.09 155.19 44.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.699 -0.682 . . . . 2.1699999999999999 110.086 178.978 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.836 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.55 173.04 6.35 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.185 -0.462 . . . . 0.58999999999999997 110.732 -179.193 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.836 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.58 173.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.974 2.449 . . . . 0.90000000000000002 111.492 179.333 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.479 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.09 -51.03 0.69 Allowed Pre-proline 0 C--N 1.328 -0.349 0 C-N-CA 120.666 -0.414 . . . . 3.3399999999999999 110.078 179.853 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.84 152.32 82.57 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.798 2.332 . . . . 1.8500000000000001 111.483 179.219 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.67 42.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.38 0.61 . . . . 2.54 110.534 -179.869 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.817 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.67 -41.58 98.17 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.032 -0.985 . . . . 2.5299999999999998 110.68 179.709 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.533 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.6 mt -109.93 137.82 40.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.773 -0.648 . . . . 1.1699999999999999 111.271 -179.439 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.92 -72.98 0.7 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.999 -0.546 . . . . 1.27 111.865 -178.963 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.16 148.42 24.42 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.587 0.588 . . . . 1.1200000000000001 112.587 -179.625 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.85 124.87 45.14 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.319 -0.623 . . . . 0.41999999999999998 109.319 177.572 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.02 134.67 60.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.718 -0.393 . . . . 0.78000000000000003 110.72 179.939 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.928 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -119.96 128.67 53.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.055 0.455 . . . . 0.62 111.275 179.788 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.547 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 138.88 49.64 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.758 -0.655 . . . . 1.97 110.08 179.087 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.433 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.0 163.23 34.84 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.158 0.504 . . . . 0.34999999999999998 112.086 -178.198 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.489 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.51 139.57 7.83 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.482 -0.781 . . . . 1.8 110.451 178.846 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.684 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.9 Cg_endo -63.54 115.44 3.04 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.279 1.986 . . . . 0.57999999999999996 111.891 179.938 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.679 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.3 tttp -46.99 81.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.871 -0.418 . . . . 3.04 109.871 -179.827 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.58 0.06 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.92 -0.582 . . . . 2.4700000000000002 111.874 -179.584 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 p -157.7 157.81 34.21 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 120.747 -0.381 . . . . 2.5099999999999998 110.561 179.764 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.401 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.42 27.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 1.8600000000000001 110.161 179.659 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.81 -75.89 1.31 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.19 -0.528 . . . . 1.4399999999999999 111.861 -179.243 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.96 152.32 35.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.968 0.413 . . . . 4.6900000000000004 110.988 -179.383 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.18 -169.14 2.54 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.993 -0.549 . . . . 1.4299999999999999 111.922 179.425 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.6 mttp -110.14 149.62 29.81 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.477 0.656 . . . . 1.74 112.599 -177.922 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.0 156.58 46.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.768 -1.105 . . . . 1.9199999999999999 110.306 178.6 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.3 158.39 41.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.901 -0.59 . . . . 0.34000000000000002 111.785 -179.311 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.8 m -115.25 135.67 53.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.459 -0.791 . . . . 0.40999999999999998 109.784 179.317 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.595 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.43 121.95 23.73 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.419 -0.355 . . . . 0.55000000000000004 111.505 -179.105 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.0 Cg_exo -46.34 151.73 1.64 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.639 2.226 . . . . 0.44 112.189 179.019 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.89 -23.07 63.07 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-N 116.063 -0.517 . . . . 0.73999999999999999 112.81 -179.189 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.538 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.79 -16.9 46.07 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.237 -0.585 . . . . 0.93000000000000005 111.761 -178.274 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.603 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.54 138.48 31.54 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.689 -0.404 . . . . 0.96999999999999997 110.309 179.372 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.6 13.98 10.95 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.404 -0.362 . . . . 1.3400000000000001 111.567 -179.416 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.472 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.98 143.44 25.21 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.607 -0.437 . . . . 0.39000000000000001 111.052 179.586 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.708 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.82 -169.36 1.53 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.203 0.525 . . . . 0.41999999999999998 110.916 -179.523 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.708 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 t -151.69 125.89 9.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.448 -0.796 . . . . 0.39000000000000001 109.84 179.262 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.517 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.83 123.27 70.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.33 -0.548 . . . . 0.73999999999999999 111.205 -179.785 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -126.43 163.41 23.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.872 -0.603 . . . . 2.48 110.379 179.788 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.16 18.83 60.11 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.783 -0.927 . . . . 0.5 110.783 -179.953 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.517 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.2 mt -79.05 157.31 28.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.156 0.503 . . . . 0.57999999999999996 111.28 -179.521 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.848 ' O ' HG12 ' A' ' 67' ' ' VAL . 4.8 mptp? -99.59 134.0 21.44 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.554 -0.748 . . . . 2.79 110.414 179.8 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.439 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.9 Cg_endo -67.8 143.64 62.09 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.591 2.194 . . . . 0.87 111.971 179.784 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.75 25.62 75.34 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.101 -0.8 . . . . 0.64000000000000001 111.101 179.705 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.848 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.15 158.78 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.692 0.282 . . . . 0.82999999999999996 110.397 -179.574 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.17 139.96 41.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.882 0.372 . . . . 0.5 110.621 -179.825 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.672 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.2 m-85 -122.56 136.33 54.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.994 -0.548 . . . . 0.53000000000000003 110.818 -179.901 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.486 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.79 131.05 45.22 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.546 -0.909 . . . . 1.8700000000000001 108.546 177.593 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.48 153.79 16.66 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.308 -0.949 . . . . 0.28999999999999998 111.986 -178.579 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.92 140.92 46.13 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.658 -0.497 . . . . 1.4299999999999999 109.658 179.584 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.525 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.75 118.84 34.15 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.452 -0.499 . . . . 0.32000000000000001 110.536 179.672 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.714 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.42 129.05 68.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.339 -0.391 . . . . 0.79000000000000004 110.658 -179.862 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.704 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.74 120.88 43.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.27 -0.423 . . . . 1.02 110.73 -179.634 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.85 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.62 146.5 11.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.17 0.51 . . . . 0.62 110.944 -179.223 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.817 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.06 153.93 21.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.46 -0.791 . . . . 2.4399999999999999 109.891 179.826 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.18 88.52 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.896 0.379 . . . . 3.6899999999999999 110.424 -179.809 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.36 32.52 0.22 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.873 -0.603 . . . . 6.0800000000000001 110.628 -179.953 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.02 -117.38 3.3 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.431 -0.667 . . . . 1.22 111.431 -179.693 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.469 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.43 177.42 8.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.135 0.493 . . . . 2.8799999999999999 111.658 -179.189 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.1 149.54 32.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.503 -0.771 . . . . 1.47 110.391 179.167 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.18 144.66 38.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.471 -0.331 . . . . 2.7000000000000002 110.515 179.863 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.714 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.94 136.09 61.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 121.035 0.445 . . . . 0.46000000000000002 111.57 -179.806 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.7 m -124.15 141.29 52.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.753 -0.658 . . . . 0.34999999999999998 110.316 179.635 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.46 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.58 138.91 51.62 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.125 0.488 . . . . 3.6699999999999999 111.524 -179.339 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.3 164.14 38.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.575 -0.739 . . . . 0.67000000000000004 109.474 179.386 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.29 151.57 38.56 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.293 -0.563 . . . . 1.47 111.011 179.937 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.808 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.21 172.72 13.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.792 -0.64 . . . . 0.44 111.079 179.895 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.77 160.7 21.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.57 -0.741 . . . . 1.3700000000000001 109.847 179.644 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.46 121.89 22.88 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.524 -0.47 . . . . 1.28 110.712 -179.965 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.6 p -125.41 151.83 45.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.909 0.862 . . . . 1.97 112.908 179.695 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.462 0.161 0 CA-C-N 114.053 -1.43 . . . . 3.2799999999999998 113.876 -179.402 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 122.668 1.223 . . . . 0.66000000000000003 108.137 . . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.442 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.82 167.6 0.25 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.121 -1.399 . . . . 0.68999999999999995 110.904 -178.85 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.69 145.56 50.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.692 -0.686 . . . . 0.52000000000000002 110.084 -179.934 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.26 101.7 9.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.07 -0.715 . . . . 0.32000000000000001 109.07 177.678 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.2 t -112.88 139.69 36.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.989 -0.551 . . . . 0.28999999999999998 111.073 -178.914 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.9 p -128.68 152.55 48.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.637 -0.71 . . . . 0.25 109.84 179.568 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.81 -164.98 2.04 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.693 -0.403 . . . . 0.31 110.64 -179.764 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.733 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.6 t -123.95 127.16 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.48999999999999999 110.844 -179.88 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.174 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.94 58.36 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.103 -0.499 . . . . 1.53 110.415 179.808 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.29 24.59 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.931 -0.577 . . . . 0.96999999999999997 111.479 -179.541 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.174 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.2 128.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.686 -0.405 . . . . 1.5600000000000001 111.004 179.8 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -86.45 -9.62 55.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.886 -0.597 . . . . 1.8799999999999999 110.337 179.775 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.12 0.35 55.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.094 -0.503 . . . . 1.04 110.289 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.34 137.19 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.23999999999999999 109.977 179.663 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 185' ' ' ILE . 76.6 p -96.28 -15.4 21.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.304 0.574 . . . . 0.28999999999999998 110.044 -179.649 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.52 175.58 45.72 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.856 -1.297 . . . . 0.13 109.856 179.59 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.45 151.63 42.49 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.62 -0.432 . . . . 0.17000000000000001 110.484 179.745 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.459 ' NH1' ' HG2' ' A' ' 15' ' ' PRO . 45.2 ttp180 -132.33 121.22 23.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.143 -0.48 . . . . 1.29 109.899 179.814 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.554 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.13 136.54 38.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.732 -0.667 . . . . 0.25 110.634 -179.711 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 80.7 tt0 -129.5 129.86 45.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.975 -0.557 . . . . 1.3200000000000001 110.006 -179.91 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.622 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.69 135.32 34.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.937 -0.574 . . . . 0.56999999999999995 110.633 -179.676 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.421 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.32 161.4 39.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.753 -0.658 . . . . 1.1599999999999999 109.619 179.875 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.968 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.1 mt -71.04 124.8 25.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.973 0.416 . . . . 0.38 110.772 -179.642 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.79 -7.64 49.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.832 -0.622 . . . . 0.40999999999999998 110.875 -179.738 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -109.82 -69.72 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.963 0.411 . . . . 1.6599999999999999 111.407 -179.267 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.468 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.69 -35.31 75.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.014 -0.539 . . . . 1.6599999999999999 111.563 -179.155 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.076 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.07 7.29 88.55 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.829 -0.908 . . . . 1.1699999999999999 110.829 -179.83 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.319 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.95 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.734 0.302 . . . . 1.8600000000000001 110.322 179.818 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.319 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.13 45.22 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.976 0.417 . . . . 1.98 110.193 179.624 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.8 Cg_endo -70.85 145.9 52.06 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 C-N-CA 122.621 2.214 . . . . 0.55000000000000004 112.368 -179.568 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.622 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.87 145.73 42.63 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.21 -0.663 . . . . 1.1399999999999999 109.21 179.21 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 6.0 p90 -123.24 141.31 52.11 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.399 -0.52 . . . . 0.93000000000000005 111.57 -179.108 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.3 mt -128.18 127.73 43.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.337 -0.847 . . . . 0.34000000000000002 108.844 178.956 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.548 ' O ' ' OD1' ' A' ' 159' ' ' ASP . 54.4 p-10 -101.65 131.15 48.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.174 0.511 . . . . 1.0900000000000001 111.751 -178.76 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.92 157.49 73.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.362 -0.836 . . . . 0.19 109.559 179.768 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -69.76 158.0 58.47 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.485 2.123 . . . . 0.17999999999999999 112.203 179.903 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.27 -12.16 5.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.755 -0.657 . . . . 0.20999999999999999 110.75 -179.842 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.81 -8.84 42.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.113 -0.494 . . . . 0.28999999999999998 110.678 -179.823 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.11 135.32 34.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.325 -0.398 . . . . 0.5 110.463 179.68 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 32.1 p -133.07 16.6 4.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.465 -0.334 . . . . 0.29999999999999999 110.582 179.953 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.1 p -167.53 147.09 5.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.61 -0.515 . . . . 0.23000000000000001 109.61 179.897 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.554 HG11 HG21 ' A' ' 144' ' ' VAL . 6.2 p -152.2 150.52 12.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.518 -0.473 . . . . 0.28000000000000003 111.528 -179.632 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.512 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.39 124.98 50.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.608 -0.724 . . . . 1.0700000000000001 109.763 179.517 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.39 104.93 29.96 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.909 0.385 . . . . 0.28999999999999998 111.02 -179.879 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.0 Cg_endo -91.03 -179.56 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 123.12 2.547 . . . . 0.42999999999999999 112.179 179.89 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 61.81 32.54 18.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.372 -0.831 . . . . 1.26 111.435 179.246 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.456 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.0 mt -86.46 148.5 25.52 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.918 -0.313 . . . . 0.32000000000000001 110.474 179.592 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.774 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.27 114.85 61.27 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 121.06 0.457 . . . . 0.57999999999999996 110.674 -179.64 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -58.95 140.63 96.15 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.9 2.4 . . . . 0.66000000000000003 111.99 179.853 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 76.99 21.26 74.44 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.082 -0.807 . . . . 0.28999999999999998 111.082 179.864 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.468 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.84 150.15 49.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.783 0.325 . . . . 2.3300000000000001 110.669 179.944 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.17 131.66 45.99 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.85999999999999999 109.784 179.28 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.968 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.2 m-85 -120.5 148.32 43.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.096 -0.502 . . . . 0.52000000000000002 110.951 -179.813 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.35 125.39 60.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.295 -1.002 . . . . 0.29999999999999999 108.295 177.657 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.59 132.45 63.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.206 0.527 . . . . 0.23000000000000001 111.274 -178.61 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.45 122.6 20.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.46 -0.791 . . . . 0.35999999999999999 109.64 179.278 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -101.02 125.41 54.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.234 -0.439 . . . . 0.19 110.72 -179.566 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.3 m-85 -117.22 137.91 52.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.992 -0.549 . . . . 0.29999999999999999 109.884 179.535 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.583 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.75 135.04 42.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.801 -0.815 . . . . 0.37 108.801 178.872 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.606 ' O ' ' N ' ' A' ' 140' ' ' SER . 80.6 mt -98.98 122.93 51.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.134 0.492 . . . . 0.26000000000000001 110.981 -178.774 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.8 p -83.89 169.67 14.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.593 -0.73 . . . . 0.28000000000000003 110.447 -179.709 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.82 -14.49 15.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.996 -0.547 . . . . 1.6000000000000001 110.928 -179.552 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -96.05 -4.3 43.24 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.857 -0.337 . . . . 1.1799999999999999 110.808 -179.832 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.83 13.84 64.01 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.351 -0.699 . . . . 0.29999999999999999 111.351 179.848 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -84.64 139.1 32.3 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.774 -0.251 . . . . 1.22 110.43 179.737 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.4 ' OE1' ' NH1' ' A' ' 143' ' ' ARG . 15.2 pt20 -106.72 141.07 38.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.423 -0.353 . . . . 0.97999999999999998 110.53 179.773 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.75 127.06 26.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.82999999999999996 110.332 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 25.8 tp -68.13 117.21 9.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.247 -0.433 . . . . 0.26000000000000001 110.42 -179.876 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -108.98 -21.83 5.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.29999999999999999 110.688 -179.787 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.82 125.82 5.95 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.512 -0.475 . . . . 0.31 111.476 -179.803 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.47 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.82 120.15 21.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.764 -0.653 . . . . 0.28000000000000003 109.564 179.174 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.63 151.63 29.03 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.691 -0.404 . . . . 0.23999999999999999 110.932 -179.284 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.31 158.64 18.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.041 -0.527 . . . . 0.23000000000000001 110.431 179.723 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.4 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 21.4 mt-30 -146.12 157.86 43.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.078 -0.51 . . . . 0.67000000000000004 110.652 -179.997 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.22 104.29 9.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.827 -0.624 . . . . 0.64000000000000001 110.086 179.522 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.0 p . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.851 -1.071 . . . . 1.26 110.727 -179.727 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.4 m . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.269 -0.641 . . . . 3.4399999999999999 109.269 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.74 18.53 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.032 -0.827 . . . . 1.22 111.032 179.683 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -35.7 142.38 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.113 0 C-N-CA 124.004 3.136 . . . . 0.75 113.806 -179.247 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.0 t -79.93 173.4 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.14 -1.391 . . . . 0.79000000000000004 108.888 178.41 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.608 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.53 125.86 51.46 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.448 -0.501 . . . . 1.9399999999999999 111.496 -179.618 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.51 143.99 33.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.687 -0.688 . . . . 0.59999999999999998 110.585 179.967 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.07 168.27 25.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.934 0.397 . . . . 3.1400000000000001 111.074 -179.671 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.744 HG22 ' OG1' ' A' ' 11' ' ' THR . 65.9 mt -108.93 131.01 60.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.946 -0.57 . . . . 3.23 110.139 179.877 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.14 162.27 35.88 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.869 0.366 . . . . 3.6299999999999999 111.247 -179.88 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.7 mt-10 36.21 31.5 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.601 -0.518 . . . . 6.0800000000000001 109.601 179.781 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.744 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.63 33.17 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.962 -0.563 . . . . 3.3799999999999999 111.555 -178.764 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.642 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.24 -29.22 73.2 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.531 2.154 . . . . 3.9300000000000002 111.849 179.304 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.642 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.71 125.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 3.3599999999999999 110.474 179.971 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.561 ' O ' ' O ' ' A' ' 92' ' ' THR . 2.3 mp0 -123.98 158.34 60.59 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.362 -0.381 . . . . 3.6099999999999999 110.436 179.965 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.506 ' HG3' ' NH1' ' A' ' 143' ' ' ARG . 96.7 Cg_endo -82.12 -64.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.837 2.358 . . . . 1.51 113.485 -179.023 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.54 ' OD1' ' O ' ' A' ' 63' ' ' LEU . 2.5 t-20 -108.5 -19.51 13.42 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.06 0.393 . . . . 2.6800000000000002 112.06 -178.501 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 9.1 p -107.36 152.02 24.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.103 0.477 . . . . 1.21 111.299 -179.456 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.576 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.25 102.89 2.23 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.694 -0.684 . . . . 1.5600000000000001 110.649 179.844 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.443 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.4 Cg_endo -82.62 145.66 13.12 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.885 2.39 . . . . 0.81000000000000005 112.621 179.896 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.917 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.84 167.93 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.901 -0.59 . . . . 1.52 109.856 179.595 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -149.17 147.85 28.94 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.819 -0.437 . . . . 2.1400000000000001 109.819 178.872 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.584 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.19 157.34 44.97 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.685 -0.406 . . . . 0.32000000000000001 111.228 179.946 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.501 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -128.03 155.23 44.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.737 -0.665 . . . . 2.1699999999999999 110.117 179.023 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.843 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.6 173.04 6.35 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.024 0.44 . . . . 0.58999999999999997 110.79 -179.266 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.843 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.71 173.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.914 2.41 . . . . 0.90000000000000002 111.528 179.402 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.94 -51.01 0.7 Allowed Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.616 -0.434 . . . . 3.3399999999999999 110.17 179.867 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.643 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.9 152.35 82.57 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.681 2.254 . . . . 1.8500000000000001 111.48 179.183 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.71 42.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.406 0.622 . . . . 2.54 110.562 -179.82 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.818 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.7 -41.51 98.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.943 -1.026 . . . . 2.5299999999999998 110.657 179.784 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.532 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.3 mt -110.0 137.87 40.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.72 -0.673 . . . . 1.1699999999999999 111.181 -179.409 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.99 -72.97 0.7 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.939 -0.573 . . . . 1.27 111.819 -178.944 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.19 148.44 24.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.591 0.589 . . . . 1.1200000000000001 112.591 -179.592 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.79 124.75 44.93 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.363 -0.606 . . . . 0.41999999999999998 109.363 177.556 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -117.99 134.71 60.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.696 -0.402 . . . . 0.78000000000000003 110.67 179.89 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.917 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -119.98 128.58 53.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.043 0.449 . . . . 0.62 111.225 179.767 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.542 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.07 138.98 49.83 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.768 -0.651 . . . . 1.97 110.138 178.954 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.44 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.0 163.25 34.77 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 121.165 0.507 . . . . 0.34999999999999998 112.061 -178.151 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.56 139.63 7.82 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.415 -0.811 . . . . 1.8 110.399 178.825 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.71 115.52 3.12 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.308 2.005 . . . . 0.57999999999999996 111.822 179.985 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.675 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.96 81.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.897 -0.408 . . . . 3.04 109.897 -179.801 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.697 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.012 -0.54 . . . . 2.4700000000000002 111.936 -179.496 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.2 p -157.65 157.79 34.25 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.839 -0.345 . . . . 2.5099999999999998 110.568 179.77 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.38 27.79 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 1.8600000000000001 110.165 179.574 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.75 -75.79 1.31 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.183 -0.532 . . . . 1.4399999999999999 111.888 -179.245 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.4 ' HD2' HH11 ' A' ' 45' ' ' ARG . 21.4 mtp180 -118.03 152.29 35.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.931 0.396 . . . . 4.6900000000000004 110.968 -179.317 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.673 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.15 2.54 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.106 -0.497 . . . . 1.4299999999999999 112.007 179.39 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.04 149.67 29.66 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.457 0.646 . . . . 1.74 112.543 -177.836 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.15 156.44 45.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.789 -1.096 . . . . 1.9199999999999999 110.161 178.635 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.21 158.35 41.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.905 -0.589 . . . . 0.34000000000000002 111.745 -179.351 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.3 m -115.11 135.59 54.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.454 -0.794 . . . . 0.40999999999999998 109.831 179.287 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.584 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.34 121.86 23.82 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.411 -0.359 . . . . 0.55000000000000004 111.596 -179.156 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.595 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.0 Cg_exo -46.23 151.67 1.58 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.695 2.263 . . . . 0.44 112.173 178.992 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.83 -23.16 63.05 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 116.096 -0.502 . . . . 0.73999999999999999 112.796 -179.205 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.54 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.7 -16.95 46.17 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.245 -0.582 . . . . 0.93000000000000005 111.824 -178.316 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.595 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.51 138.39 31.61 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.782 -0.367 . . . . 0.96999999999999997 110.27 179.396 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.54 14.01 11.0 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.308 -0.405 . . . . 1.3400000000000001 111.466 -179.418 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -150.04 143.5 25.19 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.721 -0.392 . . . . 0.39000000000000001 111.061 179.573 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.9 -169.31 1.53 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.065 -0.516 . . . . 0.41999999999999998 110.885 -179.425 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.723 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.79 125.94 9.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.442 -0.799 . . . . 0.39000000000000001 109.793 179.305 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.519 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.89 123.19 70.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.398 -0.521 . . . . 0.73999999999999999 111.157 -179.73 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -126.47 163.32 23.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.895 -0.593 . . . . 2.48 110.467 179.695 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.443 ' N ' ' OD2' ' A' ' 159' ' ' ASP . . . 85.24 18.95 59.76 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.672 -0.971 . . . . 0.5 110.672 -179.963 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.54 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 73.6 mt -79.07 157.27 28.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.129 0.49 . . . . 0.57999999999999996 111.302 -179.594 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.84 ' O ' HG12 ' A' ' 67' ' ' VAL . 1.2 mptt -99.51 134.02 21.47 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.572 -0.74 . . . . 2.79 110.475 179.759 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.95 143.58 61.03 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.573 2.182 . . . . 0.87 111.912 179.835 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.62 75.34 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.1 -0.8 . . . . 0.64000000000000001 111.1 179.732 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.84 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.14 158.74 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.704 0.288 . . . . 0.82999999999999996 110.395 -179.564 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.17 139.95 42.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.067 0.46 . . . . 0.5 110.586 -179.861 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.648 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.3 m-85 -122.5 136.42 54.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.869 -0.605 . . . . 0.53000000000000003 110.799 -179.9 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.3 pt-20 -98.85 131.06 45.24 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.553 -0.906 . . . . 1.8700000000000001 108.553 177.557 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.495 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.47 153.84 16.65 Favored Glycine 0 C--O 1.227 -0.286 0 C-N-CA 120.364 -0.922 . . . . 0.28999999999999998 112.043 -178.681 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.99 140.92 46.05 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.706 -0.479 . . . . 1.4299999999999999 109.706 179.55 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.2 tp -115.77 119.01 34.62 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.421 -0.512 . . . . 0.32000000000000001 110.504 179.684 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 84' ' ' VAL . 64.1 mt -112.45 129.06 68.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 0.79000000000000004 110.631 -179.865 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.7 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.8 120.75 43.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.343 -0.39 . . . . 1.02 110.754 -179.682 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.856 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.54 146.38 11.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.223 0.535 . . . . 0.62 111.023 -179.258 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.818 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.01 153.85 21.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.532 -0.758 . . . . 2.4399999999999999 109.935 179.829 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.2 mt-30 -39.13 88.48 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.889 0.376 . . . . 3.6899999999999999 110.416 -179.737 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.31 32.7 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.845 -0.616 . . . . 6.0800000000000001 110.467 -179.922 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.18 -117.36 3.28 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.413 -0.675 . . . . 1.22 111.413 -179.776 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.461 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.34 177.44 8.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.295 0.569 . . . . 2.8799999999999999 111.606 -179.192 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.22 149.46 31.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.423 -0.808 . . . . 1.47 110.486 179.149 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.07 144.64 38.85 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.549 -0.296 . . . . 2.7000000000000002 110.591 179.952 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.727 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.94 136.07 61.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.036 0.446 . . . . 0.46000000000000002 111.565 -179.832 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.57 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.16 141.38 52.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.675 -0.693 . . . . 0.34999999999999998 110.241 179.645 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.4 ttp180 -117.64 138.86 51.69 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.572 -0.451 . . . . 3.6699999999999999 111.511 -179.322 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.495 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.32 164.18 37.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.606 -0.724 . . . . 0.67000000000000004 109.44 179.422 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.567 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.29 151.55 38.52 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.357 -0.537 . . . . 1.47 111.042 179.99 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.8 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.25 172.68 13.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.738 -0.665 . . . . 0.44 111.083 179.848 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.69 160.65 21.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.48 -0.782 . . . . 1.3700000000000001 109.873 179.604 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.29 121.93 23.14 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.507 -0.477 . . . . 1.28 110.731 179.959 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.561 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.5 p -127.42 159.32 34.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 1.97 111.643 179.631 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 36.3 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.904 -0.589 . . . . 3.2799999999999998 110.944 179.325 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.7 p . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.549 0.214 . . . . 0.66000000000000003 111.17 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.44 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.81 167.56 0.25 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.181 -0.463 . . . . 0.68999999999999995 110.954 179.893 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.65 145.49 50.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.807 -0.633 . . . . 0.52000000000000002 110.136 -179.933 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.18 101.62 9.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.012 -0.736 . . . . 0.32000000000000001 109.012 177.788 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.6 t -112.97 139.62 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.1 -0.5 . . . . 0.28999999999999998 111.149 -178.965 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.4 p -128.63 152.62 48.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.66 -0.7 . . . . 0.25 109.891 179.564 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.588 ' CD2' HG11 ' A' ' 182' ' ' VAL . 40.0 p90 -144.77 -165.06 2.06 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.74 -0.384 . . . . 0.31 110.704 -179.669 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.735 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.6 t -123.87 127.08 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.48999999999999999 110.897 -179.903 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.176 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.85 58.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.159 -0.473 . . . . 1.53 110.388 179.767 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.735 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.22 24.47 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.949 -0.569 . . . . 0.96999999999999997 111.433 -179.597 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.176 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.17 128.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.617 -0.433 . . . . 1.5600000000000001 110.991 179.915 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.36 -9.71 55.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.95 -0.568 . . . . 1.8799999999999999 110.293 179.829 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.07 0.2 55.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 1.04 110.253 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.21 137.17 25.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.23999999999999999 109.974 179.68 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 185' ' ' ILE . 70.5 m -96.22 -15.58 21.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.227 0.537 . . . . 0.28999999999999998 110.011 -179.66 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.61 175.52 45.76 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.821 -1.312 . . . . 0.13 109.821 179.722 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.37 151.62 42.35 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.694 -0.402 . . . . 0.17000000000000001 110.489 179.706 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.856 ' HE ' ' NE2' ' A' ' 191' ' ' GLN . 55.1 ttp85 -132.36 121.21 23.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.172 -0.467 . . . . 1.29 109.954 179.736 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.563 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.13 136.53 38.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.716 -0.675 . . . . 0.25 110.622 -179.7 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 79.5 tt0 -129.39 129.91 45.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.961 -0.563 . . . . 1.3200000000000001 110.128 179.963 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.9 p90 -138.67 135.32 34.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.006 -0.543 . . . . 0.56999999999999995 110.675 -179.658 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.414 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.39 161.33 39.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.805 -0.634 . . . . 1.1599999999999999 109.685 179.849 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.962 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.04 124.89 25.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.974 0.416 . . . . 0.38 110.737 -179.597 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.489 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.73 -7.78 50.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.741 -0.663 . . . . 0.40999999999999998 110.908 -179.791 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -109.76 -69.59 0.85 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.958 0.408 . . . . 1.6599999999999999 111.467 -179.253 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.441 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.4 mt-10 -60.85 -35.23 76.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.059 -0.519 . . . . 1.6599999999999999 111.454 -179.084 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.072 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.12 7.18 88.62 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.893 -0.883 . . . . 1.1699999999999999 110.893 -179.836 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.335 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.97 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.757 0.313 . . . . 1.8600000000000001 110.326 179.873 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.335 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.19 139.1 45.39 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.95 0.405 . . . . 1.98 110.226 179.649 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.414 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.2 Cg_endo -70.97 145.79 51.08 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.768 2.312 . . . . 0.55000000000000004 112.327 -179.499 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.85 145.68 42.65 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.28 -0.637 . . . . 1.1399999999999999 109.28 179.19 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.537 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 85.5 m-85 -123.27 141.41 52.01 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.314 -0.554 . . . . 0.93000000000000005 111.518 -179.053 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.4 mt -128.11 127.69 43.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.306 -0.861 . . . . 0.34000000000000002 108.915 179.06 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.443 ' OD2' ' N ' ' A' ' 62' ' ' GLY . 45.0 t0 -101.68 131.13 48.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.148 0.499 . . . . 1.0900000000000001 111.761 -178.783 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.92 157.62 73.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.266 -0.879 . . . . 0.19 109.6 179.619 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -69.87 158.03 58.19 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.423 2.082 . . . . 0.17999999999999999 112.197 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.26 -12.18 5.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.729 -0.669 . . . . 0.20999999999999999 110.693 -179.808 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.2 p -92.86 -8.73 42.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.28999999999999998 110.657 -179.855 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.27 135.39 34.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.393 -0.367 . . . . 0.5 110.344 179.73 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 p -133.14 16.62 4.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.335 -0.393 . . . . 0.29999999999999999 110.54 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.7 p -167.45 147.15 5.16 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.659 -0.497 . . . . 0.23000000000000001 109.659 179.874 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.563 HG11 HG21 ' A' ' 144' ' ' VAL . 5.9 p -152.19 150.36 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.011 0.434 . . . . 0.28000000000000003 111.618 -179.605 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.504 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 124.96 50.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.622 -0.717 . . . . 1.0700000000000001 109.799 179.47 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.47 104.97 30.47 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.015 0.436 . . . . 0.28999999999999998 111.062 -179.903 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.5 Cg_endo -91.04 -179.46 1.47 Allowed 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 123.144 2.563 . . . . 0.42999999999999999 112.221 179.914 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.66 32.67 18.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.399 -0.819 . . . . 1.26 111.501 179.31 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.2 mt -86.41 148.57 25.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.442 -0.345 . . . . 0.32000000000000001 110.431 179.656 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.777 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.38 114.86 61.4 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.074 0.464 . . . . 0.57999999999999996 110.714 -179.742 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -58.9 140.53 95.62 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.926 2.417 . . . . 0.66000000000000003 112.024 179.882 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.06 21.3 74.14 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.044 -0.823 . . . . 0.28999999999999998 111.044 179.861 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.441 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -127.0 150.14 49.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.942 0.401 . . . . 2.3300000000000001 110.528 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.489 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.13 131.67 45.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.878 -0.601 . . . . 0.85999999999999999 109.78 179.316 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.962 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.54 148.36 43.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.1 -0.5 . . . . 0.52000000000000002 111.035 -179.852 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.4 mt -105.39 125.33 60.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.221 -1.029 . . . . 0.29999999999999999 108.221 177.793 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.55 132.51 63.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.157 0.503 . . . . 0.23000000000000001 111.228 -178.642 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.43 122.65 20.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.492 -0.776 . . . . 0.35999999999999999 109.602 179.253 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.588 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.07 125.44 55.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.224 -0.444 . . . . 0.19 110.581 -179.53 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.9 m-85 -117.3 137.9 52.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.923 -0.581 . . . . 0.29999999999999999 109.85 179.479 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.585 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.72 135.12 42.67 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.71 -0.848 . . . . 0.37 108.71 178.911 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.588 ' O ' ' N ' ' A' ' 140' ' ' SER . 85.2 mt -99.13 122.97 51.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.131 0.491 . . . . 0.26000000000000001 110.977 -178.826 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.0 p -83.87 169.74 14.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.498 -0.774 . . . . 0.28000000000000003 110.478 -179.672 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.472 ' O ' ' CG2' ' A' ' 59' ' ' THR . 97.4 mt-10 -59.81 -14.45 14.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.056 -0.52 . . . . 1.6000000000000001 111.027 -179.571 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 96.7 m-20 -96.16 -4.25 42.98 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.791 -0.364 . . . . 1.1799999999999999 110.842 -179.781 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.407 ' HA2' ' OG1' ' A' ' 59' ' ' THR . . . 87.83 13.84 64.02 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.362 -0.695 . . . . 0.29999999999999999 111.362 179.879 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -84.64 139.16 32.25 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.047 -0.261 . . . . 1.22 110.391 179.769 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.856 ' NE2' ' HE ' ' A' ' 143' ' ' ARG . 91.0 mt-30 -106.79 141.06 38.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.41 -0.359 . . . . 0.97999999999999998 110.469 179.788 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.68 127.08 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.82999999999999996 110.33 179.872 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.21 117.25 9.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.327 -0.397 . . . . 0.26000000000000001 110.518 -179.918 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -108.99 -21.81 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.29999999999999999 110.739 -179.711 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -157.0 125.75 5.81 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.48 -0.488 . . . . 0.31 111.458 -179.847 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.473 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.66 120.21 21.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.69 -0.686 . . . . 0.28000000000000003 109.591 179.208 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.61 151.71 29.15 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.543 -0.463 . . . . 0.23999999999999999 110.875 -179.294 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.44 158.62 18.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.035 -0.53 . . . . 0.23000000000000001 110.452 179.686 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.13 157.89 43.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.14 -0.482 . . . . 0.67000000000000004 110.656 179.99 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.18 104.36 9.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.755 -0.657 . . . . 0.64000000000000001 110.03 179.584 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.959 -1.02 . . . . 1.26 110.52 -179.656 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.1 m . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.188 -0.671 . . . . 3.4399999999999999 109.188 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.7 18.53 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.927 -0.869 . . . . 1.22 110.927 179.8 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -35.62 142.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.046 0 C-N-CA 123.991 3.127 . . . . 0.75 113.793 -179.239 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -80.09 173.51 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.184 -1.371 . . . . 0.79000000000000004 108.815 178.476 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.614 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.63 125.89 51.51 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.381 -0.527 . . . . 1.9399999999999999 111.351 -179.51 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.5 144.02 33.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.698 -0.683 . . . . 0.59999999999999998 110.65 179.838 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.09 168.3 25.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.972 0.415 . . . . 3.1400000000000001 111.09 -179.715 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.741 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.88 131.01 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.974 -0.557 . . . . 3.23 110.102 179.884 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.2 p -141.16 162.29 35.83 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.815 0.34 . . . . 3.6299999999999999 111.252 -179.951 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 96.9 mt-10 36.1 31.57 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.618 -0.512 . . . . 6.0800000000000001 109.618 179.828 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.741 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.53 32.5 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.975 -0.557 . . . . 3.3799999999999999 111.609 -178.782 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.643 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.29 -29.04 72.66 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.395 2.063 . . . . 3.9300000000000002 111.893 179.322 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.643 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 3.3599999999999999 110.464 179.949 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.543 ' O ' ' O ' ' A' ' 92' ' ' THR . 0.4 OUTLIER -123.9 158.32 60.41 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.366 -0.379 . . . . 3.6099999999999999 110.515 179.956 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.699 ' CG ' ' NH1' ' A' ' 143' ' ' ARG . 97.7 Cg_endo -82.08 -64.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.926 2.417 . . . . 1.51 113.461 -178.994 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 62' ' ' GLY . 20.5 t-20 -108.42 -19.66 13.38 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.097 0.406 . . . . 2.6800000000000002 112.097 -178.504 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 36.4 m -107.32 152.09 24.6 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.45 -0.5 . . . . 1.21 111.345 -179.425 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.578 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.3 102.93 2.22 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.722 -0.672 . . . . 1.5600000000000001 110.649 179.877 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.7 145.64 12.98 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.871 2.381 . . . . 0.81000000000000005 112.635 179.967 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.916 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.77 167.95 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 1.52 109.922 179.609 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.22 147.89 28.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.743 -0.466 . . . . 2.1400000000000001 109.743 178.879 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.584 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.23 157.29 45.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.054 0.454 . . . . 0.32000000000000001 111.206 179.95 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.503 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.8 m-20 -127.99 155.21 44.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.818 -0.628 . . . . 2.1699999999999999 110.149 178.971 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.842 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.56 173.12 6.26 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.155 -0.475 . . . . 0.58999999999999997 110.795 -179.296 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.842 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.73 173.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.842 0 C-N-CA 122.884 2.389 . . . . 0.90000000000000002 111.494 179.425 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.484 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -51.02 0.69 Allowed Pre-proline 0 C--N 1.328 -0.354 0 C-N-CA 120.671 -0.412 . . . . 3.3399999999999999 110.158 179.815 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.641 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.83 152.3 82.64 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.786 2.324 . . . . 1.8500000000000001 111.454 179.139 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.68 42.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.403 0.621 . . . . 2.54 110.588 -179.906 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.821 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.54 -41.66 98.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.976 -1.011 . . . . 2.5299999999999998 110.648 179.721 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.53 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.6 mt -109.89 137.83 40.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.738 -0.665 . . . . 1.1699999999999999 111.286 -179.398 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.99 -72.92 0.7 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.055 -0.521 . . . . 1.27 111.816 -178.922 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.15 148.34 24.47 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.59 0.589 . . . . 1.1200000000000001 112.59 -179.599 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.8 124.85 45.15 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.385 -0.598 . . . . 0.41999999999999998 109.385 177.474 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 mt -117.98 134.69 60.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.669 -0.412 . . . . 0.78000000000000003 110.698 179.973 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.916 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -119.98 128.6 53.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.294 -0.412 . . . . 0.62 111.287 179.765 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.54 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.06 139.0 49.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.758 -0.656 . . . . 1.97 110.153 178.992 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.44 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.12 163.16 35.16 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 121.105 0.479 . . . . 0.34999999999999998 112.045 -178.126 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.495 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.44 139.57 7.89 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.417 -0.811 . . . . 1.8 110.493 178.857 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.46 115.43 3.02 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.336 2.024 . . . . 0.57999999999999996 111.773 179.97 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.675 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.92 81.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.884 -0.414 . . . . 3.04 109.884 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.697 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.2 -20.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.012 -0.54 . . . . 2.4700000000000002 111.893 -179.517 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.5 157.92 34.73 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.815 -0.354 . . . . 2.5099999999999998 110.565 179.7 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.407 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 16.0 m -120.5 27.85 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.145 -0.479 . . . . 1.8600000000000001 110.081 179.616 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -75.96 1.31 Allowed Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.165 -0.541 . . . . 1.4399999999999999 111.764 -179.234 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.79 152.17 35.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.846 0.355 . . . . 4.6900000000000004 111.025 -179.253 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.672 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.14 -169.14 2.55 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.127 -0.488 . . . . 1.4299999999999999 112.021 179.324 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.1 149.63 29.76 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.455 0.645 . . . . 1.74 112.597 -177.864 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.06 156.48 46.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.835 -1.075 . . . . 1.9199999999999999 110.272 178.648 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.25 158.23 41.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.984 -0.553 . . . . 0.34000000000000002 111.835 -179.319 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.1 m -115.08 135.65 53.98 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.461 -0.79 . . . . 0.40999999999999998 109.795 179.307 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.584 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.38 121.95 23.79 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.462 -0.335 . . . . 0.55000000000000004 111.5 -179.136 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.592 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.1 Cg_exo -46.32 151.66 1.65 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.63 2.22 . . . . 0.44 112.111 178.979 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.88 -23.06 63.03 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 116.055 -0.52 . . . . 0.73999999999999999 112.817 -179.211 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.69 -16.97 46.13 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.278 -0.569 . . . . 0.93000000000000005 111.829 -178.391 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.592 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.6 mt -91.53 138.44 31.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.795 -0.362 . . . . 0.96999999999999997 110.333 179.388 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -121.6 13.97 10.94 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.366 -0.379 . . . . 1.3400000000000001 111.467 -179.331 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.0 143.43 25.17 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.665 -0.414 . . . . 0.39000000000000001 111.011 179.64 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.724 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.81 -169.36 1.53 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.204 0.526 . . . . 0.41999999999999998 110.852 -179.478 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.724 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.3 m -151.77 125.96 9.28 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.373 -0.83 . . . . 0.39000000000000001 109.782 179.249 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.518 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.2 mt -114.82 123.15 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.467 -0.493 . . . . 0.73999999999999999 111.255 -179.798 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.53 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 64.7 pttt -126.38 163.39 23.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.87 -0.604 . . . . 2.48 110.5 179.682 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.503 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.11 19.07 59.75 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.699 -0.96 . . . . 0.5 110.699 179.987 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.518 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.2 mt -79.11 157.24 28.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.091 0.472 . . . . 0.57999999999999996 111.342 -179.637 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.841 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -99.56 134.06 21.42 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.611 -0.722 . . . . 2.79 110.442 179.792 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.96 143.55 60.83 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.554 2.169 . . . . 0.87 111.98 179.851 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.97 25.51 75.49 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.043 -0.823 . . . . 0.64000000000000001 111.043 179.689 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.841 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.18 158.82 40.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.697 0.284 . . . . 0.82999999999999996 110.404 -179.593 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.18 139.89 42.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.922 0.391 . . . . 0.5 110.556 -179.692 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.648 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.53 136.53 54.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.046 -0.525 . . . . 0.53000000000000003 110.762 -179.931 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.495 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.98 131.04 45.33 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.456 -0.942 . . . . 1.8700000000000001 108.456 177.701 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.45 153.91 16.64 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.391 -0.909 . . . . 0.28999999999999998 111.971 -178.588 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.07 141.0 45.99 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.595 -0.52 . . . . 1.4299999999999999 109.595 179.593 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.2 tp -115.76 118.87 34.25 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.469 -0.492 . . . . 0.32000000000000001 110.496 179.686 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.725 HG12 HG23 ' A' ' 84' ' ' VAL . 63.8 mt -112.44 129.05 68.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.373 -0.376 . . . . 0.79000000000000004 110.613 -179.918 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.699 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.85 120.73 43.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.235 -0.439 . . . . 1.02 110.724 -179.655 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.857 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.54 146.59 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.22 0.533 . . . . 0.62 111.01 -179.281 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.821 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.08 153.87 21.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.458 -0.792 . . . . 2.4399999999999999 109.95 179.859 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.2 88.56 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.896 0.379 . . . . 3.6899999999999999 110.361 -179.702 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.33 32.72 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.79 -0.641 . . . . 6.0800000000000001 110.532 -179.99 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.18 -117.4 3.28 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.388 -0.685 . . . . 1.22 111.388 -179.712 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.462 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.39 177.36 9.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.206 0.527 . . . . 2.8799999999999999 111.625 -179.182 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.1 149.51 32.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.397 -0.82 . . . . 1.47 110.404 179.178 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.23 144.66 38.56 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.463 -0.335 . . . . 2.7000000000000002 110.532 179.857 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.725 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.05 135.94 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 121.077 0.465 . . . . 0.46000000000000002 111.497 -179.711 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.01 141.38 52.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.663 -0.699 . . . . 0.34999999999999998 110.259 179.637 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.64 138.81 51.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.159 0.504 . . . . 3.6699999999999999 111.499 -179.348 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.19 164.23 37.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.563 -0.744 . . . . 0.67000000000000004 109.503 179.317 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.567 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.31 151.48 38.39 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.406 -0.518 . . . . 1.47 111.05 179.967 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.801 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.5 p90 -146.15 172.69 13.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.725 -0.671 . . . . 0.44 111.062 179.856 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.69 160.73 21.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.452 -0.795 . . . . 1.3700000000000001 109.874 179.61 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.37 121.89 22.99 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.637 -0.425 . . . . 1.28 110.737 179.985 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.543 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.5 p -127.47 163.63 23.67 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.185 0.809 . . . . 1.97 113.185 179.638 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.519 ' OG ' ' OH ' ' A' ' 157' ' ' TYR . 40.1 t . . . . . 0 C--O 1.232 0.152 0 CA-C-N 114.407 -1.269 . . . . 3.2799999999999998 110.636 178.848 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.402 ' O ' HD12 ' A' ' 172' ' ' LEU . 4.9 p . . . . . 0 N--CA 1.463 0.212 0 CA-C-O 120.682 0.277 . . . . 0.66000000000000003 110.781 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.444 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.82 167.57 0.25 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.017 -0.538 . . . . 0.68999999999999995 110.925 -179.593 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.57 145.56 50.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.656 -0.702 . . . . 0.52000000000000002 110.073 -179.918 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.29 101.62 9.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.146 -0.687 . . . . 0.32000000000000001 109.146 177.609 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.1 t -112.84 139.74 36.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.896 -0.593 . . . . 0.28999999999999998 111.038 -178.851 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.6 p -128.76 152.66 48.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.622 -0.717 . . . . 0.25 109.743 179.528 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.588 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.85 -164.97 2.04 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.659 -0.416 . . . . 0.31 110.621 -179.808 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.744 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.8 t -123.9 127.18 73.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.193 -0.458 . . . . 0.48999999999999999 110.787 -179.805 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.17 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.96 58.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 1.53 110.316 179.792 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.744 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.07 24.44 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.873 -0.603 . . . . 0.96999999999999997 111.614 -179.772 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.17 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.14 128.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.685 -0.406 . . . . 1.5600000000000001 111.023 179.896 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.43 -9.57 56.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.891 -0.595 . . . . 1.8799999999999999 110.359 179.817 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.06 0.3 55.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.037 -0.529 . . . . 1.04 110.446 179.839 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.23 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.904 -0.589 . . . . 0.23999999999999999 110.038 179.665 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.592 ' N ' ' O ' ' A' ' 185' ' ' ILE . 91.9 p -96.31 -15.41 21.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.29 0.567 . . . . 0.28999999999999998 109.987 -179.577 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.59 175.52 45.74 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.758 -1.337 . . . . 0.13 109.758 179.688 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.43 151.64 42.45 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.607 -0.437 . . . . 0.17000000000000001 110.462 179.687 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.906 ' NH1' HE22 ' A' ' 191' ' ' GLN . 52.0 ttp180 -132.35 121.1 22.98 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.111 -0.495 . . . . 1.29 109.937 179.787 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.563 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.07 136.58 38.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.678 -0.692 . . . . 0.25 110.66 -179.747 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.592 ' OE2' ' OH ' ' A' ' 157' ' ' TYR . 84.7 tt0 -129.38 129.85 45.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.942 -0.572 . . . . 1.3200000000000001 110.079 -179.912 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.7 p90 -138.68 135.26 34.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.051 -0.522 . . . . 0.56999999999999995 110.635 -179.63 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.419 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.33 161.28 40.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.776 -0.647 . . . . 1.1599999999999999 109.697 179.877 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.959 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.4 mt -71.0 124.81 25.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.993 0.425 . . . . 0.38 110.793 -179.648 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.482 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.7 p -71.82 -7.7 49.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.758 -0.655 . . . . 0.40999999999999998 110.807 -179.678 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -109.81 -69.62 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.398 -0.365 . . . . 1.6599999999999999 111.427 -179.351 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.438 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.68 -35.32 75.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.116 -0.493 . . . . 1.6599999999999999 111.521 -179.105 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.084 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.05 7.3 88.54 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.812 -0.915 . . . . 1.1699999999999999 110.812 -179.796 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.312 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.96 -171.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.851 0.358 . . . . 1.8600000000000001 110.282 179.84 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.312 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.31 139.19 45.01 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.01 0.434 . . . . 1.98 110.158 179.628 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.419 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.4 Cg_endo -70.96 145.74 50.96 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 122.707 2.271 . . . . 0.55000000000000004 112.381 -179.591 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.72 145.73 42.5 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.368 -0.604 . . . . 1.1399999999999999 109.368 179.148 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.592 ' OH ' ' OE2' ' A' ' 145' ' ' GLU . 89.9 m-85 -123.27 141.41 52.01 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.335 -0.546 . . . . 0.93000000000000005 111.491 -179.074 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.8 mt -128.17 127.66 43.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.302 -0.863 . . . . 0.34000000000000002 108.882 178.975 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -101.62 131.12 48.01 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.137 0.494 . . . . 1.0900000000000001 111.782 -178.785 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.93 157.5 73.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.349 -0.842 . . . . 0.19 109.533 179.776 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -69.89 158.01 58.22 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.403 2.069 . . . . 0.17999999999999999 112.184 179.951 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.29 -12.14 5.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.704 -0.68 . . . . 0.20999999999999999 110.785 -179.778 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.8 p -92.73 -8.84 42.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.083 -0.508 . . . . 0.28999999999999998 110.75 -179.978 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.18 135.41 34.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.5 110.358 179.739 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.11 16.67 4.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.29999999999999999 110.556 179.933 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.5 p -167.54 147.17 5.09 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.65 -0.5 . . . . 0.23000000000000001 109.65 179.899 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.563 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.3 150.44 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.52 -0.472 . . . . 0.28000000000000003 111.591 -179.648 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.508 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.25 125.03 50.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.597 -0.729 . . . . 1.0700000000000001 109.776 179.562 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.46 104.88 29.93 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.43 -0.35 . . . . 0.28999999999999998 111.021 -179.883 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.9 Cg_endo -91.01 -179.4 1.47 Allowed 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 123.088 2.526 . . . . 0.42999999999999999 112.229 179.856 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.56 32.7 18.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.359 -0.837 . . . . 1.26 111.461 179.311 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 126' ' ' SER . 24.1 mt -86.34 148.57 25.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.472 -0.331 . . . . 0.32000000000000001 110.437 179.547 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.772 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.31 114.88 61.41 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.002 0.429 . . . . 0.57999999999999996 110.644 -179.757 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.07 140.55 95.71 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.883 2.389 . . . . 0.66000000000000003 111.94 179.835 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.17 21.07 74.37 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.047 -0.821 . . . . 0.28999999999999998 111.047 179.835 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.438 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.76 150.14 49.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.341 . . . . 2.3300000000000001 110.673 -179.984 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.482 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.14 131.58 46.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.138 -0.483 . . . . 0.85999999999999999 109.878 179.252 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.959 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.1 m-85 -120.44 148.25 44.05 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.192 -0.458 . . . . 0.52000000000000002 111.107 -179.817 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.7 mt -105.33 125.41 60.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.252 -1.018 . . . . 0.29999999999999999 108.252 177.749 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.59 132.58 63.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.185 0.516 . . . . 0.23000000000000001 111.266 -178.645 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.53 122.61 20.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.608 -0.724 . . . . 0.35999999999999999 109.621 179.303 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.588 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.04 125.35 54.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.169 -0.469 . . . . 0.19 110.707 -179.535 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.4 m-85 -117.17 137.93 52.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.017 -0.538 . . . . 0.29999999999999999 109.876 179.526 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.587 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.69 135.0 42.82 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.783 -0.821 . . . . 0.37 108.783 178.864 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.592 ' O ' ' N ' ' A' ' 140' ' ' SER . 82.7 mt -99.17 123.05 51.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.153 0.501 . . . . 0.26000000000000001 110.898 -178.78 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.4 p -83.89 169.72 14.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.498 -0.773 . . . . 0.28000000000000003 110.477 -179.719 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.81 -14.47 15.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.985 -0.552 . . . . 1.6000000000000001 111.051 -179.589 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.482 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.7 m-20 -96.04 -4.31 43.28 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.842 -0.343 . . . . 1.1799999999999999 110.812 -179.855 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.699 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.82 13.85 64.02 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.341 -0.703 . . . . 0.29999999999999999 111.341 179.858 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -84.59 139.07 32.35 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.121 -0.231 . . . . 1.22 110.479 179.699 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.906 HE22 ' NH1' ' A' ' 143' ' ' ARG . 78.2 mt-30 -106.77 141.02 38.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.875 0.369 . . . . 0.97999999999999998 110.499 179.843 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.67 126.98 26.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.82999999999999996 110.481 179.844 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.407 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.02 117.34 9.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.362 -0.381 . . . . 0.26000000000000001 110.492 -179.839 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.17 -21.7 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.465 . . . . 0.29999999999999999 110.685 -179.762 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.92 125.63 5.81 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.601 -0.44 . . . . 0.31 111.537 -179.783 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.47 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.68 120.26 21.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.726 -0.67 . . . . 0.28000000000000003 109.547 179.188 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.65 29.04 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.606 -0.438 . . . . 0.23999999999999999 110.893 -179.273 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.44 158.61 18.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.23000000000000001 110.345 179.752 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.11 157.96 43.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.055 -0.52 . . . . 0.67000000000000004 110.642 179.954 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.29 104.44 9.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.817 -0.629 . . . . 0.64000000000000001 110.012 179.558 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 117.942 -1.027 . . . . 1.26 110.56 -179.631 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.1 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.261 -0.644 . . . . 3.4399999999999999 109.261 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.39 150.71 18.53 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.078 -0.809 . . . . 1.22 111.078 179.649 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -35.63 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.066 0 C-N-CA 124.013 3.142 . . . . 0.75 113.743 -179.134 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.62 HG12 ' H ' ' A' ' 5' ' ' GLU . 15.9 t -79.84 173.32 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.289 -1.323 . . . . 0.79000000000000004 108.916 178.341 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.62 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.52 125.82 51.42 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.476 -0.489 . . . . 1.9399999999999999 111.47 -179.626 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 144.06 33.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.739 -0.664 . . . . 0.59999999999999998 110.606 179.84 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.36 25.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.898 0.38 . . . . 3.1400000000000001 111.149 -179.705 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.737 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.4 mt -109.01 131.13 60.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.968 -0.56 . . . . 3.23 110.03 179.921 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 69.3 p -141.26 162.42 35.53 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.894 0.378 . . . . 3.6299999999999999 111.122 -179.915 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 32.5 tp10 36.07 31.57 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 109.631 -0.507 . . . . 6.0800000000000001 109.631 179.843 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.737 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.5 69.62 33.32 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.939 -0.573 . . . . 3.3799999999999999 111.611 -178.8 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.641 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.31 -29.14 72.55 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.437 2.092 . . . . 3.9300000000000002 111.753 179.391 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.734 ' H ' HE22 ' A' ' 14' ' ' GLN . 3.2 m 149.7 125.57 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 3.3599999999999999 110.469 179.997 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.734 HE22 ' H ' ' A' ' 13' ' ' SER . 1.6 mp0 -123.99 158.36 60.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 3.6099999999999999 110.415 -179.979 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.55 ' HG3' ' NH1' ' A' ' 143' ' ' ARG . 97.1 Cg_endo -82.04 -64.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.92 2.413 . . . . 1.51 113.483 -178.96 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.444 ' H ' ' HG2' ' A' ' 15' ' ' PRO . 98.7 m-20 -108.39 -19.61 13.4 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.097 0.406 . . . . 2.6800000000000002 112.097 -178.501 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 63.1 m -107.47 152.11 24.66 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.403 -0.519 . . . . 1.21 111.248 -179.361 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.579 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.27 102.83 2.23 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.654 -0.703 . . . . 1.5600000000000001 110.692 179.922 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.69 145.71 13.03 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.818 2.345 . . . . 0.81000000000000005 112.561 -179.984 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.918 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.79 167.9 24.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.805 -0.634 . . . . 1.52 109.883 179.604 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -149.1 148.04 29.21 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.757 -0.46 . . . . 2.1400000000000001 109.757 178.821 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.7 p90 -142.37 157.28 44.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.036 0.446 . . . . 0.32000000000000001 111.163 179.933 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.497 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -128.01 155.27 44.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.77 -0.65 . . . . 2.1699999999999999 110.102 178.999 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.822 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.56 173.0 6.4 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 121.118 0.485 . . . . 0.58999999999999997 110.73 -179.204 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.822 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.61 173.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.844 2.363 . . . . 0.90000000000000002 111.532 179.303 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.485 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -51.09 0.69 Allowed Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.714 -0.394 . . . . 3.3399999999999999 110.048 179.926 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.62 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.81 152.34 82.49 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.721 2.28 . . . . 1.8500000000000001 111.527 179.147 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.65 42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.362 0.601 . . . . 2.54 110.599 -179.915 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.813 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.52 -41.62 98.48 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.963 -1.017 . . . . 2.5299999999999998 110.725 179.661 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.532 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.5 mt -109.89 137.92 39.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.756 -0.656 . . . . 1.1699999999999999 111.287 -179.44 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.12 -72.84 0.71 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.097 -0.502 . . . . 1.27 111.839 -178.911 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.34 24.45 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.575 0.583 . . . . 1.1200000000000001 112.575 -179.633 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.89 124.88 45.14 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.267 -0.642 . . . . 0.41999999999999998 109.267 177.556 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.1 134.75 60.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.545 -0.462 . . . . 0.78000000000000003 110.648 179.926 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.918 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.01 128.67 53.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.058 0.456 . . . . 0.62 111.247 179.781 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 139.02 49.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.729 -0.668 . . . . 1.97 110.062 179.012 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.439 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.11 163.21 35.0 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.443 -0.503 . . . . 0.34999999999999998 112.058 -178.114 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.51 139.51 7.8 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.533 -0.758 . . . . 1.8 110.45 178.909 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.51 115.47 3.05 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.327 2.018 . . . . 0.57999999999999996 111.803 179.968 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.67 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.99 81.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.902 -0.407 . . . . 3.04 109.902 -179.878 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.693 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.19 -20.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.954 -0.567 . . . . 2.4700000000000002 111.919 -179.549 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 p -157.55 157.8 34.43 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.856 -0.338 . . . . 2.5099999999999998 110.626 179.726 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.401 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.37 27.85 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.27 -0.423 . . . . 1.8600000000000001 110.195 179.527 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.84 -75.91 1.31 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.036 -0.602 . . . . 1.4399999999999999 111.811 -179.255 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.83 152.41 35.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.982 0.42 . . . . 4.6900000000000004 110.991 -179.351 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.637 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.28 -169.19 2.54 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.075 -0.511 . . . . 1.4299999999999999 112.007 179.413 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.6 mttp -110.06 149.6 29.78 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.43 0.633 . . . . 1.74 112.595 -177.86 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.08 156.41 46.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.815 -1.084 . . . . 1.9199999999999999 110.214 178.679 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.457 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.16 158.42 41.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.934 -0.576 . . . . 0.34000000000000002 111.788 -179.353 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.2 135.58 54.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.46 -0.791 . . . . 0.40999999999999998 109.809 179.317 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.596 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.38 121.96 23.8 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.429 -0.351 . . . . 0.55000000000000004 111.528 -179.149 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.606 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.3 Cg_exo -46.31 151.63 1.65 Allowed 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.694 2.263 . . . . 0.44 112.145 178.977 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.81 -23.09 62.91 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 116.043 -0.526 . . . . 0.73999999999999999 112.814 -179.277 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.5 p-80 -82.81 -16.81 46.34 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.192 -0.603 . . . . 0.93000000000000005 111.809 -178.323 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.606 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.6 mt -91.67 138.4 31.59 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.719 -0.392 . . . . 0.96999999999999997 110.266 179.395 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.48 13.96 11.04 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.334 -0.393 . . . . 1.3400000000000001 111.501 -179.369 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -150.04 143.52 25.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.633 -0.427 . . . . 0.39000000000000001 111.029 179.525 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.717 ' CE2' ' O ' ' A' ' 59' ' ' THR . 65.0 t80 -114.8 -169.37 1.53 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.019 -0.537 . . . . 0.41999999999999998 110.815 -179.373 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.717 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.79 125.95 9.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.343 -0.844 . . . . 0.39000000000000001 109.852 179.21 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.513 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.3 mt -114.91 123.24 70.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.369 -0.532 . . . . 0.73999999999999999 111.192 -179.73 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.786 ' NZ ' ' N ' ' A' ' 141' ' ' GLY . 98.4 mttt -126.49 163.41 23.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.812 -0.631 . . . . 2.48 110.514 179.673 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.08 19.05 59.83 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.774 -0.93 . . . . 0.5 110.774 -179.845 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.513 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.6 mt -79.06 157.25 28.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.107 0.48 . . . . 0.57999999999999996 111.4 -179.717 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.859 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -99.46 133.93 21.57 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.635 -0.712 . . . . 2.79 110.466 179.774 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.89 143.53 61.19 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.599 2.2 . . . . 0.87 111.971 179.81 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.89 25.57 75.41 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.045 -0.822 . . . . 0.64000000000000001 111.045 179.722 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.859 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.14 158.74 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.653 0.263 . . . . 0.82999999999999996 110.459 -179.636 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.07 139.95 41.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.986 0.422 . . . . 0.5 110.553 -179.772 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.638 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.64 136.47 54.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.914 -0.584 . . . . 0.53000000000000003 110.788 -179.955 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.97 130.98 45.36 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.516 -0.92 . . . . 1.8700000000000001 108.516 177.741 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.487 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.44 153.89 16.63 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.306 -0.95 . . . . 0.28999999999999998 111.947 -178.556 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.03 141.0 46.07 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.739 -0.467 . . . . 1.4299999999999999 109.739 179.503 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.522 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.83 118.95 34.43 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.422 -0.511 . . . . 0.32000000000000001 110.354 179.831 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 84' ' ' VAL . 64.1 mt -112.48 129.11 68.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.79000000000000004 110.625 -179.97 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.707 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.86 120.75 43.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.324 -0.398 . . . . 1.02 110.737 -179.663 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.866 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.47 146.52 11.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.18 0.514 . . . . 0.62 111.068 -179.292 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.813 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.08 153.89 21.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.56 -0.746 . . . . 2.4399999999999999 109.861 179.877 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.22 88.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.742 -0.383 . . . . 3.6899999999999999 110.426 -179.772 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.14 32.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.807 -0.633 . . . . 6.0800000000000001 110.545 -179.905 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.22 -117.37 3.27 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.391 -0.683 . . . . 1.22 111.391 -179.77 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.469 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.1 m170 -81.4 177.44 8.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.202 0.525 . . . . 2.8799999999999999 111.587 -179.111 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.16 149.48 32.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.428 -0.805 . . . . 1.47 110.488 179.09 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.15 144.69 38.73 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.499 -0.318 . . . . 2.7000000000000002 110.556 179.874 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.727 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.99 136.09 61.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 120.577 -0.449 . . . . 0.46000000000000002 111.544 -179.795 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.11 141.3 52.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.607 -0.724 . . . . 0.34999999999999998 110.244 179.664 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.466 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.4 ttp180 -117.59 138.84 51.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.166 0.508 . . . . 3.6699999999999999 111.486 -179.379 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.487 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.24 164.11 38.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.501 -0.772 . . . . 0.67000000000000004 109.475 179.338 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.13 151.56 38.68 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.456 -0.498 . . . . 1.47 111.122 179.918 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.14 172.75 12.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.812 -0.631 . . . . 0.44 111.02 179.875 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.82 160.77 21.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.418 -0.81 . . . . 1.3700000000000001 109.841 179.512 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.38 121.9 22.98 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.591 -0.444 . . . . 1.28 110.748 -179.991 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.583 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.6 p -128.81 167.19 17.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.048 -0.524 . . . . 1.97 112.286 179.676 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 C--N 1.331 -0.225 0 N-CA-C 109.001 -0.74 . . . . 3.2799999999999998 109.001 177.431 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.8 p . . . . . 0 CA--C 1.523 -0.062 0 CA-C-O 121.112 0.482 . . . . 0.66000000000000003 110.121 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.441 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.94 167.51 0.27 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.621 -0.718 . . . . 0.68999999999999995 110.99 179.693 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.49 145.6 50.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.731 -0.668 . . . . 0.52000000000000002 110.139 -179.902 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.36 101.77 9.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.076 -0.713 . . . . 0.32000000000000001 109.076 177.675 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.5 t -113.01 139.74 36.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.589 . . . . 0.28999999999999998 110.946 -178.758 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.6 p -128.75 152.6 48.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.61 -0.723 . . . . 0.25 109.837 179.532 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.588 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.82 -164.99 2.04 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.672 -0.411 . . . . 0.31 110.653 -179.727 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.732 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.9 t -123.94 127.13 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.48999999999999999 110.834 -179.821 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.167 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.125 -0.489 . . . . 1.53 110.316 179.841 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.09 24.39 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.9 -0.591 . . . . 0.96999999999999997 111.481 -179.698 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.167 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.25 128.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.587 -0.445 . . . . 1.5600000000000001 110.902 179.883 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.46 -9.66 55.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.92 -0.582 . . . . 1.8799999999999999 110.246 179.78 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.1 0.31 55.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.123 -0.489 . . . . 1.04 110.35 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.26 137.07 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.984 -0.553 . . . . 0.23999999999999999 109.982 179.624 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.725 ' C ' ' HZ2' ' A' ' 61' ' ' LYS . 10.1 p -96.21 -15.48 22.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.233 0.539 . . . . 0.28999999999999998 110.028 -179.648 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.786 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.59 175.54 45.76 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.711 -1.355 . . . . 0.13 109.711 179.659 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -123.42 151.66 42.41 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.635 -0.426 . . . . 0.17000000000000001 110.556 179.637 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.72 ' NH1' ' CE1' ' A' ' 157' ' ' TYR . 38.9 ttp85 -132.44 121.17 22.99 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.125 -0.489 . . . . 1.29 109.881 179.845 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 167' ' ' VAL . 46.0 t -105.0 136.51 38.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.646 -0.706 . . . . 0.25 110.728 -179.77 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 78.5 tt0 -129.36 129.95 45.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.015 -0.539 . . . . 1.3200000000000001 110.006 -179.919 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.84 135.26 34.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.044 -0.525 . . . . 0.56999999999999995 110.525 -179.679 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.416 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.41 39.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.633 -0.712 . . . . 1.1599999999999999 109.665 179.805 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.953 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 85.7 mt -71.09 124.86 25.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.952 0.406 . . . . 0.38 110.676 -179.536 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.71 -7.77 50.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.717 -0.674 . . . . 0.40999999999999998 110.874 -179.815 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.73 -69.65 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 1.6599999999999999 111.464 -179.284 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.451 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.63 -35.45 76.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.015 -0.539 . . . . 1.6599999999999999 111.461 -179.168 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.089 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.18 7.24 88.59 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.748 -0.941 . . . . 1.1699999999999999 110.748 -179.836 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.326 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.97 -171.73 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.689 0.28 . . . . 1.8600000000000001 110.294 179.848 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.326 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.22 139.12 45.3 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.945 0.402 . . . . 1.98 110.172 179.666 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.416 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.7 Cg_endo -70.94 145.84 51.39 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 C-N-CA 122.725 2.283 . . . . 0.55000000000000004 112.303 -179.537 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.9 145.75 42.63 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.234 -0.654 . . . . 1.1399999999999999 109.234 179.183 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.72 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 94.1 m-85 -123.28 141.35 52.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.25 0.547 . . . . 0.93000000000000005 111.478 -179.047 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.9 mt -128.14 127.73 43.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.274 -0.876 . . . . 0.34000000000000002 108.892 178.942 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 27.8 t0 -101.59 131.18 47.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.165 0.507 . . . . 1.0900000000000001 111.733 -178.772 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.491 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -128.0 157.53 73.6 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.348 -0.842 . . . . 0.19 109.571 179.645 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -69.76 158.03 58.35 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.395 2.063 . . . . 0.17999999999999999 112.245 179.927 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.32 -12.13 5.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.753 -0.658 . . . . 0.20999999999999999 110.732 -179.852 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.1 p -92.8 -8.77 42.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 0.28999999999999998 110.743 -179.959 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.39 34.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.314 -0.403 . . . . 0.5 110.429 179.686 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.5 p -133.1 16.68 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.401 -0.363 . . . . 0.29999999999999999 110.532 -179.988 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.7 p -167.55 147.13 5.08 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.614 -0.514 . . . . 0.23000000000000001 109.614 179.905 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.2 150.48 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.565 -0.454 . . . . 0.28000000000000003 111.619 -179.664 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.36 124.96 50.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.618 -0.719 . . . . 1.0700000000000001 109.783 179.536 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.48 104.93 30.28 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.907 0.384 . . . . 0.28999999999999998 111.03 -179.835 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.1 Cg_endo -91.05 -179.49 1.48 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 123.155 2.57 . . . . 0.42999999999999999 112.172 179.922 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.66 32.64 18.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.329 -0.851 . . . . 1.26 111.489 179.306 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.3 mt -86.34 148.46 25.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.49 -0.323 . . . . 0.32000000000000001 110.467 179.611 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.764 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.25 114.87 61.36 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.042 0.448 . . . . 0.57999999999999996 110.706 -179.799 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.07 140.58 95.84 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.754 2.303 . . . . 0.66000000000000003 112.025 179.864 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.2 21.16 74.08 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.027 -0.829 . . . . 0.28999999999999998 111.027 179.857 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.451 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.9 150.18 49.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 2.3300000000000001 110.606 -179.941 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.491 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.1 tttt -100.11 131.68 45.92 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.85999999999999999 109.82 179.282 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.953 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.54 148.35 43.97 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.118 -0.492 . . . . 0.52000000000000002 110.991 -179.824 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.31 125.31 60.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.228 -1.027 . . . . 0.29999999999999999 108.228 177.767 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.55 132.46 63.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.053 0.454 . . . . 0.23000000000000001 111.284 -178.646 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.46 122.66 20.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.566 -0.743 . . . . 0.35999999999999999 109.613 179.299 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.588 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.05 125.36 54.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.271 -0.422 . . . . 0.19 110.694 -179.496 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.6 m-85 -117.25 137.88 52.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.041 -0.527 . . . . 0.29999999999999999 109.828 179.583 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.579 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.69 135.01 42.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.798 -0.815 . . . . 0.37 108.798 178.861 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.683 HG21 ' HE2' ' A' ' 61' ' ' LYS . 14.0 mt -99.14 122.97 51.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.095 0.474 . . . . 0.26000000000000001 110.931 -178.734 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.3 p -83.79 169.7 14.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.497 -0.774 . . . . 0.28000000000000003 110.499 -179.675 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -59.71 -14.65 15.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.047 -0.524 . . . . 1.6000000000000001 111.018 -179.663 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -95.91 -4.39 43.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.828 0.347 . . . . 1.1799999999999999 110.902 -179.819 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.79 13.97 63.87 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.301 -0.719 . . . . 0.29999999999999999 111.301 179.919 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -84.63 139.11 32.29 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.059 -0.256 . . . . 1.22 110.465 179.585 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.715 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 85.9 mt-30 -106.75 141.08 38.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.893 0.378 . . . . 0.97999999999999998 110.543 179.723 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.0 m -136.7 126.99 26.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.062 -0.517 . . . . 0.82999999999999996 110.373 179.938 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.23 117.38 9.97 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.644 -0.422 . . . . 0.26000000000000001 110.537 -179.923 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.02 -21.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.29999999999999999 110.746 -179.754 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.89 125.72 5.86 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.519 -0.472 . . . . 0.31 111.496 -179.776 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.47 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.83 120.25 21.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.772 -0.649 . . . . 0.28000000000000003 109.574 179.143 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.72 29.13 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.568 -0.453 . . . . 0.23999999999999999 110.806 -179.224 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.8 p -110.47 158.53 18.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.953 -0.567 . . . . 0.23000000000000001 110.447 179.681 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -145.98 157.97 43.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.102 -0.499 . . . . 0.67000000000000004 110.644 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.34 104.35 9.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.733 -0.667 . . . . 0.64000000000000001 109.986 179.558 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.862 -1.066 . . . . 1.26 110.599 -179.656 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.224 -0.658 . . . . 3.4399999999999999 109.224 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.7 18.54 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.023 -0.831 . . . . 1.22 111.023 179.73 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -35.61 142.41 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.048 0 C-N-CA 123.914 3.076 . . . . 0.75 113.826 -179.203 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.606 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.95 173.44 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.204 -1.362 . . . . 0.79000000000000004 108.817 178.425 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.606 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.69 125.89 51.52 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.433 -0.507 . . . . 1.9399999999999999 111.368 -179.536 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.49 143.96 34.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.682 -0.69 . . . . 0.59999999999999998 110.702 179.865 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.03 168.38 25.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.923 0.392 . . . . 3.1400000000000001 111.044 -179.684 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.746 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -109.03 131.11 60.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.963 -0.562 . . . . 3.23 110.067 179.888 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 69.0 p -141.24 162.41 35.55 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.871 0.367 . . . . 3.6299999999999999 111.121 -179.872 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.3 mt-10 36.03 31.49 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.631 -0.507 . . . . 6.0800000000000001 109.631 179.862 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.746 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.3 69.56 31.1 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.971 -0.559 . . . . 3.3799999999999999 111.663 -178.809 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.37 -29.02 71.92 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.467 2.112 . . . . 3.9300000000000002 111.822 179.46 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 3.3599999999999999 110.477 179.98 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.612 ' O ' ' O ' ' A' ' 92' ' ' THR . 10.7 mp0 -123.89 158.41 60.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 3.6099999999999999 110.447 179.941 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.523 ' CG ' ' NH1' ' A' ' 143' ' ' ARG . 98.6 Cg_endo -82.17 -64.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.866 2.378 . . . . 1.51 113.46 -178.981 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.692 ' CG ' ' CE1' ' A' ' 157' ' ' TYR . 50.0 t30 -108.44 -19.52 13.43 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.11 0.411 . . . . 2.6800000000000002 112.11 -178.536 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.536 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 99.0 p -107.34 152.1 24.6 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.452 -0.499 . . . . 1.21 111.281 -179.418 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.0 t-80 -155.36 102.83 2.21 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.696 -0.684 . . . . 1.5600000000000001 110.676 179.885 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.574 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.3 Cg_endo -82.56 145.6 13.19 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.814 2.343 . . . . 0.81000000000000005 112.675 179.904 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.903 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.81 167.89 24.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.894 -0.594 . . . . 1.52 109.862 179.561 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.1 148.0 29.16 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.737 -0.468 . . . . 2.1400000000000001 109.737 178.866 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.582 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.8 p90 -142.24 157.25 45.05 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.659 -0.416 . . . . 0.32000000000000001 111.16 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.496 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.02 155.3 44.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.823 -0.626 . . . . 2.1699999999999999 110.122 178.905 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.835 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.63 173.07 6.32 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.135 -0.484 . . . . 0.58999999999999997 110.777 -179.184 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.835 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.75 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.907 2.405 . . . . 0.90000000000000002 111.502 179.429 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.485 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -51.05 0.69 Allowed Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.679 -0.408 . . . . 3.3399999999999999 110.171 179.797 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.639 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.85 152.35 82.47 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.7 2.267 . . . . 1.8500000000000001 111.481 179.169 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.74 42.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.357 0.599 . . . . 2.54 110.525 -179.808 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.822 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.67 -41.61 98.15 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.052 -0.976 . . . . 2.5299999999999998 110.639 179.735 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.53 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.3 mt -109.85 137.84 40.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.784 -0.644 . . . . 1.1699999999999999 111.224 -179.449 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.93 -72.9 0.7 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.027 -0.533 . . . . 1.27 111.953 -179.069 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.17 148.37 24.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.588 0.588 . . . . 1.1200000000000001 112.588 -179.649 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.85 124.91 45.25 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.346 -0.613 . . . . 0.41999999999999998 109.346 177.498 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.04 134.65 60.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.646 -0.422 . . . . 0.78000000000000003 110.662 -179.997 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.903 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.98 128.67 53.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.994 0.426 . . . . 0.62 111.261 179.742 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.21 138.94 49.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.787 -0.642 . . . . 1.97 110.096 179.018 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.441 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.04 163.1 35.27 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.166 0.508 . . . . 0.34999999999999998 112.083 -178.083 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.495 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.46 139.67 7.92 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.406 -0.815 . . . . 1.8 110.451 178.766 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.696 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.2 Cg_endo -63.57 115.51 3.09 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.279 1.986 . . . . 0.57999999999999996 111.801 -179.972 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.667 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.99 81.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.87 -0.419 . . . . 3.04 109.87 -179.865 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.696 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.19 -20.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.981 -0.554 . . . . 2.4700000000000002 111.895 -179.548 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 p -157.58 157.82 34.42 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.784 -0.367 . . . . 2.5099999999999998 110.548 179.782 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.408 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.42 27.84 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 1.8600000000000001 110.138 179.575 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.78 -75.82 1.31 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.181 -0.533 . . . . 1.4399999999999999 111.895 -179.294 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.93 152.34 35.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.983 0.42 . . . . 4.6900000000000004 110.912 -179.327 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.67 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.31 -169.13 2.52 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.049 -0.523 . . . . 1.4299999999999999 111.939 179.318 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.441 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.1 149.62 29.78 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.464 0.649 . . . . 1.74 112.571 -177.811 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.01 156.47 46.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.851 -1.068 . . . . 1.9199999999999999 110.268 178.637 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.2 158.39 41.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.993 -0.549 . . . . 0.34000000000000002 111.766 -179.336 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.6 m -115.2 135.58 54.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.415 -0.811 . . . . 0.40999999999999998 109.834 179.296 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.582 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.39 121.94 23.78 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.479 -0.328 . . . . 0.55000000000000004 111.527 -179.11 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.593 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.9 Cg_exo -46.36 151.75 1.65 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.632 2.221 . . . . 0.44 112.168 179.017 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.99 -23.04 63.24 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 116.039 -0.528 . . . . 0.73999999999999999 112.755 -179.108 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.73 -16.96 46.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.35 0.575 . . . . 0.93000000000000005 111.778 -178.345 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.593 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.49 138.42 31.59 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.779 -0.368 . . . . 0.96999999999999997 110.299 179.342 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -121.55 13.91 10.97 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.333 -0.394 . . . . 1.3400000000000001 111.468 -179.382 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -149.99 143.5 25.24 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.589 -0.444 . . . . 0.39000000000000001 111.026 179.56 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.726 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.81 -169.33 1.53 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.199 0.523 . . . . 0.41999999999999998 110.845 -179.396 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.726 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.74 125.99 9.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.39 -0.823 . . . . 0.39000000000000001 109.832 179.236 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.518 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.8 mt -114.95 123.29 70.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.383 -0.527 . . . . 0.73999999999999999 111.17 -179.758 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -126.5 163.33 23.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.849 -0.614 . . . . 2.48 110.529 179.687 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.522 ' CA ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.2 19.07 59.61 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.685 -0.966 . . . . 0.5 110.685 -179.972 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.626 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 74.0 mt -79.14 157.27 27.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.138 0.494 . . . . 0.57999999999999996 111.286 -179.604 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.835 ' O ' HG12 ' A' ' 67' ' ' VAL . 13.2 mptt -99.57 134.03 21.43 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.551 -0.749 . . . . 2.79 110.393 179.85 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.98 143.55 60.76 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.554 2.169 . . . . 0.87 111.88 179.871 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.85 25.71 75.24 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.972 -0.851 . . . . 0.64000000000000001 110.972 179.685 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.835 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.3 p -128.23 158.77 40.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.597 0.237 . . . . 0.82999999999999996 110.434 -179.658 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.07 139.98 41.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.875 0.369 . . . . 0.5 110.623 -179.824 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.643 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.7 m-85 -122.67 136.47 54.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.897 -0.592 . . . . 0.53000000000000003 110.76 -179.918 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.495 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.5 pt-20 -98.91 131.01 45.32 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.524 -0.917 . . . . 1.8700000000000001 108.524 177.656 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.48 153.85 16.65 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.29 -0.957 . . . . 0.28999999999999998 111.935 -178.585 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.98 140.95 46.1 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.716 -0.476 . . . . 1.4299999999999999 109.716 179.537 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.73 118.98 34.56 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.406 -0.518 . . . . 0.32000000000000001 110.486 179.705 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.74 HG12 HG23 ' A' ' 84' ' ' VAL . 64.1 mt -112.51 129.03 68.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.909 0.385 . . . . 0.79000000000000004 110.583 -179.878 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.705 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.85 120.82 43.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.299 -0.409 . . . . 1.02 110.701 -179.646 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.855 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.57 146.53 11.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.118 0.485 . . . . 0.62 110.977 -179.227 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.822 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.09 153.85 21.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.483 -0.78 . . . . 2.4399999999999999 109.974 179.8 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.22 88.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.965 0.412 . . . . 3.6899999999999999 110.444 -179.689 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.31 32.62 0.21 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.806 -0.634 . . . . 6.0800000000000001 110.561 -179.936 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.3 3.29 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.496 -0.642 . . . . 1.22 111.496 -179.804 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.461 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.48 177.38 8.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.146 0.498 . . . . 2.8799999999999999 111.623 -179.203 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.14 149.54 32.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.411 -0.813 . . . . 1.47 110.459 179.145 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.16 144.62 38.67 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.477 -0.329 . . . . 2.7000000000000002 110.54 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.74 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -127.98 135.98 61.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 121.092 0.472 . . . . 0.46000000000000002 111.573 -179.81 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.08 141.35 52.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.664 -0.698 . . . . 0.34999999999999998 110.279 179.62 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.447 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.65 138.93 51.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.105 0.479 . . . . 3.6699999999999999 111.5 -179.368 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.38 164.04 38.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.526 -0.761 . . . . 0.67000000000000004 109.516 179.417 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.572 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.18 151.56 38.62 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.415 -0.514 . . . . 1.47 111.092 -179.995 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.8 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.24 172.71 13.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.759 -0.655 . . . . 0.44 111.039 179.875 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.73 160.69 21.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.455 -0.793 . . . . 1.3700000000000001 109.777 179.658 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.37 121.9 22.99 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.636 -0.426 . . . . 1.28 110.764 179.91 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.612 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -127.61 167.98 15.63 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.675 0.621 . . . . 1.97 112.675 179.679 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.7 m . . . . . 0 N--CA 1.463 0.212 0 CA-C-N 115.195 -0.911 . . . . 3.2799999999999998 109.997 179.225 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 31.6 p . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 121.749 0.785 . . . . 0.66000000000000003 109.0 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.442 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.92 167.62 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.025 -0.989 . . . . 0.68999999999999995 110.907 179.873 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.8 m-30 -133.68 145.47 49.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.672 -0.694 . . . . 0.52000000000000002 110.102 -179.894 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.19 101.76 9.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.108 -0.701 . . . . 0.32000000000000001 109.108 177.702 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.3 t -113.04 139.71 36.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.045 -0.525 . . . . 0.28999999999999998 110.966 -178.76 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.0 p -128.64 152.54 48.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.544 -0.753 . . . . 0.25 109.869 179.622 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.588 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.88 -165.01 2.05 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.769 -0.372 . . . . 0.31 110.64 -179.788 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.3 t -123.91 127.13 73.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.281 -0.418 . . . . 0.48999999999999999 110.922 -179.839 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.171 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.96 58.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.115 -0.493 . . . . 1.53 110.333 179.921 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.26 24.62 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.949 -0.569 . . . . 0.96999999999999997 111.456 -179.592 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.171 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.14 128.62 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.624 -0.43 . . . . 1.5600000000000001 110.998 179.897 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.39 -9.65 55.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.96 -0.564 . . . . 1.8799999999999999 110.267 179.804 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.7 p -87.11 0.28 55.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 1.04 110.341 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 136' ' ' SER . 2.6 p -65.23 137.19 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.949 -0.569 . . . . 0.23999999999999999 109.981 179.63 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 185' ' ' ILE . 7.8 m -96.29 -15.45 21.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.132 0.492 . . . . 0.28999999999999998 110.006 -179.738 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.62 175.59 45.82 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 109.838 -1.305 . . . . 0.13 109.838 179.61 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.45 151.59 42.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.002 0.429 . . . . 0.17000000000000001 110.437 179.775 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.523 ' NH1' ' CG ' ' A' ' 15' ' ' PRO . 23.9 ttp85 -132.33 121.09 22.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.168 -0.469 . . . . 1.29 109.988 179.751 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -104.99 136.53 38.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.742 -0.663 . . . . 0.25 110.703 -179.749 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 82.6 tt0 -129.35 129.96 45.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.05 -0.523 . . . . 1.3200000000000001 110.042 -179.932 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.77 135.25 34.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.053 -0.521 . . . . 0.56999999999999995 110.615 -179.67 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.412 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.27 161.35 39.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.809 -0.632 . . . . 1.1599999999999999 109.629 179.847 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.959 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.01 124.82 25.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.994 0.426 . . . . 0.38 110.804 -179.721 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.77 -7.64 49.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.719 -0.673 . . . . 0.40999999999999998 110.891 -179.754 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -109.87 -69.76 0.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.932 0.396 . . . . 1.6599999999999999 111.306 -179.189 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.437 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.6 -35.4 76.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.06 -0.518 . . . . 1.6599999999999999 111.486 -179.094 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.077 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.2 88.62 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.787 -0.925 . . . . 1.1699999999999999 110.787 -179.811 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.339 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.3 t0 -27.93 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.814 0.34 . . . . 1.8600000000000001 110.218 179.873 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.339 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.2 pm0 -82.24 139.07 45.22 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 1.98 110.214 179.626 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.412 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.1 Cg_endo -70.85 145.85 51.91 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.652 2.235 . . . . 0.55000000000000004 112.368 -179.56 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.87 145.7 42.64 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.231 -0.655 . . . . 1.1399999999999999 109.231 179.18 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.692 ' CE1' ' CG ' ' A' ' 16' ' ' ASN . 1.7 p90 -123.21 141.24 52.18 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.401 -0.52 . . . . 0.93000000000000005 111.577 -179.099 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.0 mt -128.05 127.78 43.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.311 -0.858 . . . . 0.34000000000000002 108.945 178.903 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.492 ' HB2' HD21 ' A' ' 16' ' ' ASN . 18.0 t0 -101.67 131.13 48.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.155 0.502 . . . . 1.0900000000000001 111.742 -178.728 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.94 157.56 73.41 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.294 -0.866 . . . . 0.19 109.53 179.682 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -69.69 157.94 58.79 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 C-N-CA 122.491 2.127 . . . . 0.17999999999999999 112.252 179.908 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.417 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.4 p -59.22 -12.14 4.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.786 -0.643 . . . . 0.20999999999999999 110.775 -179.91 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.2 p -92.86 -8.74 42.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.28999999999999998 110.704 -179.859 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.27 135.35 34.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.5 110.345 179.76 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.15 16.72 4.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.418 -0.355 . . . . 0.29999999999999999 110.515 179.967 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.1 p -167.53 147.06 5.07 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.617 -0.512 . . . . 0.23000000000000001 109.617 179.927 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.22 150.5 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.485 -0.486 . . . . 0.28000000000000003 111.55 -179.707 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.506 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.27 124.95 50.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.525 -0.762 . . . . 1.0700000000000001 109.818 179.49 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.37 104.94 29.92 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.476 -0.329 . . . . 0.28999999999999998 111.092 -179.921 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 84.8 Cg_endo -91.07 -179.47 1.47 Allowed 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 123.19 2.594 . . . . 0.42999999999999999 112.169 179.93 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.62 32.68 18.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.369 -0.832 . . . . 1.26 111.477 179.247 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 172' ' ' LEU . 23.8 mt -86.34 148.39 25.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.432 -0.349 . . . . 0.32000000000000001 110.47 179.6 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.772 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.16 114.78 60.88 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.964 0.411 . . . . 0.57999999999999996 110.734 -179.778 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.92 140.44 95.25 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.925 2.417 . . . . 0.66000000000000003 112.005 179.844 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.16 21.25 73.97 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.005 -0.838 . . . . 0.28999999999999998 111.005 179.832 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.437 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.94 150.21 49.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.879 0.371 . . . . 2.3300000000000001 110.623 179.931 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.491 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.23 131.61 46.08 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.013 -0.54 . . . . 0.85999999999999999 109.786 179.365 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.959 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.4 148.32 43.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.076 -0.511 . . . . 0.52000000000000002 111.066 -179.842 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.35 125.29 60.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.228 -1.027 . . . . 0.29999999999999999 108.228 177.796 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.52 132.57 63.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.136 0.493 . . . . 0.23000000000000001 111.204 -178.61 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.52 122.46 20.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.468 -0.787 . . . . 0.35999999999999999 109.636 179.324 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.588 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.03 125.33 54.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.274 -0.421 . . . . 0.19 110.694 -179.521 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.6 m-85 -117.18 137.89 52.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.97 -0.559 . . . . 0.29999999999999999 109.87 179.562 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.579 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.75 135.05 42.8 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.756 -0.831 . . . . 0.37 108.756 178.863 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.588 ' O ' ' N ' ' A' ' 140' ' ' SER . 76.7 mt -99.04 122.96 51.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.062 0.458 . . . . 0.26000000000000001 110.89 -178.715 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.3 p -83.98 169.7 14.73 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.574 -0.739 . . . . 0.28000000000000003 110.455 -179.7 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 187' ' ' GLU . 51.8 tp10 -59.7 -14.56 14.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.067 -0.515 . . . . 1.6000000000000001 110.967 -179.535 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.574 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.9 m-20 -96.06 -4.26 43.29 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.845 -0.342 . . . . 1.1799999999999999 110.792 -179.815 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.473 ' HA2' ' OG1' ' A' ' 59' ' ' THR . . . 87.78 13.89 64.02 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.383 -0.687 . . . . 0.29999999999999999 111.383 179.903 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -84.73 139.15 32.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.644 0.259 . . . . 1.22 110.394 179.766 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.501 HE22 ' NE ' ' A' ' 143' ' ' ARG . 84.3 mt-30 -106.83 141.14 38.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.97999999999999998 110.496 179.781 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.5 m -136.75 127.06 26.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.506 . . . . 0.82999999999999996 110.411 179.903 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.22 117.27 9.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.297 -0.41 . . . . 0.26000000000000001 110.499 -179.822 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -108.96 -21.89 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.29999999999999999 110.676 -179.709 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.89 125.68 5.84 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.456 -0.497 . . . . 0.31 111.516 -179.77 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.471 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.68 120.25 21.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.721 -0.672 . . . . 0.28000000000000003 109.516 179.231 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.56 151.73 29.21 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.7 -0.4 . . . . 0.23999999999999999 110.933 -179.321 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.47 158.61 18.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 0.23000000000000001 110.393 179.677 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.06 157.92 43.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.103 -0.499 . . . . 0.67000000000000004 110.702 179.919 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.17 104.39 9.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.82 -0.627 . . . . 0.64000000000000001 110.009 179.524 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.5 p . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 117.95 -1.024 . . . . 1.26 110.585 -179.744 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.548 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.9 m . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.223 -0.658 . . . . 3.4399999999999999 109.223 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.45 150.68 18.53 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.023 -0.831 . . . . 1.22 111.023 179.755 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.69 142.34 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.056 0 C-N-CA 124.067 3.178 . . . . 0.75 113.761 -179.199 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.605 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.89 173.47 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.194 -1.366 . . . . 0.79000000000000004 108.893 178.389 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.605 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.61 125.89 51.51 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.406 -0.518 . . . . 1.9399999999999999 111.349 -179.548 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 144.07 33.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.636 -0.711 . . . . 0.59999999999999998 110.662 179.75 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.02 168.32 25.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.404 -0.362 . . . . 3.1400000000000001 111.104 -179.649 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.749 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.98 131.08 60.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.925 -0.58 . . . . 3.23 110.06 179.869 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.26 162.26 35.92 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.882 0.372 . . . . 3.6299999999999999 111.209 -179.916 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 34.3 tp10 36.2 31.54 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.648 -0.501 . . . . 6.0800000000000001 109.648 179.85 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.749 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.5 69.57 33.2 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.982 -0.554 . . . . 3.3799999999999999 111.468 -178.644 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.28 -29.09 72.71 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.432 2.088 . . . . 3.9300000000000002 111.845 179.346 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 3.3599999999999999 110.472 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.535 ' CB ' ' O ' ' A' ' 17' ' ' SER . 7.7 mp0 -123.93 158.39 60.27 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.311 -0.404 . . . . 3.6099999999999999 110.441 179.99 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HB3' ' CB ' ' A' ' 93' ' ' SER . 98.1 Cg_endo -82.19 -64.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.941 2.427 . . . . 1.51 113.444 -178.991 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.664 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 41.2 t30 -108.48 -19.52 13.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.322 -0.399 . . . . 2.6800000000000002 112.07 -178.513 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.535 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 12.6 t -107.4 152.01 24.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.19 0.519 . . . . 1.21 111.252 -179.339 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.25 102.92 2.23 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.712 -0.676 . . . . 1.5600000000000001 110.67 179.796 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.584 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.4 Cg_endo -82.59 145.65 13.16 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.878 2.385 . . . . 0.81000000000000005 112.666 179.871 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.9 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.88 167.99 24.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.892 -0.594 . . . . 1.52 109.859 179.591 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -149.18 147.91 28.99 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.783 -0.451 . . . . 2.1400000000000001 109.783 178.954 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.579 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.7 p90 -142.29 157.25 45.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.027 0.442 . . . . 0.32000000000000001 111.183 179.976 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.495 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -127.96 155.26 44.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.796 -0.638 . . . . 2.1699999999999999 110.133 178.969 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.833 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.56 173.02 6.37 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 121.074 0.464 . . . . 0.58999999999999997 110.758 -179.223 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.833 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.61 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.888 0 C-N-CA 122.88 2.387 . . . . 0.90000000000000002 111.517 179.304 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.486 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -51.08 0.69 Allowed Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 120.706 -0.398 . . . . 3.3399999999999999 110.089 179.813 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.64 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.86 152.39 82.38 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.7 2.267 . . . . 1.8500000000000001 111.474 179.243 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.73 42.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.42 0.629 . . . . 2.54 110.576 -179.869 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.824 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.57 -41.67 98.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.941 -1.027 . . . . 2.5299999999999998 110.653 179.689 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.6 mt -109.87 137.77 40.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.771 -0.649 . . . . 1.1699999999999999 111.327 -179.426 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.85 -72.95 0.7 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.106 -0.497 . . . . 1.27 111.925 -179.007 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.21 148.43 24.38 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.549 0.574 . . . . 1.1200000000000001 112.549 -179.55 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.8 124.85 45.16 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.3 -0.63 . . . . 0.41999999999999998 109.3 177.563 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.3 mt -117.95 134.7 60.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.721 -0.391 . . . . 0.78000000000000003 110.654 179.905 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.9 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.99 128.7 53.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.065 0.46 . . . . 0.62 111.269 179.634 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.26 138.96 49.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.707 -0.679 . . . . 1.97 110.125 178.966 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.441 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.01 163.11 35.21 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.118 0.485 . . . . 0.34999999999999998 112.146 -178.065 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.46 139.59 7.88 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.515 -0.766 . . . . 1.8 110.504 178.815 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.58 115.53 3.1 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.31 2.007 . . . . 0.57999999999999996 111.733 -179.946 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.01 81.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.888 -0.412 . . . . 3.04 109.888 -179.926 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.17 -20.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.93 -0.577 . . . . 2.4700000000000002 111.97 -179.558 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.8 p -157.65 157.81 34.29 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.813 0.34 . . . . 2.5099999999999998 110.579 179.745 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.43 27.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 1.8600000000000001 110.233 179.58 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.84 -75.87 1.31 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.126 -0.559 . . . . 1.4399999999999999 111.864 -179.261 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.89 152.34 35.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.988 0.423 . . . . 4.6900000000000004 110.953 -179.353 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.672 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.24 -169.17 2.54 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.029 -0.532 . . . . 1.4299999999999999 111.919 179.37 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.441 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.1 149.65 29.73 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.395 0.617 . . . . 1.74 112.63 -177.88 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.06 156.5 45.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.842 -1.072 . . . . 1.9199999999999999 110.226 178.659 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.22 158.34 41.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.906 -0.588 . . . . 0.34000000000000002 111.785 -179.261 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 m -115.17 135.58 54.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.515 -0.766 . . . . 0.40999999999999998 109.716 179.382 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.579 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.36 121.9 23.8 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 0.55000000000000004 111.574 -179.229 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.597 ' HD2' HD12 ' A' ' 55' ' ' LEU . 73.8 Cg_exo -46.3 151.71 1.62 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.684 2.256 . . . . 0.44 112.046 179.042 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.91 -23.01 63.03 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 116.046 -0.524 . . . . 0.73999999999999999 112.796 -179.233 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.84 -16.81 46.25 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.251 -0.579 . . . . 0.93000000000000005 111.823 -178.329 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.597 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.67 138.46 31.55 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.684 -0.406 . . . . 0.96999999999999997 110.289 179.37 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -121.58 14.04 10.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.369 -0.378 . . . . 1.3400000000000001 111.588 -179.394 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.48 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -150.07 143.5 25.16 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.601 -0.44 . . . . 0.39000000000000001 111.003 179.579 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.725 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.85 -169.4 1.54 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.188 0.518 . . . . 0.41999999999999998 110.869 -179.405 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.725 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.9 m -151.74 125.92 9.27 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.43 -0.805 . . . . 0.39000000000000001 109.807 179.277 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.86 123.28 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.369 -0.533 . . . . 0.73999999999999999 111.243 -179.798 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -126.53 163.34 23.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.885 -0.598 . . . . 2.48 110.442 179.76 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.442 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.08 19.08 59.77 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.733 -0.947 . . . . 0.5 110.733 -179.89 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.664 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.7 mt -79.01 157.21 28.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.032 0.444 . . . . 0.57999999999999996 111.36 -179.64 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.841 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.9 mmtt -99.5 133.93 21.54 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.691 -0.686 . . . . 2.79 110.522 179.716 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.581 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.86 143.57 61.5 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.491 2.128 . . . . 0.87 112.007 179.854 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.89 25.66 75.3 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.997 -0.841 . . . . 0.64000000000000001 110.997 179.694 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.841 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.22 158.72 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.649 0.262 . . . . 0.82999999999999996 110.398 -179.55 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.11 139.88 42.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.846 0.355 . . . . 0.5 110.644 -179.79 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.642 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.6 m-85 -122.51 136.48 54.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.973 -0.558 . . . . 0.53000000000000003 110.8 -179.883 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.5 pt-20 -98.96 131.06 45.31 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.462 -0.94 . . . . 1.8700000000000001 108.462 177.699 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.47 153.92 16.64 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.341 -0.933 . . . . 0.28999999999999998 111.944 -178.616 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.98 140.95 46.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.706 -0.479 . . . . 1.4299999999999999 109.706 179.559 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.85 118.93 34.35 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.427 -0.509 . . . . 0.32000000000000001 110.531 179.616 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.744 HG12 HG23 ' A' ' 84' ' ' VAL . 63.8 mt -112.46 129.08 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.79000000000000004 110.676 -179.942 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.706 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.77 120.8 43.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.215 -0.448 . . . . 1.02 110.732 -179.639 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.857 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.56 146.43 11.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.163 0.506 . . . . 0.62 111.06 -179.261 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.824 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -105.98 153.88 21.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.528 -0.76 . . . . 2.4399999999999999 109.907 179.845 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.16 88.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.899 0.38 . . . . 3.6899999999999999 110.476 -179.814 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.35 32.54 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.834 -0.621 . . . . 6.0800000000000001 110.628 -179.915 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.08 -117.35 3.29 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.471 -0.652 . . . . 1.22 111.471 -179.652 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.46 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.38 177.45 8.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.175 0.512 . . . . 2.8799999999999999 111.609 -179.21 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.2 149.54 32.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.416 -0.811 . . . . 1.47 110.376 179.149 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.548 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.19 144.67 38.64 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.4 -0.364 . . . . 2.7000000000000002 110.574 179.823 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.744 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.0 135.99 61.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 121.037 0.446 . . . . 0.46000000000000002 111.581 -179.79 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.06 141.27 52.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.689 -0.687 . . . . 0.34999999999999998 110.302 179.649 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.453 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.55 138.91 51.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.07 0.462 . . . . 3.6699999999999999 111.535 -179.387 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.31 164.23 37.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.579 -0.737 . . . . 0.67000000000000004 109.494 179.349 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.2 p30 -145.29 151.45 38.36 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.394 -0.523 . . . . 1.47 111.083 -179.952 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.8 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.4 p90 -146.16 172.78 12.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.835 -0.62 . . . . 0.44 111.053 179.84 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.83 160.6 21.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.468 -0.787 . . . . 1.3700000000000001 109.874 179.627 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.33 121.8 22.9 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.685 -0.406 . . . . 1.28 110.745 -179.962 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.7 p -128.68 169.02 14.98 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 115.78 1.77 . . . . 1.97 115.78 179.579 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.52 ' CB ' ' HB3' ' A' ' 15' ' ' PRO . 18.2 t . . . . . 0 N--CA 1.452 -0.373 0 CA-C-N 111.87 -2.423 . . . . 3.2799999999999998 108.603 177.507 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 122.162 0.982 . . . . 0.66000000000000003 110.832 . . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.442 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.85 167.65 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.68 -1.146 . . . . 0.68999999999999995 110.937 -179.264 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.7 145.57 50.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.688 -0.687 . . . . 0.52000000000000002 110.166 -179.962 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.23 101.66 9.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.088 -0.708 . . . . 0.32000000000000001 109.088 177.751 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.2 t -113.02 139.65 37.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.99 -0.55 . . . . 0.28999999999999998 111.066 -178.884 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.2 p -128.63 152.57 48.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.643 -0.708 . . . . 0.25 109.84 179.644 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.589 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.83 -165.07 2.06 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.687 -0.405 . . . . 0.31 110.642 -179.765 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -123.81 127.17 73.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.48999999999999999 110.918 -179.905 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.168 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.96 58.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.198 -0.455 . . . . 1.53 110.346 179.814 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.12 24.46 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.902 -0.59 . . . . 0.96999999999999997 111.515 -179.732 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.168 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.18 128.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.619 -0.432 . . . . 1.5600000000000001 111.011 179.8 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.33 -9.66 55.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.915 -0.584 . . . . 1.8799999999999999 110.353 179.814 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.7 p -87.09 0.3 55.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.095 -0.502 . . . . 1.04 110.337 179.991 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.36 137.24 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.892 -0.594 . . . . 0.23999999999999999 109.936 179.734 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 185' ' ' ILE . 5.4 m -96.26 -15.45 21.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.286 0.565 . . . . 0.28999999999999998 110.12 -179.716 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.58 175.55 45.75 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 109.806 -1.318 . . . . 0.13 109.806 179.593 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.46 151.63 42.52 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.602 -0.439 . . . . 0.17000000000000001 110.558 179.718 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.812 ' NE ' HE22 ' A' ' 191' ' ' GLN . 41.9 ttp85 -132.32 121.08 22.99 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.178 -0.464 . . . . 1.29 109.957 179.939 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.1 136.55 38.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.716 -0.674 . . . . 0.25 110.629 -179.708 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 82.7 tt0 -129.4 129.9 45.3 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.939 -0.573 . . . . 1.3200000000000001 110.05 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.4 p90 -138.66 135.27 34.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.957 -0.565 . . . . 0.56999999999999995 110.644 -179.693 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.411 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.35 161.37 39.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.809 -0.632 . . . . 1.1599999999999999 109.747 179.729 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.958 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.02 124.84 25.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.064 0.459 . . . . 0.38 110.716 -179.52 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.65 -7.8 50.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.702 -0.681 . . . . 0.40999999999999998 110.919 -179.818 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.86 -69.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 1.6599999999999999 111.431 -179.257 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.444 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.66 -35.42 76.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.112 -0.495 . . . . 1.6599999999999999 111.491 -179.147 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.081 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.22 88.61 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.799 -0.92 . . . . 1.1699999999999999 110.799 -179.817 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.338 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -28.03 -171.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.762 0.315 . . . . 1.8600000000000001 110.319 179.913 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.338 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.03 45.19 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-O 120.917 0.389 . . . . 1.98 110.213 179.657 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.411 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.7 Cg_endo -70.86 145.83 51.8 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.716 2.277 . . . . 0.55000000000000004 112.394 -179.578 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.9 145.74 42.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.189 -0.671 . . . . 1.1399999999999999 109.189 179.255 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.581 ' CE1' ' HD3' ' A' ' 65' ' ' PRO . 35.3 p90 -123.26 141.39 52.03 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.33 -0.548 . . . . 0.93000000000000005 111.46 -179.062 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.5 mt -128.17 127.68 43.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.271 -0.877 . . . . 0.34000000000000002 108.918 178.919 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.609 ' HB2' ' ND2' ' A' ' 16' ' ' ASN . 38.1 t0 -101.6 131.21 47.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.24 0.543 . . . . 1.0900000000000001 111.702 -178.743 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -128.04 157.43 74.0 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.349 -0.841 . . . . 0.19 109.575 179.677 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.71 157.89 58.93 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 122.406 2.071 . . . . 0.17999999999999999 112.334 179.902 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.18 -12.22 4.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.813 -0.63 . . . . 0.20999999999999999 110.781 -179.799 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.9 p -92.74 -8.79 42.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.042 -0.526 . . . . 0.28999999999999998 110.764 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.21 135.4 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.355 -0.384 . . . . 0.5 110.436 179.691 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.6 p -133.13 16.69 4.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.328 -0.396 . . . . 0.29999999999999999 110.461 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.61 147.12 5.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.697 -0.483 . . . . 0.23000000000000001 109.697 179.838 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.15 150.42 12.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.501 -0.48 . . . . 0.28000000000000003 111.597 -179.533 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.506 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.38 124.92 50.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.62 -0.718 . . . . 1.0700000000000001 109.858 179.469 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.35 104.82 29.17 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.333 -0.394 . . . . 0.28999999999999998 111.077 -179.791 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.4 Cg_endo -90.87 -179.47 1.53 Allowed 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 123.21 2.607 . . . . 0.42999999999999999 112.25 179.882 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.61 32.73 18.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.416 -0.811 . . . . 1.26 111.376 179.224 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.408 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.2 mt -86.36 148.49 25.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.544 -0.298 . . . . 0.32000000000000001 110.45 179.541 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.767 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.33 114.89 61.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.066 0.46 . . . . 0.57999999999999996 110.656 -179.763 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.1 140.64 96.04 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.915 2.41 . . . . 0.66000000000000003 111.982 179.885 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.0 21.28 74.35 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.091 -0.804 . . . . 0.28999999999999998 111.091 179.974 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.444 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.99 150.2 49.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.862 0.363 . . . . 2.3300000000000001 110.587 -179.979 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.493 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.11 131.65 45.93 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.999 -0.546 . . . . 0.85999999999999999 109.794 179.37 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.958 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.56 148.33 44.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.134 -0.484 . . . . 0.52000000000000002 111.011 -179.874 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.38 125.31 60.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.198 -1.038 . . . . 0.29999999999999999 108.198 177.796 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.54 132.56 63.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.119 0.485 . . . . 0.23000000000000001 111.318 -178.694 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.9 m-20 -136.47 122.5 20.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.54 -0.755 . . . . 0.35999999999999999 109.719 179.327 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.589 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.02 125.45 54.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.314 -0.403 . . . . 0.19 110.715 -179.527 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.0 m-85 -117.2 137.87 52.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.04 -0.527 . . . . 0.29999999999999999 109.886 179.574 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.579 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.74 135.13 42.66 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.805 -0.813 . . . . 0.37 108.805 178.82 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.588 ' O ' ' N ' ' A' ' 140' ' ' SER . 88.9 mt -99.16 123.02 51.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.178 0.513 . . . . 0.26000000000000001 110.904 -178.713 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 89.2 p -83.95 169.83 14.63 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.497 -0.774 . . . . 0.28000000000000003 110.432 -179.614 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.448 ' O ' ' OG1' ' A' ' 59' ' ' THR . 97.9 mt-10 -59.77 -14.64 15.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.046 -0.524 . . . . 1.6000000000000001 110.946 -179.598 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . 0.605 ' C ' ' OG1' ' A' ' 59' ' ' THR . 96.4 m-20 -96.03 -4.28 43.36 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.778 -0.369 . . . . 1.1799999999999999 110.842 -179.763 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.724 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.8 13.98 63.84 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.376 -0.689 . . . . 0.29999999999999999 111.376 179.875 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -84.69 139.02 32.32 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.781 -0.246 . . . . 1.22 110.386 179.733 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.812 HE22 ' NE ' ' A' ' 143' ' ' ARG . 84.3 mt-30 -106.81 141.05 38.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.929 0.395 . . . . 0.97999999999999998 110.511 179.758 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.8 m -136.65 126.94 26.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.82999999999999996 110.45 179.913 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.406 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.06 117.28 9.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.335 -0.393 . . . . 0.26000000000000001 110.527 -179.856 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.03 -21.79 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.29999999999999999 110.752 -179.783 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.85 125.77 5.91 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.519 -0.473 . . . . 0.31 111.488 -179.824 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.47 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.79 120.14 21.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.743 -0.662 . . . . 0.28000000000000003 109.6 179.215 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.58 151.67 29.12 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.715 -0.394 . . . . 0.23999999999999999 111.009 -179.296 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.46 158.61 18.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 0.23000000000000001 110.403 179.704 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.02 157.94 43.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.098 -0.501 . . . . 0.67000000000000004 110.669 179.997 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.24 104.29 9.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.743 -0.662 . . . . 0.64000000000000001 110.086 179.482 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.947 -1.025 . . . . 1.26 110.568 -179.687 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.236 -0.653 . . . . 3.4399999999999999 109.236 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.73 18.52 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.007 -0.837 . . . . 1.22 111.007 179.708 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.66 142.32 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.06 0 C-N-CA 124.04 3.16 . . . . 0.75 113.729 -179.205 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.86 173.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.189 -1.369 . . . . 0.79000000000000004 108.832 178.402 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.615 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.54 125.8 51.41 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.503 -0.479 . . . . 1.9399999999999999 111.416 -179.569 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 144.01 33.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.731 -0.668 . . . . 0.59999999999999998 110.578 179.886 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.05 168.25 25.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.864 0.364 . . . . 3.1400000000000001 111.139 -179.695 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.745 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.87 131.04 60.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.026 -0.533 . . . . 3.23 110.141 179.877 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.5 p -141.16 162.33 35.73 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.84 0.352 . . . . 3.6299999999999999 111.239 -179.932 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 71.5 tt0 36.05 31.65 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.655 -0.498 . . . . 6.0800000000000001 109.655 179.849 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.745 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.53 69.61 33.56 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.918 -0.583 . . . . 3.3799999999999999 111.533 -178.75 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.639 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.27 -29.23 72.9 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.564 2.176 . . . . 3.9300000000000002 111.772 179.389 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.639 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.73 125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 3.3599999999999999 110.453 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 17' ' ' SER . 15.5 mt-30 -123.86 158.38 60.09 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.376 -0.375 . . . . 3.6099999999999999 110.446 179.939 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.777 ' HG2' ' NE ' ' A' ' 143' ' ' ARG . 97.4 Cg_endo -82.08 -64.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.816 2.344 . . . . 1.51 113.528 -179.029 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.906 ' ND2' ' H ' ' A' ' 62' ' ' GLY . 31.6 t30 -108.38 -19.71 13.37 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.041 0.386 . . . . 2.6800000000000002 112.041 -178.498 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 15.1 p -107.28 152.03 24.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.093 0.473 . . . . 1.21 111.347 -179.332 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.581 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.4 t-80 -155.35 102.98 2.22 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.738 -0.664 . . . . 1.5600000000000001 110.558 179.876 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.428 ' HD3' HE22 ' A' ' 14' ' ' GLN . 73.6 Cg_endo -82.68 145.67 13.03 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.8 2.333 . . . . 0.81000000000000005 112.675 179.879 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.917 HD11 HD13 ' A' ' 35' ' ' LEU . 7.0 pt -130.84 167.93 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.893 -0.594 . . . . 1.52 109.822 179.618 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.1 147.93 29.08 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.72 -0.474 . . . . 2.1400000000000001 109.72 178.901 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.592 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.4 p90 -142.21 157.29 45.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.948 0.404 . . . . 0.32000000000000001 111.263 179.858 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.491 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.02 155.23 44.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.782 -0.645 . . . . 2.1699999999999999 110.105 178.968 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.825 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.55 173.08 6.3 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.158 -0.474 . . . . 0.58999999999999997 110.845 -179.294 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.825 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.71 173.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.88 2.386 . . . . 0.90000000000000002 111.49 179.412 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.01 -51.03 0.69 Allowed Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 120.578 -0.449 . . . . 3.3399999999999999 110.143 179.856 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.63 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.84 152.37 82.39 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.696 2.264 . . . . 1.8500000000000001 111.455 179.179 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.67 42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.372 0.606 . . . . 2.54 110.584 -179.9 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.816 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.49 -41.75 98.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.986 -1.006 . . . . 2.5299999999999998 110.715 179.65 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.534 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.2 mt -109.85 137.82 40.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.708 -0.678 . . . . 1.1699999999999999 111.293 -179.445 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.89 -72.87 0.7 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.001 -0.545 . . . . 1.27 111.923 -178.968 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.2 148.4 24.39 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.557 0.577 . . . . 1.1200000000000001 112.557 -179.62 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -121.88 124.82 45.02 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.349 -0.611 . . . . 0.41999999999999998 109.349 177.527 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.0 134.79 60.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.598 -0.441 . . . . 0.78000000000000003 110.638 179.949 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.917 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.03 128.52 53.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.62 111.323 179.721 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.548 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -130.97 139.01 49.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.78 -0.646 . . . . 1.97 110.097 179.074 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.16 163.08 35.47 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 120.574 -0.45 . . . . 0.34999999999999998 112.072 -178.128 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.39 139.52 7.91 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.474 -0.785 . . . . 1.8 110.542 178.848 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.9 Cg_endo -63.53 115.48 3.07 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.353 2.036 . . . . 0.57999999999999996 111.849 179.954 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.97 81.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.904 -0.406 . . . . 3.04 109.904 -179.859 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.952 -0.567 . . . . 2.4700000000000002 111.835 -179.501 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.6 p -157.57 157.78 34.38 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.878 -0.329 . . . . 2.5099999999999998 110.615 179.793 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.38 27.82 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.236 -0.438 . . . . 1.8600000000000001 110.122 179.568 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.7 -75.99 1.32 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.18 -0.533 . . . . 1.4399999999999999 111.814 -179.223 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.89 152.32 35.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.932 0.396 . . . . 4.6900000000000004 110.963 -179.306 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.03 2.5 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.983 -0.553 . . . . 1.4299999999999999 111.929 179.337 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.2 149.66 29.79 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.512 0.672 . . . . 1.74 112.504 -177.829 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.07 156.47 45.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.764 -1.107 . . . . 1.9199999999999999 110.247 178.609 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.22 158.35 41.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.933 -0.576 . . . . 0.34000000000000002 111.824 -179.341 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.08 135.61 54.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.496 -0.774 . . . . 0.40999999999999998 109.859 179.267 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.592 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.36 121.92 23.81 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.464 -0.335 . . . . 0.55000000000000004 111.6 -179.204 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.4 Cg_exo -46.32 151.74 1.62 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.695 2.263 . . . . 0.44 112.057 179.101 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.03 -22.9 63.18 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 116.035 -0.529 . . . . 0.73999999999999999 112.743 -179.205 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.545 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.86 -16.85 46.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.392 0.596 . . . . 0.93000000000000005 111.746 -178.334 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.601 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.63 138.4 31.59 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.771 -0.372 . . . . 0.96999999999999997 110.293 179.386 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -121.47 13.86 11.03 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.366 -0.379 . . . . 1.3400000000000001 111.549 -179.363 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.477 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.93 143.53 25.31 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.624 -0.43 . . . . 0.39000000000000001 111.008 179.648 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.719 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.84 -169.38 1.54 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.069 -0.514 . . . . 0.41999999999999998 110.875 -179.46 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.719 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 94.7 m -151.8 125.89 9.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.357 -0.838 . . . . 0.39000000000000001 109.882 179.208 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.9 123.28 70.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.365 -0.534 . . . . 0.73999999999999999 111.185 -179.711 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.835 ' NZ ' ' N ' ' A' ' 141' ' ' GLY . 82.1 mttt -126.51 163.38 23.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.839 -0.619 . . . . 2.48 110.469 179.733 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.906 ' H ' ' ND2' ' A' ' 16' ' ' ASN . . . 85.17 18.88 60.0 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.723 -0.951 . . . . 0.5 110.723 -179.892 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.514 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.6 mt -78.91 157.19 28.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 0.57999999999999996 111.379 -179.629 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.859 ' O ' HG12 ' A' ' 67' ' ' VAL . 2.3 mttt -99.5 133.92 21.54 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.637 -0.711 . . . . 2.79 110.438 179.781 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.92 143.62 61.34 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.597 2.198 . . . . 0.87 111.941 179.812 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.82 25.52 75.47 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.063 -0.815 . . . . 0.64000000000000001 111.063 179.795 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.859 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.05 158.86 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.763 0.316 . . . . 0.82999999999999996 110.446 -179.631 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.23 139.93 42.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.98 0.419 . . . . 0.5 110.534 -179.786 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.665 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.6 m-85 -122.61 136.44 54.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.932 -0.576 . . . . 0.53000000000000003 110.797 -179.95 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.489 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.9 131.04 45.29 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.528 -0.915 . . . . 1.8700000000000001 108.528 177.684 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.488 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.57 153.9 16.67 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.207 -0.997 . . . . 0.28999999999999998 111.923 -178.541 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.01 140.84 45.98 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.73 -0.471 . . . . 1.4299999999999999 109.73 179.646 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.4 tp -115.66 118.89 34.36 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.45 -0.5 . . . . 0.32000000000000001 110.504 179.759 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.736 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.48 129.07 68.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.887 0.375 . . . . 0.79000000000000004 110.646 -179.939 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.75 120.9 43.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.256 -0.429 . . . . 1.02 110.761 -179.726 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.867 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.64 146.37 11.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.159 0.504 . . . . 0.62 111.079 -179.288 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.816 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -105.98 153.85 21.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.559 -0.746 . . . . 2.4399999999999999 109.938 179.884 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.24 88.66 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.995 0.426 . . . . 3.6899999999999999 110.412 -179.73 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.618 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.26 32.55 0.21 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.759 -0.655 . . . . 6.0800000000000001 110.682 -179.912 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.01 -117.26 3.29 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.93 -0.652 . . . . 1.22 111.489 -179.731 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.465 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.1 m170 -81.54 177.42 8.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.23 0.538 . . . . 2.8799999999999999 111.537 -179.159 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.15 149.54 32.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.407 -0.815 . . . . 1.47 110.381 179.179 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.19 144.68 38.64 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.462 -0.335 . . . . 2.7000000000000002 110.589 179.829 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.736 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.0 136.04 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.078 0.466 . . . . 0.46000000000000002 111.557 -179.775 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.577 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.07 141.39 52.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.706 -0.679 . . . . 0.34999999999999998 110.257 179.647 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.73 138.88 51.72 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.499 -0.481 . . . . 3.6699999999999999 111.497 -179.32 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.26 164.2 37.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.574 -0.739 . . . . 0.67000000000000004 109.479 179.473 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.577 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.36 151.48 38.34 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.443 -0.503 . . . . 1.47 111.032 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.802 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.13 172.77 12.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.7 -0.682 . . . . 0.44 111.028 179.878 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.86 160.74 21.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.479 -0.782 . . . . 1.3700000000000001 109.861 179.527 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.33 121.83 22.94 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.61 -0.436 . . . . 1.28 110.798 -179.962 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -128.83 154.67 46.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 1.97 111.081 179.652 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 C--N 1.33 -0.239 0 C-N-CA 120.032 -0.667 . . . . 3.2799999999999998 109.479 177.352 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.401 ' O ' HD12 ' A' ' 172' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.719 0 CA-C-O 122.358 1.075 . . . . 0.66000000000000003 111.135 . . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.447 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.81 167.6 0.25 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.397 -1.274 . . . . 0.68999999999999995 110.977 -178.83 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.62 145.51 50.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.691 -0.686 . . . . 0.52000000000000002 110.099 -179.833 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.31 101.62 9.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.075 -0.713 . . . . 0.32000000000000001 109.075 177.707 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.8 t -112.9 139.7 36.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.978 -0.556 . . . . 0.28999999999999998 111.143 -178.915 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.1 p -128.71 152.56 48.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.642 -0.708 . . . . 0.25 109.747 179.681 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.74 -164.9 2.02 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.731 -0.387 . . . . 0.31 110.64 -179.839 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.733 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -124.02 127.12 73.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.156 -0.474 . . . . 0.48999999999999999 110.833 -179.87 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 1.148 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.87 58.28 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.102 -0.499 . . . . 1.53 110.351 179.825 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.28 24.69 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.981 -0.554 . . . . 0.96999999999999997 111.535 -179.589 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.148 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.14 128.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.597 -0.441 . . . . 1.5600000000000001 110.907 179.818 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.39 -9.64 55.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.901 -0.591 . . . . 1.8799999999999999 110.255 179.725 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.7 p -86.98 0.23 55.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 1.04 110.338 179.954 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.3 137.31 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 116.0 -0.545 . . . . 0.23999999999999999 110.016 179.775 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.812 ' C ' ' HZ2' ' A' ' 61' ' ' LYS . 5.7 m -96.31 -15.6 21.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.234 0.54 . . . . 0.28999999999999998 109.99 -179.585 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.835 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.63 175.62 45.85 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.821 -1.311 . . . . 0.13 109.821 179.58 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.48 151.57 42.61 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.619 -0.432 . . . . 0.17000000000000001 110.465 179.801 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.777 ' NE ' ' HG2' ' A' ' 15' ' ' PRO . 19.7 ttt85 -132.25 121.22 23.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.131 -0.486 . . . . 1.29 109.96 179.759 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.556 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.13 136.54 38.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.776 -0.647 . . . . 0.25 110.619 -179.703 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 85.2 tt0 -129.36 129.88 45.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.969 -0.56 . . . . 1.3200000000000001 110.001 -179.862 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.619 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.71 135.22 34.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.099 -0.501 . . . . 0.56999999999999995 110.652 -179.673 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.424 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.26 161.44 39.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.809 -0.632 . . . . 1.1599999999999999 109.657 179.834 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.963 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.11 124.87 25.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.935 0.397 . . . . 0.38 110.769 -179.616 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.71 -7.76 50.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.808 -0.633 . . . . 0.40999999999999998 110.837 -179.748 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.83 -69.77 0.85 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.356 -0.384 . . . . 1.6599999999999999 111.394 -179.249 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 1.449 ' CD ' HH21 ' A' ' 176' ' ' ARG . 53.9 mt-10 -60.58 -35.36 75.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.083 -0.508 . . . . 1.6599999999999999 111.57 -179.167 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 1.096 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.18 7.24 88.59 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.839 -0.904 . . . . 1.1699999999999999 110.839 -179.843 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 1.313 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.95 -171.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.756 0.312 . . . . 1.8600000000000001 110.293 179.849 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.313 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.25 139.06 45.15 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.982 0.42 . . . . 1.98 110.182 179.653 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.424 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.87 145.87 51.86 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 C-N-CA 122.694 2.262 . . . . 0.55000000000000004 112.361 -179.553 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.619 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.9 145.74 42.64 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.131 -0.692 . . . . 1.1399999999999999 109.131 179.261 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 143' ' ' ARG . 71.7 m-85 -123.27 141.34 52.08 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.344 -0.542 . . . . 0.93000000000000005 111.552 -179.143 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.5 mt -128.09 127.61 43.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.291 -0.868 . . . . 0.34000000000000002 108.973 178.995 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.629 ' OD2' ' ND2' ' A' ' 16' ' ' ASN . 34.6 t0 -101.61 131.22 47.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.088 0.471 . . . . 1.0900000000000001 111.733 -178.741 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.604 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -128.01 157.57 73.49 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.321 -0.854 . . . . 0.19 109.572 179.672 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -69.87 158.04 58.15 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 C-N-CA 122.475 2.117 . . . . 0.17999999999999999 112.153 -179.987 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.34 -12.13 5.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.687 -0.688 . . . . 0.20999999999999999 110.721 -179.779 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.6 p -92.78 -8.79 42.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.28999999999999998 110.709 -179.917 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.38 34.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.5 110.358 179.743 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 p -133.13 16.61 4.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.373 -0.376 . . . . 0.29999999999999999 110.461 -179.986 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.4 p -167.52 147.12 5.09 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.556 -0.535 . . . . 0.23000000000000001 109.556 179.906 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.2 150.44 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.452 -0.499 . . . . 0.28000000000000003 111.592 -179.634 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.502 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.36 125.03 50.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.695 -0.684 . . . . 1.0700000000000001 109.776 179.504 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.4 104.91 29.87 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 0.28999999999999998 111.016 -179.826 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -91.01 -179.52 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 123.189 2.593 . . . . 0.42999999999999999 112.203 179.884 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 61.67 32.6 18.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.409 -0.814 . . . . 1.26 111.497 179.316 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.401 HD12 ' O ' ' A' ' 126' ' ' SER . 24.2 mt -86.37 148.57 25.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.483 -0.326 . . . . 0.32000000000000001 110.485 179.601 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.763 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.4 114.88 61.5 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.048 0.451 . . . . 0.57999999999999996 110.616 -179.657 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.96 140.62 96.11 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.81 2.34 . . . . 0.66000000000000003 111.993 179.825 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.11 21.15 74.34 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.072 -0.811 . . . . 0.28999999999999998 111.072 179.885 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 1.449 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.91 150.16 49.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.351 . . . . 2.3300000000000001 110.632 -179.925 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.493 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.17 131.65 45.99 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.044 -0.525 . . . . 0.85999999999999999 109.804 179.351 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.963 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.7 m-85 -120.61 148.26 44.13 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.187 -0.46 . . . . 0.52000000000000002 110.989 -179.788 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.7 mt -105.22 125.35 60.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.321 -0.992 . . . . 0.29999999999999999 108.321 177.76 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.67 132.57 63.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.218 0.532 . . . . 0.23000000000000001 111.189 -178.581 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.49 122.62 20.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.49 -0.777 . . . . 0.35999999999999999 109.614 179.319 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.2 t -101.15 125.42 55.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.195 -0.457 . . . . 0.19 110.648 -179.514 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 183' ' ' TYR . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.23 137.87 52.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.018 -0.537 . . . . 0.29999999999999999 109.843 179.602 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.578 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.7 135.04 42.78 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.878 -0.786 . . . . 0.37 108.878 178.817 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.605 HG21 ' HE2' ' A' ' 61' ' ' LYS . 68.1 mt -99.1 122.97 51.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.144 0.497 . . . . 0.26000000000000001 110.953 -178.73 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.5 p -83.94 169.68 14.79 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.518 -0.765 . . . . 0.28000000000000003 110.453 -179.636 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.77 -14.46 14.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.094 -0.503 . . . . 1.6000000000000001 110.913 -179.542 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -96.15 -4.33 42.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.773 0.321 . . . . 1.1799999999999999 110.787 -179.796 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.9 13.83 63.9 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.254 -0.738 . . . . 0.29999999999999999 111.254 179.76 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -84.68 139.1 32.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.715 0.293 . . . . 1.22 110.431 179.708 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -106.71 141.05 38.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.929 0.395 . . . . 0.97999999999999998 110.643 179.69 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.71 127.01 26.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.82999999999999996 110.388 179.927 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.1 tp -68.02 117.27 9.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.23 -0.441 . . . . 0.26000000000000001 110.548 -179.928 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 43.9 pt -109.03 -21.88 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.29999999999999999 110.78 -179.753 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.82 125.78 5.93 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.535 -0.466 . . . . 0.31 111.511 -179.846 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.473 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.76 120.16 21.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.801 -0.636 . . . . 0.28000000000000003 109.522 179.218 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.58 151.7 29.17 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.624 -0.43 . . . . 0.23999999999999999 110.873 -179.29 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.5 158.6 18.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.015 -0.538 . . . . 0.23000000000000001 110.41 179.686 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.4 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 21.5 mt-30 -146.09 157.88 43.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.07 -0.513 . . . . 0.67000000000000004 110.677 -179.977 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.23 104.37 9.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.787 -0.642 . . . . 0.64000000000000001 110.011 179.563 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.894 -1.051 . . . . 1.26 110.705 -179.725 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.19 -0.67 . . . . 3.4399999999999999 109.19 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.39 150.7 18.54 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.991 -0.844 . . . . 1.22 110.991 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -35.56 142.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 124.015 3.143 . . . . 0.75 113.76 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.604 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -80.06 173.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.268 -1.333 . . . . 0.79000000000000004 108.802 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.604 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.62 125.86 51.47 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.394 -0.522 . . . . 1.9399999999999999 111.407 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.49 144.02 33.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.662 -0.699 . . . . 0.59999999999999998 110.629 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.03 168.3 25.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.891 0.377 . . . . 3.1400000000000001 111.145 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.742 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.98 131.08 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.01 -0.541 . . . . 3.23 110.074 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.16 162.31 35.78 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.861 0.362 . . . . 3.6299999999999999 111.217 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 9' ' ' THR . 79.8 mm-40 36.07 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.611 -0.514 . . . . 6.0800000000000001 109.611 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.742 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.6 32.57 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.973 -0.558 . . . . 3.3799999999999999 111.6 -178.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.636 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.32 -29.1 72.43 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.487 2.125 . . . . 3.9300000000000002 111.819 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.636 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.64 125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 3.3599999999999999 110.443 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 17' ' ' SER . 2.8 mp0 -123.91 158.29 60.56 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 3.6099999999999999 110.435 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.662 ' HG2' ' NE ' ' A' ' 143' ' ' ARG . 97.7 Cg_endo -82.02 -64.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.94 2.427 . . . . 1.51 113.428 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.742 HD22 ' N ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -108.35 -19.53 13.44 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.067 0.395 . . . . 2.6800000000000002 112.067 -178.495 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.742 ' N ' HD22 ' A' ' 16' ' ' ASN . 9.8 p -107.31 152.04 24.67 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.484 -0.486 . . . . 1.21 111.338 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.26 102.9 2.23 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.769 -0.65 . . . . 1.5600000000000001 110.675 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.425 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.5 Cg_endo -82.68 145.61 13.01 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.853 2.369 . . . . 0.81000000000000005 112.664 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.916 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.74 167.92 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.899 -0.591 . . . . 1.52 109.919 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.12 147.95 29.09 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.829 -0.434 . . . . 2.1400000000000001 109.829 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.59 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.29 157.29 44.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.972 0.415 . . . . 0.32000000000000001 111.194 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.493 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.05 155.34 44.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.797 -0.638 . . . . 2.1699999999999999 110.092 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.839 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.65 173.05 6.34 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.118 0.485 . . . . 0.58999999999999997 110.743 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.839 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.68 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.873 2.382 . . . . 0.90000000000000002 111.515 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.11 -51.0 0.69 Allowed Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.674 -0.411 . . . . 3.3399999999999999 110.098 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.626 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.84 152.32 82.58 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.791 2.327 . . . . 1.8500000000000001 111.426 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.67 42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.413 0.625 . . . . 2.54 110.606 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.822 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.63 -41.67 98.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.976 -1.011 . . . . 2.5299999999999998 110.632 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.7 mt -109.83 137.81 40.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.821 -0.627 . . . . 1.1699999999999999 111.343 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.9 -72.94 0.7 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.109 -0.496 . . . . 1.27 111.938 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.12 148.4 24.46 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.623 0.601 . . . . 1.1200000000000001 112.623 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.81 124.82 45.07 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.424 -0.584 . . . . 0.41999999999999998 109.424 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.07 134.73 60.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.626 -0.43 . . . . 0.78000000000000003 110.625 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.916 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.0 128.66 53.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.054 0.454 . . . . 0.62 111.241 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 138.96 49.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.779 -0.646 . . . . 1.97 110.141 178.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.439 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.01 163.18 35.01 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.125 0.488 . . . . 0.34999999999999998 112.119 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.491 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.47 139.59 7.87 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 115.484 -0.78 . . . . 1.8 110.506 178.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.684 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.8 Cg_endo -63.55 115.46 3.06 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.33 2.02 . . . . 0.57999999999999996 111.784 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.674 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.96 81.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.891 -0.411 . . . . 3.04 109.891 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.23 -20.67 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.998 -0.546 . . . . 2.4700000000000002 111.906 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -157.66 157.82 34.3 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.78 -0.368 . . . . 2.5099999999999998 110.465 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.42 27.85 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 1.8600000000000001 110.151 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -75.88 1.31 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.122 -0.561 . . . . 1.4399999999999999 111.812 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.93 152.34 35.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.984 0.421 . . . . 4.6900000000000004 110.995 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.12 2.53 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.992 -0.549 . . . . 1.4299999999999999 111.886 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.17 149.63 29.81 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.457 0.646 . . . . 1.74 112.565 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.97 156.46 46.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.781 -1.099 . . . . 1.9199999999999999 110.285 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.21 158.43 41.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.967 -0.56 . . . . 0.34000000000000002 111.776 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.6 m -115.24 135.6 53.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.422 -0.808 . . . . 0.40999999999999998 109.79 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.59 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.45 121.98 23.71 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.418 -0.355 . . . . 0.55000000000000004 111.568 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.5 Cg_exo -46.27 151.75 1.58 Allowed 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.624 2.216 . . . . 0.44 112.121 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.96 -22.98 63.11 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 116.029 -0.532 . . . . 0.73999999999999999 112.81 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.54 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.8 -16.9 45.99 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 120.244 -0.582 . . . . 0.93000000000000005 111.804 -178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.603 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.57 138.39 31.61 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.707 -0.397 . . . . 0.96999999999999997 110.329 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -121.46 13.96 11.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.391 -0.368 . . . . 1.3400000000000001 111.569 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.475 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.0 143.48 25.21 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.648 -0.421 . . . . 0.39000000000000001 111.064 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.716 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.9 t80 -114.84 -169.3 1.52 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.051 -0.522 . . . . 0.41999999999999998 110.864 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.716 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.76 125.95 9.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.422 -0.808 . . . . 0.39000000000000001 109.818 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.516 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.9 mt -114.96 123.27 70.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.346 -0.542 . . . . 0.73999999999999999 111.166 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -126.47 163.4 23.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.807 -0.633 . . . . 2.48 110.498 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.18 18.94 59.88 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.714 -0.954 . . . . 0.5 110.714 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.516 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.9 mt -79.06 157.27 28.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.065 0.46 . . . . 0.57999999999999996 111.326 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.846 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -99.55 134.01 21.45 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.608 -0.723 . . . . 2.79 110.399 179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.424 ' HD3' ' CE2' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.98 143.54 60.71 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.519 2.146 . . . . 0.87 111.944 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.0 25.57 75.43 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.997 -0.841 . . . . 0.64000000000000001 110.997 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.846 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.19 158.8 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.72 0.295 . . . . 0.82999999999999996 110.43 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.15 139.9 42.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.884 0.373 . . . . 0.5 110.583 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.664 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.6 m-85 -122.54 136.49 54.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.923 -0.581 . . . . 0.53000000000000003 110.69 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.489 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.3 pt-20 -98.89 131.04 45.28 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.545 -0.909 . . . . 1.8700000000000001 108.545 177.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.46 153.9 16.64 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.326 -0.94 . . . . 0.28999999999999998 111.969 -178.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.0 140.93 46.05 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.675 -0.491 . . . . 1.4299999999999999 109.675 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.76 118.87 34.24 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.474 -0.49 . . . . 0.32000000000000001 110.468 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.721 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.43 129.08 68.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.388 . . . . 0.79000000000000004 110.68 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.707 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.79 120.79 43.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.27 -0.423 . . . . 1.02 110.732 -179.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.851 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.5 146.42 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.115 0.483 . . . . 0.62 111.082 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.822 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.02 153.85 21.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.496 -0.775 . . . . 2.4399999999999999 109.89 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.1 88.55 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.88 0.372 . . . . 3.6899999999999999 110.43 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.622 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.25 32.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.829 -0.623 . . . . 6.0800000000000001 110.614 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.1 -117.37 3.29 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.447 -0.661 . . . . 1.22 111.447 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.468 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.37 177.43 8.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.222 0.534 . . . . 2.8799999999999999 111.601 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.18 149.49 32.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.405 -0.816 . . . . 1.47 110.41 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.13 144.68 38.76 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.467 -0.333 . . . . 2.7000000000000002 110.6 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.721 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.0 136.01 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.05 0.453 . . . . 0.46000000000000002 111.555 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.09 141.33 52.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.681 -0.691 . . . . 0.34999999999999998 110.279 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.63 138.86 51.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.126 0.489 . . . . 3.6699999999999999 111.501 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.25 164.19 37.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.564 -0.744 . . . . 0.67000000000000004 109.471 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.571 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.31 151.49 38.4 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.422 -0.511 . . . . 1.47 111.042 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.7 p90 -146.18 172.7 13.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.788 -0.642 . . . . 0.44 111.017 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.69 160.65 21.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.455 -0.793 . . . . 1.3700000000000001 109.897 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.519 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.42 121.8 22.8 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.653 -0.419 . . . . 1.28 110.816 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.1 p -128.33 146.42 50.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.048 -0.524 . . . . 1.97 111.858 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.787 ' O ' HG23 ' A' ' 94' ' ' THR . 23.1 t -66.79 -36.95 83.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.798 -0.637 . . . . 3.2799999999999998 109.974 176.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.787 HG23 ' O ' ' A' ' 93' ' ' SER . 1.3 p 144.35 -123.56 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.4 t -117.64 138.45 51.96 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.518 ' O ' ' OG1' ' A' ' 99' ' ' THR . 11.4 p -139.12 156.93 72.02 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-O 120.752 0.31 . . . . 0.0 111.37 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.414 ' C ' ' H ' ' A' ' 99' ' ' THR . 31.0 Cg_endo -62.28 154.19 65.05 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.87 2.38 . . . . 0.0 112.063 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.512 ' O ' HG12 ' A' ' 98' ' ' VAL . 22.6 t 61.05 -0.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.973 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 96' ' ' THR . 63.8 m -56.95 -36.79 70.67 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.086 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.8 p -66.58 163.24 19.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.161 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -99.06 141.95 31.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.939 0.4 . . . . 0.0 110.919 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.6 p -83.03 162.66 21.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.436 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.5 t -115.7 135.49 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.706 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 48.5 m -79.51 139.11 37.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.003 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -160.15 -173.23 28.41 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.586 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -66.14 -16.11 63.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.526 -0.337 . . . . 0.0 111.257 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.3 m -68.28 137.66 54.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.941 0.401 . . . . 0.0 110.424 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 91.5 m -122.44 85.48 48.0 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.738 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.23 150.99 18.25 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.52 2.147 . . . . 0.0 111.98 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -67.15 147.98 52.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.927 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 58.3 p -123.6 82.05 54.11 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.737 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 113' ' ' LEU . 50.0 Cg_exo -52.09 150.42 18.95 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.653 2.235 . . . . 0.0 112.149 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.53 HD12 ' N ' ' A' ' 113' ' ' LEU . 8.2 mp 57.16 151.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.963 -0.562 . . . . 10.19 110.452 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 115' ' ' ALA . 41.5 t -114.61 135.6 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 115.921 -0.581 . . . . 7.2800000000000002 110.848 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 114' ' ' VAL . . . 43.64 -175.71 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.825 -0.625 . . . . 7.2999999999999998 111.585 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.4 m -122.93 142.91 50.29 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.681 -0.691 . . . . 6.4400000000000004 110.499 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.5 m -60.93 156.48 17.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 4.4199999999999999 110.39 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.53 -34.59 67.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.295 -0.412 . . . . 3.0499999999999998 110.481 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 28.4 t -120.47 140.96 50.65 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.857 0.36 . . . . 3.4300000000000002 110.421 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.3 m -129.96 159.61 41.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.998 -0.546 . . . . 2.8799999999999999 110.485 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 22.5 p -119.81 160.91 21.7 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.305 -0.407 . . . . 2.0899999999999999 110.246 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -103.6 -134.44 0.32 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.012 -0.54 . . . . 4.5300000000000002 111.141 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.455 ' CG2' ' O ' ' A' ' 172' ' ' LEU . 66.6 mt -111.07 143.53 20.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.974 -0.557 . . . . 1.4399999999999999 110.123 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.6 t -131.99 156.1 46.82 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.292 0.568 . . . . 1.78 111.672 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.549 ' C ' ' H ' ' A' ' 127' ' ' SER . . . 32.17 -124.18 0.06 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.171 -0.922 . . . . 0.64000000000000001 112.725 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.505 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 4.6 p 48.33 4.78 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.597 -0.729 . . . . 0.66000000000000003 111.988 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.549 ' H ' ' C ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.9 167.6 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.097 0.475 . . . . 0.68999999999999995 110.932 179.474 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.62 145.56 50.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.704 -0.68 . . . . 0.52000000000000002 110.123 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.26 101.66 9.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.063 -0.717 . . . . 0.32000000000000001 109.063 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.7 t -112.93 139.69 36.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.026 -0.534 . . . . 0.28999999999999998 111.109 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.2 p -128.66 152.47 48.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.7 -0.682 . . . . 0.25 109.929 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.595 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.8 -165.01 2.05 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.692 -0.403 . . . . 0.31 110.569 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -123.95 127.17 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.162 -0.472 . . . . 0.48999999999999999 110.809 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.176 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.97 58.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.126 -0.488 . . . . 1.53 110.31 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.21 24.57 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.892 -0.595 . . . . 0.96999999999999997 111.52 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.176 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.11 128.76 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.638 -0.425 . . . . 1.5600000000000001 110.919 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.5 -9.51 56.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.883 -0.599 . . . . 1.8799999999999999 110.289 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.16 0.25 55.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.14 -0.482 . . . . 1.04 110.289 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.21 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.05 -0.523 . . . . 0.23999999999999999 109.899 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 185' ' ' ILE . 94.2 p -96.28 -15.47 21.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.259 0.552 . . . . 0.28999999999999998 110.056 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.54 175.6 45.76 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.887 -1.285 . . . . 0.13 109.887 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -123.48 151.57 42.61 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.69 -0.404 . . . . 0.17000000000000001 110.509 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.662 ' NE ' ' HG2' ' A' ' 15' ' ' PRO . 73.0 ttt-85 -132.34 121.22 23.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.136 -0.484 . . . . 1.29 109.881 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.558 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.15 136.51 38.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.664 -0.698 . . . . 0.25 110.707 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 79.5 tt0 -129.29 129.95 45.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.038 -0.528 . . . . 1.3200000000000001 110.057 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.9 p90 -138.79 135.31 34.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.985 -0.552 . . . . 0.56999999999999995 110.567 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.427 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.28 39.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.762 -0.654 . . . . 1.1599999999999999 109.733 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.959 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -70.99 124.87 25.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.978 0.418 . . . . 0.38 110.713 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.497 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.76 -7.7 49.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.687 -0.688 . . . . 0.40999999999999998 110.891 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.85 -69.69 0.85 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 1.6599999999999999 111.343 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.447 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.7 -35.35 76.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.017 -0.538 . . . . 1.6599999999999999 111.492 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.093 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.19 7.25 88.58 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.806 -0.918 . . . . 1.1699999999999999 110.806 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.318 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.99 -171.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.779 0.323 . . . . 1.8600000000000001 110.275 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.318 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.32 139.09 44.95 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.947 0.403 . . . . 1.98 110.187 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.427 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.1 Cg_endo -70.81 145.75 51.91 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 122.725 2.284 . . . . 0.55000000000000004 112.31 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.85 145.71 42.62 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.195 -0.669 . . . . 1.1399999999999999 109.195 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.516 ' CE1' ' HB2' ' A' ' 16' ' ' ASN . 6.2 p90 -123.21 141.36 52.06 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.378 -0.529 . . . . 0.93000000000000005 111.573 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.1 127.67 43.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.338 -0.846 . . . . 0.34000000000000002 108.952 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 52.4 t0 -101.63 131.22 47.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.172 0.511 . . . . 1.0900000000000001 111.763 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.42 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -127.97 157.57 73.44 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.317 -0.856 . . . . 0.19 109.566 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.75 158.04 58.34 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.439 2.093 . . . . 0.17999999999999999 112.262 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.3 -12.18 5.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.842 -0.617 . . . . 0.20999999999999999 110.725 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.4 p -92.81 -8.74 42.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.28999999999999998 110.711 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.42 34.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.378 -0.374 . . . . 0.5 110.391 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.19 16.66 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.354 -0.385 . . . . 0.29999999999999999 110.491 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.0 p -167.53 147.18 5.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.644 -0.502 . . . . 0.23000000000000001 109.644 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.19 150.39 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.538 -0.465 . . . . 0.28000000000000003 111.576 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.28 124.94 50.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.624 -0.716 . . . . 1.0700000000000001 109.809 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.37 104.88 29.57 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.924 0.392 . . . . 0.28999999999999998 111.105 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.5 Cg_endo -90.94 -179.54 1.52 Allowed 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 123.197 2.598 . . . . 0.42999999999999999 112.243 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.72 32.63 18.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.394 -0.821 . . . . 1.26 111.417 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.505 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.4 mt -86.33 148.51 25.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.496 -0.32 . . . . 0.32000000000000001 110.521 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.766 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.24 114.82 61.1 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.912 0.387 . . . . 0.57999999999999996 110.696 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.0 140.53 95.76 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.858 2.372 . . . . 0.66000000000000003 112.014 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.16 21.2 74.1 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.009 -0.837 . . . . 0.28999999999999998 111.009 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.447 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.81 150.12 49.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.732 0.301 . . . . 2.3300000000000001 110.688 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.497 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.14 131.59 46.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 0.85999999999999999 109.833 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.959 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.48 148.28 44.03 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.143 -0.48 . . . . 0.52000000000000002 111.038 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.3 mt -105.33 125.29 60.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.27 -1.011 . . . . 0.29999999999999999 108.27 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.5 132.47 63.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.183 0.516 . . . . 0.23000000000000001 111.274 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.9 m-20 -136.46 122.59 20.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.532 -0.758 . . . . 0.35999999999999999 109.636 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.595 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.03 125.39 54.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.187 -0.46 . . . . 0.19 110.665 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.9 m-85 -117.25 137.97 52.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.007 -0.542 . . . . 0.29999999999999999 109.835 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.582 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.76 135.07 42.78 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.786 -0.82 . . . . 0.37 108.786 178.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 140' ' ' SER . 85.3 mt -99.09 122.92 51.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.07 0.462 . . . . 0.26000000000000001 110.96 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.5 p -83.79 169.7 14.91 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.534 -0.757 . . . . 0.28000000000000003 110.484 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.83 -14.51 15.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.04 -0.527 . . . . 1.6000000000000001 110.934 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.505 ' C ' ' OG1' ' A' ' 59' ' ' THR . 79.2 m-20 -96.1 -4.29 43.12 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.833 -0.347 . . . . 1.1799999999999999 110.825 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.49 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.78 13.89 64.02 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.379 -0.689 . . . . 0.29999999999999999 111.379 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -84.62 139.05 32.34 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.058 -0.257 . . . . 1.22 110.518 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -106.76 141.11 38.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.903 0.382 . . . . 0.97999999999999998 110.513 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.6 m -136.72 126.97 26.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.82999999999999996 110.36 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.06 117.25 9.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.329 -0.396 . . . . 0.26000000000000001 110.528 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.03 -21.84 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.29999999999999999 110.712 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.87 125.79 5.9 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.514 -0.475 . . . . 0.31 111.485 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.75 120.24 21.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.79 -0.641 . . . . 0.28000000000000003 109.578 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.71 29.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.955 0.407 . . . . 0.23999999999999999 110.927 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.47 158.66 18.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.052 -0.522 . . . . 0.23000000000000001 110.413 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.09 157.96 43.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.03 -0.532 . . . . 0.67000000000000004 110.659 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 104.26 9.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.721 -0.672 . . . . 0.64000000000000001 110.047 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.876 -1.059 . . . . 1.26 110.665 -179.729 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.197 -0.668 . . . . 3.4399999999999999 109.197 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.72 18.54 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.049 -0.821 . . . . 1.22 111.049 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.73 142.41 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.09 0 C-N-CA 123.94 3.093 . . . . 0.75 113.748 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.0 t -79.93 173.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.205 -1.361 . . . . 0.79000000000000004 108.83 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.614 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.64 125.89 51.51 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.482 -0.487 . . . . 1.9399999999999999 111.409 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 p -136.52 143.99 33.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.573 -0.74 . . . . 0.59999999999999998 110.622 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.06 168.25 25.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.936 0.398 . . . . 3.1400000000000001 111.072 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.743 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.4 mt -108.87 131.1 60.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.019 -0.537 . . . . 3.23 110.155 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.21 162.32 35.77 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.931 0.396 . . . . 3.6299999999999999 111.149 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.1 mt-10 36.06 31.68 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.559 -0.534 . . . . 6.0800000000000001 109.559 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.743 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.53 69.63 33.56 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.939 -0.573 . . . . 3.3799999999999999 111.533 -178.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.28 -29.09 72.75 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.501 2.134 . . . . 3.9300000000000002 111.881 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.64 125.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 3.3599999999999999 110.477 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.724 HE22 ' CD ' ' A' ' 191' ' ' GLN . 18.7 mm-40 -123.9 158.33 60.37 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 3.6099999999999999 110.462 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.54 ' CG ' ' NE ' ' A' ' 143' ' ' ARG . 98.8 Cg_endo -82.08 -64.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.901 2.401 . . . . 1.51 113.494 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.673 ' OD1' ' O ' ' A' ' 63' ' ' LEU . 51.6 t30 -108.43 -19.56 13.41 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.119 0.415 . . . . 2.6800000000000002 112.119 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 1.3 p -107.27 152.03 24.66 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.499 -0.48 . . . . 1.21 111.346 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.28 102.88 2.23 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.737 -0.665 . . . . 1.5600000000000001 110.689 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.57 145.63 13.19 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.914 2.409 . . . . 0.81000000000000005 112.639 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.919 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.8 167.98 24.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.808 -0.633 . . . . 1.52 109.924 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.16 147.93 29.03 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.74 -0.467 . . . . 2.1400000000000001 109.74 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.595 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.4 p90 -142.3 157.3 44.97 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.624 -0.43 . . . . 0.32000000000000001 111.212 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.49 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.04 155.22 44.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.831 -0.622 . . . . 2.1699999999999999 110.187 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.83 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.62 172.99 6.42 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.097 0.475 . . . . 0.58999999999999997 110.743 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.83 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.54 173.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.885 2.39 . . . . 0.90000000000000002 111.513 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.01 -51.15 0.69 Allowed Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.746 -0.381 . . . . 3.3399999999999999 110.093 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.622 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.8 Cg_exo -64.89 152.4 82.38 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.743 2.295 . . . . 1.8500000000000001 111.423 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.68 42.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.423 0.63 . . . . 2.54 110.587 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.815 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.59 -41.65 98.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.011 -0.995 . . . . 2.5299999999999998 110.671 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.2 mt -109.92 137.87 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.783 -0.644 . . . . 1.1699999999999999 111.251 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.95 -72.92 0.7 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.025 -0.534 . . . . 1.27 111.856 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.15 148.4 24.44 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.557 0.577 . . . . 1.1200000000000001 112.557 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.8 124.87 45.19 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.41 -0.589 . . . . 0.41999999999999998 109.41 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.8 mt -118.15 134.8 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.618 -0.433 . . . . 0.78000000000000003 110.553 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.919 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.09 128.66 53.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.071 0.462 . . . . 0.62 111.149 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.549 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.14 139.01 49.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.656 -0.702 . . . . 1.97 110.097 178.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.09 163.19 35.06 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.076 0.465 . . . . 0.34999999999999998 112.108 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.489 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.49 139.58 7.85 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 115.453 -0.794 . . . . 1.8 110.437 178.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.57 115.46 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.316 2.011 . . . . 0.57999999999999996 111.784 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.672 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.9 81.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.94 -0.392 . . . . 3.04 109.94 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.14 -20.64 0.06 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.998 -0.547 . . . . 2.4700000000000002 111.946 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.56 157.77 34.37 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.815 -0.354 . . . . 2.5099999999999998 110.559 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.403 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.39 27.88 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.23 -0.441 . . . . 1.8600000000000001 110.17 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.87 -75.9 1.31 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.825 -0.51 . . . . 1.4399999999999999 111.825 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.89 152.26 35.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.871 0.367 . . . . 4.6900000000000004 111.051 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.676 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.21 -169.16 2.54 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.077 -0.511 . . . . 1.4299999999999999 111.925 179.417 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.11 149.69 29.68 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.409 0.623 . . . . 1.74 112.557 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.08 156.47 45.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.82 -1.082 . . . . 1.9199999999999999 110.262 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.26 158.33 41.5 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.938 -0.574 . . . . 0.34000000000000002 111.791 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 m -115.13 135.67 53.94 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.368 -0.833 . . . . 0.40999999999999998 109.86 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.595 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.44 121.9 23.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.444 -0.344 . . . . 0.55000000000000004 111.555 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.2 Cg_exo -46.3 151.74 1.61 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.634 2.223 . . . . 0.44 112.2 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.02 -22.95 63.2 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 116.157 -0.474 . . . . 0.73999999999999999 112.808 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.77 -16.88 46.2 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.21 -0.596 . . . . 0.93000000000000005 111.787 -178.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.605 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.54 138.46 31.56 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.83 -0.348 . . . . 0.96999999999999997 110.271 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -121.58 13.93 10.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.362 -0.381 . . . . 1.3400000000000001 111.548 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.93 143.49 25.28 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.626 -0.43 . . . . 0.39000000000000001 111.08 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.713 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.85 -169.35 1.53 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.212 0.53 . . . . 0.41999999999999998 110.829 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.713 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 84.9 m -151.75 125.95 9.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.334 -0.848 . . . . 0.39000000000000001 109.832 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.515 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.82 123.19 70.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.428 -0.509 . . . . 0.73999999999999999 111.28 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.577 ' HE2' HG21 ' A' ' 185' ' ' ILE . 8.6 mmtt -126.44 163.31 23.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.906 -0.588 . . . . 2.48 110.482 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.607 ' HA2' HD21 ' A' ' 16' ' ' ASN . . . 85.14 19.06 59.71 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.678 -0.969 . . . . 0.5 110.678 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.673 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 73.9 mt -79.09 157.25 28.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.053 0.454 . . . . 0.57999999999999996 111.339 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.857 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -99.45 133.9 21.59 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.568 -0.742 . . . . 2.79 110.491 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.82 143.55 61.68 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.54 2.16 . . . . 0.87 112.029 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.77 25.66 75.3 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.033 -0.827 . . . . 0.64000000000000001 111.033 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.857 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.13 158.86 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.684 0.278 . . . . 0.82999999999999996 110.466 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.21 139.96 42.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.967 0.413 . . . . 0.5 110.495 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.638 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.58 136.46 54.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.863 -0.608 . . . . 0.53000000000000003 110.74 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.95 131.09 45.28 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.541 -0.911 . . . . 1.8700000000000001 108.541 177.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.487 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.57 153.91 16.67 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.201 -0.999 . . . . 0.28999999999999998 111.947 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -134.97 140.89 46.05 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.681 -0.489 . . . . 1.4299999999999999 109.681 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.73 118.97 34.53 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.418 -0.513 . . . . 0.32000000000000001 110.503 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 84' ' ' VAL . 64.2 mt -112.45 129.12 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.287 -0.415 . . . . 0.79000000000000004 110.592 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.9 120.88 43.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.253 -0.43 . . . . 1.02 110.715 -179.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.859 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.69 146.57 11.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.292 0.568 . . . . 0.62 110.921 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.815 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.12 153.88 21.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.513 -0.767 . . . . 2.4399999999999999 109.941 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.21 88.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.963 0.411 . . . . 3.6899999999999999 110.371 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.62 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.38 32.45 0.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.784 -0.644 . . . . 6.0800000000000001 110.577 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.01 -117.39 3.3 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.452 -0.659 . . . . 1.22 111.452 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.467 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.41 177.47 8.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.252 0.548 . . . . 2.8799999999999999 111.58 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.22 149.47 31.98 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.373 -0.83 . . . . 1.47 110.312 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.15 144.7 38.73 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.463 -0.335 . . . . 2.7000000000000002 110.528 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.727 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.03 136.0 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 121.041 0.448 . . . . 0.46000000000000002 111.538 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.05 141.37 52.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.687 -0.688 . . . . 0.34999999999999998 110.292 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.67 138.81 51.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.128 0.49 . . . . 3.6699999999999999 111.479 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.487 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.19 164.25 37.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.527 -0.761 . . . . 0.67000000000000004 109.494 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.33 151.49 38.4 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.442 -0.503 . . . . 1.47 111.075 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.8 p90 -146.15 172.72 13.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.724 -0.671 . . . . 0.44 111.04 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.67 160.69 21.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.431 -0.804 . . . . 1.3700000000000001 109.843 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.4 121.85 22.89 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.573 -0.451 . . . . 1.28 110.752 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.5 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.6 p -126.6 161.34 28.25 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 114.003 1.112 . . . . 1.97 114.003 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.8 t -131.1 153.1 49.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 113.272 -1.786 . . . . 3.2799999999999998 108.886 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 61.0 p -60.93 -10.51 5.84 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 51.5 p -69.0 163.02 25.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.251 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.98 164.93 14.84 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.629 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.42 145.82 35.18 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.137 1.891 . . . . 0.0 112.113 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.59 HG12 ' H ' ' A' ' 100' ' ' SER . 40.8 t -114.1 135.26 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.293 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.1 p -66.64 -28.39 68.44 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.201 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.59 ' H ' HG12 ' A' ' 98' ' ' VAL . 26.9 m 50.27 -144.71 0.5 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 110.771 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.29 45.19 14.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.011 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 48.1 m -86.16 139.21 31.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.249 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.5 p -130.56 142.38 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.817 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 37.2 m -123.67 141.99 51.49 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.228 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.96 10.09 61.68 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -56.66 -33.12 66.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.621 0.248 . . . . 0.0 110.492 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.5 p -120.85 162.32 20.02 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.681 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.4 m -126.16 79.66 69.41 Favored Pre-proline 0 N--CA 1.465 0.32 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.487 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.69 145.62 48.12 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.473 2.115 . . . . 0.0 112.409 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -99.07 135.7 40.09 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.77 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.0 m -113.75 94.36 32.7 Favored Pre-proline 0 N--CA 1.468 0.427 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.227 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.41 -15.53 45.88 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.383 2.055 . . . . 0.0 111.773 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 27.8 tp -54.57 -37.29 65.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.854 -0.612 . . . . 10.19 111.028 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.0 m -127.13 153.06 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.076 0.465 . . . . 7.2800000000000002 111.512 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.76 -32.34 73.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.624 -0.716 . . . . 7.2999999999999998 111.727 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.7 m -119.94 140.44 50.89 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.991 0.424 . . . . 6.4400000000000004 110.814 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.4 m -63.06 154.35 31.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.002 -0.544 . . . . 4.4199999999999999 110.853 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -110.81 159.92 17.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.616 -0.72 . . . . 3.0499999999999998 110.149 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 54.2 p -65.51 162.21 18.5 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.503 -0.554 . . . . 3.4300000000000002 109.503 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 43.4 t -113.18 134.5 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 121.181 0.515 . . . . 2.8799999999999999 111.488 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.1 p -123.47 162.98 21.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.347 -0.842 . . . . 2.0899999999999999 109.178 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.87 140.72 51.28 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.947 -0.701 . . . . 4.5300000000000002 109.832 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 9.4 tp -125.45 140.36 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.257 -0.429 . . . . 1.4399999999999999 111.083 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 17.8 p -122.14 159.52 27.01 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.03 -0.532 . . . . 1.78 109.695 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 127' ' ' SER . . . -148.24 155.58 41.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.547 -0.297 . . . . 0.64000000000000001 110.862 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.2 OUTLIER 41.03 19.64 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.19 0.519 . . . . 0.66000000000000003 111.418 179.434 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.85 167.57 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.525 -0.761 . . . . 0.68999999999999995 110.984 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.64 145.5 50.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.733 -0.667 . . . . 0.52000000000000002 110.081 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.23 101.67 9.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.124 -0.695 . . . . 0.32000000000000001 109.124 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.4 t -112.95 139.7 36.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.974 -0.557 . . . . 0.28999999999999998 111.069 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.0 p -128.8 152.48 48.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.612 -0.722 . . . . 0.25 109.776 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.585 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.71 -164.9 2.02 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.668 -0.413 . . . . 0.31 110.632 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.732 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.4 t -123.97 127.1 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.218 -0.446 . . . . 0.48999999999999999 110.788 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.157 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.216 -0.447 . . . . 1.53 110.374 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.14 24.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.928 -0.578 . . . . 0.96999999999999997 111.469 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.157 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.16 128.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.54 -0.464 . . . . 1.5600000000000001 110.952 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.39 -9.59 56.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.975 -0.557 . . . . 1.8799999999999999 110.249 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.18 0.17 55.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.218 -0.446 . . . . 1.04 110.299 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 136' ' ' SER . 2.6 p -65.19 137.17 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.954 -0.566 . . . . 0.23999999999999999 110.027 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 185' ' ' ILE . 92.5 p -96.14 -15.56 22.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.263 0.554 . . . . 0.28999999999999998 110.101 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.62 175.58 45.81 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 109.772 -1.331 . . . . 0.13 109.772 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.4 151.59 42.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.971 0.415 . . . . 0.17000000000000001 110.516 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.583 ' NH2' ' HB3' ' A' ' 157' ' ' TYR . 78.1 ttt-85 -132.42 121.17 23.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.103 -0.499 . . . . 1.29 109.964 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.557 HG21 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.14 136.56 38.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.708 -0.678 . . . . 0.25 110.684 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 84.1 tt0 -129.34 129.8 45.28 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.961 -0.563 . . . . 1.3200000000000001 110.085 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.64 135.24 34.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.033 -0.53 . . . . 0.56999999999999995 110.703 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.41 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.25 161.3 39.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.865 -0.607 . . . . 1.1599999999999999 109.763 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.956 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.0 124.89 25.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.006 0.432 . . . . 0.38 110.763 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.87 -7.66 49.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.816 -0.629 . . . . 0.40999999999999998 110.84 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -109.79 -69.67 0.85 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.01 0.433 . . . . 1.6599999999999999 111.514 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.461 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.3 mt-10 -60.76 -35.22 75.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.033 -0.53 . . . . 1.6599999999999999 111.51 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.094 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.07 7.27 88.56 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.804 -0.919 . . . . 1.1699999999999999 110.804 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.323 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.9 t0 -27.95 -171.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.761 0.315 . . . . 1.8600000000000001 110.314 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.323 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.2 pm0 -82.27 139.11 45.11 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.044 0.449 . . . . 1.98 110.226 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.41 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.94 145.87 51.46 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.726 2.284 . . . . 0.55000000000000004 112.32 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.81 145.7 42.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.217 -0.66 . . . . 1.1399999999999999 109.217 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.583 ' HB3' ' NH2' ' A' ' 143' ' ' ARG . 4.0 p90 -123.31 141.32 52.11 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.349 -0.54 . . . . 0.93000000000000005 111.537 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.4 mt -128.05 127.66 43.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.239 -0.892 . . . . 0.34000000000000002 108.932 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.671 ' OD2' ' ND2' ' A' ' 16' ' ' ASN . 63.3 t0 -101.49 131.12 47.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.135 0.493 . . . . 1.0900000000000001 111.879 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.437 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.1 mt -127.93 157.57 73.34 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.358 -0.837 . . . . 0.19 109.566 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.83 157.98 58.41 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.492 2.128 . . . . 0.17999999999999999 112.311 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.22 -12.16 4.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.855 -0.611 . . . . 0.20999999999999999 110.822 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.5 p -92.77 -8.69 42.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.058 -0.519 . . . . 0.28999999999999998 110.734 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.2 135.39 34.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.413 . . . . 0.5 110.357 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.16 16.68 4.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.439 -0.346 . . . . 0.29999999999999999 110.504 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.1 p -167.59 147.13 5.04 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.63 -0.507 . . . . 0.23000000000000001 109.63 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.21 150.61 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 0.28000000000000003 111.525 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.508 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.37 124.9 50.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.559 -0.746 . . . . 1.0700000000000001 109.789 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.28 104.87 29.22 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.424 -0.353 . . . . 0.28999999999999998 111.088 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.0 Cg_endo -91.0 -179.5 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.965 0 C-N-CA 123.235 2.624 . . . . 0.42999999999999999 112.251 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.71 32.58 18.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.413 -0.812 . . . . 1.26 111.438 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.45 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.0 mt -86.35 148.5 25.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.772 0.32 . . . . 0.32000000000000001 110.486 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.762 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.3 114.83 61.22 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.075 0.464 . . . . 0.57999999999999996 110.704 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.01 140.57 95.94 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.821 2.348 . . . . 0.66000000000000003 112.04 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.17 74.42 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.101 -0.8 . . . . 0.28999999999999998 111.101 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.461 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.84 150.23 49.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.896 0.379 . . . . 2.3300000000000001 110.598 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.488 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.1 tttt -100.14 131.75 45.91 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.997 -0.547 . . . . 0.85999999999999999 109.799 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.956 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.62 148.26 44.13 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.114 -0.494 . . . . 0.52000000000000002 110.992 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.2 mt -105.32 125.37 60.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.298 -1.001 . . . . 0.29999999999999999 108.298 177.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.5 132.57 63.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.154 0.502 . . . . 0.23000000000000001 111.305 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.57 122.58 20.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.494 -0.775 . . . . 0.35999999999999999 109.537 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.585 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.0 125.33 54.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.227 -0.442 . . . . 0.19 110.739 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.3 m-85 -117.21 137.76 52.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.064 -0.516 . . . . 0.29999999999999999 109.926 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.575 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.66 134.96 42.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.805 -0.813 . . . . 0.37 108.805 178.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.6 ' O ' ' N ' ' A' ' 140' ' ' SER . 7.7 mm -99.11 122.91 51.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.177 0.513 . . . . 0.26000000000000001 110.922 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.6 p -83.76 169.74 14.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.533 -0.758 . . . . 0.28000000000000003 110.494 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.706 ' O ' ' OG1' ' A' ' 59' ' ' THR . 97.5 mt-10 -59.74 -14.59 15.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.011 -0.541 . . . . 1.6000000000000001 111.028 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -96.12 -4.22 43.16 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.804 -0.358 . . . . 1.1799999999999999 110.792 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.79 13.85 64.07 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.388 -0.685 . . . . 0.29999999999999999 111.388 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -84.58 139.01 32.4 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 121.107 -0.237 . . . . 1.22 110.506 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.724 ' CD ' HE22 ' A' ' 14' ' ' GLN . 11.8 mt-30 -106.68 141.09 38.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.815 0.34 . . . . 0.97999999999999998 110.584 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.1 m -136.71 126.93 26.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.82999999999999996 110.359 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.07 117.3 9.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.278 -0.419 . . . . 0.26000000000000001 110.551 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.05 -21.7 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.29999999999999999 110.764 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.91 125.69 5.84 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.542 -0.463 . . . . 0.31 111.459 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.471 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.8 120.28 21.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.726 -0.67 . . . . 0.28000000000000003 109.517 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.63 151.62 29.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.917 0.389 . . . . 0.23999999999999999 110.984 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.43 158.5 18.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.049 -0.523 . . . . 0.23000000000000001 110.464 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -145.97 157.93 43.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.235 -0.439 . . . . 0.67000000000000004 110.768 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 104.54 9.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.784 -0.644 . . . . 0.64000000000000001 109.972 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 68.1 p . . . . . 0 C--O 1.219 -0.534 0 CA-C-O 117.882 -1.056 . . . . 1.26 110.617 -179.706 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.6 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.199 -0.667 . . . . 3.4399999999999999 109.199 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.38 150.7 18.54 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.024 -0.83 . . . . 1.22 111.024 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -35.66 142.4 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.101 0 C-N-CA 124.025 3.15 . . . . 0.75 113.742 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.97 173.32 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.29 -1.323 . . . . 0.79000000000000004 108.769 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.614 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.55 125.93 51.55 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.411 -0.516 . . . . 1.9399999999999999 111.44 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.55 143.95 34.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.618 -0.719 . . . . 0.59999999999999998 110.622 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.05 168.31 25.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.931 0.396 . . . . 3.1400000000000001 111.12 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.748 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -108.98 131.06 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.957 -0.565 . . . . 3.23 110.076 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.2 162.31 35.79 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.954 0.407 . . . . 3.6299999999999999 111.194 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.469 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 73.1 tt0 36.14 31.53 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.637 -0.505 . . . . 6.0800000000000001 109.637 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.748 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.42 69.58 32.41 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.958 -0.564 . . . . 3.3799999999999999 111.621 -178.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.29 -29.09 72.62 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.529 2.153 . . . . 3.9300000000000002 111.802 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.52 125.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 3.3599999999999999 110.548 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.529 ' CB ' ' O ' ' A' ' 17' ' ' SER . 11.7 mt-30 -123.89 158.34 60.33 Favored Pre-proline 0 C--O 1.234 0.26 0 CA-C-N 116.241 -0.436 . . . . 3.6099999999999999 110.537 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.486 ' CG ' ' NH1' ' A' ' 143' ' ' ARG . 98.3 Cg_endo -82.12 -64.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.931 2.42 . . . . 1.51 113.457 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.627 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 61.9 t30 -108.4 -19.5 13.44 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.114 0.413 . . . . 2.6800000000000002 112.114 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 29.7 t -107.31 152.1 24.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.148 0.499 . . . . 1.21 111.339 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.578 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.24 102.92 2.23 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.687 -0.688 . . . . 1.5600000000000001 110.61 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.72 145.64 12.95 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.888 2.392 . . . . 0.81000000000000005 112.568 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.932 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.81 167.98 24.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.896 -0.593 . . . . 1.52 109.961 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.23 147.89 28.94 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.776 -0.453 . . . . 2.1400000000000001 109.776 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.597 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.4 p90 -142.24 157.29 45.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.017 0.437 . . . . 0.32000000000000001 111.196 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.499 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.04 155.26 44.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.715 -0.675 . . . . 2.1699999999999999 110.064 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.835 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.6 173.05 6.34 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 121.111 0.481 . . . . 0.58999999999999997 110.728 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.835 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.69 173.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.779 2.319 . . . . 0.90000000000000002 111.533 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.484 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.1 -51.03 0.69 Allowed Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 120.694 -0.402 . . . . 3.3399999999999999 110.111 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.617 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.81 152.32 82.52 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.737 2.291 . . . . 1.8500000000000001 111.483 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.64 42.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.332 0.587 . . . . 2.54 110.564 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.814 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.65 -41.55 98.21 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.953 -1.021 . . . . 2.5299999999999998 110.722 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.1 mt -109.87 137.89 40.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.842 -0.617 . . . . 1.1699999999999999 111.276 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.93 -72.95 0.7 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.063 -0.517 . . . . 1.27 111.911 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.09 148.28 24.54 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.593 0.59 . . . . 1.1200000000000001 112.593 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.81 124.94 45.36 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.324 -0.621 . . . . 0.41999999999999998 109.324 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.03 134.75 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.619 -0.433 . . . . 0.78000000000000003 110.705 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.932 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.99 128.59 53.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.998 0.428 . . . . 0.62 111.281 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.06 138.95 49.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.741 -0.663 . . . . 1.97 110.14 179.008 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.434 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.2 p90 -145.08 163.14 35.2 Favored 'General case' 0 C--N 1.335 -0.065 0 CA-C-O 121.197 0.523 . . . . 0.34999999999999998 112.036 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.488 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.48 139.63 7.89 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.38 -0.827 . . . . 1.8 110.482 178.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.63 115.47 3.07 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.392 2.061 . . . . 0.57999999999999996 111.767 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.684 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.0 81.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.927 -0.397 . . . . 3.04 109.927 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.931 -0.577 . . . . 2.4700000000000002 111.943 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.2 p -157.59 157.8 34.37 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.865 -0.334 . . . . 2.5099999999999998 110.577 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.408 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.4 m -120.38 27.8 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 1.8600000000000001 110.213 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.7 -75.9 1.31 Allowed Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.11 -0.566 . . . . 1.4399999999999999 111.878 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.88 152.29 35.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.964 0.411 . . . . 4.6900000000000004 110.949 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.665 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.18 -169.07 2.52 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.032 -0.531 . . . . 1.4299999999999999 111.96 179.343 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.77 29.59 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 121.48 0.657 . . . . 1.74 112.539 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.15 156.47 45.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.784 -1.098 . . . . 1.9199999999999999 110.242 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.2 158.35 41.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.931 -0.577 . . . . 0.34000000000000002 111.841 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.14 135.67 53.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.539 -0.755 . . . . 0.40999999999999998 109.832 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.597 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.44 121.91 23.71 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.474 -0.33 . . . . 0.55000000000000004 111.55 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.607 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.4 Cg_exo -46.26 151.7 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.65 2.234 . . . . 0.44 112.124 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.97 -22.97 63.12 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 116.026 -0.533 . . . . 0.73999999999999999 112.843 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.82 -16.79 46.39 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.213 -0.595 . . . . 0.93000000000000005 111.837 -178.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.607 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.64 138.39 31.6 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.798 -0.361 . . . . 0.96999999999999997 110.323 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.54 14.01 11.0 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.426 -0.352 . . . . 1.3400000000000001 111.527 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.07 143.46 25.14 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.671 -0.411 . . . . 0.39000000000000001 111.075 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.716 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.78 -169.39 1.54 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.006 -0.543 . . . . 0.41999999999999998 110.888 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.716 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 m -151.69 125.89 9.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.4 -0.818 . . . . 0.39000000000000001 109.882 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.51 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.9 mt -114.88 123.23 70.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.409 -0.516 . . . . 0.73999999999999999 111.117 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.576 ' HG2' ' N ' ' A' ' 62' ' ' GLY . 37.8 ttpt -126.42 163.38 23.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.824 -0.625 . . . . 2.48 110.49 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.576 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.07 19.04 59.86 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.795 -0.922 . . . . 0.5 110.795 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.627 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.8 mt -79.06 157.17 28.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.043 0.449 . . . . 0.57999999999999996 111.345 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.844 ' O ' HG12 ' A' ' 67' ' ' VAL . 1.5 tttp -99.44 133.93 21.58 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.569 -0.741 . . . . 2.79 110.451 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.491 ' HD3' ' CD1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.84 143.61 61.76 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.505 2.137 . . . . 0.87 112.01 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.75 25.67 75.28 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.071 -0.812 . . . . 0.64000000000000001 111.071 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.3 p -128.07 158.74 39.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.715 0.293 . . . . 0.82999999999999996 110.484 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.11 139.92 42.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.88 0.371 . . . . 0.5 110.581 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.651 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.9 m-85 -122.6 136.51 54.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.974 -0.557 . . . . 0.53000000000000003 110.764 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.91 131.05 45.28 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.485 -0.932 . . . . 1.8700000000000001 108.485 177.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.52 153.93 16.65 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.251 -0.976 . . . . 0.28999999999999998 111.927 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.05 140.89 45.93 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.68 -0.489 . . . . 1.4299999999999999 109.68 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.78 118.88 34.25 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.508 -0.477 . . . . 0.32000000000000001 110.468 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.736 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.43 129.05 68.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 0.79000000000000004 110.578 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.699 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.84 120.86 43.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.213 -0.449 . . . . 1.02 110.75 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.859 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.63 146.46 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.175 0.512 . . . . 0.62 111.032 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.814 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.0 mt-30 -105.97 153.85 21.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.565 -0.743 . . . . 2.4399999999999999 110.001 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.2 mt-30 -39.21 88.58 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.92 0.391 . . . . 3.6899999999999999 110.442 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.23 32.72 0.21 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.77 -0.65 . . . . 6.0800000000000001 110.558 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.34 3.29 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.499 -0.64 . . . . 1.22 111.499 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.471 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.4 177.4 9.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.244 0.545 . . . . 2.8799999999999999 111.596 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.15 149.55 32.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.407 -0.815 . . . . 1.47 110.495 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.14 144.65 38.72 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.489 -0.323 . . . . 2.7000000000000002 110.596 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.736 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.0 135.94 61.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 121.052 0.453 . . . . 0.46000000000000002 111.573 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.562 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -123.99 141.35 52.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.688 -0.687 . . . . 0.34999999999999998 110.306 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.477 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.6 138.81 51.69 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.113 0.482 . . . . 3.6699999999999999 111.528 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.19 164.18 37.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.568 -0.742 . . . . 0.67000000000000004 109.514 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.561 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.29 151.54 38.51 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.351 -0.54 . . . . 1.47 111.008 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.807 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.16 172.71 13.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.747 -0.66 . . . . 0.44 111.015 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.68 160.73 21.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.414 -0.812 . . . . 1.3700000000000001 109.915 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.44 121.86 22.86 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.548 -0.461 . . . . 1.28 110.8 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.4 p -128.55 165.39 20.83 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.458 0.91 . . . . 1.97 113.458 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 94' ' ' THR . 76.2 p -127.99 -118.59 0.25 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 113.894 -1.503 . . . . 3.2799999999999998 107.552 177.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.505 ' N ' ' OG ' ' A' ' 93' ' ' SER . 22.7 p -121.96 158.99 27.86 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.439 ' O ' ' OG1' ' A' ' 96' ' ' THR . 84.0 p -147.86 156.99 43.3 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 119.862 -0.735 . . . . 0.0 112.506 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 95' ' ' SER . 21.0 m -172.04 62.62 0.33 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.829 178.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 96' ' ' THR . 38.7 Cg_exo -58.87 134.7 61.95 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.321 2.014 . . . . 0.0 113.515 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.81 157.3 42.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.458 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.8 m -81.87 132.66 35.28 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.239 -0.585 . . . . 0.0 109.831 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.8 m -71.96 151.25 43.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.055 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -89.6 4.51 49.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.116 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.2 t -136.65 161.85 34.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.929 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 p -128.82 142.82 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.269 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.6 m -78.94 139.08 38.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.855 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -160.29 -176.56 32.52 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -58.7 143.65 46.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.794 0.331 . . . . 0.0 110.673 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.5 p -82.82 162.39 21.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.543 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.9 p -66.14 145.21 98.99 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.375 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.86 145.2 97.63 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.307 2.005 . . . . 0.0 112.52 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -97.76 5.06 49.67 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.593 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.59 160.94 16.1 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.958 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.14 -13.99 5.66 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 122.939 2.426 . . . . 0.0 112.117 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.0 mt -76.98 147.77 36.67 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.352 -0.61 . . . . 10.19 109.352 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.631 ' O ' ' HB2' ' A' ' 115' ' ' ALA . 26.5 m -58.63 132.59 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.706 -0.398 . . . . 7.2800000000000002 111.011 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 114' ' ' VAL . . . 149.24 -0.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.312 -0.858 . . . . 7.2999999999999998 109.25 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.679 HG22 ' H ' ' A' ' 118' ' ' GLU . 38.7 m -79.78 137.64 37.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.864 -0.607 . . . . 6.4400000000000004 110.657 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 118' ' ' GLU . 87.0 p -62.04 -27.02 68.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 4.4199999999999999 110.782 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.679 ' H ' HG22 ' A' ' 116' ' ' THR . 84.3 tt0 56.45 125.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 3.0499999999999998 110.688 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 57.1 p -71.56 160.46 32.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.093 -0.503 . . . . 3.4300000000000002 110.741 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.532 HG22 ' H ' ' A' ' 122' ' ' GLU . 11.7 p -132.74 145.19 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.989 -0.551 . . . . 2.8799999999999999 110.157 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 62.1 p -65.77 -10.35 36.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.31 -0.405 . . . . 2.0899999999999999 111.812 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.532 ' H ' HG22 ' A' ' 120' ' ' VAL . 95.3 mt-10 -98.5 159.08 15.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.724 0.297 . . . . 4.5300000000000002 110.243 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.8 pt -118.65 156.13 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.144 0.497 . . . . 1.4399999999999999 111.262 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 8.4 t -123.97 33.16 5.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.381 -0.827 . . . . 1.78 110.709 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 127' ' ' SER . . . -59.91 -30.87 69.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 0.64000000000000001 111.756 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.481 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.3 OUTLIER 44.46 17.6 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.976 0.893 . . . . 0.66000000000000003 110.399 -179.257 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.9 167.54 0.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.875 -1.057 . . . . 0.68999999999999995 110.868 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.5 145.52 50.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.664 -0.698 . . . . 0.52000000000000002 110.16 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.23 101.64 9.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.104 -0.702 . . . . 0.32000000000000001 109.104 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.0 t -113.02 139.68 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.078 -0.51 . . . . 0.28999999999999998 111.033 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.6 p -128.7 152.49 48.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.6 -0.727 . . . . 0.25 109.827 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.59 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.5 p90 -144.72 -164.92 2.02 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.759 -0.376 . . . . 0.31 110.668 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.3 t -123.94 127.21 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.48999999999999999 110.812 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.174 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -58.03 58.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 1.53 110.313 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.743 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.1 24.48 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.881 -0.6 . . . . 0.96999999999999997 111.52 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.174 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.23 128.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.633 -0.427 . . . . 1.5600000000000001 110.994 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.46 -9.58 55.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.009 -0.542 . . . . 1.8799999999999999 110.38 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.4 p -87.16 0.4 55.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.043 -0.526 . . . . 1.04 110.307 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.31 137.22 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 116.018 -0.537 . . . . 0.23999999999999999 109.939 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 185' ' ' ILE . 60.9 m -96.33 -15.45 21.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.276 0.56 . . . . 0.28999999999999998 110.003 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.57 175.57 45.76 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 109.876 -1.289 . . . . 0.13 109.876 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.39 151.63 42.38 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.716 -0.394 . . . . 0.17000000000000001 110.541 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.695 ' NH1' ' OE1' ' A' ' 191' ' ' GLN . 20.6 ttm180 -132.43 121.12 22.91 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.18 -0.464 . . . . 1.29 109.955 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.555 HG21 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.11 136.56 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.652 -0.704 . . . . 0.25 110.635 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 84.7 tt0 -129.37 129.97 45.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.951 -0.568 . . . . 1.3200000000000001 109.992 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.624 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.79 135.21 34.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.983 -0.553 . . . . 0.56999999999999995 110.616 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.418 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.32 39.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.775 -0.648 . . . . 1.1599999999999999 109.668 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.972 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.4 mt -70.98 124.84 25.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.077 0.465 . . . . 0.38 110.738 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.0 p -71.6 -7.88 50.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.735 -0.666 . . . . 0.40999999999999998 110.879 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.79 -69.59 0.85 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.316 -0.402 . . . . 1.6599999999999999 111.473 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.478 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.61 -35.45 76.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.16 -0.473 . . . . 1.6599999999999999 111.477 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.085 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.21 88.61 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.783 -0.927 . . . . 1.1699999999999999 110.783 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.328 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.9 t0 -27.9 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.675 0.274 . . . . 1.8600000000000001 110.351 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.328 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.2 pm0 -82.2 139.02 45.31 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.925 0.393 . . . . 1.98 110.25 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.418 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.9 Cg_endo -70.9 145.8 51.47 Favored 'Trans proline' 0 C--N 1.302 -1.91 0 C-N-CA 122.671 2.247 . . . . 0.55000000000000004 112.392 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.77 145.82 42.47 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.237 -0.653 . . . . 1.1399999999999999 109.237 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.491 ' CD1' ' HD3' ' A' ' 65' ' ' PRO . 6.1 p90 -123.39 141.32 52.11 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.385 -0.526 . . . . 0.93000000000000005 111.486 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.0 mt -128.17 127.69 43.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.247 -0.888 . . . . 0.34000000000000002 108.922 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 68.3 t0 -101.7 131.21 48.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.184 0.516 . . . . 1.0900000000000001 111.683 -178.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.479 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -127.93 157.48 73.66 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.276 -0.875 . . . . 0.19 109.614 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -69.74 158.03 58.4 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.37 2.047 . . . . 0.17999999999999999 112.304 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.28 -12.2 5.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.825 -0.625 . . . . 0.20999999999999999 110.677 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.3 p -92.73 -8.83 42.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.28999999999999998 110.749 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.47 34.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.5 110.407 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.8 p -133.15 16.52 4.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.38 . . . . 0.29999999999999999 110.579 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.5 p -167.53 147.17 5.1 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.626 -0.509 . . . . 0.23000000000000001 109.626 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.555 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.2 150.44 12.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.518 -0.473 . . . . 0.28000000000000003 111.54 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.506 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.31 125.01 50.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.634 -0.712 . . . . 1.0700000000000001 109.789 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.51 104.88 30.09 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.911 0.386 . . . . 0.28999999999999998 111.054 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.4 Cg_endo -90.93 -179.53 1.52 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 C-N-CA 123.2 2.6 . . . . 0.42999999999999999 112.24 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.74 32.58 18.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.415 -0.812 . . . . 1.26 111.394 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.481 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.2 mt -86.27 148.56 25.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.528 -0.305 . . . . 0.32000000000000001 110.586 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.76 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.33 114.8 61.1 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.007 0.432 . . . . 0.57999999999999996 110.707 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.0 140.62 96.17 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.878 2.385 . . . . 0.66000000000000003 112.009 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.03 21.27 74.31 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.021 -0.831 . . . . 0.28999999999999998 111.021 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.478 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.86 150.13 49.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.759 0.314 . . . . 2.3300000000000001 110.685 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.17 131.61 46.02 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.052 -0.522 . . . . 0.85999999999999999 109.825 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.972 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.1 m-85 -120.48 148.27 44.04 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.161 -0.472 . . . . 0.52000000000000002 111.018 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.28 125.37 60.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.279 -1.008 . . . . 0.29999999999999999 108.279 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.52 132.5 63.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.138 0.494 . . . . 0.23000000000000001 111.202 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.5 122.54 20.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.585 -0.734 . . . . 0.35999999999999999 109.673 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.59 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -100.95 125.46 54.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.296 -0.411 . . . . 0.19 110.609 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.0 m-85 -117.31 137.93 52.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.043 -0.526 . . . . 0.29999999999999999 109.823 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.577 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.73 135.0 42.86 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.774 -0.824 . . . . 0.37 108.774 178.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.554 ' O ' ' N ' ' A' ' 140' ' ' SER . 89.1 mt -99.04 122.96 51.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.102 0.477 . . . . 0.26000000000000001 110.988 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.0 p -83.85 169.65 14.91 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.538 -0.756 . . . . 0.28000000000000003 110.444 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -59.72 -14.6 14.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.012 -0.54 . . . . 1.6000000000000001 110.937 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.477 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.0 m-20 -95.97 -4.37 43.4 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.83 -0.348 . . . . 1.1799999999999999 110.834 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.85 13.95 63.79 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.347 -0.701 . . . . 0.29999999999999999 111.347 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -84.71 138.97 32.33 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.999 -0.281 . . . . 1.22 110.481 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.695 ' OE1' ' NH1' ' A' ' 143' ' ' ARG . 14.9 pt20 -106.6 141.08 38.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.97999999999999998 110.553 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.0 m -136.64 127.1 26.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.82999999999999996 110.409 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.29 117.36 9.99 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.683 -0.407 . . . . 0.26000000000000001 110.481 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.03 -21.84 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.29999999999999999 110.677 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.89 125.75 5.88 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.565 -0.454 . . . . 0.31 111.452 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.473 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.74 120.26 21.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.683 -0.69 . . . . 0.28000000000000003 109.505 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.61 151.73 29.17 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.653 -0.419 . . . . 0.23999999999999999 110.938 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.46 158.67 18.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.055 -0.521 . . . . 0.23000000000000001 110.404 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.4 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 21.5 mt-30 -146.14 157.89 43.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.174 -0.466 . . . . 0.67000000000000004 110.67 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.25 104.41 9.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.734 -0.666 . . . . 0.64000000000000001 110.1 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.9 p . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.853 -1.07 . . . . 1.26 110.667 -179.675 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.2 m . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.191 -0.67 . . . . 3.4399999999999999 109.191 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.34 150.65 18.55 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.057 -0.817 . . . . 1.22 111.057 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -35.67 142.41 0.1 Allowed 'Trans proline' 0 C--N 1.297 -2.166 0 C-N-CA 124.115 3.21 . . . . 0.75 113.718 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.605 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.4 t -80.07 173.53 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.205 -1.361 . . . . 0.79000000000000004 108.742 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.605 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.68 125.81 51.42 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.41 -0.516 . . . . 1.9399999999999999 111.522 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.44 143.97 34.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.684 -0.689 . . . . 0.59999999999999998 110.699 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.98 168.25 25.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.971 0.415 . . . . 3.1400000000000001 111.097 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.746 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.0 mt -108.94 131.05 60.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.935 -0.575 . . . . 3.23 110.118 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.21 162.34 35.72 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.468 -0.333 . . . . 3.6299999999999999 111.257 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 72.7 tt0 36.14 31.47 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 109.653 -0.499 . . . . 6.0800000000000001 109.653 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.746 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.35 69.54 31.59 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.935 -0.575 . . . . 3.3799999999999999 111.582 -178.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.632 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.22 -29.2 73.35 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.592 2.195 . . . . 3.9300000000000002 111.814 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.668 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 3.2 m 149.63 125.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 3.3599999999999999 110.413 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.668 ' NE2' ' O ' ' A' ' 13' ' ' SER . 1.8 mp0 -123.95 158.35 60.46 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.265 -0.425 . . . . 3.6099999999999999 110.481 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.646 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 98.3 Cg_endo -82.14 -64.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.83 2.353 . . . . 1.51 113.498 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.642 ' OD1' ' N ' ' A' ' 17' ' ' SER . 23.5 p-10 -108.44 -19.61 13.4 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.027 0.38 . . . . 2.6800000000000002 112.027 -178.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.642 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 93.6 p -107.4 151.93 24.86 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.469 -0.492 . . . . 1.21 111.297 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.576 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.11 102.98 2.26 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.684 -0.689 . . . . 1.5600000000000001 110.671 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.476 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.7 Cg_endo -82.72 145.72 12.99 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.872 2.381 . . . . 0.81000000000000005 112.556 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.909 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.84 167.97 24.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.849 -0.614 . . . . 1.52 109.879 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.15 147.94 29.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.795 -0.446 . . . . 2.1400000000000001 109.795 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.585 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.7 p90 -142.26 157.31 44.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.038 0.447 . . . . 0.32000000000000001 111.248 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.494 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.04 155.33 44.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.813 -0.631 . . . . 2.1699999999999999 110.09 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.831 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.6 173.19 6.18 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.085 -0.507 . . . . 0.58999999999999997 110.779 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.831 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.72 173.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.844 2.363 . . . . 0.90000000000000002 111.51 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.479 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -51.03 0.69 Allowed Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.723 -0.391 . . . . 3.3399999999999999 110.141 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.634 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.8 152.31 82.57 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.765 2.31 . . . . 1.8500000000000001 111.449 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.68 42.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.428 0.632 . . . . 2.54 110.631 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.821 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.56 -41.63 98.4 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.931 -1.031 . . . . 2.5299999999999998 110.676 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.533 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.2 mt -109.86 137.91 39.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.763 -0.653 . . . . 1.1699999999999999 111.234 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.01 -72.9 0.7 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.987 -0.551 . . . . 1.27 111.843 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.21 148.4 24.39 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.547 0.573 . . . . 1.1200000000000001 112.547 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.76 124.82 45.12 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.458 -0.571 . . . . 0.41999999999999998 109.458 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.7 mt -118.07 134.72 60.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.665 -0.414 . . . . 0.78000000000000003 110.632 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.909 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.99 128.64 53.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.062 0.458 . . . . 0.62 111.277 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.12 138.98 49.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.73 -0.668 . . . . 1.97 110.145 178.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.437 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.05 163.14 35.16 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.178 0.513 . . . . 0.34999999999999998 112.055 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.45 139.53 7.86 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.377 -0.829 . . . . 1.8 110.451 178.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.49 115.45 3.04 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.285 1.99 . . . . 0.57999999999999996 111.796 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.667 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.91 81.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.933 -0.395 . . . . 3.04 109.933 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.688 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.24 -20.58 0.06 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.059 -0.519 . . . . 2.4700000000000002 111.971 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.9 p -157.67 157.79 34.22 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.836 -0.345 . . . . 2.5099999999999998 110.604 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.404 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.41 27.77 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 1.8600000000000001 110.195 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.86 -75.84 1.31 Allowed Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.022 -0.609 . . . . 1.4399999999999999 111.805 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.86 152.4 35.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.946 0.403 . . . . 4.6900000000000004 110.954 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.28 -169.18 2.54 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.0 -0.546 . . . . 1.4299999999999999 111.972 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.74 29.63 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.379 0.609 . . . . 1.74 112.611 -177.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.03 156.46 46.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.768 -1.105 . . . . 1.9199999999999999 110.291 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.18 158.36 41.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.004 -0.544 . . . . 0.34000000000000002 111.83 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 m -115.16 135.59 54.02 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.433 -0.803 . . . . 0.40999999999999998 109.893 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.585 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.3 121.94 23.89 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.509 -0.314 . . . . 0.55000000000000004 111.545 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.602 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.7 Cg_exo -46.28 151.74 1.59 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.744 2.296 . . . . 0.44 112.084 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.0 -23.03 63.27 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 116.045 -0.525 . . . . 0.73999999999999999 112.779 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.547 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.75 -16.88 46.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.384 0.592 . . . . 0.93000000000000005 111.81 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.602 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.6 mt -91.6 138.43 31.57 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.768 -0.373 . . . . 0.96999999999999997 110.254 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.54 14.0 11.0 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.302 -0.408 . . . . 1.3400000000000001 111.458 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.476 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.0 p -149.99 143.46 25.21 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.684 -0.406 . . . . 0.39000000000000001 111.081 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.722 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.82 -169.39 1.54 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.22 0.533 . . . . 0.41999999999999998 110.83 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.722 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.8 m -151.75 125.94 9.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.406 -0.815 . . . . 0.39000000000000001 109.832 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 67.0 mt -114.93 123.34 70.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.36 -0.536 . . . . 0.73999999999999999 111.134 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.747 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 16.6 ptpt -126.55 163.4 23.47 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.742 -0.663 . . . . 2.48 110.388 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.02 19.22 59.64 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.721 -0.951 . . . . 0.5 110.721 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.514 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.2 mt -79.16 157.23 27.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.127 0.489 . . . . 0.57999999999999996 111.306 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.85 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -99.47 133.98 21.52 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.588 -0.733 . . . . 2.79 110.486 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.458 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.88 143.62 61.6 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.554 2.169 . . . . 0.87 111.915 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.82 25.55 75.43 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.084 -0.806 . . . . 0.64000000000000001 111.084 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.85 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.3 p -128.09 158.75 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.691 0.281 . . . . 0.82999999999999996 110.51 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.06 139.99 41.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.908 0.385 . . . . 0.5 110.591 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.657 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.4 m-85 -122.62 136.43 54.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.948 -0.569 . . . . 0.53000000000000003 110.801 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.91 131.07 45.27 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.479 -0.934 . . . . 1.8700000000000001 108.479 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.57 153.89 16.67 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.281 -0.961 . . . . 0.28999999999999998 111.974 -178.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.01 140.9 46.02 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.628 -0.508 . . . . 1.4299999999999999 109.628 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.525 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.74 118.92 34.39 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.447 -0.501 . . . . 0.32000000000000001 110.551 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.738 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.42 129.1 68.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.378 -0.373 . . . . 0.79000000000000004 110.635 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.84 120.9 43.93 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.326 -0.397 . . . . 1.02 110.683 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.86 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.64 146.45 11.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.143 0.497 . . . . 0.62 111.099 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.821 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.5 mt-30 -106.0 153.92 21.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.58 -0.736 . . . . 2.4399999999999999 109.91 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.24 88.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.93 0.395 . . . . 3.6899999999999999 110.441 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.33 32.58 0.22 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.8 -0.636 . . . . 6.0800000000000001 110.543 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.03 -117.4 3.3 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.436 -0.666 . . . . 1.22 111.436 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.464 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.32 177.36 9.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.134 0.492 . . . . 2.8799999999999999 111.697 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.19 149.49 32.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.44 -0.8 . . . . 1.47 110.422 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.11 144.65 38.78 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.438 -0.346 . . . . 2.7000000000000002 110.624 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.738 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -127.97 136.02 61.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.135 0.493 . . . . 0.46000000000000002 111.527 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.09 141.37 52.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.681 -0.691 . . . . 0.34999999999999998 110.299 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.47 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.62 138.89 51.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.074 0.464 . . . . 3.6699999999999999 111.446 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.489 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.33 164.1 38.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.575 -0.739 . . . . 0.67000000000000004 109.485 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.577 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.28 151.51 38.47 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.393 -0.523 . . . . 1.47 111.048 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.804 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.2 p90 -146.21 172.79 12.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 0.44 110.972 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.82 160.72 21.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.345 -0.843 . . . . 1.3700000000000001 109.804 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.4 121.94 23.01 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.582 -0.447 . . . . 1.28 110.745 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.547 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -126.63 158.61 35.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.385 0.612 . . . . 1.97 112.279 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.739 ' O ' HG23 ' A' ' 94' ' ' THR . 22.6 t -59.33 -36.1 75.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.29 -0.868 . . . . 3.2799999999999998 111.185 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.739 HG23 ' O ' ' A' ' 93' ' ' SER . 9.8 p 131.7 37.92 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.381 1.051 . . . . 0.0 109.6 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.2 m -61.24 150.85 33.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.944 0.402 . . . . 0.0 110.63 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 44.8 p -128.96 76.47 79.17 Favored Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.719 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.93 141.76 96.2 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.631 1.554 . . . . 0.0 111.299 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.4 m -112.68 8.99 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.441 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.3 p -123.41 158.74 30.47 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.876 0.37 . . . . 0.0 110.891 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.0 m -85.31 5.2 31.56 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.443 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -100.29 145.04 28.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.937 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 50.2 m -75.13 139.05 42.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.221 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.0 m -64.48 134.47 29.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.4 t -108.4 5.65 25.59 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.224 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -167.35 -171.44 33.38 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -56.64 143.67 35.13 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.194 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.4 p -81.6 159.9 23.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.909 0.385 . . . . 0.0 110.909 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.95 77.85 75.97 Favored Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.398 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -55.21 142.33 78.63 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.097 1.865 . . . . 0.0 111.505 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.449 ' O ' ' CB ' ' A' ' 111' ' ' SER . 68.7 t80 -102.78 127.8 49.78 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.903 0.382 . . . . 0.0 110.799 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.458 ' CB ' ' CD ' ' A' ' 112' ' ' PRO . 0.5 OUTLIER 162.82 -66.22 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.474 179.255 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.458 ' CD ' ' CB ' ' A' ' 111' ' ' SER . 24.9 Cg_endo -60.21 148.53 89.47 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.583 2.189 . . . . 0.0 112.598 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 150' ' ' GLU . 53.1 mt -89.46 146.04 24.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.116 -0.698 . . . . 10.19 109.116 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.6 p -128.28 142.31 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 121.374 0.607 . . . . 7.2800000000000002 111.258 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -145.43 161.49 39.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.069 -0.969 . . . . 7.2999999999999998 109.635 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.7 p -74.84 158.03 34.1 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.729 -0.388 . . . . 6.4400000000000004 110.123 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.6 t -138.76 147.49 42.69 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.298 -0.41 . . . . 4.4199999999999999 111.449 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -61.96 -30.23 70.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.867 -0.606 . . . . 3.0499999999999998 110.082 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.7 m 65.51 99.5 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.544 -0.753 . . . . 3.4300000000000002 111.074 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.8 t -119.76 141.39 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.205 -0.907 . . . . 2.8799999999999999 109.545 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 25.3 p -73.98 159.98 31.97 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.575 -0.45 . . . . 2.0899999999999999 110.033 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.58 140.53 54.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.113 0.482 . . . . 4.5300000000000002 112.131 -178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.414 ' H ' ' HG2' ' A' ' 174' ' ' PRO . 15.5 tt -126.51 138.71 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.423 -0.808 . . . . 1.4399999999999999 109.479 178.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 38.4 m 41.56 -99.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.597 -0.274 . . . . 1.78 110.741 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -150.52 146.84 26.84 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.603 -0.439 . . . . 0.64000000000000001 111.251 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.634 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 4.5 p -133.48 11.46 4.11 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.473 0.654 . . . . 0.66000000000000003 110.167 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.438 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.9 167.55 0.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.297 -0.865 . . . . 0.68999999999999995 110.932 -179.636 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.54 145.56 50.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.707 -0.679 . . . . 0.52000000000000002 110.112 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.24 101.69 9.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.08 -0.711 . . . . 0.32000000000000001 109.08 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.3 t -113.0 139.62 37.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.108 -0.497 . . . . 0.28999999999999998 111.063 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.9 p -128.7 152.59 48.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.651 -0.704 . . . . 0.25 109.877 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.59 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.84 -164.96 2.04 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.63 -0.428 . . . . 0.31 110.621 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.9 t -123.97 127.23 73.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.48999999999999999 110.819 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.172 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.92 58.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.49 . . . . 1.53 110.37 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.17 24.62 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.925 -0.58 . . . . 0.96999999999999997 111.538 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.172 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.1 128.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.61 -0.436 . . . . 1.5600000000000001 110.932 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -86.38 -9.68 55.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.895 -0.593 . . . . 1.8799999999999999 110.332 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.07 0.21 55.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.115 -0.493 . . . . 1.04 110.304 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.26 137.16 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 0.23999999999999999 109.952 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.747 ' O ' ' NZ ' ' A' ' 61' ' ' LYS . 69.3 m -96.19 -15.56 21.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.242 0.544 . . . . 0.28999999999999998 110.019 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.61 175.56 45.78 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 109.915 -1.274 . . . . 0.13 109.915 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.44 151.66 42.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.027 0.442 . . . . 0.17000000000000001 110.465 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.764 ' NH2' ' OE2' ' A' ' 145' ' ' GLU . 31.6 ttt85 -132.43 121.23 23.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.058 -0.519 . . . . 1.29 109.887 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.11 136.47 38.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.697 -0.683 . . . . 0.25 110.655 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.764 ' OE2' ' NH2' ' A' ' 143' ' ' ARG . 97.6 mt-10 -129.37 129.86 45.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.097 -0.501 . . . . 1.3200000000000001 109.991 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.618 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.7 135.4 34.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.954 -0.566 . . . . 0.56999999999999995 110.614 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.417 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.44 161.27 40.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.78 -0.646 . . . . 1.1599999999999999 109.702 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.4 mt -71.0 124.81 25.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.029 0.442 . . . . 0.38 110.736 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.66 -7.82 50.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.726 -0.67 . . . . 0.40999999999999998 110.872 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.4 ' O ' ' O ' ' A' ' 113' ' ' LEU . 81.1 mt-10 -109.75 -69.6 0.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 1.6599999999999999 111.484 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.441 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.64 -35.39 76.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.053 -0.521 . . . . 1.6599999999999999 111.557 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.086 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.26 88.57 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.807 -0.917 . . . . 1.1699999999999999 110.807 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.337 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.89 -171.8 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 1.8600000000000001 110.278 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.337 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.09 45.2 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.021 0.439 . . . . 1.98 110.236 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.417 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.3 Cg_endo -70.96 145.86 51.26 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 C-N-CA 122.7 2.267 . . . . 0.55000000000000004 112.35 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.83 145.78 42.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.202 -0.666 . . . . 1.1399999999999999 109.202 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.521 ' CB ' ' NH1' ' A' ' 143' ' ' ARG . 35.9 p90 -123.33 141.31 52.11 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.303 -0.559 . . . . 0.93000000000000005 111.484 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.0 mt -128.1 127.7 43.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.317 -0.856 . . . . 0.34000000000000002 108.94 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.527 ' O ' ' OD1' ' A' ' 159' ' ' ASP . 54.7 p-10 -101.65 131.2 48.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.206 0.526 . . . . 1.0900000000000001 111.794 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.96 157.55 73.48 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.286 -0.87 . . . . 0.19 109.533 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.91 157.95 58.4 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 122.369 2.046 . . . . 0.17999999999999999 112.261 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.24 -12.04 4.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.832 -0.622 . . . . 0.20999999999999999 110.761 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.8 p -92.92 -8.74 42.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.207 -0.451 . . . . 0.28999999999999998 110.642 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.25 135.47 34.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.349 -0.387 . . . . 0.5 110.353 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.8 p -133.21 16.79 4.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 0.29999999999999999 110.52 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.0 p -167.6 147.11 5.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.633 -0.506 . . . . 0.23000000000000001 109.633 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.12 150.46 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.516 -0.473 . . . . 0.28000000000000003 111.521 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.509 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 124.88 50.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.659 -0.7 . . . . 1.0700000000000001 109.849 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.31 104.91 29.58 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.377 -0.374 . . . . 0.28999999999999998 111.143 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.2 Cg_endo -91.0 -179.49 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.926 0 C-N-CA 123.135 2.557 . . . . 0.42999999999999999 112.218 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.69 32.59 18.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.31 -0.859 . . . . 1.26 111.465 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.634 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.1 mt -86.33 148.56 25.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.812 0.339 . . . . 0.32000000000000001 110.404 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.769 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.32 114.82 61.21 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.093 0.473 . . . . 0.57999999999999996 110.665 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.414 ' HG2' ' H ' ' A' ' 123' ' ' ILE . 21.9 Cg_exo -58.96 140.61 96.07 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.916 2.41 . . . . 0.66000000000000003 111.935 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.11 21.06 74.57 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.132 -0.787 . . . . 0.28999999999999998 111.132 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.441 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.76 150.16 49.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.746 0.308 . . . . 2.3300000000000001 110.668 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.495 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.21 131.61 46.06 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.105 -0.498 . . . . 0.85999999999999999 109.767 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.955 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.48 148.26 44.06 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.039 -0.528 . . . . 0.52000000000000002 110.948 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.6 mt -105.33 125.43 60.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.308 -0.997 . . . . 0.29999999999999999 108.308 177.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.64 132.5 63.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.199 0.523 . . . . 0.23000000000000001 111.174 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.64 20.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.549 -0.75 . . . . 0.35999999999999999 109.617 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.59 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.16 125.44 55.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.175 -0.466 . . . . 0.19 110.65 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 47.9 m-85 -117.17 137.86 52.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.99 -0.55 . . . . 0.29999999999999999 109.883 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.581 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.68 135.05 42.74 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.76 -0.83 . . . . 0.37 108.76 178.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.598 ' O ' ' N ' ' A' ' 140' ' ' SER . 79.6 mt -99.06 123.0 51.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.151 0.501 . . . . 0.26000000000000001 110.964 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.2 p -83.91 169.66 14.83 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.531 -0.759 . . . . 0.28000000000000003 110.443 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.523 ' O ' ' OG1' ' A' ' 59' ' ' THR . 97.0 mt-10 -59.67 -14.53 14.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.031 -0.531 . . . . 1.6000000000000001 111.069 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.3 m-20 -96.15 -4.26 42.99 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.855 -0.338 . . . . 1.1799999999999999 110.825 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.81 13.93 63.9 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.301 -0.72 . . . . 0.29999999999999999 111.301 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -84.65 139.12 32.27 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.994 -0.282 . . . . 1.22 110.476 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -106.71 141.06 38.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.897 0.38 . . . . 0.97999999999999998 110.527 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.72 126.97 26.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.82999999999999996 110.408 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.406 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.1 117.31 9.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.247 -0.433 . . . . 0.26000000000000001 110.532 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.0 -21.9 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.29999999999999999 110.699 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.85 125.86 5.95 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.52 -0.472 . . . . 0.31 111.51 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.469 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.93 120.22 21.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.741 -0.663 . . . . 0.28000000000000003 109.501 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.59 151.66 29.1 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.621 -0.432 . . . . 0.23999999999999999 110.941 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.41 158.5 18.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.518 . . . . 0.23000000000000001 110.45 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.03 157.95 43.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.135 -0.484 . . . . 0.67000000000000004 110.671 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 104.3 9.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.711 -0.677 . . . . 0.64000000000000001 110.056 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.981 -1.009 . . . . 1.26 110.637 -179.691 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.157 -0.683 . . . . 3.4399999999999999 109.157 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.31 150.62 18.56 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.078 -0.809 . . . . 1.22 111.078 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -35.61 142.36 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 123.944 3.096 . . . . 0.75 113.835 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.621 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -79.89 173.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.275 -1.329 . . . . 0.79000000000000004 108.898 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.621 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.59 125.9 51.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.164 0.507 . . . . 1.9399999999999999 111.464 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 p -136.55 144.06 33.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.625 -0.716 . . . . 0.59999999999999998 110.602 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.07 168.27 25.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.908 0.385 . . . . 3.1400000000000001 111.112 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.737 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -108.99 131.2 60.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.947 -0.569 . . . . 3.23 110.04 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 69.3 p -141.25 162.31 35.79 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.368 -0.378 . . . . 3.6299999999999999 111.162 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 9' ' ' THR . 29.9 tt0 36.12 31.56 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 109.659 -0.497 . . . . 6.0800000000000001 109.659 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.737 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.48 69.56 32.91 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.881 -0.599 . . . . 3.3799999999999999 111.489 -178.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.2 -29.2 73.56 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.618 2.212 . . . . 3.9300000000000002 111.808 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.645 ' H ' HE22 ' A' ' 14' ' ' GLN . 3.2 m 149.6 125.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.14 -0.482 . . . . 3.3599999999999999 110.528 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.645 HE22 ' H ' ' A' ' 13' ' ' SER . 2.0 mp0 -124.0 158.31 60.74 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.348 -0.387 . . . . 3.6099999999999999 110.408 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.528 ' HG2' ' CD ' ' A' ' 143' ' ' ARG . 97.3 Cg_endo -81.98 -64.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.812 2.342 . . . . 1.51 113.58 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.442 ' H ' ' HG2' ' A' ' 15' ' ' PRO . 99.4 m-20 -108.51 -19.51 13.42 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.072 0.397 . . . . 2.6800000000000002 112.072 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.649 ' OG ' HD13 ' A' ' 185' ' ' ILE . 2.6 m -107.38 152.0 24.75 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.13 0.491 . . . . 1.21 111.265 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.4 t-80 -155.25 102.98 2.23 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.691 -0.686 . . . . 1.5600000000000001 110.677 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -82.69 145.61 12.99 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.936 2.424 . . . . 0.81000000000000005 112.601 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.91 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.8 167.91 24.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.932 -0.576 . . . . 1.52 109.883 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.09 147.97 29.12 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.795 -0.446 . . . . 2.1400000000000001 109.795 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.4 p90 -142.32 157.31 44.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.047 0.451 . . . . 0.32000000000000001 111.112 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.494 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -128.07 155.31 44.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.789 -0.641 . . . . 2.1699999999999999 110.127 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.827 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.59 172.93 6.51 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.17 -0.468 . . . . 0.58999999999999997 110.815 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.827 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.52 173.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 122.869 2.379 . . . . 0.90000000000000002 111.573 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.12 -51.03 0.68 Allowed Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 120.68 -0.408 . . . . 3.3399999999999999 110.126 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.621 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.79 152.39 82.27 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.744 2.296 . . . . 1.8500000000000001 111.49 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.67 42.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.379 0.609 . . . . 2.54 110.552 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.816 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.56 -41.58 98.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.011 -0.995 . . . . 2.5299999999999998 110.707 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.53 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.4 mt -109.93 137.79 40.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.765 -0.652 . . . . 1.1699999999999999 111.255 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.92 -72.9 0.7 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.096 -0.502 . . . . 1.27 111.902 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.24 148.44 24.35 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.597 0.592 . . . . 1.1200000000000001 112.597 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.84 124.93 45.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.328 -0.619 . . . . 0.41999999999999998 109.328 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.7 mt -118.16 134.74 60.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.635 -0.426 . . . . 0.78000000000000003 110.623 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.91 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.03 128.57 53.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.057 0.456 . . . . 0.62 111.216 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.12 139.04 49.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.708 -0.678 . . . . 1.97 110.069 178.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.433 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.14 163.14 35.25 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-O 121.215 0.531 . . . . 0.34999999999999998 112.017 -178.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.42 139.59 7.92 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 115.421 -0.809 . . . . 1.8 110.431 178.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.55 115.51 3.09 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.256 1.971 . . . . 0.57999999999999996 111.825 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.67 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.08 81.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.885 -0.413 . . . . 3.04 109.885 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.21 -20.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.985 -0.552 . . . . 2.4700000000000002 111.886 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 p -157.65 157.78 34.23 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.789 -0.364 . . . . 2.5099999999999998 110.548 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.3 m -120.39 27.84 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.239 -0.437 . . . . 1.8600000000000001 110.224 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.89 -75.83 1.31 Allowed Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.141 -0.552 . . . . 1.4399999999999999 111.832 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.91 152.39 35.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.398 . . . . 4.6900000000000004 111.015 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.63 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.23 -169.15 2.54 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.166 -0.47 . . . . 1.4299999999999999 111.943 179.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.11 149.71 29.65 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.485 0.66 . . . . 1.74 112.532 -177.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.12 156.5 45.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.756 -1.111 . . . . 1.9199999999999999 110.281 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.25 158.33 41.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.981 -0.554 . . . . 0.34000000000000002 111.783 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 m -115.23 135.68 53.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.545 -0.752 . . . . 0.40999999999999998 109.757 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.596 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.45 121.96 23.71 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.55000000000000004 111.512 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.5 Cg_exo -46.41 151.77 1.68 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.699 2.266 . . . . 0.44 112.135 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.01 -23.02 63.27 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 116.106 -0.497 . . . . 0.73999999999999999 112.735 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.1 p-80 -82.68 -16.97 46.16 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 117.379 0.59 . . . . 0.93000000000000005 111.811 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.605 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.2 mt -91.56 138.44 31.56 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.728 -0.389 . . . . 0.96999999999999997 110.278 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.57 13.98 10.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.39 -0.368 . . . . 1.3400000000000001 111.572 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.4 p -150.0 143.49 25.22 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.593 -0.443 . . . . 0.39000000000000001 111.071 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.84 -169.4 1.54 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.261 0.553 . . . . 0.41999999999999998 110.818 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.714 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.75 125.87 9.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.361 -0.836 . . . . 0.39000000000000001 109.792 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.51 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.81 123.25 70.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.401 -0.52 . . . . 0.73999999999999999 111.248 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.668 ' NZ ' ' OG ' ' A' ' 140' ' ' SER . 59.6 mttp -126.47 163.33 23.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.838 -0.619 . . . . 2.48 110.426 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.19 18.97 59.79 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.712 -0.955 . . . . 0.5 110.712 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.51 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.2 mt -79.05 157.29 28.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.116 0.484 . . . . 0.57999999999999996 111.319 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.858 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -99.48 134.04 21.47 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.604 -0.725 . . . . 2.79 110.384 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.99 143.62 60.99 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.551 2.167 . . . . 0.87 111.902 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.65 75.31 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.081 -0.808 . . . . 0.64000000000000001 111.081 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.858 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.21 158.79 40.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.743 0.306 . . . . 0.82999999999999996 110.44 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.16 139.96 41.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.974 0.416 . . . . 0.5 110.547 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.639 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.55 136.51 54.9 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.855 -0.611 . . . . 0.53000000000000003 110.75 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.98 131.09 45.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.538 -0.912 . . . . 1.8700000000000001 108.538 177.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.487 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.53 153.84 16.66 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.322 -0.942 . . . . 0.28999999999999998 112.006 -178.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.87 140.94 46.19 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.702 -0.481 . . . . 1.4299999999999999 109.702 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.83 118.88 34.23 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.496 -0.482 . . . . 0.32000000000000001 110.468 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.732 HG12 HG23 ' A' ' 84' ' ' VAL . 63.8 mt -112.36 129.04 68.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.293 -0.412 . . . . 0.79000000000000004 110.749 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.71 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.81 120.93 44.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.356 -0.383 . . . . 1.02 110.655 -179.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.854 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.62 146.42 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.115 0.483 . . . . 0.62 111.03 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.816 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.5 mt-30 -106.07 153.91 21.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.494 -0.776 . . . . 2.4399999999999999 109.843 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.14 88.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.958 0.409 . . . . 3.6899999999999999 110.479 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.32 32.52 0.21 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.847 -0.615 . . . . 6.0800000000000001 110.653 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.27 3.28 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.95 -0.643 . . . . 1.22 111.533 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.47 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.42 177.38 9.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.143 0.497 . . . . 2.8799999999999999 111.635 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.13 149.54 32.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.382 -0.827 . . . . 1.47 110.331 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.15 144.7 38.74 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.354 -0.385 . . . . 2.7000000000000002 110.6 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.732 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.0 136.0 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-O 121.047 0.451 . . . . 0.46000000000000002 111.587 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.599 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.07 141.39 52.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.66 -0.7 . . . . 0.34999999999999998 110.245 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.466 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.61 138.81 51.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.094 0.473 . . . . 3.6699999999999999 111.485 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.487 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.21 164.19 37.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.597 -0.729 . . . . 0.67000000000000004 109.51 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 46.9 p30 -145.21 151.56 38.59 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.441 -0.504 . . . . 1.47 111.071 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.81 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.8 p90 -146.28 172.68 13.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.729 -0.669 . . . . 0.44 110.994 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.73 160.68 21.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.443 -0.799 . . . . 1.3700000000000001 109.864 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.42 121.9 22.94 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.547 -0.461 . . . . 1.28 110.771 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.528 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.2 p -127.16 164.9 20.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 122.5 1.143 . . . . 1.97 114.033 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.522 ' OG ' ' CE2' ' A' ' 157' ' ' TYR . 22.4 t -133.75 162.48 31.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.198 -1.819 . . . . 3.2799999999999998 109.128 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 64.2 p -58.03 -7.61 0.82 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 93' ' ' SER . 52.0 p -65.3 162.73 16.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.529 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.1 m -124.03 74.41 57.56 Favored Pre-proline 0 N--CA 1.464 0.251 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.125 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.57 145.82 96.96 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.564 2.176 . . . . 0.0 112.534 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 98' ' ' VAL . 3.9 p -113.96 26.61 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.397 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.0 p 48.3 36.19 6.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.769 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.2 t -129.89 141.72 50.76 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.122 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -107.53 129.3 54.98 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.814 0.34 . . . . 0.0 110.529 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.478 ' H ' HG22 ' A' ' 102' ' ' THR . 0.0 OUTLIER -64.41 -39.34 93.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.25 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.2 p -131.67 144.24 38.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.372 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 49.8 m -117.59 138.92 51.61 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.213 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -178.35 -171.43 41.66 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.63 -33.26 72.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.831 0.348 . . . . 0.0 110.41 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.8 p -123.43 163.32 21.08 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.725 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.0 p -124.12 74.04 57.93 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.766 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -61.0 145.7 98.77 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.556 2.171 . . . . 0.0 113.293 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -58.04 -37.04 73.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.853 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.746 ' H ' ' CD ' ' A' ' 112' ' ' PRO . 1.3 p -167.56 -38.44 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.993 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.746 ' CD ' ' H ' ' A' ' 111' ' ' SER . 51.6 Cg_exo -54.8 142.06 75.14 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.029 1.819 . . . . 0.0 112.595 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.591 ' O ' ' O ' ' A' ' 114' ' ' VAL . 56.6 mt -85.15 -4.61 59.22 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.84 -0.618 . . . . 10.19 110.995 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.591 ' O ' ' O ' ' A' ' 113' ' ' LEU . 2.5 m 27.54 111.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 123.611 0.569 . . . . 7.2800000000000002 112.473 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.29 145.04 52.74 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.573 -0.528 . . . . 7.2999999999999998 109.573 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 29.5 m -57.55 -41.68 81.49 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.247 -0.581 . . . . 6.4400000000000004 110.093 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.703 ' O ' ' O ' ' A' ' 118' ' ' GLU . 55.0 m -126.19 150.83 48.07 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.727 -0.669 . . . . 4.4199999999999999 110.265 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.75 ' O ' ' O ' ' A' ' 119' ' ' SER . 57.6 mp0 -23.82 -114.57 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.675 0.609 . . . . 3.0499999999999998 112.026 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.75 ' O ' ' O ' ' A' ' 118' ' ' GLU . 83.6 p 25.67 -167.3 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.816 0.673 . . . . 3.4300000000000002 112.816 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.614 ' O ' ' O ' ' A' ' 119' ' ' SER . 41.5 t 48.81 128.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.59 -0.732 . . . . 2.8799999999999999 111.753 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.5 p -120.14 160.38 23.0 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.09 -0.504 . . . . 2.0899999999999999 110.108 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -107.37 141.1 39.27 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.168 -0.469 . . . . 4.5300000000000002 111.081 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.1 mt -113.54 134.1 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 108.847 -0.797 . . . . 1.4399999999999999 108.847 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 124' ' ' THR . 0.0 OUTLIER -75.93 110.65 10.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.107 0.48 . . . . 1.78 111.65 -178.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -116.91 -93.98 0.5 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.759 -0.83 . . . . 0.64000000000000001 108.759 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 67.5 p -66.1 -14.69 62.2 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.557 -0.905 . . . . 0.66000000000000003 108.557 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.438 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.76 167.61 0.24 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.878 -1.056 . . . . 0.68999999999999995 110.897 -179.184 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.65 145.52 50.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.688 -0.687 . . . . 0.52000000000000002 110.117 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.28 101.63 9.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.076 -0.713 . . . . 0.32000000000000001 109.076 177.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.4 t -112.87 139.73 36.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.056 -0.52 . . . . 0.28999999999999998 111.097 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.0 p -128.75 152.56 48.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.599 -0.728 . . . . 0.25 109.816 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.59 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.8 -164.93 2.03 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.742 -0.383 . . . . 0.31 110.67 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.731 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.7 t -123.98 127.17 73.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.18 -0.463 . . . . 0.48999999999999999 110.718 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.162 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.98 58.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.135 -0.484 . . . . 1.53 110.297 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.731 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.05 24.42 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.991 -0.55 . . . . 0.96999999999999997 111.533 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.162 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.23 128.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.549 -0.46 . . . . 1.5600000000000001 110.954 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.44 -9.61 55.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.979 -0.555 . . . . 1.8799999999999999 110.288 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.8 p -87.09 0.27 55.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 1.04 110.282 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.29 137.26 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.064 -0.517 . . . . 0.23999999999999999 109.913 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.668 ' OG ' ' NZ ' ' A' ' 61' ' ' LYS . 10.9 p -96.26 -15.49 21.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.287 0.565 . . . . 0.28999999999999998 110.076 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.57 175.57 45.76 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 109.91 -1.276 . . . . 0.13 109.91 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.48 151.63 42.54 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.578 -0.449 . . . . 0.17000000000000001 110.458 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.723 ' NH2' ' OE1' ' A' ' 191' ' ' GLN . 52.3 ttp85 -132.38 121.17 23.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.108 -0.496 . . . . 1.29 109.997 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.557 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.08 136.59 38.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.686 -0.688 . . . . 0.25 110.694 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 73.8 tt0 -129.34 129.87 45.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.981 -0.554 . . . . 1.3200000000000001 110.109 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.72 135.27 34.57 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.027 -0.533 . . . . 0.56999999999999995 110.602 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.421 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.32 39.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.83 -0.623 . . . . 1.1599999999999999 109.739 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.951 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.0 124.89 25.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.995 0.426 . . . . 0.38 110.694 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.494 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.9 -7.63 49.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.757 -0.656 . . . . 0.40999999999999998 110.856 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.81 -69.6 0.85 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.924 0.393 . . . . 1.6599999999999999 111.468 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.46 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.7 -35.27 75.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.02 -0.537 . . . . 1.6599999999999999 111.498 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.099 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.01 7.29 88.54 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.838 -0.905 . . . . 1.1699999999999999 110.838 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.324 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.97 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.817 0.342 . . . . 1.8600000000000001 110.261 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.324 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.17 139.04 45.43 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.954 0.407 . . . . 1.98 110.199 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.9 Cg_endo -70.86 145.8 51.75 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 122.753 2.302 . . . . 0.55000000000000004 112.376 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.79 145.63 42.65 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.276 -0.639 . . . . 1.1399999999999999 109.276 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.633 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 88.1 m-85 -123.31 141.46 51.96 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.311 -0.556 . . . . 0.93000000000000005 111.516 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.17 127.63 43.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.306 -0.861 . . . . 0.34000000000000002 108.951 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -101.61 131.21 47.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.075 0.464 . . . . 1.0900000000000001 111.687 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.96 157.59 73.37 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.347 -0.842 . . . . 0.19 109.553 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.85 158.02 58.23 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 122.413 2.075 . . . . 0.17999999999999999 112.247 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.31 -12.15 5.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.742 -0.663 . . . . 0.20999999999999999 110.684 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.9 p -92.8 -8.76 42.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.148 -0.478 . . . . 0.28999999999999998 110.783 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.46 34.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.5 110.435 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.25 16.78 4.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.29999999999999999 110.52 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.5 p -167.58 147.1 5.04 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.596 -0.52 . . . . 0.23000000000000001 109.596 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.21 150.49 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.458 -0.497 . . . . 0.28000000000000003 111.55 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.25 125.03 50.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.606 -0.725 . . . . 1.0700000000000001 109.822 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.49 104.88 30.05 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.378 -0.374 . . . . 0.28999999999999998 111.011 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.8 Cg_endo -90.97 -179.5 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 123.195 2.597 . . . . 0.42999999999999999 112.24 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.67 32.64 18.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.381 -0.827 . . . . 1.26 111.435 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.0 mt -86.29 148.59 25.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.467 -0.333 . . . . 0.32000000000000001 110.563 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.76 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.37 114.86 61.37 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.016 0.436 . . . . 0.57999999999999996 110.624 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.07 140.61 95.97 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.83 2.353 . . . . 0.66000000000000003 111.93 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.1 21.21 74.25 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.006 -0.838 . . . . 0.28999999999999998 111.006 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.46 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.87 150.13 49.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.752 0.311 . . . . 2.3300000000000001 110.756 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.494 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.15 131.7 45.94 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.85999999999999999 109.728 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.951 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.7 m-85 -120.49 148.31 44.0 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.091 -0.504 . . . . 0.52000000000000002 111.02 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.7 mt -105.25 125.25 60.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.347 -0.983 . . . . 0.29999999999999999 108.347 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.51 132.45 63.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.198 0.523 . . . . 0.23000000000000001 111.303 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.44 122.6 20.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.542 -0.754 . . . . 0.35999999999999999 109.655 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.59 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.12 125.38 55.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.257 -0.429 . . . . 0.19 110.627 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.7 m-85 -117.15 137.86 52.04 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.534 . . . . 0.29999999999999999 109.882 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.575 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.68 135.11 42.64 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.846 -0.798 . . . . 0.37 108.846 178.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.649 HD13 ' OG ' ' A' ' 17' ' ' SER . 26.6 mt -99.09 123.01 51.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.074 0.464 . . . . 0.26000000000000001 110.918 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.592 ' OG ' ' OD1' ' A' ' 188' ' ' ASP . 87.4 p -83.91 169.73 14.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.515 -0.766 . . . . 0.28000000000000003 110.529 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.77 -14.55 15.1 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.096 -0.502 . . . . 1.6000000000000001 110.953 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.671 ' OD1' ' N ' ' A' ' 190' ' ' GLU . 37.1 p30 -96.18 -4.16 43.08 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.785 -0.366 . . . . 1.1799999999999999 110.773 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.74 13.86 64.17 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.339 -0.705 . . . . 0.29999999999999999 111.339 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.671 ' N ' ' OD1' ' A' ' 188' ' ' ASP . 84.4 tt0 -84.59 139.03 32.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.705 0.288 . . . . 1.22 110.456 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.723 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 87.4 mt-30 -106.74 141.03 38.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.97999999999999998 110.557 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.0 m -136.72 127.15 26.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 0.82999999999999996 110.326 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.7 tp -68.21 117.38 9.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.26000000000000001 110.454 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.4 pt -109.08 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.29999999999999999 110.71 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.5 tp -156.91 125.74 5.86 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.511 -0.476 . . . . 0.31 111.448 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.463 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.77 120.28 21.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.775 -0.648 . . . . 0.28000000000000003 109.504 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.67 151.68 29.06 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.628 -0.429 . . . . 0.23999999999999999 110.901 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.43 158.58 18.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.986 -0.552 . . . . 0.23000000000000001 110.492 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -146.05 158.04 43.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.67000000000000004 110.633 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.35 104.31 9.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.717 -0.674 . . . . 0.64000000000000001 109.981 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.9 p . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.94 -1.028 . . . . 1.26 110.701 -179.767 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.0 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.223 -0.658 . . . . 3.4399999999999999 109.223 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.46 150.67 18.53 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.971 -0.852 . . . . 1.22 110.971 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -35.58 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.056 0 C-N-CA 124.009 3.139 . . . . 0.75 113.811 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.6 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.94 173.47 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.219 -1.355 . . . . 0.79000000000000004 108.882 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.6 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.64 125.92 51.54 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.376 -0.529 . . . . 1.9399999999999999 111.444 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.51 143.96 34.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.671 -0.695 . . . . 0.59999999999999998 110.691 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.01 168.3 25.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.923 0.392 . . . . 3.1400000000000001 111.093 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.749 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.7 mt -109.06 131.08 60.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.975 -0.557 . . . . 3.23 110.098 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.16 162.26 35.92 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.466 -0.334 . . . . 3.6299999999999999 111.255 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 73.7 mm-40 36.15 31.63 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.558 -0.534 . . . . 6.0800000000000001 109.558 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.749 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.53 69.6 33.5 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.006 -0.543 . . . . 3.3799999999999999 111.521 -178.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.639 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.37 -28.99 71.87 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.433 2.089 . . . . 3.9300000000000002 111.906 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.681 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 3.2 m 149.58 125.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 3.3599999999999999 110.481 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.681 ' NE2' ' O ' ' A' ' 13' ' ' SER . 3.4 mp0 -123.96 158.39 60.39 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.314 -0.403 . . . . 3.6099999999999999 110.409 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.619 ' CG ' ' NH1' ' A' ' 143' ' ' ARG . 97.2 Cg_endo -82.03 -64.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.902 2.402 . . . . 1.51 113.488 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.62 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 64.6 t30 -108.46 -19.59 13.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.305 -0.407 . . . . 2.6800000000000002 112.012 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 5.3 p -107.3 152.11 24.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.187 0.518 . . . . 1.21 111.242 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.573 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.34 102.89 2.22 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.7 -0.682 . . . . 1.5600000000000001 110.685 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.559 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.67 145.57 13.01 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.923 2.415 . . . . 0.81000000000000005 112.605 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.909 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.75 167.95 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.881 -0.6 . . . . 1.52 109.895 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.21 147.94 29.01 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.674 -0.491 . . . . 2.1400000000000001 109.674 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.58 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.27 157.33 44.95 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.605 -0.438 . . . . 0.32000000000000001 111.195 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.494 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.2 m-20 -128.04 155.29 44.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.781 -0.645 . . . . 2.1699999999999999 110.017 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.838 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.63 172.99 6.41 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.128 -0.487 . . . . 0.58999999999999997 110.737 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.838 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.68 173.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.851 2.367 . . . . 0.90000000000000002 111.598 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.98 -51.15 0.69 Allowed Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 120.725 -0.39 . . . . 3.3399999999999999 110.051 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.637 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.4 Cg_exo -64.75 152.36 82.31 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.783 2.322 . . . . 1.8500000000000001 111.477 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.75 42.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.35 0.595 . . . . 2.54 110.46 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.824 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.6 -41.64 98.3 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.059 -0.973 . . . . 2.5299999999999998 110.625 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.532 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.4 mt -109.82 137.76 40.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.811 -0.631 . . . . 1.1699999999999999 111.276 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.88 -72.91 0.7 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.053 -0.522 . . . . 1.27 111.965 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.18 148.4 24.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.617 0.599 . . . . 1.1200000000000001 112.617 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -121.78 124.89 45.27 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.315 -0.624 . . . . 0.41999999999999998 109.315 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.02 134.68 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.623 -0.431 . . . . 0.78000000000000003 110.67 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.909 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.93 128.6 53.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.978 0.418 . . . . 0.62 111.283 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.92 49.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.724 -0.671 . . . . 1.97 110.217 178.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.441 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.0 163.21 34.89 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.169 0.509 . . . . 0.34999999999999998 112.054 -178.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.56 139.56 7.78 Favored Pre-proline 0 C--N 1.333 -0.12 0 CA-C-N 115.346 -0.843 . . . . 1.8 110.428 178.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.46 115.42 3.01 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.318 2.012 . . . . 0.57999999999999996 111.802 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.97 81.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.92 -0.4 . . . . 3.04 109.92 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.23 -20.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.003 -0.544 . . . . 2.4700000000000002 111.936 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.2 p -157.68 157.76 34.13 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.737 -0.385 . . . . 2.5099999999999998 110.51 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.4 m -120.29 27.82 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.182 -0.463 . . . . 1.8600000000000001 110.186 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.83 -75.87 1.31 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.178 -0.534 . . . . 1.4399999999999999 111.829 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.89 152.2 35.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.898 0.38 . . . . 4.6900000000000004 111.055 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.11 -169.14 2.55 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.113 -0.494 . . . . 1.4299999999999999 111.954 179.394 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.441 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.12 149.68 29.71 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.456 0.646 . . . . 1.74 112.672 -177.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.07 156.5 45.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.858 -1.065 . . . . 1.9199999999999999 110.285 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.24 158.34 41.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.903 -0.589 . . . . 0.34000000000000002 111.873 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 m -115.19 135.58 54.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.472 -0.785 . . . . 0.40999999999999998 109.865 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.58 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.35 121.93 23.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.467 -0.333 . . . . 0.55000000000000004 111.538 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.598 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.7 Cg_exo -46.41 151.77 1.68 Allowed 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.666 2.244 . . . . 0.44 112.059 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.04 -22.85 63.14 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-N 115.957 -0.565 . . . . 0.73999999999999999 112.81 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.84 -16.89 45.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.371 0.586 . . . . 0.93000000000000005 111.825 -178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.598 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.53 138.42 31.59 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.725 -0.39 . . . . 0.96999999999999997 110.375 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.55 13.95 10.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.387 -0.369 . . . . 1.3400000000000001 111.551 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.99 143.4 25.17 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.681 -0.408 . . . . 0.39000000000000001 111.098 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.75 -169.25 1.51 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.037 -0.528 . . . . 0.41999999999999998 110.906 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.76 ' OG1' ' N ' ' A' ' 189' ' ' GLY . 1.3 m -151.82 125.86 9.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.432 -0.804 . . . . 0.39000000000000001 109.805 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.517 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.8 123.25 70.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.429 -0.508 . . . . 0.73999999999999999 111.21 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -126.48 163.41 23.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.842 -0.617 . . . . 2.48 110.436 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.457 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.17 18.99 59.79 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.631 -0.988 . . . . 0.5 110.631 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.62 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 74.1 mt -79.07 157.26 28.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.149 0.5 . . . . 0.57999999999999996 111.309 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.843 ' O ' HG12 ' A' ' 67' ' ' VAL . 10.9 mttp -99.44 133.95 21.56 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.588 -0.733 . . . . 2.79 110.494 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.421 ' HD3' ' CE2' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.84 143.6 61.72 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.637 2.225 . . . . 0.87 111.916 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.79 25.5 75.48 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.105 -0.798 . . . . 0.64000000000000001 111.105 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.843 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.09 158.79 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.321 . . . . 0.82999999999999996 110.449 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.19 139.91 42.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.94 0.4 . . . . 0.5 110.534 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.65 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.7 m-85 -122.53 136.45 54.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.944 -0.571 . . . . 0.53000000000000003 110.776 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.84 131.02 45.27 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.483 -0.932 . . . . 1.8700000000000001 108.483 177.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.49 153.9 16.65 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.301 -0.952 . . . . 0.28999999999999998 111.943 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.96 140.93 46.09 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.71 -0.478 . . . . 1.4299999999999999 109.71 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.9 tp -115.67 118.93 34.44 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.476 -0.489 . . . . 0.32000000000000001 110.488 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.733 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.51 129.19 68.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.342 -0.39 . . . . 0.79000000000000004 110.647 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.705 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.92 120.7 43.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.242 -0.436 . . . . 1.02 110.774 -179.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.853 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.52 146.5 11.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.217 0.532 . . . . 0.62 111.02 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.824 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.01 153.85 21.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.536 -0.756 . . . . 2.4399999999999999 109.982 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.13 88.47 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.898 0.38 . . . . 3.6899999999999999 110.521 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.36 32.6 0.22 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.78 -0.645 . . . . 6.0800000000000001 110.589 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.33 3.29 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.504 -0.638 . . . . 1.22 111.504 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.463 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.36 177.38 9.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.135 0.493 . . . . 2.8799999999999999 111.687 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.17 149.5 32.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.401 -0.818 . . . . 1.47 110.401 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.13 144.68 38.75 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.459 -0.337 . . . . 2.7000000000000002 110.613 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.733 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.04 135.95 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.049 0.452 . . . . 0.46000000000000002 111.473 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.02 141.34 52.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.599 -0.728 . . . . 0.34999999999999998 110.236 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.64 138.85 51.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.117 0.484 . . . . 3.6699999999999999 111.541 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.25 164.18 37.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.506 -0.77 . . . . 0.67000000000000004 109.493 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.572 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.25 151.51 38.49 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.41 -0.516 . . . . 1.47 111.084 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.802 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.5 p90 -146.19 172.65 13.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.762 -0.654 . . . . 0.44 111.104 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.61 160.67 21.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.467 -0.788 . . . . 1.3700000000000001 109.861 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.37 121.98 23.12 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 120.63 -0.428 . . . . 1.28 110.747 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.564 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.8 p -127.83 164.23 22.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.647 0.737 . . . . 1.97 112.689 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.525 ' C ' ' H ' ' A' ' 95' ' ' SER . 30.5 t -115.75 149.18 38.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.63 -1.168 . . . . 3.2799999999999998 109.682 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 58.6 p -59.48 -3.52 0.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.335 0.588 . . . . 0.0 109.863 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.525 ' H ' ' C ' ' A' ' 93' ' ' SER . 13.0 m -53.89 -33.54 56.84 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.52 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.9 m 63.29 68.19 0.95 Allowed Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.88 150.33 23.36 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.768 2.312 . . . . 0.0 112.457 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.5 m -60.02 136.67 23.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.126 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.1 m -58.56 -40.34 82.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.608 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 65.0 m -163.45 10.2 0.05 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.114 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -54.8 -36.93 65.47 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.247 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.9 m -79.72 138.4 37.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.067 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.8 m -128.69 155.55 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.929 0.395 . . . . 0.0 110.97 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 45.6 m -123.54 140.42 53.02 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.76 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -155.54 134.73 4.28 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.729 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -59.55 -31.77 69.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.077 0.465 . . . . 0.0 110.251 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.4 m -55.16 -36.09 65.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.411 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.8 p -53.92 147.06 25.57 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.682 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.93 147.59 80.95 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 122.655 2.236 . . . . 0.0 112.995 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -94.49 6.15 49.65 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.722 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.1 p -108.32 102.48 46.92 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.755 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -53.85 150.89 28.21 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.463 2.109 . . . . 0.0 112.417 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 62.5 mt -58.1 -32.74 68.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.67 -0.696 . . . . 10.19 110.87 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 25.8 m -126.01 158.32 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.922 0.392 . . . . 7.2800000000000002 110.731 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.95 144.75 52.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.02 -0.536 . . . . 7.2999999999999998 111.032 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 63.6 p -70.5 -15.67 62.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.677 -0.692 . . . . 6.4400000000000004 111.011 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.0 m -60.09 152.94 22.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.816 0.341 . . . . 4.4199999999999999 110.546 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.95 -33.65 75.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.997 -0.547 . . . . 3.0499999999999998 111.192 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 47.7 m -65.13 150.71 47.68 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.68 -0.408 . . . . 3.4300000000000002 110.856 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.1 m -131.2 156.36 42.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.002 -0.544 . . . . 2.8799999999999999 110.446 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 49.9 m -84.85 136.04 33.83 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.708 -0.479 . . . . 2.0899999999999999 109.708 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -60.51 139.99 57.5 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.595 -0.442 . . . . 4.5300000000000002 110.548 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.417 ' C ' ' OG1' ' A' ' 124' ' ' THR . 83.3 mt -94.42 -76.3 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.145 -0.48 . . . . 1.4399999999999999 110.106 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.417 ' OG1' ' C ' ' A' ' 123' ' ' ILE . 0.1 OUTLIER -177.91 50.04 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.821 -0.627 . . . . 1.78 109.589 179.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 63.74 23.43 13.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.822 -0.626 . . . . 0.64000000000000001 110.504 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.5 p -63.45 -25.78 68.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.596 . . . . 0.66000000000000003 110.312 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.438 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.85 167.57 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.483 -0.78 . . . . 0.68999999999999995 111.003 -179.283 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.58 145.57 50.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.746 -0.661 . . . . 0.52000000000000002 110.141 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.28 101.7 9.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.073 -0.714 . . . . 0.32000000000000001 109.073 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.5 t -112.93 139.63 37.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.054 -0.521 . . . . 0.28999999999999998 111.069 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 p -128.7 152.58 48.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.621 -0.718 . . . . 0.25 109.834 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.59 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.9 p90 -144.78 -165.01 2.05 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.687 -0.405 . . . . 0.31 110.675 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -123.95 127.16 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.198 -0.455 . . . . 0.48999999999999999 110.861 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.175 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.88 58.32 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.086 -0.506 . . . . 1.53 110.402 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.12 24.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.934 -0.576 . . . . 0.96999999999999997 111.435 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.175 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.12 128.69 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.594 -0.443 . . . . 1.5600000000000001 110.98 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.4 -9.55 56.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.923 -0.58 . . . . 1.8799999999999999 110.278 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.0 p -87.09 0.2 55.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.08 0.467 . . . . 1.04 110.358 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.22 137.07 25.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.951 -0.568 . . . . 0.23999999999999999 109.961 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.602 ' N ' ' O ' ' A' ' 185' ' ' ILE . 89.4 p -96.12 -15.54 22.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.262 0.553 . . . . 0.28999999999999998 110.057 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.56 175.6 45.78 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 109.861 -1.296 . . . . 0.13 109.861 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -123.45 151.65 42.47 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.65 -0.42 . . . . 0.17000000000000001 110.529 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.619 ' NH1' ' CG ' ' A' ' 15' ' ' PRO . 36.7 ttp85 -132.33 121.16 23.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.131 -0.486 . . . . 1.29 109.919 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 167' ' ' VAL . 46.5 t -105.09 136.48 38.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.705 -0.679 . . . . 0.25 110.661 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 85.2 tt0 -129.33 129.88 45.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.029 -0.532 . . . . 1.3200000000000001 110.013 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.75 135.25 34.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.56999999999999995 110.638 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.42 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.26 161.3 39.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.659 -0.7 . . . . 1.1599999999999999 109.704 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.951 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.1 mt -70.98 124.87 25.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.068 0.461 . . . . 0.38 110.729 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.73 -7.77 50.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.766 -0.652 . . . . 0.40999999999999998 110.874 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.79 -69.67 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.35 -0.386 . . . . 1.6599999999999999 111.416 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.435 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.74 -35.33 76.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.076 -0.511 . . . . 1.6599999999999999 111.42 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.088 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.22 88.6 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.785 -0.926 . . . . 1.1699999999999999 110.785 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.336 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.89 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.778 0.323 . . . . 1.8600000000000001 110.25 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.336 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.33 138.99 44.87 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.941 0.401 . . . . 1.98 110.145 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.477 ' CG ' ' OG ' ' A' ' 95' ' ' SER . 47.2 Cg_endo -70.79 145.76 52.05 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.635 2.223 . . . . 0.55000000000000004 112.406 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.79 145.66 42.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.264 -0.643 . . . . 1.1399999999999999 109.264 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.581 ' CE1' ' CG ' ' A' ' 16' ' ' ASN . 6.3 p90 -123.27 141.23 52.19 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.453 -0.499 . . . . 0.93000000000000005 111.567 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.6 mt -128.03 127.66 43.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.35 -0.841 . . . . 0.34000000000000002 108.964 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.593 ' HB2' HD21 ' A' ' 16' ' ' ASN . 30.1 t0 -101.65 131.16 48.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.185 0.517 . . . . 1.0900000000000001 111.767 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.99 157.57 73.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.31 -0.859 . . . . 0.19 109.508 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -69.8 157.96 58.52 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.437 2.091 . . . . 0.17999999999999999 112.197 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.4 p -59.11 -12.27 4.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.737 -0.665 . . . . 0.20999999999999999 110.813 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.4 p -92.83 -8.71 42.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.128 -0.487 . . . . 0.28999999999999998 110.633 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.31 34.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.454 -0.339 . . . . 0.5 110.364 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.1 p -133.05 16.65 4.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.454 -0.339 . . . . 0.29999999999999999 110.624 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.6 p -167.55 147.11 5.07 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.61 -0.515 . . . . 0.23000000000000001 109.61 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.21 150.42 12.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.548 -0.461 . . . . 0.28000000000000003 111.598 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 124.95 50.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.628 -0.715 . . . . 1.0700000000000001 109.811 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.4 104.87 29.68 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.428 -0.351 . . . . 0.28999999999999998 111.038 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.8 Cg_endo -91.04 -179.58 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 123.224 2.616 . . . . 0.42999999999999999 112.179 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.78 32.59 18.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.324 -0.853 . . . . 1.26 111.427 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.1 mt -86.36 148.51 25.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.476 -0.329 . . . . 0.32000000000000001 110.532 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.77 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.22 114.77 60.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.982 0.42 . . . . 0.57999999999999996 110.688 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -58.97 140.57 95.91 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.891 2.394 . . . . 0.66000000000000003 112.017 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.06 21.25 74.25 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.047 -0.821 . . . . 0.28999999999999998 111.047 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.435 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.97 150.23 49.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 2.3300000000000001 110.62 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.2 131.64 46.02 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.077 -0.511 . . . . 0.85999999999999999 109.809 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.951 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.54 148.33 43.99 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.136 -0.484 . . . . 0.52000000000000002 110.992 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.1 mt -105.35 125.41 60.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.281 -1.007 . . . . 0.29999999999999999 108.281 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.58 132.57 63.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.126 0.489 . . . . 0.23000000000000001 111.247 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.58 122.52 20.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.57 -0.741 . . . . 0.35999999999999999 109.69 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.59 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -100.94 125.36 54.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.242 -0.436 . . . . 0.19 110.62 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.2 m-85 -117.17 137.86 52.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.023 -0.535 . . . . 0.29999999999999999 109.956 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.582 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.67 134.95 42.88 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.838 -0.801 . . . . 0.37 108.838 178.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.602 ' O ' ' N ' ' A' ' 140' ' ' SER . 84.3 mt -99.1 122.94 51.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.09 0.471 . . . . 0.26000000000000001 110.962 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.9 p -83.88 169.68 14.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.518 -0.764 . . . . 0.28000000000000003 110.461 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 187' ' ' GLU . 43.3 tt0 -59.67 -14.63 14.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.077 -0.511 . . . . 1.6000000000000001 110.936 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.732 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.6 m-20 -96.07 -4.27 43.26 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.866 -0.333 . . . . 1.1799999999999999 110.818 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.76 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.79 13.87 64.04 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.312 -0.715 . . . . 0.29999999999999999 111.312 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -84.62 139.13 32.29 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.015 -0.274 . . . . 1.22 110.449 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.502 ' NE2' ' HG3' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -106.73 141.11 38.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.797 0.332 . . . . 0.97999999999999998 110.601 179.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.75 126.97 26.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.82999999999999996 110.402 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.12 117.22 9.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.386 -0.37 . . . . 0.26000000000000001 110.543 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 43.8 pt -108.97 -21.8 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.457 . . . . 0.29999999999999999 110.838 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.93 125.74 5.85 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.467 -0.493 . . . . 0.31 111.49 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.7 120.17 21.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.702 -0.681 . . . . 0.28000000000000003 109.576 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.58 151.76 29.23 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.594 -0.443 . . . . 0.23999999999999999 110.929 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.48 158.56 18.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.007 -0.542 . . . . 0.23000000000000001 110.38 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.08 157.9 43.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 0.67000000000000004 110.646 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.14 104.34 9.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.748 -0.66 . . . . 0.64000000000000001 110.043 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.01 -0.995 . . . . 1.26 110.653 -179.791 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.553 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.6 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.226 -0.657 . . . . 3.4399999999999999 109.226 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.64 18.54 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.071 -0.811 . . . . 1.22 111.071 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -35.62 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.297 -2.147 0 C-N-CA 124.039 3.159 . . . . 0.75 113.773 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.606 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.0 t -79.83 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.296 -1.32 . . . . 0.79000000000000004 108.912 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.606 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.66 125.9 51.53 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.489 -0.484 . . . . 1.9399999999999999 111.424 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.57 143.91 34.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.677 -0.692 . . . . 0.59999999999999998 110.57 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.97 168.33 25.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.966 0.412 . . . . 3.1400000000000001 111.142 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.742 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.0 130.99 60.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.976 -0.557 . . . . 3.23 110.101 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.8 p -141.14 162.26 35.9 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.902 0.382 . . . . 3.6299999999999999 111.164 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 21.3 pt-20 36.12 31.61 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.695 -0.483 . . . . 6.0800000000000001 109.695 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.742 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.59 32.61 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.867 -0.606 . . . . 3.3799999999999999 111.578 -178.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.633 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.28 -29.1 72.79 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.465 2.11 . . . . 3.9300000000000002 111.884 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.633 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.61 125.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 3.3599999999999999 110.511 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.577 ' O ' ' O ' ' A' ' 92' ' ' THR . 1.5 mp0 -123.91 158.36 60.31 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.304 -0.407 . . . . 3.6099999999999999 110.378 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.6 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 96.3 Cg_endo -82.11 -64.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.874 2.382 . . . . 1.51 113.542 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.66 ' ND2' ' N ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -108.48 -19.66 13.37 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.081 0.4 . . . . 2.6800000000000002 112.081 -178.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.66 ' N ' ' ND2' ' A' ' 16' ' ' ASN . 95.8 p -107.2 152.02 24.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.164 0.507 . . . . 1.21 111.333 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.25 102.98 2.23 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.79 -0.641 . . . . 1.5600000000000001 110.669 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.6 145.58 13.11 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.932 2.422 . . . . 0.81000000000000005 112.59 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.928 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.82 167.91 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.911 -0.586 . . . . 1.52 109.899 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.14 147.85 28.96 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.855 -0.424 . . . . 2.1400000000000001 109.855 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.592 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.18 157.34 44.97 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.663 -0.415 . . . . 0.32000000000000001 111.223 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.497 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.2 m-20 -128.12 155.3 44.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.81 -0.632 . . . . 2.1699999999999999 110.024 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.837 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.58 173.02 6.38 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.065 -0.516 . . . . 0.58999999999999997 110.723 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.837 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.6 173.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 122.876 2.384 . . . . 0.90000000000000002 111.543 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.04 -50.99 0.69 Allowed Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.68 -0.408 . . . . 3.3399999999999999 110.166 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.635 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.84 152.38 82.38 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.797 2.331 . . . . 1.8500000000000001 111.438 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.8 42.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.415 0.626 . . . . 2.54 110.538 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.819 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.54 -41.62 98.45 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.01 -0.996 . . . . 2.5299999999999998 110.697 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.4 mt -109.86 137.82 40.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.815 -0.63 . . . . 1.1699999999999999 111.274 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.9 -72.96 0.7 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.057 -0.52 . . . . 1.27 111.913 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.09 148.33 24.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.638 0.606 . . . . 1.1200000000000001 112.638 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.84 124.88 45.2 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.318 -0.623 . . . . 0.41999999999999998 109.318 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.0 134.79 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.647 -0.421 . . . . 0.78000000000000003 110.649 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.928 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.03 128.66 53.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.297 -0.41 . . . . 0.62 111.191 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.17 138.97 49.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.807 -0.633 . . . . 1.97 110.023 179.003 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.436 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.03 163.11 35.23 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.119 0.485 . . . . 0.34999999999999998 112.074 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.43 139.51 7.87 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.413 -0.812 . . . . 1.8 110.42 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.52 115.45 3.04 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.336 2.024 . . . . 0.57999999999999996 111.77 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.679 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.94 81.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.868 -0.419 . . . . 3.04 109.868 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.21 -20.74 0.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.983 -0.553 . . . . 2.4700000000000002 111.919 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -157.55 157.81 34.44 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.806 -0.358 . . . . 2.5099999999999998 110.592 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.406 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.34 27.68 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 1.8600000000000001 110.22 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.79 -75.86 1.31 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.08 -0.581 . . . . 1.4399999999999999 111.884 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.82 152.28 35.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.845 0.355 . . . . 4.6900000000000004 111.045 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.18 -169.16 2.55 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.071 -0.513 . . . . 1.4299999999999999 111.955 179.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.436 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.73 29.65 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.431 0.634 . . . . 1.74 112.589 -177.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.13 156.53 45.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.87 -1.059 . . . . 1.9199999999999999 110.16 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.25 158.33 41.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.898 -0.592 . . . . 0.34000000000000002 111.826 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.0 m -115.23 135.71 53.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.386 -0.824 . . . . 0.40999999999999998 109.758 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.592 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.39 121.91 23.77 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.371 -0.377 . . . . 0.55000000000000004 111.546 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.7 Cg_exo -46.41 151.76 1.68 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.653 2.235 . . . . 0.44 112.08 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.91 -23.04 63.06 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 116.028 -0.533 . . . . 0.73999999999999999 112.854 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.69 -17.03 45.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.343 0.572 . . . . 0.93000000000000005 111.803 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.601 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.49 138.46 31.56 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.699 -0.4 . . . . 0.96999999999999997 110.32 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.59 14.02 10.96 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.398 -0.365 . . . . 1.3400000000000001 111.551 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.474 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.1 143.42 25.08 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.675 -0.41 . . . . 0.39000000000000001 111.048 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.716 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.74 -169.42 1.54 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.069 -0.514 . . . . 0.41999999999999998 110.938 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.716 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.5 t -151.72 125.91 9.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.438 -0.801 . . . . 0.39000000000000001 109.828 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.519 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.77 123.29 70.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.373 -0.531 . . . . 0.73999999999999999 111.207 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.646 ' NZ ' ' N ' ' A' ' 142' ' ' PHE . 88.9 tttt -126.52 163.34 23.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.898 -0.592 . . . . 2.48 110.417 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.52 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.17 18.96 59.84 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.793 -0.923 . . . . 0.5 110.793 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.519 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.8 mt -79.15 157.28 27.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.108 0.48 . . . . 0.57999999999999996 111.299 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.848 ' O ' HG12 ' A' ' 67' ' ' VAL . 4.5 mttp -99.47 133.92 21.57 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.531 -0.759 . . . . 2.79 110.536 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.535 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.87 143.56 61.38 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.584 2.189 . . . . 0.87 111.95 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.77 25.71 75.24 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.088 -0.805 . . . . 0.64000000000000001 111.088 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.848 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.25 158.73 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.717 0.294 . . . . 0.82999999999999996 110.371 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.11 139.93 41.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.946 0.403 . . . . 0.5 110.516 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.664 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.4 m-85 -122.63 136.42 54.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.905 -0.589 . . . . 0.53000000000000003 110.782 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.87 131.04 45.27 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.442 -0.947 . . . . 1.8700000000000001 108.442 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.49 153.97 16.64 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.313 -0.946 . . . . 0.28999999999999998 111.935 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.05 140.85 45.91 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.726 -0.472 . . . . 1.4299999999999999 109.726 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.72 118.95 34.47 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.411 -0.516 . . . . 0.32000000000000001 110.53 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.722 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.44 129.03 68.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.332 -0.395 . . . . 0.79000000000000004 110.582 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.701 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.85 120.78 43.52 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.294 -0.412 . . . . 1.02 110.764 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.852 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.45 146.47 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.173 0.511 . . . . 0.62 111.069 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.819 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.08 153.85 21.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.525 -0.761 . . . . 2.4399999999999999 109.947 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.425 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.15 88.62 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.938 0.399 . . . . 3.6899999999999999 110.408 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.613 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.61 0.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.85 -0.614 . . . . 6.0800000000000001 110.592 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.17 -117.35 3.28 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.424 -0.67 . . . . 1.22 111.424 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.464 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.1 m170 -81.43 177.36 9.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.194 0.521 . . . . 2.8799999999999999 111.637 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.08 149.61 32.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.398 -0.819 . . . . 1.47 110.353 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.553 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.21 144.71 38.62 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.449 -0.341 . . . . 2.7000000000000002 110.528 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.722 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.03 135.97 61.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.002 0.43 . . . . 0.46000000000000002 111.534 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.07 141.36 52.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.677 -0.692 . . . . 0.34999999999999998 110.211 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.62 138.86 51.67 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.083 0.468 . . . . 3.6699999999999999 111.577 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.27 164.09 38.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.623 -0.717 . . . . 0.67000000000000004 109.468 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.18 151.62 38.72 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.473 -0.491 . . . . 1.47 111.046 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.804 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.7 p90 -146.35 172.71 13.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.734 -0.666 . . . . 0.44 111.033 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.78 160.65 21.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.479 -0.782 . . . . 1.3700000000000001 109.828 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.34 121.82 22.92 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.627 -0.429 . . . . 1.28 110.83 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.577 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.0 p -128.18 162.99 25.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.082 -0.508 . . . . 1.97 111.667 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.6 m -63.21 154.57 30.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 3.2799999999999998 110.028 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.417 HG23 ' N ' ' A' ' 95' ' ' SER . 12.0 t -60.49 -39.4 87.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.97 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.417 ' N ' HG23 ' A' ' 94' ' ' THR . 81.5 p -98.58 159.53 14.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.412 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.6 m -59.65 131.94 88.65 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.47 136.98 66.75 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.492 1.461 . . . . 0.0 112.931 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.84 -24.41 34.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.695 178.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 66.4 p -60.68 -15.98 34.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.524 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.9 p -67.65 156.54 36.61 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.31 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -116.56 127.95 54.98 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.451 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 56.6 m -75.54 135.34 40.6 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.59 144.71 36.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.156 0.503 . . . . 0.0 112.353 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 107' ' ' THR . 20.0 p -120.26 157.55 28.89 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.374 -0.83 . . . . 0.0 108.982 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.35 -39.95 95.39 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.401 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -63.5 -39.06 93.45 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 104' ' ' THR . 27.2 m -128.95 145.22 51.29 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.507 0.194 . . . . 0.0 111.278 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.7 m -124.02 75.65 58.49 Favored Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.553 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -63.76 146.54 92.11 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.961 2.441 . . . . 0.0 112.908 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -107.61 133.54 51.9 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.5 m -127.58 78.42 74.83 Favored Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.226 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -54.76 144.06 67.41 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.287 1.992 . . . . 0.0 111.784 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.7 mt -94.32 144.43 25.55 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.165 -0.47 . . . . 10.19 110.631 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 116' ' ' THR . 42.5 t -110.67 132.22 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.22 -0.446 . . . . 7.2800000000000002 109.967 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.48 25.77 11.34 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.362 0.504 . . . . 7.2999999999999998 112.362 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.524 ' H ' HG12 ' A' ' 114' ' ' VAL . 44.1 p -78.22 155.83 30.1 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.19 -0.604 . . . . 6.4400000000000004 110.85 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 85.7 p -65.77 -27.21 68.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.759 -0.655 . . . . 4.4199999999999999 111.82 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 118' ' ' GLU . 82.9 tt0 55.41 17.73 2.3 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.76 -0.83 . . . . 3.0499999999999998 108.76 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 60.4 p -71.94 166.7 21.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.165 -0.925 . . . . 3.4300000000000002 111.471 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.524 ' O ' HG12 ' A' ' 120' ' ' VAL . 12.1 t 64.51 15.35 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 CA-C-N 115.595 -0.729 . . . . 2.8799999999999999 111.387 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.8 t -72.07 135.37 46.27 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.548 -0.461 . . . . 2.0899999999999999 109.887 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.14 142.29 56.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.484 -0.326 . . . . 4.5300000000000002 110.777 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 32.9 pt -124.43 155.98 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.361 -0.382 . . . . 1.4399999999999999 110.763 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.468 ' OG1' ' CG ' ' A' ' 174' ' ' PRO . 24.2 p -126.78 161.76 27.43 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.055 -0.521 . . . . 1.78 110.406 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' A' ' 126' ' ' SER . . . -69.56 138.5 53.29 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.713 -0.395 . . . . 0.64000000000000001 110.337 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.3 OUTLIER 166.49 14.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.888 0.851 . . . . 0.66000000000000003 109.317 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.444 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.82 167.54 0.25 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.959 -1.018 . . . . 0.68999999999999995 110.944 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.66 145.48 49.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.757 -0.656 . . . . 0.52000000000000002 110.178 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.23 101.76 9.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.075 -0.713 . . . . 0.32000000000000001 109.075 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.0 t -112.96 139.68 36.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.982 -0.554 . . . . 0.28999999999999998 111.077 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.1 p -128.79 152.6 48.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.625 -0.716 . . . . 0.25 109.812 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.594 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.76 -164.97 2.04 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.731 -0.388 . . . . 0.31 110.666 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.5 t -123.87 127.12 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.48999999999999999 110.853 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.18 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -58.03 58.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 1.53 110.383 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.11 24.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.831 -0.622 . . . . 0.96999999999999997 111.482 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.18 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.18 128.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.59 -0.444 . . . . 1.5600000000000001 110.904 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.42 -9.59 55.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.926 -0.579 . . . . 1.8799999999999999 110.332 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.432 ' HB ' ' OE2' ' A' ' 187' ' ' GLU . 28.5 p -87.09 0.2 55.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.094 -0.503 . . . . 1.04 110.348 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.28 137.21 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.987 -0.551 . . . . 0.23999999999999999 109.905 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 185' ' ' ILE . 81.8 p -96.19 -15.59 21.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.301 0.572 . . . . 0.28999999999999998 110.04 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.627 ' HA3' ' HZ2' ' A' ' 61' ' ' LYS . . . 178.61 175.57 45.79 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 109.929 -1.269 . . . . 0.13 109.929 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.646 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . 76.2 m-85 -123.45 151.63 42.48 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.605 -0.438 . . . . 0.17000000000000001 110.521 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.6 ' CZ ' ' CG ' ' A' ' 15' ' ' PRO . 73.8 ttt-85 -132.38 121.18 23.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.14 -0.482 . . . . 1.29 109.938 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.556 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.09 136.49 38.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.646 -0.707 . . . . 0.25 110.705 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 81.4 tt0 -129.3 129.82 45.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.966 -0.561 . . . . 1.3200000000000001 110.132 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.627 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 36.1 p90 -138.65 135.3 34.73 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.06 -0.518 . . . . 0.56999999999999995 110.659 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.421 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.31 161.35 39.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.723 -0.672 . . . . 1.1599999999999999 109.699 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.961 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.01 124.84 25.31 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.666 -0.414 . . . . 0.38 110.814 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.82 -7.66 49.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.764 -0.653 . . . . 0.40999999999999998 110.76 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -109.78 -69.69 0.85 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.003 0.43 . . . . 1.6599999999999999 111.477 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.47 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.58 -35.4 75.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.995 -0.548 . . . . 1.6599999999999999 111.561 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.076 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.14 88.66 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.905 -0.878 . . . . 1.1699999999999999 110.905 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.332 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.92 -171.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.742 0.306 . . . . 1.8600000000000001 110.24 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.332 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.3 139.04 44.98 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 1.98 110.198 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 48.1 Cg_endo -70.83 145.79 51.88 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 122.755 2.304 . . . . 0.55000000000000004 112.299 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.627 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.83 145.83 42.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.263 -0.643 . . . . 1.1399999999999999 109.263 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.535 ' CE1' ' CD ' ' A' ' 65' ' ' PRO . 14.5 p90 -123.37 141.24 52.19 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.356 -0.538 . . . . 0.93000000000000005 111.54 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.5 mt -128.03 127.68 43.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.356 -0.838 . . . . 0.34000000000000002 108.95 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.479 ' OD2' ' HA2' ' A' ' 62' ' ' GLY . 95.2 m-20 -101.69 131.1 48.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.127 0.489 . . . . 1.0900000000000001 111.76 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.91 157.59 73.26 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.323 -0.853 . . . . 0.19 109.557 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -69.76 158.0 58.46 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.467 2.111 . . . . 0.17999999999999999 112.239 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.417 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.28 -12.14 5.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.754 -0.657 . . . . 0.20999999999999999 110.79 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.7 p -92.85 -8.75 42.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.28999999999999998 110.662 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.15 135.36 34.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.394 -0.366 . . . . 0.5 110.361 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.17 16.72 4.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.358 -0.383 . . . . 0.29999999999999999 110.502 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.0 p -167.55 147.04 5.05 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.694 -0.484 . . . . 0.23000000000000001 109.694 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.11 150.53 12.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.514 -0.474 . . . . 0.28000000000000003 111.509 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.512 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.34 124.89 50.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.541 -0.754 . . . . 1.0700000000000001 109.825 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.43 104.86 29.69 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.404 -0.362 . . . . 0.28999999999999998 111.117 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 84.3 Cg_endo -90.99 -179.42 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 123.046 2.497 . . . . 0.42999999999999999 112.163 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.61 32.68 18.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.393 -0.821 . . . . 1.26 111.501 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.449 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.4 mt -86.4 148.64 25.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 0.32000000000000001 110.467 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.776 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.42 114.85 61.39 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.976 0.417 . . . . 0.57999999999999996 110.585 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.468 ' CG ' ' OG1' ' A' ' 124' ' ' THR . 21.9 Cg_exo -59.0 140.62 96.16 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.866 2.377 . . . . 0.66000000000000003 111.962 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.27 74.19 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.042 -0.823 . . . . 0.28999999999999998 111.042 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.47 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.99 150.1 49.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.333 . . . . 2.3300000000000001 110.62 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.08 131.62 45.92 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.026 -0.533 . . . . 0.85999999999999999 109.745 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.961 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.5 148.47 43.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.16 -0.473 . . . . 0.52000000000000002 111.036 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.5 mt -105.42 125.32 60.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 108.271 -1.011 . . . . 0.29999999999999999 108.271 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.58 132.51 63.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.164 0.507 . . . . 0.23000000000000001 111.192 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.47 122.57 20.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.565 -0.743 . . . . 0.35999999999999999 109.628 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.594 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.02 125.42 54.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.286 -0.415 . . . . 0.19 110.713 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.26 137.81 52.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.07 -0.514 . . . . 0.29999999999999999 109.837 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.584 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.61 135.03 42.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.828 -0.805 . . . . 0.37 108.828 178.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.594 ' O ' ' N ' ' A' ' 140' ' ' SER . 50.0 mm -99.11 122.91 51.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.148 0.499 . . . . 0.26000000000000001 111.015 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.1 p -83.84 169.62 14.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.547 -0.752 . . . . 0.28000000000000003 110.49 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.612 ' O ' HG21 ' A' ' 59' ' ' THR . 0.0 OUTLIER -59.67 -14.59 14.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.06 -0.518 . . . . 1.6000000000000001 110.954 -179.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 87.2 m-20 -96.03 -4.35 43.24 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.784 -0.366 . . . . 1.1799999999999999 110.793 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.78 14.0 63.82 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.356 -0.697 . . . . 0.29999999999999999 111.356 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -84.66 139.07 32.3 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.093 -0.243 . . . . 1.22 110.439 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.516 ' NE2' ' HG3' ' A' ' 14' ' ' GLN . 4.1 mt-30 -106.78 141.05 38.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.868 0.366 . . . . 0.97999999999999998 110.537 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.4 m -136.67 127.05 26.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.82999999999999996 110.367 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 25.6 tp -68.18 117.25 9.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.319 -0.4 . . . . 0.26000000000000001 110.486 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.01 -21.69 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.29999999999999999 110.725 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.96 125.78 5.85 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.55 -0.46 . . . . 0.31 111.466 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.461 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.82 120.19 21.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.739 -0.664 . . . . 0.28000000000000003 109.591 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.62 151.66 29.08 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.608 -0.437 . . . . 0.23999999999999999 110.895 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.8 p -110.38 158.61 18.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.99 -0.55 . . . . 0.23000000000000001 110.451 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.13 157.95 43.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.068 -0.514 . . . . 0.67000000000000004 110.639 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.36 9.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.689 -0.687 . . . . 0.64000000000000001 109.99 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.5 p . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.966 -1.016 . . . . 1.26 110.556 -179.711 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.9 m . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.18 -0.674 . . . . 3.4399999999999999 109.18 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.36 150.72 18.54 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.956 -0.858 . . . . 1.22 110.956 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -35.52 142.39 0.1 OUTLIER 'Trans proline' 0 C--N 1.3 -2.024 0 C-N-CA 123.965 3.11 . . . . 0.75 113.845 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -79.96 173.47 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.25 -1.341 . . . . 0.79000000000000004 108.904 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.612 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.59 125.91 51.53 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.416 -0.513 . . . . 1.9399999999999999 111.423 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.62 144.01 33.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.688 -0.687 . . . . 0.59999999999999998 110.693 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.04 168.29 25.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.852 0.358 . . . . 3.1400000000000001 111.093 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.744 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.92 131.03 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.019 -0.537 . . . . 3.23 110.109 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.21 162.22 36.0 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.917 0.389 . . . . 3.6299999999999999 111.213 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 32.6 tp10 36.23 31.47 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.651 -0.5 . . . . 6.0800000000000001 109.651 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.744 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.65 32.74 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.914 -0.585 . . . . 3.3799999999999999 111.575 -178.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.632 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.29 -29.16 72.68 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.494 2.129 . . . . 3.9300000000000002 111.81 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.632 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.7 125.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 3.3599999999999999 110.377 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.646 ' O ' ' O ' ' A' ' 92' ' ' THR . 11.7 mp0 -123.97 158.41 60.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.321 -0.399 . . . . 3.6099999999999999 110.49 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.566 ' HB2' HH21 ' A' ' 143' ' ' ARG . 96.9 Cg_endo -82.11 -64.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.852 2.368 . . . . 1.51 113.47 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.577 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 63.5 t30 -108.35 -19.67 13.39 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.081 0.4 . . . . 2.6800000000000002 112.081 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 66.1 p -107.31 152.13 24.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.206 0.527 . . . . 1.21 111.246 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.573 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.33 102.96 2.22 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.702 -0.681 . . . . 1.5600000000000001 110.63 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.8 Cg_endo -82.75 145.58 12.88 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.912 2.408 . . . . 0.81000000000000005 112.611 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.906 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.73 167.96 24.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.938 -0.573 . . . . 1.52 109.879 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -149.14 147.99 29.11 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.609 -0.515 . . . . 2.1400000000000001 109.609 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.591 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.8 p90 -142.28 157.26 45.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.019 0.437 . . . . 0.32000000000000001 111.229 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.487 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.05 155.24 44.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.853 -0.612 . . . . 2.1699999999999999 110.098 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.835 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.57 172.99 6.41 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 121.137 0.494 . . . . 0.58999999999999997 110.801 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.835 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.61 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.913 2.409 . . . . 0.90000000000000002 111.534 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.477 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.14 -51.06 0.68 Allowed Pre-proline 0 C--N 1.328 -0.344 0 C-N-CA 120.709 -0.397 . . . . 3.3399999999999999 110.052 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.79 152.32 82.53 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.808 2.339 . . . . 1.8500000000000001 111.442 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.66 42.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.373 0.606 . . . . 2.54 110.571 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.82 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.73 -41.56 98.04 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.037 -0.983 . . . . 2.5299999999999998 110.653 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.532 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.2 mt -109.91 137.85 40.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.767 -0.651 . . . . 1.1699999999999999 111.211 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.91 -72.94 0.7 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.004 -0.544 . . . . 1.27 111.936 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.15 148.37 24.45 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.651 0.611 . . . . 1.1200000000000001 112.651 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.82 124.82 45.06 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.35 -0.611 . . . . 0.41999999999999998 109.35 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.9 mt -118.08 134.73 60.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.646 -0.422 . . . . 0.78000000000000003 110.566 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.906 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.99 128.63 53.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.434 . . . . 0.62 111.288 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.548 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.14 139.01 49.73 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.746 -0.661 . . . . 1.97 110.115 178.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.438 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.14 163.13 35.3 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.176 0.512 . . . . 0.34999999999999998 112.018 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.48 139.49 7.81 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 115.399 -0.818 . . . . 1.8 110.484 178.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.53 115.5 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.309 2.006 . . . . 0.57999999999999996 111.839 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.667 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.03 81.21 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.81 -0.441 . . . . 3.04 109.81 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.15 -20.75 0.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.027 -0.533 . . . . 2.4700000000000002 111.843 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.4 p -157.52 157.75 34.4 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.937 -0.305 . . . . 2.5099999999999998 110.65 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.43 27.9 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.27 -0.423 . . . . 1.8600000000000001 110.241 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.89 -75.83 1.31 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 121.066 -0.587 . . . . 1.4399999999999999 111.834 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.91 152.27 35.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.964 0.411 . . . . 4.6900000000000004 110.927 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.676 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.24 -169.14 2.53 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.068 -0.514 . . . . 1.4299999999999999 111.938 179.298 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.11 149.69 29.68 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.463 0.649 . . . . 1.74 112.569 -177.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -140.98 156.53 46.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.745 -1.116 . . . . 1.9199999999999999 110.257 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.3 158.47 41.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.967 -0.56 . . . . 0.34000000000000002 111.706 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.7 m -115.24 135.69 53.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.385 -0.825 . . . . 0.40999999999999998 109.799 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.591 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.43 122.05 23.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.403 -0.362 . . . . 0.55000000000000004 111.48 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.1 Cg_exo -46.45 151.75 1.71 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.675 2.25 . . . . 0.44 112.115 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.98 -22.87 63.03 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 116.092 -0.504 . . . . 0.73999999999999999 112.798 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.9 -16.9 45.66 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.259 -0.576 . . . . 0.93000000000000005 111.763 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.604 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.52 138.37 31.63 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.848 -0.341 . . . . 0.96999999999999997 110.366 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.56 13.92 10.97 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.409 -0.359 . . . . 1.3400000000000001 111.561 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.475 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -150.01 143.49 25.21 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.658 -0.417 . . . . 0.39000000000000001 111.061 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.72 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.82 -169.38 1.54 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.076 -0.511 . . . . 0.41999999999999998 110.961 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.72 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.3 m -151.69 125.92 9.31 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.483 -0.78 . . . . 0.39000000000000001 109.867 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.511 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.9 mt -114.94 123.29 70.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.404 -0.518 . . . . 0.73999999999999999 111.186 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -126.48 163.48 23.25 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.824 -0.625 . . . . 2.48 110.37 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.46 ' HA2' HD21 ' A' ' 16' ' ' ASN . . . 85.09 18.9 60.09 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.735 -0.946 . . . . 0.5 110.735 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.577 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.4 mt -78.9 157.22 28.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.065 0.459 . . . . 0.57999999999999996 111.438 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.851 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -99.52 133.94 21.52 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.684 -0.689 . . . . 2.79 110.396 179.858 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.472 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.95 143.62 61.18 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.519 2.146 . . . . 0.87 111.97 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.73 25.79 75.15 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.041 -0.823 . . . . 0.64000000000000001 111.041 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.851 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.16 158.85 39.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.705 0.288 . . . . 0.82999999999999996 110.456 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.23 139.95 42.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.946 0.403 . . . . 0.5 110.562 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.662 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.6 m-85 -122.59 136.42 54.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.949 -0.568 . . . . 0.53000000000000003 110.729 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.489 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.9 131.01 45.31 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.488 -0.93 . . . . 1.8700000000000001 108.488 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.46 153.85 16.64 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.261 -0.971 . . . . 0.28999999999999998 111.917 -178.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.93 140.9 46.1 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.73 -0.47 . . . . 1.4299999999999999 109.73 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.9 tp -115.7 118.9 34.35 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.493 -0.483 . . . . 0.32000000000000001 110.553 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.726 HG12 HG23 ' A' ' 84' ' ' VAL . 64.2 mt -112.43 129.08 68.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.303 -0.408 . . . . 0.79000000000000004 110.669 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.708 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.78 120.84 43.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.289 -0.414 . . . . 1.02 110.715 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.849 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.52 146.43 11.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.241 0.543 . . . . 0.62 111.01 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.82 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.02 153.9 21.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.524 -0.762 . . . . 2.4399999999999999 109.956 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.26 88.65 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.932 0.396 . . . . 3.6899999999999999 110.42 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.622 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.21 32.73 0.21 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.793 -0.639 . . . . 6.0800000000000001 110.609 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.12 -117.38 3.29 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.437 -0.665 . . . . 1.22 111.437 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.467 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.5 177.37 8.99 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.158 0.504 . . . . 2.8799999999999999 111.661 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.1 149.51 32.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.481 -0.781 . . . . 1.47 110.359 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.16 144.72 38.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.417 -0.356 . . . . 2.7000000000000002 110.558 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.726 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.01 136.01 61.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 121.048 0.451 . . . . 0.46000000000000002 111.506 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.6 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.04 141.37 52.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.624 -0.716 . . . . 0.34999999999999998 110.279 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.68 138.93 51.66 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.441 -0.503 . . . . 3.6699999999999999 111.466 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.491 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 53.0 p90 -152.32 164.23 37.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.521 -0.763 . . . . 0.67000000000000004 109.467 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.575 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.24 151.52 38.51 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.503 -0.479 . . . . 1.47 111.084 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.807 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.1 p90 -146.22 172.7 13.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.782 -0.645 . . . . 0.44 111.068 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.8 160.61 21.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.496 -0.774 . . . . 1.3700000000000001 109.821 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.36 121.83 22.92 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 120.587 -0.445 . . . . 1.28 110.781 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.646 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -128.08 163.55 24.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.156 -0.475 . . . . 1.97 110.309 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.6 t -109.95 132.45 54.15 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 120.312 -0.555 . . . . 3.2799999999999998 110.628 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.8 p -130.09 163.91 25.54 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.25 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 29.6 t -118.18 135.24 54.36 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 38.9 m -132.9 78.33 66.21 Favored Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.527 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.15 136.08 66.59 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 121.899 1.733 . . . . 0.0 112.145 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 83.4 t -64.28 -37.76 80.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.258 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.2 p -79.21 162.25 25.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.459 0.647 . . . . 0.0 112.047 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.5 p -69.26 -10.34 57.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.046 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -57.73 166.68 1.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.933 0.397 . . . . 0.0 110.695 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.2 p -78.19 164.17 25.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.24 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 71.6 t -58.85 -39.3 77.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.428 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.7 p -80.58 157.93 25.9 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.154 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 153.52 -173.59 32.25 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -114.19 -96.63 0.45 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.49 ' OG1' ' NZ ' ' A' ' 177' ' ' LYS . 47.4 m -126.78 137.52 53.23 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.593 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.1 p -78.72 141.0 59.35 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.6 141.61 86.67 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.767 1.645 . . . . 0.0 111.787 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.445 ' O ' ' OG ' ' A' ' 111' ' ' SER . 49.3 p90 -140.23 157.35 45.72 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.956 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 110' ' ' PHE . 49.0 m -171.95 63.5 0.35 Allowed Pre-proline 0 C--N 1.332 -0.152 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.812 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -54.62 139.28 76.23 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.995 1.797 . . . . 0.0 112.12 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.2 mt -62.2 -34.55 76.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 10.19 110.566 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 26.2 m -69.83 135.77 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.096 -0.502 . . . . 7.2800000000000002 111.336 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.22 148.12 52.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.859 -0.609 . . . . 7.2999999999999998 110.283 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.515 HG22 ' H ' ' A' ' 118' ' ' GLU . 47.6 m -73.61 135.98 43.89 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.826 -0.35 . . . . 6.4400000000000004 110.218 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.6 m -58.35 -35.13 71.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.053 -0.522 . . . . 4.4199999999999999 111.383 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.522 ' HG2' ' H ' ' A' ' 120' ' ' VAL . 84.2 tt0 -99.0 140.58 32.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.414 -0.357 . . . . 3.0499999999999998 110.256 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.0 t -57.76 -34.0 69.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 3.4300000000000002 111.033 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.618 HG22 ' H ' ' A' ' 122' ' ' GLU . 12.4 p -129.64 142.74 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.251 -0.431 . . . . 2.8799999999999999 110.136 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 59.5 p -67.9 -24.88 65.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.338 -0.392 . . . . 2.0899999999999999 111.668 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.618 ' H ' HG22 ' A' ' 120' ' ' VAL . 77.7 mm-40 -58.71 142.4 49.99 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.817 -0.353 . . . . 4.5300000000000002 110.427 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 16.8 tt -123.84 139.12 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.038 -0.528 . . . . 1.4399999999999999 110.633 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.614 ' O ' ' HB3' ' A' ' 125' ' ' ALA . 45.2 m -72.83 137.29 45.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.414 -0.357 . . . . 1.78 110.14 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 124' ' ' THR . . . 81.88 144.32 0.07 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.012 -0.54 . . . . 0.64000000000000001 109.686 -179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.3 p -61.47 -32.74 72.75 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.53 -0.468 . . . . 0.66000000000000003 110.818 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.431 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.86 167.55 0.26 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 0.68999999999999995 110.959 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.54 145.6 50.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.692 -0.685 . . . . 0.52000000000000002 110.186 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.29 101.65 9.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.086 -0.709 . . . . 0.32000000000000001 109.086 177.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.1 t -113.0 139.78 36.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.985 -0.552 . . . . 0.28999999999999998 111.063 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.7 p -128.71 152.49 48.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.67 -0.696 . . . . 0.25 109.832 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.594 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.9 p90 -144.7 -164.89 2.02 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.722 -0.391 . . . . 0.31 110.691 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.734 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -124.06 127.24 73.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.198 -0.456 . . . . 0.48999999999999999 110.73 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.172 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.099 -0.501 . . . . 1.53 110.342 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -37.96 24.45 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.946 -0.57 . . . . 0.96999999999999997 111.566 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.172 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.13 128.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.724 -0.391 . . . . 1.5600000000000001 111.002 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -86.45 -9.51 56.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.942 -0.572 . . . . 1.8799999999999999 110.281 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.14 0.16 55.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 1.04 110.315 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.06 137.15 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 116.008 -0.542 . . . . 0.23999999999999999 109.985 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 185' ' ' ILE . 87.3 p -96.26 -15.48 21.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.242 0.544 . . . . 0.28999999999999998 110.066 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.64 175.61 45.86 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 109.881 -1.288 . . . . 0.13 109.881 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.51 151.6 42.63 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.673 -0.411 . . . . 0.17000000000000001 110.434 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.566 HH21 ' HB2' ' A' ' 15' ' ' PRO . 69.4 ttt-85 -132.36 121.16 23.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.122 -0.49 . . . . 1.29 109.926 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.556 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.04 136.6 38.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.681 -0.691 . . . . 0.25 110.69 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 83.7 tt0 -129.43 129.84 45.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.067 -0.515 . . . . 1.3200000000000001 110.01 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.623 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.7 135.32 34.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.965 -0.561 . . . . 0.56999999999999995 110.656 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.425 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.38 39.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.77 -0.65 . . . . 1.1599999999999999 109.641 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.957 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.13 124.85 25.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.039 0.447 . . . . 0.38 110.673 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.73 -7.72 49.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.684 -0.689 . . . . 0.40999999999999998 110.883 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.77 -69.74 0.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.315 -0.402 . . . . 1.6599999999999999 111.432 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.438 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.68 -35.21 75.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.027 -0.533 . . . . 1.6599999999999999 111.563 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.093 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.07 7.29 88.54 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.814 -0.914 . . . . 1.1699999999999999 110.814 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.322 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.93 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.773 0.321 . . . . 1.8600000000000001 110.256 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.322 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.33 139.05 44.89 Favored Pre-proline 0 N--CA 1.454 -0.261 0 CA-C-N 116.302 -0.408 . . . . 1.98 110.157 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.425 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.2 Cg_endo -70.85 145.89 52.06 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 C-N-CA 122.656 2.237 . . . . 0.55000000000000004 112.398 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.82 145.68 42.63 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.232 -0.655 . . . . 1.1399999999999999 109.232 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.57 ' CE2' ' CG ' ' A' ' 16' ' ' ASN . 37.3 p90 -123.24 141.37 52.05 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.345 -0.542 . . . . 0.93000000000000005 111.463 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.12 127.74 43.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.313 -0.858 . . . . 0.34000000000000002 108.966 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -101.68 131.17 48.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.097 0.475 . . . . 1.0900000000000001 111.779 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.89 157.56 73.33 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.373 -0.831 . . . . 0.19 109.61 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -69.84 158.0 58.32 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.382 2.054 . . . . 0.17999999999999999 112.27 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.24 -12.17 5.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.792 -0.64 . . . . 0.20999999999999999 110.714 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.3 p -92.79 -8.74 42.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.28999999999999998 110.714 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.41 34.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.363 -0.38 . . . . 0.5 110.434 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.4 p -133.14 16.58 4.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.348 -0.387 . . . . 0.29999999999999999 110.475 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.6 p -167.48 147.23 5.15 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.642 -0.503 . . . . 0.23000000000000001 109.642 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.18 150.35 13.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.617 -0.433 . . . . 0.28000000000000003 111.606 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.25 124.95 50.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.67 -0.695 . . . . 1.0700000000000001 109.803 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.42 104.9 29.84 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.426 -0.352 . . . . 0.28999999999999998 111.117 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.3 Cg_endo -90.91 -179.46 1.51 Allowed 'Trans proline' 0 C--N 1.3 -1.988 0 C-N-CA 123.231 2.621 . . . . 0.42999999999999999 112.282 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 61.56 32.65 18.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.475 -0.784 . . . . 1.26 111.499 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.6 mt -86.4 148.58 25.51 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.887 -0.325 . . . . 0.32000000000000001 110.433 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.766 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.27 114.87 61.36 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.051 0.453 . . . . 0.57999999999999996 110.69 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.95 140.52 95.66 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.951 2.434 . . . . 0.66000000000000003 111.955 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.27 74.16 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.023 -0.831 . . . . 0.28999999999999998 111.023 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.438 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.89 150.13 49.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.839 0.352 . . . . 2.3300000000000001 110.643 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.501 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.11 131.58 45.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.85999999999999999 109.814 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.957 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.49 148.3 44.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.022 -0.536 . . . . 0.52000000000000002 111.043 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.1 mt -105.27 125.29 60.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 108.286 -1.005 . . . . 0.29999999999999999 108.286 177.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.46 132.47 63.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.193 0.52 . . . . 0.23000000000000001 111.315 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.6 20.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.501 -0.772 . . . . 0.35999999999999999 109.638 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.594 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -101.03 125.39 54.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.217 -0.447 . . . . 0.19 110.73 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.9 m-85 -117.25 137.9 52.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.954 -0.566 . . . . 0.29999999999999999 109.823 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.582 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.71 135.02 42.81 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.797 -0.816 . . . . 0.37 108.797 178.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 140' ' ' SER . 44.5 mm -99.08 123.0 51.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.136 0.493 . . . . 0.26000000000000001 110.937 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.0 p -83.94 169.73 14.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.568 -0.742 . . . . 0.28000000000000003 110.466 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -59.82 -14.44 14.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.057 -0.519 . . . . 1.6000000000000001 110.888 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.507 ' C ' ' OG1' ' A' ' 59' ' ' THR . 96.4 m-20 -96.19 -4.34 42.71 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.834 -0.347 . . . . 1.1799999999999999 110.708 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.62 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.85 13.93 63.83 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.3 -0.72 . . . . 0.29999999999999999 111.3 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -84.64 139.03 32.34 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.099 -0.24 . . . . 1.22 110.49 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.43 ' NE2' ' OG ' ' A' ' 17' ' ' SER . 1.6 mt-30 -106.64 141.05 38.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.436 -0.347 . . . . 0.97999999999999998 110.542 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.5 m -136.7 127.07 26.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.82999999999999996 110.374 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.8 tp -68.11 117.3 9.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.329 -0.396 . . . . 0.26000000000000001 110.502 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.3 pt -109.09 -21.81 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.29999999999999999 110.625 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.91 125.72 5.85 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.523 -0.471 . . . . 0.31 111.48 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.468 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.76 120.22 21.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.799 -0.637 . . . . 0.28000000000000003 109.541 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.62 151.68 29.11 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.663 -0.415 . . . . 0.23999999999999999 110.938 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.42 158.61 18.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.062 -0.517 . . . . 0.23000000000000001 110.408 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.1 157.96 43.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.107 -0.497 . . . . 0.67000000000000004 110.667 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 104.29 9.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.714 -0.676 . . . . 0.64000000000000001 110.032 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.858 -1.068 . . . . 1.26 110.664 -179.761 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.55 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.3 m . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.141 -0.688 . . . . 3.4399999999999999 109.141 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.32 150.72 18.54 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.048 -0.821 . . . . 1.22 111.048 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -35.59 142.42 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.121 0 C-N-CA 124.009 3.139 . . . . 0.75 113.824 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.3 t -80.02 173.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.199 -1.364 . . . . 0.79000000000000004 108.775 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.601 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.62 125.92 51.55 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.385 -0.526 . . . . 1.9399999999999999 111.371 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.48 143.99 34.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.629 -0.714 . . . . 0.59999999999999998 110.689 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.4 25.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.833 0.349 . . . . 3.1400000000000001 111.145 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.749 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.07 131.0 61.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 3.23 109.989 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.16 162.44 35.48 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.882 0.372 . . . . 3.6299999999999999 111.169 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 9' ' ' THR . 71.0 tt0 36.02 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.088 -0.505 . . . . 6.0800000000000001 109.689 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.749 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.59 33.07 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.924 -0.58 . . . . 3.3799999999999999 111.62 -178.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.636 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.33 -29.04 72.25 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.438 2.092 . . . . 3.9300000000000002 111.868 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.636 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.57 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 3.3599999999999999 110.518 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.744 HE21 HE21 ' A' ' 191' ' ' GLN . 23.2 mt-30 -123.96 158.22 60.92 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.36 -0.382 . . . . 3.6099999999999999 110.468 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.492 ' HG2' ' CZ ' ' A' ' 143' ' ' ARG . 96.4 Cg_endo -81.94 -64.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.903 2.402 . . . . 1.51 113.568 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.64 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 56.6 t30 -108.49 -19.55 13.41 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.027 0.38 . . . . 2.6800000000000002 112.027 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.535 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 43.3 t -107.36 152.1 24.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.091 0.472 . . . . 1.21 111.29 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.3 102.87 2.22 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.675 -0.693 . . . . 1.5600000000000001 110.666 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.68 145.59 13.0 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.882 2.388 . . . . 0.81000000000000005 112.59 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.904 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.81 167.88 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 1.52 109.863 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.08 148.0 29.17 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.804 -0.443 . . . . 2.1400000000000001 109.804 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.581 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.8 p90 -142.31 157.29 44.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.065 0.46 . . . . 0.32000000000000001 111.168 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.497 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.02 155.24 44.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.751 -0.659 . . . . 2.1699999999999999 110.122 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.833 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.53 173.13 6.25 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 121.168 0.509 . . . . 0.58999999999999997 110.665 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.833 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.8 Cg_exo -50.65 173.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.816 2.344 . . . . 0.90000000000000002 111.551 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.483 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.09 -51.13 0.68 Allowed Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.775 -0.37 . . . . 3.3399999999999999 110.062 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.64 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.72 152.22 82.81 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.856 2.371 . . . . 1.8500000000000001 111.481 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.63 42.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.479 0.657 . . . . 2.54 110.624 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.824 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.68 -41.62 98.13 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.89 -1.05 . . . . 2.5299999999999998 110.569 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.533 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.8 mt -109.79 137.79 40.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.846 -0.616 . . . . 1.1699999999999999 111.262 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.87 -72.96 0.7 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.043 -0.526 . . . . 1.27 111.939 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.12 148.35 24.48 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.593 0.59 . . . . 1.1200000000000001 112.593 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.84 124.82 45.05 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.304 -0.628 . . . . 0.41999999999999998 109.304 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -117.99 134.69 60.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.683 -0.407 . . . . 0.78000000000000003 110.658 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.904 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.0 128.58 53.68 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.053 0.454 . . . . 0.62 111.277 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.1 139.05 49.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.778 -0.646 . . . . 1.97 110.133 178.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.439 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.1 163.16 35.17 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.145 0.498 . . . . 0.34999999999999998 112.067 -178.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.494 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.4 139.69 7.99 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.452 -0.795 . . . . 1.8 110.479 178.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.58 115.49 3.08 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.273 1.982 . . . . 0.57999999999999996 111.879 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.666 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.04 81.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.865 -0.42 . . . . 3.04 109.865 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.693 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.925 -0.58 . . . . 2.4700000000000002 111.939 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.8 p -157.56 157.81 34.43 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.877 -0.329 . . . . 2.5099999999999998 110.617 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.406 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.8 m -120.38 27.8 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 1.8600000000000001 110.16 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -75.83 1.31 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.143 -0.551 . . . . 1.4399999999999999 111.846 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.85 152.25 35.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.91 0.386 . . . . 4.6900000000000004 111.084 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.673 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.16 -169.01 2.5 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.103 -0.498 . . . . 1.4299999999999999 111.919 179.352 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.17 149.72 29.68 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.434 0.635 . . . . 1.74 112.582 -177.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.08 156.48 45.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.856 -1.065 . . . . 1.9199999999999999 110.316 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.469 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.21 158.39 41.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.027 -0.533 . . . . 0.34000000000000002 111.75 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.8 m -115.22 135.61 53.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.445 -0.798 . . . . 0.40999999999999998 109.751 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.581 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.41 121.98 23.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.394 -0.367 . . . . 0.55000000000000004 111.513 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.597 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.9 Cg_exo -46.33 151.66 1.66 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.656 2.237 . . . . 0.44 112.097 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.83 -23.11 62.98 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 116.0 -0.545 . . . . 0.73999999999999999 112.771 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.545 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.71 -16.87 46.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.371 0.586 . . . . 0.93000000000000005 111.882 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.597 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.55 138.29 31.69 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.804 -0.359 . . . . 0.96999999999999997 110.368 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.39 13.8 11.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.391 -0.368 . . . . 1.3400000000000001 111.578 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.83 143.52 25.39 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.662 -0.415 . . . . 0.39000000000000001 111.084 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.725 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.85 -169.39 1.54 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.222 0.534 . . . . 0.41999999999999998 110.883 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.725 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.7 t -151.74 125.88 9.25 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.418 -0.81 . . . . 0.39000000000000001 109.806 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.516 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.9 mt -114.89 123.29 70.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.369 -0.532 . . . . 0.73999999999999999 111.24 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.749 ' CD ' HD12 ' A' ' 185' ' ' ILE . 1.2 mtmt -126.49 163.44 23.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.773 -0.649 . . . . 2.48 110.405 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.439 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.07 19.0 59.94 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.776 -0.93 . . . . 0.5 110.776 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.64 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.6 mt -79.07 157.23 28.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.124 0.488 . . . . 0.57999999999999996 111.411 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.845 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -99.49 133.9 21.57 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.677 -0.692 . . . . 2.79 110.439 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.828 ' O ' HG22 ' A' ' 116' ' ' THR . 36.7 Cg_endo -67.74 143.55 62.12 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.61 2.207 . . . . 0.87 111.948 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.86 25.63 75.34 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.98 -0.848 . . . . 0.64000000000000001 110.98 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.845 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.16 158.76 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.747 0.308 . . . . 0.82999999999999996 110.406 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.18 139.94 42.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.941 0.4 . . . . 0.5 110.566 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.646 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.55 136.5 54.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.944 -0.571 . . . . 0.53000000000000003 110.763 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.494 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.96 131.03 45.32 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.522 -0.918 . . . . 1.8700000000000001 108.522 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.44 153.9 16.63 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.354 -0.927 . . . . 0.28999999999999998 111.945 -178.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.15 140.91 45.78 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.632 -0.507 . . . . 1.4299999999999999 109.632 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.525 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.69 118.93 34.45 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.422 -0.511 . . . . 0.32000000000000001 110.469 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.74 HG12 HG23 ' A' ' 84' ' ' VAL . 64.2 mt -112.45 129.11 68.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.322 -0.399 . . . . 0.79000000000000004 110.614 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.707 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.87 120.86 43.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.305 -0.407 . . . . 1.02 110.636 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.86 HD12 ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.61 146.47 11.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.305 0.574 . . . . 0.62 110.969 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.824 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -105.96 153.84 21.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.459 -0.791 . . . . 2.4399999999999999 109.943 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.2 mt-30 -39.24 88.61 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.955 0.407 . . . . 3.6899999999999999 110.439 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.624 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.757 -0.656 . . . . 6.0800000000000001 110.57 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.11 -117.35 3.29 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.433 -0.667 . . . . 1.22 111.433 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.461 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.45 177.43 8.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.132 0.491 . . . . 2.8799999999999999 111.688 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.2 149.48 32.02 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.448 -0.797 . . . . 1.47 110.391 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.55 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.1 144.62 38.8 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.444 -0.344 . . . . 2.7000000000000002 110.588 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.74 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.99 135.93 61.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 121.075 0.464 . . . . 0.46000000000000002 111.589 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.571 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.01 141.4 52.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.747 -0.661 . . . . 0.34999999999999998 110.237 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.459 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.69 138.82 51.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.214 0.531 . . . . 3.6699999999999999 111.501 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.21 164.27 37.71 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.532 -0.758 . . . . 0.67000000000000004 109.468 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.573 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 46.9 p30 -145.29 151.53 38.49 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.335 -0.546 . . . . 1.47 111.042 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.801 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.2 p90 -146.3 172.67 13.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.842 -0.617 . . . . 0.44 110.959 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.77 160.66 21.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.43 -0.805 . . . . 1.3700000000000001 109.856 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.38 121.94 23.05 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.585 -0.446 . . . . 1.28 110.742 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.582 HG21 ' OG ' ' A' ' 95' ' ' SER . 70.2 p -130.6 162.37 29.49 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 112.963 0.727 . . . . 1.97 112.963 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.937 ' OG ' HG23 ' A' ' 114' ' ' VAL . 44.6 t -63.6 -37.05 85.85 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.39 -1.277 . . . . 3.2799999999999998 111.522 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 95' ' ' SER . 1.3 m -153.13 -52.83 0.11 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.582 ' OG ' HG21 ' A' ' 92' ' ' THR . 41.4 m 56.68 177.57 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.382 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.29 73.89 39.87 Favored Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.573 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.51 145.19 98.73 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.512 2.141 . . . . 0.0 112.418 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 98' ' ' VAL . 7.3 p -161.9 6.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.798 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.522 ' OG1' ' OD1' ' A' ' 101' ' ' ASN . 29.9 p -83.32 164.68 19.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.393 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 86.1 p -63.29 -22.16 66.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.58 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.522 ' OD1' ' OG1' ' A' ' 99' ' ' THR . 31.7 p-10 -81.91 6.35 16.13 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.613 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 99' ' ' THR . 44.3 p -83.49 163.14 20.66 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.485 HG22 ' H ' ' A' ' 105' ' ' GLY . 7.6 p -63.76 129.26 27.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.959 0.409 . . . . 0.0 110.702 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 56.7 p -73.19 -21.34 60.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.592 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.485 ' H ' HG22 ' A' ' 103' ' ' VAL . . . -83.88 178.46 52.2 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.648 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.95 142.33 57.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.729 0.3 . . . . 0.0 110.933 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.3 m -123.92 138.24 54.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.623 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.426 HG23 ' CZ ' ' A' ' 110' ' ' PHE . 0.1 OUTLIER -71.66 139.73 83.69 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.401 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.44 136.35 75.45 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.905 1.737 . . . . 0.0 113.385 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.426 ' CZ ' HG23 ' A' ' 108' ' ' THR . 96.0 m-85 -125.38 157.29 37.17 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.678 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.69 ' H ' ' CD ' ' A' ' 112' ' ' PRO . 1.2 t -165.94 -39.65 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.69 ' CD ' ' H ' ' A' ' 111' ' ' SER . 41.3 Cg_exo -56.13 141.07 87.83 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 122.413 2.075 . . . . 0.0 114.283 -177.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.893 ' O ' ' HD2' ' A' ' 155' ' ' PRO . 26.9 tp -105.61 133.32 50.54 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.256 -0.884 . . . . 10.19 108.869 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.937 HG23 ' OG ' ' A' ' 93' ' ' SER . 19.1 t -103.0 132.82 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 121.216 0.531 . . . . 7.2800000000000002 110.67 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.48 ' HB2' ' HG3' ' A' ' 154' ' ' GLU . . . -75.69 149.6 38.07 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.411 -0.813 . . . . 7.2999999999999998 111.856 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.828 HG22 ' O ' ' A' ' 65' ' ' PRO . 11.9 p -85.15 163.22 18.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.56 -0.745 . . . . 6.4400000000000004 110.283 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.579 ' CB ' ' O ' ' A' ' 116' ' ' THR . 35.5 p 105.47 171.47 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 O-C-N 123.756 0.66 . . . . 4.4199999999999999 111.174 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.441 ' HG3' ' HZ1' ' A' ' 64' ' ' LYS . 94.0 mt-10 -110.78 154.08 24.44 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.91 -0.586 . . . . 3.0499999999999998 110.623 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.4 m -64.33 157.82 25.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 3.4300000000000002 110.25 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.674 HG12 ' H ' ' A' ' 122' ' ' GLU . 38.8 t -110.57 134.14 53.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.868 0.366 . . . . 2.8799999999999999 110.493 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 58.5 p -70.95 -20.53 62.45 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.016 -0.538 . . . . 2.0899999999999999 111.919 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.674 ' H ' HG12 ' A' ' 120' ' ' VAL . 96.5 mt-10 -56.46 145.92 26.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.984 0.421 . . . . 4.5300000000000002 110.986 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 122' ' ' GLU . 87.3 mt 52.97 117.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.534 -0.757 . . . . 1.4399999999999999 111.356 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.423 ' O ' ' HB3' ' A' ' 127' ' ' SER . 7.3 t -107.47 19.88 19.65 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.314 -0.857 . . . . 1.78 109.823 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.404 ' H ' HG22 ' A' ' 123' ' ' ILE . . . -65.95 150.57 48.43 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.725 -0.671 . . . . 0.64000000000000001 111.994 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.9 OUTLIER 46.95 14.51 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.24 -0.891 . . . . 0.66000000000000003 113.086 178.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.436 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.91 167.53 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.997 0.427 . . . . 0.68999999999999995 110.94 179.169 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.51 145.51 50.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.677 -0.692 . . . . 0.52000000000000002 110.178 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.3 t -124.31 101.77 9.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.049 -0.723 . . . . 0.32000000000000001 109.049 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.0 t -112.99 139.62 37.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.985 -0.552 . . . . 0.28999999999999998 111.09 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.6 p -128.68 152.62 48.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.669 -0.696 . . . . 0.25 109.822 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.592 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.86 -165.0 2.05 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.737 -0.385 . . . . 0.31 110.653 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -123.95 127.21 73.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.189 -0.459 . . . . 0.48999999999999999 110.793 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.173 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.98 58.39 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.149 -0.478 . . . . 1.53 110.367 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.19 24.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.867 -0.606 . . . . 0.96999999999999997 111.451 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.173 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.22 128.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.998 0.428 . . . . 1.5600000000000001 110.933 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.53 -9.5 56.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.94 -0.573 . . . . 1.8799999999999999 110.319 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.22 0.33 55.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.052 -0.522 . . . . 1.04 110.288 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.38 137.3 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 115.988 -0.551 . . . . 0.23999999999999999 109.908 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 185' ' ' ILE . 1.9 m -96.24 -15.51 21.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.282 0.563 . . . . 0.28999999999999998 110.076 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.655 ' HA3' HD11 ' A' ' 185' ' ' ILE . . . 178.65 175.55 45.81 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 109.844 -1.303 . . . . 0.13 109.844 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.45 151.6 42.52 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.668 -0.413 . . . . 0.17000000000000001 110.449 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.558 ' NH2' ' HB3' ' A' ' 157' ' ' TYR . 74.4 ttt-85 -132.31 121.17 23.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.116 -0.493 . . . . 1.29 109.948 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.14 136.61 38.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.718 -0.674 . . . . 0.25 110.62 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 80.7 tt0 -129.33 129.87 45.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.902 -0.59 . . . . 1.3200000000000001 110.072 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.76 135.29 34.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.163 0.506 . . . . 0.56999999999999995 110.595 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.417 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.25 161.42 39.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.754 -0.657 . . . . 1.1599999999999999 109.695 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.14 124.89 25.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.039 0.447 . . . . 0.38 110.684 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.494 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.77 -7.7 49.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.745 -0.662 . . . . 0.40999999999999998 110.885 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -109.85 -69.64 0.85 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.224 -0.444 . . . . 1.6599999999999999 111.331 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.435 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.7 -35.33 76.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.079 -0.51 . . . . 1.6599999999999999 111.445 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.082 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.2 7.13 88.66 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.828 -0.909 . . . . 1.1699999999999999 110.828 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.339 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.96 -171.66 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 1.8600000000000001 110.272 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.339 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.22 139.07 45.28 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.941 0.401 . . . . 1.98 110.196 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.9 ' HG2' HG22 ' A' ' 114' ' ' VAL . 46.4 Cg_endo -70.89 145.79 51.55 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 122.789 2.326 . . . . 0.55000000000000004 112.295 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.8 145.77 42.54 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.264 -0.643 . . . . 1.1399999999999999 109.264 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.558 ' HB3' ' NH2' ' A' ' 143' ' ' ARG . 34.5 p90 -123.33 141.31 52.12 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.364 -0.534 . . . . 0.93000000000000005 111.449 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.8 mt -128.1 127.79 43.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.226 -0.897 . . . . 0.34000000000000002 108.915 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.499 ' HB2' ' ND2' ' A' ' 16' ' ' ASN . 67.8 t0 -101.69 131.21 48.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.16 0.505 . . . . 1.0900000000000001 111.732 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.476 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -128.03 157.62 73.41 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.334 -0.848 . . . . 0.19 109.541 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -69.83 158.08 58.08 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.385 2.057 . . . . 0.17999999999999999 112.248 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.31 -12.19 5.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.839 -0.618 . . . . 0.20999999999999999 110.673 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.9 p -92.83 -8.74 42.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.28999999999999998 110.661 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.23 135.45 34.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.405 -0.362 . . . . 0.5 110.346 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.0 p -133.13 16.6 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.33 -0.396 . . . . 0.29999999999999999 110.524 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.8 p -167.54 147.05 5.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.707 -0.479 . . . . 0.23000000000000001 109.707 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.12 150.56 12.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.533 -0.467 . . . . 0.28000000000000003 111.568 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.508 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.43 124.98 50.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.567 -0.742 . . . . 1.0700000000000001 109.768 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.31 104.9 29.5 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.344 -0.389 . . . . 0.28999999999999998 111.034 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.9 Cg_endo -91.03 -179.56 1.49 Allowed 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 123.215 2.61 . . . . 0.42999999999999999 112.212 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.77 32.61 18.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.427 -0.806 . . . . 1.26 111.458 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.433 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.0 mt -86.42 148.5 25.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.442 -0.345 . . . . 0.32000000000000001 110.391 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.771 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.4 mt -88.24 114.92 61.56 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.987 0.422 . . . . 0.57999999999999996 110.69 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.12 140.55 95.55 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.879 2.386 . . . . 0.66000000000000003 111.978 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.21 74.33 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.102 -0.799 . . . . 0.28999999999999998 111.102 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.435 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.81 150.26 49.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.781 0.324 . . . . 2.3300000000000001 110.661 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.494 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.31 131.61 46.15 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.105 -0.498 . . . . 0.85999999999999999 109.769 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.955 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.47 148.4 43.87 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.012 -0.54 . . . . 0.52000000000000002 110.962 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.36 125.37 60.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.262 -1.014 . . . . 0.29999999999999999 108.262 177.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.56 132.5 63.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.158 0.504 . . . . 0.23000000000000001 111.249 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.9 m-20 -136.48 122.63 20.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.48 -0.782 . . . . 0.35999999999999999 109.693 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.592 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.07 125.39 55.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.241 -0.436 . . . . 0.19 110.63 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 47.9 m-85 -117.2 137.88 52.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.974 -0.557 . . . . 0.29999999999999999 109.912 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.582 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.7 135.09 42.68 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.734 -0.839 . . . . 0.37 108.734 178.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.749 HD12 ' CD ' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -99.24 123.01 51.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.216 0.531 . . . . 0.26000000000000001 110.866 -178.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.4 p -83.84 169.81 14.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.512 -0.767 . . . . 0.28000000000000003 110.399 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.507 ' OE1' ' OG ' ' A' ' 140' ' ' SER . 48.0 tp10 -59.89 -14.52 15.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.948 -0.569 . . . . 1.6000000000000001 110.962 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -96.09 -4.25 43.2 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.818 -0.353 . . . . 1.1799999999999999 110.825 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.89 13.82 63.93 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.297 -0.721 . . . . 0.29999999999999999 111.297 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -84.53 139.04 32.41 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.116 -0.233 . . . . 1.22 110.519 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.744 HE21 HE21 ' A' ' 14' ' ' GLN . 74.3 mt-30 -106.77 141.06 38.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.852 0.358 . . . . 0.97999999999999998 110.596 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.0 m -136.69 126.97 26.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.82999999999999996 110.345 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.0 117.22 9.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.254 -0.43 . . . . 0.26000000000000001 110.502 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.09 -21.69 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.241 -0.436 . . . . 0.29999999999999999 110.728 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.92 125.71 5.84 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.527 -0.469 . . . . 0.31 111.5 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.469 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.76 120.31 21.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.764 -0.653 . . . . 0.28000000000000003 109.539 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.72 151.6 28.93 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.587 -0.445 . . . . 0.23999999999999999 110.89 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.41 158.58 18.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.052 -0.522 . . . . 0.23000000000000001 110.461 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -145.99 158.06 43.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.67000000000000004 110.651 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.37 104.38 9.37 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.775 -0.648 . . . . 0.64000000000000001 110.012 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.2 p . . . . . 0 C--O 1.222 -0.39 0 CA-C-O 117.887 -1.054 . . . . 1.26 110.659 -179.751 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.553 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.148 -0.686 . . . . 3.4399999999999999 109.148 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.41 150.63 18.55 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.992 -0.843 . . . . 1.22 110.992 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -35.51 142.32 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.085 0 C-N-CA 124.083 3.189 . . . . 0.75 113.799 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.3 t -79.98 173.38 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.281 -1.327 . . . . 0.79000000000000004 108.779 178.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.601 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.57 125.88 51.5 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.378 -0.529 . . . . 1.9399999999999999 111.439 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.5 144.02 33.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.653 -0.703 . . . . 0.59999999999999998 110.633 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -151.98 168.39 25.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.908 0.385 . . . . 3.1400000000000001 111.162 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.744 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.12 131.06 60.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.053 -0.521 . . . . 3.23 110.055 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.1 p -141.16 162.22 36.02 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.88 0.371 . . . . 3.6299999999999999 111.26 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 98.1 mt-10 36.17 31.59 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.587 -0.523 . . . . 6.0800000000000001 109.587 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.744 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.4 69.53 32.08 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.97 -0.559 . . . . 3.3799999999999999 111.547 -178.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.27 -29.08 72.81 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.494 2.129 . . . . 3.9300000000000002 111.858 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.61 125.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.118 -0.492 . . . . 3.3599999999999999 110.48 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.677 ' NE2' ' OE1' ' A' ' 191' ' ' GLN . 0.6 OUTLIER -123.98 158.4 60.37 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.313 -0.403 . . . . 3.6099999999999999 110.453 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.549 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 99.0 Cg_endo -82.12 -64.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.942 2.428 . . . . 1.51 113.437 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.555 ' ND2' ' H ' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -108.49 -19.57 13.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.019 0.377 . . . . 2.6800000000000002 112.019 -178.439 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.599 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 7.7 p -107.26 152.09 24.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.21 0.529 . . . . 1.21 111.252 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.37 102.94 2.21 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.67 -0.696 . . . . 1.5600000000000001 110.647 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.63 145.61 13.09 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.884 2.389 . . . . 0.81000000000000005 112.598 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.924 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.84 167.91 24.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.897 -0.592 . . . . 1.52 109.939 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.14 148.0 29.13 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.751 -0.463 . . . . 2.1400000000000001 109.751 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.586 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.7 p90 -142.19 157.25 45.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.017 0.437 . . . . 0.32000000000000001 111.242 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.497 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.06 155.32 44.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.856 -0.611 . . . . 2.1699999999999999 110.137 178.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.838 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.61 173.03 6.36 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 121.105 0.479 . . . . 0.58999999999999997 110.741 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.838 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.69 173.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.932 2.422 . . . . 0.90000000000000002 111.498 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -51.05 0.69 Allowed Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 120.714 -0.395 . . . . 3.3399999999999999 110.155 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.638 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.84 152.39 82.33 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.756 2.304 . . . . 1.8500000000000001 111.452 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.73 42.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.309 0.576 . . . . 2.54 110.496 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.82 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.66 -41.67 98.18 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.974 -1.012 . . . . 2.5299999999999998 110.645 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.532 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.4 mt -109.82 137.9 39.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.795 -0.639 . . . . 1.1699999999999999 111.242 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.06 -72.87 0.71 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.009 -0.541 . . . . 1.27 111.863 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.12 148.52 24.4 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.58 0.585 . . . . 1.1200000000000001 112.58 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.96 124.9 45.12 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.301 -0.629 . . . . 0.41999999999999998 109.301 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.07 134.7 60.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.645 -0.422 . . . . 0.78000000000000003 110.594 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.924 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.02 128.67 53.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.04 0.448 . . . . 0.62 111.237 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.542 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.11 138.94 49.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.735 -0.666 . . . . 1.97 110.088 179.031 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.436 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.04 163.16 35.09 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.181 0.515 . . . . 0.34999999999999998 112.061 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.491 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.42 139.6 7.92 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.45 -0.795 . . . . 1.8 110.462 178.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.54 115.45 3.04 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.307 2.004 . . . . 0.57999999999999996 111.837 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.676 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.97 81.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.834 -0.432 . . . . 3.04 109.834 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.693 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.979 -0.555 . . . . 2.4700000000000002 111.886 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 p -157.59 157.84 34.44 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.79 -0.364 . . . . 2.5099999999999998 110.569 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.44 27.87 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.256 -0.429 . . . . 1.8600000000000001 110.189 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.91 -75.89 1.31 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.115 -0.564 . . . . 1.4399999999999999 111.766 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.94 152.33 35.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.011 0.434 . . . . 4.6900000000000004 110.91 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.2 -169.19 2.56 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.98 -0.555 . . . . 1.4299999999999999 111.946 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.436 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.6 mttp -110.08 149.56 29.84 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.471 0.653 . . . . 1.74 112.633 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.01 156.51 46.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.836 -1.074 . . . . 1.9199999999999999 110.242 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.22 158.42 41.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.931 -0.577 . . . . 0.34000000000000002 111.718 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.1 m -115.26 135.62 53.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.4 -0.818 . . . . 0.40999999999999998 109.814 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.586 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.43 121.9 23.73 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.407 -0.36 . . . . 0.55000000000000004 111.591 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.599 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.3 Cg_exo -46.23 151.69 1.57 Allowed 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.626 2.217 . . . . 0.44 112.135 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.79 -23.15 62.93 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 116.071 -0.513 . . . . 0.73999999999999999 112.826 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.81 -16.83 46.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.371 0.586 . . . . 0.93000000000000005 111.831 -178.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.599 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.57 138.43 31.58 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.767 -0.373 . . . . 0.96999999999999997 110.307 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -121.54 13.92 10.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.418 -0.356 . . . . 1.3400000000000001 111.548 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.477 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.0 p -150.02 143.36 25.12 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.721 -0.392 . . . . 0.39000000000000001 111.06 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.721 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.77 -169.35 1.53 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.065 -0.516 . . . . 0.41999999999999998 110.918 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.721 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 t -151.75 125.83 9.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.431 -0.804 . . . . 0.39000000000000001 109.87 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.518 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.84 123.26 70.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.42 -0.512 . . . . 0.73999999999999999 111.18 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -126.57 163.34 23.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.732 -0.667 . . . . 2.48 110.412 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.555 ' H ' ' ND2' ' A' ' 16' ' ' ASN . . . 85.18 18.95 59.84 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.742 -0.943 . . . . 0.5 110.742 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.518 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.1 mt -79.1 157.23 28.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.052 0.453 . . . . 0.57999999999999996 111.357 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.847 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -99.48 133.96 21.53 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.584 -0.735 . . . . 2.79 110.433 179.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.92 143.59 61.23 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.614 2.209 . . . . 0.87 111.89 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.78 25.69 75.26 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.068 -0.813 . . . . 0.64000000000000001 111.068 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.847 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.23 158.78 40.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.679 0.276 . . . . 0.82999999999999996 110.423 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.27 139.95 42.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.034 0.445 . . . . 0.5 110.57 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.658 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.7 m-85 -122.54 136.4 54.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.967 -0.56 . . . . 0.53000000000000003 110.745 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.491 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.91 131.05 45.29 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.474 -0.936 . . . . 1.8700000000000001 108.474 177.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.494 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.52 153.84 16.66 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.283 -0.96 . . . . 0.28999999999999998 112.011 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.93 140.88 46.09 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.671 -0.492 . . . . 1.4299999999999999 109.671 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.3 tp -115.77 118.9 34.33 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.458 -0.497 . . . . 0.32000000000000001 110.476 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.726 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.45 129.12 68.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.26 -0.427 . . . . 0.79000000000000004 110.619 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.702 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.9 120.77 43.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.273 -0.421 . . . . 1.02 110.713 -179.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.854 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.52 146.46 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.107 0.48 . . . . 0.62 111.044 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.82 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.02 153.9 21.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.54 -0.755 . . . . 2.4399999999999999 109.929 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.15 88.67 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.912 0.387 . . . . 3.6899999999999999 110.401 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.616 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.16 32.64 0.2 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.835 -0.621 . . . . 6.0800000000000001 110.659 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.02 -117.36 3.3 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.495 -0.642 . . . . 1.22 111.495 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.461 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.45 177.49 8.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.17 0.509 . . . . 2.8799999999999999 111.642 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.2 149.47 31.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.427 -0.806 . . . . 1.47 110.377 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.553 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.09 144.63 38.81 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.506 -0.315 . . . . 2.7000000000000002 110.616 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.726 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.93 136.0 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.026 0.441 . . . . 0.46000000000000002 111.601 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.06 141.31 52.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.676 -0.693 . . . . 0.34999999999999998 110.3 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.466 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.65 138.74 51.77 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.095 0.474 . . . . 3.6699999999999999 111.54 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.494 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.17 164.14 37.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.562 -0.744 . . . . 0.67000000000000004 109.498 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.571 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.18 151.57 38.64 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.428 -0.509 . . . . 1.47 111.062 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.8 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.18 172.76 12.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.748 -0.66 . . . . 0.44 111.028 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.83 160.63 21.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.432 -0.804 . . . . 1.3700000000000001 109.804 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.31 121.9 23.07 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.593 -0.443 . . . . 1.28 110.798 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.632 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.7 p -127.37 168.16 15.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.256 0.55 . . . . 1.97 112.351 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.0 p -63.14 160.23 15.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.514 -0.766 . . . . 3.2799999999999998 110.931 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.4 t -64.7 -35.29 80.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.272 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.3 t -72.97 142.69 47.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.006 0.432 . . . . 0.0 111.063 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.794 ' H ' ' CD ' ' A' ' 97' ' ' PRO . 14.0 m -123.66 -33.86 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.932 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.794 ' CD ' ' H ' ' A' ' 96' ' ' THR . 49.4 Cg_exo -55.22 -19.93 22.93 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.228 1.952 . . . . 0.0 112.801 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.9 m -127.06 156.4 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-O 121.095 0.474 . . . . 0.0 110.962 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.7 p -92.2 164.41 13.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.789 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.3 t -77.23 149.69 35.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.27 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -100.56 140.44 34.81 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.838 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 49.6 m -78.79 140.31 38.26 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.524 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 28.4 m -63.25 138.45 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.491 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 t -134.85 159.88 39.99 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.678 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -138.92 176.62 20.79 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -108.79 153.29 23.69 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.802 0.334 . . . . 0.0 110.598 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.409 ' O ' ' OG1' ' A' ' 108' ' ' THR . 20.4 p -122.08 162.83 20.51 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.37 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 107' ' ' THR . 16.6 p 55.7 66.86 3.34 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.733 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -54.29 146.36 50.98 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.558 2.172 . . . . 0.0 112.02 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -108.05 138.73 43.81 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.509 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 63.8 p -124.44 73.46 60.24 Favored Pre-proline 0 N--CA 1.463 0.207 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.545 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.27 147.97 81.56 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.462 2.108 . . . . 0.0 111.941 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 27.5 tp -96.23 131.63 42.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.475 . . . . 10.19 110.005 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.567 HG22 ' H ' ' A' ' 116' ' ' THR . 12.2 p -129.96 142.59 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.079 -0.51 . . . . 7.2800000000000002 110.955 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.63 75.91 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.968 -0.56 . . . . 7.2999999999999998 111.878 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.567 ' H ' HG22 ' A' ' 114' ' ' VAL . 22.6 p -121.18 160.82 22.99 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.897 0.379 . . . . 6.4400000000000004 110.87 -179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 50.5 m -119.78 149.85 41.37 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.988 -0.551 . . . . 4.4199999999999999 110.984 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 46.18 -164.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.862 -0.608 . . . . 3.0499999999999998 111.19 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.2 p -119.93 158.49 26.59 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.829 -0.623 . . . . 3.4300000000000002 110.86 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 74.9 t -58.77 -37.92 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.974 -0.557 . . . . 2.8799999999999999 110.111 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 6.4 t -132.01 156.14 46.78 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.433 -0.349 . . . . 2.0899999999999999 110.332 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.96 141.22 57.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.127 0.489 . . . . 4.5300000000000002 111.442 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.9 pt -125.79 159.85 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.524 -0.762 . . . . 1.4399999999999999 109.917 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 126' ' ' SER . 42.0 m -81.5 132.96 35.33 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.474 -0.49 . . . . 1.78 109.887 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.546 ' O ' ' CB ' ' A' ' 126' ' ' SER . . . -64.95 -36.91 85.91 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.848 -0.341 . . . . 0.64000000000000001 110.884 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 125' ' ' ALA . 3.6 p 144.43 0.93 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.939 -0.763 . . . . 0.66000000000000003 108.939 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.437 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.77 167.5 0.25 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.288 -0.869 . . . . 0.68999999999999995 111.004 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.57 145.6 50.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.785 -0.643 . . . . 0.52000000000000002 110.118 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.3 101.55 9.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 109.126 -0.694 . . . . 0.32000000000000001 109.126 177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.8 t -112.93 139.8 36.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.006 -0.543 . . . . 0.28999999999999998 110.988 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.1 p -128.74 152.63 48.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.575 -0.739 . . . . 0.25 109.778 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.592 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.89 -164.96 2.04 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.717 -0.393 . . . . 0.31 110.622 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.734 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -123.92 127.22 73.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 0.48999999999999999 110.815 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.179 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -58.05 58.34 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.168 -0.469 . . . . 1.53 110.326 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.09 24.42 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.905 -0.589 . . . . 0.96999999999999997 111.447 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.179 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.28 128.7 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.638 -0.425 . . . . 1.5600000000000001 110.913 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -86.37 -9.58 56.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.971 -0.559 . . . . 1.8799999999999999 110.381 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.7 p -87.13 0.28 55.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 1.04 110.279 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.33 137.27 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.988 -0.551 . . . . 0.23999999999999999 109.888 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 185' ' ' ILE . 88.8 p -96.25 -15.53 21.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.25 0.548 . . . . 0.28999999999999998 109.999 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.6 175.56 45.78 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 109.832 -1.307 . . . . 0.13 109.832 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.43 151.54 42.56 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.719 -0.392 . . . . 0.17000000000000001 110.538 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.872 ' NE ' HE22 ' A' ' 191' ' ' GLN . 8.5 tmm_? -132.22 121.19 23.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.153 -0.476 . . . . 1.29 109.899 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.13 136.61 38.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.739 -0.664 . . . . 0.25 110.653 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 77.6 tt0 -129.36 129.86 45.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.943 -0.571 . . . . 1.3200000000000001 110.03 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.627 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.8 135.23 34.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.066 -0.516 . . . . 0.56999999999999995 110.638 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.42 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.27 161.38 39.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.723 -0.672 . . . . 1.1599999999999999 109.665 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.4 mt -71.02 124.88 25.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.991 0.424 . . . . 0.38 110.755 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.489 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.1 p -71.74 -7.67 49.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.725 -0.671 . . . . 0.40999999999999998 110.866 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -109.83 -69.57 0.86 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 1.6599999999999999 111.481 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.459 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.69 -35.41 76.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.11 -0.496 . . . . 1.6599999999999999 111.451 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.077 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.2 7.18 88.63 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.76 -0.936 . . . . 1.1699999999999999 110.76 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.331 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.86 -171.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.779 0.323 . . . . 1.8600000000000001 110.324 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.331 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.16 139.11 45.48 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.96 0.409 . . . . 1.98 110.216 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.42 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.5 Cg_endo -70.98 145.84 51.14 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 C-N-CA 122.746 2.297 . . . . 0.55000000000000004 112.288 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.627 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.83 145.77 42.56 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.224 -0.658 . . . . 1.1399999999999999 109.224 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 15' ' ' PRO . 7.8 m-85 -123.28 141.37 52.05 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.344 -0.543 . . . . 0.93000000000000005 111.526 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.16 127.69 43.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.286 -0.87 . . . . 0.34000000000000002 108.932 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.533 ' O ' ' OD1' ' A' ' 159' ' ' ASP . 55.4 p-10 -101.62 131.19 47.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.125 0.488 . . . . 1.0900000000000001 111.818 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -128.04 157.58 73.53 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.393 -0.821 . . . . 0.19 109.514 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -69.88 158.09 57.96 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.335 2.023 . . . . 0.17999999999999999 112.24 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.36 -12.08 5.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.842 -0.617 . . . . 0.20999999999999999 110.734 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.3 p -92.79 -8.8 42.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.101 -0.5 . . . . 0.28999999999999998 110.762 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.36 34.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.304 -0.407 . . . . 0.5 110.434 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.9 p -133.11 16.58 4.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.447 -0.342 . . . . 0.29999999999999999 110.515 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.8 p -167.47 147.21 5.16 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.607 -0.516 . . . . 0.23000000000000001 109.607 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.24 150.51 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.551 -0.459 . . . . 0.28000000000000003 111.57 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.509 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.36 124.89 50.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.604 -0.725 . . . . 1.0700000000000001 109.786 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.34 104.84 29.26 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.358 -0.383 . . . . 0.28999999999999998 111.028 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.9 Cg_endo -91.04 -179.43 1.47 Allowed 'Trans proline' 0 C--N 1.302 -1.883 0 C-N-CA 123.103 2.535 . . . . 0.42999999999999999 112.237 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.72 32.62 18.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.381 -0.827 . . . . 1.26 111.381 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.48 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.1 mt -86.34 148.51 25.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.788 0.328 . . . . 0.32000000000000001 110.476 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.777 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.26 114.83 61.18 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.969 0.414 . . . . 0.57999999999999996 110.725 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.05 140.57 95.82 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.882 2.388 . . . . 0.66000000000000003 111.977 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.17 21.12 74.25 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.078 -0.809 . . . . 0.28999999999999998 111.078 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.459 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.83 150.2 49.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.833 0.349 . . . . 2.3300000000000001 110.623 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.489 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.12 131.65 45.95 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.983 -0.553 . . . . 0.85999999999999999 109.818 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.955 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.5 148.34 43.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.138 -0.483 . . . . 0.52000000000000002 111.01 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.38 125.38 60.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.258 -1.015 . . . . 0.29999999999999999 108.258 177.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.5 132.55 63.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.092 0.473 . . . . 0.23000000000000001 111.283 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.55 122.55 20.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.624 -0.717 . . . . 0.35999999999999999 109.659 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.592 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -100.95 125.33 54.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.219 -0.446 . . . . 0.19 110.709 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.4 m-85 -117.21 137.98 52.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.997 -0.547 . . . . 0.29999999999999999 109.887 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.585 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.76 135.0 42.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.779 -0.823 . . . . 0.37 108.779 178.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.603 ' O ' ' N ' ' A' ' 140' ' ' SER . 74.6 mt -99.17 122.98 51.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.161 0.505 . . . . 0.26000000000000001 110.893 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.7 p -83.94 169.7 14.76 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.539 -0.755 . . . . 0.28000000000000003 110.383 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -59.74 -14.53 14.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.05 -0.523 . . . . 1.6000000000000001 110.964 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -96.07 -4.4 43.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.795 0.331 . . . . 1.1799999999999999 110.829 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.435 ' N ' ' HB ' ' A' ' 59' ' ' THR . . . 87.85 13.84 63.97 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.364 -0.694 . . . . 0.29999999999999999 111.364 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -84.58 139.09 32.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.059 -0.256 . . . . 1.22 110.482 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.872 HE22 ' NE ' ' A' ' 143' ' ' ARG . 88.5 mt-30 -106.81 141.08 38.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.91 0.386 . . . . 0.97999999999999998 110.526 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.4 m -136.71 126.94 26.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.82999999999999996 110.349 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.11 117.26 9.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.317 -0.401 . . . . 0.26000000000000001 110.564 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.01 -21.81 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.29999999999999999 110.77 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.85 125.71 5.89 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.547 -0.461 . . . . 0.31 111.501 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.74 120.27 21.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.821 -0.627 . . . . 0.28000000000000003 109.542 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.69 151.65 28.99 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.752 -0.379 . . . . 0.23999999999999999 110.922 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.43 158.49 18.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.967 -0.56 . . . . 0.23000000000000001 110.447 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.01 157.95 43.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.127 -0.488 . . . . 0.67000000000000004 110.669 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.26 104.37 9.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.774 -0.648 . . . . 0.64000000000000001 109.964 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.948 -1.025 . . . . 1.26 110.638 -179.774 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.1 m . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.285 -0.635 . . . . 3.4399999999999999 109.285 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.45 150.76 18.52 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.012 -0.835 . . . . 1.22 111.012 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -35.7 142.39 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.067 0 C-N-CA 123.999 3.133 . . . . 0.75 113.759 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.607 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.9 173.36 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.222 -1.354 . . . . 0.79000000000000004 108.822 178.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.607 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.62 125.88 51.5 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.435 -0.506 . . . . 1.9399999999999999 111.438 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 143.93 34.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.655 -0.702 . . . . 0.59999999999999998 110.73 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.28 25.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 3.1400000000000001 111.129 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.748 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.99 131.07 60.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.008 -0.542 . . . . 3.23 110.082 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.8 p -141.19 162.3 35.82 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.759 0.314 . . . . 3.6299999999999999 111.249 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 10' ' ' GLU . 70.6 tt0 36.02 31.6 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.69 -0.485 . . . . 6.0800000000000001 109.69 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.748 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.56 32.42 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.896 -0.593 . . . . 3.3799999999999999 111.568 -178.744 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.3 -29.08 72.53 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.449 2.1 . . . . 3.9300000000000002 111.818 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.64 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 3.3599999999999999 110.513 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.604 ' HG3' ' NE2' ' A' ' 191' ' ' GLN . 7.0 mp0 -124.01 158.35 60.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.392 -0.367 . . . . 3.6099999999999999 110.426 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.699 ' HD2' HH12 ' A' ' 143' ' ' ARG . 96.5 Cg_endo -82.0 -64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.835 2.356 . . . . 1.51 113.57 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.913 ' ND2' ' H ' ' A' ' 62' ' ' GLY . 9.9 t30 -108.46 -19.55 13.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.265 -0.425 . . . . 2.6800000000000002 112.074 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 18.0 p -107.31 152.09 24.61 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.163 0.506 . . . . 1.21 111.387 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.578 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.19 102.9 2.24 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.726 -0.67 . . . . 1.5600000000000001 110.691 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.406 ' HB3' ' HA3' ' A' ' 189' ' ' GLY . 73.6 Cg_endo -82.63 145.63 13.1 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.915 2.41 . . . . 0.81000000000000005 112.607 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.911 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.87 167.92 24.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.906 -0.588 . . . . 1.52 109.904 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.1 148.02 29.18 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.783 -0.451 . . . . 2.1400000000000001 109.783 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.588 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.4 p90 -142.29 157.27 45.01 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.621 -0.432 . . . . 0.32000000000000001 111.137 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.494 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.02 155.31 44.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.732 -0.667 . . . . 2.1699999999999999 110.051 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.827 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.63 173.12 6.26 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.214 0.531 . . . . 0.58999999999999997 110.68 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.827 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.69 173.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.819 2.346 . . . . 0.90000000000000002 111.497 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -50.97 0.69 Allowed Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.666 -0.414 . . . . 3.3399999999999999 110.191 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.634 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.82 152.3 82.63 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.821 2.347 . . . . 1.8500000000000001 111.466 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.64 42.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.331 0.586 . . . . 2.54 110.543 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.821 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.54 -41.66 98.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.047 -0.978 . . . . 2.5299999999999998 110.683 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.8 mt -109.8 137.87 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.813 -0.63 . . . . 1.1699999999999999 111.296 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.02 -72.88 0.7 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.095 -0.502 . . . . 1.27 111.84 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.19 148.35 24.43 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.558 0.577 . . . . 1.1200000000000001 112.558 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.77 124.86 45.19 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.348 -0.612 . . . . 0.41999999999999998 109.348 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.3 mt -117.99 134.73 60.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.724 -0.391 . . . . 0.78000000000000003 110.61 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.911 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -119.99 128.62 53.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.067 0.46 . . . . 0.62 111.252 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.14 138.96 49.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.799 -0.637 . . . . 1.97 110.073 179.05 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.435 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.11 163.24 34.92 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.14 0.495 . . . . 0.34999999999999998 112.059 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.5 139.55 7.83 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.423 -0.808 . . . . 1.8 110.428 178.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.62 115.47 3.07 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.347 2.032 . . . . 0.57999999999999996 111.823 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.668 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.97 81.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.887 -0.412 . . . . 3.04 109.887 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.25 -20.59 0.06 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.05 -0.523 . . . . 2.4700000000000002 111.969 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 p -157.61 157.81 34.35 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.822 -0.351 . . . . 2.5099999999999998 110.535 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.406 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.48 27.88 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 1.8600000000000001 110.123 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.82 -75.94 1.31 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.17 -0.538 . . . . 1.4399999999999999 111.839 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.87 152.36 35.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.946 0.403 . . . . 4.6900000000000004 111.058 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.09 2.52 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.101 -0.499 . . . . 1.4299999999999999 111.998 179.43 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.18 149.64 29.8 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.464 0.649 . . . . 1.74 112.565 -177.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.03 156.47 46.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.893 -1.048 . . . . 1.9199999999999999 110.302 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.18 158.44 41.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.931 -0.577 . . . . 0.34000000000000002 111.796 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.27 135.53 54.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.438 -0.801 . . . . 0.40999999999999998 109.848 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.588 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.31 121.98 23.89 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.506 -0.315 . . . . 0.55000000000000004 111.529 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.6 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.6 Cg_exo -46.39 151.76 1.67 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.716 2.277 . . . . 0.44 112.098 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.94 -23.01 63.11 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 116.076 -0.511 . . . . 0.73999999999999999 112.792 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.547 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.78 -16.94 45.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.425 0.613 . . . . 0.93000000000000005 111.821 -178.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.6 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.49 138.44 31.57 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.737 -0.385 . . . . 0.96999999999999997 110.352 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -121.48 13.93 11.03 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.442 -0.345 . . . . 1.3400000000000001 111.638 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.473 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.02 143.49 25.2 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.607 -0.437 . . . . 0.39000000000000001 111.022 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.72 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.79 -169.38 1.53 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.212 0.529 . . . . 0.41999999999999998 110.886 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.72 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.74 125.86 9.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.437 -0.801 . . . . 0.39000000000000001 109.893 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.4 mt -114.84 123.34 70.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.366 -0.533 . . . . 0.73999999999999999 111.234 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.838 ' NZ ' ' N ' ' A' ' 141' ' ' GLY . 15.9 mtpt -126.59 163.42 23.46 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.753 -0.658 . . . . 2.48 110.394 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.913 ' H ' ' ND2' ' A' ' 16' ' ' ASN . . . 85.11 19.07 59.76 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.682 -0.967 . . . . 0.5 110.682 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.514 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.0 mt -79.11 157.19 28.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.996 0.427 . . . . 0.57999999999999996 111.36 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.854 ' O ' HG12 ' A' ' 67' ' ' VAL . 4.3 mttp -99.48 133.87 21.6 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.71 -0.677 . . . . 2.79 110.464 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.89 143.63 61.6 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.497 2.131 . . . . 0.87 111.906 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.79 25.67 75.28 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.073 -0.811 . . . . 0.64000000000000001 111.073 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.854 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.3 p -128.14 158.73 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.683 0.278 . . . . 0.82999999999999996 110.461 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.03 140.03 41.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.909 0.385 . . . . 0.5 110.648 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.658 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.68 136.52 54.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.948 -0.569 . . . . 0.53000000000000003 110.71 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.96 131.1 45.28 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.436 -0.95 . . . . 1.8700000000000001 108.436 177.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.48 153.87 16.65 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.355 -0.926 . . . . 0.28999999999999998 111.918 -178.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.03 141.01 46.06 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.624 -0.51 . . . . 1.4299999999999999 109.624 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.525 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.9 tp -115.71 119.02 34.69 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.422 -0.511 . . . . 0.32000000000000001 110.545 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.74 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.53 129.1 68.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.359 -0.382 . . . . 0.79000000000000004 110.601 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.707 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.88 120.76 43.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.332 -0.395 . . . . 1.02 110.724 -179.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.866 HD12 ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.5 146.38 11.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.192 0.52 . . . . 0.62 111.032 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.821 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -105.98 153.81 21.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.512 -0.767 . . . . 2.4399999999999999 109.986 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.07 88.49 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.9 0.381 . . . . 3.6899999999999999 110.525 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.3 32.61 0.21 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.864 -0.607 . . . . 6.0800000000000001 110.661 -179.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.05 -117.37 3.29 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.437 -0.665 . . . . 1.22 111.437 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.462 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.39 177.38 9.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.153 0.501 . . . . 2.8799999999999999 111.597 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.18 149.55 32.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.39 -0.823 . . . . 1.47 110.4 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.16 144.71 38.7 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.455 -0.339 . . . . 2.7000000000000002 110.591 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.74 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.08 135.94 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 121.088 0.47 . . . . 0.46000000000000002 111.5 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.01 141.35 52.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.668 -0.696 . . . . 0.34999999999999998 110.373 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.6 138.8 51.7 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.553 -0.459 . . . . 3.6699999999999999 111.575 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.21 164.14 37.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.572 -0.74 . . . . 0.67000000000000004 109.618 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.576 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.2 151.57 38.63 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.411 -0.516 . . . . 1.47 111.027 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.802 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.26 172.64 13.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.767 -0.651 . . . . 0.44 111.023 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.7 t -118.61 160.7 21.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.479 -0.782 . . . . 1.3700000000000001 109.922 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.45 121.87 22.87 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.623 -0.431 . . . . 1.28 110.774 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.6 p -126.92 155.57 42.84 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 114.62 1.341 . . . . 1.97 114.62 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.627 ' C ' ' H ' ' A' ' 95' ' ' SER . 82.2 p -132.19 8.6 4.37 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 112.996 -1.911 . . . . 3.2799999999999998 109.102 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.1 p 58.37 -1.61 0.09 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.294 0.569 . . . . 0.0 109.8 -177.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.627 ' H ' ' C ' ' A' ' 93' ' ' SER . 83.3 p -66.44 -19.01 65.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.873 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 m -116.08 71.7 4.35 Favored Pre-proline 0 N--CA 1.465 0.294 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -176.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.17 161.73 36.09 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.554 2.169 . . . . 0.0 109.448 176.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.2 p -121.14 136.6 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.299 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.537 HG22 ' H ' ' A' ' 101' ' ' ASN . 47.3 m -129.01 149.31 50.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.939 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.896 ' O ' ' OD1' ' A' ' 101' ' ' ASN . 23.8 m -53.78 -34.19 58.28 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.896 ' OD1' ' O ' ' A' ' 100' ' ' SER . 14.9 p-10 54.93 45.3 26.76 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.376 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 49.1 m -116.86 135.57 53.63 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.5 t -121.69 136.27 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.855 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.2 p -122.14 160.43 25.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.044 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.09 -165.53 41.59 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -111.65 155.84 22.78 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.695 0.283 . . . . 0.0 110.396 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.7 p -120.39 161.1 21.77 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.216 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.5 m -126.73 79.96 71.15 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.218 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.02 146.97 45.22 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.251 1.967 . . . . 0.0 111.323 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -104.92 132.03 51.68 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.146 0.498 . . . . 0.0 111.408 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 85.9 p 44.54 57.84 14.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.728 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.16 143.98 91.17 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.232 1.955 . . . . 0.0 111.399 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.5 mt -94.93 135.9 35.89 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.755 -0.461 . . . . 10.19 109.755 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.5 m -73.49 -34.58 42.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.846 -0.342 . . . . 7.2800000000000002 111.591 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -153.83 155.66 36.2 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.909 0.385 . . . . 7.2999999999999998 111.54 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.7 m -122.32 139.89 53.29 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.193 -0.669 . . . . 6.4400000000000004 109.193 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.442 ' O ' HG22 ' A' ' 120' ' ' VAL . 99.4 p -121.74 151.28 40.71 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.222 0.534 . . . . 4.4199999999999999 111.643 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.88 -29.07 70.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.292 -0.867 . . . . 3.0499999999999998 111.256 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.5 p -58.11 -25.12 60.97 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.685 0.624 . . . . 3.4300000000000002 112.685 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 117' ' ' SER . 10.9 m -59.99 130.25 23.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 119.884 -0.727 . . . . 2.8799999999999999 109.892 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.633 ' O ' ' N ' ' A' ' 123' ' ' ILE . 48.0 p -70.67 -31.73 68.74 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.521 0.563 . . . . 2.0899999999999999 112.521 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.518 ' C ' ' O ' ' A' ' 121' ' ' THR . 97.6 mt-10 15.34 46.87 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.955 0.724 . . . . 4.5300000000000002 112.955 -179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.633 ' N ' ' O ' ' A' ' 121' ' ' THR . 17.4 tt -123.4 135.19 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 110.237 -0.283 . . . . 1.4399999999999999 110.237 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.7 t -137.99 157.85 45.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.479 -0.328 . . . . 1.78 111.079 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -105.43 143.39 33.66 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.099 -0.501 . . . . 0.64000000000000001 110.33 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.491 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 2.0 p -176.61 8.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.151 0.5 . . . . 0.66000000000000003 110.417 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.436 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.91 167.58 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.613 -0.721 . . . . 0.68999999999999995 110.92 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.56 145.55 50.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.675 -0.693 . . . . 0.52000000000000002 110.146 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.33 101.72 9.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.021 -0.733 . . . . 0.32000000000000001 109.021 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.0 t -112.94 139.74 36.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.0 -0.545 . . . . 0.28999999999999998 111.078 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.1 p -128.82 152.45 48.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.681 -0.69 . . . . 0.25 109.868 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.591 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.71 -164.88 2.02 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.667 -0.413 . . . . 0.31 110.711 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -124.0 127.11 73.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 0.48999999999999999 110.833 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.176 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 1.53 110.315 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.15 24.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.916 -0.584 . . . . 0.96999999999999997 111.471 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.176 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.16 128.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.599 -0.441 . . . . 1.5600000000000001 110.929 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.4 -9.65 55.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.975 -0.557 . . . . 1.8799999999999999 110.306 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.1 0.27 55.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 1.04 110.376 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.31 137.18 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.976 -0.556 . . . . 0.23999999999999999 109.945 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.72 ' C ' ' HZ3' ' A' ' 61' ' ' LYS . 75.7 m -96.16 -15.52 22.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.337 0.589 . . . . 0.28999999999999998 110.077 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.838 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.54 175.51 45.68 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 109.793 -1.323 . . . . 0.13 109.793 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.4 151.61 42.43 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.574 -0.45 . . . . 0.17000000000000001 110.466 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.699 HH12 ' HD2' ' A' ' 15' ' ' PRO . 60.0 ttp180 -132.28 121.25 23.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.11 -0.495 . . . . 1.29 109.954 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.559 HG21 HG11 ' A' ' 167' ' ' VAL . 46.4 t -105.19 136.58 38.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.634 -0.712 . . . . 0.25 110.665 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.522 ' CD ' ' CE2' ' A' ' 157' ' ' TYR . 80.8 tt0 -129.35 129.82 45.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.858 -0.61 . . . . 1.3200000000000001 110.065 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.71 135.31 34.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.98 -0.554 . . . . 0.56999999999999995 110.619 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.418 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.32 161.37 39.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.781 -0.645 . . . . 1.1599999999999999 109.634 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.954 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.07 124.77 25.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.019 0.438 . . . . 0.38 110.783 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.62 -7.77 49.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.74 -0.664 . . . . 0.40999999999999998 110.9 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -109.77 -69.74 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 1.6599999999999999 111.421 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.439 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.66 -35.34 75.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.065 -0.516 . . . . 1.6599999999999999 111.497 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.083 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.14 7.29 88.55 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.772 -0.931 . . . . 1.1699999999999999 110.772 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.34 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.97 -171.66 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 1.8600000000000001 110.207 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.34 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.39 139.01 44.66 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 1.98 110.17 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.418 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.3 Cg_endo -70.84 145.8 51.88 Favored 'Trans proline' 0 C--N 1.301 -1.96 0 C-N-CA 122.752 2.301 . . . . 0.55000000000000004 112.343 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.84 145.68 42.64 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.222 -0.659 . . . . 1.1399999999999999 109.222 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.522 ' CE2' ' CD ' ' A' ' 145' ' ' GLU . 83.1 m-85 -123.3 141.39 52.04 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.289 -0.564 . . . . 0.93000000000000005 111.526 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.6 mt -128.07 127.66 43.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.288 -0.869 . . . . 0.34000000000000002 108.917 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.712 ' OD1' ' ND2' ' A' ' 16' ' ' ASN . 13.6 m-20 -101.57 131.1 47.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.099 0.476 . . . . 1.0900000000000001 111.751 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.95 157.57 73.39 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.396 -0.82 . . . . 0.19 109.602 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.78 158.03 58.31 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.453 2.102 . . . . 0.17999999999999999 112.268 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.33 -12.12 5.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.782 -0.645 . . . . 0.20999999999999999 110.75 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.0 p -92.81 -8.79 42.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.068 -0.514 . . . . 0.28999999999999998 110.753 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.1 135.4 34.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.5 110.408 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.17 16.57 4.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.435 -0.348 . . . . 0.29999999999999999 110.459 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.5 p -167.5 147.16 5.12 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.612 -0.514 . . . . 0.23000000000000001 109.612 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.559 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.21 150.48 12.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.6 -0.44 . . . . 0.28000000000000003 111.629 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.508 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 4.0 t-20 -106.36 124.96 50.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.625 -0.716 . . . . 1.0700000000000001 109.758 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.43 104.99 30.5 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.408 -0.36 . . . . 0.28999999999999998 111.088 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.9 Cg_endo -91.17 -179.5 1.45 Allowed 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 123.099 2.532 . . . . 0.42999999999999999 112.138 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.67 32.75 18.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.414 -0.812 . . . . 1.26 111.391 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.491 ' O ' ' OG ' ' A' ' 126' ' ' SER . 23.7 mt -86.46 148.54 25.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.474 -0.33 . . . . 0.32000000000000001 110.436 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.77 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.3 114.91 61.57 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.059 0.457 . . . . 0.57999999999999996 110.699 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.01 140.54 95.81 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.873 2.382 . . . . 0.66000000000000003 112.041 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.18 21.06 74.35 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.061 -0.815 . . . . 0.28999999999999998 111.061 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.439 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.79 150.22 49.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.786 0.327 . . . . 2.3300000000000001 110.681 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.1 131.58 45.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.068 -0.514 . . . . 0.85999999999999999 109.811 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.954 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.3 m-85 -120.45 148.3 43.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.153 -0.476 . . . . 0.52000000000000002 111.055 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.3 125.36 60.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.261 -1.014 . . . . 0.29999999999999999 108.261 177.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.49 132.39 63.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.155 0.502 . . . . 0.23000000000000001 111.26 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.39 122.61 20.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.637 -0.71 . . . . 0.35999999999999999 109.645 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.591 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.05 125.43 54.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.214 -0.448 . . . . 0.19 110.631 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.7 m-85 -117.27 137.92 52.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.027 -0.533 . . . . 0.29999999999999999 109.842 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.581 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.78 135.07 42.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.773 -0.825 . . . . 0.37 108.773 178.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.602 ' O ' ' N ' ' A' ' 140' ' ' SER . 50.6 mm -99.12 122.96 51.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.137 0.494 . . . . 0.26000000000000001 110.864 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.3 p -83.83 169.71 14.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.565 -0.743 . . . . 0.28000000000000003 110.503 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -59.78 -14.53 15.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.006 -0.543 . . . . 1.6000000000000001 110.963 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.404 ' C ' ' OG1' ' A' ' 59' ' ' THR . 94.9 m-20 -96.03 -4.29 43.34 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.872 -0.331 . . . . 1.1799999999999999 110.795 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.631 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.76 13.93 64.01 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.403 -0.679 . . . . 0.29999999999999999 111.403 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -84.76 139.14 32.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.736 0.303 . . . . 1.22 110.349 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.604 ' NE2' ' HG3' ' A' ' 14' ' ' GLN . 7.7 pt20 -106.83 141.05 38.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.968 0.413 . . . . 0.97999999999999998 110.465 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.73 126.99 26.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.82999999999999996 110.402 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.08 117.27 9.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.371 -0.377 . . . . 0.26000000000000001 110.502 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.3 pt -109.06 -21.82 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.471 . . . . 0.29999999999999999 110.741 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.84 125.84 5.94 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.558 -0.457 . . . . 0.31 111.495 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.84 120.21 21.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.708 -0.678 . . . . 0.28000000000000003 109.497 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.59 151.69 29.14 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.712 -0.395 . . . . 0.23999999999999999 110.987 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.48 158.57 18.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.081 -0.509 . . . . 0.23000000000000001 110.382 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.07 157.97 43.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.084 -0.507 . . . . 0.67000000000000004 110.624 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.37 9.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.662 -0.699 . . . . 0.64000000000000001 109.972 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.894 -1.051 . . . . 1.26 110.719 -179.788 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.145 -0.687 . . . . 3.4399999999999999 109.145 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.77 18.53 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.061 -0.815 . . . . 1.22 111.061 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -35.66 142.44 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.057 0 C-N-CA 123.959 3.106 . . . . 0.75 113.808 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.62 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.98 173.4 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 114.286 -1.325 . . . . 0.79000000000000004 108.853 178.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.62 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.67 125.9 51.52 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.429 -0.508 . . . . 1.9399999999999999 111.384 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.45 143.95 34.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.586 -0.734 . . . . 0.59999999999999998 110.705 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.02 168.31 25.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.88 0.371 . . . . 3.1400000000000001 111.13 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.748 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.5 mt -108.97 131.02 60.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.993 -0.549 . . . . 3.23 110.154 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.15 162.35 35.69 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.954 0.407 . . . . 3.6299999999999999 111.202 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 76.1 tt0 36.04 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.659 -0.497 . . . . 6.0800000000000001 109.659 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.748 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.5 32.32 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.921 -0.581 . . . . 3.3799999999999999 111.606 -178.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.641 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.1 Cg_endo -63.17 -29.12 73.77 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.445 2.097 . . . . 3.9300000000000002 111.906 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.641 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.65 125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 3.3599999999999999 110.494 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.553 ' O ' ' O ' ' A' ' 92' ' ' THR . 2.4 mm-40 -123.9 158.39 60.19 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.32 -0.4 . . . . 3.6099999999999999 110.409 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.555 ' HG3' ' CZ ' ' A' ' 143' ' ' ARG . 97.0 Cg_endo -82.0 -64.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.976 2.451 . . . . 1.51 113.556 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.619 ' ND2' ' CD2' ' A' ' 157' ' ' TYR . 11.1 m120 -108.42 -19.71 13.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.277 -0.419 . . . . 2.6800000000000002 112.074 -178.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 7.1 p -107.26 152.08 24.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.143 0.497 . . . . 1.21 111.354 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.569 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.3 102.9 2.22 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.708 -0.678 . . . . 1.5600000000000001 110.632 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.6 145.61 13.13 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.927 2.418 . . . . 0.81000000000000005 112.589 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.926 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.84 168.01 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.919 -0.582 . . . . 1.52 109.889 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.15 147.85 28.94 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.763 -0.458 . . . . 2.1400000000000001 109.763 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.602 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.23 157.38 44.91 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.593 -0.443 . . . . 0.32000000000000001 111.241 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.486 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.8 m-20 -127.98 155.31 44.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.863 -0.608 . . . . 2.1699999999999999 110.128 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.821 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.63 173.01 6.39 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 121.125 0.488 . . . . 0.58999999999999997 110.749 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.821 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.68 174.03 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.822 2.348 . . . . 0.90000000000000002 111.557 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.484 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.15 -51.06 0.68 Allowed Pre-proline 0 C--N 1.328 -0.342 0 C-N-CA 120.719 -0.392 . . . . 3.3399999999999999 110.068 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.616 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.82 152.38 82.35 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.711 2.274 . . . . 1.8500000000000001 111.451 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.64 42.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.322 0.582 . . . . 2.54 110.575 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.813 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.69 -41.58 98.11 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.027 -0.988 . . . . 2.5299999999999998 110.63 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.4 mt -109.89 137.91 39.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.771 -0.65 . . . . 1.1699999999999999 111.207 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.98 -72.88 0.7 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.965 -0.561 . . . . 1.27 111.927 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.27 148.34 24.38 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.594 0.591 . . . . 1.1200000000000001 112.594 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -121.8 124.86 45.17 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.396 -0.594 . . . . 0.41999999999999998 109.396 177.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.08 134.78 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.614 -0.434 . . . . 0.78000000000000003 110.644 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.926 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.01 128.52 53.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.03 0.443 . . . . 0.62 111.267 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.548 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.04 139.07 49.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.81 -0.632 . . . . 1.97 110.064 178.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.435 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.09 163.15 35.18 Favored 'General case' 0 N--CA 1.458 -0.056 0 C-N-CA 120.559 -0.456 . . . . 0.34999999999999998 112.134 -178.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.4 139.69 7.99 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.478 -0.783 . . . . 1.8 110.449 178.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.65 115.44 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.366 2.044 . . . . 0.57999999999999996 111.799 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.686 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.03 81.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.901 -0.407 . . . . 3.04 109.901 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.697 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.21 -20.61 0.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.97 -0.559 . . . . 2.4700000000000002 111.933 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.6 p -157.68 157.77 34.16 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.801 -0.36 . . . . 2.5099999999999998 110.596 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.408 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.26 27.79 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.247 -0.433 . . . . 1.8600000000000001 110.159 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.81 -75.95 1.31 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.175 -0.536 . . . . 1.4399999999999999 111.826 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.87 152.27 35.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.942 0.401 . . . . 4.6900000000000004 110.944 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.648 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.16 -169.15 2.55 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.031 -0.532 . . . . 1.4299999999999999 111.927 179.386 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.18 149.67 29.76 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.483 0.659 . . . . 1.74 112.463 -177.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.03 156.59 46.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.702 -1.135 . . . . 1.9199999999999999 110.216 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.465 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.28 158.27 41.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.98 -0.554 . . . . 0.34000000000000002 111.842 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.09 135.66 53.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.493 -0.776 . . . . 0.40999999999999998 109.82 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.602 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.46 122.02 23.72 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.427 -0.351 . . . . 0.55000000000000004 111.534 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.2 Cg_exo -46.39 151.75 1.67 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.717 2.278 . . . . 0.44 112.053 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.92 -23.05 63.11 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 115.958 -0.564 . . . . 0.73999999999999999 112.79 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.545 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.87 -16.7 46.57 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.213 -0.595 . . . . 0.93000000000000005 111.809 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.604 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.66 138.42 31.57 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.83 -0.348 . . . . 0.96999999999999997 110.248 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -121.57 13.92 10.96 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.375 -0.375 . . . . 1.3400000000000001 111.462 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.482 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 86.8 p -149.93 143.46 25.26 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.651 -0.42 . . . . 0.39000000000000001 111.088 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.82 -169.4 1.54 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.203 0.525 . . . . 0.41999999999999998 110.897 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.723 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 20.2 m -151.68 125.89 9.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.444 -0.798 . . . . 0.39000000000000001 109.863 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.513 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.87 123.29 70.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.304 -0.558 . . . . 0.73999999999999999 111.217 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.578 ' HG2' ' N ' ' A' ' 62' ' ' GLY . 87.5 tttt -126.55 163.4 23.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.863 -0.608 . . . . 2.48 110.396 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.578 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.07 19.07 59.81 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.771 -0.932 . . . . 0.5 110.771 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.513 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.7 mt -79.12 157.17 28.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.147 0.498 . . . . 0.57999999999999996 111.304 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.844 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -99.42 133.9 21.62 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.544 -0.753 . . . . 2.79 110.56 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.666 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.85 143.49 61.27 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.615 2.21 . . . . 0.87 111.937 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.84 25.64 75.32 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.087 -0.805 . . . . 0.64000000000000001 111.087 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.2 158.84 40.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.754 0.311 . . . . 0.82999999999999996 110.377 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.18 139.86 42.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.364 -0.38 . . . . 0.5 110.554 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.65 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.55 136.42 54.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.985 -0.552 . . . . 0.53000000000000003 110.779 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.9 131.02 45.3 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.493 -0.928 . . . . 1.8700000000000001 108.493 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.494 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.38 153.92 16.62 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.315 -0.945 . . . . 0.28999999999999998 111.985 -178.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.98 140.95 46.09 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.693 -0.484 . . . . 1.4299999999999999 109.693 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.517 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.71 118.82 34.12 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.558 -0.457 . . . . 0.32000000000000001 110.482 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.737 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.45 129.11 68.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.371 -0.377 . . . . 0.79000000000000004 110.675 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.704 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.85 120.87 43.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.272 -0.422 . . . . 1.02 110.687 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.855 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.56 146.45 11.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.068 0.461 . . . . 0.62 111.035 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.813 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.0 153.88 21.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.514 -0.766 . . . . 2.4399999999999999 109.934 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.27 88.6 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.996 0.426 . . . . 3.6899999999999999 110.469 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.28 32.63 0.21 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.823 -0.626 . . . . 6.0800000000000001 110.6 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.35 3.29 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.483 -0.647 . . . . 1.22 111.483 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.471 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.48 177.4 8.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.301 0.572 . . . . 2.8799999999999999 111.577 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.13 149.41 31.96 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.423 -0.808 . . . . 1.47 110.369 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.06 144.71 38.9 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.43 -0.35 . . . . 2.7000000000000002 110.6 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.737 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -127.98 136.0 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-O 121.07 0.462 . . . . 0.46000000000000002 111.603 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.57 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.6 m -124.13 141.23 52.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.668 -0.697 . . . . 0.34999999999999998 110.302 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.497 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.64 138.88 51.67 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 120.493 -0.483 . . . . 3.6699999999999999 111.485 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.494 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.23 164.22 37.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.501 -0.772 . . . . 0.67000000000000004 109.48 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.565 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 46.9 p30 -145.25 151.55 38.55 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.429 -0.509 . . . . 1.47 111.037 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.25 172.77 12.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.739 -0.664 . . . . 0.44 111.007 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.84 160.58 21.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.529 -0.76 . . . . 1.3700000000000001 109.826 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.3 121.79 22.92 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.567 -0.453 . . . . 1.28 110.803 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.553 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.0 p -127.37 161.11 29.42 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.226 0.454 . . . . 1.97 112.226 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 31.2 t -121.58 135.75 54.98 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.766 -0.652 . . . . 3.2799999999999998 110.361 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.641 HG22 ' H ' ' A' ' 96' ' ' THR . 40.8 m -130.21 134.53 47.34 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.084 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.566 ' O ' ' HB ' ' A' ' 96' ' ' THR . 86.0 p -64.57 -29.91 70.94 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.928 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.641 ' H ' HG22 ' A' ' 94' ' ' THR . 44.7 m 109.35 -76.44 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 124.557 1.143 . . . . 0.0 110.953 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.479 ' CD ' ' HB ' ' A' ' 96' ' ' THR . 48.0 Cg_endo -66.28 144.69 75.44 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 121.185 1.459 . . . . 0.0 111.427 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.0 m -129.13 149.8 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.923 0.392 . . . . 0.0 110.412 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.5 t -140.69 158.15 44.4 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.814 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.9 m -66.39 156.8 33.57 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -100.37 127.94 46.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.898 0.38 . . . . 0.0 110.488 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.4 p -71.56 -21.16 61.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.12 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 p -130.89 141.87 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.905 0.383 . . . . 0.0 110.968 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 47.6 m -124.43 140.36 53.02 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.445 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 131.51 142.2 4.95 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.6 -33.38 74.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.683 0.278 . . . . 0.0 110.833 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 65.6 p -67.33 -24.19 65.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.74 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.7 m 53.98 66.06 4.78 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.076 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -55.95 148.61 56.52 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.147 1.898 . . . . 0.0 111.373 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -102.99 134.26 46.73 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.064 0.459 . . . . 0.0 111.111 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.15 158.3 87.77 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.45 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 113' ' ' LEU . 10.9 Cg_endo -54.27 150.85 31.31 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.531 2.154 . . . . 0.0 111.714 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 112' ' ' PRO . 50.2 mt 58.71 149.7 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.133 -0.485 . . . . 10.19 110.255 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.461 ' O ' ' C ' ' A' ' 115' ' ' ALA . 25.1 m -128.86 159.08 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.004 -0.544 . . . . 7.2800000000000002 111.046 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 114' ' ' VAL . . . 25.94 92.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.686 -0.688 . . . . 7.2999999999999998 111.966 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.9 m -57.93 -37.54 74.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.028 -0.533 . . . . 6.4400000000000004 110.242 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 55.8 p -68.39 163.29 23.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.028 -0.533 . . . . 4.4199999999999999 110.805 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -96.27 140.88 30.31 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.061 -0.518 . . . . 3.0499999999999998 110.435 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -115.6 145.53 42.6 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.911 -0.586 . . . . 3.4300000000000002 110.626 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.5 t -110.54 137.96 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-N 116.135 -0.484 . . . . 2.8799999999999999 110.09 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.434 HG23 ' N ' ' A' ' 122' ' ' GLU . 8.0 t -53.13 -41.64 65.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.058 -0.519 . . . . 2.0899999999999999 112.17 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.434 ' N ' HG23 ' A' ' 121' ' ' THR . 19.8 pt-20 -80.76 137.43 36.25 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.29 -0.564 . . . . 4.5300000000000002 110.244 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.472 HG22 ' H ' ' A' ' 125' ' ' ALA . 72.8 mt -117.18 130.06 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.149 -0.478 . . . . 1.4399999999999999 110.66 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.62 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 56.4 p -71.53 -28.97 64.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.466 -0.333 . . . . 1.78 110.603 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 124' ' ' THR . . . 153.05 109.43 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.754 -0.657 . . . . 0.64000000000000001 109.403 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.9 p -61.12 -32.09 71.79 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.576 -0.45 . . . . 0.66000000000000003 110.676 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.441 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.9 167.55 0.26 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 0.68999999999999995 110.914 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.61 145.53 50.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.677 -0.692 . . . . 0.52000000000000002 110.099 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.28 101.69 9.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.096 -0.705 . . . . 0.32000000000000001 109.096 177.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.0 t -112.96 139.64 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.059 -0.519 . . . . 0.28999999999999998 111.078 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.5 p -128.73 152.61 48.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.721 -0.672 . . . . 0.25 109.776 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.584 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.4 p90 -144.8 -164.95 2.04 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.682 -0.407 . . . . 0.31 110.549 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.733 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.9 t -123.91 127.19 73.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.103 -0.499 . . . . 0.48999999999999999 110.817 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.157 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.97 58.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 1.53 110.376 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.12 24.47 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.856 -0.611 . . . . 0.96999999999999997 111.524 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.157 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.13 128.76 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.542 -0.463 . . . . 1.5600000000000001 110.868 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.43 -9.71 55.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.849 -0.614 . . . . 1.8799999999999999 110.31 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.0 0.22 55.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 1.04 110.414 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.725 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.25 137.21 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.951 -0.568 . . . . 0.23999999999999999 109.955 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.579 ' N ' ' O ' ' A' ' 185' ' ' ILE . 5.6 m -96.32 -15.41 21.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.219 0.533 . . . . 0.28999999999999998 110.016 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.454 ' HA3' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.51 175.56 45.7 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 109.839 -1.304 . . . . 0.13 109.839 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -123.53 151.61 42.65 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.64 -0.424 . . . . 0.17000000000000001 110.485 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.728 ' NH2' ' CD2' ' A' ' 183' ' ' TYR . 69.8 ttp85 -132.33 121.15 23.07 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.081 -0.509 . . . . 1.29 109.931 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.545 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.08 136.53 38.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.689 -0.687 . . . . 0.25 110.65 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.516 ' HB2' HH12 ' A' ' 143' ' ' ARG . 81.1 tt0 -129.36 129.91 45.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.993 -0.548 . . . . 1.3200000000000001 110.07 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.625 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.7 p90 -138.75 135.4 34.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.023 -0.535 . . . . 0.56999999999999995 110.558 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.419 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.38 161.36 39.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.723 -0.671 . . . . 1.1599999999999999 109.717 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.969 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 85.9 mt -71.09 124.86 25.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.018 0.437 . . . . 0.38 110.725 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.492 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.76 -7.56 48.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.813 -0.631 . . . . 0.40999999999999998 110.887 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -109.89 -69.77 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 1.6599999999999999 111.428 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.45 ' CD ' HH21 ' A' ' 176' ' ' ARG . 53.8 mt-10 -60.56 -35.46 76.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.028 -0.533 . . . . 1.6599999999999999 111.535 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.074 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.26 88.58 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.8 -0.92 . . . . 1.1699999999999999 110.8 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.327 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.96 -171.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 1.8600000000000001 110.243 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.327 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.27 139.13 45.12 Favored Pre-proline 0 N--CA 1.454 -0.262 0 CA-C-O 120.997 0.427 . . . . 1.98 110.243 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.419 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.3 Cg_endo -70.93 145.77 51.22 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 C-N-CA 122.782 2.321 . . . . 0.55000000000000004 112.302 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.625 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.78 145.71 42.58 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.238 -0.653 . . . . 1.1399999999999999 109.238 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.666 ' CE1' ' CD ' ' A' ' 65' ' ' PRO . 35.6 p90 -123.28 141.31 52.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.234 0.54 . . . . 0.93000000000000005 111.577 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.2 mt -128.09 127.72 43.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.274 -0.875 . . . . 0.34000000000000002 108.944 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 5.0 t0 -101.63 131.17 48.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.102 0.477 . . . . 1.0900000000000001 111.722 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.518 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.1 mt -127.94 157.66 73.1 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.277 -0.874 . . . . 0.19 109.601 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -69.92 158.03 58.12 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 122.439 2.093 . . . . 0.17999999999999999 112.226 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.32 -12.13 5.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.773 -0.649 . . . . 0.20999999999999999 110.7 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.0 p -92.84 -8.76 42.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.094 -0.503 . . . . 0.28999999999999998 110.675 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.15 135.43 34.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.326 -0.397 . . . . 0.5 110.391 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.7 p -133.18 16.65 4.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.443 -0.344 . . . . 0.29999999999999999 110.462 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.5 p -167.6 147.11 5.03 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.607 -0.516 . . . . 0.23000000000000001 109.607 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.545 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.21 150.43 12.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.5 -0.48 . . . . 0.28000000000000003 111.594 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.503 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.28 125.0 50.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.619 -0.719 . . . . 1.0700000000000001 109.792 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.46 104.97 30.44 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.391 -0.368 . . . . 0.28999999999999998 110.99 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.4 Cg_endo -90.99 -179.48 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 123.117 2.545 . . . . 0.42999999999999999 112.162 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.61 32.64 18.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.341 -0.845 . . . . 1.26 111.493 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.7 mt -86.39 148.49 25.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.339 . . . . 0.32000000000000001 110.494 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.772 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.23 114.83 61.18 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.311 -0.404 . . . . 0.57999999999999996 110.658 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.98 140.5 95.63 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.837 2.358 . . . . 0.66000000000000003 112.08 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.16 21.21 74.04 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.036 -0.825 . . . . 0.28999999999999998 111.036 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.45 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.87 150.18 49.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.787 0.327 . . . . 2.3300000000000001 110.686 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.492 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.21 131.73 45.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.088 -0.506 . . . . 0.85999999999999999 109.747 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.969 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.55 148.19 44.19 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.129 -0.487 . . . . 0.52000000000000002 111.08 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.26 125.3 60.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.303 -0.999 . . . . 0.29999999999999999 108.303 177.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.52 132.46 63.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.162 0.506 . . . . 0.23000000000000001 111.197 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.45 122.5 20.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.555 -0.748 . . . . 0.35999999999999999 109.636 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.584 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.96 125.49 54.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.255 -0.43 . . . . 0.19 110.647 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.728 ' CD2' ' NH2' ' A' ' 143' ' ' ARG . 48.5 m-85 -117.34 137.84 52.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.985 -0.552 . . . . 0.29999999999999999 109.891 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.581 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.73 135.02 42.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.729 -0.841 . . . . 0.37 108.729 179.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 140' ' ' SER . 83.3 mt -99.05 122.86 51.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.11 0.481 . . . . 0.26000000000000001 110.961 -178.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.5 p -83.81 169.73 14.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.542 -0.754 . . . . 0.28000000000000003 110.525 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.82 -14.54 15.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.119 -0.491 . . . . 1.6000000000000001 110.956 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -96.03 -4.25 43.42 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.852 -0.339 . . . . 1.1799999999999999 110.879 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.585 ' HA3' HG23 ' A' ' 59' ' ' THR . . . 87.81 13.83 64.08 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.336 -0.706 . . . . 0.29999999999999999 111.336 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -84.6 139.17 32.28 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.027 -0.269 . . . . 1.22 110.458 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.553 HE22 ' HG2' ' A' ' 15' ' ' PRO . 86.2 mt-30 -106.77 141.04 38.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 0.97999999999999998 110.535 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.1 m -136.65 127.06 26.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.82999999999999996 110.388 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.7 tp -68.24 117.29 9.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.92 0.39 . . . . 0.26000000000000001 110.448 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.07 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.29999999999999999 110.714 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.1 tp -156.88 125.68 5.85 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.554 -0.459 . . . . 0.31 111.486 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.472 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.75 120.27 21.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.77 -0.65 . . . . 0.28000000000000003 109.536 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.66 29.06 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.602 -0.439 . . . . 0.23999999999999999 110.903 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.45 158.65 18.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.092 -0.504 . . . . 0.23000000000000001 110.442 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.15 157.99 43.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.171 -0.468 . . . . 0.67000000000000004 110.654 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 104.33 9.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.699 -0.682 . . . . 0.64000000000000001 110.025 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.888 -1.053 . . . . 1.26 110.672 -179.694 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.55 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.201 -0.666 . . . . 3.4399999999999999 109.201 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.37 150.64 18.55 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.983 -0.847 . . . . 1.22 110.983 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -35.58 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.092 0 C-N-CA 124.03 3.153 . . . . 0.75 113.754 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.622 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -80.04 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.208 -1.36 . . . . 0.79000000000000004 108.857 178.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.622 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.64 125.8 51.4 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.426 -0.51 . . . . 1.9399999999999999 111.434 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.5 143.96 34.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.625 -0.716 . . . . 0.59999999999999998 110.583 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.93 168.37 25.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.386 -0.37 . . . . 3.1400000000000001 111.09 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.738 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.02 131.09 60.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.008 -0.542 . . . . 3.23 110.047 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.1 p -141.18 162.27 35.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.84 0.352 . . . . 3.6299999999999999 111.27 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.8 mt-10 36.09 31.62 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.601 -0.518 . . . . 6.0800000000000001 109.601 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.738 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.41 69.52 32.19 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.932 -0.576 . . . . 3.3799999999999999 111.558 -178.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.24 -29.2 73.23 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.57 2.18 . . . . 3.9300000000000002 111.837 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.71 125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 3.3599999999999999 110.449 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.718 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -123.93 158.34 60.44 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.329 -0.396 . . . . 3.6099999999999999 110.444 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.497 ' HG2' ' CD ' ' A' ' 143' ' ' ARG . 96.9 Cg_endo -81.94 -64.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.965 2.443 . . . . 1.51 113.574 -179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.44 ' H ' ' HG2' ' A' ' 15' ' ' PRO . 10.2 m120 -108.47 -19.62 13.39 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.088 0.403 . . . . 2.6800000000000002 112.088 -178.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.718 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 89.1 p -107.32 152.05 24.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.101 0.477 . . . . 1.21 111.346 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.578 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.26 102.92 2.23 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.711 -0.677 . . . . 1.5600000000000001 110.583 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.75 145.68 12.93 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.781 2.321 . . . . 0.81000000000000005 112.554 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.915 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.78 167.96 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.845 -0.616 . . . . 1.52 109.903 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.16 147.95 29.05 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.742 -0.466 . . . . 2.1400000000000001 109.742 178.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.3 p90 -142.23 157.3 45.0 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.567 -0.453 . . . . 0.32000000000000001 111.169 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.494 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.8 m-20 -127.97 155.26 44.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.773 -0.649 . . . . 2.1699999999999999 110.199 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.825 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.64 173.05 6.34 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.113 0.482 . . . . 0.58999999999999997 110.702 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.825 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.8 Cg_exo -50.74 173.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.834 2.356 . . . . 0.90000000000000002 111.505 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.92 -51.08 0.7 Allowed Pre-proline 0 C--N 1.33 -0.265 0 C-N-CA 120.717 -0.393 . . . . 3.3399999999999999 110.212 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.62 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.8 152.41 82.22 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.683 2.255 . . . . 1.8500000000000001 111.501 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.68 42.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.343 0.592 . . . . 2.54 110.601 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.815 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.64 -41.66 98.22 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.004 -0.998 . . . . 2.5299999999999998 110.655 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.53 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.5 mt -109.73 137.84 40.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.784 -0.643 . . . . 1.1699999999999999 111.308 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.02 -72.89 0.7 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.075 -0.512 . . . . 1.27 111.906 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.22 148.43 24.37 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.581 0.586 . . . . 1.1200000000000001 112.581 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -121.76 124.82 45.12 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.448 -0.575 . . . . 0.41999999999999998 109.448 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.7 mt -118.08 134.75 60.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.55 -0.46 . . . . 0.78000000000000003 110.569 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.915 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.02 128.72 53.79 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.057 0.456 . . . . 0.62 111.268 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.549 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.97 49.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.707 -0.678 . . . . 1.97 110.159 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -144.98 163.19 34.93 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.092 0.473 . . . . 0.34999999999999998 112.172 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.55 139.49 7.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.512 -0.767 . . . . 1.8 110.502 178.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.694 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.44 115.45 3.03 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.296 1.997 . . . . 0.57999999999999996 111.846 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.96 81.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.9 -0.407 . . . . 3.04 109.9 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.694 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.14 -20.6 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.993 -0.549 . . . . 2.4700000000000002 111.887 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.7 p -157.69 157.76 34.12 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.884 -0.326 . . . . 2.5099999999999998 110.596 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.4 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.36 27.8 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.174 -0.466 . . . . 1.8600000000000001 110.205 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.73 -75.88 1.31 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.116 -0.564 . . . . 1.4399999999999999 111.926 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.89 152.25 35.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.966 0.412 . . . . 4.6900000000000004 110.959 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.633 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.23 -169.18 2.55 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.06 -0.518 . . . . 1.4299999999999999 111.97 179.367 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.08 149.74 29.59 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.392 0.615 . . . . 1.74 112.564 -177.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.08 156.45 45.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.81 -1.086 . . . . 1.9199999999999999 110.287 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.22 158.28 41.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.925 -0.579 . . . . 0.34000000000000002 111.8 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.04 135.69 53.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.476 -0.783 . . . . 0.40999999999999998 109.801 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.596 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.42 121.94 23.75 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.481 -0.327 . . . . 0.55000000000000004 111.526 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.0 Cg_exo -46.37 151.66 1.68 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.688 2.259 . . . . 0.44 112.151 178.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.87 -23.03 62.99 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 116.043 -0.526 . . . . 0.73999999999999999 112.784 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.6 p-80 -82.81 -16.86 46.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 117.391 0.596 . . . . 0.93000000000000005 111.804 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.605 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.63 138.4 31.6 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.751 -0.379 . . . . 0.96999999999999997 110.323 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.47 13.87 11.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.383 -0.371 . . . . 1.3400000000000001 111.542 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.48 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.0 p -149.95 143.45 25.24 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.617 -0.433 . . . . 0.39000000000000001 111.04 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.87 -169.25 1.51 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.045 -0.525 . . . . 0.41999999999999998 110.913 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.714 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 97.4 m -151.83 125.95 9.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.417 -0.811 . . . . 0.39000000000000001 109.8 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.509 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.88 123.25 70.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.376 -0.53 . . . . 0.73999999999999999 111.2 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.809 ' NZ ' ' N ' ' A' ' 141' ' ' GLY . 96.7 mttt -126.53 163.37 23.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.879 -0.601 . . . . 2.48 110.41 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.17 18.94 59.89 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.697 -0.961 . . . . 0.5 110.697 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.509 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.8 mt -79.04 157.27 28.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.13 0.491 . . . . 0.57999999999999996 111.363 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.859 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -99.45 134.01 21.51 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.598 -0.728 . . . . 2.79 110.451 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.91 143.58 61.26 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.555 2.17 . . . . 0.87 111.867 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.72 75.23 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.998 -0.841 . . . . 0.64000000000000001 110.998 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.859 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.15 158.76 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.567 0.223 . . . . 0.82999999999999996 110.46 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.15 139.95 41.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.944 0.402 . . . . 0.5 110.627 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.637 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.57 136.43 54.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.041 -0.527 . . . . 0.53000000000000003 110.77 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.92 130.99 45.33 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.53 -0.915 . . . . 1.8700000000000001 108.53 177.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.488 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.45 153.92 16.63 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.349 -0.929 . . . . 0.28999999999999998 111.913 -178.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.04 140.94 46.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.642 -0.503 . . . . 1.4299999999999999 109.642 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.52 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.78 118.86 34.21 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.505 -0.478 . . . . 0.32000000000000001 110.46 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.731 HG12 HG23 ' A' ' 84' ' ' VAL . 63.8 mt -112.43 128.94 68.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.79000000000000004 110.65 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.73 120.9 43.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.324 -0.398 . . . . 1.02 110.707 -179.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.858 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.57 146.51 11.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.137 0.494 . . . . 0.62 111.015 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.815 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.11 153.86 21.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.585 -0.734 . . . . 2.4399999999999999 109.955 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.14 88.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.004 0.43 . . . . 3.6899999999999999 110.503 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.22 32.7 0.21 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.808 -0.633 . . . . 6.0800000000000001 110.511 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.09 -117.37 3.29 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.443 -0.663 . . . . 1.22 111.443 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.468 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.37 177.35 9.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.177 0.513 . . . . 2.8799999999999999 111.69 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.1 149.59 32.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.476 -0.783 . . . . 1.47 110.371 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.55 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.2 144.78 38.67 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.407 -0.361 . . . . 2.7000000000000002 110.501 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.731 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.07 136.03 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 121.071 0.463 . . . . 0.46000000000000002 111.487 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.11 141.39 52.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.697 -0.683 . . . . 0.34999999999999998 110.212 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.461 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.4 ttp180 -117.69 138.93 51.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.185 0.517 . . . . 3.6699999999999999 111.406 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.34 164.15 38.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.539 -0.755 . . . . 0.67000000000000004 109.531 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.29 151.49 38.42 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.391 -0.523 . . . . 1.47 111.072 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.81 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.3 p90 -146.11 172.79 12.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.713 -0.676 . . . . 0.44 111.044 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.8 160.63 21.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.46 -0.791 . . . . 1.3700000000000001 109.809 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.35 121.91 23.04 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.535 -0.466 . . . . 1.28 110.776 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.549 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -128.2 164.31 22.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.668 0.747 . . . . 1.97 112.682 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.49 ' OG ' ' CE2' ' A' ' 157' ' ' TYR . 30.3 t -118.98 150.24 40.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.712 -1.131 . . . . 3.2799999999999998 109.001 177.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -40.12 140.16 0.62 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.926 0.393 . . . . 0.0 110.708 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.4 m -61.75 153.46 28.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.706 -178.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.8 p -73.46 153.69 89.9 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.577 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.93 150.64 22.68 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 121.842 1.695 . . . . 0.0 111.199 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 74.3 t -58.78 -40.3 79.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.478 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.5 p -68.78 -27.41 65.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.763 0.316 . . . . 0.0 111.142 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.2 m -66.35 156.97 32.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -102.38 139.66 37.69 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.342 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.8 p -85.47 163.46 18.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.833 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.8 m -127.66 157.65 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.41 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 57.3 p -66.6 -27.22 67.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.078 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -177.69 -176.21 45.53 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.35 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.432 ' H ' ' CD ' ' A' ' 106' ' ' GLU . 59.1 mp0 -59.28 143.67 48.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.961 0.41 . . . . 0.0 110.914 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.411 ' H ' HG22 ' A' ' 107' ' ' THR . 1.2 t -62.0 -37.0 83.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.676 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.2 p -123.51 80.94 54.03 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.792 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.39 148.29 33.97 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.579 2.186 . . . . 0.0 112.296 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.461 ' CE2' ' OG ' ' A' ' 111' ' ' SER . 67.6 t80 -97.99 133.76 42.03 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.188 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.461 ' OG ' ' CE2' ' A' ' 110' ' ' PHE . 16.0 m 57.99 64.65 3.73 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.338 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -57.25 146.0 84.3 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.53 2.154 . . . . 0.0 112.185 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.667 ' H ' HD12 ' A' ' 113' ' ' LEU . 6.5 mp -60.65 -32.7 71.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.781 -0.645 . . . . 10.19 110.98 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.1 m -126.45 160.28 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.948 0.404 . . . . 7.2800000000000002 110.691 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.68 145.37 45.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.941 -0.572 . . . . 7.2999999999999998 110.826 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 p -122.72 166.56 14.72 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.531 -0.758 . . . . 6.4400000000000004 110.613 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.1 m -58.88 159.31 7.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.008 -0.542 . . . . 4.4199999999999999 110.306 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -54.2 143.64 22.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.048 0.452 . . . . 3.0499999999999998 110.827 -178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 43.8 m -63.55 156.32 26.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.454 -0.794 . . . . 3.4300000000000002 111.645 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.6 t -114.07 137.69 46.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.334 -0.848 . . . . 2.8799999999999999 109.565 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 45.1 m -68.65 134.01 49.28 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.524 -0.47 . . . . 2.0899999999999999 110.404 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.75 142.22 57.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.683 -0.69 . . . . 4.5300000000000002 111.739 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.401 ' O ' ' OD1' ' A' ' 171' ' ' ASP . 32.0 pt -125.23 159.05 32.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.444 -0.798 . . . . 1.4399999999999999 109.226 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 19.3 p -123.27 154.34 38.97 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.133 0.492 . . . . 1.78 111.152 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.581 ' O ' ' N ' ' A' ' 127' ' ' SER . . . -162.46 152.74 16.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.611 -0.722 . . . . 0.64000000000000001 109.869 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 125' ' ' ALA . 0.1 OUTLIER 34.83 28.12 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 122.137 0.97 . . . . 0.66000000000000003 110.926 178.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.581 ' N ' ' O ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.91 167.53 0.26 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.626 -1.17 . . . . 0.68999999999999995 110.946 -179.193 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.8 m-30 -133.65 145.54 50.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.678 -0.692 . . . . 0.52000000000000002 110.102 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.28 101.68 9.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.075 -0.713 . . . . 0.32000000000000001 109.075 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.8 t -112.86 139.7 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.987 -0.551 . . . . 0.28999999999999998 111.133 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.2 p -128.73 152.5 48.35 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.624 -0.716 . . . . 0.25 109.786 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.587 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.79 -165.04 2.05 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.705 -0.398 . . . . 0.31 110.629 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.729 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -123.81 127.19 73.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.46 . . . . 0.48999999999999999 110.836 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.162 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.99 58.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.222 -0.444 . . . . 1.53 110.38 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.729 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.19 24.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.855 -0.612 . . . . 0.96999999999999997 111.518 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.162 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.15 128.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.628 -0.429 . . . . 1.5600000000000001 110.897 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -86.56 -9.6 55.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.938 -0.573 . . . . 1.8799999999999999 110.215 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.2 p -87.09 0.22 55.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.153 -0.476 . . . . 1.04 110.344 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.38 137.33 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.969 -0.56 . . . . 0.23999999999999999 109.9 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.754 ' C ' ' HZ2' ' A' ' 61' ' ' LYS . 3.5 p -96.29 -15.53 21.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.262 0.553 . . . . 0.28999999999999998 110.045 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.809 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.59 175.52 45.74 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.786 -1.325 . . . . 0.13 109.786 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -123.34 151.59 42.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.954 0.407 . . . . 0.17000000000000001 110.551 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.728 ' NH2' ' OE1' ' A' ' 191' ' ' GLN . 64.1 ttp85 -132.34 121.18 23.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.153 -0.476 . . . . 1.29 109.989 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.558 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.07 136.49 38.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.706 -0.679 . . . . 0.25 110.747 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 81.3 tt0 -129.33 129.92 45.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.994 -0.548 . . . . 1.3200000000000001 110.105 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.3 p90 -138.73 135.27 34.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.957 -0.565 . . . . 0.56999999999999995 110.57 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.417 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.31 161.43 39.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.737 -0.665 . . . . 1.1599999999999999 109.662 179.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.949 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -70.99 124.85 25.32 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.672 -0.411 . . . . 0.38 110.775 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.492 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.84 -7.6 49.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.779 -0.646 . . . . 0.40999999999999998 110.814 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -109.91 -69.63 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.845 0.355 . . . . 1.6599999999999999 111.399 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.459 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.3 mt-10 -60.75 -35.29 76.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 1.6599999999999999 111.471 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.095 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.15 7.18 88.62 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.789 -0.924 . . . . 1.1699999999999999 110.789 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.324 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.95 -171.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.765 0.316 . . . . 1.8600000000000001 110.301 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.324 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.2 139.02 45.33 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 1.98 110.221 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.417 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 45.8 Cg_endo -70.9 145.79 51.45 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.675 2.25 . . . . 0.55000000000000004 112.32 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.83 145.74 42.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.196 -0.668 . . . . 1.1399999999999999 109.196 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.673 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 86.7 m-85 -123.29 141.31 52.11 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.366 -0.534 . . . . 0.93000000000000005 111.513 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.8 mt -128.05 127.66 43.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.286 -0.87 . . . . 0.34000000000000002 108.925 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -101.58 131.05 47.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.127 0.489 . . . . 1.0900000000000001 111.751 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.86 157.56 73.25 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.388 -0.824 . . . . 0.19 109.6 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.72 158.06 58.32 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 122.479 2.12 . . . . 0.17999999999999999 112.225 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.38 -12.17 5.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.744 -0.662 . . . . 0.20999999999999999 110.675 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.7 p -92.78 -8.75 42.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.28999999999999998 110.778 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.19 135.34 34.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.5 110.329 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.5 p -133.05 16.55 4.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.396 -0.366 . . . . 0.29999999999999999 110.531 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.52 147.05 5.08 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.642 -0.503 . . . . 0.23000000000000001 109.642 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.18 150.44 12.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.46 -0.496 . . . . 0.28000000000000003 111.564 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.35 124.93 50.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.6 -0.727 . . . . 1.0700000000000001 109.837 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.36 104.91 29.72 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.879 0.371 . . . . 0.28999999999999998 111.065 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -91.0 -179.49 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.922 0 C-N-CA 123.241 2.628 . . . . 0.42999999999999999 112.191 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 123' ' ' ILE . 71.2 m-20 61.61 32.65 18.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.328 -0.851 . . . . 1.26 111.467 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.8 mt -86.41 148.54 25.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.782 0.325 . . . . 0.32000000000000001 110.4 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.759 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.26 114.86 61.3 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.919 0.39 . . . . 0.57999999999999996 110.642 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.02 140.57 95.94 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 122.915 2.41 . . . . 0.66000000000000003 111.922 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.05 21.2 74.4 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.087 -0.805 . . . . 0.28999999999999998 111.087 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.459 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.9 150.2 49.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.913 0.387 . . . . 2.3300000000000001 110.529 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.492 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.16 131.63 45.99 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.974 -0.557 . . . . 0.85999999999999999 109.813 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.949 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.51 148.35 43.95 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.127 -0.488 . . . . 0.52000000000000002 111.063 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.32 125.29 60.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.323 -0.991 . . . . 0.29999999999999999 108.323 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.46 132.45 63.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.174 0.511 . . . . 0.23000000000000001 111.346 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.44 122.49 20.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.541 -0.754 . . . . 0.35999999999999999 109.684 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.587 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -100.95 125.38 54.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.281 -0.418 . . . . 0.19 110.723 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.7 m-85 -117.22 137.86 52.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.045 -0.525 . . . . 0.29999999999999999 109.854 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.576 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.71 134.97 42.89 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.809 -0.811 . . . . 0.37 108.809 178.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.653 HG21 ' HE2' ' A' ' 61' ' ' LYS . 11.6 mt -99.05 122.94 51.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.123 0.487 . . . . 0.26000000000000001 110.926 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.3 p -83.8 169.7 14.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.582 -0.735 . . . . 0.28000000000000003 110.481 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -59.82 -14.48 15.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.016 -0.538 . . . . 1.6000000000000001 110.979 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -96.03 -4.35 43.26 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.877 -0.329 . . . . 1.1799999999999999 110.796 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.79 13.91 63.97 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.36 -0.696 . . . . 0.29999999999999999 111.36 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -84.73 139.14 32.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.632 0.253 . . . . 1.22 110.437 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.728 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 86.0 mt-30 -106.73 141.07 38.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.406 -0.361 . . . . 0.97999999999999998 110.527 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.76 127.02 26.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.125 -0.488 . . . . 0.82999999999999996 110.363 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.15 117.37 9.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.293 -0.412 . . . . 0.26000000000000001 110.486 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.11 -21.65 5.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.119 -0.491 . . . . 0.29999999999999999 110.724 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.89 125.6 5.82 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.601 -0.44 . . . . 0.31 111.482 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.75 120.2 21.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.774 -0.648 . . . . 0.28000000000000003 109.562 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.65 151.74 29.14 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.642 -0.423 . . . . 0.23999999999999999 110.89 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.54 158.55 18.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.043 -0.526 . . . . 0.23000000000000001 110.439 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.05 157.91 43.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.67000000000000004 110.723 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.33 104.34 9.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.855 -0.611 . . . . 0.64000000000000001 110.04 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.89 -1.052 . . . . 1.26 110.608 -179.659 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.553 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.9 m . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.242 -0.651 . . . . 3.4399999999999999 109.242 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.27 150.59 18.57 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.041 -0.823 . . . . 1.22 111.041 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.64 142.45 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 123.967 3.111 . . . . 0.75 113.748 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.605 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -80.0 173.41 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.176 -1.374 . . . . 0.79000000000000004 108.758 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.605 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.59 125.91 51.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.157 0.503 . . . . 1.9399999999999999 111.431 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 143.96 34.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.593 -0.73 . . . . 0.59999999999999998 110.607 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.07 168.25 25.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.916 0.389 . . . . 3.1400000000000001 111.123 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.743 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.83 131.07 60.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.986 -0.552 . . . . 3.23 110.103 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.24 162.35 35.69 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.777 0.322 . . . . 3.6299999999999999 111.255 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 67.7 tt0 36.04 31.67 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.58 -0.526 . . . . 6.0800000000000001 109.58 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.743 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.56 32.58 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.917 -0.583 . . . . 3.3799999999999999 111.585 -178.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.636 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.33 -29.14 72.33 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.499 2.133 . . . . 3.9300000000000002 111.796 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.673 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 3.2 m 149.66 125.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.143 -0.48 . . . . 3.3599999999999999 110.495 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.673 ' NE2' ' O ' ' A' ' 13' ' ' SER . 5.8 mp0 -124.02 158.36 60.61 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 3.6099999999999999 110.47 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.453 ' HG3' ' NH1' ' A' ' 143' ' ' ARG . 97.5 Cg_endo -82.08 -64.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.865 2.377 . . . . 1.51 113.51 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.657 HD22 ' HB2' ' A' ' 159' ' ' ASP . 1.1 p-10 -108.44 -19.54 13.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.36 -0.382 . . . . 2.6800000000000002 112.029 -178.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.653 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 95.9 p -107.36 152.04 24.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.174 0.512 . . . . 1.21 111.29 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.5 t-80 -155.32 102.95 2.22 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.662 -0.699 . . . . 1.5600000000000001 110.565 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.531 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.7 Cg_endo -82.63 145.61 13.09 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.85 2.367 . . . . 0.81000000000000005 112.667 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.929 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.78 167.86 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.924 -0.58 . . . . 1.52 109.899 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.06 148.06 29.26 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.74 -0.467 . . . . 2.1400000000000001 109.74 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.59 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.36 157.28 44.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.005 0.431 . . . . 0.32000000000000001 111.169 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.498 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -128.09 155.31 44.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.745 -0.661 . . . . 2.1699999999999999 110.112 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.837 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.6 173.0 6.4 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.175 -0.466 . . . . 0.58999999999999997 110.756 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.837 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.63 173.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.877 2.384 . . . . 0.90000000000000002 111.605 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.01 -51.16 0.69 Allowed Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 120.74 -0.384 . . . . 3.3399999999999999 110.083 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.635 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.75 152.33 82.44 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.798 2.332 . . . . 1.8500000000000001 111.437 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.69 42.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.456 0.646 . . . . 2.54 110.554 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.819 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.63 -41.54 98.25 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.993 -1.003 . . . . 2.5299999999999998 110.718 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.8 mt -109.87 137.77 40.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.791 -0.641 . . . . 1.1699999999999999 111.255 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.96 -72.99 0.7 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.028 -0.533 . . . . 1.27 111.837 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.13 148.5 24.41 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.556 0.576 . . . . 1.1200000000000001 112.556 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.95 124.87 45.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.263 -0.643 . . . . 0.41999999999999998 109.263 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 mt -118.05 134.72 60.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.715 -0.394 . . . . 0.78000000000000003 110.698 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.929 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.02 128.55 53.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.047 0.451 . . . . 0.62 111.271 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.08 139.1 49.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.722 -0.672 . . . . 1.97 110.126 178.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.09 163.11 35.31 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 121.134 0.492 . . . . 0.34999999999999998 112.05 -178.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.489 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.53 139.73 7.9 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.453 -0.794 . . . . 1.8 110.421 178.727 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.65 115.47 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.322 2.015 . . . . 0.57999999999999996 111.769 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.679 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.9 81.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.925 -0.398 . . . . 3.04 109.925 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.67 0.06 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.049 -0.523 . . . . 2.4700000000000002 111.893 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.7 p -157.56 157.81 34.44 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.804 -0.358 . . . . 2.5099999999999998 110.538 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.406 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.32 27.69 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.215 -0.448 . . . . 1.8600000000000001 110.204 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.77 -75.81 1.31 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 121.157 -0.544 . . . . 1.4399999999999999 111.875 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -117.95 152.34 35.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.959 0.409 . . . . 4.6900000000000004 110.983 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.29 -169.1 2.51 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.052 -0.522 . . . . 1.4299999999999999 111.925 179.424 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.22 149.67 29.79 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.497 0.665 . . . . 1.74 112.511 -177.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.08 156.44 45.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.773 -1.103 . . . . 1.9199999999999999 110.225 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.469 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.1 158.35 41.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.826 -0.624 . . . . 0.34000000000000002 111.785 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.0 m -115.21 135.71 53.89 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.458 -0.792 . . . . 0.40999999999999998 109.847 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.59 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.42 121.93 23.74 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.418 -0.355 . . . . 0.55000000000000004 111.576 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.6 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.5 Cg_exo -46.36 151.76 1.64 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.683 2.255 . . . . 0.44 112.107 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.9 -23.12 63.14 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 116.057 -0.519 . . . . 0.73999999999999999 112.765 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.5 p-80 -82.75 -16.9 46.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.37 0.585 . . . . 0.93000000000000005 111.802 -178.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.6 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.58 138.41 31.59 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.802 -0.359 . . . . 0.96999999999999997 110.334 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.52 13.83 10.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.37 -0.377 . . . . 1.3400000000000001 111.56 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.475 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.9 143.46 25.29 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.643 -0.423 . . . . 0.39000000000000001 111.09 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.717 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.77 -169.39 1.54 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.06 -0.518 . . . . 0.41999999999999998 110.888 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.717 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.5 m -151.79 125.92 9.24 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.386 -0.824 . . . . 0.39000000000000001 109.739 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.518 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.81 123.29 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.416 -0.514 . . . . 0.73999999999999999 111.161 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.624 ' CG ' ' N ' ' A' ' 62' ' ' GLY . 18.1 ttpt -126.49 163.45 23.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.874 -0.603 . . . . 2.48 110.432 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.624 ' N ' ' CG ' ' A' ' 61' ' ' LYS . . . 85.09 18.99 59.91 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.731 -0.948 . . . . 0.5 110.731 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.518 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.6 mt -79.1 157.19 28.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.074 0.464 . . . . 0.57999999999999996 111.412 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.847 ' O ' HG12 ' A' ' 67' ' ' VAL . 1.2 mttp -99.37 133.92 21.63 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.702 -0.681 . . . . 2.79 110.504 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.88 143.54 61.24 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.541 2.161 . . . . 0.87 112.059 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.91 25.58 75.41 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.063 -0.815 . . . . 0.64000000000000001 111.063 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.847 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.15 158.78 39.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.687 0.279 . . . . 0.82999999999999996 110.381 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.14 139.91 42.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.89 0.376 . . . . 0.5 110.569 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.663 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.2 m-85 -122.49 136.42 54.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.007 -0.542 . . . . 0.53000000000000003 110.842 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.489 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.95 131.02 45.33 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.464 -0.939 . . . . 1.8700000000000001 108.464 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.494 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.49 153.89 16.65 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.281 -0.961 . . . . 0.28999999999999998 111.915 -178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.99 140.92 46.06 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.677 -0.49 . . . . 1.4299999999999999 109.677 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.9 tp -115.76 118.89 34.29 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.42 -0.512 . . . . 0.32000000000000001 110.539 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.721 HG12 HG23 ' A' ' 84' ' ' VAL . 63.6 mt -112.32 129.03 68.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.369 -0.378 . . . . 0.79000000000000004 110.699 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.702 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.84 120.92 43.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.319 -0.4 . . . . 1.02 110.743 -179.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.85 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.6 146.45 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.109 0.48 . . . . 0.62 111.066 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.819 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.08 153.88 21.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.546 -0.752 . . . . 2.4399999999999999 110.018 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.424 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.2 mt-30 -39.15 88.51 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.868 0.366 . . . . 3.6899999999999999 110.409 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.31 32.61 0.21 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.853 -0.612 . . . . 6.0800000000000001 110.582 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.1 -117.37 3.29 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.419 -0.672 . . . . 1.22 111.419 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.463 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.44 177.44 8.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.249 0.547 . . . . 2.8799999999999999 111.613 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.17 149.47 32.04 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.37 -0.832 . . . . 1.47 110.363 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.553 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.15 144.7 38.73 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.441 -0.345 . . . . 2.7000000000000002 110.578 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.721 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -127.98 135.98 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 120.616 -0.434 . . . . 0.46000000000000002 111.597 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -123.99 141.26 52.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.701 -0.681 . . . . 0.34999999999999998 110.342 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.51 138.96 51.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.142 0.496 . . . . 3.6699999999999999 111.503 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.494 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.36 164.13 38.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.53 -0.759 . . . . 0.67000000000000004 109.428 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.2 151.62 38.7 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.314 -0.554 . . . . 1.47 110.972 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.802 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.8 p90 -146.29 172.69 13.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.69 -0.686 . . . . 0.44 111.008 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.76 160.74 21.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.446 -0.797 . . . . 1.3700000000000001 109.866 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.41 121.84 22.87 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.563 -0.455 . . . . 1.28 110.771 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.2 p -126.92 154.6 44.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.646 0.736 . . . . 1.97 112.759 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.401 ' OG ' ' OH ' ' A' ' 157' ' ' TYR . 22.8 t -62.7 -38.72 91.51 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.616 -1.175 . . . . 3.2799999999999998 111.91 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.2 t -139.74 158.03 44.78 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.254 0.549 . . . . 0.0 111.86 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 79.1 p -75.44 -14.61 60.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.273 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.6 p -63.0 141.08 97.7 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.112 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.31 150.06 42.91 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.298 1.998 . . . . 0.0 112.367 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.6 m -126.73 156.18 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.869 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.9 m -87.23 136.0 33.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.988 0.423 . . . . 0.0 110.935 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.6 m -66.95 156.61 35.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.436 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.462 ' O ' ' O ' ' A' ' 102' ' ' THR . 78.1 m-20 -84.26 4.03 32.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.259 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.462 ' O ' ' O ' ' A' ' 101' ' ' ASN . 28.0 p 33.68 -157.77 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.814 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.596 ' C ' ' H ' ' A' ' 105' ' ' GLY . 42.6 t -117.29 135.37 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.303 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.7 m 56.68 -3.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.992 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 103' ' ' VAL . . . -55.41 -33.32 58.5 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.82 144.0 40.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 110.642 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.0 p -81.72 162.59 22.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.445 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.542 ' O ' ' CD2' ' A' ' 110' ' ' PHE . 72.3 p -125.36 79.11 67.05 Favored Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.78 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 110' ' ' PHE . 38.7 Cg_exo -59.18 -17.94 41.65 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 122.813 2.342 . . . . 0.0 112.817 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.542 ' CD2' ' O ' ' A' ' 108' ' ' THR . 89.0 m-85 49.54 178.5 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.287 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.3 t 54.57 67.09 3.57 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.417 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.54 145.27 48.17 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.575 2.184 . . . . 0.0 112.137 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 26.2 tp -99.07 131.96 44.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.963 -0.562 . . . . 10.19 110.26 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.16 134.91 54.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.156 -0.474 . . . . 7.2800000000000002 110.343 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.78 144.75 57.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 7.2999999999999998 110.625 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.622 ' C ' ' H ' ' A' ' 118' ' ' GLU . 24.5 p -83.3 161.48 21.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.175 -0.466 . . . . 6.4400000000000004 110.591 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 118' ' ' GLU . 6.4 t 62.17 -17.07 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 4.4199999999999999 111.295 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.622 ' H ' ' C ' ' A' ' 116' ' ' THR . 96.3 mt-10 42.32 -169.62 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.606 0.241 . . . . 3.0499999999999998 111.21 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.541 ' C ' ' O ' ' A' ' 118' ' ' GLU . 9.4 t 17.62 81.83 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.978 -0.555 . . . . 3.4300000000000002 111.689 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.1 p -131.78 143.15 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.253 -0.43 . . . . 2.8799999999999999 110.659 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 44.5 m -79.79 138.63 37.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.076 -0.511 . . . . 2.0899999999999999 110.147 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -58.28 141.84 49.67 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.708 -0.397 . . . . 4.5300000000000002 110.575 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 71.1 mt -117.11 135.62 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 115.93 -0.577 . . . . 1.4399999999999999 110.573 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 23.3 p -83.59 161.1 21.27 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.997 -0.371 . . . . 1.78 109.997 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.683 ' O ' ' N ' ' A' ' 127' ' ' SER . . . -145.36 152.82 40.48 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.884 -0.326 . . . . 0.64000000000000001 111.29 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.632 ' HB2' ' HB ' ' A' ' 201' ' ' THR . 92.6 p 10.73 48.74 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 122.617 1.199 . . . . 0.66000000000000003 113.195 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.683 ' N ' ' O ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.91 167.5 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.243 -1.344 . . . . 0.68999999999999995 110.938 179.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.56 145.64 50.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.736 -0.665 . . . . 0.52000000000000002 110.156 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.26 101.47 9.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.157 -0.683 . . . . 0.32000000000000001 109.157 177.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.7 t -112.91 139.65 36.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.099 -0.5 . . . . 0.28999999999999998 111.101 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.3 p -128.61 152.55 48.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.605 -0.725 . . . . 0.25 109.83 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.594 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.4 p90 -144.75 -164.87 2.01 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.634 -0.426 . . . . 0.31 110.606 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.735 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -124.06 127.19 73.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.246 -0.434 . . . . 0.48999999999999999 110.784 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.179 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.99 58.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.028 -0.533 . . . . 1.53 110.358 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.735 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.15 24.61 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.872 -0.604 . . . . 0.96999999999999997 111.527 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.179 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.08 128.73 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.614 -0.434 . . . . 1.5600000000000001 110.942 179.824 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.31 -9.77 55.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.862 -0.608 . . . . 1.8799999999999999 110.309 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.12 0.31 55.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 1.04 110.366 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.16 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.891 -0.595 . . . . 0.23999999999999999 109.99 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.602 ' N ' ' O ' ' A' ' 185' ' ' ILE . 32.2 t -96.21 -15.51 22.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.311 0.576 . . . . 0.28999999999999998 110.062 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.433 ' HA3' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.58 175.62 45.81 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 109.795 -1.322 . . . . 0.13 109.795 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.53 151.59 42.68 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.661 -0.416 . . . . 0.17000000000000001 110.435 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.691 ' NH2' ' OE1' ' A' ' 191' ' ' GLN . 60.3 ttp85 -132.35 121.22 23.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.129 -0.487 . . . . 1.29 109.872 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.56 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.15 136.52 38.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.702 -0.681 . . . . 0.25 110.68 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 75.8 tt0 -129.33 129.84 45.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.01 -0.541 . . . . 1.3200000000000001 110.121 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.628 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.4 p90 -138.73 135.37 34.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.049 -0.523 . . . . 0.56999999999999995 110.596 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.419 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.38 161.38 39.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.702 -0.681 . . . . 1.1599999999999999 109.697 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.0 mt -71.07 124.92 25.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.004 0.43 . . . . 0.38 110.766 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.75 -7.81 50.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.756 -0.656 . . . . 0.40999999999999998 110.9 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.73 -69.65 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 1.6599999999999999 111.453 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.459 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.68 -35.25 75.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 1.6599999999999999 111.519 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.079 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 78.98 7.33 88.5 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.862 -0.895 . . . . 1.1699999999999999 110.862 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.334 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -28.01 -171.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.784 0.326 . . . . 1.8600000000000001 110.275 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.334 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.14 45.23 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.909 0.385 . . . . 1.98 110.186 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.419 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 45.9 Cg_endo -71.01 145.84 50.97 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 122.688 2.259 . . . . 0.55000000000000004 112.383 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.628 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.78 145.74 42.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.249 -0.648 . . . . 1.1399999999999999 109.249 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.57 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 93.5 m-85 -123.35 141.36 52.07 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.292 -0.563 . . . . 0.93000000000000005 111.511 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.9 mt -128.12 127.72 43.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.334 -0.848 . . . . 0.34000000000000002 108.934 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.657 ' HB2' HD22 ' A' ' 16' ' ' ASN . 4.0 t0 -101.65 131.07 48.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.183 0.516 . . . . 1.0900000000000001 111.72 -178.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.542 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.1 mt -127.88 157.6 73.16 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.262 -0.881 . . . . 0.19 109.567 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -69.89 158.16 57.73 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 C-N-CA 122.332 2.021 . . . . 0.17999999999999999 112.203 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.4 -12.1 5.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.778 -0.646 . . . . 0.20999999999999999 110.76 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.0 p -92.91 -8.64 42.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.072 -0.513 . . . . 0.28999999999999998 110.677 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.2 135.33 34.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.318 -0.401 . . . . 0.5 110.406 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.4 p -133.13 16.72 4.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.426 -0.352 . . . . 0.29999999999999999 110.493 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.55 147.18 5.09 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.663 -0.495 . . . . 0.23000000000000001 109.663 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.56 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.26 150.42 12.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.498 -0.481 . . . . 0.28000000000000003 111.521 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.32 124.96 50.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.57 -0.741 . . . . 1.0700000000000001 109.754 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.32 104.88 29.42 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.343 -0.39 . . . . 0.28999999999999998 111.119 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 84.7 Cg_endo -91.01 -179.47 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.909 0 C-N-CA 123.152 2.568 . . . . 0.42999999999999999 112.153 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.61 32.71 18.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.314 -0.857 . . . . 1.26 111.398 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.9 mt -86.44 148.59 25.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.781 0.324 . . . . 0.32000000000000001 110.43 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.776 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.4 mt -88.36 114.85 61.33 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.055 0.455 . . . . 0.57999999999999996 110.664 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.03 140.63 96.15 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.928 2.418 . . . . 0.66000000000000003 111.936 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.02 21.24 74.4 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.081 -0.808 . . . . 0.28999999999999998 111.081 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.459 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.88 150.19 49.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 2.3300000000000001 110.626 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.491 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.2 131.63 46.03 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.021 -0.536 . . . . 0.85999999999999999 109.805 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.955 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.2 m-85 -120.47 148.28 44.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.06 -0.518 . . . . 0.52000000000000002 111.048 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.2 mt -105.31 125.37 60.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.274 -1.01 . . . . 0.29999999999999999 108.274 177.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.62 132.48 63.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.19 0.519 . . . . 0.23000000000000001 111.223 -178.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.51 122.59 20.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.509 -0.768 . . . . 0.35999999999999999 109.585 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.594 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.0 125.33 54.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 0.19 110.67 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 49.0 m-85 -117.2 137.93 52.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.031 -0.531 . . . . 0.29999999999999999 109.77 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.585 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.68 135.06 42.71 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.798 -0.816 . . . . 0.37 108.798 178.786 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.602 ' O ' ' N ' ' A' ' 140' ' ' SER . 72.5 mt -99.14 122.92 51.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.08 0.467 . . . . 0.26000000000000001 110.903 -178.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.4 p -83.84 169.77 14.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.559 -0.746 . . . . 0.28000000000000003 110.522 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.555 ' O ' ' OG1' ' A' ' 59' ' ' THR . 17.1 pt-20 -59.75 -14.59 15.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.096 -0.502 . . . . 1.6000000000000001 110.966 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.544 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.3 m-20 -96.02 -4.3 43.36 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.843 -0.343 . . . . 1.1799999999999999 110.841 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.83 13.78 64.11 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.409 -0.677 . . . . 0.29999999999999999 111.409 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -84.66 139.05 32.32 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.803 -0.233 . . . . 1.22 110.461 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.691 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 87.4 mt-30 -106.75 141.09 38.56 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.835 -0.346 . . . . 0.97999999999999998 110.558 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.4 m -136.68 126.94 26.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.82999999999999996 110.42 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.09 117.26 9.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.915 0.388 . . . . 0.26000000000000001 110.528 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.4 pt -109.07 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.29999999999999999 110.653 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.9 125.61 5.81 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.524 -0.471 . . . . 0.31 111.6 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.468 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.71 120.23 21.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.841 -0.618 . . . . 0.28000000000000003 109.604 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.59 151.68 29.12 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.697 -0.401 . . . . 0.23999999999999999 110.893 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.41 158.66 18.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.005 -0.543 . . . . 0.23000000000000001 110.439 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.12 157.91 43.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.089 -0.505 . . . . 0.67000000000000004 110.649 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.43 9.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.711 -0.677 . . . . 0.64000000000000001 109.992 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' ' 126' ' ' SER . 68.3 p . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 117.986 -1.006 . . . . 1.26 110.598 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.196 -0.668 . . . . 3.4399999999999999 109.196 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.44 150.69 18.53 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.982 -0.847 . . . . 1.22 110.982 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.55 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.3 -1.986 0 C-N-CA 124.035 3.157 . . . . 0.75 113.772 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.93 173.43 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.264 -1.334 . . . . 0.79000000000000004 108.853 178.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.601 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.64 125.84 51.45 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.437 -0.505 . . . . 1.9399999999999999 111.49 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.51 143.93 34.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.661 -0.7 . . . . 0.59999999999999998 110.712 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.31 25.62 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.874 0.369 . . . . 3.1400000000000001 111.081 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.744 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.0 mt -108.96 131.08 60.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.926 -0.579 . . . . 3.23 110.044 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.15 162.28 35.87 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.838 0.352 . . . . 3.6299999999999999 111.252 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.4 mt-10 36.13 31.57 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.592 -0.521 . . . . 6.0800000000000001 109.592 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.744 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.45 69.56 32.61 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.94 -0.573 . . . . 3.3799999999999999 111.627 -178.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.37 -29.0 71.88 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.431 2.087 . . . . 3.9300000000000002 111.854 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.61 125.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.474 . . . . 3.3599999999999999 110.498 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.633 HE21 ' C ' ' A' ' 17' ' ' SER . 14.0 mt-30 -124.04 158.38 60.63 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.348 -0.387 . . . . 3.6099999999999999 110.414 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.433 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 98.4 Cg_endo -82.14 -64.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.905 2.403 . . . . 1.51 113.428 -178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.764 ' ND2' ' CD2' ' A' ' 157' ' ' TYR . 1.3 m120 -108.42 -19.62 13.39 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.08 0.4 . . . . 2.6800000000000002 112.08 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.633 ' C ' HE21 ' A' ' 14' ' ' GLN . 57.7 m -107.33 152.14 24.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.164 0.507 . . . . 1.21 111.302 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.34 103.0 2.22 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.681 -0.69 . . . . 1.5600000000000001 110.569 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.675 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.7 145.67 13.01 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.823 2.348 . . . . 0.81000000000000005 112.6 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.922 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.82 167.96 24.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.898 -0.592 . . . . 1.52 109.928 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.13 147.9 29.02 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.777 -0.453 . . . . 2.1400000000000001 109.777 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.587 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.22 157.33 44.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.0 0.428 . . . . 0.32000000000000001 111.225 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.496 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.04 155.27 44.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.779 -0.646 . . . . 2.1699999999999999 110.106 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.84 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.56 173.1 6.27 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-O 121.118 0.485 . . . . 0.58999999999999997 110.743 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.84 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.72 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.851 0 C-N-CA 122.864 2.376 . . . . 0.90000000000000002 111.507 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.479 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -51.05 0.69 Allowed Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.76 -0.376 . . . . 3.3399999999999999 110.142 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.634 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.87 152.31 82.66 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.837 2.358 . . . . 1.8500000000000001 111.369 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.71 42.25 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.426 0.631 . . . . 2.54 110.588 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.821 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.58 -41.59 98.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.019 -0.991 . . . . 2.5299999999999998 110.644 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.532 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.8 mt -109.85 137.87 40.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.748 -0.66 . . . . 1.1699999999999999 111.329 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.99 -72.93 0.7 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.099 -0.501 . . . . 1.27 111.886 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.22 148.41 24.38 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.607 0.595 . . . . 1.1200000000000001 112.607 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -121.88 124.81 44.99 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.397 -0.594 . . . . 0.41999999999999998 109.397 177.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.05 134.71 60.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.66 -0.416 . . . . 0.78000000000000003 110.647 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.922 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.96 128.63 53.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.036 0.446 . . . . 0.62 111.249 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.03 139.01 49.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.738 -0.665 . . . . 1.97 110.143 178.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.436 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.03 163.11 35.24 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 120.55 -0.46 . . . . 0.34999999999999998 112.135 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.46 139.62 7.9 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.498 -0.774 . . . . 1.8 110.485 178.763 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.62 115.46 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.302 2.001 . . . . 0.57999999999999996 111.827 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.677 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.92 81.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.84 -0.43 . . . . 3.04 109.84 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.52 0.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.016 -0.538 . . . . 2.4700000000000002 111.898 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.4 p -157.67 157.81 34.24 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.862 -0.335 . . . . 2.5099999999999998 110.554 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.36 27.77 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.181 -0.463 . . . . 1.8600000000000001 110.222 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -75.8 1.31 Allowed Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.103 -0.57 . . . . 1.4399999999999999 111.892 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.89 152.36 35.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.927 0.394 . . . . 4.6900000000000004 110.965 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.673 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.27 -169.14 2.53 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.059 -0.519 . . . . 1.4299999999999999 111.965 179.373 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.436 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.09 149.57 29.84 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.468 0.651 . . . . 1.74 112.606 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.99 156.47 46.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.807 -1.088 . . . . 1.9199999999999999 110.234 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.2 158.36 41.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.951 -0.568 . . . . 0.34000000000000002 111.792 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.0 m -115.16 135.68 53.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.446 -0.797 . . . . 0.40999999999999998 109.817 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.587 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.45 121.92 23.7 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.422 -0.353 . . . . 0.55000000000000004 111.567 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.6 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.1 Cg_exo -46.41 151.71 1.7 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.753 2.302 . . . . 0.44 112.029 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.89 -23.02 63.01 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 115.989 -0.551 . . . . 0.73999999999999999 112.742 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.54 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.81 -16.88 46.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.436 0.618 . . . . 0.93000000000000005 111.758 -178.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.6 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.6 138.36 31.63 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.799 -0.36 . . . . 0.96999999999999997 110.368 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.47 13.85 11.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.399 -0.364 . . . . 1.3400000000000001 111.447 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.477 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.95 143.52 25.28 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.657 -0.417 . . . . 0.39000000000000001 111.101 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.719 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.4 t80 -114.74 -169.36 1.53 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.089 -0.505 . . . . 0.41999999999999998 110.981 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.719 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.85 125.9 9.19 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.449 -0.796 . . . . 0.39000000000000001 109.826 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.519 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.8 mt -114.87 123.33 70.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.364 -0.534 . . . . 0.73999999999999999 111.153 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.429 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 63.9 pttt -126.54 163.36 23.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.843 -0.617 . . . . 2.48 110.425 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.16 18.87 60.05 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.749 -0.941 . . . . 0.5 110.749 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.519 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.7 mt -79.03 157.23 28.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.091 0.472 . . . . 0.57999999999999996 111.376 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.844 ' O ' HG12 ' A' ' 67' ' ' VAL . 1.8 mtmm -99.48 133.89 21.58 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.593 -0.73 . . . . 2.79 110.454 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.64 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.9 Cg_endo -67.87 143.66 61.83 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.451 2.101 . . . . 0.87 111.942 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.87 25.49 75.5 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 111.063 -0.815 . . . . 0.64000000000000001 111.063 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.08 158.86 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.744 0.307 . . . . 0.82999999999999996 110.403 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.2 139.92 42.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.945 0.402 . . . . 0.5 110.508 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.661 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.4 m-85 -122.54 136.41 54.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.922 -0.581 . . . . 0.53000000000000003 110.726 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.93 131.09 45.26 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.51 -0.922 . . . . 1.8700000000000001 108.51 177.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.495 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.5 153.93 16.65 Favored Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.338 -0.934 . . . . 0.28999999999999998 111.943 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.04 140.96 46.01 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.702 -0.481 . . . . 1.4299999999999999 109.702 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.526 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.6 tp -115.67 118.99 34.61 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.478 -0.489 . . . . 0.32000000000000001 110.503 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.724 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.52 129.15 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.301 -0.409 . . . . 0.79000000000000004 110.594 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.705 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.9 120.92 43.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.29 -0.413 . . . . 1.02 110.696 -179.714 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.853 HD12 ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.58 146.47 11.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.133 0.492 . . . . 0.62 111.019 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.821 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.12 153.97 21.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.566 -0.743 . . . . 2.4399999999999999 109.852 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.24 88.61 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.966 0.413 . . . . 3.6899999999999999 110.347 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.616 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.28 32.62 0.21 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.828 -0.624 . . . . 6.0800000000000001 110.558 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.35 3.29 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.482 -0.647 . . . . 1.22 111.482 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.466 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.41 177.41 8.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.028 0.442 . . . . 2.8799999999999999 111.699 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.23 149.48 31.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.512 -0.767 . . . . 1.47 110.378 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.18 144.65 38.64 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.436 -0.347 . . . . 2.7000000000000002 110.526 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.724 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.02 136.05 61.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-O 121.155 0.502 . . . . 0.46000000000000002 111.538 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.04 141.29 52.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.573 -0.74 . . . . 0.34999999999999998 110.318 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.463 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.62 138.87 51.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.082 0.468 . . . . 3.6699999999999999 111.486 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.495 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.32 164.1 38.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.536 -0.756 . . . . 0.67000000000000004 109.523 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.571 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.22 151.64 38.71 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.354 -0.538 . . . . 1.47 111.027 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.804 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.24 172.77 12.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.644 -0.707 . . . . 0.44 110.995 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.81 160.66 21.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.391 -0.822 . . . . 1.3700000000000001 109.854 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.38 121.89 22.97 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.536 -0.466 . . . . 1.28 110.74 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.576 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.4 p -131.76 -136.55 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 122.284 1.04 . . . . 1.97 111.303 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.594 ' C ' ' H ' ' A' ' 95' ' ' SER . 30.4 t 138.02 144.49 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 112.712 -2.04 . . . . 3.2799999999999998 106.222 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.78 -10.83 0.18 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.616 ' O ' ' HG2' ' A' ' 155' ' ' PRO . 39.7 p -86.42 1.74 50.22 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.771 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.604 HG22 ' CB ' ' A' ' 65' ' ' PRO . 19.8 p -105.5 115.41 61.88 Favored Pre-proline 0 N--CA 1.475 0.817 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -177.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.496 ' HG2' ' H ' ' A' ' 98' ' ' VAL . 0.5 OUTLIER -98.43 -106.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 123.864 3.043 . . . . 0.0 112.391 178.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.496 ' H ' ' HG2' ' A' ' 97' ' ' PRO . 35.3 t -120.58 143.69 31.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.228 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 61.2 p -54.33 -10.33 0.38 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.613 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.409 ' H ' HG12 ' A' ' 98' ' ' VAL . 49.7 m -63.46 164.79 8.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.763 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.567 ' CG ' HG21 ' A' ' 116' ' ' THR . 0.4 OUTLIER 64.99 51.96 1.62 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.075 0.464 . . . . 0.0 111.102 -179.445 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.8 t -131.79 161.09 33.73 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.541 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.584 HG12 ' N ' ' A' ' 104' ' ' THR . 76.3 t 61.44 165.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.708 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.584 ' N ' HG12 ' A' ' 103' ' ' VAL . 42.7 m -120.15 143.67 48.08 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.924 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -153.69 -175.64 25.22 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -102.12 144.36 30.79 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.618 0.247 . . . . 0.0 110.702 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 121' ' ' THR . 55.5 m -117.5 141.58 48.18 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.213 0.53 . . . . 0.0 111.156 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.9 p -66.69 160.62 66.91 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.54 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.02 -20.13 9.87 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.186 1.924 . . . . 0.0 112.23 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -68.29 153.91 42.8 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.5 m -120.54 79.63 29.9 Favored Pre-proline 0 N--CA 1.467 0.378 0 CA-C-O 120.671 0.272 . . . . 0.0 111.527 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -54.23 160.21 6.83 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 123.082 2.522 . . . . 0.0 112.055 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.2 mt -68.6 154.54 41.7 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.201 -0.666 . . . . 10.19 109.201 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.615 ' O ' ' HB2' ' A' ' 115' ' ' ALA . 18.6 m -54.52 131.36 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.405 -0.518 . . . . 7.2800000000000002 110.961 -177.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 114' ' ' VAL . . . 149.74 115.24 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 114.775 -1.102 . . . . 7.2999999999999998 108.679 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.567 HG21 ' CG ' ' A' ' 101' ' ' ASN . 24.6 p -81.36 160.39 24.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.106 0.479 . . . . 6.4400000000000004 111.14 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 119' ' ' SER . 83.1 p -146.6 167.63 23.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.626 -0.716 . . . . 4.4199999999999999 110.575 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.64 -30.01 69.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.911 -0.586 . . . . 3.0499999999999998 110.643 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.423 ' O ' ' OG ' ' A' ' 117' ' ' SER . 50.9 m -113.66 150.79 32.7 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.239 -0.437 . . . . 3.4300000000000002 110.676 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.6 t 60.22 109.22 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.932 -0.576 . . . . 2.8799999999999999 110.816 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.437 ' O ' ' OG1' ' A' ' 107' ' ' THR . 43.8 m -123.29 143.29 50.17 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.716 -0.675 . . . . 2.0899999999999999 110.22 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -96.81 143.64 27.53 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.994 0.426 . . . . 4.5300000000000002 111.626 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 16.7 tt -118.8 136.19 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 115.607 -0.724 . . . . 1.4399999999999999 109.165 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 172' ' ' LEU . 26.1 p -122.88 161.6 23.8 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.238 0.542 . . . . 1.78 112.167 -177.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.672 ' O ' ' HG3' ' A' ' 174' ' ' PRO . . . -111.28 153.37 26.02 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.422 -0.808 . . . . 0.64000000000000001 110.547 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.66 ' HB2' ' HB ' ' A' ' 201' ' ' THR . 70.4 p 123.88 39.43 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 123.697 1.713 . . . . 0.66000000000000003 108.726 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.437 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.8 167.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 113.047 -1.888 . . . . 0.68999999999999995 110.988 -178.372 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.58 145.6 50.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.729 -0.668 . . . . 0.52000000000000002 110.127 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.3 101.61 9.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.121 -0.696 . . . . 0.32000000000000001 109.121 177.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.1 t -112.94 139.64 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.027 -0.533 . . . . 0.28999999999999998 111.068 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.7 p -128.67 152.65 48.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.667 -0.697 . . . . 0.25 109.793 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.76 -164.92 2.03 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.672 -0.411 . . . . 0.31 110.636 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.738 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -124.03 127.13 73.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.48999999999999999 110.905 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.177 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.87 58.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 1.53 110.306 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.738 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.1 24.46 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.004 -0.544 . . . . 0.96999999999999997 111.426 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.177 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.24 128.73 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.657 -0.417 . . . . 1.5600000000000001 110.954 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -86.35 -9.53 56.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.933 -0.576 . . . . 1.8799999999999999 110.393 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.0 p -87.18 0.21 55.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.47 . . . . 1.04 110.264 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.26 137.16 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.001 -0.545 . . . . 0.23999999999999999 109.988 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 185' ' ' ILE . 0.9 OUTLIER -96.19 -15.47 22.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.294 0.569 . . . . 0.28999999999999998 110.1 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.633 ' N ' HG12 ' A' ' 185' ' ' ILE . . . 178.52 175.57 45.72 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 109.814 -1.315 . . . . 0.13 109.814 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.5 151.66 42.54 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.595 -0.442 . . . . 0.17000000000000001 110.465 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.673 ' NH2' ' OE1' ' A' ' 191' ' ' GLN . 58.6 ttp85 -132.42 121.2 23.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.139 -0.482 . . . . 1.29 109.943 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.559 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.15 136.57 38.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.68 -0.691 . . . . 0.25 110.648 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 81.3 tt0 -129.38 129.85 45.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.957 -0.565 . . . . 1.3200000000000001 110.016 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 36.2 p90 -138.62 135.29 34.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.972 -0.558 . . . . 0.56999999999999995 110.731 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.421 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.29 161.35 39.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.839 -0.619 . . . . 1.1599999999999999 109.632 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.954 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.1 mt -71.09 124.84 25.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.072 0.463 . . . . 0.38 110.73 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.71 -7.79 50.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.723 -0.671 . . . . 0.40999999999999998 110.881 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -109.77 -69.58 0.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 1.6599999999999999 111.519 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.449 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.69 -35.46 76.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.115 -0.493 . . . . 1.6599999999999999 111.435 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.085 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.21 88.62 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.797 -0.921 . . . . 1.1699999999999999 110.797 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.336 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.91 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 1.8600000000000001 110.224 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.336 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.31 139.07 44.97 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.247 -0.433 . . . . 1.98 110.164 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.616 ' HG2' ' O ' ' A' ' 95' ' ' SER . 46.3 Cg_endo -70.92 145.81 51.38 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 C-N-CA 122.756 2.304 . . . . 0.55000000000000004 112.363 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.91 145.74 42.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.186 -0.672 . . . . 1.1399999999999999 109.186 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.764 ' CD2' ' ND2' ' A' ' 16' ' ' ASN . 35.4 p90 -123.21 141.29 52.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.164 0.507 . . . . 0.93000000000000005 111.599 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.03 127.72 43.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.282 -0.872 . . . . 0.34000000000000002 108.987 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.493 ' OD1' ' O ' ' A' ' 159' ' ' ASP . 53.8 p-10 -101.62 131.09 48.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.207 0.527 . . . . 1.0900000000000001 111.821 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.92 157.53 73.45 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.363 -0.835 . . . . 0.19 109.604 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.77 158.06 58.24 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.366 2.044 . . . . 0.17999999999999999 112.268 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.32 -12.13 5.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.787 -0.642 . . . . 0.20999999999999999 110.685 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.86 -8.71 42.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.154 -0.475 . . . . 0.28999999999999998 110.679 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.39 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.354 -0.384 . . . . 0.5 110.404 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.7 p -133.15 16.7 4.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.429 -0.35 . . . . 0.29999999999999999 110.52 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.56 147.12 5.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.664 -0.495 . . . . 0.23000000000000001 109.664 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.559 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.18 150.41 12.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.541 -0.464 . . . . 0.28000000000000003 111.572 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.34 125.0 50.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.624 -0.716 . . . . 1.0700000000000001 109.794 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.44 104.86 29.7 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 0.28999999999999998 111.064 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.8 Cg_endo -90.92 -179.58 1.53 Allowed 'Trans proline' 0 C--N 1.302 -1.895 0 C-N-CA 123.184 2.59 . . . . 0.42999999999999999 112.219 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 61.77 32.65 18.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.382 -0.826 . . . . 1.26 111.37 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.481 ' O ' ' OG1' ' A' ' 124' ' ' THR . 24.0 mt -86.38 148.49 25.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.784 0.326 . . . . 0.32000000000000001 110.498 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.773 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.33 114.84 61.29 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.989 0.423 . . . . 0.57999999999999996 110.6 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.672 ' HG3' ' O ' ' A' ' 125' ' ' ALA . 21.9 Cg_exo -59.01 140.57 95.96 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.835 2.356 . . . . 0.66000000000000003 111.994 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.07 21.31 74.08 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.0 -0.84 . . . . 0.28999999999999998 111.0 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.449 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.8 mmm-85 -126.94 150.24 49.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 2.3300000000000001 110.604 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.495 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.18 131.7 45.97 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.052 -0.522 . . . . 0.85999999999999999 109.81 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.954 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.7 m-85 -120.57 148.34 44.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.052 -0.522 . . . . 0.52000000000000002 111.013 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.35 125.33 60.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.262 -1.014 . . . . 0.29999999999999999 108.262 177.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.6 132.59 63.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.139 0.495 . . . . 0.23000000000000001 111.206 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.5 122.47 20.14 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.483 -0.78 . . . . 0.35999999999999999 109.666 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.04 125.39 54.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.382 -0.372 . . . . 0.19 110.586 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.8 m-85 -117.24 137.86 52.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.973 -0.558 . . . . 0.29999999999999999 109.918 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.583 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.63 135.02 42.73 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.829 -0.804 . . . . 0.37 108.829 178.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.633 HG12 ' N ' ' A' ' 141' ' ' GLY . 0.8 OUTLIER -99.03 123.0 51.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.156 0.503 . . . . 0.26000000000000001 110.934 -178.828 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.9 p -83.98 169.71 14.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.566 -0.743 . . . . 0.28000000000000003 110.411 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.618 ' O ' ' OG1' ' A' ' 59' ' ' THR . 82.2 tt0 -59.62 -14.67 14.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.036 -0.529 . . . . 1.6000000000000001 110.964 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.675 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 87.8 m-20 -96.0 -4.38 43.28 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.862 -0.335 . . . . 1.1799999999999999 110.83 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.85 13.79 64.07 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.376 -0.69 . . . . 0.29999999999999999 111.376 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -84.53 139.05 32.41 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 121.096 -0.241 . . . . 1.22 110.569 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.673 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 88.9 mt-30 -106.73 140.97 38.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.48 -0.327 . . . . 0.97999999999999998 110.623 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.67 127.03 26.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.171 -0.468 . . . . 0.82999999999999996 110.407 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.23 117.33 9.89 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.717 -0.393 . . . . 0.26000000000000001 110.508 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.0 pt -108.94 -21.9 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.29999999999999999 110.752 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.87 125.75 5.88 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.509 -0.476 . . . . 0.31 111.486 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.464 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.78 120.2 21.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.701 -0.681 . . . . 0.28000000000000003 109.586 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.64 151.66 29.06 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.621 -0.432 . . . . 0.23999999999999999 110.904 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.41 158.57 18.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.02 -0.536 . . . . 0.23000000000000001 110.417 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -146.08 157.88 43.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.089 -0.505 . . . . 0.67000000000000004 110.725 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.25 104.49 9.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.772 -0.649 . . . . 0.64000000000000001 110.022 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.66 ' HB ' ' HB2' ' A' ' 126' ' ' SER . 68.0 p . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.842 -1.075 . . . . 1.26 110.588 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.55 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.142 -0.688 . . . . 3.4399999999999999 109.142 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.37 150.75 18.53 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.925 -0.87 . . . . 1.22 110.925 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -35.74 142.42 0.1 Allowed 'Trans proline' 0 C--N 1.3 -1.977 0 C-N-CA 123.902 3.068 . . . . 0.75 113.857 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.599 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.3 t -79.96 173.34 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.254 -1.339 . . . . 0.79000000000000004 108.825 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.599 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.57 125.89 51.5 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.412 -0.515 . . . . 1.9399999999999999 111.422 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.52 144.08 33.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.618 -0.719 . . . . 0.59999999999999998 110.599 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.08 168.19 26.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.875 0.369 . . . . 3.1400000000000001 111.127 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.748 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.93 131.19 60.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.964 -0.562 . . . . 3.23 110.124 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.21 162.36 35.67 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.806 0.336 . . . . 3.6299999999999999 111.208 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.7 mt-10 35.94 31.76 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.592 -0.521 . . . . 6.0800000000000001 109.592 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.748 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.54 69.58 33.63 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.959 -0.564 . . . . 3.3799999999999999 111.587 -178.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.29 -29.13 72.68 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.532 2.154 . . . . 3.9300000000000002 111.865 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 3.3599999999999999 110.532 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.717 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -124.0 158.38 60.51 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.352 -0.385 . . . . 3.6099999999999999 110.347 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.563 ' CG ' ' NH2' ' A' ' 143' ' ' ARG . 97.0 Cg_endo -82.02 -64.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.877 2.385 . . . . 1.51 113.547 -179.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.69 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 63.2 t30 -108.4 -19.62 13.4 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.11 0.411 . . . . 2.6800000000000002 112.11 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.717 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 27.6 t -107.37 152.07 24.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.184 0.516 . . . . 1.21 111.285 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.22 102.97 2.24 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.722 -0.672 . . . . 1.5600000000000001 110.606 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.442 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.7 Cg_endo -82.81 145.69 12.83 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.888 2.392 . . . . 0.81000000000000005 112.557 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.907 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.82 167.84 25.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.876 -0.602 . . . . 1.52 109.858 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.06 147.91 29.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.796 -0.446 . . . . 2.1400000000000001 109.796 178.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.586 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.21 157.25 45.07 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.686 -0.406 . . . . 0.32000000000000001 111.177 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.492 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.1 155.3 44.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.873 -0.603 . . . . 2.1699999999999999 110.102 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.836 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.63 173.01 6.39 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.156 0.503 . . . . 0.58999999999999997 110.696 -179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.836 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.62 173.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.892 2.394 . . . . 0.90000000000000002 111.481 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.1 -51.07 0.68 Allowed Pre-proline 0 C--N 1.33 -0.265 0 C-N-CA 120.686 -0.406 . . . . 3.3399999999999999 110.085 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.632 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.81 152.39 82.28 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.729 2.286 . . . . 1.8500000000000001 111.44 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.77 42.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.399 0.618 . . . . 2.54 110.522 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.823 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.55 -41.74 98.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.002 -0.999 . . . . 2.5299999999999998 110.651 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.1 mt -109.77 137.88 39.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.814 -0.63 . . . . 1.1699999999999999 111.293 -179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.97 -72.87 0.7 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.008 -0.542 . . . . 1.27 111.97 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.19 148.47 24.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.532 0.567 . . . . 1.1200000000000001 112.532 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -121.87 124.81 44.99 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.397 -0.594 . . . . 0.41999999999999998 109.397 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 mt -117.97 134.8 60.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.616 -0.434 . . . . 0.78000000000000003 110.604 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.907 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.05 128.6 53.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.983 0.42 . . . . 0.62 111.207 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.18 139.02 49.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.772 -0.649 . . . . 1.97 110.102 178.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.439 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.05 163.19 35.01 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 121.133 0.492 . . . . 0.34999999999999998 112.066 -178.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.49 139.53 7.82 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.434 -0.803 . . . . 1.8 110.416 178.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 41' ' ' ASN . 18.0 Cg_endo -63.43 115.41 3.0 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.351 2.034 . . . . 0.57999999999999996 111.847 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.668 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.99 81.22 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.866 -0.42 . . . . 3.04 109.866 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.688 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.24 -20.66 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.968 -0.56 . . . . 2.4700000000000002 111.923 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.65 157.79 34.26 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.835 -0.346 . . . . 2.5099999999999998 110.559 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.403 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.38 27.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 1.8600000000000001 110.163 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.84 -75.88 1.31 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.118 -0.563 . . . . 1.4399999999999999 111.867 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.87 152.29 35.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.973 0.416 . . . . 4.6900000000000004 111.0 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.15 -169.02 2.51 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.061 -0.518 . . . . 1.4299999999999999 111.981 179.335 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.19 149.71 29.72 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.482 0.658 . . . . 1.74 112.533 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.07 156.51 45.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.791 -1.095 . . . . 1.9199999999999999 110.213 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.469 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.21 158.4 41.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.976 -0.557 . . . . 0.34000000000000002 111.802 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.3 m -115.15 135.63 53.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.435 -0.802 . . . . 0.40999999999999998 109.906 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.586 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.4 122.06 23.79 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.512 -0.313 . . . . 0.55000000000000004 111.523 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.6 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.0 Cg_exo -46.46 151.74 1.73 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.689 2.259 . . . . 0.44 112.077 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.87 -23.09 63.03 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 116.065 -0.516 . . . . 0.73999999999999999 112.805 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.544 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.75 -16.83 46.44 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.225 -0.59 . . . . 0.93000000000000005 111.821 -178.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.6 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.6 mt -91.67 138.43 31.57 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.807 -0.357 . . . . 0.96999999999999997 110.232 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.48 13.81 11.02 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.277 -0.42 . . . . 1.3400000000000001 111.482 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.4 p -149.92 143.48 25.29 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.631 -0.428 . . . . 0.39000000000000001 111.058 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.81 -169.29 1.52 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.209 0.528 . . . . 0.41999999999999998 110.851 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.723 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 0.6 OUTLIER -151.84 125.91 9.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.433 -0.803 . . . . 0.39000000000000001 109.765 179.281 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.3 mt -114.81 123.25 70.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.435 -0.506 . . . . 0.73999999999999999 111.219 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.518 ' HB3' ' CD1' ' A' ' 185' ' ' ILE . 25.7 pttm -126.48 163.43 23.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.888 -0.596 . . . . 2.48 110.497 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.479 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.02 19.08 59.87 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.781 -0.928 . . . . 0.5 110.781 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.69 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.8 mt -79.1 157.3 28.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.09 0.472 . . . . 0.57999999999999996 111.311 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.847 ' O ' HG12 ' A' ' 67' ' ' VAL . 4.0 mttt -99.58 133.96 21.48 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.616 -0.72 . . . . 2.79 110.434 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.462 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.94 143.6 61.15 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.539 2.16 . . . . 0.87 111.936 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.84 25.58 75.39 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.091 -0.803 . . . . 0.64000000000000001 111.091 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.847 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.17 158.84 39.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.715 0.293 . . . . 0.82999999999999996 110.415 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.23 139.96 42.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.913 0.387 . . . . 0.5 110.56 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.654 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.9 m-85 -122.59 136.46 54.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.967 -0.56 . . . . 0.53000000000000003 110.778 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.82 131.05 45.23 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.491 -0.929 . . . . 1.8700000000000001 108.491 177.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.58 153.92 16.67 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.214 -0.993 . . . . 0.28999999999999998 111.933 -178.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.03 140.9 45.99 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.698 -0.482 . . . . 1.4299999999999999 109.698 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.75 118.91 34.36 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.426 -0.51 . . . . 0.32000000000000001 110.462 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.735 HG12 HG23 ' A' ' 84' ' ' VAL . 64.2 mt -112.41 129.15 68.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.79000000000000004 110.608 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.708 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.82 120.86 43.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.242 -0.435 . . . . 1.02 110.747 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.854 HD12 ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.58 146.46 11.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.169 0.509 . . . . 0.62 111.022 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.823 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.01 153.92 21.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.519 -0.764 . . . . 2.4399999999999999 109.888 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.19 88.52 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.937 0.399 . . . . 3.6899999999999999 110.428 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.41 32.53 0.22 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.841 -0.618 . . . . 6.0800000000000001 110.53 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.04 -117.34 3.29 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.472 -0.651 . . . . 1.22 111.472 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.465 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.4 177.37 9.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.218 0.532 . . . . 2.8799999999999999 111.643 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.2 149.5 32.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.435 -0.802 . . . . 1.47 110.385 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.55 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.21 144.7 38.61 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.432 -0.349 . . . . 2.7000000000000002 110.511 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.735 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -127.98 135.93 61.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-O 121.087 0.47 . . . . 0.46000000000000002 111.508 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.03 141.52 51.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.59 -0.732 . . . . 0.34999999999999998 110.192 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.462 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.66 138.93 51.65 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.482 -0.487 . . . . 3.6699999999999999 111.481 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.491 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.29 164.23 37.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.582 -0.736 . . . . 0.67000000000000004 109.399 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.574 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 46.9 p30 -145.29 151.51 38.45 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.434 -0.506 . . . . 1.47 111.064 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.804 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.2 p90 -146.2 172.72 13.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.768 -0.651 . . . . 0.44 111.005 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.78 160.76 21.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.442 -0.799 . . . . 1.3700000000000001 109.807 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.5 121.86 22.79 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.565 -0.454 . . . . 1.28 110.722 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.587 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.0 p -127.02 161.87 27.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.222 0.534 . . . . 1.97 111.864 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.1 t -115.74 148.96 39.22 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.516 -0.766 . . . . 3.2799999999999998 110.531 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.0 p -111.44 165.17 12.2 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.035 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.4 p -111.2 155.1 23.44 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.138 0.494 . . . . 0.0 111.297 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.426 ' N ' ' HD3' ' A' ' 97' ' ' PRO . 11.1 m 57.31 63.46 4.96 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.127 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.426 ' HD3' ' N ' ' A' ' 96' ' ' THR . 41.7 Cg_exo -56.77 147.56 71.31 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.577 2.185 . . . . 0.0 111.531 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.57 136.64 26.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.985 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 35.5 m -118.9 139.3 51.88 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.089 0.471 . . . . 0.0 111.092 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.8 t -120.99 145.05 48.17 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.016 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -100.47 136.1 40.87 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.044 0.449 . . . . 0.0 110.669 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.6 m -123.19 143.36 50.08 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.285 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.9 p -63.34 136.95 25.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.928 0.394 . . . . 0.0 110.485 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 47.5 m -78.38 139.31 38.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.652 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 106' ' ' GLU . . . -164.67 -174.85 34.86 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 105' ' ' GLY . 95.4 mt-10 32.92 42.64 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.983 0.42 . . . . 0.0 110.934 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 58.1 p -67.92 -16.55 64.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.96 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.2 p -125.48 77.61 68.69 Favored Pre-proline 0 N--CA 1.467 0.421 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.988 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -56.05 149.92 50.33 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.745 2.297 . . . . 0.0 111.96 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -54.86 -40.48 69.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.262 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.22 159.03 32.45 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.248 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -54.95 147.35 52.57 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.581 2.187 . . . . 0.0 111.72 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.7 mt -57.63 -35.78 70.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.494 . . . . 10.19 110.781 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 23.2 m -130.02 151.13 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.764 0.316 . . . . 7.2800000000000002 110.395 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -116.03 21.15 13.96 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.134 -0.485 . . . . 7.2999999999999998 110.586 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.3 t -136.77 160.32 39.19 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.075 0.464 . . . . 6.4400000000000004 111.339 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.9 m -63.38 158.09 21.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.687 -0.688 . . . . 4.4199999999999999 110.337 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.44 -34.09 64.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.456 -0.338 . . . . 3.0499999999999998 110.28 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 96.3 p -120.5 151.64 39.1 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.34 -0.391 . . . . 3.4300000000000002 109.999 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.684 HG22 ' H ' ' A' ' 122' ' ' GLU . 12.4 p -133.27 142.0 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.51 -0.314 . . . . 2.8799999999999999 110.533 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 69.2 p -70.36 -24.73 63.02 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.334 -0.394 . . . . 2.0899999999999999 111.25 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.684 ' H ' HG22 ' A' ' 120' ' ' VAL . 96.4 mt-10 -58.68 145.21 40.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.321 -0.399 . . . . 4.5300000000000002 110.545 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.4 mt -111.63 134.36 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.156 -0.475 . . . . 1.4399999999999999 109.846 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.9 p -123.7 161.59 24.83 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.079 -0.509 . . . . 1.78 110.627 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -136.19 -45.07 0.63 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.166 -0.47 . . . . 0.64000000000000001 110.299 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 6.0 p -153.81 -0.87 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.66000000000000003 110.311 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.435 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.68 167.5 0.24 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.883 -0.599 . . . . 0.68999999999999995 110.949 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.56 145.53 50.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.685 -0.688 . . . . 0.52000000000000002 110.197 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.23 101.62 9.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.106 -0.702 . . . . 0.32000000000000001 109.106 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.1 t -112.94 139.67 36.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.071 -0.513 . . . . 0.28999999999999998 111.103 -178.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.0 p -128.76 152.59 48.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.677 -0.692 . . . . 0.25 109.846 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.81 -164.91 2.03 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.688 -0.405 . . . . 0.31 110.675 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -123.97 127.19 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.48999999999999999 110.784 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.174 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -58.0 58.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.188 -0.46 . . . . 1.53 110.349 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.21 24.62 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.857 -0.611 . . . . 0.96999999999999997 111.485 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.174 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.11 128.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.626 -0.43 . . . . 1.5600000000000001 110.923 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.47 -9.62 55.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.837 -0.62 . . . . 1.8799999999999999 110.329 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 29.0 p -86.96 0.13 55.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.061 -0.518 . . . . 1.04 110.391 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.23 137.3 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.96 -0.564 . . . . 0.23999999999999999 109.989 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.613 ' N ' ' O ' ' A' ' 185' ' ' ILE . 7.1 p -96.33 -15.56 21.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.37 0.605 . . . . 0.28999999999999998 110.029 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 1.015 ' O ' HG22 ' A' ' 185' ' ' ILE . . . 178.58 175.53 45.74 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 109.809 -1.316 . . . . 0.13 109.809 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -123.42 151.52 42.55 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.63 -0.428 . . . . 0.17000000000000001 110.492 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.864 ' NH2' HE22 ' A' ' 191' ' ' GLN . 8.7 tmm_? -132.29 121.16 23.14 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.126 -0.488 . . . . 1.29 109.956 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.556 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.05 136.62 38.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.632 -0.713 . . . . 0.25 110.621 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 75.9 tt0 -129.39 129.89 45.31 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.95 -0.568 . . . . 1.3200000000000001 110.043 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.623 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.7 p90 -138.75 135.27 34.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.034 -0.53 . . . . 0.56999999999999995 110.673 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.422 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.36 39.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.694 -0.685 . . . . 1.1599999999999999 109.697 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.952 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.4 mt -70.97 124.79 25.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.992 0.425 . . . . 0.38 110.718 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.76 -7.64 49.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.768 -0.651 . . . . 0.40999999999999998 110.989 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.8 -69.72 0.85 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.264 -0.426 . . . . 1.6599999999999999 111.387 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.439 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.3 mt-10 -60.8 -35.25 75.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 1.6599999999999999 111.459 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.09 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.26 7.12 88.68 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.829 -0.908 . . . . 1.1699999999999999 110.829 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.336 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.3 t0 -27.98 -171.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.801 0.334 . . . . 1.8600000000000001 110.322 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.336 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.25 139.11 45.19 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-O 120.979 0.419 . . . . 1.98 110.238 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.422 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.0 Cg_endo -70.85 145.76 51.69 Favored 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 122.77 2.313 . . . . 0.55000000000000004 112.325 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.82 145.69 42.62 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.25 -0.648 . . . . 1.1399999999999999 109.25 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.646 ' CE2' ' CG ' ' A' ' 16' ' ' ASN . 25.0 p90 -123.24 141.38 52.04 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.348 -0.541 . . . . 0.93000000000000005 111.532 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.9 mt -128.18 127.69 43.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.275 -0.875 . . . . 0.34000000000000002 108.953 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.558 ' HB2' HD21 ' A' ' 16' ' ' ASN . 33.2 t0 -101.61 131.2 47.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.19 0.519 . . . . 1.0900000000000001 111.779 -178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -128.0 157.52 73.65 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.348 -0.842 . . . . 0.19 109.585 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -69.87 157.95 58.45 Favored 'Trans proline' 0 C--N 1.302 -1.904 0 C-N-CA 122.49 2.126 . . . . 0.17999999999999999 112.23 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.4 p -59.14 -12.19 4.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.743 -0.662 . . . . 0.20999999999999999 110.817 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.1 p -92.79 -8.76 42.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.164 -0.471 . . . . 0.28999999999999998 110.73 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.09 135.37 34.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.325 -0.398 . . . . 0.5 110.481 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.19 16.69 4.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.452 -0.34 . . . . 0.29999999999999999 110.514 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.4 p -167.51 147.16 5.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.609 -0.515 . . . . 0.23000000000000001 109.609 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.21 150.5 12.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 120.489 -0.484 . . . . 0.28000000000000003 111.503 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 4.0 t-20 -106.35 124.98 50.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.585 -0.734 . . . . 1.0700000000000001 109.81 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.36 104.92 29.83 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 0.28999999999999998 111.081 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.1 Cg_endo -90.97 -179.51 1.5 Allowed 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 123.231 2.621 . . . . 0.42999999999999999 112.204 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.69 32.63 18.35 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.385 -0.825 . . . . 1.26 111.411 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.448 ' O ' ' OG ' ' A' ' 126' ' ' SER . 23.9 mt -86.39 148.51 25.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.448 -0.342 . . . . 0.32000000000000001 110.489 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.77 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.5 mt -88.23 114.91 61.52 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.029 0.442 . . . . 0.57999999999999996 110.686 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.01 140.53 95.77 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.897 2.398 . . . . 0.66000000000000003 111.992 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.16 21.14 74.23 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.032 -0.827 . . . . 0.28999999999999998 111.032 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.439 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.83 150.14 49.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.768 0.318 . . . . 2.3300000000000001 110.73 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.27 131.78 46.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.139 -0.482 . . . . 0.85999999999999999 109.757 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.952 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.57 148.28 44.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.031 -0.532 . . . . 0.52000000000000002 110.99 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.2 mt -105.32 125.4 60.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.222 -1.029 . . . . 0.29999999999999999 108.222 177.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.58 132.56 63.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.205 0.526 . . . . 0.23000000000000001 111.216 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.64 20.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.575 -0.739 . . . . 0.35999999999999999 109.617 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.05 125.32 55.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.269 -0.423 . . . . 0.19 110.657 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.9 m-85 -117.21 137.94 52.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.031 -0.531 . . . . 0.29999999999999999 109.835 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.582 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.74 135.07 42.76 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.785 -0.82 . . . . 0.37 108.785 178.863 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 1.015 HG22 ' O ' ' A' ' 141' ' ' GLY . 11.7 tt -99.15 123.01 51.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.167 0.508 . . . . 0.26000000000000001 110.873 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.585 ' OG ' ' OD1' ' A' ' 188' ' ' ASP . 88.6 p -83.98 169.77 14.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.516 -0.766 . . . . 0.28000000000000003 110.485 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -59.8 -14.5 15.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.095 -0.502 . . . . 1.6000000000000001 110.897 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.671 ' OD1' ' N ' ' A' ' 190' ' ' GLU . 37.0 p30 -96.17 -4.2 43.01 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.782 -0.367 . . . . 1.1799999999999999 110.731 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.47 ' N ' ' HB ' ' A' ' 59' ' ' THR . . . 87.82 13.85 64.03 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.377 -0.689 . . . . 0.29999999999999999 111.377 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.671 ' N ' ' OD1' ' A' ' 188' ' ' ASP . 82.2 tt0 -84.67 139.0 32.34 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.04 -0.264 . . . . 1.22 110.472 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.864 HE22 ' NH2' ' A' ' 143' ' ' ARG . 90.3 mt-30 -106.72 141.11 38.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.873 0.368 . . . . 0.97999999999999998 110.523 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 61.8 m -136.72 127.07 26.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.078 -0.51 . . . . 0.82999999999999996 110.276 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.14 117.21 9.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.284 -0.416 . . . . 0.26000000000000001 110.554 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.0 pt -108.99 -21.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.29999999999999999 110.795 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.84 125.68 5.88 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.519 -0.472 . . . . 0.31 111.465 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.461 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.71 120.3 21.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.799 -0.637 . . . . 0.28000000000000003 109.585 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.66 151.74 29.13 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.667 -0.413 . . . . 0.23999999999999999 110.916 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.47 158.57 18.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.015 -0.538 . . . . 0.23000000000000001 110.41 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.1 157.86 43.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.123 -0.49 . . . . 0.67000000000000004 110.696 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.26 104.28 9.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.78 -0.646 . . . . 0.64000000000000001 110.096 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.0 p . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 117.845 -1.074 . . . . 1.26 110.655 -179.688 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.224 -0.658 . . . . 3.4399999999999999 109.224 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.39 150.62 18.55 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.012 -0.835 . . . . 1.22 111.012 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -35.62 142.35 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.05 0 C-N-CA 124.022 3.148 . . . . 0.75 113.828 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.6 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.0 t -79.91 173.3 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.283 -1.326 . . . . 0.79000000000000004 108.891 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.6 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.49 125.86 51.47 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.479 -0.488 . . . . 1.9399999999999999 111.482 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 143.99 33.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.665 -0.698 . . . . 0.59999999999999998 110.689 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.94 168.23 25.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.922 0.391 . . . . 3.1400000000000001 111.101 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.746 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.94 131.06 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.004 -0.544 . . . . 3.23 110.079 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.17 162.27 35.88 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.836 0.35 . . . . 3.6299999999999999 111.239 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.6 mt-10 36.18 31.5 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 109.648 -0.501 . . . . 6.0800000000000001 109.648 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.746 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.63 32.6 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.97 -0.559 . . . . 3.3799999999999999 111.574 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.2 Cg_endo -63.16 -29.18 73.92 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.484 2.123 . . . . 3.9300000000000002 111.888 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 3.3599999999999999 110.518 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.619 ' NE2' ' O ' ' A' ' 13' ' ' SER . 6.0 mp0 -123.98 158.29 60.74 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 3.6099999999999999 110.368 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.515 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 97.5 Cg_endo -81.98 -64.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.958 2.439 . . . . 1.51 113.431 -179.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.955 HD21 ' HB2' ' A' ' 157' ' ' TYR . 5.7 m-20 -108.48 -19.53 13.42 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.07 0.396 . . . . 2.6800000000000002 112.07 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 60.3 m -107.36 152.0 24.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.159 0.504 . . . . 1.21 111.258 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.4 t-80 -155.26 102.97 2.23 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.623 -0.717 . . . . 1.5600000000000001 110.618 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.621 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.5 Cg_endo -82.7 145.63 12.99 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.885 2.39 . . . . 0.81000000000000005 112.601 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.916 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.8 167.96 24.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.815 -0.63 . . . . 1.52 109.909 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.16 147.98 29.09 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.712 -0.477 . . . . 2.1400000000000001 109.712 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.582 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.28 157.23 45.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.026 0.441 . . . . 0.32000000000000001 111.165 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.498 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.06 155.23 44.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.752 -0.658 . . . . 2.1699999999999999 110.116 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.841 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.55 173.05 6.34 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 121.091 0.472 . . . . 0.58999999999999997 110.748 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.841 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.65 173.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.851 2.367 . . . . 0.90000000000000002 111.502 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.484 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.06 -51.12 0.69 Allowed Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.643 -0.423 . . . . 3.3399999999999999 110.08 179.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.638 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.76 152.31 82.49 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.796 2.33 . . . . 1.8500000000000001 111.416 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.66 42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.35 0.595 . . . . 2.54 110.607 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.822 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.52 -41.63 98.5 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.017 -0.992 . . . . 2.5299999999999998 110.68 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.532 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.2 mt -109.86 137.79 40.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.818 -0.628 . . . . 1.1699999999999999 111.287 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.88 -72.83 0.71 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.013 -0.539 . . . . 1.27 111.986 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.21 148.43 24.38 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.517 0.562 . . . . 1.1200000000000001 112.517 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.86 124.86 45.12 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.312 -0.625 . . . . 0.41999999999999998 109.312 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.04 134.78 60.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.614 -0.434 . . . . 0.78000000000000003 110.689 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.916 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.02 128.63 53.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.62 111.246 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.96 49.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.751 -0.659 . . . . 1.97 110.178 178.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.438 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.07 163.17 35.09 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.16 0.505 . . . . 0.34999999999999998 112.128 -178.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.47 139.54 7.84 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.468 -0.787 . . . . 1.8 110.468 178.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.695 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.57 115.52 3.09 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.313 2.009 . . . . 0.57999999999999996 111.791 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.674 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.01 81.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.885 -0.413 . . . . 3.04 109.885 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.695 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.51 0.06 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.987 -0.551 . . . . 2.4700000000000002 111.889 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.8 p -157.72 157.69 33.96 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.82 0.343 . . . . 2.5099999999999998 110.552 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.34 27.89 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 1.8600000000000001 110.194 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.81 -75.96 1.31 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.2 -0.524 . . . . 1.4399999999999999 111.81 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.79 152.29 35.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.824 0.345 . . . . 4.6900000000000004 111.042 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.24 -169.11 2.52 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.107 -0.497 . . . . 1.4299999999999999 111.884 179.334 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.67 29.73 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.524 0.678 . . . . 1.74 112.514 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.05 156.46 46.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.689 -1.141 . . . . 1.9199999999999999 110.263 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.16 158.34 41.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.91 -0.586 . . . . 0.34000000000000002 111.818 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.1 m -115.08 135.61 54.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.505 -0.77 . . . . 0.40999999999999998 109.86 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.582 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.36 121.95 23.82 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.439 -0.346 . . . . 0.55000000000000004 111.55 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.597 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.0 Cg_exo -46.37 151.79 1.64 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.653 2.235 . . . . 0.44 112.116 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.98 -23.01 63.19 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 116.052 -0.522 . . . . 0.73999999999999999 112.763 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.1 p-80 -82.8 -16.84 46.26 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.216 -0.594 . . . . 0.93000000000000005 111.861 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.597 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.66 138.51 31.5 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.657 -0.417 . . . . 0.96999999999999997 110.281 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.55 13.94 10.98 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.314 -0.403 . . . . 1.3400000000000001 111.568 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.01 143.35 25.12 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.611 -0.436 . . . . 0.39000000000000001 111.068 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.722 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.63 -169.29 1.51 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.188 0.518 . . . . 0.41999999999999998 110.941 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.722 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.3 t -151.8 125.97 9.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.416 -0.811 . . . . 0.39000000000000001 109.808 179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.517 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.93 123.2 70.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.404 -0.518 . . . . 0.73999999999999999 111.217 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -126.47 163.39 23.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.829 -0.623 . . . . 2.48 110.426 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.19 18.97 59.79 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.705 -0.958 . . . . 0.5 110.705 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.517 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.9 mt -79.1 157.14 28.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.093 0.473 . . . . 0.57999999999999996 111.324 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.84 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.0 mtpp -99.39 133.97 21.57 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.588 -0.733 . . . . 2.79 110.463 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.89 143.58 61.36 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.586 2.191 . . . . 0.87 111.963 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.87 25.58 75.4 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.023 -0.831 . . . . 0.64000000000000001 111.023 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.84 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.15 158.74 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.706 0.288 . . . . 0.82999999999999996 110.466 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.13 139.93 42.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.883 0.373 . . . . 0.5 110.602 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.653 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.3 m-85 -122.49 136.48 54.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.989 -0.55 . . . . 0.53000000000000003 110.775 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.98 130.98 45.36 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.539 -0.911 . . . . 1.8700000000000001 108.539 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.43 153.91 16.63 Favored Glycine 0 C--O 1.227 -0.344 0 C-N-CA 120.299 -0.953 . . . . 0.28999999999999998 111.962 -178.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.97 140.91 46.07 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.73 -0.47 . . . . 1.4299999999999999 109.73 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.7 tp -115.73 118.95 34.48 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.456 -0.498 . . . . 0.32000000000000001 110.533 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.728 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.42 129.05 68.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.323 -0.399 . . . . 0.79000000000000004 110.628 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.703 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.9 120.8 43.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.287 -0.415 . . . . 1.02 110.713 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.855 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.53 146.46 11.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.231 0.538 . . . . 0.62 111.058 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.822 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.03 153.94 21.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.495 -0.775 . . . . 2.4399999999999999 109.949 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.2 mt-30 -39.21 88.6 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.895 0.379 . . . . 3.6899999999999999 110.446 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.24 32.62 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.822 -0.626 . . . . 6.0800000000000001 110.598 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.08 -117.33 3.29 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.457 -0.657 . . . . 1.22 111.457 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.462 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.51 177.42 8.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.197 0.522 . . . . 2.8799999999999999 111.6 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.16 149.44 31.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.451 -0.795 . . . . 1.47 110.451 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.14 144.65 38.73 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.479 -0.328 . . . . 2.7000000000000002 110.533 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.728 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -128.01 135.99 61.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-O 121.036 0.446 . . . . 0.46000000000000002 111.555 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.05 141.32 52.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.662 -0.699 . . . . 0.34999999999999998 110.304 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.453 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.63 138.82 51.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.053 0.454 . . . . 3.6699999999999999 111.577 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.25 164.21 37.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.548 -0.751 . . . . 0.67000000000000004 109.435 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.28 151.47 38.4 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.399 -0.52 . . . . 1.47 111.058 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.804 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.2 p90 -146.18 172.66 13.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.802 -0.636 . . . . 0.44 111.039 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.6 160.71 21.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.456 -0.793 . . . . 1.3700000000000001 109.897 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.43 121.81 22.8 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.591 -0.444 . . . . 1.28 110.778 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.494 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -127.64 163.88 23.28 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 114.03 1.122 . . . . 1.97 114.03 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 55.2 m -120.57 154.74 34.97 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 113.55 -1.659 . . . . 3.2799999999999998 108.815 177.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.438 HG23 ' N ' ' A' ' 95' ' ' SER . 5.6 t -43.52 -41.22 4.32 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.146 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.438 ' N ' HG23 ' A' ' 94' ' ' THR . 28.2 t -115.45 144.31 44.01 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.8 113.37 62.71 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.037 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.36 147.17 69.18 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.289 1.993 . . . . 0.0 112.633 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.4 t -114.74 134.99 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.873 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.4 p -85.11 161.31 19.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.794 0.33 . . . . 0.0 110.954 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.2 t -118.73 143.37 46.93 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.278 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.3 p-10 -86.96 6.01 34.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.129 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.5 p -84.08 160.04 21.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.773 0.321 . . . . 0.0 110.656 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.3 m -112.98 9.18 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.703 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.7 p -83.69 161.89 20.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.913 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.94 5.23 64.42 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.832 ' O ' ' O ' ' A' ' 107' ' ' THR . 21.8 pt-20 -106.66 145.99 31.3 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.53 0.205 . . . . 0.0 110.949 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.832 ' O ' ' O ' ' A' ' 106' ' ' GLU . 5.6 m 30.86 138.68 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.6 p -126.32 78.68 71.25 Favored Pre-proline 0 N--CA 1.465 0.314 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.33 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -55.35 143.64 75.69 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.432 2.088 . . . . 0.0 112.45 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -57.63 -39.64 77.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.564 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.427 ' O ' ' OG ' ' A' ' 111' ' ' SER . 22.6 p 61.97 66.76 1.39 Allowed Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.028 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -56.48 -19.49 29.42 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.841 2.361 . . . . 0.0 111.979 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 66.6 mt -57.71 -34.33 69.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 10.19 110.687 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.7 t -66.62 134.19 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.745 -0.382 . . . . 7.2800000000000002 110.287 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -120.43 -113.24 0.33 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.134 -0.485 . . . . 7.2999999999999998 110.608 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.7 m -75.99 137.0 39.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.41 -0.359 . . . . 6.4400000000000004 110.466 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 84.1 p -140.89 163.9 31.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.018 -0.537 . . . . 4.4199999999999999 110.65 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -56.24 146.57 23.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.048 -0.524 . . . . 3.0499999999999998 110.124 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.2 t -61.26 144.29 54.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.049 0.452 . . . . 3.4300000000000002 110.606 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.9 t -119.15 138.22 50.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.654 -0.703 . . . . 2.8799999999999999 110.72 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 26.4 p -77.18 163.21 26.77 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.814 -0.439 . . . . 2.0899999999999999 109.814 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.12 141.48 45.98 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.636 -0.426 . . . . 4.5300000000000002 110.918 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.06 162.36 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.751 -0.658 . . . . 1.4399999999999999 111.09 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.6 p -120.79 160.78 22.69 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.433 -0.58 . . . . 1.78 109.433 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.97 123.42 29.42 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.586 -0.446 . . . . 0.64000000000000001 110.76 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.5 p -65.0 -27.19 68.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.943 -0.571 . . . . 0.66000000000000003 110.365 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.436 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.86 167.59 0.25 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.602 -0.726 . . . . 0.68999999999999995 110.955 -179.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.62 145.48 50.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.731 -0.668 . . . . 0.52000000000000002 110.156 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.16 101.64 9.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.095 -0.706 . . . . 0.32000000000000001 109.095 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.1 t -112.92 139.78 36.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.056 -0.52 . . . . 0.28999999999999998 110.95 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.9 p -128.74 152.57 48.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.598 -0.728 . . . . 0.25 109.792 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.592 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.8 -164.87 2.02 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.741 -0.384 . . . . 0.31 110.667 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.5 t -123.98 127.12 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.48999999999999999 110.823 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.176 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.87 58.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.126 -0.488 . . . . 1.53 110.368 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -37.95 24.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.934 -0.575 . . . . 0.96999999999999997 111.579 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.176 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.23 128.68 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.659 -0.417 . . . . 1.5600000000000001 110.96 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.42 -9.53 56.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.0 -0.545 . . . . 1.8799999999999999 110.32 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.8 p -87.16 0.25 55.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 1.04 110.29 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.26 137.26 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.994 -0.548 . . . . 0.23999999999999999 109.956 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.601 ' N ' ' O ' ' A' ' 185' ' ' ILE . 90.3 p -96.29 -15.5 21.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.27 0.557 . . . . 0.28999999999999998 110.048 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.58 175.57 45.77 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 109.88 -1.288 . . . . 0.13 109.88 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.47 151.62 42.54 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.569 -0.452 . . . . 0.17000000000000001 110.496 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.796 HH22 ' NE2' ' A' ' 191' ' ' GLN . 41.8 ttp180 -132.26 121.14 23.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.15 -0.477 . . . . 1.29 109.924 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.558 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.14 136.63 38.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.734 -0.666 . . . . 0.25 110.649 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 99.2 mt-10 -129.45 129.86 45.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.942 -0.572 . . . . 1.3200000000000001 110.044 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.625 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.7 p90 -138.68 135.35 34.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.046 -0.525 . . . . 0.56999999999999995 110.611 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.419 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.41 161.36 39.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.793 -0.64 . . . . 1.1599999999999999 109.621 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.05 124.99 25.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.036 0.446 . . . . 0.38 110.694 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.495 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.7 p -71.94 -7.7 50.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.766 -0.652 . . . . 0.40999999999999998 110.797 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -109.72 -69.67 0.85 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.967 0.413 . . . . 1.6599999999999999 111.455 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.445 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.71 -35.28 75.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.998 -0.546 . . . . 1.6599999999999999 111.522 -179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.081 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.11 7.23 88.59 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.825 -0.91 . . . . 1.1699999999999999 110.825 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.34 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.83 -171.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.324 . . . . 1.8600000000000001 110.256 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.34 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.26 139.02 45.14 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-O 120.945 0.402 . . . . 1.98 110.205 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.419 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.9 Cg_endo -70.75 145.73 52.2 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 122.808 2.339 . . . . 0.55000000000000004 112.361 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.625 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.86 145.69 42.65 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.312 -0.625 . . . . 1.1399999999999999 109.312 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.955 ' HB2' HD21 ' A' ' 16' ' ' ASN . 0.2 OUTLIER -123.26 141.32 52.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.31 0.576 . . . . 0.93000000000000005 111.421 -178.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.9 mt -128.14 127.61 43.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.271 -0.877 . . . . 0.34000000000000002 108.921 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 159' ' ' ASP . 51.4 p-10 -101.61 131.21 47.94 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.194 0.521 . . . . 1.0900000000000001 111.731 -178.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -128.02 157.58 73.5 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.237 -0.892 . . . . 0.19 109.493 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.81 158.02 58.33 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.435 2.09 . . . . 0.17999999999999999 112.267 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.36 -12.11 5.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.792 -0.64 . . . . 0.20999999999999999 110.708 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.7 p -92.82 -8.67 42.9 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.129 -0.487 . . . . 0.28999999999999998 110.715 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.38 34.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.319 -0.4 . . . . 0.5 110.394 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.12 16.53 4.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.398 -0.365 . . . . 0.29999999999999999 110.558 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.4 p -167.45 147.23 5.18 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.661 -0.496 . . . . 0.23000000000000001 109.661 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.32 150.42 12.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.565 -0.454 . . . . 0.28000000000000003 111.602 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.507 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.26 124.94 50.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.559 -0.746 . . . . 1.0700000000000001 109.843 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.45 104.86 29.72 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.918 0.389 . . . . 0.28999999999999998 111.098 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 84.4 Cg_endo -91.05 -179.42 1.47 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 123.132 2.555 . . . . 0.42999999999999999 112.163 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.56 32.73 18.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.366 -0.834 . . . . 1.26 111.419 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.1 mt -86.37 148.52 25.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.454 -0.339 . . . . 0.32000000000000001 110.454 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.773 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.31 114.88 61.44 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.018 0.437 . . . . 0.57999999999999996 110.64 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -58.98 140.62 96.14 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.815 2.343 . . . . 0.66000000000000003 112.051 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.16 74.4 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.088 -0.805 . . . . 0.28999999999999998 111.088 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.445 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.86 150.21 49.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.313 . . . . 2.3300000000000001 110.634 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.495 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.13 131.63 45.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.519 . . . . 0.85999999999999999 109.789 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.955 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.55 148.38 43.94 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.066 -0.515 . . . . 0.52000000000000002 110.995 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.4 125.28 60.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.363 -0.977 . . . . 0.29999999999999999 108.363 177.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.47 132.51 63.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.149 0.5 . . . . 0.23000000000000001 111.217 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.49 122.66 20.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.54 -0.755 . . . . 0.35999999999999999 109.729 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.592 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.09 125.37 55.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.284 -0.417 . . . . 0.19 110.664 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 49.1 m-85 -117.18 138.04 51.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.978 -0.555 . . . . 0.29999999999999999 109.875 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.582 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.81 134.97 43.0 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.77 -0.826 . . . . 0.37 108.77 178.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.601 ' O ' ' N ' ' A' ' 140' ' ' SER . 85.4 mt -99.09 122.93 51.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.145 0.498 . . . . 0.26000000000000001 110.961 -178.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.2 p -83.89 169.65 14.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.526 -0.761 . . . . 0.28000000000000003 110.447 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.63 ' O ' ' CG2' ' A' ' 59' ' ' THR . 51.5 tp10 -59.79 -14.39 14.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.034 -0.53 . . . . 1.6000000000000001 110.982 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.621 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.1 m-20 -96.18 -4.24 42.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.857 0.361 . . . . 1.1799999999999999 110.817 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.8 13.88 64.0 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.384 -0.687 . . . . 0.29999999999999999 111.384 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.5 tp10 -84.7 139.09 32.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.712 0.292 . . . . 1.22 110.422 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.796 ' NE2' HH22 ' A' ' 143' ' ' ARG . 6.9 pt20 -106.71 141.03 38.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.405 -0.362 . . . . 0.97999999999999998 110.602 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.4 m -136.72 127.06 26.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.82999999999999996 110.301 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.19 117.27 9.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.244 -0.434 . . . . 0.26000000000000001 110.577 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -108.97 -21.86 5.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.29999999999999999 110.711 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.83 125.72 5.9 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.551 -0.46 . . . . 0.31 111.535 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.79 120.12 21.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.854 -0.612 . . . . 0.28000000000000003 109.603 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.58 151.66 29.11 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.676 -0.409 . . . . 0.23999999999999999 110.97 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.49 158.66 18.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.23000000000000001 110.411 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.14 157.87 43.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.043 -0.526 . . . . 0.67000000000000004 110.627 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.2 104.31 9.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.722 -0.672 . . . . 0.64000000000000001 110.119 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.7 p . . . . . 0 C--O 1.221 -0.414 0 CA-C-O 117.902 -1.047 . . . . 1.26 110.666 -179.621 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.4 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.267 -0.642 . . . . 3.4399999999999999 109.267 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.39 150.72 18.53 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.006 -0.838 . . . . 1.22 111.006 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -35.61 142.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.071 0 C-N-CA 124.007 3.138 . . . . 0.75 113.789 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.6 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.3 t -80.04 173.39 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.288 -1.324 . . . . 0.79000000000000004 108.745 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.6 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.66 125.86 51.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.398 -0.521 . . . . 1.9399999999999999 111.444 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.48 144.06 33.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.564 -0.744 . . . . 0.59999999999999998 110.631 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.09 168.33 25.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.944 0.402 . . . . 3.1400000000000001 111.127 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.748 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -108.99 131.06 60.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.972 -0.558 . . . . 3.23 110.116 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.2 p -141.14 162.25 35.93 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.875 0.369 . . . . 3.6299999999999999 111.24 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 75.0 mm-40 36.1 31.61 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.633 -0.506 . . . . 6.0800000000000001 109.633 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.748 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.55 69.69 33.96 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.952 -0.567 . . . . 3.3799999999999999 111.618 -178.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.34 -29.07 72.2 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.498 2.132 . . . . 3.9300000000000002 111.851 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.64 125.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.098 -0.501 . . . . 3.3599999999999999 110.477 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 1.075 HE22 HG23 ' A' ' 91' ' ' THR . 0.0 OUTLIER -123.99 158.31 60.71 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 3.6099999999999999 110.437 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.444 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 97.1 Cg_endo -81.95 -64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.858 2.372 . . . . 1.51 113.553 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.7 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 52.1 t30 -108.48 -19.55 13.41 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.119 0.414 . . . . 2.6800000000000002 112.119 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.825 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 47.1 m -107.31 152.05 24.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.136 0.493 . . . . 1.21 111.281 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.569 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.5 t-80 -155.32 102.86 2.22 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.72 -0.673 . . . . 1.5600000000000001 110.682 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.452 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.6 145.72 13.17 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.875 2.383 . . . . 0.81000000000000005 112.627 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.907 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.88 167.98 24.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.896 -0.593 . . . . 1.52 109.879 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.15 148.03 29.15 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.786 -0.45 . . . . 2.1400000000000001 109.786 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.586 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.8 p90 -142.32 157.3 44.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.936 0.398 . . . . 0.32000000000000001 111.303 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.493 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.07 155.34 44.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.841 -0.618 . . . . 2.1699999999999999 110.092 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.838 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.67 173.08 6.31 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 121.122 0.487 . . . . 0.58999999999999997 110.76 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.838 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.74 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.841 2.361 . . . . 0.90000000000000002 111.512 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.14 -50.97 0.69 Allowed Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.62 -0.432 . . . . 3.3399999999999999 110.133 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.634 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.85 152.4 82.32 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.678 2.252 . . . . 1.8500000000000001 111.559 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.75 42.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.401 0.62 . . . . 2.54 110.528 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.822 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.63 -41.63 98.24 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.008 -0.996 . . . . 2.5299999999999998 110.616 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.9 mt -109.79 137.86 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.84 -0.618 . . . . 1.1699999999999999 111.227 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.0 -72.84 0.71 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.042 -0.526 . . . . 1.27 111.937 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.29 148.38 24.34 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.549 0.574 . . . . 1.1200000000000001 112.549 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.82 124.89 45.23 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.345 -0.613 . . . . 0.41999999999999998 109.345 177.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 mt -118.06 134.75 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.608 -0.437 . . . . 0.78000000000000003 110.616 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.907 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -119.98 128.66 53.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.996 0.427 . . . . 0.62 111.245 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.93 49.71 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.79 -0.641 . . . . 1.97 110.213 178.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.439 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -144.98 163.17 35.01 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.118 0.485 . . . . 0.34999999999999998 112.043 -178.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.52 139.57 7.82 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.417 -0.811 . . . . 1.8 110.503 178.746 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.3 Cg_endo -63.54 115.47 3.06 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.347 2.032 . . . . 0.57999999999999996 111.818 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.3 tttp -46.85 81.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.883 -0.414 . . . . 3.04 109.883 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.7 0.06 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.109 -0.496 . . . . 2.4700000000000002 111.914 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 p -157.55 157.81 34.46 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.857 -0.337 . . . . 2.5099999999999998 110.592 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.402 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.33 27.77 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.213 -0.449 . . . . 1.8600000000000001 110.183 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.77 -75.97 1.31 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.198 -0.525 . . . . 1.4399999999999999 111.811 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.86 152.25 35.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.947 0.403 . . . . 4.6900000000000004 111.019 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.676 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.17 -169.14 2.54 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.996 -0.547 . . . . 1.4299999999999999 112.048 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.16 149.67 29.74 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 121.476 0.655 . . . . 1.74 112.561 -177.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.99 156.42 46.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.763 -1.108 . . . . 1.9199999999999999 110.347 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.13 158.39 41.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.209 0.528 . . . . 0.34000000000000002 111.828 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.1 m -115.22 135.57 54.03 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.57 -0.741 . . . . 0.40999999999999998 109.794 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.586 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.36 121.96 23.82 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.33 -0.396 . . . . 0.55000000000000004 111.495 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.9 Cg_exo -46.3 151.65 1.64 Allowed 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.733 2.289 . . . . 0.44 112.081 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.84 -23.06 62.94 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-N 116.037 -0.529 . . . . 0.73999999999999999 112.814 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.87 -16.74 46.38 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.236 -0.585 . . . . 0.93000000000000005 111.779 -178.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.601 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.6 mt -91.69 138.41 31.59 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.807 -0.357 . . . . 0.96999999999999997 110.308 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.54 13.98 10.99 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.315 -0.402 . . . . 1.3400000000000001 111.482 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 86.8 p -149.97 143.5 25.25 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.696 -0.402 . . . . 0.39000000000000001 111.03 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.721 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.87 -169.43 1.55 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.286 0.565 . . . . 0.41999999999999998 110.808 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.721 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.4 t -151.77 125.89 9.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.375 -0.83 . . . . 0.39000000000000001 109.908 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.4 mt -114.74 123.27 70.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.424 -0.51 . . . . 0.73999999999999999 111.257 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.59 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 21.5 mtmt -126.48 163.33 23.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.88 -0.6 . . . . 2.48 110.464 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.473 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.14 18.99 59.84 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.77 -0.932 . . . . 0.5 110.77 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.7 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.6 mt -79.05 157.35 28.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.043 0.449 . . . . 0.57999999999999996 111.408 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.846 ' O ' HG12 ' A' ' 67' ' ' VAL . 6.6 mttp -99.54 133.95 21.51 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.666 -0.697 . . . . 2.79 110.412 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.575 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.92 143.66 61.53 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.495 2.13 . . . . 0.87 111.945 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.78 25.47 75.52 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.161 -0.776 . . . . 0.64000000000000001 111.161 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.846 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.04 158.84 39.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.655 0.264 . . . . 0.82999999999999996 110.51 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.23 139.89 42.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.916 0.388 . . . . 0.5 110.516 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.654 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.6 136.41 54.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.959 -0.564 . . . . 0.53000000000000003 110.799 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.88 130.91 45.3 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.51 -0.922 . . . . 1.8700000000000001 108.51 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.36 153.79 16.63 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.298 -0.953 . . . . 0.28999999999999998 112.07 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.91 140.97 46.18 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.696 -0.483 . . . . 1.4299999999999999 109.696 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.78 118.96 34.49 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.456 -0.498 . . . . 0.32000000000000001 110.483 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.735 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.5 129.02 68.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.334 -0.394 . . . . 0.79000000000000004 110.645 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.707 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.82 120.84 43.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.326 -0.397 . . . . 1.02 110.766 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.852 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.6 146.47 11.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.144 0.497 . . . . 0.62 110.985 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.822 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.0 153.88 21.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.575 -0.738 . . . . 2.4399999999999999 109.902 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.18 88.54 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.901 0.382 . . . . 3.6899999999999999 110.427 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.62 0.21 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.8 -0.636 . . . . 6.0800000000000001 110.56 -179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.34 3.29 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.406 -0.678 . . . . 1.22 111.406 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.466 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.38 177.39 9.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.132 0.492 . . . . 2.8799999999999999 111.652 -179.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.12 149.5 32.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.504 -0.771 . . . . 1.47 110.421 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.17 144.65 38.67 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.402 -0.363 . . . . 2.7000000000000002 110.623 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.735 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.0 135.96 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.997 0.427 . . . . 0.46000000000000002 111.568 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.0 141.35 52.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.667 -0.697 . . . . 0.34999999999999998 110.289 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.462 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.65 138.8 51.73 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.089 0.471 . . . . 3.6699999999999999 111.529 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.17 164.22 37.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.553 -0.749 . . . . 0.67000000000000004 109.556 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.573 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.3 151.48 38.4 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.432 -0.507 . . . . 1.47 111.004 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.805 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.15 172.75 12.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.714 -0.676 . . . . 0.44 111.024 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.69 160.71 21.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.454 -0.794 . . . . 1.3700000000000001 109.849 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 1.075 HG23 HE22 ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.43 121.89 22.91 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 120.575 -0.45 . . . . 1.28 110.778 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.634 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.8 p -127.62 165.52 19.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 1.97 111.415 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.5 t -99.1 142.55 30.44 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 109.617 -0.512 . . . . 3.2799999999999998 109.617 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 43.4 m -84.16 137.97 33.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.102 0.477 . . . . 0.0 111.79 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.445 ' O ' ' OG1' ' A' ' 96' ' ' THR . 31.5 t -121.88 143.46 49.42 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.585 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.615 ' N ' ' CD ' ' A' ' 97' ' ' PRO . 1.1 m 168.12 -35.28 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.595 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 96' ' ' THR . 51.1 Cg_exo -53.29 145.29 45.28 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.869 1.713 . . . . 0.0 112.357 -179.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 40.9 t -114.73 137.11 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.322 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.6 t -133.19 158.38 43.01 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.837 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 92.0 p -123.01 157.9 31.69 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.445 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.7 p-10 -130.17 176.22 8.27 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.92 0.39 . . . . 0.0 110.749 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.4 t -135.98 160.94 37.08 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.592 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.4 t -111.42 135.01 51.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.325 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 45.8 m -121.34 142.06 50.34 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.647 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -134.7 170.64 22.67 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -59.28 141.47 54.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.812 0.339 . . . . 0.0 110.615 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.432 ' O ' ' OG1' ' A' ' 108' ' ' THR . 64.1 p -71.72 -21.57 61.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.68 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.655 ' N ' ' HD2' ' A' ' 109' ' ' PRO . 1.2 m 166.99 -49.63 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.705 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 108' ' ' THR . 16.2 Cg_endo -56.94 149.72 59.77 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.324 2.016 . . . . 0.0 112.011 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -103.71 134.81 46.41 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.429 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.407 ' N ' ' HD3' ' A' ' 112' ' ' PRO . 11.5 t 56.64 64.77 4.46 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.549 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' A' ' 111' ' ' SER . 31.7 Cg_exo -56.6 147.12 72.19 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.662 2.241 . . . . 0.0 112.149 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.649 ' H ' HD12 ' A' ' 113' ' ' LEU . 6.5 mp -61.12 -33.64 73.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.862 -0.608 . . . . 10.19 110.802 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 115' ' ' ALA . 91.0 t 55.8 159.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.2 -0.454 . . . . 7.2800000000000002 110.654 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.514 ' N ' HG12 ' A' ' 114' ' ' VAL . . . -64.28 146.31 54.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.011 -0.541 . . . . 7.2999999999999998 110.836 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.2 p -81.49 164.24 22.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.067 -0.515 . . . . 6.4400000000000004 110.355 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.626 ' O ' ' N ' ' A' ' 119' ' ' SER . 87.6 p -60.83 -26.51 67.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 4.4199999999999999 111.183 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 120' ' ' VAL . 95.8 mt-10 44.12 -82.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.507 -0.315 . . . . 3.0499999999999998 111.323 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.626 ' N ' ' O ' ' A' ' 117' ' ' SER . 7.4 p 66.21 -47.73 0.42 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.296 -0.411 . . . . 3.4300000000000002 110.815 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.449 ' N ' ' O ' ' A' ' 118' ' ' GLU . 19.8 m -69.64 -27.91 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.459 -0.337 . . . . 2.8799999999999999 110.669 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 39.9 m -121.09 139.92 52.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.248 -0.433 . . . . 2.0899999999999999 110.291 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -103.98 134.12 47.8 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.332 -0.395 . . . . 4.5300000000000002 110.18 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.604 ' C ' ' H ' ' A' ' 125' ' ' ALA . 32.6 mm -116.78 132.68 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.815 0.341 . . . . 1.4399999999999999 111.299 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.563 ' O ' ' O ' ' A' ' 125' ' ' ALA . 19.6 m 52.5 -2.85 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.94 -0.573 . . . . 1.78 112.082 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.604 ' H ' ' C ' ' A' ' 123' ' ' ILE . . . 48.46 115.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.201 0.524 . . . . 0.64000000000000001 111.271 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.9 p -61.31 -27.53 68.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.92 -0.582 . . . . 0.66000000000000003 110.546 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.437 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.91 167.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.873 -0.603 . . . . 0.68999999999999995 110.916 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.61 145.56 50.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.674 -0.693 . . . . 0.52000000000000002 110.138 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.21 101.63 9.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.086 -0.709 . . . . 0.32000000000000001 109.086 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.7 t -112.93 139.64 36.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.033 -0.531 . . . . 0.28999999999999998 111.076 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 p -128.71 152.54 48.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.669 -0.696 . . . . 0.25 109.869 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.591 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.71 -164.93 2.03 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.688 -0.405 . . . . 0.31 110.716 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -124.01 127.19 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.48999999999999999 110.83 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.175 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.94 58.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.059 -0.519 . . . . 1.53 110.388 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.16 24.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.876 -0.602 . . . . 0.96999999999999997 111.507 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.175 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.18 128.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.618 -0.433 . . . . 1.5600000000000001 110.921 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -86.53 -9.51 56.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.942 -0.572 . . . . 1.8799999999999999 110.339 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.18 0.34 55.47 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.045 -0.525 . . . . 1.04 110.444 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.23 137.23 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.847 -0.615 . . . . 0.23999999999999999 109.93 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.612 ' N ' ' O ' ' A' ' 185' ' ' ILE . 87.2 p -96.34 -15.4 21.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.324 0.583 . . . . 0.28999999999999998 110.068 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.56 175.54 45.73 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 109.836 -1.306 . . . . 0.13 109.836 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.44 151.61 42.5 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.637 -0.425 . . . . 0.17000000000000001 110.488 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.614 ' NH1' ' OE1' ' A' ' 191' ' ' GLN . 55.9 ttp180 -132.36 121.2 23.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.141 -0.481 . . . . 1.29 109.92 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.555 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.16 136.62 38.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.753 -0.658 . . . . 0.25 110.652 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 22.4 tp10 -129.35 129.93 45.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.981 -0.554 . . . . 1.3200000000000001 109.974 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.623 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.75 135.35 34.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.993 -0.549 . . . . 0.56999999999999995 110.507 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.422 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.38 161.37 39.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.721 -0.672 . . . . 1.1599999999999999 109.666 179.778 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.952 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.06 124.88 25.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.946 0.403 . . . . 0.38 110.772 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.7 p -71.75 -7.78 50.19 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.75 -0.659 . . . . 0.40999999999999998 110.853 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -109.8 -69.76 0.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.318 -0.401 . . . . 1.6599999999999999 111.394 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.439 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.5 mt-10 -60.65 -35.32 75.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.033 -0.531 . . . . 1.6599999999999999 111.441 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.091 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.16 7.32 88.53 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.785 -0.926 . . . . 1.1699999999999999 110.785 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.334 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.4 t0 -28.15 -171.68 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.807 0.337 . . . . 1.8600000000000001 110.266 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.334 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.15 45.23 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-O 120.918 0.389 . . . . 1.98 110.139 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.422 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.1 Cg_endo -70.98 145.81 51.07 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 C-N-CA 122.717 2.278 . . . . 0.55000000000000004 112.318 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.83 145.83 42.51 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.243 -0.651 . . . . 1.1399999999999999 109.243 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.575 ' CE1' ' HD3' ' A' ' 65' ' ' PRO . 27.5 p90 -123.37 141.32 52.11 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.372 -0.531 . . . . 0.93000000000000005 111.514 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.11 127.62 43.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.318 -0.855 . . . . 0.34000000000000002 108.994 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.549 ' HB3' ' ND2' ' A' ' 16' ' ' ASN . 37.6 p-10 -101.55 131.14 47.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.08 0.467 . . . . 1.0900000000000001 111.771 -178.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.94 157.51 73.57 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.376 -0.829 . . . . 0.19 109.58 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.74 157.94 58.69 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 122.429 2.086 . . . . 0.17999999999999999 112.269 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.418 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.26 -12.14 5.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.776 -0.647 . . . . 0.20999999999999999 110.682 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.0 p -92.87 -8.7 42.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.28999999999999998 110.711 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.11 135.31 34.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.284 -0.416 . . . . 0.5 110.394 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.1 p -133.12 16.7 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 0.29999999999999999 110.502 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.8 p -167.52 147.11 5.09 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.602 -0.518 . . . . 0.23000000000000001 109.602 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.555 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.18 150.38 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.476 -0.489 . . . . 0.28000000000000003 111.589 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.509 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.22 124.94 50.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.63 -0.714 . . . . 1.0700000000000001 109.792 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.44 104.91 30.02 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.917 0.389 . . . . 0.28999999999999998 111.112 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -90.97 -179.47 1.5 Allowed 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 123.18 2.586 . . . . 0.42999999999999999 112.23 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.64 32.67 18.44 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.395 -0.821 . . . . 1.26 111.387 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.9 mt -86.39 148.56 25.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.79 0.328 . . . . 0.32000000000000001 110.489 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.769 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.4 114.77 61.01 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.978 0.418 . . . . 0.57999999999999996 110.595 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -58.92 140.52 95.62 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.823 2.348 . . . . 0.66000000000000003 112.06 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.15 21.18 74.15 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.061 -0.815 . . . . 0.28999999999999998 111.061 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.439 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.88 150.15 49.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.808 0.337 . . . . 2.3300000000000001 110.691 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.15 131.65 45.98 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.117 -0.492 . . . . 0.85999999999999999 109.772 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.952 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.5 m-85 -120.45 148.27 44.02 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.172 -0.467 . . . . 0.52000000000000002 111.09 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.2 mt -105.35 125.28 60.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.342 -0.985 . . . . 0.29999999999999999 108.342 177.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.43 132.51 63.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.096 0.474 . . . . 0.23000000000000001 111.353 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.47 122.44 20.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.523 -0.762 . . . . 0.35999999999999999 109.651 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.591 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.98 125.39 54.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.333 -0.394 . . . . 0.19 110.651 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.584 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.19 137.9 52.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.017 -0.538 . . . . 0.29999999999999999 109.888 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.58 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.65 134.98 42.81 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.758 -0.83 . . . . 0.37 108.758 178.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.612 ' O ' ' N ' ' A' ' 140' ' ' SER . 65.3 mt -99.08 123.08 51.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.214 0.53 . . . . 0.26000000000000001 110.927 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.7 p -83.99 169.73 14.69 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.498 -0.773 . . . . 0.28000000000000003 110.362 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -59.82 -14.47 15.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.978 -0.555 . . . . 1.6000000000000001 110.966 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.2 m-20 -96.05 -4.32 43.22 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.837 -0.345 . . . . 1.1799999999999999 110.856 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.79 13.95 63.9 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.359 -0.696 . . . . 0.29999999999999999 111.359 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -84.78 139.06 32.22 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.01 -0.276 . . . . 1.22 110.437 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.614 ' OE1' ' NH1' ' A' ' 143' ' ' ARG . 6.9 pt20 -106.7 141.06 38.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.893 0.378 . . . . 0.97999999999999998 110.532 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.2 m -136.78 127.05 26.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.113 -0.494 . . . . 0.82999999999999996 110.39 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.2 tp -68.15 117.28 9.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.294 -0.412 . . . . 0.26000000000000001 110.527 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 43.9 pt -108.97 -21.87 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.29999999999999999 110.724 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.87 125.81 5.91 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.457 -0.497 . . . . 0.31 111.468 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.46 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.71 120.21 21.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.75 -0.659 . . . . 0.28000000000000003 109.56 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.7 29.11 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.6 -0.44 . . . . 0.23999999999999999 110.892 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.45 158.54 18.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.23000000000000001 110.472 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.07 157.88 43.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.133 -0.485 . . . . 0.67000000000000004 110.649 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.21 104.35 9.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.703 -0.681 . . . . 0.64000000000000001 110.05 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.2 p . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.866 -1.064 . . . . 1.26 110.669 -179.682 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.5 m . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.179 -0.675 . . . . 3.4399999999999999 109.179 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.32 150.7 18.54 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.05 -0.82 . . . . 1.22 111.05 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -35.57 142.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.076 0 C-N-CA 124.004 3.136 . . . . 0.75 113.815 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.61 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -80.02 173.52 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.256 -1.338 . . . . 0.79000000000000004 108.846 178.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.61 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.6 125.88 51.49 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.453 -0.499 . . . . 1.9399999999999999 111.352 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 144.02 33.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.678 -0.692 . . . . 0.59999999999999998 110.726 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.0 168.32 25.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.895 0.379 . . . . 3.1400000000000001 111.149 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.746 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.6 mt -109.06 131.12 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.993 -0.549 . . . . 3.23 110.076 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.2 162.33 35.74 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.862 0.363 . . . . 3.6299999999999999 111.159 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 71.7 tt0 36.0 31.68 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 109.652 -0.499 . . . . 6.0800000000000001 109.652 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.746 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.53 69.61 33.55 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.916 -0.584 . . . . 3.3799999999999999 111.493 -178.735 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.38 -29.03 71.83 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.474 2.116 . . . . 3.9300000000000002 111.832 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.6 125.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 3.3599999999999999 110.433 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.697 ' O ' ' O ' ' A' ' 92' ' ' THR . 14.2 mm-40 -123.89 158.4 60.11 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.256 -0.429 . . . . 3.6099999999999999 110.434 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.577 ' HG3' HE22 ' A' ' 191' ' ' GLN . 96.3 Cg_endo -81.99 -64.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.895 2.396 . . . . 1.51 113.534 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.591 HD22 ' CG ' ' A' ' 159' ' ' ASP . 43.2 p-10 -108.38 -19.56 13.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.3 -0.409 . . . . 2.6800000000000002 112.048 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 3.5 m -107.44 152.13 24.61 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.428 -0.509 . . . . 1.21 111.314 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.58 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.0 t-80 -155.32 102.92 2.22 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.608 -0.724 . . . . 1.5600000000000001 110.674 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.68 145.67 13.02 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.823 2.349 . . . . 0.81000000000000005 112.627 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.93 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.78 168.0 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.867 -0.606 . . . . 1.52 109.874 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.23 148.02 29.1 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.688 -0.486 . . . . 2.1400000000000001 109.688 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.59 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.34 157.34 44.9 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.615 -0.434 . . . . 0.32000000000000001 111.187 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.503 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.09 155.31 44.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.789 -0.641 . . . . 2.1699999999999999 110.163 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.841 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.62 173.02 6.38 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 121.112 0.482 . . . . 0.58999999999999997 110.741 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.841 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.68 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.913 2.408 . . . . 0.90000000000000002 111.502 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.485 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.07 -51.01 0.69 Allowed Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.719 -0.392 . . . . 3.3399999999999999 110.165 179.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.626 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.85 152.38 82.39 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.757 2.305 . . . . 1.8500000000000001 111.404 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.77 42.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.363 0.601 . . . . 2.54 110.517 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.82 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.62 -41.72 98.25 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.006 -0.997 . . . . 2.5299999999999998 110.634 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.5 mt -109.8 137.85 40.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.741 -0.663 . . . . 1.1699999999999999 111.287 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.93 -72.92 0.7 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.061 -0.518 . . . . 1.27 111.897 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.37 24.44 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.618 0.599 . . . . 1.1200000000000001 112.618 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.87 124.92 45.25 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.331 -0.618 . . . . 0.41999999999999998 109.331 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.11 134.77 60.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.624 -0.43 . . . . 0.78000000000000003 110.551 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.93 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.09 128.57 53.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.064 0.459 . . . . 0.62 111.244 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.04 138.96 49.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.75 -0.659 . . . . 1.97 110.175 179.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.435 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.11 163.23 34.93 Favored 'General case' 0 CA--C 1.523 -0.067 0 CA-C-O 121.194 0.521 . . . . 0.34999999999999998 112.052 -178.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.487 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.52 139.54 7.81 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 115.389 -0.823 . . . . 1.8 110.494 178.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.47 115.49 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.286 1.991 . . . . 0.57999999999999996 111.856 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.681 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.04 81.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.803 -0.443 . . . . 3.04 109.803 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.65 0.06 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.971 -0.559 . . . . 2.4700000000000002 111.942 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 p -157.66 157.72 34.11 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.744 -0.383 . . . . 2.5099999999999998 110.538 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.26 27.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.224 -0.444 . . . . 1.8600000000000001 110.181 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.91 -75.9 1.31 Allowed Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.133 -0.556 . . . . 1.4399999999999999 111.8 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.79 152.24 35.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.895 0.378 . . . . 4.6900000000000004 110.995 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.667 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.21 -169.14 2.54 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.132 -0.486 . . . . 1.4299999999999999 111.882 179.337 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.14 149.58 29.86 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.462 0.649 . . . . 1.74 112.594 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.99 156.37 46.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.794 -1.094 . . . . 1.9199999999999999 110.316 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.09 158.44 41.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.988 -0.551 . . . . 0.34000000000000002 111.87 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.7 m -115.21 135.66 53.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.511 -0.768 . . . . 0.40999999999999998 109.832 179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.59 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.31 121.91 23.87 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.403 -0.362 . . . . 0.55000000000000004 111.554 -179.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.2 Cg_exo -46.39 151.74 1.67 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.636 2.224 . . . . 0.44 112.156 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.85 -23.11 63.03 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 116.029 -0.532 . . . . 0.73999999999999999 112.794 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.537 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.76 -16.89 46.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.375 0.587 . . . . 0.93000000000000005 111.84 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.603 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.53 138.39 31.61 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.803 -0.359 . . . . 0.96999999999999997 110.323 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.5 13.86 11.01 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.406 -0.361 . . . . 1.3400000000000001 111.554 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.476 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.96 143.46 25.24 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.659 -0.416 . . . . 0.39000000000000001 111.057 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.713 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.8 -169.37 1.53 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.019 -0.537 . . . . 0.41999999999999998 110.895 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.713 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 2.0 t -151.77 125.8 9.19 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.366 -0.834 . . . . 0.39000000000000001 109.853 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.511 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.8 mt -114.8 123.4 70.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.28 -0.568 . . . . 0.73999999999999999 111.156 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -126.53 163.4 23.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.831 -0.622 . . . . 2.48 110.423 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.14 18.92 59.98 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.757 -0.937 . . . . 0.5 110.757 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.511 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.0 mt -79.03 157.18 28.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.039 0.447 . . . . 0.57999999999999996 111.314 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.855 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.1 mttm -99.38 133.9 21.63 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.627 -0.715 . . . . 2.79 110.51 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.95 143.58 61.01 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.5 2.133 . . . . 0.87 111.95 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.86 25.7 75.25 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.049 -0.821 . . . . 0.64000000000000001 111.049 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.855 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.2 158.78 40.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.649 0.262 . . . . 0.82999999999999996 110.468 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.2 139.95 42.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.915 0.388 . . . . 0.5 110.579 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.666 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.3 m-85 -122.56 136.42 54.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.936 -0.575 . . . . 0.53000000000000003 110.81 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.487 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.93 131.03 45.32 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.516 -0.92 . . . . 1.8700000000000001 108.516 177.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.46 153.93 16.64 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.2 -1.0 . . . . 0.28999999999999998 111.97 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.98 140.99 46.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.708 -0.478 . . . . 1.4299999999999999 109.708 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.83 118.87 34.22 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.47 -0.492 . . . . 0.32000000000000001 110.523 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.731 HG12 HG23 ' A' ' 84' ' ' VAL . 64.4 mt -112.44 129.14 68.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.289 -0.414 . . . . 0.79000000000000004 110.578 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.7 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.85 120.89 43.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.256 -0.429 . . . . 1.02 110.685 -179.7 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.862 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.59 146.53 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.169 0.509 . . . . 0.62 111.018 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.82 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.08 153.87 21.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.519 -0.764 . . . . 2.4399999999999999 109.935 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.11 88.53 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.909 0.385 . . . . 3.6899999999999999 110.386 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.622 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.67 0.21 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.822 -0.626 . . . . 6.0800000000000001 110.532 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.12 -117.33 3.28 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.394 -0.682 . . . . 1.22 111.394 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.469 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.38 177.41 8.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.165 0.507 . . . . 2.8799999999999999 111.646 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.24 149.55 32.1 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.446 -0.797 . . . . 1.47 110.413 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.14 144.63 38.71 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.444 -0.344 . . . . 2.7000000000000002 110.599 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.731 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.97 135.91 61.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 120.69 -0.404 . . . . 0.46000000000000002 111.607 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.0 141.36 52.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.755 -0.657 . . . . 0.34999999999999998 110.325 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.458 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.73 138.91 51.71 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.181 0.515 . . . . 3.6699999999999999 111.478 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.29 164.1 38.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.47 -0.787 . . . . 0.67000000000000004 109.539 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.563 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.23 151.64 38.72 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.412 -0.515 . . . . 1.47 111.005 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.807 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.3 p90 -146.23 172.74 13.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.688 -0.687 . . . . 0.44 111.092 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.77 160.68 21.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.492 -0.777 . . . . 1.3700000000000001 109.887 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.36 121.96 23.1 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 120.559 -0.456 . . . . 1.28 110.761 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.697 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -130.99 -145.26 0.27 Allowed 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 121.941 0.877 . . . . 1.97 111.478 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.53 ' OG ' HG22 ' A' ' 103' ' ' VAL . 94.9 p -123.08 162.88 21.59 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.191 -1.368 . . . . 3.2799999999999998 107.897 177.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.801 ' O ' HG21 ' A' ' 102' ' ' THR . 27.2 p -74.37 169.01 18.54 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -177.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.669 ' O ' ' O ' ' A' ' 94' ' ' THR . 9.9 t -3.94 -140.84 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -178.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.35 161.91 74.94 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.044 -176.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.727 ' O ' ' O ' ' A' ' 98' ' ' VAL . 21.6 Cg_exo -64.35 -20.66 66.68 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 123.397 2.732 . . . . 0.0 113.155 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.727 ' O ' ' O ' ' A' ' 97' ' ' PRO . 30.4 m -40.92 -135.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.9 m -54.91 -36.77 65.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.029 0.443 . . . . 0.0 110.38 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.487 ' OG ' ' OG1' ' A' ' 94' ' ' THR . 13.5 t -56.38 -30.37 62.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.998 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.712 ' O ' ' OE2' ' A' ' 145' ' ' GLU . 17.6 m120 63.88 55.97 1.54 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.809 -0.356 . . . . 0.0 111.407 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.801 HG21 ' O ' ' A' ' 94' ' ' THR . 43.1 p -116.95 160.39 20.99 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.53 HG22 ' OG ' ' A' ' 93' ' ' SER . 3.4 m -72.76 -30.93 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.693 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 45.8 m -71.74 136.12 47.04 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.388 -178.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -170.09 -173.94 37.86 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -66.94 -21.17 65.99 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.6 p -76.93 156.15 32.25 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.053 0.454 . . . . 0.0 111.169 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.637 ' N ' ' HD2' ' A' ' 109' ' ' PRO . 65.3 m -78.36 -48.31 1.92 Allowed Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.836 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 108' ' ' THR . 10.1 Cg_endo -52.47 143.98 42.79 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.128 1.885 . . . . 0.0 112.846 -178.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.483 ' O ' ' C ' ' A' ' 111' ' ' SER . 49.3 p90 -137.1 168.25 19.96 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.363 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.483 ' C ' ' O ' ' A' ' 110' ' ' PHE . 15.0 m -23.86 91.83 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.498 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.903 -179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.422 ' N ' ' O ' ' A' ' 110' ' ' PHE . 47.0 Cg_exo -54.74 149.04 42.59 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 123.001 2.467 . . . . 0.0 112.469 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.813 ' N ' HD22 ' A' ' 113' ' ' LEU . 1.5 mm? -91.45 142.53 27.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.943 -0.571 . . . . 10.19 110.179 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.0 t -117.01 135.58 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.175 -0.466 . . . . 7.2800000000000002 110.453 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.93 142.92 58.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.384 -0.371 . . . . 7.2999999999999998 110.505 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 57.4 p -70.81 -24.16 62.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 6.4400000000000004 111.187 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.6 m -64.26 153.15 39.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.853 0.359 . . . . 4.4199999999999999 110.998 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.01 141.93 56.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.257 -0.429 . . . . 3.0499999999999998 110.34 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 31.1 t -136.74 145.27 44.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.524 -0.307 . . . . 3.4300000000000002 111.14 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.1 p -130.84 140.83 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 109.446 -0.576 . . . . 2.8799999999999999 109.446 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 20.9 p -126.08 161.64 27.15 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.434 0.635 . . . . 2.0899999999999999 112.222 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.2 -24.37 67.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.884 -1.053 . . . . 4.5300000000000002 110.065 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 124' ' ' THR . 80.9 mt -48.78 152.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.316 -0.856 . . . . 1.4399999999999999 111.444 -177.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.403 ' N ' HG22 ' A' ' 123' ' ' ILE . 18.4 p -116.73 167.07 11.42 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.174 -0.921 . . . . 1.78 110.134 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -56.09 142.91 34.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.44 0.638 . . . . 0.64000000000000001 111.628 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.1 OUTLIER -170.62 23.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 122.746 1.26 . . . . 0.66000000000000003 107.853 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.447 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.78 167.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.005 -1.452 . . . . 0.68999999999999995 111.022 -178.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.6 145.54 50.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.765 -0.652 . . . . 0.52000000000000002 110.14 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.22 101.59 9.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.099 -0.704 . . . . 0.32000000000000001 109.099 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.6 t -112.94 139.7 36.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.071 -0.513 . . . . 0.28999999999999998 111.052 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.3 p -128.62 152.58 48.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.642 -0.708 . . . . 0.25 109.842 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.586 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.4 p90 -144.78 -164.89 2.02 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.736 -0.386 . . . . 0.31 110.708 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.741 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -123.99 127.2 73.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.256 -0.429 . . . . 0.48999999999999999 110.833 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.161 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.99 58.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.075 -0.512 . . . . 1.53 110.332 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.741 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.12 24.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.88 -0.6 . . . . 0.96999999999999997 111.481 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.161 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.2 128.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.619 -0.433 . . . . 1.5600000000000001 110.891 179.782 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.38 -9.7 55.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.896 -0.593 . . . . 1.8799999999999999 110.325 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.07 0.31 55.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.058 -0.519 . . . . 1.04 110.39 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.34 137.17 25.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.919 -0.582 . . . . 0.23999999999999999 109.955 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 185' ' ' ILE . 1.8 m -96.15 -15.51 22.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.313 0.578 . . . . 0.28999999999999998 110.044 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.642 ' H ' HG12 ' A' ' 185' ' ' ILE . . . 178.62 175.63 45.85 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 109.846 -1.301 . . . . 0.13 109.846 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -123.4 151.57 42.47 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.705 -0.398 . . . . 0.17000000000000001 110.504 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.895 HH21 ' N ' ' A' ' 159' ' ' ASP . 1.5 tpm_? -132.39 121.25 23.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.111 -0.495 . . . . 1.29 109.878 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.559 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.06 136.56 38.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.654 -0.703 . . . . 0.25 110.649 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.712 ' OE2' ' O ' ' A' ' 101' ' ' ASN . 85.3 tt0 -129.37 129.9 45.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.016 -0.538 . . . . 1.3200000000000001 110.0 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.613 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.66 135.31 34.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.928 -0.578 . . . . 0.56999999999999995 110.632 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.415 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.29 161.37 39.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.758 -0.655 . . . . 1.1599999999999999 109.688 179.844 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.959 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.06 124.87 25.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.981 0.419 . . . . 0.38 110.72 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.485 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.84 -7.67 49.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.759 -0.655 . . . . 0.40999999999999998 110.886 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.79 -69.74 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.289 -0.414 . . . . 1.6599999999999999 111.429 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.44 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.59 -35.39 75.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.083 -0.508 . . . . 1.6599999999999999 111.441 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.092 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.15 7.24 88.59 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.776 -0.929 . . . . 1.1699999999999999 110.776 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.308 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.4 t0 -27.94 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.759 0.314 . . . . 1.8600000000000001 110.246 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.308 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.32 139.03 44.92 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.947 0.403 . . . . 1.98 110.14 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.48 ' HG2' HG12 ' A' ' 103' ' ' VAL . 47.7 Cg_endo -70.78 145.86 52.37 Favored 'Trans proline' 0 C--N 1.301 -1.952 0 C-N-CA 122.751 2.301 . . . . 0.55000000000000004 112.327 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.88 145.69 42.66 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.223 -0.658 . . . . 1.1399999999999999 109.223 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 143' ' ' ARG . 83.5 m-85 -123.28 141.34 52.09 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.354 -0.539 . . . . 0.93000000000000005 111.54 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.67 ' C ' HH21 ' A' ' 143' ' ' ARG . 70.8 mt -128.09 127.7 43.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.298 -0.865 . . . . 0.34000000000000002 108.935 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.895 ' N ' HH21 ' A' ' 143' ' ' ARG . 55.9 t0 -101.68 131.16 48.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.258 0.551 . . . . 1.0900000000000001 111.661 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.94 157.55 73.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.333 -0.849 . . . . 0.19 109.636 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -69.81 158.02 58.29 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.394 2.063 . . . . 0.17999999999999999 112.238 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.28 -12.12 5.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.806 -0.634 . . . . 0.20999999999999999 110.76 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.8 p -92.8 -8.82 42.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.124 -0.489 . . . . 0.28999999999999998 110.687 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.21 135.31 34.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.383 . . . . 0.5 110.338 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.5 p -133.09 16.75 4.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 0.29999999999999999 110.502 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.9 p -167.64 147.06 4.97 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.627 -0.508 . . . . 0.23000000000000001 109.627 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.559 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.19 150.45 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.398 -0.521 . . . . 0.28000000000000003 111.51 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.28 124.96 50.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.626 -0.716 . . . . 1.0700000000000001 109.81 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.41 104.89 29.78 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.403 -0.362 . . . . 0.28999999999999998 111.094 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.4 Cg_endo -90.98 -179.49 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.872 0 C-N-CA 123.158 2.572 . . . . 0.42999999999999999 112.198 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.75 32.61 18.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.435 -0.802 . . . . 1.26 111.359 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.428 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.1 mt -86.31 148.5 25.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.54 -0.3 . . . . 0.32000000000000001 110.487 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.764 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.5 mt -88.29 114.8 61.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.986 0.422 . . . . 0.57999999999999996 110.636 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.95 140.51 95.61 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.98 2.453 . . . . 0.66000000000000003 111.93 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.03 21.32 74.18 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.025 -0.83 . . . . 0.28999999999999998 111.025 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.44 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.86 150.21 49.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.864 0.364 . . . . 2.3300000000000001 110.589 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.485 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.2 131.65 46.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.993 -0.549 . . . . 0.85999999999999999 109.801 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.959 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.5 m-85 -120.5 148.37 43.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.069 -0.514 . . . . 0.52000000000000002 110.999 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.39 125.27 60.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 108.243 -1.021 . . . . 0.29999999999999999 108.243 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.49 132.59 63.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.211 0.529 . . . . 0.23000000000000001 111.227 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.59 20.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.526 -0.761 . . . . 0.35999999999999999 109.622 179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.586 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -101.07 125.38 55.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.293 -0.412 . . . . 0.19 110.711 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.8 m-85 -117.21 137.92 52.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.967 -0.56 . . . . 0.29999999999999999 109.866 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.582 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.78 135.07 42.8 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.763 -0.829 . . . . 0.37 108.763 178.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.642 HG12 ' H ' ' A' ' 141' ' ' GLY . 0.8 OUTLIER -99.08 122.89 51.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.175 0.512 . . . . 0.26000000000000001 110.938 -178.718 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.6 p -83.84 169.66 14.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.586 -0.734 . . . . 0.28000000000000003 110.408 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.414 ' O ' ' HB ' ' A' ' 59' ' ' THR . 97.0 mt-10 -59.72 -14.52 14.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.959 -0.564 . . . . 1.6000000000000001 111.023 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -96.12 -4.27 43.07 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.779 -0.368 . . . . 1.1799999999999999 110.793 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.84 13.92 63.86 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.346 -0.702 . . . . 0.29999999999999999 111.346 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -84.59 139.09 32.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.574 0.225 . . . . 1.22 110.433 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.577 HE22 ' HG3' ' A' ' 15' ' ' PRO . 83.8 mt-30 -106.82 141.08 38.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.373 . . . . 0.97999999999999998 110.545 179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.8 m -136.74 127.03 26.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.093 -0.503 . . . . 0.82999999999999996 110.374 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.07 117.3 9.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.26000000000000001 110.53 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.07 -21.75 5.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.29999999999999999 110.7 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.92 125.7 5.84 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.489 -0.484 . . . . 0.31 111.514 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.47 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.68 120.2 21.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.685 -0.689 . . . . 0.28000000000000003 109.563 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.6 151.68 29.13 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.692 -0.403 . . . . 0.23999999999999999 110.943 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.43 158.59 18.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 0.23000000000000001 110.409 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.1 157.91 43.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.099 -0.501 . . . . 0.67000000000000004 110.66 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.37 9.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.732 -0.667 . . . . 0.64000000000000001 109.995 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.5 p . . . . . 0 C--O 1.218 -0.555 0 CA-C-O 117.949 -1.024 . . . . 1.26 110.531 -179.673 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.8 m . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.253 -0.647 . . . . 3.4399999999999999 109.253 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.36 150.69 18.54 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.986 -0.846 . . . . 1.22 110.986 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -35.67 142.39 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 123.953 3.102 . . . . 0.75 113.789 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -80.0 173.38 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.282 -1.326 . . . . 0.79000000000000004 108.9 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.608 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.59 125.88 51.49 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.395 -0.522 . . . . 1.9399999999999999 111.413 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.46 144.03 33.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.63 -0.714 . . . . 0.59999999999999998 110.686 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.02 168.36 25.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.947 0.403 . . . . 3.1400000000000001 111.117 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.745 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -109.08 130.94 61.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.983 -0.553 . . . . 3.23 110.013 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.5 p -141.03 162.3 35.81 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.85 0.357 . . . . 3.6299999999999999 111.226 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 9' ' ' THR . 70.6 tt0 36.13 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.624 -0.509 . . . . 6.0800000000000001 109.624 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.745 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.57 33.07 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.968 -0.56 . . . . 3.3799999999999999 111.637 -178.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.22 -29.12 73.32 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.453 2.102 . . . . 3.9300000000000002 111.872 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.55 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 3.3599999999999999 110.422 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 17' ' ' SER . 3.3 mp0 -123.86 158.4 60.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 3.6099999999999999 110.438 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.586 ' N ' ' OG ' ' A' ' 93' ' ' SER . 98.1 Cg_endo -82.13 -64.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.81 2.34 . . . . 1.51 113.592 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.521 ' ND2' ' HB2' ' A' ' 157' ' ' TYR . 72.8 m-20 -108.47 -19.47 13.44 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.107 0.41 . . . . 2.6800000000000002 112.107 -178.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 4.9 p -107.47 152.05 24.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.18 0.514 . . . . 1.21 111.277 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.26 102.89 2.23 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.622 -0.717 . . . . 1.5600000000000001 110.637 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.535 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.7 Cg_endo -82.71 145.66 12.97 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.851 2.368 . . . . 0.81000000000000005 112.595 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.916 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.83 167.99 24.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.833 -0.621 . . . . 1.52 109.864 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -149.17 147.88 28.98 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.781 -0.451 . . . . 2.1400000000000001 109.781 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.583 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.27 157.32 44.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.078 0.466 . . . . 0.32000000000000001 111.177 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.502 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.09 155.23 44.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.766 -0.652 . . . . 2.1699999999999999 110.033 179.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.838 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.58 173.1 6.28 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.037 -0.529 . . . . 0.58999999999999997 110.747 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.838 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.66 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.858 2.372 . . . . 0.90000000000000002 111.548 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.483 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.05 -51.11 0.69 Allowed Pre-proline 0 C--N 1.33 -0.271 0 C-N-CA 120.687 -0.405 . . . . 3.3399999999999999 110.01 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.643 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.4 Cg_exo -64.77 152.35 82.36 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.751 2.301 . . . . 1.8500000000000001 111.484 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.77 42.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.363 0.602 . . . . 2.54 110.581 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.82 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.69 -41.69 98.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.969 -1.014 . . . . 2.5299999999999998 110.55 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.3 mt -109.82 137.91 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.846 -0.615 . . . . 1.1699999999999999 111.258 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.06 -72.96 0.7 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.978 -0.555 . . . . 1.27 111.828 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.19 148.31 24.45 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.583 0.586 . . . . 1.1200000000000001 112.583 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.82 124.92 45.31 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.302 -0.629 . . . . 0.41999999999999998 109.302 177.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 49' ' ' ALA . 72.0 mt -118.09 134.83 60.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.616 -0.434 . . . . 0.78000000000000003 110.604 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.916 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.08 128.56 53.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.62 111.243 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.54 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.11 139.07 49.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.757 -0.656 . . . . 1.97 110.064 179.006 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.437 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.18 163.1 35.41 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 121.176 0.512 . . . . 0.34999999999999998 112.014 -178.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.42 139.62 7.93 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.448 -0.796 . . . . 1.8 110.449 178.852 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.696 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.55 115.5 3.08 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.251 1.968 . . . . 0.57999999999999996 111.85 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.673 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.95 81.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.908 -0.405 . . . . 3.04 109.908 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.696 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.2 -20.73 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.034 -0.53 . . . . 2.4700000000000002 112.03 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.6 p -157.6 157.74 34.24 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.879 -0.328 . . . . 2.5099999999999998 110.599 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.8 m -120.37 27.83 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 1.8600000000000001 110.207 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.83 -75.9 1.31 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.121 -0.562 . . . . 1.4399999999999999 111.886 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.83 152.29 35.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.073 0.463 . . . . 4.6900000000000004 110.919 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.2 -169.14 2.54 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.991 -0.55 . . . . 1.4299999999999999 111.997 179.292 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.09 149.61 29.78 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-O 121.431 0.634 . . . . 1.74 112.684 -177.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.96 156.52 46.05 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 114.809 -1.087 . . . . 1.9199999999999999 110.302 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.2 158.43 41.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.872 -0.604 . . . . 0.34000000000000002 111.785 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.7 m -115.25 135.55 54.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.517 -0.765 . . . . 0.40999999999999998 109.755 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.583 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.4 121.97 23.78 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.433 -0.348 . . . . 0.55000000000000004 111.584 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.593 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.4 Cg_exo -46.28 151.72 1.6 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.73 2.287 . . . . 0.44 112.12 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.93 -23.02 63.09 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-N 116.055 -0.521 . . . . 0.73999999999999999 112.785 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.77 -16.89 46.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.407 0.604 . . . . 0.93000000000000005 111.803 -178.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.593 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.2 mt -91.57 138.41 31.59 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.841 -0.344 . . . . 0.96999999999999997 110.348 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.58 13.91 10.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.364 -0.38 . . . . 1.3400000000000001 111.544 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -149.98 143.46 25.22 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.714 -0.394 . . . . 0.39000000000000001 111.003 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.724 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.8 -169.37 1.53 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.071 -0.513 . . . . 0.41999999999999998 110.942 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.724 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 t -151.81 125.86 9.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.443 -0.799 . . . . 0.39000000000000001 109.816 179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.519 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.86 123.4 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.312 -0.555 . . . . 0.73999999999999999 111.195 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.694 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 63.1 pttt -126.63 163.37 23.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.782 -0.644 . . . . 2.48 110.402 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.12 19.03 59.8 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.733 -0.947 . . . . 0.5 110.733 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.519 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.3 mt -78.97 157.18 28.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.045 0.45 . . . . 0.57999999999999996 111.378 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.844 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -99.48 133.87 21.6 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.62 -0.718 . . . . 2.79 110.486 179.737 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.8 143.5 61.54 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.594 2.196 . . . . 0.87 111.988 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.93 25.59 75.4 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.034 -0.826 . . . . 0.64000000000000001 111.034 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.18 158.74 40.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.73 0.3 . . . . 0.82999999999999996 110.409 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.12 139.97 41.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.926 0.394 . . . . 0.5 110.522 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.647 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.8 m-85 -122.59 136.43 54.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.986 -0.552 . . . . 0.53000000000000003 110.757 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.91 131.01 45.31 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.463 -0.94 . . . . 1.8700000000000001 108.463 177.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.494 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.43 153.9 16.63 Favored Glycine 0 C--O 1.228 -0.269 0 C-N-CA 120.357 -0.925 . . . . 0.28999999999999998 111.968 -178.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.08 140.85 45.85 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.723 -0.473 . . . . 1.4299999999999999 109.723 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.2 tp -115.7 118.93 34.43 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.483 -0.487 . . . . 0.32000000000000001 110.573 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.732 HG12 HG23 ' A' ' 84' ' ' VAL . 64.2 mt -112.55 129.09 68.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.409 . . . . 0.79000000000000004 110.603 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.701 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.78 120.74 43.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.259 -0.428 . . . . 1.02 110.739 -179.599 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.855 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.58 146.5 11.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.098 0.475 . . . . 0.62 111.058 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.82 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.11 153.91 21.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.505 -0.771 . . . . 2.4399999999999999 109.835 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.18 88.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.928 0.395 . . . . 3.6899999999999999 110.381 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.622 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.29 32.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.859 -0.609 . . . . 6.0800000000000001 110.549 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.09 -117.36 3.29 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.43 -0.668 . . . . 1.22 111.43 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.459 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.29 177.41 9.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.182 0.515 . . . . 2.8799999999999999 111.638 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.27 149.5 31.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.466 -0.788 . . . . 1.47 110.425 179.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.21 144.67 38.61 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.482 -0.326 . . . . 2.7000000000000002 110.576 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.732 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.02 136.0 61.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 121.139 0.495 . . . . 0.46000000000000002 111.499 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.574 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.09 141.45 52.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.622 -0.717 . . . . 0.34999999999999998 110.248 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.457 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.75 138.91 51.72 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 120.492 -0.483 . . . . 3.6699999999999999 111.438 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.494 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.28 164.18 37.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.545 -0.752 . . . . 0.67000000000000004 109.521 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.27 151.54 38.52 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.327 -0.549 . . . . 1.47 111.009 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.797 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.2 172.75 12.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.743 -0.662 . . . . 0.44 111.033 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.77 160.7 21.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.459 -0.791 . . . . 1.3700000000000001 109.806 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.34 121.91 23.05 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.54 -0.464 . . . . 1.28 110.749 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.512 ' O ' ' OG ' ' A' ' 93' ' ' SER . 70.3 p -128.92 -114.48 0.26 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.392 0.886 . . . . 1.97 113.392 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.586 ' OG ' ' N ' ' A' ' 15' ' ' PRO . 48.0 p 72.39 63.87 0.12 Allowed 'General case' 0 C--N 1.343 0.317 0 CA-C-N 114.956 -1.02 . . . . 3.2799999999999998 110.789 -178.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.6 p -120.16 165.54 14.63 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.823 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.5 m -56.34 -33.6 65.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.062 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 58.7 p -124.5 77.36 62.86 Favored Pre-proline 0 N--CA 1.466 0.354 0 CA-C-O 120.507 0.194 . . . . 0.0 110.828 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.62 147.27 88.04 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.612 2.208 . . . . 0.0 112.138 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.7 m -68.23 -27.95 38.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.2 m -57.61 -36.9 72.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.935 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.2 t 62.83 12.6 5.86 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.665 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -104.04 143.85 32.34 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.723 0.297 . . . . 0.0 110.297 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.2 t -133.86 160.01 38.93 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.433 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.668 HG22 ' H ' ' A' ' 105' ' ' GLY . 11.7 p -130.01 143.53 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.497 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 56.2 p -67.81 -9.45 44.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.371 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.668 ' H ' HG22 ' A' ' 103' ' ' VAL . . . -51.98 -32.33 34.37 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -58.01 142.8 45.49 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.551 -0.459 . . . . 0.0 109.888 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.5 p -123.24 160.9 25.62 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.084 0.469 . . . . 0.0 111.221 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.613 ' O ' ' CD2' ' A' ' 110' ' ' PHE . 25.0 m -126.65 78.88 72.32 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.783 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.6 -23.06 69.71 Favored 'Trans proline' 0 N--CA 1.499 1.794 0 C-N-CA 122.335 2.024 . . . . 0.0 113.303 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.613 ' CD2' ' O ' ' A' ' 108' ' ' THR . 94.3 m-85 62.78 31.45 16.49 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 80.0 p -123.44 75.61 53.43 Favored Pre-proline 0 N--CA 1.465 0.31 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.127 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.479 ' O ' ' N ' ' A' ' 114' ' ' VAL . 63.9 Cg_endo -75.62 -57.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.376 2.05 . . . . 0.0 111.691 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.5 mt 38.16 26.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.975 -0.557 . . . . 10.19 111.425 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 112' ' ' PRO . 31.3 m -67.34 134.69 29.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 7.2800000000000002 110.593 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.72 144.2 32.8 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.12 -0.491 . . . . 7.2999999999999998 110.586 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 118' ' ' GLU . 40.0 m -122.59 139.27 54.1 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.298 -0.41 . . . . 6.4400000000000004 110.153 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 119' ' ' SER . 23.2 m -59.02 -36.53 75.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.376 0.509 . . . . 4.4199999999999999 112.376 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 117' ' ' SER . 96.7 mt-10 30.29 35.32 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 111.953 0.353 . . . . 3.0499999999999998 111.953 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 117' ' ' SER . 22.3 m -57.4 -37.3 72.5 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.617 -0.433 . . . . 3.4300000000000002 110.516 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.9 t -123.16 134.13 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 109.539 -0.541 . . . . 2.8799999999999999 109.539 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.9 m -58.93 -41.22 86.83 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.655 -0.418 . . . . 2.0899999999999999 111.018 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -127.05 151.08 49.08 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.491 -0.322 . . . . 4.5300000000000002 111.036 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 71.5 mt -116.77 132.0 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.709 -0.478 . . . . 1.4399999999999999 109.709 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 42.8 m -58.98 -40.2 84.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.275 -0.42 . . . . 1.78 111.663 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -106.8 144.9 32.78 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.888 0.375 . . . . 0.64000000000000001 111.266 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.3 p -62.89 -28.4 70.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.422 0.629 . . . . 0.66000000000000003 109.672 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.439 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.77 167.57 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.427 -0.806 . . . . 0.68999999999999995 110.983 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.65 145.47 50.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.809 -0.632 . . . . 0.52000000000000002 110.133 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.9 t -124.19 101.44 9.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.165 -0.68 . . . . 0.32000000000000001 109.165 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.5 t -112.87 139.71 36.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.094 -0.503 . . . . 0.28999999999999998 111.09 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 p -128.69 152.59 48.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.59 -0.732 . . . . 0.25 109.75 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.585 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.84 -164.88 2.02 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.641 -0.423 . . . . 0.31 110.675 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.737 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -123.98 127.22 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.24 -0.436 . . . . 0.48999999999999999 110.82 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.169 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -58.06 58.4 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.123 -0.49 . . . . 1.53 110.368 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.737 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.17 24.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.809 -0.632 . . . . 0.96999999999999997 111.437 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.169 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.14 128.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.646 -0.422 . . . . 1.5600000000000001 111.036 179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.41 -9.59 56.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.935 -0.575 . . . . 1.8799999999999999 110.295 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.22 0.38 55.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 1.04 110.286 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.22 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.029 -0.532 . . . . 0.23999999999999999 109.938 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.694 ' O ' ' NZ ' ' A' ' 61' ' ' LYS . 70.5 m -96.24 -15.58 21.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.256 0.55 . . . . 0.28999999999999998 110.022 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.62 175.61 45.83 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 109.858 -1.297 . . . . 0.13 109.858 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.49 151.61 42.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.961 0.41 . . . . 0.17000000000000001 110.426 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.75 HH12 ' NE2' ' A' ' 191' ' ' GLN . 50.8 ttp180 -132.31 121.16 23.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.119 -0.491 . . . . 1.29 109.918 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.563 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.05 136.49 38.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.761 -0.654 . . . . 0.25 110.693 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.525 ' HG2' ' CD2' ' A' ' 157' ' ' TYR . 94.4 mt-10 -129.36 129.86 45.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.06 -0.518 . . . . 1.3200000000000001 110.056 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.613 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.67 135.27 34.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.987 -0.552 . . . . 0.56999999999999995 110.622 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.407 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.28 161.34 39.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.751 -0.659 . . . . 1.1599999999999999 109.665 179.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.967 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.5 mt -70.92 124.76 25.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.975 0.417 . . . . 0.38 110.735 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.486 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.7 p -71.71 -7.79 50.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.768 -0.651 . . . . 0.40999999999999998 110.833 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -109.81 -69.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.295 -0.411 . . . . 1.6599999999999999 111.332 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.429 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.64 -35.39 76.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.106 -0.497 . . . . 1.6599999999999999 111.469 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.074 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.1 7.23 88.59 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.853 -0.899 . . . . 1.1699999999999999 110.853 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.331 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.89 -171.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.753 0.311 . . . . 1.8600000000000001 110.365 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.331 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.23 139.11 45.24 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.965 0.412 . . . . 1.98 110.23 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.419 ' HG2' ' OH ' ' A' ' 157' ' ' TYR . 46.4 Cg_endo -70.94 145.76 51.17 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.762 2.308 . . . . 0.55000000000000004 112.332 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.77 145.76 42.52 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.24 -0.652 . . . . 1.1399999999999999 109.24 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.702 ' N ' ' CD1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -123.37 141.3 52.13 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.312 -0.555 . . . . 0.93000000000000005 111.5 -179.048 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.3 mt -128.04 127.67 43.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.333 -0.848 . . . . 0.34000000000000002 109.016 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -101.73 131.21 48.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.15 0.5 . . . . 1.0900000000000001 111.708 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.94 157.64 73.15 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.273 -0.876 . . . . 0.19 109.54 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.9 157.99 58.27 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.376 2.051 . . . . 0.17999999999999999 112.282 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.3 -12.1 5.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 0.20999999999999999 110.743 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.1 p -92.83 -8.75 42.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.28999999999999998 110.722 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.15 135.33 34.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.306 -0.406 . . . . 0.5 110.428 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 p -133.17 16.75 4.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.478 -0.328 . . . . 0.29999999999999999 110.506 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.9 p -167.57 147.09 5.05 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.598 -0.519 . . . . 0.23000000000000001 109.598 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.563 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.14 150.48 12.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.508 -0.477 . . . . 0.28000000000000003 111.589 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.501 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 124.97 50.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.596 -0.729 . . . . 1.0700000000000001 109.78 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.46 104.86 29.79 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.872 0.368 . . . . 0.28999999999999998 111.025 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.2 Cg_endo -90.96 -179.53 1.51 Allowed 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 123.216 2.611 . . . . 0.42999999999999999 112.203 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 61.7 32.66 18.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.374 -0.83 . . . . 1.26 111.403 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 172' ' ' LEU . 24.1 mt -86.42 148.52 25.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.444 -0.343 . . . . 0.32000000000000001 110.471 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.774 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.8 mt -88.28 114.96 61.75 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.06 0.457 . . . . 0.57999999999999996 110.677 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.14 140.6 95.71 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.824 2.349 . . . . 0.66000000000000003 112.026 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.23 74.23 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.046 -0.822 . . . . 0.28999999999999998 111.046 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.429 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.91 150.22 49.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.803 0.335 . . . . 2.3300000000000001 110.641 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.486 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.2 131.63 46.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.008 -0.542 . . . . 0.85999999999999999 109.756 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.967 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.2 m-85 -120.5 148.27 44.05 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.105 -0.498 . . . . 0.52000000000000002 111.062 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.7 mt -105.36 125.38 60.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.194 -1.039 . . . . 0.29999999999999999 108.194 177.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.54 132.52 63.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.172 0.511 . . . . 0.23000000000000001 111.3 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.47 122.62 20.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.549 -0.751 . . . . 0.35999999999999999 109.613 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.585 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.1 125.35 55.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.268 -0.424 . . . . 0.19 110.622 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.28 137.91 52.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.946 -0.57 . . . . 0.29999999999999999 109.84 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.58 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.63 135.07 42.65 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.745 -0.835 . . . . 0.37 108.745 178.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.573 ' O ' ' N ' ' A' ' 140' ' ' SER . 47.2 mm -99.1 122.93 51.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.155 0.502 . . . . 0.26000000000000001 110.969 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.5 p -83.91 169.59 14.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.591 -0.731 . . . . 0.28000000000000003 110.496 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -59.62 -14.56 14.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.046 -0.524 . . . . 1.6000000000000001 110.966 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.535 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.6 m-20 -96.13 -4.29 43.01 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.905 -0.318 . . . . 1.1799999999999999 110.749 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.86 13.78 64.06 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.389 -0.684 . . . . 0.29999999999999999 111.389 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -84.59 139.01 32.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.625 0.25 . . . . 1.22 110.415 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.75 ' NE2' HH12 ' A' ' 143' ' ' ARG . 3.3 mt-30 -106.68 141.15 38.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.339 . . . . 0.97999999999999998 110.565 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 61.9 m -136.72 127.04 26.49 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.216 -0.447 . . . . 0.82999999999999996 110.383 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.14 117.43 9.96 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.699 -0.401 . . . . 0.26000000000000001 110.519 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.1 -21.73 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.29999999999999999 110.767 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.98 125.72 5.81 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.422 -0.511 . . . . 0.31 111.448 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.475 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.69 120.2 21.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.787 -0.642 . . . . 0.28000000000000003 109.601 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.62 151.68 29.1 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.757 -0.377 . . . . 0.23999999999999999 110.916 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.5 158.56 18.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.002 -0.545 . . . . 0.23000000000000001 110.438 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.02 157.89 43.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.119 -0.491 . . . . 0.67000000000000004 110.609 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.29 104.39 9.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.779 -0.646 . . . . 0.64000000000000001 110.069 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.99 -1.005 . . . . 1.26 110.56 -179.578 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.208 -0.664 . . . . 3.4399999999999999 109.208 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.69 18.54 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.032 -0.827 . . . . 1.22 111.032 179.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -35.66 142.4 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.042 0 C-N-CA 123.97 3.113 . . . . 0.75 113.826 -179.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.0 t -79.98 173.33 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.308 -1.315 . . . . 0.79000000000000004 108.846 178.431 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.614 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.55 125.87 51.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.435 -0.506 . . . . 1.9399999999999999 111.393 -179.538 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 144.01 33.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.628 -0.715 . . . . 0.59999999999999998 110.564 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.98 168.4 25.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.319 -0.401 . . . . 3.1400000000000001 111.131 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.746 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -109.06 131.1 60.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.98 -0.554 . . . . 3.23 110.048 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.14 162.25 35.94 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.442 -0.345 . . . . 3.6299999999999999 111.284 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.4 mt-10 36.21 31.51 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 109.607 -0.516 . . . . 6.0800000000000001 109.607 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.746 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.58 32.55 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.019 -0.537 . . . . 3.3799999999999999 111.558 -178.737 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.637 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.29 -29.14 72.69 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.494 2.129 . . . . 3.9300000000000002 111.854 179.395 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.637 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.65 125.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.016 -0.538 . . . . 3.3599999999999999 110.502 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.613 ' NE2' ' N ' ' A' ' 14' ' ' GLN . 0.8 OUTLIER -123.91 158.33 60.43 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.368 -0.378 . . . . 3.6099999999999999 110.486 179.995 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.512 ' HG2' HE22 ' A' ' 191' ' ' GLN . 97.6 Cg_endo -82.11 -64.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.808 2.339 . . . . 1.51 113.446 -178.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.657 HD22 ' NZ ' ' A' ' 61' ' ' LYS . 52.9 t30 -108.42 -19.54 13.42 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.087 0.403 . . . . 2.6800000000000002 112.087 -178.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 27.2 m -107.33 152.07 24.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.214 0.531 . . . . 1.21 111.256 -179.411 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.575 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.0 t-80 -155.22 102.91 2.24 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.705 -0.68 . . . . 1.5600000000000001 110.66 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.5 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.4 Cg_endo -82.6 145.59 13.12 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.882 2.388 . . . . 0.81000000000000005 112.676 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.933 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.77 167.99 24.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 1.52 109.982 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.14 147.95 29.07 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.75 -0.463 . . . . 2.1400000000000001 109.75 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.27 157.28 45.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.017 0.437 . . . . 0.32000000000000001 111.242 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.497 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.8 m-20 -127.96 155.3 44.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.786 -0.643 . . . . 2.1699999999999999 110.132 178.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.835 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.66 173.06 6.33 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 121.14 0.495 . . . . 0.58999999999999997 110.666 -179.214 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.835 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.66 173.88 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.882 2.388 . . . . 0.90000000000000002 111.506 179.338 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.06 -50.93 0.69 Allowed Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 120.717 -0.393 . . . . 3.3399999999999999 110.134 179.902 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.62 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.8 Cg_exo -64.96 152.43 82.35 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.697 2.264 . . . . 1.8500000000000001 111.451 179.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.77 42.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.385 0.612 . . . . 2.54 110.518 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.813 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.67 -41.68 98.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.02 -0.991 . . . . 2.5299999999999998 110.722 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.533 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.5 mt -109.78 137.86 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.723 -0.672 . . . . 1.1699999999999999 111.311 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.98 -72.82 0.71 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.013 -0.54 . . . . 1.27 111.92 -178.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.23 148.4 24.37 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.593 0.59 . . . . 1.1200000000000001 112.593 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.85 124.74 44.84 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.413 -0.588 . . . . 0.41999999999999998 109.413 177.514 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 mt -117.88 134.72 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.666 -0.414 . . . . 0.78000000000000003 110.701 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.933 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.02 128.55 53.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 0.62 111.228 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.15 138.99 49.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.708 -0.678 . . . . 1.97 110.11 178.974 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -144.99 163.23 34.83 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.152 0.501 . . . . 0.34999999999999998 112.066 -178.081 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.488 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.59 139.65 7.81 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.435 -0.802 . . . . 1.8 110.397 178.808 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.66 115.54 3.12 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.284 1.989 . . . . 0.57999999999999996 111.793 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.683 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.03 81.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.899 -0.408 . . . . 3.04 109.899 -179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.688 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.22 -20.54 0.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.969 -0.56 . . . . 2.4700000000000002 111.9 -179.526 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 p -157.65 157.69 34.05 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 120.855 -0.338 . . . . 2.5099999999999998 110.569 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.403 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.3 27.79 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.249 -0.432 . . . . 1.8600000000000001 110.223 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.79 -75.91 1.31 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.184 -0.531 . . . . 1.4399999999999999 111.831 -179.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.93 152.31 35.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.981 0.419 . . . . 4.6900000000000004 110.939 -179.285 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.669 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.2 -169.14 2.54 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.001 -0.545 . . . . 1.4299999999999999 111.873 179.415 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.6 mttp -110.13 149.66 29.74 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.48 0.657 . . . . 1.74 112.568 -177.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.01 156.42 46.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.757 -1.111 . . . . 1.9199999999999999 110.325 178.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.21 158.27 41.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.978 -0.555 . . . . 0.34000000000000002 111.788 -179.296 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.8 m -115.07 135.58 54.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.502 -0.772 . . . . 0.40999999999999998 109.889 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.596 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.33 121.96 23.86 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.422 -0.353 . . . . 0.55000000000000004 111.588 -179.171 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.607 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.3 Cg_exo -46.29 151.7 1.62 Allowed 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.706 2.271 . . . . 0.44 112.181 178.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.01 -23.02 63.28 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 116.133 -0.485 . . . . 0.73999999999999999 112.708 -179.107 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.78 -16.79 46.49 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.223 -0.591 . . . . 0.93000000000000005 111.854 -178.341 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.607 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.6 138.45 31.56 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.779 -0.368 . . . . 0.96999999999999997 110.321 179.338 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.54 13.79 10.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.433 -0.349 . . . . 1.3400000000000001 111.475 -179.285 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.477 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.91 143.56 25.35 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.591 -0.444 . . . . 0.39000000000000001 111.003 179.633 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.4 t80 -114.88 -169.41 1.54 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.127 0.489 . . . . 0.41999999999999998 110.904 -179.455 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.714 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.74 125.85 9.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.408 -0.815 . . . . 0.39000000000000001 109.805 179.288 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.515 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.77 123.21 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.415 -0.514 . . . . 0.73999999999999999 111.268 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.657 ' NZ ' HD22 ' A' ' 16' ' ' ASN . 50.4 tttp -126.5 163.4 23.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.884 -0.598 . . . . 2.48 110.431 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.648 ' H ' ' ND2' ' A' ' 16' ' ' ASN . . . 85.15 19.02 59.78 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.737 -0.945 . . . . 0.5 110.737 -179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.515 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.5 mt -79.09 157.18 28.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.077 0.465 . . . . 0.57999999999999996 111.327 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.844 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -99.41 134.05 21.5 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.525 -0.762 . . . . 2.79 110.49 179.722 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.587 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -68.03 143.66 60.89 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.463 2.109 . . . . 0.87 111.908 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.79 25.64 75.32 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.031 -0.828 . . . . 0.64000000000000001 111.031 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.15 158.8 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.735 0.302 . . . . 0.82999999999999996 110.369 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.09 139.94 41.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.333 -0.394 . . . . 0.5 110.565 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.648 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.58 136.46 54.89 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.954 -0.566 . . . . 0.53000000000000003 110.82 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.98 131.06 45.32 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.481 -0.933 . . . . 1.8700000000000001 108.481 177.67 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.5 153.87 16.65 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.221 -0.99 . . . . 0.28999999999999998 111.935 -178.566 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.93 140.94 46.14 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.648 -0.501 . . . . 1.4299999999999999 109.648 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.2 tp -115.79 118.86 34.21 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.488 -0.485 . . . . 0.32000000000000001 110.524 179.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 84' ' ' VAL . 63.8 mt -112.4 129.08 68.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 0.79000000000000004 110.66 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.703 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.82 120.89 43.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.261 -0.427 . . . . 1.02 110.701 -179.649 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.857 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.55 146.44 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.184 0.516 . . . . 0.62 111.001 -179.284 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.813 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.06 153.82 21.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.499 -0.773 . . . . 2.4399999999999999 109.974 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.23 88.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.959 0.409 . . . . 3.6899999999999999 110.433 -179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.43 32.56 0.23 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.74 -0.664 . . . . 6.0800000000000001 110.604 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.16 -117.33 3.28 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.443 -0.663 . . . . 1.22 111.443 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.468 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.48 177.42 8.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.157 0.503 . . . . 2.8799999999999999 111.655 -179.131 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.17 149.59 32.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.468 -0.787 . . . . 1.47 110.35 179.181 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.2 144.62 38.59 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.386 -0.37 . . . . 2.7000000000000002 110.527 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.727 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.94 136.01 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 121.032 0.444 . . . . 0.46000000000000002 111.617 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.1 141.35 52.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.634 -0.712 . . . . 0.34999999999999998 110.285 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.471 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.62 138.87 51.67 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.085 0.469 . . . . 3.6699999999999999 111.535 -179.354 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.28 164.15 38.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.524 -0.762 . . . . 0.67000000000000004 109.53 179.371 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.565 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.22 151.52 38.53 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.411 -0.516 . . . . 1.47 111.049 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.807 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.2 p90 -146.19 172.73 13.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.781 -0.645 . . . . 0.44 111.053 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.73 160.67 21.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.414 -0.812 . . . . 1.3700000000000001 109.841 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.47 121.9 22.88 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.563 -0.455 . . . . 1.28 110.768 179.927 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.413 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -128.28 151.03 49.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.051 -0.522 . . . . 1.97 111.421 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.8 t -65.0 -43.19 93.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.357 0.599 . . . . 3.2799999999999998 110.337 177.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.7 p -130.62 165.15 23.42 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.06 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.0 t -58.91 -36.72 75.19 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.503 -0.479 . . . . 0.0 109.917 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 48.9 p -129.99 77.15 77.1 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.281 179.429 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -58.14 143.89 96.04 Favored 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.905 2.403 . . . . 0.0 113.37 -178.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.472 ' O ' ' ND2' ' A' ' 101' ' ' ASN . 19.9 m -113.25 14.2 8.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.643 178.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.417 HG23 ' N ' ' A' ' 100' ' ' SER . 8.7 t -56.04 -38.79 71.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.506 -179.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.417 ' N ' HG23 ' A' ' 99' ' ' THR . 91.9 p -58.88 -30.24 67.6 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.366 -179.319 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.472 ' ND2' ' O ' ' A' ' 98' ' ' VAL . 18.4 m120 56.63 43.79 24.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.825 179.105 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.447 HG23 ' N ' ' A' ' 103' ' ' VAL . 10.2 t -58.67 -39.75 81.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.79 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.447 ' N ' HG23 ' A' ' 102' ' ' THR . 77.5 t -60.51 -38.12 77.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.851 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 38.8 m -72.71 138.16 46.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.024 0.44 . . . . 0.0 111.059 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 96.5 -2.62 62.88 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -68.75 -23.31 64.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.999 0.428 . . . . 0.0 110.492 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 30.1 p -79.98 160.62 25.85 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.116 -179.429 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.418 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 90.8 m -52.15 -45.57 93.86 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.163 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 108' ' ' THR . 58.2 Cg_exo -50.76 142.96 30.96 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 121.719 1.612 . . . . 0.0 112.689 -179.228 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.423 ' CD2' ' O ' ' A' ' 111' ' ' SER . 68.0 t80 -101.47 135.49 42.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.06 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.423 ' O ' ' CD2' ' A' ' 110' ' ' PHE . 5.2 t -59.45 147.37 76.92 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 120.936 -0.305 . . . . 0.0 110.52 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.7 146.66 34.12 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.264 1.976 . . . . 0.0 113.003 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 70.8 mt -60.01 -33.31 71.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.478 -0.783 . . . . 10.19 110.73 179.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.583 ' O ' ' CB ' ' A' ' 115' ' ' ALA . 45.9 t -107.9 135.38 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.267 -0.424 . . . . 7.2800000000000002 110.931 -178.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 114' ' ' VAL . . . 114.0 -29.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.326 1.016 . . . . 7.2999999999999998 109.698 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.2 p -73.3 -15.51 61.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.853 -0.612 . . . . 6.4400000000000004 110.641 179.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.9 m -60.75 155.25 19.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.111 -0.495 . . . . 4.4199999999999999 111.156 -179.046 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -61.89 -32.22 72.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.641 -0.708 . . . . 3.0499999999999998 111.357 -179.503 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 31.8 t -112.67 139.85 47.93 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.985 0.421 . . . . 3.4300000000000002 110.967 -179.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 40.4 t -123.47 138.58 52.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.499 -0.773 . . . . 2.8799999999999999 110.436 -179.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 24.6 p -77.23 161.2 28.34 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.538 -0.541 . . . . 2.0899999999999999 109.538 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -85.31 124.38 31.86 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.347 -0.541 . . . . 4.5300000000000002 111.246 -178.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.496 HG22 ' HB3' ' A' ' 125' ' ' ALA . 76.6 mt -68.97 -30.36 46.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.663 -0.699 . . . . 1.4399999999999999 110.153 178.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 43.5 p 49.46 42.28 22.28 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.771 -0.649 . . . . 1.78 110.598 -178.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.496 ' HB3' HG22 ' A' ' 123' ' ' ILE . . . -151.35 165.68 33.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.928 -0.578 . . . . 0.64000000000000001 110.755 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.3 OUTLIER 54.32 19.26 2.17 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.878 -0.601 . . . . 0.66000000000000003 112.286 178.883 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.441 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.9 167.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.064 -0.516 . . . . 0.68999999999999995 110.931 179.124 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.66 145.52 50.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.772 -0.649 . . . . 0.52000000000000002 110.111 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.29 101.62 9.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.087 -0.708 . . . . 0.32000000000000001 109.087 177.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.4 t -112.85 139.67 36.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.015 -0.538 . . . . 0.28999999999999998 111.129 -178.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.4 p -128.72 152.49 48.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.692 -0.685 . . . . 0.25 109.852 179.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.72 -164.84 2.01 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.705 -0.398 . . . . 0.31 110.678 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.734 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.3 t -124.01 127.17 73.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 0.48999999999999999 110.799 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.172 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.95 58.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.138 -0.483 . . . . 1.53 110.283 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.07 24.4 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.003 -0.544 . . . . 0.96999999999999997 111.442 -179.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.172 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.2 128.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.688 -0.405 . . . . 1.5600000000000001 111.002 179.823 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -86.41 -9.6 55.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.885 -0.598 . . . . 1.8799999999999999 110.294 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.15 0.25 55.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.471 . . . . 1.04 110.351 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.22 137.3 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.943 -0.571 . . . . 0.23999999999999999 109.955 179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.61 ' N ' ' O ' ' A' ' 185' ' ' ILE . 69.3 m -96.38 -15.51 21.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.336 0.588 . . . . 0.28999999999999998 110.011 -179.65 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.55 175.56 45.74 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 109.847 -1.301 . . . . 0.13 109.847 179.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.43 151.65 42.44 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.601 -0.439 . . . . 0.17000000000000001 110.488 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.495 ' NH2' ' CD2' ' A' ' 183' ' ' TYR . 68.8 ttp85 -132.37 121.13 23.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.175 -0.466 . . . . 1.29 109.87 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.554 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.03 136.61 38.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.678 -0.692 . . . . 0.25 110.687 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 83.3 tt0 -129.37 129.95 45.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.942 -0.572 . . . . 1.3200000000000001 110.031 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.62 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.9 p90 -138.77 135.26 34.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.998 -0.547 . . . . 0.56999999999999995 110.582 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.418 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.32 161.4 39.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.769 -0.65 . . . . 1.1599999999999999 109.638 179.804 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.969 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.05 124.79 25.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.99 0.424 . . . . 0.38 110.666 -179.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.74 -7.65 49.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.756 -0.656 . . . . 0.40999999999999998 110.909 -179.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.9 -69.71 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.301 -0.409 . . . . 1.6599999999999999 111.357 -179.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.472 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.65 -35.35 76.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.083 -0.508 . . . . 1.6599999999999999 111.471 -179.09 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.076 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.12 88.67 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.771 -0.932 . . . . 1.1699999999999999 110.771 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.324 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.9 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.74 0.305 . . . . 1.8600000000000001 110.334 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.324 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.35 139.11 44.85 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.01 0.433 . . . . 1.98 110.165 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.418 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.5 Cg_endo -70.97 145.89 51.34 Favored 'Trans proline' 0 C--N 1.301 -1.936 0 C-N-CA 122.601 2.201 . . . . 0.55000000000000004 112.365 -179.472 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.89 145.67 42.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.147 -0.686 . . . . 1.1399999999999999 109.147 179.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.587 ' CE1' ' CD ' ' A' ' 65' ' ' PRO . 11.5 p90 -123.2 141.41 52.0 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.363 -0.535 . . . . 0.93000000000000005 111.6 -179.2 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.14 127.61 43.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.326 -0.852 . . . . 0.34000000000000002 108.911 179.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.593 ' OD2' ' ND2' ' A' ' 16' ' ' ASN . 66.9 m-20 -101.59 131.23 47.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.143 0.497 . . . . 1.0900000000000001 111.781 -178.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -128.03 157.52 73.71 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.324 -0.853 . . . . 0.19 109.477 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -69.78 158.05 58.25 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.433 2.089 . . . . 0.17999999999999999 112.218 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.417 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.33 -12.14 5.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.824 -0.626 . . . . 0.20999999999999999 110.698 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.1 p -92.8 -8.8 42.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.28999999999999998 110.742 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.39 34.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.5 110.433 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.7 p -133.14 16.68 4.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.413 -0.358 . . . . 0.29999999999999999 110.483 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.58 147.09 5.04 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.658 -0.497 . . . . 0.23000000000000001 109.658 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.554 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.14 150.49 12.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.515 -0.474 . . . . 0.28000000000000003 111.588 -179.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 125.0 50.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.667 -0.697 . . . . 1.0700000000000001 109.761 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.6 105.01 31.17 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.985 0.422 . . . . 0.28999999999999998 110.999 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.0 Cg_endo -91.03 -179.51 1.48 Allowed 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 123.158 2.572 . . . . 0.42999999999999999 112.174 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.69 32.64 18.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.428 -0.805 . . . . 1.26 111.443 179.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.443 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.0 mt -86.34 148.47 25.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.47 -0.332 . . . . 0.32000000000000001 110.487 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.773 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.14 114.91 61.45 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.982 0.42 . . . . 0.57999999999999996 110.666 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.1 140.61 95.89 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.901 2.401 . . . . 0.66000000000000003 111.971 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.1 21.12 74.47 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.072 -0.811 . . . . 0.28999999999999998 111.072 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.472 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.79 150.24 49.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.849 0.357 . . . . 2.3300000000000001 110.641 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.3 131.69 46.09 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.062 -0.517 . . . . 0.85999999999999999 109.755 179.335 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.969 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.6 m-85 -120.61 148.36 44.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.07 -0.514 . . . . 0.52000000000000002 110.94 -179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.39 125.41 60.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.255 -1.017 . . . . 0.29999999999999999 108.255 177.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.53 132.53 63.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.084 0.469 . . . . 0.23000000000000001 111.251 -178.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.9 m-20 -136.47 122.54 20.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.604 -0.725 . . . . 0.35999999999999999 109.669 179.297 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.02 125.41 54.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.281 -0.418 . . . . 0.19 110.682 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.2 m-85 -117.23 137.8 52.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.999 -0.546 . . . . 0.29999999999999999 109.9 179.538 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.585 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.64 135.01 42.74 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.853 -0.795 . . . . 0.37 108.853 178.816 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.61 ' O ' ' N ' ' A' ' 140' ' ' SER . 81.3 mt -99.12 122.94 51.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.212 0.53 . . . . 0.26000000000000001 110.909 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.7 p -83.87 169.72 14.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.512 -0.767 . . . . 0.28000000000000003 110.501 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 187' ' ' GLU . 49.5 tp10 -59.74 -14.59 15.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.01 -0.541 . . . . 1.6000000000000001 110.902 -179.563 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.55 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.8 m-20 -96.06 -4.27 43.3 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.836 -0.346 . . . . 1.1799999999999999 110.809 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.82 13.89 63.94 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.346 -0.701 . . . . 0.29999999999999999 111.346 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -84.73 139.1 32.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.67 0.271 . . . . 1.22 110.437 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.512 HE22 ' HG2' ' A' ' 15' ' ' PRO . 87.1 mt-30 -106.75 141.08 38.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.361 . . . . 0.97999999999999998 110.551 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.0 m -136.72 127.05 26.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 0.82999999999999996 110.35 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 25.6 tp -68.17 117.29 9.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.266 -0.424 . . . . 0.26000000000000001 110.566 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.0 pt -108.96 -21.89 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.29999999999999999 110.706 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.86 125.76 5.89 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.412 -0.515 . . . . 0.31 111.449 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.471 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.72 120.21 21.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.793 -0.64 . . . . 0.28000000000000003 109.643 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.63 151.7 29.11 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.642 -0.423 . . . . 0.23999999999999999 110.954 -179.272 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.54 158.58 18.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.04 -0.527 . . . . 0.23000000000000001 110.38 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.402 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 21.5 mt-30 -146.04 157.95 43.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.67000000000000004 110.645 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.29 104.34 9.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.732 -0.667 . . . . 0.64000000000000001 110.061 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 C--O 1.221 -0.407 0 CA-C-O 117.837 -1.078 . . . . 1.26 110.593 -179.607 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.9 m . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.244 -0.65 . . . . 3.4399999999999999 109.244 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.442 ' H ' ' HB3' ' A' ' 1' ' ' SER . . . -116.33 150.73 18.54 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.03 -0.828 . . . . 1.22 111.03 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -35.67 142.41 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.054 0 C-N-CA 123.934 3.089 . . . . 0.75 113.813 -179.23 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.629 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -79.94 173.43 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.257 -1.338 . . . . 0.79000000000000004 108.804 178.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.629 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.64 125.85 51.47 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.424 -0.51 . . . . 1.9399999999999999 111.392 -179.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.58 144.06 33.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.655 -0.702 . . . . 0.59999999999999998 110.597 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.04 168.36 25.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.857 0.361 . . . . 3.1400000000000001 111.105 -179.636 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.739 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.4 mt -109.0 131.08 60.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.002 -0.545 . . . . 3.23 110.063 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.5 p -141.17 162.3 35.82 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.829 0.347 . . . . 3.6299999999999999 111.202 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 69.3 mm-40 36.1 31.57 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.563 -0.532 . . . . 6.0800000000000001 109.563 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.739 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.41 69.59 32.3 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.968 -0.56 . . . . 3.3799999999999999 111.625 -178.833 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.639 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.21 -29.23 73.47 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.496 2.131 . . . . 3.9300000000000002 111.864 179.339 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.639 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.72 125.58 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.142 -0.481 . . . . 3.3599999999999999 110.512 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.585 HE21 ' HB2' ' A' ' 17' ' ' SER . 28.2 mt-30 -124.02 158.34 60.69 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.406 -0.361 . . . . 3.6099999999999999 110.466 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.539 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 98.1 Cg_endo -82.01 -64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.843 2.362 . . . . 1.51 113.503 -178.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.811 ' ND2' ' CE2' ' A' ' 157' ' ' TYR . 5.1 t-20 -108.38 -19.65 13.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.326 -0.397 . . . . 2.6800000000000002 112.064 -178.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.585 ' HB2' HE21 ' A' ' 14' ' ' GLN . 31.1 m -107.3 152.05 24.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.145 0.498 . . . . 1.21 111.266 -179.358 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.569 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.31 102.96 2.22 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.677 -0.692 . . . . 1.5600000000000001 110.637 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.69 145.55 12.97 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.915 2.41 . . . . 0.81000000000000005 112.646 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.902 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.74 167.98 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.881 -0.6 . . . . 1.52 109.922 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.15 147.96 29.07 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.738 -0.467 . . . . 2.1400000000000001 109.738 178.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.598 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.29 157.25 45.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.017 0.437 . . . . 0.32000000000000001 111.204 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.498 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -127.99 155.31 44.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.817 -0.629 . . . . 2.1699999999999999 110.087 178.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.819 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.62 173.05 6.33 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.187 -0.461 . . . . 0.58999999999999997 110.741 -179.199 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.819 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.8 Cg_exo -50.72 173.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.885 0 C-N-CA 122.867 2.378 . . . . 0.90000000000000002 111.497 179.33 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.485 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.95 -50.97 0.7 Allowed Pre-proline 0 C--N 1.33 -0.255 0 C-N-CA 120.672 -0.411 . . . . 3.3399999999999999 110.134 179.847 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.623 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.97 152.4 82.48 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.652 2.235 . . . . 1.8500000000000001 111.419 179.219 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.68 42.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.427 0.632 . . . . 2.54 110.615 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.82 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.65 -41.56 98.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.97 -1.014 . . . . 2.5299999999999998 110.691 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.529 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.6 mt -109.95 137.92 40.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.728 -0.669 . . . . 1.1699999999999999 111.259 -179.462 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.03 -72.87 0.7 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.039 -0.528 . . . . 1.27 111.894 -178.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.35 24.45 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.581 0.586 . . . . 1.1200000000000001 112.581 -179.631 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -121.84 124.9 45.22 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.338 -0.616 . . . . 0.41999999999999998 109.338 177.476 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.9 mt -118.04 134.7 60.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.651 -0.42 . . . . 0.78000000000000003 110.61 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.902 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.99 128.6 53.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.978 0.418 . . . . 0.62 111.334 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.551 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.07 138.99 49.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.715 -0.675 . . . . 1.97 110.215 178.972 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.437 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.06 163.12 35.23 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.109 0.48 . . . . 0.34999999999999998 112.093 -178.065 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.4 139.58 7.93 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.466 -0.788 . . . . 1.8 110.538 178.777 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.694 ' O ' ' N ' ' A' ' 41' ' ' ASN . 18.2 Cg_endo -63.46 115.4 3.01 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.322 2.014 . . . . 0.57999999999999996 111.94 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.674 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.98 81.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.837 -0.431 . . . . 3.04 109.837 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.694 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.31 -20.65 0.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.015 -0.538 . . . . 2.4700000000000002 111.927 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.2 p -157.56 157.83 34.48 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.809 -0.356 . . . . 2.5099999999999998 110.56 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.42 27.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 1.8600000000000001 110.125 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.87 -75.84 1.31 Allowed Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.178 -0.534 . . . . 1.4399999999999999 111.89 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.91 152.31 35.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.961 0.41 . . . . 4.6900000000000004 111.056 -179.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.645 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.13 2.53 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.126 -0.488 . . . . 1.4299999999999999 111.985 179.364 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.08 149.67 29.69 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.464 0.649 . . . . 1.74 112.563 -177.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.04 156.52 46.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.762 -1.108 . . . . 1.9199999999999999 110.259 178.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.22 158.34 41.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.916 -0.584 . . . . 0.34000000000000002 111.82 -179.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.6 m -115.23 135.7 53.89 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.479 -0.782 . . . . 0.40999999999999998 109.75 179.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.598 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.31 121.96 23.88 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.55000000000000004 111.546 -179.153 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.4 Cg_exo -46.41 151.71 1.7 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.731 2.287 . . . . 0.44 112.083 179.029 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.99 -22.92 63.11 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.076 -0.511 . . . . 0.73999999999999999 112.747 -179.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.544 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.85 -16.83 46.1 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 117.382 0.591 . . . . 0.93000000000000005 111.786 -178.34 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.604 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.58 138.42 31.58 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.766 -0.373 . . . . 0.96999999999999997 110.385 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.55 13.88 10.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.442 -0.344 . . . . 1.3400000000000001 111.587 -179.318 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.48 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.4 p -150.03 143.37 25.12 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.595 -0.442 . . . . 0.39000000000000001 111.03 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.72 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.67 -169.36 1.53 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.98 -0.554 . . . . 0.41999999999999998 110.969 -179.452 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.72 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.81 125.86 9.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.411 -0.813 . . . . 0.39000000000000001 109.841 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.506 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.4 mt -114.78 123.25 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.429 -0.508 . . . . 0.73999999999999999 111.208 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.756 ' HD3' HG21 ' A' ' 185' ' ' ILE . 52.0 mtmt -126.5 163.38 23.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.77 -0.65 . . . . 2.48 110.469 179.686 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.705 ' C ' HD21 ' A' ' 16' ' ' ASN . . . 85.11 19.14 59.63 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.662 -0.975 . . . . 0.5 110.662 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.687 ' N ' ' ND2' ' A' ' 16' ' ' ASN . 73.6 mt -79.13 157.17 27.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.975 0.417 . . . . 0.57999999999999996 111.331 -179.658 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.854 ' O ' HG12 ' A' ' 67' ' ' VAL . 2.7 mttm -99.46 133.87 21.61 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.571 -0.74 . . . . 2.79 110.43 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.84 143.62 61.8 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.548 2.165 . . . . 0.87 111.908 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.81 25.61 75.35 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.071 -0.812 . . . . 0.64000000000000001 111.071 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.854 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.3 p -128.15 158.67 40.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.651 0.262 . . . . 0.82999999999999996 110.475 -179.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.12 139.85 42.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.988 0.423 . . . . 0.5 110.571 -179.73 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.644 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.3 m-85 -122.46 136.52 54.91 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.902 -0.59 . . . . 0.53000000000000003 110.766 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -99.02 131.07 45.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.468 -0.938 . . . . 1.8700000000000001 108.468 177.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.482 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.54 153.82 16.67 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.341 -0.933 . . . . 0.28999999999999998 112.0 -178.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.94 140.96 46.14 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.689 -0.486 . . . . 1.4299999999999999 109.689 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.513 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.4 tp -115.75 118.88 34.27 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.454 -0.498 . . . . 0.32000000000000001 110.48 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.746 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.46 129.14 68.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.347 -0.388 . . . . 0.79000000000000004 110.63 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.9 120.74 43.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.287 -0.415 . . . . 1.02 110.69 -179.568 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.841 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.47 146.36 11.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.139 0.495 . . . . 0.62 111.076 -179.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.82 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -105.95 153.86 21.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.559 -0.746 . . . . 2.4399999999999999 109.925 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.16 88.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.865 0.364 . . . . 3.6899999999999999 110.42 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.633 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.39 32.55 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.826 -0.624 . . . . 6.0800000000000001 110.558 -179.942 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.04 -117.44 3.3 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.418 -0.673 . . . . 1.22 111.418 -179.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.471 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.38 177.31 9.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.209 0.528 . . . . 2.8799999999999999 111.665 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.11 149.43 32.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.442 -0.799 . . . . 1.47 110.403 179.221 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.08 144.65 38.85 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.458 -0.337 . . . . 2.7000000000000002 110.594 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.746 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -127.94 135.97 61.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 121.118 0.485 . . . . 0.46000000000000002 111.582 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.601 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -123.95 141.37 52.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.657 -0.701 . . . . 0.34999999999999998 110.359 179.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.492 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.6 138.89 51.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.08 0.467 . . . . 3.6699999999999999 111.527 -179.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.482 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.31 164.15 38.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.577 -0.738 . . . . 0.67000000000000004 109.526 179.353 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 46.8 p30 -145.21 151.59 38.64 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.392 -0.523 . . . . 1.47 111.069 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.812 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.2 172.72 13.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.767 -0.652 . . . . 0.44 111.045 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.71 160.69 21.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.47 -0.786 . . . . 1.3700000000000001 109.815 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.35 121.84 22.93 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.582 -0.447 . . . . 1.28 110.759 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -127.45 154.65 44.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 1.97 112.109 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.759 ' O ' ' O ' ' A' ' 94' ' ' THR . 84.2 p -68.05 -32.35 72.64 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.662 -0.699 . . . . 3.2799999999999998 111.459 178.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.759 ' O ' ' O ' ' A' ' 93' ' ' SER . 87.7 m 30.96 178.76 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 O-C-N 123.64 0.587 . . . . 0.0 112.502 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.737 ' N ' HG22 ' A' ' 94' ' ' THR . 89.8 p -64.48 -22.93 67.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.609 -179.331 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 95' ' ' SER . 17.2 p 62.6 64.61 1.62 Allowed Pre-proline 0 N--CA 1.465 0.286 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.992 -178.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.82 151.98 52.92 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.672 2.248 . . . . 0.0 111.736 179.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.5 t -104.01 133.27 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.873 0.368 . . . . 0.0 110.152 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.2 m -58.69 -39.84 81.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.68 -179.159 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.3 t -58.33 -39.17 78.74 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.755 -179.157 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 53.4 44.68 29.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.7 179.246 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.641 HG22 ' H ' ' A' ' 104' ' ' THR . 55.6 m -122.39 135.88 54.78 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.936 0.398 . . . . 0.0 111.24 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 m -116.74 13.93 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.677 179.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.641 ' H ' HG22 ' A' ' 102' ' ' THR . 21.5 p -121.17 164.11 17.41 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.142 0.496 . . . . 0.0 111.475 -178.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.96 -176.06 43.76 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.334 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -115.38 155.79 26.73 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.612 0.244 . . . . 0.0 110.574 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.9 p -82.05 158.31 23.82 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.565 ' N ' ' HD2' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -53.16 -52.4 66.19 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.362 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 108' ' ' THR . 17.9 Cg_endo -58.47 144.38 96.84 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 122.227 1.951 . . . . 0.0 112.234 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.415 ' CD2' ' N ' ' A' ' 111' ' ' SER . 68.3 t80 -146.1 -97.6 0.09 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.464 179.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.415 ' N ' ' CD2' ' A' ' 110' ' ' PHE . 40.7 p -127.78 79.23 73.95 Favored Pre-proline 0 N--CA 1.467 0.415 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.002 -179.737 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -52.49 141.19 52.54 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.18 1.92 . . . . 0.0 112.163 -179.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.9 tp -59.44 -36.74 76.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.798 -0.637 . . . . 10.19 111.552 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.4 p -129.82 144.42 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.068 0.461 . . . . 7.2800000000000002 111.423 -178.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.11 147.41 43.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.634 -0.712 . . . . 7.2999999999999998 110.751 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.498 HG23 ' H ' ' A' ' 118' ' ' GLU . 9.9 t -66.26 -147.96 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.88 -0.6 . . . . 6.4400000000000004 111.462 -179.371 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.481 ' N ' ' OG1' ' A' ' 116' ' ' THR . 90.6 p -59.93 -23.71 63.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.845 -0.616 . . . . 4.4199999999999999 112.247 -178.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.498 ' H ' HG23 ' A' ' 116' ' ' THR . 96.9 mt-10 -59.14 -34.21 71.8 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.502 -0.479 . . . . 3.0499999999999998 110.553 -179.181 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.1 p 39.32 -124.89 0.36 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.276 -0.42 . . . . 3.4300000000000002 111.012 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.6 p -133.14 -17.38 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.39 -0.368 . . . . 2.8799999999999999 110.519 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.546 ' O ' ' O ' ' A' ' 122' ' ' GLU . 24.0 p -92.96 162.33 14.1 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.18 -0.464 . . . . 2.0899999999999999 110.995 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.546 ' O ' ' O ' ' A' ' 121' ' ' THR . 48.0 tp10 52.38 126.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.994 -0.548 . . . . 4.5300000000000002 111.079 179.695 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 31.5 pt -123.5 157.09 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.046 -0.524 . . . . 1.4399999999999999 110.663 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 16.3 p -125.76 164.06 21.5 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.066 -0.515 . . . . 1.78 110.247 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.48 -94.83 0.47 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 121.014 -0.274 . . . . 0.64000000000000001 111.148 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 84.6 p -63.42 -36.53 84.04 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.481 -0.488 . . . . 0.66000000000000003 111.259 -179.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.447 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.84 167.57 0.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.977 -0.556 . . . . 0.68999999999999995 110.855 179.743 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.61 145.61 50.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.665 -0.698 . . . . 0.52000000000000002 110.154 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.32 101.65 9.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.108 -0.701 . . . . 0.32000000000000001 109.108 177.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.6 t -112.91 139.75 36.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.997 -0.547 . . . . 0.28999999999999998 111.132 -178.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 p -128.74 152.56 48.29 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.686 -0.688 . . . . 0.25 109.883 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.584 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.5 p90 -144.82 -164.98 2.04 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.738 -0.385 . . . . 0.31 110.612 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.74 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.4 t -123.93 127.13 73.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.48999999999999999 110.801 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.149 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.451 . . . . 1.53 110.378 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.74 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.06 24.41 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.932 -0.576 . . . . 0.96999999999999997 111.4 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.149 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.21 128.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.652 -0.419 . . . . 1.5600000000000001 110.937 179.819 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -86.36 -9.62 56.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.869 -0.605 . . . . 1.8799999999999999 110.376 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.12 0.26 55.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 1.04 110.307 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.34 137.28 25.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.993 -0.549 . . . . 0.23999999999999999 109.894 179.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 185' ' ' ILE . 72.0 m -96.25 -15.5 21.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.305 0.574 . . . . 0.28999999999999998 110.053 -179.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.54 175.57 45.73 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 109.822 -1.311 . . . . 0.13 109.822 179.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -123.48 151.62 42.56 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.65 -0.42 . . . . 0.17000000000000001 110.545 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.64 ' NH2' ' CD2' ' A' ' 183' ' ' TYR . 69.2 ttp85 -132.26 121.11 23.1 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.12 -0.491 . . . . 1.29 109.979 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.541 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.01 136.49 38.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.744 -0.662 . . . . 0.25 110.658 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.497 ' HB2' HH12 ' A' ' 143' ' ' ARG . 80.0 tt0 -129.34 129.88 45.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.987 -0.551 . . . . 1.3200000000000001 110.096 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.619 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.72 135.34 34.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.998 -0.546 . . . . 0.56999999999999995 110.605 -179.708 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.423 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.31 161.36 39.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.679 -0.692 . . . . 1.1599999999999999 109.627 179.844 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.96 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.02 124.9 25.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.054 0.454 . . . . 0.38 110.708 -179.676 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.78 -7.6 49.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.713 -0.676 . . . . 0.40999999999999998 110.952 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -109.86 -69.7 0.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.405 . . . . 1.6599999999999999 111.417 -179.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.445 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.66 -35.34 76.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.108 -0.496 . . . . 1.6599999999999999 111.486 -179.142 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.094 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.19 7.21 88.61 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.806 -0.918 . . . . 1.1699999999999999 110.806 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.312 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.91 -171.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.739 0.304 . . . . 1.8600000000000001 110.23 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.312 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.37 139.07 44.75 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.973 0.416 . . . . 1.98 110.205 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.423 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.8 Cg_endo -70.89 145.87 51.72 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.662 2.241 . . . . 0.55000000000000004 112.391 -179.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.619 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.9 145.75 42.62 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.217 -0.66 . . . . 1.1399999999999999 109.217 179.276 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.811 ' CE2' ' ND2' ' A' ' 16' ' ' ASN . 49.2 p90 -123.26 141.22 52.21 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.418 -0.513 . . . . 0.93000000000000005 111.536 -179.013 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.9 mt -128.05 127.67 43.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.329 -0.85 . . . . 0.34000000000000002 109.068 178.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -101.74 131.2 48.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.236 0.541 . . . . 1.0900000000000001 111.726 -178.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.97 157.55 73.51 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.226 -0.897 . . . . 0.19 109.558 179.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.78 157.96 58.56 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 122.521 2.148 . . . . 0.17999999999999999 112.178 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.28 -12.11 5.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.77 -0.65 . . . . 0.20999999999999999 110.74 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.79 -8.83 42.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.085 -0.507 . . . . 0.28999999999999998 110.703 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.13 135.39 34.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 0.5 110.364 179.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.1 p -133.21 16.71 4.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.339 -0.392 . . . . 0.29999999999999999 110.521 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.7 p -167.56 147.14 5.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.65 -0.5 . . . . 0.23000000000000001 109.65 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.541 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.22 150.5 12.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.561 -0.456 . . . . 0.28000000000000003 111.545 -179.619 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.497 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.39 124.93 50.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.644 -0.707 . . . . 1.0700000000000001 109.827 179.466 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.32 104.82 29.08 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.428 -0.351 . . . . 0.28999999999999998 111.158 -179.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.7 Cg_endo -91.02 -179.47 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.917 0 C-N-CA 123.188 2.592 . . . . 0.42999999999999999 112.188 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.53 32.8 18.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.444 -0.798 . . . . 1.26 111.467 179.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.1 mt -86.43 148.49 25.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.468 -0.333 . . . . 0.32000000000000001 110.409 179.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.761 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.29 114.83 61.2 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.091 0.472 . . . . 0.57999999999999996 110.722 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -59.01 140.63 96.19 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.878 2.385 . . . . 0.66000000000000003 111.952 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.03 21.25 74.35 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.087 -0.805 . . . . 0.28999999999999998 111.087 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.445 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.97 150.25 49.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.928 0.394 . . . . 2.3300000000000001 110.541 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.18 131.66 45.99 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.983 -0.553 . . . . 0.85999999999999999 109.792 179.316 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.96 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.56 148.22 44.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.07 -0.513 . . . . 0.52000000000000002 111.101 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.24 125.4 60.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.263 -1.014 . . . . 0.29999999999999999 108.263 177.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.6 132.43 63.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.202 0.525 . . . . 0.23000000000000001 111.338 -178.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.46 122.62 20.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.477 -0.783 . . . . 0.35999999999999999 109.63 179.342 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.584 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.07 125.39 55.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.176 -0.465 . . . . 0.19 110.654 -179.493 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.64 ' CD2' ' NH2' ' A' ' 143' ' ' ARG . 48.7 m-85 -117.3 137.93 52.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.001 -0.545 . . . . 0.29999999999999999 109.839 179.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.573 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.63 135.06 42.66 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.79 -0.819 . . . . 0.37 108.79 178.916 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.756 HG21 ' HD3' ' A' ' 61' ' ' LYS . 81.3 mt -99.14 122.83 51.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.101 0.477 . . . . 0.26000000000000001 111.022 -178.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.5 p -83.73 169.74 14.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.568 -0.742 . . . . 0.28000000000000003 110.499 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.81 -14.5 15.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.028 -0.533 . . . . 1.6000000000000001 110.975 -179.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -96.09 -4.26 43.21 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.854 -0.339 . . . . 1.1799999999999999 110.86 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.7 14.03 63.94 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.365 -0.694 . . . . 0.29999999999999999 111.365 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -84.73 139.08 32.24 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.03 -0.268 . . . . 1.22 110.484 179.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -106.72 141.03 38.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.871 0.367 . . . . 0.97999999999999998 110.517 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.0 m -136.74 126.99 26.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.82999999999999996 110.337 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.05 117.35 9.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.308 -0.406 . . . . 0.26000000000000001 110.534 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.09 -21.82 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.29999999999999999 110.68 -179.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.8 125.72 5.92 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.489 -0.484 . . . . 0.31 111.487 -179.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.78 120.26 21.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.835 -0.62 . . . . 0.28000000000000003 109.554 179.123 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.66 29.05 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.71 -0.396 . . . . 0.23999999999999999 110.942 -179.28 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.8 p -110.4 158.64 18.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.055 -0.521 . . . . 0.23000000000000001 110.382 179.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.11 157.83 43.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.057 -0.519 . . . . 0.67000000000000004 110.691 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.22 104.31 9.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.762 -0.654 . . . . 0.64000000000000001 110.058 179.513 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.2 p . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 117.991 -1.005 . . . . 1.26 110.577 -179.674 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.0 m . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.196 -0.668 . . . . 3.4399999999999999 109.196 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.36 150.7 18.54 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.981 -0.848 . . . . 1.22 110.981 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -35.68 142.38 0.1 Allowed 'Trans proline' 0 C--N 1.3 -2.0 0 C-N-CA 123.982 3.122 . . . . 0.75 113.835 -179.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.622 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.92 173.41 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.306 -1.316 . . . . 0.79000000000000004 108.81 178.413 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.622 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.55 125.84 51.45 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.484 -0.486 . . . . 1.9399999999999999 111.46 -179.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.5 144.01 33.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.638 -0.71 . . . . 0.59999999999999998 110.689 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.36 25.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.946 0.403 . . . . 3.1400000000000001 111.089 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.747 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -109.01 131.15 60.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.99 -0.55 . . . . 3.23 110.05 179.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.7 p -141.25 162.33 35.74 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.823 0.344 . . . . 3.6299999999999999 111.236 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.3 mt-10 35.99 31.69 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.626 -0.509 . . . . 6.0800000000000001 109.626 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.747 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.55 32.99 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.944 -0.571 . . . . 3.3799999999999999 111.541 -178.816 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.643 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.21 -29.09 73.38 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.478 2.119 . . . . 3.9300000000000002 111.883 179.333 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.643 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.55 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 3.3599999999999999 110.487 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.62 ' NE2' ' O ' ' A' ' 13' ' ' SER . 1.7 mp0 -124.0 158.3 60.77 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.32 -0.4 . . . . 3.6099999999999999 110.456 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.542 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 97.0 Cg_endo -82.0 -64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.939 2.426 . . . . 1.51 113.511 -178.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.585 HD22 ' CD ' ' A' ' 143' ' ' ARG . 78.2 m-20 -108.52 -19.48 13.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.311 -0.404 . . . . 2.6800000000000002 112.082 -178.531 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 27.5 m -107.29 152.01 24.7 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.44 -0.504 . . . . 1.21 111.329 -179.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.571 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.0 t-80 -155.17 102.87 2.25 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.796 -0.638 . . . . 1.5600000000000001 110.742 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.429 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.61 145.71 13.16 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.862 2.375 . . . . 0.81000000000000005 112.55 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.922 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.85 167.94 24.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.795 -0.639 . . . . 1.52 109.847 179.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.17 147.88 28.97 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.754 -0.462 . . . . 2.1400000000000001 109.754 178.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.6 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.23 157.34 44.96 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.673 -0.411 . . . . 0.32000000000000001 111.252 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.488 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -128.06 155.31 44.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.866 -0.607 . . . . 2.1699999999999999 110.085 179.029 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.822 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.67 172.98 6.44 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.128 -0.487 . . . . 0.58999999999999997 110.798 -179.189 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.822 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.6 174.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 122.859 2.373 . . . . 0.90000000000000002 111.552 179.434 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.483 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.07 -51.15 0.68 Allowed Pre-proline 0 C--N 1.328 -0.332 0 C-N-CA 120.664 -0.414 . . . . 3.3399999999999999 110.112 179.795 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.617 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.83 152.33 82.52 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.757 2.304 . . . . 1.8500000000000001 111.44 179.225 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.68 42.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.426 0.632 . . . . 2.54 110.628 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.813 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.66 -41.58 98.17 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.966 -1.015 . . . . 2.5299999999999998 110.651 179.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.533 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.9 mt -109.82 137.85 40.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.851 -0.613 . . . . 1.1699999999999999 111.311 -179.511 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.06 -72.9 0.7 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.054 -0.521 . . . . 1.27 111.853 -178.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.16 148.41 24.43 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.59 0.589 . . . . 1.1200000000000001 112.59 -179.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.79 124.86 45.18 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.327 -0.62 . . . . 0.41999999999999998 109.327 177.53 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.05 134.76 60.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.678 -0.409 . . . . 0.78000000000000003 110.636 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.922 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.99 128.49 53.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.24 -0.437 . . . . 0.62 111.237 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.547 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -130.99 139.07 49.96 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.756 -0.657 . . . . 1.97 110.151 178.899 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.12 163.18 35.11 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.165 0.507 . . . . 0.34999999999999998 112.094 -178.162 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.51 139.59 7.84 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.431 -0.804 . . . . 1.8 110.479 178.829 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.698 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.9 Cg_endo -63.51 115.43 3.03 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.436 2.091 . . . . 0.57999999999999996 111.787 -179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.685 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.08 81.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.984 0.421 . . . . 3.04 109.874 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.698 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.94 -0.573 . . . . 2.4700000000000002 111.946 -179.532 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 44.8 p -157.52 157.79 34.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.759 0.314 . . . . 2.5099999999999998 110.601 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 16.0 m -120.43 27.92 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 1.8600000000000001 110.092 179.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.92 -75.89 1.31 Allowed Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.083 -0.58 . . . . 1.4399999999999999 111.764 -179.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.84 152.3 35.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 4.6900000000000004 110.973 -179.295 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.649 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.24 -169.17 2.54 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.084 -0.507 . . . . 1.4299999999999999 111.936 179.337 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.09 149.65 29.73 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.495 0.664 . . . . 1.74 112.556 -177.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.05 156.49 46.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.789 -1.096 . . . . 1.9199999999999999 110.274 178.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.15 158.39 41.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.981 -0.554 . . . . 0.34000000000000002 111.837 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.1 m -115.19 135.64 53.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.476 -0.784 . . . . 0.40999999999999998 109.784 179.292 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.6 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.38 121.94 23.79 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.432 -0.349 . . . . 0.55000000000000004 111.548 -179.158 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.4 Cg_exo -46.32 151.74 1.62 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.658 2.239 . . . . 0.44 112.101 179.023 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.91 -23.01 63.04 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 116.015 -0.539 . . . . 0.73999999999999999 112.799 -179.289 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.544 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.87 -16.87 45.9 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.208 -0.597 . . . . 0.93000000000000005 111.755 -178.306 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.603 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.2 mt -91.47 138.44 31.58 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.809 -0.356 . . . . 0.96999999999999997 110.321 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.62 13.95 10.93 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.36 -0.382 . . . . 1.3400000000000001 111.464 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.482 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.5 p -150.05 143.48 25.16 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.648 -0.421 . . . . 0.39000000000000001 111.005 179.602 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.722 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.78 -169.31 1.52 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.016 -0.538 . . . . 0.41999999999999998 110.857 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.722 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.79 125.83 9.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.333 -0.849 . . . . 0.39000000000000001 109.841 179.275 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.511 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.74 123.19 70.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.417 -0.513 . . . . 0.73999999999999999 111.23 -179.733 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.863 ' HZ3' ' CB ' ' A' ' 140' ' ' SER . 66.4 mttt -126.47 163.44 23.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.928 -0.578 . . . . 2.48 110.441 179.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.01 19.14 59.78 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.759 -0.937 . . . . 0.5 110.759 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.511 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.1 mt -79.12 157.31 27.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.078 0.466 . . . . 0.57999999999999996 111.291 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.844 ' O ' HG12 ' A' ' 67' ' ' VAL . 1.2 mttm -99.55 134.0 21.46 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.659 -0.7 . . . . 2.79 110.393 179.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.654 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.92 143.53 61.0 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.579 2.186 . . . . 0.87 111.925 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.92 25.57 75.41 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.035 -0.826 . . . . 0.64000000000000001 111.035 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.844 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.19 158.74 40.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.64 0.257 . . . . 0.82999999999999996 110.421 -179.521 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.17 139.86 42.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.925 0.393 . . . . 0.5 110.582 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.651 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.46 136.41 54.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.969 -0.56 . . . . 0.53000000000000003 110.878 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.86 131.01 45.29 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.545 -0.909 . . . . 1.8700000000000001 108.545 177.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.52 153.87 16.66 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.237 -0.982 . . . . 0.28999999999999998 111.867 -178.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.97 140.99 46.13 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.684 -0.487 . . . . 1.4299999999999999 109.684 179.561 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.518 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.79 118.92 34.36 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.459 -0.496 . . . . 0.32000000000000001 110.507 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.738 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.49 129.1 68.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.349 -0.387 . . . . 0.79000000000000004 110.564 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.704 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.8 120.89 43.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.251 -0.432 . . . . 1.02 110.669 -179.695 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.855 HD12 ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.64 146.5 11.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.246 0.546 . . . . 0.62 111.005 -179.332 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.813 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.09 153.94 21.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.499 -0.773 . . . . 2.4399999999999999 109.924 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.13 88.57 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.85 0.357 . . . . 3.6899999999999999 110.427 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.24 32.59 0.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.869 -0.605 . . . . 6.0800000000000001 110.616 -179.887 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.06 -117.33 3.29 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.471 -0.652 . . . . 1.22 111.471 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.472 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.36 177.35 9.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.198 0.523 . . . . 2.8799999999999999 111.692 -179.256 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.12 149.61 32.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.464 -0.789 . . . . 1.47 110.478 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.15 144.68 38.72 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.501 -0.318 . . . . 2.7000000000000002 110.529 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.738 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -128.0 136.01 61.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 120.615 -0.434 . . . . 0.46000000000000002 111.549 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.03 141.37 52.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.677 -0.692 . . . . 0.34999999999999998 110.27 179.656 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.501 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.61 138.91 51.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.128 0.489 . . . . 3.6699999999999999 111.506 -179.379 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 53.0 p90 -152.39 164.19 38.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.554 -0.748 . . . . 0.67000000000000004 109.4 179.365 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.564 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.1 p30 -145.24 151.54 38.54 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.327 -0.549 . . . . 1.47 111.051 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.2 p90 -146.2 172.72 13.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.719 -0.673 . . . . 0.44 110.997 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.72 160.76 21.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.426 -0.807 . . . . 1.3700000000000001 109.82 179.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.46 121.9 22.9 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 120.514 -0.475 . . . . 1.28 110.735 179.942 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.5 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.1 p -128.23 163.84 23.84 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.495 0.924 . . . . 1.97 113.495 179.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.2 t -118.55 144.23 46.22 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.16 -1.422 . . . . 3.2799999999999998 107.16 176.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.3 p -77.93 151.76 33.56 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.562 -178.011 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 78.2 p -80.38 -14.77 58.06 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.7 179.334 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.8 p -124.27 80.67 58.99 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.905 -178.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -56.1 -22.26 38.78 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.812 1.674 . . . . 0.0 110.923 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.53 HG22 HD21 ' A' ' 181' ' ' ASN . 44.9 t -117.69 134.35 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.021 178.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.45 HG23 ' N ' ' A' ' 100' ' ' SER . 10.0 t -62.43 -39.56 93.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.035 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.45 ' N ' HG23 ' A' ' 99' ' ' THR . 84.2 p -62.29 -24.29 67.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.133 -179.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -84.85 131.32 34.54 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.033 0.444 . . . . 0.0 111.028 -179.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.2 p -79.26 164.2 24.33 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.625 -179.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.4 p -61.15 133.45 26.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.106 0.479 . . . . 0.0 110.829 -179.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 42.2 m -123.58 142.48 50.99 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.239 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.03 11.89 60.92 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 43.14 -112.52 0.22 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.539 0.209 . . . . 0.0 110.946 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.9 p -80.16 160.8 25.55 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.948 0.404 . . . . 0.0 110.622 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.583 ' O ' ' CD2' ' A' ' 110' ' ' PHE . 43.9 p -126.93 80.1 71.69 Favored Pre-proline 0 N--CA 1.464 0.237 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.688 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.76 -21.28 39.08 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.578 2.185 . . . . 0.0 112.49 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 108' ' ' THR . 89.0 m-85 69.91 23.35 5.55 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.588 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.9 t -128.18 75.33 78.89 Favored Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.182 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -56.4 144.01 84.81 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.246 1.964 . . . . 0.0 111.736 179.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.3 mt -95.8 139.76 31.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.444 -0.344 . . . . 10.19 110.33 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.553 ' O ' ' HB2' ' A' ' 115' ' ' ALA . 42.3 t -120.08 134.61 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.255 -0.43 . . . . 7.2800000000000002 110.408 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' A' ' 114' ' ' VAL . . . 169.31 -14.97 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.308 -0.405 . . . . 7.2999999999999998 110.399 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.674 HG22 ' N ' ' A' ' 117' ' ' SER . 32.7 m 45.24 174.96 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.175 -0.466 . . . . 6.4400000000000004 111.156 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.674 ' N ' HG22 ' A' ' 116' ' ' THR . 60.7 p -71.53 160.42 32.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.392 . . . . 4.4199999999999999 110.773 -179.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.05 -33.2 74.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 3.0499999999999998 111.221 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.445 ' O ' ' OG ' ' A' ' 117' ' ' SER . 28.6 t -118.25 144.47 45.77 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.381 -0.372 . . . . 3.4300000000000002 110.797 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.8 t -112.6 134.92 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.173 -0.467 . . . . 2.8799999999999999 110.421 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 44.6 m -121.87 142.38 50.31 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.82 -0.627 . . . . 2.0899999999999999 110.351 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 122' ' ' GLU . 59.3 mp0 -57.45 143.41 40.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.385 -0.37 . . . . 4.5300000000000002 110.148 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 70.7 mt -114.55 134.97 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.157 -0.474 . . . . 1.4399999999999999 110.778 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 22.3 p -84.07 162.75 20.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.015 -0.539 . . . . 1.78 110.056 179.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.83 142.18 57.49 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.67 -0.412 . . . . 0.64000000000000001 110.478 -179.691 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.1 OUTLIER -153.74 17.69 0.52 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.343 0.592 . . . . 0.66000000000000003 110.081 -179.884 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.443 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.86 167.56 0.25 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.351 -0.84 . . . . 0.68999999999999995 110.906 -179.696 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.64 145.59 50.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.671 -0.695 . . . . 0.52000000000000002 110.112 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.23 101.66 9.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.124 -0.695 . . . . 0.32000000000000001 109.124 177.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.0 t -112.94 139.6 37.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.031 -0.531 . . . . 0.28999999999999998 111.075 -178.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.1 p -128.63 152.5 48.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.638 -0.71 . . . . 0.25 109.87 179.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.584 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.5 p90 -144.8 -164.88 2.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.67 -0.412 . . . . 0.31 110.631 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.732 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.2 t -124.0 127.21 73.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.298 -0.41 . . . . 0.48999999999999999 110.83 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.154 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -58.11 58.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 1.53 110.239 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.23 24.48 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.882 -0.599 . . . . 0.96999999999999997 111.435 -179.661 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.154 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.14 128.75 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.586 -0.446 . . . . 1.5600000000000001 110.894 179.872 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.32 -9.75 55.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.886 -0.597 . . . . 1.8799999999999999 110.339 179.78 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.59 ' O ' ' CD ' ' A' ' 187' ' ' GLU . 27.8 p -87.12 0.3 55.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.004 -0.543 . . . . 1.04 110.314 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.723 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.37 137.23 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.915 -0.584 . . . . 0.23999999999999999 109.959 179.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.863 ' CB ' ' HZ3' ' A' ' 61' ' ' LYS . 89.3 p -96.27 -15.49 21.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.304 0.573 . . . . 0.28999999999999998 110.017 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.58 175.56 45.76 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.788 -1.325 . . . . 0.13 109.788 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.52 151.65 42.59 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.614 -0.435 . . . . 0.17000000000000001 110.455 179.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.647 ' NH1' HD11 ' A' ' 185' ' ' ILE . 38.3 ttp-105 -132.37 121.18 23.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.038 -0.528 . . . . 1.29 109.884 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.545 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -104.97 136.57 38.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.752 -0.658 . . . . 0.25 110.669 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 97.5 mt-10 -129.43 129.82 45.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.998 -0.547 . . . . 1.3200000000000001 110.091 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.624 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.63 135.34 34.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.079 -0.51 . . . . 0.56999999999999995 110.587 -179.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.417 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.36 161.38 39.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.783 -0.644 . . . . 1.1599999999999999 109.647 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.969 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.1 124.88 25.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.063 0.459 . . . . 0.38 110.709 -179.623 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.91 -7.57 49.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.745 -0.661 . . . . 0.40999999999999998 110.869 -179.74 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.81 -69.63 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 1.6599999999999999 111.439 -179.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.445 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.71 -35.35 76.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.006 -0.543 . . . . 1.6599999999999999 111.47 -179.094 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.078 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.17 88.64 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.763 -0.935 . . . . 1.1699999999999999 110.763 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.326 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.4 t0 -27.88 -171.7 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.792 0.33 . . . . 1.8600000000000001 110.275 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.326 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.27 139.12 45.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.958 0.408 . . . . 1.98 110.152 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.417 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 48.1 Cg_endo -70.86 145.85 51.86 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 C-N-CA 122.695 2.264 . . . . 0.55000000000000004 112.299 -179.591 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.92 145.75 42.65 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.173 -0.677 . . . . 1.1399999999999999 109.173 179.157 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.654 ' CE1' ' CD ' ' A' ' 65' ' ' PRO . 48.4 p90 -123.34 141.33 52.1 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.336 -0.546 . . . . 0.93000000000000005 111.564 -179.117 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.8 mt -128.04 127.6 43.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.349 -0.841 . . . . 0.34000000000000002 109.001 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -101.65 131.1 48.06 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.207 0.527 . . . . 1.0900000000000001 111.783 -178.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.87 157.62 73.09 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.308 -0.86 . . . . 0.19 109.586 179.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -69.75 157.98 58.56 Favored 'Trans proline' 0 C--N 1.301 -1.926 0 C-N-CA 122.431 2.087 . . . . 0.17999999999999999 112.29 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.23 -12.22 5.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.871 -0.604 . . . . 0.20999999999999999 110.725 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.9 p -92.83 -8.73 42.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.107 -0.497 . . . . 0.28999999999999998 110.753 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.15 135.35 34.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.451 . . . . 0.5 110.436 179.672 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 p -133.11 16.71 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.437 -0.347 . . . . 0.29999999999999999 110.536 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.9 p -167.52 147.04 5.07 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.639 -0.504 . . . . 0.23000000000000001 109.639 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.545 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.21 150.42 12.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.567 -0.453 . . . . 0.28000000000000003 111.63 -179.658 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.505 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.32 124.96 50.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.595 -0.729 . . . . 1.0700000000000001 109.832 179.519 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.38 104.92 29.88 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.882 0.372 . . . . 0.28999999999999998 111.03 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.1 Cg_endo -91.0 -179.44 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 123.175 2.583 . . . . 0.42999999999999999 112.137 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.54 32.69 18.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.362 -0.835 . . . . 1.26 111.49 179.325 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.425 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.1 mt -86.33 148.54 25.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.427 -0.351 . . . . 0.32000000000000001 110.435 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.771 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.35 114.82 61.19 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.026 0.441 . . . . 0.57999999999999996 110.705 -179.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.96 140.55 95.82 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.904 2.403 . . . . 0.66000000000000003 111.969 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.1 21.24 74.17 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.064 -0.814 . . . . 0.28999999999999998 111.064 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.445 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.87 150.18 49.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.808 0.337 . . . . 2.3300000000000001 110.631 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.493 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.26 131.61 46.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.057 -0.52 . . . . 0.85999999999999999 109.737 179.381 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.969 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.45 148.2 44.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.107 -0.497 . . . . 0.52000000000000002 111.119 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.31 125.4 60.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.275 -1.009 . . . . 0.29999999999999999 108.275 177.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.5 132.54 63.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.156 0.503 . . . . 0.23000000000000001 111.249 -178.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.55 122.63 20.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.485 -0.78 . . . . 0.35999999999999999 109.553 179.288 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.584 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.0 125.4 54.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.224 -0.443 . . . . 0.19 110.658 -179.526 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 47.9 m-85 -117.23 137.79 52.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.101 -0.5 . . . . 0.29999999999999999 109.921 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.583 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.74 135.01 42.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.743 -0.836 . . . . 0.37 108.743 178.922 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.647 HD11 ' NH1' ' A' ' 143' ' ' ARG . 42.1 mm -99.1 122.91 51.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.107 0.479 . . . . 0.26000000000000001 110.949 -178.757 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.6 p -83.86 169.67 14.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.483 -0.78 . . . . 0.28000000000000003 110.447 -179.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.59 ' CD ' ' O ' ' A' ' 138' ' ' THR . 41.0 mp0 -59.64 -14.6 14.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.975 -0.557 . . . . 1.6000000000000001 111.036 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.8 m-20 -96.16 -4.21 43.06 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.853 -0.339 . . . . 1.1799999999999999 110.765 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.736 ' O ' ' NE2' ' A' ' 191' ' ' GLN . . . 87.69 13.94 64.13 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.366 -0.693 . . . . 0.29999999999999999 111.366 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -84.61 139.1 32.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.63 0.252 . . . . 1.22 110.484 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.736 ' NE2' ' O ' ' A' ' 189' ' ' GLY . 0.0 OUTLIER -106.69 141.06 38.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 0.97999999999999998 110.564 179.733 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.67 127.0 26.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.82999999999999996 110.392 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.11 117.35 9.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.323 -0.399 . . . . 0.26000000000000001 110.531 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.04 -21.91 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.29999999999999999 110.659 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.9 125.78 5.88 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.527 -0.469 . . . . 0.31 111.507 -179.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.473 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.77 120.2 21.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.77 -0.65 . . . . 0.28000000000000003 109.539 179.249 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.6 151.66 29.09 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.724 -0.39 . . . . 0.23999999999999999 110.938 -179.271 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.42 158.61 18.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.065 -0.516 . . . . 0.23000000000000001 110.404 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -146.16 157.91 43.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.502 . . . . 0.67000000000000004 110.666 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.27 104.3 9.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.801 -0.636 . . . . 0.64000000000000001 110.007 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.5 p . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 117.948 -1.025 . . . . 1.26 110.641 -179.743 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.203 -0.666 . . . . 3.4399999999999999 109.203 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.34 150.67 18.55 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.037 -0.825 . . . . 1.22 111.037 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -35.67 142.38 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.077 0 C-N-CA 124.039 3.159 . . . . 0.75 113.792 -179.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.622 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -79.98 173.41 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.281 -1.327 . . . . 0.79000000000000004 108.881 178.428 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.622 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.6 125.86 51.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.214 0.531 . . . . 1.9399999999999999 111.354 -179.526 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 143.98 33.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.564 -0.744 . . . . 0.59999999999999998 110.596 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -151.99 168.35 25.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.943 0.401 . . . . 3.1400000000000001 111.076 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.738 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.97 131.02 60.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.974 -0.557 . . . . 3.23 110.076 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.19 162.33 35.74 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.834 0.349 . . . . 3.6299999999999999 111.197 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 79.9 mm-40 36.13 31.59 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.146 0 N-CA-C 109.547 -0.538 . . . . 6.0800000000000001 109.547 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.738 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.48 69.56 32.95 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.964 -0.562 . . . . 3.3799999999999999 111.624 -178.831 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.22 -29.11 73.27 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.414 2.076 . . . . 3.9300000000000002 111.856 179.351 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.124 -0.489 . . . . 3.3599999999999999 110.49 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.534 ' OE1' ' O ' ' A' ' 13' ' ' SER . 2.0 mp0 -123.93 158.4 60.22 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.304 -0.407 . . . . 3.6099999999999999 110.379 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.571 ' HD2' HE22 ' A' ' 191' ' ' GLN . 98.3 Cg_endo -82.09 -64.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.922 2.415 . . . . 1.51 113.431 -178.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.627 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 60.7 t30 -108.46 -19.53 13.42 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.312 -0.404 . . . . 2.6800000000000002 112.065 -178.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 4.2 p -107.26 152.02 24.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.149 0.499 . . . . 1.21 111.313 -179.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.25 102.94 2.23 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.723 -0.671 . . . . 1.5600000000000001 110.68 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.6 Cg_endo -82.65 145.61 13.05 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.847 2.365 . . . . 0.81000000000000005 112.651 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.91 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.84 167.84 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.949 -0.569 . . . . 1.52 109.843 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.05 148.02 29.21 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.826 -0.435 . . . . 2.1400000000000001 109.826 178.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.594 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.25 157.2 45.1 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.66 -0.416 . . . . 0.32000000000000001 111.203 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.492 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -127.98 155.29 44.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.783 -0.644 . . . . 2.1699999999999999 110.129 178.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.83 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.57 173.05 6.34 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.172 -0.467 . . . . 0.58999999999999997 110.807 -179.224 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.83 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.1 Cg_exo -50.74 173.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.886 0 C-N-CA 122.839 2.359 . . . . 0.90000000000000002 111.449 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.48 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.03 -51.04 0.69 Allowed Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.688 -0.405 . . . . 3.3399999999999999 110.062 179.868 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.619 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.8 Cg_exo -64.87 152.32 82.62 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.789 2.326 . . . . 1.8500000000000001 111.441 179.258 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.75 42.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.465 0.65 . . . . 2.54 110.547 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.817 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.66 -41.73 98.16 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.962 -1.017 . . . . 2.5299999999999998 110.65 179.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.53 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.5 mt -109.73 137.91 39.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.711 -0.677 . . . . 1.1699999999999999 111.343 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.93 -73.01 0.7 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.084 -0.507 . . . . 1.27 111.874 -178.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.19 148.41 24.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.575 0.583 . . . . 1.1200000000000001 112.575 -179.545 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -121.86 124.81 45.0 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.341 -0.615 . . . . 0.41999999999999998 109.341 177.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.09 134.68 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.721 -0.391 . . . . 0.78000000000000003 110.614 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.91 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.98 128.59 53.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.055 0.455 . . . . 0.62 111.326 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.549 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.04 138.95 49.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.738 -0.664 . . . . 1.97 110.153 179.014 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.433 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -145.04 163.17 35.07 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 121.133 0.492 . . . . 0.34999999999999998 112.098 -178.166 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.491 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.48 139.57 7.86 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.42 -0.809 . . . . 1.8 110.482 178.85 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.8 Cg_endo -63.64 115.53 3.11 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.25 1.966 . . . . 0.57999999999999996 111.852 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.67 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.93 81.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.871 -0.418 . . . . 3.04 109.871 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.16 -20.62 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.015 -0.538 . . . . 2.4700000000000002 111.899 -179.546 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.0 p -157.7 157.76 34.12 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.812 -0.355 . . . . 2.5099999999999998 110.56 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.36 27.87 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.173 -0.467 . . . . 1.8600000000000001 110.178 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.83 -75.94 1.31 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.129 -0.557 . . . . 1.4399999999999999 111.808 -179.243 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.88 152.29 35.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.918 0.389 . . . . 4.6900000000000004 111.021 -179.312 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.12 2.53 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.093 -0.503 . . . . 1.4299999999999999 111.902 179.44 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.431 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.18 149.77 29.62 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 121.433 0.635 . . . . 1.74 112.543 -177.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.12 156.45 45.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.834 -1.076 . . . . 1.9199999999999999 110.154 178.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.22 158.4 41.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.848 -0.614 . . . . 0.34000000000000002 111.773 -179.403 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.9 m -115.17 135.64 53.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.476 -0.783 . . . . 0.40999999999999998 109.839 179.308 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.594 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.44 121.91 23.71 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.483 -0.326 . . . . 0.55000000000000004 111.528 -179.09 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.5 Cg_exo -46.26 151.67 1.6 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.663 2.242 . . . . 0.44 112.212 178.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.97 -22.96 63.1 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 116.097 -0.502 . . . . 0.73999999999999999 112.755 -179.162 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.54 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.1 p-80 -82.75 -16.95 46.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.432 0.616 . . . . 0.93000000000000005 111.815 -178.372 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.605 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.58 138.31 31.67 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.773 -0.371 . . . . 0.96999999999999997 110.354 179.354 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -121.48 13.95 11.04 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.353 -0.385 . . . . 1.3400000000000001 111.564 -179.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.0 p -149.96 143.51 25.27 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.654 -0.418 . . . . 0.39000000000000001 111.034 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.84 -169.38 1.54 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.052 -0.522 . . . . 0.41999999999999998 110.894 -179.463 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.711 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 t -151.77 125.89 9.24 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.427 -0.806 . . . . 0.39000000000000001 109.795 179.273 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.511 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.91 123.22 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.396 -0.522 . . . . 0.73999999999999999 111.196 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.744 ' HD3' HG21 ' A' ' 185' ' ' ILE . 53.1 mtmt -126.4 163.31 23.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.809 -0.632 . . . . 2.48 110.514 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.477 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.2 18.83 60.07 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.823 -0.911 . . . . 0.5 110.823 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.627 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.7 mt -78.93 157.3 28.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.002 0.43 . . . . 0.57999999999999996 111.446 -179.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.855 ' O ' HG12 ' A' ' 67' ' ' VAL . 2.9 mptp? -99.53 133.98 21.49 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.638 -0.71 . . . . 2.79 110.422 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.96 ' HB3' ' O ' ' A' ' 93' ' ' SER . 36.6 Cg_endo -67.82 143.51 61.47 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.613 2.209 . . . . 0.87 111.901 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.96 25.55 75.45 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.987 -0.845 . . . . 0.64000000000000001 110.987 179.566 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.855 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.1 158.71 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.654 0.264 . . . . 0.82999999999999996 110.408 -179.532 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.09 139.98 41.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.85 0.357 . . . . 0.5 110.593 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.64 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.53 136.45 54.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.035 -0.53 . . . . 0.53000000000000003 110.687 -179.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.491 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.89 131.08 45.25 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.522 -0.918 . . . . 1.8700000000000001 108.522 177.482 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.486 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.58 153.9 16.67 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.273 -0.965 . . . . 0.28999999999999998 111.924 -178.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.98 140.91 46.06 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.699 -0.482 . . . . 1.4299999999999999 109.699 179.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.71 118.86 34.22 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.398 -0.521 . . . . 0.32000000000000001 110.494 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.735 HG12 HG23 ' A' ' 84' ' ' VAL . 63.8 mt -112.45 129.11 68.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.372 -0.377 . . . . 0.79000000000000004 110.66 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.83 120.84 43.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.289 -0.414 . . . . 1.02 110.726 -179.657 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.849 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.52 146.41 11.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.099 0.476 . . . . 0.62 111.042 -179.238 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.817 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.03 153.89 21.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.586 -0.733 . . . . 2.4399999999999999 109.963 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.18 88.55 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.856 0.36 . . . . 3.6899999999999999 110.425 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.34 32.58 0.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.814 -0.63 . . . . 6.0800000000000001 110.605 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.15 -117.32 3.28 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.471 -0.652 . . . . 1.22 111.471 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.472 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.42 177.4 8.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.293 0.568 . . . . 2.8799999999999999 111.593 -179.188 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.19 149.57 32.18 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.397 -0.82 . . . . 1.47 110.365 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.22 144.59 38.55 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.396 -0.365 . . . . 2.7000000000000002 110.59 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.735 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.91 136.02 61.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 121.13 0.49 . . . . 0.46000000000000002 111.462 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.09 141.27 52.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.593 -0.73 . . . . 0.34999999999999998 110.34 179.55 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.467 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.4 ttp180 -117.56 138.88 51.62 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.573 -0.451 . . . . 3.6699999999999999 111.598 -179.4 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.486 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.23 164.15 37.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.59 -0.732 . . . . 0.67000000000000004 109.513 179.452 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.572 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 46.9 p30 -145.27 151.56 38.55 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.374 -0.53 . . . . 1.47 111.059 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.28 172.76 13.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.74 -0.664 . . . . 0.44 111.012 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.71 160.61 21.54 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.483 -0.781 . . . . 1.3700000000000001 109.937 179.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.38 121.88 22.96 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.548 -0.461 . . . . 1.28 110.742 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.541 ' O ' ' CB ' ' A' ' 93' ' ' SER . 70.1 p -124.86 154.63 40.75 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 113.092 0.775 . . . . 1.97 113.092 179.652 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.96 ' O ' ' HB3' ' A' ' 65' ' ' PRO . 27.6 t 109.94 142.86 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 113.607 -1.633 . . . . 3.2799999999999998 108.04 -178.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.965 ' HA ' ' HG2' ' A' ' 155' ' ' PRO . 36.4 p 70.7 35.74 1.75 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -179.236 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 154' ' ' GLU . 29.9 t -44.01 150.3 0.28 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.988 -0.445 . . . . 0.0 110.606 179.176 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 p -107.58 151.93 41.22 Favored Pre-proline 0 N--CA 1.468 0.434 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.764 -178.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.426 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 38.2 Cg_endo -64.91 144.41 82.79 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 122.917 2.411 . . . . 0.0 113.499 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.6 m -129.9 154.64 40.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.4 p -124.88 156.78 37.37 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.622 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.6 t 175.38 107.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.679 178.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -111.43 120.69 43.02 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.673 0.273 . . . . 0.0 111.03 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.3 p -74.08 -23.36 59.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.268 179.019 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.9 m -129.46 161.07 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.825 -179.311 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.1 p -78.75 162.83 25.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.161 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -83.12 -178.43 52.28 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -179.131 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -112.62 157.1 21.63 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.797 0.332 . . . . 0.0 110.68 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.6 m -76.22 138.58 40.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.198 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.4 p -108.6 160.04 28.68 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.387 -179.337 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -51.7 145.49 30.49 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.191 1.927 . . . . 0.0 112.102 179.621 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -58.92 -37.59 77.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.405 -178.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.804 ' H ' ' HD2' ' A' ' 112' ' ' PRO . 1.0 OUTLIER -163.26 -37.65 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.805 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.804 ' HD2' ' H ' ' A' ' 111' ' ' SER . 79.8 Cg_exo -46.6 -140.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 122.528 2.152 . . . . 0.0 113.463 -178.204 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.787 ' N ' HD22 ' A' ' 113' ' ' LEU . 1.4 mm? -85.21 144.48 28.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.266 -0.425 . . . . 10.19 110.074 -179.171 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.7 m -127.14 158.26 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.946 -0.57 . . . . 7.2800000000000002 110.803 -179.171 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.57 148.12 25.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.874 -0.603 . . . . 7.2999999999999998 109.872 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.8 m -71.42 135.05 47.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.132 0.491 . . . . 6.4400000000000004 110.872 -179.122 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.482 ' OG ' ' N ' ' A' ' 118' ' ' GLU . 27.8 t 177.78 -122.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.228 -0.897 . . . . 4.4199999999999999 109.221 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.482 ' N ' ' OG ' ' A' ' 117' ' ' SER . 84.4 tt0 -57.83 -32.17 67.35 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.347 -0.612 . . . . 3.0499999999999998 109.347 178.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 118' ' ' GLU . 11.7 t 51.83 168.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.443 -0.799 . . . . 3.4300000000000002 111.633 179.737 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 44.8 t -116.6 136.9 52.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.395 -0.82 . . . . 2.8799999999999999 110.306 -179.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 43.7 m -75.64 137.44 40.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.315 -0.402 . . . . 2.0899999999999999 110.372 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -105.55 153.11 22.22 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.133 -0.485 . . . . 4.5300000000000002 110.55 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 16.3 pt -69.01 -9.82 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 1.4399999999999999 110.935 -179.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 19.1 p -119.43 159.31 24.47 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.781 -0.451 . . . . 1.78 109.781 178.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -148.59 155.47 41.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.996 0.426 . . . . 0.64000000000000001 110.915 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.601 ' CB ' ' HB ' ' A' ' 201' ' ' THR . 33.5 p -75.76 63.93 1.7 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 122.571 1.177 . . . . 0.66000000000000003 109.69 179.163 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.436 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.93 167.58 0.26 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.208 -1.36 . . . . 0.68999999999999995 110.979 -178.914 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.52 145.57 50.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.727 -0.669 . . . . 0.52000000000000002 110.169 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.28 101.67 9.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.075 -0.713 . . . . 0.32000000000000001 109.075 177.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.1 t -112.94 139.6 37.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.018 -0.537 . . . . 0.28999999999999998 111.117 -178.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.9 p -128.58 152.55 48.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.692 -0.686 . . . . 0.25 109.839 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.594 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.82 -164.97 2.04 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.661 -0.416 . . . . 0.31 110.655 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.734 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.9 t -123.88 127.23 73.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.48999999999999999 110.891 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.168 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.98 58.29 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 1.53 110.322 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.734 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.07 24.5 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 0.96999999999999997 111.574 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.168 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.2 128.79 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.622 -0.431 . . . . 1.5600000000000001 110.919 179.905 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.55 -9.51 55.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.92 -0.582 . . . . 1.8799999999999999 110.354 179.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.3 p -87.18 0.18 55.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.086 -0.506 . . . . 1.04 110.275 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.721 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.16 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.976 -0.556 . . . . 0.23999999999999999 109.881 179.757 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 185' ' ' ILE . 89.3 p -96.2 -15.53 21.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.313 0.578 . . . . 0.28999999999999998 110.101 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.64 175.64 45.87 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 109.891 -1.284 . . . . 0.13 109.891 179.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.51 151.54 42.69 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.605 -0.438 . . . . 0.17000000000000001 110.55 179.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.536 ' CZ ' ' HG3' ' A' ' 15' ' ' PRO . 64.1 ttp85 -132.2 121.14 23.21 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.148 -0.478 . . . . 1.29 109.936 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.551 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.11 136.48 38.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.782 -0.644 . . . . 0.25 110.713 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 80.2 tt0 -129.28 129.85 45.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.879 -0.6 . . . . 1.3200000000000001 110.121 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.618 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.3 p90 -138.66 135.34 34.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.998 -0.546 . . . . 0.56999999999999995 110.614 -179.686 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.422 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.41 161.4 39.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.792 -0.64 . . . . 1.1599999999999999 109.617 179.84 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.961 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.15 124.95 25.61 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.606 -0.438 . . . . 0.38 110.749 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.502 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.84 -7.57 49.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.753 -0.658 . . . . 0.40999999999999998 110.916 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -109.87 -69.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.01 0.433 . . . . 1.6599999999999999 111.354 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.438 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.65 -35.36 76.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.066 -0.515 . . . . 1.6599999999999999 111.466 -179.093 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.091 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.13 7.23 88.59 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.763 -0.935 . . . . 1.1699999999999999 110.763 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.314 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.96 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.777 0.322 . . . . 1.8600000000000001 110.32 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.314 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.33 139.08 44.92 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.036 0.446 . . . . 1.98 110.192 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.965 ' HG2' ' HA ' ' A' ' 94' ' ' THR . 46.8 Cg_endo -70.89 145.81 51.61 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 C-N-CA 122.778 2.318 . . . . 0.55000000000000004 112.309 -179.48 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.85 145.73 42.61 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.184 -0.673 . . . . 1.1399999999999999 109.184 179.237 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.624 ' CE1' ' CG ' ' A' ' 16' ' ' ASN . 7.6 p90 -123.35 141.36 52.06 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.249 -0.58 . . . . 0.93000000000000005 111.449 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.4 mt -128.11 127.64 43.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.228 -0.896 . . . . 0.34000000000000002 109.039 178.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -101.66 131.18 48.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.199 0.523 . . . . 1.0900000000000001 111.72 -178.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.98 157.53 73.58 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.315 -0.857 . . . . 0.19 109.521 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -69.81 158.02 58.3 Favored 'Trans proline' 0 C--N 1.302 -1.869 0 C-N-CA 122.307 2.005 . . . . 0.17999999999999999 112.291 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.13 -12.25 4.81 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.831 -0.622 . . . . 0.20999999999999999 110.759 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.86 -8.82 42.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.103 -0.499 . . . . 0.28999999999999998 110.676 -179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.06 135.27 34.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.35 -0.386 . . . . 0.5 110.473 179.675 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.9 p -133.06 16.66 4.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.489 -0.323 . . . . 0.29999999999999999 110.573 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.1 p -167.53 147.12 5.09 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.624 -0.51 . . . . 0.23000000000000001 109.624 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.551 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.18 150.5 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.564 -0.455 . . . . 0.28000000000000003 111.526 -179.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.507 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.24 124.91 50.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.566 -0.743 . . . . 1.0700000000000001 109.832 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.39 104.84 29.43 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.83 0.348 . . . . 0.28999999999999998 111.08 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.0 Cg_endo -90.92 -179.47 1.51 Allowed 'Trans proline' 0 C--N 1.301 -1.933 0 C-N-CA 123.186 2.591 . . . . 0.42999999999999999 112.172 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 61.59 32.61 18.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.331 -0.85 . . . . 1.26 111.476 179.256 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 23.8 mt -86.27 148.53 25.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.469 -0.332 . . . . 0.32000000000000001 110.522 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.766 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.4 mt -88.28 114.89 61.45 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.959 0.409 . . . . 0.57999999999999996 110.721 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.12 140.61 95.81 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.826 2.351 . . . . 0.66000000000000003 112.01 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.11 21.17 74.32 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.028 -0.829 . . . . 0.28999999999999998 111.028 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.438 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.8 mmm-85 -126.83 150.31 49.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 2.3300000000000001 110.625 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.502 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.28 131.65 46.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.978 -0.555 . . . . 0.85999999999999999 109.814 179.316 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.961 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.55 148.36 43.96 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.113 -0.494 . . . . 0.52000000000000002 110.974 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.5 mt -105.35 125.38 60.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.296 -1.002 . . . . 0.29999999999999999 108.296 177.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.52 132.44 63.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.177 0.513 . . . . 0.23000000000000001 111.222 -178.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.62 20.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.64 -0.709 . . . . 0.35999999999999999 109.633 179.216 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.594 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.97 125.46 54.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 0.19 110.71 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.26 137.87 52.11 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.048 -0.524 . . . . 0.29999999999999999 109.891 179.51 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.579 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.73 135.06 42.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.765 -0.828 . . . . 0.37 108.765 178.887 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.744 HG21 ' HD3' ' A' ' 61' ' ' LYS . 63.1 mt -99.03 122.91 51.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.106 0.479 . . . . 0.26000000000000001 110.956 -178.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.4 p -83.88 169.66 14.87 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.563 -0.744 . . . . 0.28000000000000003 110.54 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -59.76 -14.49 14.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.085 -0.507 . . . . 1.6000000000000001 110.914 -179.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 94.7 m-20 -96.13 -4.31 42.97 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.79 -0.364 . . . . 1.1799999999999999 110.769 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.82 13.96 63.83 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.316 -0.713 . . . . 0.29999999999999999 111.316 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -84.64 139.13 32.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.642 0.258 . . . . 1.22 110.443 179.658 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.571 HE22 ' HD2' ' A' ' 15' ' ' PRO . 41.0 mt-30 -106.79 141.06 38.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.97 0.414 . . . . 0.97999999999999998 110.552 179.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.1 m -136.62 127.11 26.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.487 . . . . 0.82999999999999996 110.408 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.2 117.31 9.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.39 -0.368 . . . . 0.26000000000000001 110.438 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 43.9 pt -109.09 -21.76 5.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.29999999999999999 110.744 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.92 125.68 5.83 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.477 -0.489 . . . . 0.31 111.475 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.474 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.71 120.21 21.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.731 -0.668 . . . . 0.28000000000000003 109.58 179.191 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.58 151.69 29.15 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.71 -0.396 . . . . 0.23999999999999999 110.881 -179.242 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.54 158.58 18.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.23000000000000001 110.339 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.4 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 21.6 mt-30 -146.03 157.94 43.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.031 -0.531 . . . . 0.67000000000000004 110.714 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.39 9.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.753 -0.658 . . . . 0.64000000000000001 110.05 179.568 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.601 ' HB ' ' CB ' ' A' ' 126' ' ' SER . 67.9 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 117.829 -1.081 . . . . 1.26 110.619 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.5 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.196 -0.668 . . . . 3.4399999999999999 109.196 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.64 18.55 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.999 -0.84 . . . . 1.22 110.999 179.753 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -35.5 142.39 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 124.002 3.135 . . . . 0.75 113.794 -179.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.607 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.3 t -80.06 173.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.246 -1.343 . . . . 0.79000000000000004 108.825 178.451 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.607 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.55 125.98 51.6 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.45 -0.5 . . . . 1.9399999999999999 111.412 -179.567 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.62 143.91 34.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.658 -0.701 . . . . 0.59999999999999998 110.667 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.4 25.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.925 0.393 . . . . 3.1400000000000001 111.042 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.742 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -109.06 131.05 60.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.926 -0.579 . . . . 3.23 110.091 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.8 p -141.17 162.37 35.64 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.438 -0.347 . . . . 3.6299999999999999 111.249 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 9' ' ' THR . 96.3 mt-10 35.98 31.65 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.616 -0.513 . . . . 6.0800000000000001 109.616 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.742 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.51 69.64 33.42 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.007 -0.542 . . . . 3.3799999999999999 111.609 -178.833 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.23 -29.18 73.3 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.5 2.133 . . . . 3.9300000000000002 111.868 179.32 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.63 125.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.493 . . . . 3.3599999999999999 110.514 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.716 ' HB2' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -123.89 158.39 60.17 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.306 -0.407 . . . . 3.6099999999999999 110.45 -179.988 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.562 ' HG3' ' CZ ' ' A' ' 143' ' ' ARG . 98.2 Cg_endo -82.1 -64.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.916 2.411 . . . . 1.51 113.44 -178.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.462 ' OD1' ' HB2' ' A' ' 157' ' ' TYR . 6.5 m120 -108.4 -19.52 13.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.065 0.394 . . . . 2.6800000000000002 112.065 -178.48 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.716 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 7.0 p -107.48 152.0 24.81 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.436 -0.506 . . . . 1.21 111.28 -179.361 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.57 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.18 102.94 2.25 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.709 -0.678 . . . . 1.5600000000000001 110.654 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -82.74 145.64 12.93 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.879 2.386 . . . . 0.81000000000000005 112.577 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.912 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.85 167.96 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.871 -0.604 . . . . 1.52 109.892 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -149.12 147.97 29.12 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.708 -0.478 . . . . 2.1400000000000001 109.708 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.593 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.3 157.23 45.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.04 0.448 . . . . 0.32000000000000001 111.188 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.49 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -128.03 155.19 44.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.705 -0.679 . . . . 2.1699999999999999 110.101 179.055 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.84 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.58 173.01 6.39 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-O 121.155 0.503 . . . . 0.58999999999999997 110.688 -179.153 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.84 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.62 173.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 122.831 2.354 . . . . 0.90000000000000002 111.555 179.365 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.484 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.04 -51.13 0.69 Allowed Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.76 -0.376 . . . . 3.3399999999999999 110.074 179.831 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.623 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.81 152.35 82.45 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.813 2.342 . . . . 1.8500000000000001 111.426 179.259 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.76 42.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.418 0.628 . . . . 2.54 110.526 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.818 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.54 -41.71 98.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.964 -1.016 . . . . 2.5299999999999998 110.642 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.53 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.7 mt -109.8 137.79 40.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.857 -0.611 . . . . 1.1699999999999999 111.305 -179.416 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.95 -72.92 0.7 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.105 -0.498 . . . . 1.27 111.891 -178.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.16 148.43 24.42 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.571 0.582 . . . . 1.1200000000000001 112.571 -179.649 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.79 124.83 45.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.36 -0.607 . . . . 0.41999999999999998 109.36 177.493 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -117.97 134.72 60.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.685 -0.406 . . . . 0.78000000000000003 110.676 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.912 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.01 128.65 53.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.421 . . . . 0.62 111.233 179.742 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.551 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 138.89 49.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.766 -0.652 . . . . 1.97 110.156 178.998 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.438 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -144.99 163.25 34.76 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.118 0.485 . . . . 0.34999999999999998 112.113 -178.114 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.491 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.53 139.55 7.81 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.493 -0.776 . . . . 1.8 110.485 178.887 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.59 115.44 3.05 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.279 1.986 . . . . 0.57999999999999996 111.865 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.673 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.95 81.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.925 -0.398 . . . . 3.04 109.925 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.921 -0.582 . . . . 2.4700000000000002 111.95 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -157.68 157.76 34.15 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.813 -0.355 . . . . 2.5099999999999998 110.523 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.37 27.9 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 1.8600000000000001 110.147 179.569 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.83 -75.91 1.31 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.154 -0.546 . . . . 1.4399999999999999 111.832 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.4 mtp180 -117.82 152.33 35.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.943 0.401 . . . . 4.6900000000000004 110.959 -179.32 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.35 -169.11 2.51 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.976 -0.556 . . . . 1.4299999999999999 111.954 179.271 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.436 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.05 149.61 29.76 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.483 0.659 . . . . 1.74 112.532 -177.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.02 156.5 46.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.788 -1.096 . . . . 1.9199999999999999 110.199 178.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.24 158.42 41.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.932 -0.576 . . . . 0.34000000000000002 111.777 -179.407 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.3 m -115.13 135.62 54.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.479 -0.782 . . . . 0.40999999999999998 109.838 179.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.593 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.4 122.04 23.79 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.444 -0.344 . . . . 0.55000000000000004 111.497 -179.164 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.4 Cg_exo -46.43 151.78 1.69 Allowed 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.692 2.261 . . . . 0.44 112.128 179.046 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.0 -22.99 63.21 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 116.044 -0.526 . . . . 0.73999999999999999 112.728 -179.116 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.54 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.83 -16.8 46.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.383 0.592 . . . . 0.93000000000000005 111.818 -178.352 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.603 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.68 138.37 31.62 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.716 -0.393 . . . . 0.96999999999999997 110.25 179.387 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.5 14.06 11.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.342 -0.39 . . . . 1.3400000000000001 111.601 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.472 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -150.0 143.39 25.16 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.682 -0.407 . . . . 0.39000000000000001 111.07 179.607 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.709 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.84 -169.33 1.53 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.222 0.534 . . . . 0.41999999999999998 110.844 -179.439 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.709 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 m -151.75 125.87 9.23 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.439 -0.8 . . . . 0.39000000000000001 109.887 179.283 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.513 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.85 123.3 70.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.372 -0.531 . . . . 0.73999999999999999 111.143 -179.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.632 ' CD ' HD13 ' A' ' 185' ' ' ILE . 56.1 mtmt -126.59 163.4 23.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.827 -0.624 . . . . 2.48 110.381 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.11 18.93 60.01 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.817 -0.913 . . . . 0.5 110.817 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.513 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.3 mt -79.04 157.32 28.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.106 0.479 . . . . 0.57999999999999996 111.369 -179.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.846 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -99.53 134.0 21.48 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.601 -0.727 . . . . 2.79 110.404 179.811 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.94 143.59 61.1 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.533 2.155 . . . . 0.87 111.925 179.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.88 25.51 75.48 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 111.056 -0.818 . . . . 0.64000000000000001 111.056 179.685 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.846 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.07 158.91 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.667 0.27 . . . . 0.82999999999999996 110.421 -179.639 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.23 139.96 42.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.393 -0.367 . . . . 0.5 110.588 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.668 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 94.0 m-85 -122.65 136.52 54.9 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.906 -0.588 . . . . 0.53000000000000003 110.713 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.94 131.03 45.32 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.527 -0.916 . . . . 1.8700000000000001 108.527 177.661 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.48 153.89 16.65 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.331 -0.937 . . . . 0.28999999999999998 111.931 -178.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.02 140.88 45.99 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.69 -0.485 . . . . 1.4299999999999999 109.69 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.71 118.8 34.08 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.513 -0.475 . . . . 0.32000000000000001 110.509 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.725 HG12 HG23 ' A' ' 84' ' ' VAL . 63.7 mt -112.32 129.0 68.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.357 -0.383 . . . . 0.79000000000000004 110.707 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.708 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.79 120.76 43.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.374 -0.375 . . . . 1.02 110.785 -179.694 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.849 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.55 146.57 11.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.219 0.533 . . . . 0.62 111.017 -179.255 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.818 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.11 153.81 21.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.523 -0.762 . . . . 2.4399999999999999 109.948 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.25 88.66 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.012 0.434 . . . . 3.6899999999999999 110.448 -179.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.22 32.74 0.21 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.786 -0.643 . . . . 6.0800000000000001 110.56 -179.871 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.22 -117.41 3.27 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.443 -0.663 . . . . 1.22 111.443 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.471 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.31 177.3 9.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.168 0.509 . . . . 2.8799999999999999 111.635 -179.229 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.09 149.57 32.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.428 -0.805 . . . . 1.47 110.34 179.186 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.14 144.64 38.72 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.429 -0.35 . . . . 2.7000000000000002 110.509 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.725 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.06 136.09 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 121.056 0.455 . . . . 0.46000000000000002 111.525 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.559 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.05 141.26 52.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.653 -0.703 . . . . 0.34999999999999998 110.277 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.453 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.61 138.86 51.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.127 0.489 . . . . 3.6699999999999999 111.481 -179.374 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.3 164.2 37.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.534 -0.757 . . . . 0.67000000000000004 109.518 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.23 151.61 38.66 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.43 -0.508 . . . . 1.47 111.131 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.811 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.32 172.69 13.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.82 -0.627 . . . . 0.44 110.998 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.76 160.75 21.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.455 -0.793 . . . . 1.3700000000000001 109.897 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.39 121.91 22.98 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.584 -0.446 . . . . 1.28 110.67 -179.943 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.592 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.6 p -127.44 165.36 19.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.469 0.652 . . . . 1.97 112.562 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.6 t -65.49 161.4 20.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.211 -0.904 . . . . 3.2799999999999998 109.978 178.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 12.9 t -67.88 166.19 16.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.18 0.514 . . . . 0.0 111.442 -178.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.794 ' O ' ' O ' ' A' ' 96' ' ' THR . 60.7 p -64.58 169.09 5.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.716 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.794 ' O ' ' O ' ' A' ' 95' ' ' SER . 0.1 OUTLIER -14.62 153.1 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.831 0 O-C-N 123.982 0.801 . . . . 0.0 112.348 -178.753 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.48 138.38 65.87 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.948 1.766 . . . . 0.0 112.476 -178.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 82.4 t -63.89 -34.92 71.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.774 179.783 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.9 m -67.06 136.66 55.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.289 0.566 . . . . 0.0 110.995 -178.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.7 m -119.57 153.06 36.0 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.15 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.478 ' O ' ' OE2' ' A' ' 106' ' ' GLU . 25.4 t30 61.49 50.53 4.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.953 0.406 . . . . 0.0 110.677 -179.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 69.4 p -61.16 -7.54 2.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.421 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 41.2 t -59.36 137.47 21.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.459 -179.609 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.0 p -77.87 166.86 22.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.529 -178.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.41 -2.05 56.09 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.478 ' OE2' ' O ' ' A' ' 101' ' ' ASN . 96.1 mt-10 -61.08 145.94 49.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.769 0.319 . . . . 0.0 110.522 178.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.7 m -73.11 139.08 46.19 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.2 p -121.7 77.09 37.83 Favored Pre-proline 0 N--CA 1.465 0.315 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -178.453 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.21 -17.3 51.78 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.232 1.955 . . . . 0.0 110.849 178.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -86.52 8.36 22.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.787 -179.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.1 m -120.71 80.1 31.7 Favored Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.498 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.59 152.8 20.32 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 123.057 2.505 . . . . 0.0 113.178 -179.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 26.9 tp -90.67 139.75 30.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.226 -0.897 . . . . 10.19 109.141 179.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.553 HG22 ' H ' ' A' ' 116' ' ' THR . 11.5 p -121.64 143.01 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.442 0.639 . . . . 7.2800000000000002 111.052 -178.385 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.44 -22.18 66.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.914 -1.039 . . . . 7.2999999999999998 112.823 -178.268 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.553 ' H ' HG22 ' A' ' 114' ' ' VAL . 43.1 p -71.14 155.23 41.0 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.041 -0.663 . . . . 6.4400000000000004 111.197 -178.52 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.0 m -71.96 157.96 36.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.145 -0.934 . . . . 4.4199999999999999 112.579 -178.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -59.53 -24.26 63.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.917 -1.038 . . . . 3.0499999999999998 110.017 178.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -53.95 -21.92 9.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.615 -0.72 . . . . 3.4300000000000002 111.796 -178.066 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.2 m -55.62 144.39 7.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 108.948 -0.76 . . . . 2.8799999999999999 108.948 179.065 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.656 HG22 ' H ' ' A' ' 123' ' ' ILE . 33.7 m -65.98 129.27 39.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.268 0.556 . . . . 2.0899999999999999 111.266 -177.562 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -97.68 11.36 37.33 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.178 -0.919 . . . . 4.5300000000000002 112.598 -179.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.656 ' H ' HG22 ' A' ' 121' ' ' THR . 15.5 tt -117.64 137.94 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.626 0.727 . . . . 1.4399999999999999 111.937 -178.318 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.543 ' O ' ' C ' ' A' ' 125' ' ' ALA . 49.1 m -120.01 144.98 47.23 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 114.747 -1.115 . . . . 1.78 109.739 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.543 ' C ' ' O ' ' A' ' 124' ' ' THR . . . -16.25 -76.92 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.434 0.459 . . . . 0.64000000000000001 112.204 -178.64 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.402 ' O ' HD12 ' A' ' 172' ' ' LEU . 20.9 p 179.64 -58.92 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.643 -0.423 . . . . 0.66000000000000003 111.652 179.652 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.437 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.96 167.56 0.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.075 -0.511 . . . . 0.68999999999999995 110.946 -179.033 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.57 145.52 50.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.79 -0.641 . . . . 0.52000000000000002 110.078 -179.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.26 101.78 9.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.055 -0.72 . . . . 0.32000000000000001 109.055 177.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.2 t -113.05 139.72 36.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.28999999999999998 110.942 -178.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.2 p -128.74 152.63 48.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.588 -0.733 . . . . 0.25 109.781 179.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.594 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.83 -165.06 2.06 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.793 -0.363 . . . . 0.31 110.638 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -123.89 127.15 73.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.466 . . . . 0.48999999999999999 110.896 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.173 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.84 58.26 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.123 -0.489 . . . . 1.53 110.365 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.743 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.08 24.49 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.936 -0.575 . . . . 0.96999999999999997 111.44 -179.705 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.173 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.14 128.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.619 -0.432 . . . . 1.5600000000000001 110.881 179.853 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -86.49 -9.56 55.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.915 -0.584 . . . . 1.8799999999999999 110.311 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.5 p -87.17 0.27 55.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.141 -0.481 . . . . 1.04 110.286 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.725 HG12 ' O ' ' A' ' 136' ' ' SER . 2.6 p -65.18 137.16 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.011 -0.54 . . . . 0.23999999999999999 110.037 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.591 ' HB3' ' HZ1' ' A' ' 61' ' ' LYS . 69.4 m -96.19 -15.54 22.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.356 0.598 . . . . 0.28999999999999998 110.065 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 1.012 ' O ' HG22 ' A' ' 185' ' ' ILE . . . 178.6 175.55 45.77 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 109.881 -1.288 . . . . 0.13 109.881 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -123.36 151.64 42.32 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.698 -0.401 . . . . 0.17000000000000001 110.484 179.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.835 ' NH2' ' CE1' ' A' ' 157' ' ' TYR . 70.3 ttt-85 -132.42 121.26 23.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.059 0.457 . . . . 1.29 109.803 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.559 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.16 136.47 38.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.635 -0.711 . . . . 0.25 110.66 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.58 ' C ' ' CD ' ' A' ' 145' ' ' GLU . 0.3 OUTLIER -129.31 129.89 45.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.014 -0.539 . . . . 1.3200000000000001 110.037 -179.937 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.67 135.21 34.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.07 -0.513 . . . . 0.56999999999999995 110.673 -179.7 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.425 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.28 161.38 39.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.875 -0.602 . . . . 1.1599999999999999 109.728 179.823 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.957 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.0 mt -71.14 124.91 25.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.038 0.447 . . . . 0.38 110.649 -179.459 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.2 p -71.75 -7.76 50.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.787 -0.642 . . . . 0.40999999999999998 110.874 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -109.78 -69.68 0.85 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.913 0.387 . . . . 1.6599999999999999 111.347 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.435 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.67 -35.29 75.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.118 -0.492 . . . . 1.6599999999999999 111.505 -179.101 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.102 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.1 7.12 88.66 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.864 -0.894 . . . . 1.1699999999999999 110.864 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.327 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.89 -171.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.811 0.339 . . . . 1.8600000000000001 110.264 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.327 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.32 139.09 44.94 Favored Pre-proline 0 N--CA 1.453 -0.308 0 CA-C-O 120.98 0.419 . . . . 1.98 110.211 179.685 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.425 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.89 145.86 51.7 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 C-N-CA 122.741 2.294 . . . . 0.55000000000000004 112.321 -179.516 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.95 145.73 42.69 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.211 -0.663 . . . . 1.1399999999999999 109.211 179.216 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.835 ' CE1' ' NH2' ' A' ' 143' ' ' ARG . 8.3 m-85 -123.22 141.37 52.05 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.358 -0.537 . . . . 0.93000000000000005 111.54 -179.089 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.2 mt -128.07 127.65 43.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.269 -0.878 . . . . 0.34000000000000002 108.986 178.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -101.62 131.19 47.97 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.162 0.506 . . . . 1.0900000000000001 111.791 -178.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.97 157.55 73.5 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.257 -0.883 . . . . 0.19 109.552 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.73 157.98 58.57 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 C-N-CA 122.473 2.115 . . . . 0.17999999999999999 112.207 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.35 -12.08 5.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.764 -0.653 . . . . 0.20999999999999999 110.721 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.3 p -92.88 -8.68 42.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.185 -0.461 . . . . 0.28999999999999998 110.713 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.21 135.4 34.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.5 110.383 179.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.9 p -133.09 16.61 4.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.386 -0.37 . . . . 0.29999999999999999 110.548 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.5 p -167.54 147.11 5.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.58 -0.526 . . . . 0.23000000000000001 109.58 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.559 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.23 150.43 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.519 -0.472 . . . . 0.28000000000000003 111.542 -179.634 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.509 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.23 124.98 50.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.66 -0.7 . . . . 1.0700000000000001 109.845 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.45 104.92 30.11 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.43 -0.35 . . . . 0.28999999999999998 110.986 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.5 Cg_endo -91.02 -179.49 1.48 Allowed 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 123.116 2.544 . . . . 0.42999999999999999 112.201 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.67 32.68 18.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.401 -0.818 . . . . 1.26 111.463 179.261 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 126' ' ' SER . 24.2 mt -86.39 148.51 25.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.455 -0.339 . . . . 0.32000000000000001 110.496 179.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.765 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.25 114.86 61.32 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.029 0.442 . . . . 0.57999999999999996 110.662 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.98 140.51 95.67 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.921 2.414 . . . . 0.66000000000000003 112.026 179.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.18 21.14 74.19 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.052 -0.819 . . . . 0.28999999999999998 111.052 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.435 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.86 150.21 49.36 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.966 -0.293 . . . . 2.3300000000000001 110.671 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.491 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.23 131.67 46.03 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.094 -0.503 . . . . 0.85999999999999999 109.782 179.32 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.957 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.1 m-85 -120.46 148.33 43.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.09 -0.504 . . . . 0.52000000000000002 111.056 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.4 125.3 60.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.284 -1.006 . . . . 0.29999999999999999 108.284 177.696 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.49 132.47 63.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.154 0.502 . . . . 0.23000000000000001 111.236 -178.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.43 122.56 20.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.509 -0.769 . . . . 0.35999999999999999 109.644 179.268 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.594 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.99 125.41 54.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.318 -0.401 . . . . 0.19 110.672 -179.512 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.8 m-85 -117.31 137.95 52.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.987 -0.551 . . . . 0.29999999999999999 109.793 179.585 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.576 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.75 134.99 42.9 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.778 -0.823 . . . . 0.37 108.778 178.917 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 1.012 HG22 ' O ' ' A' ' 141' ' ' GLY . 5.3 tt -99.18 122.99 51.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.204 0.526 . . . . 0.26000000000000001 110.891 -178.692 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.7 p -83.78 169.7 14.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.524 -0.762 . . . . 0.28000000000000003 110.46 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.81 -14.49 15.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.09 -0.505 . . . . 1.6000000000000001 110.933 -179.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -96.14 -4.23 43.07 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.827 -0.349 . . . . 1.1799999999999999 110.807 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.83 13.8 64.08 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.349 -0.701 . . . . 0.29999999999999999 111.349 179.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -84.63 139.11 32.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.675 0.274 . . . . 1.22 110.453 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.522 HE22 ' HD2' ' A' ' 15' ' ' PRO . 77.3 mt-30 -106.71 141.02 38.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.36 . . . . 0.97999999999999998 110.588 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.2 m -136.71 127.01 26.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.82999999999999996 110.43 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.09 117.28 9.72 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.254 -0.43 . . . . 0.26000000000000001 110.507 -179.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.03 -21.75 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.29999999999999999 110.693 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.1 tp -156.88 125.64 5.84 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.542 -0.463 . . . . 0.31 111.477 -179.707 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.468 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.74 120.16 21.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.843 -0.617 . . . . 0.28000000000000003 109.554 179.188 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.6 151.74 29.18 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.642 -0.423 . . . . 0.23999999999999999 110.91 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.44 158.53 18.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.015 -0.539 . . . . 0.23000000000000001 110.406 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -146.03 157.93 43.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 0.67000000000000004 110.719 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.18 104.32 9.38 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.826 -0.624 . . . . 0.64000000000000001 110.083 179.526 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.7 p . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.914 -1.041 . . . . 1.26 110.637 -179.679 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.3 m . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.231 -0.655 . . . . 3.4399999999999999 109.231 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.72 18.53 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.952 -0.859 . . . . 1.22 110.952 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -35.54 142.4 0.1 OUTLIER 'Trans proline' 0 C--N 1.298 -2.106 0 C-N-CA 123.99 3.127 . . . . 0.75 113.733 -179.293 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.618 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -80.06 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 114.189 -1.369 . . . . 0.79000000000000004 108.837 178.372 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.618 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.62 125.82 51.43 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.407 -0.517 . . . . 1.9399999999999999 111.496 -179.568 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.46 144.02 33.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.685 -0.689 . . . . 0.59999999999999998 110.636 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.03 168.35 25.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.985 0.421 . . . . 3.1400000000000001 111.054 -179.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.741 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.99 131.07 60.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.905 -0.589 . . . . 3.23 110.087 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 69.0 p -141.22 162.36 35.67 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.853 0.359 . . . . 3.6299999999999999 111.178 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 9' ' ' THR . 53.2 mp0 35.94 31.69 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.638 -0.505 . . . . 6.0800000000000001 109.638 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.741 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.55 32.47 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.932 -0.577 . . . . 3.3799999999999999 111.563 -178.817 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.7 Cg_endo -63.24 -29.22 73.25 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.466 2.11 . . . . 3.9300000000000002 111.815 179.348 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.72 125.49 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.123 -0.489 . . . . 3.3599999999999999 110.574 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.658 ' O ' ' O ' ' A' ' 92' ' ' THR . 39.6 mt-30 -123.86 158.28 60.44 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.862 0.363 . . . . 3.6099999999999999 110.474 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.443 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 98.1 Cg_endo -82.05 -64.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.875 2.383 . . . . 1.51 113.474 -178.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.702 ' CG ' ' CD2' ' A' ' 157' ' ' TYR . 64.4 t30 -108.41 -19.68 13.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.287 -0.415 . . . . 2.6800000000000002 112.063 -178.468 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 43.0 t -107.26 152.07 24.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.14 0.495 . . . . 1.21 111.38 -179.438 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.573 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.3 102.92 2.22 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.725 -0.67 . . . . 1.5600000000000001 110.688 179.868 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.62 145.61 13.1 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.935 2.423 . . . . 0.81000000000000005 112.574 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.919 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.83 167.92 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.95 -0.568 . . . . 1.52 109.926 179.506 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.16 147.95 29.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.73 -0.47 . . . . 2.1400000000000001 109.73 178.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.597 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.27 157.28 45.01 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.597 -0.441 . . . . 0.32000000000000001 111.215 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.488 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.02 155.29 44.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.754 -0.657 . . . . 2.1699999999999999 110.12 178.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.831 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.55 173.1 6.28 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.172 -0.467 . . . . 0.58999999999999997 110.785 -179.229 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.831 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.61 173.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.902 2.401 . . . . 0.90000000000000002 111.555 179.32 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.48 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.05 -51.06 0.69 Allowed Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.757 -0.377 . . . . 3.3399999999999999 110.13 179.777 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.617 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.9 152.34 82.6 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.72 2.28 . . . . 1.8500000000000001 111.419 179.202 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.64 42.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.411 0.624 . . . . 2.54 110.614 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.814 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.66 -41.68 98.18 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.001 -0.999 . . . . 2.5299999999999998 110.626 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.7 mt -109.77 137.87 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.793 -0.64 . . . . 1.1699999999999999 111.315 -179.516 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.99 -72.93 0.7 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.996 -0.547 . . . . 1.27 111.84 -178.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -88.12 148.37 24.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.582 0.586 . . . . 1.1200000000000001 112.582 -179.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.78 124.91 45.31 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.328 -0.619 . . . . 0.41999999999999998 109.328 177.43 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.11 134.78 60.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.658 -0.417 . . . . 0.78000000000000003 110.617 179.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.919 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.01 128.61 53.7 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.62 111.236 179.774 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.07 138.97 49.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.814 -0.63 . . . . 1.97 110.18 178.956 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.432 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.07 163.14 35.17 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.1 0.476 . . . . 0.34999999999999998 112.094 -178.115 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.46 139.58 7.88 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.438 -0.801 . . . . 1.8 110.493 178.836 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.687 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.3 Cg_endo -63.65 115.52 3.11 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.265 1.977 . . . . 0.57999999999999996 111.807 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.676 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.94 81.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.908 -0.404 . . . . 3.04 109.908 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.687 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.992 -0.549 . . . . 2.4700000000000002 111.901 -179.517 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.9 p -157.64 157.71 34.11 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.882 -0.327 . . . . 2.5099999999999998 110.575 179.766 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.4 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.27 27.76 3.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.169 -0.469 . . . . 1.8600000000000001 110.19 179.544 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.77 -75.95 1.31 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.785 -0.526 . . . . 1.4399999999999999 111.785 -179.217 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.86 152.3 35.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 4.6900000000000004 111.0 -179.322 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.676 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.14 -169.11 2.54 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.028 -0.533 . . . . 1.4299999999999999 111.926 179.382 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.17 149.66 29.77 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.416 0.627 . . . . 1.74 112.598 -177.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.05 156.41 46.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.843 -1.072 . . . . 1.9199999999999999 110.262 178.667 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.462 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.23 158.29 41.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.933 -0.576 . . . . 0.34000000000000002 111.773 -179.31 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.04 135.67 53.96 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.483 -0.781 . . . . 0.40999999999999998 109.859 179.303 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.597 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.47 121.99 23.69 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.533 -0.303 . . . . 0.55000000000000004 111.585 -179.186 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.606 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.0 Cg_exo -46.31 151.71 1.63 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.727 2.285 . . . . 0.44 112.029 179.119 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.81 -23.19 63.04 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 116.049 -0.523 . . . . 0.73999999999999999 112.782 -179.341 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.79 -16.74 46.64 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.213 -0.595 . . . . 0.93000000000000005 111.761 -178.259 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.606 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.6 mt -91.7 138.44 31.56 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.709 -0.396 . . . . 0.96999999999999997 110.298 179.381 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.46 13.85 11.04 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.392 -0.367 . . . . 1.3400000000000001 111.518 -179.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.475 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.7 p -150.01 143.45 25.18 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.65 -0.42 . . . . 0.39000000000000001 110.973 179.7 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.9 t80 -114.84 -169.48 1.56 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.043 -0.526 . . . . 0.41999999999999998 110.869 -179.404 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.711 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.2 t -151.67 125.91 9.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.412 -0.813 . . . . 0.39000000000000001 109.797 179.292 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.513 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.9 mt -114.85 123.32 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.356 -0.538 . . . . 0.73999999999999999 111.189 -179.808 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -126.56 163.3 23.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.894 -0.594 . . . . 2.48 110.448 179.746 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.476 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.14 19.03 59.77 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.75 -0.94 . . . . 0.5 110.75 -179.897 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.676 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.9 mt -79.05 157.3 28.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.124 0.488 . . . . 0.57999999999999996 111.301 -179.642 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.853 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -99.52 133.85 21.59 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.575 -0.739 . . . . 2.79 110.489 179.741 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.447 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.8 Cg_endo -67.81 143.74 62.47 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.454 2.103 . . . . 0.87 112.001 179.773 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.7 25.59 75.37 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.125 -0.79 . . . . 0.64000000000000001 111.125 179.774 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.853 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.21 158.66 40.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.648 0.261 . . . . 0.82999999999999996 110.439 -179.533 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.09 139.98 41.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.0 0.429 . . . . 0.5 110.535 -179.737 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.643 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.59 136.49 54.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.89 -0.595 . . . . 0.53000000000000003 110.689 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.92 130.96 45.32 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.523 -0.917 . . . . 1.8700000000000001 108.523 177.566 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.489 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.43 153.93 16.63 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.318 -0.944 . . . . 0.28999999999999998 111.999 -178.658 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.03 140.85 45.95 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.779 -0.452 . . . . 1.4299999999999999 109.779 179.585 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.5 tp -115.71 119.0 34.62 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.422 -0.511 . . . . 0.32000000000000001 110.48 179.757 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.51 129.02 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.332 -0.395 . . . . 0.79000000000000004 110.578 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.7 120.86 43.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.283 -0.417 . . . . 1.02 110.749 -179.754 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.853 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.53 146.47 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.116 0.484 . . . . 0.62 111.104 -179.375 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.814 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -106.06 153.82 21.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.581 -0.736 . . . . 2.4399999999999999 109.965 179.776 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.12 88.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.913 0.387 . . . . 3.6899999999999999 110.467 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.41 32.56 0.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.809 -0.632 . . . . 6.0800000000000001 110.51 179.998 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.02 -117.37 3.3 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.479 -0.648 . . . . 1.22 111.479 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.471 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.41 177.37 9.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.268 0.556 . . . . 2.8799999999999999 111.634 -179.244 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.17 149.48 32.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.485 -0.78 . . . . 1.47 110.415 179.179 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.1 144.69 38.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.489 -0.323 . . . . 2.7000000000000002 110.598 179.872 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.727 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.02 136.05 61.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-O 121.063 0.459 . . . . 0.46000000000000002 111.544 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.2 m -124.11 141.31 52.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.624 -0.717 . . . . 0.34999999999999998 110.214 179.695 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.469 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.55 138.88 51.62 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.111 0.481 . . . . 3.6699999999999999 111.538 -179.391 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.489 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.34 164.19 37.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.569 -0.741 . . . . 0.67000000000000004 109.405 179.37 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.572 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.28 151.6 38.6 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.369 -0.533 . . . . 1.47 111.062 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.8 p90 -146.23 172.7 13.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.778 -0.646 . . . . 0.44 111.033 179.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.72 160.69 21.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.483 -0.781 . . . . 1.3700000000000001 109.939 179.515 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.38 121.93 23.04 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.547 -0.461 . . . . 1.28 110.671 -179.932 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.658 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.7 p -128.45 165.74 20.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.099 -0.501 . . . . 1.97 110.497 179.636 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.4 t -101.36 136.14 41.7 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.468 -0.493 . . . . 3.2799999999999998 109.914 178.812 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 69.6 p -110.54 13.12 22.71 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.603 -179.074 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.2 t -68.12 145.29 54.52 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.709 -179.127 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 96' ' ' THR . 1.6 t -68.65 145.87 97.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.375 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.09 -61.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.927 1.751 . . . . 0.0 112.128 179.823 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.3 t -122.44 133.99 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 111.319 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.4 m -124.87 138.57 54.25 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.6 178.493 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.9 t -122.35 139.63 53.6 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.942 0.401 . . . . 0.0 111.076 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -123.1 17.85 9.99 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.241 179.207 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 47.2 m -121.43 143.0 49.48 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.936 -179.158 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.7 t -111.18 135.47 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.052 179.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.0 p -82.74 162.29 21.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.048 -179.372 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -141.49 177.48 21.14 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 179.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.49 -34.18 75.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.736 0.303 . . . . 0.0 110.701 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.79 66.79 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.097 0.475 . . . . 0.0 109.938 179.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.53 ' O ' ' CD2' ' A' ' 110' ' ' PHE . 6.5 m -125.48 74.31 68.8 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.407 -179.76 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -61.78 -15.46 42.63 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.76 2.307 . . . . 0.0 112.926 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.53 ' CD2' ' O ' ' A' ' 108' ' ' THR . 96.4 m-85 53.21 173.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.894 0.378 . . . . 0.0 110.038 -178.328 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 m -65.71 152.58 92.63 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.325 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -56.8 146.74 76.53 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.477 2.118 . . . . 0.0 112.0 -179.591 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.2 tp -57.24 -36.9 71.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.596 . . . . 10.19 110.39 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.14 134.37 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.909 0.385 . . . . 7.2800000000000002 110.572 -179.788 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -118.22 -83.94 0.65 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.899 -0.591 . . . . 7.2999999999999998 110.616 -179.831 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.3 t -80.98 170.16 16.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.97 -0.559 . . . . 6.4400000000000004 110.933 -179.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 58.2 p -66.51 163.63 18.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.955 -0.566 . . . . 4.4199999999999999 110.795 -179.549 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -56.65 143.77 34.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.982 -0.554 . . . . 3.0499999999999998 110.893 -179.387 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.3 p -124.74 158.78 32.44 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.569 -0.741 . . . . 3.4300000000000002 110.352 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.3 t -109.1 135.66 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.317 -0.401 . . . . 2.8799999999999999 110.115 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 49.8 m -119.88 142.09 49.0 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.9 -0.591 . . . . 2.0899999999999999 110.901 -179.28 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.564 ' C ' ' H ' ' A' ' 124' ' ' THR . 59.3 mp0 -56.87 145.71 28.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.885 -0.598 . . . . 4.5300000000000002 110.601 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.54 ' C ' ' H ' ' A' ' 125' ' ' ALA . 19.1 mm 68.18 -30.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.82 -0.627 . . . . 1.4399999999999999 110.454 -179.726 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.628 ' C ' ' H ' ' A' ' 126' ' ' SER . 25.9 m 57.3 -1.56 0.06 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.688 -0.233 . . . . 1.78 111.566 179.424 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.54 ' H ' ' C ' ' A' ' 123' ' ' ILE . . . -62.45 26.26 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.666 -0.243 . . . . 0.64000000000000001 111.234 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.628 ' H ' ' C ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 47.57 17.29 0.08 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.264 0.554 . . . . 0.66000000000000003 110.79 -179.933 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.438 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.8 167.52 0.25 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.503 -0.771 . . . . 0.68999999999999995 110.942 179.419 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.6 145.51 50.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.704 -0.68 . . . . 0.52000000000000002 110.128 -179.879 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.27 101.65 9.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.087 -0.708 . . . . 0.32000000000000001 109.087 177.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.2 t -112.94 139.74 36.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.055 -0.52 . . . . 0.28999999999999998 111.033 -178.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 p -128.7 152.54 48.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.549 -0.75 . . . . 0.25 109.81 179.631 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.591 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.79 -164.93 2.03 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.769 -0.373 . . . . 0.31 110.64 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -123.99 127.15 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.183 -0.462 . . . . 0.48999999999999999 110.814 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.164 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.92 58.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 1.53 110.339 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.06 24.48 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.923 -0.581 . . . . 0.96999999999999997 111.465 -179.698 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.164 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.13 128.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.601 -0.44 . . . . 1.5600000000000001 110.918 179.801 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.46 -9.54 56.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.855 -0.611 . . . . 1.8799999999999999 110.309 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.8 p -87.1 0.25 55.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.073 -0.512 . . . . 1.04 110.343 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.29 137.26 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.016 -0.538 . . . . 0.23999999999999999 109.982 179.69 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 185' ' ' ILE . 71.1 m -96.24 -15.55 21.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.239 0.542 . . . . 0.28999999999999998 110.0 -179.629 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.59 175.54 45.76 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 109.845 -1.302 . . . . 0.13 109.845 179.707 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -123.48 151.58 42.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.989 0.423 . . . . 0.17000000000000001 110.43 179.78 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.834 ' HE ' ' NE2' ' A' ' 191' ' ' GLN . 62.5 ttp85 -132.38 121.18 23.07 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.145 -0.479 . . . . 1.29 109.977 179.744 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.546 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.01 136.62 37.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.615 -0.721 . . . . 0.25 110.655 -179.755 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.501 ' CD ' ' O ' ' A' ' 156' ' ' GLN . 24.8 tp10 -129.41 129.9 45.28 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.933 -0.576 . . . . 1.3200000000000001 110.067 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.2 p90 -138.72 135.3 34.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.962 -0.563 . . . . 0.56999999999999995 110.627 -179.717 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.415 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.33 161.35 39.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.815 -0.629 . . . . 1.1599999999999999 109.682 179.79 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.967 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.02 124.83 25.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.049 0.452 . . . . 0.38 110.747 -179.596 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.499 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.74 -7.69 49.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.704 -0.68 . . . . 0.40999999999999998 110.779 -179.73 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -109.86 -69.76 0.85 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.937 0.399 . . . . 1.6599999999999999 111.336 -179.231 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.447 ' CD ' HH21 ' A' ' 176' ' ' ARG . 53.9 mt-10 -60.61 -35.39 76.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.111 -0.495 . . . . 1.6599999999999999 111.493 -179.083 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.089 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.18 7.23 88.6 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.808 -0.917 . . . . 1.1699999999999999 110.808 -179.854 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.32 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.91 -171.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.835 0.35 . . . . 1.8600000000000001 110.262 179.861 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.32 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.29 139.1 45.05 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.974 0.416 . . . . 1.98 110.126 179.619 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.415 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.5 Cg_endo -70.92 145.81 51.38 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 122.71 2.273 . . . . 0.55000000000000004 112.275 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.85 145.75 42.59 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.243 -0.651 . . . . 1.1399999999999999 109.243 179.16 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.702 ' CD2' ' CG ' ' A' ' 16' ' ' ASN . 27.3 p90 -123.26 141.34 52.08 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.296 -0.561 . . . . 0.93000000000000005 111.57 -179.115 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.7 mt -128.09 127.76 43.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.313 -0.858 . . . . 0.34000000000000002 108.978 178.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -101.68 131.1 48.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.171 0.51 . . . . 1.0900000000000001 111.747 -178.733 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.88 157.51 73.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.248 -0.887 . . . . 0.19 109.624 179.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.76 158.02 58.4 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.464 2.109 . . . . 0.17999999999999999 112.297 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.21 -12.25 5.05 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.879 -0.6 . . . . 0.20999999999999999 110.696 -179.839 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.2 p -92.81 -8.73 42.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.28999999999999998 110.724 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.23 135.33 34.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.348 -0.387 . . . . 0.5 110.374 179.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.1 p -133.12 16.68 4.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 0.29999999999999999 110.499 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.7 p -167.54 147.12 5.08 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.617 -0.512 . . . . 0.23000000000000001 109.617 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.546 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.12 150.49 12.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.495 -0.482 . . . . 0.28000000000000003 111.538 -179.636 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.507 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.32 124.8 50.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 1.0700000000000001 109.833 179.452 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.31 104.93 29.7 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.915 0.388 . . . . 0.28999999999999998 111.077 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.2 Cg_endo -91.02 -179.47 1.48 Allowed 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 123.177 2.585 . . . . 0.42999999999999999 112.18 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.69 32.59 18.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.382 -0.826 . . . . 1.26 111.422 179.276 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.1 mt -86.31 148.53 25.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.52 -0.309 . . . . 0.32000000000000001 110.501 179.562 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.77 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.34 114.84 61.28 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.041 0.448 . . . . 0.57999999999999996 110.631 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.0 140.6 96.09 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.871 2.381 . . . . 0.66000000000000003 111.94 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.03 21.2 74.47 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.032 -0.827 . . . . 0.28999999999999998 111.032 179.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.447 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.81 150.31 49.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.784 0.326 . . . . 2.3300000000000001 110.677 179.882 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.499 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.28 131.58 46.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.097 -0.501 . . . . 0.85999999999999999 109.773 179.377 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.967 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.2 m-85 -120.45 148.31 43.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.111 -0.495 . . . . 0.52000000000000002 111.022 -179.806 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.32 125.36 60.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.271 -1.011 . . . . 0.29999999999999999 108.271 177.726 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.55 132.45 63.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.139 0.495 . . . . 0.23000000000000001 111.218 -178.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.48 122.46 20.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.594 -0.73 . . . . 0.35999999999999999 109.682 179.286 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.591 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.7 t -100.84 125.32 54.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.291 -0.413 . . . . 0.19 110.798 -179.585 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.806 ' CD2' ' NH2' ' A' ' 143' ' ' ARG . 48.5 m-85 -117.18 137.84 52.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.103 -0.499 . . . . 0.29999999999999999 109.875 179.535 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.584 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.62 135.03 42.69 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.853 -0.795 . . . . 0.37 108.853 178.814 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.606 ' O ' ' N ' ' A' ' 140' ' ' SER . 84.8 mt -99.09 122.93 51.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.1 0.476 . . . . 0.26000000000000001 110.923 -178.724 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.1 p -83.91 169.75 14.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.566 -0.743 . . . . 0.28000000000000003 110.481 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -59.82 -14.47 15.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.096 -0.502 . . . . 1.6000000000000001 110.938 -179.539 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -96.11 -4.25 43.15 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.863 -0.335 . . . . 1.1799999999999999 110.758 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.449 ' N ' ' HB ' ' A' ' 59' ' ' THR . . . 87.75 13.84 64.18 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.431 -0.668 . . . . 0.29999999999999999 111.431 179.884 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -84.62 139.0 32.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.622 0.248 . . . . 1.22 110.443 179.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.834 ' NE2' ' HE ' ' A' ' 143' ' ' ARG . 86.6 mt-30 -106.62 141.02 38.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.871 0.367 . . . . 0.97999999999999998 110.639 179.682 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.6 m -136.68 127.04 26.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.168 -0.469 . . . . 0.82999999999999996 110.431 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.17 117.35 9.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.348 -0.387 . . . . 0.26000000000000001 110.507 -179.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.1 -21.81 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.125 -0.489 . . . . 0.29999999999999999 110.652 -179.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.9 125.68 5.84 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.489 -0.484 . . . . 0.31 111.479 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.473 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.73 120.33 21.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.756 -0.656 . . . . 0.28000000000000003 109.504 179.165 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.67 151.67 29.04 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.659 -0.416 . . . . 0.23999999999999999 110.952 -179.314 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.45 158.58 18.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.523 . . . . 0.23000000000000001 110.467 179.707 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.4 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 21.5 mt-30 -146.08 157.93 43.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.046 -0.525 . . . . 0.67000000000000004 110.527 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.21 104.41 9.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.728 -0.669 . . . . 0.64000000000000001 110.088 179.44 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 117.839 -1.077 . . . . 1.26 110.659 -179.712 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.219 -0.66 . . . . 3.4399999999999999 109.219 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.36 150.81 18.52 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.012 -0.835 . . . . 1.22 111.012 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -35.81 142.43 0.11 Allowed 'Trans proline' 0 C--N 1.297 -2.141 0 C-N-CA 123.975 3.117 . . . . 0.75 113.761 -179.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -79.9 173.4 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 114.196 -1.365 . . . . 0.79000000000000004 108.839 178.425 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.616 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.62 125.9 51.52 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.412 -0.515 . . . . 1.9399999999999999 111.421 -179.662 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.47 144.01 33.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.613 -0.721 . . . . 0.59999999999999998 110.649 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.01 168.33 25.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.837 0.351 . . . . 3.1400000000000001 111.215 -179.762 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.74 HG22 ' OG1' ' A' ' 11' ' ' THR . 65.9 mt -108.95 131.16 60.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.053 -0.521 . . . . 3.23 110.074 179.864 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.8 p -141.26 162.25 35.93 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.835 0.35 . . . . 3.6299999999999999 111.223 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 9' ' ' THR . 98.0 mt-10 36.21 31.51 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 109.636 -0.505 . . . . 6.0800000000000001 109.636 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.74 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.43 69.66 32.71 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.939 -0.573 . . . . 3.3799999999999999 111.587 -178.787 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.641 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.24 -29.28 73.21 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.529 2.153 . . . . 3.9300000000000002 111.82 179.391 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.641 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.71 125.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 3.3599999999999999 110.43 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.666 ' CG ' HE22 ' A' ' 191' ' ' GLN . 10.2 mp0 -124.05 158.28 60.97 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.405 . . . . 3.6099999999999999 110.432 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.57 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 96.4 Cg_endo -81.94 -64.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.935 2.423 . . . . 1.51 113.547 -179.037 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.813 ' ND2' ' CD1' ' A' ' 157' ' ' TYR . 7.3 m-20 -108.39 -19.55 13.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.262 -0.426 . . . . 2.6800000000000002 112.084 -178.551 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 37.5 t -107.3 152.08 24.61 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.488 -0.485 . . . . 1.21 111.322 -179.435 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.573 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.29 102.92 2.23 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.716 -0.675 . . . . 1.5600000000000001 110.705 179.803 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.63 145.68 13.12 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.928 2.419 . . . . 0.81000000000000005 112.522 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.923 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.9 168.02 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.86 -0.609 . . . . 1.52 109.919 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.17 147.94 29.04 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.736 -0.468 . . . . 2.1400000000000001 109.736 178.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.599 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.26 157.27 45.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.994 0.426 . . . . 0.32000000000000001 111.229 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.491 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.8 m-20 -128.02 155.27 44.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.86 -0.609 . . . . 2.1699999999999999 110.163 178.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.829 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.6 172.95 6.48 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.082 0.467 . . . . 0.58999999999999997 110.777 -179.197 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.829 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.59 173.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.836 2.357 . . . . 0.90000000000000002 111.597 179.351 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.06 -51.01 0.69 Allowed Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.729 -0.388 . . . . 3.3399999999999999 110.051 179.89 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.615 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.83 152.37 82.39 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.797 2.331 . . . . 1.8500000000000001 111.449 179.22 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.78 42.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.433 0.635 . . . . 2.54 110.554 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.813 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.65 -41.65 98.21 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.019 -0.991 . . . . 2.5299999999999998 110.702 179.727 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.4 mt -109.84 137.86 40.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.659 -0.701 . . . . 1.1699999999999999 111.24 -179.437 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.96 -72.89 0.7 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.017 -0.538 . . . . 1.27 111.933 -179.018 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.12 148.28 24.51 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.594 0.59 . . . . 1.1200000000000001 112.594 -179.661 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.74 124.83 45.16 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.43 -0.582 . . . . 0.41999999999999998 109.43 177.432 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.02 134.75 60.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.612 -0.435 . . . . 0.78000000000000003 110.611 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.923 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.97 128.65 53.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.042 0.448 . . . . 0.62 111.309 179.674 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.19 139.02 49.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.679 -0.692 . . . . 1.97 110.114 178.967 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.0 163.15 35.07 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 121.119 0.485 . . . . 0.34999999999999998 112.099 -178.094 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.492 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.49 139.6 7.86 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.406 -0.816 . . . . 1.8 110.533 178.728 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.686 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.8 Cg_endo -63.43 115.39 2.99 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.313 2.008 . . . . 0.57999999999999996 111.893 179.968 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.676 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.89 81.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.92 -0.4 . . . . 3.04 109.92 -179.856 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.686 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.023 -0.535 . . . . 2.4700000000000002 111.875 -179.41 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.2 p -157.63 157.87 34.44 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.787 -0.365 . . . . 2.5099999999999998 110.506 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.45 27.83 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.478 . . . . 1.8600000000000001 110.164 179.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.8 -75.87 1.31 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.157 -0.544 . . . . 1.4399999999999999 111.859 -179.255 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.89 152.29 35.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 4.6900000000000004 111.037 -179.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.637 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.23 -169.17 2.55 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.041 -0.527 . . . . 1.4299999999999999 111.928 179.422 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.13 149.69 29.69 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.397 0.617 . . . . 1.74 112.615 -177.854 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.01 156.46 46.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.891 -1.05 . . . . 1.9199999999999999 110.326 178.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.19 158.37 41.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.038 -0.528 . . . . 0.34000000000000002 111.85 -179.317 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.8 m -115.17 135.67 53.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.5 -0.773 . . . . 0.40999999999999998 109.815 179.296 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.599 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.43 122.01 23.75 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.515 -0.311 . . . . 0.55000000000000004 111.511 -179.141 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.607 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.4 Cg_exo -46.48 151.81 1.71 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.668 2.245 . . . . 0.44 112.083 179.04 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.91 -23.08 63.13 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 116.033 -0.53 . . . . 0.73999999999999999 112.821 -179.249 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.5 p-80 -82.79 -16.77 46.56 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.167 -0.613 . . . . 0.93000000000000005 111.762 -178.293 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.607 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.69 138.47 31.54 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.766 -0.374 . . . . 0.96999999999999997 110.266 179.399 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.61 13.93 10.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.409 -0.36 . . . . 1.3400000000000001 111.476 -179.341 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.478 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -150.0 143.47 25.2 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.65 -0.42 . . . . 0.39000000000000001 111.093 179.522 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.9 t80 -114.77 -169.32 1.52 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.263 0.554 . . . . 0.41999999999999998 110.853 -179.386 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 1.003 HG21 ' O ' ' A' ' 187' ' ' GLU . 5.4 p -151.83 125.95 9.23 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.403 -0.817 . . . . 0.39000000000000001 109.737 179.284 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.97 123.32 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.278 -0.569 . . . . 0.73999999999999999 111.146 -179.797 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -126.57 163.41 23.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.835 -0.621 . . . . 2.48 110.371 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.04 19.04 59.9 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.743 -0.943 . . . . 0.5 110.743 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.514 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.4 mt -79.08 157.27 28.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.125 0.488 . . . . 0.57999999999999996 111.361 -179.694 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.856 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -99.49 133.9 21.57 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.562 -0.744 . . . . 2.79 110.406 179.838 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.446 ' HD3' ' CE2' ' A' ' 157' ' ' TYR . 36.9 Cg_endo -67.84 143.56 61.6 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.563 2.175 . . . . 0.87 111.893 179.799 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.88 25.58 75.39 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.999 -0.841 . . . . 0.64000000000000001 110.999 179.649 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.856 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.16 158.82 39.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.689 0.28 . . . . 0.82999999999999996 110.426 -179.641 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.12 139.98 41.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.344 -0.389 . . . . 0.5 110.637 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.643 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.6 m-85 -122.63 136.39 54.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.53000000000000003 110.753 -179.878 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.3 pt-20 -98.83 130.95 45.27 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.51 -0.922 . . . . 1.8700000000000001 108.51 177.615 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.42 153.86 16.63 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.365 -0.922 . . . . 0.28999999999999998 112.082 -178.711 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.98 140.86 46.02 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.709 -0.478 . . . . 1.4299999999999999 109.709 179.647 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.519 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.3 tp -115.69 118.91 34.38 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.493 -0.483 . . . . 0.32000000000000001 110.526 179.685 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.725 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.48 129.08 68.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.298 -0.41 . . . . 0.79000000000000004 110.648 -179.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.707 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.82 120.8 43.61 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.325 -0.398 . . . . 1.02 110.669 -179.558 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.854 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.56 146.4 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.089 0.471 . . . . 0.62 111.098 -179.299 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.813 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.1 mt-30 -106.01 153.86 21.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.601 -0.727 . . . . 2.4399999999999999 109.989 179.798 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.11 88.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.899 0.38 . . . . 3.6899999999999999 110.439 -179.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.3 32.66 0.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.791 -0.64 . . . . 6.0800000000000001 110.539 -179.915 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.16 -117.29 3.27 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.464 -0.654 . . . . 1.22 111.464 -179.765 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.469 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.1 m170 -81.5 177.45 8.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.234 0.54 . . . . 2.8799999999999999 111.571 -179.173 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.1 149.59 32.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.392 -0.822 . . . . 1.47 110.406 179.18 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.19 144.58 38.6 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.453 -0.34 . . . . 2.7000000000000002 110.629 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.725 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -127.96 136.02 61.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 120.582 -0.447 . . . . 0.46000000000000002 111.536 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.06 141.3 52.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.671 -0.695 . . . . 0.34999999999999998 110.347 179.595 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.472 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.55 138.88 51.62 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 120.588 -0.445 . . . . 3.6699999999999999 111.546 -179.329 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.35 164.17 38.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.604 -0.725 . . . . 0.67000000000000004 109.474 179.336 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.571 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.24 151.62 38.67 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.4 -0.52 . . . . 1.47 111.065 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.811 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.3 p90 -146.28 172.63 13.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.727 -0.67 . . . . 0.44 111.047 179.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.68 160.72 21.33 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.485 -0.78 . . . . 1.3700000000000001 109.846 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.39 121.89 22.97 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.558 -0.457 . . . . 1.28 110.784 179.913 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.601 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.8 p -128.0 162.8 25.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.14 -0.482 . . . . 1.97 111.126 179.706 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.6 t -114.4 136.01 53.46 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.914 -0.402 . . . . 3.2799999999999998 109.914 178.427 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.2 t -141.67 159.74 41.61 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.993 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 92.3 p -123.18 151.95 41.69 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.45 135.48 8.74 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.417 -179.926 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.03 146.58 95.7 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.871 1.714 . . . . 0.0 111.417 179.066 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.694 HG12 ' H ' ' A' ' 100' ' ' SER . 74.6 t -60.09 -42.41 89.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.339 -179.806 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.576 ' O ' HG22 ' A' ' 99' ' ' THR . 90.5 m 50.59 -2.85 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 178.641 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.694 ' H ' HG12 ' A' ' 98' ' ' VAL . 16.5 m -62.53 152.71 33.96 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.907 -179.258 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -57.47 -34.03 68.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.818 179.72 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.3 p -121.69 164.84 16.7 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.801 -179.488 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 103' ' ' VAL . 14.5 p -105.87 17.38 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.063 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.4 t -134.43 159.14 41.99 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.222 179.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -63.9 137.05 41.13 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.661 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -59.96 -34.19 72.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.741 0.305 . . . . 0.0 110.894 -179.977 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.1 p -84.48 160.68 20.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.017 0.437 . . . . 0.0 111.173 -179.37 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.6 m -72.06 137.97 81.99 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.183 179.664 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.03 145.48 41.68 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 121.47 1.447 . . . . 0.0 111.403 179.173 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.542 ' O ' ' O ' ' A' ' 111' ' ' SER . 99.0 m-85 -88.84 -2.5 58.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.057 -179.422 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.542 ' O ' ' O ' ' A' ' 110' ' ' PHE . 45.1 p 55.47 132.3 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.575 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.69 143.36 98.76 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.681 1.587 . . . . 0.0 111.711 -179.186 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 66.5 mt -60.18 -35.76 76.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 10.19 110.552 -179.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.7 p -133.16 142.71 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.229 -0.441 . . . . 7.2800000000000002 110.781 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.68 146.17 54.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 7.2999999999999998 110.252 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.0 p -121.12 160.81 22.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.863 0.363 . . . . 6.4400000000000004 110.76 -179.847 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.6 t -122.39 145.4 48.31 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.766 -0.652 . . . . 4.4199999999999999 110.307 -179.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -103.69 148.42 26.07 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.363 -0.38 . . . . 3.0499999999999998 110.543 179.889 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.559 ' O ' ' O ' ' A' ' 120' ' ' VAL . 20.5 m -59.32 -35.31 73.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 3.4300000000000002 111.15 -179.733 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.559 ' O ' ' O ' ' A' ' 119' ' ' SER . 57.6 t 51.7 151.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.165 -0.47 . . . . 2.8799999999999999 111.029 -179.584 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 4.3 m 43.89 41.26 3.74 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.175 -0.466 . . . . 2.0899999999999999 110.614 -179.458 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -105.03 139.78 39.2 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.111 -0.495 . . . . 4.5300000000000002 110.659 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.9 mt -115.47 135.15 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.013 -0.54 . . . . 1.4399999999999999 109.66 179.552 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.9 t -135.56 158.78 43.53 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.944 0.402 . . . . 1.78 111.196 -179.529 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -73.18 -147.24 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.752 -0.658 . . . . 0.64000000000000001 110.317 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.4 p -59.2 -27.93 66.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 0.66000000000000003 110.278 -179.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.435 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.88 167.54 0.26 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.917 -0.583 . . . . 0.68999999999999995 110.916 179.932 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.53 145.51 50.2 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.707 -0.679 . . . . 0.52000000000000002 110.196 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.21 101.74 9.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.064 -0.717 . . . . 0.32000000000000001 109.064 177.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.2 t -112.99 139.75 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.03 -0.532 . . . . 0.28999999999999998 111.008 -178.902 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.4 p -128.76 152.54 48.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.574 -0.739 . . . . 0.25 109.746 179.615 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.8 -164.96 2.04 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.657 -0.417 . . . . 0.31 110.578 -179.781 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -124.0 127.22 73.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.122 -0.49 . . . . 0.48999999999999999 110.793 -179.794 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.175 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -58.1 58.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.141 -0.481 . . . . 1.53 110.299 179.918 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.18 24.52 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.863 -0.608 . . . . 0.96999999999999997 111.476 -179.674 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.175 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.14 128.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.654 -0.418 . . . . 1.5600000000000001 111.0 179.842 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.39 -9.56 56.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.931 -0.577 . . . . 1.8799999999999999 110.352 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.6 p -87.1 0.17 55.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.073 -0.512 . . . . 1.04 110.297 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.22 137.22 25.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.977 -0.556 . . . . 0.23999999999999999 109.972 179.69 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.589 ' N ' ' O ' ' A' ' 185' ' ' ILE . 72.3 m -96.22 -15.66 21.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.296 0.569 . . . . 0.28999999999999998 110.055 -179.674 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.67 175.63 45.9 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 109.888 -1.285 . . . . 0.13 109.888 179.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.4 151.69 42.34 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.605 -0.438 . . . . 0.17000000000000001 110.501 179.719 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.865 HH12 ' NE2' ' A' ' 191' ' ' GLN . 52.9 ttp180 -132.37 121.27 23.23 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.128 -0.487 . . . . 1.29 109.883 179.747 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.557 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.1 136.49 38.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.698 -0.683 . . . . 0.25 110.693 -179.826 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 82.7 tt0 -129.34 129.89 45.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.973 -0.558 . . . . 1.3200000000000001 110.047 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.71 135.28 34.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.053 -0.521 . . . . 0.56999999999999995 110.623 -179.706 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.425 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.33 161.27 40.03 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.773 -0.649 . . . . 1.1599999999999999 109.705 179.84 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.962 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.0 mt -71.0 124.91 25.45 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.641 -0.424 . . . . 0.38 110.751 -179.568 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.76 -7.72 49.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.763 -0.653 . . . . 0.40999999999999998 110.913 -179.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -109.77 -69.69 0.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 1.6599999999999999 111.393 -179.28 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.45 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.4 mt-10 -60.64 -35.39 76.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.003 -0.544 . . . . 1.6599999999999999 111.45 -179.077 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.089 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.17 7.15 88.64 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.785 -0.926 . . . . 1.1699999999999999 110.785 -179.793 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.315 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.3 t0 -27.94 -171.71 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.725 0.297 . . . . 1.8600000000000001 110.283 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.315 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.14 45.22 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.043 0.449 . . . . 1.98 110.224 179.595 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.425 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 45.4 Cg_endo -70.96 145.88 51.34 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.729 2.286 . . . . 0.55000000000000004 112.248 -179.467 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.83 145.75 42.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.228 -0.656 . . . . 1.1399999999999999 109.228 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.813 ' CD1' ' ND2' ' A' ' 16' ' ' ASN . 21.3 p90 -123.31 141.33 52.1 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.377 -0.529 . . . . 0.93000000000000005 111.491 -179.115 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.6 mt -128.16 127.71 43.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.269 -0.878 . . . . 0.34000000000000002 108.872 178.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.499 ' O ' ' OD1' ' A' ' 159' ' ' ASP . 54.2 p-10 -101.62 131.1 48.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.195 0.522 . . . . 1.0900000000000001 111.751 -178.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.9 mt -127.87 157.55 73.29 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.318 -0.855 . . . . 0.19 109.617 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -69.89 158.07 58.01 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.297 1.998 . . . . 0.17999999999999999 112.251 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.25 -12.16 5.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.785 -0.643 . . . . 0.20999999999999999 110.684 -179.831 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.78 -8.8 42.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.28999999999999998 110.7 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.24 135.39 34.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.5 110.351 179.788 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.7 p -133.09 16.65 4.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.388 -0.369 . . . . 0.29999999999999999 110.573 179.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.3 p -167.56 147.17 5.07 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.59 -0.522 . . . . 0.23000000000000001 109.59 179.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.21 150.55 12.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.532 -0.467 . . . . 0.28000000000000003 111.535 -179.658 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.38 124.9 50.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.572 -0.74 . . . . 1.0700000000000001 109.851 179.463 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.33 104.85 29.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.385 -0.37 . . . . 0.28999999999999998 111.062 -179.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -90.96 -179.58 1.52 Allowed 'Trans proline' 0 C--N 1.301 -1.951 0 C-N-CA 123.28 2.653 . . . . 0.42999999999999999 112.211 179.909 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.73 32.64 18.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.407 -0.815 . . . . 1.26 111.449 179.271 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.2 mt -86.33 148.44 25.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.551 -0.295 . . . . 0.32000000000000001 110.509 179.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.767 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.4 mt -88.17 114.89 61.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.349 -0.387 . . . . 0.57999999999999996 110.702 -179.75 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.12 140.63 95.91 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.744 2.296 . . . . 0.66000000000000003 111.99 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.14 21.15 74.26 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.012 -0.835 . . . . 0.28999999999999998 111.012 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.45 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.86 150.24 49.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.847 0.356 . . . . 2.3300000000000001 110.682 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.498 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.26 131.65 46.08 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.044 -0.525 . . . . 0.85999999999999999 109.733 179.426 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.962 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.55 148.3 44.05 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.064 -0.516 . . . . 0.52000000000000002 111.048 -179.84 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.3 mt -105.31 125.41 60.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.218 -1.03 . . . . 0.29999999999999999 108.218 177.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.61 132.43 63.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.13 0.491 . . . . 0.23000000000000001 111.285 -178.632 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.41 122.46 20.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.519 -0.764 . . . . 0.35999999999999999 109.655 179.369 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.95 125.44 54.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.3 -0.409 . . . . 0.19 110.632 -179.516 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 49.4 m-85 -117.31 137.89 52.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.981 -0.554 . . . . 0.29999999999999999 109.802 179.53 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.583 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.68 135.08 42.69 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.776 -0.824 . . . . 0.37 108.776 178.837 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 140' ' ' SER . 78.1 mt -99.13 122.93 51.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.126 0.489 . . . . 0.26000000000000001 111.003 -178.805 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.9 p -83.9 169.71 14.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.546 -0.752 . . . . 0.28000000000000003 110.489 -179.646 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 1.003 ' O ' HG21 ' A' ' 59' ' ' THR . 97.8 mt-10 -59.74 -14.52 14.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.08 -0.509 . . . . 1.6000000000000001 111.01 -179.564 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -96.02 -4.32 43.34 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.837 -0.345 . . . . 1.1799999999999999 110.868 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.8 13.9 63.97 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.329 -0.708 . . . . 0.29999999999999999 111.329 179.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -84.72 139.0 32.31 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.01 -0.276 . . . . 1.22 110.462 179.652 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.865 ' NE2' HH12 ' A' ' 143' ' ' ARG . 2.3 mt-30 -106.61 141.11 38.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.877 0.37 . . . . 0.97999999999999998 110.536 179.789 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.0 m -136.8 127.0 26.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.82999999999999996 110.386 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.3 tp -68.17 117.2 9.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.318 -0.401 . . . . 0.26000000000000001 110.549 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -108.94 -21.84 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.29999999999999999 110.7 -179.694 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.86 125.76 5.9 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.559 -0.456 . . . . 0.31 111.513 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.467 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.69 120.2 21.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.756 -0.656 . . . . 0.28000000000000003 109.585 179.189 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.65 29.05 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.718 -0.393 . . . . 0.23999999999999999 110.87 -179.264 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.36 158.57 18.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.23000000000000001 110.48 179.664 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -146.09 158.01 43.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.095 -0.502 . . . . 0.67000000000000004 110.648 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 104.35 9.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.772 -0.649 . . . . 0.64000000000000001 110.013 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.7 p . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.94 -1.028 . . . . 1.26 110.66 -179.686 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.2 m . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.206 -0.664 . . . . 3.4399999999999999 109.206 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.438 ' H ' ' HB3' ' A' ' 1' ' ' SER . . . -116.33 150.73 18.54 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.999 -0.841 . . . . 1.22 110.999 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.62 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.061 0 C-N-CA 123.98 3.12 . . . . 0.75 113.788 -179.236 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.629 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -80.02 173.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.329 -1.305 . . . . 0.79000000000000004 108.772 178.412 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.629 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.63 125.89 51.51 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.41 -0.516 . . . . 1.9399999999999999 111.438 -179.558 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.55 143.93 34.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.656 -0.702 . . . . 0.59999999999999998 110.662 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.95 168.37 25.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.934 0.397 . . . . 3.1400000000000001 110.996 -179.625 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.737 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.98 131.08 60.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.893 -0.594 . . . . 3.23 110.057 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.18 162.37 35.66 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.828 0.347 . . . . 3.6299999999999999 111.253 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.2 mt-10 35.93 31.74 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.159 0.504 . . . . 6.0800000000000001 109.696 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.737 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.57 69.58 33.92 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.814 -0.63 . . . . 3.3799999999999999 111.492 -178.728 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.615 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.23 -29.16 73.24 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.444 2.096 . . . . 3.9300000000000002 111.794 179.318 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.615 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.68 125.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.228 -0.442 . . . . 3.3599999999999999 110.447 -179.926 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 17' ' ' SER . 3.1 mp0 -123.91 158.31 60.48 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 3.6099999999999999 110.494 179.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.443 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 97.6 Cg_endo -81.93 -64.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.0 2.467 . . . . 1.51 113.532 -179.005 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.716 ' CG ' ' CD1' ' A' ' 157' ' ' TYR . 66.5 t30 -108.37 -19.64 13.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.268 -0.424 . . . . 2.6800000000000002 112.08 -178.559 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 29.1 t -107.3 152.08 24.61 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.46 -0.496 . . . . 1.21 111.339 -179.398 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.33 102.98 2.22 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.734 -0.666 . . . . 1.5600000000000001 110.583 179.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.69 145.6 12.99 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.93 2.42 . . . . 0.81000000000000005 112.569 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.906 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.8 167.9 24.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.916 -0.584 . . . . 1.52 109.835 179.563 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.15 147.97 29.08 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.756 -0.461 . . . . 2.1400000000000001 109.756 178.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.598 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.24 157.28 45.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.026 0.441 . . . . 0.32000000000000001 111.235 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.499 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.0 155.35 44.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.83 -0.623 . . . . 2.1699999999999999 110.176 178.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.818 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.62 173.05 6.34 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.145 0.498 . . . . 0.58999999999999997 110.682 -179.129 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.818 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.71 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.851 2.368 . . . . 0.90000000000000002 111.501 179.367 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.98 -51.06 0.69 Allowed Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 120.767 -0.373 . . . . 3.3399999999999999 110.139 179.856 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.624 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.9 152.31 82.7 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.782 2.322 . . . . 1.8500000000000001 111.428 179.232 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.73 42.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.388 0.613 . . . . 2.54 110.526 -179.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.82 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.58 -41.64 98.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.988 -1.005 . . . . 2.5299999999999998 110.685 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.528 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.6 mt -109.93 137.84 40.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.771 -0.649 . . . . 1.1699999999999999 111.31 -179.488 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.0 -72.83 0.71 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.022 -0.536 . . . . 1.27 111.851 -178.948 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.24 148.33 24.4 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.604 0.594 . . . . 1.1200000000000001 112.604 -179.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.84 124.93 45.31 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.307 -0.627 . . . . 0.41999999999999998 109.307 177.572 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.8 mt -118.09 134.77 60.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.589 -0.444 . . . . 0.78000000000000003 110.685 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.906 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.06 128.61 53.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.036 0.446 . . . . 0.62 111.216 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.551 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.08 138.98 49.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.809 -0.632 . . . . 1.97 110.104 178.981 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.435 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.03 163.22 34.89 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 121.168 0.509 . . . . 0.34999999999999998 112.126 -178.222 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.494 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.47 139.62 7.89 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.444 -0.798 . . . . 1.8 110.449 178.861 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.68 115.62 3.17 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.261 1.974 . . . . 0.57999999999999996 111.781 179.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.02 81.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.879 -0.415 . . . . 3.04 109.879 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.69 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.23 -20.49 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.053 -0.522 . . . . 2.4700000000000002 111.898 -179.546 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.1 p -157.7 157.79 34.17 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.803 -0.359 . . . . 2.5099999999999998 110.527 179.677 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.402 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.4 m -120.34 27.76 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 1.8600000000000001 110.179 179.631 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.69 -76.05 1.32 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.793 -0.523 . . . . 1.4399999999999999 111.793 -179.211 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.403 ' HD2' HH11 ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.88 152.33 35.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.922 0.391 . . . . 4.6900000000000004 111.023 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.642 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.06 2.51 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.081 -0.509 . . . . 1.4299999999999999 111.948 179.372 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.17 149.66 29.77 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 112.59 0.589 . . . . 1.74 112.59 -177.812 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.01 156.45 46.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.826 -1.079 . . . . 1.9199999999999999 110.268 178.679 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.21 158.34 41.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.961 -0.563 . . . . 0.34000000000000002 111.778 -179.37 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 m -115.2 135.63 53.97 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.44 -0.8 . . . . 0.40999999999999998 109.759 179.291 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.598 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.31 121.98 23.89 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.341 -0.39 . . . . 0.55000000000000004 111.576 -179.157 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.5 Cg_exo -46.42 151.69 1.71 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.731 2.287 . . . . 0.44 112.068 179.052 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.8 -23.15 62.96 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 116.053 -0.521 . . . . 0.73999999999999999 112.783 -179.258 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.1 p-80 -82.66 -17.02 46.08 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.264 -0.574 . . . . 0.93000000000000005 111.798 -178.294 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.601 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.54 138.4 31.6 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.745 -0.382 . . . . 0.96999999999999997 110.29 179.506 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.51 13.93 11.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.487 -0.324 . . . . 1.3400000000000001 111.558 -179.385 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.479 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -150.04 143.54 25.21 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.633 -0.427 . . . . 0.39000000000000001 111.016 179.598 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.718 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.9 t80 -114.87 -169.35 1.53 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.209 0.528 . . . . 0.41999999999999998 110.836 -179.336 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.718 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.78 125.9 9.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.389 -0.823 . . . . 0.39000000000000001 109.806 179.278 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.504 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.8 mt -114.9 123.33 70.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.328 -0.549 . . . . 0.73999999999999999 111.111 -179.759 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.88 ' HD2' HG21 ' A' ' 185' ' ' ILE . 51.6 mtpt -126.57 163.31 23.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.788 -0.642 . . . . 2.48 110.491 179.667 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.464 ' HA2' HD21 ' A' ' 16' ' ' ASN . . . 85.25 18.91 59.83 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.749 -0.941 . . . . 0.5 110.749 -179.876 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.581 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 74.1 mt -79.12 157.34 27.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.099 0.476 . . . . 0.57999999999999996 111.381 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.861 ' O ' HG12 ' A' ' 67' ' ' VAL . 8.7 mttm -99.55 133.94 21.51 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.642 -0.708 . . . . 2.79 110.416 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.636 ' HB2' HG21 ' A' ' 94' ' ' THR . 36.8 Cg_endo -67.85 143.66 61.91 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.538 2.159 . . . . 0.87 111.931 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.82 25.44 75.56 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.098 -0.801 . . . . 0.64000000000000001 111.098 179.716 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.861 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.0 158.82 39.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.755 0.312 . . . . 0.82999999999999996 110.419 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.12 139.94 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.307 -0.406 . . . . 0.5 110.642 -179.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.64 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.58 136.54 54.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.534 . . . . 0.53000000000000003 110.704 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.494 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -99.0 131.17 45.25 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.422 -0.955 . . . . 1.8700000000000001 108.422 177.647 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.485 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.66 153.84 16.69 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.246 -0.978 . . . . 0.28999999999999998 111.907 -178.595 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.94 140.9 46.1 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.734 -0.469 . . . . 1.4299999999999999 109.734 179.584 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.513 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.75 118.89 34.31 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.462 -0.495 . . . . 0.32000000000000001 110.522 179.679 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.744 HG12 HG23 ' A' ' 84' ' ' VAL . 64.2 mt -112.4 129.18 68.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.282 -0.417 . . . . 0.79000000000000004 110.6 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.71 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.9 120.83 43.7 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.227 -0.442 . . . . 1.02 110.698 -179.677 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.846 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.58 146.42 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.22 0.533 . . . . 0.62 111.018 -179.269 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.82 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.02 153.9 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.472 -0.786 . . . . 2.4399999999999999 109.864 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.434 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.05 88.47 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.875 0.369 . . . . 3.6899999999999999 110.499 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.631 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.26 32.63 0.21 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.868 -0.605 . . . . 6.0800000000000001 110.625 -179.867 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.14 -117.28 3.28 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.447 -0.661 . . . . 1.22 111.447 -179.746 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.472 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.39 177.35 9.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.126 0.489 . . . . 2.8799999999999999 111.681 -179.218 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.14 149.56 32.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.454 -0.794 . . . . 1.47 110.367 179.162 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.19 144.68 38.64 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.484 -0.325 . . . . 2.7000000000000002 110.593 179.865 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.744 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.04 135.93 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 121.065 0.46 . . . . 0.46000000000000002 111.53 -179.706 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.599 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -123.98 141.3 52.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.625 -0.716 . . . . 0.34999999999999998 110.247 179.692 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.481 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.61 138.87 51.66 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.091 0.472 . . . . 3.6699999999999999 111.527 -179.421 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.485 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.31 164.22 37.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.55 -0.75 . . . . 0.67000000000000004 109.455 179.393 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.576 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.28 151.56 38.54 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.384 -0.526 . . . . 1.47 110.985 -179.962 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.812 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.24 172.72 13.04 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.75 -0.659 . . . . 0.44 111.013 179.84 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.73 160.71 21.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.431 -0.804 . . . . 1.3700000000000001 109.889 179.572 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.34 121.82 22.92 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.612 -0.435 . . . . 1.28 110.757 -179.995 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.457 ' OG1' ' N ' ' A' ' 93' ' ' SER . 70.3 p -129.54 -122.56 0.22 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.252 0.549 . . . . 1.97 112.0 179.609 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.457 ' N ' ' OG1' ' A' ' 92' ' ' THR . 8.1 t 86.19 6.47 0.37 Allowed 'General case' 0 C--N 1.347 0.457 0 CA-C-N 114.8 -1.091 . . . . 3.2799999999999998 111.057 -179.707 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.636 HG21 ' HB2' ' A' ' 65' ' ' PRO . 44.4 p -106.41 10.72 31.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.792 179.44 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.2 m -56.89 -36.9 70.65 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.256 -178.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 40.2 p 44.3 64.8 6.75 Favored Pre-proline 0 N--CA 1.463 0.21 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.43 136.92 78.98 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.244 1.963 . . . . 0.0 113.371 -178.165 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.9 m -131.59 160.49 42.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.874 178.566 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.55 HG22 ' H ' ' A' ' 101' ' ' ASN . 40.8 m -72.2 127.96 34.19 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.388 -0.925 . . . . 0.0 108.654 179.445 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 60.7 p -88.13 -5.28 58.52 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.55 ' H ' HG22 ' A' ' 99' ' ' THR . 78.0 m-20 57.13 48.57 15.14 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.213 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.7 p -46.53 132.71 10.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.688 0.756 . . . . 0.0 112.703 -177.086 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.581 ' O ' ' O ' ' A' ' 106' ' ' GLU . 43.7 t -124.74 137.37 57.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.181 178.101 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 51.5 p -60.21 -38.81 84.47 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.617 -178.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -62.73 -38.0 95.75 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.331 -0.461 . . . . 0.0 112.198 179.417 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.581 ' O ' ' O ' ' A' ' 103' ' ' VAL . 84.7 tt0 -112.61 147.1 37.4 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.946 0.403 . . . . 0.0 111.662 -178.323 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.3 p -115.1 161.91 17.73 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.792 179.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.8 77.54 57.12 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.125 -179.006 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -57.13 150.49 56.72 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.343 2.029 . . . . 0.0 111.939 179.751 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -58.14 156.74 9.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.793 -179.757 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.0 t 72.44 64.11 0.36 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.541 -178.802 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.81 148.39 83.84 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.855 2.37 . . . . 0.0 112.219 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.5 mt -88.97 145.98 25.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.894 -0.593 . . . . 10.19 110.273 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.0 p -128.29 142.54 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.335 -0.393 . . . . 7.2800000000000002 110.467 -179.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.31 147.37 28.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.036 -0.529 . . . . 7.2999999999999998 111.413 -179.375 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.6 m -119.85 141.88 49.16 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.691 -0.686 . . . . 6.4400000000000004 109.478 179.332 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 41.1 m -60.79 147.67 41.75 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.406 -0.518 . . . . 4.4199999999999999 110.814 -179.014 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -72.51 -25.18 61.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.653 -0.703 . . . . 3.0499999999999998 112.099 -179.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.9 m -119.38 149.34 41.99 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.312 0.577 . . . . 3.4300000000000002 112.254 -178.186 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 43.0 t -116.38 138.19 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 115.068 -0.969 . . . . 2.8799999999999999 109.33 179.302 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.1 p -116.53 161.83 18.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.239 0.543 . . . . 2.0899999999999999 111.474 -178.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -58.67 145.37 40.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.306 -0.861 . . . . 4.5300000000000002 111.537 -179.51 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 17.0 tt -120.6 138.92 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 115.625 -0.716 . . . . 1.4399999999999999 110.022 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.496 ' O ' ' OG ' ' A' ' 126' ' ' SER . 15.8 p -118.46 165.67 13.62 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.341 -0.39 . . . . 1.78 110.408 -179.627 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 127' ' ' SER . . . -29.62 -74.88 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.258 0.836 . . . . 0.64000000000000001 113.258 -178.39 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 43.8 17.23 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.124 0.964 . . . . 0.66000000000000003 110.191 -178.206 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.534 ' N ' ' O ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.79 167.54 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.676 -1.147 . . . . 0.68999999999999995 110.955 -179.956 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.55 145.65 50.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.626 -0.715 . . . . 0.52000000000000002 110.087 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.38 101.65 9.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.027 -0.731 . . . . 0.32000000000000001 109.027 177.724 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.4 t -112.9 139.66 36.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.018 -0.537 . . . . 0.28999999999999998 111.049 -178.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.0 p -128.7 152.5 48.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.598 -0.728 . . . . 0.25 109.83 179.588 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.584 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.9 p90 -144.74 -164.86 2.01 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.738 -0.385 . . . . 0.31 110.727 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -124.01 127.18 73.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.259 -0.428 . . . . 0.48999999999999999 110.838 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.144 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.97 58.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 1.53 110.292 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.2 24.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.993 -0.549 . . . . 0.96999999999999997 111.514 -179.66 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.144 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.14 128.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.639 -0.425 . . . . 1.5600000000000001 110.961 179.828 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.47 -9.57 55.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.918 -0.583 . . . . 1.8799999999999999 110.357 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.2 p -87.06 0.17 55.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.103 -0.499 . . . . 1.04 110.332 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.29 137.19 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.951 -0.568 . . . . 0.23999999999999999 110.009 179.776 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.583 ' N ' ' O ' ' A' ' 185' ' ' ILE . 84.8 p -96.16 -15.58 22.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.355 0.597 . . . . 0.28999999999999998 110.062 -179.602 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.61 175.59 45.81 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 109.882 -1.287 . . . . 0.13 109.882 179.651 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.42 151.49 42.57 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.701 -0.4 . . . . 0.17000000000000001 110.558 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.841 ' NH2' ' CD2' ' A' ' 183' ' ' TYR . 66.7 ttp85 -132.27 121.27 23.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.19 -0.459 . . . . 1.29 109.94 179.751 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.537 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -105.1 136.62 38.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.738 -0.664 . . . . 0.25 110.695 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 21.7 tp10 -129.46 129.85 45.13 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.004 -0.543 . . . . 1.3200000000000001 110.013 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.613 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.4 p90 -138.74 135.26 34.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.983 -0.553 . . . . 0.56999999999999995 110.537 -179.678 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.421 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.28 161.34 39.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.729 -0.669 . . . . 1.1599999999999999 109.679 179.766 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.961 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -70.96 124.77 25.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.04 0.448 . . . . 0.38 110.772 -179.624 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.76 -7.62 49.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.737 -0.665 . . . . 0.40999999999999998 110.908 -179.781 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -109.83 -69.69 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.304 -0.407 . . . . 1.6599999999999999 111.433 -179.314 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.452 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.72 -35.26 75.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.056 -0.52 . . . . 1.6599999999999999 111.529 -179.119 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.096 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.19 88.62 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.828 -0.909 . . . . 1.1699999999999999 110.828 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.318 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -28.06 -171.71 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 1.8600000000000001 110.317 179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.318 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.16 139.05 45.47 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 1.98 110.237 179.61 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.91 145.82 51.49 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 122.702 2.268 . . . . 0.55000000000000004 112.366 -179.554 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.8 145.7 42.6 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.287 -0.635 . . . . 1.1399999999999999 109.287 179.235 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.716 ' CD1' ' CG ' ' A' ' 16' ' ' ASN . 49.3 p90 -123.29 141.43 51.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.209 0.528 . . . . 0.93000000000000005 111.489 -179.069 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.6 mt -128.17 127.61 43.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.25 -0.886 . . . . 0.34000000000000002 108.988 178.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 40.7 t0 -101.67 131.22 48.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.202 0.525 . . . . 1.0900000000000001 111.679 -178.698 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.578 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -127.88 157.59 73.19 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.23 -0.896 . . . . 0.19 109.679 179.614 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.78 157.91 58.72 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 C-N-CA 122.51 2.14 . . . . 0.17999999999999999 112.241 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.3 p -59.2 -12.18 4.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.781 -0.645 . . . . 0.20999999999999999 110.768 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.6 p -92.85 -8.69 42.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.068 -0.515 . . . . 0.28999999999999998 110.717 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.29 135.46 34.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.349 -0.387 . . . . 0.5 110.349 179.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.4 p -133.19 16.64 4.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.402 -0.363 . . . . 0.29999999999999999 110.531 -179.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.7 p -167.55 147.09 5.06 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.651 -0.5 . . . . 0.23000000000000001 109.651 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.537 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.18 150.51 12.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.462 -0.495 . . . . 0.28000000000000003 111.588 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.501 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.38 125.02 50.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.626 -0.715 . . . . 1.0700000000000001 109.772 179.483 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.42 104.88 29.77 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.334 -0.394 . . . . 0.28999999999999998 111.036 -179.891 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -90.94 -179.49 1.51 Allowed 'Trans proline' 0 C--N 1.301 -1.944 0 C-N-CA 123.146 2.564 . . . . 0.42999999999999999 112.277 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 61.64 32.7 18.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.373 -0.831 . . . . 1.26 111.479 179.315 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.463 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.2 mt -86.51 148.59 25.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.778 0.323 . . . . 0.32000000000000001 110.388 179.632 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.767 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.35 114.86 61.36 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.093 0.473 . . . . 0.57999999999999996 110.58 -179.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.05 140.59 95.93 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.974 2.449 . . . . 0.66000000000000003 111.858 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.02 21.3 74.26 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.049 -0.821 . . . . 0.28999999999999998 111.049 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.452 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.9 150.16 49.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.758 0.314 . . . . 2.3300000000000001 110.584 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.5 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.22 131.64 46.05 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.018 -0.537 . . . . 0.85999999999999999 109.767 179.327 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.961 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.9 m-85 -120.55 148.26 44.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.091 -0.504 . . . . 0.52000000000000002 111.049 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.1 mt -105.3 125.3 60.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.288 -1.004 . . . . 0.29999999999999999 108.288 177.812 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.52 132.51 63.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.169 0.509 . . . . 0.23000000000000001 111.261 -178.591 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.53 122.64 20.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.527 -0.76 . . . . 0.35999999999999999 109.552 179.321 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.584 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.14 125.35 55.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.157 -0.474 . . . . 0.19 110.666 -179.545 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.841 ' CD2' ' NH2' ' A' ' 143' ' ' ARG . 48.3 m-85 -117.2 137.95 52.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.912 -0.586 . . . . 0.29999999999999999 109.869 179.556 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.576 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.73 134.92 42.98 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.817 -0.808 . . . . 0.37 108.817 178.895 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.88 HG21 ' HD2' ' A' ' 61' ' ' LYS . 51.6 mm -99.05 123.01 51.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.107 0.479 . . . . 0.26000000000000001 110.962 -178.769 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.0 p -83.97 169.73 14.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.557 -0.747 . . . . 0.28000000000000003 110.492 -179.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.84 -14.4 14.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.956 -0.566 . . . . 1.6000000000000001 110.916 -179.448 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -96.13 -4.28 43.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.839 0.352 . . . . 1.1799999999999999 110.875 -179.853 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.85 13.91 63.86 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.285 -0.726 . . . . 0.29999999999999999 111.285 179.792 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -84.66 139.14 32.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.728 0.299 . . . . 1.22 110.432 179.641 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -106.81 141.05 38.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.424 -0.353 . . . . 0.97999999999999998 110.545 179.764 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.2 m -136.64 126.99 26.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.82999999999999996 110.375 179.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.18 117.31 9.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.32 -0.4 . . . . 0.26000000000000001 110.467 -179.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.3 pt -108.99 -21.84 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.29999999999999999 110.676 -179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.89 125.68 5.85 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.526 -0.47 . . . . 0.31 111.555 -179.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.47 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.77 120.24 21.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.814 -0.63 . . . . 0.28000000000000003 109.538 179.259 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.65 151.69 29.08 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.619 -0.432 . . . . 0.23999999999999999 110.85 -179.259 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.4 158.65 18.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.042 -0.526 . . . . 0.23000000000000001 110.382 179.714 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -146.08 157.89 43.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.097 -0.501 . . . . 0.67000000000000004 110.643 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.24 104.31 9.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.819 -0.628 . . . . 0.64000000000000001 110.068 179.523 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.2 p . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.909 -1.043 . . . . 1.26 110.635 -179.657 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.549 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.2 m . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.189 -0.671 . . . . 3.4399999999999999 109.189 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.73 18.54 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.045 -0.822 . . . . 1.22 111.045 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -35.68 142.37 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.086 0 C-N-CA 123.97 3.113 . . . . 0.75 113.832 -179.271 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.604 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.96 173.5 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 114.192 -1.367 . . . . 0.79000000000000004 108.817 178.451 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.604 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.62 125.88 51.5 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.406 -0.518 . . . . 1.9399999999999999 111.41 -179.571 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 143.97 34.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.615 -0.721 . . . . 0.59999999999999998 110.71 179.82 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.27 25.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.893 0.378 . . . . 3.1400000000000001 111.133 -179.641 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.748 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.89 131.09 60.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.989 -0.551 . . . . 3.23 110.085 179.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.19 162.39 35.6 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.479 -0.328 . . . . 3.6299999999999999 111.257 -179.995 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 95.0 mt-10 36.06 31.56 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.642 -0.503 . . . . 6.0800000000000001 109.642 179.901 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.748 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.35 69.52 31.59 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.881 -0.599 . . . . 3.3799999999999999 111.564 -178.721 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.635 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.23 -29.16 73.21 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.522 2.148 . . . . 3.9300000000000002 111.821 179.39 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.635 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.65 125.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 3.3599999999999999 110.367 -179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.534 ' OE1' ' O ' ' A' ' 13' ' ' SER . 3.1 mp0 -123.97 158.31 60.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.334 -0.394 . . . . 3.6099999999999999 110.479 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.434 ' HG2' ' H ' ' A' ' 16' ' ' ASN . 97.0 Cg_endo -81.99 -64.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.935 2.424 . . . . 1.51 113.551 -179.035 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.863 HD21 ' CB ' ' A' ' 157' ' ' TYR . 28.1 m-80 -108.41 -19.64 13.39 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.051 0.389 . . . . 2.6800000000000002 112.051 -178.546 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 79.3 p -107.35 152.08 24.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.159 0.504 . . . . 1.21 111.302 -179.369 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.29 102.9 2.23 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.671 -0.695 . . . . 1.5600000000000001 110.656 179.918 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.5 Cg_endo -82.7 145.59 12.97 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.872 2.381 . . . . 0.81000000000000005 112.614 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.912 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.73 167.97 24.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.858 -0.61 . . . . 1.52 109.834 179.642 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.2 148.01 29.11 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.67 -0.493 . . . . 2.1400000000000001 109.67 178.822 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.59 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.7 p90 -142.27 157.2 45.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.979 0.419 . . . . 0.32000000000000001 111.223 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.494 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -127.99 155.37 44.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.851 -0.613 . . . . 2.1699999999999999 110.094 178.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.83 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.64 173.13 6.24 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.07 -0.514 . . . . 0.58999999999999997 110.716 -179.22 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.83 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.65 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 122.849 2.366 . . . . 0.90000000000000002 111.515 179.393 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -51.08 0.69 Allowed Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.741 -0.383 . . . . 3.3399999999999999 110.072 179.838 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.633 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.88 152.34 82.57 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.754 2.303 . . . . 1.8500000000000001 111.456 179.245 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.66 42.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.446 0.641 . . . . 2.54 110.647 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.821 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.59 -41.64 98.33 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.004 -0.998 . . . . 2.5299999999999998 110.669 179.742 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.532 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.8 mt -109.82 137.8 40.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.814 -0.63 . . . . 1.1699999999999999 111.349 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.01 -72.89 0.7 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.125 -0.489 . . . . 1.27 111.833 -178.906 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -88.19 148.41 24.4 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.546 0.573 . . . . 1.1200000000000001 112.546 -179.651 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -121.76 124.82 45.12 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.34 -0.615 . . . . 0.41999999999999998 109.34 177.542 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.01 134.66 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.731 -0.388 . . . . 0.78000000000000003 110.74 179.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.912 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.01 128.71 53.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.008 0.432 . . . . 0.62 111.213 179.78 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 139.02 49.7 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.693 -0.685 . . . . 1.97 110.112 179.004 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.435 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.12 163.21 35.01 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-O 121.162 0.506 . . . . 0.34999999999999998 112.077 -178.135 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.491 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.46 139.52 7.84 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 115.473 -0.785 . . . . 1.8 110.487 178.927 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.5 Cg_endo -63.55 115.55 3.1 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.279 1.986 . . . . 0.57999999999999996 111.82 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.667 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.98 81.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.894 -0.409 . . . . 3.04 109.894 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.688 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.3 -20.68 0.06 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.025 -0.534 . . . . 2.4700000000000002 111.932 -179.48 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.62 157.81 34.33 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.819 -0.352 . . . . 2.5099999999999998 110.598 179.682 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.406 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.33 27.78 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 1.8600000000000001 110.203 179.611 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.89 -75.78 1.31 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.088 -0.577 . . . . 1.4399999999999999 111.836 -179.242 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.95 152.29 35.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.991 0.424 . . . . 4.6900000000000004 110.946 -179.35 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.18 -169.07 2.52 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.009 -0.542 . . . . 1.4299999999999999 111.911 179.373 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.19 149.61 29.85 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 121.473 0.654 . . . . 1.74 112.543 -177.822 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.03 156.47 46.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.8 -1.091 . . . . 1.9199999999999999 110.25 178.633 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.466 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.23 158.38 41.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.964 -0.562 . . . . 0.34000000000000002 111.866 -179.368 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.3 m -115.19 135.57 54.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.519 -0.764 . . . . 0.40999999999999998 109.862 179.33 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.59 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.36 121.97 23.82 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.415 -0.357 . . . . 0.55000000000000004 111.493 -179.073 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.6 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.4 Cg_exo -46.33 151.74 1.63 Allowed 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.593 2.195 . . . . 0.44 112.177 178.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.89 -23.01 62.99 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 116.128 -0.487 . . . . 0.73999999999999999 112.77 -179.252 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.546 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.86 -16.91 45.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.456 0.628 . . . . 0.93000000000000005 111.734 -178.264 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.6 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.56 138.37 31.62 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.873 -0.331 . . . . 0.96999999999999997 110.314 179.361 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.58 14.05 10.97 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.32 -0.4 . . . . 1.3400000000000001 111.479 -179.402 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.474 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.4 p -150.04 143.4 25.13 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.599 -0.441 . . . . 0.39000000000000001 110.961 179.644 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.721 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.78 -169.37 1.53 Allowed 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.242 0.544 . . . . 0.41999999999999998 110.874 -179.505 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.739 ' OG1' ' C ' ' A' ' 188' ' ' ASP . 2.6 m -151.78 125.92 9.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.371 -0.832 . . . . 0.39000000000000001 109.814 179.276 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.515 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.8 mt -114.88 123.25 70.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.448 -0.501 . . . . 0.73999999999999999 111.199 -179.699 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -126.49 163.35 23.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.842 -0.617 . . . . 2.48 110.394 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.684 ' H ' HH22 ' A' ' 143' ' ' ARG . . . 85.04 19.07 59.86 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.728 -0.949 . . . . 0.5 110.728 -179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.515 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.5 mt -79.11 157.22 28.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.06 0.457 . . . . 0.57999999999999996 111.362 -179.679 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.854 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.7 mtpp -99.46 134.02 21.5 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.561 -0.745 . . . . 2.79 110.473 179.779 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.91 143.58 61.24 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.573 2.182 . . . . 0.87 111.899 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.81 25.63 75.33 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.034 -0.826 . . . . 0.64000000000000001 111.034 179.686 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.854 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.14 158.81 39.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.694 0.283 . . . . 0.82999999999999996 110.398 -179.592 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.16 140.02 41.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.843 0.354 . . . . 0.5 110.565 -179.813 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.658 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.7 m-85 -122.63 136.38 54.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.901 -0.59 . . . . 0.53000000000000003 110.792 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.491 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.76 131.03 45.21 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.593 -0.892 . . . . 1.8700000000000001 108.593 177.574 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.55 153.83 16.67 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.244 -0.979 . . . . 0.28999999999999998 111.981 -178.635 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.89 140.98 46.2 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.782 -0.451 . . . . 1.4299999999999999 109.782 179.534 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.525 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.4 tp -115.78 118.92 34.38 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.39 -0.524 . . . . 0.32000000000000001 110.525 179.72 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.738 HG12 HG23 ' A' ' 84' ' ' VAL . 63.9 mt -112.42 129.05 68.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.372 -0.376 . . . . 0.79000000000000004 110.632 -179.851 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.708 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.75 120.82 43.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.333 -0.394 . . . . 1.02 110.756 -179.7 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.864 HD12 ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.55 146.52 11.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.182 0.515 . . . . 0.62 111.04 -179.302 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.821 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.03 153.9 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.515 -0.766 . . . . 2.4399999999999999 109.973 179.816 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.2 88.6 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.965 0.412 . . . . 3.6899999999999999 110.392 -179.768 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.618 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.27 32.69 0.21 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.786 -0.643 . . . . 6.0800000000000001 110.582 -179.94 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.12 -117.43 3.29 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.405 -0.678 . . . . 1.22 111.405 -179.684 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.464 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.5 177.37 8.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.168 0.509 . . . . 2.8799999999999999 111.652 -179.181 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -148.12 149.54 32.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.38 -0.827 . . . . 1.47 110.375 179.223 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.18 144.63 38.64 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.485 -0.325 . . . . 2.7000000000000002 110.513 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.738 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.97 136.02 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 120.619 -0.432 . . . . 0.46000000000000002 111.519 -179.777 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.574 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.15 141.32 52.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.645 -0.707 . . . . 0.34999999999999998 110.284 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.4 ttp180 -117.66 138.9 51.67 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.502 -0.479 . . . . 3.6699999999999999 111.531 -179.32 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.25 164.21 37.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.524 -0.762 . . . . 0.67000000000000004 109.502 179.467 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.575 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.31 151.53 38.48 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.37 -0.532 . . . . 1.47 110.974 179.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.802 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.19 172.81 12.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.754 -0.657 . . . . 0.44 111.027 179.817 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.77 160.63 21.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.523 -0.762 . . . . 1.3700000000000001 109.892 179.621 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.33 121.89 23.03 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.568 -0.453 . . . . 1.28 110.777 179.972 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.2 p -127.56 147.96 50.34 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.119 -0.491 . . . . 1.97 112.292 179.728 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.1 t -66.36 -36.91 84.07 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.417 -0.811 . . . . 3.2799999999999998 113.008 178.691 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.9 p -81.97 163.51 22.12 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.715 -177.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 82.9 p -112.06 148.63 33.49 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.534 179.696 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.413 ' N ' ' CD ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER -54.98 -50.58 85.58 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.742 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 96' ' ' THR . 34.4 Cg_exo -59.85 140.81 94.91 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 122.279 1.986 . . . . 0.0 113.05 -178.828 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.2 m -130.64 157.54 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.533 178.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 19.9 p -122.34 154.2 37.97 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.011 0.434 . . . . 0.0 110.821 179.534 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.9 p -90.57 -0.56 57.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.311 179.704 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.617 ' C ' ' H ' ' A' ' 103' ' ' VAL . 80.9 m-20 -74.24 -70.83 0.37 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.183 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 102' ' ' THR . 78.7 m 54.75 -2.4 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.893 0.378 . . . . 0.0 110.641 -179.293 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.617 ' H ' ' C ' ' A' ' 101' ' ' ASN . 80.8 t -61.91 -36.37 73.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.187 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 45.5 m -65.66 136.64 56.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.212 0.53 . . . . 0.0 111.407 -178.403 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.468 ' H ' HG22 ' A' ' 107' ' ' THR . . . 149.04 -51.06 0.55 Allowed Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.773 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.475 ' C ' ' H ' ' A' ' 108' ' ' THR . 97.0 mt-10 -62.7 -30.48 71.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.933 0.397 . . . . 0.0 110.714 179.27 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -53.91 -4.45 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.405 -179.238 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.475 ' H ' ' C ' ' A' ' 106' ' ' GLU . 33.7 p -119.79 75.19 19.65 Favored Pre-proline 0 N--CA 1.465 0.306 0 CA-C-O 120.595 0.236 . . . . 0.0 110.43 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.43 151.85 50.72 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.657 2.238 . . . . 0.0 111.871 179.646 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -100.68 129.7 46.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.09 0.472 . . . . 0.0 111.45 -179.425 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.5 p -128.98 76.09 79.62 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.653 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.61 148.19 45.39 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.422 2.081 . . . . 0.0 112.703 -179.544 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.744 HD12 ' N ' ' A' ' 113' ' ' LEU . 4.7 mp -84.29 150.5 25.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.527 -0.761 . . . . 10.19 110.416 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.7 t -61.18 135.26 26.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.159 0.504 . . . . 7.2800000000000002 110.797 -179.187 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.72 151.08 34.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.453 -0.794 . . . . 7.2999999999999998 111.513 -179.403 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.2 p -76.98 165.32 24.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.694 -0.684 . . . . 6.4400000000000004 109.686 179.816 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.5 p -65.21 157.85 27.72 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.409 -0.516 . . . . 4.4199999999999999 110.922 -178.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -63.9 -31.58 72.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.572 -0.74 . . . . 3.0499999999999998 111.764 -179.425 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.9 t -56.42 -38.46 71.6 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.756 -0.378 . . . . 3.4300000000000002 111.689 -177.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.8 m -132.32 150.96 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 120.644 -0.423 . . . . 2.8799999999999999 111.55 179.73 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 52.5 p -115.39 9.75 15.65 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.589 -0.732 . . . . 2.0899999999999999 109.531 178.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.58 144.47 42.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.526 -0.761 . . . . 4.5300000000000002 112.002 -178.981 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.454 HG22 ' H ' ' A' ' 125' ' ' ALA . 27.1 mm -112.49 136.69 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.37 -0.832 . . . . 1.4399999999999999 109.085 179.145 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.665 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 65.5 p -62.69 -34.31 76.88 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.684 -0.407 . . . . 1.78 111.344 -178.781 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' A' ' 124' ' ' THR . . . 157.63 92.13 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.127 0.267 . . . . 0.64000000000000001 110.395 179.679 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.5 p -61.79 -30.73 71.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.259 0.552 . . . . 0.66000000000000003 109.881 179.449 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.444 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.85 167.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.536 -0.756 . . . . 0.68999999999999995 110.96 179.939 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.59 145.57 50.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.664 -0.698 . . . . 0.52000000000000002 110.125 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.25 101.68 9.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.051 -0.722 . . . . 0.32000000000000001 109.051 177.725 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.3 t -112.95 139.7 36.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.992 -0.549 . . . . 0.28999999999999998 111.107 -178.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.0 p -128.76 152.55 48.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.705 -0.679 . . . . 0.25 109.795 179.609 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.75 -164.85 2.01 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.62 -0.432 . . . . 0.31 110.651 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.6 t -123.97 127.17 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.48999999999999999 110.804 -179.835 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.174 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.1 p -57.89 58.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.111 -0.495 . . . . 1.53 110.44 179.733 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.743 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.13 24.57 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.971 -0.559 . . . . 0.96999999999999997 111.478 -179.591 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.174 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.1 128.62 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.674 -0.41 . . . . 1.5600000000000001 110.999 179.833 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.35 -9.52 56.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.883 -0.599 . . . . 1.8799999999999999 110.381 179.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.8 p -87.16 0.32 55.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.52 . . . . 1.04 110.27 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.33 137.19 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.023 -0.535 . . . . 0.23999999999999999 109.977 179.717 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.614 ' N ' ' O ' ' A' ' 185' ' ' ILE . 93.8 p -96.2 -15.56 21.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.248 0.547 . . . . 0.28999999999999998 110.046 -179.673 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.61 175.67 45.88 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 109.859 -1.297 . . . . 0.13 109.859 179.595 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.46 151.6 42.54 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.683 -0.407 . . . . 0.17000000000000001 110.525 179.778 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.684 HH22 ' H ' ' A' ' 62' ' ' GLY . 10.3 tpp180 -132.35 121.18 23.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.172 -0.467 . . . . 1.29 109.911 179.809 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.555 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.08 136.63 38.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.74 -0.664 . . . . 0.25 110.632 -179.777 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 79.3 tt0 -129.41 129.89 45.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.996 -0.547 . . . . 1.3200000000000001 110.044 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.625 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.4 p90 -138.71 135.24 34.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.055 -0.52 . . . . 0.56999999999999995 110.611 -179.669 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.418 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.27 161.32 39.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.841 -0.618 . . . . 1.1599999999999999 109.734 179.834 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.955 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.4 mt -71.02 124.78 25.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.011 0.434 . . . . 0.38 110.767 -179.644 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.67 -7.7 49.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.777 -0.647 . . . . 0.40999999999999998 110.915 -179.814 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.88 -69.58 0.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.303 -0.408 . . . . 1.6599999999999999 111.449 -179.283 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.449 ' CD ' HH21 ' A' ' 176' ' ' ARG . 53.9 mt-10 -60.74 -35.33 76.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.074 -0.512 . . . . 1.6599999999999999 111.506 -179.184 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.08 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.15 7.26 88.57 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.857 -0.897 . . . . 1.1699999999999999 110.857 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.341 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.4 t0 -27.9 -171.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 1.8600000000000001 110.229 179.798 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.341 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.4 139.1 44.67 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.036 0.446 . . . . 1.98 110.185 179.614 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.418 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 45.8 Cg_endo -70.91 145.79 51.39 Favored 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 122.675 2.25 . . . . 0.55000000000000004 112.302 -179.466 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.625 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.75 145.72 42.54 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.318 -0.623 . . . . 1.1399999999999999 109.318 179.157 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.863 ' CB ' HD21 ' A' ' 16' ' ' ASN . 22.3 p90 -123.27 141.34 52.09 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.384 -0.526 . . . . 0.93000000000000005 111.536 -179.067 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.9 mt -128.14 127.66 43.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.314 -0.857 . . . . 0.34000000000000002 108.936 178.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.625 ' HB2' ' NH1' ' A' ' 143' ' ' ARG . 29.5 t0 -101.6 131.09 47.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.171 0.51 . . . . 1.0900000000000001 111.738 -178.77 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.91 157.52 73.49 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.2 -0.909 . . . . 0.19 109.583 179.643 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -69.8 158.14 57.94 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.351 2.034 . . . . 0.17999999999999999 112.3 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.36 -12.19 5.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.733 -0.667 . . . . 0.20999999999999999 110.744 -179.782 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.9 p -92.77 -8.71 42.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.086 -0.506 . . . . 0.28999999999999998 110.718 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.14 135.38 34.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 0.5 110.378 179.67 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.5 p -133.18 16.72 4.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.29999999999999999 110.552 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.1 p -167.59 147.12 5.04 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.619 -0.512 . . . . 0.23000000000000001 109.619 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.555 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.2 150.46 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.548 -0.461 . . . . 0.28000000000000003 111.59 -179.653 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.509 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.31 124.98 50.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.637 -0.71 . . . . 1.0700000000000001 109.812 179.493 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.37 104.9 29.71 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.412 -0.358 . . . . 0.28999999999999998 111.107 -179.897 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.7 Cg_endo -91.06 -179.49 1.47 Allowed 'Trans proline' 0 C--N 1.301 -1.964 0 C-N-CA 123.178 2.585 . . . . 0.42999999999999999 112.213 179.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 61.63 32.71 18.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.463 -0.79 . . . . 1.26 111.439 179.302 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.1 mt -86.35 148.51 25.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.436 -0.347 . . . . 0.32000000000000001 110.469 179.547 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.774 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.29 114.83 61.2 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.076 0.465 . . . . 0.57999999999999996 110.645 -179.75 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.98 140.58 95.96 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.908 2.405 . . . . 0.66000000000000003 111.959 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.08 21.15 74.45 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.006 -0.837 . . . . 0.28999999999999998 111.006 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.449 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.8 mmm-85 -126.87 150.27 49.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.38 . . . . 2.3300000000000001 110.6 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.5 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.23 131.63 46.06 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.011 -0.54 . . . . 0.85999999999999999 109.737 179.392 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.955 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.44 148.36 43.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.099 -0.501 . . . . 0.52000000000000002 111.037 -179.868 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.34 125.34 60.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.258 -1.016 . . . . 0.29999999999999999 108.258 177.745 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.54 132.53 63.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.085 0.469 . . . . 0.23000000000000001 111.221 -178.595 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.54 122.56 20.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.591 -0.732 . . . . 0.35999999999999999 109.626 179.258 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.03 125.37 54.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.181 -0.463 . . . . 0.19 110.729 -179.556 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.14 137.83 52.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.014 -0.539 . . . . 0.29999999999999999 109.903 179.565 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.584 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.63 134.98 42.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.815 -0.809 . . . . 0.37 108.815 178.832 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.614 ' O ' ' N ' ' A' ' 140' ' ' SER . 46.0 mm -99.05 122.94 51.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.131 0.491 . . . . 0.26000000000000001 111.024 -178.826 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.6 p -83.76 169.66 14.98 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.571 -0.74 . . . . 0.28000000000000003 110.511 -179.688 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.87 -14.43 15.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.034 -0.53 . . . . 1.6000000000000001 110.979 -179.593 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.739 ' C ' ' OG1' ' A' ' 59' ' ' THR . 96.3 m-20 -96.03 -4.3 43.31 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.894 -0.323 . . . . 1.1799999999999999 110.861 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.508 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.79 13.9 63.99 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.354 -0.699 . . . . 0.29999999999999999 111.354 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -84.72 139.06 32.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.696 0.284 . . . . 1.22 110.389 179.731 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -106.61 141.02 38.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.423 -0.353 . . . . 0.97999999999999998 110.674 179.646 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.0 m -136.73 127.09 26.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.82999999999999996 110.338 179.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 25.5 tp -68.19 117.38 9.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.959 0.409 . . . . 0.26000000000000001 110.451 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.06 -21.86 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.29999999999999999 110.71 -179.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.86 125.73 5.88 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 120.442 -0.503 . . . . 0.31 111.508 -179.757 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.46 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.81 120.21 21.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.792 -0.64 . . . . 0.28000000000000003 109.581 179.195 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.63 151.7 29.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.96 0.41 . . . . 0.23999999999999999 110.883 -179.239 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.45 158.6 18.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.009 -0.542 . . . . 0.23000000000000001 110.409 179.725 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -146.11 157.92 43.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.087 -0.506 . . . . 0.67000000000000004 110.678 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.3 104.34 9.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.811 -0.631 . . . . 0.64000000000000001 110.053 179.582 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.58 ' O ' HD13 ' A' ' 113' ' ' LEU . 67.3 p . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.964 -1.017 . . . . 1.26 110.61 -179.641 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.548 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.7 m . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.209 -0.663 . . . . 3.4399999999999999 109.209 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.4 150.66 18.54 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.023 -0.831 . . . . 1.22 111.023 179.814 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -35.65 142.37 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.114 0 C-N-CA 123.956 3.104 . . . . 0.75 113.881 -179.23 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.617 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.96 173.35 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.261 -1.336 . . . . 0.79000000000000004 108.841 178.507 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.617 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.49 125.89 51.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.127 0.489 . . . . 1.9399999999999999 111.454 -179.639 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.56 144.01 33.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.575 -0.739 . . . . 0.59999999999999998 110.621 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.08 168.24 25.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.914 0.388 . . . . 3.1400000000000001 111.118 -179.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.741 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.5 mt -108.91 131.07 60.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.042 -0.526 . . . . 3.23 110.06 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.5 p -141.24 162.27 35.88 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.853 0.358 . . . . 3.6299999999999999 111.203 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 48.1 mt-10 36.1 31.61 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.625 -0.509 . . . . 6.0800000000000001 109.625 179.847 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.741 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.6 33.11 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.951 -0.568 . . . . 3.3799999999999999 111.609 -178.844 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.639 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.24 -29.13 73.12 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.486 2.124 . . . . 3.9300000000000002 111.838 179.325 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.683 ' H ' HE22 ' A' ' 14' ' ' GLN . 3.2 m 149.58 125.62 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 3.3599999999999999 110.527 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.707 ' O ' ' O ' ' A' ' 92' ' ' THR . 1.8 mp0 -123.99 158.3 60.75 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 3.6099999999999999 110.411 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.552 ' CG ' ' CZ ' ' A' ' 143' ' ' ARG . 98.3 Cg_endo -82.05 -64.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.874 2.383 . . . . 1.51 113.491 -178.983 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.727 ' ND2' ' CD1' ' A' ' 157' ' ' TYR . 1.2 m120 -108.44 -19.6 13.4 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.12 0.415 . . . . 2.6800000000000002 112.12 -178.562 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.736 ' OG ' ' NZ ' ' A' ' 61' ' ' LYS . 55.8 m -107.3 152.03 24.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.171 0.51 . . . . 1.21 111.298 -179.411 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.571 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.1 t-80 -155.21 102.88 2.24 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.681 -0.69 . . . . 1.5600000000000001 110.618 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.66 145.64 13.04 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.925 2.417 . . . . 0.81000000000000005 112.643 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.915 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.8 167.9 24.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.89 -0.595 . . . . 1.52 109.885 179.561 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -149.12 147.97 29.1 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.677 -0.49 . . . . 2.1400000000000001 109.677 178.859 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.597 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.3 p90 -142.21 157.35 44.96 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.623 -0.431 . . . . 0.32000000000000001 111.167 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.49 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.05 155.24 44.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.822 -0.626 . . . . 2.1699999999999999 110.119 178.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.83 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.58 173.09 6.29 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.081 -0.508 . . . . 0.58999999999999997 110.765 -179.217 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.83 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.68 174.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.909 2.406 . . . . 0.90000000000000002 111.518 179.362 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.11 -51.16 0.68 Allowed Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.727 -0.389 . . . . 3.3399999999999999 110.054 179.899 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.617 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.74 152.32 82.44 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.769 2.312 . . . . 1.8500000000000001 111.442 179.189 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.69 42.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.351 0.596 . . . . 2.54 110.531 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.815 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.58 -41.72 98.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.05 -0.977 . . . . 2.5299999999999998 110.609 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.532 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.2 mt -109.86 137.83 40.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.782 -0.644 . . . . 1.1699999999999999 111.23 -179.363 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.94 -72.88 0.7 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.031 -0.531 . . . . 1.27 111.937 -178.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.15 148.36 24.46 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.559 0.577 . . . . 1.1200000000000001 112.559 -179.665 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.87 124.84 45.06 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.302 -0.629 . . . . 0.41999999999999998 109.302 177.543 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 mt -117.97 134.68 60.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.787 -0.365 . . . . 0.78000000000000003 110.642 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.915 HD13 HD11 ' A' ' 20' ' ' ILE . 8.8 mt -120.01 128.63 53.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.435 . . . . 0.62 111.292 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.14 138.97 49.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.727 -0.67 . . . . 1.97 110.145 179.014 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.433 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.1 p90 -145.07 163.26 34.81 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 121.265 0.555 . . . . 0.34999999999999998 112.037 -178.117 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.491 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.55 139.51 7.76 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 115.431 -0.804 . . . . 1.8 110.506 178.873 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.3 Cg_endo -63.5 115.46 3.05 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.344 2.03 . . . . 0.57999999999999996 111.81 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.674 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.02 81.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.882 -0.414 . . . . 3.04 109.882 -179.81 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.72 0.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.943 -0.571 . . . . 2.4700000000000002 111.916 -179.467 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.4 p -157.55 157.82 34.48 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.848 -0.341 . . . . 2.5099999999999998 110.613 179.769 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.4 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.8 m -120.42 27.85 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.438 . . . . 1.8600000000000001 110.144 179.558 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.78 -75.9 1.31 Allowed Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.107 -0.568 . . . . 1.4399999999999999 111.886 -179.284 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.88 152.34 35.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.944 0.402 . . . . 4.6900000000000004 110.994 -179.42 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.676 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.21 -169.1 2.53 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.033 -0.53 . . . . 1.4299999999999999 111.989 179.367 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.431 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.19 149.68 29.75 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.412 0.625 . . . . 1.74 112.583 -177.848 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.06 156.52 45.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.837 -1.074 . . . . 1.9199999999999999 110.241 178.688 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.2 158.46 41.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.968 -0.56 . . . . 0.34000000000000002 111.822 -179.349 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.6 m -115.31 135.72 53.85 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.479 -0.782 . . . . 0.40999999999999998 109.747 179.291 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.597 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.46 121.93 23.69 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.385 -0.371 . . . . 0.55000000000000004 111.579 -179.182 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.0 Cg_exo -46.24 151.67 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.729 2.286 . . . . 0.44 112.129 179.042 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.84 -23.11 63.01 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 116.083 -0.508 . . . . 0.73999999999999999 112.77 -179.227 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.81 -16.83 46.24 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.224 -0.59 . . . . 0.93000000000000005 111.819 -178.319 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.604 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.67 138.49 31.52 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.709 -0.397 . . . . 0.96999999999999997 110.246 179.398 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.54 13.9 10.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.345 -0.389 . . . . 1.3400000000000001 111.542 -179.363 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.476 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.97 143.41 25.19 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.63 -0.428 . . . . 0.39000000000000001 111.059 179.676 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.714 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.4 t80 -114.76 -169.37 1.53 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.167 0.508 . . . . 0.41999999999999998 110.899 -179.432 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.714 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.81 125.78 9.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.454 -0.794 . . . . 0.39000000000000001 109.858 179.278 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.513 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.81 123.16 70.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.382 -0.527 . . . . 0.73999999999999999 111.282 -179.798 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.736 ' NZ ' ' OG ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -126.41 163.4 23.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.882 -0.599 . . . . 2.48 110.426 179.749 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.642 ' H ' ' HD3' ' A' ' 61' ' ' LYS . . . 85.11 19.0 59.86 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.759 -0.936 . . . . 0.5 110.759 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.513 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.9 mt -78.98 157.25 28.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.111 0.482 . . . . 0.57999999999999996 111.3 -179.631 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.855 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -99.51 133.9 21.56 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.627 -0.715 . . . . 2.79 110.415 179.743 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.423 ' HD3' ' CE2' ' A' ' 157' ' ' TYR . 36.9 Cg_endo -67.76 143.61 62.21 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.571 2.181 . . . . 0.87 112.022 179.731 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.76 25.6 75.37 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.061 -0.816 . . . . 0.64000000000000001 111.061 179.715 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.855 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.14 158.77 39.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.751 0.31 . . . . 0.82999999999999996 110.444 -179.673 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.13 140.08 41.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.932 0.396 . . . . 0.5 110.516 -179.765 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.644 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.4 m-85 -122.65 136.46 54.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.886 -0.597 . . . . 0.53000000000000003 110.75 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.491 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.86 131.02 45.28 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.506 -0.924 . . . . 1.8700000000000001 108.506 177.637 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.46 153.92 16.64 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 120.321 -0.942 . . . . 0.28999999999999998 111.985 -178.685 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.98 140.87 46.03 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.71 -0.478 . . . . 1.4299999999999999 109.71 179.61 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.71 118.9 34.34 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.526 -0.47 . . . . 0.32000000000000001 110.534 179.691 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.731 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.5 129.09 68.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 0.79000000000000004 110.647 -179.883 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.708 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.86 120.76 43.47 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.327 -0.397 . . . . 1.02 110.691 -179.577 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.85 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.54 146.47 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.197 0.523 . . . . 0.62 111.0 -179.266 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.815 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.09 153.9 21.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.501 -0.772 . . . . 2.4399999999999999 109.924 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.21 88.51 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.938 0.399 . . . . 3.6899999999999999 110.426 -179.653 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.628 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.42 32.61 0.23 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.807 -0.633 . . . . 6.0800000000000001 110.581 -179.906 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.14 -117.28 3.28 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.492 -0.643 . . . . 1.22 111.492 -179.722 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.47 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.1 m170 -81.55 177.41 8.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.18 0.514 . . . . 2.8799999999999999 111.516 -179.106 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.2 149.58 32.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.444 -0.798 . . . . 1.47 110.415 179.107 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.548 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.22 144.58 38.54 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.454 -0.339 . . . . 2.7000000000000002 110.592 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.731 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.91 135.97 61.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.597 -0.441 . . . . 0.46000000000000002 111.586 -179.761 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -123.99 141.32 52.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.733 -0.667 . . . . 0.34999999999999998 110.259 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.468 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.65 138.96 51.62 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.134 0.492 . . . . 3.6699999999999999 111.463 -179.414 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.37 164.15 38.07 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.514 -0.766 . . . . 0.67000000000000004 109.442 179.352 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.569 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.15 151.59 38.69 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.366 -0.534 . . . . 1.47 110.985 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.3 172.75 13.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.689 -0.687 . . . . 0.44 111.018 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.74 160.67 21.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.443 -0.799 . . . . 1.3700000000000001 109.846 179.66 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.38 121.8 22.84 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.624 -0.43 . . . . 1.28 110.833 179.962 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.707 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.2 p -127.85 170.0 13.28 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 116.09 -0.504 . . . . 1.97 110.677 179.683 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.9 m -106.22 146.07 30.77 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.11 0.481 . . . . 3.2799999999999998 110.119 179.415 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.3 t -78.0 -15.92 58.54 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.393 -178.254 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 61.7 m -60.07 151.21 27.18 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.187 -178.89 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.438 ' CB ' ' CD ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER -177.69 -63.86 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.982 179.799 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 96' ' ' THR . 19.2 Cg_endo -58.27 142.49 97.48 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.358 2.038 . . . . 0.0 111.964 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.2 p -133.59 141.58 43.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.842 179.621 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' ' 149' ' ' SER . 18.9 p -125.49 157.26 37.43 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 84.8 p -146.36 157.75 43.82 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.075 0.464 . . . . 0.0 111.536 179.608 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.45 ' CG ' ' HZ2' ' A' ' 177' ' ' LYS . 35.7 p-10 -125.8 15.06 8.06 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.298 178.536 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 58.0 m -84.72 141.26 30.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.757 -178.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.8 t -65.9 139.71 20.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.024 179.367 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.3 t -128.25 159.89 33.83 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.539 -179.098 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.09 -89.05 1.01 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -178.263 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.43 -31.42 72.11 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.567 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 47.5 m -73.93 142.72 45.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.709 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.34 156.76 14.45 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.304 -179.637 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -49.91 149.29 11.45 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.395 2.063 . . . . 0.0 112.864 -179.359 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -56.92 -34.14 67.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.021 -179.748 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.1 t -123.47 80.24 54.04 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.178 -179.157 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.41 149.9 28.43 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.51 2.14 . . . . 0.0 111.602 179.487 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.9 tp -55.49 -37.48 67.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.374 -0.375 . . . . 10.19 110.382 -179.66 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.0 t -114.9 134.29 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.304 -0.407 . . . . 7.2800000000000002 110.449 179.634 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.93 144.51 56.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 7.2999999999999998 110.653 179.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.2 m -57.85 -39.0 76.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.288 -0.415 . . . . 6.4400000000000004 110.445 179.755 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 92.4 p -124.15 155.3 38.7 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.127 -0.488 . . . . 4.4199999999999999 110.447 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.56 142.8 51.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 3.0499999999999998 110.747 -179.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.2 p -62.35 -25.9 68.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 3.4300000000000002 110.726 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 121' ' ' THR . 71.2 t -59.66 -39.79 80.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 2.8799999999999999 110.474 -179.572 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 120' ' ' VAL . 25.0 m 37.17 78.18 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.306 -0.406 . . . . 2.0899999999999999 111.062 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.63 -32.73 72.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.062 -0.517 . . . . 4.5300000000000002 111.09 -179.559 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 17.2 tt -121.48 137.76 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.834 0.349 . . . . 1.4399999999999999 110.685 -179.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.2 p -120.99 161.08 22.22 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.068 -0.515 . . . . 1.78 110.463 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' A' ' 127' ' ' SER . . . -174.1 -121.7 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.998 -0.546 . . . . 0.64000000000000001 110.21 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.3 OUTLIER 42.93 17.04 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.272 -0.422 . . . . 0.66000000000000003 111.511 179.709 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.83 167.54 0.25 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.917 -0.583 . . . . 0.68999999999999995 110.99 179.868 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.59 145.59 50.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.748 -0.66 . . . . 0.52000000000000002 110.11 -179.881 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.4 t -124.35 101.65 9.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.08 -0.711 . . . . 0.32000000000000001 109.08 177.734 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.5 t -112.96 139.74 36.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.978 -0.555 . . . . 0.28999999999999998 111.071 -178.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.1 p -128.78 152.5 48.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.613 -0.721 . . . . 0.25 109.741 179.745 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.588 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.8 -165.0 2.05 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.675 -0.41 . . . . 0.31 110.618 -179.775 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.738 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.0 t -123.86 127.15 73.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.218 -0.446 . . . . 0.48999999999999999 110.894 -179.881 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.158 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.8 58.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 1.53 110.36 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.738 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.19 24.56 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.99 -0.55 . . . . 0.96999999999999997 111.541 -179.583 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.158 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.16 128.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.615 -0.434 . . . . 1.5600000000000001 110.95 179.831 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -86.45 -9.66 55.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.973 -0.558 . . . . 1.8799999999999999 110.295 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.09 0.2 55.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 1.04 110.313 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.25 137.16 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.957 -0.565 . . . . 0.23999999999999999 109.997 179.711 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 185' ' ' ILE . 0.2 OUTLIER -96.2 -15.55 21.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.32 0.581 . . . . 0.28999999999999998 110.021 -179.613 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.6 175.52 45.74 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 109.863 -1.295 . . . . 0.13 109.863 179.685 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -123.39 151.63 42.38 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.655 -0.418 . . . . 0.17000000000000001 110.523 179.711 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.632 ' NH1' ' CB ' ' A' ' 157' ' ' TYR . 10.4 ttt85 -132.34 121.22 23.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.078 -0.51 . . . . 1.29 109.954 179.754 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.542 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.09 136.53 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.666 -0.697 . . . . 0.25 110.678 -179.752 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 84.2 tt0 -129.37 129.88 45.33 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.017 -0.538 . . . . 1.3200000000000001 110.128 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.73 135.29 34.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.001 -0.545 . . . . 0.56999999999999995 110.653 -179.684 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.412 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.26 161.34 39.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.721 -0.672 . . . . 1.1599999999999999 109.682 179.883 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.965 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.06 124.83 25.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.971 0.415 . . . . 0.38 110.764 -179.662 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.74 -7.63 49.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.709 -0.678 . . . . 0.40999999999999998 110.872 -179.775 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -109.87 -69.67 0.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.979 0.418 . . . . 1.6599999999999999 111.386 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.441 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.74 -35.28 75.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.03 -0.532 . . . . 1.6599999999999999 111.44 -179.095 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.09 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.08 7.26 88.56 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.858 -0.897 . . . . 1.1699999999999999 110.858 -179.787 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.315 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.98 -171.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.331 . . . . 1.8600000000000001 110.218 179.86 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.315 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.19 139.03 45.35 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.962 0.41 . . . . 1.98 110.233 179.627 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.412 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.1 Cg_endo -70.88 145.87 51.79 Favored 'Trans proline' 0 C--N 1.299 -2.053 0 C-N-CA 122.751 2.301 . . . . 0.55000000000000004 112.286 -179.469 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.91 145.7 42.68 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.199 -0.667 . . . . 1.1399999999999999 109.199 179.237 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.727 ' CD1' ' ND2' ' A' ' 16' ' ' ASN . 43.2 p90 -123.31 141.33 52.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.269 0.557 . . . . 0.93000000000000005 111.506 -179.102 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.3 mt -128.08 127.62 43.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.297 -0.865 . . . . 0.34000000000000002 109.021 178.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -101.58 131.11 47.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.178 0.513 . . . . 1.0900000000000001 111.812 -178.736 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.93 157.51 73.56 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.315 -0.857 . . . . 0.19 109.658 179.653 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -69.83 158.08 58.08 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 C-N-CA 122.389 2.059 . . . . 0.17999999999999999 112.215 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.28 -12.2 5.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.754 -0.657 . . . . 0.20999999999999999 110.736 -179.775 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.7 p -92.8 -8.68 42.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.132 -0.486 . . . . 0.28999999999999998 110.79 -179.93 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.39 34.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.247 -0.433 . . . . 0.5 110.354 179.701 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.8 p -133.16 16.73 4.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.394 -0.367 . . . . 0.29999999999999999 110.492 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.4 p -167.54 147.13 5.08 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.569 -0.53 . . . . 0.23000000000000001 109.569 179.841 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.542 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.14 150.52 12.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.467 -0.493 . . . . 0.28000000000000003 111.592 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.506 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.34 124.9 50.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.674 -0.694 . . . . 1.0700000000000001 109.803 179.504 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.33 104.82 29.06 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.382 -0.372 . . . . 0.28999999999999998 111.131 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.5 Cg_endo -90.92 -179.48 1.51 Allowed 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 123.192 2.595 . . . . 0.42999999999999999 112.296 179.883 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.7 32.59 18.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.46 -0.791 . . . . 1.26 111.462 179.262 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.44 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.1 mt -86.32 148.51 25.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.457 -0.338 . . . . 0.32000000000000001 110.44 179.615 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.769 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.28 114.83 61.19 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.008 0.432 . . . . 0.57999999999999996 110.7 -179.767 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -58.98 140.59 96.03 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.851 2.367 . . . . 0.66000000000000003 112.039 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.06 21.24 74.27 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.028 -0.829 . . . . 0.28999999999999998 111.028 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.441 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.9 150.17 49.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.857 0.36 . . . . 2.3300000000000001 110.578 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.501 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.19 131.62 46.03 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.039 -0.528 . . . . 0.85999999999999999 109.795 179.335 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.965 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.48 148.25 44.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.117 -0.492 . . . . 0.52000000000000002 111.089 -179.863 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.21 125.28 60.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.342 -0.984 . . . . 0.29999999999999999 108.342 177.742 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.53 132.58 63.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.129 0.49 . . . . 0.23000000000000001 111.238 -178.593 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.55 122.52 20.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.461 -0.791 . . . . 0.35999999999999999 109.574 179.362 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.588 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.99 125.39 54.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.337 -0.392 . . . . 0.19 110.706 -179.563 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.24 137.92 52.06 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.086 -0.506 . . . . 0.29999999999999999 109.833 179.573 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.584 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.83 134.96 43.02 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.802 -0.814 . . . . 0.37 108.802 178.865 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.606 ' O ' ' N ' ' A' ' 140' ' ' SER . 3.7 mt -99.01 122.92 51.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.09 0.472 . . . . 0.26000000000000001 111.001 -178.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.8 p -83.84 169.82 14.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.562 -0.744 . . . . 0.28000000000000003 110.469 -179.685 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.84 -14.51 15.4 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.058 -0.519 . . . . 1.6000000000000001 110.928 -179.556 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -96.07 -4.42 42.97 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.878 -0.329 . . . . 1.1799999999999999 110.83 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.9 13.85 63.86 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.368 -0.693 . . . . 0.29999999999999999 111.368 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -84.62 139.04 32.35 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.775 -0.25 . . . . 1.22 110.446 179.694 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.453 HE22 ' HG2' ' A' ' 14' ' ' GLN . 4.0 mp0 -106.71 141.07 38.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.485 -0.325 . . . . 0.97999999999999998 110.63 179.708 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.4 m -136.7 127.02 26.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.82999999999999996 110.329 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.11 117.29 9.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.327 -0.397 . . . . 0.26000000000000001 110.477 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.03 -21.85 5.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 0.29999999999999999 110.716 -179.785 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.1 tp -156.87 125.8 5.91 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.566 -0.454 . . . . 0.31 111.564 -179.829 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.474 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.7 120.16 21.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.731 -0.668 . . . . 0.28000000000000003 109.579 179.289 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.65 151.75 29.16 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.714 -0.394 . . . . 0.23999999999999999 110.884 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.55 158.6 18.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.054 -0.521 . . . . 0.23000000000000001 110.469 179.675 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.09 157.87 43.86 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.191 -0.459 . . . . 0.67000000000000004 110.725 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.27 104.41 9.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.771 -0.649 . . . . 0.64000000000000001 110.024 179.559 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 117.88 -1.057 . . . . 1.26 110.638 -179.691 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.9 m . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.248 -0.649 . . . . 3.4399999999999999 109.248 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.42 150.73 18.53 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.037 -0.825 . . . . 1.22 111.037 179.692 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -35.65 142.43 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 123.988 3.125 . . . . 0.75 113.795 -179.197 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.624 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.3 t -80.04 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 114.295 -1.321 . . . . 0.79000000000000004 108.808 178.447 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.624 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.68 125.87 51.49 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.415 -0.514 . . . . 1.9399999999999999 111.395 -179.533 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 144.03 33.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.555 -0.748 . . . . 0.59999999999999998 110.646 179.921 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.05 168.33 25.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.894 0.378 . . . . 3.1400000000000001 111.096 -179.614 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.747 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.4 mt -109.03 131.14 60.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.006 -0.543 . . . . 3.23 110.074 179.861 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.505 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.3 p -141.21 162.3 35.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.859 0.361 . . . . 3.6299999999999999 111.217 -179.903 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 10' ' ' GLU . 80.1 tt0 36.13 31.57 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.629 -0.508 . . . . 6.0800000000000001 109.629 179.811 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.747 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.55 69.58 33.73 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.945 -0.57 . . . . 3.3799999999999999 111.58 -178.753 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.17 -29.14 73.74 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.525 2.15 . . . . 3.9300000000000002 111.868 179.304 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.63 125.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 3.3599999999999999 110.41 -179.973 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.699 HE21 ' C ' ' A' ' 17' ' ' SER . 14.3 mt-30 -123.96 158.38 60.41 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 3.6099999999999999 110.405 179.942 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.587 ' HD2' HH12 ' A' ' 143' ' ' ARG . 97.4 Cg_endo -82.03 -64.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.942 2.428 . . . . 1.51 113.558 -179.086 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.552 ' ND2' ' OD1' ' A' ' 159' ' ' ASP . 98.7 m-20 -108.48 -19.51 13.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.075 0.398 . . . . 2.6800000000000002 112.075 -178.54 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.699 ' C ' HE21 ' A' ' 14' ' ' GLN . 29.1 t -107.35 151.99 24.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.083 0.468 . . . . 1.21 111.296 -179.405 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.577 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.2 102.92 2.24 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.656 -0.702 . . . . 1.5600000000000001 110.722 179.786 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.72 145.59 12.93 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.962 2.441 . . . . 0.81000000000000005 112.636 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.937 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.75 167.92 24.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.894 -0.594 . . . . 1.52 109.853 179.672 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -149.12 148.02 29.17 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.768 -0.456 . . . . 2.1400000000000001 109.768 178.816 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.601 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.34 157.29 44.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.031 0.443 . . . . 0.32000000000000001 111.212 179.954 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.496 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.02 155.29 44.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.777 -0.647 . . . . 2.1699999999999999 110.111 179.072 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.825 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.69 172.95 6.49 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.155 0.502 . . . . 0.58999999999999997 110.701 -179.171 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.825 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.6 173.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.844 0 C-N-CA 122.876 2.384 . . . . 0.90000000000000002 111.475 179.421 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.1 -51.07 0.68 Allowed Pre-proline 0 C--N 1.329 -0.314 0 C-N-CA 120.68 -0.408 . . . . 3.3399999999999999 110.111 179.881 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.613 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.5 Cg_exo -64.81 152.33 82.49 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.716 2.277 . . . . 1.8500000000000001 111.497 179.139 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.66 42.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.417 0.627 . . . . 2.54 110.58 -179.881 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.814 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.69 -41.54 98.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.959 -1.019 . . . . 2.5299999999999998 110.7 179.775 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.533 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.8 mt -109.9 137.82 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.738 -0.665 . . . . 1.1699999999999999 111.29 -179.479 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.89 -72.96 0.7 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.056 -0.52 . . . . 1.27 111.982 -179.006 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.43 24.41 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.62 0.6 . . . . 1.1200000000000001 112.62 -179.689 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.78 124.88 45.24 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.365 -0.606 . . . . 0.41999999999999998 109.365 177.524 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.06 134.82 60.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.724 -0.391 . . . . 0.78000000000000003 110.63 179.913 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.937 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.15 128.68 53.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.078 0.466 . . . . 0.62 111.138 179.792 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.546 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.13 138.99 49.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.716 -0.674 . . . . 1.97 110.162 178.92 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.437 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.0 163.22 34.87 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.153 0.502 . . . . 0.34999999999999998 112.097 -178.127 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.488 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.56 139.53 7.76 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.483 -0.781 . . . . 1.8 110.443 178.805 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.691 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.43 115.5 3.06 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.283 1.989 . . . . 0.57999999999999996 111.855 179.946 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.686 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.06 81.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.914 0.388 . . . . 3.04 109.964 -179.853 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.691 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.14 -20.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.962 -0.563 . . . . 2.4700000000000002 111.901 -179.466 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.5 p -157.62 157.75 34.22 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.885 -0.326 . . . . 2.5099999999999998 110.586 179.819 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.406 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.34 27.81 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.173 -0.467 . . . . 1.8600000000000001 110.232 179.567 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.84 -75.86 1.31 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.144 -0.55 . . . . 1.4399999999999999 111.796 -179.204 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.86 152.3 35.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.959 0.409 . . . . 4.6900000000000004 110.951 -179.268 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.66 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.26 -169.16 2.54 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.033 -0.53 . . . . 1.4299999999999999 111.938 179.352 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.08 149.58 29.83 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.436 0.636 . . . . 1.74 112.634 -177.903 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.0 156.48 46.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.83 -1.077 . . . . 1.9199999999999999 110.318 178.562 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.16 158.45 41.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.926 -0.579 . . . . 0.34000000000000002 111.82 -179.373 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 m -115.22 135.62 53.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.483 -0.781 . . . . 0.40999999999999998 109.8 179.322 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.601 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.48 121.95 23.67 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.459 -0.337 . . . . 0.55000000000000004 111.489 -179.14 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.607 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.2 Cg_exo -46.25 151.68 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.67 2.246 . . . . 0.44 112.141 178.993 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.88 -22.98 62.95 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 115.998 -0.547 . . . . 0.73999999999999999 112.882 -179.268 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.83 -16.81 46.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.346 0.573 . . . . 0.93000000000000005 111.839 -178.38 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.607 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.73 138.36 31.62 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.749 -0.38 . . . . 0.96999999999999997 110.335 179.371 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 p-10 -121.45 13.93 11.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.353 -0.385 . . . . 1.3400000000000001 111.546 -179.3 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.8 p -149.98 143.54 25.27 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.612 -0.435 . . . . 0.39000000000000001 111.028 179.594 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.721 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.85 -169.32 1.53 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.174 0.511 . . . . 0.41999999999999998 110.855 -179.423 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.721 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 50.1 m -151.8 125.93 9.24 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.332 -0.849 . . . . 0.39000000000000001 109.783 179.247 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.511 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.91 123.28 70.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.336 -0.546 . . . . 0.73999999999999999 111.162 -179.793 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.57 ' HG2' ' N ' ' A' ' 62' ' ' GLY . 88.2 tttt -126.48 163.4 23.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.788 -0.642 . . . . 2.48 110.431 179.709 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.57 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.1 18.99 59.89 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.833 -0.907 . . . . 0.5 110.833 -179.906 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.511 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.9 mt -79.03 157.23 28.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.054 0.454 . . . . 0.57999999999999996 111.33 -179.589 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.839 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.6 mttp -99.55 134.05 21.43 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.571 -0.741 . . . . 2.79 110.413 179.77 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.94 143.62 61.22 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.501 2.134 . . . . 0.87 111.948 179.82 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.64 75.32 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.054 -0.818 . . . . 0.64000000000000001 111.054 179.721 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.839 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.17 158.79 40.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.743 0.306 . . . . 0.82999999999999996 110.428 -179.662 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.14 139.93 42.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.971 0.415 . . . . 0.5 110.582 -179.778 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.649 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.3 m-85 -122.5 136.43 54.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.0 -0.546 . . . . 0.53000000000000003 110.803 -179.886 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.95 130.95 45.34 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.548 -0.908 . . . . 1.8700000000000001 108.548 177.639 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.495 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.47 153.86 16.65 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.332 -0.937 . . . . 0.28999999999999998 111.89 -178.517 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.01 140.89 46.01 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.717 -0.475 . . . . 1.4299999999999999 109.717 179.529 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.72 119.01 34.67 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.498 -0.481 . . . . 0.32000000000000001 110.477 179.683 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.742 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.53 129.15 68.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.79000000000000004 110.579 -179.904 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.699 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.83 120.74 43.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.322 -0.399 . . . . 1.02 110.715 -179.67 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.839 HD12 ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.53 146.52 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.184 0.516 . . . . 0.62 111.025 -179.349 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.814 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.01 153.86 21.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.482 -0.781 . . . . 2.4399999999999999 109.986 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.16 88.57 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.953 0.406 . . . . 3.6899999999999999 110.375 -179.758 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.624 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.33 32.51 0.21 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.843 -0.617 . . . . 6.0800000000000001 110.602 -179.966 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.99 -117.35 3.3 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.502 -0.639 . . . . 1.22 111.502 -179.758 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.47 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.44 177.36 9.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.254 0.55 . . . . 2.8799999999999999 111.604 -179.239 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.06 149.47 32.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.428 -0.806 . . . . 1.47 110.502 179.185 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.13 144.73 38.77 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.479 -0.328 . . . . 2.7000000000000002 110.544 179.854 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.742 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -128.01 135.91 61.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 CA-C-O 120.936 0.398 . . . . 0.46000000000000002 111.597 -179.775 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.571 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -123.94 141.34 52.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.678 -0.692 . . . . 0.34999999999999998 110.301 179.634 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.493 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.68 138.86 51.71 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.136 0.493 . . . . 3.6699999999999999 111.451 -179.382 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.495 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.25 164.14 37.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.567 -0.742 . . . . 0.67000000000000004 109.464 179.403 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.561 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.23 151.56 38.58 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.391 -0.524 . . . . 1.47 111.015 179.983 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.805 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.19 172.74 13.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.81 -0.632 . . . . 0.44 111.058 179.807 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.75 160.78 21.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.46 -0.791 . . . . 1.3700000000000001 109.89 179.529 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.42 121.92 22.98 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.556 -0.458 . . . . 1.28 110.722 179.955 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.521 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.3 p -130.01 166.07 20.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.673 0.749 . . . . 1.97 112.861 179.669 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.55 ' HB2' ' CE1' ' A' ' 157' ' ' TYR . 0.3 OUTLIER -88.01 -16.16 34.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.692 -1.14 . . . . 3.2799999999999998 110.563 177.226 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 19.0 p -124.22 167.1 14.74 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.911 -178.153 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.616 ' O ' ' OG1' ' A' ' 96' ' ' THR . 23.9 m -56.85 -31.8 65.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.612 179.496 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.616 ' OG1' ' O ' ' A' ' 95' ' ' SER . 20.1 p 93.93 56.12 0.01 OUTLIER Pre-proline 0 N--CA 1.471 0.576 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.875 -179.69 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.86 150.96 68.24 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.743 2.295 . . . . 0.0 111.161 178.789 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.0 m -59.38 135.28 24.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.138 -179.718 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.762 HG22 ' H ' ' A' ' 101' ' ' ASN . 50.2 m -121.45 141.52 50.92 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.802 -179.243 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 86.2 p -61.65 -24.89 67.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.578 -179.994 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.762 ' H ' HG22 ' A' ' 99' ' ' THR . 76.5 m-20 60.4 44.38 12.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.702 -179.699 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.413 ' O ' ' O ' ' A' ' 101' ' ' ASN . 69.2 p 37.79 -161.94 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.75 179.627 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.739 HG12 ' H ' ' A' ' 105' ' ' GLY . 36.2 t -115.34 136.19 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.048 -179.552 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 56.0 p -66.08 -19.32 65.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.855 0.36 . . . . 0.0 110.899 -179.201 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.739 ' H ' HG12 ' A' ' 103' ' ' VAL . . . -54.07 -29.64 44.55 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 179.75 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -90.33 141.12 29.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.845 0.355 . . . . 0.0 110.148 -179.787 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 19.1 p -119.86 164.9 15.32 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.872 -179.133 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.69 80.12 31.58 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.232 -179.583 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.01 152.06 31.39 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.546 2.164 . . . . 0.0 112.36 -179.472 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.426 ' O ' ' CB ' ' A' ' 111' ' ' SER . 45.6 p90 -46.94 161.93 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.136 -179.571 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 110' ' ' PHE . 1.2 t 80.13 57.74 0.14 Allowed Pre-proline 0 N--CA 1.464 0.235 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.273 -179.036 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.06 150.63 77.7 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.883 2.389 . . . . 0.0 112.008 179.435 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.2 mt -86.88 143.5 27.4 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.814 -0.439 . . . . 10.19 109.814 179.775 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.3 p -129.89 143.52 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.051 0.453 . . . . 7.2800000000000002 111.094 -179.186 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.56 149.17 46.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.582 -0.735 . . . . 7.2999999999999998 110.557 179.762 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.0 m -70.82 138.6 50.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 6.4400000000000004 110.38 -179.751 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.3 m -61.57 153.59 27.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.042 -0.526 . . . . 4.4199999999999999 111.102 -179.256 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 22.9 pt-20 -126.77 52.35 1.77 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.623 -0.717 . . . . 3.0499999999999998 110.66 -179.969 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 74.2 m -81.03 6.12 14.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.962 -0.563 . . . . 3.4300000000000002 110.72 -179.838 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.2 t -110.6 135.68 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.146 -0.479 . . . . 2.8799999999999999 110.083 179.824 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.1 p -121.29 161.67 21.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.089 -0.505 . . . . 2.0899999999999999 110.771 -179.464 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -111.76 156.65 21.6 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.807 -0.633 . . . . 4.5300000000000002 110.573 -179.847 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 19.7 tt -58.07 -24.96 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 1.4399999999999999 110.293 179.868 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 56.8 p -66.85 -14.17 62.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.999 -0.546 . . . . 1.78 110.194 179.61 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 53.95 91.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.934 -0.576 . . . . 0.64000000000000001 110.886 -179.888 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.9 p -62.9 -25.06 68.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.601 -0.727 . . . . 0.66000000000000003 110.753 179.653 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.437 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.92 167.57 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.74 -0.664 . . . . 0.68999999999999995 110.985 -179.359 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.57 145.49 50.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.808 -0.633 . . . . 0.52000000000000002 110.182 -179.92 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.27 101.67 9.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.083 -0.71 . . . . 0.32000000000000001 109.083 177.714 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.1 t -112.96 139.77 36.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.943 -0.572 . . . . 0.28999999999999998 111.004 -178.834 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.4 p -128.79 152.53 48.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.642 -0.708 . . . . 0.25 109.799 179.619 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.587 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.82 -165.02 2.05 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.776 -0.37 . . . . 0.31 110.674 -179.737 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.745 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -123.97 127.2 73.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.198 -0.455 . . . . 0.48999999999999999 110.815 -179.856 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.175 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.89 58.37 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.076 -0.511 . . . . 1.53 110.363 179.821 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.745 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.21 24.6 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 0.96999999999999997 111.509 -179.705 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.175 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.18 128.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.627 -0.429 . . . . 1.5600000000000001 110.95 179.822 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.45 -9.55 56.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.977 -0.556 . . . . 1.8799999999999999 110.379 179.703 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.0 p -87.09 0.19 55.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.119 -0.491 . . . . 1.04 110.278 179.924 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 136' ' ' SER . 2.6 p -65.27 137.15 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.02 -0.537 . . . . 0.23999999999999999 109.994 179.711 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 185' ' ' ILE . 91.1 p -96.23 -15.53 21.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.236 0.541 . . . . 0.28999999999999998 109.992 -179.608 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.437 ' HA3' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.62 175.55 45.79 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 109.88 -1.288 . . . . 0.13 109.88 179.662 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.4 151.56 42.47 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.957 0.408 . . . . 0.17000000000000001 110.487 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 1.168 ' NE ' HD11 ' A' ' 185' ' ' ILE . 77.1 mtm180 -132.29 121.1 23.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.112 -0.495 . . . . 1.29 109.966 179.758 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.557 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.05 136.62 38.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.781 -0.645 . . . . 0.25 110.661 -179.779 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.495 ' OE2' ' OH ' ' A' ' 157' ' ' TYR . 85.5 tt0 -129.42 129.84 45.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.914 -0.584 . . . . 1.3200000000000001 110.041 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.627 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 36.0 p90 -138.7 135.36 34.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.024 -0.535 . . . . 0.56999999999999995 110.66 -179.742 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.42 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.36 161.33 39.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.778 -0.646 . . . . 1.1599999999999999 109.6 179.897 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.974 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.11 124.88 25.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.104 0.478 . . . . 0.38 110.768 -179.674 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.79 -7.61 49.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.664 -0.698 . . . . 0.40999999999999998 110.861 -179.724 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -109.85 -69.71 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.354 -0.384 . . . . 1.6599999999999999 111.395 -179.305 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.495 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.61 -35.36 75.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.04 -0.527 . . . . 1.6599999999999999 111.582 -179.165 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.08 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.12 7.2 88.61 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.895 -0.882 . . . . 1.1699999999999999 110.895 -179.798 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.335 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.8 t0 -27.92 -171.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.849 0.357 . . . . 1.8600000000000001 110.257 179.897 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.335 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.21 138.98 45.29 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.948 0.404 . . . . 1.98 110.229 179.599 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.42 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 48.3 Cg_endo -70.73 145.74 52.33 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 C-N-CA 122.729 2.286 . . . . 0.55000000000000004 112.377 -179.586 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.627 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.79 145.75 42.54 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.251 -0.648 . . . . 1.1399999999999999 109.251 179.155 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.55 ' CE1' ' HB2' ' A' ' 93' ' ' SER . 96.4 m-85 -123.31 141.33 52.1 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.346 -0.542 . . . . 0.93000000000000005 111.553 -179.124 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.5 mt -128.08 127.68 43.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.372 -0.831 . . . . 0.34000000000000002 108.959 178.987 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.552 ' OD1' ' ND2' ' A' ' 16' ' ' ASN . 67.3 m-20 -101.63 131.15 48.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.154 0.502 . . . . 1.0900000000000001 111.725 -178.726 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.99 157.49 73.73 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.316 -0.857 . . . . 0.19 109.581 179.667 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.67 157.99 58.64 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.414 2.076 . . . . 0.17999999999999999 112.261 179.936 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.0 p -59.32 -12.09 5.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.823 -0.626 . . . . 0.20999999999999999 110.689 -179.855 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.9 -8.7 42.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.28999999999999998 110.67 -179.933 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.24 135.41 34.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.368 -0.378 . . . . 0.5 110.425 179.662 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.17 16.71 4.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.348 -0.387 . . . . 0.29999999999999999 110.476 179.983 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.4 p -167.59 147.1 5.03 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.629 -0.508 . . . . 0.23000000000000001 109.629 179.797 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.14 150.49 12.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.567 -0.453 . . . . 0.28000000000000003 111.592 -179.573 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.502 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.32 124.91 50.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.657 -0.701 . . . . 1.0700000000000001 109.812 179.499 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.42 104.93 30.04 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.912 0.387 . . . . 0.28999999999999998 111.058 -179.884 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.3 Cg_endo -91.0 -179.53 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.914 0 C-N-CA 123.256 2.638 . . . . 0.42999999999999999 112.243 179.86 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 61.69 32.61 18.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.36 -0.836 . . . . 1.26 111.461 179.308 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 172' ' ' LEU . 24.5 mt -86.36 148.54 25.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.51 -0.314 . . . . 0.32000000000000001 110.464 179.619 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.757 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.32 114.93 61.66 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.986 0.422 . . . . 0.57999999999999996 110.643 -179.701 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -58.95 140.54 95.78 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.949 2.433 . . . . 0.66000000000000003 111.922 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.1 21.16 74.36 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.018 -0.833 . . . . 0.28999999999999998 111.018 179.785 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.495 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.81 150.17 49.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 2.3300000000000001 110.669 179.996 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.5 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.15 131.66 45.97 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.074 -0.512 . . . . 0.85999999999999999 109.783 179.371 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.974 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.5 m-85 -120.61 148.26 44.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.159 -0.473 . . . . 0.52000000000000002 111.039 -179.822 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.3 mt -105.35 125.36 60.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 108.244 -1.021 . . . . 0.29999999999999999 108.244 177.804 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.53 132.54 63.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.143 0.496 . . . . 0.23000000000000001 111.228 -178.586 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.51 122.51 20.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.502 -0.772 . . . . 0.35999999999999999 109.689 179.276 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.587 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -100.95 125.32 54.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.199 -0.455 . . . . 0.19 110.716 -179.55 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.7 m-85 -117.15 137.99 51.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.955 -0.566 . . . . 0.29999999999999999 109.889 179.443 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.74 134.98 42.9 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.806 -0.813 . . . . 0.37 108.806 178.882 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 1.168 HD11 ' NE ' ' A' ' 143' ' ' ARG . 13.2 mt -99.04 122.9 51.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.116 0.484 . . . . 0.26000000000000001 110.959 -178.738 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.7 p -83.83 169.72 14.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.609 -0.723 . . . . 0.28000000000000003 110.479 -179.693 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -59.86 -14.46 15.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.053 -0.521 . . . . 1.6000000000000001 110.92 -179.555 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -96.15 -4.24 43.03 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.825 -0.35 . . . . 1.1799999999999999 110.809 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.81 13.89 63.97 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.342 -0.703 . . . . 0.29999999999999999 111.342 179.835 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -84.63 139.01 32.37 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.076 -0.25 . . . . 1.22 110.424 179.686 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.828 ' NE2' HH22 ' A' ' 143' ' ' ARG . 0.0 OUTLIER -106.69 141.12 38.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.87 0.367 . . . . 0.97999999999999998 110.558 179.718 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.3 m -136.7 127.03 26.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.82999999999999996 110.327 179.952 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.5 tp -68.16 117.38 9.91 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.675 -0.41 . . . . 0.26000000000000001 110.533 -179.95 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.01 -21.82 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.29999999999999999 110.773 -179.778 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.5 tp -156.95 125.75 5.84 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.523 -0.471 . . . . 0.31 111.475 -179.77 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.474 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.8 120.23 21.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.787 -0.642 . . . . 0.28000000000000003 109.519 179.253 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.68 29.08 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.591 -0.444 . . . . 0.23999999999999999 110.868 -179.265 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.9 p -110.43 158.57 18.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.014 -0.539 . . . . 0.23000000000000001 110.44 179.702 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.02 157.89 43.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.088 -0.505 . . . . 0.67000000000000004 110.698 179.995 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.19 104.32 9.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.761 -0.654 . . . . 0.64000000000000001 110.101 179.493 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.8 p . . . . . 0 C--O 1.221 -0.414 0 CA-C-O 117.953 -1.022 . . . . 1.26 110.631 -179.628 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.553 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.1 m . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.161 -0.681 . . . . 3.4399999999999999 109.161 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.69 18.54 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.011 -0.835 . . . . 1.22 111.011 179.809 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -35.67 142.4 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.084 0 C-N-CA 123.933 3.089 . . . . 0.75 113.76 -179.222 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.61 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.1 t -79.93 173.43 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.173 -1.376 . . . . 0.79000000000000004 108.785 178.416 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.61 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.66 125.78 51.38 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.425 -0.51 . . . . 1.9399999999999999 111.44 -179.559 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.38 144.01 34.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.692 -0.685 . . . . 0.59999999999999998 110.652 179.959 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.1 168.24 25.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.97 0.414 . . . . 3.1400000000000001 111.111 -179.67 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.742 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.2 mt -108.96 131.04 60.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.002 -0.544 . . . . 3.23 110.123 179.868 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.4 p -141.12 162.34 35.71 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.822 0.344 . . . . 3.6299999999999999 111.274 -179.924 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 9' ' ' THR . 98.9 mt-10 36.14 31.51 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 109.592 -0.521 . . . . 6.0800000000000001 109.592 179.819 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.742 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.59 32.58 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.001 -0.545 . . . . 3.3799999999999999 111.512 -178.721 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.3 -28.98 72.54 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.424 2.083 . . . . 3.9300000000000002 111.92 179.301 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.64 125.54 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.101 -0.499 . . . . 3.3599999999999999 110.442 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.618 ' O ' ' O ' ' A' ' 92' ' ' THR . 4.7 mt-30 -123.87 158.33 60.32 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 3.6099999999999999 110.491 179.914 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 143' ' ' ARG . 97.5 Cg_endo -82.07 -64.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.927 2.418 . . . . 1.51 113.515 -179.047 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.662 ' OD1' ' NH1' ' A' ' 143' ' ' ARG . 9.7 m120 -108.49 -19.59 13.4 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.076 0.399 . . . . 2.6800000000000002 112.076 -178.509 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 8.3 p -107.32 152.06 24.64 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.479 -0.488 . . . . 1.21 111.338 -179.442 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.28 102.94 2.23 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.653 -0.703 . . . . 1.5600000000000001 110.634 179.894 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.578 ' CD ' HE22 ' A' ' 14' ' ' GLN . 73.8 Cg_endo -82.72 145.53 12.91 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.974 2.45 . . . . 0.81000000000000005 112.575 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.925 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.76 167.92 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.884 -0.598 . . . . 1.52 109.892 179.579 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.15 147.91 29.02 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.682 -0.488 . . . . 2.1400000000000001 109.682 178.913 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.9 p90 -142.2 157.37 44.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.979 0.419 . . . . 0.32000000000000001 111.242 179.907 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.49 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.12 155.26 44.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.819 -0.628 . . . . 2.1699999999999999 110.095 179.0 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.836 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.59 173.03 6.36 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 121.105 0.478 . . . . 0.58999999999999997 110.774 -179.243 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.836 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.8 Cg_exo -50.58 173.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 122.818 2.346 . . . . 0.90000000000000002 111.588 179.29 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -50.95 0.7 Allowed Pre-proline 0 C--N 1.33 -0.245 0 C-N-CA 120.713 -0.395 . . . . 3.3399999999999999 110.159 179.81 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.62 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.99 152.36 82.65 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.752 2.301 . . . . 1.8500000000000001 111.404 179.197 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.5 p -63.76 42.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.355 0.598 . . . . 2.54 110.495 -179.769 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.815 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.1 t-80 -63.7 -41.6 98.09 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.997 -1.001 . . . . 2.5299999999999998 110.579 179.8 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.532 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.6 mt -109.79 137.89 39.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.823 -0.626 . . . . 1.1699999999999999 111.262 -179.421 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.04 -72.9 0.7 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.023 -0.535 . . . . 1.27 111.887 -179.029 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.47 24.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.521 0.564 . . . . 1.1200000000000001 112.521 -179.609 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.89 124.92 45.24 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.311 -0.626 . . . . 0.41999999999999998 109.311 177.483 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.2 mt -118.02 134.76 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.703 -0.399 . . . . 0.78000000000000003 110.666 179.917 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.925 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.07 128.64 53.67 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 120.985 0.422 . . . . 0.62 111.22 179.748 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.548 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.11 139.02 49.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.753 -0.658 . . . . 1.97 110.057 179.001 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.433 ' O ' ' HB2' ' A' ' 46' ' ' TRP . 48.2 p90 -145.06 163.14 35.18 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.162 0.506 . . . . 0.34999999999999998 112.086 -178.166 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.488 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.43 139.69 7.97 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 115.472 -0.785 . . . . 1.8 110.441 178.743 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.687 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.3 Cg_endo -63.58 115.45 3.05 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.364 2.043 . . . . 0.57999999999999996 111.836 179.995 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.68 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -47.05 81.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.973 0.416 . . . . 3.04 109.884 -179.786 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.687 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.26 -20.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.003 -0.544 . . . . 2.4700000000000002 111.942 -179.442 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.64 157.78 34.24 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 120.887 -0.325 . . . . 2.5099999999999998 110.561 179.78 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.401 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.4 27.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.166 -0.47 . . . . 1.8600000000000001 110.235 179.517 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.86 -75.89 1.31 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.029 -0.605 . . . . 1.4399999999999999 111.796 -179.224 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.81 152.34 35.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.92 0.39 . . . . 4.6900000000000004 110.957 -179.286 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.23 -169.06 2.51 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.043 -0.526 . . . . 1.4299999999999999 111.938 179.332 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.18 149.64 29.8 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.449 0.643 . . . . 1.74 112.581 -177.858 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.02 156.49 46.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.853 -1.067 . . . . 1.9199999999999999 110.236 178.718 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.466 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.33 158.35 41.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.966 -0.561 . . . . 0.34000000000000002 111.722 -179.327 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.2 m -115.18 135.56 54.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.441 -0.799 . . . . 0.40999999999999998 109.829 179.314 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.596 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.37 122.04 23.83 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.391 -0.368 . . . . 0.55000000000000004 111.529 -179.17 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.606 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.7 Cg_exo -46.31 151.75 1.62 Allowed 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.734 2.289 . . . . 0.44 112.081 178.987 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.92 -23.0 63.06 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 115.957 -0.565 . . . . 0.73999999999999999 112.809 -179.312 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.85 -16.85 46.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.369 0.584 . . . . 0.93000000000000005 111.756 -178.268 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.606 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.63 138.47 31.54 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.76 -0.376 . . . . 0.96999999999999997 110.323 179.362 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.54 13.86 10.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.295 -0.411 . . . . 1.3400000000000001 111.512 -179.297 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.473 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.98 143.41 25.19 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.664 -0.415 . . . . 0.39000000000000001 110.998 179.7 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.711 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.74 -169.43 1.54 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.035 -0.53 . . . . 0.41999999999999998 110.932 -179.512 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.711 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 7.7 m -151.66 125.93 9.33 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.429 -0.805 . . . . 0.39000000000000001 109.946 179.118 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.516 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.85 123.2 70.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.412 -0.515 . . . . 0.73999999999999999 111.17 -179.712 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.723 ' NZ ' HD13 ' A' ' 185' ' ' ILE . 86.3 tttt -126.43 163.4 23.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.812 -0.631 . . . . 2.48 110.5 179.645 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.513 ' N ' ' HG2' ' A' ' 61' ' ' LYS . . . 85.11 18.97 59.92 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.775 -0.93 . . . . 0.5 110.775 -179.922 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.516 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.4 mt -78.95 157.22 28.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.135 0.493 . . . . 0.57999999999999996 111.385 -179.696 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.848 ' O ' HG12 ' A' ' 67' ' ' VAL . 2.9 mttp -99.52 133.95 21.52 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.593 -0.73 . . . . 2.79 110.442 179.758 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.528 ' CD ' ' CE1' ' A' ' 157' ' ' TYR . 36.6 Cg_endo -67.81 143.57 61.82 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.553 2.169 . . . . 0.87 111.975 179.794 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.87 25.55 75.43 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.016 -0.834 . . . . 0.64000000000000001 111.016 179.716 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.848 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.1 158.82 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.709 0.29 . . . . 0.82999999999999996 110.448 -179.591 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.15 139.79 42.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.924 0.392 . . . . 0.5 110.575 -179.74 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.645 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.5 m-85 -122.51 136.52 54.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.001 -0.545 . . . . 0.53000000000000003 110.78 -179.984 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.488 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.89 131.06 45.27 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.492 -0.929 . . . . 1.8700000000000001 108.492 177.622 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.49 153.85 16.65 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.3 -0.952 . . . . 0.28999999999999998 111.965 -178.664 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.92 141.02 46.19 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.687 -0.486 . . . . 1.4299999999999999 109.687 179.504 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.522 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.83 118.89 34.26 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.499 -0.48 . . . . 0.32000000000000001 110.534 179.651 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.722 HG12 HG23 ' A' ' 84' ' ' VAL . 64.1 mt -112.42 129.11 68.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.239 -0.437 . . . . 0.79000000000000004 110.585 -179.874 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.706 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.81 120.86 43.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.326 -0.397 . . . . 1.02 110.707 -179.726 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.849 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.6 146.43 11.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.13 0.491 . . . . 0.62 110.978 -179.271 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.815 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.1 mt-30 -106.03 153.87 21.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.508 -0.769 . . . . 2.4399999999999999 109.938 179.735 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.16 88.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.917 0.389 . . . . 3.6899999999999999 110.45 -179.729 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.624 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.25 32.72 0.21 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.819 -0.628 . . . . 6.0800000000000001 110.573 -179.923 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.23 -117.39 3.27 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.407 -0.677 . . . . 1.22 111.407 -179.727 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.469 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.25 177.41 9.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.238 0.542 . . . . 2.8799999999999999 111.604 -179.218 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.21 149.47 31.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.401 -0.818 . . . . 1.47 110.418 179.108 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.553 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.15 144.62 38.69 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.487 -0.324 . . . . 2.7000000000000002 110.562 179.905 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.722 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.89 135.99 61.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 120.649 -0.421 . . . . 0.46000000000000002 111.552 -179.761 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.03 141.41 52.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.714 -0.675 . . . . 0.34999999999999998 110.318 179.544 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.465 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.78 138.92 51.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.184 0.516 . . . . 3.6699999999999999 111.428 -179.324 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.29 164.23 37.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.513 -0.767 . . . . 0.67000000000000004 109.42 179.438 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.32 151.52 38.45 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.384 -0.526 . . . . 1.47 110.996 -179.994 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.81 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.17 172.76 12.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.754 -0.657 . . . . 0.44 111.0 179.844 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.74 160.74 21.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.42 -0.809 . . . . 1.3700000000000001 109.863 179.561 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.43 121.85 22.85 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.645 -0.422 . . . . 1.28 110.766 179.974 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.618 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.8 p -126.42 163.75 22.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.346 0.593 . . . . 1.97 112.08 179.72 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.2 t -103.66 150.17 24.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.413 -0.812 . . . . 3.2799999999999998 110.665 -179.686 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.0 t -59.98 167.79 2.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.952 -179.164 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 54.9 p -65.44 162.33 18.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.432 -178.749 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.6 83.93 53.42 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.542 -179.386 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.56 147.42 30.37 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.006 1.804 . . . . 0.0 111.618 -179.439 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.703 HG12 ' H ' ' A' ' 100' ' ' SER . 23.5 t -111.02 136.97 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.76 -178.721 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.1 p -66.88 -5.49 12.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.274 -179.469 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.703 ' H ' HG12 ' A' ' 98' ' ' VAL . 32.6 t -57.26 162.61 2.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.366 -179.438 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.3 m120 62.61 44.19 7.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.225 0.536 . . . . 0.0 109.878 -178.535 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 104' ' ' THR . 39.9 m -77.99 141.84 38.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.369 179.863 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 78.1 t -58.13 -39.5 73.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.439 -179.426 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.461 ' H ' HG22 ' A' ' 102' ' ' THR . 19.4 p -120.8 159.63 25.05 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.748 0.308 . . . . 0.0 110.348 179.764 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -159.69 47.86 0.41 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.831 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -91.4 151.96 20.61 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.127 0.489 . . . . 0.0 111.021 -179.692 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 48.0 m -56.13 -37.04 68.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.143 -178.759 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 50.2 m -121.92 80.55 42.04 Favored Pre-proline 0 N--CA 1.467 0.388 0 CA-C-O 120.581 0.229 . . . . 0.0 111.4 -179.007 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -55.28 150.24 41.77 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.592 2.195 . . . . 0.0 111.779 179.422 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.404 ' O ' ' CB ' ' A' ' 111' ' ' SER . 49.7 p90 -66.4 144.03 56.77 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.961 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.616 ' N ' ' CD ' ' A' ' 112' ' ' PRO . 0.2 OUTLIER 168.0 -36.79 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.566 -179.464 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 111' ' ' SER . 53.2 Cg_exo -55.19 -18.05 16.93 Favored 'Trans proline' 0 N--CA 1.501 1.952 0 C-N-CA 122.772 2.315 . . . . 0.0 113.323 -178.958 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.5 mt -85.56 143.02 28.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.91 0.386 . . . . 10.19 110.776 -179.309 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.4 p -57.16 -34.27 45.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.903 -0.59 . . . . 7.2800000000000002 110.779 -179.484 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.94 -24.72 67.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.073 -0.512 . . . . 7.2999999999999998 109.938 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 30.9 p -116.06 164.38 14.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.48 -0.782 . . . . 6.4400000000000004 110.602 -179.338 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 111' ' ' SER . 26.2 t -69.9 156.29 39.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.087 -0.506 . . . . 4.4199999999999999 110.883 -179.383 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.534 ' HG2' ' H ' ' A' ' 120' ' ' VAL . 84.2 tt0 -87.41 139.72 30.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.206 -0.452 . . . . 3.0499999999999998 110.041 -179.63 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.574 ' O ' ' O ' ' A' ' 120' ' ' VAL . 85.8 p -61.52 -29.07 69.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 3.4300000000000002 111.675 -178.678 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.574 ' O ' ' O ' ' A' ' 119' ' ' SER . 61.1 t 50.18 117.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.742 0.306 . . . . 2.8799999999999999 110.722 -179.809 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 47.6 m -117.55 137.37 52.62 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.039 0.447 . . . . 2.0899999999999999 110.726 -179.841 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.48 ' OE2' ' CB ' ' A' ' 125' ' ' ALA . 83.0 tt0 -113.51 141.55 47.0 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.895 -0.78 . . . . 4.5300000000000002 108.895 -179.991 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.63 ' O ' ' N ' ' A' ' 125' ' ' ALA . 72.2 mt -115.22 135.14 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 113.746 1.017 . . . . 1.4399999999999999 113.746 -176.999 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 82.4 p 33.26 17.72 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.499 -1.228 . . . . 1.78 113.922 177.795 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.63 ' N ' ' O ' ' A' ' 123' ' ' ILE . . . -64.44 -28.85 69.95 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.709 -0.396 . . . . 0.64000000000000001 111.057 179.606 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.496 ' OG ' ' N ' ' A' ' 127' ' ' SER . 95.7 p 49.88 -89.67 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.715 -0.476 . . . . 0.66000000000000003 109.715 -178.374 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.496 ' N ' ' OG ' ' A' ' 126' ' ' SER . 0.9 OUTLIER -53.7 167.48 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.019 0.438 . . . . 0.68999999999999995 111.005 179.481 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.56 145.6 50.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.718 -0.674 . . . . 0.52000000000000002 110.101 -179.949 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.3 101.72 9.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.986 -0.746 . . . . 0.32000000000000001 108.986 177.755 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.9 t -112.99 139.7 36.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.089 -0.505 . . . . 0.28999999999999998 111.054 -178.904 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.7 p -128.74 152.5 48.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.603 -0.726 . . . . 0.25 109.849 179.603 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.72 -164.98 2.04 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.732 -0.387 . . . . 0.31 110.688 -179.736 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.736 ' O ' ' N ' ' A' ' 135' ' ' ALA . 32.5 t -123.93 127.17 73.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.48999999999999999 110.843 -179.885 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.164 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.95 58.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.178 -0.464 . . . . 1.53 110.329 179.862 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.736 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.07 24.41 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.916 -0.584 . . . . 0.96999999999999997 111.499 -179.673 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.164 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.22 128.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.568 -0.453 . . . . 1.5600000000000001 110.899 179.829 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -86.31 -9.76 55.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.879 -0.601 . . . . 1.8799999999999999 110.323 179.76 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.4 p -87.04 0.26 55.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 1.04 110.4 179.994 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.725 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.29 137.25 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.877 -0.601 . . . . 0.23999999999999999 109.969 179.74 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 185' ' ' ILE . 88.8 p -96.27 -15.54 21.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.279 0.562 . . . . 0.28999999999999998 110.035 -179.643 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.432 ' HA3' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.58 175.56 45.77 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.83 -1.308 . . . . 0.13 109.83 179.679 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -123.49 151.59 42.6 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.621 -0.431 . . . . 0.17000000000000001 110.468 179.723 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.662 ' NH1' ' OD1' ' A' ' 16' ' ' ASN . 12.7 ttt85 -132.29 121.1 23.04 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.086 -0.506 . . . . 1.29 110.005 179.805 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.548 HG21 HG11 ' A' ' 167' ' ' VAL . 46.0 t -105.03 136.49 38.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.777 -0.647 . . . . 0.25 110.724 -179.759 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 78.8 tt0 -129.27 129.91 45.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.061 -0.518 . . . . 1.3200000000000001 110.151 179.98 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.618 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.8 p90 -138.71 135.34 34.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.994 -0.548 . . . . 0.56999999999999995 110.623 -179.709 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.413 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.34 161.38 39.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.703 -0.68 . . . . 1.1599999999999999 109.716 179.846 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.969 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 85.8 mt -71.12 124.91 25.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.986 0.422 . . . . 0.38 110.689 -179.534 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.499 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.8 -7.68 49.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.739 -0.664 . . . . 0.40999999999999998 110.862 -179.81 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -109.84 -69.58 0.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.365 -0.38 . . . . 1.6599999999999999 111.519 -179.381 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.453 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.69 -35.32 76.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.095 -0.502 . . . . 1.6599999999999999 111.569 -179.192 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.086 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.2 7.2 88.62 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.75 -0.94 . . . . 1.1699999999999999 110.75 -179.936 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.325 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.85 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 1.8600000000000001 110.291 179.801 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.325 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.25 139.08 45.17 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 1.98 110.165 179.64 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.413 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.3 Cg_endo -70.94 145.84 51.38 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 C-N-CA 122.712 2.275 . . . . 0.55000000000000004 112.31 -179.546 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.87 145.81 42.56 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.182 -0.673 . . . . 1.1399999999999999 109.182 179.267 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.657 ' CD2' ' OD1' ' A' ' 16' ' ' ASN . 51.0 p90 -123.38 141.27 52.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.185 0.517 . . . . 0.93000000000000005 111.536 -179.093 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.5 mt -128.05 127.65 43.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.242 -0.89 . . . . 0.34000000000000002 108.92 179.007 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 19.1 t0 -101.58 131.05 47.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.15 0.5 . . . . 1.0900000000000001 111.824 -178.85 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.517 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.1 mt -127.83 157.61 73.04 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.303 -0.862 . . . . 0.19 109.624 179.624 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.84 158.04 58.21 Favored 'Trans proline' 0 C--N 1.302 -1.89 0 C-N-CA 122.395 2.063 . . . . 0.17999999999999999 112.239 179.938 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.24 -12.22 5.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.739 -0.664 . . . . 0.20999999999999999 110.746 -179.824 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.4 p -92.81 -8.68 42.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.09 -0.505 . . . . 0.28999999999999998 110.689 -179.883 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.3 135.35 34.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.332 -0.395 . . . . 0.5 110.318 179.734 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.4 p -133.08 16.69 4.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.322 -0.399 . . . . 0.29999999999999999 110.508 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.0 p -167.54 147.05 5.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.579 -0.526 . . . . 0.23000000000000001 109.579 179.851 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.548 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.11 150.48 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.095 0.474 . . . . 0.28000000000000003 111.585 -179.695 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.507 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.3 125.01 50.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.571 -0.741 . . . . 1.0700000000000001 109.828 179.456 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.4 104.93 30.03 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.358 -0.383 . . . . 0.28999999999999998 111.066 -179.895 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.5 Cg_endo -90.98 -179.5 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 123.22 2.613 . . . . 0.42999999999999999 112.15 179.916 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.74 32.53 18.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.371 -0.831 . . . . 1.26 111.418 179.175 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 172' ' ' LEU . 24.2 mt -86.33 148.53 25.56 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.911 -0.315 . . . . 0.32000000000000001 110.505 179.587 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.774 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.32 114.88 61.43 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 121.069 0.461 . . . . 0.57999999999999996 110.688 -179.732 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.97 140.5 95.62 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.877 2.384 . . . . 0.66000000000000003 112.1 179.815 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.18 21.13 74.2 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.029 -0.828 . . . . 0.28999999999999998 111.029 179.907 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.453 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.77 150.25 49.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.75 0.31 . . . . 2.3300000000000001 110.747 179.881 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.499 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.22 131.65 46.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.063 -0.517 . . . . 0.85999999999999999 109.799 179.333 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.969 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.47 148.33 43.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.079 -0.51 . . . . 0.52000000000000002 111.077 -179.892 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.9 mt -105.34 125.4 60.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.281 -1.007 . . . . 0.29999999999999999 108.281 177.701 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.63 132.55 63.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.308 0.575 . . . . 0.23000000000000001 111.17 -178.595 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.5 122.59 20.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.433 -0.803 . . . . 0.35999999999999999 109.642 179.285 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.3 t -101.05 125.39 55.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.2 -0.454 . . . . 0.19 110.598 -179.436 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.3 m-85 -117.25 137.88 52.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.017 -0.538 . . . . 0.29999999999999999 109.899 179.456 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.586 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.68 135.02 42.79 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.811 -0.811 . . . . 0.37 108.811 178.872 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.723 HD13 ' NZ ' ' A' ' 61' ' ' LYS . 5.2 mp -99.04 122.94 51.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.16 0.505 . . . . 0.26000000000000001 110.926 -178.747 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.3 p -83.86 169.79 14.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.517 -0.765 . . . . 0.28000000000000003 110.453 -179.71 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.89 -14.53 15.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.048 -0.523 . . . . 1.6000000000000001 110.823 -179.504 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.548 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.3 m-20 -96.11 -4.22 43.21 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.817 -0.353 . . . . 1.1799999999999999 110.847 -179.811 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.566 ' HA3' HG23 ' A' ' 59' ' ' THR . . . 87.74 13.9 64.09 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.376 -0.69 . . . . 0.29999999999999999 111.376 179.858 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.62 139.03 32.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.652 0.263 . . . . 1.22 110.438 179.652 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.467 ' NE2' ' HD3' ' A' ' 143' ' ' ARG . 97.1 mt-30 -106.69 141.04 38.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.809 0.337 . . . . 0.97999999999999998 110.617 179.675 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 61.8 m -136.65 127.12 26.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.82999999999999996 110.316 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.1 117.36 9.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.287 -0.415 . . . . 0.26000000000000001 110.584 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.0 pt -109.18 -21.67 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.29999999999999999 110.732 -179.69 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -156.97 125.73 5.82 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 120.542 -0.463 . . . . 0.31 111.521 -179.879 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.475 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.79 120.13 21.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.777 -0.647 . . . . 0.28000000000000003 109.58 179.248 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.55 151.71 29.19 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.639 -0.424 . . . . 0.23999999999999999 110.882 -179.276 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.8 p -110.36 158.56 18.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.019 -0.537 . . . . 0.23000000000000001 110.442 179.709 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.401 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 21.6 mt-30 -146.05 157.86 43.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.158 -0.474 . . . . 0.67000000000000004 110.663 -179.969 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.31 104.36 9.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.801 -0.636 . . . . 0.64000000000000001 110.043 179.49 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.9 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.843 -1.075 . . . . 1.26 110.621 -179.655 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.552 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.2 m . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.189 -0.671 . . . . 3.4399999999999999 109.189 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.66 18.54 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.988 -0.845 . . . . 1.22 110.988 179.72 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -35.47 142.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.058 0 C-N-CA 123.934 3.089 . . . . 0.75 113.832 -179.283 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.609 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.99 173.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.274 -1.33 . . . . 0.79000000000000004 108.83 178.368 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.609 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.62 125.94 51.57 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.376 -0.529 . . . . 1.9399999999999999 111.461 -179.601 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.47 144.01 33.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.63 -0.713 . . . . 0.59999999999999998 110.72 179.869 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.03 168.34 25.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.925 0.393 . . . . 3.1400000000000001 111.137 -179.674 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.745 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.5 mt -109.06 131.02 60.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.957 -0.565 . . . . 3.23 110.024 179.928 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.15 162.36 35.67 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.865 0.364 . . . . 3.6299999999999999 111.219 -179.961 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 16.9 pt-20 36.16 31.45 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.682 -0.488 . . . . 6.0800000000000001 109.682 179.847 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.745 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.4 69.61 32.3 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.934 -0.575 . . . . 3.3799999999999999 111.593 -178.747 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.634 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.28 -29.08 72.73 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 C-N-CA 122.497 2.132 . . . . 3.9300000000000002 111.822 179.354 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.634 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.58 125.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 3.3599999999999999 110.481 -179.947 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 17' ' ' SER . 13.2 mp0 -123.8 158.41 59.85 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.294 -0.412 . . . . 3.6099999999999999 110.456 179.959 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.459 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 97.2 Cg_endo -82.1 -64.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.861 2.374 . . . . 1.51 113.456 -179.039 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.674 ' OD1' ' N ' ' A' ' 17' ' ' SER . 1.4 p-10 -108.39 -19.61 13.4 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.106 0.41 . . . . 2.6800000000000002 112.106 -178.498 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.674 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 33.4 m -107.34 152.1 24.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.116 0.484 . . . . 1.21 111.328 -179.421 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.572 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.37 102.96 2.21 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.693 -0.685 . . . . 1.5600000000000001 110.652 179.804 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.6 145.57 13.12 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.921 2.414 . . . . 0.81000000000000005 112.61 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.928 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.78 167.9 24.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.955 -0.566 . . . . 1.52 109.842 179.567 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.17 147.9 28.99 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.812 -0.44 . . . . 2.1400000000000001 109.812 178.822 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.595 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.21 157.32 44.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.005 0.431 . . . . 0.32000000000000001 111.11 -179.951 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.492 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.0 m-20 -128.09 155.19 44.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.699 -0.682 . . . . 2.1699999999999999 110.086 178.978 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.836 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.55 173.04 6.35 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.185 -0.462 . . . . 0.58999999999999997 110.732 -179.193 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.836 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.58 173.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.974 2.449 . . . . 0.90000000000000002 111.492 179.333 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.479 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.09 -51.03 0.69 Allowed Pre-proline 0 C--N 1.328 -0.349 0 C-N-CA 120.666 -0.414 . . . . 3.3399999999999999 110.078 179.853 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.84 152.32 82.57 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.798 2.332 . . . . 1.8500000000000001 111.483 179.219 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.67 42.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.38 0.61 . . . . 2.54 110.534 -179.869 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.817 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.67 -41.58 98.17 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.032 -0.985 . . . . 2.5299999999999998 110.68 179.709 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.533 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.6 mt -109.93 137.82 40.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.773 -0.648 . . . . 1.1699999999999999 111.271 -179.439 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.92 -72.98 0.7 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.999 -0.546 . . . . 1.27 111.865 -178.963 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.16 148.42 24.42 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.587 0.588 . . . . 1.1200000000000001 112.587 -179.625 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.85 124.87 45.14 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.319 -0.623 . . . . 0.41999999999999998 109.319 177.572 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.02 134.67 60.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.718 -0.393 . . . . 0.78000000000000003 110.72 179.939 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.928 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -119.96 128.67 53.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.055 0.455 . . . . 0.62 111.275 179.788 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.547 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 138.88 49.64 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.758 -0.655 . . . . 1.97 110.08 179.087 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.433 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.0 163.23 34.84 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.158 0.504 . . . . 0.34999999999999998 112.086 -178.198 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.489 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.51 139.57 7.83 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.482 -0.781 . . . . 1.8 110.451 178.846 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.684 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.9 Cg_endo -63.54 115.44 3.04 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.279 1.986 . . . . 0.57999999999999996 111.891 179.938 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.679 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.3 tttp -46.99 81.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.871 -0.418 . . . . 3.04 109.871 -179.827 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.684 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.24 -20.58 0.06 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.92 -0.582 . . . . 2.4700000000000002 111.874 -179.584 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 p -157.7 157.81 34.21 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 120.747 -0.381 . . . . 2.5099999999999998 110.561 179.764 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.401 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.42 27.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 1.8600000000000001 110.161 179.659 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.81 -75.89 1.31 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.19 -0.528 . . . . 1.4399999999999999 111.861 -179.243 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.96 152.32 35.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.968 0.413 . . . . 4.6900000000000004 110.988 -179.383 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.674 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.18 -169.14 2.54 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.993 -0.549 . . . . 1.4299999999999999 111.922 179.425 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.6 mttp -110.14 149.62 29.81 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.477 0.656 . . . . 1.74 112.599 -177.922 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.0 156.58 46.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.768 -1.105 . . . . 1.9199999999999999 110.306 178.6 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.3 158.39 41.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.901 -0.59 . . . . 0.34000000000000002 111.785 -179.311 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.8 m -115.25 135.67 53.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.459 -0.791 . . . . 0.40999999999999998 109.784 179.317 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.595 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.43 121.95 23.73 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.419 -0.355 . . . . 0.55000000000000004 111.505 -179.105 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.0 Cg_exo -46.34 151.73 1.64 Allowed 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.639 2.226 . . . . 0.44 112.189 179.019 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.89 -23.07 63.07 Favored Glycine 0 CA--C 1.532 1.094 0 CA-C-N 116.063 -0.517 . . . . 0.73999999999999999 112.81 -179.189 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.538 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.79 -16.9 46.07 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.237 -0.585 . . . . 0.93000000000000005 111.761 -178.274 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.603 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.54 138.48 31.54 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.689 -0.404 . . . . 0.96999999999999997 110.309 179.372 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.6 13.98 10.95 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.404 -0.362 . . . . 1.3400000000000001 111.567 -179.416 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.472 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -149.98 143.44 25.21 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.607 -0.437 . . . . 0.39000000000000001 111.052 179.586 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.708 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.82 -169.36 1.53 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.203 0.525 . . . . 0.41999999999999998 110.916 -179.523 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.708 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 t -151.69 125.89 9.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.448 -0.796 . . . . 0.39000000000000001 109.84 179.262 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.517 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.7 mt -114.83 123.27 70.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.33 -0.548 . . . . 0.73999999999999999 111.205 -179.785 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -126.43 163.41 23.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.872 -0.603 . . . . 2.48 110.379 179.788 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.16 18.83 60.11 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.783 -0.927 . . . . 0.5 110.783 -179.953 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.517 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.2 mt -79.05 157.31 28.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.156 0.503 . . . . 0.57999999999999996 111.28 -179.521 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.848 ' O ' HG12 ' A' ' 67' ' ' VAL . 4.8 mptp? -99.59 134.0 21.44 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.554 -0.748 . . . . 2.79 110.414 179.8 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.439 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.9 Cg_endo -67.8 143.64 62.09 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.591 2.194 . . . . 0.87 111.971 179.784 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.75 25.62 75.34 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.101 -0.8 . . . . 0.64000000000000001 111.101 179.705 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.848 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.15 158.78 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.692 0.282 . . . . 0.82999999999999996 110.397 -179.574 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.17 139.96 41.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.882 0.372 . . . . 0.5 110.621 -179.825 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.672 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.2 m-85 -122.56 136.33 54.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.994 -0.548 . . . . 0.53000000000000003 110.818 -179.901 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.486 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.79 131.05 45.22 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.546 -0.909 . . . . 1.8700000000000001 108.546 177.593 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.48 153.79 16.66 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.308 -0.949 . . . . 0.28999999999999998 111.986 -178.579 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.92 140.92 46.13 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.658 -0.497 . . . . 1.4299999999999999 109.658 179.584 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.525 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.1 tp -115.75 118.84 34.15 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.452 -0.499 . . . . 0.32000000000000001 110.536 179.672 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.714 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.42 129.05 68.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.339 -0.391 . . . . 0.79000000000000004 110.658 -179.862 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.704 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.74 120.88 43.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.27 -0.423 . . . . 1.02 110.73 -179.634 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.85 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.62 146.5 11.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.17 0.51 . . . . 0.62 110.944 -179.223 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.817 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.06 153.93 21.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.46 -0.791 . . . . 2.4399999999999999 109.891 179.826 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.18 88.52 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.896 0.379 . . . . 3.6899999999999999 110.424 -179.809 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.36 32.52 0.22 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.873 -0.603 . . . . 6.0800000000000001 110.628 -179.953 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.02 -117.38 3.3 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.431 -0.667 . . . . 1.22 111.431 -179.693 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.469 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.43 177.42 8.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.135 0.493 . . . . 2.8799999999999999 111.658 -179.189 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.1 149.54 32.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.503 -0.771 . . . . 1.47 110.391 179.167 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.552 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.18 144.66 38.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.471 -0.331 . . . . 2.7000000000000002 110.515 179.863 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.714 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.94 136.09 61.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 121.035 0.445 . . . . 0.46000000000000002 111.57 -179.806 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.7 m -124.15 141.29 52.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.753 -0.658 . . . . 0.34999999999999998 110.316 179.635 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.46 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.58 138.91 51.62 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.125 0.488 . . . . 3.6699999999999999 111.524 -179.339 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.3 164.14 38.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.575 -0.739 . . . . 0.67000000000000004 109.474 179.386 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.57 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.29 151.57 38.56 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.293 -0.563 . . . . 1.47 111.011 179.937 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.808 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.21 172.72 13.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.792 -0.64 . . . . 0.44 111.079 179.895 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.77 160.7 21.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.57 -0.741 . . . . 1.3700000000000001 109.847 179.644 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.46 121.89 22.88 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.524 -0.47 . . . . 1.28 110.712 -179.965 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.6 p -125.41 151.83 45.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.909 0.862 . . . . 1.97 112.908 179.695 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.9 t -63.55 -33.94 76.7 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 114.053 -1.43 . . . . 3.2799999999999998 113.876 -179.402 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.2 p -78.78 158.53 28.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.438 0.637 . . . . 0.0 112.43 -176.966 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.622 ' O ' ' C ' ' A' ' 96' ' ' THR . 83.2 p -147.15 160.19 42.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.414 179.158 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.622 ' C ' ' O ' ' A' ' 95' ' ' SER . 30.1 p 0.21 76.37 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.714 0 O-C-N 123.237 0.336 . . . . 0.0 111.603 179.667 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.467 ' N ' ' O ' ' A' ' 95' ' ' SER . 31.4 Cg_exo -56.65 139.26 87.75 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.198 1.932 . . . . 0.0 112.321 -179.118 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.581 ' C ' ' H ' ' A' ' 100' ' ' SER . 5.9 p -61.94 -34.37 62.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.758 179.565 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.0 p 53.99 -4.9 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.197 -179.382 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.581 ' H ' ' C ' ' A' ' 98' ' ' VAL . 32.3 t -60.84 -35.3 76.18 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.0 179.285 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -87.62 7.19 30.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.891 -178.893 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.0 m -76.9 134.58 38.92 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.797 -179.774 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.6 p -133.64 143.26 39.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.201 179.721 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 25.2 p -82.33 160.66 22.8 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.614 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.1 37.68 37.04 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.938 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 106' ' ' GLU . 59.3 mp0 -56.27 143.26 34.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.013 0.435 . . . . 0.0 110.745 -179.258 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.0 p -87.17 163.26 17.04 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.95 -179.706 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.41 81.46 59.17 Favored Pre-proline 0 N--CA 1.465 0.313 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.002 179.722 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.47 143.95 53.1 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.509 2.139 . . . . 0.0 112.626 -179.124 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.48 ' CD2' ' OG ' ' A' ' 111' ' ' SER . 68.4 t80 -102.15 135.78 43.15 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.305 179.888 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.48 ' OG ' ' CD2' ' A' ' 110' ' ' PHE . 14.7 m 62.13 71.17 0.75 Allowed Pre-proline 0 N--CA 1.464 0.23 0 CA-C-O 120.793 0.33 . . . . 0.0 110.785 -179.724 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -50.64 149.87 13.06 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.899 2.399 . . . . 0.0 112.224 -179.609 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.4 mt -58.24 -34.12 70.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.835 -0.62 . . . . 10.19 111.104 -179.285 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.631 ' O ' ' HB2' ' A' ' 115' ' ' ALA . 41.4 t -110.73 133.63 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.765 0.316 . . . . 7.2800000000000002 110.674 -179.689 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 114' ' ' VAL . . . 156.65 17.67 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.621 -0.718 . . . . 7.2999999999999998 109.625 179.957 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.402 ' H ' ' H ' ' A' ' 115' ' ' ALA . 23.3 p -84.24 162.25 20.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.057 -0.519 . . . . 6.4400000000000004 111.167 -179.265 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.7 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 47.0 m -65.03 159.05 24.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.598 -0.728 . . . . 4.4199999999999999 110.861 179.835 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.7 ' HG3' ' O ' ' A' ' 117' ' ' SER . 95.0 mt-10 132.09 69.12 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.479 1.112 . . . . 3.0499999999999998 110.46 179.929 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.4 p -62.8 -25.82 68.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.916 -0.583 . . . . 3.4300000000000002 110.488 179.494 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.4 t -112.43 135.85 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 115.932 -0.576 . . . . 2.8799999999999999 110.158 -179.928 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 21.1 p -121.83 161.94 21.81 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.116 0.484 . . . . 2.0899999999999999 111.157 -179.326 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -103.41 146.48 28.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.516 -0.766 . . . . 4.5300000000000002 109.656 179.821 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 70.8 mt -108.8 132.32 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 121.204 0.526 . . . . 1.4399999999999999 110.63 -179.368 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 67.1 m -124.18 145.59 49.23 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.298 -0.865 . . . . 1.78 110.472 -179.576 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -58.09 142.1 48.03 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.28 0.562 . . . . 0.64000000000000001 111.112 -179.234 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.1 OUTLIER 170.77 19.92 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 122.668 1.223 . . . . 0.66000000000000003 108.137 -179.445 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.454 ' H ' ' H ' ' A' ' 126' ' ' SER . 0.9 OUTLIER -53.82 167.6 0.25 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.121 -1.399 . . . . 0.68999999999999995 110.904 -178.85 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.69 145.56 50.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.692 -0.686 . . . . 0.52000000000000002 110.084 -179.934 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.26 101.7 9.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.07 -0.715 . . . . 0.32000000000000001 109.07 177.678 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.2 t -112.88 139.69 36.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.989 -0.551 . . . . 0.28999999999999998 111.073 -178.914 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.9 p -128.68 152.55 48.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.637 -0.71 . . . . 0.25 109.84 179.568 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.81 -164.98 2.04 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.693 -0.403 . . . . 0.31 110.64 -179.764 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.733 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.6 t -123.95 127.16 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.48999999999999999 110.844 -179.88 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.174 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.94 58.36 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.103 -0.499 . . . . 1.53 110.415 179.808 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.29 24.59 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.931 -0.577 . . . . 0.96999999999999997 111.479 -179.541 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.174 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.2 128.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.686 -0.405 . . . . 1.5600000000000001 111.004 179.8 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -86.45 -9.62 55.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.886 -0.597 . . . . 1.8799999999999999 110.337 179.775 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.12 0.35 55.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.094 -0.503 . . . . 1.04 110.289 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.34 137.19 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.23999999999999999 109.977 179.663 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 185' ' ' ILE . 76.6 p -96.28 -15.4 21.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.304 0.574 . . . . 0.28999999999999998 110.044 -179.649 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.52 175.58 45.72 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.856 -1.297 . . . . 0.13 109.856 179.59 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.45 151.63 42.49 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.62 -0.432 . . . . 0.17000000000000001 110.484 179.745 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.459 ' NH1' ' HG2' ' A' ' 15' ' ' PRO . 45.2 ttp180 -132.33 121.22 23.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.143 -0.48 . . . . 1.29 109.899 179.814 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.554 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.13 136.54 38.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.732 -0.667 . . . . 0.25 110.634 -179.711 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 80.7 tt0 -129.5 129.86 45.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.975 -0.557 . . . . 1.3200000000000001 110.006 -179.91 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.622 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.6 p90 -138.69 135.32 34.67 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.937 -0.574 . . . . 0.56999999999999995 110.633 -179.676 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.421 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.32 161.4 39.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.753 -0.658 . . . . 1.1599999999999999 109.619 179.875 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.968 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.1 mt -71.04 124.8 25.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.973 0.416 . . . . 0.38 110.772 -179.642 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.496 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.5 p -71.79 -7.64 49.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.832 -0.622 . . . . 0.40999999999999998 110.875 -179.738 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -109.82 -69.72 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.963 0.411 . . . . 1.6599999999999999 111.407 -179.267 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.468 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.69 -35.31 75.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.014 -0.539 . . . . 1.6599999999999999 111.563 -179.155 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.076 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.07 7.29 88.55 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.829 -0.908 . . . . 1.1699999999999999 110.829 -179.83 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.319 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.95 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.734 0.302 . . . . 1.8600000000000001 110.322 179.818 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.319 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.13 45.22 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.976 0.417 . . . . 1.98 110.193 179.624 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.8 Cg_endo -70.85 145.9 52.06 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 C-N-CA 122.621 2.214 . . . . 0.55000000000000004 112.368 -179.568 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.622 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.87 145.73 42.63 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.21 -0.663 . . . . 1.1399999999999999 109.21 179.21 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 6.0 p90 -123.24 141.31 52.11 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.399 -0.52 . . . . 0.93000000000000005 111.57 -179.108 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.3 mt -128.18 127.73 43.47 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.337 -0.847 . . . . 0.34000000000000002 108.844 178.956 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.548 ' O ' ' OD1' ' A' ' 159' ' ' ASP . 54.4 p-10 -101.65 131.15 48.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.174 0.511 . . . . 1.0900000000000001 111.751 -178.76 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.92 157.49 73.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.362 -0.836 . . . . 0.19 109.559 179.768 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -69.76 158.0 58.47 Favored 'Trans proline' 0 C--N 1.301 -1.924 0 C-N-CA 122.485 2.123 . . . . 0.17999999999999999 112.203 179.903 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.27 -12.16 5.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.755 -0.657 . . . . 0.20999999999999999 110.75 -179.842 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.5 p -92.81 -8.84 42.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.113 -0.494 . . . . 0.28999999999999998 110.678 -179.823 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.11 135.32 34.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.325 -0.398 . . . . 0.5 110.463 179.68 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 32.1 p -133.07 16.6 4.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.465 -0.334 . . . . 0.29999999999999999 110.582 179.953 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.1 p -167.53 147.09 5.08 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.61 -0.515 . . . . 0.23000000000000001 109.61 179.897 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.554 HG11 HG21 ' A' ' 144' ' ' VAL . 6.2 p -152.2 150.52 12.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.518 -0.473 . . . . 0.28000000000000003 111.528 -179.632 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.512 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.39 124.98 50.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.608 -0.724 . . . . 1.0700000000000001 109.763 179.517 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.39 104.93 29.96 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.909 0.385 . . . . 0.28999999999999998 111.02 -179.879 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.0 Cg_endo -91.03 -179.56 1.5 Allowed 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 123.12 2.547 . . . . 0.42999999999999999 112.179 179.89 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 61.81 32.54 18.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.372 -0.831 . . . . 1.26 111.435 179.246 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.456 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.0 mt -86.46 148.5 25.52 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.918 -0.313 . . . . 0.32000000000000001 110.474 179.592 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.774 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.2 mt -88.27 114.85 61.27 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 121.06 0.457 . . . . 0.57999999999999996 110.674 -179.64 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -58.95 140.63 96.15 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.9 2.4 . . . . 0.66000000000000003 111.99 179.853 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 76.99 21.26 74.44 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.082 -0.807 . . . . 0.28999999999999998 111.082 179.864 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.468 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.84 150.15 49.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.783 0.325 . . . . 2.3300000000000001 110.669 179.944 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.17 131.66 45.99 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.047 -0.524 . . . . 0.85999999999999999 109.784 179.28 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.968 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.2 m-85 -120.5 148.32 43.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.096 -0.502 . . . . 0.52000000000000002 110.951 -179.813 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.35 125.39 60.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.295 -1.002 . . . . 0.29999999999999999 108.295 177.657 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.59 132.45 63.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.206 0.527 . . . . 0.23000000000000001 111.274 -178.61 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.45 122.6 20.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.46 -0.791 . . . . 0.35999999999999999 109.64 179.278 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.8 t -101.02 125.41 54.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.234 -0.439 . . . . 0.19 110.72 -179.566 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.3 m-85 -117.22 137.91 52.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.992 -0.549 . . . . 0.29999999999999999 109.884 179.535 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.583 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.75 135.04 42.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.801 -0.815 . . . . 0.37 108.801 178.872 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.606 ' O ' ' N ' ' A' ' 140' ' ' SER . 80.6 mt -98.98 122.93 51.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.134 0.492 . . . . 0.26000000000000001 110.981 -178.774 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.8 p -83.89 169.67 14.85 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.593 -0.73 . . . . 0.28000000000000003 110.447 -179.709 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.82 -14.49 15.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.996 -0.547 . . . . 1.6000000000000001 110.928 -179.552 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -96.05 -4.3 43.24 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.857 -0.337 . . . . 1.1799999999999999 110.808 -179.832 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.83 13.84 64.01 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.351 -0.699 . . . . 0.29999999999999999 111.351 179.848 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -84.64 139.1 32.3 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.774 -0.251 . . . . 1.22 110.43 179.737 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.4 ' OE1' ' NH1' ' A' ' 143' ' ' ARG . 15.2 pt20 -106.72 141.07 38.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.423 -0.353 . . . . 0.97999999999999998 110.53 179.773 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.75 127.06 26.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.82999999999999996 110.332 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 25.8 tp -68.13 117.21 9.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.247 -0.433 . . . . 0.26000000000000001 110.42 -179.876 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.1 pt -108.98 -21.83 5.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.29999999999999999 110.688 -179.787 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.82 125.82 5.95 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.512 -0.475 . . . . 0.31 111.476 -179.803 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.47 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.82 120.15 21.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.764 -0.653 . . . . 0.28000000000000003 109.564 179.174 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.63 151.63 29.03 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.691 -0.404 . . . . 0.23999999999999999 110.932 -179.284 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.31 158.64 18.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.041 -0.527 . . . . 0.23000000000000001 110.431 179.723 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.4 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 21.4 mt-30 -146.12 157.86 43.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.078 -0.51 . . . . 0.67000000000000004 110.652 -179.997 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.22 104.29 9.35 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.827 -0.624 . . . . 0.64000000000000001 110.086 179.522 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.0 p . . . . . 0 C--O 1.221 -0.417 0 CA-C-O 117.851 -1.071 . . . . 1.26 110.727 -179.727 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.4 m . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.269 -0.641 . . . . 3.4399999999999999 109.269 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.74 18.53 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.032 -0.827 . . . . 1.22 111.032 179.683 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -35.7 142.38 0.1 Allowed 'Trans proline' 0 C--N 1.298 -2.113 0 C-N-CA 124.004 3.136 . . . . 0.75 113.806 -179.247 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.0 t -79.93 173.4 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.14 -1.391 . . . . 0.79000000000000004 108.888 178.41 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.608 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.53 125.86 51.46 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.448 -0.501 . . . . 1.9399999999999999 111.496 -179.618 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.51 143.99 33.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.687 -0.688 . . . . 0.59999999999999998 110.585 179.967 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.07 168.27 25.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.934 0.397 . . . . 3.1400000000000001 111.074 -179.671 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.744 HG22 ' OG1' ' A' ' 11' ' ' THR . 65.9 mt -108.93 131.01 60.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.946 -0.57 . . . . 3.23 110.139 179.877 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.6 p -141.14 162.27 35.88 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.869 0.366 . . . . 3.6299999999999999 111.247 -179.88 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.7 mt-10 36.21 31.5 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.601 -0.518 . . . . 6.0800000000000001 109.601 179.781 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.744 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.49 69.63 33.17 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.962 -0.563 . . . . 3.3799999999999999 111.555 -178.764 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.642 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.9 Cg_endo -63.24 -29.22 73.2 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.531 2.154 . . . . 3.9300000000000002 111.849 179.304 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.642 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.71 125.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 3.3599999999999999 110.474 179.971 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.561 ' O ' ' O ' ' A' ' 92' ' ' THR . 2.3 mp0 -123.98 158.34 60.59 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.362 -0.381 . . . . 3.6099999999999999 110.436 179.965 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.506 ' HG3' ' NH1' ' A' ' 143' ' ' ARG . 96.7 Cg_endo -82.12 -64.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.837 2.358 . . . . 1.51 113.485 -179.023 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.54 ' OD1' ' O ' ' A' ' 63' ' ' LEU . 2.5 t-20 -108.5 -19.51 13.42 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.06 0.393 . . . . 2.6800000000000002 112.06 -178.501 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 9.1 p -107.36 152.02 24.71 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.103 0.477 . . . . 1.21 111.299 -179.456 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.576 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.25 102.89 2.23 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.694 -0.684 . . . . 1.5600000000000001 110.649 179.844 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.443 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.4 Cg_endo -82.62 145.66 13.12 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.885 2.39 . . . . 0.81000000000000005 112.621 179.896 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.917 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.84 167.93 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.901 -0.59 . . . . 1.52 109.856 179.595 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -149.17 147.85 28.94 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.819 -0.437 . . . . 2.1400000000000001 109.819 178.872 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.584 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.6 p90 -142.19 157.34 44.97 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.685 -0.406 . . . . 0.32000000000000001 111.228 179.946 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.501 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -128.03 155.23 44.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.737 -0.665 . . . . 2.1699999999999999 110.117 179.023 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.843 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.6 173.04 6.35 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.024 0.44 . . . . 0.58999999999999997 110.79 -179.266 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.843 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.71 173.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.914 2.41 . . . . 0.90000000000000002 111.528 179.402 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -82.94 -51.01 0.7 Allowed Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.616 -0.434 . . . . 3.3399999999999999 110.17 179.867 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.643 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.9 152.35 82.57 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.681 2.254 . . . . 1.8500000000000001 111.48 179.183 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.71 42.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.406 0.622 . . . . 2.54 110.562 -179.82 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.818 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.7 -41.51 98.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.943 -1.026 . . . . 2.5299999999999998 110.657 179.784 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.532 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.3 mt -110.0 137.87 40.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.72 -0.673 . . . . 1.1699999999999999 111.181 -179.409 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.99 -72.97 0.7 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.939 -0.573 . . . . 1.27 111.819 -178.944 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.19 148.44 24.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.591 0.589 . . . . 1.1200000000000001 112.591 -179.592 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.79 124.75 44.93 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.363 -0.606 . . . . 0.41999999999999998 109.363 177.556 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -117.99 134.71 60.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.696 -0.402 . . . . 0.78000000000000003 110.67 179.89 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.917 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -119.98 128.58 53.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.043 0.449 . . . . 0.62 111.225 179.767 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.542 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.07 138.98 49.83 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.768 -0.651 . . . . 1.97 110.138 178.954 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.44 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.0 163.25 34.77 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 121.165 0.507 . . . . 0.34999999999999998 112.061 -178.151 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.56 139.63 7.82 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.415 -0.811 . . . . 1.8 110.399 178.825 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.7 Cg_endo -63.71 115.52 3.12 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.308 2.005 . . . . 0.57999999999999996 111.822 179.985 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.675 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.96 81.13 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.897 -0.408 . . . . 3.04 109.897 -179.801 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.697 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.16 -20.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.012 -0.54 . . . . 2.4700000000000002 111.936 -179.496 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.2 p -157.65 157.79 34.25 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.839 -0.345 . . . . 2.5099999999999998 110.568 179.77 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.38 27.79 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 1.8600000000000001 110.165 179.574 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.75 -75.79 1.31 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.183 -0.532 . . . . 1.4399999999999999 111.888 -179.245 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.4 ' HD2' HH11 ' A' ' 45' ' ' ARG . 21.4 mtp180 -118.03 152.29 35.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.931 0.396 . . . . 4.6900000000000004 110.968 -179.317 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.673 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.15 2.54 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.106 -0.497 . . . . 1.4299999999999999 112.007 179.39 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.04 149.67 29.66 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.457 0.646 . . . . 1.74 112.543 -177.836 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.15 156.44 45.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.789 -1.096 . . . . 1.9199999999999999 110.161 178.635 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.21 158.35 41.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.905 -0.589 . . . . 0.34000000000000002 111.745 -179.351 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.3 m -115.11 135.59 54.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.454 -0.794 . . . . 0.40999999999999998 109.831 179.287 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.584 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.34 121.86 23.82 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.411 -0.359 . . . . 0.55000000000000004 111.596 -179.156 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.595 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.0 Cg_exo -46.23 151.67 1.58 Allowed 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.695 2.263 . . . . 0.44 112.173 178.992 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.83 -23.16 63.05 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 116.096 -0.502 . . . . 0.73999999999999999 112.796 -179.205 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.54 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.7 -16.95 46.17 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.245 -0.582 . . . . 0.93000000000000005 111.824 -178.316 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.595 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.51 138.39 31.61 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.782 -0.367 . . . . 0.96999999999999997 110.27 179.396 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -121.54 14.01 11.0 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.308 -0.405 . . . . 1.3400000000000001 111.466 -179.418 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.1 p -150.04 143.5 25.19 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.721 -0.392 . . . . 0.39000000000000001 111.061 179.573 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.723 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.9 -169.31 1.53 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.065 -0.516 . . . . 0.41999999999999998 110.885 -179.425 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.723 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.79 125.94 9.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.442 -0.799 . . . . 0.39000000000000001 109.793 179.305 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.519 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.6 mt -114.89 123.19 70.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.398 -0.521 . . . . 0.73999999999999999 111.157 -179.73 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -126.47 163.32 23.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.895 -0.593 . . . . 2.48 110.467 179.695 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.443 ' N ' ' OD2' ' A' ' 159' ' ' ASP . . . 85.24 18.95 59.76 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.672 -0.971 . . . . 0.5 110.672 -179.963 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.54 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 73.6 mt -79.07 157.27 28.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.129 0.49 . . . . 0.57999999999999996 111.302 -179.594 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.84 ' O ' HG12 ' A' ' 67' ' ' VAL . 1.2 mptt -99.51 134.02 21.47 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.572 -0.74 . . . . 2.79 110.475 179.759 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.95 143.58 61.03 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.573 2.182 . . . . 0.87 111.912 179.835 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.62 75.34 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.1 -0.8 . . . . 0.64000000000000001 111.1 179.732 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.84 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.14 158.74 39.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.704 0.288 . . . . 0.82999999999999996 110.395 -179.564 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.17 139.95 42.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.067 0.46 . . . . 0.5 110.586 -179.861 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.648 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.3 m-85 -122.5 136.42 54.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.869 -0.605 . . . . 0.53000000000000003 110.799 -179.9 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.3 pt-20 -98.85 131.06 45.24 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.553 -0.906 . . . . 1.8700000000000001 108.553 177.557 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.495 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.47 153.84 16.65 Favored Glycine 0 C--O 1.227 -0.286 0 C-N-CA 120.364 -0.922 . . . . 0.28999999999999998 112.043 -178.681 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -134.99 140.92 46.05 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.706 -0.479 . . . . 1.4299999999999999 109.706 179.55 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.2 tp -115.77 119.01 34.62 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.421 -0.512 . . . . 0.32000000000000001 110.504 179.684 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 84' ' ' VAL . 64.1 mt -112.45 129.06 68.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 0.79000000000000004 110.631 -179.865 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.7 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.8 120.75 43.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.343 -0.39 . . . . 1.02 110.754 -179.682 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.856 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.54 146.38 11.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.223 0.535 . . . . 0.62 111.023 -179.258 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.818 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.01 153.85 21.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.532 -0.758 . . . . 2.4399999999999999 109.935 179.829 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.2 mt-30 -39.13 88.48 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.889 0.376 . . . . 3.6899999999999999 110.416 -179.737 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.31 32.7 0.22 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.845 -0.616 . . . . 6.0800000000000001 110.467 -179.922 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.18 -117.36 3.28 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.413 -0.675 . . . . 1.22 111.413 -179.776 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.461 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.34 177.44 8.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.295 0.569 . . . . 2.8799999999999999 111.606 -179.192 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.22 149.46 31.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.423 -0.808 . . . . 1.47 110.486 179.149 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.07 144.64 38.85 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.549 -0.296 . . . . 2.7000000000000002 110.591 179.952 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.727 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.94 136.07 61.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.036 0.446 . . . . 0.46000000000000002 111.565 -179.832 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.57 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.16 141.38 52.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.675 -0.693 . . . . 0.34999999999999998 110.241 179.645 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.4 ttp180 -117.64 138.86 51.69 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.572 -0.451 . . . . 3.6699999999999999 111.511 -179.322 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.495 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.9 p90 -152.32 164.18 37.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.606 -0.724 . . . . 0.67000000000000004 109.44 179.422 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.567 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.29 151.55 38.52 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.357 -0.537 . . . . 1.47 111.042 179.99 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.8 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.25 172.68 13.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.738 -0.665 . . . . 0.44 111.083 179.848 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.69 160.65 21.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.48 -0.782 . . . . 1.3700000000000001 109.873 179.604 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.29 121.93 23.14 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 120.507 -0.477 . . . . 1.28 110.731 179.959 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.561 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.5 p -127.42 159.32 34.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 1.97 111.643 179.631 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 36.3 t -67.7 -82.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.904 -0.589 . . . . 3.2799999999999998 110.944 179.325 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 69.4 p -114.52 10.5 16.88 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.663 179.81 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.407 ' O ' ' OG1' ' A' ' 96' ' ' THR . 32.2 t 51.67 -147.71 0.42 Allowed 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.897 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 95' ' ' SER . 30.6 p 52.12 68.83 2.82 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.866 179.59 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -54.66 -20.0 20.2 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.791 2.328 . . . . 0.0 112.114 -179.595 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 100' ' ' SER . 35.1 m -126.89 156.9 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.0 -179.794 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 47.9 m -57.24 -39.09 74.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.947 -179.192 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.511 ' O ' HG23 ' A' ' 98' ' ' VAL . 29.3 t -115.86 138.41 51.18 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.065 0.46 . . . . 0.0 111.151 -179.311 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -57.06 -33.04 66.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.005 179.398 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.558 ' O ' ' O ' ' A' ' 103' ' ' VAL . 50.1 m -116.87 139.32 50.76 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.075 -178.776 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.558 ' O ' ' O ' ' A' ' 102' ' ' THR . 62.9 t 50.3 155.7 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.526 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.404 ' N ' HG12 ' A' ' 103' ' ' VAL . 13.5 p -123.97 163.52 21.18 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.986 179.971 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -164.37 -178.08 37.54 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.488 179.877 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -59.77 145.02 46.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.952 0.406 . . . . 0.0 110.984 -179.824 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.9 m -74.65 140.58 44.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.849 179.565 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.27 82.1 30.54 Favored Pre-proline 0 N--CA 1.465 0.286 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.191 -178.883 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.56 151.15 47.88 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.157 1.905 . . . . 0.0 111.504 179.73 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -102.41 135.09 44.65 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.161 0.505 . . . . 0.0 110.911 -179.242 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.5 m -124.18 80.7 58.37 Favored Pre-proline 0 CA--C 1.529 0.158 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.97 179.963 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.73 144.4 54.16 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.069 1.846 . . . . 0.0 112.359 -178.746 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 66.5 mt -60.1 -32.62 71.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.277 -0.874 . . . . 10.19 111.47 -179.463 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 43.2 t -106.04 134.85 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.268 0.556 . . . . 7.2800000000000002 111.38 -178.654 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -104.84 151.54 23.69 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.222 -0.899 . . . . 7.2999999999999998 110.193 179.925 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 48.9 m -70.69 137.29 49.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.906 0.384 . . . . 6.4400000000000004 110.412 -179.63 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.0 m -62.91 155.05 28.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.946 -0.57 . . . . 4.4199999999999999 111.324 -179.287 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -58.43 145.49 38.38 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.725 -0.67 . . . . 3.0499999999999998 110.585 179.838 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.3 p -114.43 155.01 27.13 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.121 -0.49 . . . . 3.4300000000000002 110.489 -179.879 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.9 t -113.11 135.89 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.016 -0.538 . . . . 2.8799999999999999 110.59 -179.596 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 24.0 p -82.14 161.8 22.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.098 -0.501 . . . . 2.0899999999999999 110.941 -179.605 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -114.02 -91.22 0.51 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.714 -0.676 . . . . 4.5300000000000002 110.505 -179.779 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 32.1 pt -121.43 161.83 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.997 -0.547 . . . . 1.4399999999999999 110.098 -179.819 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.626 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 44.4 m -71.65 134.34 46.28 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.718 -0.393 . . . . 1.78 110.476 -179.18 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 124' ' ' THR . . . 151.61 75.64 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.451 -0.795 . . . . 0.64000000000000001 109.021 -179.607 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.7 p -60.66 -31.33 70.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.324 -0.398 . . . . 0.66000000000000003 111.17 -178.768 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.44 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.81 167.56 0.25 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.181 -0.463 . . . . 0.68999999999999995 110.954 179.893 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 8.0 m-30 -133.65 145.49 50.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.807 -0.633 . . . . 0.52000000000000002 110.136 -179.933 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.6 t -124.18 101.62 9.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.012 -0.736 . . . . 0.32000000000000001 109.012 177.788 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.6 t -112.97 139.62 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.1 -0.5 . . . . 0.28999999999999998 111.149 -178.965 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 66.4 p -128.63 152.62 48.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.66 -0.7 . . . . 0.25 109.891 179.564 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.588 ' CD2' HG11 ' A' ' 182' ' ' VAL . 40.0 p90 -144.77 -165.06 2.06 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.74 -0.384 . . . . 0.31 110.704 -179.669 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.735 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.6 t -123.87 127.08 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.48999999999999999 110.897 -179.903 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.176 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.85 58.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.159 -0.473 . . . . 1.53 110.388 179.767 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.735 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.22 24.47 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.949 -0.569 . . . . 0.96999999999999997 111.433 -179.597 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.176 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.17 128.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.617 -0.433 . . . . 1.5600000000000001 110.991 179.915 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.36 -9.71 55.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.95 -0.568 . . . . 1.8799999999999999 110.293 179.829 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 28.1 p -87.07 0.2 55.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 1.04 110.253 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.21 137.17 25.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.23999999999999999 109.974 179.68 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 185' ' ' ILE . 70.5 m -96.22 -15.58 21.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.227 0.537 . . . . 0.28999999999999998 110.011 -179.66 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.61 175.52 45.76 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.821 -1.312 . . . . 0.13 109.821 179.722 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.37 151.62 42.35 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.694 -0.402 . . . . 0.17000000000000001 110.489 179.706 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.856 ' HE ' ' NE2' ' A' ' 191' ' ' GLN . 55.1 ttp85 -132.36 121.21 23.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.172 -0.467 . . . . 1.29 109.954 179.736 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.563 HG21 HG11 ' A' ' 167' ' ' VAL . 46.2 t -105.13 136.53 38.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.716 -0.675 . . . . 0.25 110.622 -179.7 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 79.5 tt0 -129.39 129.91 45.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.961 -0.563 . . . . 1.3200000000000001 110.128 179.963 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.9 p90 -138.67 135.32 34.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.006 -0.543 . . . . 0.56999999999999995 110.675 -179.658 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.414 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.39 161.33 39.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.805 -0.634 . . . . 1.1599999999999999 109.685 179.849 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.962 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.04 124.89 25.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.974 0.416 . . . . 0.38 110.737 -179.597 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.489 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.73 -7.78 50.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.741 -0.663 . . . . 0.40999999999999998 110.908 -179.791 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -109.76 -69.59 0.85 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.958 0.408 . . . . 1.6599999999999999 111.467 -179.253 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.441 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.4 mt-10 -60.85 -35.23 76.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.059 -0.519 . . . . 1.6599999999999999 111.454 -179.084 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.072 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.12 7.18 88.62 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.893 -0.883 . . . . 1.1699999999999999 110.893 -179.836 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.335 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -27.97 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.757 0.313 . . . . 1.8600000000000001 110.326 179.873 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.335 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.19 139.1 45.39 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.95 0.405 . . . . 1.98 110.226 179.649 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.414 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.2 Cg_endo -70.97 145.79 51.08 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 122.768 2.312 . . . . 0.55000000000000004 112.327 -179.499 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.85 145.68 42.65 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.28 -0.637 . . . . 1.1399999999999999 109.28 179.19 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.537 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 85.5 m-85 -123.27 141.41 52.01 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.314 -0.554 . . . . 0.93000000000000005 111.518 -179.053 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.4 mt -128.11 127.69 43.51 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.306 -0.861 . . . . 0.34000000000000002 108.915 179.06 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.443 ' OD2' ' N ' ' A' ' 62' ' ' GLY . 45.0 t0 -101.68 131.13 48.1 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.148 0.499 . . . . 1.0900000000000001 111.761 -178.783 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.1 mt -127.92 157.62 73.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.266 -0.879 . . . . 0.19 109.6 179.619 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -69.87 158.03 58.19 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.423 2.082 . . . . 0.17999999999999999 112.197 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.26 -12.18 5.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.729 -0.669 . . . . 0.20999999999999999 110.693 -179.808 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.2 p -92.86 -8.73 42.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.28999999999999998 110.657 -179.855 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.27 135.39 34.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.393 -0.367 . . . . 0.5 110.344 179.73 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 p -133.14 16.62 4.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.335 -0.393 . . . . 0.29999999999999999 110.54 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.7 p -167.45 147.15 5.16 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.659 -0.497 . . . . 0.23000000000000001 109.659 179.874 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.563 HG11 HG21 ' A' ' 144' ' ' VAL . 5.9 p -152.19 150.36 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.011 0.434 . . . . 0.28000000000000003 111.618 -179.605 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.504 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.29 124.96 50.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.622 -0.717 . . . . 1.0700000000000001 109.799 179.47 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.47 104.97 30.47 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.015 0.436 . . . . 0.28999999999999998 111.062 -179.903 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.5 Cg_endo -91.04 -179.46 1.47 Allowed 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 123.144 2.563 . . . . 0.42999999999999999 112.221 179.914 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.66 32.67 18.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.399 -0.819 . . . . 1.26 111.501 179.31 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.2 mt -86.41 148.57 25.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.442 -0.345 . . . . 0.32000000000000001 110.431 179.656 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.777 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.38 114.86 61.4 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.074 0.464 . . . . 0.57999999999999996 110.714 -179.742 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -58.9 140.53 95.62 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.926 2.417 . . . . 0.66000000000000003 112.024 179.882 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.06 21.3 74.14 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.044 -0.823 . . . . 0.28999999999999998 111.044 179.861 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.441 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -127.0 150.14 49.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.942 0.401 . . . . 2.3300000000000001 110.528 -179.984 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.489 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.13 131.67 45.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.878 -0.601 . . . . 0.85999999999999999 109.78 179.316 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.962 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.54 148.36 43.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.1 -0.5 . . . . 0.52000000000000002 111.035 -179.852 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.4 mt -105.39 125.33 60.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.221 -1.029 . . . . 0.29999999999999999 108.221 177.793 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.55 132.51 63.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.157 0.503 . . . . 0.23000000000000001 111.228 -178.642 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.43 122.65 20.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.492 -0.776 . . . . 0.35999999999999999 109.602 179.253 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.588 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.1 t -101.07 125.44 55.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.224 -0.444 . . . . 0.19 110.581 -179.53 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.9 m-85 -117.3 137.9 52.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.923 -0.581 . . . . 0.29999999999999999 109.85 179.479 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.585 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.72 135.12 42.67 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.71 -0.848 . . . . 0.37 108.71 178.911 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.588 ' O ' ' N ' ' A' ' 140' ' ' SER . 85.2 mt -99.13 122.97 51.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.131 0.491 . . . . 0.26000000000000001 110.977 -178.826 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.0 p -83.87 169.74 14.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.498 -0.774 . . . . 0.28000000000000003 110.478 -179.672 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.472 ' O ' ' CG2' ' A' ' 59' ' ' THR . 97.4 mt-10 -59.81 -14.45 14.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.056 -0.52 . . . . 1.6000000000000001 111.027 -179.571 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 96.7 m-20 -96.16 -4.25 42.98 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.791 -0.364 . . . . 1.1799999999999999 110.842 -179.781 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.407 ' HA2' ' OG1' ' A' ' 59' ' ' THR . . . 87.83 13.84 64.02 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.362 -0.695 . . . . 0.29999999999999999 111.362 179.879 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -84.64 139.16 32.25 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.047 -0.261 . . . . 1.22 110.391 179.769 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.856 ' NE2' ' HE ' ' A' ' 143' ' ' ARG . 91.0 mt-30 -106.79 141.06 38.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.41 -0.359 . . . . 0.97999999999999998 110.469 179.788 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.68 127.08 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.82999999999999996 110.33 179.872 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.21 117.25 9.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.327 -0.397 . . . . 0.26000000000000001 110.518 -179.918 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -108.99 -21.81 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.29999999999999999 110.739 -179.711 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.4 tp -157.0 125.75 5.81 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.48 -0.488 . . . . 0.31 111.458 -179.847 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.473 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.66 120.21 21.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.69 -0.686 . . . . 0.28000000000000003 109.591 179.208 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.61 151.71 29.15 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.543 -0.463 . . . . 0.23999999999999999 110.875 -179.294 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.44 158.62 18.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.035 -0.53 . . . . 0.23000000000000001 110.452 179.686 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.13 157.89 43.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.14 -0.482 . . . . 0.67000000000000004 110.656 179.99 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.18 104.36 9.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.755 -0.657 . . . . 0.64000000000000001 110.03 179.584 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.959 -1.02 . . . . 1.26 110.52 -179.656 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.1 m . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.188 -0.671 . . . . 3.4399999999999999 109.188 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.7 18.53 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.927 -0.869 . . . . 1.22 110.927 179.8 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -35.62 142.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.046 0 C-N-CA 123.991 3.127 . . . . 0.75 113.793 -179.239 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -80.09 173.51 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.184 -1.371 . . . . 0.79000000000000004 108.815 178.476 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.614 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.63 125.89 51.51 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.381 -0.527 . . . . 1.9399999999999999 111.351 -179.51 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.5 144.02 33.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.698 -0.683 . . . . 0.59999999999999998 110.65 179.838 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.09 168.3 25.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.972 0.415 . . . . 3.1400000000000001 111.09 -179.715 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.741 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.88 131.01 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.974 -0.557 . . . . 3.23 110.102 179.884 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.2 p -141.16 162.29 35.83 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.815 0.34 . . . . 3.6299999999999999 111.252 -179.951 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 9' ' ' THR . 96.9 mt-10 36.1 31.57 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.618 -0.512 . . . . 6.0800000000000001 109.618 179.828 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.741 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.44 69.53 32.5 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.975 -0.557 . . . . 3.3799999999999999 111.609 -178.782 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.643 ' O ' ' CB ' ' A' ' 13' ' ' SER . 18.0 Cg_endo -63.29 -29.04 72.66 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.395 2.063 . . . . 3.9300000000000002 111.893 179.322 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.643 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.66 125.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 3.3599999999999999 110.464 179.949 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.543 ' O ' ' O ' ' A' ' 92' ' ' THR . 0.4 OUTLIER -123.9 158.32 60.41 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.366 -0.379 . . . . 3.6099999999999999 110.515 179.956 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.699 ' CG ' ' NH1' ' A' ' 143' ' ' ARG . 97.7 Cg_endo -82.08 -64.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.926 2.417 . . . . 1.51 113.461 -178.994 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 62' ' ' GLY . 20.5 t-20 -108.42 -19.66 13.38 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.097 0.406 . . . . 2.6800000000000002 112.097 -178.504 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 36.4 m -107.32 152.09 24.6 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.45 -0.5 . . . . 1.21 111.345 -179.425 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.578 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.3 102.93 2.22 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.722 -0.672 . . . . 1.5600000000000001 110.649 179.877 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.7 145.64 12.98 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.871 2.381 . . . . 0.81000000000000005 112.635 179.967 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.916 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.77 167.95 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 1.52 109.922 179.609 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -149.22 147.89 28.95 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.743 -0.466 . . . . 2.1400000000000001 109.743 178.879 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.584 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.5 p90 -142.23 157.29 45.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.054 0.454 . . . . 0.32000000000000001 111.206 179.95 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.503 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.8 m-20 -127.99 155.21 44.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.818 -0.628 . . . . 2.1699999999999999 110.149 178.971 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.842 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.56 173.12 6.26 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.155 -0.475 . . . . 0.58999999999999997 110.795 -179.296 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.842 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.73 173.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.842 0 C-N-CA 122.884 2.389 . . . . 0.90000000000000002 111.494 179.425 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.484 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -51.02 0.69 Allowed Pre-proline 0 C--N 1.328 -0.354 0 C-N-CA 120.671 -0.412 . . . . 3.3399999999999999 110.158 179.815 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.641 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.83 152.3 82.64 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.786 2.324 . . . . 1.8500000000000001 111.454 179.139 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.68 42.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.403 0.621 . . . . 2.54 110.588 -179.906 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.821 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.54 -41.66 98.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.976 -1.011 . . . . 2.5299999999999998 110.648 179.721 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.53 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.6 mt -109.89 137.83 40.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.738 -0.665 . . . . 1.1699999999999999 111.286 -179.398 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.99 -72.92 0.7 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.055 -0.521 . . . . 1.27 111.816 -178.922 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.15 148.34 24.47 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.59 0.589 . . . . 1.1200000000000001 112.59 -179.599 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.8 124.85 45.15 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.385 -0.598 . . . . 0.41999999999999998 109.385 177.474 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 mt -117.98 134.69 60.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.669 -0.412 . . . . 0.78000000000000003 110.698 179.973 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.916 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -119.98 128.6 53.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.294 -0.412 . . . . 0.62 111.287 179.765 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.54 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.06 139.0 49.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.758 -0.656 . . . . 1.97 110.153 178.992 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.44 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.0 p90 -145.12 163.16 35.16 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 121.105 0.479 . . . . 0.34999999999999998 112.045 -178.126 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.495 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.44 139.57 7.89 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.417 -0.811 . . . . 1.8 110.493 178.857 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.46 115.43 3.02 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.336 2.024 . . . . 0.57999999999999996 111.773 179.97 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.675 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.5 tttp -46.92 81.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.884 -0.414 . . . . 3.04 109.884 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.697 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.2 -20.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.012 -0.54 . . . . 2.4700000000000002 111.893 -179.517 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.3 p -157.5 157.92 34.73 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.815 -0.354 . . . . 2.5099999999999998 110.565 179.7 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.407 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 16.0 m -120.5 27.85 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.145 -0.479 . . . . 1.8600000000000001 110.081 179.616 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.85 -75.96 1.31 Allowed Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.165 -0.541 . . . . 1.4399999999999999 111.764 -179.234 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.79 152.17 35.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.846 0.355 . . . . 4.6900000000000004 111.025 -179.253 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.672 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.14 -169.14 2.55 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.127 -0.488 . . . . 1.4299999999999999 112.021 179.324 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.1 149.63 29.76 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.455 0.645 . . . . 1.74 112.597 -177.864 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.06 156.48 46.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.835 -1.075 . . . . 1.9199999999999999 110.272 178.648 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.25 158.23 41.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.984 -0.553 . . . . 0.34000000000000002 111.835 -179.319 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.1 m -115.08 135.65 53.98 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.461 -0.79 . . . . 0.40999999999999998 109.795 179.307 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.584 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.38 121.95 23.79 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.462 -0.335 . . . . 0.55000000000000004 111.5 -179.136 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.592 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.1 Cg_exo -46.32 151.66 1.65 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.63 2.22 . . . . 0.44 112.111 178.979 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.88 -23.06 63.03 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 116.055 -0.52 . . . . 0.73999999999999999 112.817 -179.211 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.2 p-80 -82.69 -16.97 46.13 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.278 -0.569 . . . . 0.93000000000000005 111.829 -178.391 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.592 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.6 mt -91.53 138.44 31.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.795 -0.362 . . . . 0.96999999999999997 110.333 179.388 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -121.6 13.97 10.94 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.366 -0.379 . . . . 1.3400000000000001 111.467 -179.331 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -150.0 143.43 25.17 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.665 -0.414 . . . . 0.39000000000000001 111.011 179.64 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.724 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.7 t80 -114.81 -169.36 1.53 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.204 0.526 . . . . 0.41999999999999998 110.852 -179.478 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.724 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.3 m -151.77 125.96 9.28 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.373 -0.83 . . . . 0.39000000000000001 109.782 179.249 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.518 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.2 mt -114.82 123.15 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.467 -0.493 . . . . 0.73999999999999999 111.255 -179.798 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.53 ' NZ ' ' O ' ' A' ' 140' ' ' SER . 64.7 pttt -126.38 163.39 23.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.87 -0.604 . . . . 2.48 110.5 179.682 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.503 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.11 19.07 59.75 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.699 -0.96 . . . . 0.5 110.699 179.987 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.518 HD21 ' CG2' ' A' ' 60' ' ' ILE . 74.2 mt -79.11 157.24 28.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.091 0.472 . . . . 0.57999999999999996 111.342 -179.637 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.841 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -99.56 134.06 21.42 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.611 -0.722 . . . . 2.79 110.442 179.792 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.96 143.55 60.83 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.554 2.169 . . . . 0.87 111.98 179.851 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.97 25.51 75.49 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.043 -0.823 . . . . 0.64000000000000001 111.043 179.689 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.841 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.18 158.82 40.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.697 0.284 . . . . 0.82999999999999996 110.404 -179.593 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.18 139.89 42.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.922 0.391 . . . . 0.5 110.556 -179.692 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.648 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.53 136.53 54.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.046 -0.525 . . . . 0.53000000000000003 110.762 -179.931 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.495 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.98 131.04 45.33 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.456 -0.942 . . . . 1.8700000000000001 108.456 177.701 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.45 153.91 16.64 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.391 -0.909 . . . . 0.28999999999999998 111.971 -178.588 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.07 141.0 45.99 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.595 -0.52 . . . . 1.4299999999999999 109.595 179.593 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.2 tp -115.76 118.87 34.25 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.469 -0.492 . . . . 0.32000000000000001 110.496 179.686 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.725 HG12 HG23 ' A' ' 84' ' ' VAL . 63.8 mt -112.44 129.05 68.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.373 -0.376 . . . . 0.79000000000000004 110.613 -179.918 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.699 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.85 120.73 43.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.235 -0.439 . . . . 1.02 110.724 -179.655 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.857 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.54 146.59 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.22 0.533 . . . . 0.62 111.01 -179.281 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.821 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.3 mt-30 -106.08 153.87 21.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.458 -0.792 . . . . 2.4399999999999999 109.95 179.859 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.2 88.56 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.896 0.379 . . . . 3.6899999999999999 110.361 -179.702 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.33 32.72 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.79 -0.641 . . . . 6.0800000000000001 110.532 -179.99 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.18 -117.4 3.28 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.388 -0.685 . . . . 1.22 111.388 -179.712 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.462 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 62.9 m170 -81.39 177.36 9.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.206 0.527 . . . . 2.8799999999999999 111.625 -179.182 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.1 149.51 32.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.397 -0.82 . . . . 1.47 110.404 179.178 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.23 144.66 38.56 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.463 -0.335 . . . . 2.7000000000000002 110.532 179.857 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.725 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -128.05 135.94 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 121.077 0.465 . . . . 0.46000000000000002 111.497 -179.711 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.01 141.38 52.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.663 -0.699 . . . . 0.34999999999999998 110.259 179.637 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.64 138.81 51.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.159 0.504 . . . . 3.6699999999999999 111.499 -179.348 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.19 164.23 37.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.563 -0.744 . . . . 0.67000000000000004 109.503 179.317 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.567 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.31 151.48 38.39 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.406 -0.518 . . . . 1.47 111.05 179.967 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.801 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.5 p90 -146.15 172.69 13.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.725 -0.671 . . . . 0.44 111.062 179.856 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.69 160.73 21.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.452 -0.795 . . . . 1.3700000000000001 109.874 179.61 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.37 121.89 22.99 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.637 -0.425 . . . . 1.28 110.737 179.985 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.543 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.5 p -127.47 163.63 23.67 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.185 0.809 . . . . 1.97 113.185 179.638 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.519 ' OG ' ' OH ' ' A' ' 157' ' ' TYR . 40.1 t -123.67 147.9 46.99 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.407 -1.269 . . . . 3.2799999999999998 110.636 178.848 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.5 m 58.68 -2.09 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.251 179.169 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.453 ' H ' ' C ' ' A' ' 93' ' ' SER . 84.6 p -60.64 -29.03 69.01 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.411 179.678 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.8 m -127.3 78.74 74.16 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.434 178.942 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -54.57 138.08 74.31 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.3 2.0 . . . . 0.0 112.835 -178.475 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.4 t -123.6 137.03 58.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.075 179.389 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.8 m -116.68 135.82 53.47 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.964 0.411 . . . . 0.0 110.082 179.702 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.8 t -142.47 151.38 41.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.973 -179.422 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -95.18 126.9 40.83 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.254 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 48.0 m -117.33 141.14 48.67 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.226 0.536 . . . . 0.0 111.389 -178.839 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.9 t -115.4 138.35 46.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.777 179.762 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 t -131.42 158.1 41.7 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.135 0.493 . . . . 0.0 111.076 -179.246 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 96.27 -2.34 63.21 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -179.143 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.19 -31.77 70.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.468 -0.366 . . . . 0.0 110.525 179.368 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.4 p -118.38 164.47 15.19 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.033 -178.992 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.628 ' N ' ' CD ' ' A' ' 109' ' ' PRO . 1.2 m 170.64 -36.42 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.496 -179.467 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 108' ' ' THR . 51.0 Cg_exo -54.14 152.49 24.48 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.289 1.992 . . . . 0.0 111.941 179.732 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -89.27 135.32 33.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.592 -179.407 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.644 ' N ' ' HD2' ' A' ' 112' ' ' PRO . 1.2 t 169.44 -48.9 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.924 -179.55 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 111' ' ' SER . 14.0 Cg_endo -56.74 145.85 80.47 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.02 1.813 . . . . 0.0 111.8 179.417 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.7 mt -93.04 141.75 28.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.285 -0.416 . . . . 10.19 110.431 -179.689 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.61 154.98 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.075 -0.511 . . . . 7.2800000000000002 110.475 179.748 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.16 143.22 34.6 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.273 -0.421 . . . . 7.2999999999999998 110.534 179.882 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.8 p -123.86 159.05 30.48 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.367 -0.378 . . . . 6.4400000000000004 110.426 179.493 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.2 t -134.27 141.24 46.9 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.47 -0.332 . . . . 4.4199999999999999 110.499 179.504 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -63.21 -33.28 75.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.995 0.426 . . . . 3.0499999999999998 110.238 179.334 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 120' ' ' VAL . 57.5 p -70.94 162.67 28.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.799 -0.637 . . . . 3.4300000000000002 110.958 -179.809 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 119' ' ' SER . 42.5 t 55.68 120.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.935 -0.575 . . . . 2.8799999999999999 111.076 179.622 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 123' ' ' ILE . 24.8 p -80.92 163.51 23.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.896 -0.593 . . . . 2.0899999999999999 110.618 179.898 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.38 -33.35 67.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.077 -0.511 . . . . 4.5300000000000002 110.806 -179.441 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.4 ' O ' ' OG1' ' A' ' 121' ' ' THR . 70.8 mt -114.23 133.64 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.74 0.305 . . . . 1.4399999999999999 110.427 -179.888 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.4 p -122.85 161.08 24.75 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.108 -0.497 . . . . 1.78 110.555 -179.908 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.88 -33.99 76.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.024 -0.535 . . . . 0.64000000000000001 111.49 -179.452 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.402 ' O ' HD12 ' A' ' 172' ' ' LEU . 4.9 p -161.43 -28.45 0.05 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.807 -0.357 . . . . 0.66000000000000003 110.781 -179.654 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.444 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.82 167.57 0.25 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.017 -0.538 . . . . 0.68999999999999995 110.925 -179.593 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.57 145.56 50.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.656 -0.702 . . . . 0.52000000000000002 110.073 -179.918 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.29 101.62 9.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.146 -0.687 . . . . 0.32000000000000001 109.146 177.609 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.1 t -112.84 139.74 36.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.896 -0.593 . . . . 0.28999999999999998 111.038 -178.851 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.6 p -128.76 152.66 48.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.622 -0.717 . . . . 0.25 109.743 179.528 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.588 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.85 -164.97 2.04 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.659 -0.416 . . . . 0.31 110.621 -179.808 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.744 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.8 t -123.9 127.18 73.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.193 -0.458 . . . . 0.48999999999999999 110.787 -179.805 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.17 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 p -57.96 58.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 1.53 110.316 179.792 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.744 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.07 24.44 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.873 -0.603 . . . . 0.96999999999999997 111.614 -179.772 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.17 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.14 128.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.685 -0.406 . . . . 1.5600000000000001 111.023 179.896 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.43 -9.57 56.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.891 -0.595 . . . . 1.8799999999999999 110.359 179.817 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.06 0.3 55.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.037 -0.529 . . . . 1.04 110.446 179.839 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.27 137.23 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.904 -0.589 . . . . 0.23999999999999999 110.038 179.665 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.592 ' N ' ' O ' ' A' ' 185' ' ' ILE . 91.9 p -96.31 -15.41 21.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.29 0.567 . . . . 0.28999999999999998 109.987 -179.577 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.59 175.52 45.74 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.758 -1.337 . . . . 0.13 109.758 179.688 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.43 151.64 42.45 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.607 -0.437 . . . . 0.17000000000000001 110.462 179.687 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.906 ' NH1' HE22 ' A' ' 191' ' ' GLN . 52.0 ttp180 -132.35 121.1 22.98 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.111 -0.495 . . . . 1.29 109.937 179.787 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.563 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.07 136.58 38.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.678 -0.692 . . . . 0.25 110.66 -179.747 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.592 ' OE2' ' OH ' ' A' ' 157' ' ' TYR . 84.7 tt0 -129.38 129.85 45.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.942 -0.572 . . . . 1.3200000000000001 110.079 -179.912 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.7 p90 -138.68 135.26 34.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.051 -0.522 . . . . 0.56999999999999995 110.635 -179.63 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.419 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.33 161.28 40.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.776 -0.647 . . . . 1.1599999999999999 109.697 179.877 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.959 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.4 mt -71.0 124.81 25.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.993 0.425 . . . . 0.38 110.793 -179.648 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.482 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.7 p -71.82 -7.7 49.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.758 -0.655 . . . . 0.40999999999999998 110.807 -179.678 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -109.81 -69.62 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.398 -0.365 . . . . 1.6599999999999999 111.427 -179.351 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.438 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.0 mt-10 -60.68 -35.32 75.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.116 -0.493 . . . . 1.6599999999999999 111.521 -179.105 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.084 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.05 7.3 88.54 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.812 -0.915 . . . . 1.1699999999999999 110.812 -179.796 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.312 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.96 -171.69 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.851 0.358 . . . . 1.8600000000000001 110.282 179.84 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.312 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.31 139.19 45.01 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.01 0.434 . . . . 1.98 110.158 179.628 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.419 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.4 Cg_endo -70.96 145.74 50.96 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 122.707 2.271 . . . . 0.55000000000000004 112.381 -179.591 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.72 145.73 42.5 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.368 -0.604 . . . . 1.1399999999999999 109.368 179.148 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.592 ' OH ' ' OE2' ' A' ' 145' ' ' GLU . 89.9 m-85 -123.27 141.41 52.01 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.335 -0.546 . . . . 0.93000000000000005 111.491 -179.074 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.8 mt -128.17 127.66 43.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.302 -0.863 . . . . 0.34000000000000002 108.882 178.975 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -101.62 131.12 48.01 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.137 0.494 . . . . 1.0900000000000001 111.782 -178.785 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.93 157.5 73.6 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.349 -0.842 . . . . 0.19 109.533 179.776 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -69.89 158.01 58.22 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.403 2.069 . . . . 0.17999999999999999 112.184 179.951 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.29 -12.14 5.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.704 -0.68 . . . . 0.20999999999999999 110.785 -179.778 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.8 p -92.73 -8.84 42.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.083 -0.508 . . . . 0.28999999999999998 110.75 -179.978 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.18 135.41 34.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.309 -0.405 . . . . 0.5 110.358 179.739 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.6 p -133.11 16.67 4.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.29999999999999999 110.556 179.933 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.5 p -167.54 147.17 5.09 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.65 -0.5 . . . . 0.23000000000000001 109.65 179.899 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.563 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.3 150.44 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.52 -0.472 . . . . 0.28000000000000003 111.591 -179.648 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.508 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.25 125.03 50.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.597 -0.729 . . . . 1.0700000000000001 109.776 179.562 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.46 104.88 29.93 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.43 -0.35 . . . . 0.28999999999999998 111.021 -179.883 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.9 Cg_endo -91.01 -179.4 1.47 Allowed 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 123.088 2.526 . . . . 0.42999999999999999 112.229 179.856 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.56 32.7 18.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.359 -0.837 . . . . 1.26 111.461 179.311 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 126' ' ' SER . 24.1 mt -86.34 148.57 25.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.472 -0.331 . . . . 0.32000000000000001 110.437 179.547 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.772 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.31 114.88 61.41 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.002 0.429 . . . . 0.57999999999999996 110.644 -179.757 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.07 140.55 95.71 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.883 2.389 . . . . 0.66000000000000003 111.94 179.835 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.17 21.07 74.37 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.047 -0.821 . . . . 0.28999999999999998 111.047 179.835 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.438 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.76 150.14 49.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.817 0.341 . . . . 2.3300000000000001 110.673 -179.984 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.482 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.14 131.58 46.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.138 -0.483 . . . . 0.85999999999999999 109.878 179.252 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.959 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.1 m-85 -120.44 148.25 44.05 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.192 -0.458 . . . . 0.52000000000000002 111.107 -179.817 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.7 mt -105.33 125.41 60.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.252 -1.018 . . . . 0.29999999999999999 108.252 177.749 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.59 132.58 63.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.185 0.516 . . . . 0.23000000000000001 111.266 -178.645 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.53 122.61 20.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.608 -0.724 . . . . 0.35999999999999999 109.621 179.303 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.588 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.04 125.35 54.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.169 -0.469 . . . . 0.19 110.707 -179.535 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.4 m-85 -117.17 137.93 52.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.017 -0.538 . . . . 0.29999999999999999 109.876 179.526 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.587 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.69 135.0 42.82 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.783 -0.821 . . . . 0.37 108.783 178.864 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.592 ' O ' ' N ' ' A' ' 140' ' ' SER . 82.7 mt -99.17 123.05 51.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.153 0.501 . . . . 0.26000000000000001 110.898 -178.78 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.4 p -83.89 169.72 14.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.498 -0.773 . . . . 0.28000000000000003 110.477 -179.719 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.81 -14.47 15.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.985 -0.552 . . . . 1.6000000000000001 111.051 -179.589 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.482 ' C ' ' OG1' ' A' ' 59' ' ' THR . 95.7 m-20 -96.04 -4.31 43.28 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.842 -0.343 . . . . 1.1799999999999999 110.812 -179.855 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.699 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.82 13.85 64.02 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.341 -0.703 . . . . 0.29999999999999999 111.341 179.858 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -84.59 139.07 32.35 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 121.121 -0.231 . . . . 1.22 110.479 179.699 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.906 HE22 ' NH1' ' A' ' 143' ' ' ARG . 78.2 mt-30 -106.77 141.02 38.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.875 0.369 . . . . 0.97999999999999998 110.499 179.843 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.7 m -136.67 126.98 26.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 0.82999999999999996 110.481 179.844 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.407 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.02 117.34 9.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.362 -0.381 . . . . 0.26000000000000001 110.492 -179.839 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.17 -21.7 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.465 . . . . 0.29999999999999999 110.685 -179.762 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.92 125.63 5.81 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.601 -0.44 . . . . 0.31 111.537 -179.783 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.47 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.68 120.26 21.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.726 -0.67 . . . . 0.28000000000000003 109.547 179.188 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.65 29.04 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.606 -0.438 . . . . 0.23999999999999999 110.893 -179.273 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.44 158.61 18.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.23000000000000001 110.345 179.752 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.11 157.96 43.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.055 -0.52 . . . . 0.67000000000000004 110.642 179.954 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.29 104.44 9.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.817 -0.629 . . . . 0.64000000000000001 110.012 179.558 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 117.942 -1.027 . . . . 1.26 110.56 -179.631 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 30.1 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.261 -0.644 . . . . 3.4399999999999999 109.261 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.39 150.71 18.53 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.078 -0.809 . . . . 1.22 111.078 179.649 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -35.63 142.37 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.066 0 C-N-CA 124.013 3.142 . . . . 0.75 113.743 -179.134 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.62 HG12 ' H ' ' A' ' 5' ' ' GLU . 15.9 t -79.84 173.32 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.289 -1.323 . . . . 0.79000000000000004 108.916 178.341 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.62 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.52 125.82 51.42 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.476 -0.489 . . . . 1.9399999999999999 111.47 -179.626 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 144.06 33.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.739 -0.664 . . . . 0.59999999999999998 110.606 179.84 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -151.99 168.36 25.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.898 0.38 . . . . 3.1400000000000001 111.149 -179.705 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.737 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.4 mt -109.01 131.13 60.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.968 -0.56 . . . . 3.23 110.03 179.921 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 69.3 p -141.26 162.42 35.53 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.894 0.378 . . . . 3.6299999999999999 111.122 -179.915 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 32.5 tp10 36.07 31.57 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 109.631 -0.507 . . . . 6.0800000000000001 109.631 179.843 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.737 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.5 69.62 33.32 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.939 -0.573 . . . . 3.3799999999999999 111.611 -178.8 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.641 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.31 -29.14 72.55 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.437 2.092 . . . . 3.9300000000000002 111.753 179.391 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.734 ' H ' HE22 ' A' ' 14' ' ' GLN . 3.2 m 149.7 125.57 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 3.3599999999999999 110.469 179.997 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.734 HE22 ' H ' ' A' ' 13' ' ' SER . 1.6 mp0 -123.99 158.36 60.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 3.6099999999999999 110.415 -179.979 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.55 ' HG3' ' NH1' ' A' ' 143' ' ' ARG . 97.1 Cg_endo -82.04 -64.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.92 2.413 . . . . 1.51 113.483 -178.96 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.444 ' H ' ' HG2' ' A' ' 15' ' ' PRO . 98.7 m-20 -108.39 -19.61 13.4 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.097 0.406 . . . . 2.6800000000000002 112.097 -178.501 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 63.1 m -107.47 152.11 24.66 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.403 -0.519 . . . . 1.21 111.248 -179.361 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.579 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.2 t-80 -155.27 102.83 2.23 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.654 -0.703 . . . . 1.5600000000000001 110.692 179.922 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.69 145.71 13.03 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.818 2.345 . . . . 0.81000000000000005 112.561 -179.984 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.918 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.79 167.9 24.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.805 -0.634 . . . . 1.52 109.883 179.604 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -149.1 148.04 29.21 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.757 -0.46 . . . . 2.1400000000000001 109.757 178.821 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.7 p90 -142.37 157.28 44.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.036 0.446 . . . . 0.32000000000000001 111.163 179.933 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.497 ' O ' HG12 ' A' ' 4' ' ' VAL . 85.1 m-20 -128.01 155.27 44.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.77 -0.65 . . . . 2.1699999999999999 110.102 178.999 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.822 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.56 173.0 6.4 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 121.118 0.485 . . . . 0.58999999999999997 110.73 -179.204 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.822 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.61 173.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 122.844 2.363 . . . . 0.90000000000000002 111.532 179.303 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.485 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -51.09 0.69 Allowed Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 120.714 -0.394 . . . . 3.3399999999999999 110.048 179.926 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.62 ' C ' ' H ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.81 152.34 82.49 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.721 2.28 . . . . 1.8500000000000001 111.527 179.147 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.65 42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.362 0.601 . . . . 2.54 110.599 -179.915 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.813 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.52 -41.62 98.48 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.963 -1.017 . . . . 2.5299999999999998 110.725 179.661 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.532 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.5 mt -109.89 137.92 39.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.756 -0.656 . . . . 1.1699999999999999 111.287 -179.44 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.12 -72.84 0.71 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.097 -0.502 . . . . 1.27 111.839 -178.911 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.17 148.34 24.45 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.575 0.583 . . . . 1.1200000000000001 112.575 -179.633 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -121.89 124.88 45.14 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.267 -0.642 . . . . 0.41999999999999998 109.267 177.556 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.1 134.75 60.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.545 -0.462 . . . . 0.78000000000000003 110.648 179.926 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.918 HD13 HD11 ' A' ' 20' ' ' ILE . 8.6 mt -120.01 128.67 53.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.058 0.456 . . . . 0.62 111.247 179.781 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.55 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.16 139.02 49.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.729 -0.668 . . . . 1.97 110.062 179.012 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.439 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.11 163.21 35.0 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 120.443 -0.503 . . . . 0.34999999999999998 112.058 -178.114 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.51 139.51 7.8 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 115.533 -0.758 . . . . 1.8 110.45 178.909 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.6 Cg_endo -63.51 115.47 3.05 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.327 2.018 . . . . 0.57999999999999996 111.803 179.968 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.67 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.99 81.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.902 -0.407 . . . . 3.04 109.902 -179.878 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.693 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.6 m120 -160.19 -20.63 0.06 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.954 -0.567 . . . . 2.4700000000000002 111.919 -179.549 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 p -157.55 157.8 34.43 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.856 -0.338 . . . . 2.5099999999999998 110.626 179.726 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.401 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.5 m -120.37 27.85 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.27 -0.423 . . . . 1.8600000000000001 110.195 179.527 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.84 -75.91 1.31 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.036 -0.602 . . . . 1.4399999999999999 111.811 -179.255 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.83 152.41 35.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.982 0.42 . . . . 4.6900000000000004 110.991 -179.351 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.637 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.28 -169.19 2.54 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.075 -0.511 . . . . 1.4299999999999999 112.007 179.413 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.6 mttp -110.06 149.6 29.78 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.43 0.633 . . . . 1.74 112.595 -177.86 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.08 156.41 46.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.815 -1.084 . . . . 1.9199999999999999 110.214 178.679 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.457 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.16 158.42 41.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.934 -0.576 . . . . 0.34000000000000002 111.788 -179.353 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.2 135.58 54.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.46 -0.791 . . . . 0.40999999999999998 109.809 179.317 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.596 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.38 121.96 23.8 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.429 -0.351 . . . . 0.55000000000000004 111.528 -179.149 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.606 ' HD2' HD12 ' A' ' 55' ' ' LEU . 75.3 Cg_exo -46.31 151.63 1.65 Allowed 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.694 2.263 . . . . 0.44 112.145 178.977 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.81 -23.09 62.91 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 116.043 -0.526 . . . . 0.73999999999999999 112.814 -179.277 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.539 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.5 p-80 -82.81 -16.81 46.34 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.192 -0.603 . . . . 0.93000000000000005 111.809 -178.323 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.606 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.6 mt -91.67 138.4 31.59 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.719 -0.392 . . . . 0.96999999999999997 110.266 179.395 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -121.48 13.96 11.04 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.334 -0.393 . . . . 1.3400000000000001 111.501 -179.369 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -150.04 143.52 25.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.633 -0.427 . . . . 0.39000000000000001 111.029 179.525 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.717 ' CE2' ' O ' ' A' ' 59' ' ' THR . 65.0 t80 -114.8 -169.37 1.53 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.019 -0.537 . . . . 0.41999999999999998 110.815 -179.373 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.717 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.79 125.95 9.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.343 -0.844 . . . . 0.39000000000000001 109.852 179.21 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.513 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.3 mt -114.91 123.24 70.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.369 -0.532 . . . . 0.73999999999999999 111.192 -179.73 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.786 ' NZ ' ' N ' ' A' ' 141' ' ' GLY . 98.4 mttt -126.49 163.41 23.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.812 -0.631 . . . . 2.48 110.514 179.673 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.08 19.05 59.83 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.774 -0.93 . . . . 0.5 110.774 -179.845 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.513 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.6 mt -79.06 157.25 28.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.107 0.48 . . . . 0.57999999999999996 111.4 -179.717 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.859 ' O ' HG12 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -99.46 133.93 21.57 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.635 -0.712 . . . . 2.79 110.466 179.774 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.89 143.53 61.19 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.599 2.2 . . . . 0.87 111.971 179.81 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.89 25.57 75.41 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.045 -0.822 . . . . 0.64000000000000001 111.045 179.722 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.859 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.14 158.74 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.653 0.263 . . . . 0.82999999999999996 110.459 -179.636 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.07 139.95 41.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.986 0.422 . . . . 0.5 110.553 -179.772 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.638 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.5 m-85 -122.64 136.47 54.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.914 -0.584 . . . . 0.53000000000000003 110.788 -179.955 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.49 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.97 130.98 45.36 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.516 -0.92 . . . . 1.8700000000000001 108.516 177.741 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.487 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.44 153.89 16.63 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.306 -0.95 . . . . 0.28999999999999998 111.947 -178.556 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.03 141.0 46.07 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.739 -0.467 . . . . 1.4299999999999999 109.739 179.503 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.522 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.83 118.95 34.43 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.422 -0.511 . . . . 0.32000000000000001 110.354 179.831 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 84' ' ' VAL . 64.1 mt -112.48 129.11 68.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.79000000000000004 110.625 -179.97 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.707 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.86 120.75 43.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.324 -0.398 . . . . 1.02 110.737 -179.663 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.866 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.47 146.52 11.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.18 0.514 . . . . 0.62 111.068 -179.292 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.813 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.08 153.89 21.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.56 -0.746 . . . . 2.4399999999999999 109.861 179.877 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.22 88.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.742 -0.383 . . . . 3.6899999999999999 110.426 -179.772 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.623 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.14 32.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.807 -0.633 . . . . 6.0800000000000001 110.545 -179.905 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.22 -117.37 3.27 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.391 -0.683 . . . . 1.22 111.391 -179.77 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.469 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.1 m170 -81.4 177.44 8.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.202 0.525 . . . . 2.8799999999999999 111.587 -179.111 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.16 149.48 32.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.428 -0.805 . . . . 1.47 110.488 179.09 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.15 144.69 38.73 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.499 -0.318 . . . . 2.7000000000000002 110.556 179.874 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.727 HG23 HG12 ' A' ' 74' ' ' ILE . 12.6 p -127.99 136.09 61.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 120.577 -0.449 . . . . 0.46000000000000002 111.544 -179.795 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.575 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.3 m -124.11 141.3 52.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.607 -0.724 . . . . 0.34999999999999998 110.244 179.664 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.466 ' HD3' HH11 ' A' ' 86' ' ' ARG . 42.4 ttp180 -117.59 138.84 51.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.166 0.508 . . . . 3.6699999999999999 111.486 -179.379 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.487 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.8 p90 -152.24 164.11 38.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.501 -0.772 . . . . 0.67000000000000004 109.475 179.338 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.0 p30 -145.13 151.56 38.68 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.456 -0.498 . . . . 1.47 111.122 179.918 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.809 ' O ' HG23 ' A' ' 68' ' ' VAL . 38.9 p90 -146.14 172.75 12.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.812 -0.631 . . . . 0.44 111.02 179.875 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -118.82 160.77 21.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.418 -0.81 . . . . 1.3700000000000001 109.841 179.512 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.38 121.9 22.98 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.591 -0.444 . . . . 1.28 110.748 -179.991 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.583 ' O ' ' O ' ' A' ' 14' ' ' GLN . 70.6 p -128.81 167.19 17.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.048 -0.524 . . . . 1.97 112.286 179.676 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.2 t -66.54 161.93 21.93 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.001 -0.74 . . . . 3.2799999999999998 109.001 177.431 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.7 p -75.76 157.56 33.34 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.525 0.679 . . . . 0.0 112.109 -178.054 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.8 m -86.55 11.47 12.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.13 179.832 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 24.8 p -46.72 144.73 3.43 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.945 -177.993 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -60.64 148.15 92.39 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.999 2.466 . . . . 0.0 113.42 -178.491 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.3 m -128.6 158.82 40.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.21 178.985 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.5 t -133.29 154.97 50.23 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.284 0.564 . . . . 0.0 111.954 -179.444 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.6 m -127.78 152.9 47.2 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.904 -179.797 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 61.5 47.45 6.62 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 178.708 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.7 p -67.52 -9.63 44.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.273 178.895 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.1 t 60.44 104.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.883 -179.339 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 22.5 p -124.27 168.27 13.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.854 -179.995 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.64 18.51 37.87 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.534 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -54.37 146.45 15.71 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.517 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 43.6 m -68.08 133.6 49.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.428 0.632 . . . . 0.0 111.173 -178.129 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.518 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 36.9 m -154.74 140.96 12.94 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.696 179.822 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.72 140.47 46.6 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 CA-C-N 120.131 1.082 . . . . 0.0 111.311 179.488 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.518 ' CE2' ' O ' ' A' ' 108' ' ' THR . 99.4 m-85 -119.9 154.42 34.41 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.238 -179.446 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.28 165.61 37.65 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.445 178.855 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.0 -26.37 31.71 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.74 1.627 . . . . 0.0 111.802 -179.647 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 55.8 mt -98.23 139.85 33.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.236 -0.438 . . . . 10.19 109.83 179.123 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 80.5 t -61.72 -40.95 88.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.556 -0.458 . . . . 7.2800000000000002 110.146 179.931 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -148.69 154.16 39.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.992 -0.549 . . . . 7.2999999999999998 109.976 179.532 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.7 p -123.14 159.04 29.4 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.06 0.457 . . . . 6.4400000000000004 110.906 179.838 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.8 m -59.73 -33.32 71.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.706 -0.679 . . . . 4.4199999999999999 110.811 179.629 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -99.43 153.23 19.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.104 -0.498 . . . . 3.0499999999999998 111.292 -178.803 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 28.5 m -102.01 -123.5 0.18 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.685 -0.688 . . . . 3.4300000000000002 110.557 179.806 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 92.8 t -61.36 -41.9 91.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.892 -0.323 . . . . 2.8799999999999999 110.672 -179.574 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 20.6 p -125.36 154.83 41.26 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.722 0.296 . . . . 2.0899999999999999 110.702 179.345 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.01 -37.2 83.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.296 -0.411 . . . . 4.5300000000000002 111.566 179.526 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.934 HG23 HG23 ' A' ' 124' ' ' THR . 10.1 tp -63.79 -26.42 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.28 0.474 . . . . 1.4399999999999999 112.28 -178.765 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.934 HG23 HG23 ' A' ' 123' ' ' ILE . 29.8 p -122.46 162.64 21.32 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.41 0.624 . . . . 1.78 111.945 -179.522 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -114.78 -117.58 0.32 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.108 -0.951 . . . . 0.64000000000000001 109.716 179.183 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.8 p -61.01 -30.34 70.24 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.112 0.482 . . . . 0.66000000000000003 110.121 179.661 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.441 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.94 167.51 0.27 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.621 -0.718 . . . . 0.68999999999999995 110.99 179.693 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.49 145.6 50.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.731 -0.668 . . . . 0.52000000000000002 110.139 -179.902 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.36 101.77 9.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.076 -0.713 . . . . 0.32000000000000001 109.076 177.675 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.5 t -113.01 139.74 36.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.589 . . . . 0.28999999999999998 110.946 -178.758 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.6 p -128.75 152.6 48.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.61 -0.723 . . . . 0.25 109.837 179.532 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.588 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.6 p90 -144.82 -164.99 2.04 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.672 -0.411 . . . . 0.31 110.653 -179.727 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.732 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.9 t -123.94 127.13 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.48999999999999999 110.834 -179.821 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.167 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.93 58.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.125 -0.489 . . . . 1.53 110.316 179.841 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.732 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.09 24.39 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.9 -0.591 . . . . 0.96999999999999997 111.481 -179.698 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.167 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.25 128.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.587 -0.445 . . . . 1.5600000000000001 110.902 179.883 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -86.46 -9.66 55.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.92 -0.582 . . . . 1.8799999999999999 110.246 179.78 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.9 p -87.1 0.31 55.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.123 -0.489 . . . . 1.04 110.35 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.26 137.07 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.984 -0.553 . . . . 0.23999999999999999 109.982 179.624 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.725 ' C ' ' HZ2' ' A' ' 61' ' ' LYS . 10.1 p -96.21 -15.48 22.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.233 0.539 . . . . 0.28999999999999998 110.028 -179.648 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.786 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.59 175.54 45.76 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.711 -1.355 . . . . 0.13 109.711 179.659 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -123.42 151.66 42.41 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.635 -0.426 . . . . 0.17000000000000001 110.556 179.637 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.72 ' NH1' ' CE1' ' A' ' 157' ' ' TYR . 38.9 ttp85 -132.44 121.17 22.99 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.125 -0.489 . . . . 1.29 109.881 179.845 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 167' ' ' VAL . 46.0 t -105.0 136.51 38.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.646 -0.706 . . . . 0.25 110.728 -179.77 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 78.5 tt0 -129.36 129.95 45.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.015 -0.539 . . . . 1.3200000000000001 110.006 -179.919 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.84 135.26 34.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.044 -0.525 . . . . 0.56999999999999995 110.525 -179.679 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.416 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.3 161.41 39.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.633 -0.712 . . . . 1.1599999999999999 109.665 179.805 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.953 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 85.7 mt -71.09 124.86 25.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.952 0.406 . . . . 0.38 110.676 -179.536 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.71 -7.77 50.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.717 -0.674 . . . . 0.40999999999999998 110.874 -179.815 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.73 -69.65 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 1.6599999999999999 111.464 -179.284 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.451 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.63 -35.45 76.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.015 -0.539 . . . . 1.6599999999999999 111.461 -179.168 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.089 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.18 7.24 88.59 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.748 -0.941 . . . . 1.1699999999999999 110.748 -179.836 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.326 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.5 t0 -27.97 -171.73 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.689 0.28 . . . . 1.8600000000000001 110.294 179.848 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.326 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.22 139.12 45.3 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.945 0.402 . . . . 1.98 110.172 179.666 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.416 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.7 Cg_endo -70.94 145.84 51.39 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 C-N-CA 122.725 2.283 . . . . 0.55000000000000004 112.303 -179.537 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.9 145.75 42.63 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.234 -0.654 . . . . 1.1399999999999999 109.234 179.183 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.72 ' CE1' ' NH1' ' A' ' 143' ' ' ARG . 94.1 m-85 -123.28 141.35 52.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.25 0.547 . . . . 0.93000000000000005 111.478 -179.047 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.9 mt -128.14 127.73 43.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.274 -0.876 . . . . 0.34000000000000002 108.892 178.942 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 160' ' ' LEU . 27.8 t0 -101.59 131.18 47.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.165 0.507 . . . . 1.0900000000000001 111.733 -178.772 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.491 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -128.0 157.53 73.6 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.348 -0.842 . . . . 0.19 109.571 179.645 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -69.76 158.03 58.35 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.395 2.063 . . . . 0.17999999999999999 112.245 179.927 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.2 p -59.32 -12.13 5.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.753 -0.658 . . . . 0.20999999999999999 110.732 -179.852 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.1 p -92.8 -8.77 42.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 0.28999999999999998 110.743 -179.959 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.39 34.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.314 -0.403 . . . . 0.5 110.429 179.686 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.5 p -133.1 16.68 4.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.401 -0.363 . . . . 0.29999999999999999 110.532 -179.988 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.7 p -167.55 147.13 5.08 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.614 -0.514 . . . . 0.23000000000000001 109.614 179.905 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.2 150.48 12.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.565 -0.454 . . . . 0.28000000000000003 111.619 -179.664 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.51 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.36 124.96 50.39 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.618 -0.719 . . . . 1.0700000000000001 109.783 179.536 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.48 104.93 30.28 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.907 0.384 . . . . 0.28999999999999998 111.03 -179.835 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.51 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 85.1 Cg_endo -91.05 -179.49 1.48 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 123.155 2.57 . . . . 0.42999999999999999 112.172 179.922 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 61.66 32.64 18.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.329 -0.851 . . . . 1.26 111.489 179.306 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 24.3 mt -86.34 148.46 25.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.49 -0.323 . . . . 0.32000000000000001 110.467 179.611 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.764 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.25 114.87 61.36 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.042 0.448 . . . . 0.57999999999999996 110.706 -179.799 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.07 140.58 95.84 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.754 2.303 . . . . 0.66000000000000003 112.025 179.864 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.2 21.16 74.08 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.027 -0.829 . . . . 0.28999999999999998 111.027 179.857 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.451 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.9 150.18 49.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 2.3300000000000001 110.606 -179.941 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.491 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.1 tttt -100.11 131.68 45.92 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.85999999999999999 109.82 179.282 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.953 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.54 148.35 43.97 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.118 -0.492 . . . . 0.52000000000000002 110.991 -179.824 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.31 125.31 60.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 108.228 -1.027 . . . . 0.29999999999999999 108.228 177.767 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.55 132.46 63.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.053 0.454 . . . . 0.23000000000000001 111.284 -178.646 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.46 122.66 20.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.566 -0.743 . . . . 0.35999999999999999 109.613 179.299 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.588 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.05 125.36 54.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.271 -0.422 . . . . 0.19 110.694 -179.496 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.6 m-85 -117.25 137.88 52.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.041 -0.527 . . . . 0.29999999999999999 109.828 179.583 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.579 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.69 135.01 42.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.798 -0.815 . . . . 0.37 108.798 178.861 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.683 HG21 ' HE2' ' A' ' 61' ' ' LYS . 14.0 mt -99.14 122.97 51.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.095 0.474 . . . . 0.26000000000000001 110.931 -178.734 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.3 p -83.79 169.7 14.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.497 -0.774 . . . . 0.28000000000000003 110.499 -179.675 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -59.71 -14.65 15.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.047 -0.524 . . . . 1.6000000000000001 111.018 -179.663 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -95.91 -4.39 43.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.828 0.347 . . . . 1.1799999999999999 110.902 -179.819 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.79 13.97 63.87 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.301 -0.719 . . . . 0.29999999999999999 111.301 179.919 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -84.63 139.11 32.29 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.059 -0.256 . . . . 1.22 110.465 179.585 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.715 ' OE1' ' NH2' ' A' ' 143' ' ' ARG . 85.9 mt-30 -106.75 141.08 38.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.893 0.378 . . . . 0.97999999999999998 110.543 179.723 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 63.0 m -136.7 126.99 26.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.062 -0.517 . . . . 0.82999999999999996 110.373 179.938 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.6 tp -68.23 117.38 9.97 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.644 -0.422 . . . . 0.26000000000000001 110.537 -179.923 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.02 -21.78 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 0.29999999999999999 110.746 -179.754 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.89 125.72 5.86 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.519 -0.472 . . . . 0.31 111.496 -179.776 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.47 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.2 t -132.83 120.25 21.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.772 -0.649 . . . . 0.28000000000000003 109.574 179.143 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.64 151.72 29.13 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.568 -0.453 . . . . 0.23999999999999999 110.806 -179.224 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 51.8 p -110.47 158.53 18.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.953 -0.567 . . . . 0.23000000000000001 110.447 179.681 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -145.98 157.97 43.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.102 -0.499 . . . . 0.67000000000000004 110.644 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.34 104.35 9.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.733 -0.667 . . . . 0.64000000000000001 109.986 179.558 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.862 -1.066 . . . . 1.26 110.599 -179.656 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.551 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.224 -0.658 . . . . 3.4399999999999999 109.224 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.35 150.7 18.54 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.023 -0.831 . . . . 1.22 111.023 179.73 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -35.61 142.41 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.048 0 C-N-CA 123.914 3.076 . . . . 0.75 113.826 -179.203 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.606 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.95 173.44 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.204 -1.362 . . . . 0.79000000000000004 108.817 178.425 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.606 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.2 mt-10 -105.69 125.89 51.52 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.433 -0.507 . . . . 1.9399999999999999 111.368 -179.536 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.49 143.96 34.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.682 -0.69 . . . . 0.59999999999999998 110.702 179.865 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.03 168.38 25.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.923 0.392 . . . . 3.1400000000000001 111.044 -179.684 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.746 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.3 mt -109.03 131.11 60.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.963 -0.562 . . . . 3.23 110.067 179.888 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 11' ' ' THR . 69.0 p -141.24 162.41 35.55 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.871 0.367 . . . . 3.6299999999999999 111.121 -179.872 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 9' ' ' THR . 97.3 mt-10 36.03 31.49 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.631 -0.507 . . . . 6.0800000000000001 109.631 179.862 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.746 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.3 69.56 31.1 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.971 -0.559 . . . . 3.3799999999999999 111.663 -178.809 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.64 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.37 -29.02 71.92 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.467 2.112 . . . . 3.9300000000000002 111.822 179.46 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.64 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 3.3599999999999999 110.477 179.98 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.612 ' O ' ' O ' ' A' ' 92' ' ' THR . 10.7 mp0 -123.89 158.41 60.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 3.6099999999999999 110.447 179.941 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.523 ' CG ' ' NH1' ' A' ' 143' ' ' ARG . 98.6 Cg_endo -82.17 -64.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.866 2.378 . . . . 1.51 113.46 -178.981 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.692 ' CG ' ' CE1' ' A' ' 157' ' ' TYR . 50.0 t30 -108.44 -19.52 13.43 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.11 0.411 . . . . 2.6800000000000002 112.11 -178.536 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.536 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 99.0 p -107.34 152.1 24.6 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.452 -0.499 . . . . 1.21 111.281 -179.418 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.0 t-80 -155.36 102.83 2.21 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.696 -0.684 . . . . 1.5600000000000001 110.676 179.885 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.574 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.3 Cg_endo -82.56 145.6 13.19 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.814 2.343 . . . . 0.81000000000000005 112.675 179.904 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.903 HD11 HD13 ' A' ' 35' ' ' LEU . 6.8 pt -130.81 167.89 24.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.894 -0.594 . . . . 1.52 109.862 179.561 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -149.1 148.0 29.16 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.737 -0.468 . . . . 2.1400000000000001 109.737 178.866 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.582 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.8 p90 -142.24 157.25 45.05 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.659 -0.416 . . . . 0.32000000000000001 111.16 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.496 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.02 155.3 44.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.823 -0.626 . . . . 2.1699999999999999 110.122 178.905 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.835 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.63 173.07 6.32 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.135 -0.484 . . . . 0.58999999999999997 110.777 -179.184 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.835 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 32.0 Cg_exo -50.75 173.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.907 2.405 . . . . 0.90000000000000002 111.502 179.429 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.485 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.02 -51.05 0.69 Allowed Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.679 -0.408 . . . . 3.3399999999999999 110.171 179.797 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.639 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.85 152.35 82.47 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.7 2.267 . . . . 1.8500000000000001 111.481 179.169 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.6 p -63.74 42.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.357 0.599 . . . . 2.54 110.525 -179.808 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.822 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.67 -41.61 98.15 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.052 -0.976 . . . . 2.5299999999999998 110.639 179.735 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.53 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.3 mt -109.85 137.84 40.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.784 -0.644 . . . . 1.1699999999999999 111.224 -179.449 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.93 -72.9 0.7 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.027 -0.533 . . . . 1.27 111.953 -179.069 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.17 148.37 24.43 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.588 0.588 . . . . 1.1200000000000001 112.588 -179.649 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.85 124.91 45.25 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.346 -0.613 . . . . 0.41999999999999998 109.346 177.498 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.5 mt -118.04 134.65 60.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.646 -0.422 . . . . 0.78000000000000003 110.662 -179.997 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.903 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.98 128.67 53.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.994 0.426 . . . . 0.62 111.261 179.742 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.21 138.94 49.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.787 -0.642 . . . . 1.97 110.096 179.018 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.441 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.1 p90 -145.04 163.1 35.27 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 121.166 0.508 . . . . 0.34999999999999998 112.083 -178.083 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.495 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.46 139.67 7.92 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.406 -0.815 . . . . 1.8 110.451 178.766 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.696 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.2 Cg_endo -63.57 115.51 3.09 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.279 1.986 . . . . 0.57999999999999996 111.801 -179.972 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.667 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.99 81.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.87 -0.419 . . . . 3.04 109.87 -179.865 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.696 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.19 -20.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.981 -0.554 . . . . 2.4700000000000002 111.895 -179.548 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.2 p -157.58 157.82 34.42 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.784 -0.367 . . . . 2.5099999999999998 110.548 179.782 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.408 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.42 27.84 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 1.8600000000000001 110.138 179.575 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.78 -75.82 1.31 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.181 -0.533 . . . . 1.4399999999999999 111.895 -179.294 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.93 152.34 35.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.983 0.42 . . . . 4.6900000000000004 110.912 -179.327 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.67 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.31 -169.13 2.52 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.049 -0.523 . . . . 1.4299999999999999 111.939 179.318 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.441 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.1 149.62 29.78 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.464 0.649 . . . . 1.74 112.571 -177.811 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.01 156.47 46.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.851 -1.068 . . . . 1.9199999999999999 110.268 178.637 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.2 158.39 41.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.993 -0.549 . . . . 0.34000000000000002 111.766 -179.336 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.6 m -115.2 135.58 54.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.415 -0.811 . . . . 0.40999999999999998 109.834 179.296 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.582 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.39 121.94 23.78 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.479 -0.328 . . . . 0.55000000000000004 111.527 -179.11 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.593 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.9 Cg_exo -46.36 151.75 1.65 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.632 2.221 . . . . 0.44 112.168 179.017 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.99 -23.04 63.24 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 116.039 -0.528 . . . . 0.73999999999999999 112.755 -179.108 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.541 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.73 -16.96 46.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.35 0.575 . . . . 0.93000000000000005 111.778 -178.345 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.593 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.3 mt -91.49 138.42 31.59 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.779 -0.368 . . . . 0.96999999999999997 110.299 179.342 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -121.55 13.91 10.97 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.333 -0.394 . . . . 1.3400000000000001 111.468 -179.382 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.481 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -149.99 143.5 25.24 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.589 -0.444 . . . . 0.39000000000000001 111.026 179.56 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.726 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.5 t80 -114.81 -169.33 1.53 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.199 0.523 . . . . 0.41999999999999998 110.845 -179.396 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.726 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.7 t -151.74 125.99 9.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.39 -0.823 . . . . 0.39000000000000001 109.832 179.236 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.518 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.8 mt -114.95 123.29 70.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.383 -0.527 . . . . 0.73999999999999999 111.17 -179.758 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -126.5 163.33 23.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.849 -0.614 . . . . 2.48 110.529 179.687 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.522 ' CA ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.2 19.07 59.61 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.685 -0.966 . . . . 0.5 110.685 -179.972 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.626 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 74.0 mt -79.14 157.27 27.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.138 0.494 . . . . 0.57999999999999996 111.286 -179.604 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.835 ' O ' HG12 ' A' ' 67' ' ' VAL . 13.2 mptt -99.57 134.03 21.43 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.551 -0.749 . . . . 2.79 110.393 179.85 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.98 143.55 60.76 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.554 2.169 . . . . 0.87 111.88 179.871 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.85 25.71 75.24 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.972 -0.851 . . . . 0.64000000000000001 110.972 179.685 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.835 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.3 p -128.23 158.77 40.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.597 0.237 . . . . 0.82999999999999996 110.434 -179.658 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.07 139.98 41.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.875 0.369 . . . . 0.5 110.623 -179.824 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.643 ' CE2' ' CG1' ' A' ' 67' ' ' VAL . 93.7 m-85 -122.67 136.47 54.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.897 -0.592 . . . . 0.53000000000000003 110.76 -179.918 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.495 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.5 pt-20 -98.91 131.01 45.32 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.524 -0.917 . . . . 1.8700000000000001 108.524 177.656 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.48 153.85 16.65 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.29 -0.957 . . . . 0.28999999999999998 111.935 -178.585 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.98 140.95 46.1 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.716 -0.476 . . . . 1.4299999999999999 109.716 179.537 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.0 tp -115.73 118.98 34.56 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.406 -0.518 . . . . 0.32000000000000001 110.486 179.705 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.74 HG12 HG23 ' A' ' 84' ' ' VAL . 64.1 mt -112.51 129.03 68.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.909 0.385 . . . . 0.79000000000000004 110.583 -179.878 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.705 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.85 120.82 43.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.299 -0.409 . . . . 1.02 110.701 -179.646 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.855 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.57 146.53 11.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.118 0.485 . . . . 0.62 110.977 -179.227 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.822 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -106.09 153.85 21.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.483 -0.78 . . . . 2.4399999999999999 109.974 179.8 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.22 88.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.965 0.412 . . . . 3.6899999999999999 110.444 -179.689 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.31 32.62 0.21 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.806 -0.634 . . . . 6.0800000000000001 110.561 -179.936 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.07 -117.3 3.29 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.496 -0.642 . . . . 1.22 111.496 -179.804 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.461 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.48 177.38 8.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.146 0.498 . . . . 2.8799999999999999 111.623 -179.203 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.14 149.54 32.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.411 -0.813 . . . . 1.47 110.459 179.145 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.551 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.7 tp10 -139.16 144.62 38.67 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.477 -0.329 . . . . 2.7000000000000002 110.54 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.74 HG23 HG12 ' A' ' 74' ' ' ILE . 12.5 p -127.98 135.98 61.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-O 121.092 0.472 . . . . 0.46000000000000002 111.573 -179.81 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.4 m -124.08 141.35 52.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.664 -0.698 . . . . 0.34999999999999998 110.279 179.62 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.447 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.65 138.93 51.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.105 0.479 . . . . 3.6699999999999999 111.5 -179.368 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.38 164.04 38.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.526 -0.761 . . . . 0.67000000000000004 109.516 179.417 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.572 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.1 p30 -145.18 151.56 38.62 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.415 -0.514 . . . . 1.47 111.092 -179.995 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.8 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.24 172.71 13.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.759 -0.655 . . . . 0.44 111.039 179.875 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.73 160.69 21.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.455 -0.793 . . . . 1.3700000000000001 109.777 179.658 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.37 121.9 22.99 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.636 -0.426 . . . . 1.28 110.764 179.91 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.612 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -127.61 167.98 15.63 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.675 0.621 . . . . 1.97 112.675 179.679 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.7 m -111.64 153.38 26.45 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.195 -0.911 . . . . 3.2799999999999998 109.997 179.225 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 58.0 p -62.53 -11.77 18.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.999 -178.908 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 47.5 m -115.3 147.96 39.79 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.868 0.366 . . . . 0.0 110.204 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 28.5 p -96.88 119.36 63.73 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.883 -179.546 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.42 147.68 36.62 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.032 1.821 . . . . 0.0 111.829 179.226 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.8 m -127.82 158.22 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.479 -179.824 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 48.8 m -119.76 141.19 49.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.509 -179.695 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 93.8 p -121.63 156.68 32.47 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.465 -179.776 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.8 p-10 -132.78 -179.88 5.74 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.476 -179.832 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.9 p -122.07 162.97 20.26 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.826 -179.574 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 75.2 t -60.44 -38.39 77.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.399 179.984 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 45.6 m -73.02 138.23 45.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.374 -179.736 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -82.77 -176.22 51.34 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.524 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -98.14 139.28 34.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.852 0.358 . . . . 0.0 110.554 -179.598 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.6 m -138.11 -122.51 0.13 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.936 179.78 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.478 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 81.8 p -63.65 151.1 89.2 Favored Pre-proline 0 C--N 1.331 -0.208 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.75 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.84 142.94 50.31 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.742 1.628 . . . . 0.0 112.067 -179.783 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.478 ' CE2' ' O ' ' A' ' 108' ' ' THR . 99.1 m-85 -120.41 155.9 32.51 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.561 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.8 m -123.57 71.19 47.91 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.972 179.37 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.9 -21.94 60.24 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.568 2.178 . . . . 0.0 112.586 -179.736 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.3 mt -90.68 140.58 29.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.019 0.438 . . . . 10.19 110.423 -179.465 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.17 160.46 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.653 -0.703 . . . . 7.2800000000000002 110.538 -179.68 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.5 147.07 38.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.421 -0.354 . . . . 7.2999999999999998 110.076 -179.978 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 57.2 m -116.65 143.08 46.07 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.133 0.492 . . . . 6.4400000000000004 111.086 -179.051 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.9 t -110.7 148.59 31.97 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.481 -0.781 . . . . 4.4199999999999999 109.893 -179.916 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -53.08 -34.34 56.14 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.806 -0.358 . . . . 3.0499999999999998 110.409 -179.02 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 54.5 p -71.51 160.84 32.0 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.407 -0.59 . . . . 3.4300000000000002 109.407 178.776 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.64 132.52 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.99 0.424 . . . . 2.8799999999999999 111.191 -179.772 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.1 3.42 1.78 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.611 -0.722 . . . . 2.0899999999999999 109.742 179.013 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -110.79 159.24 17.83 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.77 -0.65 . . . . 4.5300000000000002 110.862 -179.45 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 18.3 mm 38.89 58.1 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.966 -0.561 . . . . 1.4399999999999999 110.556 179.796 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 47.0 m -55.28 -38.25 68.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.971 -0.559 . . . . 1.78 110.714 -179.545 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.542 ' O ' ' CB ' ' A' ' 126' ' ' SER . . . -140.97 150.33 42.95 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.542 -0.299 . . . . 0.64000000000000001 110.548 179.677 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.542 ' CB ' ' O ' ' A' ' 125' ' ' ALA . 31.6 p 144.72 -30.94 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.308 -0.86 . . . . 0.66000000000000003 109.0 179.912 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.442 ' O ' ' HD1' ' A' ' 128' ' ' PHE . 0.9 OUTLIER -53.92 167.62 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.025 -0.989 . . . . 0.68999999999999995 110.907 179.873 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.8 m-30 -133.68 145.47 49.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.672 -0.694 . . . . 0.52000000000000002 110.102 -179.894 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.5 t -124.19 101.76 9.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.108 -0.701 . . . . 0.32000000000000001 109.108 177.702 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.3 t -113.04 139.71 36.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.045 -0.525 . . . . 0.28999999999999998 110.966 -178.76 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.0 p -128.64 152.54 48.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.544 -0.753 . . . . 0.25 109.869 179.622 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.588 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.7 p90 -144.88 -165.01 2.05 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.769 -0.372 . . . . 0.31 110.64 -179.788 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.3 t -123.91 127.13 73.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.281 -0.418 . . . . 0.48999999999999999 110.922 -179.839 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.171 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.96 58.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.115 -0.493 . . . . 1.53 110.333 179.921 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.26 24.62 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.949 -0.569 . . . . 0.96999999999999997 111.456 -179.592 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.171 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.14 128.62 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.624 -0.43 . . . . 1.5600000000000001 110.998 179.897 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.39 -9.65 55.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.96 -0.564 . . . . 1.8799999999999999 110.267 179.804 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.7 p -87.11 0.28 55.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 1.04 110.341 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 136' ' ' SER . 2.6 p -65.23 137.19 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.949 -0.569 . . . . 0.23999999999999999 109.981 179.63 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 185' ' ' ILE . 7.8 m -96.29 -15.45 21.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.132 0.492 . . . . 0.28999999999999998 110.006 -179.738 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.62 175.59 45.82 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 109.838 -1.305 . . . . 0.13 109.838 179.61 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -123.45 151.59 42.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.002 0.429 . . . . 0.17000000000000001 110.437 179.775 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.523 ' NH1' ' CG ' ' A' ' 15' ' ' PRO . 23.9 ttp85 -132.33 121.09 22.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.168 -0.469 . . . . 1.29 109.988 179.751 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 167' ' ' VAL . 46.1 t -104.99 136.53 38.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.742 -0.663 . . . . 0.25 110.703 -179.749 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 82.6 tt0 -129.35 129.96 45.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.05 -0.523 . . . . 1.3200000000000001 110.042 -179.932 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.77 135.25 34.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.053 -0.521 . . . . 0.56999999999999995 110.615 -179.67 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.412 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.27 161.35 39.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.809 -0.632 . . . . 1.1599999999999999 109.629 179.847 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.959 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.01 124.82 25.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.994 0.426 . . . . 0.38 110.804 -179.721 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.6 p -71.77 -7.64 49.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.719 -0.673 . . . . 0.40999999999999998 110.891 -179.754 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -109.87 -69.76 0.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.932 0.396 . . . . 1.6599999999999999 111.306 -179.189 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.437 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.1 mt-10 -60.6 -35.4 76.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.06 -0.518 . . . . 1.6599999999999999 111.486 -179.094 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.077 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.2 88.62 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.787 -0.925 . . . . 1.1699999999999999 110.787 -179.811 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.339 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.3 t0 -27.93 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.814 0.34 . . . . 1.8600000000000001 110.218 179.873 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.339 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.2 pm0 -82.24 139.07 45.22 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 1.98 110.214 179.626 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.412 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 47.1 Cg_endo -70.85 145.85 51.91 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.652 2.235 . . . . 0.55000000000000004 112.368 -179.56 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 10.9 mt-30 -115.87 145.7 42.64 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.231 -0.655 . . . . 1.1399999999999999 109.231 179.18 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.692 ' CE1' ' CG ' ' A' ' 16' ' ' ASN . 1.7 p90 -123.21 141.24 52.18 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.401 -0.52 . . . . 0.93000000000000005 111.577 -179.099 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.0 mt -128.05 127.78 43.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.311 -0.858 . . . . 0.34000000000000002 108.945 178.903 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.492 ' HB2' HD21 ' A' ' 16' ' ' ASN . 18.0 t0 -101.67 131.13 48.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.155 0.502 . . . . 1.0900000000000001 111.742 -178.728 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -127.94 157.56 73.41 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.294 -0.866 . . . . 0.19 109.53 179.682 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -69.69 157.94 58.79 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 C-N-CA 122.491 2.127 . . . . 0.17999999999999999 112.252 179.908 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.417 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.4 p -59.22 -12.14 4.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.786 -0.643 . . . . 0.20999999999999999 110.775 -179.91 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.2 p -92.86 -8.74 42.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.28999999999999998 110.704 -179.859 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.27 135.35 34.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.265 -0.425 . . . . 0.5 110.345 179.76 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.2 p -133.15 16.72 4.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.418 -0.355 . . . . 0.29999999999999999 110.515 179.967 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.1 p -167.53 147.06 5.07 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.617 -0.512 . . . . 0.23000000000000001 109.617 179.927 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.22 150.5 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.485 -0.486 . . . . 0.28000000000000003 111.55 -179.707 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.506 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.27 124.95 50.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.525 -0.762 . . . . 1.0700000000000001 109.818 179.49 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.37 104.94 29.92 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.476 -0.329 . . . . 0.28999999999999998 111.092 -179.921 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 84.8 Cg_endo -91.07 -179.47 1.47 Allowed 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 123.19 2.594 . . . . 0.42999999999999999 112.169 179.93 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.62 32.68 18.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.369 -0.832 . . . . 1.26 111.477 179.247 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 172' ' ' LEU . 23.8 mt -86.34 148.39 25.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.432 -0.349 . . . . 0.32000000000000001 110.47 179.6 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.772 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.16 114.78 60.88 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.964 0.411 . . . . 0.57999999999999996 110.734 -179.778 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.92 140.44 95.25 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.925 2.417 . . . . 0.66000000000000003 112.005 179.844 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.16 21.25 73.97 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.005 -0.838 . . . . 0.28999999999999998 111.005 179.832 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.437 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.94 150.21 49.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.879 0.371 . . . . 2.3300000000000001 110.623 179.931 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.491 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.3 tttt -100.23 131.61 46.08 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.013 -0.54 . . . . 0.85999999999999999 109.786 179.365 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.959 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.8 m-85 -120.4 148.32 43.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.076 -0.511 . . . . 0.52000000000000002 111.066 -179.842 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 72.0 mt -105.35 125.29 60.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.228 -1.027 . . . . 0.29999999999999999 108.228 177.796 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.52 132.57 63.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.136 0.493 . . . . 0.23000000000000001 111.204 -178.61 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.52 122.46 20.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.468 -0.787 . . . . 0.35999999999999999 109.636 179.324 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.588 HG11 ' CD2' ' A' ' 132' ' ' TRP . 13.9 t -101.03 125.33 54.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.274 -0.421 . . . . 0.19 110.694 -179.521 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.6 m-85 -117.18 137.89 52.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.97 -0.559 . . . . 0.29999999999999999 109.87 179.562 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.579 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.75 135.05 42.8 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.756 -0.831 . . . . 0.37 108.756 178.863 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.588 ' O ' ' N ' ' A' ' 140' ' ' SER . 76.7 mt -99.04 122.96 51.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.062 0.458 . . . . 0.26000000000000001 110.89 -178.715 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.3 p -83.98 169.7 14.73 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.574 -0.739 . . . . 0.28000000000000003 110.455 -179.7 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 187' ' ' GLU . 51.8 tp10 -59.7 -14.56 14.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.067 -0.515 . . . . 1.6000000000000001 110.967 -179.535 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.574 ' O ' ' HB3' ' A' ' 19' ' ' PRO . 95.9 m-20 -96.06 -4.26 43.29 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.845 -0.342 . . . . 1.1799999999999999 110.792 -179.815 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.473 ' HA2' ' OG1' ' A' ' 59' ' ' THR . . . 87.78 13.89 64.02 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.383 -0.687 . . . . 0.29999999999999999 111.383 179.903 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -84.73 139.15 32.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.644 0.259 . . . . 1.22 110.394 179.766 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.501 HE22 ' NE ' ' A' ' 143' ' ' ARG . 84.3 mt-30 -106.83 141.14 38.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.97999999999999998 110.496 179.781 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.5 m -136.75 127.06 26.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.506 . . . . 0.82999999999999996 110.411 179.903 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.22 117.27 9.82 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.297 -0.41 . . . . 0.26000000000000001 110.499 -179.822 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -108.96 -21.89 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.29999999999999999 110.676 -179.709 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.89 125.68 5.84 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.456 -0.497 . . . . 0.31 111.516 -179.77 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.471 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.68 120.25 21.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.721 -0.672 . . . . 0.28000000000000003 109.516 179.231 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.56 151.73 29.21 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.7 -0.4 . . . . 0.23999999999999999 110.933 -179.321 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.47 158.61 18.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 0.23000000000000001 110.393 179.677 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.06 157.92 43.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.103 -0.499 . . . . 0.67000000000000004 110.702 179.919 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.17 104.39 9.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.82 -0.627 . . . . 0.64000000000000001 110.009 179.524 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 67.5 p . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 117.95 -1.024 . . . . 1.26 110.585 -179.744 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.548 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.9 m . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.223 -0.658 . . . . 3.4399999999999999 109.223 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.45 150.68 18.53 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.023 -0.831 . . . . 1.22 111.023 179.755 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.69 142.34 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.056 0 C-N-CA 124.067 3.178 . . . . 0.75 113.761 -179.199 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.605 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.89 173.47 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.194 -1.366 . . . . 0.79000000000000004 108.893 178.389 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.605 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.61 125.89 51.51 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.406 -0.518 . . . . 1.9399999999999999 111.349 -179.548 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.53 144.07 33.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.636 -0.711 . . . . 0.59999999999999998 110.662 179.75 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.02 168.32 25.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.404 -0.362 . . . . 3.1400000000000001 111.104 -179.649 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.749 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.98 131.08 60.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.925 -0.58 . . . . 3.23 110.06 179.869 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.9 p -141.26 162.26 35.92 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.882 0.372 . . . . 3.6299999999999999 111.209 -179.916 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 34.3 tp10 36.2 31.54 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.648 -0.501 . . . . 6.0800000000000001 109.648 179.85 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.749 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.5 69.57 33.2 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.982 -0.554 . . . . 3.3799999999999999 111.468 -178.644 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.638 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.28 -29.09 72.71 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.432 2.088 . . . . 3.9300000000000002 111.845 179.346 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.638 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.62 125.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 3.3599999999999999 110.472 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.535 ' CB ' ' O ' ' A' ' 17' ' ' SER . 7.7 mp0 -123.93 158.39 60.27 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.311 -0.404 . . . . 3.6099999999999999 110.441 179.99 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HB3' ' CB ' ' A' ' 93' ' ' SER . 98.1 Cg_endo -82.19 -64.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.941 2.427 . . . . 1.51 113.444 -178.991 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.664 ' OD1' ' N ' ' A' ' 63' ' ' LEU . 41.2 t30 -108.48 -19.52 13.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.322 -0.399 . . . . 2.6800000000000002 112.07 -178.513 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.535 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 12.6 t -107.4 152.01 24.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.19 0.519 . . . . 1.21 111.252 -179.339 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.574 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.3 t-80 -155.25 102.92 2.23 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.712 -0.676 . . . . 1.5600000000000001 110.67 179.796 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.584 ' HB3' ' O ' ' A' ' 188' ' ' ASP . 73.4 Cg_endo -82.59 145.65 13.16 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.878 2.385 . . . . 0.81000000000000005 112.666 179.871 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.9 HD11 HD13 ' A' ' 35' ' ' LEU . 6.9 pt -130.88 167.99 24.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.892 -0.594 . . . . 1.52 109.859 179.591 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -149.18 147.91 28.99 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.783 -0.451 . . . . 2.1400000000000001 109.783 178.954 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.579 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.7 p90 -142.29 157.25 45.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.027 0.442 . . . . 0.32000000000000001 111.183 179.976 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.495 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -127.96 155.26 44.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.796 -0.638 . . . . 2.1699999999999999 110.133 178.969 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.833 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.56 173.02 6.37 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 121.074 0.464 . . . . 0.58999999999999997 110.758 -179.223 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.833 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.61 173.95 0.06 OUTLIER 'Trans proline' 0 C--N 1.302 -1.888 0 C-N-CA 122.88 2.387 . . . . 0.90000000000000002 111.517 179.304 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.486 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.08 -51.08 0.69 Allowed Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 120.706 -0.398 . . . . 3.3399999999999999 110.089 179.813 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.64 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.6 Cg_exo -64.86 152.39 82.38 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.7 2.267 . . . . 1.8500000000000001 111.474 179.243 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 p -63.73 42.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.42 0.629 . . . . 2.54 110.576 -179.869 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.824 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.2 t-80 -63.57 -41.67 98.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.941 -1.027 . . . . 2.5299999999999998 110.653 179.689 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.6 mt -109.87 137.77 40.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.771 -0.649 . . . . 1.1699999999999999 111.327 -179.426 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.85 -72.95 0.7 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.106 -0.497 . . . . 1.27 111.925 -179.007 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -88.21 148.43 24.38 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.549 0.574 . . . . 1.1200000000000001 112.549 -179.55 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -121.8 124.85 45.16 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.3 -0.63 . . . . 0.41999999999999998 109.3 177.563 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.3 mt -117.95 134.7 60.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.721 -0.391 . . . . 0.78000000000000003 110.654 179.905 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.9 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -119.99 128.7 53.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.065 0.46 . . . . 0.62 111.269 179.634 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -131.26 138.96 49.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.707 -0.679 . . . . 1.97 110.125 178.966 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.441 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.01 163.11 35.21 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.118 0.485 . . . . 0.34999999999999998 112.146 -178.065 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.493 ' NE ' ' OE2' ' A' ' 70' ' ' GLU . 0.9 OUTLIER -160.46 139.59 7.88 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.515 -0.766 . . . . 1.8 110.504 178.815 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.4 Cg_endo -63.58 115.53 3.1 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.31 2.007 . . . . 0.57999999999999996 111.733 -179.946 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -47.01 81.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.888 -0.412 . . . . 3.04 109.888 -179.926 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.17 -20.63 0.06 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.93 -0.577 . . . . 2.4700000000000002 111.97 -179.558 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.8 p -157.65 157.81 34.29 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.813 0.34 . . . . 2.5099999999999998 110.579 179.745 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.6 m -120.43 27.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 1.8600000000000001 110.233 179.58 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.84 -75.87 1.31 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.126 -0.559 . . . . 1.4399999999999999 111.864 -179.261 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -117.89 152.34 35.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.988 0.423 . . . . 4.6900000000000004 110.953 -179.353 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.672 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.24 -169.17 2.54 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.029 -0.532 . . . . 1.4299999999999999 111.919 179.37 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.441 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.8 mttp -110.1 149.65 29.73 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.395 0.617 . . . . 1.74 112.63 -177.88 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -141.06 156.5 45.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.842 -1.072 . . . . 1.9199999999999999 110.226 178.659 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.22 158.34 41.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.906 -0.588 . . . . 0.34000000000000002 111.785 -179.261 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 m -115.17 135.58 54.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.515 -0.766 . . . . 0.40999999999999998 109.716 179.382 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.579 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.36 121.9 23.8 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.43 -0.35 . . . . 0.55000000000000004 111.574 -179.229 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.597 ' HD2' HD12 ' A' ' 55' ' ' LEU . 73.8 Cg_exo -46.3 151.71 1.62 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.684 2.256 . . . . 0.44 112.046 179.042 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.91 -23.01 63.03 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 116.046 -0.524 . . . . 0.73999999999999999 112.796 -179.233 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.3 p-80 -82.84 -16.81 46.25 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.251 -0.579 . . . . 0.93000000000000005 111.823 -178.329 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.597 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.5 mt -91.67 138.46 31.55 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.684 -0.406 . . . . 0.96999999999999997 110.289 179.37 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -121.58 14.04 10.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.369 -0.378 . . . . 1.3400000000000001 111.588 -179.394 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.48 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.3 p -150.07 143.5 25.16 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.601 -0.44 . . . . 0.39000000000000001 111.003 179.579 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.725 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.8 t80 -114.85 -169.4 1.54 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.188 0.518 . . . . 0.41999999999999998 110.869 -179.405 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.725 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 1.9 m -151.74 125.92 9.27 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.43 -0.805 . . . . 0.39000000000000001 109.807 179.277 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.86 123.28 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 120.369 -0.533 . . . . 0.73999999999999999 111.243 -179.798 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -126.53 163.34 23.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.885 -0.598 . . . . 2.48 110.442 179.76 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.442 ' C ' ' OD1' ' A' ' 16' ' ' ASN . . . 85.08 19.08 59.77 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.733 -0.947 . . . . 0.5 110.733 -179.89 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.664 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 73.7 mt -79.01 157.21 28.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.032 0.444 . . . . 0.57999999999999996 111.36 -179.64 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.841 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.9 mmtt -99.5 133.93 21.54 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.691 -0.686 . . . . 2.79 110.522 179.716 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.581 ' HD3' ' CE1' ' A' ' 157' ' ' TYR . 36.7 Cg_endo -67.86 143.57 61.5 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.491 2.128 . . . . 0.87 112.007 179.854 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.89 25.66 75.3 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.997 -0.841 . . . . 0.64000000000000001 110.997 179.694 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.841 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.22 158.72 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.649 0.262 . . . . 0.82999999999999996 110.398 -179.55 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.8 p -117.11 139.88 42.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.846 0.355 . . . . 0.5 110.644 -179.79 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.642 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.6 m-85 -122.51 136.48 54.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.973 -0.558 . . . . 0.53000000000000003 110.8 -179.883 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.5 pt-20 -98.96 131.06 45.31 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.462 -0.94 . . . . 1.8700000000000001 108.462 177.699 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.492 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.47 153.92 16.64 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.341 -0.933 . . . . 0.28999999999999998 111.944 -178.616 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.98 140.95 46.09 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.706 -0.479 . . . . 1.4299999999999999 109.706 179.559 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD22 ' CB ' ' A' ' 22' ' ' TRP . 40.8 tp -115.85 118.93 34.35 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.427 -0.509 . . . . 0.32000000000000001 110.531 179.616 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.744 HG12 HG23 ' A' ' 84' ' ' VAL . 63.8 mt -112.46 129.08 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.79000000000000004 110.676 -179.942 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.706 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.77 120.8 43.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.215 -0.448 . . . . 1.02 110.732 -179.639 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.857 ' N ' HD12 ' A' ' 76' ' ' ILE . 1.3 mp -103.56 146.43 11.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.163 0.506 . . . . 0.62 111.06 -179.261 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.824 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.2 mt-30 -105.98 153.88 21.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.528 -0.76 . . . . 2.4399999999999999 109.907 179.845 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.16 88.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.899 0.38 . . . . 3.6899999999999999 110.476 -179.814 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.35 32.54 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.834 -0.621 . . . . 6.0800000000000001 110.628 -179.915 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.08 -117.35 3.29 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.471 -0.652 . . . . 1.22 111.471 -179.652 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.46 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.0 m170 -81.38 177.45 8.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.175 0.512 . . . . 2.8799999999999999 111.609 -179.21 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -148.2 149.54 32.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.416 -0.811 . . . . 1.47 110.376 179.149 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.548 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.9 tp10 -139.19 144.67 38.64 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.4 -0.364 . . . . 2.7000000000000002 110.574 179.823 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.744 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.0 135.99 61.42 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 121.037 0.446 . . . . 0.46000000000000002 111.581 -179.79 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.06 141.27 52.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.689 -0.687 . . . . 0.34999999999999998 110.302 179.649 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.453 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.55 138.91 51.6 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.07 0.462 . . . . 3.6699999999999999 111.535 -179.387 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.31 164.23 37.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.579 -0.737 . . . . 0.67000000000000004 109.494 179.349 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 88' ' ' ASP . 47.2 p30 -145.29 151.45 38.36 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.394 -0.523 . . . . 1.47 111.083 -179.952 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.8 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.4 p90 -146.16 172.78 12.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.835 -0.62 . . . . 0.44 111.053 179.84 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.83 160.6 21.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.468 -0.787 . . . . 1.3700000000000001 109.874 179.627 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.33 121.8 22.9 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.685 -0.406 . . . . 1.28 110.745 -179.962 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.7 p -128.68 169.02 14.98 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 115.78 1.77 . . . . 1.97 115.78 179.579 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.52 ' CB ' ' HB3' ' A' ' 15' ' ' PRO . 18.2 t 174.18 -62.29 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 111.87 -2.423 . . . . 3.2799999999999998 108.603 177.507 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.8 t -140.78 165.69 26.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.563 178.896 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.4 m -114.19 145.71 41.33 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.306 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 46.8 p -147.39 122.33 5.19 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.788 -178.906 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.07 142.48 54.14 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.626 1.551 . . . . 0.0 111.522 178.772 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.901 HG13 HG23 ' A' ' 99' ' ' THR . 8.3 p -59.32 -30.5 44.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.435 -179.626 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.901 HG23 HG13 ' A' ' 98' ' ' VAL . 25.4 p -120.18 160.82 22.16 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.164 0.507 . . . . 0.0 110.976 179.704 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 87.0 p -140.35 158.61 43.75 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.863 179.157 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.473 ' H ' HD22 ' A' ' 101' ' ' ASN . 0.1 OUTLIER -142.58 176.44 9.02 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.912 0.387 . . . . 0.0 110.9 179.889 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 103' ' ' VAL . 24.6 p -95.43 162.82 13.5 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.971 179.583 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 102' ' ' THR . 53.8 t 42.8 94.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 120.831 0.348 . . . . 0.0 110.506 -179.677 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 26.4 p -81.25 161.83 23.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.087 0.47 . . . . 0.0 111.183 -179.317 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -146.74 -99.71 0.25 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.966 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -95.14 140.27 30.31 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.413 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.8 p -81.41 159.35 24.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.861 0.362 . . . . 0.0 110.711 -179.378 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 37.3 p -108.9 113.75 59.13 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.519 -179.945 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.61 -19.15 58.83 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.709 1.606 . . . . 0.0 111.588 -179.813 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -108.81 141.94 40.1 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.165 179.955 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.2 t -124.56 80.13 61.42 Favored Pre-proline 0 N--CA 1.465 0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.024 -179.368 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -54.03 147.75 42.06 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 122.436 2.091 . . . . 0.0 111.66 179.691 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.5 mt -90.42 139.89 30.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.895 0.379 . . . . 10.19 110.758 -179.488 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 115' ' ' ALA . 43.1 t -121.24 135.88 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.731 -0.668 . . . . 7.2800000000000002 110.048 179.599 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 114' ' ' VAL . . . -33.0 -83.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.406 -0.361 . . . . 7.2999999999999998 111.301 -179.857 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.2 p -124.17 160.76 27.14 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.291 -0.413 . . . . 6.4400000000000004 110.321 179.516 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.0 t -124.42 142.93 50.92 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.279 -0.419 . . . . 4.4199999999999999 110.755 179.718 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -115.66 153.31 31.55 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.085 -0.507 . . . . 3.0499999999999998 109.99 179.547 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.8 p -122.65 152.69 40.25 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.912 0.387 . . . . 3.4300000000000002 110.665 179.91 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 43.7 t -123.35 136.4 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.801 -0.636 . . . . 2.8799999999999999 110.454 179.713 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.9 p -122.65 158.26 30.41 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.53 -0.304 . . . . 2.0899999999999999 110.333 179.442 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -121.5 151.87 39.79 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.198 -0.456 . . . . 4.5300000000000002 110.612 179.89 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 90.5 mt -58.78 -38.92 75.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.825 -0.435 . . . . 1.4399999999999999 109.825 179.126 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 56.5 m -123.65 139.67 53.76 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.609 -0.723 . . . . 1.78 109.754 179.352 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 127' ' ' SER . . . -178.35 65.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.506 -0.478 . . . . 0.64000000000000001 111.276 179.99 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 172' ' ' LEU . 0.1 OUTLIER 36.76 27.61 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.162 0.982 . . . . 0.66000000000000003 110.832 178.998 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.85 167.65 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.68 -1.146 . . . . 0.68999999999999995 110.937 -179.264 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.7 145.57 50.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.688 -0.687 . . . . 0.52000000000000002 110.166 -179.962 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.23 101.66 9.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.088 -0.708 . . . . 0.32000000000000001 109.088 177.751 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.2 t -113.02 139.65 37.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.99 -0.55 . . . . 0.28999999999999998 111.066 -178.884 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 67.2 p -128.63 152.57 48.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.643 -0.708 . . . . 0.25 109.84 179.644 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.589 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.83 -165.07 2.06 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.687 -0.405 . . . . 0.31 110.642 -179.765 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.739 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -123.81 127.17 73.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.48999999999999999 110.918 -179.905 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.168 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.96 58.35 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.198 -0.455 . . . . 1.53 110.346 179.814 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.739 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.12 24.46 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.902 -0.59 . . . . 0.96999999999999997 111.515 -179.732 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.168 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.6 OUTLIER 179.18 128.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.619 -0.432 . . . . 1.5600000000000001 111.011 179.8 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -86.33 -9.66 55.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.915 -0.584 . . . . 1.8799999999999999 110.353 179.814 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.7 p -87.09 0.3 55.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.095 -0.502 . . . . 1.04 110.337 179.991 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.36 137.24 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.892 -0.594 . . . . 0.23999999999999999 109.936 179.734 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 185' ' ' ILE . 5.4 m -96.26 -15.45 21.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.286 0.565 . . . . 0.28999999999999998 110.12 -179.716 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 178.58 175.55 45.75 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 109.806 -1.318 . . . . 0.13 109.806 179.593 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -123.46 151.63 42.52 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.602 -0.439 . . . . 0.17000000000000001 110.558 179.718 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.812 ' NE ' HE22 ' A' ' 191' ' ' GLN . 41.9 ttp85 -132.32 121.08 22.99 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.178 -0.464 . . . . 1.29 109.957 179.939 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.1 136.55 38.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.716 -0.674 . . . . 0.25 110.629 -179.708 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 82.7 tt0 -129.4 129.9 45.3 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.939 -0.573 . . . . 1.3200000000000001 110.05 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.4 p90 -138.66 135.27 34.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.957 -0.565 . . . . 0.56999999999999995 110.644 -179.693 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.411 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.35 161.37 39.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.809 -0.632 . . . . 1.1599999999999999 109.747 179.729 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.958 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.3 mt -71.02 124.84 25.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.064 0.459 . . . . 0.38 110.716 -179.52 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.3 p -71.65 -7.8 50.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.702 -0.681 . . . . 0.40999999999999998 110.919 -179.818 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -109.86 -69.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 1.6599999999999999 111.431 -179.257 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.444 ' CD ' HH21 ' A' ' 176' ' ' ARG . 54.2 mt-10 -60.66 -35.42 76.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.112 -0.495 . . . . 1.6599999999999999 111.491 -179.147 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.081 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.21 7.22 88.61 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.799 -0.92 . . . . 1.1699999999999999 110.799 -179.817 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.338 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.6 t0 -28.03 -171.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.762 0.315 . . . . 1.8600000000000001 110.319 179.913 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.338 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.24 139.03 45.19 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-O 120.917 0.389 . . . . 1.98 110.213 179.657 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.411 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.7 Cg_endo -70.86 145.83 51.8 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 C-N-CA 122.716 2.277 . . . . 0.55000000000000004 112.394 -179.578 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.0 mt-30 -115.9 145.74 42.64 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.189 -0.671 . . . . 1.1399999999999999 109.189 179.255 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.581 ' CE1' ' HD3' ' A' ' 65' ' ' PRO . 35.3 p90 -123.26 141.39 52.03 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.33 -0.548 . . . . 0.93000000000000005 111.46 -179.062 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.5 mt -128.17 127.68 43.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.271 -0.877 . . . . 0.34000000000000002 108.918 178.919 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.609 ' HB2' ' ND2' ' A' ' 16' ' ' ASN . 38.1 t0 -101.6 131.21 47.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.24 0.543 . . . . 1.0900000000000001 111.702 -178.743 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.0 mt -128.04 157.43 74.0 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.349 -0.841 . . . . 0.19 109.575 179.677 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -69.71 157.89 58.93 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 122.406 2.071 . . . . 0.17999999999999999 112.334 179.902 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.18 -12.22 4.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.813 -0.63 . . . . 0.20999999999999999 110.781 -179.799 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.9 p -92.74 -8.79 42.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.042 -0.526 . . . . 0.28999999999999998 110.764 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.21 135.4 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.355 -0.384 . . . . 0.5 110.436 179.691 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.6 p -133.13 16.69 4.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.328 -0.396 . . . . 0.29999999999999999 110.461 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 36.8 p -167.61 147.12 5.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.697 -0.483 . . . . 0.23000000000000001 109.697 179.838 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 144' ' ' VAL . 6.0 p -152.15 150.42 12.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.501 -0.48 . . . . 0.28000000000000003 111.597 -179.533 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.506 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.38 124.92 50.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.62 -0.718 . . . . 1.0700000000000001 109.858 179.469 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.7 mt -99.35 104.82 29.17 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.333 -0.394 . . . . 0.28999999999999998 111.077 -179.791 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 87.4 Cg_endo -90.87 -179.47 1.53 Allowed 'Trans proline' 0 C--N 1.302 -1.912 0 C-N-CA 123.21 2.607 . . . . 0.42999999999999999 112.25 179.882 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 61.61 32.73 18.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.416 -0.811 . . . . 1.26 111.376 179.224 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.408 ' O ' ' OG ' ' A' ' 126' ' ' SER . 24.2 mt -86.36 148.49 25.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.544 -0.298 . . . . 0.32000000000000001 110.45 179.541 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.767 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.3 mt -88.33 114.89 61.48 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.066 0.46 . . . . 0.57999999999999996 110.656 -179.763 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -59.1 140.64 96.04 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.915 2.41 . . . . 0.66000000000000003 111.982 179.885 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.0 21.28 74.35 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.091 -0.804 . . . . 0.28999999999999998 111.091 179.974 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.444 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.6 mmm-85 -126.99 150.2 49.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.862 0.363 . . . . 2.3300000000000001 110.587 -179.979 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.493 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.11 131.65 45.93 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.999 -0.546 . . . . 0.85999999999999999 109.794 179.37 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.958 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 75.0 m-85 -120.56 148.33 44.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.134 -0.484 . . . . 0.52000000000000002 111.011 -179.874 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.8 mt -105.38 125.31 60.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.198 -1.038 . . . . 0.29999999999999999 108.198 177.796 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.54 132.56 63.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.119 0.485 . . . . 0.23000000000000001 111.318 -178.694 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.9 m-20 -136.47 122.5 20.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.54 -0.755 . . . . 0.35999999999999999 109.719 179.327 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.589 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.0 t -101.02 125.45 54.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.314 -0.403 . . . . 0.19 110.715 -179.527 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.0 m-85 -117.2 137.87 52.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.04 -0.527 . . . . 0.29999999999999999 109.886 179.574 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.579 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.74 135.13 42.66 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.805 -0.813 . . . . 0.37 108.805 178.82 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.588 ' O ' ' N ' ' A' ' 140' ' ' SER . 88.9 mt -99.16 123.02 51.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.178 0.513 . . . . 0.26000000000000001 110.904 -178.713 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 89.2 p -83.95 169.83 14.63 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.497 -0.774 . . . . 0.28000000000000003 110.432 -179.614 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.448 ' O ' ' OG1' ' A' ' 59' ' ' THR . 97.9 mt-10 -59.77 -14.64 15.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.046 -0.524 . . . . 1.6000000000000001 110.946 -179.598 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.605 ' C ' ' OG1' ' A' ' 59' ' ' THR . 96.4 m-20 -96.03 -4.28 43.36 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.778 -0.369 . . . . 1.1799999999999999 110.842 -179.763 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.724 ' N ' ' OG1' ' A' ' 59' ' ' THR . . . 87.8 13.98 63.84 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.376 -0.689 . . . . 0.29999999999999999 111.376 179.875 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -84.69 139.02 32.32 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.781 -0.246 . . . . 1.22 110.386 179.733 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.812 HE22 ' NE ' ' A' ' 143' ' ' ARG . 84.3 mt-30 -106.81 141.05 38.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.929 0.395 . . . . 0.97999999999999998 110.511 179.758 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.8 m -136.65 126.94 26.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.82999999999999996 110.45 179.913 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.406 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.4 tp -68.06 117.28 9.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.335 -0.393 . . . . 0.26000000000000001 110.527 -179.856 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.2 pt -109.03 -21.79 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.29999999999999999 110.752 -179.783 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.85 125.77 5.91 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.519 -0.473 . . . . 0.31 111.488 -179.824 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.47 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.4 t -132.79 120.14 21.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.743 -0.662 . . . . 0.28000000000000003 109.6 179.215 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.5 t -154.58 151.67 29.12 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.715 -0.394 . . . . 0.23999999999999999 111.009 -179.296 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.0 p -110.46 158.61 18.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 0.23000000000000001 110.403 179.704 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -146.02 157.94 43.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.098 -0.501 . . . . 0.67000000000000004 110.669 179.997 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.24 104.29 9.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.743 -0.662 . . . . 0.64000000000000001 110.086 179.482 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.947 -1.025 . . . . 1.26 110.568 -179.687 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.547 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 29.8 m . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.236 -0.653 . . . . 3.4399999999999999 109.236 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.432 ' O ' ' HG2' ' A' ' 83' ' ' GLU . . . -116.43 150.73 18.52 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.007 -0.837 . . . . 1.22 111.007 179.708 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -35.66 142.32 0.1 Allowed 'Trans proline' 0 C--N 1.299 -2.06 0 C-N-CA 124.04 3.16 . . . . 0.75 113.729 -179.205 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 5' ' ' GLU . 16.2 t -79.86 173.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.189 -1.369 . . . . 0.79000000000000004 108.832 178.402 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.615 ' H ' HG12 ' A' ' 4' ' ' VAL . 96.1 mt-10 -105.54 125.8 51.41 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.503 -0.479 . . . . 1.9399999999999999 111.416 -179.569 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.54 144.01 33.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.731 -0.668 . . . . 0.59999999999999998 110.578 179.886 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -152.05 168.25 25.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.864 0.364 . . . . 3.1400000000000001 111.139 -179.695 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.745 HG22 ' OG1' ' A' ' 11' ' ' THR . 66.1 mt -108.87 131.04 60.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.026 -0.533 . . . . 3.23 110.141 179.877 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 11' ' ' THR . 68.5 p -141.16 162.33 35.73 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.84 0.352 . . . . 3.6299999999999999 111.239 -179.932 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 9' ' ' THR . 71.5 tt0 36.05 31.65 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.655 -0.498 . . . . 6.0800000000000001 109.655 179.849 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.745 ' OG1' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -122.53 69.61 33.56 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.918 -0.583 . . . . 3.3799999999999999 111.533 -178.75 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.639 ' O ' ' CB ' ' A' ' 13' ' ' SER . 17.8 Cg_endo -63.27 -29.23 72.9 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.564 2.176 . . . . 3.9300000000000002 111.772 179.389 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.639 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 3.2 m 149.73 125.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 3.3599999999999999 110.453 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 17' ' ' SER . 15.5 mt-30 -123.86 158.38 60.09 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.376 -0.375 . . . . 3.6099999999999999 110.446 179.939 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.777 ' HG2' ' NE ' ' A' ' 143' ' ' ARG . 97.4 Cg_endo -82.08 -64.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.816 2.344 . . . . 1.51 113.528 -179.029 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.906 ' ND2' ' H ' ' A' ' 62' ' ' GLY . 31.6 t30 -108.38 -19.71 13.37 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.041 0.386 . . . . 2.6800000000000002 112.041 -178.498 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 15.1 p -107.28 152.03 24.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.093 0.473 . . . . 1.21 111.347 -179.332 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.581 ' CE1' ' CD2' ' A' ' 89' ' ' PHE . 52.4 t-80 -155.35 102.98 2.22 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.738 -0.664 . . . . 1.5600000000000001 110.558 179.876 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.428 ' HD3' HE22 ' A' ' 14' ' ' GLN . 73.6 Cg_endo -82.68 145.67 13.03 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.8 2.333 . . . . 0.81000000000000005 112.675 179.879 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.917 HD11 HD13 ' A' ' 35' ' ' LEU . 7.0 pt -130.84 167.93 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.893 -0.594 . . . . 1.52 109.822 179.618 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -149.1 147.93 29.08 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.72 -0.474 . . . . 2.1400000000000001 109.72 178.901 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.592 ' HZ2' HG21 ' A' ' 51' ' ' ILE . 42.4 p90 -142.21 157.29 45.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.948 0.404 . . . . 0.32000000000000001 111.263 179.858 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.491 ' O ' HG12 ' A' ' 4' ' ' VAL . 84.9 m-20 -128.02 155.23 44.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.782 -0.645 . . . . 2.1699999999999999 110.105 178.968 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.825 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -132.55 173.08 6.3 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.158 -0.474 . . . . 0.58999999999999997 110.845 -179.294 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.825 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 31.9 Cg_exo -50.71 173.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.88 2.386 . . . . 0.90000000000000002 111.49 179.412 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -83.01 -51.03 0.69 Allowed Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 120.578 -0.449 . . . . 3.3399999999999999 110.143 179.856 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.63 ' O ' ' N ' ' A' ' 29' ' ' HIS . 13.7 Cg_exo -64.84 152.37 82.39 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.696 2.264 . . . . 1.8500000000000001 111.455 179.179 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.7 p -63.67 42.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.372 0.606 . . . . 2.54 110.584 -179.9 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.816 ' CE1' ' NE2' ' A' ' 77' ' ' GLN . 57.3 t-80 -63.49 -41.75 98.56 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.986 -1.006 . . . . 2.5299999999999998 110.715 179.65 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.534 HD13 ' CB ' ' A' ' 75' ' ' SER . 74.2 mt -109.85 137.82 40.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.708 -0.678 . . . . 1.1699999999999999 111.293 -179.445 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.89 -72.87 0.7 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.001 -0.545 . . . . 1.27 111.923 -178.968 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -88.2 148.4 24.39 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.557 0.577 . . . . 1.1200000000000001 112.557 -179.62 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -121.88 124.82 45.02 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.349 -0.611 . . . . 0.41999999999999998 109.349 177.527 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.6 mt -118.0 134.79 60.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.598 -0.441 . . . . 0.78000000000000003 110.638 179.949 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.917 HD13 HD11 ' A' ' 20' ' ' ILE . 8.7 mt -120.03 128.52 53.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.62 111.323 179.721 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.548 ' HB2' ' CZ3' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -130.97 139.01 49.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.78 -0.646 . . . . 1.97 110.097 179.074 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.434 ' NE1' ' HB2' ' A' ' 47' ' ' LYS . 48.2 p90 -145.16 163.08 35.47 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 120.574 -0.45 . . . . 0.34999999999999998 112.072 -178.128 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' CB ' ' HB3' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -160.39 139.52 7.91 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.474 -0.785 . . . . 1.8 110.542 178.848 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 41' ' ' ASN . 17.9 Cg_endo -63.53 115.48 3.07 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.353 2.036 . . . . 0.57999999999999996 111.849 179.954 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.669 ' O ' ' ND2' ' A' ' 41' ' ' ASN . 39.4 tttp -46.97 81.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.904 -0.406 . . . . 3.04 109.904 -179.859 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 39' ' ' PRO . 31.7 m120 -160.22 -20.71 0.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.952 -0.567 . . . . 2.4700000000000002 111.835 -179.501 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.6 p -157.57 157.78 34.38 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.878 -0.329 . . . . 2.5099999999999998 110.615 179.793 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 38' ' ' ARG . 15.7 m -120.38 27.82 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.236 -0.438 . . . . 1.8600000000000001 110.122 179.568 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.7 -75.99 1.32 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.18 -0.533 . . . . 1.4399999999999999 111.814 -179.223 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 45' ' ' ARG . 21.5 mtp180 -117.89 152.32 35.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.932 0.396 . . . . 4.6900000000000004 110.963 -179.306 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 0.0 OUTLIER -159.22 -169.03 2.5 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.983 -0.553 . . . . 1.4299999999999999 111.929 179.337 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' ' NE1' ' A' ' 37' ' ' TRP . 39.7 mttp -110.2 149.66 29.79 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.512 0.672 . . . . 1.74 112.504 -177.829 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -141.07 156.47 45.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.764 -1.107 . . . . 1.9199999999999999 110.247 178.609 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 34' ' ' ILE . . . -153.22 158.35 41.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.933 -0.576 . . . . 0.34000000000000002 111.824 -179.341 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.4 m -115.08 135.61 54.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.496 -0.774 . . . . 0.40999999999999998 109.859 179.267 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.592 HG21 ' HZ2' ' A' ' 22' ' ' TRP . 5.2 mp -126.36 121.92 23.81 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.464 -0.335 . . . . 0.55000000000000004 111.6 -179.204 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD2' HD12 ' A' ' 55' ' ' LEU . 74.4 Cg_exo -46.32 151.74 1.62 Allowed 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.695 2.263 . . . . 0.44 112.057 179.101 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.03 -22.9 63.18 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 116.035 -0.529 . . . . 0.73999999999999999 112.743 -179.205 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.545 ' CE1' ' HB2' ' A' ' 52' ' ' PRO . 42.4 p-80 -82.86 -16.85 46.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.392 0.596 . . . . 0.93000000000000005 111.746 -178.334 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.601 HD12 ' HD2' ' A' ' 52' ' ' PRO . 80.4 mt -91.63 138.4 31.59 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.771 -0.372 . . . . 0.96999999999999997 110.293 179.386 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -121.47 13.86 11.03 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.366 -0.379 . . . . 1.3400000000000001 111.549 -179.363 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.477 ' C ' ' CH2' ' A' ' 22' ' ' TRP . 87.2 p -149.93 143.53 25.31 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.624 -0.43 . . . . 0.39000000000000001 111.008 179.648 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.719 ' CE2' ' O ' ' A' ' 59' ' ' THR . 64.6 t80 -114.84 -169.38 1.54 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.069 -0.514 . . . . 0.41999999999999998 110.875 -179.46 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.719 ' O ' ' CE2' ' A' ' 58' ' ' TYR . 94.7 m -151.8 125.89 9.22 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.357 -0.838 . . . . 0.39000000000000001 109.882 179.208 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG2' HD21 ' A' ' 63' ' ' LEU . 66.5 mt -114.9 123.28 70.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.365 -0.534 . . . . 0.73999999999999999 111.185 -179.711 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.835 ' NZ ' ' N ' ' A' ' 141' ' ' GLY . 82.1 mttt -126.51 163.38 23.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.839 -0.619 . . . . 2.48 110.469 179.733 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.906 ' H ' ' ND2' ' A' ' 16' ' ' ASN . . . 85.17 18.88 60.0 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.723 -0.951 . . . . 0.5 110.723 -179.892 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.514 HD21 ' CG2' ' A' ' 60' ' ' ILE . 73.6 mt -78.91 157.19 28.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 0.57999999999999996 111.379 -179.629 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.859 ' O ' HG12 ' A' ' 67' ' ' VAL . 2.3 mttt -99.5 133.92 21.54 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.637 -0.711 . . . . 2.79 110.438 179.781 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.92 143.62 61.34 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.597 2.198 . . . . 0.87 111.941 179.812 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.82 25.52 75.47 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.063 -0.815 . . . . 0.64000000000000001 111.063 179.795 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.859 HG12 ' O ' ' A' ' 64' ' ' LYS . 1.4 p -128.05 158.86 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.763 0.316 . . . . 0.82999999999999996 110.446 -179.631 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 89' ' ' PHE . 14.9 p -117.23 139.93 42.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.98 0.419 . . . . 0.5 110.534 -179.786 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.665 ' OH ' ' N ' ' A' ' 64' ' ' LYS . 93.6 m-85 -122.61 136.44 54.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.932 -0.576 . . . . 0.53000000000000003 110.797 -179.95 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.489 ' OE2' ' NE ' ' A' ' 38' ' ' ARG . 22.4 pt-20 -98.9 131.04 45.29 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.528 -0.915 . . . . 1.8700000000000001 108.528 177.684 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.488 ' HA3' ' CZ ' ' A' ' 87' ' ' PHE . . . -121.57 153.9 16.67 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.207 -0.997 . . . . 0.28999999999999998 111.923 -178.541 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -135.01 140.84 45.98 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.73 -0.471 . . . . 1.4299999999999999 109.73 179.646 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 22' ' ' TRP . 41.4 tp -115.66 118.89 34.36 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.45 -0.5 . . . . 0.32000000000000001 110.504 179.759 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.736 HG12 HG23 ' A' ' 84' ' ' VAL . 64.0 mt -112.48 129.07 68.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.887 0.375 . . . . 0.79000000000000004 110.646 -179.939 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.709 ' C ' HD12 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -110.75 120.9 43.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.256 -0.429 . . . . 1.02 110.761 -179.726 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.867 HD12 ' N ' ' A' ' 76' ' ' ILE . 1.3 mp -103.64 146.37 11.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.159 0.504 . . . . 0.62 111.079 -179.288 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.816 ' NE2' ' CE1' ' A' ' 29' ' ' HIS . 72.4 mt-30 -105.98 153.85 21.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.559 -0.746 . . . . 2.4399999999999999 109.938 179.884 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 77' ' ' GLN . 26.1 mt-30 -39.24 88.66 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.995 0.426 . . . . 3.6899999999999999 110.412 -179.73 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.618 ' N ' ' O ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER 41.26 32.55 0.21 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.759 -0.655 . . . . 6.0800000000000001 110.682 -179.912 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.01 -117.26 3.29 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.93 -0.652 . . . . 1.22 111.489 -179.731 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.465 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 63.1 m170 -81.54 177.42 8.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.23 0.538 . . . . 2.8799999999999999 111.537 -179.159 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -148.15 149.54 32.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.407 -0.815 . . . . 1.47 110.381 179.179 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.547 ' OE1' ' C ' ' A' ' 1' ' ' SER . 52.8 tp10 -139.19 144.68 38.64 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.462 -0.335 . . . . 2.7000000000000002 110.589 179.829 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.736 HG23 HG12 ' A' ' 74' ' ' ILE . 12.7 p -128.0 136.04 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.078 0.466 . . . . 0.46000000000000002 111.557 -179.775 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.577 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 8.5 m -124.07 141.39 52.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.706 -0.679 . . . . 0.34999999999999998 110.257 179.647 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 86' ' ' ARG . 42.5 ttp180 -117.73 138.88 51.72 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.499 -0.481 . . . . 3.6699999999999999 111.497 -179.32 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 52.7 p90 -152.26 164.2 37.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.574 -0.739 . . . . 0.67000000000000004 109.479 179.473 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.577 ' OD1' ' O ' ' A' ' 88' ' ' ASP . 47.0 p30 -145.36 151.48 38.34 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.443 -0.503 . . . . 1.47 111.032 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.802 ' O ' HG23 ' A' ' 68' ' ' VAL . 39.0 p90 -146.13 172.77 12.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.7 -0.682 . . . . 0.44 111.028 179.878 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.6 t -118.86 160.74 21.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.479 -0.782 . . . . 1.3700000000000001 109.861 179.527 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 14' ' ' GLN . 0.2 OUTLIER -133.33 121.83 22.94 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.61 -0.436 . . . . 1.28 110.798 -179.962 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 14' ' ' GLN . 69.9 p -128.83 154.67 46.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 1.97 111.081 179.652 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.3 t -63.16 -41.21 99.21 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.032 -0.667 . . . . 3.2799999999999998 109.479 177.352 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.5 p -129.73 164.38 24.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.396 179.029 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 54.5 p -69.29 156.96 37.91 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.317 178.959 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.63 158.95 42.41 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.903 -179.423 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.9 155.05 29.4 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.508 2.139 . . . . 0.0 110.885 178.301 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 39.0 t -60.03 134.76 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.151 -179.245 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.2 p -121.64 165.16 16.16 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.839 -179.051 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.2 p -67.15 164.09 18.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.597 -179.89 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -61.37 136.45 58.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.277 -179.362 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 104' ' ' THR . 43.4 m 46.48 91.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.083 -179.947 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 83.0 t -62.96 -37.52 79.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.022 179.91 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 102' ' ' THR . 26.0 p -75.39 165.4 25.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -178.842 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.94 26.71 36.59 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -179.293 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.418 ' H ' ' CD ' ' A' ' 106' ' ' GLU . 58.3 mp0 -56.42 143.97 32.75 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.957 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.4 m -58.95 -39.1 80.63 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.374 -179.62 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.5 m -126.66 78.69 72.58 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.442 -179.138 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -58.8 142.81 99.21 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 121.705 1.603 . . . . 0.0 111.393 -179.992 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -59.65 -38.63 81.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.209 -179.365 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.3 m -127.65 78.74 74.5 Favored Pre-proline 0 N--CA 1.465 0.297 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.977 -179.695 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.733 ' O ' ' O ' ' A' ' 113' ' ' LEU . 31.9 Cg_exo -55.78 142.98 82.6 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.315 2.01 . . . . 0.0 111.882 -179.773 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.733 ' O ' ' O ' ' A' ' 112' ' ' PRO . 49.7 mt 43.28 149.34 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.365 0.602 . . . . 10.19 112.082 179.583 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.412 ' O ' ' O ' ' A' ' 113' ' ' LEU . 44.4 t 42.77 97.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.813 -0.63 . . . . 7.2800000000000002 111.237 179.725 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -173.32 20.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.326 -0.397 . . . . 7.2999999999999998 110.826 179.531 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.3 p -83.69 159.0 21.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.046 0.45 . . . . 6.4400000000000004 110.897 -179.717 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.4 p -83.74 -2.01 55.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.76 -0.654 . . . . 4.4199999999999999 110.817 179.695 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.46 -34.25 73.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.293 -0.412 . . . . 3.0499999999999998 111.43 -178.731 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.0 m -65.79 150.54 48.37 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.495 -0.482 . . . . 3.4300000000000002 110.419 179.928 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.9 t -124.1 133.07 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.408 -0.36 . . . . 2.8799999999999999 110.39 179.246 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.46 ' OG1' ' N ' ' A' ' 122' ' ' GLU . 68.9 p -99.62 -76.07 0.55 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.044 0.45 . . . . 2.0899999999999999 110.51 179.226 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.46 ' N ' ' OG1' ' A' ' 121' ' ' THR . 48.8 tp10 -116.0 145.05 43.29 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.589 -0.732 . . . . 4.5300000000000002 109.967 179.722 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 31.9 pt -118.66 152.39 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.93 0.395 . . . . 1.4399999999999999 110.652 179.647 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.3 p -128.15 166.52 18.33 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.797 -0.638 . . . . 1.78 110.98 -179.512 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.663 ' O ' ' N ' ' A' ' 127' ' ' SER . . . -113.54 -94.61 0.46 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.572 -0.529 . . . . 0.64000000000000001 109.572 179.146 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 125' ' ' ALA . 0.1 OUTLIER 29.94 29.89 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 122.358 1.075 . . . . 0.66000000000000003 111.135 178.806 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.663 ' N ' ' O ' ' A' ' 125' ' ' ALA . 0.9 OUTLIER -53.81 167.6 0.25 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.397 -1.274 . . . . 0.68999999999999995 110.977 -178.83 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 168' ' ' ASN . 7.9 m-30 -133.62 145.51 50.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.691 -0.686 . . . . 0.52000000000000002 110.099 -179.833 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 41.7 t -124.31 101.62 9.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.075 -0.713 . . . . 0.32000000000000001 109.075 177.707 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.8 t -112.9 139.7 36.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.978 -0.556 . . . . 0.28999999999999998 111.143 -178.915 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.1 p -128.71 152.56 48.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.642 -0.708 . . . . 0.25 109.747 179.681 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 182' ' ' VAL . 39.8 p90 -144.74 -164.9 2.02 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.731 -0.387 . . . . 0.31 110.64 -179.839 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.733 ' O ' ' N ' ' A' ' 135' ' ' ALA . 31.7 t -124.02 127.12 73.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.156 -0.474 . . . . 0.48999999999999999 110.833 -179.87 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 1.148 ' O ' ' N ' ' A' ' 136' ' ' SER . 4.0 p -57.87 58.28 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.102 -0.499 . . . . 1.53 110.351 179.825 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.733 ' N ' ' O ' ' A' ' 133' ' ' VAL . . . -38.28 24.69 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.981 -0.554 . . . . 0.96999999999999997 111.535 -179.589 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.148 ' N ' ' O ' ' A' ' 134' ' ' SER . 0.5 OUTLIER 179.14 128.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.597 -0.441 . . . . 1.5600000000000001 110.907 179.818 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -86.39 -9.64 55.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.901 -0.591 . . . . 1.8799999999999999 110.255 179.725 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.7 p -86.98 0.23 55.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 1.04 110.338 179.954 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 136' ' ' SER . 2.5 p -65.3 137.31 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 116.0 -0.545 . . . . 0.23999999999999999 110.016 179.775 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.812 ' C ' ' HZ2' ' A' ' 61' ' ' LYS . 5.7 m -96.31 -15.6 21.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.234 0.54 . . . . 0.28999999999999998 109.99 -179.585 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.835 ' N ' ' NZ ' ' A' ' 61' ' ' LYS . . . 178.63 175.62 45.85 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.821 -1.311 . . . . 0.13 109.821 179.58 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -123.48 151.57 42.61 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.619 -0.432 . . . . 0.17000000000000001 110.465 179.801 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.777 ' NE ' ' HG2' ' A' ' 15' ' ' PRO . 19.7 ttt85 -132.25 121.22 23.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.131 -0.486 . . . . 1.29 109.96 179.759 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.556 HG21 HG11 ' A' ' 167' ' ' VAL . 46.3 t -105.13 136.54 38.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.776 -0.647 . . . . 0.25 110.619 -179.703 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 156' ' ' GLN . 85.2 tt0 -129.36 129.88 45.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.969 -0.56 . . . . 1.3200000000000001 110.001 -179.862 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.619 ' CZ ' ' HB2' ' A' ' 156' ' ' GLN . 35.5 p90 -138.71 135.22 34.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.099 -0.501 . . . . 0.56999999999999995 110.652 -179.673 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.424 ' CD ' ' HB3' ' A' ' 155' ' ' PRO . 0.4 OUTLIER -145.26 161.44 39.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.809 -0.632 . . . . 1.1599999999999999 109.657 179.834 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.963 HD21 ' CZ ' ' A' ' 178' ' ' TYR . 86.2 mt -71.11 124.87 25.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.935 0.397 . . . . 0.38 110.769 -179.616 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 177' ' ' LYS . 19.4 p -71.71 -7.76 50.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.808 -0.633 . . . . 0.40999999999999998 110.837 -179.748 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -109.83 -69.77 0.85 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.356 -0.384 . . . . 1.6599999999999999 111.394 -179.249 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 1.449 ' CD ' HH21 ' A' ' 176' ' ' ARG . 53.9 mt-10 -60.58 -35.36 75.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.083 -0.508 . . . . 1.6599999999999999 111.57 -179.167 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 1.096 ' O ' ' O ' ' A' ' 153' ' ' ASP . . . 79.18 7.24 88.59 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.839 -0.904 . . . . 1.1699999999999999 110.839 -179.843 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 1.313 ' OD1' ' CD ' ' A' ' 154' ' ' GLU . 37.7 t0 -27.95 -171.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.756 0.312 . . . . 1.8600000000000001 110.293 179.849 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.313 ' CD ' ' OD1' ' A' ' 153' ' ' ASP . 3.1 pm0 -82.25 139.06 45.15 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.982 0.42 . . . . 1.98 110.182 179.653 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.424 ' HB3' ' CD ' ' A' ' 147' ' ' GLU . 46.8 Cg_endo -70.87 145.87 51.86 Favored 'Trans proline' 0 C--N 1.302 -1.905 0 C-N-CA 122.694 2.262 . . . . 0.55000000000000004 112.361 -179.553 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.619 ' HB2' ' CZ ' ' A' ' 146' ' ' TYR . 11.1 mt-30 -115.9 145.74 42.64 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.131 -0.692 . . . . 1.1399999999999999 109.131 179.261 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 143' ' ' ARG . 71.7 m-85 -123.27 141.34 52.08 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.344 -0.542 . . . . 0.93000000000000005 111.552 -179.143 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 70.5 mt -128.09 127.61 43.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.291 -0.868 . . . . 0.34000000000000002 108.973 178.995 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.629 ' OD2' ' ND2' ' A' ' 16' ' ' ASN . 34.6 t0 -101.61 131.22 47.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.088 0.471 . . . . 1.0900000000000001 111.733 -178.741 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.604 ' N ' ' OD1' ' A' ' 159' ' ' ASP . 6.0 mt -128.01 157.57 73.49 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.321 -0.854 . . . . 0.19 109.572 179.672 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -69.87 158.04 58.15 Favored 'Trans proline' 0 C--N 1.301 -1.922 0 C-N-CA 122.475 2.117 . . . . 0.17999999999999999 112.153 -179.987 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 139' ' ' VAL . 13.1 p -59.34 -12.13 5.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.687 -0.688 . . . . 0.20999999999999999 110.721 -179.779 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.6 p -92.78 -8.79 42.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.28999999999999998 110.709 -179.917 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -83.22 135.38 34.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.5 110.358 179.743 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 p -133.13 16.61 4.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.373 -0.376 . . . . 0.29999999999999999 110.461 -179.986 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.4 p -167.52 147.12 5.09 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.556 -0.535 . . . . 0.23000000000000001 109.556 179.906 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 144' ' ' VAL . 6.1 p -152.2 150.44 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.452 -0.499 . . . . 0.28000000000000003 111.592 -179.634 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.502 ' O ' ' HD3' ' A' ' 170' ' ' PRO . 3.9 t-20 -106.36 125.03 50.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.695 -0.684 . . . . 1.0700000000000001 109.776 179.504 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.8 mt -99.4 104.91 29.87 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 0.28999999999999998 111.016 -179.826 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 168' ' ' ASN . 86.3 Cg_endo -91.01 -179.52 1.49 Allowed 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 123.189 2.593 . . . . 0.42999999999999999 112.203 179.884 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 61.67 32.6 18.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.409 -0.814 . . . . 1.26 111.497 179.316 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.401 HD12 ' O ' ' A' ' 126' ' ' SER . 24.2 mt -86.37 148.57 25.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.483 -0.326 . . . . 0.32000000000000001 110.485 179.601 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.763 ' HB2' ' OH ' ' A' ' 178' ' ' TYR . 26.1 mt -88.4 114.88 61.5 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.048 0.451 . . . . 0.57999999999999996 110.616 -179.657 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.96 140.62 96.11 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.81 2.34 . . . . 0.66000000000000003 111.993 179.825 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.11 21.15 74.34 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.072 -0.811 . . . . 0.28999999999999998 111.072 179.885 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 1.449 HH21 ' CD ' ' A' ' 151' ' ' GLU . 9.7 mmm-85 -126.91 150.16 49.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.351 . . . . 2.3300000000000001 110.632 -179.925 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.493 ' HB3' ' OG ' ' A' ' 149' ' ' SER . 75.2 tttt -100.17 131.65 45.99 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.044 -0.525 . . . . 0.85999999999999999 109.804 179.351 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.963 ' CZ ' HD21 ' A' ' 148' ' ' LEU . 74.7 m-85 -120.61 148.26 44.13 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.187 -0.46 . . . . 0.52000000000000002 110.989 -179.788 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 71.7 mt -105.22 125.35 60.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.321 -0.992 . . . . 0.29999999999999999 108.321 177.76 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.67 132.57 63.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.218 0.532 . . . . 0.23000000000000001 111.189 -178.581 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 183' ' ' TYR . 2.8 m-20 -136.49 122.62 20.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.49 -0.777 . . . . 0.35999999999999999 109.614 179.319 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 132' ' ' TRP . 14.2 t -101.15 125.42 55.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.195 -0.457 . . . . 0.19 110.648 -179.514 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 183' ' ' TYR . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 181' ' ' ASN . 48.5 m-85 -117.23 137.87 52.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.018 -0.537 . . . . 0.29999999999999999 109.843 179.602 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.578 ' NE2' ' HB2' ' A' ' 136' ' ' SER . 0.5 OUTLIER -100.7 135.04 42.78 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.878 -0.786 . . . . 0.37 108.878 178.817 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.605 HG21 ' HE2' ' A' ' 61' ' ' LYS . 68.1 mt -99.1 122.97 51.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.144 0.497 . . . . 0.26000000000000001 110.953 -178.73 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 88.5 p -83.94 169.68 14.79 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.518 -0.765 . . . . 0.28000000000000003 110.453 -179.636 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.77 -14.46 14.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.094 -0.503 . . . . 1.6000000000000001 110.913 -179.542 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -96.15 -4.33 42.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.773 0.321 . . . . 1.1799999999999999 110.787 -179.796 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 87.9 13.83 63.9 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.254 -0.738 . . . . 0.29999999999999999 111.254 179.76 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -84.68 139.1 32.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.715 0.293 . . . . 1.22 110.431 179.708 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -106.71 141.05 38.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.929 0.395 . . . . 0.97999999999999998 110.643 179.69 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 62.9 m -136.71 127.01 26.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.82999999999999996 110.388 179.927 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' A' ' 196' ' ' SER . 25.1 tp -68.02 117.27 9.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.23 -0.441 . . . . 0.26000000000000001 110.548 -179.928 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 43.9 pt -109.03 -21.88 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.29999999999999999 110.78 -179.753 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 20.3 tp -156.82 125.78 5.93 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.535 -0.466 . . . . 0.31 111.511 -179.846 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.473 ' CB ' ' OD1' ' A' ' 181' ' ' ASN . 28.3 t -132.76 120.16 21.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.801 -0.636 . . . . 0.28000000000000003 109.522 179.218 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 3.6 t -154.58 151.7 29.17 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.624 -0.43 . . . . 0.23999999999999999 110.873 -179.29 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.1 p -110.5 158.6 18.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.015 -0.538 . . . . 0.23000000000000001 110.41 179.686 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.4 ' HB2' ' CE2' ' A' ' 128' ' ' PHE . 21.5 mt-30 -146.09 157.88 43.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.07 -0.513 . . . . 0.67000000000000004 110.677 -179.977 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.23 104.37 9.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.787 -0.642 . . . . 0.64000000000000001 110.011 179.563 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 66.5 p . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.894 -1.051 . . . . 1.26 110.705 -179.725 . . . . . . . . 0 0 . 1 stop_ save_